id|nct_id|result_group_id|ctgov_group_code|title|period|description|count
7515302|NCT04608500|18504848|P2|NOT COMPLETED|Overall Study||18
7515303|NCT04608500|18504849|P1|NOT COMPLETED|Overall Study||35
7515304|NCT04608500|18504848|P2|COMPLETED|Overall Study||239
7515305|NCT04608500|18504849|P1|COMPLETED|Overall Study||479
7515306|NCT04608500|18504848|P2|STARTED|Overall Study||257
7515307|NCT04608500|18504849|P1|STARTED|Overall Study||514
7515308|NCT04578496|18504867|P1|NOT COMPLETED|Overall Study||4
7515309|NCT04578496|18504867|P1|COMPLETED|Overall Study||12
7515310|NCT04578496|18504867|P1|STARTED|Overall Study||16
7515311|NCT04574999|18504874|P2|NOT COMPLETED|Overall Study||5
7515312|NCT04574999|18504875|P1|NOT COMPLETED|Overall Study||9
7515313|NCT04574999|18504874|P2|COMPLETED|Overall Study||48
7515314|NCT04574999|18504875|P1|COMPLETED|Overall Study||105
7515315|NCT04574999|18504874|P2|STARTED|Overall Study||53
7515316|NCT04574999|18504875|P1|STARTED|Overall Study||114
7515317|NCT04555525|18504893|P2|NOT COMPLETED|Overall Study||0
7515318|NCT04555525|18504894|P1|NOT COMPLETED|Overall Study||3
7515319|NCT04555525|18504893|P2|COMPLETED|Overall Study||25
7515320|NCT04555525|18504894|P1|COMPLETED|Overall Study||72
7515321|NCT04555525|18504893|P2|STARTED|Overall Study||25
7515322|NCT04555525|18504894|P1|STARTED|Overall Study||75
7515323|NCT04553497|18504912|P2|NOT COMPLETED|Overall Study||1
7515324|NCT04553497|18504913|P1|NOT COMPLETED|Overall Study||2
7515325|NCT04553497|18504912|P2|COMPLETED|Overall Study||17
7515326|NCT04553497|18504913|P1|COMPLETED|Overall Study||15
7515327|NCT04553497|18504912|P2|STARTED|Overall Study||18
7515328|NCT04553497|18504913|P1|STARTED|Overall Study||17
7515329|NCT04548622|18504923|P1|NOT COMPLETED|Overall Study||0
7515330|NCT04548622|18504923|P1|COMPLETED|Overall Study||15
7515331|NCT04548622|18504923|P1|STARTED|Overall Study||15
7515332|NCT04542694|18504931|P2|NOT COMPLETED|Overall Study||0
7515333|NCT04542694|18504932|P1|NOT COMPLETED|Overall Study||4
7515334|NCT04542694|18504931|P2|COMPLETED|Overall Study||100
7515335|NCT04542694|18504932|P1|COMPLETED|Overall Study||96
7515336|NCT04542694|18504931|P2|STARTED|Overall Study||100
7515337|NCT04542694|18504932|P1|STARTED|Overall Study||100
7515338|NCT04542226|18504960|P1|NOT COMPLETED|Overall Study||0
7515339|NCT04542226|18504960|P1|COMPLETED|Overall Study||81
7515340|NCT04542226|18504960|P1|STARTED|Overall Study||81
7515341|NCT04534491|18504972|P1|NOT COMPLETED|Overall Study||152
7515342|NCT04534491|18504972|P1|COMPLETED|Overall Study||703
7515343|NCT04534491|18504972|P1|Treated|Overall Study||727
7515344|NCT04534491|18504972|P1|STARTED|Overall Study||855
7515345|NCT04534465|18504981|P5|NOT COMPLETED|Overall Study||0
7515346|NCT04534465|18504982|P4|NOT COMPLETED|Overall Study||0
7515347|NCT04534465|18504983|P3|NOT COMPLETED|Overall Study||0
7515348|NCT04534465|18504984|P2|NOT COMPLETED|Overall Study||0
7515349|NCT04534465|18504985|P1|NOT COMPLETED|Overall Study||0
7515350|NCT04534465|18504981|P5|COMPLETED|Overall Study||10
7515351|NCT04534465|18504982|P4|COMPLETED|Overall Study||10
7515352|NCT04534465|18504983|P3|COMPLETED|Overall Study||10
7515353|NCT04534465|18504984|P2|COMPLETED|Overall Study||10
7515354|NCT04534465|18504985|P1|COMPLETED|Overall Study||10
7515355|NCT04534465|18504981|P5|STARTED|Overall Study||10
7515356|NCT04534465|18504982|P4|STARTED|Overall Study||10
7515357|NCT04534465|18504983|P3|STARTED|Overall Study||10
7515358|NCT04534465|18504984|P2|STARTED|Overall Study||10
7515359|NCT04534465|18504985|P1|STARTED|Overall Study||10
7515360|NCT04532164|18505067|P1|NOT COMPLETED|Overall Study||24
7515361|NCT04532164|18505067|P1|COMPLETED|Overall Study||113
7515362|NCT04532164|18505067|P1|Treated|Overall Study||132
7515363|NCT04532164|18505067|P1|STARTED|Overall Study||137
7515364|NCT04531813|18505078|P1|NOT COMPLETED|Overall Study||2
7515365|NCT04531813|18505078|P1|COMPLETED|Overall Study||30
7515366|NCT04531813|18505078|P1|Treated|Overall Study||31
7515367|NCT04531813|18505078|P1|STARTED|Overall Study||32
7515368|NCT04531540|18505082|P1|NOT COMPLETED|Overall Study||9
7515369|NCT04531540|18505082|P1|COMPLETED|Overall Study||216
7515370|NCT04531540|18505082|P1|Treated|Overall Study||222
7515371|NCT04531540|18505082|P1|STARTED|Overall Study||225
7515372|NCT04531527|18505089|P1|NOT COMPLETED|Overall Study||3
7515373|NCT04531527|18505089|P1|COMPLETED|Overall Study||29
7515374|NCT04531527|18505089|P1|Treated|Overall Study||29
7515375|NCT04531527|18505089|P1|STARTED|Overall Study||32
7515376|NCT04523831|18505096|P2|NOT COMPLETED|Overall Study||20
7515377|NCT04523831|18505097|P1|NOT COMPLETED|Overall Study||17
7515378|NCT04523831|18505096|P2|COMPLETED|Overall Study||180
7515379|NCT04523831|18505097|P1|COMPLETED|Overall Study||183
7515380|NCT04523831|18505096|P2|STARTED|Overall Study||200
7515381|NCT04523831|18505097|P1|STARTED|Overall Study||200
7515382|NCT04512482|18505111|P2|NOT COMPLETED|Second Intervention (1 Day)||1
7515383|NCT04512482|18505112|P1|NOT COMPLETED|Second Intervention (1 Day)||2
7515384|NCT04512482|18505111|P2|COMPLETED|Second Intervention (1 Day)||20
7515385|NCT04512482|18505112|P1|COMPLETED|Second Intervention (1 Day)||22
7515386|NCT04512482|18505111|P2|Post-Waterpik Photographs|Second Intervention (1 Day)||20
7515387|NCT04512482|18505112|P1|Post-Waterpik Photographs|Second Intervention (1 Day)||22
7515388|NCT04512482|18505111|P2|Waterpik Utilization|Second Intervention (1 Day)||20
7515389|NCT04512482|18505112|P1|Waterpik Utilization|Second Intervention (1 Day)||22
7515390|NCT04512482|18505111|P2|Post-toothbrush Photographs|Second Intervention (1 Day)||20
7515391|NCT04512482|18505112|P1|Post-toothbrush Photographs|Second Intervention (1 Day)||22
7515392|NCT04512482|18505111|P2|Toothbrush Utilization|Second Intervention (1 Day)||20
7515393|NCT04512482|18505112|P1|Toothbrush Utilization|Second Intervention (1 Day)||22
7515394|NCT04512482|18505111|P2|Post-rinse Photographs|Second Intervention (1 Day)||20
7515395|NCT04512482|18505112|P1|Post-rinse Photographs|Second Intervention (1 Day)||22
7515396|NCT04512482|18505111|P2|Received Intervention|Second Intervention (1 Day)||20
7515397|NCT04512482|18505112|P1|Received Intervention|Second Intervention (1 Day)||22
7515398|NCT04512482|18505111|P2|Baseline Photographs|Second Intervention (1 Day)||20
7515399|NCT04512482|18505112|P1|Baseline Photographs|Second Intervention (1 Day)||22
7515400|NCT04512482|18505111|P2|Baseline Plaque Assessment|Second Intervention (1 Day)||20
7515401|NCT04512482|18505112|P1|Baseline Plaque Assessment|Second Intervention (1 Day)||22
7515402|NCT04512482|18505111|P2|STARTED|Second Intervention (1 Day)||21
7515403|NCT04512482|18505112|P1|STARTED|Second Intervention (1 Day)||24
7515404|NCT04512482|18505111|P2|NOT COMPLETED|Washout (1 Week)||0
7515405|NCT04512482|18505112|P1|NOT COMPLETED|Washout (1 Week)||0
7515406|NCT04512482|18505111|P2|COMPLETED|Washout (1 Week)||21
7515407|NCT04512482|18505112|P1|COMPLETED|Washout (1 Week)||24
7515408|NCT04512482|18505111|P2|STARTED|Washout (1 Week)||21
7515409|NCT04512482|18505112|P1|STARTED|Washout (1 Week)||24
7515410|NCT04512482|18505111|P2|NOT COMPLETED|First Intervention (1 Day)||0
7515411|NCT04512482|18505112|P1|NOT COMPLETED|First Intervention (1 Day)||0
7515412|NCT04512482|18505111|P2|COMPLETED|First Intervention (1 Day)||21
7515413|NCT04512482|18505112|P1|COMPLETED|First Intervention (1 Day)||24
7515414|NCT04512482|18505111|P2|Post-Waterpik Photographs|First Intervention (1 Day)||21
7515415|NCT04512482|18505112|P1|Post-Waterpik Photographs|First Intervention (1 Day)||24
7515416|NCT04512482|18505111|P2|Waterpik Utilization|First Intervention (1 Day)||21
7515417|NCT04512482|18505112|P1|Waterpik Utilization|First Intervention (1 Day)||24
7515418|NCT04512482|18505111|P2|Post-toothbrush Photographs|First Intervention (1 Day)||21
7515419|NCT04512482|18505112|P1|Post-toothbrush Photographs|First Intervention (1 Day)||24
7515420|NCT04512482|18505111|P2|Toothbrush Utilization|First Intervention (1 Day)||21
7515421|NCT04512482|18505112|P1|Toothbrush Utilization|First Intervention (1 Day)||24
7515422|NCT04512482|18505111|P2|Post-rinse Photographs|First Intervention (1 Day)||21
7515423|NCT04512482|18505112|P1|Post-rinse Photographs|First Intervention (1 Day)||24
7515424|NCT04512482|18505111|P2|Received Rinse Intervention|First Intervention (1 Day)||21
7515425|NCT04512482|18505112|P1|Received Rinse Intervention|First Intervention (1 Day)||24
7515426|NCT04512482|18505111|P2|Baseline Photographs|First Intervention (1 Day)||21
7515427|NCT04512482|18505112|P1|Baseline Photographs|First Intervention (1 Day)||24
7515428|NCT04512482|18505111|P2|Baseline Plaque Assessment|First Intervention (1 Day)||21
7515429|NCT04512482|18505112|P1|Baseline Plaque Assessment|First Intervention (1 Day)||24
7515430|NCT04512482|18505111|P2|STARTED|First Intervention (1 Day)||21
7515431|NCT04512482|18505112|P1|STARTED|First Intervention (1 Day)||24
7515432|NCT04502979|18505120|P2|NOT COMPLETED|Overall Study||4
7515433|NCT04502979|18505121|P1|NOT COMPLETED|Overall Study||3
7515434|NCT04502979|18505120|P2|COMPLETED|Overall Study||30
7515435|NCT04502979|18505121|P1|COMPLETED|Overall Study||34
7515436|NCT04502979|18505120|P2|STARTED|Overall Study||34
7515437|NCT04502979|18505121|P1|STARTED|Overall Study||37
7515438|NCT04495712|18505131|P2|NOT COMPLETED|Overall Study||0
7515439|NCT04495712|18505132|P1|NOT COMPLETED|Overall Study||0
7515440|NCT04495712|18505131|P2|COMPLETED|Overall Study||46
7515441|NCT04495712|18505132|P1|COMPLETED|Overall Study||44
7515442|NCT04495712|18505131|P2|STARTED|Overall Study||46
7515443|NCT04495712|18505132|P1|STARTED|Overall Study||44
7515444|NCT04491994|18505150|P2|NOT COMPLETED|Overall Study||11
7515445|NCT04491994|18505151|P1|NOT COMPLETED|Overall Study||29
7515446|NCT04491994|18505150|P2|COMPLETED|Overall Study||349
7515447|NCT04491994|18505151|P1|COMPLETED|Overall Study||151
7515448|NCT04491994|18505150|P2|STARTED|Overall Study||360
7515449|NCT04491994|18505151|P1|STARTED|Overall Study||180
7515450|NCT04491240|18505160|P3|NOT COMPLETED|Overall Study||0
7515451|NCT04491240|18505161|P2|NOT COMPLETED|Overall Study||0
7515452|NCT04491240|18505162|P1|NOT COMPLETED|Overall Study||0
7515453|NCT04491240|18505160|P3|COMPLETED|Overall Study||10
7515454|NCT04491240|18505161|P2|COMPLETED|Overall Study||10
7515455|NCT04491240|18505162|P1|COMPLETED|Overall Study||10
7515456|NCT04491240|18505160|P3|STARTED|Overall Study||10
7515457|NCT04491240|18505161|P2|STARTED|Overall Study||10
7515458|NCT04491240|18505162|P1|STARTED|Overall Study||10
7515459|NCT04483011|18505187|P2|NOT COMPLETED|Intervention Period 2 (8 Days)||0
7515460|NCT04483011|18505188|P1|NOT COMPLETED|Intervention Period 2 (8 Days)||0
7515461|NCT04483011|18505187|P2|COMPLETED|Intervention Period 2 (8 Days)||8
7515462|NCT04483011|18505188|P1|COMPLETED|Intervention Period 2 (8 Days)||9
7515463|NCT04483011|18505187|P2|STARTED|Intervention Period 2 (8 Days)||8
7515464|NCT04483011|18505188|P1|STARTED|Intervention Period 2 (8 Days)||9
7515465|NCT04483011|18505187|P2|NOT COMPLETED|Washout (7 Days)||1
7515466|NCT04483011|18505188|P1|NOT COMPLETED|Washout (7 Days)||0
7515467|NCT04483011|18505187|P2|COMPLETED|Washout (7 Days)||8
7515468|NCT04483011|18505188|P1|COMPLETED|Washout (7 Days)||9
7515469|NCT04483011|18505187|P2|STARTED|Washout (7 Days)||9
7515470|NCT04483011|18505188|P1|STARTED|Washout (7 Days)||9
7515471|NCT04483011|18505187|P2|NOT COMPLETED|Intervention Period 1 (8 Days)||0
7515472|NCT04483011|18505188|P1|NOT COMPLETED|Intervention Period 1 (8 Days)||0
7515473|NCT04483011|18505187|P2|COMPLETED|Intervention Period 1 (8 Days)||9
7515474|NCT04483011|18505188|P1|COMPLETED|Intervention Period 1 (8 Days)||9
7515475|NCT04483011|18505187|P2|STARTED|Intervention Period 1 (8 Days)||9
7515476|NCT04483011|18505188|P1|STARTED|Intervention Period 1 (8 Days)||9
7515477|NCT04474405|18505222|P6|NOT COMPLETED|Overall Study||0
7515478|NCT04474405|18505223|P5|NOT COMPLETED|Overall Study||4
7515479|NCT04474405|18505224|P4|NOT COMPLETED|Overall Study||0
7515480|NCT04474405|18505225|P3|NOT COMPLETED|Overall Study||1
7515481|NCT04474405|18505226|P2|NOT COMPLETED|Overall Study||0
7515482|NCT04474405|18505227|P1|NOT COMPLETED|Overall Study||0
7515483|NCT04474405|18505222|P6|COMPLETED|Overall Study||7
7515484|NCT04474405|18505223|P5|COMPLETED|Overall Study||9
7515485|NCT04474405|18505224|P4|COMPLETED|Overall Study||4
7515486|NCT04474405|18505225|P3|COMPLETED|Overall Study||4
7515487|NCT04474405|18505226|P2|COMPLETED|Overall Study||3
7515488|NCT04474405|18505227|P1|COMPLETED|Overall Study||4
7515489|NCT04474405|18505222|P6|Florbetapir PET Scan|Overall Study||4
7515490|NCT04474405|18505223|P5|Florbetapir PET Scan|Overall Study||0
7515491|NCT04474405|18505224|P4|Florbetapir PET Scan|Overall Study||4
7515492|NCT04474405|18505225|P3|Florbetapir PET Scan|Overall Study||0
7515493|NCT04474405|18505226|P2|Florbetapir PET Scan|Overall Study||3
7515494|NCT04474405|18505227|P1|Florbetapir PET Scan|Overall Study||4
7515495|NCT04474405|18505222|P6|Flortaucipir PET Scan|Overall Study||0
7515496|NCT04474405|18505223|P5|Flortaucipir PET Scan|Overall Study||9
7515497|NCT04474405|18505224|P4|Flortaucipir PET Scan|Overall Study||4
7515498|NCT04474405|18505225|P3|Flortaucipir PET Scan|Overall Study||4
7515499|NCT04474405|18505226|P2|Flortaucipir PET Scan|Overall Study||3
7515500|NCT04474405|18505227|P1|Flortaucipir PET Scan|Overall Study||4
7515501|NCT04474405|18505222|P6|STARTED|Overall Study||7
7515502|NCT04474405|18505223|P5|STARTED|Overall Study||13
7515503|NCT04474405|18505224|P4|STARTED|Overall Study||4
7515504|NCT04474405|18505225|P3|STARTED|Overall Study||5
7515505|NCT04474405|18505226|P2|STARTED|Overall Study||3
7515506|NCT04474405|18505227|P1|STARTED|Overall Study||4
7515507|NCT04470375|18505244|P1|NOT COMPLETED|Overall Study||0
7515508|NCT04470375|18505244|P1|COMPLETED|Overall Study||20
7515509|NCT04470375|18505244|P1|STARTED|Overall Study||20
7515510|NCT04468347|18505254|P4|NOT COMPLETED|Overall Study||4
7515511|NCT04468347|18505255|P3|NOT COMPLETED|Overall Study||6
7515512|NCT04468347|18505256|P2|NOT COMPLETED|Overall Study||1
7515513|NCT04468347|18505257|P1|NOT COMPLETED|Overall Study||2
7515514|NCT04468347|18505254|P4|COMPLETED|Overall Study||21
7515515|NCT04468347|18505255|P3|COMPLETED|Overall Study||41
7515516|NCT04468347|18505256|P2|COMPLETED|Overall Study||10
7515517|NCT04468347|18505257|P1|COMPLETED|Overall Study||4
7515518|NCT04468347|18505254|P4|Baseline Flortacuipir PET Scan|Overall Study||25
7515519|NCT04468347|18505255|P3|Baseline Flortacuipir PET Scan|Overall Study||45
7515520|NCT04468347|18505256|P2|Baseline Flortacuipir PET Scan|Overall Study||11
7515521|NCT04468347|18505257|P1|Baseline Flortacuipir PET Scan|Overall Study||5
7515522|NCT04468347|18505254|P4|STARTED|Overall Study||25
7515523|NCT04468347|18505255|P3|STARTED|Overall Study||47
7515524|NCT04468347|18505256|P2|STARTED|Overall Study||11
7515525|NCT04468347|18505257|P1|STARTED|Overall Study||6
7515526|NCT04462731|18505279|P2|NOT COMPLETED|Overall Study||46
7515527|NCT04462731|18505280|P1|NOT COMPLETED|Overall Study||56
7515528|NCT04462731|18505279|P2|COMPLETED|Overall Study||51
7515529|NCT04462731|18505280|P1|COMPLETED|Overall Study||41
7515530|NCT04462731|18505279|P2|STARTED|Overall Study||97
7515531|NCT04462731|18505280|P1|STARTED|Overall Study||97
7515532|NCT04454138|18505288|P2|NOT COMPLETED|Overall Study||0
7515533|NCT04454138|18505289|P1|NOT COMPLETED|Overall Study||0
7515534|NCT04454138|18505288|P2|COMPLETED|Overall Study||77
7515535|NCT04454138|18505289|P1|COMPLETED|Overall Study||65
7515536|NCT04454138|18505288|P2|STARTED|Overall Study||77
7515537|NCT04454138|18505289|P1|STARTED|Overall Study||65
7515538|NCT04450823|18505309|P1|NOT COMPLETED|Overall Study||3
7515539|NCT04450823|18505309|P1|COMPLETED|Overall Study||58
7515540|NCT04450823|18505309|P1|STARTED|Overall Study||61
7515541|NCT04448210|18505328|P2|NOT COMPLETED|Overall Study||0
7515542|NCT04448210|18505329|P1|NOT COMPLETED|Overall Study||0
7515543|NCT04448210|18505328|P2|COMPLETED|Overall Study||20
7515544|NCT04448210|18505329|P1|COMPLETED|Overall Study||22
7515545|NCT04448210|18505328|P2|STARTED|Overall Study||20
7515546|NCT04448210|18505329|P1|STARTED|Overall Study||22
7515547|NCT04446247|18505351|P1|NOT COMPLETED|Overall Study||0
7515548|NCT04446247|18505351|P1|COMPLETED|Overall Study||14
7515549|NCT04446247|18505351|P1|STARTED|Overall Study||14
7515550|NCT04435808|18505359|P2|NOT COMPLETED|Overall Study||1
7515551|NCT04435808|18505360|P1|NOT COMPLETED|Overall Study||0
7515552|NCT04435808|18505359|P2|COMPLETED|Overall Study|Study stopped prior to any data collection for this lone participant|0
7515553|NCT04435808|18505360|P1|COMPLETED|Overall Study||0
7515554|NCT04435808|18505359|P2|STARTED|Overall Study||1
7515555|NCT04435808|18505360|P1|STARTED|Overall Study||0
7515556|NCT04425863|18505369|P3|NOT COMPLETED|Overall Study||1
7515557|NCT04425863|18505370|P2|NOT COMPLETED|Overall Study||0
7515558|NCT04425863|18505371|P1|NOT COMPLETED|Overall Study||0
7515559|NCT04425863|18505369|P3|COMPLETED|Overall Study||19
7515560|NCT04425863|18505370|P2|COMPLETED|Overall Study||12
7515561|NCT04425863|18505371|P1|COMPLETED|Overall Study||135
7515562|NCT04425863|18505369|P3|STARTED|Overall Study||20
7515563|NCT04425863|18505370|P2|STARTED|Overall Study||12
7515564|NCT04425863|18505371|P1|STARTED|Overall Study||135
7515565|NCT04425850|18505393|P2|NOT COMPLETED|Overall Study||0
7515566|NCT04425850|18505394|P1|NOT COMPLETED|Overall Study||0
7515567|NCT04425850|18505393|P2|COMPLETED|Overall Study||98
7515568|NCT04425850|18505394|P1|COMPLETED|Overall Study||131
7515569|NCT04425850|18505393|P2|STARTED|Overall Study|Standard prophylactic measures and PPE only|98
7515570|NCT04425850|18505394|P1|STARTED|Overall Study|Standard prophylactic measures and PPE + iota carrageenan (nasal and buccal) and ivermectin (buccal)|131
7515571|NCT04422561|18505404|P2|NOT COMPLETED|Overall Study||11
7515572|NCT04422561|18505405|P1|NOT COMPLETED|Overall Study||25
7515573|NCT04422561|18505404|P2|COMPLETED|Overall Study||101
7515574|NCT04422561|18505405|P1|COMPLETED|Overall Study||203
7515575|NCT04422561|18505404|P2|STARTED|Overall Study||112
7515576|NCT04422561|18505405|P1|STARTED|Overall Study||228
7515577|NCT04410159|18505415|P4|NOT COMPLETED|Overall Study||0
7515578|NCT04410159|18505416|P3|NOT COMPLETED|Overall Study||0
7515579|NCT04410159|18505417|P2|NOT COMPLETED|Overall Study||0
7515580|NCT04410159|18505418|P1|NOT COMPLETED|Overall Study||0
7515581|NCT04410159|18505415|P4|COMPLETED|Overall Study||5
7515582|NCT04410159|18505416|P3|COMPLETED|Overall Study||5
7515583|NCT04410159|18505417|P2|COMPLETED|Overall Study||5
7515584|NCT04410159|18505418|P1|COMPLETED|Overall Study||5
7515585|NCT04410159|18505415|P4|STARTED|Overall Study||5
7515586|NCT04410159|18505416|P3|STARTED|Overall Study||5
7515587|NCT04410159|18505417|P2|STARTED|Overall Study||5
7515588|NCT04410159|18505418|P1|STARTED|Overall Study||5
7515589|NCT04406194|18505446|P2|NOT COMPLETED|Period 2||0
7515590|NCT04406194|18505447|P1|NOT COMPLETED|Period 2||0
7515591|NCT04406194|18505446|P2|COMPLETED|Period 2||14
7515592|NCT04406194|18505447|P1|COMPLETED|Period 2||15
7515593|NCT04406194|18505446|P2|STARTED|Period 2||14
7515594|NCT04406194|18505447|P1|STARTED|Period 2||15
7515595|NCT04406194|18505446|P2|NOT COMPLETED|Period 1||1
7515596|NCT04406194|18505447|P1|NOT COMPLETED|Period 1||0
7515597|NCT04406194|18505446|P2|COMPLETED|Period 1||14
7515598|NCT04406194|18505447|P1|COMPLETED|Period 1||15
7515599|NCT04406194|18505446|P2|STARTED|Period 1||15
7515600|NCT04406194|18505447|P1|STARTED|Period 1||15
7515601|NCT04404907|18505461|P2|NOT COMPLETED|Overall Study||0
7515602|NCT04404907|18505462|P1|NOT COMPLETED|Overall Study||0
7515603|NCT04404907|18505461|P2|COMPLETED|Overall Study||95
7515604|NCT04404907|18505462|P1|COMPLETED|Overall Study||442
7515605|NCT04404907|18505461|P2|Frequent Tan|Overall Study||7
7515606|NCT04404907|18505462|P1|Frequent Tan|Overall Study||0
7515607|NCT04404907|18505461|P2|Occasional Tan|Overall Study||88
7515608|NCT04404907|18505462|P1|Occasional Tan|Overall Study||0
7515609|NCT04404907|18505461|P2|STARTED|Overall Study||95
7515610|NCT04404907|18505462|P1|STARTED|Overall Study||442
7515611|NCT04403113|18505470|P2|NOT COMPLETED|Overall Study||0
7515612|NCT04403113|18505471|P1|NOT COMPLETED|Overall Study||0
7515613|NCT04403113|18505470|P2|COMPLETED|Overall Study||20
7515614|NCT04403113|18505471|P1|COMPLETED|Overall Study||20
7515615|NCT04403113|18505470|P2|STARTED|Overall Study||20
7515616|NCT04403113|18505471|P1|STARTED|Overall Study||20
7515617|NCT04400682|18505491|P2|NOT COMPLETED|Period 2||0
7515618|NCT04400682|18505492|P1|NOT COMPLETED|Period 2||0
7515619|NCT04400682|18505491|P2|COMPLETED|Period 2||11
7515620|NCT04400682|18505492|P1|COMPLETED|Period 2||14
7515621|NCT04400682|18505491|P2|STARTED|Period 2||11
7515622|NCT04400682|18505492|P1|STARTED|Period 2||14
7515623|NCT04400682|18505491|P2|NOT COMPLETED|Period 1||4
7515624|NCT04400682|18505492|P1|NOT COMPLETED|Period 1||1
7515625|NCT04400682|18505491|P2|COMPLETED|Period 1||11
7515626|NCT04400682|18505492|P1|COMPLETED|Period 1||14
7515627|NCT04400682|18505491|P2|STARTED|Period 1||15
7515628|NCT04400682|18505492|P1|STARTED|Period 1||15
7515629|NCT04399161|18505507|P3|NOT COMPLETED|Overall Study||2
7515630|NCT04399161|18505508|P2|NOT COMPLETED|Overall Study||2
7515631|NCT04399161|18505509|P1|NOT COMPLETED|Overall Study||2
7515632|NCT04399161|18505507|P3|COMPLETED|Overall Study||18
7515633|NCT04399161|18505508|P2|COMPLETED|Overall Study||18
7515634|NCT04399161|18505509|P1|COMPLETED|Overall Study||18
7515635|NCT04399161|18505507|P3|STARTED|Overall Study||20
7515636|NCT04399161|18505508|P2|STARTED|Overall Study||20
7515637|NCT04399161|18505509|P1|STARTED|Overall Study||20
7515638|NCT04397094|18505519|P2|NOT COMPLETED|Overall Study||0
7515639|NCT04397094|18505520|P1|NOT COMPLETED|Overall Study||0
7515640|NCT04397094|18505519|P2|COMPLETED|Overall Study||30
7515641|NCT04397094|18505520|P1|COMPLETED|Overall Study||30
7515642|NCT04397094|18505519|P2|STARTED|Overall Study||30
7515643|NCT04397094|18505520|P1|STARTED|Overall Study||30
7515644|NCT04393493|18505530|P2|NOT COMPLETED|First 4 Days of Intervention||7
7515645|NCT04393493|18505531|P1|NOT COMPLETED|First 4 Days of Intervention||5
7515646|NCT04393493|18505530|P2|COMPLETED|First 4 Days of Intervention||33
7515647|NCT04393493|18505531|P1|COMPLETED|First 4 Days of Intervention||35
7515648|NCT04393493|18505530|P2|STARTED|First 4 Days of Intervention||40
7515649|NCT04393493|18505531|P1|STARTED|First 4 Days of Intervention||40
7515650|NCT04393493|18505530|P2|NOT COMPLETED|Follow up||0
7515651|NCT04393493|18505531|P1|NOT COMPLETED|Follow up||0
7515652|NCT04393493|18505530|P2|COMPLETED|Follow up||40
7515653|NCT04393493|18505531|P1|COMPLETED|Follow up||40
7515654|NCT04393493|18505530|P2|STARTED|Follow up||40
7515655|NCT04393493|18505531|P1|STARTED|Follow up||40
7515656|NCT04390022|18505585|P2|NOT COMPLETED|Overall Study||0
7515657|NCT04390022|18505586|P1|NOT COMPLETED|Overall Study||0
7515658|NCT04390022|18505585|P2|COMPLETED|Overall Study||12
7515659|NCT04390022|18505586|P1|COMPLETED|Overall Study||12
7515660|NCT04390022|18505585|P2|STARTED|Overall Study||12
7515661|NCT04390022|18505586|P1|STARTED|Overall Study||12
7515662|NCT04383132|18505602|P2|NOT COMPLETED|Overall Study||0
7515663|NCT04383132|18505603|P1|NOT COMPLETED|Overall Study||0
7515664|NCT04383132|18505602|P2|COMPLETED|Overall Study||173
7515665|NCT04383132|18505603|P1|COMPLETED|Overall Study||173
7515666|NCT04383132|18505602|P2|STARTED|Overall Study||173
7515667|NCT04383132|18505603|P1|STARTED|Overall Study||173
7515668|NCT04376060|18505621|P1|NOT COMPLETED|Overall Study||1
7515669|NCT04376060|18505621|P1|COMPLETED|Overall Study||14
7515670|NCT04376060|18505621|P1|STARTED|Overall Study||15
7515671|NCT04374500|18505635|P3|NOT COMPLETED|Overall Study||0
7515672|NCT04374500|18505636|P2|NOT COMPLETED|Overall Study||0
7515673|NCT04374500|18505637|P1|NOT COMPLETED|Overall Study||0
7515674|NCT04374500|18505635|P3|COMPLETED|Overall Study||83
7515675|NCT04374500|18505636|P2|COMPLETED|Overall Study||10
7515676|NCT04374500|18505637|P1|COMPLETED|Overall Study||10
7515677|NCT04374500|18505635|P3|STARTED|Overall Study||83
7515678|NCT04374500|18505636|P2|STARTED|Overall Study||10
7515679|NCT04374500|18505637|P1|STARTED|Overall Study||10
7515680|NCT04366583|18505656|P2|NOT COMPLETED|Overall Study||0
7515681|NCT04366583|18505657|P1|NOT COMPLETED|Overall Study||0
7515682|NCT04366583|18505656|P2|COMPLETED|Overall Study||84
7515683|NCT04366583|18505657|P1|COMPLETED|Overall Study||82
7515684|NCT04366583|18505656|P2|STARTED|Overall Study||84
7515685|NCT04366583|18505657|P1|STARTED|Overall Study||82
7515686|NCT04363879|18505669|P2|NOT COMPLETED|Overall Study||0
7515687|NCT04363879|18505670|P1|NOT COMPLETED|Overall Study||0
7515688|NCT04363879|18505669|P2|COMPLETED|Overall Study||92
7515689|NCT04363879|18505670|P1|COMPLETED|Overall Study||78
7515690|NCT04363879|18505669|P2|STARTED|Overall Study||92
7515691|NCT04363879|18505670|P1|STARTED|Overall Study||78
7515692|NCT04359771|18505684|P2|NOT COMPLETED|Overall Study||2
7515693|NCT04359771|18505685|P1|NOT COMPLETED|Overall Study||2
7515694|NCT04359771|18505684|P2|COMPLETED|Overall Study|The left eye of every participant was assigned to the diode MPL group|13
7515695|NCT04359771|18505685|P1|COMPLETED|Overall Study|The right eye of each participant was assigned to the diode MPL group|13
7515696|NCT04359771|18505684|P2|STARTED|Overall Study|Left eye of every participant was assigned to the diode MPL group|15
7515697|NCT04359771|18505685|P1|STARTED|Overall Study|Right eye of every participant was assigned to the diode MPL group|15
7515698|NCT04358991|18505693|P1|NOT COMPLETED|Overall Study||0
7515699|NCT04358991|18505693|P1|COMPLETED|Overall Study||20
7515700|NCT04358991|18505693|P1|STARTED|Overall Study||20
7515701|NCT04355663|18505700|P3|NOT COMPLETED|Overall Study||4
7515702|NCT04355663|18505701|P2|NOT COMPLETED|Overall Study||15
7515703|NCT04355663|18505702|P1|NOT COMPLETED|Overall Study||2
7515704|NCT04355663|18505700|P3|COMPLETED|Overall Study||17
7515705|NCT04355663|18505701|P2|COMPLETED|Overall Study||14
7515706|NCT04355663|18505702|P1|COMPLETED|Overall Study||40
7515707|NCT04355663|18505700|P3|STARTED|Overall Study||21
7515708|NCT04355663|18505701|P2|STARTED|Overall Study||29
7515709|NCT04355663|18505702|P1|STARTED|Overall Study||42
7515710|NCT04352660|18505724|P2|NOT COMPLETED|Overall Study||10
7515711|NCT04352660|18505725|P1|NOT COMPLETED|Overall Study||14
7515712|NCT04352660|18505724|P2|COMPLETED|Overall Study||40
7515713|NCT04352660|18505725|P1|COMPLETED|Overall Study||36
7515714|NCT04352660|18505724|P2|STARTED|Overall Study||50
7515715|NCT04352660|18505725|P1|STARTED|Overall Study||50
7515716|NCT04350788|18505745|P2|NOT COMPLETED|Overall Study||6
7515717|NCT04350788|18505746|P1|NOT COMPLETED|Overall Study||12
7515718|NCT04350788|18505745|P2|COMPLETED|Overall Study||56
7515719|NCT04350788|18505746|P1|COMPLETED|Overall Study||50
7515720|NCT04350788|18505745|P2|STARTED|Overall Study||62
7515721|NCT04350788|18505746|P1|STARTED|Overall Study||62
7515722|NCT04350307|18505789|P2|NOT COMPLETED|Overall Study||0
7515723|NCT04350307|18505790|P1|NOT COMPLETED|Overall Study||0
7515724|NCT04350307|18505789|P2|COMPLETED|Overall Study||78
7515725|NCT04350307|18505790|P1|COMPLETED|Overall Study||84
7515726|NCT04350307|18505789|P2|STARTED|Overall Study||78
7515727|NCT04350307|18505790|P1|STARTED|Overall Study||84
7515728|NCT04348851|18505802|P4|NOT COMPLETED|Post-Test 2||1
7515729|NCT04348851|18505803|P3|NOT COMPLETED|Post-Test 2||0
7515730|NCT04348851|18505804|P2|NOT COMPLETED|Post-Test 2||1
7515731|NCT04348851|18505805|P1|NOT COMPLETED|Post-Test 2||0
7515732|NCT04348851|18505802|P4|COMPLETED|Post-Test 2||13
7515733|NCT04348851|18505803|P3|COMPLETED|Post-Test 2||13
7515734|NCT04348851|18505804|P2|COMPLETED|Post-Test 2||10
7515735|NCT04348851|18505805|P1|COMPLETED|Post-Test 2||13
7515736|NCT04348851|18505802|P4|STARTED|Post-Test 2||14
7515737|NCT04348851|18505803|P3|STARTED|Post-Test 2||13
7515738|NCT04348851|18505804|P2|STARTED|Post-Test 2||11
7515739|NCT04348851|18505805|P1|STARTED|Post-Test 2||13
7515740|NCT04348851|18505802|P4|NOT COMPLETED|Post-Test 1||0
7515741|NCT04348851|18505803|P3|NOT COMPLETED|Post-Test 1||0
7515742|NCT04348851|18505804|P2|NOT COMPLETED|Post-Test 1||2
7515743|NCT04348851|18505805|P1|NOT COMPLETED|Post-Test 1||0
7515744|NCT04348851|18505802|P4|COMPLETED|Post-Test 1||14
7515745|NCT04348851|18505803|P3|COMPLETED|Post-Test 1||13
7515746|NCT04348851|18505804|P2|COMPLETED|Post-Test 1||11
7515747|NCT04348851|18505805|P1|COMPLETED|Post-Test 1||13
7515748|NCT04348851|18505802|P4|STARTED|Post-Test 1||14
7515749|NCT04348851|18505803|P3|STARTED|Post-Test 1||13
7515750|NCT04348851|18505804|P2|STARTED|Post-Test 1||13
7515751|NCT04348851|18505805|P1|STARTED|Post-Test 1||13
7515752|NCT04348357|18505885|P2|NOT COMPLETED|Overall Study||12
7515753|NCT04348357|18505886|P1|NOT COMPLETED|Overall Study||0
7515754|NCT04348357|18505885|P2|COMPLETED|Overall Study||16
7515755|NCT04348357|18505886|P1|COMPLETED|Overall Study||25
7515756|NCT04348357|18505885|P2|STARTED|Overall Study||28
7515757|NCT04348357|18505886|P1|STARTED|Overall Study||25
7515758|NCT04343261|18505912|P1|NOT COMPLETED|Overall Study||8
7515759|NCT04343261|18505912|P1|COMPLETED|Overall Study||40
7515760|NCT04343261|18505912|P1|STARTED|Overall Study||48
7515761|NCT04343222|18505921|P3|NOT COMPLETED|Overall Study||0
7515762|NCT04343222|18505922|P2|NOT COMPLETED|Overall Study||0
7515763|NCT04343222|18505923|P1|NOT COMPLETED|Overall Study||0
7515764|NCT04343222|18505921|P3|COMPLETED|Overall Study||15
7515765|NCT04343222|18505922|P2|COMPLETED|Overall Study||15
7515766|NCT04343222|18505923|P1|COMPLETED|Overall Study||16
7515767|NCT04343222|18505921|P3|STARTED|Overall Study||15
7515768|NCT04343222|18505922|P2|STARTED|Overall Study||15
7515769|NCT04343222|18505923|P1|STARTED|Overall Study||16
7515770|NCT04343092|18505946|P1|NOT COMPLETED|Overall Study||0
7515771|NCT04343092|18505946|P1|COMPLETED|Overall Study||16
7515772|NCT04343092|18505946|P1|STARTED|Overall Study||16
7515773|NCT04339296|18505953|P2|NOT COMPLETED|Overall Study||9
7515774|NCT04339296|18505954|P1|NOT COMPLETED|Overall Study||8
7515775|NCT04339296|18505953|P2|COMPLETED|Overall Study||17
7515776|NCT04339296|18505954|P1|COMPLETED|Overall Study||16
7515777|NCT04339296|18505953|P2|Received Allocated Intervention|Overall Study||24
7515778|NCT04339296|18505954|P1|Received Allocated Intervention|Overall Study||21
7515779|NCT04339296|18505953|P2|Completed Baseline|Overall Study||25
7515780|NCT04339296|18505954|P1|Completed Baseline|Overall Study||23
7515781|NCT04339296|18505953|P2|STARTED|Overall Study||26
7515782|NCT04339296|18505954|P1|STARTED|Overall Study||24
7515783|NCT04336475|18505964|P2|NOT COMPLETED|Overall Study||2
7515784|NCT04336475|18505965|P1|NOT COMPLETED|Overall Study||2
7515785|NCT04336475|18505964|P2|COMPLETED|Overall Study||28
7515786|NCT04336475|18505965|P1|COMPLETED|Overall Study||28
7515787|NCT04336475|18505964|P2|STARTED|Overall Study||30
7515788|NCT04336475|18505965|P1|STARTED|Overall Study||30
7515789|NCT04329923|18505977|P6|NOT COMPLETED|Overall Study||5
7515790|NCT04329923|18505978|P5|NOT COMPLETED|Overall Study||2
7515791|NCT04329923|18505979|P4|NOT COMPLETED|Overall Study||1
7515792|NCT04329923|18505980|P3|NOT COMPLETED|Overall Study||1
7515793|NCT04329923|18505981|P2|NOT COMPLETED|Overall Study||4
7515794|NCT04329923|18505982|P1|NOT COMPLETED|Overall Study||1
7515795|NCT04329923|18505977|P6|COMPLETED|Overall Study||61
7515796|NCT04329923|18505978|P5|COMPLETED|Overall Study||64
7515797|NCT04329923|18505979|P4|COMPLETED|Overall Study||2
7515798|NCT04329923|18505980|P3|COMPLETED|Overall Study||3
7515799|NCT04329923|18505981|P2|COMPLETED|Overall Study||13
7515800|NCT04329923|18505982|P1|COMPLETED|Overall Study||16
7515801|NCT04329923|18505977|P6|STARTED|Overall Study||66
7515802|NCT04329923|18505978|P5|STARTED|Overall Study||66
7515803|NCT04329923|18505979|P4|STARTED|Overall Study||3
7515804|NCT04329923|18505980|P3|STARTED|Overall Study||4
7515805|NCT04329923|18505981|P2|STARTED|Overall Study||17
7515806|NCT04329923|18505982|P1|STARTED|Overall Study||17
7515807|NCT04326842|18506002|P2|NOT COMPLETED|Overall Study||58
7515808|NCT04326842|18506003|P1|NOT COMPLETED|Overall Study||9
7515809|NCT04326842|18506002|P2|COMPLETED|Overall Study||31
7515810|NCT04326842|18506003|P1|COMPLETED|Overall Study||31
7515811|NCT04326842|18506002|P2|STARTED|Overall Study||89
7515812|NCT04326842|18506003|P1|STARTED|Overall Study||40
7515813|NCT04325542|18506021|P1|NOT COMPLETED|Overall Study||1
7515814|NCT04325542|18506021|P1|COMPLETED|Overall Study||742
7515815|NCT04325542|18506021|P1|STARTED|Overall Study|one participant withdraw consent during the study|743
7515816|NCT04323592|18506027|P2|NOT COMPLETED|Overall Study||0
7515817|NCT04323592|18506028|P1|NOT COMPLETED|Overall Study||0
7515818|NCT04323592|18506027|P2|COMPLETED|Overall Study||90
7515819|NCT04323592|18506028|P1|COMPLETED|Overall Study||83
7515820|NCT04323592|18506027|P2|STARTED|Overall Study||90
7515821|NCT04323592|18506028|P1|STARTED|Overall Study||83
7515822|NCT04322968|18506048|P4|NOT COMPLETED|Overall Study||0
7515823|NCT04322968|18506049|P3|NOT COMPLETED|Overall Study||0
7515824|NCT04322968|18506050|P2|NOT COMPLETED|Overall Study||1
7515825|NCT04322968|18506051|P1|NOT COMPLETED|Overall Study||1
7515826|NCT04322968|18506048|P4|COMPLETED|Overall Study||10
7515827|NCT04322968|18506049|P3|COMPLETED|Overall Study||10
7515828|NCT04322968|18506050|P2|COMPLETED|Overall Study||9
7515829|NCT04322968|18506051|P1|COMPLETED|Overall Study||10
7515830|NCT04322968|18506048|P4|STARTED|Overall Study||10
7515831|NCT04322968|18506049|P3|STARTED|Overall Study||10
7515832|NCT04322968|18506050|P2|STARTED|Overall Study||10
7515833|NCT04322968|18506051|P1|STARTED|Overall Study||11
7515834|NCT04322526|18506079|P2|NOT COMPLETED|Second Intervention (1day)||0
7515835|NCT04322526|18506080|P1|NOT COMPLETED|Second Intervention (1day)||0
7515836|NCT04322526|18506079|P2|COMPLETED|Second Intervention (1day)||9
7515837|NCT04322526|18506080|P1|COMPLETED|Second Intervention (1day)||11
7515838|NCT04322526|18506079|P2|STARTED|Second Intervention (1day)||9
7515839|NCT04322526|18506080|P1|STARTED|Second Intervention (1day)||11
7515840|NCT04322526|18506079|P2|NOT COMPLETED|Washout (1 Week)||2
7515841|NCT04322526|18506080|P1|NOT COMPLETED|Washout (1 Week)||1
7515842|NCT04322526|18506079|P2|COMPLETED|Washout (1 Week)||9
7515843|NCT04322526|18506080|P1|COMPLETED|Washout (1 Week)||11
7515844|NCT04322526|18506079|P2|STARTED|Washout (1 Week)||11
7515845|NCT04322526|18506080|P1|STARTED|Washout (1 Week)||12
7515846|NCT04322526|18506079|P2|NOT COMPLETED|First Intervention (1 Day)||1
7515847|NCT04322526|18506080|P1|NOT COMPLETED|First Intervention (1 Day)||1
7515848|NCT04322526|18506079|P2|COMPLETED|First Intervention (1 Day)||11
7515849|NCT04322526|18506080|P1|COMPLETED|First Intervention (1 Day)||12
7515850|NCT04322526|18506079|P2|STARTED|First Intervention (1 Day)||12
7515851|NCT04322526|18506080|P1|STARTED|First Intervention (1 Day)||13
7515852|NCT04322500|18506088|P2|NOT COMPLETED|Overall Study||0
7515853|NCT04322500|18506089|P1|NOT COMPLETED|Overall Study||0
7515854|NCT04322500|18506088|P2|COMPLETED|Overall Study||13
7515855|NCT04322500|18506089|P1|COMPLETED|Overall Study||13
7515856|NCT04322500|18506088|P2|STARTED|Overall Study||13
7515857|NCT04322500|18506089|P1|STARTED|Overall Study||13
7515858|NCT04318535|18506097|P3|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
7515859|NCT04318535|18506098|P2|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
7515860|NCT04318535|18506099|P1|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
7515861|NCT04318535|18506097|P3|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12
7515862|NCT04318535|18506098|P2|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||11
7515863|NCT04318535|18506099|P1|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12
7515864|NCT04318535|18506097|P3|STARTED|Treatment Period 3 (Day 17 to Day 22)||12
7515865|NCT04318535|18506098|P2|STARTED|Treatment Period 3 (Day 17 to Day 22)||11
7515866|NCT04318535|18506099|P1|STARTED|Treatment Period 3 (Day 17 to Day 22)||12
7515867|NCT04318535|18506097|P3|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0
7515868|NCT04318535|18506098|P2|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||1
7515869|NCT04318535|18506099|P1|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0
7515870|NCT04318535|18506097|P3|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12
7515871|NCT04318535|18506098|P2|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||11
7515872|NCT04318535|18506099|P1|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12
7515873|NCT04318535|18506097|P3|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
7515874|NCT04318535|18506098|P2|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
7515875|NCT04318535|18506099|P1|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
7515876|NCT04318535|18506097|P3|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
7515877|NCT04318535|18506098|P2|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
7515878|NCT04318535|18506099|P1|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
7515879|NCT04318535|18506097|P3|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
7515880|NCT04318535|18506098|P2|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
7515881|NCT04318535|18506099|P1|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
7515882|NCT04318535|18506097|P3|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
7515883|NCT04318535|18506098|P2|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
7515884|NCT04318535|18506099|P1|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
7515885|NCT04318535|18506097|P3|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
7515886|NCT04318535|18506098|P2|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
7515887|NCT04318535|18506099|P1|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
7515888|NCT04318535|18506097|P3|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
7515889|NCT04318535|18506098|P2|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
7515890|NCT04318535|18506099|P1|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
7515891|NCT04318535|18506097|P3|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
7515892|NCT04318535|18506098|P2|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
7515893|NCT04318535|18506099|P1|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
7515894|NCT04318535|18506097|P3|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
7515895|NCT04318535|18506098|P2|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
7515896|NCT04318535|18506099|P1|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
7515897|NCT04318535|18506097|P3|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
7515898|NCT04318535|18506098|P2|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
7515899|NCT04318535|18506099|P1|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
7515900|NCT04318535|18506097|P3|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
7515901|NCT04318535|18506098|P2|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
7515902|NCT04318535|18506099|P1|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
7515903|NCT04316260|18506138|P2|NOT COMPLETED|Overall Study||0
7515904|NCT04316260|18506139|P1|NOT COMPLETED|Overall Study||0
7515905|NCT04316260|18506138|P2|COMPLETED|Overall Study||17
7515906|NCT04316260|18506139|P1|COMPLETED|Overall Study||34
7515907|NCT04316260|18506138|P2|STARTED|Overall Study||17
7515908|NCT04316260|18506139|P1|STARTED|Overall Study||34
7515909|NCT04308239|18506173|P2|NOT COMPLETED|Post-intervention Evaluation (1 Week)||4
7515910|NCT04308239|18506174|P1|NOT COMPLETED|Post-intervention Evaluation (1 Week)||1
7515911|NCT04308239|18506173|P2|COMPLETED|Post-intervention Evaluation (1 Week)||10
7515912|NCT04308239|18506174|P1|COMPLETED|Post-intervention Evaluation (1 Week)||19
7515913|NCT04308239|18506173|P2|STARTED|Post-intervention Evaluation (1 Week)||14
7515914|NCT04308239|18506174|P1|STARTED|Post-intervention Evaluation (1 Week)||20
7515915|NCT04308239|18506173|P2|NOT COMPLETED|Intervention (2 Weeks)||0
7515916|NCT04308239|18506174|P1|NOT COMPLETED|Intervention (2 Weeks)||0
7515917|NCT04308239|18506173|P2|COMPLETED|Intervention (2 Weeks)||14
7515918|NCT04308239|18506174|P1|COMPLETED|Intervention (2 Weeks)||20
7515919|NCT04308239|18506173|P2|STARTED|Intervention (2 Weeks)||14
7515920|NCT04308239|18506174|P1|STARTED|Intervention (2 Weeks)||20
7515921|NCT04308239|18506173|P2|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
7515922|NCT04308239|18506174|P1|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
7515923|NCT04308239|18506173|P2|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|11
7515924|NCT04308239|18506174|P1|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|17
7515925|NCT04308239|18506173|P2|STARTED|Pre-intervention Evaluation (1 Week)||14
7515926|NCT04308239|18506174|P1|STARTED|Pre-intervention Evaluation (1 Week)||20
7515927|NCT04296448|18506198|P2|NOT COMPLETED|Overall Study||0
7515928|NCT04296448|18506199|P1|NOT COMPLETED|Overall Study||0
7515929|NCT04296448|18506198|P2|COMPLETED|Overall Study||99
7515930|NCT04296448|18506199|P1|COMPLETED|Overall Study||98
7515931|NCT04296448|18506198|P2|STARTED|Overall Study||99
7515932|NCT04296448|18506199|P1|STARTED|Overall Study||98
7515933|NCT04296227|18506211|P1|NOT COMPLETED|Overall Study||0
7515934|NCT04296227|18506211|P1|COMPLETED|Overall Study||85
7515935|NCT04296227|18506211|P1|STARTED|Overall Study||85
7515936|NCT04295356|18506217|P2|NOT COMPLETED|Overall Study||4
7515937|NCT04295356|18506218|P1|NOT COMPLETED|Overall Study||1
7515938|NCT04295356|18506217|P2|COMPLETED|Overall Study||83
7515939|NCT04295356|18506218|P1|COMPLETED|Overall Study||92
7515940|NCT04295356|18506217|P2|STARTED|Overall Study||87
7515941|NCT04295356|18506218|P1|STARTED|Overall Study||93
7515942|NCT04292899|18506246|P4|NOT COMPLETED|Overall Study||645
7515943|NCT04292899|18506247|P3|NOT COMPLETED|Overall Study||223
7515944|NCT04292899|18506248|P2|NOT COMPLETED|Overall Study||33
7515945|NCT04292899|18506249|P1|NOT COMPLETED|Overall Study||32
7515946|NCT04292899|18506246|P4|COMPLETED|Overall Study||2952
7515947|NCT04292899|18506247|P3|COMPLETED|Overall Study||621
7515948|NCT04292899|18506248|P2|COMPLETED|Overall Study||164
7515949|NCT04292899|18506249|P1|COMPLETED|Overall Study||168
7515950|NCT04292899|18506246|P4|STARTED|Overall Study||3597
7515951|NCT04292899|18506247|P3|STARTED|Overall Study||844
7515952|NCT04292899|18506248|P2|STARTED|Overall Study||197
7515953|NCT04292899|18506249|P1|STARTED|Overall Study||200
7515954|NCT04292639|18506259|P1|NOT COMPLETED|Overall Study||0
7515955|NCT04292639|18506259|P1|COMPLETED|Overall Study||20
7515956|NCT04292639|18506259|P1|STARTED|Overall Study||20
7515957|NCT04292171|18506265|P2|NOT COMPLETED|Overall Study||1
7515958|NCT04292171|18506266|P1|NOT COMPLETED|Overall Study||2
7515959|NCT04292171|18506265|P2|COMPLETED|Overall Study||109
7515960|NCT04292171|18506266|P1|COMPLETED|Overall Study||107
7515961|NCT04292171|18506265|P2|STARTED|Overall Study||110
7515962|NCT04292171|18506266|P1|STARTED|Overall Study||109
7515963|NCT04289714|18506283|P3|NOT COMPLETED|Overall Study||6
7515964|NCT04289714|18506284|P2|NOT COMPLETED|Overall Study||5
7515965|NCT04289714|18506285|P1|NOT COMPLETED|Overall Study||6
7515966|NCT04289714|18506283|P3|COMPLETED|Overall Study||4
7515967|NCT04289714|18506284|P2|COMPLETED|Overall Study||6
7515968|NCT04289714|18506285|P1|COMPLETED|Overall Study||8
7515969|NCT04289714|18506283|P3|STARTED|Overall Study||10
7515970|NCT04289714|18506284|P2|STARTED|Overall Study||11
7515971|NCT04289714|18506285|P1|STARTED|Overall Study||14
7515972|NCT04287517|18506301|P2|NOT COMPLETED|Overall Study||1
7515973|NCT04287517|18506302|P1|NOT COMPLETED|Overall Study||1
7515974|NCT04287517|18506301|P2|COMPLETED|Overall Study||18
7515975|NCT04287517|18506302|P1|COMPLETED|Overall Study||18
7515976|NCT04287517|18506301|P2|STARTED|Overall Study||19
7515977|NCT04287517|18506302|P1|STARTED|Overall Study||19
7515978|NCT04285411|18506316|P1|NOT COMPLETED|Overall Study||0
7515979|NCT04285411|18506316|P1|COMPLETED|Overall Study||10
7515980|NCT04285411|18506316|P1|STARTED|Overall Study||10
7515981|NCT04281901|18506323|P2|NOT COMPLETED|Overall Study||1
7515982|NCT04281901|18506324|P1|NOT COMPLETED|Overall Study||1
7515983|NCT04281901|18506323|P2|COMPLETED|Overall Study||11
7515984|NCT04281901|18506324|P1|COMPLETED|Overall Study||11
7515985|NCT04281901|18506323|P2|3. Check-up|Overall Study||11
7515986|NCT04281901|18506324|P1|3. Check-up|Overall Study||11
7515987|NCT04281901|18506323|P2|2. Check-up|Overall Study||11
7515988|NCT04281901|18506324|P1|2. Check-up|Overall Study||11
7515989|NCT04281901|18506323|P2|STARTED|Overall Study||12
7515990|NCT04281901|18506324|P1|STARTED|Overall Study||12
7515991|NCT04280705|18506336|P2|NOT COMPLETED|Overall Study||24
7515992|NCT04280705|18506337|P1|NOT COMPLETED|Overall Study||13
7515993|NCT04280705|18506336|P2|COMPLETED|Overall Study||517
7515994|NCT04280705|18506337|P1|COMPLETED|Overall Study||508
7515995|NCT04280705|18506336|P2|Received Treatment|Overall Study||531
7515996|NCT04280705|18506337|P1|Received Treatment|Overall Study||517
7515997|NCT04280705|18506336|P2|STARTED|Overall Study||541
7515998|NCT04280705|18506337|P1|STARTED|Overall Study||521
7515999|NCT04280653|18506421|P1|NOT COMPLETED|Overall Study||0
7516000|NCT04280653|18506421|P1|COMPLETED|Overall Study||15
7516001|NCT04280653|18506421|P1|STARTED|Overall Study||15
7516002|NCT04274556|18506427|P1|NOT COMPLETED|Overall Study||0
7516003|NCT04274556|18506427|P1|COMPLETED|Overall Study||86
7516004|NCT04274556|18506427|P1|STARTED|Overall Study||86
7516005|NCT04272775|18506435|P2|NOT COMPLETED|Overall Study||7
7516006|NCT04272775|18506436|P1|NOT COMPLETED|Overall Study||7
7516007|NCT04272775|18506435|P2|COMPLETED|Overall Study||0
7516008|NCT04272775|18506436|P1|COMPLETED|Overall Study||0
7516009|NCT04272775|18506435|P2|STARTED|Overall Study||7
7516010|NCT04272775|18506436|P1|STARTED|Overall Study||7
7516011|NCT04271020|18506456|P1|NOT COMPLETED|Overall Study||0
7516012|NCT04271020|18506456|P1|COMPLETED|Overall Study||12
7516013|NCT04271020|18506456|P1|STARTED|Overall Study||12
7516014|NCT04270292|18506462|P1|NOT COMPLETED|Overall Study||0
7516015|NCT04270292|18506462|P1|COMPLETED|Overall Study||164
7516016|NCT04270292|18506462|P1|STARTED|Overall Study||164
7516017|NCT04269629|18506469|P1|NOT COMPLETED|Overall Study||239
7516018|NCT04269629|18506469|P1|COMPLETED|Overall Study|Visit 3 was performed with 1186 patients|1186
7516019|NCT04269629|18506469|P1|Number of Patients Who Performed VIT|Overall Study|Visit 2 was performed with 1342 patients|1342
7516020|NCT04269629|18506469|P1|STARTED|Overall Study|1425 patients were included in the study (=Visit 1)|1425
7516021|NCT04267770|18506483|P2|NOT COMPLETED|Overall Study||0
7516022|NCT04267770|18506484|P1|NOT COMPLETED|Overall Study||0
7516023|NCT04267770|18506483|P2|COMPLETED|Overall Study||8
7516024|NCT04267770|18506484|P1|COMPLETED|Overall Study||9
7516025|NCT04267770|18506483|P2|STARTED|Overall Study||8
7516026|NCT04267770|18506484|P1|STARTED|Overall Study||9
7516027|NCT04267380|18506492|P2|NOT COMPLETED|Overall Study||0
7516028|NCT04267380|18506493|P1|NOT COMPLETED|Overall Study||0
7516029|NCT04267380|18506492|P2|COMPLETED|Overall Study||149
7516030|NCT04267380|18506493|P1|COMPLETED|Overall Study||149
7516031|NCT04267380|18506492|P2|STARTED|Overall Study||149
7516032|NCT04267380|18506493|P1|STARTED|Overall Study||149
7516033|NCT04266925|18506539|P2|NOT COMPLETED|3 Referee Game (~1 Hour)||0
7516034|NCT04266925|18506540|P1|NOT COMPLETED|3 Referee Game (~1 Hour)||0
7516035|NCT04266925|18506539|P2|COMPLETED|3 Referee Game (~1 Hour)||26
7516036|NCT04266925|18506540|P1|COMPLETED|3 Referee Game (~1 Hour)||23
7516037|NCT04266925|18506539|P2|STARTED|3 Referee Game (~1 Hour)||26
7516038|NCT04266925|18506540|P1|STARTED|3 Referee Game (~1 Hour)||23
7516039|NCT04266925|18506539|P2|NOT COMPLETED|1 Referee Game (~1 Hour)||0
7516040|NCT04266925|18506540|P1|NOT COMPLETED|1 Referee Game (~1 Hour)||0
7516041|NCT04266925|18506539|P2|COMPLETED|1 Referee Game (~1 Hour)||26
7516042|NCT04266925|18506540|P1|COMPLETED|1 Referee Game (~1 Hour)||23
7516043|NCT04266925|18506539|P2|STARTED|1 Referee Game (~1 Hour)||26
7516044|NCT04266925|18506540|P1|STARTED|1 Referee Game (~1 Hour)||23
7516045|NCT04252092|18506548|P2|NOT COMPLETED|Overall Study||0
7516046|NCT04252092|18506549|P1|NOT COMPLETED|Overall Study||0
7516047|NCT04252092|18506548|P2|COMPLETED|Overall Study||15
7516048|NCT04252092|18506549|P1|COMPLETED|Overall Study||15
7516049|NCT04252092|18506548|P2|STARTED|Overall Study||15
7516050|NCT04252092|18506549|P1|STARTED|Overall Study||15
7516051|NCT04251884|18506573|P2|NOT COMPLETED|Overall Study||0
7516052|NCT04251884|18506574|P1|NOT COMPLETED|Overall Study||0
7516053|NCT04251884|18506573|P2|COMPLETED|Overall Study||26
7516054|NCT04251884|18506574|P1|COMPLETED|Overall Study||23
7516055|NCT04251884|18506573|P2|STARTED|Overall Study||26
7516056|NCT04251884|18506574|P1|STARTED|Overall Study||23
7516057|NCT04250987|18506588|P1|NOT COMPLETED|Overall Study||0
7516058|NCT04250987|18506588|P1|COMPLETED|Overall Study||12
7516059|NCT04250987|18506588|P1|STARTED|Overall Study||12
7516060|NCT04243369|18506592|P1|NOT COMPLETED|Overall Study||0
7516061|NCT04243369|18506592|P1|COMPLETED|Overall Study||30
7516062|NCT04243369|18506592|P1|STARTED|Overall Study||30
7516063|NCT04241146|18506605|P2|NOT COMPLETED|Overall Study||0
7516064|NCT04241146|18506606|P1|NOT COMPLETED|Overall Study||0
7516065|NCT04241146|18506605|P2|COMPLETED|Overall Study||28
7516066|NCT04241146|18506606|P1|COMPLETED|Overall Study||24
7516067|NCT04241146|18506605|P2|STARTED|Overall Study||28
7516068|NCT04241146|18506606|P1|STARTED|Overall Study||24
7516069|NCT04238429|18506616|P2|NOT COMPLETED|Overall Study||2
7516070|NCT04238429|18506617|P1|NOT COMPLETED|Overall Study||3
7516071|NCT04238429|18506616|P2|COMPLETED|Overall Study||41
7516072|NCT04238429|18506617|P1|COMPLETED|Overall Study||40
7516073|NCT04238429|18506616|P2|STARTED|Overall Study||43
7516074|NCT04238429|18506617|P1|STARTED|Overall Study||43
7516075|NCT04232137|18506635|P2|NOT COMPLETED|Overall Study||0
7516076|NCT04232137|18506636|P1|NOT COMPLETED|Overall Study||0
7516077|NCT04232137|18506635|P2|COMPLETED|Overall Study||185
7516078|NCT04232137|18506636|P1|COMPLETED|Overall Study||254
7516079|NCT04232137|18506635|P2|STARTED|Overall Study||185
7516080|NCT04232137|18506636|P1|STARTED|Overall Study||254
7516081|NCT04224753|18506642|P1|NOT COMPLETED|Overall Study||0
7516082|NCT04224753|18506642|P1|COMPLETED|Overall Study||51
7516083|NCT04224753|18506642|P1|STARTED|Overall Study||51
7516084|NCT04223232|18506646|P1|NOT COMPLETED|Overall Study||1
7516085|NCT04223232|18506646|P1|COMPLETED|Overall Study||5
7516086|NCT04223232|18506646|P1|STARTED|Overall Study||6
7516087|NCT04222699|18506675|P1|NOT COMPLETED|Overall Study||2
7516088|NCT04222699|18506675|P1|COMPLETED|Overall Study||26
7516089|NCT04222699|18506675|P1|STARTED|Overall Study||28
7516090|NCT04218799|18506682|P1|NOT COMPLETED|Overall Study||0
7516091|NCT04218799|18506682|P1|COMPLETED|Overall Study||7
7516092|NCT04218799|18506682|P1|STARTED|Overall Study||7
7516093|NCT04214951|18506691|P2|NOT COMPLETED|Overall Study||40
7516094|NCT04214951|18506692|P1|NOT COMPLETED|Overall Study||40
7516095|NCT04214951|18506691|P2|COMPLETED|Overall Study||10
7516096|NCT04214951|18506692|P1|COMPLETED|Overall Study||10
7516097|NCT04214951|18506691|P2|STARTED|Overall Study||50
7516098|NCT04214951|18506692|P1|STARTED|Overall Study||50
7516099|NCT04214600|18506710|P2|NOT COMPLETED|Overall Study||14
7516100|NCT04214600|18506711|P1|NOT COMPLETED|Overall Study||9
7516101|NCT04214600|18506710|P2|COMPLETED|Overall Study||36
7516102|NCT04214600|18506711|P1|COMPLETED|Overall Study||41
7516103|NCT04214600|18506710|P2|STARTED|Overall Study||50
7516104|NCT04214600|18506711|P1|STARTED|Overall Study||50
7516105|NCT04214080|18506721|P2|NOT COMPLETED|Overall Study||0
7516106|NCT04214080|18506722|P1|NOT COMPLETED|Overall Study||0
7516107|NCT04214080|18506721|P2|COMPLETED|Overall Study||20
7516108|NCT04214080|18506722|P1|COMPLETED|Overall Study||20
7516109|NCT04214080|18506721|P2|STARTED|Overall Study||20
7516110|NCT04214080|18506722|P1|STARTED|Overall Study||20
7516111|NCT04209335|18506740|P1|NOT COMPLETED|Overall Study||0
7516112|NCT04209335|18506740|P1|COMPLETED|Overall Study||48
7516113|NCT04209335|18506740|P1|STARTED|Overall Study||48
7516114|NCT04206800|18506749|P2|NOT COMPLETED|Overall Study||0
7516115|NCT04206800|18506750|P1|NOT COMPLETED|Overall Study||0
7516116|NCT04206800|18506749|P2|COMPLETED|Overall Study||1
7516117|NCT04206800|18506750|P1|COMPLETED|Overall Study||4
7516118|NCT04206800|18506749|P2|STARTED|Overall Study||1
7516119|NCT04206800|18506750|P1|STARTED|Overall Study||4
7516120|NCT04205669|18506758|P2|NOT COMPLETED|Overall Study||12
7516121|NCT04205669|18506759|P1|NOT COMPLETED|Overall Study||13
7516122|NCT04205669|18506758|P2|COMPLETED|Overall Study||45
7516123|NCT04205669|18506759|P1|COMPLETED|Overall Study||34
7516124|NCT04205669|18506758|P2|STARTED|Overall Study||57
7516125|NCT04205669|18506759|P1|STARTED|Overall Study||47
7516126|NCT04204200|18506768|P3|NOT COMPLETED|Overall Study||0
7516127|NCT04204200|18506769|P2|NOT COMPLETED|Overall Study||0
7516128|NCT04204200|18506770|P1|NOT COMPLETED|Overall Study||0
7516129|NCT04204200|18506768|P3|COMPLETED|Overall Study||22
7516130|NCT04204200|18506769|P2|COMPLETED|Overall Study||22
7516131|NCT04204200|18506770|P1|COMPLETED|Overall Study||22
7516132|NCT04204200|18506768|P3|STARTED|Overall Study||22
7516133|NCT04204200|18506769|P2|STARTED|Overall Study||22
7516134|NCT04204200|18506770|P1|STARTED|Overall Study||22
7516135|NCT04195893|18506787|P2|NOT COMPLETED|Second Intervention||0
7516136|NCT04195893|18506788|P1|NOT COMPLETED|Second Intervention||1
7516137|NCT04195893|18506787|P2|COMPLETED|Second Intervention||29
7516138|NCT04195893|18506788|P1|COMPLETED|Second Intervention||26
7516139|NCT04195893|18506787|P2|STARTED|Second Intervention||29
7516140|NCT04195893|18506788|P1|STARTED|Second Intervention||27
7516141|NCT04195893|18506787|P2|NOT COMPLETED|First Intervention||0
7516142|NCT04195893|18506788|P1|NOT COMPLETED|First Intervention||0
7516143|NCT04195893|18506787|P2|COMPLETED|First Intervention||29
7516144|NCT04195893|18506788|P1|COMPLETED|First Intervention||27
7516145|NCT04195893|18506787|P2|STARTED|First Intervention||29
7516146|NCT04195893|18506788|P1|STARTED|First Intervention||27
7516147|NCT04195880|18506832|P2|NOT COMPLETED|Overall Study||0
7516148|NCT04195880|18506833|P1|NOT COMPLETED|Overall Study||0
7516149|NCT04195880|18506832|P2|COMPLETED|Overall Study||3338
7516150|NCT04195880|18506833|P1|COMPLETED|Overall Study||3205
7516151|NCT04195880|18506832|P2|STARTED|Overall Study||3338
7516152|NCT04195880|18506833|P1|STARTED|Overall Study||3205
7516153|NCT04194151|18506847|P6|NOT COMPLETED|Overall Study||1
7516154|NCT04194151|18506848|P5|NOT COMPLETED|Overall Study||0
7516155|NCT04194151|18506849|P4|NOT COMPLETED|Overall Study||1
7516156|NCT04194151|18506850|P3|NOT COMPLETED|Overall Study||1
7516157|NCT04194151|18506851|P2|NOT COMPLETED|Overall Study||2
7516158|NCT04194151|18506852|P1|NOT COMPLETED|Overall Study||1
7516159|NCT04194151|18506847|P6|COMPLETED|Overall Study||31
7516160|NCT04194151|18506848|P5|COMPLETED|Overall Study||32
7516161|NCT04194151|18506849|P4|COMPLETED|Overall Study||31
7516162|NCT04194151|18506850|P3|COMPLETED|Overall Study||31
7516163|NCT04194151|18506851|P2|COMPLETED|Overall Study||30
7516164|NCT04194151|18506852|P1|COMPLETED|Overall Study||31
7516165|NCT04194151|18506847|P6|STARTED|Overall Study||32
7516166|NCT04194151|18506848|P5|STARTED|Overall Study||32
7516167|NCT04194151|18506849|P4|STARTED|Overall Study||32
7516168|NCT04194151|18506850|P3|STARTED|Overall Study||32
7516169|NCT04194151|18506851|P2|STARTED|Overall Study||32
7516170|NCT04194151|18506852|P1|STARTED|Overall Study||32
7516171|NCT04186806|18506892|P2|NOT COMPLETED|Period 2: 7 Days||0
7516172|NCT04186806|18506893|P1|NOT COMPLETED|Period 2: 7 Days||0
7516173|NCT04186806|18506892|P2|COMPLETED|Period 2: 7 Days||20
7516174|NCT04186806|18506893|P1|COMPLETED|Period 2: 7 Days||19
7516175|NCT04186806|18506892|P2|STARTED|Period 2: 7 Days||20
7516176|NCT04186806|18506893|P1|STARTED|Period 2: 7 Days||19
7516177|NCT04186806|18506892|P2|NOT COMPLETED|Washout Period: at Least 2 Days||0
7516178|NCT04186806|18506893|P1|NOT COMPLETED|Washout Period: at Least 2 Days||0
7516179|NCT04186806|18506892|P2|COMPLETED|Washout Period: at Least 2 Days||20
7516180|NCT04186806|18506893|P1|COMPLETED|Washout Period: at Least 2 Days||19
7516181|NCT04186806|18506892|P2|STARTED|Washout Period: at Least 2 Days||20
7516182|NCT04186806|18506893|P1|STARTED|Washout Period: at Least 2 Days||19
7516183|NCT04186806|18506892|P2|NOT COMPLETED|Period 1: 7 Days||0
7516184|NCT04186806|18506893|P1|NOT COMPLETED|Period 1: 7 Days||1
7516185|NCT04186806|18506892|P2|COMPLETED|Period 1: 7 Days||20
7516186|NCT04186806|18506893|P1|COMPLETED|Period 1: 7 Days||19
7516187|NCT04186806|18506892|P2|STARTED|Period 1: 7 Days||20
7516188|NCT04186806|18506893|P1|STARTED|Period 1: 7 Days||20
7516189|NCT04186780|18506983|P2|NOT COMPLETED|Overall Study||7
7516190|NCT04186780|18506984|P1|NOT COMPLETED|Overall Study||14
7516191|NCT04186780|18506983|P2|COMPLETED|Overall Study||25
7516192|NCT04186780|18506984|P1|COMPLETED|Overall Study||22
7516193|NCT04186780|18506983|P2|STARTED|Overall Study||32
7516194|NCT04186780|18506984|P1|STARTED|Overall Study||36
7516195|NCT04184297|18507000|P2|NOT COMPLETED|Overall Study||0
7516196|NCT04184297|18507001|P1|NOT COMPLETED|Overall Study||0
7516197|NCT04184297|18507000|P2|COMPLETED|Overall Study||24326
7516198|NCT04184297|18507001|P1|COMPLETED|Overall Study||2864
7516199|NCT04184297|18507000|P2|STARTED|Overall Study||24326
7516200|NCT04184297|18507001|P1|STARTED|Overall Study||2864
7516201|NCT04184271|18507011|P1|NOT COMPLETED|Overall Study||0
7516202|NCT04184271|18507011|P1|COMPLETED|Overall Study||16
7516203|NCT04184271|18507011|P1|STARTED|Overall Study||16
7516204|NCT04183231|18507020|P1|NOT COMPLETED|Overall Study||0
7516205|NCT04183231|18507020|P1|COMPLETED|Overall Study||16
7516206|NCT04183231|18507020|P1|STARTED|Overall Study||16
7516207|NCT04182217|18507036|P1|NOT COMPLETED|Overall Study||0
7516208|NCT04182217|18507036|P1|COMPLETED|Overall Study||91
7516209|NCT04182217|18507036|P1|STARTED|Overall Study||91
7516210|NCT04179838|18507049|P2|NOT COMPLETED|Second Intervention (1 Day)||1
7516211|NCT04179838|18507050|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7516212|NCT04179838|18507049|P2|COMPLETED|Second Intervention (1 Day)||12
7516213|NCT04179838|18507050|P1|COMPLETED|Second Intervention (1 Day)||13
7516214|NCT04179838|18507049|P2|STARTED|Second Intervention (1 Day)||13
7516215|NCT04179838|18507050|P1|STARTED|Second Intervention (1 Day)||13
7516216|NCT04179838|18507049|P2|NOT COMPLETED|Washout (4 Weeks)||0
7516217|NCT04179838|18507050|P1|NOT COMPLETED|Washout (4 Weeks)||0
7516218|NCT04179838|18507049|P2|COMPLETED|Washout (4 Weeks)||13
7516219|NCT04179838|18507050|P1|COMPLETED|Washout (4 Weeks)||13
7516220|NCT04179838|18507049|P2|STARTED|Washout (4 Weeks)||13
7516221|NCT04179838|18507050|P1|STARTED|Washout (4 Weeks)||13
7516222|NCT04179838|18507049|P2|NOT COMPLETED|First Intervention (1 Day)||3
7516223|NCT04179838|18507050|P1|NOT COMPLETED|First Intervention (1 Day)||0
7516224|NCT04179838|18507049|P2|COMPLETED|First Intervention (1 Day)||13
7516225|NCT04179838|18507050|P1|COMPLETED|First Intervention (1 Day)||13
7516226|NCT04179838|18507049|P2|STARTED|First Intervention (1 Day)||16
7516227|NCT04179838|18507050|P1|STARTED|First Intervention (1 Day)||13
7516228|NCT04178590|18507068|P1|NOT COMPLETED|Overall Study||2
7516229|NCT04178590|18507068|P1|COMPLETED|Overall Study||30
7516230|NCT04178590|18507068|P1|STARTED|Overall Study||32
7516231|NCT04173741|18507178|P2|NOT COMPLETED|Overall Study||1
7516232|NCT04173741|18507179|P1|NOT COMPLETED|Overall Study||1
7516233|NCT04173741|18507178|P2|COMPLETED|Overall Study||22
7516234|NCT04173741|18507179|P1|COMPLETED|Overall Study||22
7516235|NCT04173741|18507178|P2|STARTED|Overall Study||23
7516236|NCT04173741|18507179|P1|STARTED|Overall Study||23
7516237|NCT04171102|18507188|P3|NOT COMPLETED|Overall Study||0
7516238|NCT04171102|18507189|P2|NOT COMPLETED|Overall Study||0
7516239|NCT04171102|18507190|P1|NOT COMPLETED|Overall Study||0
7516240|NCT04171102|18507188|P3|COMPLETED|Overall Study||6
7516241|NCT04171102|18507189|P2|COMPLETED|Overall Study||5
7516242|NCT04171102|18507190|P1|COMPLETED|Overall Study||4
7516243|NCT04171102|18507188|P3|STARTED|Overall Study||6
7516244|NCT04171102|18507189|P2|STARTED|Overall Study||5
7516245|NCT04171102|18507190|P1|STARTED|Overall Study||4
7516246|NCT04170686|18507200|P2|NOT COMPLETED|Randomization and Treatment||15
7516247|NCT04170686|18507201|P1|NOT COMPLETED|Randomization and Treatment||26
7516248|NCT04170686|18507200|P2|COMPLETED|Randomization and Treatment||44
7516249|NCT04170686|18507201|P1|COMPLETED|Randomization and Treatment||36
7516250|NCT04170686|18507200|P2|STARTED|Randomization and Treatment||59
7516251|NCT04170686|18507201|P1|STARTED|Randomization and Treatment||62
7516252|NCT04170686|18507200|P2|NOT COMPLETED|Screening||13
7516253|NCT04170686|18507201|P1|NOT COMPLETED|Screening||12
7516254|NCT04170686|18507200|P2|COMPLETED|Screening||59
7516255|NCT04170686|18507201|P1|COMPLETED|Screening||62
7516256|NCT04170686|18507200|P2|STARTED|Screening||72
7516257|NCT04170686|18507201|P1|STARTED|Screening||74
7516258|NCT04169113|18507225|P2|NOT COMPLETED|Overall Study||6
7516259|NCT04169113|18507226|P1|NOT COMPLETED|Overall Study||5
7516260|NCT04169113|18507225|P2|COMPLETED|Overall Study||53
7516261|NCT04169113|18507226|P1|COMPLETED|Overall Study||47
7516262|NCT04169113|18507225|P2|STARTED|Overall Study||59
7516263|NCT04169113|18507226|P1|STARTED|Overall Study||52
7516264|NCT04161079|18507268|P1|NOT COMPLETED|2010-040FU5 >5 Years Follow-up||0
7516265|NCT04161079|18507268|P1|COMPLETED|2010-040FU5 >5 Years Follow-up|Timepoint distribution for individual patients ranged approximately 6-8 yrs after MAR implantation.|7
7516266|NCT04161079|18507268|P1|STARTED|2010-040FU5 >5 Years Follow-up|Of 11 subjects 3 refused to participate and 1 died.|7
7516267|NCT04161079|18507268|P1|NOT COMPLETED|Clinical Investigation 2010-040||1
7516268|NCT04161079|18507268|P1|COMPLETED|Clinical Investigation 2010-040||11
7516269|NCT04161079|18507268|P1|STARTED|Clinical Investigation 2010-040||12
7516270|NCT04158466|18507290|P2|NOT COMPLETED|Overall Study||1
7516271|NCT04158466|18507291|P1|NOT COMPLETED|Overall Study||3
7516272|NCT04158466|18507290|P2|COMPLETED|Overall Study||126
7516273|NCT04158466|18507291|P1|COMPLETED|Overall Study||121
7516274|NCT04158466|18507290|P2|STARTED|Overall Study||127
7516275|NCT04158466|18507291|P1|STARTED|Overall Study||124
7516276|NCT04150861|18507302|P3|NOT COMPLETED|Overall Study||0
7516277|NCT04150861|18507303|P2|NOT COMPLETED|Overall Study||0
7516278|NCT04150861|18507304|P1|NOT COMPLETED|Overall Study||0
7516279|NCT04150861|18507302|P3|COMPLETED|Overall Study||8
7516280|NCT04150861|18507303|P2|COMPLETED|Overall Study||8
7516281|NCT04150861|18507304|P1|COMPLETED|Overall Study||8
7516282|NCT04150861|18507302|P3|STARTED|Overall Study||8
7516283|NCT04150861|18507303|P2|STARTED|Overall Study||8
7516284|NCT04150861|18507304|P1|STARTED|Overall Study||8
7516285|NCT04150224|18507354|P6|NOT COMPLETED|Overall Study||0
7516286|NCT04150224|18507355|P5|NOT COMPLETED|Overall Study||0
7516287|NCT04150224|18507356|P4|NOT COMPLETED|Overall Study||0
7516288|NCT04150224|18507357|P3|NOT COMPLETED|Overall Study||0
7516289|NCT04150224|18507358|P2|NOT COMPLETED|Overall Study||0
7516290|NCT04150224|18507359|P1|NOT COMPLETED|Overall Study||0
7516291|NCT04150224|18507354|P6|COMPLETED|Overall Study|Period 2: Multple Dosing|10
7516292|NCT04150224|18507355|P5|COMPLETED|Overall Study||10
7516293|NCT04150224|18507356|P4|COMPLETED|Overall Study||10
7516294|NCT04150224|18507357|P3|COMPLETED|Overall Study||10
7516295|NCT04150224|18507358|P2|COMPLETED|Overall Study||10
7516296|NCT04150224|18507359|P1|COMPLETED|Overall Study||10
7516297|NCT04150224|18507354|P6|STARTED|Overall Study|Period 2: Multple Dosing|10
7516298|NCT04150224|18507355|P5|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
7516299|NCT04150224|18507356|P4|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
7516300|NCT04150224|18507357|P3|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
7516301|NCT04150224|18507358|P2|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
7516302|NCT04150224|18507359|P1|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
7516303|NCT04149925|18507460|P2|NOT COMPLETED|Overall Study||0
7516304|NCT04149925|18507461|P1|NOT COMPLETED|Overall Study||0
7516305|NCT04149925|18507460|P2|COMPLETED|Overall Study||30
7516306|NCT04149925|18507461|P1|COMPLETED|Overall Study||30
7516307|NCT04149925|18507460|P2|STARTED|Overall Study||30
7516308|NCT04149925|18507461|P1|STARTED|Overall Study||30
7516309|NCT04149405|18507481|P4|NOT COMPLETED|Overall Study||0
7516310|NCT04149405|18507482|P3|NOT COMPLETED|Overall Study||0
7516311|NCT04149405|18507483|P2|NOT COMPLETED|Overall Study||0
7516312|NCT04149405|18507484|P1|NOT COMPLETED|Overall Study||0
7516313|NCT04149405|18507481|P4|COMPLETED|Overall Study||10
7516314|NCT04149405|18507482|P3|COMPLETED|Overall Study||11
7516315|NCT04149405|18507483|P2|COMPLETED|Overall Study||10
7516316|NCT04149405|18507484|P1|COMPLETED|Overall Study||12
7516317|NCT04149405|18507481|P4|STARTED|Overall Study||10
7516318|NCT04149405|18507482|P3|STARTED|Overall Study||11
7516319|NCT04149405|18507483|P2|STARTED|Overall Study||10
7516320|NCT04149405|18507484|P1|STARTED|Overall Study||12
7516321|NCT04149353|18507506|P1|NOT COMPLETED|Overall Study||1
7516322|NCT04149353|18507506|P1|COMPLETED|Overall Study||0
7516323|NCT04149353|18507506|P1|STARTED|Overall Study|The study was terminated for low recruitment before this subject's second imaging scan was due.|1
7516324|NCT04144088|18507514|P3|NOT COMPLETED|Overall Study||7
7516325|NCT04144088|18507515|P2|NOT COMPLETED|Overall Study||5
7516326|NCT04144088|18507516|P1|NOT COMPLETED|Overall Study||6
7516327|NCT04144088|18507514|P3|COMPLETED|Overall Study||13
7516328|NCT04144088|18507515|P2|COMPLETED|Overall Study||15
7516329|NCT04144088|18507516|P1|COMPLETED|Overall Study||14
7516330|NCT04144088|18507514|P3|STARTED|Overall Study||20
7516331|NCT04144088|18507515|P2|STARTED|Overall Study||20
7516332|NCT04144088|18507516|P1|STARTED|Overall Study||20
7516333|NCT04143373|18507524|P2|NOT COMPLETED|Overall Study||0
7516334|NCT04143373|18507525|P1|NOT COMPLETED|Overall Study||0
7516335|NCT04143373|18507524|P2|COMPLETED|Overall Study||20
7516336|NCT04143373|18507525|P1|COMPLETED|Overall Study||20
7516337|NCT04143373|18507524|P2|STARTED|Overall Study||20
7516338|NCT04143373|18507525|P1|STARTED|Overall Study||20
7516339|NCT04142216|18507534|P2|NOT COMPLETED|Overall Study||6
7516340|NCT04142216|18507535|P1|NOT COMPLETED|Overall Study||6
7516341|NCT04142216|18507534|P2|COMPLETED|Overall Study||22
7516342|NCT04142216|18507535|P1|COMPLETED|Overall Study||22
7516343|NCT04142216|18507534|P2|STARTED|Overall Study||28
7516344|NCT04142216|18507535|P1|STARTED|Overall Study||28
7516345|NCT04140890|18507557|P2|NOT COMPLETED|Overall Study||1
7516346|NCT04140890|18507558|P1|NOT COMPLETED|Overall Study||0
7516347|NCT04140890|18507557|P2|COMPLETED|Overall Study||11
7516348|NCT04140890|18507558|P1|COMPLETED|Overall Study||9
7516349|NCT04140890|18507557|P2|STARTED|Overall Study||12
7516350|NCT04140890|18507558|P1|STARTED|Overall Study||9
7516351|NCT04138810|18507586|P2|NOT COMPLETED|Overall Study||1
7516352|NCT04138810|18507587|P1|NOT COMPLETED|Overall Study||1
7516353|NCT04138810|18507586|P2|COMPLETED|Overall Study||26
7516354|NCT04138810|18507587|P1|COMPLETED|Overall Study||26
7516355|NCT04138810|18507586|P2|STARTED|Overall Study||27
7516356|NCT04138810|18507587|P1|STARTED|Overall Study||27
7516357|NCT04138758|18507595|P2|NOT COMPLETED|Overall Study||0
7516358|NCT04138758|18507596|P1|NOT COMPLETED|Overall Study||0
7516359|NCT04138758|18507595|P2|COMPLETED|Overall Study||40353
7516360|NCT04138758|18507596|P1|COMPLETED|Overall Study||2600
7516361|NCT04138758|18507595|P2|STARTED|Overall Study||40353
7516362|NCT04138758|18507596|P1|STARTED|Overall Study||2600
7516363|NCT04137627|18507614|P2|NOT COMPLETED|Overall Study||13
7516364|NCT04137627|18507615|P1|NOT COMPLETED|Overall Study||12
7516365|NCT04137627|18507614|P2|COMPLETED|Overall Study||12
7516366|NCT04137627|18507615|P1|COMPLETED|Overall Study||13
7516367|NCT04137627|18507614|P2|STARTED|Overall Study||25
7516368|NCT04137627|18507615|P1|STARTED|Overall Study||25
7516369|NCT04136145|18507631|P2|NOT COMPLETED|Overall Study||0
7516370|NCT04136145|18507632|P1|NOT COMPLETED|Overall Study||0
7516371|NCT04136145|18507631|P2|COMPLETED|Overall Study||24
7516372|NCT04136145|18507632|P1|COMPLETED|Overall Study||12
7516373|NCT04136145|18507631|P2|STARTED|Overall Study||24
7516374|NCT04136145|18507632|P1|STARTED|Overall Study||12
7516375|NCT04130425|18507652|P1|NOT COMPLETED|Overall Study||0
7516376|NCT04130425|18507652|P1|COMPLETED|Overall Study||30
7516377|NCT04130425|18507652|P1|STARTED|Overall Study||30
7516378|NCT04128293|18507667|P4|NOT COMPLETED|Treatment Period 4 (1 Day)||0
7516379|NCT04128293|18507668|P3|NOT COMPLETED|Treatment Period 4 (1 Day)||0
7516380|NCT04128293|18507669|P2|NOT COMPLETED|Treatment Period 4 (1 Day)||0
7516381|NCT04128293|18507670|P1|NOT COMPLETED|Treatment Period 4 (1 Day)||0
7516382|NCT04128293|18507667|P4|COMPLETED|Treatment Period 4 (1 Day)||0
7516383|NCT04128293|18507668|P3|COMPLETED|Treatment Period 4 (1 Day)||0
7516384|NCT04128293|18507669|P2|COMPLETED|Treatment Period 4 (1 Day)||0
7516385|NCT04128293|18507670|P1|COMPLETED|Treatment Period 4 (1 Day)||0
7516386|NCT04128293|18507667|P4|STARTED|Treatment Period 4 (1 Day)||0
7516387|NCT04128293|18507668|P3|STARTED|Treatment Period 4 (1 Day)||0
7516388|NCT04128293|18507669|P2|STARTED|Treatment Period 4 (1 Day)||0
7516389|NCT04128293|18507670|P1|STARTED|Treatment Period 4 (1 Day)||0
7516390|NCT04128293|18507667|P4|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
7516391|NCT04128293|18507668|P3|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
7516392|NCT04128293|18507669|P2|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
7516393|NCT04128293|18507670|P1|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
7516394|NCT04128293|18507667|P4|COMPLETED|Washout Period 3 (Up to 7 Days)||0
7516395|NCT04128293|18507668|P3|COMPLETED|Washout Period 3 (Up to 7 Days)||0
7516396|NCT04128293|18507669|P2|COMPLETED|Washout Period 3 (Up to 7 Days)||0
7516397|NCT04128293|18507670|P1|COMPLETED|Washout Period 3 (Up to 7 Days)||0
7516398|NCT04128293|18507667|P4|STARTED|Washout Period 3 (Up to 7 Days)||0
7516399|NCT04128293|18507668|P3|STARTED|Washout Period 3 (Up to 7 Days)||0
7516400|NCT04128293|18507669|P2|STARTED|Washout Period 3 (Up to 7 Days)||0
7516401|NCT04128293|18507670|P1|STARTED|Washout Period 3 (Up to 7 Days)||0
7516402|NCT04128293|18507667|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7516403|NCT04128293|18507668|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7516404|NCT04128293|18507669|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7516405|NCT04128293|18507670|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7516406|NCT04128293|18507667|P4|COMPLETED|Treatment Period 3 (1 Day)||0
7516407|NCT04128293|18507668|P3|COMPLETED|Treatment Period 3 (1 Day)||0
7516408|NCT04128293|18507669|P2|COMPLETED|Treatment Period 3 (1 Day)||0
7516409|NCT04128293|18507670|P1|COMPLETED|Treatment Period 3 (1 Day)||0
7516410|NCT04128293|18507667|P4|STARTED|Treatment Period 3 (1 Day)||0
7516411|NCT04128293|18507668|P3|STARTED|Treatment Period 3 (1 Day)||0
7516412|NCT04128293|18507669|P2|STARTED|Treatment Period 3 (1 Day)||0
7516413|NCT04128293|18507670|P1|STARTED|Treatment Period 3 (1 Day)||0
7516414|NCT04128293|18507667|P4|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
7516415|NCT04128293|18507668|P3|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
7516416|NCT04128293|18507669|P2|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
7516417|NCT04128293|18507670|P1|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
7516418|NCT04128293|18507667|P4|COMPLETED|Washout Period 2 (Up to 7 Days)||0
7516419|NCT04128293|18507668|P3|COMPLETED|Washout Period 2 (Up to 7 Days)||0
7516420|NCT04128293|18507669|P2|COMPLETED|Washout Period 2 (Up to 7 Days)||0
7516421|NCT04128293|18507670|P1|COMPLETED|Washout Period 2 (Up to 7 Days)||0
7516422|NCT04128293|18507667|P4|STARTED|Washout Period 2 (Up to 7 Days)||4
7516423|NCT04128293|18507668|P3|STARTED|Washout Period 2 (Up to 7 Days)||4
7516424|NCT04128293|18507669|P2|STARTED|Washout Period 2 (Up to 7 Days)||4
7516425|NCT04128293|18507670|P1|STARTED|Washout Period 2 (Up to 7 Days)||4
7516426|NCT04128293|18507667|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7516427|NCT04128293|18507668|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7516428|NCT04128293|18507669|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7516429|NCT04128293|18507670|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7516430|NCT04128293|18507667|P4|COMPLETED|Treatment Period 2 (1 Day)||4
7516431|NCT04128293|18507668|P3|COMPLETED|Treatment Period 2 (1 Day)||4
7516432|NCT04128293|18507669|P2|COMPLETED|Treatment Period 2 (1 Day)||4
7516433|NCT04128293|18507670|P1|COMPLETED|Treatment Period 2 (1 Day)||4
7516434|NCT04128293|18507667|P4|STARTED|Treatment Period 2 (1 Day)||4
7516435|NCT04128293|18507668|P3|STARTED|Treatment Period 2 (1 Day)||4
7516436|NCT04128293|18507669|P2|STARTED|Treatment Period 2 (1 Day)||4
7516437|NCT04128293|18507670|P1|STARTED|Treatment Period 2 (1 Day)||4
7516438|NCT04128293|18507667|P4|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
7516439|NCT04128293|18507668|P3|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
7516440|NCT04128293|18507669|P2|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
7516441|NCT04128293|18507670|P1|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
7516442|NCT04128293|18507667|P4|COMPLETED|Washout Period 1 (Up to 7 Days)||4
7516443|NCT04128293|18507668|P3|COMPLETED|Washout Period 1 (Up to 7 Days)||4
7516444|NCT04128293|18507669|P2|COMPLETED|Washout Period 1 (Up to 7 Days)||4
7516445|NCT04128293|18507670|P1|COMPLETED|Washout Period 1 (Up to 7 Days)||4
7516446|NCT04128293|18507667|P4|STARTED|Washout Period 1 (Up to 7 Days)||4
7516447|NCT04128293|18507668|P3|STARTED|Washout Period 1 (Up to 7 Days)||4
7516448|NCT04128293|18507669|P2|STARTED|Washout Period 1 (Up to 7 Days)||4
7516449|NCT04128293|18507670|P1|STARTED|Washout Period 1 (Up to 7 Days)||4
7516450|NCT04128293|18507667|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7516451|NCT04128293|18507668|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7516452|NCT04128293|18507669|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7516453|NCT04128293|18507670|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7516454|NCT04128293|18507667|P4|COMPLETED|Treatment Period 1 (1 Day)||4
7516455|NCT04128293|18507668|P3|COMPLETED|Treatment Period 1 (1 Day)||4
7516456|NCT04128293|18507669|P2|COMPLETED|Treatment Period 1 (1 Day)||4
7516457|NCT04128293|18507670|P1|COMPLETED|Treatment Period 1 (1 Day)||4
7516458|NCT04128293|18507667|P4|STARTED|Treatment Period 1 (1 Day)||4
7516459|NCT04128293|18507668|P3|STARTED|Treatment Period 1 (1 Day)||4
7516460|NCT04128293|18507669|P2|STARTED|Treatment Period 1 (1 Day)||4
7516461|NCT04128293|18507670|P1|STARTED|Treatment Period 1 (1 Day)||4
7516462|NCT04123665|18507870|P2|NOT COMPLETED|Overall Study||0
7516463|NCT04123665|18507871|P1|NOT COMPLETED|Overall Study||8
7516464|NCT04123665|18507870|P2|COMPLETED|Overall Study||48
7516465|NCT04123665|18507871|P1|COMPLETED|Overall Study||42
7516466|NCT04123665|18507870|P2|STARTED|Overall Study||48
7516467|NCT04123665|18507871|P1|STARTED|Overall Study||50
7516468|NCT04122534|18507893|P1|NOT COMPLETED|Overall Study||4
7516469|NCT04122534|18507893|P1|COMPLETED|Overall Study||44
7516470|NCT04122534|18507893|P1|STARTED|Overall Study||48
7516471|NCT04121078|18507900|P2|NOT COMPLETED|Study Period 2 (1 Day)||0
7516472|NCT04121078|18507901|P1|NOT COMPLETED|Study Period 2 (1 Day)||0
7516473|NCT04121078|18507900|P2|COMPLETED|Study Period 2 (1 Day)||6
7516474|NCT04121078|18507901|P1|COMPLETED|Study Period 2 (1 Day)||6
7516475|NCT04121078|18507900|P2|STARTED|Study Period 2 (1 Day)||6
7516476|NCT04121078|18507901|P1|STARTED|Study Period 2 (1 Day)||6
7516477|NCT04121078|18507900|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7516478|NCT04121078|18507901|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7516479|NCT04121078|18507900|P2|COMPLETED|Washout Period (at Least 7 Days)||6
7516480|NCT04121078|18507901|P1|COMPLETED|Washout Period (at Least 7 Days)||6
7516481|NCT04121078|18507900|P2|STARTED|Washout Period (at Least 7 Days)||6
7516482|NCT04121078|18507901|P1|STARTED|Washout Period (at Least 7 Days)||6
7516483|NCT04121078|18507900|P2|NOT COMPLETED|Study Period 1 (1 Day)||0
7516484|NCT04121078|18507901|P1|NOT COMPLETED|Study Period 1 (1 Day)||0
7516485|NCT04121078|18507900|P2|COMPLETED|Study Period 1 (1 Day)||6
7516486|NCT04121078|18507901|P1|COMPLETED|Study Period 1 (1 Day)||6
7516487|NCT04121078|18507900|P2|STARTED|Study Period 1 (1 Day)||6
7516488|NCT04121078|18507901|P1|STARTED|Study Period 1 (1 Day)||6
7516489|NCT04113785|18507919|P1|NOT COMPLETED|Overall Study||0
7516490|NCT04113785|18507919|P1|COMPLETED|Overall Study||21
7516491|NCT04113785|18507919|P1|STARTED|Overall Study||21
7516492|NCT04112160|18507928|P2|NOT COMPLETED|Overall Study||0
7516493|NCT04112160|18507929|P1|NOT COMPLETED|Overall Study||1
7516494|NCT04112160|18507928|P2|COMPLETED|Overall Study||62
7516495|NCT04112160|18507929|P1|COMPLETED|Overall Study||62
7516496|NCT04112160|18507928|P2|STARTED|Overall Study||62
7516497|NCT04112160|18507929|P1|STARTED|Overall Study||63
7516498|NCT04112069|18507945|P2|NOT COMPLETED|Overall Study||0
7516499|NCT04112069|18507946|P1|NOT COMPLETED|Overall Study||0
7516500|NCT04112069|18507945|P2|COMPLETED|Overall Study||10
7516501|NCT04112069|18507946|P1|COMPLETED|Overall Study||10
7516502|NCT04112069|18507945|P2|STARTED|Overall Study||10
7516503|NCT04112069|18507946|P1|STARTED|Overall Study||10
7516504|NCT04109703|18507968|P2|NOT COMPLETED|Overall Study||0
7516505|NCT04109703|18507969|P1|NOT COMPLETED|Overall Study||0
7516506|NCT04109703|18507968|P2|COMPLETED|Overall Study||51
7516507|NCT04109703|18507969|P1|COMPLETED|Overall Study||49
7516508|NCT04109703|18507968|P2|STARTED|Overall Study||51
7516509|NCT04109703|18507969|P1|STARTED|Overall Study||49
7516510|NCT04109222|18507980|P3|NOT COMPLETED|Overall Study||0
7516511|NCT04109222|18507981|P2|NOT COMPLETED|Overall Study||0
7516512|NCT04109222|18507982|P1|NOT COMPLETED|Overall Study||1
7516513|NCT04109222|18507980|P3|COMPLETED|Overall Study||30
7516514|NCT04109222|18507981|P2|COMPLETED|Overall Study||30
7516515|NCT04109222|18507982|P1|COMPLETED|Overall Study||29
7516516|NCT04109222|18507980|P3|STARTED|Overall Study||30
7516517|NCT04109222|18507981|P2|STARTED|Overall Study||30
7516518|NCT04109222|18507982|P1|STARTED|Overall Study||30
7516519|NCT04106817|18507993|P3|NOT COMPLETED|Overall Study||0
7516520|NCT04106817|18507994|P2|NOT COMPLETED|Overall Study||0
7516521|NCT04106817|18507995|P1|NOT COMPLETED|Overall Study||1
7516522|NCT04106817|18507993|P3|COMPLETED|Overall Study||12
7516523|NCT04106817|18507994|P2|COMPLETED|Overall Study||11
7516524|NCT04106817|18507995|P1|COMPLETED|Overall Study||11
7516525|NCT04106817|18507993|P3|STARTED|Overall Study||12
7516526|NCT04106817|18507994|P2|STARTED|Overall Study||11
7516527|NCT04106817|18507995|P1|STARTED|Overall Study||12
7516528|NCT04098809|18508011|P2|NOT COMPLETED|Overall Study||4
7516529|NCT04098809|18508012|P1|NOT COMPLETED|Overall Study||3
7516530|NCT04098809|18508011|P2|COMPLETED|Overall Study||21
7516531|NCT04098809|18508012|P1|COMPLETED|Overall Study||24
7516532|NCT04098809|18508011|P2|STARTED|Overall Study||25
7516533|NCT04098809|18508012|P1|STARTED|Overall Study||27
7516534|NCT04095286|18508038|P6|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
7516535|NCT04095286|18508039|P5|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
7516536|NCT04095286|18508040|P4|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
7516537|NCT04095286|18508041|P3|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
7516538|NCT04095286|18508042|P2|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
7516539|NCT04095286|18508043|P1|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
7516540|NCT04095286|18508038|P6|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
7516541|NCT04095286|18508039|P5|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
7516542|NCT04095286|18508040|P4|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
7516543|NCT04095286|18508041|P3|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||2
7516544|NCT04095286|18508042|P2|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
7516545|NCT04095286|18508043|P1|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||3
7516546|NCT04095286|18508038|P6|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
7516547|NCT04095286|18508039|P5|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
7516548|NCT04095286|18508040|P4|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
7516549|NCT04095286|18508041|P3|STARTED|Period 3 (4 Days) + Follow up (14 Days)||2
7516550|NCT04095286|18508042|P2|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
7516551|NCT04095286|18508043|P1|STARTED|Period 3 (4 Days) + Follow up (14 Days)||3
7516552|NCT04095286|18508038|P6|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
7516553|NCT04095286|18508039|P5|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||1
7516554|NCT04095286|18508040|P4|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
7516555|NCT04095286|18508041|P3|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||2
7516556|NCT04095286|18508042|P2|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
7516557|NCT04095286|18508043|P1|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
7516558|NCT04095286|18508038|P6|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
7516559|NCT04095286|18508039|P5|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
7516560|NCT04095286|18508040|P4|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
7516561|NCT04095286|18508041|P3|COMPLETED|Period 2 (4 Days) + Washout (7days)||2
7516562|NCT04095286|18508042|P2|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
7516563|NCT04095286|18508043|P1|COMPLETED|Period 2 (4 Days) + Washout (7days)||3
7516564|NCT04095286|18508038|P6|STARTED|Period 2 (4 Days) + Washout (7days)||5
7516565|NCT04095286|18508039|P5|STARTED|Period 2 (4 Days) + Washout (7days)||5
7516566|NCT04095286|18508040|P4|STARTED|Period 2 (4 Days) + Washout (7days)||5
7516567|NCT04095286|18508041|P3|STARTED|Period 2 (4 Days) + Washout (7days)||4
7516568|NCT04095286|18508042|P2|STARTED|Period 2 (4 Days) + Washout (7days)||4
7516569|NCT04095286|18508043|P1|STARTED|Period 2 (4 Days) + Washout (7days)||3
7516570|NCT04095286|18508038|P6|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
7516571|NCT04095286|18508039|P5|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
7516572|NCT04095286|18508040|P4|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
7516573|NCT04095286|18508041|P3|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
7516574|NCT04095286|18508042|P2|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
7516575|NCT04095286|18508043|P1|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
7516576|NCT04095286|18508038|P6|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
7516577|NCT04095286|18508039|P5|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
7516578|NCT04095286|18508040|P4|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
7516579|NCT04095286|18508041|P3|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
7516580|NCT04095286|18508042|P2|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
7516581|NCT04095286|18508043|P1|COMPLETED|Period 1 (4 Days) + Washout (7days)||3
7516582|NCT04095286|18508038|P6|STARTED|Period 1 (4 Days) + Washout (7days)||5
7516583|NCT04095286|18508039|P5|STARTED|Period 1 (4 Days) + Washout (7days)||5
7516584|NCT04095286|18508040|P4|STARTED|Period 1 (4 Days) + Washout (7days)||5
7516585|NCT04095286|18508041|P3|STARTED|Period 1 (4 Days) + Washout (7days)||5
7516586|NCT04095286|18508042|P2|STARTED|Period 1 (4 Days) + Washout (7days)||5
7516587|NCT04095286|18508043|P1|STARTED|Period 1 (4 Days) + Washout (7days)||4
7516588|NCT04091659|18508086|P2|NOT COMPLETED|Overall Study||1
7516589|NCT04091659|18508087|P1|NOT COMPLETED|Overall Study||3
7516590|NCT04091659|18508086|P2|COMPLETED|Overall Study||57
7516591|NCT04091659|18508087|P1|COMPLETED|Overall Study||37
7516592|NCT04091659|18508086|P2|STARTED|Overall Study||58
7516593|NCT04091659|18508087|P1|STARTED|Overall Study||40
7516594|NCT04090164|18508097|P2|NOT COMPLETED|Overall Study||0
7516595|NCT04090164|18508098|P1|NOT COMPLETED|Overall Study||245
7516596|NCT04090164|18508097|P2|COMPLETED|Overall Study||145
7516597|NCT04090164|18508098|P1|COMPLETED|Overall Study|Number of patients analyzed.|405
7516598|NCT04090164|18508097|P2|STARTED|Overall Study||145
7516599|NCT04090164|18508098|P1|STARTED|Overall Study|Number of patients retrivied from the hospital files.|650
7516600|NCT04086641|18508107|P2|NOT COMPLETED|Foot 2 (Two Week Utilization)||0
7516601|NCT04086641|18508108|P1|NOT COMPLETED|Foot 2 (Two Week Utilization)||0
7516602|NCT04086641|18508107|P2|COMPLETED|Foot 2 (Two Week Utilization)||1
7516603|NCT04086641|18508108|P1|COMPLETED|Foot 2 (Two Week Utilization)||1
7516604|NCT04086641|18508107|P2|STARTED|Foot 2 (Two Week Utilization)||1
7516605|NCT04086641|18508108|P1|STARTED|Foot 2 (Two Week Utilization)||1
7516606|NCT04086641|18508107|P2|NOT COMPLETED|Foot 1 (Two Week Utilization)||2
7516607|NCT04086641|18508108|P1|NOT COMPLETED|Foot 1 (Two Week Utilization)||1
7516608|NCT04086641|18508107|P2|COMPLETED|Foot 1 (Two Week Utilization)||1
7516609|NCT04086641|18508108|P1|COMPLETED|Foot 1 (Two Week Utilization)||1
7516610|NCT04086641|18508107|P2|STARTED|Foot 1 (Two Week Utilization)||3
7516611|NCT04086641|18508108|P1|STARTED|Foot 1 (Two Week Utilization)||2
7516612|NCT04086576|18508130|P2|NOT COMPLETED|Overall Study||0
7516613|NCT04086576|18508131|P1|NOT COMPLETED|Overall Study||0
7516614|NCT04086576|18508130|P2|COMPLETED|Overall Study||10
7516615|NCT04086576|18508131|P1|COMPLETED|Overall Study||10
7516616|NCT04086576|18508130|P2|STARTED|Overall Study||10
7516617|NCT04086576|18508131|P1|STARTED|Overall Study||10
7516618|NCT04086433|18508152|P2|NOT COMPLETED|Overall Study||0
7516619|NCT04086433|18508153|P1|NOT COMPLETED|Overall Study||0
7516620|NCT04086433|18508152|P2|COMPLETED|Overall Study||18
7516621|NCT04086433|18508153|P1|COMPLETED|Overall Study||17
7516622|NCT04086433|18508152|P2|STARTED|Overall Study||18
7516623|NCT04086433|18508153|P1|STARTED|Overall Study||17
7516624|NCT04086407|18508159|P1|NOT COMPLETED|Overall Study||0
7516625|NCT04086407|18508159|P1|COMPLETED|Overall Study||8
7516626|NCT04086407|18508159|P1|STARTED|Overall Study||8
7516627|NCT04083404|18508166|P1|NOT COMPLETED|Overall Study||0
7516628|NCT04083404|18508166|P1|COMPLETED|Overall Study||202
7516629|NCT04083404|18508166|P1|STARTED|Overall Study||202
7516630|NCT04082819|18508174|P3|NOT COMPLETED|Overall Study||0
7516631|NCT04082819|18508175|P2|NOT COMPLETED|Overall Study||0
7516632|NCT04082819|18508176|P1|NOT COMPLETED|Overall Study||0
7516633|NCT04082819|18508174|P3|COMPLETED|Overall Study||3
7516634|NCT04082819|18508175|P2|COMPLETED|Overall Study||54
7516635|NCT04082819|18508176|P1|COMPLETED|Overall Study||37
7516636|NCT04082819|18508174|P3|STARTED|Overall Study||3
7516637|NCT04082819|18508175|P2|STARTED|Overall Study||54
7516638|NCT04082819|18508176|P1|STARTED|Overall Study||37
7516639|NCT04081961|18508190|P3|NOT COMPLETED|Overall Study||0
7516640|NCT04081961|18508191|P2|NOT COMPLETED|Overall Study||0
7516641|NCT04081961|18508192|P1|NOT COMPLETED|Overall Study||0
7516642|NCT04081961|18508190|P3|COMPLETED|Overall Study||9
7516643|NCT04081961|18508191|P2|COMPLETED|Overall Study||9
7516644|NCT04081961|18508192|P1|COMPLETED|Overall Study||9
7516645|NCT04081961|18508190|P3|STARTED|Overall Study||9
7516646|NCT04081961|18508191|P2|STARTED|Overall Study||9
7516647|NCT04081961|18508192|P1|STARTED|Overall Study||9
7516648|NCT04080297|18508208|P2|NOT COMPLETED|Overall Study||3
7516649|NCT04080297|18508209|P1|NOT COMPLETED|Overall Study||2
7516650|NCT04080297|18508208|P2|COMPLETED|Overall Study||8
7516651|NCT04080297|18508209|P1|COMPLETED|Overall Study||8
7516652|NCT04080297|18508208|P2|STARTED|Overall Study||11
7516653|NCT04080297|18508209|P1|STARTED|Overall Study||10
7516654|NCT04079790|18508231|P4|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
7516655|NCT04079790|18508232|P3|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
7516656|NCT04079790|18508233|P2|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
7516657|NCT04079790|18508234|P1|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
7516658|NCT04079790|18508231|P4|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||3
7516659|NCT04079790|18508232|P3|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||12
7516660|NCT04079790|18508233|P2|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
7516661|NCT04079790|18508234|P1|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
7516662|NCT04079790|18508231|P4|STARTED|Part 2, Period 2 (Day 1 to Day 3)||3
7516663|NCT04079790|18508232|P3|STARTED|Part 2, Period 2 (Day 1 to Day 3)||12
7516664|NCT04079790|18508233|P2|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
7516665|NCT04079790|18508234|P1|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
7516666|NCT04079790|18508231|P4|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
7516667|NCT04079790|18508232|P3|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
7516668|NCT04079790|18508233|P2|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
7516669|NCT04079790|18508234|P1|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
7516670|NCT04079790|18508231|P4|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
7516671|NCT04079790|18508232|P3|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||12
7516672|NCT04079790|18508233|P2|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
7516673|NCT04079790|18508234|P1|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
7516674|NCT04079790|18508231|P4|STARTED|Part 2, Period 1 (Day 1 to Day 3)||3
7516675|NCT04079790|18508232|P3|STARTED|Part 2, Period 1 (Day 1 to Day 3)||15
7516676|NCT04079790|18508233|P2|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
7516677|NCT04079790|18508234|P1|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
7516678|NCT04079790|18508231|P4|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
7516679|NCT04079790|18508232|P3|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
7516680|NCT04079790|18508233|P2|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
7516681|NCT04079790|18508234|P1|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
7516682|NCT04079790|18508231|P4|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
7516683|NCT04079790|18508232|P3|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
7516684|NCT04079790|18508233|P2|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||2
7516685|NCT04079790|18508234|P1|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||13
7516686|NCT04079790|18508231|P4|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
7516687|NCT04079790|18508232|P3|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
7516688|NCT04079790|18508233|P2|STARTED|Part 1, Period 3 (Day 9 to Day 11)||2
7516689|NCT04079790|18508234|P1|STARTED|Part 1, Period 3 (Day 9 to Day 11)||13
7516690|NCT04079790|18508231|P4|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
7516691|NCT04079790|18508232|P3|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
7516692|NCT04079790|18508233|P2|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
7516693|NCT04079790|18508234|P1|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
7516694|NCT04079790|18508231|P4|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
7516695|NCT04079790|18508232|P3|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
7516696|NCT04079790|18508233|P2|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||2
7516697|NCT04079790|18508234|P1|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||13
7516698|NCT04079790|18508231|P4|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
7516699|NCT04079790|18508232|P3|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
7516700|NCT04079790|18508233|P2|STARTED|Part 1, Period 2 (Day 5 to Day 8)||2
7516701|NCT04079790|18508234|P1|STARTED|Part 1, Period 2 (Day 5 to Day 8)||13
7516702|NCT04079790|18508231|P4|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
7516703|NCT04079790|18508232|P3|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
7516704|NCT04079790|18508233|P2|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
7516705|NCT04079790|18508234|P1|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||1
7516706|NCT04079790|18508231|P4|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
7516707|NCT04079790|18508232|P3|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
7516708|NCT04079790|18508233|P2|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||2
7516709|NCT04079790|18508234|P1|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||13
7516710|NCT04079790|18508231|P4|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
7516711|NCT04079790|18508232|P3|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
7516712|NCT04079790|18508233|P2|STARTED|Part 1, Period 1(Day 1 to Day 4)||2
7516713|NCT04079790|18508234|P1|STARTED|Part 1, Period 1(Day 1 to Day 4)||14
7516714|NCT04079127|18508372|P1|NOT COMPLETED|Overall Study||61
7516715|NCT04079127|18508372|P1|COMPLETED|Overall Study|89 cases have completed the study, and all 10 year data of 81 were available for analysis.|89
7516716|NCT04079127|18508372|P1|STARTED|Overall Study||150
7516717|NCT04079114|18508378|P1|NOT COMPLETED|Overall Study||166
7516718|NCT04079114|18508378|P1|COMPLETED|Overall Study|Study prematurely terminated.|0
7516719|NCT04079114|18508378|P1|STARTED|Overall Study||166
7516720|NCT04076787|18508388|P3|NOT COMPLETED|Overall Study||0
7516721|NCT04076787|18508389|P2|NOT COMPLETED|Overall Study||0
7516722|NCT04076787|18508390|P1|NOT COMPLETED|Overall Study||0
7516723|NCT04076787|18508388|P3|COMPLETED|Overall Study||420
7516724|NCT04076787|18508389|P2|COMPLETED|Overall Study||1031
7516725|NCT04076787|18508390|P1|COMPLETED|Overall Study||318
7516726|NCT04076787|18508388|P3|STARTED|Overall Study||420
7516727|NCT04076787|18508389|P2|STARTED|Overall Study||1031
7516728|NCT04076787|18508390|P1|STARTED|Overall Study||318
7516729|NCT04072432|18508416|P3|NOT COMPLETED|Overall Study||0
7516730|NCT04072432|18508417|P2|NOT COMPLETED|Overall Study||0
7516731|NCT04072432|18508418|P1|NOT COMPLETED|Overall Study||0
7516732|NCT04072432|18508416|P3|COMPLETED|Overall Study||6
7516733|NCT04072432|18508417|P2|COMPLETED|Overall Study||6
7516734|NCT04072432|18508418|P1|COMPLETED|Overall Study||6
7516735|NCT04072432|18508416|P3|STARTED|Overall Study||6
7516736|NCT04072432|18508417|P2|STARTED|Overall Study||6
7516737|NCT04072432|18508418|P1|STARTED|Overall Study||6
7516738|NCT04071392|18508428|P2|NOT COMPLETED|Overall Study||2
7516739|NCT04071392|18508429|P1|NOT COMPLETED|Overall Study||2
7516740|NCT04071392|18508428|P2|COMPLETED|Overall Study||10
7516741|NCT04071392|18508429|P1|COMPLETED|Overall Study||10
7516742|NCT04071392|18508428|P2|STARTED|Overall Study||12
7516743|NCT04071392|18508429|P1|STARTED|Overall Study||12
7516744|NCT04069715|18508439|P2|NOT COMPLETED|Overall Study||5
7516745|NCT04069715|18508440|P1|NOT COMPLETED|Overall Study||5
7516746|NCT04069715|18508439|P2|COMPLETED|Overall Study||43
7516747|NCT04069715|18508440|P1|COMPLETED|Overall Study||42
7516748|NCT04069715|18508439|P2|STARTED|Overall Study||48
7516749|NCT04069715|18508440|P1|STARTED|Overall Study||47
7516750|NCT04069221|18508470|P4|NOT COMPLETED|Overall Study||0
7516751|NCT04069221|18508471|P3|NOT COMPLETED|Overall Study||0
7516752|NCT04069221|18508472|P2|NOT COMPLETED|Overall Study||0
7516753|NCT04069221|18508473|P1|NOT COMPLETED|Overall Study||0
7516754|NCT04069221|18508470|P4|COMPLETED|Overall Study||6
7516755|NCT04069221|18508471|P3|COMPLETED|Overall Study||6
7516756|NCT04069221|18508472|P2|COMPLETED|Overall Study||6
7516757|NCT04069221|18508473|P1|COMPLETED|Overall Study||8
7516758|NCT04069221|18508470|P4|STARTED|Overall Study||6
7516759|NCT04069221|18508471|P3|STARTED|Overall Study||6
7516760|NCT04069221|18508472|P2|STARTED|Overall Study||6
7516761|NCT04069221|18508473|P1|STARTED|Overall Study||8
7516762|NCT04067401|18508494|P2|NOT COMPLETED|Overall Study||0
7516763|NCT04067401|18508495|P1|NOT COMPLETED|Overall Study||8
7516764|NCT04067401|18508494|P2|COMPLETED|Overall Study||737
7516765|NCT04067401|18508495|P1|COMPLETED|Overall Study||740
7516766|NCT04067401|18508494|P2|6 Month Survey Completion|Overall Study||618
7516767|NCT04067401|18508495|P1|6 Month Survey Completion|Overall Study||629
7516768|NCT04067401|18508494|P2|1 Month Survey Completion|Overall Study||694
7516769|NCT04067401|18508495|P1|1 Month Survey Completion|Overall Study||697
7516770|NCT04067401|18508494|P2|Baseline Survey Completion|Overall Study||735
7516771|NCT04067401|18508495|P1|Baseline Survey Completion|Overall Study||746
7516772|NCT04067401|18508494|P2|STARTED|Overall Study||737
7516773|NCT04067401|18508495|P1|STARTED|Overall Study||748
7516774|NCT04067141|18508515|P2|NOT COMPLETED|Second Intervention||2
7516775|NCT04067141|18508516|P1|NOT COMPLETED|Second Intervention||0
7516776|NCT04067141|18508515|P2|COMPLETED|Second Intervention||31
7516777|NCT04067141|18508516|P1|COMPLETED|Second Intervention||34
7516778|NCT04067141|18508515|P2|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject|33
7516779|NCT04067141|18508516|P1|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject.|34
7516780|NCT04067141|18508515|P2|NOT COMPLETED|First Intervention||1
7516781|NCT04067141|18508516|P1|NOT COMPLETED|First Intervention||0
7516782|NCT04067141|18508515|P2|COMPLETED|First Intervention||34
7516783|NCT04067141|18508516|P1|COMPLETED|First Intervention||35
7516784|NCT04067141|18508515|P2|STARTED|First Intervention||35
7516785|NCT04067141|18508516|P1|STARTED|First Intervention||35
7516786|NCT04066647|18508562|P1|NOT COMPLETED|Overall Study||0
7516787|NCT04066647|18508562|P1|COMPLETED|Overall Study||7
7516788|NCT04066647|18508562|P1|STARTED|Overall Study||7
7516789|NCT04065074|18508566|P1|NOT COMPLETED|Overall Study||2
7516790|NCT04065074|18508566|P1|COMPLETED|Overall Study||14
7516791|NCT04065074|18508566|P1|STARTED|Overall Study||16
7516792|NCT04061694|18508572|P2|NOT COMPLETED|Overall Study||0
7516793|NCT04061694|18508573|P1|NOT COMPLETED|Overall Study||2
7516794|NCT04061694|18508572|P2|COMPLETED|Overall Study||25
7516795|NCT04061694|18508573|P1|COMPLETED|Overall Study||19
7516796|NCT04061694|18508572|P2|STARTED|Overall Study||25
7516797|NCT04061694|18508573|P1|STARTED|Overall Study||21
7516798|NCT04057235|18508587|P1|NOT COMPLETED|Overall Study||0
7516799|NCT04057235|18508587|P1|COMPLETED|Overall Study|All 129 participants had data for at least one of the primary/secondary outcomes or adverse events|129
7516800|NCT04057235|18508587|P1|Had VAS Leg Data|Overall Study||45
7516801|NCT04057235|18508587|P1|Had VAS Back Data|Overall Study||45
7516802|NCT04057235|18508587|P1|Had ODI Data|Overall Study||43
7516803|NCT04057235|18508587|P1|Had Radiographic Data|Overall Study||58
7516804|NCT04057235|18508587|P1|STARTED|Overall Study||129
7516805|NCT04055675|18508596|P2|NOT COMPLETED|Overall Study||0
7516806|NCT04055675|18508597|P1|NOT COMPLETED|Overall Study||0
7516807|NCT04055675|18508596|P2|COMPLETED|Overall Study||104
7516808|NCT04055675|18508597|P1|COMPLETED|Overall Study||96
7516809|NCT04055675|18508596|P2|STARTED|Overall Study||104
7516810|NCT04055675|18508597|P1|STARTED|Overall Study||96
7516811|NCT04054011|18508603|P1|NOT COMPLETED|Overall Study||3
7516812|NCT04054011|18508603|P1|COMPLETED|Overall Study||12
7516813|NCT04054011|18508603|P1|STARTED|Overall Study||15
7516814|NCT04053465|18508611|P2|NOT COMPLETED|Overall Study||4
7516815|NCT04053465|18508612|P1|NOT COMPLETED|Overall Study||4
7516816|NCT04053465|18508611|P2|COMPLETED|Overall Study||8
7516817|NCT04053465|18508612|P1|COMPLETED|Overall Study||18
7516818|NCT04053465|18508611|P2|STARTED|Overall Study||12
7516819|NCT04053465|18508612|P1|STARTED|Overall Study||22
7516820|NCT04053270|18508622|P2|NOT COMPLETED|Overall Study||5
7516821|NCT04053270|18508623|P1|NOT COMPLETED|Overall Study||2
7516822|NCT04053270|18508622|P2|COMPLETED|Overall Study||46
7516823|NCT04053270|18508623|P1|COMPLETED|Overall Study||47
7516824|NCT04053270|18508622|P2|STARTED|Overall Study||51
7516825|NCT04053270|18508623|P1|STARTED|Overall Study||49
7516826|NCT04053023|18508641|P2|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
7516827|NCT04053023|18508642|P1|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
7516828|NCT04053023|18508641|P2|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
7516829|NCT04053023|18508642|P1|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
7516830|NCT04053023|18508641|P2|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
7516831|NCT04053023|18508642|P1|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
7516832|NCT04053023|18508641|P2|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
7516833|NCT04053023|18508642|P1|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
7516834|NCT04053023|18508641|P2|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
7516835|NCT04053023|18508642|P1|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
7516836|NCT04053023|18508641|P2|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
7516837|NCT04053023|18508642|P1|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
7516838|NCT04053023|18508641|P2|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
7516839|NCT04053023|18508642|P1|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||1
7516840|NCT04053023|18508641|P2|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
7516841|NCT04053023|18508642|P1|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||18
7516842|NCT04053023|18508641|P2|STARTED|Part A: Period 2 (Day 20 to Day 38)||0
7516843|NCT04053023|18508642|P1|STARTED|Part A: Period 2 (Day 20 to Day 38)||19
7516844|NCT04053023|18508641|P2|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
7516845|NCT04053023|18508642|P1|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
7516846|NCT04053023|18508641|P2|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
7516847|NCT04053023|18508642|P1|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||19
7516848|NCT04053023|18508641|P2|STARTED|Part A: Period 1 (Day 1 to Day 19)||0
7516849|NCT04053023|18508642|P1|STARTED|Part A: Period 1 (Day 1 to Day 19)||19
7516850|NCT04051710|18508807|P3|NOT COMPLETED|Overall Study||4
7516851|NCT04051710|18508808|P2|NOT COMPLETED|Overall Study||8
7516852|NCT04051710|18508809|P1|NOT COMPLETED|Overall Study||4
7516853|NCT04051710|18508807|P3|COMPLETED|Overall Study||306
7516854|NCT04051710|18508808|P2|COMPLETED|Overall Study||612
7516855|NCT04051710|18508809|P1|COMPLETED|Overall Study||616
7516856|NCT04051710|18508807|P3|STARTED|Overall Study||310
7516857|NCT04051710|18508808|P2|STARTED|Overall Study||620
7516858|NCT04051710|18508809|P1|STARTED|Overall Study||620
7516859|NCT04051684|18508819|P2|NOT COMPLETED|Overall Study||0
7516860|NCT04051684|18508820|P1|NOT COMPLETED|Overall Study||0
7516861|NCT04051684|18508819|P2|COMPLETED|Overall Study||11
7516862|NCT04051684|18508820|P1|COMPLETED|Overall Study||12
7516863|NCT04051684|18508819|P2|STARTED|Overall Study||11
7516864|NCT04051684|18508820|P1|STARTED|Overall Study||12
7516865|NCT04050722|18508834|P2|NOT COMPLETED|Overall Study||0
7516866|NCT04050722|18508835|P1|NOT COMPLETED|Overall Study||1
7516867|NCT04050722|18508834|P2|COMPLETED|Overall Study||65
7516868|NCT04050722|18508835|P1|COMPLETED|Overall Study||64
7516869|NCT04050722|18508834|P2|STARTED|Overall Study||65
7516870|NCT04050722|18508835|P1|STARTED|Overall Study||65
7516871|NCT04050618|18508853|P2|NOT COMPLETED|Second Intervention||0
7516872|NCT04050618|18508854|P1|NOT COMPLETED|Second Intervention||1
7516873|NCT04050618|18508853|P2|COMPLETED|Second Intervention||56
7516874|NCT04050618|18508854|P1|COMPLETED|Second Intervention||55
7516875|NCT04050618|18508853|P2|STARTED|Second Intervention||56
7516876|NCT04050618|18508854|P1|STARTED|Second Intervention||56
7516877|NCT04050618|18508853|P2|NOT COMPLETED|First Intervention||0
7516878|NCT04050618|18508854|P1|NOT COMPLETED|First Intervention||2
7516879|NCT04050618|18508853|P2|COMPLETED|First Intervention||56
7516880|NCT04050618|18508854|P1|COMPLETED|First Intervention||56
7516881|NCT04050618|18508853|P2|STARTED|First Intervention||56
7516882|NCT04050618|18508854|P1|STARTED|First Intervention||58
7516883|NCT04050605|18508992|P1|NOT COMPLETED|Overall Study||0
7516884|NCT04050605|18508992|P1|COMPLETED|Overall Study||40
7516885|NCT04050605|18508992|P1|STARTED|Overall Study||40
7516886|NCT04049578|18509022|P1|NOT COMPLETED|Overall Study||1
7516887|NCT04049578|18509022|P1|COMPLETED|Overall Study||1
7516888|NCT04049578|18509022|P1|STARTED|Overall Study||2
7516889|NCT04049552|18509032|P1|NOT COMPLETED|Overall Study||1
7516890|NCT04049552|18509032|P1|COMPLETED|Overall Study||3
7516891|NCT04049552|18509032|P1|STARTED|Overall Study||4
7516892|NCT04048681|18509040|P5|NOT COMPLETED|Overall Study||0
7516893|NCT04048681|18509041|P4|NOT COMPLETED|Overall Study||1
7516894|NCT04048681|18509042|P3|NOT COMPLETED|Overall Study||0
7516895|NCT04048681|18509043|P2|NOT COMPLETED|Overall Study||0
7516896|NCT04048681|18509044|P1|NOT COMPLETED|Overall Study||0
7516897|NCT04048681|18509040|P5|COMPLETED|Overall Study||1
7516898|NCT04048681|18509041|P4|COMPLETED|Overall Study||0
7516899|NCT04048681|18509042|P3|COMPLETED|Overall Study||1
7516900|NCT04048681|18509043|P2|COMPLETED|Overall Study||1
7516901|NCT04048681|18509044|P1|COMPLETED|Overall Study||1
7516902|NCT04048681|18509040|P5|STARTED|Overall Study||1
7516903|NCT04048681|18509041|P4|STARTED|Overall Study||1
7516904|NCT04048681|18509042|P3|STARTED|Overall Study||1
7516905|NCT04048681|18509043|P2|STARTED|Overall Study||1
7516906|NCT04048681|18509044|P1|STARTED|Overall Study||1
7516907|NCT04047121|18509061|P6|NOT COMPLETED|Overall Study||0
7516908|NCT04047121|18509062|P5|NOT COMPLETED|Overall Study||0
7516909|NCT04047121|18509063|P4|NOT COMPLETED|Overall Study||0
7516910|NCT04047121|18509064|P3|NOT COMPLETED|Overall Study||0
7516911|NCT04047121|18509065|P2|NOT COMPLETED|Overall Study||0
7516912|NCT04047121|18509066|P1|NOT COMPLETED|Overall Study||0
7516913|NCT04047121|18509061|P6|COMPLETED|Overall Study||262
7516914|NCT04047121|18509062|P5|COMPLETED|Overall Study||112
7516915|NCT04047121|18509063|P4|COMPLETED|Overall Study||287
7516916|NCT04047121|18509064|P3|COMPLETED|Overall Study||79
7516917|NCT04047121|18509065|P2|COMPLETED|Overall Study||299
7516918|NCT04047121|18509066|P1|COMPLETED|Overall Study||310
7516919|NCT04047121|18509061|P6|STARTED|Overall Study||262
7516920|NCT04047121|18509062|P5|STARTED|Overall Study||112
7516921|NCT04047121|18509063|P4|STARTED|Overall Study||287
7516922|NCT04047121|18509064|P3|STARTED|Overall Study||79
7516923|NCT04047121|18509065|P2|STARTED|Overall Study||299
7516924|NCT04047121|18509066|P1|STARTED|Overall Study||310
7516925|NCT04045964|18509328|P2|NOT COMPLETED|Overall Study||1
7516926|NCT04045964|18509329|P1|NOT COMPLETED|Overall Study||1
7516927|NCT04045964|18509328|P2|COMPLETED|Overall Study||15
7516928|NCT04045964|18509329|P1|COMPLETED|Overall Study||15
7516929|NCT04045964|18509328|P2|Follow up Visit 2|Overall Study||15
7516930|NCT04045964|18509329|P1|Follow up Visit 2|Overall Study||15
7516931|NCT04045964|18509328|P2|Follow up Visit 1|Overall Study||15
7516932|NCT04045964|18509329|P1|Follow up Visit 1|Overall Study||15
7516933|NCT04045964|18509328|P2|Intervention Visit(s)|Overall Study||16
7516934|NCT04045964|18509329|P1|Intervention Visit(s)|Overall Study||15
7516935|NCT04045964|18509328|P2|STARTED|Overall Study||16
7516936|NCT04045964|18509329|P1|STARTED|Overall Study||16
7516937|NCT04043416|18509360|P2|NOT COMPLETED|Campaign 2||0
7516938|NCT04043416|18509361|P1|NOT COMPLETED|Campaign 2||0
7516939|NCT04043416|18509360|P2|COMPLETED|Campaign 2||13
7516940|NCT04043416|18509361|P1|COMPLETED|Campaign 2||14
7516941|NCT04043416|18509360|P2|STARTED|Campaign 2||13
7516942|NCT04043416|18509361|P1|STARTED|Campaign 2||14
7516943|NCT04043416|18509360|P2|NOT COMPLETED|Washout||1
7516944|NCT04043416|18509361|P1|NOT COMPLETED|Washout||0
7516945|NCT04043416|18509360|P2|COMPLETED|Washout||13
7516946|NCT04043416|18509361|P1|COMPLETED|Washout||14
7516947|NCT04043416|18509360|P2|STARTED|Washout||14
7516948|NCT04043416|18509361|P1|STARTED|Washout||14
7516949|NCT04043416|18509360|P2|NOT COMPLETED|Campaign 1||0
7516950|NCT04043416|18509361|P1|NOT COMPLETED|Campaign 1||0
7516951|NCT04043416|18509360|P2|COMPLETED|Campaign 1||14
7516952|NCT04043416|18509361|P1|COMPLETED|Campaign 1||14
7516953|NCT04043416|18509360|P2|STARTED|Campaign 1||14
7516954|NCT04043416|18509361|P1|STARTED|Campaign 1||14
7516955|NCT04042324|18509395|P3|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
7516956|NCT04042324|18509396|P2|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
7516957|NCT04042324|18509397|P1|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
7516958|NCT04042324|18509395|P3|COMPLETED|Triferic Pre-dialyzer (Day 5)||12
7516959|NCT04042324|18509396|P2|COMPLETED|Triferic Pre-dialyzer (Day 5)||0
7516960|NCT04042324|18509397|P1|COMPLETED|Triferic Pre-dialyzer (Day 5)||0
7516961|NCT04042324|18509395|P3|STARTED|Triferic Pre-dialyzer (Day 5)||12
7516962|NCT04042324|18509396|P2|STARTED|Triferic Pre-dialyzer (Day 5)||0
7516963|NCT04042324|18509397|P1|STARTED|Triferic Pre-dialyzer (Day 5)||0
7516964|NCT04042324|18509395|P3|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
7516965|NCT04042324|18509396|P2|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
7516966|NCT04042324|18509397|P1|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
7516967|NCT04042324|18509395|P3|COMPLETED|Triferic Post-dialyzer (Day 3)||0
7516968|NCT04042324|18509396|P2|COMPLETED|Triferic Post-dialyzer (Day 3)||12
7516969|NCT04042324|18509397|P1|COMPLETED|Triferic Post-dialyzer (Day 3)||0
7516970|NCT04042324|18509395|P3|STARTED|Triferic Post-dialyzer (Day 3)||0
7516971|NCT04042324|18509396|P2|STARTED|Triferic Post-dialyzer (Day 3)||12
7516972|NCT04042324|18509397|P1|STARTED|Triferic Post-dialyzer (Day 3)||0
7516973|NCT04042324|18509395|P3|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
7516974|NCT04042324|18509396|P2|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
7516975|NCT04042324|18509397|P1|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
7516976|NCT04042324|18509395|P3|COMPLETED|UFH and Triferic Admixture (Day 1)||0
7516977|NCT04042324|18509396|P2|COMPLETED|UFH and Triferic Admixture (Day 1)||0
7516978|NCT04042324|18509397|P1|COMPLETED|UFH and Triferic Admixture (Day 1)||12
7516979|NCT04042324|18509395|P3|STARTED|UFH and Triferic Admixture (Day 1)||0
7516980|NCT04042324|18509396|P2|STARTED|UFH and Triferic Admixture (Day 1)||0
7516981|NCT04042324|18509397|P1|STARTED|UFH and Triferic Admixture (Day 1)||12
7516982|NCT04041453|18509421|P4|NOT COMPLETED|Overall Study||18
7516983|NCT04041453|18509422|P3|NOT COMPLETED|Overall Study||5
7516984|NCT04041453|18509423|P2|NOT COMPLETED|Overall Study||22
7516985|NCT04041453|18509424|P1|NOT COMPLETED|Overall Study||14
7516986|NCT04041453|18509421|P4|COMPLETED|Overall Study||40
7516987|NCT04041453|18509422|P3|COMPLETED|Overall Study||18
7516988|NCT04041453|18509423|P2|COMPLETED|Overall Study||35
7516989|NCT04041453|18509424|P1|COMPLETED|Overall Study||24
7516990|NCT04041453|18509421|P4|Safety Population|Overall Study||58
7516991|NCT04041453|18509422|P3|Safety Population|Overall Study||23
7516992|NCT04041453|18509423|P2|Safety Population|Overall Study||56
7516993|NCT04041453|18509424|P1|Safety Population|Overall Study||38
7516994|NCT04041453|18509421|P4|STARTED|Overall Study||58
7516995|NCT04041453|18509422|P3|STARTED|Overall Study||23
7516996|NCT04041453|18509423|P2|STARTED|Overall Study||57
7516997|NCT04041453|18509424|P1|STARTED|Overall Study||38
7516998|NCT04041219|18509438|P1|NOT COMPLETED|Overall Study||0
7516999|NCT04041219|18509438|P1|COMPLETED|Overall Study||10
7517000|NCT04041219|18509438|P1|STARTED|Overall Study||10
7517001|NCT04041037|18509443|P1|NOT COMPLETED|Overall Study||0
7517002|NCT04041037|18509443|P1|COMPLETED|Overall Study||2
7517003|NCT04041037|18509443|P1|STARTED|Overall Study||2
7517004|NCT04039867|18509450|P1|NOT COMPLETED|Overall Study||0
7517005|NCT04039867|18509450|P1|COMPLETED|Overall Study||17
7517006|NCT04039867|18509450|P1|STARTED|Overall Study||17
7517007|NCT04039412|18509459|P3|NOT COMPLETED|Overall Study||2
7517008|NCT04039412|18509460|P2|NOT COMPLETED|Overall Study||3
7517009|NCT04039412|18509461|P1|NOT COMPLETED|Overall Study||1
7517010|NCT04039412|18509459|P3|COMPLETED|Overall Study||108
7517011|NCT04039412|18509460|P2|COMPLETED|Overall Study||107
7517012|NCT04039412|18509461|P1|COMPLETED|Overall Study||109
7517013|NCT04039412|18509459|P3|STARTED|Overall Study||110
7517014|NCT04039412|18509460|P2|STARTED|Overall Study||110
7517015|NCT04039412|18509461|P1|STARTED|Overall Study||110
7517016|NCT04037748|18509477|P2|NOT COMPLETED|Treatment Period 2||1
7517017|NCT04037748|18509478|P1|NOT COMPLETED|Treatment Period 2||2
7517018|NCT04037748|18509477|P2|COMPLETED|Treatment Period 2||29
7517019|NCT04037748|18509478|P1|COMPLETED|Treatment Period 2||26
7517020|NCT04037748|18509477|P2|STARTED|Treatment Period 2||30
7517021|NCT04037748|18509478|P1|STARTED|Treatment Period 2||28
7517022|NCT04037748|18509477|P2|NOT COMPLETED|Treatment Period 1||6
7517023|NCT04037748|18509478|P1|NOT COMPLETED|Treatment Period 1||8
7517024|NCT04037748|18509477|P2|COMPLETED|Treatment Period 1||30
7517025|NCT04037748|18509478|P1|COMPLETED|Treatment Period 1||28
7517026|NCT04037748|18509477|P2|STARTED|Treatment Period 1||36
7517027|NCT04037748|18509478|P1|STARTED|Treatment Period 1||36
7517028|NCT04036838|18509492|P1|NOT COMPLETED|Overall Study||91
7517029|NCT04036838|18509492|P1|COMPLETED|Overall Study||324
7517030|NCT04036838|18509492|P1|STARTED|Overall Study||415
7517031|NCT04035577|18509496|P1|NOT COMPLETED|Overall Study||2
7517032|NCT04035577|18509496|P1|COMPLETED|Overall Study||19
7517033|NCT04035577|18509496|P1|STARTED|Overall Study|One participant withdrew after signing the consent but before initiating any study activities.|21
7517034|NCT04035564|18509516|P2|NOT COMPLETED|Overall Study||6
7517035|NCT04035564|18509517|P1|NOT COMPLETED|Overall Study||4
7517036|NCT04035564|18509516|P2|COMPLETED|Overall Study||19
7517037|NCT04035564|18509517|P1|COMPLETED|Overall Study||23
7517038|NCT04035564|18509516|P2|STARTED|Overall Study||25
7517039|NCT04035564|18509517|P1|STARTED|Overall Study||27
7517040|NCT04034043|18509539|P1|NOT COMPLETED|Overall Study||0
7517041|NCT04034043|18509539|P1|COMPLETED|Overall Study||68
7517042|NCT04034043|18509539|P1|STARTED|Overall Study||68
7517043|NCT04032652|18509548|P2|NOT COMPLETED|Overall Study||1
7517044|NCT04032652|18509549|P1|NOT COMPLETED|Overall Study||1
7517045|NCT04032652|18509548|P2|COMPLETED|Overall Study||0
7517046|NCT04032652|18509549|P1|COMPLETED|Overall Study||0
7517047|NCT04032652|18509548|P2|STARTED|Overall Study||1
7517048|NCT04032652|18509549|P1|STARTED|Overall Study||1
7517049|NCT04032613|18509559|P2|NOT COMPLETED|Overall Study||2
7517050|NCT04032613|18509560|P1|NOT COMPLETED|Overall Study||5
7517051|NCT04032613|18509559|P2|COMPLETED|Overall Study||23
7517052|NCT04032613|18509560|P1|COMPLETED|Overall Study||16
7517053|NCT04032613|18509559|P2|STARTED|Overall Study||25
7517054|NCT04032613|18509560|P1|STARTED|Overall Study||21
7517055|NCT04027803|18509569|P2|NOT COMPLETED|Overall Study||0
7517056|NCT04027803|18509570|P1|NOT COMPLETED|Overall Study||0
7517057|NCT04027803|18509569|P2|COMPLETED|Overall Study||39
7517058|NCT04027803|18509570|P1|COMPLETED|Overall Study||39
7517059|NCT04027803|18509569|P2|STARTED|Overall Study||39
7517060|NCT04027803|18509570|P1|STARTED|Overall Study||39
7517061|NCT04027218|18509608|P6|NOT COMPLETED|Overall Study||0
7517062|NCT04027218|18509609|P5|NOT COMPLETED|Overall Study||0
7517063|NCT04027218|18509610|P4|NOT COMPLETED|Overall Study||0
7517064|NCT04027218|18509611|P3|NOT COMPLETED|Overall Study||0
7517065|NCT04027218|18509612|P2|NOT COMPLETED|Overall Study||3
7517066|NCT04027218|18509613|P1|NOT COMPLETED|Overall Study||0
7517067|NCT04027218|18509608|P6|COMPLETED|Overall Study||11
7517068|NCT04027218|18509609|P5|COMPLETED|Overall Study||10
7517069|NCT04027218|18509610|P4|COMPLETED|Overall Study||11
7517070|NCT04027218|18509611|P3|COMPLETED|Overall Study||9
7517071|NCT04027218|18509612|P2|COMPLETED|Overall Study||8
7517072|NCT04027218|18509613|P1|COMPLETED|Overall Study||10
7517073|NCT04027218|18509608|P6|STARTED|Overall Study||11
7517074|NCT04027218|18509609|P5|STARTED|Overall Study||10
7517075|NCT04027218|18509610|P4|STARTED|Overall Study||11
7517076|NCT04027218|18509611|P3|STARTED|Overall Study||9
7517077|NCT04027218|18509612|P2|STARTED|Overall Study||11
7517078|NCT04027218|18509613|P1|STARTED|Overall Study||10
7517079|NCT04024501|18509643|P1|NOT COMPLETED|Overall Study||0
7517080|NCT04024501|18509643|P1|COMPLETED|Overall Study||25
7517081|NCT04024501|18509643|P1|STARTED|Overall Study||25
7517082|NCT04023695|18509712|P2|NOT COMPLETED|Overall Study||0
7517083|NCT04023695|18509713|P1|NOT COMPLETED|Overall Study||0
7517084|NCT04023695|18509712|P2|COMPLETED|Overall Study||53
7517085|NCT04023695|18509713|P1|COMPLETED|Overall Study||57
7517086|NCT04023695|18509712|P2|STARTED|Overall Study||53
7517087|NCT04023695|18509713|P1|STARTED|Overall Study||57
7517088|NCT04023578|18509721|P1|NOT COMPLETED|Overall Study||2
7517089|NCT04023578|18509721|P1|COMPLETED|Overall Study||13
7517090|NCT04023578|18509721|P1|STARTED|Overall Study||15
7517091|NCT04022668|18509729|P3|NOT COMPLETED|Overall Study||0
7517092|NCT04022668|18509730|P2|NOT COMPLETED|Overall Study||27
7517093|NCT04022668|18509731|P1|NOT COMPLETED|Overall Study||14
7517094|NCT04022668|18509729|P3|COMPLETED|Overall Study||1000
7517095|NCT04022668|18509730|P2|COMPLETED|Overall Study||973
7517096|NCT04022668|18509731|P1|COMPLETED|Overall Study||986
7517097|NCT04022668|18509729|P3|STARTED|Overall Study||1000
7517098|NCT04022668|18509730|P2|STARTED|Overall Study||1000
7517099|NCT04022668|18509731|P1|STARTED|Overall Study||1000
7517100|NCT04020822|18509754|P1|NOT COMPLETED|Overall Study||0
7517101|NCT04020822|18509754|P1|COMPLETED|Overall Study||19
7517102|NCT04020822|18509754|P1|STARTED|Overall Study||19
7517103|NCT04019990|18509758|P2|NOT COMPLETED|Overall Study||3
7517104|NCT04019990|18509759|P1|NOT COMPLETED|Overall Study||1
7517105|NCT04019990|18509758|P2|COMPLETED|Overall Study||12
7517106|NCT04019990|18509759|P1|COMPLETED|Overall Study||12
7517107|NCT04019990|18509758|P2|STARTED|Overall Study||15
7517108|NCT04019990|18509759|P1|STARTED|Overall Study||13
7517109|NCT04018664|18509774|P8|NOT COMPLETED|Overall Study||0
7517110|NCT04018664|18509775|P7|NOT COMPLETED|Overall Study||0
7517111|NCT04018664|18509776|P6|NOT COMPLETED|Overall Study||0
7517112|NCT04018664|18509777|P5|NOT COMPLETED|Overall Study||0
7517113|NCT04018664|18509778|P4|NOT COMPLETED|Overall Study||0
7517114|NCT04018664|18509779|P3|NOT COMPLETED|Overall Study||0
7517115|NCT04018664|18509780|P2|NOT COMPLETED|Overall Study||0
7517116|NCT04018664|18509781|P1|NOT COMPLETED|Overall Study||0
7517117|NCT04018664|18509774|P8|COMPLETED|Overall Study||6
7517118|NCT04018664|18509775|P7|COMPLETED|Overall Study||6
7517119|NCT04018664|18509776|P6|COMPLETED|Overall Study||6
7517120|NCT04018664|18509777|P5|COMPLETED|Overall Study||6
7517121|NCT04018664|18509778|P4|COMPLETED|Overall Study||6
7517122|NCT04018664|18509779|P3|COMPLETED|Overall Study||6
7517123|NCT04018664|18509780|P2|COMPLETED|Overall Study||6
7517124|NCT04018664|18509781|P1|COMPLETED|Overall Study||14
7517125|NCT04018664|18509774|P8|STARTED|Overall Study||6
7517126|NCT04018664|18509775|P7|STARTED|Overall Study||6
7517127|NCT04018664|18509776|P6|STARTED|Overall Study||6
7517128|NCT04018664|18509777|P5|STARTED|Overall Study||6
7517129|NCT04018664|18509778|P4|STARTED|Overall Study||6
7517130|NCT04018664|18509779|P3|STARTED|Overall Study||6
7517131|NCT04018664|18509780|P2|STARTED|Overall Study||6
7517132|NCT04018664|18509781|P1|STARTED|Overall Study||14
7517133|NCT04018001|18509801|P2|NOT COMPLETED|Overall Study||0
7517134|NCT04018001|18509802|P1|NOT COMPLETED|Overall Study||0
7517135|NCT04018001|18509801|P2|COMPLETED|Overall Study||379
7517136|NCT04018001|18509802|P1|COMPLETED|Overall Study||678
7517137|NCT04018001|18509801|P2|STARTED|Overall Study||379
7517138|NCT04018001|18509802|P1|STARTED|Overall Study||678
7517139|NCT04017611|18509832|P1|NOT COMPLETED|Overall Study||1
7517140|NCT04017611|18509832|P1|COMPLETED|Overall Study||12
7517141|NCT04017611|18509832|P1|STARTED|Overall Study||13
7517142|NCT04016623|18509836|P1|NOT COMPLETED|Pair 4 Test /Control Follow up||0
7517143|NCT04016623|18509836|P1|COMPLETED|Pair 4 Test /Control Follow up||10
7517144|NCT04016623|18509836|P1|STARTED|Pair 4 Test /Control Follow up||10
7517145|NCT04016623|18509836|P1|NOT COMPLETED|Pair 4 Test / Control Dispense||0
7517146|NCT04016623|18509836|P1|COMPLETED|Pair 4 Test / Control Dispense||10
7517147|NCT04016623|18509836|P1|STARTED|Pair 4 Test / Control Dispense||10
7517148|NCT04016623|18509836|P1|NOT COMPLETED|Pair 3 Test /Control Follow up||0
7517149|NCT04016623|18509836|P1|COMPLETED|Pair 3 Test /Control Follow up||10
7517150|NCT04016623|18509836|P1|STARTED|Pair 3 Test /Control Follow up||10
7517151|NCT04016623|18509836|P1|NOT COMPLETED|Pair 3 Test / Control Dispense||0
7517152|NCT04016623|18509836|P1|COMPLETED|Pair 3 Test / Control Dispense||10
7517153|NCT04016623|18509836|P1|STARTED|Pair 3 Test / Control Dispense||10
7517154|NCT04016623|18509836|P1|NOT COMPLETED|Pair 2 Test /Control Follow up||0
7517155|NCT04016623|18509836|P1|COMPLETED|Pair 2 Test /Control Follow up||10
7517156|NCT04016623|18509836|P1|STARTED|Pair 2 Test /Control Follow up||10
7517157|NCT04016623|18509836|P1|NOT COMPLETED|Pair 2 Test / Control Dispense||0
7517158|NCT04016623|18509836|P1|COMPLETED|Pair 2 Test / Control Dispense||10
7517159|NCT04016623|18509836|P1|STARTED|Pair 2 Test / Control Dispense||10
7517160|NCT04016623|18509836|P1|NOT COMPLETED|Pair 1 Test /Control Follow up||0
7517161|NCT04016623|18509836|P1|COMPLETED|Pair 1 Test /Control Follow up||10
7517162|NCT04016623|18509836|P1|STARTED|Pair 1 Test /Control Follow up||10
7517163|NCT04016623|18509836|P1|NOT COMPLETED|Pair 1 Test / Control Dispense||0
7517164|NCT04016623|18509836|P1|COMPLETED|Pair 1 Test / Control Dispense||10
7517165|NCT04016623|18509836|P1|STARTED|Pair 1 Test / Control Dispense||10
7517166|NCT04016259|18509894|P2|NOT COMPLETED|Overall Study||0
7517167|NCT04016259|18509895|P1|NOT COMPLETED|Overall Study||0
7517168|NCT04016259|18509894|P2|COMPLETED|Overall Study||15
7517169|NCT04016259|18509895|P1|COMPLETED|Overall Study||15
7517170|NCT04016259|18509894|P2|STARTED|Overall Study||15
7517171|NCT04016259|18509895|P1|STARTED|Overall Study||15
7517172|NCT04015232|18509931|P2|NOT COMPLETED|Overall Study||7
7517173|NCT04015232|18509932|P1|NOT COMPLETED|Overall Study||11
7517174|NCT04015232|18509931|P2|COMPLETED|Overall Study||93
7517175|NCT04015232|18509932|P1|COMPLETED|Overall Study||89
7517176|NCT04015232|18509931|P2|STARTED|Overall Study||100
7517177|NCT04015232|18509932|P1|STARTED|Overall Study||100
7517178|NCT04014062|18510004|P2|NOT COMPLETED|Period II: Crossover Dosing||0
7517179|NCT04014062|18510005|P1|NOT COMPLETED|Period II: Crossover Dosing||0
7517180|NCT04014062|18510004|P2|COMPLETED|Period II: Crossover Dosing||65
7517181|NCT04014062|18510005|P1|COMPLETED|Period II: Crossover Dosing||64
7517182|NCT04014062|18510004|P2|STARTED|Period II: Crossover Dosing||65
7517183|NCT04014062|18510005|P1|STARTED|Period II: Crossover Dosing||64
7517184|NCT04014062|18510004|P2|NOT COMPLETED|Period I: Dosing||6
7517185|NCT04014062|18510005|P1|NOT COMPLETED|Period I: Dosing||7
7517186|NCT04014062|18510004|P2|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|65
7517187|NCT04014062|18510005|P1|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|64
7517188|NCT04014062|18510004|P2|STARTED|Period I: Dosing||71
7517189|NCT04014062|18510005|P1|STARTED|Period I: Dosing||71
7517190|NCT04013789|18510043|P2|NOT COMPLETED|Second Wear Period (1 Week)||0
7517191|NCT04013789|18510044|P1|NOT COMPLETED|Second Wear Period (1 Week)||0
7517192|NCT04013789|18510043|P2|COMPLETED|Second Wear Period (1 Week)||34
7517193|NCT04013789|18510044|P1|COMPLETED|Second Wear Period (1 Week)||32
7517194|NCT04013789|18510043|P2|STARTED|Second Wear Period (1 Week)||34
7517195|NCT04013789|18510044|P1|STARTED|Second Wear Period (1 Week)|One subject withdrew from the study between the first wear period and the second wear period.|32
7517196|NCT04013789|18510043|P2|NOT COMPLETED|First Wear Period (1 Week)||0
7517197|NCT04013789|18510044|P1|NOT COMPLETED|First Wear Period (1 Week)||0
7517198|NCT04013789|18510043|P2|COMPLETED|First Wear Period (1 Week)||34
7517199|NCT04013789|18510044|P1|COMPLETED|First Wear Period (1 Week)||33
7517200|NCT04013789|18510043|P2|STARTED|First Wear Period (1 Week)||34
7517201|NCT04013789|18510044|P1|STARTED|First Wear Period (1 Week)||33
7517202|NCT04012970|18510054|P2|NOT COMPLETED|Control Session, 30 Minutes||0
7517203|NCT04012970|18510055|P1|NOT COMPLETED|Control Session, 30 Minutes||0
7517204|NCT04012970|18510054|P2|COMPLETED|Control Session, 30 Minutes||14
7517205|NCT04012970|18510055|P1|COMPLETED|Control Session, 30 Minutes||26
7517206|NCT04012970|18510054|P2|STARTED|Control Session, 30 Minutes||14
7517207|NCT04012970|18510055|P1|STARTED|Control Session, 30 Minutes||26
7517208|NCT04012970|18510054|P2|NOT COMPLETED|Intervention Session, 30 Minutes||0
7517209|NCT04012970|18510055|P1|NOT COMPLETED|Intervention Session, 30 Minutes||0
7517210|NCT04012970|18510054|P2|COMPLETED|Intervention Session, 30 Minutes||14
7517211|NCT04012970|18510055|P1|COMPLETED|Intervention Session, 30 Minutes||26
7517212|NCT04012970|18510054|P2|STARTED|Intervention Session, 30 Minutes||14
7517213|NCT04012970|18510055|P1|STARTED|Intervention Session, 30 Minutes||26
7517214|NCT04011592|18510069|P2|NOT COMPLETED|Overall Study||0
7517215|NCT04011592|18510070|P1|NOT COMPLETED|Overall Study||0
7517216|NCT04011592|18510069|P2|COMPLETED|Overall Study||0
7517217|NCT04011592|18510070|P1|COMPLETED|Overall Study||1
7517218|NCT04011592|18510069|P2|STARTED|Overall Study||0
7517219|NCT04011592|18510070|P1|STARTED|Overall Study||1
7517220|NCT04010370|18510088|P1|NOT COMPLETED|Overall Study||0
7517221|NCT04010370|18510088|P1|COMPLETED|Overall Study||25
7517222|NCT04010370|18510088|P1|STARTED|Overall Study||25
7517223|NCT04007159|18510106|P1|NOT COMPLETED|Challenge Phase||3
7517224|NCT04007159|18510106|P1|COMPLETED|Challenge Phase||255
7517225|NCT04007159|18510106|P1|STARTED|Challenge Phase||258
7517226|NCT04007159|18510106|P1|NOT COMPLETED|Rest Phase||0
7517227|NCT04007159|18510106|P1|COMPLETED|Rest Phase||258
7517228|NCT04007159|18510106|P1|STARTED|Rest Phase||258
7517229|NCT04007159|18510106|P1|NOT COMPLETED|Induction Phase||22
7517230|NCT04007159|18510106|P1|COMPLETED|Induction Phase||258
7517231|NCT04007159|18510106|P1|STARTED|Induction Phase||280
7517232|NCT04007107|18510121|P4|NOT COMPLETED|Treatment Period 2 (Day 1)||0
7517233|NCT04007107|18510122|P3|NOT COMPLETED|Treatment Period 2 (Day 1)||0
7517234|NCT04007107|18510123|P2|NOT COMPLETED|Treatment Period 2 (Day 1)||1
7517235|NCT04007107|18510124|P1|NOT COMPLETED|Treatment Period 2 (Day 1)||0
7517236|NCT04007107|18510121|P4|COMPLETED|Treatment Period 2 (Day 1)||26
7517237|NCT04007107|18510122|P3|COMPLETED|Treatment Period 2 (Day 1)||25
7517238|NCT04007107|18510123|P2|COMPLETED|Treatment Period 2 (Day 1)||25
7517239|NCT04007107|18510124|P1|COMPLETED|Treatment Period 2 (Day 1)||26
7517240|NCT04007107|18510121|P4|STARTED|Treatment Period 2 (Day 1)||26
7517241|NCT04007107|18510122|P3|STARTED|Treatment Period 2 (Day 1)||25
7517242|NCT04007107|18510123|P2|STARTED|Treatment Period 2 (Day 1)||26
7517243|NCT04007107|18510124|P1|STARTED|Treatment Period 2 (Day 1)||26
7517244|NCT04007107|18510121|P4|NOT COMPLETED|Treatment Period 1 (Day 1)||0
7517245|NCT04007107|18510122|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
7517246|NCT04007107|18510123|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
7517247|NCT04007107|18510124|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
7517248|NCT04007107|18510121|P4|COMPLETED|Treatment Period 1 (Day 1)||26
7517249|NCT04007107|18510122|P3|COMPLETED|Treatment Period 1 (Day 1)||25
7517250|NCT04007107|18510123|P2|COMPLETED|Treatment Period 1 (Day 1)||26
7517251|NCT04007107|18510124|P1|COMPLETED|Treatment Period 1 (Day 1)||26
7517252|NCT04007107|18510121|P4|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
7517253|NCT04007107|18510122|P3|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
7517254|NCT04007107|18510123|P2|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
7517255|NCT04007107|18510124|P1|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
7517256|NCT04007107|18510121|P4|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
7517257|NCT04007107|18510122|P3|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||25
7517258|NCT04007107|18510123|P2|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
7517259|NCT04007107|18510124|P1|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
7517260|NCT04007107|18510121|P4|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
7517261|NCT04007107|18510122|P3|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||25
7517262|NCT04007107|18510123|P2|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
7517263|NCT04007107|18510124|P1|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
7517264|NCT04007107|18510121|P4|STARTED|Treatment Period 1 (Day 1)||26
7517265|NCT04007107|18510122|P3|STARTED|Treatment Period 1 (Day 1)||25
7517266|NCT04007107|18510123|P2|STARTED|Treatment Period 1 (Day 1)||26
7517267|NCT04007107|18510124|P1|STARTED|Treatment Period 1 (Day 1)||26
7517268|NCT04006795|18510129|P1|NOT COMPLETED|Challenge Phase||0
7517269|NCT04006795|18510129|P1|COMPLETED|Challenge Phase||37
7517270|NCT04006795|18510129|P1|STARTED|Challenge Phase||37
7517271|NCT04006795|18510129|P1|NOT COMPLETED|Rest Phase||0
7517272|NCT04006795|18510129|P1|COMPLETED|Rest Phase||37
7517273|NCT04006795|18510129|P1|STARTED|Rest Phase||37
7517274|NCT04006795|18510129|P1|NOT COMPLETED|Induction Phase||0
7517275|NCT04006795|18510129|P1|COMPLETED|Induction Phase||37
7517276|NCT04006795|18510129|P1|STARTED|Induction Phase||37
7517277|NCT04006366|18510152|P1|NOT COMPLETED|Overall Study||1
7517278|NCT04006366|18510152|P1|COMPLETED|Overall Study||5
7517279|NCT04006366|18510152|P1|STARTED|Overall Study||6
7517280|NCT04005885|18510158|P2|NOT COMPLETED|Third Intervention||0
7517281|NCT04005885|18510159|P1|NOT COMPLETED|Third Intervention||0
7517282|NCT04005885|18510158|P2|COMPLETED|Third Intervention||26
7517283|NCT04005885|18510159|P1|COMPLETED|Third Intervention||25
7517284|NCT04005885|18510158|P2|STARTED|Third Intervention||26
7517285|NCT04005885|18510159|P1|STARTED|Third Intervention||25
7517286|NCT04005885|18510158|P2|NOT COMPLETED|Second Intervention||2
7517287|NCT04005885|18510159|P1|NOT COMPLETED|Second Intervention||0
7517288|NCT04005885|18510158|P2|COMPLETED|Second Intervention||26
7517289|NCT04005885|18510159|P1|COMPLETED|Second Intervention||25
7517290|NCT04005885|18510158|P2|STARTED|Second Intervention||28
7517291|NCT04005885|18510159|P1|STARTED|Second Intervention||25
7517292|NCT04005885|18510158|P2|NOT COMPLETED|First Intervention||1
7517293|NCT04005885|18510159|P1|NOT COMPLETED|First Intervention||1
7517294|NCT04005885|18510158|P2|COMPLETED|First Intervention||28
7517295|NCT04005885|18510159|P1|COMPLETED|First Intervention||25
7517296|NCT04005885|18510158|P2|STARTED|First Intervention||29
7517297|NCT04005885|18510159|P1|STARTED|First Intervention||26
7517298|NCT04005391|18510205|P2|NOT COMPLETED|Overall Study||0
7517299|NCT04005391|18510206|P1|NOT COMPLETED|Overall Study||7
7517300|NCT04005391|18510205|P2|COMPLETED|Overall Study||100
7517301|NCT04005391|18510206|P1|COMPLETED|Overall Study||101
7517302|NCT04005391|18510205|P2|STARTED|Overall Study|10/23/18|100
7517303|NCT04005391|18510206|P1|STARTED|Overall Study|10/23/18|108
7517304|NCT04002973|18510214|P1|NOT COMPLETED|Overall Study||0
7517305|NCT04002973|18510214|P1|COMPLETED|Overall Study||11
7517306|NCT04002973|18510214|P1|STARTED|Overall Study||11
7517307|NCT04002960|18510218|P1|NOT COMPLETED|Overall Study||2
7517308|NCT04002960|18510218|P1|COMPLETED|Overall Study||21
7517309|NCT04002960|18510218|P1|STARTED|Overall Study||23
7517310|NCT04002791|18510224|P2|NOT COMPLETED|Overall Study||0
7517311|NCT04002791|18510225|P1|NOT COMPLETED|Overall Study||0
7517312|NCT04002791|18510224|P2|COMPLETED|Overall Study||126
7517313|NCT04002791|18510225|P1|COMPLETED|Overall Study||127
7517314|NCT04002791|18510224|P2|STARTED|Overall Study||126
7517315|NCT04002791|18510225|P1|STARTED|Overall Study||127
7517316|NCT04002648|18510235|P2|NOT COMPLETED|Overall Study||0
7517317|NCT04002648|18510236|P1|NOT COMPLETED|Overall Study||2
7517318|NCT04002648|18510235|P2|COMPLETED|Overall Study||104
7517319|NCT04002648|18510236|P1|COMPLETED|Overall Study||102
7517320|NCT04002648|18510235|P2|STARTED|Overall Study||104
7517321|NCT04002648|18510236|P1|STARTED|Overall Study||104
7517322|NCT04000815|18510247|P3|NOT COMPLETED|Overall Study||7
7517323|NCT04000815|18510248|P2|NOT COMPLETED|Overall Study||5
7517324|NCT04000815|18510249|P1|NOT COMPLETED|Overall Study||14
7517325|NCT04000815|18510247|P3|COMPLETED|Overall Study||15
7517326|NCT04000815|18510248|P2|COMPLETED|Overall Study||15
7517327|NCT04000815|18510249|P1|COMPLETED|Overall Study||15
7517328|NCT04000815|18510247|P3|STARTED|Overall Study||22
7517329|NCT04000815|18510248|P2|STARTED|Overall Study||20
7517330|NCT04000815|18510249|P1|STARTED|Overall Study||29
7517331|NCT04000373|18510263|P1|NOT COMPLETED|Overall Study||0
7517332|NCT04000373|18510263|P1|COMPLETED|Overall Study||5
7517333|NCT04000373|18510263|P1|STARTED|Overall Study||5
7517334|NCT03997825|18510269|P1|NOT COMPLETED|Overall Study||17
7517335|NCT03997825|18510269|P1|COMPLETED|Overall Study||100
7517336|NCT03997825|18510269|P1|STARTED|Overall Study||117
7517337|NCT03995680|18510280|P2|NOT COMPLETED|Overall Study||2
7517338|NCT03995680|18510281|P1|NOT COMPLETED|Overall Study||2
7517339|NCT03995680|18510280|P2|COMPLETED|Overall Study||196
7517340|NCT03995680|18510281|P1|COMPLETED|Overall Study||197
7517341|NCT03995680|18510280|P2|STARTED|Overall Study||198
7517342|NCT03995680|18510281|P1|STARTED|Overall Study||199
7517343|NCT03993392|18510303|P1|NOT COMPLETED|Overall Study||6
7517344|NCT03993392|18510303|P1|COMPLETED|Overall Study||20
7517345|NCT03993392|18510303|P1|Treated With SUBLOCADE|Overall Study||24
7517346|NCT03993392|18510303|P1|STARTED|Overall Study||26
7517347|NCT03993210|18510316|P2|NOT COMPLETED|Overall Study||0
7517348|NCT03993210|18510317|P1|NOT COMPLETED|Overall Study||0
7517349|NCT03993210|18510316|P2|COMPLETED|Overall Study||0
7517350|NCT03993210|18510317|P1|COMPLETED|Overall Study||1
7517351|NCT03993210|18510316|P2|STARTED|Overall Study||0
7517352|NCT03993210|18510317|P1|STARTED|Overall Study||1
7517353|NCT03992482|18510341|P2|NOT COMPLETED|Overall Study||0
7517354|NCT03992482|18510342|P1|NOT COMPLETED|Overall Study||0
7517355|NCT03992482|18510341|P2|COMPLETED|Overall Study||14
7517356|NCT03992482|18510342|P1|COMPLETED|Overall Study||13
7517357|NCT03992482|18510341|P2|STARTED|Overall Study||14
7517358|NCT03992482|18510342|P1|STARTED|Overall Study||13
7517359|NCT03992014|18510352|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
7517360|NCT03992014|18510352|P1|COMPLETED|Treatment Period 2 (8 Days)||6
7517361|NCT03992014|18510352|P1|STARTED|Treatment Period 2 (8 Days)||6
7517362|NCT03992014|18510352|P1|NOT COMPLETED|Washout Period (7 Days)||0
7517363|NCT03992014|18510352|P1|COMPLETED|Washout Period (7 Days)||6
7517364|NCT03992014|18510352|P1|STARTED|Washout Period (7 Days)||6
7517365|NCT03992014|18510352|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7517366|NCT03992014|18510352|P1|COMPLETED|Treatment Period 1 (8 Days)||6
7517367|NCT03992014|18510352|P1|STARTED|Treatment Period 1 (8 Days)||6
7517368|NCT03991715|18510411|P1|NOT COMPLETED|Overall Study||0
7517369|NCT03991715|18510411|P1|COMPLETED|Overall Study||5
7517370|NCT03991715|18510411|P1|STARTED|Overall Study||5
7517371|NCT03989570|18510423|P3|NOT COMPLETED|Overall Study||0
7517372|NCT03989570|18510424|P2|NOT COMPLETED|Overall Study||0
7517373|NCT03989570|18510425|P1|NOT COMPLETED|Overall Study||0
7517374|NCT03989570|18510423|P3|COMPLETED|Overall Study||31
7517375|NCT03989570|18510424|P2|COMPLETED|Overall Study||31
7517376|NCT03989570|18510425|P1|COMPLETED|Overall Study||31
7517377|NCT03989570|18510423|P3|STARTED|Overall Study||31
7517378|NCT03989570|18510424|P2|STARTED|Overall Study||31
7517379|NCT03989570|18510425|P1|STARTED|Overall Study||31
7517380|NCT03989427|18510441|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
7517381|NCT03989427|18510442|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
7517382|NCT03989427|18510441|P2|COMPLETED|Second Intervention (2 Weeks)||15
7517383|NCT03989427|18510442|P1|COMPLETED|Second Intervention (2 Weeks)||15
7517384|NCT03989427|18510441|P2|STARTED|Second Intervention (2 Weeks)||15
7517385|NCT03989427|18510442|P1|STARTED|Second Intervention (2 Weeks)||15
7517386|NCT03989427|18510441|P2|NOT COMPLETED|Washout (1 Week)||0
7517387|NCT03989427|18510442|P1|NOT COMPLETED|Washout (1 Week)||0
7517388|NCT03989427|18510441|P2|COMPLETED|Washout (1 Week)||15
7517389|NCT03989427|18510442|P1|COMPLETED|Washout (1 Week)||15
7517390|NCT03989427|18510441|P2|STARTED|Washout (1 Week)||15
7517391|NCT03989427|18510442|P1|STARTED|Washout (1 Week)||15
7517392|NCT03989427|18510441|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
7517393|NCT03989427|18510442|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
7517394|NCT03989427|18510441|P2|COMPLETED|First Intervention (2 Weeks)||15
7517395|NCT03989427|18510442|P1|COMPLETED|First Intervention (2 Weeks)||15
7517396|NCT03989427|18510441|P2|STARTED|First Intervention (2 Weeks)||15
7517397|NCT03989427|18510442|P1|STARTED|First Intervention (2 Weeks)||15
7517398|NCT03988907|18510451|P2|NOT COMPLETED|Overall Study||1
7517399|NCT03988907|18510452|P1|NOT COMPLETED|Overall Study||0
7517400|NCT03988907|18510451|P2|COMPLETED|Overall Study||26
7517401|NCT03988907|18510452|P1|COMPLETED|Overall Study||8
7517402|NCT03988907|18510451|P2|STARTED|Overall Study||27
7517403|NCT03988907|18510452|P1|STARTED|Overall Study||8
7517404|NCT03988426|18510484|P1|NOT COMPLETED|Overall Study||1
7517405|NCT03988426|18510484|P1|COMPLETED|Overall Study||24
7517406|NCT03988426|18510484|P1|STARTED|Overall Study||25
7517407|NCT03988088|18510508|P4|NOT COMPLETED|Open-Label Addendum||0
7517408|NCT03988088|18510509|P3|NOT COMPLETED|Open-Label Addendum||1
7517409|NCT03988088|18510510|P2|NOT COMPLETED|Open-Label Addendum||0
7517410|NCT03988088|18510511|P1|NOT COMPLETED|Open-Label Addendum||0
7517411|NCT03988088|18510508|P4|COMPLETED|Open-Label Addendum||2
7517412|NCT03988088|18510509|P3|COMPLETED|Open-Label Addendum||1
7517413|NCT03988088|18510510|P2|COMPLETED|Open-Label Addendum||0
7517414|NCT03988088|18510511|P1|COMPLETED|Open-Label Addendum||0
7517415|NCT03988088|18510508|P4|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
7517416|NCT03988088|18510509|P3|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
7517417|NCT03988088|18510510|P2|STARTED|Open-Label Addendum||0
7517418|NCT03988088|18510511|P1|STARTED|Open-Label Addendum||0
7517419|NCT03988088|18510508|P4|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
7517420|NCT03988088|18510509|P3|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
7517421|NCT03988088|18510510|P2|NOT COMPLETED|Single-Dose Pharmacokinetic Study||1
7517422|NCT03988088|18510511|P1|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
7517423|NCT03988088|18510508|P4|COMPLETED|Single-Dose Pharmacokinetic Study||0
7517424|NCT03988088|18510509|P3|COMPLETED|Single-Dose Pharmacokinetic Study||0
7517425|NCT03988088|18510510|P2|COMPLETED|Single-Dose Pharmacokinetic Study||6
7517426|NCT03988088|18510511|P1|COMPLETED|Single-Dose Pharmacokinetic Study||11
7517427|NCT03988088|18510508|P4|STARTED|Single-Dose Pharmacokinetic Study||0
7517428|NCT03988088|18510509|P3|STARTED|Single-Dose Pharmacokinetic Study||0
7517429|NCT03988088|18510510|P2|STARTED|Single-Dose Pharmacokinetic Study||7
7517430|NCT03988088|18510511|P1|STARTED|Single-Dose Pharmacokinetic Study||11
7517431|NCT03985657|18510521|P2|NOT COMPLETED|Intervention 2 (One Night)||0
7517432|NCT03985657|18510522|P1|NOT COMPLETED|Intervention 2 (One Night)||0
7517433|NCT03985657|18510521|P2|COMPLETED|Intervention 2 (One Night)||10
7517434|NCT03985657|18510522|P1|COMPLETED|Intervention 2 (One Night)||20
7517435|NCT03985657|18510521|P2|STARTED|Intervention 2 (One Night)||10
7517436|NCT03985657|18510522|P1|STARTED|Intervention 2 (One Night)||20
7517437|NCT03985657|18510521|P2|NOT COMPLETED|Washout (Up to 1 Week)||0
7517438|NCT03985657|18510522|P1|NOT COMPLETED|Washout (Up to 1 Week)||0
7517439|NCT03985657|18510521|P2|COMPLETED|Washout (Up to 1 Week)||10
7517440|NCT03985657|18510522|P1|COMPLETED|Washout (Up to 1 Week)||20
7517441|NCT03985657|18510521|P2|STARTED|Washout (Up to 1 Week)||10
7517442|NCT03985657|18510522|P1|STARTED|Washout (Up to 1 Week)||20
7517443|NCT03985657|18510521|P2|NOT COMPLETED|Intervention 1 (One Night)||1
7517444|NCT03985657|18510522|P1|NOT COMPLETED|Intervention 1 (One Night)||0
7517445|NCT03985657|18510521|P2|COMPLETED|Intervention 1 (One Night)||10
7517446|NCT03985657|18510522|P1|COMPLETED|Intervention 1 (One Night)||20
7517447|NCT03985657|18510521|P2|STARTED|Intervention 1 (One Night)||11
7517448|NCT03985657|18510522|P1|STARTED|Intervention 1 (One Night)||20
7517449|NCT03984838|18510534|P1|NOT COMPLETED|Overall Study||0
7517450|NCT03984838|18510534|P1|COMPLETED|Overall Study||16
7517451|NCT03984838|18510534|P1|STARTED|Overall Study||16
7517452|NCT03984825|18510594|P1|NOT COMPLETED|Treatment Period 2 (Day 11 to 21)||4
7517453|NCT03984825|18510594|P1|COMPLETED|Treatment Period 2 (Day 11 to 21)||17
7517454|NCT03984825|18510594|P1|STARTED|Treatment Period 2 (Day 11 to 21)||21
7517455|NCT03984825|18510594|P1|NOT COMPLETED|Treatment Period 1 (Day 1 to 10)||2
7517456|NCT03984825|18510594|P1|COMPLETED|Treatment Period 1 (Day 1 to 10)||21
7517457|NCT03984825|18510594|P1|STARTED|Treatment Period 1 (Day 1 to 10)||23
7517458|NCT03984825|18510594|P1|NOT COMPLETED|Run-in Period (Day -3 to -1)||0
7517459|NCT03984825|18510594|P1|COMPLETED|Run-in Period (Day -3 to -1)||23
7517460|NCT03984825|18510594|P1|STARTED|Run-in Period (Day -3 to -1)||23
7517461|NCT03983317|18510708|P1|NOT COMPLETED|Overall Study||5
7517462|NCT03983317|18510708|P1|COMPLETED|Overall Study||20
7517463|NCT03983317|18510708|P1|STARTED|Overall Study||25
7517464|NCT03982433|18510715|P1|NOT COMPLETED|Overall Study||1
7517465|NCT03982433|18510715|P1|COMPLETED|Overall Study||7
7517466|NCT03982433|18510715|P1|STARTED|Overall Study||8
7517467|NCT03979807|18510728|P2|NOT COMPLETED|Overall Study||0
7517468|NCT03979807|18510729|P1|NOT COMPLETED|Overall Study||0
7517469|NCT03979807|18510728|P2|COMPLETED|Overall Study||7420
7517470|NCT03979807|18510729|P1|COMPLETED|Overall Study||3876
7517471|NCT03979807|18510728|P2|STARTED|Overall Study||7420
7517472|NCT03979807|18510729|P1|STARTED|Overall Study||3876
7517473|NCT03979079|18510735|P1|NOT COMPLETED|Overall Study||0
7517474|NCT03979079|18510735|P1|COMPLETED|Overall Study||2384
7517475|NCT03979079|18510735|P1|STARTED|Overall Study||2384
7517476|NCT03979066|18510743|P2|NOT COMPLETED|Overall Study||0
7517477|NCT03979066|18510744|P1|NOT COMPLETED|Overall Study||0
7517478|NCT03979066|18510743|P2|COMPLETED|Overall Study||0
7517479|NCT03979066|18510744|P1|COMPLETED|Overall Study||0
7517480|NCT03979066|18510743|P2|STARTED|Overall Study||0
7517481|NCT03979066|18510744|P1|STARTED|Overall Study||0
7517482|NCT03977935|18510760|P2|NOT COMPLETED|Overall Study||0
7517483|NCT03977935|18510761|P1|NOT COMPLETED|Overall Study||0
7517484|NCT03977935|18510760|P2|COMPLETED|Overall Study||40
7517485|NCT03977935|18510761|P1|COMPLETED|Overall Study||40
7517486|NCT03977935|18510760|P2|STARTED|Overall Study||40
7517487|NCT03977935|18510761|P1|STARTED|Overall Study||40
7517488|NCT03977818|18510787|P1|NOT COMPLETED|Overall Study||0
7517489|NCT03977818|18510787|P1|COMPLETED|Overall Study||2165
7517490|NCT03977818|18510787|P1|STARTED|Overall Study||2165
7517491|NCT03977727|18510793|P2|NOT COMPLETED|Second Treatment||3
7517492|NCT03977727|18510794|P1|NOT COMPLETED|Second Treatment||0
7517493|NCT03977727|18510793|P2|COMPLETED|Second Treatment||17
7517494|NCT03977727|18510794|P1|COMPLETED|Second Treatment||20
7517495|NCT03977727|18510793|P2|STARTED|Second Treatment||20
7517496|NCT03977727|18510794|P1|STARTED|Second Treatment||20
7517497|NCT03977727|18510793|P2|NOT COMPLETED|First Treatment||0
7517498|NCT03977727|18510794|P1|NOT COMPLETED|First Treatment||0
7517499|NCT03977727|18510793|P2|COMPLETED|First Treatment||20
7517500|NCT03977727|18510794|P1|COMPLETED|First Treatment||20
7517501|NCT03977727|18510793|P2|Received Treatment|First Treatment||20
7517502|NCT03977727|18510794|P1|Received Treatment|First Treatment||20
7517503|NCT03977727|18510793|P2|STARTED|First Treatment||20
7517504|NCT03977727|18510794|P1|STARTED|First Treatment||20
7517505|NCT03976466|18510840|P2|NOT COMPLETED|Overall Study||3
7517506|NCT03976466|18510841|P1|NOT COMPLETED|Overall Study||1
7517507|NCT03976466|18510840|P2|COMPLETED|Overall Study||40
7517508|NCT03976466|18510841|P1|COMPLETED|Overall Study||43
7517509|NCT03976466|18510840|P2|STARTED|Overall Study||43
7517510|NCT03976466|18510841|P1|STARTED|Overall Study||44
7517511|NCT03975790|18510852|P3|NOT COMPLETED|Overall Study||0
7517512|NCT03975790|18510853|P2|NOT COMPLETED|Overall Study||0
7517513|NCT03975790|18510854|P1|NOT COMPLETED|Overall Study||0
7517514|NCT03975790|18510852|P3|COMPLETED|Overall Study||48
7517515|NCT03975790|18510853|P2|COMPLETED|Overall Study||94
7517516|NCT03975790|18510854|P1|COMPLETED|Overall Study||337
7517517|NCT03975790|18510852|P3|STARTED|Overall Study||48
7517518|NCT03975790|18510853|P2|STARTED|Overall Study||94
7517519|NCT03975790|18510854|P1|STARTED|Overall Study||337
7517520|NCT03974802|18511067|P1|NOT COMPLETED|Overall Study||0
7517521|NCT03974802|18511067|P1|COMPLETED|Overall Study||41
7517522|NCT03974802|18511067|P1|STARTED|Overall Study||41
7517523|NCT03973905|18511104|P2|NOT COMPLETED|Overall Study||0
7517524|NCT03973905|18511105|P1|NOT COMPLETED|Overall Study||0
7517525|NCT03973905|18511104|P2|COMPLETED|Overall Study||183
7517526|NCT03973905|18511105|P1|COMPLETED|Overall Study||107
7517527|NCT03973905|18511104|P2|STARTED|Overall Study||183
7517528|NCT03973905|18511105|P1|STARTED|Overall Study||107
7517529|NCT03972813|18511135|P18|NOT COMPLETED|Overall Study||2
7517530|NCT03972813|18511136|P17|NOT COMPLETED|Overall Study||3
7517531|NCT03972813|18511137|P16|NOT COMPLETED|Overall Study||6
7517532|NCT03972813|18511138|P15|NOT COMPLETED|Overall Study||2
7517533|NCT03972813|18511139|P14|NOT COMPLETED|Overall Study||3
7517534|NCT03972813|18511140|P13|NOT COMPLETED|Overall Study||3
7517535|NCT03972813|18511141|P12|NOT COMPLETED|Overall Study||4
7517536|NCT03972813|18511142|P11|NOT COMPLETED|Overall Study||5
7517537|NCT03972813|18511143|P10|NOT COMPLETED|Overall Study||2
7517538|NCT03972813|18511144|P9|NOT COMPLETED|Overall Study||5
7517539|NCT03972813|18511145|P8|NOT COMPLETED|Overall Study||3
7517540|NCT03972813|18511146|P7|NOT COMPLETED|Overall Study||4
7517541|NCT03972813|18511147|P6|NOT COMPLETED|Overall Study||2
7517542|NCT03972813|18511148|P5|NOT COMPLETED|Overall Study||4
7517543|NCT03972813|18511149|P4|NOT COMPLETED|Overall Study||4
7517544|NCT03972813|18511150|P3|NOT COMPLETED|Overall Study||6
7517545|NCT03972813|18511151|P2|NOT COMPLETED|Overall Study||4
7517546|NCT03972813|18511152|P1|NOT COMPLETED|Overall Study||6
7517547|NCT03972813|18511135|P18|COMPLETED|Overall Study||48
7517548|NCT03972813|18511136|P17|COMPLETED|Overall Study||48
7517549|NCT03972813|18511137|P16|COMPLETED|Overall Study||50
7517550|NCT03972813|18511138|P15|COMPLETED|Overall Study||56
7517551|NCT03972813|18511139|P14|COMPLETED|Overall Study||52
7517552|NCT03972813|18511140|P13|COMPLETED|Overall Study||55
7517553|NCT03972813|18511141|P12|COMPLETED|Overall Study||51
7517554|NCT03972813|18511142|P11|COMPLETED|Overall Study||57
7517555|NCT03972813|18511143|P10|COMPLETED|Overall Study||58
7517556|NCT03972813|18511144|P9|COMPLETED|Overall Study||53
7517557|NCT03972813|18511145|P8|COMPLETED|Overall Study||52
7517558|NCT03972813|18511146|P7|COMPLETED|Overall Study||49
7517559|NCT03972813|18511147|P6|COMPLETED|Overall Study||49
7517560|NCT03972813|18511148|P5|COMPLETED|Overall Study||48
7517561|NCT03972813|18511149|P4|COMPLETED|Overall Study||51
7517562|NCT03972813|18511150|P3|COMPLETED|Overall Study||52
7517563|NCT03972813|18511151|P2|COMPLETED|Overall Study||45
7517564|NCT03972813|18511152|P1|COMPLETED|Overall Study||79
7517565|NCT03972813|18511135|P18|STARTED|Overall Study||50
7517566|NCT03972813|18511136|P17|STARTED|Overall Study||51
7517567|NCT03972813|18511137|P16|STARTED|Overall Study||56
7517568|NCT03972813|18511138|P15|STARTED|Overall Study||58
7517569|NCT03972813|18511139|P14|STARTED|Overall Study||55
7517570|NCT03972813|18511140|P13|STARTED|Overall Study||58
7517571|NCT03972813|18511141|P12|STARTED|Overall Study||55
7517572|NCT03972813|18511142|P11|STARTED|Overall Study||62
7517573|NCT03972813|18511143|P10|STARTED|Overall Study||60
7517574|NCT03972813|18511144|P9|STARTED|Overall Study||58
7517575|NCT03972813|18511145|P8|STARTED|Overall Study||55
7517576|NCT03972813|18511146|P7|STARTED|Overall Study||53
7517577|NCT03972813|18511147|P6|STARTED|Overall Study||51
7517578|NCT03972813|18511148|P5|STARTED|Overall Study||52
7517579|NCT03972813|18511149|P4|STARTED|Overall Study||55
7517580|NCT03972813|18511150|P3|STARTED|Overall Study||58
7517581|NCT03972813|18511151|P2|STARTED|Overall Study||49
7517582|NCT03972813|18511152|P1|STARTED|Overall Study||85
7517583|NCT03972137|18511190|P1|NOT COMPLETED|Overall Study||6
7517584|NCT03972137|18511190|P1|COMPLETED|Overall Study||4
7517585|NCT03972137|18511190|P1|Follow-up Completed|Overall Study||4
7517586|NCT03972137|18511190|P1|Treatment Completed|Overall Study||6
7517587|NCT03972137|18511190|P1|Enrolled|Overall Study||10
7517588|NCT03972137|18511190|P1|STARTED|Overall Study||10
7517589|NCT03970824|18511215|P3|NOT COMPLETED|Overall Study||4
7517590|NCT03970824|18511216|P2|NOT COMPLETED|Overall Study||3
7517591|NCT03970824|18511217|P1|NOT COMPLETED|Overall Study||2
7517592|NCT03970824|18511215|P3|COMPLETED|Overall Study||102
7517593|NCT03970824|18511216|P2|COMPLETED|Overall Study||100
7517594|NCT03970824|18511217|P1|COMPLETED|Overall Study||101
7517595|NCT03970824|18511215|P3|STARTED|Overall Study||106
7517596|NCT03970824|18511216|P2|STARTED|Overall Study||103
7517597|NCT03970824|18511217|P1|STARTED|Overall Study||103
7517598|NCT03970395|18511239|P2|NOT COMPLETED|Overall Study||12
7517599|NCT03970395|18511240|P1|NOT COMPLETED|Overall Study||7
7517600|NCT03970395|18511239|P2|COMPLETED|Overall Study||36
7517601|NCT03970395|18511240|P1|COMPLETED|Overall Study||41
7517602|NCT03970395|18511239|P2|STARTED|Overall Study||48
7517603|NCT03970395|18511240|P1|STARTED|Overall Study||48
7517604|NCT03966365|18511258|P2|NOT COMPLETED|Overall Study||0
7517605|NCT03966365|18511259|P1|NOT COMPLETED|Overall Study||1
7517606|NCT03966365|18511258|P2|COMPLETED|Overall Study||12
7517607|NCT03966365|18511259|P1|COMPLETED|Overall Study||11
7517608|NCT03966365|18511258|P2|STARTED|Overall Study||12
7517609|NCT03966365|18511259|P1|STARTED|Overall Study||12
7517610|NCT03965754|18511281|P4|NOT COMPLETED|Overall Study||0
7517611|NCT03965754|18511282|P3|NOT COMPLETED|Overall Study||0
7517612|NCT03965754|18511283|P2|NOT COMPLETED|Overall Study||0
7517613|NCT03965754|18511284|P1|NOT COMPLETED|Overall Study||0
7517614|NCT03965754|18511281|P4|COMPLETED|Overall Study||1425
7517615|NCT03965754|18511282|P3|COMPLETED|Overall Study||1425
7517616|NCT03965754|18511283|P2|COMPLETED|Overall Study||1425
7517617|NCT03965754|18511284|P1|COMPLETED|Overall Study||1422
7517618|NCT03965754|18511281|P4|STARTED|Overall Study||1425
7517619|NCT03965754|18511282|P3|STARTED|Overall Study||1425
7517620|NCT03965754|18511283|P2|STARTED|Overall Study||1425
7517621|NCT03965754|18511284|P1|STARTED|Overall Study||1422
7517622|NCT03965533|18511305|P7|NOT COMPLETED|Part B (112 Days)||0
7517623|NCT03965533|18511306|P6|NOT COMPLETED|Part B (112 Days)||0
7517624|NCT03965533|18511307|P5|NOT COMPLETED|Part B (112 Days)||0
7517625|NCT03965533|18511308|P4|NOT COMPLETED|Part B (112 Days)||0
7517626|NCT03965533|18511309|P3|NOT COMPLETED|Part B (112 Days)||0
7517627|NCT03965533|18511310|P2|NOT COMPLETED|Part B (112 Days)||0
7517628|NCT03965533|18511311|P1|NOT COMPLETED|Part B (112 Days)||0
7517629|NCT03965533|18511305|P7|COMPLETED|Part B (112 Days)||8
7517630|NCT03965533|18511306|P6|COMPLETED|Part B (112 Days)||8
7517631|NCT03965533|18511307|P5|COMPLETED|Part B (112 Days)||4
7517632|NCT03965533|18511308|P4|COMPLETED|Part B (112 Days)||0
7517633|NCT03965533|18511309|P3|COMPLETED|Part B (112 Days)||0
7517634|NCT03965533|18511310|P2|COMPLETED|Part B (112 Days)||0
7517635|NCT03965533|18511311|P1|COMPLETED|Part B (112 Days)||0
7517636|NCT03965533|18511305|P7|STARTED|Part B (112 Days)||8
7517637|NCT03965533|18511306|P6|STARTED|Part B (112 Days)||8
7517638|NCT03965533|18511307|P5|STARTED|Part B (112 Days)||4
7517639|NCT03965533|18511308|P4|STARTED|Part B (112 Days)||0
7517640|NCT03965533|18511309|P3|STARTED|Part B (112 Days)||0
7517641|NCT03965533|18511310|P2|STARTED|Part B (112 Days)||0
7517642|NCT03965533|18511311|P1|STARTED|Part B (112 Days)||0
7517643|NCT03965533|18511305|P7|NOT COMPLETED|Part A (112 Days)||0
7517644|NCT03965533|18511306|P6|NOT COMPLETED|Part A (112 Days)||0
7517645|NCT03965533|18511307|P5|NOT COMPLETED|Part A (112 Days)||0
7517646|NCT03965533|18511308|P4|NOT COMPLETED|Part A (112 Days)||0
7517647|NCT03965533|18511309|P3|NOT COMPLETED|Part A (112 Days)||0
7517648|NCT03965533|18511310|P2|NOT COMPLETED|Part A (112 Days)||0
7517649|NCT03965533|18511311|P1|NOT COMPLETED|Part A (112 Days)||0
7517650|NCT03965533|18511305|P7|COMPLETED|Part A (112 Days)||0
7517651|NCT03965533|18511306|P6|COMPLETED|Part A (112 Days)||0
7517652|NCT03965533|18511307|P5|COMPLETED|Part A (112 Days)||0
7517653|NCT03965533|18511308|P4|COMPLETED|Part A (112 Days)||6
7517654|NCT03965533|18511309|P3|COMPLETED|Part A (112 Days)||2
7517655|NCT03965533|18511310|P2|COMPLETED|Part A (112 Days)||6
7517656|NCT03965533|18511311|P1|COMPLETED|Part A (112 Days)||2
7517657|NCT03965533|18511305|P7|STARTED|Part A (112 Days)||0
7517658|NCT03965533|18511306|P6|STARTED|Part A (112 Days)||0
7517659|NCT03965533|18511307|P5|STARTED|Part A (112 Days)||0
7517660|NCT03965533|18511308|P4|STARTED|Part A (112 Days)||6
7517661|NCT03965533|18511309|P3|STARTED|Part A (112 Days)||2
7517662|NCT03965533|18511310|P2|STARTED|Part A (112 Days)||6
7517663|NCT03965533|18511311|P1|STARTED|Part A (112 Days)||2
7517664|NCT03965403|18511394|P1|NOT COMPLETED|Overall Study||1
7517665|NCT03965403|18511394|P1|COMPLETED|Overall Study||6
7517666|NCT03965403|18511394|P1|STARTED|Overall Study||7
7517667|NCT03965052|18511407|P2|NOT COMPLETED|Overall Study||0
7517668|NCT03965052|18511408|P1|NOT COMPLETED|Overall Study||1
7517669|NCT03965052|18511407|P2|COMPLETED|Overall Study||12
7517670|NCT03965052|18511408|P1|COMPLETED|Overall Study||11
7517671|NCT03965052|18511407|P2|STARTED|Overall Study||12
7517672|NCT03965052|18511408|P1|STARTED|Overall Study||12
7517673|NCT03965039|18511430|P4|NOT COMPLETED|Overall Study||1
7517674|NCT03965039|18511431|P3|NOT COMPLETED|Overall Study||0
7517675|NCT03965039|18511432|P2|NOT COMPLETED|Overall Study||1
7517676|NCT03965039|18511433|P1|NOT COMPLETED|Overall Study||0
7517677|NCT03965039|18511430|P4|COMPLETED|Overall Study||29
7517678|NCT03965039|18511431|P3|COMPLETED|Overall Study||30
7517679|NCT03965039|18511432|P2|COMPLETED|Overall Study||29
7517680|NCT03965039|18511433|P1|COMPLETED|Overall Study||30
7517681|NCT03965039|18511430|P4|STARTED|Overall Study||30
7517682|NCT03965039|18511431|P3|STARTED|Overall Study||30
7517683|NCT03965039|18511432|P2|STARTED|Overall Study||30
7517684|NCT03965039|18511433|P1|STARTED|Overall Study||30
7517685|NCT03964220|18511489|P2|NOT COMPLETED|Overall Study||0
7517686|NCT03964220|18511490|P1|NOT COMPLETED|Overall Study||0
7517687|NCT03964220|18511489|P2|COMPLETED|Overall Study||5238
7517688|NCT03964220|18511490|P1|COMPLETED|Overall Study||2619
7517689|NCT03964220|18511489|P2|STARTED|Overall Study||5238
7517690|NCT03964220|18511490|P1|STARTED|Overall Study||2619
7517691|NCT03962790|18511504|P2|NOT COMPLETED|Period 2||0
7517692|NCT03962790|18511505|P1|NOT COMPLETED|Period 2||0
7517693|NCT03962790|18511504|P2|COMPLETED|Period 2||44
7517694|NCT03962790|18511505|P1|COMPLETED|Period 2||45
7517695|NCT03962790|18511504|P2|STARTED|Period 2||44
7517696|NCT03962790|18511505|P1|STARTED|Period 2||45
7517697|NCT03962790|18511504|P2|NOT COMPLETED|Period 1||2
7517698|NCT03962790|18511505|P1|NOT COMPLETED|Period 1||3
7517699|NCT03962790|18511504|P2|COMPLETED|Period 1||44
7517700|NCT03962790|18511505|P1|COMPLETED|Period 1||45
7517701|NCT03962790|18511504|P2|STARTED|Period 1||46
7517702|NCT03962790|18511505|P1|STARTED|Period 1||48
7517703|NCT03962634|18511519|P2|NOT COMPLETED|Overall Study||0
7517704|NCT03962634|18511520|P1|NOT COMPLETED|Overall Study||0
7517705|NCT03962634|18511519|P2|COMPLETED|Overall Study||2
7517706|NCT03962634|18511520|P1|COMPLETED|Overall Study||1
7517707|NCT03962634|18511519|P2|STARTED|Overall Study||2
7517708|NCT03962634|18511520|P1|STARTED|Overall Study||1
7517709|NCT03961308|18511540|P2|NOT COMPLETED|Overall Study||2
7517710|NCT03961308|18511541|P1|NOT COMPLETED|Overall Study||2
7517711|NCT03961308|18511540|P2|COMPLETED|Overall Study||100
7517712|NCT03961308|18511541|P1|COMPLETED|Overall Study||100
7517713|NCT03961308|18511540|P2|STARTED|Overall Study||102
7517714|NCT03961308|18511541|P1|STARTED|Overall Study||102
7517715|NCT03961295|18511553|P2|NOT COMPLETED|Overall Study||0
7517716|NCT03961295|18511554|P1|NOT COMPLETED|Overall Study||0
7517717|NCT03961295|18511553|P2|COMPLETED|Overall Study||12
7517718|NCT03961295|18511554|P1|COMPLETED|Overall Study||12
7517719|NCT03961295|18511553|P2|STARTED|Overall Study||12
7517720|NCT03961295|18511554|P1|STARTED|Overall Study||12
7517721|NCT03961100|18511569|P5|NOT COMPLETED|Part 2||0
7517722|NCT03961100|18511570|P4|NOT COMPLETED|Part 2||0
7517723|NCT03961100|18511571|P3|NOT COMPLETED|Part 2||0
7517724|NCT03961100|18511572|P2|NOT COMPLETED|Part 2||0
7517725|NCT03961100|18511573|P1|NOT COMPLETED|Part 2||0
7517726|NCT03961100|18511569|P5|COMPLETED|Part 2||8
7517727|NCT03961100|18511570|P4|COMPLETED|Part 2||8
7517728|NCT03961100|18511571|P3|COMPLETED|Part 2||0
7517729|NCT03961100|18511572|P2|COMPLETED|Part 2||0
7517730|NCT03961100|18511573|P1|COMPLETED|Part 2||0
7517731|NCT03961100|18511569|P5|STARTED|Part 2||8
7517732|NCT03961100|18511570|P4|STARTED|Part 2||8
7517733|NCT03961100|18511571|P3|STARTED|Part 2||0
7517734|NCT03961100|18511572|P2|STARTED|Part 2||0
7517735|NCT03961100|18511573|P1|STARTED|Part 2||0
7517736|NCT03961100|18511569|P5|NOT COMPLETED|Part 1||0
7517737|NCT03961100|18511570|P4|NOT COMPLETED|Part 1||0
7517738|NCT03961100|18511571|P3|NOT COMPLETED|Part 1||0
7517739|NCT03961100|18511572|P2|NOT COMPLETED|Part 1||0
7517740|NCT03961100|18511573|P1|NOT COMPLETED|Part 1||0
7517741|NCT03961100|18511569|P5|COMPLETED|Part 1||0
7517742|NCT03961100|18511570|P4|COMPLETED|Part 1||0
7517743|NCT03961100|18511571|P3|COMPLETED|Part 1||5
7517744|NCT03961100|18511572|P2|COMPLETED|Part 1||5
7517745|NCT03961100|18511573|P1|COMPLETED|Part 1||5
7517746|NCT03961100|18511569|P5|STARTED|Part 1||0
7517747|NCT03961100|18511570|P4|STARTED|Part 1||0
7517748|NCT03961100|18511571|P3|STARTED|Part 1||5
7517749|NCT03961100|18511572|P2|STARTED|Part 1||5
7517750|NCT03961100|18511573|P1|STARTED|Part 1||5
7517751|NCT03959332|18511607|P2|NOT COMPLETED|Overall Study||0
7517752|NCT03959332|18511608|P1|NOT COMPLETED|Overall Study||0
7517753|NCT03959332|18511607|P2|COMPLETED|Overall Study||16
7517754|NCT03959332|18511608|P1|COMPLETED|Overall Study||16
7517755|NCT03959332|18511607|P2|STARTED|Overall Study||16
7517756|NCT03959332|18511608|P1|STARTED|Overall Study||16
7517757|NCT03958071|18511635|P3|NOT COMPLETED|Overall Study||0
7517758|NCT03958071|18511636|P2|NOT COMPLETED|Overall Study||0
7517759|NCT03958071|18511637|P1|NOT COMPLETED|Overall Study||0
7517760|NCT03958071|18511635|P3|COMPLETED|Overall Study||12494
7517761|NCT03958071|18511636|P2|COMPLETED|Overall Study||423
7517762|NCT03958071|18511637|P1|COMPLETED|Overall Study||347
7517763|NCT03958071|18511635|P3|STARTED|Overall Study||12494
7517764|NCT03958071|18511636|P2|STARTED|Overall Study||423
7517765|NCT03958071|18511637|P1|STARTED|Overall Study||347
7517766|NCT03954626|18511661|P1|NOT COMPLETED|Overall Study||0
7517767|NCT03954626|18511661|P1|COMPLETED|Overall Study||14
7517768|NCT03954626|18511661|P1|STARTED|Overall Study||14
7517769|NCT03954158|18511669|P4|NOT COMPLETED|Overall Study||0
7517770|NCT03954158|18511670|P3|NOT COMPLETED|Overall Study||0
7517771|NCT03954158|18511671|P2|NOT COMPLETED|Overall Study||0
7517772|NCT03954158|18511672|P1|NOT COMPLETED|Overall Study||0
7517773|NCT03954158|18511669|P4|COMPLETED|Overall Study||20
7517774|NCT03954158|18511670|P3|COMPLETED|Overall Study||20
7517775|NCT03954158|18511671|P2|COMPLETED|Overall Study||21
7517776|NCT03954158|18511672|P1|COMPLETED|Overall Study||20
7517777|NCT03954158|18511669|P4|STARTED|Overall Study||20
7517778|NCT03954158|18511670|P3|STARTED|Overall Study||20
7517779|NCT03954158|18511671|P2|STARTED|Overall Study||21
7517780|NCT03954158|18511672|P1|STARTED|Overall Study||20
7517781|NCT03953820|18511734|P3|NOT COMPLETED|DBF Following High-Fat Meal||0
7517782|NCT03953820|18511735|P2|NOT COMPLETED|DBF Following High-Fat Meal||0
7517783|NCT03953820|18511736|P1|NOT COMPLETED|DBF Following High-Fat Meal||0
7517784|NCT03953820|18511734|P3|COMPLETED|DBF Following High-Fat Meal||10
7517785|NCT03953820|18511735|P2|COMPLETED|DBF Following High-Fat Meal||0
7517786|NCT03953820|18511736|P1|COMPLETED|DBF Following High-Fat Meal||0
7517787|NCT03953820|18511734|P3|STARTED|DBF Following High-Fat Meal|Participants in Period 2 completed 1 of the 2 arms in Period 1 and volunteered to continue.|10
7517788|NCT03953820|18511735|P2|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
7517789|NCT03953820|18511736|P1|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
7517790|NCT03953820|18511734|P3|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
7517791|NCT03953820|18511735|P2|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
7517792|NCT03953820|18511736|P1|NOT COMPLETED|Two-Sequence, Two-Way Crossover||2
7517793|NCT03953820|18511734|P3|COMPLETED|Two-Sequence, Two-Way Crossover||0
7517794|NCT03953820|18511735|P2|COMPLETED|Two-Sequence, Two-Way Crossover||16
7517795|NCT03953820|18511736|P1|COMPLETED|Two-Sequence, Two-Way Crossover||13
7517796|NCT03953820|18511734|P3|STARTED|Two-Sequence, Two-Way Crossover||0
7517797|NCT03953820|18511735|P2|STARTED|Two-Sequence, Two-Way Crossover||16
7517798|NCT03953820|18511736|P1|STARTED|Two-Sequence, Two-Way Crossover||15
7517799|NCT03953183|18511752|P2|NOT COMPLETED|Overall Study||2
7517800|NCT03953183|18511753|P1|NOT COMPLETED|Overall Study||0
7517801|NCT03953183|18511752|P2|COMPLETED|Overall Study||28
7517802|NCT03953183|18511753|P1|COMPLETED|Overall Study||30
7517803|NCT03953183|18511752|P2|STARTED|Overall Study||30
7517804|NCT03953183|18511753|P1|STARTED|Overall Study||30
7517805|NCT03951610|18511789|P2|NOT COMPLETED|Second Intervention||0
7517806|NCT03951610|18511790|P1|NOT COMPLETED|Second Intervention||0
7517807|NCT03951610|18511789|P2|COMPLETED|Second Intervention||25
7517808|NCT03951610|18511790|P1|COMPLETED|Second Intervention||27
7517809|NCT03951610|18511789|P2|STARTED|Second Intervention||25
7517810|NCT03951610|18511790|P1|STARTED|Second Intervention||27
7517811|NCT03951610|18511789|P2|NOT COMPLETED|First Intervention||0
7517812|NCT03951610|18511790|P1|NOT COMPLETED|First Intervention||0
7517813|NCT03951610|18511789|P2|COMPLETED|First Intervention||25
7517814|NCT03951610|18511790|P1|COMPLETED|First Intervention||27
7517815|NCT03951610|18511789|P2|STARTED|First Intervention||25
7517816|NCT03951610|18511790|P1|STARTED|First Intervention||27
7517817|NCT03950674|18511828|P2|NOT COMPLETED|Overall Study||15
7517818|NCT03950674|18511829|P1|NOT COMPLETED|Overall Study||25
7517819|NCT03950674|18511828|P2|COMPLETED|Overall Study||0
7517820|NCT03950674|18511829|P1|COMPLETED|Overall Study||0
7517821|NCT03950674|18511828|P2|Switched to Pembrolizumab|Overall Study||4
7517822|NCT03950674|18511829|P1|Switched to Pembrolizumab|Overall Study||0
7517823|NCT03950674|18511828|P2|Treated|Overall Study||15
7517824|NCT03950674|18511829|P1|Treated|Overall Study||25
7517825|NCT03950674|18511828|P2|STARTED|Overall Study||15
7517826|NCT03950674|18511829|P1|STARTED|Overall Study||25
7517827|NCT03949621|18511850|P2|NOT COMPLETED|Overall Study||0
7517828|NCT03949621|18511851|P1|NOT COMPLETED|Overall Study||0
7517829|NCT03949621|18511850|P2|COMPLETED|Overall Study||12
7517830|NCT03949621|18511851|P1|COMPLETED|Overall Study||12
7517831|NCT03949621|18511850|P2|STARTED|Overall Study||12
7517832|NCT03949621|18511851|P1|STARTED|Overall Study||12
7517833|NCT03948581|18511863|P2|NOT COMPLETED|Overall Study||1
7517834|NCT03948581|18511864|P1|NOT COMPLETED|Overall Study||0
7517835|NCT03948581|18511863|P2|COMPLETED|Overall Study||50
7517836|NCT03948581|18511864|P1|COMPLETED|Overall Study||51
7517837|NCT03948581|18511863|P2|STARTED|Overall Study||51
7517838|NCT03948581|18511864|P1|STARTED|Overall Study||51
7517839|NCT03946124|18511874|P1|NOT COMPLETED|Overall Study||19
7517840|NCT03946124|18511874|P1|COMPLETED|Overall Study||55
7517841|NCT03946124|18511874|P1|STARTED|Overall Study||74
7517842|NCT03943095|18511880|P2|NOT COMPLETED|Overall Study||1
7517843|NCT03943095|18511881|P1|NOT COMPLETED|Overall Study||1
7517844|NCT03943095|18511880|P2|COMPLETED|Overall Study||51
7517845|NCT03943095|18511881|P1|COMPLETED|Overall Study||51
7517846|NCT03943095|18511880|P2|STARTED|Overall Study||52
7517847|NCT03943095|18511881|P1|STARTED|Overall Study||52
7517848|NCT03937479|18511930|P5|NOT COMPLETED|Overall Study||5
7517849|NCT03937479|18511931|P4|NOT COMPLETED|Overall Study||6
7517850|NCT03937479|18511932|P3|NOT COMPLETED|Overall Study||7
7517851|NCT03937479|18511933|P2|NOT COMPLETED|Overall Study||15
7517852|NCT03937479|18511934|P1|NOT COMPLETED|Overall Study||10
7517853|NCT03937479|18511930|P5|COMPLETED|Overall Study||79
7517854|NCT03937479|18511931|P4|COMPLETED|Overall Study||76
7517855|NCT03937479|18511932|P3|COMPLETED|Overall Study||75
7517856|NCT03937479|18511933|P2|COMPLETED|Overall Study||70
7517857|NCT03937479|18511934|P1|COMPLETED|Overall Study||73
7517858|NCT03937479|18511930|P5|Received Treatment|Overall Study||84
7517859|NCT03937479|18511931|P4|Received Treatment|Overall Study||82
7517860|NCT03937479|18511932|P3|Received Treatment|Overall Study||81
7517861|NCT03937479|18511933|P2|Received Treatment|Overall Study||83
7517862|NCT03937479|18511934|P1|Received Treatment|Overall Study||83
7517863|NCT03937479|18511930|P5|STARTED|Overall Study||84
7517864|NCT03937479|18511931|P4|STARTED|Overall Study||82
7517865|NCT03937479|18511932|P3|STARTED|Overall Study||82
7517866|NCT03937479|18511933|P2|STARTED|Overall Study||85
7517867|NCT03937479|18511934|P1|STARTED|Overall Study||83
7517868|NCT03936608|18512028|P2|NOT COMPLETED|Overall Study||2
7517869|NCT03936608|18512029|P1|NOT COMPLETED|Overall Study||2
7517870|NCT03936608|18512028|P2|COMPLETED|Overall Study||0
7517871|NCT03936608|18512029|P1|COMPLETED|Overall Study||0
7517872|NCT03936608|18512028|P2|STARTED|Overall Study||2
7517873|NCT03936608|18512029|P1|STARTED|Overall Study||2
7517874|NCT03936244|18512037|P2|NOT COMPLETED|Overall Study||4
7517875|NCT03936244|18512038|P1|NOT COMPLETED|Overall Study||12
7517876|NCT03936244|18512037|P2|COMPLETED|Overall Study||39
7517877|NCT03936244|18512038|P1|COMPLETED|Overall Study||45
7517878|NCT03936244|18512037|P2|STARTED|Overall Study||43
7517879|NCT03936244|18512038|P1|STARTED|Overall Study||57
7517880|NCT03933774|18512106|P2|NOT COMPLETED|Overall Study||2
7517881|NCT03933774|18512107|P1|NOT COMPLETED|Overall Study||2
7517882|NCT03933774|18512106|P2|COMPLETED|Overall Study||11
7517883|NCT03933774|18512107|P1|COMPLETED|Overall Study||10
7517884|NCT03933774|18512106|P2|STARTED|Overall Study||13
7517885|NCT03933774|18512107|P1|STARTED|Overall Study||12
7517886|NCT03933618|18512121|P6|NOT COMPLETED|Week 16 to Week 24||0
7517887|NCT03933618|18512122|P5|NOT COMPLETED|Week 16 to Week 24||0
7517888|NCT03933618|18512123|P4|NOT COMPLETED|Week 16 to Week 24||0
7517889|NCT03933618|18512124|P3|NOT COMPLETED|Week 16 to Week 24||0
7517890|NCT03933618|18512125|P2|NOT COMPLETED|Week 16 to Week 24||0
7517891|NCT03933618|18512126|P1|NOT COMPLETED|Week 16 to Week 24||0
7517892|NCT03933618|18512121|P6|COMPLETED|Week 16 to Week 24||4
7517893|NCT03933618|18512122|P5|COMPLETED|Week 16 to Week 24||4
7517894|NCT03933618|18512123|P4|COMPLETED|Week 16 to Week 24||4
7517895|NCT03933618|18512124|P3|COMPLETED|Week 16 to Week 24||4
7517896|NCT03933618|18512125|P2|COMPLETED|Week 16 to Week 24||4
7517897|NCT03933618|18512126|P1|COMPLETED|Week 16 to Week 24||4
7517898|NCT03933618|18512121|P6|STARTED|Week 16 to Week 24||4
7517899|NCT03933618|18512122|P5|STARTED|Week 16 to Week 24||4
7517900|NCT03933618|18512123|P4|STARTED|Week 16 to Week 24||4
7517901|NCT03933618|18512124|P3|STARTED|Week 16 to Week 24||4
7517902|NCT03933618|18512125|P2|STARTED|Week 16 to Week 24||4
7517903|NCT03933618|18512126|P1|STARTED|Week 16 to Week 24||4
7517904|NCT03933618|18512121|P6|NOT COMPLETED|Week 8 to Week 16||0
7517905|NCT03933618|18512122|P5|NOT COMPLETED|Week 8 to Week 16||0
7517906|NCT03933618|18512123|P4|NOT COMPLETED|Week 8 to Week 16||0
7517907|NCT03933618|18512124|P3|NOT COMPLETED|Week 8 to Week 16||0
7517908|NCT03933618|18512125|P2|NOT COMPLETED|Week 8 to Week 16||0
7517909|NCT03933618|18512126|P1|NOT COMPLETED|Week 8 to Week 16||0
7517910|NCT03933618|18512121|P6|COMPLETED|Week 8 to Week 16||4
7517911|NCT03933618|18512122|P5|COMPLETED|Week 8 to Week 16||4
7517912|NCT03933618|18512123|P4|COMPLETED|Week 8 to Week 16||4
7517913|NCT03933618|18512124|P3|COMPLETED|Week 8 to Week 16||4
7517914|NCT03933618|18512125|P2|COMPLETED|Week 8 to Week 16||4
7517915|NCT03933618|18512126|P1|COMPLETED|Week 8 to Week 16||4
7517916|NCT03933618|18512121|P6|STARTED|Week 8 to Week 16||4
7517917|NCT03933618|18512122|P5|STARTED|Week 8 to Week 16||4
7517918|NCT03933618|18512123|P4|STARTED|Week 8 to Week 16||4
7517919|NCT03933618|18512124|P3|STARTED|Week 8 to Week 16||4
7517920|NCT03933618|18512125|P2|STARTED|Week 8 to Week 16||4
7517921|NCT03933618|18512126|P1|STARTED|Week 8 to Week 16||4
7517922|NCT03933618|18512121|P6|NOT COMPLETED|Baseline to Week 8||0
7517923|NCT03933618|18512122|P5|NOT COMPLETED|Baseline to Week 8||0
7517924|NCT03933618|18512123|P4|NOT COMPLETED|Baseline to Week 8||0
7517925|NCT03933618|18512124|P3|NOT COMPLETED|Baseline to Week 8||0
7517926|NCT03933618|18512125|P2|NOT COMPLETED|Baseline to Week 8||0
7517927|NCT03933618|18512126|P1|NOT COMPLETED|Baseline to Week 8||0
7517928|NCT03933618|18512121|P6|COMPLETED|Baseline to Week 8||4
7517929|NCT03933618|18512122|P5|COMPLETED|Baseline to Week 8||4
7517930|NCT03933618|18512123|P4|COMPLETED|Baseline to Week 8||4
7517931|NCT03933618|18512124|P3|COMPLETED|Baseline to Week 8||4
7517932|NCT03933618|18512125|P2|COMPLETED|Baseline to Week 8||4
7517933|NCT03933618|18512126|P1|COMPLETED|Baseline to Week 8||4
7517934|NCT03933618|18512121|P6|STARTED|Baseline to Week 8||4
7517935|NCT03933618|18512122|P5|STARTED|Baseline to Week 8||4
7517936|NCT03933618|18512123|P4|STARTED|Baseline to Week 8||4
7517937|NCT03933618|18512124|P3|STARTED|Baseline to Week 8||4
7517938|NCT03933618|18512125|P2|STARTED|Baseline to Week 8||4
7517939|NCT03933618|18512126|P1|STARTED|Baseline to Week 8||4
7517940|NCT03933618|18512121|P6|NOT COMPLETED|Baseline||0
7517941|NCT03933618|18512122|P5|NOT COMPLETED|Baseline||0
7517942|NCT03933618|18512123|P4|NOT COMPLETED|Baseline||0
7517943|NCT03933618|18512124|P3|NOT COMPLETED|Baseline||0
7517944|NCT03933618|18512125|P2|NOT COMPLETED|Baseline||0
7517945|NCT03933618|18512126|P1|NOT COMPLETED|Baseline||0
7517946|NCT03933618|18512121|P6|COMPLETED|Baseline||4
7517947|NCT03933618|18512122|P5|COMPLETED|Baseline||4
7517948|NCT03933618|18512123|P4|COMPLETED|Baseline||4
7517949|NCT03933618|18512124|P3|COMPLETED|Baseline||4
7517950|NCT03933618|18512125|P2|COMPLETED|Baseline||4
7517951|NCT03933618|18512126|P1|COMPLETED|Baseline||4
7517952|NCT03933618|18512121|P6|STARTED|Baseline||4
7517953|NCT03933618|18512122|P5|STARTED|Baseline||4
7517954|NCT03933618|18512123|P4|STARTED|Baseline||4
7517955|NCT03933618|18512124|P3|STARTED|Baseline||4
7517956|NCT03933618|18512125|P2|STARTED|Baseline||4
7517957|NCT03933618|18512126|P1|STARTED|Baseline||4
7517958|NCT03933462|18512374|P2|NOT COMPLETED|Overall Study||0
7517959|NCT03933462|18512375|P1|NOT COMPLETED|Overall Study||2
7517960|NCT03933462|18512374|P2|COMPLETED|Overall Study||10
7517961|NCT03933462|18512375|P1|COMPLETED|Overall Study||8
7517962|NCT03933462|18512374|P2|Crossover|Overall Study||10
7517963|NCT03933462|18512375|P1|Crossover|Overall Study||8
7517964|NCT03933462|18512374|P2|STARTED|Overall Study||10
7517965|NCT03933462|18512375|P1|STARTED|Overall Study||10
7517966|NCT03933449|18512399|P2|NOT COMPLETED|Overall Study||61
7517967|NCT03933449|18512400|P1|NOT COMPLETED|Overall Study||62
7517968|NCT03933449|18512399|P2|COMPLETED|Overall Study||0
7517969|NCT03933449|18512400|P1|COMPLETED|Overall Study||0
7517970|NCT03933449|18512399|P2|Treated|Overall Study||59
7517971|NCT03933449|18512400|P1|Treated|Overall Study||62
7517972|NCT03933449|18512399|P2|STARTED|Overall Study||61
7517973|NCT03933449|18512400|P1|STARTED|Overall Study||62
7517974|NCT03930641|18512422|P1|NOT COMPLETED|Overall Study||0
7517975|NCT03930641|18512422|P1|COMPLETED|Overall Study||34
7517976|NCT03930641|18512422|P1|STARTED|Overall Study||34
7517977|NCT03928522|18512431|P5|NOT COMPLETED|Overall Study||0
7517978|NCT03928522|18512432|P4|NOT COMPLETED|Overall Study||0
7517979|NCT03928522|18512433|P3|NOT COMPLETED|Overall Study||0
7517980|NCT03928522|18512434|P2|NOT COMPLETED|Overall Study||0
7517981|NCT03928522|18512435|P1|NOT COMPLETED|Overall Study||0
7517982|NCT03928522|18512431|P5|COMPLETED|Overall Study||12
7517983|NCT03928522|18512432|P4|COMPLETED|Overall Study||12
7517984|NCT03928522|18512433|P3|COMPLETED|Overall Study||12
7517985|NCT03928522|18512434|P2|COMPLETED|Overall Study||12
7517986|NCT03928522|18512435|P1|COMPLETED|Overall Study||12
7517987|NCT03928522|18512431|P5|STARTED|Overall Study||12
7517988|NCT03928522|18512432|P4|STARTED|Overall Study||12
7517989|NCT03928522|18512433|P3|STARTED|Overall Study||12
7517990|NCT03928522|18512434|P2|STARTED|Overall Study||12
7517991|NCT03928522|18512435|P1|STARTED|Overall Study||12
7517992|NCT03928327|18512449|P2|NOT COMPLETED|Period 2||0
7517993|NCT03928327|18512450|P1|NOT COMPLETED|Period 2||0
7517994|NCT03928327|18512449|P2|COMPLETED|Period 2||12
7517995|NCT03928327|18512450|P1|COMPLETED|Period 2||12
7517996|NCT03928327|18512449|P2|STARTED|Period 2||12
7517997|NCT03928327|18512450|P1|STARTED|Period 2||12
7517998|NCT03928327|18512449|P2|NOT COMPLETED|Washout Period||0
7517999|NCT03928327|18512450|P1|NOT COMPLETED|Washout Period||0
7518000|NCT03928327|18512449|P2|COMPLETED|Washout Period||12
7518001|NCT03928327|18512450|P1|COMPLETED|Washout Period||12
7518002|NCT03928327|18512449|P2|STARTED|Washout Period||12
7518003|NCT03928327|18512450|P1|STARTED|Washout Period||12
7518004|NCT03928327|18512449|P2|NOT COMPLETED|Period 1||0
7518005|NCT03928327|18512450|P1|NOT COMPLETED|Period 1||0
7518006|NCT03928327|18512449|P2|COMPLETED|Period 1||12
7518007|NCT03928327|18512450|P1|COMPLETED|Period 1||12
7518008|NCT03928327|18512449|P2|STARTED|Period 1||12
7518009|NCT03928327|18512450|P1|STARTED|Period 1||12
7518010|NCT03927950|18512476|P1|NOT COMPLETED|Overall Study||9
7518011|NCT03927950|18512476|P1|COMPLETED|Overall Study||126
7518012|NCT03927950|18512476|P1|STARTED|Overall Study||135
7518013|NCT03926065|18512481|P5|NOT COMPLETED|Study Week 4||0
7518014|NCT03926065|18512482|P4|NOT COMPLETED|Study Week 4||0
7518015|NCT03926065|18512483|P3|NOT COMPLETED|Study Week 4||0
7518016|NCT03926065|18512484|P2|NOT COMPLETED|Study Week 4||0
7518017|NCT03926065|18512485|P1|NOT COMPLETED|Study Week 4||0
7518018|NCT03926065|18512481|P5|COMPLETED|Study Week 4||15
7518019|NCT03926065|18512482|P4|COMPLETED|Study Week 4||18
7518020|NCT03926065|18512483|P3|COMPLETED|Study Week 4||14
7518021|NCT03926065|18512484|P2|COMPLETED|Study Week 4||9
7518022|NCT03926065|18512485|P1|COMPLETED|Study Week 4||11
7518023|NCT03926065|18512481|P5|STARTED|Study Week 4||15
7518024|NCT03926065|18512482|P4|STARTED|Study Week 4||18
7518025|NCT03926065|18512483|P3|STARTED|Study Week 4||14
7518026|NCT03926065|18512484|P2|STARTED|Study Week 4||9
7518027|NCT03926065|18512485|P1|STARTED|Study Week 4||11
7518028|NCT03926065|18512481|P5|NOT COMPLETED|Study Week 3||0
7518029|NCT03926065|18512482|P4|NOT COMPLETED|Study Week 3||0
7518030|NCT03926065|18512483|P3|NOT COMPLETED|Study Week 3||0
7518031|NCT03926065|18512484|P2|NOT COMPLETED|Study Week 3||0
7518032|NCT03926065|18512485|P1|NOT COMPLETED|Study Week 3||0
7518033|NCT03926065|18512481|P5|COMPLETED|Study Week 3||15
7518034|NCT03926065|18512482|P4|COMPLETED|Study Week 3||18
7518035|NCT03926065|18512483|P3|COMPLETED|Study Week 3||14
7518036|NCT03926065|18512484|P2|COMPLETED|Study Week 3||9
7518037|NCT03926065|18512485|P1|COMPLETED|Study Week 3||11
7518038|NCT03926065|18512481|P5|STARTED|Study Week 3||15
7518039|NCT03926065|18512482|P4|STARTED|Study Week 3||18
7518040|NCT03926065|18512483|P3|STARTED|Study Week 3||14
7518041|NCT03926065|18512484|P2|STARTED|Study Week 3||9
7518042|NCT03926065|18512485|P1|STARTED|Study Week 3||11
7518043|NCT03926065|18512481|P5|NOT COMPLETED|Study Week 2||0
7518044|NCT03926065|18512482|P4|NOT COMPLETED|Study Week 2||0
7518045|NCT03926065|18512483|P3|NOT COMPLETED|Study Week 2||0
7518046|NCT03926065|18512484|P2|NOT COMPLETED|Study Week 2||0
7518047|NCT03926065|18512485|P1|NOT COMPLETED|Study Week 2||0
7518048|NCT03926065|18512481|P5|COMPLETED|Study Week 2||15
7518049|NCT03926065|18512482|P4|COMPLETED|Study Week 2||18
7518050|NCT03926065|18512483|P3|COMPLETED|Study Week 2||14
7518051|NCT03926065|18512484|P2|COMPLETED|Study Week 2||9
7518052|NCT03926065|18512485|P1|COMPLETED|Study Week 2||11
7518053|NCT03926065|18512481|P5|STARTED|Study Week 2||15
7518054|NCT03926065|18512482|P4|STARTED|Study Week 2||18
7518055|NCT03926065|18512483|P3|STARTED|Study Week 2||14
7518056|NCT03926065|18512484|P2|STARTED|Study Week 2||9
7518057|NCT03926065|18512485|P1|STARTED|Study Week 2||11
7518058|NCT03926065|18512481|P5|NOT COMPLETED|Study Week 1||0
7518059|NCT03926065|18512482|P4|NOT COMPLETED|Study Week 1||0
7518060|NCT03926065|18512483|P3|NOT COMPLETED|Study Week 1||0
7518061|NCT03926065|18512484|P2|NOT COMPLETED|Study Week 1||0
7518062|NCT03926065|18512485|P1|NOT COMPLETED|Study Week 1||0
7518063|NCT03926065|18512481|P5|COMPLETED|Study Week 1||15
7518064|NCT03926065|18512482|P4|COMPLETED|Study Week 1||18
7518065|NCT03926065|18512483|P3|COMPLETED|Study Week 1||14
7518066|NCT03926065|18512484|P2|COMPLETED|Study Week 1||9
7518067|NCT03926065|18512485|P1|COMPLETED|Study Week 1||11
7518068|NCT03926065|18512481|P5|STARTED|Study Week 1||15
7518069|NCT03926065|18512482|P4|STARTED|Study Week 1||18
7518070|NCT03926065|18512483|P3|STARTED|Study Week 1||14
7518071|NCT03926065|18512484|P2|STARTED|Study Week 1||9
7518072|NCT03926065|18512485|P1|STARTED|Study Week 1||11
7518073|NCT03923933|18512509|P2|NOT COMPLETED|Overall Study||1
7518074|NCT03923933|18512510|P1|NOT COMPLETED|Overall Study||1
7518075|NCT03923933|18512509|P2|COMPLETED|Overall Study||16
7518076|NCT03923933|18512510|P1|COMPLETED|Overall Study||16
7518077|NCT03923933|18512509|P2|STARTED|Overall Study||17
7518078|NCT03923933|18512510|P1|STARTED|Overall Study||17
7518079|NCT03923530|18512528|P1|NOT COMPLETED|Overall Study||4
7518080|NCT03923530|18512528|P1|COMPLETED|Overall Study||8
7518081|NCT03923530|18512528|P1|STARTED|Overall Study||12
7518082|NCT03921723|18512538|P1|NOT COMPLETED|Period 3 (4 Days)||1
7518083|NCT03921723|18512538|P1|COMPLETED|Period 3 (4 Days)||18
7518084|NCT03921723|18512538|P1|STARTED|Period 3 (4 Days)||19
7518085|NCT03921723|18512538|P1|NOT COMPLETED|Period 2 (4 Days)||3
7518086|NCT03921723|18512538|P1|COMPLETED|Period 2 (4 Days)||19
7518087|NCT03921723|18512538|P1|STARTED|Period 2 (4 Days)||22
7518088|NCT03921723|18512538|P1|NOT COMPLETED|Period 1 (4 Days)||0
7518089|NCT03921723|18512538|P1|COMPLETED|Period 1 (4 Days)||22
7518090|NCT03921723|18512538|P1|STARTED|Period 1 (4 Days)||22
7518091|NCT03918239|18512608|P2|NOT COMPLETED|Overall Study||7
7518092|NCT03918239|18512609|P1|NOT COMPLETED|Overall Study||10
7518093|NCT03918239|18512608|P2|COMPLETED|Overall Study||89
7518094|NCT03918239|18512609|P1|COMPLETED|Overall Study||84
7518095|NCT03918239|18512608|P2|STARTED|Overall Study||96
7518096|NCT03918239|18512609|P1|STARTED|Overall Study||94
7518097|NCT03914950|18512633|P1|NOT COMPLETED|Overall Study||54
7518098|NCT03914950|18512633|P1|COMPLETED|Overall Study||120
7518099|NCT03914950|18512633|P1|STARTED|Overall Study||174
7518100|NCT03914417|18512643|P1|NOT COMPLETED|Overall Study||2
7518101|NCT03914417|18512643|P1|COMPLETED|Overall Study||19
7518102|NCT03914417|18512643|P1|STARTED|Overall Study||21
7518103|NCT03913377|18512650|P3|NOT COMPLETED|Period 2||0
7518104|NCT03913377|18512651|P2|NOT COMPLETED|Period 2||0
7518105|NCT03913377|18512652|P1|NOT COMPLETED|Period 2||0
7518106|NCT03913377|18512650|P3|COMPLETED|Period 2||21
7518107|NCT03913377|18512651|P2|COMPLETED|Period 2||21
7518108|NCT03913377|18512652|P1|COMPLETED|Period 2||0
7518109|NCT03913377|18512650|P3|STARTED|Period 2||21
7518110|NCT03913377|18512651|P2|STARTED|Period 2||21
7518111|NCT03913377|18512652|P1|STARTED|Period 2||0
7518112|NCT03913377|18512650|P3|NOT COMPLETED|Period 1||1
7518113|NCT03913377|18512651|P2|NOT COMPLETED|Period 1||1
7518114|NCT03913377|18512652|P1|NOT COMPLETED|Period 1||0
7518115|NCT03913377|18512650|P3|COMPLETED|Period 1||21
7518116|NCT03913377|18512651|P2|COMPLETED|Period 1||21
7518117|NCT03913377|18512652|P1|COMPLETED|Period 1||21
7518118|NCT03913377|18512650|P3|STARTED|Period 1||22
7518119|NCT03913377|18512651|P2|STARTED|Period 1||22
7518120|NCT03913377|18512652|P1|STARTED|Period 1||21
7518121|NCT03911960|18512669|P2|NOT COMPLETED|Overall Study||3
7518122|NCT03911960|18512670|P1|NOT COMPLETED|Overall Study||5
7518123|NCT03911960|18512669|P2|COMPLETED|Overall Study||2
7518124|NCT03911960|18512670|P1|COMPLETED|Overall Study||4
7518125|NCT03911960|18512669|P2|STARTED|Overall Study||5
7518126|NCT03911960|18512670|P1|STARTED|Overall Study||9
7518127|NCT03911752|18512692|P3|NOT COMPLETED|Overall Study||0
7518128|NCT03911752|18512693|P2|NOT COMPLETED|Overall Study||0
7518129|NCT03911752|18512694|P1|NOT COMPLETED|Overall Study||0
7518130|NCT03911752|18512692|P3|COMPLETED|Overall Study||2
7518131|NCT03911752|18512693|P2|COMPLETED|Overall Study||2
7518132|NCT03911752|18512694|P1|COMPLETED|Overall Study||8
7518133|NCT03911752|18512692|P3|STARTED|Overall Study||2
7518134|NCT03911752|18512693|P2|STARTED|Overall Study||2
7518135|NCT03911752|18512694|P1|STARTED|Overall Study||8
7518136|NCT03909763|18512711|P1|NOT COMPLETED|Overall Study||10
7518137|NCT03909763|18512711|P1|COMPLETED|Overall Study||45
7518138|NCT03909763|18512711|P1|STARTED|Overall Study||55
7518139|NCT03909295|18512718|P1|NOT COMPLETED|Overall Study||52
7518140|NCT03909295|18512718|P1|COMPLETED|Overall Study||0
7518141|NCT03909295|18512718|P1|Safety Set (SAF)|Overall Study||52
7518142|NCT03909295|18512718|P1|STARTED|Overall Study||52
7518143|NCT03909009|18512724|P2|NOT COMPLETED|Overall Study||0
7518144|NCT03909009|18512725|P1|NOT COMPLETED|Overall Study||0
7518145|NCT03909009|18512724|P2|COMPLETED|Overall Study||10
7518146|NCT03909009|18512725|P1|COMPLETED|Overall Study||10
7518147|NCT03909009|18512724|P2|STARTED|Overall Study||10
7518148|NCT03909009|18512725|P1|STARTED|Overall Study||10
7518149|NCT03907579|18512745|P1|NOT COMPLETED|Overall Study||0
7518150|NCT03907579|18512745|P1|COMPLETED|Overall Study||100
7518151|NCT03907579|18512745|P1|STARTED|Overall Study||100
7518152|NCT03907241|18512754|P1|NOT COMPLETED|Overall Study||4
7518153|NCT03907241|18512754|P1|COMPLETED|Overall Study||23
7518154|NCT03907241|18512754|P1|STARTED|Overall Study||27
7518155|NCT03905642|18512873|P1|NOT COMPLETED|Overall Study||8
7518156|NCT03905642|18512873|P1|COMPLETED|Overall Study||41
7518157|NCT03905642|18512873|P1|STARTED|Overall Study||49
7518158|NCT03904420|18512884|P2|NOT COMPLETED|Overall Study||2
7518159|NCT03904420|18512885|P1|NOT COMPLETED|Overall Study||2
7518160|NCT03904420|18512884|P2|COMPLETED|Overall Study||0
7518161|NCT03904420|18512885|P1|COMPLETED|Overall Study||0
7518162|NCT03904420|18512884|P2|STARTED|Overall Study||2
7518163|NCT03904420|18512885|P1|STARTED|Overall Study||2
7518164|NCT03902613|18512891|P1|NOT COMPLETED|Overall Study||1
7518165|NCT03902613|18512891|P1|COMPLETED|Overall Study||0
7518166|NCT03902613|18512891|P1|STARTED|Overall Study||1
7518167|NCT03902392|18512897|P2|NOT COMPLETED|Overall Study||7
7518168|NCT03902392|18512898|P1|NOT COMPLETED|Overall Study||7
7518169|NCT03902392|18512897|P2|COMPLETED|Overall Study||18
7518170|NCT03902392|18512898|P1|COMPLETED|Overall Study||18
7518171|NCT03902392|18512897|P2|STARTED|Overall Study||25
7518172|NCT03902392|18512898|P1|STARTED|Overall Study||25
7518173|NCT03901313|18512906|P6|NOT COMPLETED|Overall Study||0
7518174|NCT03901313|18512907|P5|NOT COMPLETED|Overall Study||0
7518175|NCT03901313|18512908|P4|NOT COMPLETED|Overall Study||0
7518176|NCT03901313|18512909|P3|NOT COMPLETED|Overall Study||0
7518177|NCT03901313|18512910|P2|NOT COMPLETED|Overall Study||0
7518178|NCT03901313|18512911|P1|NOT COMPLETED|Overall Study||0
7518179|NCT03901313|18512906|P6|COMPLETED|Overall Study||4
7518180|NCT03901313|18512907|P5|COMPLETED|Overall Study||4
7518181|NCT03901313|18512908|P4|COMPLETED|Overall Study||4
7518182|NCT03901313|18512909|P3|COMPLETED|Overall Study||4
7518183|NCT03901313|18512910|P2|COMPLETED|Overall Study||4
7518184|NCT03901313|18512911|P1|COMPLETED|Overall Study||4
7518185|NCT03901313|18512906|P6|STARTED|Overall Study||4
7518186|NCT03901313|18512907|P5|STARTED|Overall Study||4
7518187|NCT03901313|18512908|P4|STARTED|Overall Study||4
7518188|NCT03901313|18512909|P3|STARTED|Overall Study||4
7518189|NCT03901313|18512910|P2|STARTED|Overall Study||4
7518190|NCT03901313|18512911|P1|STARTED|Overall Study||4
7518191|NCT03901105|18512928|P1|NOT COMPLETED|Overall Study||0
7518192|NCT03901105|18512928|P1|COMPLETED|Overall Study||205
7518193|NCT03901105|18512928|P1|STARTED|Overall Study||205
7518194|NCT03901092|18512938|P2|NOT COMPLETED|Overall Study||0
7518195|NCT03901092|18512939|P1|NOT COMPLETED|Overall Study||0
7518196|NCT03901092|18512938|P2|COMPLETED|Overall Study||159
7518197|NCT03901092|18512939|P1|COMPLETED|Overall Study||83
7518198|NCT03901092|18512938|P2|STARTED|Overall Study||159
7518199|NCT03901092|18512939|P1|STARTED|Overall Study||83
7518200|NCT03900299|18512956|P2|NOT COMPLETED|Overall Study||0
7518201|NCT03900299|18512957|P1|NOT COMPLETED|Overall Study||0
7518202|NCT03900299|18512956|P2|COMPLETED|Overall Study||58
7518203|NCT03900299|18512957|P1|COMPLETED|Overall Study||56
7518204|NCT03900299|18512956|P2|STARTED|Overall Study||58
7518205|NCT03900299|18512957|P1|STARTED|Overall Study||56
7518206|NCT03899064|18512964|P1|NOT COMPLETED|Overall Study||7
7518207|NCT03899064|18512964|P1|COMPLETED|Overall Study||51
7518208|NCT03899064|18512964|P1|Control, Irradiation|Overall Study||58
7518209|NCT03899064|18512964|P1|MC2-01 Vehicle, no Irradiation|Overall Study||58
7518210|NCT03899064|18512964|P1|MC2-01 Vehicle, Irradiation|Overall Study||58
7518211|NCT03899064|18512964|P1|MC2-01 Cream, No Irradiation|Overall Study||58
7518212|NCT03899064|18512964|P1|MC2-01 Cream, Irradiation|Overall Study||58
7518213|NCT03899064|18512964|P1|STARTED|Overall Study||58
7518214|NCT03898349|18512972|P2|NOT COMPLETED|Overall Study||610
7518215|NCT03898349|18512973|P1|NOT COMPLETED|Overall Study||110
7518216|NCT03898349|18512972|P2|COMPLETED|Overall Study||15
7518217|NCT03898349|18512973|P1|COMPLETED|Overall Study||15
7518218|NCT03898349|18512972|P2|STARTED|Overall Study||625
7518219|NCT03898349|18512973|P1|STARTED|Overall Study||125
7518220|NCT03897179|18512979|P1|NOT COMPLETED|Overall Study||1
7518221|NCT03897179|18512979|P1|COMPLETED|Overall Study||26
7518222|NCT03897179|18512979|P1|STARTED|Overall Study||27
7518223|NCT03895632|18512983|P1|NOT COMPLETED|Overall Study||0
7518224|NCT03895632|18512983|P1|COMPLETED|Overall Study||25
7518225|NCT03895632|18512983|P1|STARTED|Overall Study||25
7518226|NCT03895307|18512995|P4|NOT COMPLETED|Overall Study||0
7518227|NCT03895307|18512996|P3|NOT COMPLETED|Overall Study||2
7518228|NCT03895307|18512997|P2|NOT COMPLETED|Overall Study||0
7518229|NCT03895307|18512998|P1|NOT COMPLETED|Overall Study||2
7518230|NCT03895307|18512995|P4|COMPLETED|Overall Study||21
7518231|NCT03895307|18512996|P3|COMPLETED|Overall Study||20
7518232|NCT03895307|18512997|P2|COMPLETED|Overall Study||20
7518233|NCT03895307|18512998|P1|COMPLETED|Overall Study||19
7518234|NCT03895307|18512995|P4|STARTED|Overall Study||21
7518235|NCT03895307|18512996|P3|STARTED|Overall Study||22
7518236|NCT03895307|18512997|P2|STARTED|Overall Study||20
7518237|NCT03895307|18512998|P1|STARTED|Overall Study||21
7518238|NCT03894449|18513089|P5|NOT COMPLETED|Overall Study||0
7518239|NCT03894449|18513090|P4|NOT COMPLETED|Overall Study||0
7518240|NCT03894449|18513091|P3|NOT COMPLETED|Overall Study||0
7518241|NCT03894449|18513092|P2|NOT COMPLETED|Overall Study||0
7518242|NCT03894449|18513093|P1|NOT COMPLETED|Overall Study||0
7518243|NCT03894449|18513089|P5|COMPLETED|Overall Study||15
7518244|NCT03894449|18513090|P4|COMPLETED|Overall Study||15
7518245|NCT03894449|18513091|P3|COMPLETED|Overall Study||15
7518246|NCT03894449|18513092|P2|COMPLETED|Overall Study||15
7518247|NCT03894449|18513093|P1|COMPLETED|Overall Study||15
7518248|NCT03894449|18513089|P5|STARTED|Overall Study||15
7518249|NCT03894449|18513090|P4|STARTED|Overall Study||15
7518250|NCT03894449|18513091|P3|STARTED|Overall Study||15
7518251|NCT03894449|18513092|P2|STARTED|Overall Study||15
7518252|NCT03894449|18513093|P1|STARTED|Overall Study||15
7518253|NCT03892564|18513205|P1|NOT COMPLETED|Overall Study||2
7518254|NCT03892564|18513205|P1|COMPLETED|Overall Study||33
7518255|NCT03892564|18513205|P1|Control Site|Overall Study||35
7518256|NCT03892564|18513205|P1|MC2-01 Vehicle + Non-irridiation|Overall Study||35
7518257|NCT03892564|18513205|P1|MC2-01 Vehicle + Irridiation|Overall Study||35
7518258|NCT03892564|18513205|P1|MC2-01 Cream + Non-irridiation|Overall Study||35
7518259|NCT03892564|18513205|P1|MC2-01 Cream + Irridiation|Overall Study||35
7518260|NCT03892564|18513205|P1|STARTED|Overall Study||35
7518261|NCT03891641|18513213|P2|NOT COMPLETED|Overall Study||2
7518262|NCT03891641|18513214|P1|NOT COMPLETED|Overall Study||2
7518263|NCT03891641|18513213|P2|COMPLETED|Overall Study||5
7518264|NCT03891641|18513214|P1|COMPLETED|Overall Study||8
7518265|NCT03891641|18513213|P2|STARTED|Overall Study||7
7518266|NCT03891641|18513214|P1|STARTED|Overall Study||10
7518267|NCT03889444|18513226|P1|NOT COMPLETED|Overall Study||0
7518268|NCT03889444|18513226|P1|COMPLETED|Overall Study||141
7518269|NCT03889444|18513226|P1|STARTED|Overall Study||141
7518270|NCT03889028|18513239|P3|NOT COMPLETED|Overall Study||0
7518271|NCT03889028|18513240|P2|NOT COMPLETED|Overall Study||0
7518272|NCT03889028|18513241|P1|NOT COMPLETED|Overall Study||0
7518273|NCT03889028|18513239|P3|COMPLETED|Overall Study||312
7518274|NCT03889028|18513240|P2|COMPLETED|Overall Study||422
7518275|NCT03889028|18513241|P1|COMPLETED|Overall Study||144
7518276|NCT03889028|18513239|P3|STARTED|Overall Study||312
7518277|NCT03889028|18513240|P2|STARTED|Overall Study||422
7518278|NCT03889028|18513241|P1|STARTED|Overall Study||144
7518279|NCT03888755|18513252|P1|NOT COMPLETED|Overall Study||0
7518280|NCT03888755|18513252|P1|COMPLETED|Overall Study||8
7518281|NCT03888755|18513252|P1|STARTED|Overall Study||8
7518282|NCT03888482|18513275|P2|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
7518283|NCT03888482|18513276|P1|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
7518284|NCT03888482|18513275|P2|COMPLETED|Second Wear (8 -1/+2 Days)||74
7518285|NCT03888482|18513276|P1|COMPLETED|Second Wear (8 -1/+2 Days)||73
7518286|NCT03888482|18513275|P2|STARTED|Second Wear (8 -1/+2 Days)||75
7518287|NCT03888482|18513276|P1|STARTED|Second Wear (8 -1/+2 Days)|2 subjects were discontinued between Treatment 1 and Treatment 2.|74
7518288|NCT03888482|18513275|P2|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
7518289|NCT03888482|18513276|P1|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
7518290|NCT03888482|18513275|P2|COMPLETED|First Wear Period (8 -1/+2 Days)||75
7518291|NCT03888482|18513276|P1|COMPLETED|First Wear Period (8 -1/+2 Days)||76
7518292|NCT03888482|18513275|P2|STARTED|First Wear Period (8 -1/+2 Days)||75
7518293|NCT03888482|18513276|P1|STARTED|First Wear Period (8 -1/+2 Days)||76
7518294|NCT03888469|18513286|P2|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
7518295|NCT03888469|18513287|P1|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
7518296|NCT03888469|18513286|P2|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
7518297|NCT03888469|18513287|P1|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
7518298|NCT03888469|18513286|P2|STARTED|Second Wear Period (8 -1/+2 Days)||46
7518299|NCT03888469|18513287|P1|STARTED|Second Wear Period (8 -1/+2 Days)||46
7518300|NCT03888469|18513286|P2|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
7518301|NCT03888469|18513287|P1|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
7518302|NCT03888469|18513286|P2|COMPLETED|First Wear Period (8 -1/+2 Days)||46
7518303|NCT03888469|18513287|P1|COMPLETED|First Wear Period (8 -1/+2 Days)||46
7518304|NCT03888469|18513286|P2|STARTED|First Wear Period (8 -1/+2 Days)||46
7518305|NCT03888469|18513287|P1|STARTED|First Wear Period (8 -1/+2 Days)||46
7518306|NCT03888391|18513295|P1|NOT COMPLETED|Overall Study||15
7518307|NCT03888391|18513295|P1|COMPLETED|Overall Study||3
7518308|NCT03888391|18513295|P1|STARTED|Overall Study||18
7518309|NCT03888274|18513305|P1|NOT COMPLETED|Overall Study||0
7518310|NCT03888274|18513305|P1|COMPLETED|Overall Study||30
7518311|NCT03888274|18513305|P1|STARTED|Overall Study||30
7518312|NCT03887442|18513313|P2|NOT COMPLETED|Overall Study||0
7518313|NCT03887442|18513314|P1|NOT COMPLETED|Overall Study||1
7518314|NCT03887442|18513313|P2|COMPLETED|Overall Study||8
7518315|NCT03887442|18513314|P1|COMPLETED|Overall Study||8
7518316|NCT03887442|18513313|P2|STARTED|Overall Study||8
7518317|NCT03887442|18513314|P1|STARTED|Overall Study||9
7518318|NCT03887429|18513332|P4|NOT COMPLETED|Overall Study||1
7518319|NCT03887429|18513333|P3|NOT COMPLETED|Overall Study||2
7518320|NCT03887429|18513334|P2|NOT COMPLETED|Overall Study||1
7518321|NCT03887429|18513335|P1|NOT COMPLETED|Overall Study||1
7518322|NCT03887429|18513332|P4|COMPLETED|Overall Study||7
7518323|NCT03887429|18513333|P3|COMPLETED|Overall Study||7
7518324|NCT03887429|18513334|P2|COMPLETED|Overall Study||8
7518325|NCT03887429|18513335|P1|COMPLETED|Overall Study||7
7518326|NCT03887429|18513332|P4|Completed Second Intervention (5 Days)|Overall Study||7
7518327|NCT03887429|18513333|P3|Completed Second Intervention (5 Days)|Overall Study||7
7518328|NCT03887429|18513334|P2|Completed Second Intervention (5 Days)|Overall Study||8
7518329|NCT03887429|18513335|P1|Completed Second Intervention (5 Days)|Overall Study||7
7518330|NCT03887429|18513332|P4|Completed Washout (9 Days)|Overall Study||7
7518331|NCT03887429|18513333|P3|Completed Washout (9 Days)|Overall Study||7
7518332|NCT03887429|18513334|P2|Completed Washout (9 Days)|Overall Study||8
7518333|NCT03887429|18513335|P1|Completed Washout (9 Days)|Overall Study||7
7518334|NCT03887429|18513332|P4|Completed First Intervention (5 Days)|Overall Study||7
7518335|NCT03887429|18513333|P3|Completed First Intervention (5 Days)|Overall Study||7
7518336|NCT03887429|18513334|P2|Completed First Intervention (5 Days)|Overall Study||8
7518337|NCT03887429|18513335|P1|Completed First Intervention (5 Days)|Overall Study||7
7518338|NCT03887429|18513332|P4|STARTED|Overall Study||8
7518339|NCT03887429|18513333|P3|STARTED|Overall Study||9
7518340|NCT03887429|18513334|P2|STARTED|Overall Study||9
7518341|NCT03887429|18513335|P1|STARTED|Overall Study||8
7518342|NCT03887286|18513359|P1|NOT COMPLETED|Overall Study||0
7518343|NCT03887286|18513359|P1|COMPLETED|Overall Study||47
7518344|NCT03887286|18513359|P1|STARTED|Overall Study||47
7518345|NCT03886701|18513364|P1|NOT COMPLETED|Period 2: Study Days 7-21||0
7518346|NCT03886701|18513364|P1|COMPLETED|Period 2: Study Days 7-21||11
7518347|NCT03886701|18513364|P1|STARTED|Period 2: Study Days 7-21||11
7518348|NCT03886701|18513364|P1|NOT COMPLETED|Period 1: Study Days 1-4||0
7518349|NCT03886701|18513364|P1|COMPLETED|Period 1: Study Days 1-4||11
7518350|NCT03886701|18513364|P1|STARTED|Period 1: Study Days 1-4||11
7518351|NCT03885726|18513376|P1|NOT COMPLETED|Overall Study||4
7518352|NCT03885726|18513376|P1|COMPLETED|Overall Study||28
7518353|NCT03885726|18513376|P1|STARTED|Overall Study||32
7518354|NCT03883386|18513442|P2|NOT COMPLETED|Washout and Second Assignment||0
7518355|NCT03883386|18513443|P1|NOT COMPLETED|Washout and Second Assignment||0
7518356|NCT03883386|18513442|P2|COMPLETED|Washout and Second Assignment||0
7518357|NCT03883386|18513443|P1|COMPLETED|Washout and Second Assignment||0
7518358|NCT03883386|18513442|P2|STARTED|Washout and Second Assignment||0
7518359|NCT03883386|18513443|P1|STARTED|Washout and Second Assignment||0
7518360|NCT03883386|18513442|P2|NOT COMPLETED|First Assignment||1
7518361|NCT03883386|18513443|P1|NOT COMPLETED|First Assignment||2
7518362|NCT03883386|18513442|P2|COMPLETED|First Assignment||0
7518363|NCT03883386|18513443|P1|COMPLETED|First Assignment||0
7518364|NCT03883386|18513442|P2|Surveys Begun|First Assignment||1
7518365|NCT03883386|18513443|P1|Surveys Begun|First Assignment||1
7518366|NCT03883386|18513442|P2|STARTED|First Assignment||1
7518367|NCT03883386|18513443|P1|STARTED|First Assignment||2
7518368|NCT03882801|18513453|P2|NOT COMPLETED|Period 2||1
7518369|NCT03882801|18513454|P1|NOT COMPLETED|Period 2||0
7518370|NCT03882801|18513453|P2|COMPLETED|Period 2||8
7518371|NCT03882801|18513454|P1|COMPLETED|Period 2||10
7518372|NCT03882801|18513453|P2|STARTED|Period 2||9
7518373|NCT03882801|18513454|P1|STARTED|Period 2||10
7518374|NCT03882801|18513453|P2|NOT COMPLETED|Washout Period||1
7518375|NCT03882801|18513454|P1|NOT COMPLETED|Washout Period||0
7518376|NCT03882801|18513453|P2|COMPLETED|Washout Period||9
7518377|NCT03882801|18513454|P1|COMPLETED|Washout Period||10
7518378|NCT03882801|18513453|P2|STARTED|Washout Period||10
7518379|NCT03882801|18513454|P1|STARTED|Washout Period||10
7518380|NCT03882801|18513453|P2|NOT COMPLETED|Period 1||2
7518381|NCT03882801|18513454|P1|NOT COMPLETED|Period 1||2
7518382|NCT03882801|18513453|P2|COMPLETED|Period 1||10
7518383|NCT03882801|18513454|P1|COMPLETED|Period 1||10
7518384|NCT03882801|18513453|P2|Treated|Period 1||12
7518385|NCT03882801|18513454|P1|Treated|Period 1|1 participant did not receive any dose of study drug|11
7518386|NCT03882801|18513453|P2|STARTED|Period 1||12
7518387|NCT03882801|18513454|P1|STARTED|Period 1||12
7518388|NCT03882424|18513469|P3|NOT COMPLETED|Overall Study||0
7518389|NCT03882424|18513470|P2|NOT COMPLETED|Overall Study||0
7518390|NCT03882424|18513471|P1|NOT COMPLETED|Overall Study||4
7518391|NCT03882424|18513469|P3|COMPLETED|Overall Study||38
7518392|NCT03882424|18513470|P2|COMPLETED|Overall Study||38
7518393|NCT03882424|18513471|P1|COMPLETED|Overall Study||34
7518394|NCT03882424|18513469|P3|STARTED|Overall Study||38
7518395|NCT03882424|18513470|P2|STARTED|Overall Study||38
7518396|NCT03882424|18513471|P1|STARTED|Overall Study||38
7518397|NCT03882047|18513494|P3|NOT COMPLETED|Overall Study||16
7518398|NCT03882047|18513495|P2|NOT COMPLETED|Overall Study||10
7518399|NCT03882047|18513496|P1|NOT COMPLETED|Overall Study||6
7518400|NCT03882047|18513494|P3|COMPLETED|Overall Study||88
7518401|NCT03882047|18513495|P2|COMPLETED|Overall Study||95
7518402|NCT03882047|18513496|P1|COMPLETED|Overall Study||98
7518403|NCT03882047|18513494|P3|Treated|Overall Study||103
7518404|NCT03882047|18513495|P2|Treated|Overall Study||104
7518405|NCT03882047|18513496|P1|Treated|Overall Study||104
7518406|NCT03882047|18513494|P3|STARTED|Overall Study||104
7518407|NCT03882047|18513495|P2|STARTED|Overall Study||105
7518408|NCT03882047|18513496|P1|STARTED|Overall Study||104
7518409|NCT03881670|18513536|P2|NOT COMPLETED|Overall Study||0
7518410|NCT03881670|18513537|P1|NOT COMPLETED|Overall Study||0
7518411|NCT03881670|18513536|P2|COMPLETED|Overall Study||12
7518412|NCT03881670|18513537|P1|COMPLETED|Overall Study||12
7518413|NCT03881670|18513536|P2|Completed Second Intervetion|Overall Study||12
7518414|NCT03881670|18513537|P1|Completed Second Intervetion|Overall Study||12
7518415|NCT03881670|18513536|P2|Completed First Intervention|Overall Study||12
7518416|NCT03881670|18513537|P1|Completed First Intervention|Overall Study||12
7518417|NCT03881670|18513536|P2|STARTED|Overall Study||12
7518418|NCT03881670|18513537|P1|STARTED|Overall Study||12
7518419|NCT03879772|18513552|P5|NOT COMPLETED|Overall Study||8
7518420|NCT03879772|18513553|P4|NOT COMPLETED|Overall Study||8
7518421|NCT03879772|18513554|P3|NOT COMPLETED|Overall Study||10
7518422|NCT03879772|18513555|P2|NOT COMPLETED|Overall Study||3
7518423|NCT03879772|18513556|P1|NOT COMPLETED|Overall Study||4
7518424|NCT03879772|18513552|P5|COMPLETED|Overall Study||128
7518425|NCT03879772|18513553|P4|COMPLETED|Overall Study||130
7518426|NCT03879772|18513554|P3|COMPLETED|Overall Study||123
7518427|NCT03879772|18513555|P2|COMPLETED|Overall Study||132
7518428|NCT03879772|18513556|P1|COMPLETED|Overall Study||133
7518429|NCT03879772|18513552|P5|STARTED|Overall Study||136
7518430|NCT03879772|18513553|P4|STARTED|Overall Study||138
7518431|NCT03879772|18513554|P3|STARTED|Overall Study||133
7518432|NCT03879772|18513555|P2|STARTED|Overall Study||135
7518433|NCT03879772|18513556|P1|STARTED|Overall Study||137
7518434|NCT03878758|18513593|P1|NOT COMPLETED|Overall Study||4
7518435|NCT03878758|18513593|P1|COMPLETED|Overall Study||154
7518436|NCT03878758|18513593|P1|STARTED|Overall Study||158
7518437|NCT03878745|18513616|P1|NOT COMPLETED|Overall Study||0
7518438|NCT03878745|18513616|P1|COMPLETED|Overall Study||55
7518439|NCT03878745|18513616|P1|STARTED|Overall Study||55
7518440|NCT03876743|18513634|P4|NOT COMPLETED|Overall Study||7
7518441|NCT03876743|18513635|P3|NOT COMPLETED|Overall Study||4
7518442|NCT03876743|18513636|P2|NOT COMPLETED|Overall Study||4
7518443|NCT03876743|18513637|P1|NOT COMPLETED|Overall Study||6
7518444|NCT03876743|18513634|P4|COMPLETED|Overall Study||43
7518445|NCT03876743|18513635|P3|COMPLETED|Overall Study||42
7518446|NCT03876743|18513636|P2|COMPLETED|Overall Study||47
7518447|NCT03876743|18513637|P1|COMPLETED|Overall Study||48
7518448|NCT03876743|18513634|P4|STARTED|Overall Study||50
7518449|NCT03876743|18513635|P3|STARTED|Overall Study||46
7518450|NCT03876743|18513636|P2|STARTED|Overall Study||51
7518451|NCT03876743|18513637|P1|STARTED|Overall Study||54
7518452|NCT03875664|18513701|P2|NOT COMPLETED|Overall Study||0
7518453|NCT03875664|18513702|P1|NOT COMPLETED|Overall Study||0
7518454|NCT03875664|18513701|P2|COMPLETED|Overall Study|Vaginal surgery n=18; vaginal + abdominal surgery n=17|35
7518455|NCT03875664|18513702|P1|COMPLETED|Overall Study|vaginal surgery n=18; vaginal + abdominal surgery n=19|37
7518456|NCT03875664|18513701|P2|STARTED|Overall Study||35
7518457|NCT03875664|18513702|P1|STARTED|Overall Study||37
7518458|NCT03870997|18513732|P6|NOT COMPLETED|Overall Study||10531
7518459|NCT03870997|18513733|P5|NOT COMPLETED|Overall Study||10588
7518460|NCT03870997|18513734|P4|NOT COMPLETED|Overall Study||10947
7518461|NCT03870997|18513735|P3|NOT COMPLETED|Overall Study||10978
7518462|NCT03870997|18513736|P2|NOT COMPLETED|Overall Study||10431
7518463|NCT03870997|18513737|P1|NOT COMPLETED|Overall Study||10544
7518464|NCT03870997|18513732|P6|COMPLETED|Overall Study||5171
7518465|NCT03870997|18513733|P5|COMPLETED|Overall Study||5114
7518466|NCT03870997|18513734|P4|COMPLETED|Overall Study||4810
7518467|NCT03870997|18513735|P3|COMPLETED|Overall Study||4778
7518468|NCT03870997|18513736|P2|COMPLETED|Overall Study||5271
7518469|NCT03870997|18513737|P1|COMPLETED|Overall Study||5158
7518470|NCT03870997|18513732|P6|STARTED|Overall Study||15702
7518471|NCT03870997|18513733|P5|STARTED|Overall Study||15702
7518472|NCT03870997|18513734|P4|STARTED|Overall Study||15757
7518473|NCT03870997|18513735|P3|STARTED|Overall Study||15756
7518474|NCT03870997|18513736|P2|STARTED|Overall Study||15702
7518475|NCT03870997|18513737|P1|STARTED|Overall Study||15702
7518476|NCT03870893|18513748|P2|NOT COMPLETED|Overall Study||1
7518477|NCT03870893|18513749|P1|NOT COMPLETED|Overall Study||0
7518478|NCT03870893|18513748|P2|COMPLETED|Overall Study||23
7518479|NCT03870893|18513749|P1|COMPLETED|Overall Study||23
7518480|NCT03870893|18513748|P2|STARTED|Overall Study||24
7518481|NCT03870893|18513749|P1|STARTED|Overall Study||23
7518482|NCT03870737|18513791|P1|NOT COMPLETED|Overall Study||2
7518483|NCT03870737|18513791|P1|COMPLETED|Overall Study||20
7518484|NCT03870737|18513791|P1|STARTED|Overall Study||22
7518485|NCT03870555|18513804|P3|NOT COMPLETED|Period 3 (2 Days)||0
7518486|NCT03870555|18513805|P2|NOT COMPLETED|Period 3 (2 Days)||0
7518487|NCT03870555|18513806|P1|NOT COMPLETED|Period 3 (2 Days)||1
7518488|NCT03870555|18513804|P3|COMPLETED|Period 3 (2 Days)||2
7518489|NCT03870555|18513805|P2|COMPLETED|Period 3 (2 Days)||2
7518490|NCT03870555|18513806|P1|COMPLETED|Period 3 (2 Days)||1
7518491|NCT03870555|18513804|P3|STARTED|Period 3 (2 Days)||2
7518492|NCT03870555|18513805|P2|STARTED|Period 3 (2 Days)||2
7518493|NCT03870555|18513806|P1|STARTED|Period 3 (2 Days)||2
7518494|NCT03870555|18513804|P3|NOT COMPLETED|Washout Period (at Least 16 Days)||0
7518495|NCT03870555|18513805|P2|NOT COMPLETED|Washout Period (at Least 16 Days)||0
7518496|NCT03870555|18513806|P1|NOT COMPLETED|Washout Period (at Least 16 Days)||0
7518497|NCT03870555|18513804|P3|COMPLETED|Washout Period (at Least 16 Days)||2
7518498|NCT03870555|18513805|P2|COMPLETED|Washout Period (at Least 16 Days)||2
7518499|NCT03870555|18513806|P1|COMPLETED|Washout Period (at Least 16 Days)||2
7518500|NCT03870555|18513804|P3|STARTED|Washout Period (at Least 16 Days)||2
7518501|NCT03870555|18513805|P2|STARTED|Washout Period (at Least 16 Days)||2
7518502|NCT03870555|18513806|P1|STARTED|Washout Period (at Least 16 Days)||2
7518503|NCT03870555|18513804|P3|NOT COMPLETED|Period 2 (2 Days)||0
7518504|NCT03870555|18513805|P2|NOT COMPLETED|Period 2 (2 Days)||0
7518505|NCT03870555|18513806|P1|NOT COMPLETED|Period 2 (2 Days)||0
7518506|NCT03870555|18513804|P3|COMPLETED|Period 2 (2 Days)||2
7518507|NCT03870555|18513805|P2|COMPLETED|Period 2 (2 Days)||2
7518508|NCT03870555|18513806|P1|COMPLETED|Period 2 (2 Days)||2
7518509|NCT03870555|18513804|P3|STARTED|Period 2 (2 Days)||2
7518510|NCT03870555|18513805|P2|STARTED|Period 2 (2 Days)||2
7518511|NCT03870555|18513806|P1|STARTED|Period 2 (2 Days)||2
7518512|NCT03870555|18513804|P3|NOT COMPLETED|Washout Period (at Least 16 Days)||0
7518513|NCT03870555|18513805|P2|NOT COMPLETED|Washout Period (at Least 16 Days)||0
7518514|NCT03870555|18513806|P1|NOT COMPLETED|Washout Period (at Least 16 Days)||0
7518515|NCT03870555|18513804|P3|COMPLETED|Washout Period (at Least 16 Days)||2
7518516|NCT03870555|18513805|P2|COMPLETED|Washout Period (at Least 16 Days)||2
7518517|NCT03870555|18513806|P1|COMPLETED|Washout Period (at Least 16 Days)||2
7518518|NCT03870555|18513804|P3|STARTED|Washout Period (at Least 16 Days)||2
7518519|NCT03870555|18513805|P2|STARTED|Washout Period (at Least 16 Days)||2
7518520|NCT03870555|18513806|P1|STARTED|Washout Period (at Least 16 Days)||2
7518521|NCT03870555|18513804|P3|NOT COMPLETED|Period 1 (2 Days)||0
7518522|NCT03870555|18513805|P2|NOT COMPLETED|Period 1 (2 Days)||0
7518523|NCT03870555|18513806|P1|NOT COMPLETED|Period 1 (2 Days)||0
7518524|NCT03870555|18513804|P3|COMPLETED|Period 1 (2 Days)||2
7518525|NCT03870555|18513805|P2|COMPLETED|Period 1 (2 Days)||2
7518526|NCT03870555|18513806|P1|COMPLETED|Period 1 (2 Days)||2
7518527|NCT03870555|18513804|P3|STARTED|Period 1 (2 Days)||2
7518528|NCT03870555|18513805|P2|STARTED|Period 1 (2 Days)||2
7518529|NCT03870555|18513806|P1|STARTED|Period 1 (2 Days)||2
7518530|NCT03869450|18513874|P3|NOT COMPLETED|Overall Study||0
7518531|NCT03869450|18513875|P2|NOT COMPLETED|Overall Study||2
7518532|NCT03869450|18513876|P1|NOT COMPLETED|Overall Study||1
7518533|NCT03869450|18513874|P3|COMPLETED|Overall Study||34
7518534|NCT03869450|18513875|P2|COMPLETED|Overall Study||23
7518535|NCT03869450|18513876|P1|COMPLETED|Overall Study||30
7518536|NCT03869450|18513874|P3|STARTED|Overall Study||34
7518537|NCT03869450|18513875|P2|STARTED|Overall Study||25
7518538|NCT03869450|18513876|P1|STARTED|Overall Study||31
7518539|NCT03868631|18513892|P2|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||1
7518540|NCT03868631|18513893|P1|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||4
7518541|NCT03868631|18513892|P2|COMPLETED|Week 6 to Week 12 (Study Completion)||26
7518542|NCT03868631|18513893|P1|COMPLETED|Week 6 to Week 12 (Study Completion)||22
7518543|NCT03868631|18513892|P2|STARTED|Week 6 to Week 12 (Study Completion)||27
7518544|NCT03868631|18513893|P1|STARTED|Week 6 to Week 12 (Study Completion)||26
7518545|NCT03868631|18513892|P2|NOT COMPLETED|Baseline to Week 6||4
7518546|NCT03868631|18513893|P1|NOT COMPLETED|Baseline to Week 6||4
7518547|NCT03868631|18513892|P2|COMPLETED|Baseline to Week 6||27
7518548|NCT03868631|18513893|P1|COMPLETED|Baseline to Week 6||26
7518549|NCT03868631|18513892|P2|STARTED|Baseline to Week 6||31
7518550|NCT03868631|18513893|P1|STARTED|Baseline to Week 6||30
7518551|NCT03868254|18513907|P2|NOT COMPLETED|Overall Study||0
7518552|NCT03868254|18513908|P1|NOT COMPLETED|Overall Study||0
7518553|NCT03868254|18513907|P2|COMPLETED|Overall Study||76
7518554|NCT03868254|18513908|P1|COMPLETED|Overall Study||98
7518555|NCT03868254|18513907|P2|STARTED|Overall Study||76
7518556|NCT03868254|18513908|P1|STARTED|Overall Study||98
7518557|NCT03866434|18513930|P1|NOT COMPLETED|Overall Study||0
7518558|NCT03866434|18513930|P1|COMPLETED|Overall Study||20
7518559|NCT03866434|18513930|P1|STARTED|Overall Study||20
7518560|NCT03865446|18513948|P2|NOT COMPLETED|Overall Study||0
7518561|NCT03865446|18513949|P1|NOT COMPLETED|Overall Study||0
7518562|NCT03865446|18513948|P2|COMPLETED|Overall Study||8
7518563|NCT03865446|18513949|P1|COMPLETED|Overall Study||8
7518564|NCT03865446|18513948|P2|STARTED|Overall Study||8
7518565|NCT03865446|18513949|P1|STARTED|Overall Study||8
7518566|NCT03865329|18513969|P1|NOT COMPLETED|Overall Study||0
7518567|NCT03865329|18513969|P1|COMPLETED|Overall Study||9
7518568|NCT03865329|18513969|P1|STARTED|Overall Study||9
7518569|NCT03864653|18513981|P1|NOT COMPLETED|Overall Study||1
7518570|NCT03864653|18513981|P1|COMPLETED|Overall Study||38
7518571|NCT03864653|18513981|P1|STARTED|Overall Study||39
7518572|NCT03863210|18513986|P1|NOT COMPLETED|Overall Study||2
7518573|NCT03863210|18513986|P1|COMPLETED|Overall Study|September 1st, 2014.|102
7518574|NCT03863210|18513986|P1|STARTED|Overall Study|March 1st, 2014.|104
7518575|NCT03862040|18513995|P1|NOT COMPLETED|Overall Study||0
7518576|NCT03862040|18513995|P1|COMPLETED|Overall Study||7
7518577|NCT03862040|18513995|P1|STARTED|Overall Study||7
7518578|NCT03861845|18514003|P3|NOT COMPLETED|Overall Study||0
7518579|NCT03861845|18514004|P2|NOT COMPLETED|Overall Study||0
7518580|NCT03861845|18514005|P1|NOT COMPLETED|Overall Study||0
7518581|NCT03861845|18514003|P3|COMPLETED|Overall Study||4
7518582|NCT03861845|18514004|P2|COMPLETED|Overall Study||5
7518583|NCT03861845|18514005|P1|COMPLETED|Overall Study||6
7518584|NCT03861845|18514003|P3|STARTED|Overall Study||4
7518585|NCT03861845|18514004|P2|STARTED|Overall Study||5
7518586|NCT03861845|18514005|P1|STARTED|Overall Study||6
7518587|NCT03861559|18514021|P2|NOT COMPLETED|Overall Study||5
7518588|NCT03861559|18514022|P1|NOT COMPLETED|Overall Study||2
7518589|NCT03861559|18514021|P2|COMPLETED|Overall Study||95
7518590|NCT03861559|18514022|P1|COMPLETED|Overall Study||99
7518591|NCT03861559|18514021|P2|STARTED|Overall Study||100
7518592|NCT03861559|18514022|P1|STARTED|Overall Study||101
7518593|NCT03860753|18514070|P2|NOT COMPLETED|Overall Study||0
7518594|NCT03860753|18514071|P1|NOT COMPLETED|Overall Study||0
7518595|NCT03860753|18514070|P2|COMPLETED|Overall Study||0
7518596|NCT03860753|18514071|P1|COMPLETED|Overall Study||4
7518597|NCT03860753|18514070|P2|STARTED|Overall Study||0
7518598|NCT03860753|18514071|P1|STARTED|Overall Study||4
7518599|NCT03859960|18514091|P2|NOT COMPLETED|Overall Study||0
7518600|NCT03859960|18514092|P1|NOT COMPLETED|Overall Study||0
7518601|NCT03859960|18514091|P2|COMPLETED|Overall Study||19
7518602|NCT03859960|18514092|P1|COMPLETED|Overall Study||14
7518603|NCT03859960|18514091|P2|STARTED|Overall Study||19
7518604|NCT03859960|18514092|P1|STARTED|Overall Study||14
7518605|NCT03859622|18514108|P1|NOT COMPLETED|Overall Study||0
7518606|NCT03859622|18514108|P1|COMPLETED|Overall Study||289
7518607|NCT03859622|18514108|P1|STARTED|Overall Study||289
7518608|NCT03858894|18514118|P2|NOT COMPLETED|Overall Study||0
7518609|NCT03858894|18514119|P1|NOT COMPLETED|Overall Study||4
7518610|NCT03858894|18514118|P2|COMPLETED|Overall Study||50
7518611|NCT03858894|18514119|P1|COMPLETED|Overall Study||44
7518612|NCT03858894|18514118|P2|STARTED|Overall Study||50
7518613|NCT03858894|18514119|P1|STARTED|Overall Study||48
7518614|NCT03858335|18514139|P2|NOT COMPLETED|Overall Study||4
7518615|NCT03858335|18514140|P1|NOT COMPLETED|Overall Study||4
7518616|NCT03858335|18514139|P2|COMPLETED|Overall Study||12
7518617|NCT03858335|18514140|P1|COMPLETED|Overall Study||12
7518618|NCT03858335|18514139|P2|STARTED|Overall Study||16
7518619|NCT03858335|18514140|P1|STARTED|Overall Study||16
7518620|NCT03857750|18514160|P2|NOT COMPLETED|Overall Study||0
7518621|NCT03857750|18514161|P1|NOT COMPLETED|Overall Study||0
7518622|NCT03857750|18514160|P2|COMPLETED|Overall Study||16
7518623|NCT03857750|18514161|P1|COMPLETED|Overall Study||16
7518624|NCT03857750|18514160|P2|STARTED|Overall Study||16
7518625|NCT03857750|18514161|P1|STARTED|Overall Study||16
7518626|NCT03857243|18514173|P2|NOT COMPLETED|Overall Study||0
7518627|NCT03857243|18514174|P1|NOT COMPLETED|Overall Study||0
7518628|NCT03857243|18514173|P2|COMPLETED|Overall Study||1
7518629|NCT03857243|18514174|P1|COMPLETED|Overall Study||1
7518630|NCT03857243|18514173|P2|STARTED|Overall Study||1
7518631|NCT03857243|18514174|P1|STARTED|Overall Study||1
7518632|NCT03857230|18514186|P2|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
7518633|NCT03857230|18514187|P1|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
7518634|NCT03857230|18514186|P2|COMPLETED|Period 2 (Gonal-F-Primapur)||12
7518635|NCT03857230|18514187|P1|COMPLETED|Period 2 (Gonal-F-Primapur)||12
7518636|NCT03857230|18514186|P2|STARTED|Period 2 (Gonal-F-Primapur)||12
7518637|NCT03857230|18514187|P1|STARTED|Period 2 (Gonal-F-Primapur)||12
7518638|NCT03857230|18514186|P2|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
7518639|NCT03857230|18514187|P1|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
7518640|NCT03857230|18514186|P2|COMPLETED|Period 1 (Primapur-Gonal-F)||12
7518641|NCT03857230|18514187|P1|COMPLETED|Period 1 (Primapur-Gonal-F)||12
7518642|NCT03857230|18514186|P2|STARTED|Period 1 (Primapur-Gonal-F)||12
7518643|NCT03857230|18514187|P1|STARTED|Period 1 (Primapur-Gonal-F)||12
7518644|NCT03855228|18514205|P4|NOT COMPLETED|Overall Study||19
7518645|NCT03855228|18514206|P3|NOT COMPLETED|Overall Study||8
7518646|NCT03855228|18514207|P2|NOT COMPLETED|Overall Study||9
7518647|NCT03855228|18514208|P1|NOT COMPLETED|Overall Study||3
7518648|NCT03855228|18514205|P4|COMPLETED|Overall Study||158
7518649|NCT03855228|18514206|P3|COMPLETED|Overall Study||174
7518650|NCT03855228|18514207|P2|COMPLETED|Overall Study||167
7518651|NCT03855228|18514208|P1|COMPLETED|Overall Study||166
7518652|NCT03855228|18514205|P4|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|176
7518653|NCT03855228|18514206|P3|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|181
7518654|NCT03855228|18514207|P2|Treated|Overall Study||176
7518655|NCT03855228|18514208|P1|Treated|Overall Study||169
7518656|NCT03855228|18514205|P4|STARTED|Overall Study||177
7518657|NCT03855228|18514206|P3|STARTED|Overall Study||182
7518658|NCT03855228|18514207|P2|STARTED|Overall Study||176
7518659|NCT03855228|18514208|P1|STARTED|Overall Study||169
7518660|NCT03855189|18514257|P3|NOT COMPLETED|Overall Study||6
7518661|NCT03855189|18514258|P2|NOT COMPLETED|Overall Study||7
7518662|NCT03855189|18514259|P1|NOT COMPLETED|Overall Study||10
7518663|NCT03855189|18514257|P3|COMPLETED|Overall Study||110
7518664|NCT03855189|18514258|P2|COMPLETED|Overall Study||109
7518665|NCT03855189|18514259|P1|COMPLETED|Overall Study||103
7518666|NCT03855189|18514257|P3|Treated|Overall Study||116
7518667|NCT03855189|18514258|P2|Treated|Overall Study||116
7518668|NCT03855189|18514259|P1|Treated|Overall Study|Does not include 1 participant who received first dose but was excluded from safety analysis.|112
7518669|NCT03855189|18514257|P3|STARTED|Overall Study||116
7518670|NCT03855189|18514258|P2|STARTED|Overall Study||116
7518671|NCT03855189|18514259|P1|STARTED|Overall Study||113
7518672|NCT03854253|18514350|P2|NOT COMPLETED|Overall Study||0
7518673|NCT03854253|18514351|P1|NOT COMPLETED|Overall Study||1
7518674|NCT03854253|18514350|P2|COMPLETED|Overall Study||50
7518675|NCT03854253|18514351|P1|COMPLETED|Overall Study||49
7518676|NCT03854253|18514350|P2|STARTED|Overall Study||50
7518677|NCT03854253|18514351|P1|STARTED|Overall Study||50
7518678|NCT03851016|18514377|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
7518679|NCT03851016|18514378|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
7518680|NCT03851016|18514377|P2|COMPLETED|Second Intervention (3 Weeks)||10
7518681|NCT03851016|18514378|P1|COMPLETED|Second Intervention (3 Weeks)||11
7518682|NCT03851016|18514377|P2|STARTED|Second Intervention (3 Weeks)||10
7518683|NCT03851016|18514378|P1|STARTED|Second Intervention (3 Weeks)||11
7518684|NCT03851016|18514377|P2|NOT COMPLETED|Washout (1 Week)||0
7518685|NCT03851016|18514378|P1|NOT COMPLETED|Washout (1 Week)||0
7518686|NCT03851016|18514377|P2|COMPLETED|Washout (1 Week)||10
7518687|NCT03851016|18514378|P1|COMPLETED|Washout (1 Week)||11
7518688|NCT03851016|18514377|P2|STARTED|Washout (1 Week)||10
7518689|NCT03851016|18514378|P1|STARTED|Washout (1 Week)||11
7518690|NCT03851016|18514377|P2|NOT COMPLETED|First Intervention (3 Weeks)||2
7518691|NCT03851016|18514378|P1|NOT COMPLETED|First Intervention (3 Weeks)||1
7518692|NCT03851016|18514377|P2|COMPLETED|First Intervention (3 Weeks)||10
7518693|NCT03851016|18514378|P1|COMPLETED|First Intervention (3 Weeks)||11
7518694|NCT03851016|18514377|P2|STARTED|First Intervention (3 Weeks)||12
7518695|NCT03851016|18514378|P1|STARTED|First Intervention (3 Weeks)||12
7518696|NCT03850496|18514391|P3|NOT COMPLETED|Overall Study||4
7518697|NCT03850496|18514392|P2|NOT COMPLETED|Overall Study||1
7518698|NCT03850496|18514393|P1|NOT COMPLETED|Overall Study||1
7518699|NCT03850496|18514391|P3|COMPLETED|Overall Study||21
7518700|NCT03850496|18514392|P2|COMPLETED|Overall Study||24
7518701|NCT03850496|18514393|P1|COMPLETED|Overall Study||25
7518702|NCT03850496|18514391|P3|STARTED|Overall Study||25
7518703|NCT03850496|18514392|P2|STARTED|Overall Study||25
7518704|NCT03850496|18514393|P1|STARTED|Overall Study||26
7518705|NCT03850444|18514415|P2|NOT COMPLETED|Overall Study||134
7518706|NCT03850444|18514416|P1|NOT COMPLETED|Overall Study||128
7518707|NCT03850444|18514415|P2|COMPLETED|Overall Study||0
7518708|NCT03850444|18514416|P1|COMPLETED|Overall Study||0
7518709|NCT03850444|18514415|P2|STARTED|Overall Study||134
7518710|NCT03850444|18514416|P1|STARTED|Overall Study||128
7518711|NCT03850093|18514445|P3|NOT COMPLETED|Overall Study||2
7518712|NCT03850093|18514446|P2|NOT COMPLETED|Overall Study||0
7518713|NCT03850093|18514447|P1|NOT COMPLETED|Overall Study||1
7518714|NCT03850093|18514445|P3|COMPLETED|Overall Study||17
7518715|NCT03850093|18514446|P2|COMPLETED|Overall Study||22
7518716|NCT03850093|18514447|P1|COMPLETED|Overall Study||21
7518717|NCT03850093|18514445|P3|STARTED|Overall Study||19
7518718|NCT03850093|18514446|P2|STARTED|Overall Study||22
7518719|NCT03850093|18514447|P1|STARTED|Overall Study||22
7518720|NCT03849690|18514482|P1|NOT COMPLETED|Period 2 (6 Days)||0
7518721|NCT03849690|18514482|P1|COMPLETED|Period 2 (6 Days)||12
7518722|NCT03849690|18514482|P1|STARTED|Period 2 (6 Days)||12
7518723|NCT03849690|18514482|P1|NOT COMPLETED|Washout Period (at Least 4 Days)||0
7518724|NCT03849690|18514482|P1|COMPLETED|Washout Period (at Least 4 Days)||12
7518725|NCT03849690|18514482|P1|STARTED|Washout Period (at Least 4 Days)||12
7518726|NCT03849690|18514482|P1|NOT COMPLETED|Period 1 (3 Days)||0
7518727|NCT03849690|18514482|P1|COMPLETED|Period 1 (3 Days)||12
7518728|NCT03849690|18514482|P1|STARTED|Period 1 (3 Days)||12
7518729|NCT03849300|18514509|P4|NOT COMPLETED|Overall Study||6
7518730|NCT03849300|18514510|P3|NOT COMPLETED|Overall Study||4
7518731|NCT03849300|18514511|P2|NOT COMPLETED|Overall Study||7
7518732|NCT03849300|18514512|P1|NOT COMPLETED|Overall Study||5
7518733|NCT03849300|18514509|P4|COMPLETED|Overall Study||25
7518734|NCT03849300|18514510|P3|COMPLETED|Overall Study||28
7518735|NCT03849300|18514511|P2|COMPLETED|Overall Study||35
7518736|NCT03849300|18514512|P1|COMPLETED|Overall Study||37
7518737|NCT03849300|18514509|P4|STARTED|Overall Study||31
7518738|NCT03849300|18514510|P3|STARTED|Overall Study||32
7518739|NCT03849300|18514511|P2|STARTED|Overall Study||42
7518740|NCT03849300|18514512|P1|STARTED|Overall Study||42
7518741|NCT03848910|18514566|P1|NOT COMPLETED|Overall Study||0
7518742|NCT03848910|18514566|P1|COMPLETED|Overall Study||11
7518743|NCT03848910|18514566|P1|STARTED|Overall Study||11
7518744|NCT03848871|18514583|P1|NOT COMPLETED|Overall Study||0
7518745|NCT03848871|18514583|P1|COMPLETED|Overall Study||20
7518746|NCT03848871|18514583|P1|STARTED|Overall Study||20
7518747|NCT03848455|18514595|P3|NOT COMPLETED|Overall Study||0
7518748|NCT03848455|18514596|P2|NOT COMPLETED|Overall Study||0
7518749|NCT03848455|18514597|P1|NOT COMPLETED|Overall Study||0
7518750|NCT03848455|18514595|P3|COMPLETED|Overall Study||23
7518751|NCT03848455|18514596|P2|COMPLETED|Overall Study||125
7518752|NCT03848455|18514597|P1|COMPLETED|Overall Study||90
7518753|NCT03848455|18514595|P3|STARTED|Overall Study||23
7518754|NCT03848455|18514596|P2|STARTED|Overall Study||125
7518755|NCT03848455|18514597|P1|STARTED|Overall Study||90
7518756|NCT03848416|18514614|P3|NOT COMPLETED|Overall Study||1
7518757|NCT03848416|18514615|P2|NOT COMPLETED|Overall Study||0
7518758|NCT03848416|18514616|P1|NOT COMPLETED|Overall Study||1
7518759|NCT03848416|18514614|P3|COMPLETED|Overall Study||32
7518760|NCT03848416|18514615|P2|COMPLETED|Overall Study||33
7518761|NCT03848416|18514616|P1|COMPLETED|Overall Study||32
7518762|NCT03848416|18514614|P3|Received at Least One Dose of Study Drug|Overall Study||33
7518763|NCT03848416|18514615|P2|Received at Least One Dose of Study Drug|Overall Study||33
7518764|NCT03848416|18514616|P1|Received at Least One Dose of Study Drug|Overall Study||33
7518765|NCT03848416|18514614|P3|STARTED|Overall Study||33
7518766|NCT03848416|18514615|P2|STARTED|Overall Study||33
7518767|NCT03848416|18514616|P1|STARTED|Overall Study||33
7518768|NCT03848403|18514630|P3|NOT COMPLETED|Period 3 (Day 15)||0
7518769|NCT03848403|18514631|P2|NOT COMPLETED|Period 3 (Day 15)||0
7518770|NCT03848403|18514632|P1|NOT COMPLETED|Period 3 (Day 15)||0
7518771|NCT03848403|18514630|P3|COMPLETED|Period 3 (Day 15)||15
7518772|NCT03848403|18514631|P2|COMPLETED|Period 3 (Day 15)||15
7518773|NCT03848403|18514632|P1|COMPLETED|Period 3 (Day 15)||15
7518774|NCT03848403|18514630|P3|STARTED|Period 3 (Day 15)||15
7518775|NCT03848403|18514631|P2|STARTED|Period 3 (Day 15)||15
7518776|NCT03848403|18514632|P1|STARTED|Period 3 (Day 15)||15
7518777|NCT03848403|18514630|P3|NOT COMPLETED|Period 2 (Day 8)||7
7518778|NCT03848403|18514631|P2|NOT COMPLETED|Period 2 (Day 8)||9
7518779|NCT03848403|18514632|P1|NOT COMPLETED|Period 2 (Day 8)||9
7518780|NCT03848403|18514630|P3|COMPLETED|Period 2 (Day 8)||15
7518781|NCT03848403|18514631|P2|COMPLETED|Period 2 (Day 8)||15
7518782|NCT03848403|18514632|P1|COMPLETED|Period 2 (Day 8)||15
7518783|NCT03848403|18514630|P3|Received at Least One Dose of Study Drug|Period 2 (Day 8)||22
7518784|NCT03848403|18514631|P2|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
7518785|NCT03848403|18514632|P1|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
7518786|NCT03848403|18514630|P3|STARTED|Period 2 (Day 8)||22
7518787|NCT03848403|18514631|P2|STARTED|Period 2 (Day 8)||24
7518788|NCT03848403|18514632|P1|STARTED|Period 2 (Day 8)||24
7518789|NCT03848403|18514630|P3|NOT COMPLETED|Period 1 (Day 1)||0
7518790|NCT03848403|18514631|P2|NOT COMPLETED|Period 1 (Day 1)||0
7518791|NCT03848403|18514632|P1|NOT COMPLETED|Period 1 (Day 1)||0
7518792|NCT03848403|18514630|P3|COMPLETED|Period 1 (Day 1)||22
7518793|NCT03848403|18514631|P2|COMPLETED|Period 1 (Day 1)||24
7518794|NCT03848403|18514632|P1|COMPLETED|Period 1 (Day 1)||24
7518795|NCT03848403|18514630|P3|Received Intervention|Period 1 (Day 1)||22
7518796|NCT03848403|18514631|P2|Received Intervention|Period 1 (Day 1)||24
7518797|NCT03848403|18514632|P1|Received Intervention|Period 1 (Day 1)||24
7518798|NCT03848403|18514630|P3|STARTED|Period 1 (Day 1)||22
7518799|NCT03848403|18514631|P2|STARTED|Period 1 (Day 1)||24
7518800|NCT03848403|18514632|P1|STARTED|Period 1 (Day 1)||24
7518801|NCT03848221|18514643|P3|NOT COMPLETED|Overall Study||0
7518802|NCT03848221|18514644|P2|NOT COMPLETED|Overall Study||0
7518803|NCT03848221|18514645|P1|NOT COMPLETED|Overall Study||0
7518804|NCT03848221|18514643|P3|COMPLETED|Overall Study||24
7518805|NCT03848221|18514644|P2|COMPLETED|Overall Study||24
7518806|NCT03848221|18514645|P1|COMPLETED|Overall Study||25
7518807|NCT03848221|18514643|P3|STARTED|Overall Study||24
7518808|NCT03848221|18514644|P2|STARTED|Overall Study||24
7518809|NCT03848221|18514645|P1|STARTED|Overall Study||25
7518810|NCT03848208|18514666|P10|NOT COMPLETED|Overall Study||0
7518811|NCT03848208|18514667|P9|NOT COMPLETED|Overall Study||0
7518812|NCT03848208|18514668|P8|NOT COMPLETED|Overall Study||0
7518813|NCT03848208|18514669|P7|NOT COMPLETED|Overall Study||0
7518814|NCT03848208|18514670|P6|NOT COMPLETED|Overall Study||0
7518815|NCT03848208|18514671|P5|NOT COMPLETED|Overall Study||0
7518816|NCT03848208|18514672|P4|NOT COMPLETED|Overall Study||0
7518817|NCT03848208|18514673|P3|NOT COMPLETED|Overall Study||0
7518818|NCT03848208|18514674|P2|NOT COMPLETED|Overall Study||0
7518819|NCT03848208|18514675|P1|NOT COMPLETED|Overall Study||0
7518820|NCT03848208|18514666|P10|COMPLETED|Overall Study||6
7518821|NCT03848208|18514667|P9|COMPLETED|Overall Study||6
7518822|NCT03848208|18514668|P8|COMPLETED|Overall Study||6
7518823|NCT03848208|18514669|P7|COMPLETED|Overall Study||6
7518824|NCT03848208|18514670|P6|COMPLETED|Overall Study||6
7518825|NCT03848208|18514671|P5|COMPLETED|Overall Study||6
7518826|NCT03848208|18514672|P4|COMPLETED|Overall Study||6
7518827|NCT03848208|18514673|P3|COMPLETED|Overall Study||6
7518828|NCT03848208|18514674|P2|COMPLETED|Overall Study||6
7518829|NCT03848208|18514675|P1|COMPLETED|Overall Study||18
7518830|NCT03848208|18514666|P10|STARTED|Overall Study||6
7518831|NCT03848208|18514667|P9|STARTED|Overall Study||6
7518832|NCT03848208|18514668|P8|STARTED|Overall Study||6
7518833|NCT03848208|18514669|P7|STARTED|Overall Study||6
7518834|NCT03848208|18514670|P6|STARTED|Overall Study||6
7518835|NCT03848208|18514671|P5|STARTED|Overall Study||6
7518836|NCT03848208|18514672|P4|STARTED|Overall Study||6
7518837|NCT03848208|18514673|P3|STARTED|Overall Study||6
7518838|NCT03848208|18514674|P2|STARTED|Overall Study||6
7518839|NCT03848208|18514675|P1|STARTED|Overall Study||18
7518840|NCT03847987|18514717|P2|NOT COMPLETED|Overall Study||0
7518841|NCT03847987|18514718|P1|NOT COMPLETED|Overall Study||3
7518842|NCT03847987|18514717|P2|COMPLETED|Overall Study||8
7518843|NCT03847987|18514718|P1|COMPLETED|Overall Study||13
7518844|NCT03847987|18514717|P2|STARTED|Overall Study||8
7518845|NCT03847987|18514718|P1|STARTED|Overall Study||16
7518846|NCT03847610|18514741|P1|NOT COMPLETED|Overall Study||1
7518847|NCT03847610|18514741|P1|COMPLETED|Overall Study||10
7518848|NCT03847610|18514741|P1|STARTED|Overall Study||11
7518849|NCT03847233|18514745|P1|NOT COMPLETED|Overall Study||0
7518850|NCT03847233|18514745|P1|COMPLETED|Overall Study|The number of subjects completed the index procedure.|31
7518851|NCT03847233|18514745|P1|STARTED|Overall Study||31
7518852|NCT03845933|18514754|P2|NOT COMPLETED|Overall Study||0
7518853|NCT03845933|18514755|P1|NOT COMPLETED|Overall Study||0
7518854|NCT03845933|18514754|P2|COMPLETED|Overall Study||131
7518855|NCT03845933|18514755|P1|COMPLETED|Overall Study||131
7518856|NCT03845933|18514754|P2|STARTED|Overall Study||131
7518857|NCT03845933|18514755|P1|STARTED|Overall Study||131
7518858|NCT03844945|18514765|P4|NOT COMPLETED|Overall Study||1
7518859|NCT03844945|18514766|P3|NOT COMPLETED|Overall Study||5
7518860|NCT03844945|18514767|P2|NOT COMPLETED|Overall Study||1
7518861|NCT03844945|18514768|P1|NOT COMPLETED|Overall Study||1
7518862|NCT03844945|18514765|P4|COMPLETED|Overall Study||54
7518863|NCT03844945|18514766|P3|COMPLETED|Overall Study||46
7518864|NCT03844945|18514767|P2|COMPLETED|Overall Study||53
7518865|NCT03844945|18514768|P1|COMPLETED|Overall Study||54
7518866|NCT03844945|18514765|P4|STARTED|Overall Study||55
7518867|NCT03844945|18514766|P3|STARTED|Overall Study||51
7518868|NCT03844945|18514767|P2|STARTED|Overall Study||54
7518869|NCT03844945|18514768|P1|STARTED|Overall Study||55
7518870|NCT03843372|18514780|P2|NOT COMPLETED|Overall Study||2
7518871|NCT03843372|18514781|P1|NOT COMPLETED|Overall Study||2
7518872|NCT03843372|18514780|P2|COMPLETED|Overall Study||16
7518873|NCT03843372|18514781|P1|COMPLETED|Overall Study||12
7518874|NCT03843372|18514780|P2|STARTED|Overall Study||18
7518875|NCT03843372|18514781|P1|STARTED|Overall Study||14
7518876|NCT03842683|18514793|P1|NOT COMPLETED|Overall Study||0
7518877|NCT03842683|18514793|P1|COMPLETED|Overall Study||472
7518878|NCT03842683|18514793|P1|STARTED|Overall Study||472
7518879|NCT03841331|18514800|P2|NOT COMPLETED|Overall Study||10
7518880|NCT03841331|18514801|P1|NOT COMPLETED|Overall Study||9
7518881|NCT03841331|18514800|P2|COMPLETED|Overall Study||106
7518882|NCT03841331|18514801|P1|COMPLETED|Overall Study||108
7518883|NCT03841331|18514800|P2|STARTED|Overall Study||116
7518884|NCT03841331|18514801|P1|STARTED|Overall Study||117
7518885|NCT03840278|18514821|P2|NOT COMPLETED|Overall Study||0
7518886|NCT03840278|18514822|P1|NOT COMPLETED|Overall Study||0
7518887|NCT03840278|18514821|P2|COMPLETED|Overall Study||5
7518888|NCT03840278|18514822|P1|COMPLETED|Overall Study||5
7518889|NCT03840278|18514821|P2|STARTED|Overall Study||5
7518890|NCT03840278|18514822|P1|STARTED|Overall Study||5
7518891|NCT03840135|18514842|P2|NOT COMPLETED|Overall Study||1
7518892|NCT03840135|18514843|P1|NOT COMPLETED|Overall Study||7
7518893|NCT03840135|18514842|P2|COMPLETED|Overall Study||85
7518894|NCT03840135|18514843|P1|COMPLETED|Overall Study||79
7518895|NCT03840135|18514842|P2|STARTED|Overall Study||86
7518896|NCT03840135|18514843|P1|STARTED|Overall Study||86
7518897|NCT03837028|18514873|P4|NOT COMPLETED|Overall Study||7
7518898|NCT03837028|18514874|P3|NOT COMPLETED|Overall Study||13
7518899|NCT03837028|18514875|P2|NOT COMPLETED|Overall Study||11
7518900|NCT03837028|18514876|P1|NOT COMPLETED|Overall Study||16
7518901|NCT03837028|18514873|P4|COMPLETED|Overall Study||18
7518902|NCT03837028|18514874|P3|COMPLETED|Overall Study||20
7518903|NCT03837028|18514875|P2|COMPLETED|Overall Study||23
7518904|NCT03837028|18514876|P1|COMPLETED|Overall Study||19
7518905|NCT03837028|18514873|P4|STARTED|Overall Study||25
7518906|NCT03837028|18514874|P3|STARTED|Overall Study||33
7518907|NCT03837028|18514875|P2|STARTED|Overall Study||34
7518908|NCT03837028|18514876|P1|STARTED|Overall Study||35
7518909|NCT03836859|18514892|P2|NOT COMPLETED|Overall Study||0
7518910|NCT03836859|18514893|P1|NOT COMPLETED|Overall Study||0
7518911|NCT03836859|18514892|P2|COMPLETED|Overall Study||10
7518912|NCT03836859|18514893|P1|COMPLETED|Overall Study||20
7518913|NCT03836859|18514892|P2|STARTED|Overall Study||10
7518914|NCT03836859|18514893|P1|STARTED|Overall Study||20
7518915|NCT03836729|18514929|P1|NOT COMPLETED|Treatment Period 2 (Up to Day 7)||1
7518916|NCT03836729|18514929|P1|COMPLETED|Treatment Period 2 (Up to Day 7)||15
7518917|NCT03836729|18514929|P1|STARTED|Treatment Period 2 (Up to Day 7)||16
7518918|NCT03836729|18514929|P1|NOT COMPLETED|Treatment Period 1 (Up to Day 14)||0
7518919|NCT03836729|18514929|P1|COMPLETED|Treatment Period 1 (Up to Day 14)||16
7518920|NCT03836729|18514929|P1|STARTED|Treatment Period 1 (Up to Day 14)||16
7518921|NCT03836664|18515043|P2|NOT COMPLETED|Overall Study||3
7518922|NCT03836664|18515044|P1|NOT COMPLETED|Overall Study||3
7518923|NCT03836664|18515043|P2|COMPLETED|Overall Study||8
7518924|NCT03836664|18515044|P1|COMPLETED|Overall Study||11
7518925|NCT03836664|18515043|P2|STARTED|Overall Study||11
7518926|NCT03836664|18515044|P1|STARTED|Overall Study||14
7518927|NCT03835546|18515057|P3|NOT COMPLETED|Overall Study||0
7518928|NCT03835546|18515058|P2|NOT COMPLETED|Overall Study||0
7518929|NCT03835546|18515059|P1|NOT COMPLETED|Overall Study||3
7518930|NCT03835546|18515057|P3|COMPLETED|Overall Study||15
7518931|NCT03835546|18515058|P2|COMPLETED|Overall Study||15
7518932|NCT03835546|18515059|P1|COMPLETED|Overall Study||12
7518933|NCT03835546|18515057|P3|STARTED|Overall Study||15
7518934|NCT03835546|18515058|P2|STARTED|Overall Study||15
7518935|NCT03835546|18515059|P1|STARTED|Overall Study||15
7518936|NCT03835221|18515085|P1|NOT COMPLETED|Fanfilcon A||0
7518937|NCT03835221|18515085|P1|COMPLETED|Fanfilcon A||42
7518938|NCT03835221|18515085|P1|STARTED|Fanfilcon A||42
7518939|NCT03835221|18515085|P1|NOT COMPLETED|Methafilcon A||1
7518940|NCT03835221|18515085|P1|COMPLETED|Methafilcon A||42
7518941|NCT03835221|18515085|P1|STARTED|Methafilcon A||43
7518942|NCT03835078|18515130|P1|NOT COMPLETED|Overall Study||0
7518943|NCT03835078|18515130|P1|COMPLETED|Overall Study||39
7518944|NCT03835078|18515130|P1|STARTED|Overall Study||39
7518945|NCT03832387|18515167|P2|NOT COMPLETED|Overall Study||7
7518946|NCT03832387|18515168|P1|NOT COMPLETED|Overall Study||5
7518947|NCT03832387|18515167|P2|COMPLETED|Overall Study||32
7518948|NCT03832387|18515168|P1|COMPLETED|Overall Study||33
7518949|NCT03832387|18515167|P2|STARTED|Overall Study||39
7518950|NCT03832387|18515168|P1|STARTED|Overall Study||38
7518951|NCT03832322|18515198|P2|NOT COMPLETED|Overall Study||1
7518952|NCT03832322|18515199|P1|NOT COMPLETED|Overall Study||3
7518953|NCT03832322|18515198|P2|COMPLETED|Overall Study||86
7518954|NCT03832322|18515199|P1|COMPLETED|Overall Study||86
7518955|NCT03832322|18515198|P2|STARTED|Overall Study||87
7518956|NCT03832322|18515199|P1|STARTED|Overall Study||89
7518957|NCT03831971|18515207|P1|NOT COMPLETED|Overall Study||0
7518958|NCT03831971|18515207|P1|COMPLETED|Overall Study||12
7518959|NCT03831971|18515207|P1|STARTED|Overall Study||12
7518960|NCT03831451|18515228|P2|NOT COMPLETED|Overall Study||0
7518961|NCT03831451|18515229|P1|NOT COMPLETED|Overall Study||0
7518962|NCT03831451|18515228|P2|COMPLETED|Overall Study||55
7518963|NCT03831451|18515229|P1|COMPLETED|Overall Study||74
7518964|NCT03831451|18515228|P2|STARTED|Overall Study||55
7518965|NCT03831451|18515229|P1|STARTED|Overall Study||74
7518966|NCT03831282|18515235|P1|NOT COMPLETED|Overall Study||1
7518967|NCT03831282|18515235|P1|COMPLETED|Overall Study||11
7518968|NCT03831282|18515235|P1|STARTED|Overall Study||12
7518969|NCT03830307|18515239|P1|NOT COMPLETED|Overall Study||0
7518970|NCT03830307|18515239|P1|COMPLETED|Overall Study||5
7518971|NCT03830307|18515239|P1|STARTED|Overall Study||5
7518972|NCT03828734|18515260|P2|NOT COMPLETED|Second Intervention||0
7518973|NCT03828734|18515261|P1|NOT COMPLETED|Second Intervention||0
7518974|NCT03828734|18515260|P2|COMPLETED|Second Intervention||24
7518975|NCT03828734|18515261|P1|COMPLETED|Second Intervention||25
7518976|NCT03828734|18515260|P2|STARTED|Second Intervention||24
7518977|NCT03828734|18515261|P1|STARTED|Second Intervention||25
7518978|NCT03828734|18515260|P2|NOT COMPLETED|First Washout (1 Week)||1
7518979|NCT03828734|18515261|P1|NOT COMPLETED|First Washout (1 Week)||0
7518980|NCT03828734|18515260|P2|COMPLETED|First Washout (1 Week)||24
7518981|NCT03828734|18515261|P1|COMPLETED|First Washout (1 Week)||25
7518982|NCT03828734|18515260|P2|STARTED|First Washout (1 Week)||25
7518983|NCT03828734|18515261|P1|STARTED|First Washout (1 Week)||25
7518984|NCT03828734|18515260|P2|NOT COMPLETED|First Intervention||0
7518985|NCT03828734|18515261|P1|NOT COMPLETED|First Intervention||4
7518986|NCT03828734|18515260|P2|COMPLETED|First Intervention||25
7518987|NCT03828734|18515261|P1|COMPLETED|First Intervention||25
7518988|NCT03828734|18515260|P2|STARTED|First Intervention||25
7518989|NCT03828734|18515261|P1|STARTED|First Intervention||29
7518990|NCT03828734|18515260|P2|NOT COMPLETED|Pre-Randomization (1 Week)||1
7518991|NCT03828734|18515261|P1|NOT COMPLETED|Pre-Randomization (1 Week)||3
7518992|NCT03828734|18515260|P2|COMPLETED|Pre-Randomization (1 Week)||25
7518993|NCT03828734|18515261|P1|COMPLETED|Pre-Randomization (1 Week)||29
7518994|NCT03828734|18515260|P2|STARTED|Pre-Randomization (1 Week)||26
7518995|NCT03828734|18515261|P1|STARTED|Pre-Randomization (1 Week)||32
7518996|NCT03828734|18515260|P2|NOT COMPLETED|Baseline||0
7518997|NCT03828734|18515261|P1|NOT COMPLETED|Baseline||0
7518998|NCT03828734|18515260|P2|COMPLETED|Baseline||26
7518999|NCT03828734|18515261|P1|COMPLETED|Baseline||32
7519000|NCT03828734|18515260|P2|STARTED|Baseline||26
7519001|NCT03828734|18515261|P1|STARTED|Baseline||32
7519002|NCT03828617|18515275|P4|NOT COMPLETED|Overall Study||10
7519003|NCT03828617|18515276|P3|NOT COMPLETED|Overall Study||26
7519004|NCT03828617|18515277|P2|NOT COMPLETED|Overall Study||15
7519005|NCT03828617|18515278|P1|NOT COMPLETED|Overall Study||24
7519006|NCT03828617|18515275|P4|COMPLETED|Overall Study||235
7519007|NCT03828617|18515276|P3|COMPLETED|Overall Study||460
7519008|NCT03828617|18515277|P2|COMPLETED|Overall Study||475
7519009|NCT03828617|18515278|P1|COMPLETED|Overall Study||465
7519010|NCT03828617|18515275|P4|Evaluable Immunogenicity Population(EIP)|Overall Study||232
7519011|NCT03828617|18515276|P3|Evaluable Immunogenicity Population(EIP)|Overall Study||456
7519012|NCT03828617|18515277|P2|Evaluable Immunogenicity Population(EIP)|Overall Study||473
7519013|NCT03828617|18515278|P1|Evaluable Immunogenicity Population(EIP)|Overall Study||463
7519014|NCT03828617|18515275|P4|Safety Population|Overall Study||245
7519015|NCT03828617|18515276|P3|Safety Population|Overall Study||486
7519016|NCT03828617|18515277|P2|Safety Population|Overall Study||489
7519017|NCT03828617|18515278|P1|Safety Population|Overall Study||488
7519018|NCT03828617|18515275|P4|Vaccinated|Overall Study||245
7519019|NCT03828617|18515276|P3|Vaccinated|Overall Study||486
7519020|NCT03828617|18515277|P2|Vaccinated|Overall Study||489
7519021|NCT03828617|18515278|P1|Vaccinated|Overall Study||488
7519022|NCT03828617|18515275|P4|STARTED|Overall Study||245
7519023|NCT03828617|18515276|P3|STARTED|Overall Study||486
7519024|NCT03828617|18515277|P2|STARTED|Overall Study||490
7519025|NCT03828617|18515278|P1|STARTED|Overall Study||489
7519026|NCT03828149|18515306|P2|NOT COMPLETED|Second Intervention (Single Dose)||0
7519027|NCT03828149|18515307|P1|NOT COMPLETED|Second Intervention (Single Dose)||0
7519028|NCT03828149|18515306|P2|COMPLETED|Second Intervention (Single Dose)||8
7519029|NCT03828149|18515307|P1|COMPLETED|Second Intervention (Single Dose)||9
7519030|NCT03828149|18515306|P2|STARTED|Second Intervention (Single Dose)||8
7519031|NCT03828149|18515307|P1|STARTED|Second Intervention (Single Dose)||9
7519032|NCT03828149|18515306|P2|NOT COMPLETED|Washout (6 Days)||0
7519033|NCT03828149|18515307|P1|NOT COMPLETED|Washout (6 Days)||0
7519034|NCT03828149|18515306|P2|COMPLETED|Washout (6 Days)||8
7519035|NCT03828149|18515307|P1|COMPLETED|Washout (6 Days)||9
7519036|NCT03828149|18515306|P2|STARTED|Washout (6 Days)||8
7519037|NCT03828149|18515307|P1|STARTED|Washout (6 Days)||9
7519038|NCT03828149|18515306|P2|NOT COMPLETED|First Intervention (Single Dose)||0
7519039|NCT03828149|18515307|P1|NOT COMPLETED|First Intervention (Single Dose)||0
7519040|NCT03828149|18515306|P2|COMPLETED|First Intervention (Single Dose)||8
7519041|NCT03828149|18515307|P1|COMPLETED|First Intervention (Single Dose)||9
7519042|NCT03828149|18515306|P2|STARTED|First Intervention (Single Dose)||8
7519043|NCT03828149|18515307|P1|STARTED|First Intervention (Single Dose)||9
7519044|NCT03827473|18515315|P2|NOT COMPLETED|Overall Study||0
7519045|NCT03827473|18515316|P1|NOT COMPLETED|Overall Study||1
7519046|NCT03827473|18515315|P2|COMPLETED|Overall Study||0
7519047|NCT03827473|18515316|P1|COMPLETED|Overall Study||0
7519048|NCT03827473|18515315|P2|STARTED|Overall Study||0
7519049|NCT03827473|18515316|P1|STARTED|Overall Study||1
7519050|NCT03826914|18515332|P2|NOT COMPLETED|Overall Study||1
7519051|NCT03826914|18515333|P1|NOT COMPLETED|Overall Study||1
7519052|NCT03826914|18515332|P2|COMPLETED|Overall Study||33
7519053|NCT03826914|18515333|P1|COMPLETED|Overall Study||34
7519054|NCT03826914|18515332|P2|STARTED|Overall Study||34
7519055|NCT03826914|18515333|P1|STARTED|Overall Study||35
7519056|NCT03825393|18515343|P2|NOT COMPLETED|Overall Study||0
7519057|NCT03825393|18515344|P1|NOT COMPLETED|Overall Study||0
7519058|NCT03825393|18515343|P2|COMPLETED|Overall Study||100
7519059|NCT03825393|18515344|P1|COMPLETED|Overall Study||100
7519060|NCT03825393|18515343|P2|STARTED|Overall Study||100
7519061|NCT03825393|18515344|P1|STARTED|Overall Study||100
7519062|NCT03825042|18515356|P2|NOT COMPLETED|Overall Study||0
7519063|NCT03825042|18515357|P1|NOT COMPLETED|Overall Study||2
7519064|NCT03825042|18515356|P2|COMPLETED|Overall Study||40
7519065|NCT03825042|18515357|P1|COMPLETED|Overall Study||38
7519066|NCT03825042|18515356|P2|STARTED|Overall Study||40
7519067|NCT03825042|18515357|P1|STARTED|Overall Study||40
7519068|NCT03824912|18515370|P3|NOT COMPLETED|Overall Study||68
7519069|NCT03824912|18515371|P2|NOT COMPLETED|Overall Study||134
7519070|NCT03824912|18515372|P1|NOT COMPLETED|Overall Study||140
7519071|NCT03824912|18515370|P3|COMPLETED|Overall Study||96
7519072|NCT03824912|18515371|P2|COMPLETED|Overall Study||201
7519073|NCT03824912|18515372|P1|COMPLETED|Overall Study||192
7519074|NCT03824912|18515370|P3|STARTED|Overall Study||164
7519075|NCT03824912|18515371|P2|STARTED|Overall Study||335
7519076|NCT03824912|18515372|P1|STARTED|Overall Study||332
7519077|NCT03824236|18515395|P3|NOT COMPLETED|Overall Study||1
7519078|NCT03824236|18515396|P2|NOT COMPLETED|Overall Study||0
7519079|NCT03824236|18515397|P1|NOT COMPLETED|Overall Study||0
7519080|NCT03824236|18515395|P3|COMPLETED|Overall Study||11
7519081|NCT03824236|18515396|P2|COMPLETED|Overall Study||24
7519082|NCT03824236|18515397|P1|COMPLETED|Overall Study||25
7519083|NCT03824236|18515395|P3|STARTED|Overall Study||12
7519084|NCT03824236|18515396|P2|STARTED|Overall Study||24
7519085|NCT03824236|18515397|P1|STARTED|Overall Study||25
7519086|NCT03823937|18515432|P2|NOT COMPLETED|Overall Study||0
7519087|NCT03823937|18515433|P1|NOT COMPLETED|Overall Study||0
7519088|NCT03823937|18515432|P2|COMPLETED|Overall Study||20
7519089|NCT03823937|18515433|P1|COMPLETED|Overall Study||30
7519090|NCT03823937|18515432|P2|STARTED|Overall Study||20
7519091|NCT03823937|18515433|P1|STARTED|Overall Study||30
7519092|NCT03822884|18515455|P6|NOT COMPLETED|Overall Study||0
7519093|NCT03822884|18515456|P5|NOT COMPLETED|Overall Study||1
7519094|NCT03822884|18515457|P4|NOT COMPLETED|Overall Study||0
7519095|NCT03822884|18515458|P3|NOT COMPLETED|Overall Study||0
7519096|NCT03822884|18515459|P2|NOT COMPLETED|Overall Study||0
7519097|NCT03822884|18515460|P1|NOT COMPLETED|Overall Study||0
7519098|NCT03822884|18515455|P6|COMPLETED|Overall Study||4
7519099|NCT03822884|18515456|P5|COMPLETED|Overall Study||3
7519100|NCT03822884|18515457|P4|COMPLETED|Overall Study||4
7519101|NCT03822884|18515458|P3|COMPLETED|Overall Study||4
7519102|NCT03822884|18515459|P2|COMPLETED|Overall Study||4
7519103|NCT03822884|18515460|P1|COMPLETED|Overall Study||4
7519104|NCT03822884|18515455|P6|STARTED|Overall Study||4
7519105|NCT03822884|18515456|P5|STARTED|Overall Study||4
7519106|NCT03822884|18515457|P4|STARTED|Overall Study||4
7519107|NCT03822884|18515458|P3|STARTED|Overall Study||4
7519108|NCT03822884|18515459|P2|STARTED|Overall Study||4
7519109|NCT03822884|18515460|P1|STARTED|Overall Study||4
7519110|NCT03822182|18515492|P3|NOT COMPLETED|Overall Study||1
7519111|NCT03822182|18515493|P2|NOT COMPLETED|Overall Study||1
7519112|NCT03822182|18515494|P1|NOT COMPLETED|Overall Study||0
7519113|NCT03822182|18515492|P3|COMPLETED|Overall Study||26
7519114|NCT03822182|18515493|P2|COMPLETED|Overall Study||24
7519115|NCT03822182|18515494|P1|COMPLETED|Overall Study||26
7519116|NCT03822182|18515492|P3|STARTED|Overall Study||27
7519117|NCT03822182|18515493|P2|STARTED|Overall Study||25
7519118|NCT03822182|18515494|P1|STARTED|Overall Study||26
7519119|NCT03822078|18515511|P6|NOT COMPLETED|Overall Study||0
7519120|NCT03822078|18515512|P5|NOT COMPLETED|Overall Study||1
7519121|NCT03822078|18515513|P4|NOT COMPLETED|Overall Study||2
7519122|NCT03822078|18515514|P3|NOT COMPLETED|Overall Study||0
7519123|NCT03822078|18515515|P2|NOT COMPLETED|Overall Study||0
7519124|NCT03822078|18515516|P1|NOT COMPLETED|Overall Study||2
7519125|NCT03822078|18515511|P6|COMPLETED|Overall Study||6
7519126|NCT03822078|18515512|P5|COMPLETED|Overall Study||6
7519127|NCT03822078|18515513|P4|COMPLETED|Overall Study||6
7519128|NCT03822078|18515514|P3|COMPLETED|Overall Study||6
7519129|NCT03822078|18515515|P2|COMPLETED|Overall Study||6
7519130|NCT03822078|18515516|P1|COMPLETED|Overall Study||10
7519131|NCT03822078|18515511|P6|Received Study Drug|Overall Study||6
7519132|NCT03822078|18515512|P5|Received Study Drug|Overall Study||6
7519133|NCT03822078|18515513|P4|Received Study Drug|Overall Study||6
7519134|NCT03822078|18515514|P3|Received Study Drug|Overall Study||6
7519135|NCT03822078|18515515|P2|Received Study Drug|Overall Study||6
7519136|NCT03822078|18515516|P1|Received Study Drug|Overall Study||10
7519137|NCT03822078|18515511|P6|STARTED|Overall Study||6
7519138|NCT03822078|18515512|P5|STARTED|Overall Study||7
7519139|NCT03822078|18515513|P4|STARTED|Overall Study||8
7519140|NCT03822078|18515514|P3|STARTED|Overall Study||6
7519141|NCT03822078|18515515|P2|STARTED|Overall Study||6
7519142|NCT03822078|18515516|P1|STARTED|Overall Study||12
7519143|NCT03821259|18515574|P1|NOT COMPLETED|Overall Study||0
7519144|NCT03821259|18515574|P1|COMPLETED|Overall Study||88
7519145|NCT03821259|18515574|P1|STARTED|Overall Study||88
7519146|NCT03820544|18515584|P2|NOT COMPLETED|Overall Study||0
7519147|NCT03820544|18515585|P1|NOT COMPLETED|Overall Study||0
7519148|NCT03820544|18515584|P2|COMPLETED|Overall Study||2
7519149|NCT03820544|18515585|P1|COMPLETED|Overall Study||2
7519150|NCT03820544|18515584|P2|STARTED|Overall Study||2
7519151|NCT03820544|18515585|P1|STARTED|Overall Study||2
7519152|NCT03820258|18515593|P1|NOT COMPLETED|Overall Study||0
7519153|NCT03820258|18515593|P1|COMPLETED|Overall Study||21
7519154|NCT03820258|18515593|P1|STARTED|Overall Study||21
7519155|NCT03819491|18515622|P2|NOT COMPLETED|After Randomization||0
7519156|NCT03819491|18515623|P1|NOT COMPLETED|After Randomization||0
7519157|NCT03819491|18515622|P2|COMPLETED|After Randomization||12
7519158|NCT03819491|18515623|P1|COMPLETED|After Randomization||12
7519159|NCT03819491|18515622|P2|STARTED|After Randomization||12
7519160|NCT03819491|18515623|P1|STARTED|After Randomization||12
7519161|NCT03819491|18515622|P2|NOT COMPLETED|Before Randomization||0
7519162|NCT03819491|18515623|P1|NOT COMPLETED|Before Randomization||0
7519163|NCT03819491|18515622|P2|COMPLETED|Before Randomization||0
7519164|NCT03819491|18515623|P1|COMPLETED|Before Randomization||24
7519165|NCT03819491|18515622|P2|STARTED|Before Randomization||0
7519166|NCT03819491|18515623|P1|STARTED|Before Randomization||24
7519167|NCT03818815|18515636|P2|NOT COMPLETED|Overall Study||5
7519168|NCT03818815|18515637|P1|NOT COMPLETED|Overall Study||8
7519169|NCT03818815|18515636|P2|COMPLETED|Overall Study||42
7519170|NCT03818815|18515637|P1|COMPLETED|Overall Study||48
7519171|NCT03818815|18515636|P2|STARTED|Overall Study||47
7519172|NCT03818815|18515637|P1|STARTED|Overall Study||56
7519173|NCT03817879|18515649|P2|NOT COMPLETED|Overall Study||13
7519174|NCT03817879|18515650|P1|NOT COMPLETED|Overall Study||5
7519175|NCT03817879|18515649|P2|COMPLETED|Overall Study||22
7519176|NCT03817879|18515650|P1|COMPLETED|Overall Study||30
7519177|NCT03817879|18515649|P2|STARTED|Overall Study||35
7519178|NCT03817879|18515650|P1|STARTED|Overall Study||35
7519179|NCT03817775|18515658|P2|NOT COMPLETED|Overall Study||0
7519180|NCT03817775|18515659|P1|NOT COMPLETED|Overall Study||0
7519181|NCT03817775|18515658|P2|COMPLETED|Overall Study||54
7519182|NCT03817775|18515659|P1|COMPLETED|Overall Study||22
7519183|NCT03817775|18515658|P2|STARTED|Overall Study||54
7519184|NCT03817775|18515659|P1|STARTED|Overall Study||22
7519185|NCT03816761|18515686|P6|NOT COMPLETED|Second Treatment Period (7 Days)||0
7519186|NCT03816761|18515687|P5|NOT COMPLETED|Second Treatment Period (7 Days)||0
7519187|NCT03816761|18515688|P4|NOT COMPLETED|Second Treatment Period (7 Days)||1
7519188|NCT03816761|18515689|P3|NOT COMPLETED|Second Treatment Period (7 Days)||0
7519189|NCT03816761|18515690|P2|NOT COMPLETED|Second Treatment Period (7 Days)||0
7519190|NCT03816761|18515691|P1|NOT COMPLETED|Second Treatment Period (7 Days)||0
7519191|NCT03816761|18515686|P6|COMPLETED|Second Treatment Period (7 Days)||3
7519192|NCT03816761|18515687|P5|COMPLETED|Second Treatment Period (7 Days)||4
7519193|NCT03816761|18515688|P4|COMPLETED|Second Treatment Period (7 Days)||3
7519194|NCT03816761|18515689|P3|COMPLETED|Second Treatment Period (7 Days)||4
7519195|NCT03816761|18515690|P2|COMPLETED|Second Treatment Period (7 Days)||4
7519196|NCT03816761|18515691|P1|COMPLETED|Second Treatment Period (7 Days)||4
7519197|NCT03816761|18515686|P6|STARTED|Second Treatment Period (7 Days)||3
7519198|NCT03816761|18515687|P5|STARTED|Second Treatment Period (7 Days)||4
7519199|NCT03816761|18515688|P4|STARTED|Second Treatment Period (7 Days)||4
7519200|NCT03816761|18515689|P3|STARTED|Second Treatment Period (7 Days)||4
7519201|NCT03816761|18515690|P2|STARTED|Second Treatment Period (7 Days)||4
7519202|NCT03816761|18515691|P1|STARTED|Second Treatment Period (7 Days)||4
7519203|NCT03816761|18515686|P6|NOT COMPLETED|First Treatment Period (7 Days)||1
7519204|NCT03816761|18515687|P5|NOT COMPLETED|First Treatment Period (7 Days)||0
7519205|NCT03816761|18515688|P4|NOT COMPLETED|First Treatment Period (7 Days)||0
7519206|NCT03816761|18515689|P3|NOT COMPLETED|First Treatment Period (7 Days)||0
7519207|NCT03816761|18515690|P2|NOT COMPLETED|First Treatment Period (7 Days)||0
7519208|NCT03816761|18515691|P1|NOT COMPLETED|First Treatment Period (7 Days)||0
7519209|NCT03816761|18515686|P6|COMPLETED|First Treatment Period (7 Days)||3
7519210|NCT03816761|18515687|P5|COMPLETED|First Treatment Period (7 Days)||4
7519211|NCT03816761|18515688|P4|COMPLETED|First Treatment Period (7 Days)||4
7519212|NCT03816761|18515689|P3|COMPLETED|First Treatment Period (7 Days)||4
7519213|NCT03816761|18515690|P2|COMPLETED|First Treatment Period (7 Days)||4
7519214|NCT03816761|18515691|P1|COMPLETED|First Treatment Period (7 Days)||4
7519215|NCT03816761|18515686|P6|STARTED|First Treatment Period (7 Days)||4
7519216|NCT03816761|18515687|P5|STARTED|First Treatment Period (7 Days)||4
7519217|NCT03816761|18515688|P4|STARTED|First Treatment Period (7 Days)||4
7519218|NCT03816761|18515689|P3|STARTED|First Treatment Period (7 Days)||4
7519219|NCT03816761|18515690|P2|STARTED|First Treatment Period (7 Days)||4
7519220|NCT03816761|18515691|P1|STARTED|First Treatment Period (7 Days)||4
7519221|NCT03816696|18515789|P1|NOT COMPLETED|Period 3 (Up to Day 11)||0
7519222|NCT03816696|18515789|P1|COMPLETED|Period 3 (Up to Day 11)||16
7519223|NCT03816696|18515789|P1|STARTED|Period 3 (Up to Day 11)||16
7519224|NCT03816696|18515789|P1|NOT COMPLETED|Period 2 (Up to Day 7)||0
7519225|NCT03816696|18515789|P1|COMPLETED|Period 2 (Up to Day 7)||16
7519226|NCT03816696|18515789|P1|STARTED|Period 2 (Up to Day 7)||16
7519227|NCT03816696|18515789|P1|NOT COMPLETED|Wash Out Period (Days 6 to 9)||0
7519228|NCT03816696|18515789|P1|COMPLETED|Wash Out Period (Days 6 to 9)||16
7519229|NCT03816696|18515789|P1|STARTED|Wash Out Period (Days 6 to 9)||16
7519230|NCT03816696|18515789|P1|NOT COMPLETED|Period 1 (Up to Day 5)||0
7519231|NCT03816696|18515789|P1|COMPLETED|Period 1 (Up to Day 5)||16
7519232|NCT03816696|18515789|P1|STARTED|Period 1 (Up to Day 5)||16
7519233|NCT03815240|18515934|P9|NOT COMPLETED|Intervention Optifoam Dressing||0
7519234|NCT03815240|18515935|P8|NOT COMPLETED|Intervention Optifoam Dressing||0
7519235|NCT03815240|18515936|P7|NOT COMPLETED|Intervention Optifoam Dressing||0
7519236|NCT03815240|18515937|P6|NOT COMPLETED|Intervention Optifoam Dressing||0
7519237|NCT03815240|18515938|P5|NOT COMPLETED|Intervention Optifoam Dressing||0
7519238|NCT03815240|18515939|P4|NOT COMPLETED|Intervention Optifoam Dressing||0
7519239|NCT03815240|18515940|P3|NOT COMPLETED|Intervention Optifoam Dressing||0
7519240|NCT03815240|18515941|P2|NOT COMPLETED|Intervention Optifoam Dressing||0
7519241|NCT03815240|18515942|P1|NOT COMPLETED|Intervention Optifoam Dressing||0
7519242|NCT03815240|18515934|P9|COMPLETED|Intervention Optifoam Dressing||1
7519243|NCT03815240|18515935|P8|COMPLETED|Intervention Optifoam Dressing||1
7519244|NCT03815240|18515936|P7|COMPLETED|Intervention Optifoam Dressing||1
7519245|NCT03815240|18515937|P6|COMPLETED|Intervention Optifoam Dressing||2
7519246|NCT03815240|18515938|P5|COMPLETED|Intervention Optifoam Dressing||1
7519247|NCT03815240|18515939|P4|COMPLETED|Intervention Optifoam Dressing||2
7519248|NCT03815240|18515940|P3|COMPLETED|Intervention Optifoam Dressing||1
7519249|NCT03815240|18515941|P2|COMPLETED|Intervention Optifoam Dressing||1
7519250|NCT03815240|18515942|P1|COMPLETED|Intervention Optifoam Dressing||2
7519251|NCT03815240|18515934|P9|STARTED|Intervention Optifoam Dressing||1
7519252|NCT03815240|18515935|P8|STARTED|Intervention Optifoam Dressing||1
7519253|NCT03815240|18515936|P7|STARTED|Intervention Optifoam Dressing||1
7519254|NCT03815240|18515937|P6|STARTED|Intervention Optifoam Dressing||2
7519255|NCT03815240|18515938|P5|STARTED|Intervention Optifoam Dressing||1
7519256|NCT03815240|18515939|P4|STARTED|Intervention Optifoam Dressing||2
7519257|NCT03815240|18515940|P3|STARTED|Intervention Optifoam Dressing||1
7519258|NCT03815240|18515941|P2|STARTED|Intervention Optifoam Dressing||1
7519259|NCT03815240|18515942|P1|STARTED|Intervention Optifoam Dressing||2
7519260|NCT03815240|18515934|P9|NOT COMPLETED|Intervention Allevyn Dressing||0
7519261|NCT03815240|18515935|P8|NOT COMPLETED|Intervention Allevyn Dressing||0
7519262|NCT03815240|18515936|P7|NOT COMPLETED|Intervention Allevyn Dressing||0
7519263|NCT03815240|18515937|P6|NOT COMPLETED|Intervention Allevyn Dressing||0
7519264|NCT03815240|18515938|P5|NOT COMPLETED|Intervention Allevyn Dressing||0
7519265|NCT03815240|18515939|P4|NOT COMPLETED|Intervention Allevyn Dressing||0
7519266|NCT03815240|18515940|P3|NOT COMPLETED|Intervention Allevyn Dressing||0
7519267|NCT03815240|18515941|P2|NOT COMPLETED|Intervention Allevyn Dressing||0
7519268|NCT03815240|18515942|P1|NOT COMPLETED|Intervention Allevyn Dressing||0
7519269|NCT03815240|18515934|P9|COMPLETED|Intervention Allevyn Dressing||1
7519270|NCT03815240|18515935|P8|COMPLETED|Intervention Allevyn Dressing||1
7519271|NCT03815240|18515936|P7|COMPLETED|Intervention Allevyn Dressing||1
7519272|NCT03815240|18515937|P6|COMPLETED|Intervention Allevyn Dressing||2
7519273|NCT03815240|18515938|P5|COMPLETED|Intervention Allevyn Dressing||1
7519274|NCT03815240|18515939|P4|COMPLETED|Intervention Allevyn Dressing||2
7519275|NCT03815240|18515940|P3|COMPLETED|Intervention Allevyn Dressing||1
7519276|NCT03815240|18515941|P2|COMPLETED|Intervention Allevyn Dressing||1
7519277|NCT03815240|18515942|P1|COMPLETED|Intervention Allevyn Dressing||2
7519278|NCT03815240|18515934|P9|STARTED|Intervention Allevyn Dressing||1
7519279|NCT03815240|18515935|P8|STARTED|Intervention Allevyn Dressing||1
7519280|NCT03815240|18515936|P7|STARTED|Intervention Allevyn Dressing||1
7519281|NCT03815240|18515937|P6|STARTED|Intervention Allevyn Dressing||2
7519282|NCT03815240|18515938|P5|STARTED|Intervention Allevyn Dressing||1
7519283|NCT03815240|18515939|P4|STARTED|Intervention Allevyn Dressing||2
7519284|NCT03815240|18515940|P3|STARTED|Intervention Allevyn Dressing||1
7519285|NCT03815240|18515941|P2|STARTED|Intervention Allevyn Dressing||1
7519286|NCT03815240|18515942|P1|STARTED|Intervention Allevyn Dressing||2
7519287|NCT03815240|18515934|P9|NOT COMPLETED|Intervention Mepilex Dressing||0
7519288|NCT03815240|18515935|P8|NOT COMPLETED|Intervention Mepilex Dressing||0
7519289|NCT03815240|18515936|P7|NOT COMPLETED|Intervention Mepilex Dressing||0
7519290|NCT03815240|18515937|P6|NOT COMPLETED|Intervention Mepilex Dressing||0
7519291|NCT03815240|18515938|P5|NOT COMPLETED|Intervention Mepilex Dressing||0
7519292|NCT03815240|18515939|P4|NOT COMPLETED|Intervention Mepilex Dressing||0
7519293|NCT03815240|18515940|P3|NOT COMPLETED|Intervention Mepilex Dressing||0
7519294|NCT03815240|18515941|P2|NOT COMPLETED|Intervention Mepilex Dressing||0
7519295|NCT03815240|18515942|P1|NOT COMPLETED|Intervention Mepilex Dressing||0
7519296|NCT03815240|18515934|P9|COMPLETED|Intervention Mepilex Dressing||1
7519297|NCT03815240|18515935|P8|COMPLETED|Intervention Mepilex Dressing||1
7519298|NCT03815240|18515936|P7|COMPLETED|Intervention Mepilex Dressing||1
7519299|NCT03815240|18515937|P6|COMPLETED|Intervention Mepilex Dressing||2
7519300|NCT03815240|18515938|P5|COMPLETED|Intervention Mepilex Dressing||1
7519301|NCT03815240|18515939|P4|COMPLETED|Intervention Mepilex Dressing||2
7519302|NCT03815240|18515940|P3|COMPLETED|Intervention Mepilex Dressing||1
7519303|NCT03815240|18515941|P2|COMPLETED|Intervention Mepilex Dressing||1
7519304|NCT03815240|18515942|P1|COMPLETED|Intervention Mepilex Dressing||2
7519305|NCT03815240|18515934|P9|STARTED|Intervention Mepilex Dressing||1
7519306|NCT03815240|18515935|P8|STARTED|Intervention Mepilex Dressing||1
7519307|NCT03815240|18515936|P7|STARTED|Intervention Mepilex Dressing||1
7519308|NCT03815240|18515937|P6|STARTED|Intervention Mepilex Dressing||2
7519309|NCT03815240|18515938|P5|STARTED|Intervention Mepilex Dressing||1
7519310|NCT03815240|18515939|P4|STARTED|Intervention Mepilex Dressing||2
7519311|NCT03815240|18515940|P3|STARTED|Intervention Mepilex Dressing||1
7519312|NCT03815240|18515941|P2|STARTED|Intervention Mepilex Dressing||1
7519313|NCT03815240|18515942|P1|STARTED|Intervention Mepilex Dressing||2
7519314|NCT03815240|18515934|P9|NOT COMPLETED|Intervention no Dressing||0
7519315|NCT03815240|18515935|P8|NOT COMPLETED|Intervention no Dressing||0
7519316|NCT03815240|18515936|P7|NOT COMPLETED|Intervention no Dressing||0
7519317|NCT03815240|18515937|P6|NOT COMPLETED|Intervention no Dressing||0
7519318|NCT03815240|18515938|P5|NOT COMPLETED|Intervention no Dressing||0
7519319|NCT03815240|18515939|P4|NOT COMPLETED|Intervention no Dressing||0
7519320|NCT03815240|18515940|P3|NOT COMPLETED|Intervention no Dressing||0
7519321|NCT03815240|18515941|P2|NOT COMPLETED|Intervention no Dressing||0
7519322|NCT03815240|18515942|P1|NOT COMPLETED|Intervention no Dressing||0
7519323|NCT03815240|18515934|P9|COMPLETED|Intervention no Dressing||1
7519324|NCT03815240|18515935|P8|COMPLETED|Intervention no Dressing||1
7519325|NCT03815240|18515936|P7|COMPLETED|Intervention no Dressing||1
7519326|NCT03815240|18515937|P6|COMPLETED|Intervention no Dressing||2
7519327|NCT03815240|18515938|P5|COMPLETED|Intervention no Dressing||1
7519328|NCT03815240|18515939|P4|COMPLETED|Intervention no Dressing||2
7519329|NCT03815240|18515940|P3|COMPLETED|Intervention no Dressing||1
7519330|NCT03815240|18515941|P2|COMPLETED|Intervention no Dressing||1
7519331|NCT03815240|18515942|P1|COMPLETED|Intervention no Dressing||2
7519332|NCT03815240|18515934|P9|STARTED|Intervention no Dressing||1
7519333|NCT03815240|18515935|P8|STARTED|Intervention no Dressing||1
7519334|NCT03815240|18515936|P7|STARTED|Intervention no Dressing||1
7519335|NCT03815240|18515937|P6|STARTED|Intervention no Dressing||2
7519336|NCT03815240|18515938|P5|STARTED|Intervention no Dressing||1
7519337|NCT03815240|18515939|P4|STARTED|Intervention no Dressing||2
7519338|NCT03815240|18515940|P3|STARTED|Intervention no Dressing||1
7519339|NCT03815240|18515941|P2|STARTED|Intervention no Dressing||1
7519340|NCT03815240|18515942|P1|STARTED|Intervention no Dressing||2
7519341|NCT03813719|18515988|P1|NOT COMPLETED|Overall Study||0
7519342|NCT03813719|18515988|P1|COMPLETED|Overall Study||250
7519343|NCT03813719|18515988|P1|STARTED|Overall Study||250
7519344|NCT03812510|18515994|P1|NOT COMPLETED|Overall Study||152
7519345|NCT03812510|18515994|P1|COMPLETED|Overall Study||274
7519346|NCT03812510|18515994|P1|STARTED|Overall Study||426
7519347|NCT03812328|18516026|P3|NOT COMPLETED|Overall Study||1
7519348|NCT03812328|18516027|P2|NOT COMPLETED|Overall Study||3
7519349|NCT03812328|18516028|P1|NOT COMPLETED|Overall Study||0
7519350|NCT03812328|18516026|P3|COMPLETED|Overall Study||88
7519351|NCT03812328|18516027|P2|COMPLETED|Overall Study||60
7519352|NCT03812328|18516028|P1|COMPLETED|Overall Study||55
7519353|NCT03812328|18516026|P3|STARTED|Overall Study||89
7519354|NCT03812328|18516027|P2|STARTED|Overall Study||63
7519355|NCT03812328|18516028|P1|STARTED|Overall Study||55
7519356|NCT03811093|18516041|P2|NOT COMPLETED|Overall Study||4
7519357|NCT03811093|18516042|P1|NOT COMPLETED|Overall Study||2
7519358|NCT03811093|18516041|P2|COMPLETED|Overall Study||15
7519359|NCT03811093|18516042|P1|COMPLETED|Overall Study||18
7519360|NCT03811093|18516041|P2|STARTED|Overall Study||19
7519361|NCT03811093|18516042|P1|STARTED|Overall Study||20
7519362|NCT03810235|18516054|P2|NOT COMPLETED|Overall Study||0
7519363|NCT03810235|18516055|P1|NOT COMPLETED|Overall Study||2
7519364|NCT03810235|18516054|P2|COMPLETED|Overall Study||31
7519365|NCT03810235|18516055|P1|COMPLETED|Overall Study||30
7519366|NCT03810235|18516054|P2|Participant Data Analyzed|Overall Study||31
7519367|NCT03810235|18516055|P1|Participant Data Analyzed|Overall Study||30
7519368|NCT03810235|18516054|P2|STARTED|Overall Study||31
7519369|NCT03810235|18516055|P1|STARTED|Overall Study||32
7519370|NCT03810014|18516087|P4|NOT COMPLETED|Overall Study||2
7519371|NCT03810014|18516088|P3|NOT COMPLETED|Overall Study||0
7519372|NCT03810014|18516089|P2|NOT COMPLETED|Overall Study||2
7519373|NCT03810014|18516090|P1|NOT COMPLETED|Overall Study||2
7519374|NCT03810014|18516087|P4|COMPLETED|Overall Study||211
7519375|NCT03810014|18516088|P3|COMPLETED|Overall Study||210
7519376|NCT03810014|18516089|P2|COMPLETED|Overall Study||202
7519377|NCT03810014|18516090|P1|COMPLETED|Overall Study||213
7519378|NCT03810014|18516087|P4|STARTED|Overall Study||213
7519379|NCT03810014|18516088|P3|STARTED|Overall Study||210
7519380|NCT03810014|18516089|P2|STARTED|Overall Study||204
7519381|NCT03810014|18516090|P1|STARTED|Overall Study||215
7519382|NCT03809910|18516112|P2|NOT COMPLETED|Period 3 (Visit 4)||0
7519383|NCT03809910|18516113|P1|NOT COMPLETED|Period 3 (Visit 4)||0
7519384|NCT03809910|18516112|P2|COMPLETED|Period 3 (Visit 4)||19
7519385|NCT03809910|18516113|P1|COMPLETED|Period 3 (Visit 4)||20
7519386|NCT03809910|18516112|P2|STARTED|Period 3 (Visit 4)||19
7519387|NCT03809910|18516113|P1|STARTED|Period 3 (Visit 4)||20
7519388|NCT03809910|18516112|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
7519389|NCT03809910|18516113|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
7519390|NCT03809910|18516112|P2|COMPLETED|Washout Period 2 (3 Days)||19
7519391|NCT03809910|18516113|P1|COMPLETED|Washout Period 2 (3 Days)||20
7519392|NCT03809910|18516112|P2|STARTED|Washout Period 2 (3 Days)||19
7519393|NCT03809910|18516113|P1|STARTED|Washout Period 2 (3 Days)||20
7519394|NCT03809910|18516112|P2|NOT COMPLETED|Period 2 (Visit 3)||0
7519395|NCT03809910|18516113|P1|NOT COMPLETED|Period 2 (Visit 3)||0
7519396|NCT03809910|18516112|P2|COMPLETED|Period 2 (Visit 3)||19
7519397|NCT03809910|18516113|P1|COMPLETED|Period 2 (Visit 3)||20
7519398|NCT03809910|18516112|P2|STARTED|Period 2 (Visit 3)||19
7519399|NCT03809910|18516113|P1|STARTED|Period 2 (Visit 3)||20
7519400|NCT03809910|18516112|P2|NOT COMPLETED|Washout Period 1 (3 Days)||0
7519401|NCT03809910|18516113|P1|NOT COMPLETED|Washout Period 1 (3 Days)||0
7519402|NCT03809910|18516112|P2|COMPLETED|Washout Period 1 (3 Days)||19
7519403|NCT03809910|18516113|P1|COMPLETED|Washout Period 1 (3 Days)||20
7519404|NCT03809910|18516112|P2|STARTED|Washout Period 1 (3 Days)||19
7519405|NCT03809910|18516113|P1|STARTED|Washout Period 1 (3 Days)||20
7519406|NCT03809910|18516112|P2|NOT COMPLETED|Period 1 (Visit 2)||0
7519407|NCT03809910|18516113|P1|NOT COMPLETED|Period 1 (Visit 2)||0
7519408|NCT03809910|18516112|P2|COMPLETED|Period 1 (Visit 2)||19
7519409|NCT03809910|18516113|P1|COMPLETED|Period 1 (Visit 2)||20
7519410|NCT03809910|18516112|P2|STARTED|Period 1 (Visit 2)||19
7519411|NCT03809910|18516113|P1|STARTED|Period 1 (Visit 2)||20
7519412|NCT03809611|18516147|P2|NOT COMPLETED|Overall Study||1
7519413|NCT03809611|18516148|P1|NOT COMPLETED|Overall Study||1
7519414|NCT03809611|18516147|P2|COMPLETED|Overall Study||61
7519415|NCT03809611|18516148|P1|COMPLETED|Overall Study||61
7519416|NCT03809611|18516147|P2|STARTED|Overall Study||62
7519417|NCT03809611|18516148|P1|STARTED|Overall Study||62
7519418|NCT03809182|18516161|P2|NOT COMPLETED|Overall Study||0
7519419|NCT03809182|18516162|P1|NOT COMPLETED|Overall Study||0
7519420|NCT03809182|18516161|P2|COMPLETED|Overall Study||20
7519421|NCT03809182|18516162|P1|COMPLETED|Overall Study||20
7519422|NCT03809182|18516161|P2|STARTED|Overall Study||20
7519423|NCT03809182|18516162|P1|STARTED|Overall Study||20
7519424|NCT03809104|18516180|P1|NOT COMPLETED|Overall Study||3
7519425|NCT03809104|18516180|P1|COMPLETED|Overall Study||40
7519426|NCT03809104|18516180|P1|STARTED|Overall Study||43
7519427|NCT03808688|18516191|P2|NOT COMPLETED|Overall Study||23
7519428|NCT03808688|18516192|P1|NOT COMPLETED|Overall Study||18
7519429|NCT03808688|18516191|P2|COMPLETED|Overall Study||138
7519430|NCT03808688|18516192|P1|COMPLETED|Overall Study||81
7519431|NCT03808688|18516191|P2|STARTED|Overall Study||161
7519432|NCT03808688|18516192|P1|STARTED|Overall Study||99
7519433|NCT03808493|18516204|P4|NOT COMPLETED|Overall Study||0
7519434|NCT03808493|18516205|P3|NOT COMPLETED|Overall Study||0
7519435|NCT03808493|18516206|P2|NOT COMPLETED|Overall Study||0
7519436|NCT03808493|18516207|P1|NOT COMPLETED|Overall Study||0
7519437|NCT03808493|18516204|P4|COMPLETED|Overall Study||12
7519438|NCT03808493|18516205|P3|COMPLETED|Overall Study||12
7519439|NCT03808493|18516206|P2|COMPLETED|Overall Study||12
7519440|NCT03808493|18516207|P1|COMPLETED|Overall Study||12
7519441|NCT03808493|18516204|P4|STARTED|Overall Study||12
7519442|NCT03808493|18516205|P3|STARTED|Overall Study||12
7519443|NCT03808493|18516206|P2|STARTED|Overall Study||12
7519444|NCT03808493|18516207|P1|STARTED|Overall Study||12
7519445|NCT03808298|18516237|P1|NOT COMPLETED|Overall Study||8
7519446|NCT03808298|18516237|P1|COMPLETED|Overall Study||49
7519447|NCT03808298|18516237|P1|STARTED|Overall Study||57
7519448|NCT03807739|18516314|P4|NOT COMPLETED|Overall Study||0
7519449|NCT03807739|18516315|P3|NOT COMPLETED|Overall Study||0
7519450|NCT03807739|18516316|P2|NOT COMPLETED|Overall Study||0
7519451|NCT03807739|18516317|P1|NOT COMPLETED|Overall Study||2
7519452|NCT03807739|18516314|P4|COMPLETED|Overall Study||10
7519453|NCT03807739|18516315|P3|COMPLETED|Overall Study||9
7519454|NCT03807739|18516316|P2|COMPLETED|Overall Study||10
7519455|NCT03807739|18516317|P1|COMPLETED|Overall Study||7
7519456|NCT03807739|18516314|P4|STARTED|Overall Study||10
7519457|NCT03807739|18516315|P3|STARTED|Overall Study||9
7519458|NCT03807739|18516316|P2|STARTED|Overall Study||10
7519459|NCT03807739|18516317|P1|STARTED|Overall Study||9
7519460|NCT03807700|18516333|P2|NOT COMPLETED|Overall Study||1
7519461|NCT03807700|18516334|P1|NOT COMPLETED|Overall Study||2
7519462|NCT03807700|18516333|P2|COMPLETED|Overall Study||58
7519463|NCT03807700|18516334|P1|COMPLETED|Overall Study||58
7519464|NCT03807700|18516333|P2|STARTED|Overall Study||59
7519465|NCT03807700|18516334|P1|STARTED|Overall Study||60
7519466|NCT03807544|18516357|P1|NOT COMPLETED|Overall Study||0
7519467|NCT03807544|18516357|P1|COMPLETED|Overall Study||17
7519468|NCT03807544|18516357|P1|STARTED|Overall Study||17
7519469|NCT03807245|18516365|P3|NOT COMPLETED|Overall Study||0
7519470|NCT03807245|18516366|P2|NOT COMPLETED|Overall Study||0
7519471|NCT03807245|18516367|P1|NOT COMPLETED|Overall Study||1
7519472|NCT03807245|18516365|P3|COMPLETED|Overall Study||12
7519473|NCT03807245|18516366|P2|COMPLETED|Overall Study||24
7519474|NCT03807245|18516367|P1|COMPLETED|Overall Study||23
7519475|NCT03807245|18516365|P3|STARTED|Overall Study||12
7519476|NCT03807245|18516366|P2|STARTED|Overall Study||24
7519477|NCT03807245|18516367|P1|STARTED|Overall Study||24
7519478|NCT03807089|18516389|P2|NOT COMPLETED|Overall Study||0
7519479|NCT03807089|18516390|P1|NOT COMPLETED|Overall Study||0
7519480|NCT03807089|18516389|P2|COMPLETED|Overall Study||93
7519481|NCT03807089|18516390|P1|COMPLETED|Overall Study||101
7519482|NCT03807089|18516389|P2|STARTED|Overall Study||93
7519483|NCT03807089|18516390|P1|STARTED|Overall Study||101
7519484|NCT03806790|18516406|P2|NOT COMPLETED|Overall Study||0
7519485|NCT03806790|18516407|P1|NOT COMPLETED|Overall Study||0
7519486|NCT03806790|18516406|P2|COMPLETED|Overall Study||95
7519487|NCT03806790|18516407|P1|COMPLETED|Overall Study||87
7519488|NCT03806790|18516406|P2|STARTED|Overall Study||95
7519489|NCT03806790|18516407|P1|STARTED|Overall Study||87
7519490|NCT03806270|18516422|P3|NOT COMPLETED|Overall Study||0
7519491|NCT03806270|18516423|P2|NOT COMPLETED|Overall Study||0
7519492|NCT03806270|18516424|P1|NOT COMPLETED|Overall Study||0
7519493|NCT03806270|18516422|P3|COMPLETED|Overall Study||15
7519494|NCT03806270|18516423|P2|COMPLETED|Overall Study||15
7519495|NCT03806270|18516424|P1|COMPLETED|Overall Study||15
7519496|NCT03806270|18516422|P3|STARTED|Overall Study||15
7519497|NCT03806270|18516423|P2|STARTED|Overall Study||15
7519498|NCT03806270|18516424|P1|STARTED|Overall Study||15
7519499|NCT03805971|18516450|P1|NOT COMPLETED|Overall Study||3
7519500|NCT03805971|18516450|P1|COMPLETED|Overall Study||62
7519501|NCT03805971|18516450|P1|STARTED|Overall Study||65
7519502|NCT03805672|18516465|P2|NOT COMPLETED|Overall Study||0
7519503|NCT03805672|18516466|P1|NOT COMPLETED|Overall Study||0
7519504|NCT03805672|18516465|P2|COMPLETED|Overall Study||2
7519505|NCT03805672|18516466|P1|COMPLETED|Overall Study||2
7519506|NCT03805672|18516465|P2|STARTED|Overall Study||2
7519507|NCT03805672|18516466|P1|STARTED|Overall Study||2
7519508|NCT03804918|18516472|P1|NOT COMPLETED|Overall Study||1
7519509|NCT03804918|18516472|P1|COMPLETED|Overall Study||16
7519510|NCT03804918|18516472|P1|STARTED|Overall Study||17
7519511|NCT03804710|18516479|P2|NOT COMPLETED|Overall Study||5
7519512|NCT03804710|18516480|P1|NOT COMPLETED|Overall Study||2
7519513|NCT03804710|18516479|P2|COMPLETED|Overall Study||69
7519514|NCT03804710|18516480|P1|COMPLETED|Overall Study||73
7519515|NCT03804710|18516479|P2|STARTED|Overall Study||74
7519516|NCT03804710|18516480|P1|STARTED|Overall Study||75
7519517|NCT03803085|18516537|P2|NOT COMPLETED|Overall Study||2
7519518|NCT03803085|18516538|P1|NOT COMPLETED|Overall Study||2
7519519|NCT03803085|18516537|P2|COMPLETED|Overall Study||28
7519520|NCT03803085|18516538|P1|COMPLETED|Overall Study||28
7519521|NCT03803085|18516537|P2|STARTED|Overall Study||30
7519522|NCT03803085|18516538|P1|STARTED|Overall Study||30
7519523|NCT03802864|18516550|P2|NOT COMPLETED|Overall Study||0
7519524|NCT03802864|18516551|P1|NOT COMPLETED|Overall Study||0
7519525|NCT03802864|18516550|P2|COMPLETED|Overall Study||25
7519526|NCT03802864|18516551|P1|COMPLETED|Overall Study||25
7519527|NCT03802864|18516550|P2|STARTED|Overall Study||25
7519528|NCT03802864|18516551|P1|STARTED|Overall Study||25
7519529|NCT03802565|18516574|P5|NOT COMPLETED|Overall Study||6
7519530|NCT03802565|18516575|P4|NOT COMPLETED|Overall Study||8
7519531|NCT03802565|18516576|P3|NOT COMPLETED|Overall Study||9
7519532|NCT03802565|18516577|P2|NOT COMPLETED|Overall Study||4
7519533|NCT03802565|18516578|P1|NOT COMPLETED|Overall Study||5
7519534|NCT03802565|18516574|P5|COMPLETED|Overall Study||72
7519535|NCT03802565|18516575|P4|COMPLETED|Overall Study||77
7519536|NCT03802565|18516576|P3|COMPLETED|Overall Study||74
7519537|NCT03802565|18516577|P2|COMPLETED|Overall Study||83
7519538|NCT03802565|18516578|P1|COMPLETED|Overall Study||77
7519539|NCT03802565|18516574|P5|STARTED|Overall Study||78
7519540|NCT03802565|18516575|P4|STARTED|Overall Study||85
7519541|NCT03802565|18516576|P3|STARTED|Overall Study||83
7519542|NCT03802565|18516577|P2|STARTED|Overall Study||87
7519543|NCT03802565|18516578|P1|STARTED|Overall Study||82
7519544|NCT03802344|18516593|P3|NOT COMPLETED|Overall Study||13
7519545|NCT03802344|18516594|P2|NOT COMPLETED|Overall Study||6
7519546|NCT03802344|18516595|P1|NOT COMPLETED|Overall Study||8
7519547|NCT03802344|18516593|P3|COMPLETED|Overall Study||55
7519548|NCT03802344|18516594|P2|COMPLETED|Overall Study||203
7519549|NCT03802344|18516595|P1|COMPLETED|Overall Study||205
7519550|NCT03802344|18516593|P3|STARTED|Overall Study||68
7519551|NCT03802344|18516594|P2|STARTED|Overall Study||209
7519552|NCT03802344|18516595|P1|STARTED|Overall Study||213
7519553|NCT03801148|18516610|P4|NOT COMPLETED|Follow-Up (12 Days)||0
7519554|NCT03801148|18516611|P3|NOT COMPLETED|Follow-Up (12 Days)||1
7519555|NCT03801148|18516612|P2|NOT COMPLETED|Follow-Up (12 Days)||1
7519556|NCT03801148|18516613|P1|NOT COMPLETED|Follow-Up (12 Days)||0
7519557|NCT03801148|18516610|P4|COMPLETED|Follow-Up (12 Days)||29
7519558|NCT03801148|18516611|P3|COMPLETED|Follow-Up (12 Days)||28
7519559|NCT03801148|18516612|P2|COMPLETED|Follow-Up (12 Days)||29
7519560|NCT03801148|18516613|P1|COMPLETED|Follow-Up (12 Days)||30
7519561|NCT03801148|18516610|P4|STARTED|Follow-Up (12 Days)||29
7519562|NCT03801148|18516611|P3|STARTED|Follow-Up (12 Days)||29
7519563|NCT03801148|18516612|P2|STARTED|Follow-Up (12 Days)||30
7519564|NCT03801148|18516613|P1|STARTED|Follow-Up (12 Days)||30
7519565|NCT03801148|18516610|P4|NOT COMPLETED|Period 2 (2 Days)||0
7519566|NCT03801148|18516611|P3|NOT COMPLETED|Period 2 (2 Days)||0
7519567|NCT03801148|18516612|P2|NOT COMPLETED|Period 2 (2 Days)||0
7519568|NCT03801148|18516613|P1|NOT COMPLETED|Period 2 (2 Days)||0
7519569|NCT03801148|18516610|P4|COMPLETED|Period 2 (2 Days)||29
7519570|NCT03801148|18516611|P3|COMPLETED|Period 2 (2 Days)||29
7519571|NCT03801148|18516612|P2|COMPLETED|Period 2 (2 Days)||30
7519572|NCT03801148|18516613|P1|COMPLETED|Period 2 (2 Days)||30
7519573|NCT03801148|18516610|P4|STARTED|Period 2 (2 Days)||29
7519574|NCT03801148|18516611|P3|STARTED|Period 2 (2 Days)||29
7519575|NCT03801148|18516612|P2|STARTED|Period 2 (2 Days)||30
7519576|NCT03801148|18516613|P1|STARTED|Period 2 (2 Days)||30
7519577|NCT03801148|18516610|P4|NOT COMPLETED|Washout Period (at Least 5 Days)||1
7519578|NCT03801148|18516611|P3|NOT COMPLETED|Washout Period (at Least 5 Days)||1
7519579|NCT03801148|18516612|P2|NOT COMPLETED|Washout Period (at Least 5 Days)||0
7519580|NCT03801148|18516613|P1|NOT COMPLETED|Washout Period (at Least 5 Days)||0
7519581|NCT03801148|18516610|P4|COMPLETED|Washout Period (at Least 5 Days)||29
7519582|NCT03801148|18516611|P3|COMPLETED|Washout Period (at Least 5 Days)||29
7519583|NCT03801148|18516612|P2|COMPLETED|Washout Period (at Least 5 Days)||30
7519584|NCT03801148|18516613|P1|COMPLETED|Washout Period (at Least 5 Days)||30
7519585|NCT03801148|18516610|P4|STARTED|Washout Period (at Least 5 Days)||30
7519586|NCT03801148|18516611|P3|STARTED|Washout Period (at Least 5 Days)||30
7519587|NCT03801148|18516612|P2|STARTED|Washout Period (at Least 5 Days)||30
7519588|NCT03801148|18516613|P1|STARTED|Washout Period (at Least 5 Days)||30
7519589|NCT03801148|18516610|P4|NOT COMPLETED|Period 1 (2 Days)||0
7519590|NCT03801148|18516611|P3|NOT COMPLETED|Period 1 (2 Days)||0
7519591|NCT03801148|18516612|P2|NOT COMPLETED|Period 1 (2 Days)||1
7519592|NCT03801148|18516613|P1|NOT COMPLETED|Period 1 (2 Days)||1
7519593|NCT03801148|18516610|P4|COMPLETED|Period 1 (2 Days)||30
7519594|NCT03801148|18516611|P3|COMPLETED|Period 1 (2 Days)||30
7519595|NCT03801148|18516612|P2|COMPLETED|Period 1 (2 Days)||30
7519596|NCT03801148|18516613|P1|COMPLETED|Period 1 (2 Days)||30
7519597|NCT03801148|18516610|P4|STARTED|Period 1 (2 Days)||30
7519598|NCT03801148|18516611|P3|STARTED|Period 1 (2 Days)||30
7519599|NCT03801148|18516612|P2|STARTED|Period 1 (2 Days)||31
7519600|NCT03801148|18516613|P1|STARTED|Period 1 (2 Days)||31
7519601|NCT03801044|18516635|P1|NOT COMPLETED|Overall Study||0
7519602|NCT03801044|18516635|P1|COMPLETED|Overall Study||21
7519603|NCT03801044|18516635|P1|STARTED|Overall Study||21
7519604|NCT03800030|18516654|P6|NOT COMPLETED|Third Intervention||0
7519605|NCT03800030|18516655|P5|NOT COMPLETED|Third Intervention||0
7519606|NCT03800030|18516656|P4|NOT COMPLETED|Third Intervention||0
7519607|NCT03800030|18516657|P3|NOT COMPLETED|Third Intervention||0
7519608|NCT03800030|18516658|P2|NOT COMPLETED|Third Intervention||0
7519609|NCT03800030|18516659|P1|NOT COMPLETED|Third Intervention||0
7519610|NCT03800030|18516654|P6|COMPLETED|Third Intervention||4
7519611|NCT03800030|18516655|P5|COMPLETED|Third Intervention||4
7519612|NCT03800030|18516656|P4|COMPLETED|Third Intervention||4
7519613|NCT03800030|18516657|P3|COMPLETED|Third Intervention||4
7519614|NCT03800030|18516658|P2|COMPLETED|Third Intervention||4
7519615|NCT03800030|18516659|P1|COMPLETED|Third Intervention||4
7519616|NCT03800030|18516654|P6|STARTED|Third Intervention||4
7519617|NCT03800030|18516655|P5|STARTED|Third Intervention||4
7519618|NCT03800030|18516656|P4|STARTED|Third Intervention||4
7519619|NCT03800030|18516657|P3|STARTED|Third Intervention||4
7519620|NCT03800030|18516658|P2|STARTED|Third Intervention||4
7519621|NCT03800030|18516659|P1|STARTED|Third Intervention||4
7519622|NCT03800030|18516654|P6|NOT COMPLETED|Second Washout (1 Week)||0
7519623|NCT03800030|18516655|P5|NOT COMPLETED|Second Washout (1 Week)||0
7519624|NCT03800030|18516656|P4|NOT COMPLETED|Second Washout (1 Week)||1
7519625|NCT03800030|18516657|P3|NOT COMPLETED|Second Washout (1 Week)||0
7519626|NCT03800030|18516658|P2|NOT COMPLETED|Second Washout (1 Week)||0
7519627|NCT03800030|18516659|P1|NOT COMPLETED|Second Washout (1 Week)||0
7519628|NCT03800030|18516654|P6|COMPLETED|Second Washout (1 Week)||4
7519629|NCT03800030|18516655|P5|COMPLETED|Second Washout (1 Week)||4
7519630|NCT03800030|18516656|P4|COMPLETED|Second Washout (1 Week)||4
7519631|NCT03800030|18516657|P3|COMPLETED|Second Washout (1 Week)||4
7519632|NCT03800030|18516658|P2|COMPLETED|Second Washout (1 Week)||4
7519633|NCT03800030|18516659|P1|COMPLETED|Second Washout (1 Week)||4
7519634|NCT03800030|18516654|P6|STARTED|Second Washout (1 Week)||4
7519635|NCT03800030|18516655|P5|STARTED|Second Washout (1 Week)||4
7519636|NCT03800030|18516656|P4|STARTED|Second Washout (1 Week)||5
7519637|NCT03800030|18516657|P3|STARTED|Second Washout (1 Week)||4
7519638|NCT03800030|18516658|P2|STARTED|Second Washout (1 Week)||4
7519639|NCT03800030|18516659|P1|STARTED|Second Washout (1 Week)||4
7519640|NCT03800030|18516654|P6|NOT COMPLETED|Second Intervention||0
7519641|NCT03800030|18516655|P5|NOT COMPLETED|Second Intervention||0
7519642|NCT03800030|18516656|P4|NOT COMPLETED|Second Intervention||1
7519643|NCT03800030|18516657|P3|NOT COMPLETED|Second Intervention||0
7519644|NCT03800030|18516658|P2|NOT COMPLETED|Second Intervention||0
7519645|NCT03800030|18516659|P1|NOT COMPLETED|Second Intervention||0
7519646|NCT03800030|18516654|P6|COMPLETED|Second Intervention||4
7519647|NCT03800030|18516655|P5|COMPLETED|Second Intervention||4
7519648|NCT03800030|18516656|P4|COMPLETED|Second Intervention||5
7519649|NCT03800030|18516657|P3|COMPLETED|Second Intervention||4
7519650|NCT03800030|18516658|P2|COMPLETED|Second Intervention||4
7519651|NCT03800030|18516659|P1|COMPLETED|Second Intervention||4
7519652|NCT03800030|18516654|P6|STARTED|Second Intervention||4
7519653|NCT03800030|18516655|P5|STARTED|Second Intervention||4
7519654|NCT03800030|18516656|P4|STARTED|Second Intervention||6
7519655|NCT03800030|18516657|P3|STARTED|Second Intervention||4
7519656|NCT03800030|18516658|P2|STARTED|Second Intervention||4
7519657|NCT03800030|18516659|P1|STARTED|Second Intervention||4
7519658|NCT03800030|18516654|P6|NOT COMPLETED|First Washout (1 Week)||0
7519659|NCT03800030|18516655|P5|NOT COMPLETED|First Washout (1 Week)||0
7519660|NCT03800030|18516656|P4|NOT COMPLETED|First Washout (1 Week)||0
7519661|NCT03800030|18516657|P3|NOT COMPLETED|First Washout (1 Week)||0
7519662|NCT03800030|18516658|P2|NOT COMPLETED|First Washout (1 Week)||0
7519663|NCT03800030|18516659|P1|NOT COMPLETED|First Washout (1 Week)||0
7519664|NCT03800030|18516654|P6|COMPLETED|First Washout (1 Week)||4
7519665|NCT03800030|18516655|P5|COMPLETED|First Washout (1 Week)||4
7519666|NCT03800030|18516656|P4|COMPLETED|First Washout (1 Week)||6
7519667|NCT03800030|18516657|P3|COMPLETED|First Washout (1 Week)||4
7519668|NCT03800030|18516658|P2|COMPLETED|First Washout (1 Week)||4
7519669|NCT03800030|18516659|P1|COMPLETED|First Washout (1 Week)||4
7519670|NCT03800030|18516654|P6|STARTED|First Washout (1 Week)||4
7519671|NCT03800030|18516655|P5|STARTED|First Washout (1 Week)||4
7519672|NCT03800030|18516656|P4|STARTED|First Washout (1 Week)||6
7519673|NCT03800030|18516657|P3|STARTED|First Washout (1 Week)||4
7519674|NCT03800030|18516658|P2|STARTED|First Washout (1 Week)||4
7519675|NCT03800030|18516659|P1|STARTED|First Washout (1 Week)||4
7519676|NCT03800030|18516654|P6|NOT COMPLETED|First Intervention||0
7519677|NCT03800030|18516655|P5|NOT COMPLETED|First Intervention||0
7519678|NCT03800030|18516656|P4|NOT COMPLETED|First Intervention||0
7519679|NCT03800030|18516657|P3|NOT COMPLETED|First Intervention||0
7519680|NCT03800030|18516658|P2|NOT COMPLETED|First Intervention||0
7519681|NCT03800030|18516659|P1|NOT COMPLETED|First Intervention||0
7519682|NCT03800030|18516654|P6|COMPLETED|First Intervention||4
7519683|NCT03800030|18516655|P5|COMPLETED|First Intervention||4
7519684|NCT03800030|18516656|P4|COMPLETED|First Intervention||6
7519685|NCT03800030|18516657|P3|COMPLETED|First Intervention||4
7519686|NCT03800030|18516658|P2|COMPLETED|First Intervention||4
7519687|NCT03800030|18516659|P1|COMPLETED|First Intervention||4
7519688|NCT03800030|18516654|P6|STARTED|First Intervention||4
7519689|NCT03800030|18516655|P5|STARTED|First Intervention||4
7519690|NCT03800030|18516656|P4|STARTED|First Intervention||6
7519691|NCT03800030|18516657|P3|STARTED|First Intervention||4
7519692|NCT03800030|18516658|P2|STARTED|First Intervention||4
7519693|NCT03800030|18516659|P1|STARTED|First Intervention||4
7519694|NCT03800030|18516654|P6|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
7519695|NCT03800030|18516655|P5|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
7519696|NCT03800030|18516656|P4|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
7519697|NCT03800030|18516657|P3|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
7519698|NCT03800030|18516658|P2|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
7519699|NCT03800030|18516659|P1|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
7519700|NCT03800030|18516654|P6|COMPLETED|Pre-Randomization Period (1 Week)||4
7519701|NCT03800030|18516655|P5|COMPLETED|Pre-Randomization Period (1 Week)||4
7519702|NCT03800030|18516656|P4|COMPLETED|Pre-Randomization Period (1 Week)||6
7519703|NCT03800030|18516657|P3|COMPLETED|Pre-Randomization Period (1 Week)||4
7519704|NCT03800030|18516658|P2|COMPLETED|Pre-Randomization Period (1 Week)||4
7519705|NCT03800030|18516659|P1|COMPLETED|Pre-Randomization Period (1 Week)||4
7519706|NCT03800030|18516654|P6|STARTED|Pre-Randomization Period (1 Week)||4
7519707|NCT03800030|18516655|P5|STARTED|Pre-Randomization Period (1 Week)||4
7519708|NCT03800030|18516656|P4|STARTED|Pre-Randomization Period (1 Week)||6
7519709|NCT03800030|18516657|P3|STARTED|Pre-Randomization Period (1 Week)||4
7519710|NCT03800030|18516658|P2|STARTED|Pre-Randomization Period (1 Week)||4
7519711|NCT03800030|18516659|P1|STARTED|Pre-Randomization Period (1 Week)||4
7519712|NCT03800030|18516654|P6|NOT COMPLETED|Baseline||0
7519713|NCT03800030|18516655|P5|NOT COMPLETED|Baseline||0
7519714|NCT03800030|18516656|P4|NOT COMPLETED|Baseline||0
7519715|NCT03800030|18516657|P3|NOT COMPLETED|Baseline||0
7519716|NCT03800030|18516658|P2|NOT COMPLETED|Baseline||0
7519717|NCT03800030|18516659|P1|NOT COMPLETED|Baseline||0
7519718|NCT03800030|18516654|P6|COMPLETED|Baseline||4
7519719|NCT03800030|18516655|P5|COMPLETED|Baseline||4
7519720|NCT03800030|18516656|P4|COMPLETED|Baseline||6
7519721|NCT03800030|18516657|P3|COMPLETED|Baseline||4
7519722|NCT03800030|18516658|P2|COMPLETED|Baseline||4
7519723|NCT03800030|18516659|P1|COMPLETED|Baseline||4
7519724|NCT03800030|18516654|P6|STARTED|Baseline||4
7519725|NCT03800030|18516655|P5|STARTED|Baseline||4
7519726|NCT03800030|18516656|P4|STARTED|Baseline||6
7519727|NCT03800030|18516657|P3|STARTED|Baseline||4
7519728|NCT03800030|18516658|P2|STARTED|Baseline||4
7519729|NCT03800030|18516659|P1|STARTED|Baseline||4
7519730|NCT03799614|18516684|P2|NOT COMPLETED|Overall Study||0
7519731|NCT03799614|18516685|P1|NOT COMPLETED|Overall Study||0
7519732|NCT03799614|18516684|P2|COMPLETED|Overall Study||15
7519733|NCT03799614|18516685|P1|COMPLETED|Overall Study||15
7519734|NCT03799614|18516684|P2|STARTED|Overall Study||15
7519735|NCT03799614|18516685|P1|STARTED|Overall Study||15
7519736|NCT03799484|18516697|P1|NOT COMPLETED|Overall Study||0
7519737|NCT03799484|18516697|P1|COMPLETED|Overall Study||14
7519738|NCT03799484|18516697|P1|STARTED|Overall Study||14
7519739|NCT03799211|18516727|P2|NOT COMPLETED|Overall Study||13
7519740|NCT03799211|18516728|P1|NOT COMPLETED|Overall Study||4
7519741|NCT03799211|18516727|P2|COMPLETED|Overall Study||27
7519742|NCT03799211|18516728|P1|COMPLETED|Overall Study||32
7519743|NCT03799211|18516727|P2|STARTED|Overall Study||40
7519744|NCT03799211|18516728|P1|STARTED|Overall Study||36
7519745|NCT03796260|18516746|P2|NOT COMPLETED|Period 2||0
7519746|NCT03796260|18516747|P1|NOT COMPLETED|Period 2||0
7519747|NCT03796260|18516746|P2|COMPLETED|Period 2||7
7519748|NCT03796260|18516747|P1|COMPLETED|Period 2||7
7519749|NCT03796260|18516746|P2|STARTED|Period 2||7
7519750|NCT03796260|18516747|P1|STARTED|Period 2||7
7519751|NCT03796260|18516746|P2|NOT COMPLETED|Period 1||0
7519752|NCT03796260|18516747|P1|NOT COMPLETED|Period 1||0
7519753|NCT03796260|18516746|P2|COMPLETED|Period 1||7
7519754|NCT03796260|18516747|P1|COMPLETED|Period 1||7
7519755|NCT03796260|18516746|P2|STARTED|Period 1||7
7519756|NCT03796260|18516747|P1|STARTED|Period 1||7
7519757|NCT03796182|18516759|P2|NOT COMPLETED|Period 2||0
7519758|NCT03796182|18516760|P1|NOT COMPLETED|Period 2||0
7519759|NCT03796182|18516759|P2|COMPLETED|Period 2||6
7519760|NCT03796182|18516760|P1|COMPLETED|Period 2||6
7519761|NCT03796182|18516759|P2|STARTED|Period 2||6
7519762|NCT03796182|18516760|P1|STARTED|Period 2||6
7519763|NCT03796182|18516759|P2|NOT COMPLETED|Washout Period||0
7519764|NCT03796182|18516760|P1|NOT COMPLETED|Washout Period||0
7519765|NCT03796182|18516759|P2|COMPLETED|Washout Period||6
7519766|NCT03796182|18516760|P1|COMPLETED|Washout Period||6
7519767|NCT03796182|18516759|P2|STARTED|Washout Period||6
7519768|NCT03796182|18516760|P1|STARTED|Washout Period||6
7519769|NCT03796182|18516759|P2|NOT COMPLETED|Period 1||0
7519770|NCT03796182|18516760|P1|NOT COMPLETED|Period 1||0
7519771|NCT03796182|18516759|P2|COMPLETED|Period 1||6
7519772|NCT03796182|18516760|P1|COMPLETED|Period 1||6
7519773|NCT03796182|18516759|P2|STARTED|Period 1||6
7519774|NCT03796182|18516760|P1|STARTED|Period 1||6
7519775|NCT03796013|18516794|P2|NOT COMPLETED|Period 2||0
7519776|NCT03796013|18516795|P1|NOT COMPLETED|Period 2||0
7519777|NCT03796013|18516794|P2|COMPLETED|Period 2||14
7519778|NCT03796013|18516795|P1|COMPLETED|Period 2||14
7519779|NCT03796013|18516794|P2|STARTED|Period 2||14
7519780|NCT03796013|18516795|P1|STARTED|Period 2||14
7519781|NCT03796013|18516794|P2|NOT COMPLETED|Period 1||0
7519782|NCT03796013|18516795|P1|NOT COMPLETED|Period 1||0
7519783|NCT03796013|18516794|P2|COMPLETED|Period 1||14
7519784|NCT03796013|18516795|P1|COMPLETED|Period 1||14
7519785|NCT03796013|18516794|P2|STARTED|Period 1||14
7519786|NCT03796013|18516795|P1|STARTED|Period 1||14
7519787|NCT03795753|18516807|P2|NOT COMPLETED|Overall Study||0
7519788|NCT03795753|18516808|P1|NOT COMPLETED|Overall Study||0
7519789|NCT03795753|18516807|P2|COMPLETED|Overall Study||13
7519790|NCT03795753|18516808|P1|COMPLETED|Overall Study||23
7519791|NCT03795753|18516807|P2|STARTED|Overall Study||13
7519792|NCT03795753|18516808|P1|STARTED|Overall Study||23
7519793|NCT03794024|18516822|P2|NOT COMPLETED|Overall Study||0
7519794|NCT03794024|18516823|P1|NOT COMPLETED|Overall Study||1
7519795|NCT03794024|18516822|P2|COMPLETED|Overall Study||0
7519796|NCT03794024|18516823|P1|COMPLETED|Overall Study||0
7519797|NCT03794024|18516822|P2|STARTED|Overall Study||0
7519798|NCT03794024|18516823|P1|STARTED|Overall Study||1
7519799|NCT03793751|18516845|P2|NOT COMPLETED|Overall Study||0
7519800|NCT03793751|18516846|P1|NOT COMPLETED|Overall Study||0
7519801|NCT03793751|18516845|P2|COMPLETED|Overall Study||60
7519802|NCT03793751|18516846|P1|COMPLETED|Overall Study||60
7519803|NCT03793751|18516845|P2|STARTED|Overall Study||60
7519804|NCT03793751|18516846|P1|STARTED|Overall Study||60
7519805|NCT03793556|18516862|P2|NOT COMPLETED|Overall Study||2
7519806|NCT03793556|18516863|P1|NOT COMPLETED|Overall Study||13
7519807|NCT03793556|18516862|P2|COMPLETED|Overall Study||34
7519808|NCT03793556|18516863|P1|COMPLETED|Overall Study||22
7519809|NCT03793556|18516862|P2|STARTED|Overall Study||36
7519810|NCT03793556|18516863|P1|STARTED|Overall Study||35
7519811|NCT03793010|18516907|P2|NOT COMPLETED|Overall Study||27
7519812|NCT03793010|18516908|P1|NOT COMPLETED|Overall Study||28
7519813|NCT03793010|18516907|P2|COMPLETED|Overall Study||8
7519814|NCT03793010|18516908|P1|COMPLETED|Overall Study||7
7519815|NCT03793010|18516907|P2|Randomized But Not Dosed|Overall Study||0
7519816|NCT03793010|18516908|P1|Randomized But Not Dosed|Overall Study||2
7519817|NCT03793010|18516907|P2|STARTED|Overall Study||35
7519818|NCT03793010|18516908|P1|STARTED|Overall Study||35
7519819|NCT03792672|18516918|P6|NOT COMPLETED|Treatment Period 4 (2 Days)||0
7519820|NCT03792672|18516919|P5|NOT COMPLETED|Treatment Period 4 (2 Days)||0
7519821|NCT03792672|18516920|P4|NOT COMPLETED|Treatment Period 4 (2 Days)||0
7519822|NCT03792672|18516921|P3|NOT COMPLETED|Treatment Period 4 (2 Days)||0
7519823|NCT03792672|18516922|P2|NOT COMPLETED|Treatment Period 4 (2 Days)||0
7519824|NCT03792672|18516923|P1|NOT COMPLETED|Treatment Period 4 (2 Days)||1
7519825|NCT03792672|18516918|P6|COMPLETED|Treatment Period 4 (2 Days)||4
7519826|NCT03792672|18516919|P5|COMPLETED|Treatment Period 4 (2 Days)||4
7519827|NCT03792672|18516920|P4|COMPLETED|Treatment Period 4 (2 Days)||2
7519828|NCT03792672|18516921|P3|COMPLETED|Treatment Period 4 (2 Days)||3
7519829|NCT03792672|18516922|P2|COMPLETED|Treatment Period 4 (2 Days)||4
7519830|NCT03792672|18516923|P1|COMPLETED|Treatment Period 4 (2 Days)||2
7519831|NCT03792672|18516918|P6|STARTED|Treatment Period 4 (2 Days)||4
7519832|NCT03792672|18516919|P5|STARTED|Treatment Period 4 (2 Days)||4
7519833|NCT03792672|18516920|P4|STARTED|Treatment Period 4 (2 Days)||2
7519834|NCT03792672|18516921|P3|STARTED|Treatment Period 4 (2 Days)||3
7519835|NCT03792672|18516922|P2|STARTED|Treatment Period 4 (2 Days)||4
7519836|NCT03792672|18516923|P1|STARTED|Treatment Period 4 (2 Days)||3
7519837|NCT03792672|18516918|P6|NOT COMPLETED|Washout Period 3 (10 Days)||0
7519838|NCT03792672|18516919|P5|NOT COMPLETED|Washout Period 3 (10 Days)||0
7519839|NCT03792672|18516920|P4|NOT COMPLETED|Washout Period 3 (10 Days)||2
7519840|NCT03792672|18516921|P3|NOT COMPLETED|Washout Period 3 (10 Days)||1
7519841|NCT03792672|18516922|P2|NOT COMPLETED|Washout Period 3 (10 Days)||0
7519842|NCT03792672|18516923|P1|NOT COMPLETED|Washout Period 3 (10 Days)||1
7519843|NCT03792672|18516918|P6|COMPLETED|Washout Period 3 (10 Days)||4
7519844|NCT03792672|18516919|P5|COMPLETED|Washout Period 3 (10 Days)||4
7519845|NCT03792672|18516920|P4|COMPLETED|Washout Period 3 (10 Days)||2
7519846|NCT03792672|18516921|P3|COMPLETED|Washout Period 3 (10 Days)||3
7519847|NCT03792672|18516922|P2|COMPLETED|Washout Period 3 (10 Days)||4
7519848|NCT03792672|18516923|P1|COMPLETED|Washout Period 3 (10 Days)||3
7519849|NCT03792672|18516918|P6|STARTED|Washout Period 3 (10 Days)||4
7519850|NCT03792672|18516919|P5|STARTED|Washout Period 3 (10 Days)||4
7519851|NCT03792672|18516920|P4|STARTED|Washout Period 3 (10 Days)||4
7519852|NCT03792672|18516921|P3|STARTED|Washout Period 3 (10 Days)||4
7519853|NCT03792672|18516922|P2|STARTED|Washout Period 3 (10 Days)||4
7519854|NCT03792672|18516923|P1|STARTED|Washout Period 3 (10 Days)||4
7519855|NCT03792672|18516918|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7519856|NCT03792672|18516919|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7519857|NCT03792672|18516920|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7519858|NCT03792672|18516921|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7519859|NCT03792672|18516922|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7519860|NCT03792672|18516923|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7519861|NCT03792672|18516918|P6|COMPLETED|Treatment Period 3 (1 Day)||4
7519862|NCT03792672|18516919|P5|COMPLETED|Treatment Period 3 (1 Day)||4
7519863|NCT03792672|18516920|P4|COMPLETED|Treatment Period 3 (1 Day)||4
7519864|NCT03792672|18516921|P3|COMPLETED|Treatment Period 3 (1 Day)||4
7519865|NCT03792672|18516922|P2|COMPLETED|Treatment Period 3 (1 Day)||4
7519866|NCT03792672|18516923|P1|COMPLETED|Treatment Period 3 (1 Day)||4
7519867|NCT03792672|18516918|P6|STARTED|Treatment Period 3 (1 Day)||4
7519868|NCT03792672|18516919|P5|STARTED|Treatment Period 3 (1 Day)||4
7519869|NCT03792672|18516920|P4|STARTED|Treatment Period 3 (1 Day)||4
7519870|NCT03792672|18516921|P3|STARTED|Treatment Period 3 (1 Day)||4
7519871|NCT03792672|18516922|P2|STARTED|Treatment Period 3 (1 Day)||4
7519872|NCT03792672|18516923|P1|STARTED|Treatment Period 3 (1 Day)||4
7519873|NCT03792672|18516918|P6|NOT COMPLETED|Washout Period 2 (10 Days)||0
7519874|NCT03792672|18516919|P5|NOT COMPLETED|Washout Period 2 (10 Days)||0
7519875|NCT03792672|18516920|P4|NOT COMPLETED|Washout Period 2 (10 Days)||0
7519876|NCT03792672|18516921|P3|NOT COMPLETED|Washout Period 2 (10 Days)||0
7519877|NCT03792672|18516922|P2|NOT COMPLETED|Washout Period 2 (10 Days)||0
7519878|NCT03792672|18516923|P1|NOT COMPLETED|Washout Period 2 (10 Days)||0
7519879|NCT03792672|18516918|P6|COMPLETED|Washout Period 2 (10 Days)||4
7519880|NCT03792672|18516919|P5|COMPLETED|Washout Period 2 (10 Days)||4
7519881|NCT03792672|18516920|P4|COMPLETED|Washout Period 2 (10 Days)||4
7519882|NCT03792672|18516921|P3|COMPLETED|Washout Period 2 (10 Days)||4
7519883|NCT03792672|18516922|P2|COMPLETED|Washout Period 2 (10 Days)||4
7519884|NCT03792672|18516923|P1|COMPLETED|Washout Period 2 (10 Days)||4
7519885|NCT03792672|18516918|P6|STARTED|Washout Period 2 (10 Days)||4
7519886|NCT03792672|18516919|P5|STARTED|Washout Period 2 (10 Days)||4
7519887|NCT03792672|18516920|P4|STARTED|Washout Period 2 (10 Days)||4
7519888|NCT03792672|18516921|P3|STARTED|Washout Period 2 (10 Days)||4
7519889|NCT03792672|18516922|P2|STARTED|Washout Period 2 (10 Days)||4
7519890|NCT03792672|18516923|P1|STARTED|Washout Period 2 (10 Days)||4
7519891|NCT03792672|18516918|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7519892|NCT03792672|18516919|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7519893|NCT03792672|18516920|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7519894|NCT03792672|18516921|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7519895|NCT03792672|18516922|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7519896|NCT03792672|18516923|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7519897|NCT03792672|18516918|P6|COMPLETED|Treatment Period 2 (1 Day)||4
7519898|NCT03792672|18516919|P5|COMPLETED|Treatment Period 2 (1 Day)||4
7519899|NCT03792672|18516920|P4|COMPLETED|Treatment Period 2 (1 Day)||4
7519900|NCT03792672|18516921|P3|COMPLETED|Treatment Period 2 (1 Day)||4
7519901|NCT03792672|18516922|P2|COMPLETED|Treatment Period 2 (1 Day)||4
7519902|NCT03792672|18516923|P1|COMPLETED|Treatment Period 2 (1 Day)||4
7519903|NCT03792672|18516918|P6|STARTED|Treatment Period 2 (1 Day)||4
7519904|NCT03792672|18516919|P5|STARTED|Treatment Period 2 (1 Day)||4
7519905|NCT03792672|18516920|P4|STARTED|Treatment Period 2 (1 Day)||4
7519906|NCT03792672|18516921|P3|STARTED|Treatment Period 2 (1 Day)||4
7519907|NCT03792672|18516922|P2|STARTED|Treatment Period 2 (1 Day)||4
7519908|NCT03792672|18516923|P1|STARTED|Treatment Period 2 (1 Day)||4
7519909|NCT03792672|18516918|P6|NOT COMPLETED|Washout Period 1 (10 Days)||0
7519910|NCT03792672|18516919|P5|NOT COMPLETED|Washout Period 1 (10 Days)||0
7519911|NCT03792672|18516920|P4|NOT COMPLETED|Washout Period 1 (10 Days)||0
7519912|NCT03792672|18516921|P3|NOT COMPLETED|Washout Period 1 (10 Days)||0
7519913|NCT03792672|18516922|P2|NOT COMPLETED|Washout Period 1 (10 Days)||0
7519914|NCT03792672|18516923|P1|NOT COMPLETED|Washout Period 1 (10 Days)||0
7519915|NCT03792672|18516918|P6|COMPLETED|Washout Period 1 (10 Days)||4
7519916|NCT03792672|18516919|P5|COMPLETED|Washout Period 1 (10 Days)||4
7519917|NCT03792672|18516920|P4|COMPLETED|Washout Period 1 (10 Days)||4
7519918|NCT03792672|18516921|P3|COMPLETED|Washout Period 1 (10 Days)||4
7519919|NCT03792672|18516922|P2|COMPLETED|Washout Period 1 (10 Days)||4
7519920|NCT03792672|18516923|P1|COMPLETED|Washout Period 1 (10 Days)||4
7519921|NCT03792672|18516918|P6|STARTED|Washout Period 1 (10 Days)||4
7519922|NCT03792672|18516919|P5|STARTED|Washout Period 1 (10 Days)||4
7519923|NCT03792672|18516920|P4|STARTED|Washout Period 1 (10 Days)||4
7519924|NCT03792672|18516921|P3|STARTED|Washout Period 1 (10 Days)||4
7519925|NCT03792672|18516922|P2|STARTED|Washout Period 1 (10 Days)||4
7519926|NCT03792672|18516923|P1|STARTED|Washout Period 1 (10 Days)||4
7519927|NCT03792672|18516918|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7519928|NCT03792672|18516919|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7519929|NCT03792672|18516920|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7519930|NCT03792672|18516921|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7519931|NCT03792672|18516922|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7519932|NCT03792672|18516923|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7519933|NCT03792672|18516918|P6|COMPLETED|Treatment Period 1 (1 Day)||4
7519934|NCT03792672|18516919|P5|COMPLETED|Treatment Period 1 (1 Day)||4
7519935|NCT03792672|18516920|P4|COMPLETED|Treatment Period 1 (1 Day)||4
7519936|NCT03792672|18516921|P3|COMPLETED|Treatment Period 1 (1 Day)||4
7519937|NCT03792672|18516922|P2|COMPLETED|Treatment Period 1 (1 Day)||4
7519938|NCT03792672|18516923|P1|COMPLETED|Treatment Period 1 (1 Day)||4
7519939|NCT03792672|18516918|P6|STARTED|Treatment Period 1 (1 Day)||4
7519940|NCT03792672|18516919|P5|STARTED|Treatment Period 1 (1 Day)||4
7519941|NCT03792672|18516920|P4|STARTED|Treatment Period 1 (1 Day)||4
7519942|NCT03792672|18516921|P3|STARTED|Treatment Period 1 (1 Day)||4
7519943|NCT03792672|18516922|P2|STARTED|Treatment Period 1 (1 Day)||4
7519944|NCT03792672|18516923|P1|STARTED|Treatment Period 1 (1 Day)||4
7519945|NCT03791489|18516943|P1|NOT COMPLETED|90 Days (Primary Endpoint)||0
7519946|NCT03791489|18516943|P1|COMPLETED|90 Days (Primary Endpoint)||30
7519947|NCT03791489|18516943|P1|STARTED|90 Days (Primary Endpoint)||30
7519948|NCT03791489|18516943|P1|NOT COMPLETED|30 Days||0
7519949|NCT03791489|18516943|P1|COMPLETED|30 Days||30
7519950|NCT03791489|18516943|P1|STARTED|30 Days||30
7519951|NCT03790917|18516950|P1|NOT COMPLETED|Overall Study||1
7519952|NCT03790917|18516950|P1|COMPLETED|Overall Study||200
7519953|NCT03790917|18516950|P1|STARTED|Overall Study||201
7519954|NCT03790306|18516960|P1|NOT COMPLETED|Overall Study||0
7519955|NCT03790306|18516960|P1|COMPLETED|Overall Study||207
7519956|NCT03790306|18516960|P1|STARTED|Overall Study||207
7519957|NCT03789474|18516974|P2|NOT COMPLETED|Overall Study||0
7519958|NCT03789474|18516975|P1|NOT COMPLETED|Overall Study||0
7519959|NCT03789474|18516974|P2|COMPLETED|Overall Study||30
7519960|NCT03789474|18516975|P1|COMPLETED|Overall Study||30
7519961|NCT03789474|18516974|P2|STARTED|Overall Study||30
7519962|NCT03789474|18516975|P1|STARTED|Overall Study||30
7519963|NCT03789175|18517071|P1|NOT COMPLETED|Week 12 to Week 24 of NR||0
7519964|NCT03789175|18517071|P1|COMPLETED|Week 12 to Week 24 of NR|Participant did not meet primary endpoint and completed study at week 24|1
7519965|NCT03789175|18517071|P1|STARTED|Week 12 to Week 24 of NR||1
7519966|NCT03789175|18517071|P1|NOT COMPLETED|Week 0 to Week 12 of NR||0
7519967|NCT03789175|18517071|P1|COMPLETED|Week 0 to Week 12 of NR||1
7519968|NCT03789175|18517071|P1|STARTED|Week 0 to Week 12 of NR||1
7519969|NCT03787472|18517078|P2|NOT COMPLETED|Period 2||0
7519970|NCT03787472|18517079|P1|NOT COMPLETED|Period 2||0
7519971|NCT03787472|18517078|P2|COMPLETED|Period 2||22
7519972|NCT03787472|18517079|P1|COMPLETED|Period 2||23
7519973|NCT03787472|18517078|P2|STARTED|Period 2||22
7519974|NCT03787472|18517079|P1|STARTED|Period 2||23
7519975|NCT03787472|18517078|P2|NOT COMPLETED|Period 1||0
7519976|NCT03787472|18517079|P1|NOT COMPLETED|Period 1||0
7519977|NCT03787472|18517078|P2|COMPLETED|Period 1||22
7519978|NCT03787472|18517079|P1|COMPLETED|Period 1||23
7519979|NCT03787472|18517078|P2|STARTED|Period 1||22
7519980|NCT03787472|18517079|P1|STARTED|Period 1||23
7519981|NCT03787212|18517087|P2|NOT COMPLETED|Period 1||2
7519982|NCT03787212|18517088|P1|NOT COMPLETED|Period 1||2
7519983|NCT03787212|18517087|P2|COMPLETED|Period 1||0
7519984|NCT03787212|18517088|P1|COMPLETED|Period 1||0
7519985|NCT03787212|18517087|P2|STARTED|Period 1||2
7519986|NCT03787212|18517088|P1|STARTED|Period 1||2
7519987|NCT03787212|18517087|P2|NOT COMPLETED|Period 1||0
7519988|NCT03787212|18517088|P1|NOT COMPLETED|Period 1||0
7519989|NCT03787212|18517087|P2|COMPLETED|Period 1||2
7519990|NCT03787212|18517088|P1|COMPLETED|Period 1||2
7519991|NCT03787212|18517087|P2|STARTED|Period 1||2
7519992|NCT03787212|18517088|P1|STARTED|Period 1||2
7519993|NCT03786744|18517096|P2|NOT COMPLETED|Overall Study||0
7519994|NCT03786744|18517097|P1|NOT COMPLETED|Overall Study||0
7519995|NCT03786744|18517096|P2|COMPLETED|Overall Study||10
7519996|NCT03786744|18517097|P1|COMPLETED|Overall Study||10
7519997|NCT03786744|18517096|P2|STARTED|Overall Study||10
7519998|NCT03786744|18517097|P1|STARTED|Overall Study||10
7519999|NCT03786718|18517108|P1|NOT COMPLETED|Overall Study||7
7520000|NCT03786718|18517108|P1|COMPLETED|Overall Study||60
7520001|NCT03786718|18517108|P1|STARTED|Overall Study||67
7520002|NCT03785548|18517125|P2|NOT COMPLETED|Overall Study||0
7520003|NCT03785548|18517126|P1|NOT COMPLETED|Overall Study||2
7520004|NCT03785548|18517125|P2|COMPLETED|Overall Study||74
7520005|NCT03785548|18517126|P1|COMPLETED|Overall Study||71
7520006|NCT03785548|18517125|P2|STARTED|Overall Study||74
7520007|NCT03785548|18517126|P1|STARTED|Overall Study||73
7520008|NCT03784898|18517134|P1|NOT COMPLETED|Overall Study||0
7520009|NCT03784898|18517134|P1|COMPLETED|Overall Study||13
7520010|NCT03784898|18517134|P1|STARTED|Overall Study||13
7520011|NCT03784001|18517141|P3|NOT COMPLETED|Overall Study||1
7520012|NCT03784001|18517142|P2|NOT COMPLETED|Overall Study||0
7520013|NCT03784001|18517143|P1|NOT COMPLETED|Overall Study||2
7520014|NCT03784001|18517141|P3|COMPLETED|Overall Study||40
7520015|NCT03784001|18517142|P2|COMPLETED|Overall Study||38
7520016|NCT03784001|18517143|P1|COMPLETED|Overall Study||44
7520017|NCT03784001|18517141|P3|STARTED|Overall Study||41
7520018|NCT03784001|18517142|P2|STARTED|Overall Study||38
7520019|NCT03784001|18517143|P1|STARTED|Overall Study||46
7520020|NCT03783780|18517175|P1|NOT COMPLETED|Overall Study||1
7520021|NCT03783780|18517175|P1|COMPLETED|Overall Study||20
7520022|NCT03783780|18517175|P1|STARTED|Overall Study||21
7520023|NCT03783039|18517182|P2|NOT COMPLETED|Overall Study||0
7520024|NCT03783039|18517183|P1|NOT COMPLETED|Overall Study||0
7520025|NCT03783039|18517182|P2|COMPLETED|Overall Study||115
7520026|NCT03783039|18517183|P1|COMPLETED|Overall Study||119
7520027|NCT03783039|18517182|P2|STARTED|Overall Study||115
7520028|NCT03783039|18517183|P1|STARTED|Overall Study||119
7520029|NCT03782571|18517189|P4|NOT COMPLETED|Period 4||0
7520030|NCT03782571|18517190|P3|NOT COMPLETED|Period 4||0
7520031|NCT03782571|18517191|P2|NOT COMPLETED|Period 4||0
7520032|NCT03782571|18517192|P1|NOT COMPLETED|Period 4||0
7520033|NCT03782571|18517189|P4|COMPLETED|Period 4||7
7520034|NCT03782571|18517190|P3|COMPLETED|Period 4||6
7520035|NCT03782571|18517191|P2|COMPLETED|Period 4||6
7520036|NCT03782571|18517192|P1|COMPLETED|Period 4||3
7520037|NCT03782571|18517189|P4|STARTED|Period 4||7
7520038|NCT03782571|18517190|P3|STARTED|Period 4||6
7520039|NCT03782571|18517191|P2|STARTED|Period 4||6
7520040|NCT03782571|18517192|P1|STARTED|Period 4||3
7520041|NCT03782571|18517189|P4|NOT COMPLETED|Period 3||0
7520042|NCT03782571|18517190|P3|NOT COMPLETED|Period 3||0
7520043|NCT03782571|18517191|P2|NOT COMPLETED|Period 3||0
7520044|NCT03782571|18517192|P1|NOT COMPLETED|Period 3||2
7520045|NCT03782571|18517189|P4|COMPLETED|Period 3||7
7520046|NCT03782571|18517190|P3|COMPLETED|Period 3||6
7520047|NCT03782571|18517191|P2|COMPLETED|Period 3||6
7520048|NCT03782571|18517192|P1|COMPLETED|Period 3||3
7520049|NCT03782571|18517189|P4|STARTED|Period 3||7
7520050|NCT03782571|18517190|P3|STARTED|Period 3||6
7520051|NCT03782571|18517191|P2|STARTED|Period 3||6
7520052|NCT03782571|18517192|P1|STARTED|Period 3||5
7520053|NCT03782571|18517189|P4|NOT COMPLETED|Period 2||0
7520054|NCT03782571|18517190|P3|NOT COMPLETED|Period 2||0
7520055|NCT03782571|18517191|P2|NOT COMPLETED|Period 2||0
7520056|NCT03782571|18517192|P1|NOT COMPLETED|Period 2||0
7520057|NCT03782571|18517189|P4|COMPLETED|Period 2||7
7520058|NCT03782571|18517190|P3|COMPLETED|Period 2||6
7520059|NCT03782571|18517191|P2|COMPLETED|Period 2||6
7520060|NCT03782571|18517192|P1|COMPLETED|Period 2||5
7520061|NCT03782571|18517189|P4|STARTED|Period 2||7
7520062|NCT03782571|18517190|P3|STARTED|Period 2||6
7520063|NCT03782571|18517191|P2|STARTED|Period 2||6
7520064|NCT03782571|18517192|P1|STARTED|Period 2||5
7520065|NCT03782571|18517189|P4|NOT COMPLETED|Period 1||0
7520066|NCT03782571|18517190|P3|NOT COMPLETED|Period 1||0
7520067|NCT03782571|18517191|P2|NOT COMPLETED|Period 1||0
7520068|NCT03782571|18517192|P1|NOT COMPLETED|Period 1||1
7520069|NCT03782571|18517189|P4|COMPLETED|Period 1||7
7520070|NCT03782571|18517190|P3|COMPLETED|Period 1||6
7520071|NCT03782571|18517191|P2|COMPLETED|Period 1||6
7520072|NCT03782571|18517192|P1|COMPLETED|Period 1||5
7520073|NCT03782571|18517189|P4|STARTED|Period 1||7
7520074|NCT03782571|18517190|P3|STARTED|Period 1||6
7520075|NCT03782571|18517191|P2|STARTED|Period 1||6
7520076|NCT03782571|18517192|P1|STARTED|Period 1||6
7520077|NCT03782233|18517218|P2|NOT COMPLETED|Overall Study||2
7520078|NCT03782233|18517219|P1|NOT COMPLETED|Overall Study||4
7520079|NCT03782233|18517218|P2|COMPLETED|Overall Study||31
7520080|NCT03782233|18517219|P1|COMPLETED|Overall Study||46
7520081|NCT03782233|18517218|P2|STARTED|Overall Study||33
7520082|NCT03782233|18517219|P1|STARTED|Overall Study||50
7520083|NCT03782181|18517263|P2|NOT COMPLETED|Overall Study||0
7520084|NCT03782181|18517264|P1|NOT COMPLETED|Overall Study||0
7520085|NCT03782181|18517263|P2|COMPLETED|Overall Study||20
7520086|NCT03782181|18517264|P1|COMPLETED|Overall Study||20
7520087|NCT03782181|18517263|P2|STARTED|Overall Study||20
7520088|NCT03782181|18517264|P1|STARTED|Overall Study||20
7520089|NCT03781375|18517290|P2|NOT COMPLETED|Open-label Phase||3
7520090|NCT03781375|18517291|P1|NOT COMPLETED|Open-label Phase||3
7520091|NCT03781375|18517290|P2|COMPLETED|Open-label Phase||6
7520092|NCT03781375|18517291|P1|COMPLETED|Open-label Phase||8
7520093|NCT03781375|18517290|P2|Received Study Drug|Open-label Phase||9
7520094|NCT03781375|18517291|P1|Received Study Drug|Open-label Phase||10
7520095|NCT03781375|18517290|P2|STARTED|Open-label Phase||9
7520096|NCT03781375|18517291|P1|STARTED|Open-label Phase||11
7520097|NCT03781375|18517290|P2|NOT COMPLETED|Double-blind Phase||6
7520098|NCT03781375|18517291|P1|NOT COMPLETED|Double-blind Phase||7
7520099|NCT03781375|18517290|P2|COMPLETED|Double-blind Phase||7
7520100|NCT03781375|18517291|P1|COMPLETED|Double-blind Phase||5
7520101|NCT03781375|18517290|P2|Received Study Drug|Double-blind Phase||13
7520102|NCT03781375|18517291|P1|Received Study Drug|Double-blind Phase||12
7520103|NCT03781375|18517290|P2|STARTED|Double-blind Phase||13
7520104|NCT03781375|18517291|P1|STARTED|Double-blind Phase||12
7520105|NCT03780959|18517305|P3|NOT COMPLETED|Part 2||6
7520106|NCT03780959|18517306|P2|NOT COMPLETED|Part 2||19
7520107|NCT03780959|18517307|P1|NOT COMPLETED|Part 2||0
7520108|NCT03780959|18517305|P3|COMPLETED|Part 2||19
7520109|NCT03780959|18517306|P2|COMPLETED|Part 2||7
7520110|NCT03780959|18517307|P1|COMPLETED|Part 2||0
7520111|NCT03780959|18517305|P3|STARTED|Part 2||25
7520112|NCT03780959|18517306|P2|STARTED|Part 2||26
7520113|NCT03780959|18517307|P1|STARTED|Part 2||0
7520114|NCT03780959|18517305|P3|NOT COMPLETED|Part 1||0
7520115|NCT03780959|18517306|P2|NOT COMPLETED|Part 1||0
7520116|NCT03780959|18517307|P1|NOT COMPLETED|Part 1||5
7520117|NCT03780959|18517305|P3|COMPLETED|Part 1||0
7520118|NCT03780959|18517306|P2|COMPLETED|Part 1||0
7520119|NCT03780959|18517307|P1|COMPLETED|Part 1||64
7520120|NCT03780959|18517305|P3|STARTED|Part 1||0
7520121|NCT03780959|18517306|P2|STARTED|Part 1||0
7520122|NCT03780959|18517307|P1|STARTED|Part 1||69
7520123|NCT03780400|18517319|P1|NOT COMPLETED|Overall Study||7
7520124|NCT03780400|18517319|P1|COMPLETED|Overall Study||53
7520125|NCT03780400|18517319|P1|STARTED|Overall Study||60
7520126|NCT03780010|18517329|P2|NOT COMPLETED|Overall Study||0
7520127|NCT03780010|18517330|P1|NOT COMPLETED|Overall Study||0
7520128|NCT03780010|18517329|P2|COMPLETED|Overall Study||12
7520129|NCT03780010|18517330|P1|COMPLETED|Overall Study||3
7520130|NCT03780010|18517329|P2|STARTED|Overall Study||12
7520131|NCT03780010|18517330|P1|STARTED|Overall Study||3
7520132|NCT03779724|18517357|P2|NOT COMPLETED|Overall Study||4
7520133|NCT03779724|18517358|P1|NOT COMPLETED|Overall Study||6
7520134|NCT03779724|18517357|P2|COMPLETED|Overall Study||21
7520135|NCT03779724|18517358|P1|COMPLETED|Overall Study||19
7520136|NCT03779724|18517357|P2|STARTED|Overall Study||25
7520137|NCT03779724|18517358|P1|STARTED|Overall Study||25
7520138|NCT03779503|18517382|P2|NOT COMPLETED|Second Intervention||0
7520139|NCT03779503|18517383|P1|NOT COMPLETED|Second Intervention||0
7520140|NCT03779503|18517382|P2|COMPLETED|Second Intervention||26
7520141|NCT03779503|18517383|P1|COMPLETED|Second Intervention||27
7520142|NCT03779503|18517382|P2|STARTED|Second Intervention||26
7520143|NCT03779503|18517383|P1|STARTED|Second Intervention||27
7520144|NCT03779503|18517382|P2|NOT COMPLETED|First Intervention||1
7520145|NCT03779503|18517383|P1|NOT COMPLETED|First Intervention||1
7520146|NCT03779503|18517382|P2|COMPLETED|First Intervention||26
7520147|NCT03779503|18517383|P1|COMPLETED|First Intervention||27
7520148|NCT03779503|18517382|P2|STARTED|First Intervention||27
7520149|NCT03779503|18517383|P1|STARTED|First Intervention||28
7520150|NCT03778190|18517407|P1|NOT COMPLETED|Overall Study||0
7520151|NCT03778190|18517407|P1|COMPLETED|Overall Study||10
7520152|NCT03778190|18517407|P1|STARTED|Overall Study||10
7520153|NCT03777865|18517412|P1|NOT COMPLETED|Overall Study||0
7520154|NCT03777865|18517412|P1|COMPLETED|Overall Study||100
7520155|NCT03777865|18517412|P1|STARTED|Overall Study||100
7520156|NCT03776175|18517422|P4|NOT COMPLETED|Follow-Up Period (35 Days)||2
7520157|NCT03776175|18517423|P3|NOT COMPLETED|Follow-Up Period (35 Days)||0
7520158|NCT03776175|18517424|P2|NOT COMPLETED|Follow-Up Period (35 Days)||0
7520159|NCT03776175|18517425|P1|NOT COMPLETED|Follow-Up Period (35 Days)||0
7520160|NCT03776175|18517422|P4|COMPLETED|Follow-Up Period (35 Days)||24
7520161|NCT03776175|18517423|P3|COMPLETED|Follow-Up Period (35 Days)||24
7520162|NCT03776175|18517424|P2|COMPLETED|Follow-Up Period (35 Days)||22
7520163|NCT03776175|18517425|P1|COMPLETED|Follow-Up Period (35 Days)||13
7520164|NCT03776175|18517422|P4|STARTED|Follow-Up Period (35 Days)||26
7520165|NCT03776175|18517423|P3|STARTED|Follow-Up Period (35 Days)||24
7520166|NCT03776175|18517424|P2|STARTED|Follow-Up Period (35 Days)||22
7520167|NCT03776175|18517425|P1|STARTED|Follow-Up Period (35 Days)||13
7520168|NCT03776175|18517422|P4|NOT COMPLETED|Treatment Period (42 Days)||2
7520169|NCT03776175|18517423|P3|NOT COMPLETED|Treatment Period (42 Days)||4
7520170|NCT03776175|18517424|P2|NOT COMPLETED|Treatment Period (42 Days)||7
7520171|NCT03776175|18517425|P1|NOT COMPLETED|Treatment Period (42 Days)||1
7520172|NCT03776175|18517422|P4|COMPLETED|Treatment Period (42 Days)||26
7520173|NCT03776175|18517423|P3|COMPLETED|Treatment Period (42 Days)||24
7520174|NCT03776175|18517424|P2|COMPLETED|Treatment Period (42 Days)||22
7520175|NCT03776175|18517425|P1|COMPLETED|Treatment Period (42 Days)||13
7520176|NCT03776175|18517422|P4|Treated|Treatment Period (42 Days)||28
7520177|NCT03776175|18517423|P3|Treated|Treatment Period (42 Days)||28
7520178|NCT03776175|18517424|P2|Treated|Treatment Period (42 Days)||29
7520179|NCT03776175|18517425|P1|Treated|Treatment Period (42 Days)||14
7520180|NCT03776175|18517422|P4|STARTED|Treatment Period (42 Days)||28
7520181|NCT03776175|18517423|P3|STARTED|Treatment Period (42 Days)||28
7520182|NCT03776175|18517424|P2|STARTED|Treatment Period (42 Days)||29
7520183|NCT03776175|18517425|P1|STARTED|Treatment Period (42 Days)||14
7520184|NCT03774745|18517457|P2|NOT COMPLETED|Overall Study||4
7520185|NCT03774745|18517458|P1|NOT COMPLETED|Overall Study||2
7520186|NCT03774745|18517457|P2|COMPLETED|Overall Study||2
7520187|NCT03774745|18517458|P1|COMPLETED|Overall Study||4
7520188|NCT03774745|18517457|P2|Follow-up 2|Overall Study||2
7520189|NCT03774745|18517458|P1|Follow-up 2|Overall Study||4
7520190|NCT03774745|18517457|P2|Follow-Up 1|Overall Study||6
7520191|NCT03774745|18517458|P1|Follow-Up 1|Overall Study||5
7520192|NCT03774745|18517457|P2|STARTED|Overall Study||6
7520193|NCT03774745|18517458|P1|STARTED|Overall Study||6
7520194|NCT03774576|18517472|P1|NOT COMPLETED|Period 2||1
7520195|NCT03774576|18517472|P1|COMPLETED|Period 2||13
7520196|NCT03774576|18517472|P1|STARTED|Period 2||14
7520197|NCT03774576|18517472|P1|NOT COMPLETED|Period 1||0
7520198|NCT03774576|18517472|P1|COMPLETED|Period 1||14
7520199|NCT03774576|18517472|P1|STARTED|Period 1||14
7520200|NCT03773133|18517485|P1|NOT COMPLETED|Overall Study||8
7520201|NCT03773133|18517485|P1|COMPLETED|Overall Study||0
7520202|NCT03773133|18517485|P1|Received the Therapeutic IRPP|Overall Study||0
7520203|NCT03773133|18517485|P1|Received the Screening IIP|Overall Study||8
7520204|NCT03773133|18517485|P1|STARTED|Overall Study||8
7520205|NCT03772522|18517492|P2|NOT COMPLETED|Post-intervention Follow-up||0
7520206|NCT03772522|18517493|P1|NOT COMPLETED|Post-intervention Follow-up||1
7520207|NCT03772522|18517492|P2|COMPLETED|Post-intervention Follow-up||11
7520208|NCT03772522|18517493|P1|COMPLETED|Post-intervention Follow-up||7
7520209|NCT03772522|18517492|P2|STARTED|Post-intervention Follow-up||11
7520210|NCT03772522|18517493|P1|STARTED|Post-intervention Follow-up||8
7520211|NCT03772522|18517492|P2|NOT COMPLETED|Intervention||0
7520212|NCT03772522|18517493|P1|NOT COMPLETED|Intervention||1
7520213|NCT03772522|18517492|P2|COMPLETED|Intervention||11
7520214|NCT03772522|18517493|P1|COMPLETED|Intervention||8
7520215|NCT03772522|18517492|P2|STARTED|Intervention||11
7520216|NCT03772522|18517493|P1|STARTED|Intervention||9
7520217|NCT03772522|18517492|P2|NOT COMPLETED|Pre-intervention||4
7520218|NCT03772522|18517493|P1|NOT COMPLETED|Pre-intervention||3
7520219|NCT03772522|18517492|P2|COMPLETED|Pre-intervention||11
7520220|NCT03772522|18517493|P1|COMPLETED|Pre-intervention||9
7520221|NCT03772522|18517492|P2|STARTED|Pre-intervention||15
7520222|NCT03772522|18517493|P1|STARTED|Pre-intervention||12
7520223|NCT03772327|18517516|P2|NOT COMPLETED|Overall Study||7
7520224|NCT03772327|18517517|P1|NOT COMPLETED|Overall Study||5
7520225|NCT03772327|18517516|P2|COMPLETED|Overall Study||26
7520226|NCT03772327|18517517|P1|COMPLETED|Overall Study||25
7520227|NCT03772327|18517516|P2|Week 0 Visit|Overall Study||33
7520228|NCT03772327|18517517|P1|Week 0 Visit|Overall Study|2 participants were lost to follow up after randomization prior to any study interventions.|28
7520229|NCT03772327|18517516|P2|STARTED|Overall Study||33
7520230|NCT03772327|18517517|P1|STARTED|Overall Study||30
7520231|NCT03771560|18517533|P1|NOT COMPLETED|Overall Study||6
7520232|NCT03771560|18517533|P1|COMPLETED|Overall Study||12
7520233|NCT03771560|18517533|P1|STARTED|Overall Study||18
7520234|NCT03771274|18517541|P1|NOT COMPLETED|Overall Study||0
7520235|NCT03771274|18517541|P1|COMPLETED|Overall Study||39
7520236|NCT03771274|18517541|P1|STARTED|Overall Study||39
7520237|NCT03769207|18517548|P1|NOT COMPLETED|Overall Study||11
7520238|NCT03769207|18517548|P1|COMPLETED|Overall Study||6
7520239|NCT03769207|18517548|P1|Attended Second Study Visit|Overall Study||6
7520240|NCT03769207|18517548|P1|ECG Patch Returned and Readable|Overall Study||9
7520241|NCT03769207|18517548|P1|ECG Patch Shipped|Overall Study||11
7520242|NCT03769207|18517548|P1|Attended First Study Visit|Overall Study||11
7520243|NCT03769207|18517548|P1|STARTED|Overall Study||17
7520244|NCT03768856|18517554|P1|NOT COMPLETED|Overall Study||0
7520245|NCT03768856|18517554|P1|COMPLETED|Overall Study||5
7520246|NCT03768856|18517554|P1|STARTED|Overall Study||5
7520247|NCT03767894|18517563|P1|NOT COMPLETED|Overall Study||1
7520248|NCT03767894|18517563|P1|COMPLETED|Overall Study||11
7520249|NCT03767894|18517563|P1|STARTED|Overall Study||12
7520250|NCT03767062|18517574|P2|NOT COMPLETED|Overall Study||4
7520251|NCT03767062|18517575|P1|NOT COMPLETED|Overall Study||8
7520252|NCT03767062|18517574|P2|COMPLETED|Overall Study||41
7520253|NCT03767062|18517575|P1|COMPLETED|Overall Study||37
7520254|NCT03767062|18517574|P2|STARTED|Overall Study||45
7520255|NCT03767062|18517575|P1|STARTED|Overall Study||45
7520256|NCT03766646|18517585|P2|NOT COMPLETED|Overall Study||3
7520257|NCT03766646|18517586|P1|NOT COMPLETED|Overall Study||1
7520258|NCT03766646|18517585|P2|COMPLETED|Overall Study||12
7520259|NCT03766646|18517586|P1|COMPLETED|Overall Study||18
7520260|NCT03766646|18517585|P2|STARTED|Overall Study||15
7520261|NCT03766646|18517586|P1|STARTED|Overall Study||19
7520262|NCT03766373|18517594|P2|NOT COMPLETED|Overall Study||0
7520263|NCT03766373|18517595|P1|NOT COMPLETED|Overall Study||0
7520264|NCT03766373|18517594|P2|COMPLETED|Overall Study||12
7520265|NCT03766373|18517595|P1|COMPLETED|Overall Study||12
7520266|NCT03766373|18517594|P2|STARTED|Overall Study||12
7520267|NCT03766373|18517595|P1|STARTED|Overall Study||12
7520268|NCT03766165|18517603|P2|NOT COMPLETED|Overall Study||0
7520269|NCT03766165|18517604|P1|NOT COMPLETED|Overall Study||0
7520270|NCT03766165|18517603|P2|COMPLETED|Overall Study||19
7520271|NCT03766165|18517604|P1|COMPLETED|Overall Study||19
7520272|NCT03766165|18517603|P2|STARTED|Overall Study||19
7520273|NCT03766165|18517604|P1|STARTED|Overall Study||19
7520274|NCT03765996|18517630|P2|NOT COMPLETED|Overall Study||0
7520275|NCT03765996|18517631|P1|NOT COMPLETED|Overall Study||4
7520276|NCT03765996|18517630|P2|COMPLETED|Overall Study||18
7520277|NCT03765996|18517631|P1|COMPLETED|Overall Study||14
7520278|NCT03765996|18517630|P2|STARTED|Overall Study||18
7520279|NCT03765996|18517631|P1|STARTED|Overall Study||18
7520280|NCT03765502|18517640|P5|NOT COMPLETED|Simulation 2||0
7520281|NCT03765502|18517641|P4|NOT COMPLETED|Simulation 2||0
7520282|NCT03765502|18517642|P3|NOT COMPLETED|Simulation 2||0
7520283|NCT03765502|18517643|P2|NOT COMPLETED|Simulation 2||0
7520284|NCT03765502|18517644|P1|NOT COMPLETED|Simulation 2||0
7520285|NCT03765502|18517640|P5|COMPLETED|Simulation 2||17
7520286|NCT03765502|18517641|P4|COMPLETED|Simulation 2||16
7520287|NCT03765502|18517642|P3|COMPLETED|Simulation 2||32
7520288|NCT03765502|18517643|P2|COMPLETED|Simulation 2||12
7520289|NCT03765502|18517644|P1|COMPLETED|Simulation 2||20
7520290|NCT03765502|18517640|P5|STARTED|Simulation 2||17
7520291|NCT03765502|18517641|P4|STARTED|Simulation 2||16
7520292|NCT03765502|18517642|P3|STARTED|Simulation 2|PWD completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|32
7520293|NCT03765502|18517643|P2|STARTED|Simulation 2|Participant completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|12
7520294|NCT03765502|18517644|P1|STARTED|Simulation 2||20
7520295|NCT03765502|18517640|P5|NOT COMPLETED|Simulation 1||0
7520296|NCT03765502|18517641|P4|NOT COMPLETED|Simulation 1||0
7520297|NCT03765502|18517642|P3|NOT COMPLETED|Simulation 1||0
7520298|NCT03765502|18517643|P2|NOT COMPLETED|Simulation 1||0
7520299|NCT03765502|18517644|P1|NOT COMPLETED|Simulation 1||0
7520300|NCT03765502|18517640|P5|COMPLETED|Simulation 1||17
7520301|NCT03765502|18517641|P4|COMPLETED|Simulation 1||16
7520302|NCT03765502|18517642|P3|COMPLETED|Simulation 1||33
7520303|NCT03765502|18517643|P2|COMPLETED|Simulation 1||13
7520304|NCT03765502|18517644|P1|COMPLETED|Simulation 1||20
7520305|NCT03765502|18517640|P5|STARTED|Simulation 1||17
7520306|NCT03765502|18517641|P4|STARTED|Simulation 1||16
7520307|NCT03765502|18517642|P3|STARTED|Simulation 1||33
7520308|NCT03765502|18517643|P2|STARTED|Simulation 1||13
7520309|NCT03765502|18517644|P1|STARTED|Simulation 1||20
7520310|NCT03765164|18517666|P2|NOT COMPLETED|Post-intervention||72
7520311|NCT03765164|18517667|P1|NOT COMPLETED|Post-intervention||73
7520312|NCT03765164|18517666|P2|COMPLETED|Post-intervention||0
7520313|NCT03765164|18517667|P1|COMPLETED|Post-intervention||0
7520314|NCT03765164|18517666|P2|STARTED|Post-intervention||72
7520315|NCT03765164|18517667|P1|STARTED|Post-intervention||73
7520316|NCT03765164|18517666|P2|NOT COMPLETED|Pre-intervention||6
7520317|NCT03765164|18517667|P1|NOT COMPLETED|Pre-intervention||5
7520318|NCT03765164|18517666|P2|COMPLETED|Pre-intervention||72
7520319|NCT03765164|18517667|P1|COMPLETED|Pre-intervention||73
7520320|NCT03765164|18517666|P2|STARTED|Pre-intervention||78
7520321|NCT03765164|18517667|P1|STARTED|Pre-intervention||78
7520322|NCT03765138|18517677|P1|NOT COMPLETED|Overall Study||1
7520323|NCT03765138|18517677|P1|COMPLETED|Overall Study||0
7520324|NCT03765138|18517677|P1|STARTED|Overall Study||1
7520325|NCT03764813|18517687|P4|NOT COMPLETED|From Enrollment to the Last HbF Test||0
7520326|NCT03764813|18517688|P3|NOT COMPLETED|From Enrollment to the Last HbF Test||0
7520327|NCT03764813|18517689|P2|NOT COMPLETED|From Enrollment to the Last HbF Test||0
7520328|NCT03764813|18517690|P1|NOT COMPLETED|From Enrollment to the Last HbF Test||0
7520329|NCT03764813|18517687|P4|COMPLETED|From Enrollment to the Last HbF Test||5
7520330|NCT03764813|18517688|P3|COMPLETED|From Enrollment to the Last HbF Test||4
7520331|NCT03764813|18517689|P2|COMPLETED|From Enrollment to the Last HbF Test||3
7520332|NCT03764813|18517690|P1|COMPLETED|From Enrollment to the Last HbF Test||13
7520333|NCT03764813|18517687|P4|STARTED|From Enrollment to the Last HbF Test|Patients receiving both cord and adult-RBCs before the last HbFtest(age of 36 wk,discharge or death)|5
7520334|NCT03764813|18517688|P3|STARTED|From Enrollment to the Last HbF Test|Patients receiving only adult-RBC before last HbF test (occurring at 36 wks,discharge or death)|4
7520335|NCT03764813|18517689|P2|STARTED|From Enrollment to the Last HbF Test|Patients receiving only cord-RBCs before last HbF test (occurring at 36 wks,discharge or death)|3
7520336|NCT03764813|18517690|P1|STARTED|From Enrollment to the Last HbF Test|Patients receiving no transfusions before last HbF test (occurring at 36 weeks,discharge or death)|13
7520337|NCT03764813|18517687|P4|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
7520338|NCT03764813|18517688|P3|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
7520339|NCT03764813|18517689|P2|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
7520340|NCT03764813|18517690|P1|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
7520341|NCT03764813|18517687|P4|COMPLETED|From Enrollment to the Age of 32 Weeks||4
7520342|NCT03764813|18517688|P3|COMPLETED|From Enrollment to the Age of 32 Weeks||3
7520343|NCT03764813|18517689|P2|COMPLETED|From Enrollment to the Age of 32 Weeks||2
7520344|NCT03764813|18517690|P1|COMPLETED|From Enrollment to the Age of 32 Weeks||14
7520345|NCT03764813|18517687|P4|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving both adult-RBC and cord-RBCs before the age of 32 weeks|4
7520346|NCT03764813|18517688|P3|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only adult-RBC transfusions before the age of 32 weeks|4
7520347|NCT03764813|18517689|P2|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only cord-RBC transfusions before the age of 32 weeks|3
7520348|NCT03764813|18517690|P1|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving no transfusions before the age of 32 weeks|14
7520349|NCT03764449|18517710|P2|NOT COMPLETED|Overall Study||0
7520350|NCT03764449|18517711|P1|NOT COMPLETED|Overall Study||0
7520351|NCT03764449|18517710|P2|COMPLETED|Overall Study||8
7520352|NCT03764449|18517711|P1|COMPLETED|Overall Study||8
7520353|NCT03764449|18517710|P2|STARTED|Overall Study||8
7520354|NCT03764449|18517711|P1|STARTED|Overall Study||8
7520355|NCT03763058|18517801|P1|NOT COMPLETED|Overall Study||2
7520356|NCT03763058|18517801|P1|COMPLETED|Overall Study||18
7520357|NCT03763058|18517801|P1|STARTED|Overall Study||20
7520358|NCT03762668|18517811|P2|NOT COMPLETED|Period 2, Second Week of Wear||0
7520359|NCT03762668|18517812|P1|NOT COMPLETED|Period 2, Second Week of Wear||0
7520360|NCT03762668|18517811|P2|COMPLETED|Period 2, Second Week of Wear||29
7520361|NCT03762668|18517812|P1|COMPLETED|Period 2, Second Week of Wear||30
7520362|NCT03762668|18517811|P2|STARTED|Period 2, Second Week of Wear||29
7520363|NCT03762668|18517812|P1|STARTED|Period 2, Second Week of Wear||30
7520364|NCT03762668|18517811|P2|NOT COMPLETED|Period 1, First Week of Wear||1
7520365|NCT03762668|18517812|P1|NOT COMPLETED|Period 1, First Week of Wear||0
7520366|NCT03762668|18517811|P2|COMPLETED|Period 1, First Week of Wear||29
7520367|NCT03762668|18517812|P1|COMPLETED|Period 1, First Week of Wear||30
7520368|NCT03762668|18517811|P2|STARTED|Period 1, First Week of Wear||30
7520369|NCT03762668|18517812|P1|STARTED|Period 1, First Week of Wear||30
7520370|NCT03762200|18517818|P1|NOT COMPLETED|Overall Study||0
7520371|NCT03762200|18517818|P1|COMPLETED|Overall Study|Completed Primary Endpoint|103
7520372|NCT03762200|18517818|P1|STARTED|Overall Study||103
7520373|NCT03761368|18517824|P2|NOT COMPLETED|Overall Study||0
7520374|NCT03761368|18517825|P1|NOT COMPLETED|Overall Study||0
7520375|NCT03761368|18517824|P2|COMPLETED|Overall Study||51
7520376|NCT03761368|18517825|P1|COMPLETED|Overall Study||50
7520377|NCT03761368|18517824|P2|STARTED|Overall Study||51
7520378|NCT03761368|18517825|P1|STARTED|Overall Study||50
7520379|NCT03760640|18517839|P2|NOT COMPLETED|Period 2||0
7520380|NCT03760640|18517840|P1|NOT COMPLETED|Period 2||0
7520381|NCT03760640|18517839|P2|COMPLETED|Period 2||22
7520382|NCT03760640|18517840|P1|COMPLETED|Period 2||20
7520383|NCT03760640|18517839|P2|STARTED|Period 2||22
7520384|NCT03760640|18517840|P1|STARTED|Period 2||20
7520385|NCT03760640|18517839|P2|NOT COMPLETED|Period 1||0
7520386|NCT03760640|18517840|P1|NOT COMPLETED|Period 1||0
7520387|NCT03760640|18517839|P2|COMPLETED|Period 1||22
7520388|NCT03760640|18517840|P1|COMPLETED|Period 1||20
7520389|NCT03760640|18517839|P2|Received at Least 1 Dose of Study Drug|Period 1||22
7520390|NCT03760640|18517840|P1|Received at Least 1 Dose of Study Drug|Period 1||20
7520391|NCT03760640|18517839|P2|STARTED|Period 1||22
7520392|NCT03760640|18517840|P1|STARTED|Period 1||20
7520393|NCT03760510|18517858|P2|NOT COMPLETED|Overall Study||97
7520394|NCT03760510|18517859|P1|NOT COMPLETED|Overall Study||105
7520395|NCT03760510|18517858|P2|COMPLETED|Overall Study||153
7520396|NCT03760510|18517859|P1|COMPLETED|Overall Study||145
7520397|NCT03760510|18517858|P2|STARTED|Overall Study||250
7520398|NCT03760510|18517859|P1|STARTED|Overall Study||250
7520399|NCT03760250|18517871|P1|NOT COMPLETED|Overall Study||2
7520400|NCT03760250|18517871|P1|COMPLETED|Overall Study||4
7520401|NCT03760250|18517871|P1|STARTED|Overall Study||6
7520402|NCT03760146|18517882|P6|NOT COMPLETED|Overall Study||8
7520403|NCT03760146|18517883|P5|NOT COMPLETED|Overall Study||17
7520404|NCT03760146|18517884|P4|NOT COMPLETED|Overall Study||2
7520405|NCT03760146|18517885|P3|NOT COMPLETED|Overall Study||11
7520406|NCT03760146|18517886|P2|NOT COMPLETED|Overall Study||78
7520407|NCT03760146|18517887|P1|NOT COMPLETED|Overall Study||96
7520408|NCT03760146|18517882|P6|COMPLETED|Overall Study||104
7520409|NCT03760146|18517883|P5|COMPLETED|Overall Study||319
7520410|NCT03760146|18517884|P4|COMPLETED|Overall Study||109
7520411|NCT03760146|18517885|P3|COMPLETED|Overall Study||323
7520412|NCT03760146|18517886|P2|COMPLETED|Overall Study||1417
7520413|NCT03760146|18517887|P1|COMPLETED|Overall Study||1418
7520414|NCT03760146|18517882|P6|Evaluable-20 Immunogenicity Population|Overall Study||0
7520415|NCT03760146|18517883|P5|Evaluable-20 Immunogenicity Population|Overall Study||317
7520416|NCT03760146|18517884|P4|Evaluable-20 Immunogenicity Population|Overall Study||0
7520417|NCT03760146|18517885|P3|Evaluable-20 Immunogenicity Population|Overall Study||321
7520418|NCT03760146|18517886|P2|Evaluable-20 Immunogenicity Population|Overall Study||0
7520419|NCT03760146|18517887|P1|Evaluable-20 Immunogenicity Population|Overall Study|Only for 60-64 years of age.|946
7520420|NCT03760146|18517882|P6|Safety Population|Overall Study||112
7520421|NCT03760146|18517883|P5|Safety Population|Overall Study||335
7520422|NCT03760146|18517884|P4|Safety Population|Overall Study||111
7520423|NCT03760146|18517885|P3|Safety Population|Overall Study||334
7520424|NCT03760146|18517886|P2|Safety Population|Overall Study||1490
7520425|NCT03760146|18517887|P1|Safety Population|Overall Study||1507
7520426|NCT03760146|18517882|P6|Vaccination 2|Overall Study||0
7520427|NCT03760146|18517883|P5|Vaccination 2|Overall Study||0
7520428|NCT03760146|18517884|P4|Vaccination 2|Overall Study||0
7520429|NCT03760146|18517885|P3|Vaccination 2|Overall Study||0
7520430|NCT03760146|18517886|P2|Vaccination 2|Overall Study||1446
7520431|NCT03760146|18517887|P1|Vaccination 2|Overall Study||1461
7520432|NCT03760146|18517882|P6|Vaccination 1|Overall Study||112
7520433|NCT03760146|18517883|P5|Vaccination 1|Overall Study||335
7520434|NCT03760146|18517884|P4|Vaccination 1|Overall Study||111
7520435|NCT03760146|18517885|P3|Vaccination 1|Overall Study||334
7520436|NCT03760146|18517886|P2|Vaccination 1|Overall Study||1490
7520437|NCT03760146|18517887|P1|Vaccination 1|Overall Study||1507
7520438|NCT03760146|18517882|P6|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
7520439|NCT03760146|18517883|P5|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
7520440|NCT03760146|18517884|P4|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
7520441|NCT03760146|18517885|P3|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
7520442|NCT03760146|18517886|P2|Evaluable 7-Additional Immunogenicity Population|Overall Study||1383
7520443|NCT03760146|18517887|P1|Evaluable 7-Additional Immunogenicity Population|Overall Study||1433
7520444|NCT03760146|18517882|P6|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
7520445|NCT03760146|18517883|P5|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
7520446|NCT03760146|18517884|P4|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
7520447|NCT03760146|18517885|P3|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
7520448|NCT03760146|18517886|P2|Evaluable 13-Matched Immunogenicity Population|Overall Study||1420
7520449|NCT03760146|18517887|P1|Evaluable 13-Matched Immunogenicity Population|Overall Study||1435
7520450|NCT03760146|18517882|P6|STARTED|Overall Study||112
7520451|NCT03760146|18517883|P5|STARTED|Overall Study||336
7520452|NCT03760146|18517884|P4|STARTED|Overall Study||111
7520453|NCT03760146|18517885|P3|STARTED|Overall Study||334
7520454|NCT03760146|18517886|P2|STARTED|Overall Study||1495
7520455|NCT03760146|18517887|P1|STARTED|Overall Study||1514
7520456|NCT03759600|18517951|P1|NOT COMPLETED|Overall Study||20
7520457|NCT03759600|18517951|P1|COMPLETED|Overall Study||0
7520458|NCT03759600|18517951|P1|STARTED|Overall Study||20
7520459|NCT03759587|18517965|P1|NOT COMPLETED|Overall Study||19
7520460|NCT03759587|18517965|P1|COMPLETED|Overall Study||0
7520461|NCT03759587|18517965|P1|STARTED|Overall Study||19
7520462|NCT03759340|18517978|P1|NOT COMPLETED|Overall Study||56
7520463|NCT03759340|18517978|P1|COMPLETED|Overall Study||0
7520464|NCT03759340|18517978|P1|STARTED|Overall Study||56
7520465|NCT03758365|18517987|P1|NOT COMPLETED|Overall Study||0
7520466|NCT03758365|18517987|P1|COMPLETED|Overall Study||36
7520467|NCT03758365|18517987|P1|Vehicle Cream|Overall Study||36
7520468|NCT03758365|18517987|P1|Desonide 0.05% Cream|Overall Study||36
7520469|NCT03758365|18517987|P1|Hydrocortisone Butyrate 0.1% Cream|Overall Study||36
7520470|NCT03758365|18517987|P1|Triamcinolone Acetonide 0,1% Cream|Overall Study||36
7520471|NCT03758365|18517987|P1|Betamethasone Dipropionate 0.05% Cream|Overall Study||36
7520472|NCT03758365|18517987|P1|Clobetasol Propionate 0.05% Lotion|Overall Study||36
7520473|NCT03758365|18517987|P1|MC2-01 Cream|Overall Study||36
7520474|NCT03758365|18517987|P1|STARTED|Overall Study||36
7520475|NCT03757988|18517998|P1|NOT COMPLETED|Overall Study||1
7520476|NCT03757988|18517998|P1|COMPLETED|Overall Study||16
7520477|NCT03757988|18517998|P1|STARTED|Overall Study||17
7520478|NCT03757234|18518021|P5|NOT COMPLETED|Overall Study||4
7520479|NCT03757234|18518022|P4|NOT COMPLETED|Overall Study||1
7520480|NCT03757234|18518023|P3|NOT COMPLETED|Overall Study||0
7520481|NCT03757234|18518024|P2|NOT COMPLETED|Overall Study||2
7520482|NCT03757234|18518025|P1|NOT COMPLETED|Overall Study||3
7520483|NCT03757234|18518021|P5|COMPLETED|Overall Study||70
7520484|NCT03757234|18518022|P4|COMPLETED|Overall Study||16
7520485|NCT03757234|18518023|P3|COMPLETED|Overall Study||17
7520486|NCT03757234|18518024|P2|COMPLETED|Overall Study||16
7520487|NCT03757234|18518025|P1|COMPLETED|Overall Study||72
7520488|NCT03757234|18518021|P5|Completed PTE Visit|Overall Study||71
7520489|NCT03757234|18518022|P4|Completed PTE Visit|Overall Study||16
7520490|NCT03757234|18518023|P3|Completed PTE Visit|Overall Study||17
7520491|NCT03757234|18518024|P2|Completed PTE Visit|Overall Study||16
7520492|NCT03757234|18518025|P1|Completed PTE Visit|Overall Study||72
7520493|NCT03757234|18518021|P5|STARTED|Overall Study||74
7520494|NCT03757234|18518022|P4|STARTED|Overall Study||17
7520495|NCT03757234|18518023|P3|STARTED|Overall Study||17
7520496|NCT03757234|18518024|P2|STARTED|Overall Study||18
7520497|NCT03757234|18518025|P1|STARTED|Overall Study||75
7520498|NCT03757039|18518061|P2|NOT COMPLETED|Overall Study||0
7520499|NCT03757039|18518062|P1|NOT COMPLETED|Overall Study||0
7520500|NCT03757039|18518061|P2|COMPLETED|Overall Study||9
7520501|NCT03757039|18518062|P1|COMPLETED|Overall Study||32
7520502|NCT03757039|18518061|P2|DACP MF|Overall Study||0
7520503|NCT03757039|18518062|P1|DACP MF|Overall Study||10
7520504|NCT03757039|18518061|P2|DT1 MF|Overall Study||0
7520505|NCT03757039|18518062|P1|DT1 MF|Overall Study||11
7520506|NCT03757039|18518061|P2|AOHG MF|Overall Study||0
7520507|NCT03757039|18518062|P1|AOHG MF|Overall Study||11
7520508|NCT03757039|18518061|P2|STARTED|Overall Study||9
7520509|NCT03757039|18518062|P1|STARTED|Overall Study||32
7520510|NCT03756506|18518072|P2|NOT COMPLETED|Overall Study||0
7520511|NCT03756506|18518073|P1|NOT COMPLETED|Overall Study||1
7520512|NCT03756506|18518072|P2|COMPLETED|Overall Study||6
7520513|NCT03756506|18518073|P1|COMPLETED|Overall Study||6
7520514|NCT03756506|18518072|P2|STARTED|Overall Study||6
7520515|NCT03756506|18518073|P1|STARTED|Overall Study||7
7520516|NCT03756038|18518083|P2|NOT COMPLETED|Overall Study||0
7520517|NCT03756038|18518084|P1|NOT COMPLETED|Overall Study||0
7520518|NCT03756038|18518083|P2|COMPLETED|Overall Study||0
7520519|NCT03756038|18518084|P1|COMPLETED|Overall Study||1
7520520|NCT03756038|18518083|P2|STARTED|Overall Study||0
7520521|NCT03756038|18518084|P1|STARTED|Overall Study||1
7520522|NCT03755882|18518092|P2|NOT COMPLETED|Period 2||0
7520523|NCT03755882|18518093|P1|NOT COMPLETED|Period 2||0
7520524|NCT03755882|18518092|P2|COMPLETED|Period 2||22
7520525|NCT03755882|18518093|P1|COMPLETED|Period 2||19
7520526|NCT03755882|18518092|P2|STARTED|Period 2||22
7520527|NCT03755882|18518093|P1|STARTED|Period 2||19
7520528|NCT03755882|18518092|P2|NOT COMPLETED|Period 1||0
7520529|NCT03755882|18518093|P1|NOT COMPLETED|Period 1||4
7520530|NCT03755882|18518092|P2|COMPLETED|Period 1||22
7520531|NCT03755882|18518093|P1|COMPLETED|Period 1||19
7520532|NCT03755882|18518092|P2|STARTED|Period 1||22
7520533|NCT03755882|18518093|P1|STARTED|Period 1||23
7520534|NCT03754556|18518099|P1|NOT COMPLETED|Overall Study||0
7520535|NCT03754556|18518099|P1|COMPLETED|Overall Study||326658
7520536|NCT03754556|18518099|P1|STARTED|Overall Study||326658
7520537|NCT03753113|18518143|P2|NOT COMPLETED|Overall Study||0
7520538|NCT03753113|18518144|P1|NOT COMPLETED|Overall Study||0
7520539|NCT03753113|18518143|P2|COMPLETED|Overall Study||12
7520540|NCT03753113|18518144|P1|COMPLETED|Overall Study||12
7520541|NCT03753113|18518143|P2|STARTED|Overall Study||12
7520542|NCT03753113|18518144|P1|STARTED|Overall Study||12
7520543|NCT03752567|18518154|P1|NOT COMPLETED|Overall Study||0
7520544|NCT03752567|18518154|P1|COMPLETED|Overall Study||40
7520545|NCT03752567|18518154|P1|STARTED|Overall Study||40
7520546|NCT03752528|18518163|P1|NOT COMPLETED|Part B||4
7520547|NCT03752528|18518163|P1|COMPLETED|Part B||20
7520548|NCT03752528|18518163|P1|STARTED|Part B||24
7520549|NCT03752528|18518163|P1|NOT COMPLETED|Part A||2
7520550|NCT03752528|18518163|P1|COMPLETED|Part A||51
7520551|NCT03752528|18518163|P1|STARTED|Part A||53
7520552|NCT03752151|18518182|P1|NOT COMPLETED|Overall Study||2
7520553|NCT03752151|18518182|P1|COMPLETED|Overall Study||75
7520554|NCT03752151|18518182|P1|STARTED|Overall Study||77
7520555|NCT03751280|18518190|P2|NOT COMPLETED|Overall Study||12
7520556|NCT03751280|18518191|P1|NOT COMPLETED|Overall Study||8
7520557|NCT03751280|18518190|P2|COMPLETED|Overall Study||44
7520558|NCT03751280|18518191|P1|COMPLETED|Overall Study||48
7520559|NCT03751280|18518190|P2|Safety Set (SAF)|Overall Study||55
7520560|NCT03751280|18518191|P1|Safety Set (SAF)|Overall Study||55
7520561|NCT03751280|18518190|P2|Full Analysis Set (FAS)|Overall Study||55
7520562|NCT03751280|18518191|P1|Full Analysis Set (FAS)|Overall Study||54
7520563|NCT03751280|18518190|P2|STARTED|Overall Study||56
7520564|NCT03751280|18518191|P1|STARTED|Overall Study||56
7520565|NCT03751020|18518227|P3|NOT COMPLETED|Overall Study||10
7520566|NCT03751020|18518228|P2|NOT COMPLETED|Overall Study||4
7520567|NCT03751020|18518229|P1|NOT COMPLETED|Overall Study||9
7520568|NCT03751020|18518227|P3|COMPLETED|Overall Study||26
7520569|NCT03751020|18518228|P2|COMPLETED|Overall Study||32
7520570|NCT03751020|18518229|P1|COMPLETED|Overall Study||27
7520571|NCT03751020|18518227|P3|3 Month Follow Up|Overall Study||26
7520572|NCT03751020|18518228|P2|3 Month Follow Up|Overall Study||32
7520573|NCT03751020|18518229|P1|3 Month Follow Up|Overall Study||27
7520574|NCT03751020|18518227|P3|Post Intervention|Overall Study||30
7520575|NCT03751020|18518228|P2|Post Intervention|Overall Study||33
7520576|NCT03751020|18518229|P1|Post Intervention|Overall Study||33
7520577|NCT03751020|18518227|P3|STARTED|Overall Study||36
7520578|NCT03751020|18518228|P2|STARTED|Overall Study||36
7520579|NCT03751020|18518229|P1|STARTED|Overall Study||36
7520580|NCT03748979|18518335|P11|NOT COMPLETED|Overall Study||0
7520581|NCT03748979|18518336|P10|NOT COMPLETED|Overall Study||0
7520582|NCT03748979|18518337|P9|NOT COMPLETED|Overall Study||0
7520583|NCT03748979|18518338|P8|NOT COMPLETED|Overall Study||0
7520584|NCT03748979|18518339|P7|NOT COMPLETED|Overall Study||0
7520585|NCT03748979|18518340|P6|NOT COMPLETED|Overall Study||0
7520586|NCT03748979|18518341|P5|NOT COMPLETED|Overall Study||0
7520587|NCT03748979|18518342|P4|NOT COMPLETED|Overall Study||0
7520588|NCT03748979|18518343|P3|NOT COMPLETED|Overall Study||0
7520589|NCT03748979|18518344|P2|NOT COMPLETED|Overall Study||0
7520590|NCT03748979|18518345|P1|NOT COMPLETED|Overall Study||0
7520591|NCT03748979|18518335|P11|COMPLETED|Overall Study||6
7520592|NCT03748979|18518336|P10|COMPLETED|Overall Study||5
7520593|NCT03748979|18518337|P9|COMPLETED|Overall Study||4
7520594|NCT03748979|18518338|P8|COMPLETED|Overall Study||5
7520595|NCT03748979|18518339|P7|COMPLETED|Overall Study||5
7520596|NCT03748979|18518340|P6|COMPLETED|Overall Study||4
7520597|NCT03748979|18518341|P5|COMPLETED|Overall Study||4
7520598|NCT03748979|18518342|P4|COMPLETED|Overall Study||6
7520599|NCT03748979|18518343|P3|COMPLETED|Overall Study||6
7520600|NCT03748979|18518344|P2|COMPLETED|Overall Study||6
7520601|NCT03748979|18518345|P1|COMPLETED|Overall Study||6
7520602|NCT03748979|18518335|P11|STARTED|Overall Study||6
7520603|NCT03748979|18518336|P10|STARTED|Overall Study||5
7520604|NCT03748979|18518337|P9|STARTED|Overall Study||4
7520605|NCT03748979|18518338|P8|STARTED|Overall Study||5
7520606|NCT03748979|18518339|P7|STARTED|Overall Study||5
7520607|NCT03748979|18518340|P6|STARTED|Overall Study||4
7520608|NCT03748979|18518341|P5|STARTED|Overall Study||4
7520609|NCT03748979|18518342|P4|STARTED|Overall Study||6
7520610|NCT03748979|18518343|P3|STARTED|Overall Study||6
7520611|NCT03748979|18518344|P2|STARTED|Overall Study||6
7520612|NCT03748979|18518345|P1|STARTED|Overall Study||6
7520613|NCT03748758|18518399|P3|NOT COMPLETED|Overall Study||1
7520614|NCT03748758|18518400|P2|NOT COMPLETED|Overall Study||0
7520615|NCT03748758|18518401|P1|NOT COMPLETED|Overall Study||0
7520616|NCT03748758|18518399|P3|COMPLETED|Overall Study||5
7520617|NCT03748758|18518400|P2|COMPLETED|Overall Study||12
7520618|NCT03748758|18518401|P1|COMPLETED|Overall Study||12
7520619|NCT03748758|18518399|P3|STARTED|Overall Study||6
7520620|NCT03748758|18518400|P2|STARTED|Overall Study||12
7520621|NCT03748758|18518401|P1|STARTED|Overall Study||12
7520622|NCT03746405|18518455|P2|NOT COMPLETED|Overall Study||2
7520623|NCT03746405|18518456|P1|NOT COMPLETED|Overall Study||3
7520624|NCT03746405|18518455|P2|COMPLETED|Overall Study||6
7520625|NCT03746405|18518456|P1|COMPLETED|Overall Study||7
7520626|NCT03746405|18518455|P2|STARTED|Overall Study||8
7520627|NCT03746405|18518456|P1|STARTED|Overall Study||10
7520628|NCT03745937|18518466|P4|NOT COMPLETED|Overall Study||2
7520629|NCT03745937|18518467|P3|NOT COMPLETED|Overall Study||0
7520630|NCT03745937|18518468|P2|NOT COMPLETED|Overall Study||1
7520631|NCT03745937|18518469|P1|NOT COMPLETED|Overall Study||0
7520632|NCT03745937|18518466|P4|COMPLETED|Overall Study||7
7520633|NCT03745937|18518467|P3|COMPLETED|Overall Study||3
7520634|NCT03745937|18518468|P2|COMPLETED|Overall Study||5
7520635|NCT03745937|18518469|P1|COMPLETED|Overall Study||2
7520636|NCT03745937|18518466|P4|STARTED|Overall Study||9
7520637|NCT03745937|18518467|P3|STARTED|Overall Study||3
7520638|NCT03745937|18518468|P2|STARTED|Overall Study||6
7520639|NCT03745937|18518469|P1|STARTED|Overall Study||2
7520640|NCT03745222|18518583|P3|NOT COMPLETED|Overall Study||0
7520641|NCT03745222|18518584|P2|NOT COMPLETED|Overall Study||1
7520642|NCT03745222|18518585|P1|NOT COMPLETED|Overall Study||0
7520643|NCT03745222|18518583|P3|COMPLETED|Overall Study||0
7520644|NCT03745222|18518584|P2|COMPLETED|Overall Study||0
7520645|NCT03745222|18518585|P1|COMPLETED|Overall Study||0
7520646|NCT03745222|18518583|P3|STARTED|Overall Study||0
7520647|NCT03745222|18518584|P2|STARTED|Overall Study||1
7520648|NCT03745222|18518585|P1|STARTED|Overall Study||0
7520649|NCT03745092|18518625|P2|NOT COMPLETED|Overall Study||0
7520650|NCT03745092|18518626|P1|NOT COMPLETED|Overall Study||0
7520651|NCT03745092|18518625|P2|COMPLETED|Overall Study||23
7520652|NCT03745092|18518626|P1|COMPLETED|Overall Study||26
7520653|NCT03745092|18518625|P2|STARTED|Overall Study||23
7520654|NCT03745092|18518626|P1|STARTED|Overall Study||26
7520655|NCT03744780|18518642|P1|NOT COMPLETED|Overall Study||0
7520656|NCT03744780|18518642|P1|COMPLETED|Overall Study||32
7520657|NCT03744780|18518642|P1|STARTED|Overall Study||32
7520658|NCT03742973|18518662|P2|NOT COMPLETED|Overall Study||0
7520659|NCT03742973|18518663|P1|NOT COMPLETED|Overall Study||0
7520660|NCT03742973|18518662|P2|COMPLETED|Overall Study||0
7520661|NCT03742973|18518663|P1|COMPLETED|Overall Study||0
7520662|NCT03742973|18518662|P2|STARTED|Overall Study||0
7520663|NCT03742973|18518663|P1|STARTED|Overall Study||0
7520664|NCT03742440|18518674|P1|NOT COMPLETED|Overall Study||0
7520665|NCT03742440|18518674|P1|COMPLETED|Overall Study||40
7520666|NCT03742440|18518674|P1|STARTED|Overall Study||40
7520667|NCT03742271|18518680|P1|NOT COMPLETED|Overall Study||12
7520668|NCT03742271|18518680|P1|COMPLETED|Overall Study||115
7520669|NCT03742271|18518680|P1|STARTED|Overall Study||127
7520670|NCT03742154|18518686|P2|NOT COMPLETED|Overall Study||0
7520671|NCT03742154|18518687|P1|NOT COMPLETED|Overall Study||0
7520672|NCT03742154|18518686|P2|COMPLETED|Overall Study||49
7520673|NCT03742154|18518687|P1|COMPLETED|Overall Study||50
7520674|NCT03742154|18518686|P2|STARTED|Overall Study||49
7520675|NCT03742154|18518687|P1|STARTED|Overall Study||50
7520676|NCT03741725|18518697|P3|NOT COMPLETED|Overall Study||0
7520677|NCT03741725|18518698|P2|NOT COMPLETED|Overall Study||0
7520678|NCT03741725|18518699|P1|NOT COMPLETED|Overall Study||0
7520679|NCT03741725|18518697|P3|COMPLETED|Overall Study||100
7520680|NCT03741725|18518698|P2|COMPLETED|Overall Study||100
7520681|NCT03741725|18518699|P1|COMPLETED|Overall Study||101
7520682|NCT03741725|18518697|P3|STARTED|Overall Study||100
7520683|NCT03741725|18518698|P2|STARTED|Overall Study||100
7520684|NCT03741725|18518699|P1|STARTED|Overall Study||101
7520685|NCT03741062|18518730|P2|NOT COMPLETED|Overall Study||0
7520686|NCT03741062|18518731|P1|NOT COMPLETED|Overall Study||1
7520687|NCT03741062|18518730|P2|COMPLETED|Overall Study||6
7520688|NCT03741062|18518731|P1|COMPLETED|Overall Study||4
7520689|NCT03741062|18518730|P2|STARTED|Overall Study||6
7520690|NCT03741062|18518731|P1|STARTED|Overall Study||5
7520691|NCT03740659|18518744|P3|NOT COMPLETED|Overall Study||0
7520692|NCT03740659|18518745|P2|NOT COMPLETED|Overall Study||0
7520693|NCT03740659|18518746|P1|NOT COMPLETED|Overall Study||0
7520694|NCT03740659|18518744|P3|COMPLETED|Overall Study||41
7520695|NCT03740659|18518745|P2|COMPLETED|Overall Study||42
7520696|NCT03740659|18518746|P1|COMPLETED|Overall Study||42
7520697|NCT03740659|18518744|P3|STARTED|Overall Study||41
7520698|NCT03740659|18518745|P2|STARTED|Overall Study||42
7520699|NCT03740659|18518746|P1|STARTED|Overall Study||42
7520700|NCT03740152|18518760|P1|NOT COMPLETED|Overall Study||0
7520701|NCT03740152|18518760|P1|COMPLETED|Overall Study||10
7520702|NCT03740152|18518760|P1|STARTED|Overall Study||10
7520703|NCT03739866|18518774|P8|NOT COMPLETED|Overall Study||0
7520704|NCT03739866|18518775|P7|NOT COMPLETED|Overall Study||0
7520705|NCT03739866|18518776|P6|NOT COMPLETED|Overall Study||0
7520706|NCT03739866|18518777|P5|NOT COMPLETED|Overall Study||1
7520707|NCT03739866|18518778|P4|NOT COMPLETED|Overall Study||1
7520708|NCT03739866|18518779|P3|NOT COMPLETED|Overall Study||1
7520709|NCT03739866|18518780|P2|NOT COMPLETED|Overall Study||0
7520710|NCT03739866|18518781|P1|NOT COMPLETED|Overall Study||0
7520711|NCT03739866|18518774|P8|COMPLETED|Overall Study||5
7520712|NCT03739866|18518775|P7|COMPLETED|Overall Study||7
7520713|NCT03739866|18518776|P6|COMPLETED|Overall Study||10
7520714|NCT03739866|18518777|P5|COMPLETED|Overall Study||5
7520715|NCT03739866|18518778|P4|COMPLETED|Overall Study||5
7520716|NCT03739866|18518779|P3|COMPLETED|Overall Study||6
7520717|NCT03739866|18518780|P2|COMPLETED|Overall Study||6
7520718|NCT03739866|18518781|P1|COMPLETED|Overall Study||6
7520719|NCT03739866|18518774|P8|STARTED|Overall Study||5
7520720|NCT03739866|18518775|P7|STARTED|Overall Study||7
7520721|NCT03739866|18518776|P6|STARTED|Overall Study||10
7520722|NCT03739866|18518777|P5|STARTED|Overall Study||6
7520723|NCT03739866|18518778|P4|STARTED|Overall Study||6
7520724|NCT03739866|18518779|P3|STARTED|Overall Study||7
7520725|NCT03739866|18518780|P2|STARTED|Overall Study||6
7520726|NCT03739866|18518781|P1|STARTED|Overall Study||6
7520727|NCT03739528|18518850|P2|NOT COMPLETED|Overall Study||17
7520728|NCT03739528|18518851|P1|NOT COMPLETED|Overall Study||15
7520729|NCT03739528|18518850|P2|COMPLETED|Overall Study||388
7520730|NCT03739528|18518851|P1|COMPLETED|Overall Study||388
7520731|NCT03739528|18518850|P2|Received at Least One Treatment|Overall Study||393
7520732|NCT03739528|18518851|P1|Received at Least One Treatment|Overall Study||395
7520733|NCT03739528|18518850|P2|STARTED|Overall Study||405
7520734|NCT03739528|18518851|P1|STARTED|Overall Study||403
7520735|NCT03739242|18518883|P2|NOT COMPLETED|Overall Study||2
7520736|NCT03739242|18518884|P1|NOT COMPLETED|Overall Study||1
7520737|NCT03739242|18518883|P2|COMPLETED|Overall Study||42
7520738|NCT03739242|18518884|P1|COMPLETED|Overall Study||43
7520739|NCT03739242|18518883|P2|STARTED|Overall Study||44
7520740|NCT03739242|18518884|P1|STARTED|Overall Study||44
7520741|NCT03738865|18518922|P2|NOT COMPLETED|Overall Study||4
7520742|NCT03738865|18518923|P1|NOT COMPLETED|Overall Study||5
7520743|NCT03738865|18518922|P2|COMPLETED|Overall Study||62
7520744|NCT03738865|18518923|P1|COMPLETED|Overall Study||61
7520745|NCT03738865|18518922|P2|STARTED|Overall Study||66
7520746|NCT03738865|18518923|P1|STARTED|Overall Study||66
7520747|NCT03738475|18518939|P2|NOT COMPLETED|Overall Study||0
7520748|NCT03738475|18518940|P1|NOT COMPLETED|Overall Study||1
7520749|NCT03738475|18518939|P2|COMPLETED|Overall Study||18
7520750|NCT03738475|18518940|P1|COMPLETED|Overall Study||15
7520751|NCT03738475|18518939|P2|STARTED|Overall Study||18
7520752|NCT03738475|18518940|P1|STARTED|Overall Study||16
7520753|NCT03738020|18518977|P1|NOT COMPLETED|Overall Study||1
7520754|NCT03738020|18518977|P1|COMPLETED|Overall Study||57
7520755|NCT03738020|18518977|P1|STARTED|Overall Study||58
7520756|NCT03736031|18518986|P2|NOT COMPLETED|Overall Study||6
7520757|NCT03736031|18518987|P1|NOT COMPLETED|Overall Study||32
7520758|NCT03736031|18518986|P2|COMPLETED|Overall Study||40
7520759|NCT03736031|18518987|P1|COMPLETED|Overall Study||24
7520760|NCT03736031|18518986|P2|STARTED|Overall Study||46
7520761|NCT03736031|18518987|P1|STARTED|Overall Study||56
7520762|NCT03735862|18518999|P1|NOT COMPLETED|Overall Study||0
7520763|NCT03735862|18518999|P1|COMPLETED|Overall Study||73
7520764|NCT03735862|18518999|P1|STARTED|Overall Study||73
7520765|NCT03734822|18519007|P1|NOT COMPLETED|Overall Study||0
7520766|NCT03734822|18519007|P1|COMPLETED|Overall Study||47
7520767|NCT03734822|18519007|P1|STARTED|Overall Study||47
7520768|NCT03733899|18519011|P6|NOT COMPLETED|Period 3||0
7520769|NCT03733899|18519012|P5|NOT COMPLETED|Period 3||0
7520770|NCT03733899|18519013|P4|NOT COMPLETED|Period 3||0
7520771|NCT03733899|18519014|P3|NOT COMPLETED|Period 3||0
7520772|NCT03733899|18519015|P2|NOT COMPLETED|Period 3||0
7520773|NCT03733899|18519016|P1|NOT COMPLETED|Period 3||1
7520774|NCT03733899|18519011|P6|COMPLETED|Period 3||2
7520775|NCT03733899|18519012|P5|COMPLETED|Period 3||4
7520776|NCT03733899|18519013|P4|COMPLETED|Period 3||4
7520777|NCT03733899|18519014|P3|COMPLETED|Period 3||3
7520778|NCT03733899|18519015|P2|COMPLETED|Period 3||2
7520779|NCT03733899|18519016|P1|COMPLETED|Period 3||2
7520780|NCT03733899|18519011|P6|STARTED|Period 3||2
7520781|NCT03733899|18519012|P5|STARTED|Period 3||4
7520782|NCT03733899|18519013|P4|STARTED|Period 3||4
7520783|NCT03733899|18519014|P3|STARTED|Period 3||3
7520784|NCT03733899|18519015|P2|STARTED|Period 3||2
7520785|NCT03733899|18519016|P1|STARTED|Period 3||3
7520786|NCT03733899|18519011|P6|NOT COMPLETED|Period 2||0
7520787|NCT03733899|18519012|P5|NOT COMPLETED|Period 2||0
7520788|NCT03733899|18519013|P4|NOT COMPLETED|Period 2||0
7520789|NCT03733899|18519014|P3|NOT COMPLETED|Period 2||0
7520790|NCT03733899|18519015|P2|NOT COMPLETED|Period 2||1
7520791|NCT03733899|18519016|P1|NOT COMPLETED|Period 2||0
7520792|NCT03733899|18519011|P6|COMPLETED|Period 2||2
7520793|NCT03733899|18519012|P5|COMPLETED|Period 2||4
7520794|NCT03733899|18519013|P4|COMPLETED|Period 2||4
7520795|NCT03733899|18519014|P3|COMPLETED|Period 2||3
7520796|NCT03733899|18519015|P2|COMPLETED|Period 2||2
7520797|NCT03733899|18519016|P1|COMPLETED|Period 2||3
7520798|NCT03733899|18519011|P6|STARTED|Period 2||2
7520799|NCT03733899|18519012|P5|STARTED|Period 2||4
7520800|NCT03733899|18519013|P4|STARTED|Period 2||4
7520801|NCT03733899|18519014|P3|STARTED|Period 2||3
7520802|NCT03733899|18519015|P2|STARTED|Period 2||3
7520803|NCT03733899|18519016|P1|STARTED|Period 2||3
7520804|NCT03733899|18519011|P6|NOT COMPLETED|Period 1||1
7520805|NCT03733899|18519012|P5|NOT COMPLETED|Period 1||0
7520806|NCT03733899|18519013|P4|NOT COMPLETED|Period 1||0
7520807|NCT03733899|18519014|P3|NOT COMPLETED|Period 1||0
7520808|NCT03733899|18519015|P2|NOT COMPLETED|Period 1||0
7520809|NCT03733899|18519016|P1|NOT COMPLETED|Period 1||0
7520810|NCT03733899|18519011|P6|COMPLETED|Period 1||2
7520811|NCT03733899|18519012|P5|COMPLETED|Period 1||4
7520812|NCT03733899|18519013|P4|COMPLETED|Period 1||4
7520813|NCT03733899|18519014|P3|COMPLETED|Period 1||3
7520814|NCT03733899|18519015|P2|COMPLETED|Period 1||3
7520815|NCT03733899|18519016|P1|COMPLETED|Period 1||3
7520816|NCT03733899|18519011|P6|STARTED|Period 1||3
7520817|NCT03733899|18519012|P5|STARTED|Period 1||4
7520818|NCT03733899|18519013|P4|STARTED|Period 1||4
7520819|NCT03733899|18519014|P3|STARTED|Period 1||3
7520820|NCT03733899|18519015|P2|STARTED|Period 1||3
7520821|NCT03733899|18519016|P1|STARTED|Period 1||3
7520822|NCT03733470|18519044|P2|NOT COMPLETED|Overall Study||1
7520823|NCT03733470|18519045|P1|NOT COMPLETED|Overall Study||1
7520824|NCT03733470|18519044|P2|COMPLETED|Overall Study||10
7520825|NCT03733470|18519045|P1|COMPLETED|Overall Study||7
7520826|NCT03733470|18519044|P2|STARTED|Overall Study||11
7520827|NCT03733470|18519045|P1|STARTED|Overall Study||8
7520828|NCT03733301|18519054|P3|NOT COMPLETED|Overall Study||4
7520829|NCT03733301|18519055|P2|NOT COMPLETED|Overall Study||9
7520830|NCT03733301|18519056|P1|NOT COMPLETED|Overall Study||7
7520831|NCT03733301|18519054|P3|COMPLETED|Overall Study||107
7520832|NCT03733301|18519055|P2|COMPLETED|Overall Study||100
7520833|NCT03733301|18519056|P1|COMPLETED|Overall Study||102
7520834|NCT03733301|18519054|P3|Received One Dose of Study Drug|Overall Study||111
7520835|NCT03733301|18519055|P2|Received One Dose of Study Drug|Overall Study||109
7520836|NCT03733301|18519056|P1|Received One Dose of Study Drug|Overall Study||108
7520837|NCT03733301|18519054|P3|STARTED|Overall Study||111
7520838|NCT03733301|18519055|P2|STARTED|Overall Study||109
7520839|NCT03733301|18519056|P1|STARTED|Overall Study||109
7520840|NCT03730116|18519136|P1|NOT COMPLETED|3 Month After Inclusion||17
7520841|NCT03730116|18519136|P1|COMPLETED|3 Month After Inclusion||1892
7520842|NCT03730116|18519136|P1|3 Month After Inclusion|3 Month After Inclusion||1909
7520843|NCT03730116|18519136|P1|STARTED|3 Month After Inclusion||1909
7520844|NCT03730116|18519136|P1|NOT COMPLETED|1 Month After Inclusion||0
7520845|NCT03730116|18519136|P1|COMPLETED|1 Month After Inclusion||1909
7520846|NCT03730116|18519136|P1|1 Month After Inclusion|1 Month After Inclusion||1909
7520847|NCT03730116|18519136|P1|STARTED|1 Month After Inclusion||1909
7520848|NCT03730116|18519136|P1|NOT COMPLETED|Inclusion||0
7520849|NCT03730116|18519136|P1|COMPLETED|Inclusion||1909
7520850|NCT03730116|18519136|P1|FVFP|Inclusion||1909
7520851|NCT03730116|18519136|P1|STARTED|Inclusion|Planned to include 1920 pts, included 1909|1909
7520852|NCT03730103|18519147|P2|NOT COMPLETED|Overall Study||5
7520853|NCT03730103|18519148|P1|NOT COMPLETED|Overall Study||0
7520854|NCT03730103|18519147|P2|COMPLETED|Overall Study||47
7520855|NCT03730103|18519148|P1|COMPLETED|Overall Study||61
7520856|NCT03730103|18519147|P2|STARTED|Overall Study||52
7520857|NCT03730103|18519148|P1|STARTED|Overall Study||61
7520858|NCT03729960|18519160|P1|NOT COMPLETED|Overall Study||0
7520859|NCT03729960|18519160|P1|COMPLETED|Overall Study||20
7520860|NCT03729960|18519160|P1|STARTED|Overall Study||20
7520861|NCT03728790|18519171|P2|NOT COMPLETED|Overall Study||0
7520862|NCT03728790|18519172|P1|NOT COMPLETED|Overall Study||0
7520863|NCT03728790|18519171|P2|COMPLETED|Overall Study||101
7520864|NCT03728790|18519172|P1|COMPLETED|Overall Study||112
7520865|NCT03728790|18519171|P2|STARTED|Overall Study||101
7520866|NCT03728790|18519172|P1|STARTED|Overall Study||112
7520867|NCT03728140|18519196|P2|NOT COMPLETED|Overall Study||7
7520868|NCT03728140|18519197|P1|NOT COMPLETED|Overall Study||10
7520869|NCT03728140|18519196|P2|COMPLETED|Overall Study||168
7520870|NCT03728140|18519197|P1|COMPLETED|Overall Study||150
7520871|NCT03728140|18519196|P2|STARTED|Overall Study|embryo transfer with new culture medium|175
7520872|NCT03728140|18519197|P1|STARTED|Overall Study|embryo transfer with self-spent culture medium|160
7520873|NCT03727854|18519207|P2|NOT COMPLETED|Overall Study||0
7520874|NCT03727854|18519208|P1|NOT COMPLETED|Overall Study||0
7520875|NCT03727854|18519207|P2|COMPLETED|Overall Study||20
7520876|NCT03727854|18519208|P1|COMPLETED|Overall Study||20
7520877|NCT03727854|18519207|P2|STARTED|Overall Study||20
7520878|NCT03727854|18519208|P1|STARTED|Overall Study||20
7520879|NCT03727425|18519230|P1|NOT COMPLETED|Overall Study||0
7520880|NCT03727425|18519230|P1|COMPLETED|Overall Study||55
7520881|NCT03727425|18519230|P1|STARTED|Overall Study||55
7520882|NCT03727373|18519239|P1|NOT COMPLETED|Overall Study||0
7520883|NCT03727373|18519239|P1|COMPLETED|Overall Study||8
7520884|NCT03727373|18519239|P1|STARTED|Overall Study||8
7520885|NCT03726996|18519250|P1|NOT COMPLETED|Overall Study||4
7520886|NCT03726996|18519250|P1|COMPLETED|Overall Study||0
7520887|NCT03726996|18519250|P1|STARTED|Overall Study||4
7520888|NCT03726164|18519260|P2|NOT COMPLETED|Overall Study||197
7520889|NCT03726164|18519261|P1|NOT COMPLETED|Overall Study||211
7520890|NCT03726164|18519260|P2|COMPLETED|Overall Study||119
7520891|NCT03726164|18519261|P1|COMPLETED|Overall Study||99
7520892|NCT03726164|18519260|P2|STARTED|Overall Study||316
7520893|NCT03726164|18519261|P1|STARTED|Overall Study||310
7520894|NCT03725982|18519269|P2|NOT COMPLETED|Second Intervention||0
7520895|NCT03725982|18519270|P1|NOT COMPLETED|Second Intervention||0
7520896|NCT03725982|18519269|P2|COMPLETED|Second Intervention||17
7520897|NCT03725982|18519270|P1|COMPLETED|Second Intervention||19
7520898|NCT03725982|18519269|P2|STARTED|Second Intervention||17
7520899|NCT03725982|18519270|P1|STARTED|Second Intervention||19
7520900|NCT03725982|18519269|P2|NOT COMPLETED|First Intervention||2
7520901|NCT03725982|18519270|P1|NOT COMPLETED|First Intervention||1
7520902|NCT03725982|18519269|P2|COMPLETED|First Intervention||17
7520903|NCT03725982|18519270|P1|COMPLETED|First Intervention||19
7520904|NCT03725982|18519269|P2|STARTED|First Intervention||19
7520905|NCT03725982|18519270|P1|STARTED|First Intervention||20
7520906|NCT03725098|18519294|P2|NOT COMPLETED|Overall Study||0
7520907|NCT03725098|18519295|P1|NOT COMPLETED|Overall Study||0
7520908|NCT03725098|18519294|P2|COMPLETED|Overall Study||52
7520909|NCT03725098|18519295|P1|COMPLETED|Overall Study||53
7520910|NCT03725098|18519294|P2|STARTED|Overall Study||52
7520911|NCT03725098|18519295|P1|STARTED|Overall Study||53
7520912|NCT03725085|18519303|P1|NOT COMPLETED|Overall Study||2
7520913|NCT03725085|18519303|P1|COMPLETED|Overall Study||550
7520914|NCT03725085|18519303|P1|STARTED|Overall Study||552
7520915|NCT03724981|18519311|P2|NOT COMPLETED|Second Device||0
7520916|NCT03724981|18519312|P1|NOT COMPLETED|Second Device||0
7520917|NCT03724981|18519311|P2|COMPLETED|Second Device||155
7520918|NCT03724981|18519312|P1|COMPLETED|Second Device||155
7520919|NCT03724981|18519311|P2|STARTED|Second Device||155
7520920|NCT03724981|18519312|P1|STARTED|Second Device||155
7520921|NCT03724981|18519311|P2|NOT COMPLETED|First Device||1
7520922|NCT03724981|18519312|P1|NOT COMPLETED|First Device||1
7520923|NCT03724981|18519311|P2|COMPLETED|First Device||155
7520924|NCT03724981|18519312|P1|COMPLETED|First Device||155
7520925|NCT03724981|18519311|P2|STARTED|First Device||156
7520926|NCT03724981|18519312|P1|STARTED|First Device||156
7520927|NCT03724877|18519322|P2|NOT COMPLETED|Overall Study||0
7520928|NCT03724877|18519323|P1|NOT COMPLETED|Overall Study||0
7520929|NCT03724877|18519322|P2|COMPLETED|Overall Study||1932
7520930|NCT03724877|18519323|P1|COMPLETED|Overall Study||6921
7520931|NCT03724877|18519322|P2|STARTED|Overall Study||1932
7520932|NCT03724877|18519323|P1|STARTED|Overall Study||6921
7520933|NCT03724253|18519340|P5|NOT COMPLETED|Overall Study||0
7520934|NCT03724253|18519341|P4|NOT COMPLETED|Overall Study||0
7520935|NCT03724253|18519342|P3|NOT COMPLETED|Overall Study||0
7520936|NCT03724253|18519343|P2|NOT COMPLETED|Overall Study||0
7520937|NCT03724253|18519344|P1|NOT COMPLETED|Overall Study||0
7520938|NCT03724253|18519340|P5|COMPLETED|Overall Study||1
7520939|NCT03724253|18519341|P4|COMPLETED|Overall Study||3
7520940|NCT03724253|18519342|P3|COMPLETED|Overall Study||5
7520941|NCT03724253|18519343|P2|COMPLETED|Overall Study||5
7520942|NCT03724253|18519344|P1|COMPLETED|Overall Study||5
7520943|NCT03724253|18519340|P5|STARTED|Overall Study||1
7520944|NCT03724253|18519341|P4|STARTED|Overall Study||3
7520945|NCT03724253|18519342|P3|STARTED|Overall Study||5
7520946|NCT03724253|18519343|P2|STARTED|Overall Study||5
7520947|NCT03724253|18519344|P1|STARTED|Overall Study||5
7520948|NCT03723980|18519417|P2|NOT COMPLETED|Overall Study||5
7520949|NCT03723980|18519418|P1|NOT COMPLETED|Overall Study||7
7520950|NCT03723980|18519417|P2|COMPLETED|Overall Study||35
7520951|NCT03723980|18519418|P1|COMPLETED|Overall Study||33
7520952|NCT03723980|18519417|P2|STARTED|Overall Study||40
7520953|NCT03723980|18519418|P1|STARTED|Overall Study||40
7520954|NCT03723603|18519434|P1|NOT COMPLETED|Overall Study||3
7520955|NCT03723603|18519434|P1|COMPLETED|Overall Study||5
7520956|NCT03723603|18519434|P1|STARTED|Overall Study||8
7520957|NCT03722810|18519442|P2|NOT COMPLETED|Overall Study||4
7520958|NCT03722810|18519443|P1|NOT COMPLETED|Overall Study||7
7520959|NCT03722810|18519442|P2|COMPLETED|Overall Study||156
7520960|NCT03722810|18519443|P1|COMPLETED|Overall Study||150
7520961|NCT03722810|18519442|P2|STARTED|Overall Study||160
7520962|NCT03722810|18519443|P1|STARTED|Overall Study||157
7520963|NCT03722784|18519458|P2|NOT COMPLETED|Overall Study||2
7520964|NCT03722784|18519459|P1|NOT COMPLETED|Overall Study||2
7520965|NCT03722784|18519458|P2|COMPLETED|Overall Study||28
7520966|NCT03722784|18519459|P1|COMPLETED|Overall Study||56
7520967|NCT03722784|18519458|P2|STARTED|Overall Study||30
7520968|NCT03722784|18519459|P1|STARTED|Overall Study||58
7520969|NCT03722446|18519503|P2|NOT COMPLETED|Overall Study||2
7520970|NCT03722446|18519504|P1|NOT COMPLETED|Overall Study||15
7520971|NCT03722446|18519503|P2|COMPLETED|Overall Study||120
7520972|NCT03722446|18519504|P1|COMPLETED|Overall Study||120
7520973|NCT03722446|18519503|P2|STARTED|Overall Study||122
7520974|NCT03722446|18519504|P1|STARTED|Overall Study||135
7520975|NCT03722264|18519520|P1|NOT COMPLETED|Overall Study||3
7520976|NCT03722264|18519520|P1|COMPLETED|Overall Study||9
7520977|NCT03722264|18519520|P1|STARTED|Overall Study||12
7520978|NCT03722030|18519532|P2|NOT COMPLETED|Overall Study||0
7520979|NCT03722030|18519533|P1|NOT COMPLETED|Overall Study||1
7520980|NCT03722030|18519532|P2|COMPLETED|Overall Study||20
7520981|NCT03722030|18519533|P1|COMPLETED|Overall Study||19
7520982|NCT03722030|18519532|P2|STARTED|Overall Study||20
7520983|NCT03722030|18519533|P1|STARTED|Overall Study||20
7520984|NCT03721549|18519547|P2|NOT COMPLETED|Overall Study||0
7520985|NCT03721549|18519548|P1|NOT COMPLETED|Overall Study||1
7520986|NCT03721549|18519547|P2|COMPLETED|Overall Study||8
7520987|NCT03721549|18519548|P1|COMPLETED|Overall Study||7
7520988|NCT03721549|18519547|P2|STARTED|Overall Study||8
7520989|NCT03721549|18519548|P1|STARTED|Overall Study||8
7520990|NCT03720938|18519558|P2|NOT COMPLETED|Overall Study||623
7520991|NCT03720938|18519559|P1|NOT COMPLETED|Overall Study||189
7520992|NCT03720938|18519558|P2|COMPLETED|Overall Study||53
7520993|NCT03720938|18519559|P1|COMPLETED|Overall Study||53
7520994|NCT03720938|18519558|P2|STARTED|Overall Study||676
7520995|NCT03720938|18519559|P1|STARTED|Overall Study||242
7520996|NCT03720847|18519603|P2|NOT COMPLETED|Condition 2||0
7520997|NCT03720847|18519604|P1|NOT COMPLETED|Condition 2||0
7520998|NCT03720847|18519603|P2|COMPLETED|Condition 2||13
7520999|NCT03720847|18519604|P1|COMPLETED|Condition 2||14
7521000|NCT03720847|18519603|P2|STARTED|Condition 2||13
7521001|NCT03720847|18519604|P1|STARTED|Condition 2||14
7521002|NCT03720847|18519603|P2|NOT COMPLETED|Washout||2
7521003|NCT03720847|18519604|P1|NOT COMPLETED|Washout||1
7521004|NCT03720847|18519603|P2|COMPLETED|Washout||13
7521005|NCT03720847|18519604|P1|COMPLETED|Washout||14
7521006|NCT03720847|18519603|P2|STARTED|Washout||15
7521007|NCT03720847|18519604|P1|STARTED|Washout||15
7521008|NCT03720847|18519603|P2|NOT COMPLETED|Condition 1||0
7521009|NCT03720847|18519604|P1|NOT COMPLETED|Condition 1||0
7521010|NCT03720847|18519603|P2|COMPLETED|Condition 1||15
7521011|NCT03720847|18519604|P1|COMPLETED|Condition 1||15
7521012|NCT03720847|18519603|P2|STARTED|Condition 1||15
7521013|NCT03720847|18519604|P1|STARTED|Condition 1||15
7521014|NCT03720119|18519622|P1|NOT COMPLETED|Overall Study||9
7521015|NCT03720119|18519622|P1|COMPLETED|Overall Study||69
7521016|NCT03720119|18519622|P1|STARTED|Overall Study||78
7521017|NCT03719885|18519628|P1|NOT COMPLETED|Overall Study||20
7521018|NCT03719885|18519628|P1|COMPLETED|Overall Study||35
7521019|NCT03719885|18519628|P1|STARTED|Overall Study||55
7521020|NCT03719677|18519635|P1|NOT COMPLETED|Overall Study||0
7521021|NCT03719677|18519635|P1|COMPLETED|Overall Study||7
7521022|NCT03719677|18519635|P1|STARTED|Overall Study||7
7521023|NCT03719300|18519639|P1|NOT COMPLETED|Overall Study||0
7521024|NCT03719300|18519639|P1|COMPLETED|Overall Study||32
7521025|NCT03719300|18519639|P1|STARTED|Overall Study||32
7521026|NCT03718455|18519650|P1|NOT COMPLETED|Overall Study||0
7521027|NCT03718455|18519650|P1|COMPLETED|Overall Study||1
7521028|NCT03718455|18519650|P1|STARTED|Overall Study||1
7521029|NCT03718143|18519656|P3|NOT COMPLETED|Overall Study||1
7521030|NCT03718143|18519657|P2|NOT COMPLETED|Overall Study||2
7521031|NCT03718143|18519658|P1|NOT COMPLETED|Overall Study||3
7521032|NCT03718143|18519656|P3|COMPLETED|Overall Study||0
7521033|NCT03718143|18519657|P2|COMPLETED|Overall Study||0
7521034|NCT03718143|18519658|P1|COMPLETED|Overall Study||0
7521035|NCT03718143|18519656|P3|STARTED|Overall Study||1
7521036|NCT03718143|18519657|P2|STARTED|Overall Study||2
7521037|NCT03718143|18519658|P1|STARTED|Overall Study||3
7521038|NCT03718000|18519674|P2|NOT COMPLETED|Overall Study||5
7521039|NCT03718000|18519675|P1|NOT COMPLETED|Overall Study||2
7521040|NCT03718000|18519674|P2|COMPLETED|Overall Study||51
7521041|NCT03718000|18519675|P1|COMPLETED|Overall Study||53
7521042|NCT03718000|18519674|P2|STARTED|Overall Study||56
7521043|NCT03718000|18519675|P1|STARTED|Overall Study||55
7521044|NCT03717064|18519697|P1|NOT COMPLETED|Period 2||1
7521045|NCT03717064|18519697|P1|COMPLETED|Period 2||17
7521046|NCT03717064|18519697|P1|STARTED|Period 2||18
7521047|NCT03717064|18519697|P1|NOT COMPLETED|Period 1||0
7521048|NCT03717064|18519697|P1|COMPLETED|Period 1||18
7521049|NCT03717064|18519697|P1|STARTED|Period 1||18
7521050|NCT03716050|18519729|P8|NOT COMPLETED|Overall Study||2
7521051|NCT03716050|18519730|P7|NOT COMPLETED|Overall Study||0
7521052|NCT03716050|18519731|P6|NOT COMPLETED|Overall Study||0
7521053|NCT03716050|18519732|P5|NOT COMPLETED|Overall Study||0
7521054|NCT03716050|18519733|P4|NOT COMPLETED|Overall Study||2
7521055|NCT03716050|18519734|P3|NOT COMPLETED|Overall Study||1
7521056|NCT03716050|18519735|P2|NOT COMPLETED|Overall Study||0
7521057|NCT03716050|18519736|P1|NOT COMPLETED|Overall Study||0
7521058|NCT03716050|18519729|P8|COMPLETED|Overall Study||0
7521059|NCT03716050|18519730|P7|COMPLETED|Overall Study||4
7521060|NCT03716050|18519731|P6|COMPLETED|Overall Study||0
7521061|NCT03716050|18519732|P5|COMPLETED|Overall Study||1
7521062|NCT03716050|18519733|P4|COMPLETED|Overall Study||1
7521063|NCT03716050|18519734|P3|COMPLETED|Overall Study||0
7521064|NCT03716050|18519735|P2|COMPLETED|Overall Study||4
7521065|NCT03716050|18519736|P1|COMPLETED|Overall Study||2
7521066|NCT03716050|18519729|P8|STARTED|Overall Study||2
7521067|NCT03716050|18519730|P7|STARTED|Overall Study||4
7521068|NCT03716050|18519731|P6|STARTED|Overall Study||0
7521069|NCT03716050|18519732|P5|STARTED|Overall Study||1
7521070|NCT03716050|18519733|P4|STARTED|Overall Study||3
7521071|NCT03716050|18519734|P3|STARTED|Overall Study||1
7521072|NCT03716050|18519735|P2|STARTED|Overall Study||4
7521073|NCT03716050|18519736|P1|STARTED|Overall Study||2
7521074|NCT03716024|18519790|P2|NOT COMPLETED|Overall Study||18
7521075|NCT03716024|18519791|P1|NOT COMPLETED|Overall Study||11
7521076|NCT03716024|18519790|P2|COMPLETED|Overall Study||98
7521077|NCT03716024|18519791|P1|COMPLETED|Overall Study||107
7521078|NCT03716024|18519790|P2|STARTED|Overall Study||116
7521079|NCT03716024|18519791|P1|STARTED|Overall Study||118
7521080|NCT03715803|18519805|P2|NOT COMPLETED|Overall Study||0
7521081|NCT03715803|18519806|P1|NOT COMPLETED|Overall Study||0
7521082|NCT03715803|18519805|P2|COMPLETED|Overall Study||126
7521083|NCT03715803|18519806|P1|COMPLETED|Overall Study||91
7521084|NCT03715803|18519805|P2|STARTED|Overall Study||126
7521085|NCT03715803|18519806|P1|STARTED|Overall Study||91
7521086|NCT03715530|18519825|P3|NOT COMPLETED|Overall Study||2
7521087|NCT03715530|18519826|P2|NOT COMPLETED|Overall Study||1
7521088|NCT03715530|18519827|P1|NOT COMPLETED|Overall Study||3
7521089|NCT03715530|18519825|P3|COMPLETED|Overall Study||85
7521090|NCT03715530|18519826|P2|COMPLETED|Overall Study||41
7521091|NCT03715530|18519827|P1|COMPLETED|Overall Study||30
7521092|NCT03715530|18519825|P3|STARTED|Overall Study||87
7521093|NCT03715530|18519826|P2|STARTED|Overall Study||42
7521094|NCT03715530|18519827|P1|STARTED|Overall Study||33
7521095|NCT03715452|18519835|P1|NOT COMPLETED|Overall Study||0
7521096|NCT03715452|18519835|P1|COMPLETED|Overall Study||114
7521097|NCT03715452|18519835|P1|STARTED|Overall Study||114
7521098|NCT03715426|18519842|P2|NOT COMPLETED|Overall Study||25
7521099|NCT03715426|18519843|P1|NOT COMPLETED|Overall Study||21
7521100|NCT03715426|18519842|P2|COMPLETED|Overall Study||92
7521101|NCT03715426|18519843|P1|COMPLETED|Overall Study||112
7521102|NCT03715426|18519842|P2|4-Month Follow-Up Survey|Overall Study||92
7521103|NCT03715426|18519843|P1|4-Month Follow-Up Survey|Overall Study||112
7521104|NCT03715426|18519842|P2|1-Month Follow-Up Survey|Overall Study||97
7521105|NCT03715426|18519843|P1|1-Month Follow-Up Survey|Overall Study||113
7521106|NCT03715426|18519842|P2|STARTED|Overall Study||117
7521107|NCT03715426|18519843|P1|STARTED|Overall Study||133
7521108|NCT03714672|18519887|P4|NOT COMPLETED|Overall Study||1
7521109|NCT03714672|18519888|P3|NOT COMPLETED|Overall Study||4
7521110|NCT03714672|18519889|P2|NOT COMPLETED|Overall Study||4
7521111|NCT03714672|18519890|P1|NOT COMPLETED|Overall Study||2
7521112|NCT03714672|18519887|P4|COMPLETED|Overall Study||207
7521113|NCT03714672|18519888|P3|COMPLETED|Overall Study||202
7521114|NCT03714672|18519889|P2|COMPLETED|Overall Study||202
7521115|NCT03714672|18519890|P1|COMPLETED|Overall Study||207
7521116|NCT03714672|18519887|P4|Safety Set|Overall Study||207
7521117|NCT03714672|18519888|P3|Safety Set|Overall Study||206
7521118|NCT03714672|18519889|P2|Safety Set|Overall Study||205
7521119|NCT03714672|18519890|P1|Safety Set|Overall Study||208
7521120|NCT03714672|18519887|P4|STARTED|Overall Study||208
7521121|NCT03714672|18519888|P3|STARTED|Overall Study||206
7521122|NCT03714672|18519889|P2|STARTED|Overall Study||206
7521123|NCT03714672|18519890|P1|STARTED|Overall Study||209
7521124|NCT03714659|18519936|P1|NOT COMPLETED|Overall Study||1
7521125|NCT03714659|18519936|P1|COMPLETED|Overall Study||19
7521126|NCT03714659|18519936|P1|STARTED|Overall Study||20
7521127|NCT03712917|18519944|P3|NOT COMPLETED|Overall Study||9
7521128|NCT03712917|18519945|P2|NOT COMPLETED|Overall Study||8
7521129|NCT03712917|18519946|P1|NOT COMPLETED|Overall Study||9
7521130|NCT03712917|18519944|P3|COMPLETED|Overall Study||31
7521131|NCT03712917|18519945|P2|COMPLETED|Overall Study||32
7521132|NCT03712917|18519946|P1|COMPLETED|Overall Study||31
7521133|NCT03712917|18519944|P3|STARTED|Overall Study||40
7521134|NCT03712917|18519945|P2|STARTED|Overall Study||40
7521135|NCT03712917|18519946|P1|STARTED|Overall Study||40
7521136|NCT03710577|18519959|P2|NOT COMPLETED|Second Intervention||0
7521137|NCT03710577|18519960|P1|NOT COMPLETED|Second Intervention||0
7521138|NCT03710577|18519959|P2|COMPLETED|Second Intervention||4
7521139|NCT03710577|18519960|P1|COMPLETED|Second Intervention||8
7521140|NCT03710577|18519959|P2|STARTED|Second Intervention||4
7521141|NCT03710577|18519960|P1|STARTED|Second Intervention||8
7521142|NCT03710577|18519959|P2|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
7521143|NCT03710577|18519960|P1|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
7521144|NCT03710577|18519959|P2|COMPLETED|Time Between Sessions (2-5 Days)||4
7521145|NCT03710577|18519960|P1|COMPLETED|Time Between Sessions (2-5 Days)||8
7521146|NCT03710577|18519959|P2|STARTED|Time Between Sessions (2-5 Days)||4
7521147|NCT03710577|18519960|P1|STARTED|Time Between Sessions (2-5 Days)||8
7521148|NCT03710577|18519959|P2|NOT COMPLETED|First Intervention||0
7521149|NCT03710577|18519960|P1|NOT COMPLETED|First Intervention||0
7521150|NCT03710577|18519959|P2|COMPLETED|First Intervention||4
7521151|NCT03710577|18519960|P1|COMPLETED|First Intervention||8
7521152|NCT03710577|18519959|P2|STARTED|First Intervention||4
7521153|NCT03710577|18519960|P1|STARTED|First Intervention||8
7521154|NCT03710083|18519974|P1|NOT COMPLETED|Overall Study||3
7521155|NCT03710083|18519974|P1|COMPLETED|Overall Study||63
7521156|NCT03710083|18519974|P1|STARTED|Overall Study||66
7521157|NCT03709823|18519987|P6|NOT COMPLETED|Overall Study||0
7521158|NCT03709823|18519988|P5|NOT COMPLETED|Overall Study||1
7521159|NCT03709823|18519989|P4|NOT COMPLETED|Overall Study||2
7521160|NCT03709823|18519990|P3|NOT COMPLETED|Overall Study||3
7521161|NCT03709823|18519991|P2|NOT COMPLETED|Overall Study||5
7521162|NCT03709823|18519992|P1|NOT COMPLETED|Overall Study||3
7521163|NCT03709823|18519987|P6|COMPLETED|Overall Study||26
7521164|NCT03709823|18519988|P5|COMPLETED|Overall Study||49
7521165|NCT03709823|18519989|P4|COMPLETED|Overall Study||50
7521166|NCT03709823|18519990|P3|COMPLETED|Overall Study||22
7521167|NCT03709823|18519991|P2|COMPLETED|Overall Study||45
7521168|NCT03709823|18519992|P1|COMPLETED|Overall Study||48
7521169|NCT03709823|18519987|P6|STARTED|Overall Study||26
7521170|NCT03709823|18519988|P5|STARTED|Overall Study||50
7521171|NCT03709823|18519989|P4|STARTED|Overall Study||52
7521172|NCT03709823|18519990|P3|STARTED|Overall Study||25
7521173|NCT03709823|18519991|P2|STARTED|Overall Study||50
7521174|NCT03709823|18519992|P1|STARTED|Overall Study||51
7521175|NCT03709810|18520012|P2|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
7521176|NCT03709810|18520013|P1|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
7521177|NCT03709810|18520012|P2|COMPLETED|Treatment Period 2 (Visit 3)||24
7521178|NCT03709810|18520013|P1|COMPLETED|Treatment Period 2 (Visit 3)||24
7521179|NCT03709810|18520012|P2|STARTED|Treatment Period 2 (Visit 3)||24
7521180|NCT03709810|18520013|P1|STARTED|Treatment Period 2 (Visit 3)||24
7521181|NCT03709810|18520012|P2|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
7521182|NCT03709810|18520013|P1|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
7521183|NCT03709810|18520012|P2|COMPLETED|Treatment Period 1 (Visit 2)||24
7521184|NCT03709810|18520013|P1|COMPLETED|Treatment Period 1 (Visit 2)||24
7521185|NCT03709810|18520012|P2|STARTED|Treatment Period 1 (Visit 2)||24
7521186|NCT03709810|18520013|P1|STARTED|Treatment Period 1 (Visit 2)||24
7521187|NCT03709654|18520029|P2|NOT COMPLETED|Overall Study||2
7521188|NCT03709654|18520030|P1|NOT COMPLETED|Overall Study||3
7521189|NCT03709654|18520029|P2|COMPLETED|Overall Study||11
7521190|NCT03709654|18520030|P1|COMPLETED|Overall Study||20
7521191|NCT03709654|18520029|P2|STARTED|Overall Study||13
7521192|NCT03709654|18520030|P1|STARTED|Overall Study||23
7521193|NCT03709602|18520059|P3|NOT COMPLETED|Overall Study||0
7521194|NCT03709602|18520060|P2|NOT COMPLETED|Overall Study||0
7521195|NCT03709602|18520061|P1|NOT COMPLETED|Overall Study||0
7521196|NCT03709602|18520059|P3|COMPLETED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
7521197|NCT03709602|18520060|P2|COMPLETED|Overall Study|Parents recruited for qualitative interviews.|16
7521198|NCT03709602|18520061|P1|COMPLETED|Overall Study|Adolescents recruited for qualitative interviews.|16
7521199|NCT03709602|18520059|P3|STARTED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
7521200|NCT03709602|18520060|P2|STARTED|Overall Study|Parents recruited for qualitative interviews.|16
7521201|NCT03709602|18520061|P1|STARTED|Overall Study|Adolescents recruited for qualitative interviews.|16
7521202|NCT03709576|18520067|P1|NOT COMPLETED|Overall Study||1
7521203|NCT03709576|18520067|P1|COMPLETED|Overall Study||2
7521204|NCT03709576|18520067|P1|STARTED|Overall Study||3
7521205|NCT03708770|18520079|P1|NOT COMPLETED|Overall Study||10
7521206|NCT03708770|18520079|P1|COMPLETED|Overall Study||22
7521207|NCT03708770|18520079|P1|STARTED|Overall Study||32
7521208|NCT03708744|18520090|P4|NOT COMPLETED|Overall Study||0
7521209|NCT03708744|18520091|P3|NOT COMPLETED|Overall Study||1
7521210|NCT03708744|18520092|P2|NOT COMPLETED|Overall Study||0
7521211|NCT03708744|18520093|P1|NOT COMPLETED|Overall Study||0
7521212|NCT03708744|18520090|P4|COMPLETED|Overall Study||6
7521213|NCT03708744|18520091|P3|COMPLETED|Overall Study||4
7521214|NCT03708744|18520092|P2|COMPLETED|Overall Study||6
7521215|NCT03708744|18520093|P1|COMPLETED|Overall Study||7
7521216|NCT03708744|18520090|P4|STARTED|Overall Study||6
7521217|NCT03708744|18520091|P3|STARTED|Overall Study||5
7521218|NCT03708744|18520092|P2|STARTED|Overall Study||6
7521219|NCT03708744|18520093|P1|STARTED|Overall Study||7
7521220|NCT03708562|18520111|P1|NOT COMPLETED|Overall Study||12
7521221|NCT03708562|18520111|P1|COMPLETED|Overall Study||12
7521222|NCT03708562|18520111|P1|STARTED|Overall Study||24
7521223|NCT03708211|18520127|P2|NOT COMPLETED|Overall Study||8
7521224|NCT03708211|18520128|P1|NOT COMPLETED|Overall Study||12
7521225|NCT03708211|18520127|P2|COMPLETED|Overall Study||0
7521226|NCT03708211|18520128|P1|COMPLETED|Overall Study||0
7521227|NCT03708211|18520127|P2|STARTED|Overall Study||8
7521228|NCT03708211|18520128|P1|STARTED|Overall Study||12
7521229|NCT03707912|18520160|P2|NOT COMPLETED|Overall Study||0
7521230|NCT03707912|18520161|P1|NOT COMPLETED|Overall Study||1
7521231|NCT03707912|18520160|P2|COMPLETED|Overall Study||100
7521232|NCT03707912|18520161|P1|COMPLETED|Overall Study||103
7521233|NCT03707912|18520160|P2|STARTED|Overall Study||100
7521234|NCT03707912|18520161|P1|STARTED|Overall Study||104
7521235|NCT03707821|18520181|P2|NOT COMPLETED|Overall Study||1
7521236|NCT03707821|18520182|P1|NOT COMPLETED|Overall Study||2
7521237|NCT03707821|18520181|P2|COMPLETED|Overall Study||125
7521238|NCT03707821|18520182|P1|COMPLETED|Overall Study||123
7521239|NCT03707821|18520181|P2|STARTED|Overall Study||126
7521240|NCT03707821|18520182|P1|STARTED|Overall Study||125
7521241|NCT03707587|18520202|P2|NOT COMPLETED|Overall Study||1
7521242|NCT03707587|18520203|P1|NOT COMPLETED|Overall Study||0
7521243|NCT03707587|18520202|P2|COMPLETED|Overall Study||1
7521244|NCT03707587|18520203|P1|COMPLETED|Overall Study||7
7521245|NCT03707587|18520202|P2|STARTED|Overall Study||2
7521246|NCT03707587|18520203|P1|STARTED|Overall Study||7
7521247|NCT03707522|18520219|P4|NOT COMPLETED|Overall Study||36
7521248|NCT03707522|18520220|P3|NOT COMPLETED|Overall Study||41
7521249|NCT03707522|18520221|P2|NOT COMPLETED|Overall Study||27
7521250|NCT03707522|18520222|P1|NOT COMPLETED|Overall Study||24
7521251|NCT03707522|18520219|P4|COMPLETED|Overall Study||7
7521252|NCT03707522|18520220|P3|COMPLETED|Overall Study||11
7521253|NCT03707522|18520221|P2|COMPLETED|Overall Study||9
7521254|NCT03707522|18520222|P1|COMPLETED|Overall Study||7
7521255|NCT03707522|18520219|P4|STARTED|Overall Study||43
7521256|NCT03707522|18520220|P3|STARTED|Overall Study||52
7521257|NCT03707522|18520221|P2|STARTED|Overall Study||36
7521258|NCT03707522|18520222|P1|STARTED|Overall Study||31
7521259|NCT03706469|18520252|P4|NOT COMPLETED|Overall Study||0
7521260|NCT03706469|18520253|P3|NOT COMPLETED|Overall Study||0
7521261|NCT03706469|18520254|P2|NOT COMPLETED|Overall Study||0
7521262|NCT03706469|18520255|P1|NOT COMPLETED|Overall Study||0
7521263|NCT03706469|18520252|P4|COMPLETED|Overall Study||4
7521264|NCT03706469|18520253|P3|COMPLETED|Overall Study||4
7521265|NCT03706469|18520254|P2|COMPLETED|Overall Study||4
7521266|NCT03706469|18520255|P1|COMPLETED|Overall Study||4
7521267|NCT03706469|18520252|P4|STARTED|Overall Study||4
7521268|NCT03706469|18520253|P3|STARTED|Overall Study||4
7521269|NCT03706469|18520254|P2|STARTED|Overall Study||4
7521270|NCT03706469|18520255|P1|STARTED|Overall Study||4
7521271|NCT03706313|18520284|P2|NOT COMPLETED|Overall Study||0
7521272|NCT03706313|18520285|P1|NOT COMPLETED|Overall Study||0
7521273|NCT03706313|18520284|P2|COMPLETED|Overall Study||20
7521274|NCT03706313|18520285|P1|COMPLETED|Overall Study||20
7521275|NCT03706313|18520284|P2|STARTED|Overall Study||20
7521276|NCT03706313|18520285|P1|STARTED|Overall Study||20
7521277|NCT03705793|18520311|P2|NOT COMPLETED|Overall Study||5
7521278|NCT03705793|18520312|P1|NOT COMPLETED|Overall Study||5
7521279|NCT03705793|18520311|P2|COMPLETED|Overall Study||21
7521280|NCT03705793|18520312|P1|COMPLETED|Overall Study||22
7521281|NCT03705793|18520311|P2|STARTED|Overall Study||26
7521282|NCT03705793|18520312|P1|STARTED|Overall Study||27
7521283|NCT03705494|18520324|P2|NOT COMPLETED|Overall Study||3
7521284|NCT03705494|18520325|P1|NOT COMPLETED|Overall Study||7
7521285|NCT03705494|18520324|P2|COMPLETED|Overall Study||7
7521286|NCT03705494|18520325|P1|COMPLETED|Overall Study||3
7521287|NCT03705494|18520324|P2|STARTED|Overall Study||10
7521288|NCT03705494|18520325|P1|STARTED|Overall Study||10
7521289|NCT03705481|18520339|P1|NOT COMPLETED|Overall Study||0
7521290|NCT03705481|18520339|P1|COMPLETED|Overall Study||5
7521291|NCT03705481|18520339|P1|STARTED|Overall Study||5
7521292|NCT03704467|18520346|P1|NOT COMPLETED|Overall Study||0
7521293|NCT03704467|18520346|P1|COMPLETED|Overall Study||3
7521294|NCT03704467|18520346|P1|STARTED|Overall Study||3
7521295|NCT03704376|18520366|P2|NOT COMPLETED|Overall Study||4
7521296|NCT03704376|18520367|P1|NOT COMPLETED|Overall Study||4
7521297|NCT03704376|18520366|P2|COMPLETED|Overall Study||40
7521298|NCT03704376|18520367|P1|COMPLETED|Overall Study||38
7521299|NCT03704376|18520366|P2|STARTED|Overall Study||44
7521300|NCT03704376|18520367|P1|STARTED|Overall Study||42
7521301|NCT03704194|18520411|P2|NOT COMPLETED|Overall Study||1
7521302|NCT03704194|18520412|P1|NOT COMPLETED|Overall Study||0
7521303|NCT03704194|18520411|P2|COMPLETED|Overall Study||8
7521304|NCT03704194|18520412|P1|COMPLETED|Overall Study||8
7521305|NCT03704194|18520411|P2|STARTED|Overall Study||9
7521306|NCT03704194|18520412|P1|STARTED|Overall Study||8
7521307|NCT03703466|18520440|P3|NOT COMPLETED|Overall Study||2
7521308|NCT03703466|18520441|P2|NOT COMPLETED|Overall Study||6
7521309|NCT03703466|18520442|P1|NOT COMPLETED|Overall Study||4
7521310|NCT03703466|18520440|P3|COMPLETED|Overall Study||22
7521311|NCT03703466|18520441|P2|COMPLETED|Overall Study||18
7521312|NCT03703466|18520442|P1|COMPLETED|Overall Study||20
7521313|NCT03703466|18520440|P3|Received at Least One Dose of Study Drug|Overall Study||24
7521314|NCT03703466|18520441|P2|Received at Least One Dose of Study Drug|Overall Study||23
7521315|NCT03703466|18520442|P1|Received at Least One Dose of Study Drug|Overall Study||24
7521316|NCT03703466|18520440|P3|STARTED|Overall Study||24
7521317|NCT03703466|18520441|P2|STARTED|Overall Study||24
7521318|NCT03703466|18520442|P1|STARTED|Overall Study||24
7521319|NCT03702608|18520474|P1|NOT COMPLETED|Overall Study||0
7521320|NCT03702608|18520474|P1|COMPLETED|Overall Study||50
7521321|NCT03702608|18520474|P1|STARTED|Overall Study||50
7521322|NCT03702166|18520479|P1|NOT COMPLETED|Overall Study||2
7521323|NCT03702166|18520479|P1|COMPLETED|Overall Study||8
7521324|NCT03702166|18520479|P1|STARTED|Overall Study||10
7521325|NCT03701061|18520490|P2|NOT COMPLETED|Overall Study||0
7521326|NCT03701061|18520491|P1|NOT COMPLETED|Overall Study||0
7521327|NCT03701061|18520490|P2|COMPLETED|Overall Study||3
7521328|NCT03701061|18520491|P1|COMPLETED|Overall Study||9
7521329|NCT03701061|18520490|P2|STARTED|Overall Study||3
7521330|NCT03701061|18520491|P1|STARTED|Overall Study||9
7521331|NCT03700671|18520505|P2|NOT COMPLETED|Overall Study||2
7521332|NCT03700671|18520506|P1|NOT COMPLETED|Overall Study||1
7521333|NCT03700671|18520505|P2|COMPLETED|Overall Study||19
7521334|NCT03700671|18520506|P1|COMPLETED|Overall Study||20
7521335|NCT03700671|18520505|P2|STARTED|Overall Study||21
7521336|NCT03700671|18520506|P1|STARTED|Overall Study||21
7521337|NCT03700385|18520518|P1|NOT COMPLETED|Overall Study||1
7521338|NCT03700385|18520518|P1|COMPLETED|Overall Study||39
7521339|NCT03700385|18520518|P1|STARTED|Overall Study||40
7521340|NCT03698591|18520525|P2|NOT COMPLETED|Overall Study||5
7521341|NCT03698591|18520526|P1|NOT COMPLETED|Overall Study||5
7521342|NCT03698591|18520525|P2|COMPLETED|Overall Study||15
7521343|NCT03698591|18520526|P1|COMPLETED|Overall Study||15
7521344|NCT03698591|18520525|P2|STARTED|Overall Study||20
7521345|NCT03698591|18520526|P1|STARTED|Overall Study||20
7521346|NCT03698331|18520540|P2|NOT COMPLETED|Overall Study||6
7521347|NCT03698331|18520541|P1|NOT COMPLETED|Overall Study||4
7521348|NCT03698331|18520540|P2|COMPLETED|Overall Study||39
7521349|NCT03698331|18520541|P1|COMPLETED|Overall Study||40
7521350|NCT03698331|18520540|P2|Entered Withdrawal Period|Overall Study||39
7521351|NCT03698331|18520541|P1|Entered Withdrawal Period|Overall Study||42
7521352|NCT03698331|18520540|P2|STARTED|Overall Study||45
7521353|NCT03698331|18520541|P1|STARTED|Overall Study||44
7521354|NCT03698279|18520563|P6|NOT COMPLETED|Overall Study||0
7521355|NCT03698279|18520564|P5|NOT COMPLETED|Overall Study||0
7521356|NCT03698279|18520565|P4|NOT COMPLETED|Overall Study||6
7521357|NCT03698279|18520566|P3|NOT COMPLETED|Overall Study||7
7521358|NCT03698279|18520567|P2|NOT COMPLETED|Overall Study||2
7521359|NCT03698279|18520568|P1|NOT COMPLETED|Overall Study||5
7521360|NCT03698279|18520563|P6|COMPLETED|Overall Study||13
7521361|NCT03698279|18520564|P5|COMPLETED|Overall Study||13
7521362|NCT03698279|18520565|P4|COMPLETED|Overall Study||228
7521363|NCT03698279|18520566|P3|COMPLETED|Overall Study||152
7521364|NCT03698279|18520567|P2|COMPLETED|Overall Study||120
7521365|NCT03698279|18520568|P1|COMPLETED|Overall Study||119
7521366|NCT03698279|18520563|P6|Safety Analysis Set Population (SafAS)|Overall Study||13
7521367|NCT03698279|18520564|P5|Safety Analysis Set Population (SafAS)|Overall Study||13
7521368|NCT03698279|18520565|P4|Safety Analysis Set Population (SafAS)|Overall Study||234
7521369|NCT03698279|18520566|P3|Safety Analysis Set Population (SafAS)|Overall Study||158
7521370|NCT03698279|18520567|P2|Safety Analysis Set Population (SafAS)|Overall Study||121
7521371|NCT03698279|18520568|P1|Safety Analysis Set Population (SafAS)|Overall Study||122
7521372|NCT03698279|18520563|P6|STARTED|Overall Study||13
7521373|NCT03698279|18520564|P5|STARTED|Overall Study||13
7521374|NCT03698279|18520565|P4|STARTED|Overall Study||234
7521375|NCT03698279|18520566|P3|STARTED|Overall Study||159
7521376|NCT03698279|18520567|P2|STARTED|Overall Study||122
7521377|NCT03698279|18520568|P1|STARTED|Overall Study||124
7521378|NCT03697993|18520664|P2|NOT COMPLETED|Overall Study||5
7521379|NCT03697993|18520665|P1|NOT COMPLETED|Overall Study||10
7521380|NCT03697993|18520664|P2|COMPLETED|Overall Study||25
7521381|NCT03697993|18520665|P1|COMPLETED|Overall Study||22
7521382|NCT03697993|18520664|P2|Treated With at Least Two Dose of Fosfomycin|Overall Study||4
7521383|NCT03697993|18520665|P1|Treated With at Least Two Dose of Fosfomycin|Overall Study||27
7521384|NCT03697993|18520664|P2|Switched Treatment|Overall Study|Five (5) participants switched to Fosfomycin; 1 participant switched to Cefixime.|6
7521385|NCT03697993|18520665|P1|Switched Treatment|Overall Study||0
7521386|NCT03697993|18520664|P2|Initiated Treatment|Overall Study||28
7521387|NCT03697993|18520665|P1|Initiated Treatment|Overall Study||30
7521388|NCT03697993|18520664|P2|STARTED|Overall Study||30
7521389|NCT03697993|18520665|P1|STARTED|Overall Study||32
7521390|NCT03697551|18520684|P1|NOT COMPLETED|Overall Study||0
7521391|NCT03697551|18520684|P1|COMPLETED|Overall Study||4
7521392|NCT03697551|18520684|P1|STARTED|Overall Study||4
7521393|NCT03697252|18520691|P2|NOT COMPLETED|Overall Study||19
7521394|NCT03697252|18520692|P1|NOT COMPLETED|Overall Study||18
7521395|NCT03697252|18520691|P2|COMPLETED|Overall Study||73
7521396|NCT03697252|18520692|P1|COMPLETED|Overall Study||72
7521397|NCT03697252|18520691|P2|STARTED|Overall Study||92
7521398|NCT03697252|18520692|P1|STARTED|Overall Study||90
7521399|NCT03697122|18520708|P1|NOT COMPLETED|Overall Study||0
7521400|NCT03697122|18520708|P1|COMPLETED|Overall Study||14
7521401|NCT03697122|18520708|P1|STARTED|Overall Study||14
7521402|NCT03697083|18520723|P3|NOT COMPLETED|Overall Study||0
7521403|NCT03697083|18520724|P2|NOT COMPLETED|Overall Study||10
7521404|NCT03697083|18520725|P1|NOT COMPLETED|Overall Study||0
7521405|NCT03697083|18520723|P3|COMPLETED|Overall Study||255
7521406|NCT03697083|18520724|P2|COMPLETED|Overall Study||250
7521407|NCT03697083|18520725|P1|COMPLETED|Overall Study||262
7521408|NCT03697083|18520723|P3|STARTED|Overall Study||255
7521409|NCT03697083|18520724|P2|STARTED|Overall Study||260
7521410|NCT03697083|18520725|P1|STARTED|Overall Study||262
7521411|NCT03696589|18520733|P1|NOT COMPLETED|Overall Study||1
7521412|NCT03696589|18520733|P1|COMPLETED|Overall Study||12
7521413|NCT03696589|18520733|P1|STARTED|Overall Study||13
7521414|NCT03695913|18520756|P1|NOT COMPLETED|Overall Study||0
7521415|NCT03695913|18520756|P1|COMPLETED|Overall Study||15
7521416|NCT03695913|18520756|P1|STARTED|Overall Study||15
7521417|NCT03695094|18520773|P2|NOT COMPLETED|Overall Study||1
7521418|NCT03695094|18520774|P1|NOT COMPLETED|Overall Study||2
7521419|NCT03695094|18520773|P2|COMPLETED|Overall Study||14
7521420|NCT03695094|18520774|P1|COMPLETED|Overall Study||14
7521421|NCT03695094|18520773|P2|STARTED|Overall Study||15
7521422|NCT03695094|18520774|P1|STARTED|Overall Study||16
7521423|NCT03694925|18520810|P3|NOT COMPLETED|Overall Study||0
7521424|NCT03694925|18520811|P2|NOT COMPLETED|Overall Study||3
7521425|NCT03694925|18520812|P1|NOT COMPLETED|Overall Study||0
7521426|NCT03694925|18520810|P3|COMPLETED|Overall Study||53
7521427|NCT03694925|18520811|P2|COMPLETED|Overall Study||70
7521428|NCT03694925|18520812|P1|COMPLETED|Overall Study||30
7521429|NCT03694925|18520810|P3|STARTED|Overall Study||53
7521430|NCT03694925|18520811|P2|STARTED|Overall Study||73
7521431|NCT03694925|18520812|P1|STARTED|Overall Study||30
7521432|NCT03694821|18520828|P3|NOT COMPLETED|Overall Study||4
7521433|NCT03694821|18520829|P2|NOT COMPLETED|Overall Study||8
7521434|NCT03694821|18520830|P1|NOT COMPLETED|Overall Study||4
7521435|NCT03694821|18520828|P3|COMPLETED|Overall Study||2
7521436|NCT03694821|18520829|P2|COMPLETED|Overall Study||0
7521437|NCT03694821|18520830|P1|COMPLETED|Overall Study||0
7521438|NCT03694821|18520828|P3|STARTED|Overall Study||6
7521439|NCT03694821|18520829|P2|STARTED|Overall Study||8
7521440|NCT03694821|18520830|P1|STARTED|Overall Study||4
7521441|NCT03693989|18520861|P2|NOT COMPLETED|Overall Study||4
7521442|NCT03693989|18520862|P1|NOT COMPLETED|Overall Study||3
7521443|NCT03693989|18520861|P2|COMPLETED|Overall Study||86
7521444|NCT03693989|18520862|P1|COMPLETED|Overall Study||85
7521445|NCT03693989|18520861|P2|STARTED|Overall Study||90
7521446|NCT03693989|18520862|P1|STARTED|Overall Study||88
7521447|NCT03693950|18520886|P2|NOT COMPLETED|Overall Study||0
7521448|NCT03693950|18520887|P1|NOT COMPLETED|Overall Study||1
7521449|NCT03693950|18520886|P2|COMPLETED|Overall Study||28
7521450|NCT03693950|18520887|P1|COMPLETED|Overall Study||28
7521451|NCT03693950|18520886|P2|STARTED|Overall Study||28
7521452|NCT03693950|18520887|P1|STARTED|Overall Study||29
7521453|NCT03693937|18520905|P1|NOT COMPLETED|Overall Study||0
7521454|NCT03693937|18520905|P1|COMPLETED|Overall Study||776
7521455|NCT03693937|18520905|P1|STARTED|Overall Study||776
7521456|NCT03693625|18520911|P2|NOT COMPLETED|Overall Study||8
7521457|NCT03693625|18520912|P1|NOT COMPLETED|Overall Study||23
7521458|NCT03693625|18520911|P2|COMPLETED|Overall Study||0
7521459|NCT03693625|18520912|P1|COMPLETED|Overall Study||0
7521460|NCT03693625|18520911|P2|STARTED|Overall Study||8
7521461|NCT03693625|18520912|P1|STARTED|Overall Study||23
7521462|NCT03692676|18520924|P4|NOT COMPLETED|Overall Study||3586
7521463|NCT03692676|18520925|P3|NOT COMPLETED|Overall Study||38344
7521464|NCT03692676|18520926|P2|NOT COMPLETED|Overall Study||47438
7521465|NCT03692676|18520927|P1|NOT COMPLETED|Overall Study||9425
7521466|NCT03692676|18520924|P4|COMPLETED|Overall Study||1561
7521467|NCT03692676|18520925|P3|COMPLETED|Overall Study||11135
7521468|NCT03692676|18520926|P2|COMPLETED|Overall Study||3704
7521469|NCT03692676|18520927|P1|COMPLETED|Overall Study||940
7521470|NCT03692676|18520924|P4|STARTED|Overall Study||5147
7521471|NCT03692676|18520925|P3|STARTED|Overall Study||49479
7521472|NCT03692676|18520926|P2|STARTED|Overall Study||51142
7521473|NCT03692676|18520927|P1|STARTED|Overall Study||10365
7521474|NCT03691948|18520943|P2|NOT COMPLETED|Overall Study||3
7521475|NCT03691948|18520944|P1|NOT COMPLETED|Overall Study||1
7521476|NCT03691948|18520943|P2|COMPLETED|Overall Study||30
7521477|NCT03691948|18520944|P1|COMPLETED|Overall Study||26
7521478|NCT03691948|18520943|P2|STARTED|Overall Study||33
7521479|NCT03691948|18520944|P1|STARTED|Overall Study||27
7521480|NCT03691844|18520963|P4|NOT COMPLETED|Overall Study||11
7521481|NCT03691844|18520964|P3|NOT COMPLETED|Overall Study||13
7521482|NCT03691844|18520965|P2|NOT COMPLETED|Overall Study||12
7521483|NCT03691844|18520966|P1|NOT COMPLETED|Overall Study||7
7521484|NCT03691844|18520963|P4|COMPLETED|Overall Study||70
7521485|NCT03691844|18520964|P3|COMPLETED|Overall Study||108
7521486|NCT03691844|18520965|P2|COMPLETED|Overall Study||109
7521487|NCT03691844|18520966|P1|COMPLETED|Overall Study||114
7521488|NCT03691844|18520963|P4|STARTED|Overall Study||81
7521489|NCT03691844|18520964|P3|STARTED|Overall Study||121
7521490|NCT03691844|18520965|P2|STARTED|Overall Study||121
7521491|NCT03691844|18520966|P1|STARTED|Overall Study||121
7521492|NCT03691831|18521031|P2|NOT COMPLETED|Overall Study||31
7521493|NCT03691831|18521032|P1|NOT COMPLETED|Overall Study||27
7521494|NCT03691831|18521031|P2|COMPLETED|Overall Study||220
7521495|NCT03691831|18521032|P1|COMPLETED|Overall Study||224
7521496|NCT03691831|18521031|P2|STARTED|Overall Study||251
7521497|NCT03691831|18521032|P1|STARTED|Overall Study||251
7521498|NCT03689920|18521048|P2|NOT COMPLETED|Overall Study||4
7521499|NCT03689920|18521049|P1|NOT COMPLETED|Overall Study||6
7521500|NCT03689920|18521048|P2|COMPLETED|Overall Study||48
7521501|NCT03689920|18521049|P1|COMPLETED|Overall Study||41
7521502|NCT03689920|18521048|P2|STARTED|Overall Study||52
7521503|NCT03689920|18521049|P1|STARTED|Overall Study||47
7521504|NCT03689452|18521057|P2|NOT COMPLETED|Overall Study||1
7521505|NCT03689452|18521058|P1|NOT COMPLETED|Overall Study||1
7521506|NCT03689452|18521057|P2|COMPLETED|Overall Study||14
7521507|NCT03689452|18521058|P1|COMPLETED|Overall Study||14
7521508|NCT03689452|18521057|P2|STARTED|Overall Study||15
7521509|NCT03689452|18521058|P1|STARTED|Overall Study||15
7521510|NCT03688880|18521076|P2|NOT COMPLETED|Overall Study||31
7521511|NCT03688880|18521077|P1|NOT COMPLETED|Overall Study||14
7521512|NCT03688880|18521076|P2|COMPLETED|Overall Study||29
7521513|NCT03688880|18521077|P1|COMPLETED|Overall Study||15
7521514|NCT03688880|18521076|P2|STARTED|Overall Study||60
7521515|NCT03688880|18521077|P1|STARTED|Overall Study||29
7521516|NCT03688620|18521104|P3|NOT COMPLETED|Overall Study||8
7521517|NCT03688620|18521105|P2|NOT COMPLETED|Overall Study||1
7521518|NCT03688620|18521106|P1|NOT COMPLETED|Overall Study||16
7521519|NCT03688620|18521104|P3|COMPLETED|Overall Study||445
7521520|NCT03688620|18521105|P2|COMPLETED|Overall Study||277
7521521|NCT03688620|18521106|P1|COMPLETED|Overall Study||313
7521522|NCT03688620|18521104|P3|STARTED|Overall Study||453
7521523|NCT03688620|18521105|P2|STARTED|Overall Study||278
7521524|NCT03688620|18521106|P1|STARTED|Overall Study||329
7521525|NCT03687970|18521589|P2|NOT COMPLETED|Overall Study||0
7521526|NCT03687970|18521590|P1|NOT COMPLETED|Overall Study||2
7521527|NCT03687970|18521589|P2|COMPLETED|Overall Study||20
7521528|NCT03687970|18521590|P1|COMPLETED|Overall Study||20
7521529|NCT03687970|18521589|P2|STARTED|Overall Study||20
7521530|NCT03687970|18521590|P1|STARTED|Overall Study||22
7521531|NCT03687736|18521600|P1|NOT COMPLETED|Overall Study||10
7521532|NCT03687736|18521600|P1|COMPLETED|Overall Study||110
7521533|NCT03687736|18521600|P1|STARTED|Overall Study||120
7521534|NCT03687684|18521619|P9|NOT COMPLETED|Overall Study||0
7521535|NCT03687684|18521620|P8|NOT COMPLETED|Overall Study||0
7521536|NCT03687684|18521621|P7|NOT COMPLETED|Overall Study||0
7521537|NCT03687684|18521622|P6|NOT COMPLETED|Overall Study||0
7521538|NCT03687684|18521623|P5|NOT COMPLETED|Overall Study||0
7521539|NCT03687684|18521624|P4|NOT COMPLETED|Overall Study||0
7521540|NCT03687684|18521625|P3|NOT COMPLETED|Overall Study||0
7521541|NCT03687684|18521626|P2|NOT COMPLETED|Overall Study||0
7521542|NCT03687684|18521627|P1|NOT COMPLETED|Overall Study||0
7521543|NCT03687684|18521619|P9|COMPLETED|Overall Study||6
7521544|NCT03687684|18521620|P8|COMPLETED|Overall Study||2
7521545|NCT03687684|18521621|P7|COMPLETED|Overall Study||6
7521546|NCT03687684|18521622|P6|COMPLETED|Overall Study||6
7521547|NCT03687684|18521623|P5|COMPLETED|Overall Study||6
7521548|NCT03687684|18521624|P4|COMPLETED|Overall Study||6
7521549|NCT03687684|18521625|P3|COMPLETED|Overall Study||2
7521550|NCT03687684|18521626|P2|COMPLETED|Overall Study||2
7521551|NCT03687684|18521627|P1|COMPLETED|Overall Study||4
7521552|NCT03687684|18521619|P9|STARTED|Overall Study||6
7521553|NCT03687684|18521620|P8|STARTED|Overall Study||2
7521554|NCT03687684|18521621|P7|STARTED|Overall Study||6
7521555|NCT03687684|18521622|P6|STARTED|Overall Study||6
7521556|NCT03687684|18521623|P5|STARTED|Overall Study||6
7521557|NCT03687684|18521624|P4|STARTED|Overall Study||6
7521558|NCT03687684|18521625|P3|STARTED|Overall Study||2
7521559|NCT03687684|18521626|P2|STARTED|Overall Study||2
7521560|NCT03687684|18521627|P1|STARTED|Overall Study||4
7521561|NCT03687450|18521717|P2|NOT COMPLETED|Overall Study||2
7521562|NCT03687450|18521718|P1|NOT COMPLETED|Overall Study||12
7521563|NCT03687450|18521717|P2|COMPLETED|Overall Study||16
7521564|NCT03687450|18521718|P1|COMPLETED|Overall Study||26
7521565|NCT03687450|18521717|P2|Two-month Follow-up|Overall Study|2 lost to follow-up (N.B. 1 participant completed 2-month follow-up but not post-program follow-up)|16
7521566|NCT03687450|18521718|P1|Two-month Follow-up|Overall Study|2 lost to follow-up|26
7521567|NCT03687450|18521717|P2|Post-Program Follow-Up|Overall Study|3 lost to follow-up|15
7521568|NCT03687450|18521718|P1|Post-Program Follow-Up|Overall Study|1 withdrew, 9 lost to follow-up|28
7521569|NCT03687450|18521717|P2|STARTED|Overall Study||18
7521570|NCT03687450|18521718|P1|STARTED|Overall Study||38
7521571|NCT03687372|18521746|P2|NOT COMPLETED|Overall Study||39
7521572|NCT03687372|18521747|P1|NOT COMPLETED|Overall Study||17
7521573|NCT03687372|18521746|P2|COMPLETED|Overall Study||210
7521574|NCT03687372|18521747|P1|COMPLETED|Overall Study||237
7521575|NCT03687372|18521746|P2|STARTED|Overall Study||249
7521576|NCT03687372|18521747|P1|STARTED|Overall Study||254
7521577|NCT03686176|18521764|P3|NOT COMPLETED|Overall Study||0
7521578|NCT03686176|18521765|P2|NOT COMPLETED|Overall Study||0
7521579|NCT03686176|18521766|P1|NOT COMPLETED|Overall Study||2
7521580|NCT03686176|18521764|P3|COMPLETED|Overall Study||20
7521581|NCT03686176|18521765|P2|COMPLETED|Overall Study||25
7521582|NCT03686176|18521766|P1|COMPLETED|Overall Study||17
7521583|NCT03686176|18521764|P3|STARTED|Overall Study||20
7521584|NCT03686176|18521765|P2|STARTED|Overall Study||25
7521585|NCT03686176|18521766|P1|STARTED|Overall Study||19
7521586|NCT03686033|18521805|P6|NOT COMPLETED|Treatment Period 4 (1 Day)||0
7521587|NCT03686033|18521806|P5|NOT COMPLETED|Treatment Period 4 (1 Day)||0
7521588|NCT03686033|18521807|P4|NOT COMPLETED|Treatment Period 4 (1 Day)||0
7521589|NCT03686033|18521808|P3|NOT COMPLETED|Treatment Period 4 (1 Day)||0
7521590|NCT03686033|18521809|P2|NOT COMPLETED|Treatment Period 4 (1 Day)||0
7521591|NCT03686033|18521810|P1|NOT COMPLETED|Treatment Period 4 (1 Day)||0
7521592|NCT03686033|18521805|P6|COMPLETED|Treatment Period 4 (1 Day)||0
7521593|NCT03686033|18521806|P5|COMPLETED|Treatment Period 4 (1 Day)||0
7521594|NCT03686033|18521807|P4|COMPLETED|Treatment Period 4 (1 Day)||1
7521595|NCT03686033|18521808|P3|COMPLETED|Treatment Period 4 (1 Day)||1
7521596|NCT03686033|18521809|P2|COMPLETED|Treatment Period 4 (1 Day)||1
7521597|NCT03686033|18521810|P1|COMPLETED|Treatment Period 4 (1 Day)||1
7521598|NCT03686033|18521805|P6|STARTED|Treatment Period 4 (1 Day)||0
7521599|NCT03686033|18521806|P5|STARTED|Treatment Period 4 (1 Day)||0
7521600|NCT03686033|18521807|P4|STARTED|Treatment Period 4 (1 Day)||1
7521601|NCT03686033|18521808|P3|STARTED|Treatment Period 4 (1 Day)||1
7521602|NCT03686033|18521809|P2|STARTED|Treatment Period 4 (1 Day)||1
7521603|NCT03686033|18521810|P1|STARTED|Treatment Period 4 (1 Day)||1
7521604|NCT03686033|18521805|P6|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521605|NCT03686033|18521806|P5|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521606|NCT03686033|18521807|P4|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521607|NCT03686033|18521808|P3|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521608|NCT03686033|18521809|P2|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521609|NCT03686033|18521810|P1|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521610|NCT03686033|18521805|P6|COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521611|NCT03686033|18521806|P5|COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521612|NCT03686033|18521807|P4|COMPLETED|Washout Phase (at Least 2 Weeks)||1
7521613|NCT03686033|18521808|P3|COMPLETED|Washout Phase (at Least 2 Weeks)||1
7521614|NCT03686033|18521809|P2|COMPLETED|Washout Phase (at Least 2 Weeks)||1
7521615|NCT03686033|18521810|P1|COMPLETED|Washout Phase (at Least 2 Weeks)||1
7521616|NCT03686033|18521805|P6|STARTED|Washout Phase (at Least 2 Weeks)||0
7521617|NCT03686033|18521806|P5|STARTED|Washout Phase (at Least 2 Weeks)||0
7521618|NCT03686033|18521807|P4|STARTED|Washout Phase (at Least 2 Weeks)||1
7521619|NCT03686033|18521808|P3|STARTED|Washout Phase (at Least 2 Weeks)||1
7521620|NCT03686033|18521809|P2|STARTED|Washout Phase (at Least 2 Weeks)||1
7521621|NCT03686033|18521810|P1|STARTED|Washout Phase (at Least 2 Weeks)||1
7521622|NCT03686033|18521805|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7521623|NCT03686033|18521806|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7521624|NCT03686033|18521807|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7521625|NCT03686033|18521808|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7521626|NCT03686033|18521809|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7521627|NCT03686033|18521810|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7521628|NCT03686033|18521805|P6|COMPLETED|Treatment Period 3 (1 Day)||0
7521629|NCT03686033|18521806|P5|COMPLETED|Treatment Period 3 (1 Day)||0
7521630|NCT03686033|18521807|P4|COMPLETED|Treatment Period 3 (1 Day)||1
7521631|NCT03686033|18521808|P3|COMPLETED|Treatment Period 3 (1 Day)||1
7521632|NCT03686033|18521809|P2|COMPLETED|Treatment Period 3 (1 Day)||1
7521633|NCT03686033|18521810|P1|COMPLETED|Treatment Period 3 (1 Day)||1
7521634|NCT03686033|18521805|P6|STARTED|Treatment Period 3 (1 Day)||0
7521635|NCT03686033|18521806|P5|STARTED|Treatment Period 3 (1 Day)||0
7521636|NCT03686033|18521807|P4|STARTED|Treatment Period 3 (1 Day)||1
7521637|NCT03686033|18521808|P3|STARTED|Treatment Period 3 (1 Day)||1
7521638|NCT03686033|18521809|P2|STARTED|Treatment Period 3 (1 Day)||1
7521639|NCT03686033|18521810|P1|STARTED|Treatment Period 3 (1 Day)||1
7521640|NCT03686033|18521805|P6|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521641|NCT03686033|18521806|P5|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521642|NCT03686033|18521807|P4|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521643|NCT03686033|18521808|P3|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521644|NCT03686033|18521809|P2|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521645|NCT03686033|18521810|P1|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521646|NCT03686033|18521805|P6|COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521647|NCT03686033|18521806|P5|COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521648|NCT03686033|18521807|P4|COMPLETED|Washout Phase (at Least 2 Weeks)||1
7521649|NCT03686033|18521808|P3|COMPLETED|Washout Phase (at Least 2 Weeks)||1
7521650|NCT03686033|18521809|P2|COMPLETED|Washout Phase (at Least 2 Weeks)||1
7521651|NCT03686033|18521810|P1|COMPLETED|Washout Phase (at Least 2 Weeks)||1
7521652|NCT03686033|18521805|P6|STARTED|Washout Phase (at Least 2 Weeks)||0
7521653|NCT03686033|18521806|P5|STARTED|Washout Phase (at Least 2 Weeks)||0
7521654|NCT03686033|18521807|P4|STARTED|Washout Phase (at Least 2 Weeks)||1
7521655|NCT03686033|18521808|P3|STARTED|Washout Phase (at Least 2 Weeks)||1
7521656|NCT03686033|18521809|P2|STARTED|Washout Phase (at Least 2 Weeks)||1
7521657|NCT03686033|18521810|P1|STARTED|Washout Phase (at Least 2 Weeks)||1
7521658|NCT03686033|18521805|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7521659|NCT03686033|18521806|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||1
7521660|NCT03686033|18521807|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7521661|NCT03686033|18521808|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7521662|NCT03686033|18521809|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7521663|NCT03686033|18521810|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7521664|NCT03686033|18521805|P6|COMPLETED|Treatment Period 2 (1 Day)||0
7521665|NCT03686033|18521806|P5|COMPLETED|Treatment Period 2 (1 Day)||0
7521666|NCT03686033|18521807|P4|COMPLETED|Treatment Period 2 (1 Day)||1
7521667|NCT03686033|18521808|P3|COMPLETED|Treatment Period 2 (1 Day)||1
7521668|NCT03686033|18521809|P2|COMPLETED|Treatment Period 2 (1 Day)||1
7521669|NCT03686033|18521810|P1|COMPLETED|Treatment Period 2 (1 Day)||1
7521670|NCT03686033|18521805|P6|STARTED|Treatment Period 2 (1 Day)||0
7521671|NCT03686033|18521806|P5|STARTED|Treatment Period 2 (1 Day)||1
7521672|NCT03686033|18521807|P4|STARTED|Treatment Period 2 (1 Day)||1
7521673|NCT03686033|18521808|P3|STARTED|Treatment Period 2 (1 Day)||1
7521674|NCT03686033|18521809|P2|STARTED|Treatment Period 2 (1 Day)||1
7521675|NCT03686033|18521810|P1|STARTED|Treatment Period 2 (1 Day)||1
7521676|NCT03686033|18521805|P6|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521677|NCT03686033|18521806|P5|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521678|NCT03686033|18521807|P4|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521679|NCT03686033|18521808|P3|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521680|NCT03686033|18521809|P2|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521681|NCT03686033|18521810|P1|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521682|NCT03686033|18521805|P6|COMPLETED|Washout Phase (at Least 2 Weeks)||0
7521683|NCT03686033|18521806|P5|COMPLETED|Washout Phase (at Least 2 Weeks)||1
7521684|NCT03686033|18521807|P4|COMPLETED|Washout Phase (at Least 2 Weeks)||1
7521685|NCT03686033|18521808|P3|COMPLETED|Washout Phase (at Least 2 Weeks)||1
7521686|NCT03686033|18521809|P2|COMPLETED|Washout Phase (at Least 2 Weeks)||1
7521687|NCT03686033|18521810|P1|COMPLETED|Washout Phase (at Least 2 Weeks)||1
7521688|NCT03686033|18521805|P6|STARTED|Washout Phase (at Least 2 Weeks)||0
7521689|NCT03686033|18521806|P5|STARTED|Washout Phase (at Least 2 Weeks)||1
7521690|NCT03686033|18521807|P4|STARTED|Washout Phase (at Least 2 Weeks)||1
7521691|NCT03686033|18521808|P3|STARTED|Washout Phase (at Least 2 Weeks)||1
7521692|NCT03686033|18521809|P2|STARTED|Washout Phase (at Least 2 Weeks)||1
7521693|NCT03686033|18521810|P1|STARTED|Washout Phase (at Least 2 Weeks)||1
7521694|NCT03686033|18521805|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7521695|NCT03686033|18521806|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7521696|NCT03686033|18521807|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7521697|NCT03686033|18521808|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7521698|NCT03686033|18521809|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7521699|NCT03686033|18521810|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7521700|NCT03686033|18521805|P6|COMPLETED|Treatment Period 1 (1 Day)||0
7521701|NCT03686033|18521806|P5|COMPLETED|Treatment Period 1 (1 Day)||1
7521702|NCT03686033|18521807|P4|COMPLETED|Treatment Period 1 (1 Day)||1
7521703|NCT03686033|18521808|P3|COMPLETED|Treatment Period 1 (1 Day)||1
7521704|NCT03686033|18521809|P2|COMPLETED|Treatment Period 1 (1 Day)||1
7521705|NCT03686033|18521810|P1|COMPLETED|Treatment Period 1 (1 Day)||1
7521706|NCT03686033|18521805|P6|STARTED|Treatment Period 1 (1 Day)||0
7521707|NCT03686033|18521806|P5|STARTED|Treatment Period 1 (1 Day)||1
7521708|NCT03686033|18521807|P4|STARTED|Treatment Period 1 (1 Day)||1
7521709|NCT03686033|18521808|P3|STARTED|Treatment Period 1 (1 Day)||1
7521710|NCT03686033|18521809|P2|STARTED|Treatment Period 1 (1 Day)||1
7521711|NCT03686033|18521810|P1|STARTED|Treatment Period 1 (1 Day)||1
7521712|NCT03685968|18521868|P3|NOT COMPLETED|Overall Study||0
7521713|NCT03685968|18521869|P2|NOT COMPLETED|Overall Study||0
7521714|NCT03685968|18521870|P1|NOT COMPLETED|Overall Study||0
7521715|NCT03685968|18521868|P3|COMPLETED|Overall Study||75
7521716|NCT03685968|18521869|P2|COMPLETED|Overall Study||75
7521717|NCT03685968|18521870|P1|COMPLETED|Overall Study||75
7521718|NCT03685968|18521868|P3|STARTED|Overall Study||75
7521719|NCT03685968|18521869|P2|STARTED|Overall Study||75
7521720|NCT03685968|18521870|P1|STARTED|Overall Study||75
7521721|NCT03685643|18521886|P2|NOT COMPLETED|Overall Study||22
7521722|NCT03685643|18521887|P1|NOT COMPLETED|Overall Study||14
7521723|NCT03685643|18521886|P2|COMPLETED|Overall Study||266
7521724|NCT03685643|18521887|P1|COMPLETED|Overall Study||276
7521725|NCT03685643|18521886|P2|STARTED|Overall Study||288
7521726|NCT03685643|18521887|P1|STARTED|Overall Study||290
7521727|NCT03685396|18521899|P2|NOT COMPLETED|Overall Study||0
7521728|NCT03685396|18521900|P1|NOT COMPLETED|Overall Study||0
7521729|NCT03685396|18521899|P2|COMPLETED|Overall Study||21
7521730|NCT03685396|18521900|P1|COMPLETED|Overall Study||21
7521731|NCT03685396|18521899|P2|STARTED|Overall Study||21
7521732|NCT03685396|18521900|P1|STARTED|Overall Study||21
7521733|NCT03684928|18521912|P2|NOT COMPLETED|Second Intervention||0
7521734|NCT03684928|18521913|P1|NOT COMPLETED|Second Intervention||1
7521735|NCT03684928|18521912|P2|COMPLETED|Second Intervention||19
7521736|NCT03684928|18521913|P1|COMPLETED|Second Intervention||20
7521737|NCT03684928|18521912|P2|STARTED|Second Intervention||19
7521738|NCT03684928|18521913|P1|STARTED|Second Intervention|Two participants discontinued between the first intervention and second intervention.|21
7521739|NCT03684928|18521912|P2|NOT COMPLETED|First Intervention||3
7521740|NCT03684928|18521913|P1|NOT COMPLETED|First Intervention||0
7521741|NCT03684928|18521912|P2|COMPLETED|First Intervention||19
7521742|NCT03684928|18521913|P1|COMPLETED|First Intervention||23
7521743|NCT03684928|18521912|P2|STARTED|First Intervention||22
7521744|NCT03684928|18521913|P1|STARTED|First Intervention||23
7521745|NCT03684265|18521929|P2|NOT COMPLETED|Treatment Period 2||0
7521746|NCT03684265|18521930|P1|NOT COMPLETED|Treatment Period 2||0
7521747|NCT03684265|18521929|P2|COMPLETED|Treatment Period 2||13
7521748|NCT03684265|18521930|P1|COMPLETED|Treatment Period 2||13
7521749|NCT03684265|18521929|P2|STARTED|Treatment Period 2||13
7521750|NCT03684265|18521930|P1|STARTED|Treatment Period 2||13
7521751|NCT03684265|18521929|P2|NOT COMPLETED|Washout Period of 1 Week||0
7521752|NCT03684265|18521930|P1|NOT COMPLETED|Washout Period of 1 Week||0
7521753|NCT03684265|18521929|P2|COMPLETED|Washout Period of 1 Week||13
7521754|NCT03684265|18521930|P1|COMPLETED|Washout Period of 1 Week||13
7521755|NCT03684265|18521929|P2|STARTED|Washout Period of 1 Week||13
7521756|NCT03684265|18521930|P1|STARTED|Washout Period of 1 Week||13
7521757|NCT03684265|18521929|P2|NOT COMPLETED|Treatment Period 1||0
7521758|NCT03684265|18521930|P1|NOT COMPLETED|Treatment Period 1||0
7521759|NCT03684265|18521929|P2|COMPLETED|Treatment Period 1||13
7521760|NCT03684265|18521930|P1|COMPLETED|Treatment Period 1||13
7521761|NCT03684265|18521929|P2|STARTED|Treatment Period 1||13
7521762|NCT03684265|18521930|P1|STARTED|Treatment Period 1||13
7521763|NCT03684044|18521942|P2|NOT COMPLETED|Overall Study||20
7521764|NCT03684044|18521943|P1|NOT COMPLETED|Overall Study||22
7521765|NCT03684044|18521942|P2|COMPLETED|Overall Study||104
7521766|NCT03684044|18521943|P1|COMPLETED|Overall Study||217
7521767|NCT03684044|18521942|P2|STARTED|Overall Study||124
7521768|NCT03684044|18521943|P1|STARTED|Overall Study||239
7521769|NCT03683901|18522000|P1|NOT COMPLETED|Overall Study||0
7521770|NCT03683901|18522000|P1|COMPLETED|Overall Study||10
7521771|NCT03683901|18522000|P1|STARTED|Overall Study||10
7521772|NCT03683758|18522011|P2|NOT COMPLETED|Overall Study||3
7521773|NCT03683758|18522012|P1|NOT COMPLETED|Overall Study||3
7521774|NCT03683758|18522011|P2|COMPLETED|Overall Study||7
7521775|NCT03683758|18522012|P1|COMPLETED|Overall Study||8
7521776|NCT03683758|18522011|P2|STARTED|Overall Study||10
7521777|NCT03683758|18522012|P1|STARTED|Overall Study||11
7521778|NCT03682809|18522026|P2|NOT COMPLETED|Overall Study||0
7521779|NCT03682809|18522027|P1|NOT COMPLETED|Overall Study||0
7521780|NCT03682809|18522026|P2|COMPLETED|Overall Study||24
7521781|NCT03682809|18522027|P1|COMPLETED|Overall Study||22
7521782|NCT03682809|18522026|P2|STARTED|Overall Study||24
7521783|NCT03682809|18522027|P1|STARTED|Overall Study||22
7521784|NCT03681951|18522049|P8|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521785|NCT03681951|18522050|P7|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521786|NCT03681951|18522051|P6|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521787|NCT03681951|18522052|P5|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521788|NCT03681951|18522053|P4|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521789|NCT03681951|18522054|P3|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521790|NCT03681951|18522055|P2|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521791|NCT03681951|18522056|P1|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521792|NCT03681951|18522049|P8|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521793|NCT03681951|18522050|P7|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521794|NCT03681951|18522051|P6|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521795|NCT03681951|18522052|P5|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521796|NCT03681951|18522053|P4|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521797|NCT03681951|18522054|P3|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521798|NCT03681951|18522055|P2|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521799|NCT03681951|18522056|P1|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521800|NCT03681951|18522049|P8|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521801|NCT03681951|18522050|P7|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521802|NCT03681951|18522051|P6|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521803|NCT03681951|18522052|P5|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521804|NCT03681951|18522053|P4|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521805|NCT03681951|18522054|P3|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521806|NCT03681951|18522055|P2|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521807|NCT03681951|18522056|P1|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
7521808|NCT03681951|18522049|P8|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521809|NCT03681951|18522050|P7|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521810|NCT03681951|18522051|P6|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521811|NCT03681951|18522052|P5|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521812|NCT03681951|18522053|P4|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521813|NCT03681951|18522054|P3|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521814|NCT03681951|18522055|P2|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521815|NCT03681951|18522056|P1|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521816|NCT03681951|18522049|P8|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521817|NCT03681951|18522050|P7|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521818|NCT03681951|18522051|P6|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521819|NCT03681951|18522052|P5|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521820|NCT03681951|18522053|P4|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521821|NCT03681951|18522054|P3|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521822|NCT03681951|18522055|P2|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521823|NCT03681951|18522056|P1|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521824|NCT03681951|18522049|P8|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521825|NCT03681951|18522050|P7|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521826|NCT03681951|18522051|P6|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521827|NCT03681951|18522052|P5|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521828|NCT03681951|18522053|P4|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521829|NCT03681951|18522054|P3|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521830|NCT03681951|18522055|P2|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521831|NCT03681951|18522056|P1|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
7521832|NCT03681951|18522049|P8|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
7521833|NCT03681951|18522050|P7|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
7521834|NCT03681951|18522051|P6|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
7521835|NCT03681951|18522052|P5|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
7521836|NCT03681951|18522053|P4|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
7521837|NCT03681951|18522054|P3|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
7521838|NCT03681951|18522055|P2|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
7521839|NCT03681951|18522056|P1|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
7521840|NCT03681951|18522049|P8|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
7521841|NCT03681951|18522050|P7|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
7521842|NCT03681951|18522051|P6|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
7521843|NCT03681951|18522052|P5|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
7521844|NCT03681951|18522053|P4|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
7521845|NCT03681951|18522054|P3|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
7521846|NCT03681951|18522055|P2|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
7521847|NCT03681951|18522056|P1|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
7521848|NCT03681951|18522049|P8|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
7521849|NCT03681951|18522050|P7|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
7521850|NCT03681951|18522051|P6|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
7521851|NCT03681951|18522052|P5|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
7521852|NCT03681951|18522053|P4|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
7521853|NCT03681951|18522054|P3|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
7521854|NCT03681951|18522055|P2|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
7521855|NCT03681951|18522056|P1|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
7521856|NCT03681951|18522049|P8|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
7521857|NCT03681951|18522050|P7|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
7521858|NCT03681951|18522051|P6|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
7521859|NCT03681951|18522052|P5|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
7521860|NCT03681951|18522053|P4|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
7521861|NCT03681951|18522054|P3|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
7521862|NCT03681951|18522055|P2|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
7521863|NCT03681951|18522056|P1|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||8
7521864|NCT03681951|18522049|P8|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
7521865|NCT03681951|18522050|P7|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
7521866|NCT03681951|18522051|P6|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
7521867|NCT03681951|18522052|P5|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
7521868|NCT03681951|18522053|P4|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
7521869|NCT03681951|18522054|P3|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
7521870|NCT03681951|18522055|P2|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
7521871|NCT03681951|18522056|P1|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
7521872|NCT03681951|18522049|P8|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 4 was not initiated as this study was terminated during Part 1|0
7521873|NCT03681951|18522050|P7|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 3 was not initiated as this study was terminated during Part 1|0
7521874|NCT03681951|18522051|P6|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 2 was not initiated as this study was terminated during Part 1|0
7521875|NCT03681951|18522052|P5|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
7521876|NCT03681951|18522053|P4|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
7521877|NCT03681951|18522054|P3|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID."|0
7521878|NCT03681951|18522055|P2|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
7521879|NCT03681951|18522056|P1|STARTED|Part1: Monotherapy DE (Up to Day 95)||8
7521880|NCT03681808|18522249|P2|NOT COMPLETED|Overall Study||17
7521881|NCT03681808|18522250|P1|NOT COMPLETED|Overall Study||14
7521882|NCT03681808|18522249|P2|COMPLETED|Overall Study||102
7521883|NCT03681808|18522250|P1|COMPLETED|Overall Study||109
7521884|NCT03681808|18522249|P2|STARTED|Overall Study||119
7521885|NCT03681808|18522250|P1|STARTED|Overall Study||123
7521886|NCT03681119|18522258|P2|NOT COMPLETED|Overall Study||0
7521887|NCT03681119|18522259|P1|NOT COMPLETED|Overall Study||6
7521888|NCT03681119|18522258|P2|COMPLETED|Overall Study||11
7521889|NCT03681119|18522259|P1|COMPLETED|Overall Study||66
7521890|NCT03681119|18522258|P2|STARTED|Overall Study||11
7521891|NCT03681119|18522259|P1|STARTED|Overall Study||72
7521892|NCT03680105|18522272|P9|NOT COMPLETED|Overall Study||0
7521893|NCT03680105|18522273|P8|NOT COMPLETED|Overall Study||0
7521894|NCT03680105|18522274|P7|NOT COMPLETED|Overall Study||0
7521895|NCT03680105|18522275|P6|NOT COMPLETED|Overall Study||0
7521896|NCT03680105|18522276|P5|NOT COMPLETED|Overall Study||0
7521897|NCT03680105|18522277|P4|NOT COMPLETED|Overall Study||0
7521898|NCT03680105|18522278|P3|NOT COMPLETED|Overall Study||0
7521899|NCT03680105|18522279|P2|NOT COMPLETED|Overall Study||0
7521900|NCT03680105|18522280|P1|NOT COMPLETED|Overall Study||0
7521901|NCT03680105|18522272|P9|COMPLETED|Overall Study||8
7521902|NCT03680105|18522273|P8|COMPLETED|Overall Study||8
7521903|NCT03680105|18522274|P7|COMPLETED|Overall Study||8
7521904|NCT03680105|18522275|P6|COMPLETED|Overall Study||12
7521905|NCT03680105|18522276|P5|COMPLETED|Overall Study||8
7521906|NCT03680105|18522277|P4|COMPLETED|Overall Study||8
7521907|NCT03680105|18522278|P3|COMPLETED|Overall Study||8
7521908|NCT03680105|18522279|P2|COMPLETED|Overall Study||8
7521909|NCT03680105|18522280|P1|COMPLETED|Overall Study||8
7521910|NCT03680105|18522272|P9|STARTED|Overall Study||8
7521911|NCT03680105|18522273|P8|STARTED|Overall Study||8
7521912|NCT03680105|18522274|P7|STARTED|Overall Study||8
7521913|NCT03680105|18522275|P6|STARTED|Overall Study||12
7521914|NCT03680105|18522276|P5|STARTED|Overall Study||8
7521915|NCT03680105|18522277|P4|STARTED|Overall Study||8
7521916|NCT03680105|18522278|P3|STARTED|Overall Study||8
7521917|NCT03680105|18522279|P2|STARTED|Overall Study||8
7521918|NCT03680105|18522280|P1|STARTED|Overall Study||8
7521919|NCT03679975|18522326|P1|NOT COMPLETED|Overall Study||0
7521920|NCT03679975|18522326|P1|COMPLETED|Overall Study||9
7521921|NCT03679975|18522326|P1|STARTED|Overall Study||9
7521922|NCT03679741|18522330|P2|NOT COMPLETED|Period 3||0
7521923|NCT03679741|18522331|P1|NOT COMPLETED|Period 3||0
7521924|NCT03679741|18522330|P2|COMPLETED|Period 3||56
7521925|NCT03679741|18522331|P1|COMPLETED|Period 3||54
7521926|NCT03679741|18522330|P2|STARTED|Period 3||56
7521927|NCT03679741|18522331|P1|STARTED|Period 3||54
7521928|NCT03679741|18522330|P2|NOT COMPLETED|Period 2||2
7521929|NCT03679741|18522331|P1|NOT COMPLETED|Period 2||3
7521930|NCT03679741|18522330|P2|COMPLETED|Period 2||56
7521931|NCT03679741|18522331|P1|COMPLETED|Period 2||54
7521932|NCT03679741|18522330|P2|STARTED|Period 2||58
7521933|NCT03679741|18522331|P1|STARTED|Period 2||57
7521934|NCT03679741|18522330|P2|NOT COMPLETED|Period 1||3
7521935|NCT03679741|18522331|P1|NOT COMPLETED|Period 1||2
7521936|NCT03679741|18522330|P2|COMPLETED|Period 1||58
7521937|NCT03679741|18522331|P1|COMPLETED|Period 1||57
7521938|NCT03679741|18522330|P2|STARTED|Period 1||61
7521939|NCT03679741|18522331|P1|STARTED|Period 1||59
7521940|NCT03679494|18522353|P2|NOT COMPLETED|Overall Study||0
7521941|NCT03679494|18522354|P1|NOT COMPLETED|Overall Study||0
7521942|NCT03679494|18522353|P2|COMPLETED|Overall Study||63
7521943|NCT03679494|18522354|P1|COMPLETED|Overall Study||67
7521944|NCT03679494|18522353|P2|STARTED|Overall Study||63
7521945|NCT03679494|18522354|P1|STARTED|Overall Study||67
7521946|NCT03678870|18522374|P2|NOT COMPLETED|Overall Study||8
7521947|NCT03678870|18522375|P1|NOT COMPLETED|Overall Study||13
7521948|NCT03678870|18522374|P2|COMPLETED|Overall Study||91
7521949|NCT03678870|18522375|P1|COMPLETED|Overall Study||84
7521950|NCT03678870|18522374|P2|STARTED|Overall Study||99
7521951|NCT03678870|18522375|P1|STARTED|Overall Study||97
7521952|NCT03678311|18522387|P1|NOT COMPLETED|Overall Study||0
7521953|NCT03678311|18522387|P1|COMPLETED|Overall Study||9
7521954|NCT03678311|18522387|P1|STARTED|Overall Study||9
7521955|NCT03677401|18522395|P2|NOT COMPLETED|Overall Study||18
7521956|NCT03677401|18522396|P1|NOT COMPLETED|Overall Study||10
7521957|NCT03677401|18522395|P2|COMPLETED|Overall Study||129
7521958|NCT03677401|18522396|P1|COMPLETED|Overall Study||138
7521959|NCT03677401|18522395|P2|STARTED|Overall Study||147
7521960|NCT03677401|18522396|P1|STARTED|Overall Study||148
7521961|NCT03677375|18522420|P1|NOT COMPLETED|Overall Study||12
7521962|NCT03677375|18522420|P1|COMPLETED|Overall Study||81
7521963|NCT03677375|18522420|P1|STARTED|Overall Study||93
7521964|NCT03677245|18522424|P1|NOT COMPLETED|Overall Study||0
7521965|NCT03677245|18522424|P1|COMPLETED|Overall Study||8
7521966|NCT03677245|18522424|P1|STARTED|Overall Study||8
7521967|NCT03677089|18522431|P1|NOT COMPLETED|Overall Study||34
7521968|NCT03677089|18522431|P1|COMPLETED|Overall Study||114
7521969|NCT03677089|18522431|P1|Follow-Up|Overall Study||114
7521970|NCT03677089|18522431|P1|Post-Intervention|Overall Study||117
7521971|NCT03677089|18522431|P1|Mid-Intervention|Overall Study||120
7521972|NCT03677089|18522431|P1|Baseline/Pre-Intervention|Overall Study||137
7521973|NCT03677089|18522431|P1|STARTED|Overall Study||148
7521974|NCT03676803|18522462|P2|NOT COMPLETED|Overall Study||0
7521975|NCT03676803|18522463|P1|NOT COMPLETED|Overall Study||0
7521976|NCT03676803|18522462|P2|COMPLETED|Overall Study||16
7521977|NCT03676803|18522463|P1|COMPLETED|Overall Study||15
7521978|NCT03676803|18522462|P2|STARTED|Overall Study||16
7521979|NCT03676803|18522463|P1|STARTED|Overall Study||15
7521980|NCT03675776|18522474|P3|NOT COMPLETED|Safety Follow-up Period||0
7521981|NCT03675776|18522475|P2|NOT COMPLETED|Safety Follow-up Period||0
7521982|NCT03675776|18522476|P1|NOT COMPLETED|Safety Follow-up Period||0
7521983|NCT03675776|18522474|P3|COMPLETED|Safety Follow-up Period||7
7521984|NCT03675776|18522475|P2|COMPLETED|Safety Follow-up Period||8
7521985|NCT03675776|18522476|P1|COMPLETED|Safety Follow-up Period||6
7521986|NCT03675776|18522474|P3|STARTED|Safety Follow-up Period||7
7521987|NCT03675776|18522475|P2|STARTED|Safety Follow-up Period||8
7521988|NCT03675776|18522476|P1|STARTED|Safety Follow-up Period||6
7521989|NCT03675776|18522474|P3|NOT COMPLETED|Double Blind Treatment Period||8
7521990|NCT03675776|18522475|P2|NOT COMPLETED|Double Blind Treatment Period||6
7521991|NCT03675776|18522476|P1|NOT COMPLETED|Double Blind Treatment Period||6
7521992|NCT03675776|18522474|P3|COMPLETED|Double Blind Treatment Period||10
7521993|NCT03675776|18522475|P2|COMPLETED|Double Blind Treatment Period||11
7521994|NCT03675776|18522476|P1|COMPLETED|Double Blind Treatment Period||9
7521995|NCT03675776|18522474|P3|STARTED|Double Blind Treatment Period||18
7521996|NCT03675776|18522475|P2|STARTED|Double Blind Treatment Period||17
7521997|NCT03675776|18522476|P1|STARTED|Double Blind Treatment Period||15
7521998|NCT03675685|18522487|P1|NOT COMPLETED|Overall Study||0
7521999|NCT03675685|18522487|P1|COMPLETED|Overall Study||12
7522000|NCT03675685|18522487|P1|STARTED|Overall Study||12
7522001|NCT03675581|18522503|P1|NOT COMPLETED|Period 2: Microgynon + Nintedanib||0
7522002|NCT03675581|18522503|P1|COMPLETED|Period 2: Microgynon + Nintedanib||17
7522003|NCT03675581|18522503|P1|STARTED|Period 2: Microgynon + Nintedanib||17
7522004|NCT03675581|18522503|P1|NOT COMPLETED|Period 1: Microgynon Alone||0
7522005|NCT03675581|18522503|P1|COMPLETED|Period 1: Microgynon Alone||17
7522006|NCT03675581|18522503|P1|STARTED|Period 1: Microgynon Alone||17
7522007|NCT03675451|18522521|P1|NOT COMPLETED|Overall Study||0
7522008|NCT03675451|18522521|P1|COMPLETED|Overall Study||20
7522009|NCT03675451|18522521|P1|STARTED|Overall Study||20
7522010|NCT03674177|18522542|P4|NOT COMPLETED|Overall Study||2
7522011|NCT03674177|18522543|P3|NOT COMPLETED|Overall Study||0
7522012|NCT03674177|18522544|P2|NOT COMPLETED|Overall Study||1
7522013|NCT03674177|18522545|P1|NOT COMPLETED|Overall Study||2
7522014|NCT03674177|18522542|P4|COMPLETED|Overall Study||124
7522015|NCT03674177|18522543|P3|COMPLETED|Overall Study||126
7522016|NCT03674177|18522544|P2|COMPLETED|Overall Study||125
7522017|NCT03674177|18522545|P1|COMPLETED|Overall Study||122
7522018|NCT03674177|18522542|P4|STARTED|Overall Study||126
7522019|NCT03674177|18522543|P3|STARTED|Overall Study||126
7522020|NCT03674177|18522544|P2|STARTED|Overall Study||126
7522021|NCT03674177|18522545|P1|STARTED|Overall Study||124
7522022|NCT03673670|18522617|P6|NOT COMPLETED|Treatment Period 3 (3 Days)||0
7522023|NCT03673670|18522618|P5|NOT COMPLETED|Treatment Period 3 (3 Days)||1
7522024|NCT03673670|18522619|P4|NOT COMPLETED|Treatment Period 3 (3 Days)||0
7522025|NCT03673670|18522620|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
7522026|NCT03673670|18522621|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
7522027|NCT03673670|18522622|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
7522028|NCT03673670|18522617|P6|COMPLETED|Treatment Period 3 (3 Days)||11
7522029|NCT03673670|18522618|P5|COMPLETED|Treatment Period 3 (3 Days)||10
7522030|NCT03673670|18522619|P4|COMPLETED|Treatment Period 3 (3 Days)||12
7522031|NCT03673670|18522620|P3|COMPLETED|Treatment Period 3 (3 Days)||11
7522032|NCT03673670|18522621|P2|COMPLETED|Treatment Period 3 (3 Days)||14
7522033|NCT03673670|18522622|P1|COMPLETED|Treatment Period 3 (3 Days)||13
7522034|NCT03673670|18522617|P6|STARTED|Treatment Period 3 (3 Days)||11
7522035|NCT03673670|18522618|P5|STARTED|Treatment Period 3 (3 Days)||11
7522036|NCT03673670|18522619|P4|STARTED|Treatment Period 3 (3 Days)||12
7522037|NCT03673670|18522620|P3|STARTED|Treatment Period 3 (3 Days)||11
7522038|NCT03673670|18522621|P2|STARTED|Treatment Period 3 (3 Days)||14
7522039|NCT03673670|18522622|P1|STARTED|Treatment Period 3 (3 Days)||13
7522040|NCT03673670|18522617|P6|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
7522041|NCT03673670|18522618|P5|NOT COMPLETED|Washout Period 2 (7-14 Days)||1
7522042|NCT03673670|18522619|P4|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
7522043|NCT03673670|18522620|P3|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
7522044|NCT03673670|18522621|P2|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
7522045|NCT03673670|18522622|P1|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
7522046|NCT03673670|18522617|P6|COMPLETED|Washout Period 2 (7-14 Days)||11
7522047|NCT03673670|18522618|P5|COMPLETED|Washout Period 2 (7-14 Days)||11
7522048|NCT03673670|18522619|P4|COMPLETED|Washout Period 2 (7-14 Days)||12
7522049|NCT03673670|18522620|P3|COMPLETED|Washout Period 2 (7-14 Days)||11
7522050|NCT03673670|18522621|P2|COMPLETED|Washout Period 2 (7-14 Days)||14
7522051|NCT03673670|18522622|P1|COMPLETED|Washout Period 2 (7-14 Days)||13
7522052|NCT03673670|18522617|P6|STARTED|Washout Period 2 (7-14 Days)||11
7522053|NCT03673670|18522618|P5|STARTED|Washout Period 2 (7-14 Days)||12
7522054|NCT03673670|18522619|P4|STARTED|Washout Period 2 (7-14 Days)||12
7522055|NCT03673670|18522620|P3|STARTED|Washout Period 2 (7-14 Days)||11
7522056|NCT03673670|18522621|P2|STARTED|Washout Period 2 (7-14 Days)||14
7522057|NCT03673670|18522622|P1|STARTED|Washout Period 2 (7-14 Days)||13
7522058|NCT03673670|18522617|P6|NOT COMPLETED|Treatment Period 2 (3 Days)||0
7522059|NCT03673670|18522618|P5|NOT COMPLETED|Treatment Period 2 (3 Days)||1
7522060|NCT03673670|18522619|P4|NOT COMPLETED|Treatment Period 2 (3 Days)||0
7522061|NCT03673670|18522620|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||1
7522062|NCT03673670|18522621|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||0
7522063|NCT03673670|18522622|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
7522064|NCT03673670|18522617|P6|COMPLETED|Treatment Period 2 (3 Days)||11
7522065|NCT03673670|18522618|P5|COMPLETED|Treatment Period 2 (3 Days)||12
7522066|NCT03673670|18522619|P4|COMPLETED|Treatment Period 2 (3 Days)||12
7522067|NCT03673670|18522620|P3|COMPLETED|Treatment Period 2 (3 Days)||11
7522068|NCT03673670|18522621|P2|COMPLETED|Treatment Period 2 (3 Days)||14
7522069|NCT03673670|18522622|P1|COMPLETED|Treatment Period 2 (3 Days)||13
7522070|NCT03673670|18522617|P6|STARTED|Treatment Period 2 (3 Days)||11
7522071|NCT03673670|18522618|P5|STARTED|Treatment Period 2 (3 Days)||13
7522072|NCT03673670|18522619|P4|STARTED|Treatment Period 2 (3 Days)||12
7522073|NCT03673670|18522620|P3|STARTED|Treatment Period 2 (3 Days)||12
7522074|NCT03673670|18522621|P2|STARTED|Treatment Period 2 (3 Days)||14
7522075|NCT03673670|18522622|P1|STARTED|Treatment Period 2 (3 Days)||13
7522076|NCT03673670|18522617|P6|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
7522077|NCT03673670|18522618|P5|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
7522078|NCT03673670|18522619|P4|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
7522079|NCT03673670|18522620|P3|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
7522080|NCT03673670|18522621|P2|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
7522081|NCT03673670|18522622|P1|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
7522082|NCT03673670|18522617|P6|COMPLETED|Washout Period 1 (7-14 Days)||11
7522083|NCT03673670|18522618|P5|COMPLETED|Washout Period 1 (7-14 Days)||13
7522084|NCT03673670|18522619|P4|COMPLETED|Washout Period 1 (7-14 Days)||12
7522085|NCT03673670|18522620|P3|COMPLETED|Washout Period 1 (7-14 Days)||12
7522086|NCT03673670|18522621|P2|COMPLETED|Washout Period 1 (7-14 Days)||14
7522087|NCT03673670|18522622|P1|COMPLETED|Washout Period 1 (7-14 Days)||13
7522088|NCT03673670|18522617|P6|STARTED|Washout Period 1 (7-14 Days)||11
7522089|NCT03673670|18522618|P5|STARTED|Washout Period 1 (7-14 Days)||13
7522090|NCT03673670|18522619|P4|STARTED|Washout Period 1 (7-14 Days)||12
7522091|NCT03673670|18522620|P3|STARTED|Washout Period 1 (7-14 Days)||12
7522092|NCT03673670|18522621|P2|STARTED|Washout Period 1 (7-14 Days)||14
7522093|NCT03673670|18522622|P1|STARTED|Washout Period 1 (7-14 Days)||13
7522094|NCT03673670|18522617|P6|NOT COMPLETED|Treatment Period 1 (3 Days)||2
7522095|NCT03673670|18522618|P5|NOT COMPLETED|Treatment Period 1 (3 Days)||0
7522096|NCT03673670|18522619|P4|NOT COMPLETED|Treatment Period 1 (3 Days)||0
7522097|NCT03673670|18522620|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||1
7522098|NCT03673670|18522621|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
7522099|NCT03673670|18522622|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||1
7522100|NCT03673670|18522617|P6|COMPLETED|Treatment Period 1 (3 Days)||11
7522101|NCT03673670|18522618|P5|COMPLETED|Treatment Period 1 (3 Days)||13
7522102|NCT03673670|18522619|P4|COMPLETED|Treatment Period 1 (3 Days)||12
7522103|NCT03673670|18522620|P3|COMPLETED|Treatment Period 1 (3 Days)||12
7522104|NCT03673670|18522621|P2|COMPLETED|Treatment Period 1 (3 Days)||14
7522105|NCT03673670|18522622|P1|COMPLETED|Treatment Period 1 (3 Days)||13
7522106|NCT03673670|18522617|P6|STARTED|Treatment Period 1 (3 Days)||13
7522107|NCT03673670|18522618|P5|STARTED|Treatment Period 1 (3 Days)||13
7522108|NCT03673670|18522619|P4|STARTED|Treatment Period 1 (3 Days)||12
7522109|NCT03673670|18522620|P3|STARTED|Treatment Period 1 (3 Days)||13
7522110|NCT03673670|18522621|P2|STARTED|Treatment Period 1 (3 Days)||14
7522111|NCT03673670|18522622|P1|STARTED|Treatment Period 1 (3 Days)||14
7522112|NCT03670537|18522669|P1|NOT COMPLETED|Overall Study||1
7522113|NCT03670537|18522669|P1|COMPLETED|Overall Study||101
7522114|NCT03670537|18522669|P1|STARTED|Overall Study||102
7522115|NCT03669081|18522675|P2|NOT COMPLETED|Overall Study||1
7522116|NCT03669081|18522676|P1|NOT COMPLETED|Overall Study||1
7522117|NCT03669081|18522675|P2|COMPLETED|Overall Study||29
7522118|NCT03669081|18522676|P1|COMPLETED|Overall Study||33
7522119|NCT03669081|18522675|P2|STARTED|Overall Study||30
7522120|NCT03669081|18522676|P1|STARTED|Overall Study||34
7522121|NCT03668600|18522692|P1|NOT COMPLETED|Overall Study||230
7522122|NCT03668600|18522692|P1|COMPLETED|Overall Study||0
7522123|NCT03668600|18522692|P1|STARTED|Overall Study||230
7522124|NCT03667547|18522696|P1|NOT COMPLETED|Overall Study||0
7522125|NCT03667547|18522696|P1|COMPLETED|Overall Study||12
7522126|NCT03667547|18522696|P1|STARTED|Overall Study||12
7522127|NCT03664544|18522712|P2|NOT COMPLETED|Overall Study||0
7522128|NCT03664544|18522713|P1|NOT COMPLETED|Overall Study||0
7522129|NCT03664544|18522712|P2|COMPLETED|Overall Study||6
7522130|NCT03664544|18522713|P1|COMPLETED|Overall Study||6
7522131|NCT03664544|18522712|P2|STARTED|Overall Study||6
7522132|NCT03664544|18522713|P1|STARTED|Overall Study||6
7522133|NCT03663582|18522743|P1|NOT COMPLETED|Overall Study||1
7522134|NCT03663582|18522743|P1|COMPLETED|Overall Study||6
7522135|NCT03663582|18522743|P1|STARTED|Overall Study||7
7522136|NCT03663569|18522775|P1|NOT COMPLETED|Overall Study||63
7522137|NCT03663569|18522775|P1|COMPLETED|Overall Study||4756
7522138|NCT03663569|18522775|P1|STARTED|Overall Study||4819
7522139|NCT03663179|18522788|P2|NOT COMPLETED|Overall Study||1
7522140|NCT03663179|18522789|P1|NOT COMPLETED|Overall Study||4
7522141|NCT03663179|18522788|P2|COMPLETED|Overall Study||13
7522142|NCT03663179|18522789|P1|COMPLETED|Overall Study||14
7522143|NCT03663179|18522788|P2|STARTED|Overall Study||14
7522144|NCT03663179|18522789|P1|STARTED|Overall Study||18
7522145|NCT03663101|18522801|P4|NOT COMPLETED|Overall Study||0
7522146|NCT03663101|18522802|P3|NOT COMPLETED|Overall Study||0
7522147|NCT03663101|18522803|P2|NOT COMPLETED|Overall Study||0
7522148|NCT03663101|18522804|P1|NOT COMPLETED|Overall Study||0
7522149|NCT03663101|18522801|P4|COMPLETED|Overall Study||4
7522150|NCT03663101|18522802|P3|COMPLETED|Overall Study||5
7522151|NCT03663101|18522803|P2|COMPLETED|Overall Study||3
7522152|NCT03663101|18522804|P1|COMPLETED|Overall Study||4
7522153|NCT03663101|18522801|P4|STARTED|Overall Study||4
7522154|NCT03663101|18522802|P3|STARTED|Overall Study||5
7522155|NCT03663101|18522803|P2|STARTED|Overall Study||3
7522156|NCT03663101|18522804|P1|STARTED|Overall Study||4
7522157|NCT03662334|18522836|P2|NOT COMPLETED|Part 3: Treatment Period 2||0
7522158|NCT03662334|18522837|P1|NOT COMPLETED|Part 3: Treatment Period 2||0
7522159|NCT03662334|18522836|P2|COMPLETED|Part 3: Treatment Period 2||0
7522160|NCT03662334|18522837|P1|COMPLETED|Part 3: Treatment Period 2||0
7522161|NCT03662334|18522836|P2|STARTED|Part 3: Treatment Period 2||0
7522162|NCT03662334|18522837|P1|STARTED|Part 3: Treatment Period 2||0
7522163|NCT03662334|18522836|P2|NOT COMPLETED|Part 3: Treatment Period 1||0
7522164|NCT03662334|18522837|P1|NOT COMPLETED|Part 3: Treatment Period 1||0
7522165|NCT03662334|18522836|P2|COMPLETED|Part 3: Treatment Period 1||0
7522166|NCT03662334|18522837|P1|COMPLETED|Part 3: Treatment Period 1||0
7522167|NCT03662334|18522836|P2|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
7522168|NCT03662334|18522837|P1|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
7522169|NCT03662334|18522836|P2|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||0
7522170|NCT03662334|18522837|P1|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||1
7522171|NCT03662334|18522836|P2|COMPLETED|Part 2: Treatment Period 2 (2 Days)||7
7522172|NCT03662334|18522837|P1|COMPLETED|Part 2: Treatment Period 2 (2 Days)||6
7522173|NCT03662334|18522836|P2|STARTED|Part 2: Treatment Period 2 (2 Days)||7
7522174|NCT03662334|18522837|P1|STARTED|Part 2: Treatment Period 2 (2 Days)||7
7522175|NCT03662334|18522836|P2|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
7522176|NCT03662334|18522837|P1|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
7522177|NCT03662334|18522836|P2|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
7522178|NCT03662334|18522837|P1|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
7522179|NCT03662334|18522836|P2|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
7522180|NCT03662334|18522837|P1|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
7522181|NCT03662334|18522836|P2|NOT COMPLETED|Part 1: Treatment Period 2||0
7522182|NCT03662334|18522837|P1|NOT COMPLETED|Part 1: Treatment Period 2||0
7522183|NCT03662334|18522836|P2|COMPLETED|Part 1: Treatment Period 2||0
7522184|NCT03662334|18522837|P1|COMPLETED|Part 1: Treatment Period 2||0
7522185|NCT03662334|18522836|P2|STARTED|Part 1: Treatment Period 2||0
7522186|NCT03662334|18522837|P1|STARTED|Part 1: Treatment Period 2||0
7522187|NCT03662334|18522836|P2|NOT COMPLETED|Part 1: Treatment Period 1||0
7522188|NCT03662334|18522837|P1|NOT COMPLETED|Part 1: Treatment Period 1||0
7522189|NCT03662334|18522836|P2|COMPLETED|Part 1: Treatment Period 1||0
7522190|NCT03662334|18522837|P1|COMPLETED|Part 1: Treatment Period 1||0
7522191|NCT03662334|18522836|P2|STARTED|Part 1: Treatment Period 1||0
7522192|NCT03662334|18522837|P1|STARTED|Part 1: Treatment Period 1||0
7522193|NCT03662282|18522873|P1|NOT COMPLETED|Overall Study||0
7522194|NCT03662282|18522873|P1|COMPLETED|Overall Study||2
7522195|NCT03662282|18522873|P1|STARTED|Overall Study||2
7522196|NCT03662139|18522883|P2|NOT COMPLETED|Overall Study||0
7522197|NCT03662139|18522884|P1|NOT COMPLETED|Overall Study||0
7522198|NCT03662139|18522883|P2|COMPLETED|Overall Study||16
7522199|NCT03662139|18522884|P1|COMPLETED|Overall Study||16
7522200|NCT03662139|18522883|P2|STARTED|Overall Study||16
7522201|NCT03662139|18522884|P1|STARTED|Overall Study||16
7522202|NCT03661814|18522898|P2|NOT COMPLETED|Overall Study||0
7522203|NCT03661814|18522899|P1|NOT COMPLETED|Overall Study||0
7522204|NCT03661814|18522898|P2|COMPLETED|Overall Study||5
7522205|NCT03661814|18522899|P1|COMPLETED|Overall Study||2
7522206|NCT03661814|18522898|P2|STARTED|Overall Study||5
7522207|NCT03661814|18522899|P1|STARTED|Overall Study||2
7522208|NCT03661762|18522909|P1|NOT COMPLETED|Overall Study||8
7522209|NCT03661762|18522909|P1|COMPLETED|Overall Study||10
7522210|NCT03661762|18522909|P1|STARTED|Overall Study||18
7522211|NCT03661697|18522923|P2|NOT COMPLETED|Overall Study||0
7522212|NCT03661697|18522924|P1|NOT COMPLETED|Overall Study||0
7522213|NCT03661697|18522923|P2|COMPLETED|Overall Study||7
7522214|NCT03661697|18522924|P1|COMPLETED|Overall Study||7
7522215|NCT03661697|18522923|P2|STARTED|Overall Study||7
7522216|NCT03661697|18522924|P1|STARTED|Overall Study||7
7522217|NCT03660839|18522936|P4|NOT COMPLETED|Overall Study||0
7522218|NCT03660839|18522937|P3|NOT COMPLETED|Overall Study||0
7522219|NCT03660839|18522938|P2|NOT COMPLETED|Overall Study||0
7522220|NCT03660839|18522939|P1|NOT COMPLETED|Overall Study||0
7522221|NCT03660839|18522936|P4|COMPLETED|Overall Study||33
7522222|NCT03660839|18522937|P3|COMPLETED|Overall Study||36
7522223|NCT03660839|18522938|P2|COMPLETED|Overall Study||36
7522224|NCT03660839|18522939|P1|COMPLETED|Overall Study||35
7522225|NCT03660839|18522936|P4|STARTED|Overall Study||33
7522226|NCT03660839|18522937|P3|STARTED|Overall Study||36
7522227|NCT03660839|18522938|P2|STARTED|Overall Study||36
7522228|NCT03660839|18522939|P1|STARTED|Overall Study||35
7522229|NCT03660787|18523043|P4|NOT COMPLETED|Overall Study||0
7522230|NCT03660787|18523044|P3|NOT COMPLETED|Overall Study||1
7522231|NCT03660787|18523045|P2|NOT COMPLETED|Overall Study||1
7522232|NCT03660787|18523046|P1|NOT COMPLETED|Overall Study||1
7522233|NCT03660787|18523043|P4|COMPLETED|Overall Study||26
7522234|NCT03660787|18523044|P3|COMPLETED|Overall Study||25
7522235|NCT03660787|18523045|P2|COMPLETED|Overall Study||25
7522236|NCT03660787|18523046|P1|COMPLETED|Overall Study||25
7522237|NCT03660787|18523043|P4|STARTED|Overall Study||26
7522238|NCT03660787|18523044|P3|STARTED|Overall Study||26
7522239|NCT03660787|18523045|P2|STARTED|Overall Study||26
7522240|NCT03660787|18523046|P1|STARTED|Overall Study||26
7522241|NCT03660241|18523083|P3|NOT COMPLETED|Overall Study||0
7522242|NCT03660241|18523084|P2|NOT COMPLETED|Overall Study||0
7522243|NCT03660241|18523085|P1|NOT COMPLETED|Overall Study||0
7522244|NCT03660241|18523083|P3|COMPLETED|Overall Study||8
7522245|NCT03660241|18523084|P2|COMPLETED|Overall Study||7
7522246|NCT03660241|18523085|P1|COMPLETED|Overall Study||8
7522247|NCT03660241|18523083|P3|STARTED|Overall Study||8
7522248|NCT03660241|18523084|P2|STARTED|Overall Study||7
7522249|NCT03660241|18523085|P1|STARTED|Overall Study||8
7522250|NCT03658889|18523128|P2|NOT COMPLETED|Overall Study||0
7522251|NCT03658889|18523129|P1|NOT COMPLETED|Overall Study||2
7522252|NCT03658889|18523128|P2|COMPLETED|Overall Study||69
7522253|NCT03658889|18523129|P1|COMPLETED|Overall Study|Analysis population|306
7522254|NCT03658889|18523128|P2|STARTED|Overall Study||69
7522255|NCT03658889|18523129|P1|STARTED|Overall Study|Enrolled population|308
7522256|NCT03658876|18523160|P2|NOT COMPLETED|Overall Study||12
7522257|NCT03658876|18523161|P1|NOT COMPLETED|Overall Study||12
7522258|NCT03658876|18523160|P2|COMPLETED|Overall Study||84
7522259|NCT03658876|18523161|P1|COMPLETED|Overall Study||76
7522260|NCT03658876|18523160|P2|STARTED|Overall Study||96
7522261|NCT03658876|18523161|P1|STARTED|Overall Study||88
7522262|NCT03658811|18523167|P1|NOT COMPLETED|Overall Study||3
7522263|NCT03658811|18523167|P1|COMPLETED|Overall Study||16
7522264|NCT03658811|18523167|P1|STARTED|Overall Study||19
7522265|NCT03657407|18523176|P2|NOT COMPLETED|Overall Study||0
7522266|NCT03657407|18523177|P1|NOT COMPLETED|Overall Study||0
7522267|NCT03657407|18523176|P2|COMPLETED|Overall Study||27
7522268|NCT03657407|18523177|P1|COMPLETED|Overall Study||29
7522269|NCT03657407|18523176|P2|STARTED|Overall Study||27
7522270|NCT03657407|18523177|P1|STARTED|Overall Study||29
7522271|NCT03657264|18523193|P4|NOT COMPLETED|Overall Study||0
7522272|NCT03657264|18523194|P3|NOT COMPLETED|Overall Study||0
7522273|NCT03657264|18523195|P2|NOT COMPLETED|Overall Study||0
7522274|NCT03657264|18523196|P1|NOT COMPLETED|Overall Study||0
7522275|NCT03657264|18523193|P4|COMPLETED|Overall Study||12
7522276|NCT03657264|18523194|P3|COMPLETED|Overall Study||12
7522277|NCT03657264|18523195|P2|COMPLETED|Overall Study||12
7522278|NCT03657264|18523196|P1|COMPLETED|Overall Study||12
7522279|NCT03657264|18523193|P4|STARTED|Overall Study||12
7522280|NCT03657264|18523194|P3|STARTED|Overall Study||12
7522281|NCT03657264|18523195|P2|STARTED|Overall Study||12
7522282|NCT03657264|18523196|P1|STARTED|Overall Study||12
7522283|NCT03657095|18523211|P2|NOT COMPLETED|Overall Study||53
7522284|NCT03657095|18523212|P1|NOT COMPLETED|Overall Study||59
7522285|NCT03657095|18523211|P2|COMPLETED|Overall Study||0
7522286|NCT03657095|18523212|P1|COMPLETED|Overall Study||0
7522287|NCT03657095|18523211|P2|Received at Least 1 Dose of Study Drug|Overall Study||53
7522288|NCT03657095|18523212|P1|Received at Least 1 Dose of Study Drug|Overall Study||59
7522289|NCT03657095|18523211|P2|STARTED|Overall Study||53
7522290|NCT03657095|18523212|P1|STARTED|Overall Study||59
7522291|NCT03655951|18523228|P2|NOT COMPLETED|Overall Study||21
7522292|NCT03655951|18523229|P1|NOT COMPLETED|Overall Study||39
7522293|NCT03655951|18523228|P2|COMPLETED|Overall Study||351
7522294|NCT03655951|18523229|P1|COMPLETED|Overall Study||319
7522295|NCT03655951|18523228|P2|Completed Pretest|Overall Study||366
7522296|NCT03655951|18523229|P1|Completed Pretest|Overall Study||344
7522297|NCT03655951|18523228|P2|STARTED|Overall Study||372
7522298|NCT03655951|18523229|P1|STARTED|Overall Study||358
7522299|NCT03655444|18523391|P2|NOT COMPLETED|Overall Study||0
7522300|NCT03655444|18523392|P1|NOT COMPLETED|Overall Study||0
7522301|NCT03655444|18523391|P2|COMPLETED|Overall Study||3
7522302|NCT03655444|18523392|P1|COMPLETED|Overall Study||3
7522303|NCT03655444|18523391|P2|STARTED|Overall Study||3
7522304|NCT03655444|18523392|P1|STARTED|Overall Study||3
7522305|NCT03655301|18523406|P1|NOT COMPLETED|Overall Study||0
7522306|NCT03655301|18523406|P1|COMPLETED|Overall Study||13
7522307|NCT03655301|18523406|P1|STARTED|Overall Study||13
7522308|NCT03655106|18523418|P2|NOT COMPLETED|Overall Study||4
7522309|NCT03655106|18523419|P1|NOT COMPLETED|Overall Study||9
7522310|NCT03655106|18523418|P2|COMPLETED|Overall Study||131
7522311|NCT03655106|18523419|P1|COMPLETED|Overall Study||126
7522312|NCT03655106|18523418|P2|STARTED|Overall Study||135
7522313|NCT03655106|18523419|P1|STARTED|Overall Study||135
7522314|NCT03654560|18523431|P2|NOT COMPLETED|Overall Study||1
7522315|NCT03654560|18523432|P1|NOT COMPLETED|Overall Study||4
7522316|NCT03654560|18523431|P2|COMPLETED|Overall Study||117
7522317|NCT03654560|18523432|P1|COMPLETED|Overall Study||114
7522318|NCT03654560|18523431|P2|STARTED|Overall Study||118
7522319|NCT03654560|18523432|P1|STARTED|Overall Study||118
7522320|NCT03654417|18523448|P2|NOT COMPLETED|Overall Study||0
7522321|NCT03654417|18523449|P1|NOT COMPLETED|Overall Study||0
7522322|NCT03654417|18523448|P2|COMPLETED|Overall Study||18
7522323|NCT03654417|18523449|P1|COMPLETED|Overall Study||19
7522324|NCT03654417|18523448|P2|STARTED|Overall Study||18
7522325|NCT03654417|18523449|P1|STARTED|Overall Study||19
7522326|NCT03653429|18523473|P2|NOT COMPLETED|Overall Study||10
7522327|NCT03653429|18523474|P1|NOT COMPLETED|Overall Study||4
7522328|NCT03653429|18523473|P2|COMPLETED|Overall Study||41
7522329|NCT03653429|18523474|P1|COMPLETED|Overall Study||45
7522330|NCT03653429|18523473|P2|STARTED|Overall Study||51
7522331|NCT03653429|18523474|P1|STARTED|Overall Study||49
7522332|NCT03653416|18523488|P2|NOT COMPLETED|Overall Study||1
7522333|NCT03653416|18523489|P1|NOT COMPLETED|Overall Study||6
7522334|NCT03653416|18523488|P2|COMPLETED|Overall Study||46
7522335|NCT03653416|18523489|P1|COMPLETED|Overall Study||46
7522336|NCT03653416|18523488|P2|STARTED|Overall Study||47
7522337|NCT03653416|18523489|P1|STARTED|Overall Study||52
7522338|NCT03651856|18523507|P1|NOT COMPLETED|Overall Study||0
7522339|NCT03651856|18523507|P1|COMPLETED|Overall Study||10
7522340|NCT03651856|18523507|P1|STARTED|Overall Study||10
7522341|NCT03651479|18523513|P2|NOT COMPLETED|Overall Study||0
7522342|NCT03651479|18523514|P1|NOT COMPLETED|Overall Study||0
7522343|NCT03651479|18523513|P2|COMPLETED|Overall Study||20
7522344|NCT03651479|18523514|P1|COMPLETED|Overall Study||20
7522345|NCT03651479|18523513|P2|STARTED|Overall Study||20
7522346|NCT03651479|18523514|P1|STARTED|Overall Study||20
7522347|NCT03650842|18523530|P1|NOT COMPLETED|Overall Study||0
7522348|NCT03650842|18523530|P1|COMPLETED|Overall Study||25
7522349|NCT03650842|18523530|P1|STARTED|Overall Study||25
7522350|NCT03650400|18523539|P2|NOT COMPLETED|Overall Study||5
7522351|NCT03650400|18523540|P1|NOT COMPLETED|Overall Study||0
7522352|NCT03650400|18523539|P2|COMPLETED|Overall Study||0
7522353|NCT03650400|18523540|P1|COMPLETED|Overall Study||6
7522354|NCT03650400|18523539|P2|STARTED|Overall Study||5
7522355|NCT03650400|18523540|P1|STARTED|Overall Study||6
7522356|NCT03649867|18523568|P1|NOT COMPLETED|Overall Study||0
7522357|NCT03649867|18523568|P1|COMPLETED|Overall Study||13
7522358|NCT03649867|18523568|P1|STARTED|Overall Study||13
7522359|NCT03649815|18523572|P1|NOT COMPLETED|Overall Study||0
7522360|NCT03649815|18523572|P1|COMPLETED|Overall Study||38
7522361|NCT03649815|18523572|P1|STARTED|Overall Study||38
7522362|NCT03649750|18523578|P2|NOT COMPLETED|Period 2||0
7522363|NCT03649750|18523579|P1|NOT COMPLETED|Period 2||0
7522364|NCT03649750|18523578|P2|COMPLETED|Period 2||24
7522365|NCT03649750|18523579|P1|COMPLETED|Period 2||12
7522366|NCT03649750|18523578|P2|STARTED|Period 2||24
7522367|NCT03649750|18523579|P1|STARTED|Period 2||12
7522368|NCT03649750|18523578|P2|NOT COMPLETED|Washout: 7 Days||0
7522369|NCT03649750|18523579|P1|NOT COMPLETED|Washout: 7 Days||0
7522370|NCT03649750|18523578|P2|COMPLETED|Washout: 7 Days||24
7522371|NCT03649750|18523579|P1|COMPLETED|Washout: 7 Days||12
7522372|NCT03649750|18523578|P2|STARTED|Washout: 7 Days||24
7522373|NCT03649750|18523579|P1|STARTED|Washout: 7 Days||12
7522374|NCT03649750|18523578|P2|NOT COMPLETED|Period 1||0
7522375|NCT03649750|18523579|P1|NOT COMPLETED|Period 1||0
7522376|NCT03649750|18523578|P2|COMPLETED|Period 1||24
7522377|NCT03649750|18523579|P1|COMPLETED|Period 1||12
7522378|NCT03649750|18523578|P2|STARTED|Period 1||24
7522379|NCT03649750|18523579|P1|STARTED|Period 1||12
7522380|NCT03649646|18523598|P1|NOT COMPLETED|Overall Study||467
7522381|NCT03649646|18523598|P1|COMPLETED|Overall Study||4075
7522382|NCT03649646|18523598|P1|STARTED|Overall Study||4542
7522383|NCT03649412|18523607|P2|NOT COMPLETED|Part B, Period 6 (4days)||0
7522384|NCT03649412|18523608|P1|NOT COMPLETED|Part B, Period 6 (4days)||0
7522385|NCT03649412|18523607|P2|COMPLETED|Part B, Period 6 (4days)||14
7522386|NCT03649412|18523608|P1|COMPLETED|Part B, Period 6 (4days)||0
7522387|NCT03649412|18523607|P2|STARTED|Part B, Period 6 (4days)|Participant who did not start Period 5 directly joined into Period 6|14
7522388|NCT03649412|18523608|P1|STARTED|Part B, Period 6 (4days)||0
7522389|NCT03649412|18523607|P2|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||1
7522390|NCT03649412|18523608|P1|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||0
7522391|NCT03649412|18523607|P2|COMPLETED|Part B, Washout Period 5 (7 Days)||13
7522392|NCT03649412|18523608|P1|COMPLETED|Part B, Washout Period 5 (7 Days)||0
7522393|NCT03649412|18523607|P2|STARTED|Part B, Washout Period 5 (7 Days)||14
7522394|NCT03649412|18523608|P1|STARTED|Part B, Washout Period 5 (7 Days)||0
7522395|NCT03649412|18523607|P2|NOT COMPLETED|Part B, Period 5 (4 Days)||0
7522396|NCT03649412|18523608|P1|NOT COMPLETED|Part B, Period 5 (4 Days)||0
7522397|NCT03649412|18523607|P2|COMPLETED|Part B, Period 5 (4 Days)||14
7522398|NCT03649412|18523608|P1|COMPLETED|Part B, Period 5 (4 Days)||0
7522399|NCT03649412|18523607|P2|STARTED|Part B, Period 5 (4 Days)|One participant did not start in Period 5|14
7522400|NCT03649412|18523608|P1|STARTED|Part B, Period 5 (4 Days)||0
7522401|NCT03649412|18523607|P2|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
7522402|NCT03649412|18523608|P1|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
7522403|NCT03649412|18523607|P2|COMPLETED|Part B, Washout Period 4 (7 Days)||15
7522404|NCT03649412|18523608|P1|COMPLETED|Part B, Washout Period 4 (7 Days)||0
7522405|NCT03649412|18523607|P2|STARTED|Part B, Washout Period 4 (7 Days)||15
7522406|NCT03649412|18523608|P1|STARTED|Part B, Washout Period 4 (7 Days)||0
7522407|NCT03649412|18523607|P2|NOT COMPLETED|Part B, Period 4 (4 Days)||0
7522408|NCT03649412|18523608|P1|NOT COMPLETED|Part B, Period 4 (4 Days)||0
7522409|NCT03649412|18523607|P2|COMPLETED|Part B, Period 4 (4 Days)||15
7522410|NCT03649412|18523608|P1|COMPLETED|Part B, Period 4 (4 Days)||0
7522411|NCT03649412|18523607|P2|STARTED|Part B, Period 4 (4 Days)||15
7522412|NCT03649412|18523608|P1|STARTED|Part B, Period 4 (4 Days)||0
7522413|NCT03649412|18523607|P2|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
7522414|NCT03649412|18523608|P1|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
7522415|NCT03649412|18523607|P2|COMPLETED|Part B, Washout Period 3 (7 Days)||15
7522416|NCT03649412|18523608|P1|COMPLETED|Part B, Washout Period 3 (7 Days)||0
7522417|NCT03649412|18523607|P2|STARTED|Part B, Washout Period 3 (7 Days)||15
7522418|NCT03649412|18523608|P1|STARTED|Part B, Washout Period 3 (7 Days)||0
7522419|NCT03649412|18523607|P2|NOT COMPLETED|Part B, Period 3 (4 Days)||0
7522420|NCT03649412|18523608|P1|NOT COMPLETED|Part B, Period 3 (4 Days)||0
7522421|NCT03649412|18523607|P2|COMPLETED|Part B, Period 3 (4 Days)||15
7522422|NCT03649412|18523608|P1|COMPLETED|Part B, Period 3 (4 Days)||0
7522423|NCT03649412|18523607|P2|STARTED|Part B, Period 3 (4 Days)||15
7522424|NCT03649412|18523608|P1|STARTED|Part B, Period 3 (4 Days)||0
7522425|NCT03649412|18523607|P2|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
7522426|NCT03649412|18523608|P1|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
7522427|NCT03649412|18523607|P2|COMPLETED|Part B, Washout Period 2 (7 Days)||15
7522428|NCT03649412|18523608|P1|COMPLETED|Part B, Washout Period 2 (7 Days)||0
7522429|NCT03649412|18523607|P2|STARTED|Part B, Washout Period 2 (7 Days)||15
7522430|NCT03649412|18523608|P1|STARTED|Part B, Washout Period 2 (7 Days)||0
7522431|NCT03649412|18523607|P2|NOT COMPLETED|Part B, Period 2 (4 Days)||0
7522432|NCT03649412|18523608|P1|NOT COMPLETED|Part B, Period 2 (4 Days)||0
7522433|NCT03649412|18523607|P2|COMPLETED|Part B, Period 2 (4 Days)||15
7522434|NCT03649412|18523608|P1|COMPLETED|Part B, Period 2 (4 Days)||0
7522435|NCT03649412|18523607|P2|STARTED|Part B, Period 2 (4 Days)||15
7522436|NCT03649412|18523608|P1|STARTED|Part B, Period 2 (4 Days)||0
7522437|NCT03649412|18523607|P2|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||1
7522438|NCT03649412|18523608|P1|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||0
7522439|NCT03649412|18523607|P2|COMPLETED|Part B, Washout Period 1 (7 Days)||15
7522440|NCT03649412|18523608|P1|COMPLETED|Part B, Washout Period 1 (7 Days)||0
7522441|NCT03649412|18523607|P2|STARTED|Part B, Washout Period 1 (7 Days)||16
7522442|NCT03649412|18523608|P1|STARTED|Part B, Washout Period 1 (7 Days)||0
7522443|NCT03649412|18523607|P2|NOT COMPLETED|Part B, Period 1 (4 Days)||0
7522444|NCT03649412|18523608|P1|NOT COMPLETED|Part B, Period 1 (4 Days)||0
7522445|NCT03649412|18523607|P2|COMPLETED|Part B, Period 1 (4 Days)||16
7522446|NCT03649412|18523608|P1|COMPLETED|Part B, Period 1 (4 Days)||0
7522447|NCT03649412|18523607|P2|STARTED|Part B, Period 1 (4 Days)|16 new participants enrolled in Part B|16
7522448|NCT03649412|18523608|P1|STARTED|Part B, Period 1 (4 Days)|Participants in Part A did not enter Part B|0
7522449|NCT03649412|18523607|P2|NOT COMPLETED|Part A, Period 6 (4 Days)||0
7522450|NCT03649412|18523608|P1|NOT COMPLETED|Part A, Period 6 (4 Days)||0
7522451|NCT03649412|18523607|P2|COMPLETED|Part A, Period 6 (4 Days)||0
7522452|NCT03649412|18523608|P1|COMPLETED|Part A, Period 6 (4 Days)||12
7522453|NCT03649412|18523607|P2|STARTED|Part A, Period 6 (4 Days)||0
7522454|NCT03649412|18523608|P1|STARTED|Part A, Period 6 (4 Days)|1 of the participant who did not start Period 5 directly joined into Period 6|12
7522455|NCT03649412|18523607|P2|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||0
7522456|NCT03649412|18523608|P1|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||1
7522457|NCT03649412|18523607|P2|COMPLETED|Part A, Washout Period 5 (7 Days)||0
7522458|NCT03649412|18523608|P1|COMPLETED|Part A, Washout Period 5 (7 Days)||11
7522459|NCT03649412|18523607|P2|STARTED|Part A, Washout Period 5 (7 Days)||0
7522460|NCT03649412|18523608|P1|STARTED|Part A, Washout Period 5 (7 Days)||12
7522461|NCT03649412|18523607|P2|NOT COMPLETED|Part A, Period 5 (4 Days)||0
7522462|NCT03649412|18523608|P1|NOT COMPLETED|Part A, Period 5 (4 Days)||0
7522463|NCT03649412|18523607|P2|COMPLETED|Part A, Period 5 (4 Days)||0
7522464|NCT03649412|18523608|P1|COMPLETED|Part A, Period 5 (4 Days)||12
7522465|NCT03649412|18523607|P2|STARTED|Part A, Period 5 (4 Days)||0
7522466|NCT03649412|18523608|P1|STARTED|Part A, Period 5 (4 Days)|Two participant did not start in Period 5|12
7522467|NCT03649412|18523607|P2|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||0
7522468|NCT03649412|18523608|P1|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||2
7522469|NCT03649412|18523607|P2|COMPLETED|Part A, Washout Period 4 (7 Days)||0
7522470|NCT03649412|18523608|P1|COMPLETED|Part A, Washout Period 4 (7 Days)||14
7522471|NCT03649412|18523607|P2|STARTED|Part A, Washout Period 4 (7 Days)||0
7522472|NCT03649412|18523608|P1|STARTED|Part A, Washout Period 4 (7 Days)||16
7522473|NCT03649412|18523607|P2|NOT COMPLETED|Part A, Period 4 (4 Days)||0
7522474|NCT03649412|18523608|P1|NOT COMPLETED|Part A, Period 4 (4 Days)||0
7522475|NCT03649412|18523607|P2|COMPLETED|Part A, Period 4 (4 Days)||0
7522476|NCT03649412|18523608|P1|COMPLETED|Part A, Period 4 (4 Days)||16
7522477|NCT03649412|18523607|P2|STARTED|Part A, Period 4 (4 Days)||0
7522478|NCT03649412|18523608|P1|STARTED|Part A, Period 4 (4 Days)||16
7522479|NCT03649412|18523607|P2|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
7522480|NCT03649412|18523608|P1|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
7522481|NCT03649412|18523607|P2|COMPLETED|Part A, Washout Period 3 (7 Days)||0
7522482|NCT03649412|18523608|P1|COMPLETED|Part A, Washout Period 3 (7 Days)||16
7522483|NCT03649412|18523607|P2|STARTED|Part A, Washout Period 3 (7 Days)||0
7522484|NCT03649412|18523608|P1|STARTED|Part A, Washout Period 3 (7 Days)||16
7522485|NCT03649412|18523607|P2|NOT COMPLETED|Part A, Period 3 (4 Days)||0
7522486|NCT03649412|18523608|P1|NOT COMPLETED|Part A, Period 3 (4 Days)||0
7522487|NCT03649412|18523607|P2|COMPLETED|Part A, Period 3 (4 Days)||0
7522488|NCT03649412|18523608|P1|COMPLETED|Part A, Period 3 (4 Days)||16
7522489|NCT03649412|18523607|P2|STARTED|Part A, Period 3 (4 Days)||0
7522490|NCT03649412|18523608|P1|STARTED|Part A, Period 3 (4 Days)||16
7522491|NCT03649412|18523607|P2|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
7522492|NCT03649412|18523608|P1|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
7522493|NCT03649412|18523607|P2|COMPLETED|Part A, Washout Period 2 (7 Days)||0
7522494|NCT03649412|18523608|P1|COMPLETED|Part A, Washout Period 2 (7 Days)||16
7522495|NCT03649412|18523607|P2|STARTED|Part A, Washout Period 2 (7 Days)||0
7522496|NCT03649412|18523608|P1|STARTED|Part A, Washout Period 2 (7 Days)||16
7522497|NCT03649412|18523607|P2|NOT COMPLETED|Part A, Period 2 (3 Days)||0
7522498|NCT03649412|18523608|P1|NOT COMPLETED|Part A, Period 2 (3 Days)||0
7522499|NCT03649412|18523607|P2|COMPLETED|Part A, Period 2 (3 Days)||0
7522500|NCT03649412|18523608|P1|COMPLETED|Part A, Period 2 (3 Days)||16
7522501|NCT03649412|18523607|P2|STARTED|Part A, Period 2 (3 Days)||0
7522502|NCT03649412|18523608|P1|STARTED|Part A, Period 2 (3 Days)|1 Replacement par. was enrolled & dosed|16
7522503|NCT03649412|18523607|P2|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||0
7522504|NCT03649412|18523608|P1|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||1
7522505|NCT03649412|18523607|P2|COMPLETED|Part A, Washout Period 1 (7 Days)||0
7522506|NCT03649412|18523608|P1|COMPLETED|Part A, Washout Period 1 (7 Days)||15
7522507|NCT03649412|18523607|P2|STARTED|Part A, Washout Period 1 (7 Days)||0
7522508|NCT03649412|18523608|P1|STARTED|Part A, Washout Period 1 (7 Days)||16
7522509|NCT03649412|18523607|P2|NOT COMPLETED|Part A, Period 1 (4 Days)||0
7522510|NCT03649412|18523608|P1|NOT COMPLETED|Part A, Period 1 (4 Days)||0
7522511|NCT03649412|18523607|P2|COMPLETED|Part A, Period 1 (4 Days)||0
7522512|NCT03649412|18523608|P1|COMPLETED|Part A, Period 1 (4 Days)||16
7522513|NCT03649412|18523607|P2|STARTED|Part A, Period 1 (4 Days)||0
7522514|NCT03649412|18523608|P1|STARTED|Part A, Period 1 (4 Days)||16
7522515|NCT03648983|18523766|P1|NOT COMPLETED|Overall Study||95
7522516|NCT03648983|18523766|P1|COMPLETED|Overall Study||0
7522517|NCT03648983|18523766|P1|STARTED|Overall Study||95
7522518|NCT03648853|18523772|P1|NOT COMPLETED|Overall Study||0
7522519|NCT03648853|18523772|P1|COMPLETED|Overall Study||12
7522520|NCT03648853|18523772|P1|STARTED|Overall Study||12
7522521|NCT03647709|18523776|P1|NOT COMPLETED|Overall Study||14
7522522|NCT03647709|18523776|P1|COMPLETED|Overall Study||386
7522523|NCT03647709|18523776|P1|STARTED|Overall Study||400
7522524|NCT03647046|18523792|P1|NOT COMPLETED|Overall Study||4
7522525|NCT03647046|18523792|P1|COMPLETED|Overall Study||8
7522526|NCT03647046|18523792|P1|STARTED|Overall Study||12
7522527|NCT03647033|18523798|P2|NOT COMPLETED|Overall Study||0
7522528|NCT03647033|18523799|P1|NOT COMPLETED|Overall Study||0
7522529|NCT03647033|18523798|P2|COMPLETED|Overall Study||16
7522530|NCT03647033|18523799|P1|COMPLETED|Overall Study||16
7522531|NCT03647033|18523798|P2|STARTED|Overall Study||16
7522532|NCT03647033|18523799|P1|STARTED|Overall Study||16
7522533|NCT03646656|18523809|P2|NOT COMPLETED|Overall Study||0
7522534|NCT03646656|18523810|P1|NOT COMPLETED|Overall Study||3
7522535|NCT03646656|18523809|P2|COMPLETED|Overall Study||3
7522536|NCT03646656|18523810|P1|COMPLETED|Overall Study||9
7522537|NCT03646656|18523809|P2|Attended 1st Group Session|Overall Study||3
7522538|NCT03646656|18523810|P1|Attended 1st Group Session|Overall Study||10
7522539|NCT03646656|18523809|P2|STARTED|Overall Study||3
7522540|NCT03646656|18523810|P1|STARTED|Overall Study||12
7522541|NCT03645811|18523830|P3|NOT COMPLETED|Overall Study||2
7522542|NCT03645811|18523831|P2|NOT COMPLETED|Overall Study||2
7522543|NCT03645811|18523832|P1|NOT COMPLETED|Overall Study||2
7522544|NCT03645811|18523830|P3|COMPLETED|Overall Study||30
7522545|NCT03645811|18523831|P2|COMPLETED|Overall Study||30
7522546|NCT03645811|18523832|P1|COMPLETED|Overall Study||30
7522547|NCT03645811|18523830|P3|STARTED|Overall Study||32
7522548|NCT03645811|18523831|P2|STARTED|Overall Study||32
7522549|NCT03645811|18523832|P1|STARTED|Overall Study||32
7522550|NCT03645434|18523840|P6|NOT COMPLETED|Period 3||0
7522551|NCT03645434|18523841|P5|NOT COMPLETED|Period 3||0
7522552|NCT03645434|18523842|P4|NOT COMPLETED|Period 3||0
7522553|NCT03645434|18523843|P3|NOT COMPLETED|Period 3||0
7522554|NCT03645434|18523844|P2|NOT COMPLETED|Period 3||0
7522555|NCT03645434|18523845|P1|NOT COMPLETED|Period 3||0
7522556|NCT03645434|18523840|P6|COMPLETED|Period 3||11
7522557|NCT03645434|18523841|P5|COMPLETED|Period 3||11
7522558|NCT03645434|18523842|P4|COMPLETED|Period 3||10
7522559|NCT03645434|18523843|P3|COMPLETED|Period 3||11
7522560|NCT03645434|18523844|P2|COMPLETED|Period 3||13
7522561|NCT03645434|18523845|P1|COMPLETED|Period 3||10
7522562|NCT03645434|18523840|P6|STARTED|Period 3||11
7522563|NCT03645434|18523841|P5|STARTED|Period 3||11
7522564|NCT03645434|18523842|P4|STARTED|Period 3||10
7522565|NCT03645434|18523843|P3|STARTED|Period 3|2 subjects discontinued as they did not meet FEV1 stability criteria or pfts variability criteria.|11
7522566|NCT03645434|18523844|P2|STARTED|Period 3||13
7522567|NCT03645434|18523845|P1|STARTED|Period 3||10
7522568|NCT03645434|18523840|P6|NOT COMPLETED|Period 2||0
7522569|NCT03645434|18523841|P5|NOT COMPLETED|Period 2||0
7522570|NCT03645434|18523842|P4|NOT COMPLETED|Period 2||0
7522571|NCT03645434|18523843|P3|NOT COMPLETED|Period 2||0
7522572|NCT03645434|18523844|P2|NOT COMPLETED|Period 2||0
7522573|NCT03645434|18523845|P1|NOT COMPLETED|Period 2||0
7522574|NCT03645434|18523840|P6|COMPLETED|Period 2||11
7522575|NCT03645434|18523841|P5|COMPLETED|Period 2||11
7522576|NCT03645434|18523842|P4|COMPLETED|Period 2||10
7522577|NCT03645434|18523843|P3|COMPLETED|Period 2||13
7522578|NCT03645434|18523844|P2|COMPLETED|Period 2||13
7522579|NCT03645434|18523845|P1|COMPLETED|Period 2||10
7522580|NCT03645434|18523840|P6|STARTED|Period 2|1 subject completed Period 1 but not allowed to enter Period 2 due to physician decision.|11
7522581|NCT03645434|18523841|P5|STARTED|Period 2||11
7522582|NCT03645434|18523842|P4|STARTED|Period 2||10
7522583|NCT03645434|18523843|P3|STARTED|Period 2||13
7522584|NCT03645434|18523844|P2|STARTED|Period 2||13
7522585|NCT03645434|18523845|P1|STARTED|Period 2|2 subject discontinued as they did not meet stability or FEV1 variability.|10
7522586|NCT03645434|18523840|P6|NOT COMPLETED|Period 1||0
7522587|NCT03645434|18523841|P5|NOT COMPLETED|Period 1||1
7522588|NCT03645434|18523842|P4|NOT COMPLETED|Period 1||1
7522589|NCT03645434|18523843|P3|NOT COMPLETED|Period 1||0
7522590|NCT03645434|18523844|P2|NOT COMPLETED|Period 1||0
7522591|NCT03645434|18523845|P1|NOT COMPLETED|Period 1||0
7522592|NCT03645434|18523840|P6|COMPLETED|Period 1||12
7522593|NCT03645434|18523841|P5|COMPLETED|Period 1||11
7522594|NCT03645434|18523842|P4|COMPLETED|Period 1||10
7522595|NCT03645434|18523843|P3|COMPLETED|Period 1||13
7522596|NCT03645434|18523844|P2|COMPLETED|Period 1||13
7522597|NCT03645434|18523845|P1|COMPLETED|Period 1||12
7522598|NCT03645434|18523840|P6|STARTED|Period 1||12
7522599|NCT03645434|18523841|P5|STARTED|Period 1||12
7522600|NCT03645434|18523842|P4|STARTED|Period 1||11
7522601|NCT03645434|18523843|P3|STARTED|Period 1||13
7522602|NCT03645434|18523844|P2|STARTED|Period 1||13
7522603|NCT03645434|18523845|P1|STARTED|Period 1||12
7522604|NCT03645421|18523896|P4|NOT COMPLETED|Overall Study||4
7522605|NCT03645421|18523897|P3|NOT COMPLETED|Overall Study||5
7522606|NCT03645421|18523898|P2|NOT COMPLETED|Overall Study||0
7522607|NCT03645421|18523899|P1|NOT COMPLETED|Overall Study||0
7522608|NCT03645421|18523896|P4|COMPLETED|Overall Study||11
7522609|NCT03645421|18523897|P3|COMPLETED|Overall Study||10
7522610|NCT03645421|18523898|P2|COMPLETED|Overall Study||15
7522611|NCT03645421|18523899|P1|COMPLETED|Overall Study||16
7522612|NCT03645421|18523896|P4|Received Investigational Product (IP)|Overall Study||15
7522613|NCT03645421|18523897|P3|Received Investigational Product (IP)|Overall Study||15
7522614|NCT03645421|18523898|P2|Received Investigational Product (IP)|Overall Study||15
7522615|NCT03645421|18523899|P1|Received Investigational Product (IP)|Overall Study||16
7522616|NCT03645421|18523896|P4|STARTED|Overall Study||15
7522617|NCT03645421|18523897|P3|STARTED|Overall Study||15
7522618|NCT03645421|18523898|P2|STARTED|Overall Study||15
7522619|NCT03645421|18523899|P1|STARTED|Overall Study||16
7522620|NCT03644212|18523965|P2|NOT COMPLETED|Overall Study||0
7522621|NCT03644212|18523966|P1|NOT COMPLETED|Overall Study||0
7522622|NCT03644212|18523965|P2|COMPLETED|Overall Study||16
7522623|NCT03644212|18523966|P1|COMPLETED|Overall Study||63
7522624|NCT03644212|18523965|P2|STARTED|Overall Study||16
7522625|NCT03644212|18523966|P1|STARTED|Overall Study||63
7522626|NCT03644108|18523972|P1|NOT COMPLETED|Overall Study||0
7522627|NCT03644108|18523972|P1|COMPLETED|Overall Study||30
7522628|NCT03644108|18523972|P1|STARTED|Overall Study||30
7522629|NCT03644095|18523983|P2|NOT COMPLETED|Period 2||0
7522630|NCT03644095|18523984|P1|NOT COMPLETED|Period 2||0
7522631|NCT03644095|18523983|P2|COMPLETED|Period 2||15
7522632|NCT03644095|18523984|P1|COMPLETED|Period 2||15
7522633|NCT03644095|18523983|P2|STARTED|Period 2||15
7522634|NCT03644095|18523984|P1|STARTED|Period 2||15
7522635|NCT03644095|18523983|P2|NOT COMPLETED|Washout (7 Days)||0
7522636|NCT03644095|18523984|P1|NOT COMPLETED|Washout (7 Days)||0
7522637|NCT03644095|18523983|P2|COMPLETED|Washout (7 Days)||15
7522638|NCT03644095|18523984|P1|COMPLETED|Washout (7 Days)||15
7522639|NCT03644095|18523983|P2|STARTED|Washout (7 Days)||15
7522640|NCT03644095|18523984|P1|STARTED|Washout (7 Days)||15
7522641|NCT03644095|18523983|P2|NOT COMPLETED|Period 1||0
7522642|NCT03644095|18523984|P1|NOT COMPLETED|Period 1||0
7522643|NCT03644095|18523983|P2|COMPLETED|Period 1||15
7522644|NCT03644095|18523984|P1|COMPLETED|Period 1||15
7522645|NCT03644095|18523983|P2|STARTED|Period 1||15
7522646|NCT03644095|18523984|P1|STARTED|Period 1||15
7522647|NCT03643692|18524004|P1|NOT COMPLETED|Overall Study||0
7522648|NCT03643692|18524004|P1|COMPLETED|Overall Study||12
7522649|NCT03643692|18524004|P1|STARTED|Overall Study||12
7522650|NCT03643575|18524008|P6|NOT COMPLETED|Period 3||0
7522651|NCT03643575|18524009|P5|NOT COMPLETED|Period 3||0
7522652|NCT03643575|18524010|P4|NOT COMPLETED|Period 3||0
7522653|NCT03643575|18524011|P3|NOT COMPLETED|Period 3||0
7522654|NCT03643575|18524012|P2|NOT COMPLETED|Period 3||0
7522655|NCT03643575|18524013|P1|NOT COMPLETED|Period 3||0
7522656|NCT03643575|18524008|P6|COMPLETED|Period 3||5
7522657|NCT03643575|18524009|P5|COMPLETED|Period 3||5
7522658|NCT03643575|18524010|P4|COMPLETED|Period 3||4
7522659|NCT03643575|18524011|P3|COMPLETED|Period 3||5
7522660|NCT03643575|18524012|P2|COMPLETED|Period 3||4
7522661|NCT03643575|18524013|P1|COMPLETED|Period 3||4
7522662|NCT03643575|18524008|P6|STARTED|Period 3||5
7522663|NCT03643575|18524009|P5|STARTED|Period 3||5
7522664|NCT03643575|18524010|P4|STARTED|Period 3||4
7522665|NCT03643575|18524011|P3|STARTED|Period 3||5
7522666|NCT03643575|18524012|P2|STARTED|Period 3||4
7522667|NCT03643575|18524013|P1|STARTED|Period 3||4
7522668|NCT03643575|18524008|P6|NOT COMPLETED|Washout: 7 Days||0
7522669|NCT03643575|18524009|P5|NOT COMPLETED|Washout: 7 Days||0
7522670|NCT03643575|18524010|P4|NOT COMPLETED|Washout: 7 Days||0
7522671|NCT03643575|18524011|P3|NOT COMPLETED|Washout: 7 Days||0
7522672|NCT03643575|18524012|P2|NOT COMPLETED|Washout: 7 Days||1
7522673|NCT03643575|18524013|P1|NOT COMPLETED|Washout: 7 Days||0
7522674|NCT03643575|18524008|P6|COMPLETED|Washout: 7 Days||5
7522675|NCT03643575|18524009|P5|COMPLETED|Washout: 7 Days||5
7522676|NCT03643575|18524010|P4|COMPLETED|Washout: 7 Days||4
7522677|NCT03643575|18524011|P3|COMPLETED|Washout: 7 Days||5
7522678|NCT03643575|18524012|P2|COMPLETED|Washout: 7 Days||4
7522679|NCT03643575|18524013|P1|COMPLETED|Washout: 7 Days||4
7522680|NCT03643575|18524008|P6|STARTED|Washout: 7 Days||5
7522681|NCT03643575|18524009|P5|STARTED|Washout: 7 Days||5
7522682|NCT03643575|18524010|P4|STARTED|Washout: 7 Days||4
7522683|NCT03643575|18524011|P3|STARTED|Washout: 7 Days||5
7522684|NCT03643575|18524012|P2|STARTED|Washout: 7 Days||5
7522685|NCT03643575|18524013|P1|STARTED|Washout: 7 Days||4
7522686|NCT03643575|18524008|P6|NOT COMPLETED|Period 2||0
7522687|NCT03643575|18524009|P5|NOT COMPLETED|Period 2||0
7522688|NCT03643575|18524010|P4|NOT COMPLETED|Period 2||0
7522689|NCT03643575|18524011|P3|NOT COMPLETED|Period 2||0
7522690|NCT03643575|18524012|P2|NOT COMPLETED|Period 2||0
7522691|NCT03643575|18524013|P1|NOT COMPLETED|Period 2||0
7522692|NCT03643575|18524008|P6|COMPLETED|Period 2||5
7522693|NCT03643575|18524009|P5|COMPLETED|Period 2||5
7522694|NCT03643575|18524010|P4|COMPLETED|Period 2||4
7522695|NCT03643575|18524011|P3|COMPLETED|Period 2||5
7522696|NCT03643575|18524012|P2|COMPLETED|Period 2||5
7522697|NCT03643575|18524013|P1|COMPLETED|Period 2||4
7522698|NCT03643575|18524008|P6|STARTED|Period 2||5
7522699|NCT03643575|18524009|P5|STARTED|Period 2||5
7522700|NCT03643575|18524010|P4|STARTED|Period 2||4
7522701|NCT03643575|18524011|P3|STARTED|Period 2||5
7522702|NCT03643575|18524012|P2|STARTED|Period 2||5
7522703|NCT03643575|18524013|P1|STARTED|Period 2||4
7522704|NCT03643575|18524008|P6|NOT COMPLETED|Washout: 7 Days||0
7522705|NCT03643575|18524009|P5|NOT COMPLETED|Washout: 7 Days||0
7522706|NCT03643575|18524010|P4|NOT COMPLETED|Washout: 7 Days||1
7522707|NCT03643575|18524011|P3|NOT COMPLETED|Washout: 7 Days||0
7522708|NCT03643575|18524012|P2|NOT COMPLETED|Washout: 7 Days||0
7522709|NCT03643575|18524013|P1|NOT COMPLETED|Washout: 7 Days||1
7522710|NCT03643575|18524008|P6|COMPLETED|Washout: 7 Days||5
7522711|NCT03643575|18524009|P5|COMPLETED|Washout: 7 Days||5
7522712|NCT03643575|18524010|P4|COMPLETED|Washout: 7 Days||4
7522713|NCT03643575|18524011|P3|COMPLETED|Washout: 7 Days||5
7522714|NCT03643575|18524012|P2|COMPLETED|Washout: 7 Days||5
7522715|NCT03643575|18524013|P1|COMPLETED|Washout: 7 Days||4
7522716|NCT03643575|18524008|P6|STARTED|Washout: 7 Days||5
7522717|NCT03643575|18524009|P5|STARTED|Washout: 7 Days||5
7522718|NCT03643575|18524010|P4|STARTED|Washout: 7 Days||5
7522719|NCT03643575|18524011|P3|STARTED|Washout: 7 Days||5
7522720|NCT03643575|18524012|P2|STARTED|Washout: 7 Days||5
7522721|NCT03643575|18524013|P1|STARTED|Washout: 7 Days||5
7522722|NCT03643575|18524008|P6|NOT COMPLETED|Period 1||0
7522723|NCT03643575|18524009|P5|NOT COMPLETED|Period 1||0
7522724|NCT03643575|18524010|P4|NOT COMPLETED|Period 1||0
7522725|NCT03643575|18524011|P3|NOT COMPLETED|Period 1||0
7522726|NCT03643575|18524012|P2|NOT COMPLETED|Period 1||0
7522727|NCT03643575|18524013|P1|NOT COMPLETED|Period 1||0
7522728|NCT03643575|18524008|P6|COMPLETED|Period 1||5
7522729|NCT03643575|18524009|P5|COMPLETED|Period 1||5
7522730|NCT03643575|18524010|P4|COMPLETED|Period 1||5
7522731|NCT03643575|18524011|P3|COMPLETED|Period 1||5
7522732|NCT03643575|18524012|P2|COMPLETED|Period 1||5
7522733|NCT03643575|18524013|P1|COMPLETED|Period 1||5
7522734|NCT03643575|18524008|P6|STARTED|Period 1||5
7522735|NCT03643575|18524009|P5|STARTED|Period 1||5
7522736|NCT03643575|18524010|P4|STARTED|Period 1||5
7522737|NCT03643575|18524011|P3|STARTED|Period 1||5
7522738|NCT03643575|18524012|P2|STARTED|Period 1||5
7522739|NCT03643575|18524013|P1|STARTED|Period 1||5
7522740|NCT03643432|18524071|P2|NOT COMPLETED|Overall Study||0
7522741|NCT03643432|18524072|P1|NOT COMPLETED|Overall Study||1
7522742|NCT03643432|18524071|P2|COMPLETED|Overall Study||21
7522743|NCT03643432|18524072|P1|COMPLETED|Overall Study||26
7522744|NCT03643432|18524071|P2|STARTED|Overall Study||21
7522745|NCT03643432|18524072|P1|STARTED|Overall Study||27
7522746|NCT03643159|18524096|P1|NOT COMPLETED|Overall Study||2
7522747|NCT03643159|18524096|P1|COMPLETED|Overall Study||0
7522748|NCT03643159|18524096|P1|Received At Least 1 Dose Of Study Drug|Overall Study||2
7522749|NCT03643159|18524096|P1|STARTED|Overall Study||2
7522750|NCT03642873|18524103|P6|NOT COMPLETED|Third Intervention (1 Day)||0
7522751|NCT03642873|18524104|P5|NOT COMPLETED|Third Intervention (1 Day)||1
7522752|NCT03642873|18524105|P4|NOT COMPLETED|Third Intervention (1 Day)||0
7522753|NCT03642873|18524106|P3|NOT COMPLETED|Third Intervention (1 Day)||0
7522754|NCT03642873|18524107|P2|NOT COMPLETED|Third Intervention (1 Day)||0
7522755|NCT03642873|18524108|P1|NOT COMPLETED|Third Intervention (1 Day)||0
7522756|NCT03642873|18524103|P6|COMPLETED|Third Intervention (1 Day)||4
7522757|NCT03642873|18524104|P5|COMPLETED|Third Intervention (1 Day)||3
7522758|NCT03642873|18524105|P4|COMPLETED|Third Intervention (1 Day)||4
7522759|NCT03642873|18524106|P3|COMPLETED|Third Intervention (1 Day)||4
7522760|NCT03642873|18524107|P2|COMPLETED|Third Intervention (1 Day)||4
7522761|NCT03642873|18524108|P1|COMPLETED|Third Intervention (1 Day)||4
7522762|NCT03642873|18524103|P6|STARTED|Third Intervention (1 Day)||4
7522763|NCT03642873|18524104|P5|STARTED|Third Intervention (1 Day)||4
7522764|NCT03642873|18524105|P4|STARTED|Third Intervention (1 Day)||4
7522765|NCT03642873|18524106|P3|STARTED|Third Intervention (1 Day)||4
7522766|NCT03642873|18524107|P2|STARTED|Third Intervention (1 Day)||4
7522767|NCT03642873|18524108|P1|STARTED|Third Intervention (1 Day)||4
7522768|NCT03642873|18524103|P6|NOT COMPLETED|Washout (7 Days)||0
7522769|NCT03642873|18524104|P5|NOT COMPLETED|Washout (7 Days)||0
7522770|NCT03642873|18524105|P4|NOT COMPLETED|Washout (7 Days)||0
7522771|NCT03642873|18524106|P3|NOT COMPLETED|Washout (7 Days)||0
7522772|NCT03642873|18524107|P2|NOT COMPLETED|Washout (7 Days)||0
7522773|NCT03642873|18524108|P1|NOT COMPLETED|Washout (7 Days)||0
7522774|NCT03642873|18524103|P6|COMPLETED|Washout (7 Days)||4
7522775|NCT03642873|18524104|P5|COMPLETED|Washout (7 Days)||4
7522776|NCT03642873|18524105|P4|COMPLETED|Washout (7 Days)||4
7522777|NCT03642873|18524106|P3|COMPLETED|Washout (7 Days)||4
7522778|NCT03642873|18524107|P2|COMPLETED|Washout (7 Days)||4
7522779|NCT03642873|18524108|P1|COMPLETED|Washout (7 Days)||4
7522780|NCT03642873|18524103|P6|STARTED|Washout (7 Days)||4
7522781|NCT03642873|18524104|P5|STARTED|Washout (7 Days)||4
7522782|NCT03642873|18524105|P4|STARTED|Washout (7 Days)||4
7522783|NCT03642873|18524106|P3|STARTED|Washout (7 Days)||4
7522784|NCT03642873|18524107|P2|STARTED|Washout (7 Days)||4
7522785|NCT03642873|18524108|P1|STARTED|Washout (7 Days)||4
7522786|NCT03642873|18524103|P6|NOT COMPLETED|Second Intervention (1 Day)||0
7522787|NCT03642873|18524104|P5|NOT COMPLETED|Second Intervention (1 Day)||0
7522788|NCT03642873|18524105|P4|NOT COMPLETED|Second Intervention (1 Day)||0
7522789|NCT03642873|18524106|P3|NOT COMPLETED|Second Intervention (1 Day)||0
7522790|NCT03642873|18524107|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7522791|NCT03642873|18524108|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7522792|NCT03642873|18524103|P6|COMPLETED|Second Intervention (1 Day)||4
7522793|NCT03642873|18524104|P5|COMPLETED|Second Intervention (1 Day)||4
7522794|NCT03642873|18524105|P4|COMPLETED|Second Intervention (1 Day)||4
7522795|NCT03642873|18524106|P3|COMPLETED|Second Intervention (1 Day)||4
7522796|NCT03642873|18524107|P2|COMPLETED|Second Intervention (1 Day)||4
7522797|NCT03642873|18524108|P1|COMPLETED|Second Intervention (1 Day)||4
7522798|NCT03642873|18524103|P6|STARTED|Second Intervention (1 Day)||4
7522799|NCT03642873|18524104|P5|STARTED|Second Intervention (1 Day)||4
7522800|NCT03642873|18524105|P4|STARTED|Second Intervention (1 Day)||4
7522801|NCT03642873|18524106|P3|STARTED|Second Intervention (1 Day)||4
7522802|NCT03642873|18524107|P2|STARTED|Second Intervention (1 Day)||4
7522803|NCT03642873|18524108|P1|STARTED|Second Intervention (1 Day)||4
7522804|NCT03642873|18524103|P6|NOT COMPLETED|Washout (7 Days)||0
7522805|NCT03642873|18524104|P5|NOT COMPLETED|Washout (7 Days)||0
7522806|NCT03642873|18524105|P4|NOT COMPLETED|Washout (7 Days)||0
7522807|NCT03642873|18524106|P3|NOT COMPLETED|Washout (7 Days)||0
7522808|NCT03642873|18524107|P2|NOT COMPLETED|Washout (7 Days)||0
7522809|NCT03642873|18524108|P1|NOT COMPLETED|Washout (7 Days)||0
7522810|NCT03642873|18524103|P6|COMPLETED|Washout (7 Days)||4
7522811|NCT03642873|18524104|P5|COMPLETED|Washout (7 Days)||4
7522812|NCT03642873|18524105|P4|COMPLETED|Washout (7 Days)||4
7522813|NCT03642873|18524106|P3|COMPLETED|Washout (7 Days)||4
7522814|NCT03642873|18524107|P2|COMPLETED|Washout (7 Days)||4
7522815|NCT03642873|18524108|P1|COMPLETED|Washout (7 Days)||4
7522816|NCT03642873|18524103|P6|STARTED|Washout (7 Days)||4
7522817|NCT03642873|18524104|P5|STARTED|Washout (7 Days)||4
7522818|NCT03642873|18524105|P4|STARTED|Washout (7 Days)||4
7522819|NCT03642873|18524106|P3|STARTED|Washout (7 Days)||4
7522820|NCT03642873|18524107|P2|STARTED|Washout (7 Days)||4
7522821|NCT03642873|18524108|P1|STARTED|Washout (7 Days)||4
7522822|NCT03642873|18524103|P6|NOT COMPLETED|First Intervention (1 Day)||0
7522823|NCT03642873|18524104|P5|NOT COMPLETED|First Intervention (1 Day)||0
7522824|NCT03642873|18524105|P4|NOT COMPLETED|First Intervention (1 Day)||0
7522825|NCT03642873|18524106|P3|NOT COMPLETED|First Intervention (1 Day)||0
7522826|NCT03642873|18524107|P2|NOT COMPLETED|First Intervention (1 Day)||0
7522827|NCT03642873|18524108|P1|NOT COMPLETED|First Intervention (1 Day)||0
7522828|NCT03642873|18524103|P6|COMPLETED|First Intervention (1 Day)||4
7522829|NCT03642873|18524104|P5|COMPLETED|First Intervention (1 Day)||4
7522830|NCT03642873|18524105|P4|COMPLETED|First Intervention (1 Day)||4
7522831|NCT03642873|18524106|P3|COMPLETED|First Intervention (1 Day)||4
7522832|NCT03642873|18524107|P2|COMPLETED|First Intervention (1 Day)||4
7522833|NCT03642873|18524108|P1|COMPLETED|First Intervention (1 Day)||4
7522834|NCT03642873|18524103|P6|STARTED|First Intervention (1 Day)||4
7522835|NCT03642873|18524104|P5|STARTED|First Intervention (1 Day)||4
7522836|NCT03642873|18524105|P4|STARTED|First Intervention (1 Day)||4
7522837|NCT03642873|18524106|P3|STARTED|First Intervention (1 Day)||4
7522838|NCT03642873|18524107|P2|STARTED|First Intervention (1 Day)||4
7522839|NCT03642873|18524108|P1|STARTED|First Intervention (1 Day)||4
7522840|NCT03642457|18524142|P2|NOT COMPLETED|Overall Study||0
7522841|NCT03642457|18524143|P1|NOT COMPLETED|Overall Study||0
7522842|NCT03642457|18524142|P2|COMPLETED|Overall Study||30
7522843|NCT03642457|18524143|P1|COMPLETED|Overall Study||35
7522844|NCT03642457|18524142|P2|STARTED|Overall Study||30
7522845|NCT03642457|18524143|P1|STARTED|Overall Study||35
7522846|NCT03642262|18524159|P2|NOT COMPLETED|Period 2||0
7522847|NCT03642262|18524160|P1|NOT COMPLETED|Period 2||0
7522848|NCT03642262|18524159|P2|COMPLETED|Period 2||16
7522849|NCT03642262|18524160|P1|COMPLETED|Period 2||11
7522850|NCT03642262|18524159|P2|STARTED|Period 2||16
7522851|NCT03642262|18524160|P1|STARTED|Period 2||11
7522852|NCT03642262|18524159|P2|NOT COMPLETED|Washout: 7 Days||0
7522853|NCT03642262|18524160|P1|NOT COMPLETED|Washout: 7 Days||0
7522854|NCT03642262|18524159|P2|COMPLETED|Washout: 7 Days||16
7522855|NCT03642262|18524160|P1|COMPLETED|Washout: 7 Days||11
7522856|NCT03642262|18524159|P2|STARTED|Washout: 7 Days||16
7522857|NCT03642262|18524160|P1|STARTED|Washout: 7 Days||11
7522858|NCT03642262|18524159|P2|NOT COMPLETED|Period 1||2
7522859|NCT03642262|18524160|P1|NOT COMPLETED|Period 1||1
7522860|NCT03642262|18524159|P2|COMPLETED|Period 1||16
7522861|NCT03642262|18524160|P1|COMPLETED|Period 1||11
7522862|NCT03642262|18524159|P2|STARTED|Period 1||18
7522863|NCT03642262|18524160|P1|STARTED|Period 1||12
7522864|NCT03641508|18524181|P2|NOT COMPLETED|Follow-up/Second Injection||0
7522865|NCT03641508|18524182|P1|NOT COMPLETED|Follow-up/Second Injection||0
7522866|NCT03641508|18524181|P2|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
7522867|NCT03641508|18524182|P1|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|2
7522868|NCT03641508|18524181|P2|STARTED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
7522869|NCT03641508|18524182|P1|STARTED|Follow-up/Second Injection||2
7522870|NCT03641508|18524181|P2|NOT COMPLETED|First Injection||0
7522871|NCT03641508|18524182|P1|NOT COMPLETED|First Injection||2
7522872|NCT03641508|18524181|P2|COMPLETED|First Injection||32
7522873|NCT03641508|18524182|P1|COMPLETED|First Injection||35
7522874|NCT03641508|18524181|P2|STARTED|First Injection||32
7522875|NCT03641508|18524182|P1|STARTED|First Injection||37
7522876|NCT03640832|18524194|P2|NOT COMPLETED|Overall Study||0
7522877|NCT03640832|18524195|P1|NOT COMPLETED|Overall Study||0
7522878|NCT03640832|18524194|P2|COMPLETED|Overall Study||46
7522879|NCT03640832|18524195|P1|COMPLETED|Overall Study||44
7522880|NCT03640832|18524194|P2|STARTED|Overall Study||46
7522881|NCT03640832|18524195|P1|STARTED|Overall Study||44
7522882|NCT03640559|18524209|P2|NOT COMPLETED|Overall Study||1
7522883|NCT03640559|18524210|P1|NOT COMPLETED|Overall Study||2
7522884|NCT03640559|18524209|P2|COMPLETED|Overall Study||24
7522885|NCT03640559|18524210|P1|COMPLETED|Overall Study||23
7522886|NCT03640559|18524209|P2|STARTED|Overall Study||25
7522887|NCT03640559|18524210|P1|STARTED|Overall Study||25
7522888|NCT03640507|18524219|P3|NOT COMPLETED|Overall Study||1
7522889|NCT03640507|18524220|P2|NOT COMPLETED|Overall Study||0
7522890|NCT03640507|18524221|P1|NOT COMPLETED|Overall Study||0
7522891|NCT03640507|18524219|P3|COMPLETED|Overall Study||10
7522892|NCT03640507|18524220|P2|COMPLETED|Overall Study||9
7522893|NCT03640507|18524221|P1|COMPLETED|Overall Study||10
7522894|NCT03640507|18524219|P3|STARTED|Overall Study||11
7522895|NCT03640507|18524220|P2|STARTED|Overall Study||9
7522896|NCT03640507|18524221|P1|STARTED|Overall Study||10
7522897|NCT03640052|18524241|P5|NOT COMPLETED|Overall Study||0
7522898|NCT03640052|18524242|P4|NOT COMPLETED|Overall Study||0
7522899|NCT03640052|18524243|P3|NOT COMPLETED|Overall Study||0
7522900|NCT03640052|18524244|P2|NOT COMPLETED|Overall Study||1
7522901|NCT03640052|18524245|P1|NOT COMPLETED|Overall Study||0
7522902|NCT03640052|18524241|P5|COMPLETED|Overall Study||1
7522903|NCT03640052|18524242|P4|COMPLETED|Overall Study||1
7522904|NCT03640052|18524243|P3|COMPLETED|Overall Study||1
7522905|NCT03640052|18524244|P2|COMPLETED|Overall Study|the patient performed 4 out of 5 nights|0
7522906|NCT03640052|18524245|P1|COMPLETED|Overall Study||2
7522907|NCT03640052|18524241|P5|STARTED|Overall Study||1
7522908|NCT03640052|18524242|P4|STARTED|Overall Study||1
7522909|NCT03640052|18524243|P3|STARTED|Overall Study||1
7522910|NCT03640052|18524244|P2|STARTED|Overall Study||1
7522911|NCT03640052|18524245|P1|STARTED|Overall Study||2
7522912|NCT03639675|18524262|P1|NOT COMPLETED|Overall Study||1
7522913|NCT03639675|18524262|P1|COMPLETED|Overall Study||15
7522914|NCT03639675|18524262|P1|Received Treatment|Overall Study||16
7522915|NCT03639675|18524262|P1|STARTED|Overall Study||16
7522916|NCT03638908|18524267|P1|NOT COMPLETED|Overall Study||1
7522917|NCT03638908|18524267|P1|COMPLETED|Overall Study||7
7522918|NCT03638908|18524267|P1|STARTED|Overall Study||8
7522919|NCT03638635|18524284|P2|NOT COMPLETED|Follow-Up (30 Days After Discharge)||22
7522920|NCT03638635|18524285|P1|NOT COMPLETED|Follow-Up (30 Days After Discharge)||39
7522921|NCT03638635|18524284|P2|COMPLETED|Follow-Up (30 Days After Discharge)||0
7522922|NCT03638635|18524285|P1|COMPLETED|Follow-Up (30 Days After Discharge)||0
7522923|NCT03638635|18524284|P2|STARTED|Follow-Up (30 Days After Discharge)||22
7522924|NCT03638635|18524285|P1|STARTED|Follow-Up (30 Days After Discharge)||39
7522925|NCT03638635|18524284|P2|NOT COMPLETED|Initial Hospitalization||2
7522926|NCT03638635|18524285|P1|NOT COMPLETED|Initial Hospitalization||0
7522927|NCT03638635|18524284|P2|COMPLETED|Initial Hospitalization||22
7522928|NCT03638635|18524285|P1|COMPLETED|Initial Hospitalization||39
7522929|NCT03638635|18524284|P2|STARTED|Initial Hospitalization||24
7522930|NCT03638635|18524285|P1|STARTED|Initial Hospitalization||39
7522931|NCT03638323|18524315|P1|NOT COMPLETED|Overall Study||1
7522932|NCT03638323|18524315|P1|COMPLETED|Overall Study||37
7522933|NCT03638323|18524315|P1|STARTED|Overall Study||38
7522934|NCT03637517|18524339|P3|NOT COMPLETED|Overall Study||0
7522935|NCT03637517|18524340|P2|NOT COMPLETED|Overall Study||0
7522936|NCT03637517|18524341|P1|NOT COMPLETED|Overall Study||0
7522937|NCT03637517|18524339|P3|COMPLETED|Overall Study||14
7522938|NCT03637517|18524340|P2|COMPLETED|Overall Study||14
7522939|NCT03637517|18524341|P1|COMPLETED|Overall Study||14
7522940|NCT03637517|18524339|P3|STARTED|Overall Study||14
7522941|NCT03637517|18524340|P2|STARTED|Overall Study||14
7522942|NCT03637517|18524341|P1|STARTED|Overall Study||14
7522943|NCT03637348|18524367|P1|NOT COMPLETED|Overall Study||0
7522944|NCT03637348|18524367|P1|COMPLETED|Overall Study||45
7522945|NCT03637348|18524367|P1|STARTED|Overall Study||45
7522946|NCT03636893|18524374|P2|NOT COMPLETED|Overall Study||10
7522947|NCT03636893|18524375|P1|NOT COMPLETED|Overall Study||9
7522948|NCT03636893|18524374|P2|COMPLETED|Overall Study||24
7522949|NCT03636893|18524375|P1|COMPLETED|Overall Study||31
7522950|NCT03636893|18524374|P2|STARTED|Overall Study||34
7522951|NCT03636893|18524375|P1|STARTED|Overall Study||40
7522952|NCT03636386|18524383|P2|NOT COMPLETED|Overall Study||0
7522953|NCT03636386|18524384|P1|NOT COMPLETED|Overall Study||0
7522954|NCT03636386|18524383|P2|COMPLETED|Overall Study||24
7522955|NCT03636386|18524384|P1|COMPLETED|Overall Study||24
7522956|NCT03636386|18524383|P2|STARTED|Overall Study||24
7522957|NCT03636386|18524384|P1|STARTED|Overall Study||24
7522958|NCT03635957|18524392|P1|NOT COMPLETED|Pegloticase + IMM Period||3
7522959|NCT03635957|18524392|P1|COMPLETED|Pegloticase + IMM Period||11
7522960|NCT03635957|18524392|P1|Discontinued Study Treatment Early|Pegloticase + IMM Period||5
7522961|NCT03635957|18524392|P1|Completed Study at 52 Weeks-Amendment 2|Pegloticase + IMM Period||10
7522962|NCT03635957|18524392|P1|Completed Study at 24 Weeks-Amendment 1|Pegloticase + IMM Period||1
7522963|NCT03635957|18524392|P1|STARTED|Pegloticase + IMM Period||14
7522964|NCT03635957|18524392|P1|NOT COMPLETED|Run-In Period||1
7522965|NCT03635957|18524392|P1|COMPLETED|Run-In Period||14
7522966|NCT03635957|18524392|P1|STARTED|Run-In Period||15
7522967|NCT03635424|18524403|P1|NOT COMPLETED|Overall Study||3
7522968|NCT03635424|18524403|P1|COMPLETED|Overall Study||147
7522969|NCT03635424|18524403|P1|STARTED|Overall Study||150
7522970|NCT03634579|18524424|P1|NOT COMPLETED|Overall Study||9
7522971|NCT03634579|18524424|P1|COMPLETED|Overall Study||0
7522972|NCT03634579|18524424|P1|STARTED|Overall Study||9
7522973|NCT03634306|18524435|P3|NOT COMPLETED|Overall Study||0
7522974|NCT03634306|18524436|P2|NOT COMPLETED|Overall Study||0
7522975|NCT03634306|18524437|P1|NOT COMPLETED|Overall Study||0
7522976|NCT03634306|18524435|P3|COMPLETED|Overall Study||5
7522977|NCT03634306|18524436|P2|COMPLETED|Overall Study||15
7522978|NCT03634306|18524437|P1|COMPLETED|Overall Study||15
7522979|NCT03634306|18524435|P3|STARTED|Overall Study||5
7522980|NCT03634306|18524436|P2|STARTED|Overall Study||15
7522981|NCT03634306|18524437|P1|STARTED|Overall Study||15
7522982|NCT03634085|18524522|P2|NOT COMPLETED|Overall Study||2
7522983|NCT03634085|18524523|P1|NOT COMPLETED|Overall Study||1
7522984|NCT03634085|18524522|P2|COMPLETED|Overall Study|"1 subject dropped out due to personal emergency
~1 subject dropped out due to personal circumstances"|6
7522985|NCT03634085|18524523|P1|COMPLETED|Overall Study|1 subject dropped out due to car accident|7
7522986|NCT03634085|18524522|P2|Period 4|Overall Study|this period is not applicable for Cohort B|0
7522987|NCT03634085|18524523|P1|Period 4|Overall Study|8 subjects started BDM2 - 3100 mg and 7 subjects completed BDM2 - 3100 mg (drop out; 1 active)|8
7522988|NCT03634085|18524522|P2|Period 3|Overall Study|8 subjects started and 6 subjects completed BDM2 - 900 mg fed (dropout; 1 active 1 placebo)|8
7522989|NCT03634085|18524523|P1|Period 3|Overall Study|8 subjects started BDM2 - 1800 mg and 7 subjects completed BDM2 - 1800 mg (drop out; 1 active)|8
7522990|NCT03634085|18524522|P2|Period 2|Overall Study|8 subjects started BDM2 - 900 mg fasted and 8 subjects completed BDM2 - 900 mg fasted|8
7522991|NCT03634085|18524523|P1|Period 2|Overall Study|8 subjects started BDM2 - 450 mg and 7 subjects completed BDM2 - 450 mg (drop out; 1 active)|8
7522992|NCT03634085|18524522|P2|Period 1|Overall Study|8 subjects started BDM2 - 150mg and 8 subjects completed BDM2 - 150 mg including matching placebo|8
7522993|NCT03634085|18524523|P1|Period 1|Overall Study|8 subjects started BDM2-50 mg and 8 subjects completed BDM2-50 mg including matching placebo.|8
7522994|NCT03634085|18524522|P2|STARTED|Overall Study||8
7522995|NCT03634085|18524523|P1|STARTED|Overall Study||8
7522996|NCT03633825|18524538|P2|NOT COMPLETED|Analysis||0
7522997|NCT03633825|18524539|P1|NOT COMPLETED|Analysis||0
7522998|NCT03633825|18524538|P2|COMPLETED|Analysis||325
7522999|NCT03633825|18524539|P1|COMPLETED|Analysis||327
7523000|NCT03633825|18524538|P2|STARTED|Analysis||325
7523001|NCT03633825|18524539|P1|STARTED|Analysis||327
7523002|NCT03633825|18524538|P2|NOT COMPLETED|Follow up||450
7523003|NCT03633825|18524539|P1|NOT COMPLETED|Follow up||478
7523004|NCT03633825|18524538|P2|COMPLETED|Follow up||325
7523005|NCT03633825|18524539|P1|COMPLETED|Follow up||327
7523006|NCT03633825|18524538|P2|STARTED|Follow up||775
7523007|NCT03633825|18524539|P1|STARTED|Follow up||805
7523008|NCT03633825|18524538|P2|NOT COMPLETED|Allocation||0
7523009|NCT03633825|18524539|P1|NOT COMPLETED|Allocation||0
7523010|NCT03633825|18524538|P2|COMPLETED|Allocation||775
7523011|NCT03633825|18524539|P1|COMPLETED|Allocation||805
7523012|NCT03633825|18524538|P2|STARTED|Allocation||775
7523013|NCT03633825|18524539|P1|STARTED|Allocation||805
7523014|NCT03633825|18524538|P2|NOT COMPLETED|Enrollment||18837
7523015|NCT03633825|18524539|P1|NOT COMPLETED|Enrollment||19033
7523016|NCT03633825|18524538|P2|COMPLETED|Enrollment||775
7523017|NCT03633825|18524539|P1|COMPLETED|Enrollment||805
7523018|NCT03633825|18524538|P2|STARTED|Enrollment||19612
7523019|NCT03633825|18524539|P1|STARTED|Enrollment||19838
7523020|NCT03633526|18524547|P1|NOT COMPLETED|Overall Study||0
7523021|NCT03633526|18524547|P1|COMPLETED|Overall Study||16
7523022|NCT03633526|18524547|P1|STARTED|Overall Study||16
7523023|NCT03633487|18524557|P1|NOT COMPLETED|Overall Study||0
7523024|NCT03633487|18524557|P1|COMPLETED|Overall Study||24
7523025|NCT03633487|18524557|P1|STARTED|Overall Study||24
7523026|NCT03633448|18524571|P2|NOT COMPLETED|Period 2 (1 Day)||0
7523027|NCT03633448|18524572|P1|NOT COMPLETED|Period 2 (1 Day)||0
7523028|NCT03633448|18524571|P2|COMPLETED|Period 2 (1 Day)||12
7523029|NCT03633448|18524572|P1|COMPLETED|Period 2 (1 Day)||12
7523030|NCT03633448|18524571|P2|STARTED|Period 2 (1 Day)||12
7523031|NCT03633448|18524572|P1|STARTED|Period 2 (1 Day)||12
7523032|NCT03633448|18524571|P2|NOT COMPLETED|Washout (7 Days)||0
7523033|NCT03633448|18524572|P1|NOT COMPLETED|Washout (7 Days)||0
7523034|NCT03633448|18524571|P2|COMPLETED|Washout (7 Days)||12
7523035|NCT03633448|18524572|P1|COMPLETED|Washout (7 Days)||12
7523036|NCT03633448|18524571|P2|STARTED|Washout (7 Days)||12
7523037|NCT03633448|18524572|P1|STARTED|Washout (7 Days)||12
7523038|NCT03633448|18524571|P2|NOT COMPLETED|Period 1 (1 Day)||0
7523039|NCT03633448|18524572|P1|NOT COMPLETED|Period 1 (1 Day)||0
7523040|NCT03633448|18524571|P2|COMPLETED|Period 1 (1 Day)||12
7523041|NCT03633448|18524572|P1|COMPLETED|Period 1 (1 Day)||12
7523042|NCT03633448|18524571|P2|STARTED|Period 1 (1 Day)||12
7523043|NCT03633448|18524572|P1|STARTED|Period 1 (1 Day)||12
7523044|NCT03633344|18524612|P2|NOT COMPLETED|Overall Study||0
7523045|NCT03633344|18524613|P1|NOT COMPLETED|Overall Study||0
7523046|NCT03633344|18524612|P2|COMPLETED|Overall Study||24
7523047|NCT03633344|18524613|P1|COMPLETED|Overall Study||120
7523048|NCT03633344|18524612|P2|STARTED|Overall Study||24
7523049|NCT03633344|18524613|P1|STARTED|Overall Study||120
7523050|NCT03632109|18524625|P1|NOT COMPLETED|Overall Study||0
7523051|NCT03632109|18524625|P1|COMPLETED|Overall Study||13
7523052|NCT03632109|18524625|P1|STARTED|Overall Study||13
7523053|NCT03632083|18524633|P8|NOT COMPLETED|Second Intervention||2
7523054|NCT03632083|18524634|P7|NOT COMPLETED|Second Intervention||0
7523055|NCT03632083|18524635|P6|NOT COMPLETED|Second Intervention||0
7523056|NCT03632083|18524636|P5|NOT COMPLETED|Second Intervention||0
7523057|NCT03632083|18524637|P4|NOT COMPLETED|Second Intervention||0
7523058|NCT03632083|18524638|P3|NOT COMPLETED|Second Intervention||0
7523059|NCT03632083|18524639|P2|NOT COMPLETED|Second Intervention||0
7523060|NCT03632083|18524640|P1|NOT COMPLETED|Second Intervention||0
7523061|NCT03632083|18524633|P8|COMPLETED|Second Intervention||5
7523062|NCT03632083|18524634|P7|COMPLETED|Second Intervention||7
7523063|NCT03632083|18524635|P6|COMPLETED|Second Intervention||9
7523064|NCT03632083|18524636|P5|COMPLETED|Second Intervention||9
7523065|NCT03632083|18524637|P4|COMPLETED|Second Intervention||7
7523066|NCT03632083|18524638|P3|COMPLETED|Second Intervention||7
7523067|NCT03632083|18524639|P2|COMPLETED|Second Intervention||5
7523068|NCT03632083|18524640|P1|COMPLETED|Second Intervention||5
7523069|NCT03632083|18524633|P8|STARTED|Second Intervention||7
7523070|NCT03632083|18524634|P7|STARTED|Second Intervention||7
7523071|NCT03632083|18524635|P6|STARTED|Second Intervention||9
7523072|NCT03632083|18524636|P5|STARTED|Second Intervention||9
7523073|NCT03632083|18524637|P4|STARTED|Second Intervention||7
7523074|NCT03632083|18524638|P3|STARTED|Second Intervention||7
7523075|NCT03632083|18524639|P2|STARTED|Second Intervention||5
7523076|NCT03632083|18524640|P1|STARTED|Second Intervention||5
7523077|NCT03632083|18524633|P8|NOT COMPLETED|First Intervention||0
7523078|NCT03632083|18524634|P7|NOT COMPLETED|First Intervention||0
7523079|NCT03632083|18524635|P6|NOT COMPLETED|First Intervention||0
7523080|NCT03632083|18524636|P5|NOT COMPLETED|First Intervention||0
7523081|NCT03632083|18524637|P4|NOT COMPLETED|First Intervention||0
7523082|NCT03632083|18524638|P3|NOT COMPLETED|First Intervention||0
7523083|NCT03632083|18524639|P2|NOT COMPLETED|First Intervention||0
7523084|NCT03632083|18524640|P1|NOT COMPLETED|First Intervention||0
7523085|NCT03632083|18524633|P8|COMPLETED|First Intervention||7
7523086|NCT03632083|18524634|P7|COMPLETED|First Intervention||7
7523087|NCT03632083|18524635|P6|COMPLETED|First Intervention||9
7523088|NCT03632083|18524636|P5|COMPLETED|First Intervention||9
7523089|NCT03632083|18524637|P4|COMPLETED|First Intervention||7
7523090|NCT03632083|18524638|P3|COMPLETED|First Intervention||7
7523091|NCT03632083|18524639|P2|COMPLETED|First Intervention||5
7523092|NCT03632083|18524640|P1|COMPLETED|First Intervention||5
7523093|NCT03632083|18524633|P8|STARTED|First Intervention||7
7523094|NCT03632083|18524634|P7|STARTED|First Intervention||7
7523095|NCT03632083|18524635|P6|STARTED|First Intervention||9
7523096|NCT03632083|18524636|P5|STARTED|First Intervention||9
7523097|NCT03632083|18524637|P4|STARTED|First Intervention||7
7523098|NCT03632083|18524638|P3|STARTED|First Intervention||7
7523099|NCT03632083|18524639|P2|STARTED|First Intervention||5
7523100|NCT03632083|18524640|P1|STARTED|First Intervention||5
7523101|NCT03631732|18524724|P2|NOT COMPLETED|Overall Study||153
7523102|NCT03631732|18524725|P1|NOT COMPLETED|Overall Study||300
7523103|NCT03631732|18524724|P2|COMPLETED|Overall Study||12
7523104|NCT03631732|18524725|P1|COMPLETED|Overall Study||31
7523105|NCT03631732|18524724|P2|STARTED|Overall Study||165
7523106|NCT03631732|18524725|P1|STARTED|Overall Study||331
7523107|NCT03630679|18524749|P2|NOT COMPLETED|Overall Study||12
7523108|NCT03630679|18524750|P1|NOT COMPLETED|Overall Study||7
7523109|NCT03630679|18524749|P2|COMPLETED|Overall Study||13
7523110|NCT03630679|18524750|P1|COMPLETED|Overall Study||13
7523111|NCT03630679|18524749|P2|STARTED|Overall Study||25
7523112|NCT03630679|18524750|P1|STARTED|Overall Study||20
7523113|NCT03630185|18524766|P2|NOT COMPLETED|Overall Study||4
7523114|NCT03630185|18524767|P1|NOT COMPLETED|Overall Study||4
7523115|NCT03630185|18524766|P2|COMPLETED|Overall Study||0
7523116|NCT03630185|18524767|P1|COMPLETED|Overall Study||0
7523117|NCT03630185|18524766|P2|6 Month Follow up|Overall Study||0
7523118|NCT03630185|18524767|P1|6 Month Follow up|Overall Study||0
7523119|NCT03630185|18524766|P2|90 Day Follow up|Overall Study||1
7523120|NCT03630185|18524767|P1|90 Day Follow up|Overall Study||0
7523121|NCT03630185|18524766|P2|30 Day Follow up|Overall Study||1
7523122|NCT03630185|18524767|P1|30 Day Follow up|Overall Study||1
7523123|NCT03630185|18524766|P2|STARTED|Overall Study||4
7523124|NCT03630185|18524767|P1|STARTED|Overall Study||4
7523125|NCT03630016|18524811|P1|NOT COMPLETED|Overall Study||1
7523126|NCT03630016|18524811|P1|COMPLETED|Overall Study||10
7523127|NCT03630016|18524811|P1|STARTED|Overall Study||11
7523128|NCT03629886|18524817|P2|NOT COMPLETED|Overall Study||180
7523129|NCT03629886|18524818|P1|NOT COMPLETED|Overall Study||0
7523130|NCT03629886|18524817|P2|COMPLETED|Overall Study||1686
7523131|NCT03629886|18524818|P1|COMPLETED|Overall Study||1671
7523132|NCT03629886|18524817|P2|STARTED|Overall Study||1866
7523133|NCT03629886|18524818|P1|STARTED|Overall Study||1671
7523134|NCT03629184|18524837|P2|NOT COMPLETED|Overall Study||1
7523135|NCT03629184|18524838|P1|NOT COMPLETED|Overall Study||3
7523136|NCT03629184|18524837|P2|COMPLETED|Overall Study||57
7523137|NCT03629184|18524838|P1|COMPLETED|Overall Study||112
7523138|NCT03629184|18524837|P2|STARTED|Overall Study||58
7523139|NCT03629184|18524838|P1|STARTED|Overall Study||115
7523140|NCT03629054|18524888|P2|NOT COMPLETED|Period 2 (4 Days)||1
7523141|NCT03629054|18524889|P1|NOT COMPLETED|Period 2 (4 Days)||0
7523142|NCT03629054|18524888|P2|COMPLETED|Period 2 (4 Days)||14
7523143|NCT03629054|18524889|P1|COMPLETED|Period 2 (4 Days)||15
7523144|NCT03629054|18524888|P2|Treated|Period 2 (4 Days)||14
7523145|NCT03629054|18524889|P1|Treated|Period 2 (4 Days)||15
7523146|NCT03629054|18524888|P2|STARTED|Period 2 (4 Days)|Started this period|15
7523147|NCT03629054|18524889|P1|STARTED|Period 2 (4 Days)|Started this period|15
7523148|NCT03629054|18524888|P2|NOT COMPLETED|Wasout Period (35 Days)||0
7523149|NCT03629054|18524889|P1|NOT COMPLETED|Wasout Period (35 Days)||0
7523150|NCT03629054|18524888|P2|COMPLETED|Wasout Period (35 Days)||15
7523151|NCT03629054|18524889|P1|COMPLETED|Wasout Period (35 Days)||15
7523152|NCT03629054|18524888|P2|STARTED|Wasout Period (35 Days)|Started this period|15
7523153|NCT03629054|18524889|P1|STARTED|Wasout Period (35 Days)|Started this period|15
7523154|NCT03629054|18524888|P2|NOT COMPLETED|Period 1 (4 Days)||0
7523155|NCT03629054|18524889|P1|NOT COMPLETED|Period 1 (4 Days)||0
7523156|NCT03629054|18524888|P2|COMPLETED|Period 1 (4 Days)||15
7523157|NCT03629054|18524889|P1|COMPLETED|Period 1 (4 Days)||15
7523158|NCT03629054|18524888|P2|STARTED|Period 1 (4 Days)|Started this period|15
7523159|NCT03629054|18524889|P1|STARTED|Period 1 (4 Days)|Started this period|15
7523160|NCT03629041|18524913|P4|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
7523161|NCT03629041|18524914|P3|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
7523162|NCT03629041|18524915|P2|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||1
7523163|NCT03629041|18524916|P1|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
7523164|NCT03629041|18524913|P4|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
7523165|NCT03629041|18524914|P3|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
7523166|NCT03629041|18524915|P2|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||3
7523167|NCT03629041|18524916|P1|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
7523168|NCT03629041|18524913|P4|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
7523169|NCT03629041|18524914|P3|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
7523170|NCT03629041|18524915|P2|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
7523171|NCT03629041|18524916|P1|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
7523172|NCT03629041|18524913|P4|NOT COMPLETED|Visit 1||0
7523173|NCT03629041|18524914|P3|NOT COMPLETED|Visit 1||0
7523174|NCT03629041|18524915|P2|NOT COMPLETED|Visit 1||0
7523175|NCT03629041|18524916|P1|NOT COMPLETED|Visit 1||0
7523176|NCT03629041|18524913|P4|COMPLETED|Visit 1||4
7523177|NCT03629041|18524914|P3|COMPLETED|Visit 1||4
7523178|NCT03629041|18524915|P2|COMPLETED|Visit 1||4
7523179|NCT03629041|18524916|P1|COMPLETED|Visit 1||4
7523180|NCT03629041|18524913|P4|STARTED|Visit 1||4
7523181|NCT03629041|18524914|P3|STARTED|Visit 1||4
7523182|NCT03629041|18524915|P2|STARTED|Visit 1||4
7523183|NCT03629041|18524916|P1|STARTED|Visit 1||4
7523184|NCT03629028|18524944|P2|NOT COMPLETED|Overall Study||25
7523185|NCT03629028|18524945|P1|NOT COMPLETED|Overall Study||32
7523186|NCT03629028|18524944|P2|COMPLETED|Overall Study||116
7523187|NCT03629028|18524945|P1|COMPLETED|Overall Study||109
7523188|NCT03629028|18524944|P2|STARTED|Overall Study||141
7523189|NCT03629028|18524945|P1|STARTED|Overall Study||141
7523190|NCT03628885|18524964|P3|NOT COMPLETED|Overall Study||60
7523191|NCT03628885|18524965|P2|NOT COMPLETED|Overall Study||47
7523192|NCT03628885|18524966|P1|NOT COMPLETED|Overall Study||39
7523193|NCT03628885|18524964|P3|COMPLETED|Overall Study||243
7523194|NCT03628885|18524965|P2|COMPLETED|Overall Study||252
7523195|NCT03628885|18524966|P1|COMPLETED|Overall Study||267
7523196|NCT03628885|18524964|P3|STARTED|Overall Study||303
7523197|NCT03628885|18524965|P2|STARTED|Overall Study||299
7523198|NCT03628885|18524966|P1|STARTED|Overall Study||306
7523199|NCT03628599|18524976|P2|NOT COMPLETED|Overall Study||1
7523200|NCT03628599|18524977|P1|NOT COMPLETED|Overall Study||0
7523201|NCT03628599|18524976|P2|COMPLETED|Overall Study||18
7523202|NCT03628599|18524977|P1|COMPLETED|Overall Study||18
7523203|NCT03628599|18524976|P2|STARTED|Overall Study||19
7523204|NCT03628599|18524977|P1|STARTED|Overall Study||18
7523205|NCT03628456|18524987|P1|NOT COMPLETED|Overall Study||0
7523206|NCT03628456|18524987|P1|COMPLETED|Overall Study||10
7523207|NCT03628456|18524987|P1|STARTED|Overall Study||10
7523208|NCT03628417|18525007|P2|NOT COMPLETED|Overall Study||1
7523209|NCT03628417|18525008|P1|NOT COMPLETED|Overall Study||1
7523210|NCT03628417|18525007|P2|COMPLETED|Overall Study|One patient died before the one-year closing visit,this is why decreased the number of metastases|6
7523211|NCT03628417|18525008|P1|COMPLETED|Overall Study|One patient died and 3 more Ca electroporated lesions were removed before the one-year closing visit|6
7523212|NCT03628417|18525007|P2|Day 180|Overall Study||7
7523213|NCT03628417|18525008|P1|Day 180|Overall Study||7
7523214|NCT03628417|18525007|P2|Day 90|Overall Study||7
7523215|NCT03628417|18525008|P1|Day 90|Overall Study||7
7523216|NCT03628417|18525007|P2|Day 60|Overall Study||7
7523217|NCT03628417|18525008|P1|Day 60|Overall Study||7
7523218|NCT03628417|18525007|P2|Day 30|Overall Study||7
7523219|NCT03628417|18525008|P1|Day 30|Overall Study||7
7523220|NCT03628417|18525007|P2|Day 15|Overall Study||7
7523221|NCT03628417|18525008|P1|Day 15|Overall Study||7
7523222|NCT03628417|18525007|P2|Day 7|Overall Study||7
7523223|NCT03628417|18525008|P1|Day 7|Overall Study||7
7523224|NCT03628417|18525007|P2|Day 0|Overall Study||7
7523225|NCT03628417|18525008|P1|Day 0|Overall Study||7
7523226|NCT03628417|18525007|P2|STARTED|Overall Study||7
7523227|NCT03628417|18525008|P1|STARTED|Overall Study||7
7523228|NCT03627832|18525020|P2|NOT COMPLETED|Overall Study||1
7523229|NCT03627832|18525021|P1|NOT COMPLETED|Overall Study||10
7523230|NCT03627832|18525020|P2|COMPLETED|Overall Study||27
7523231|NCT03627832|18525021|P1|COMPLETED|Overall Study||18
7523232|NCT03627832|18525020|P2|STARTED|Overall Study||28
7523233|NCT03627832|18525021|P1|STARTED|Overall Study||28
7523234|NCT03627494|18525055|P12|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523235|NCT03627494|18525056|P11|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523236|NCT03627494|18525057|P10|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523237|NCT03627494|18525058|P9|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523238|NCT03627494|18525059|P8|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523239|NCT03627494|18525060|P7|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523240|NCT03627494|18525061|P6|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523241|NCT03627494|18525062|P5|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523242|NCT03627494|18525063|P4|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523243|NCT03627494|18525064|P3|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523244|NCT03627494|18525065|P2|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523245|NCT03627494|18525066|P1|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523246|NCT03627494|18525055|P12|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
7523247|NCT03627494|18525056|P11|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
7523248|NCT03627494|18525057|P10|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523249|NCT03627494|18525058|P9|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523250|NCT03627494|18525059|P8|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523251|NCT03627494|18525060|P7|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523252|NCT03627494|18525061|P6|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523253|NCT03627494|18525062|P5|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523254|NCT03627494|18525063|P4|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523255|NCT03627494|18525064|P3|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523256|NCT03627494|18525065|P2|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523257|NCT03627494|18525066|P1|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
7523258|NCT03627494|18525055|P12|STARTED|Part C Period2(4days)+Follow-up(14days)||5
7523259|NCT03627494|18525056|P11|STARTED|Part C Period2(4days)+Follow-up(14days)||5
7523260|NCT03627494|18525057|P10|STARTED|Part C Period2(4days)+Follow-up(14days)||0
7523261|NCT03627494|18525058|P9|STARTED|Part C Period2(4days)+Follow-up(14days)||0
7523262|NCT03627494|18525059|P8|STARTED|Part C Period2(4days)+Follow-up(14days)||0
7523263|NCT03627494|18525060|P7|STARTED|Part C Period2(4days)+Follow-up(14days)||0
7523264|NCT03627494|18525061|P6|STARTED|Part C Period2(4days)+Follow-up(14days)||0
7523265|NCT03627494|18525062|P5|STARTED|Part C Period2(4days)+Follow-up(14days)||0
7523266|NCT03627494|18525063|P4|STARTED|Part C Period2(4days)+Follow-up(14days)||0
7523267|NCT03627494|18525064|P3|STARTED|Part C Period2(4days)+Follow-up(14days)||0
7523268|NCT03627494|18525065|P2|STARTED|Part C Period2(4days)+Follow-up(14days)||0
7523269|NCT03627494|18525066|P1|STARTED|Part C Period2(4days)+Follow-up(14days)||0
7523270|NCT03627494|18525055|P12|NOT COMPLETED|Part C Washout 1 (7 Days)||1
7523271|NCT03627494|18525056|P11|NOT COMPLETED|Part C Washout 1 (7 Days)||1
7523272|NCT03627494|18525057|P10|NOT COMPLETED|Part C Washout 1 (7 Days)||0
7523273|NCT03627494|18525058|P9|NOT COMPLETED|Part C Washout 1 (7 Days)||0
7523274|NCT03627494|18525059|P8|NOT COMPLETED|Part C Washout 1 (7 Days)||0
7523275|NCT03627494|18525060|P7|NOT COMPLETED|Part C Washout 1 (7 Days)||0
7523276|NCT03627494|18525061|P6|NOT COMPLETED|Part C Washout 1 (7 Days)||0
7523277|NCT03627494|18525062|P5|NOT COMPLETED|Part C Washout 1 (7 Days)||0
7523278|NCT03627494|18525063|P4|NOT COMPLETED|Part C Washout 1 (7 Days)||0
7523279|NCT03627494|18525064|P3|NOT COMPLETED|Part C Washout 1 (7 Days)||0
7523280|NCT03627494|18525065|P2|NOT COMPLETED|Part C Washout 1 (7 Days)||0
7523281|NCT03627494|18525066|P1|NOT COMPLETED|Part C Washout 1 (7 Days)||0
7523282|NCT03627494|18525055|P12|COMPLETED|Part C Washout 1 (7 Days)||5
7523283|NCT03627494|18525056|P11|COMPLETED|Part C Washout 1 (7 Days)||5
7523284|NCT03627494|18525057|P10|COMPLETED|Part C Washout 1 (7 Days)||0
7523285|NCT03627494|18525058|P9|COMPLETED|Part C Washout 1 (7 Days)||0
7523286|NCT03627494|18525059|P8|COMPLETED|Part C Washout 1 (7 Days)||0
7523287|NCT03627494|18525060|P7|COMPLETED|Part C Washout 1 (7 Days)||0
7523288|NCT03627494|18525061|P6|COMPLETED|Part C Washout 1 (7 Days)||0
7523289|NCT03627494|18525062|P5|COMPLETED|Part C Washout 1 (7 Days)||0
7523290|NCT03627494|18525063|P4|COMPLETED|Part C Washout 1 (7 Days)||0
7523291|NCT03627494|18525064|P3|COMPLETED|Part C Washout 1 (7 Days)||0
7523292|NCT03627494|18525065|P2|COMPLETED|Part C Washout 1 (7 Days)||0
7523293|NCT03627494|18525066|P1|COMPLETED|Part C Washout 1 (7 Days)||0
7523294|NCT03627494|18525055|P12|STARTED|Part C Washout 1 (7 Days)||6
7523295|NCT03627494|18525056|P11|STARTED|Part C Washout 1 (7 Days)||6
7523296|NCT03627494|18525057|P10|STARTED|Part C Washout 1 (7 Days)||0
7523297|NCT03627494|18525058|P9|STARTED|Part C Washout 1 (7 Days)||0
7523298|NCT03627494|18525059|P8|STARTED|Part C Washout 1 (7 Days)||0
7523299|NCT03627494|18525060|P7|STARTED|Part C Washout 1 (7 Days)||0
7523300|NCT03627494|18525061|P6|STARTED|Part C Washout 1 (7 Days)||0
7523301|NCT03627494|18525062|P5|STARTED|Part C Washout 1 (7 Days)||0
7523302|NCT03627494|18525063|P4|STARTED|Part C Washout 1 (7 Days)||0
7523303|NCT03627494|18525064|P3|STARTED|Part C Washout 1 (7 Days)||0
7523304|NCT03627494|18525065|P2|STARTED|Part C Washout 1 (7 Days)||0
7523305|NCT03627494|18525066|P1|STARTED|Part C Washout 1 (7 Days)||0
7523306|NCT03627494|18525055|P12|NOT COMPLETED|Part C Period 1 (4 Days)||0
7523307|NCT03627494|18525056|P11|NOT COMPLETED|Part C Period 1 (4 Days)||0
7523308|NCT03627494|18525057|P10|NOT COMPLETED|Part C Period 1 (4 Days)||0
7523309|NCT03627494|18525058|P9|NOT COMPLETED|Part C Period 1 (4 Days)||0
7523310|NCT03627494|18525059|P8|NOT COMPLETED|Part C Period 1 (4 Days)||0
7523311|NCT03627494|18525060|P7|NOT COMPLETED|Part C Period 1 (4 Days)||0
7523312|NCT03627494|18525061|P6|NOT COMPLETED|Part C Period 1 (4 Days)||0
7523313|NCT03627494|18525062|P5|NOT COMPLETED|Part C Period 1 (4 Days)||0
7523314|NCT03627494|18525063|P4|NOT COMPLETED|Part C Period 1 (4 Days)||0
7523315|NCT03627494|18525064|P3|NOT COMPLETED|Part C Period 1 (4 Days)||0
7523316|NCT03627494|18525065|P2|NOT COMPLETED|Part C Period 1 (4 Days)||0
7523317|NCT03627494|18525066|P1|NOT COMPLETED|Part C Period 1 (4 Days)||0
7523318|NCT03627494|18525055|P12|COMPLETED|Part C Period 1 (4 Days)||6
7523319|NCT03627494|18525056|P11|COMPLETED|Part C Period 1 (4 Days)||6
7523320|NCT03627494|18525057|P10|COMPLETED|Part C Period 1 (4 Days)||0
7523321|NCT03627494|18525058|P9|COMPLETED|Part C Period 1 (4 Days)||0
7523322|NCT03627494|18525059|P8|COMPLETED|Part C Period 1 (4 Days)||0
7523323|NCT03627494|18525060|P7|COMPLETED|Part C Period 1 (4 Days)||0
7523324|NCT03627494|18525061|P6|COMPLETED|Part C Period 1 (4 Days)||0
7523325|NCT03627494|18525062|P5|COMPLETED|Part C Period 1 (4 Days)||0
7523326|NCT03627494|18525063|P4|COMPLETED|Part C Period 1 (4 Days)||0
7523327|NCT03627494|18525064|P3|COMPLETED|Part C Period 1 (4 Days)||0
7523328|NCT03627494|18525065|P2|COMPLETED|Part C Period 1 (4 Days)||0
7523329|NCT03627494|18525066|P1|COMPLETED|Part C Period 1 (4 Days)||0
7523330|NCT03627494|18525055|P12|STARTED|Part C Period 1 (4 Days)||6
7523331|NCT03627494|18525056|P11|STARTED|Part C Period 1 (4 Days)||6
7523332|NCT03627494|18525057|P10|STARTED|Part C Period 1 (4 Days)||0
7523333|NCT03627494|18525058|P9|STARTED|Part C Period 1 (4 Days)||0
7523334|NCT03627494|18525059|P8|STARTED|Part C Period 1 (4 Days)||0
7523335|NCT03627494|18525060|P7|STARTED|Part C Period 1 (4 Days)||0
7523336|NCT03627494|18525061|P6|STARTED|Part C Period 1 (4 Days)||0
7523337|NCT03627494|18525062|P5|STARTED|Part C Period 1 (4 Days)||0
7523338|NCT03627494|18525063|P4|STARTED|Part C Period 1 (4 Days)||0
7523339|NCT03627494|18525064|P3|STARTED|Part C Period 1 (4 Days)||0
7523340|NCT03627494|18525065|P2|STARTED|Part C Period 1 (4 Days)||0
7523341|NCT03627494|18525066|P1|STARTED|Part C Period 1 (4 Days)||0
7523342|NCT03627494|18525055|P12|NOT COMPLETED|Part B (Maximum of 34 Days)||0
7523343|NCT03627494|18525056|P11|NOT COMPLETED|Part B (Maximum of 34 Days)||0
7523344|NCT03627494|18525057|P10|NOT COMPLETED|Part B (Maximum of 34 Days)||0
7523345|NCT03627494|18525058|P9|NOT COMPLETED|Part B (Maximum of 34 Days)||2
7523346|NCT03627494|18525059|P8|NOT COMPLETED|Part B (Maximum of 34 Days)||0
7523347|NCT03627494|18525060|P7|NOT COMPLETED|Part B (Maximum of 34 Days)||0
7523348|NCT03627494|18525061|P6|NOT COMPLETED|Part B (Maximum of 34 Days)||0
7523349|NCT03627494|18525062|P5|NOT COMPLETED|Part B (Maximum of 34 Days)||0
7523350|NCT03627494|18525063|P4|NOT COMPLETED|Part B (Maximum of 34 Days)||0
7523351|NCT03627494|18525064|P3|NOT COMPLETED|Part B (Maximum of 34 Days)||0
7523352|NCT03627494|18525065|P2|NOT COMPLETED|Part B (Maximum of 34 Days)||0
7523353|NCT03627494|18525066|P1|NOT COMPLETED|Part B (Maximum of 34 Days)||0
7523354|NCT03627494|18525055|P12|COMPLETED|Part B (Maximum of 34 Days)||0
7523355|NCT03627494|18525056|P11|COMPLETED|Part B (Maximum of 34 Days)||0
7523356|NCT03627494|18525057|P10|COMPLETED|Part B (Maximum of 34 Days)||9
7523357|NCT03627494|18525058|P9|COMPLETED|Part B (Maximum of 34 Days)||7
7523358|NCT03627494|18525059|P8|COMPLETED|Part B (Maximum of 34 Days)||9
7523359|NCT03627494|18525060|P7|COMPLETED|Part B (Maximum of 34 Days)||9
7523360|NCT03627494|18525061|P6|COMPLETED|Part B (Maximum of 34 Days)||0
7523361|NCT03627494|18525062|P5|COMPLETED|Part B (Maximum of 34 Days)||0
7523362|NCT03627494|18525063|P4|COMPLETED|Part B (Maximum of 34 Days)||0
7523363|NCT03627494|18525064|P3|COMPLETED|Part B (Maximum of 34 Days)||0
7523364|NCT03627494|18525065|P2|COMPLETED|Part B (Maximum of 34 Days)||0
7523365|NCT03627494|18525066|P1|COMPLETED|Part B (Maximum of 34 Days)||0
7523366|NCT03627494|18525055|P12|STARTED|Part B (Maximum of 34 Days)||0
7523367|NCT03627494|18525056|P11|STARTED|Part B (Maximum of 34 Days)||0
7523368|NCT03627494|18525057|P10|STARTED|Part B (Maximum of 34 Days)||9
7523369|NCT03627494|18525058|P9|STARTED|Part B (Maximum of 34 Days)||9
7523370|NCT03627494|18525059|P8|STARTED|Part B (Maximum of 34 Days)||9
7523371|NCT03627494|18525060|P7|STARTED|Part B (Maximum of 34 Days)||9
7523372|NCT03627494|18525061|P6|STARTED|Part B (Maximum of 34 Days)||0
7523373|NCT03627494|18525062|P5|STARTED|Part B (Maximum of 34 Days)||0
7523374|NCT03627494|18525063|P4|STARTED|Part B (Maximum of 34 Days)||0
7523375|NCT03627494|18525064|P3|STARTED|Part B (Maximum of 34 Days)||0
7523376|NCT03627494|18525065|P2|STARTED|Part B (Maximum of 34 Days)||0
7523377|NCT03627494|18525066|P1|STARTED|Part B (Maximum of 34 Days)||0
7523378|NCT03627494|18525055|P12|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
7523379|NCT03627494|18525056|P11|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
7523380|NCT03627494|18525057|P10|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
7523381|NCT03627494|18525058|P9|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
7523382|NCT03627494|18525059|P8|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
7523383|NCT03627494|18525060|P7|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
7523384|NCT03627494|18525061|P6|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
7523385|NCT03627494|18525062|P5|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
7523386|NCT03627494|18525063|P4|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
7523387|NCT03627494|18525064|P3|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
7523388|NCT03627494|18525065|P2|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
7523389|NCT03627494|18525066|P1|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
7523390|NCT03627494|18525055|P12|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
7523391|NCT03627494|18525056|P11|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
7523392|NCT03627494|18525057|P10|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
7523393|NCT03627494|18525058|P9|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
7523394|NCT03627494|18525059|P8|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
7523395|NCT03627494|18525060|P7|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
7523396|NCT03627494|18525061|P6|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
7523397|NCT03627494|18525062|P5|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
7523398|NCT03627494|18525063|P4|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
7523399|NCT03627494|18525064|P3|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
7523400|NCT03627494|18525065|P2|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
7523401|NCT03627494|18525066|P1|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
7523402|NCT03627494|18525055|P12|STARTED|Part A Period3(4days)+Follow-up(14days)||0
7523403|NCT03627494|18525056|P11|STARTED|Part A Period3(4days)+Follow-up(14days)||0
7523404|NCT03627494|18525057|P10|STARTED|Part A Period3(4days)+Follow-up(14days)||0
7523405|NCT03627494|18525058|P9|STARTED|Part A Period3(4days)+Follow-up(14days)||0
7523406|NCT03627494|18525059|P8|STARTED|Part A Period3(4days)+Follow-up(14days)||0
7523407|NCT03627494|18525060|P7|STARTED|Part A Period3(4days)+Follow-up(14days)||0
7523408|NCT03627494|18525061|P6|STARTED|Part A Period3(4days)+Follow-up(14days)||3
7523409|NCT03627494|18525062|P5|STARTED|Part A Period3(4days)+Follow-up(14days)||3
7523410|NCT03627494|18525063|P4|STARTED|Part A Period3(4days)+Follow-up(14days)||3
7523411|NCT03627494|18525064|P3|STARTED|Part A Period3(4days)+Follow-up(14days)||2
7523412|NCT03627494|18525065|P2|STARTED|Part A Period3(4days)+Follow-up(14days)||3
7523413|NCT03627494|18525066|P1|STARTED|Part A Period3(4days)+Follow-up(14days)||2
7523414|NCT03627494|18525055|P12|NOT COMPLETED|Part A Washout 2 (7 Days)||0
7523415|NCT03627494|18525056|P11|NOT COMPLETED|Part A Washout 2 (7 Days)||0
7523416|NCT03627494|18525057|P10|NOT COMPLETED|Part A Washout 2 (7 Days)||0
7523417|NCT03627494|18525058|P9|NOT COMPLETED|Part A Washout 2 (7 Days)||0
7523418|NCT03627494|18525059|P8|NOT COMPLETED|Part A Washout 2 (7 Days)||0
7523419|NCT03627494|18525060|P7|NOT COMPLETED|Part A Washout 2 (7 Days)||0
7523420|NCT03627494|18525061|P6|NOT COMPLETED|Part A Washout 2 (7 Days)||0
7523421|NCT03627494|18525062|P5|NOT COMPLETED|Part A Washout 2 (7 Days)||0
7523422|NCT03627494|18525063|P4|NOT COMPLETED|Part A Washout 2 (7 Days)||0
7523423|NCT03627494|18525064|P3|NOT COMPLETED|Part A Washout 2 (7 Days)||1
7523424|NCT03627494|18525065|P2|NOT COMPLETED|Part A Washout 2 (7 Days)||0
7523425|NCT03627494|18525066|P1|NOT COMPLETED|Part A Washout 2 (7 Days)||1
7523426|NCT03627494|18525055|P12|COMPLETED|Part A Washout 2 (7 Days)||0
7523427|NCT03627494|18525056|P11|COMPLETED|Part A Washout 2 (7 Days)||0
7523428|NCT03627494|18525057|P10|COMPLETED|Part A Washout 2 (7 Days)||0
7523429|NCT03627494|18525058|P9|COMPLETED|Part A Washout 2 (7 Days)||0
7523430|NCT03627494|18525059|P8|COMPLETED|Part A Washout 2 (7 Days)||0
7523431|NCT03627494|18525060|P7|COMPLETED|Part A Washout 2 (7 Days)||0
7523432|NCT03627494|18525061|P6|COMPLETED|Part A Washout 2 (7 Days)||3
7523433|NCT03627494|18525062|P5|COMPLETED|Part A Washout 2 (7 Days)||3
7523434|NCT03627494|18525063|P4|COMPLETED|Part A Washout 2 (7 Days)||3
7523435|NCT03627494|18525064|P3|COMPLETED|Part A Washout 2 (7 Days)||2
7523436|NCT03627494|18525065|P2|COMPLETED|Part A Washout 2 (7 Days)||3
7523437|NCT03627494|18525066|P1|COMPLETED|Part A Washout 2 (7 Days)||2
7523438|NCT03627494|18525055|P12|STARTED|Part A Washout 2 (7 Days)||0
7523439|NCT03627494|18525056|P11|STARTED|Part A Washout 2 (7 Days)||0
7523440|NCT03627494|18525057|P10|STARTED|Part A Washout 2 (7 Days)||0
7523441|NCT03627494|18525058|P9|STARTED|Part A Washout 2 (7 Days)||0
7523442|NCT03627494|18525059|P8|STARTED|Part A Washout 2 (7 Days)||0
7523443|NCT03627494|18525060|P7|STARTED|Part A Washout 2 (7 Days)||0
7523444|NCT03627494|18525061|P6|STARTED|Part A Washout 2 (7 Days)||3
7523445|NCT03627494|18525062|P5|STARTED|Part A Washout 2 (7 Days)||3
7523446|NCT03627494|18525063|P4|STARTED|Part A Washout 2 (7 Days)||3
7523447|NCT03627494|18525064|P3|STARTED|Part A Washout 2 (7 Days)||3
7523448|NCT03627494|18525065|P2|STARTED|Part A Washout 2 (7 Days)||3
7523449|NCT03627494|18525066|P1|STARTED|Part A Washout 2 (7 Days)||3
7523450|NCT03627494|18525055|P12|NOT COMPLETED|Part A Period 2 (4 Days)||0
7523451|NCT03627494|18525056|P11|NOT COMPLETED|Part A Period 2 (4 Days)||0
7523452|NCT03627494|18525057|P10|NOT COMPLETED|Part A Period 2 (4 Days)||0
7523453|NCT03627494|18525058|P9|NOT COMPLETED|Part A Period 2 (4 Days)||0
7523454|NCT03627494|18525059|P8|NOT COMPLETED|Part A Period 2 (4 Days)||0
7523455|NCT03627494|18525060|P7|NOT COMPLETED|Part A Period 2 (4 Days)||0
7523456|NCT03627494|18525061|P6|NOT COMPLETED|Part A Period 2 (4 Days)||0
7523457|NCT03627494|18525062|P5|NOT COMPLETED|Part A Period 2 (4 Days)||0
7523458|NCT03627494|18525063|P4|NOT COMPLETED|Part A Period 2 (4 Days)||0
7523459|NCT03627494|18525064|P3|NOT COMPLETED|Part A Period 2 (4 Days)||0
7523460|NCT03627494|18525065|P2|NOT COMPLETED|Part A Period 2 (4 Days)||0
7523461|NCT03627494|18525066|P1|NOT COMPLETED|Part A Period 2 (4 Days)||0
7523462|NCT03627494|18525055|P12|COMPLETED|Part A Period 2 (4 Days)||0
7523463|NCT03627494|18525056|P11|COMPLETED|Part A Period 2 (4 Days)||0
7523464|NCT03627494|18525057|P10|COMPLETED|Part A Period 2 (4 Days)||0
7523465|NCT03627494|18525058|P9|COMPLETED|Part A Period 2 (4 Days)||0
7523466|NCT03627494|18525059|P8|COMPLETED|Part A Period 2 (4 Days)||0
7523467|NCT03627494|18525060|P7|COMPLETED|Part A Period 2 (4 Days)||0
7523468|NCT03627494|18525061|P6|COMPLETED|Part A Period 2 (4 Days)||3
7523469|NCT03627494|18525062|P5|COMPLETED|Part A Period 2 (4 Days)||3
7523470|NCT03627494|18525063|P4|COMPLETED|Part A Period 2 (4 Days)||3
7523471|NCT03627494|18525064|P3|COMPLETED|Part A Period 2 (4 Days)||3
7523472|NCT03627494|18525065|P2|COMPLETED|Part A Period 2 (4 Days)||3
7523473|NCT03627494|18525066|P1|COMPLETED|Part A Period 2 (4 Days)||3
7523474|NCT03627494|18525055|P12|STARTED|Part A Period 2 (4 Days)||0
7523475|NCT03627494|18525056|P11|STARTED|Part A Period 2 (4 Days)||0
7523476|NCT03627494|18525057|P10|STARTED|Part A Period 2 (4 Days)||0
7523477|NCT03627494|18525058|P9|STARTED|Part A Period 2 (4 Days)||0
7523478|NCT03627494|18525059|P8|STARTED|Part A Period 2 (4 Days)||0
7523479|NCT03627494|18525060|P7|STARTED|Part A Period 2 (4 Days)||0
7523480|NCT03627494|18525061|P6|STARTED|Part A Period 2 (4 Days)||3
7523481|NCT03627494|18525062|P5|STARTED|Part A Period 2 (4 Days)||3
7523482|NCT03627494|18525063|P4|STARTED|Part A Period 2 (4 Days)||3
7523483|NCT03627494|18525064|P3|STARTED|Part A Period 2 (4 Days)||3
7523484|NCT03627494|18525065|P2|STARTED|Part A Period 2 (4 Days)||3
7523485|NCT03627494|18525066|P1|STARTED|Part A Period 2 (4 Days)||3
7523486|NCT03627494|18525055|P12|NOT COMPLETED|Part A Washout 1 (7 Days)||0
7523487|NCT03627494|18525056|P11|NOT COMPLETED|Part A Washout 1 (7 Days)||0
7523488|NCT03627494|18525057|P10|NOT COMPLETED|Part A Washout 1 (7 Days)||0
7523489|NCT03627494|18525058|P9|NOT COMPLETED|Part A Washout 1 (7 Days)||0
7523490|NCT03627494|18525059|P8|NOT COMPLETED|Part A Washout 1 (7 Days)||0
7523491|NCT03627494|18525060|P7|NOT COMPLETED|Part A Washout 1 (7 Days)||0
7523492|NCT03627494|18525061|P6|NOT COMPLETED|Part A Washout 1 (7 Days)||0
7523493|NCT03627494|18525062|P5|NOT COMPLETED|Part A Washout 1 (7 Days)||0
7523494|NCT03627494|18525063|P4|NOT COMPLETED|Part A Washout 1 (7 Days)||0
7523495|NCT03627494|18525064|P3|NOT COMPLETED|Part A Washout 1 (7 Days)||0
7523496|NCT03627494|18525065|P2|NOT COMPLETED|Part A Washout 1 (7 Days)||0
7523497|NCT03627494|18525066|P1|NOT COMPLETED|Part A Washout 1 (7 Days)||0
7523498|NCT03627494|18525055|P12|COMPLETED|Part A Washout 1 (7 Days)||0
7523499|NCT03627494|18525056|P11|COMPLETED|Part A Washout 1 (7 Days)||0
7523500|NCT03627494|18525057|P10|COMPLETED|Part A Washout 1 (7 Days)||0
7523501|NCT03627494|18525058|P9|COMPLETED|Part A Washout 1 (7 Days)||0
7523502|NCT03627494|18525059|P8|COMPLETED|Part A Washout 1 (7 Days)||0
7523503|NCT03627494|18525060|P7|COMPLETED|Part A Washout 1 (7 Days)||0
7523504|NCT03627494|18525061|P6|COMPLETED|Part A Washout 1 (7 Days)||3
7523505|NCT03627494|18525062|P5|COMPLETED|Part A Washout 1 (7 Days)||3
7523506|NCT03627494|18525063|P4|COMPLETED|Part A Washout 1 (7 Days)||3
7523507|NCT03627494|18525064|P3|COMPLETED|Part A Washout 1 (7 Days)||3
7523508|NCT03627494|18525065|P2|COMPLETED|Part A Washout 1 (7 Days)||3
7523509|NCT03627494|18525066|P1|COMPLETED|Part A Washout 1 (7 Days)||3
7523510|NCT03627494|18525055|P12|STARTED|Part A Washout 1 (7 Days)||0
7523511|NCT03627494|18525056|P11|STARTED|Part A Washout 1 (7 Days)||0
7523512|NCT03627494|18525057|P10|STARTED|Part A Washout 1 (7 Days)||0
7523513|NCT03627494|18525058|P9|STARTED|Part A Washout 1 (7 Days)||0
7523514|NCT03627494|18525059|P8|STARTED|Part A Washout 1 (7 Days)||0
7523515|NCT03627494|18525060|P7|STARTED|Part A Washout 1 (7 Days)||0
7523516|NCT03627494|18525061|P6|STARTED|Part A Washout 1 (7 Days)||3
7523517|NCT03627494|18525062|P5|STARTED|Part A Washout 1 (7 Days)||3
7523518|NCT03627494|18525063|P4|STARTED|Part A Washout 1 (7 Days)||3
7523519|NCT03627494|18525064|P3|STARTED|Part A Washout 1 (7 Days)||3
7523520|NCT03627494|18525065|P2|STARTED|Part A Washout 1 (7 Days)||3
7523521|NCT03627494|18525066|P1|STARTED|Part A Washout 1 (7 Days)||3
7523522|NCT03627494|18525055|P12|NOT COMPLETED|Part A Period 1 (4 Days)||0
7523523|NCT03627494|18525056|P11|NOT COMPLETED|Part A Period 1 (4 Days)||0
7523524|NCT03627494|18525057|P10|NOT COMPLETED|Part A Period 1 (4 Days)||0
7523525|NCT03627494|18525058|P9|NOT COMPLETED|Part A Period 1 (4 Days)||0
7523526|NCT03627494|18525059|P8|NOT COMPLETED|Part A Period 1 (4 Days)||0
7523527|NCT03627494|18525060|P7|NOT COMPLETED|Part A Period 1 (4 Days)||0
7523528|NCT03627494|18525061|P6|NOT COMPLETED|Part A Period 1 (4 Days)||0
7523529|NCT03627494|18525062|P5|NOT COMPLETED|Part A Period 1 (4 Days)||0
7523530|NCT03627494|18525063|P4|NOT COMPLETED|Part A Period 1 (4 Days)||0
7523531|NCT03627494|18525064|P3|NOT COMPLETED|Part A Period 1 (4 Days)||0
7523532|NCT03627494|18525065|P2|NOT COMPLETED|Part A Period 1 (4 Days)||0
7523533|NCT03627494|18525066|P1|NOT COMPLETED|Part A Period 1 (4 Days)||0
7523534|NCT03627494|18525055|P12|COMPLETED|Part A Period 1 (4 Days)||0
7523535|NCT03627494|18525056|P11|COMPLETED|Part A Period 1 (4 Days)||0
7523536|NCT03627494|18525057|P10|COMPLETED|Part A Period 1 (4 Days)||0
7523537|NCT03627494|18525058|P9|COMPLETED|Part A Period 1 (4 Days)||0
7523538|NCT03627494|18525059|P8|COMPLETED|Part A Period 1 (4 Days)||0
7523539|NCT03627494|18525060|P7|COMPLETED|Part A Period 1 (4 Days)||0
7523540|NCT03627494|18525061|P6|COMPLETED|Part A Period 1 (4 Days)||3
7523541|NCT03627494|18525062|P5|COMPLETED|Part A Period 1 (4 Days)||3
7523542|NCT03627494|18525063|P4|COMPLETED|Part A Period 1 (4 Days)||3
7523543|NCT03627494|18525064|P3|COMPLETED|Part A Period 1 (4 Days)||3
7523544|NCT03627494|18525065|P2|COMPLETED|Part A Period 1 (4 Days)||3
7523545|NCT03627494|18525066|P1|COMPLETED|Part A Period 1 (4 Days)||3
7523546|NCT03627494|18525055|P12|STARTED|Part A Period 1 (4 Days)||0
7523547|NCT03627494|18525056|P11|STARTED|Part A Period 1 (4 Days)||0
7523548|NCT03627494|18525057|P10|STARTED|Part A Period 1 (4 Days)||0
7523549|NCT03627494|18525058|P9|STARTED|Part A Period 1 (4 Days)||0
7523550|NCT03627494|18525059|P8|STARTED|Part A Period 1 (4 Days)||0
7523551|NCT03627494|18525060|P7|STARTED|Part A Period 1 (4 Days)||0
7523552|NCT03627494|18525061|P6|STARTED|Part A Period 1 (4 Days)||3
7523553|NCT03627494|18525062|P5|STARTED|Part A Period 1 (4 Days)||3
7523554|NCT03627494|18525063|P4|STARTED|Part A Period 1 (4 Days)||3
7523555|NCT03627494|18525064|P3|STARTED|Part A Period 1 (4 Days)||3
7523556|NCT03627494|18525065|P2|STARTED|Part A Period 1 (4 Days)||3
7523557|NCT03627494|18525066|P1|STARTED|Part A Period 1 (4 Days)||3
7523558|NCT03627299|18525262|P1|NOT COMPLETED|Overall Study||0
7523559|NCT03627299|18525262|P1|COMPLETED|Overall Study||10
7523560|NCT03627299|18525262|P1|STARTED|Overall Study||10
7523561|NCT03627195|18525280|P6|NOT COMPLETED|Overall Study||0
7523562|NCT03627195|18525281|P5|NOT COMPLETED|Overall Study||0
7523563|NCT03627195|18525282|P4|NOT COMPLETED|Overall Study||0
7523564|NCT03627195|18525283|P3|NOT COMPLETED|Overall Study||0
7523565|NCT03627195|18525284|P2|NOT COMPLETED|Overall Study||0
7523566|NCT03627195|18525285|P1|NOT COMPLETED|Overall Study||1
7523567|NCT03627195|18525280|P6|COMPLETED|Overall Study||10
7523568|NCT03627195|18525281|P5|COMPLETED|Overall Study||6
7523569|NCT03627195|18525282|P4|COMPLETED|Overall Study||6
7523570|NCT03627195|18525283|P3|COMPLETED|Overall Study||6
7523571|NCT03627195|18525284|P2|COMPLETED|Overall Study||6
7523572|NCT03627195|18525285|P1|COMPLETED|Overall Study||5
7523573|NCT03627195|18525280|P6|STARTED|Overall Study||10
7523574|NCT03627195|18525281|P5|STARTED|Overall Study||6
7523575|NCT03627195|18525282|P4|STARTED|Overall Study||6
7523576|NCT03627195|18525283|P3|STARTED|Overall Study||6
7523577|NCT03627195|18525284|P2|STARTED|Overall Study||6
7523578|NCT03627195|18525285|P1|STARTED|Overall Study||6
7523579|NCT03626714|18525311|P1|NOT COMPLETED|Overall Study||0
7523580|NCT03626714|18525311|P1|COMPLETED|Overall Study||8
7523581|NCT03626714|18525311|P1|STARTED|Overall Study||8
7523582|NCT03626415|18525323|P3|NOT COMPLETED|Overall Study||0
7523583|NCT03626415|18525324|P2|NOT COMPLETED|Overall Study||0
7523584|NCT03626415|18525325|P1|NOT COMPLETED|Overall Study||0
7523585|NCT03626415|18525323|P3|COMPLETED|Overall Study||8
7523586|NCT03626415|18525324|P2|COMPLETED|Overall Study||8
7523587|NCT03626415|18525325|P1|COMPLETED|Overall Study||8
7523588|NCT03626415|18525323|P3|STARTED|Overall Study||8
7523589|NCT03626415|18525324|P2|STARTED|Overall Study||8
7523590|NCT03626415|18525325|P1|STARTED|Overall Study||8
7523591|NCT03624946|18525356|P2|NOT COMPLETED|Overall Study||1
7523592|NCT03624946|18525357|P1|NOT COMPLETED|Overall Study||0
7523593|NCT03624946|18525356|P2|COMPLETED|Overall Study||10
7523594|NCT03624946|18525357|P1|COMPLETED|Overall Study||19
7523595|NCT03624946|18525356|P2|STARTED|Overall Study||11
7523596|NCT03624946|18525357|P1|STARTED|Overall Study||19
7523597|NCT03624920|18525383|P6|NOT COMPLETED|Overall Study||1
7523598|NCT03624920|18525384|P5|NOT COMPLETED|Overall Study||4
7523599|NCT03624920|18525385|P4|NOT COMPLETED|Overall Study||1
7523600|NCT03624920|18525386|P3|NOT COMPLETED|Overall Study||1
7523601|NCT03624920|18525387|P2|NOT COMPLETED|Overall Study||2
7523602|NCT03624920|18525388|P1|NOT COMPLETED|Overall Study||1
7523603|NCT03624920|18525383|P6|COMPLETED|Overall Study||11
7523604|NCT03624920|18525384|P5|COMPLETED|Overall Study||7
7523605|NCT03624920|18525385|P4|COMPLETED|Overall Study||12
7523606|NCT03624920|18525386|P3|COMPLETED|Overall Study||12
7523607|NCT03624920|18525387|P2|COMPLETED|Overall Study||12
7523608|NCT03624920|18525388|P1|COMPLETED|Overall Study||13
7523609|NCT03624920|18525383|P6|STARTED|Overall Study||12
7523610|NCT03624920|18525384|P5|STARTED|Overall Study||11
7523611|NCT03624920|18525385|P4|STARTED|Overall Study||13
7523612|NCT03624920|18525386|P3|STARTED|Overall Study||13
7523613|NCT03624920|18525387|P2|STARTED|Overall Study||14
7523614|NCT03624920|18525388|P1|STARTED|Overall Study||14
7523615|NCT03624504|18525411|P1|NOT COMPLETED|Overall Study||1
7523616|NCT03624504|18525411|P1|COMPLETED|Overall Study||81
7523617|NCT03624504|18525411|P1|STARTED|Overall Study||82
7523618|NCT03623698|18525419|P1|NOT COMPLETED|Overall Study||0
7523619|NCT03623698|18525419|P1|COMPLETED|Overall Study||24
7523620|NCT03623698|18525419|P1|STARTED|Overall Study||24
7523621|NCT03623035|18525450|P1|NOT COMPLETED|Overall Study||0
7523622|NCT03623035|18525450|P1|COMPLETED|Overall Study||10
7523623|NCT03623035|18525450|P1|STARTED|Overall Study||10
7523624|NCT03622112|18525463|P7|NOT COMPLETED|Overall Study||9
7523625|NCT03622112|18525464|P6|NOT COMPLETED|Overall Study||42
7523626|NCT03622112|18525465|P5|NOT COMPLETED|Overall Study||10
7523627|NCT03622112|18525466|P4|NOT COMPLETED|Overall Study||22
7523628|NCT03622112|18525467|P3|NOT COMPLETED|Overall Study||16
7523629|NCT03622112|18525468|P2|NOT COMPLETED|Overall Study||20
7523630|NCT03622112|18525469|P1|NOT COMPLETED|Overall Study||25
7523631|NCT03622112|18525463|P7|COMPLETED|Overall Study||103
7523632|NCT03622112|18525464|P6|COMPLETED|Overall Study||71
7523633|NCT03622112|18525465|P5|COMPLETED|Overall Study||124
7523634|NCT03622112|18525466|P4|COMPLETED|Overall Study||91
7523635|NCT03622112|18525467|P3|COMPLETED|Overall Study||95
7523636|NCT03622112|18525468|P2|COMPLETED|Overall Study||92
7523637|NCT03622112|18525469|P1|COMPLETED|Overall Study||85
7523638|NCT03622112|18525463|P7|STARTED|Overall Study||112
7523639|NCT03622112|18525464|P6|STARTED|Overall Study||113
7523640|NCT03622112|18525465|P5|STARTED|Overall Study||134
7523641|NCT03622112|18525466|P4|STARTED|Overall Study||113
7523642|NCT03622112|18525467|P3|STARTED|Overall Study||111
7523643|NCT03622112|18525468|P2|STARTED|Overall Study||112
7523644|NCT03622112|18525469|P1|STARTED|Overall Study||110
7523645|NCT03621878|18525656|P3|NOT COMPLETED|Overall Study||0
7523646|NCT03621878|18525657|P2|NOT COMPLETED|Overall Study||0
7523647|NCT03621878|18525658|P1|NOT COMPLETED|Overall Study||0
7523648|NCT03621878|18525656|P3|COMPLETED|Overall Study||17
7523649|NCT03621878|18525657|P2|COMPLETED|Overall Study||17
7523650|NCT03621878|18525658|P1|COMPLETED|Overall Study||17
7523651|NCT03621878|18525656|P3|STARTED|Overall Study||17
7523652|NCT03621878|18525657|P2|STARTED|Overall Study||17
7523653|NCT03621878|18525658|P1|STARTED|Overall Study||17
7523654|NCT03621787|18525678|P1|NOT COMPLETED|Overall Study||0
7523655|NCT03621787|18525678|P1|COMPLETED|Overall Study||9
7523656|NCT03621787|18525678|P1|STARTED|Overall Study||9
7523657|NCT03621202|18525689|P1|NOT COMPLETED|Overall Study||6
7523658|NCT03621202|18525689|P1|COMPLETED|Overall Study||60
7523659|NCT03621202|18525689|P1|STARTED|Overall Study||66
7523660|NCT03620708|18525698|P3|NOT COMPLETED|Overall Study||3
7523661|NCT03620708|18525699|P2|NOT COMPLETED|Overall Study||1
7523662|NCT03620708|18525700|P1|NOT COMPLETED|Overall Study||1
7523663|NCT03620708|18525698|P3|COMPLETED|Overall Study||17
7523664|NCT03620708|18525699|P2|COMPLETED|Overall Study||18
7523665|NCT03620708|18525700|P1|COMPLETED|Overall Study||18
7523666|NCT03620708|18525698|P3|STARTED|Overall Study||20
7523667|NCT03620708|18525699|P2|STARTED|Overall Study||19
7523668|NCT03620708|18525700|P1|STARTED|Overall Study||19
7523669|NCT03620383|18525722|P2|NOT COMPLETED|Overall Study||0
7523670|NCT03620383|18525723|P1|NOT COMPLETED|Overall Study||0
7523671|NCT03620383|18525722|P2|COMPLETED|Overall Study||15
7523672|NCT03620383|18525723|P1|COMPLETED|Overall Study||30
7523673|NCT03620383|18525722|P2|STARTED|Overall Study||15
7523674|NCT03620383|18525723|P1|STARTED|Overall Study||30
7523675|NCT03619889|18525731|P2|NOT COMPLETED|Overall Study||0
7523676|NCT03619889|18525732|P1|NOT COMPLETED|Overall Study||2
7523677|NCT03619889|18525731|P2|COMPLETED|Overall Study||37
7523678|NCT03619889|18525732|P1|COMPLETED|Overall Study||35
7523679|NCT03619889|18525731|P2|STARTED|Overall Study||37
7523680|NCT03619889|18525732|P1|STARTED|Overall Study||37
7523681|NCT03619590|18525762|P1|NOT COMPLETED|Overall Study||0
7523682|NCT03619590|18525762|P1|COMPLETED|Overall Study||103
7523683|NCT03619590|18525762|P1|STARTED|Overall Study||103
7523684|NCT03619135|18525772|P2|NOT COMPLETED|Overall Study||0
7523685|NCT03619135|18525773|P1|NOT COMPLETED|Overall Study||0
7523686|NCT03619135|18525772|P2|COMPLETED|Overall Study||50
7523687|NCT03619135|18525773|P1|COMPLETED|Overall Study||50
7523688|NCT03619135|18525772|P2|STARTED|Overall Study||50
7523689|NCT03619135|18525773|P1|STARTED|Overall Study||50
7523690|NCT03618628|18525781|P1|NOT COMPLETED|Overall Study||2
7523691|NCT03618628|18525781|P1|COMPLETED|Overall Study||1
7523692|NCT03618628|18525781|P1|STARTED|Overall Study||3
7523693|NCT03618147|18525785|P1|NOT COMPLETED|Overall Study||0
7523694|NCT03618147|18525785|P1|COMPLETED|Overall Study||314
7523695|NCT03618147|18525785|P1|STARTED|Overall Study||314
7523696|NCT03618017|18525792|P2|NOT COMPLETED|Overall Study||5
7523697|NCT03618017|18525793|P1|NOT COMPLETED|Overall Study||7
7523698|NCT03618017|18525792|P2|COMPLETED|Overall Study||28
7523699|NCT03618017|18525793|P1|COMPLETED|Overall Study||26
7523700|NCT03618017|18525792|P2|STARTED|Overall Study||33
7523701|NCT03618017|18525793|P1|STARTED|Overall Study||33
7523702|NCT03617861|18525811|P4|NOT COMPLETED|Second Intervention (1 Day)||0
7523703|NCT03617861|18525812|P3|NOT COMPLETED|Second Intervention (1 Day)||1
7523704|NCT03617861|18525813|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7523705|NCT03617861|18525814|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7523706|NCT03617861|18525811|P4|COMPLETED|Second Intervention (1 Day)||5
7523707|NCT03617861|18525812|P3|COMPLETED|Second Intervention (1 Day)||4
7523708|NCT03617861|18525813|P2|COMPLETED|Second Intervention (1 Day)||5
7523709|NCT03617861|18525814|P1|COMPLETED|Second Intervention (1 Day)||5
7523710|NCT03617861|18525811|P4|STARTED|Second Intervention (1 Day)||5
7523711|NCT03617861|18525812|P3|STARTED|Second Intervention (1 Day)||5
7523712|NCT03617861|18525813|P2|STARTED|Second Intervention (1 Day)||5
7523713|NCT03617861|18525814|P1|STARTED|Second Intervention (1 Day)||5
7523714|NCT03617861|18525811|P4|NOT COMPLETED|Washout (1 to 4 Weeks)||0
7523715|NCT03617861|18525812|P3|NOT COMPLETED|Washout (1 to 4 Weeks)||0
7523716|NCT03617861|18525813|P2|NOT COMPLETED|Washout (1 to 4 Weeks)||0
7523717|NCT03617861|18525814|P1|NOT COMPLETED|Washout (1 to 4 Weeks)||0
7523718|NCT03617861|18525811|P4|COMPLETED|Washout (1 to 4 Weeks)||5
7523719|NCT03617861|18525812|P3|COMPLETED|Washout (1 to 4 Weeks)||5
7523720|NCT03617861|18525813|P2|COMPLETED|Washout (1 to 4 Weeks)||5
7523721|NCT03617861|18525814|P1|COMPLETED|Washout (1 to 4 Weeks)||5
7523722|NCT03617861|18525811|P4|STARTED|Washout (1 to 4 Weeks)||5
7523723|NCT03617861|18525812|P3|STARTED|Washout (1 to 4 Weeks)||5
7523724|NCT03617861|18525813|P2|STARTED|Washout (1 to 4 Weeks)||5
7523725|NCT03617861|18525814|P1|STARTED|Washout (1 to 4 Weeks)||5
7523726|NCT03617861|18525811|P4|NOT COMPLETED|First Intervention (1 Day)||0
7523727|NCT03617861|18525812|P3|NOT COMPLETED|First Intervention (1 Day)||0
7523728|NCT03617861|18525813|P2|NOT COMPLETED|First Intervention (1 Day)||0
7523729|NCT03617861|18525814|P1|NOT COMPLETED|First Intervention (1 Day)||0
7523730|NCT03617861|18525811|P4|COMPLETED|First Intervention (1 Day)||5
7523731|NCT03617861|18525812|P3|COMPLETED|First Intervention (1 Day)||5
7523732|NCT03617861|18525813|P2|COMPLETED|First Intervention (1 Day)||5
7523733|NCT03617861|18525814|P1|COMPLETED|First Intervention (1 Day)||5
7523734|NCT03617861|18525811|P4|STARTED|First Intervention (1 Day)||5
7523735|NCT03617861|18525812|P3|STARTED|First Intervention (1 Day)||5
7523736|NCT03617861|18525813|P2|STARTED|First Intervention (1 Day)||5
7523737|NCT03617861|18525814|P1|STARTED|First Intervention (1 Day)||5
7523738|NCT03617588|18525846|P2|NOT COMPLETED|Overall Study||0
7523739|NCT03617588|18525847|P1|NOT COMPLETED|Overall Study||1
7523740|NCT03617588|18525846|P2|COMPLETED|Overall Study||29
7523741|NCT03617588|18525847|P1|COMPLETED|Overall Study||19
7523742|NCT03617588|18525846|P2|STARTED|Overall Study||29
7523743|NCT03617588|18525847|P1|STARTED|Overall Study||20
7523744|NCT03617523|18525864|P5|NOT COMPLETED|Overall Study||0
7523745|NCT03617523|18525865|P4|NOT COMPLETED|Overall Study||0
7523746|NCT03617523|18525866|P3|NOT COMPLETED|Overall Study||0
7523747|NCT03617523|18525867|P2|NOT COMPLETED|Overall Study||0
7523748|NCT03617523|18525868|P1|NOT COMPLETED|Overall Study||0
7523749|NCT03617523|18525864|P5|COMPLETED|Overall Study||60
7523750|NCT03617523|18525865|P4|COMPLETED|Overall Study||59
7523751|NCT03617523|18525866|P3|COMPLETED|Overall Study||61
7523752|NCT03617523|18525867|P2|COMPLETED|Overall Study||30
7523753|NCT03617523|18525868|P1|COMPLETED|Overall Study||30
7523754|NCT03617523|18525864|P5|STARTED|Overall Study||60
7523755|NCT03617523|18525865|P4|STARTED|Overall Study||59
7523756|NCT03617523|18525866|P3|STARTED|Overall Study||61
7523757|NCT03617523|18525867|P2|STARTED|Overall Study||30
7523758|NCT03617523|18525868|P1|STARTED|Overall Study||30
7523759|NCT03617419|18525900|P1|NOT COMPLETED|Part 2||0
7523760|NCT03617419|18525900|P1|COMPLETED|Part 2||14
7523761|NCT03617419|18525900|P1|STARTED|Part 2||14
7523762|NCT03617419|18525900|P1|NOT COMPLETED|Part 1||0
7523763|NCT03617419|18525900|P1|COMPLETED|Part 1||2
7523764|NCT03617419|18525900|P1|STARTED|Part 1||2
7523765|NCT03616977|18525908|P2|NOT COMPLETED|Period 4||0
7523766|NCT03616977|18525909|P1|NOT COMPLETED|Period 4||0
7523767|NCT03616977|18525908|P2|COMPLETED|Period 4||32
7523768|NCT03616977|18525909|P1|COMPLETED|Period 4||33
7523769|NCT03616977|18525908|P2|STARTED|Period 4||32
7523770|NCT03616977|18525909|P1|STARTED|Period 4||33
7523771|NCT03616977|18525908|P2|NOT COMPLETED|Period 3||1
7523772|NCT03616977|18525909|P1|NOT COMPLETED|Period 3||1
7523773|NCT03616977|18525908|P2|COMPLETED|Period 3||32
7523774|NCT03616977|18525909|P1|COMPLETED|Period 3||33
7523775|NCT03616977|18525908|P2|Received Study Drug|Period 3|Participant not dosed due to adverse event.|32
7523776|NCT03616977|18525909|P1|Received Study Drug|Period 3|Participant not dosed due to adverse event.|33
7523777|NCT03616977|18525908|P2|STARTED|Period 3|Participant completed Period 2 and withdrew from the study.|33
7523778|NCT03616977|18525909|P1|STARTED|Period 3||34
7523779|NCT03616977|18525908|P2|NOT COMPLETED|Period 2||0
7523780|NCT03616977|18525909|P1|NOT COMPLETED|Period 2||0
7523781|NCT03616977|18525908|P2|COMPLETED|Period 2||34
7523782|NCT03616977|18525909|P1|COMPLETED|Period 2||34
7523783|NCT03616977|18525908|P2|STARTED|Period 2||34
7523784|NCT03616977|18525909|P1|STARTED|Period 2||34
7523785|NCT03616977|18525908|P2|NOT COMPLETED|Period 1||1
7523786|NCT03616977|18525909|P1|NOT COMPLETED|Period 1||0
7523787|NCT03616977|18525908|P2|COMPLETED|Period 1||34
7523788|NCT03616977|18525909|P1|COMPLETED|Period 1||34
7523789|NCT03616977|18525908|P2|Received at Least One Dose of Study Drug|Period 1||34
7523790|NCT03616977|18525909|P1|Received at Least One Dose of Study Drug|Period 1||34
7523791|NCT03616977|18525908|P2|STARTED|Period 1||35
7523792|NCT03616977|18525909|P1|STARTED|Period 1||34
7523793|NCT03616600|18525919|P2|NOT COMPLETED|Overall Study||0
7523794|NCT03616600|18525920|P1|NOT COMPLETED|Overall Study||1
7523795|NCT03616600|18525919|P2|COMPLETED|Overall Study||15
7523796|NCT03616600|18525920|P1|COMPLETED|Overall Study||15
7523797|NCT03616600|18525919|P2|STARTED|Overall Study||15
7523798|NCT03616600|18525920|P1|STARTED|Overall Study||16
7523799|NCT03616171|18525938|P2|NOT COMPLETED|Overall Study||0
7523800|NCT03616171|18525939|P1|NOT COMPLETED|Overall Study||0
7523801|NCT03616171|18525938|P2|COMPLETED|Overall Study||2
7523802|NCT03616171|18525939|P1|COMPLETED|Overall Study||4
7523803|NCT03616171|18525938|P2|STARTED|Overall Study||2
7523804|NCT03616171|18525939|P1|STARTED|Overall Study||4
7523805|NCT03616106|18525954|P2|NOT COMPLETED|Overall Study||1
7523806|NCT03616106|18525955|P1|NOT COMPLETED|Overall Study||14
7523807|NCT03616106|18525954|P2|COMPLETED|Overall Study||2
7523808|NCT03616106|18525955|P1|COMPLETED|Overall Study||42
7523809|NCT03616106|18525954|P2|STARTED|Overall Study||3
7523810|NCT03616106|18525955|P1|STARTED|Overall Study||56
7523811|NCT03615911|18525992|P2|NOT COMPLETED|Overall Study||1
7523812|NCT03615911|18525993|P1|NOT COMPLETED|Overall Study||2
7523813|NCT03615911|18525992|P2|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|11
7523814|NCT03615911|18525993|P1|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|12
7523815|NCT03615911|18525992|P2|Received Late Booster Immunization|Overall Study||7
7523816|NCT03615911|18525993|P1|Received Late Booster Immunization|Overall Study||3
7523817|NCT03615911|18525992|P2|STARTED|Overall Study||12
7523818|NCT03615911|18525993|P1|STARTED|Overall Study||14
7523819|NCT03615807|18526011|P2|NOT COMPLETED|Overall Study||11
7523820|NCT03615807|18526012|P1|NOT COMPLETED|Overall Study||12
7523821|NCT03615807|18526011|P2|COMPLETED|Overall Study||80
7523822|NCT03615807|18526012|P1|COMPLETED|Overall Study||79
7523823|NCT03615807|18526011|P2|STARTED|Overall Study||91
7523824|NCT03615807|18526012|P1|STARTED|Overall Study||91
7523825|NCT03615534|18526024|P4|NOT COMPLETED|Overall Study||1
7523826|NCT03615534|18526025|P3|NOT COMPLETED|Overall Study||0
7523827|NCT03615534|18526026|P2|NOT COMPLETED|Overall Study||0
7523828|NCT03615534|18526027|P1|NOT COMPLETED|Overall Study||2
7523829|NCT03615534|18526024|P4|COMPLETED|Overall Study||13
7523830|NCT03615534|18526025|P3|COMPLETED|Overall Study||14
7523831|NCT03615534|18526026|P2|COMPLETED|Overall Study||15
7523832|NCT03615534|18526027|P1|COMPLETED|Overall Study||12
7523833|NCT03615534|18526024|P4|STARTED|Overall Study||14
7523834|NCT03615534|18526025|P3|STARTED|Overall Study||14
7523835|NCT03615534|18526026|P2|STARTED|Overall Study||15
7523836|NCT03615534|18526027|P1|STARTED|Overall Study||14
7523837|NCT03615508|18526069|P1|NOT COMPLETED|Overall Study||0
7523838|NCT03615508|18526069|P1|COMPLETED|Overall Study||1
7523839|NCT03615508|18526069|P1|STARTED|Overall Study||1
7523840|NCT03615482|18526075|P2|NOT COMPLETED|Overall Study||17
7523841|NCT03615482|18526076|P1|NOT COMPLETED|Overall Study||17
7523842|NCT03615482|18526075|P2|COMPLETED|Overall Study||583
7523843|NCT03615482|18526076|P1|COMPLETED|Overall Study||583
7523844|NCT03615482|18526075|P2|Vaccinated|Overall Study||598
7523845|NCT03615482|18526076|P1|Vaccinated|Overall Study||599
7523846|NCT03615482|18526075|P2|STARTED|Overall Study||600
7523847|NCT03615482|18526076|P1|STARTED|Overall Study||600
7523848|NCT03615183|18526111|P5|NOT COMPLETED|Overall Study||0
7523849|NCT03615183|18526112|P4|NOT COMPLETED|Overall Study||0
7523850|NCT03615183|18526113|P3|NOT COMPLETED|Overall Study||0
7523851|NCT03615183|18526114|P2|NOT COMPLETED|Overall Study||0
7523852|NCT03615183|18526115|P1|NOT COMPLETED|Overall Study||0
7523853|NCT03615183|18526111|P5|COMPLETED|Overall Study||0
7523854|NCT03615183|18526112|P4|COMPLETED|Overall Study||0
7523855|NCT03615183|18526113|P3|COMPLETED|Overall Study||5
7523856|NCT03615183|18526114|P2|COMPLETED|Overall Study||6
7523857|NCT03615183|18526115|P1|COMPLETED|Overall Study||6
7523858|NCT03615183|18526111|P5|STARTED|Overall Study|Panel E was not conducted as the scientific study objectives were met in the conducted panels.|0
7523859|NCT03615183|18526112|P4|STARTED|Overall Study|Panel D was not conducted as the scientific study objectives were met in the conducted panels.|0
7523860|NCT03615183|18526113|P3|STARTED|Overall Study||5
7523861|NCT03615183|18526114|P2|STARTED|Overall Study||6
7523862|NCT03615183|18526115|P1|STARTED|Overall Study||6
7523863|NCT03615001|18526171|P1|NOT COMPLETED|Overall Study||0
7523864|NCT03615001|18526171|P1|COMPLETED|Overall Study||20
7523865|NCT03615001|18526171|P1|STARTED|Overall Study||20
7523866|NCT03614975|18526178|P2|NOT COMPLETED|Overall Study||8
7523867|NCT03614975|18526179|P1|NOT COMPLETED|Overall Study||10
7523868|NCT03614975|18526178|P2|COMPLETED|Overall Study||73
7523869|NCT03614975|18526179|P1|COMPLETED|Overall Study||75
7523870|NCT03614975|18526178|P2|STARTED|Overall Study||81
7523871|NCT03614975|18526179|P1|STARTED|Overall Study||85
7523872|NCT03614156|18526192|P4|NOT COMPLETED|Safety Follow-Up Period||1
7523873|NCT03614156|18526193|P3|NOT COMPLETED|Safety Follow-Up Period||1
7523874|NCT03614156|18526194|P2|NOT COMPLETED|Safety Follow-Up Period||0
7523875|NCT03614156|18526195|P1|NOT COMPLETED|Safety Follow-Up Period||3
7523876|NCT03614156|18526192|P4|COMPLETED|Safety Follow-Up Period||34
7523877|NCT03614156|18526193|P3|COMPLETED|Safety Follow-Up Period||29
7523878|NCT03614156|18526194|P2|COMPLETED|Safety Follow-Up Period||26
7523879|NCT03614156|18526195|P1|COMPLETED|Safety Follow-Up Period||162
7523880|NCT03614156|18526192|P4|STARTED|Safety Follow-Up Period||35
7523881|NCT03614156|18526193|P3|STARTED|Safety Follow-Up Period||30
7523882|NCT03614156|18526194|P2|STARTED|Safety Follow-Up Period||26
7523883|NCT03614156|18526195|P1|STARTED|Safety Follow-Up Period||165
7523884|NCT03614156|18526192|P4|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||45
7523885|NCT03614156|18526193|P3|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||31
7523886|NCT03614156|18526194|P2|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||30
7523887|NCT03614156|18526195|P1|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
7523888|NCT03614156|18526192|P4|COMPLETED|Double-Blind Treatment Period (DBTP)||10
7523889|NCT03614156|18526193|P3|COMPLETED|Double-Blind Treatment Period (DBTP)||11
7523890|NCT03614156|18526194|P2|COMPLETED|Double-Blind Treatment Period (DBTP)||10
7523891|NCT03614156|18526195|P1|COMPLETED|Double-Blind Treatment Period (DBTP)||0
7523892|NCT03614156|18526192|P4|STARTED|Double-Blind Treatment Period (DBTP)||55
7523893|NCT03614156|18526193|P3|STARTED|Double-Blind Treatment Period (DBTP)||42
7523894|NCT03614156|18526194|P2|STARTED|Double-Blind Treatment Period (DBTP)||40
7523895|NCT03614156|18526195|P1|STARTED|Double-Blind Treatment Period (DBTP)||0
7523896|NCT03614156|18526192|P4|NOT COMPLETED|Open-Label Treatment Period||0
7523897|NCT03614156|18526193|P3|NOT COMPLETED|Open-Label Treatment Period||0
7523898|NCT03614156|18526194|P2|NOT COMPLETED|Open-Label Treatment Period||0
7523899|NCT03614156|18526195|P1|NOT COMPLETED|Open-Label Treatment Period||154
7523900|NCT03614156|18526192|P4|COMPLETED|Open-Label Treatment Period||0
7523901|NCT03614156|18526193|P3|COMPLETED|Open-Label Treatment Period||0
7523902|NCT03614156|18526194|P2|COMPLETED|Open-Label Treatment Period||0
7523903|NCT03614156|18526195|P1|COMPLETED|Open-Label Treatment Period||209
7523904|NCT03614156|18526192|P4|STARTED|Open-Label Treatment Period||0
7523905|NCT03614156|18526193|P3|STARTED|Open-Label Treatment Period||0
7523906|NCT03614156|18526194|P2|STARTED|Open-Label Treatment Period||0
7523907|NCT03614156|18526195|P1|STARTED|Open-Label Treatment Period||363
7523908|NCT03614078|18526207|P3|NOT COMPLETED|Overall Study||5
7523909|NCT03614078|18526208|P2|NOT COMPLETED|Overall Study||7
7523910|NCT03614078|18526209|P1|NOT COMPLETED|Overall Study||3
7523911|NCT03614078|18526207|P3|COMPLETED|Overall Study||26
7523912|NCT03614078|18526208|P2|COMPLETED|Overall Study||23
7523913|NCT03614078|18526209|P1|COMPLETED|Overall Study||28
7523914|NCT03614078|18526207|P3|STARTED|Overall Study||31
7523915|NCT03614078|18526208|P2|STARTED|Overall Study||30
7523916|NCT03614078|18526209|P1|STARTED|Overall Study||31
7523917|NCT03613649|18526238|P12|NOT COMPLETED|Fourth Treatment||0
7523918|NCT03613649|18526239|P11|NOT COMPLETED|Fourth Treatment||0
7523919|NCT03613649|18526240|P10|NOT COMPLETED|Fourth Treatment||0
7523920|NCT03613649|18526241|P9|NOT COMPLETED|Fourth Treatment||0
7523921|NCT03613649|18526242|P8|NOT COMPLETED|Fourth Treatment||0
7523922|NCT03613649|18526243|P7|NOT COMPLETED|Fourth Treatment||1
7523923|NCT03613649|18526244|P6|NOT COMPLETED|Fourth Treatment||0
7523924|NCT03613649|18526245|P5|NOT COMPLETED|Fourth Treatment||1
7523925|NCT03613649|18526246|P4|NOT COMPLETED|Fourth Treatment||0
7523926|NCT03613649|18526247|P3|NOT COMPLETED|Fourth Treatment||0
7523927|NCT03613649|18526248|P2|NOT COMPLETED|Fourth Treatment||0
7523928|NCT03613649|18526249|P1|NOT COMPLETED|Fourth Treatment||1
7523929|NCT03613649|18526238|P12|COMPLETED|Fourth Treatment||4
7523930|NCT03613649|18526239|P11|COMPLETED|Fourth Treatment||6
7523931|NCT03613649|18526240|P10|COMPLETED|Fourth Treatment||6
7523932|NCT03613649|18526241|P9|COMPLETED|Fourth Treatment||6
7523933|NCT03613649|18526242|P8|COMPLETED|Fourth Treatment||6
7523934|NCT03613649|18526243|P7|COMPLETED|Fourth Treatment||4
7523935|NCT03613649|18526244|P6|COMPLETED|Fourth Treatment||6
7523936|NCT03613649|18526245|P5|COMPLETED|Fourth Treatment||3
7523937|NCT03613649|18526246|P4|COMPLETED|Fourth Treatment||6
7523938|NCT03613649|18526247|P3|COMPLETED|Fourth Treatment||5
7523939|NCT03613649|18526248|P2|COMPLETED|Fourth Treatment||6
7523940|NCT03613649|18526249|P1|COMPLETED|Fourth Treatment||5
7523941|NCT03613649|18526238|P12|Received Treatment|Fourth Treatment||4
7523942|NCT03613649|18526239|P11|Received Treatment|Fourth Treatment||6
7523943|NCT03613649|18526240|P10|Received Treatment|Fourth Treatment||6
7523944|NCT03613649|18526241|P9|Received Treatment|Fourth Treatment||6
7523945|NCT03613649|18526242|P8|Received Treatment|Fourth Treatment||6
7523946|NCT03613649|18526243|P7|Received Treatment|Fourth Treatment||4
7523947|NCT03613649|18526244|P6|Received Treatment|Fourth Treatment||6
7523948|NCT03613649|18526245|P5|Received Treatment|Fourth Treatment||4
7523949|NCT03613649|18526246|P4|Received Treatment|Fourth Treatment||6
7523950|NCT03613649|18526247|P3|Received Treatment|Fourth Treatment||5
7523951|NCT03613649|18526248|P2|Received Treatment|Fourth Treatment||6
7523952|NCT03613649|18526249|P1|Received Treatment|Fourth Treatment||5
7523953|NCT03613649|18526238|P12|STARTED|Fourth Treatment||4
7523954|NCT03613649|18526239|P11|STARTED|Fourth Treatment||6
7523955|NCT03613649|18526240|P10|STARTED|Fourth Treatment||6
7523956|NCT03613649|18526241|P9|STARTED|Fourth Treatment||6
7523957|NCT03613649|18526242|P8|STARTED|Fourth Treatment||6
7523958|NCT03613649|18526243|P7|STARTED|Fourth Treatment||5
7523959|NCT03613649|18526244|P6|STARTED|Fourth Treatment||6
7523960|NCT03613649|18526245|P5|STARTED|Fourth Treatment||4
7523961|NCT03613649|18526246|P4|STARTED|Fourth Treatment||6
7523962|NCT03613649|18526247|P3|STARTED|Fourth Treatment||5
7523963|NCT03613649|18526248|P2|STARTED|Fourth Treatment||6
7523964|NCT03613649|18526249|P1|STARTED|Fourth Treatment||6
7523965|NCT03613649|18526238|P12|NOT COMPLETED|Third Treatment||2
7523966|NCT03613649|18526239|P11|NOT COMPLETED|Third Treatment||0
7523967|NCT03613649|18526240|P10|NOT COMPLETED|Third Treatment||0
7523968|NCT03613649|18526241|P9|NOT COMPLETED|Third Treatment||0
7523969|NCT03613649|18526242|P8|NOT COMPLETED|Third Treatment||0
7523970|NCT03613649|18526243|P7|NOT COMPLETED|Third Treatment||1
7523971|NCT03613649|18526244|P6|NOT COMPLETED|Third Treatment||0
7523972|NCT03613649|18526245|P5|NOT COMPLETED|Third Treatment||1
7523973|NCT03613649|18526246|P4|NOT COMPLETED|Third Treatment||0
7523974|NCT03613649|18526247|P3|NOT COMPLETED|Third Treatment||0
7523975|NCT03613649|18526248|P2|NOT COMPLETED|Third Treatment||0
7523976|NCT03613649|18526249|P1|NOT COMPLETED|Third Treatment||0
7523977|NCT03613649|18526238|P12|COMPLETED|Third Treatment||4
7523978|NCT03613649|18526239|P11|COMPLETED|Third Treatment||6
7523979|NCT03613649|18526240|P10|COMPLETED|Third Treatment||6
7523980|NCT03613649|18526241|P9|COMPLETED|Third Treatment||6
7523981|NCT03613649|18526242|P8|COMPLETED|Third Treatment||6
7523982|NCT03613649|18526243|P7|COMPLETED|Third Treatment||5
7523983|NCT03613649|18526244|P6|COMPLETED|Third Treatment||6
7523984|NCT03613649|18526245|P5|COMPLETED|Third Treatment||4
7523985|NCT03613649|18526246|P4|COMPLETED|Third Treatment||6
7523986|NCT03613649|18526247|P3|COMPLETED|Third Treatment||5
7523987|NCT03613649|18526248|P2|COMPLETED|Third Treatment||6
7523988|NCT03613649|18526249|P1|COMPLETED|Third Treatment||6
7523989|NCT03613649|18526238|P12|Received Treatment|Third Treatment||6
7523990|NCT03613649|18526239|P11|Received Treatment|Third Treatment||6
7523991|NCT03613649|18526240|P10|Received Treatment|Third Treatment||6
7523992|NCT03613649|18526241|P9|Received Treatment|Third Treatment||6
7523993|NCT03613649|18526242|P8|Received Treatment|Third Treatment||6
7523994|NCT03613649|18526243|P7|Received Treatment|Third Treatment||5
7523995|NCT03613649|18526244|P6|Received Treatment|Third Treatment||6
7523996|NCT03613649|18526245|P5|Received Treatment|Third Treatment||5
7523997|NCT03613649|18526246|P4|Received Treatment|Third Treatment||6
7523998|NCT03613649|18526247|P3|Received Treatment|Third Treatment||5
7523999|NCT03613649|18526248|P2|Received Treatment|Third Treatment||6
7524000|NCT03613649|18526249|P1|Received Treatment|Third Treatment||6
7524001|NCT03613649|18526238|P12|STARTED|Third Treatment||6
7524002|NCT03613649|18526239|P11|STARTED|Third Treatment||6
7524003|NCT03613649|18526240|P10|STARTED|Third Treatment||6
7524004|NCT03613649|18526241|P9|STARTED|Third Treatment||6
7524005|NCT03613649|18526242|P8|STARTED|Third Treatment||6
7524006|NCT03613649|18526243|P7|STARTED|Third Treatment||6
7524007|NCT03613649|18526244|P6|STARTED|Third Treatment||6
7524008|NCT03613649|18526245|P5|STARTED|Third Treatment||5
7524009|NCT03613649|18526246|P4|STARTED|Third Treatment||6
7524010|NCT03613649|18526247|P3|STARTED|Third Treatment||5
7524011|NCT03613649|18526248|P2|STARTED|Third Treatment||6
7524012|NCT03613649|18526249|P1|STARTED|Third Treatment||6
7524013|NCT03613649|18526238|P12|NOT COMPLETED|Second Treatment||0
7524014|NCT03613649|18526239|P11|NOT COMPLETED|Second Treatment||0
7524015|NCT03613649|18526240|P10|NOT COMPLETED|Second Treatment||0
7524016|NCT03613649|18526241|P9|NOT COMPLETED|Second Treatment||0
7524017|NCT03613649|18526242|P8|NOT COMPLETED|Second Treatment||0
7524018|NCT03613649|18526243|P7|NOT COMPLETED|Second Treatment||0
7524019|NCT03613649|18526244|P6|NOT COMPLETED|Second Treatment||0
7524020|NCT03613649|18526245|P5|NOT COMPLETED|Second Treatment||1
7524021|NCT03613649|18526246|P4|NOT COMPLETED|Second Treatment||0
7524022|NCT03613649|18526247|P3|NOT COMPLETED|Second Treatment||1
7524023|NCT03613649|18526248|P2|NOT COMPLETED|Second Treatment||0
7524024|NCT03613649|18526249|P1|NOT COMPLETED|Second Treatment||0
7524025|NCT03613649|18526238|P12|COMPLETED|Second Treatment||6
7524026|NCT03613649|18526239|P11|COMPLETED|Second Treatment||6
7524027|NCT03613649|18526240|P10|COMPLETED|Second Treatment||6
7524028|NCT03613649|18526241|P9|COMPLETED|Second Treatment||6
7524029|NCT03613649|18526242|P8|COMPLETED|Second Treatment||6
7524030|NCT03613649|18526243|P7|COMPLETED|Second Treatment||6
7524031|NCT03613649|18526244|P6|COMPLETED|Second Treatment||6
7524032|NCT03613649|18526245|P5|COMPLETED|Second Treatment||5
7524033|NCT03613649|18526246|P4|COMPLETED|Second Treatment||6
7524034|NCT03613649|18526247|P3|COMPLETED|Second Treatment||5
7524035|NCT03613649|18526248|P2|COMPLETED|Second Treatment||6
7524036|NCT03613649|18526249|P1|COMPLETED|Second Treatment||6
7524037|NCT03613649|18526238|P12|Received Treatment|Second Treatment||6
7524038|NCT03613649|18526239|P11|Received Treatment|Second Treatment||6
7524039|NCT03613649|18526240|P10|Received Treatment|Second Treatment||6
7524040|NCT03613649|18526241|P9|Received Treatment|Second Treatment||6
7524041|NCT03613649|18526242|P8|Received Treatment|Second Treatment||6
7524042|NCT03613649|18526243|P7|Received Treatment|Second Treatment||6
7524043|NCT03613649|18526244|P6|Received Treatment|Second Treatment||6
7524044|NCT03613649|18526245|P5|Received Treatment|Second Treatment||6
7524045|NCT03613649|18526246|P4|Received Treatment|Second Treatment||6
7524046|NCT03613649|18526247|P3|Received Treatment|Second Treatment||6
7524047|NCT03613649|18526248|P2|Received Treatment|Second Treatment||6
7524048|NCT03613649|18526249|P1|Received Treatment|Second Treatment||6
7524049|NCT03613649|18526238|P12|STARTED|Second Treatment||6
7524050|NCT03613649|18526239|P11|STARTED|Second Treatment||6
7524051|NCT03613649|18526240|P10|STARTED|Second Treatment||6
7524052|NCT03613649|18526241|P9|STARTED|Second Treatment||6
7524053|NCT03613649|18526242|P8|STARTED|Second Treatment||6
7524054|NCT03613649|18526243|P7|STARTED|Second Treatment||6
7524055|NCT03613649|18526244|P6|STARTED|Second Treatment||6
7524056|NCT03613649|18526245|P5|STARTED|Second Treatment||6
7524057|NCT03613649|18526246|P4|STARTED|Second Treatment||6
7524058|NCT03613649|18526247|P3|STARTED|Second Treatment||6
7524059|NCT03613649|18526248|P2|STARTED|Second Treatment||6
7524060|NCT03613649|18526249|P1|STARTED|Second Treatment||6
7524061|NCT03613649|18526238|P12|NOT COMPLETED|First Treatment||0
7524062|NCT03613649|18526239|P11|NOT COMPLETED|First Treatment||0
7524063|NCT03613649|18526240|P10|NOT COMPLETED|First Treatment||0
7524064|NCT03613649|18526241|P9|NOT COMPLETED|First Treatment||0
7524065|NCT03613649|18526242|P8|NOT COMPLETED|First Treatment||0
7524066|NCT03613649|18526243|P7|NOT COMPLETED|First Treatment||0
7524067|NCT03613649|18526244|P6|NOT COMPLETED|First Treatment||0
7524068|NCT03613649|18526245|P5|NOT COMPLETED|First Treatment||0
7524069|NCT03613649|18526246|P4|NOT COMPLETED|First Treatment||0
7524070|NCT03613649|18526247|P3|NOT COMPLETED|First Treatment||0
7524071|NCT03613649|18526248|P2|NOT COMPLETED|First Treatment||0
7524072|NCT03613649|18526249|P1|NOT COMPLETED|First Treatment||0
7524073|NCT03613649|18526238|P12|COMPLETED|First Treatment||6
7524074|NCT03613649|18526239|P11|COMPLETED|First Treatment||6
7524075|NCT03613649|18526240|P10|COMPLETED|First Treatment||6
7524076|NCT03613649|18526241|P9|COMPLETED|First Treatment||6
7524077|NCT03613649|18526242|P8|COMPLETED|First Treatment||6
7524078|NCT03613649|18526243|P7|COMPLETED|First Treatment||6
7524079|NCT03613649|18526244|P6|COMPLETED|First Treatment||6
7524080|NCT03613649|18526245|P5|COMPLETED|First Treatment||6
7524081|NCT03613649|18526246|P4|COMPLETED|First Treatment||6
7524082|NCT03613649|18526247|P3|COMPLETED|First Treatment||6
7524083|NCT03613649|18526248|P2|COMPLETED|First Treatment||6
7524084|NCT03613649|18526249|P1|COMPLETED|First Treatment||6
7524085|NCT03613649|18526238|P12|Received Treatment|First Treatment||6
7524086|NCT03613649|18526239|P11|Received Treatment|First Treatment||6
7524087|NCT03613649|18526240|P10|Received Treatment|First Treatment||6
7524088|NCT03613649|18526241|P9|Received Treatment|First Treatment||6
7524089|NCT03613649|18526242|P8|Received Treatment|First Treatment||6
7524090|NCT03613649|18526243|P7|Received Treatment|First Treatment||6
7524091|NCT03613649|18526244|P6|Received Treatment|First Treatment||6
7524092|NCT03613649|18526245|P5|Received Treatment|First Treatment||6
7524093|NCT03613649|18526246|P4|Received Treatment|First Treatment||6
7524094|NCT03613649|18526247|P3|Received Treatment|First Treatment||6
7524095|NCT03613649|18526248|P2|Received Treatment|First Treatment||6
7524096|NCT03613649|18526249|P1|Received Treatment|First Treatment||6
7524097|NCT03613649|18526238|P12|STARTED|First Treatment||6
7524098|NCT03613649|18526239|P11|STARTED|First Treatment||6
7524099|NCT03613649|18526240|P10|STARTED|First Treatment||6
7524100|NCT03613649|18526241|P9|STARTED|First Treatment||6
7524101|NCT03613649|18526242|P8|STARTED|First Treatment||6
7524102|NCT03613649|18526243|P7|STARTED|First Treatment||6
7524103|NCT03613649|18526244|P6|STARTED|First Treatment||6
7524104|NCT03613649|18526245|P5|STARTED|First Treatment||6
7524105|NCT03613649|18526246|P4|STARTED|First Treatment||6
7524106|NCT03613649|18526247|P3|STARTED|First Treatment||6
7524107|NCT03613649|18526248|P2|STARTED|First Treatment||6
7524108|NCT03613649|18526249|P1|STARTED|First Treatment||6
7524109|NCT03613493|18526378|P4|NOT COMPLETED|Overall Study||7
7524110|NCT03613493|18526379|P3|NOT COMPLETED|Overall Study||0
7524111|NCT03613493|18526380|P2|NOT COMPLETED|Overall Study||2
7524112|NCT03613493|18526381|P1|NOT COMPLETED|Overall Study||0
7524113|NCT03613493|18526378|P4|COMPLETED|Overall Study||83
7524114|NCT03613493|18526379|P3|COMPLETED|Overall Study||0
7524115|NCT03613493|18526380|P2|COMPLETED|Overall Study||73
7524116|NCT03613493|18526381|P1|COMPLETED|Overall Study||10
7524117|NCT03613493|18526378|P4|Enrollment Criteria Met|Overall Study||89
7524118|NCT03613493|18526379|P3|Enrollment Criteria Met|Overall Study||0
7524119|NCT03613493|18526380|P2|Enrollment Criteria Met|Overall Study||74
7524120|NCT03613493|18526381|P1|Enrollment Criteria Met|Overall Study||10
7524121|NCT03613493|18526378|P4|STARTED|Overall Study||90
7524122|NCT03613493|18526379|P3|STARTED|Overall Study||0
7524123|NCT03613493|18526380|P2|STARTED|Overall Study||75
7524124|NCT03613493|18526381|P1|STARTED|Overall Study||10
7524125|NCT03613129|18526394|P5|NOT COMPLETED|Post-treatment Assessment||0
7524126|NCT03613129|18526395|P4|NOT COMPLETED|Post-treatment Assessment||0
7524127|NCT03613129|18526396|P3|NOT COMPLETED|Post-treatment Assessment||0
7524128|NCT03613129|18526397|P2|NOT COMPLETED|Post-treatment Assessment||0
7524129|NCT03613129|18526398|P1|NOT COMPLETED|Post-treatment Assessment||0
7524130|NCT03613129|18526394|P5|COMPLETED|Post-treatment Assessment||2
7524131|NCT03613129|18526395|P4|COMPLETED|Post-treatment Assessment||2
7524132|NCT03613129|18526396|P3|COMPLETED|Post-treatment Assessment||7
7524133|NCT03613129|18526397|P2|COMPLETED|Post-treatment Assessment||3
7524134|NCT03613129|18526398|P1|COMPLETED|Post-treatment Assessment||0
7524135|NCT03613129|18526394|P5|STARTED|Post-treatment Assessment||2
7524136|NCT03613129|18526395|P4|STARTED|Post-treatment Assessment||2
7524137|NCT03613129|18526396|P3|STARTED|Post-treatment Assessment||7
7524138|NCT03613129|18526397|P2|STARTED|Post-treatment Assessment||3
7524139|NCT03613129|18526398|P1|STARTED|Post-treatment Assessment||0
7524140|NCT03613129|18526394|P5|NOT COMPLETED|Treatment||0
7524141|NCT03613129|18526395|P4|NOT COMPLETED|Treatment||0
7524142|NCT03613129|18526396|P3|NOT COMPLETED|Treatment||0
7524143|NCT03613129|18526397|P2|NOT COMPLETED|Treatment||0
7524144|NCT03613129|18526398|P1|NOT COMPLETED|Treatment||0
7524145|NCT03613129|18526394|P5|COMPLETED|Treatment||2
7524146|NCT03613129|18526395|P4|COMPLETED|Treatment|ID34 did not receive 3rd infusion (for lack of venous access)|2
7524147|NCT03613129|18526396|P3|COMPLETED|Treatment||7
7524148|NCT03613129|18526397|P2|COMPLETED|Treatment|ID35 received only 1 infusion (due to symptom worsening)|3
7524149|NCT03613129|18526398|P1|COMPLETED|Treatment||0
7524150|NCT03613129|18526394|P5|STARTED|Treatment||2
7524151|NCT03613129|18526395|P4|STARTED|Treatment||2
7524152|NCT03613129|18526396|P3|STARTED|Treatment||7
7524153|NCT03613129|18526397|P2|STARTED|Treatment||3
7524154|NCT03613129|18526398|P1|STARTED|Treatment||0
7524155|NCT03613129|18526394|P5|NOT COMPLETED|Pre-treatment Assessment||0
7524156|NCT03613129|18526395|P4|NOT COMPLETED|Pre-treatment Assessment||0
7524157|NCT03613129|18526396|P3|NOT COMPLETED|Pre-treatment Assessment||0
7524158|NCT03613129|18526397|P2|NOT COMPLETED|Pre-treatment Assessment||0
7524159|NCT03613129|18526398|P1|NOT COMPLETED|Pre-treatment Assessment||3
7524160|NCT03613129|18526394|P5|COMPLETED|Pre-treatment Assessment||2
7524161|NCT03613129|18526395|P4|COMPLETED|Pre-treatment Assessment||2
7524162|NCT03613129|18526396|P3|COMPLETED|Pre-treatment Assessment||7
7524163|NCT03613129|18526397|P2|COMPLETED|Pre-treatment Assessment||3
7524164|NCT03613129|18526398|P1|COMPLETED|Pre-treatment Assessment||0
7524165|NCT03613129|18526394|P5|STARTED|Pre-treatment Assessment||2
7524166|NCT03613129|18526395|P4|STARTED|Pre-treatment Assessment||2
7524167|NCT03613129|18526396|P3|STARTED|Pre-treatment Assessment||7
7524168|NCT03613129|18526397|P2|STARTED|Pre-treatment Assessment||3
7524169|NCT03613129|18526398|P1|STARTED|Pre-treatment Assessment||3
7524170|NCT03612856|18526423|P3|NOT COMPLETED|Post-dose Period||0
7524171|NCT03612856|18526424|P2|NOT COMPLETED|Post-dose Period||0
7524172|NCT03612856|18526425|P1|NOT COMPLETED|Post-dose Period||0
7524173|NCT03612856|18526423|P3|COMPLETED|Post-dose Period||8
7524174|NCT03612856|18526424|P2|COMPLETED|Post-dose Period||8
7524175|NCT03612856|18526425|P1|COMPLETED|Post-dose Period||8
7524176|NCT03612856|18526423|P3|STARTED|Post-dose Period||8
7524177|NCT03612856|18526424|P2|STARTED|Post-dose Period||8
7524178|NCT03612856|18526425|P1|STARTED|Post-dose Period||8
7524179|NCT03612856|18526423|P3|NOT COMPLETED|Pre-dose Period||1
7524180|NCT03612856|18526424|P2|NOT COMPLETED|Pre-dose Period||2
7524181|NCT03612856|18526425|P1|NOT COMPLETED|Pre-dose Period||0
7524182|NCT03612856|18526423|P3|COMPLETED|Pre-dose Period||8
7524183|NCT03612856|18526424|P2|COMPLETED|Pre-dose Period||8
7524184|NCT03612856|18526425|P1|COMPLETED|Pre-dose Period||8
7524185|NCT03612856|18526423|P3|STARTED|Pre-dose Period||9
7524186|NCT03612856|18526424|P2|STARTED|Pre-dose Period||10
7524187|NCT03612856|18526425|P1|STARTED|Pre-dose Period||8
7524188|NCT03611829|18526579|P2|NOT COMPLETED|Overall Study||25
7524189|NCT03611829|18526580|P1|NOT COMPLETED|Overall Study||22
7524190|NCT03611829|18526579|P2|COMPLETED|Overall Study||19
7524191|NCT03611829|18526580|P1|COMPLETED|Overall Study||21
7524192|NCT03611829|18526579|P2|STARTED|Overall Study||44
7524193|NCT03611829|18526580|P1|STARTED|Overall Study||43
7524194|NCT03610633|18526613|P2|NOT COMPLETED|Overall Study||1
7524195|NCT03610633|18526614|P1|NOT COMPLETED|Overall Study||0
7524196|NCT03610633|18526613|P2|COMPLETED|Overall Study||5
7524197|NCT03610633|18526614|P1|COMPLETED|Overall Study||5
7524198|NCT03610633|18526613|P2|STARTED|Overall Study||6
7524199|NCT03610633|18526614|P1|STARTED|Overall Study||5
7524200|NCT03610464|18526620|P1|NOT COMPLETED|Overall Study||0
7524201|NCT03610464|18526620|P1|COMPLETED|Overall Study||5
7524202|NCT03610464|18526620|P1|STARTED|Overall Study||5
7524203|NCT03610269|18526625|P1|NOT COMPLETED|Overall Study||16
7524204|NCT03610269|18526625|P1|COMPLETED|Overall Study||127
7524205|NCT03610269|18526625|P1|STARTED|Overall Study||143
7524206|NCT03609619|18526631|P2|NOT COMPLETED|Overall Study||6
7524207|NCT03609619|18526632|P1|NOT COMPLETED|Overall Study||10
7524208|NCT03609619|18526631|P2|COMPLETED|Overall Study||49
7524209|NCT03609619|18526632|P1|COMPLETED|Overall Study||44
7524210|NCT03609619|18526631|P2|STARTED|Overall Study||55
7524211|NCT03609619|18526632|P1|STARTED|Overall Study||54
7524212|NCT03608839|18526643|P3|NOT COMPLETED|Overall Study||0
7524213|NCT03608839|18526644|P2|NOT COMPLETED|Overall Study||0
7524214|NCT03608839|18526645|P1|NOT COMPLETED|Overall Study||0
7524215|NCT03608839|18526643|P3|COMPLETED|Overall Study||9
7524216|NCT03608839|18526644|P2|COMPLETED|Overall Study||9
7524217|NCT03608839|18526645|P1|COMPLETED|Overall Study||9
7524218|NCT03608839|18526643|P3|STARTED|Overall Study||9
7524219|NCT03608839|18526644|P2|STARTED|Overall Study||9
7524220|NCT03608839|18526645|P1|STARTED|Overall Study||9
7524221|NCT03608488|18526672|P4|NOT COMPLETED|Overall Study||5
7524222|NCT03608488|18526673|P3|NOT COMPLETED|Overall Study||2
7524223|NCT03608488|18526674|P2|NOT COMPLETED|Overall Study||3
7524224|NCT03608488|18526675|P1|NOT COMPLETED|Overall Study||1
7524225|NCT03608488|18526672|P4|COMPLETED|Overall Study||40
7524226|NCT03608488|18526673|P3|COMPLETED|Overall Study||20
7524227|NCT03608488|18526674|P2|COMPLETED|Overall Study||18
7524228|NCT03608488|18526675|P1|COMPLETED|Overall Study||21
7524229|NCT03608488|18526672|P4|STARTED|Overall Study||45
7524230|NCT03608488|18526673|P3|STARTED|Overall Study||22
7524231|NCT03608488|18526674|P2|STARTED|Overall Study||21
7524232|NCT03608488|18526675|P1|STARTED|Overall Study||22
7524233|NCT03607682|18526713|P1|NOT COMPLETED|Overall Study||2
7524234|NCT03607682|18526713|P1|COMPLETED|Overall Study||0
7524235|NCT03607682|18526713|P1|STARTED|Overall Study||2
7524236|NCT03607487|18526729|P4|NOT COMPLETED|Overall Study||1
7524237|NCT03607487|18526730|P3|NOT COMPLETED|Overall Study||0
7524238|NCT03607487|18526731|P2|NOT COMPLETED|Overall Study||0
7524239|NCT03607487|18526732|P1|NOT COMPLETED|Overall Study||2
7524240|NCT03607487|18526729|P4|COMPLETED|Overall Study||7
7524241|NCT03607487|18526730|P3|COMPLETED|Overall Study||9
7524242|NCT03607487|18526731|P2|COMPLETED|Overall Study||9
7524243|NCT03607487|18526732|P1|COMPLETED|Overall Study||7
7524244|NCT03607487|18526729|P4|STARTED|Overall Study||8
7524245|NCT03607487|18526730|P3|STARTED|Overall Study||9
7524246|NCT03607487|18526731|P2|STARTED|Overall Study||9
7524247|NCT03607487|18526732|P1|STARTED|Overall Study||9
7524248|NCT03606460|18526783|P2|NOT COMPLETED|Overall Study||8
7524249|NCT03606460|18526784|P1|NOT COMPLETED|Overall Study||1
7524250|NCT03606460|18526783|P2|COMPLETED|Overall Study||38
7524251|NCT03606460|18526784|P1|COMPLETED|Overall Study||94
7524252|NCT03606460|18526783|P2|STARTED|Overall Study||46
7524253|NCT03606460|18526784|P1|STARTED|Overall Study||95
7524254|NCT03606343|18526792|P1|NOT COMPLETED|Overall Study||0
7524255|NCT03606343|18526792|P1|COMPLETED|Overall Study||21
7524256|NCT03606343|18526792|P1|STARTED|Overall Study||21
7524257|NCT03605693|18526804|P2|NOT COMPLETED|Overall Study||0
7524258|NCT03605693|18526805|P1|NOT COMPLETED|Overall Study||5
7524259|NCT03605693|18526804|P2|COMPLETED|Overall Study||5
7524260|NCT03605693|18526805|P1|COMPLETED|Overall Study||0
7524261|NCT03605693|18526804|P2|STARTED|Overall Study||5
7524262|NCT03605693|18526805|P1|STARTED|Overall Study||5
7524263|NCT03605303|18526819|P2|NOT COMPLETED|Period 2||0
7524264|NCT03605303|18526820|P1|NOT COMPLETED|Period 2||0
7524265|NCT03605303|18526819|P2|COMPLETED|Period 2||0
7524266|NCT03605303|18526820|P1|COMPLETED|Period 2||0
7524267|NCT03605303|18526819|P2|STARTED|Period 2||0
7524268|NCT03605303|18526820|P1|STARTED|Period 2||0
7524269|NCT03605303|18526819|P2|NOT COMPLETED|Period 1||1
7524270|NCT03605303|18526820|P1|NOT COMPLETED|Period 1||2
7524271|NCT03605303|18526819|P2|COMPLETED|Period 1||0
7524272|NCT03605303|18526820|P1|COMPLETED|Period 1||0
7524273|NCT03605303|18526819|P2|STARTED|Period 1||1
7524274|NCT03605303|18526820|P1|STARTED|Period 1||2
7524275|NCT03604497|18526828|P1|NOT COMPLETED|Overall Study||52
7524276|NCT03604497|18526828|P1|COMPLETED|Overall Study||385
7524277|NCT03604497|18526828|P1|STARTED|Overall Study||437
7524278|NCT03604341|18526838|P2|NOT COMPLETED|Overall Study||2
7524279|NCT03604341|18526839|P1|NOT COMPLETED|Overall Study||2
7524280|NCT03604341|18526838|P2|COMPLETED|Overall Study||33
7524281|NCT03604341|18526839|P1|COMPLETED|Overall Study||33
7524282|NCT03604341|18526838|P2|STARTED|Overall Study||35
7524283|NCT03604341|18526839|P1|STARTED|Overall Study||35
7524284|NCT03604263|18526845|P1|NOT COMPLETED|Overall Study||2
7524285|NCT03604263|18526845|P1|COMPLETED|Overall Study||15
7524286|NCT03604263|18526845|P1|STARTED|Overall Study||17
7524287|NCT03603652|18526849|P1|NOT COMPLETED|Overall Study||2
7524288|NCT03603652|18526849|P1|COMPLETED|Overall Study||8
7524289|NCT03603652|18526849|P1|STARTED|Overall Study||10
7524290|NCT03603106|18526872|P11|NOT COMPLETED|Overall Study||0
7524291|NCT03603106|18526873|P10|NOT COMPLETED|Overall Study||0
7524292|NCT03603106|18526874|P9|NOT COMPLETED|Overall Study||0
7524293|NCT03603106|18526875|P8|NOT COMPLETED|Overall Study||0
7524294|NCT03603106|18526876|P7|NOT COMPLETED|Overall Study||0
7524295|NCT03603106|18526877|P6|NOT COMPLETED|Overall Study||0
7524296|NCT03603106|18526878|P5|NOT COMPLETED|Overall Study||0
7524297|NCT03603106|18526879|P4|NOT COMPLETED|Overall Study||0
7524298|NCT03603106|18526880|P3|NOT COMPLETED|Overall Study||0
7524299|NCT03603106|18526881|P2|NOT COMPLETED|Overall Study||0
7524300|NCT03603106|18526882|P1|NOT COMPLETED|Overall Study||0
7524301|NCT03603106|18526872|P11|COMPLETED|Overall Study||3
7524302|NCT03603106|18526873|P10|COMPLETED|Overall Study||3
7524303|NCT03603106|18526874|P9|COMPLETED|Overall Study||3
7524304|NCT03603106|18526875|P8|COMPLETED|Overall Study||3
7524305|NCT03603106|18526876|P7|COMPLETED|Overall Study||18
7524306|NCT03603106|18526877|P6|COMPLETED|Overall Study||6
7524307|NCT03603106|18526878|P5|COMPLETED|Overall Study||6
7524308|NCT03603106|18526879|P4|COMPLETED|Overall Study||6
7524309|NCT03603106|18526880|P3|COMPLETED|Overall Study||6
7524310|NCT03603106|18526881|P2|COMPLETED|Overall Study||6
7524311|NCT03603106|18526882|P1|COMPLETED|Overall Study||6
7524312|NCT03603106|18526872|P11|STARTED|Overall Study||3
7524313|NCT03603106|18526873|P10|STARTED|Overall Study||3
7524314|NCT03603106|18526874|P9|STARTED|Overall Study||3
7524315|NCT03603106|18526875|P8|STARTED|Overall Study||3
7524316|NCT03603106|18526876|P7|STARTED|Overall Study||18
7524317|NCT03603106|18526877|P6|STARTED|Overall Study||6
7524318|NCT03603106|18526878|P5|STARTED|Overall Study||6
7524319|NCT03603106|18526879|P4|STARTED|Overall Study||6
7524320|NCT03603106|18526880|P3|STARTED|Overall Study||6
7524321|NCT03603106|18526881|P2|STARTED|Overall Study||6
7524322|NCT03603106|18526882|P1|STARTED|Overall Study||6
7524323|NCT03603028|18526935|P1|NOT COMPLETED|Overall Study||1
7524324|NCT03603028|18526935|P1|COMPLETED|Overall Study||12
7524325|NCT03603028|18526935|P1|STARTED|Overall Study||13
7524326|NCT03602053|18526943|P3|NOT COMPLETED|Overall Study||11
7524327|NCT03602053|18526944|P2|NOT COMPLETED|Overall Study||18
7524328|NCT03602053|18526945|P1|NOT COMPLETED|Overall Study||19
7524329|NCT03602053|18526943|P3|COMPLETED|Overall Study||139
7524330|NCT03602053|18526944|P2|COMPLETED|Overall Study||132
7524331|NCT03602053|18526945|P1|COMPLETED|Overall Study||131
7524332|NCT03602053|18526943|P3|STARTED|Overall Study||150
7524333|NCT03602053|18526944|P2|STARTED|Overall Study||150
7524334|NCT03602053|18526945|P1|STARTED|Overall Study||150
7524335|NCT03601715|18526991|P3|NOT COMPLETED|Third Intervention||0
7524336|NCT03601715|18526992|P2|NOT COMPLETED|Third Intervention||0
7524337|NCT03601715|18526993|P1|NOT COMPLETED|Third Intervention||0
7524338|NCT03601715|18526991|P3|COMPLETED|Third Intervention||6
7524339|NCT03601715|18526992|P2|COMPLETED|Third Intervention||6
7524340|NCT03601715|18526993|P1|COMPLETED|Third Intervention||6
7524341|NCT03601715|18526991|P3|STARTED|Third Intervention||6
7524342|NCT03601715|18526992|P2|STARTED|Third Intervention||6
7524343|NCT03601715|18526993|P1|STARTED|Third Intervention||6
7524344|NCT03601715|18526991|P3|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
7524345|NCT03601715|18526992|P2|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
7524346|NCT03601715|18526993|P1|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
7524347|NCT03601715|18526991|P3|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
7524348|NCT03601715|18526992|P2|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
7524349|NCT03601715|18526993|P1|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
7524350|NCT03601715|18526991|P3|STARTED|Wash Out 2 (at Least 24 Hours)||6
7524351|NCT03601715|18526992|P2|STARTED|Wash Out 2 (at Least 24 Hours)||6
7524352|NCT03601715|18526993|P1|STARTED|Wash Out 2 (at Least 24 Hours)||6
7524353|NCT03601715|18526991|P3|NOT COMPLETED|Second Intervention||0
7524354|NCT03601715|18526992|P2|NOT COMPLETED|Second Intervention||1
7524355|NCT03601715|18526993|P1|NOT COMPLETED|Second Intervention||1
7524356|NCT03601715|18526991|P3|COMPLETED|Second Intervention||6
7524357|NCT03601715|18526992|P2|COMPLETED|Second Intervention||6
7524358|NCT03601715|18526993|P1|COMPLETED|Second Intervention||6
7524359|NCT03601715|18526991|P3|STARTED|Second Intervention||6
7524360|NCT03601715|18526992|P2|STARTED|Second Intervention||7
7524361|NCT03601715|18526993|P1|STARTED|Second Intervention||7
7524362|NCT03601715|18526991|P3|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
7524363|NCT03601715|18526992|P2|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
7524364|NCT03601715|18526993|P1|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
7524365|NCT03601715|18526991|P3|COMPLETED|Washout 1 (at Least 24 Hours)||6
7524366|NCT03601715|18526992|P2|COMPLETED|Washout 1 (at Least 24 Hours)||7
7524367|NCT03601715|18526993|P1|COMPLETED|Washout 1 (at Least 24 Hours)||7
7524368|NCT03601715|18526991|P3|STARTED|Washout 1 (at Least 24 Hours)||6
7524369|NCT03601715|18526992|P2|STARTED|Washout 1 (at Least 24 Hours)||7
7524370|NCT03601715|18526993|P1|STARTED|Washout 1 (at Least 24 Hours)||7
7524371|NCT03601715|18526991|P3|NOT COMPLETED|First Intervention||0
7524372|NCT03601715|18526992|P2|NOT COMPLETED|First Intervention||0
7524373|NCT03601715|18526993|P1|NOT COMPLETED|First Intervention||0
7524374|NCT03601715|18526991|P3|COMPLETED|First Intervention||6
7524375|NCT03601715|18526992|P2|COMPLETED|First Intervention||7
7524376|NCT03601715|18526993|P1|COMPLETED|First Intervention||7
7524377|NCT03601715|18526991|P3|STARTED|First Intervention||6
7524378|NCT03601715|18526992|P2|STARTED|First Intervention||7
7524379|NCT03601715|18526993|P1|STARTED|First Intervention||7
7524380|NCT03599986|18527007|P1|NOT COMPLETED|Overall Study||32
7524381|NCT03599986|18527007|P1|COMPLETED|Overall Study||366
7524382|NCT03599986|18527007|P1|STARTED|Overall Study||398
7524383|NCT03599687|18527015|P2|NOT COMPLETED|Overall Study||0
7524384|NCT03599687|18527016|P1|NOT COMPLETED|Overall Study||0
7524385|NCT03599687|18527015|P2|COMPLETED|Overall Study||82
7524386|NCT03599687|18527016|P1|COMPLETED|Overall Study||82
7524387|NCT03599687|18527015|P2|STARTED|Overall Study||82
7524388|NCT03599687|18527016|P1|STARTED|Overall Study||82
7524389|NCT03599349|18527026|P1|NOT COMPLETED|Overall Study||1
7524390|NCT03599349|18527026|P1|COMPLETED|Overall Study||19
7524391|NCT03599349|18527026|P1|Treated|Overall Study||20
7524392|NCT03599349|18527026|P1|STARTED|Overall Study||20
7524393|NCT03599193|18527040|P2|NOT COMPLETED|Overall Study||3
7524394|NCT03599193|18527041|P1|NOT COMPLETED|Overall Study||2
7524395|NCT03599193|18527040|P2|COMPLETED|Overall Study||21
7524396|NCT03599193|18527041|P1|COMPLETED|Overall Study||32
7524397|NCT03599193|18527040|P2|STARTED|Overall Study||24
7524398|NCT03599193|18527041|P1|STARTED|Overall Study||34
7524399|NCT03598140|18527055|P2|NOT COMPLETED|Overall Study||0
7524400|NCT03598140|18527056|P1|NOT COMPLETED|Overall Study||1
7524401|NCT03598140|18527055|P2|COMPLETED|Overall Study||11
7524402|NCT03598140|18527056|P1|COMPLETED|Overall Study||9
7524403|NCT03598140|18527055|P2|STARTED|Overall Study||11
7524404|NCT03598140|18527056|P1|STARTED|Overall Study||10
7524405|NCT03597178|18527068|P1|NOT COMPLETED|Overall Study||0
7524406|NCT03597178|18527068|P1|COMPLETED|Overall Study||14
7524407|NCT03597178|18527068|P1|STARTED|Overall Study||14
7524408|NCT03597022|18527075|P3|NOT COMPLETED|Overall Study||8
7524409|NCT03597022|18527076|P2|NOT COMPLETED|Overall Study||8
7524410|NCT03597022|18527077|P1|NOT COMPLETED|Overall Study||8
7524411|NCT03597022|18527075|P3|COMPLETED|Overall Study||0
7524412|NCT03597022|18527076|P2|COMPLETED|Overall Study||0
7524413|NCT03597022|18527077|P1|COMPLETED|Overall Study||0
7524414|NCT03597022|18527075|P3|STARTED|Overall Study||8
7524415|NCT03597022|18527076|P2|STARTED|Overall Study||8
7524416|NCT03597022|18527077|P1|STARTED|Overall Study||8
7524417|NCT03596723|18527096|P2|NOT COMPLETED|Overall Study||0
7524418|NCT03596723|18527097|P1|NOT COMPLETED|Overall Study||0
7524419|NCT03596723|18527096|P2|COMPLETED|Overall Study||1
7524420|NCT03596723|18527097|P1|COMPLETED|Overall Study||1
7524421|NCT03596723|18527096|P2|STARTED|Overall Study||1
7524422|NCT03596723|18527097|P1|STARTED|Overall Study||1
7524423|NCT03595215|18527105|P1|NOT COMPLETED|Overall Study||8
7524424|NCT03595215|18527105|P1|COMPLETED|Overall Study||10
7524425|NCT03595215|18527105|P1|STARTED|Overall Study||18
7524426|NCT03594227|18527113|P4|NOT COMPLETED|Overall Study||5
7524427|NCT03594227|18527114|P3|NOT COMPLETED|Overall Study||3
7524428|NCT03594227|18527115|P2|NOT COMPLETED|Overall Study||4
7524429|NCT03594227|18527116|P1|NOT COMPLETED|Overall Study||5
7524430|NCT03594227|18527113|P4|COMPLETED|Overall Study||14
7524431|NCT03594227|18527114|P3|COMPLETED|Overall Study||19
7524432|NCT03594227|18527115|P2|COMPLETED|Overall Study||19
7524433|NCT03594227|18527116|P1|COMPLETED|Overall Study||18
7524434|NCT03594227|18527113|P4|STARTED|Overall Study||19
7524435|NCT03594227|18527114|P3|STARTED|Overall Study||22
7524436|NCT03594227|18527115|P2|STARTED|Overall Study||23
7524437|NCT03594227|18527116|P1|STARTED|Overall Study||23
7524438|NCT03594045|18527252|P2|NOT COMPLETED|Overall Study||0
7524439|NCT03594045|18527253|P1|NOT COMPLETED|Overall Study||0
7524440|NCT03594045|18527252|P2|COMPLETED|Overall Study||5
7524441|NCT03594045|18527253|P1|COMPLETED|Overall Study||0
7524442|NCT03594045|18527252|P2|STARTED|Overall Study||5
7524443|NCT03594045|18527253|P1|STARTED|Overall Study||0
7524444|NCT03593902|18527273|P1|NOT COMPLETED|Overall Study||0
7524445|NCT03593902|18527273|P1|COMPLETED|Overall Study||9
7524446|NCT03593902|18527273|P1|STARTED|Overall Study||9
7524447|NCT03593200|18527278|P1|NOT COMPLETED|Overall Study||0
7524448|NCT03593200|18527278|P1|COMPLETED|Overall Study||4
7524449|NCT03593200|18527278|P1|STARTED|Overall Study||4
7524450|NCT03592186|18527295|P2|NOT COMPLETED|Overall Study||11
7524451|NCT03592186|18527296|P1|NOT COMPLETED|Overall Study||17
7524452|NCT03592186|18527295|P2|COMPLETED|Overall Study||51
7524453|NCT03592186|18527296|P1|COMPLETED|Overall Study||43
7524454|NCT03592186|18527295|P2|12-week Follow-up|Overall Study||51
7524455|NCT03592186|18527296|P1|12-week Follow-up|Overall Study||47
7524456|NCT03592186|18527295|P2|6-week Follow-up|Overall Study||56
7524457|NCT03592186|18527296|P1|6-week Follow-up|Overall Study||49
7524458|NCT03592186|18527295|P2|STARTED|Overall Study||62
7524459|NCT03592186|18527296|P1|STARTED|Overall Study||60
7524460|NCT03592121|18527304|P2|NOT COMPLETED|Overall Study||0
7524461|NCT03592121|18527305|P1|NOT COMPLETED|Overall Study||0
7524462|NCT03592121|18527304|P2|COMPLETED|Overall Study||0
7524463|NCT03592121|18527305|P1|COMPLETED|Overall Study||3
7524464|NCT03592121|18527304|P2|STARTED|Overall Study||0
7524465|NCT03592121|18527305|P1|STARTED|Overall Study||3
7524466|NCT03591458|18527313|P2|NOT COMPLETED|Overall Study||0
7524467|NCT03591458|18527314|P1|NOT COMPLETED|Overall Study||0
7524468|NCT03591458|18527313|P2|COMPLETED|Overall Study||1
7524469|NCT03591458|18527314|P1|COMPLETED|Overall Study||1
7524470|NCT03591458|18527313|P2|STARTED|Overall Study||1
7524471|NCT03591458|18527314|P1|STARTED|Overall Study||1
7524472|NCT03591406|18527344|P2|NOT COMPLETED|Overall Study||9
7524473|NCT03591406|18527345|P1|NOT COMPLETED|Overall Study||7
7524474|NCT03591406|18527344|P2|COMPLETED|Overall Study||174
7524475|NCT03591406|18527345|P1|COMPLETED|Overall Study||181
7524476|NCT03591406|18527344|P2|STARTED|Overall Study||183
7524477|NCT03591406|18527345|P1|STARTED|Overall Study||188
7524478|NCT03591068|18527373|P1|NOT COMPLETED|Overall Study||2
7524479|NCT03591068|18527373|P1|COMPLETED|Overall Study||9
7524480|NCT03591068|18527373|P1|STARTED|Overall Study||11
7524481|NCT03590743|18527391|P2|NOT COMPLETED|Overall Study||1
7524482|NCT03590743|18527392|P1|NOT COMPLETED|Overall Study||0
7524483|NCT03590743|18527391|P2|COMPLETED|Overall Study||2
7524484|NCT03590743|18527392|P1|COMPLETED|Overall Study||2
7524485|NCT03590743|18527391|P2|STARTED|Overall Study||3
7524486|NCT03590743|18527392|P1|STARTED|Overall Study||2
7524487|NCT03590613|18527404|P4|NOT COMPLETED|Period 4, 4 Days||0
7524488|NCT03590613|18527405|P3|NOT COMPLETED|Period 4, 4 Days||0
7524489|NCT03590613|18527406|P2|NOT COMPLETED|Period 4, 4 Days||0
7524490|NCT03590613|18527407|P1|NOT COMPLETED|Period 4, 4 Days||0
7524491|NCT03590613|18527404|P4|COMPLETED|Period 4, 4 Days||3
7524492|NCT03590613|18527405|P3|COMPLETED|Period 4, 4 Days||3
7524493|NCT03590613|18527406|P2|COMPLETED|Period 4, 4 Days||3
7524494|NCT03590613|18527407|P1|COMPLETED|Period 4, 4 Days||3
7524495|NCT03590613|18527404|P4|STARTED|Period 4, 4 Days||3
7524496|NCT03590613|18527405|P3|STARTED|Period 4, 4 Days||3
7524497|NCT03590613|18527406|P2|STARTED|Period 4, 4 Days||3
7524498|NCT03590613|18527407|P1|STARTED|Period 4, 4 Days||3
7524499|NCT03590613|18527404|P4|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
7524500|NCT03590613|18527405|P3|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
7524501|NCT03590613|18527406|P2|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
7524502|NCT03590613|18527407|P1|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
7524503|NCT03590613|18527404|P4|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
7524504|NCT03590613|18527405|P3|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
7524505|NCT03590613|18527406|P2|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
7524506|NCT03590613|18527407|P1|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
7524507|NCT03590613|18527404|P4|STARTED|Period 3,Wash-out, at Least 3 Days||3
7524508|NCT03590613|18527405|P3|STARTED|Period 3,Wash-out, at Least 3 Days||3
7524509|NCT03590613|18527406|P2|STARTED|Period 3,Wash-out, at Least 3 Days||3
7524510|NCT03590613|18527407|P1|STARTED|Period 3,Wash-out, at Least 3 Days||3
7524511|NCT03590613|18527404|P4|NOT COMPLETED|Period 3, 4 Days||0
7524512|NCT03590613|18527405|P3|NOT COMPLETED|Period 3, 4 Days||0
7524513|NCT03590613|18527406|P2|NOT COMPLETED|Period 3, 4 Days||0
7524514|NCT03590613|18527407|P1|NOT COMPLETED|Period 3, 4 Days||0
7524515|NCT03590613|18527404|P4|COMPLETED|Period 3, 4 Days||3
7524516|NCT03590613|18527405|P3|COMPLETED|Period 3, 4 Days||3
7524517|NCT03590613|18527406|P2|COMPLETED|Period 3, 4 Days||3
7524518|NCT03590613|18527407|P1|COMPLETED|Period 3, 4 Days||3
7524519|NCT03590613|18527404|P4|STARTED|Period 3, 4 Days||3
7524520|NCT03590613|18527405|P3|STARTED|Period 3, 4 Days||3
7524521|NCT03590613|18527406|P2|STARTED|Period 3, 4 Days||3
7524522|NCT03590613|18527407|P1|STARTED|Period 3, 4 Days||3
7524523|NCT03590613|18527404|P4|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
7524524|NCT03590613|18527405|P3|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
7524525|NCT03590613|18527406|P2|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
7524526|NCT03590613|18527407|P1|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
7524527|NCT03590613|18527404|P4|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
7524528|NCT03590613|18527405|P3|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
7524529|NCT03590613|18527406|P2|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
7524530|NCT03590613|18527407|P1|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
7524531|NCT03590613|18527404|P4|STARTED|Period 2, Wash-out, at Least 3 Days||3
7524532|NCT03590613|18527405|P3|STARTED|Period 2, Wash-out, at Least 3 Days||3
7524533|NCT03590613|18527406|P2|STARTED|Period 2, Wash-out, at Least 3 Days||3
7524534|NCT03590613|18527407|P1|STARTED|Period 2, Wash-out, at Least 3 Days||3
7524535|NCT03590613|18527404|P4|NOT COMPLETED|Period 2, 4 Days||1
7524536|NCT03590613|18527405|P3|NOT COMPLETED|Period 2, 4 Days||0
7524537|NCT03590613|18527406|P2|NOT COMPLETED|Period 2, 4 Days||0
7524538|NCT03590613|18527407|P1|NOT COMPLETED|Period 2, 4 Days||0
7524539|NCT03590613|18527404|P4|COMPLETED|Period 2, 4 Days||3
7524540|NCT03590613|18527405|P3|COMPLETED|Period 2, 4 Days||3
7524541|NCT03590613|18527406|P2|COMPLETED|Period 2, 4 Days||3
7524542|NCT03590613|18527407|P1|COMPLETED|Period 2, 4 Days||3
7524543|NCT03590613|18527404|P4|STARTED|Period 2, 4 Days|One additional participant was enrolled in Period 2.|4
7524544|NCT03590613|18527405|P3|STARTED|Period 2, 4 Days||3
7524545|NCT03590613|18527406|P2|STARTED|Period 2, 4 Days||3
7524546|NCT03590613|18527407|P1|STARTED|Period 2, 4 Days||3
7524547|NCT03590613|18527404|P4|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
7524548|NCT03590613|18527405|P3|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
7524549|NCT03590613|18527406|P2|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
7524550|NCT03590613|18527407|P1|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
7524551|NCT03590613|18527404|P4|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
7524552|NCT03590613|18527405|P3|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
7524553|NCT03590613|18527406|P2|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
7524554|NCT03590613|18527407|P1|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
7524555|NCT03590613|18527404|P4|STARTED|Period 1, Wash-out, at Least 3 Days||3
7524556|NCT03590613|18527405|P3|STARTED|Period 1, Wash-out, at Least 3 Days||3
7524557|NCT03590613|18527406|P2|STARTED|Period 1, Wash-out, at Least 3 Days||3
7524558|NCT03590613|18527407|P1|STARTED|Period 1, Wash-out, at Least 3 Days||3
7524559|NCT03590613|18527404|P4|NOT COMPLETED|Period 1, 4 Days||0
7524560|NCT03590613|18527405|P3|NOT COMPLETED|Period 1, 4 Days||0
7524561|NCT03590613|18527406|P2|NOT COMPLETED|Period 1, 4 Days||0
7524562|NCT03590613|18527407|P1|NOT COMPLETED|Period 1, 4 Days||0
7524563|NCT03590613|18527404|P4|COMPLETED|Period 1, 4 Days||3
7524564|NCT03590613|18527405|P3|COMPLETED|Period 1, 4 Days||3
7524565|NCT03590613|18527406|P2|COMPLETED|Period 1, 4 Days||3
7524566|NCT03590613|18527407|P1|COMPLETED|Period 1, 4 Days||3
7524567|NCT03590613|18527404|P4|STARTED|Period 1, 4 Days||3
7524568|NCT03590613|18527405|P3|STARTED|Period 1, 4 Days||3
7524569|NCT03590613|18527406|P2|STARTED|Period 1, 4 Days||3
7524570|NCT03590613|18527407|P1|STARTED|Period 1, 4 Days||3
7524571|NCT03588806|18527525|P1|NOT COMPLETED|Overall Study||0
7524572|NCT03588806|18527525|P1|COMPLETED|Overall Study||11
7524573|NCT03588806|18527525|P1|STARTED|Overall Study||11
7524574|NCT03588741|18527536|P1|NOT COMPLETED|Overall Study||1
7524575|NCT03588741|18527536|P1|COMPLETED|Overall Study||0
7524576|NCT03588741|18527536|P1|STARTED|Overall Study||1
7524577|NCT03588572|18527543|P2|NOT COMPLETED|Visitation 3||2
7524578|NCT03588572|18527544|P1|NOT COMPLETED|Visitation 3||3
7524579|NCT03588572|18527543|P2|COMPLETED|Visitation 3||16
7524580|NCT03588572|18527544|P1|COMPLETED|Visitation 3||16
7524581|NCT03588572|18527543|P2|STARTED|Visitation 3||18
7524582|NCT03588572|18527544|P1|STARTED|Visitation 3||19
7524583|NCT03588572|18527543|P2|NOT COMPLETED|Visitation 2||2
7524584|NCT03588572|18527544|P1|NOT COMPLETED|Visitation 2||2
7524585|NCT03588572|18527543|P2|COMPLETED|Visitation 2||18
7524586|NCT03588572|18527544|P1|COMPLETED|Visitation 2||19
7524587|NCT03588572|18527543|P2|STARTED|Visitation 2||20
7524588|NCT03588572|18527544|P1|STARTED|Visitation 2||21
7524589|NCT03588572|18527543|P2|NOT COMPLETED|Visitation 1||1
7524590|NCT03588572|18527544|P1|NOT COMPLETED|Visitation 1||1
7524591|NCT03588572|18527543|P2|COMPLETED|Visitation 1||20
7524592|NCT03588572|18527544|P1|COMPLETED|Visitation 1||21
7524593|NCT03588572|18527543|P2|STARTED|Visitation 1||21
7524594|NCT03588572|18527544|P1|STARTED|Visitation 1||22
7524595|NCT03587974|18527562|P2|NOT COMPLETED|Overall Study||4
7524596|NCT03587974|18527563|P1|NOT COMPLETED|Overall Study||5
7524597|NCT03587974|18527562|P2|COMPLETED|Overall Study||26
7524598|NCT03587974|18527563|P1|COMPLETED|Overall Study||25
7524599|NCT03587974|18527562|P2|STARTED|Overall Study||30
7524600|NCT03587974|18527563|P1|STARTED|Overall Study||30
7524601|NCT03587428|18527573|P6|NOT COMPLETED|Period 3||0
7524602|NCT03587428|18527574|P5|NOT COMPLETED|Period 3||0
7524603|NCT03587428|18527575|P4|NOT COMPLETED|Period 3||0
7524604|NCT03587428|18527576|P3|NOT COMPLETED|Period 3||0
7524605|NCT03587428|18527577|P2|NOT COMPLETED|Period 3||0
7524606|NCT03587428|18527578|P1|NOT COMPLETED|Period 3||0
7524607|NCT03587428|18527573|P6|COMPLETED|Period 3||2
7524608|NCT03587428|18527574|P5|COMPLETED|Period 3||2
7524609|NCT03587428|18527575|P4|COMPLETED|Period 3||3
7524610|NCT03587428|18527576|P3|COMPLETED|Period 3||3
7524611|NCT03587428|18527577|P2|COMPLETED|Period 3||2
7524612|NCT03587428|18527578|P1|COMPLETED|Period 3||3
7524613|NCT03587428|18527573|P6|STARTED|Period 3||2
7524614|NCT03587428|18527574|P5|STARTED|Period 3||2
7524615|NCT03587428|18527575|P4|STARTED|Period 3||3
7524616|NCT03587428|18527576|P3|STARTED|Period 3||3
7524617|NCT03587428|18527577|P2|STARTED|Period 3||2
7524618|NCT03587428|18527578|P1|STARTED|Period 3||3
7524619|NCT03587428|18527573|P6|NOT COMPLETED|Period 2||0
7524620|NCT03587428|18527574|P5|NOT COMPLETED|Period 2||0
7524621|NCT03587428|18527575|P4|NOT COMPLETED|Period 2||0
7524622|NCT03587428|18527576|P3|NOT COMPLETED|Period 2||0
7524623|NCT03587428|18527577|P2|NOT COMPLETED|Period 2||0
7524624|NCT03587428|18527578|P1|NOT COMPLETED|Period 2||0
7524625|NCT03587428|18527573|P6|COMPLETED|Period 2||2
7524626|NCT03587428|18527574|P5|COMPLETED|Period 2||2
7524627|NCT03587428|18527575|P4|COMPLETED|Period 2||3
7524628|NCT03587428|18527576|P3|COMPLETED|Period 2||3
7524629|NCT03587428|18527577|P2|COMPLETED|Period 2||2
7524630|NCT03587428|18527578|P1|COMPLETED|Period 2||3
7524631|NCT03587428|18527573|P6|STARTED|Period 2||2
7524632|NCT03587428|18527574|P5|STARTED|Period 2||2
7524633|NCT03587428|18527575|P4|STARTED|Period 2||3
7524634|NCT03587428|18527576|P3|STARTED|Period 2||3
7524635|NCT03587428|18527577|P2|STARTED|Period 2||2
7524636|NCT03587428|18527578|P1|STARTED|Period 2||3
7524637|NCT03587428|18527573|P6|NOT COMPLETED|Period 1||0
7524638|NCT03587428|18527574|P5|NOT COMPLETED|Period 1||0
7524639|NCT03587428|18527575|P4|NOT COMPLETED|Period 1||0
7524640|NCT03587428|18527576|P3|NOT COMPLETED|Period 1||0
7524641|NCT03587428|18527577|P2|NOT COMPLETED|Period 1||0
7524642|NCT03587428|18527578|P1|NOT COMPLETED|Period 1||0
7524643|NCT03587428|18527573|P6|COMPLETED|Period 1||2
7524644|NCT03587428|18527574|P5|COMPLETED|Period 1||2
7524645|NCT03587428|18527575|P4|COMPLETED|Period 1||3
7524646|NCT03587428|18527576|P3|COMPLETED|Period 1||3
7524647|NCT03587428|18527577|P2|COMPLETED|Period 1||2
7524648|NCT03587428|18527578|P1|COMPLETED|Period 1||3
7524649|NCT03587428|18527573|P6|STARTED|Period 1||2
7524650|NCT03587428|18527574|P5|STARTED|Period 1||2
7524651|NCT03587428|18527575|P4|STARTED|Period 1||3
7524652|NCT03587428|18527576|P3|STARTED|Period 1||3
7524653|NCT03587428|18527577|P2|STARTED|Period 1||2
7524654|NCT03587428|18527578|P1|STARTED|Period 1||3
7524655|NCT03587207|18527600|P5|NOT COMPLETED|Overall Study||0
7524656|NCT03587207|18527601|P4|NOT COMPLETED|Overall Study||0
7524657|NCT03587207|18527602|P3|NOT COMPLETED|Overall Study||0
7524658|NCT03587207|18527603|P2|NOT COMPLETED|Overall Study||0
7524659|NCT03587207|18527604|P1|NOT COMPLETED|Overall Study||0
7524660|NCT03587207|18527600|P5|COMPLETED|Overall Study||102
7524661|NCT03587207|18527601|P4|COMPLETED|Overall Study||94
7524662|NCT03587207|18527602|P3|COMPLETED|Overall Study||100
7524663|NCT03587207|18527603|P2|COMPLETED|Overall Study||104
7524664|NCT03587207|18527604|P1|COMPLETED|Overall Study||100
7524665|NCT03587207|18527600|P5|STARTED|Overall Study||102
7524666|NCT03587207|18527601|P4|STARTED|Overall Study||94
7524667|NCT03587207|18527602|P3|STARTED|Overall Study||100
7524668|NCT03587207|18527603|P2|STARTED|Overall Study||104
7524669|NCT03587207|18527604|P1|STARTED|Overall Study||100
7524670|NCT03586830|18527679|P4|NOT COMPLETED|Overall Study||5
7524671|NCT03586830|18527680|P3|NOT COMPLETED|Overall Study||8
7524672|NCT03586830|18527681|P2|NOT COMPLETED|Overall Study||6
7524673|NCT03586830|18527682|P1|NOT COMPLETED|Overall Study||2
7524674|NCT03586830|18527679|P4|COMPLETED|Overall Study||44
7524675|NCT03586830|18527680|P3|COMPLETED|Overall Study||41
7524676|NCT03586830|18527681|P2|COMPLETED|Overall Study||42
7524677|NCT03586830|18527682|P1|COMPLETED|Overall Study||48
7524678|NCT03586830|18527679|P4|Treated|Overall Study||49
7524679|NCT03586830|18527680|P3|Treated|Overall Study||49
7524680|NCT03586830|18527681|P2|Treated|Overall Study||48
7524681|NCT03586830|18527682|P1|Treated|Overall Study||49
7524682|NCT03586830|18527679|P4|STARTED|Overall Study||49
7524683|NCT03586830|18527680|P3|STARTED|Overall Study||49
7524684|NCT03586830|18527681|P2|STARTED|Overall Study||48
7524685|NCT03586830|18527682|P1|STARTED|Overall Study||50
7524686|NCT03586726|18527704|P1|NOT COMPLETED|Overall Study||1
7524687|NCT03586726|18527704|P1|COMPLETED|Overall Study||15
7524688|NCT03586726|18527704|P1|STARTED|Overall Study||16
7524689|NCT03586648|18527721|P2|NOT COMPLETED|Period 2||0
7524690|NCT03586648|18527722|P1|NOT COMPLETED|Period 2||1
7524691|NCT03586648|18527721|P2|COMPLETED|Period 2||30
7524692|NCT03586648|18527722|P1|COMPLETED|Period 2||31
7524693|NCT03586648|18527721|P2|STARTED|Period 2||30
7524694|NCT03586648|18527722|P1|STARTED|Period 2||32
7524695|NCT03586648|18527721|P2|NOT COMPLETED|Period 1||4
7524696|NCT03586648|18527722|P1|NOT COMPLETED|Period 1||4
7524697|NCT03586648|18527721|P2|COMPLETED|Period 1||30
7524698|NCT03586648|18527722|P1|COMPLETED|Period 1||32
7524699|NCT03586648|18527721|P2|STARTED|Period 1||34
7524700|NCT03586648|18527722|P1|STARTED|Period 1||36
7524701|NCT03586583|18527730|P1|NOT COMPLETED|Overall Study||0
7524702|NCT03586583|18527730|P1|COMPLETED|Overall Study||600
7524703|NCT03586583|18527730|P1|STARTED|Overall Study||600
7524704|NCT03585959|18527735|P1|NOT COMPLETED|Overall Study||3
7524705|NCT03585959|18527735|P1|COMPLETED|Overall Study||47
7524706|NCT03585959|18527735|P1|STARTED|Overall Study||50
7524707|NCT03585790|18527757|P2|NOT COMPLETED|Second Intervention (1 Week)||0
7524708|NCT03585790|18527758|P1|NOT COMPLETED|Second Intervention (1 Week)||0
7524709|NCT03585790|18527757|P2|COMPLETED|Second Intervention (1 Week)||22
7524710|NCT03585790|18527758|P1|COMPLETED|Second Intervention (1 Week)||23
7524711|NCT03585790|18527757|P2|STARTED|Second Intervention (1 Week)||22
7524712|NCT03585790|18527758|P1|STARTED|Second Intervention (1 Week)||23
7524713|NCT03585790|18527757|P2|NOT COMPLETED|First Intervention (1 Week)||0
7524714|NCT03585790|18527758|P1|NOT COMPLETED|First Intervention (1 Week)||0
7524715|NCT03585790|18527757|P2|COMPLETED|First Intervention (1 Week)||22
7524716|NCT03585790|18527758|P1|COMPLETED|First Intervention (1 Week)||23
7524717|NCT03585790|18527757|P2|STARTED|First Intervention (1 Week)||22
7524718|NCT03585790|18527758|P1|STARTED|First Intervention (1 Week)||23
7524719|NCT03585543|18527765|P1|NOT COMPLETED|Overall Study||15
7524720|NCT03585543|18527765|P1|COMPLETED|Overall Study||15
7524721|NCT03585543|18527765|P1|3-month Post-intervention Follow-up (6 m|Overall Study||15
7524722|NCT03585543|18527765|P1|End-of-intervention Assessment (12 Weeks|Overall Study||22
7524723|NCT03585543|18527765|P1|Mid-intervention Assessment (6-weeks)|Overall Study||25
7524724|NCT03585543|18527765|P1|STARTED|Overall Study||30
7524725|NCT03585504|18527786|P2|NOT COMPLETED|Overall Study||29
7524726|NCT03585504|18527787|P1|NOT COMPLETED|Overall Study||26
7524727|NCT03585504|18527786|P2|COMPLETED|Overall Study||11
7524728|NCT03585504|18527787|P1|COMPLETED|Overall Study||15
7524729|NCT03585504|18527786|P2|STARTED|Overall Study||40
7524730|NCT03585504|18527787|P1|STARTED|Overall Study||41
7524731|NCT03585296|18527797|P1|NOT COMPLETED|Overall Study||5
7524732|NCT03585296|18527797|P1|COMPLETED|Overall Study||17
7524733|NCT03585296|18527797|P1|STARTED|Overall Study||22
7524734|NCT03583450|18527803|P2|NOT COMPLETED|Overall Study||0
7524735|NCT03583450|18527804|P1|NOT COMPLETED|Overall Study||1
7524736|NCT03583450|18527803|P2|COMPLETED|Overall Study||37
7524737|NCT03583450|18527804|P1|COMPLETED|Overall Study||33
7524738|NCT03583450|18527803|P2|STARTED|Overall Study||37
7524739|NCT03583450|18527804|P1|STARTED|Overall Study||34
7524740|NCT03583385|18527826|P2|NOT COMPLETED|Treatment Period 2||0
7524741|NCT03583385|18527827|P1|NOT COMPLETED|Treatment Period 2||1
7524742|NCT03583385|18527826|P2|COMPLETED|Treatment Period 2||23
7524743|NCT03583385|18527827|P1|COMPLETED|Treatment Period 2||21
7524744|NCT03583385|18527826|P2|STARTED|Treatment Period 2||23
7524745|NCT03583385|18527827|P1|STARTED|Treatment Period 2|Of 46 participants who completed period 1, 45 entered period2 & 1 participant didn't attend period2.|22
7524746|NCT03583385|18527826|P2|NOT COMPLETED|Treatment Period 1||1
7524747|NCT03583385|18527827|P1|NOT COMPLETED|Treatment Period 1||1
7524748|NCT03583385|18527826|P2|COMPLETED|Treatment Period 1||23
7524749|NCT03583385|18527827|P1|COMPLETED|Treatment Period 1||23
7524750|NCT03583385|18527826|P2|STARTED|Treatment Period 1||24
7524751|NCT03583385|18527827|P1|STARTED|Treatment Period 1||24
7524752|NCT03582943|18527845|P2|NOT COMPLETED|Analyzed||1
7524753|NCT03582943|18527846|P1|NOT COMPLETED|Analyzed||4
7524754|NCT03582943|18527845|P2|COMPLETED|Analyzed||36
7524755|NCT03582943|18527846|P1|COMPLETED|Analyzed||33
7524756|NCT03582943|18527845|P2|STARTED|Analyzed||37
7524757|NCT03582943|18527846|P1|STARTED|Analyzed||37
7524758|NCT03582943|18527845|P2|NOT COMPLETED|Intervention and Follow up||2
7524759|NCT03582943|18527846|P1|NOT COMPLETED|Intervention and Follow up||4
7524760|NCT03582943|18527845|P2|COMPLETED|Intervention and Follow up||37
7524761|NCT03582943|18527846|P1|COMPLETED|Intervention and Follow up||37
7524762|NCT03582943|18527845|P2|STARTED|Intervention and Follow up||39
7524763|NCT03582943|18527846|P1|STARTED|Intervention and Follow up||41
7524764|NCT03582943|18527845|P2|NOT COMPLETED|Allocated to Groups||1
7524765|NCT03582943|18527846|P1|NOT COMPLETED|Allocated to Groups||1
7524766|NCT03582943|18527845|P2|COMPLETED|Allocated to Groups||39
7524767|NCT03582943|18527846|P1|COMPLETED|Allocated to Groups||41
7524768|NCT03582943|18527845|P2|STARTED|Allocated to Groups||40
7524769|NCT03582943|18527846|P1|STARTED|Allocated to Groups||42
7524770|NCT03582813|18527854|P2|NOT COMPLETED|Overall Study||21
7524771|NCT03582813|18527855|P1|NOT COMPLETED|Overall Study||19
7524772|NCT03582813|18527854|P2|COMPLETED|Overall Study||81
7524773|NCT03582813|18527855|P1|COMPLETED|Overall Study||95
7524774|NCT03582813|18527854|P2|STARTED|Overall Study||102
7524775|NCT03582813|18527855|P1|STARTED|Overall Study||114
7524776|NCT03582553|18527879|P6|NOT COMPLETED|Intervention 3/Visit 3||0
7524777|NCT03582553|18527880|P5|NOT COMPLETED|Intervention 3/Visit 3||0
7524778|NCT03582553|18527881|P4|NOT COMPLETED|Intervention 3/Visit 3||0
7524779|NCT03582553|18527882|P3|NOT COMPLETED|Intervention 3/Visit 3||0
7524780|NCT03582553|18527883|P2|NOT COMPLETED|Intervention 3/Visit 3||0
7524781|NCT03582553|18527884|P1|NOT COMPLETED|Intervention 3/Visit 3||0
7524782|NCT03582553|18527879|P6|COMPLETED|Intervention 3/Visit 3||3
7524783|NCT03582553|18527880|P5|COMPLETED|Intervention 3/Visit 3||3
7524784|NCT03582553|18527881|P4|COMPLETED|Intervention 3/Visit 3||3
7524785|NCT03582553|18527882|P3|COMPLETED|Intervention 3/Visit 3||3
7524786|NCT03582553|18527883|P2|COMPLETED|Intervention 3/Visit 3||3
7524787|NCT03582553|18527884|P1|COMPLETED|Intervention 3/Visit 3||3
7524788|NCT03582553|18527879|P6|STARTED|Intervention 3/Visit 3||3
7524789|NCT03582553|18527880|P5|STARTED|Intervention 3/Visit 3||3
7524790|NCT03582553|18527881|P4|STARTED|Intervention 3/Visit 3||3
7524791|NCT03582553|18527882|P3|STARTED|Intervention 3/Visit 3||3
7524792|NCT03582553|18527883|P2|STARTED|Intervention 3/Visit 3||3
7524793|NCT03582553|18527884|P1|STARTED|Intervention 3/Visit 3||3
7524794|NCT03582553|18527879|P6|NOT COMPLETED|Washout Period (At Least 1 Week)||0
7524795|NCT03582553|18527880|P5|NOT COMPLETED|Washout Period (At Least 1 Week)||0
7524796|NCT03582553|18527881|P4|NOT COMPLETED|Washout Period (At Least 1 Week)||0
7524797|NCT03582553|18527882|P3|NOT COMPLETED|Washout Period (At Least 1 Week)||0
7524798|NCT03582553|18527883|P2|NOT COMPLETED|Washout Period (At Least 1 Week)||0
7524799|NCT03582553|18527884|P1|NOT COMPLETED|Washout Period (At Least 1 Week)||0
7524800|NCT03582553|18527879|P6|COMPLETED|Washout Period (At Least 1 Week)||3
7524801|NCT03582553|18527880|P5|COMPLETED|Washout Period (At Least 1 Week)||3
7524802|NCT03582553|18527881|P4|COMPLETED|Washout Period (At Least 1 Week)||3
7524803|NCT03582553|18527882|P3|COMPLETED|Washout Period (At Least 1 Week)||3
7524804|NCT03582553|18527883|P2|COMPLETED|Washout Period (At Least 1 Week)||3
7524805|NCT03582553|18527884|P1|COMPLETED|Washout Period (At Least 1 Week)||3
7524806|NCT03582553|18527879|P6|STARTED|Washout Period (At Least 1 Week)||3
7524807|NCT03582553|18527880|P5|STARTED|Washout Period (At Least 1 Week)||3
7524808|NCT03582553|18527881|P4|STARTED|Washout Period (At Least 1 Week)||3
7524809|NCT03582553|18527882|P3|STARTED|Washout Period (At Least 1 Week)||3
7524810|NCT03582553|18527883|P2|STARTED|Washout Period (At Least 1 Week)||3
7524811|NCT03582553|18527884|P1|STARTED|Washout Period (At Least 1 Week)||3
7524812|NCT03582553|18527879|P6|NOT COMPLETED|Intervention 2/Visit 2||0
7524813|NCT03582553|18527880|P5|NOT COMPLETED|Intervention 2/Visit 2||0
7524814|NCT03582553|18527881|P4|NOT COMPLETED|Intervention 2/Visit 2||0
7524815|NCT03582553|18527882|P3|NOT COMPLETED|Intervention 2/Visit 2||0
7524816|NCT03582553|18527883|P2|NOT COMPLETED|Intervention 2/Visit 2||0
7524817|NCT03582553|18527884|P1|NOT COMPLETED|Intervention 2/Visit 2||0
7524818|NCT03582553|18527879|P6|COMPLETED|Intervention 2/Visit 2||3
7524819|NCT03582553|18527880|P5|COMPLETED|Intervention 2/Visit 2||3
7524820|NCT03582553|18527881|P4|COMPLETED|Intervention 2/Visit 2||3
7524821|NCT03582553|18527882|P3|COMPLETED|Intervention 2/Visit 2||3
7524822|NCT03582553|18527883|P2|COMPLETED|Intervention 2/Visit 2||3
7524823|NCT03582553|18527884|P1|COMPLETED|Intervention 2/Visit 2||3
7524824|NCT03582553|18527879|P6|STARTED|Intervention 2/Visit 2||3
7524825|NCT03582553|18527880|P5|STARTED|Intervention 2/Visit 2||3
7524826|NCT03582553|18527881|P4|STARTED|Intervention 2/Visit 2||3
7524827|NCT03582553|18527882|P3|STARTED|Intervention 2/Visit 2||3
7524828|NCT03582553|18527883|P2|STARTED|Intervention 2/Visit 2||3
7524829|NCT03582553|18527884|P1|STARTED|Intervention 2/Visit 2||3
7524830|NCT03582553|18527879|P6|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
7524831|NCT03582553|18527880|P5|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
7524832|NCT03582553|18527881|P4|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
7524833|NCT03582553|18527882|P3|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
7524834|NCT03582553|18527883|P2|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
7524835|NCT03582553|18527884|P1|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
7524836|NCT03582553|18527879|P6|COMPLETED|Washout Period ( At Least 1 Week)||3
7524837|NCT03582553|18527880|P5|COMPLETED|Washout Period ( At Least 1 Week)||3
7524838|NCT03582553|18527881|P4|COMPLETED|Washout Period ( At Least 1 Week)||3
7524839|NCT03582553|18527882|P3|COMPLETED|Washout Period ( At Least 1 Week)||3
7524840|NCT03582553|18527883|P2|COMPLETED|Washout Period ( At Least 1 Week)||3
7524841|NCT03582553|18527884|P1|COMPLETED|Washout Period ( At Least 1 Week)||3
7524842|NCT03582553|18527879|P6|STARTED|Washout Period ( At Least 1 Week)||3
7524843|NCT03582553|18527880|P5|STARTED|Washout Period ( At Least 1 Week)||3
7524844|NCT03582553|18527881|P4|STARTED|Washout Period ( At Least 1 Week)||3
7524845|NCT03582553|18527882|P3|STARTED|Washout Period ( At Least 1 Week)||3
7524846|NCT03582553|18527883|P2|STARTED|Washout Period ( At Least 1 Week)||3
7524847|NCT03582553|18527884|P1|STARTED|Washout Period ( At Least 1 Week)||3
7524848|NCT03582553|18527879|P6|NOT COMPLETED|Intervention 1/Visit 1||0
7524849|NCT03582553|18527880|P5|NOT COMPLETED|Intervention 1/Visit 1||0
7524850|NCT03582553|18527881|P4|NOT COMPLETED|Intervention 1/Visit 1||0
7524851|NCT03582553|18527882|P3|NOT COMPLETED|Intervention 1/Visit 1||0
7524852|NCT03582553|18527883|P2|NOT COMPLETED|Intervention 1/Visit 1||0
7524853|NCT03582553|18527884|P1|NOT COMPLETED|Intervention 1/Visit 1||0
7524854|NCT03582553|18527879|P6|COMPLETED|Intervention 1/Visit 1||3
7524855|NCT03582553|18527880|P5|COMPLETED|Intervention 1/Visit 1||3
7524856|NCT03582553|18527881|P4|COMPLETED|Intervention 1/Visit 1||3
7524857|NCT03582553|18527882|P3|COMPLETED|Intervention 1/Visit 1||3
7524858|NCT03582553|18527883|P2|COMPLETED|Intervention 1/Visit 1||3
7524859|NCT03582553|18527884|P1|COMPLETED|Intervention 1/Visit 1||3
7524860|NCT03582553|18527879|P6|STARTED|Intervention 1/Visit 1||3
7524861|NCT03582553|18527880|P5|STARTED|Intervention 1/Visit 1||3
7524862|NCT03582553|18527881|P4|STARTED|Intervention 1/Visit 1||3
7524863|NCT03582553|18527882|P3|STARTED|Intervention 1/Visit 1||3
7524864|NCT03582553|18527883|P2|STARTED|Intervention 1/Visit 1||3
7524865|NCT03582553|18527884|P1|STARTED|Intervention 1/Visit 1||3
7524866|NCT03582215|18527922|P8|NOT COMPLETED|Overall Study||2
7524867|NCT03582215|18527923|P7|NOT COMPLETED|Overall Study||2
7524868|NCT03582215|18527924|P6|NOT COMPLETED|Overall Study||0
7524869|NCT03582215|18527925|P5|NOT COMPLETED|Overall Study||0
7524870|NCT03582215|18527926|P4|NOT COMPLETED|Overall Study||0
7524871|NCT03582215|18527927|P3|NOT COMPLETED|Overall Study||0
7524872|NCT03582215|18527928|P2|NOT COMPLETED|Overall Study||0
7524873|NCT03582215|18527929|P1|NOT COMPLETED|Overall Study||1
7524874|NCT03582215|18527922|P8|COMPLETED|Overall Study||10
7524875|NCT03582215|18527923|P7|COMPLETED|Overall Study||10
7524876|NCT03582215|18527924|P6|COMPLETED|Overall Study||12
7524877|NCT03582215|18527925|P5|COMPLETED|Overall Study||12
7524878|NCT03582215|18527926|P4|COMPLETED|Overall Study||6
7524879|NCT03582215|18527927|P3|COMPLETED|Overall Study||6
7524880|NCT03582215|18527928|P2|COMPLETED|Overall Study||6
7524881|NCT03582215|18527929|P1|COMPLETED|Overall Study||5
7524882|NCT03582215|18527922|P8|STARTED|Overall Study||12
7524883|NCT03582215|18527923|P7|STARTED|Overall Study||12
7524884|NCT03582215|18527924|P6|STARTED|Overall Study||12
7524885|NCT03582215|18527925|P5|STARTED|Overall Study||12
7524886|NCT03582215|18527926|P4|STARTED|Overall Study||6
7524887|NCT03582215|18527927|P3|STARTED|Overall Study||6
7524888|NCT03582215|18527928|P2|STARTED|Overall Study||6
7524889|NCT03582215|18527929|P1|STARTED|Overall Study||6
7524890|NCT03581825|18527970|P2|NOT COMPLETED|Period 2||1
7524891|NCT03581825|18527971|P1|NOT COMPLETED|Period 2||0
7524892|NCT03581825|18527970|P2|COMPLETED|Period 2||30
7524893|NCT03581825|18527971|P1|COMPLETED|Period 2||30
7524894|NCT03581825|18527970|P2|STARTED|Period 2||31
7524895|NCT03581825|18527971|P1|STARTED|Period 2||30
7524896|NCT03581825|18527970|P2|NOT COMPLETED|Period 1||0
7524897|NCT03581825|18527971|P1|NOT COMPLETED|Period 1||1
7524898|NCT03581825|18527970|P2|COMPLETED|Period 1||31
7524899|NCT03581825|18527971|P1|COMPLETED|Period 1||30
7524900|NCT03581825|18527970|P2|STARTED|Period 1||31
7524901|NCT03581825|18527971|P1|STARTED|Period 1||31
7524902|NCT03581474|18527978|P1|NOT COMPLETED|Overall Study||0
7524903|NCT03581474|18527978|P1|COMPLETED|Overall Study||12
7524904|NCT03581474|18527978|P1|STARTED|Overall Study||12
7524905|NCT03581097|18527984|P2|NOT COMPLETED|Overall Study||0
7524906|NCT03581097|18527985|P1|NOT COMPLETED|Overall Study||0
7524907|NCT03581097|18527984|P2|COMPLETED|Overall Study||47
7524908|NCT03581097|18527985|P1|COMPLETED|Overall Study||46
7524909|NCT03581097|18527984|P2|STARTED|Overall Study||47
7524910|NCT03581097|18527985|P1|STARTED|Overall Study||46
7524911|NCT03580382|18528007|P2|NOT COMPLETED|Overall Study||3
7524912|NCT03580382|18528008|P1|NOT COMPLETED|Overall Study||0
7524913|NCT03580382|18528007|P2|COMPLETED|Overall Study||0
7524914|NCT03580382|18528008|P1|COMPLETED|Overall Study||0
7524915|NCT03580382|18528007|P2|STARTED|Overall Study||3
7524916|NCT03580382|18528008|P1|STARTED|Overall Study||0
7524917|NCT03579940|18528026|P11|NOT COMPLETED|Period 3||0
7524918|NCT03579940|18528027|P10|NOT COMPLETED|Period 3||0
7524919|NCT03579940|18528028|P9|NOT COMPLETED|Period 3||0
7524920|NCT03579940|18528029|P8|NOT COMPLETED|Period 3||0
7524921|NCT03579940|18528030|P7|NOT COMPLETED|Period 3||0
7524922|NCT03579940|18528031|P6|NOT COMPLETED|Period 3||0
7524923|NCT03579940|18528032|P5|NOT COMPLETED|Period 3||0
7524924|NCT03579940|18528033|P4|NOT COMPLETED|Period 3||0
7524925|NCT03579940|18528034|P3|NOT COMPLETED|Period 3||0
7524926|NCT03579940|18528035|P2|NOT COMPLETED|Period 3||0
7524927|NCT03579940|18528036|P1|NOT COMPLETED|Period 3||0
7524928|NCT03579940|18528026|P11|COMPLETED|Period 3||3
7524929|NCT03579940|18528027|P10|COMPLETED|Period 3||2
7524930|NCT03579940|18528028|P9|COMPLETED|Period 3||3
7524931|NCT03579940|18528029|P8|COMPLETED|Period 3||3
7524932|NCT03579940|18528030|P7|COMPLETED|Period 3||3
7524933|NCT03579940|18528031|P6|COMPLETED|Period 3||2
7524934|NCT03579940|18528032|P5|COMPLETED|Period 3||2
7524935|NCT03579940|18528033|P4|COMPLETED|Period 3||2
7524936|NCT03579940|18528034|P3|COMPLETED|Period 3||1
7524937|NCT03579940|18528035|P2|COMPLETED|Period 3||2
7524938|NCT03579940|18528036|P1|COMPLETED|Period 3||3
7524939|NCT03579940|18528026|P11|STARTED|Period 3||3
7524940|NCT03579940|18528027|P10|STARTED|Period 3||2
7524941|NCT03579940|18528028|P9|STARTED|Period 3||3
7524942|NCT03579940|18528029|P8|STARTED|Period 3||3
7524943|NCT03579940|18528030|P7|STARTED|Period 3||3
7524944|NCT03579940|18528031|P6|STARTED|Period 3||2
7524945|NCT03579940|18528032|P5|STARTED|Period 3||2
7524946|NCT03579940|18528033|P4|STARTED|Period 3||2
7524947|NCT03579940|18528034|P3|STARTED|Period 3||1
7524948|NCT03579940|18528035|P2|STARTED|Period 3||2
7524949|NCT03579940|18528036|P1|STARTED|Period 3||3
7524950|NCT03579940|18528026|P11|NOT COMPLETED|Period 2||0
7524951|NCT03579940|18528027|P10|NOT COMPLETED|Period 2||0
7524952|NCT03579940|18528028|P9|NOT COMPLETED|Period 2||0
7524953|NCT03579940|18528029|P8|NOT COMPLETED|Period 2||0
7524954|NCT03579940|18528030|P7|NOT COMPLETED|Period 2||0
7524955|NCT03579940|18528031|P6|NOT COMPLETED|Period 2||0
7524956|NCT03579940|18528032|P5|NOT COMPLETED|Period 2||0
7524957|NCT03579940|18528033|P4|NOT COMPLETED|Period 2||0
7524958|NCT03579940|18528034|P3|NOT COMPLETED|Period 2||1
7524959|NCT03579940|18528035|P2|NOT COMPLETED|Period 2||0
7524960|NCT03579940|18528036|P1|NOT COMPLETED|Period 2||0
7524961|NCT03579940|18528026|P11|COMPLETED|Period 2||3
7524962|NCT03579940|18528027|P10|COMPLETED|Period 2||2
7524963|NCT03579940|18528028|P9|COMPLETED|Period 2||3
7524964|NCT03579940|18528029|P8|COMPLETED|Period 2||3
7524965|NCT03579940|18528030|P7|COMPLETED|Period 2||3
7524966|NCT03579940|18528031|P6|COMPLETED|Period 2||2
7524967|NCT03579940|18528032|P5|COMPLETED|Period 2||2
7524968|NCT03579940|18528033|P4|COMPLETED|Period 2||2
7524969|NCT03579940|18528034|P3|COMPLETED|Period 2||1
7524970|NCT03579940|18528035|P2|COMPLETED|Period 2||2
7524971|NCT03579940|18528036|P1|COMPLETED|Period 2||3
7524972|NCT03579940|18528026|P11|STARTED|Period 2||3
7524973|NCT03579940|18528027|P10|STARTED|Period 2||2
7524974|NCT03579940|18528028|P9|STARTED|Period 2||3
7524975|NCT03579940|18528029|P8|STARTED|Period 2||3
7524976|NCT03579940|18528030|P7|STARTED|Period 2||3
7524977|NCT03579940|18528031|P6|STARTED|Period 2||2
7524978|NCT03579940|18528032|P5|STARTED|Period 2||2
7524979|NCT03579940|18528033|P4|STARTED|Period 2||2
7524980|NCT03579940|18528034|P3|STARTED|Period 2||2
7524981|NCT03579940|18528035|P2|STARTED|Period 2||2
7524982|NCT03579940|18528036|P1|STARTED|Period 2||3
7524983|NCT03579940|18528026|P11|NOT COMPLETED|Period 1||0
7524984|NCT03579940|18528027|P10|NOT COMPLETED|Period 1||0
7524985|NCT03579940|18528028|P9|NOT COMPLETED|Period 1||0
7524986|NCT03579940|18528029|P8|NOT COMPLETED|Period 1||0
7524987|NCT03579940|18528030|P7|NOT COMPLETED|Period 1||0
7524988|NCT03579940|18528031|P6|NOT COMPLETED|Period 1||0
7524989|NCT03579940|18528032|P5|NOT COMPLETED|Period 1||0
7524990|NCT03579940|18528033|P4|NOT COMPLETED|Period 1||0
7524991|NCT03579940|18528034|P3|NOT COMPLETED|Period 1||0
7524992|NCT03579940|18528035|P2|NOT COMPLETED|Period 1||0
7524993|NCT03579940|18528036|P1|NOT COMPLETED|Period 1||0
7524994|NCT03579940|18528026|P11|COMPLETED|Period 1||3
7524995|NCT03579940|18528027|P10|COMPLETED|Period 1||2
7524996|NCT03579940|18528028|P9|COMPLETED|Period 1||3
7524997|NCT03579940|18528029|P8|COMPLETED|Period 1||3
7524998|NCT03579940|18528030|P7|COMPLETED|Period 1||3
7524999|NCT03579940|18528031|P6|COMPLETED|Period 1||2
7525000|NCT03579940|18528032|P5|COMPLETED|Period 1||2
7525001|NCT03579940|18528033|P4|COMPLETED|Period 1||2
7525002|NCT03579940|18528034|P3|COMPLETED|Period 1||2
7525003|NCT03579940|18528035|P2|COMPLETED|Period 1||2
7525004|NCT03579940|18528036|P1|COMPLETED|Period 1||3
7525005|NCT03579940|18528026|P11|Received at Least 1 Dose of Study Drug|Period 1||3
7525006|NCT03579940|18528027|P10|Received at Least 1 Dose of Study Drug|Period 1||2
7525007|NCT03579940|18528028|P9|Received at Least 1 Dose of Study Drug|Period 1||3
7525008|NCT03579940|18528029|P8|Received at Least 1 Dose of Study Drug|Period 1||3
7525009|NCT03579940|18528030|P7|Received at Least 1 Dose of Study Drug|Period 1||3
7525010|NCT03579940|18528031|P6|Received at Least 1 Dose of Study Drug|Period 1||2
7525011|NCT03579940|18528032|P5|Received at Least 1 Dose of Study Drug|Period 1||2
7525012|NCT03579940|18528033|P4|Received at Least 1 Dose of Study Drug|Period 1||2
7525013|NCT03579940|18528034|P3|Received at Least 1 Dose of Study Drug|Period 1||2
7525014|NCT03579940|18528035|P2|Received at Least 1 Dose of Study Drug|Period 1||2
7525015|NCT03579940|18528036|P1|Received at Least 1 Dose of Study Drug|Period 1||3
7525016|NCT03579940|18528026|P11|STARTED|Period 1||3
7525017|NCT03579940|18528027|P10|STARTED|Period 1||2
7525018|NCT03579940|18528028|P9|STARTED|Period 1||3
7525019|NCT03579940|18528029|P8|STARTED|Period 1||3
7525020|NCT03579940|18528030|P7|STARTED|Period 1||3
7525021|NCT03579940|18528031|P6|STARTED|Period 1||2
7525022|NCT03579940|18528032|P5|STARTED|Period 1||2
7525023|NCT03579940|18528033|P4|STARTED|Period 1||2
7525024|NCT03579940|18528034|P3|STARTED|Period 1||2
7525025|NCT03579940|18528035|P2|STARTED|Period 1||2
7525026|NCT03579940|18528036|P1|STARTED|Period 1||3
7525027|NCT03579719|18528076|P1|NOT COMPLETED|Overall Study||1
7525028|NCT03579719|18528076|P1|COMPLETED|Overall Study||14
7525029|NCT03579719|18528076|P1|STARTED|Overall Study||15
7525030|NCT03579433|18528093|P1|NOT COMPLETED|Overall Study||6
7525031|NCT03579433|18528093|P1|COMPLETED|Overall Study||98
7525032|NCT03579433|18528093|P1|Barrett Calculator|Overall Study||102
7525033|NCT03579433|18528093|P1|ORA With VerifEye+|Overall Study||96
7525034|NCT03579433|18528093|P1|STARTED|Overall Study||104
7525035|NCT03578926|18528101|P2|NOT COMPLETED|Second Intervention||0
7525036|NCT03578926|18528102|P1|NOT COMPLETED|Second Intervention||0
7525037|NCT03578926|18528101|P2|COMPLETED|Second Intervention||21
7525038|NCT03578926|18528102|P1|COMPLETED|Second Intervention||23
7525039|NCT03578926|18528101|P2|STARTED|Second Intervention||21
7525040|NCT03578926|18528102|P1|STARTED|Second Intervention||23
7525041|NCT03578926|18528101|P2|NOT COMPLETED|First Intervention||0
7525042|NCT03578926|18528102|P1|NOT COMPLETED|First Intervention||0
7525043|NCT03578926|18528101|P2|COMPLETED|First Intervention||23
7525044|NCT03578926|18528102|P1|COMPLETED|First Intervention||21
7525045|NCT03578926|18528101|P2|STARTED|First Intervention||23
7525046|NCT03578926|18528102|P1|STARTED|First Intervention||21
7525047|NCT03578549|18528122|P1|NOT COMPLETED|Overall Study||1
7525048|NCT03578549|18528122|P1|COMPLETED|Overall Study||29
7525049|NCT03578549|18528122|P1|STARTED|Overall Study||30
7525050|NCT03578146|18528133|P6|NOT COMPLETED|Overall Study||3
7525051|NCT03578146|18528134|P5|NOT COMPLETED|Overall Study||0
7525052|NCT03578146|18528135|P4|NOT COMPLETED|Overall Study||0
7525053|NCT03578146|18528136|P3|NOT COMPLETED|Overall Study||1
7525054|NCT03578146|18528137|P2|NOT COMPLETED|Overall Study||1
7525055|NCT03578146|18528138|P1|NOT COMPLETED|Overall Study||1
7525056|NCT03578146|18528133|P6|COMPLETED|Overall Study||5
7525057|NCT03578146|18528134|P5|COMPLETED|Overall Study||6
7525058|NCT03578146|18528135|P4|COMPLETED|Overall Study||6
7525059|NCT03578146|18528136|P3|COMPLETED|Overall Study||5
7525060|NCT03578146|18528137|P2|COMPLETED|Overall Study||5
7525061|NCT03578146|18528138|P1|COMPLETED|Overall Study||15
7525062|NCT03578146|18528133|P6|STARTED|Overall Study||8
7525063|NCT03578146|18528134|P5|STARTED|Overall Study||6
7525064|NCT03578146|18528135|P4|STARTED|Overall Study||6
7525065|NCT03578146|18528136|P3|STARTED|Overall Study||6
7525066|NCT03578146|18528137|P2|STARTED|Overall Study||6
7525067|NCT03578146|18528138|P1|STARTED|Overall Study||16
7525068|NCT03577275|18528200|P1|NOT COMPLETED|Overall Study||0
7525069|NCT03577275|18528200|P1|COMPLETED|Overall Study||32
7525070|NCT03577275|18528200|P1|NST-4016 2000mg|Overall Study||32
7525071|NCT03577275|18528200|P1|NST-4016 600mg|Overall Study||32
7525072|NCT03577275|18528200|P1|Moxifloxacin 400mg|Overall Study||32
7525073|NCT03577275|18528200|P1|Placebo|Overall Study||32
7525074|NCT03577275|18528200|P1|STARTED|Overall Study|All participants received all of the 4 interventions|32
7525075|NCT03576118|18528228|P2|NOT COMPLETED|Overall Study||4
7525076|NCT03576118|18528229|P1|NOT COMPLETED|Overall Study||3
7525077|NCT03576118|18528228|P2|COMPLETED|Overall Study||33
7525078|NCT03576118|18528229|P1|COMPLETED|Overall Study||34
7525079|NCT03576118|18528228|P2|STARTED|Overall Study||37
7525080|NCT03576118|18528229|P1|STARTED|Overall Study||37
7525081|NCT03575962|18528235|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7525082|NCT03575962|18528236|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7525083|NCT03575962|18528235|P2|COMPLETED|Treatment Period 2 (4 Days)||7
7525084|NCT03575962|18528236|P1|COMPLETED|Treatment Period 2 (4 Days)||7
7525085|NCT03575962|18528235|P2|STARTED|Treatment Period 2 (4 Days)||7
7525086|NCT03575962|18528236|P1|STARTED|Treatment Period 2 (4 Days)||7
7525087|NCT03575962|18528235|P2|NOT COMPLETED|Washout Period (7 Days)||0
7525088|NCT03575962|18528236|P1|NOT COMPLETED|Washout Period (7 Days)||0
7525089|NCT03575962|18528235|P2|COMPLETED|Washout Period (7 Days)||7
7525090|NCT03575962|18528236|P1|COMPLETED|Washout Period (7 Days)||7
7525091|NCT03575962|18528235|P2|STARTED|Washout Period (7 Days)||7
7525092|NCT03575962|18528236|P1|STARTED|Washout Period (7 Days)||7
7525093|NCT03575962|18528235|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
7525094|NCT03575962|18528236|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
7525095|NCT03575962|18528235|P2|COMPLETED|Treatment Period 1 (4 Days)||7
7525096|NCT03575962|18528236|P1|COMPLETED|Treatment Period 1 (4 Days)||7
7525097|NCT03575962|18528235|P2|STARTED|Treatment Period 1 (4 Days)||7
7525098|NCT03575962|18528236|P1|STARTED|Treatment Period 1 (4 Days)||7
7525099|NCT03575871|18528279|P3|NOT COMPLETED|Overall Study||26
7525100|NCT03575871|18528280|P2|NOT COMPLETED|Overall Study||14
7525101|NCT03575871|18528281|P1|NOT COMPLETED|Overall Study||21
7525102|NCT03575871|18528279|P3|COMPLETED|Overall Study||52
7525103|NCT03575871|18528280|P2|COMPLETED|Overall Study||141
7525104|NCT03575871|18528281|P1|COMPLETED|Overall Study||137
7525105|NCT03575871|18528279|P3|STARTED|Overall Study||78
7525106|NCT03575871|18528280|P2|STARTED|Overall Study||155
7525107|NCT03575871|18528281|P1|STARTED|Overall Study||158
7525108|NCT03575806|18528345|P2|NOT COMPLETED|Overall Study||4
7525109|NCT03575806|18528346|P1|NOT COMPLETED|Overall Study||0
7525110|NCT03575806|18528345|P2|COMPLETED|Overall Study||23
7525111|NCT03575806|18528346|P1|COMPLETED|Overall Study||25
7525112|NCT03575806|18528345|P2|STARTED|Overall Study||27
7525113|NCT03575806|18528346|P1|STARTED|Overall Study||25
7525114|NCT03575702|18528356|P2|NOT COMPLETED|Overall Study||4
7525115|NCT03575702|18528357|P1|NOT COMPLETED|Overall Study||6
7525116|NCT03575702|18528356|P2|COMPLETED|Overall Study||146
7525117|NCT03575702|18528357|P1|COMPLETED|Overall Study||143
7525118|NCT03575702|18528356|P2|STARTED|Overall Study||150
7525119|NCT03575702|18528357|P1|STARTED|Overall Study||149
7525120|NCT03574818|18528391|P1|NOT COMPLETED|Overall Study||0
7525121|NCT03574818|18528391|P1|COMPLETED|Overall Study||1
7525122|NCT03574818|18528391|P1|STARTED|Overall Study||1
7525123|NCT03574441|18528398|P3|NOT COMPLETED|Overall Study||0
7525124|NCT03574441|18528399|P2|NOT COMPLETED|Overall Study||0
7525125|NCT03574441|18528400|P1|NOT COMPLETED|Overall Study||0
7525126|NCT03574441|18528398|P3|COMPLETED|Overall Study||30
7525127|NCT03574441|18528399|P2|COMPLETED|Overall Study||30
7525128|NCT03574441|18528400|P1|COMPLETED|Overall Study||31
7525129|NCT03574441|18528398|P3|STARTED|Overall Study||30
7525130|NCT03574441|18528399|P2|STARTED|Overall Study||30
7525131|NCT03574441|18528400|P1|STARTED|Overall Study||31
7525132|NCT03573908|18528413|P5|NOT COMPLETED|Randomized Withdrawal Period||2
7525133|NCT03573908|18528414|P4|NOT COMPLETED|Randomized Withdrawal Period||2
7525134|NCT03573908|18528415|P3|NOT COMPLETED|Randomized Withdrawal Period||8
7525135|NCT03573908|18528416|P2|NOT COMPLETED|Randomized Withdrawal Period||0
7525136|NCT03573908|18528417|P1|NOT COMPLETED|Randomized Withdrawal Period||0
7525137|NCT03573908|18528413|P5|COMPLETED|Randomized Withdrawal Period||137
7525138|NCT03573908|18528414|P4|COMPLETED|Randomized Withdrawal Period||136
7525139|NCT03573908|18528415|P3|COMPLETED|Randomized Withdrawal Period||272
7525140|NCT03573908|18528416|P2|COMPLETED|Randomized Withdrawal Period||0
7525141|NCT03573908|18528417|P1|COMPLETED|Randomized Withdrawal Period||0
7525142|NCT03573908|18528413|P5|STARTED|Randomized Withdrawal Period||139
7525143|NCT03573908|18528414|P4|STARTED|Randomized Withdrawal Period||138
7525144|NCT03573908|18528415|P3|STARTED|Randomized Withdrawal Period||280
7525145|NCT03573908|18528416|P2|STARTED|Randomized Withdrawal Period||0
7525146|NCT03573908|18528417|P1|STARTED|Randomized Withdrawal Period||0
7525147|NCT03573908|18528413|P5|NOT COMPLETED|Treatment Period||0
7525148|NCT03573908|18528414|P4|NOT COMPLETED|Treatment Period||0
7525149|NCT03573908|18528415|P3|NOT COMPLETED|Treatment Period||0
7525150|NCT03573908|18528416|P2|NOT COMPLETED|Treatment Period||26
7525151|NCT03573908|18528417|P1|NOT COMPLETED|Treatment Period||24
7525152|NCT03573908|18528413|P5|COMPLETED|Treatment Period||0
7525153|NCT03573908|18528414|P4|COMPLETED|Treatment Period||0
7525154|NCT03573908|18528415|P3|COMPLETED|Treatment Period||0
7525155|NCT03573908|18528416|P2|COMPLETED|Treatment Period||280
7525156|NCT03573908|18528417|P1|COMPLETED|Treatment Period||284
7525157|NCT03573908|18528413|P5|STARTED|Treatment Period||0
7525158|NCT03573908|18528414|P4|STARTED|Treatment Period||0
7525159|NCT03573908|18528415|P3|STARTED|Treatment Period||0
7525160|NCT03573908|18528416|P2|STARTED|Treatment Period||306
7525161|NCT03573908|18528417|P1|STARTED|Treatment Period||308
7525162|NCT03573830|18528434|P2|NOT COMPLETED|Overall Study||7
7525163|NCT03573830|18528435|P1|NOT COMPLETED|Overall Study||4
7525164|NCT03573830|18528434|P2|COMPLETED|Overall Study||360
7525165|NCT03573830|18528435|P1|COMPLETED|Overall Study||360
7525166|NCT03573830|18528434|P2|Reviewed Assigned Material|Overall Study|360 reviewed their assigned material:Transport Canada information plus the enhanced material.|360
7525167|NCT03573830|18528435|P1|Reviewed Assigned Material|Overall Study|All participants assigned to this arm reviewed their assigned material.|364
7525168|NCT03573830|18528434|P2|STARTED|Overall Study||367
7525169|NCT03573830|18528435|P1|STARTED|Overall Study||364
7525170|NCT03573817|18528458|P2|NOT COMPLETED|Overall Study||4
7525171|NCT03573817|18528459|P1|NOT COMPLETED|Overall Study||1
7525172|NCT03573817|18528458|P2|COMPLETED|Overall Study||55
7525173|NCT03573817|18528459|P1|COMPLETED|Overall Study||62
7525174|NCT03573817|18528458|P2|Randomized and Treated With Study Drug|Overall Study||59
7525175|NCT03573817|18528459|P1|Randomized and Treated With Study Drug|Overall Study||63
7525176|NCT03573817|18528458|P2|STARTED|Overall Study||59
7525177|NCT03573817|18528459|P1|STARTED|Overall Study||63
7525178|NCT03573505|18528487|P2|NOT COMPLETED|Overall Study||54
7525179|NCT03573505|18528488|P1|NOT COMPLETED|Overall Study||52
7525180|NCT03573505|18528487|P2|COMPLETED|Overall Study||0
7525181|NCT03573505|18528488|P1|COMPLETED|Overall Study||0
7525182|NCT03573505|18528487|P2|STARTED|Overall Study||54
7525183|NCT03573505|18528488|P1|STARTED|Overall Study||52
7525184|NCT03573323|18528533|P2|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||57
7525185|NCT03573323|18528534|P1|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||59
7525186|NCT03573323|18528533|P2|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||399
7525187|NCT03573323|18528534|P1|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||406
7525188|NCT03573323|18528533|P2|STARTED|Post-Treatment Follow Up (Weeks 25-36)|Excludes participants who completed treatment and did not enter the PTFU.|456
7525189|NCT03573323|18528534|P1|STARTED|Post-Treatment Follow Up (Weeks 25-36)||465
7525190|NCT03573323|18528533|P2|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||48
7525191|NCT03573323|18528534|P1|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||55
7525192|NCT03573323|18528533|P2|COMPLETED|Blinded Treatment Period (Weeks 0-24)||459
7525193|NCT03573323|18528534|P1|COMPLETED|Blinded Treatment Period (Weeks 0-24)||465
7525194|NCT03573323|18528533|P2|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||506
7525195|NCT03573323|18528534|P1|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||519
7525196|NCT03573323|18528533|P2|STARTED|Blinded Treatment Period (Weeks 0-24)||507
7525197|NCT03573323|18528534|P1|STARTED|Blinded Treatment Period (Weeks 0-24)||520
7525198|NCT03573206|18528558|P1|NOT COMPLETED|Overall Study||0
7525199|NCT03573206|18528558|P1|COMPLETED|Overall Study||168
7525200|NCT03573206|18528558|P1|STARTED|Overall Study||168
7525201|NCT03572972|18528573|P5|NOT COMPLETED|Overall Study||0
7525202|NCT03572972|18528574|P4|NOT COMPLETED|Overall Study||0
7525203|NCT03572972|18528575|P3|NOT COMPLETED|Overall Study||0
7525204|NCT03572972|18528576|P2|NOT COMPLETED|Overall Study||0
7525205|NCT03572972|18528577|P1|NOT COMPLETED|Overall Study||0
7525206|NCT03572972|18528573|P5|COMPLETED|Overall Study||16295
7525207|NCT03572972|18528574|P4|COMPLETED|Overall Study||8648
7525208|NCT03572972|18528575|P3|COMPLETED|Overall Study||17779
7525209|NCT03572972|18528576|P2|COMPLETED|Overall Study||11414
7525210|NCT03572972|18528577|P1|COMPLETED|Overall Study||10548
7525211|NCT03572972|18528573|P5|STARTED|Overall Study||16295
7525212|NCT03572972|18528574|P4|STARTED|Overall Study||8648
7525213|NCT03572972|18528575|P3|STARTED|Overall Study||17779
7525214|NCT03572972|18528576|P2|STARTED|Overall Study||11414
7525215|NCT03572972|18528577|P1|STARTED|Overall Study||10548
7525216|NCT03572218|18528682|P2|NOT COMPLETED|Overall Study||5
7525217|NCT03572218|18528683|P1|NOT COMPLETED|Overall Study||6
7525218|NCT03572218|18528682|P2|COMPLETED|Overall Study||31
7525219|NCT03572218|18528683|P1|COMPLETED|Overall Study||30
7525220|NCT03572218|18528682|P2|Week 26|Overall Study||31
7525221|NCT03572218|18528683|P1|Week 26|Overall Study||30
7525222|NCT03572218|18528682|P2|Week 12|Overall Study||31
7525223|NCT03572218|18528683|P1|Week 12|Overall Study||30
7525224|NCT03572218|18528682|P2|STARTED|Overall Study||36
7525225|NCT03572218|18528683|P1|STARTED|Overall Study||36
7525226|NCT03571724|18528801|P4|NOT COMPLETED|Week 1-6||0
7525227|NCT03571724|18528802|P3|NOT COMPLETED|Week 1-6||3
7525228|NCT03571724|18528803|P2|NOT COMPLETED|Week 1-6||8
7525229|NCT03571724|18528804|P1|NOT COMPLETED|Week 1-6||7
7525230|NCT03571724|18528801|P4|COMPLETED|Week 1-6||20
7525231|NCT03571724|18528802|P3|COMPLETED|Week 1-6||19
7525232|NCT03571724|18528803|P2|COMPLETED|Week 1-6||42
7525233|NCT03571724|18528804|P1|COMPLETED|Week 1-6||43
7525234|NCT03571724|18528801|P4|STARTED|Week 1-6||20
7525235|NCT03571724|18528802|P3|STARTED|Week 1-6||22
7525236|NCT03571724|18528803|P2|STARTED|Week 1-6|Menthol VLN subjects were assigned to this arm after randomization at week 1|50
7525237|NCT03571724|18528804|P1|STARTED|Week 1-6|Non-menthol VLN subjects were assigned to this arm after randomization at week 1|50
7525238|NCT03571724|18528801|P4|NOT COMPLETED|Week -1 (Prior to Switching)||0
7525239|NCT03571724|18528802|P3|NOT COMPLETED|Week -1 (Prior to Switching)||0
7525240|NCT03571724|18528803|P2|NOT COMPLETED|Week -1 (Prior to Switching)||0
7525241|NCT03571724|18528804|P1|NOT COMPLETED|Week -1 (Prior to Switching)||0
7525242|NCT03571724|18528801|P4|COMPLETED|Week -1 (Prior to Switching)||70
7525243|NCT03571724|18528802|P3|COMPLETED|Week -1 (Prior to Switching)||72
7525244|NCT03571724|18528803|P2|COMPLETED|Week -1 (Prior to Switching)||0
7525245|NCT03571724|18528804|P1|COMPLETED|Week -1 (Prior to Switching)||0
7525246|NCT03571724|18528801|P4|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
7525247|NCT03571724|18528802|P3|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
7525248|NCT03571724|18528803|P2|PK Nicotine|Week -1 (Prior to Switching)||0
7525249|NCT03571724|18528804|P1|PK Nicotine|Week -1 (Prior to Switching)||0
7525250|NCT03571724|18528801|P4|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
7525251|NCT03571724|18528802|P3|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
7525252|NCT03571724|18528803|P2|Topography|Week -1 (Prior to Switching)||0
7525253|NCT03571724|18528804|P1|Topography|Week -1 (Prior to Switching)||0
7525254|NCT03571724|18528801|P4|STARTED|Week -1 (Prior to Switching)||70
7525255|NCT03571724|18528802|P3|STARTED|Week -1 (Prior to Switching)||72
7525256|NCT03571724|18528803|P2|STARTED|Week -1 (Prior to Switching)||0
7525257|NCT03571724|18528804|P1|STARTED|Week -1 (Prior to Switching)||0
7525258|NCT03571672|18528913|P1|NOT COMPLETED|Overall Study||5
7525259|NCT03571672|18528913|P1|COMPLETED|Overall Study||148
7525260|NCT03571672|18528913|P1|STARTED|Overall Study||153
7525261|NCT03571607|18528936|P2|NOT COMPLETED|Overall Study||0
7525262|NCT03571607|18528937|P1|NOT COMPLETED|Overall Study||0
7525263|NCT03571607|18528936|P2|COMPLETED|Overall Study||153
7525264|NCT03571607|18528937|P1|COMPLETED|Overall Study||53
7525265|NCT03571607|18528936|P2|Vaccinated|Overall Study||153
7525266|NCT03571607|18528937|P1|Vaccinated|Overall Study||53
7525267|NCT03571607|18528936|P2|STARTED|Overall Study||153
7525268|NCT03571607|18528937|P1|STARTED|Overall Study||53
7525269|NCT03571256|18528954|P3|NOT COMPLETED|Overall Study||4
7525270|NCT03571256|18528955|P2|NOT COMPLETED|Overall Study||3
7525271|NCT03571256|18528956|P1|NOT COMPLETED|Overall Study||6
7525272|NCT03571256|18528954|P3|COMPLETED|Overall Study||48
7525273|NCT03571256|18528955|P2|COMPLETED|Overall Study||51
7525274|NCT03571256|18528956|P1|COMPLETED|Overall Study||46
7525275|NCT03571256|18528954|P3|Modified ITT (mITT) Analysis Set|Overall Study||51
7525276|NCT03571256|18528955|P2|Modified ITT (mITT) Analysis Set|Overall Study||53
7525277|NCT03571256|18528956|P1|Modified ITT (mITT) Analysis Set|Overall Study||49
7525278|NCT03571256|18528954|P3|Safety Analysis Set|Overall Study||51
7525279|NCT03571256|18528955|P2|Safety Analysis Set|Overall Study||54
7525280|NCT03571256|18528956|P1|Safety Analysis Set|Overall Study||52
7525281|NCT03571256|18528954|P3|STARTED|Overall Study||52
7525282|NCT03571256|18528955|P2|STARTED|Overall Study||54
7525283|NCT03571256|18528956|P1|STARTED|Overall Study||52
7525284|NCT03570658|18528987|P4|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
7525285|NCT03570658|18528988|P3|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
7525286|NCT03570658|18528989|P2|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
7525287|NCT03570658|18528990|P1|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
7525288|NCT03570658|18528987|P4|COMPLETED|Multiple Ascending Dose (MAD)||10
7525289|NCT03570658|18528988|P3|COMPLETED|Multiple Ascending Dose (MAD)||10
7525290|NCT03570658|18528989|P2|COMPLETED|Multiple Ascending Dose (MAD)||0
7525291|NCT03570658|18528990|P1|COMPLETED|Multiple Ascending Dose (MAD)||4
7525292|NCT03570658|18528987|P4|STARTED|Multiple Ascending Dose (MAD)||10
7525293|NCT03570658|18528988|P3|STARTED|Multiple Ascending Dose (MAD)||10
7525294|NCT03570658|18528989|P2|STARTED|Multiple Ascending Dose (MAD)||0
7525295|NCT03570658|18528990|P1|STARTED|Multiple Ascending Dose (MAD)||4
7525296|NCT03570658|18528987|P4|NOT COMPLETED|Single Ascending Dose (SAD)||0
7525297|NCT03570658|18528988|P3|NOT COMPLETED|Single Ascending Dose (SAD)||0
7525298|NCT03570658|18528989|P2|NOT COMPLETED|Single Ascending Dose (SAD)||0
7525299|NCT03570658|18528990|P1|NOT COMPLETED|Single Ascending Dose (SAD)||0
7525300|NCT03570658|18528987|P4|COMPLETED|Single Ascending Dose (SAD)||10
7525301|NCT03570658|18528988|P3|COMPLETED|Single Ascending Dose (SAD)||10
7525302|NCT03570658|18528989|P2|COMPLETED|Single Ascending Dose (SAD)||2
7525303|NCT03570658|18528990|P1|COMPLETED|Single Ascending Dose (SAD)||6
7525304|NCT03570658|18528987|P4|STARTED|Single Ascending Dose (SAD)||10
7525305|NCT03570658|18528988|P3|STARTED|Single Ascending Dose (SAD)||10
7525306|NCT03570658|18528989|P2|STARTED|Single Ascending Dose (SAD)||2
7525307|NCT03570658|18528990|P1|STARTED|Single Ascending Dose (SAD)||6
7525308|NCT03570554|18529044|P4|NOT COMPLETED|Overall Study||1
7525309|NCT03570554|18529045|P3|NOT COMPLETED|Overall Study||1
7525310|NCT03570554|18529046|P2|NOT COMPLETED|Overall Study||0
7525311|NCT03570554|18529047|P1|NOT COMPLETED|Overall Study||0
7525312|NCT03570554|18529044|P4|COMPLETED|Overall Study||9
7525313|NCT03570554|18529045|P3|COMPLETED|Overall Study||10
7525314|NCT03570554|18529046|P2|COMPLETED|Overall Study||10
7525315|NCT03570554|18529047|P1|COMPLETED|Overall Study||10
7525316|NCT03570554|18529044|P4|STARTED|Overall Study||10
7525317|NCT03570554|18529045|P3|STARTED|Overall Study||11
7525318|NCT03570554|18529046|P2|STARTED|Overall Study||10
7525319|NCT03570554|18529047|P1|STARTED|Overall Study||10
7525320|NCT03570476|18529065|P1|NOT COMPLETED|Overall Study||0
7525321|NCT03570476|18529065|P1|COMPLETED|Overall Study||2
7525322|NCT03570476|18529065|P1|STARTED|Overall Study||2
7525323|NCT03570255|18529072|P1|NOT COMPLETED|Overall Study||0
7525324|NCT03570255|18529072|P1|COMPLETED|Overall Study||28
7525325|NCT03570255|18529072|P1|STARTED|Overall Study||28
7525326|NCT03570047|18529081|P5|NOT COMPLETED|Overall Study||0
7525327|NCT03570047|18529082|P4|NOT COMPLETED|Overall Study||0
7525328|NCT03570047|18529083|P3|NOT COMPLETED|Overall Study||0
7525329|NCT03570047|18529084|P2|NOT COMPLETED|Overall Study||0
7525330|NCT03570047|18529085|P1|NOT COMPLETED|Overall Study||0
7525331|NCT03570047|18529081|P5|COMPLETED|Overall Study||12262
7525332|NCT03570047|18529082|P4|COMPLETED|Overall Study||16564
7525333|NCT03570047|18529083|P3|COMPLETED|Overall Study||6925
7525334|NCT03570047|18529084|P2|COMPLETED|Overall Study||22336
7525335|NCT03570047|18529085|P1|COMPLETED|Overall Study||15902
7525336|NCT03570047|18529081|P5|STARTED|Overall Study||12262
7525337|NCT03570047|18529082|P4|STARTED|Overall Study||16564
7525338|NCT03570047|18529083|P3|STARTED|Overall Study||6925
7525339|NCT03570047|18529084|P2|STARTED|Overall Study||22336
7525340|NCT03570047|18529085|P1|STARTED|Overall Study||15902
7525341|NCT03569618|18529144|P2|NOT COMPLETED|Overall Study||1
7525342|NCT03569618|18529145|P1|NOT COMPLETED|Overall Study||3
7525343|NCT03569618|18529144|P2|COMPLETED|Overall Study||20
7525344|NCT03569618|18529145|P1|COMPLETED|Overall Study||20
7525345|NCT03569618|18529144|P2|STARTED|Overall Study||21
7525346|NCT03569618|18529145|P1|STARTED|Overall Study||23
7525347|NCT03569371|18529161|P1|NOT COMPLETED|Overall Study||3
7525348|NCT03569371|18529161|P1|COMPLETED|Overall Study||7
7525349|NCT03569371|18529161|P1|STARTED|Overall Study||10
7525350|NCT03569202|18529182|P2|NOT COMPLETED|Part 3||1
7525351|NCT03569202|18529183|P1|NOT COMPLETED|Part 3||2
7525352|NCT03569202|18529182|P2|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|25
7525353|NCT03569202|18529183|P1|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|24
7525354|NCT03569202|18529182|P2|STARTED|Part 3|Control Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
7525355|NCT03569202|18529183|P1|STARTED|Part 3|Emulsion Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
7525356|NCT03569202|18529182|P2|NOT COMPLETED|Part 2||0
7525357|NCT03569202|18529183|P1|NOT COMPLETED|Part 2||0
7525358|NCT03569202|18529182|P2|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
7525359|NCT03569202|18529183|P1|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
7525360|NCT03569202|18529182|P2|STARTED|Part 2|Control Eye Drops were used on contralateral eye. Participants were different from Part 1.|9
7525361|NCT03569202|18529183|P1|STARTED|Part 2|Emulsion Eye Drops were used on one randomized eye. Participants were different from Part 1.|9
7525362|NCT03569202|18529182|P2|NOT COMPLETED|Part 1||0
7525363|NCT03569202|18529183|P1|NOT COMPLETED|Part 1||0
7525364|NCT03569202|18529182|P2|COMPLETED|Part 1||0
7525365|NCT03569202|18529183|P1|COMPLETED|Part 1|No participant completing Part 1 was allowed to continue to Parts 2 or 3.|3
7525366|NCT03569202|18529182|P2|STARTED|Part 1|Control Eye Drops were not used for Part 1.|0
7525367|NCT03569202|18529183|P1|STARTED|Part 1|Emulsion Eye Drops were used on one eye only.|3
7525368|NCT03569033|18529215|P2|NOT COMPLETED|Overall Study||0
7525369|NCT03569033|18529216|P1|NOT COMPLETED|Overall Study||0
7525370|NCT03569033|18529215|P2|COMPLETED|Overall Study||23
7525371|NCT03569033|18529216|P1|COMPLETED|Overall Study||23
7525372|NCT03569033|18529215|P2|STARTED|Overall Study||23
7525373|NCT03569033|18529216|P1|STARTED|Overall Study||23
7525374|NCT03568942|18529232|P1|NOT COMPLETED|Overall Study||2
7525375|NCT03568942|18529232|P1|COMPLETED|Overall Study||20
7525376|NCT03568942|18529232|P1|STARTED|Overall Study||22
7525377|NCT03568500|18529270|P3|NOT COMPLETED|Overall Study||4
7525378|NCT03568500|18529271|P2|NOT COMPLETED|Overall Study||6
7525379|NCT03568500|18529272|P1|NOT COMPLETED|Overall Study||10
7525380|NCT03568500|18529270|P3|COMPLETED|Overall Study||2
7525381|NCT03568500|18529271|P2|COMPLETED|Overall Study||14
7525382|NCT03568500|18529272|P1|COMPLETED|Overall Study||8
7525383|NCT03568500|18529270|P3|Received At Least 1 Dose of Study Drug|Overall Study||6
7525384|NCT03568500|18529271|P2|Received At Least 1 Dose of Study Drug|Overall Study||19
7525385|NCT03568500|18529272|P1|Received At Least 1 Dose of Study Drug|Overall Study||18
7525386|NCT03568500|18529270|P3|STARTED|Overall Study||6
7525387|NCT03568500|18529271|P2|STARTED|Overall Study||20
7525388|NCT03568500|18529272|P1|STARTED|Overall Study||18
7525389|NCT03567005|18529286|P2|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
7525390|NCT03567005|18529287|P1|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
7525391|NCT03567005|18529286|P2|COMPLETED|Period 2, Second 7 Days of Wear||31
7525392|NCT03567005|18529287|P1|COMPLETED|Period 2, Second 7 Days of Wear||29
7525393|NCT03567005|18529286|P2|STARTED|Period 2, Second 7 Days of Wear||31
7525394|NCT03567005|18529287|P1|STARTED|Period 2, Second 7 Days of Wear||29
7525395|NCT03567005|18529286|P2|NOT COMPLETED|Period 1, First 7 Days of Wear||0
7525396|NCT03567005|18529287|P1|NOT COMPLETED|Period 1, First 7 Days of Wear||0
7525397|NCT03567005|18529286|P2|COMPLETED|Period 1, First 7 Days of Wear||31
7525398|NCT03567005|18529287|P1|COMPLETED|Period 1, First 7 Days of Wear||29
7525399|NCT03567005|18529286|P2|STARTED|Period 1, First 7 Days of Wear||31
7525400|NCT03567005|18529287|P1|STARTED|Period 1, First 7 Days of Wear||29
7525401|NCT03566979|18529299|P4|NOT COMPLETED|Overall Study||6
7525402|NCT03566979|18529300|P3|NOT COMPLETED|Overall Study||10
7525403|NCT03566979|18529301|P2|NOT COMPLETED|Overall Study||7
7525404|NCT03566979|18529302|P1|NOT COMPLETED|Overall Study||5
7525405|NCT03566979|18529299|P4|COMPLETED|Overall Study||143
7525406|NCT03566979|18529300|P3|COMPLETED|Overall Study||132
7525407|NCT03566979|18529301|P2|COMPLETED|Overall Study||145
7525408|NCT03566979|18529302|P1|COMPLETED|Overall Study||53
7525409|NCT03566979|18529299|P4|STARTED|Overall Study||149
7525410|NCT03566979|18529300|P3|STARTED|Overall Study||142
7525411|NCT03566979|18529301|P2|STARTED|Overall Study||152
7525412|NCT03566979|18529302|P1|STARTED|Overall Study||58
7525413|NCT03566810|18529318|P4|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
7525414|NCT03566810|18529319|P3|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
7525415|NCT03566810|18529320|P2|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
7525416|NCT03566810|18529321|P1|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
7525417|NCT03566810|18529318|P4|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
7525418|NCT03566810|18529319|P3|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
7525419|NCT03566810|18529320|P2|COMPLETED|Treatment Period 2 (Day 8- Day 10)||18
7525420|NCT03566810|18529321|P1|COMPLETED|Treatment Period 2 (Day 8- Day 10)||19
7525421|NCT03566810|18529318|P4|STARTED|Treatment Period 2 (Day 8- Day 10)||8
7525422|NCT03566810|18529319|P3|STARTED|Treatment Period 2 (Day 8- Day 10)||8
7525423|NCT03566810|18529320|P2|STARTED|Treatment Period 2 (Day 8- Day 10)||18
7525424|NCT03566810|18529321|P1|STARTED|Treatment Period 2 (Day 8- Day 10)||19
7525425|NCT03566810|18529318|P4|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
7525426|NCT03566810|18529319|P3|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
7525427|NCT03566810|18529320|P2|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||1
7525428|NCT03566810|18529321|P1|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
7525429|NCT03566810|18529318|P4|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
7525430|NCT03566810|18529319|P3|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
7525431|NCT03566810|18529320|P2|COMPLETED|Treatment Period 1 (Day 1-Day 3)||18
7525432|NCT03566810|18529321|P1|COMPLETED|Treatment Period 1 (Day 1-Day 3)||19
7525433|NCT03566810|18529318|P4|Treated|Treatment Period 1 (Day 1-Day 3)||8
7525434|NCT03566810|18529319|P3|Treated|Treatment Period 1 (Day 1-Day 3)||8
7525435|NCT03566810|18529320|P2|Treated|Treatment Period 1 (Day 1-Day 3)||18
7525436|NCT03566810|18529321|P1|Treated|Treatment Period 1 (Day 1-Day 3)||19
7525437|NCT03566810|18529318|P4|STARTED|Treatment Period 1 (Day 1-Day 3)||8
7525438|NCT03566810|18529319|P3|STARTED|Treatment Period 1 (Day 1-Day 3)||8
7525439|NCT03566810|18529320|P2|STARTED|Treatment Period 1 (Day 1-Day 3)||19
7525440|NCT03566810|18529321|P1|STARTED|Treatment Period 1 (Day 1-Day 3)||19
7525441|NCT03566680|18529383|P1|NOT COMPLETED|Overall Study||17
7525442|NCT03566680|18529383|P1|COMPLETED|Overall Study||29
7525443|NCT03566680|18529383|P1|STARTED|Overall Study||46
7525444|NCT03565887|18529394|P2|NOT COMPLETED|Overall Study||2
7525445|NCT03565887|18529395|P1|NOT COMPLETED|Overall Study||1
7525446|NCT03565887|18529394|P2|COMPLETED|Overall Study||53
7525447|NCT03565887|18529395|P1|COMPLETED|Overall Study||108
7525448|NCT03565887|18529394|P2|STARTED|Overall Study||55
7525449|NCT03565887|18529395|P1|STARTED|Overall Study||109
7525450|NCT03565874|18529403|P1|NOT COMPLETED|Overall Study||2
7525451|NCT03565874|18529403|P1|COMPLETED|Overall Study||4
7525452|NCT03565874|18529403|P1|STARTED|Overall Study||6
7525453|NCT03565679|18529416|P1|NOT COMPLETED|Overall Study||0
7525454|NCT03565679|18529416|P1|COMPLETED|Overall Study||10
7525455|NCT03565679|18529416|P1|STARTED|Overall Study||10
7525456|NCT03565666|18529423|P3|NOT COMPLETED|Overall Study||1
7525457|NCT03565666|18529424|P2|NOT COMPLETED|Overall Study||0
7525458|NCT03565666|18529425|P1|NOT COMPLETED|Overall Study||0
7525459|NCT03565666|18529423|P3|COMPLETED|Overall Study||11
7525460|NCT03565666|18529424|P2|COMPLETED|Overall Study||12
7525461|NCT03565666|18529425|P1|COMPLETED|Overall Study||12
7525462|NCT03565666|18529423|P3|STARTED|Overall Study||12
7525463|NCT03565666|18529424|P2|STARTED|Overall Study||12
7525464|NCT03565666|18529425|P1|STARTED|Overall Study||12
7525465|NCT03565328|18529462|P1|NOT COMPLETED|Overall Study||0
7525466|NCT03565328|18529462|P1|COMPLETED|Overall Study||1
7525467|NCT03565328|18529462|P1|STARTED|Overall Study||1
7525468|NCT03565315|18529474|P4|NOT COMPLETED|Overall Study||1
7525469|NCT03565315|18529475|P3|NOT COMPLETED|Overall Study||0
7525470|NCT03565315|18529476|P2|NOT COMPLETED|Overall Study||0
7525471|NCT03565315|18529477|P1|NOT COMPLETED|Overall Study||0
7525472|NCT03565315|18529474|P4|COMPLETED|Overall Study||1
7525473|NCT03565315|18529475|P3|COMPLETED|Overall Study||1
7525474|NCT03565315|18529476|P2|COMPLETED|Overall Study||3
7525475|NCT03565315|18529477|P1|COMPLETED|Overall Study||3
7525476|NCT03565315|18529474|P4|Discontinued Product Administrations|Overall Study|One Group 4 participant enrolled but did not receive product due to IND/PI voluntary study pause.|2
7525477|NCT03565315|18529475|P3|Discontinued Product Administrations|Overall Study||0
7525478|NCT03565315|18529476|P2|Discontinued Product Administrations|Overall Study||3
7525479|NCT03565315|18529477|P1|Discontinued Product Administrations|Overall Study||0
7525480|NCT03565315|18529474|P4|Product Administration Completed|Overall Study||0
7525481|NCT03565315|18529475|P3|Product Administration Completed|Overall Study||1
7525482|NCT03565315|18529476|P2|Product Administration Completed|Overall Study||0
7525483|NCT03565315|18529477|P1|Product Administration Completed|Overall Study||3
7525484|NCT03565315|18529474|P4|STARTED|Overall Study||2
7525485|NCT03565315|18529475|P3|STARTED|Overall Study||1
7525486|NCT03565315|18529476|P2|STARTED|Overall Study||3
7525487|NCT03565315|18529477|P1|STARTED|Overall Study||3
7525488|NCT03565211|18529514|P1|NOT COMPLETED|Overall Study||48
7525489|NCT03565211|18529514|P1|COMPLETED|Overall Study||206
7525490|NCT03565211|18529514|P1|Modified Intention-to-treat (mITT)|Overall Study|Had successful oocyte retrieval, received >=1 dose of IMP, and completed fresh embryo transfer|243
7525491|NCT03565211|18529514|P1|STARTED|Overall Study||254
7525492|NCT03564886|18529539|P2|NOT COMPLETED|Overall Study||1
7525493|NCT03564886|18529540|P1|NOT COMPLETED|Overall Study||1
7525494|NCT03564886|18529539|P2|COMPLETED|Overall Study||23
7525495|NCT03564886|18529540|P1|COMPLETED|Overall Study||23
7525496|NCT03564886|18529539|P2|STARTED|Overall Study||24
7525497|NCT03564886|18529540|P1|STARTED|Overall Study||24
7525498|NCT03564444|18529552|P2|NOT COMPLETED|Overall Study||0
7525499|NCT03564444|18529553|P1|NOT COMPLETED|Overall Study||0
7525500|NCT03564444|18529552|P2|COMPLETED|Overall Study||240
7525501|NCT03564444|18529553|P1|COMPLETED|Overall Study||60
7525502|NCT03564444|18529552|P2|STARTED|Overall Study||240
7525503|NCT03564444|18529553|P1|STARTED|Overall Study||60
7525504|NCT03564353|18529573|P4|NOT COMPLETED|Overall Study||0
7525505|NCT03564353|18529574|P3|NOT COMPLETED|Overall Study||0
7525506|NCT03564353|18529575|P2|NOT COMPLETED|Overall Study||0
7525507|NCT03564353|18529576|P1|NOT COMPLETED|Overall Study||0
7525508|NCT03564353|18529573|P4|COMPLETED|Overall Study||10
7525509|NCT03564353|18529574|P3|COMPLETED|Overall Study||10
7525510|NCT03564353|18529575|P2|COMPLETED|Overall Study||10
7525511|NCT03564353|18529576|P1|COMPLETED|Overall Study||10
7525512|NCT03564353|18529573|P4|STARTED|Overall Study||10
7525513|NCT03564353|18529574|P3|STARTED|Overall Study||10
7525514|NCT03564353|18529575|P2|STARTED|Overall Study||10
7525515|NCT03564353|18529576|P1|STARTED|Overall Study||10
7525516|NCT03563716|18529588|P2|NOT COMPLETED|Overall Study||67
7525517|NCT03563716|18529589|P1|NOT COMPLETED|Overall Study||68
7525518|NCT03563716|18529588|P2|COMPLETED|Overall Study|"One participant who died had as reason for discontinuation Withdrawal by Subject"|0
7525519|NCT03563716|18529589|P1|COMPLETED|Overall Study||0
7525520|NCT03563716|18529588|P2|STARTED|Overall Study||67
7525521|NCT03563716|18529589|P1|STARTED|Overall Study||68
7525522|NCT03563313|18529599|P2|NOT COMPLETED|Overall Study||0
7525523|NCT03563313|18529600|P1|NOT COMPLETED|Overall Study||0
7525524|NCT03563313|18529599|P2|COMPLETED|Overall Study||56
7525525|NCT03563313|18529600|P1|COMPLETED|Overall Study||112
7525526|NCT03563313|18529599|P2|STARTED|Overall Study||56
7525527|NCT03563313|18529600|P1|STARTED|Overall Study||112
7525528|NCT03563209|18529708|P1|NOT COMPLETED|Overall Study||0
7525529|NCT03563209|18529708|P1|COMPLETED|Overall Study||60
7525530|NCT03563209|18529708|P1|STARTED|Overall Study||60
7525531|NCT03563183|18529714|P1|NOT COMPLETED|Overall Study||0
7525532|NCT03563183|18529714|P1|COMPLETED|Overall Study||26976
7525533|NCT03563183|18529714|P1|STARTED|Overall Study||26976
7525534|NCT03562559|18529815|P1|NOT COMPLETED|Overall Study||0
7525535|NCT03562559|18529815|P1|COMPLETED|Overall Study||40
7525536|NCT03562559|18529815|P1|STARTED|Overall Study||40
7525537|NCT03562481|18529821|P2|NOT COMPLETED|Second Intervention||0
7525538|NCT03562481|18529822|P1|NOT COMPLETED|Second Intervention||0
7525539|NCT03562481|18529821|P2|COMPLETED|Second Intervention||14
7525540|NCT03562481|18529822|P1|COMPLETED|Second Intervention||11
7525541|NCT03562481|18529821|P2|STARTED|Second Intervention||14
7525542|NCT03562481|18529822|P1|STARTED|Second Intervention||11
7525543|NCT03562481|18529821|P2|NOT COMPLETED|Washout||0
7525544|NCT03562481|18529822|P1|NOT COMPLETED|Washout||0
7525545|NCT03562481|18529821|P2|COMPLETED|Washout||14
7525546|NCT03562481|18529822|P1|COMPLETED|Washout||11
7525547|NCT03562481|18529821|P2|STARTED|Washout||14
7525548|NCT03562481|18529822|P1|STARTED|Washout||11
7525549|NCT03562481|18529821|P2|NOT COMPLETED|First Intervention||0
7525550|NCT03562481|18529822|P1|NOT COMPLETED|First Intervention||1
7525551|NCT03562481|18529821|P2|COMPLETED|First Intervention||14
7525552|NCT03562481|18529822|P1|COMPLETED|First Intervention||11
7525553|NCT03562481|18529821|P2|STARTED|First Intervention||14
7525554|NCT03562481|18529822|P1|STARTED|First Intervention||12
7525555|NCT03562117|18529847|P3|NOT COMPLETED|Part 2, Up to 3 Days||0
7525556|NCT03562117|18529848|P2|NOT COMPLETED|Part 2, Up to 3 Days||0
7525557|NCT03562117|18529849|P1|NOT COMPLETED|Part 2, Up to 3 Days||0
7525558|NCT03562117|18529847|P3|COMPLETED|Part 2, Up to 3 Days||8
7525559|NCT03562117|18529848|P2|COMPLETED|Part 2, Up to 3 Days||0
7525560|NCT03562117|18529849|P1|COMPLETED|Part 2, Up to 3 Days||8
7525561|NCT03562117|18529847|P3|STARTED|Part 2, Up to 3 Days||8
7525562|NCT03562117|18529848|P2|STARTED|Part 2, Up to 3 Days||0
7525563|NCT03562117|18529849|P1|STARTED|Part 2, Up to 3 Days|Only 1 additional participant with normal hepatic function enrolled in Part 2 received dosing|8
7525564|NCT03562117|18529847|P3|NOT COMPLETED|Part 1, Up to 3 Days||0
7525565|NCT03562117|18529848|P2|NOT COMPLETED|Part 1, Up to 3 Days||0
7525566|NCT03562117|18529849|P1|NOT COMPLETED|Part 1, Up to 3 Days||1
7525567|NCT03562117|18529847|P3|COMPLETED|Part 1, Up to 3 Days||0
7525568|NCT03562117|18529848|P2|COMPLETED|Part 1, Up to 3 Days||8
7525569|NCT03562117|18529849|P1|COMPLETED|Part 1, Up to 3 Days||7
7525570|NCT03562117|18529847|P3|STARTED|Part 1, Up to 3 Days||0
7525571|NCT03562117|18529848|P2|STARTED|Part 1, Up to 3 Days||8
7525572|NCT03562117|18529849|P1|STARTED|Part 1, Up to 3 Days||8
7525573|NCT03560986|18529937|P2|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
7525574|NCT03560986|18529938|P1|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
7525575|NCT03560986|18529937|P2|COMPLETED|Treatment Period B/Follow-up Period 2||0
7525576|NCT03560986|18529938|P1|COMPLETED|Treatment Period B/Follow-up Period 2||1
7525577|NCT03560986|18529937|P2|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
7525578|NCT03560986|18529938|P1|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
7525579|NCT03560986|18529937|P2|STARTED|Treatment Period B/Follow-up Period 2|5 Part. completed Placebo Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|8
7525580|NCT03560986|18529938|P1|STARTED|Treatment Period B/Follow-up Period 2|3 Participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|9
7525581|NCT03560986|18529937|P2|NOT COMPLETED|Treatment Period A/Follow-up Period 1||38
7525582|NCT03560986|18529938|P1|NOT COMPLETED|Treatment Period A/Follow-up Period 1||36
7525583|NCT03560986|18529937|P2|COMPLETED|Treatment Period A/Follow-up Period 1||13
7525584|NCT03560986|18529938|P1|COMPLETED|Treatment Period A/Follow-up Period 1||12
7525585|NCT03560986|18529937|P2|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
7525586|NCT03560986|18529938|P1|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
7525587|NCT03560986|18529937|P2|STARTED|Treatment Period A/Follow-up Period 1|One additional participant was allocated to placebo but not treated.|51
7525588|NCT03560986|18529938|P1|STARTED|Treatment Period A/Follow-up Period 1||48
7525589|NCT03560739|18529964|P4|NOT COMPLETED|Overall Study||0
7525590|NCT03560739|18529965|P3|NOT COMPLETED|Overall Study||0
7525591|NCT03560739|18529966|P2|NOT COMPLETED|Overall Study||1
7525592|NCT03560739|18529967|P1|NOT COMPLETED|Overall Study||0
7525593|NCT03560739|18529964|P4|COMPLETED|Overall Study||13
7525594|NCT03560739|18529965|P3|COMPLETED|Overall Study||13
7525595|NCT03560739|18529966|P2|COMPLETED|Overall Study||129
7525596|NCT03560739|18529967|P1|COMPLETED|Overall Study||128
7525597|NCT03560739|18529964|P4|STARTED|Overall Study||13
7525598|NCT03560739|18529965|P3|STARTED|Overall Study||13
7525599|NCT03560739|18529966|P2|STARTED|Overall Study||130
7525600|NCT03560739|18529967|P1|STARTED|Overall Study||128
7525601|NCT03560518|18529996|P3|NOT COMPLETED|Safety Follow-Up Period||0
7525602|NCT03560518|18529997|P2|NOT COMPLETED|Safety Follow-Up Period||0
7525603|NCT03560518|18529998|P1|NOT COMPLETED|Safety Follow-Up Period||0
7525604|NCT03560518|18529996|P3|COMPLETED|Safety Follow-Up Period||22
7525605|NCT03560518|18529997|P2|COMPLETED|Safety Follow-Up Period||17
7525606|NCT03560518|18529998|P1|COMPLETED|Safety Follow-Up Period||10
7525607|NCT03560518|18529996|P3|STARTED|Safety Follow-Up Period||22
7525608|NCT03560518|18529997|P2|STARTED|Safety Follow-Up Period||17
7525609|NCT03560518|18529998|P1|STARTED|Safety Follow-Up Period||10
7525610|NCT03560518|18529996|P3|NOT COMPLETED|Double Blind Treatment Period||23
7525611|NCT03560518|18529997|P2|NOT COMPLETED|Double Blind Treatment Period||29
7525612|NCT03560518|18529998|P1|NOT COMPLETED|Double Blind Treatment Period||25
7525613|NCT03560518|18529996|P3|COMPLETED|Double Blind Treatment Period||124
7525614|NCT03560518|18529997|P2|COMPLETED|Double Blind Treatment Period||116
7525615|NCT03560518|18529998|P1|COMPLETED|Double Blind Treatment Period||122
7525616|NCT03560518|18529996|P3|STARTED|Double Blind Treatment Period||147
7525617|NCT03560518|18529997|P2|STARTED|Double Blind Treatment Period||145
7525618|NCT03560518|18529998|P1|STARTED|Double Blind Treatment Period||147
7525619|NCT03560245|18530011|P2|NOT COMPLETED|Overall Study||7
7525620|NCT03560245|18530012|P1|NOT COMPLETED|Overall Study||5
7525621|NCT03560245|18530011|P2|COMPLETED|Overall Study||48
7525622|NCT03560245|18530012|P1|COMPLETED|Overall Study||48
7525623|NCT03560245|18530011|P2|STARTED|Overall Study||55
7525624|NCT03560245|18530012|P1|STARTED|Overall Study||53
7525625|NCT03560128|18530030|P2|NOT COMPLETED|Overall Study||8
7525626|NCT03560128|18530031|P1|NOT COMPLETED|Overall Study||12
7525627|NCT03560128|18530030|P2|COMPLETED|Overall Study||298
7525628|NCT03560128|18530031|P1|COMPLETED|Overall Study||294
7525629|NCT03560128|18530030|P2|STARTED|Overall Study||306
7525630|NCT03560128|18530031|P1|STARTED|Overall Study||306
7525631|NCT03559829|18530051|P1|NOT COMPLETED|Overall Study||0
7525632|NCT03559829|18530051|P1|COMPLETED|Overall Study||20
7525633|NCT03559829|18530051|P1|STARTED|Overall Study||20
7525634|NCT03559257|18530066|P2|NOT COMPLETED|Open-label Treatment Period||7
7525635|NCT03559257|18530067|P1|NOT COMPLETED|Open-label Treatment Period||10
7525636|NCT03559257|18530066|P2|COMPLETED|Open-label Treatment Period||217
7525637|NCT03559257|18530067|P1|COMPLETED|Open-label Treatment Period||215
7525730|NCT03557775|18530314|P2|STARTED|Overall Study||7
7525638|NCT03559257|18530066|P2|STARTED|Open-label Treatment Period|One participant who completed double blind period had discontinued due to adverse event.|224
7525639|NCT03559257|18530067|P1|STARTED|Open-label Treatment Period|One participant who completed double blind period has withdrawn from the study.|225
7525640|NCT03559257|18530066|P2|NOT COMPLETED|Double Blind Treatment Period||8
7525641|NCT03559257|18530067|P1|NOT COMPLETED|Double Blind Treatment Period||4
7525642|NCT03559257|18530066|P2|COMPLETED|Double Blind Treatment Period||225
7525643|NCT03559257|18530067|P1|COMPLETED|Double Blind Treatment Period||226
7525644|NCT03559257|18530066|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Period||232
7525645|NCT03559257|18530067|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Period||230
7525646|NCT03559257|18530066|P2|STARTED|Double Blind Treatment Period||233
7525647|NCT03559257|18530067|P1|STARTED|Double Blind Treatment Period||230
7525648|NCT03559179|18530114|P3|NOT COMPLETED|Overall Study||0
7525649|NCT03559179|18530115|P2|NOT COMPLETED|Overall Study||1
7525650|NCT03559179|18530116|P1|NOT COMPLETED|Overall Study||0
7525651|NCT03559179|18530114|P3|COMPLETED|Overall Study||23
7525652|NCT03559179|18530115|P2|COMPLETED|Overall Study||23
7525653|NCT03559179|18530116|P1|COMPLETED|Overall Study||8
7525654|NCT03559179|18530114|P3|STARTED|Overall Study||23
7525655|NCT03559179|18530115|P2|STARTED|Overall Study||24
7525656|NCT03559179|18530116|P1|STARTED|Overall Study||8
7525657|NCT03559062|18530137|P3|NOT COMPLETED|Overall Study||0
7525658|NCT03559062|18530138|P2|NOT COMPLETED|Overall Study||1
7525659|NCT03559062|18530139|P1|NOT COMPLETED|Overall Study||0
7525660|NCT03559062|18530137|P3|COMPLETED|Overall Study||3
7525661|NCT03559062|18530138|P2|COMPLETED|Overall Study||53
7525662|NCT03559062|18530139|P1|COMPLETED|Overall Study||10
7525663|NCT03559062|18530137|P3|STARTED|Overall Study||3
7525664|NCT03559062|18530138|P2|STARTED|Overall Study||54
7525665|NCT03559062|18530139|P1|STARTED|Overall Study||10
7525666|NCT03558997|18530154|P4|NOT COMPLETED|Overall Study||2
7525667|NCT03558997|18530155|P3|NOT COMPLETED|Overall Study||8
7525668|NCT03558997|18530156|P2|NOT COMPLETED|Overall Study||2
7525669|NCT03558997|18530157|P1|NOT COMPLETED|Overall Study||1
7525670|NCT03558997|18530154|P4|COMPLETED|Overall Study||24
7525671|NCT03558997|18530155|P3|COMPLETED|Overall Study||18
7525672|NCT03558997|18530156|P2|COMPLETED|Overall Study||24
7525673|NCT03558997|18530157|P1|COMPLETED|Overall Study||24
7525674|NCT03558997|18530154|P4|STARTED|Overall Study||26
7525675|NCT03558997|18530155|P3|STARTED|Overall Study||26
7525676|NCT03558997|18530156|P2|STARTED|Overall Study||26
7525677|NCT03558997|18530157|P1|STARTED|Overall Study||25
7525678|NCT03558672|18530189|P1|NOT COMPLETED|Overall Study||10
7525679|NCT03558672|18530189|P1|COMPLETED|Overall Study||8
7525680|NCT03558672|18530189|P1|STARTED|Overall Study||18
7525681|NCT03558555|18530201|P2|NOT COMPLETED|Overall Study||1
7525682|NCT03558555|18530202|P1|NOT COMPLETED|Overall Study||2
7525683|NCT03558555|18530201|P2|COMPLETED|Overall Study||44
7525684|NCT03558555|18530202|P1|COMPLETED|Overall Study||56
7525685|NCT03558555|18530201|P2|STARTED|Overall Study||45
7525686|NCT03558555|18530202|P1|STARTED|Overall Study||58
7525687|NCT03558516|18530220|P2|NOT COMPLETED|Overall Study||2
7525688|NCT03558516|18530221|P1|NOT COMPLETED|Overall Study||2
7525689|NCT03558516|18530220|P2|COMPLETED|Overall Study||38
7525690|NCT03558516|18530221|P1|COMPLETED|Overall Study||38
7525691|NCT03558516|18530220|P2|STARTED|Overall Study||40
7525692|NCT03558516|18530221|P1|STARTED|Overall Study||40
7525693|NCT03558230|18530241|P2|NOT COMPLETED|Overall Study||0
7525694|NCT03558230|18530242|P1|NOT COMPLETED|Overall Study||0
7525695|NCT03558230|18530241|P2|COMPLETED|Overall Study||6
7525696|NCT03558230|18530242|P1|COMPLETED|Overall Study||7
7525697|NCT03558230|18530241|P2|STARTED|Overall Study||6
7525698|NCT03558230|18530242|P1|STARTED|Overall Study||7
7525699|NCT03558074|18530248|P1|NOT COMPLETED|Overall Study||2
7525700|NCT03558074|18530248|P1|COMPLETED|Overall Study||24
7525701|NCT03558074|18530248|P1|STARTED|Overall Study||26
7525702|NCT03558061|18530253|P1|NOT COMPLETED|Overall Study||1
7525703|NCT03558061|18530253|P1|COMPLETED|Overall Study||29
7525704|NCT03558061|18530253|P1|STARTED|Overall Study||30
7525705|NCT03557931|18530261|P3|NOT COMPLETED|Overall Study||13
7525706|NCT03557931|18530262|P2|NOT COMPLETED|Overall Study||19
7525707|NCT03557931|18530263|P1|NOT COMPLETED|Overall Study||31
7525708|NCT03557931|18530261|P3|COMPLETED|Overall Study||55
7525709|NCT03557931|18530262|P2|COMPLETED|Overall Study||46
7525710|NCT03557931|18530263|P1|COMPLETED|Overall Study||69
7525711|NCT03557931|18530261|P3|STARTED|Overall Study||68
7525712|NCT03557931|18530262|P2|STARTED|Overall Study||65
7525713|NCT03557931|18530263|P1|STARTED|Overall Study||100
7525714|NCT03557801|18530294|P3|NOT COMPLETED|Overall Study||3
7525715|NCT03557801|18530295|P2|NOT COMPLETED|Overall Study||1
7525716|NCT03557801|18530296|P1|NOT COMPLETED|Overall Study||2
7525717|NCT03557801|18530294|P3|COMPLETED|Overall Study||30
7525718|NCT03557801|18530295|P2|COMPLETED|Overall Study||32
7525719|NCT03557801|18530296|P1|COMPLETED|Overall Study||32
7525720|NCT03557801|18530294|P3|STARTED|Overall Study||33
7525721|NCT03557801|18530295|P2|STARTED|Overall Study||33
7525722|NCT03557801|18530296|P1|STARTED|Overall Study||34
7525723|NCT03557775|18530313|P3|NOT COMPLETED|Overall Study||4
7525724|NCT03557775|18530314|P2|NOT COMPLETED|Overall Study||3
7525725|NCT03557775|18530315|P1|NOT COMPLETED|Overall Study||1
7525726|NCT03557775|18530313|P3|COMPLETED|Overall Study||4
7525727|NCT03557775|18530314|P2|COMPLETED|Overall Study||4
7525728|NCT03557775|18530315|P1|COMPLETED|Overall Study||4
7525729|NCT03557775|18530313|P3|STARTED|Overall Study||8
7525731|NCT03557775|18530315|P1|STARTED|Overall Study||5
7525732|NCT03557476|18530373|P2|NOT COMPLETED|Overall Study||0
7525733|NCT03557476|18530374|P1|NOT COMPLETED|Overall Study||0
7525734|NCT03557476|18530373|P2|COMPLETED|Overall Study||13
7525735|NCT03557476|18530374|P1|COMPLETED|Overall Study||13
7525736|NCT03557476|18530373|P2|STARTED|Overall Study||13
7525737|NCT03557476|18530374|P1|STARTED|Overall Study||13
7525738|NCT03556761|18530394|P2|NOT COMPLETED|Overall Study||29
7525739|NCT03556761|18530395|P1|NOT COMPLETED|Overall Study||24
7525740|NCT03556761|18530394|P2|COMPLETED|Overall Study||163
7525741|NCT03556761|18530395|P1|COMPLETED|Overall Study||168
7525742|NCT03556761|18530394|P2|STARTED|Overall Study||192
7525743|NCT03556761|18530395|P1|STARTED|Overall Study||192
7525744|NCT03556579|18530415|P4|NOT COMPLETED|Visit 2||0
7525745|NCT03556579|18530416|P3|NOT COMPLETED|Visit 2||0
7525746|NCT03556579|18530417|P2|NOT COMPLETED|Visit 2||0
7525747|NCT03556579|18530418|P1|NOT COMPLETED|Visit 2||0
7525748|NCT03556579|18530415|P4|COMPLETED|Visit 2||16
7525749|NCT03556579|18530416|P3|COMPLETED|Visit 2||14
7525750|NCT03556579|18530417|P2|COMPLETED|Visit 2||14
7525751|NCT03556579|18530418|P1|COMPLETED|Visit 2||16
7525752|NCT03556579|18530415|P4|STARTED|Visit 2||16
7525753|NCT03556579|18530416|P3|STARTED|Visit 2||14
7525754|NCT03556579|18530417|P2|STARTED|Visit 2||14
7525755|NCT03556579|18530418|P1|STARTED|Visit 2||16
7525756|NCT03556579|18530415|P4|NOT COMPLETED|Visit 1||0
7525757|NCT03556579|18530416|P3|NOT COMPLETED|Visit 1||0
7525758|NCT03556579|18530417|P2|NOT COMPLETED|Visit 1||0
7525759|NCT03556579|18530418|P1|NOT COMPLETED|Visit 1||0
7525760|NCT03556579|18530415|P4|COMPLETED|Visit 1||16
7525761|NCT03556579|18530416|P3|COMPLETED|Visit 1||14
7525762|NCT03556579|18530417|P2|COMPLETED|Visit 1||14
7525763|NCT03556579|18530418|P1|COMPLETED|Visit 1||16
7525764|NCT03556579|18530415|P4|STARTED|Visit 1||16
7525765|NCT03556579|18530416|P3|STARTED|Visit 1||14
7525766|NCT03556579|18530417|P2|STARTED|Visit 1||14
7525767|NCT03556579|18530418|P1|STARTED|Visit 1||16
7525768|NCT03555890|18530446|P4|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
7525769|NCT03555890|18530447|P3|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
7525770|NCT03555890|18530448|P2|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
7525771|NCT03555890|18530449|P1|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
7525772|NCT03555890|18530446|P4|COMPLETED|Part 2:Treatment Period 2 (10 Days)||23
7525773|NCT03555890|18530447|P3|COMPLETED|Part 2:Treatment Period 2 (10 Days)||24
7525774|NCT03555890|18530448|P2|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
7525775|NCT03555890|18530449|P1|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
7525776|NCT03555890|18530446|P4|STARTED|Part 2:Treatment Period 2 (10 Days)||23
7525777|NCT03555890|18530447|P3|STARTED|Part 2:Treatment Period 2 (10 Days)||24
7525778|NCT03555890|18530448|P2|STARTED|Part 2:Treatment Period 2 (10 Days)||0
7525779|NCT03555890|18530449|P1|STARTED|Part 2:Treatment Period 2 (10 Days)||0
7525780|NCT03555890|18530446|P4|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||1
7525781|NCT03555890|18530447|P3|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
7525782|NCT03555890|18530448|P2|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
7525783|NCT03555890|18530449|P1|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
7525784|NCT03555890|18530446|P4|COMPLETED|Part 2:Washout Period (at Least 5 Days)||23
7525785|NCT03555890|18530447|P3|COMPLETED|Part 2:Washout Period (at Least 5 Days)||24
7525786|NCT03555890|18530448|P2|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
7525787|NCT03555890|18530449|P1|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
7525788|NCT03555890|18530446|P4|STARTED|Part 2:Washout Period (at Least 5 Days)||24
7525789|NCT03555890|18530447|P3|STARTED|Part 2:Washout Period (at Least 5 Days)||24
7525790|NCT03555890|18530448|P2|STARTED|Part 2:Washout Period (at Least 5 Days)||0
7525791|NCT03555890|18530449|P1|STARTED|Part 2:Washout Period (at Least 5 Days)||0
7525792|NCT03555890|18530446|P4|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
7525793|NCT03555890|18530447|P3|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
7525794|NCT03555890|18530448|P2|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
7525795|NCT03555890|18530449|P1|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
7525796|NCT03555890|18530446|P4|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
7525797|NCT03555890|18530447|P3|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
7525798|NCT03555890|18530448|P2|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
7525799|NCT03555890|18530449|P1|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
7525800|NCT03555890|18530446|P4|STARTED|Part 2:Treatment Period 1 (3 Days)||24
7525801|NCT03555890|18530447|P3|STARTED|Part 2:Treatment Period 1 (3 Days)||24
7525802|NCT03555890|18530448|P2|STARTED|Part 2:Treatment Period 1 (3 Days)||0
7525803|NCT03555890|18530449|P1|STARTED|Part 2:Treatment Period 1 (3 Days)||0
7525804|NCT03555890|18530446|P4|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
7525805|NCT03555890|18530447|P3|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
7525806|NCT03555890|18530448|P2|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
7525807|NCT03555890|18530449|P1|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
7525808|NCT03555890|18530446|P4|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
7525809|NCT03555890|18530447|P3|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
7525810|NCT03555890|18530448|P2|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
7525811|NCT03555890|18530449|P1|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
7525812|NCT03555890|18530446|P4|STARTED|Part 1:Treatment Period 2 (10 Days)||0
7525813|NCT03555890|18530447|P3|STARTED|Part 1:Treatment Period 2 (10 Days)||0
7525814|NCT03555890|18530448|P2|STARTED|Part 1:Treatment Period 2 (10 Days)||12
7525815|NCT03555890|18530449|P1|STARTED|Part 1:Treatment Period 2 (10 Days)||12
7525816|NCT03555890|18530446|P4|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
7525817|NCT03555890|18530447|P3|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
7525818|NCT03555890|18530448|P2|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
7525819|NCT03555890|18530449|P1|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
7525820|NCT03555890|18530446|P4|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
7525821|NCT03555890|18530447|P3|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
7525822|NCT03555890|18530448|P2|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
7525823|NCT03555890|18530449|P1|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
7525824|NCT03555890|18530446|P4|STARTED|Part 1:Washout Period (at Least 5 Days)||0
7525825|NCT03555890|18530447|P3|STARTED|Part 1:Washout Period (at Least 5 Days)||0
7525826|NCT03555890|18530448|P2|STARTED|Part 1:Washout Period (at Least 5 Days)||12
7525827|NCT03555890|18530449|P1|STARTED|Part 1:Washout Period (at Least 5 Days)||12
7525828|NCT03555890|18530446|P4|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
7525829|NCT03555890|18530447|P3|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
7525830|NCT03555890|18530448|P2|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
7525831|NCT03555890|18530449|P1|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
7525832|NCT03555890|18530446|P4|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
7525833|NCT03555890|18530447|P3|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
7525834|NCT03555890|18530448|P2|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
7525835|NCT03555890|18530449|P1|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
7525836|NCT03555890|18530446|P4|STARTED|Part 1:Treatment Period 1 (3 Days)||0
7525837|NCT03555890|18530447|P3|STARTED|Part 1:Treatment Period 1 (3 Days)||0
7525838|NCT03555890|18530448|P2|STARTED|Part 1:Treatment Period 1 (3 Days)||12
7525839|NCT03555890|18530449|P1|STARTED|Part 1:Treatment Period 1 (3 Days)||12
7525840|NCT03555565|18530583|P1|NOT COMPLETED|Overall Study||15
7525841|NCT03555565|18530583|P1|COMPLETED|Overall Study||1011
7525842|NCT03555565|18530583|P1|STARTED|Overall Study||1026
7525843|NCT03555435|18530593|P3|NOT COMPLETED|Overall Study||8
7525844|NCT03555435|18530594|P2|NOT COMPLETED|Overall Study||19
7525845|NCT03555435|18530595|P1|NOT COMPLETED|Overall Study||17
7525846|NCT03555435|18530593|P3|COMPLETED|Overall Study||18
7525847|NCT03555435|18530594|P2|COMPLETED|Overall Study||8
7525848|NCT03555435|18530595|P1|COMPLETED|Overall Study||11
7525849|NCT03555435|18530593|P3|STARTED|Overall Study||26
7525850|NCT03555435|18530594|P2|STARTED|Overall Study||27
7525851|NCT03555435|18530595|P1|STARTED|Overall Study||28
7525852|NCT03555305|18530606|P2|NOT COMPLETED|Period 2||0
7525853|NCT03555305|18530607|P1|NOT COMPLETED|Period 2||0
7525854|NCT03555305|18530606|P2|COMPLETED|Period 2||27
7525855|NCT03555305|18530607|P1|COMPLETED|Period 2||29
7525856|NCT03555305|18530606|P2|STARTED|Period 2||27
7525857|NCT03555305|18530607|P1|STARTED|Period 2||29
7525858|NCT03555305|18530606|P2|NOT COMPLETED|Period 1||2
7525859|NCT03555305|18530607|P1|NOT COMPLETED|Period 1||0
7525860|NCT03555305|18530606|P2|COMPLETED|Period 1||27
7525861|NCT03555305|18530607|P1|COMPLETED|Period 1||29
7525862|NCT03555305|18530606|P2|Received at Least 1 Dose of Study Drug|Period 1||29
7525863|NCT03555305|18530607|P1|Received at Least 1 Dose of Study Drug|Period 1||29
7525864|NCT03555305|18530606|P2|STARTED|Period 1||29
7525865|NCT03555305|18530607|P1|STARTED|Period 1||29
7525866|NCT03554954|18530619|P1|NOT COMPLETED|Overall Study||0
7525867|NCT03554954|18530619|P1|COMPLETED|Overall Study||108
7525868|NCT03554954|18530619|P1|STARTED|Overall Study||108
7525869|NCT03554746|18530672|P2|NOT COMPLETED|Overall Study||0
7525870|NCT03554746|18530673|P1|NOT COMPLETED|Overall Study||0
7525871|NCT03554746|18530672|P2|COMPLETED|Overall Study||24
7525872|NCT03554746|18530673|P1|COMPLETED|Overall Study||24
7525873|NCT03554746|18530672|P2|STARTED|Overall Study||24
7525874|NCT03554746|18530673|P1|STARTED|Overall Study||24
7525875|NCT03554629|18530689|P1|NOT COMPLETED|Overall Study||6
7525876|NCT03554629|18530689|P1|COMPLETED|Overall Study|8 filterlines (CCSF) per participate for four scripted activities with supplemental oxygen.|23
7525877|NCT03554629|18530689|P1|STARTED|Overall Study|8 filterlines per participant for four scripted activities with supplemental oxygen|29
7525878|NCT03554005|18530723|P6|NOT COMPLETED|Overall Study||11
7525879|NCT03554005|18530724|P5|NOT COMPLETED|Overall Study||6
7525880|NCT03554005|18530725|P4|NOT COMPLETED|Overall Study||1
7525881|NCT03554005|18530726|P3|NOT COMPLETED|Overall Study||1
7525882|NCT03554005|18530727|P2|NOT COMPLETED|Overall Study||1
7525883|NCT03554005|18530728|P1|NOT COMPLETED|Overall Study||1
7525884|NCT03554005|18530723|P6|COMPLETED|Overall Study||0
7525885|NCT03554005|18530724|P5|COMPLETED|Overall Study||5
7525886|NCT03554005|18530725|P4|COMPLETED|Overall Study||1
7525887|NCT03554005|18530726|P3|COMPLETED|Overall Study||1
7525888|NCT03554005|18530727|P2|COMPLETED|Overall Study||1
7525889|NCT03554005|18530728|P1|COMPLETED|Overall Study||0
7525890|NCT03554005|18530723|P6|STARTED|Overall Study||11
7525891|NCT03554005|18530724|P5|STARTED|Overall Study||11
7525892|NCT03554005|18530725|P4|STARTED|Overall Study||2
7525893|NCT03554005|18530726|P3|STARTED|Overall Study||2
7525894|NCT03554005|18530727|P2|STARTED|Overall Study||2
7525895|NCT03554005|18530728|P1|STARTED|Overall Study||1
7525896|NCT03553758|18530754|P1|NOT COMPLETED|Overall Study||1
7525897|NCT03553758|18530754|P1|COMPLETED|Overall Study||15
7525898|NCT03553758|18530754|P1|Completed Screening Visit|Overall Study||16
7525899|NCT03553758|18530754|P1|STARTED|Overall Study||16
7525900|NCT03552549|18530762|P2|NOT COMPLETED|Overall Study||52
7525901|NCT03552549|18530763|P1|NOT COMPLETED|Overall Study||53
7525902|NCT03552549|18530762|P2|COMPLETED|Overall Study||11
7525903|NCT03552549|18530763|P1|COMPLETED|Overall Study||10
7525904|NCT03552549|18530762|P2|Treated|Overall Study||62
7525905|NCT03552549|18530763|P1|Treated|Overall Study||62
7525906|NCT03552549|18530762|P2|STARTED|Overall Study||63
7525907|NCT03552549|18530763|P1|STARTED|Overall Study||63
7525908|NCT03552536|18530774|P3|NOT COMPLETED|Overall Study||0
7525909|NCT03552536|18530775|P2|NOT COMPLETED|Overall Study||0
7525910|NCT03552536|18530776|P1|NOT COMPLETED|Overall Study||0
7525911|NCT03552536|18530774|P3|COMPLETED|Overall Study||0
7525912|NCT03552536|18530775|P2|COMPLETED|Overall Study||0
7525913|NCT03552536|18530776|P1|COMPLETED|Overall Study||5
7525914|NCT03552536|18530774|P3|STARTED|Overall Study||0
7525915|NCT03552536|18530775|P2|STARTED|Overall Study||0
7525916|NCT03552536|18530776|P1|STARTED|Overall Study||5
7525917|NCT03552523|18530801|P2|NOT COMPLETED|Overall Study||1
7525918|NCT03552523|18530802|P1|NOT COMPLETED|Overall Study||1
7525919|NCT03552523|18530801|P2|COMPLETED|Overall Study||1
7525920|NCT03552523|18530802|P1|COMPLETED|Overall Study||4
7525921|NCT03552523|18530801|P2|STARTED|Overall Study||2
7525922|NCT03552523|18530802|P1|STARTED|Overall Study||5
7525923|NCT03552289|18530812|P2|NOT COMPLETED|Overall Study||3
7525924|NCT03552289|18530813|P1|NOT COMPLETED|Overall Study||1
7525925|NCT03552289|18530812|P2|COMPLETED|Overall Study||106
7525926|NCT03552289|18530813|P1|COMPLETED|Overall Study||101
7525927|NCT03552289|18530812|P2|STARTED|Overall Study||109
7525928|NCT03552289|18530813|P1|STARTED|Overall Study||102
7525929|NCT03551821|18530819|P1|NOT COMPLETED|Overall Study||0
7525930|NCT03551821|18530819|P1|COMPLETED|Overall Study||1
7525931|NCT03551821|18530819|P1|STARTED|Overall Study||1
7525932|NCT03551743|18530828|P4|NOT COMPLETED|Overall Study||0
7525933|NCT03551743|18530829|P3|NOT COMPLETED|Overall Study||0
7525934|NCT03551743|18530830|P2|NOT COMPLETED|Overall Study||0
7525935|NCT03551743|18530831|P1|NOT COMPLETED|Overall Study||2
7525936|NCT03551743|18530828|P4|COMPLETED|Overall Study||6
7525937|NCT03551743|18530829|P3|COMPLETED|Overall Study||6
7525938|NCT03551743|18530830|P2|COMPLETED|Overall Study||6
7525939|NCT03551743|18530831|P1|COMPLETED|Overall Study||8
7525940|NCT03551743|18530828|P4|STARTED|Overall Study||6
7525941|NCT03551743|18530829|P3|STARTED|Overall Study||6
7525942|NCT03551743|18530830|P2|STARTED|Overall Study||6
7525943|NCT03551743|18530831|P1|STARTED|Overall Study||10
7525944|NCT03551730|18530877|P4|NOT COMPLETED|Overall Study||0
7525945|NCT03551730|18530878|P3|NOT COMPLETED|Overall Study||0
7525946|NCT03551730|18530879|P2|NOT COMPLETED|Overall Study||0
7525947|NCT03551730|18530880|P1|NOT COMPLETED|Overall Study||1
7525948|NCT03551730|18530877|P4|COMPLETED|Overall Study||6
7525949|NCT03551730|18530878|P3|COMPLETED|Overall Study||6
7525950|NCT03551730|18530879|P2|COMPLETED|Overall Study||6
7525951|NCT03551730|18530880|P1|COMPLETED|Overall Study||8
7525952|NCT03551730|18530877|P4|STARTED|Overall Study||6
7525953|NCT03551730|18530878|P3|STARTED|Overall Study||6
7525954|NCT03551730|18530879|P2|STARTED|Overall Study||6
7525955|NCT03551730|18530880|P1|STARTED|Overall Study||9
7525956|NCT03550989|18530922|P4|NOT COMPLETED|Overall Study||0
7525957|NCT03550989|18530923|P3|NOT COMPLETED|Overall Study||1
7525958|NCT03550989|18530924|P2|NOT COMPLETED|Overall Study||1
7525959|NCT03550989|18530925|P1|NOT COMPLETED|Overall Study||2
7525960|NCT03550989|18530922|P4|COMPLETED|Overall Study||60
7525961|NCT03550989|18530923|P3|COMPLETED|Overall Study||76
7525962|NCT03550989|18530924|P2|COMPLETED|Overall Study||73
7525963|NCT03550989|18530925|P1|COMPLETED|Overall Study||188
7525964|NCT03550989|18530922|P4|STARTED|Overall Study||60
7525965|NCT03550989|18530923|P3|STARTED|Overall Study||77
7525966|NCT03550989|18530924|P2|STARTED|Overall Study||74
7525967|NCT03550989|18530925|P1|STARTED|Overall Study||190
7525968|NCT03550378|18531002|P2|NOT COMPLETED|Overall Study||1
7525969|NCT03550378|18531003|P1|NOT COMPLETED|Overall Study||0
7525970|NCT03550378|18531002|P2|COMPLETED|Overall Study||20
7525971|NCT03550378|18531003|P1|COMPLETED|Overall Study||20
7525972|NCT03550378|18531002|P2|STARTED|Overall Study||21
7525973|NCT03550378|18531003|P1|STARTED|Overall Study||20
7525974|NCT03550066|18531043|P2|NOT COMPLETED|Overall Study||0
7525975|NCT03550066|18531044|P1|NOT COMPLETED|Overall Study||0
7525976|NCT03550066|18531043|P2|COMPLETED|Overall Study||41
7525977|NCT03550066|18531044|P1|COMPLETED|Overall Study||49
7525978|NCT03550066|18531043|P2|STARTED|Overall Study||41
7525979|NCT03550066|18531044|P1|STARTED|Overall Study||49
7525980|NCT03549598|18531054|P1|NOT COMPLETED|Overall Study||0
7525981|NCT03549598|18531054|P1|COMPLETED|Overall Study||15
7525982|NCT03549598|18531054|P1|STARTED|Overall Study||15
7525983|NCT03549429|18531066|P2|NOT COMPLETED|Overall Study||3
7525984|NCT03549429|18531067|P1|NOT COMPLETED|Overall Study||5
7525985|NCT03549429|18531066|P2|COMPLETED|Overall Study||75
7525986|NCT03549429|18531067|P1|COMPLETED|Overall Study||76
7525987|NCT03549429|18531066|P2|STARTED|Overall Study||78
7525988|NCT03549429|18531067|P1|STARTED|Overall Study||81
7525989|NCT03549338|18531080|P3|NOT COMPLETED|Overall Study||0
7525990|NCT03549338|18531081|P2|NOT COMPLETED|Overall Study||1
7525991|NCT03549338|18531082|P1|NOT COMPLETED|Overall Study||1
7525992|NCT03549338|18531080|P3|COMPLETED|Overall Study||0
7525993|NCT03549338|18531081|P2|COMPLETED|Overall Study|Patient crossed-over to Sym004 at the EOC1 per Sponsor decision following trial termination.|0
7525994|NCT03549338|18531082|P1|COMPLETED|Overall Study||0
7525995|NCT03549338|18531080|P3|STARTED|Overall Study||0
7525996|NCT03549338|18531081|P2|STARTED|Overall Study||1
7525997|NCT03549338|18531082|P1|STARTED|Overall Study||1
7525998|NCT03549234|18531090|P2|NOT COMPLETED|Overall Study||0
7525999|NCT03549234|18531091|P1|NOT COMPLETED|Overall Study||0
7526000|NCT03549234|18531090|P2|COMPLETED|Overall Study||50
7526001|NCT03549234|18531091|P1|COMPLETED|Overall Study||50
7526002|NCT03549234|18531090|P2|STARTED|Overall Study||50
7526003|NCT03549234|18531091|P1|STARTED|Overall Study||50
7526004|NCT03549130|18531109|P2|NOT COMPLETED|Overall Study||2
7526005|NCT03549130|18531110|P1|NOT COMPLETED|Overall Study||0
7526006|NCT03549130|18531109|P2|COMPLETED|Overall Study||64
7526007|NCT03549130|18531110|P1|COMPLETED|Overall Study||64
7526008|NCT03549130|18531109|P2|STARTED|Overall Study||66
7526009|NCT03549130|18531110|P1|STARTED|Overall Study||64
7526010|NCT03549117|18531128|P2|NOT COMPLETED|Overall Study||0
7526011|NCT03549117|18531129|P1|NOT COMPLETED|Overall Study||1
7526012|NCT03549117|18531128|P2|COMPLETED|Overall Study||70
7526013|NCT03549117|18531129|P1|COMPLETED|Overall Study||69
7526014|NCT03549117|18531128|P2|STARTED|Overall Study||70
7526015|NCT03549117|18531129|P1|STARTED|Overall Study||70
7526016|NCT03548337|18531157|P2|NOT COMPLETED|Toddler Dose||1
7526017|NCT03548337|18531158|P1|NOT COMPLETED|Toddler Dose||1
7526018|NCT03548337|18531157|P2|COMPLETED|Toddler Dose||138
7526019|NCT03548337|18531158|P1|COMPLETED|Toddler Dose||138
7526020|NCT03548337|18531157|P2|Vaccination 4|Toddler Dose||139
7526021|NCT03548337|18531158|P1|Vaccination 4|Toddler Dose||139
7526022|NCT03548337|18531157|P2|STARTED|Toddler Dose||139
7526023|NCT03548337|18531158|P1|STARTED|Toddler Dose||139
7526024|NCT03548337|18531157|P2|NOT COMPLETED|Infant Series||11
7526025|NCT03548337|18531158|P1|NOT COMPLETED|Infant Series||12
7526026|NCT03548337|18531157|P2|COMPLETED|Infant Series||139
7526027|NCT03548337|18531158|P1|COMPLETED|Infant Series||139
7526028|NCT03548337|18531157|P2|Vaccination 3|Infant Series||141
7526029|NCT03548337|18531158|P1|Vaccination 3|Infant Series||144
7526030|NCT03548337|18531157|P2|Vaccination 2|Infant Series||144
7526031|NCT03548337|18531158|P1|Vaccination 2|Infant Series||144
7526032|NCT03548337|18531157|P2|Vaccination 1|Infant Series||150
7526033|NCT03548337|18531158|P1|Vaccination 1|Infant Series||150
7526034|NCT03548337|18531157|P2|STARTED|Infant Series||150
7526035|NCT03548337|18531158|P1|STARTED|Infant Series||151
7526036|NCT03547635|18531209|P3|NOT COMPLETED|Overall Study||8
7526037|NCT03547635|18531210|P2|NOT COMPLETED|Overall Study||7
7526038|NCT03547635|18531211|P1|NOT COMPLETED|Overall Study||8
7526039|NCT03547635|18531209|P3|COMPLETED|Overall Study||29
7526040|NCT03547635|18531210|P2|COMPLETED|Overall Study||31
7526041|NCT03547635|18531211|P1|COMPLETED|Overall Study||33
7526042|NCT03547635|18531209|P3|STARTED|Overall Study||37
7526043|NCT03547635|18531210|P2|STARTED|Overall Study||38
7526044|NCT03547635|18531211|P1|STARTED|Overall Study||41
7526045|NCT03547583|18531222|P3|NOT COMPLETED|Overall Study||32
7526046|NCT03547583|18531223|P2|NOT COMPLETED|Overall Study||40
7526047|NCT03547583|18531224|P1|NOT COMPLETED|Overall Study||45
7526048|NCT03547583|18531222|P3|COMPLETED|Overall Study||230
7526049|NCT03547583|18531223|P2|COMPLETED|Overall Study||224
7526050|NCT03547583|18531224|P1|COMPLETED|Overall Study||218
7526051|NCT03547583|18531222|P3|Treated|Overall Study||262
7526052|NCT03547583|18531223|P2|Treated|Overall Study||264
7526053|NCT03547583|18531224|P1|Treated|Overall Study||262
7526054|NCT03547583|18531222|P3|STARTED|Overall Study||262
7526055|NCT03547583|18531223|P2|STARTED|Overall Study||264
7526056|NCT03547583|18531224|P1|STARTED|Overall Study||263
7526057|NCT03547531|18531240|P2|NOT COMPLETED|Overall Study||4
7526058|NCT03547531|18531241|P1|NOT COMPLETED|Overall Study||2
7526059|NCT03547531|18531240|P2|COMPLETED|Overall Study||58
7526060|NCT03547531|18531241|P1|COMPLETED|Overall Study||60
7526061|NCT03547531|18531240|P2|STARTED|Overall Study||62
7526062|NCT03547531|18531241|P1|STARTED|Overall Study||62
7526063|NCT03547154|18531255|P2|NOT COMPLETED|Overall Study||116
7526064|NCT03547154|18531256|P1|NOT COMPLETED|Overall Study||123
7526065|NCT03547154|18531255|P2|COMPLETED|Overall Study||55
7526066|NCT03547154|18531256|P1|COMPLETED|Overall Study||50
7526067|NCT03547154|18531255|P2|STARTED|Overall Study||171
7526068|NCT03547154|18531256|P1|STARTED|Overall Study||173
7526069|NCT03546842|18531268|P1|NOT COMPLETED|Overall Study||3
7526070|NCT03546842|18531268|P1|COMPLETED|Overall Study||198
7526071|NCT03546842|18531268|P1|Vaccination 3|Overall Study||198
7526072|NCT03546842|18531268|P1|Vaccination 2|Overall Study||200
7526073|NCT03546842|18531268|P1|Vaccination 1|Overall Study||200
7526074|NCT03546842|18531268|P1|STARTED|Overall Study||201
7526075|NCT03546816|18531279|P2|NOT COMPLETED|Overall Study||19
7526076|NCT03546816|18531280|P1|NOT COMPLETED|Overall Study||21
7526077|NCT03546816|18531279|P2|COMPLETED|Overall Study||124
7526078|NCT03546816|18531280|P1|COMPLETED|Overall Study||121
7526079|NCT03546816|18531279|P2|STARTED|Overall Study||143
7526080|NCT03546816|18531280|P1|STARTED|Overall Study||142
7526081|NCT03546621|18531308|P4|NOT COMPLETED|Overall Study||3
7526082|NCT03546621|18531309|P3|NOT COMPLETED|Overall Study||2
7526083|NCT03546621|18531310|P2|NOT COMPLETED|Overall Study||3
7526084|NCT03546621|18531311|P1|NOT COMPLETED|Overall Study||0
7526085|NCT03546621|18531308|P4|COMPLETED|Overall Study||25
7526086|NCT03546621|18531309|P3|COMPLETED|Overall Study||28
7526087|NCT03546621|18531310|P2|COMPLETED|Overall Study||29
7526088|NCT03546621|18531311|P1|COMPLETED|Overall Study||28
7526089|NCT03546621|18531308|P4|STARTED|Overall Study|2 patients from Tenofovir only group withdrew from the study before treatment.|28
7526090|NCT03546621|18531309|P3|STARTED|Overall Study||30
7526091|NCT03546621|18531310|P2|STARTED|Overall Study||32
7526092|NCT03546621|18531311|P1|STARTED|Overall Study||28
7526093|NCT03546491|18531349|P1|NOT COMPLETED|Overall Study||2
7526094|NCT03546491|18531349|P1|COMPLETED|Overall Study||30
7526095|NCT03546491|18531349|P1|Received Test Product 2|Overall Study||32
7526096|NCT03546491|18531349|P1|Recieved Test Product 1|Overall Study||32
7526097|NCT03546491|18531349|P1|STARTED|Overall Study||32
7526098|NCT03546270|18531363|P2|NOT COMPLETED|Overall Study||0
7526099|NCT03546270|18531364|P1|NOT COMPLETED|Overall Study||0
7526100|NCT03546270|18531363|P2|COMPLETED|Overall Study||48
7526101|NCT03546270|18531364|P1|COMPLETED|Overall Study||52
7526102|NCT03546270|18531363|P2|STARTED|Overall Study||48
7526103|NCT03546270|18531364|P1|STARTED|Overall Study||52
7526104|NCT03546192|18531382|P2|NOT COMPLETED|Overall Study||0
7526105|NCT03546192|18531383|P1|NOT COMPLETED|Overall Study||0
7526106|NCT03546192|18531382|P2|COMPLETED|Overall Study||60
7526107|NCT03546192|18531383|P1|COMPLETED|Overall Study||60
7526108|NCT03546192|18531382|P2|STARTED|Overall Study||60
7526109|NCT03546192|18531383|P1|STARTED|Overall Study||60
7526110|NCT03545984|18531401|P2|NOT COMPLETED|Overall Study||9
7526111|NCT03545984|18531402|P1|NOT COMPLETED|Overall Study||11
7526112|NCT03545984|18531401|P2|COMPLETED|Overall Study||15
7526113|NCT03545984|18531402|P1|COMPLETED|Overall Study||13
7526114|NCT03545984|18531401|P2|STARTED|Overall Study||24
7526115|NCT03545984|18531402|P1|STARTED|Overall Study||24
7526116|NCT03545893|18531410|P2|NOT COMPLETED|Overall Study||0
7526117|NCT03545893|18531411|P1|NOT COMPLETED|Overall Study||0
7526118|NCT03545893|18531410|P2|COMPLETED|Overall Study||35
7526119|NCT03545893|18531411|P1|COMPLETED|Overall Study||35
7526120|NCT03545893|18531410|P2|STARTED|Overall Study||35
7526121|NCT03545893|18531411|P1|STARTED|Overall Study||35
7526122|NCT03545412|18531417|P1|NOT COMPLETED|Overall Study||0
7526123|NCT03545412|18531417|P1|COMPLETED|Overall Study||25
7526124|NCT03545412|18531417|P1|STARTED|Overall Study||25
7526125|NCT03544879|18531429|P2|NOT COMPLETED|Overall Study||1
7526126|NCT03544879|18531430|P1|NOT COMPLETED|Overall Study||0
7526127|NCT03544879|18531429|P2|COMPLETED|Overall Study||23
7526128|NCT03544879|18531430|P1|COMPLETED|Overall Study||22
7526129|NCT03544879|18531429|P2|Completed Follow-up Physical Assessment|Overall Study||21
7526130|NCT03544879|18531430|P1|Completed Follow-up Physical Assessment|Overall Study||20
7526131|NCT03544879|18531429|P2|STARTED|Overall Study||24
7526132|NCT03544879|18531430|P1|STARTED|Overall Study||22
7526133|NCT03544307|18531458|P2|NOT COMPLETED|Overall Study||0
7526134|NCT03544307|18531459|P1|NOT COMPLETED|Overall Study||0
7526135|NCT03544307|18531458|P2|COMPLETED|Overall Study||10
7526136|NCT03544307|18531459|P1|COMPLETED|Overall Study||10
7526137|NCT03544307|18531458|P2|STARTED|Overall Study||10
7526138|NCT03544307|18531459|P1|STARTED|Overall Study||10
7526139|NCT03544242|18531480|P3|NOT COMPLETED|Overall Study||0
7526140|NCT03544242|18531481|P2|NOT COMPLETED|Overall Study||0
7526141|NCT03544242|18531482|P1|NOT COMPLETED|Overall Study||0
7526142|NCT03544242|18531480|P3|COMPLETED|Overall Study||2
7526143|NCT03544242|18531481|P2|COMPLETED|Overall Study||1
7526144|NCT03544242|18531482|P1|COMPLETED|Overall Study||1
7526145|NCT03544242|18531480|P3|STARTED|Overall Study||2
7526146|NCT03544242|18531481|P2|STARTED|Overall Study||1
7526147|NCT03544242|18531482|P1|STARTED|Overall Study||1
7526148|NCT03544216|18531513|P2|NOT COMPLETED|Overall Study||0
7526149|NCT03544216|18531514|P1|NOT COMPLETED|Overall Study||0
7526150|NCT03544216|18531513|P2|COMPLETED|Overall Study||42
7526151|NCT03544216|18531514|P1|COMPLETED|Overall Study||42
7526152|NCT03544216|18531513|P2|STARTED|Overall Study||42
7526153|NCT03544216|18531514|P1|STARTED|Overall Study||42
7526154|NCT03543176|18531523|P2|NOT COMPLETED|Overall Study||0
7526155|NCT03543176|18531524|P1|NOT COMPLETED|Overall Study||0
7526156|NCT03543176|18531523|P2|COMPLETED|Overall Study||397
7526157|NCT03543176|18531524|P1|COMPLETED|Overall Study||392
7526158|NCT03543176|18531523|P2|STARTED|Overall Study||397
7526159|NCT03543176|18531524|P1|STARTED|Overall Study||392
7526160|NCT03543137|18531566|P2|NOT COMPLETED|Study Period 2: Up to Day 8||1
7526161|NCT03543137|18531567|P1|NOT COMPLETED|Study Period 2: Up to Day 8||2
7526162|NCT03543137|18531566|P2|COMPLETED|Study Period 2: Up to Day 8||18
7526163|NCT03543137|18531567|P1|COMPLETED|Study Period 2: Up to Day 8||16
7526164|NCT03543137|18531566|P2|Treated|Study Period 2: Up to Day 8||18
7526165|NCT03543137|18531567|P1|Treated|Study Period 2: Up to Day 8||16
7526166|NCT03543137|18531566|P2|STARTED|Study Period 2: Up to Day 8||19
7526167|NCT03543137|18531567|P1|STARTED|Study Period 2: Up to Day 8||18
7526168|NCT03543137|18531566|P2|NOT COMPLETED|Washout Period: 5 to 7 Days||0
7526169|NCT03543137|18531567|P1|NOT COMPLETED|Washout Period: 5 to 7 Days||0
7526170|NCT03543137|18531566|P2|COMPLETED|Washout Period: 5 to 7 Days||19
7526171|NCT03543137|18531567|P1|COMPLETED|Washout Period: 5 to 7 Days||18
7526172|NCT03543137|18531566|P2|STARTED|Washout Period: 5 to 7 Days||19
7526173|NCT03543137|18531567|P1|STARTED|Washout Period: 5 to 7 Days||18
7526174|NCT03543137|18531566|P2|NOT COMPLETED|Study Period 1: Up to Day 1||0
7526175|NCT03543137|18531567|P1|NOT COMPLETED|Study Period 1: Up to Day 1||0
7526176|NCT03543137|18531566|P2|COMPLETED|Study Period 1: Up to Day 1||19
7526177|NCT03543137|18531567|P1|COMPLETED|Study Period 1: Up to Day 1||18
7526178|NCT03543137|18531566|P2|STARTED|Study Period 1: Up to Day 1||19
7526179|NCT03543137|18531567|P1|STARTED|Study Period 1: Up to Day 1||18
7526180|NCT03542474|18531587|P1|NOT COMPLETED|Overall Study||0
7526181|NCT03542474|18531587|P1|COMPLETED|Overall Study||8
7526182|NCT03542474|18531587|P1|STARTED|Overall Study||8
7526183|NCT03541356|18531597|P5|NOT COMPLETED|Overall Study||0
7526184|NCT03541356|18531598|P4|NOT COMPLETED|Overall Study||0
7526185|NCT03541356|18531599|P3|NOT COMPLETED|Overall Study||0
7526186|NCT03541356|18531600|P2|NOT COMPLETED|Overall Study||0
7526187|NCT03541356|18531601|P1|NOT COMPLETED|Overall Study||0
7526188|NCT03541356|18531597|P5|COMPLETED|Overall Study||6
7526189|NCT03541356|18531598|P4|COMPLETED|Overall Study||6
7526190|NCT03541356|18531599|P3|COMPLETED|Overall Study||6
7526191|NCT03541356|18531600|P2|COMPLETED|Overall Study||6
7526192|NCT03541356|18531601|P1|COMPLETED|Overall Study||8
7526193|NCT03541356|18531597|P5|STARTED|Overall Study||6
7526194|NCT03541356|18531598|P4|STARTED|Overall Study||6
7526195|NCT03541356|18531599|P3|STARTED|Overall Study||6
7526196|NCT03541356|18531600|P2|STARTED|Overall Study||6
7526197|NCT03541356|18531601|P1|STARTED|Overall Study||8
7526198|NCT03541044|18531668|P2|NOT COMPLETED|Study Period 2: Up to Day 8||0
7526199|NCT03541044|18531669|P1|NOT COMPLETED|Study Period 2: Up to Day 8||2
7526200|NCT03541044|18531668|P2|COMPLETED|Study Period 2: Up to Day 8||23
7526201|NCT03541044|18531669|P1|COMPLETED|Study Period 2: Up to Day 8||21
7526202|NCT03541044|18531668|P2|STARTED|Study Period 2: Up to Day 8||23
7526203|NCT03541044|18531669|P1|STARTED|Study Period 2: Up to Day 8||23
7526204|NCT03541044|18531668|P2|NOT COMPLETED|Washout Period: 5 to 7 Days||0
7526205|NCT03541044|18531669|P1|NOT COMPLETED|Washout Period: 5 to 7 Days||0
7526206|NCT03541044|18531668|P2|COMPLETED|Washout Period: 5 to 7 Days||23
7526207|NCT03541044|18531669|P1|COMPLETED|Washout Period: 5 to 7 Days||23
7526208|NCT03541044|18531668|P2|STARTED|Washout Period: 5 to 7 Days||23
7526209|NCT03541044|18531669|P1|STARTED|Washout Period: 5 to 7 Days||23
7526210|NCT03541044|18531668|P2|NOT COMPLETED|Study Period 1: Up to Day 1||0
7526211|NCT03541044|18531669|P1|NOT COMPLETED|Study Period 1: Up to Day 1||0
7526212|NCT03541044|18531668|P2|COMPLETED|Study Period 1: Up to Day 1||23
7526213|NCT03541044|18531669|P1|COMPLETED|Study Period 1: Up to Day 1||23
7526214|NCT03541044|18531668|P2|STARTED|Study Period 1: Up to Day 1||23
7526215|NCT03541044|18531669|P1|STARTED|Study Period 1: Up to Day 1||23
7526216|NCT03540160|18531689|P1|NOT COMPLETED|Overall Study||379
7526217|NCT03540160|18531689|P1|COMPLETED|Overall Study||179
7526218|NCT03540160|18531689|P1|STARTED|Overall Study||558
7526219|NCT03540030|18531695|P2|NOT COMPLETED|Overall Study||3
7526220|NCT03540030|18531696|P1|NOT COMPLETED|Overall Study||18
7526221|NCT03540030|18531695|P2|COMPLETED|Overall Study||35
7526222|NCT03540030|18531696|P1|COMPLETED|Overall Study||30
7526223|NCT03540030|18531695|P2|STARTED|Overall Study||38
7526224|NCT03540030|18531696|P1|STARTED|Overall Study||48
7526225|NCT03539549|18531732|P1|NOT COMPLETED|Overall Study||17
7526226|NCT03539549|18531732|P1|COMPLETED|Overall Study||106
7526227|NCT03539549|18531732|P1|STARTED|Overall Study||123
7526228|NCT03539484|18531747|P7|NOT COMPLETED|Overall Study||2
7526229|NCT03539484|18531748|P6|NOT COMPLETED|Overall Study||5
7526230|NCT03539484|18531749|P5|NOT COMPLETED|Overall Study||13
7526231|NCT03539484|18531750|P4|NOT COMPLETED|Overall Study||3
7526232|NCT03539484|18531751|P3|NOT COMPLETED|Overall Study||1
7526233|NCT03539484|18531752|P2|NOT COMPLETED|Overall Study||1
7526234|NCT03539484|18531753|P1|NOT COMPLETED|Overall Study||1
7526235|NCT03539484|18531747|P7|COMPLETED|Overall Study||0
7526236|NCT03539484|18531748|P6|COMPLETED|Overall Study||0
7526237|NCT03539484|18531749|P5|COMPLETED|Overall Study||0
7526238|NCT03539484|18531750|P4|COMPLETED|Overall Study||0
7526239|NCT03539484|18531751|P3|COMPLETED|Overall Study||0
7526240|NCT03539484|18531752|P2|COMPLETED|Overall Study||0
7526241|NCT03539484|18531753|P1|COMPLETED|Overall Study||0
7526242|NCT03539484|18531747|P7|STARTED|Overall Study||2
7526243|NCT03539484|18531748|P6|STARTED|Overall Study||5
7526244|NCT03539484|18531749|P5|STARTED|Overall Study||13
7526245|NCT03539484|18531750|P4|STARTED|Overall Study||3
7526246|NCT03539484|18531751|P3|STARTED|Overall Study||1
7526247|NCT03539484|18531752|P2|STARTED|Overall Study||1
7526248|NCT03539484|18531753|P1|STARTED|Overall Study||1
7526249|NCT03539211|18531889|P2|NOT COMPLETED|Overall Study||0
7526250|NCT03539211|18531890|P1|NOT COMPLETED|Overall Study||0
7526251|NCT03539211|18531889|P2|COMPLETED|Overall Study||15
7526252|NCT03539211|18531890|P1|COMPLETED|Overall Study||16
7526253|NCT03539211|18531889|P2|STARTED|Overall Study||15
7526254|NCT03539211|18531890|P1|STARTED|Overall Study||16
7526255|NCT03538808|18531902|P4|NOT COMPLETED|Overall Study||2
7526256|NCT03538808|18531903|P3|NOT COMPLETED|Overall Study||4
7526257|NCT03538808|18531904|P2|NOT COMPLETED|Overall Study||0
7526258|NCT03538808|18531905|P1|NOT COMPLETED|Overall Study||2
7526259|NCT03538808|18531902|P4|COMPLETED|Overall Study||18
7526260|NCT03538808|18531903|P3|COMPLETED|Overall Study||16
7526261|NCT03538808|18531904|P2|COMPLETED|Overall Study||20
7526262|NCT03538808|18531905|P1|COMPLETED|Overall Study||18
7526263|NCT03538808|18531902|P4|STARTED|Overall Study||20
7526264|NCT03538808|18531903|P3|STARTED|Overall Study||20
7526265|NCT03538808|18531904|P2|STARTED|Overall Study||20
7526266|NCT03538808|18531905|P1|STARTED|Overall Study||20
7526267|NCT03538795|18531923|P1|NOT COMPLETED|Overall Study||0
7526268|NCT03538795|18531923|P1|COMPLETED|Overall Study||3
7526269|NCT03538795|18531923|P1|STARTED|Overall Study||3
7526270|NCT03538743|18531938|P9|NOT COMPLETED|Overall Study||3
7526271|NCT03538743|18531939|P8|NOT COMPLETED|Overall Study||0
7526272|NCT03538743|18531940|P7|NOT COMPLETED|Overall Study||0
7526273|NCT03538743|18531941|P6|NOT COMPLETED|Overall Study||0
7526274|NCT03538743|18531942|P5|NOT COMPLETED|Overall Study||0
7526275|NCT03538743|18531943|P4|NOT COMPLETED|Overall Study||2
7526276|NCT03538743|18531944|P3|NOT COMPLETED|Overall Study||1
7526277|NCT03538743|18531945|P2|NOT COMPLETED|Overall Study||0
7526278|NCT03538743|18531946|P1|NOT COMPLETED|Overall Study||0
7526279|NCT03538743|18531938|P9|COMPLETED|Overall Study||7
7526280|NCT03538743|18531939|P8|COMPLETED|Overall Study||8
7526281|NCT03538743|18531940|P7|COMPLETED|Overall Study||9
7526282|NCT03538743|18531941|P6|COMPLETED|Overall Study||9
7526283|NCT03538743|18531942|P5|COMPLETED|Overall Study||9
7526284|NCT03538743|18531943|P4|COMPLETED|Overall Study||8
7526285|NCT03538743|18531944|P3|COMPLETED|Overall Study||8
7526286|NCT03538743|18531945|P2|COMPLETED|Overall Study||9
7526287|NCT03538743|18531946|P1|COMPLETED|Overall Study||25
7526288|NCT03538743|18531938|P9|Received Treatment|Overall Study||10
7526289|NCT03538743|18531939|P8|Received Treatment|Overall Study||8
7526290|NCT03538743|18531940|P7|Received Treatment|Overall Study||9
7526291|NCT03538743|18531941|P6|Received Treatment|Overall Study||9
7526292|NCT03538743|18531942|P5|Received Treatment|Overall Study||9
7526293|NCT03538743|18531943|P4|Received Treatment|Overall Study||10
7526294|NCT03538743|18531944|P3|Received Treatment|Overall Study||9
7526295|NCT03538743|18531945|P2|Received Treatment|Overall Study||9
7526296|NCT03538743|18531946|P1|Received Treatment|Overall Study||25
7526297|NCT03538743|18531938|P9|STARTED|Overall Study||10
7526298|NCT03538743|18531939|P8|STARTED|Overall Study||8
7526299|NCT03538743|18531940|P7|STARTED|Overall Study||9
7526300|NCT03538743|18531941|P6|STARTED|Overall Study||9
7526301|NCT03538743|18531942|P5|STARTED|Overall Study||9
7526302|NCT03538743|18531943|P4|STARTED|Overall Study||10
7526303|NCT03538743|18531944|P3|STARTED|Overall Study||9
7526304|NCT03538743|18531945|P2|STARTED|Overall Study||9
7526305|NCT03538743|18531946|P1|STARTED|Overall Study||25
7526306|NCT03538717|18532049|P1|NOT COMPLETED|Overall Study||0
7526307|NCT03538717|18532049|P1|COMPLETED|Overall Study||157
7526308|NCT03538717|18532049|P1|STARTED|Overall Study||157
7526309|NCT03538015|18532110|P3|NOT COMPLETED|Overall Study||1
7526310|NCT03538015|18532111|P2|NOT COMPLETED|Overall Study||0
7526311|NCT03538015|18532112|P1|NOT COMPLETED|Overall Study||0
7526312|NCT03538015|18532110|P3|COMPLETED|Overall Study||0
7526313|NCT03538015|18532111|P2|COMPLETED|Overall Study||0
7526314|NCT03538015|18532112|P1|COMPLETED|Overall Study||0
7526315|NCT03538015|18532110|P3|STARTED|Overall Study||1
7526316|NCT03538015|18532111|P2|STARTED|Overall Study||0
7526317|NCT03538015|18532112|P1|STARTED|Overall Study||0
7526318|NCT03537664|18532138|P2|NOT COMPLETED|Overall Study||0
7526319|NCT03537664|18532139|P1|NOT COMPLETED|Overall Study||0
7526320|NCT03537664|18532138|P2|COMPLETED|Overall Study||25
7526321|NCT03537664|18532139|P1|COMPLETED|Overall Study||20
7526322|NCT03537664|18532138|P2|Endodontic Success|Overall Study||10
7526323|NCT03537664|18532139|P1|Endodontic Success|Overall Study||20
7526324|NCT03537664|18532138|P2|Bacterial Community Diversity|Overall Study||0
7526325|NCT03537664|18532139|P1|Bacterial Community Diversity|Overall Study||10
7526326|NCT03537664|18532138|P2|Bacterial Levels|Overall Study||25
7526327|NCT03537664|18532139|P1|Bacterial Levels|Overall Study||20
7526328|NCT03537664|18532138|P2|Metabolic Activity of Bacteria|Overall Study||25
7526329|NCT03537664|18532139|P1|Metabolic Activity of Bacteria|Overall Study|5 patients were excluded from metabolic activity analysis (lost of RNA)|15
7526330|NCT03537664|18532138|P2|STARTED|Overall Study||25
7526331|NCT03537664|18532139|P1|STARTED|Overall Study||20
7526332|NCT03537404|18532153|P2|NOT COMPLETED|Third Intervention (A or B or C)||0
7526333|NCT03537404|18532154|P1|NOT COMPLETED|Third Intervention (A or B or C)||0
7526334|NCT03537404|18532153|P2|COMPLETED|Third Intervention (A or B or C)||18
7526335|NCT03537404|18532154|P1|COMPLETED|Third Intervention (A or B or C)||18
7526336|NCT03537404|18532153|P2|STARTED|Third Intervention (A or B or C)||18
7526337|NCT03537404|18532154|P1|STARTED|Third Intervention (A or B or C)||18
7526338|NCT03537404|18532153|P2|NOT COMPLETED|Second Washout Period (8 Days)||0
7526339|NCT03537404|18532154|P1|NOT COMPLETED|Second Washout Period (8 Days)||0
7526340|NCT03537404|18532153|P2|COMPLETED|Second Washout Period (8 Days)||18
7526341|NCT03537404|18532154|P1|COMPLETED|Second Washout Period (8 Days)||18
7526342|NCT03537404|18532153|P2|STARTED|Second Washout Period (8 Days)||18
7526343|NCT03537404|18532154|P1|STARTED|Second Washout Period (8 Days)||18
7526344|NCT03537404|18532153|P2|NOT COMPLETED|Second Intervention (A or B or C)||0
7526345|NCT03537404|18532154|P1|NOT COMPLETED|Second Intervention (A or B or C)||0
7526346|NCT03537404|18532153|P2|COMPLETED|Second Intervention (A or B or C)||18
7526347|NCT03537404|18532154|P1|COMPLETED|Second Intervention (A or B or C)||18
7526348|NCT03537404|18532153|P2|STARTED|Second Intervention (A or B or C)||18
7526349|NCT03537404|18532154|P1|STARTED|Second Intervention (A or B or C)||18
7526350|NCT03537404|18532153|P2|NOT COMPLETED|First Washout Period (8 Days)||0
7526351|NCT03537404|18532154|P1|NOT COMPLETED|First Washout Period (8 Days)||0
7526352|NCT03537404|18532153|P2|COMPLETED|First Washout Period (8 Days)||18
7526353|NCT03537404|18532154|P1|COMPLETED|First Washout Period (8 Days)||18
7526354|NCT03537404|18532153|P2|STARTED|First Washout Period (8 Days)||18
7526355|NCT03537404|18532154|P1|STARTED|First Washout Period (8 Days)||18
7526356|NCT03537404|18532153|P2|NOT COMPLETED|First Intervention (A or B or C)||0
7526357|NCT03537404|18532154|P1|NOT COMPLETED|First Intervention (A or B or C)||0
7526358|NCT03537404|18532153|P2|COMPLETED|First Intervention (A or B or C)||18
7526359|NCT03537404|18532154|P1|COMPLETED|First Intervention (A or B or C)||18
7526360|NCT03537404|18532153|P2|STARTED|First Intervention (A or B or C)||18
7526361|NCT03537404|18532154|P1|STARTED|First Intervention (A or B or C)||18
7526362|NCT03537274|18532200|P4|NOT COMPLETED|Overall Study||76
7526363|NCT03537274|18532201|P3|NOT COMPLETED|Overall Study||76
7526364|NCT03537274|18532202|P2|NOT COMPLETED|Overall Study||69
7526365|NCT03537274|18532203|P1|NOT COMPLETED|Overall Study||60
7526366|NCT03537274|18532200|P4|COMPLETED|Overall Study||231
7526367|NCT03537274|18532201|P3|COMPLETED|Overall Study||228
7526368|NCT03537274|18532202|P2|COMPLETED|Overall Study||229
7526369|NCT03537274|18532203|P1|COMPLETED|Overall Study||255
7526370|NCT03537274|18532200|P4|Treated|Overall Study||303
7526371|NCT03537274|18532201|P3|Treated|Overall Study||304
7526372|NCT03537274|18532202|P2|Treated|Overall Study||297
7526373|NCT03537274|18532203|P1|Treated|Overall Study||315
7526374|NCT03537274|18532200|P4|STARTED|Overall Study||307
7526375|NCT03537274|18532201|P3|STARTED|Overall Study||304
7526376|NCT03537274|18532202|P2|STARTED|Overall Study||298
7526377|NCT03537274|18532203|P1|STARTED|Overall Study||315
7526378|NCT03537092|18532217|P1|NOT COMPLETED|Overall Study||0
7526379|NCT03537092|18532217|P1|COMPLETED|Overall Study||64
7526380|NCT03537092|18532217|P1|STARTED|Overall Study||64
7526381|NCT03536949|18532226|P2|NOT COMPLETED|Overall Study||2
7526382|NCT03536949|18532227|P1|NOT COMPLETED|Overall Study||14
7526383|NCT03536949|18532226|P2|COMPLETED|Overall Study||75
7526384|NCT03536949|18532227|P1|COMPLETED|Overall Study||143
7526385|NCT03536949|18532226|P2|STARTED|Overall Study||77
7526386|NCT03536949|18532227|P1|STARTED|Overall Study||157
7526387|NCT03536923|18532235|P1|NOT COMPLETED|Overall Study||0
7526388|NCT03536923|18532235|P1|COMPLETED|Overall Study||23
7526389|NCT03536923|18532235|P1|STARTED|Overall Study||23
7526390|NCT03536819|18532242|P1|NOT COMPLETED|Overall Study||5
7526391|NCT03536819|18532242|P1|COMPLETED|Overall Study||15
7526392|NCT03536819|18532242|P1|STARTED|Overall Study||20
7526393|NCT03536702|18532255|P2|NOT COMPLETED|Overall Study||12
7526394|NCT03536702|18532256|P1|NOT COMPLETED|Overall Study||14
7526395|NCT03536702|18532255|P2|COMPLETED|Overall Study||8
7526396|NCT03536702|18532256|P1|COMPLETED|Overall Study||26
7526397|NCT03536702|18532255|P2|STARTED|Overall Study||20
7526398|NCT03536702|18532256|P1|STARTED|Overall Study||40
7526399|NCT03536663|18532290|P1|NOT COMPLETED|Endexo||1
7526400|NCT03536663|18532290|P1|COMPLETED|Endexo||17
7526401|NCT03536663|18532290|P1|STARTED|Endexo|One subject completed the Optiflux period but missed Visit 13 and was withdrawn per protocol.|18
7526402|NCT03536663|18532290|P1|NOT COMPLETED|Optiflux||4
7526403|NCT03536663|18532290|P1|COMPLETED|Optiflux||19
7526404|NCT03536663|18532290|P1|STARTED|Optiflux||23
7526405|NCT03535974|18532308|P3|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
7526406|NCT03535974|18532309|P2|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
7526407|NCT03535974|18532310|P1|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
7526408|NCT03535974|18532308|P3|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||5
7526409|NCT03535974|18532309|P2|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||17
7526410|NCT03535974|18532310|P1|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||12
7526411|NCT03535974|18532308|P3|STARTED|Second Intervention Weeks 6-12 (V2-V3)||5
7526412|NCT03535974|18532309|P2|STARTED|Second Intervention Weeks 6-12 (V2-V3)||17
7526413|NCT03535974|18532310|P1|STARTED|Second Intervention Weeks 6-12 (V2-V3)||12
7526414|NCT03535974|18532308|P3|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||0
7526415|NCT03535974|18532309|P2|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
7526416|NCT03535974|18532310|P1|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
7526417|NCT03535974|18532308|P3|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||5
7526418|NCT03535974|18532309|P2|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||17
7526419|NCT03535974|18532310|P1|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||12
7526420|NCT03535974|18532308|P3|STARTED|First Intervention Weeks 0-6 (V1-V2)||5
7526421|NCT03535974|18532309|P2|STARTED|First Intervention Weeks 0-6 (V1-V2)||19
7526422|NCT03535974|18532310|P1|STARTED|First Intervention Weeks 0-6 (V1-V2)||14
7526423|NCT03535844|18532320|P2|NOT COMPLETED|Overall Study||1
7526424|NCT03535844|18532321|P1|NOT COMPLETED|Overall Study||0
7526425|NCT03535844|18532320|P2|COMPLETED|Overall Study||18
7526426|NCT03535844|18532321|P1|COMPLETED|Overall Study||22
7526427|NCT03535844|18532320|P2|STARTED|Overall Study||19
7526428|NCT03535844|18532321|P1|STARTED|Overall Study||22
7526429|NCT03535649|18532357|P1|NOT COMPLETED|Overall Study||0
7526430|NCT03535649|18532357|P1|COMPLETED|Overall Study||105
7526431|NCT03535649|18532357|P1|STARTED|Overall Study||105
7526432|NCT03535571|18532366|P1|NOT COMPLETED|Overall Study||1
7526433|NCT03535571|18532366|P1|COMPLETED|Overall Study||19
7526434|NCT03535571|18532366|P1|STARTED|Overall Study||20
7526435|NCT03534986|18532398|P3|NOT COMPLETED|Overall Study||2
7526436|NCT03534986|18532399|P2|NOT COMPLETED|Overall Study||0
7526437|NCT03534986|18532400|P1|NOT COMPLETED|Overall Study||0
7526438|NCT03534986|18532398|P3|COMPLETED|Overall Study||10
7526439|NCT03534986|18532399|P2|COMPLETED|Overall Study||10
7526440|NCT03534986|18532400|P1|COMPLETED|Overall Study||10
7526441|NCT03534986|18532398|P3|STARTED|Overall Study||12
7526442|NCT03534986|18532399|P2|STARTED|Overall Study||10
7526443|NCT03534986|18532400|P1|STARTED|Overall Study||10
7526444|NCT03534427|18532422|P2|NOT COMPLETED|Overall Study||0
7526445|NCT03534427|18532423|P1|NOT COMPLETED|Overall Study||0
7526446|NCT03534427|18532422|P2|COMPLETED|Overall Study||20
7526447|NCT03534427|18532423|P1|COMPLETED|Overall Study||20
7526448|NCT03534427|18532422|P2|STARTED|Overall Study||20
7526449|NCT03534427|18532423|P1|STARTED|Overall Study||20
7526450|NCT03534362|18532451|P2|NOT COMPLETED|Overall Study||0
7526451|NCT03534362|18532452|P1|NOT COMPLETED|Overall Study||0
7526452|NCT03534362|18532451|P2|COMPLETED|Overall Study||1
7526453|NCT03534362|18532452|P1|COMPLETED|Overall Study||0
7526454|NCT03534362|18532451|P2|STARTED|Overall Study||1
7526455|NCT03534362|18532452|P1|STARTED|Overall Study||0
7526456|NCT03533829|18532465|P3|NOT COMPLETED|Overall Study||0
7526457|NCT03533829|18532466|P2|NOT COMPLETED|Overall Study||0
7526458|NCT03533829|18532467|P1|NOT COMPLETED|Overall Study||0
7526459|NCT03533829|18532465|P3|COMPLETED|Overall Study||10
7526460|NCT03533829|18532466|P2|COMPLETED|Overall Study||10
7526461|NCT03533829|18532467|P1|COMPLETED|Overall Study||10
7526462|NCT03533829|18532465|P3|STARTED|Overall Study||10
7526463|NCT03533829|18532466|P2|STARTED|Overall Study||10
7526464|NCT03533829|18532467|P1|STARTED|Overall Study||10
7526465|NCT03533374|18532567|P2|NOT COMPLETED|Overall Study||0
7526466|NCT03533374|18532568|P1|NOT COMPLETED|Overall Study||0
7526467|NCT03533374|18532567|P2|COMPLETED|Overall Study||46
7526468|NCT03533374|18532568|P1|COMPLETED|Overall Study||54
7526469|NCT03533374|18532567|P2|STARTED|Overall Study||46
7526470|NCT03533374|18532568|P1|STARTED|Overall Study||54
7526471|NCT03533244|18532581|P3|NOT COMPLETED|Overall Study||0
7526472|NCT03533244|18532582|P2|NOT COMPLETED|Overall Study||1
7526473|NCT03533244|18532583|P1|NOT COMPLETED|Overall Study||2
7526474|NCT03533244|18532581|P3|COMPLETED|Overall Study||22
7526475|NCT03533244|18532582|P2|COMPLETED|Overall Study||21
7526476|NCT03533244|18532583|P1|COMPLETED|Overall Study||18
7526477|NCT03533244|18532581|P3|STARTED|Overall Study||22
7526478|NCT03533244|18532582|P2|STARTED|Overall Study||22
7526479|NCT03533244|18532583|P1|STARTED|Overall Study||20
7526480|NCT03533036|18532599|P2|NOT COMPLETED|Overall Study||0
7526481|NCT03533036|18532600|P1|NOT COMPLETED|Overall Study||0
7526482|NCT03533036|18532599|P2|COMPLETED|Overall Study||15
7526483|NCT03533036|18532600|P1|COMPLETED|Overall Study||15
7526484|NCT03533036|18532599|P2|STARTED|Overall Study||15
7526485|NCT03533036|18532600|P1|STARTED|Overall Study||15
7526486|NCT03532048|18532609|P2|NOT COMPLETED|Overall Study||17
7526487|NCT03532048|18532610|P1|NOT COMPLETED|Overall Study||19
7526488|NCT03532048|18532609|P2|COMPLETED|Overall Study|50 individuals (13 fathers, 24 children & 13 mothers)|50
7526489|NCT03532048|18532610|P1|COMPLETED|Overall Study|49 individuals (14 fathers, 22 children, 13 mothers). 1 father only took part in interview|49
7526490|NCT03532048|18532609|P2|STARTED|Overall Study|67 individuals (17 fathers, 33 children & 17 mothers)|67
7526491|NCT03532048|18532610|P1|STARTED|Overall Study|68 individuals (19 fathers, 31 children & 18 mothers)|68
7526492|NCT03531905|18532627|P3|NOT COMPLETED|Overall Study||3
7526493|NCT03531905|18532628|P2|NOT COMPLETED|Overall Study||5
7526494|NCT03531905|18532629|P1|NOT COMPLETED|Overall Study||7
7526495|NCT03531905|18532627|P3|COMPLETED|Overall Study||77
7526496|NCT03531905|18532628|P2|COMPLETED|Overall Study||76
7526497|NCT03531905|18532629|P1|COMPLETED|Overall Study||74
7526498|NCT03531905|18532627|P3|STARTED|Overall Study||80
7526499|NCT03531905|18532628|P2|STARTED|Overall Study||81
7526500|NCT03531905|18532629|P1|STARTED|Overall Study||81
7526501|NCT03531710|18532687|P6|NOT COMPLETED|Overall Study||0
7526502|NCT03531710|18532688|P5|NOT COMPLETED|Overall Study||0
7526503|NCT03531710|18532689|P4|NOT COMPLETED|Overall Study||0
7526504|NCT03531710|18532690|P3|NOT COMPLETED|Overall Study||0
7526505|NCT03531710|18532691|P2|NOT COMPLETED|Overall Study||0
7526506|NCT03531710|18532692|P1|NOT COMPLETED|Overall Study||2
7526507|NCT03531710|18532687|P6|COMPLETED|Overall Study||2
7526508|NCT03531710|18532688|P5|COMPLETED|Overall Study||8
7526509|NCT03531710|18532689|P4|COMPLETED|Overall Study||5
7526510|NCT03531710|18532690|P3|COMPLETED|Overall Study||7
7526511|NCT03531710|18532691|P2|COMPLETED|Overall Study||2
7526512|NCT03531710|18532692|P1|COMPLETED|Overall Study||8
7526513|NCT03531710|18532687|P6|STARTED|Overall Study||2
7526514|NCT03531710|18532688|P5|STARTED|Overall Study||8
7526515|NCT03531710|18532689|P4|STARTED|Overall Study||5
7526516|NCT03531710|18532690|P3|STARTED|Overall Study||7
7526517|NCT03531710|18532691|P2|STARTED|Overall Study||2
7526518|NCT03531710|18532692|P1|STARTED|Overall Study||10
7526519|NCT03530917|18532720|P8|NOT COMPLETED|Overall Study||0
7526520|NCT03530917|18532721|P7|NOT COMPLETED|Overall Study||0
7526521|NCT03530917|18532722|P6|NOT COMPLETED|Overall Study||0
7526522|NCT03530917|18532723|P5|NOT COMPLETED|Overall Study||0
7526523|NCT03530917|18532724|P4|NOT COMPLETED|Overall Study||0
7526524|NCT03530917|18532725|P3|NOT COMPLETED|Overall Study||0
7526525|NCT03530917|18532726|P2|NOT COMPLETED|Overall Study||0
7526526|NCT03530917|18532727|P1|NOT COMPLETED|Overall Study||0
7526527|NCT03530917|18532720|P8|COMPLETED|Overall Study||16
7526528|NCT03530917|18532721|P7|COMPLETED|Overall Study||8
7526529|NCT03530917|18532722|P6|COMPLETED|Overall Study||6
7526530|NCT03530917|18532723|P5|COMPLETED|Overall Study||8
7526531|NCT03530917|18532724|P4|COMPLETED|Overall Study||8
7526532|NCT03530917|18532725|P3|COMPLETED|Overall Study||8
7526533|NCT03530917|18532726|P2|COMPLETED|Overall Study||8
7526534|NCT03530917|18532727|P1|COMPLETED|Overall Study||8
7526535|NCT03530917|18532720|P8|STARTED|Overall Study||16
7526536|NCT03530917|18532721|P7|STARTED|Overall Study||8
7526537|NCT03530917|18532722|P6|STARTED|Overall Study||6
7526538|NCT03530917|18532723|P5|STARTED|Overall Study||8
7526539|NCT03530917|18532724|P4|STARTED|Overall Study||8
7526540|NCT03530917|18532725|P3|STARTED|Overall Study||8
7526541|NCT03530917|18532726|P2|STARTED|Overall Study||8
7526542|NCT03530917|18532727|P1|STARTED|Overall Study||8
7526543|NCT03530631|18532811|P1|NOT COMPLETED|Placebo/Deception||0
7526544|NCT03530631|18532811|P1|COMPLETED|Placebo/Deception||4
7526545|NCT03530631|18532811|P1|STARTED|Placebo/Deception||4
7526546|NCT03530631|18532811|P1|NOT COMPLETED|Adderall/Deception||0
7526547|NCT03530631|18532811|P1|COMPLETED|Adderall/Deception||4
7526548|NCT03530631|18532811|P1|STARTED|Adderall/Deception||4
7526549|NCT03530631|18532811|P1|NOT COMPLETED|Placebo/Truth||0
7526550|NCT03530631|18532811|P1|COMPLETED|Placebo/Truth||4
7526551|NCT03530631|18532811|P1|STARTED|Placebo/Truth||4
7526552|NCT03530631|18532811|P1|NOT COMPLETED|Adderall/Truth||0
7526553|NCT03530631|18532811|P1|COMPLETED|Adderall/Truth||4
7526554|NCT03530631|18532811|P1|STARTED|Adderall/Truth||4
7526555|NCT03530345|18532823|P2|NOT COMPLETED|Treatment Period B/Follow-up Period 2||7
7526556|NCT03530345|18532824|P1|NOT COMPLETED|Treatment Period B/Follow-up Period 2||5
7526557|NCT03530345|18532823|P2|COMPLETED|Treatment Period B/Follow-up Period 2||0
7526558|NCT03530345|18532824|P1|COMPLETED|Treatment Period B/Follow-up Period 2||0
7526559|NCT03530345|18532823|P2|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||6
7526560|NCT03530345|18532824|P1|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||4
7526561|NCT03530345|18532823|P2|STARTED|Treatment Period B/Follow-up Period 2||7
7526562|NCT03530345|18532824|P1|STARTED|Treatment Period B/Follow-up Period 2|2 participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|5
7526563|NCT03530345|18532823|P2|NOT COMPLETED|Treatment Period A/Follow-up Period 1||22
7526564|NCT03530345|18532824|P1|NOT COMPLETED|Treatment Period A/Follow-up Period 1||21
7526565|NCT03530345|18532823|P2|COMPLETED|Treatment Period A/Follow-up Period 1||7
7526566|NCT03530345|18532824|P1|COMPLETED|Treatment Period A/Follow-up Period 1||7
7526567|NCT03530345|18532823|P2|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||27
7526568|NCT03530345|18532824|P1|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||26
7526569|NCT03530345|18532823|P2|STARTED|Treatment Period A/Follow-up Period 1||29
7526570|NCT03530345|18532824|P1|STARTED|Treatment Period A/Follow-up Period 1||28
7526571|NCT03530098|18532848|P2|NOT COMPLETED|Overall Study||0
7526572|NCT03530098|18532849|P1|NOT COMPLETED|Overall Study||0
7526573|NCT03530098|18532848|P2|COMPLETED|Overall Study||964
7526574|NCT03530098|18532849|P1|COMPLETED|Overall Study||939
7526575|NCT03530098|18532848|P2|Primary Analysis Set|Overall Study||792
7526576|NCT03530098|18532849|P1|Primary Analysis Set|Overall Study||739
7526577|NCT03530098|18532848|P2|Ground-truth Labeled|Overall Study||794
7526578|NCT03530098|18532849|P1|Ground-truth Labeled|Overall Study||741
7526579|NCT03530098|18532848|P2|STARTED|Overall Study||964
7526580|NCT03530098|18532849|P1|STARTED|Overall Study||939
7526581|NCT03529942|18532857|P1|NOT COMPLETED|Overall Study||23
7526582|NCT03529942|18532857|P1|COMPLETED|Overall Study||106
7526583|NCT03529942|18532857|P1|Reached Week 6 With Paired MRI|Overall Study||108
7526584|NCT03529942|18532857|P1|STARTED|Overall Study||129
7526585|NCT03529461|18532871|P2|NOT COMPLETED|Overall Study||0
7526586|NCT03529461|18532872|P1|NOT COMPLETED|Overall Study||0
7526587|NCT03529461|18532871|P2|COMPLETED|Overall Study||28
7526588|NCT03529461|18532872|P1|COMPLETED|Overall Study||28
7526589|NCT03529461|18532871|P2|STARTED|Overall Study||28
7526590|NCT03529461|18532872|P1|STARTED|Overall Study||28
7526591|NCT03528369|18532884|P3|NOT COMPLETED|Overall Study||0
7526592|NCT03528369|18532885|P2|NOT COMPLETED|Overall Study||1
7526593|NCT03528369|18532886|P1|NOT COMPLETED|Overall Study||3
7526594|NCT03528369|18532884|P3|COMPLETED|Overall Study||40
7526595|NCT03528369|18532885|P2|COMPLETED|Overall Study||41
7526596|NCT03528369|18532886|P1|COMPLETED|Overall Study||37
7526597|NCT03528369|18532884|P3|STARTED|Overall Study||40
7526598|NCT03528369|18532885|P2|STARTED|Overall Study||42
7526599|NCT03528369|18532886|P1|STARTED|Overall Study||40
7526600|NCT03528174|18532915|P1|NOT COMPLETED|Overall Study||2
7526601|NCT03528174|18532915|P1|COMPLETED|Overall Study||8
7526602|NCT03528174|18532915|P1|STARTED|Overall Study||10
7526603|NCT03527966|18532935|P2|NOT COMPLETED|Overall Study||0
7526604|NCT03527966|18532936|P1|NOT COMPLETED|Overall Study||3
7526605|NCT03527966|18532935|P2|COMPLETED|Overall Study||0
7526606|NCT03527966|18532936|P1|COMPLETED|Overall Study||0
7526607|NCT03527966|18532935|P2|STARTED|Overall Study||0
7526608|NCT03527966|18532936|P1|STARTED|Overall Study||3
7526609|NCT03527173|18532950|P2|NOT COMPLETED|Overall Study||7
7526610|NCT03527173|18532951|P1|NOT COMPLETED|Overall Study||7
7526611|NCT03527173|18532950|P2|COMPLETED|Overall Study||28
7526612|NCT03527173|18532951|P1|COMPLETED|Overall Study||29
7526613|NCT03527173|18532950|P2|STARTED|Overall Study||35
7526614|NCT03527173|18532951|P1|STARTED|Overall Study||36
7526615|NCT03526055|18532993|P2|NOT COMPLETED|Second Program||0
7526616|NCT03526055|18532994|P1|NOT COMPLETED|Second Program||0
7526617|NCT03526055|18532993|P2|COMPLETED|Second Program||5
7526618|NCT03526055|18532994|P1|COMPLETED|Second Program||5
7526619|NCT03526055|18532993|P2|STARTED|Second Program||5
7526620|NCT03526055|18532994|P1|STARTED|Second Program||5
7526621|NCT03526055|18532993|P2|NOT COMPLETED|Initial Program||0
7526622|NCT03526055|18532994|P1|NOT COMPLETED|Initial Program||0
7526623|NCT03526055|18532993|P2|COMPLETED|Initial Program||5
7526624|NCT03526055|18532994|P1|COMPLETED|Initial Program||5
7526625|NCT03526055|18532993|P2|STARTED|Initial Program||5
7526626|NCT03526055|18532994|P1|STARTED|Initial Program||5
7526627|NCT03525678|18533011|P3|NOT COMPLETED|Overall Study||25
7526628|NCT03525678|18533012|P2|NOT COMPLETED|Overall Study||99
7526629|NCT03525678|18533013|P1|NOT COMPLETED|Overall Study||97
7526630|NCT03525678|18533011|P3|COMPLETED|Overall Study||0
7526631|NCT03525678|18533012|P2|COMPLETED|Overall Study||0
7526632|NCT03525678|18533013|P1|COMPLETED|Overall Study||0
7526633|NCT03525678|18533011|P3|Received Study Treatment|Overall Study||24
7526634|NCT03525678|18533012|P2|Received Study Treatment|Overall Study||99
7526635|NCT03525678|18533013|P1|Received Study Treatment|Overall Study||95
7526636|NCT03525678|18533011|P3|STARTED|Overall Study||25
7526637|NCT03525678|18533012|P2|STARTED|Overall Study||99
7526638|NCT03525678|18533013|P1|STARTED|Overall Study||97
7526639|NCT03525548|18533198|P2|NOT COMPLETED|Overall Study||0
7526640|NCT03525548|18533199|P1|NOT COMPLETED|Overall Study||0
7526641|NCT03525548|18533198|P2|COMPLETED|Overall Study||55
7526642|NCT03525548|18533199|P1|COMPLETED|Overall Study||52
7526643|NCT03525548|18533198|P2|STARTED|Overall Study||55
7526644|NCT03525548|18533199|P1|STARTED|Overall Study||52
7526645|NCT03525444|18533215|P2|NOT COMPLETED|Overall Study||3
7526646|NCT03525444|18533216|P1|NOT COMPLETED|Overall Study||0
7526647|NCT03525444|18533215|P2|COMPLETED|Overall Study||197
7526648|NCT03525444|18533216|P1|COMPLETED|Overall Study||203
7526649|NCT03525444|18533215|P2|Safety Set|Overall Study||202
7526650|NCT03525444|18533216|P1|Safety Set|Overall Study||201
7526651|NCT03525444|18533215|P2|STARTED|Overall Study||200
7526652|NCT03525444|18533216|P1|STARTED|Overall Study||203
7526653|NCT03525210|18533247|P2|NOT COMPLETED|Overall Study||2
7526654|NCT03525210|18533248|P1|NOT COMPLETED|Overall Study||4
7526655|NCT03525210|18533247|P2|COMPLETED|Overall Study||169
7526656|NCT03525210|18533248|P1|COMPLETED|Overall Study||96
7526657|NCT03525210|18533247|P2|STARTED|Overall Study||171
7526658|NCT03525210|18533248|P1|STARTED|Overall Study||100
7526659|NCT03525119|18533259|P3|NOT COMPLETED|Overall Study||43
7526660|NCT03525119|18533260|P2|NOT COMPLETED|Overall Study||39
7526661|NCT03525119|18533261|P1|NOT COMPLETED|Overall Study||40
7526662|NCT03525119|18533259|P3|COMPLETED|Overall Study||257
7526663|NCT03525119|18533260|P2|COMPLETED|Overall Study||261
7526664|NCT03525119|18533261|P1|COMPLETED|Overall Study||260
7526665|NCT03525119|18533259|P3|Safety Population|Overall Study||298
7526666|NCT03525119|18533260|P2|Safety Population|Overall Study||300
7526667|NCT03525119|18533261|P1|Safety Population|Overall Study||299
7526668|NCT03525119|18533259|P3|STARTED|Overall Study||300
7526669|NCT03525119|18533260|P2|STARTED|Overall Study||300
7526670|NCT03525119|18533261|P1|STARTED|Overall Study||300
7526671|NCT03524157|18533296|P3|NOT COMPLETED|Overall Study||1
7526672|NCT03524157|18533297|P2|NOT COMPLETED|Overall Study||0
7526673|NCT03524157|18533298|P1|NOT COMPLETED|Overall Study||0
7526674|NCT03524157|18533296|P3|COMPLETED|Overall Study||9
7526675|NCT03524157|18533297|P2|COMPLETED|Overall Study||10
7526676|NCT03524157|18533298|P1|COMPLETED|Overall Study||10
7526677|NCT03524157|18533296|P3|STARTED|Overall Study||10
7526678|NCT03524157|18533297|P2|STARTED|Overall Study||10
7526679|NCT03524157|18533298|P1|STARTED|Overall Study||10
7526680|NCT03523988|18533336|P3|NOT COMPLETED|Overall Study||18
7526681|NCT03523988|18533337|P2|NOT COMPLETED|Overall Study||16
7526682|NCT03523988|18533338|P1|NOT COMPLETED|Overall Study||17
7526683|NCT03523988|18533336|P3|COMPLETED|Overall Study||7
7526684|NCT03523988|18533337|P2|COMPLETED|Overall Study||8
7526685|NCT03523988|18533338|P1|COMPLETED|Overall Study||7
7526686|NCT03523988|18533336|P3|STARTED|Overall Study||25
7526687|NCT03523988|18533337|P2|STARTED|Overall Study||24
7526688|NCT03523988|18533338|P1|STARTED|Overall Study||24
7526689|NCT03522675|18533352|P1|NOT COMPLETED|Overall Study||2
7526690|NCT03522675|18533352|P1|COMPLETED|Overall Study||20
7526691|NCT03522675|18533352|P1|STARTED|Overall Study||22
7526692|NCT03522506|18533370|P4|NOT COMPLETED|Treatment Period 4 (2 Days)||0
7526693|NCT03522506|18533371|P3|NOT COMPLETED|Treatment Period 4 (2 Days)||0
7526694|NCT03522506|18533372|P2|NOT COMPLETED|Treatment Period 4 (2 Days)||0
7526695|NCT03522506|18533373|P1|NOT COMPLETED|Treatment Period 4 (2 Days)||0
7526696|NCT03522506|18533370|P4|COMPLETED|Treatment Period 4 (2 Days)||3
7526697|NCT03522506|18533371|P3|COMPLETED|Treatment Period 4 (2 Days)||5
7526698|NCT03522506|18533372|P2|COMPLETED|Treatment Period 4 (2 Days)||5
7526699|NCT03522506|18533373|P1|COMPLETED|Treatment Period 4 (2 Days)||5
7526700|NCT03522506|18533370|P4|STARTED|Treatment Period 4 (2 Days)||3
7526701|NCT03522506|18533371|P3|STARTED|Treatment Period 4 (2 Days)||5
7526702|NCT03522506|18533372|P2|STARTED|Treatment Period 4 (2 Days)||5
7526703|NCT03522506|18533373|P1|STARTED|Treatment Period 4 (2 Days)||5
7526704|NCT03522506|18533370|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
7526705|NCT03522506|18533371|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
7526706|NCT03522506|18533372|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
7526707|NCT03522506|18533373|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
7526708|NCT03522506|18533370|P4|COMPLETED|Washout Period 3 (7 Days)||3
7526709|NCT03522506|18533371|P3|COMPLETED|Washout Period 3 (7 Days)||5
7526710|NCT03522506|18533372|P2|COMPLETED|Washout Period 3 (7 Days)||5
7526711|NCT03522506|18533373|P1|COMPLETED|Washout Period 3 (7 Days)||5
7526712|NCT03522506|18533370|P4|STARTED|Washout Period 3 (7 Days)||3
7526713|NCT03522506|18533371|P3|STARTED|Washout Period 3 (7 Days)||5
7526714|NCT03522506|18533372|P2|STARTED|Washout Period 3 (7 Days)||5
7526715|NCT03522506|18533373|P1|STARTED|Washout Period 3 (7 Days)||5
7526716|NCT03522506|18533370|P4|NOT COMPLETED|Treatment Period 3 (2 Days)||0
7526717|NCT03522506|18533371|P3|NOT COMPLETED|Treatment Period 3 (2 Days)||0
7526718|NCT03522506|18533372|P2|NOT COMPLETED|Treatment Period 3 (2 Days)||0
7526719|NCT03522506|18533373|P1|NOT COMPLETED|Treatment Period 3 (2 Days)||0
7526720|NCT03522506|18533370|P4|COMPLETED|Treatment Period 3 (2 Days)||3
7526721|NCT03522506|18533371|P3|COMPLETED|Treatment Period 3 (2 Days)||5
7526722|NCT03522506|18533372|P2|COMPLETED|Treatment Period 3 (2 Days)||5
7526723|NCT03522506|18533373|P1|COMPLETED|Treatment Period 3 (2 Days)||5
7526724|NCT03522506|18533370|P4|STARTED|Treatment Period 3 (2 Days)||3
7526725|NCT03522506|18533371|P3|STARTED|Treatment Period 3 (2 Days)||5
7526726|NCT03522506|18533372|P2|STARTED|Treatment Period 3 (2 Days)||5
7526727|NCT03522506|18533373|P1|STARTED|Treatment Period 3 (2 Days)||5
7526728|NCT03522506|18533370|P4|NOT COMPLETED|Washout Period 2 (7 Days)||1
7526729|NCT03522506|18533371|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
7526730|NCT03522506|18533372|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
7526731|NCT03522506|18533373|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
7526732|NCT03522506|18533370|P4|COMPLETED|Washout Period 2 (7 Days)||3
7526733|NCT03522506|18533371|P3|COMPLETED|Washout Period 2 (7 Days)||5
7526734|NCT03522506|18533372|P2|COMPLETED|Washout Period 2 (7 Days)||5
7526735|NCT03522506|18533373|P1|COMPLETED|Washout Period 2 (7 Days)||5
7526736|NCT03522506|18533370|P4|STARTED|Washout Period 2 (7 Days)||4
7526737|NCT03522506|18533371|P3|STARTED|Washout Period 2 (7 Days)||5
7526738|NCT03522506|18533372|P2|STARTED|Washout Period 2 (7 Days)||5
7526739|NCT03522506|18533373|P1|STARTED|Washout Period 2 (7 Days)||5
7526740|NCT03522506|18533370|P4|NOT COMPLETED|Treatment Period 2 (2 Days)||0
7526741|NCT03522506|18533371|P3|NOT COMPLETED|Treatment Period 2 (2 Days)||0
7526742|NCT03522506|18533372|P2|NOT COMPLETED|Treatment Period 2 (2 Days)||0
7526743|NCT03522506|18533373|P1|NOT COMPLETED|Treatment Period 2 (2 Days)||0
7526744|NCT03522506|18533370|P4|COMPLETED|Treatment Period 2 (2 Days)||4
7526745|NCT03522506|18533371|P3|COMPLETED|Treatment Period 2 (2 Days)||5
7526746|NCT03522506|18533372|P2|COMPLETED|Treatment Period 2 (2 Days)||5
7526747|NCT03522506|18533373|P1|COMPLETED|Treatment Period 2 (2 Days)||5
7526748|NCT03522506|18533370|P4|STARTED|Treatment Period 2 (2 Days)||4
7526749|NCT03522506|18533371|P3|STARTED|Treatment Period 2 (2 Days)||5
7526750|NCT03522506|18533372|P2|STARTED|Treatment Period 2 (2 Days)||5
7526751|NCT03522506|18533373|P1|STARTED|Treatment Period 2 (2 Days)||5
7526752|NCT03522506|18533370|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
7526753|NCT03522506|18533371|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
7526754|NCT03522506|18533372|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
7526755|NCT03522506|18533373|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
7526756|NCT03522506|18533370|P4|COMPLETED|Washout Period 1 (7 Days)||4
7526757|NCT03522506|18533371|P3|COMPLETED|Washout Period 1 (7 Days)||5
7526758|NCT03522506|18533372|P2|COMPLETED|Washout Period 1 (7 Days)||5
7526759|NCT03522506|18533373|P1|COMPLETED|Washout Period 1 (7 Days)||5
7526760|NCT03522506|18533370|P4|STARTED|Washout Period 1 (7 Days)||5
7526761|NCT03522506|18533371|P3|STARTED|Washout Period 1 (7 Days)||5
7526762|NCT03522506|18533372|P2|STARTED|Washout Period 1 (7 Days)||5
7526763|NCT03522506|18533373|P1|STARTED|Washout Period 1 (7 Days)||5
7526764|NCT03522506|18533370|P4|NOT COMPLETED|Treatment Period 1 (2 Days)||0
7526765|NCT03522506|18533371|P3|NOT COMPLETED|Treatment Period 1 (2 Days)||0
7526766|NCT03522506|18533372|P2|NOT COMPLETED|Treatment Period 1 (2 Days)||0
7526767|NCT03522506|18533373|P1|NOT COMPLETED|Treatment Period 1 (2 Days)||0
7526768|NCT03522506|18533370|P4|COMPLETED|Treatment Period 1 (2 Days)||5
7526769|NCT03522506|18533371|P3|COMPLETED|Treatment Period 1 (2 Days)||5
7526770|NCT03522506|18533372|P2|COMPLETED|Treatment Period 1 (2 Days)||5
7526771|NCT03522506|18533373|P1|COMPLETED|Treatment Period 1 (2 Days)||5
7526772|NCT03522506|18533370|P4|STARTED|Treatment Period 1 (2 Days)||5
7526773|NCT03522506|18533371|P3|STARTED|Treatment Period 1 (2 Days)||5
7526774|NCT03522506|18533372|P2|STARTED|Treatment Period 1 (2 Days)||5
7526775|NCT03522506|18533373|P1|STARTED|Treatment Period 1 (2 Days)||5
7526776|NCT03522441|18533424|P3|NOT COMPLETED|Overall Study||11
7526777|NCT03522441|18533425|P2|NOT COMPLETED|Overall Study||19
7526778|NCT03522441|18533426|P1|NOT COMPLETED|Overall Study||26
7526779|NCT03522441|18533424|P3|COMPLETED|Overall Study||214
7526780|NCT03522441|18533425|P2|COMPLETED|Overall Study||431
7526781|NCT03522441|18533426|P1|COMPLETED|Overall Study||424
7526782|NCT03522441|18533424|P3|STARTED|Overall Study||225
7526783|NCT03522441|18533425|P2|STARTED|Overall Study||450
7526784|NCT03522441|18533426|P1|STARTED|Overall Study||450
7526785|NCT03522350|18533437|P2|NOT COMPLETED|Overall Study||0
7526786|NCT03522350|18533438|P1|NOT COMPLETED|Overall Study||0
7526787|NCT03522350|18533437|P2|COMPLETED|Overall Study||18
7526788|NCT03522350|18533438|P1|COMPLETED|Overall Study||18
7526789|NCT03522350|18533437|P2|STARTED|Overall Study||18
7526790|NCT03522350|18533438|P1|STARTED|Overall Study||18
7526791|NCT03521817|18533451|P2|NOT COMPLETED|Overall Study||1
7526792|NCT03521817|18533452|P1|NOT COMPLETED|Overall Study||0
7526793|NCT03521817|18533451|P2|COMPLETED|Overall Study|1 completer was non adherent based on weekly intervention body weight|4
7526794|NCT03521817|18533452|P1|COMPLETED|Overall Study||7
7526795|NCT03521817|18533451|P2|STARTED|Overall Study||5
7526796|NCT03521817|18533452|P1|STARTED|Overall Study||7
7526797|NCT03521791|18533460|P2|NOT COMPLETED|Overall Study||17
7526798|NCT03521791|18533461|P1|NOT COMPLETED|Overall Study||7
7526799|NCT03521791|18533460|P2|COMPLETED|Overall Study||73
7526800|NCT03521791|18533461|P1|COMPLETED|Overall Study||69
7526801|NCT03521791|18533460|P2|STARTED|Overall Study||90
7526802|NCT03521791|18533461|P1|STARTED|Overall Study||76
7526803|NCT03521141|18533488|P3|NOT COMPLETED|Overall Study||1
7526804|NCT03521141|18533489|P2|NOT COMPLETED|Overall Study||0
7526805|NCT03521141|18533490|P1|NOT COMPLETED|Overall Study||1
7526806|NCT03521141|18533488|P3|COMPLETED|Overall Study||19
7526807|NCT03521141|18533489|P2|COMPLETED|Overall Study||19
7526808|NCT03521141|18533490|P1|COMPLETED|Overall Study||18
7526809|NCT03521141|18533488|P3|STARTED|Overall Study||20
7526810|NCT03521141|18533489|P2|STARTED|Overall Study||19
7526811|NCT03521141|18533490|P1|STARTED|Overall Study||19
7526812|NCT03521089|18533515|P2|NOT COMPLETED|Overall Study||0
7526813|NCT03521089|18533516|P1|NOT COMPLETED|Overall Study||0
7526814|NCT03521089|18533515|P2|COMPLETED|Overall Study||8
7526815|NCT03521089|18533516|P1|COMPLETED|Overall Study||8
7526816|NCT03521089|18533515|P2|STARTED|Overall Study||8
7526817|NCT03521089|18533516|P1|STARTED|Overall Study||8
7526818|NCT03520998|18533536|P2|NOT COMPLETED|Overall Study||2
7526819|NCT03520998|18533537|P1|NOT COMPLETED|Overall Study||6
7526820|NCT03520998|18533536|P2|COMPLETED|Overall Study||21
7526821|NCT03520998|18533537|P1|COMPLETED|Overall Study||18
7526822|NCT03520998|18533536|P2|STARTED|Overall Study||23
7526823|NCT03520998|18533537|P1|STARTED|Overall Study||24
7526824|NCT03520959|18533557|P2|NOT COMPLETED|Overall Study||1
7526825|NCT03520959|18533558|P1|NOT COMPLETED|Overall Study||0
7526826|NCT03520959|18533557|P2|COMPLETED|Overall Study||0
7526827|NCT03520959|18533558|P1|COMPLETED|Overall Study||0
7526828|NCT03520959|18533557|P2|STARTED|Overall Study||1
7526829|NCT03520959|18533558|P1|STARTED|Overall Study||0
7526830|NCT03520348|18533580|P2|NOT COMPLETED|Overall Study||0
7526831|NCT03520348|18533581|P1|NOT COMPLETED|Overall Study||0
7526832|NCT03520348|18533580|P2|COMPLETED|Overall Study||12
7526833|NCT03520348|18533581|P1|COMPLETED|Overall Study||12
7526834|NCT03520348|18533580|P2|STARTED|Overall Study||12
7526835|NCT03520348|18533581|P1|STARTED|Overall Study||12
7526836|NCT03519932|18533605|P2|NOT COMPLETED|Second Intervention||0
7526837|NCT03519932|18533606|P1|NOT COMPLETED|Second Intervention||0
7526838|NCT03519932|18533605|P2|COMPLETED|Second Intervention||23
7526839|NCT03519932|18533606|P1|COMPLETED|Second Intervention||22
7526840|NCT03519932|18533605|P2|STARTED|Second Intervention|Subjects who wore comfilcon A toric at 1st intervention wear Samfilcon A toric at 2nd intervention|23
7526841|NCT03519932|18533606|P1|STARTED|Second Intervention|Subjects who wore samfilcon A toric at 1st intervention wear comfilcon A toric at 2nd intervention|22
7526842|NCT03519932|18533605|P2|NOT COMPLETED|First Intervention||3
7526843|NCT03519932|18533606|P1|NOT COMPLETED|First Intervention||1
7526844|NCT03519932|18533605|P2|COMPLETED|First Intervention|3 subjects had non-significant adverse events and data not included in analysis.|22
7526845|NCT03519932|18533606|P1|COMPLETED|First Intervention|One subject had non-significant adverse event and data not included in the analysis|23
7526846|NCT03519932|18533605|P2|STARTED|First Intervention||25
7526847|NCT03519932|18533606|P1|STARTED|First Intervention||24
7526848|NCT03519919|18533632|P1|NOT COMPLETED|Overall Study||3
7526849|NCT03519919|18533632|P1|COMPLETED|Overall Study||48
7526850|NCT03519919|18533632|P1|STARTED|Overall Study||51
7526851|NCT03519867|18533684|P10|NOT COMPLETED|Overall Study||0
7526852|NCT03519867|18533685|P9|NOT COMPLETED|Overall Study||1
7526853|NCT03519867|18533686|P8|NOT COMPLETED|Overall Study||1
7526854|NCT03519867|18533687|P7|NOT COMPLETED|Overall Study||1
7526855|NCT03519867|18533688|P6|NOT COMPLETED|Overall Study||3
7526856|NCT03519867|18533689|P5|NOT COMPLETED|Overall Study||0
7526857|NCT03519867|18533690|P4|NOT COMPLETED|Overall Study||1
7526858|NCT03519867|18533691|P3|NOT COMPLETED|Overall Study||1
7526859|NCT03519867|18533692|P2|NOT COMPLETED|Overall Study||3
7526860|NCT03519867|18533693|P1|NOT COMPLETED|Overall Study||3
7526861|NCT03519867|18533684|P10|COMPLETED|Overall Study||4
7526862|NCT03519867|18533685|P9|COMPLETED|Overall Study||3
7526863|NCT03519867|18533686|P8|COMPLETED|Overall Study||4
7526864|NCT03519867|18533687|P7|COMPLETED|Overall Study||3
7526865|NCT03519867|18533688|P6|COMPLETED|Overall Study||2
7526866|NCT03519867|18533689|P5|COMPLETED|Overall Study||5
7526867|NCT03519867|18533690|P4|COMPLETED|Overall Study||3
7526868|NCT03519867|18533691|P3|COMPLETED|Overall Study||5
7526869|NCT03519867|18533692|P2|COMPLETED|Overall Study||4
7526870|NCT03519867|18533693|P1|COMPLETED|Overall Study||3
7526871|NCT03519867|18533684|P10|Treated|Overall Study||4
7526872|NCT03519867|18533685|P9|Treated|Overall Study||3
7526873|NCT03519867|18533686|P8|Treated|Overall Study||4
7526874|NCT03519867|18533687|P7|Treated|Overall Study||4
7526875|NCT03519867|18533688|P6|Treated|Overall Study||4
7526876|NCT03519867|18533689|P5|Treated|Overall Study||5
7526877|NCT03519867|18533690|P4|Treated|Overall Study||3
7526878|NCT03519867|18533691|P3|Treated|Overall Study||5
7526879|NCT03519867|18533692|P2|Treated|Overall Study||6
7526880|NCT03519867|18533693|P1|Treated|Overall Study||5
7526881|NCT03519867|18533684|P10|STARTED|Overall Study||4
7526882|NCT03519867|18533685|P9|STARTED|Overall Study||4
7526883|NCT03519867|18533686|P8|STARTED|Overall Study||5
7526884|NCT03519867|18533687|P7|STARTED|Overall Study||4
7526885|NCT03519867|18533688|P6|STARTED|Overall Study||5
7526886|NCT03519867|18533689|P5|STARTED|Overall Study||5
7526887|NCT03519867|18533690|P4|STARTED|Overall Study||4
7526888|NCT03519867|18533691|P3|STARTED|Overall Study||6
7526889|NCT03519867|18533692|P2|STARTED|Overall Study|One participant randomized to receive MK-8616 8.0 mg/kg received MK-8616 0.8 mg/kg.|7
7526890|NCT03519867|18533693|P1|STARTED|Overall Study||6
7526891|NCT03519854|18533743|P18|NOT COMPLETED|Overall Study||0
7526892|NCT03519854|18533744|P17|NOT COMPLETED|Overall Study||0
7526893|NCT03519854|18533745|P16|NOT COMPLETED|Overall Study||0
7526894|NCT03519854|18533746|P15|NOT COMPLETED|Overall Study||0
7526895|NCT03519854|18533747|P14|NOT COMPLETED|Overall Study||0
7526896|NCT03519854|18533748|P13|NOT COMPLETED|Overall Study||0
7526897|NCT03519854|18533749|P12|NOT COMPLETED|Overall Study||0
7526898|NCT03519854|18533750|P11|NOT COMPLETED|Overall Study||0
7526899|NCT03519854|18533751|P10|NOT COMPLETED|Overall Study||0
7526900|NCT03519854|18533752|P9|NOT COMPLETED|Overall Study||0
7526901|NCT03519854|18533753|P8|NOT COMPLETED|Overall Study||0
7526902|NCT03519854|18533754|P7|NOT COMPLETED|Overall Study||0
7526903|NCT03519854|18533755|P6|NOT COMPLETED|Overall Study||0
7526904|NCT03519854|18533756|P5|NOT COMPLETED|Overall Study||0
7526905|NCT03519854|18533757|P4|NOT COMPLETED|Overall Study||0
7526906|NCT03519854|18533758|P3|NOT COMPLETED|Overall Study||1
7526907|NCT03519854|18533759|P2|NOT COMPLETED|Overall Study||0
7526908|NCT03519854|18533760|P1|NOT COMPLETED|Overall Study||0
7526909|NCT03519854|18533743|P18|COMPLETED|Overall Study||6
7526910|NCT03519854|18533744|P17|COMPLETED|Overall Study||6
7526911|NCT03519854|18533745|P16|COMPLETED|Overall Study||6
7526912|NCT03519854|18533746|P15|COMPLETED|Overall Study||6
7526913|NCT03519854|18533747|P14|COMPLETED|Overall Study||6
7526914|NCT03519854|18533748|P13|COMPLETED|Overall Study||3
7526915|NCT03519854|18533749|P12|COMPLETED|Overall Study||6
7526916|NCT03519854|18533750|P11|COMPLETED|Overall Study||6
7526917|NCT03519854|18533751|P10|COMPLETED|Overall Study||6
7526918|NCT03519854|18533752|P9|COMPLETED|Overall Study||6
7526919|NCT03519854|18533753|P8|COMPLETED|Overall Study||6
7526920|NCT03519854|18533754|P7|COMPLETED|Overall Study||3
7526921|NCT03519854|18533755|P6|COMPLETED|Overall Study||6
7526922|NCT03519854|18533756|P5|COMPLETED|Overall Study||6
7526923|NCT03519854|18533757|P4|COMPLETED|Overall Study||6
7526924|NCT03519854|18533758|P3|COMPLETED|Overall Study||4
7526925|NCT03519854|18533759|P2|COMPLETED|Overall Study||6
7526926|NCT03519854|18533760|P1|COMPLETED|Overall Study||4
7526927|NCT03519854|18533743|P18|Treated|Overall Study||6
7526928|NCT03519854|18533744|P17|Treated|Overall Study||6
7526929|NCT03519854|18533745|P16|Treated|Overall Study||6
7526930|NCT03519854|18533746|P15|Treated|Overall Study||6
7526931|NCT03519854|18533747|P14|Treated|Overall Study||6
7526932|NCT03519854|18533748|P13|Treated|Overall Study||3
7526933|NCT03519854|18533749|P12|Treated|Overall Study||6
7526934|NCT03519854|18533750|P11|Treated|Overall Study||6
7526935|NCT03519854|18533751|P10|Treated|Overall Study||6
7526936|NCT03519854|18533752|P9|Treated|Overall Study||6
7526937|NCT03519854|18533753|P8|Treated|Overall Study||6
7526938|NCT03519854|18533754|P7|Treated|Overall Study||3
7526939|NCT03519854|18533755|P6|Treated|Overall Study||6
7526940|NCT03519854|18533756|P5|Treated|Overall Study||6
7526941|NCT03519854|18533757|P4|Treated|Overall Study||6
7526942|NCT03519854|18533758|P3|Treated|Overall Study||4
7526943|NCT03519854|18533759|P2|Treated|Overall Study||6
7526944|NCT03519854|18533760|P1|Treated|Overall Study|N=1 (randomized to Arm C) received placebo, 3 min after 1.2 mg/kg Esmeron®|4
7526945|NCT03519854|18533743|P18|STARTED|Overall Study||6
7526946|NCT03519854|18533744|P17|STARTED|Overall Study||6
7526947|NCT03519854|18533745|P16|STARTED|Overall Study||6
7526948|NCT03519854|18533746|P15|STARTED|Overall Study||6
7526949|NCT03519854|18533747|P14|STARTED|Overall Study||6
7526950|NCT03519854|18533748|P13|STARTED|Overall Study||3
7526951|NCT03519854|18533749|P12|STARTED|Overall Study||6
7526952|NCT03519854|18533750|P11|STARTED|Overall Study||6
7526953|NCT03519854|18533751|P10|STARTED|Overall Study||6
7526954|NCT03519854|18533752|P9|STARTED|Overall Study||6
7526955|NCT03519854|18533753|P8|STARTED|Overall Study||6
7526956|NCT03519854|18533754|P7|STARTED|Overall Study||3
7526957|NCT03519854|18533755|P6|STARTED|Overall Study||6
7526958|NCT03519854|18533756|P5|STARTED|Overall Study||6
7526959|NCT03519854|18533757|P4|STARTED|Overall Study||6
7526960|NCT03519854|18533758|P3|STARTED|Overall Study||5
7526961|NCT03519854|18533759|P2|STARTED|Overall Study||6
7526962|NCT03519854|18533760|P1|STARTED|Overall Study|N=3 randomized to Arm A. An additional N=1 (randomized to Arm C) is counted as Started in Arm A|4
7526963|NCT03519516|18533926|P2|NOT COMPLETED|Overall Study||1
7526964|NCT03519516|18533927|P1|NOT COMPLETED|Overall Study||0
7526965|NCT03519516|18533926|P2|COMPLETED|Overall Study||14
7526966|NCT03519516|18533927|P1|COMPLETED|Overall Study||15
7526967|NCT03519516|18533926|P2|STARTED|Overall Study||15
7526968|NCT03519516|18533927|P1|STARTED|Overall Study||15
7526969|NCT03519282|18533951|P2|NOT COMPLETED|Second Intervention||0
7526970|NCT03519282|18533952|P1|NOT COMPLETED|Second Intervention||0
7526971|NCT03519282|18533951|P2|COMPLETED|Second Intervention||5
7526972|NCT03519282|18533952|P1|COMPLETED|Second Intervention||5
7526973|NCT03519282|18533951|P2|STARTED|Second Intervention||5
7526974|NCT03519282|18533952|P1|STARTED|Second Intervention||5
7526975|NCT03519282|18533951|P2|NOT COMPLETED|First Intervention||0
7526976|NCT03519282|18533952|P1|NOT COMPLETED|First Intervention||0
7526977|NCT03519282|18533951|P2|COMPLETED|First Intervention||5
7526978|NCT03519282|18533952|P1|COMPLETED|First Intervention||5
7526979|NCT03519282|18533951|P2|STARTED|First Intervention||5
7526980|NCT03519282|18533952|P1|STARTED|First Intervention||5
7526981|NCT03519243|18533967|P4|NOT COMPLETED|Overall Study||1
7526982|NCT03519243|18533968|P3|NOT COMPLETED|Overall Study||0
7526983|NCT03519243|18533969|P2|NOT COMPLETED|Overall Study||4
7526984|NCT03519243|18533970|P1|NOT COMPLETED|Overall Study||5
7526985|NCT03519243|18533967|P4|COMPLETED|Overall Study||24
7526986|NCT03519243|18533968|P3|COMPLETED|Overall Study||0
7526987|NCT03519243|18533969|P2|COMPLETED|Overall Study||21
7526988|NCT03519243|18533970|P1|COMPLETED|Overall Study||20
7526989|NCT03519243|18533967|P4|STARTED|Overall Study||25
7526990|NCT03519243|18533968|P3|STARTED|Overall Study|The dose level was not studied due to the dose level l.7 µg/kg demonstrated the sufficient PD effect|0
7526991|NCT03519243|18533969|P2|STARTED|Overall Study||25
7526992|NCT03519243|18533970|P1|STARTED|Overall Study||25
7526993|NCT03519204|18534001|P2|NOT COMPLETED|Overall Study||15
7526994|NCT03519204|18534002|P1|NOT COMPLETED|Overall Study||13
7526995|NCT03519204|18534001|P2|COMPLETED|Overall Study||118
7526996|NCT03519204|18534002|P1|COMPLETED|Overall Study||30
7526997|NCT03519204|18534001|P2|Safety Population|Overall Study||136
7526998|NCT03519204|18534002|P1|Safety Population|Overall Study||40
7526999|NCT03519204|18534001|P2|mITT Population|Overall Study||130
7527000|NCT03519204|18534002|P1|mITT Population|Overall Study||33
7527001|NCT03519204|18534001|P2|STARTED|Overall Study||133
7527002|NCT03519204|18534002|P1|STARTED|Overall Study|3 control participants were treated in error; 29 participants received treatment after 3 months.|43
7527003|NCT03519087|18534021|P5|NOT COMPLETED|Laboratory Testing||6
7527004|NCT03519087|18534022|P4|NOT COMPLETED|Laboratory Testing||4
7527005|NCT03519087|18534023|P3|NOT COMPLETED|Laboratory Testing||2
7527006|NCT03519087|18534024|P2|NOT COMPLETED|Laboratory Testing||0
7527007|NCT03519087|18534025|P1|NOT COMPLETED|Laboratory Testing||0
7527008|NCT03519087|18534021|P5|COMPLETED|Laboratory Testing||1
7527009|NCT03519087|18534022|P4|COMPLETED|Laboratory Testing||2
7527010|NCT03519087|18534023|P3|COMPLETED|Laboratory Testing||4
7527011|NCT03519087|18534024|P2|COMPLETED|Laboratory Testing||0
7527012|NCT03519087|18534025|P1|COMPLETED|Laboratory Testing||0
7527013|NCT03519087|18534021|P5|Baseline Lab Testing|Laboratory Testing||3
7527014|NCT03519087|18534022|P4|Baseline Lab Testing|Laboratory Testing||4
7527015|NCT03519087|18534023|P3|Baseline Lab Testing|Laboratory Testing||5
7527016|NCT03519087|18534024|P2|Baseline Lab Testing|Laboratory Testing||0
7527017|NCT03519087|18534025|P1|Baseline Lab Testing|Laboratory Testing||0
7527018|NCT03519087|18534021|P5|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (3) evaluation from Period 1|7
7527019|NCT03519087|18534022|P4|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
7527020|NCT03519087|18534023|P3|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
7527021|NCT03519087|18534024|P2|STARTED|Laboratory Testing||0
7527022|NCT03519087|18534025|P1|STARTED|Laboratory Testing||0
7527023|NCT03519087|18534021|P5|NOT COMPLETED|Re-randomization for Treatment||0
7527024|NCT03519087|18534022|P4|NOT COMPLETED|Re-randomization for Treatment||0
7527025|NCT03519087|18534023|P3|NOT COMPLETED|Re-randomization for Treatment||0
7527026|NCT03519087|18534024|P2|NOT COMPLETED|Re-randomization for Treatment||32
7527027|NCT03519087|18534025|P1|NOT COMPLETED|Re-randomization for Treatment||27
7527028|NCT03519087|18534021|P5|COMPLETED|Re-randomization for Treatment||0
7527029|NCT03519087|18534022|P4|COMPLETED|Re-randomization for Treatment||0
7527030|NCT03519087|18534023|P3|COMPLETED|Re-randomization for Treatment||0
7527031|NCT03519087|18534024|P2|COMPLETED|Re-randomization for Treatment||7
7527032|NCT03519087|18534025|P1|COMPLETED|Re-randomization for Treatment||12
7527033|NCT03519087|18534021|P5|STARTED|Re-randomization for Treatment||0
7527034|NCT03519087|18534022|P4|STARTED|Re-randomization for Treatment||0
7527035|NCT03519087|18534023|P3|STARTED|Re-randomization for Treatment||0
7527036|NCT03519087|18534024|P2|STARTED|Re-randomization for Treatment||39
7527037|NCT03519087|18534025|P1|STARTED|Re-randomization for Treatment||39
7527038|NCT03519087|18534021|P5|NOT COMPLETED|Clinic Evaluation||0
7527039|NCT03519087|18534022|P4|NOT COMPLETED|Clinic Evaluation||0
7527040|NCT03519087|18534023|P3|NOT COMPLETED|Clinic Evaluation||0
7527041|NCT03519087|18534024|P2|NOT COMPLETED|Clinic Evaluation||18
7527042|NCT03519087|18534025|P1|NOT COMPLETED|Clinic Evaluation||16
7527043|NCT03519087|18534021|P5|COMPLETED|Clinic Evaluation||0
7527044|NCT03519087|18534022|P4|COMPLETED|Clinic Evaluation||0
7527045|NCT03519087|18534023|P3|COMPLETED|Clinic Evaluation||0
7527046|NCT03519087|18534024|P2|COMPLETED|Clinic Evaluation||39
7527047|NCT03519087|18534025|P1|COMPLETED|Clinic Evaluation||39
7527048|NCT03519087|18534021|P5|Confirmed Diagnosis by Physician|Clinic Evaluation||0
7527049|NCT03519087|18534022|P4|Confirmed Diagnosis by Physician|Clinic Evaluation||0
7527050|NCT03519087|18534023|P3|Confirmed Diagnosis by Physician|Clinic Evaluation||0
7527051|NCT03519087|18534024|P2|Confirmed Diagnosis by Physician|Clinic Evaluation||39
7527052|NCT03519087|18534025|P1|Confirmed Diagnosis by Physician|Clinic Evaluation||39
7527053|NCT03519087|18534021|P5|Received Assigned Intervention|Clinic Evaluation||0
7527054|NCT03519087|18534022|P4|Received Assigned Intervention|Clinic Evaluation||0
7527055|NCT03519087|18534023|P3|Received Assigned Intervention|Clinic Evaluation||0
7527056|NCT03519087|18534024|P2|Received Assigned Intervention|Clinic Evaluation||57
7527057|NCT03519087|18534025|P1|Received Assigned Intervention|Clinic Evaluation||54
7527058|NCT03519087|18534021|P5|STARTED|Clinic Evaluation||0
7527059|NCT03519087|18534022|P4|STARTED|Clinic Evaluation||0
7527060|NCT03519087|18534023|P3|STARTED|Clinic Evaluation||0
7527061|NCT03519087|18534024|P2|STARTED|Clinic Evaluation||57
7527062|NCT03519087|18534025|P1|STARTED|Clinic Evaluation||55
7527063|NCT03518840|18534061|P1|NOT COMPLETED|Overall Study||6
7527064|NCT03518840|18534061|P1|COMPLETED|Overall Study||57
7527065|NCT03518840|18534061|P1|STARTED|Overall Study||63
7527066|NCT03518125|18534074|P6|NOT COMPLETED|Overall Study||8
7527067|NCT03518125|18534075|P5|NOT COMPLETED|Overall Study||4
7527068|NCT03518125|18534076|P4|NOT COMPLETED|Overall Study||1
7527069|NCT03518125|18534077|P3|NOT COMPLETED|Overall Study||0
7527070|NCT03518125|18534078|P2|NOT COMPLETED|Overall Study||4
7527071|NCT03518125|18534079|P1|NOT COMPLETED|Overall Study||2
7527072|NCT03518125|18534074|P6|COMPLETED|Overall Study||44
7527073|NCT03518125|18534075|P5|COMPLETED|Overall Study||48
7527074|NCT03518125|18534076|P4|COMPLETED|Overall Study||51
7527075|NCT03518125|18534077|P3|COMPLETED|Overall Study||49
7527076|NCT03518125|18534078|P2|COMPLETED|Overall Study||46
7527077|NCT03518125|18534079|P1|COMPLETED|Overall Study||48
7527078|NCT03518125|18534074|P6|STARTED|Overall Study||52
7527079|NCT03518125|18534075|P5|STARTED|Overall Study||52
7527080|NCT03518125|18534076|P4|STARTED|Overall Study||52
7527081|NCT03518125|18534077|P3|STARTED|Overall Study||49
7527082|NCT03518125|18534078|P2|STARTED|Overall Study||50
7527083|NCT03518125|18534079|P1|STARTED|Overall Study||50
7527084|NCT03518008|18534177|P2|NOT COMPLETED|Period 2, Second Week of Wear||1
7527085|NCT03518008|18534178|P1|NOT COMPLETED|Period 2, Second Week of Wear||0
7527086|NCT03518008|18534177|P2|COMPLETED|Period 2, Second Week of Wear||10
7527087|NCT03518008|18534178|P1|COMPLETED|Period 2, Second Week of Wear||11
7527088|NCT03518008|18534177|P2|STARTED|Period 2, Second Week of Wear||11
7527089|NCT03518008|18534178|P1|STARTED|Period 2, Second Week of Wear||11
7527090|NCT03518008|18534177|P2|NOT COMPLETED|Period 1, First Week of Wear||0
7527091|NCT03518008|18534178|P1|NOT COMPLETED|Period 1, First Week of Wear||0
7527092|NCT03518008|18534177|P2|COMPLETED|Period 1, First Week of Wear||11
7527093|NCT03518008|18534178|P1|COMPLETED|Period 1, First Week of Wear||11
7527094|NCT03518008|18534177|P2|STARTED|Period 1, First Week of Wear||11
7527095|NCT03518008|18534178|P1|STARTED|Period 1, First Week of Wear||11
7527096|NCT03516227|18534186|P2|NOT COMPLETED|Overall Study||4
7527097|NCT03516227|18534187|P1|NOT COMPLETED|Overall Study||1
7527098|NCT03516227|18534186|P2|COMPLETED|Overall Study||16
7527099|NCT03516227|18534187|P1|COMPLETED|Overall Study||19
7527100|NCT03516227|18534186|P2|STARTED|Overall Study||20
7527101|NCT03516227|18534187|P1|STARTED|Overall Study||20
7527102|NCT03515941|18534203|P2|NOT COMPLETED|Overall Study||0
7527103|NCT03515941|18534204|P1|NOT COMPLETED|Overall Study||1
7527104|NCT03515941|18534203|P2|COMPLETED|Overall Study||2
7527105|NCT03515941|18534204|P1|COMPLETED|Overall Study||3
7527106|NCT03515941|18534203|P2|STARTED|Overall Study||2
7527107|NCT03515941|18534204|P1|STARTED|Overall Study||4
7527108|NCT03514966|18534214|P2|NOT COMPLETED|Overall Study||0
7527109|NCT03514966|18534215|P1|NOT COMPLETED|Overall Study||0
7527110|NCT03514966|18534214|P2|COMPLETED|Overall Study||43
7527111|NCT03514966|18534215|P1|COMPLETED|Overall Study||40
7527112|NCT03514966|18534214|P2|STARTED|Overall Study||43
7527113|NCT03514966|18534215|P1|STARTED|Overall Study||40
7527114|NCT03513848|18534227|P2|NOT COMPLETED|Overall Study||0
7527115|NCT03513848|18534228|P1|NOT COMPLETED|Overall Study||0
7527116|NCT03513848|18534227|P2|COMPLETED|Overall Study||6
7527117|NCT03513848|18534228|P1|COMPLETED|Overall Study||9
7527118|NCT03513848|18534227|P2|STARTED|Overall Study||6
7527119|NCT03513848|18534228|P1|STARTED|Overall Study||9
7527120|NCT03513757|18534238|P2|NOT COMPLETED|Overall Study||0
7527121|NCT03513757|18534239|P1|NOT COMPLETED|Overall Study||0
7527122|NCT03513757|18534238|P2|COMPLETED|Overall Study||18
7527123|NCT03513757|18534239|P1|COMPLETED|Overall Study||22
7527124|NCT03513757|18534238|P2|STARTED|Overall Study||18
7527125|NCT03513757|18534239|P1|STARTED|Overall Study||22
7527126|NCT03513588|18534272|P3|NOT COMPLETED|Overall Study||2
7527127|NCT03513588|18534273|P2|NOT COMPLETED|Overall Study||2
7527128|NCT03513588|18534274|P1|NOT COMPLETED|Overall Study||1
7527129|NCT03513588|18534272|P3|COMPLETED|Overall Study||13
7527130|NCT03513588|18534273|P2|COMPLETED|Overall Study||15
7527131|NCT03513588|18534274|P1|COMPLETED|Overall Study||15
7527132|NCT03513588|18534272|P3|STARTED|Overall Study||15
7527133|NCT03513588|18534273|P2|STARTED|Overall Study||17
7527134|NCT03513588|18534274|P1|STARTED|Overall Study||16
7527135|NCT03512457|18534308|P2|NOT COMPLETED|Overall Study||40
7527136|NCT03512457|18534309|P1|NOT COMPLETED|Overall Study||34
7527137|NCT03512457|18534308|P2|COMPLETED|Overall Study||185
7527138|NCT03512457|18534309|P1|COMPLETED|Overall Study||161
7527139|NCT03512457|18534308|P2|STARTED|Overall Study||225
7527140|NCT03512457|18534309|P1|STARTED|Overall Study||195
7527141|NCT03512067|18534317|P1|NOT COMPLETED|Overall Study||0
7527142|NCT03512067|18534317|P1|COMPLETED|Overall Study||1
7527143|NCT03512067|18534317|P1|STARTED|Overall Study||1
7527144|NCT03512041|18534326|P4|NOT COMPLETED|Overall Study||0
7527145|NCT03512041|18534327|P3|NOT COMPLETED|Overall Study||0
7527146|NCT03512041|18534328|P2|NOT COMPLETED|Overall Study||0
7527147|NCT03512041|18534329|P1|NOT COMPLETED|Overall Study||0
7527148|NCT03512041|18534326|P4|COMPLETED|Overall Study||9
7527149|NCT03512041|18534327|P3|COMPLETED|Overall Study||11
7527150|NCT03512041|18534328|P2|COMPLETED|Overall Study||10
7527151|NCT03512041|18534329|P1|COMPLETED|Overall Study||10
7527152|NCT03512041|18534326|P4|STARTED|Overall Study||9
7527153|NCT03512041|18534327|P3|STARTED|Overall Study||11
7527154|NCT03512041|18534328|P2|STARTED|Overall Study||10
7527155|NCT03512041|18534329|P1|STARTED|Overall Study||10
7527156|NCT03512028|18534349|P2|NOT COMPLETED|Overall Study||0
7527157|NCT03512028|18534350|P1|NOT COMPLETED|Overall Study||4
7527158|NCT03512028|18534349|P2|COMPLETED|Overall Study||15
7527159|NCT03512028|18534350|P1|COMPLETED|Overall Study||15
7527160|NCT03512028|18534349|P2|STARTED|Overall Study||15
7527161|NCT03512028|18534350|P1|STARTED|Overall Study||19
7527162|NCT03511521|18534358|P2|NOT COMPLETED|Overall Study||0
7527163|NCT03511521|18534359|P1|NOT COMPLETED|Overall Study||0
7527164|NCT03511521|18534358|P2|COMPLETED|Overall Study||1
7527165|NCT03511521|18534359|P1|COMPLETED|Overall Study||2
7527166|NCT03511521|18534358|P2|STARTED|Overall Study||1
7527167|NCT03511521|18534359|P1|STARTED|Overall Study||2
7527168|NCT03511326|18534369|P1|NOT COMPLETED|Overall Study||1
7527169|NCT03511326|18534369|P1|COMPLETED|Overall Study||49
7527170|NCT03511326|18534369|P1|STARTED|Overall Study||50
7527171|NCT03511105|18534376|P2|NOT COMPLETED|Overall Study||0
7527172|NCT03511105|18534377|P1|NOT COMPLETED|Overall Study||2
7527173|NCT03511105|18534376|P2|COMPLETED|Overall Study||22
7527174|NCT03511105|18534377|P1|COMPLETED|Overall Study||23
7527175|NCT03511105|18534376|P2|STARTED|Overall Study||22
7527176|NCT03511105|18534377|P1|STARTED|Overall Study||25
7527177|NCT03510715|18534433|P2|NOT COMPLETED|Overall Study||0
7527178|NCT03510715|18534434|P1|NOT COMPLETED|Overall Study||1
7527179|NCT03510715|18534433|P2|COMPLETED|Overall Study||9
7527180|NCT03510715|18534434|P1|COMPLETED|Overall Study||8
7527181|NCT03510715|18534433|P2|STARTED|Overall Study||9
7527182|NCT03510715|18534434|P1|STARTED|Overall Study||9
7527183|NCT03510273|18534452|P1|NOT COMPLETED|Overall Study||9
7527184|NCT03510273|18534452|P1|COMPLETED|Overall Study||310
7527185|NCT03510273|18534452|P1|Completed All One-year Follow up Visits|Overall Study||118
7527186|NCT03510273|18534452|P1|Completed 1-mth Follow-up Visit & Cont'd|Overall Study||126
7527187|NCT03510273|18534452|P1|Completed 1-mth Follow-up Visit & Exited|Overall Study||192
7527188|NCT03510273|18534452|P1|Treated With Thermal Coagulation|Overall Study||319
7527189|NCT03510273|18534452|P1|STARTED|Overall Study||319
7527190|NCT03510195|18534461|P1|NOT COMPLETED|Overall Study||166
7527191|NCT03510195|18534461|P1|COMPLETED|Overall Study||101
7527192|NCT03510195|18534461|P1|STARTED|Overall Study||267
7527193|NCT03509948|18534475|P2|NOT COMPLETED|Overall Study||1
7527194|NCT03509948|18534476|P1|NOT COMPLETED|Overall Study||0
7527195|NCT03509948|18534475|P2|COMPLETED|Overall Study||6
7527196|NCT03509948|18534476|P1|COMPLETED|Overall Study||6
7527197|NCT03509948|18534475|P2|STARTED|Overall Study||7
7527198|NCT03509948|18534476|P1|STARTED|Overall Study||6
7527199|NCT03509883|18534500|P2|NOT COMPLETED|Cross-over and Treatment||0
7527200|NCT03509883|18534501|P1|NOT COMPLETED|Cross-over and Treatment||0
7527201|NCT03509883|18534500|P2|COMPLETED|Cross-over and Treatment||15
7527202|NCT03509883|18534501|P1|COMPLETED|Cross-over and Treatment||15
7527203|NCT03509883|18534500|P2|STARTED|Cross-over and Treatment||15
7527204|NCT03509883|18534501|P1|STARTED|Cross-over and Treatment||15
7527205|NCT03509883|18534500|P2|NOT COMPLETED|Initial Treatment Washout||0
7527206|NCT03509883|18534501|P1|NOT COMPLETED|Initial Treatment Washout||0
7527207|NCT03509883|18534500|P2|COMPLETED|Initial Treatment Washout||15
7527208|NCT03509883|18534501|P1|COMPLETED|Initial Treatment Washout||15
7527209|NCT03509883|18534500|P2|STARTED|Initial Treatment Washout||15
7527210|NCT03509883|18534501|P1|STARTED|Initial Treatment Washout||15
7527211|NCT03509883|18534500|P2|NOT COMPLETED|Initial Treatment||0
7527212|NCT03509883|18534501|P1|NOT COMPLETED|Initial Treatment||0
7527213|NCT03509883|18534500|P2|COMPLETED|Initial Treatment||15
7527214|NCT03509883|18534501|P1|COMPLETED|Initial Treatment||15
7527215|NCT03509883|18534500|P2|STARTED|Initial Treatment||15
7527216|NCT03509883|18534501|P1|STARTED|Initial Treatment||15
7527217|NCT03509766|18534536|P1|NOT COMPLETED|Overall Study||0
7527218|NCT03509766|18534536|P1|COMPLETED|Overall Study||24
7527219|NCT03509766|18534536|P1|STARTED|Overall Study||24
7527220|NCT03509675|18534544|P2|NOT COMPLETED|Second Intervention )7 Days)||0
7527221|NCT03509675|18534545|P1|NOT COMPLETED|Second Intervention )7 Days)||2
7527222|NCT03509675|18534544|P2|COMPLETED|Second Intervention )7 Days)||8
7527223|NCT03509675|18534545|P1|COMPLETED|Second Intervention )7 Days)||4
7527224|NCT03509675|18534544|P2|STARTED|Second Intervention )7 Days)||8
7527225|NCT03509675|18534545|P1|STARTED|Second Intervention )7 Days)||6
7527226|NCT03509675|18534544|P2|NOT COMPLETED|Washout Period (7 Days)||0
7527227|NCT03509675|18534545|P1|NOT COMPLETED|Washout Period (7 Days)||0
7527228|NCT03509675|18534544|P2|COMPLETED|Washout Period (7 Days)||8
7527229|NCT03509675|18534545|P1|COMPLETED|Washout Period (7 Days)||6
7527230|NCT03509675|18534544|P2|STARTED|Washout Period (7 Days)||8
7527231|NCT03509675|18534545|P1|STARTED|Washout Period (7 Days)||6
7527232|NCT03509675|18534544|P2|NOT COMPLETED|First Intervention (7 Days)||4
7527233|NCT03509675|18534545|P1|NOT COMPLETED|First Intervention (7 Days)||5
7527234|NCT03509675|18534544|P2|COMPLETED|First Intervention (7 Days)||8
7527235|NCT03509675|18534545|P1|COMPLETED|First Intervention (7 Days)||6
7527236|NCT03509675|18534544|P2|STARTED|First Intervention (7 Days)||12
7527237|NCT03509675|18534545|P1|STARTED|First Intervention (7 Days)||11
7527238|NCT03509350|18534553|P2|NOT COMPLETED|Overall Study||2
7527239|NCT03509350|18534554|P1|NOT COMPLETED|Overall Study||0
7527240|NCT03509350|18534553|P2|COMPLETED|Overall Study||247
7527241|NCT03509350|18534554|P1|COMPLETED|Overall Study||252
7527242|NCT03509350|18534553|P2|STARTED|Overall Study||249
7527243|NCT03509350|18534554|P1|STARTED|Overall Study||252
7527244|NCT03509207|18534560|P1|NOT COMPLETED|Overall Study||2
7527245|NCT03509207|18534560|P1|COMPLETED|Overall Study||1
7527246|NCT03509207|18534560|P1|STARTED|Overall Study||3
7527247|NCT03508843|18534565|P1|NOT COMPLETED|Overall Study||3
7527248|NCT03508843|18534565|P1|COMPLETED|Overall Study||147
7527249|NCT03508843|18534565|P1|STARTED|Overall Study||150
7527250|NCT03508687|18534573|P2|NOT COMPLETED|Overall Study||0
7527251|NCT03508687|18534574|P1|NOT COMPLETED|Overall Study||0
7527252|NCT03508687|18534573|P2|COMPLETED|Overall Study||3
7527253|NCT03508687|18534574|P1|COMPLETED|Overall Study||2
7527254|NCT03508687|18534573|P2|STARTED|Overall Study||3
7527255|NCT03508687|18534574|P1|STARTED|Overall Study||2
7527256|NCT03508661|18534616|P1|NOT COMPLETED|Overall Study||0
7527257|NCT03508661|18534616|P1|COMPLETED|Overall Study||10
7527258|NCT03508661|18534616|P1|STARTED|Overall Study||10
7527259|NCT03508050|18534632|P2|NOT COMPLETED|Overall Study||2
7527260|NCT03508050|18534633|P1|NOT COMPLETED|Overall Study||5
7527261|NCT03508050|18534632|P2|COMPLETED|Overall Study||15
7527262|NCT03508050|18534633|P1|COMPLETED|Overall Study||15
7527263|NCT03508050|18534632|P2|STARTED|Overall Study||17
7527264|NCT03508050|18534633|P1|STARTED|Overall Study||20
7527265|NCT03507569|18534667|P4|NOT COMPLETED|Overall Study||0
7527266|NCT03507569|18534668|P3|NOT COMPLETED|Overall Study||0
7527267|NCT03507569|18534669|P2|NOT COMPLETED|Overall Study||0
7527268|NCT03507569|18534670|P1|NOT COMPLETED|Overall Study||0
7527269|NCT03507569|18534667|P4|COMPLETED|Overall Study||1
7527270|NCT03507569|18534668|P3|COMPLETED|Overall Study||2
7527271|NCT03507569|18534669|P2|COMPLETED|Overall Study||1
7527272|NCT03507569|18534670|P1|COMPLETED|Overall Study||2
7527273|NCT03507569|18534667|P4|STARTED|Overall Study||1
7527274|NCT03507569|18534668|P3|STARTED|Overall Study||2
7527275|NCT03507569|18534669|P2|STARTED|Overall Study||1
7527276|NCT03507569|18534670|P1|STARTED|Overall Study||2
7527277|NCT03507036|18534688|P1|NOT COMPLETED|Overall Study||5
7527278|NCT03507036|18534688|P1|COMPLETED|Overall Study||15
7527279|NCT03507036|18534688|P1|STARTED|Overall Study||20
7527280|NCT03506425|18534709|P3|NOT COMPLETED|Overall Study||1
7527281|NCT03506425|18534710|P2|NOT COMPLETED|Overall Study||3
7527282|NCT03506425|18534711|P1|NOT COMPLETED|Overall Study||2
7527283|NCT03506425|18534709|P3|COMPLETED|Overall Study||4
7527284|NCT03506425|18534710|P2|COMPLETED|Overall Study||2
7527285|NCT03506425|18534711|P1|COMPLETED|Overall Study||3
7527286|NCT03506425|18534709|P3|STARTED|Overall Study||5
7527287|NCT03506425|18534710|P2|STARTED|Overall Study||5
7527288|NCT03506425|18534711|P1|STARTED|Overall Study||5
7527289|NCT03506347|18534724|P2|NOT COMPLETED|Overall Study||0
7527290|NCT03506347|18534725|P1|NOT COMPLETED|Overall Study||0
7527291|NCT03506347|18534724|P2|COMPLETED|Overall Study||12
7527292|NCT03506347|18534725|P1|COMPLETED|Overall Study||12
7527293|NCT03506347|18534724|P2|STARTED|Overall Study||12
7527294|NCT03506347|18534725|P1|STARTED|Overall Study||12
7527295|NCT03506295|18534733|P1|NOT COMPLETED|Overall Study||0
7527296|NCT03506295|18534733|P1|COMPLETED|Overall Study||10
7527297|NCT03506295|18534733|P1|STARTED|Overall Study||10
7527298|NCT03505593|18534746|P1|NOT COMPLETED|Overall Study||5
7527299|NCT03505593|18534746|P1|COMPLETED|Overall Study||43
7527300|NCT03505593|18534746|P1|STARTED|Overall Study||48
7527301|NCT03505372|18534752|P1|NOT COMPLETED|Overall Study||0
7527302|NCT03505372|18534752|P1|COMPLETED|Overall Study||5
7527303|NCT03505372|18534752|P1|STARTED|Overall Study||5
7527304|NCT03505190|18534762|P5|NOT COMPLETED|Overall Study||0
7527305|NCT03505190|18534763|P4|NOT COMPLETED|Overall Study||0
7527306|NCT03505190|18534764|P3|NOT COMPLETED|Overall Study||0
7527307|NCT03505190|18534765|P2|NOT COMPLETED|Overall Study||0
7527308|NCT03505190|18534766|P1|NOT COMPLETED|Overall Study||0
7527309|NCT03505190|18534762|P5|COMPLETED|Overall Study||8
7527310|NCT03505190|18534763|P4|COMPLETED|Overall Study||8
7527311|NCT03505190|18534764|P3|COMPLETED|Overall Study||8
7527312|NCT03505190|18534765|P2|COMPLETED|Overall Study||8
7527313|NCT03505190|18534766|P1|COMPLETED|Overall Study||9
7527314|NCT03505190|18534762|P5|STARTED|Overall Study||8
7527315|NCT03505190|18534763|P4|STARTED|Overall Study||8
7527316|NCT03505190|18534764|P3|STARTED|Overall Study||8
7527317|NCT03505190|18534765|P2|STARTED|Overall Study||8
7527318|NCT03505190|18534766|P1|STARTED|Overall Study||9
7527319|NCT03504189|18534843|P1|NOT COMPLETED|Overall Study||4
7527320|NCT03504189|18534843|P1|COMPLETED|Overall Study||147
7527321|NCT03504189|18534843|P1|STARTED|Overall Study||151
7527322|NCT03503578|18534852|P1|NOT COMPLETED|Overall Study||0
7527323|NCT03503578|18534852|P1|COMPLETED|Overall Study||12
7527324|NCT03503578|18534852|P1|STARTED|Overall Study||12
7527325|NCT03503292|18534858|P2|NOT COMPLETED|Overall Study||0
7527326|NCT03503292|18534859|P1|NOT COMPLETED|Overall Study||0
7527327|NCT03503292|18534858|P2|COMPLETED|Overall Study||90
7527328|NCT03503292|18534859|P1|COMPLETED|Overall Study||2
7527329|NCT03503292|18534858|P2|STARTED|Overall Study||90
7527330|NCT03503292|18534859|P1|STARTED|Overall Study||2
7527331|NCT03503188|18534869|P2|NOT COMPLETED|Overall Study||1
7527332|NCT03503188|18534870|P1|NOT COMPLETED|Overall Study||0
7527333|NCT03503188|18534869|P2|COMPLETED|Overall Study||145
7527334|NCT03503188|18534870|P1|COMPLETED|Overall Study||128
7527335|NCT03503188|18534869|P2|Sub-study|Overall Study||44
7527336|NCT03503188|18534870|P1|Sub-study|Overall Study||29
7527337|NCT03503188|18534869|P2|Main Study|Overall Study||101
7527338|NCT03503188|18534870|P1|Main Study|Overall Study||99
7527339|NCT03503188|18534869|P2|Entered in the Entire Study|Overall Study||145
7527340|NCT03503188|18534870|P1|Entered in the Entire Study|Overall Study||128
7527341|NCT03503188|18534869|P2|STARTED|Overall Study||146
7527342|NCT03503188|18534870|P1|STARTED|Overall Study||128
7527343|NCT03502915|18534888|P2|NOT COMPLETED|Overall Study||0
7527344|NCT03502915|18534889|P1|NOT COMPLETED|Overall Study||0
7527345|NCT03502915|18534888|P2|COMPLETED|Overall Study||24
7527346|NCT03502915|18534889|P1|COMPLETED|Overall Study||24
7527347|NCT03502915|18534888|P2|STARTED|Overall Study||24
7527348|NCT03502915|18534889|P1|STARTED|Overall Study||24
7527349|NCT03502681|18534905|P2|NOT COMPLETED|Overall Study||2
7527350|NCT03502681|18534906|P1|NOT COMPLETED|Overall Study||3
7527351|NCT03502681|18534905|P2|COMPLETED|Overall Study||1
7527352|NCT03502681|18534906|P1|COMPLETED|Overall Study||0
7527353|NCT03502681|18534905|P2|STARTED|Overall Study||3
7527354|NCT03502681|18534906|P1|STARTED|Overall Study||3
7527355|NCT03502070|18534925|P1|NOT COMPLETED|Overall Study||2
7527356|NCT03502070|18534925|P1|COMPLETED|Overall Study||45
7527357|NCT03502070|18534925|P1|STARTED|Overall Study||47
7527358|NCT03501693|18534929|P2|NOT COMPLETED|Second Reading Session||0
7527359|NCT03501693|18534930|P1|NOT COMPLETED|Second Reading Session||0
7527360|NCT03501693|18534929|P2|COMPLETED|Second Reading Session||75
7527361|NCT03501693|18534930|P1|COMPLETED|Second Reading Session||75
7527362|NCT03501693|18534929|P2|STARTED|Second Reading Session||75
7527363|NCT03501693|18534930|P1|STARTED|Second Reading Session||75
7527364|NCT03501693|18534929|P2|NOT COMPLETED|4 Week Memory Washout Period||0
7527365|NCT03501693|18534930|P1|NOT COMPLETED|4 Week Memory Washout Period||0
7527366|NCT03501693|18534929|P2|COMPLETED|4 Week Memory Washout Period||75
7527367|NCT03501693|18534930|P1|COMPLETED|4 Week Memory Washout Period||75
7527368|NCT03501693|18534929|P2|STARTED|4 Week Memory Washout Period||75
7527369|NCT03501693|18534930|P1|STARTED|4 Week Memory Washout Period||75
7527370|NCT03501693|18534929|P2|NOT COMPLETED|First Reading Session||0
7527371|NCT03501693|18534930|P1|NOT COMPLETED|First Reading Session||0
7527372|NCT03501693|18534929|P2|COMPLETED|First Reading Session||75
7527373|NCT03501693|18534930|P1|COMPLETED|First Reading Session||75
7527374|NCT03501693|18534929|P2|STARTED|First Reading Session||75
7527375|NCT03501693|18534930|P1|STARTED|First Reading Session||75
7527376|NCT03501277|18534946|P4|NOT COMPLETED|Intervention Period 4 (4 Days)||0
7527377|NCT03501277|18534947|P3|NOT COMPLETED|Intervention Period 4 (4 Days)||0
7527378|NCT03501277|18534948|P2|NOT COMPLETED|Intervention Period 4 (4 Days)||0
7527379|NCT03501277|18534949|P1|NOT COMPLETED|Intervention Period 4 (4 Days)||0
7527380|NCT03501277|18534946|P4|COMPLETED|Intervention Period 4 (4 Days)||15
7527381|NCT03501277|18534947|P3|COMPLETED|Intervention Period 4 (4 Days)||17
7527382|NCT03501277|18534948|P2|COMPLETED|Intervention Period 4 (4 Days)||18
7527383|NCT03501277|18534949|P1|COMPLETED|Intervention Period 4 (4 Days)||18
7527384|NCT03501277|18534946|P4|STARTED|Intervention Period 4 (4 Days)||15
7527385|NCT03501277|18534947|P3|STARTED|Intervention Period 4 (4 Days)||17
7527386|NCT03501277|18534948|P2|STARTED|Intervention Period 4 (4 Days)||18
7527387|NCT03501277|18534949|P1|STARTED|Intervention Period 4 (4 Days)||18
7527388|NCT03501277|18534946|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
7527389|NCT03501277|18534947|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
7527390|NCT03501277|18534948|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
7527391|NCT03501277|18534949|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
7527392|NCT03501277|18534946|P4|COMPLETED|Washout Period 3 (7 Days)||15
7527393|NCT03501277|18534947|P3|COMPLETED|Washout Period 3 (7 Days)||17
7527394|NCT03501277|18534948|P2|COMPLETED|Washout Period 3 (7 Days)||18
7527395|NCT03501277|18534949|P1|COMPLETED|Washout Period 3 (7 Days)||18
7527396|NCT03501277|18534946|P4|STARTED|Washout Period 3 (7 Days)||15
7527397|NCT03501277|18534947|P3|STARTED|Washout Period 3 (7 Days)||17
7527398|NCT03501277|18534948|P2|STARTED|Washout Period 3 (7 Days)||18
7527399|NCT03501277|18534949|P1|STARTED|Washout Period 3 (7 Days)||18
7527400|NCT03501277|18534946|P4|NOT COMPLETED|Intervention Period 3 (4 Days)||1
7527401|NCT03501277|18534947|P3|NOT COMPLETED|Intervention Period 3 (4 Days)||0
7527402|NCT03501277|18534948|P2|NOT COMPLETED|Intervention Period 3 (4 Days)||0
7527403|NCT03501277|18534949|P1|NOT COMPLETED|Intervention Period 3 (4 Days)||0
7527404|NCT03501277|18534946|P4|COMPLETED|Intervention Period 3 (4 Days)||15
7527405|NCT03501277|18534947|P3|COMPLETED|Intervention Period 3 (4 Days)||17
7527406|NCT03501277|18534948|P2|COMPLETED|Intervention Period 3 (4 Days)||18
7527407|NCT03501277|18534949|P1|COMPLETED|Intervention Period 3 (4 Days)||18
7527408|NCT03501277|18534946|P4|STARTED|Intervention Period 3 (4 Days)||16
7527409|NCT03501277|18534947|P3|STARTED|Intervention Period 3 (4 Days)||17
7527410|NCT03501277|18534948|P2|STARTED|Intervention Period 3 (4 Days)||18
7527411|NCT03501277|18534949|P1|STARTED|Intervention Period 3 (4 Days)||18
7527412|NCT03501277|18534946|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
7527413|NCT03501277|18534947|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
7527414|NCT03501277|18534948|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
7527415|NCT03501277|18534949|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
7527416|NCT03501277|18534946|P4|COMPLETED|Washout Period 2 (7 Days)||16
7527417|NCT03501277|18534947|P3|COMPLETED|Washout Period 2 (7 Days)||17
7527418|NCT03501277|18534948|P2|COMPLETED|Washout Period 2 (7 Days)||18
7527419|NCT03501277|18534949|P1|COMPLETED|Washout Period 2 (7 Days)||18
7527420|NCT03501277|18534946|P4|STARTED|Washout Period 2 (7 Days)||16
7527421|NCT03501277|18534947|P3|STARTED|Washout Period 2 (7 Days)||17
7527422|NCT03501277|18534948|P2|STARTED|Washout Period 2 (7 Days)||18
7527423|NCT03501277|18534949|P1|STARTED|Washout Period 2 (7 Days)||18
7527424|NCT03501277|18534946|P4|NOT COMPLETED|Intervention Period 2 (4 Days)||1
7527425|NCT03501277|18534947|P3|NOT COMPLETED|Intervention Period 2 (4 Days)||0
7527426|NCT03501277|18534948|P2|NOT COMPLETED|Intervention Period 2 (4 Days)||0
7527427|NCT03501277|18534949|P1|NOT COMPLETED|Intervention Period 2 (4 Days)||0
7527428|NCT03501277|18534946|P4|COMPLETED|Intervention Period 2 (4 Days)||16
7527429|NCT03501277|18534947|P3|COMPLETED|Intervention Period 2 (4 Days)||17
7527430|NCT03501277|18534948|P2|COMPLETED|Intervention Period 2 (4 Days)||18
7527431|NCT03501277|18534949|P1|COMPLETED|Intervention Period 2 (4 Days)||18
7527432|NCT03501277|18534946|P4|STARTED|Intervention Period 2 (4 Days)||17
7527433|NCT03501277|18534947|P3|STARTED|Intervention Period 2 (4 Days)||17
7527434|NCT03501277|18534948|P2|STARTED|Intervention Period 2 (4 Days)||18
7527435|NCT03501277|18534949|P1|STARTED|Intervention Period 2 (4 Days)||18
7527436|NCT03501277|18534946|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
7527437|NCT03501277|18534947|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
7527438|NCT03501277|18534948|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
7527439|NCT03501277|18534949|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
7527440|NCT03501277|18534946|P4|COMPLETED|Washout Period 1 (7 Days)||17
7527441|NCT03501277|18534947|P3|COMPLETED|Washout Period 1 (7 Days)||17
7527442|NCT03501277|18534948|P2|COMPLETED|Washout Period 1 (7 Days)||18
7527443|NCT03501277|18534949|P1|COMPLETED|Washout Period 1 (7 Days)||18
7527444|NCT03501277|18534946|P4|STARTED|Washout Period 1 (7 Days)||17
7527445|NCT03501277|18534947|P3|STARTED|Washout Period 1 (7 Days)||17
7527446|NCT03501277|18534948|P2|STARTED|Washout Period 1 (7 Days)||18
7527447|NCT03501277|18534949|P1|STARTED|Washout Period 1 (7 Days)||18
7527448|NCT03501277|18534946|P4|NOT COMPLETED|Intervention Period 1 (4 Days)||1
7527449|NCT03501277|18534947|P3|NOT COMPLETED|Intervention Period 1 (4 Days)||1
7527450|NCT03501277|18534948|P2|NOT COMPLETED|Intervention Period 1 (4 Days)||0
7527451|NCT03501277|18534949|P1|NOT COMPLETED|Intervention Period 1 (4 Days)||0
7527452|NCT03501277|18534946|P4|COMPLETED|Intervention Period 1 (4 Days)||17
7527453|NCT03501277|18534947|P3|COMPLETED|Intervention Period 1 (4 Days)||17
7527454|NCT03501277|18534948|P2|COMPLETED|Intervention Period 1 (4 Days)||18
7527455|NCT03501277|18534949|P1|COMPLETED|Intervention Period 1 (4 Days)||18
7527456|NCT03501277|18534946|P4|Safety Analysis Set|Intervention Period 1 (4 Days)||17
7527457|NCT03501277|18534947|P3|Safety Analysis Set|Intervention Period 1 (4 Days)||17
7527458|NCT03501277|18534948|P2|Safety Analysis Set|Intervention Period 1 (4 Days)||18
7527459|NCT03501277|18534949|P1|Safety Analysis Set|Intervention Period 1 (4 Days)||18
7527460|NCT03501277|18534946|P4|STARTED|Intervention Period 1 (4 Days)||18
7527461|NCT03501277|18534947|P3|STARTED|Intervention Period 1 (4 Days)||18
7527462|NCT03501277|18534948|P2|STARTED|Intervention Period 1 (4 Days)||18
7527463|NCT03501277|18534949|P1|STARTED|Intervention Period 1 (4 Days)||18
7527464|NCT03501264|18534965|P2|NOT COMPLETED|Overall Study||0
7527465|NCT03501264|18534966|P1|NOT COMPLETED|Overall Study||0
7527466|NCT03501264|18534965|P2|COMPLETED|Overall Study||120
7527467|NCT03501264|18534966|P1|COMPLETED|Overall Study||120
7527468|NCT03501264|18534965|P2|STARTED|Overall Study||120
7527469|NCT03501264|18534966|P1|STARTED|Overall Study||120
7527470|NCT03501069|18534981|P9|NOT COMPLETED|Period B||0
7527471|NCT03501069|18534982|P8|NOT COMPLETED|Period B||0
7527472|NCT03501069|18534983|P7|NOT COMPLETED|Period B||0
7527473|NCT03501069|18534984|P6|NOT COMPLETED|Period B||0
7527474|NCT03501069|18534985|P5|NOT COMPLETED|Period B||0
7527475|NCT03501069|18534986|P4|NOT COMPLETED|Period B||0
7527476|NCT03501069|18534987|P3|NOT COMPLETED|Period B||0
7527477|NCT03501069|18534988|P2|NOT COMPLETED|Period B||0
7527478|NCT03501069|18534989|P1|NOT COMPLETED|Period B||0
7527479|NCT03501069|18534981|P9|COMPLETED|Period B||0
7527480|NCT03501069|18534982|P8|COMPLETED|Period B||0
7527481|NCT03501069|18534983|P7|COMPLETED|Period B||0
7527482|NCT03501069|18534984|P6|COMPLETED|Period B||0
7527483|NCT03501069|18534985|P5|COMPLETED|Period B||0
7527484|NCT03501069|18534986|P4|COMPLETED|Period B||0
7527485|NCT03501069|18534987|P3|COMPLETED|Period B||2
7527486|NCT03501069|18534988|P2|COMPLETED|Period B||4
7527487|NCT03501069|18534989|P1|COMPLETED|Period B||2
7527488|NCT03501069|18534981|P9|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
7527489|NCT03501069|18534982|P8|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
7527490|NCT03501069|18534983|P7|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
7527491|NCT03501069|18534984|P6|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
7527492|NCT03501069|18534985|P5|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
7527493|NCT03501069|18534986|P4|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
7527494|NCT03501069|18534987|P3|STARTED|Period B||2
7527495|NCT03501069|18534988|P2|STARTED|Period B||4
7527496|NCT03501069|18534989|P1|STARTED|Period B||2
7527497|NCT03501069|18534981|P9|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7527498|NCT03501069|18534982|P8|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7527499|NCT03501069|18534983|P7|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7527500|NCT03501069|18534984|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7527501|NCT03501069|18534985|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7527502|NCT03501069|18534986|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7527503|NCT03501069|18534987|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7527504|NCT03501069|18534988|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7527505|NCT03501069|18534989|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7527506|NCT03501069|18534981|P9|COMPLETED|Washout Period (at Least 14 Days)||0
7527507|NCT03501069|18534982|P8|COMPLETED|Washout Period (at Least 14 Days)||0
7527508|NCT03501069|18534983|P7|COMPLETED|Washout Period (at Least 14 Days)||0
7527509|NCT03501069|18534984|P6|COMPLETED|Washout Period (at Least 14 Days)||0
7527510|NCT03501069|18534985|P5|COMPLETED|Washout Period (at Least 14 Days)||0
7527511|NCT03501069|18534986|P4|COMPLETED|Washout Period (at Least 14 Days)||0
7527512|NCT03501069|18534987|P3|COMPLETED|Washout Period (at Least 14 Days)||2
7527513|NCT03501069|18534988|P2|COMPLETED|Washout Period (at Least 14 Days)||4
7527514|NCT03501069|18534989|P1|COMPLETED|Washout Period (at Least 14 Days)||2
7527515|NCT03501069|18534981|P9|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
7527516|NCT03501069|18534982|P8|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
7527517|NCT03501069|18534983|P7|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
7527518|NCT03501069|18534984|P6|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
7527519|NCT03501069|18534985|P5|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
7527520|NCT03501069|18534986|P4|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
7527521|NCT03501069|18534987|P3|STARTED|Washout Period (at Least 14 Days)||2
7527522|NCT03501069|18534988|P2|STARTED|Washout Period (at Least 14 Days)||4
7527523|NCT03501069|18534989|P1|STARTED|Washout Period (at Least 14 Days)||2
7527524|NCT03501069|18534981|P9|NOT COMPLETED|Period A||0
7527525|NCT03501069|18534982|P8|NOT COMPLETED|Period A||0
7527526|NCT03501069|18534983|P7|NOT COMPLETED|Period A||0
7527527|NCT03501069|18534984|P6|NOT COMPLETED|Period A||0
7527528|NCT03501069|18534985|P5|NOT COMPLETED|Period A||0
7527529|NCT03501069|18534986|P4|NOT COMPLETED|Period A||0
7527530|NCT03501069|18534987|P3|NOT COMPLETED|Period A||0
7527531|NCT03501069|18534988|P2|NOT COMPLETED|Period A||0
7527532|NCT03501069|18534989|P1|NOT COMPLETED|Period A||0
7527533|NCT03501069|18534981|P9|COMPLETED|Period A||3
7527534|NCT03501069|18534982|P8|COMPLETED|Period A||3
7527535|NCT03501069|18534983|P7|COMPLETED|Period A||6
7527536|NCT03501069|18534984|P6|COMPLETED|Period A||6
7527537|NCT03501069|18534985|P5|COMPLETED|Period A||1
7527538|NCT03501069|18534986|P4|COMPLETED|Period A||5
7527539|NCT03501069|18534987|P3|COMPLETED|Period A||2
7527540|NCT03501069|18534988|P2|COMPLETED|Period A||4
7527541|NCT03501069|18534989|P1|COMPLETED|Period A||2
7527542|NCT03501069|18534981|P9|STARTED|Period A||3
7527543|NCT03501069|18534982|P8|STARTED|Period A||3
7527544|NCT03501069|18534983|P7|STARTED|Period A||6
7527545|NCT03501069|18534984|P6|STARTED|Period A||6
7527546|NCT03501069|18534985|P5|STARTED|Period A||1
7527547|NCT03501069|18534986|P4|STARTED|Period A||5
7527548|NCT03501069|18534987|P3|STARTED|Period A||2
7527549|NCT03501069|18534988|P2|STARTED|Period A||4
7527550|NCT03501069|18534989|P1|STARTED|Period A||2
7527551|NCT03501043|18535059|P1|NOT COMPLETED|Overall Study||1
7527552|NCT03501043|18535059|P1|COMPLETED|Overall Study||10
7527553|NCT03501043|18535059|P1|STARTED|Overall Study||11
7527554|NCT03500679|18535076|P2|NOT COMPLETED|Overall Study||3
7527555|NCT03500679|18535077|P1|NOT COMPLETED|Overall Study||9
7527556|NCT03500679|18535076|P2|COMPLETED|Overall Study||22
7527557|NCT03500679|18535077|P1|COMPLETED|Overall Study||66
7527558|NCT03500679|18535076|P2|STARTED|Overall Study||25
7527559|NCT03500679|18535077|P1|STARTED|Overall Study||75
7527560|NCT03500406|18535125|P2|NOT COMPLETED|Overall Study||0
7527561|NCT03500406|18535126|P1|NOT COMPLETED|Overall Study||0
7527562|NCT03500406|18535125|P2|COMPLETED|Overall Study||20
7527563|NCT03500406|18535126|P1|COMPLETED|Overall Study||4
7527564|NCT03500406|18535125|P2|STARTED|Overall Study||20
7527565|NCT03500406|18535126|P1|STARTED|Overall Study||4
7527566|NCT03500302|18535144|P1|NOT COMPLETED|Overall Study||0
7527567|NCT03500302|18535144|P1|COMPLETED|Overall Study||19
7527568|NCT03500302|18535144|P1|STARTED|Overall Study||19
7527569|NCT03500289|18535151|P2|NOT COMPLETED|Overall Study||0
7527570|NCT03500289|18535152|P1|NOT COMPLETED|Overall Study||0
7527571|NCT03500289|18535151|P2|COMPLETED|Overall Study||6
7527572|NCT03500289|18535152|P1|COMPLETED|Overall Study||12
7527573|NCT03500289|18535151|P2|STARTED|Overall Study||6
7527574|NCT03500289|18535152|P1|STARTED|Overall Study||12
7527575|NCT03500224|18535168|P1|NOT COMPLETED|Overall Study||2
7527576|NCT03500224|18535168|P1|COMPLETED|Overall Study||4
7527577|NCT03500224|18535168|P1|STARTED|Overall Study||6
7527578|NCT03500211|18535207|P2|NOT COMPLETED|Overall Study||1
7527579|NCT03500211|18535208|P1|NOT COMPLETED|Overall Study||1
7527580|NCT03500211|18535207|P2|COMPLETED|Overall Study||24
7527581|NCT03500211|18535208|P1|COMPLETED|Overall Study||24
7527582|NCT03500211|18535207|P2|STARTED|Overall Study||25
7527583|NCT03500211|18535208|P1|STARTED|Overall Study||25
7527584|NCT03500198|18535224|P2|NOT COMPLETED|Overall Study||1
7527585|NCT03500198|18535225|P1|NOT COMPLETED|Overall Study||0
7527586|NCT03500198|18535224|P2|COMPLETED|Overall Study||107
7527587|NCT03500198|18535225|P1|COMPLETED|Overall Study||110
7527588|NCT03500198|18535224|P2|Second Eye|Overall Study||108
7527589|NCT03500198|18535225|P1|Second Eye|Overall Study||109
7527590|NCT03500198|18535224|P2|First Eye|Overall Study||108
7527591|NCT03500198|18535225|P1|First Eye|Overall Study||110
7527592|NCT03500198|18535224|P2|STARTED|Overall Study||108
7527593|NCT03500198|18535225|P1|STARTED|Overall Study||110
7527594|NCT03500159|18535241|P2|NOT COMPLETED|Overall Study||1
7527595|NCT03500159|18535242|P1|NOT COMPLETED|Overall Study||2
7527596|NCT03500159|18535241|P2|COMPLETED|Overall Study||0
7527597|NCT03500159|18535242|P1|COMPLETED|Overall Study||0
7527598|NCT03500159|18535241|P2|STARTED|Overall Study||1
7527599|NCT03500159|18535242|P1|STARTED|Overall Study||2
7527600|NCT03499067|18535248|P2|NOT COMPLETED|Second Intervention||0
7527601|NCT03499067|18535249|P1|NOT COMPLETED|Second Intervention||0
7527602|NCT03499067|18535248|P2|COMPLETED|Second Intervention||24
7527603|NCT03499067|18535249|P1|COMPLETED|Second Intervention||22
7527604|NCT03499067|18535248|P2|STARTED|Second Intervention||24
7527605|NCT03499067|18535249|P1|STARTED|Second Intervention||22
7527606|NCT03499067|18535248|P2|NOT COMPLETED|First Intervention||7
7527607|NCT03499067|18535249|P1|NOT COMPLETED|First Intervention||5
7527608|NCT03499067|18535248|P2|COMPLETED|First Intervention||24
7527609|NCT03499067|18535249|P1|COMPLETED|First Intervention||22
7527610|NCT03499067|18535248|P2|STARTED|First Intervention||31
7527611|NCT03499067|18535249|P1|STARTED|First Intervention||27
7527612|NCT03498560|18535289|P1|NOT COMPLETED|Overall Study||21
7527613|NCT03498560|18535289|P1|COMPLETED|Overall Study||17
7527614|NCT03498560|18535289|P1|Completed PSG|Overall Study||25
7527615|NCT03498560|18535289|P1|Completed Baseline Assessment|Overall Study||32
7527616|NCT03498560|18535289|P1|STARTED|Overall Study||38
7527617|NCT03498300|18535296|P2|NOT COMPLETED|Overall Study||8
7527618|NCT03498300|18535297|P1|NOT COMPLETED|Overall Study||3
7527619|NCT03498300|18535296|P2|COMPLETED|Overall Study||13
7527620|NCT03498300|18535297|P1|COMPLETED|Overall Study||18
7527621|NCT03498300|18535296|P2|STARTED|Overall Study||21
7527622|NCT03498300|18535297|P1|STARTED|Overall Study||21
7527623|NCT03498287|18535306|P2|NOT COMPLETED|Overall Study||5
7527624|NCT03498287|18535307|P1|NOT COMPLETED|Overall Study||3
7527625|NCT03498287|18535306|P2|COMPLETED|Overall Study||38
7527626|NCT03498287|18535307|P1|COMPLETED|Overall Study||42
7527627|NCT03498287|18535306|P2|STARTED|Overall Study||43
7527628|NCT03498287|18535307|P1|STARTED|Overall Study||45
7527629|NCT03498196|18535315|P1|NOT COMPLETED|Overall Study||0
7527630|NCT03498196|18535315|P1|COMPLETED|Overall Study||1
7527631|NCT03498196|18535315|P1|STARTED|Overall Study||1
7527632|NCT03497845|18535334|P12|NOT COMPLETED|Overall Study||22
7527633|NCT03497845|18535335|P11|NOT COMPLETED|Overall Study||15
7527634|NCT03497845|18535336|P10|NOT COMPLETED|Overall Study||6
7527635|NCT03497845|18535337|P9|NOT COMPLETED|Overall Study||14
7527636|NCT03497845|18535338|P8|NOT COMPLETED|Overall Study||10
7527637|NCT03497845|18535339|P7|NOT COMPLETED|Overall Study||8
7527638|NCT03497845|18535340|P6|NOT COMPLETED|Overall Study||18
7527639|NCT03497845|18535341|P5|NOT COMPLETED|Overall Study||21
7527640|NCT03497845|18535342|P4|NOT COMPLETED|Overall Study||10
7527641|NCT03497845|18535343|P3|NOT COMPLETED|Overall Study||11
7527642|NCT03497845|18535344|P2|NOT COMPLETED|Overall Study||13
7527643|NCT03497845|18535345|P1|NOT COMPLETED|Overall Study||5
7527644|NCT03497845|18535334|P12|COMPLETED|Overall Study|Day 262|38
7527645|NCT03497845|18535335|P11|COMPLETED|Overall Study|Day 262|46
7527646|NCT03497845|18535336|P10|COMPLETED|Overall Study|Day 142|53
7527647|NCT03497845|18535337|P9|COMPLETED|Overall Study|Day 142|47
7527648|NCT03497845|18535338|P8|COMPLETED|Overall Study|Day 142|50
7527649|NCT03497845|18535339|P7|COMPLETED|Overall Study|Day 142|51
7527650|NCT03497845|18535340|P6|COMPLETED|Overall Study|Day 262|44
7527651|NCT03497845|18535341|P5|COMPLETED|Overall Study|Day 262|38
7527652|NCT03497845|18535342|P4|COMPLETED|Overall Study|Day 142|50
7527653|NCT03497845|18535343|P3|COMPLETED|Overall Study|Day 142|50
7527654|NCT03497845|18535344|P2|COMPLETED|Overall Study|Day 142|45
7527655|NCT03497845|18535345|P1|COMPLETED|Overall Study|Day 142|55
7527656|NCT03497845|18535334|P12|STARTED|Overall Study||60
7527657|NCT03497845|18535335|P11|STARTED|Overall Study||61
7527658|NCT03497845|18535336|P10|STARTED|Overall Study||59
7527659|NCT03497845|18535337|P9|STARTED|Overall Study||61
7527660|NCT03497845|18535338|P8|STARTED|Overall Study||60
7527661|NCT03497845|18535339|P7|STARTED|Overall Study||59
7527662|NCT03497845|18535340|P6|STARTED|Overall Study||62
7527663|NCT03497845|18535341|P5|STARTED|Overall Study||59
7527664|NCT03497845|18535342|P4|STARTED|Overall Study||60
7527665|NCT03497845|18535343|P3|STARTED|Overall Study||61
7527666|NCT03497845|18535344|P2|STARTED|Overall Study||58
7527667|NCT03497845|18535345|P1|STARTED|Overall Study||60
7527668|NCT03497585|18535399|P1|NOT COMPLETED|Overall Study||55
7527669|NCT03497585|18535399|P1|COMPLETED|Overall Study||57
7527670|NCT03497585|18535399|P1|STARTED|Overall Study|112 participants were recruited: 107 patients, plus 5 HCPs for the acceptability interviews.|112
7527671|NCT03497130|18535432|P2|NOT COMPLETED|Overall Study||1
7527672|NCT03497130|18535433|P1|NOT COMPLETED|Overall Study||1
7527673|NCT03497130|18535432|P2|COMPLETED|Overall Study||13
7527674|NCT03497130|18535433|P1|COMPLETED|Overall Study||39
7527675|NCT03497130|18535432|P2|STARTED|Overall Study||14
7527676|NCT03497130|18535433|P1|STARTED|Overall Study||40
7527677|NCT03497039|18535445|P2|NOT COMPLETED|Overall Study||1
7527678|NCT03497039|18535446|P1|NOT COMPLETED|Overall Study||1
7527679|NCT03497039|18535445|P2|COMPLETED|Overall Study||16
7527680|NCT03497039|18535446|P1|COMPLETED|Overall Study||29
7527681|NCT03497039|18535445|P2|Treated|Overall Study||17
7527682|NCT03497039|18535446|P1|Treated|Overall Study||29
7527683|NCT03497039|18535445|P2|STARTED|Overall Study||17
7527684|NCT03497039|18535446|P1|STARTED|Overall Study||30
7527685|NCT03496987|18535460|P2|NOT COMPLETED|Overall Study||0
7527686|NCT03496987|18535461|P1|NOT COMPLETED|Overall Study||0
7527687|NCT03496987|18535460|P2|COMPLETED|Overall Study||51
7527688|NCT03496987|18535461|P1|COMPLETED|Overall Study||49
7527689|NCT03496987|18535460|P2|STARTED|Overall Study||51
7527690|NCT03496987|18535461|P1|STARTED|Overall Study||49
7527691|NCT03496974|18535481|P2|NOT COMPLETED|Overall Study||8
7527692|NCT03496974|18535482|P1|NOT COMPLETED|Overall Study||1
7527693|NCT03496974|18535481|P2|COMPLETED|Overall Study||20
7527694|NCT03496974|18535482|P1|COMPLETED|Overall Study||9
7527695|NCT03496974|18535481|P2|STARTED|Overall Study||28
7527696|NCT03496974|18535482|P1|STARTED|Overall Study||10
7527697|NCT03496428|18535516|P1|NOT COMPLETED|Overall Study||0
7527698|NCT03496428|18535516|P1|COMPLETED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
7527699|NCT03496428|18535516|P1|STARTED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
7527700|NCT03496324|18535521|P4|NOT COMPLETED|Period 7: Period 4||0
7527701|NCT03496324|18535522|P3|NOT COMPLETED|Period 7: Period 4||0
7527702|NCT03496324|18535523|P2|NOT COMPLETED|Period 7: Period 4||0
7527703|NCT03496324|18535524|P1|NOT COMPLETED|Period 7: Period 4||0
7527704|NCT03496324|18535521|P4|COMPLETED|Period 7: Period 4||6
7527705|NCT03496324|18535522|P3|COMPLETED|Period 7: Period 4||6
7527706|NCT03496324|18535523|P2|COMPLETED|Period 7: Period 4||6
7527707|NCT03496324|18535524|P1|COMPLETED|Period 7: Period 4||6
7527708|NCT03496324|18535521|P4|STARTED|Period 7: Period 4||6
7527709|NCT03496324|18535522|P3|STARTED|Period 7: Period 4||6
7527710|NCT03496324|18535523|P2|STARTED|Period 7: Period 4||6
7527711|NCT03496324|18535524|P1|STARTED|Period 7: Period 4||6
7527712|NCT03496324|18535521|P4|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
7527713|NCT03496324|18535522|P3|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
7527714|NCT03496324|18535523|P2|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
7527715|NCT03496324|18535524|P1|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
7527716|NCT03496324|18535521|P4|COMPLETED|Period 3: Washout (3 to 7 Days)||6
7527717|NCT03496324|18535522|P3|COMPLETED|Period 3: Washout (3 to 7 Days)||6
7527718|NCT03496324|18535523|P2|COMPLETED|Period 3: Washout (3 to 7 Days)||6
7527719|NCT03496324|18535524|P1|COMPLETED|Period 3: Washout (3 to 7 Days)||6
7527720|NCT03496324|18535521|P4|STARTED|Period 3: Washout (3 to 7 Days)||6
7527721|NCT03496324|18535522|P3|STARTED|Period 3: Washout (3 to 7 Days)||6
7527722|NCT03496324|18535523|P2|STARTED|Period 3: Washout (3 to 7 Days)||6
7527723|NCT03496324|18535524|P1|STARTED|Period 3: Washout (3 to 7 Days)||6
7527724|NCT03496324|18535521|P4|NOT COMPLETED|Period 3||0
7527725|NCT03496324|18535522|P3|NOT COMPLETED|Period 3||0
7527726|NCT03496324|18535523|P2|NOT COMPLETED|Period 3||0
7527727|NCT03496324|18535524|P1|NOT COMPLETED|Period 3||0
7527728|NCT03496324|18535521|P4|COMPLETED|Period 3||6
7527729|NCT03496324|18535522|P3|COMPLETED|Period 3||6
7527730|NCT03496324|18535523|P2|COMPLETED|Period 3||6
7527731|NCT03496324|18535524|P1|COMPLETED|Period 3||6
7527732|NCT03496324|18535521|P4|STARTED|Period 3||6
7527733|NCT03496324|18535522|P3|STARTED|Period 3||6
7527734|NCT03496324|18535523|P2|STARTED|Period 3||6
7527735|NCT03496324|18535524|P1|STARTED|Period 3||6
7527736|NCT03496324|18535521|P4|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
7527737|NCT03496324|18535522|P3|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
7527738|NCT03496324|18535523|P2|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
7527739|NCT03496324|18535524|P1|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
7527740|NCT03496324|18535521|P4|COMPLETED|Period 2: Washout (3 to 7 Days)||6
7527741|NCT03496324|18535522|P3|COMPLETED|Period 2: Washout (3 to 7 Days)||6
7527742|NCT03496324|18535523|P2|COMPLETED|Period 2: Washout (3 to 7 Days)||6
7527743|NCT03496324|18535524|P1|COMPLETED|Period 2: Washout (3 to 7 Days)||6
7527744|NCT03496324|18535521|P4|STARTED|Period 2: Washout (3 to 7 Days)||6
7527745|NCT03496324|18535522|P3|STARTED|Period 2: Washout (3 to 7 Days)||6
7527746|NCT03496324|18535523|P2|STARTED|Period 2: Washout (3 to 7 Days)||6
7527747|NCT03496324|18535524|P1|STARTED|Period 2: Washout (3 to 7 Days)||6
7527748|NCT03496324|18535521|P4|NOT COMPLETED|Period 2||0
7527749|NCT03496324|18535522|P3|NOT COMPLETED|Period 2||0
7527750|NCT03496324|18535523|P2|NOT COMPLETED|Period 2||0
7527751|NCT03496324|18535524|P1|NOT COMPLETED|Period 2||0
7527752|NCT03496324|18535521|P4|COMPLETED|Period 2||6
7527753|NCT03496324|18535522|P3|COMPLETED|Period 2||6
7527754|NCT03496324|18535523|P2|COMPLETED|Period 2||6
7527755|NCT03496324|18535524|P1|COMPLETED|Period 2||6
7527756|NCT03496324|18535521|P4|STARTED|Period 2||6
7527757|NCT03496324|18535522|P3|STARTED|Period 2||6
7527758|NCT03496324|18535523|P2|STARTED|Period 2||6
7527759|NCT03496324|18535524|P1|STARTED|Period 2||6
7527760|NCT03496324|18535521|P4|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
7527761|NCT03496324|18535522|P3|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
7527762|NCT03496324|18535523|P2|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
7527763|NCT03496324|18535524|P1|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
7527764|NCT03496324|18535521|P4|COMPLETED|Period 1: Washout (3 to 7 Days)||6
7527765|NCT03496324|18535522|P3|COMPLETED|Period 1: Washout (3 to 7 Days)||6
7527766|NCT03496324|18535523|P2|COMPLETED|Period 1: Washout (3 to 7 Days)||6
7527767|NCT03496324|18535524|P1|COMPLETED|Period 1: Washout (3 to 7 Days)||6
7527768|NCT03496324|18535521|P4|STARTED|Period 1: Washout (3 to 7 Days)||6
7527769|NCT03496324|18535522|P3|STARTED|Period 1: Washout (3 to 7 Days)||6
7527770|NCT03496324|18535523|P2|STARTED|Period 1: Washout (3 to 7 Days)||6
7527771|NCT03496324|18535524|P1|STARTED|Period 1: Washout (3 to 7 Days)||6
7527772|NCT03496324|18535521|P4|NOT COMPLETED|Period 1||0
7527773|NCT03496324|18535522|P3|NOT COMPLETED|Period 1||0
7527774|NCT03496324|18535523|P2|NOT COMPLETED|Period 1||0
7527775|NCT03496324|18535524|P1|NOT COMPLETED|Period 1||0
7527776|NCT03496324|18535521|P4|COMPLETED|Period 1||6
7527777|NCT03496324|18535522|P3|COMPLETED|Period 1||6
7527778|NCT03496324|18535523|P2|COMPLETED|Period 1||6
7527779|NCT03496324|18535524|P1|COMPLETED|Period 1||6
7527780|NCT03496324|18535521|P4|STARTED|Period 1||6
7527781|NCT03496324|18535522|P3|STARTED|Period 1||6
7527782|NCT03496324|18535523|P2|STARTED|Period 1||6
7527783|NCT03496324|18535524|P1|STARTED|Period 1||6
7527784|NCT03495856|18535562|P1|NOT COMPLETED|Overall Study||1
7527785|NCT03495856|18535562|P1|COMPLETED|Overall Study||22
7527786|NCT03495856|18535562|P1|STARTED|Overall Study||23
7527787|NCT03495817|18535580|P1|NOT COMPLETED|26 Week Extension||2
7527788|NCT03495817|18535580|P1|COMPLETED|26 Week Extension||17
7527789|NCT03495817|18535580|P1|STARTED|26 Week Extension||19
7527790|NCT03495817|18535580|P1|NOT COMPLETED|26 Week Open Label||8
7527791|NCT03495817|18535580|P1|COMPLETED|26 Week Open Label||23
7527792|NCT03495817|18535580|P1|STARTED|26 Week Open Label||31
7527793|NCT03495102|18535598|P3|NOT COMPLETED|Overall Study||54
7527794|NCT03495102|18535599|P2|NOT COMPLETED|Overall Study||67
7527795|NCT03495102|18535600|P1|NOT COMPLETED|Overall Study||56
7527796|NCT03495102|18535598|P3|COMPLETED|Overall Study||560
7527797|NCT03495102|18535599|P2|COMPLETED|Overall Study||549
7527798|NCT03495102|18535600|P1|COMPLETED|Overall Study||556
7527799|NCT03495102|18535598|P3|Received at Least One Dose of Study Drug|Overall Study||614
7527800|NCT03495102|18535599|P2|Received at Least One Dose of Study Drug|Overall Study||616
7527801|NCT03495102|18535600|P1|Received at Least One Dose of Study Drug|Overall Study||612
7527802|NCT03495102|18535598|P3|STARTED|Overall Study||614
7527803|NCT03495102|18535599|P2|STARTED|Overall Study||616
7527804|NCT03495102|18535600|P1|STARTED|Overall Study||612
7527805|NCT03494985|18535630|P4|NOT COMPLETED|Overall Study||5
7527806|NCT03494985|18535631|P3|NOT COMPLETED|Overall Study||6
7527807|NCT03494985|18535632|P2|NOT COMPLETED|Overall Study||6
7527808|NCT03494985|18535633|P1|NOT COMPLETED|Overall Study||5
7527809|NCT03494985|18535630|P4|COMPLETED|Overall Study||94
7527810|NCT03494985|18535631|P3|COMPLETED|Overall Study||92
7527811|NCT03494985|18535632|P2|COMPLETED|Overall Study||92
7527812|NCT03494985|18535633|P1|COMPLETED|Overall Study||96
7527813|NCT03494985|18535630|P4|STARTED|Overall Study||99
7527814|NCT03494985|18535631|P3|STARTED|Overall Study||98
7527815|NCT03494985|18535632|P2|STARTED|Overall Study||98
7527816|NCT03494985|18535633|P1|STARTED|Overall Study||101
7527817|NCT03493854|18535669|P2|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||17
7527818|NCT03493854|18535670|P1|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||19
7527819|NCT03493854|18535669|P2|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
7527820|NCT03493854|18535670|P1|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
7527821|NCT03493854|18535669|P2|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|17
7527822|NCT03493854|18535670|P1|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|19
7527823|NCT03493854|18535669|P2|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||234
7527824|NCT03493854|18535670|P1|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||242
7527825|NCT03493854|18535669|P2|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
7527826|NCT03493854|18535670|P1|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
7527827|NCT03493854|18535669|P2|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||234
7527828|NCT03493854|18535670|P1|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||239
7527829|NCT03493854|18535669|P2|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||234
7527830|NCT03493854|18535670|P1|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||242
7527831|NCT03493854|18535669|P2|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||14
7527832|NCT03493854|18535670|P1|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||10
7527833|NCT03493854|18535669|P2|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||234
7527834|NCT03493854|18535670|P1|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||242
7527835|NCT03493854|18535669|P2|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||248
7527836|NCT03493854|18535670|P1|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||252
7527837|NCT03493854|18535669|P2|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|248
7527838|NCT03493854|18535670|P1|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|252
7527839|NCT03493828|18535691|P3|NOT COMPLETED|Overall Study||0
7527840|NCT03493828|18535692|P2|NOT COMPLETED|Overall Study||0
7527841|NCT03493828|18535693|P1|NOT COMPLETED|Overall Study||0
7527842|NCT03493828|18535691|P3|COMPLETED|Overall Study||20
7527843|NCT03493828|18535692|P2|COMPLETED|Overall Study||20
7527844|NCT03493828|18535693|P1|COMPLETED|Overall Study||20
7527845|NCT03493828|18535691|P3|STARTED|Overall Study||20
7527846|NCT03493828|18535692|P2|STARTED|Overall Study||20
7527847|NCT03493828|18535693|P1|STARTED|Overall Study||20
7527848|NCT03493815|18535703|P2|NOT COMPLETED|Overall Study||11
7527849|NCT03493815|18535704|P1|NOT COMPLETED|Overall Study||9
7527850|NCT03493815|18535703|P2|COMPLETED|Overall Study||32
7527851|NCT03493815|18535704|P1|COMPLETED|Overall Study||33
7527852|NCT03493815|18535703|P2|STARTED|Overall Study||43
7527853|NCT03493815|18535704|P1|STARTED|Overall Study||42
7527854|NCT03493698|18535716|P1|NOT COMPLETED|Treatment Period D||0
7527855|NCT03493698|18535716|P1|COMPLETED|Treatment Period D||15
7527856|NCT03493698|18535716|P1|STARTED|Treatment Period D||15
7527857|NCT03493698|18535716|P1|NOT COMPLETED|Treatment Period C||2
7527858|NCT03493698|18535716|P1|COMPLETED|Treatment Period C||15
7527859|NCT03493698|18535716|P1|STARTED|Treatment Period C||17
7527860|NCT03493698|18535716|P1|NOT COMPLETED|Treatment Period B||0
7527861|NCT03493698|18535716|P1|COMPLETED|Treatment Period B||17
7527862|NCT03493698|18535716|P1|STARTED|Treatment Period B||17
7527863|NCT03493698|18535716|P1|NOT COMPLETED|Treatment Period A||0
7527864|NCT03493698|18535716|P1|COMPLETED|Treatment Period A||17
7527865|NCT03493698|18535716|P1|STARTED|Treatment Period A||17
7527866|NCT03493542|18535741|P2|NOT COMPLETED|Overall Study||9
7527867|NCT03493542|18535742|P1|NOT COMPLETED|Overall Study||7
7527868|NCT03493542|18535741|P2|COMPLETED|Overall Study||374
7527869|NCT03493542|18535742|P1|COMPLETED|Overall Study||376
7527870|NCT03493542|18535741|P2|Vaccination 3|Overall Study||374
7527871|NCT03493542|18535742|P1|Vaccination 3|Overall Study||376
7527872|NCT03493542|18535741|P2|Vaccination 2|Overall Study||378
7527873|NCT03493542|18535742|P1|Vaccination 2|Overall Study||379
7527874|NCT03493542|18535741|P2|Vaccination 1|Overall Study||383
7527875|NCT03493542|18535742|P1|Vaccination 1|Overall Study||383
7527876|NCT03493542|18535741|P2|STARTED|Overall Study||383
7527877|NCT03493542|18535742|P1|STARTED|Overall Study||383
7527878|NCT03493386|18535766|P4|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
7527879|NCT03493386|18535767|P3|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
7527880|NCT03493386|18535768|P2|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
7527881|NCT03493386|18535769|P1|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
7527882|NCT03493386|18535766|P4|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
7527883|NCT03493386|18535767|P3|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
7527884|NCT03493386|18535768|P2|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
7527885|NCT03493386|18535769|P1|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
7527886|NCT03493386|18535766|P4|STARTED|Part 2, Intervention Period 2 (2 Days)||6
7527887|NCT03493386|18535767|P3|STARTED|Part 2, Intervention Period 2 (2 Days)||6
7527888|NCT03493386|18535768|P2|STARTED|Part 2, Intervention Period 2 (2 Days)||0
7527889|NCT03493386|18535769|P1|STARTED|Part 2, Intervention Period 2 (2 Days)||0
7527890|NCT03493386|18535766|P4|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
7527891|NCT03493386|18535767|P3|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
7527892|NCT03493386|18535768|P2|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
7527893|NCT03493386|18535769|P1|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
7527894|NCT03493386|18535766|P4|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
7527895|NCT03493386|18535767|P3|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
7527896|NCT03493386|18535768|P2|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
7527897|NCT03493386|18535769|P1|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
7527898|NCT03493386|18535766|P4|STARTED|Part 2, Washout Period (at Least 5 Days)||6
7527899|NCT03493386|18535767|P3|STARTED|Part 2, Washout Period (at Least 5 Days)||6
7527900|NCT03493386|18535768|P2|STARTED|Part 2, Washout Period (at Least 5 Days)||0
7527901|NCT03493386|18535769|P1|STARTED|Part 2, Washout Period (at Least 5 Days)||0
7527902|NCT03493386|18535766|P4|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
7527903|NCT03493386|18535767|P3|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
7527904|NCT03493386|18535768|P2|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
7527905|NCT03493386|18535769|P1|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
7527906|NCT03493386|18535766|P4|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
7527907|NCT03493386|18535767|P3|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
7527908|NCT03493386|18535768|P2|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
7527909|NCT03493386|18535769|P1|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
7527910|NCT03493386|18535766|P4|STARTED|Part 2, Intervention Period 1 (2 Days)||6
7527911|NCT03493386|18535767|P3|STARTED|Part 2, Intervention Period 1 (2 Days)||6
7527912|NCT03493386|18535768|P2|STARTED|Part 2, Intervention Period 1 (2 Days)||0
7527913|NCT03493386|18535769|P1|STARTED|Part 2, Intervention Period 1 (2 Days)||0
7527914|NCT03493386|18535766|P4|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
7527915|NCT03493386|18535767|P3|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
7527916|NCT03493386|18535768|P2|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
7527917|NCT03493386|18535769|P1|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
7527918|NCT03493386|18535766|P4|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
7527919|NCT03493386|18535767|P3|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
7527920|NCT03493386|18535768|P2|COMPLETED|Part 1, Intervention Period 2 (2 Days)||25
7527921|NCT03493386|18535769|P1|COMPLETED|Part 1, Intervention Period 2 (2 Days)||26
7527922|NCT03493386|18535766|P4|STARTED|Part 1, Intervention Period 2 (2 Days)||0
7527923|NCT03493386|18535767|P3|STARTED|Part 1, Intervention Period 2 (2 Days)||0
7527924|NCT03493386|18535768|P2|STARTED|Part 1, Intervention Period 2 (2 Days)||25
7527925|NCT03493386|18535769|P1|STARTED|Part 1, Intervention Period 2 (2 Days)||26
7527926|NCT03493386|18535766|P4|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
7527927|NCT03493386|18535767|P3|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
7527928|NCT03493386|18535768|P2|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||1
7527929|NCT03493386|18535769|P1|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
7527930|NCT03493386|18535766|P4|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
7527931|NCT03493386|18535767|P3|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
7527932|NCT03493386|18535768|P2|COMPLETED|Part 1, Washout Period (at Least 5 Days)||25
7527933|NCT03493386|18535769|P1|COMPLETED|Part 1, Washout Period (at Least 5 Days)||26
7527934|NCT03493386|18535766|P4|STARTED|Part 1, Washout Period (at Least 5 Days)||0
7527935|NCT03493386|18535767|P3|STARTED|Part 1, Washout Period (at Least 5 Days)||0
7527936|NCT03493386|18535768|P2|STARTED|Part 1, Washout Period (at Least 5 Days)||26
7527937|NCT03493386|18535769|P1|STARTED|Part 1, Washout Period (at Least 5 Days)||26
7527938|NCT03493386|18535766|P4|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
7527939|NCT03493386|18535767|P3|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
7527940|NCT03493386|18535768|P2|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
7527941|NCT03493386|18535769|P1|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
7527942|NCT03493386|18535766|P4|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
7527943|NCT03493386|18535767|P3|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
7527944|NCT03493386|18535768|P2|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
7527945|NCT03493386|18535769|P1|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
7527946|NCT03493386|18535766|P4|STARTED|Part 1, Intervention Period 1 (2 Days)||0
7527947|NCT03493386|18535767|P3|STARTED|Part 1, Intervention Period 1 (2 Days)||0
7527948|NCT03493386|18535768|P2|STARTED|Part 1, Intervention Period 1 (2 Days)||26
7527949|NCT03493386|18535769|P1|STARTED|Part 1, Intervention Period 1 (2 Days)||26
7527950|NCT03492554|18535889|P2|NOT COMPLETED|Overall Study||14
7527951|NCT03492554|18535890|P1|NOT COMPLETED|Overall Study||0
7527952|NCT03492554|18535889|P2|COMPLETED|Overall Study||287
7527953|NCT03492554|18535890|P1|COMPLETED|Overall Study||301
7527954|NCT03492554|18535889|P2|STARTED|Overall Study||301
7527955|NCT03492554|18535890|P1|STARTED|Overall Study||301
7527956|NCT03492398|18535911|P9|NOT COMPLETED|Overall Study||0
7527957|NCT03492398|18535912|P8|NOT COMPLETED|Overall Study||1
7527958|NCT03492398|18535913|P7|NOT COMPLETED|Overall Study||1
7527959|NCT03492398|18535914|P6|NOT COMPLETED|Overall Study||0
7527960|NCT03492398|18535915|P5|NOT COMPLETED|Overall Study||0
7527961|NCT03492398|18535916|P4|NOT COMPLETED|Overall Study||0
7527962|NCT03492398|18535917|P3|NOT COMPLETED|Overall Study||0
7527963|NCT03492398|18535918|P2|NOT COMPLETED|Overall Study||0
7527964|NCT03492398|18535919|P1|NOT COMPLETED|Overall Study||0
7527965|NCT03492398|18535911|P9|COMPLETED|Overall Study||6
7527966|NCT03492398|18535912|P8|COMPLETED|Overall Study||5
7527967|NCT03492398|18535913|P7|COMPLETED|Overall Study||5
7527968|NCT03492398|18535914|P6|COMPLETED|Overall Study||6
7527969|NCT03492398|18535915|P5|COMPLETED|Overall Study||6
7527970|NCT03492398|18535916|P4|COMPLETED|Overall Study||6
7527971|NCT03492398|18535917|P3|COMPLETED|Overall Study||6
7527972|NCT03492398|18535918|P2|COMPLETED|Overall Study||6
7527973|NCT03492398|18535919|P1|COMPLETED|Overall Study||8
7527974|NCT03492398|18535911|P9|STARTED|Overall Study||6
7527975|NCT03492398|18535912|P8|STARTED|Overall Study||6
7527976|NCT03492398|18535913|P7|STARTED|Overall Study||6
7527977|NCT03492398|18535914|P6|STARTED|Overall Study||6
7527978|NCT03492398|18535915|P5|STARTED|Overall Study||6
7527979|NCT03492398|18535916|P4|STARTED|Overall Study||6
7527980|NCT03492398|18535917|P3|STARTED|Overall Study||6
7527981|NCT03492398|18535918|P2|STARTED|Overall Study||6
7527982|NCT03492398|18535919|P1|STARTED|Overall Study||8
7527983|NCT03492099|18535975|P1|NOT COMPLETED|Overall Study||9
7527984|NCT03492099|18535975|P1|COMPLETED|Overall Study||38
7527985|NCT03492099|18535975|P1|STARTED|Overall Study||47
7527986|NCT03491917|18535979|P2|NOT COMPLETED|Second Reading Session||0
7527987|NCT03491917|18535980|P1|NOT COMPLETED|Second Reading Session||0
7527988|NCT03491917|18535979|P2|COMPLETED|Second Reading Session||50
7527989|NCT03491917|18535980|P1|COMPLETED|Second Reading Session||50
7527990|NCT03491917|18535979|P2|STARTED|Second Reading Session||50
7527991|NCT03491917|18535980|P1|STARTED|Second Reading Session||50
7527992|NCT03491917|18535979|P2|NOT COMPLETED|4 Week Memory Washout Period||0
7527993|NCT03491917|18535980|P1|NOT COMPLETED|4 Week Memory Washout Period||0
7527994|NCT03491917|18535979|P2|COMPLETED|4 Week Memory Washout Period||50
7527995|NCT03491917|18535980|P1|COMPLETED|4 Week Memory Washout Period||50
7527996|NCT03491917|18535979|P2|STARTED|4 Week Memory Washout Period||50
7527997|NCT03491917|18535980|P1|STARTED|4 Week Memory Washout Period||50
7527998|NCT03491917|18535979|P2|NOT COMPLETED|First Reading Session||0
7527999|NCT03491917|18535980|P1|NOT COMPLETED|First Reading Session||0
7528000|NCT03491917|18535979|P2|COMPLETED|First Reading Session||50
7528001|NCT03491917|18535980|P1|COMPLETED|First Reading Session||50
7528002|NCT03491917|18535979|P2|STARTED|First Reading Session||50
7528003|NCT03491917|18535980|P1|STARTED|First Reading Session||50
7528004|NCT03491891|18535988|P2|NOT COMPLETED|Overall Study||380
7528005|NCT03491891|18535989|P1|NOT COMPLETED|Overall Study||853
7528006|NCT03491891|18535988|P2|COMPLETED|Overall Study||2058
7528007|NCT03491891|18535989|P1|COMPLETED|Overall Study||5185
7528008|NCT03491891|18535988|P2|STARTED|Overall Study||2438
7528009|NCT03491891|18535989|P1|STARTED|Overall Study||6038
7528010|NCT03491800|18535998|P3|NOT COMPLETED|Overall Study||0
7528011|NCT03491800|18535999|P2|NOT COMPLETED|Overall Study||0
7528012|NCT03491800|18536000|P1|NOT COMPLETED|Overall Study||0
7528013|NCT03491800|18535998|P3|COMPLETED|Overall Study||7
7528014|NCT03491800|18535999|P2|COMPLETED|Overall Study||23
7528015|NCT03491800|18536000|P1|COMPLETED|Overall Study||23
7528016|NCT03491800|18535998|P3|STARTED|Overall Study||7
7528017|NCT03491800|18535999|P2|STARTED|Overall Study||23
7528018|NCT03491800|18536000|P1|STARTED|Overall Study||23
7528019|NCT03491553|18536039|P6|NOT COMPLETED|Overall Study||0
7528020|NCT03491553|18536040|P5|NOT COMPLETED|Overall Study||0
7528021|NCT03491553|18536041|P4|NOT COMPLETED|Overall Study||1
7528022|NCT03491553|18536042|P3|NOT COMPLETED|Overall Study||0
7528023|NCT03491553|18536043|P2|NOT COMPLETED|Overall Study||1
7528024|NCT03491553|18536044|P1|NOT COMPLETED|Overall Study||1
7528025|NCT03491553|18536039|P6|COMPLETED|Overall Study||4
7528026|NCT03491553|18536040|P5|COMPLETED|Overall Study||5
7528027|NCT03491553|18536041|P4|COMPLETED|Overall Study||9
7528028|NCT03491553|18536042|P3|COMPLETED|Overall Study||10
7528029|NCT03491553|18536043|P2|COMPLETED|Overall Study||9
7528030|NCT03491553|18536044|P1|COMPLETED|Overall Study||8
7528031|NCT03491553|18536039|P6|STARTED|Overall Study||4
7528032|NCT03491553|18536040|P5|STARTED|Overall Study||5
7528033|NCT03491553|18536041|P4|STARTED|Overall Study||10
7528034|NCT03491553|18536042|P3|STARTED|Overall Study||10
7528035|NCT03491553|18536043|P2|STARTED|Overall Study||10
7528036|NCT03491553|18536044|P1|STARTED|Overall Study||9
7528037|NCT03491228|18536151|P1|NOT COMPLETED|Overall Study||0
7528038|NCT03491228|18536151|P1|COMPLETED|Overall Study||107
7528039|NCT03491228|18536151|P1|STARTED|Overall Study||107
7528040|NCT03491150|18536159|P2|NOT COMPLETED|Overall Study||73
7528041|NCT03491150|18536160|P1|NOT COMPLETED|Overall Study||76
7528042|NCT03491150|18536159|P2|COMPLETED|Overall Study||0
7528043|NCT03491150|18536160|P1|COMPLETED|Overall Study||0
7528044|NCT03491150|18536159|P2|STARTED|Overall Study||73
7528045|NCT03491150|18536160|P1|STARTED|Overall Study||76
7528046|NCT03490916|18536170|P2|NOT COMPLETED|Overall Study||0
7528047|NCT03490916|18536171|P1|NOT COMPLETED|Overall Study||0
7528048|NCT03490916|18536170|P2|COMPLETED|Overall Study||0
7528049|NCT03490916|18536171|P1|COMPLETED|Overall Study||0
7528050|NCT03490916|18536170|P2|STARTED|Overall Study||0
7528051|NCT03490916|18536171|P1|STARTED|Overall Study||0
7528052|NCT03490110|18536181|P2|NOT COMPLETED|Overall Study||3
7528053|NCT03490110|18536182|P1|NOT COMPLETED|Overall Study||3
7528054|NCT03490110|18536181|P2|COMPLETED|Overall Study||6
7528055|NCT03490110|18536182|P1|COMPLETED|Overall Study||6
7528056|NCT03490110|18536181|P2|STARTED|Overall Study||9
7528057|NCT03490110|18536182|P1|STARTED|Overall Study||9
7528058|NCT03490032|18536199|P3|NOT COMPLETED|Overall Study||0
7528059|NCT03490032|18536200|P2|NOT COMPLETED|Overall Study||0
7528060|NCT03490032|18536201|P1|NOT COMPLETED|Overall Study||1
7528061|NCT03490032|18536199|P3|COMPLETED|Overall Study||12
7528062|NCT03490032|18536200|P2|COMPLETED|Overall Study||12
7528063|NCT03490032|18536201|P1|COMPLETED|Overall Study||5
7528064|NCT03490032|18536199|P3|STARTED|Overall Study||12
7528065|NCT03490032|18536200|P2|STARTED|Overall Study||12
7528066|NCT03490032|18536201|P1|STARTED|Overall Study||6
7528067|NCT03489863|18536241|P2|NOT COMPLETED|Overall Study||1
7528068|NCT03489863|18536242|P1|NOT COMPLETED|Overall Study||0
7528069|NCT03489863|18536241|P2|COMPLETED|Overall Study||6
7528070|NCT03489863|18536242|P1|COMPLETED|Overall Study||7
7528071|NCT03489863|18536241|P2|STARTED|Overall Study||7
7528072|NCT03489863|18536242|P1|STARTED|Overall Study||7
7528073|NCT03489720|18536250|P2|NOT COMPLETED|Overall Study||0
7528074|NCT03489720|18536251|P1|NOT COMPLETED|Overall Study||2
7528075|NCT03489720|18536250|P2|COMPLETED|Overall Study||22
7528076|NCT03489720|18536251|P1|COMPLETED|Overall Study||22
7528077|NCT03489720|18536250|P2|STARTED|Overall Study||22
7528078|NCT03489720|18536251|P1|STARTED|Overall Study||24
7528079|NCT03489551|18536276|P1|NOT COMPLETED|Overall Study||2
7528080|NCT03489551|18536276|P1|COMPLETED|Overall Study||15
7528081|NCT03489551|18536276|P1|STARTED|Overall Study||17
7528082|NCT03489304|18536280|P1|NOT COMPLETED|Overall Study||4
7528083|NCT03489304|18536280|P1|COMPLETED|Overall Study||16
7528084|NCT03489304|18536280|P1|STARTED|Overall Study||20
7528085|NCT03488927|18536289|P3|NOT COMPLETED|Overall Study||217
7528086|NCT03488927|18536290|P2|NOT COMPLETED|Overall Study||118
7528087|NCT03488927|18536291|P1|NOT COMPLETED|Overall Study||44
7528088|NCT03488927|18536289|P3|COMPLETED|Overall Study||314
7528089|NCT03488927|18536290|P2|COMPLETED|Overall Study||314
7528090|NCT03488927|18536291|P1|COMPLETED|Overall Study||261
7528091|NCT03488927|18536289|P3|STARTED|Overall Study||531
7528092|NCT03488927|18536290|P2|STARTED|Overall Study||432
7528093|NCT03488927|18536291|P1|STARTED|Overall Study||305
7528094|NCT03488108|18536304|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
7528095|NCT03488108|18536305|P1|NOT COMPLETED|Second Intervention (12 Weeks)||1
7528096|NCT03488108|18536304|P2|COMPLETED|Second Intervention (12 Weeks)||9
7528097|NCT03488108|18536305|P1|COMPLETED|Second Intervention (12 Weeks)||9
7528098|NCT03488108|18536304|P2|STARTED|Second Intervention (12 Weeks)||9
7528099|NCT03488108|18536305|P1|STARTED|Second Intervention (12 Weeks)||10
7528100|NCT03488108|18536304|P2|NOT COMPLETED|Washout (2 Months)||0
7528101|NCT03488108|18536305|P1|NOT COMPLETED|Washout (2 Months)||0
7528102|NCT03488108|18536304|P2|COMPLETED|Washout (2 Months)||9
7528103|NCT03488108|18536305|P1|COMPLETED|Washout (2 Months)||10
7528104|NCT03488108|18536304|P2|STARTED|Washout (2 Months)||9
7528105|NCT03488108|18536305|P1|STARTED|Washout (2 Months)||10
7528106|NCT03488108|18536304|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
7528107|NCT03488108|18536305|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
7528108|NCT03488108|18536304|P2|COMPLETED|First Intervention (12 Weeks)||9
7528109|NCT03488108|18536305|P1|COMPLETED|First Intervention (12 Weeks)||10
7528110|NCT03488108|18536304|P2|STARTED|First Intervention (12 Weeks)||10
7528111|NCT03488108|18536305|P1|STARTED|First Intervention (12 Weeks)||10
7528112|NCT03488030|18536323|P2|NOT COMPLETED|Overall Study||0
7528113|NCT03488030|18536324|P1|NOT COMPLETED|Overall Study||0
7528114|NCT03488030|18536323|P2|COMPLETED|Overall Study||145
7528115|NCT03488030|18536324|P1|COMPLETED|Overall Study||101
7528116|NCT03488030|18536323|P2|STARTED|Overall Study||145
7528117|NCT03488030|18536324|P1|STARTED|Overall Study||101
7528118|NCT03487588|18536372|P1|NOT COMPLETED|Overall Study||0
7528119|NCT03487588|18536372|P1|COMPLETED|Overall Study||41
7528120|NCT03487588|18536372|P1|STARTED|Overall Study||41
7528121|NCT03486990|18536387|P9|NOT COMPLETED|Overall Study||0
7528122|NCT03486990|18536388|P8|NOT COMPLETED|Overall Study||0
7528123|NCT03486990|18536389|P7|NOT COMPLETED|Overall Study||0
7528124|NCT03486990|18536390|P6|NOT COMPLETED|Overall Study||0
7528125|NCT03486990|18536391|P5|NOT COMPLETED|Overall Study||0
7528126|NCT03486990|18536392|P4|NOT COMPLETED|Overall Study||0
7528127|NCT03486990|18536393|P3|NOT COMPLETED|Overall Study||0
7528128|NCT03486990|18536394|P2|NOT COMPLETED|Overall Study||0
7528129|NCT03486990|18536395|P1|NOT COMPLETED|Overall Study||0
7528130|NCT03486990|18536387|P9|COMPLETED|Overall Study||2
7528131|NCT03486990|18536388|P8|COMPLETED|Overall Study||2
7528132|NCT03486990|18536389|P7|COMPLETED|Overall Study||2
7528133|NCT03486990|18536390|P6|COMPLETED|Overall Study||4
7528134|NCT03486990|18536391|P5|COMPLETED|Overall Study||3
7528135|NCT03486990|18536392|P4|COMPLETED|Overall Study||3
7528136|NCT03486990|18536393|P3|COMPLETED|Overall Study||3
7528137|NCT03486990|18536394|P2|COMPLETED|Overall Study||2
7528138|NCT03486990|18536395|P1|COMPLETED|Overall Study||2
7528139|NCT03486990|18536387|P9|STARTED|Overall Study||2
7528140|NCT03486990|18536388|P8|STARTED|Overall Study||2
7528141|NCT03486990|18536389|P7|STARTED|Overall Study||2
7528142|NCT03486990|18536390|P6|STARTED|Overall Study||4
7528143|NCT03486990|18536391|P5|STARTED|Overall Study||3
7528144|NCT03486990|18536392|P4|STARTED|Overall Study||3
7528145|NCT03486990|18536393|P3|STARTED|Overall Study||3
7528146|NCT03486990|18536394|P2|STARTED|Overall Study||2
7528147|NCT03486990|18536395|P1|STARTED|Overall Study||2
7528148|NCT03486392|18536574|P5|NOT COMPLETED|Overall Study||4
7528149|NCT03486392|18536575|P4|NOT COMPLETED|Overall Study||9
7528150|NCT03486392|18536576|P3|NOT COMPLETED|Overall Study||14
7528151|NCT03486392|18536577|P2|NOT COMPLETED|Overall Study||0
7528152|NCT03486392|18536578|P1|NOT COMPLETED|Overall Study||3
7528153|NCT03486392|18536574|P5|COMPLETED|Overall Study||115
7528154|NCT03486392|18536575|P4|COMPLETED|Overall Study||109
7528155|NCT03486392|18536576|P3|COMPLETED|Overall Study||104
7528156|NCT03486392|18536577|P2|COMPLETED|Overall Study||59
7528157|NCT03486392|18536578|P1|COMPLETED|Overall Study||57
7528158|NCT03486392|18536574|P5|STARTED|Overall Study||119
7528159|NCT03486392|18536575|P4|STARTED|Overall Study||118
7528160|NCT03486392|18536576|P3|STARTED|Overall Study||118
7528161|NCT03486392|18536577|P2|STARTED|Overall Study||59
7528162|NCT03486392|18536578|P1|STARTED|Overall Study||60
7528163|NCT03485976|18536610|P1|NOT COMPLETED|Overall Study||1
7528164|NCT03485976|18536610|P1|COMPLETED|Overall Study||11
7528165|NCT03485976|18536610|P1|STARTED|Overall Study||12
7528166|NCT03483896|18536618|P2|NOT COMPLETED|Overall Study||4
7528167|NCT03483896|18536619|P1|NOT COMPLETED|Overall Study||2
7528168|NCT03483896|18536618|P2|COMPLETED|Overall Study||46
7528169|NCT03483896|18536619|P1|COMPLETED|Overall Study||31
7528170|NCT03483896|18536618|P2|STARTED|Overall Study||50
7528171|NCT03483896|18536619|P1|STARTED|Overall Study||33
7528172|NCT03483623|18536627|P1|NOT COMPLETED|Overall Study||1
7528173|NCT03483623|18536627|P1|COMPLETED|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
7528174|NCT03483623|18536627|P1|Completed RAVEN FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
7528175|NCT03483623|18536627|P1|Started RAVEN FIS|Overall Study||44
7528176|NCT03483623|18536627|P1|Completed RAVEN WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
7528177|NCT03483623|18536627|P1|Started RAVEN WELP|Overall Study||44
7528178|NCT03483623|18536627|P1|Completed NATO FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
7528179|NCT03483623|18536627|P1|Started NATO FIS|Overall Study||44
7528180|NCT03483623|18536627|P1|Completeded NATO WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
7528181|NCT03483623|18536627|P1|Started NATO WELP|Overall Study||44
7528182|NCT03483623|18536627|P1|STARTED|Overall Study||44
7528183|NCT03483051|18536640|P2|NOT COMPLETED|Second Treatment, After Crossover||0
7528184|NCT03483051|18536641|P1|NOT COMPLETED|Second Treatment, After Crossover||0
7528185|NCT03483051|18536640|P2|COMPLETED|Second Treatment, After Crossover||1
7528186|NCT03483051|18536641|P1|COMPLETED|Second Treatment, After Crossover||2
7528187|NCT03483051|18536640|P2|STARTED|Second Treatment, After Crossover||1
7528188|NCT03483051|18536641|P1|STARTED|Second Treatment, After Crossover||2
7528189|NCT03483051|18536640|P2|NOT COMPLETED|First Treatment, Pre Crossover||0
7528190|NCT03483051|18536641|P1|NOT COMPLETED|First Treatment, Pre Crossover||0
7528191|NCT03483051|18536640|P2|COMPLETED|First Treatment, Pre Crossover||1
7528192|NCT03483051|18536641|P1|COMPLETED|First Treatment, Pre Crossover||2
7528193|NCT03483051|18536640|P2|STARTED|First Treatment, Pre Crossover||1
7528194|NCT03483051|18536641|P1|STARTED|First Treatment, Pre Crossover||2
7528195|NCT03482973|18536661|P2|NOT COMPLETED|Overall Study||0
7528196|NCT03482973|18536662|P1|NOT COMPLETED|Overall Study||0
7528197|NCT03482973|18536661|P2|COMPLETED|Overall Study||40
7528198|NCT03482973|18536662|P1|COMPLETED|Overall Study||40
7528199|NCT03482973|18536661|P2|STARTED|Overall Study||40
7528200|NCT03482973|18536662|P1|STARTED|Overall Study||40
7528201|NCT03482882|18536676|P1|NOT COMPLETED|Overall Study||7
7528202|NCT03482882|18536676|P1|COMPLETED|Overall Study||40
7528203|NCT03482882|18536676|P1|STARTED|Overall Study||47
7528204|NCT03482713|18536689|P2|NOT COMPLETED|Overall Study||0
7528205|NCT03482713|18536690|P1|NOT COMPLETED|Overall Study||0
7528206|NCT03482713|18536689|P2|COMPLETED|Overall Study||12
7528207|NCT03482713|18536690|P1|COMPLETED|Overall Study||11
7528208|NCT03482713|18536689|P2|STARTED|Overall Study||12
7528209|NCT03482713|18536690|P1|STARTED|Overall Study||11
7528210|NCT03482583|18536705|P3|NOT COMPLETED|Overall Study||21
7528211|NCT03482583|18536706|P2|NOT COMPLETED|Overall Study||9
7528212|NCT03482583|18536707|P1|NOT COMPLETED|Overall Study||25
7528213|NCT03482583|18536705|P3|COMPLETED|Overall Study||18
7528214|NCT03482583|18536706|P2|COMPLETED|Overall Study||5
7528215|NCT03482583|18536707|P1|COMPLETED|Overall Study||12
7528216|NCT03482583|18536705|P3|STARTED|Overall Study||39
7528217|NCT03482583|18536706|P2|STARTED|Overall Study||14
7528218|NCT03482583|18536707|P1|STARTED|Overall Study||37
7528219|NCT03482453|18536737|P12|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528220|NCT03482453|18536738|P11|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528221|NCT03482453|18536739|P10|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528222|NCT03482453|18536740|P9|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528223|NCT03482453|18536741|P8|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528224|NCT03482453|18536742|P7|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528225|NCT03482453|18536743|P6|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528226|NCT03482453|18536744|P5|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528227|NCT03482453|18536745|P4|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528228|NCT03482453|18536746|P3|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528229|NCT03482453|18536747|P2|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528230|NCT03482453|18536748|P1|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528231|NCT03482453|18536737|P12|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
7528232|NCT03482453|18536738|P11|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
7528233|NCT03482453|18536739|P10|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
7528234|NCT03482453|18536740|P9|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
7528235|NCT03482453|18536741|P8|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
7528236|NCT03482453|18536742|P7|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
7528237|NCT03482453|18536743|P6|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528238|NCT03482453|18536744|P5|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528239|NCT03482453|18536745|P4|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528240|NCT03482453|18536746|P3|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528241|NCT03482453|18536747|P2|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528242|NCT03482453|18536748|P1|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528243|NCT03482453|18536737|P12|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
7528244|NCT03482453|18536738|P11|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
7528245|NCT03482453|18536739|P10|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
7528246|NCT03482453|18536740|P9|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
7528247|NCT03482453|18536741|P8|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
7528248|NCT03482453|18536742|P7|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
7528249|NCT03482453|18536743|P6|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528250|NCT03482453|18536744|P5|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528251|NCT03482453|18536745|P4|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528252|NCT03482453|18536746|P3|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528253|NCT03482453|18536747|P2|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528254|NCT03482453|18536748|P1|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
7528255|NCT03482453|18536737|P12|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
7528256|NCT03482453|18536738|P11|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
7528257|NCT03482453|18536739|P10|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
7528258|NCT03482453|18536740|P9|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
7528259|NCT03482453|18536741|P8|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
7528260|NCT03482453|18536742|P7|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
7528261|NCT03482453|18536743|P6|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
7528262|NCT03482453|18536744|P5|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
7528263|NCT03482453|18536745|P4|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
7528264|NCT03482453|18536746|P3|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
7528265|NCT03482453|18536747|P2|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
7528266|NCT03482453|18536748|P1|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
7528267|NCT03482453|18536737|P12|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
7528268|NCT03482453|18536738|P11|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
7528269|NCT03482453|18536739|P10|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
7528270|NCT03482453|18536740|P9|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
7528271|NCT03482453|18536741|P8|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
7528272|NCT03482453|18536742|P7|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
7528273|NCT03482453|18536743|P6|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
7528274|NCT03482453|18536744|P5|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
7528275|NCT03482453|18536745|P4|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
7528276|NCT03482453|18536746|P3|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
7528277|NCT03482453|18536747|P2|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
7528278|NCT03482453|18536748|P1|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
7528279|NCT03482453|18536737|P12|STARTED|Parts 2, 3 Washout Period (7 Days)||6
7528280|NCT03482453|18536738|P11|STARTED|Parts 2, 3 Washout Period (7 Days)||6
7528281|NCT03482453|18536739|P10|STARTED|Parts 2, 3 Washout Period (7 Days)||5
7528282|NCT03482453|18536740|P9|STARTED|Parts 2, 3 Washout Period (7 Days)||5
7528283|NCT03482453|18536741|P8|STARTED|Parts 2, 3 Washout Period (7 Days)||3
7528284|NCT03482453|18536742|P7|STARTED|Parts 2, 3 Washout Period (7 Days)||3
7528285|NCT03482453|18536743|P6|STARTED|Parts 2, 3 Washout Period (7 Days)||0
7528286|NCT03482453|18536744|P5|STARTED|Parts 2, 3 Washout Period (7 Days)||0
7528287|NCT03482453|18536745|P4|STARTED|Parts 2, 3 Washout Period (7 Days)||0
7528288|NCT03482453|18536746|P3|STARTED|Parts 2, 3 Washout Period (7 Days)||0
7528289|NCT03482453|18536747|P2|STARTED|Parts 2, 3 Washout Period (7 Days)||0
7528290|NCT03482453|18536748|P1|STARTED|Parts 2, 3 Washout Period (7 Days)||0
7528291|NCT03482453|18536737|P12|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528292|NCT03482453|18536738|P11|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||1
7528293|NCT03482453|18536739|P10|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528294|NCT03482453|18536740|P9|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528295|NCT03482453|18536741|P8|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528296|NCT03482453|18536742|P7|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528297|NCT03482453|18536743|P6|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528298|NCT03482453|18536744|P5|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528299|NCT03482453|18536745|P4|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528300|NCT03482453|18536746|P3|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528301|NCT03482453|18536747|P2|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528302|NCT03482453|18536748|P1|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528303|NCT03482453|18536737|P12|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
7528304|NCT03482453|18536738|P11|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
7528305|NCT03482453|18536739|P10|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
7528306|NCT03482453|18536740|P9|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
7528307|NCT03482453|18536741|P8|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
7528308|NCT03482453|18536742|P7|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
7528309|NCT03482453|18536743|P6|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528310|NCT03482453|18536744|P5|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528311|NCT03482453|18536745|P4|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528312|NCT03482453|18536746|P3|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528313|NCT03482453|18536747|P2|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528314|NCT03482453|18536748|P1|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528315|NCT03482453|18536737|P12|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||6
7528316|NCT03482453|18536738|P11|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||7
7528317|NCT03482453|18536739|P10|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
7528318|NCT03482453|18536740|P9|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
7528319|NCT03482453|18536741|P8|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
7528320|NCT03482453|18536742|P7|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
7528321|NCT03482453|18536743|P6|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528322|NCT03482453|18536744|P5|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528323|NCT03482453|18536745|P4|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528324|NCT03482453|18536746|P3|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528325|NCT03482453|18536747|P2|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528326|NCT03482453|18536748|P1|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
7528327|NCT03482453|18536737|P12|NOT COMPLETED|Part 1 (1 Day)||0
7528328|NCT03482453|18536738|P11|NOT COMPLETED|Part 1 (1 Day)||0
7528329|NCT03482453|18536739|P10|NOT COMPLETED|Part 1 (1 Day)||0
7528330|NCT03482453|18536740|P9|NOT COMPLETED|Part 1 (1 Day)||0
7528331|NCT03482453|18536741|P8|NOT COMPLETED|Part 1 (1 Day)||0
7528332|NCT03482453|18536742|P7|NOT COMPLETED|Part 1 (1 Day)||0
7528333|NCT03482453|18536743|P6|NOT COMPLETED|Part 1 (1 Day)||0
7528334|NCT03482453|18536744|P5|NOT COMPLETED|Part 1 (1 Day)||0
7528335|NCT03482453|18536745|P4|NOT COMPLETED|Part 1 (1 Day)||0
7528336|NCT03482453|18536746|P3|NOT COMPLETED|Part 1 (1 Day)||0
7528337|NCT03482453|18536747|P2|NOT COMPLETED|Part 1 (1 Day)||0
7528338|NCT03482453|18536748|P1|NOT COMPLETED|Part 1 (1 Day)||0
7528339|NCT03482453|18536737|P12|COMPLETED|Part 1 (1 Day)||0
7528340|NCT03482453|18536738|P11|COMPLETED|Part 1 (1 Day)||0
7528341|NCT03482453|18536739|P10|COMPLETED|Part 1 (1 Day)||0
7528342|NCT03482453|18536740|P9|COMPLETED|Part 1 (1 Day)||0
7528343|NCT03482453|18536741|P8|COMPLETED|Part 1 (1 Day)||0
7528344|NCT03482453|18536742|P7|COMPLETED|Part 1 (1 Day)||0
7528345|NCT03482453|18536743|P6|COMPLETED|Part 1 (1 Day)||6
7528346|NCT03482453|18536744|P5|COMPLETED|Part 1 (1 Day)||6
7528347|NCT03482453|18536745|P4|COMPLETED|Part 1 (1 Day)||6
7528348|NCT03482453|18536746|P3|COMPLETED|Part 1 (1 Day)||6
7528349|NCT03482453|18536747|P2|COMPLETED|Part 1 (1 Day)||6
7528350|NCT03482453|18536748|P1|COMPLETED|Part 1 (1 Day)||10
7528351|NCT03482453|18536737|P12|STARTED|Part 1 (1 Day)||0
7528352|NCT03482453|18536738|P11|STARTED|Part 1 (1 Day)||0
7528353|NCT03482453|18536739|P10|STARTED|Part 1 (1 Day)||0
7528354|NCT03482453|18536740|P9|STARTED|Part 1 (1 Day)||0
7528355|NCT03482453|18536741|P8|STARTED|Part 1 (1 Day)||0
7528356|NCT03482453|18536742|P7|STARTED|Part 1 (1 Day)||0
7528357|NCT03482453|18536743|P6|STARTED|Part 1 (1 Day)||6
7528358|NCT03482453|18536744|P5|STARTED|Part 1 (1 Day)||6
7528359|NCT03482453|18536745|P4|STARTED|Part 1 (1 Day)||6
7528360|NCT03482453|18536746|P3|STARTED|Part 1 (1 Day)||6
7528361|NCT03482453|18536747|P2|STARTED|Part 1 (1 Day)||6
7528362|NCT03482453|18536748|P1|STARTED|Part 1 (1 Day)||10
7528363|NCT03482011|18536867|P8|NOT COMPLETED|Follow-up Period (12 Weeks)||17
7528364|NCT03482011|18536868|P7|NOT COMPLETED|Follow-up Period (12 Weeks)||2
7528365|NCT03482011|18536869|P6|NOT COMPLETED|Follow-up Period (12 Weeks)||1
7528366|NCT03482011|18536870|P5|NOT COMPLETED|Follow-up Period (12 Weeks)||0
7528367|NCT03482011|18536871|P4|NOT COMPLETED|Follow-up Period (12 Weeks)||5
7528368|NCT03482011|18536872|P3|NOT COMPLETED|Follow-up Period (12 Weeks)||1
7528369|NCT03482011|18536873|P2|NOT COMPLETED|Follow-up Period (12 Weeks)||0
7528370|NCT03482011|18536874|P1|NOT COMPLETED|Follow-up Period (12 Weeks)||0
7528371|NCT03482011|18536867|P8|COMPLETED|Follow-up Period (12 Weeks)||4
7528372|NCT03482011|18536868|P7|COMPLETED|Follow-up Period (12 Weeks)||2
7528373|NCT03482011|18536869|P6|COMPLETED|Follow-up Period (12 Weeks)||3
7528374|NCT03482011|18536870|P5|COMPLETED|Follow-up Period (12 Weeks)||2
7528375|NCT03482011|18536871|P4|COMPLETED|Follow-up Period (12 Weeks)||5
7528376|NCT03482011|18536872|P3|COMPLETED|Follow-up Period (12 Weeks)||0
7528377|NCT03482011|18536873|P2|COMPLETED|Follow-up Period (12 Weeks)||0
7528378|NCT03482011|18536874|P1|COMPLETED|Follow-up Period (12 Weeks)||0
7528379|NCT03482011|18536867|P8|STARTED|Follow-up Period (12 Weeks)||21
7528380|NCT03482011|18536868|P7|STARTED|Follow-up Period (12 Weeks)||4
7528381|NCT03482011|18536869|P6|STARTED|Follow-up Period (12 Weeks)||4
7528382|NCT03482011|18536870|P5|STARTED|Follow-up Period (12 Weeks)||2
7528383|NCT03482011|18536871|P4|STARTED|Follow-up Period (12 Weeks)||10
7528384|NCT03482011|18536872|P3|STARTED|Follow-up Period (12 Weeks)||1
7528385|NCT03482011|18536873|P2|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
7528386|NCT03482011|18536874|P1|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
7528387|NCT03482011|18536867|P8|NOT COMPLETED|Maintenance Period (36 Weeks)||17
7528388|NCT03482011|18536868|P7|NOT COMPLETED|Maintenance Period (36 Weeks)||4
7528389|NCT03482011|18536869|P6|NOT COMPLETED|Maintenance Period (36 Weeks)||4
7528390|NCT03482011|18536870|P5|NOT COMPLETED|Maintenance Period (36 Weeks)||5
7528391|NCT03482011|18536871|P4|NOT COMPLETED|Maintenance Period (36 Weeks)||4
7528392|NCT03482011|18536872|P3|NOT COMPLETED|Maintenance Period (36 Weeks)||1
7528393|NCT03482011|18536873|P2|NOT COMPLETED|Maintenance Period (36 Weeks)||0
7528394|NCT03482011|18536874|P1|NOT COMPLETED|Maintenance Period (36 Weeks)||0
7528395|NCT03482011|18536867|P8|COMPLETED|Maintenance Period (36 Weeks)||123
7528396|NCT03482011|18536868|P7|COMPLETED|Maintenance Period (36 Weeks)||87
7528397|NCT03482011|18536869|P6|COMPLETED|Maintenance Period (36 Weeks)||86
7528398|NCT03482011|18536870|P5|COMPLETED|Maintenance Period (36 Weeks)||86
7528399|NCT03482011|18536871|P4|COMPLETED|Maintenance Period (36 Weeks)||90
7528400|NCT03482011|18536872|P3|COMPLETED|Maintenance Period (36 Weeks)||6
7528401|NCT03482011|18536873|P2|COMPLETED|Maintenance Period (36 Weeks)||0
7528402|NCT03482011|18536874|P1|COMPLETED|Maintenance Period (36 Weeks)||0
7528403|NCT03482011|18536867|P8|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||121
7528404|NCT03482011|18536868|P7|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||87
7528405|NCT03482011|18536869|P6|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||85
7528406|NCT03482011|18536870|P5|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||86
7528407|NCT03482011|18536871|P4|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||88
7528408|NCT03482011|18536872|P3|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||6
7528409|NCT03482011|18536873|P2|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
7528410|NCT03482011|18536874|P1|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
7528411|NCT03482011|18536867|P8|Relapse|Maintenance Period (36 Weeks)||0
7528412|NCT03482011|18536868|P7|Relapse|Maintenance Period (36 Weeks)||2
7528413|NCT03482011|18536869|P6|Relapse|Maintenance Period (36 Weeks)||3
7528414|NCT03482011|18536870|P5|Relapse|Maintenance Period (36 Weeks)||41
7528415|NCT03482011|18536871|P4|Relapse|Maintenance Period (36 Weeks)||0
7528416|NCT03482011|18536872|P3|Relapse|Maintenance Period (36 Weeks)||1
7528417|NCT03482011|18536873|P2|Relapse|Maintenance Period (36 Weeks)||0
7528418|NCT03482011|18536874|P1|Relapse|Maintenance Period (36 Weeks)||0
7528419|NCT03482011|18536867|P8|STARTED|Maintenance Period (36 Weeks)||140
7528420|NCT03482011|18536868|P7|STARTED|Maintenance Period (36 Weeks)||91
7528421|NCT03482011|18536869|P6|STARTED|Maintenance Period (36 Weeks)||90
7528422|NCT03482011|18536870|P5|STARTED|Maintenance Period (36 Weeks)||91
7528423|NCT03482011|18536871|P4|STARTED|Maintenance Period (36 Weeks)||94
7528424|NCT03482011|18536872|P3|STARTED|Maintenance Period (36 Weeks)||7
7528425|NCT03482011|18536873|P2|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
7528426|NCT03482011|18536874|P1|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
7528427|NCT03482011|18536867|P8|NOT COMPLETED|Induction Period (16 Weeks)||0
7528428|NCT03482011|18536868|P7|NOT COMPLETED|Induction Period (16 Weeks)||0
7528429|NCT03482011|18536869|P6|NOT COMPLETED|Induction Period (16 Weeks)||0
7528430|NCT03482011|18536870|P5|NOT COMPLETED|Induction Period (16 Weeks)||0
7528431|NCT03482011|18536871|P4|NOT COMPLETED|Induction Period (16 Weeks)||0
7528432|NCT03482011|18536872|P3|NOT COMPLETED|Induction Period (16 Weeks)||0
7528433|NCT03482011|18536873|P2|NOT COMPLETED|Induction Period (16 Weeks)||11
7528434|NCT03482011|18536874|P1|NOT COMPLETED|Induction Period (16 Weeks)||6
7528435|NCT03482011|18536867|P8|COMPLETED|Induction Period (16 Weeks)||0
7528436|NCT03482011|18536868|P7|COMPLETED|Induction Period (16 Weeks)||0
7528437|NCT03482011|18536869|P6|COMPLETED|Induction Period (16 Weeks)||0
7528438|NCT03482011|18536870|P5|COMPLETED|Induction Period (16 Weeks)||0
7528439|NCT03482011|18536871|P4|COMPLETED|Induction Period (16 Weeks)||0
7528440|NCT03482011|18536872|P3|COMPLETED|Induction Period (16 Weeks)||0
7528441|NCT03482011|18536873|P2|COMPLETED|Induction Period (16 Weeks)||412
7528442|NCT03482011|18536874|P1|COMPLETED|Induction Period (16 Weeks)||101
7528443|NCT03482011|18536867|P8|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
7528444|NCT03482011|18536868|P7|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
7528445|NCT03482011|18536869|P6|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
7528446|NCT03482011|18536870|P5|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
7528447|NCT03482011|18536871|P4|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
7528448|NCT03482011|18536872|P3|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
7528449|NCT03482011|18536873|P2|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||422
7528450|NCT03482011|18536874|P1|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||107
7528451|NCT03482011|18536867|P8|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
7528452|NCT03482011|18536868|P7|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
7528453|NCT03482011|18536869|P6|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
7528454|NCT03482011|18536870|P5|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
7528455|NCT03482011|18536871|P4|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
7528456|NCT03482011|18536872|P3|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
7528457|NCT03482011|18536873|P2|STARTED|Induction Period (16 Weeks)||423
7528458|NCT03482011|18536874|P1|STARTED|Induction Period (16 Weeks)||107
7528459|NCT03481816|18536933|P2|NOT COMPLETED|Dose Expansion||12
7528460|NCT03481816|18536934|P1|NOT COMPLETED|Dose Expansion||0
7528461|NCT03481816|18536933|P2|COMPLETED|Dose Expansion||0
7528462|NCT03481816|18536934|P1|COMPLETED|Dose Expansion||0
7528463|NCT03481816|18536933|P2|STARTED|Dose Expansion||12
7528464|NCT03481816|18536934|P1|STARTED|Dose Expansion||0
7528465|NCT03481816|18536933|P2|NOT COMPLETED|Starting Dose||0
7528466|NCT03481816|18536934|P1|NOT COMPLETED|Starting Dose||1
7528467|NCT03481816|18536933|P2|COMPLETED|Starting Dose||0
7528468|NCT03481816|18536934|P1|COMPLETED|Starting Dose||5
7528469|NCT03481816|18536933|P2|STARTED|Starting Dose||0
7528470|NCT03481816|18536934|P1|STARTED|Starting Dose||6
7528471|NCT03481309|18536961|P6|NOT COMPLETED|Third Intervention (1 Day)||0
7528472|NCT03481309|18536962|P5|NOT COMPLETED|Third Intervention (1 Day)||0
7528473|NCT03481309|18536963|P4|NOT COMPLETED|Third Intervention (1 Day)||0
7528474|NCT03481309|18536964|P3|NOT COMPLETED|Third Intervention (1 Day)||0
7528475|NCT03481309|18536965|P2|NOT COMPLETED|Third Intervention (1 Day)||0
7528476|NCT03481309|18536966|P1|NOT COMPLETED|Third Intervention (1 Day)||0
7528477|NCT03481309|18536961|P6|COMPLETED|Third Intervention (1 Day)||3
7528478|NCT03481309|18536962|P5|COMPLETED|Third Intervention (1 Day)||3
7528479|NCT03481309|18536963|P4|COMPLETED|Third Intervention (1 Day)||3
7528480|NCT03481309|18536964|P3|COMPLETED|Third Intervention (1 Day)||3
7528481|NCT03481309|18536965|P2|COMPLETED|Third Intervention (1 Day)||3
7528482|NCT03481309|18536966|P1|COMPLETED|Third Intervention (1 Day)||3
7528483|NCT03481309|18536961|P6|STARTED|Third Intervention (1 Day)||3
7528484|NCT03481309|18536962|P5|STARTED|Third Intervention (1 Day)||3
7528485|NCT03481309|18536963|P4|STARTED|Third Intervention (1 Day)||3
7528486|NCT03481309|18536964|P3|STARTED|Third Intervention (1 Day)||3
7528487|NCT03481309|18536965|P2|STARTED|Third Intervention (1 Day)||3
7528488|NCT03481309|18536966|P1|STARTED|Third Intervention (1 Day)||3
7528489|NCT03481309|18536961|P6|NOT COMPLETED|Washout (at Least 3 Days)||0
7528490|NCT03481309|18536962|P5|NOT COMPLETED|Washout (at Least 3 Days)||0
7528491|NCT03481309|18536963|P4|NOT COMPLETED|Washout (at Least 3 Days)||0
7528492|NCT03481309|18536964|P3|NOT COMPLETED|Washout (at Least 3 Days)||0
7528493|NCT03481309|18536965|P2|NOT COMPLETED|Washout (at Least 3 Days)||0
7528494|NCT03481309|18536966|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
7528495|NCT03481309|18536961|P6|COMPLETED|Washout (at Least 3 Days)||3
7528496|NCT03481309|18536962|P5|COMPLETED|Washout (at Least 3 Days)||3
7528497|NCT03481309|18536963|P4|COMPLETED|Washout (at Least 3 Days)||3
7528498|NCT03481309|18536964|P3|COMPLETED|Washout (at Least 3 Days)||3
7528499|NCT03481309|18536965|P2|COMPLETED|Washout (at Least 3 Days)||3
7528500|NCT03481309|18536966|P1|COMPLETED|Washout (at Least 3 Days)||3
7528501|NCT03481309|18536961|P6|STARTED|Washout (at Least 3 Days)||3
7528502|NCT03481309|18536962|P5|STARTED|Washout (at Least 3 Days)||3
7528503|NCT03481309|18536963|P4|STARTED|Washout (at Least 3 Days)||3
7528504|NCT03481309|18536964|P3|STARTED|Washout (at Least 3 Days)||3
7528505|NCT03481309|18536965|P2|STARTED|Washout (at Least 3 Days)||3
7528506|NCT03481309|18536966|P1|STARTED|Washout (at Least 3 Days)||3
7528507|NCT03481309|18536961|P6|NOT COMPLETED|Second Intervention (1 Day)||0
7528508|NCT03481309|18536962|P5|NOT COMPLETED|Second Intervention (1 Day)||0
7528509|NCT03481309|18536963|P4|NOT COMPLETED|Second Intervention (1 Day)||0
7528510|NCT03481309|18536964|P3|NOT COMPLETED|Second Intervention (1 Day)||0
7528511|NCT03481309|18536965|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7528512|NCT03481309|18536966|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7528513|NCT03481309|18536961|P6|COMPLETED|Second Intervention (1 Day)||3
7528514|NCT03481309|18536962|P5|COMPLETED|Second Intervention (1 Day)||3
7528515|NCT03481309|18536963|P4|COMPLETED|Second Intervention (1 Day)||3
7528516|NCT03481309|18536964|P3|COMPLETED|Second Intervention (1 Day)||3
7528517|NCT03481309|18536965|P2|COMPLETED|Second Intervention (1 Day)||3
7528518|NCT03481309|18536966|P1|COMPLETED|Second Intervention (1 Day)||3
7528519|NCT03481309|18536961|P6|STARTED|Second Intervention (1 Day)||3
7528520|NCT03481309|18536962|P5|STARTED|Second Intervention (1 Day)||3
7528521|NCT03481309|18536963|P4|STARTED|Second Intervention (1 Day)||3
7528522|NCT03481309|18536964|P3|STARTED|Second Intervention (1 Day)||3
7528523|NCT03481309|18536965|P2|STARTED|Second Intervention (1 Day)||3
7528524|NCT03481309|18536966|P1|STARTED|Second Intervention (1 Day)||3
7528525|NCT03481309|18536961|P6|NOT COMPLETED|Washout (at Least 3 Days)||0
7528526|NCT03481309|18536962|P5|NOT COMPLETED|Washout (at Least 3 Days)||0
7528527|NCT03481309|18536963|P4|NOT COMPLETED|Washout (at Least 3 Days)||0
7528528|NCT03481309|18536964|P3|NOT COMPLETED|Washout (at Least 3 Days)||0
7528529|NCT03481309|18536965|P2|NOT COMPLETED|Washout (at Least 3 Days)||0
7528530|NCT03481309|18536966|P1|NOT COMPLETED|Washout (at Least 3 Days)||1
7528531|NCT03481309|18536961|P6|COMPLETED|Washout (at Least 3 Days)||3
7528532|NCT03481309|18536962|P5|COMPLETED|Washout (at Least 3 Days)||3
7528533|NCT03481309|18536963|P4|COMPLETED|Washout (at Least 3 Days)||3
7528534|NCT03481309|18536964|P3|COMPLETED|Washout (at Least 3 Days)||3
7528535|NCT03481309|18536965|P2|COMPLETED|Washout (at Least 3 Days)||3
7528536|NCT03481309|18536966|P1|COMPLETED|Washout (at Least 3 Days)||3
7528537|NCT03481309|18536961|P6|STARTED|Washout (at Least 3 Days)||3
7528538|NCT03481309|18536962|P5|STARTED|Washout (at Least 3 Days)||3
7528539|NCT03481309|18536963|P4|STARTED|Washout (at Least 3 Days)||3
7528540|NCT03481309|18536964|P3|STARTED|Washout (at Least 3 Days)||3
7528541|NCT03481309|18536965|P2|STARTED|Washout (at Least 3 Days)||3
7528542|NCT03481309|18536966|P1|STARTED|Washout (at Least 3 Days)||4
7528543|NCT03481309|18536961|P6|NOT COMPLETED|First Intervention (1 Day)||0
7528544|NCT03481309|18536962|P5|NOT COMPLETED|First Intervention (1 Day)||0
7528545|NCT03481309|18536963|P4|NOT COMPLETED|First Intervention (1 Day)||0
7528546|NCT03481309|18536964|P3|NOT COMPLETED|First Intervention (1 Day)||0
7528547|NCT03481309|18536965|P2|NOT COMPLETED|First Intervention (1 Day)||0
7528548|NCT03481309|18536966|P1|NOT COMPLETED|First Intervention (1 Day)||0
7528549|NCT03481309|18536961|P6|COMPLETED|First Intervention (1 Day)||3
7528550|NCT03481309|18536962|P5|COMPLETED|First Intervention (1 Day)||3
7528551|NCT03481309|18536963|P4|COMPLETED|First Intervention (1 Day)||3
7528552|NCT03481309|18536964|P3|COMPLETED|First Intervention (1 Day)||3
7528553|NCT03481309|18536965|P2|COMPLETED|First Intervention (1 Day)||3
7528554|NCT03481309|18536966|P1|COMPLETED|First Intervention (1 Day)||4
7528555|NCT03481309|18536961|P6|STARTED|First Intervention (1 Day)||3
7528556|NCT03481309|18536962|P5|STARTED|First Intervention (1 Day)||3
7528557|NCT03481309|18536963|P4|STARTED|First Intervention (1 Day)||3
7528558|NCT03481309|18536964|P3|STARTED|First Intervention (1 Day)||3
7528559|NCT03481309|18536965|P2|STARTED|First Intervention (1 Day)||3
7528560|NCT03481309|18536966|P1|STARTED|First Intervention (1 Day)||4
7528561|NCT03481270|18536982|P2|NOT COMPLETED|Overall Study||0
7528562|NCT03481270|18536983|P1|NOT COMPLETED|Overall Study||0
7528563|NCT03481270|18536982|P2|COMPLETED|Overall Study||313
7528564|NCT03481270|18536983|P1|COMPLETED|Overall Study||324
7528565|NCT03481270|18536982|P2|STARTED|Overall Study||313
7528566|NCT03481270|18536983|P1|STARTED|Overall Study||324
7528567|NCT03480919|18536992|P3|NOT COMPLETED|Overall Study||0
7528568|NCT03480919|18536993|P2|NOT COMPLETED|Overall Study||0
7528569|NCT03480919|18536994|P1|NOT COMPLETED|Overall Study||0
7528570|NCT03480919|18536992|P3|COMPLETED|Overall Study||1
7528571|NCT03480919|18536993|P2|COMPLETED|Overall Study||2
7528572|NCT03480919|18536994|P1|COMPLETED|Overall Study||1
7528573|NCT03480919|18536992|P3|STARTED|Overall Study||1
7528574|NCT03480919|18536993|P2|STARTED|Overall Study||2
7528575|NCT03480919|18536994|P1|STARTED|Overall Study||1
7528576|NCT03480841|18537008|P1|NOT COMPLETED|Overall Study||2
7528577|NCT03480841|18537008|P1|COMPLETED|Overall Study||8
7528578|NCT03480841|18537008|P1|Time 2 Data Collection (T2)|Overall Study||8
7528579|NCT03480841|18537008|P1|LENA Time 5|Overall Study||8
7528580|NCT03480841|18537008|P1|LENA Time 4|Overall Study||9
7528581|NCT03480841|18537008|P1|LENA Time 3|Overall Study||10
7528582|NCT03480841|18537008|P1|LENA Time 2|Overall Study||10
7528583|NCT03480841|18537008|P1|LENA Time 1|Overall Study||10
7528584|NCT03480841|18537008|P1|LENA Baseline|Overall Study||10
7528585|NCT03480841|18537008|P1|Time 1 Data Collection (T1)|Overall Study||10
7528586|NCT03480841|18537008|P1|STARTED|Overall Study||10
7528587|NCT03480802|18537019|P2|NOT COMPLETED|Overall Study||3
7528588|NCT03480802|18537020|P1|NOT COMPLETED|Overall Study||7
7528589|NCT03480802|18537019|P2|COMPLETED|Overall Study||147
7528590|NCT03480802|18537020|P1|COMPLETED|Overall Study||145
7528591|NCT03480802|18537019|P2|Week 8|Overall Study||148
7528592|NCT03480802|18537020|P1|Week 8|Overall Study||150
7528593|NCT03480802|18537019|P2|STARTED|Overall Study||150
7528594|NCT03480802|18537020|P1|STARTED|Overall Study||152
7528595|NCT03480750|18537052|P6|NOT COMPLETED|Overall Study||1
7528596|NCT03480750|18537053|P5|NOT COMPLETED|Overall Study||0
7528597|NCT03480750|18537054|P4|NOT COMPLETED|Overall Study||0
7528598|NCT03480750|18537055|P3|NOT COMPLETED|Overall Study||0
7528599|NCT03480750|18537056|P2|NOT COMPLETED|Overall Study||1
7528600|NCT03480750|18537057|P1|NOT COMPLETED|Overall Study||0
7528601|NCT03480750|18537052|P6|COMPLETED|Overall Study||1
7528602|NCT03480750|18537053|P5|COMPLETED|Overall Study||3
7528603|NCT03480750|18537054|P4|COMPLETED|Overall Study||3
7528604|NCT03480750|18537055|P3|COMPLETED|Overall Study||3
7528605|NCT03480750|18537056|P2|COMPLETED|Overall Study||3
7528606|NCT03480750|18537057|P1|COMPLETED|Overall Study||3
7528607|NCT03480750|18537052|P6|STARTED|Overall Study||2
7528608|NCT03480750|18537053|P5|STARTED|Overall Study||3
7528609|NCT03480750|18537054|P4|STARTED|Overall Study||3
7528610|NCT03480750|18537055|P3|STARTED|Overall Study||3
7528611|NCT03480750|18537056|P2|STARTED|Overall Study||4
7528612|NCT03480750|18537057|P1|STARTED|Overall Study||3
7528613|NCT03480425|18537081|P1|NOT COMPLETED|Overall Study||1
7528614|NCT03480425|18537081|P1|COMPLETED|Overall Study||10
7528615|NCT03480425|18537081|P1|STARTED|Overall Study||11
7528616|NCT03480152|18537087|P3|NOT COMPLETED|Phase II||0
7528617|NCT03480152|18537088|P2|NOT COMPLETED|Phase II||0
7528618|NCT03480152|18537089|P1|NOT COMPLETED|Phase II||0
7528619|NCT03480152|18537087|P3|COMPLETED|Phase II||0
7528620|NCT03480152|18537088|P2|COMPLETED|Phase II||0
7528621|NCT03480152|18537089|P1|COMPLETED|Phase II||0
7528622|NCT03480152|18537087|P3|STARTED|Phase II||0
7528623|NCT03480152|18537088|P2|STARTED|Phase II||0
7528624|NCT03480152|18537089|P1|STARTED|Phase II||0
7528625|NCT03480152|18537087|P3|NOT COMPLETED|Phase I||0
7528626|NCT03480152|18537088|P2|NOT COMPLETED|Phase I||0
7528627|NCT03480152|18537089|P1|NOT COMPLETED|Phase I||1
7528628|NCT03480152|18537087|P3|COMPLETED|Phase I||0
7528629|NCT03480152|18537088|P2|COMPLETED|Phase I||2
7528630|NCT03480152|18537089|P1|COMPLETED|Phase I||2
7528631|NCT03480152|18537087|P3|Received Intervention|Phase I||0
7528632|NCT03480152|18537088|P2|Received Intervention|Phase I||2
7528633|NCT03480152|18537089|P1|Received Intervention|Phase I||2
7528634|NCT03480152|18537087|P3|STARTED|Phase I||0
7528635|NCT03480152|18537088|P2|STARTED|Phase I||2
7528636|NCT03480152|18537089|P1|STARTED|Phase I||3
7528637|NCT03480048|18537106|P2|NOT COMPLETED|Overall Study||8
7528638|NCT03480048|18537107|P1|NOT COMPLETED|Overall Study||10
7528639|NCT03480048|18537106|P2|COMPLETED|Overall Study||17
7528640|NCT03480048|18537107|P1|COMPLETED|Overall Study||18
7528641|NCT03480048|18537106|P2|STARTED|Overall Study||25
7528642|NCT03480048|18537107|P1|STARTED|Overall Study||28
7528643|NCT03480009|18537119|P4|NOT COMPLETED|Overall Study||0
7528644|NCT03480009|18537120|P3|NOT COMPLETED|Overall Study||4
7528645|NCT03480009|18537121|P2|NOT COMPLETED|Overall Study||5
7528646|NCT03480009|18537122|P1|NOT COMPLETED|Overall Study||4
7528647|NCT03480009|18537119|P4|COMPLETED|Overall Study||16
7528648|NCT03480009|18537120|P3|COMPLETED|Overall Study||12
7528649|NCT03480009|18537121|P2|COMPLETED|Overall Study||57
7528650|NCT03480009|18537122|P1|COMPLETED|Overall Study||58
7528651|NCT03480009|18537119|P4|STARTED|Overall Study||16
7528652|NCT03480009|18537120|P3|STARTED|Overall Study||16
7528653|NCT03480009|18537121|P2|STARTED|Overall Study||62
7528654|NCT03480009|18537122|P1|STARTED|Overall Study||62
7528655|NCT03479944|18537144|P1|NOT COMPLETED|Overall Study||0
7528656|NCT03479944|18537144|P1|COMPLETED|Overall Study||55
7528657|NCT03479944|18537144|P1|Full Analysis Set|Overall Study||53
7528658|NCT03479944|18537144|P1|Conventional|Overall Study||55
7528659|NCT03479944|18537144|P1|FLACS|Overall Study||55
7528660|NCT03479944|18537144|P1|STARTED|Overall Study||55
7528661|NCT03479216|18537157|P2|NOT COMPLETED|Overall Study||5
7528662|NCT03479216|18537158|P1|NOT COMPLETED|Overall Study||5
7528663|NCT03479216|18537157|P2|COMPLETED|Overall Study||26
7528664|NCT03479216|18537158|P1|COMPLETED|Overall Study||26
7528665|NCT03479216|18537157|P2|STARTED|Overall Study||31
7528666|NCT03479216|18537158|P1|STARTED|Overall Study||31
7528667|NCT03478956|18537178|P2|NOT COMPLETED|Overall Study||12
7528668|NCT03478956|18537179|P1|NOT COMPLETED|Overall Study||12
7528669|NCT03478956|18537178|P2|COMPLETED|Overall Study||0
7528670|NCT03478956|18537179|P1|COMPLETED|Overall Study||0
7528671|NCT03478956|18537178|P2|Started PML Safety Monitoring Phase|Overall Study||2
7528672|NCT03478956|18537179|P1|Started PML Safety Monitoring Phase|Overall Study||1
7528673|NCT03478956|18537178|P2|Completed OLE Treatment Phase|Overall Study||0
7528674|NCT03478956|18537179|P1|Completed OLE Treatment Phase|Overall Study||0
7528675|NCT03478956|18537178|P2|Started OLE Treatment Phase|Overall Study||10
7528676|NCT03478956|18537179|P1|Started OLE Treatment Phase|Overall Study||11
7528677|NCT03478956|18537178|P2|Completed Randomized Treatment Phase|Overall Study||10
7528678|NCT03478956|18537179|P1|Completed Randomized Treatment Phase|Overall Study||11
7528679|NCT03478956|18537178|P2|Received at Least One Dose of Study Drug|Overall Study||12
7528680|NCT03478956|18537179|P1|Received at Least One Dose of Study Drug|Overall Study||12
7528681|NCT03478956|18537178|P2|STARTED|Overall Study||12
7528682|NCT03478956|18537179|P1|STARTED|Overall Study||12
7528683|NCT03478891|18537208|P3|NOT COMPLETED|Overall Study||3
7528684|NCT03478891|18537209|P2|NOT COMPLETED|Overall Study||0
7528685|NCT03478891|18537210|P1|NOT COMPLETED|Overall Study||1
7528686|NCT03478891|18537208|P3|COMPLETED|Overall Study||8
7528687|NCT03478891|18537209|P2|COMPLETED|Overall Study||5
7528688|NCT03478891|18537210|P1|COMPLETED|Overall Study||2
7528689|NCT03478891|18537208|P3|Received MAb114|Overall Study|One Group 3 subject discontinued prior to MAb114 infusion due to inadequate venous access|10
7528690|NCT03478891|18537209|P2|Received MAb114|Overall Study||5
7528691|NCT03478891|18537210|P1|Received MAb114|Overall Study||3
7528692|NCT03478891|18537208|P3|STARTED|Overall Study||11
7528693|NCT03478891|18537209|P2|STARTED|Overall Study||5
7528694|NCT03478891|18537210|P1|STARTED|Overall Study||3
7528695|NCT03478696|18537261|P2|NOT COMPLETED|Overall Study||12
7528696|NCT03478696|18537262|P1|NOT COMPLETED|Overall Study||17
7528697|NCT03478696|18537261|P2|COMPLETED|Overall Study||354
7528698|NCT03478696|18537262|P1|COMPLETED|Overall Study||349
7528699|NCT03478696|18537261|P2|STARTED|Overall Study||366
7528700|NCT03478696|18537262|P1|STARTED|Overall Study||366
7528701|NCT03478683|18537276|P2|NOT COMPLETED|Overall Study||18
7528702|NCT03478683|18537277|P1|NOT COMPLETED|Overall Study||13
7528703|NCT03478683|18537276|P2|COMPLETED|Overall Study||347
7528704|NCT03478683|18537277|P1|COMPLETED|Overall Study||350
7528705|NCT03478683|18537276|P2|STARTED|Overall Study||365
7528706|NCT03478683|18537277|P1|STARTED|Overall Study||363
7528707|NCT03478657|18537291|P2|NOT COMPLETED|Overall Study||1
7528708|NCT03478657|18537292|P1|NOT COMPLETED|Overall Study||0
7528709|NCT03478657|18537291|P2|COMPLETED|Overall Study||133
7528710|NCT03478657|18537292|P1|COMPLETED|Overall Study||88
7528711|NCT03478657|18537291|P2|STARTED|Overall Study||134
7528712|NCT03478657|18537292|P1|STARTED|Overall Study||88
7528713|NCT03478644|18537307|P2|NOT COMPLETED|Phase 2||1
7528714|NCT03478644|18537308|P1|NOT COMPLETED|Phase 2||3
7528715|NCT03478644|18537307|P2|COMPLETED|Phase 2||75
7528716|NCT03478644|18537308|P1|COMPLETED|Phase 2||73
7528717|NCT03478644|18537307|P2|STARTED|Phase 2||76
7528718|NCT03478644|18537308|P1|STARTED|Phase 2||76
7528719|NCT03478644|18537307|P2|NOT COMPLETED|Phase 1||0
7528720|NCT03478644|18537308|P1|NOT COMPLETED|Phase 1||0
7528721|NCT03478644|18537307|P2|COMPLETED|Phase 1||0
7528722|NCT03478644|18537308|P1|COMPLETED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
7528723|NCT03478644|18537307|P2|STARTED|Phase 1||0
7528724|NCT03478644|18537308|P1|STARTED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
7528725|NCT03478371|18537320|P1|NOT COMPLETED|Overall Study||5
7528726|NCT03478371|18537320|P1|COMPLETED|Overall Study||89
7528727|NCT03478371|18537320|P1|Received Tampon V|Overall Study||91
7528728|NCT03478371|18537320|P1|Recived Tampon T|Overall Study||90
7528729|NCT03478371|18537320|P1|Received Tampon M|Overall Study||92
7528730|NCT03478371|18537320|P1|Received Tampon D|Overall Study||91
7528731|NCT03478371|18537320|P1|STARTED|Overall Study||94
7528732|NCT03477903|18537342|P1|NOT COMPLETED|Overall Study||1
7528733|NCT03477903|18537342|P1|COMPLETED|Overall Study||0
7528734|NCT03477903|18537342|P1|STARTED|Overall Study||1
7528735|NCT03476850|18537355|P2|NOT COMPLETED|Overall Study||0
7528736|NCT03476850|18537356|P1|NOT COMPLETED|Overall Study||0
7528737|NCT03476850|18537355|P2|COMPLETED|Overall Study||24
7528738|NCT03476850|18537356|P1|COMPLETED|Overall Study||24
7528739|NCT03476850|18537355|P2|STARTED|Overall Study||24
7528740|NCT03476850|18537356|P1|STARTED|Overall Study||24
7528741|NCT03476278|18537372|P1|NOT COMPLETED|Overall Study||0
7528742|NCT03476278|18537372|P1|COMPLETED|Overall Study||300
7528743|NCT03476278|18537372|P1|STARTED|Overall Study||300
7528744|NCT03476239|18537418|P1|NOT COMPLETED|Overall Study||106
7528745|NCT03476239|18537418|P1|COMPLETED|Overall Study||0
7528746|NCT03476239|18537418|P1|Interim Analysis Set|Overall Study||90
7528747|NCT03476239|18537418|P1|Enrolled Before 21 February 2019|Overall Study||91
7528748|NCT03476239|18537418|P1|STARTED|Overall Study||106
7528749|NCT03476135|18537439|P2|NOT COMPLETED|Overall Study||0
7528750|NCT03476135|18537440|P1|NOT COMPLETED|Overall Study||0
7528751|NCT03476135|18537439|P2|COMPLETED|Overall Study||49
7528752|NCT03476135|18537440|P1|COMPLETED|Overall Study||42
7528753|NCT03476135|18537439|P2|STARTED|Overall Study||49
7528754|NCT03476135|18537440|P1|STARTED|Overall Study||42
7528755|NCT03475875|18537468|P2|NOT COMPLETED|Period 3||0
7528756|NCT03475875|18537469|P1|NOT COMPLETED|Period 3||0
7528757|NCT03475875|18537468|P2|COMPLETED|Period 3||43
7528758|NCT03475875|18537469|P1|COMPLETED|Period 3||40
7528759|NCT03475875|18537468|P2|STARTED|Period 3||43
7528760|NCT03475875|18537469|P1|STARTED|Period 3||40
7528761|NCT03475875|18537468|P2|NOT COMPLETED|Period 2||1
7528762|NCT03475875|18537469|P1|NOT COMPLETED|Period 2||3
7528763|NCT03475875|18537468|P2|COMPLETED|Period 2||43
7528764|NCT03475875|18537469|P1|COMPLETED|Period 2||40
7528765|NCT03475875|18537468|P2|STARTED|Period 2||44
7528766|NCT03475875|18537469|P1|STARTED|Period 2||43
7528767|NCT03475875|18537468|P2|NOT COMPLETED|Period 1||1
7528768|NCT03475875|18537469|P1|NOT COMPLETED|Period 1||3
7528769|NCT03475875|18537468|P2|COMPLETED|Period 1||44
7528770|NCT03475875|18537469|P1|COMPLETED|Period 1||43
7528771|NCT03475875|18537468|P2|STARTED|Period 1||45
7528772|NCT03475875|18537469|P1|STARTED|Period 1||46
7528773|NCT03474874|18537477|P1|NOT COMPLETED|Overall Study||14
7528774|NCT03474874|18537477|P1|COMPLETED|Overall Study||54
7528775|NCT03474874|18537477|P1|STARTED|Overall Study||68
7528776|NCT03474172|18537488|P2|NOT COMPLETED|Overall Study||0
7528777|NCT03474172|18537489|P1|NOT COMPLETED|Overall Study||0
7528778|NCT03474172|18537488|P2|COMPLETED|Overall Study||30
7528779|NCT03474172|18537489|P1|COMPLETED|Overall Study||30
7528780|NCT03474172|18537488|P2|STARTED|Overall Study||30
7528781|NCT03474172|18537489|P1|STARTED|Overall Study||30
7528782|NCT03474081|18537507|P2|NOT COMPLETED|Overall Study||13
7528783|NCT03474081|18537508|P1|NOT COMPLETED|Overall Study||17
7528784|NCT03474081|18537507|P2|COMPLETED|Overall Study||387
7528785|NCT03474081|18537508|P1|COMPLETED|Overall Study||383
7528786|NCT03474081|18537507|P2|Received Study Treatment|Overall Study|One randomized participant withdrew consent and never received study treatment.|399
7528787|NCT03474081|18537508|P1|Received Study Treatment|Overall Study||400
7528788|NCT03474081|18537507|P2|STARTED|Overall Study||400
7528789|NCT03474081|18537508|P1|STARTED|Overall Study||400
7528790|NCT03473886|18537524|P1|NOT COMPLETED|Overall Study||1
7528791|NCT03473886|18537524|P1|COMPLETED|Overall Study||7
7528792|NCT03473886|18537524|P1|STARTED|Overall Study||8
7528793|NCT03473808|18537549|P1|NOT COMPLETED|Overall Study||1
7528794|NCT03473808|18537549|P1|COMPLETED|Overall Study||4
7528795|NCT03473808|18537549|P1|STARTED|Overall Study||5
7528796|NCT03473665|18537556|P1|NOT COMPLETED|Overall Study||0
7528797|NCT03473665|18537556|P1|COMPLETED|Overall Study||9
7528798|NCT03473665|18537556|P1|STARTED|Overall Study||9
7528799|NCT03473236|18537581|P10|NOT COMPLETED|Overall Study||0
7528800|NCT03473236|18537582|P9|NOT COMPLETED|Overall Study||1
7528801|NCT03473236|18537583|P8|NOT COMPLETED|Overall Study||0
7528802|NCT03473236|18537584|P7|NOT COMPLETED|Overall Study||0
7528803|NCT03473236|18537585|P6|NOT COMPLETED|Overall Study||1
7528804|NCT03473236|18537586|P5|NOT COMPLETED|Overall Study||0
7528805|NCT03473236|18537587|P4|NOT COMPLETED|Overall Study||0
7528806|NCT03473236|18537588|P3|NOT COMPLETED|Overall Study||0
7528807|NCT03473236|18537589|P2|NOT COMPLETED|Overall Study||0
7528808|NCT03473236|18537590|P1|NOT COMPLETED|Overall Study||0
7528809|NCT03473236|18537581|P10|COMPLETED|Overall Study||6
7528810|NCT03473236|18537582|P9|COMPLETED|Overall Study||6
7528811|NCT03473236|18537583|P8|COMPLETED|Overall Study||6
7528812|NCT03473236|18537584|P7|COMPLETED|Overall Study||6
7528813|NCT03473236|18537585|P6|COMPLETED|Overall Study||6
7528814|NCT03473236|18537586|P5|COMPLETED|Overall Study||6
7528815|NCT03473236|18537587|P4|COMPLETED|Overall Study||6
7528816|NCT03473236|18537588|P3|COMPLETED|Overall Study||6
7528817|NCT03473236|18537589|P2|COMPLETED|Overall Study||6
7528818|NCT03473236|18537590|P1|COMPLETED|Overall Study||10
7528819|NCT03473236|18537581|P10|STARTED|Overall Study||6
7528820|NCT03473236|18537582|P9|STARTED|Overall Study||7
7528821|NCT03473236|18537583|P8|STARTED|Overall Study||6
7528822|NCT03473236|18537584|P7|STARTED|Overall Study||6
7528823|NCT03473236|18537585|P6|STARTED|Overall Study||7
7528824|NCT03473236|18537586|P5|STARTED|Overall Study||6
7528825|NCT03473236|18537587|P4|STARTED|Overall Study||6
7528826|NCT03473236|18537588|P3|STARTED|Overall Study||6
7528827|NCT03473236|18537589|P2|STARTED|Overall Study||6
7528828|NCT03473236|18537590|P1|STARTED|Overall Study||10
7528829|NCT03473197|18537757|P1|NOT COMPLETED|Overall Study||10
7528830|NCT03473197|18537757|P1|COMPLETED|Overall Study||51
7528831|NCT03473197|18537757|P1|Untreated Irradiated|Overall Study||51
7528832|NCT03473197|18537757|P1|Vehicle Ointment Non-irradiated|Overall Study||51
7528833|NCT03473197|18537757|P1|Diacerein 1% Ointment Non-irradiated|Overall Study||51
7528834|NCT03473197|18537757|P1|Vehicle Ointment Irradiated|Overall Study||51
7528835|NCT03473197|18537757|P1|Diacerein 1% Ointment Irradiated|Overall Study||51
7528836|NCT03473197|18537757|P1|STARTED|Overall Study||61
7528837|NCT03473184|18537761|P1|NOT COMPLETED|Overall Study||0
7528838|NCT03473184|18537761|P1|COMPLETED|Overall Study||34
7528839|NCT03473184|18537761|P1|Untreated Irradiated|Overall Study||34
7528840|NCT03473184|18537761|P1|Vehicle Ointment Non-irradiated|Overall Study||34
7528841|NCT03473184|18537761|P1|Diacerein 1% Ointment Non-irradiated|Overall Study||34
7528842|NCT03473184|18537761|P1|Vehicle Ointment Irradiated|Overall Study||34
7528843|NCT03473184|18537761|P1|Diacerein 1% Ointment Irradiated|Overall Study||34
7528844|NCT03473184|18537761|P1|STARTED|Overall Study||34
7528845|NCT03473171|18537765|P1|NOT COMPLETED|Overall Study||0
7528846|NCT03473171|18537765|P1|COMPLETED|Overall Study||5
7528847|NCT03473171|18537765|P1|STARTED|Overall Study||5
7528848|NCT03472547|18537769|P1|NOT COMPLETED|Overall Study||30
7528849|NCT03472547|18537769|P1|COMPLETED|Overall Study||204
7528850|NCT03472547|18537769|P1|STARTED|Overall Study||234
7528851|NCT03472534|18537773|P1|NOT COMPLETED|Overall Study||11
7528852|NCT03472534|18537773|P1|COMPLETED|Overall Study||35
7528853|NCT03472534|18537773|P1|0.9% Saline|Overall Study||46
7528854|NCT03472534|18537773|P1|0.2% Sodium Lauryl Sulfate (SLS)|Overall Study||46
7528855|NCT03472534|18537773|P1|Vehicle Ointment|Overall Study||46
7528856|NCT03472534|18537773|P1|Diacerein 1% Ointment|Overall Study||46
7528857|NCT03472534|18537773|P1|STARTED|Overall Study|Each participant receives all 4 unit interventions.|46
7528858|NCT03472287|18537779|P2|NOT COMPLETED|Overall Study||0
7528859|NCT03472287|18537780|P1|NOT COMPLETED|Overall Study||0
7528860|NCT03472287|18537779|P2|COMPLETED|Overall Study||3
7528861|NCT03472287|18537780|P1|COMPLETED|Overall Study||8
7528862|NCT03472287|18537779|P2|STARTED|Overall Study||3
7528863|NCT03472287|18537780|P1|STARTED|Overall Study||8
7528864|NCT03472014|18537786|P1|NOT COMPLETED|Overall Study||4
7528865|NCT03472014|18537786|P1|COMPLETED|Overall Study||18
7528866|NCT03472014|18537786|P1|STARTED|Overall Study||22
7528867|NCT03471975|18537797|P2|NOT COMPLETED|Overall Study||0
7528868|NCT03471975|18537798|P1|NOT COMPLETED|Overall Study||0
7528869|NCT03471975|18537797|P2|COMPLETED|Overall Study||20
7528870|NCT03471975|18537798|P1|COMPLETED|Overall Study||17
7528871|NCT03471975|18537797|P2|STARTED|Overall Study||20
7528872|NCT03471975|18537798|P1|STARTED|Overall Study||17
7528873|NCT03471871|18537808|P5|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
7528874|NCT03471871|18537809|P4|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
7528875|NCT03471871|18537810|P3|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
7528876|NCT03471871|18537811|P2|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
7528877|NCT03471871|18537812|P1|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
7528878|NCT03471871|18537808|P5|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
7528879|NCT03471871|18537809|P4|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
7528880|NCT03471871|18537810|P3|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
7528881|NCT03471871|18537811|P2|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
7528882|NCT03471871|18537812|P1|COMPLETED|Follow Up (14 Days for Both HV and OSA)||6
7528883|NCT03471871|18537808|P5|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
7528884|NCT03471871|18537809|P4|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
7528885|NCT03471871|18537810|P3|STARTED|Follow Up (14 Days for Both HV and OSA)||5
7528886|NCT03471871|18537811|P2|STARTED|Follow Up (14 Days for Both HV and OSA)||5
7528887|NCT03471871|18537812|P1|STARTED|Follow Up (14 Days for Both HV and OSA)||6
7528888|NCT03471871|18537808|P5|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
7528889|NCT03471871|18537809|P4|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
7528890|NCT03471871|18537810|P3|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
7528891|NCT03471871|18537811|P2|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
7528892|NCT03471871|18537812|P1|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
7528893|NCT03471871|18537808|P5|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
7528894|NCT03471871|18537809|P4|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
7528895|NCT03471871|18537810|P3|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
7528896|NCT03471871|18537811|P2|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
7528897|NCT03471871|18537812|P1|COMPLETED|Treatment Period 3: ( HV:1 Day)||6
7528898|NCT03471871|18537808|P5|STARTED|Treatment Period 3: ( HV:1 Day)||0
7528899|NCT03471871|18537809|P4|STARTED|Treatment Period 3: ( HV:1 Day)||0
7528900|NCT03471871|18537810|P3|STARTED|Treatment Period 3: ( HV:1 Day)||5
7528901|NCT03471871|18537811|P2|STARTED|Treatment Period 3: ( HV:1 Day)||5
7528902|NCT03471871|18537812|P1|STARTED|Treatment Period 3: ( HV:1 Day)||6
7528903|NCT03471871|18537808|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
7528904|NCT03471871|18537809|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
7528905|NCT03471871|18537810|P3|NOT COMPLETED|Washout Period 2 (14 Days)||0
7528906|NCT03471871|18537811|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
7528907|NCT03471871|18537812|P1|NOT COMPLETED|Washout Period 2 (14 Days)||0
7528908|NCT03471871|18537808|P5|COMPLETED|Washout Period 2 (14 Days)||0
7528909|NCT03471871|18537809|P4|COMPLETED|Washout Period 2 (14 Days)||0
7528910|NCT03471871|18537810|P3|COMPLETED|Washout Period 2 (14 Days)||5
7528911|NCT03471871|18537811|P2|COMPLETED|Washout Period 2 (14 Days)||5
7528912|NCT03471871|18537812|P1|COMPLETED|Washout Period 2 (14 Days)||6
7528913|NCT03471871|18537808|P5|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
7528914|NCT03471871|18537809|P4|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
7528915|NCT03471871|18537810|P3|STARTED|Washout Period 2 (14 Days)||5
7528916|NCT03471871|18537811|P2|STARTED|Washout Period 2 (14 Days)||5
7528917|NCT03471871|18537812|P1|STARTED|Washout Period 2 (14 Days)||6
7528918|NCT03471871|18537808|P5|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||1
7528919|NCT03471871|18537809|P4|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
7528920|NCT03471871|18537810|P3|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
7528921|NCT03471871|18537811|P2|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
7528922|NCT03471871|18537812|P1|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
7528923|NCT03471871|18537808|P5|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
7528924|NCT03471871|18537809|P4|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
7528925|NCT03471871|18537810|P3|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
7528926|NCT03471871|18537811|P2|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
7528927|NCT03471871|18537812|P1|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
7528928|NCT03471871|18537808|P5|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||19
7528929|NCT03471871|18537809|P4|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
7528930|NCT03471871|18537810|P3|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
7528931|NCT03471871|18537811|P2|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
7528932|NCT03471871|18537812|P1|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
7528933|NCT03471871|18537808|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
7528934|NCT03471871|18537809|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
7528935|NCT03471871|18537810|P3|NOT COMPLETED|Washout Period 1 (14 Days)||0
7528936|NCT03471871|18537811|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
7528937|NCT03471871|18537812|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
7528938|NCT03471871|18537808|P5|COMPLETED|Washout Period 1 (14 Days)||19
7528939|NCT03471871|18537809|P4|COMPLETED|Washout Period 1 (14 Days)||18
7528940|NCT03471871|18537810|P3|COMPLETED|Washout Period 1 (14 Days)||5
7528941|NCT03471871|18537811|P2|COMPLETED|Washout Period 1 (14 Days)||5
7528942|NCT03471871|18537812|P1|COMPLETED|Washout Period 1 (14 Days)||6
7528943|NCT03471871|18537808|P5|STARTED|Washout Period 1 (14 Days)||19
7528944|NCT03471871|18537809|P4|STARTED|Washout Period 1 (14 Days)||18
7528945|NCT03471871|18537810|P3|STARTED|Washout Period 1 (14 Days)||5
7528946|NCT03471871|18537811|P2|STARTED|Washout Period 1 (14 Days)||5
7528947|NCT03471871|18537812|P1|STARTED|Washout Period 1 (14 Days)||6
7528948|NCT03471871|18537808|P5|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
7528949|NCT03471871|18537809|P4|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
7528950|NCT03471871|18537810|P3|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
7528951|NCT03471871|18537811|P2|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
7528952|NCT03471871|18537812|P1|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
7528953|NCT03471871|18537808|P5|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
7528954|NCT03471871|18537809|P4|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
7528955|NCT03471871|18537810|P3|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
7528956|NCT03471871|18537811|P2|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
7528957|NCT03471871|18537812|P1|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
7528958|NCT03471871|18537808|P5|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
7528959|NCT03471871|18537809|P4|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
7528960|NCT03471871|18537810|P3|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
7528961|NCT03471871|18537811|P2|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
7528962|NCT03471871|18537812|P1|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
7528963|NCT03471871|18537808|P5|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
7528964|NCT03471871|18537809|P4|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
7528965|NCT03471871|18537810|P3|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
7528966|NCT03471871|18537811|P2|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
7528967|NCT03471871|18537812|P1|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
7528968|NCT03471832|18537841|P2|NOT COMPLETED|Overall Study||0
7528969|NCT03471832|18537842|P1|NOT COMPLETED|Overall Study||0
7528970|NCT03471832|18537841|P2|COMPLETED|Overall Study||40
7528971|NCT03471832|18537842|P1|COMPLETED|Overall Study||40
7528972|NCT03471832|18537841|P2|STARTED|Overall Study||40
7528973|NCT03471832|18537842|P1|STARTED|Overall Study||40
7528974|NCT03470740|18537901|P2|NOT COMPLETED|Overall Study||6
7528975|NCT03470740|18537902|P1|NOT COMPLETED|Overall Study||4
7528976|NCT03470740|18537901|P2|COMPLETED|Overall Study||106
7528977|NCT03470740|18537902|P1|COMPLETED|Overall Study||108
7528978|NCT03470740|18537901|P2|STARTED|Overall Study||112
7528979|NCT03470740|18537902|P1|STARTED|Overall Study||112
7528980|NCT03470012|18537920|P1|NOT COMPLETED|Overall Study||0
7528981|NCT03470012|18537920|P1|COMPLETED|Overall Study||24
7528982|NCT03470012|18537920|P1|STARTED|Overall Study||24
7528983|NCT03469349|18537926|P2|NOT COMPLETED|Overall Study||10
7528984|NCT03469349|18537927|P1|NOT COMPLETED|Overall Study||5
7528985|NCT03469349|18537926|P2|COMPLETED|Overall Study||174
7528986|NCT03469349|18537927|P1|COMPLETED|Overall Study||177
7528987|NCT03469349|18537926|P2|STARTED|Overall Study||184
7528988|NCT03469349|18537927|P1|STARTED|Overall Study||182
7528989|NCT03469336|18537943|P1|NOT COMPLETED|Overall Study||1
7528990|NCT03469336|18537943|P1|COMPLETED|Overall Study||17
7528991|NCT03469336|18537943|P1|STARTED|Overall Study||18
7528992|NCT03469258|18537966|P1|NOT COMPLETED|Overall Study||4
7528993|NCT03469258|18537966|P1|COMPLETED|Overall Study||0
7528994|NCT03469258|18537966|P1|STARTED|Overall Study||4
7528995|NCT03468920|18537980|P2|NOT COMPLETED|Overall Study||0
7528996|NCT03468920|18537981|P1|NOT COMPLETED|Overall Study||0
7528997|NCT03468920|18537980|P2|COMPLETED|Overall Study||60
7528998|NCT03468920|18537981|P1|COMPLETED|Overall Study||60
7528999|NCT03468920|18537980|P2|STARTED|Overall Study||60
7529000|NCT03468920|18537981|P1|STARTED|Overall Study||60
7529001|NCT03468855|18537995|P1|NOT COMPLETED|Overall Study||11
7529002|NCT03468855|18537995|P1|COMPLETED|Overall Study||23
7529003|NCT03468855|18537995|P1|STARTED|Overall Study||34
7529004|NCT03468816|18538031|P2|NOT COMPLETED|Overall Study||0
7529005|NCT03468816|18538032|P1|NOT COMPLETED|Overall Study||0
7529006|NCT03468816|18538031|P2|COMPLETED|Overall Study||3
7529007|NCT03468816|18538032|P1|COMPLETED|Overall Study||2
7529008|NCT03468816|18538031|P2|STARTED|Overall Study||3
7529009|NCT03468816|18538032|P1|STARTED|Overall Study||2
7529010|NCT03468543|18538049|P1|NOT COMPLETED|Overall Study||3
7529011|NCT03468543|18538049|P1|COMPLETED|Overall Study||0
7529012|NCT03468543|18538049|P1|STARTED|Overall Study||3
7529013|NCT03468179|18538053|P1|NOT COMPLETED|Overall Study||0
7529014|NCT03468179|18538053|P1|COMPLETED|Overall Study||10
7529015|NCT03468179|18538053|P1|STARTED|Overall Study||10
7529016|NCT03468075|18538059|P1|NOT COMPLETED|Overall Study||0
7529017|NCT03468075|18538059|P1|COMPLETED|Overall Study||10
7529018|NCT03468075|18538059|P1|STARTED|Overall Study||10
7529019|NCT03467971|18538068|P2|NOT COMPLETED|Treatment Period 2||1
7529020|NCT03467971|18538069|P1|NOT COMPLETED|Treatment Period 2||0
7529021|NCT03467971|18538068|P2|COMPLETED|Treatment Period 2||10
7529022|NCT03467971|18538069|P1|COMPLETED|Treatment Period 2||10
7529023|NCT03467971|18538068|P2|STARTED|Treatment Period 2||11
7529024|NCT03467971|18538069|P1|STARTED|Treatment Period 2||10
7529025|NCT03467971|18538068|P2|NOT COMPLETED|Treatment Period 1||0
7529026|NCT03467971|18538069|P1|NOT COMPLETED|Treatment Period 1||0
7529027|NCT03467971|18538068|P2|COMPLETED|Treatment Period 1||11
7529028|NCT03467971|18538069|P1|COMPLETED|Treatment Period 1||10
7529029|NCT03467971|18538068|P2|STARTED|Treatment Period 1||11
7529030|NCT03467971|18538069|P1|STARTED|Treatment Period 1||10
7529031|NCT03467945|18538093|P4|NOT COMPLETED|Treatment Period 4||0
7529032|NCT03467945|18538094|P3|NOT COMPLETED|Treatment Period 4||0
7529033|NCT03467945|18538095|P2|NOT COMPLETED|Treatment Period 4||0
7529034|NCT03467945|18538096|P1|NOT COMPLETED|Treatment Period 4||0
7529035|NCT03467945|18538093|P4|COMPLETED|Treatment Period 4||9
7529036|NCT03467945|18538094|P3|COMPLETED|Treatment Period 4||8
7529037|NCT03467945|18538095|P2|COMPLETED|Treatment Period 4||9
7529038|NCT03467945|18538096|P1|COMPLETED|Treatment Period 4||9
7529039|NCT03467945|18538093|P4|STARTED|Treatment Period 4||9
7529040|NCT03467945|18538094|P3|STARTED|Treatment Period 4||8
7529041|NCT03467945|18538095|P2|STARTED|Treatment Period 4||9
7529042|NCT03467945|18538096|P1|STARTED|Treatment Period 4||9
7529043|NCT03467945|18538093|P4|NOT COMPLETED|Treatment Period 3||1
7529044|NCT03467945|18538094|P3|NOT COMPLETED|Treatment Period 3||2
7529045|NCT03467945|18538095|P2|NOT COMPLETED|Treatment Period 3||0
7529046|NCT03467945|18538096|P1|NOT COMPLETED|Treatment Period 3||1
7529047|NCT03467945|18538093|P4|COMPLETED|Treatment Period 3||9
7529048|NCT03467945|18538094|P3|COMPLETED|Treatment Period 3||8
7529049|NCT03467945|18538095|P2|COMPLETED|Treatment Period 3||9
7529050|NCT03467945|18538096|P1|COMPLETED|Treatment Period 3||9
7529051|NCT03467945|18538093|P4|STARTED|Treatment Period 3||10
7529052|NCT03467945|18538094|P3|STARTED|Treatment Period 3||10
7529053|NCT03467945|18538095|P2|STARTED|Treatment Period 3||9
7529054|NCT03467945|18538096|P1|STARTED|Treatment Period 3||10
7529055|NCT03467945|18538093|P4|NOT COMPLETED|Treatment Period 2||0
7529056|NCT03467945|18538094|P3|NOT COMPLETED|Treatment Period 2||0
7529057|NCT03467945|18538095|P2|NOT COMPLETED|Treatment Period 2||1
7529058|NCT03467945|18538096|P1|NOT COMPLETED|Treatment Period 2||0
7529059|NCT03467945|18538093|P4|COMPLETED|Treatment Period 2||10
7529060|NCT03467945|18538094|P3|COMPLETED|Treatment Period 2||10
7529061|NCT03467945|18538095|P2|COMPLETED|Treatment Period 2||9
7529062|NCT03467945|18538096|P1|COMPLETED|Treatment Period 2||10
7529063|NCT03467945|18538093|P4|STARTED|Treatment Period 2||10
7529064|NCT03467945|18538094|P3|STARTED|Treatment Period 2||10
7529065|NCT03467945|18538095|P2|STARTED|Treatment Period 2||10
7529066|NCT03467945|18538096|P1|STARTED|Treatment Period 2||10
7529067|NCT03467945|18538093|P4|NOT COMPLETED|Treatment Period 1||0
7529068|NCT03467945|18538094|P3|NOT COMPLETED|Treatment Period 1||0
7529069|NCT03467945|18538095|P2|NOT COMPLETED|Treatment Period 1||0
7529070|NCT03467945|18538096|P1|NOT COMPLETED|Treatment Period 1||0
7529071|NCT03467945|18538093|P4|COMPLETED|Treatment Period 1||10
7529072|NCT03467945|18538094|P3|COMPLETED|Treatment Period 1||10
7529073|NCT03467945|18538095|P2|COMPLETED|Treatment Period 1||10
7529074|NCT03467945|18538096|P1|COMPLETED|Treatment Period 1||10
7529075|NCT03467945|18538093|P4|STARTED|Treatment Period 1||10
7529076|NCT03467945|18538094|P3|STARTED|Treatment Period 1||10
7529077|NCT03467945|18538095|P2|STARTED|Treatment Period 1||10
7529078|NCT03467945|18538096|P1|STARTED|Treatment Period 1||10
7529079|NCT03467763|18538148|P1|NOT COMPLETED|Overall Study||3
7529080|NCT03467763|18538148|P1|COMPLETED|Overall Study||10
7529081|NCT03467763|18538148|P1|Weeks 15-16|Overall Study||2
7529082|NCT03467763|18538148|P1|Weeks 13-14|Overall Study||2
7529083|NCT03467763|18538148|P1|Week 11-12|Overall Study||6
7529084|NCT03467763|18538148|P1|Weeks 9 - 10|Overall Study||6
7529085|NCT03467763|18538148|P1|Weeks 7-8|Overall Study||7
7529086|NCT03467763|18538148|P1|Weeks 5-6|Overall Study||8
7529087|NCT03467763|18538148|P1|Weeks 3-4|Overall Study||10
7529088|NCT03467763|18538148|P1|Weeks 1-2|Overall Study||13
7529089|NCT03467763|18538148|P1|STARTED|Overall Study||13
7529090|NCT03467685|18538158|P2|NOT COMPLETED|Overall Study||0
7529091|NCT03467685|18538159|P1|NOT COMPLETED|Overall Study||0
7529092|NCT03467685|18538158|P2|COMPLETED|Overall Study||49
7529093|NCT03467685|18538159|P1|COMPLETED|Overall Study||52
7529094|NCT03467685|18538158|P2|STARTED|Overall Study||49
7529095|NCT03467685|18538159|P1|STARTED|Overall Study||52
7529096|NCT03467477|18538165|P1|NOT COMPLETED|Overall Study||0
7529097|NCT03467477|18538165|P1|COMPLETED|Overall Study||161
7529098|NCT03467477|18538165|P1|STARTED|Overall Study||161
7529099|NCT03467425|18538178|P2|NOT COMPLETED|Overall Study||54
7529100|NCT03467425|18538179|P1|NOT COMPLETED|Overall Study||47
7529101|NCT03467425|18538178|P2|COMPLETED|Overall Study||1493
7529102|NCT03467425|18538179|P1|COMPLETED|Overall Study||1498
7529103|NCT03467425|18538178|P2|WIP: Withdrawal by Participant|Overall Study||78
7529104|NCT03467425|18538179|P1|WIP: Withdrawal by Participant|Overall Study||91
7529105|NCT03467425|18538178|P2|WIP: Physician Decision|Overall Study||27
7529106|NCT03467425|18538179|P1|WIP: Physician Decision|Overall Study||14
7529107|NCT03467425|18538178|P2|WIP: Lack of Efficacy|Overall Study||28
7529108|NCT03467425|18538179|P1|WIP: Lack of Efficacy|Overall Study||56
7529109|NCT03467425|18538178|P2|WIP: Adverse Event|Overall Study||29
7529110|NCT03467425|18538179|P1|WIP: Adverse Event|Overall Study||112
7529111|NCT03467425|18538178|P2|WIP: Protocol Deviation|Overall Study||2
7529112|NCT03467425|18538179|P1|WIP: Protocol Deviation|Overall Study||0
7529113|NCT03467425|18538178|P2|Withdrew IP (WIP): Lost to Follow-up|Overall Study||24
7529114|NCT03467425|18538179|P1|Withdrew IP (WIP): Lost to Follow-up|Overall Study||15
7529115|NCT03467425|18538178|P2|Not Completed IP|Overall Study||188
7529116|NCT03467425|18538179|P1|Not Completed IP|Overall Study||288
7529117|NCT03467425|18538178|P2|Completed IP|Overall Study||1359
7529118|NCT03467425|18538179|P1|Completed IP|Overall Study||1256
7529119|NCT03467425|18538178|P2|Randomized But Did Not Start IP|Overall Study||0
7529120|NCT03467425|18538179|P1|Randomized But Did Not Start IP|Overall Study||1
7529121|NCT03467425|18538178|P2|STARTED|Overall Study||1547
7529122|NCT03467425|18538179|P1|STARTED|Overall Study||1545
7529123|NCT03467412|18538189|P5|NOT COMPLETED|Overall Study||3
7529124|NCT03467412|18538190|P4|NOT COMPLETED|Overall Study||2
7529125|NCT03467412|18538191|P3|NOT COMPLETED|Overall Study||5
7529126|NCT03467412|18538192|P2|NOT COMPLETED|Overall Study||1
7529127|NCT03467412|18538193|P1|NOT COMPLETED|Overall Study||3
7529128|NCT03467412|18538189|P5|COMPLETED|Overall Study||17
7529129|NCT03467412|18538190|P4|COMPLETED|Overall Study||23
7529130|NCT03467412|18538191|P3|COMPLETED|Overall Study||20
7529131|NCT03467412|18538192|P2|COMPLETED|Overall Study||24
7529132|NCT03467412|18538193|P1|COMPLETED|Overall Study||22
7529133|NCT03467412|18538189|P5|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|20
7529134|NCT03467412|18538190|P4|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
7529135|NCT03467412|18538191|P3|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
7529136|NCT03467412|18538192|P2|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
7529137|NCT03467412|18538193|P1|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
7529138|NCT03467048|18538228|P2|NOT COMPLETED|Overall Study||1
7529139|NCT03467048|18538229|P1|NOT COMPLETED|Overall Study||0
7529140|NCT03467048|18538228|P2|COMPLETED|Overall Study||63
7529141|NCT03467048|18538229|P1|COMPLETED|Overall Study||66
7529142|NCT03467048|18538228|P2|STARTED|Overall Study||64
7529143|NCT03467048|18538229|P1|STARTED|Overall Study||66
7529144|NCT03466918|18538239|P1|NOT COMPLETED|Overall Study||0
7529145|NCT03466918|18538239|P1|COMPLETED|Overall Study|All 58 patients completed the 30-day primary endpoint.|58
7529146|NCT03466918|18538239|P1|Analysis Population|Overall Study||50
7529147|NCT03466918|18538239|P1|STARTED|Overall Study||58
7529148|NCT03466658|18538246|P1|NOT COMPLETED|Overall Study||3
7529149|NCT03466658|18538246|P1|COMPLETED|Overall Study||14
7529150|NCT03466658|18538246|P1|STARTED|Overall Study||17
7529151|NCT03466099|18538255|P3|NOT COMPLETED|Overall Study||17
7529152|NCT03466099|18538256|P2|NOT COMPLETED|Overall Study||14
7529153|NCT03466099|18538257|P1|NOT COMPLETED|Overall Study||17
7529154|NCT03466099|18538255|P3|COMPLETED|Overall Study||28
7529155|NCT03466099|18538256|P2|COMPLETED|Overall Study||30
7529156|NCT03466099|18538257|P1|COMPLETED|Overall Study||24
7529157|NCT03466099|18538255|P3|Treated|Overall Study||44
7529158|NCT03466099|18538256|P2|Treated|Overall Study||44
7529159|NCT03466099|18538257|P1|Treated|Overall Study||41
7529160|NCT03466099|18538255|P3|STARTED|Overall Study|One study subject consented and was randomized, but withdrew prior to receiving any study treatments|45
7529161|NCT03466099|18538256|P2|STARTED|Overall Study||44
7529162|NCT03466099|18538257|P1|STARTED|Overall Study||41
7529163|NCT03466086|18538271|P2|NOT COMPLETED|Period 2||0
7529164|NCT03466086|18538272|P1|NOT COMPLETED|Period 2||0
7529165|NCT03466086|18538271|P2|COMPLETED|Period 2||27
7529166|NCT03466086|18538272|P1|COMPLETED|Period 2||26
7529167|NCT03466086|18538271|P2|STARTED|Period 2||27
7529168|NCT03466086|18538272|P1|STARTED|Period 2||26
7529169|NCT03466086|18538271|P2|NOT COMPLETED|Period 1||0
7529170|NCT03466086|18538272|P1|NOT COMPLETED|Period 1||2
7529171|NCT03466086|18538271|P2|COMPLETED|Period 1||27
7529172|NCT03466086|18538272|P1|COMPLETED|Period 1||26
7529173|NCT03466086|18538271|P2|STARTED|Period 1||27
7529174|NCT03466086|18538272|P1|STARTED|Period 1||28
7529175|NCT03466073|18538286|P6|NOT COMPLETED|Overall Study||1
7529176|NCT03466073|18538287|P5|NOT COMPLETED|Overall Study||0
7529177|NCT03466073|18538288|P4|NOT COMPLETED|Overall Study||0
7529178|NCT03466073|18538289|P3|NOT COMPLETED|Overall Study||0
7529179|NCT03466073|18538290|P2|NOT COMPLETED|Overall Study||0
7529180|NCT03466073|18538291|P1|NOT COMPLETED|Overall Study||1
7529181|NCT03466073|18538286|P6|COMPLETED|Overall Study||6
7529182|NCT03466073|18538287|P5|COMPLETED|Overall Study||6
7529183|NCT03466073|18538288|P4|COMPLETED|Overall Study||6
7529184|NCT03466073|18538289|P3|COMPLETED|Overall Study||6
7529185|NCT03466073|18538290|P2|COMPLETED|Overall Study||2
7529186|NCT03466073|18538291|P1|COMPLETED|Overall Study||5
7529187|NCT03466073|18538286|P6|STARTED|Overall Study||7
7529188|NCT03466073|18538287|P5|STARTED|Overall Study||6
7529189|NCT03466073|18538288|P4|STARTED|Overall Study||6
7529190|NCT03466073|18538289|P3|STARTED|Overall Study||6
7529191|NCT03466073|18538290|P2|STARTED|Overall Study||2
7529192|NCT03466073|18538291|P1|STARTED|Overall Study||6
7529193|NCT03466060|18538324|P6|NOT COMPLETED|Period 2||0
7529194|NCT03466060|18538325|P5|NOT COMPLETED|Period 2||0
7529195|NCT03466060|18538326|P4|NOT COMPLETED|Period 2||0
7529196|NCT03466060|18538327|P3|NOT COMPLETED|Period 2||1
7529197|NCT03466060|18538328|P2|NOT COMPLETED|Period 2||0
7529198|NCT03466060|18538329|P1|NOT COMPLETED|Period 2||0
7529199|NCT03466060|18538324|P6|COMPLETED|Period 2||18
7529200|NCT03466060|18538325|P5|COMPLETED|Period 2||20
7529201|NCT03466060|18538326|P4|COMPLETED|Period 2||17
7529202|NCT03466060|18538327|P3|COMPLETED|Period 2||16
7529203|NCT03466060|18538328|P2|COMPLETED|Period 2||16
7529204|NCT03466060|18538329|P1|COMPLETED|Period 2||19
7529205|NCT03466060|18538324|P6|STARTED|Period 2||18
7529206|NCT03466060|18538325|P5|STARTED|Period 2||20
7529207|NCT03466060|18538326|P4|STARTED|Period 2||17
7529208|NCT03466060|18538327|P3|STARTED|Period 2||17
7529209|NCT03466060|18538328|P2|STARTED|Period 2||16
7529210|NCT03466060|18538329|P1|STARTED|Period 2||19
7529211|NCT03466060|18538324|P6|NOT COMPLETED|Period 1||0
7529212|NCT03466060|18538325|P5|NOT COMPLETED|Period 1||0
7529213|NCT03466060|18538326|P4|NOT COMPLETED|Period 1||1
7529214|NCT03466060|18538327|P3|NOT COMPLETED|Period 1||3
7529215|NCT03466060|18538328|P2|NOT COMPLETED|Period 1||2
7529216|NCT03466060|18538329|P1|NOT COMPLETED|Period 1||0
7529217|NCT03466060|18538324|P6|COMPLETED|Period 1||18
7529218|NCT03466060|18538325|P5|COMPLETED|Period 1||20
7529219|NCT03466060|18538326|P4|COMPLETED|Period 1||17
7529220|NCT03466060|18538327|P3|COMPLETED|Period 1||17
7529221|NCT03466060|18538328|P2|COMPLETED|Period 1||16
7529222|NCT03466060|18538329|P1|COMPLETED|Period 1||19
7529223|NCT03466060|18538324|P6|STARTED|Period 1||18
7529224|NCT03466060|18538325|P5|STARTED|Period 1||20
7529225|NCT03466060|18538326|P4|STARTED|Period 1||18
7529226|NCT03466060|18538327|P3|STARTED|Period 1||20
7529227|NCT03466060|18538328|P2|STARTED|Period 1||18
7529228|NCT03466060|18538329|P1|STARTED|Period 1||19
7529229|NCT03466047|18538343|P1|NOT COMPLETED|Fat Small Intestine (1 Day)||0
7529230|NCT03466047|18538343|P1|COMPLETED|Fat Small Intestine (1 Day)||8
7529231|NCT03466047|18538343|P1|STARTED|Fat Small Intestine (1 Day)||8
7529232|NCT03466047|18538343|P1|NOT COMPLETED|Fat Stomach (1 Day)||0
7529233|NCT03466047|18538343|P1|COMPLETED|Fat Stomach (1 Day)||8
7529234|NCT03466047|18538343|P1|STARTED|Fat Stomach (1 Day)||8
7529235|NCT03466047|18538343|P1|NOT COMPLETED|CHO Small Intestine (1 Day)||0
7529236|NCT03466047|18538343|P1|COMPLETED|CHO Small Intestine (1 Day)||8
7529237|NCT03466047|18538343|P1|STARTED|CHO Small Intestine (1 Day)||8
7529238|NCT03466047|18538343|P1|NOT COMPLETED|CHO Stomach (1 Day)||0
7529239|NCT03466047|18538343|P1|COMPLETED|CHO Stomach (1 Day)||8
7529240|NCT03466047|18538343|P1|STARTED|CHO Stomach (1 Day)||8
7529241|NCT03466047|18538343|P1|NOT COMPLETED|Protein Small Intestine (1 Day)||0
7529242|NCT03466047|18538343|P1|COMPLETED|Protein Small Intestine (1 Day)||8
7529243|NCT03466047|18538343|P1|STARTED|Protein Small Intestine (1 Day)||8
7529244|NCT03466047|18538343|P1|NOT COMPLETED|Protein Stomach (1day)||0
7529245|NCT03466047|18538343|P1|COMPLETED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
7529246|NCT03466047|18538343|P1|STARTED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
7529247|NCT03465904|18538371|P2|NOT COMPLETED|Overall Study||66
7529248|NCT03465904|18538372|P1|NOT COMPLETED|Overall Study||89
7529249|NCT03465904|18538371|P2|COMPLETED|Overall Study||237
7529250|NCT03465904|18538372|P1|COMPLETED|Overall Study||209
7529251|NCT03465904|18538371|P2|STARTED|Overall Study||303
7529252|NCT03465904|18538372|P1|STARTED|Overall Study||298
7529253|NCT03465878|18538392|P4|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
7529254|NCT03465878|18538393|P3|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
7529255|NCT03465878|18538394|P2|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
7529256|NCT03465878|18538395|P1|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
7529257|NCT03465878|18538392|P4|COMPLETED|Period2-Part B Second Intervention Day 1||17
7529258|NCT03465878|18538393|P3|COMPLETED|Period2-Part B Second Intervention Day 1||20
7529259|NCT03465878|18538394|P2|COMPLETED|Period2-Part B Second Intervention Day 1||0
7529260|NCT03465878|18538395|P1|COMPLETED|Period2-Part B Second Intervention Day 1||0
7529261|NCT03465878|18538392|P4|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||5
7529262|NCT03465878|18538393|P3|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||7
7529263|NCT03465878|18538394|P2|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
7529264|NCT03465878|18538395|P1|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
7529265|NCT03465878|18538392|P4|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||6
7529266|NCT03465878|18538393|P3|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||7
7529267|NCT03465878|18538394|P2|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
7529268|NCT03465878|18538395|P1|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
7529269|NCT03465878|18538392|P4|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
7529270|NCT03465878|18538393|P3|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
7529271|NCT03465878|18538394|P2|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
7529272|NCT03465878|18538395|P1|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
7529273|NCT03465878|18538392|P4|STARTED|Period2-Part B Second Intervention Day 1||17
7529274|NCT03465878|18538393|P3|STARTED|Period2-Part B Second Intervention Day 1||20
7529275|NCT03465878|18538394|P2|STARTED|Period2-Part B Second Intervention Day 1||0
7529276|NCT03465878|18538395|P1|STARTED|Period2-Part B Second Intervention Day 1||0
7529277|NCT03465878|18538392|P4|NOT COMPLETED|Period 1-Part B First Intervention Day 1||2
7529278|NCT03465878|18538393|P3|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
7529279|NCT03465878|18538394|P2|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
7529280|NCT03465878|18538395|P1|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
7529281|NCT03465878|18538392|P4|COMPLETED|Period 1-Part B First Intervention Day 1||17
7529282|NCT03465878|18538393|P3|COMPLETED|Period 1-Part B First Intervention Day 1||20
7529283|NCT03465878|18538394|P2|COMPLETED|Period 1-Part B First Intervention Day 1||0
7529284|NCT03465878|18538395|P1|COMPLETED|Period 1-Part B First Intervention Day 1||0
7529285|NCT03465878|18538392|P4|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||5
7529286|NCT03465878|18538393|P3|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||7
7529287|NCT03465878|18538394|P2|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
7529288|NCT03465878|18538395|P1|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
7529289|NCT03465878|18538392|P4|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||6
7529290|NCT03465878|18538393|P3|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||7
7529291|NCT03465878|18538394|P2|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
7529292|NCT03465878|18538395|P1|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
7529293|NCT03465878|18538392|P4|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
7529294|NCT03465878|18538393|P3|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
7529295|NCT03465878|18538394|P2|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
7529296|NCT03465878|18538395|P1|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
7529297|NCT03465878|18538392|P4|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||17
7529298|NCT03465878|18538393|P3|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||20
7529299|NCT03465878|18538394|P2|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
7529300|NCT03465878|18538395|P1|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
7529301|NCT03465878|18538392|P4|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|19
7529302|NCT03465878|18538393|P3|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|20
7529303|NCT03465878|18538394|P2|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
7529304|NCT03465878|18538395|P1|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
7529305|NCT03465878|18538392|P4|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
7529306|NCT03465878|18538393|P3|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
7529307|NCT03465878|18538394|P2|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
7529308|NCT03465878|18538395|P1|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
7529309|NCT03465878|18538392|P4|COMPLETED|Period2-Part A Second Intervention Day 1||0
7529310|NCT03465878|18538393|P3|COMPLETED|Period2-Part A Second Intervention Day 1||0
7529311|NCT03465878|18538394|P2|COMPLETED|Period2-Part A Second Intervention Day 1||20
7529312|NCT03465878|18538395|P1|COMPLETED|Period2-Part A Second Intervention Day 1||21
7529313|NCT03465878|18538392|P4|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
7529314|NCT03465878|18538393|P3|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
7529315|NCT03465878|18538394|P2|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
7529316|NCT03465878|18538395|P1|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
7529317|NCT03465878|18538392|P4|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
7529318|NCT03465878|18538393|P3|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
7529319|NCT03465878|18538394|P2|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
7529320|NCT03465878|18538395|P1|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
7529321|NCT03465878|18538392|P4|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
7529322|NCT03465878|18538393|P3|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
7529323|NCT03465878|18538394|P2|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||6
7529324|NCT03465878|18538395|P1|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||7
7529325|NCT03465878|18538392|P4|STARTED|Period2-Part A Second Intervention Day 1||0
7529326|NCT03465878|18538393|P3|STARTED|Period2-Part A Second Intervention Day 1||0
7529327|NCT03465878|18538394|P2|STARTED|Period2-Part A Second Intervention Day 1||20
7529328|NCT03465878|18538395|P1|STARTED|Period2-Part A Second Intervention Day 1||21
7529329|NCT03465878|18538392|P4|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
7529330|NCT03465878|18538393|P3|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
7529331|NCT03465878|18538394|P2|NOT COMPLETED|Period 1-Part A First Intervention Day 1||1
7529332|NCT03465878|18538395|P1|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
7529333|NCT03465878|18538392|P4|COMPLETED|Period 1-Part A First Intervention Day 1||0
7529334|NCT03465878|18538393|P3|COMPLETED|Period 1-Part A First Intervention Day 1||0
7529335|NCT03465878|18538394|P2|COMPLETED|Period 1-Part A First Intervention Day 1||20
7529336|NCT03465878|18538395|P1|COMPLETED|Period 1-Part A First Intervention Day 1||21
7529337|NCT03465878|18538392|P4|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
7529338|NCT03465878|18538393|P3|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
7529339|NCT03465878|18538394|P2|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||8
7529340|NCT03465878|18538395|P1|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||7
7529341|NCT03465878|18538392|P4|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
7529342|NCT03465878|18538393|P3|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
7529343|NCT03465878|18538394|P2|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
7529344|NCT03465878|18538395|P1|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
7529345|NCT03465878|18538392|P4|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
7529346|NCT03465878|18538393|P3|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
7529347|NCT03465878|18538394|P2|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||6
7529348|NCT03465878|18538395|P1|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||7
7529349|NCT03465878|18538392|P4|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
7529350|NCT03465878|18538393|P3|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
7529351|NCT03465878|18538394|P2|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
7529352|NCT03465878|18538395|P1|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
7529353|NCT03465878|18538392|P4|STARTED|Period 1-Part A First Intervention Day 1||0
7529354|NCT03465878|18538393|P3|STARTED|Period 1-Part A First Intervention Day 1||0
7529355|NCT03465878|18538394|P2|STARTED|Period 1-Part A First Intervention Day 1||21
7529356|NCT03465878|18538395|P1|STARTED|Period 1-Part A First Intervention Day 1||21
7529357|NCT03465735|18538435|P2|NOT COMPLETED|Overall Study||2
7529358|NCT03465735|18538436|P1|NOT COMPLETED|Overall Study||1
7529359|NCT03465735|18538435|P2|COMPLETED|Overall Study||5
7529360|NCT03465735|18538436|P1|COMPLETED|Overall Study||7
7529361|NCT03465735|18538435|P2|STARTED|Overall Study||7
7529362|NCT03465735|18538436|P1|STARTED|Overall Study||8
7529363|NCT03465709|18538442|P1|NOT COMPLETED|Overall Study||17
7529364|NCT03465709|18538442|P1|COMPLETED|Overall Study||0
7529365|NCT03465709|18538442|P1|STARTED|Overall Study||17
7529366|NCT03465436|18538454|P4|NOT COMPLETED|Period 4||0
7529367|NCT03465436|18538455|P3|NOT COMPLETED|Period 4||1
7529368|NCT03465436|18538456|P2|NOT COMPLETED|Period 4||0
7529369|NCT03465436|18538457|P1|NOT COMPLETED|Period 4||0
7529370|NCT03465436|18538454|P4|COMPLETED|Period 4||14
7529371|NCT03465436|18538455|P3|COMPLETED|Period 4||12
7529372|NCT03465436|18538456|P2|COMPLETED|Period 4||12
7529373|NCT03465436|18538457|P1|COMPLETED|Period 4||13
7529374|NCT03465436|18538454|P4|Received at Least 1 Dose of Study Drug|Period 4||14
7529375|NCT03465436|18538455|P3|Received at Least 1 Dose of Study Drug|Period 4||13
7529376|NCT03465436|18538456|P2|Received at Least 1 Dose of Study Drug|Period 4||12
7529377|NCT03465436|18538457|P1|Received at Least 1 Dose of Study Drug|Period 4||13
7529378|NCT03465436|18538454|P4|STARTED|Period 4||14
7529379|NCT03465436|18538455|P3|STARTED|Period 4||13
7529380|NCT03465436|18538456|P2|STARTED|Period 4||12
7529381|NCT03465436|18538457|P1|STARTED|Period 4||13
7529382|NCT03465436|18538454|P4|NOT COMPLETED|Period 3||0
7529383|NCT03465436|18538455|P3|NOT COMPLETED|Period 3||0
7529384|NCT03465436|18538456|P2|NOT COMPLETED|Period 3||1
7529385|NCT03465436|18538457|P1|NOT COMPLETED|Period 3||1
7529386|NCT03465436|18538454|P4|COMPLETED|Period 3||14
7529387|NCT03465436|18538455|P3|COMPLETED|Period 3||13
7529388|NCT03465436|18538456|P2|COMPLETED|Period 3||12
7529389|NCT03465436|18538457|P1|COMPLETED|Period 3||13
7529390|NCT03465436|18538454|P4|Received at Least One Dose of Study Drug|Period 3||14
7529391|NCT03465436|18538455|P3|Received at Least One Dose of Study Drug|Period 3||13
7529392|NCT03465436|18538456|P2|Received at Least One Dose of Study Drug|Period 3||12
7529393|NCT03465436|18538457|P1|Received at Least One Dose of Study Drug|Period 3||13
7529394|NCT03465436|18538454|P4|STARTED|Period 3||14
7529395|NCT03465436|18538455|P3|STARTED|Period 3||13
7529396|NCT03465436|18538456|P2|STARTED|Period 3||13
7529397|NCT03465436|18538457|P1|STARTED|Period 3||14
7529398|NCT03465436|18538454|P4|NOT COMPLETED|Period 2||0
7529399|NCT03465436|18538455|P3|NOT COMPLETED|Period 2||0
7529400|NCT03465436|18538456|P2|NOT COMPLETED|Period 2||1
7529401|NCT03465436|18538457|P1|NOT COMPLETED|Period 2||0
7529402|NCT03465436|18538454|P4|COMPLETED|Period 2||14
7529403|NCT03465436|18538455|P3|COMPLETED|Period 2||13
7529404|NCT03465436|18538456|P2|COMPLETED|Period 2||13
7529405|NCT03465436|18538457|P1|COMPLETED|Period 2||14
7529406|NCT03465436|18538454|P4|Received at Least 1 Dose of Study Drug|Period 2||14
7529407|NCT03465436|18538455|P3|Received at Least 1 Dose of Study Drug|Period 2||13
7529408|NCT03465436|18538456|P2|Received at Least 1 Dose of Study Drug|Period 2||13
7529409|NCT03465436|18538457|P1|Received at Least 1 Dose of Study Drug|Period 2||14
7529410|NCT03465436|18538454|P4|STARTED|Period 2||14
7529411|NCT03465436|18538455|P3|STARTED|Period 2||13
7529412|NCT03465436|18538456|P2|STARTED|Period 2||14
7529413|NCT03465436|18538457|P1|STARTED|Period 2||14
7529414|NCT03465436|18538454|P4|NOT COMPLETED|Period 1||0
7529415|NCT03465436|18538455|P3|NOT COMPLETED|Period 1||1
7529416|NCT03465436|18538456|P2|NOT COMPLETED|Period 1||0
7529417|NCT03465436|18538457|P1|NOT COMPLETED|Period 1||0
7529418|NCT03465436|18538454|P4|COMPLETED|Period 1||14
7529419|NCT03465436|18538455|P3|COMPLETED|Period 1||13
7529420|NCT03465436|18538456|P2|COMPLETED|Period 1||14
7529421|NCT03465436|18538457|P1|COMPLETED|Period 1||14
7529422|NCT03465436|18538454|P4|Received at Least 1 Dose of Study Drug|Period 1||14
7529423|NCT03465436|18538455|P3|Received at Least 1 Dose of Study Drug|Period 1||14
7529424|NCT03465436|18538456|P2|Received at Least 1 Dose of Study Drug|Period 1||14
7529425|NCT03465436|18538457|P1|Received at Least 1 Dose of Study Drug|Period 1||14
7529426|NCT03465436|18538454|P4|STARTED|Period 1||14
7529427|NCT03465436|18538455|P3|STARTED|Period 1||14
7529428|NCT03465436|18538456|P2|STARTED|Period 1||14
7529429|NCT03465436|18538457|P1|STARTED|Period 1||14
7529430|NCT03464383|18538494|P3|NOT COMPLETED|Overall Study||0
7529431|NCT03464383|18538495|P2|NOT COMPLETED|Overall Study||1
7529432|NCT03464383|18538496|P1|NOT COMPLETED|Overall Study||1
7529433|NCT03464383|18538494|P3|COMPLETED|Overall Study||63
7529434|NCT03464383|18538495|P2|COMPLETED|Overall Study||2
7529435|NCT03464383|18538496|P1|COMPLETED|Overall Study||2
7529436|NCT03464383|18538494|P3|STARTED|Overall Study||63
7529437|NCT03464383|18538495|P2|STARTED|Overall Study||3
7529438|NCT03464383|18538496|P1|STARTED|Overall Study||3
7529439|NCT03463941|18538521|P1|NOT COMPLETED|Overall Study||18
7529440|NCT03463941|18538521|P1|COMPLETED|Overall Study||62
7529441|NCT03463941|18538521|P1|STARTED|Overall Study||80
7529442|NCT03463512|18538533|P2|NOT COMPLETED|Overall Study||0
7529443|NCT03463512|18538534|P1|NOT COMPLETED|Overall Study||0
7529444|NCT03463512|18538533|P2|COMPLETED|Overall Study||62
7529445|NCT03463512|18538534|P1|COMPLETED|Overall Study||62
7529446|NCT03463512|18538533|P2|STARTED|Overall Study||62
7529447|NCT03463512|18538534|P1|STARTED|Overall Study||62
7529448|NCT03463161|18538544|P1|NOT COMPLETED|Overall Study||0
7529449|NCT03463161|18538544|P1|COMPLETED|Overall Study||2
7529450|NCT03463161|18538544|P1|STARTED|Overall Study||2
7529451|NCT03463031|18538553|P2|NOT COMPLETED|Overall Study||5
7529452|NCT03463031|18538554|P1|NOT COMPLETED|Overall Study||10
7529453|NCT03463031|18538553|P2|COMPLETED|Overall Study||216
7529454|NCT03463031|18538554|P1|COMPLETED|Overall Study||215
7529455|NCT03463031|18538553|P2|STARTED|Overall Study||221
7529456|NCT03463031|18538554|P1|STARTED|Overall Study||225
7529457|NCT03462927|18538568|P2|NOT COMPLETED|Overall Study||2
7529458|NCT03462927|18538569|P1|NOT COMPLETED|Overall Study||6
7529459|NCT03462927|18538568|P2|COMPLETED|Overall Study||29
7529460|NCT03462927|18538569|P1|COMPLETED|Overall Study||26
7529461|NCT03462927|18538568|P2|STARTED|Overall Study||31
7529462|NCT03462927|18538569|P1|STARTED|Overall Study||32
7529463|NCT03462745|18538595|P2|NOT COMPLETED|Overall Study||0
7529464|NCT03462745|18538596|P1|NOT COMPLETED|Overall Study||0
7529465|NCT03462745|18538595|P2|COMPLETED|Overall Study||92
7529466|NCT03462745|18538596|P1|COMPLETED|Overall Study||92
7529467|NCT03462745|18538595|P2|STARTED|Overall Study||92
7529468|NCT03462745|18538596|P1|STARTED|Overall Study||92
7529469|NCT03461757|18538604|P2|NOT COMPLETED|Overall Study||45
7529470|NCT03461757|18538605|P1|NOT COMPLETED|Overall Study||53
7529471|NCT03461757|18538604|P2|COMPLETED|Overall Study||689
7529472|NCT03461757|18538605|P1|COMPLETED|Overall Study||679
7529473|NCT03461757|18538604|P2|Treated|Overall Study||693
7529474|NCT03461757|18538605|P1|Treated|Overall Study||682
7529475|NCT03461757|18538604|P2|STARTED|Overall Study||734
7529476|NCT03461757|18538605|P1|STARTED|Overall Study||732
7529477|NCT03461705|18538655|P1|NOT COMPLETED|Overall Study||0
7529478|NCT03461705|18538655|P1|COMPLETED|Overall Study||5
7529479|NCT03461705|18538655|P1|STARTED|Overall Study||5
7529480|NCT03460990|18538668|P2|NOT COMPLETED|Overall Study||0
7529481|NCT03460990|18538669|P1|NOT COMPLETED|Overall Study||0
7529482|NCT03460990|18538668|P2|COMPLETED|Overall Study||54
7529483|NCT03460990|18538669|P1|COMPLETED|Overall Study||57
7529484|NCT03460990|18538668|P2|STARTED|Overall Study||54
7529485|NCT03460990|18538669|P1|STARTED|Overall Study||57
7529486|NCT03460899|18538683|P1|NOT COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp||0
7529487|NCT03460899|18538683|P1|COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp|Last Hyperinsulinaemic/Hypoglycaemic Clamp completed: 05. June 2018|14
7529488|NCT03460899|18538683|P1|STARTED|Hyperinsulinaemic/Hypoglycaemic Clamp|First Hyperinsulinaemic/Hypoglycaemic Clamp completed: 15. March 2018|14
7529489|NCT03460899|18538683|P1|NOT COMPLETED|Euglycaemic Clamp||0
7529490|NCT03460899|18538683|P1|COMPLETED|Euglycaemic Clamp|Last Euglycaemic clamp completed: 23. May 2018|14
7529491|NCT03460899|18538683|P1|STARTED|Euglycaemic Clamp|First Euglycaemic Clamp completed: 05. March 2018|14
7529492|NCT03460587|18538690|P1|NOT COMPLETED|Overall Study||0
7529493|NCT03460587|18538690|P1|COMPLETED|Overall Study||13
7529494|NCT03460587|18538690|P1|STARTED|Overall Study||13
7529495|NCT03459794|18538697|P2|NOT COMPLETED|Overall Study||0
7529496|NCT03459794|18538698|P1|NOT COMPLETED|Overall Study||0
7529497|NCT03459794|18538697|P2|COMPLETED|Overall Study||4
7529498|NCT03459794|18538698|P1|COMPLETED|Overall Study||8
7529499|NCT03459794|18538697|P2|STARTED|Overall Study||4
7529500|NCT03459794|18538698|P1|STARTED|Overall Study||8
7529501|NCT03459612|18538718|P4|NOT COMPLETED|Period 4||0
7529502|NCT03459612|18538719|P3|NOT COMPLETED|Period 4||0
7529503|NCT03459612|18538720|P2|NOT COMPLETED|Period 4||0
7529504|NCT03459612|18538721|P1|NOT COMPLETED|Period 4||0
7529505|NCT03459612|18538718|P4|COMPLETED|Period 4||17
7529506|NCT03459612|18538719|P3|COMPLETED|Period 4||16
7529507|NCT03459612|18538720|P2|COMPLETED|Period 4||17
7529508|NCT03459612|18538721|P1|COMPLETED|Period 4||17
7529509|NCT03459612|18538718|P4|Received at Least 1 Dose of Study Drug|Period 4||17
7529510|NCT03459612|18538719|P3|Received at Least 1 Dose of Study Drug|Period 4||16
7529511|NCT03459612|18538720|P2|Received at Least 1 Dose of Study Drug|Period 4||17
7529512|NCT03459612|18538721|P1|Received at Least 1 Dose of Study Drug|Period 4||17
7529513|NCT03459612|18538718|P4|STARTED|Period 4||17
7529514|NCT03459612|18538719|P3|STARTED|Period 4|One participant completed period 3 and withdrew for personal reasons prior to Period 4.|16
7529515|NCT03459612|18538720|P2|STARTED|Period 4||17
7529516|NCT03459612|18538721|P1|STARTED|Period 4||17
7529517|NCT03459612|18538718|P4|NOT COMPLETED|Period 3||0
7529518|NCT03459612|18538719|P3|NOT COMPLETED|Period 3||0
7529519|NCT03459612|18538720|P2|NOT COMPLETED|Period 3||0
7529520|NCT03459612|18538721|P1|NOT COMPLETED|Period 3||0
7529521|NCT03459612|18538718|P4|COMPLETED|Period 3||17
7529522|NCT03459612|18538719|P3|COMPLETED|Period 3||17
7529523|NCT03459612|18538720|P2|COMPLETED|Period 3||17
7529524|NCT03459612|18538721|P1|COMPLETED|Period 3||17
7529525|NCT03459612|18538718|P4|Received at Least 1 Dose of Study Drug|Period 3||17
7529526|NCT03459612|18538719|P3|Received at Least 1 Dose of Study Drug|Period 3||17
7529527|NCT03459612|18538720|P2|Received at Least 1 Dose of Study Drug|Period 3||17
7529528|NCT03459612|18538721|P1|Received at Least 1 Dose of Study Drug|Period 3||17
7529529|NCT03459612|18538718|P4|STARTED|Period 3||17
7529530|NCT03459612|18538719|P3|STARTED|Period 3||17
7529531|NCT03459612|18538720|P2|STARTED|Period 3||17
7529532|NCT03459612|18538721|P1|STARTED|Period 3||17
7529533|NCT03459612|18538718|P4|NOT COMPLETED|Period 2||0
7529534|NCT03459612|18538719|P3|NOT COMPLETED|Period 2||0
7529535|NCT03459612|18538720|P2|NOT COMPLETED|Period 2||0
7529536|NCT03459612|18538721|P1|NOT COMPLETED|Period 2||0
7529537|NCT03459612|18538718|P4|COMPLETED|Period 2||17
7529538|NCT03459612|18538719|P3|COMPLETED|Period 2||17
7529539|NCT03459612|18538720|P2|COMPLETED|Period 2||17
7529540|NCT03459612|18538721|P1|COMPLETED|Period 2||17
7529541|NCT03459612|18538718|P4|Received at Least 1 Dose of Study Drug|Period 2||17
7529542|NCT03459612|18538719|P3|Received at Least 1 Dose of Study Drug|Period 2||17
7529543|NCT03459612|18538720|P2|Received at Least 1 Dose of Study Drug|Period 2||17
7529544|NCT03459612|18538721|P1|Received at Least 1 Dose of Study Drug|Period 2||17
7529545|NCT03459612|18538718|P4|STARTED|Period 2||17
7529546|NCT03459612|18538719|P3|STARTED|Period 2||17
7529547|NCT03459612|18538720|P2|STARTED|Period 2||17
7529548|NCT03459612|18538721|P1|STARTED|Period 2||17
7529549|NCT03459612|18538718|P4|NOT COMPLETED|Period 1||0
7529550|NCT03459612|18538719|P3|NOT COMPLETED|Period 1||0
7529551|NCT03459612|18538720|P2|NOT COMPLETED|Period 1||0
7529552|NCT03459612|18538721|P1|NOT COMPLETED|Period 1||0
7529553|NCT03459612|18538718|P4|COMPLETED|Period 1||17
7529554|NCT03459612|18538719|P3|COMPLETED|Period 1||17
7529555|NCT03459612|18538720|P2|COMPLETED|Period 1||17
7529556|NCT03459612|18538721|P1|COMPLETED|Period 1||17
7529557|NCT03459612|18538718|P4|Received at Least 1 Dose of Study Drug|Period 1||17
7529558|NCT03459612|18538719|P3|Received at Least 1 Dose of Study Drug|Period 1||17
7529559|NCT03459612|18538720|P2|Received at Least 1 Dose of Study Drug|Period 1||17
7529560|NCT03459612|18538721|P1|Received at Least 1 Dose of Study Drug|Period 1||17
7529561|NCT03459612|18538718|P4|STARTED|Period 1||17
7529562|NCT03459612|18538719|P3|STARTED|Period 1||17
7529563|NCT03459612|18538720|P2|STARTED|Period 1||17
7529564|NCT03459612|18538721|P1|STARTED|Period 1||17
7529565|NCT03459196|18538779|P1|NOT COMPLETED|Overall Study||2
7529566|NCT03459196|18538779|P1|COMPLETED|Overall Study||52
7529567|NCT03459196|18538779|P1|STARTED|Overall Study||54
7529568|NCT03459131|18538784|P2|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
7529569|NCT03459131|18538785|P1|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
7529570|NCT03459131|18538784|P2|COMPLETED|Period 2, Second 7 Days of Wear||8
7529571|NCT03459131|18538785|P1|COMPLETED|Period 2, Second 7 Days of Wear||7
7529572|NCT03459131|18538784|P2|STARTED|Period 2, Second 7 Days of Wear||8
7529573|NCT03459131|18538785|P1|STARTED|Period 2, Second 7 Days of Wear||7
7529574|NCT03459131|18538784|P2|NOT COMPLETED|Period 1, First 7 Days of Wear||0
7529575|NCT03459131|18538785|P1|NOT COMPLETED|Period 1, First 7 Days of Wear||0
7529576|NCT03459131|18538784|P2|COMPLETED|Period 1, First 7 Days of Wear||8
7529577|NCT03459131|18538785|P1|COMPLETED|Period 1, First 7 Days of Wear||7
7529578|NCT03459131|18538784|P2|STARTED|Period 1, First 7 Days of Wear||8
7529579|NCT03459131|18538785|P1|STARTED|Period 1, First 7 Days of Wear||7
7529580|NCT03458871|18538793|P1|NOT COMPLETED|Overall Study||0
7529581|NCT03458871|18538793|P1|COMPLETED|Overall Study||16
7529582|NCT03458871|18538793|P1|STARTED|Overall Study||16
7529583|NCT03458702|18538823|P2|NOT COMPLETED|Picture Rating/Body Composition||0
7529584|NCT03458702|18538824|P1|NOT COMPLETED|Picture Rating/Body Composition||0
7529585|NCT03458702|18538823|P2|COMPLETED|Picture Rating/Body Composition||20
7529586|NCT03458702|18538824|P1|COMPLETED|Picture Rating/Body Composition||20
7529587|NCT03458702|18538823|P2|STARTED|Picture Rating/Body Composition||20
7529588|NCT03458702|18538824|P1|STARTED|Picture Rating/Body Composition||20
7529589|NCT03458702|18538823|P2|NOT COMPLETED|Study Condition B (Yoga or Rest)||2
7529590|NCT03458702|18538824|P1|NOT COMPLETED|Study Condition B (Yoga or Rest)||4
7529591|NCT03458702|18538823|P2|COMPLETED|Study Condition B (Yoga or Rest)||20
7529592|NCT03458702|18538824|P1|COMPLETED|Study Condition B (Yoga or Rest)||20
7529593|NCT03458702|18538823|P2|STARTED|Study Condition B (Yoga or Rest)||22
7529594|NCT03458702|18538824|P1|STARTED|Study Condition B (Yoga or Rest)||24
7529595|NCT03458702|18538823|P2|NOT COMPLETED|Study Condition A (Yoga or Rest)||6
7529596|NCT03458702|18538824|P1|NOT COMPLETED|Study Condition A (Yoga or Rest)||4
7529597|NCT03458702|18538823|P2|COMPLETED|Study Condition A (Yoga or Rest)||22
7529598|NCT03458702|18538824|P1|COMPLETED|Study Condition A (Yoga or Rest)||24
7529599|NCT03458702|18538823|P2|STARTED|Study Condition A (Yoga or Rest)||28
7529600|NCT03458702|18538824|P1|STARTED|Study Condition A (Yoga or Rest)||28
7529601|NCT03457909|18538840|P1|NOT COMPLETED|Overall Study||0
7529602|NCT03457909|18538840|P1|COMPLETED|Overall Study||25
7529603|NCT03457909|18538840|P1|STARTED|Overall Study||25
7529604|NCT03457727|18538853|P4|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
7529605|NCT03457727|18538854|P3|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
7529606|NCT03457727|18538855|P2|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
7529607|NCT03457727|18538856|P1|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
7529608|NCT03457727|18538853|P4|COMPLETED|Part 2, Period 4 (1 Day)||0
7529609|NCT03457727|18538854|P3|COMPLETED|Part 2, Period 4 (1 Day)||12
7529610|NCT03457727|18538855|P2|COMPLETED|Part 2, Period 4 (1 Day)||0
7529611|NCT03457727|18538856|P1|COMPLETED|Part 2, Period 4 (1 Day)||0
7529612|NCT03457727|18538853|P4|STARTED|Part 2, Period 4 (1 Day)||0
7529613|NCT03457727|18538854|P3|STARTED|Part 2, Period 4 (1 Day)||12
7529614|NCT03457727|18538855|P2|STARTED|Part 2, Period 4 (1 Day)||0
7529615|NCT03457727|18538856|P1|STARTED|Part 2, Period 4 (1 Day)||0
7529616|NCT03457727|18538853|P4|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
7529617|NCT03457727|18538854|P3|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
7529618|NCT03457727|18538855|P2|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
7529619|NCT03457727|18538856|P1|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
7529620|NCT03457727|18538853|P4|COMPLETED|Part 2, Washout Period 3 (5 Days)||11
7529621|NCT03457727|18538854|P3|COMPLETED|Part 2, Washout Period 3 (5 Days)||12
7529622|NCT03457727|18538855|P2|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
7529623|NCT03457727|18538856|P1|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
7529624|NCT03457727|18538853|P4|STARTED|Part 2, Washout Period 3 (5 Days)||11
7529625|NCT03457727|18538854|P3|STARTED|Part 2, Washout Period 3 (5 Days)||12
7529626|NCT03457727|18538855|P2|STARTED|Part 2, Washout Period 3 (5 Days)||0
7529627|NCT03457727|18538856|P1|STARTED|Part 2, Washout Period 3 (5 Days)||0
7529628|NCT03457727|18538853|P4|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
7529629|NCT03457727|18538854|P3|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
7529630|NCT03457727|18538855|P2|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
7529631|NCT03457727|18538856|P1|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
7529632|NCT03457727|18538853|P4|COMPLETED|Part 2, Period 3 (1 Day)||11
7529633|NCT03457727|18538854|P3|COMPLETED|Part 2, Period 3 (1 Day)||12
7529634|NCT03457727|18538855|P2|COMPLETED|Part 2, Period 3 (1 Day)||0
7529635|NCT03457727|18538856|P1|COMPLETED|Part 2, Period 3 (1 Day)||0
7529636|NCT03457727|18538853|P4|STARTED|Part 2, Period 3 (1 Day)||11
7529637|NCT03457727|18538854|P3|STARTED|Part 2, Period 3 (1 Day)||12
7529638|NCT03457727|18538855|P2|STARTED|Part 2, Period 3 (1 Day)||0
7529639|NCT03457727|18538856|P1|STARTED|Part 2, Period 3 (1 Day)||0
7529640|NCT03457727|18538853|P4|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
7529641|NCT03457727|18538854|P3|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
7529642|NCT03457727|18538855|P2|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
7529643|NCT03457727|18538856|P1|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
7529644|NCT03457727|18538853|P4|COMPLETED|Part 2, Washout Period 2 (5 Days)||11
7529645|NCT03457727|18538854|P3|COMPLETED|Part 2, Washout Period 2 (5 Days)||12
7529646|NCT03457727|18538855|P2|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
7529647|NCT03457727|18538856|P1|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
7529648|NCT03457727|18538853|P4|STARTED|Part 2, Washout Period 2 (5 Days)||11
7529649|NCT03457727|18538854|P3|STARTED|Part 2, Washout Period 2 (5 Days)||12
7529650|NCT03457727|18538855|P2|STARTED|Part 2, Washout Period 2 (5 Days)||0
7529651|NCT03457727|18538856|P1|STARTED|Part 2, Washout Period 2 (5 Days)||0
7529652|NCT03457727|18538853|P4|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
7529653|NCT03457727|18538854|P3|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
7529654|NCT03457727|18538855|P2|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
7529655|NCT03457727|18538856|P1|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
7529656|NCT03457727|18538853|P4|COMPLETED|Part 2, Period 2 (1 Day)||11
7529657|NCT03457727|18538854|P3|COMPLETED|Part 2, Period 2 (1 Day)||12
7529658|NCT03457727|18538855|P2|COMPLETED|Part 2, Period 2 (1 Day)||0
7529659|NCT03457727|18538856|P1|COMPLETED|Part 2, Period 2 (1 Day)||0
7529660|NCT03457727|18538853|P4|STARTED|Part 2, Period 2 (1 Day)||11
7529661|NCT03457727|18538854|P3|STARTED|Part 2, Period 2 (1 Day)||12
7529662|NCT03457727|18538855|P2|STARTED|Part 2, Period 2 (1 Day)||0
7529663|NCT03457727|18538856|P1|STARTED|Part 2, Period 2 (1 Day)||0
7529664|NCT03457727|18538853|P4|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||1
7529665|NCT03457727|18538854|P3|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
7529666|NCT03457727|18538855|P2|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
7529667|NCT03457727|18538856|P1|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
7529668|NCT03457727|18538853|P4|COMPLETED|Part 2, Washout Period 1 (5 Days)||11
7529669|NCT03457727|18538854|P3|COMPLETED|Part 2, Washout Period 1 (5 Days)||12
7529670|NCT03457727|18538855|P2|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
7529671|NCT03457727|18538856|P1|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
7529672|NCT03457727|18538853|P4|STARTED|Part 2, Washout Period 1 (5 Days)||12
7529673|NCT03457727|18538854|P3|STARTED|Part 2, Washout Period 1 (5 Days)||12
7529674|NCT03457727|18538855|P2|STARTED|Part 2, Washout Period 1 (5 Days)||0
7529675|NCT03457727|18538856|P1|STARTED|Part 2, Washout Period 1 (5 Days)||0
7529676|NCT03457727|18538853|P4|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
7529677|NCT03457727|18538854|P3|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
7529678|NCT03457727|18538855|P2|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
7529679|NCT03457727|18538856|P1|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
7529680|NCT03457727|18538853|P4|COMPLETED|Part 2, Period 1 (1 Day)||12
7529681|NCT03457727|18538854|P3|COMPLETED|Part 2, Period 1 (1 Day)||12
7529682|NCT03457727|18538855|P2|COMPLETED|Part 2, Period 1 (1 Day)||0
7529683|NCT03457727|18538856|P1|COMPLETED|Part 2, Period 1 (1 Day)||0
7529684|NCT03457727|18538853|P4|STARTED|Part 2, Period 1 (1 Day)||12
7529685|NCT03457727|18538854|P3|STARTED|Part 2, Period 1 (1 Day)||12
7529686|NCT03457727|18538855|P2|STARTED|Part 2, Period 1 (1 Day)||0
7529687|NCT03457727|18538856|P1|STARTED|Part 2, Period 1 (1 Day)||0
7529688|NCT03457727|18538853|P4|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
7529689|NCT03457727|18538854|P3|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
7529690|NCT03457727|18538855|P2|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
7529691|NCT03457727|18538856|P1|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
7529692|NCT03457727|18538853|P4|COMPLETED|Part 1, Period 4 (1 Day)||0
7529693|NCT03457727|18538854|P3|COMPLETED|Part 1, Period 4 (1 Day)||0
7529694|NCT03457727|18538855|P2|COMPLETED|Part 1, Period 4 (1 Day)||8
7529695|NCT03457727|18538856|P1|COMPLETED|Part 1, Period 4 (1 Day)||8
7529696|NCT03457727|18538853|P4|STARTED|Part 1, Period 4 (1 Day)||0
7529697|NCT03457727|18538854|P3|STARTED|Part 1, Period 4 (1 Day)||0
7529698|NCT03457727|18538855|P2|STARTED|Part 1, Period 4 (1 Day)||8
7529699|NCT03457727|18538856|P1|STARTED|Part 1, Period 4 (1 Day)||8
7529700|NCT03457727|18538853|P4|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
7529701|NCT03457727|18538854|P3|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
7529702|NCT03457727|18538855|P2|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
7529703|NCT03457727|18538856|P1|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
7529704|NCT03457727|18538853|P4|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
7529705|NCT03457727|18538854|P3|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
7529706|NCT03457727|18538855|P2|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
7529707|NCT03457727|18538856|P1|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
7529708|NCT03457727|18538853|P4|STARTED|Part 1, Washout Period 3 (5 Days)||0
7529709|NCT03457727|18538854|P3|STARTED|Part 1, Washout Period 3 (5 Days)||0
7529710|NCT03457727|18538855|P2|STARTED|Part 1, Washout Period 3 (5 Days)||8
7529711|NCT03457727|18538856|P1|STARTED|Part 1, Washout Period 3 (5 Days)||8
7529712|NCT03457727|18538853|P4|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
7529713|NCT03457727|18538854|P3|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
7529714|NCT03457727|18538855|P2|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
7529715|NCT03457727|18538856|P1|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
7529716|NCT03457727|18538853|P4|COMPLETED|Part 1, Period 3 (1 Day)||0
7529717|NCT03457727|18538854|P3|COMPLETED|Part 1, Period 3 (1 Day)||0
7529718|NCT03457727|18538855|P2|COMPLETED|Part 1, Period 3 (1 Day)||8
7529719|NCT03457727|18538856|P1|COMPLETED|Part 1, Period 3 (1 Day)||8
7529720|NCT03457727|18538853|P4|STARTED|Part 1, Period 3 (1 Day)||0
7529721|NCT03457727|18538854|P3|STARTED|Part 1, Period 3 (1 Day)||0
7529722|NCT03457727|18538855|P2|STARTED|Part 1, Period 3 (1 Day)||8
7529723|NCT03457727|18538856|P1|STARTED|Part 1, Period 3 (1 Day)||8
7529724|NCT03457727|18538853|P4|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
7529725|NCT03457727|18538854|P3|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
7529726|NCT03457727|18538855|P2|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
7529727|NCT03457727|18538856|P1|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
7529728|NCT03457727|18538853|P4|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
7529729|NCT03457727|18538854|P3|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
7529730|NCT03457727|18538855|P2|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
7529731|NCT03457727|18538856|P1|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
7529732|NCT03457727|18538853|P4|STARTED|Part 1, Washout Period 2 (5 Days)||0
7529733|NCT03457727|18538854|P3|STARTED|Part 1, Washout Period 2 (5 Days)||0
7529734|NCT03457727|18538855|P2|STARTED|Part 1, Washout Period 2 (5 Days)||8
7529735|NCT03457727|18538856|P1|STARTED|Part 1, Washout Period 2 (5 Days)||8
7529736|NCT03457727|18538853|P4|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
7529737|NCT03457727|18538854|P3|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
7529738|NCT03457727|18538855|P2|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
7529739|NCT03457727|18538856|P1|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
7529740|NCT03457727|18538853|P4|COMPLETED|Part 1, Period 2 (1 Day)||0
7529741|NCT03457727|18538854|P3|COMPLETED|Part 1, Period 2 (1 Day)||0
7529742|NCT03457727|18538855|P2|COMPLETED|Part 1, Period 2 (1 Day)||8
7529743|NCT03457727|18538856|P1|COMPLETED|Part 1, Period 2 (1 Day)||8
7529744|NCT03457727|18538853|P4|STARTED|Part 1, Period 2 (1 Day)||0
7529745|NCT03457727|18538854|P3|STARTED|Part 1, Period 2 (1 Day)||0
7529746|NCT03457727|18538855|P2|STARTED|Part 1, Period 2 (1 Day)||8
7529747|NCT03457727|18538856|P1|STARTED|Part 1, Period 2 (1 Day)||8
7529748|NCT03457727|18538853|P4|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
7529749|NCT03457727|18538854|P3|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
7529750|NCT03457727|18538855|P2|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
7529751|NCT03457727|18538856|P1|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
7529752|NCT03457727|18538853|P4|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
7529753|NCT03457727|18538854|P3|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
7529754|NCT03457727|18538855|P2|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
7529755|NCT03457727|18538856|P1|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
7529756|NCT03457727|18538853|P4|STARTED|Part 1, Washout Period 1 (5 Days)||0
7529757|NCT03457727|18538854|P3|STARTED|Part 1, Washout Period 1 (5 Days)||0
7529758|NCT03457727|18538855|P2|STARTED|Part 1, Washout Period 1 (5 Days)||8
7529759|NCT03457727|18538856|P1|STARTED|Part 1, Washout Period 1 (5 Days)||8
7529760|NCT03457727|18538853|P4|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
7529761|NCT03457727|18538854|P3|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
7529762|NCT03457727|18538855|P2|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
7529763|NCT03457727|18538856|P1|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
7529764|NCT03457727|18538853|P4|COMPLETED|Part 1, Period 1 (1 Day)||0
7529765|NCT03457727|18538854|P3|COMPLETED|Part 1, Period 1 (1 Day)||0
7529766|NCT03457727|18538855|P2|COMPLETED|Part 1, Period 1 (1 Day)||8
7529767|NCT03457727|18538856|P1|COMPLETED|Part 1, Period 1 (1 Day)||8
7529768|NCT03457727|18538853|P4|STARTED|Part 1, Period 1 (1 Day)||0
7529769|NCT03457727|18538854|P3|STARTED|Part 1, Period 1 (1 Day)||0
7529770|NCT03457727|18538855|P2|STARTED|Part 1, Period 1 (1 Day)||8
7529771|NCT03457727|18538856|P1|STARTED|Part 1, Period 1 (1 Day)||8
7529772|NCT03457636|18539053|P1|NOT COMPLETED|Overall Study||2
7529773|NCT03457636|18539053|P1|COMPLETED|Overall Study||20
7529774|NCT03457636|18539053|P1|STARTED|Overall Study||22
7529775|NCT03456960|18539066|P6|NOT COMPLETED|Period 2 (1 Day)||0
7529776|NCT03456960|18539067|P5|NOT COMPLETED|Period 2 (1 Day)||0
7529777|NCT03456960|18539068|P4|NOT COMPLETED|Period 2 (1 Day)||1
7529778|NCT03456960|18539069|P3|NOT COMPLETED|Period 2 (1 Day)||0
7529779|NCT03456960|18539070|P2|NOT COMPLETED|Period 2 (1 Day)||0
7529780|NCT03456960|18539071|P1|NOT COMPLETED|Period 2 (1 Day)||1
7529781|NCT03456960|18539066|P6|COMPLETED|Period 2 (1 Day)||6
7529782|NCT03456960|18539067|P5|COMPLETED|Period 2 (1 Day)||6
7529783|NCT03456960|18539068|P4|COMPLETED|Period 2 (1 Day)||117
7529784|NCT03456960|18539069|P3|COMPLETED|Period 2 (1 Day)||119
7529785|NCT03456960|18539070|P2|COMPLETED|Period 2 (1 Day)||12
7529786|NCT03456960|18539071|P1|COMPLETED|Period 2 (1 Day)||11
7529787|NCT03456960|18539066|P6|STARTED|Period 2 (1 Day)||6
7529788|NCT03456960|18539067|P5|STARTED|Period 2 (1 Day)||6
7529789|NCT03456960|18539068|P4|STARTED|Period 2 (1 Day)||118
7529790|NCT03456960|18539069|P3|STARTED|Period 2 (1 Day)||119
7529791|NCT03456960|18539070|P2|STARTED|Period 2 (1 Day)||12
7529792|NCT03456960|18539071|P1|STARTED|Period 2 (1 Day)||12
7529793|NCT03456960|18539066|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7529794|NCT03456960|18539067|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7529795|NCT03456960|18539068|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||2
7529796|NCT03456960|18539069|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||1
7529797|NCT03456960|18539070|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7529798|NCT03456960|18539071|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7529799|NCT03456960|18539066|P6|COMPLETED|Washout Period (at Least 14 Days)||6
7529800|NCT03456960|18539067|P5|COMPLETED|Washout Period (at Least 14 Days)||6
7529801|NCT03456960|18539068|P4|COMPLETED|Washout Period (at Least 14 Days)||118
7529802|NCT03456960|18539069|P3|COMPLETED|Washout Period (at Least 14 Days)||119
7529803|NCT03456960|18539070|P2|COMPLETED|Washout Period (at Least 14 Days)||12
7529804|NCT03456960|18539071|P1|COMPLETED|Washout Period (at Least 14 Days)||12
7529805|NCT03456960|18539066|P6|STARTED|Washout Period (at Least 14 Days)||6
7529806|NCT03456960|18539067|P5|STARTED|Washout Period (at Least 14 Days)||6
7529807|NCT03456960|18539068|P4|STARTED|Washout Period (at Least 14 Days)||120
7529808|NCT03456960|18539069|P3|STARTED|Washout Period (at Least 14 Days)||120
7529809|NCT03456960|18539070|P2|STARTED|Washout Period (at Least 14 Days)||12
7529810|NCT03456960|18539071|P1|STARTED|Washout Period (at Least 14 Days)||12
7529811|NCT03456960|18539066|P6|NOT COMPLETED|Period 1 (1 Day)||0
7529812|NCT03456960|18539067|P5|NOT COMPLETED|Period 1 (1 Day)||0
7529813|NCT03456960|18539068|P4|NOT COMPLETED|Period 1 (1 Day)||0
7529814|NCT03456960|18539069|P3|NOT COMPLETED|Period 1 (1 Day)||0
7529815|NCT03456960|18539070|P2|NOT COMPLETED|Period 1 (1 Day)||0
7529816|NCT03456960|18539071|P1|NOT COMPLETED|Period 1 (1 Day)||0
7529817|NCT03456960|18539066|P6|COMPLETED|Period 1 (1 Day)||6
7529818|NCT03456960|18539067|P5|COMPLETED|Period 1 (1 Day)||6
7529819|NCT03456960|18539068|P4|COMPLETED|Period 1 (1 Day)||120
7529820|NCT03456960|18539069|P3|COMPLETED|Period 1 (1 Day)||120
7529821|NCT03456960|18539070|P2|COMPLETED|Period 1 (1 Day)||12
7529822|NCT03456960|18539071|P1|COMPLETED|Period 1 (1 Day)||12
7529823|NCT03456960|18539066|P6|STARTED|Period 1 (1 Day)||6
7529824|NCT03456960|18539067|P5|STARTED|Period 1 (1 Day)||6
7529825|NCT03456960|18539068|P4|STARTED|Period 1 (1 Day)||120
7529826|NCT03456960|18539069|P3|STARTED|Period 1 (1 Day)||120
7529827|NCT03456960|18539070|P2|STARTED|Period 1 (1 Day)||12
7529828|NCT03456960|18539071|P1|STARTED|Period 1 (1 Day)||12
7529829|NCT03456856|18539163|P1|NOT COMPLETED|Overall Study||3
7529830|NCT03456856|18539163|P1|COMPLETED|Overall Study||27
7529831|NCT03456856|18539163|P1|STARTED|Overall Study||30
7529832|NCT03456700|18539167|P1|NOT COMPLETED|Overall Study||1
7529833|NCT03456700|18539167|P1|COMPLETED|Overall Study||21
7529834|NCT03456700|18539167|P1|STARTED|Overall Study||22
7529835|NCT03456427|18539175|P1|NOT COMPLETED|Overall Study||3
7529836|NCT03456427|18539175|P1|COMPLETED|Overall Study||33
7529837|NCT03456427|18539175|P1|STARTED|Overall Study||36
7529838|NCT03456245|18539184|P1|NOT COMPLETED|Overall Study||15
7529839|NCT03456245|18539184|P1|COMPLETED|Overall Study||190
7529840|NCT03456245|18539184|P1|STARTED|Overall Study||205
7529841|NCT03455556|18539188|P1|NOT COMPLETED|Overall Study||0
7529842|NCT03455556|18539188|P1|COMPLETED|Overall Study||1
7529843|NCT03455556|18539188|P1|STARTED|Overall Study||1
7529844|NCT03455543|18539199|P3|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||37
7529845|NCT03455543|18539200|P2|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
7529846|NCT03455543|18539201|P1|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
7529847|NCT03455543|18539199|P3|COMPLETED|Part B: Open-label Extension (24 Weeks)||115
7529848|NCT03455543|18539200|P2|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
7529849|NCT03455543|18539201|P1|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
7529850|NCT03455543|18539199|P3|STARTED|Part B: Open-label Extension (24 Weeks)||152
7529851|NCT03455543|18539200|P2|STARTED|Part B: Open-label Extension (24 Weeks)||0
7529852|NCT03455543|18539201|P1|STARTED|Part B: Open-label Extension (24 Weeks)||0
7529853|NCT03455543|18539199|P3|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
7529854|NCT03455543|18539200|P2|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||7
7529855|NCT03455543|18539201|P1|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||11
7529856|NCT03455543|18539199|P3|COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
7529857|NCT03455543|18539200|P2|COMPLETED|Part A: Randomized Treatment (17 Weeks)||83
7529858|NCT03455543|18539201|P1|COMPLETED|Part A: Randomized Treatment (17 Weeks)||81
7529859|NCT03455543|18539199|P3|STARTED|Part A: Randomized Treatment (17 Weeks)||0
7529860|NCT03455543|18539200|P2|STARTED|Part A: Randomized Treatment (17 Weeks)||90
7529861|NCT03455543|18539201|P1|STARTED|Part A: Randomized Treatment (17 Weeks)||92
7529862|NCT03455491|18539242|P3|NOT COMPLETED|Overall Study||0
7529863|NCT03455491|18539243|P2|NOT COMPLETED|Overall Study||0
7529864|NCT03455491|18539244|P1|NOT COMPLETED|Overall Study||0
7529865|NCT03455491|18539242|P3|COMPLETED|Overall Study||40
7529866|NCT03455491|18539243|P2|COMPLETED|Overall Study||40
7529867|NCT03455491|18539244|P1|COMPLETED|Overall Study||40
7529868|NCT03455491|18539242|P3|STARTED|Overall Study||40
7529869|NCT03455491|18539243|P2|STARTED|Overall Study||40
7529870|NCT03455491|18539244|P1|STARTED|Overall Study||40
7529871|NCT03455218|18539263|P2|NOT COMPLETED|Overall Study||0
7529872|NCT03455218|18539264|P1|NOT COMPLETED|Overall Study||0
7529873|NCT03455218|18539263|P2|COMPLETED|Overall Study||22
7529874|NCT03455218|18539264|P1|COMPLETED|Overall Study||18
7529875|NCT03455218|18539263|P2|STARTED|Overall Study||22
7529876|NCT03455218|18539264|P1|STARTED|Overall Study||18
7529877|NCT03454581|18539303|P3|NOT COMPLETED|Overall Study||3
7529878|NCT03454581|18539304|P2|NOT COMPLETED|Overall Study||3
7529879|NCT03454581|18539305|P1|NOT COMPLETED|Overall Study||4
7529880|NCT03454581|18539303|P3|COMPLETED|Overall Study||14
7529881|NCT03454581|18539304|P2|COMPLETED|Overall Study||13
7529882|NCT03454581|18539305|P1|COMPLETED|Overall Study||14
7529883|NCT03454581|18539303|P3|STARTED|Overall Study||17
7529884|NCT03454581|18539304|P2|STARTED|Overall Study||16
7529885|NCT03454581|18539305|P1|STARTED|Overall Study||18
7529886|NCT03454048|18539338|P4|NOT COMPLETED|Overall Study||0
7529887|NCT03454048|18539339|P3|NOT COMPLETED|Overall Study||0
7529888|NCT03454048|18539340|P2|NOT COMPLETED|Overall Study||0
7529889|NCT03454048|18539341|P1|NOT COMPLETED|Overall Study||0
7529890|NCT03454048|18539338|P4|COMPLETED|Overall Study||6
7529891|NCT03454048|18539339|P3|COMPLETED|Overall Study||6
7529892|NCT03454048|18539340|P2|COMPLETED|Overall Study||6
7529893|NCT03454048|18539341|P1|COMPLETED|Overall Study||6
7529894|NCT03454048|18539338|P4|STARTED|Overall Study||6
7529895|NCT03454048|18539339|P3|STARTED|Overall Study||6
7529896|NCT03454048|18539340|P2|STARTED|Overall Study||6
7529897|NCT03454048|18539341|P1|STARTED|Overall Study||6
7529898|NCT03453515|18539373|P2|NOT COMPLETED|Overall Study||13
7529899|NCT03453515|18539374|P1|NOT COMPLETED|Overall Study||6
7529900|NCT03453515|18539373|P2|COMPLETED|Overall Study||100
7529901|NCT03453515|18539374|P1|COMPLETED|Overall Study||107
7529902|NCT03453515|18539373|P2|STARTED|Overall Study||113
7529903|NCT03453515|18539374|P1|STARTED|Overall Study||113
7529904|NCT03453151|18539390|P1|NOT COMPLETED|Overall Study||4
7529905|NCT03453151|18539390|P1|COMPLETED|Overall Study||15
7529906|NCT03453151|18539390|P1|STARTED|Overall Study||19
7529907|NCT03453060|18539404|P5|NOT COMPLETED|Overall Study||0
7529908|NCT03453060|18539405|P4|NOT COMPLETED|Overall Study||0
7529909|NCT03453060|18539406|P3|NOT COMPLETED|Overall Study||0
7529910|NCT03453060|18539407|P2|NOT COMPLETED|Overall Study||0
7529911|NCT03453060|18539408|P1|NOT COMPLETED|Overall Study||0
7529912|NCT03453060|18539404|P5|COMPLETED|Overall Study||5
7529913|NCT03453060|18539405|P4|COMPLETED|Overall Study||4
7529914|NCT03453060|18539406|P3|COMPLETED|Overall Study||4
7529915|NCT03453060|18539407|P2|COMPLETED|Overall Study||4
7529916|NCT03453060|18539408|P1|COMPLETED|Overall Study||4
7529917|NCT03453060|18539404|P5|STARTED|Overall Study||5
7529918|NCT03453060|18539405|P4|STARTED|Overall Study||4
7529919|NCT03453060|18539406|P3|STARTED|Overall Study||4
7529920|NCT03453060|18539407|P2|STARTED|Overall Study||4
7529921|NCT03453060|18539408|P1|STARTED|Overall Study||4
7529922|NCT03452943|18539627|P2|NOT COMPLETED|Maintenance Period (5 Weeks)||0
7529923|NCT03452943|18539628|P1|NOT COMPLETED|Maintenance Period (5 Weeks)||3
7529924|NCT03452943|18539627|P2|COMPLETED|Maintenance Period (5 Weeks)||56
7529925|NCT03452943|18539628|P1|COMPLETED|Maintenance Period (5 Weeks)||51
7529926|NCT03452943|18539627|P2|STARTED|Maintenance Period (5 Weeks)||56
7529927|NCT03452943|18539628|P1|STARTED|Maintenance Period (5 Weeks)||54
7529928|NCT03452943|18539627|P2|NOT COMPLETED|Titration Period (7 Weeks)||4
7529929|NCT03452943|18539628|P1|NOT COMPLETED|Titration Period (7 Weeks)||5
7529930|NCT03452943|18539627|P2|COMPLETED|Titration Period (7 Weeks)||56
7529931|NCT03452943|18539628|P1|COMPLETED|Titration Period (7 Weeks)||54
7529932|NCT03452943|18539627|P2|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||59
7529933|NCT03452943|18539628|P1|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||58
7529934|NCT03452943|18539627|P2|Safety Analysis Set|Titration Period (7 Weeks)||59
7529935|NCT03452943|18539628|P1|Safety Analysis Set|Titration Period (7 Weeks)||58
7529936|NCT03452943|18539627|P2|STARTED|Titration Period (7 Weeks)||60
7529937|NCT03452943|18539628|P1|STARTED|Titration Period (7 Weeks)||59
7529938|NCT03452371|18539644|P2|NOT COMPLETED|Overall Study||0
7529939|NCT03452371|18539645|P1|NOT COMPLETED|Overall Study||0
7529940|NCT03452371|18539644|P2|COMPLETED|Overall Study||23
7529941|NCT03452371|18539645|P1|COMPLETED|Overall Study||21
7529942|NCT03452371|18539644|P2|STARTED|Overall Study||23
7529943|NCT03452371|18539645|P1|STARTED|Overall Study||21
7529944|NCT03452176|18539663|P2|NOT COMPLETED|Overall Study||0
7529945|NCT03452176|18539664|P1|NOT COMPLETED|Overall Study||0
7529946|NCT03452176|18539663|P2|COMPLETED|Overall Study||11
7529947|NCT03452176|18539664|P1|COMPLETED|Overall Study||11
7529948|NCT03452176|18539663|P2|STARTED|Overall Study||11
7529949|NCT03452176|18539664|P1|STARTED|Overall Study||11
7529950|NCT03451721|18539680|P1|NOT COMPLETED|Overall Study||1
7529951|NCT03451721|18539680|P1|COMPLETED|Overall Study||19
7529952|NCT03451721|18539680|P1|STARTED|Overall Study||20
7529953|NCT03450369|18539691|P2|NOT COMPLETED|Overall Study||0
7529954|NCT03450369|18539692|P1|NOT COMPLETED|Overall Study||0
7529955|NCT03450369|18539691|P2|COMPLETED|Overall Study||5
7529956|NCT03450369|18539692|P1|COMPLETED|Overall Study||5
7529957|NCT03450369|18539691|P2|STARTED|Overall Study||5
7529958|NCT03450369|18539692|P1|STARTED|Overall Study||5
7529959|NCT03450070|18539720|P1|NOT COMPLETED|Overall Study||8
7529960|NCT03450070|18539720|P1|COMPLETED|Overall Study||110
7529961|NCT03450070|18539720|P1|STARTED|Overall Study||118
7529962|NCT03449979|18539728|P4|NOT COMPLETED|Overall Study||1
7529963|NCT03449979|18539729|P3|NOT COMPLETED|Overall Study||0
7529964|NCT03449979|18539730|P2|NOT COMPLETED|Overall Study||0
7529965|NCT03449979|18539731|P1|NOT COMPLETED|Overall Study||0
7529966|NCT03449979|18539728|P4|COMPLETED|Overall Study||21
7529967|NCT03449979|18539729|P3|COMPLETED|Overall Study||21
7529968|NCT03449979|18539730|P2|COMPLETED|Overall Study||20
7529969|NCT03449979|18539731|P1|COMPLETED|Overall Study||21
7529970|NCT03449979|18539728|P4|STARTED|Overall Study||22
7529971|NCT03449979|18539729|P3|STARTED|Overall Study||21
7529972|NCT03449979|18539730|P2|STARTED|Overall Study||20
7529973|NCT03449979|18539731|P1|STARTED|Overall Study||21
7529974|NCT03449758|18539741|P1|NOT COMPLETED|Overall Study||19
7529975|NCT03449758|18539741|P1|COMPLETED|Overall Study||65
7529976|NCT03449758|18539741|P1|STARTED|Overall Study||84
7529977|NCT03449446|18539781|P7|NOT COMPLETED|Overall Study||1
7529978|NCT03449446|18539782|P6|NOT COMPLETED|Overall Study||9
7529979|NCT03449446|18539783|P5|NOT COMPLETED|Overall Study||12
7529980|NCT03449446|18539784|P4|NOT COMPLETED|Overall Study||9
7529981|NCT03449446|18539785|P3|NOT COMPLETED|Overall Study||7
7529982|NCT03449446|18539786|P2|NOT COMPLETED|Overall Study||7
7529983|NCT03449446|18539787|P1|NOT COMPLETED|Overall Study||36
7529984|NCT03449446|18539781|P7|COMPLETED|Overall Study||38
7529985|NCT03449446|18539782|P6|COMPLETED|Overall Study||69
7529986|NCT03449446|18539783|P5|COMPLETED|Overall Study||66
7529987|NCT03449446|18539784|P4|COMPLETED|Overall Study||71
7529988|NCT03449446|18539785|P3|COMPLETED|Overall Study||34
7529989|NCT03449446|18539786|P2|COMPLETED|Overall Study||33
7529990|NCT03449446|18539787|P1|COMPLETED|Overall Study||3
7529991|NCT03449446|18539781|P7|STARTED|Overall Study||39
7529992|NCT03449446|18539782|P6|STARTED|Overall Study||78
7529993|NCT03449446|18539783|P5|STARTED|Overall Study||78
7529994|NCT03449446|18539784|P4|STARTED|Overall Study||80
7529995|NCT03449446|18539785|P3|STARTED|Overall Study||41
7529996|NCT03449446|18539786|P2|STARTED|Overall Study||40
7529997|NCT03449446|18539787|P1|STARTED|Overall Study||39
7529998|NCT03449433|18539819|P5|NOT COMPLETED|Period 4||0
7529999|NCT03449433|18539820|P4|NOT COMPLETED|Period 4||0
7530000|NCT03449433|18539821|P3|NOT COMPLETED|Period 4||0
7530001|NCT03449433|18539822|P2|NOT COMPLETED|Period 4||0
7530002|NCT03449433|18539823|P1|NOT COMPLETED|Period 4||0
7530003|NCT03449433|18539819|P5|COMPLETED|Period 4||12
7530004|NCT03449433|18539820|P4|COMPLETED|Period 4||17
7530005|NCT03449433|18539821|P3|COMPLETED|Period 4||18
7530006|NCT03449433|18539822|P2|COMPLETED|Period 4||15
7530007|NCT03449433|18539823|P1|COMPLETED|Period 4||17
7530008|NCT03449433|18539819|P5|Received at Least 1 Dose of Study Drug|Period 4||0
7530009|NCT03449433|18539820|P4|Received at Least 1 Dose of Study Drug|Period 4||17
7530010|NCT03449433|18539821|P3|Received at Least 1 Dose of Study Drug|Period 4||18
7530011|NCT03449433|18539822|P2|Received at Least 1 Dose of Study Drug|Period 4||15
7530012|NCT03449433|18539823|P1|Received at Least 1 Dose of Study Drug|Period 4||17
7530013|NCT03449433|18539819|P5|STARTED|Period 4||12
7530014|NCT03449433|18539820|P4|STARTED|Period 4||17
7530015|NCT03449433|18539821|P3|STARTED|Period 4||18
7530016|NCT03449433|18539822|P2|STARTED|Period 4||15
7530017|NCT03449433|18539823|P1|STARTED|Period 4||17
7530018|NCT03449433|18539819|P5|NOT COMPLETED|Period 3||0
7530019|NCT03449433|18539820|P4|NOT COMPLETED|Period 3||0
7530020|NCT03449433|18539821|P3|NOT COMPLETED|Period 3||0
7530021|NCT03449433|18539822|P2|NOT COMPLETED|Period 3||1
7530022|NCT03449433|18539823|P1|NOT COMPLETED|Period 3||0
7530023|NCT03449433|18539819|P5|COMPLETED|Period 3||12
7530024|NCT03449433|18539820|P4|COMPLETED|Period 3||17
7530025|NCT03449433|18539821|P3|COMPLETED|Period 3||18
7530026|NCT03449433|18539822|P2|COMPLETED|Period 3||15
7530027|NCT03449433|18539823|P1|COMPLETED|Period 3||17
7530028|NCT03449433|18539819|P5|Received at Least 1 Dose of Study Drug|Period 3||0
7530029|NCT03449433|18539820|P4|Received at Least 1 Dose of Study Drug|Period 3||17
7530030|NCT03449433|18539821|P3|Received at Least 1 Dose of Study Drug|Period 3||18
7530031|NCT03449433|18539822|P2|Received at Least 1 Dose of Study Drug|Period 3||15
7530032|NCT03449433|18539823|P1|Received at Least 1 Dose of Study Drug|Period 3||17
7530033|NCT03449433|18539819|P5|STARTED|Period 3||12
7530034|NCT03449433|18539820|P4|STARTED|Period 3||17
7530035|NCT03449433|18539821|P3|STARTED|Period 3||18
7530036|NCT03449433|18539822|P2|STARTED|Period 3||16
7530037|NCT03449433|18539823|P1|STARTED|Period 3||17
7530038|NCT03449433|18539819|P5|NOT COMPLETED|Period 2||0
7530039|NCT03449433|18539820|P4|NOT COMPLETED|Period 2||0
7530040|NCT03449433|18539821|P3|NOT COMPLETED|Period 2||0
7530041|NCT03449433|18539822|P2|NOT COMPLETED|Period 2||0
7530042|NCT03449433|18539823|P1|NOT COMPLETED|Period 2||0
7530043|NCT03449433|18539819|P5|COMPLETED|Period 2||12
7530044|NCT03449433|18539820|P4|COMPLETED|Period 2||17
7530045|NCT03449433|18539821|P3|COMPLETED|Period 2||18
7530046|NCT03449433|18539822|P2|COMPLETED|Period 2||16
7530047|NCT03449433|18539823|P1|COMPLETED|Period 2||17
7530048|NCT03449433|18539819|P5|Received at Least 1 Dose of Study Drug|Period 2||0
7530049|NCT03449433|18539820|P4|Received at Least 1 Dose of Study Drug|Period 2||17
7530050|NCT03449433|18539821|P3|Received at Least 1 Dose of Study Drug|Period 2||18
7530051|NCT03449433|18539822|P2|Received at Least 1 Dose of Study Drug|Period 2||16
7530052|NCT03449433|18539823|P1|Received at Least 1 Dose of Study Drug|Period 2||17
7530053|NCT03449433|18539819|P5|STARTED|Period 2||12
7530054|NCT03449433|18539820|P4|STARTED|Period 2||17
7530055|NCT03449433|18539821|P3|STARTED|Period 2||18
7530056|NCT03449433|18539822|P2|STARTED|Period 2||16
7530057|NCT03449433|18539823|P1|STARTED|Period 2||17
7530058|NCT03449433|18539819|P5|NOT COMPLETED|Period 1||0
7530059|NCT03449433|18539820|P4|NOT COMPLETED|Period 1||0
7530060|NCT03449433|18539821|P3|NOT COMPLETED|Period 1||0
7530061|NCT03449433|18539822|P2|NOT COMPLETED|Period 1||0
7530062|NCT03449433|18539823|P1|NOT COMPLETED|Period 1||0
7530063|NCT03449433|18539819|P5|COMPLETED|Period 1||12
7530064|NCT03449433|18539820|P4|COMPLETED|Period 1||17
7530065|NCT03449433|18539821|P3|COMPLETED|Period 1||18
7530066|NCT03449433|18539822|P2|COMPLETED|Period 1||16
7530067|NCT03449433|18539823|P1|COMPLETED|Period 1||17
7530068|NCT03449433|18539819|P5|Received at Least 1 Dose of Study Drug|Period 1||0
7530069|NCT03449433|18539820|P4|Received at Least 1 Dose of Study Drug|Period 1||17
7530070|NCT03449433|18539821|P3|Received at Least 1 Dose of Study Drug|Period 1||18
7530071|NCT03449433|18539822|P2|Received at Least 1 Dose of Study Drug|Period 1||16
7530072|NCT03449433|18539823|P1|Received at Least 1 Dose of Study Drug|Period 1||17
7530073|NCT03449433|18539819|P5|STARTED|Period 1||12
7530074|NCT03449433|18539820|P4|STARTED|Period 1||17
7530075|NCT03449433|18539821|P3|STARTED|Period 1||18
7530076|NCT03449433|18539822|P2|STARTED|Period 1||16
7530077|NCT03449433|18539823|P1|STARTED|Period 1||17
7530078|NCT03449342|18539841|P2|NOT COMPLETED|Overall Study||0
7530079|NCT03449342|18539842|P1|NOT COMPLETED|Overall Study||0
7530080|NCT03449342|18539841|P2|COMPLETED|Overall Study||50
7530081|NCT03449342|18539842|P1|COMPLETED|Overall Study||10
7530082|NCT03449342|18539841|P2|STARTED|Overall Study||50
7530083|NCT03449342|18539842|P1|STARTED|Overall Study||10
7530084|NCT03448536|18539858|P2|NOT COMPLETED|Overall Study||4
7530085|NCT03448536|18539859|P1|NOT COMPLETED|Overall Study||12
7530086|NCT03448536|18539858|P2|COMPLETED|Overall Study||97
7530087|NCT03448536|18539859|P1|COMPLETED|Overall Study||88
7530088|NCT03448536|18539858|P2|Completed Second Intervention|Overall Study||87
7530089|NCT03448536|18539859|P1|Completed Second Intervention|Overall Study||82
7530090|NCT03448536|18539858|P2|Completed First Intervention|Overall Study||97
7530091|NCT03448536|18539859|P1|Completed First Intervention|Overall Study||95
7530092|NCT03448536|18539858|P2|Completed First Intervention|Overall Study||78
7530093|NCT03448536|18539859|P1|Completed First Intervention|Overall Study||83
7530094|NCT03448536|18539858|P2|STARTED|Overall Study||101
7530095|NCT03448536|18539859|P1|STARTED|Overall Study||100
7530096|NCT03448419|18539885|P2|NOT COMPLETED|Overall Study||16
7530097|NCT03448419|18539886|P1|NOT COMPLETED|Overall Study||13
7530098|NCT03448419|18539885|P2|COMPLETED|Overall Study||140
7530099|NCT03448419|18539886|P1|COMPLETED|Overall Study||143
7530100|NCT03448419|18539885|P2|Treated|Overall Study||155
7530101|NCT03448419|18539886|P1|Treated|Overall Study||156
7530102|NCT03448419|18539885|P2|STARTED|Overall Study||156
7530103|NCT03448419|18539886|P1|STARTED|Overall Study||156
7530104|NCT03448406|18539912|P2|NOT COMPLETED|Overall Study||13
7530105|NCT03448406|18539913|P1|NOT COMPLETED|Overall Study||11
7530106|NCT03448406|18539912|P2|COMPLETED|Overall Study||144
7530107|NCT03448406|18539913|P1|COMPLETED|Overall Study||147
7530108|NCT03448406|18539912|P2|STARTED|Overall Study||157
7530109|NCT03448406|18539913|P1|STARTED|Overall Study||158
7530110|NCT03448224|18539939|P2|NOT COMPLETED|Overall Study||0
7530111|NCT03448224|18539940|P1|NOT COMPLETED|Overall Study||1
7530112|NCT03448224|18539939|P2|COMPLETED|Overall Study||26
7530113|NCT03448224|18539940|P1|COMPLETED|Overall Study||27
7530114|NCT03448224|18539939|P2|STARTED|Overall Study||26
7530115|NCT03448224|18539940|P1|STARTED|Overall Study||28
7530116|NCT03447821|18539957|P3|NOT COMPLETED|Overall Study||1
7530117|NCT03447821|18539958|P2|NOT COMPLETED|Overall Study||1
7530118|NCT03447821|18539959|P1|NOT COMPLETED|Overall Study||1
7530119|NCT03447821|18539957|P3|COMPLETED|Overall Study||12
7530120|NCT03447821|18539958|P2|COMPLETED|Overall Study||12
7530121|NCT03447821|18539959|P1|COMPLETED|Overall Study||13
7530122|NCT03447821|18539957|P3|STARTED|Overall Study||13
7530123|NCT03447821|18539958|P2|STARTED|Overall Study||13
7530124|NCT03447821|18539959|P1|STARTED|Overall Study||14
7530125|NCT03447730|18539985|P3|NOT COMPLETED|Overall Study||0
7530126|NCT03447730|18539986|P2|NOT COMPLETED|Overall Study||2
7530127|NCT03447730|18539987|P1|NOT COMPLETED|Overall Study||0
7530128|NCT03447730|18539985|P3|COMPLETED|Overall Study||8
7530129|NCT03447730|18539986|P2|COMPLETED|Overall Study||7
7530130|NCT03447730|18539987|P1|COMPLETED|Overall Study||6
7530131|NCT03447730|18539985|P3|STARTED|Overall Study||8
7530132|NCT03447730|18539986|P2|STARTED|Overall Study||9
7530133|NCT03447730|18539987|P1|STARTED|Overall Study||6
7530134|NCT03447639|18540003|P2|NOT COMPLETED|Overall Study||2
7530135|NCT03447639|18540004|P1|NOT COMPLETED|Overall Study||0
7530136|NCT03447639|18540003|P2|COMPLETED|Overall Study|2 patients were withdrawn because their catheters had to be re-inserted.|1
7530137|NCT03447639|18540004|P1|COMPLETED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
7530138|NCT03447639|18540003|P2|STARTED|Overall Study|3 patients were randomized to the Standard of Care arm.|3
7530139|NCT03447639|18540004|P1|STARTED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
7530140|NCT03447353|18540014|P1|NOT COMPLETED|Overall Study||10
7530141|NCT03447353|18540014|P1|COMPLETED|Overall Study||8
7530142|NCT03447353|18540014|P1|STARTED|Overall Study||18
7530143|NCT03447249|18540030|P2|NOT COMPLETED|Overall Study||0
7530144|NCT03447249|18540031|P1|NOT COMPLETED|Overall Study||5
7530145|NCT03447249|18540030|P2|COMPLETED|Overall Study||192
7530146|NCT03447249|18540031|P1|COMPLETED|Overall Study||185
7530147|NCT03447249|18540030|P2|Safety Set|Overall Study||193
7530148|NCT03447249|18540031|P1|Safety Set|Overall Study||189
7530149|NCT03447249|18540030|P2|STARTED|Overall Study||192
7530150|NCT03447249|18540031|P1|STARTED|Overall Study||190
7530151|NCT03447015|18540062|P2|NOT COMPLETED|Overall Study||44
7530152|NCT03447015|18540063|P1|NOT COMPLETED|Overall Study||45
7530153|NCT03447015|18540062|P2|COMPLETED|Overall Study||106
7530154|NCT03447015|18540063|P1|COMPLETED|Overall Study||95
7530155|NCT03447015|18540062|P2|STARTED|Overall Study||150
7530156|NCT03447015|18540063|P1|STARTED|Overall Study||140
7530157|NCT03446846|18540082|P3|NOT COMPLETED|Overall Study||16
7530158|NCT03446846|18540083|P2|NOT COMPLETED|Overall Study||5
7530159|NCT03446846|18540084|P1|NOT COMPLETED|Overall Study||7
7530160|NCT03446846|18540082|P3|COMPLETED|Overall Study||162
7530161|NCT03446846|18540083|P2|COMPLETED|Overall Study||87
7530162|NCT03446846|18540084|P1|COMPLETED|Overall Study||83
7530163|NCT03446846|18540082|P3|STARTED|Overall Study||178
7530164|NCT03446846|18540083|P2|STARTED|Overall Study||92
7530165|NCT03446846|18540084|P1|STARTED|Overall Study||90
7530166|NCT03446781|18540103|P2|NOT COMPLETED|Overall Study||17
7530167|NCT03446781|18540104|P1|NOT COMPLETED|Overall Study||28
7530168|NCT03446781|18540103|P2|COMPLETED|Overall Study||191
7530169|NCT03446781|18540104|P1|COMPLETED|Overall Study||186
7530170|NCT03446781|18540103|P2|STARTED|Overall Study||208
7530171|NCT03446781|18540104|P1|STARTED|Overall Study||214
7530172|NCT03446690|18540153|P2|NOT COMPLETED|Overall Study||0
7530173|NCT03446690|18540154|P1|NOT COMPLETED|Overall Study||7
7530174|NCT03446690|18540153|P2|COMPLETED|Overall Study||29
7530175|NCT03446690|18540154|P1|COMPLETED|Overall Study||26
7530176|NCT03446690|18540153|P2|STARTED|Overall Study||29
7530177|NCT03446690|18540154|P1|STARTED|Overall Study||33
7530178|NCT03446573|18540162|P2|NOT COMPLETED|Overall Study||372
7530179|NCT03446573|18540163|P1|NOT COMPLETED|Overall Study||369
7530180|NCT03446573|18540162|P2|COMPLETED|Overall Study||0
7530181|NCT03446573|18540163|P1|COMPLETED|Overall Study||0
7530182|NCT03446573|18540162|P2|STARTED|Overall Study||372
7530183|NCT03446573|18540163|P1|STARTED|Overall Study||369
7530184|NCT03445390|18540235|P2|NOT COMPLETED|Second Intervention||1
7530185|NCT03445390|18540236|P1|NOT COMPLETED|Second Intervention||2
7530186|NCT03445390|18540235|P2|COMPLETED|Second Intervention||10
7530187|NCT03445390|18540236|P1|COMPLETED|Second Intervention||10
7530188|NCT03445390|18540235|P2|STARTED|Second Intervention||11
7530189|NCT03445390|18540236|P1|STARTED|Second Intervention||12
7530190|NCT03445390|18540235|P2|NOT COMPLETED|First Intervention||2
7530191|NCT03445390|18540236|P1|NOT COMPLETED|First Intervention||2
7530192|NCT03445390|18540235|P2|COMPLETED|First Intervention||11
7530193|NCT03445390|18540236|P1|COMPLETED|First Intervention||12
7530194|NCT03445390|18540235|P2|STARTED|First Intervention||13
7530195|NCT03445390|18540236|P1|STARTED|First Intervention||14
7530196|NCT03445195|18540248|P2|NOT COMPLETED|Overall Study||0
7530197|NCT03445195|18540249|P1|NOT COMPLETED|Overall Study||2
7530198|NCT03445195|18540248|P2|COMPLETED|Overall Study||27
7530199|NCT03445195|18540249|P1|COMPLETED|Overall Study||51
7530200|NCT03445195|18540248|P2|STARTED|Overall Study||27
7530201|NCT03445195|18540249|P1|STARTED|Overall Study||53
7530202|NCT03445156|18540264|P3|NOT COMPLETED|Experiment Proper||0
7530203|NCT03445156|18540265|P2|NOT COMPLETED|Experiment Proper||0
7530204|NCT03445156|18540266|P1|NOT COMPLETED|Experiment Proper||0
7530205|NCT03445156|18540264|P3|COMPLETED|Experiment Proper||59
7530206|NCT03445156|18540265|P2|COMPLETED|Experiment Proper||115
7530207|NCT03445156|18540266|P1|COMPLETED|Experiment Proper||113
7530208|NCT03445156|18540264|P3|STARTED|Experiment Proper||59
7530209|NCT03445156|18540265|P2|STARTED|Experiment Proper||115
7530210|NCT03445156|18540266|P1|STARTED|Experiment Proper||113
7530211|NCT03445156|18540264|P3|NOT COMPLETED|Pilot Study||0
7530212|NCT03445156|18540265|P2|NOT COMPLETED|Pilot Study||0
7530213|NCT03445156|18540266|P1|NOT COMPLETED|Pilot Study||0
7530214|NCT03445156|18540264|P3|COMPLETED|Pilot Study||0
7530215|NCT03445156|18540265|P2|COMPLETED|Pilot Study||20
7530216|NCT03445156|18540266|P1|COMPLETED|Pilot Study||20
7530217|NCT03445156|18540264|P3|STARTED|Pilot Study||0
7530218|NCT03445156|18540265|P2|STARTED|Pilot Study||20
7530219|NCT03445156|18540266|P1|STARTED|Pilot Study||20
7530220|NCT03444766|18540283|P1|NOT COMPLETED|Overall Study||66
7530221|NCT03444766|18540283|P1|COMPLETED|Overall Study||34
7530222|NCT03444766|18540283|P1|STARTED|Overall Study||100
7530223|NCT03444584|18540292|P2|NOT COMPLETED|Overall Study||2
7530224|NCT03444584|18540293|P1|NOT COMPLETED|Overall Study||0
7530225|NCT03444584|18540292|P2|COMPLETED|Overall Study||23
7530226|NCT03444584|18540293|P1|COMPLETED|Overall Study||24
7530227|NCT03444584|18540292|P2|STARTED|Overall Study||25
7530228|NCT03444584|18540293|P1|STARTED|Overall Study||24
7530229|NCT03444090|18540351|P2|NOT COMPLETED|Overall Study||4
7530230|NCT03444090|18540352|P1|NOT COMPLETED|Overall Study||3
7530231|NCT03444090|18540351|P2|COMPLETED|Overall Study||210
7530232|NCT03444090|18540352|P1|COMPLETED|Overall Study||211
7530233|NCT03444090|18540351|P2|STARTED|Overall Study||214
7530234|NCT03444090|18540352|P1|STARTED|Overall Study||214
7530235|NCT03443713|18540363|P3|NOT COMPLETED|Close-out Visit (30 Minutes)||0
7530236|NCT03443713|18540364|P2|NOT COMPLETED|Close-out Visit (30 Minutes)||0
7530237|NCT03443713|18540365|P1|NOT COMPLETED|Close-out Visit (30 Minutes)||0
7530238|NCT03443713|18540363|P3|COMPLETED|Close-out Visit (30 Minutes)||8
7530239|NCT03443713|18540364|P2|COMPLETED|Close-out Visit (30 Minutes)||8
7530240|NCT03443713|18540365|P1|COMPLETED|Close-out Visit (30 Minutes)||8
7530241|NCT03443713|18540363|P3|STARTED|Close-out Visit (30 Minutes)||8
7530242|NCT03443713|18540364|P2|STARTED|Close-out Visit (30 Minutes)||8
7530243|NCT03443713|18540365|P1|STARTED|Close-out Visit (30 Minutes)||8
7530244|NCT03443713|18540363|P3|NOT COMPLETED|Third at Home Period (8-12 Days)||0
7530245|NCT03443713|18540364|P2|NOT COMPLETED|Third at Home Period (8-12 Days)||0
7530246|NCT03443713|18540365|P1|NOT COMPLETED|Third at Home Period (8-12 Days)||0
7530247|NCT03443713|18540363|P3|COMPLETED|Third at Home Period (8-12 Days)||8
7530248|NCT03443713|18540364|P2|COMPLETED|Third at Home Period (8-12 Days)||8
7530249|NCT03443713|18540365|P1|COMPLETED|Third at Home Period (8-12 Days)||8
7530250|NCT03443713|18540363|P3|STARTED|Third at Home Period (8-12 Days)||8
7530251|NCT03443713|18540364|P2|STARTED|Third at Home Period (8-12 Days)||8
7530252|NCT03443713|18540365|P1|STARTED|Third at Home Period (8-12 Days)||8
7530253|NCT03443713|18540363|P3|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
7530254|NCT03443713|18540364|P2|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
7530255|NCT03443713|18540365|P1|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
7530256|NCT03443713|18540363|P3|COMPLETED|Second Exercise Visit (1 Hour)||8
7530257|NCT03443713|18540364|P2|COMPLETED|Second Exercise Visit (1 Hour)||8
7530258|NCT03443713|18540365|P1|COMPLETED|Second Exercise Visit (1 Hour)||8
7530259|NCT03443713|18540363|P3|STARTED|Second Exercise Visit (1 Hour)||8
7530260|NCT03443713|18540364|P2|STARTED|Second Exercise Visit (1 Hour)||8
7530261|NCT03443713|18540365|P1|STARTED|Second Exercise Visit (1 Hour)||8
7530262|NCT03443713|18540363|P3|NOT COMPLETED|Second at Home Period (2-11 Days)||0
7530263|NCT03443713|18540364|P2|NOT COMPLETED|Second at Home Period (2-11 Days)||0
7530264|NCT03443713|18540365|P1|NOT COMPLETED|Second at Home Period (2-11 Days)||0
7530265|NCT03443713|18540363|P3|COMPLETED|Second at Home Period (2-11 Days)||8
7530266|NCT03443713|18540364|P2|COMPLETED|Second at Home Period (2-11 Days)||8
7530267|NCT03443713|18540365|P1|COMPLETED|Second at Home Period (2-11 Days)||8
7530268|NCT03443713|18540363|P3|STARTED|Second at Home Period (2-11 Days)||8
7530269|NCT03443713|18540364|P2|STARTED|Second at Home Period (2-11 Days)||8
7530270|NCT03443713|18540365|P1|STARTED|Second at Home Period (2-11 Days)||8
7530271|NCT03443713|18540363|P3|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
7530272|NCT03443713|18540364|P2|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
7530273|NCT03443713|18540365|P1|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
7530274|NCT03443713|18540363|P3|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
7530275|NCT03443713|18540364|P2|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
7530276|NCT03443713|18540365|P1|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
7530277|NCT03443713|18540363|P3|STARTED|Dexcom Insertion Visit (30 Minutes)||8
7530278|NCT03443713|18540364|P2|STARTED|Dexcom Insertion Visit (30 Minutes)||8
7530279|NCT03443713|18540365|P1|STARTED|Dexcom Insertion Visit (30 Minutes)||8
7530280|NCT03443713|18540363|P3|NOT COMPLETED|First Exercise Visit (1 Hour)||0
7530281|NCT03443713|18540364|P2|NOT COMPLETED|First Exercise Visit (1 Hour)||0
7530282|NCT03443713|18540365|P1|NOT COMPLETED|First Exercise Visit (1 Hour)||0
7530283|NCT03443713|18540363|P3|COMPLETED|First Exercise Visit (1 Hour)||8
7530284|NCT03443713|18540364|P2|COMPLETED|First Exercise Visit (1 Hour)||8
7530285|NCT03443713|18540365|P1|COMPLETED|First Exercise Visit (1 Hour)||8
7530286|NCT03443713|18540363|P3|STARTED|First Exercise Visit (1 Hour)||8
7530287|NCT03443713|18540364|P2|STARTED|First Exercise Visit (1 Hour)||8
7530288|NCT03443713|18540365|P1|STARTED|First Exercise Visit (1 Hour)||8
7530289|NCT03443713|18540363|P3|NOT COMPLETED|First at Home Period (9-14 Days)||1
7530290|NCT03443713|18540364|P2|NOT COMPLETED|First at Home Period (9-14 Days)||0
7530291|NCT03443713|18540365|P1|NOT COMPLETED|First at Home Period (9-14 Days)||0
7530292|NCT03443713|18540363|P3|COMPLETED|First at Home Period (9-14 Days)||8
7530293|NCT03443713|18540364|P2|COMPLETED|First at Home Period (9-14 Days)||8
7530294|NCT03443713|18540365|P1|COMPLETED|First at Home Period (9-14 Days)||8
7530295|NCT03443713|18540363|P3|STARTED|First at Home Period (9-14 Days)||9
7530296|NCT03443713|18540364|P2|STARTED|First at Home Period (9-14 Days)||8
7530297|NCT03443713|18540365|P1|STARTED|First at Home Period (9-14 Days)||8
7530298|NCT03443713|18540363|P3|NOT COMPLETED|Start up Visit (2 Hours)||0
7530299|NCT03443713|18540364|P2|NOT COMPLETED|Start up Visit (2 Hours)||0
7530300|NCT03443713|18540365|P1|NOT COMPLETED|Start up Visit (2 Hours)||0
7530301|NCT03443713|18540363|P3|COMPLETED|Start up Visit (2 Hours)||9
7530302|NCT03443713|18540364|P2|COMPLETED|Start up Visit (2 Hours)||8
7530303|NCT03443713|18540365|P1|COMPLETED|Start up Visit (2 Hours)||8
7530304|NCT03443713|18540363|P3|STARTED|Start up Visit (2 Hours)||9
7530305|NCT03443713|18540364|P2|STARTED|Start up Visit (2 Hours)||8
7530306|NCT03443713|18540365|P1|STARTED|Start up Visit (2 Hours)||8
7530307|NCT03443427|18540396|P2|NOT COMPLETED|Overall Study||5
7530308|NCT03443427|18540397|P1|NOT COMPLETED|Overall Study||8
7530309|NCT03443427|18540396|P2|COMPLETED|Overall Study||95
7530310|NCT03443427|18540397|P1|COMPLETED|Overall Study||92
7530311|NCT03443427|18540396|P2|STARTED|Overall Study||100
7530312|NCT03443427|18540397|P1|STARTED|Overall Study||100
7530313|NCT03443414|18540434|P5|NOT COMPLETED|Overall Study||5
7530314|NCT03443414|18540435|P4|NOT COMPLETED|Overall Study||5
7530315|NCT03443414|18540436|P3|NOT COMPLETED|Overall Study||6
7530316|NCT03443414|18540437|P2|NOT COMPLETED|Overall Study||3
7530317|NCT03443414|18540438|P1|NOT COMPLETED|Overall Study||11
7530318|NCT03443414|18540434|P5|COMPLETED|Overall Study||75
7530319|NCT03443414|18540435|P4|COMPLETED|Overall Study||75
7530320|NCT03443414|18540436|P3|COMPLETED|Overall Study||76
7530321|NCT03443414|18540437|P2|COMPLETED|Overall Study||78
7530322|NCT03443414|18540438|P1|COMPLETED|Overall Study||71
7530323|NCT03443414|18540434|P5|Received Treatment|Overall Study||79
7530324|NCT03443414|18540435|P4|Received Treatment|Overall Study||80
7530325|NCT03443414|18540436|P3|Received Treatment|Overall Study||82
7530326|NCT03443414|18540437|P2|Received Treatment|Overall Study||81
7530327|NCT03443414|18540438|P1|Received Treatment|Overall Study||81
7530328|NCT03443414|18540434|P5|STARTED|Overall Study||80
7530329|NCT03443414|18540435|P4|STARTED|Overall Study||80
7530330|NCT03443414|18540436|P3|STARTED|Overall Study||82
7530331|NCT03443414|18540437|P2|STARTED|Overall Study||81
7530332|NCT03443414|18540438|P1|STARTED|Overall Study||82
7530333|NCT03443063|18540477|P2|NOT COMPLETED|Overall Study||0
7530334|NCT03443063|18540478|P1|NOT COMPLETED|Overall Study||0
7530335|NCT03443063|18540477|P2|COMPLETED|Overall Study||8
7530336|NCT03443063|18540478|P1|COMPLETED|Overall Study||8
7530337|NCT03443063|18540477|P2|STARTED|Overall Study||8
7530338|NCT03443063|18540478|P1|STARTED|Overall Study||8
7530339|NCT03442933|18540528|P2|NOT COMPLETED|Overall Study||0
7530340|NCT03442933|18540529|P1|NOT COMPLETED|Overall Study||0
7530341|NCT03442933|18540528|P2|COMPLETED|Overall Study||20
7530342|NCT03442933|18540529|P1|COMPLETED|Overall Study||20
7530343|NCT03442933|18540528|P2|STARTED|Overall Study||20
7530344|NCT03442933|18540529|P1|STARTED|Overall Study||20
7530345|NCT03442868|18540540|P1|NOT COMPLETED|Overall Study||0
7530346|NCT03442868|18540540|P1|COMPLETED|Overall Study||15
7530347|NCT03442868|18540540|P1|STARTED|Overall Study||15
7530348|NCT03442829|18540549|P2|NOT COMPLETED|Overall Study||2
7530349|NCT03442829|18540550|P1|NOT COMPLETED|Overall Study||4
7530350|NCT03442829|18540549|P2|COMPLETED|Overall Study||25
7530351|NCT03442829|18540550|P1|COMPLETED|Overall Study||23
7530352|NCT03442829|18540549|P2|STARTED|Overall Study||27
7530353|NCT03442829|18540550|P1|STARTED|Overall Study||27
7530354|NCT03442725|18540566|P2|NOT COMPLETED|Overall Study||0
7530355|NCT03442725|18540567|P1|NOT COMPLETED|Overall Study||0
7530356|NCT03442725|18540566|P2|COMPLETED|Overall Study||8
7530357|NCT03442725|18540567|P1|COMPLETED|Overall Study||8
7530358|NCT03442725|18540566|P2|STARTED|Overall Study||8
7530359|NCT03442725|18540567|P1|STARTED|Overall Study||8
7530360|NCT03442699|18540599|P1|NOT COMPLETED|Overall Study||0
7530361|NCT03442699|18540599|P1|COMPLETED|Overall Study||6
7530362|NCT03442699|18540599|P1|STARTED|Overall Study||6
7530363|NCT03442595|18540609|P2|NOT COMPLETED|Overall Study||0
7530364|NCT03442595|18540610|P1|NOT COMPLETED|Overall Study||94
7530365|NCT03442595|18540609|P2|COMPLETED|Overall Study||366
7530366|NCT03442595|18540610|P1|COMPLETED|Overall Study||366
7530367|NCT03442595|18540609|P2|STARTED|Overall Study||366
7530368|NCT03442595|18540610|P1|STARTED|Overall Study||460
7530369|NCT03442036|18540629|P2|NOT COMPLETED|Overall Study||0
7530370|NCT03442036|18540630|P1|NOT COMPLETED|Overall Study||0
7530371|NCT03442036|18540629|P2|COMPLETED|Overall Study||35
7530372|NCT03442036|18540630|P1|COMPLETED|Overall Study||35
7530373|NCT03442036|18540629|P2|STARTED|Overall Study||35
7530374|NCT03442036|18540630|P1|STARTED|Overall Study||35
7530375|NCT03441984|18540642|P12|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
7530376|NCT03441984|18540643|P11|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
7530377|NCT03441984|18540644|P10|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
7530378|NCT03441984|18540645|P9|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
7530379|NCT03441984|18540646|P8|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
7530380|NCT03441984|18540647|P7|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
7530381|NCT03441984|18540648|P6|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
7530382|NCT03441984|18540649|P5|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
7530383|NCT03441984|18540650|P4|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
7530384|NCT03441984|18540651|P3|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
7530385|NCT03441984|18540652|P2|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
7530386|NCT03441984|18540653|P1|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
7530387|NCT03441984|18540642|P12|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
7530388|NCT03441984|18540643|P11|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
7530389|NCT03441984|18540644|P10|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
7530390|NCT03441984|18540645|P9|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
7530391|NCT03441984|18540646|P8|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
7530392|NCT03441984|18540647|P7|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
7530393|NCT03441984|18540648|P6|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
7530394|NCT03441984|18540649|P5|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
7530395|NCT03441984|18540650|P4|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
7530396|NCT03441984|18540651|P3|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
7530397|NCT03441984|18540652|P2|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
7530398|NCT03441984|18540653|P1|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
7530399|NCT03441984|18540642|P12|STARTED|Part 2: Period 3 (Up to Day 4)||3
7530400|NCT03441984|18540643|P11|STARTED|Part 2: Period 3 (Up to Day 4)||3
7530401|NCT03441984|18540644|P10|STARTED|Part 2: Period 3 (Up to Day 4)||3
7530402|NCT03441984|18540645|P9|STARTED|Part 2: Period 3 (Up to Day 4)||3
7530403|NCT03441984|18540646|P8|STARTED|Part 2: Period 3 (Up to Day 4)||3
7530404|NCT03441984|18540647|P7|STARTED|Part 2: Period 3 (Up to Day 4)||3
7530405|NCT03441984|18540648|P6|STARTED|Part 2: Period 3 (Up to Day 4)||0
7530406|NCT03441984|18540649|P5|STARTED|Part 2: Period 3 (Up to Day 4)||0
7530407|NCT03441984|18540650|P4|STARTED|Part 2: Period 3 (Up to Day 4)||0
7530408|NCT03441984|18540651|P3|STARTED|Part 2: Period 3 (Up to Day 4)||0
7530409|NCT03441984|18540652|P2|STARTED|Part 2: Period 3 (Up to Day 4)||0
7530410|NCT03441984|18540653|P1|STARTED|Part 2: Period 3 (Up to Day 4)||0
7530411|NCT03441984|18540642|P12|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530412|NCT03441984|18540643|P11|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530413|NCT03441984|18540644|P10|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530414|NCT03441984|18540645|P9|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530415|NCT03441984|18540646|P8|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530416|NCT03441984|18540647|P7|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530417|NCT03441984|18540648|P6|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530418|NCT03441984|18540649|P5|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530419|NCT03441984|18540650|P4|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530420|NCT03441984|18540651|P3|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530421|NCT03441984|18540652|P2|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530422|NCT03441984|18540653|P1|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530423|NCT03441984|18540642|P12|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
7530424|NCT03441984|18540643|P11|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
7530425|NCT03441984|18540644|P10|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
7530426|NCT03441984|18540645|P9|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
7530427|NCT03441984|18540646|P8|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
7530428|NCT03441984|18540647|P7|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
7530429|NCT03441984|18540648|P6|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530430|NCT03441984|18540649|P5|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530431|NCT03441984|18540650|P4|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530432|NCT03441984|18540651|P3|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530433|NCT03441984|18540652|P2|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530434|NCT03441984|18540653|P1|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530435|NCT03441984|18540642|P12|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
7530436|NCT03441984|18540643|P11|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
7530437|NCT03441984|18540644|P10|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
7530438|NCT03441984|18540645|P9|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
7530439|NCT03441984|18540646|P8|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
7530440|NCT03441984|18540647|P7|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
7530441|NCT03441984|18540648|P6|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530442|NCT03441984|18540649|P5|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530443|NCT03441984|18540650|P4|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530444|NCT03441984|18540651|P3|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530445|NCT03441984|18540652|P2|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530446|NCT03441984|18540653|P1|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
7530447|NCT03441984|18540642|P12|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
7530448|NCT03441984|18540643|P11|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
7530449|NCT03441984|18540644|P10|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
7530450|NCT03441984|18540645|P9|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
7530451|NCT03441984|18540646|P8|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
7530452|NCT03441984|18540647|P7|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
7530453|NCT03441984|18540648|P6|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
7530454|NCT03441984|18540649|P5|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
7530455|NCT03441984|18540650|P4|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
7530456|NCT03441984|18540651|P3|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
7530457|NCT03441984|18540652|P2|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
7530458|NCT03441984|18540653|P1|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
7530459|NCT03441984|18540642|P12|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
7530460|NCT03441984|18540643|P11|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
7530461|NCT03441984|18540644|P10|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
7530462|NCT03441984|18540645|P9|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
7530463|NCT03441984|18540646|P8|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
7530464|NCT03441984|18540647|P7|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
7530465|NCT03441984|18540648|P6|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
7530466|NCT03441984|18540649|P5|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
7530467|NCT03441984|18540650|P4|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
7530468|NCT03441984|18540651|P3|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
7530469|NCT03441984|18540652|P2|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
7530470|NCT03441984|18540653|P1|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
7530471|NCT03441984|18540642|P12|STARTED|Part 2: Period 2 (Up to Day 4)||3
7530472|NCT03441984|18540643|P11|STARTED|Part 2: Period 2 (Up to Day 4)||3
7530473|NCT03441984|18540644|P10|STARTED|Part 2: Period 2 (Up to Day 4)||3
7530474|NCT03441984|18540645|P9|STARTED|Part 2: Period 2 (Up to Day 4)||3
7530475|NCT03441984|18540646|P8|STARTED|Part 2: Period 2 (Up to Day 4)||3
7530476|NCT03441984|18540647|P7|STARTED|Part 2: Period 2 (Up to Day 4)||3
7530477|NCT03441984|18540648|P6|STARTED|Part 2: Period 2 (Up to Day 4)||0
7530478|NCT03441984|18540649|P5|STARTED|Part 2: Period 2 (Up to Day 4)||0
7530479|NCT03441984|18540650|P4|STARTED|Part 2: Period 2 (Up to Day 4)||0
7530480|NCT03441984|18540651|P3|STARTED|Part 2: Period 2 (Up to Day 4)||0
7530481|NCT03441984|18540652|P2|STARTED|Part 2: Period 2 (Up to Day 4)||0
7530482|NCT03441984|18540653|P1|STARTED|Part 2: Period 2 (Up to Day 4)||0
7530483|NCT03441984|18540642|P12|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530484|NCT03441984|18540643|P11|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530485|NCT03441984|18540644|P10|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530486|NCT03441984|18540645|P9|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530487|NCT03441984|18540646|P8|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530488|NCT03441984|18540647|P7|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530489|NCT03441984|18540648|P6|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530490|NCT03441984|18540649|P5|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530491|NCT03441984|18540650|P4|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530492|NCT03441984|18540651|P3|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530493|NCT03441984|18540652|P2|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530494|NCT03441984|18540653|P1|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530495|NCT03441984|18540642|P12|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
7530496|NCT03441984|18540643|P11|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
7530497|NCT03441984|18540644|P10|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
7530498|NCT03441984|18540645|P9|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
7530499|NCT03441984|18540646|P8|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
7530500|NCT03441984|18540647|P7|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
7530501|NCT03441984|18540648|P6|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530502|NCT03441984|18540649|P5|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530503|NCT03441984|18540650|P4|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530504|NCT03441984|18540651|P3|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530505|NCT03441984|18540652|P2|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530506|NCT03441984|18540653|P1|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530507|NCT03441984|18540642|P12|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
7530508|NCT03441984|18540643|P11|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
7530509|NCT03441984|18540644|P10|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
7530510|NCT03441984|18540645|P9|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
7530511|NCT03441984|18540646|P8|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
7530512|NCT03441984|18540647|P7|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
7530513|NCT03441984|18540648|P6|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530514|NCT03441984|18540649|P5|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530515|NCT03441984|18540650|P4|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530516|NCT03441984|18540651|P3|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530517|NCT03441984|18540652|P2|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530518|NCT03441984|18540653|P1|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
7530519|NCT03441984|18540642|P12|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
7530520|NCT03441984|18540643|P11|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
7530521|NCT03441984|18540644|P10|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
7530522|NCT03441984|18540645|P9|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
7530523|NCT03441984|18540646|P8|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
7530524|NCT03441984|18540647|P7|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
7530525|NCT03441984|18540648|P6|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
7530526|NCT03441984|18540649|P5|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
7530527|NCT03441984|18540650|P4|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
7530528|NCT03441984|18540651|P3|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
7530529|NCT03441984|18540652|P2|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
7530530|NCT03441984|18540653|P1|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
7530531|NCT03441984|18540642|P12|COMPLETED|Part 2: Period 1(Up to Day 4)||3
7530532|NCT03441984|18540643|P11|COMPLETED|Part 2: Period 1(Up to Day 4)||3
7530533|NCT03441984|18540644|P10|COMPLETED|Part 2: Period 1(Up to Day 4)||3
7530534|NCT03441984|18540645|P9|COMPLETED|Part 2: Period 1(Up to Day 4)||3
7530535|NCT03441984|18540646|P8|COMPLETED|Part 2: Period 1(Up to Day 4)||3
7530536|NCT03441984|18540647|P7|COMPLETED|Part 2: Period 1(Up to Day 4)||3
7530537|NCT03441984|18540648|P6|COMPLETED|Part 2: Period 1(Up to Day 4)||0
7530538|NCT03441984|18540649|P5|COMPLETED|Part 2: Period 1(Up to Day 4)||0
7530539|NCT03441984|18540650|P4|COMPLETED|Part 2: Period 1(Up to Day 4)||0
7530540|NCT03441984|18540651|P3|COMPLETED|Part 2: Period 1(Up to Day 4)||0
7530541|NCT03441984|18540652|P2|COMPLETED|Part 2: Period 1(Up to Day 4)||0
7530542|NCT03441984|18540653|P1|COMPLETED|Part 2: Period 1(Up to Day 4)||0
7530543|NCT03441984|18540642|P12|STARTED|Part 2: Period 1(Up to Day 4)||3
7530544|NCT03441984|18540643|P11|STARTED|Part 2: Period 1(Up to Day 4)||3
7530545|NCT03441984|18540644|P10|STARTED|Part 2: Period 1(Up to Day 4)||3
7530546|NCT03441984|18540645|P9|STARTED|Part 2: Period 1(Up to Day 4)||3
7530547|NCT03441984|18540646|P8|STARTED|Part 2: Period 1(Up to Day 4)||3
7530548|NCT03441984|18540647|P7|STARTED|Part 2: Period 1(Up to Day 4)||3
7530549|NCT03441984|18540648|P6|STARTED|Part 2: Period 1(Up to Day 4)||0
7530550|NCT03441984|18540649|P5|STARTED|Part 2: Period 1(Up to Day 4)||0
7530551|NCT03441984|18540650|P4|STARTED|Part 2: Period 1(Up to Day 4)||0
7530552|NCT03441984|18540651|P3|STARTED|Part 2: Period 1(Up to Day 4)||0
7530553|NCT03441984|18540652|P2|STARTED|Part 2: Period 1(Up to Day 4)||0
7530554|NCT03441984|18540653|P1|STARTED|Part 2: Period 1(Up to Day 4)||0
7530555|NCT03441984|18540642|P12|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
7530556|NCT03441984|18540643|P11|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
7530557|NCT03441984|18540644|P10|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
7530558|NCT03441984|18540645|P9|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
7530559|NCT03441984|18540646|P8|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
7530560|NCT03441984|18540647|P7|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
7530561|NCT03441984|18540648|P6|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
7530562|NCT03441984|18540649|P5|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
7530563|NCT03441984|18540650|P4|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
7530564|NCT03441984|18540651|P3|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
7530565|NCT03441984|18540652|P2|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
7530566|NCT03441984|18540653|P1|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
7530567|NCT03441984|18540642|P12|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
7530568|NCT03441984|18540643|P11|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
7530569|NCT03441984|18540644|P10|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
7530570|NCT03441984|18540645|P9|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
7530571|NCT03441984|18540646|P8|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
7530572|NCT03441984|18540647|P7|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
7530573|NCT03441984|18540648|P6|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
7530574|NCT03441984|18540649|P5|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
7530575|NCT03441984|18540650|P4|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
7530576|NCT03441984|18540651|P3|COMPLETED|Part 1: Period 3 (Up to Day 4 )||2
7530577|NCT03441984|18540652|P2|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
7530578|NCT03441984|18540653|P1|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
7530579|NCT03441984|18540642|P12|STARTED|Part 1: Period 3 (Up to Day 4 )||0
7530580|NCT03441984|18540643|P11|STARTED|Part 1: Period 3 (Up to Day 4 )||0
7530581|NCT03441984|18540644|P10|STARTED|Part 1: Period 3 (Up to Day 4 )||0
7530582|NCT03441984|18540645|P9|STARTED|Part 1: Period 3 (Up to Day 4 )||0
7530583|NCT03441984|18540646|P8|STARTED|Part 1: Period 3 (Up to Day 4 )||0
7530584|NCT03441984|18540647|P7|STARTED|Part 1: Period 3 (Up to Day 4 )||0
7530585|NCT03441984|18540648|P6|STARTED|Part 1: Period 3 (Up to Day 4 )||3
7530586|NCT03441984|18540649|P5|STARTED|Part 1: Period 3 (Up to Day 4 )||3
7530587|NCT03441984|18540650|P4|STARTED|Part 1: Period 3 (Up to Day 4 )||3
7530588|NCT03441984|18540651|P3|STARTED|Part 1: Period 3 (Up to Day 4 )||2
7530589|NCT03441984|18540652|P2|STARTED|Part 1: Period 3 (Up to Day 4 )||3
7530590|NCT03441984|18540653|P1|STARTED|Part 1: Period 3 (Up to Day 4 )||3
7530591|NCT03441984|18540642|P12|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530592|NCT03441984|18540643|P11|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530593|NCT03441984|18540644|P10|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530594|NCT03441984|18540645|P9|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530595|NCT03441984|18540646|P8|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530596|NCT03441984|18540647|P7|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530597|NCT03441984|18540648|P6|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530598|NCT03441984|18540649|P5|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530599|NCT03441984|18540650|P4|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530600|NCT03441984|18540651|P3|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530601|NCT03441984|18540652|P2|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530602|NCT03441984|18540653|P1|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530603|NCT03441984|18540642|P12|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530604|NCT03441984|18540643|P11|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530605|NCT03441984|18540644|P10|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530606|NCT03441984|18540645|P9|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530607|NCT03441984|18540646|P8|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530608|NCT03441984|18540647|P7|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530609|NCT03441984|18540648|P6|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
7530610|NCT03441984|18540649|P5|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
7530611|NCT03441984|18540650|P4|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
7530612|NCT03441984|18540651|P3|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||2
7530613|NCT03441984|18540652|P2|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
7530614|NCT03441984|18540653|P1|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
7530615|NCT03441984|18540642|P12|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530616|NCT03441984|18540643|P11|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530617|NCT03441984|18540644|P10|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530618|NCT03441984|18540645|P9|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530619|NCT03441984|18540646|P8|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530620|NCT03441984|18540647|P7|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
7530621|NCT03441984|18540648|P6|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
7530622|NCT03441984|18540649|P5|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
7530623|NCT03441984|18540650|P4|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
7530624|NCT03441984|18540651|P3|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||2
7530625|NCT03441984|18540652|P2|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
7530626|NCT03441984|18540653|P1|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
7530627|NCT03441984|18540642|P12|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
7530628|NCT03441984|18540643|P11|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
7530629|NCT03441984|18540644|P10|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
7530630|NCT03441984|18540645|P9|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
7530631|NCT03441984|18540646|P8|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
7530632|NCT03441984|18540647|P7|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
7530633|NCT03441984|18540648|P6|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
7530634|NCT03441984|18540649|P5|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
7530635|NCT03441984|18540650|P4|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
7530636|NCT03441984|18540651|P3|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||1
7530637|NCT03441984|18540652|P2|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
7530638|NCT03441984|18540653|P1|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
7530639|NCT03441984|18540642|P12|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
7530640|NCT03441984|18540643|P11|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
7530641|NCT03441984|18540644|P10|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
7530642|NCT03441984|18540645|P9|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
7530643|NCT03441984|18540646|P8|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
7530644|NCT03441984|18540647|P7|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
7530645|NCT03441984|18540648|P6|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
7530646|NCT03441984|18540649|P5|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
7530647|NCT03441984|18540650|P4|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
7530648|NCT03441984|18540651|P3|COMPLETED|Part 1: Period 2 (Up to Day 4 )||2
7530649|NCT03441984|18540652|P2|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
7530650|NCT03441984|18540653|P1|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
7530651|NCT03441984|18540642|P12|STARTED|Part 1: Period 2 (Up to Day 4 )||0
7530652|NCT03441984|18540643|P11|STARTED|Part 1: Period 2 (Up to Day 4 )||0
7530653|NCT03441984|18540644|P10|STARTED|Part 1: Period 2 (Up to Day 4 )||0
7530654|NCT03441984|18540645|P9|STARTED|Part 1: Period 2 (Up to Day 4 )||0
7530655|NCT03441984|18540646|P8|STARTED|Part 1: Period 2 (Up to Day 4 )||0
7530656|NCT03441984|18540647|P7|STARTED|Part 1: Period 2 (Up to Day 4 )||0
7530657|NCT03441984|18540648|P6|STARTED|Part 1: Period 2 (Up to Day 4 )||3
7530658|NCT03441984|18540649|P5|STARTED|Part 1: Period 2 (Up to Day 4 )||3
7530659|NCT03441984|18540650|P4|STARTED|Part 1: Period 2 (Up to Day 4 )||3
7530660|NCT03441984|18540651|P3|STARTED|Part 1: Period 2 (Up to Day 4 )||3
7530661|NCT03441984|18540652|P2|STARTED|Part 1: Period 2 (Up to Day 4 )||3
7530662|NCT03441984|18540653|P1|STARTED|Part 1: Period 2 (Up to Day 4 )||3
7530663|NCT03441984|18540642|P12|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530664|NCT03441984|18540643|P11|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530665|NCT03441984|18540644|P10|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530666|NCT03441984|18540645|P9|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530667|NCT03441984|18540646|P8|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530668|NCT03441984|18540647|P7|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530669|NCT03441984|18540648|P6|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530670|NCT03441984|18540649|P5|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530671|NCT03441984|18540650|P4|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530672|NCT03441984|18540651|P3|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530673|NCT03441984|18540652|P2|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530674|NCT03441984|18540653|P1|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530675|NCT03441984|18540642|P12|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530676|NCT03441984|18540643|P11|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530677|NCT03441984|18540644|P10|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530678|NCT03441984|18540645|P9|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530679|NCT03441984|18540646|P8|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530680|NCT03441984|18540647|P7|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530681|NCT03441984|18540648|P6|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
7530682|NCT03441984|18540649|P5|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
7530683|NCT03441984|18540650|P4|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
7530684|NCT03441984|18540651|P3|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
7530685|NCT03441984|18540652|P2|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
7530686|NCT03441984|18540653|P1|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
7530687|NCT03441984|18540642|P12|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530688|NCT03441984|18540643|P11|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530689|NCT03441984|18540644|P10|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530690|NCT03441984|18540645|P9|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530691|NCT03441984|18540646|P8|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530692|NCT03441984|18540647|P7|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
7530693|NCT03441984|18540648|P6|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
7530694|NCT03441984|18540649|P5|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
7530695|NCT03441984|18540650|P4|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
7530696|NCT03441984|18540651|P3|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
7530697|NCT03441984|18540652|P2|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
7530698|NCT03441984|18540653|P1|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
7530699|NCT03441984|18540642|P12|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
7530700|NCT03441984|18540643|P11|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
7530701|NCT03441984|18540644|P10|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
7530702|NCT03441984|18540645|P9|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
7530703|NCT03441984|18540646|P8|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
7530704|NCT03441984|18540647|P7|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
7530705|NCT03441984|18540648|P6|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
7530706|NCT03441984|18540649|P5|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
7530707|NCT03441984|18540650|P4|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
7530708|NCT03441984|18540651|P3|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
7530709|NCT03441984|18540652|P2|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
7530710|NCT03441984|18540653|P1|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
7530711|NCT03441984|18540642|P12|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
7530712|NCT03441984|18540643|P11|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
7530713|NCT03441984|18540644|P10|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
7530714|NCT03441984|18540645|P9|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
7530715|NCT03441984|18540646|P8|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
7530716|NCT03441984|18540647|P7|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
7530717|NCT03441984|18540648|P6|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
7530718|NCT03441984|18540649|P5|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
7530719|NCT03441984|18540650|P4|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
7530720|NCT03441984|18540651|P3|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
7530721|NCT03441984|18540652|P2|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
7530722|NCT03441984|18540653|P1|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
7530723|NCT03441984|18540642|P12|STARTED|Part 1: Period 1 (Up to Day 4)||0
7530724|NCT03441984|18540643|P11|STARTED|Part 1: Period 1 (Up to Day 4)||0
7530725|NCT03441984|18540644|P10|STARTED|Part 1: Period 1 (Up to Day 4)||0
7530726|NCT03441984|18540645|P9|STARTED|Part 1: Period 1 (Up to Day 4)||0
7530727|NCT03441984|18540646|P8|STARTED|Part 1: Period 1 (Up to Day 4)||0
7530728|NCT03441984|18540647|P7|STARTED|Part 1: Period 1 (Up to Day 4)||0
7530729|NCT03441984|18540648|P6|STARTED|Part 1: Period 1 (Up to Day 4)||3
7530730|NCT03441984|18540649|P5|STARTED|Part 1: Period 1 (Up to Day 4)||3
7530731|NCT03441984|18540650|P4|STARTED|Part 1: Period 1 (Up to Day 4)||3
7530732|NCT03441984|18540651|P3|STARTED|Part 1: Period 1 (Up to Day 4)||3
7530733|NCT03441984|18540652|P2|STARTED|Part 1: Period 1 (Up to Day 4)||3
7530734|NCT03441984|18540653|P1|STARTED|Part 1: Period 1 (Up to Day 4)||3
7530735|NCT03441789|18541014|P2|NOT COMPLETED|Overall Study||4
7530736|NCT03441789|18541015|P1|NOT COMPLETED|Overall Study||1
7530737|NCT03441789|18541014|P2|COMPLETED|Overall Study||10
7530738|NCT03441789|18541015|P1|COMPLETED|Overall Study||13
7530739|NCT03441789|18541014|P2|STARTED|Overall Study||14
7530740|NCT03441789|18541015|P1|STARTED|Overall Study||14
7530741|NCT03441633|18541041|P10|NOT COMPLETED|Overall Study||0
7530742|NCT03441633|18541042|P9|NOT COMPLETED|Overall Study||0
7530743|NCT03441633|18541043|P8|NOT COMPLETED|Overall Study||0
7530744|NCT03441633|18541044|P7|NOT COMPLETED|Overall Study||0
7530745|NCT03441633|18541045|P6|NOT COMPLETED|Overall Study||0
7530746|NCT03441633|18541046|P5|NOT COMPLETED|Overall Study||0
7530747|NCT03441633|18541047|P4|NOT COMPLETED|Overall Study||0
7530748|NCT03441633|18541048|P3|NOT COMPLETED|Overall Study||0
7530749|NCT03441633|18541049|P2|NOT COMPLETED|Overall Study||0
7530750|NCT03441633|18541050|P1|NOT COMPLETED|Overall Study||0
7530751|NCT03441633|18541041|P10|COMPLETED|Overall Study||1562
7530752|NCT03441633|18541042|P9|COMPLETED|Overall Study||5132
7530753|NCT03441633|18541043|P8|COMPLETED|Overall Study||953
7530754|NCT03441633|18541044|P7|COMPLETED|Overall Study||2855
7530755|NCT03441633|18541045|P6|COMPLETED|Overall Study||363
7530756|NCT03441633|18541046|P5|COMPLETED|Overall Study||2286
7530757|NCT03441633|18541047|P4|COMPLETED|Overall Study||192
7530758|NCT03441633|18541048|P3|COMPLETED|Overall Study||32212
7530759|NCT03441633|18541049|P2|COMPLETED|Overall Study||1423
7530760|NCT03441633|18541050|P1|COMPLETED|Overall Study||4712
7530761|NCT03441633|18541041|P10|STARTED|Overall Study||1562
7530762|NCT03441633|18541042|P9|STARTED|Overall Study||5132
7530763|NCT03441633|18541043|P8|STARTED|Overall Study||953
7530764|NCT03441633|18541044|P7|STARTED|Overall Study||2855
7530765|NCT03441633|18541045|P6|STARTED|Overall Study||363
7530766|NCT03441633|18541046|P5|STARTED|Overall Study||2286
7530767|NCT03441633|18541047|P4|STARTED|Overall Study||192
7530768|NCT03441633|18541048|P3|STARTED|Overall Study||32212
7530769|NCT03441633|18541049|P2|STARTED|Overall Study||1423
7530770|NCT03441633|18541050|P1|STARTED|Overall Study||4712
7530771|NCT03441594|18541190|P1|NOT COMPLETED|Overall Study||0
7530772|NCT03441594|18541190|P1|COMPLETED|Overall Study||56
7530773|NCT03441594|18541190|P1|STARTED|Overall Study||56
7530774|NCT03441269|18541198|P3|NOT COMPLETED|Overall Study||1
7530775|NCT03441269|18541199|P2|NOT COMPLETED|Overall Study||1
7530776|NCT03441269|18541200|P1|NOT COMPLETED|Overall Study||0
7530777|NCT03441269|18541198|P3|COMPLETED|Overall Study||74
7530778|NCT03441269|18541199|P2|COMPLETED|Overall Study||74
7530779|NCT03441269|18541200|P1|COMPLETED|Overall Study||75
7530780|NCT03441269|18541198|P3|STARTED|Overall Study||75
7530781|NCT03441269|18541199|P2|STARTED|Overall Study||75
7530782|NCT03441269|18541200|P1|STARTED|Overall Study||75
7530783|NCT03441178|18541214|P3|NOT COMPLETED|Overall Study||1
7530784|NCT03441178|18541215|P2|NOT COMPLETED|Overall Study||1
7530785|NCT03441178|18541216|P1|NOT COMPLETED|Overall Study||0
7530786|NCT03441178|18541214|P3|COMPLETED|Overall Study||20
7530787|NCT03441178|18541215|P2|COMPLETED|Overall Study||43
7530788|NCT03441178|18541216|P1|COMPLETED|Overall Study||36
7530789|NCT03441178|18541214|P3|STARTED|Overall Study||21
7530790|NCT03441178|18541215|P2|STARTED|Overall Study||44
7530791|NCT03441178|18541216|P1|STARTED|Overall Study||36
7530792|NCT03440918|18541236|P2|NOT COMPLETED|Overall Study||16
7530793|NCT03440918|18541237|P1|NOT COMPLETED|Overall Study||0
7530794|NCT03440918|18541236|P2|COMPLETED|Overall Study||122
7530795|NCT03440918|18541237|P1|COMPLETED|Overall Study||133
7530796|NCT03440918|18541236|P2|STARTED|Overall Study||138
7530797|NCT03440918|18541237|P1|STARTED|Overall Study||133
7530798|NCT03440619|18541265|P1|NOT COMPLETED|Overall Study||0
7530799|NCT03440619|18541265|P1|COMPLETED|Overall Study||28
7530800|NCT03440619|18541265|P1|STARTED|Overall Study||28
7530801|NCT03440424|18541272|P3|NOT COMPLETED|Overall Study||0
7530802|NCT03440424|18541273|P2|NOT COMPLETED|Overall Study||0
7530803|NCT03440424|18541274|P1|NOT COMPLETED|Overall Study||0
7530804|NCT03440424|18541272|P3|COMPLETED|Overall Study||8
7530805|NCT03440424|18541273|P2|COMPLETED|Overall Study||8
7530806|NCT03440424|18541274|P1|COMPLETED|Overall Study||8
7530807|NCT03440424|18541272|P3|STARTED|Overall Study||8
7530808|NCT03440424|18541273|P2|STARTED|Overall Study||8
7530809|NCT03440424|18541274|P1|STARTED|Overall Study||8
7530810|NCT03439124|18541335|P2|NOT COMPLETED|Overall Study||0
7530811|NCT03439124|18541336|P1|NOT COMPLETED|Overall Study||4
7530812|NCT03439124|18541335|P2|COMPLETED|Overall Study||44
7530813|NCT03439124|18541336|P1|COMPLETED|Overall Study||90
7530814|NCT03439124|18541335|P2|STARTED|Overall Study||44
7530815|NCT03439124|18541336|P1|STARTED|Overall Study||94
7530816|NCT03439072|18541350|P2|NOT COMPLETED|Overall Study||4
7530817|NCT03439072|18541351|P1|NOT COMPLETED|Overall Study||2
7530818|NCT03439072|18541350|P2|COMPLETED|Overall Study|1 subject dropped before Lilly Glucagon; 3 others after Lilly Glucagon (N=39 Lilly; N=36 G-Pen)|36
7530819|NCT03439072|18541351|P1|COMPLETED|Overall Study|1 subject dropped before G-Pen; another after G-Pen (n=40 G-Pen; N=39 Lilly Glucagon)|39
7530820|NCT03439072|18541350|P2|STARTED|Overall Study||40
7530821|NCT03439072|18541351|P1|STARTED|Overall Study||41
7530822|NCT03438578|18541385|P2|NOT COMPLETED|Overall Study||4
7530823|NCT03438578|18541386|P1|NOT COMPLETED|Overall Study||1
7530824|NCT03438578|18541385|P2|COMPLETED|Overall Study||96
7530825|NCT03438578|18541386|P1|COMPLETED|Overall Study||99
7530826|NCT03438578|18541385|P2|STARTED|Overall Study||100
7530827|NCT03438578|18541386|P1|STARTED|Overall Study||100
7530828|NCT03438539|18541402|P6|NOT COMPLETED|Overall Study||8
7530829|NCT03438539|18541403|P5|NOT COMPLETED|Overall Study||3
7530830|NCT03438539|18541404|P4|NOT COMPLETED|Overall Study||9
7530831|NCT03438539|18541405|P3|NOT COMPLETED|Overall Study||10
7530832|NCT03438539|18541406|P2|NOT COMPLETED|Overall Study||4
7530833|NCT03438539|18541407|P1|NOT COMPLETED|Overall Study||8
7530834|NCT03438539|18541402|P6|COMPLETED|Overall Study||66
7530835|NCT03438539|18541403|P5|COMPLETED|Overall Study||70
7530836|NCT03438539|18541404|P4|COMPLETED|Overall Study||64
7530837|NCT03438539|18541405|P3|COMPLETED|Overall Study||66
7530838|NCT03438539|18541406|P2|COMPLETED|Overall Study||68
7530839|NCT03438539|18541407|P1|COMPLETED|Overall Study||68
7530840|NCT03438539|18541402|P6|STARTED|Overall Study||74
7530841|NCT03438539|18541403|P5|STARTED|Overall Study||73
7530842|NCT03438539|18541404|P4|STARTED|Overall Study||73
7530843|NCT03438539|18541405|P3|STARTED|Overall Study||76
7530844|NCT03438539|18541406|P2|STARTED|Overall Study||72
7530845|NCT03438539|18541407|P1|STARTED|Overall Study||76
7530846|NCT03438383|18541435|P2|NOT COMPLETED|Overall Study||3
7530847|NCT03438383|18541436|P1|NOT COMPLETED|Overall Study||9
7530848|NCT03438383|18541435|P2|COMPLETED|Overall Study||21
7530849|NCT03438383|18541436|P1|COMPLETED|Overall Study||14
7530850|NCT03438383|18541435|P2|STARTED|Overall Study||24
7530851|NCT03438383|18541436|P1|STARTED|Overall Study||23
7530852|NCT03438266|18541456|P1|NOT COMPLETED|Overall Study||0
7530853|NCT03438266|18541456|P1|COMPLETED|Overall Study||60
7530854|NCT03438266|18541456|P1|STARTED|Overall Study||60
7530855|NCT03437733|18541467|P2|NOT COMPLETED|Overall Study||3
7530856|NCT03437733|18541468|P1|NOT COMPLETED|Overall Study||0
7530857|NCT03437733|18541467|P2|COMPLETED|Overall Study||87
7530858|NCT03437733|18541468|P1|COMPLETED|Overall Study||8
7530859|NCT03437733|18541467|P2|Safety|Overall Study||87
7530860|NCT03437733|18541468|P1|Safety|Overall Study||8
7530861|NCT03437733|18541467|P2|STARTED|Overall Study||90
7530862|NCT03437733|18541468|P1|STARTED|Overall Study||8
7530863|NCT03437564|18541491|P2|NOT COMPLETED|Overall Study||0
7530864|NCT03437564|18541492|P1|NOT COMPLETED|Overall Study||0
7530865|NCT03437564|18541491|P2|COMPLETED|Overall Study||14
7530866|NCT03437564|18541492|P1|COMPLETED|Overall Study||14
7530867|NCT03437564|18541491|P2|STARTED|Overall Study||14
7530868|NCT03437564|18541492|P1|STARTED|Overall Study||14
7530869|NCT03437447|18541523|P3|NOT COMPLETED|Treatment Period 3||0
7530870|NCT03437447|18541524|P2|NOT COMPLETED|Treatment Period 3||0
7530871|NCT03437447|18541525|P1|NOT COMPLETED|Treatment Period 3||0
7530872|NCT03437447|18541523|P3|COMPLETED|Treatment Period 3||19
7530873|NCT03437447|18541524|P2|COMPLETED|Treatment Period 3||20
7530874|NCT03437447|18541525|P1|COMPLETED|Treatment Period 3||20
7530875|NCT03437447|18541523|P3|STARTED|Treatment Period 3||19
7530876|NCT03437447|18541524|P2|STARTED|Treatment Period 3||20
7530877|NCT03437447|18541525|P1|STARTED|Treatment Period 3||20
7530878|NCT03437447|18541523|P3|NOT COMPLETED|Treatment Period 2||0
7530879|NCT03437447|18541524|P2|NOT COMPLETED|Treatment Period 2||0
7530880|NCT03437447|18541525|P1|NOT COMPLETED|Treatment Period 2||0
7530881|NCT03437447|18541523|P3|COMPLETED|Treatment Period 2||19
7530882|NCT03437447|18541524|P2|COMPLETED|Treatment Period 2||20
7530883|NCT03437447|18541525|P1|COMPLETED|Treatment Period 2||20
7530884|NCT03437447|18541523|P3|STARTED|Treatment Period 2||19
7530885|NCT03437447|18541524|P2|STARTED|Treatment Period 2||20
7530886|NCT03437447|18541525|P1|STARTED|Treatment Period 2||20
7530887|NCT03437447|18541523|P3|NOT COMPLETED|Treatment Period 1||1
7530888|NCT03437447|18541524|P2|NOT COMPLETED|Treatment Period 1||0
7530889|NCT03437447|18541525|P1|NOT COMPLETED|Treatment Period 1||0
7530890|NCT03437447|18541523|P3|COMPLETED|Treatment Period 1||19
7530891|NCT03437447|18541524|P2|COMPLETED|Treatment Period 1||20
7530892|NCT03437447|18541525|P1|COMPLETED|Treatment Period 1||20
7530893|NCT03437447|18541523|P3|STARTED|Treatment Period 1||20
7530894|NCT03437447|18541524|P2|STARTED|Treatment Period 1||20
7530895|NCT03437447|18541525|P1|STARTED|Treatment Period 1||20
7530896|NCT03436732|18541580|P2|NOT COMPLETED|Overall Study||1
7530897|NCT03436732|18541581|P1|NOT COMPLETED|Overall Study||4
7530898|NCT03436732|18541580|P2|COMPLETED|Overall Study||0
7530899|NCT03436732|18541581|P1|COMPLETED|Overall Study||0
7530900|NCT03436732|18541580|P2|STARTED|Overall Study||1
7530901|NCT03436732|18541581|P1|STARTED|Overall Study||4
7530902|NCT03436420|18541594|P1|NOT COMPLETED|Overall Study||3
7530903|NCT03436420|18541594|P1|COMPLETED|Overall Study||3
7530904|NCT03436420|18541594|P1|STARTED|Overall Study||6
7530905|NCT03436147|18541637|P2|NOT COMPLETED|Overall Study||11
7530906|NCT03436147|18541638|P1|NOT COMPLETED|Overall Study||4
7530907|NCT03436147|18541637|P2|COMPLETED|Overall Study||19
7530908|NCT03436147|18541638|P1|COMPLETED|Overall Study||15
7530909|NCT03436147|18541637|P2|STARTED|Overall Study||30
7530910|NCT03436147|18541638|P1|STARTED|Overall Study||19
7530911|NCT03435783|18541650|P2|NOT COMPLETED|Overall Study||1
7530912|NCT03435783|18541651|P1|NOT COMPLETED|Overall Study||0
7530913|NCT03435783|18541650|P2|COMPLETED|Overall Study||19
7530914|NCT03435783|18541651|P1|COMPLETED|Overall Study||20
7530915|NCT03435783|18541650|P2|STARTED|Overall Study||20
7530916|NCT03435783|18541651|P1|STARTED|Overall Study||20
7530917|NCT03435562|18541665|P1|NOT COMPLETED|Overall Study||4
7530918|NCT03435562|18541665|P1|COMPLETED|Overall Study||18
7530919|NCT03435562|18541665|P1|STARTED|Overall Study||22
7530920|NCT03435497|18541747|P2|NOT COMPLETED|Overall Study||6
7530921|NCT03435497|18541748|P1|NOT COMPLETED|Overall Study||2
7530922|NCT03435497|18541747|P2|COMPLETED|Overall Study||41
7530923|NCT03435497|18541748|P1|COMPLETED|Overall Study||49
7530924|NCT03435497|18541747|P2|STARTED|Overall Study||47
7530925|NCT03435497|18541748|P1|STARTED|Overall Study||51
7530926|NCT03435185|18541764|P2|NOT COMPLETED|Overall Study||15
7530927|NCT03435185|18541765|P1|NOT COMPLETED|Overall Study||1
7530928|NCT03435185|18541764|P2|COMPLETED|Overall Study||28
7530929|NCT03435185|18541765|P1|COMPLETED|Overall Study||43
7530930|NCT03435185|18541764|P2|STARTED|Overall Study||43
7530931|NCT03435185|18541765|P1|STARTED|Overall Study||44
7530932|NCT03434977|18541775|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
7530933|NCT03434977|18541776|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
7530934|NCT03434977|18541775|P2|COMPLETED|Intervention Period 2 (6 Days)||5
7530935|NCT03434977|18541776|P1|COMPLETED|Intervention Period 2 (6 Days)||6
7530936|NCT03434977|18541775|P2|STARTED|Intervention Period 2 (6 Days)||5
7530937|NCT03434977|18541776|P1|STARTED|Intervention Period 2 (6 Days)||6
7530938|NCT03434977|18541775|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||1
7530939|NCT03434977|18541776|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||0
7530940|NCT03434977|18541775|P2|COMPLETED|Washout Period (at Least 6 Days)||5
7530941|NCT03434977|18541776|P1|COMPLETED|Washout Period (at Least 6 Days)||6
7530942|NCT03434977|18541775|P2|STARTED|Washout Period (at Least 6 Days)||6
7530943|NCT03434977|18541776|P1|STARTED|Washout Period (at Least 6 Days)||6
7530944|NCT03434977|18541775|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
7530945|NCT03434977|18541776|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
7530946|NCT03434977|18541775|P2|COMPLETED|Intervention Period 1 (6 Days)||6
7530947|NCT03434977|18541776|P1|COMPLETED|Intervention Period 1 (6 Days)||6
7530948|NCT03434977|18541775|P2|STARTED|Intervention Period 1 (6 Days)||6
7530949|NCT03434977|18541776|P1|STARTED|Intervention Period 1 (6 Days)||6
7530950|NCT03434457|18541810|P1|NOT COMPLETED|Overall Study||0
7530951|NCT03434457|18541810|P1|COMPLETED|Overall Study||630
7530952|NCT03434457|18541810|P1|STARTED|Overall Study||630
7530953|NCT03434249|18541843|P2|NOT COMPLETED|Overall Study||3
7530954|NCT03434249|18541844|P1|NOT COMPLETED|Overall Study||5
7530955|NCT03434249|18541843|P2|COMPLETED|Overall Study||37
7530956|NCT03434249|18541844|P1|COMPLETED|Overall Study||35
7530957|NCT03434249|18541843|P2|STARTED|Overall Study||40
7530958|NCT03434249|18541844|P1|STARTED|Overall Study||40
7530959|NCT03434119|18541878|P2|NOT COMPLETED|Overall Study||113
7530960|NCT03434119|18541879|P1|NOT COMPLETED|Overall Study||107
7530961|NCT03434119|18541878|P2|COMPLETED|Overall Study||12
7530962|NCT03434119|18541879|P1|COMPLETED|Overall Study||9
7530963|NCT03434119|18541878|P2|Treated|Overall Study||125
7530964|NCT03434119|18541879|P1|Treated|Overall Study||115
7530965|NCT03434119|18541878|P2|STARTED|Overall Study||125
7530966|NCT03434119|18541879|P1|STARTED|Overall Study||116
7530967|NCT03433794|18541900|P3|NOT COMPLETED|9-Month Assessment||142
7530968|NCT03433794|18541901|P2|NOT COMPLETED|9-Month Assessment||121
7530969|NCT03433794|18541902|P1|NOT COMPLETED|9-Month Assessment||134
7530970|NCT03433794|18541900|P3|COMPLETED|9-Month Assessment||39
7530971|NCT03433794|18541901|P2|COMPLETED|9-Month Assessment||52
7530972|NCT03433794|18541902|P1|COMPLETED|9-Month Assessment||49
7530973|NCT03433794|18541900|P3|STARTED|9-Month Assessment||181
7530974|NCT03433794|18541901|P2|STARTED|9-Month Assessment||173
7530975|NCT03433794|18541902|P1|STARTED|9-Month Assessment||183
7530976|NCT03433794|18541900|P3|NOT COMPLETED|6-Month Assessment||131
7530977|NCT03433794|18541901|P2|NOT COMPLETED|6-Month Assessment||115
7530978|NCT03433794|18541902|P1|NOT COMPLETED|6-Month Assessment||118
7530979|NCT03433794|18541900|P3|COMPLETED|6-Month Assessment||50
7530980|NCT03433794|18541901|P2|COMPLETED|6-Month Assessment||58
7530981|NCT03433794|18541902|P1|COMPLETED|6-Month Assessment||65
7530982|NCT03433794|18541900|P3|STARTED|6-Month Assessment||181
7530983|NCT03433794|18541901|P2|STARTED|6-Month Assessment||173
7530984|NCT03433794|18541902|P1|STARTED|6-Month Assessment||183
7530985|NCT03433794|18541900|P3|NOT COMPLETED|3-Month Assessment||110
7530986|NCT03433794|18541901|P2|NOT COMPLETED|3-Month Assessment||100
7530987|NCT03433794|18541902|P1|NOT COMPLETED|3-Month Assessment||114
7530988|NCT03433794|18541900|P3|COMPLETED|3-Month Assessment||71
7530989|NCT03433794|18541901|P2|COMPLETED|3-Month Assessment||73
7530990|NCT03433794|18541902|P1|COMPLETED|3-Month Assessment||69
7530991|NCT03433794|18541900|P3|STARTED|3-Month Assessment||181
7530992|NCT03433794|18541901|P2|STARTED|3-Month Assessment||173
7530993|NCT03433794|18541902|P1|STARTED|3-Month Assessment||183
7530994|NCT03433794|18541900|P3|NOT COMPLETED|6-Week Assessment||101
7530995|NCT03433794|18541901|P2|NOT COMPLETED|6-Week Assessment||88
7530996|NCT03433794|18541902|P1|NOT COMPLETED|6-Week Assessment||89
7530997|NCT03433794|18541900|P3|COMPLETED|6-Week Assessment||80
7530998|NCT03433794|18541901|P2|COMPLETED|6-Week Assessment||85
7530999|NCT03433794|18541902|P1|COMPLETED|6-Week Assessment||94
7531000|NCT03433794|18541900|P3|STARTED|6-Week Assessment||181
7531001|NCT03433794|18541901|P2|STARTED|6-Week Assessment||173
7531002|NCT03433794|18541902|P1|STARTED|6-Week Assessment||183
7531003|NCT03433794|18541900|P3|NOT COMPLETED|4-Week Assessment||90
7531004|NCT03433794|18541901|P2|NOT COMPLETED|4-Week Assessment||78
7531005|NCT03433794|18541902|P1|NOT COMPLETED|4-Week Assessment||85
7531006|NCT03433794|18541900|P3|COMPLETED|4-Week Assessment||91
7531007|NCT03433794|18541901|P2|COMPLETED|4-Week Assessment||95
7531008|NCT03433794|18541902|P1|COMPLETED|4-Week Assessment||98
7531009|NCT03433794|18541900|P3|STARTED|4-Week Assessment||181
7531010|NCT03433794|18541901|P2|STARTED|4-Week Assessment||173
7531011|NCT03433794|18541902|P1|STARTED|4-Week Assessment||183
7531012|NCT03433794|18541900|P3|NOT COMPLETED|2-Week Assessment||72
7531013|NCT03433794|18541901|P2|NOT COMPLETED|2-Week Assessment||61
7531014|NCT03433794|18541902|P1|NOT COMPLETED|2-Week Assessment||66
7531015|NCT03433794|18541900|P3|COMPLETED|2-Week Assessment||109
7531016|NCT03433794|18541901|P2|COMPLETED|2-Week Assessment||112
7531017|NCT03433794|18541902|P1|COMPLETED|2-Week Assessment||117
7531018|NCT03433794|18541900|P3|STARTED|2-Week Assessment||181
7531019|NCT03433794|18541901|P2|STARTED|2-Week Assessment||173
7531020|NCT03433794|18541902|P1|STARTED|2-Week Assessment||183
7531021|NCT03433794|18541900|P3|NOT COMPLETED|Baseline||0
7531022|NCT03433794|18541901|P2|NOT COMPLETED|Baseline||0
7531023|NCT03433794|18541902|P1|NOT COMPLETED|Baseline||0
7531024|NCT03433794|18541900|P3|COMPLETED|Baseline||181
7531025|NCT03433794|18541901|P2|COMPLETED|Baseline||173
7531026|NCT03433794|18541902|P1|COMPLETED|Baseline||183
7531027|NCT03433794|18541900|P3|STARTED|Baseline||181
7531028|NCT03433794|18541901|P2|STARTED|Baseline||173
7531029|NCT03433794|18541902|P1|STARTED|Baseline||183
7531030|NCT03433703|18541913|P1|NOT COMPLETED|Overall Study||2
7531031|NCT03433703|18541913|P1|COMPLETED|Overall Study||0
7531032|NCT03433703|18541913|P1|STARTED|Overall Study||2
7531033|NCT03433677|18541922|P2|NOT COMPLETED|Period 2||1
7531034|NCT03433677|18541923|P1|NOT COMPLETED|Period 2||1
7531035|NCT03433677|18541922|P2|COMPLETED|Period 2||24
7531036|NCT03433677|18541923|P1|COMPLETED|Period 2||22
7531037|NCT03433677|18541922|P2|Received at Least 1 Dose of Study Drug|Period 2||25
7531038|NCT03433677|18541923|P1|Received at Least 1 Dose of Study Drug|Period 2||23
7531039|NCT03433677|18541922|P2|STARTED|Period 2||25
7531040|NCT03433677|18541923|P1|STARTED|Period 2||23
7531041|NCT03433677|18541922|P2|NOT COMPLETED|Period 1||0
7531042|NCT03433677|18541923|P1|NOT COMPLETED|Period 1||1
7531043|NCT03433677|18541922|P2|COMPLETED|Period 1||25
7531044|NCT03433677|18541923|P1|COMPLETED|Period 1||23
7531045|NCT03433677|18541922|P2|Received at Least 1 Dose of Study Drug|Period 1||25
7531046|NCT03433677|18541923|P1|Received at Least 1 Dose of Study Drug|Period 1||24
7531047|NCT03433677|18541922|P2|STARTED|Period 1||25
7531048|NCT03433677|18541923|P1|STARTED|Period 1||24
7531049|NCT03432533|18541943|P2|NOT COMPLETED|Overall Study||11
7531050|NCT03432533|18541944|P1|NOT COMPLETED|Overall Study||15
7531051|NCT03432533|18541943|P2|COMPLETED|Overall Study||131
7531052|NCT03432533|18541944|P1|COMPLETED|Overall Study||126
7531053|NCT03432533|18541943|P2|Completed 6-Month Treatment Period|Overall Study||137
7531054|NCT03432533|18541944|P1|Completed 6-Month Treatment Period|Overall Study||136
7531055|NCT03432533|18541943|P2|STARTED|Overall Study||142
7531056|NCT03432533|18541944|P1|STARTED|Overall Study||141
7531057|NCT03432390|18541960|P2|NOT COMPLETED|Recovery Period||0
7531058|NCT03432390|18541961|P1|NOT COMPLETED|Recovery Period||0
7531059|NCT03432390|18541960|P2|COMPLETED|Recovery Period||34
7531060|NCT03432390|18541961|P1|COMPLETED|Recovery Period||34
7531061|NCT03432390|18541960|P2|STARTED|Recovery Period||34
7531062|NCT03432390|18541961|P1|STARTED|Recovery Period||34
7531063|NCT03432390|18541960|P2|NOT COMPLETED|Apnea Period||2
7531064|NCT03432390|18541961|P1|NOT COMPLETED|Apnea Period||2
7531065|NCT03432390|18541960|P2|COMPLETED|Apnea Period||34
7531066|NCT03432390|18541961|P1|COMPLETED|Apnea Period||34
7531067|NCT03432390|18541960|P2|STARTED|Apnea Period||36
7531068|NCT03432390|18541961|P1|STARTED|Apnea Period||36
7531069|NCT03431441|18541971|P1|NOT COMPLETED|Overall Study||5
7531070|NCT03431441|18541971|P1|COMPLETED|Overall Study||19
7531071|NCT03431441|18541971|P1|STARTED|Overall Study||24
7531072|NCT03431012|18541979|P4|NOT COMPLETED|Overall Study||0
7531073|NCT03431012|18541980|P3|NOT COMPLETED|Overall Study||0
7531074|NCT03431012|18541981|P2|NOT COMPLETED|Overall Study||0
7531075|NCT03431012|18541982|P1|NOT COMPLETED|Overall Study||0
7531076|NCT03431012|18541979|P4|COMPLETED|Overall Study||53
7531077|NCT03431012|18541980|P3|COMPLETED|Overall Study||56
7531078|NCT03431012|18541981|P2|COMPLETED|Overall Study||60
7531079|NCT03431012|18541982|P1|COMPLETED|Overall Study||47
7531080|NCT03431012|18541979|P4|STARTED|Overall Study||53
7531081|NCT03431012|18541980|P3|STARTED|Overall Study||56
7531082|NCT03431012|18541981|P2|STARTED|Overall Study||60
7531083|NCT03431012|18541982|P1|STARTED|Overall Study||47
7531084|NCT03430986|18542006|P2|NOT COMPLETED|24-week Post-Control Period||2
7531085|NCT03430986|18542007|P1|NOT COMPLETED|24-week Post-Control Period||1
7531086|NCT03430986|18542006|P2|COMPLETED|24-week Post-Control Period||116
7531087|NCT03430986|18542007|P1|COMPLETED|24-week Post-Control Period||30
7531088|NCT03430986|18542006|P2|STARTED|24-week Post-Control Period||118
7531089|NCT03430986|18542007|P1|STARTED|24-week Post-Control Period|Not all participants received the Optional Treatment.|31
7531090|NCT03430986|18542006|P2|NOT COMPLETED|24-week Control Period||4
7531091|NCT03430986|18542007|P1|NOT COMPLETED|24-week Control Period||8
7531092|NCT03430986|18542006|P2|COMPLETED|24-week Control Period||118
7531093|NCT03430986|18542007|P1|COMPLETED|24-week Control Period||34
7531094|NCT03430986|18542006|P2|Treated as Randomized|24-week Control Period||120
7531095|NCT03430986|18542007|P1|Treated as Randomized|24-week Control Period||42
7531096|NCT03430986|18542006|P2|STARTED|24-week Control Period||122
7531097|NCT03430986|18542007|P1|STARTED|24-week Control Period||42
7531098|NCT03430856|18542024|P3|NOT COMPLETED|Overall Study||1
7531099|NCT03430856|18542025|P2|NOT COMPLETED|Overall Study||3
7531100|NCT03430856|18542026|P1|NOT COMPLETED|Overall Study||2
7531101|NCT03430856|18542024|P3|COMPLETED|Overall Study||29
7531102|NCT03430856|18542025|P2|COMPLETED|Overall Study||27
7531103|NCT03430856|18542026|P1|COMPLETED|Overall Study||29
7531104|NCT03430856|18542024|P3|Exposed|Overall Study||30
7531105|NCT03430856|18542025|P2|Exposed|Overall Study||30
7531106|NCT03430856|18542026|P1|Exposed|Overall Study||31
7531107|NCT03430856|18542024|P3|STARTED|Overall Study||30
7531108|NCT03430856|18542025|P2|STARTED|Overall Study||30
7531109|NCT03430856|18542026|P1|STARTED|Overall Study||31
7531110|NCT03430245|18542064|P1|NOT COMPLETED|Overall Study||7
7531111|NCT03430245|18542064|P1|COMPLETED|Overall Study|6 subjects withdrew from study due to lengthy treatment. Treatment protocol amended.|9
7531112|NCT03430245|18542064|P1|STARTED|Overall Study||16
7531113|NCT03430206|18542073|P2|NOT COMPLETED|Overall Study||17
7531114|NCT03430206|18542074|P1|NOT COMPLETED|Overall Study||22
7531115|NCT03430206|18542073|P2|COMPLETED|Overall Study||21
7531116|NCT03430206|18542074|P1|COMPLETED|Overall Study||18
7531117|NCT03430206|18542073|P2|STARTED|Overall Study||38
7531118|NCT03430206|18542074|P1|STARTED|Overall Study||40
7531119|NCT03430050|18542094|P2|NOT COMPLETED|Overall Study||0
7531120|NCT03430050|18542095|P1|NOT COMPLETED|Overall Study||0
7531121|NCT03430050|18542094|P2|COMPLETED|Overall Study||5
7531122|NCT03430050|18542095|P1|COMPLETED|Overall Study||3
7531123|NCT03430050|18542094|P2|STARTED|Overall Study||5
7531124|NCT03430050|18542095|P1|STARTED|Overall Study||3
7531125|NCT03429712|18542103|P1|NOT COMPLETED|Overall Study||9
7531126|NCT03429712|18542103|P1|COMPLETED|Overall Study||10
7531127|NCT03429712|18542103|P1|STARTED|Overall Study||19
7531128|NCT03429556|18542111|P4|NOT COMPLETED|Overall Study||0
7531129|NCT03429556|18542112|P3|NOT COMPLETED|Overall Study||0
7531130|NCT03429556|18542113|P2|NOT COMPLETED|Overall Study||1
7531131|NCT03429556|18542114|P1|NOT COMPLETED|Overall Study||0
7531132|NCT03429556|18542111|P4|COMPLETED|Overall Study||3
7531133|NCT03429556|18542112|P3|COMPLETED|Overall Study||4
7531134|NCT03429556|18542113|P2|COMPLETED|Overall Study||3
7531135|NCT03429556|18542114|P1|COMPLETED|Overall Study||12
7531136|NCT03429556|18542111|P4|STARTED|Overall Study||3
7531137|NCT03429556|18542112|P3|STARTED|Overall Study||4
7531138|NCT03429556|18542113|P2|STARTED|Overall Study||4
7531139|NCT03429556|18542114|P1|STARTED|Overall Study||12
7531140|NCT03429270|18542160|P1|NOT COMPLETED|Overall Study||0
7531141|NCT03429270|18542160|P1|COMPLETED|Overall Study||28
7531142|NCT03429270|18542160|P1|STARTED|Overall Study||28
7531143|NCT03428997|18542165|P1|NOT COMPLETED|Overall Study||8
7531144|NCT03428997|18542165|P1|COMPLETED|Overall Study||16
7531145|NCT03428997|18542165|P1|STARTED|Overall Study||24
7531146|NCT03428750|18542173|P2|NOT COMPLETED|Overall Study||21
7531147|NCT03428750|18542174|P1|NOT COMPLETED|Overall Study||24
7531148|NCT03428750|18542173|P2|COMPLETED|Overall Study||192
7531149|NCT03428750|18542174|P1|COMPLETED|Overall Study||186
7531150|NCT03428750|18542173|P2|STARTED|Overall Study||213
7531151|NCT03428750|18542174|P1|STARTED|Overall Study||210
7531152|NCT03428152|18542223|P2|NOT COMPLETED|Overall Study||11
7531153|NCT03428152|18542224|P1|NOT COMPLETED|Overall Study||7
7531154|NCT03428152|18542223|P2|COMPLETED|Overall Study|exclusions: epidural / TAP / wound infiltration malignity retroperitone was opened age >65|30
7531155|NCT03428152|18542224|P1|COMPLETED|Overall Study||30
7531156|NCT03428152|18542223|P2|STARTED|Overall Study||41
7531157|NCT03428152|18542224|P1|STARTED|Overall Study||37
7531158|NCT03427931|18542240|P1|NOT COMPLETED|Overall Study||2
7531159|NCT03427931|18542240|P1|COMPLETED|Overall Study||5
7531160|NCT03427931|18542240|P1|STARTED|Overall Study||7
7531161|NCT03427892|18542245|P1|NOT COMPLETED|Overall Study||2
7531162|NCT03427892|18542245|P1|COMPLETED|Overall Study|Of the 21 recruited, 19 completed at least one post baseline visit, included in the analysis.|19
7531163|NCT03427892|18542245|P1|STARTED|Overall Study||21
7531164|NCT03427073|18542269|P8|NOT COMPLETED|Overall Study||4
7531165|NCT03427073|18542270|P7|NOT COMPLETED|Overall Study||3
7531166|NCT03427073|18542271|P6|NOT COMPLETED|Overall Study||4
7531167|NCT03427073|18542272|P5|NOT COMPLETED|Overall Study||3
7531168|NCT03427073|18542273|P4|NOT COMPLETED|Overall Study||3
7531169|NCT03427073|18542274|P3|NOT COMPLETED|Overall Study||1
7531170|NCT03427073|18542275|P2|NOT COMPLETED|Overall Study||1
7531171|NCT03427073|18542276|P1|NOT COMPLETED|Overall Study||1
7531172|NCT03427073|18542269|P8|COMPLETED|Overall Study||0
7531173|NCT03427073|18542270|P7|COMPLETED|Overall Study||0
7531174|NCT03427073|18542271|P6|COMPLETED|Overall Study||0
7531175|NCT03427073|18542272|P5|COMPLETED|Overall Study||0
7531176|NCT03427073|18542273|P4|COMPLETED|Overall Study||0
7531177|NCT03427073|18542274|P3|COMPLETED|Overall Study||0
7531178|NCT03427073|18542275|P2|COMPLETED|Overall Study||0
7531179|NCT03427073|18542276|P1|COMPLETED|Overall Study||0
7531180|NCT03427073|18542269|P8|STARTED|Overall Study||4
7531181|NCT03427073|18542270|P7|STARTED|Overall Study||3
7531182|NCT03427073|18542271|P6|STARTED|Overall Study||4
7531183|NCT03427073|18542272|P5|STARTED|Overall Study||3
7531184|NCT03427073|18542273|P4|STARTED|Overall Study||3
7531185|NCT03427073|18542274|P3|STARTED|Overall Study||1
7531186|NCT03427073|18542275|P2|STARTED|Overall Study||1
7531187|NCT03427073|18542276|P1|STARTED|Overall Study||1
7531188|NCT03426995|18542345|P19|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531189|NCT03426995|18542346|P18|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531190|NCT03426995|18542347|P17|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531191|NCT03426995|18542348|P16|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||12
7531192|NCT03426995|18542349|P15|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||9
7531193|NCT03426995|18542350|P14|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531194|NCT03426995|18542351|P13|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531195|NCT03426995|18542352|P12|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531196|NCT03426995|18542353|P11|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531197|NCT03426995|18542354|P10|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531198|NCT03426995|18542355|P9|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531199|NCT03426995|18542356|P8|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531200|NCT03426995|18542357|P7|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531201|NCT03426995|18542358|P6|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531202|NCT03426995|18542359|P5|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531203|NCT03426995|18542360|P4|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531204|NCT03426995|18542361|P3|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531205|NCT03426995|18542362|P2|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531206|NCT03426995|18542363|P1|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531207|NCT03426995|18542345|P19|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531208|NCT03426995|18542346|P18|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531209|NCT03426995|18542347|P17|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531210|NCT03426995|18542348|P16|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2
7531211|NCT03426995|18542349|P15|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2
7531212|NCT03426995|18542350|P14|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531213|NCT03426995|18542351|P13|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531214|NCT03426995|18542352|P12|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531215|NCT03426995|18542353|P11|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531216|NCT03426995|18542354|P10|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531217|NCT03426995|18542355|P9|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531218|NCT03426995|18542356|P8|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531219|NCT03426995|18542357|P7|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531220|NCT03426995|18542358|P6|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531221|NCT03426995|18542359|P5|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531222|NCT03426995|18542360|P4|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531223|NCT03426995|18542361|P3|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531224|NCT03426995|18542362|P2|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531225|NCT03426995|18542363|P1|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531226|NCT03426995|18542345|P19|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531227|NCT03426995|18542346|P18|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531228|NCT03426995|18542347|P17|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531229|NCT03426995|18542348|P16|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||14
7531230|NCT03426995|18542349|P15|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||11
7531231|NCT03426995|18542350|P14|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531232|NCT03426995|18542351|P13|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531233|NCT03426995|18542352|P12|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531234|NCT03426995|18542353|P11|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531235|NCT03426995|18542354|P10|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531236|NCT03426995|18542355|P9|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531237|NCT03426995|18542356|P8|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531238|NCT03426995|18542357|P7|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531239|NCT03426995|18542358|P6|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531240|NCT03426995|18542359|P5|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531241|NCT03426995|18542360|P4|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531242|NCT03426995|18542361|P3|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531243|NCT03426995|18542362|P2|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531244|NCT03426995|18542363|P1|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
7531245|NCT03426995|18542345|P19|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531246|NCT03426995|18542346|P18|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531247|NCT03426995|18542347|P17|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531248|NCT03426995|18542348|P16|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531249|NCT03426995|18542349|P15|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531250|NCT03426995|18542350|P14|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531251|NCT03426995|18542351|P13|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531252|NCT03426995|18542352|P12|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531253|NCT03426995|18542353|P11|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531254|NCT03426995|18542354|P10|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531255|NCT03426995|18542355|P9|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531256|NCT03426995|18542356|P8|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531257|NCT03426995|18542357|P7|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531258|NCT03426995|18542358|P6|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531259|NCT03426995|18542359|P5|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531260|NCT03426995|18542360|P4|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531261|NCT03426995|18542361|P3|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531262|NCT03426995|18542362|P2|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531263|NCT03426995|18542363|P1|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531264|NCT03426995|18542345|P19|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531265|NCT03426995|18542346|P18|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531266|NCT03426995|18542347|P17|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531267|NCT03426995|18542348|P16|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531268|NCT03426995|18542349|P15|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531269|NCT03426995|18542350|P14|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531270|NCT03426995|18542351|P13|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531271|NCT03426995|18542352|P12|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531272|NCT03426995|18542353|P11|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531273|NCT03426995|18542354|P10|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531274|NCT03426995|18542355|P9|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531275|NCT03426995|18542356|P8|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531276|NCT03426995|18542357|P7|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531277|NCT03426995|18542358|P6|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531278|NCT03426995|18542359|P5|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531279|NCT03426995|18542360|P4|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531280|NCT03426995|18542361|P3|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531281|NCT03426995|18542362|P2|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531282|NCT03426995|18542363|P1|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
7531283|NCT03426995|18542345|P19|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
7531284|NCT03426995|18542346|P18|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
7531285|NCT03426995|18542347|P17|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
7531286|NCT03426995|18542348|P16|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
7531287|NCT03426995|18542349|P15|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
7531288|NCT03426995|18542350|P14|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
7531289|NCT03426995|18542351|P13|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
7531290|NCT03426995|18542352|P12|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
7531291|NCT03426995|18542353|P11|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
7531292|NCT03426995|18542354|P10|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
7531293|NCT03426995|18542355|P9|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
7531294|NCT03426995|18542356|P8|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
7531295|NCT03426995|18542357|P7|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
7531296|NCT03426995|18542358|P6|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
7531297|NCT03426995|18542359|P5|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
7531298|NCT03426995|18542360|P4|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
7531299|NCT03426995|18542361|P3|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
7531300|NCT03426995|18542362|P2|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
7531301|NCT03426995|18542363|P1|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
7531302|NCT03426995|18542345|P19|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531303|NCT03426995|18542346|P18|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531304|NCT03426995|18542347|P17|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531305|NCT03426995|18542348|P16|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531306|NCT03426995|18542349|P15|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531307|NCT03426995|18542350|P14|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531308|NCT03426995|18542351|P13|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531309|NCT03426995|18542352|P12|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531310|NCT03426995|18542353|P11|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531311|NCT03426995|18542354|P10|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531312|NCT03426995|18542355|P9|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531313|NCT03426995|18542356|P8|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531314|NCT03426995|18542357|P7|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531315|NCT03426995|18542358|P6|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531316|NCT03426995|18542359|P5|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531317|NCT03426995|18542360|P4|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531318|NCT03426995|18542361|P3|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531319|NCT03426995|18542362|P2|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531320|NCT03426995|18542363|P1|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531321|NCT03426995|18542345|P19|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531322|NCT03426995|18542346|P18|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531323|NCT03426995|18542347|P17|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531324|NCT03426995|18542348|P16|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531325|NCT03426995|18542349|P15|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531326|NCT03426995|18542350|P14|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531327|NCT03426995|18542351|P13|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531328|NCT03426995|18542352|P12|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531329|NCT03426995|18542353|P11|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531330|NCT03426995|18542354|P10|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531331|NCT03426995|18542355|P9|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531332|NCT03426995|18542356|P8|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531333|NCT03426995|18542357|P7|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531334|NCT03426995|18542358|P6|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531335|NCT03426995|18542359|P5|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531336|NCT03426995|18542360|P4|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531337|NCT03426995|18542361|P3|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531338|NCT03426995|18542362|P2|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531339|NCT03426995|18542363|P1|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531340|NCT03426995|18542345|P19|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531341|NCT03426995|18542346|P18|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531342|NCT03426995|18542347|P17|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531343|NCT03426995|18542348|P16|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531344|NCT03426995|18542349|P15|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531345|NCT03426995|18542350|P14|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531346|NCT03426995|18542351|P13|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531347|NCT03426995|18542352|P12|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531348|NCT03426995|18542353|P11|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531349|NCT03426995|18542354|P10|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531350|NCT03426995|18542355|P9|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531351|NCT03426995|18542356|P8|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531352|NCT03426995|18542357|P7|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531353|NCT03426995|18542358|P6|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531354|NCT03426995|18542359|P5|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531355|NCT03426995|18542360|P4|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531356|NCT03426995|18542361|P3|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531357|NCT03426995|18542362|P2|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531358|NCT03426995|18542363|P1|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
7531359|NCT03426995|18542345|P19|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531360|NCT03426995|18542346|P18|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531361|NCT03426995|18542347|P17|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531362|NCT03426995|18542348|P16|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531363|NCT03426995|18542349|P15|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531364|NCT03426995|18542350|P14|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531365|NCT03426995|18542351|P13|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531366|NCT03426995|18542352|P12|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531367|NCT03426995|18542353|P11|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531368|NCT03426995|18542354|P10|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531369|NCT03426995|18542355|P9|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531370|NCT03426995|18542356|P8|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531371|NCT03426995|18542357|P7|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531372|NCT03426995|18542358|P6|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531373|NCT03426995|18542359|P5|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531374|NCT03426995|18542360|P4|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531375|NCT03426995|18542361|P3|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531376|NCT03426995|18542362|P2|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531377|NCT03426995|18542363|P1|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531378|NCT03426995|18542345|P19|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531379|NCT03426995|18542346|P18|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531380|NCT03426995|18542347|P17|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531381|NCT03426995|18542348|P16|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531382|NCT03426995|18542349|P15|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531383|NCT03426995|18542350|P14|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531384|NCT03426995|18542351|P13|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531385|NCT03426995|18542352|P12|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531386|NCT03426995|18542353|P11|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531387|NCT03426995|18542354|P10|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531388|NCT03426995|18542355|P9|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531389|NCT03426995|18542356|P8|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531390|NCT03426995|18542357|P7|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531391|NCT03426995|18542358|P6|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531392|NCT03426995|18542359|P5|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531393|NCT03426995|18542360|P4|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531394|NCT03426995|18542361|P3|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531395|NCT03426995|18542362|P2|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531396|NCT03426995|18542363|P1|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
7531397|NCT03426995|18542345|P19|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
7531398|NCT03426995|18542346|P18|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
7531399|NCT03426995|18542347|P17|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
7531400|NCT03426995|18542348|P16|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
7531401|NCT03426995|18542349|P15|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
7531402|NCT03426995|18542350|P14|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
7531403|NCT03426995|18542351|P13|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
7531404|NCT03426995|18542352|P12|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
7531405|NCT03426995|18542353|P11|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
7531406|NCT03426995|18542354|P10|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
7531407|NCT03426995|18542355|P9|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
7531408|NCT03426995|18542356|P8|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
7531409|NCT03426995|18542357|P7|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
7531410|NCT03426995|18542358|P6|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
7531411|NCT03426995|18542359|P5|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
7531412|NCT03426995|18542360|P4|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
7531413|NCT03426995|18542361|P3|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
7531414|NCT03426995|18542362|P2|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
7531415|NCT03426995|18542363|P1|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
7531416|NCT03426995|18542345|P19|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531417|NCT03426995|18542346|P18|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531418|NCT03426995|18542347|P17|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531419|NCT03426995|18542348|P16|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531420|NCT03426995|18542349|P15|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531421|NCT03426995|18542350|P14|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531422|NCT03426995|18542351|P13|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531423|NCT03426995|18542352|P12|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531424|NCT03426995|18542353|P11|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
7531425|NCT03426995|18542354|P10|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531426|NCT03426995|18542355|P9|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531427|NCT03426995|18542356|P8|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
7531428|NCT03426995|18542357|P7|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531429|NCT03426995|18542358|P6|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531430|NCT03426995|18542359|P5|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531431|NCT03426995|18542360|P4|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531432|NCT03426995|18542361|P3|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531433|NCT03426995|18542362|P2|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531434|NCT03426995|18542363|P1|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531435|NCT03426995|18542345|P19|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531436|NCT03426995|18542346|P18|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531437|NCT03426995|18542347|P17|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531438|NCT03426995|18542348|P16|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531439|NCT03426995|18542349|P15|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531440|NCT03426995|18542350|P14|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531441|NCT03426995|18542351|P13|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531442|NCT03426995|18542352|P12|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
7531443|NCT03426995|18542353|P11|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531444|NCT03426995|18542354|P10|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
7531445|NCT03426995|18542355|P9|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
7531446|NCT03426995|18542356|P8|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
7531447|NCT03426995|18542357|P7|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
7531448|NCT03426995|18542358|P6|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531449|NCT03426995|18542359|P5|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531450|NCT03426995|18542360|P4|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531451|NCT03426995|18542361|P3|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531452|NCT03426995|18542362|P2|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531453|NCT03426995|18542363|P1|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
7531454|NCT03426995|18542345|P19|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
7531455|NCT03426995|18542346|P18|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
7531456|NCT03426995|18542347|P17|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
7531457|NCT03426995|18542348|P16|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
7531458|NCT03426995|18542349|P15|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
7531459|NCT03426995|18542350|P14|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
7531460|NCT03426995|18542351|P13|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
7531461|NCT03426995|18542352|P12|STARTED|Part A: Cohort 2-Period 4 (Day1)||2
7531462|NCT03426995|18542353|P11|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
7531463|NCT03426995|18542354|P10|STARTED|Part A: Cohort 2-Period 4 (Day1)||2
7531464|NCT03426995|18542355|P9|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
7531465|NCT03426995|18542356|P8|STARTED|Part A: Cohort 2-Period 4 (Day1)|New participant enrolled and dosed.|3
7531466|NCT03426995|18542357|P7|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
7531467|NCT03426995|18542358|P6|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
7531468|NCT03426995|18542359|P5|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
7531469|NCT03426995|18542360|P4|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
7531470|NCT03426995|18542361|P3|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
7531471|NCT03426995|18542362|P2|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
7531472|NCT03426995|18542363|P1|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
7531473|NCT03426995|18542345|P19|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531474|NCT03426995|18542346|P18|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531475|NCT03426995|18542347|P17|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531476|NCT03426995|18542348|P16|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531477|NCT03426995|18542349|P15|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531478|NCT03426995|18542350|P14|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531479|NCT03426995|18542351|P13|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531480|NCT03426995|18542352|P12|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531481|NCT03426995|18542353|P11|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531482|NCT03426995|18542354|P10|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531483|NCT03426995|18542355|P9|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531484|NCT03426995|18542356|P8|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531485|NCT03426995|18542357|P7|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531486|NCT03426995|18542358|P6|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531487|NCT03426995|18542359|P5|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531488|NCT03426995|18542360|P4|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531489|NCT03426995|18542361|P3|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531490|NCT03426995|18542362|P2|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531491|NCT03426995|18542363|P1|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531492|NCT03426995|18542345|P19|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531493|NCT03426995|18542346|P18|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531494|NCT03426995|18542347|P17|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531495|NCT03426995|18542348|P16|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531496|NCT03426995|18542349|P15|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531497|NCT03426995|18542350|P14|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531498|NCT03426995|18542351|P13|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531499|NCT03426995|18542352|P12|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
7531500|NCT03426995|18542353|P11|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
7531501|NCT03426995|18542354|P10|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
7531502|NCT03426995|18542355|P9|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
7531503|NCT03426995|18542356|P8|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
7531504|NCT03426995|18542357|P7|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
7531505|NCT03426995|18542358|P6|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531506|NCT03426995|18542359|P5|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531507|NCT03426995|18542360|P4|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531508|NCT03426995|18542361|P3|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531509|NCT03426995|18542362|P2|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531510|NCT03426995|18542363|P1|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531511|NCT03426995|18542345|P19|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531512|NCT03426995|18542346|P18|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531513|NCT03426995|18542347|P17|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531514|NCT03426995|18542348|P16|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531515|NCT03426995|18542349|P15|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531516|NCT03426995|18542350|P14|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531517|NCT03426995|18542351|P13|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531518|NCT03426995|18542352|P12|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
7531519|NCT03426995|18542353|P11|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
7531520|NCT03426995|18542354|P10|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
7531521|NCT03426995|18542355|P9|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
7531522|NCT03426995|18542356|P8|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
7531523|NCT03426995|18542357|P7|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
7531524|NCT03426995|18542358|P6|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531525|NCT03426995|18542359|P5|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531526|NCT03426995|18542360|P4|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531527|NCT03426995|18542361|P3|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531528|NCT03426995|18542362|P2|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531529|NCT03426995|18542363|P1|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
7531530|NCT03426995|18542345|P19|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531531|NCT03426995|18542346|P18|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531532|NCT03426995|18542347|P17|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531533|NCT03426995|18542348|P16|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531534|NCT03426995|18542349|P15|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531535|NCT03426995|18542350|P14|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531536|NCT03426995|18542351|P13|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531537|NCT03426995|18542352|P12|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531538|NCT03426995|18542353|P11|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531539|NCT03426995|18542354|P10|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531540|NCT03426995|18542355|P9|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531541|NCT03426995|18542356|P8|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531542|NCT03426995|18542357|P7|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531543|NCT03426995|18542358|P6|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531544|NCT03426995|18542359|P5|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531545|NCT03426995|18542360|P4|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531546|NCT03426995|18542361|P3|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531547|NCT03426995|18542362|P2|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531548|NCT03426995|18542363|P1|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531549|NCT03426995|18542345|P19|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531550|NCT03426995|18542346|P18|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531551|NCT03426995|18542347|P17|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531552|NCT03426995|18542348|P16|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531553|NCT03426995|18542349|P15|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531554|NCT03426995|18542350|P14|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531555|NCT03426995|18542351|P13|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531556|NCT03426995|18542352|P12|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
7531557|NCT03426995|18542353|P11|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
7531558|NCT03426995|18542354|P10|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
7531559|NCT03426995|18542355|P9|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
7531560|NCT03426995|18542356|P8|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
7531561|NCT03426995|18542357|P7|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
7531562|NCT03426995|18542358|P6|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531563|NCT03426995|18542359|P5|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531564|NCT03426995|18542360|P4|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531565|NCT03426995|18542361|P3|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531566|NCT03426995|18542362|P2|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531567|NCT03426995|18542363|P1|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
7531568|NCT03426995|18542345|P19|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
7531569|NCT03426995|18542346|P18|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
7531570|NCT03426995|18542347|P17|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
7531571|NCT03426995|18542348|P16|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
7531572|NCT03426995|18542349|P15|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
7531573|NCT03426995|18542350|P14|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
7531574|NCT03426995|18542351|P13|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
7531575|NCT03426995|18542352|P12|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
7531576|NCT03426995|18542353|P11|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
7531577|NCT03426995|18542354|P10|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
7531578|NCT03426995|18542355|P9|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
7531579|NCT03426995|18542356|P8|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
7531580|NCT03426995|18542357|P7|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
7531581|NCT03426995|18542358|P6|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
7531582|NCT03426995|18542359|P5|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
7531583|NCT03426995|18542360|P4|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
7531584|NCT03426995|18542361|P3|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
7531585|NCT03426995|18542362|P2|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
7531586|NCT03426995|18542363|P1|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
7531587|NCT03426995|18542345|P19|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531588|NCT03426995|18542346|P18|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531589|NCT03426995|18542347|P17|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531590|NCT03426995|18542348|P16|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531591|NCT03426995|18542349|P15|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531592|NCT03426995|18542350|P14|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531593|NCT03426995|18542351|P13|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531594|NCT03426995|18542352|P12|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531595|NCT03426995|18542353|P11|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531596|NCT03426995|18542354|P10|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531597|NCT03426995|18542355|P9|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531598|NCT03426995|18542356|P8|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531599|NCT03426995|18542357|P7|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531600|NCT03426995|18542358|P6|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531601|NCT03426995|18542359|P5|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531602|NCT03426995|18542360|P4|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531603|NCT03426995|18542361|P3|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531604|NCT03426995|18542362|P2|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531605|NCT03426995|18542363|P1|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531606|NCT03426995|18542345|P19|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531607|NCT03426995|18542346|P18|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531608|NCT03426995|18542347|P17|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531609|NCT03426995|18542348|P16|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531610|NCT03426995|18542349|P15|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531611|NCT03426995|18542350|P14|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531612|NCT03426995|18542351|P13|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531613|NCT03426995|18542352|P12|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
7531614|NCT03426995|18542353|P11|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
7531615|NCT03426995|18542354|P10|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
7531616|NCT03426995|18542355|P9|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
7531617|NCT03426995|18542356|P8|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
7531618|NCT03426995|18542357|P7|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
7531619|NCT03426995|18542358|P6|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531620|NCT03426995|18542359|P5|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531621|NCT03426995|18542360|P4|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531622|NCT03426995|18542361|P3|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531623|NCT03426995|18542362|P2|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531624|NCT03426995|18542363|P1|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531625|NCT03426995|18542345|P19|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531626|NCT03426995|18542346|P18|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531627|NCT03426995|18542347|P17|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531628|NCT03426995|18542348|P16|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531629|NCT03426995|18542349|P15|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531630|NCT03426995|18542350|P14|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531631|NCT03426995|18542351|P13|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531632|NCT03426995|18542352|P12|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
7531633|NCT03426995|18542353|P11|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
7531634|NCT03426995|18542354|P10|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
7531635|NCT03426995|18542355|P9|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
7531636|NCT03426995|18542356|P8|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
7531637|NCT03426995|18542357|P7|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
7531638|NCT03426995|18542358|P6|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531639|NCT03426995|18542359|P5|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531640|NCT03426995|18542360|P4|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531641|NCT03426995|18542361|P3|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531642|NCT03426995|18542362|P2|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531643|NCT03426995|18542363|P1|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
7531644|NCT03426995|18542345|P19|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531645|NCT03426995|18542346|P18|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531646|NCT03426995|18542347|P17|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531647|NCT03426995|18542348|P16|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531648|NCT03426995|18542349|P15|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531649|NCT03426995|18542350|P14|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531650|NCT03426995|18542351|P13|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531651|NCT03426995|18542352|P12|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531652|NCT03426995|18542353|P11|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531653|NCT03426995|18542354|P10|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531654|NCT03426995|18542355|P9|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531655|NCT03426995|18542356|P8|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531656|NCT03426995|18542357|P7|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531657|NCT03426995|18542358|P6|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531658|NCT03426995|18542359|P5|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531659|NCT03426995|18542360|P4|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531660|NCT03426995|18542361|P3|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531661|NCT03426995|18542362|P2|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531662|NCT03426995|18542363|P1|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531663|NCT03426995|18542345|P19|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531664|NCT03426995|18542346|P18|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531665|NCT03426995|18542347|P17|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531666|NCT03426995|18542348|P16|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531667|NCT03426995|18542349|P15|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531668|NCT03426995|18542350|P14|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531669|NCT03426995|18542351|P13|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531670|NCT03426995|18542352|P12|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
7531671|NCT03426995|18542353|P11|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
7531672|NCT03426995|18542354|P10|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
7531673|NCT03426995|18542355|P9|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
7531674|NCT03426995|18542356|P8|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
7531675|NCT03426995|18542357|P7|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
7531676|NCT03426995|18542358|P6|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531677|NCT03426995|18542359|P5|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531678|NCT03426995|18542360|P4|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531679|NCT03426995|18542361|P3|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531680|NCT03426995|18542362|P2|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531681|NCT03426995|18542363|P1|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
7531682|NCT03426995|18542345|P19|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
7531683|NCT03426995|18542346|P18|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
7531684|NCT03426995|18542347|P17|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
7531685|NCT03426995|18542348|P16|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
7531686|NCT03426995|18542349|P15|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
7531687|NCT03426995|18542350|P14|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
7531688|NCT03426995|18542351|P13|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
7531689|NCT03426995|18542352|P12|STARTED|Part A: Cohort 2-Period 2 (Day1)|New participant enrolled and dosed.|2
7531690|NCT03426995|18542353|P11|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
7531691|NCT03426995|18542354|P10|STARTED|Part A: Cohort 2-Period 2 (Day1)|Two additional participants were enrolled and dosed.|2
7531692|NCT03426995|18542355|P9|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
7531693|NCT03426995|18542356|P8|STARTED|Part A: Cohort 2-Period 2 (Day1)||2
7531694|NCT03426995|18542357|P7|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
7531695|NCT03426995|18542358|P6|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
7531696|NCT03426995|18542359|P5|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
7531697|NCT03426995|18542360|P4|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
7531698|NCT03426995|18542361|P3|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
7531699|NCT03426995|18542362|P2|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
7531700|NCT03426995|18542363|P1|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
7531701|NCT03426995|18542345|P19|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531702|NCT03426995|18542346|P18|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531703|NCT03426995|18542347|P17|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531704|NCT03426995|18542348|P16|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531705|NCT03426995|18542349|P15|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531706|NCT03426995|18542350|P14|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531707|NCT03426995|18542351|P13|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531708|NCT03426995|18542352|P12|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531709|NCT03426995|18542353|P11|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531710|NCT03426995|18542354|P10|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531711|NCT03426995|18542355|P9|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531712|NCT03426995|18542356|P8|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531713|NCT03426995|18542357|P7|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531714|NCT03426995|18542358|P6|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531715|NCT03426995|18542359|P5|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531716|NCT03426995|18542360|P4|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531717|NCT03426995|18542361|P3|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531718|NCT03426995|18542362|P2|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531719|NCT03426995|18542363|P1|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531720|NCT03426995|18542345|P19|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531721|NCT03426995|18542346|P18|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531722|NCT03426995|18542347|P17|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531723|NCT03426995|18542348|P16|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531724|NCT03426995|18542349|P15|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531725|NCT03426995|18542350|P14|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531726|NCT03426995|18542351|P13|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531727|NCT03426995|18542352|P12|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
7531728|NCT03426995|18542353|P11|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
7531729|NCT03426995|18542354|P10|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531730|NCT03426995|18542355|P9|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
7531731|NCT03426995|18542356|P8|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2
7531732|NCT03426995|18542357|P7|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
7531733|NCT03426995|18542358|P6|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531734|NCT03426995|18542359|P5|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531735|NCT03426995|18542360|P4|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531736|NCT03426995|18542361|P3|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531737|NCT03426995|18542362|P2|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531738|NCT03426995|18542363|P1|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531739|NCT03426995|18542345|P19|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531740|NCT03426995|18542346|P18|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531741|NCT03426995|18542347|P17|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531742|NCT03426995|18542348|P16|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531743|NCT03426995|18542349|P15|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531744|NCT03426995|18542350|P14|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531745|NCT03426995|18542351|P13|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531746|NCT03426995|18542352|P12|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
7531747|NCT03426995|18542353|P11|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
7531748|NCT03426995|18542354|P10|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531749|NCT03426995|18542355|P9|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
7531750|NCT03426995|18542356|P8|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2
7531751|NCT03426995|18542357|P7|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
7531752|NCT03426995|18542358|P6|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531753|NCT03426995|18542359|P5|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531754|NCT03426995|18542360|P4|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531755|NCT03426995|18542361|P3|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531756|NCT03426995|18542362|P2|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531757|NCT03426995|18542363|P1|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
7531758|NCT03426995|18542345|P19|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531759|NCT03426995|18542346|P18|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531760|NCT03426995|18542347|P17|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531761|NCT03426995|18542348|P16|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531762|NCT03426995|18542349|P15|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531763|NCT03426995|18542350|P14|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531764|NCT03426995|18542351|P13|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531765|NCT03426995|18542352|P12|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531766|NCT03426995|18542353|P11|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531767|NCT03426995|18542354|P10|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531768|NCT03426995|18542355|P9|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531769|NCT03426995|18542356|P8|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531770|NCT03426995|18542357|P7|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531771|NCT03426995|18542358|P6|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531772|NCT03426995|18542359|P5|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531773|NCT03426995|18542360|P4|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531774|NCT03426995|18542361|P3|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531775|NCT03426995|18542362|P2|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531776|NCT03426995|18542363|P1|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531777|NCT03426995|18542345|P19|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531778|NCT03426995|18542346|P18|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531779|NCT03426995|18542347|P17|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531780|NCT03426995|18542348|P16|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531781|NCT03426995|18542349|P15|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531782|NCT03426995|18542350|P14|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531783|NCT03426995|18542351|P13|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531784|NCT03426995|18542352|P12|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
7531785|NCT03426995|18542353|P11|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
7531786|NCT03426995|18542354|P10|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531787|NCT03426995|18542355|P9|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
7531788|NCT03426995|18542356|P8|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||2
7531789|NCT03426995|18542357|P7|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
7531790|NCT03426995|18542358|P6|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531791|NCT03426995|18542359|P5|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531792|NCT03426995|18542360|P4|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531793|NCT03426995|18542361|P3|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531794|NCT03426995|18542362|P2|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531795|NCT03426995|18542363|P1|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
7531796|NCT03426995|18542345|P19|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
7531797|NCT03426995|18542346|P18|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
7531798|NCT03426995|18542347|P17|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
7531799|NCT03426995|18542348|P16|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
7531800|NCT03426995|18542349|P15|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
7531801|NCT03426995|18542350|P14|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
7531802|NCT03426995|18542351|P13|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
7531803|NCT03426995|18542352|P12|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
7531804|NCT03426995|18542353|P11|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
7531805|NCT03426995|18542354|P10|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
7531806|NCT03426995|18542355|P9|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
7531807|NCT03426995|18542356|P8|STARTED|Part A: Cohort 2-Period 1 (Day1)||2
7531808|NCT03426995|18542357|P7|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
7531809|NCT03426995|18542358|P6|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
7531810|NCT03426995|18542359|P5|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
7531811|NCT03426995|18542360|P4|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
7531812|NCT03426995|18542361|P3|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
7531813|NCT03426995|18542362|P2|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
7531814|NCT03426995|18542363|P1|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
7531815|NCT03426995|18542345|P19|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531816|NCT03426995|18542346|P18|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531817|NCT03426995|18542347|P17|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531818|NCT03426995|18542348|P16|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531819|NCT03426995|18542349|P15|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531820|NCT03426995|18542350|P14|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531821|NCT03426995|18542351|P13|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531822|NCT03426995|18542352|P12|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531823|NCT03426995|18542353|P11|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531824|NCT03426995|18542354|P10|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531825|NCT03426995|18542355|P9|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531826|NCT03426995|18542356|P8|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531827|NCT03426995|18542357|P7|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531828|NCT03426995|18542358|P6|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531829|NCT03426995|18542359|P5|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531830|NCT03426995|18542360|P4|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531831|NCT03426995|18542361|P3|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531832|NCT03426995|18542362|P2|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531833|NCT03426995|18542363|P1|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531834|NCT03426995|18542345|P19|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531835|NCT03426995|18542346|P18|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531836|NCT03426995|18542347|P17|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531837|NCT03426995|18542348|P16|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531838|NCT03426995|18542349|P15|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531839|NCT03426995|18542350|P14|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531840|NCT03426995|18542351|P13|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531841|NCT03426995|18542352|P12|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531842|NCT03426995|18542353|P11|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531843|NCT03426995|18542354|P10|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531844|NCT03426995|18542355|P9|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531845|NCT03426995|18542356|P8|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531846|NCT03426995|18542357|P7|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
7531847|NCT03426995|18542358|P6|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
7531848|NCT03426995|18542359|P5|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
7531849|NCT03426995|18542360|P4|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
7531850|NCT03426995|18542361|P3|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
7531851|NCT03426995|18542362|P2|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
7531852|NCT03426995|18542363|P1|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
7531853|NCT03426995|18542345|P19|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
7531854|NCT03426995|18542346|P18|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
7531855|NCT03426995|18542347|P17|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
7531856|NCT03426995|18542348|P16|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
7531857|NCT03426995|18542349|P15|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
7531858|NCT03426995|18542350|P14|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
7531859|NCT03426995|18542351|P13|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
7531860|NCT03426995|18542352|P12|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
7531861|NCT03426995|18542353|P11|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
7531862|NCT03426995|18542354|P10|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
7531863|NCT03426995|18542355|P9|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
7531864|NCT03426995|18542356|P8|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
7531865|NCT03426995|18542357|P7|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
7531866|NCT03426995|18542358|P6|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
7531867|NCT03426995|18542359|P5|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
7531868|NCT03426995|18542360|P4|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
7531869|NCT03426995|18542361|P3|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
7531870|NCT03426995|18542362|P2|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
7531871|NCT03426995|18542363|P1|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
7531872|NCT03426995|18542345|P19|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531873|NCT03426995|18542346|P18|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531874|NCT03426995|18542347|P17|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531875|NCT03426995|18542348|P16|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531876|NCT03426995|18542349|P15|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531877|NCT03426995|18542350|P14|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531878|NCT03426995|18542351|P13|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531879|NCT03426995|18542352|P12|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531880|NCT03426995|18542353|P11|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531881|NCT03426995|18542354|P10|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531882|NCT03426995|18542355|P9|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531883|NCT03426995|18542356|P8|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531884|NCT03426995|18542357|P7|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531885|NCT03426995|18542358|P6|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531886|NCT03426995|18542359|P5|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531887|NCT03426995|18542360|P4|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531888|NCT03426995|18542361|P3|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531889|NCT03426995|18542362|P2|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531890|NCT03426995|18542363|P1|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531891|NCT03426995|18542345|P19|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531892|NCT03426995|18542346|P18|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531893|NCT03426995|18542347|P17|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531894|NCT03426995|18542348|P16|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531895|NCT03426995|18542349|P15|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531896|NCT03426995|18542350|P14|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531897|NCT03426995|18542351|P13|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531898|NCT03426995|18542352|P12|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531899|NCT03426995|18542353|P11|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531900|NCT03426995|18542354|P10|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531901|NCT03426995|18542355|P9|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531902|NCT03426995|18542356|P8|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531903|NCT03426995|18542357|P7|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531904|NCT03426995|18542358|P6|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
7531905|NCT03426995|18542359|P5|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
7531906|NCT03426995|18542360|P4|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
7531907|NCT03426995|18542361|P3|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
7531908|NCT03426995|18542362|P2|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
7531909|NCT03426995|18542363|P1|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
7531910|NCT03426995|18542345|P19|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531911|NCT03426995|18542346|P18|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531912|NCT03426995|18542347|P17|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531913|NCT03426995|18542348|P16|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531914|NCT03426995|18542349|P15|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531915|NCT03426995|18542350|P14|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531916|NCT03426995|18542351|P13|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531917|NCT03426995|18542352|P12|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531918|NCT03426995|18542353|P11|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531919|NCT03426995|18542354|P10|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531920|NCT03426995|18542355|P9|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531921|NCT03426995|18542356|P8|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531922|NCT03426995|18542357|P7|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
7531923|NCT03426995|18542358|P6|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
7531924|NCT03426995|18542359|P5|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
7531925|NCT03426995|18542360|P4|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
7531926|NCT03426995|18542361|P3|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
7531927|NCT03426995|18542362|P2|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
7531928|NCT03426995|18542363|P1|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
7531929|NCT03426995|18542345|P19|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531930|NCT03426995|18542346|P18|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531931|NCT03426995|18542347|P17|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531932|NCT03426995|18542348|P16|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531933|NCT03426995|18542349|P15|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531934|NCT03426995|18542350|P14|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531935|NCT03426995|18542351|P13|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531936|NCT03426995|18542352|P12|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531937|NCT03426995|18542353|P11|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531938|NCT03426995|18542354|P10|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531939|NCT03426995|18542355|P9|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531940|NCT03426995|18542356|P8|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531941|NCT03426995|18542357|P7|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531942|NCT03426995|18542358|P6|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531943|NCT03426995|18542359|P5|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531944|NCT03426995|18542360|P4|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531945|NCT03426995|18542361|P3|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531946|NCT03426995|18542362|P2|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531947|NCT03426995|18542363|P1|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531948|NCT03426995|18542345|P19|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531949|NCT03426995|18542346|P18|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531950|NCT03426995|18542347|P17|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531951|NCT03426995|18542348|P16|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531952|NCT03426995|18542349|P15|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531953|NCT03426995|18542350|P14|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531954|NCT03426995|18542351|P13|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531955|NCT03426995|18542352|P12|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531956|NCT03426995|18542353|P11|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531957|NCT03426995|18542354|P10|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531958|NCT03426995|18542355|P9|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531959|NCT03426995|18542356|P8|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531960|NCT03426995|18542357|P7|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
7531961|NCT03426995|18542358|P6|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
7531962|NCT03426995|18542359|P5|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
7531963|NCT03426995|18542360|P4|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
7531964|NCT03426995|18542361|P3|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
7531965|NCT03426995|18542362|P2|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
7531966|NCT03426995|18542363|P1|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
7531967|NCT03426995|18542345|P19|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
7531968|NCT03426995|18542346|P18|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
7531969|NCT03426995|18542347|P17|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
7531970|NCT03426995|18542348|P16|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
7531971|NCT03426995|18542349|P15|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
7531972|NCT03426995|18542350|P14|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
7531973|NCT03426995|18542351|P13|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
7531974|NCT03426995|18542352|P12|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
7531975|NCT03426995|18542353|P11|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
7531976|NCT03426995|18542354|P10|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
7531977|NCT03426995|18542355|P9|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
7531978|NCT03426995|18542356|P8|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
7531979|NCT03426995|18542357|P7|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
7531980|NCT03426995|18542358|P6|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|2
7531981|NCT03426995|18542359|P5|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|1
7531982|NCT03426995|18542360|P4|STARTED|Part A: Cohort 1-Period 3 (Day1)||2
7531983|NCT03426995|18542361|P3|STARTED|Part A: Cohort 1-Period 3 (Day1)||1
7531984|NCT03426995|18542362|P2|STARTED|Part A: Cohort 1-Period 3 (Day1)||2
7531985|NCT03426995|18542363|P1|STARTED|Part A: Cohort 1-Period 3 (Day1)||1
7531986|NCT03426995|18542345|P19|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7531987|NCT03426995|18542346|P18|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7531988|NCT03426995|18542347|P17|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7531989|NCT03426995|18542348|P16|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7531990|NCT03426995|18542349|P15|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7531991|NCT03426995|18542350|P14|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7531992|NCT03426995|18542351|P13|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7531993|NCT03426995|18542352|P12|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7531994|NCT03426995|18542353|P11|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7531995|NCT03426995|18542354|P10|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7531996|NCT03426995|18542355|P9|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7531997|NCT03426995|18542356|P8|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7531998|NCT03426995|18542357|P7|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7531999|NCT03426995|18542358|P6|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532000|NCT03426995|18542359|P5|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532001|NCT03426995|18542360|P4|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532002|NCT03426995|18542361|P3|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532003|NCT03426995|18542362|P2|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532004|NCT03426995|18542363|P1|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532005|NCT03426995|18542345|P19|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532006|NCT03426995|18542346|P18|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532007|NCT03426995|18542347|P17|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532008|NCT03426995|18542348|P16|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532009|NCT03426995|18542349|P15|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532010|NCT03426995|18542350|P14|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532011|NCT03426995|18542351|P13|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532012|NCT03426995|18542352|P12|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532013|NCT03426995|18542353|P11|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532014|NCT03426995|18542354|P10|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532015|NCT03426995|18542355|P9|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532016|NCT03426995|18542356|P8|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532017|NCT03426995|18542357|P7|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532018|NCT03426995|18542358|P6|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
7532019|NCT03426995|18542359|P5|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532020|NCT03426995|18542360|P4|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
7532021|NCT03426995|18542361|P3|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
7532022|NCT03426995|18542362|P2|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
7532023|NCT03426995|18542363|P1|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
7532024|NCT03426995|18542345|P19|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532025|NCT03426995|18542346|P18|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532026|NCT03426995|18542347|P17|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532027|NCT03426995|18542348|P16|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532028|NCT03426995|18542349|P15|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532029|NCT03426995|18542350|P14|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532030|NCT03426995|18542351|P13|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532031|NCT03426995|18542352|P12|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532032|NCT03426995|18542353|P11|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532033|NCT03426995|18542354|P10|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532034|NCT03426995|18542355|P9|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532035|NCT03426995|18542356|P8|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532036|NCT03426995|18542357|P7|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532037|NCT03426995|18542358|P6|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
7532038|NCT03426995|18542359|P5|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
7532039|NCT03426995|18542360|P4|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
7532040|NCT03426995|18542361|P3|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
7532041|NCT03426995|18542362|P2|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
7532042|NCT03426995|18542363|P1|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
7532043|NCT03426995|18542345|P19|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532044|NCT03426995|18542346|P18|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532045|NCT03426995|18542347|P17|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532046|NCT03426995|18542348|P16|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532047|NCT03426995|18542349|P15|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532048|NCT03426995|18542350|P14|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532049|NCT03426995|18542351|P13|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532050|NCT03426995|18542352|P12|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532051|NCT03426995|18542353|P11|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532052|NCT03426995|18542354|P10|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532053|NCT03426995|18542355|P9|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532054|NCT03426995|18542356|P8|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532055|NCT03426995|18542357|P7|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532056|NCT03426995|18542358|P6|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
7532057|NCT03426995|18542359|P5|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
7532058|NCT03426995|18542360|P4|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532059|NCT03426995|18542361|P3|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532060|NCT03426995|18542362|P2|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532061|NCT03426995|18542363|P1|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532062|NCT03426995|18542345|P19|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532063|NCT03426995|18542346|P18|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532064|NCT03426995|18542347|P17|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532065|NCT03426995|18542348|P16|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532066|NCT03426995|18542349|P15|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532067|NCT03426995|18542350|P14|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532068|NCT03426995|18542351|P13|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532069|NCT03426995|18542352|P12|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532070|NCT03426995|18542353|P11|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532071|NCT03426995|18542354|P10|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532072|NCT03426995|18542355|P9|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532073|NCT03426995|18542356|P8|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532074|NCT03426995|18542357|P7|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532075|NCT03426995|18542358|P6|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
7532076|NCT03426995|18542359|P5|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
7532077|NCT03426995|18542360|P4|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
7532078|NCT03426995|18542361|P3|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
7532079|NCT03426995|18542362|P2|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
7532080|NCT03426995|18542363|P1|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
7532081|NCT03426995|18542345|P19|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
7532082|NCT03426995|18542346|P18|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
7532083|NCT03426995|18542347|P17|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
7532084|NCT03426995|18542348|P16|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
7532085|NCT03426995|18542349|P15|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
7532086|NCT03426995|18542350|P14|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
7532087|NCT03426995|18542351|P13|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
7532088|NCT03426995|18542352|P12|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
7532089|NCT03426995|18542353|P11|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
7532090|NCT03426995|18542354|P10|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
7532091|NCT03426995|18542355|P9|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
7532092|NCT03426995|18542356|P8|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
7532093|NCT03426995|18542357|P7|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
7532094|NCT03426995|18542358|P6|STARTED|Part A: Cohort 1-Period 2 (Day1)|Two additional participants were enrolled and dosed.|3
7532095|NCT03426995|18542359|P5|STARTED|Part A: Cohort 1-Period 2 (Day1)||1
7532096|NCT03426995|18542360|P4|STARTED|Part A: Cohort 1-Period 2 (Day1)||2
7532097|NCT03426995|18542361|P3|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1
7532098|NCT03426995|18542362|P2|STARTED|Part A: Cohort 1-Period 2 (Day1)||2
7532099|NCT03426995|18542363|P1|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1
7532100|NCT03426995|18542345|P19|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532101|NCT03426995|18542346|P18|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532102|NCT03426995|18542347|P17|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532103|NCT03426995|18542348|P16|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532104|NCT03426995|18542349|P15|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532105|NCT03426995|18542350|P14|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532106|NCT03426995|18542351|P13|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532107|NCT03426995|18542352|P12|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532108|NCT03426995|18542353|P11|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532109|NCT03426995|18542354|P10|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532110|NCT03426995|18542355|P9|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532111|NCT03426995|18542356|P8|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532112|NCT03426995|18542357|P7|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532113|NCT03426995|18542358|P6|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532114|NCT03426995|18542359|P5|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532115|NCT03426995|18542360|P4|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532116|NCT03426995|18542361|P3|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532117|NCT03426995|18542362|P2|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532118|NCT03426995|18542363|P1|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532119|NCT03426995|18542345|P19|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532120|NCT03426995|18542346|P18|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532121|NCT03426995|18542347|P17|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532122|NCT03426995|18542348|P16|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532123|NCT03426995|18542349|P15|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532124|NCT03426995|18542350|P14|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532125|NCT03426995|18542351|P13|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532126|NCT03426995|18542352|P12|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532127|NCT03426995|18542353|P11|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532128|NCT03426995|18542354|P10|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532129|NCT03426995|18542355|P9|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532130|NCT03426995|18542356|P8|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532131|NCT03426995|18542357|P7|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532132|NCT03426995|18542358|P6|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
7532133|NCT03426995|18542359|P5|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
7532134|NCT03426995|18542360|P4|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
7532135|NCT03426995|18542361|P3|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532136|NCT03426995|18542362|P2|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
7532137|NCT03426995|18542363|P1|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532138|NCT03426995|18542345|P19|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532139|NCT03426995|18542346|P18|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532140|NCT03426995|18542347|P17|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532141|NCT03426995|18542348|P16|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532142|NCT03426995|18542349|P15|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532143|NCT03426995|18542350|P14|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532144|NCT03426995|18542351|P13|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532145|NCT03426995|18542352|P12|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532146|NCT03426995|18542353|P11|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532147|NCT03426995|18542354|P10|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532148|NCT03426995|18542355|P9|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532149|NCT03426995|18542356|P8|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532150|NCT03426995|18542357|P7|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532151|NCT03426995|18542358|P6|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
7532152|NCT03426995|18542359|P5|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
7532153|NCT03426995|18542360|P4|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
7532154|NCT03426995|18542361|P3|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532155|NCT03426995|18542362|P2|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
7532156|NCT03426995|18542363|P1|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
7532157|NCT03426995|18542345|P19|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532158|NCT03426995|18542346|P18|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532159|NCT03426995|18542347|P17|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532160|NCT03426995|18542348|P16|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532161|NCT03426995|18542349|P15|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532162|NCT03426995|18542350|P14|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532163|NCT03426995|18542351|P13|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532164|NCT03426995|18542352|P12|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532165|NCT03426995|18542353|P11|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532166|NCT03426995|18542354|P10|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532167|NCT03426995|18542355|P9|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532168|NCT03426995|18542356|P8|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532169|NCT03426995|18542357|P7|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532170|NCT03426995|18542358|P6|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532171|NCT03426995|18542359|P5|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532172|NCT03426995|18542360|P4|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532173|NCT03426995|18542361|P3|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
7532174|NCT03426995|18542362|P2|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532175|NCT03426995|18542363|P1|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532176|NCT03426995|18542345|P19|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532177|NCT03426995|18542346|P18|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532178|NCT03426995|18542347|P17|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532179|NCT03426995|18542348|P16|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532180|NCT03426995|18542349|P15|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532181|NCT03426995|18542350|P14|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532182|NCT03426995|18542351|P13|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532183|NCT03426995|18542352|P12|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532184|NCT03426995|18542353|P11|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532185|NCT03426995|18542354|P10|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532186|NCT03426995|18542355|P9|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532187|NCT03426995|18542356|P8|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532188|NCT03426995|18542357|P7|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532189|NCT03426995|18542358|P6|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
7532190|NCT03426995|18542359|P5|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
7532191|NCT03426995|18542360|P4|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2
7532192|NCT03426995|18542361|P3|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532193|NCT03426995|18542362|P2|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2
7532194|NCT03426995|18542363|P1|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
7532195|NCT03426995|18542345|P19|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
7532196|NCT03426995|18542346|P18|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
7532197|NCT03426995|18542347|P17|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
7532198|NCT03426995|18542348|P16|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
7532199|NCT03426995|18542349|P15|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
7532200|NCT03426995|18542350|P14|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
7532201|NCT03426995|18542351|P13|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
7532202|NCT03426995|18542352|P12|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
7532203|NCT03426995|18542353|P11|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
7532204|NCT03426995|18542354|P10|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
7532205|NCT03426995|18542355|P9|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
7532206|NCT03426995|18542356|P8|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
7532207|NCT03426995|18542357|P7|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
7532208|NCT03426995|18542358|P6|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
7532209|NCT03426995|18542359|P5|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
7532210|NCT03426995|18542360|P4|STARTED|Part A: Cohort 1-Period 1 (Day1)||2
7532211|NCT03426995|18542361|P3|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
7532212|NCT03426995|18542362|P2|STARTED|Part A: Cohort 1-Period 1 (Day1)||2
7532213|NCT03426995|18542363|P1|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
7532214|NCT03426787|18542710|P1|NOT COMPLETED|Overall Study||14
7532215|NCT03426787|18542710|P1|COMPLETED|Overall Study||56
7532216|NCT03426787|18542710|P1|STARTED|Overall Study||70
7532217|NCT03426631|18542720|P2|NOT COMPLETED|Overall Study||1
7532218|NCT03426631|18542721|P1|NOT COMPLETED|Overall Study||0
7532219|NCT03426631|18542720|P2|COMPLETED|Overall Study||5
7532220|NCT03426631|18542721|P1|COMPLETED|Overall Study||7
7532221|NCT03426631|18542720|P2|STARTED|Overall Study||6
7532222|NCT03426631|18542721|P1|STARTED|Overall Study||7
7532223|NCT03426566|18542727|P1|NOT COMPLETED|Overall Study||0
7532224|NCT03426566|18542727|P1|COMPLETED|Overall Study||974
7532225|NCT03426566|18542727|P1|STARTED|Overall Study||974
7532226|NCT03426436|18542733|P1|NOT COMPLETED|Overall Study||19
7532227|NCT03426436|18542733|P1|COMPLETED|Overall Study||295
7532228|NCT03426436|18542733|P1|STARTED|Overall Study||314
7532229|NCT03426137|18542741|P3|NOT COMPLETED|Overall Study||0
7532230|NCT03426137|18542742|P2|NOT COMPLETED|Overall Study||0
7532231|NCT03426137|18542743|P1|NOT COMPLETED|Overall Study||3
7532232|NCT03426137|18542741|P3|COMPLETED|Overall Study||0
7532233|NCT03426137|18542742|P2|COMPLETED|Overall Study||0
7532234|NCT03426137|18542743|P1|COMPLETED|Overall Study||0
7532235|NCT03426137|18542741|P3|STARTED|Overall Study||0
7532236|NCT03426137|18542742|P2|STARTED|Overall Study||0
7532237|NCT03426137|18542743|P1|STARTED|Overall Study||3
7532238|NCT03425396|18542756|P5|NOT COMPLETED|Overall Study||1
7532239|NCT03425396|18542757|P4|NOT COMPLETED|Overall Study||1
7532240|NCT03425396|18542758|P3|NOT COMPLETED|Overall Study||3
7532241|NCT03425396|18542759|P2|NOT COMPLETED|Overall Study||7
7532242|NCT03425396|18542760|P1|NOT COMPLETED|Overall Study||2
7532243|NCT03425396|18542756|P5|COMPLETED|Overall Study||53
7532244|NCT03425396|18542757|P4|COMPLETED|Overall Study||7
7532245|NCT03425396|18542758|P3|COMPLETED|Overall Study||51
7532246|NCT03425396|18542759|P2|COMPLETED|Overall Study||47
7532247|NCT03425396|18542760|P1|COMPLETED|Overall Study||53
7532248|NCT03425396|18542756|P5|Completed Final Follow-up Visit|Overall Study||53
7532249|NCT03425396|18542757|P4|Completed Final Follow-up Visit|Overall Study||7
7532250|NCT03425396|18542758|P3|Completed Final Follow-up Visit|Overall Study||51
7532251|NCT03425396|18542759|P2|Completed Final Follow-up Visit|Overall Study||47
7532252|NCT03425396|18542760|P1|Completed Final Follow-up Visit|Overall Study||53
7532253|NCT03425396|18542756|P5|Completed Post-therapy Evaluation Visit|Overall Study||54
7532254|NCT03425396|18542757|P4|Completed Post-therapy Evaluation Visit|Overall Study||7
7532255|NCT03425396|18542758|P3|Completed Post-therapy Evaluation Visit|Overall Study||51
7532256|NCT03425396|18542759|P2|Completed Post-therapy Evaluation Visit|Overall Study||49
7532257|NCT03425396|18542760|P1|Completed Post-therapy Evaluation Visit|Overall Study||53
7532258|NCT03425396|18542756|P5|Completed End of Treatment Visit|Overall Study||53
7532259|NCT03425396|18542757|P4|Completed End of Treatment Visit|Overall Study||7
7532260|NCT03425396|18542758|P3|Completed End of Treatment Visit|Overall Study||51
7532261|NCT03425396|18542759|P2|Completed End of Treatment Visit|Overall Study||52
7532262|NCT03425396|18542760|P1|Completed End of Treatment Visit|Overall Study||53
7532263|NCT03425396|18542756|P5|STARTED|Overall Study||54
7532264|NCT03425396|18542757|P4|STARTED|Overall Study||8
7532265|NCT03425396|18542758|P3|STARTED|Overall Study||54
7532266|NCT03425396|18542759|P2|STARTED|Overall Study||54
7532267|NCT03425396|18542760|P1|STARTED|Overall Study||55
7532268|NCT03425253|18542842|P1|NOT COMPLETED|Overall Study||16
7532269|NCT03425253|18542842|P1|COMPLETED|Overall Study||42
7532270|NCT03425253|18542842|P1|Evaluable Set (ES)|Overall Study||42
7532271|NCT03425253|18542842|P1|FAS|Overall Study||53
7532272|NCT03425253|18542842|P1|Safety Analysis Set|Overall Study||53
7532273|NCT03425253|18542842|P1|STARTED|Overall Study||58
7532274|NCT03424681|18542856|P2|NOT COMPLETED|Overall Study||1
7532275|NCT03424681|18542857|P1|NOT COMPLETED|Overall Study||0
7532276|NCT03424681|18542856|P2|COMPLETED|Overall Study||5
7532277|NCT03424681|18542857|P1|COMPLETED|Overall Study||6
7532278|NCT03424681|18542856|P2|STARTED|Overall Study||6
7532279|NCT03424681|18542857|P1|STARTED|Overall Study||6
7532280|NCT03424265|18542871|P2|NOT COMPLETED|Overall Study||2
7532281|NCT03424265|18542872|P1|NOT COMPLETED|Overall Study||1
7532282|NCT03424265|18542871|P2|COMPLETED|Overall Study||32
7532283|NCT03424265|18542872|P1|COMPLETED|Overall Study||28
7532284|NCT03424265|18542871|P2|STARTED|Overall Study||34
7532285|NCT03424265|18542872|P1|STARTED|Overall Study||29
7532286|NCT03424044|18542878|P9|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
7532287|NCT03424044|18542879|P8|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
7532288|NCT03424044|18542880|P7|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
7532289|NCT03424044|18542881|P6|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
7532290|NCT03424044|18542882|P5|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
7532291|NCT03424044|18542883|P4|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
7532292|NCT03424044|18542884|P3|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
7532293|NCT03424044|18542885|P2|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
7532294|NCT03424044|18542886|P1|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
7532295|NCT03424044|18542878|P9|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
7532296|NCT03424044|18542879|P8|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
7532297|NCT03424044|18542880|P7|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
7532298|NCT03424044|18542881|P6|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
7532299|NCT03424044|18542882|P5|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
7532300|NCT03424044|18542883|P4|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
7532301|NCT03424044|18542884|P3|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
7532302|NCT03424044|18542885|P2|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
7532303|NCT03424044|18542886|P1|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
7532304|NCT03424044|18542878|P9|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
7532305|NCT03424044|18542879|P8|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
7532306|NCT03424044|18542880|P7|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
7532307|NCT03424044|18542881|P6|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
7532308|NCT03424044|18542882|P5|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
7532309|NCT03424044|18542883|P4|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
7532310|NCT03424044|18542884|P3|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
7532311|NCT03424044|18542885|P2|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
7532312|NCT03424044|18542886|P1|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
7532313|NCT03424044|18542878|P9|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
7532314|NCT03424044|18542879|P8|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
7532315|NCT03424044|18542880|P7|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
7532316|NCT03424044|18542881|P6|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
7532317|NCT03424044|18542882|P5|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
7532318|NCT03424044|18542883|P4|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
7532319|NCT03424044|18542884|P3|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
7532320|NCT03424044|18542885|P2|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
7532321|NCT03424044|18542886|P1|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
7532322|NCT03424044|18542878|P9|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
7532323|NCT03424044|18542879|P8|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
7532324|NCT03424044|18542880|P7|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
7532325|NCT03424044|18542881|P6|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
7532326|NCT03424044|18542882|P5|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
7532327|NCT03424044|18542883|P4|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
7532328|NCT03424044|18542884|P3|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
7532329|NCT03424044|18542885|P2|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
7532330|NCT03424044|18542886|P1|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
7532331|NCT03424044|18542878|P9|STARTED|Optional Fourth Rest Period (7-45 Days)||1
7532332|NCT03424044|18542879|P8|STARTED|Optional Fourth Rest Period (7-45 Days)||1
7532333|NCT03424044|18542880|P7|STARTED|Optional Fourth Rest Period (7-45 Days)||0
7532334|NCT03424044|18542881|P6|STARTED|Optional Fourth Rest Period (7-45 Days)||0
7532335|NCT03424044|18542882|P5|STARTED|Optional Fourth Rest Period (7-45 Days)||0
7532336|NCT03424044|18542883|P4|STARTED|Optional Fourth Rest Period (7-45 Days)||0
7532337|NCT03424044|18542884|P3|STARTED|Optional Fourth Rest Period (7-45 Days)||0
7532338|NCT03424044|18542885|P2|STARTED|Optional Fourth Rest Period (7-45 Days)||0
7532339|NCT03424044|18542886|P1|STARTED|Optional Fourth Rest Period (7-45 Days)||0
7532340|NCT03424044|18542878|P9|NOT COMPLETED|Third Intervention (76 Hours)||0
7532341|NCT03424044|18542879|P8|NOT COMPLETED|Third Intervention (76 Hours)||0
7532342|NCT03424044|18542880|P7|NOT COMPLETED|Third Intervention (76 Hours)||1
7532343|NCT03424044|18542881|P6|NOT COMPLETED|Third Intervention (76 Hours)||0
7532344|NCT03424044|18542882|P5|NOT COMPLETED|Third Intervention (76 Hours)||0
7532345|NCT03424044|18542883|P4|NOT COMPLETED|Third Intervention (76 Hours)||1
7532346|NCT03424044|18542884|P3|NOT COMPLETED|Third Intervention (76 Hours)||0
7532347|NCT03424044|18542885|P2|NOT COMPLETED|Third Intervention (76 Hours)||0
7532348|NCT03424044|18542886|P1|NOT COMPLETED|Third Intervention (76 Hours)||1
7532349|NCT03424044|18542878|P9|COMPLETED|Third Intervention (76 Hours)||1
7532350|NCT03424044|18542879|P8|COMPLETED|Third Intervention (76 Hours)||1
7532351|NCT03424044|18542880|P7|COMPLETED|Third Intervention (76 Hours)||0
7532352|NCT03424044|18542881|P6|COMPLETED|Third Intervention (76 Hours)||4
7532353|NCT03424044|18542882|P5|COMPLETED|Third Intervention (76 Hours)||2
7532354|NCT03424044|18542883|P4|COMPLETED|Third Intervention (76 Hours)||2
7532355|NCT03424044|18542884|P3|COMPLETED|Third Intervention (76 Hours)||2
7532356|NCT03424044|18542885|P2|COMPLETED|Third Intervention (76 Hours)||3
7532357|NCT03424044|18542886|P1|COMPLETED|Third Intervention (76 Hours)||3
7532358|NCT03424044|18542878|P9|STARTED|Third Intervention (76 Hours)||1
7532359|NCT03424044|18542879|P8|STARTED|Third Intervention (76 Hours)||1
7532360|NCT03424044|18542880|P7|STARTED|Third Intervention (76 Hours)||1
7532361|NCT03424044|18542881|P6|STARTED|Third Intervention (76 Hours)||4
7532362|NCT03424044|18542882|P5|STARTED|Third Intervention (76 Hours)||2
7532363|NCT03424044|18542883|P4|STARTED|Third Intervention (76 Hours)||3
7532364|NCT03424044|18542884|P3|STARTED|Third Intervention (76 Hours)||2
7532365|NCT03424044|18542885|P2|STARTED|Third Intervention (76 Hours)||3
7532366|NCT03424044|18542886|P1|STARTED|Third Intervention (76 Hours)||4
7532367|NCT03424044|18542878|P9|NOT COMPLETED|Third Rest Period (7-45 Days)||0
7532368|NCT03424044|18542879|P8|NOT COMPLETED|Third Rest Period (7-45 Days)||0
7532369|NCT03424044|18542880|P7|NOT COMPLETED|Third Rest Period (7-45 Days)||0
7532370|NCT03424044|18542881|P6|NOT COMPLETED|Third Rest Period (7-45 Days)||0
7532371|NCT03424044|18542882|P5|NOT COMPLETED|Third Rest Period (7-45 Days)||0
7532372|NCT03424044|18542883|P4|NOT COMPLETED|Third Rest Period (7-45 Days)||0
7532373|NCT03424044|18542884|P3|NOT COMPLETED|Third Rest Period (7-45 Days)||0
7532374|NCT03424044|18542885|P2|NOT COMPLETED|Third Rest Period (7-45 Days)||0
7532375|NCT03424044|18542886|P1|NOT COMPLETED|Third Rest Period (7-45 Days)||0
7532376|NCT03424044|18542878|P9|COMPLETED|Third Rest Period (7-45 Days)||1
7532377|NCT03424044|18542879|P8|COMPLETED|Third Rest Period (7-45 Days)||1
7532378|NCT03424044|18542880|P7|COMPLETED|Third Rest Period (7-45 Days)||1
7532379|NCT03424044|18542881|P6|COMPLETED|Third Rest Period (7-45 Days)||4
7532380|NCT03424044|18542882|P5|COMPLETED|Third Rest Period (7-45 Days)||2
7532381|NCT03424044|18542883|P4|COMPLETED|Third Rest Period (7-45 Days)||3
7532382|NCT03424044|18542884|P3|COMPLETED|Third Rest Period (7-45 Days)||2
7532383|NCT03424044|18542885|P2|COMPLETED|Third Rest Period (7-45 Days)||3
7532384|NCT03424044|18542886|P1|COMPLETED|Third Rest Period (7-45 Days)||4
7532385|NCT03424044|18542878|P9|STARTED|Third Rest Period (7-45 Days)||1
7532386|NCT03424044|18542879|P8|STARTED|Third Rest Period (7-45 Days)||1
7532387|NCT03424044|18542880|P7|STARTED|Third Rest Period (7-45 Days)||1
7532388|NCT03424044|18542881|P6|STARTED|Third Rest Period (7-45 Days)||4
7532389|NCT03424044|18542882|P5|STARTED|Third Rest Period (7-45 Days)||2
7532390|NCT03424044|18542883|P4|STARTED|Third Rest Period (7-45 Days)||3
7532391|NCT03424044|18542884|P3|STARTED|Third Rest Period (7-45 Days)||2
7532392|NCT03424044|18542885|P2|STARTED|Third Rest Period (7-45 Days)||3
7532393|NCT03424044|18542886|P1|STARTED|Third Rest Period (7-45 Days)||4
7532394|NCT03424044|18542878|P9|NOT COMPLETED|Second Intervention (76 Hours)||0
7532395|NCT03424044|18542879|P8|NOT COMPLETED|Second Intervention (76 Hours)||0
7532396|NCT03424044|18542880|P7|NOT COMPLETED|Second Intervention (76 Hours)||0
7532397|NCT03424044|18542881|P6|NOT COMPLETED|Second Intervention (76 Hours)||0
7532398|NCT03424044|18542882|P5|NOT COMPLETED|Second Intervention (76 Hours)||0
7532399|NCT03424044|18542883|P4|NOT COMPLETED|Second Intervention (76 Hours)||0
7532400|NCT03424044|18542884|P3|NOT COMPLETED|Second Intervention (76 Hours)||0
7532401|NCT03424044|18542885|P2|NOT COMPLETED|Second Intervention (76 Hours)||0
7532402|NCT03424044|18542886|P1|NOT COMPLETED|Second Intervention (76 Hours)||0
7532403|NCT03424044|18542878|P9|COMPLETED|Second Intervention (76 Hours)||1
7532404|NCT03424044|18542879|P8|COMPLETED|Second Intervention (76 Hours)||1
7532405|NCT03424044|18542880|P7|COMPLETED|Second Intervention (76 Hours)||1
7532406|NCT03424044|18542881|P6|COMPLETED|Second Intervention (76 Hours)||4
7532407|NCT03424044|18542882|P5|COMPLETED|Second Intervention (76 Hours)||2
7532408|NCT03424044|18542883|P4|COMPLETED|Second Intervention (76 Hours)||3
7532409|NCT03424044|18542884|P3|COMPLETED|Second Intervention (76 Hours)||2
7532410|NCT03424044|18542885|P2|COMPLETED|Second Intervention (76 Hours)||3
7532411|NCT03424044|18542886|P1|COMPLETED|Second Intervention (76 Hours)||4
7532412|NCT03424044|18542878|P9|STARTED|Second Intervention (76 Hours)||1
7532413|NCT03424044|18542879|P8|STARTED|Second Intervention (76 Hours)||1
7532414|NCT03424044|18542880|P7|STARTED|Second Intervention (76 Hours)||1
7532415|NCT03424044|18542881|P6|STARTED|Second Intervention (76 Hours)||4
7532416|NCT03424044|18542882|P5|STARTED|Second Intervention (76 Hours)||2
7532417|NCT03424044|18542883|P4|STARTED|Second Intervention (76 Hours)||3
7532418|NCT03424044|18542884|P3|STARTED|Second Intervention (76 Hours)||2
7532419|NCT03424044|18542885|P2|STARTED|Second Intervention (76 Hours)||3
7532420|NCT03424044|18542886|P1|STARTED|Second Intervention (76 Hours)||4
7532421|NCT03424044|18542878|P9|NOT COMPLETED|Second Rest Period (7-45 Days)||0
7532422|NCT03424044|18542879|P8|NOT COMPLETED|Second Rest Period (7-45 Days)||0
7532423|NCT03424044|18542880|P7|NOT COMPLETED|Second Rest Period (7-45 Days)||0
7532424|NCT03424044|18542881|P6|NOT COMPLETED|Second Rest Period (7-45 Days)||0
7532425|NCT03424044|18542882|P5|NOT COMPLETED|Second Rest Period (7-45 Days)||0
7532426|NCT03424044|18542883|P4|NOT COMPLETED|Second Rest Period (7-45 Days)||0
7532427|NCT03424044|18542884|P3|NOT COMPLETED|Second Rest Period (7-45 Days)||0
7532428|NCT03424044|18542885|P2|NOT COMPLETED|Second Rest Period (7-45 Days)||0
7532429|NCT03424044|18542886|P1|NOT COMPLETED|Second Rest Period (7-45 Days)||0
7532430|NCT03424044|18542878|P9|COMPLETED|Second Rest Period (7-45 Days)||1
7532431|NCT03424044|18542879|P8|COMPLETED|Second Rest Period (7-45 Days)||1
7532432|NCT03424044|18542880|P7|COMPLETED|Second Rest Period (7-45 Days)||1
7532433|NCT03424044|18542881|P6|COMPLETED|Second Rest Period (7-45 Days)||4
7532434|NCT03424044|18542882|P5|COMPLETED|Second Rest Period (7-45 Days)||2
7532435|NCT03424044|18542883|P4|COMPLETED|Second Rest Period (7-45 Days)||3
7532436|NCT03424044|18542884|P3|COMPLETED|Second Rest Period (7-45 Days)||2
7532437|NCT03424044|18542885|P2|COMPLETED|Second Rest Period (7-45 Days)||3
7532438|NCT03424044|18542886|P1|COMPLETED|Second Rest Period (7-45 Days)||4
7532439|NCT03424044|18542878|P9|STARTED|Second Rest Period (7-45 Days)||1
7532440|NCT03424044|18542879|P8|STARTED|Second Rest Period (7-45 Days)||1
7532441|NCT03424044|18542880|P7|STARTED|Second Rest Period (7-45 Days)||1
7532442|NCT03424044|18542881|P6|STARTED|Second Rest Period (7-45 Days)||4
7532443|NCT03424044|18542882|P5|STARTED|Second Rest Period (7-45 Days)||2
7532444|NCT03424044|18542883|P4|STARTED|Second Rest Period (7-45 Days)||3
7532445|NCT03424044|18542884|P3|STARTED|Second Rest Period (7-45 Days)||2
7532446|NCT03424044|18542885|P2|STARTED|Second Rest Period (7-45 Days)||3
7532447|NCT03424044|18542886|P1|STARTED|Second Rest Period (7-45 Days)||4
7532448|NCT03424044|18542878|P9|NOT COMPLETED|First Intervention (76 Hours)||1
7532449|NCT03424044|18542879|P8|NOT COMPLETED|First Intervention (76 Hours)||1
7532450|NCT03424044|18542880|P7|NOT COMPLETED|First Intervention (76 Hours)||1
7532451|NCT03424044|18542881|P6|NOT COMPLETED|First Intervention (76 Hours)||0
7532452|NCT03424044|18542882|P5|NOT COMPLETED|First Intervention (76 Hours)||1
7532453|NCT03424044|18542883|P4|NOT COMPLETED|First Intervention (76 Hours)||0
7532454|NCT03424044|18542884|P3|NOT COMPLETED|First Intervention (76 Hours)||0
7532455|NCT03424044|18542885|P2|NOT COMPLETED|First Intervention (76 Hours)||0
7532456|NCT03424044|18542886|P1|NOT COMPLETED|First Intervention (76 Hours)||0
7532457|NCT03424044|18542878|P9|COMPLETED|First Intervention (76 Hours)||0
7532458|NCT03424044|18542879|P8|COMPLETED|First Intervention (76 Hours)||0
7532459|NCT03424044|18542880|P7|COMPLETED|First Intervention (76 Hours)||0
7532460|NCT03424044|18542881|P6|COMPLETED|First Intervention (76 Hours)||4
7532461|NCT03424044|18542882|P5|COMPLETED|First Intervention (76 Hours)||2
7532462|NCT03424044|18542883|P4|COMPLETED|First Intervention (76 Hours)||3
7532463|NCT03424044|18542884|P3|COMPLETED|First Intervention (76 Hours)||2
7532464|NCT03424044|18542885|P2|COMPLETED|First Intervention (76 Hours)||3
7532465|NCT03424044|18542886|P1|COMPLETED|First Intervention (76 Hours)||4
7532466|NCT03424044|18542878|P9|STARTED|First Intervention (76 Hours)||1
7532467|NCT03424044|18542879|P8|STARTED|First Intervention (76 Hours)||1
7532468|NCT03424044|18542880|P7|STARTED|First Intervention (76 Hours)||1
7532469|NCT03424044|18542881|P6|STARTED|First Intervention (76 Hours)||4
7532470|NCT03424044|18542882|P5|STARTED|First Intervention (76 Hours)||3
7532471|NCT03424044|18542883|P4|STARTED|First Intervention (76 Hours)||3
7532472|NCT03424044|18542884|P3|STARTED|First Intervention (76 Hours)||2
7532473|NCT03424044|18542885|P2|STARTED|First Intervention (76 Hours)||3
7532474|NCT03424044|18542886|P1|STARTED|First Intervention (76 Hours)||4
7532475|NCT03424044|18542878|P9|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
7532476|NCT03424044|18542879|P8|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
7532477|NCT03424044|18542880|P7|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
7532478|NCT03424044|18542881|P6|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
7532479|NCT03424044|18542882|P5|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
7532480|NCT03424044|18542883|P4|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
7532481|NCT03424044|18542884|P3|NOT COMPLETED|First Rest Period (1-12 Weeks)||1
7532482|NCT03424044|18542885|P2|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
7532483|NCT03424044|18542886|P1|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
7532484|NCT03424044|18542878|P9|COMPLETED|First Rest Period (1-12 Weeks)||1
7532485|NCT03424044|18542879|P8|COMPLETED|First Rest Period (1-12 Weeks)||1
7532486|NCT03424044|18542880|P7|COMPLETED|First Rest Period (1-12 Weeks)||1
7532487|NCT03424044|18542881|P6|COMPLETED|First Rest Period (1-12 Weeks)||4
7532488|NCT03424044|18542882|P5|COMPLETED|First Rest Period (1-12 Weeks)||3
7532489|NCT03424044|18542883|P4|COMPLETED|First Rest Period (1-12 Weeks)||3
7532490|NCT03424044|18542884|P3|COMPLETED|First Rest Period (1-12 Weeks)||2
7532491|NCT03424044|18542885|P2|COMPLETED|First Rest Period (1-12 Weeks)||3
7532492|NCT03424044|18542886|P1|COMPLETED|First Rest Period (1-12 Weeks)||4
7532493|NCT03424044|18542878|P9|STARTED|First Rest Period (1-12 Weeks)||1
7532494|NCT03424044|18542879|P8|STARTED|First Rest Period (1-12 Weeks)||1
7532495|NCT03424044|18542880|P7|STARTED|First Rest Period (1-12 Weeks)||1
7532496|NCT03424044|18542881|P6|STARTED|First Rest Period (1-12 Weeks)||4
7532497|NCT03424044|18542882|P5|STARTED|First Rest Period (1-12 Weeks)||3
7532498|NCT03424044|18542883|P4|STARTED|First Rest Period (1-12 Weeks)||3
7532499|NCT03424044|18542884|P3|STARTED|First Rest Period (1-12 Weeks)||3
7532500|NCT03424044|18542885|P2|STARTED|First Rest Period (1-12 Weeks)||3
7532501|NCT03424044|18542886|P1|STARTED|First Rest Period (1-12 Weeks)||4
7532502|NCT03424044|18542878|P9|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
7532503|NCT03424044|18542879|P8|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
7532504|NCT03424044|18542880|P7|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
7532505|NCT03424044|18542881|P6|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
7532506|NCT03424044|18542882|P5|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
7532507|NCT03424044|18542883|P4|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
7532508|NCT03424044|18542884|P3|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
7532509|NCT03424044|18542885|P2|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
7532510|NCT03424044|18542886|P1|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
7532511|NCT03424044|18542878|P9|COMPLETED|Dexcom Training Visit (1 Week)||1
7532512|NCT03424044|18542879|P8|COMPLETED|Dexcom Training Visit (1 Week)||1
7532513|NCT03424044|18542880|P7|COMPLETED|Dexcom Training Visit (1 Week)||1
7532514|NCT03424044|18542881|P6|COMPLETED|Dexcom Training Visit (1 Week)||4
7532515|NCT03424044|18542882|P5|COMPLETED|Dexcom Training Visit (1 Week)||3
7532516|NCT03424044|18542883|P4|COMPLETED|Dexcom Training Visit (1 Week)||3
7532517|NCT03424044|18542884|P3|COMPLETED|Dexcom Training Visit (1 Week)||3
7532518|NCT03424044|18542885|P2|COMPLETED|Dexcom Training Visit (1 Week)||3
7532519|NCT03424044|18542886|P1|COMPLETED|Dexcom Training Visit (1 Week)||4
7532520|NCT03424044|18542878|P9|STARTED|Dexcom Training Visit (1 Week)||1
7532521|NCT03424044|18542879|P8|STARTED|Dexcom Training Visit (1 Week)||1
7532522|NCT03424044|18542880|P7|STARTED|Dexcom Training Visit (1 Week)||1
7532523|NCT03424044|18542881|P6|STARTED|Dexcom Training Visit (1 Week)||4
7532524|NCT03424044|18542882|P5|STARTED|Dexcom Training Visit (1 Week)||3
7532525|NCT03424044|18542883|P4|STARTED|Dexcom Training Visit (1 Week)||3
7532526|NCT03424044|18542884|P3|STARTED|Dexcom Training Visit (1 Week)||3
7532527|NCT03424044|18542885|P2|STARTED|Dexcom Training Visit (1 Week)||3
7532528|NCT03424044|18542886|P1|STARTED|Dexcom Training Visit (1 Week)||4
7532529|NCT03423654|18542913|P2|NOT COMPLETED|Overall Study||0
7532530|NCT03423654|18542914|P1|NOT COMPLETED|Overall Study||0
7532531|NCT03423654|18542913|P2|COMPLETED|Overall Study||3
7532532|NCT03423654|18542914|P1|COMPLETED|Overall Study||3
7532533|NCT03423654|18542913|P2|STARTED|Overall Study||3
7532534|NCT03423654|18542914|P1|STARTED|Overall Study||3
7532535|NCT03423641|18542922|P2|NOT COMPLETED|Overall Study||8074
7532536|NCT03423641|18542923|P1|NOT COMPLETED|Overall Study||331
7532537|NCT03423641|18542922|P2|COMPLETED|Overall Study||10210
7532538|NCT03423641|18542923|P1|COMPLETED|Overall Study||15193
7532539|NCT03423641|18542922|P2|STARTED|Overall Study||18284
7532540|NCT03423641|18542923|P1|STARTED|Overall Study||15524
7532541|NCT03423173|18542958|P4|NOT COMPLETED|Overall Study||30
7532542|NCT03423173|18542959|P3|NOT COMPLETED|Overall Study||27
7532543|NCT03423173|18542960|P2|NOT COMPLETED|Overall Study||35
7532544|NCT03423173|18542961|P1|NOT COMPLETED|Overall Study||19
7532545|NCT03423173|18542958|P4|COMPLETED|Overall Study||234
7532546|NCT03423173|18542959|P3|COMPLETED|Overall Study||237
7532547|NCT03423173|18542960|P2|COMPLETED|Overall Study||228
7532548|NCT03423173|18542961|P1|COMPLETED|Overall Study||113
7532549|NCT03423173|18542958|P4|Received at Least 1 Dose of the IP|Overall Study||263
7532550|NCT03423173|18542959|P3|Received at Least 1 Dose of the IP|Overall Study|1 participant of TDV Lot 2 received vaccine of Lot 1 and was included in TDV Lot 1 in Safety Set.|262
7532551|NCT03423173|18542960|P2|Received at Least 1 Dose of the IP|Overall Study||263
7532552|NCT03423173|18542961|P1|Received at Least 1 Dose of the IP|Overall Study||131
7532553|NCT03423173|18542958|P4|STARTED|Overall Study||264
7532554|NCT03423173|18542959|P3|STARTED|Overall Study||264
7532555|NCT03423173|18542960|P2|STARTED|Overall Study||263
7532556|NCT03423173|18542961|P1|STARTED|Overall Study||132
7532557|NCT03423082|18542999|P1|NOT COMPLETED|Overall Study||0
7532558|NCT03423082|18542999|P1|COMPLETED|Overall Study||1
7532559|NCT03423082|18542999|P1|STARTED|Overall Study||1
7532560|NCT03421886|18543008|P2|NOT COMPLETED|Overall Study||2
7532561|NCT03421886|18543009|P1|NOT COMPLETED|Overall Study||7
7532562|NCT03421886|18543008|P2|COMPLETED|Overall Study||13
7532563|NCT03421886|18543009|P1|COMPLETED|Overall Study||23
7532564|NCT03421886|18543008|P2|STARTED|Overall Study||15
7532565|NCT03421886|18543009|P1|STARTED|Overall Study||30
7532566|NCT03421730|18543015|P12|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
7532567|NCT03421730|18543016|P11|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
7532568|NCT03421730|18543017|P10|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
7532569|NCT03421730|18543018|P9|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
7532570|NCT03421730|18543019|P8|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
7532571|NCT03421730|18543020|P7|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
7532572|NCT03421730|18543021|P6|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
7532573|NCT03421730|18543022|P5|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
7532574|NCT03421730|18543023|P4|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
7532575|NCT03421730|18543024|P3|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
7532576|NCT03421730|18543025|P2|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
7532577|NCT03421730|18543026|P1|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
7532578|NCT03421730|18543015|P12|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
7532579|NCT03421730|18543016|P11|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
7532580|NCT03421730|18543017|P10|COMPLETED|Second Intervention (Day 8±3, Visit 3)||2
7532581|NCT03421730|18543018|P9|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
7532582|NCT03421730|18543019|P8|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
7532583|NCT03421730|18543020|P7|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
7532584|NCT03421730|18543021|P6|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
7532585|NCT03421730|18543022|P5|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
7532586|NCT03421730|18543023|P4|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
7532587|NCT03421730|18543024|P3|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
7532588|NCT03421730|18543025|P2|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
7532589|NCT03421730|18543026|P1|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
7532590|NCT03421730|18543015|P12|STARTED|Second Intervention (Day 8±3, Visit 3)||1
7532591|NCT03421730|18543016|P11|STARTED|Second Intervention (Day 8±3, Visit 3)||1
7532592|NCT03421730|18543017|P10|STARTED|Second Intervention (Day 8±3, Visit 3)||2
7532593|NCT03421730|18543018|P9|STARTED|Second Intervention (Day 8±3, Visit 3)||1
7532594|NCT03421730|18543019|P8|STARTED|Second Intervention (Day 8±3, Visit 3)||1
7532595|NCT03421730|18543020|P7|STARTED|Second Intervention (Day 8±3, Visit 3)||1
7532596|NCT03421730|18543021|P6|STARTED|Second Intervention (Day 8±3, Visit 3)||1
7532597|NCT03421730|18543022|P5|STARTED|Second Intervention (Day 8±3, Visit 3)||1
7532598|NCT03421730|18543023|P4|STARTED|Second Intervention (Day 8±3, Visit 3)||1
7532599|NCT03421730|18543024|P3|STARTED|Second Intervention (Day 8±3, Visit 3)||1
7532600|NCT03421730|18543025|P2|STARTED|Second Intervention (Day 8±3, Visit 3)||1
7532601|NCT03421730|18543026|P1|STARTED|Second Intervention (Day 8±3, Visit 3)||1
7532602|NCT03421730|18543015|P12|NOT COMPLETED|Washout (Days 4 to 10)||0
7532603|NCT03421730|18543016|P11|NOT COMPLETED|Washout (Days 4 to 10)||0
7532604|NCT03421730|18543017|P10|NOT COMPLETED|Washout (Days 4 to 10)||0
7532605|NCT03421730|18543018|P9|NOT COMPLETED|Washout (Days 4 to 10)||0
7532606|NCT03421730|18543019|P8|NOT COMPLETED|Washout (Days 4 to 10)||0
7532607|NCT03421730|18543020|P7|NOT COMPLETED|Washout (Days 4 to 10)||0
7532608|NCT03421730|18543021|P6|NOT COMPLETED|Washout (Days 4 to 10)||0
7532609|NCT03421730|18543022|P5|NOT COMPLETED|Washout (Days 4 to 10)||2
7532610|NCT03421730|18543023|P4|NOT COMPLETED|Washout (Days 4 to 10)||0
7532611|NCT03421730|18543024|P3|NOT COMPLETED|Washout (Days 4 to 10)||0
7532612|NCT03421730|18543025|P2|NOT COMPLETED|Washout (Days 4 to 10)||0
7532613|NCT03421730|18543026|P1|NOT COMPLETED|Washout (Days 4 to 10)||0
7532614|NCT03421730|18543015|P12|COMPLETED|Washout (Days 4 to 10)||1
7532615|NCT03421730|18543016|P11|COMPLETED|Washout (Days 4 to 10)||1
7532616|NCT03421730|18543017|P10|COMPLETED|Washout (Days 4 to 10)||2
7532617|NCT03421730|18543018|P9|COMPLETED|Washout (Days 4 to 10)||1
7532618|NCT03421730|18543019|P8|COMPLETED|Washout (Days 4 to 10)||1
7532619|NCT03421730|18543020|P7|COMPLETED|Washout (Days 4 to 10)||1
7532620|NCT03421730|18543021|P6|COMPLETED|Washout (Days 4 to 10)||1
7532621|NCT03421730|18543022|P5|COMPLETED|Washout (Days 4 to 10)|Two subjects withdrew after receiving treatment with B but before receiving treatment with C.|1
7532622|NCT03421730|18543023|P4|COMPLETED|Washout (Days 4 to 10)||1
7532623|NCT03421730|18543024|P3|COMPLETED|Washout (Days 4 to 10)||1
7532624|NCT03421730|18543025|P2|COMPLETED|Washout (Days 4 to 10)||1
7532625|NCT03421730|18543026|P1|COMPLETED|Washout (Days 4 to 10)||1
7532626|NCT03421730|18543015|P12|STARTED|Washout (Days 4 to 10)||1
7532627|NCT03421730|18543016|P11|STARTED|Washout (Days 4 to 10)||1
7532628|NCT03421730|18543017|P10|STARTED|Washout (Days 4 to 10)||2
7532629|NCT03421730|18543018|P9|STARTED|Washout (Days 4 to 10)||1
7532630|NCT03421730|18543019|P8|STARTED|Washout (Days 4 to 10)||1
7532631|NCT03421730|18543020|P7|STARTED|Washout (Days 4 to 10)||1
7532632|NCT03421730|18543021|P6|STARTED|Washout (Days 4 to 10)||1
7532633|NCT03421730|18543022|P5|STARTED|Washout (Days 4 to 10)||3
7532634|NCT03421730|18543023|P4|STARTED|Washout (Days 4 to 10)||1
7532635|NCT03421730|18543024|P3|STARTED|Washout (Days 4 to 10)||1
7532636|NCT03421730|18543025|P2|STARTED|Washout (Days 4 to 10)||1
7532637|NCT03421730|18543026|P1|STARTED|Washout (Days 4 to 10)||1
7532638|NCT03421730|18543015|P12|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
7532639|NCT03421730|18543016|P11|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
7532640|NCT03421730|18543017|P10|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
7532641|NCT03421730|18543018|P9|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
7532642|NCT03421730|18543019|P8|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
7532643|NCT03421730|18543020|P7|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
7532644|NCT03421730|18543021|P6|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
7532645|NCT03421730|18543022|P5|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
7532646|NCT03421730|18543023|P4|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
7532647|NCT03421730|18543024|P3|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
7532648|NCT03421730|18543025|P2|NOT COMPLETED|First Intervention (Day 1, Visit 2)||2
7532649|NCT03421730|18543026|P1|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
7532650|NCT03421730|18543015|P12|COMPLETED|First Intervention (Day 1, Visit 2)||1
7532651|NCT03421730|18543016|P11|COMPLETED|First Intervention (Day 1, Visit 2)||1
7532652|NCT03421730|18543017|P10|COMPLETED|First Intervention (Day 1, Visit 2)||2
7532653|NCT03421730|18543018|P9|COMPLETED|First Intervention (Day 1, Visit 2)||1
7532654|NCT03421730|18543019|P8|COMPLETED|First Intervention (Day 1, Visit 2)||1
7532655|NCT03421730|18543020|P7|COMPLETED|First Intervention (Day 1, Visit 2)||1
7532656|NCT03421730|18543021|P6|COMPLETED|First Intervention (Day 1, Visit 2)||1
7532657|NCT03421730|18543022|P5|COMPLETED|First Intervention (Day 1, Visit 2)||3
7532658|NCT03421730|18543023|P4|COMPLETED|First Intervention (Day 1, Visit 2)||1
7532659|NCT03421730|18543024|P3|COMPLETED|First Intervention (Day 1, Visit 2)||1
7532660|NCT03421730|18543025|P2|COMPLETED|First Intervention (Day 1, Visit 2)|Two subjects withdrew without receiving treatment with either A or C.|1
7532661|NCT03421730|18543026|P1|COMPLETED|First Intervention (Day 1, Visit 2)||1
7532662|NCT03421730|18543015|P12|STARTED|First Intervention (Day 1, Visit 2)||1
7532663|NCT03421730|18543016|P11|STARTED|First Intervention (Day 1, Visit 2)||1
7532664|NCT03421730|18543017|P10|STARTED|First Intervention (Day 1, Visit 2)||2
7532665|NCT03421730|18543018|P9|STARTED|First Intervention (Day 1, Visit 2)||1
7532666|NCT03421730|18543019|P8|STARTED|First Intervention (Day 1, Visit 2)||1
7532667|NCT03421730|18543020|P7|STARTED|First Intervention (Day 1, Visit 2)||1
7532668|NCT03421730|18543021|P6|STARTED|First Intervention (Day 1, Visit 2)||1
7532669|NCT03421730|18543022|P5|STARTED|First Intervention (Day 1, Visit 2)||3
7532670|NCT03421730|18543023|P4|STARTED|First Intervention (Day 1, Visit 2)||1
7532671|NCT03421730|18543024|P3|STARTED|First Intervention (Day 1, Visit 2)||1
7532672|NCT03421730|18543025|P2|STARTED|First Intervention (Day 1, Visit 2)||3
7532673|NCT03421730|18543026|P1|STARTED|First Intervention (Day 1, Visit 2)||1
7532674|NCT03421379|18543099|P2|NOT COMPLETED|Period 2||0
7532675|NCT03421379|18543100|P1|NOT COMPLETED|Period 2||0
7532676|NCT03421379|18543099|P2|COMPLETED|Period 2||37
7532677|NCT03421379|18543100|P1|COMPLETED|Period 2||32
7532678|NCT03421379|18543099|P2|STARTED|Period 2||37
7532679|NCT03421379|18543100|P1|STARTED|Period 2||32
7532680|NCT03421379|18543099|P2|NOT COMPLETED|Washout Period (3 to 14 Days)||0
7532681|NCT03421379|18543100|P1|NOT COMPLETED|Washout Period (3 to 14 Days)||0
7532682|NCT03421379|18543099|P2|COMPLETED|Washout Period (3 to 14 Days)||37
7532683|NCT03421379|18543100|P1|COMPLETED|Washout Period (3 to 14 Days)||32
7532684|NCT03421379|18543099|P2|STARTED|Washout Period (3 to 14 Days)||37
7532685|NCT03421379|18543100|P1|STARTED|Washout Period (3 to 14 Days)||32
7532686|NCT03421379|18543099|P2|NOT COMPLETED|Period 1||4
7532687|NCT03421379|18543100|P1|NOT COMPLETED|Period 1||2
7532688|NCT03421379|18543099|P2|COMPLETED|Period 1||37
7532689|NCT03421379|18543100|P1|COMPLETED|Period 1||32
7532690|NCT03421379|18543099|P2|Received at Least One Dose of Study Drug|Period 1||39
7532691|NCT03421379|18543100|P1|Received at Least One Dose of Study Drug|Period 1||33
7532692|NCT03421379|18543099|P2|STARTED|Period 1||41
7532693|NCT03421379|18543100|P1|STARTED|Period 1||34
7532694|NCT03421210|18543116|P1|NOT COMPLETED|Overall Study||53
7532695|NCT03421210|18543116|P1|COMPLETED|Overall Study||35
7532696|NCT03421210|18543116|P1|Received Functional Magnetic Resonance Imaging (fMRI)|Overall Study||42
7532697|NCT03421210|18543116|P1|STARTED|Overall Study||88
7532698|NCT03420625|18543120|P1|NOT COMPLETED|Overall Study||0
7532699|NCT03420625|18543120|P1|COMPLETED|Overall Study||10
7532700|NCT03420625|18543120|P1|Calf NMES|Overall Study||10
7532701|NCT03420625|18543120|P1|Slow Calf IPC|Overall Study||10
7532702|NCT03420625|18543120|P1|Rapid Calf IPC|Overall Study||10
7532703|NCT03420625|18543120|P1|Foot IPC|Overall Study||10
7532704|NCT03420625|18543120|P1|Baseline|Overall Study||10
7532705|NCT03420625|18543120|P1|STARTED|Overall Study||10
7532706|NCT03420300|18543150|P1|NOT COMPLETED|Overall Study||2
7532707|NCT03420300|18543150|P1|COMPLETED|Overall Study||38
7532708|NCT03420300|18543150|P1|STARTED|Overall Study||40
7532709|NCT03419962|18543159|P1|NOT COMPLETED|Overall Study||37
7532710|NCT03419962|18543159|P1|COMPLETED|Overall Study||1322
7532711|NCT03419962|18543159|P1|STARTED|Overall Study||1359
7532712|NCT03419780|18543171|P2|NOT COMPLETED|Overall Study||0
7532713|NCT03419780|18543172|P1|NOT COMPLETED|Overall Study||0
7532714|NCT03419780|18543171|P2|COMPLETED|Overall Study||33
7532715|NCT03419780|18543172|P1|COMPLETED|Overall Study||33
7532716|NCT03419780|18543171|P2|STARTED|Overall Study||33
7532717|NCT03419780|18543172|P1|STARTED|Overall Study||33
7532718|NCT03419598|18543190|P1|NOT COMPLETED|Overall Study||2
7532719|NCT03419598|18543190|P1|COMPLETED|Overall Study||28
7532720|NCT03419598|18543190|P1|FE Models Solved for Generic HTO Plate Stabilised Cohort Copy|Overall Study||28
7532721|NCT03419598|18543190|P1|FE Models Solved for Personalised HTO Plate Stabilised Cohort Copy|Overall Study||28
7532722|NCT03419598|18543190|P1|FE Models Created for Cohort Copy Stabilised by Generic HTO Plate|Overall Study||28
7532723|NCT03419598|18543190|P1|Finite Element (FE) Model Created for Cohort Copy Stabilised by Personalised HTO Plate|Overall Study||28
7532724|NCT03419598|18543190|P1|Virtual Cohort Duplicated Into A. Personalised and B. Generic Copies|Overall Study||28
7532725|NCT03419598|18543190|P1|Subject Specific Tibia Models Created and Virtual Osteotomy Performed|Overall Study||28
7532726|NCT03419598|18543190|P1|STARTED|Overall Study||30
7532727|NCT03419078|18543200|P3|NOT COMPLETED|Overall Study||0
7532728|NCT03419078|18543201|P2|NOT COMPLETED|Overall Study||0
7532729|NCT03419078|18543202|P1|NOT COMPLETED|Overall Study||0
7532730|NCT03419078|18543200|P3|COMPLETED|Overall Study||91
7532731|NCT03419078|18543201|P2|COMPLETED|Overall Study||148
7532732|NCT03419078|18543202|P1|COMPLETED|Overall Study||245
7532733|NCT03419078|18543200|P3|STARTED|Overall Study||91
7532734|NCT03419078|18543201|P2|STARTED|Overall Study||148
7532735|NCT03419078|18543202|P1|STARTED|Overall Study||245
7532736|NCT03418662|18543221|P2|NOT COMPLETED|Overall Study||4
7532737|NCT03418662|18543222|P1|NOT COMPLETED|Overall Study||3
7532738|NCT03418662|18543221|P2|COMPLETED|Overall Study||278
7532739|NCT03418662|18543222|P1|COMPLETED|Overall Study||284
7532740|NCT03418662|18543221|P2|STARTED|Overall Study||282
7532741|NCT03418662|18543222|P1|STARTED|Overall Study||287
7532742|NCT03418571|18543246|P2|NOT COMPLETED|Overall Study||0
7532743|NCT03418571|18543247|P1|NOT COMPLETED|Overall Study||1
7532744|NCT03418571|18543246|P2|COMPLETED|Overall Study||3
7532745|NCT03418571|18543247|P1|COMPLETED|Overall Study||11
7532746|NCT03418571|18543246|P2|STARTED|Overall Study||3
7532747|NCT03418571|18543247|P1|STARTED|Overall Study||12
7532748|NCT03418376|18543259|P4|NOT COMPLETED|Overall Study||1
7532749|NCT03418376|18543260|P3|NOT COMPLETED|Overall Study||3
7532750|NCT03418376|18543261|P2|NOT COMPLETED|Overall Study||5
7532751|NCT03418376|18543262|P1|NOT COMPLETED|Overall Study||1
7532752|NCT03418376|18543259|P4|COMPLETED|Overall Study||10
7532753|NCT03418376|18543260|P3|COMPLETED|Overall Study||8
7532754|NCT03418376|18543261|P2|COMPLETED|Overall Study||6
7532755|NCT03418376|18543262|P1|COMPLETED|Overall Study||11
7532756|NCT03418376|18543259|P4|STARTED|Overall Study||11
7532757|NCT03418376|18543260|P3|STARTED|Overall Study||11
7532758|NCT03418376|18543261|P2|STARTED|Overall Study||11
7532759|NCT03418376|18543262|P1|STARTED|Overall Study||12
7532760|NCT03418324|18543290|P2|NOT COMPLETED|Overall Study||2
7532761|NCT03418324|18543291|P1|NOT COMPLETED|Overall Study||1
7532762|NCT03418324|18543290|P2|COMPLETED|Overall Study||6
7532763|NCT03418324|18543291|P1|COMPLETED|Overall Study||2
7532764|NCT03418324|18543290|P2|STARTED|Overall Study||8
7532765|NCT03418324|18543291|P1|STARTED|Overall Study||3
7532766|NCT03418064|18543309|P2|NOT COMPLETED|Second Intervention (1 Month)||0
7532767|NCT03418064|18543310|P1|NOT COMPLETED|Second Intervention (1 Month)||0
7532768|NCT03418064|18543309|P2|COMPLETED|Second Intervention (1 Month)||21
7532769|NCT03418064|18543310|P1|COMPLETED|Second Intervention (1 Month)||21
7532770|NCT03418064|18543309|P2|STARTED|Second Intervention (1 Month)||21
7532771|NCT03418064|18543310|P1|STARTED|Second Intervention (1 Month)||21
7532772|NCT03418064|18543309|P2|NOT COMPLETED|First Intervention (1 Month)||0
7532773|NCT03418064|18543310|P1|NOT COMPLETED|First Intervention (1 Month)||0
7532774|NCT03418064|18543309|P2|COMPLETED|First Intervention (1 Month)||21
7532775|NCT03418064|18543310|P1|COMPLETED|First Intervention (1 Month)||21
7532776|NCT03418064|18543309|P2|STARTED|First Intervention (1 Month)||21
7532777|NCT03418064|18543310|P1|STARTED|First Intervention (1 Month)||21
7532778|NCT03417830|18543341|P2|NOT COMPLETED|Part B (up to 26 Days)||0
7532779|NCT03417830|18543342|P1|NOT COMPLETED|Part B (up to 26 Days)||0
7532780|NCT03417830|18543341|P2|COMPLETED|Part B (up to 26 Days)||0
7532781|NCT03417830|18543342|P1|COMPLETED|Part B (up to 26 Days)||0
7532782|NCT03417830|18543341|P2|STARTED|Part B (up to 26 Days)||0
7532783|NCT03417830|18543342|P1|STARTED|Part B (up to 26 Days)||0
7532784|NCT03417830|18543341|P2|NOT COMPLETED|Part A (up to 26 Days)||0
7532785|NCT03417830|18543342|P1|NOT COMPLETED|Part A (up to 26 Days)||1
7532786|NCT03417830|18543341|P2|COMPLETED|Part A (up to 26 Days)||0
7532787|NCT03417830|18543342|P1|COMPLETED|Part A (up to 26 Days)||1
7532788|NCT03417830|18543341|P2|STARTED|Part A (up to 26 Days)||0
7532789|NCT03417830|18543342|P1|STARTED|Part A (up to 26 Days)||2
7532790|NCT03417752|18543439|P3|NOT COMPLETED|Overall Study||40
7532791|NCT03417752|18543440|P2|NOT COMPLETED|Overall Study||42
7532792|NCT03417752|18543441|P1|NOT COMPLETED|Overall Study||34
7532793|NCT03417752|18543439|P3|COMPLETED|Overall Study||110
7532794|NCT03417752|18543440|P2|COMPLETED|Overall Study||133
7532795|NCT03417752|18543441|P1|COMPLETED|Overall Study||115
7532796|NCT03417752|18543439|P3|STARTED|Overall Study||150
7532797|NCT03417752|18543440|P2|STARTED|Overall Study||175
7532798|NCT03417752|18543441|P1|STARTED|Overall Study||149
7532799|NCT03417713|18543458|P1|NOT COMPLETED|Overall Study||3
7532800|NCT03417713|18543458|P1|COMPLETED|Overall Study||30
7532801|NCT03417713|18543458|P1|STARTED|Overall Study||33
7532802|NCT03417557|18543463|P2|NOT COMPLETED|2nd Intervention (3 Hours)||0
7532803|NCT03417557|18543464|P1|NOT COMPLETED|2nd Intervention (3 Hours)||0
7532804|NCT03417557|18543463|P2|COMPLETED|2nd Intervention (3 Hours)||8
7532805|NCT03417557|18543464|P1|COMPLETED|2nd Intervention (3 Hours)||9
7532806|NCT03417557|18543463|P2|STARTED|2nd Intervention (3 Hours)||8
7532807|NCT03417557|18543464|P1|STARTED|2nd Intervention (3 Hours)||9
7532808|NCT03417557|18543463|P2|NOT COMPLETED|1st Intervention (3 Hours)||0
7532809|NCT03417557|18543464|P1|NOT COMPLETED|1st Intervention (3 Hours)||0
7532810|NCT03417557|18543463|P2|COMPLETED|1st Intervention (3 Hours)||9
7532811|NCT03417557|18543464|P1|COMPLETED|1st Intervention (3 Hours)||8
7532812|NCT03417557|18543463|P2|STARTED|1st Intervention (3 Hours)||9
7532813|NCT03417557|18543464|P1|STARTED|1st Intervention (3 Hours)||8
7532814|NCT03417505|18543476|P2|NOT COMPLETED|Second Lens Type (30 Days)||0
7532815|NCT03417505|18543477|P1|NOT COMPLETED|Second Lens Type (30 Days)||0
7532816|NCT03417505|18543476|P2|COMPLETED|Second Lens Type (30 Days)||11
7532817|NCT03417505|18543477|P1|COMPLETED|Second Lens Type (30 Days)||8
7532818|NCT03417505|18543476|P2|STARTED|Second Lens Type (30 Days)||11
7532819|NCT03417505|18543477|P1|STARTED|Second Lens Type (30 Days)||8
7532820|NCT03417505|18543476|P2|NOT COMPLETED|Washout Period (7 Days)||0
7532821|NCT03417505|18543477|P1|NOT COMPLETED|Washout Period (7 Days)||0
7532822|NCT03417505|18543476|P2|COMPLETED|Washout Period (7 Days)||11
7532823|NCT03417505|18543477|P1|COMPLETED|Washout Period (7 Days)||8
7532824|NCT03417505|18543476|P2|STARTED|Washout Period (7 Days)||11
7532825|NCT03417505|18543477|P1|STARTED|Washout Period (7 Days)||8
7532826|NCT03417505|18543476|P2|NOT COMPLETED|First Lens Type (30 Days)||1
7532827|NCT03417505|18543477|P1|NOT COMPLETED|First Lens Type (30 Days)||1
7532828|NCT03417505|18543476|P2|COMPLETED|First Lens Type (30 Days)||11
7532829|NCT03417505|18543477|P1|COMPLETED|First Lens Type (30 Days)||8
7532830|NCT03417505|18543476|P2|STARTED|First Lens Type (30 Days)||12
7532831|NCT03417505|18543477|P1|STARTED|First Lens Type (30 Days)||9
7532832|NCT03417466|18543499|P1|NOT COMPLETED|Overall Study||0
7532833|NCT03417466|18543499|P1|COMPLETED|Overall Study||66
7532834|NCT03417466|18543499|P1|STARTED|Overall Study||66
7532835|NCT03417219|18543508|P2|NOT COMPLETED|Overall Study||3
7532836|NCT03417219|18543509|P1|NOT COMPLETED|Overall Study||0
7532837|NCT03417219|18543508|P2|COMPLETED|Overall Study||5
7532838|NCT03417219|18543509|P1|COMPLETED|Overall Study||8
7532839|NCT03417219|18543508|P2|STARTED|Overall Study||8
7532840|NCT03417219|18543509|P1|STARTED|Overall Study||8
7532841|NCT03417141|18543519|P1|NOT COMPLETED|Overall Study||4
7532842|NCT03417141|18543519|P1|COMPLETED|Overall Study||8
7532843|NCT03417141|18543519|P1|STARTED|Overall Study||12
7532844|NCT03417024|18543526|P1|NOT COMPLETED|Overall Study||13
7532845|NCT03417024|18543526|P1|COMPLETED|Overall Study||0
7532846|NCT03417024|18543526|P1|STARTED|Overall Study||13
7532847|NCT03416985|18543535|P3|NOT COMPLETED|Overall Study||6
7532848|NCT03416985|18543536|P2|NOT COMPLETED|Overall Study||0
7532849|NCT03416985|18543537|P1|NOT COMPLETED|Overall Study||2
7532850|NCT03416985|18543535|P3|COMPLETED|Overall Study||24
7532851|NCT03416985|18543536|P2|COMPLETED|Overall Study||30
7532852|NCT03416985|18543537|P1|COMPLETED|Overall Study||28
7532853|NCT03416985|18543535|P3|STARTED|Overall Study||30
7532854|NCT03416985|18543536|P2|STARTED|Overall Study||30
7532855|NCT03416985|18543537|P1|STARTED|Overall Study||30
7532856|NCT03416127|18543551|P3|NOT COMPLETED|Overall Study||1
7532857|NCT03416127|18543552|P2|NOT COMPLETED|Overall Study||1
7532858|NCT03416127|18543553|P1|NOT COMPLETED|Overall Study||0
7532859|NCT03416127|18543551|P3|COMPLETED|Overall Study||11
7532860|NCT03416127|18543552|P2|COMPLETED|Overall Study||11
7532861|NCT03416127|18543553|P1|COMPLETED|Overall Study||12
7532862|NCT03416127|18543551|P3|STARTED|Overall Study||12
7532863|NCT03416127|18543552|P2|STARTED|Overall Study||12
7532864|NCT03416127|18543553|P1|STARTED|Overall Study||12
7532865|NCT03415243|18543632|P2|NOT COMPLETED|Overall Study||0
7532866|NCT03415243|18543633|P1|NOT COMPLETED|Overall Study||0
7532867|NCT03415243|18543632|P2|COMPLETED|Overall Study||14
7532868|NCT03415243|18543633|P1|COMPLETED|Overall Study||14
7532869|NCT03415243|18543632|P2|STARTED|Overall Study||14
7532870|NCT03415243|18543633|P1|STARTED|Overall Study||14
7532871|NCT03415178|18543697|P2|NOT COMPLETED|Single Arm Period (up to Week 16)||1
7532872|NCT03415178|18543698|P1|NOT COMPLETED|Single Arm Period (up to Week 16)||0
7532873|NCT03415178|18543697|P2|COMPLETED|Single Arm Period (up to Week 16)||65
7532874|NCT03415178|18543698|P1|COMPLETED|Single Arm Period (up to Week 16)||0
7532875|NCT03415178|18543697|P2|STARTED|Single Arm Period (up to Week 16)|65 (participants completed period 1) + 1 (randomized to SYDNEY arm but not treated in period 1).|66
7532876|NCT03415178|18543698|P1|STARTED|Single Arm Period (up to Week 16)|Out of 34 participants from AI group, 33 participants entered entered in single arm period.|0
7532877|NCT03415178|18543697|P2|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||2
7532878|NCT03415178|18543698|P1|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||0
7532879|NCT03415178|18543697|P2|COMPLETED|Parallel-Arm Period (up to Week 4)|32 participants entered in single arm period & 1 participant decided not to enter single arm period.|33
7532880|NCT03415178|18543698|P1|COMPLETED|Parallel-Arm Period (up to Week 4)|33 participants entered in single arm period & 1 participant decided not to enter single arm period.|34
7532881|NCT03415178|18543697|P2|Treated|Parallel-Arm Period (up to Week 4)||33
7532882|NCT03415178|18543698|P1|Treated|Parallel-Arm Period (up to Week 4)||34
7532883|NCT03415178|18543697|P2|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|35
7532884|NCT03415178|18543698|P1|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|34
7532885|NCT03415152|18543733|P1|NOT COMPLETED|Overall Study||1025
7532886|NCT03415152|18543733|P1|COMPLETED|Overall Study||1975
7532887|NCT03415152|18543733|P1|STARTED|Overall Study||3000
7532888|NCT03415022|18543752|P2|NOT COMPLETED|Overall Study||5
7532889|NCT03415022|18543753|P1|NOT COMPLETED|Overall Study||5
7532890|NCT03415022|18543752|P2|COMPLETED|Overall Study||15
7532891|NCT03415022|18543753|P1|COMPLETED|Overall Study||16
7532892|NCT03415022|18543752|P2|STARTED|Overall Study||20
7532893|NCT03415022|18543753|P1|STARTED|Overall Study||21
7532894|NCT03414359|18543763|P2|NOT COMPLETED|Overall Study||2
7532895|NCT03414359|18543764|P1|NOT COMPLETED|Overall Study||1
7532896|NCT03414359|18543763|P2|COMPLETED|Overall Study||33
7532897|NCT03414359|18543764|P1|COMPLETED|Overall Study||34
7532898|NCT03414359|18543763|P2|STARTED|Overall Study||35
7532899|NCT03414359|18543764|P1|STARTED|Overall Study||35
7532900|NCT03414047|18543776|P4|NOT COMPLETED|Overall Study||3
7532901|NCT03414047|18543777|P3|NOT COMPLETED|Overall Study||0
7532902|NCT03414047|18543778|P2|NOT COMPLETED|Overall Study||0
7532903|NCT03414047|18543779|P1|NOT COMPLETED|Overall Study||1
7532904|NCT03414047|18543776|P4|COMPLETED|Overall Study||28
7532905|NCT03414047|18543777|P3|COMPLETED|Overall Study||40
7532906|NCT03414047|18543778|P2|COMPLETED|Overall Study||44
7532907|NCT03414047|18543779|P1|COMPLETED|Overall Study||53
7532908|NCT03414047|18543776|P4|STARTED|Overall Study||31
7532909|NCT03414047|18543777|P3|STARTED|Overall Study||40
7532910|NCT03414047|18543778|P2|STARTED|Overall Study||44
7532911|NCT03414047|18543779|P1|STARTED|Overall Study||54
7532912|NCT03413618|18543812|P2|NOT COMPLETED|Overall Study||0
7532913|NCT03413618|18543813|P1|NOT COMPLETED|Overall Study||0
7532914|NCT03413618|18543812|P2|COMPLETED|Overall Study||45
7532915|NCT03413618|18543813|P1|COMPLETED|Overall Study||45
7532916|NCT03413618|18543812|P2|STARTED|Overall Study||45
7532917|NCT03413618|18543813|P1|STARTED|Overall Study||45
7532918|NCT03412929|18543839|P1|NOT COMPLETED|Overall Study||3
7532919|NCT03412929|18543839|P1|COMPLETED|Overall Study||5
7532920|NCT03412929|18543839|P1|STARTED|Overall Study||8
7532921|NCT03412734|18543850|P2|NOT COMPLETED|Overall Study||0
7532922|NCT03412734|18543851|P1|NOT COMPLETED|Overall Study||3
7532923|NCT03412734|18543850|P2|COMPLETED|Overall Study||41
7532924|NCT03412734|18543851|P1|COMPLETED|Overall Study||44
7532925|NCT03412734|18543850|P2|STARTED|Overall Study||41
7532926|NCT03412734|18543851|P1|STARTED|Overall Study||47
7532927|NCT03412084|18543859|P2|NOT COMPLETED|Overall Study||1
7532928|NCT03412084|18543860|P1|NOT COMPLETED|Overall Study||4
7532929|NCT03412084|18543859|P2|COMPLETED|Overall Study||35
7532930|NCT03412084|18543860|P1|COMPLETED|Overall Study||44
7532931|NCT03412084|18543859|P2|STARTED|Overall Study||36
7532932|NCT03412084|18543860|P1|STARTED|Overall Study||48
7532933|NCT03412019|18543870|P2|NOT COMPLETED|Overall Study||1
7532934|NCT03412019|18543871|P1|NOT COMPLETED|Overall Study||1
7532935|NCT03412019|18543870|P2|COMPLETED|Overall Study||10
7532936|NCT03412019|18543871|P1|COMPLETED|Overall Study||10
7532937|NCT03412019|18543870|P2|STARTED|Overall Study||11
7532938|NCT03412019|18543871|P1|STARTED|Overall Study||11
7532939|NCT03410628|18543881|P1|NOT COMPLETED|Overall Study||6
7532940|NCT03410628|18543881|P1|COMPLETED|Overall Study||15
7532941|NCT03410628|18543881|P1|STARTED|Overall Study||21
7532942|NCT03409796|18543888|P2|NOT COMPLETED|Overall Study||1
7532943|NCT03409796|18543889|P1|NOT COMPLETED|Overall Study||2
7532944|NCT03409796|18543888|P2|COMPLETED|Overall Study||6
7532945|NCT03409796|18543889|P1|COMPLETED|Overall Study||7
7532946|NCT03409796|18543888|P2|STARTED|Overall Study||7
7532947|NCT03409796|18543889|P1|STARTED|Overall Study||9
7532948|NCT03409731|18543901|P1|NOT COMPLETED|Overall Study||3
7532949|NCT03409731|18543901|P1|COMPLETED|Overall Study||132
7532950|NCT03409731|18543901|P1|STARTED|Overall Study||135
7532951|NCT03408730|18543975|P4|NOT COMPLETED|Overall Study||81
7532952|NCT03408730|18543976|P3|NOT COMPLETED|Overall Study||72
7532953|NCT03408730|18543977|P2|NOT COMPLETED|Overall Study||75
7532954|NCT03408730|18543978|P1|NOT COMPLETED|Overall Study||69
7532955|NCT03408730|18543975|P4|COMPLETED|Overall Study||625
7532956|NCT03408730|18543976|P3|COMPLETED|Overall Study||637
7532957|NCT03408730|18543977|P2|COMPLETED|Overall Study||636
7532958|NCT03408730|18543978|P1|COMPLETED|Overall Study||643
7532959|NCT03408730|18543975|P4|STARTED|Overall Study||706
7532960|NCT03408730|18543976|P3|STARTED|Overall Study||709
7532961|NCT03408730|18543977|P2|STARTED|Overall Study||711
7532962|NCT03408730|18543978|P1|STARTED|Overall Study||712
7532963|NCT03408639|18543995|P2|NOT COMPLETED|Overall Study||22
7532964|NCT03408639|18543996|P1|NOT COMPLETED|Overall Study||11
7532965|NCT03408639|18543995|P2|COMPLETED|Overall Study||56
7532966|NCT03408639|18543996|P1|COMPLETED|Overall Study||67
7532967|NCT03408639|18543995|P2|STARTED|Overall Study||78
7532968|NCT03408639|18543996|P1|STARTED|Overall Study||78
7532969|NCT03408483|18544026|P2|NOT COMPLETED|Overall Study||3
7532970|NCT03408483|18544027|P1|NOT COMPLETED|Overall Study||6
7532971|NCT03408483|18544026|P2|COMPLETED|Overall Study||35
7532972|NCT03408483|18544027|P1|COMPLETED|Overall Study||36
7532973|NCT03408483|18544026|P2|STARTED|Overall Study||38
7532974|NCT03408483|18544027|P1|STARTED|Overall Study||42
7532975|NCT03408392|18544053|P2|NOT COMPLETED|Treatment Period 2 (16 Days)||0
7532976|NCT03408392|18544054|P1|NOT COMPLETED|Treatment Period 2 (16 Days)||0
7532977|NCT03408392|18544053|P2|COMPLETED|Treatment Period 2 (16 Days)||14
7532978|NCT03408392|18544054|P1|COMPLETED|Treatment Period 2 (16 Days)||14
7532979|NCT03408392|18544053|P2|STARTED|Treatment Period 2 (16 Days)||14
7532980|NCT03408392|18544054|P1|STARTED|Treatment Period 2 (16 Days)||14
7532981|NCT03408392|18544053|P2|NOT COMPLETED|Wash-out Period (14 Days)||0
7532982|NCT03408392|18544054|P1|NOT COMPLETED|Wash-out Period (14 Days)||0
7532983|NCT03408392|18544053|P2|COMPLETED|Wash-out Period (14 Days)||14
7532984|NCT03408392|18544054|P1|COMPLETED|Wash-out Period (14 Days)||14
7532985|NCT03408392|18544053|P2|STARTED|Wash-out Period (14 Days)||14
7532986|NCT03408392|18544054|P1|STARTED|Wash-out Period (14 Days)||14
7532987|NCT03408392|18544053|P2|NOT COMPLETED|Treatment Period 1 (16 Days)||0
7532988|NCT03408392|18544054|P1|NOT COMPLETED|Treatment Period 1 (16 Days)||0
7532989|NCT03408392|18544053|P2|COMPLETED|Treatment Period 1 (16 Days)||14
7532990|NCT03408392|18544054|P1|COMPLETED|Treatment Period 1 (16 Days)||14
7532991|NCT03408392|18544053|P2|STARTED|Treatment Period 1 (16 Days)||14
7532992|NCT03408392|18544054|P1|STARTED|Treatment Period 1 (16 Days)||14
7532993|NCT03408171|18544108|P2|NOT COMPLETED|Overall Study||0
7532994|NCT03408171|18544109|P1|NOT COMPLETED|Overall Study||0
7532995|NCT03408171|18544108|P2|COMPLETED|Overall Study||20
7532996|NCT03408171|18544109|P1|COMPLETED|Overall Study||20
7532997|NCT03408171|18544108|P2|STARTED|Overall Study||20
7532998|NCT03408171|18544109|P1|STARTED|Overall Study||20
7532999|NCT03407625|18544137|P2|NOT COMPLETED|Overall Study||0
7533000|NCT03407625|18544138|P1|NOT COMPLETED|Overall Study||0
7533001|NCT03407625|18544137|P2|COMPLETED|Overall Study||1110
7533002|NCT03407625|18544138|P1|COMPLETED|Overall Study||1117
7533003|NCT03407625|18544137|P2|STARTED|Overall Study||1110
7533004|NCT03407625|18544138|P1|STARTED|Overall Study||1117
7533005|NCT03407612|18544192|P2|NOT COMPLETED|Overall Study||0
7533006|NCT03407612|18544193|P1|NOT COMPLETED|Overall Study||0
7533007|NCT03407612|18544192|P2|COMPLETED|Overall Study||23
7533008|NCT03407612|18544193|P1|COMPLETED|Overall Study||19
7533009|NCT03407612|18544192|P2|STARTED|Overall Study||23
7533010|NCT03407612|18544193|P1|STARTED|Overall Study||19
7533011|NCT03407482|18544203|P1|NOT COMPLETED|Overall Study||131
7533012|NCT03407482|18544203|P1|COMPLETED|Overall Study||29
7533013|NCT03407482|18544203|P1|STARTED|Overall Study||160
7533014|NCT03407430|18544214|P2|NOT COMPLETED|Second Intervention||0
7533015|NCT03407430|18544215|P1|NOT COMPLETED|Second Intervention||0
7533016|NCT03407430|18544214|P2|COMPLETED|Second Intervention||3
7533017|NCT03407430|18544215|P1|COMPLETED|Second Intervention||4
7533018|NCT03407430|18544214|P2|STARTED|Second Intervention||3
7533019|NCT03407430|18544215|P1|STARTED|Second Intervention||4
7533020|NCT03407430|18544214|P2|NOT COMPLETED|Washout||0
7533021|NCT03407430|18544215|P1|NOT COMPLETED|Washout||1
7533022|NCT03407430|18544214|P2|COMPLETED|Washout||3
7533023|NCT03407430|18544215|P1|COMPLETED|Washout||4
7533024|NCT03407430|18544214|P2|STARTED|Washout||3
7533025|NCT03407430|18544215|P1|STARTED|Washout||5
7533026|NCT03407430|18544214|P2|NOT COMPLETED|First Intervention||0
7533027|NCT03407430|18544215|P1|NOT COMPLETED|First Intervention||0
7533028|NCT03407430|18544214|P2|COMPLETED|First Intervention||3
7533029|NCT03407430|18544215|P1|COMPLETED|First Intervention||5
7533030|NCT03407430|18544214|P2|STARTED|First Intervention||3
7533031|NCT03407430|18544215|P1|STARTED|First Intervention||5
7533032|NCT03407170|18544247|P1|NOT COMPLETED|Overall Study||1
7533033|NCT03407170|18544247|P1|COMPLETED|Overall Study||0
7533034|NCT03407170|18544247|P1|STARTED|Overall Study||1
7533035|NCT03407118|18544260|P2|NOT COMPLETED|Period 2||0
7533036|NCT03407118|18544261|P1|NOT COMPLETED|Period 2||1
7533037|NCT03407118|18544260|P2|COMPLETED|Period 2||17
7533038|NCT03407118|18544261|P1|COMPLETED|Period 2||13
7533039|NCT03407118|18544260|P2|Received at Least 1 Dose of Study Drug|Period 2||17
7533040|NCT03407118|18544261|P1|Received at Least 1 Dose of Study Drug|Period 2||13
7533041|NCT03407118|18544260|P2|STARTED|Period 2||17
7533042|NCT03407118|18544261|P1|STARTED|Period 2||14
7533043|NCT03407118|18544260|P2|NOT COMPLETED|Period 1||0
7533044|NCT03407118|18544261|P1|NOT COMPLETED|Period 1||0
7533045|NCT03407118|18544260|P2|COMPLETED|Period 1||17
7533046|NCT03407118|18544261|P1|COMPLETED|Period 1||14
7533047|NCT03407118|18544260|P2|Received at Least 1 Dose of Study Drug|Period 1||17
7533048|NCT03407118|18544261|P1|Received at Least 1 Dose of Study Drug|Period 1||14
7533049|NCT03407118|18544260|P2|STARTED|Period 1||17
7533050|NCT03407118|18544261|P1|STARTED|Period 1||14
7533051|NCT03406325|18544277|P8|NOT COMPLETED|Overall Study||0
7533052|NCT03406325|18544278|P7|NOT COMPLETED|Overall Study||0
7533053|NCT03406325|18544279|P6|NOT COMPLETED|Overall Study||0
7533054|NCT03406325|18544280|P5|NOT COMPLETED|Overall Study||0
7533055|NCT03406325|18544281|P4|NOT COMPLETED|Overall Study||0
7533056|NCT03406325|18544282|P3|NOT COMPLETED|Overall Study||0
7533057|NCT03406325|18544283|P2|NOT COMPLETED|Overall Study||0
7533058|NCT03406325|18544284|P1|NOT COMPLETED|Overall Study||0
7533059|NCT03406325|18544277|P8|COMPLETED|Overall Study||1
7533060|NCT03406325|18544278|P7|COMPLETED|Overall Study||1
7533061|NCT03406325|18544279|P6|COMPLETED|Overall Study||1
7533062|NCT03406325|18544280|P5|COMPLETED|Overall Study||1
7533063|NCT03406325|18544281|P4|COMPLETED|Overall Study||1
7533064|NCT03406325|18544282|P3|COMPLETED|Overall Study||1
7533065|NCT03406325|18544283|P2|COMPLETED|Overall Study||1
7533066|NCT03406325|18544284|P1|COMPLETED|Overall Study||12
7533067|NCT03406325|18544277|P8|STARTED|Overall Study||1
7533068|NCT03406325|18544278|P7|STARTED|Overall Study||1
7533069|NCT03406325|18544279|P6|STARTED|Overall Study||1
7533070|NCT03406325|18544280|P5|STARTED|Overall Study||1
7533071|NCT03406325|18544281|P4|STARTED|Overall Study||1
7533072|NCT03406325|18544282|P3|STARTED|Overall Study||1
7533073|NCT03406325|18544283|P2|STARTED|Overall Study||1
7533074|NCT03406325|18544284|P1|STARTED|Overall Study||12
7533075|NCT03406260|18544338|P6|NOT COMPLETED|Period 3||0
7533076|NCT03406260|18544339|P5|NOT COMPLETED|Period 3||0
7533077|NCT03406260|18544340|P4|NOT COMPLETED|Period 3||0
7533078|NCT03406260|18544341|P3|NOT COMPLETED|Period 3||0
7533079|NCT03406260|18544342|P2|NOT COMPLETED|Period 3||0
7533080|NCT03406260|18544343|P1|NOT COMPLETED|Period 3||0
7533081|NCT03406260|18544338|P6|COMPLETED|Period 3||6
7533082|NCT03406260|18544339|P5|COMPLETED|Period 3||5
7533083|NCT03406260|18544340|P4|COMPLETED|Period 3||6
7533084|NCT03406260|18544341|P3|COMPLETED|Period 3||6
7533085|NCT03406260|18544342|P2|COMPLETED|Period 3||6
7533086|NCT03406260|18544343|P1|COMPLETED|Period 3||6
7533087|NCT03406260|18544338|P6|STARTED|Period 3||6
7533088|NCT03406260|18544339|P5|STARTED|Period 3||5
7533089|NCT03406260|18544340|P4|STARTED|Period 3||6
7533090|NCT03406260|18544341|P3|STARTED|Period 3||6
7533091|NCT03406260|18544342|P2|STARTED|Period 3||6
7533092|NCT03406260|18544343|P1|STARTED|Period 3||6
7533093|NCT03406260|18544338|P6|NOT COMPLETED|Period 2||0
7533094|NCT03406260|18544339|P5|NOT COMPLETED|Period 2||0
7533095|NCT03406260|18544340|P4|NOT COMPLETED|Period 2||0
7533096|NCT03406260|18544341|P3|NOT COMPLETED|Period 2||0
7533097|NCT03406260|18544342|P2|NOT COMPLETED|Period 2||0
7533098|NCT03406260|18544343|P1|NOT COMPLETED|Period 2||0
7533099|NCT03406260|18544338|P6|COMPLETED|Period 2||6
7533100|NCT03406260|18544339|P5|COMPLETED|Period 2||5
7533101|NCT03406260|18544340|P4|COMPLETED|Period 2||6
7533102|NCT03406260|18544341|P3|COMPLETED|Period 2||6
7533103|NCT03406260|18544342|P2|COMPLETED|Period 2||6
7533104|NCT03406260|18544343|P1|COMPLETED|Period 2||6
7533105|NCT03406260|18544338|P6|STARTED|Period 2||6
7533106|NCT03406260|18544339|P5|STARTED|Period 2||5
7533107|NCT03406260|18544340|P4|STARTED|Period 2||6
7533108|NCT03406260|18544341|P3|STARTED|Period 2||6
7533109|NCT03406260|18544342|P2|STARTED|Period 2||6
7533110|NCT03406260|18544343|P1|STARTED|Period 2||6
7533111|NCT03406260|18544338|P6|NOT COMPLETED|Period 1||0
7533112|NCT03406260|18544339|P5|NOT COMPLETED|Period 1||1
7533113|NCT03406260|18544340|P4|NOT COMPLETED|Period 1||0
7533114|NCT03406260|18544341|P3|NOT COMPLETED|Period 1||0
7533115|NCT03406260|18544342|P2|NOT COMPLETED|Period 1||0
7533116|NCT03406260|18544343|P1|NOT COMPLETED|Period 1||0
7533117|NCT03406260|18544338|P6|COMPLETED|Period 1||6
7533118|NCT03406260|18544339|P5|COMPLETED|Period 1||5
7533119|NCT03406260|18544340|P4|COMPLETED|Period 1||6
7533120|NCT03406260|18544341|P3|COMPLETED|Period 1||6
7533121|NCT03406260|18544342|P2|COMPLETED|Period 1||6
7533122|NCT03406260|18544343|P1|COMPLETED|Period 1||6
7533123|NCT03406260|18544338|P6|Received at Least 1 Dose of Study Drug|Period 1||6
7533124|NCT03406260|18544339|P5|Received at Least 1 Dose of Study Drug|Period 1||6
7533125|NCT03406260|18544340|P4|Received at Least 1 Dose of Study Drug|Period 1||6
7533126|NCT03406260|18544341|P3|Received at Least 1 Dose of Study Drug|Period 1||6
7533127|NCT03406260|18544342|P2|Received at Least 1 Dose of Study Drug|Period 1||6
7533128|NCT03406260|18544343|P1|Received at Least 1 Dose of Study Drug|Period 1||6
7533129|NCT03406260|18544338|P6|STARTED|Period 1||6
7533130|NCT03406260|18544339|P5|STARTED|Period 1||6
7533131|NCT03406260|18544340|P4|STARTED|Period 1||6
7533132|NCT03406260|18544341|P3|STARTED|Period 1||6
7533133|NCT03406260|18544342|P2|STARTED|Period 1||6
7533134|NCT03406260|18544343|P1|STARTED|Period 1||6
7533135|NCT03405935|18544355|P1|NOT COMPLETED|Overall Study||8
7533136|NCT03405935|18544355|P1|COMPLETED|Overall Study||78
7533137|NCT03405935|18544355|P1|STARTED|Overall Study||86
7533138|NCT03405818|18544382|P1|NOT COMPLETED|Overall Study||8
7533139|NCT03405818|18544382|P1|COMPLETED|Overall Study||47
7533140|NCT03405818|18544382|P1|STARTED|Overall Study||55
7533141|NCT03405259|18544425|P2|NOT COMPLETED|Overall Study||0
7533142|NCT03405259|18544426|P1|NOT COMPLETED|Overall Study||0
7533143|NCT03405259|18544425|P2|COMPLETED|Overall Study||11
7533144|NCT03405259|18544426|P1|COMPLETED|Overall Study||11
7533145|NCT03405259|18544425|P2|STARTED|Overall Study||11
7533146|NCT03405259|18544426|P1|STARTED|Overall Study||11
7533147|NCT03404843|18544436|P2|NOT COMPLETED|Overall Study||1
7533148|NCT03404843|18544437|P1|NOT COMPLETED|Overall Study||4
7533149|NCT03404843|18544436|P2|COMPLETED|Overall Study||13
7533150|NCT03404843|18544437|P1|COMPLETED|Overall Study||13
7533151|NCT03404843|18544436|P2|STARTED|Overall Study||14
7533152|NCT03404843|18544437|P1|STARTED|Overall Study||17
7533153|NCT03404206|18544466|P3|NOT COMPLETED|Overall Study||0
7533154|NCT03404206|18544467|P2|NOT COMPLETED|Overall Study||2
7533155|NCT03404206|18544468|P1|NOT COMPLETED|Overall Study||4
7533156|NCT03404206|18544466|P3|COMPLETED|Overall Study||55
7533157|NCT03404206|18544467|P2|COMPLETED|Overall Study||164
7533158|NCT03404206|18544468|P1|COMPLETED|Overall Study||162
7533159|NCT03404206|18544466|P3|STARTED|Overall Study||55
7533160|NCT03404206|18544467|P2|STARTED|Overall Study||166
7533161|NCT03404206|18544468|P1|STARTED|Overall Study||166
7533162|NCT03404167|18544482|P1|NOT COMPLETED|Overall Study||0
7533163|NCT03404167|18544482|P1|COMPLETED|Overall Study||8
7533164|NCT03404167|18544482|P1|STARTED|Overall Study||8
7533165|NCT03403712|18544519|P2|NOT COMPLETED|Overall Study||100
7533166|NCT03403712|18544520|P1|NOT COMPLETED|Overall Study||105
7533167|NCT03403712|18544519|P2|COMPLETED|Overall Study||102
7533168|NCT03403712|18544520|P1|COMPLETED|Overall Study||95
7533169|NCT03403712|18544519|P2|STARTED|Overall Study||202
7533170|NCT03403712|18544520|P1|STARTED|Overall Study||200
7533171|NCT03403504|18544542|P2|NOT COMPLETED|Period 2||0
7533172|NCT03403504|18544543|P1|NOT COMPLETED|Period 2||0
7533173|NCT03403504|18544542|P2|COMPLETED|Period 2||11
7533174|NCT03403504|18544543|P1|COMPLETED|Period 2||12
7533175|NCT03403504|18544542|P2|STARTED|Period 2||11
7533176|NCT03403504|18544543|P1|STARTED|Period 2||12
7533177|NCT03403504|18544542|P2|NOT COMPLETED|Period 1||1
7533178|NCT03403504|18544543|P1|NOT COMPLETED|Period 1||0
7533179|NCT03403504|18544542|P2|COMPLETED|Period 1||11
7533180|NCT03403504|18544543|P1|COMPLETED|Period 1||12
7533181|NCT03403504|18544542|P2|STARTED|Period 1||12
7533182|NCT03403504|18544543|P1|STARTED|Period 1||12
7533183|NCT03403491|18544563|P2|NOT COMPLETED|Overall Study||5
7533184|NCT03403491|18544564|P1|NOT COMPLETED|Overall Study||3
7533185|NCT03403491|18544563|P2|COMPLETED|Overall Study||18
7533186|NCT03403491|18544564|P1|COMPLETED|Overall Study||17
7533187|NCT03403491|18544563|P2|STARTED|Overall Study||23
7533188|NCT03403491|18544564|P1|STARTED|Overall Study||20
7533189|NCT03403413|18544596|P1|NOT COMPLETED|Overall Study||2
7533190|NCT03403413|18544596|P1|COMPLETED|Overall Study||3
7533191|NCT03403413|18544596|P1|STARTED|Overall Study||5
7533192|NCT03403400|18544614|P3|NOT COMPLETED|Overall Study||2
7533193|NCT03403400|18544615|P2|NOT COMPLETED|Overall Study||0
7533194|NCT03403400|18544616|P1|NOT COMPLETED|Overall Study||2
7533195|NCT03403400|18544614|P3|COMPLETED|Overall Study||4
7533196|NCT03403400|18544615|P2|COMPLETED|Overall Study||6
7533197|NCT03403400|18544616|P1|COMPLETED|Overall Study||3
7533198|NCT03403400|18544614|P3|STARTED|Overall Study||6
7533199|NCT03403400|18544615|P2|STARTED|Overall Study||6
7533200|NCT03403400|18544616|P1|STARTED|Overall Study||5
7533201|NCT03403374|18544648|P1|NOT COMPLETED|Overall Study||1
7533202|NCT03403374|18544648|P1|COMPLETED|Overall Study||29
7533203|NCT03403374|18544648|P1|STARTED|Overall Study||30
7533204|NCT03403036|18544655|P1|NOT COMPLETED|Overall Study||5
7533205|NCT03403036|18544655|P1|COMPLETED|Overall Study||34
7533206|NCT03403036|18544655|P1|STARTED|Overall Study||39
7533207|NCT03402932|18544665|P4|NOT COMPLETED|Overall Study||0
7533208|NCT03402932|18544666|P3|NOT COMPLETED|Overall Study||0
7533209|NCT03402932|18544667|P2|NOT COMPLETED|Overall Study||0
7533210|NCT03402932|18544668|P1|NOT COMPLETED|Overall Study||0
7533211|NCT03402932|18544665|P4|COMPLETED|Overall Study||8
7533212|NCT03402932|18544666|P3|COMPLETED|Overall Study||8
7533213|NCT03402932|18544667|P2|COMPLETED|Overall Study||8
7533214|NCT03402932|18544668|P1|COMPLETED|Overall Study||13
7533215|NCT03402932|18544665|P4|STARTED|Overall Study||8
7533216|NCT03402932|18544666|P3|STARTED|Overall Study||8
7533217|NCT03402932|18544667|P2|STARTED|Overall Study||8
7533218|NCT03402932|18544668|P1|STARTED|Overall Study||13
7533219|NCT03402893|18544682|P1|NOT COMPLETED|Overall Study||1
7533220|NCT03402893|18544682|P1|COMPLETED|Overall Study||20
7533221|NCT03402893|18544682|P1|STARTED|Overall Study||21
7533222|NCT03402750|18544693|P2|NOT COMPLETED|Overall Study||1
7533223|NCT03402750|18544694|P1|NOT COMPLETED|Overall Study||2
7533224|NCT03402750|18544693|P2|COMPLETED|Overall Study||19
7533225|NCT03402750|18544694|P1|COMPLETED|Overall Study||18
7533226|NCT03402750|18544693|P2|STARTED|Overall Study||20
7533227|NCT03402750|18544694|P1|STARTED|Overall Study||20
7533228|NCT03402555|18544708|P1|NOT COMPLETED|Overall Study||5
7533229|NCT03402555|18544708|P1|COMPLETED|Overall Study||91
7533230|NCT03402555|18544708|P1|STARTED|Overall Study||96
7533231|NCT03401671|18544716|P2|NOT COMPLETED|Overall Study||0
7533232|NCT03401671|18544717|P1|NOT COMPLETED|Overall Study||0
7533233|NCT03401671|18544716|P2|COMPLETED|Overall Study||16
7533234|NCT03401671|18544717|P1|COMPLETED|Overall Study||16
7533235|NCT03401671|18544716|P2|STARTED|Overall Study||16
7533236|NCT03401671|18544717|P1|STARTED|Overall Study||16
7533237|NCT03401450|18544759|P2|NOT COMPLETED|Overall Study||13
7533238|NCT03401450|18544760|P1|NOT COMPLETED|Overall Study||12
7533239|NCT03401450|18544759|P2|COMPLETED|Overall Study||23
7533240|NCT03401450|18544760|P1|COMPLETED|Overall Study||21
7533241|NCT03401450|18544759|P2|STARTED|Overall Study||36
7533242|NCT03401450|18544760|P1|STARTED|Overall Study||33
7533243|NCT03400800|18544772|P2|NOT COMPLETED|Overall Study||37
7533244|NCT03400800|18544773|P1|NOT COMPLETED|Overall Study||38
7533245|NCT03400800|18544772|P2|COMPLETED|Overall Study||770
7533246|NCT03400800|18544773|P1|COMPLETED|Overall Study||772
7533247|NCT03400800|18544772|P2|STARTED|Overall Study||807
7533248|NCT03400800|18544773|P1|STARTED|Overall Study||810
7533249|NCT03400787|18544795|P2|NOT COMPLETED|Overall Study||8
7533250|NCT03400787|18544796|P1|NOT COMPLETED|Overall Study||2
7533251|NCT03400787|18544795|P2|COMPLETED|Overall Study||63
7533252|NCT03400787|18544796|P1|COMPLETED|Overall Study||64
7533253|NCT03400787|18544795|P2|3-Month Follow-up|Overall Study||63
7533254|NCT03400787|18544796|P1|3-Month Follow-up|Overall Study||64
7533255|NCT03400787|18544795|P2|STARTED|Overall Study||71
7533256|NCT03400787|18544796|P1|STARTED|Overall Study||66
7533257|NCT03400579|18544802|P1|NOT COMPLETED|Overall Study||0
7533258|NCT03400579|18544802|P1|COMPLETED|Overall Study||10
7533259|NCT03400579|18544802|P1|STARTED|Overall Study||10
7533260|NCT03400475|18544814|P2|NOT COMPLETED|Overall Study||0
7533261|NCT03400475|18544815|P1|NOT COMPLETED|Overall Study||0
7533262|NCT03400475|18544814|P2|COMPLETED|Overall Study||22
7533263|NCT03400475|18544815|P1|COMPLETED|Overall Study||24
7533264|NCT03400475|18544814|P2|STARTED|Overall Study||22
7533265|NCT03400475|18544815|P1|STARTED|Overall Study||24
7533266|NCT03400449|18544857|P2|NOT COMPLETED|Overall Study||0
7533267|NCT03400449|18544858|P1|NOT COMPLETED|Overall Study||1
7533268|NCT03400449|18544857|P2|COMPLETED|Overall Study||119
7533269|NCT03400449|18544858|P1|COMPLETED|Overall Study||120
7533270|NCT03400449|18544857|P2|STARTED|Overall Study||119
7533271|NCT03400449|18544858|P1|STARTED|Overall Study||121
7533272|NCT03400163|18544870|P2|NOT COMPLETED|Follow-up Period||0
7533273|NCT03400163|18544871|P1|NOT COMPLETED|Follow-up Period||0
7533274|NCT03400163|18544870|P2|COMPLETED|Follow-up Period||2
7533275|NCT03400163|18544871|P1|COMPLETED|Follow-up Period||1
7533276|NCT03400163|18544870|P2|STARTED|Follow-up Period||2
7533277|NCT03400163|18544871|P1|STARTED|Follow-up Period||1
7533278|NCT03400163|18544870|P2|NOT COMPLETED|Treatment Period||0
7533279|NCT03400163|18544871|P1|NOT COMPLETED|Treatment Period||0
7533280|NCT03400163|18544870|P2|COMPLETED|Treatment Period||2
7533281|NCT03400163|18544871|P1|COMPLETED|Treatment Period||1
7533282|NCT03400163|18544870|P2|STARTED|Treatment Period||2
7533283|NCT03400163|18544871|P1|STARTED|Treatment Period||1
7533284|NCT03399370|18544905|P2|NOT COMPLETED|Overall Study||86
7533285|NCT03399370|18544906|P1|NOT COMPLETED|Overall Study||60
7533286|NCT03399370|18544905|P2|COMPLETED|Overall Study||694
7533287|NCT03399370|18544906|P1|COMPLETED|Overall Study||721
7533288|NCT03399370|18544905|P2|STARTED|Overall Study||780
7533289|NCT03399370|18544906|P1|STARTED|Overall Study||781
7533290|NCT03398928|18544928|P2|NOT COMPLETED|Overall Study||0
7533291|NCT03398928|18544929|P1|NOT COMPLETED|Overall Study||0
7533292|NCT03398928|18544928|P2|COMPLETED|Overall Study||31
7533293|NCT03398928|18544929|P1|COMPLETED|Overall Study||50
7533294|NCT03398928|18544928|P2|STARTED|Overall Study||31
7533295|NCT03398928|18544929|P1|STARTED|Overall Study||50
7533296|NCT03398798|18544957|P4|NOT COMPLETED|Overall Study||0
7533297|NCT03398798|18544958|P3|NOT COMPLETED|Overall Study||0
7533298|NCT03398798|18544959|P2|NOT COMPLETED|Overall Study||0
7533299|NCT03398798|18544960|P1|NOT COMPLETED|Overall Study||0
7533300|NCT03398798|18544957|P4|COMPLETED|Overall Study||9
7533301|NCT03398798|18544958|P3|COMPLETED|Overall Study||9
7533302|NCT03398798|18544959|P2|COMPLETED|Overall Study||9
7533303|NCT03398798|18544960|P1|COMPLETED|Overall Study||9
7533304|NCT03398798|18544957|P4|STARTED|Overall Study||9
7533305|NCT03398798|18544958|P3|STARTED|Overall Study||9
7533306|NCT03398798|18544959|P2|STARTED|Overall Study||9
7533307|NCT03398798|18544960|P1|STARTED|Overall Study||9
7533308|NCT03398421|18544994|P2|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
7533309|NCT03398421|18544995|P1|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
7533310|NCT03398421|18544994|P2|COMPLETED|Treatment Period 2 (Up to 11 Days)||20
7533311|NCT03398421|18544995|P1|COMPLETED|Treatment Period 2 (Up to 11 Days)||0
7533312|NCT03398421|18544994|P2|STARTED|Treatment Period 2 (Up to 11 Days)||20
7533313|NCT03398421|18544995|P1|STARTED|Treatment Period 2 (Up to 11 Days)||0
7533314|NCT03398421|18544994|P2|NOT COMPLETED|Washout Period (Up to 14 Days)||0
7533315|NCT03398421|18544995|P1|NOT COMPLETED|Washout Period (Up to 14 Days)||0
7533316|NCT03398421|18544994|P2|COMPLETED|Washout Period (Up to 14 Days)||0
7533317|NCT03398421|18544995|P1|COMPLETED|Washout Period (Up to 14 Days)||20
7533318|NCT03398421|18544994|P2|STARTED|Washout Period (Up to 14 Days)||0
7533319|NCT03398421|18544995|P1|STARTED|Washout Period (Up to 14 Days)||20
7533320|NCT03398421|18544994|P2|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
7533321|NCT03398421|18544995|P1|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
7533322|NCT03398421|18544994|P2|COMPLETED|Treatment Period 1 (Up to 6 Days)||0
7533323|NCT03398421|18544995|P1|COMPLETED|Treatment Period 1 (Up to 6 Days)||20
7533324|NCT03398421|18544994|P2|STARTED|Treatment Period 1 (Up to 6 Days)||0
7533325|NCT03398421|18544995|P1|STARTED|Treatment Period 1 (Up to 6 Days)||20
7533326|NCT03398356|18545059|P3|NOT COMPLETED|After 15 Weeks of Treatment||0
7533327|NCT03398356|18545060|P2|NOT COMPLETED|After 15 Weeks of Treatment||0
7533328|NCT03398356|18545061|P1|NOT COMPLETED|After 15 Weeks of Treatment||0
7533329|NCT03398356|18545059|P3|COMPLETED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
7533330|NCT03398356|18545060|P2|COMPLETED|After 15 Weeks of Treatment||11
7533331|NCT03398356|18545061|P1|COMPLETED|After 15 Weeks of Treatment||14
7533332|NCT03398356|18545059|P3|STARTED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
7533333|NCT03398356|18545060|P2|STARTED|After 15 Weeks of Treatment||11
7533334|NCT03398356|18545061|P1|STARTED|After 15 Weeks of Treatment||14
7533335|NCT03398356|18545059|P3|NOT COMPLETED|After 12 Weeks of Treatment||0
7533336|NCT03398356|18545060|P2|NOT COMPLETED|After 12 Weeks of Treatment||0
7533337|NCT03398356|18545061|P1|NOT COMPLETED|After 12 Weeks of Treatment||0
7533338|NCT03398356|18545059|P3|COMPLETED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
7533339|NCT03398356|18545060|P2|COMPLETED|After 12 Weeks of Treatment||11
7533340|NCT03398356|18545061|P1|COMPLETED|After 12 Weeks of Treatment||14
7533341|NCT03398356|18545059|P3|STARTED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
7533342|NCT03398356|18545060|P2|STARTED|After 12 Weeks of Treatment||11
7533343|NCT03398356|18545061|P1|STARTED|After 12 Weeks of Treatment||14
7533344|NCT03398356|18545059|P3|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
7533345|NCT03398356|18545060|P2|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
7533346|NCT03398356|18545061|P1|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
7533347|NCT03398356|18545059|P3|COMPLETED|Post 6 Week Period Initial Evaluation||0
7533348|NCT03398356|18545060|P2|COMPLETED|Post 6 Week Period Initial Evaluation||11
7533349|NCT03398356|18545061|P1|COMPLETED|Post 6 Week Period Initial Evaluation||14
7533350|NCT03398356|18545059|P3|STARTED|Post 6 Week Period Initial Evaluation||0
7533351|NCT03398356|18545060|P2|STARTED|Post 6 Week Period Initial Evaluation||11
7533352|NCT03398356|18545061|P1|STARTED|Post 6 Week Period Initial Evaluation|two of the patients were moved from group B, because of intolerance of the higher dose of the drug|14
7533353|NCT03398356|18545059|P3|NOT COMPLETED|After 6 Weeks of Treatment||0
7533354|NCT03398356|18545060|P2|NOT COMPLETED|After 6 Weeks of Treatment||2
7533355|NCT03398356|18545061|P1|NOT COMPLETED|After 6 Weeks of Treatment||0
7533356|NCT03398356|18545059|P3|COMPLETED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
7533357|NCT03398356|18545060|P2|COMPLETED|After 6 Weeks of Treatment||11
7533358|NCT03398356|18545061|P1|COMPLETED|After 6 Weeks of Treatment||12
7533359|NCT03398356|18545059|P3|STARTED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
7533360|NCT03398356|18545060|P2|STARTED|After 6 Weeks of Treatment||13
7533361|NCT03398356|18545061|P1|STARTED|After 6 Weeks of Treatment||12
7533362|NCT03398356|18545059|P3|NOT COMPLETED|Before Treatment||11
7533363|NCT03398356|18545060|P2|NOT COMPLETED|Before Treatment||8
7533364|NCT03398356|18545061|P1|NOT COMPLETED|Before Treatment||3
7533365|NCT03398356|18545059|P3|COMPLETED|Before Treatment|only baseline parameters were taken, this group did not participate in the further part of the study|0
7533366|NCT03398356|18545060|P2|COMPLETED|Before Treatment||13
7533367|NCT03398356|18545061|P1|COMPLETED|Before Treatment||12
7533368|NCT03398356|18545059|P3|STARTED|Before Treatment||11
7533369|NCT03398356|18545060|P2|STARTED|Before Treatment||21
7533370|NCT03398356|18545061|P1|STARTED|Before Treatment||15
7533371|NCT03398330|18545086|P2|NOT COMPLETED|Period 2||0
7533372|NCT03398330|18545087|P1|NOT COMPLETED|Period 2||1
7533373|NCT03398330|18545086|P2|COMPLETED|Period 2||17
7533374|NCT03398330|18545087|P1|COMPLETED|Period 2||19
7533375|NCT03398330|18545086|P2|STARTED|Period 2||17
7533376|NCT03398330|18545087|P1|STARTED|Period 2||20
7533377|NCT03398330|18545086|P2|NOT COMPLETED|Period 1||4
7533378|NCT03398330|18545087|P1|NOT COMPLETED|Period 1||1
7533379|NCT03398330|18545086|P2|COMPLETED|Period 1||17
7533380|NCT03398330|18545087|P1|COMPLETED|Period 1||20
7533381|NCT03398330|18545086|P2|STARTED|Period 1||21
7533382|NCT03398330|18545087|P1|STARTED|Period 1||21
7533383|NCT03398278|18545109|P2|NOT COMPLETED|Period 2||2
7533384|NCT03398278|18545110|P1|NOT COMPLETED|Period 2||2
7533385|NCT03398278|18545109|P2|COMPLETED|Period 2||17
7533386|NCT03398278|18545110|P1|COMPLETED|Period 2||16
7533387|NCT03398278|18545109|P2|STARTED|Period 2||19
7533388|NCT03398278|18545110|P1|STARTED|Period 2||18
7533389|NCT03398278|18545109|P2|NOT COMPLETED|Period 1||0
7533390|NCT03398278|18545110|P1|NOT COMPLETED|Period 1||1
7533391|NCT03398278|18545109|P2|COMPLETED|Period 1||19
7533392|NCT03398278|18545110|P1|COMPLETED|Period 1||18
7533393|NCT03398278|18545109|P2|STARTED|Period 1||19
7533394|NCT03398278|18545110|P1|STARTED|Period 1||19
7533395|NCT03398213|18545133|P3|NOT COMPLETED|Overall Study||0
7533396|NCT03398213|18545134|P2|NOT COMPLETED|Overall Study||0
7533397|NCT03398213|18545135|P1|NOT COMPLETED|Overall Study||0
7533398|NCT03398213|18545133|P3|COMPLETED|Overall Study||22
7533399|NCT03398213|18545134|P2|COMPLETED|Overall Study||24
7533400|NCT03398213|18545135|P1|COMPLETED|Overall Study||26
7533401|NCT03398213|18545133|P3|STARTED|Overall Study||22
7533402|NCT03398213|18545134|P2|STARTED|Overall Study||24
7533403|NCT03398213|18545135|P1|STARTED|Overall Study||26
7533404|NCT03397771|18545166|P2|NOT COMPLETED|Overall Study||7
7533405|NCT03397771|18545167|P1|NOT COMPLETED|Overall Study||8
7533406|NCT03397771|18545166|P2|COMPLETED|Overall Study||22
7533407|NCT03397771|18545167|P1|COMPLETED|Overall Study||45
7533408|NCT03397771|18545166|P2|STARTED|Overall Study||29
7533409|NCT03397771|18545167|P1|STARTED|Overall Study||53
7533410|NCT03397394|18545178|P3|NOT COMPLETED|Overall Study||0
7533411|NCT03397394|18545179|P2|NOT COMPLETED|Overall Study||0
7533412|NCT03397394|18545180|P1|NOT COMPLETED|Overall Study||0
7533413|NCT03397394|18545178|P3|COMPLETED|Overall Study||20
7533414|NCT03397394|18545179|P2|COMPLETED|Overall Study||30
7533415|NCT03397394|18545180|P1|COMPLETED|Overall Study||47
7533416|NCT03397394|18545178|P3|STARTED|Overall Study||20
7533417|NCT03397394|18545179|P2|STARTED|Overall Study||30
7533418|NCT03397394|18545180|P1|STARTED|Overall Study||47
7533419|NCT03397121|18545204|P2|NOT COMPLETED|Overall Study||9
7533420|NCT03397121|18545205|P1|NOT COMPLETED|Overall Study||7
7533421|NCT03397121|18545204|P2|COMPLETED|Overall Study||231
7533422|NCT03397121|18545205|P1|COMPLETED|Overall Study||235
7533423|NCT03397121|18545204|P2|STARTED|Overall Study||240
7533424|NCT03397121|18545205|P1|STARTED|Overall Study||242
7533425|NCT03396913|18545227|P2|NOT COMPLETED|Overall Study||6
7533426|NCT03396913|18545228|P1|NOT COMPLETED|Overall Study||0
7533427|NCT03396913|18545227|P2|COMPLETED|Overall Study||39
7533428|NCT03396913|18545228|P1|COMPLETED|Overall Study||43
7533429|NCT03396913|18545227|P2|STARTED|Overall Study||45
7533430|NCT03396913|18545228|P1|STARTED|Overall Study||43
7533431|NCT03396835|18545238|P1|NOT COMPLETED|Overall Study||2
7533432|NCT03396835|18545238|P1|COMPLETED|Overall Study||14
7533433|NCT03396835|18545238|P1|STARTED|Overall Study||16
7533434|NCT03396432|18545244|P2|NOT COMPLETED|Overall Study||6
7533435|NCT03396432|18545245|P1|NOT COMPLETED|Overall Study||9
7533436|NCT03396432|18545244|P2|COMPLETED|Overall Study||277
7533437|NCT03396432|18545245|P1|COMPLETED|Overall Study||274
7533438|NCT03396432|18545244|P2|STARTED|Overall Study||283
7533439|NCT03396432|18545245|P1|STARTED|Overall Study||283
7533440|NCT03395990|18545253|P2|NOT COMPLETED|Overall Study||0
7533441|NCT03395990|18545254|P1|NOT COMPLETED|Overall Study||0
7533442|NCT03395990|18545253|P2|COMPLETED|Overall Study||8
7533443|NCT03395990|18545254|P1|COMPLETED|Overall Study||8
7533444|NCT03395990|18545253|P2|STARTED|Overall Study||8
7533445|NCT03395990|18545254|P1|STARTED|Overall Study||8
7533446|NCT03395886|18545262|P2|NOT COMPLETED|Overall Study||38
7533447|NCT03395886|18545263|P1|NOT COMPLETED|Overall Study||52
7533448|NCT03395886|18545262|P2|COMPLETED|Overall Study||0
7533449|NCT03395886|18545263|P1|COMPLETED|Overall Study||0
7533450|NCT03395886|18545262|P2|STARTED|Overall Study||38
7533451|NCT03395886|18545263|P1|STARTED|Overall Study||52
7533452|NCT03394508|18545273|P2|NOT COMPLETED|Overall Study||3
7533453|NCT03394508|18545274|P1|NOT COMPLETED|Overall Study||1
7533454|NCT03394508|18545273|P2|COMPLETED|Overall Study||14
7533455|NCT03394508|18545274|P1|COMPLETED|Overall Study||12
7533456|NCT03394508|18545273|P2|STARTED|Overall Study||17
7533457|NCT03394508|18545274|P1|STARTED|Overall Study||13
7533458|NCT03394391|18545300|P2|NOT COMPLETED|Overall Study||2
7533459|NCT03394391|18545301|P1|NOT COMPLETED|Overall Study||1
7533460|NCT03394391|18545300|P2|COMPLETED|Overall Study||104
7533461|NCT03394391|18545301|P1|COMPLETED|Overall Study||105
7533462|NCT03394391|18545300|P2|STARTED|Overall Study||106
7533463|NCT03394391|18545301|P1|STARTED|Overall Study||106
7533464|NCT03393806|18545319|P2|NOT COMPLETED|Overall Study||0
7533465|NCT03393806|18545320|P1|NOT COMPLETED|Overall Study||1
7533466|NCT03393806|18545319|P2|COMPLETED|Overall Study||8
7533467|NCT03393806|18545320|P1|COMPLETED|Overall Study||8
7533468|NCT03393806|18545319|P2|STARTED|Overall Study||8
7533469|NCT03393806|18545320|P1|STARTED|Overall Study||9
7533470|NCT03393754|18545365|P2|NOT COMPLETED|Overall Study||38
7533471|NCT03393754|18545366|P1|NOT COMPLETED|Overall Study||26
7533472|NCT03393754|18545365|P2|COMPLETED|Overall Study||758
7533473|NCT03393754|18545366|P1|COMPLETED|Overall Study||785
7533474|NCT03393754|18545365|P2|STARTED|Overall Study||796
7533475|NCT03393754|18545366|P1|STARTED|Overall Study||811
7533476|NCT03393208|18545380|P4|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
7533477|NCT03393208|18545381|P3|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
7533478|NCT03393208|18545382|P2|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
7533479|NCT03393208|18545383|P1|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
7533480|NCT03393208|18545380|P4|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
7533481|NCT03393208|18545381|P3|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
7533482|NCT03393208|18545382|P2|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
7533483|NCT03393208|18545383|P1|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
7533484|NCT03393208|18545380|P4|STARTED|Treatment Period 2 (Day 8- Day 10)||9
7533485|NCT03393208|18545381|P3|STARTED|Treatment Period 2 (Day 8- Day 10)||9
7533486|NCT03393208|18545382|P2|STARTED|Treatment Period 2 (Day 8- Day 10)||13
7533487|NCT03393208|18545383|P1|STARTED|Treatment Period 2 (Day 8- Day 10)||13
7533488|NCT03393208|18545380|P4|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
7533489|NCT03393208|18545381|P3|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
7533490|NCT03393208|18545382|P2|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
7533491|NCT03393208|18545383|P1|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
7533492|NCT03393208|18545380|P4|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
7533493|NCT03393208|18545381|P3|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
7533494|NCT03393208|18545382|P2|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
7533495|NCT03393208|18545383|P1|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
7533496|NCT03393208|18545380|P4|STARTED|Treatment Period 1 (Day 1-Day 3)||9
7533497|NCT03393208|18545381|P3|STARTED|Treatment Period 1 (Day 1-Day 3)||9
7533498|NCT03393208|18545382|P2|STARTED|Treatment Period 1 (Day 1-Day 3)||13
7533499|NCT03393208|18545383|P1|STARTED|Treatment Period 1 (Day 1-Day 3)||13
7533500|NCT03392532|18545437|P2|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
7533501|NCT03392532|18545438|P1|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
7533502|NCT03392532|18545437|P2|COMPLETED|Period 2, Second 30 Minutes of Wear||18
7533503|NCT03392532|18545438|P1|COMPLETED|Period 2, Second 30 Minutes of Wear||18
7533504|NCT03392532|18545437|P2|STARTED|Period 2, Second 30 Minutes of Wear||18
7533505|NCT03392532|18545438|P1|STARTED|Period 2, Second 30 Minutes of Wear||18
7533506|NCT03392532|18545437|P2|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
7533507|NCT03392532|18545438|P1|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
7533508|NCT03392532|18545437|P2|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
7533509|NCT03392532|18545438|P1|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
7533510|NCT03392532|18545437|P2|STARTED|Period 1, FIrst 30 Minutes of Wear||18
7533511|NCT03392532|18545438|P1|STARTED|Period 1, FIrst 30 Minutes of Wear||18
7533512|NCT03392194|18545446|P2|NOT COMPLETED|Overall Study||2
7533513|NCT03392194|18545447|P1|NOT COMPLETED|Overall Study||2
7533514|NCT03392194|18545446|P2|COMPLETED|Overall Study||15
7533515|NCT03392194|18545447|P1|COMPLETED|Overall Study||14
7533516|NCT03392194|18545446|P2|STARTED|Overall Study||17
7533517|NCT03392194|18545447|P1|STARTED|Overall Study||16
7533518|NCT03391986|18545456|P3|NOT COMPLETED|Overall Study||0
7533519|NCT03391986|18545457|P2|NOT COMPLETED|Overall Study||0
7533520|NCT03391986|18545458|P1|NOT COMPLETED|Overall Study||0
7533521|NCT03391986|18545456|P3|COMPLETED|Overall Study||50
7533522|NCT03391986|18545457|P2|COMPLETED|Overall Study||50
7533523|NCT03391986|18545458|P1|COMPLETED|Overall Study||53
7533524|NCT03391986|18545456|P3|STARTED|Overall Study||50
7533525|NCT03391986|18545457|P2|STARTED|Overall Study||50
7533526|NCT03391986|18545458|P1|STARTED|Overall Study||53
7533527|NCT03391115|18545471|P2|NOT COMPLETED|Overall Study||0
7533528|NCT03391115|18545472|P1|NOT COMPLETED|Overall Study||0
7533529|NCT03391115|18545471|P2|COMPLETED|Overall Study|Two Nurse participants in the dyadic patient-nurse enrollment were not successfully recruited.|18
7533530|NCT03391115|18545472|P1|COMPLETED|Overall Study||20
7533531|NCT03391115|18545471|P2|STARTED|Overall Study||18
7533532|NCT03391115|18545472|P1|STARTED|Overall Study||20
7533533|NCT03390426|18545482|P2|NOT COMPLETED|Overall Study||1
7533534|NCT03390426|18545483|P1|NOT COMPLETED|Overall Study||0
7533535|NCT03390426|18545482|P2|COMPLETED|Overall Study||15
7533536|NCT03390426|18545483|P1|COMPLETED|Overall Study||15
7533537|NCT03390426|18545482|P2|STARTED|Overall Study||16
7533538|NCT03390426|18545483|P1|STARTED|Overall Study||15
7533539|NCT03390257|18545495|P1|NOT COMPLETED|Overall Study||0
7533540|NCT03390257|18545495|P1|COMPLETED|Overall Study||14
7533541|NCT03390257|18545495|P1|STARTED|Overall Study||14
7533542|NCT03390166|18545503|P2|NOT COMPLETED|Overall Study||10
7533543|NCT03390166|18545504|P1|NOT COMPLETED|Overall Study||12
7533544|NCT03390166|18545503|P2|COMPLETED|Overall Study||305
7533545|NCT03390166|18545504|P1|COMPLETED|Overall Study||618
7533546|NCT03390166|18545503|P2|STARTED|Overall Study||315
7533547|NCT03390166|18545504|P1|STARTED|Overall Study||630
7533548|NCT03389854|18545520|P4|NOT COMPLETED|Overall Study||8
7533549|NCT03389854|18545521|P3|NOT COMPLETED|Overall Study||5
7533550|NCT03389854|18545522|P2|NOT COMPLETED|Overall Study||6
7533551|NCT03389854|18545523|P1|NOT COMPLETED|Overall Study||1
7533552|NCT03389854|18545520|P4|COMPLETED|Overall Study||19
7533553|NCT03389854|18545521|P3|COMPLETED|Overall Study||23
7533554|NCT03389854|18545522|P2|COMPLETED|Overall Study||21
7533555|NCT03389854|18545523|P1|COMPLETED|Overall Study||27
7533556|NCT03389854|18545520|P4|STARTED|Overall Study||27
7533557|NCT03389854|18545521|P3|STARTED|Overall Study||28
7533558|NCT03389854|18545522|P2|STARTED|Overall Study||27
7533559|NCT03389854|18545523|P1|STARTED|Overall Study||28
7533560|NCT03389308|18545558|P1|NOT COMPLETED|Overall Study||12
7533561|NCT03389308|18545558|P1|COMPLETED|Overall Study||39
7533562|NCT03389308|18545558|P1|STARTED|Overall Study||51
7533563|NCT03388645|18545564|P2|NOT COMPLETED|High Dose RSV A2||1
7533564|NCT03388645|18545565|P1|NOT COMPLETED|High Dose RSV A2||0
7533565|NCT03388645|18545564|P2|COMPLETED|High Dose RSV A2||7
7533566|NCT03388645|18545565|P1|COMPLETED|High Dose RSV A2||0
7533567|NCT03388645|18545564|P2|STARTED|High Dose RSV A2||8
7533568|NCT03388645|18545565|P1|STARTED|High Dose RSV A2||0
7533569|NCT03388645|18545564|P2|NOT COMPLETED|Low Dose RSV A2||0
7533570|NCT03388645|18545565|P1|NOT COMPLETED|Low Dose RSV A2||0
7533571|NCT03388645|18545564|P2|COMPLETED|Low Dose RSV A2||0
7533572|NCT03388645|18545565|P1|COMPLETED|Low Dose RSV A2||4
7533573|NCT03388645|18545564|P2|STARTED|Low Dose RSV A2||0
7533574|NCT03388645|18545565|P1|STARTED|Low Dose RSV A2||4
7533575|NCT03387683|18545583|P2|NOT COMPLETED|Overall Study||0
7533576|NCT03387683|18545584|P1|NOT COMPLETED|Overall Study||2
7533577|NCT03387683|18545583|P2|COMPLETED|Overall Study||26
7533578|NCT03387683|18545584|P1|COMPLETED|Overall Study||25
7533579|NCT03387683|18545583|P2|STARTED|Overall Study||26
7533580|NCT03387683|18545584|P1|STARTED|Overall Study||27
7533581|NCT03387462|18545592|P1|NOT COMPLETED|Overall Study||1
7533582|NCT03387462|18545592|P1|COMPLETED|Overall Study||19
7533583|NCT03387462|18545592|P1|8 Weeks|Overall Study||19
7533584|NCT03387462|18545592|P1|4 Weeks|Overall Study||20
7533585|NCT03387462|18545592|P1|STARTED|Overall Study||20
7533586|NCT03387319|18545601|P2|NOT COMPLETED|Overall Study||0
7533587|NCT03387319|18545602|P1|NOT COMPLETED|Overall Study||0
7533588|NCT03387319|18545601|P2|COMPLETED|Overall Study||25
7533589|NCT03387319|18545602|P1|COMPLETED|Overall Study||25
7533590|NCT03387319|18545601|P2|STARTED|Overall Study||25
7533591|NCT03387319|18545602|P1|STARTED|Overall Study||25
7533592|NCT03387059|18545622|P2|NOT COMPLETED|Overall Study||4
7533593|NCT03387059|18545623|P1|NOT COMPLETED|Overall Study||5
7533594|NCT03387059|18545622|P2|COMPLETED|Overall Study||0
7533595|NCT03387059|18545623|P1|COMPLETED|Overall Study||0
7533596|NCT03387059|18545622|P2|STARTED|Overall Study||4
7533597|NCT03387059|18545623|P1|STARTED|Overall Study||5
7533598|NCT03387046|18545637|P2|NOT COMPLETED|Overall Study||1
7533599|NCT03387046|18545638|P1|NOT COMPLETED|Overall Study||1
7533600|NCT03387046|18545637|P2|COMPLETED|Overall Study||1
7533601|NCT03387046|18545638|P1|COMPLETED|Overall Study||4
7533602|NCT03387046|18545637|P2|STARTED|Overall Study||2
7533603|NCT03387046|18545638|P1|STARTED|Overall Study||5
7533604|NCT03386994|18545665|P1|NOT COMPLETED|Overall Study||38
7533605|NCT03386994|18545665|P1|COMPLETED|Overall Study||166
7533606|NCT03386994|18545665|P1|STARTED|Overall Study||204
7533607|NCT03386474|18545725|P2|NOT COMPLETED|Overall Study||1
7533608|NCT03386474|18545726|P1|NOT COMPLETED|Overall Study||1
7533609|NCT03386474|18545725|P2|COMPLETED|Overall Study||42
7533610|NCT03386474|18545726|P1|COMPLETED|Overall Study||106
7533611|NCT03386474|18545725|P2|STARTED|Overall Study||43
7533612|NCT03386474|18545726|P1|STARTED|Overall Study||107
7533613|NCT03386448|18545748|P2|NOT COMPLETED|Overall Study||2
7533614|NCT03386448|18545749|P1|NOT COMPLETED|Overall Study||0
7533615|NCT03386448|18545748|P2|COMPLETED|Overall Study||6
7533616|NCT03386448|18545749|P1|COMPLETED|Overall Study||6
7533617|NCT03386448|18545748|P2|STARTED|Overall Study||8
7533618|NCT03386448|18545749|P1|STARTED|Overall Study||6
7533619|NCT03386435|18545757|P2|NOT COMPLETED|Overall Study||7
7533620|NCT03386435|18545758|P1|NOT COMPLETED|Overall Study||5
7533621|NCT03386435|18545757|P2|COMPLETED|Overall Study||73
7533622|NCT03386435|18545758|P1|COMPLETED|Overall Study||75
7533623|NCT03386435|18545757|P2|STARTED|Overall Study||80
7533624|NCT03386435|18545758|P1|STARTED|Overall Study||80
7533625|NCT03386032|18545773|P3|NOT COMPLETED|Overall Study||0
7533626|NCT03386032|18545774|P2|NOT COMPLETED|Overall Study||7
7533627|NCT03386032|18545775|P1|NOT COMPLETED|Overall Study||18
7533628|NCT03386032|18545773|P3|COMPLETED|Overall Study||11
7533629|NCT03386032|18545774|P2|COMPLETED|Overall Study||11
7533630|NCT03386032|18545775|P1|COMPLETED|Overall Study||18
7533631|NCT03386032|18545773|P3|STARTED|Overall Study||11
7533632|NCT03386032|18545774|P2|STARTED|Overall Study||18
7533633|NCT03386032|18545775|P1|STARTED|Overall Study||36
7533634|NCT03384953|18545788|P2|NOT COMPLETED|Overall Study||8
7533635|NCT03384953|18545789|P1|NOT COMPLETED|Overall Study||40
7533636|NCT03384953|18545788|P2|COMPLETED|Overall Study||4
7533637|NCT03384953|18545789|P1|COMPLETED|Overall Study||51
7533638|NCT03384953|18545788|P2|Completed Treatment|Overall Study||6
7533639|NCT03384953|18545789|P1|Completed Treatment|Overall Study||68
7533640|NCT03384953|18545788|P2|STARTED|Overall Study||12
7533641|NCT03384953|18545789|P1|STARTED|Overall Study||91
7533642|NCT03384329|18545797|P2|NOT COMPLETED|Overall Study||0
7533643|NCT03384329|18545798|P1|NOT COMPLETED|Overall Study||0
7533644|NCT03384329|18545797|P2|COMPLETED|Overall Study||11
7533645|NCT03384329|18545798|P1|COMPLETED|Overall Study||11
7533646|NCT03384329|18545797|P2|STARTED|Overall Study||11
7533647|NCT03384329|18545798|P1|STARTED|Overall Study||11
7533648|NCT03384316|18545810|P2|NOT COMPLETED|Overall Study||1
7533649|NCT03384316|18545811|P1|NOT COMPLETED|Overall Study||0
7533650|NCT03384316|18545810|P2|COMPLETED|Overall Study||4
7533651|NCT03384316|18545811|P1|COMPLETED|Overall Study||6
7533652|NCT03384316|18545810|P2|STARTED|Overall Study||5
7533653|NCT03384316|18545811|P1|STARTED|Overall Study||6
7533654|NCT03384173|18545836|P1|NOT COMPLETED|Overall Study||0
7533655|NCT03384173|18545836|P1|COMPLETED|Overall Study||35
7533656|NCT03384173|18545836|P1|STARTED|Overall Study||35
7533657|NCT03383887|18545850|P2|NOT COMPLETED|Overall Study||1
7533658|NCT03383887|18545851|P1|NOT COMPLETED|Overall Study||0
7533659|NCT03383887|18545850|P2|COMPLETED|Overall Study||5
7533660|NCT03383887|18545851|P1|COMPLETED|Overall Study||5
7533661|NCT03383887|18545850|P2|STARTED|Overall Study||6
7533662|NCT03383887|18545851|P1|STARTED|Overall Study||5
7533663|NCT03383783|18545859|P1|NOT COMPLETED|Overall Study||2
7533664|NCT03383783|18545859|P1|COMPLETED|Overall Study||25
7533665|NCT03383783|18545859|P1|STARTED|Overall Study||27
7533666|NCT03383757|18545923|P1|NOT COMPLETED|Overall Study||39
7533667|NCT03383757|18545923|P1|COMPLETED|Overall Study||78
7533668|NCT03383757|18545923|P1|TruSignal Sensitive Sensor Data Pairs|Overall Study||51
7533669|NCT03383757|18545923|P1|TruSignal AllFit Sensor Data Pairs|Overall Study||52
7533670|NCT03383757|18545923|P1|TruSignal Sensitive Sensor Subjects|Overall Study||59
7533671|NCT03383757|18545923|P1|TruSignal AllFit Sensor Subjects|Overall Study||56
7533672|NCT03383757|18545923|P1|STARTED|Overall Study||117
7533673|NCT03383627|18545929|P1|NOT COMPLETED|Overall Study||0
7533674|NCT03383627|18545929|P1|COMPLETED|Overall Study||80
7533675|NCT03383627|18545929|P1|STARTED|Overall Study||80
7533676|NCT03383614|18545943|P4|NOT COMPLETED|Overall Study||0
7533677|NCT03383614|18545944|P3|NOT COMPLETED|Overall Study||0
7533678|NCT03383614|18545945|P2|NOT COMPLETED|Overall Study||1
7533679|NCT03383614|18545946|P1|NOT COMPLETED|Overall Study||0
7533680|NCT03383614|18545943|P4|COMPLETED|Overall Study||6
7533681|NCT03383614|18545944|P3|COMPLETED|Overall Study||6
7533682|NCT03383614|18545945|P2|COMPLETED|Overall Study||5
7533683|NCT03383614|18545946|P1|COMPLETED|Overall Study||6
7533684|NCT03383614|18545943|P4|STARTED|Overall Study||6
7533685|NCT03383614|18545944|P3|STARTED|Overall Study||6
7533686|NCT03383614|18545945|P2|STARTED|Overall Study||6
7533687|NCT03383614|18545946|P1|STARTED|Overall Study||6
7533688|NCT03383588|18546113|P3|NOT COMPLETED|Overall Study||0
7533689|NCT03383588|18546114|P2|NOT COMPLETED|Overall Study||0
7533690|NCT03383588|18546115|P1|NOT COMPLETED|Overall Study||0
7533691|NCT03383588|18546113|P3|COMPLETED|Overall Study||9
7533692|NCT03383588|18546114|P2|COMPLETED|Overall Study||9
7533693|NCT03383588|18546115|P1|COMPLETED|Overall Study||8
7533694|NCT03383588|18546113|P3|STARTED|Overall Study||9
7533695|NCT03383588|18546114|P2|STARTED|Overall Study||9
7533696|NCT03383588|18546115|P1|STARTED|Overall Study||8
7533697|NCT03383523|18546130|P7|NOT COMPLETED|Overall Study||0
7533698|NCT03383523|18546131|P6|NOT COMPLETED|Overall Study||0
7533699|NCT03383523|18546132|P5|NOT COMPLETED|Overall Study||0
7533700|NCT03383523|18546133|P4|NOT COMPLETED|Overall Study||0
7533701|NCT03383523|18546134|P3|NOT COMPLETED|Overall Study||1
7533702|NCT03383523|18546135|P2|NOT COMPLETED|Overall Study||0
7533703|NCT03383523|18546136|P1|NOT COMPLETED|Overall Study||1
7533704|NCT03383523|18546130|P7|COMPLETED|Overall Study||10
7533705|NCT03383523|18546131|P6|COMPLETED|Overall Study||12
7533706|NCT03383523|18546132|P5|COMPLETED|Overall Study||11
7533707|NCT03383523|18546133|P4|COMPLETED|Overall Study||12
7533708|NCT03383523|18546134|P3|COMPLETED|Overall Study||9
7533709|NCT03383523|18546135|P2|COMPLETED|Overall Study||11
7533710|NCT03383523|18546136|P1|COMPLETED|Overall Study||10
7533711|NCT03383523|18546130|P7|STARTED|Overall Study||10
7533712|NCT03383523|18546131|P6|STARTED|Overall Study||12
7533713|NCT03383523|18546132|P5|STARTED|Overall Study||11
7533714|NCT03383523|18546133|P4|STARTED|Overall Study||12
7533715|NCT03383523|18546134|P3|STARTED|Overall Study||10
7533716|NCT03383523|18546135|P2|STARTED|Overall Study||11
7533717|NCT03383523|18546136|P1|STARTED|Overall Study||11
7533718|NCT03383198|18546203|P2|NOT COMPLETED|Overall Study||0
7533719|NCT03383198|18546204|P1|NOT COMPLETED|Overall Study||0
7533720|NCT03383198|18546203|P2|COMPLETED|Overall Study||1
7533721|NCT03383198|18546204|P1|COMPLETED|Overall Study||4
7533722|NCT03383198|18546203|P2|STARTED|Overall Study||1
7533723|NCT03383198|18546204|P1|STARTED|Overall Study||4
7533724|NCT03382912|18546214|P2|NOT COMPLETED|Overall Study||12
7533725|NCT03382912|18546215|P1|NOT COMPLETED|Overall Study||6
7533726|NCT03382912|18546214|P2|COMPLETED|Overall Study||13
7533727|NCT03382912|18546215|P1|COMPLETED|Overall Study||21
7533728|NCT03382912|18546214|P2|Received at Least 1 Dose of Study Drug|Overall Study||24
7533729|NCT03382912|18546215|P1|Received at Least 1 Dose of Study Drug|Overall Study||27
7533730|NCT03382912|18546214|P2|STARTED|Overall Study||25
7533731|NCT03382912|18546215|P1|STARTED|Overall Study||27
7533732|NCT03382834|18546231|P2|NOT COMPLETED|Overall Study||1
7533733|NCT03382834|18546232|P1|NOT COMPLETED|Overall Study||1
7533734|NCT03382834|18546231|P2|COMPLETED|Overall Study||9
7533735|NCT03382834|18546232|P1|COMPLETED|Overall Study||20
7533736|NCT03382834|18546231|P2|STARTED|Overall Study||10
7533737|NCT03382834|18546232|P1|STARTED|Overall Study||21
7533738|NCT03382665|18546244|P1|NOT COMPLETED|Overall Study||45
7533739|NCT03382665|18546244|P1|COMPLETED|Overall Study||25
7533740|NCT03382665|18546244|P1|5 Year Follow up|Overall Study||25
7533741|NCT03382665|18546244|P1|Actual Enrollment|Overall Study||59
7533742|NCT03382665|18546244|P1|STARTED|Overall Study||70
7533743|NCT03382262|18546256|P4|NOT COMPLETED|Overall Study||1
7533744|NCT03382262|18546257|P3|NOT COMPLETED|Overall Study||1
7533745|NCT03382262|18546258|P2|NOT COMPLETED|Overall Study||0
7533746|NCT03382262|18546259|P1|NOT COMPLETED|Overall Study||0
7533747|NCT03382262|18546256|P4|COMPLETED|Overall Study||14
7533748|NCT03382262|18546257|P3|COMPLETED|Overall Study||14
7533749|NCT03382262|18546258|P2|COMPLETED|Overall Study||13
7533750|NCT03382262|18546259|P1|COMPLETED|Overall Study||12
7533751|NCT03382262|18546256|P4|STARTED|Overall Study||15
7533752|NCT03382262|18546257|P3|STARTED|Overall Study||15
7533753|NCT03382262|18546258|P2|STARTED|Overall Study||13
7533754|NCT03382262|18546259|P1|STARTED|Overall Study||12
7533755|NCT03381989|18546273|P1|NOT COMPLETED|Overall Study||8
7533756|NCT03381989|18546273|P1|COMPLETED|Overall Study||22
7533757|NCT03381989|18546273|P1|STARTED|Overall Study||30
7533758|NCT03381742|18546282|P4|NOT COMPLETED|Overall Study||0
7533759|NCT03381742|18546283|P3|NOT COMPLETED|Overall Study||0
7533760|NCT03381742|18546284|P2|NOT COMPLETED|Overall Study||0
7533761|NCT03381742|18546285|P1|NOT COMPLETED|Overall Study||0
7533762|NCT03381742|18546282|P4|COMPLETED|Overall Study||506
7533763|NCT03381742|18546283|P3|COMPLETED|Overall Study||1511
7533764|NCT03381742|18546284|P2|COMPLETED|Overall Study||501
7533765|NCT03381742|18546285|P1|COMPLETED|Overall Study||525
7533766|NCT03381742|18546282|P4|STARTED|Overall Study||506
7533767|NCT03381742|18546283|P3|STARTED|Overall Study||1511
7533768|NCT03381742|18546284|P2|STARTED|Overall Study||501
7533769|NCT03381742|18546285|P1|STARTED|Overall Study||525
7533770|NCT03381248|18546317|P2|NOT COMPLETED|Overall Study||6
7533771|NCT03381248|18546318|P1|NOT COMPLETED|Overall Study||13
7533772|NCT03381248|18546317|P2|COMPLETED|Overall Study||82
7533773|NCT03381248|18546318|P1|COMPLETED|Overall Study||76
7533774|NCT03381248|18546317|P2|STARTED|Overall Study||88
7533775|NCT03381248|18546318|P1|STARTED|Overall Study||89
7533776|NCT03380845|18546332|P1|NOT COMPLETED|Overall Study||0
7533777|NCT03380845|18546332|P1|COMPLETED|Overall Study||4
7533778|NCT03380845|18546332|P1|STARTED|Overall Study|Participants got bilateral face treatments with Fraxel on one side of face; Fractora on the other.|4
7533779|NCT03380780|18546342|P1|NOT COMPLETED|Overall Study||0
7533780|NCT03380780|18546342|P1|COMPLETED|Overall Study||16
7533781|NCT03380780|18546342|P1|STARTED|Overall Study||16
7533782|NCT03380572|18546411|P2|NOT COMPLETED|Overall Study||0
7533783|NCT03380572|18546412|P1|NOT COMPLETED|Overall Study||0
7533784|NCT03380572|18546411|P2|COMPLETED|Overall Study||20
7533785|NCT03380572|18546412|P1|COMPLETED|Overall Study||20
7533786|NCT03380572|18546411|P2|STARTED|Overall Study||20
7533787|NCT03380572|18546412|P1|STARTED|Overall Study||20
7533788|NCT03380429|18546425|P5|NOT COMPLETED|Overall Study||5
7533789|NCT03380429|18546426|P4|NOT COMPLETED|Overall Study||10
7533790|NCT03380429|18546427|P3|NOT COMPLETED|Overall Study||11
7533791|NCT03380429|18546428|P2|NOT COMPLETED|Overall Study||7
7533792|NCT03380429|18546429|P1|NOT COMPLETED|Overall Study||5
7533793|NCT03380429|18546425|P5|COMPLETED|Overall Study||81
7533794|NCT03380429|18546426|P4|COMPLETED|Overall Study||78
7533795|NCT03380429|18546427|P3|COMPLETED|Overall Study||77
7533796|NCT03380429|18546428|P2|COMPLETED|Overall Study||81
7533797|NCT03380429|18546429|P1|COMPLETED|Overall Study||82
7533798|NCT03380429|18546425|P5|STARTED|Overall Study||86
7533799|NCT03380429|18546426|P4|STARTED|Overall Study||88
7533800|NCT03380429|18546427|P3|STARTED|Overall Study||88
7533801|NCT03380429|18546428|P2|STARTED|Overall Study||88
7533802|NCT03380429|18546429|P1|STARTED|Overall Study||87
7533803|NCT03380390|18546482|P1|NOT COMPLETED|Overall Study||3
7533804|NCT03380390|18546482|P1|COMPLETED|Overall Study||43
7533805|NCT03380390|18546482|P1|STARTED|Overall Study||46
7533806|NCT03379740|18546490|P2|NOT COMPLETED|Overall Study||0
7533807|NCT03379740|18546491|P1|NOT COMPLETED|Overall Study||0
7533808|NCT03379740|18546490|P2|COMPLETED|Overall Study||7
7533809|NCT03379740|18546491|P1|COMPLETED|Overall Study||8
7533810|NCT03379740|18546490|P2|STARTED|Overall Study||7
7533811|NCT03379740|18546491|P1|STARTED|Overall Study||8
7533812|NCT03379545|18546569|P1|NOT COMPLETED|Overall Study||0
7533813|NCT03379545|18546569|P1|COMPLETED|Overall Study||29
7533814|NCT03379545|18546569|P1|STARTED|Overall Study||29
7533815|NCT03379506|18546578|P4|NOT COMPLETED|Overall Study||11
7533816|NCT03379506|18546579|P3|NOT COMPLETED|Overall Study||0
7533817|NCT03379506|18546580|P2|NOT COMPLETED|Overall Study||9
7533818|NCT03379506|18546581|P1|NOT COMPLETED|Overall Study||0
7533819|NCT03379506|18546578|P4|COMPLETED|Overall Study||0
7533820|NCT03379506|18546579|P3|COMPLETED|Overall Study||7
7533821|NCT03379506|18546580|P2|COMPLETED|Overall Study||8
7533822|NCT03379506|18546581|P1|COMPLETED|Overall Study||22
7533823|NCT03379506|18546578|P4|STARTED|Overall Study||11
7533824|NCT03379506|18546579|P3|STARTED|Overall Study||7
7533825|NCT03379506|18546580|P2|STARTED|Overall Study||17
7533826|NCT03379506|18546581|P1|STARTED|Overall Study||22
7533827|NCT03379376|18546631|P1|NOT COMPLETED|Overall Study||5
7533828|NCT03379376|18546631|P1|COMPLETED|Overall Study||5
7533829|NCT03379376|18546631|P1|STARTED|Overall Study||10
7533830|NCT03379233|18546641|P2|NOT COMPLETED|Overall Study||6
7533831|NCT03379233|18546642|P1|NOT COMPLETED|Overall Study||1
7533832|NCT03379233|18546641|P2|COMPLETED|Overall Study||0
7533833|NCT03379233|18546642|P1|COMPLETED|Overall Study||0
7533834|NCT03379233|18546641|P2|STARTED|Overall Study||6
7533835|NCT03379233|18546642|P1|STARTED|Overall Study||1
7533836|NCT03378973|18546656|P2|NOT COMPLETED|Overall Study||0
7533837|NCT03378973|18546657|P1|NOT COMPLETED|Overall Study||0
7533838|NCT03378973|18546656|P2|COMPLETED|Overall Study||3
7533839|NCT03378973|18546657|P1|COMPLETED|Overall Study||4
7533840|NCT03378973|18546656|P2|STARTED|Overall Study||3
7533841|NCT03378973|18546657|P1|STARTED|Overall Study||4
7533842|NCT03378076|18546665|P2|NOT COMPLETED|Overall Study||0
7533843|NCT03378076|18546666|P1|NOT COMPLETED|Overall Study||0
7533844|NCT03378076|18546665|P2|COMPLETED|Overall Study||12
7533845|NCT03378076|18546666|P1|COMPLETED|Overall Study||12
7533846|NCT03378076|18546665|P2|STARTED|Overall Study||12
7533847|NCT03378076|18546666|P1|STARTED|Overall Study||12
7533848|NCT03377244|18546677|P3|NOT COMPLETED|6 Months Post-intervention||14
7533849|NCT03377244|18546678|P2|NOT COMPLETED|6 Months Post-intervention||7
7533850|NCT03377244|18546679|P1|NOT COMPLETED|6 Months Post-intervention||6
7533851|NCT03377244|18546677|P3|COMPLETED|6 Months Post-intervention||55
7533852|NCT03377244|18546678|P2|COMPLETED|6 Months Post-intervention||7
7533853|NCT03377244|18546679|P1|COMPLETED|6 Months Post-intervention||13
7533854|NCT03377244|18546677|P3|STARTED|6 Months Post-intervention||69
7533855|NCT03377244|18546678|P2|STARTED|6 Months Post-intervention||14
7533856|NCT03377244|18546679|P1|STARTED|6 Months Post-intervention||19
7533857|NCT03377244|18546677|P3|NOT COMPLETED|Baseline||0
7533858|NCT03377244|18546678|P2|NOT COMPLETED|Baseline||0
7533859|NCT03377244|18546679|P1|NOT COMPLETED|Baseline||0
7533860|NCT03377244|18546677|P3|COMPLETED|Baseline||69
7533861|NCT03377244|18546678|P2|COMPLETED|Baseline||14
7533862|NCT03377244|18546679|P1|COMPLETED|Baseline||19
7533863|NCT03377244|18546677|P3|STARTED|Baseline||69
7533864|NCT03377244|18546678|P2|STARTED|Baseline||14
7533865|NCT03377244|18546679|P1|STARTED|Baseline||19
7533866|NCT03376516|18546714|P1|NOT COMPLETED|Overall Study||2
7533867|NCT03376516|18546714|P1|COMPLETED|Overall Study||9
7533868|NCT03376516|18546714|P1|SURG Population|Overall Study||2
7533869|NCT03376516|18546714|P1|PP Population|Overall Study||9
7533870|NCT03376516|18546714|P1|PK Population|Overall Study||10
7533871|NCT03376516|18546714|P1|FAS Population|Overall Study||10
7533872|NCT03376516|18546714|P1|SAF Population|Overall Study||10
7533873|NCT03376516|18546714|P1|Received Treatment|Overall Study||10
7533874|NCT03376516|18546714|P1|STARTED|Overall Study||11
7533875|NCT03376295|18546746|P2|NOT COMPLETED|Overall Study||0
7533876|NCT03376295|18546747|P1|NOT COMPLETED|Overall Study||0
7533877|NCT03376295|18546746|P2|COMPLETED|Overall Study||1977
7533878|NCT03376295|18546747|P1|COMPLETED|Overall Study||1977
7533879|NCT03376295|18546746|P2|STARTED|Overall Study||1977
7533880|NCT03376295|18546747|P1|STARTED|Overall Study||1977
7533881|NCT03376256|18546759|P2|NOT COMPLETED|Overall Study||0
7533882|NCT03376256|18546760|P1|NOT COMPLETED|Overall Study||0
7533883|NCT03376256|18546759|P2|COMPLETED|Overall Study||0
7533884|NCT03376256|18546760|P1|COMPLETED|Overall Study||2
7533885|NCT03376256|18546759|P2|STARTED|Overall Study||0
7533886|NCT03376256|18546760|P1|STARTED|Overall Study||2
7533887|NCT03376061|18546770|P2|NOT COMPLETED|Overall Study||0
7533888|NCT03376061|18546771|P1|NOT COMPLETED|Overall Study||0
7533889|NCT03376061|18546770|P2|COMPLETED|Overall Study||48
7533890|NCT03376061|18546771|P1|COMPLETED|Overall Study||49
7533891|NCT03376061|18546770|P2|STARTED|Overall Study||48
7533892|NCT03376061|18546771|P1|STARTED|Overall Study||49
7533893|NCT03375294|18546789|P1|NOT COMPLETED|Overall Study||0
7533894|NCT03375294|18546789|P1|COMPLETED|Overall Study||3
7533895|NCT03375294|18546789|P1|STARTED|Overall Study||3
7533896|NCT03374995|18546795|P2|NOT COMPLETED|Overall Study||1
7533897|NCT03374995|18546796|P1|NOT COMPLETED|Overall Study||0
7533898|NCT03374995|18546795|P2|COMPLETED|Overall Study||11
7533899|NCT03374995|18546796|P1|COMPLETED|Overall Study||13
7533900|NCT03374995|18546795|P2|STARTED|Overall Study||12
7533901|NCT03374995|18546796|P1|STARTED|Overall Study||13
7533902|NCT03374488|18546810|P2|NOT COMPLETED|Overall Study||37
7533903|NCT03374488|18546811|P1|NOT COMPLETED|Overall Study||41
7533904|NCT03374488|18546810|P2|COMPLETED|Overall Study||5
7533905|NCT03374488|18546811|P1|COMPLETED|Overall Study||1
7533906|NCT03374488|18546810|P2|All Participants as Treated (APaT)|Overall Study||41
7533907|NCT03374488|18546811|P1|All Participants as Treated (APaT)|Overall Study||42
7533908|NCT03374488|18546810|P2|Intention-to-Treat (ITT)|Overall Study||42
7533909|NCT03374488|18546811|P1|Intention-to-Treat (ITT)|Overall Study||42
7533910|NCT03374488|18546810|P2|STARTED|Overall Study||42
7533911|NCT03374488|18546811|P1|STARTED|Overall Study||42
7533912|NCT03374189|18546823|P2|NOT COMPLETED|Overall Study||0
7533913|NCT03374189|18546824|P1|NOT COMPLETED|Overall Study||1
7533914|NCT03374189|18546823|P2|COMPLETED|Overall Study||39
7533915|NCT03374189|18546824|P1|COMPLETED|Overall Study||39
7533916|NCT03374189|18546823|P2|STARTED|Overall Study||39
7533917|NCT03374189|18546824|P1|STARTED|Overall Study||40
7533918|NCT03374176|18546844|P2|NOT COMPLETED|Overall Study||0
7533919|NCT03374176|18546845|P1|NOT COMPLETED|Overall Study||0
7533920|NCT03374176|18546844|P2|COMPLETED|Overall Study||21
7533921|NCT03374176|18546845|P1|COMPLETED|Overall Study||21
7533922|NCT03374176|18546844|P2|STARTED|Overall Study||21
7533923|NCT03374176|18546845|P1|STARTED|Overall Study||21
7533924|NCT03373890|18546859|P2|NOT COMPLETED|Overall Study||0
7533925|NCT03373890|18546860|P1|NOT COMPLETED|Overall Study||0
7533926|NCT03373890|18546859|P2|COMPLETED|Overall Study||6
7533927|NCT03373890|18546860|P1|COMPLETED|Overall Study||6
7533928|NCT03373890|18546859|P2|STARTED|Overall Study||6
7533929|NCT03373890|18546860|P1|STARTED|Overall Study||6
7533930|NCT03373591|18546883|P3|NOT COMPLETED|Overall Study||0
7533931|NCT03373591|18546884|P2|NOT COMPLETED|Overall Study||0
7533932|NCT03373591|18546885|P1|NOT COMPLETED|Overall Study||0
7533933|NCT03373591|18546883|P3|COMPLETED|Overall Study||73
7533934|NCT03373591|18546884|P2|COMPLETED|Overall Study||71
7533935|NCT03373591|18546885|P1|COMPLETED|Overall Study||75
7533936|NCT03373591|18546883|P3|STARTED|Overall Study||73
7533937|NCT03373591|18546884|P2|STARTED|Overall Study||71
7533938|NCT03373591|18546885|P1|STARTED|Overall Study||75
7533939|NCT03373162|18546914|P1|NOT COMPLETED|Overall Study||0
7533940|NCT03373162|18546914|P1|COMPLETED|Overall Study||10
7533941|NCT03373162|18546914|P1|STARTED|Overall Study||10
7533942|NCT03373006|18546920|P1|NOT COMPLETED|Overall Study||0
7533943|NCT03373006|18546920|P1|COMPLETED|Overall Study||20
7533944|NCT03373006|18546920|P1|STARTED|Overall Study||20
7533945|NCT03372928|18546924|P2|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0
7533946|NCT03372928|18546925|P1|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0
7533947|NCT03372928|18546924|P2|COMPLETED|Second Intervention (5 d Energy Deficit)||9
7533948|NCT03372928|18546925|P1|COMPLETED|Second Intervention (5 d Energy Deficit)||10
7533949|NCT03372928|18546924|P2|STARTED|Second Intervention (5 d Energy Deficit)||9
7533950|NCT03372928|18546925|P1|STARTED|Second Intervention (5 d Energy Deficit)||10
7533951|NCT03372928|18546924|P2|NOT COMPLETED|Washout (14 d)||1
7533952|NCT03372928|18546925|P1|NOT COMPLETED|Washout (14 d)||0
7533953|NCT03372928|18546924|P2|COMPLETED|Washout (14 d)||9
7533954|NCT03372928|18546925|P1|COMPLETED|Washout (14 d)||10
7533955|NCT03372928|18546924|P2|STARTED|Washout (14 d)||10
7533956|NCT03372928|18546925|P1|STARTED|Washout (14 d)||10
7533957|NCT03372928|18546924|P2|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0
7533958|NCT03372928|18546925|P1|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0
7533959|NCT03372928|18546924|P2|COMPLETED|First Intervention (5 d Energy Deficit)||10
7533960|NCT03372928|18546925|P1|COMPLETED|First Intervention (5 d Energy Deficit)||10
7533961|NCT03372928|18546924|P2|STARTED|First Intervention (5 d Energy Deficit)||10
7533962|NCT03372928|18546925|P1|STARTED|First Intervention (5 d Energy Deficit)||10
7533963|NCT03372603|18546937|P2|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||0
7533964|NCT03372603|18546938|P1|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||1
7533965|NCT03372603|18546937|P2|COMPLETED|Treatment Period 2 (Up to 7 Days)||8
7533966|NCT03372603|18546938|P1|COMPLETED|Treatment Period 2 (Up to 7 Days)||7
7533967|NCT03372603|18546937|P2|STARTED|Treatment Period 2 (Up to 7 Days)||8
7533968|NCT03372603|18546938|P1|STARTED|Treatment Period 2 (Up to 7 Days)||8
7533969|NCT03372603|18546937|P2|NOT COMPLETED|Wash-out Period (14-21 Days)||0
7533970|NCT03372603|18546938|P1|NOT COMPLETED|Wash-out Period (14-21 Days)||1
7533971|NCT03372603|18546937|P2|COMPLETED|Wash-out Period (14-21 Days)||8
7533972|NCT03372603|18546938|P1|COMPLETED|Wash-out Period (14-21 Days)||8
7533973|NCT03372603|18546937|P2|STARTED|Wash-out Period (14-21 Days)||8
7533974|NCT03372603|18546938|P1|STARTED|Wash-out Period (14-21 Days)||9
7533975|NCT03372603|18546937|P2|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
7533976|NCT03372603|18546938|P1|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
7533977|NCT03372603|18546937|P2|COMPLETED|Treatment Period 1 (Up to 7 Days)||8
7533978|NCT03372603|18546938|P1|COMPLETED|Treatment Period 1 (Up to 7 Days)||9
7533979|NCT03372603|18546937|P2|STARTED|Treatment Period 1 (Up to 7 Days)||8
7533980|NCT03372603|18546938|P1|STARTED|Treatment Period 1 (Up to 7 Days)||9
7533981|NCT03372551|18546980|P2|NOT COMPLETED|Second Intervention (1 Week)||0
7533982|NCT03372551|18546981|P1|NOT COMPLETED|Second Intervention (1 Week)||0
7533983|NCT03372551|18546980|P2|COMPLETED|Second Intervention (1 Week)||16
7533984|NCT03372551|18546981|P1|COMPLETED|Second Intervention (1 Week)||16
7533985|NCT03372551|18546980|P2|STARTED|Second Intervention (1 Week)||16
7533986|NCT03372551|18546981|P1|STARTED|Second Intervention (1 Week)||16
7533987|NCT03372551|18546980|P2|NOT COMPLETED|First Intervention (1 Week)||0
7533988|NCT03372551|18546981|P1|NOT COMPLETED|First Intervention (1 Week)||1
7533989|NCT03372551|18546980|P2|COMPLETED|First Intervention (1 Week)||16
7533990|NCT03372551|18546981|P1|COMPLETED|First Intervention (1 Week)||16
7533991|NCT03372551|18546980|P2|STARTED|First Intervention (1 Week)||16
7533992|NCT03372551|18546981|P1|STARTED|First Intervention (1 Week)||17
7533993|NCT03372382|18547000|P2|NOT COMPLETED|Overall Study||4
7533994|NCT03372382|18547001|P1|NOT COMPLETED|Overall Study||9
7533995|NCT03372382|18547000|P2|COMPLETED|Overall Study||81
7533996|NCT03372382|18547001|P1|COMPLETED|Overall Study||76
7533997|NCT03372382|18547000|P2|STARTED|Overall Study||85
7533998|NCT03372382|18547001|P1|STARTED|Overall Study||85
7533999|NCT03372369|18547011|P2|NOT COMPLETED|Intervention and Follow-Up Period||3
7534000|NCT03372369|18547012|P1|NOT COMPLETED|Intervention and Follow-Up Period||3
7534001|NCT03372369|18547011|P2|COMPLETED|Intervention and Follow-Up Period||470
7534002|NCT03372369|18547012|P1|COMPLETED|Intervention and Follow-Up Period||466
7534003|NCT03372369|18547011|P2|STARTED|Intervention and Follow-Up Period||473
7534004|NCT03372369|18547012|P1|STARTED|Intervention and Follow-Up Period||469
7534005|NCT03372369|18547011|P2|NOT COMPLETED|Qualification Period||22
7534006|NCT03372369|18547012|P1|NOT COMPLETED|Qualification Period||26
7534007|NCT03372369|18547011|P2|COMPLETED|Qualification Period||473
7534008|NCT03372369|18547012|P1|COMPLETED|Qualification Period||469
7534009|NCT03372369|18547011|P2|STARTED|Qualification Period||495
7534010|NCT03372369|18547012|P1|STARTED|Qualification Period||495
7534011|NCT03372083|18547024|P1|NOT COMPLETED|Overall Study||5
7534012|NCT03372083|18547024|P1|COMPLETED|Overall Study||39
7534013|NCT03372083|18547024|P1|STARTED|Overall Study||44
7534014|NCT03371459|18547056|P2|NOT COMPLETED|Period 2||0
7534015|NCT03371459|18547057|P1|NOT COMPLETED|Period 2||0
7534016|NCT03371459|18547056|P2|COMPLETED|Period 2||22
7534017|NCT03371459|18547057|P1|COMPLETED|Period 2||23
7534018|NCT03371459|18547056|P2|STARTED|Period 2||22
7534019|NCT03371459|18547057|P1|STARTED|Period 2||23
7534020|NCT03371459|18547056|P2|NOT COMPLETED|Washout||1
7534021|NCT03371459|18547057|P1|NOT COMPLETED|Washout||0
7534022|NCT03371459|18547056|P2|COMPLETED|Washout||22
7534023|NCT03371459|18547057|P1|COMPLETED|Washout||23
7534024|NCT03371459|18547056|P2|STARTED|Washout||23
7534025|NCT03371459|18547057|P1|STARTED|Washout||23
7534026|NCT03371459|18547056|P2|NOT COMPLETED|Period 1||0
7534027|NCT03371459|18547057|P1|NOT COMPLETED|Period 1||0
7534028|NCT03371459|18547056|P2|COMPLETED|Period 1||23
7534029|NCT03371459|18547057|P1|COMPLETED|Period 1||23
7534030|NCT03371459|18547056|P2|STARTED|Period 1||23
7534031|NCT03371459|18547057|P1|STARTED|Period 1||23
7534032|NCT03371381|18547065|P1|NOT COMPLETED|Overall Study||12
7534033|NCT03371381|18547065|P1|COMPLETED|Overall Study||0
7534034|NCT03371381|18547065|P1|STARTED|Overall Study||12
7534035|NCT03370770|18547077|P1|NOT COMPLETED|Overall Study||106
7534036|NCT03370770|18547077|P1|COMPLETED|Overall Study||98
7534037|NCT03370770|18547077|P1|STARTED|Overall Study||204
7534038|NCT03370536|18547082|P1|NOT COMPLETED|Overall Study||1
7534039|NCT03370536|18547082|P1|COMPLETED|Overall Study||0
7534040|NCT03370536|18547082|P1|STARTED|Overall Study||1
7534041|NCT03370419|18547091|P1|NOT COMPLETED|Overall Study||16
7534042|NCT03370419|18547091|P1|COMPLETED|Overall Study||24
7534043|NCT03370419|18547091|P1|STARTED|Overall Study||40
7534044|NCT03370302|18547101|P6|NOT COMPLETED|Dose Expansion Phase||0
7534045|NCT03370302|18547102|P5|NOT COMPLETED|Dose Expansion Phase||0
7534046|NCT03370302|18547103|P4|NOT COMPLETED|Dose Expansion Phase||6
7534047|NCT03370302|18547104|P3|NOT COMPLETED|Dose Expansion Phase||0
7534048|NCT03370302|18547105|P2|NOT COMPLETED|Dose Expansion Phase||0
7534049|NCT03370302|18547106|P1|NOT COMPLETED|Dose Expansion Phase||0
7534050|NCT03370302|18547101|P6|COMPLETED|Dose Expansion Phase||0
7534051|NCT03370302|18547102|P5|COMPLETED|Dose Expansion Phase||0
7534052|NCT03370302|18547103|P4|COMPLETED|Dose Expansion Phase||0
7534053|NCT03370302|18547104|P3|COMPLETED|Dose Expansion Phase||0
7534054|NCT03370302|18547105|P2|COMPLETED|Dose Expansion Phase||0
7534055|NCT03370302|18547106|P1|COMPLETED|Dose Expansion Phase||0
7534056|NCT03370302|18547101|P6|STARTED|Dose Expansion Phase||0
7534057|NCT03370302|18547102|P5|STARTED|Dose Expansion Phase||0
7534058|NCT03370302|18547103|P4|STARTED|Dose Expansion Phase||6
7534059|NCT03370302|18547104|P3|STARTED|Dose Expansion Phase||0
7534060|NCT03370302|18547105|P2|STARTED|Dose Expansion Phase||0
7534061|NCT03370302|18547106|P1|STARTED|Dose Expansion Phase||0
7534062|NCT03370302|18547101|P6|NOT COMPLETED|Dose Escalation Phase||3
7534063|NCT03370302|18547102|P5|NOT COMPLETED|Dose Escalation Phase||3
7534064|NCT03370302|18547103|P4|NOT COMPLETED|Dose Escalation Phase||0
7534065|NCT03370302|18547104|P3|NOT COMPLETED|Dose Escalation Phase||7
7534066|NCT03370302|18547105|P2|NOT COMPLETED|Dose Escalation Phase||6
7534067|NCT03370302|18547106|P1|NOT COMPLETED|Dose Escalation Phase||3
7534068|NCT03370302|18547101|P6|COMPLETED|Dose Escalation Phase||0
7534069|NCT03370302|18547102|P5|COMPLETED|Dose Escalation Phase||0
7534070|NCT03370302|18547103|P4|COMPLETED|Dose Escalation Phase||0
7534071|NCT03370302|18547104|P3|COMPLETED|Dose Escalation Phase||0
7534072|NCT03370302|18547105|P2|COMPLETED|Dose Escalation Phase||0
7534073|NCT03370302|18547106|P1|COMPLETED|Dose Escalation Phase||0
7534074|NCT03370302|18547101|P6|STARTED|Dose Escalation Phase||3
7534075|NCT03370302|18547102|P5|STARTED|Dose Escalation Phase||3
7534076|NCT03370302|18547103|P4|STARTED|Dose Escalation Phase||0
7534077|NCT03370302|18547104|P3|STARTED|Dose Escalation Phase||7
7534078|NCT03370302|18547105|P2|STARTED|Dose Escalation Phase||6
7534079|NCT03370302|18547106|P1|STARTED|Dose Escalation Phase||3
7534080|NCT03370289|18547203|P1|NOT COMPLETED|Overall Study||5
7534081|NCT03370289|18547203|P1|COMPLETED|Overall Study||50
7534082|NCT03370289|18547203|P1|STARTED|Overall Study||55
7534083|NCT03370042|18547222|P2|NOT COMPLETED|Overall Study||0
7534084|NCT03370042|18547223|P1|NOT COMPLETED|Overall Study||0
7534085|NCT03370042|18547222|P2|COMPLETED|Overall Study||10
7534086|NCT03370042|18547223|P1|COMPLETED|Overall Study||10
7534087|NCT03370042|18547222|P2|STARTED|Overall Study||10
7534088|NCT03370042|18547223|P1|STARTED|Overall Study||10
7534089|NCT03369951|18547237|P1|NOT COMPLETED|Overall Study||6
7534090|NCT03369951|18547237|P1|COMPLETED|Overall Study||52
7534091|NCT03369951|18547237|P1|Received Study Drug|Overall Study||57
7534092|NCT03369951|18547237|P1|STARTED|Overall Study||58
7534093|NCT03369756|18547262|P1|NOT COMPLETED|Overall Study||7
7534094|NCT03369756|18547262|P1|COMPLETED|Overall Study|36 completed 4 weeks of treatment; 40 were considered statistical completers|36
7534095|NCT03369756|18547262|P1|STARTED|Overall Study||43
7534096|NCT03369704|18547272|P2|NOT COMPLETED|Follow-up Epoch||0
7534097|NCT03369704|18547273|P1|NOT COMPLETED|Follow-up Epoch||1
7534098|NCT03369704|18547272|P2|COMPLETED|Follow-up Epoch||174
7534099|NCT03369704|18547273|P1|COMPLETED|Follow-up Epoch||160
7534100|NCT03369704|18547272|P2|STARTED|Follow-up Epoch||174
7534101|NCT03369704|18547273|P1|STARTED|Follow-up Epoch||161
7534102|NCT03369704|18547272|P2|NOT COMPLETED|Treatment Epoch||3
7534103|NCT03369704|18547273|P1|NOT COMPLETED|Treatment Epoch||4
7534104|NCT03369704|18547272|P2|COMPLETED|Treatment Epoch||172
7534105|NCT03369704|18547273|P1|COMPLETED|Treatment Epoch||158
7534106|NCT03369704|18547272|P2|STARTED|Treatment Epoch||175
7534107|NCT03369704|18547273|P1|STARTED|Treatment Epoch||162
7534108|NCT03369418|18547308|P2|NOT COMPLETED|Overall Study||3
7534109|NCT03369418|18547309|P1|NOT COMPLETED|Overall Study||3
7534110|NCT03369418|18547308|P2|COMPLETED|Overall Study||11
7534111|NCT03369418|18547309|P1|COMPLETED|Overall Study||13
7534112|NCT03369418|18547308|P2|STARTED|Overall Study||14
7534113|NCT03369418|18547309|P1|STARTED|Overall Study||16
7534114|NCT03369340|18547317|P6|NOT COMPLETED|Day 4||0
7534115|NCT03369340|18547318|P5|NOT COMPLETED|Day 4||0
7534116|NCT03369340|18547319|P4|NOT COMPLETED|Day 4||0
7534117|NCT03369340|18547320|P3|NOT COMPLETED|Day 4||0
7534118|NCT03369340|18547321|P2|NOT COMPLETED|Day 4||0
7534119|NCT03369340|18547322|P1|NOT COMPLETED|Day 4||0
7534120|NCT03369340|18547317|P6|COMPLETED|Day 4||3
7534121|NCT03369340|18547318|P5|COMPLETED|Day 4||3
7534122|NCT03369340|18547319|P4|COMPLETED|Day 4||3
7534123|NCT03369340|18547320|P3|COMPLETED|Day 4||3
7534124|NCT03369340|18547321|P2|COMPLETED|Day 4||3
7534125|NCT03369340|18547322|P1|COMPLETED|Day 4||3
7534126|NCT03369340|18547317|P6|STARTED|Day 4||3
7534127|NCT03369340|18547318|P5|STARTED|Day 4||3
7534128|NCT03369340|18547319|P4|STARTED|Day 4||3
7534129|NCT03369340|18547320|P3|STARTED|Day 4||3
7534130|NCT03369340|18547321|P2|STARTED|Day 4||3
7534131|NCT03369340|18547322|P1|STARTED|Day 4||3
7534132|NCT03369340|18547317|P6|NOT COMPLETED|Day 3||0
7534133|NCT03369340|18547318|P5|NOT COMPLETED|Day 3||0
7534134|NCT03369340|18547319|P4|NOT COMPLETED|Day 3||0
7534135|NCT03369340|18547320|P3|NOT COMPLETED|Day 3||0
7534136|NCT03369340|18547321|P2|NOT COMPLETED|Day 3||0
7534137|NCT03369340|18547322|P1|NOT COMPLETED|Day 3||0
7534138|NCT03369340|18547317|P6|COMPLETED|Day 3||3
7534139|NCT03369340|18547318|P5|COMPLETED|Day 3||3
7534140|NCT03369340|18547319|P4|COMPLETED|Day 3||3
7534141|NCT03369340|18547320|P3|COMPLETED|Day 3||3
7534142|NCT03369340|18547321|P2|COMPLETED|Day 3||3
7534143|NCT03369340|18547322|P1|COMPLETED|Day 3||3
7534144|NCT03369340|18547317|P6|STARTED|Day 3||3
7534145|NCT03369340|18547318|P5|STARTED|Day 3||3
7534146|NCT03369340|18547319|P4|STARTED|Day 3||3
7534147|NCT03369340|18547320|P3|STARTED|Day 3||3
7534148|NCT03369340|18547321|P2|STARTED|Day 3||3
7534149|NCT03369340|18547322|P1|STARTED|Day 3||3
7534150|NCT03369340|18547317|P6|NOT COMPLETED|Day 2||0
7534151|NCT03369340|18547318|P5|NOT COMPLETED|Day 2||0
7534152|NCT03369340|18547319|P4|NOT COMPLETED|Day 2||0
7534153|NCT03369340|18547320|P3|NOT COMPLETED|Day 2||0
7534154|NCT03369340|18547321|P2|NOT COMPLETED|Day 2||0
7534155|NCT03369340|18547322|P1|NOT COMPLETED|Day 2||0
7534156|NCT03369340|18547317|P6|COMPLETED|Day 2||3
7534157|NCT03369340|18547318|P5|COMPLETED|Day 2||3
7534158|NCT03369340|18547319|P4|COMPLETED|Day 2||3
7534159|NCT03369340|18547320|P3|COMPLETED|Day 2||3
7534160|NCT03369340|18547321|P2|COMPLETED|Day 2||3
7534161|NCT03369340|18547322|P1|COMPLETED|Day 2||3
7534162|NCT03369340|18547317|P6|STARTED|Day 2||3
7534163|NCT03369340|18547318|P5|STARTED|Day 2||3
7534164|NCT03369340|18547319|P4|STARTED|Day 2||3
7534165|NCT03369340|18547320|P3|STARTED|Day 2||3
7534166|NCT03369340|18547321|P2|STARTED|Day 2||3
7534167|NCT03369340|18547322|P1|STARTED|Day 2||3
7534168|NCT03369197|18547402|P2|NOT COMPLETED|Overall Study||0
7534169|NCT03369197|18547403|P1|NOT COMPLETED|Overall Study||0
7534170|NCT03369197|18547402|P2|COMPLETED|Overall Study||57
7534171|NCT03369197|18547403|P1|COMPLETED|Overall Study||53
7534172|NCT03369197|18547402|P2|STARTED|Overall Study||57
7534173|NCT03369197|18547403|P1|STARTED|Overall Study||53
7534174|NCT03369158|18547423|P2|NOT COMPLETED|Overall Study||0
7534175|NCT03369158|18547424|P1|NOT COMPLETED|Overall Study||0
7534176|NCT03369158|18547423|P2|COMPLETED|Overall Study||15
7534177|NCT03369158|18547424|P1|COMPLETED|Overall Study||14
7534178|NCT03369158|18547423|P2|STARTED|Overall Study||15
7534179|NCT03369158|18547424|P1|STARTED|Overall Study||14
7534180|NCT03368937|18547436|P1|NOT COMPLETED|Overall Study||0
7534181|NCT03368937|18547436|P1|COMPLETED|Overall Study||5
7534182|NCT03368937|18547436|P1|STARTED|Overall Study||5
7534183|NCT03368898|18547443|P3|NOT COMPLETED|Overall Study||0
7534184|NCT03368898|18547444|P2|NOT COMPLETED|Overall Study||0
7534185|NCT03368898|18547445|P1|NOT COMPLETED|Overall Study||0
7534186|NCT03368898|18547443|P3|COMPLETED|Overall Study||34
7534187|NCT03368898|18547444|P2|COMPLETED|Overall Study||33
7534188|NCT03368898|18547445|P1|COMPLETED|Overall Study||37
7534189|NCT03368898|18547443|P3|STARTED|Overall Study||34
7534190|NCT03368898|18547444|P2|STARTED|Overall Study||33
7534191|NCT03368898|18547445|P1|STARTED|Overall Study||37
7534192|NCT03368807|18547465|P1|NOT COMPLETED|Period 2 (Unblinded CGM)||0
7534193|NCT03368807|18547465|P1|COMPLETED|Period 2 (Unblinded CGM)||73
7534194|NCT03368807|18547465|P1|STARTED|Period 2 (Unblinded CGM)||73
7534195|NCT03368807|18547465|P1|NOT COMPLETED|Period 1 (Blinded CGM)||6
7534196|NCT03368807|18547465|P1|COMPLETED|Period 1 (Blinded CGM)||73
7534197|NCT03368807|18547465|P1|Received at Least 1 Dose of Study Drug|Period 1 (Blinded CGM)||78
7534198|NCT03368807|18547465|P1|STARTED|Period 1 (Blinded CGM)||79
7534199|NCT03368235|18547481|P2|NOT COMPLETED|Overall Study||0
7534200|NCT03368235|18547482|P1|NOT COMPLETED|Overall Study||0
7534201|NCT03368235|18547481|P2|COMPLETED|Overall Study||10
7534202|NCT03368235|18547482|P1|COMPLETED|Overall Study||11
7534203|NCT03368235|18547481|P2|STARTED|Overall Study||10
7534204|NCT03368235|18547482|P1|STARTED|Overall Study||11
7534205|NCT03368170|18547515|P2|NOT COMPLETED|Overall Study||1
7534206|NCT03368170|18547516|P1|NOT COMPLETED|Overall Study||2
7534207|NCT03368170|18547515|P2|COMPLETED|Overall Study||35
7534208|NCT03368170|18547516|P1|COMPLETED|Overall Study||37
7534209|NCT03368170|18547515|P2|STARTED|Overall Study||36
7534210|NCT03368170|18547516|P1|STARTED|Overall Study||39
7534211|NCT03368053|18547528|P1|NOT COMPLETED|Overall Study||0
7534212|NCT03368053|18547528|P1|COMPLETED|Overall Study||36
7534213|NCT03368053|18547528|P1|STARTED|Overall Study||36
7534214|NCT03366207|18547543|P1|NOT COMPLETED|Overall Study||8
7534215|NCT03366207|18547543|P1|COMPLETED|Overall Study||242
7534216|NCT03366207|18547543|P1|STARTED|Overall Study||250
7534217|NCT03365934|18547548|P1|NOT COMPLETED|Overall Study||2
7534218|NCT03365934|18547548|P1|COMPLETED|Overall Study||33
7534219|NCT03365934|18547548|P1|STARTED|Overall Study||35
7534220|NCT03365778|18547824|P3|NOT COMPLETED|Overall Study||0
7534221|NCT03365778|18547825|P2|NOT COMPLETED|Overall Study||0
7534222|NCT03365778|18547826|P1|NOT COMPLETED|Overall Study||0
7534223|NCT03365778|18547824|P3|COMPLETED|Overall Study||53
7534224|NCT03365778|18547825|P2|COMPLETED|Overall Study||17
7534225|NCT03365778|18547826|P1|COMPLETED|Overall Study||16
7534226|NCT03365778|18547824|P3|STARTED|Overall Study||53
7534227|NCT03365778|18547825|P2|STARTED|Overall Study||17
7534228|NCT03365778|18547826|P1|STARTED|Overall Study||16
7534229|NCT03365011|18547838|P2|NOT COMPLETED|Overall Study||2
7534230|NCT03365011|18547839|P1|NOT COMPLETED|Overall Study||1
7534231|NCT03365011|18547838|P2|COMPLETED|Overall Study||18
7534232|NCT03365011|18547839|P1|COMPLETED|Overall Study||19
7534233|NCT03365011|18547838|P2|STARTED|Overall Study||20
7534234|NCT03365011|18547839|P1|STARTED|Overall Study||20
7534235|NCT03364608|18547849|P1|NOT COMPLETED|Overall Study||8
7534236|NCT03364608|18547849|P1|COMPLETED|Overall Study||78
7534237|NCT03364608|18547849|P1|Proventil 180 µg|Overall Study||79
7534238|NCT03364608|18547849|P1|Proventil 90 µg|Overall Study||82
7534239|NCT03364608|18547849|P1|AS MDI 180 µg|Overall Study||81
7534240|NCT03364608|18547849|P1|AS MDI 90 µg|Overall Study||81
7534241|NCT03364608|18547849|P1|Placebo MDI|Overall Study||82
7534242|NCT03364608|18547849|P1|STARTED|Overall Study||86
7534243|NCT03364335|18547876|P5|NOT COMPLETED|Overall Study||11
7534244|NCT03364335|18547877|P4|NOT COMPLETED|Overall Study||13
7534245|NCT03364335|18547878|P3|NOT COMPLETED|Overall Study||11
7534246|NCT03364335|18547879|P2|NOT COMPLETED|Overall Study||11
7534247|NCT03364335|18547880|P1|NOT COMPLETED|Overall Study||10
7534248|NCT03364335|18547876|P5|COMPLETED|Overall Study||41
7534249|NCT03364335|18547877|P4|COMPLETED|Overall Study||37
7534250|NCT03364335|18547878|P3|COMPLETED|Overall Study||42
7534251|NCT03364335|18547879|P2|COMPLETED|Overall Study||40
7534252|NCT03364335|18547880|P1|COMPLETED|Overall Study||42
7534253|NCT03364335|18547876|P5|STARTED|Overall Study||52
7534254|NCT03364335|18547877|P4|STARTED|Overall Study||50
7534255|NCT03364335|18547878|P3|STARTED|Overall Study||53
7534256|NCT03364335|18547879|P2|STARTED|Overall Study||51
7534257|NCT03364335|18547880|P1|STARTED|Overall Study||52
7534258|NCT03364192|18547952|P1|NOT COMPLETED|Overall Study||16
7534259|NCT03364192|18547952|P1|COMPLETED|Overall Study||12
7534260|NCT03364192|18547952|P1|STARTED|Overall Study||28
7534261|NCT03364023|18547959|P1|NOT COMPLETED|Overall Study||17
7534262|NCT03364023|18547959|P1|COMPLETED|Overall Study||166
7534263|NCT03364023|18547959|P1|STARTED|Overall Study||183
7534264|NCT03363906|18547966|P2|NOT COMPLETED|Period 2 (Test or Reference)||1
7534265|NCT03363906|18547967|P1|NOT COMPLETED|Period 2 (Test or Reference)||4
7534266|NCT03363906|18547966|P2|COMPLETED|Period 2 (Test or Reference)||9
7534267|NCT03363906|18547967|P1|COMPLETED|Period 2 (Test or Reference)||10
7534268|NCT03363906|18547966|P2|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||9
7534269|NCT03363906|18547967|P1|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||12
7534270|NCT03363906|18547966|P2|STARTED|Period 2 (Test or Reference)||10
7534271|NCT03363906|18547967|P1|STARTED|Period 2 (Test or Reference)||14
7534272|NCT03363906|18547966|P2|NOT COMPLETED|Period 1 (Reference or Test)||2
7534273|NCT03363906|18547967|P1|NOT COMPLETED|Period 1 (Reference or Test)||1
7534274|NCT03363906|18547966|P2|COMPLETED|Period 1 (Reference or Test)||10
7534275|NCT03363906|18547967|P1|COMPLETED|Period 1 (Reference or Test)||14
7534276|NCT03363906|18547966|P2|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||11
7534277|NCT03363906|18547967|P1|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||15
7534278|NCT03363906|18547966|P2|STARTED|Period 1 (Reference or Test)||12
7534279|NCT03363906|18547967|P1|STARTED|Period 1 (Reference or Test)||15
7534280|NCT03363776|18547978|P3|NOT COMPLETED|Overall Study||2
7534281|NCT03363776|18547979|P2|NOT COMPLETED|Overall Study||3
7534282|NCT03363776|18547980|P1|NOT COMPLETED|Overall Study||3
7534283|NCT03363776|18547978|P3|COMPLETED|Overall Study||1
7534284|NCT03363776|18547979|P2|COMPLETED|Overall Study||0
7534285|NCT03363776|18547980|P1|COMPLETED|Overall Study||1
7534286|NCT03363776|18547978|P3|STARTED|Overall Study||3
7534287|NCT03363776|18547979|P2|STARTED|Overall Study||3
7534288|NCT03363776|18547980|P1|STARTED|Overall Study||4
7534289|NCT03363633|18548072|P1|NOT COMPLETED|Overall Study||12
7534290|NCT03363633|18548072|P1|COMPLETED|Overall Study|See note in Pre-Assignment Details|0
7534291|NCT03363633|18548072|P1|STARTED|Overall Study||12
7534292|NCT03362944|18548080|P2|NOT COMPLETED|Second Intervention||0
7534293|NCT03362944|18548081|P1|NOT COMPLETED|Second Intervention||0
7534294|NCT03362944|18548080|P2|COMPLETED|Second Intervention||8
7534295|NCT03362944|18548081|P1|COMPLETED|Second Intervention||8
7534296|NCT03362944|18548080|P2|STARTED|Second Intervention||8
7534297|NCT03362944|18548081|P1|STARTED|Second Intervention||8
7534298|NCT03362944|18548080|P2|NOT COMPLETED|Single Week Washout Period||0
7534299|NCT03362944|18548081|P1|NOT COMPLETED|Single Week Washout Period||0
7534300|NCT03362944|18548080|P2|COMPLETED|Single Week Washout Period||8
7534301|NCT03362944|18548081|P1|COMPLETED|Single Week Washout Period||8
7534302|NCT03362944|18548080|P2|STARTED|Single Week Washout Period||8
7534303|NCT03362944|18548081|P1|STARTED|Single Week Washout Period||8
7534304|NCT03362944|18548080|P2|NOT COMPLETED|First Intervention||0
7534305|NCT03362944|18548081|P1|NOT COMPLETED|First Intervention||0
7534306|NCT03362944|18548080|P2|COMPLETED|First Intervention||8
7534307|NCT03362944|18548081|P1|COMPLETED|First Intervention||8
7534308|NCT03362944|18548080|P2|STARTED|First Intervention||8
7534309|NCT03362944|18548081|P1|STARTED|First Intervention||8
7534310|NCT03362879|18548097|P1|NOT COMPLETED|Overall Study||0
7534311|NCT03362879|18548097|P1|COMPLETED|Overall Study||409
7534312|NCT03362879|18548097|P1|STARTED|Overall Study||409
7534313|NCT03361917|18548115|P2|NOT COMPLETED|Overall Study||0
7534314|NCT03361917|18548116|P1|NOT COMPLETED|Overall Study||0
7534315|NCT03361917|18548115|P2|COMPLETED|Overall Study||101
7534316|NCT03361917|18548116|P1|COMPLETED|Overall Study||99
7534317|NCT03361917|18548115|P2|STARTED|Overall Study||101
7534318|NCT03361917|18548116|P1|STARTED|Overall Study||99
7534319|NCT03361865|18548134|P2|NOT COMPLETED|Overall Study||49
7534320|NCT03361865|18548135|P1|NOT COMPLETED|Overall Study||43
7534321|NCT03361865|18548134|P2|COMPLETED|Overall Study||0
7534322|NCT03361865|18548135|P1|COMPLETED|Overall Study||1
7534323|NCT03361865|18548134|P2|All Participants as Treated (APaT)|Overall Study||49
7534324|NCT03361865|18548135|P1|All Participants as Treated (APaT)|Overall Study||43
7534325|NCT03361865|18548134|P2|Intention-to-Treat (ITT)|Overall Study||49
7534326|NCT03361865|18548135|P1|Intention-to-Treat (ITT)|Overall Study||44
7534327|NCT03361865|18548134|P2|STARTED|Overall Study||49
7534328|NCT03361865|18548135|P1|STARTED|Overall Study||44
7534329|NCT03361605|18548145|P1|NOT COMPLETED|Overall Study||3
7534330|NCT03361605|18548145|P1|COMPLETED|Overall Study||26
7534331|NCT03361605|18548145|P1|STARTED|Overall Study||29
7534332|NCT03361228|18548152|P2|NOT COMPLETED|Overall Study||1
7534333|NCT03361228|18548153|P1|NOT COMPLETED|Overall Study||4
7534334|NCT03361228|18548152|P2|COMPLETED|Overall Study||0
7534335|NCT03361228|18548153|P1|COMPLETED|Overall Study||0
7534336|NCT03361228|18548152|P2|STARTED|Overall Study||1
7534337|NCT03361228|18548153|P1|STARTED|Overall Study||4
7534338|NCT03361176|18548175|P2|NOT COMPLETED|Overall Study||5
7534339|NCT03361176|18548176|P1|NOT COMPLETED|Overall Study||1
7534340|NCT03361176|18548175|P2|COMPLETED|Overall Study||15
7534341|NCT03361176|18548176|P1|COMPLETED|Overall Study||9
7534342|NCT03361176|18548175|P2|STARTED|Overall Study||20
7534343|NCT03361176|18548176|P1|STARTED|Overall Study||10
7534344|NCT03360903|18548188|P2|NOT COMPLETED|Second Intervention||0
7534345|NCT03360903|18548189|P1|NOT COMPLETED|Second Intervention||0
7534346|NCT03360903|18548188|P2|COMPLETED|Second Intervention||4
7534347|NCT03360903|18548189|P1|COMPLETED|Second Intervention||4
7534348|NCT03360903|18548188|P2|STARTED|Second Intervention||4
7534349|NCT03360903|18548189|P1|STARTED|Second Intervention||4
7534350|NCT03360903|18548188|P2|NOT COMPLETED|Washout (2 Weeks)||0
7534351|NCT03360903|18548189|P1|NOT COMPLETED|Washout (2 Weeks)||0
7534352|NCT03360903|18548188|P2|COMPLETED|Washout (2 Weeks)||4
7534353|NCT03360903|18548189|P1|COMPLETED|Washout (2 Weeks)||4
7534354|NCT03360903|18548188|P2|STARTED|Washout (2 Weeks)||4
7534355|NCT03360903|18548189|P1|STARTED|Washout (2 Weeks)||4
7534356|NCT03360903|18548188|P2|NOT COMPLETED|First Intervention||0
7534357|NCT03360903|18548189|P1|NOT COMPLETED|First Intervention||0
7534358|NCT03360903|18548188|P2|COMPLETED|First Intervention||4
7534359|NCT03360903|18548189|P1|COMPLETED|First Intervention||4
7534360|NCT03360903|18548188|P2|STARTED|First Intervention||4
7534361|NCT03360903|18548189|P1|STARTED|First Intervention||4
7534362|NCT03360344|18548210|P3|NOT COMPLETED|Overall Study||1
7534363|NCT03360344|18548211|P2|NOT COMPLETED|Overall Study||1
7534364|NCT03360344|18548212|P1|NOT COMPLETED|Overall Study||0
7534365|NCT03360344|18548210|P3|COMPLETED|Overall Study||12
7534366|NCT03360344|18548211|P2|COMPLETED|Overall Study||15
7534367|NCT03360344|18548212|P1|COMPLETED|Overall Study||15
7534368|NCT03360344|18548210|P3|STARTED|Overall Study||13
7534369|NCT03360344|18548211|P2|STARTED|Overall Study||16
7534370|NCT03360344|18548212|P1|STARTED|Overall Study||15
7534371|NCT03360110|18548232|P2|NOT COMPLETED|Second Intervention||0
7534372|NCT03360110|18548233|P1|NOT COMPLETED|Second Intervention||0
7534373|NCT03360110|18548232|P2|COMPLETED|Second Intervention||26
7534374|NCT03360110|18548233|P1|COMPLETED|Second Intervention||27
7534375|NCT03360110|18548232|P2|STARTED|Second Intervention||26
7534376|NCT03360110|18548233|P1|STARTED|Second Intervention||27
7534377|NCT03360110|18548232|P2|NOT COMPLETED|First Intervention||0
7534378|NCT03360110|18548233|P1|NOT COMPLETED|First Intervention||0
7534379|NCT03360110|18548232|P2|COMPLETED|First Intervention||26
7534380|NCT03360110|18548233|P1|COMPLETED|First Intervention||27
7534381|NCT03360110|18548232|P2|STARTED|First Intervention||26
7534382|NCT03360110|18548233|P1|STARTED|First Intervention||27
7534383|NCT03360071|18548275|P2|NOT COMPLETED|Overall Study||0
7534384|NCT03360071|18548276|P1|NOT COMPLETED|Overall Study||1
7534385|NCT03360071|18548275|P2|COMPLETED|Overall Study||14
7534386|NCT03360071|18548276|P1|COMPLETED|Overall Study||16
7534387|NCT03360071|18548275|P2|STARTED|Overall Study||14
7534388|NCT03360071|18548276|P1|STARTED|Overall Study||17
7534389|NCT03359850|18548290|P2|NOT COMPLETED|Extension Phase (Up to 18 Months)||7
7534390|NCT03359850|18548291|P1|NOT COMPLETED|Extension Phase (Up to 18 Months)||8
7534391|NCT03359850|18548290|P2|COMPLETED|Extension Phase (Up to 18 Months)||0
7534392|NCT03359850|18548291|P1|COMPLETED|Extension Phase (Up to 18 Months)||0
7534393|NCT03359850|18548290|P2|STARTED|Extension Phase (Up to 18 Months)||7
7534394|NCT03359850|18548291|P1|STARTED|Extension Phase (Up to 18 Months)||8
7534395|NCT03359850|18548290|P2|NOT COMPLETED|PK Phase (Up to Day 8)||1
7534396|NCT03359850|18548291|P1|NOT COMPLETED|PK Phase (Up to Day 8)||1
7534397|NCT03359850|18548290|P2|COMPLETED|PK Phase (Up to Day 8)||7
7534398|NCT03359850|18548291|P1|COMPLETED|PK Phase (Up to Day 8)||8
7534399|NCT03359850|18548290|P2|STARTED|PK Phase (Up to Day 8)||8
7534400|NCT03359850|18548291|P1|STARTED|PK Phase (Up to Day 8)||9
7534401|NCT03359629|18548363|P2|NOT COMPLETED|Overall Study||0
7534402|NCT03359629|18548364|P1|NOT COMPLETED|Overall Study||0
7534403|NCT03359629|18548363|P2|COMPLETED|Overall Study||10
7534404|NCT03359629|18548364|P1|COMPLETED|Overall Study||200
7534405|NCT03359629|18548363|P2|STARTED|Overall Study||10
7534406|NCT03359629|18548364|P1|STARTED|Overall Study||200
7534407|NCT03359473|18548374|P4|NOT COMPLETED|Overall Study||5
7534408|NCT03359473|18548375|P3|NOT COMPLETED|Overall Study||6
7534409|NCT03359473|18548376|P2|NOT COMPLETED|Overall Study||6
7534410|NCT03359473|18548377|P1|NOT COMPLETED|Overall Study||2
7534411|NCT03359473|18548374|P4|COMPLETED|Overall Study||20
7534412|NCT03359473|18548375|P3|COMPLETED|Overall Study||18
7534413|NCT03359473|18548376|P2|COMPLETED|Overall Study||18
7534414|NCT03359473|18548377|P1|COMPLETED|Overall Study||21
7534415|NCT03359473|18548374|P4|STARTED|Overall Study||25
7534416|NCT03359473|18548375|P3|STARTED|Overall Study||24
7534417|NCT03359473|18548376|P2|STARTED|Overall Study||24
7534418|NCT03359473|18548377|P1|STARTED|Overall Study||23
7534419|NCT03358576|18548589|P2|NOT COMPLETED|Overall Study||25
7534420|NCT03358576|18548590|P1|NOT COMPLETED|Overall Study||26
7534421|NCT03358576|18548589|P2|COMPLETED|Overall Study||311
7534422|NCT03358576|18548590|P1|COMPLETED|Overall Study||312
7534423|NCT03358576|18548589|P2|STARTED|Overall Study||336
7534424|NCT03358576|18548590|P1|STARTED|Overall Study||338
7534425|NCT03358472|18548601|P3|NOT COMPLETED|Overall Study||16
7534426|NCT03358472|18548602|P2|NOT COMPLETED|Overall Study||10
7534427|NCT03358472|18548603|P1|NOT COMPLETED|Overall Study||15
7534428|NCT03358472|18548601|P3|COMPLETED|Overall Study||19
7534429|NCT03358472|18548602|P2|COMPLETED|Overall Study||9
7534430|NCT03358472|18548603|P1|COMPLETED|Overall Study||20
7534431|NCT03358472|18548601|P3|All Participants as Treated (APaT)|Overall Study||34
7534432|NCT03358472|18548602|P2|All Participants as Treated (APaT)|Overall Study||19
7534433|NCT03358472|18548603|P1|All Participants as Treated (APaT)|Overall Study||34
7534434|NCT03358472|18548601|P3|Intention-to-Treat (ITT)|Overall Study||35
7534435|NCT03358472|18548602|P2|Intention-to-Treat (ITT)|Overall Study||19
7534436|NCT03358472|18548603|P1|Intention-to-Treat (ITT)|Overall Study||35
7534437|NCT03358472|18548601|P3|STARTED|Overall Study||35
7534438|NCT03358472|18548602|P2|STARTED|Overall Study||19
7534439|NCT03358472|18548603|P1|STARTED|Overall Study||35
7534440|NCT03358407|18548627|P10|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
7534441|NCT03358407|18548628|P9|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
7534442|NCT03358407|18548629|P8|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
7534443|NCT03358407|18548630|P7|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
7534444|NCT03358407|18548631|P6|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
7534445|NCT03358407|18548632|P5|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
7534446|NCT03358407|18548633|P4|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
7534447|NCT03358407|18548634|P3|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
7534448|NCT03358407|18548635|P2|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
7534449|NCT03358407|18548636|P1|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
7534450|NCT03358407|18548627|P10|COMPLETED|Part B: Overall Period (11 Weeks)||0
7534451|NCT03358407|18548628|P9|COMPLETED|Part B: Overall Period (11 Weeks)||0
7534452|NCT03358407|18548629|P8|COMPLETED|Part B: Overall Period (11 Weeks)||0
7534453|NCT03358407|18548630|P7|COMPLETED|Part B: Overall Period (11 Weeks)||0
7534454|NCT03358407|18548631|P6|COMPLETED|Part B: Overall Period (11 Weeks)||0
7534455|NCT03358407|18548632|P5|COMPLETED|Part B: Overall Period (11 Weeks)||0
7534456|NCT03358407|18548633|P4|COMPLETED|Part B: Overall Period (11 Weeks)||0
7534457|NCT03358407|18548634|P3|COMPLETED|Part B: Overall Period (11 Weeks)||0
7534458|NCT03358407|18548635|P2|COMPLETED|Part B: Overall Period (11 Weeks)||0
7534459|NCT03358407|18548636|P1|COMPLETED|Part B: Overall Period (11 Weeks)||0
7534460|NCT03358407|18548627|P10|STARTED|Part B: Overall Period (11 Weeks)||0
7534461|NCT03358407|18548628|P9|STARTED|Part B: Overall Period (11 Weeks)||0
7534462|NCT03358407|18548629|P8|STARTED|Part B: Overall Period (11 Weeks)||0
7534463|NCT03358407|18548630|P7|STARTED|Part B: Overall Period (11 Weeks)||0
7534464|NCT03358407|18548631|P6|STARTED|Part B: Overall Period (11 Weeks)||0
7534465|NCT03358407|18548632|P5|STARTED|Part B: Overall Period (11 Weeks)||0
7534466|NCT03358407|18548633|P4|STARTED|Part B: Overall Period (11 Weeks)||0
7534467|NCT03358407|18548634|P3|STARTED|Part B: Overall Period (11 Weeks)||0
7534468|NCT03358407|18548635|P2|STARTED|Part B: Overall Period (11 Weeks)||0
7534469|NCT03358407|18548636|P1|STARTED|Part B: Overall Period (11 Weeks)||0
7534470|NCT03358407|18548627|P10|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534471|NCT03358407|18548628|P9|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534472|NCT03358407|18548629|P8|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||6
7534473|NCT03358407|18548630|P7|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
7534474|NCT03358407|18548631|P6|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
7534475|NCT03358407|18548632|P5|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534476|NCT03358407|18548633|P4|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534477|NCT03358407|18548634|P3|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534478|NCT03358407|18548635|P2|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534479|NCT03358407|18548636|P1|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534480|NCT03358407|18548627|P10|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534481|NCT03358407|18548628|P9|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534482|NCT03358407|18548629|P8|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534483|NCT03358407|18548630|P7|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534484|NCT03358407|18548631|P6|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534485|NCT03358407|18548632|P5|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534486|NCT03358407|18548633|P4|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534487|NCT03358407|18548634|P3|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534488|NCT03358407|18548635|P2|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534489|NCT03358407|18548636|P1|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534490|NCT03358407|18548627|P10|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534491|NCT03358407|18548628|P9|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534492|NCT03358407|18548629|P8|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: GSK 200mg/GSK 400mg arm|6
7534493|NCT03358407|18548630|P7|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|1 participant was added to Part A-Cohort 2: GSK 200mg/ Placebo arm|3
7534494|NCT03358407|18548631|P6|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: Placebo/GSK 400mg arm|3
7534495|NCT03358407|18548632|P5|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534496|NCT03358407|18548633|P4|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534497|NCT03358407|18548634|P3|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534498|NCT03358407|18548635|P2|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534499|NCT03358407|18548636|P1|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
7534500|NCT03358407|18548627|P10|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534501|NCT03358407|18548628|P9|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534502|NCT03358407|18548629|P8|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
7534503|NCT03358407|18548630|P7|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||1
7534504|NCT03358407|18548631|P6|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
7534505|NCT03358407|18548632|P5|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534506|NCT03358407|18548633|P4|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534507|NCT03358407|18548634|P3|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534508|NCT03358407|18548635|P2|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534509|NCT03358407|18548636|P1|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534510|NCT03358407|18548627|P10|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534511|NCT03358407|18548628|P9|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534512|NCT03358407|18548629|P8|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
7534513|NCT03358407|18548630|P7|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||2
7534514|NCT03358407|18548631|P6|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534515|NCT03358407|18548632|P5|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534516|NCT03358407|18548633|P4|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534517|NCT03358407|18548634|P3|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534518|NCT03358407|18548635|P2|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534519|NCT03358407|18548636|P1|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534520|NCT03358407|18548627|P10|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534521|NCT03358407|18548628|P9|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534522|NCT03358407|18548629|P8|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||6
7534523|NCT03358407|18548630|P7|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
7534524|NCT03358407|18548631|P6|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
7534525|NCT03358407|18548632|P5|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534526|NCT03358407|18548633|P4|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534527|NCT03358407|18548634|P3|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534528|NCT03358407|18548635|P2|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534529|NCT03358407|18548636|P1|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
7534530|NCT03358407|18548627|P10|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
7534531|NCT03358407|18548628|P9|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
7534532|NCT03358407|18548629|P8|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
7534533|NCT03358407|18548630|P7|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
7534534|NCT03358407|18548631|P6|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
7534535|NCT03358407|18548632|P5|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
7534536|NCT03358407|18548633|P4|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
7534537|NCT03358407|18548634|P3|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
7534538|NCT03358407|18548635|P2|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
7534539|NCT03358407|18548636|P1|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
7534540|NCT03358407|18548627|P10|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
7534541|NCT03358407|18548628|P9|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
7534542|NCT03358407|18548629|P8|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
7534543|NCT03358407|18548630|P7|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
7534544|NCT03358407|18548631|P6|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
7534545|NCT03358407|18548632|P5|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
7534546|NCT03358407|18548633|P4|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
7534547|NCT03358407|18548634|P3|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
7534548|NCT03358407|18548635|P2|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
7534549|NCT03358407|18548636|P1|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
7534550|NCT03358407|18548627|P10|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
7534551|NCT03358407|18548628|P9|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
7534552|NCT03358407|18548629|P8|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
7534553|NCT03358407|18548630|P7|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
7534554|NCT03358407|18548631|P6|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
7534555|NCT03358407|18548632|P5|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/GSK 10mg/GSK 30mg/Placebo arm|2
7534556|NCT03358407|18548633|P4|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
7534557|NCT03358407|18548634|P3|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
7534558|NCT03358407|18548635|P2|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
7534559|NCT03358407|18548636|P1|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
7534560|NCT03358407|18548627|P10|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
7534561|NCT03358407|18548628|P9|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
7534562|NCT03358407|18548629|P8|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
7534563|NCT03358407|18548630|P7|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
7534564|NCT03358407|18548631|P6|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
7534565|NCT03358407|18548632|P5|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
7534566|NCT03358407|18548633|P4|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
7534567|NCT03358407|18548634|P3|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
7534568|NCT03358407|18548635|P2|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
7534569|NCT03358407|18548636|P1|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
7534570|NCT03358407|18548627|P10|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
7534571|NCT03358407|18548628|P9|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
7534572|NCT03358407|18548629|P8|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
7534573|NCT03358407|18548630|P7|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
7534574|NCT03358407|18548631|P6|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
7534575|NCT03358407|18548632|P5|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
7534576|NCT03358407|18548633|P4|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
7534577|NCT03358407|18548634|P3|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
7534578|NCT03358407|18548635|P2|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
7534579|NCT03358407|18548636|P1|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
7534580|NCT03358407|18548627|P10|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
7534581|NCT03358407|18548628|P9|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
7534582|NCT03358407|18548629|P8|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
7534583|NCT03358407|18548630|P7|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
7534584|NCT03358407|18548631|P6|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
7534585|NCT03358407|18548632|P5|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
7534586|NCT03358407|18548633|P4|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
7534587|NCT03358407|18548634|P3|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
7534588|NCT03358407|18548635|P2|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
7534589|NCT03358407|18548636|P1|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
7534590|NCT03358407|18548627|P10|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
7534591|NCT03358407|18548628|P9|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
7534592|NCT03358407|18548629|P8|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
7534593|NCT03358407|18548630|P7|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
7534594|NCT03358407|18548631|P6|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
7534595|NCT03358407|18548632|P5|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
7534596|NCT03358407|18548633|P4|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
7534597|NCT03358407|18548634|P3|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
7534598|NCT03358407|18548635|P2|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
7534599|NCT03358407|18548636|P1|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
7534600|NCT03358407|18548627|P10|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
7534601|NCT03358407|18548628|P9|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
7534602|NCT03358407|18548629|P8|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
7534603|NCT03358407|18548630|P7|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
7534604|NCT03358407|18548631|P6|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
7534605|NCT03358407|18548632|P5|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
7534606|NCT03358407|18548633|P4|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
7534607|NCT03358407|18548634|P3|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
7534608|NCT03358407|18548635|P2|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
7534609|NCT03358407|18548636|P1|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
7534610|NCT03358407|18548627|P10|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
7534611|NCT03358407|18548628|P9|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
7534612|NCT03358407|18548629|P8|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
7534613|NCT03358407|18548630|P7|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
7534614|NCT03358407|18548631|P6|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
7534615|NCT03358407|18548632|P5|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
7534616|NCT03358407|18548633|P4|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
7534617|NCT03358407|18548634|P3|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/Placebo/GSK 30mg/GSK 100mg arm|2
7534618|NCT03358407|18548635|P2|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
7534619|NCT03358407|18548636|P1|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
7534620|NCT03358407|18548627|P10|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
7534621|NCT03358407|18548628|P9|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
7534622|NCT03358407|18548629|P8|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
7534623|NCT03358407|18548630|P7|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
7534624|NCT03358407|18548631|P6|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
7534625|NCT03358407|18548632|P5|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
7534626|NCT03358407|18548633|P4|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
7534627|NCT03358407|18548634|P3|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
7534628|NCT03358407|18548635|P2|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
7534629|NCT03358407|18548636|P1|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
7534630|NCT03358407|18548627|P10|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
7534631|NCT03358407|18548628|P9|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
7534632|NCT03358407|18548629|P8|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
7534633|NCT03358407|18548630|P7|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
7534634|NCT03358407|18548631|P6|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
7534635|NCT03358407|18548632|P5|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
7534636|NCT03358407|18548633|P4|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
7534637|NCT03358407|18548634|P3|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
7534638|NCT03358407|18548635|P2|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
7534639|NCT03358407|18548636|P1|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
7534640|NCT03358407|18548627|P10|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
7534641|NCT03358407|18548628|P9|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
7534642|NCT03358407|18548629|P8|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
7534643|NCT03358407|18548630|P7|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
7534644|NCT03358407|18548631|P6|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
7534645|NCT03358407|18548632|P5|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
7534646|NCT03358407|18548633|P4|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
7534647|NCT03358407|18548634|P3|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
7534648|NCT03358407|18548635|P2|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
7534649|NCT03358407|18548636|P1|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
7534650|NCT03358407|18548627|P10|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
7534651|NCT03358407|18548628|P9|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
7534652|NCT03358407|18548629|P8|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
7534653|NCT03358407|18548630|P7|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
7534654|NCT03358407|18548631|P6|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
7534655|NCT03358407|18548632|P5|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
7534656|NCT03358407|18548633|P4|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
7534657|NCT03358407|18548634|P3|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
7534658|NCT03358407|18548635|P2|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
7534659|NCT03358407|18548636|P1|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
7534660|NCT03358407|18548627|P10|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
7534661|NCT03358407|18548628|P9|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
7534662|NCT03358407|18548629|P8|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
7534663|NCT03358407|18548630|P7|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
7534664|NCT03358407|18548631|P6|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
7534665|NCT03358407|18548632|P5|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
7534666|NCT03358407|18548633|P4|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
7534667|NCT03358407|18548634|P3|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
7534668|NCT03358407|18548635|P2|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
7534669|NCT03358407|18548636|P1|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
7534670|NCT03358407|18548627|P10|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
7534671|NCT03358407|18548628|P9|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
7534672|NCT03358407|18548629|P8|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
7534673|NCT03358407|18548630|P7|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
7534674|NCT03358407|18548631|P6|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
7534675|NCT03358407|18548632|P5|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
7534676|NCT03358407|18548633|P4|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
7534677|NCT03358407|18548634|P3|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
7534678|NCT03358407|18548635|P2|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
7534679|NCT03358407|18548636|P1|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
7534680|NCT03358355|18548898|P1|NOT COMPLETED|Overall Study||0
7534681|NCT03358355|18548898|P1|COMPLETED|Overall Study||9
7534682|NCT03358355|18548898|P1|STARTED|Overall Study||9
7534683|NCT03358329|18548913|P1|NOT COMPLETED|Overall Study||4
7534684|NCT03358329|18548913|P1|COMPLETED|Overall Study||46
7534685|NCT03358329|18548913|P1|STARTED|Overall Study||50
7534686|NCT03358251|18548919|P1|NOT COMPLETED|Overall Study||0
7534687|NCT03358251|18548919|P1|COMPLETED|Overall Study||34
7534688|NCT03358251|18548919|P1|STARTED|Overall Study||34
7534689|NCT03358238|18548944|P2|NOT COMPLETED|Overall Study||1
7534690|NCT03358238|18548945|P1|NOT COMPLETED|Overall Study||0
7534691|NCT03358238|18548944|P2|COMPLETED|Overall Study||24
7534692|NCT03358238|18548945|P1|COMPLETED|Overall Study||23
7534693|NCT03358238|18548944|P2|STARTED|Overall Study||25
7534694|NCT03358238|18548945|P1|STARTED|Overall Study||23
7534695|NCT03358147|18548965|P5|NOT COMPLETED|Overall Study||14
7534696|NCT03358147|18548966|P4|NOT COMPLETED|Overall Study||36
7534697|NCT03358147|18548967|P3|NOT COMPLETED|Overall Study||34
7534698|NCT03358147|18548968|P2|NOT COMPLETED|Overall Study||39
7534699|NCT03358147|18548969|P1|NOT COMPLETED|Overall Study||34
7534700|NCT03358147|18548965|P5|COMPLETED|Overall Study||105
7534701|NCT03358147|18548966|P4|COMPLETED|Overall Study||201
7534702|NCT03358147|18548967|P3|COMPLETED|Overall Study||206
7534703|NCT03358147|18548968|P2|COMPLETED|Overall Study||201
7534704|NCT03358147|18548969|P1|COMPLETED|Overall Study||201
7534705|NCT03358147|18548965|P5|STARTED|Overall Study||119
7534706|NCT03358147|18548966|P4|STARTED|Overall Study||237
7534707|NCT03358147|18548967|P3|STARTED|Overall Study||240
7534708|NCT03358147|18548968|P2|STARTED|Overall Study||240
7534709|NCT03358147|18548969|P1|STARTED|Overall Study||235
7534710|NCT03357952|18549008|P2|NOT COMPLETED|Overall Study||1
7534711|NCT03357952|18549009|P1|NOT COMPLETED|Overall Study||9
7534712|NCT03357952|18549008|P2|COMPLETED|Overall Study||0
7534713|NCT03357952|18549009|P1|COMPLETED|Overall Study||0
7534714|NCT03357952|18549008|P2|STARTED|Overall Study||1
7534715|NCT03357952|18549009|P1|STARTED|Overall Study||9
7534716|NCT03357731|18549016|P6|NOT COMPLETED|Overall Study||1
7534717|NCT03357731|18549017|P5|NOT COMPLETED|Overall Study||1
7534718|NCT03357731|18549018|P4|NOT COMPLETED|Overall Study||3
7534719|NCT03357731|18549019|P3|NOT COMPLETED|Overall Study||1
7534720|NCT03357731|18549020|P2|NOT COMPLETED|Overall Study||0
7534721|NCT03357731|18549021|P1|NOT COMPLETED|Overall Study||0
7534722|NCT03357731|18549016|P6|COMPLETED|Overall Study||7
7534723|NCT03357731|18549017|P5|COMPLETED|Overall Study||7
7534724|NCT03357731|18549018|P4|COMPLETED|Overall Study||4
7534725|NCT03357731|18549019|P3|COMPLETED|Overall Study|1 discontinuation due to hypotension|6
7534726|NCT03357731|18549020|P2|COMPLETED|Overall Study||7
7534727|NCT03357731|18549021|P1|COMPLETED|Overall Study||8
7534728|NCT03357731|18549016|P6|Completed Period 2 (P2)|Overall Study|1 discontinued P2 due to an Adverse Event (AE)|7
7534729|NCT03357731|18549017|P5|Completed Period 2 (P2)|Overall Study|1 only completed P1, did not continue to P2/P3 (withdrew consent due to personal reasons)|7
7534730|NCT03357731|18549018|P4|Completed Period 2 (P2)|Overall Study|"1 completed P1, did not proceed to P2/P3 (lost to follow-up);
~1 discontinued P2 due to hypotension"|4
7534731|NCT03357731|18549019|P3|Completed Period 2 (P2)|Overall Study||7
7534732|NCT03357731|18549020|P2|Completed Period 2 (P2)|Overall Study||7
7534733|NCT03357731|18549021|P1|Completed Period 2 (P2)|Overall Study||8
7534734|NCT03357731|18549016|P6|Completed Period 1 (P1)|Overall Study||8
7534735|NCT03357731|18549017|P5|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to hypotension but resumed P2/P3|7
7534736|NCT03357731|18549018|P4|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to acute bradycardia and hypotension|6
7534737|NCT03357731|18549019|P3|Completed Period 1 (P1)|Overall Study||7
7534738|NCT03357731|18549020|P2|Completed Period 1 (P1)|Overall Study||7
7534739|NCT03357731|18549021|P1|Completed Period 1 (P1)|Overall Study|1 withdrew post-P1 completion/prior to P2 therapy due to acute cholecystitis, but returned for P2/P3|8
7534740|NCT03357731|18549016|P6|STARTED|Overall Study||8
7534741|NCT03357731|18549017|P5|STARTED|Overall Study||8
7534742|NCT03357731|18549018|P4|STARTED|Overall Study||7
7534743|NCT03357731|18549019|P3|STARTED|Overall Study||7
7534744|NCT03357731|18549020|P2|STARTED|Overall Study||7
7534745|NCT03357731|18549021|P1|STARTED|Overall Study||8
7534746|NCT03357614|18549049|P2|NOT COMPLETED|Overall Study||28
7534747|NCT03357614|18549050|P1|NOT COMPLETED|Overall Study||25
7534748|NCT03357614|18549049|P2|COMPLETED|Overall Study||670
7534749|NCT03357614|18549050|P1|COMPLETED|Overall Study||672
7534750|NCT03357614|18549049|P2|STARTED|Overall Study||698
7534751|NCT03357614|18549050|P1|STARTED|Overall Study||697
7534752|NCT03357471|18549060|P2|NOT COMPLETED|Overall Study||0
7534753|NCT03357471|18549061|P1|NOT COMPLETED|Overall Study||2
7534754|NCT03357471|18549060|P2|COMPLETED|Overall Study||32
7534755|NCT03357471|18549061|P1|COMPLETED|Overall Study||33
7534756|NCT03357471|18549060|P2|STARTED|Overall Study||32
7534757|NCT03357471|18549061|P1|STARTED|Overall Study||35
7534758|NCT03357341|18549087|P2|NOT COMPLETED|Overall Study||12
7534759|NCT03357341|18549088|P1|NOT COMPLETED|Overall Study||7
7534760|NCT03357341|18549087|P2|COMPLETED|Overall Study||86
7534761|NCT03357341|18549088|P1|COMPLETED|Overall Study||89
7534762|NCT03357341|18549087|P2|STARTED|Overall Study||98
7534763|NCT03357341|18549088|P1|STARTED|Overall Study||96
7534764|NCT03356977|18549128|P1|NOT COMPLETED|Overall Study||5
7534765|NCT03356977|18549128|P1|COMPLETED|Overall Study||132
7534766|NCT03356977|18549128|P1|STARTED|Overall Study||137
7534767|NCT03355820|18549140|P1|NOT COMPLETED|Overall Study||0
7534768|NCT03355820|18549140|P1|COMPLETED|Overall Study||227
7534769|NCT03355820|18549140|P1|STARTED|Overall Study||227
7534770|NCT03354754|18549153|P2|NOT COMPLETED|Overall Study||0
7534771|NCT03354754|18549154|P1|NOT COMPLETED|Overall Study||0
7534772|NCT03354754|18549153|P2|COMPLETED|Overall Study||1
7534773|NCT03354754|18549154|P1|COMPLETED|Overall Study||2
7534774|NCT03354754|18549153|P2|STARTED|Overall Study||1
7534775|NCT03354754|18549154|P1|STARTED|Overall Study||2
7534776|NCT03354663|18549176|P1|NOT COMPLETED|Completed 30-day Visit||2
7534777|NCT03354663|18549176|P1|COMPLETED|Completed 30-day Visit||149
7534778|NCT03354663|18549176|P1|STARTED|Completed 30-day Visit||151
7534779|NCT03354663|18549176|P1|NOT COMPLETED|Enrollment to Catheter Insertion||5
7534780|NCT03354663|18549176|P1|COMPLETED|Enrollment to Catheter Insertion||151
7534781|NCT03354663|18549176|P1|STARTED|Enrollment to Catheter Insertion||156
7534782|NCT03354637|18549203|P3|NOT COMPLETED|Open Label Extension||28
7534783|NCT03354637|18549204|P2|NOT COMPLETED|Open Label Extension||0
7534784|NCT03354637|18549205|P1|NOT COMPLETED|Open Label Extension||0
7534785|NCT03354637|18549203|P3|COMPLETED|Open Label Extension||33
7534786|NCT03354637|18549204|P2|COMPLETED|Open Label Extension||0
7534787|NCT03354637|18549205|P1|COMPLETED|Open Label Extension||0
7534788|NCT03354637|18549203|P3|STARTED|Open Label Extension||61
7534789|NCT03354637|18549204|P2|STARTED|Open Label Extension||0
7534790|NCT03354637|18549205|P1|STARTED|Open Label Extension||0
7534791|NCT03354637|18549203|P3|NOT COMPLETED|Double-blind Period||7
7534792|NCT03354637|18549204|P2|NOT COMPLETED|Double-blind Period||13
7534793|NCT03354637|18549205|P1|NOT COMPLETED|Double-blind Period||17
7534794|NCT03354637|18549203|P3|COMPLETED|Double-blind Period||35
7534795|NCT03354637|18549204|P2|COMPLETED|Double-blind Period||31
7534796|NCT03354637|18549205|P1|COMPLETED|Double-blind Period||26
7534797|NCT03354637|18549203|P3|STARTED|Double-blind Period||42
7534798|NCT03354637|18549204|P2|STARTED|Double-blind Period||44
7534799|NCT03354637|18549205|P1|STARTED|Double-blind Period||43
7534800|NCT03354598|18549264|P2|NOT COMPLETED|Overall Study||75
7534801|NCT03354598|18549265|P1|NOT COMPLETED|Overall Study||80
7534802|NCT03354598|18549264|P2|COMPLETED|Overall Study||761
7534803|NCT03354598|18549265|P1|COMPLETED|Overall Study||755
7534804|NCT03354598|18549264|P2|STARTED|Overall Study||836
7534805|NCT03354598|18549265|P1|STARTED|Overall Study||835
7534806|NCT03354429|18549279|P2|NOT COMPLETED|Overall Study||7
7534807|NCT03354429|18549280|P1|NOT COMPLETED|Overall Study||9
7534808|NCT03354429|18549279|P2|COMPLETED|Overall Study||5486
7534809|NCT03354429|18549280|P1|COMPLETED|Overall Study||5514
7534810|NCT03354429|18549279|P2|STARTED|Overall Study||5493
7534811|NCT03354429|18549280|P1|STARTED|Overall Study||5523
7534812|NCT03354325|18549300|P2|NOT COMPLETED|Overall Study||15
7534813|NCT03354325|18549301|P1|NOT COMPLETED|Overall Study||20
7534814|NCT03354325|18549300|P2|COMPLETED|Overall Study||138
7534815|NCT03354325|18549301|P1|COMPLETED|Overall Study||131
7534816|NCT03354325|18549300|P2|STARTED|Overall Study||153
7534817|NCT03354325|18549301|P1|STARTED|Overall Study||151
7534818|NCT03353922|18549331|P6|NOT COMPLETED|Overall Study||0
7534819|NCT03353922|18549332|P5|NOT COMPLETED|Overall Study||0
7534820|NCT03353922|18549333|P4|NOT COMPLETED|Overall Study||1
7534821|NCT03353922|18549334|P3|NOT COMPLETED|Overall Study||1
7534822|NCT03353922|18549335|P2|NOT COMPLETED|Overall Study||1
7534823|NCT03353922|18549336|P1|NOT COMPLETED|Overall Study||1
7534824|NCT03353922|18549331|P6|COMPLETED|Overall Study||6
7534825|NCT03353922|18549332|P5|COMPLETED|Overall Study||5
7534826|NCT03353922|18549333|P4|COMPLETED|Overall Study||5
7534827|NCT03353922|18549334|P3|COMPLETED|Overall Study||5
7534828|NCT03353922|18549335|P2|COMPLETED|Overall Study||5
7534829|NCT03353922|18549336|P1|COMPLETED|Overall Study||5
7534830|NCT03353922|18549331|P6|STARTED|Overall Study||6
7534831|NCT03353922|18549332|P5|STARTED|Overall Study||5
7534832|NCT03353922|18549333|P4|STARTED|Overall Study||6
7534833|NCT03353922|18549334|P3|STARTED|Overall Study||6
7534834|NCT03353922|18549335|P2|STARTED|Overall Study||6
7534835|NCT03353922|18549336|P1|STARTED|Overall Study||6
7534836|NCT03353246|18549353|P1|NOT COMPLETED|Overall Study||0
7534837|NCT03353246|18549353|P1|COMPLETED|Overall Study||500
7534838|NCT03353246|18549353|P1|STARTED|Overall Study||500
7534839|NCT03352882|18549370|P1|NOT COMPLETED|Overall Study||0
7534840|NCT03352882|18549370|P1|COMPLETED|Overall Study||1
7534841|NCT03352882|18549370|P1|STARTED|Overall Study||1
7534842|NCT03352713|18549378|P1|NOT COMPLETED|Overall Study||26
7534843|NCT03352713|18549378|P1|COMPLETED|Overall Study|Participants who completed at least 1 EMA for inclusion in data analysis|159
7534844|NCT03352713|18549378|P1|STARTED|Overall Study||185
7534845|NCT03352609|18549386|P2|NOT COMPLETED|Overall Study||0
7534846|NCT03352609|18549387|P1|NOT COMPLETED|Overall Study||0
7534847|NCT03352609|18549386|P2|COMPLETED|Overall Study||3
7534848|NCT03352609|18549387|P1|COMPLETED|Overall Study||2
7534849|NCT03352609|18549386|P2|STARTED|Overall Study||3
7534850|NCT03352609|18549387|P1|STARTED|Overall Study||2
7534851|NCT03352453|18549399|P2|NOT COMPLETED|Overall Study||32
7534852|NCT03352453|18549400|P1|NOT COMPLETED|Overall Study||22
7534853|NCT03352453|18549399|P2|COMPLETED|Overall Study||40
7534854|NCT03352453|18549400|P1|COMPLETED|Overall Study||44
7534855|NCT03352453|18549399|P2|STARTED|Overall Study||72
7534856|NCT03352453|18549400|P1|STARTED|Overall Study||66
7534857|NCT03351933|18549412|P1|NOT COMPLETED|Overall Study||2
7534858|NCT03351933|18549412|P1|COMPLETED|Overall Study||26
7534859|NCT03351933|18549412|P1|STARTED|Overall Study||28
7534860|NCT03351738|18549422|P6|NOT COMPLETED|Overall Study||0
7534861|NCT03351738|18549423|P5|NOT COMPLETED|Overall Study||0
7534862|NCT03351738|18549424|P4|NOT COMPLETED|Overall Study||1
7534863|NCT03351738|18549425|P3|NOT COMPLETED|Overall Study||0
7534864|NCT03351738|18549426|P2|NOT COMPLETED|Overall Study||1
7534865|NCT03351738|18549427|P1|NOT COMPLETED|Overall Study||0
7534866|NCT03351738|18549422|P6|COMPLETED|Overall Study||22
7534867|NCT03351738|18549423|P5|COMPLETED|Overall Study||21
7534868|NCT03351738|18549424|P4|COMPLETED|Overall Study||21
7534869|NCT03351738|18549425|P3|COMPLETED|Overall Study||24
7534870|NCT03351738|18549426|P2|COMPLETED|Overall Study||19
7534871|NCT03351738|18549427|P1|COMPLETED|Overall Study||23
7534872|NCT03351738|18549422|P6|STARTED|Overall Study||22
7534873|NCT03351738|18549423|P5|STARTED|Overall Study||21
7534874|NCT03351738|18549424|P4|STARTED|Overall Study||22
7534875|NCT03351738|18549425|P3|STARTED|Overall Study||24
7534876|NCT03351738|18549426|P2|STARTED|Overall Study||20
7534877|NCT03351738|18549427|P1|STARTED|Overall Study||23
7534878|NCT03351699|18549503|P5|NOT COMPLETED|Overall Study||0
7534879|NCT03351699|18549504|P4|NOT COMPLETED|Overall Study||0
7534880|NCT03351699|18549505|P3|NOT COMPLETED|Overall Study||0
7534881|NCT03351699|18549506|P2|NOT COMPLETED|Overall Study||0
7534882|NCT03351699|18549507|P1|NOT COMPLETED|Overall Study||0
7534969|NCT03349632|18549774|P4|NOT COMPLETED|Period 1, First Week of Wear||0
7534883|NCT03351699|18549503|P5|COMPLETED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
7534884|NCT03351699|18549504|P4|COMPLETED|Overall Study||6
7534885|NCT03351699|18549505|P3|COMPLETED|Overall Study||6
7534886|NCT03351699|18549506|P2|COMPLETED|Overall Study||6
7534887|NCT03351699|18549507|P1|COMPLETED|Overall Study||6
7534888|NCT03351699|18549503|P5|STARTED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
7534889|NCT03351699|18549504|P4|STARTED|Overall Study||6
7534890|NCT03351699|18549505|P3|STARTED|Overall Study||6
7534891|NCT03351699|18549506|P2|STARTED|Overall Study||6
7534892|NCT03351699|18549507|P1|STARTED|Overall Study||6
7534893|NCT03351335|18549579|P3|NOT COMPLETED|Overall Study||4
7534894|NCT03351335|18549580|P2|NOT COMPLETED|Overall Study||0
7534895|NCT03351335|18549581|P1|NOT COMPLETED|Overall Study||0
7534896|NCT03351335|18549579|P3|COMPLETED|Overall Study||16
7534897|NCT03351335|18549580|P2|COMPLETED|Overall Study||19
7534898|NCT03351335|18549581|P1|COMPLETED|Overall Study||21
7534899|NCT03351335|18549579|P3|STARTED|Overall Study||20
7534900|NCT03351335|18549580|P2|STARTED|Overall Study||19
7534901|NCT03351335|18549581|P1|STARTED|Overall Study||21
7534902|NCT03351231|18549601|P1|NOT COMPLETED|Safety Follow-Up Period||3
7534903|NCT03351231|18549601|P1|COMPLETED|Safety Follow-Up Period|Completed = Finishing safety follow-up and continuing in study|0
7534904|NCT03351231|18549601|P1|STARTED|Safety Follow-Up Period|Started = Initiated Safety Follow-up|3
7534905|NCT03351231|18549601|P1|NOT COMPLETED|Combination Therapy Period||5
7534906|NCT03351231|18549601|P1|COMPLETED|Combination Therapy Period|Completed = finished combination therapy|0
7534907|NCT03351231|18549601|P1|STARTED|Combination Therapy Period|Started = initiated and completed monotherapy, then initiated combination therapy|5
7534908|NCT03351101|18549625|P2|NOT COMPLETED|Overall Study||3
7534909|NCT03351101|18549626|P1|NOT COMPLETED|Overall Study||1
7534910|NCT03351101|18549625|P2|COMPLETED|Overall Study||129
7534911|NCT03351101|18549626|P1|COMPLETED|Overall Study||135
7534912|NCT03351101|18549625|P2|STARTED|Overall Study||132
7534913|NCT03351101|18549626|P1|STARTED|Overall Study||136
7534914|NCT03350984|18549636|P2|NOT COMPLETED|Overall Study||8
7534915|NCT03350984|18549637|P1|NOT COMPLETED|Overall Study||8
7534916|NCT03350984|18549636|P2|COMPLETED|Overall Study||28
7534917|NCT03350984|18549637|P1|COMPLETED|Overall Study||31
7534918|NCT03350984|18549636|P2|STARTED|Overall Study||36
7534919|NCT03350984|18549637|P1|STARTED|Overall Study||39
7534920|NCT03350919|18549649|P2|NOT COMPLETED|Overall Study||0
7534921|NCT03350919|18549650|P1|NOT COMPLETED|Overall Study||2
7534922|NCT03350919|18549649|P2|COMPLETED|Overall Study||23
7534923|NCT03350919|18549650|P1|COMPLETED|Overall Study||23
7534924|NCT03350919|18549649|P2|STARTED|Overall Study||23
7534925|NCT03350919|18549650|P1|STARTED|Overall Study||25
7534926|NCT03350724|18549660|P2|NOT COMPLETED|Overall Study||0
7534927|NCT03350724|18549661|P1|NOT COMPLETED|Overall Study||0
7534928|NCT03350724|18549660|P2|COMPLETED|Overall Study||17
7534929|NCT03350724|18549661|P1|COMPLETED|Overall Study||17
7534930|NCT03350724|18549660|P2|STARTED|Overall Study||17
7534931|NCT03350724|18549661|P1|STARTED|Overall Study||17
7534932|NCT03350503|18549715|P1|NOT COMPLETED|Overall Study||5
7534933|NCT03350503|18549715|P1|COMPLETED|Overall Study||116
7534934|NCT03350503|18549715|P1|STARTED|Overall Study||121
7534935|NCT03350256|18549719|P1|NOT COMPLETED|Overall Study||36
7534936|NCT03350256|18549719|P1|COMPLETED|Overall Study||24
7534937|NCT03350256|18549719|P1|6 Month Follow up|Overall Study||24
7534938|NCT03350256|18549719|P1|3 Month Follow up|Overall Study||27
7534939|NCT03350256|18549719|P1|1 Month Follow up|Overall Study||30
7534940|NCT03350256|18549719|P1|Permanent Implant|Overall Study|subjects that underwent permanent SCS implant|35
7534941|NCT03350256|18549719|P1|Spinal Cord Stimulation Trial|Overall Study|Subject that underwent SCS trial|50
7534942|NCT03350256|18549719|P1|STARTED|Overall Study||60
7534943|NCT03350217|18549741|P2|NOT COMPLETED|Overall Study||0
7534944|NCT03350217|18549742|P1|NOT COMPLETED|Overall Study||2
7534945|NCT03350217|18549741|P2|COMPLETED|Overall Study||81
7534946|NCT03350217|18549742|P1|COMPLETED|Overall Study||77
7534947|NCT03350217|18549741|P2|STARTED|Overall Study||81
7534948|NCT03350217|18549742|P1|STARTED|Overall Study||79
7534949|NCT03349632|18549772|P6|NOT COMPLETED|Period 2, Second Week of Wear||0
7534950|NCT03349632|18549773|P5|NOT COMPLETED|Period 2, Second Week of Wear||0
7534951|NCT03349632|18549774|P4|NOT COMPLETED|Period 2, Second Week of Wear||0
7534952|NCT03349632|18549775|P3|NOT COMPLETED|Period 2, Second Week of Wear||0
7534953|NCT03349632|18549776|P2|NOT COMPLETED|Period 2, Second Week of Wear||0
7534954|NCT03349632|18549777|P1|NOT COMPLETED|Period 2, Second Week of Wear||0
7534955|NCT03349632|18549772|P6|COMPLETED|Period 2, Second Week of Wear||11
7534956|NCT03349632|18549773|P5|COMPLETED|Period 2, Second Week of Wear||11
7534957|NCT03349632|18549774|P4|COMPLETED|Period 2, Second Week of Wear||11
7534958|NCT03349632|18549775|P3|COMPLETED|Period 2, Second Week of Wear||11
7534959|NCT03349632|18549776|P2|COMPLETED|Period 2, Second Week of Wear||11
7534960|NCT03349632|18549777|P1|COMPLETED|Period 2, Second Week of Wear||11
7534961|NCT03349632|18549772|P6|STARTED|Period 2, Second Week of Wear||11
7534962|NCT03349632|18549773|P5|STARTED|Period 2, Second Week of Wear||11
7534963|NCT03349632|18549774|P4|STARTED|Period 2, Second Week of Wear||11
7534964|NCT03349632|18549775|P3|STARTED|Period 2, Second Week of Wear||11
7534965|NCT03349632|18549776|P2|STARTED|Period 2, Second Week of Wear||11
7534966|NCT03349632|18549777|P1|STARTED|Period 2, Second Week of Wear||11
7534967|NCT03349632|18549772|P6|NOT COMPLETED|Period 1, First Week of Wear||0
7534968|NCT03349632|18549773|P5|NOT COMPLETED|Period 1, First Week of Wear||0
7534970|NCT03349632|18549775|P3|NOT COMPLETED|Period 1, First Week of Wear||0
7534971|NCT03349632|18549776|P2|NOT COMPLETED|Period 1, First Week of Wear||0
7534972|NCT03349632|18549777|P1|NOT COMPLETED|Period 1, First Week of Wear||0
7534973|NCT03349632|18549772|P6|COMPLETED|Period 1, First Week of Wear||11
7534974|NCT03349632|18549773|P5|COMPLETED|Period 1, First Week of Wear||11
7534975|NCT03349632|18549774|P4|COMPLETED|Period 1, First Week of Wear||11
7534976|NCT03349632|18549775|P3|COMPLETED|Period 1, First Week of Wear||11
7534977|NCT03349632|18549776|P2|COMPLETED|Period 1, First Week of Wear||11
7534978|NCT03349632|18549777|P1|COMPLETED|Period 1, First Week of Wear||11
7534979|NCT03349632|18549772|P6|STARTED|Period 1, First Week of Wear||11
7534980|NCT03349632|18549773|P5|STARTED|Period 1, First Week of Wear||11
7534981|NCT03349632|18549774|P4|STARTED|Period 1, First Week of Wear||11
7534982|NCT03349632|18549775|P3|STARTED|Period 1, First Week of Wear||11
7534983|NCT03349632|18549776|P2|STARTED|Period 1, First Week of Wear||11
7534984|NCT03349632|18549777|P1|STARTED|Period 1, First Week of Wear||11
7534985|NCT03349515|18549793|P2|NOT COMPLETED|Overall Study||1
7534986|NCT03349515|18549794|P1|NOT COMPLETED|Overall Study||5
7534987|NCT03349515|18549793|P2|COMPLETED|Overall Study||50
7534988|NCT03349515|18549794|P1|COMPLETED|Overall Study||50
7534989|NCT03349515|18549793|P2|STARTED|Overall Study||51
7534990|NCT03349515|18549794|P1|STARTED|Overall Study||55
7534991|NCT03349437|18549800|P3|NOT COMPLETED|Intervention||0
7534992|NCT03349437|18549801|P2|NOT COMPLETED|Intervention||0
7534993|NCT03349437|18549802|P1|NOT COMPLETED|Intervention||0
7534994|NCT03349437|18549800|P3|COMPLETED|Intervention||10
7534995|NCT03349437|18549801|P2|COMPLETED|Intervention||10
7534996|NCT03349437|18549802|P1|COMPLETED|Intervention||0
7534997|NCT03349437|18549800|P3|STARTED|Intervention||10
7534998|NCT03349437|18549801|P2|STARTED|Intervention||10
7534999|NCT03349437|18549802|P1|STARTED|Intervention||0
7535000|NCT03349437|18549800|P3|NOT COMPLETED|Screening||0
7535001|NCT03349437|18549801|P2|NOT COMPLETED|Screening||0
7535002|NCT03349437|18549802|P1|NOT COMPLETED|Screening||5
7535003|NCT03349437|18549800|P3|COMPLETED|Screening||0
7535004|NCT03349437|18549801|P2|COMPLETED|Screening||0
7535005|NCT03349437|18549802|P1|COMPLETED|Screening||20
7535006|NCT03349437|18549800|P3|STARTED|Screening||0
7535007|NCT03349437|18549801|P2|STARTED|Screening||0
7535008|NCT03349437|18549802|P1|STARTED|Screening||25
7535009|NCT03349333|18549809|P1|NOT COMPLETED|Overall Study||71
7535010|NCT03349333|18549809|P1|COMPLETED|Overall Study||0
7535011|NCT03349333|18549809|P1|STARTED|Overall Study||71
7535012|NCT03349099|18549832|P2|NOT COMPLETED|Overall Study||4
7535013|NCT03349099|18549833|P1|NOT COMPLETED|Overall Study||4
7535014|NCT03349099|18549832|P2|COMPLETED|Overall Study||43
7535015|NCT03349099|18549833|P1|COMPLETED|Overall Study||44
7535016|NCT03349099|18549832|P2|STARTED|Overall Study||47
7535017|NCT03349099|18549833|P1|STARTED|Overall Study||48
7535018|NCT03349060|18549846|P3|NOT COMPLETED|Overall Study||16
7535019|NCT03349060|18549847|P2|NOT COMPLETED|Overall Study||17
7535020|NCT03349060|18549848|P1|NOT COMPLETED|Overall Study||21
7535021|NCT03349060|18549846|P3|COMPLETED|Overall Study||61
7535022|NCT03349060|18549847|P2|COMPLETED|Overall Study||137
7535023|NCT03349060|18549848|P1|COMPLETED|Overall Study||135
7535024|NCT03349060|18549846|P3|STARTED|Overall Study||77
7535025|NCT03349060|18549847|P2|STARTED|Overall Study||154
7535026|NCT03349060|18549848|P1|STARTED|Overall Study||156
7535027|NCT03349034|18549989|P2|NOT COMPLETED|Overall Study||2
7535028|NCT03349034|18549990|P1|NOT COMPLETED|Overall Study||4
7535029|NCT03349034|18549989|P2|COMPLETED|Overall Study||10
7535030|NCT03349034|18549990|P1|COMPLETED|Overall Study||8
7535031|NCT03349034|18549989|P2|STARTED|Overall Study||12
7535032|NCT03349034|18549990|P1|STARTED|Overall Study||12
7535033|NCT03348904|18550011|P3|NOT COMPLETED|Overall Study||0
7535034|NCT03348904|18550012|P2|NOT COMPLETED|Overall Study||1
7535035|NCT03348904|18550013|P1|NOT COMPLETED|Overall Study||0
7535036|NCT03348904|18550011|P3|COMPLETED|Overall Study||0
7535037|NCT03348904|18550012|P2|COMPLETED|Overall Study||1
7535038|NCT03348904|18550013|P1|COMPLETED|Overall Study||0
7535039|NCT03348904|18550011|P3|STARTED|Overall Study||0
7535040|NCT03348904|18550012|P2|STARTED|Overall Study||2
7535041|NCT03348904|18550013|P1|STARTED|Overall Study||0
7535042|NCT03348683|18550032|P2|NOT COMPLETED|Overall Study||0
7535043|NCT03348683|18550033|P1|NOT COMPLETED|Overall Study||0
7535044|NCT03348683|18550032|P2|COMPLETED|Overall Study||119
7535045|NCT03348683|18550033|P1|COMPLETED|Overall Study||121
7535046|NCT03348683|18550032|P2|STARTED|Overall Study||119
7535047|NCT03348683|18550033|P1|STARTED|Overall Study||121
7535048|NCT03346902|18550057|P2|NOT COMPLETED|Overall Study||0
7535049|NCT03346902|18550058|P1|NOT COMPLETED|Overall Study||0
7535050|NCT03346902|18550057|P2|COMPLETED|Overall Study||8
7535051|NCT03346902|18550058|P1|COMPLETED|Overall Study||4
7535052|NCT03346902|18550057|P2|STARTED|Overall Study||8
7535053|NCT03346902|18550058|P1|STARTED|Overall Study||4
7535054|NCT03346850|18550066|P2|NOT COMPLETED|Overall Study||3
7535055|NCT03346850|18550067|P1|NOT COMPLETED|Overall Study||2
7535056|NCT03346850|18550066|P2|COMPLETED|Overall Study||17
7535057|NCT03346850|18550067|P1|COMPLETED|Overall Study||18
7535058|NCT03346850|18550066|P2|STARTED|Overall Study||20
7535059|NCT03346850|18550067|P1|STARTED|Overall Study||20
7535060|NCT03346759|18550089|P2|NOT COMPLETED|Third Menstrual Cycle||0
7535061|NCT03346759|18550090|P1|NOT COMPLETED|Third Menstrual Cycle||0
7535062|NCT03346759|18550089|P2|COMPLETED|Third Menstrual Cycle||10
7535063|NCT03346759|18550090|P1|COMPLETED|Third Menstrual Cycle||11
7535064|NCT03346759|18550089|P2|STARTED|Third Menstrual Cycle||10
7535065|NCT03346759|18550090|P1|STARTED|Third Menstrual Cycle||11
7535066|NCT03346759|18550089|P2|NOT COMPLETED|Second Menstrual Cycle||0
7535067|NCT03346759|18550090|P1|NOT COMPLETED|Second Menstrual Cycle||1
7535068|NCT03346759|18550089|P2|COMPLETED|Second Menstrual Cycle||10
7535069|NCT03346759|18550090|P1|COMPLETED|Second Menstrual Cycle||11
7535070|NCT03346759|18550089|P2|STARTED|Second Menstrual Cycle||10
7535071|NCT03346759|18550090|P1|STARTED|Second Menstrual Cycle||12
7535072|NCT03346759|18550089|P2|NOT COMPLETED|First Menstrual Cycle||0
7535073|NCT03346759|18550090|P1|NOT COMPLETED|First Menstrual Cycle||1
7535074|NCT03346759|18550089|P2|COMPLETED|First Menstrual Cycle||10
7535075|NCT03346759|18550090|P1|COMPLETED|First Menstrual Cycle||12
7535076|NCT03346759|18550089|P2|STARTED|First Menstrual Cycle||10
7535077|NCT03346759|18550090|P1|STARTED|First Menstrual Cycle||13
7535078|NCT03346759|18550089|P2|NOT COMPLETED|Enrollment to Baseline Data Collected||3
7535079|NCT03346759|18550090|P1|NOT COMPLETED|Enrollment to Baseline Data Collected||2
7535080|NCT03346759|18550089|P2|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon B First arm who provided at least one vaginal microbiota sample.|10
7535081|NCT03346759|18550090|P1|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon A First arm who provided at least one vaginal microbiota sample.|13
7535082|NCT03346759|18550089|P2|STARTED|Enrollment to Baseline Data Collected||13
7535083|NCT03346759|18550090|P1|STARTED|Enrollment to Baseline Data Collected||15
7535084|NCT03346161|18550101|P2|NOT COMPLETED|Overall Study||0
7535085|NCT03346161|18550102|P1|NOT COMPLETED|Overall Study||0
7535086|NCT03346161|18550101|P2|COMPLETED|Overall Study||60
7535087|NCT03346161|18550102|P1|COMPLETED|Overall Study||60
7535088|NCT03346161|18550101|P2|STARTED|Overall Study||60
7535089|NCT03346161|18550102|P1|STARTED|Overall Study||60
7535090|NCT03346070|18550135|P5|NOT COMPLETED|Overall Study||5
7535091|NCT03346070|18550136|P4|NOT COMPLETED|Overall Study||6
7535092|NCT03346070|18550137|P3|NOT COMPLETED|Overall Study||4
7535093|NCT03346070|18550138|P2|NOT COMPLETED|Overall Study||4
7535094|NCT03346070|18550139|P1|NOT COMPLETED|Overall Study||3
7535095|NCT03346070|18550135|P5|COMPLETED|Overall Study||37
7535096|NCT03346070|18550136|P4|COMPLETED|Overall Study||36
7535097|NCT03346070|18550137|P3|COMPLETED|Overall Study||37
7535098|NCT03346070|18550138|P2|COMPLETED|Overall Study||37
7535099|NCT03346070|18550139|P1|COMPLETED|Overall Study||38
7535100|NCT03346070|18550135|P5|Treated|Overall Study||38
7535101|NCT03346070|18550136|P4|Treated|Overall Study||36
7535102|NCT03346070|18550137|P3|Treated|Overall Study||38
7535103|NCT03346070|18550138|P2|Treated|Overall Study||38
7535104|NCT03346070|18550139|P1|Treated|Overall Study||38
7535105|NCT03346070|18550135|P5|STARTED|Overall Study||42
7535106|NCT03346070|18550136|P4|STARTED|Overall Study||42
7535107|NCT03346070|18550137|P3|STARTED|Overall Study||41
7535108|NCT03346070|18550138|P2|STARTED|Overall Study||41
7535109|NCT03346070|18550139|P1|STARTED|Overall Study||41
7535110|NCT03346057|18550227|P4|NOT COMPLETED|Overall Study||2
7535111|NCT03346057|18550228|P3|NOT COMPLETED|Overall Study||1
7535112|NCT03346057|18550229|P2|NOT COMPLETED|Overall Study||8
7535113|NCT03346057|18550230|P1|NOT COMPLETED|Overall Study||7
7535114|NCT03346057|18550227|P4|COMPLETED|Overall Study||51
7535115|NCT03346057|18550228|P3|COMPLETED|Overall Study||67
7535116|NCT03346057|18550229|P2|COMPLETED|Overall Study||104
7535117|NCT03346057|18550230|P1|COMPLETED|Overall Study||104
7535118|NCT03346057|18550227|P4|Treated|Overall Study||51
7535119|NCT03346057|18550228|P3|Treated|Overall Study||68
7535120|NCT03346057|18550229|P2|Treated|Overall Study||107
7535121|NCT03346057|18550230|P1|Treated|Overall Study||105
7535122|NCT03346057|18550227|P4|STARTED|Overall Study||53
7535123|NCT03346057|18550228|P3|STARTED|Overall Study||68
7535124|NCT03346057|18550229|P2|STARTED|Overall Study||112
7535125|NCT03346057|18550230|P1|STARTED|Overall Study||111
7535126|NCT03345979|18550262|P2|NOT COMPLETED|Overall Study||58
7535127|NCT03345979|18550263|P1|NOT COMPLETED|Overall Study||43
7535128|NCT03345979|18550262|P2|COMPLETED|Overall Study||43
7535129|NCT03345979|18550263|P1|COMPLETED|Overall Study||56
7535130|NCT03345979|18550262|P2|STARTED|Overall Study||101
7535131|NCT03345979|18550263|P1|STARTED|Overall Study||99
7535132|NCT03345914|18550284|P3|NOT COMPLETED|Overall Study||122
7535133|NCT03345914|18550285|P2|NOT COMPLETED|Overall Study||122
7535134|NCT03345914|18550286|P1|NOT COMPLETED|Overall Study||123
7535135|NCT03345914|18550284|P3|COMPLETED|Overall Study||0
7535136|NCT03345914|18550285|P2|COMPLETED|Overall Study||0
7535137|NCT03345914|18550286|P1|COMPLETED|Overall Study||0
7535138|NCT03345914|18550284|P3|Completed Week 28 End of Study|Overall Study||0
7535139|NCT03345914|18550285|P2|Completed Week 28 End of Study|Overall Study||0
7535140|NCT03345914|18550286|P1|Completed Week 28 End of Study|Overall Study||0
7535141|NCT03345914|18550284|P3|Completed Week 16 Study Treatment|Overall Study||119
7535142|NCT03345914|18550285|P2|Completed Week 16 Study Treatment|Overall Study||118
7535143|NCT03345914|18550286|P1|Completed Week 16 Study Treatment|Overall Study||114
7535144|NCT03345914|18550284|P3|STARTED|Overall Study||122
7535145|NCT03345914|18550285|P2|STARTED|Overall Study||122
7535146|NCT03345914|18550286|P1|STARTED|Overall Study||123
7535147|NCT03345901|18550357|P1|NOT COMPLETED|Overall Study||18
7535148|NCT03345901|18550357|P1|COMPLETED|Overall Study||0
7535149|NCT03345901|18550357|P1|STARTED|Overall Study||18
7535150|NCT03345472|18550362|P1|NOT COMPLETED|3 Months to 12 Months||8
7535151|NCT03345472|18550362|P1|COMPLETED|3 Months to 12 Months||91
7535152|NCT03345472|18550362|P1|STARTED|3 Months to 12 Months||99
7535153|NCT03345472|18550362|P1|NOT COMPLETED|Implant to 3 Months||4
7535154|NCT03345472|18550362|P1|COMPLETED|Implant to 3 Months||99
7535155|NCT03345472|18550362|P1|STARTED|Implant to 3 Months||103
7535156|NCT03345407|18550376|P7|NOT COMPLETED|Overall Study||45
7535157|NCT03345407|18550377|P6|NOT COMPLETED|Overall Study||16
7535158|NCT03345407|18550378|P5|NOT COMPLETED|Overall Study||15
7535159|NCT03345407|18550379|P4|NOT COMPLETED|Overall Study||11
7535160|NCT03345407|18550380|P3|NOT COMPLETED|Overall Study||12
7535161|NCT03345407|18550381|P2|NOT COMPLETED|Overall Study||3
7535162|NCT03345407|18550382|P1|NOT COMPLETED|Overall Study||32
7535163|NCT03345407|18550376|P7|COMPLETED|Overall Study||233
7535164|NCT03345407|18550377|P6|COMPLETED|Overall Study||73
7535165|NCT03345407|18550378|P5|COMPLETED|Overall Study||75
7535166|NCT03345407|18550379|P4|COMPLETED|Overall Study||81
7535167|NCT03345407|18550380|P3|COMPLETED|Overall Study||79
7535168|NCT03345407|18550381|P2|COMPLETED|Overall Study||19
7535169|NCT03345407|18550382|P1|COMPLETED|Overall Study||244
7535170|NCT03345407|18550376|P7|STARTED|Overall Study||278
7535171|NCT03345407|18550377|P6|STARTED|Overall Study||89
7535172|NCT03345407|18550378|P5|STARTED|Overall Study||90
7535173|NCT03345407|18550379|P4|STARTED|Overall Study||92
7535174|NCT03345407|18550380|P3|STARTED|Overall Study||91
7535175|NCT03345407|18550381|P2|STARTED|Overall Study||22
7535176|NCT03345407|18550382|P1|STARTED|Overall Study||276
7535177|NCT03345108|18550567|P6|NOT COMPLETED|Period-3||0
7535178|NCT03345108|18550568|P5|NOT COMPLETED|Period-3||0
7535179|NCT03345108|18550569|P4|NOT COMPLETED|Period-3||0
7535180|NCT03345108|18550570|P3|NOT COMPLETED|Period-3||0
7535181|NCT03345108|18550571|P2|NOT COMPLETED|Period-3||0
7535182|NCT03345108|18550572|P1|NOT COMPLETED|Period-3||0
7535183|NCT03345108|18550567|P6|COMPLETED|Period-3||8
7535184|NCT03345108|18550568|P5|COMPLETED|Period-3||8
7535185|NCT03345108|18550569|P4|COMPLETED|Period-3||8
7535186|NCT03345108|18550570|P3|COMPLETED|Period-3||8
7535187|NCT03345108|18550571|P2|COMPLETED|Period-3||8
7535188|NCT03345108|18550572|P1|COMPLETED|Period-3||7
7535189|NCT03345108|18550567|P6|STARTED|Period-3||8
7535190|NCT03345108|18550568|P5|STARTED|Period-3||8
7535191|NCT03345108|18550569|P4|STARTED|Period-3||8
7535192|NCT03345108|18550570|P3|STARTED|Period-3||8
7535193|NCT03345108|18550571|P2|STARTED|Period-3||8
7535194|NCT03345108|18550572|P1|STARTED|Period-3||7
7535195|NCT03345108|18550567|P6|NOT COMPLETED|Period-2||0
7535196|NCT03345108|18550568|P5|NOT COMPLETED|Period-2||0
7535197|NCT03345108|18550569|P4|NOT COMPLETED|Period-2||0
7535198|NCT03345108|18550570|P3|NOT COMPLETED|Period-2||0
7535199|NCT03345108|18550571|P2|NOT COMPLETED|Period-2||0
7535200|NCT03345108|18550572|P1|NOT COMPLETED|Period-2||0
7535201|NCT03345108|18550567|P6|COMPLETED|Period-2||8
7535202|NCT03345108|18550568|P5|COMPLETED|Period-2||8
7535203|NCT03345108|18550569|P4|COMPLETED|Period-2||8
7535204|NCT03345108|18550570|P3|COMPLETED|Period-2||8
7535205|NCT03345108|18550571|P2|COMPLETED|Period-2||8
7535206|NCT03345108|18550572|P1|COMPLETED|Period-2||8
7535207|NCT03345108|18550567|P6|STARTED|Period-2||8
7535208|NCT03345108|18550568|P5|STARTED|Period-2||8
7535209|NCT03345108|18550569|P4|STARTED|Period-2||8
7535210|NCT03345108|18550570|P3|STARTED|Period-2||8
7535211|NCT03345108|18550571|P2|STARTED|Period-2||8
7535212|NCT03345108|18550572|P1|STARTED|Period-2||8
7535213|NCT03345108|18550567|P6|NOT COMPLETED|Period-1||0
7535214|NCT03345108|18550568|P5|NOT COMPLETED|Period-1||0
7535215|NCT03345108|18550569|P4|NOT COMPLETED|Period-1||0
7535216|NCT03345108|18550570|P3|NOT COMPLETED|Period-1||0
7535217|NCT03345108|18550571|P2|NOT COMPLETED|Period-1||0
7535218|NCT03345108|18550572|P1|NOT COMPLETED|Period-1||0
7535219|NCT03345108|18550567|P6|COMPLETED|Period-1||8
7535220|NCT03345108|18550568|P5|COMPLETED|Period-1||8
7535221|NCT03345108|18550569|P4|COMPLETED|Period-1||8
7535222|NCT03345108|18550570|P3|COMPLETED|Period-1||8
7535223|NCT03345108|18550571|P2|COMPLETED|Period-1||8
7535224|NCT03345108|18550572|P1|COMPLETED|Period-1||8
7535225|NCT03345108|18550567|P6|STARTED|Period-1||8
7535226|NCT03345108|18550568|P5|STARTED|Period-1||8
7535227|NCT03345108|18550569|P4|STARTED|Period-1||8
7535228|NCT03345108|18550570|P3|STARTED|Period-1||8
7535229|NCT03345108|18550571|P2|STARTED|Period-1||8
7535230|NCT03345108|18550572|P1|STARTED|Period-1||8
7535231|NCT03344861|18550580|P1|NOT COMPLETED|Overall Study||0
7535232|NCT03344861|18550580|P1|COMPLETED|Overall Study||10
7535233|NCT03344861|18550580|P1|STARTED|Overall Study||10
7535234|NCT03344640|18550611|P2|NOT COMPLETED|Follow-up Epoch||2
7535235|NCT03344640|18550612|P1|NOT COMPLETED|Follow-up Epoch||0
7535236|NCT03344640|18550611|P2|COMPLETED|Follow-up Epoch||42
7535237|NCT03344640|18550612|P1|COMPLETED|Follow-up Epoch||46
7535238|NCT03344640|18550611|P2|STARTED|Follow-up Epoch||44
7535239|NCT03344640|18550612|P1|STARTED|Follow-up Epoch||46
7535240|NCT03344640|18550611|P2|NOT COMPLETED|Overall Study||3
7535241|NCT03344640|18550612|P1|NOT COMPLETED|Overall Study||3
7535242|NCT03344640|18550611|P2|COMPLETED|Overall Study||44
7535243|NCT03344640|18550612|P1|COMPLETED|Overall Study||46
7535244|NCT03344640|18550611|P2|STARTED|Overall Study||47
7535245|NCT03344640|18550612|P1|STARTED|Overall Study||49
7535246|NCT03344562|18550641|P2|NOT COMPLETED|Overall Study||0
7535247|NCT03344562|18550642|P1|NOT COMPLETED|Overall Study||2
7535248|NCT03344562|18550641|P2|COMPLETED|Overall Study||9
7535249|NCT03344562|18550642|P1|COMPLETED|Overall Study||8
7535250|NCT03344562|18550641|P2|STARTED|Overall Study||9
7535251|NCT03344562|18550642|P1|STARTED|Overall Study||10
7535252|NCT03344510|18550652|P2|NOT COMPLETED|Second Injection (5 Minutes)||0
7535253|NCT03344510|18550653|P1|NOT COMPLETED|Second Injection (5 Minutes)||0
7535254|NCT03344510|18550652|P2|COMPLETED|Second Injection (5 Minutes)||26
7535255|NCT03344510|18550653|P1|COMPLETED|Second Injection (5 Minutes)||21
7535256|NCT03344510|18550652|P2|Received Injection|Second Injection (5 Minutes)||26
7535257|NCT03344510|18550653|P1|Received Injection|Second Injection (5 Minutes)||21
7535258|NCT03344510|18550652|P2|STARTED|Second Injection (5 Minutes)||26
7535259|NCT03344510|18550653|P1|STARTED|Second Injection (5 Minutes)||21
7535260|NCT03344510|18550652|P2|NOT COMPLETED|Wash Out (10 Minutes||0
7535261|NCT03344510|18550653|P1|NOT COMPLETED|Wash Out (10 Minutes||0
7535262|NCT03344510|18550652|P2|COMPLETED|Wash Out (10 Minutes||26
7535263|NCT03344510|18550653|P1|COMPLETED|Wash Out (10 Minutes||21
7535264|NCT03344510|18550652|P2|STARTED|Wash Out (10 Minutes||26
7535265|NCT03344510|18550653|P1|STARTED|Wash Out (10 Minutes||21
7535266|NCT03344510|18550652|P2|NOT COMPLETED|First Injection (5 Minutes)||0
7535267|NCT03344510|18550653|P1|NOT COMPLETED|First Injection (5 Minutes)||0
7535268|NCT03344510|18550652|P2|COMPLETED|First Injection (5 Minutes)||26
7535269|NCT03344510|18550653|P1|COMPLETED|First Injection (5 Minutes)||21
7535270|NCT03344510|18550652|P2|Received Injection|First Injection (5 Minutes)||26
7535271|NCT03344510|18550653|P1|Received Injection|First Injection (5 Minutes)||21
7535272|NCT03344510|18550652|P2|STARTED|First Injection (5 Minutes)||26
7535273|NCT03344510|18550653|P1|STARTED|First Injection (5 Minutes)||21
7535274|NCT03344172|18550662|P2|NOT COMPLETED|Overall Study||0
7535275|NCT03344172|18550663|P1|NOT COMPLETED|Overall Study||1
7535276|NCT03344172|18550662|P2|COMPLETED|Overall Study||16
7535277|NCT03344172|18550663|P1|COMPLETED|Overall Study||15
7535278|NCT03344172|18550662|P2|STARTED|Overall Study||16
7535279|NCT03344172|18550663|P1|STARTED|Overall Study||16
7535280|NCT03343639|18550681|P2|NOT COMPLETED|Overall Study||12
7535281|NCT03343639|18550682|P1|NOT COMPLETED|Overall Study||14
7535282|NCT03343639|18550681|P2|COMPLETED|Overall Study||90
7535283|NCT03343639|18550682|P1|COMPLETED|Overall Study||88
7535284|NCT03343639|18550681|P2|STARTED|Overall Study||102
7535285|NCT03343639|18550682|P1|STARTED|Overall Study||102
7535286|NCT03343080|18550696|P2|NOT COMPLETED|Overall Study||0
7535287|NCT03343080|18550697|P1|NOT COMPLETED|Overall Study||0
7535288|NCT03343080|18550696|P2|COMPLETED|Overall Study||18
7535289|NCT03343080|18550697|P1|COMPLETED|Overall Study||14
7535290|NCT03343080|18550696|P2|STARTED|Overall Study||18
7535291|NCT03343080|18550697|P1|STARTED|Overall Study||14
7535292|NCT03343067|18550710|P3|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||1
7535293|NCT03343067|18550711|P2|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||3
7535294|NCT03343067|18550712|P1|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||0
7535295|NCT03343067|18550710|P3|COMPLETED|Double Blind Period: Month 3 to Month 6||0
7535296|NCT03343067|18550711|P2|COMPLETED|Double Blind Period: Month 3 to Month 6||0
7535297|NCT03343067|18550712|P1|COMPLETED|Double Blind Period: Month 3 to Month 6||0
7535298|NCT03343067|18550710|P3|STARTED|Double Blind Period: Month 3 to Month 6||1
7535299|NCT03343067|18550711|P2|STARTED|Double Blind Period: Month 3 to Month 6||3
7535300|NCT03343067|18550712|P1|STARTED|Double Blind Period: Month 3 to Month 6||0
7535301|NCT03343067|18550710|P3|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
7535302|NCT03343067|18550711|P2|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
7535303|NCT03343067|18550712|P1|NOT COMPLETED|Open Label Period: Day 1 to Month 3||7
7535304|NCT03343067|18550710|P3|COMPLETED|Open Label Period: Day 1 to Month 3||1
7535305|NCT03343067|18550711|P2|COMPLETED|Open Label Period: Day 1 to Month 3||3
7535306|NCT03343067|18550712|P1|COMPLETED|Open Label Period: Day 1 to Month 3||0
7535307|NCT03343067|18550710|P3|STARTED|Open Label Period: Day 1 to Month 3||1
7535308|NCT03343067|18550711|P2|STARTED|Open Label Period: Day 1 to Month 3||3
7535309|NCT03343067|18550712|P1|STARTED|Open Label Period: Day 1 to Month 3||7
7535310|NCT03342898|18550840|P3|NOT COMPLETED|Overall Study||54
7535311|NCT03342898|18550841|P2|NOT COMPLETED|Overall Study||53
7535312|NCT03342898|18550842|P1|NOT COMPLETED|Overall Study||54
7535313|NCT03342898|18550840|P3|COMPLETED|Overall Study||246
7535314|NCT03342898|18550841|P2|COMPLETED|Overall Study||247
7535315|NCT03342898|18550842|P1|COMPLETED|Overall Study||246
7535316|NCT03342898|18550840|P3|STARTED|Overall Study||300
7535317|NCT03342898|18550841|P2|STARTED|Overall Study||300
7535318|NCT03342898|18550842|P1|STARTED|Overall Study||300
7535319|NCT03342560|18550883|P1|NOT COMPLETED|Overall Study||2
7535320|NCT03342560|18550883|P1|COMPLETED|Overall Study||28
7535321|NCT03342560|18550883|P1|STARTED|Overall Study||30
7535322|NCT03342469|18550893|P4|NOT COMPLETED|Overall Study||0
7535323|NCT03342469|18550894|P3|NOT COMPLETED|Overall Study||0
7535324|NCT03342469|18550895|P2|NOT COMPLETED|Overall Study||1
7535325|NCT03342469|18550896|P1|NOT COMPLETED|Overall Study||0
7535326|NCT03342469|18550893|P4|COMPLETED|Overall Study||8
7535327|NCT03342469|18550894|P3|COMPLETED|Overall Study||3
7535328|NCT03342469|18550895|P2|COMPLETED|Overall Study||8
7535329|NCT03342469|18550896|P1|COMPLETED|Overall Study||9
7535330|NCT03342469|18550893|P4|STARTED|Overall Study||8
7535331|NCT03342469|18550894|P3|STARTED|Overall Study||3
7535332|NCT03342469|18550895|P2|STARTED|Overall Study||9
7535333|NCT03342469|18550896|P1|STARTED|Overall Study||9
7535334|NCT03342157|18550914|P2|NOT COMPLETED|Overall Study||0
7535335|NCT03342157|18550915|P1|NOT COMPLETED|Overall Study||0
7535336|NCT03342157|18550914|P2|COMPLETED|Overall Study||1
7535337|NCT03342157|18550915|P1|COMPLETED|Overall Study||1
7535338|NCT03342157|18550914|P2|STARTED|Overall Study||1
7535339|NCT03342157|18550915|P1|STARTED|Overall Study||1
7535340|NCT03341923|18550925|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||1
7535341|NCT03341923|18550926|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
7535342|NCT03341923|18550925|P2|COMPLETED|Period 2, Second 14 Days of Wear||65
7535343|NCT03341923|18550926|P1|COMPLETED|Period 2, Second 14 Days of Wear||67
7535344|NCT03341923|18550925|P2|STARTED|Period 2, Second 14 Days of Wear|Subject completed Period 1 but was discontinued before starting Period 2.|66
7535345|NCT03341923|18550926|P1|STARTED|Period 2, Second 14 Days of Wear||67
7535346|NCT03341923|18550925|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||0
7535347|NCT03341923|18550926|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||0
7535348|NCT03341923|18550925|P2|COMPLETED|Period 1, First 14 Days of Wear||67
7535349|NCT03341923|18550926|P1|COMPLETED|Period 1, First 14 Days of Wear||67
7535350|NCT03341923|18550925|P2|STARTED|Period 1, First 14 Days of Wear||67
7535351|NCT03341923|18550926|P1|STARTED|Period 1, First 14 Days of Wear||67
7535352|NCT03341910|18550938|P4|NOT COMPLETED|Overall Study||0
7535353|NCT03341910|18550939|P3|NOT COMPLETED|Overall Study||0
7535354|NCT03341910|18550940|P2|NOT COMPLETED|Overall Study||0
7535355|NCT03341910|18550941|P1|NOT COMPLETED|Overall Study||0
7535356|NCT03341910|18550938|P4|COMPLETED|Overall Study||26
7535357|NCT03341910|18550939|P3|COMPLETED|Overall Study||26
7535358|NCT03341910|18550940|P2|COMPLETED|Overall Study||49
7535359|NCT03341910|18550941|P1|COMPLETED|Overall Study||54
7535360|NCT03341910|18550938|P4|STARTED|Overall Study||26
7535361|NCT03341910|18550939|P3|STARTED|Overall Study||26
7535362|NCT03341910|18550940|P2|STARTED|Overall Study||49
7535363|NCT03341910|18550941|P1|STARTED|Overall Study||54
7535364|NCT03341728|18550951|P2|NOT COMPLETED|Session 2||0
7535365|NCT03341728|18550952|P1|NOT COMPLETED|Session 2||0
7535366|NCT03341728|18550951|P2|COMPLETED|Session 2||7
7535367|NCT03341728|18550952|P1|COMPLETED|Session 2||7
7535368|NCT03341728|18550951|P2|STARTED|Session 2||7
7535369|NCT03341728|18550952|P1|STARTED|Session 2||7
7535370|NCT03341728|18550951|P2|NOT COMPLETED|Washout (1 Week)||0
7535371|NCT03341728|18550952|P1|NOT COMPLETED|Washout (1 Week)||0
7535372|NCT03341728|18550951|P2|COMPLETED|Washout (1 Week)||7
7535373|NCT03341728|18550952|P1|COMPLETED|Washout (1 Week)||7
7535374|NCT03341728|18550951|P2|STARTED|Washout (1 Week)||7
7535375|NCT03341728|18550952|P1|STARTED|Washout (1 Week)||7
7535376|NCT03341728|18550951|P2|NOT COMPLETED|Session 1||0
7535377|NCT03341728|18550952|P1|NOT COMPLETED|Session 1||0
7535378|NCT03341728|18550951|P2|COMPLETED|Session 1||7
7535379|NCT03341728|18550952|P1|COMPLETED|Session 1||7
7535380|NCT03341728|18550951|P2|STARTED|Session 1||7
7535381|NCT03341728|18550952|P1|STARTED|Session 1||7
7535382|NCT03341637|18550970|P2|NOT COMPLETED|Overall Study||4
7535383|NCT03341637|18550971|P1|NOT COMPLETED|Overall Study||5
7535384|NCT03341637|18550970|P2|COMPLETED|Overall Study||296
7535385|NCT03341637|18550971|P1|COMPLETED|Overall Study||95
7535386|NCT03341637|18550970|P2|STARTED|Overall Study||300
7535387|NCT03341637|18550971|P1|STARTED|Overall Study||100
7535388|NCT03341546|18550993|P1|NOT COMPLETED|Overall Study||0
7535389|NCT03341546|18550993|P1|COMPLETED|Overall Study||20
7535390|NCT03341546|18550993|P1|STARTED|Overall Study||20
7535391|NCT03341533|18550999|P2|NOT COMPLETED|Overall Study||2
7535392|NCT03341533|18551000|P1|NOT COMPLETED|Overall Study||3
7535393|NCT03341533|18550999|P2|COMPLETED|Overall Study||68
7535394|NCT03341533|18551000|P1|COMPLETED|Overall Study||69
7535395|NCT03341533|18550999|P2|STARTED|Overall Study||70
7535396|NCT03341533|18551000|P1|STARTED|Overall Study||72
7535397|NCT03341312|18551012|P4|NOT COMPLETED|Period 4||0
7535398|NCT03341312|18551013|P3|NOT COMPLETED|Period 4||0
7535399|NCT03341312|18551014|P2|NOT COMPLETED|Period 4||0
7535400|NCT03341312|18551015|P1|NOT COMPLETED|Period 4||0
7535401|NCT03341312|18551012|P4|COMPLETED|Period 4||8
7535402|NCT03341312|18551013|P3|COMPLETED|Period 4||9
7535403|NCT03341312|18551014|P2|COMPLETED|Period 4||9
7535404|NCT03341312|18551015|P1|COMPLETED|Period 4||9
7535405|NCT03341312|18551012|P4|STARTED|Period 4||8
7535406|NCT03341312|18551013|P3|STARTED|Period 4||9
7535407|NCT03341312|18551014|P2|STARTED|Period 4||9
7535408|NCT03341312|18551015|P1|STARTED|Period 4||9
7535409|NCT03341312|18551012|P4|NOT COMPLETED|Period 3||0
7535410|NCT03341312|18551013|P3|NOT COMPLETED|Period 3||0
7535411|NCT03341312|18551014|P2|NOT COMPLETED|Period 3||0
7535412|NCT03341312|18551015|P1|NOT COMPLETED|Period 3||0
7535413|NCT03341312|18551012|P4|COMPLETED|Period 3||8
7535414|NCT03341312|18551013|P3|COMPLETED|Period 3||9
7535415|NCT03341312|18551014|P2|COMPLETED|Period 3||9
7535416|NCT03341312|18551015|P1|COMPLETED|Period 3||9
7535417|NCT03341312|18551012|P4|STARTED|Period 3||8
7535418|NCT03341312|18551013|P3|STARTED|Period 3||9
7535419|NCT03341312|18551014|P2|STARTED|Period 3||9
7535420|NCT03341312|18551015|P1|STARTED|Period 3||9
7535421|NCT03341312|18551012|P4|NOT COMPLETED|Period 2||0
7535422|NCT03341312|18551013|P3|NOT COMPLETED|Period 2||0
7535423|NCT03341312|18551014|P2|NOT COMPLETED|Period 2||0
7535424|NCT03341312|18551015|P1|NOT COMPLETED|Period 2||0
7535425|NCT03341312|18551012|P4|COMPLETED|Period 2||8
7535426|NCT03341312|18551013|P3|COMPLETED|Period 2||9
7535427|NCT03341312|18551014|P2|COMPLETED|Period 2||9
7535428|NCT03341312|18551015|P1|COMPLETED|Period 2||9
7535429|NCT03341312|18551012|P4|STARTED|Period 2||8
7535430|NCT03341312|18551013|P3|STARTED|Period 2||9
7535431|NCT03341312|18551014|P2|STARTED|Period 2||9
7535432|NCT03341312|18551015|P1|STARTED|Period 2||9
7535433|NCT03341312|18551012|P4|NOT COMPLETED|Period 1||0
7535434|NCT03341312|18551013|P3|NOT COMPLETED|Period 1||0
7535435|NCT03341312|18551014|P2|NOT COMPLETED|Period 1||1
7535436|NCT03341312|18551015|P1|NOT COMPLETED|Period 1||0
7535437|NCT03341312|18551012|P4|COMPLETED|Period 1||8
7535438|NCT03341312|18551013|P3|COMPLETED|Period 1||9
7535439|NCT03341312|18551014|P2|COMPLETED|Period 1||9
7535440|NCT03341312|18551015|P1|COMPLETED|Period 1||9
7535441|NCT03341312|18551012|P4|Received at Least One Dose of Study Drug|Period 1||8
7535442|NCT03341312|18551013|P3|Received at Least One Dose of Study Drug|Period 1||9
7535443|NCT03341312|18551014|P2|Received at Least One Dose of Study Drug|Period 1||10
7535444|NCT03341312|18551015|P1|Received at Least One Dose of Study Drug|Period 1||9
7535445|NCT03341312|18551012|P4|STARTED|Period 1||8
7535446|NCT03341312|18551013|P3|STARTED|Period 1||9
7535447|NCT03341312|18551014|P2|STARTED|Period 1||10
7535448|NCT03341312|18551015|P1|STARTED|Period 1||9
7535449|NCT03341299|18551027|P4|NOT COMPLETED|Period 4||0
7535450|NCT03341299|18551028|P3|NOT COMPLETED|Period 4||0
7535451|NCT03341299|18551029|P2|NOT COMPLETED|Period 4||0
7535452|NCT03341299|18551030|P1|NOT COMPLETED|Period 4||0
7535453|NCT03341299|18551027|P4|COMPLETED|Period 4||9
7535454|NCT03341299|18551028|P3|COMPLETED|Period 4||8
7535455|NCT03341299|18551029|P2|COMPLETED|Period 4||9
7535456|NCT03341299|18551030|P1|COMPLETED|Period 4||9
7535457|NCT03341299|18551027|P4|STARTED|Period 4||9
7535458|NCT03341299|18551028|P3|STARTED|Period 4||8
7535459|NCT03341299|18551029|P2|STARTED|Period 4||9
7535460|NCT03341299|18551030|P1|STARTED|Period 4||9
7535461|NCT03341299|18551027|P4|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
7535462|NCT03341299|18551028|P3|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
7535463|NCT03341299|18551029|P2|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
7535464|NCT03341299|18551030|P1|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
7535465|NCT03341299|18551027|P4|COMPLETED|Washout (A Minimum of 21 Hours)||9
7535466|NCT03341299|18551028|P3|COMPLETED|Washout (A Minimum of 21 Hours)||8
7535467|NCT03341299|18551029|P2|COMPLETED|Washout (A Minimum of 21 Hours)||9
7535468|NCT03341299|18551030|P1|COMPLETED|Washout (A Minimum of 21 Hours)||9
7535469|NCT03341299|18551027|P4|STARTED|Washout (A Minimum of 21 Hours)||9
7535470|NCT03341299|18551028|P3|STARTED|Washout (A Minimum of 21 Hours)||8
7535471|NCT03341299|18551029|P2|STARTED|Washout (A Minimum of 21 Hours)||9
7535472|NCT03341299|18551030|P1|STARTED|Washout (A Minimum of 21 Hours)||9
7535473|NCT03341299|18551027|P4|NOT COMPLETED|Period 3||0
7535474|NCT03341299|18551028|P3|NOT COMPLETED|Period 3||0
7535475|NCT03341299|18551029|P2|NOT COMPLETED|Period 3||0
7535476|NCT03341299|18551030|P1|NOT COMPLETED|Period 3||0
7535477|NCT03341299|18551027|P4|COMPLETED|Period 3||9
7535478|NCT03341299|18551028|P3|COMPLETED|Period 3||8
7535479|NCT03341299|18551029|P2|COMPLETED|Period 3||9
7535480|NCT03341299|18551030|P1|COMPLETED|Period 3||9
7535481|NCT03341299|18551027|P4|STARTED|Period 3||9
7535482|NCT03341299|18551028|P3|STARTED|Period 3||8
7535483|NCT03341299|18551029|P2|STARTED|Period 3||9
7535484|NCT03341299|18551030|P1|STARTED|Period 3||9
7535485|NCT03341299|18551027|P4|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
7535486|NCT03341299|18551028|P3|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
7535487|NCT03341299|18551029|P2|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
7535488|NCT03341299|18551030|P1|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
7535489|NCT03341299|18551027|P4|COMPLETED|Washout (A Minimum of 21 Hours)||9
7535490|NCT03341299|18551028|P3|COMPLETED|Washout (A Minimum of 21 Hours)||8
7535491|NCT03341299|18551029|P2|COMPLETED|Washout (A Minimum of 21 Hours)||9
7535492|NCT03341299|18551030|P1|COMPLETED|Washout (A Minimum of 21 Hours)||9
7535493|NCT03341299|18551027|P4|STARTED|Washout (A Minimum of 21 Hours)||9
7535494|NCT03341299|18551028|P3|STARTED|Washout (A Minimum of 21 Hours)||8
7535495|NCT03341299|18551029|P2|STARTED|Washout (A Minimum of 21 Hours)||9
7535496|NCT03341299|18551030|P1|STARTED|Washout (A Minimum of 21 Hours)||9
7535497|NCT03341299|18551027|P4|NOT COMPLETED|Period 2||0
7535498|NCT03341299|18551028|P3|NOT COMPLETED|Period 2||0
7535499|NCT03341299|18551029|P2|NOT COMPLETED|Period 2||0
7535500|NCT03341299|18551030|P1|NOT COMPLETED|Period 2||0
7535501|NCT03341299|18551027|P4|COMPLETED|Period 2||9
7535502|NCT03341299|18551028|P3|COMPLETED|Period 2||8
7535503|NCT03341299|18551029|P2|COMPLETED|Period 2||9
7535504|NCT03341299|18551030|P1|COMPLETED|Period 2||9
7535505|NCT03341299|18551027|P4|STARTED|Period 2||9
7535506|NCT03341299|18551028|P3|STARTED|Period 2||8
7535507|NCT03341299|18551029|P2|STARTED|Period 2||9
7535508|NCT03341299|18551030|P1|STARTED|Period 2||9
7535509|NCT03341299|18551027|P4|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
7535510|NCT03341299|18551028|P3|NOT COMPLETED|Washout (A Minimum of 21 Hours)||1
7535511|NCT03341299|18551029|P2|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
7535512|NCT03341299|18551030|P1|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
7535513|NCT03341299|18551027|P4|COMPLETED|Washout (A Minimum of 21 Hours)||9
7535514|NCT03341299|18551028|P3|COMPLETED|Washout (A Minimum of 21 Hours)||8
7535515|NCT03341299|18551029|P2|COMPLETED|Washout (A Minimum of 21 Hours)||9
7535516|NCT03341299|18551030|P1|COMPLETED|Washout (A Minimum of 21 Hours)||9
7535517|NCT03341299|18551027|P4|STARTED|Washout (A Minimum of 21 Hours)||9
7535518|NCT03341299|18551028|P3|STARTED|Washout (A Minimum of 21 Hours)||9
7535519|NCT03341299|18551029|P2|STARTED|Washout (A Minimum of 21 Hours)||9
7535520|NCT03341299|18551030|P1|STARTED|Washout (A Minimum of 21 Hours)||9
7535521|NCT03341299|18551027|P4|NOT COMPLETED|Period 1||0
7535522|NCT03341299|18551028|P3|NOT COMPLETED|Period 1||0
7535523|NCT03341299|18551029|P2|NOT COMPLETED|Period 1||0
7535524|NCT03341299|18551030|P1|NOT COMPLETED|Period 1||0
7535525|NCT03341299|18551027|P4|COMPLETED|Period 1||9
7535526|NCT03341299|18551028|P3|COMPLETED|Period 1||9
7535527|NCT03341299|18551029|P2|COMPLETED|Period 1||9
7535528|NCT03341299|18551030|P1|COMPLETED|Period 1||9
7535529|NCT03341299|18551027|P4|STARTED|Period 1||9
7535530|NCT03341299|18551028|P3|STARTED|Period 1||9
7535531|NCT03341299|18551029|P2|STARTED|Period 1||9
7535532|NCT03341299|18551030|P1|STARTED|Period 1||9
7535533|NCT03340961|18551046|P4|NOT COMPLETED|Overall Study||18
7535534|NCT03340961|18551047|P3|NOT COMPLETED|Overall Study||9
7535535|NCT03340961|18551048|P2|NOT COMPLETED|Overall Study||12
7535536|NCT03340961|18551049|P1|NOT COMPLETED|Overall Study||6
7535537|NCT03340961|18551046|P4|COMPLETED|Overall Study||35
7535538|NCT03340961|18551047|P3|COMPLETED|Overall Study||40
7535539|NCT03340961|18551048|P2|COMPLETED|Overall Study||38
7535540|NCT03340961|18551049|P1|COMPLETED|Overall Study||47
7535541|NCT03340961|18551046|P4|STARTED|Overall Study||53
7535542|NCT03340961|18551047|P3|STARTED|Overall Study||49
7535543|NCT03340961|18551048|P2|STARTED|Overall Study||50
7535544|NCT03340961|18551049|P1|STARTED|Overall Study||53
7535545|NCT03340883|18551067|P6|NOT COMPLETED|Overall Study||0
7535546|NCT03340883|18551068|P5|NOT COMPLETED|Overall Study||0
7535547|NCT03340883|18551069|P4|NOT COMPLETED|Overall Study||0
7535548|NCT03340883|18551070|P3|NOT COMPLETED|Overall Study||0
7535549|NCT03340883|18551071|P2|NOT COMPLETED|Overall Study||0
7535550|NCT03340883|18551072|P1|NOT COMPLETED|Overall Study||0
7535551|NCT03340883|18551067|P6|COMPLETED|Overall Study||3
7535552|NCT03340883|18551068|P5|COMPLETED|Overall Study||3
7535553|NCT03340883|18551069|P4|COMPLETED|Overall Study||4
7535554|NCT03340883|18551070|P3|COMPLETED|Overall Study||4
7535555|NCT03340883|18551071|P2|COMPLETED|Overall Study||3
7535556|NCT03340883|18551072|P1|COMPLETED|Overall Study||4
7535557|NCT03340883|18551067|P6|STARTED|Overall Study||3
7535558|NCT03340883|18551068|P5|STARTED|Overall Study||3
7535559|NCT03340883|18551069|P4|STARTED|Overall Study||4
7535560|NCT03340883|18551070|P3|STARTED|Overall Study||4
7535561|NCT03340883|18551071|P2|STARTED|Overall Study||3
7535562|NCT03340883|18551072|P1|STARTED|Overall Study||4
7535563|NCT03340805|18551130|P2|NOT COMPLETED|Overall Study||0
7535564|NCT03340805|18551131|P1|NOT COMPLETED|Overall Study||0
7535565|NCT03340805|18551130|P2|COMPLETED|Overall Study||26
7535566|NCT03340805|18551131|P1|COMPLETED|Overall Study|1 subject withdrew early from study fluid administration but stayed in trial for outcome assessment|24
7535567|NCT03340805|18551130|P2|STARTED|Overall Study||26
7535568|NCT03340805|18551131|P1|STARTED|Overall Study||24
7535569|NCT03340610|18551151|P1|NOT COMPLETED|Overall Study||3
7535570|NCT03340610|18551151|P1|COMPLETED|Overall Study||27
7535571|NCT03340610|18551151|P1|STARTED|Overall Study||30
7535572|NCT03340350|18551155|P1|NOT COMPLETED|Overall Study||6
7535573|NCT03340350|18551155|P1|COMPLETED|Overall Study||4
7535574|NCT03340350|18551155|P1|STARTED|Overall Study||10
7535575|NCT03339726|18551170|P3|NOT COMPLETED|Overall Study||0
7535576|NCT03339726|18551171|P2|NOT COMPLETED|Overall Study||1
7535577|NCT03339726|18551172|P1|NOT COMPLETED|Overall Study||1
7535578|NCT03339726|18551170|P3|COMPLETED|Overall Study||63
7535579|NCT03339726|18551171|P2|COMPLETED|Overall Study||65
7535580|NCT03339726|18551172|P1|COMPLETED|Overall Study||63
7535581|NCT03339726|18551170|P3|STARTED|Overall Study||63
7535582|NCT03339726|18551171|P2|STARTED|Overall Study||66
7535583|NCT03339726|18551172|P1|STARTED|Overall Study||64
7535584|NCT03339583|18551230|P2|NOT COMPLETED|Follow-up (14 Days)||3
7535585|NCT03339583|18551231|P1|NOT COMPLETED|Follow-up (14 Days)||6
7535586|NCT03339583|18551230|P2|COMPLETED|Follow-up (14 Days)||18
7535587|NCT03339583|18551231|P1|COMPLETED|Follow-up (14 Days)||12
7535588|NCT03339583|18551230|P2|STARTED|Follow-up (14 Days)||21
7535589|NCT03339583|18551231|P1|STARTED|Follow-up (14 Days)||18
7535590|NCT03339583|18551230|P2|NOT COMPLETED|Second Intervention (14 Days)||2
7535591|NCT03339583|18551231|P1|NOT COMPLETED|Second Intervention (14 Days)||0
7535592|NCT03339583|18551230|P2|COMPLETED|Second Intervention (14 Days)||21
7535593|NCT03339583|18551231|P1|COMPLETED|Second Intervention (14 Days)||18
7535594|NCT03339583|18551230|P2|STARTED|Second Intervention (14 Days)||23
7535595|NCT03339583|18551231|P1|STARTED|Second Intervention (14 Days)||18
7535596|NCT03339583|18551230|P2|NOT COMPLETED|Washout (14 Days)||0
7535597|NCT03339583|18551231|P1|NOT COMPLETED|Washout (14 Days)||0
7535598|NCT03339583|18551230|P2|COMPLETED|Washout (14 Days)||23
7535599|NCT03339583|18551231|P1|COMPLETED|Washout (14 Days)||18
7535600|NCT03339583|18551230|P2|STARTED|Washout (14 Days)||23
7535601|NCT03339583|18551231|P1|STARTED|Washout (14 Days)||18
7535602|NCT03339583|18551230|P2|NOT COMPLETED|First Intervention (14 Days)||0
7535603|NCT03339583|18551231|P1|NOT COMPLETED|First Intervention (14 Days)||1
7535604|NCT03339583|18551230|P2|COMPLETED|First Intervention (14 Days)||23
7535605|NCT03339583|18551231|P1|COMPLETED|First Intervention (14 Days)||18
7535606|NCT03339583|18551230|P2|STARTED|First Intervention (14 Days)||23
7535607|NCT03339583|18551231|P1|STARTED|First Intervention (14 Days)||19
7535608|NCT03339453|18551269|P2|NOT COMPLETED|Second Visit for Alternate Glucagon||0
7535609|NCT03339453|18551270|P1|NOT COMPLETED|Second Visit for Alternate Glucagon||0
7535610|NCT03339453|18551269|P2|COMPLETED|Second Visit for Alternate Glucagon||34
7535611|NCT03339453|18551270|P1|COMPLETED|Second Visit for Alternate Glucagon||35
7535612|NCT03339453|18551269|P2|STARTED|Second Visit for Alternate Glucagon||34
7535613|NCT03339453|18551270|P1|STARTED|Second Visit for Alternate Glucagon||35
7535614|NCT03339453|18551269|P2|NOT COMPLETED|First Visit of Glucagon Treatment||1
7535615|NCT03339453|18551270|P1|NOT COMPLETED|First Visit of Glucagon Treatment||0
7535616|NCT03339453|18551269|P2|COMPLETED|First Visit of Glucagon Treatment||34
7535617|NCT03339453|18551270|P1|COMPLETED|First Visit of Glucagon Treatment||35
7535710|NCT03336853|18551525|P1|NOT COMPLETED|Overall Study||0
7535618|NCT03339453|18551269|P2|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
7535619|NCT03339453|18551270|P1|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
7535620|NCT03339453|18551269|P2|STARTED|First Visit of Glucagon Treatment||35
7535621|NCT03339453|18551270|P1|STARTED|First Visit of Glucagon Treatment||35
7535622|NCT03339206|18551289|P3|NOT COMPLETED|Overall Study||0
7535623|NCT03339206|18551290|P2|NOT COMPLETED|Overall Study||0
7535624|NCT03339206|18551291|P1|NOT COMPLETED|Overall Study||0
7535625|NCT03339206|18551289|P3|COMPLETED|Overall Study||264
7535626|NCT03339206|18551290|P2|COMPLETED|Overall Study||263
7535627|NCT03339206|18551291|P1|COMPLETED|Overall Study||262
7535628|NCT03339206|18551289|P3|STARTED|Overall Study||264
7535629|NCT03339206|18551290|P2|STARTED|Overall Study||263
7535630|NCT03339206|18551291|P1|STARTED|Overall Study||262
7535631|NCT03338816|18551334|P2|NOT COMPLETED|Open-Label Extension Period||47
7535632|NCT03338816|18551335|P1|NOT COMPLETED|Open-Label Extension Period||46
7535633|NCT03338816|18551334|P2|COMPLETED|Open-Label Extension Period||0
7535634|NCT03338816|18551335|P1|COMPLETED|Open-Label Extension Period||0
7535635|NCT03338816|18551334|P2|STARTED|Open-Label Extension Period||47
7535636|NCT03338816|18551335|P1|STARTED|Open-Label Extension Period||46
7535637|NCT03338816|18551334|P2|NOT COMPLETED|6-Month Double-blind Period||1
7535638|NCT03338816|18551335|P1|NOT COMPLETED|6-Month Double-blind Period||0
7535639|NCT03338816|18551334|P2|COMPLETED|6-Month Double-blind Period|1 participant discontinued treatment during the 6-month DB period but completed the 6-month DB Visit|47
7535640|NCT03338816|18551335|P1|COMPLETED|6-Month Double-blind Period||46
7535641|NCT03338816|18551334|P2|STARTED|6-Month Double-blind Period||48
7535642|NCT03338816|18551335|P1|STARTED|6-Month Double-blind Period||46
7535643|NCT03338803|18551363|P1|NOT COMPLETED|Overall Study||0
7535644|NCT03338803|18551363|P1|COMPLETED|Overall Study||11001
7535645|NCT03338803|18551363|P1|STARTED|Overall Study||11001
7535646|NCT03338673|18551372|P2|NOT COMPLETED|Overall Study||1
7535647|NCT03338673|18551373|P1|NOT COMPLETED|Overall Study||1
7535648|NCT03338673|18551372|P2|COMPLETED|Overall Study||5
7535649|NCT03338673|18551373|P1|COMPLETED|Overall Study||5
7535650|NCT03338673|18551372|P2|STARTED|Overall Study||6
7535651|NCT03338673|18551373|P1|STARTED|Overall Study||6
7535652|NCT03338556|18551385|P4|NOT COMPLETED|Overall Study||2
7535653|NCT03338556|18551386|P3|NOT COMPLETED|Overall Study||2
7535654|NCT03338556|18551387|P2|NOT COMPLETED|Overall Study||4
7535655|NCT03338556|18551388|P1|NOT COMPLETED|Overall Study||2
7535656|NCT03338556|18551385|P4|COMPLETED|Overall Study||24
7535657|NCT03338556|18551386|P3|COMPLETED|Overall Study||22
7535658|NCT03338556|18551387|P2|COMPLETED|Overall Study||23
7535659|NCT03338556|18551388|P1|COMPLETED|Overall Study||23
7535660|NCT03338556|18551385|P4|STARTED|Overall Study||26
7535661|NCT03338556|18551386|P3|STARTED|Overall Study||24
7535662|NCT03338556|18551387|P2|STARTED|Overall Study||27
7535663|NCT03338556|18551388|P1|STARTED|Overall Study||25
7535664|NCT03338400|18551408|P2|NOT COMPLETED|Overall Study||2
7535665|NCT03338400|18551409|P1|NOT COMPLETED|Overall Study||1
7535666|NCT03338400|18551408|P2|COMPLETED|Overall Study||24
7535667|NCT03338400|18551409|P1|COMPLETED|Overall Study||24
7535668|NCT03338400|18551408|P2|STARTED|Overall Study||26
7535669|NCT03338400|18551409|P1|STARTED|Overall Study||25
7535670|NCT03338036|18551419|P4|NOT COMPLETED|Overall Study||0
7535671|NCT03338036|18551420|P3|NOT COMPLETED|Overall Study||3
7535672|NCT03338036|18551421|P2|NOT COMPLETED|Overall Study||4
7535673|NCT03338036|18551422|P1|NOT COMPLETED|Overall Study||0
7535674|NCT03338036|18551419|P4|COMPLETED|Overall Study||8
7535675|NCT03338036|18551420|P3|COMPLETED|Overall Study||9
7535676|NCT03338036|18551421|P2|COMPLETED|Overall Study||7
7535677|NCT03338036|18551422|P1|COMPLETED|Overall Study||0
7535678|NCT03338036|18551419|P4|STARTED|Overall Study||8
7535679|NCT03338036|18551420|P3|STARTED|Overall Study||12
7535680|NCT03338036|18551421|P2|STARTED|Overall Study||11
7535681|NCT03338036|18551422|P1|STARTED|Overall Study||0
7535682|NCT03337490|18551445|P3|NOT COMPLETED|Overall Study||35
7535683|NCT03337490|18551446|P2|NOT COMPLETED|Overall Study||14
7535684|NCT03337490|18551447|P1|NOT COMPLETED|Overall Study||11
7535685|NCT03337490|18551445|P3|COMPLETED|Overall Study||7
7535686|NCT03337490|18551446|P2|COMPLETED|Overall Study||112
7535687|NCT03337490|18551447|P1|COMPLETED|Overall Study||117
7535688|NCT03337490|18551445|P3|STARTED|Overall Study||42
7535689|NCT03337490|18551446|P2|STARTED|Overall Study||126
7535690|NCT03337490|18551447|P1|STARTED|Overall Study||128
7535691|NCT03337477|18551460|P2|NOT COMPLETED|Overall Study||13
7535692|NCT03337477|18551461|P1|NOT COMPLETED|Overall Study||11
7535693|NCT03337477|18551460|P2|COMPLETED|Overall Study||24
7535694|NCT03337477|18551461|P1|COMPLETED|Overall Study||22
7535695|NCT03337477|18551460|P2|STARTED|Overall Study||37
7535696|NCT03337477|18551461|P1|STARTED|Overall Study||33
7535697|NCT03337308|18551485|P4|NOT COMPLETED|Overall Study||2
7535698|NCT03337308|18551486|P3|NOT COMPLETED|Overall Study||5
7535699|NCT03337308|18551487|P2|NOT COMPLETED|Overall Study||7
7535700|NCT03337308|18551488|P1|NOT COMPLETED|Overall Study||5
7535701|NCT03337308|18551485|P4|COMPLETED|Overall Study||53
7535702|NCT03337308|18551486|P3|COMPLETED|Overall Study||104
7535703|NCT03337308|18551487|P2|COMPLETED|Overall Study||103
7535704|NCT03337308|18551488|P1|COMPLETED|Overall Study||103
7535705|NCT03337308|18551485|P4|STARTED|Overall Study||55
7535706|NCT03337308|18551486|P3|STARTED|Overall Study||109
7535707|NCT03337308|18551487|P2|STARTED|Overall Study||110
7535708|NCT03337308|18551488|P1|STARTED|Overall Study||108
7535709|NCT03336853|18551524|P2|NOT COMPLETED|Overall Study||0
7535711|NCT03336853|18551524|P2|COMPLETED|Overall Study||30
7535712|NCT03336853|18551525|P1|COMPLETED|Overall Study||30
7535713|NCT03336853|18551524|P2|STARTED|Overall Study||30
7535714|NCT03336853|18551525|P1|STARTED|Overall Study||30
7535715|NCT03336645|18551531|P1|NOT COMPLETED|Overall Study||0
7535716|NCT03336645|18551531|P1|COMPLETED|Overall Study||25
7535717|NCT03336645|18551531|P1|STARTED|Overall Study||25
7535718|NCT03336502|18551555|P2|NOT COMPLETED|Overall Study||9
7535719|NCT03336502|18551556|P1|NOT COMPLETED|Overall Study||4
7535720|NCT03336502|18551555|P2|COMPLETED|Overall Study||31
7535721|NCT03336502|18551556|P1|COMPLETED|Overall Study||26
7535722|NCT03336502|18551555|P2|STARTED|Overall Study||40
7535723|NCT03336502|18551556|P1|STARTED|Overall Study||30
7535724|NCT03335800|18551583|P1|NOT COMPLETED|Overall Study||419531
7535725|NCT03335800|18551583|P1|COMPLETED|Overall Study||396
7535726|NCT03335800|18551583|P1|Attended Second Study Visit|Overall Study||396
7535727|NCT03335800|18551583|P1|ECG Patch Returned for Analysis|Overall Study||450
7535728|NCT03335800|18551583|P1|ECG Patch Shipped|Overall Study||658
7535729|NCT03335800|18551583|P1|Attended First Study Visit|Overall Study||945
7535730|NCT03335800|18551583|P1|Received Irregular Pulse Notification|Overall Study||2161
7535731|NCT03335800|18551583|P1|STARTED|Overall Study||419927
7535732|NCT03335566|18551592|P2|NOT COMPLETED|Overall Study||3
7535733|NCT03335566|18551593|P1|NOT COMPLETED|Overall Study||4
7535734|NCT03335566|18551592|P2|COMPLETED|Overall Study||203
7535735|NCT03335566|18551593|P1|COMPLETED|Overall Study||214
7535736|NCT03335566|18551592|P2|STARTED|Overall Study||206
7535737|NCT03335566|18551593|P1|STARTED|Overall Study||218
7535738|NCT03335254|18551625|P20|NOT COMPLETED|Period 3, Day 26-30||0
7535739|NCT03335254|18551626|P19|NOT COMPLETED|Period 3, Day 26-30||0
7535740|NCT03335254|18551627|P18|NOT COMPLETED|Period 3, Day 26-30||0
7535741|NCT03335254|18551628|P17|NOT COMPLETED|Period 3, Day 26-30||0
7535742|NCT03335254|18551629|P16|NOT COMPLETED|Period 3, Day 26-30||0
7535743|NCT03335254|18551630|P15|NOT COMPLETED|Period 3, Day 26-30||0
7535744|NCT03335254|18551631|P14|NOT COMPLETED|Period 3, Day 26-30||0
7535745|NCT03335254|18551632|P13|NOT COMPLETED|Period 3, Day 26-30||0
7535746|NCT03335254|18551633|P12|NOT COMPLETED|Period 3, Day 26-30||0
7535747|NCT03335254|18551634|P11|NOT COMPLETED|Period 3, Day 26-30||0
7535748|NCT03335254|18551635|P10|NOT COMPLETED|Period 3, Day 26-30||0
7535749|NCT03335254|18551636|P9|NOT COMPLETED|Period 3, Day 26-30||0
7535750|NCT03335254|18551637|P8|NOT COMPLETED|Period 3, Day 26-30||0
7535751|NCT03335254|18551638|P7|NOT COMPLETED|Period 3, Day 26-30||0
7535752|NCT03335254|18551639|P6|NOT COMPLETED|Period 3, Day 26-30||0
7535753|NCT03335254|18551640|P5|NOT COMPLETED|Period 3, Day 26-30||0
7535754|NCT03335254|18551641|P4|NOT COMPLETED|Period 3, Day 26-30||0
7535755|NCT03335254|18551642|P3|NOT COMPLETED|Period 3, Day 26-30||0
7535756|NCT03335254|18551643|P2|NOT COMPLETED|Period 3, Day 26-30||0
7535757|NCT03335254|18551644|P1|NOT COMPLETED|Period 3, Day 26-30||0
7535758|NCT03335254|18551625|P20|COMPLETED|Period 3, Day 26-30||0
7535759|NCT03335254|18551626|P19|COMPLETED|Period 3, Day 26-30||0
7535760|NCT03335254|18551627|P18|COMPLETED|Period 3, Day 26-30||0
7535761|NCT03335254|18551628|P17|COMPLETED|Period 3, Day 26-30||0
7535762|NCT03335254|18551629|P16|COMPLETED|Period 3, Day 26-30||0
7535763|NCT03335254|18551630|P15|COMPLETED|Period 3, Day 26-30||0
7535764|NCT03335254|18551631|P14|COMPLETED|Period 3, Day 26-30||0
7535765|NCT03335254|18551632|P13|COMPLETED|Period 3, Day 26-30||0
7535766|NCT03335254|18551633|P12|COMPLETED|Period 3, Day 26-30||0
7535767|NCT03335254|18551634|P11|COMPLETED|Period 3, Day 26-30||0
7535768|NCT03335254|18551635|P10|COMPLETED|Period 3, Day 26-30||0
7535769|NCT03335254|18551636|P9|COMPLETED|Period 3, Day 26-30||0
7535770|NCT03335254|18551637|P8|COMPLETED|Period 3, Day 26-30||0
7535771|NCT03335254|18551638|P7|COMPLETED|Period 3, Day 26-30||0
7535772|NCT03335254|18551639|P6|COMPLETED|Period 3, Day 26-30||0
7535773|NCT03335254|18551640|P5|COMPLETED|Period 3, Day 26-30||0
7535774|NCT03335254|18551641|P4|COMPLETED|Period 3, Day 26-30||0
7535775|NCT03335254|18551642|P3|COMPLETED|Period 3, Day 26-30||0
7535776|NCT03335254|18551643|P2|COMPLETED|Period 3, Day 26-30||0
7535777|NCT03335254|18551644|P1|COMPLETED|Period 3, Day 26-30||9
7535778|NCT03335254|18551625|P20|STARTED|Period 3, Day 26-30||0
7535779|NCT03335254|18551626|P19|STARTED|Period 3, Day 26-30||0
7535780|NCT03335254|18551627|P18|STARTED|Period 3, Day 26-30||0
7535781|NCT03335254|18551628|P17|STARTED|Period 3, Day 26-30||0
7535782|NCT03335254|18551629|P16|STARTED|Period 3, Day 26-30||0
7535783|NCT03335254|18551630|P15|STARTED|Period 3, Day 26-30||0
7535784|NCT03335254|18551631|P14|STARTED|Period 3, Day 26-30||0
7535785|NCT03335254|18551632|P13|STARTED|Period 3, Day 26-30||0
7535786|NCT03335254|18551633|P12|STARTED|Period 3, Day 26-30||0
7535787|NCT03335254|18551634|P11|STARTED|Period 3, Day 26-30||0
7535788|NCT03335254|18551635|P10|STARTED|Period 3, Day 26-30||0
7535789|NCT03335254|18551636|P9|STARTED|Period 3, Day 26-30||0
7535790|NCT03335254|18551637|P8|STARTED|Period 3, Day 26-30||0
7535791|NCT03335254|18551638|P7|STARTED|Period 3, Day 26-30||0
7535792|NCT03335254|18551639|P6|STARTED|Period 3, Day 26-30||0
7535793|NCT03335254|18551640|P5|STARTED|Period 3, Day 26-30||0
7535794|NCT03335254|18551641|P4|STARTED|Period 3, Day 26-30||0
7535795|NCT03335254|18551642|P3|STARTED|Period 3, Day 26-30||0
7535796|NCT03335254|18551643|P2|STARTED|Period 3, Day 26-30||0
7535797|NCT03335254|18551644|P1|STARTED|Period 3, Day 26-30||9
7535798|NCT03335254|18551625|P20|NOT COMPLETED|Period 3, Day 16-25||0
7535799|NCT03335254|18551626|P19|NOT COMPLETED|Period 3, Day 16-25||0
7535800|NCT03335254|18551627|P18|NOT COMPLETED|Period 3, Day 16-25||0
7535801|NCT03335254|18551628|P17|NOT COMPLETED|Period 3, Day 16-25||0
7535802|NCT03335254|18551629|P16|NOT COMPLETED|Period 3, Day 16-25||0
7535803|NCT03335254|18551630|P15|NOT COMPLETED|Period 3, Day 16-25||0
7535804|NCT03335254|18551631|P14|NOT COMPLETED|Period 3, Day 16-25||0
7535805|NCT03335254|18551632|P13|NOT COMPLETED|Period 3, Day 16-25||0
7535806|NCT03335254|18551633|P12|NOT COMPLETED|Period 3, Day 16-25||0
7535807|NCT03335254|18551634|P11|NOT COMPLETED|Period 3, Day 16-25||0
7535808|NCT03335254|18551635|P10|NOT COMPLETED|Period 3, Day 16-25||0
7535809|NCT03335254|18551636|P9|NOT COMPLETED|Period 3, Day 16-25||0
7535810|NCT03335254|18551637|P8|NOT COMPLETED|Period 3, Day 16-25||0
7535811|NCT03335254|18551638|P7|NOT COMPLETED|Period 3, Day 16-25||0
7535812|NCT03335254|18551639|P6|NOT COMPLETED|Period 3, Day 16-25||0
7535813|NCT03335254|18551640|P5|NOT COMPLETED|Period 3, Day 16-25||0
7535814|NCT03335254|18551641|P4|NOT COMPLETED|Period 3, Day 16-25||0
7535815|NCT03335254|18551642|P3|NOT COMPLETED|Period 3, Day 16-25||0
7535816|NCT03335254|18551643|P2|NOT COMPLETED|Period 3, Day 16-25||0
7535817|NCT03335254|18551644|P1|NOT COMPLETED|Period 3, Day 16-25||0
7535818|NCT03335254|18551625|P20|COMPLETED|Period 3, Day 16-25||0
7535819|NCT03335254|18551626|P19|COMPLETED|Period 3, Day 16-25||0
7535820|NCT03335254|18551627|P18|COMPLETED|Period 3, Day 16-25||0
7535821|NCT03335254|18551628|P17|COMPLETED|Period 3, Day 16-25||0
7535822|NCT03335254|18551629|P16|COMPLETED|Period 3, Day 16-25||0
7535823|NCT03335254|18551630|P15|COMPLETED|Period 3, Day 16-25||0
7535824|NCT03335254|18551631|P14|COMPLETED|Period 3, Day 16-25||0
7535825|NCT03335254|18551632|P13|COMPLETED|Period 3, Day 16-25||0
7535826|NCT03335254|18551633|P12|COMPLETED|Period 3, Day 16-25||0
7535827|NCT03335254|18551634|P11|COMPLETED|Period 3, Day 16-25||0
7535828|NCT03335254|18551635|P10|COMPLETED|Period 3, Day 16-25||0
7535829|NCT03335254|18551636|P9|COMPLETED|Period 3, Day 16-25||0
7535830|NCT03335254|18551637|P8|COMPLETED|Period 3, Day 16-25||0
7535831|NCT03335254|18551638|P7|COMPLETED|Period 3, Day 16-25||0
7535832|NCT03335254|18551639|P6|COMPLETED|Period 3, Day 16-25||0
7535833|NCT03335254|18551640|P5|COMPLETED|Period 3, Day 16-25||0
7535834|NCT03335254|18551641|P4|COMPLETED|Period 3, Day 16-25||0
7535835|NCT03335254|18551642|P3|COMPLETED|Period 3, Day 16-25||0
7535836|NCT03335254|18551643|P2|COMPLETED|Period 3, Day 16-25||0
7535837|NCT03335254|18551644|P1|COMPLETED|Period 3, Day 16-25||9
7535838|NCT03335254|18551625|P20|STARTED|Period 3, Day 16-25||0
7535839|NCT03335254|18551626|P19|STARTED|Period 3, Day 16-25||0
7535840|NCT03335254|18551627|P18|STARTED|Period 3, Day 16-25||0
7535841|NCT03335254|18551628|P17|STARTED|Period 3, Day 16-25||0
7535842|NCT03335254|18551629|P16|STARTED|Period 3, Day 16-25||0
7535843|NCT03335254|18551630|P15|STARTED|Period 3, Day 16-25||0
7535844|NCT03335254|18551631|P14|STARTED|Period 3, Day 16-25||0
7535845|NCT03335254|18551632|P13|STARTED|Period 3, Day 16-25||0
7535846|NCT03335254|18551633|P12|STARTED|Period 3, Day 16-25||0
7535847|NCT03335254|18551634|P11|STARTED|Period 3, Day 16-25||0
7535848|NCT03335254|18551635|P10|STARTED|Period 3, Day 16-25||0
7535849|NCT03335254|18551636|P9|STARTED|Period 3, Day 16-25||0
7535850|NCT03335254|18551637|P8|STARTED|Period 3, Day 16-25||0
7535851|NCT03335254|18551638|P7|STARTED|Period 3, Day 16-25||0
7535852|NCT03335254|18551639|P6|STARTED|Period 3, Day 16-25||0
7535853|NCT03335254|18551640|P5|STARTED|Period 3, Day 16-25||0
7535854|NCT03335254|18551641|P4|STARTED|Period 3, Day 16-25||0
7535855|NCT03335254|18551642|P3|STARTED|Period 3, Day 16-25||0
7535856|NCT03335254|18551643|P2|STARTED|Period 3, Day 16-25||0
7535857|NCT03335254|18551644|P1|STARTED|Period 3, Day 16-25||9
7535858|NCT03335254|18551625|P20|NOT COMPLETED|Period 2, Day 1-15||0
7535859|NCT03335254|18551626|P19|NOT COMPLETED|Period 2, Day 1-15||0
7535860|NCT03335254|18551627|P18|NOT COMPLETED|Period 2, Day 1-15||0
7535861|NCT03335254|18551628|P17|NOT COMPLETED|Period 2, Day 1-15||0
7535862|NCT03335254|18551629|P16|NOT COMPLETED|Period 2, Day 1-15||0
7535863|NCT03335254|18551630|P15|NOT COMPLETED|Period 2, Day 1-15||0
7535864|NCT03335254|18551631|P14|NOT COMPLETED|Period 2, Day 1-15||0
7535865|NCT03335254|18551632|P13|NOT COMPLETED|Period 2, Day 1-15||0
7535866|NCT03335254|18551633|P12|NOT COMPLETED|Period 2, Day 1-15||0
7535867|NCT03335254|18551634|P11|NOT COMPLETED|Period 2, Day 1-15||0
7535868|NCT03335254|18551635|P10|NOT COMPLETED|Period 2, Day 1-15||0
7535869|NCT03335254|18551636|P9|NOT COMPLETED|Period 2, Day 1-15||0
7535870|NCT03335254|18551637|P8|NOT COMPLETED|Period 2, Day 1-15||0
7535871|NCT03335254|18551638|P7|NOT COMPLETED|Period 2, Day 1-15||0
7535872|NCT03335254|18551639|P6|NOT COMPLETED|Period 2, Day 1-15||0
7535873|NCT03335254|18551640|P5|NOT COMPLETED|Period 2, Day 1-15||0
7535874|NCT03335254|18551641|P4|NOT COMPLETED|Period 2, Day 1-15||0
7535875|NCT03335254|18551642|P3|NOT COMPLETED|Period 2, Day 1-15||0
7535876|NCT03335254|18551643|P2|NOT COMPLETED|Period 2, Day 1-15||0
7535877|NCT03335254|18551644|P1|NOT COMPLETED|Period 2, Day 1-15||0
7535878|NCT03335254|18551625|P20|COMPLETED|Period 2, Day 1-15||0
7535879|NCT03335254|18551626|P19|COMPLETED|Period 2, Day 1-15||0
7535880|NCT03335254|18551627|P18|COMPLETED|Period 2, Day 1-15||0
7535881|NCT03335254|18551628|P17|COMPLETED|Period 2, Day 1-15||0
7535882|NCT03335254|18551629|P16|COMPLETED|Period 2, Day 1-15||0
7535883|NCT03335254|18551630|P15|COMPLETED|Period 2, Day 1-15||0
7535884|NCT03335254|18551631|P14|COMPLETED|Period 2, Day 1-15||0
7535885|NCT03335254|18551632|P13|COMPLETED|Period 2, Day 1-15||0
7535886|NCT03335254|18551633|P12|COMPLETED|Period 2, Day 1-15||0
7535887|NCT03335254|18551634|P11|COMPLETED|Period 2, Day 1-15||0
7535888|NCT03335254|18551635|P10|COMPLETED|Period 2, Day 1-15||0
7535889|NCT03335254|18551636|P9|COMPLETED|Period 2, Day 1-15||0
7535890|NCT03335254|18551637|P8|COMPLETED|Period 2, Day 1-15||0
7535891|NCT03335254|18551638|P7|COMPLETED|Period 2, Day 1-15||0
7535892|NCT03335254|18551639|P6|COMPLETED|Period 2, Day 1-15||0
7535893|NCT03335254|18551640|P5|COMPLETED|Period 2, Day 1-15||0
7535894|NCT03335254|18551641|P4|COMPLETED|Period 2, Day 1-15||0
7535895|NCT03335254|18551642|P3|COMPLETED|Period 2, Day 1-15||0
7535896|NCT03335254|18551643|P2|COMPLETED|Period 2, Day 1-15||0
7535897|NCT03335254|18551644|P1|COMPLETED|Period 2, Day 1-15||9
7535898|NCT03335254|18551625|P20|STARTED|Period 2, Day 1-15||0
7535899|NCT03335254|18551626|P19|STARTED|Period 2, Day 1-15||0
7535900|NCT03335254|18551627|P18|STARTED|Period 2, Day 1-15||0
7535901|NCT03335254|18551628|P17|STARTED|Period 2, Day 1-15||0
7535902|NCT03335254|18551629|P16|STARTED|Period 2, Day 1-15||0
7535903|NCT03335254|18551630|P15|STARTED|Period 2, Day 1-15||0
7535904|NCT03335254|18551631|P14|STARTED|Period 2, Day 1-15||0
7535905|NCT03335254|18551632|P13|STARTED|Period 2, Day 1-15||0
7535906|NCT03335254|18551633|P12|STARTED|Period 2, Day 1-15||0
7535907|NCT03335254|18551634|P11|STARTED|Period 2, Day 1-15||0
7535908|NCT03335254|18551635|P10|STARTED|Period 2, Day 1-15||0
7535909|NCT03335254|18551636|P9|STARTED|Period 2, Day 1-15||0
7535910|NCT03335254|18551637|P8|STARTED|Period 2, Day 1-15||0
7535911|NCT03335254|18551638|P7|STARTED|Period 2, Day 1-15||0
7535912|NCT03335254|18551639|P6|STARTED|Period 2, Day 1-15||0
7535913|NCT03335254|18551640|P5|STARTED|Period 2, Day 1-15||0
7535914|NCT03335254|18551641|P4|STARTED|Period 2, Day 1-15||0
7535915|NCT03335254|18551642|P3|STARTED|Period 2, Day 1-15||0
7535916|NCT03335254|18551643|P2|STARTED|Period 2, Day 1-15||0
7535917|NCT03335254|18551644|P1|STARTED|Period 2, Day 1-15||9
7535918|NCT03335254|18551625|P20|NOT COMPLETED|Period 1||0
7535919|NCT03335254|18551626|P19|NOT COMPLETED|Period 1||0
7535920|NCT03335254|18551627|P18|NOT COMPLETED|Period 1||0
7535921|NCT03335254|18551628|P17|NOT COMPLETED|Period 1||0
7535922|NCT03335254|18551629|P16|NOT COMPLETED|Period 1||0
7535923|NCT03335254|18551630|P15|NOT COMPLETED|Period 1||0
7535924|NCT03335254|18551631|P14|NOT COMPLETED|Period 1||0
7535925|NCT03335254|18551632|P13|NOT COMPLETED|Period 1||0
7535926|NCT03335254|18551633|P12|NOT COMPLETED|Period 1||0
7535927|NCT03335254|18551634|P11|NOT COMPLETED|Period 1||0
7535928|NCT03335254|18551635|P10|NOT COMPLETED|Period 1||0
7535929|NCT03335254|18551636|P9|NOT COMPLETED|Period 1||0
7535930|NCT03335254|18551637|P8|NOT COMPLETED|Period 1||0
7535931|NCT03335254|18551638|P7|NOT COMPLETED|Period 1||0
7535932|NCT03335254|18551639|P6|NOT COMPLETED|Period 1||0
7535933|NCT03335254|18551640|P5|NOT COMPLETED|Period 1||0
7535934|NCT03335254|18551641|P4|NOT COMPLETED|Period 1||0
7535935|NCT03335254|18551642|P3|NOT COMPLETED|Period 1||0
7535936|NCT03335254|18551643|P2|NOT COMPLETED|Period 1||0
7535937|NCT03335254|18551644|P1|NOT COMPLETED|Period 1||0
7535938|NCT03335254|18551625|P20|COMPLETED|Period 1||0
7535939|NCT03335254|18551626|P19|COMPLETED|Period 1||0
7535940|NCT03335254|18551627|P18|COMPLETED|Period 1||0
7535941|NCT03335254|18551628|P17|COMPLETED|Period 1||0
7535942|NCT03335254|18551629|P16|COMPLETED|Period 1||0
7535943|NCT03335254|18551630|P15|COMPLETED|Period 1||0
7535944|NCT03335254|18551631|P14|COMPLETED|Period 1||0
7535945|NCT03335254|18551632|P13|COMPLETED|Period 1||0
7535946|NCT03335254|18551633|P12|COMPLETED|Period 1||0
7535947|NCT03335254|18551634|P11|COMPLETED|Period 1||0
7535948|NCT03335254|18551635|P10|COMPLETED|Period 1||0
7535949|NCT03335254|18551636|P9|COMPLETED|Period 1||0
7535950|NCT03335254|18551637|P8|COMPLETED|Period 1||0
7535951|NCT03335254|18551638|P7|COMPLETED|Period 1||0
7535952|NCT03335254|18551639|P6|COMPLETED|Period 1||0
7535953|NCT03335254|18551640|P5|COMPLETED|Period 1||0
7535954|NCT03335254|18551641|P4|COMPLETED|Period 1||0
7535955|NCT03335254|18551642|P3|COMPLETED|Period 1||0
7535956|NCT03335254|18551643|P2|COMPLETED|Period 1||0
7535957|NCT03335254|18551644|P1|COMPLETED|Period 1||9
7535958|NCT03335254|18551625|P20|STARTED|Period 1||0
7535959|NCT03335254|18551626|P19|STARTED|Period 1||0
7535960|NCT03335254|18551627|P18|STARTED|Period 1||0
7535961|NCT03335254|18551628|P17|STARTED|Period 1||0
7535962|NCT03335254|18551629|P16|STARTED|Period 1||0
7535963|NCT03335254|18551630|P15|STARTED|Period 1||0
7535964|NCT03335254|18551631|P14|STARTED|Period 1||0
7535965|NCT03335254|18551632|P13|STARTED|Period 1||0
7535966|NCT03335254|18551633|P12|STARTED|Period 1||0
7535967|NCT03335254|18551634|P11|STARTED|Period 1||0
7535968|NCT03335254|18551635|P10|STARTED|Period 1||0
7535969|NCT03335254|18551636|P9|STARTED|Period 1||0
7535970|NCT03335254|18551637|P8|STARTED|Period 1||0
7535971|NCT03335254|18551638|P7|STARTED|Period 1||0
7535972|NCT03335254|18551639|P6|STARTED|Period 1||0
7535973|NCT03335254|18551640|P5|STARTED|Period 1||0
7535974|NCT03335254|18551641|P4|STARTED|Period 1||0
7535975|NCT03335254|18551642|P3|STARTED|Period 1||0
7535976|NCT03335254|18551643|P2|STARTED|Period 1||0
7535977|NCT03335254|18551644|P1|STARTED|Period 1||9
7535978|NCT03335150|18551675|P2|NOT COMPLETED|Overall Study||5
7535979|NCT03335150|18551676|P1|NOT COMPLETED|Overall Study||10
7535980|NCT03335150|18551675|P2|COMPLETED|Overall Study||50
7535981|NCT03335150|18551676|P1|COMPLETED|Overall Study||45
7535982|NCT03335150|18551675|P2|POST Testing Session|Overall Study||50
7535983|NCT03335150|18551676|P1|POST Testing Session|Overall Study||45
7535984|NCT03335150|18551675|P2|Commenced Group|Overall Study||52
7535985|NCT03335150|18551676|P1|Commenced Group|Overall Study||47
7535986|NCT03335150|18551675|P2|PRE Testing Session|Overall Study||55
7535987|NCT03335150|18551676|P1|PRE Testing Session|Overall Study||53
7535988|NCT03335150|18551675|P2|Enrolled + Assigned Group|Overall Study||55
7535989|NCT03335150|18551676|P1|Enrolled + Assigned Group|Overall Study||54
7535990|NCT03335150|18551675|P2|STARTED|Overall Study||55
7535991|NCT03335150|18551676|P1|STARTED|Overall Study||55
7535992|NCT03334825|18551700|P2|NOT COMPLETED|Overall Study||4
7535993|NCT03334825|18551701|P1|NOT COMPLETED|Overall Study||7
7535994|NCT03334825|18551700|P2|COMPLETED|Overall Study||113
7535995|NCT03334825|18551701|P1|COMPLETED|Overall Study||112
7535996|NCT03334825|18551700|P2|STARTED|Overall Study||117
7535997|NCT03334825|18551701|P1|STARTED|Overall Study||119
7535998|NCT03334812|18551713|P4|NOT COMPLETED|Overall Study||0
7535999|NCT03334812|18551714|P3|NOT COMPLETED|Overall Study||0
7536000|NCT03334812|18551715|P2|NOT COMPLETED|Overall Study||0
7536001|NCT03334812|18551716|P1|NOT COMPLETED|Overall Study||0
7536002|NCT03334812|18551713|P4|COMPLETED|Overall Study||0
7536003|NCT03334812|18551714|P3|COMPLETED|Overall Study||0
7536004|NCT03334812|18551715|P2|COMPLETED|Overall Study||5
7536005|NCT03334812|18551716|P1|COMPLETED|Overall Study||9
7536006|NCT03334812|18551713|P4|STARTED|Overall Study||0
7536007|NCT03334812|18551714|P3|STARTED|Overall Study||0
7536008|NCT03334812|18551715|P2|STARTED|Overall Study||5
7536009|NCT03334812|18551716|P1|STARTED|Overall Study||9
7536010|NCT03334747|18551747|P9|NOT COMPLETED|Follow-Up Phase||1
7536011|NCT03334747|18551748|P8|NOT COMPLETED|Follow-Up Phase||0
7536012|NCT03334747|18551749|P7|NOT COMPLETED|Follow-Up Phase||1
7536013|NCT03334747|18551750|P6|NOT COMPLETED|Follow-Up Phase||0
7536014|NCT03334747|18551751|P5|NOT COMPLETED|Follow-Up Phase||0
7536015|NCT03334747|18551752|P4|NOT COMPLETED|Follow-Up Phase||0
7536016|NCT03334747|18551753|P3|NOT COMPLETED|Follow-Up Phase||0
7536017|NCT03334747|18551754|P2|NOT COMPLETED|Follow-Up Phase||0
7536018|NCT03334747|18551755|P1|NOT COMPLETED|Follow-Up Phase||0
7536019|NCT03334747|18551747|P9|COMPLETED|Follow-Up Phase||50
7536020|NCT03334747|18551748|P8|COMPLETED|Follow-Up Phase||22
7536021|NCT03334747|18551749|P7|COMPLETED|Follow-Up Phase||20
7536022|NCT03334747|18551750|P6|COMPLETED|Follow-Up Phase||19
7536023|NCT03334747|18551751|P5|COMPLETED|Follow-Up Phase||21
7536024|NCT03334747|18551752|P4|COMPLETED|Follow-Up Phase||20
7536025|NCT03334747|18551753|P3|COMPLETED|Follow-Up Phase||12
7536026|NCT03334747|18551754|P2|COMPLETED|Follow-Up Phase||10
7536027|NCT03334747|18551755|P1|COMPLETED|Follow-Up Phase||9
7536028|NCT03334747|18551747|P9|STARTED|Follow-Up Phase||51
7536029|NCT03334747|18551748|P8|STARTED|Follow-Up Phase||22
7536030|NCT03334747|18551749|P7|STARTED|Follow-Up Phase||21
7536031|NCT03334747|18551750|P6|STARTED|Follow-Up Phase||19
7536032|NCT03334747|18551751|P5|STARTED|Follow-Up Phase||21
7536033|NCT03334747|18551752|P4|STARTED|Follow-Up Phase||20
7536034|NCT03334747|18551753|P3|STARTED|Follow-Up Phase||12
7536035|NCT03334747|18551754|P2|STARTED|Follow-Up Phase||10
7536036|NCT03334747|18551755|P1|STARTED|Follow-Up Phase||9
7536037|NCT03334747|18551747|P9|NOT COMPLETED|Treatment Phase||0
7536038|NCT03334747|18551748|P8|NOT COMPLETED|Treatment Phase||0
7536039|NCT03334747|18551749|P7|NOT COMPLETED|Treatment Phase||0
7536040|NCT03334747|18551750|P6|NOT COMPLETED|Treatment Phase||1
7536041|NCT03334747|18551751|P5|NOT COMPLETED|Treatment Phase||1
7536042|NCT03334747|18551752|P4|NOT COMPLETED|Treatment Phase||0
7536043|NCT03334747|18551753|P3|NOT COMPLETED|Treatment Phase||0
7536044|NCT03334747|18551754|P2|NOT COMPLETED|Treatment Phase||0
7536045|NCT03334747|18551755|P1|NOT COMPLETED|Treatment Phase||1
7536046|NCT03334747|18551747|P9|COMPLETED|Treatment Phase||51
7536047|NCT03334747|18551748|P8|COMPLETED|Treatment Phase||22
7536048|NCT03334747|18551749|P7|COMPLETED|Treatment Phase||21
7536049|NCT03334747|18551750|P6|COMPLETED|Treatment Phase||19
7536050|NCT03334747|18551751|P5|COMPLETED|Treatment Phase||21
7536051|NCT03334747|18551752|P4|COMPLETED|Treatment Phase||20
7536052|NCT03334747|18551753|P3|COMPLETED|Treatment Phase||12
7536053|NCT03334747|18551754|P2|COMPLETED|Treatment Phase||10
7536054|NCT03334747|18551755|P1|COMPLETED|Treatment Phase||9
7536055|NCT03334747|18551747|P9|STARTED|Treatment Phase||51
7536056|NCT03334747|18551748|P8|STARTED|Treatment Phase||22
7536057|NCT03334747|18551749|P7|STARTED|Treatment Phase||21
7536058|NCT03334747|18551750|P6|STARTED|Treatment Phase||20
7536059|NCT03334747|18551751|P5|STARTED|Treatment Phase||22
7536060|NCT03334747|18551752|P4|STARTED|Treatment Phase||20
7536061|NCT03334747|18551753|P3|STARTED|Treatment Phase||12
7536062|NCT03334747|18551754|P2|STARTED|Treatment Phase||10
7536063|NCT03334747|18551755|P1|STARTED|Treatment Phase||10
7536064|NCT03334734|18551847|P4|NOT COMPLETED|Overall Study||0
7536065|NCT03334734|18551848|P3|NOT COMPLETED|Overall Study||2
7536066|NCT03334734|18551849|P2|NOT COMPLETED|Overall Study||0
7536067|NCT03334734|18551850|P1|NOT COMPLETED|Overall Study||0
7536068|NCT03334734|18551847|P4|COMPLETED|Overall Study||1
7536069|NCT03334734|18551848|P3|COMPLETED|Overall Study||5
7536070|NCT03334734|18551849|P2|COMPLETED|Overall Study||4
7536071|NCT03334734|18551850|P1|COMPLETED|Overall Study||4
7536072|NCT03334734|18551847|P4|STARTED|Overall Study||1
7536073|NCT03334734|18551848|P3|STARTED|Overall Study||7
7536074|NCT03334734|18551849|P2|STARTED|Overall Study||4
7536075|NCT03334734|18551850|P1|STARTED|Overall Study||4
7536076|NCT03334721|18551945|P2|NOT COMPLETED|Overall Study||0
7536077|NCT03334721|18551946|P1|NOT COMPLETED|Overall Study||2
7536078|NCT03334721|18551945|P2|COMPLETED|Overall Study||11
7536079|NCT03334721|18551946|P1|COMPLETED|Overall Study||10
7536080|NCT03334721|18551945|P2|STARTED|Overall Study||11
7536081|NCT03334721|18551946|P1|STARTED|Overall Study||12
7536082|NCT03334630|18551954|P2|NOT COMPLETED|Overall Study||13
7536083|NCT03334630|18551955|P1|NOT COMPLETED|Overall Study||14
7536084|NCT03334630|18551954|P2|COMPLETED|Overall Study||230
7536085|NCT03334630|18551955|P1|COMPLETED|Overall Study||225
7536086|NCT03334630|18551954|P2|STARTED|Overall Study||243
7536087|NCT03334630|18551955|P1|STARTED|Overall Study||239
7536088|NCT03334448|18551997|P4|NOT COMPLETED|Period 4||0
7536089|NCT03334448|18551998|P3|NOT COMPLETED|Period 4||0
7536090|NCT03334448|18551999|P2|NOT COMPLETED|Period 4||0
7536091|NCT03334448|18552000|P1|NOT COMPLETED|Period 4||0
7536092|NCT03334448|18551997|P4|COMPLETED|Period 4||11
7536093|NCT03334448|18551998|P3|COMPLETED|Period 4||13
7536094|NCT03334448|18551999|P2|COMPLETED|Period 4||11
7536095|NCT03334448|18552000|P1|COMPLETED|Period 4||12
7536096|NCT03334448|18551997|P4|Received at Least 1 Dose of Study Drug|Period 4||11
7536097|NCT03334448|18551998|P3|Received at Least 1 Dose of Study Drug|Period 4||13
7536098|NCT03334448|18551999|P2|Received at Least 1 Dose of Study Drug|Period 4||11
7536099|NCT03334448|18552000|P1|Received at Least 1 Dose of Study Drug|Period 4||12
7536100|NCT03334448|18551997|P4|STARTED|Period 4||11
7536101|NCT03334448|18551998|P3|STARTED|Period 4||13
7536102|NCT03334448|18551999|P2|STARTED|Period 4||11
7536103|NCT03334448|18552000|P1|STARTED|Period 4||12
7536104|NCT03334448|18551997|P4|NOT COMPLETED|Washout||1
7536105|NCT03334448|18551998|P3|NOT COMPLETED|Washout||0
7536106|NCT03334448|18551999|P2|NOT COMPLETED|Washout||0
7536107|NCT03334448|18552000|P1|NOT COMPLETED|Washout||0
7536108|NCT03334448|18551997|P4|COMPLETED|Washout||11
7536109|NCT03334448|18551998|P3|COMPLETED|Washout||13
7536110|NCT03334448|18551999|P2|COMPLETED|Washout||11
7536111|NCT03334448|18552000|P1|COMPLETED|Washout||12
7536112|NCT03334448|18551997|P4|STARTED|Washout||12
7536113|NCT03334448|18551998|P3|STARTED|Washout||13
7536114|NCT03334448|18551999|P2|STARTED|Washout||11
7536115|NCT03334448|18552000|P1|STARTED|Washout||12
7536116|NCT03334448|18551997|P4|NOT COMPLETED|Period 3||0
7536117|NCT03334448|18551998|P3|NOT COMPLETED|Period 3||0
7536118|NCT03334448|18551999|P2|NOT COMPLETED|Period 3||0
7536119|NCT03334448|18552000|P1|NOT COMPLETED|Period 3||0
7536120|NCT03334448|18551997|P4|COMPLETED|Period 3||12
7536121|NCT03334448|18551998|P3|COMPLETED|Period 3||13
7536122|NCT03334448|18551999|P2|COMPLETED|Period 3||11
7536123|NCT03334448|18552000|P1|COMPLETED|Period 3||12
7536124|NCT03334448|18551997|P4|Received at Least 1 Dose of Study Drug|Period 3||12
7536125|NCT03334448|18551998|P3|Received at Least 1 Dose of Study Drug|Period 3||13
7536126|NCT03334448|18551999|P2|Received at Least 1 Dose of Study Drug|Period 3||11
7536127|NCT03334448|18552000|P1|Received at Least 1 Dose of Study Drug|Period 3||12
7536128|NCT03334448|18551997|P4|STARTED|Period 3||12
7536129|NCT03334448|18551998|P3|STARTED|Period 3||13
7536130|NCT03334448|18551999|P2|STARTED|Period 3||11
7536131|NCT03334448|18552000|P1|STARTED|Period 3||12
7536132|NCT03334448|18551997|P4|NOT COMPLETED|Washout||0
7536133|NCT03334448|18551998|P3|NOT COMPLETED|Washout||0
7536134|NCT03334448|18551999|P2|NOT COMPLETED|Washout||1
7536135|NCT03334448|18552000|P1|NOT COMPLETED|Washout||0
7536136|NCT03334448|18551997|P4|COMPLETED|Washout||12
7536137|NCT03334448|18551998|P3|COMPLETED|Washout||13
7536138|NCT03334448|18551999|P2|COMPLETED|Washout||11
7536139|NCT03334448|18552000|P1|COMPLETED|Washout||12
7536140|NCT03334448|18551997|P4|STARTED|Washout||12
7536141|NCT03334448|18551998|P3|STARTED|Washout||13
7536142|NCT03334448|18551999|P2|STARTED|Washout||12
7536143|NCT03334448|18552000|P1|STARTED|Washout||12
7536144|NCT03334448|18551997|P4|NOT COMPLETED|Period 2||0
7536145|NCT03334448|18551998|P3|NOT COMPLETED|Period 2||0
7536146|NCT03334448|18551999|P2|NOT COMPLETED|Period 2||0
7536147|NCT03334448|18552000|P1|NOT COMPLETED|Period 2||0
7536148|NCT03334448|18551997|P4|COMPLETED|Period 2||12
7536149|NCT03334448|18551998|P3|COMPLETED|Period 2||13
7536150|NCT03334448|18551999|P2|COMPLETED|Period 2||12
7536151|NCT03334448|18552000|P1|COMPLETED|Period 2||12
7536152|NCT03334448|18551997|P4|Received at Least 1 Dose of Study Drug|Period 2||12
7536153|NCT03334448|18551998|P3|Received at Least 1 Dose of Study Drug|Period 2||13
7536154|NCT03334448|18551999|P2|Received at Least 1 Dose of Study Drug|Period 2||12
7536155|NCT03334448|18552000|P1|Received at Least 1 Dose of Study Drug|Period 2||12
7536156|NCT03334448|18551997|P4|STARTED|Period 2||12
7536157|NCT03334448|18551998|P3|STARTED|Period 2||13
7536158|NCT03334448|18551999|P2|STARTED|Period 2||12
7536159|NCT03334448|18552000|P1|STARTED|Period 2||12
7536160|NCT03334448|18551997|P4|NOT COMPLETED|Washout||0
7536161|NCT03334448|18551998|P3|NOT COMPLETED|Washout||0
7536162|NCT03334448|18551999|P2|NOT COMPLETED|Washout||0
7536163|NCT03334448|18552000|P1|NOT COMPLETED|Washout||0
7536164|NCT03334448|18551997|P4|COMPLETED|Washout||12
7536165|NCT03334448|18551998|P3|COMPLETED|Washout||13
7536166|NCT03334448|18551999|P2|COMPLETED|Washout||12
7536167|NCT03334448|18552000|P1|COMPLETED|Washout||12
7536168|NCT03334448|18551997|P4|STARTED|Washout||12
7536169|NCT03334448|18551998|P3|STARTED|Washout||13
7536170|NCT03334448|18551999|P2|STARTED|Washout||12
7536171|NCT03334448|18552000|P1|STARTED|Washout||12
7536172|NCT03334448|18551997|P4|NOT COMPLETED|Period 1||0
7536173|NCT03334448|18551998|P3|NOT COMPLETED|Period 1||0
7536174|NCT03334448|18551999|P2|NOT COMPLETED|Period 1||0
7536175|NCT03334448|18552000|P1|NOT COMPLETED|Period 1||0
7536176|NCT03334448|18551997|P4|COMPLETED|Period 1||12
7536177|NCT03334448|18551998|P3|COMPLETED|Period 1||13
7536178|NCT03334448|18551999|P2|COMPLETED|Period 1||12
7536179|NCT03334448|18552000|P1|COMPLETED|Period 1||12
7536180|NCT03334448|18551997|P4|Received at Least 1 Dose of Study Drug|Period 1||12
7536181|NCT03334448|18551998|P3|Received at Least 1 Dose of Study Drug|Period 1||13
7536182|NCT03334448|18551999|P2|Received at Least 1 Dose of Study Drug|Period 1||12
7536183|NCT03334448|18552000|P1|Received at Least 1 Dose of Study Drug|Period 1||12
7536184|NCT03334448|18551997|P4|STARTED|Period 1||12
7536185|NCT03334448|18551998|P3|STARTED|Period 1||13
7536186|NCT03334448|18551999|P2|STARTED|Period 1||12
7536187|NCT03334448|18552000|P1|STARTED|Period 1||12
7536188|NCT03334422|18552012|P4|NOT COMPLETED|Overall Study||6
7536189|NCT03334422|18552013|P3|NOT COMPLETED|Overall Study||10
7536190|NCT03334422|18552014|P2|NOT COMPLETED|Overall Study||10
7536191|NCT03334422|18552015|P1|NOT COMPLETED|Overall Study||19
7536192|NCT03334422|18552012|P4|COMPLETED|Overall Study||117
7536193|NCT03334422|18552013|P3|COMPLETED|Overall Study||113
7536194|NCT03334422|18552014|P2|COMPLETED|Overall Study||115
7536195|NCT03334422|18552015|P1|COMPLETED|Overall Study||225
7536196|NCT03334422|18552012|P4|Received at Least One Dose of Study Drug|Overall Study||123
7536197|NCT03334422|18552013|P3|Received at Least One Dose of Study Drug|Overall Study||123
7536198|NCT03334422|18552014|P2|Received at Least One Dose of Study Drug|Overall Study||124
7536199|NCT03334422|18552015|P1|Received at Least One Dose of Study Drug|Overall Study||244
7536200|NCT03334422|18552012|P4|STARTED|Overall Study||123
7536201|NCT03334422|18552013|P3|STARTED|Overall Study||123
7536202|NCT03334422|18552014|P2|STARTED|Overall Study||125
7536203|NCT03334422|18552015|P1|STARTED|Overall Study||244
7536204|NCT03334396|18552122|P8|NOT COMPLETED|Overall Study||1
7536205|NCT03334396|18552123|P7|NOT COMPLETED|Overall Study||3
7536206|NCT03334396|18552124|P6|NOT COMPLETED|Overall Study||1
7536207|NCT03334396|18552125|P5|NOT COMPLETED|Overall Study||3
7536208|NCT03334396|18552126|P4|NOT COMPLETED|Overall Study||5
7536209|NCT03334396|18552127|P3|NOT COMPLETED|Overall Study||10
7536210|NCT03334396|18552128|P2|NOT COMPLETED|Overall Study||11
7536211|NCT03334396|18552129|P1|NOT COMPLETED|Overall Study||23
7536212|NCT03334396|18552122|P8|COMPLETED|Overall Study||7
7536213|NCT03334396|18552123|P7|COMPLETED|Overall Study||5
7536214|NCT03334396|18552124|P6|COMPLETED|Overall Study||4
7536215|NCT03334396|18552125|P5|COMPLETED|Overall Study||12
7536216|NCT03334396|18552126|P4|COMPLETED|Overall Study||120
7536217|NCT03334396|18552127|P3|COMPLETED|Overall Study||113
7536218|NCT03334396|18552128|P2|COMPLETED|Overall Study||116
7536219|NCT03334396|18552129|P1|COMPLETED|Overall Study||226
7536220|NCT03334396|18552122|P8|Received at Least One Dose of Study Drug|Overall Study||8
7536221|NCT03334396|18552123|P7|Received at Least One Dose of Study Drug|Overall Study||8
7536222|NCT03334396|18552124|P6|Received at Least One Dose of Study Drug|Overall Study||5
7536223|NCT03334396|18552125|P5|Received at Least One Dose of Study Drug|Overall Study||15
7536224|NCT03334396|18552126|P4|Received at Least One Dose of Study Drug|Overall Study||125
7536225|NCT03334396|18552127|P3|Received at Least One Dose of Study Drug|Overall Study||123
7536226|NCT03334396|18552128|P2|Received at Least One Dose of Study Drug|Overall Study||127
7536227|NCT03334396|18552129|P1|Received at Least One Dose of Study Drug|Overall Study||249
7536228|NCT03334396|18552122|P8|STARTED|Overall Study||8
7536229|NCT03334396|18552123|P7|STARTED|Overall Study||8
7536230|NCT03334396|18552124|P6|STARTED|Overall Study||5
7536231|NCT03334396|18552125|P5|STARTED|Overall Study||15
7536232|NCT03334396|18552126|P4|STARTED|Overall Study||125
7536233|NCT03334396|18552127|P3|STARTED|Overall Study||123
7536234|NCT03334396|18552128|P2|STARTED|Overall Study||127
7536235|NCT03334396|18552129|P1|STARTED|Overall Study||249
7536236|NCT03334214|18552234|P2|NOT COMPLETED|Overall Study||2
7536237|NCT03334214|18552235|P1|NOT COMPLETED|Overall Study||1
7536238|NCT03334214|18552234|P2|COMPLETED|Overall Study||27
7536239|NCT03334214|18552235|P1|COMPLETED|Overall Study||14
7536240|NCT03334214|18552234|P2|STARTED|Overall Study||29
7536241|NCT03334214|18552235|P1|STARTED|Overall Study||15
7536242|NCT03334175|18552261|P2|NOT COMPLETED|Overall Study||1
7536243|NCT03334175|18552262|P1|NOT COMPLETED|Overall Study||0
7536244|NCT03334175|18552261|P2|COMPLETED|Overall Study||9
7536245|NCT03334175|18552262|P1|COMPLETED|Overall Study||8
7536246|NCT03334175|18552261|P2|STARTED|Overall Study||10
7536247|NCT03334175|18552262|P1|STARTED|Overall Study||8
7536248|NCT03333876|18552284|P1|NOT COMPLETED|Positional Therapy||0
7536249|NCT03333876|18552284|P1|COMPLETED|Positional Therapy||54
7536250|NCT03333876|18552284|P1|STARTED|Positional Therapy||54
7536251|NCT03333876|18552284|P1|NOT COMPLETED|Mandibular Advancement||4
7536252|NCT03333876|18552284|P1|COMPLETED|Mandibular Advancement||50
7536253|NCT03333876|18552284|P1|STARTED|Mandibular Advancement||54
7536254|NCT03333876|18552284|P1|NOT COMPLETED|Nasal Dilator||6
7536255|NCT03333876|18552284|P1|COMPLETED|Nasal Dilator||48
7536256|NCT03333876|18552284|P1|STARTED|Nasal Dilator||54
7536257|NCT03333876|18552284|P1|NOT COMPLETED|Screening Period||4
7536258|NCT03333876|18552284|P1|COMPLETED|Screening Period||54
7536259|NCT03333876|18552284|P1|STARTED|Screening Period||58
7536260|NCT03333746|18552305|P1|NOT COMPLETED|Overall Study||1
7536261|NCT03333746|18552305|P1|COMPLETED|Overall Study||0
7536262|NCT03333746|18552305|P1|STARTED|Overall Study||1
7536263|NCT03333577|18552316|P1|NOT COMPLETED|Overall Study||7
7536264|NCT03333577|18552316|P1|COMPLETED|Overall Study||25
7536265|NCT03333577|18552316|P1|STARTED|Overall Study||32
7536266|NCT03333317|18552324|P3|NOT COMPLETED|Overall Study||0
7536267|NCT03333317|18552325|P2|NOT COMPLETED|Overall Study||0
7536268|NCT03333317|18552326|P1|NOT COMPLETED|Overall Study||0
7536269|NCT03333317|18552324|P3|COMPLETED|Overall Study||3
7536270|NCT03333317|18552325|P2|COMPLETED|Overall Study||1
7536271|NCT03333317|18552326|P1|COMPLETED|Overall Study||3
7536272|NCT03333317|18552324|P3|STARTED|Overall Study||3
7536273|NCT03333317|18552325|P2|STARTED|Overall Study||1
7536274|NCT03333317|18552326|P1|STARTED|Overall Study||3
7536275|NCT03332979|18552444|P1|NOT COMPLETED|Overall Study||0
7536276|NCT03332979|18552444|P1|COMPLETED|Overall Study||150
7536277|NCT03332979|18552444|P1|STARTED|Overall Study||150
7536278|NCT03332784|18552475|P20|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
7536279|NCT03332784|18552476|P19|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
7536280|NCT03332784|18552477|P18|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
7536281|NCT03332784|18552478|P17|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
7536282|NCT03332784|18552479|P16|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
7536283|NCT03332784|18552480|P15|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
7536284|NCT03332784|18552481|P14|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
7536285|NCT03332784|18552482|P13|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
7536286|NCT03332784|18552483|P12|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
7536287|NCT03332784|18552484|P11|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
7536288|NCT03332784|18552485|P10|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
7536289|NCT03332784|18552486|P9|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
7536290|NCT03332784|18552487|P8|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
7536291|NCT03332784|18552488|P7|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
7536292|NCT03332784|18552489|P6|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
7536293|NCT03332784|18552490|P5|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
7536294|NCT03332784|18552491|P4|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
7536295|NCT03332784|18552492|P3|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
7536296|NCT03332784|18552493|P2|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
7536297|NCT03332784|18552494|P1|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
7536298|NCT03332784|18552475|P20|COMPLETED|Part 1- Period 3 (1 Day)||0
7536299|NCT03332784|18552476|P19|COMPLETED|Part 1- Period 3 (1 Day)||0
7536300|NCT03332784|18552477|P18|COMPLETED|Part 1- Period 3 (1 Day)||0
7536301|NCT03332784|18552478|P17|COMPLETED|Part 1- Period 3 (1 Day)||0
7536302|NCT03332784|18552479|P16|COMPLETED|Part 1- Period 3 (1 Day)||0
7536303|NCT03332784|18552480|P15|COMPLETED|Part 1- Period 3 (1 Day)||0
7536304|NCT03332784|18552481|P14|COMPLETED|Part 1- Period 3 (1 Day)||0
7536305|NCT03332784|18552482|P13|COMPLETED|Part 1- Period 3 (1 Day)||0
7536306|NCT03332784|18552483|P12|COMPLETED|Part 1- Period 3 (1 Day)||0
7536307|NCT03332784|18552484|P11|COMPLETED|Part 1- Period 3 (1 Day)||0
7536308|NCT03332784|18552485|P10|COMPLETED|Part 1- Period 3 (1 Day)||0
7536309|NCT03332784|18552486|P9|COMPLETED|Part 1- Period 3 (1 Day)||0
7536310|NCT03332784|18552487|P8|COMPLETED|Part 1- Period 3 (1 Day)||2
7536311|NCT03332784|18552488|P7|COMPLETED|Part 1- Period 3 (1 Day)||2
7536312|NCT03332784|18552489|P6|COMPLETED|Part 1- Period 3 (1 Day)||2
7536313|NCT03332784|18552490|P5|COMPLETED|Part 1- Period 3 (1 Day)||2
7536314|NCT03332784|18552491|P4|COMPLETED|Part 1- Period 3 (1 Day)||2
7536315|NCT03332784|18552492|P3|COMPLETED|Part 1- Period 3 (1 Day)||2
7536316|NCT03332784|18552493|P2|COMPLETED|Part 1- Period 3 (1 Day)||1
7536317|NCT03332784|18552494|P1|COMPLETED|Part 1- Period 3 (1 Day)||2
7536318|NCT03332784|18552475|P20|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
7536319|NCT03332784|18552476|P19|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
7536320|NCT03332784|18552477|P18|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
7536321|NCT03332784|18552478|P17|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
7536322|NCT03332784|18552479|P16|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
7536323|NCT03332784|18552480|P15|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
7536324|NCT03332784|18552481|P14|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
7536325|NCT03332784|18552482|P13|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
7536326|NCT03332784|18552483|P12|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
7536327|NCT03332784|18552484|P11|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
7536328|NCT03332784|18552485|P10|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
7536329|NCT03332784|18552486|P9|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
7536330|NCT03332784|18552487|P8|STARTED|Part 1- Period 3 (1 Day)||2
7536331|NCT03332784|18552488|P7|STARTED|Part 1- Period 3 (1 Day)||2
7536332|NCT03332784|18552489|P6|STARTED|Part 1- Period 3 (1 Day)||2
7536333|NCT03332784|18552490|P5|STARTED|Part 1- Period 3 (1 Day)||2
7536334|NCT03332784|18552491|P4|STARTED|Part 1- Period 3 (1 Day)||2
7536335|NCT03332784|18552492|P3|STARTED|Part 1- Period 3 (1 Day)||2
7536336|NCT03332784|18552493|P2|STARTED|Part 1- Period 3 (1 Day)||1
7536337|NCT03332784|18552494|P1|STARTED|Part 1- Period 3 (1 Day)||2
7536338|NCT03332784|18552475|P20|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536339|NCT03332784|18552476|P19|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536340|NCT03332784|18552477|P18|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536341|NCT03332784|18552478|P17|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536342|NCT03332784|18552479|P16|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536343|NCT03332784|18552480|P15|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536344|NCT03332784|18552481|P14|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536345|NCT03332784|18552482|P13|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536346|NCT03332784|18552483|P12|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536347|NCT03332784|18552484|P11|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536348|NCT03332784|18552485|P10|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536349|NCT03332784|18552486|P9|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536350|NCT03332784|18552487|P8|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536351|NCT03332784|18552488|P7|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536352|NCT03332784|18552489|P6|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536353|NCT03332784|18552490|P5|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536354|NCT03332784|18552491|P4|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536355|NCT03332784|18552492|P3|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536356|NCT03332784|18552493|P2|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536357|NCT03332784|18552494|P1|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536358|NCT03332784|18552475|P20|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3
7536359|NCT03332784|18552476|P19|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3
7536360|NCT03332784|18552477|P18|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
7536361|NCT03332784|18552478|P17|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
7536362|NCT03332784|18552479|P16|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
7536363|NCT03332784|18552480|P15|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1
7536364|NCT03332784|18552481|P14|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536365|NCT03332784|18552482|P13|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536366|NCT03332784|18552483|P12|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536367|NCT03332784|18552484|P11|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536368|NCT03332784|18552485|P10|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536369|NCT03332784|18552486|P9|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
7536370|NCT03332784|18552487|P8|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
7536371|NCT03332784|18552488|P7|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
7536372|NCT03332784|18552489|P6|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
7536373|NCT03332784|18552490|P5|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
7536374|NCT03332784|18552491|P4|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
7536375|NCT03332784|18552492|P3|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
7536376|NCT03332784|18552493|P2|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1
7536377|NCT03332784|18552494|P1|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
7536378|NCT03332784|18552475|P20|STARTED|Parts 1 and 2- Period 2 (1 Day)||3
7536379|NCT03332784|18552476|P19|STARTED|Parts 1 and 2- Period 2 (1 Day)||3
7536380|NCT03332784|18552477|P18|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
7536381|NCT03332784|18552478|P17|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
7536382|NCT03332784|18552479|P16|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
7536383|NCT03332784|18552480|P15|STARTED|Parts 1 and 2- Period 2 (1 Day)||1
7536384|NCT03332784|18552481|P14|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
7536385|NCT03332784|18552482|P13|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
7536386|NCT03332784|18552483|P12|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
7536387|NCT03332784|18552484|P11|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
7536388|NCT03332784|18552485|P10|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
7536389|NCT03332784|18552486|P9|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
7536390|NCT03332784|18552487|P8|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
7536391|NCT03332784|18552488|P7|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
7536392|NCT03332784|18552489|P6|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
7536393|NCT03332784|18552490|P5|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
7536394|NCT03332784|18552491|P4|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
7536395|NCT03332784|18552492|P3|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
7536396|NCT03332784|18552493|P2|STARTED|Parts 1 and 2- Period 2 (1 Day)||1
7536397|NCT03332784|18552494|P1|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
7536398|NCT03332784|18552475|P20|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
7536399|NCT03332784|18552476|P19|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
7536400|NCT03332784|18552477|P18|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
7536401|NCT03332784|18552478|P17|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
7536402|NCT03332784|18552479|P16|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
7536403|NCT03332784|18552480|P15|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
7536404|NCT03332784|18552481|P14|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
7536405|NCT03332784|18552482|P13|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
7536406|NCT03332784|18552483|P12|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
7536407|NCT03332784|18552484|P11|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
7536408|NCT03332784|18552485|P10|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
7536409|NCT03332784|18552486|P9|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
7536410|NCT03332784|18552487|P8|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
7536411|NCT03332784|18552488|P7|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
7536412|NCT03332784|18552489|P6|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
7536413|NCT03332784|18552490|P5|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
7536414|NCT03332784|18552491|P4|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
7536415|NCT03332784|18552492|P3|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
7536416|NCT03332784|18552493|P2|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
7536417|NCT03332784|18552494|P1|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
7536418|NCT03332784|18552475|P20|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3
7536419|NCT03332784|18552476|P19|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3
7536420|NCT03332784|18552477|P18|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
7536421|NCT03332784|18552478|P17|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
7536422|NCT03332784|18552479|P16|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
7536423|NCT03332784|18552480|P15|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
7536424|NCT03332784|18552481|P14|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4
7536425|NCT03332784|18552482|P13|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
7536426|NCT03332784|18552483|P12|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
7536427|NCT03332784|18552484|P11|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
7536428|NCT03332784|18552485|P10|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
7536429|NCT03332784|18552486|P9|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4
7536430|NCT03332784|18552487|P8|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
7536431|NCT03332784|18552488|P7|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
7536432|NCT03332784|18552489|P6|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
7536433|NCT03332784|18552490|P5|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
7536434|NCT03332784|18552491|P4|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
7536435|NCT03332784|18552492|P3|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
7536436|NCT03332784|18552493|P2|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
7536437|NCT03332784|18552494|P1|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
7536438|NCT03332784|18552475|P20|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3
7536439|NCT03332784|18552476|P19|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3
7536440|NCT03332784|18552477|P18|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
7536441|NCT03332784|18552478|P17|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
7536442|NCT03332784|18552479|P16|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
7536443|NCT03332784|18552480|P15|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
7536444|NCT03332784|18552481|P14|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4
7536445|NCT03332784|18552482|P13|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
7536446|NCT03332784|18552483|P12|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
7536447|NCT03332784|18552484|P11|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
7536448|NCT03332784|18552485|P10|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
7536449|NCT03332784|18552486|P9|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4
7536450|NCT03332784|18552487|P8|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
7536451|NCT03332784|18552488|P7|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
7536452|NCT03332784|18552489|P6|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
7536453|NCT03332784|18552490|P5|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
7536454|NCT03332784|18552491|P4|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
7536455|NCT03332784|18552492|P3|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
7536456|NCT03332784|18552493|P2|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
7536457|NCT03332784|18552494|P1|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
7536458|NCT03332160|18552752|P2|NOT COMPLETED|Overall Study||5
7536459|NCT03332160|18552753|P1|NOT COMPLETED|Overall Study||1
7536460|NCT03332160|18552752|P2|COMPLETED|Overall Study||19
7536461|NCT03332160|18552753|P1|COMPLETED|Overall Study||24
7536462|NCT03332160|18552752|P2|STARTED|Overall Study||24
7536463|NCT03332160|18552753|P1|STARTED|Overall Study||25
7536464|NCT03331965|18552785|P2|NOT COMPLETED|Overall Study||4
7536465|NCT03331965|18552786|P1|NOT COMPLETED|Overall Study||10
7536466|NCT03331965|18552785|P2|COMPLETED|Overall Study||51
7536467|NCT03331965|18552786|P1|COMPLETED|Overall Study||45
7536468|NCT03331965|18552785|P2|STARTED|Overall Study||55
7536469|NCT03331965|18552786|P1|STARTED|Overall Study||55
7536470|NCT03331835|18552802|P2|NOT COMPLETED|Overall Study||47
7536471|NCT03331835|18552803|P1|NOT COMPLETED|Overall Study||14
7536472|NCT03331835|18552802|P2|COMPLETED|Overall Study||58
7536473|NCT03331835|18552803|P1|COMPLETED|Overall Study||91
7536474|NCT03331835|18552802|P2|STARTED|Overall Study||105
7536475|NCT03331835|18552803|P1|STARTED|Overall Study||105
7536476|NCT03331315|18552837|P2|NOT COMPLETED|Overall Study||14
7536477|NCT03331315|18552838|P1|NOT COMPLETED|Overall Study||18
7536478|NCT03331315|18552837|P2|COMPLETED|Overall Study||68
7536479|NCT03331315|18552838|P1|COMPLETED|Overall Study||70
7536480|NCT03331315|18552837|P2|STARTED|Overall Study||82
7536481|NCT03331315|18552838|P1|STARTED|Overall Study||88
7536482|NCT03331185|18552860|P2|NOT COMPLETED|Overall Study||0
7536483|NCT03331185|18552861|P1|NOT COMPLETED|Overall Study||0
7536484|NCT03331185|18552860|P2|COMPLETED|Overall Study||12
7536485|NCT03331185|18552861|P1|COMPLETED|Overall Study||14
7536486|NCT03331185|18552860|P2|STARTED|Overall Study||12
7536487|NCT03331185|18552861|P1|STARTED|Overall Study||14
7536488|NCT03331042|18552875|P4|NOT COMPLETED|Overall Study||1
7536489|NCT03331042|18552876|P3|NOT COMPLETED|Overall Study||1
7536490|NCT03331042|18552877|P2|NOT COMPLETED|Overall Study||0
7536491|NCT03331042|18552878|P1|NOT COMPLETED|Overall Study||1
7536492|NCT03331042|18552875|P4|COMPLETED|Overall Study||20
7536493|NCT03331042|18552876|P3|COMPLETED|Overall Study||20
7536494|NCT03331042|18552877|P2|COMPLETED|Overall Study||21
7536495|NCT03331042|18552878|P1|COMPLETED|Overall Study||21
7536496|NCT03331042|18552875|P4|STARTED|Overall Study||21
7536497|NCT03331042|18552876|P3|STARTED|Overall Study||21
7536498|NCT03331042|18552877|P2|STARTED|Overall Study||21
7536499|NCT03331042|18552878|P1|STARTED|Overall Study||22
7536500|NCT03330834|18552924|P1|NOT COMPLETED|Overall Study||0
7536501|NCT03330834|18552924|P1|COMPLETED|Overall Study||1
7536502|NCT03330834|18552924|P1|STARTED|Overall Study||1
7536503|NCT03330457|18552934|P4|NOT COMPLETED|Overall Study||0
7536504|NCT03330457|18552935|P3|NOT COMPLETED|Overall Study||0
7536505|NCT03330457|18552936|P2|NOT COMPLETED|Overall Study||0
7536506|NCT03330457|18552937|P1|NOT COMPLETED|Overall Study||0
7536507|NCT03330457|18552934|P4|COMPLETED|Overall Study||3
7536508|NCT03330457|18552935|P3|COMPLETED|Overall Study||6
7536509|NCT03330457|18552936|P2|COMPLETED|Overall Study||3
7536510|NCT03330457|18552937|P1|COMPLETED|Overall Study||6
7536511|NCT03330457|18552934|P4|STARTED|Overall Study||3
7536512|NCT03330457|18552935|P3|STARTED|Overall Study||6
7536513|NCT03330457|18552936|P2|STARTED|Overall Study||3
7536514|NCT03330457|18552937|P1|STARTED|Overall Study||6
7536515|NCT03330275|18552951|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
7536516|NCT03330275|18552952|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
7536517|NCT03330275|18552953|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
7536518|NCT03330275|18552954|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
7536519|NCT03330275|18552955|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
7536520|NCT03330275|18552956|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
7536521|NCT03330275|18552957|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
7536522|NCT03330275|18552958|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
7536523|NCT03330275|18552959|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
7536524|NCT03330275|18552960|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
7536525|NCT03330275|18552951|P10|COMPLETED|Visits 2, 3 and 4 - Period 3||4
7536526|NCT03330275|18552952|P9|COMPLETED|Visits 2, 3 and 4 - Period 3||4
7536527|NCT03330275|18552953|P8|COMPLETED|Visits 2, 3 and 4 - Period 3||4
7536528|NCT03330275|18552954|P7|COMPLETED|Visits 2, 3 and 4 - Period 3||4
7536529|NCT03330275|18552955|P6|COMPLETED|Visits 2, 3 and 4 - Period 3||4
7536530|NCT03330275|18552956|P5|COMPLETED|Visits 2, 3 and 4 - Period 3||4
7536531|NCT03330275|18552957|P4|COMPLETED|Visits 2, 3 and 4 - Period 3||0
7536532|NCT03330275|18552958|P3|COMPLETED|Visits 2, 3 and 4 - Period 3||0
7536533|NCT03330275|18552959|P2|COMPLETED|Visits 2, 3 and 4 - Period 3||0
7536534|NCT03330275|18552960|P1|COMPLETED|Visits 2, 3 and 4 - Period 3||0
7536535|NCT03330275|18552951|P10|STARTED|Visits 2, 3 and 4 - Period 3||4
7536536|NCT03330275|18552952|P9|STARTED|Visits 2, 3 and 4 - Period 3||4
7536537|NCT03330275|18552953|P8|STARTED|Visits 2, 3 and 4 - Period 3||4
7536538|NCT03330275|18552954|P7|STARTED|Visits 2, 3 and 4 - Period 3||4
7536539|NCT03330275|18552955|P6|STARTED|Visits 2, 3 and 4 - Period 3||4
7536540|NCT03330275|18552956|P5|STARTED|Visits 2, 3 and 4 - Period 3||4
7536541|NCT03330275|18552957|P4|STARTED|Visits 2, 3 and 4 - Period 3||0
7536542|NCT03330275|18552958|P3|STARTED|Visits 2, 3 and 4 - Period 3||0
7536543|NCT03330275|18552959|P2|STARTED|Visits 2, 3 and 4 - Period 3||0
7536544|NCT03330275|18552960|P1|STARTED|Visits 2, 3 and 4 - Period 3||0
7536545|NCT03330275|18552951|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
7536546|NCT03330275|18552952|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
7536547|NCT03330275|18552953|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
7536548|NCT03330275|18552954|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
7536549|NCT03330275|18552955|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
7536550|NCT03330275|18552956|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
7536551|NCT03330275|18552957|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
7536552|NCT03330275|18552958|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
7536553|NCT03330275|18552959|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
7536554|NCT03330275|18552960|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
7536555|NCT03330275|18552951|P10|COMPLETED|Visits 2, 3 and 4 - Period 2||4
7536556|NCT03330275|18552952|P9|COMPLETED|Visits 2, 3 and 4 - Period 2||4
7536557|NCT03330275|18552953|P8|COMPLETED|Visits 2, 3 and 4 - Period 2||4
7536558|NCT03330275|18552954|P7|COMPLETED|Visits 2, 3 and 4 - Period 2||4
7536559|NCT03330275|18552955|P6|COMPLETED|Visits 2, 3 and 4 - Period 2||4
7536560|NCT03330275|18552956|P5|COMPLETED|Visits 2, 3 and 4 - Period 2||4
7536561|NCT03330275|18552957|P4|COMPLETED|Visits 2, 3 and 4 - Period 2||0
7536562|NCT03330275|18552958|P3|COMPLETED|Visits 2, 3 and 4 - Period 2||0
7536563|NCT03330275|18552959|P2|COMPLETED|Visits 2, 3 and 4 - Period 2||0
7536564|NCT03330275|18552960|P1|COMPLETED|Visits 2, 3 and 4 - Period 2||0
7536565|NCT03330275|18552951|P10|STARTED|Visits 2, 3 and 4 - Period 2||4
7536566|NCT03330275|18552952|P9|STARTED|Visits 2, 3 and 4 - Period 2||4
7536567|NCT03330275|18552953|P8|STARTED|Visits 2, 3 and 4 - Period 2||4
7536568|NCT03330275|18552954|P7|STARTED|Visits 2, 3 and 4 - Period 2||4
7536569|NCT03330275|18552955|P6|STARTED|Visits 2, 3 and 4 - Period 2||4
7536570|NCT03330275|18552956|P5|STARTED|Visits 2, 3 and 4 - Period 2||4
7536571|NCT03330275|18552957|P4|STARTED|Visits 2, 3 and 4 - Period 2||0
7536572|NCT03330275|18552958|P3|STARTED|Visits 2, 3 and 4 - Period 2||0
7536573|NCT03330275|18552959|P2|STARTED|Visits 2, 3 and 4 - Period 2||0
7536574|NCT03330275|18552960|P1|STARTED|Visits 2, 3 and 4 - Period 2||0
7536575|NCT03330275|18552951|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
7536576|NCT03330275|18552952|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
7536577|NCT03330275|18552953|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
7536578|NCT03330275|18552954|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
7536579|NCT03330275|18552955|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
7536580|NCT03330275|18552956|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
7536581|NCT03330275|18552957|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
7536582|NCT03330275|18552958|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
7536583|NCT03330275|18552959|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
7536584|NCT03330275|18552960|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
7536585|NCT03330275|18552951|P10|COMPLETED|Visits 2, 3 and 4 - Period 1||4
7536586|NCT03330275|18552952|P9|COMPLETED|Visits 2, 3 and 4 - Period 1||4
7536587|NCT03330275|18552953|P8|COMPLETED|Visits 2, 3 and 4 - Period 1||4
7536588|NCT03330275|18552954|P7|COMPLETED|Visits 2, 3 and 4 - Period 1||4
7536589|NCT03330275|18552955|P6|COMPLETED|Visits 2, 3 and 4 - Period 1||4
7536590|NCT03330275|18552956|P5|COMPLETED|Visits 2, 3 and 4 - Period 1||4
7536591|NCT03330275|18552957|P4|COMPLETED|Visits 2, 3 and 4 - Period 1||0
7536592|NCT03330275|18552958|P3|COMPLETED|Visits 2, 3 and 4 - Period 1||0
7536593|NCT03330275|18552959|P2|COMPLETED|Visits 2, 3 and 4 - Period 1||0
7536594|NCT03330275|18552960|P1|COMPLETED|Visits 2, 3 and 4 - Period 1||0
7536595|NCT03330275|18552951|P10|STARTED|Visits 2, 3 and 4 - Period 1||4
7536596|NCT03330275|18552952|P9|STARTED|Visits 2, 3 and 4 - Period 1||4
7536597|NCT03330275|18552953|P8|STARTED|Visits 2, 3 and 4 - Period 1||4
7536598|NCT03330275|18552954|P7|STARTED|Visits 2, 3 and 4 - Period 1||4
7536599|NCT03330275|18552955|P6|STARTED|Visits 2, 3 and 4 - Period 1||4
7536600|NCT03330275|18552956|P5|STARTED|Visits 2, 3 and 4 - Period 1||4
7536601|NCT03330275|18552957|P4|STARTED|Visits 2, 3 and 4 - Period 1||0
7536602|NCT03330275|18552958|P3|STARTED|Visits 2, 3 and 4 - Period 1||0
7536603|NCT03330275|18552959|P2|STARTED|Visits 2, 3 and 4 - Period 1||0
7536604|NCT03330275|18552960|P1|STARTED|Visits 2, 3 and 4 - Period 1||0
7536605|NCT03330275|18552951|P10|NOT COMPLETED|Visit 1 - Period 2||0
7536606|NCT03330275|18552952|P9|NOT COMPLETED|Visit 1 - Period 2||0
7536607|NCT03330275|18552953|P8|NOT COMPLETED|Visit 1 - Period 2||0
7536608|NCT03330275|18552954|P7|NOT COMPLETED|Visit 1 - Period 2||0
7536609|NCT03330275|18552955|P6|NOT COMPLETED|Visit 1 - Period 2||0
7536610|NCT03330275|18552956|P5|NOT COMPLETED|Visit 1 - Period 2||0
7536611|NCT03330275|18552957|P4|NOT COMPLETED|Visit 1 - Period 2||0
7536612|NCT03330275|18552958|P3|NOT COMPLETED|Visit 1 - Period 2||0
7536613|NCT03330275|18552959|P2|NOT COMPLETED|Visit 1 - Period 2||0
7536614|NCT03330275|18552960|P1|NOT COMPLETED|Visit 1 - Period 2||0
7536615|NCT03330275|18552951|P10|COMPLETED|Visit 1 - Period 2||0
7536616|NCT03330275|18552952|P9|COMPLETED|Visit 1 - Period 2||0
7536617|NCT03330275|18552953|P8|COMPLETED|Visit 1 - Period 2||0
7536618|NCT03330275|18552954|P7|COMPLETED|Visit 1 - Period 2||0
7536619|NCT03330275|18552955|P6|COMPLETED|Visit 1 - Period 2||0
7536620|NCT03330275|18552956|P5|COMPLETED|Visit 1 - Period 2||0
7536621|NCT03330275|18552957|P4|COMPLETED|Visit 1 - Period 2||6
7536622|NCT03330275|18552958|P3|COMPLETED|Visit 1 - Period 2||6
7536623|NCT03330275|18552959|P2|COMPLETED|Visit 1 - Period 2||6
7536624|NCT03330275|18552960|P1|COMPLETED|Visit 1 - Period 2||6
7536625|NCT03330275|18552951|P10|STARTED|Visit 1 - Period 2||0
7536626|NCT03330275|18552952|P9|STARTED|Visit 1 - Period 2||0
7536627|NCT03330275|18552953|P8|STARTED|Visit 1 - Period 2||0
7536628|NCT03330275|18552954|P7|STARTED|Visit 1 - Period 2||0
7536629|NCT03330275|18552955|P6|STARTED|Visit 1 - Period 2||0
7536630|NCT03330275|18552956|P5|STARTED|Visit 1 - Period 2||0
7536631|NCT03330275|18552957|P4|STARTED|Visit 1 - Period 2||6
7536632|NCT03330275|18552958|P3|STARTED|Visit 1 - Period 2||6
7536633|NCT03330275|18552959|P2|STARTED|Visit 1 - Period 2||6
7536634|NCT03330275|18552960|P1|STARTED|Visit 1 - Period 2||6
7536635|NCT03330275|18552951|P10|NOT COMPLETED|Visit 1 - Period 1||0
7536636|NCT03330275|18552952|P9|NOT COMPLETED|Visit 1 - Period 1||0
7536637|NCT03330275|18552953|P8|NOT COMPLETED|Visit 1 - Period 1||0
7536638|NCT03330275|18552954|P7|NOT COMPLETED|Visit 1 - Period 1||0
7536639|NCT03330275|18552955|P6|NOT COMPLETED|Visit 1 - Period 1||0
7536640|NCT03330275|18552956|P5|NOT COMPLETED|Visit 1 - Period 1||0
7536641|NCT03330275|18552957|P4|NOT COMPLETED|Visit 1 - Period 1||0
7536642|NCT03330275|18552958|P3|NOT COMPLETED|Visit 1 - Period 1||0
7536643|NCT03330275|18552959|P2|NOT COMPLETED|Visit 1 - Period 1||0
7536644|NCT03330275|18552960|P1|NOT COMPLETED|Visit 1 - Period 1||0
7536645|NCT03330275|18552951|P10|COMPLETED|Visit 1 - Period 1||0
7536646|NCT03330275|18552952|P9|COMPLETED|Visit 1 - Period 1||0
7536647|NCT03330275|18552953|P8|COMPLETED|Visit 1 - Period 1||0
7536648|NCT03330275|18552954|P7|COMPLETED|Visit 1 - Period 1||0
7536649|NCT03330275|18552955|P6|COMPLETED|Visit 1 - Period 1||0
7536650|NCT03330275|18552956|P5|COMPLETED|Visit 1 - Period 1||0
7536651|NCT03330275|18552957|P4|COMPLETED|Visit 1 - Period 1||6
7536652|NCT03330275|18552958|P3|COMPLETED|Visit 1 - Period 1||6
7536653|NCT03330275|18552959|P2|COMPLETED|Visit 1 - Period 1||6
7536654|NCT03330275|18552960|P1|COMPLETED|Visit 1 - Period 1||6
7536655|NCT03330275|18552951|P10|STARTED|Visit 1 - Period 1||0
7536656|NCT03330275|18552952|P9|STARTED|Visit 1 - Period 1||0
7536657|NCT03330275|18552953|P8|STARTED|Visit 1 - Period 1||0
7536658|NCT03330275|18552954|P7|STARTED|Visit 1 - Period 1||0
7536659|NCT03330275|18552955|P6|STARTED|Visit 1 - Period 1||0
7536660|NCT03330275|18552956|P5|STARTED|Visit 1 - Period 1||0
7536661|NCT03330275|18552957|P4|STARTED|Visit 1 - Period 1||6
7536662|NCT03330275|18552958|P3|STARTED|Visit 1 - Period 1||6
7536663|NCT03330275|18552959|P2|STARTED|Visit 1 - Period 1||6
7536664|NCT03330275|18552960|P1|STARTED|Visit 1 - Period 1||6
7536665|NCT03330236|18552988|P2|NOT COMPLETED|Overall Study||84
7536666|NCT03330236|18552989|P1|NOT COMPLETED|Overall Study||100
7536667|NCT03330236|18552988|P2|COMPLETED|Overall Study||697
7536668|NCT03330236|18552989|P1|COMPLETED|Overall Study||679
7536669|NCT03330236|18552988|P2|Modified ITT|Overall Study||774
7536670|NCT03330236|18552989|P1|Modified ITT|Overall Study||773
7536671|NCT03330236|18552988|P2|Received Surgery|Overall Study||781
7536672|NCT03330236|18552989|P1|Received Surgery|Overall Study||779
7536673|NCT03330236|18552988|P2|STARTED|Overall Study||781
7536674|NCT03330236|18552989|P1|STARTED|Overall Study||779
7536675|NCT03330041|18553013|P1|NOT COMPLETED|Overall Study||2
7536676|NCT03330041|18553013|P1|COMPLETED|Overall Study||48
7536677|NCT03330041|18553013|P1|STARTED|Overall Study||50
7536678|NCT03329989|18553023|P1|NOT COMPLETED|Overall Study||23
7536679|NCT03329989|18553023|P1|COMPLETED|Overall Study||135
7536680|NCT03329989|18553023|P1|STARTED|Overall Study||158
7536681|NCT03329885|18553041|P9|NOT COMPLETED|Overall Study||0
7536682|NCT03329885|18553042|P8|NOT COMPLETED|Overall Study||1
7536683|NCT03329885|18553043|P7|NOT COMPLETED|Overall Study||1
7536684|NCT03329885|18553044|P6|NOT COMPLETED|Overall Study||0
7536685|NCT03329885|18553045|P5|NOT COMPLETED|Overall Study||0
7536686|NCT03329885|18553046|P4|NOT COMPLETED|Overall Study||0
7536687|NCT03329885|18553047|P3|NOT COMPLETED|Overall Study||0
7536688|NCT03329885|18553048|P2|NOT COMPLETED|Overall Study||0
7536689|NCT03329885|18553049|P1|NOT COMPLETED|Overall Study||0
7536690|NCT03329885|18553041|P9|COMPLETED|Overall Study||0
7536691|NCT03329885|18553042|P8|COMPLETED|Overall Study||0
7536692|NCT03329885|18553043|P7|COMPLETED|Overall Study||0
7536693|NCT03329885|18553044|P6|COMPLETED|Overall Study||3
7536694|NCT03329885|18553045|P5|COMPLETED|Overall Study||6
7536695|NCT03329885|18553046|P4|COMPLETED|Overall Study||6
7536696|NCT03329885|18553047|P3|COMPLETED|Overall Study||6
7536697|NCT03329885|18553048|P2|COMPLETED|Overall Study||6
7536698|NCT03329885|18553049|P1|COMPLETED|Overall Study||9
7536699|NCT03329885|18553041|P9|STARTED|Overall Study|Due to early termination of study, Part C was cancelled and no patients were dosed|0
7536700|NCT03329885|18553042|P8|STARTED|Overall Study||1
7536701|NCT03329885|18553043|P7|STARTED|Overall Study||1
7536702|NCT03329885|18553044|P6|STARTED|Overall Study||3
7536703|NCT03329885|18553045|P5|STARTED|Overall Study||6
7536704|NCT03329885|18553046|P4|STARTED|Overall Study||6
7536705|NCT03329885|18553047|P3|STARTED|Overall Study||6
7536706|NCT03329885|18553048|P2|STARTED|Overall Study||6
7536707|NCT03329885|18553049|P1|STARTED|Overall Study||9
7536708|NCT03329690|18553218|P5|NOT COMPLETED|Overall Study||22
7536709|NCT03329690|18553219|P4|NOT COMPLETED|Overall Study||21
7536710|NCT03329690|18553220|P3|NOT COMPLETED|Overall Study||6
7536711|NCT03329690|18553221|P2|NOT COMPLETED|Overall Study||53
7536712|NCT03329690|18553222|P1|NOT COMPLETED|Overall Study||98
7536713|NCT03329690|18553218|P5|COMPLETED|Overall Study||2
7536714|NCT03329690|18553219|P4|COMPLETED|Overall Study||0
7536715|NCT03329690|18553220|P3|COMPLETED|Overall Study||1
7536716|NCT03329690|18553221|P2|COMPLETED|Overall Study||2
7536717|NCT03329690|18553222|P1|COMPLETED|Overall Study||28
7536718|NCT03329690|18553218|P5|Received Treatment|Overall Study||24
7536719|NCT03329690|18553219|P4|Received Treatment|Overall Study||20
7536720|NCT03329690|18553220|P3|Received Treatment|Overall Study||7
7536721|NCT03329690|18553221|P2|Received Treatment|Overall Study||55
7536722|NCT03329690|18553222|P1|Received Treatment|Overall Study||125
7536723|NCT03329690|18553218|P5|STARTED|Overall Study||24
7536724|NCT03329690|18553219|P4|STARTED|Overall Study||21
7536725|NCT03329690|18553220|P3|STARTED|Overall Study||7
7536726|NCT03329690|18553221|P2|STARTED|Overall Study||55
7536727|NCT03329690|18553222|P1|STARTED|Overall Study||126
7536728|NCT03329573|18553304|P4|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
7536729|NCT03329573|18553305|P3|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
7536730|NCT03329573|18553306|P2|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
7536731|NCT03329573|18553307|P1|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
7536732|NCT03329573|18553304|P4|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
7536733|NCT03329573|18553305|P3|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
7536734|NCT03329573|18553306|P2|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||20
7536735|NCT03329573|18553307|P1|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||21
7536736|NCT03329573|18553304|P4|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
7536737|NCT03329573|18553305|P3|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
7536738|NCT03329573|18553306|P2|STARTED|Treatment Period 2 (Day 12 to Day 26)||21
7536739|NCT03329573|18553307|P1|STARTED|Treatment Period 2 (Day 12 to Day 26)||22
7536740|NCT03329573|18553304|P4|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
7536741|NCT03329573|18553305|P3|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
7536742|NCT03329573|18553306|P2|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
7536743|NCT03329573|18553307|P1|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
7536744|NCT03329573|18553304|P4|COMPLETED|Washout Period (Day 6 to Day 11)||19
7536745|NCT03329573|18553305|P3|COMPLETED|Washout Period (Day 6 to Day 11)||19
7536746|NCT03329573|18553306|P2|COMPLETED|Washout Period (Day 6 to Day 11)||21
7536747|NCT03329573|18553307|P1|COMPLETED|Washout Period (Day 6 to Day 11)||22
7536748|NCT03329573|18553304|P4|STARTED|Washout Period (Day 6 to Day 11)||19
7536749|NCT03329573|18553305|P3|STARTED|Washout Period (Day 6 to Day 11)||19
7536750|NCT03329573|18553306|P2|STARTED|Washout Period (Day 6 to Day 11)||21
7536751|NCT03329573|18553307|P1|STARTED|Washout Period (Day 6 to Day 11)||22
7536752|NCT03329573|18553304|P4|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
7536753|NCT03329573|18553305|P3|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
7536754|NCT03329573|18553306|P2|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||3
7536755|NCT03329573|18553307|P1|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||1
7536756|NCT03329573|18553304|P4|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
7536757|NCT03329573|18553305|P3|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
7536758|NCT03329573|18553306|P2|COMPLETED|Treatment Period 1 (Up to 5 Days)||21
7536759|NCT03329573|18553307|P1|COMPLETED|Treatment Period 1 (Up to 5 Days)||22
7536760|NCT03329573|18553304|P4|STARTED|Treatment Period 1 (Up to 5 Days)||19
7536761|NCT03329573|18553305|P3|STARTED|Treatment Period 1 (Up to 5 Days)||19
7536762|NCT03329573|18553306|P2|STARTED|Treatment Period 1 (Up to 5 Days)||24
7536763|NCT03329573|18553307|P1|STARTED|Treatment Period 1 (Up to 5 Days)||23
7536764|NCT03329209|18553373|P1|NOT COMPLETED|Overall Study||0
7536765|NCT03329209|18553373|P1|COMPLETED|Overall Study||16
7536766|NCT03329209|18553373|P1|STARTED|Overall Study||16
7536767|NCT03328949|18553381|P1|NOT COMPLETED|Overall Study||0
7536768|NCT03328949|18553381|P1|COMPLETED|Overall Study||120
7536769|NCT03328949|18553381|P1|STARTED|Overall Study||120
7536770|NCT03328897|18553391|P3|NOT COMPLETED|Follow-up Epoch||2
7536771|NCT03328897|18553392|P2|NOT COMPLETED|Follow-up Epoch||3
7536772|NCT03328897|18553393|P1|NOT COMPLETED|Follow-up Epoch||8
7536773|NCT03328897|18553391|P3|COMPLETED|Follow-up Epoch||79
7536774|NCT03328897|18553392|P2|COMPLETED|Follow-up Epoch||160
7536775|NCT03328897|18553393|P1|COMPLETED|Follow-up Epoch||153
7536776|NCT03328897|18553391|P3|STARTED|Follow-up Epoch||81
7536777|NCT03328897|18553392|P2|STARTED|Follow-up Epoch||163
7536778|NCT03328897|18553393|P1|STARTED|Follow-up Epoch||161
7536779|NCT03328897|18553391|P3|NOT COMPLETED|Randomized-treatment Epoch||2
7536780|NCT03328897|18553392|P2|NOT COMPLETED|Randomized-treatment Epoch||5
7536781|NCT03328897|18553393|P1|NOT COMPLETED|Randomized-treatment Epoch||16
7536782|NCT03328897|18553391|P3|COMPLETED|Randomized-treatment Epoch||81
7536783|NCT03328897|18553392|P2|COMPLETED|Randomized-treatment Epoch||162
7536784|NCT03328897|18553393|P1|COMPLETED|Randomized-treatment Epoch||152
7536785|NCT03328897|18553391|P3|Full Analysis Set (FAS)|Randomized-treatment Epoch||83
7536786|NCT03328897|18553392|P2|Full Analysis Set (FAS)|Randomized-treatment Epoch||167
7536787|NCT03328897|18553393|P1|Full Analysis Set (FAS)|Randomized-treatment Epoch||167
7536788|NCT03328897|18553391|P3|STARTED|Randomized-treatment Epoch||83
7536789|NCT03328897|18553392|P2|STARTED|Randomized-treatment Epoch||167
7536790|NCT03328897|18553393|P1|STARTED|Randomized-treatment Epoch||168
7536791|NCT03328624|18553422|P1|NOT COMPLETED|Overall Study||0
7536792|NCT03328624|18553422|P1|COMPLETED|Overall Study||36
7536793|NCT03328624|18553422|P1|STARTED|Overall Study||36
7536794|NCT03328208|18553428|P2|NOT COMPLETED|Overall Study||0
7536795|NCT03328208|18553429|P1|NOT COMPLETED|Overall Study||0
7536796|NCT03328208|18553428|P2|COMPLETED|Overall Study||35
7536797|NCT03328208|18553429|P1|COMPLETED|Overall Study||37
7536798|NCT03328208|18553428|P2|STARTED|Overall Study||35
7536799|NCT03328208|18553429|P1|STARTED|Overall Study||37
7536800|NCT03328182|18553455|P1|NOT COMPLETED|Overall Study||4
7536801|NCT03328182|18553455|P1|COMPLETED|Overall Study||30
7536802|NCT03328182|18553455|P1|STARTED|Overall Study||34
7536803|NCT03327402|18553460|P1|NOT COMPLETED|Overall Study||2
7536804|NCT03327402|18553460|P1|COMPLETED|Overall Study||22
7536805|NCT03327402|18553460|P1|Sparse PK Sampling Group|Overall Study||12
7536806|NCT03327402|18553460|P1|Rich PK Sampling Group|Overall Study||12
7536807|NCT03327402|18553460|P1|STARTED|Overall Study||24
7536808|NCT03327051|18553495|P2|NOT COMPLETED|Overall Study||5
7536809|NCT03327051|18553496|P1|NOT COMPLETED|Overall Study||5
7536810|NCT03327051|18553495|P2|COMPLETED|Overall Study||15
7536811|NCT03327051|18553496|P1|COMPLETED|Overall Study||14
7536812|NCT03327051|18553495|P2|Attended Visit 2 (Week 0)|Overall Study||15
7536813|NCT03327051|18553496|P1|Attended Visit 2 (Week 0)|Overall Study||15
7536814|NCT03327051|18553495|P2|Received Treatment|Overall Study||16
7536815|NCT03327051|18553496|P1|Received Treatment|Overall Study||16
7536816|NCT03327051|18553495|P2|STARTED|Overall Study||20
7536817|NCT03327051|18553496|P1|STARTED|Overall Study||19
7536818|NCT03326999|18553510|P2|NOT COMPLETED|Overall Study||0
7536819|NCT03326999|18553511|P1|NOT COMPLETED|Overall Study||0
7536820|NCT03326999|18553510|P2|COMPLETED|Overall Study||30
7536821|NCT03326999|18553511|P1|COMPLETED|Overall Study||30
7536822|NCT03326999|18553510|P2|STARTED|Overall Study||30
7536823|NCT03326999|18553511|P1|STARTED|Overall Study||30
7536824|NCT03326986|18553530|P3|NOT COMPLETED|Overall Study||0
7536825|NCT03326986|18553531|P2|NOT COMPLETED|Overall Study||0
7536826|NCT03326986|18553532|P1|NOT COMPLETED|Overall Study||0
7536827|NCT03326986|18553530|P3|COMPLETED|Overall Study||8
7536828|NCT03326986|18553531|P2|COMPLETED|Overall Study||8
7536829|NCT03326986|18553532|P1|COMPLETED|Overall Study||8
7536830|NCT03326986|18553530|P3|STARTED|Overall Study||8
7536831|NCT03326986|18553531|P2|STARTED|Overall Study||8
7536832|NCT03326986|18553532|P1|STARTED|Overall Study||8
7536833|NCT03326869|18553774|P2|NOT COMPLETED|Overall Study||1
7536834|NCT03326869|18553775|P1|NOT COMPLETED|Overall Study||1
7536835|NCT03326869|18553774|P2|COMPLETED|Overall Study||0
7536836|NCT03326869|18553775|P1|COMPLETED|Overall Study||0
7536837|NCT03326869|18553774|P2|STARTED|Overall Study||1
7536838|NCT03326869|18553775|P1|STARTED|Overall Study||1
7536839|NCT03326843|18553783|P1|NOT COMPLETED|Overall Study||0
7536840|NCT03326843|18553783|P1|COMPLETED|Overall Study||4
7536841|NCT03326843|18553783|P1|STARTED|Overall Study||4
7536842|NCT03326518|18553791|P3|NOT COMPLETED|Overall Study||1
7536843|NCT03326518|18553792|P2|NOT COMPLETED|Overall Study||0
7536844|NCT03326518|18553793|P1|NOT COMPLETED|Overall Study||3
7536845|NCT03326518|18553791|P3|COMPLETED|Overall Study||13
7536846|NCT03326518|18553792|P2|COMPLETED|Overall Study||12
7536847|NCT03326518|18553793|P1|COMPLETED|Overall Study||16
7536848|NCT03326518|18553791|P3|STARTED|Overall Study||14
7536849|NCT03326518|18553792|P2|STARTED|Overall Study||12
7536850|NCT03326518|18553793|P1|STARTED|Overall Study||19
7536851|NCT03326323|18553828|P1|NOT COMPLETED|Overall Study||3
7536852|NCT03326323|18553828|P1|COMPLETED|Overall Study||40
7536853|NCT03326323|18553828|P1|STARTED|Overall Study||43
7536854|NCT03325894|18553835|P2|NOT COMPLETED|Overall Study||77
7536855|NCT03325894|18553836|P1|NOT COMPLETED|Overall Study||64
7536856|NCT03325894|18553835|P2|COMPLETED|Overall Study||0
7536857|NCT03325894|18553836|P1|COMPLETED|Overall Study||0
7536858|NCT03325894|18553835|P2|STARTED|Overall Study||77
7536859|NCT03325894|18553836|P1|STARTED|Overall Study||64
7536860|NCT03325881|18553904|P2|NOT COMPLETED|Overall Study||3
7536861|NCT03325881|18553905|P1|NOT COMPLETED|Overall Study||3
7536862|NCT03325881|18553904|P2|COMPLETED|Overall Study||42
7536863|NCT03325881|18553905|P1|COMPLETED|Overall Study||41
7536864|NCT03325881|18553904|P2|Treated|Overall Study||45
7536865|NCT03325881|18553905|P1|Treated|Overall Study||43
7536866|NCT03325881|18553904|P2|STARTED|Overall Study||45
7536867|NCT03325881|18553905|P1|STARTED|Overall Study||44
7536868|NCT03325673|18553933|P2|NOT COMPLETED|Overall Study||0
7536869|NCT03325673|18553934|P1|NOT COMPLETED|Overall Study||4
7536870|NCT03325673|18553933|P2|COMPLETED|Overall Study||42
7536871|NCT03325673|18553934|P1|COMPLETED|Overall Study||38
7536872|NCT03325673|18553933|P2|STARTED|Overall Study||42
7536873|NCT03325673|18553934|P1|STARTED|Overall Study||42
7536874|NCT03324451|18553948|P2|NOT COMPLETED|Overall Study||13
7536875|NCT03324451|18553949|P1|NOT COMPLETED|Overall Study||32
7536876|NCT03324451|18553948|P2|COMPLETED|Overall Study||41
7536877|NCT03324451|18553949|P1|COMPLETED|Overall Study||65
7536878|NCT03324451|18553948|P2|STARTED|Overall Study||54
7536879|NCT03324451|18553949|P1|STARTED|Overall Study||97
7536880|NCT03323736|18553966|P3|NOT COMPLETED|Overall Study||2
7536881|NCT03323736|18553967|P2|NOT COMPLETED|Overall Study||12
7536882|NCT03323736|18553968|P1|NOT COMPLETED|Overall Study||19
7536883|NCT03323736|18553966|P3|COMPLETED|Overall Study||68
7536884|NCT03323736|18553967|P2|COMPLETED|Overall Study||47
7536885|NCT03323736|18553968|P1|COMPLETED|Overall Study||222
7536886|NCT03323736|18553966|P3|Treated|Overall Study||68
7536887|NCT03323736|18553967|P2|Treated|Overall Study||47
7536888|NCT03323736|18553968|P1|Treated|Overall Study||222
7536889|NCT03323736|18553966|P3|STARTED|Overall Study||70
7536890|NCT03323736|18553967|P2|STARTED|Overall Study||59
7536891|NCT03323736|18553968|P1|STARTED|Overall Study||241
7536892|NCT03323723|18553979|P1|NOT COMPLETED|Treatment Phase||9
7536893|NCT03323723|18553979|P1|COMPLETED|Treatment Phase||51
7536894|NCT03323723|18553979|P1|STARTED|Treatment Phase||60
7536895|NCT03323723|18553979|P1|NOT COMPLETED|Baseline Phase||4
7536896|NCT03323723|18553979|P1|COMPLETED|Baseline Phase||60
7536897|NCT03323723|18553979|P1|STARTED|Baseline Phase||64
7536898|NCT03323723|18553979|P1|NOT COMPLETED|Screening||9
7536899|NCT03323723|18553979|P1|COMPLETED|Screening||64
7536900|NCT03323723|18553979|P1|STARTED|Screening||73
7536901|NCT03323307|18553986|P1|NOT COMPLETED|Overall Study||0
7536902|NCT03323307|18553986|P1|COMPLETED|Overall Study||70
7536903|NCT03323307|18553986|P1|STARTED|Overall Study||70
7536904|NCT03323164|18553995|P2|NOT COMPLETED|Overall Study||2
7536905|NCT03323164|18553996|P1|NOT COMPLETED|Overall Study||2
7536906|NCT03323164|18553995|P2|COMPLETED|Overall Study||15
7536907|NCT03323164|18553996|P1|COMPLETED|Overall Study||16
7536908|NCT03323164|18553995|P2|STARTED|Overall Study||17
7536909|NCT03323164|18553996|P1|STARTED|Overall Study||18
7536910|NCT03323086|18554022|P2|NOT COMPLETED|Overall Study||2
7536911|NCT03323086|18554023|P1|NOT COMPLETED|Overall Study||3
7536912|NCT03323086|18554022|P2|COMPLETED|Overall Study||20
7536913|NCT03323086|18554023|P1|COMPLETED|Overall Study||23
7536914|NCT03323086|18554022|P2|STARTED|Overall Study||22
7536915|NCT03323086|18554023|P1|STARTED|Overall Study||26
7536916|NCT03322930|18554041|P2|NOT COMPLETED|Overall Study||0
7536917|NCT03322930|18554042|P1|NOT COMPLETED|Overall Study||0
7536918|NCT03322930|18554041|P2|COMPLETED|Overall Study||20
7536919|NCT03322930|18554042|P1|COMPLETED|Overall Study||20
7536920|NCT03322930|18554041|P2|STARTED|Overall Study|recruitment of 20 patients with macular degeneration|20
7536921|NCT03322930|18554042|P1|STARTED|Overall Study|recruitment of 20 patients with retinitis pigmentosa|20
7536922|NCT03322566|18554051|P3|NOT COMPLETED|Overall Study||55
7536923|NCT03322566|18554052|P2|NOT COMPLETED|Overall Study||87
7536924|NCT03322566|18554053|P1|NOT COMPLETED|Overall Study||91
7536925|NCT03322566|18554051|P3|COMPLETED|Overall Study||0
7536926|NCT03322566|18554052|P2|COMPLETED|Overall Study||0
7536927|NCT03322566|18554053|P1|COMPLETED|Overall Study||0
7536928|NCT03322566|18554051|P3|STARTED|Overall Study||55
7536929|NCT03322566|18554052|P2|STARTED|Overall Study||87
7536930|NCT03322566|18554053|P1|STARTED|Overall Study||91
7536931|NCT03322540|18554072|P2|NOT COMPLETED|Overall Study||77
7536932|NCT03322540|18554073|P1|NOT COMPLETED|Overall Study||77
7536933|NCT03322540|18554072|P2|COMPLETED|Overall Study||0
7536934|NCT03322540|18554073|P1|COMPLETED|Overall Study||0
7536935|NCT03322540|18554072|P2|STARTED|Overall Study||77
7536936|NCT03322540|18554073|P1|STARTED|Overall Study||77
7536937|NCT03322514|18554081|P2|NOT COMPLETED|Overall Study||1
7536938|NCT03322514|18554082|P1|NOT COMPLETED|Overall Study||1
7536939|NCT03322514|18554081|P2|COMPLETED|Overall Study||5
7536940|NCT03322514|18554082|P1|COMPLETED|Overall Study||5
7536941|NCT03322514|18554081|P2|STARTED|Overall Study||6
7536942|NCT03322514|18554082|P1|STARTED|Overall Study||6
7536943|NCT03322462|18554092|P1|NOT COMPLETED|Overall Study||3
7536944|NCT03322462|18554092|P1|COMPLETED|Overall Study||152
7536945|NCT03322462|18554092|P1|Flortaucipir PET Scan|Overall Study||155
7536946|NCT03322462|18554092|P1|STARTED|Overall Study||155
7536947|NCT03322423|18554101|P2|NOT COMPLETED|Period 2||2
7536948|NCT03322423|18554102|P1|NOT COMPLETED|Period 2||1
7536949|NCT03322423|18554101|P2|COMPLETED|Period 2||36
7536950|NCT03322423|18554102|P1|COMPLETED|Period 2||35
7536951|NCT03322423|18554101|P2|STARTED|Period 2||38
7536952|NCT03322423|18554102|P1|STARTED|Period 2||36
7536953|NCT03322423|18554101|P2|NOT COMPLETED|Period 1||2
7536954|NCT03322423|18554102|P1|NOT COMPLETED|Period 1||2
7536955|NCT03322423|18554101|P2|COMPLETED|Period 1||38
7536956|NCT03322423|18554102|P1|COMPLETED|Period 1||36
7536957|NCT03322423|18554101|P2|STARTED|Period 1||40
7536958|NCT03322423|18554102|P1|STARTED|Period 1||38
7536959|NCT03322293|18554115|P3|NOT COMPLETED|Overall Study||1
7536960|NCT03322293|18554116|P2|NOT COMPLETED|Overall Study||0
7536961|NCT03322293|18554117|P1|NOT COMPLETED|Overall Study||0
7536962|NCT03322293|18554115|P3|COMPLETED|Overall Study||7
7536963|NCT03322293|18554116|P2|COMPLETED|Overall Study||8
7536964|NCT03322293|18554117|P1|COMPLETED|Overall Study||8
7536965|NCT03322293|18554115|P3|STARTED|Overall Study||8
7536966|NCT03322293|18554116|P2|STARTED|Overall Study||8
7536967|NCT03322293|18554117|P1|STARTED|Overall Study||8
7536968|NCT03321721|18554140|P3|NOT COMPLETED|Overall Study||11
7536969|NCT03321721|18554141|P2|NOT COMPLETED|Overall Study||8
7536970|NCT03321721|18554142|P1|NOT COMPLETED|Overall Study||4
7536971|NCT03321721|18554140|P3|COMPLETED|Overall Study||1
7536972|NCT03321721|18554141|P2|COMPLETED|Overall Study||2
7536973|NCT03321721|18554142|P1|COMPLETED|Overall Study||0
7536974|NCT03321721|18554140|P3|STARTED|Overall Study||12
7536975|NCT03321721|18554141|P2|STARTED|Overall Study||10
7536976|NCT03321721|18554142|P1|STARTED|Overall Study||4
7536977|NCT03321396|18554159|P1|NOT COMPLETED|Overall Study||1
7536978|NCT03321396|18554159|P1|COMPLETED|Overall Study||12
7536979|NCT03321396|18554159|P1|STARTED|Overall Study||13
7536980|NCT03321253|18554165|P1|NOT COMPLETED|Overall Study||0
7536981|NCT03321253|18554165|P1|COMPLETED|Overall Study||38
7536982|NCT03321253|18554165|P1|STARTED|Overall Study||38
7536983|NCT03321097|18554175|P2|NOT COMPLETED|Overall Study||0
7536984|NCT03321097|18554176|P1|NOT COMPLETED|Overall Study||0
7536985|NCT03321097|18554175|P2|COMPLETED|Overall Study||18
7536986|NCT03321097|18554176|P1|COMPLETED|Overall Study||18
7536987|NCT03321097|18554175|P2|STARTED|Overall Study||18
7536988|NCT03321097|18554176|P1|STARTED|Overall Study||18
7536989|NCT03320941|18554197|P5|NOT COMPLETED|Overall Study||0
7536990|NCT03320941|18554198|P4|NOT COMPLETED|Overall Study||1
7536991|NCT03320941|18554199|P3|NOT COMPLETED|Overall Study||0
7536992|NCT03320941|18554200|P2|NOT COMPLETED|Overall Study||0
7536993|NCT03320941|18554201|P1|NOT COMPLETED|Overall Study||0
7536994|NCT03320941|18554197|P5|COMPLETED|Overall Study||29
7536995|NCT03320941|18554198|P4|COMPLETED|Overall Study||30
7536996|NCT03320941|18554199|P3|COMPLETED|Overall Study||28
7536997|NCT03320941|18554200|P2|COMPLETED|Overall Study||19
7536998|NCT03320941|18554201|P1|COMPLETED|Overall Study||19
7536999|NCT03320941|18554197|P5|STARTED|Overall Study||29
7537000|NCT03320941|18554198|P4|STARTED|Overall Study||31
7537001|NCT03320941|18554199|P3|STARTED|Overall Study||28
7537002|NCT03320941|18554200|P2|STARTED|Overall Study||19
7537003|NCT03320941|18554201|P1|STARTED|Overall Study||19
7537004|NCT03320824|18554304|P2|NOT COMPLETED|Overall Study||4
7537005|NCT03320824|18554305|P1|NOT COMPLETED|Overall Study||18
7537006|NCT03320824|18554304|P2|COMPLETED|Overall Study||85
7537007|NCT03320824|18554305|P1|COMPLETED|Overall Study||166
7537008|NCT03320824|18554304|P2|STARTED|Overall Study||89
7537009|NCT03320824|18554305|P1|STARTED|Overall Study||184
7537010|NCT03320564|18554321|P1|NOT COMPLETED|Overall Study||1
7537011|NCT03320564|18554321|P1|COMPLETED|Overall Study||1
7537012|NCT03320564|18554321|P1|STARTED|Overall Study||2
7537013|NCT03320369|18554325|P1|NOT COMPLETED|Overall Study||3
7537014|NCT03320369|18554325|P1|COMPLETED|Overall Study||15
7537015|NCT03320369|18554325|P1|STARTED|Overall Study||18
7537016|NCT03320096|18554334|P1|NOT COMPLETED|Overall Study||0
7537017|NCT03320096|18554334|P1|COMPLETED|Overall Study||20
7537018|NCT03320096|18554334|P1|STARTED|Overall Study||20
7537019|NCT03319810|18554341|P1|NOT COMPLETED|Overall Study||0
7537020|NCT03319810|18554341|P1|COMPLETED|Overall Study||5
7537021|NCT03319810|18554341|P1|STARTED|Overall Study||5
7537022|NCT03319719|18554346|P1|NOT COMPLETED|Overall Study||1
7537023|NCT03319719|18554346|P1|COMPLETED|Overall Study||51
7537024|NCT03319719|18554346|P1|STARTED|Overall Study||52
7537025|NCT03319407|18554360|P1|NOT COMPLETED|Overall Study||21
7537026|NCT03319407|18554360|P1|COMPLETED|Overall Study||0
7537027|NCT03319407|18554360|P1|STARTED|Overall Study||21
7537028|NCT03319277|18554366|P2|NOT COMPLETED|Overall Study||0
7537029|NCT03319277|18554367|P1|NOT COMPLETED|Overall Study||0
7537030|NCT03319277|18554366|P2|COMPLETED|Overall Study||59
7537031|NCT03319277|18554367|P1|COMPLETED|Overall Study||59
7537032|NCT03319277|18554366|P2|STARTED|Overall Study||59
7537033|NCT03319277|18554367|P1|STARTED|Overall Study||59
7537034|NCT03319212|18554379|P2|NOT COMPLETED|Overall Study||5
7537035|NCT03319212|18554380|P1|NOT COMPLETED|Overall Study||3
7537036|NCT03319212|18554379|P2|COMPLETED|Overall Study||47
7537037|NCT03319212|18554380|P1|COMPLETED|Overall Study||26
7537038|NCT03319212|18554379|P2|STARTED|Overall Study||52
7537039|NCT03319212|18554380|P1|STARTED|Overall Study||29
7537040|NCT03319173|18554407|P2|NOT COMPLETED|Overall Study||0
7537041|NCT03319173|18554408|P1|NOT COMPLETED|Overall Study||0
7537042|NCT03319173|18554407|P2|COMPLETED|Overall Study||50
7537043|NCT03319173|18554408|P1|COMPLETED|Overall Study||48
7537044|NCT03319173|18554407|P2|STARTED|Overall Study||50
7537045|NCT03319173|18554408|P1|STARTED|Overall Study||48
7537046|NCT03319134|18554447|P3|NOT COMPLETED|Overall Study||0
7537047|NCT03319134|18554448|P2|NOT COMPLETED|Overall Study||0
7537048|NCT03319134|18554449|P1|NOT COMPLETED|Overall Study||0
7537049|NCT03319134|18554447|P3|COMPLETED|Overall Study||15
7537050|NCT03319134|18554448|P2|COMPLETED|Overall Study||15
7537051|NCT03319134|18554449|P1|COMPLETED|Overall Study||15
7537052|NCT03319134|18554447|P3|STARTED|Overall Study||15
7537053|NCT03319134|18554448|P2|STARTED|Overall Study||15
7537054|NCT03319134|18554449|P1|STARTED|Overall Study||15
7537055|NCT03318861|18554462|P5|NOT COMPLETED|Overall Study||3
7537056|NCT03318861|18554463|P4|NOT COMPLETED|Overall Study||4
7537057|NCT03318861|18554464|P3|NOT COMPLETED|Overall Study||3
7537058|NCT03318861|18554465|P2|NOT COMPLETED|Overall Study||4
7537059|NCT03318861|18554466|P1|NOT COMPLETED|Overall Study||3
7537060|NCT03318861|18554462|P5|COMPLETED|Overall Study||0
7537061|NCT03318861|18554463|P4|COMPLETED|Overall Study||0
7537062|NCT03318861|18554464|P3|COMPLETED|Overall Study||0
7537063|NCT03318861|18554465|P2|COMPLETED|Overall Study||0
7537064|NCT03318861|18554466|P1|COMPLETED|Overall Study||0
7537065|NCT03318861|18554462|P5|STARTED|Overall Study||3
7537066|NCT03318861|18554463|P4|STARTED|Overall Study||4
7537067|NCT03318861|18554464|P3|STARTED|Overall Study||3
7537068|NCT03318861|18554465|P2|STARTED|Overall Study||4
7537069|NCT03318861|18554466|P1|STARTED|Overall Study||3
7537070|NCT03318341|18554514|P2|NOT COMPLETED|Month 2||0
7537071|NCT03318341|18554515|P1|NOT COMPLETED|Month 2||0
7537072|NCT03318341|18554514|P2|COMPLETED|Month 2||12
7537073|NCT03318341|18554515|P1|COMPLETED|Month 2||13
7537074|NCT03318341|18554514|P2|STARTED|Month 2||12
7537075|NCT03318341|18554515|P1|STARTED|Month 2||13
7537076|NCT03318341|18554514|P2|NOT COMPLETED|Month 1||1
7537077|NCT03318341|18554515|P1|NOT COMPLETED|Month 1||0
7537078|NCT03318341|18554514|P2|COMPLETED|Month 1||12
7537079|NCT03318341|18554515|P1|COMPLETED|Month 1||13
7537080|NCT03318341|18554514|P2|STARTED|Month 1||13
7537081|NCT03318341|18554515|P1|STARTED|Month 1||13
7537082|NCT03318315|18554528|P3|NOT COMPLETED|Overall Study||4
7537083|NCT03318315|18554529|P2|NOT COMPLETED|Overall Study||3
7537084|NCT03318315|18554530|P1|NOT COMPLETED|Overall Study||4
7537085|NCT03318315|18554528|P3|COMPLETED|Overall Study||30
7537086|NCT03318315|18554529|P2|COMPLETED|Overall Study||50
7537087|NCT03318315|18554530|P1|COMPLETED|Overall Study||58
7537088|NCT03318315|18554528|P3|Received Third Vaccination|Overall Study||0
7537089|NCT03318315|18554529|P2|Received Third Vaccination|Overall Study||46
7537090|NCT03318315|18554530|P1|Received Third Vaccination|Overall Study||0
7537091|NCT03318315|18554528|P3|Received Second Vaccination|Overall Study||0
7537092|NCT03318315|18554529|P2|Received Second Vaccination|Overall Study||48
7537093|NCT03318315|18554530|P1|Received Second Vaccination|Overall Study||59
7537094|NCT03318315|18554528|P3|Received First Vaccination|Overall Study||34
7537095|NCT03318315|18554529|P2|Received First Vaccination|Overall Study||53
7537096|NCT03318315|18554530|P1|Received First Vaccination|Overall Study||62
7537097|NCT03318315|18554528|P3|STARTED|Overall Study||34
7537098|NCT03318315|18554529|P2|STARTED|Overall Study||53
7537099|NCT03318315|18554530|P1|STARTED|Overall Study||62
7537100|NCT03317431|18554621|P1|NOT COMPLETED|Overall Study||0
7537101|NCT03317431|18554621|P1|COMPLETED|Overall Study||46
7537102|NCT03317431|18554621|P1|STARTED|Overall Study||46
7537103|NCT03316976|18554631|P2|NOT COMPLETED|Overall Study||0
7537104|NCT03316976|18554632|P1|NOT COMPLETED|Overall Study||0
7537105|NCT03316976|18554631|P2|COMPLETED|Overall Study||20
7537106|NCT03316976|18554632|P1|COMPLETED|Overall Study||20
7537107|NCT03316976|18554631|P2|STARTED|Overall Study||20
7537108|NCT03316976|18554632|P1|STARTED|Overall Study||20
7537109|NCT03316911|18554644|P2|NOT COMPLETED|Overall Study||29
7537110|NCT03316911|18554645|P1|NOT COMPLETED|Overall Study||33
7537111|NCT03316911|18554644|P2|COMPLETED|Overall Study||110
7537112|NCT03316911|18554645|P1|COMPLETED|Overall Study||89
7537113|NCT03316911|18554644|P2|5-Month Follow-up Survey|Overall Study||110
7537114|NCT03316911|18554645|P1|5-Month Follow-up Survey|Overall Study||89
7537115|NCT03316911|18554644|P2|3-Month Follow-up Survey|Overall Study||112
7537116|NCT03316911|18554645|P1|3-Month Follow-up Survey|Overall Study||93
7537117|NCT03316911|18554644|P2|STARTED|Overall Study|3 did not complete baseline survey|139
7537118|NCT03316911|18554645|P1|STARTED|Overall Study|2 did not complete baseline survey|122
7537119|NCT03316378|18554679|P2|NOT COMPLETED|Overall Study||0
7537120|NCT03316378|18554680|P1|NOT COMPLETED|Overall Study||0
7537121|NCT03316378|18554679|P2|COMPLETED|Overall Study||23
7537122|NCT03316378|18554680|P1|COMPLETED|Overall Study||23
7537123|NCT03316378|18554679|P2|STARTED|Overall Study||23
7537124|NCT03316378|18554680|P1|STARTED|Overall Study||23
7537125|NCT03316131|18554690|P2|NOT COMPLETED|Treatment Period 2||0
7537126|NCT03316131|18554691|P1|NOT COMPLETED|Treatment Period 2||1
7537127|NCT03316131|18554690|P2|COMPLETED|Treatment Period 2||18
7537128|NCT03316131|18554691|P1|COMPLETED|Treatment Period 2||17
7537129|NCT03316131|18554690|P2|STARTED|Treatment Period 2||18
7537130|NCT03316131|18554691|P1|STARTED|Treatment Period 2||18
7537131|NCT03316131|18554690|P2|NOT COMPLETED|Treatment Period 1||0
7537132|NCT03316131|18554691|P1|NOT COMPLETED|Treatment Period 1||0
7537133|NCT03316131|18554690|P2|COMPLETED|Treatment Period 1||18
7537134|NCT03316131|18554691|P1|COMPLETED|Treatment Period 1||18
7537135|NCT03316131|18554690|P2|STARTED|Treatment Period 1||18
7537136|NCT03316131|18554691|P1|STARTED|Treatment Period 1||18
7537137|NCT03316105|18554711|P2|NOT COMPLETED|Overall Study||0
7537138|NCT03316105|18554712|P1|NOT COMPLETED|Overall Study||0
7537139|NCT03316105|18554711|P2|COMPLETED|Overall Study||7
7537140|NCT03316105|18554712|P1|COMPLETED|Overall Study||9
7537141|NCT03316105|18554711|P2|STARTED|Overall Study||7
7537142|NCT03316105|18554712|P1|STARTED|Overall Study||9
7537143|NCT03315949|18554720|P2|NOT COMPLETED|Overall Study||10
7537144|NCT03315949|18554721|P1|NOT COMPLETED|Overall Study||5
7537145|NCT03315949|18554720|P2|COMPLETED|Overall Study||166
7537146|NCT03315949|18554721|P1|COMPLETED|Overall Study||171
7537147|NCT03315949|18554720|P2|STARTED|Overall Study||176
7537148|NCT03315949|18554721|P1|STARTED|Overall Study||176
7537149|NCT03315780|18554727|P2|NOT COMPLETED|Period 2||0
7537150|NCT03315780|18554728|P1|NOT COMPLETED|Period 2||0
7537151|NCT03315780|18554727|P2|COMPLETED|Period 2||6
7537152|NCT03315780|18554728|P1|COMPLETED|Period 2||6
7537153|NCT03315780|18554727|P2|STARTED|Period 2||6
7537154|NCT03315780|18554728|P1|STARTED|Period 2||6
7537155|NCT03315780|18554727|P2|NOT COMPLETED|Period 1||0
7537156|NCT03315780|18554728|P1|NOT COMPLETED|Period 1||0
7537157|NCT03315780|18554727|P2|COMPLETED|Period 1||6
7537158|NCT03315780|18554728|P1|COMPLETED|Period 1||6
7537159|NCT03315780|18554727|P2|Received One Dose of Study Drug|Period 1||6
7537160|NCT03315780|18554728|P1|Received One Dose of Study Drug|Period 1||6
7537161|NCT03315780|18554727|P2|STARTED|Period 1||6
7537162|NCT03315780|18554728|P1|STARTED|Period 1||6
7537163|NCT03315702|18554748|P1|NOT COMPLETED|Overall Study||0
7537164|NCT03315702|18554748|P1|COMPLETED|Overall Study||52
7537165|NCT03315702|18554748|P1|STARTED|Overall Study||52
7537166|NCT03315689|18554757|P2|NOT COMPLETED|Open Label Extension = 52 Weeks||3
7537167|NCT03315689|18554758|P1|NOT COMPLETED|Open Label Extension = 52 Weeks||0
7537168|NCT03315689|18554757|P2|COMPLETED|Open Label Extension = 52 Weeks||7
7537169|NCT03315689|18554758|P1|COMPLETED|Open Label Extension = 52 Weeks||0
7537170|NCT03315689|18554757|P2|STARTED|Open Label Extension = 52 Weeks||10
7537171|NCT03315689|18554758|P1|STARTED|Open Label Extension = 52 Weeks||0
7537172|NCT03315689|18554757|P2|NOT COMPLETED|Double-blind Period = 28 Days||0
7537173|NCT03315689|18554758|P1|NOT COMPLETED|Double-blind Period = 28 Days||1
7537174|NCT03315689|18554757|P2|COMPLETED|Double-blind Period = 28 Days||7
7537175|NCT03315689|18554758|P1|COMPLETED|Double-blind Period = 28 Days||3
7537176|NCT03315689|18554757|P2|STARTED|Double-blind Period = 28 Days||7
7537177|NCT03315689|18554758|P1|STARTED|Double-blind Period = 28 Days||4
7537178|NCT03315572|18554788|P2|NOT COMPLETED|Overall Study||0
7537179|NCT03315572|18554789|P1|NOT COMPLETED|Overall Study||0
7537180|NCT03315572|18554788|P2|COMPLETED|Overall Study||14
7537181|NCT03315572|18554789|P1|COMPLETED|Overall Study||14
7537182|NCT03315572|18554788|P2|STARTED|Overall Study||14
7537183|NCT03315572|18554789|P1|STARTED|Overall Study||14
7537184|NCT03315559|18554812|P1|NOT COMPLETED|Treatment Period 2 (15 Days)||0
7537185|NCT03315559|18554812|P1|COMPLETED|Treatment Period 2 (15 Days)||6
7537186|NCT03315559|18554812|P1|STARTED|Treatment Period 2 (15 Days)||6
7537187|NCT03315559|18554812|P1|NOT COMPLETED|Washout Period (14 Days)||0
7537188|NCT03315559|18554812|P1|COMPLETED|Washout Period (14 Days)||6
7537189|NCT03315559|18554812|P1|STARTED|Washout Period (14 Days)||6
7537190|NCT03315559|18554812|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7537191|NCT03315559|18554812|P1|COMPLETED|Treatment Period 1 (8 Days)||6
7537192|NCT03315559|18554812|P1|STARTED|Treatment Period 1 (8 Days)||6
7537193|NCT03315286|18554852|P2|NOT COMPLETED|Overall Study||4
7537194|NCT03315286|18554853|P1|NOT COMPLETED|Overall Study||1
7537195|NCT03315286|18554852|P2|COMPLETED|Overall Study||43
7537196|NCT03315286|18554853|P1|COMPLETED|Overall Study||49
7537197|NCT03315286|18554852|P2|STARTED|Overall Study||47
7537198|NCT03315286|18554853|P1|STARTED|Overall Study||50
7537199|NCT03315104|18554872|P3|NOT COMPLETED|Overall Study||5
7537200|NCT03315104|18554873|P2|NOT COMPLETED|Overall Study||4
7537201|NCT03315104|18554874|P1|NOT COMPLETED|Overall Study||3
7537202|NCT03315104|18554872|P3|COMPLETED|Overall Study||19
7537203|NCT03315104|18554873|P2|COMPLETED|Overall Study||16
7537204|NCT03315104|18554874|P1|COMPLETED|Overall Study||18
7537205|NCT03315104|18554872|P3|Dosed (Safety Population)|Overall Study||22
7537206|NCT03315104|18554873|P2|Dosed (Safety Population)|Overall Study||19
7537207|NCT03315104|18554874|P1|Dosed (Safety Population)|Overall Study||19
7537208|NCT03315104|18554872|P3|STARTED|Overall Study||24
7537209|NCT03315104|18554873|P2|STARTED|Overall Study||20
7537210|NCT03315104|18554874|P1|STARTED|Overall Study||21
7537211|NCT03314857|18554894|P1|NOT COMPLETED|Overall Study||5
7537212|NCT03314857|18554894|P1|COMPLETED|Overall Study|62/67 patients completed the 30-day primary endpoint visit.|62
7537213|NCT03314857|18554894|P1|Analysis Population|Overall Study||61
7537214|NCT03314857|18554894|P1|STARTED|Overall Study||67
7537215|NCT03314753|18554902|P2|NOT COMPLETED|Overall Study||0
7537216|NCT03314753|18554903|P1|NOT COMPLETED|Overall Study||0
7537217|NCT03314753|18554902|P2|COMPLETED|Overall Study||36
7537218|NCT03314753|18554903|P1|COMPLETED|Overall Study||53
7537219|NCT03314753|18554902|P2|STARTED|Overall Study||36
7537220|NCT03314753|18554903|P1|STARTED|Overall Study||53
7537221|NCT03314662|18554928|P3|NOT COMPLETED|Overall Study||5
7537222|NCT03314662|18554929|P2|NOT COMPLETED|Overall Study||5
7537223|NCT03314662|18554930|P1|NOT COMPLETED|Overall Study||8
7537224|NCT03314662|18554928|P3|COMPLETED|Overall Study||439
7537225|NCT03314662|18554929|P2|COMPLETED|Overall Study||440
7537226|NCT03314662|18554930|P1|COMPLETED|Overall Study||881
7537227|NCT03314662|18554928|P3|Treated|Overall Study||444
7537228|NCT03314662|18554929|P2|Treated|Overall Study||444
7537229|NCT03314662|18554930|P1|Treated|Overall Study||888
7537230|NCT03314662|18554928|P3|STARTED|Overall Study||444
7537231|NCT03314662|18554929|P2|STARTED|Overall Study||445
7537232|NCT03314662|18554930|P1|STARTED|Overall Study||889
7537233|NCT03314519|18554975|P2|NOT COMPLETED|Overall Study||2
7537234|NCT03314519|18554976|P1|NOT COMPLETED|Overall Study||3
7537235|NCT03314519|18554975|P2|COMPLETED|Overall Study||98
7537236|NCT03314519|18554976|P1|COMPLETED|Overall Study||97
7537237|NCT03314519|18554975|P2|STARTED|Overall Study||100
7537238|NCT03314519|18554976|P1|STARTED|Overall Study||100
7537239|NCT03314233|18554986|P1|NOT COMPLETED|Overall Study||1
7537240|NCT03314233|18554986|P1|COMPLETED|Overall Study|20 mothers who had provided informed consent met eligibility criteria at time of delivery.|20
7537241|NCT03314233|18554986|P1|STARTED|Overall Study|21 mothers provided informed consent for participation in the trial.|21
7537242|NCT03313310|18554999|P2|NOT COMPLETED|Phase 3||1
7537243|NCT03313310|18555000|P1|NOT COMPLETED|Phase 3||0
7537244|NCT03313310|18554999|P2|COMPLETED|Phase 3||40
7537245|NCT03313310|18555000|P1|COMPLETED|Phase 3|Phase 3 participants did not participate in Phase 2.|0
7537246|NCT03313310|18554999|P2|STARTED|Phase 3||41
7537247|NCT03313310|18555000|P1|STARTED|Phase 3|Phase 3 participants did not participate in Phase 2.|0
7537248|NCT03313310|18554999|P2|NOT COMPLETED|Phase 2||0
7537249|NCT03313310|18555000|P1|NOT COMPLETED|Phase 2||4
7537250|NCT03313310|18554999|P2|COMPLETED|Phase 2|Phase 2 participants did not participate in Phase 3.|0
7537251|NCT03313310|18555000|P1|COMPLETED|Phase 2||47
7537252|NCT03313310|18554999|P2|STARTED|Phase 2|Phase 2 participants did not participate in Phase 3.|0
7537253|NCT03313310|18555000|P1|STARTED|Phase 2||51
7537254|NCT03313050|18555042|P4|NOT COMPLETED|Stage 2: 12 Months||20
7537255|NCT03313050|18555043|P3|NOT COMPLETED|Stage 2: 12 Months||11
7537256|NCT03313050|18555044|P2|NOT COMPLETED|Stage 2: 12 Months||0
7537257|NCT03313050|18555045|P1|NOT COMPLETED|Stage 2: 12 Months||0
7537258|NCT03313050|18555042|P4|COMPLETED|Stage 2: 12 Months||204
7537259|NCT03313050|18555043|P3|COMPLETED|Stage 2: 12 Months||210
7537260|NCT03313050|18555044|P2|COMPLETED|Stage 2: 12 Months||0
7537261|NCT03313050|18555045|P1|COMPLETED|Stage 2: 12 Months||0
7537262|NCT03313050|18555042|P4|Vaccinated|Stage 2: 12 Months||223
7537263|NCT03313050|18555043|P3|Vaccinated|Stage 2: 12 Months||221
7537264|NCT03313050|18555044|P2|Vaccinated|Stage 2: 12 Months||0
7537265|NCT03313050|18555045|P1|Vaccinated|Stage 2: 12 Months||0
7537266|NCT03313050|18555042|P4|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|224
7537267|NCT03313050|18555043|P3|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|221
7537268|NCT03313050|18555044|P2|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
7537269|NCT03313050|18555045|P1|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
7537270|NCT03313050|18555042|P4|NOT COMPLETED|Stage 1: 6 Months||0
7537271|NCT03313050|18555043|P3|NOT COMPLETED|Stage 1: 6 Months||0
7537272|NCT03313050|18555044|P2|NOT COMPLETED|Stage 1: 6 Months||0
7537273|NCT03313050|18555045|P1|NOT COMPLETED|Stage 1: 6 Months||0
7537274|NCT03313050|18555042|P4|COMPLETED|Stage 1: 6 Months||0
7537275|NCT03313050|18555043|P3|COMPLETED|Stage 1: 6 Months||0
7537276|NCT03313050|18555044|P2|COMPLETED|Stage 1: 6 Months||32
7537277|NCT03313050|18555045|P1|COMPLETED|Stage 1: 6 Months||34
7537278|NCT03313050|18555042|P4|Vaccinated|Stage 1: 6 Months||0
7537279|NCT03313050|18555043|P3|Vaccinated|Stage 1: 6 Months||0
7537280|NCT03313050|18555044|P2|Vaccinated|Stage 1: 6 Months||32
7537281|NCT03313050|18555045|P1|Vaccinated|Stage 1: 6 Months||34
7537282|NCT03313050|18555042|P4|STARTED|Stage 1: 6 Months||0
7537283|NCT03313050|18555043|P3|STARTED|Stage 1: 6 Months||0
7537284|NCT03313050|18555044|P2|STARTED|Stage 1: 6 Months||32
7537285|NCT03313050|18555045|P1|STARTED|Stage 1: 6 Months||34
7537286|NCT03313037|18555085|P2|NOT COMPLETED|Overall Study||20
7537287|NCT03313037|18555086|P1|NOT COMPLETED|Overall Study||20
7537288|NCT03313037|18555085|P2|COMPLETED|Overall Study||202
7537289|NCT03313037|18555086|P1|COMPLETED|Overall Study||202
7537290|NCT03313037|18555085|P2|Evaluable Immunogenicity Population(EIP)|Overall Study||208
7537291|NCT03313037|18555086|P1|Evaluable Immunogenicity Population(EIP)|Overall Study||210
7537292|NCT03313037|18555085|P2|Safety Population|Overall Study||222
7537293|NCT03313037|18555086|P1|Safety Population|Overall Study||221
7537294|NCT03313037|18555085|P2|STARTED|Overall Study||222
7537295|NCT03313037|18555086|P1|STARTED|Overall Study||222
7537296|NCT03312933|18555108|P1|NOT COMPLETED|Overall Study||54
7537297|NCT03312933|18555108|P1|COMPLETED|Overall Study||46
7537298|NCT03312933|18555108|P1|STARTED|Overall Study||100
7537299|NCT03312543|18555114|P2|NOT COMPLETED|Regression (Week 12 to Week 24)||2
7537300|NCT03312543|18555115|P1|NOT COMPLETED|Regression (Week 12 to Week 24)||1
7537301|NCT03312543|18555114|P2|COMPLETED|Regression (Week 12 to Week 24)||52
7537302|NCT03312543|18555115|P1|COMPLETED|Regression (Week 12 to Week 24)||55
7537303|NCT03312543|18555114|P2|STARTED|Regression (Week 12 to Week 24)||54
7537304|NCT03312543|18555115|P1|STARTED|Regression (Week 12 to Week 24)||56
7537305|NCT03312543|18555114|P2|NOT COMPLETED|Treatment (Baseline to Week 12)||5
7537306|NCT03312543|18555115|P1|NOT COMPLETED|Treatment (Baseline to Week 12)||4
7537307|NCT03312543|18555114|P2|COMPLETED|Treatment (Baseline to Week 12)||54
7537308|NCT03312543|18555115|P1|COMPLETED|Treatment (Baseline to Week 12)||56
7537309|NCT03312543|18555114|P2|STARTED|Treatment (Baseline to Week 12)||59
7537310|NCT03312543|18555115|P1|STARTED|Treatment (Baseline to Week 12)||60
7537311|NCT03312543|18555114|P2|NOT COMPLETED|Before Treatment (Screening to Baseline)||4
7537312|NCT03312543|18555115|P1|NOT COMPLETED|Before Treatment (Screening to Baseline)||1
7537313|NCT03312543|18555114|P2|COMPLETED|Before Treatment (Screening to Baseline)||59
7537314|NCT03312543|18555115|P1|COMPLETED|Before Treatment (Screening to Baseline)||60
7537315|NCT03312543|18555114|P2|STARTED|Before Treatment (Screening to Baseline)||63
7537316|NCT03312543|18555115|P1|STARTED|Before Treatment (Screening to Baseline)||61
7537317|NCT03312517|18555189|P6|NOT COMPLETED|Overall Study||0
7537318|NCT03312517|18555190|P5|NOT COMPLETED|Overall Study||0
7537319|NCT03312517|18555191|P4|NOT COMPLETED|Overall Study||0
7537320|NCT03312517|18555192|P3|NOT COMPLETED|Overall Study||0
7537321|NCT03312517|18555193|P2|NOT COMPLETED|Overall Study||0
7537322|NCT03312517|18555194|P1|NOT COMPLETED|Overall Study||0
7537323|NCT03312517|18555189|P6|COMPLETED|Overall Study||2
7537324|NCT03312517|18555190|P5|COMPLETED|Overall Study||2
7537325|NCT03312517|18555191|P4|COMPLETED|Overall Study||2
7537326|NCT03312517|18555192|P3|COMPLETED|Overall Study||2
7537327|NCT03312517|18555193|P2|COMPLETED|Overall Study||2
7537328|NCT03312517|18555194|P1|COMPLETED|Overall Study||2
7537329|NCT03312517|18555189|P6|STARTED|Overall Study||2
7537330|NCT03312517|18555190|P5|STARTED|Overall Study||2
7537331|NCT03312517|18555191|P4|STARTED|Overall Study||2
7537332|NCT03312517|18555192|P3|STARTED|Overall Study||2
7537333|NCT03312517|18555193|P2|STARTED|Overall Study||2
7537334|NCT03312517|18555194|P1|STARTED|Overall Study||2
7537335|NCT03312348|18555202|P1|NOT COMPLETED|Overall Study||0
7537336|NCT03312348|18555202|P1|COMPLETED|Overall Study||30
7537337|NCT03312348|18555202|P1|STARTED|Overall Study||30
7537338|NCT03312231|18555211|P5|NOT COMPLETED|Overall Study||1
7537339|NCT03312231|18555212|P4|NOT COMPLETED|Overall Study||3
7537340|NCT03312231|18555213|P3|NOT COMPLETED|Overall Study||4
7537341|NCT03312231|18555214|P2|NOT COMPLETED|Overall Study||11
7537342|NCT03312231|18555215|P1|NOT COMPLETED|Overall Study||3
7537343|NCT03312231|18555211|P5|COMPLETED|Overall Study||89
7537344|NCT03312231|18555212|P4|COMPLETED|Overall Study||86
7537345|NCT03312231|18555213|P3|COMPLETED|Overall Study||177
7537346|NCT03312231|18555214|P2|COMPLETED|Overall Study||165
7537347|NCT03312231|18555215|P1|COMPLETED|Overall Study||181
7537348|NCT03312231|18555211|P5|STARTED|Overall Study||90
7537349|NCT03312231|18555212|P4|STARTED|Overall Study||89
7537350|NCT03312231|18555213|P3|STARTED|Overall Study||181
7537351|NCT03312231|18555214|P2|STARTED|Overall Study||176
7537352|NCT03312231|18555215|P1|STARTED|Overall Study||184
7537353|NCT03312114|18555417|P1|NOT COMPLETED|Overall Study||5
7537354|NCT03312114|18555417|P1|COMPLETED|Overall Study||0
7537355|NCT03312114|18555417|P1|STARTED|Overall Study||5
7537356|NCT03311841|18555427|P5|NOT COMPLETED|Period 2||0
7537357|NCT03311841|18555428|P4|NOT COMPLETED|Period 2||0
7537358|NCT03311841|18555429|P3|NOT COMPLETED|Period 2||0
7537359|NCT03311841|18555430|P2|NOT COMPLETED|Period 2||0
7537360|NCT03311841|18555431|P1|NOT COMPLETED|Period 2||0
7537361|NCT03311841|18555427|P5|COMPLETED|Period 2||6
7537362|NCT03311841|18555428|P4|COMPLETED|Period 2||6
7537363|NCT03311841|18555429|P3|COMPLETED|Period 2||6
7537364|NCT03311841|18555430|P2|COMPLETED|Period 2||6
7537365|NCT03311841|18555431|P1|COMPLETED|Period 2||6
7537366|NCT03311841|18555427|P5|STARTED|Period 2||6
7537367|NCT03311841|18555428|P4|STARTED|Period 2||6
7537368|NCT03311841|18555429|P3|STARTED|Period 2||6
7537369|NCT03311841|18555430|P2|STARTED|Period 2||6
7537370|NCT03311841|18555431|P1|STARTED|Period 2||6
7537371|NCT03311841|18555427|P5|NOT COMPLETED|14-day Wash-out||0
7537372|NCT03311841|18555428|P4|NOT COMPLETED|14-day Wash-out||1
7537373|NCT03311841|18555429|P3|NOT COMPLETED|14-day Wash-out||0
7537374|NCT03311841|18555430|P2|NOT COMPLETED|14-day Wash-out||1
7537375|NCT03311841|18555431|P1|NOT COMPLETED|14-day Wash-out||0
7537376|NCT03311841|18555427|P5|COMPLETED|14-day Wash-out||6
7537377|NCT03311841|18555428|P4|COMPLETED|14-day Wash-out||6
7537378|NCT03311841|18555429|P3|COMPLETED|14-day Wash-out||6
7537379|NCT03311841|18555430|P2|COMPLETED|14-day Wash-out||6
7537380|NCT03311841|18555431|P1|COMPLETED|14-day Wash-out||6
7537381|NCT03311841|18555427|P5|STARTED|14-day Wash-out||6
7537382|NCT03311841|18555428|P4|STARTED|14-day Wash-out||7
7537383|NCT03311841|18555429|P3|STARTED|14-day Wash-out||6
7537384|NCT03311841|18555430|P2|STARTED|14-day Wash-out||7
7537385|NCT03311841|18555431|P1|STARTED|14-day Wash-out||6
7537386|NCT03311841|18555427|P5|NOT COMPLETED|Period 1||0
7537387|NCT03311841|18555428|P4|NOT COMPLETED|Period 1||0
7537388|NCT03311841|18555429|P3|NOT COMPLETED|Period 1||0
7537389|NCT03311841|18555430|P2|NOT COMPLETED|Period 1||0
7537390|NCT03311841|18555431|P1|NOT COMPLETED|Period 1||0
7537391|NCT03311841|18555427|P5|COMPLETED|Period 1||6
7537392|NCT03311841|18555428|P4|COMPLETED|Period 1||7
7537393|NCT03311841|18555429|P3|COMPLETED|Period 1||6
7537394|NCT03311841|18555430|P2|COMPLETED|Period 1||7
7537395|NCT03311841|18555431|P1|COMPLETED|Period 1||6
7537396|NCT03311841|18555427|P5|STARTED|Period 1||6
7537397|NCT03311841|18555428|P4|STARTED|Period 1||7
7537398|NCT03311841|18555429|P3|STARTED|Period 1||6
7537399|NCT03311841|18555430|P2|STARTED|Period 1||7
7537400|NCT03311841|18555431|P1|STARTED|Period 1||6
7537401|NCT03311659|18555532|P1|NOT COMPLETED|Overall Study||1
7537402|NCT03311659|18555532|P1|COMPLETED|Overall Study||446
7537403|NCT03311659|18555532|P1|STARTED|Overall Study||447
7537404|NCT03311646|18555547|P1|NOT COMPLETED|Overall Study||15
7537405|NCT03311646|18555547|P1|COMPLETED|Overall Study|Completed VLNC Condition|16
7537406|NCT03311646|18555547|P1|STARTED|Overall Study|Number who were eligible and consented.|31
7537407|NCT03311373|18555554|P1|NOT COMPLETED|Overall Study||9
7537408|NCT03311373|18555554|P1|COMPLETED|Overall Study||47
7537409|NCT03311373|18555554|P1|STARTED|Overall Study||56
7537410|NCT03311230|18555612|P4|NOT COMPLETED|Overall Study||7
7537411|NCT03311230|18555613|P3|NOT COMPLETED|Overall Study||2
7537412|NCT03311230|18555614|P2|NOT COMPLETED|Overall Study||5
7537413|NCT03311230|18555615|P1|NOT COMPLETED|Overall Study||1
7537414|NCT03311230|18555612|P4|COMPLETED|Overall Study||143
7537415|NCT03311230|18555613|P3|COMPLETED|Overall Study||148
7537416|NCT03311230|18555614|P2|COMPLETED|Overall Study||146
7537417|NCT03311230|18555615|P1|COMPLETED|Overall Study||150
7537418|NCT03311230|18555612|P4|STARTED|Overall Study||150
7537419|NCT03311230|18555613|P3|STARTED|Overall Study||150
7537420|NCT03311230|18555614|P2|STARTED|Overall Study||151
7537421|NCT03311230|18555615|P1|STARTED|Overall Study||151
7537422|NCT03310775|18555639|P2|NOT COMPLETED|Overall Study||4
7537423|NCT03310775|18555640|P1|NOT COMPLETED|Overall Study||2
7537424|NCT03310775|18555639|P2|COMPLETED|Overall Study||14
7537425|NCT03310775|18555640|P1|COMPLETED|Overall Study||17
7537426|NCT03310775|18555639|P2|STARTED|Overall Study||18
7537427|NCT03310775|18555640|P1|STARTED|Overall Study||19
7537428|NCT03310723|18555658|P2|NOT COMPLETED|Overall Study||3
7537429|NCT03310723|18555659|P1|NOT COMPLETED|Overall Study||0
7537430|NCT03310723|18555658|P2|COMPLETED|Overall Study||17
7537431|NCT03310723|18555659|P1|COMPLETED|Overall Study||20
7537432|NCT03310723|18555658|P2|STARTED|Overall Study||20
7537433|NCT03310723|18555659|P1|STARTED|Overall Study||20
7537434|NCT03310580|18555670|P3|NOT COMPLETED|Overall Study||0
7537435|NCT03310580|18555671|P2|NOT COMPLETED|Overall Study||1
7537436|NCT03310580|18555672|P1|NOT COMPLETED|Overall Study||0
7537437|NCT03310580|18555670|P3|COMPLETED|Overall Study||12
7537438|NCT03310580|18555671|P2|COMPLETED|Overall Study||14
7537439|NCT03310580|18555672|P1|COMPLETED|Overall Study||15
7537440|NCT03310580|18555670|P3|STARTED|Overall Study||12
7537441|NCT03310580|18555671|P2|STARTED|Overall Study||15
7537442|NCT03310580|18555672|P1|STARTED|Overall Study||15
7537443|NCT03310450|18555686|P3|NOT COMPLETED|Overall Study||0
7537444|NCT03310450|18555687|P2|NOT COMPLETED|Overall Study||4
7537445|NCT03310450|18555688|P1|NOT COMPLETED|Overall Study||2
7537446|NCT03310450|18555686|P3|COMPLETED|Overall Study||28
7537447|NCT03310450|18555687|P2|COMPLETED|Overall Study||30
7537448|NCT03310450|18555688|P1|COMPLETED|Overall Study||30
7537449|NCT03310450|18555686|P3|STARTED|Overall Study||28
7537450|NCT03310450|18555687|P2|STARTED|Overall Study||34
7537451|NCT03310450|18555688|P1|STARTED|Overall Study||32
7537452|NCT03310411|18555705|P4|NOT COMPLETED|Period Title: Period 4||0
7537453|NCT03310411|18555706|P3|NOT COMPLETED|Period Title: Period 4||0
7537454|NCT03310411|18555707|P2|NOT COMPLETED|Period Title: Period 4||0
7537455|NCT03310411|18555708|P1|NOT COMPLETED|Period Title: Period 4||0
7537456|NCT03310411|18555705|P4|COMPLETED|Period Title: Period 4||9
7537457|NCT03310411|18555706|P3|COMPLETED|Period Title: Period 4||10
7537458|NCT03310411|18555707|P2|COMPLETED|Period Title: Period 4||10
7537459|NCT03310411|18555708|P1|COMPLETED|Period Title: Period 4||10
7537460|NCT03310411|18555705|P4|STARTED|Period Title: Period 4||9
7537461|NCT03310411|18555706|P3|STARTED|Period Title: Period 4||10
7537462|NCT03310411|18555707|P2|STARTED|Period Title: Period 4||10
7537463|NCT03310411|18555708|P1|STARTED|Period Title: Period 4||10
7537464|NCT03310411|18555705|P4|NOT COMPLETED|Period 3||0
7537465|NCT03310411|18555706|P3|NOT COMPLETED|Period 3||0
7537466|NCT03310411|18555707|P2|NOT COMPLETED|Period 3||0
7537467|NCT03310411|18555708|P1|NOT COMPLETED|Period 3||0
7537468|NCT03310411|18555705|P4|COMPLETED|Period 3||9
7537469|NCT03310411|18555706|P3|COMPLETED|Period 3||10
7537470|NCT03310411|18555707|P2|COMPLETED|Period 3||10
7537471|NCT03310411|18555708|P1|COMPLETED|Period 3||10
7537472|NCT03310411|18555705|P4|STARTED|Period 3||9
7537473|NCT03310411|18555706|P3|STARTED|Period 3||10
7537474|NCT03310411|18555707|P2|STARTED|Period 3||10
7537475|NCT03310411|18555708|P1|STARTED|Period 3||10
7537476|NCT03310411|18555705|P4|NOT COMPLETED|Period 2||0
7537477|NCT03310411|18555706|P3|NOT COMPLETED|Period 2||0
7537478|NCT03310411|18555707|P2|NOT COMPLETED|Period 2||0
7537479|NCT03310411|18555708|P1|NOT COMPLETED|Period 2||0
7537480|NCT03310411|18555705|P4|COMPLETED|Period 2||9
7537481|NCT03310411|18555706|P3|COMPLETED|Period 2||10
7537482|NCT03310411|18555707|P2|COMPLETED|Period 2||10
7537483|NCT03310411|18555708|P1|COMPLETED|Period 2||10
7537484|NCT03310411|18555705|P4|STARTED|Period 2||9
7537485|NCT03310411|18555706|P3|STARTED|Period 2||10
7537486|NCT03310411|18555707|P2|STARTED|Period 2||10
7537487|NCT03310411|18555708|P1|STARTED|Period 2||10
7537488|NCT03310411|18555705|P4|NOT COMPLETED|Period 1||1
7537489|NCT03310411|18555706|P3|NOT COMPLETED|Period 1||0
7537490|NCT03310411|18555707|P2|NOT COMPLETED|Period 1||0
7537491|NCT03310411|18555708|P1|NOT COMPLETED|Period 1||0
7537492|NCT03310411|18555705|P4|COMPLETED|Period 1||9
7537493|NCT03310411|18555706|P3|COMPLETED|Period 1||10
7537494|NCT03310411|18555707|P2|COMPLETED|Period 1||10
7537495|NCT03310411|18555708|P1|COMPLETED|Period 1||10
7537496|NCT03310411|18555705|P4|Received at Least 1 Dose of Study Drug|Period 1||10
7537497|NCT03310411|18555706|P3|Received at Least 1 Dose of Study Drug|Period 1||10
7537498|NCT03310411|18555707|P2|Received at Least 1 Dose of Study Drug|Period 1||10
7537499|NCT03310411|18555708|P1|Received at Least 1 Dose of Study Drug|Period 1||10
7537500|NCT03310411|18555705|P4|STARTED|Period 1||10
7537501|NCT03310411|18555706|P3|STARTED|Period 1||10
7537502|NCT03310411|18555707|P2|STARTED|Period 1||10
7537503|NCT03310411|18555708|P1|STARTED|Period 1||10
7537504|NCT03310268|18555729|P3|NOT COMPLETED|Overall Study||0
7537505|NCT03310268|18555730|P2|NOT COMPLETED|Overall Study||5
7537506|NCT03310268|18555731|P1|NOT COMPLETED|Overall Study||1
7537507|NCT03310268|18555729|P3|COMPLETED|Overall Study||61
7537508|NCT03310268|18555730|P2|COMPLETED|Overall Study||57
7537509|NCT03310268|18555731|P1|COMPLETED|Overall Study||61
7537510|NCT03310268|18555729|P3|STARTED|Overall Study||61
7537511|NCT03310268|18555730|P2|STARTED|Overall Study||62
7537512|NCT03310268|18555731|P1|STARTED|Overall Study||62
7537513|NCT03310021|18555762|P20|NOT COMPLETED|Overall Study||0
7537514|NCT03310021|18555763|P19|NOT COMPLETED|Overall Study||0
7537515|NCT03310021|18555764|P18|NOT COMPLETED|Overall Study||0
7537516|NCT03310021|18555765|P17|NOT COMPLETED|Overall Study||0
7537517|NCT03310021|18555766|P16|NOT COMPLETED|Overall Study||0
7537518|NCT03310021|18555767|P15|NOT COMPLETED|Overall Study||0
7537519|NCT03310021|18555768|P14|NOT COMPLETED|Overall Study||0
7537520|NCT03310021|18555769|P13|NOT COMPLETED|Overall Study||0
7537521|NCT03310021|18555770|P12|NOT COMPLETED|Overall Study||0
7537522|NCT03310021|18555771|P11|NOT COMPLETED|Overall Study||1
7537523|NCT03310021|18555772|P10|NOT COMPLETED|Overall Study||0
7537524|NCT03310021|18555773|P9|NOT COMPLETED|Overall Study||0
7537525|NCT03310021|18555774|P8|NOT COMPLETED|Overall Study||0
7537526|NCT03310021|18555775|P7|NOT COMPLETED|Overall Study||1
7537527|NCT03310021|18555776|P6|NOT COMPLETED|Overall Study||0
7537528|NCT03310021|18555777|P5|NOT COMPLETED|Overall Study||0
7537529|NCT03310021|18555778|P4|NOT COMPLETED|Overall Study||0
7537530|NCT03310021|18555779|P3|NOT COMPLETED|Overall Study||0
7537531|NCT03310021|18555780|P2|NOT COMPLETED|Overall Study||0
7537532|NCT03310021|18555781|P1|NOT COMPLETED|Overall Study||0
7537533|NCT03310021|18555762|P20|COMPLETED|Overall Study||3
7537534|NCT03310021|18555763|P19|COMPLETED|Overall Study||8
7537535|NCT03310021|18555764|P18|COMPLETED|Overall Study||5
7537536|NCT03310021|18555765|P17|COMPLETED|Overall Study||10
7537537|NCT03310021|18555766|P16|COMPLETED|Overall Study||3
7537538|NCT03310021|18555767|P15|COMPLETED|Overall Study||6
7537539|NCT03310021|18555768|P14|COMPLETED|Overall Study||4
7537540|NCT03310021|18555769|P13|COMPLETED|Overall Study||8
7537541|NCT03310021|18555770|P12|COMPLETED|Overall Study||3
7537542|NCT03310021|18555771|P11|COMPLETED|Overall Study||5
7537543|NCT03310021|18555772|P10|COMPLETED|Overall Study||3
7537544|NCT03310021|18555773|P9|COMPLETED|Overall Study||6
7537545|NCT03310021|18555774|P8|COMPLETED|Overall Study||4
7537546|NCT03310021|18555775|P7|COMPLETED|Overall Study||7
7537547|NCT03310021|18555776|P6|COMPLETED|Overall Study||4
7537548|NCT03310021|18555777|P5|COMPLETED|Overall Study||8
7537549|NCT03310021|18555778|P4|COMPLETED|Overall Study||3
7537550|NCT03310021|18555779|P3|COMPLETED|Overall Study||6
7537551|NCT03310021|18555780|P2|COMPLETED|Overall Study||3
7537552|NCT03310021|18555781|P1|COMPLETED|Overall Study||6
7537553|NCT03310021|18555762|P20|STARTED|Overall Study||3
7537554|NCT03310021|18555763|P19|STARTED|Overall Study||8
7537555|NCT03310021|18555764|P18|STARTED|Overall Study||5
7537556|NCT03310021|18555765|P17|STARTED|Overall Study||10
7537557|NCT03310021|18555766|P16|STARTED|Overall Study||3
7537558|NCT03310021|18555767|P15|STARTED|Overall Study||6
7537559|NCT03310021|18555768|P14|STARTED|Overall Study||4
7537560|NCT03310021|18555769|P13|STARTED|Overall Study||8
7537561|NCT03310021|18555770|P12|STARTED|Overall Study||3
7537562|NCT03310021|18555771|P11|STARTED|Overall Study||6
7537563|NCT03310021|18555772|P10|STARTED|Overall Study||3
7537564|NCT03310021|18555773|P9|STARTED|Overall Study||6
7537565|NCT03310021|18555774|P8|STARTED|Overall Study||4
7537566|NCT03310021|18555775|P7|STARTED|Overall Study||8
7537567|NCT03310021|18555776|P6|STARTED|Overall Study||4
7537568|NCT03310021|18555777|P5|STARTED|Overall Study||8
7537569|NCT03310021|18555778|P4|STARTED|Overall Study||3
7537570|NCT03310021|18555779|P3|STARTED|Overall Study||6
7537571|NCT03310021|18555780|P2|STARTED|Overall Study||3
7537572|NCT03310021|18555781|P1|STARTED|Overall Study||6
7537573|NCT03309943|18555925|P2|NOT COMPLETED|Overall Study||2
7537574|NCT03309943|18555926|P1|NOT COMPLETED|Overall Study||0
7537575|NCT03309943|18555925|P2|COMPLETED|Overall Study||20
7537576|NCT03309943|18555926|P1|COMPLETED|Overall Study||22
7537577|NCT03309943|18555925|P2|STARTED|Overall Study||22
7537578|NCT03309943|18555926|P1|STARTED|Overall Study||22
7537579|NCT03309787|18555955|P3|NOT COMPLETED|Overall Study||2
7537580|NCT03309787|18555956|P2|NOT COMPLETED|Overall Study||6
7537581|NCT03309787|18555957|P1|NOT COMPLETED|Overall Study||2
7537582|NCT03309787|18555955|P3|COMPLETED|Overall Study||7
7537583|NCT03309787|18555956|P2|COMPLETED|Overall Study||14
7537584|NCT03309787|18555957|P1|COMPLETED|Overall Study||6
7537585|NCT03309787|18555955|P3|STARTED|Overall Study||9
7537586|NCT03309787|18555956|P2|STARTED|Overall Study||20
7537587|NCT03309787|18555957|P1|STARTED|Overall Study||8
7537588|NCT03309696|18555989|P4|NOT COMPLETED|Overall Study||0
7537589|NCT03309696|18555990|P3|NOT COMPLETED|Overall Study||0
7537590|NCT03309696|18555991|P2|NOT COMPLETED|Overall Study||5
7537591|NCT03309696|18555992|P1|NOT COMPLETED|Overall Study||0
7537592|NCT03309696|18555989|P4|COMPLETED|Overall Study||0
7537593|NCT03309696|18555990|P3|COMPLETED|Overall Study||0
7537594|NCT03309696|18555991|P2|COMPLETED|Overall Study||0
7537595|NCT03309696|18555992|P1|COMPLETED|Overall Study||5
7537596|NCT03309696|18555989|P4|STARTED|Overall Study||0
7537597|NCT03309696|18555990|P3|STARTED|Overall Study||0
7537598|NCT03309696|18555991|P2|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5
7537599|NCT03309696|18555992|P1|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5
7537600|NCT03309657|18556000|P1|NOT COMPLETED|Overall Study||0
7537601|NCT03309657|18556000|P1|COMPLETED|Overall Study||10
7537602|NCT03309657|18556000|P1|STARTED|Overall Study||10
7537603|NCT03309202|18556011|P4|NOT COMPLETED|Overall Study||0
7537604|NCT03309202|18556012|P3|NOT COMPLETED|Overall Study||0
7537605|NCT03309202|18556013|P2|NOT COMPLETED|Overall Study||0
7537606|NCT03309202|18556014|P1|NOT COMPLETED|Overall Study||1
7537607|NCT03309202|18556011|P4|COMPLETED|Overall Study||6
7537608|NCT03309202|18556012|P3|COMPLETED|Overall Study||6
7537609|NCT03309202|18556013|P2|COMPLETED|Overall Study||6
7537610|NCT03309202|18556014|P1|COMPLETED|Overall Study||5
7537611|NCT03309202|18556011|P4|STARTED|Overall Study||6
7537612|NCT03309202|18556012|P3|STARTED|Overall Study||6
7537613|NCT03309202|18556013|P2|STARTED|Overall Study||6
7537614|NCT03309202|18556014|P1|STARTED|Overall Study||6
7537615|NCT03309072|18556098|P2|NOT COMPLETED|Overall Study||0
7537616|NCT03309072|18556099|P1|NOT COMPLETED|Overall Study||0
7537617|NCT03309072|18556098|P2|COMPLETED|Overall Study||15
7537618|NCT03309072|18556099|P1|COMPLETED|Overall Study||15
7537619|NCT03309072|18556098|P2|STARTED|Overall Study||15
7537620|NCT03309072|18556099|P1|STARTED|Overall Study||15
7537621|NCT03308968|18556108|P3|NOT COMPLETED|Open-Label Period (12 Weeks)||12
7537622|NCT03308968|18556109|P2|NOT COMPLETED|Open-Label Period (12 Weeks)||12
7537623|NCT03308968|18556110|P1|NOT COMPLETED|Open-Label Period (12 Weeks)||11
7537624|NCT03308968|18556108|P3|COMPLETED|Open-Label Period (12 Weeks)||260
7537625|NCT03308968|18556109|P2|COMPLETED|Open-Label Period (12 Weeks)||259
7537626|NCT03308968|18556110|P1|COMPLETED|Open-Label Period (12 Weeks)||253
7537627|NCT03308968|18556108|P3|OL mITT Analysis Set|Open-Label Period (12 Weeks)||272
7537628|NCT03308968|18556109|P2|OL mITT Analysis Set|Open-Label Period (12 Weeks)||271
7537629|NCT03308968|18556110|P1|OL mITT Analysis Set|Open-Label Period (12 Weeks)||263
7537630|NCT03308968|18556108|P3|STARTED|Open-Label Period (12 Weeks)||272
7537631|NCT03308968|18556109|P2|STARTED|Open-Label Period (12 Weeks)||271
7537632|NCT03308968|18556110|P1|STARTED|Open-Label Period (12 Weeks)||264
7537633|NCT03308968|18556108|P3|NOT COMPLETED|Double-Blind Period (12 Weeks)||11
7537634|NCT03308968|18556109|P2|NOT COMPLETED|Double-Blind Period (12 Weeks)||5
7537635|NCT03308968|18556110|P1|NOT COMPLETED|Double-Blind Period (12 Weeks)||15
7537636|NCT03308968|18556108|P3|COMPLETED|Double-Blind Period (12 Weeks)||272
7537637|NCT03308968|18556109|P2|COMPLETED|Double-Blind Period (12 Weeks)||271
7537638|NCT03308968|18556110|P1|COMPLETED|Double-Blind Period (12 Weeks)||264
7537639|NCT03308968|18556108|P3|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||283
7537640|NCT03308968|18556109|P2|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||276
7537641|NCT03308968|18556110|P1|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||278
7537642|NCT03308968|18556108|P3|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|285
7537643|NCT03308968|18556109|P2|DB Safety Analysis Set|Double-Blind Period (12 Weeks)||276
7537644|NCT03308968|18556110|P1|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|277
7537645|NCT03308968|18556108|P3|STARTED|Double-Blind Period (12 Weeks)||283
7537646|NCT03308968|18556109|P2|STARTED|Double-Blind Period (12 Weeks)||276
7537647|NCT03308968|18556110|P1|STARTED|Double-Blind Period (12 Weeks)||279
7537648|NCT03308825|18556188|P4|NOT COMPLETED|Overall Study||0
7537649|NCT03308825|18556189|P3|NOT COMPLETED|Overall Study||1
7537650|NCT03308825|18556190|P2|NOT COMPLETED|Overall Study||4
7537651|NCT03308825|18556191|P1|NOT COMPLETED|Overall Study||2
7537652|NCT03308825|18556188|P4|COMPLETED|Overall Study||60
7537653|NCT03308825|18556189|P3|COMPLETED|Overall Study||59
7537654|NCT03308825|18556190|P2|COMPLETED|Overall Study||57
7537655|NCT03308825|18556191|P1|COMPLETED|Overall Study||57
7537656|NCT03308825|18556188|P4|STARTED|Overall Study||60
7537657|NCT03308825|18556189|P3|STARTED|Overall Study||60
7537658|NCT03308825|18556190|P2|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|61
7537659|NCT03308825|18556191|P1|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|59
7537660|NCT03308799|18556220|P3|NOT COMPLETED|Overall Study||21
7537661|NCT03308799|18556221|P2|NOT COMPLETED|Overall Study||28
7537662|NCT03308799|18556222|P1|NOT COMPLETED|Overall Study||22
7537663|NCT03308799|18556220|P3|COMPLETED|Overall Study||94
7537664|NCT03308799|18556221|P2|COMPLETED|Overall Study||309
7537665|NCT03308799|18556222|P1|COMPLETED|Overall Study||320
7537666|NCT03308799|18556220|P3|STARTED|Overall Study||115
7537667|NCT03308799|18556221|P2|STARTED|Overall Study||337
7537668|NCT03308799|18556222|P1|STARTED|Overall Study||342
7537669|NCT03308669|18556238|P2|NOT COMPLETED|Overall Study||0
7537670|NCT03308669|18556239|P1|NOT COMPLETED|Overall Study||0
7537671|NCT03308669|18556238|P2|COMPLETED|Overall Study||20
7537672|NCT03308669|18556239|P1|COMPLETED|Overall Study||10
7537673|NCT03308669|18556238|P2|Received at Least One Dose of Study Drug|Overall Study||20
7537674|NCT03308669|18556239|P1|Received at Least One Dose of Study Drug|Overall Study||10
7537675|NCT03308669|18556238|P2|STARTED|Overall Study||20
7537676|NCT03308669|18556239|P1|STARTED|Overall Study||10
7537677|NCT03308058|18556261|P2|NOT COMPLETED|Overall Study||0
7537678|NCT03308058|18556262|P1|NOT COMPLETED|Overall Study||0
7537679|NCT03308058|18556261|P2|COMPLETED|Overall Study||23
7537680|NCT03308058|18556262|P1|COMPLETED|Overall Study||23
7537681|NCT03308058|18556261|P2|STARTED|Overall Study||23
7537682|NCT03308058|18556262|P1|STARTED|Overall Study||23
7537683|NCT03307252|18556279|P11|NOT COMPLETED|Part 3, Period 4||0
7537684|NCT03307252|18556280|P10|NOT COMPLETED|Part 3, Period 4||0
7537685|NCT03307252|18556281|P9|NOT COMPLETED|Part 3, Period 4||0
7537686|NCT03307252|18556282|P8|NOT COMPLETED|Part 3, Period 4||0
7537687|NCT03307252|18556283|P7|NOT COMPLETED|Part 3, Period 4||0
7537688|NCT03307252|18556284|P6|NOT COMPLETED|Part 3, Period 4||0
7537689|NCT03307252|18556285|P5|NOT COMPLETED|Part 3, Period 4||0
7537690|NCT03307252|18556286|P4|NOT COMPLETED|Part 3, Period 4||0
7537691|NCT03307252|18556287|P3|NOT COMPLETED|Part 3, Period 4||0
7537692|NCT03307252|18556288|P2|NOT COMPLETED|Part 3, Period 4||0
7537693|NCT03307252|18556289|P1|NOT COMPLETED|Part 3, Period 4||0
7537694|NCT03307252|18556279|P11|COMPLETED|Part 3, Period 4||3
7537695|NCT03307252|18556280|P10|COMPLETED|Part 3, Period 4||4
7537696|NCT03307252|18556281|P9|COMPLETED|Part 3, Period 4||4
7537697|NCT03307252|18556282|P8|COMPLETED|Part 3, Period 4||4
7537698|NCT03307252|18556283|P7|COMPLETED|Part 3, Period 4||0
7537699|NCT03307252|18556284|P6|COMPLETED|Part 3, Period 4||0
7537700|NCT03307252|18556285|P5|COMPLETED|Part 3, Period 4||0
7537701|NCT03307252|18556286|P4|COMPLETED|Part 3, Period 4||0
7537702|NCT03307252|18556287|P3|COMPLETED|Part 3, Period 4||0
7537703|NCT03307252|18556288|P2|COMPLETED|Part 3, Period 4||0
7537704|NCT03307252|18556289|P1|COMPLETED|Part 3, Period 4||0
7537705|NCT03307252|18556279|P11|STARTED|Part 3, Period 4||3
7537706|NCT03307252|18556280|P10|STARTED|Part 3, Period 4||4
7537707|NCT03307252|18556281|P9|STARTED|Part 3, Period 4||4
7537708|NCT03307252|18556282|P8|STARTED|Part 3, Period 4||4
7537709|NCT03307252|18556283|P7|STARTED|Part 3, Period 4||0
7537710|NCT03307252|18556284|P6|STARTED|Part 3, Period 4||0
7537711|NCT03307252|18556285|P5|STARTED|Part 3, Period 4||0
7537712|NCT03307252|18556286|P4|STARTED|Part 3, Period 4||0
7537713|NCT03307252|18556287|P3|STARTED|Part 3, Period 4||0
7537714|NCT03307252|18556288|P2|STARTED|Part 3, Period 4||0
7537715|NCT03307252|18556289|P1|STARTED|Part 3, Period 4||0
7537716|NCT03307252|18556279|P11|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||1
7537717|NCT03307252|18556280|P10|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
7537718|NCT03307252|18556281|P9|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
7537719|NCT03307252|18556282|P8|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
7537720|NCT03307252|18556283|P7|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
7537721|NCT03307252|18556284|P6|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
7537722|NCT03307252|18556285|P5|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
7537723|NCT03307252|18556286|P4|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
7537724|NCT03307252|18556287|P3|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
7537725|NCT03307252|18556288|P2|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
7537726|NCT03307252|18556289|P1|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
7537727|NCT03307252|18556279|P11|COMPLETED|Part 3, Washout Period 3 (7 Days)||3
7537728|NCT03307252|18556280|P10|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
7537729|NCT03307252|18556281|P9|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
7537730|NCT03307252|18556282|P8|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
7537731|NCT03307252|18556283|P7|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
7537732|NCT03307252|18556284|P6|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
7537733|NCT03307252|18556285|P5|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
7537734|NCT03307252|18556286|P4|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
7537735|NCT03307252|18556287|P3|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
7537736|NCT03307252|18556288|P2|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
7537737|NCT03307252|18556289|P1|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
7537738|NCT03307252|18556279|P11|STARTED|Part 3, Washout Period 3 (7 Days)||4
7537739|NCT03307252|18556280|P10|STARTED|Part 3, Washout Period 3 (7 Days)||4
7537740|NCT03307252|18556281|P9|STARTED|Part 3, Washout Period 3 (7 Days)||4
7537741|NCT03307252|18556282|P8|STARTED|Part 3, Washout Period 3 (7 Days)||4
7537742|NCT03307252|18556283|P7|STARTED|Part 3, Washout Period 3 (7 Days)||0
7537743|NCT03307252|18556284|P6|STARTED|Part 3, Washout Period 3 (7 Days)||0
7537744|NCT03307252|18556285|P5|STARTED|Part 3, Washout Period 3 (7 Days)||0
7537745|NCT03307252|18556286|P4|STARTED|Part 3, Washout Period 3 (7 Days)||0
7537746|NCT03307252|18556287|P3|STARTED|Part 3, Washout Period 3 (7 Days)||0
7537747|NCT03307252|18556288|P2|STARTED|Part 3, Washout Period 3 (7 Days)||0
7537748|NCT03307252|18556289|P1|STARTED|Part 3, Washout Period 3 (7 Days)||0
7537749|NCT03307252|18556279|P11|NOT COMPLETED|Part 3, Period 3||0
7537750|NCT03307252|18556280|P10|NOT COMPLETED|Part 3, Period 3||0
7537751|NCT03307252|18556281|P9|NOT COMPLETED|Part 3, Period 3||0
7537752|NCT03307252|18556282|P8|NOT COMPLETED|Part 3, Period 3||0
7537753|NCT03307252|18556283|P7|NOT COMPLETED|Part 3, Period 3||0
7537754|NCT03307252|18556284|P6|NOT COMPLETED|Part 3, Period 3||0
7537755|NCT03307252|18556285|P5|NOT COMPLETED|Part 3, Period 3||0
7537756|NCT03307252|18556286|P4|NOT COMPLETED|Part 3, Period 3||0
7537757|NCT03307252|18556287|P3|NOT COMPLETED|Part 3, Period 3||0
7537758|NCT03307252|18556288|P2|NOT COMPLETED|Part 3, Period 3||0
7537759|NCT03307252|18556289|P1|NOT COMPLETED|Part 3, Period 3||0
7537760|NCT03307252|18556279|P11|COMPLETED|Part 3, Period 3||4
7537761|NCT03307252|18556280|P10|COMPLETED|Part 3, Period 3||4
7537762|NCT03307252|18556281|P9|COMPLETED|Part 3, Period 3||4
7537763|NCT03307252|18556282|P8|COMPLETED|Part 3, Period 3||4
7537764|NCT03307252|18556283|P7|COMPLETED|Part 3, Period 3||0
7537765|NCT03307252|18556284|P6|COMPLETED|Part 3, Period 3||0
7537766|NCT03307252|18556285|P5|COMPLETED|Part 3, Period 3||0
7537767|NCT03307252|18556286|P4|COMPLETED|Part 3, Period 3||0
7537768|NCT03307252|18556287|P3|COMPLETED|Part 3, Period 3||0
7537769|NCT03307252|18556288|P2|COMPLETED|Part 3, Period 3||0
7537770|NCT03307252|18556289|P1|COMPLETED|Part 3, Period 3||0
7537771|NCT03307252|18556279|P11|STARTED|Part 3, Period 3||4
7537772|NCT03307252|18556280|P10|STARTED|Part 3, Period 3||4
7537773|NCT03307252|18556281|P9|STARTED|Part 3, Period 3||4
7537774|NCT03307252|18556282|P8|STARTED|Part 3, Period 3||4
7537775|NCT03307252|18556283|P7|STARTED|Part 3, Period 3||0
7537776|NCT03307252|18556284|P6|STARTED|Part 3, Period 3||0
7537777|NCT03307252|18556285|P5|STARTED|Part 3, Period 3||0
7537778|NCT03307252|18556286|P4|STARTED|Part 3, Period 3||0
7537779|NCT03307252|18556287|P3|STARTED|Part 3, Period 3||0
7537780|NCT03307252|18556288|P2|STARTED|Part 3, Period 3||0
7537781|NCT03307252|18556289|P1|STARTED|Part 3, Period 3||0
7537782|NCT03307252|18556279|P11|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
7537783|NCT03307252|18556280|P10|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
7537784|NCT03307252|18556281|P9|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
7537785|NCT03307252|18556282|P8|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
7537786|NCT03307252|18556283|P7|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
7537787|NCT03307252|18556284|P6|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
7537788|NCT03307252|18556285|P5|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
7537789|NCT03307252|18556286|P4|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
7537790|NCT03307252|18556287|P3|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
7537791|NCT03307252|18556288|P2|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
7537792|NCT03307252|18556289|P1|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
7537793|NCT03307252|18556279|P11|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
7537794|NCT03307252|18556280|P10|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
7537795|NCT03307252|18556281|P9|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
7537796|NCT03307252|18556282|P8|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
7537797|NCT03307252|18556283|P7|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
7537798|NCT03307252|18556284|P6|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
7537799|NCT03307252|18556285|P5|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
7537800|NCT03307252|18556286|P4|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
7537801|NCT03307252|18556287|P3|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
7537802|NCT03307252|18556288|P2|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
7537803|NCT03307252|18556289|P1|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
7537804|NCT03307252|18556279|P11|STARTED|Part 3, Washout Period 2 (7 Days)||4
7537805|NCT03307252|18556280|P10|STARTED|Part 3, Washout Period 2 (7 Days)||4
7537806|NCT03307252|18556281|P9|STARTED|Part 3, Washout Period 2 (7 Days)||4
7537807|NCT03307252|18556282|P8|STARTED|Part 3, Washout Period 2 (7 Days)||4
7537808|NCT03307252|18556283|P7|STARTED|Part 3, Washout Period 2 (7 Days)||0
7537809|NCT03307252|18556284|P6|STARTED|Part 3, Washout Period 2 (7 Days)||0
7537810|NCT03307252|18556285|P5|STARTED|Part 3, Washout Period 2 (7 Days)||0
7537811|NCT03307252|18556286|P4|STARTED|Part 3, Washout Period 2 (7 Days)||0
7537812|NCT03307252|18556287|P3|STARTED|Part 3, Washout Period 2 (7 Days)||0
7537813|NCT03307252|18556288|P2|STARTED|Part 3, Washout Period 2 (7 Days)||0
7537814|NCT03307252|18556289|P1|STARTED|Part 3, Washout Period 2 (7 Days)||0
7537815|NCT03307252|18556279|P11|NOT COMPLETED|Part 3, Period 2||0
7537816|NCT03307252|18556280|P10|NOT COMPLETED|Part 3, Period 2||0
7537817|NCT03307252|18556281|P9|NOT COMPLETED|Part 3, Period 2||0
7537818|NCT03307252|18556282|P8|NOT COMPLETED|Part 3, Period 2||0
7537819|NCT03307252|18556283|P7|NOT COMPLETED|Part 3, Period 2||0
7537820|NCT03307252|18556284|P6|NOT COMPLETED|Part 3, Period 2||0
7537821|NCT03307252|18556285|P5|NOT COMPLETED|Part 3, Period 2||0
7537822|NCT03307252|18556286|P4|NOT COMPLETED|Part 3, Period 2||0
7537823|NCT03307252|18556287|P3|NOT COMPLETED|Part 3, Period 2||0
7537824|NCT03307252|18556288|P2|NOT COMPLETED|Part 3, Period 2||0
7537825|NCT03307252|18556289|P1|NOT COMPLETED|Part 3, Period 2||0
7537826|NCT03307252|18556279|P11|COMPLETED|Part 3, Period 2||4
7537827|NCT03307252|18556280|P10|COMPLETED|Part 3, Period 2||4
7537828|NCT03307252|18556281|P9|COMPLETED|Part 3, Period 2||4
7537829|NCT03307252|18556282|P8|COMPLETED|Part 3, Period 2||4
7537830|NCT03307252|18556283|P7|COMPLETED|Part 3, Period 2||0
7537831|NCT03307252|18556284|P6|COMPLETED|Part 3, Period 2||0
7537832|NCT03307252|18556285|P5|COMPLETED|Part 3, Period 2||0
7537833|NCT03307252|18556286|P4|COMPLETED|Part 3, Period 2||0
7537834|NCT03307252|18556287|P3|COMPLETED|Part 3, Period 2||0
7537835|NCT03307252|18556288|P2|COMPLETED|Part 3, Period 2||0
7537836|NCT03307252|18556289|P1|COMPLETED|Part 3, Period 2||0
7537837|NCT03307252|18556279|P11|STARTED|Part 3, Period 2||4
7537838|NCT03307252|18556280|P10|STARTED|Part 3, Period 2||4
7537839|NCT03307252|18556281|P9|STARTED|Part 3, Period 2||4
7537840|NCT03307252|18556282|P8|STARTED|Part 3, Period 2||4
7537841|NCT03307252|18556283|P7|STARTED|Part 3, Period 2||0
7537842|NCT03307252|18556284|P6|STARTED|Part 3, Period 2||0
7537843|NCT03307252|18556285|P5|STARTED|Part 3, Period 2||0
7537844|NCT03307252|18556286|P4|STARTED|Part 3, Period 2||0
7537845|NCT03307252|18556287|P3|STARTED|Part 3, Period 2||0
7537846|NCT03307252|18556288|P2|STARTED|Part 3, Period 2||0
7537847|NCT03307252|18556289|P1|STARTED|Part 3, Period 2||0
7537848|NCT03307252|18556279|P11|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
7537849|NCT03307252|18556280|P10|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
7537850|NCT03307252|18556281|P9|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
7537851|NCT03307252|18556282|P8|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
7537852|NCT03307252|18556283|P7|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
7537853|NCT03307252|18556284|P6|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
7537854|NCT03307252|18556285|P5|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
7537855|NCT03307252|18556286|P4|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
7537856|NCT03307252|18556287|P3|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
7537857|NCT03307252|18556288|P2|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
7537858|NCT03307252|18556289|P1|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
7537859|NCT03307252|18556279|P11|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
7537860|NCT03307252|18556280|P10|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
7537861|NCT03307252|18556281|P9|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
7537862|NCT03307252|18556282|P8|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
7537863|NCT03307252|18556283|P7|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
7537864|NCT03307252|18556284|P6|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
7537865|NCT03307252|18556285|P5|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
7537866|NCT03307252|18556286|P4|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
7537867|NCT03307252|18556287|P3|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
7537868|NCT03307252|18556288|P2|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
7537869|NCT03307252|18556289|P1|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
7537870|NCT03307252|18556279|P11|STARTED|Part 3, Washout Period 1 (7 Days)||4
7537871|NCT03307252|18556280|P10|STARTED|Part 3, Washout Period 1 (7 Days)||4
7537872|NCT03307252|18556281|P9|STARTED|Part 3, Washout Period 1 (7 Days)||4
7537873|NCT03307252|18556282|P8|STARTED|Part 3, Washout Period 1 (7 Days)||4
7537874|NCT03307252|18556283|P7|STARTED|Part 3, Washout Period 1 (7 Days)||0
7537875|NCT03307252|18556284|P6|STARTED|Part 3, Washout Period 1 (7 Days)||0
7537876|NCT03307252|18556285|P5|STARTED|Part 3, Washout Period 1 (7 Days)||0
7537877|NCT03307252|18556286|P4|STARTED|Part 3, Washout Period 1 (7 Days)||0
7537878|NCT03307252|18556287|P3|STARTED|Part 3, Washout Period 1 (7 Days)||0
7537879|NCT03307252|18556288|P2|STARTED|Part 3, Washout Period 1 (7 Days)||0
7537880|NCT03307252|18556289|P1|STARTED|Part 3, Washout Period 1 (7 Days)||0
7537881|NCT03307252|18556279|P11|NOT COMPLETED|Part 3, Period 1||0
7537882|NCT03307252|18556280|P10|NOT COMPLETED|Part 3, Period 1||0
7537883|NCT03307252|18556281|P9|NOT COMPLETED|Part 3, Period 1||0
7537884|NCT03307252|18556282|P8|NOT COMPLETED|Part 3, Period 1||0
7537885|NCT03307252|18556283|P7|NOT COMPLETED|Part 3, Period 1||0
7537886|NCT03307252|18556284|P6|NOT COMPLETED|Part 3, Period 1||0
7537887|NCT03307252|18556285|P5|NOT COMPLETED|Part 3, Period 1||0
7537888|NCT03307252|18556286|P4|NOT COMPLETED|Part 3, Period 1||0
7537889|NCT03307252|18556287|P3|NOT COMPLETED|Part 3, Period 1||0
7537890|NCT03307252|18556288|P2|NOT COMPLETED|Part 3, Period 1||0
7537891|NCT03307252|18556289|P1|NOT COMPLETED|Part 3, Period 1||0
7537892|NCT03307252|18556279|P11|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
7537893|NCT03307252|18556280|P10|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
7537894|NCT03307252|18556281|P9|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
7537895|NCT03307252|18556282|P8|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
7537896|NCT03307252|18556283|P7|COMPLETED|Part 3, Period 1||0
7537897|NCT03307252|18556284|P6|COMPLETED|Part 3, Period 1||0
7537898|NCT03307252|18556285|P5|COMPLETED|Part 3, Period 1||0
7537899|NCT03307252|18556286|P4|COMPLETED|Part 3, Period 1||0
7537900|NCT03307252|18556287|P3|COMPLETED|Part 3, Period 1||0
7537901|NCT03307252|18556288|P2|COMPLETED|Part 3, Period 1||0
7537902|NCT03307252|18556289|P1|COMPLETED|Part 3, Period 1||0
7537903|NCT03307252|18556279|P11|STARTED|Part 3, Period 1||4
7537904|NCT03307252|18556280|P10|STARTED|Part 3, Period 1||4
7537905|NCT03307252|18556281|P9|STARTED|Part 3, Period 1||4
7537906|NCT03307252|18556282|P8|STARTED|Part 3, Period 1||4
7537907|NCT03307252|18556283|P7|STARTED|Part 3, Period 1||0
7537908|NCT03307252|18556284|P6|STARTED|Part 3, Period 1||0
7537909|NCT03307252|18556285|P5|STARTED|Part 3, Period 1||0
7537910|NCT03307252|18556286|P4|STARTED|Part 3, Period 1||0
7537911|NCT03307252|18556287|P3|STARTED|Part 3, Period 1||0
7537912|NCT03307252|18556288|P2|STARTED|Part 3, Period 1||0
7537913|NCT03307252|18556289|P1|STARTED|Part 3, Period 1||0
7537914|NCT03307252|18556279|P11|NOT COMPLETED|Part 2, Period 4||0
7537915|NCT03307252|18556280|P10|NOT COMPLETED|Part 2, Period 4||0
7537916|NCT03307252|18556281|P9|NOT COMPLETED|Part 2, Period 4||0
7537917|NCT03307252|18556282|P8|NOT COMPLETED|Part 2, Period 4||0
7537918|NCT03307252|18556283|P7|NOT COMPLETED|Part 2, Period 4||1
7537919|NCT03307252|18556284|P6|NOT COMPLETED|Part 2, Period 4||0
7537920|NCT03307252|18556285|P5|NOT COMPLETED|Part 2, Period 4||0
7537921|NCT03307252|18556286|P4|NOT COMPLETED|Part 2, Period 4||0
7537922|NCT03307252|18556287|P3|NOT COMPLETED|Part 2, Period 4||0
7537923|NCT03307252|18556288|P2|NOT COMPLETED|Part 2, Period 4||0
7537924|NCT03307252|18556289|P1|NOT COMPLETED|Part 2, Period 4||0
7537925|NCT03307252|18556279|P11|COMPLETED|Part 2, Period 4||0
7537926|NCT03307252|18556280|P10|COMPLETED|Part 2, Period 4||0
7537927|NCT03307252|18556281|P9|COMPLETED|Part 2, Period 4||0
7537928|NCT03307252|18556282|P8|COMPLETED|Part 2, Period 4||0
7537929|NCT03307252|18556283|P7|COMPLETED|Part 2, Period 4||4
7537930|NCT03307252|18556284|P6|COMPLETED|Part 2, Period 4||3
7537931|NCT03307252|18556285|P5|COMPLETED|Part 2, Period 4||3
7537932|NCT03307252|18556286|P4|COMPLETED|Part 2, Period 4||4
7537933|NCT03307252|18556287|P3|COMPLETED|Part 2, Period 4||0
7537934|NCT03307252|18556288|P2|COMPLETED|Part 2, Period 4||0
7537935|NCT03307252|18556289|P1|COMPLETED|Part 2, Period 4||0
7537936|NCT03307252|18556279|P11|STARTED|Part 2, Period 4||0
7537937|NCT03307252|18556280|P10|STARTED|Part 2, Period 4||0
7537938|NCT03307252|18556281|P9|STARTED|Part 2, Period 4||0
7537939|NCT03307252|18556282|P8|STARTED|Part 2, Period 4||0
7537940|NCT03307252|18556283|P7|STARTED|Part 2, Period 4||5
7537941|NCT03307252|18556284|P6|STARTED|Part 2, Period 4||3
7537942|NCT03307252|18556285|P5|STARTED|Part 2, Period 4||3
7537943|NCT03307252|18556286|P4|STARTED|Part 2, Period 4||4
7537944|NCT03307252|18556287|P3|STARTED|Part 2, Period 4||0
7537945|NCT03307252|18556288|P2|STARTED|Part 2, Period 4||0
7537946|NCT03307252|18556289|P1|STARTED|Part 2, Period 4||0
7537947|NCT03307252|18556279|P11|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
7537948|NCT03307252|18556280|P10|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
7537949|NCT03307252|18556281|P9|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
7537950|NCT03307252|18556282|P8|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
7537951|NCT03307252|18556283|P7|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||1
7537952|NCT03307252|18556284|P6|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
7537953|NCT03307252|18556285|P5|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
7537954|NCT03307252|18556286|P4|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
7537955|NCT03307252|18556287|P3|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
7537956|NCT03307252|18556288|P2|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
7537957|NCT03307252|18556289|P1|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
7537958|NCT03307252|18556279|P11|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
7537959|NCT03307252|18556280|P10|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
7537960|NCT03307252|18556281|P9|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
7537961|NCT03307252|18556282|P8|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
7537962|NCT03307252|18556283|P7|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
7537963|NCT03307252|18556284|P6|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
7537964|NCT03307252|18556285|P5|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
7537965|NCT03307252|18556286|P4|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
7537966|NCT03307252|18556287|P3|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
7537967|NCT03307252|18556288|P2|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
7537968|NCT03307252|18556289|P1|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
7537969|NCT03307252|18556279|P11|STARTED|Part 2, Washout Period 3 (7 Days)||0
7537970|NCT03307252|18556280|P10|STARTED|Part 2, Washout Period 3 (7 Days)||0
7537971|NCT03307252|18556281|P9|STARTED|Part 2, Washout Period 3 (7 Days)||0
7537972|NCT03307252|18556282|P8|STARTED|Part 2, Washout Period 3 (7 Days)||0
7537973|NCT03307252|18556283|P7|STARTED|Part 2, Washout Period 3 (7 Days)||5
7537974|NCT03307252|18556284|P6|STARTED|Part 2, Washout Period 3 (7 Days)||3
7537975|NCT03307252|18556285|P5|STARTED|Part 2, Washout Period 3 (7 Days)||3
7537976|NCT03307252|18556286|P4|STARTED|Part 2, Washout Period 3 (7 Days)||4
7537977|NCT03307252|18556287|P3|STARTED|Part 2, Washout Period 3 (7 Days)||0
7537978|NCT03307252|18556288|P2|STARTED|Part 2, Washout Period 3 (7 Days)||0
7537979|NCT03307252|18556289|P1|STARTED|Part 2, Washout Period 3 (7 Days)||0
7537980|NCT03307252|18556279|P11|NOT COMPLETED|Part 2, Period 3||0
7537981|NCT03307252|18556280|P10|NOT COMPLETED|Part 2, Period 3||0
7537982|NCT03307252|18556281|P9|NOT COMPLETED|Part 2, Period 3||0
7537983|NCT03307252|18556282|P8|NOT COMPLETED|Part 2, Period 3||0
7537984|NCT03307252|18556283|P7|NOT COMPLETED|Part 2, Period 3||0
7537985|NCT03307252|18556284|P6|NOT COMPLETED|Part 2, Period 3||0
7537986|NCT03307252|18556285|P5|NOT COMPLETED|Part 2, Period 3||1
7537987|NCT03307252|18556286|P4|NOT COMPLETED|Part 2, Period 3||0
7537988|NCT03307252|18556287|P3|NOT COMPLETED|Part 2, Period 3||0
7537989|NCT03307252|18556288|P2|NOT COMPLETED|Part 2, Period 3||0
7537990|NCT03307252|18556289|P1|NOT COMPLETED|Part 2, Period 3||0
7537991|NCT03307252|18556279|P11|COMPLETED|Part 2, Period 3||0
7537992|NCT03307252|18556280|P10|COMPLETED|Part 2, Period 3||0
7537993|NCT03307252|18556281|P9|COMPLETED|Part 2, Period 3||0
7537994|NCT03307252|18556282|P8|COMPLETED|Part 2, Period 3||0
7537995|NCT03307252|18556283|P7|COMPLETED|Part 2, Period 3||5
7537996|NCT03307252|18556284|P6|COMPLETED|Part 2, Period 3||3
7537997|NCT03307252|18556285|P5|COMPLETED|Part 2, Period 3||3
7537998|NCT03307252|18556286|P4|COMPLETED|Part 2, Period 3||4
7537999|NCT03307252|18556287|P3|COMPLETED|Part 2, Period 3||0
7538000|NCT03307252|18556288|P2|COMPLETED|Part 2, Period 3||0
7538001|NCT03307252|18556289|P1|COMPLETED|Part 2, Period 3||0
7538002|NCT03307252|18556279|P11|STARTED|Part 2, Period 3||0
7538003|NCT03307252|18556280|P10|STARTED|Part 2, Period 3||0
7538004|NCT03307252|18556281|P9|STARTED|Part 2, Period 3||0
7538005|NCT03307252|18556282|P8|STARTED|Part 2, Period 3||0
7538006|NCT03307252|18556283|P7|STARTED|Part 2, Period 3||5
7538007|NCT03307252|18556284|P6|STARTED|Part 2, Period 3||3
7538008|NCT03307252|18556285|P5|STARTED|Part 2, Period 3||4
7538009|NCT03307252|18556286|P4|STARTED|Part 2, Period 3||4
7538010|NCT03307252|18556287|P3|STARTED|Part 2, Period 3||0
7538011|NCT03307252|18556288|P2|STARTED|Part 2, Period 3||0
7538012|NCT03307252|18556289|P1|STARTED|Part 2, Period 3||0
7538013|NCT03307252|18556279|P11|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
7538014|NCT03307252|18556280|P10|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
7538015|NCT03307252|18556281|P9|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
7538016|NCT03307252|18556282|P8|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
7538017|NCT03307252|18556283|P7|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
7538018|NCT03307252|18556284|P6|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
7538019|NCT03307252|18556285|P5|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
7538020|NCT03307252|18556286|P4|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
7538021|NCT03307252|18556287|P3|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
7538022|NCT03307252|18556288|P2|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
7538023|NCT03307252|18556289|P1|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
7538024|NCT03307252|18556279|P11|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
7538025|NCT03307252|18556280|P10|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
7538026|NCT03307252|18556281|P9|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
7538027|NCT03307252|18556282|P8|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
7538028|NCT03307252|18556283|P7|COMPLETED|Part 2, Washout Period 2 (7 Days)||5
7538029|NCT03307252|18556284|P6|COMPLETED|Part 2, Washout Period 2 (7 Days)||3
7538030|NCT03307252|18556285|P5|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
7538031|NCT03307252|18556286|P4|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
7538032|NCT03307252|18556287|P3|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
7538033|NCT03307252|18556288|P2|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
7538034|NCT03307252|18556289|P1|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
7538035|NCT03307252|18556279|P11|STARTED|Part 2, Washout Period 2 (7 Days)||0
7538036|NCT03307252|18556280|P10|STARTED|Part 2, Washout Period 2 (7 Days)||0
7538037|NCT03307252|18556281|P9|STARTED|Part 2, Washout Period 2 (7 Days)||0
7538038|NCT03307252|18556282|P8|STARTED|Part 2, Washout Period 2 (7 Days)||0
7538039|NCT03307252|18556283|P7|STARTED|Part 2, Washout Period 2 (7 Days)||5
7538040|NCT03307252|18556284|P6|STARTED|Part 2, Washout Period 2 (7 Days)||3
7538041|NCT03307252|18556285|P5|STARTED|Part 2, Washout Period 2 (7 Days)||4
7538042|NCT03307252|18556286|P4|STARTED|Part 2, Washout Period 2 (7 Days)||4
7538043|NCT03307252|18556287|P3|STARTED|Part 2, Washout Period 2 (7 Days)||0
7538044|NCT03307252|18556288|P2|STARTED|Part 2, Washout Period 2 (7 Days)||0
7538045|NCT03307252|18556289|P1|STARTED|Part 2, Washout Period 2 (7 Days)||0
7538046|NCT03307252|18556279|P11|NOT COMPLETED|Part 2, Period 2||0
7538047|NCT03307252|18556280|P10|NOT COMPLETED|Part 2, Period 2||0
7538048|NCT03307252|18556281|P9|NOT COMPLETED|Part 2, Period 2||0
7538049|NCT03307252|18556282|P8|NOT COMPLETED|Part 2, Period 2||0
7538050|NCT03307252|18556283|P7|NOT COMPLETED|Part 2, Period 2||0
7538051|NCT03307252|18556284|P6|NOT COMPLETED|Part 2, Period 2||0
7538052|NCT03307252|18556285|P5|NOT COMPLETED|Part 2, Period 2||0
7538053|NCT03307252|18556286|P4|NOT COMPLETED|Part 2, Period 2||0
7538054|NCT03307252|18556287|P3|NOT COMPLETED|Part 2, Period 2||0
7538055|NCT03307252|18556288|P2|NOT COMPLETED|Part 2, Period 2||0
7538056|NCT03307252|18556289|P1|NOT COMPLETED|Part 2, Period 2||0
7538057|NCT03307252|18556279|P11|COMPLETED|Part 2, Period 2||0
7538058|NCT03307252|18556280|P10|COMPLETED|Part 2, Period 2||0
7538059|NCT03307252|18556281|P9|COMPLETED|Part 2, Period 2||0
7538060|NCT03307252|18556282|P8|COMPLETED|Part 2, Period 2||0
7538061|NCT03307252|18556283|P7|COMPLETED|Part 2, Period 2||5
7538062|NCT03307252|18556284|P6|COMPLETED|Part 2, Period 2||3
7538063|NCT03307252|18556285|P5|COMPLETED|Part 2, Period 2||4
7538064|NCT03307252|18556286|P4|COMPLETED|Part 2, Period 2||4
7538065|NCT03307252|18556287|P3|COMPLETED|Part 2, Period 2||0
7538066|NCT03307252|18556288|P2|COMPLETED|Part 2, Period 2||0
7538067|NCT03307252|18556289|P1|COMPLETED|Part 2, Period 2||0
7538068|NCT03307252|18556279|P11|STARTED|Part 2, Period 2||0
7538069|NCT03307252|18556280|P10|STARTED|Part 2, Period 2||0
7538070|NCT03307252|18556281|P9|STARTED|Part 2, Period 2||0
7538071|NCT03307252|18556282|P8|STARTED|Part 2, Period 2||0
7538072|NCT03307252|18556283|P7|STARTED|Part 2, Period 2||5
7538073|NCT03307252|18556284|P6|STARTED|Part 2, Period 2||3
7538074|NCT03307252|18556285|P5|STARTED|Part 2, Period 2||4
7538075|NCT03307252|18556286|P4|STARTED|Part 2, Period 2||4
7538076|NCT03307252|18556287|P3|STARTED|Part 2, Period 2||0
7538077|NCT03307252|18556288|P2|STARTED|Part 2, Period 2||0
7538078|NCT03307252|18556289|P1|STARTED|Part 2, Period 2||0
7538079|NCT03307252|18556279|P11|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7538080|NCT03307252|18556280|P10|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7538081|NCT03307252|18556281|P9|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7538082|NCT03307252|18556282|P8|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7538083|NCT03307252|18556283|P7|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7538084|NCT03307252|18556284|P6|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7538085|NCT03307252|18556285|P5|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7538086|NCT03307252|18556286|P4|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7538087|NCT03307252|18556287|P3|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7538088|NCT03307252|18556288|P2|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7538089|NCT03307252|18556289|P1|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7538090|NCT03307252|18556279|P11|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7538091|NCT03307252|18556280|P10|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7538092|NCT03307252|18556281|P9|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7538093|NCT03307252|18556282|P8|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7538094|NCT03307252|18556283|P7|COMPLETED|Part 2, Washout Period 1 (7 Days)||5
7538095|NCT03307252|18556284|P6|COMPLETED|Part 2, Washout Period 1 (7 Days)||3
7538096|NCT03307252|18556285|P5|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
7538097|NCT03307252|18556286|P4|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
7538098|NCT03307252|18556287|P3|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7538099|NCT03307252|18556288|P2|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7538100|NCT03307252|18556289|P1|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7538101|NCT03307252|18556279|P11|STARTED|Part 2, Washout Period 1 (7 Days)||0
7538102|NCT03307252|18556280|P10|STARTED|Part 2, Washout Period 1 (7 Days)||0
7538103|NCT03307252|18556281|P9|STARTED|Part 2, Washout Period 1 (7 Days)||0
7538104|NCT03307252|18556282|P8|STARTED|Part 2, Washout Period 1 (7 Days)||0
7538105|NCT03307252|18556283|P7|STARTED|Part 2, Washout Period 1 (7 Days)||5
7538106|NCT03307252|18556284|P6|STARTED|Part 2, Washout Period 1 (7 Days)||3
7538107|NCT03307252|18556285|P5|STARTED|Part 2, Washout Period 1 (7 Days)||4
7538108|NCT03307252|18556286|P4|STARTED|Part 2, Washout Period 1 (7 Days)||4
7538109|NCT03307252|18556287|P3|STARTED|Part 2, Washout Period 1 (7 Days)||0
7538110|NCT03307252|18556288|P2|STARTED|Part 2, Washout Period 1 (7 Days)||0
7538111|NCT03307252|18556289|P1|STARTED|Part 2, Washout Period 1 (7 Days)||0
7538112|NCT03307252|18556279|P11|NOT COMPLETED|Part 2, Period 1||0
7538113|NCT03307252|18556280|P10|NOT COMPLETED|Part 2, Period 1||0
7538114|NCT03307252|18556281|P9|NOT COMPLETED|Part 2, Period 1||0
7538115|NCT03307252|18556282|P8|NOT COMPLETED|Part 2, Period 1||0
7538116|NCT03307252|18556283|P7|NOT COMPLETED|Part 2, Period 1||0
7538117|NCT03307252|18556284|P6|NOT COMPLETED|Part 2, Period 1||1
7538118|NCT03307252|18556285|P5|NOT COMPLETED|Part 2, Period 1||0
7538119|NCT03307252|18556286|P4|NOT COMPLETED|Part 2, Period 1||0
7538120|NCT03307252|18556287|P3|NOT COMPLETED|Part 2, Period 1||0
7538121|NCT03307252|18556288|P2|NOT COMPLETED|Part 2, Period 1||0
7538122|NCT03307252|18556289|P1|NOT COMPLETED|Part 2, Period 1||0
7538123|NCT03307252|18556279|P11|COMPLETED|Part 2, Period 1||0
7538124|NCT03307252|18556280|P10|COMPLETED|Part 2, Period 1||0
7538125|NCT03307252|18556281|P9|COMPLETED|Part 2, Period 1||0
7538126|NCT03307252|18556282|P8|COMPLETED|Part 2, Period 1||0
7538127|NCT03307252|18556283|P7|COMPLETED|Part 2, Period 1||5
7538128|NCT03307252|18556284|P6|COMPLETED|Part 2, Period 1||3
7538129|NCT03307252|18556285|P5|COMPLETED|Part 2, Period 1||4
7538130|NCT03307252|18556286|P4|COMPLETED|Part 2, Period 1||4
7538131|NCT03307252|18556287|P3|COMPLETED|Part 2, Period 1||0
7538132|NCT03307252|18556288|P2|COMPLETED|Part 2, Period 1||0
7538133|NCT03307252|18556289|P1|COMPLETED|Part 2, Period 1||0
7538134|NCT03307252|18556279|P11|STARTED|Part 2, Period 1||0
7538135|NCT03307252|18556280|P10|STARTED|Part 2, Period 1||0
7538136|NCT03307252|18556281|P9|STARTED|Part 2, Period 1||0
7538137|NCT03307252|18556282|P8|STARTED|Part 2, Period 1||0
7538138|NCT03307252|18556283|P7|STARTED|Part 2, Period 1|Participants randomized in Part 2|5
7538139|NCT03307252|18556284|P6|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
7538140|NCT03307252|18556285|P5|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
7538141|NCT03307252|18556286|P4|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
7538142|NCT03307252|18556287|P3|STARTED|Part 2, Period 1||0
7538143|NCT03307252|18556288|P2|STARTED|Part 2, Period 1||0
7538144|NCT03307252|18556289|P1|STARTED|Part 2, Period 1||0
7538145|NCT03307252|18556279|P11|NOT COMPLETED|Part 1, Period 3||0
7538146|NCT03307252|18556280|P10|NOT COMPLETED|Part 1, Period 3||0
7538147|NCT03307252|18556281|P9|NOT COMPLETED|Part 1, Period 3||0
7538148|NCT03307252|18556282|P8|NOT COMPLETED|Part 1, Period 3||0
7538149|NCT03307252|18556283|P7|NOT COMPLETED|Part 1, Period 3||0
7538150|NCT03307252|18556284|P6|NOT COMPLETED|Part 1, Period 3||0
7538151|NCT03307252|18556285|P5|NOT COMPLETED|Part 1, Period 3||0
7538152|NCT03307252|18556286|P4|NOT COMPLETED|Part 1, Period 3||0
7538153|NCT03307252|18556287|P3|NOT COMPLETED|Part 1, Period 3||0
7538154|NCT03307252|18556288|P2|NOT COMPLETED|Part 1, Period 3||0
7538155|NCT03307252|18556289|P1|NOT COMPLETED|Part 1, Period 3||0
7538156|NCT03307252|18556279|P11|COMPLETED|Part 1, Period 3||0
7538157|NCT03307252|18556280|P10|COMPLETED|Part 1, Period 3||0
7538158|NCT03307252|18556281|P9|COMPLETED|Part 1, Period 3||0
7538159|NCT03307252|18556282|P8|COMPLETED|Part 1, Period 3||0
7538160|NCT03307252|18556283|P7|COMPLETED|Part 1, Period 3||0
7538161|NCT03307252|18556284|P6|COMPLETED|Part 1, Period 3||0
7538162|NCT03307252|18556285|P5|COMPLETED|Part 1, Period 3||0
7538163|NCT03307252|18556286|P4|COMPLETED|Part 1, Period 3||0
7538164|NCT03307252|18556287|P3|COMPLETED|Part 1, Period 3||4
7538165|NCT03307252|18556288|P2|COMPLETED|Part 1, Period 3||4
7538166|NCT03307252|18556289|P1|COMPLETED|Part 1, Period 3||4
7538167|NCT03307252|18556279|P11|STARTED|Part 1, Period 3||0
7538168|NCT03307252|18556280|P10|STARTED|Part 1, Period 3||0
7538169|NCT03307252|18556281|P9|STARTED|Part 1, Period 3||0
7538170|NCT03307252|18556282|P8|STARTED|Part 1, Period 3||0
7538171|NCT03307252|18556283|P7|STARTED|Part 1, Period 3||0
7538172|NCT03307252|18556284|P6|STARTED|Part 1, Period 3||0
7538173|NCT03307252|18556285|P5|STARTED|Part 1, Period 3||0
7538174|NCT03307252|18556286|P4|STARTED|Part 1, Period 3||0
7538175|NCT03307252|18556287|P3|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
7538176|NCT03307252|18556288|P2|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
7538177|NCT03307252|18556289|P1|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
7538178|NCT03307252|18556279|P11|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
7538179|NCT03307252|18556280|P10|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
7538180|NCT03307252|18556281|P9|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
7538181|NCT03307252|18556282|P8|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
7538182|NCT03307252|18556283|P7|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
7538183|NCT03307252|18556284|P6|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
7538184|NCT03307252|18556285|P5|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
7538185|NCT03307252|18556286|P4|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
7538186|NCT03307252|18556287|P3|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
7538187|NCT03307252|18556288|P2|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
7538188|NCT03307252|18556289|P1|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
7538189|NCT03307252|18556279|P11|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
7538190|NCT03307252|18556280|P10|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
7538191|NCT03307252|18556281|P9|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
7538192|NCT03307252|18556282|P8|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
7538193|NCT03307252|18556283|P7|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
7538194|NCT03307252|18556284|P6|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
7538195|NCT03307252|18556285|P5|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
7538196|NCT03307252|18556286|P4|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
7538197|NCT03307252|18556287|P3|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
7538198|NCT03307252|18556288|P2|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
7538199|NCT03307252|18556289|P1|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
7538200|NCT03307252|18556279|P11|STARTED|Part 1, Washout Period 2 (13 Days)||0
7538201|NCT03307252|18556280|P10|STARTED|Part 1, Washout Period 2 (13 Days)||0
7538202|NCT03307252|18556281|P9|STARTED|Part 1, Washout Period 2 (13 Days)||0
7538203|NCT03307252|18556282|P8|STARTED|Part 1, Washout Period 2 (13 Days)||0
7538204|NCT03307252|18556283|P7|STARTED|Part 1, Washout Period 2 (13 Days)||0
7538205|NCT03307252|18556284|P6|STARTED|Part 1, Washout Period 2 (13 Days)||0
7538206|NCT03307252|18556285|P5|STARTED|Part 1, Washout Period 2 (13 Days)||0
7538207|NCT03307252|18556286|P4|STARTED|Part 1, Washout Period 2 (13 Days)||0
7538208|NCT03307252|18556287|P3|STARTED|Part 1, Washout Period 2 (13 Days)||4
7538209|NCT03307252|18556288|P2|STARTED|Part 1, Washout Period 2 (13 Days)||4
7538210|NCT03307252|18556289|P1|STARTED|Part 1, Washout Period 2 (13 Days)||4
7538211|NCT03307252|18556279|P11|NOT COMPLETED|Part 1, Period 2||0
7538212|NCT03307252|18556280|P10|NOT COMPLETED|Part 1, Period 2||0
7538213|NCT03307252|18556281|P9|NOT COMPLETED|Part 1, Period 2||0
7538214|NCT03307252|18556282|P8|NOT COMPLETED|Part 1, Period 2||0
7538215|NCT03307252|18556283|P7|NOT COMPLETED|Part 1, Period 2||0
7538216|NCT03307252|18556284|P6|NOT COMPLETED|Part 1, Period 2||0
7538217|NCT03307252|18556285|P5|NOT COMPLETED|Part 1, Period 2||0
7538218|NCT03307252|18556286|P4|NOT COMPLETED|Part 1, Period 2||0
7538219|NCT03307252|18556287|P3|NOT COMPLETED|Part 1, Period 2||0
7538220|NCT03307252|18556288|P2|NOT COMPLETED|Part 1, Period 2||0
7538221|NCT03307252|18556289|P1|NOT COMPLETED|Part 1, Period 2||0
7538222|NCT03307252|18556279|P11|COMPLETED|Part 1, Period 2||0
7538223|NCT03307252|18556280|P10|COMPLETED|Part 1, Period 2||0
7538224|NCT03307252|18556281|P9|COMPLETED|Part 1, Period 2||0
7538225|NCT03307252|18556282|P8|COMPLETED|Part 1, Period 2||0
7538226|NCT03307252|18556283|P7|COMPLETED|Part 1, Period 2||0
7538227|NCT03307252|18556284|P6|COMPLETED|Part 1, Period 2||0
7538228|NCT03307252|18556285|P5|COMPLETED|Part 1, Period 2||0
7538229|NCT03307252|18556286|P4|COMPLETED|Part 1, Period 2||0
7538230|NCT03307252|18556287|P3|COMPLETED|Part 1, Period 2||4
7538231|NCT03307252|18556288|P2|COMPLETED|Part 1, Period 2||4
7538232|NCT03307252|18556289|P1|COMPLETED|Part 1, Period 2||4
7538233|NCT03307252|18556279|P11|STARTED|Part 1, Period 2||0
7538234|NCT03307252|18556280|P10|STARTED|Part 1, Period 2||0
7538235|NCT03307252|18556281|P9|STARTED|Part 1, Period 2||0
7538236|NCT03307252|18556282|P8|STARTED|Part 1, Period 2||0
7538237|NCT03307252|18556283|P7|STARTED|Part 1, Period 2||0
7538238|NCT03307252|18556284|P6|STARTED|Part 1, Period 2||0
7538239|NCT03307252|18556285|P5|STARTED|Part 1, Period 2||0
7538240|NCT03307252|18556286|P4|STARTED|Part 1, Period 2||0
7538241|NCT03307252|18556287|P3|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
7538242|NCT03307252|18556288|P2|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
7538243|NCT03307252|18556289|P1|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
7538244|NCT03307252|18556279|P11|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
7538245|NCT03307252|18556280|P10|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
7538246|NCT03307252|18556281|P9|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
7538247|NCT03307252|18556282|P8|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
7538248|NCT03307252|18556283|P7|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
7538249|NCT03307252|18556284|P6|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
7538250|NCT03307252|18556285|P5|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
7538251|NCT03307252|18556286|P4|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
7538252|NCT03307252|18556287|P3|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
7538253|NCT03307252|18556288|P2|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
7538254|NCT03307252|18556289|P1|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
7538255|NCT03307252|18556279|P11|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
7538256|NCT03307252|18556280|P10|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
7538257|NCT03307252|18556281|P9|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
7538258|NCT03307252|18556282|P8|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
7538259|NCT03307252|18556283|P7|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
7538260|NCT03307252|18556284|P6|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
7538261|NCT03307252|18556285|P5|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
7538262|NCT03307252|18556286|P4|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
7538263|NCT03307252|18556287|P3|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
7538264|NCT03307252|18556288|P2|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
7538265|NCT03307252|18556289|P1|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
7538266|NCT03307252|18556279|P11|STARTED|Part 1, Washout Period 1 (13 Days)||0
7538267|NCT03307252|18556280|P10|STARTED|Part 1, Washout Period 1 (13 Days)||0
7538268|NCT03307252|18556281|P9|STARTED|Part 1, Washout Period 1 (13 Days)||0
7538269|NCT03307252|18556282|P8|STARTED|Part 1, Washout Period 1 (13 Days)||0
7538270|NCT03307252|18556283|P7|STARTED|Part 1, Washout Period 1 (13 Days)||0
7538271|NCT03307252|18556284|P6|STARTED|Part 1, Washout Period 1 (13 Days)||0
7538272|NCT03307252|18556285|P5|STARTED|Part 1, Washout Period 1 (13 Days)||0
7538273|NCT03307252|18556286|P4|STARTED|Part 1, Washout Period 1 (13 Days)||0
7538274|NCT03307252|18556287|P3|STARTED|Part 1, Washout Period 1 (13 Days)||4
7538275|NCT03307252|18556288|P2|STARTED|Part 1, Washout Period 1 (13 Days)||4
7538276|NCT03307252|18556289|P1|STARTED|Part 1, Washout Period 1 (13 Days)||4
7538277|NCT03307252|18556279|P11|NOT COMPLETED|Part 1, Period 1||0
7538278|NCT03307252|18556280|P10|NOT COMPLETED|Part 1, Period 1||0
7538279|NCT03307252|18556281|P9|NOT COMPLETED|Part 1, Period 1||0
7538280|NCT03307252|18556282|P8|NOT COMPLETED|Part 1, Period 1||0
7538281|NCT03307252|18556283|P7|NOT COMPLETED|Part 1, Period 1||0
7538282|NCT03307252|18556284|P6|NOT COMPLETED|Part 1, Period 1||0
7538283|NCT03307252|18556285|P5|NOT COMPLETED|Part 1, Period 1||0
7538284|NCT03307252|18556286|P4|NOT COMPLETED|Part 1, Period 1||0
7538285|NCT03307252|18556287|P3|NOT COMPLETED|Part 1, Period 1||0
7538286|NCT03307252|18556288|P2|NOT COMPLETED|Part 1, Period 1||0
7538287|NCT03307252|18556289|P1|NOT COMPLETED|Part 1, Period 1||0
7538288|NCT03307252|18556279|P11|COMPLETED|Part 1, Period 1||0
7538289|NCT03307252|18556280|P10|COMPLETED|Part 1, Period 1||0
7538290|NCT03307252|18556281|P9|COMPLETED|Part 1, Period 1||0
7538291|NCT03307252|18556282|P8|COMPLETED|Part 1, Period 1||0
7538292|NCT03307252|18556283|P7|COMPLETED|Part 1, Period 1||0
7538293|NCT03307252|18556284|P6|COMPLETED|Part 1, Period 1||0
7538294|NCT03307252|18556285|P5|COMPLETED|Part 1, Period 1||0
7538295|NCT03307252|18556286|P4|COMPLETED|Part 1, Period 1||0
7538296|NCT03307252|18556287|P3|COMPLETED|Part 1, Period 1||4
7538297|NCT03307252|18556288|P2|COMPLETED|Part 1, Period 1||4
7538298|NCT03307252|18556289|P1|COMPLETED|Part 1, Period 1||4
7538299|NCT03307252|18556279|P11|STARTED|Part 1, Period 1||0
7538300|NCT03307252|18556280|P10|STARTED|Part 1, Period 1||0
7538301|NCT03307252|18556281|P9|STARTED|Part 1, Period 1||0
7538302|NCT03307252|18556282|P8|STARTED|Part 1, Period 1||0
7538303|NCT03307252|18556283|P7|STARTED|Part 1, Period 1||0
7538304|NCT03307252|18556284|P6|STARTED|Part 1, Period 1||0
7538305|NCT03307252|18556285|P5|STARTED|Part 1, Period 1||0
7538306|NCT03307252|18556286|P4|STARTED|Part 1, Period 1||0
7538307|NCT03307252|18556287|P3|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
7538308|NCT03307252|18556288|P2|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
7538309|NCT03307252|18556289|P1|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
7538310|NCT03307174|18556326|P2|NOT COMPLETED|Overall Study||7
7538311|NCT03307174|18556327|P1|NOT COMPLETED|Overall Study||14
7538312|NCT03307174|18556326|P2|COMPLETED|Overall Study||53
7538313|NCT03307174|18556327|P1|COMPLETED|Overall Study||46
7538314|NCT03307174|18556326|P2|STARTED|Overall Study||60
7538315|NCT03307174|18556327|P1|STARTED|Overall Study||60
7538316|NCT03307005|18556347|P2|NOT COMPLETED|Overall Study||0
7538317|NCT03307005|18556348|P1|NOT COMPLETED|Overall Study||0
7538318|NCT03307005|18556347|P2|COMPLETED|Overall Study||2
7538319|NCT03307005|18556348|P1|COMPLETED|Overall Study||3
7538320|NCT03307005|18556347|P2|STARTED|Overall Study||2
7538321|NCT03307005|18556348|P1|STARTED|Overall Study||3
7538322|NCT03306641|18556366|P2|NOT COMPLETED|Second Intervention||0
7538323|NCT03306641|18556367|P1|NOT COMPLETED|Second Intervention||0
7538324|NCT03306641|18556366|P2|COMPLETED|Second Intervention||22
7538325|NCT03306641|18556367|P1|COMPLETED|Second Intervention||23
7538326|NCT03306641|18556366|P2|STARTED|Second Intervention||22
7538327|NCT03306641|18556367|P1|STARTED|Second Intervention||23
7538328|NCT03306641|18556366|P2|NOT COMPLETED|First Intervention||0
7538329|NCT03306641|18556367|P1|NOT COMPLETED|First Intervention||0
7538330|NCT03306641|18556366|P2|COMPLETED|First Intervention||22
7538331|NCT03306641|18556367|P1|COMPLETED|First Intervention||23
7538332|NCT03306641|18556366|P2|STARTED|First Intervention||22
7538333|NCT03306641|18556367|P1|STARTED|First Intervention||23
7538334|NCT03306589|18556381|P6|NOT COMPLETED|Part 2 (69 Days)||0
7538335|NCT03306589|18556382|P5|NOT COMPLETED|Part 2 (69 Days)||0
7538336|NCT03306589|18556383|P4|NOT COMPLETED|Part 2 (69 Days)||0
7538337|NCT03306589|18556384|P3|NOT COMPLETED|Part 2 (69 Days)||0
7538338|NCT03306589|18556385|P2|NOT COMPLETED|Part 2 (69 Days)||0
7538339|NCT03306589|18556386|P1|NOT COMPLETED|Part 2 (69 Days)||0
7538340|NCT03306589|18556381|P6|COMPLETED|Part 2 (69 Days)||0
7538341|NCT03306589|18556382|P5|COMPLETED|Part 2 (69 Days)||0
7538342|NCT03306589|18556383|P4|COMPLETED|Part 2 (69 Days)||0
7538343|NCT03306589|18556384|P3|COMPLETED|Part 2 (69 Days)||0
7538344|NCT03306589|18556385|P2|COMPLETED|Part 2 (69 Days)||0
7538345|NCT03306589|18556386|P1|COMPLETED|Part 2 (69 Days)||0
7538346|NCT03306589|18556381|P6|STARTED|Part 2 (69 Days)||0
7538347|NCT03306589|18556382|P5|STARTED|Part 2 (69 Days)||0
7538348|NCT03306589|18556383|P4|STARTED|Part 2 (69 Days)||0
7538349|NCT03306589|18556384|P3|STARTED|Part 2 (69 Days)||0
7538350|NCT03306589|18556385|P2|STARTED|Part 2 (69 Days)||0
7538351|NCT03306589|18556386|P1|STARTED|Part 2 (69 Days)||0
7538352|NCT03306589|18556381|P6|NOT COMPLETED|Part 1 (69 Days)||0
7538353|NCT03306589|18556382|P5|NOT COMPLETED|Part 1 (69 Days)||0
7538354|NCT03306589|18556383|P4|NOT COMPLETED|Part 1 (69 Days)||0
7538355|NCT03306589|18556384|P3|NOT COMPLETED|Part 1 (69 Days)||0
7538356|NCT03306589|18556385|P2|NOT COMPLETED|Part 1 (69 Days)||0
7538357|NCT03306589|18556386|P1|NOT COMPLETED|Part 1 (69 Days)||0
7538358|NCT03306589|18556381|P6|COMPLETED|Part 1 (69 Days)||0
7538359|NCT03306589|18556382|P5|COMPLETED|Part 1 (69 Days)||0
7538360|NCT03306589|18556383|P4|COMPLETED|Part 1 (69 Days)||4
7538361|NCT03306589|18556384|P3|COMPLETED|Part 1 (69 Days)||2
7538362|NCT03306589|18556385|P2|COMPLETED|Part 1 (69 Days)||4
7538363|NCT03306589|18556386|P1|COMPLETED|Part 1 (69 Days)||2
7538364|NCT03306589|18556381|P6|STARTED|Part 1 (69 Days)||0
7538365|NCT03306589|18556382|P5|STARTED|Part 1 (69 Days)||0
7538366|NCT03306589|18556383|P4|STARTED|Part 1 (69 Days)||4
7538367|NCT03306589|18556384|P3|STARTED|Part 1 (69 Days)||2
7538368|NCT03306589|18556385|P2|STARTED|Part 1 (69 Days)||4
7538369|NCT03306589|18556386|P1|STARTED|Part 1 (69 Days)||2
7538370|NCT03306420|18556492|P5|NOT COMPLETED|Overall Study||0
7538371|NCT03306420|18556493|P4|NOT COMPLETED|Overall Study||0
7538372|NCT03306420|18556494|P3|NOT COMPLETED|Overall Study||0
7538373|NCT03306420|18556495|P2|NOT COMPLETED|Overall Study||0
7538374|NCT03306420|18556496|P1|NOT COMPLETED|Overall Study||0
7538375|NCT03306420|18556492|P5|COMPLETED|Overall Study||3
7538376|NCT03306420|18556493|P4|COMPLETED|Overall Study||3
7538377|NCT03306420|18556494|P3|COMPLETED|Overall Study||3
7538378|NCT03306420|18556495|P2|COMPLETED|Overall Study||3
7538379|NCT03306420|18556496|P1|COMPLETED|Overall Study||3
7538380|NCT03306420|18556492|P5|STARTED|Overall Study||3
7538381|NCT03306420|18556493|P4|STARTED|Overall Study||3
7538382|NCT03306420|18556494|P3|STARTED|Overall Study||3
7538383|NCT03306420|18556495|P2|STARTED|Overall Study||3
7538384|NCT03306420|18556496|P1|STARTED|Overall Study||3
7538385|NCT03306277|18556608|P1|NOT COMPLETED|Overall Study||3
7538386|NCT03306277|18556608|P1|COMPLETED|Overall Study||19
7538387|NCT03306277|18556608|P1|STARTED|Overall Study||22
7538388|NCT03306199|18556615|P1|NOT COMPLETED|Overall Study||15
7538389|NCT03306199|18556615|P1|COMPLETED|Overall Study||67
7538390|NCT03306199|18556615|P1|STARTED|Overall Study||82
7538391|NCT03306043|18556619|P1|NOT COMPLETED|Overall Study||4
7538392|NCT03306043|18556619|P1|COMPLETED|Overall Study||98
7538393|NCT03306043|18556619|P1|STARTED|Overall Study||102
7538394|NCT03305887|18556627|P2|NOT COMPLETED|Overall Study||10
7538395|NCT03305887|18556628|P1|NOT COMPLETED|Overall Study||11
7538396|NCT03305887|18556627|P2|COMPLETED|Overall Study||83
7538397|NCT03305887|18556628|P1|COMPLETED|Overall Study||80
7538398|NCT03305887|18556627|P2|STARTED|Overall Study||93
7538399|NCT03305887|18556628|P1|STARTED|Overall Study||91
7538400|NCT03305822|18556634|P2|NOT COMPLETED|Period 2||0
7538401|NCT03305822|18556635|P1|NOT COMPLETED|Period 2||0
7538402|NCT03305822|18556634|P2|COMPLETED|Period 2||18
7538403|NCT03305822|18556635|P1|COMPLETED|Period 2||20
7538404|NCT03305822|18556634|P2|Received at Least 1 Dose of Study Drug|Period 2||18
7538405|NCT03305822|18556635|P1|Received at Least 1 Dose of Study Drug|Period 2||20
7538406|NCT03305822|18556634|P2|STARTED|Period 2||18
7538407|NCT03305822|18556635|P1|STARTED|Period 2||20
7538408|NCT03305822|18556634|P2|NOT COMPLETED|Washout||0
7538409|NCT03305822|18556635|P1|NOT COMPLETED|Washout||0
7538410|NCT03305822|18556634|P2|COMPLETED|Washout||18
7538411|NCT03305822|18556635|P1|COMPLETED|Washout||20
7538412|NCT03305822|18556634|P2|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|18
7538413|NCT03305822|18556635|P1|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|20
7538414|NCT03305822|18556634|P2|NOT COMPLETED|Period 1||0
7538415|NCT03305822|18556635|P1|NOT COMPLETED|Period 1||0
7538416|NCT03305822|18556634|P2|COMPLETED|Period 1||18
7538417|NCT03305822|18556635|P1|COMPLETED|Period 1||20
7538418|NCT03305822|18556634|P2|Received at Least 1 Dose of Study Drug|Period 1||18
7538419|NCT03305822|18556635|P1|Received at Least 1 Dose of Study Drug|Period 1||20
7538420|NCT03305822|18556634|P2|STARTED|Period 1||18
7538421|NCT03305822|18556635|P1|STARTED|Period 1||20
7538422|NCT03305770|18556645|P2|NOT COMPLETED|Overall Study||1
7538423|NCT03305770|18556646|P1|NOT COMPLETED|Overall Study||1
7538424|NCT03305770|18556645|P2|COMPLETED|Overall Study||36
7538425|NCT03305770|18556646|P1|COMPLETED|Overall Study||69
7538426|NCT03305770|18556645|P2|Completed Analysis Set|Overall Study||36
7538427|NCT03305770|18556646|P1|Completed Analysis Set|Overall Study||69
7538428|NCT03305770|18556645|P2|Enrolled Dispensed Analysis Set|Overall Study||36
7538429|NCT03305770|18556646|P1|Enrolled Dispensed Analysis Set|Overall Study||70
7538430|NCT03305770|18556645|P2|STARTED|Overall Study||37
7538431|NCT03305770|18556646|P1|STARTED|Overall Study||70
7538432|NCT03305731|18556654|P1|NOT COMPLETED|Overall Study||1
7538433|NCT03305731|18556654|P1|COMPLETED|Overall Study||20
7538434|NCT03305731|18556654|P1|Week 11|Overall Study||20
7538435|NCT03305731|18556654|P1|Week 6|Overall Study||20
7538436|NCT03305731|18556654|P1|STARTED|Overall Study||21
7538437|NCT03305575|18556665|P2|NOT COMPLETED|Overall Study||0
7538438|NCT03305575|18556666|P1|NOT COMPLETED|Overall Study||1
7538439|NCT03305575|18556665|P2|COMPLETED|Overall Study||5
7538440|NCT03305575|18556666|P1|COMPLETED|Overall Study||4
7538441|NCT03305575|18556665|P2|STARTED|Overall Study||5
7538442|NCT03305575|18556666|P1|STARTED|Overall Study||5
7538443|NCT03305419|18556686|P8|NOT COMPLETED|Part B (14 Days)||0
7538444|NCT03305419|18556687|P7|NOT COMPLETED|Part B (14 Days)||5
7538445|NCT03305419|18556688|P6|NOT COMPLETED|Part B (14 Days)||10
7538446|NCT03305419|18556689|P5|NOT COMPLETED|Part B (14 Days)||3
7538447|NCT03305419|18556690|P4|NOT COMPLETED|Part B (14 Days)||0
7538448|NCT03305419|18556691|P3|NOT COMPLETED|Part B (14 Days)||0
7538449|NCT03305419|18556692|P2|NOT COMPLETED|Part B (14 Days)||0
7538450|NCT03305419|18556693|P1|NOT COMPLETED|Part B (14 Days)||0
7538451|NCT03305419|18556686|P8|COMPLETED|Part B (14 Days)||0
7538452|NCT03305419|18556687|P7|COMPLETED|Part B (14 Days)||8
7538453|NCT03305419|18556688|P6|COMPLETED|Part B (14 Days)||10
7538454|NCT03305419|18556689|P5|COMPLETED|Part B (14 Days)||11
7538455|NCT03305419|18556690|P4|COMPLETED|Part B (14 Days)||0
7538456|NCT03305419|18556691|P3|COMPLETED|Part B (14 Days)||0
7538457|NCT03305419|18556692|P2|COMPLETED|Part B (14 Days)||0
7538458|NCT03305419|18556693|P1|COMPLETED|Part B (14 Days)||0
7538459|NCT03305419|18556686|P8|STARTED|Part B (14 Days)||0
7538460|NCT03305419|18556687|P7|STARTED|Part B (14 Days)||13
7538461|NCT03305419|18556688|P6|STARTED|Part B (14 Days)||20
7538462|NCT03305419|18556689|P5|STARTED|Part B (14 Days)||14
7538463|NCT03305419|18556690|P4|STARTED|Part B (14 Days)||0
7538464|NCT03305419|18556691|P3|STARTED|Part B (14 Days)||0
7538465|NCT03305419|18556692|P2|STARTED|Part B (14 Days)||0
7538466|NCT03305419|18556693|P1|STARTED|Part B (14 Days)||0
7538467|NCT03305419|18556686|P8|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
7538468|NCT03305419|18556687|P7|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
7538469|NCT03305419|18556688|P6|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
7538470|NCT03305419|18556689|P5|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
7538471|NCT03305419|18556690|P4|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
7538472|NCT03305419|18556691|P3|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
7538473|NCT03305419|18556692|P2|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
7538474|NCT03305419|18556693|P1|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
7538475|NCT03305419|18556686|P8|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
7538476|NCT03305419|18556687|P7|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
7538477|NCT03305419|18556688|P6|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
7538478|NCT03305419|18556689|P5|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
7538479|NCT03305419|18556690|P4|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
7538480|NCT03305419|18556691|P3|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
7538481|NCT03305419|18556692|P2|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
7538482|NCT03305419|18556693|P1|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
7538483|NCT03305419|18556686|P8|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
7538484|NCT03305419|18556687|P7|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
7538485|NCT03305419|18556688|P6|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
7538486|NCT03305419|18556689|P5|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
7538487|NCT03305419|18556690|P4|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
7538488|NCT03305419|18556691|P3|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
7538489|NCT03305419|18556692|P2|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
7538490|NCT03305419|18556693|P1|STARTED|Part A Period 3 (1Day) + Washout (7days)|2 participants were added to GSK2982772 120 mg TID/240 mg TID/360 mg BID arm after Washout Period.|3
7538491|NCT03305419|18556686|P8|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
7538492|NCT03305419|18556687|P7|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
7538493|NCT03305419|18556688|P6|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
7538494|NCT03305419|18556689|P5|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
7538495|NCT03305419|18556690|P4|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
7538496|NCT03305419|18556691|P3|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
7538497|NCT03305419|18556692|P2|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
7538498|NCT03305419|18556693|P1|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||2
7538499|NCT03305419|18556686|P8|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
7538500|NCT03305419|18556687|P7|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
7538501|NCT03305419|18556688|P6|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
7538502|NCT03305419|18556689|P5|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
7538503|NCT03305419|18556690|P4|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
7538504|NCT03305419|18556691|P3|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
7538505|NCT03305419|18556692|P2|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
7538506|NCT03305419|18556693|P1|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||1
7538507|NCT03305419|18556686|P8|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
7538508|NCT03305419|18556687|P7|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
7538509|NCT03305419|18556688|P6|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
7538510|NCT03305419|18556689|P5|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
7538511|NCT03305419|18556690|P4|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
7538512|NCT03305419|18556691|P3|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
7538513|NCT03305419|18556692|P2|STARTED|Part A Period 2 (1Day) + Washout (7days)|1 participant was added to GSK2982772 120 mg TID/240 mg TID/Placebo arm|3
7538514|NCT03305419|18556693|P1|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
7538515|NCT03305419|18556686|P8|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
7538516|NCT03305419|18556687|P7|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
7538517|NCT03305419|18556688|P6|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
7538518|NCT03305419|18556689|P5|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
7538519|NCT03305419|18556690|P4|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
7538520|NCT03305419|18556691|P3|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
7538521|NCT03305419|18556692|P2|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||1
7538522|NCT03305419|18556693|P1|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
7538523|NCT03305419|18556686|P8|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
7538524|NCT03305419|18556687|P7|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
7538525|NCT03305419|18556688|P6|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
7538526|NCT03305419|18556689|P5|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
7538527|NCT03305419|18556690|P4|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
7538528|NCT03305419|18556691|P3|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
7538529|NCT03305419|18556692|P2|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||2
7538530|NCT03305419|18556693|P1|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
7538531|NCT03305419|18556686|P8|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
7538532|NCT03305419|18556687|P7|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
7538533|NCT03305419|18556688|P6|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
7538534|NCT03305419|18556689|P5|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
7538535|NCT03305419|18556690|P4|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
7538536|NCT03305419|18556691|P3|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
7538537|NCT03305419|18556692|P2|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
7538538|NCT03305419|18556693|P1|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
7538539|NCT03305159|18556825|P2|NOT COMPLETED|Overall Study||8
7538540|NCT03305159|18556826|P1|NOT COMPLETED|Overall Study||3
7538541|NCT03305159|18556825|P2|COMPLETED|Overall Study||60
7538542|NCT03305159|18556826|P1|COMPLETED|Overall Study||63
7538543|NCT03305159|18556825|P2|STARTED|Overall Study||68
7538544|NCT03305159|18556826|P1|STARTED|Overall Study||66
7538545|NCT03305055|18556834|P2|NOT COMPLETED|Overall Study||2
7538546|NCT03305055|18556835|P1|NOT COMPLETED|Overall Study||1
7538547|NCT03305055|18556834|P2|COMPLETED|Overall Study||0
7538548|NCT03305055|18556835|P1|COMPLETED|Overall Study||1
7538549|NCT03305055|18556834|P2|STARTED|Overall Study||2
7538550|NCT03305055|18556835|P1|STARTED|Overall Study||2
7538551|NCT03304873|18556853|P2|NOT COMPLETED|Overall Study||8
7538552|NCT03304873|18556854|P1|NOT COMPLETED|Overall Study||1
7538553|NCT03304873|18556853|P2|COMPLETED|Overall Study||16
7538554|NCT03304873|18556854|P1|COMPLETED|Overall Study||22
7538555|NCT03304873|18556853|P2|STARTED|Overall Study||24
7538556|NCT03304873|18556854|P1|STARTED|Overall Study||23
7538557|NCT03304119|18556864|P2|NOT COMPLETED|Overall Study||0
7538558|NCT03304119|18556865|P1|NOT COMPLETED|Overall Study||0
7538559|NCT03304119|18556864|P2|COMPLETED|Overall Study||55
7538560|NCT03304119|18556865|P1|COMPLETED|Overall Study||37
7538561|NCT03304119|18556864|P2|STARTED|Overall Study||55
7538562|NCT03304119|18556865|P1|STARTED|Overall Study||37
7538563|NCT03304106|18556877|P2|NOT COMPLETED|Overall Study||2
7538564|NCT03304106|18556878|P1|NOT COMPLETED|Overall Study||13
7538565|NCT03304106|18556877|P2|COMPLETED|Overall Study||56
7538566|NCT03304106|18556878|P1|COMPLETED|Overall Study||31
7538567|NCT03304106|18556877|P2|STARTED|Overall Study||58
7538568|NCT03304106|18556878|P1|STARTED|Overall Study||44
7538569|NCT03303950|18556884|P1|NOT COMPLETED|Overall Study||0
7538570|NCT03303950|18556884|P1|COMPLETED|Overall Study||6
7538571|NCT03303950|18556884|P1|STARTED|Overall Study||6
7538572|NCT03303911|18556890|P2|NOT COMPLETED|Overall Study||0
7538573|NCT03303911|18556891|P1|NOT COMPLETED|Overall Study||0
7538574|NCT03303911|18556890|P2|COMPLETED|Overall Study||13
7538575|NCT03303911|18556891|P1|COMPLETED|Overall Study||13
7538576|NCT03303911|18556890|P2|STARTED|Overall Study||13
7538577|NCT03303911|18556891|P1|STARTED|Overall Study||13
7538578|NCT03303794|18556947|P2|NOT COMPLETED|Overall Study||0
7538579|NCT03303794|18556948|P1|NOT COMPLETED|Overall Study||0
7538580|NCT03303794|18556947|P2|COMPLETED|Overall Study||12
7538581|NCT03303794|18556948|P1|COMPLETED|Overall Study||13
7538582|NCT03303794|18556947|P2|STARTED|Overall Study||12
7538583|NCT03303794|18556948|P1|STARTED|Overall Study||13
7538584|NCT03303521|18556960|P2|NOT COMPLETED|Overall Study||3
7538585|NCT03303521|18556961|P1|NOT COMPLETED|Overall Study||5
7538586|NCT03303521|18556960|P2|COMPLETED|Overall Study||96
7538587|NCT03303521|18556961|P1|COMPLETED|Overall Study||92
7538588|NCT03303521|18556960|P2|STARTED|Overall Study||99
7538589|NCT03303521|18556961|P1|STARTED|Overall Study||97
7538590|NCT03303417|18556971|P2|NOT COMPLETED|Overall Study||1
7538591|NCT03303417|18556972|P1|NOT COMPLETED|Overall Study||1
7538592|NCT03303417|18556971|P2|COMPLETED|Overall Study||7
7538593|NCT03303417|18556972|P1|COMPLETED|Overall Study||7
7538594|NCT03303417|18556971|P2|STARTED|Overall Study||8
7538595|NCT03303417|18556972|P1|STARTED|Overall Study||8
7538596|NCT03303404|18556986|P1|NOT COMPLETED|Overall Study||0
7538597|NCT03303404|18556986|P1|COMPLETED|Overall Study||22
7538598|NCT03303404|18556986|P1|STARTED|Overall Study||22
7538599|NCT03303196|18556990|P2|NOT COMPLETED|Overall Study||0
7538600|NCT03303196|18556991|P1|NOT COMPLETED|Overall Study||0
7538601|NCT03303196|18556990|P2|COMPLETED|Overall Study||5
7538602|NCT03303196|18556991|P1|COMPLETED|Overall Study||5
7538603|NCT03303196|18556990|P2|Washout|Overall Study||5
7538604|NCT03303196|18556991|P1|Washout|Overall Study||5
7538605|NCT03303196|18556990|P2|STARTED|Overall Study|Individuals who were assigned to SC admission then BHBP admission.|5
7538606|NCT03303196|18556991|P1|STARTED|Overall Study|Individuals who were assigned to BHBP admission then SC admission.|5
7538607|NCT03303144|18556996|P3|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||1
7538608|NCT03303144|18556997|P2|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0
7538609|NCT03303144|18556998|P1|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0
7538610|NCT03303144|18556996|P3|COMPLETED|Triferic Via IV Infusion (Day 10)||25
7538611|NCT03303144|18556997|P2|COMPLETED|Triferic Via IV Infusion (Day 10)||0
7538612|NCT03303144|18556998|P1|COMPLETED|Triferic Via IV Infusion (Day 10)||0
7538613|NCT03303144|18556996|P3|STARTED|Triferic Via IV Infusion (Day 10)||26
7538614|NCT03303144|18556997|P2|STARTED|Triferic Via IV Infusion (Day 10)||0
7538615|NCT03303144|18556998|P1|STARTED|Triferic Via IV Infusion (Day 10)||0
7538616|NCT03303144|18556996|P3|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0
7538617|NCT03303144|18556997|P2|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||1
7538618|NCT03303144|18556998|P1|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0
7538619|NCT03303144|18556996|P3|COMPLETED|Triferic Via IV Infusion (Day 8)||0
7538620|NCT03303144|18556997|P2|COMPLETED|Triferic Via IV Infusion (Day 8)||25
7538621|NCT03303144|18556998|P1|COMPLETED|Triferic Via IV Infusion (Day 8)||0
7538622|NCT03303144|18556996|P3|STARTED|Triferic Via IV Infusion (Day 8)||0
7538623|NCT03303144|18556997|P2|STARTED|Triferic Via IV Infusion (Day 8)||26
7538624|NCT03303144|18556998|P1|STARTED|Triferic Via IV Infusion (Day 8)||0
7538625|NCT03303144|18556996|P3|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
7538626|NCT03303144|18556997|P2|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
7538627|NCT03303144|18556998|P1|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
7538628|NCT03303144|18556996|P3|COMPLETED|Triferic Via Hemodialysate (Day 3)||0
7538629|NCT03303144|18556997|P2|COMPLETED|Triferic Via Hemodialysate (Day 3)||0
7538630|NCT03303144|18556998|P1|COMPLETED|Triferic Via Hemodialysate (Day 3)||26
7538631|NCT03303144|18556996|P3|STARTED|Triferic Via Hemodialysate (Day 3)||0
7538632|NCT03303144|18556997|P2|STARTED|Triferic Via Hemodialysate (Day 3)||0
7538633|NCT03303144|18556998|P1|STARTED|Triferic Via Hemodialysate (Day 3)||26
7538634|NCT03302975|18557013|P1|NOT COMPLETED|Overall Study||4
7538635|NCT03302975|18557013|P1|COMPLETED|Overall Study||12
7538636|NCT03302975|18557013|P1|STARTED|Overall Study||16
7538637|NCT03302936|18557021|P2|NOT COMPLETED|Overall Study||4
7538638|NCT03302936|18557022|P1|NOT COMPLETED|Overall Study||3
7538639|NCT03302936|18557021|P2|COMPLETED|Overall Study||45
7538640|NCT03302936|18557022|P1|COMPLETED|Overall Study||46
7538641|NCT03302936|18557021|P2|STARTED|Overall Study||49
7538642|NCT03302936|18557022|P1|STARTED|Overall Study||49
7538643|NCT03302793|18557032|P2|NOT COMPLETED|Overall Study||2
7538644|NCT03302793|18557033|P1|NOT COMPLETED|Overall Study||0
7538645|NCT03302793|18557032|P2|COMPLETED|Overall Study||4
7538646|NCT03302793|18557033|P1|COMPLETED|Overall Study||6
7538647|NCT03302793|18557032|P2|STARTED|Overall Study||6
7538648|NCT03302793|18557033|P1|STARTED|Overall Study||6
7538649|NCT03302780|18557043|P2|NOT COMPLETED|Overall Study||0
7538650|NCT03302780|18557044|P1|NOT COMPLETED|Overall Study||0
7538651|NCT03302780|18557043|P2|COMPLETED|Overall Study||3
7538652|NCT03302780|18557044|P1|COMPLETED|Overall Study||3
7538653|NCT03302780|18557043|P2|STARTED|Overall Study||3
7538654|NCT03302780|18557044|P1|STARTED|Overall Study||3
7538655|NCT03302741|18557054|P2|NOT COMPLETED|Overall Study||1
7538656|NCT03302741|18557055|P1|NOT COMPLETED|Overall Study||1
7538657|NCT03302741|18557054|P2|COMPLETED|Overall Study||8
7538658|NCT03302741|18557055|P1|COMPLETED|Overall Study||7
7538659|NCT03302741|18557054|P2|STARTED|Overall Study||9
7538660|NCT03302741|18557055|P1|STARTED|Overall Study||8
7538661|NCT03302559|18557071|P1|NOT COMPLETED|Overall Study||6
7538662|NCT03302559|18557071|P1|COMPLETED|Overall Study||23
7538663|NCT03302559|18557071|P1|STARTED|Overall Study||29
7538664|NCT03302416|18557085|P1|NOT COMPLETED|Overall Study||0
7538665|NCT03302416|18557085|P1|COMPLETED|Overall Study||19
7538666|NCT03302416|18557085|P1|STARTED|Overall Study||19
7538667|NCT03302247|18557089|P1|NOT COMPLETED|Overall Study||3
7538668|NCT03302247|18557089|P1|COMPLETED|Overall Study||0
7538669|NCT03302247|18557089|P1|STARTED|Overall Study||3
7538670|NCT03301844|18557096|P2|NOT COMPLETED|Overall Study||1
7538671|NCT03301844|18557097|P1|NOT COMPLETED|Overall Study||1
7538672|NCT03301844|18557096|P2|COMPLETED|Overall Study||18
7538673|NCT03301844|18557097|P1|COMPLETED|Overall Study||18
7538674|NCT03301844|18557096|P2|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
7538675|NCT03301844|18557097|P1|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
7538676|NCT03301779|18557111|P2|NOT COMPLETED|Overall Study||7
7538677|NCT03301779|18557112|P1|NOT COMPLETED|Overall Study||8
7538678|NCT03301779|18557111|P2|COMPLETED|Overall Study||45
7538679|NCT03301779|18557112|P1|COMPLETED|Overall Study||40
7538680|NCT03301779|18557111|P2|STARTED|Overall Study||52
7538681|NCT03301779|18557112|P1|STARTED|Overall Study||48
7538682|NCT03301740|18557124|P2|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||0
7538683|NCT03301740|18557125|P1|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||1
7538684|NCT03301740|18557124|P2|COMPLETED|Phase 4 Intervention (3 Weeks)||16
7538685|NCT03301740|18557125|P1|COMPLETED|Phase 4 Intervention (3 Weeks)||16
7538686|NCT03301740|18557124|P2|STARTED|Phase 4 Intervention (3 Weeks)||16
7538687|NCT03301740|18557125|P1|STARTED|Phase 4 Intervention (3 Weeks)||17
7538688|NCT03301740|18557124|P2|NOT COMPLETED|Third Washout (1 Week)||0
7538689|NCT03301740|18557125|P1|NOT COMPLETED|Third Washout (1 Week)||0
7538690|NCT03301740|18557124|P2|COMPLETED|Third Washout (1 Week)||16
7538691|NCT03301740|18557125|P1|COMPLETED|Third Washout (1 Week)||17
7538692|NCT03301740|18557124|P2|STARTED|Third Washout (1 Week)||16
7538693|NCT03301740|18557125|P1|STARTED|Third Washout (1 Week)||17
7538694|NCT03301740|18557124|P2|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
7538695|NCT03301740|18557125|P1|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
7538696|NCT03301740|18557124|P2|COMPLETED|Phase 3 Intervention (3 Weeks)||16
7538697|NCT03301740|18557125|P1|COMPLETED|Phase 3 Intervention (3 Weeks)||17
7538698|NCT03301740|18557124|P2|STARTED|Phase 3 Intervention (3 Weeks)||16
7538699|NCT03301740|18557125|P1|STARTED|Phase 3 Intervention (3 Weeks)||17
7538700|NCT03301740|18557124|P2|NOT COMPLETED|Second Washout (1 Week)||0
7538701|NCT03301740|18557125|P1|NOT COMPLETED|Second Washout (1 Week)||0
7538702|NCT03301740|18557124|P2|COMPLETED|Second Washout (1 Week)||16
7538703|NCT03301740|18557125|P1|COMPLETED|Second Washout (1 Week)||17
7538704|NCT03301740|18557124|P2|STARTED|Second Washout (1 Week)||16
7538705|NCT03301740|18557125|P1|STARTED|Second Washout (1 Week)||17
7538706|NCT03301740|18557124|P2|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||0
7538707|NCT03301740|18557125|P1|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||1
7538708|NCT03301740|18557124|P2|COMPLETED|Phase 2 Intervention (3 Weeks)||16
7538709|NCT03301740|18557125|P1|COMPLETED|Phase 2 Intervention (3 Weeks)||17
7538710|NCT03301740|18557124|P2|STARTED|Phase 2 Intervention (3 Weeks)||16
7538711|NCT03301740|18557125|P1|STARTED|Phase 2 Intervention (3 Weeks)||18
7538712|NCT03301740|18557124|P2|NOT COMPLETED|First Washout (1 Week)||0
7538713|NCT03301740|18557125|P1|NOT COMPLETED|First Washout (1 Week)||0
7538714|NCT03301740|18557124|P2|COMPLETED|First Washout (1 Week)||16
7538715|NCT03301740|18557125|P1|COMPLETED|First Washout (1 Week)||18
7538716|NCT03301740|18557124|P2|STARTED|First Washout (1 Week)||16
7538717|NCT03301740|18557125|P1|STARTED|First Washout (1 Week)||18
7538718|NCT03301740|18557124|P2|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
7538719|NCT03301740|18557125|P1|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
7538720|NCT03301740|18557124|P2|COMPLETED|Phase 1 Intervention (3 Weeks)||16
7538721|NCT03301740|18557125|P1|COMPLETED|Phase 1 Intervention (3 Weeks)||18
7538722|NCT03301740|18557124|P2|STARTED|Phase 1 Intervention (3 Weeks)||16
7538723|NCT03301740|18557125|P1|STARTED|Phase 1 Intervention (3 Weeks)||18
7538724|NCT03301714|18557168|P3|NOT COMPLETED|Overall Study||7
7538725|NCT03301714|18557169|P2|NOT COMPLETED|Overall Study||6
7538726|NCT03301714|18557170|P1|NOT COMPLETED|Overall Study||10
7538727|NCT03301714|18557168|P3|COMPLETED|Overall Study||53
7538728|NCT03301714|18557169|P2|COMPLETED|Overall Study||54
7538729|NCT03301714|18557170|P1|COMPLETED|Overall Study||50
7538730|NCT03301714|18557168|P3|STARTED|Overall Study||60
7538731|NCT03301714|18557169|P2|STARTED|Overall Study||60
7538732|NCT03301714|18557170|P1|STARTED|Overall Study||60
7538733|NCT03301649|18557187|P3|NOT COMPLETED|Overall Study||85
7538734|NCT03301649|18557188|P2|NOT COMPLETED|Overall Study||44
7538735|NCT03301649|18557189|P1|NOT COMPLETED|Overall Study||43
7538736|NCT03301649|18557187|P3|COMPLETED|Overall Study||27
7538737|NCT03301649|18557188|P2|COMPLETED|Overall Study||356
7538738|NCT03301649|18557189|P1|COMPLETED|Overall Study||356
7538739|NCT03301649|18557187|P3|Per-protocol (PP) Population|Overall Study||103
7538740|NCT03301649|18557188|P2|Per-protocol (PP) Population|Overall Study||354
7538741|NCT03301649|18557189|P1|Per-protocol (PP) Population|Overall Study||345
7538742|NCT03301649|18557187|P3|Modified Intent-to-treat(mITT)Population|Overall Study||111
7538743|NCT03301649|18557188|P2|Modified Intent-to-treat(mITT)Population|Overall Study||380
7538744|NCT03301649|18557189|P1|Modified Intent-to-treat(mITT)Population|Overall Study||372
7538745|NCT03301649|18557187|P3|Safety Population|Overall Study||112
7538746|NCT03301649|18557188|P2|Safety Population|Overall Study||400
7538747|NCT03301649|18557189|P1|Safety Population|Overall Study||399
7538748|NCT03301649|18557187|P3|STARTED|Overall Study||112
7538749|NCT03301649|18557188|P2|STARTED|Overall Study||400
7538750|NCT03301649|18557189|P1|STARTED|Overall Study||399
7538751|NCT03301298|18557211|P7|NOT COMPLETED|Fed Conditions||0
7538752|NCT03301298|18557212|P6|NOT COMPLETED|Fed Conditions||0
7538753|NCT03301298|18557213|P5|NOT COMPLETED|Fed Conditions||0
7538754|NCT03301298|18557214|P4|NOT COMPLETED|Fed Conditions||0
7538755|NCT03301298|18557215|P3|NOT COMPLETED|Fed Conditions||0
7538756|NCT03301298|18557216|P2|NOT COMPLETED|Fed Conditions||0
7538757|NCT03301298|18557217|P1|NOT COMPLETED|Fed Conditions||0
7538758|NCT03301298|18557211|P7|COMPLETED|Fed Conditions||2
7538759|NCT03301298|18557212|P6|COMPLETED|Fed Conditions||0
7538760|NCT03301298|18557213|P5|COMPLETED|Fed Conditions||5
7538761|NCT03301298|18557214|P4|COMPLETED|Fed Conditions||0
7538762|NCT03301298|18557215|P3|COMPLETED|Fed Conditions||0
7538763|NCT03301298|18557216|P2|COMPLETED|Fed Conditions||0
7538764|NCT03301298|18557217|P1|COMPLETED|Fed Conditions||0
7538765|NCT03301298|18557211|P7|STARTED|Fed Conditions||2
7538766|NCT03301298|18557212|P6|STARTED|Fed Conditions||0
7538767|NCT03301298|18557213|P5|STARTED|Fed Conditions||5
7538768|NCT03301298|18557214|P4|STARTED|Fed Conditions||0
7538769|NCT03301298|18557215|P3|STARTED|Fed Conditions||0
7538770|NCT03301298|18557216|P2|STARTED|Fed Conditions||0
7538771|NCT03301298|18557217|P1|STARTED|Fed Conditions||0
7538772|NCT03301298|18557211|P7|NOT COMPLETED|Unfed Conditions||0
7538773|NCT03301298|18557212|P6|NOT COMPLETED|Unfed Conditions||0
7538774|NCT03301298|18557213|P5|NOT COMPLETED|Unfed Conditions||0
7538775|NCT03301298|18557214|P4|NOT COMPLETED|Unfed Conditions||0
7538776|NCT03301298|18557215|P3|NOT COMPLETED|Unfed Conditions||0
7538777|NCT03301298|18557216|P2|NOT COMPLETED|Unfed Conditions||0
7538778|NCT03301298|18557217|P1|NOT COMPLETED|Unfed Conditions||0
7538779|NCT03301298|18557211|P7|COMPLETED|Unfed Conditions||12
7538780|NCT03301298|18557212|P6|COMPLETED|Unfed Conditions||6
7538781|NCT03301298|18557213|P5|COMPLETED|Unfed Conditions||6
7538782|NCT03301298|18557214|P4|COMPLETED|Unfed Conditions||6
7538783|NCT03301298|18557215|P3|COMPLETED|Unfed Conditions||6
7538784|NCT03301298|18557216|P2|COMPLETED|Unfed Conditions||6
7538785|NCT03301298|18557217|P1|COMPLETED|Unfed Conditions||6
7538786|NCT03301298|18557211|P7|STARTED|Unfed Conditions||12
7538787|NCT03301298|18557212|P6|STARTED|Unfed Conditions||6
7538788|NCT03301298|18557213|P5|STARTED|Unfed Conditions||6
7538789|NCT03301298|18557214|P4|STARTED|Unfed Conditions||6
7538790|NCT03301298|18557215|P3|STARTED|Unfed Conditions||6
7538791|NCT03301298|18557216|P2|STARTED|Unfed Conditions||6
7538792|NCT03301298|18557217|P1|STARTED|Unfed Conditions||6
7538793|NCT03301272|18557255|P2|NOT COMPLETED|Second Intervention (30 Days)||0
7538794|NCT03301272|18557256|P1|NOT COMPLETED|Second Intervention (30 Days)||0
7538795|NCT03301272|18557255|P2|COMPLETED|Second Intervention (30 Days)||9
7538796|NCT03301272|18557256|P1|COMPLETED|Second Intervention (30 Days)||7
7538797|NCT03301272|18557255|P2|STARTED|Second Intervention (30 Days)||9
7538798|NCT03301272|18557256|P1|STARTED|Second Intervention (30 Days)||7
7538799|NCT03301272|18557255|P2|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
7538800|NCT03301272|18557256|P1|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
7538801|NCT03301272|18557255|P2|COMPLETED|Washout (90 Days From 1st Intervention)||9
7538802|NCT03301272|18557256|P1|COMPLETED|Washout (90 Days From 1st Intervention)||7
7538803|NCT03301272|18557255|P2|STARTED|Washout (90 Days From 1st Intervention)||9
7538804|NCT03301272|18557256|P1|STARTED|Washout (90 Days From 1st Intervention)||7
7538805|NCT03301272|18557255|P2|NOT COMPLETED|First Intervention (30 Days)||0
7538806|NCT03301272|18557256|P1|NOT COMPLETED|First Intervention (30 Days)||0
7538807|NCT03301272|18557255|P2|COMPLETED|First Intervention (30 Days)||9
7538808|NCT03301272|18557256|P1|COMPLETED|First Intervention (30 Days)||7
7538809|NCT03301272|18557255|P2|STARTED|First Intervention (30 Days)||9
7538810|NCT03301272|18557256|P1|STARTED|First Intervention (30 Days)||7
7538811|NCT03301155|18557272|P2|NOT COMPLETED|Overall Study||7
7538812|NCT03301155|18557273|P1|NOT COMPLETED|Overall Study||8
7538813|NCT03301155|18557272|P2|COMPLETED|Overall Study||501
7538814|NCT03301155|18557273|P1|COMPLETED|Overall Study||520
7538815|NCT03301155|18557272|P2|STARTED|Overall Study||508
7538816|NCT03301155|18557273|P1|STARTED|Overall Study||528
7538817|NCT03300843|18557287|P1|NOT COMPLETED|Overall Study||0
7538818|NCT03300843|18557287|P1|COMPLETED|Overall Study||1
7538819|NCT03300843|18557287|P1|STARTED|Overall Study||1
7538820|NCT03300674|18557295|P2|NOT COMPLETED|Overall Study||0
7538821|NCT03300674|18557296|P1|NOT COMPLETED|Overall Study||0
7538822|NCT03300674|18557295|P2|COMPLETED|Overall Study||77
7538823|NCT03300674|18557296|P1|COMPLETED|Overall Study||77
7538824|NCT03300674|18557295|P2|STARTED|Overall Study||77
7538825|NCT03300674|18557296|P1|STARTED|Overall Study||77
7538826|NCT03300570|18557308|P2|NOT COMPLETED|Overall Study||1
7538827|NCT03300570|18557309|P1|NOT COMPLETED|Overall Study||2
7538828|NCT03300570|18557308|P2|COMPLETED|Overall Study||13
7538829|NCT03300570|18557309|P1|COMPLETED|Overall Study||11
7538830|NCT03300570|18557308|P2|STARTED|Overall Study||14
7538831|NCT03300570|18557309|P1|STARTED|Overall Study||13
7538832|NCT03300466|18557321|P2|NOT COMPLETED|Overall Study||0
7538833|NCT03300466|18557322|P1|NOT COMPLETED|Overall Study||1
7538834|NCT03300466|18557321|P2|COMPLETED|Overall Study||10
7538835|NCT03300466|18557322|P1|COMPLETED|Overall Study||9
7538836|NCT03300466|18557321|P2|STARTED|Overall Study||10
7538837|NCT03300466|18557322|P1|STARTED|Overall Study||10
7538838|NCT03300024|18557332|P2|NOT COMPLETED|Overall Study||6
7538839|NCT03300024|18557333|P1|NOT COMPLETED|Overall Study||4
7538840|NCT03300024|18557332|P2|COMPLETED|Overall Study||0
7538841|NCT03300024|18557333|P1|COMPLETED|Overall Study||0
7538842|NCT03300024|18557332|P2|STARTED|Overall Study||6
7538843|NCT03300024|18557333|P1|STARTED|Overall Study||4
7538844|NCT03299686|18557387|P2|NOT COMPLETED|Follow-up Epoch||1
7538845|NCT03299686|18557388|P1|NOT COMPLETED|Follow-up Epoch||0
7538846|NCT03299686|18557387|P2|COMPLETED|Follow-up Epoch||43
7538847|NCT03299686|18557388|P1|COMPLETED|Follow-up Epoch||59
7538848|NCT03299686|18557387|P2|STARTED|Follow-up Epoch||44
7538849|NCT03299686|18557388|P1|STARTED|Follow-up Epoch||59
7538850|NCT03299686|18557387|P2|NOT COMPLETED|Treatment Epoch||4
7538851|NCT03299686|18557388|P1|NOT COMPLETED|Treatment Epoch||11
7538852|NCT03299686|18557387|P2|COMPLETED|Treatment Epoch||44
7538853|NCT03299686|18557388|P1|COMPLETED|Treatment Epoch||59
7538854|NCT03299686|18557387|P2|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||48
7538855|NCT03299686|18557388|P1|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||69
7538856|NCT03299686|18557387|P2|STARTED|Treatment Epoch||48
7538857|NCT03299686|18557388|P1|STARTED|Treatment Epoch||70
7538858|NCT03299101|18557404|P1|NOT COMPLETED|Overall Study||10
7538859|NCT03299101|18557404|P1|COMPLETED|Overall Study||25
7538860|NCT03299101|18557404|P1|STARTED|Overall Study||35
7538861|NCT03299049|18557427|P2|NOT COMPLETED|Overall Study||523
7538862|NCT03299049|18557428|P1|NOT COMPLETED|Overall Study||522
7538863|NCT03299049|18557427|P2|COMPLETED|Overall Study||0
7538864|NCT03299049|18557428|P1|COMPLETED|Overall Study||0
7538865|NCT03299049|18557427|P2|STARTED|Overall Study||523
7538866|NCT03299049|18557428|P1|STARTED|Overall Study||522
7538867|NCT03298867|18557527|P2|NOT COMPLETED|Overall Study||2
7538868|NCT03298867|18557528|P1|NOT COMPLETED|Overall Study||2
7538869|NCT03298867|18557527|P2|COMPLETED|Overall Study||39
7538870|NCT03298867|18557528|P1|COMPLETED|Overall Study||40
7538871|NCT03298867|18557527|P2|STARTED|Overall Study||41
7538872|NCT03298867|18557528|P1|STARTED|Overall Study||42
7538873|NCT03298412|18557544|P1|NOT COMPLETED|Treatment Period||0
7538874|NCT03298412|18557544|P1|COMPLETED|Treatment Period||1
7538875|NCT03298412|18557544|P1|STARTED|Treatment Period||1
7538876|NCT03298412|18557544|P1|NOT COMPLETED|Run-in Period||9
7538877|NCT03298412|18557544|P1|COMPLETED|Run-in Period||1
7538878|NCT03298412|18557544|P1|STARTED|Run-in Period||10
7538879|NCT03298113|18557554|P2|NOT COMPLETED|Overall Study||0
7538880|NCT03298113|18557555|P1|NOT COMPLETED|Overall Study||0
7538881|NCT03298113|18557554|P2|COMPLETED|Overall Study||10
7538882|NCT03298113|18557555|P1|COMPLETED|Overall Study||10
7538883|NCT03298113|18557554|P2|IAD 2A|Overall Study||6
7538884|NCT03298113|18557555|P1|IAD 2A|Overall Study||7
7538885|NCT03298113|18557554|P2|IAD 1A|Overall Study||4
7538886|NCT03298113|18557555|P1|IAD 1A|Overall Study||3
7538887|NCT03298113|18557554|P2|STARTED|Overall Study|10 subjects were treated with IAD Hospital Standard Care. Study terminated due to low enrollment.|10
7538888|NCT03298113|18557555|P1|STARTED|Overall Study|10 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|10
7538889|NCT03298048|18557594|P3|NOT COMPLETED|Overall Study||0
7538890|NCT03298048|18557595|P2|NOT COMPLETED|Overall Study||0
7538891|NCT03298048|18557596|P1|NOT COMPLETED|Overall Study||0
7538892|NCT03298048|18557594|P3|COMPLETED|Overall Study||8
7538893|NCT03298048|18557595|P2|COMPLETED|Overall Study||3
7538894|NCT03298048|18557596|P1|COMPLETED|Overall Study||4
7538895|NCT03298048|18557594|P3|STARTED|Overall Study||8
7538896|NCT03298048|18557595|P2|STARTED|Overall Study||3
7538897|NCT03298048|18557596|P1|STARTED|Overall Study||4
7538898|NCT03298035|18557621|P2|NOT COMPLETED|Overall Study||2
7538899|NCT03298035|18557622|P1|NOT COMPLETED|Overall Study||1
7538900|NCT03298035|18557621|P2|COMPLETED|Overall Study||7
7538901|NCT03298035|18557622|P1|COMPLETED|Overall Study||9
7538902|NCT03298035|18557621|P2|Received Intervention|Overall Study||7
7538903|NCT03298035|18557622|P1|Received Intervention|Overall Study||9
7538904|NCT03298035|18557621|P2|STARTED|Overall Study||9
7538905|NCT03298035|18557622|P1|STARTED|Overall Study||10
7538906|NCT03297944|18557644|P1|NOT COMPLETED|Overall Study||0
7538907|NCT03297944|18557644|P1|COMPLETED|Overall Study||15
7538908|NCT03297944|18557644|P1|PLC/ALP|Overall Study||15
7538909|NCT03297944|18557644|P1|PLC/PLC|Overall Study||15
7538910|NCT03297944|18557644|P1|ZOL/PLC|Overall Study||15
7538911|NCT03297944|18557644|P1|0.5ALP/PLC|Overall Study||15
7538912|NCT03297944|18557644|P1|1ALP/PLC|Overall Study||15
7538913|NCT03297944|18557644|P1|2ALP/PLC|Overall Study||15
7538914|NCT03297944|18557644|P1|STARTED|Overall Study||15
7538915|NCT03297294|18557655|P5|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
7538916|NCT03297294|18557656|P4|NOT COMPLETED|Treatment Withdrawal Period (TW)||1
7538917|NCT03297294|18557657|P3|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
7538918|NCT03297294|18557658|P2|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
7538919|NCT03297294|18557659|P1|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
7538920|NCT03297294|18557655|P5|COMPLETED|Treatment Withdrawal Period (TW)||27
7538921|NCT03297294|18557656|P4|COMPLETED|Treatment Withdrawal Period (TW)||11
7538922|NCT03297294|18557657|P3|COMPLETED|Treatment Withdrawal Period (TW)||14
7538923|NCT03297294|18557658|P2|COMPLETED|Treatment Withdrawal Period (TW)||0
7538924|NCT03297294|18557659|P1|COMPLETED|Treatment Withdrawal Period (TW)||0
7538925|NCT03297294|18557655|P5|STARTED|Treatment Withdrawal Period (TW)||27
7538926|NCT03297294|18557656|P4|STARTED|Treatment Withdrawal Period (TW)||12
7538927|NCT03297294|18557657|P3|STARTED|Treatment Withdrawal Period (TW)||14
7538928|NCT03297294|18557658|P2|STARTED|Treatment Withdrawal Period (TW)||0
7538929|NCT03297294|18557659|P1|STARTED|Treatment Withdrawal Period (TW)||0
7538930|NCT03297294|18557655|P5|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
7538931|NCT03297294|18557656|P4|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
7538932|NCT03297294|18557657|P3|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
7538933|NCT03297294|18557658|P2|NOT COMPLETED|Double-Blind Treatment Period (DB)||37
7538934|NCT03297294|18557659|P1|NOT COMPLETED|Double-Blind Treatment Period (DB)||38
7538935|NCT03297294|18557655|P5|COMPLETED|Double-Blind Treatment Period (DB)||0
7538936|NCT03297294|18557656|P4|COMPLETED|Double-Blind Treatment Period (DB)||0
7538937|NCT03297294|18557657|P3|COMPLETED|Double-Blind Treatment Period (DB)||0
7538938|NCT03297294|18557658|P2|COMPLETED|Double-Blind Treatment Period (DB)||30
7538939|NCT03297294|18557659|P1|COMPLETED|Double-Blind Treatment Period (DB)||32
7538940|NCT03297294|18557655|P5|STARTED|Double-Blind Treatment Period (DB)||0
7538941|NCT03297294|18557656|P4|STARTED|Double-Blind Treatment Period (DB)||0
7538942|NCT03297294|18557657|P3|STARTED|Double-Blind Treatment Period (DB)||0
7538943|NCT03297294|18557658|P2|STARTED|Double-Blind Treatment Period (DB)||67
7538944|NCT03297294|18557659|P1|STARTED|Double-Blind Treatment Period (DB)||70
7538945|NCT03297112|18557693|P1|NOT COMPLETED|Overall Study||0
7538946|NCT03297112|18557693|P1|COMPLETED|Overall Study||12
7538947|NCT03297112|18557693|P1|STARTED|Overall Study||12
7538948|NCT03297021|18557701|P3|NOT COMPLETED|Overall Study||4
7538949|NCT03297021|18557702|P2|NOT COMPLETED|Overall Study||4
7538950|NCT03297021|18557703|P1|NOT COMPLETED|Overall Study||5
7538951|NCT03297021|18557701|P3|COMPLETED|Overall Study||43
7538952|NCT03297021|18557702|P2|COMPLETED|Overall Study||42
7538953|NCT03297021|18557703|P1|COMPLETED|Overall Study||43
7538954|NCT03297021|18557701|P3|STARTED|Overall Study||47
7538955|NCT03297021|18557702|P2|STARTED|Overall Study||46
7538956|NCT03297021|18557703|P1|STARTED|Overall Study||48
7538957|NCT03296787|18557727|P4|NOT COMPLETED|Overall Study||0
7538958|NCT03296787|18557728|P3|NOT COMPLETED|Overall Study||0
7538959|NCT03296787|18557729|P2|NOT COMPLETED|Overall Study||0
7538960|NCT03296787|18557730|P1|NOT COMPLETED|Overall Study||0
7538961|NCT03296787|18557727|P4|COMPLETED|Overall Study||7
7538962|NCT03296787|18557728|P3|COMPLETED|Overall Study||9
7538963|NCT03296787|18557729|P2|COMPLETED|Overall Study||8
7538964|NCT03296787|18557730|P1|COMPLETED|Overall Study||8
7538965|NCT03296787|18557727|P4|STARTED|Overall Study||7
7538966|NCT03296787|18557728|P3|STARTED|Overall Study||9
7538967|NCT03296787|18557729|P2|STARTED|Overall Study||8
7538968|NCT03296787|18557730|P1|STARTED|Overall Study||8
7538969|NCT03296566|18557767|P2|NOT COMPLETED|Overall Study||49
7538970|NCT03296566|18557768|P1|NOT COMPLETED|Overall Study||19
7538971|NCT03296566|18557767|P2|COMPLETED|Overall Study||103
7538972|NCT03296566|18557768|P1|COMPLETED|Overall Study||126
7538973|NCT03296566|18557767|P2|STARTED|Overall Study||152
7538974|NCT03296566|18557768|P1|STARTED|Overall Study||145
7538975|NCT03296280|18557784|P2|NOT COMPLETED|Overall Study||7
7538976|NCT03296280|18557785|P1|NOT COMPLETED|Overall Study||6
7538977|NCT03296280|18557784|P2|COMPLETED|Overall Study||36
7538978|NCT03296280|18557785|P1|COMPLETED|Overall Study||67
7538979|NCT03296280|18557784|P2|STARTED|Overall Study||43
7538980|NCT03296280|18557785|P1|STARTED|Overall Study||73
7538981|NCT03296072|18557805|P6|NOT COMPLETED|Treament Period 3||0
7538982|NCT03296072|18557806|P5|NOT COMPLETED|Treament Period 3||0
7538983|NCT03296072|18557807|P4|NOT COMPLETED|Treament Period 3||0
7538984|NCT03296072|18557808|P3|NOT COMPLETED|Treament Period 3||0
7538985|NCT03296072|18557809|P2|NOT COMPLETED|Treament Period 3||0
7538986|NCT03296072|18557810|P1|NOT COMPLETED|Treament Period 3||0
7538987|NCT03296072|18557805|P6|COMPLETED|Treament Period 3||11
7538988|NCT03296072|18557806|P5|COMPLETED|Treament Period 3||10
7538989|NCT03296072|18557807|P4|COMPLETED|Treament Period 3||10
7538990|NCT03296072|18557808|P3|COMPLETED|Treament Period 3||10
7538991|NCT03296072|18557809|P2|COMPLETED|Treament Period 3||11
7538992|NCT03296072|18557810|P1|COMPLETED|Treament Period 3||10
7538993|NCT03296072|18557805|P6|STARTED|Treament Period 3||11
7538994|NCT03296072|18557806|P5|STARTED|Treament Period 3||10
7538995|NCT03296072|18557807|P4|STARTED|Treament Period 3||10
7538996|NCT03296072|18557808|P3|STARTED|Treament Period 3||10
7538997|NCT03296072|18557809|P2|STARTED|Treament Period 3||11
7538998|NCT03296072|18557810|P1|STARTED|Treament Period 3||10
7538999|NCT03296072|18557805|P6|NOT COMPLETED|Treament Period 2: Wash Out Period||0
7539000|NCT03296072|18557806|P5|NOT COMPLETED|Treament Period 2: Wash Out Period||0
7539001|NCT03296072|18557807|P4|NOT COMPLETED|Treament Period 2: Wash Out Period||0
7539002|NCT03296072|18557808|P3|NOT COMPLETED|Treament Period 2: Wash Out Period||0
7539003|NCT03296072|18557809|P2|NOT COMPLETED|Treament Period 2: Wash Out Period||0
7539004|NCT03296072|18557810|P1|NOT COMPLETED|Treament Period 2: Wash Out Period||0
7539005|NCT03296072|18557805|P6|COMPLETED|Treament Period 2: Wash Out Period||11
7539006|NCT03296072|18557806|P5|COMPLETED|Treament Period 2: Wash Out Period||10
7539007|NCT03296072|18557807|P4|COMPLETED|Treament Period 2: Wash Out Period||10
7539008|NCT03296072|18557808|P3|COMPLETED|Treament Period 2: Wash Out Period||10
7539009|NCT03296072|18557809|P2|COMPLETED|Treament Period 2: Wash Out Period||11
7539010|NCT03296072|18557810|P1|COMPLETED|Treament Period 2: Wash Out Period||10
7539011|NCT03296072|18557805|P6|STARTED|Treament Period 2: Wash Out Period||11
7539012|NCT03296072|18557806|P5|STARTED|Treament Period 2: Wash Out Period||10
7539013|NCT03296072|18557807|P4|STARTED|Treament Period 2: Wash Out Period||10
7539014|NCT03296072|18557808|P3|STARTED|Treament Period 2: Wash Out Period||10
7539015|NCT03296072|18557809|P2|STARTED|Treament Period 2: Wash Out Period||11
7539016|NCT03296072|18557810|P1|STARTED|Treament Period 2: Wash Out Period||10
7539017|NCT03296072|18557805|P6|NOT COMPLETED|Treament Period 2||0
7539018|NCT03296072|18557806|P5|NOT COMPLETED|Treament Period 2||0
7539019|NCT03296072|18557807|P4|NOT COMPLETED|Treament Period 2||0
7539020|NCT03296072|18557808|P3|NOT COMPLETED|Treament Period 2||0
7539021|NCT03296072|18557809|P2|NOT COMPLETED|Treament Period 2||0
7539022|NCT03296072|18557810|P1|NOT COMPLETED|Treament Period 2||0
7539023|NCT03296072|18557805|P6|COMPLETED|Treament Period 2||11
7539024|NCT03296072|18557806|P5|COMPLETED|Treament Period 2||10
7539025|NCT03296072|18557807|P4|COMPLETED|Treament Period 2||10
7539026|NCT03296072|18557808|P3|COMPLETED|Treament Period 2||10
7539027|NCT03296072|18557809|P2|COMPLETED|Treament Period 2||11
7539028|NCT03296072|18557810|P1|COMPLETED|Treament Period 2||10
7539029|NCT03296072|18557805|P6|STARTED|Treament Period 2||11
7539030|NCT03296072|18557806|P5|STARTED|Treament Period 2||10
7539031|NCT03296072|18557807|P4|STARTED|Treament Period 2||10
7539032|NCT03296072|18557808|P3|STARTED|Treament Period 2||10
7539033|NCT03296072|18557809|P2|STARTED|Treament Period 2||11
7539034|NCT03296072|18557810|P1|STARTED|Treament Period 2||10
7539035|NCT03296072|18557805|P6|NOT COMPLETED|Treament Period 1: Wash Out Period||0
7539036|NCT03296072|18557806|P5|NOT COMPLETED|Treament Period 1: Wash Out Period||0
7539037|NCT03296072|18557807|P4|NOT COMPLETED|Treament Period 1: Wash Out Period||0
7539038|NCT03296072|18557808|P3|NOT COMPLETED|Treament Period 1: Wash Out Period||0
7539039|NCT03296072|18557809|P2|NOT COMPLETED|Treament Period 1: Wash Out Period||0
7539040|NCT03296072|18557810|P1|NOT COMPLETED|Treament Period 1: Wash Out Period||0
7539041|NCT03296072|18557805|P6|COMPLETED|Treament Period 1: Wash Out Period||11
7539042|NCT03296072|18557806|P5|COMPLETED|Treament Period 1: Wash Out Period||10
7539043|NCT03296072|18557807|P4|COMPLETED|Treament Period 1: Wash Out Period||10
7539044|NCT03296072|18557808|P3|COMPLETED|Treament Period 1: Wash Out Period||10
7539045|NCT03296072|18557809|P2|COMPLETED|Treament Period 1: Wash Out Period||11
7539046|NCT03296072|18557810|P1|COMPLETED|Treament Period 1: Wash Out Period||10
7539047|NCT03296072|18557805|P6|STARTED|Treament Period 1: Wash Out Period||11
7539048|NCT03296072|18557806|P5|STARTED|Treament Period 1: Wash Out Period||10
7539049|NCT03296072|18557807|P4|STARTED|Treament Period 1: Wash Out Period||10
7539050|NCT03296072|18557808|P3|STARTED|Treament Period 1: Wash Out Period||10
7539051|NCT03296072|18557809|P2|STARTED|Treament Period 1: Wash Out Period||11
7539052|NCT03296072|18557810|P1|STARTED|Treament Period 1: Wash Out Period||10
7539053|NCT03296072|18557805|P6|NOT COMPLETED|Treatment Period 1||0
7539054|NCT03296072|18557806|P5|NOT COMPLETED|Treatment Period 1||0
7539055|NCT03296072|18557807|P4|NOT COMPLETED|Treatment Period 1||0
7539056|NCT03296072|18557808|P3|NOT COMPLETED|Treatment Period 1||0
7539057|NCT03296072|18557809|P2|NOT COMPLETED|Treatment Period 1||0
7539058|NCT03296072|18557810|P1|NOT COMPLETED|Treatment Period 1||0
7539059|NCT03296072|18557805|P6|COMPLETED|Treatment Period 1||11
7539060|NCT03296072|18557806|P5|COMPLETED|Treatment Period 1||10
7539061|NCT03296072|18557807|P4|COMPLETED|Treatment Period 1||10
7539062|NCT03296072|18557808|P3|COMPLETED|Treatment Period 1||10
7539063|NCT03296072|18557809|P2|COMPLETED|Treatment Period 1||11
7539064|NCT03296072|18557810|P1|COMPLETED|Treatment Period 1||10
7539065|NCT03296072|18557805|P6|STARTED|Treatment Period 1||11
7539066|NCT03296072|18557806|P5|STARTED|Treatment Period 1||10
7539067|NCT03296072|18557807|P4|STARTED|Treatment Period 1||10
7539068|NCT03296072|18557808|P3|STARTED|Treatment Period 1||10
7539069|NCT03296072|18557809|P2|STARTED|Treatment Period 1||11
7539070|NCT03296072|18557810|P1|STARTED|Treatment Period 1||10
7539071|NCT03295630|18557827|P1|NOT COMPLETED|Overall Study||0
7539072|NCT03295630|18557827|P1|COMPLETED|Overall Study||20
7539073|NCT03295630|18557827|P1|STARTED|Overall Study||20
7539074|NCT03295266|18557834|P2|NOT COMPLETED|Overall Study||0
7539075|NCT03295266|18557835|P1|NOT COMPLETED|Overall Study||0
7539076|NCT03295266|18557834|P2|COMPLETED|Overall Study||4
7539077|NCT03295266|18557835|P1|COMPLETED|Overall Study||5
7539078|NCT03295266|18557834|P2|STARTED|Overall Study||4
7539079|NCT03295266|18557835|P1|STARTED|Overall Study||5
7539080|NCT03295201|18557865|P2|NOT COMPLETED|Overall Study||2
7539081|NCT03295201|18557866|P1|NOT COMPLETED|Overall Study||1
7539082|NCT03295201|18557865|P2|COMPLETED|Overall Study||9
7539083|NCT03295201|18557866|P1|COMPLETED|Overall Study||10
7539084|NCT03295201|18557865|P2|STARTED|Overall Study||11
7539085|NCT03295201|18557866|P1|STARTED|Overall Study||11
7539086|NCT03294681|18557918|P1|NOT COMPLETED|Overall Study||1
7539087|NCT03294681|18557918|P1|COMPLETED|Overall Study||152
7539088|NCT03294681|18557918|P1|STARTED|Overall Study||153
7539089|NCT03294629|18557924|P2|NOT COMPLETED|Second Intervention (2 Weeks)||2
7539090|NCT03294629|18557925|P1|NOT COMPLETED|Second Intervention (2 Weeks)||2
7539091|NCT03294629|18557924|P2|COMPLETED|Second Intervention (2 Weeks)||13
7539092|NCT03294629|18557925|P1|COMPLETED|Second Intervention (2 Weeks)||12
7539093|NCT03294629|18557924|P2|STARTED|Second Intervention (2 Weeks)||15
7539094|NCT03294629|18557925|P1|STARTED|Second Intervention (2 Weeks)||14
7539095|NCT03294629|18557924|P2|NOT COMPLETED|First Intervention (2 Weeks)||4
7539096|NCT03294629|18557925|P1|NOT COMPLETED|First Intervention (2 Weeks)||2
7539097|NCT03294629|18557924|P2|COMPLETED|First Intervention (2 Weeks)||15
7539098|NCT03294629|18557925|P1|COMPLETED|First Intervention (2 Weeks)||14
7539099|NCT03294629|18557924|P2|STARTED|First Intervention (2 Weeks)||19
7539100|NCT03294629|18557925|P1|STARTED|First Intervention (2 Weeks)||16
7539101|NCT03294538|18557956|P3|NOT COMPLETED|Overall Study||2
7539102|NCT03294538|18557957|P2|NOT COMPLETED|Overall Study||5
7539103|NCT03294538|18557958|P1|NOT COMPLETED|Overall Study||5
7539104|NCT03294538|18557956|P3|COMPLETED|Overall Study||131
7539105|NCT03294538|18557957|P2|COMPLETED|Overall Study||257
7539106|NCT03294538|18557958|P1|COMPLETED|Overall Study||263
7539107|NCT03294538|18557956|P3|PP Population|Overall Study||126
7539108|NCT03294538|18557957|P2|PP Population|Overall Study||227
7539109|NCT03294538|18557958|P1|PP Population|Overall Study||244
7539110|NCT03294538|18557956|P3|mITT Population|Overall Study||132
7539111|NCT03294538|18557957|P2|mITT Population|Overall Study||262
7539112|NCT03294538|18557958|P1|mITT Population|Overall Study||267
7539113|NCT03294538|18557956|P3|Safety Population|Overall Study||132
7539114|NCT03294538|18557957|P2|Safety Population|Overall Study||262
7539115|NCT03294538|18557958|P1|Safety Population|Overall Study||267
7539116|NCT03294538|18557956|P3|STARTED|Overall Study||133
7539117|NCT03294538|18557957|P2|STARTED|Overall Study||262
7539118|NCT03294538|18557958|P1|STARTED|Overall Study||268
7539119|NCT03293654|18557976|P3|NOT COMPLETED|Overall Study||0
7539120|NCT03293654|18557977|P2|NOT COMPLETED|Overall Study||1
7539121|NCT03293654|18557978|P1|NOT COMPLETED|Overall Study||0
7539122|NCT03293654|18557976|P3|COMPLETED|Overall Study||38
7539123|NCT03293654|18557977|P2|COMPLETED|Overall Study||37
7539124|NCT03293654|18557978|P1|COMPLETED|Overall Study||38
7539125|NCT03293654|18557976|P3|STARTED|Overall Study||38
7539126|NCT03293654|18557977|P2|STARTED|Overall Study||38
7539127|NCT03293654|18557978|P1|STARTED|Overall Study||38
7539128|NCT03293485|18558016|P1|NOT COMPLETED|Overall Study||5
7539129|NCT03293485|18558016|P1|COMPLETED|Overall Study||78
7539130|NCT03293485|18558016|P1|Treated|Overall Study||81
7539131|NCT03293485|18558016|P1|STARTED|Overall Study||83
7539132|NCT03293394|18558027|P2|NOT COMPLETED|Follow-up (6 Months)||2
7539133|NCT03293394|18558028|P1|NOT COMPLETED|Follow-up (6 Months)||4
7539134|NCT03293394|18558027|P2|COMPLETED|Follow-up (6 Months)||8
7539135|NCT03293394|18558028|P1|COMPLETED|Follow-up (6 Months)||16
7539136|NCT03293394|18558027|P2|STARTED|Follow-up (6 Months)||10
7539137|NCT03293394|18558028|P1|STARTED|Follow-up (6 Months)||20
7539138|NCT03293394|18558027|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
7539139|NCT03293394|18558028|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
7539140|NCT03293394|18558027|P2|COMPLETED|First Intervention (2 Weeks)||10
7539141|NCT03293394|18558028|P1|COMPLETED|First Intervention (2 Weeks)||20
7539142|NCT03293394|18558027|P2|STARTED|First Intervention (2 Weeks)||10
7539143|NCT03293394|18558028|P1|STARTED|First Intervention (2 Weeks)||20
7539144|NCT03293238|18558052|P4|NOT COMPLETED|Overall Study||0
7539145|NCT03293238|18558053|P3|NOT COMPLETED|Overall Study||0
7539146|NCT03293238|18558054|P2|NOT COMPLETED|Overall Study||0
7539147|NCT03293238|18558055|P1|NOT COMPLETED|Overall Study||0
7539148|NCT03293238|18558052|P4|COMPLETED|Overall Study||14
7539149|NCT03293238|18558053|P3|COMPLETED|Overall Study||14
7539150|NCT03293238|18558054|P2|COMPLETED|Overall Study||16
7539151|NCT03293238|18558055|P1|COMPLETED|Overall Study||19
7539152|NCT03293238|18558052|P4|STARTED|Overall Study||14
7539153|NCT03293238|18558053|P3|STARTED|Overall Study||14
7539154|NCT03293238|18558054|P2|STARTED|Overall Study||16
7539155|NCT03293238|18558055|P1|STARTED|Overall Study||19
7539156|NCT03292692|18558075|P2|NOT COMPLETED|Overall Study||38
7539157|NCT03292692|18558076|P1|NOT COMPLETED|Overall Study||38
7539158|NCT03292692|18558075|P2|COMPLETED|Overall Study||260
7539159|NCT03292692|18558076|P1|COMPLETED|Overall Study||264
7539160|NCT03292692|18558075|P2|STARTED|Overall Study||298
7539161|NCT03292692|18558076|P1|STARTED|Overall Study||302
7539162|NCT03292640|18558090|P2|NOT COMPLETED|Overall Study||42
7539163|NCT03292640|18558091|P1|NOT COMPLETED|Overall Study||61
7539164|NCT03292640|18558090|P2|COMPLETED|Overall Study||230
7539165|NCT03292640|18558091|P1|COMPLETED|Overall Study||214
7539166|NCT03292640|18558090|P2|STARTED|Overall Study||272
7539167|NCT03292640|18558091|P1|STARTED|Overall Study||275
7539168|NCT03292614|18558101|P1|NOT COMPLETED|Overall Study||0
7539169|NCT03292614|18558101|P1|COMPLETED|Overall Study||25
7539170|NCT03292614|18558101|P1|STARTED|Overall Study||25
7539171|NCT03292562|18558107|P2|NOT COMPLETED|Overall Study||1
7539172|NCT03292562|18558108|P1|NOT COMPLETED|Overall Study||6
7539173|NCT03292562|18558107|P2|COMPLETED|Overall Study||30
7539174|NCT03292562|18558108|P1|COMPLETED|Overall Study||29
7539175|NCT03292562|18558107|P2|STARTED|Overall Study||31
7539176|NCT03292562|18558108|P1|STARTED|Overall Study||35
7539177|NCT03292016|18558134|P6|NOT COMPLETED|Third Intervention||0
7539178|NCT03292016|18558135|P5|NOT COMPLETED|Third Intervention||0
7539179|NCT03292016|18558136|P4|NOT COMPLETED|Third Intervention||0
7539180|NCT03292016|18558137|P3|NOT COMPLETED|Third Intervention||0
7539181|NCT03292016|18558138|P2|NOT COMPLETED|Third Intervention||0
7539182|NCT03292016|18558139|P1|NOT COMPLETED|Third Intervention||0
7539183|NCT03292016|18558134|P6|COMPLETED|Third Intervention||2
7539184|NCT03292016|18558135|P5|COMPLETED|Third Intervention||1
7539185|NCT03292016|18558136|P4|COMPLETED|Third Intervention||1
7539186|NCT03292016|18558137|P3|COMPLETED|Third Intervention||2
7539187|NCT03292016|18558138|P2|COMPLETED|Third Intervention||0
7539188|NCT03292016|18558139|P1|COMPLETED|Third Intervention||1
7539189|NCT03292016|18558134|P6|STARTED|Third Intervention||2
7539190|NCT03292016|18558135|P5|STARTED|Third Intervention||1
7539191|NCT03292016|18558136|P4|STARTED|Third Intervention||1
7539192|NCT03292016|18558137|P3|STARTED|Third Intervention||2
7539193|NCT03292016|18558138|P2|STARTED|Third Intervention||0
7539194|NCT03292016|18558139|P1|STARTED|Third Intervention||1
7539195|NCT03292016|18558134|P6|NOT COMPLETED|Second Washout||0
7539196|NCT03292016|18558135|P5|NOT COMPLETED|Second Washout||0
7539197|NCT03292016|18558136|P4|NOT COMPLETED|Second Washout||0
7539198|NCT03292016|18558137|P3|NOT COMPLETED|Second Washout||0
7539199|NCT03292016|18558138|P2|NOT COMPLETED|Second Washout||1
7539200|NCT03292016|18558139|P1|NOT COMPLETED|Second Washout||0
7539201|NCT03292016|18558134|P6|COMPLETED|Second Washout||2
7539202|NCT03292016|18558135|P5|COMPLETED|Second Washout||1
7539203|NCT03292016|18558136|P4|COMPLETED|Second Washout||1
7539204|NCT03292016|18558137|P3|COMPLETED|Second Washout||2
7539205|NCT03292016|18558138|P2|COMPLETED|Second Washout||0
7539206|NCT03292016|18558139|P1|COMPLETED|Second Washout||1
7539207|NCT03292016|18558134|P6|STARTED|Second Washout||2
7539208|NCT03292016|18558135|P5|STARTED|Second Washout||1
7539209|NCT03292016|18558136|P4|STARTED|Second Washout||1
7539210|NCT03292016|18558137|P3|STARTED|Second Washout||2
7539211|NCT03292016|18558138|P2|STARTED|Second Washout||1
7539212|NCT03292016|18558139|P1|STARTED|Second Washout||1
7539213|NCT03292016|18558134|P6|NOT COMPLETED|Second Intervention||0
7539214|NCT03292016|18558135|P5|NOT COMPLETED|Second Intervention||0
7539215|NCT03292016|18558136|P4|NOT COMPLETED|Second Intervention||0
7539216|NCT03292016|18558137|P3|NOT COMPLETED|Second Intervention||0
7539217|NCT03292016|18558138|P2|NOT COMPLETED|Second Intervention||0
7539218|NCT03292016|18558139|P1|NOT COMPLETED|Second Intervention||0
7539219|NCT03292016|18558134|P6|COMPLETED|Second Intervention||2
7539220|NCT03292016|18558135|P5|COMPLETED|Second Intervention||1
7539221|NCT03292016|18558136|P4|COMPLETED|Second Intervention||1
7539222|NCT03292016|18558137|P3|COMPLETED|Second Intervention||2
7539223|NCT03292016|18558138|P2|COMPLETED|Second Intervention||1
7539224|NCT03292016|18558139|P1|COMPLETED|Second Intervention||1
7539225|NCT03292016|18558134|P6|STARTED|Second Intervention||2
7539226|NCT03292016|18558135|P5|STARTED|Second Intervention||1
7539227|NCT03292016|18558136|P4|STARTED|Second Intervention||1
7539228|NCT03292016|18558137|P3|STARTED|Second Intervention||2
7539229|NCT03292016|18558138|P2|STARTED|Second Intervention||1
7539230|NCT03292016|18558139|P1|STARTED|Second Intervention||1
7539231|NCT03292016|18558134|P6|NOT COMPLETED|First Washout||0
7539232|NCT03292016|18558135|P5|NOT COMPLETED|First Washout||0
7539233|NCT03292016|18558136|P4|NOT COMPLETED|First Washout||0
7539234|NCT03292016|18558137|P3|NOT COMPLETED|First Washout||0
7539235|NCT03292016|18558138|P2|NOT COMPLETED|First Washout||0
7539236|NCT03292016|18558139|P1|NOT COMPLETED|First Washout||0
7539237|NCT03292016|18558134|P6|COMPLETED|First Washout||2
7539238|NCT03292016|18558135|P5|COMPLETED|First Washout||1
7539239|NCT03292016|18558136|P4|COMPLETED|First Washout||1
7539240|NCT03292016|18558137|P3|COMPLETED|First Washout||2
7539241|NCT03292016|18558138|P2|COMPLETED|First Washout||1
7539242|NCT03292016|18558139|P1|COMPLETED|First Washout||1
7539243|NCT03292016|18558134|P6|STARTED|First Washout||2
7539244|NCT03292016|18558135|P5|STARTED|First Washout||1
7539245|NCT03292016|18558136|P4|STARTED|First Washout||1
7539246|NCT03292016|18558137|P3|STARTED|First Washout||2
7539247|NCT03292016|18558138|P2|STARTED|First Washout||1
7539248|NCT03292016|18558139|P1|STARTED|First Washout||1
7539249|NCT03292016|18558134|P6|NOT COMPLETED|First Intervention||0
7539250|NCT03292016|18558135|P5|NOT COMPLETED|First Intervention||0
7539251|NCT03292016|18558136|P4|NOT COMPLETED|First Intervention||0
7539252|NCT03292016|18558137|P3|NOT COMPLETED|First Intervention||0
7539253|NCT03292016|18558138|P2|NOT COMPLETED|First Intervention||0
7539254|NCT03292016|18558139|P1|NOT COMPLETED|First Intervention||0
7539255|NCT03292016|18558134|P6|COMPLETED|First Intervention||2
7539256|NCT03292016|18558135|P5|COMPLETED|First Intervention||1
7539257|NCT03292016|18558136|P4|COMPLETED|First Intervention||1
7539258|NCT03292016|18558137|P3|COMPLETED|First Intervention||2
7539259|NCT03292016|18558138|P2|COMPLETED|First Intervention||1
7539260|NCT03292016|18558139|P1|COMPLETED|First Intervention||1
7539261|NCT03292016|18558134|P6|STARTED|First Intervention||2
7539262|NCT03292016|18558135|P5|STARTED|First Intervention||1
7539263|NCT03292016|18558136|P4|STARTED|First Intervention||1
7539264|NCT03292016|18558137|P3|STARTED|First Intervention||2
7539265|NCT03292016|18558138|P2|STARTED|First Intervention||1
7539266|NCT03292016|18558139|P1|STARTED|First Intervention||1
7539267|NCT03291613|18558177|P1|NOT COMPLETED|Overall Study||1
7539268|NCT03291613|18558177|P1|COMPLETED|Overall Study||12
7539269|NCT03291613|18558177|P1|STARTED|Overall Study||13
7539270|NCT03291288|18558181|P2|NOT COMPLETED|Pexidartinib Only||25
7539271|NCT03291288|18558182|P1|NOT COMPLETED|Pexidartinib Only||0
7539272|NCT03291288|18558181|P2|COMPLETED|Pexidartinib Only||0
7539273|NCT03291288|18558182|P1|COMPLETED|Pexidartinib Only||0
7539274|NCT03291288|18558181|P2|STARTED|Pexidartinib Only|1 participant completed Part 1 but did not enter Part 2.|25
7539275|NCT03291288|18558182|P1|STARTED|Pexidartinib Only|This is a crossover trial; participants who completed Part 1 continued to Part 2.|0
7539276|NCT03291288|18558181|P2|NOT COMPLETED|Drug-drug Interaction Phase||0
7539277|NCT03291288|18558182|P1|NOT COMPLETED|Drug-drug Interaction Phase||7
7539278|NCT03291288|18558181|P2|COMPLETED|Drug-drug Interaction Phase||0
7539279|NCT03291288|18558182|P1|COMPLETED|Drug-drug Interaction Phase||25
7539280|NCT03291288|18558181|P2|Ongoing|Drug-drug Interaction Phase||0
7539281|NCT03291288|18558182|P1|Ongoing|Drug-drug Interaction Phase||1
7539282|NCT03291288|18558181|P2|STARTED|Drug-drug Interaction Phase||0
7539283|NCT03291288|18558182|P1|STARTED|Drug-drug Interaction Phase||32
7539284|NCT03291197|18558224|P1|NOT COMPLETED|Overall Study||0
7539285|NCT03291197|18558224|P1|COMPLETED|Overall Study||5
7539286|NCT03291197|18558224|P1|STARTED|Overall Study||5
7539287|NCT03290768|18558232|P1|NOT COMPLETED|Overall Study||165
7539288|NCT03290768|18558232|P1|COMPLETED|Overall Study||193
7539289|NCT03290768|18558232|P1|STARTED|Overall Study||358
7539290|NCT03290378|18558246|P3|NOT COMPLETED|Overall Study||16
7539291|NCT03290378|18558247|P2|NOT COMPLETED|Overall Study||10
7539292|NCT03290378|18558248|P1|NOT COMPLETED|Overall Study||3
7539293|NCT03290378|18558246|P3|COMPLETED|Overall Study||120
7539294|NCT03290378|18558247|P2|COMPLETED|Overall Study||123
7539295|NCT03290378|18558248|P1|COMPLETED|Overall Study||137
7539296|NCT03290378|18558246|P3|STARTED|Overall Study||136
7539297|NCT03290378|18558247|P2|STARTED|Overall Study||133
7539298|NCT03290378|18558248|P1|STARTED|Overall Study||140
7539299|NCT03290300|18558256|P1|NOT COMPLETED|Overall Study||3
7539300|NCT03290300|18558256|P1|COMPLETED|Overall Study||36
7539301|NCT03290300|18558256|P1|STARTED|Overall Study||39
7539302|NCT03290027|18558267|P2|NOT COMPLETED|Overall Study||45
7539303|NCT03290027|18558268|P1|NOT COMPLETED|Overall Study||58
7539304|NCT03290027|18558267|P2|COMPLETED|Overall Study||228
7539305|NCT03290027|18558268|P1|COMPLETED|Overall Study||219
7539306|NCT03290027|18558267|P2|STARTED|Overall Study||273
7539307|NCT03290027|18558268|P1|STARTED|Overall Study||277
7539308|NCT03289858|18558280|P2|NOT COMPLETED|Overall Study||0
7539309|NCT03289858|18558281|P1|NOT COMPLETED|Overall Study||2
7539310|NCT03289858|18558280|P2|COMPLETED|Overall Study||28
7539311|NCT03289858|18558281|P1|COMPLETED|Overall Study||25
7539312|NCT03289858|18558280|P2|STARTED|Overall Study||28
7539313|NCT03289858|18558281|P1|STARTED|Overall Study||27
7539314|NCT03289676|18558289|P2|NOT COMPLETED|Overall Study||1
7539315|NCT03289676|18558290|P1|NOT COMPLETED|Overall Study||4
7539316|NCT03289676|18558289|P2|COMPLETED|Overall Study|Received 80% of the allotted intervention|25
7539317|NCT03289676|18558290|P1|COMPLETED|Overall Study||23
7539318|NCT03289676|18558289|P2|STARTED|Overall Study||26
7539319|NCT03289676|18558290|P1|STARTED|Overall Study||27
7539320|NCT03289533|18558300|P1|NOT COMPLETED|Overall Study||22
7539321|NCT03289533|18558300|P1|COMPLETED|Overall Study||0
7539322|NCT03289533|18558300|P1|STARTED|Overall Study||22
7539323|NCT03289481|18558323|P2|NOT COMPLETED|Overall Study||2
7539324|NCT03289481|18558324|P1|NOT COMPLETED|Overall Study||2
7539325|NCT03289481|18558323|P2|COMPLETED|Overall Study||5
7539326|NCT03289481|18558324|P1|COMPLETED|Overall Study||4
7539327|NCT03289481|18558323|P2|STARTED|Overall Study||7
7539328|NCT03289481|18558324|P1|STARTED|Overall Study||6
7539329|NCT03289234|18558339|P3|NOT COMPLETED|Overall Study||0
7539330|NCT03289234|18558340|P2|NOT COMPLETED|Overall Study||0
7539331|NCT03289234|18558341|P1|NOT COMPLETED|Overall Study||0
7539332|NCT03289234|18558339|P3|COMPLETED|Overall Study||8
7539333|NCT03289234|18558340|P2|COMPLETED|Overall Study||6
7539334|NCT03289234|18558341|P1|COMPLETED|Overall Study||8
7539335|NCT03289234|18558339|P3|STARTED|Overall Study||8
7539336|NCT03289234|18558340|P2|STARTED|Overall Study||6
7539337|NCT03289234|18558341|P1|STARTED|Overall Study||8
7539338|NCT03289208|18558361|P3|NOT COMPLETED|Overall Study||0
7539339|NCT03289208|18558362|P2|NOT COMPLETED|Overall Study||0
7539340|NCT03289208|18558363|P1|NOT COMPLETED|Overall Study||1
7539341|NCT03289208|18558361|P3|COMPLETED|Overall Study||11
7539342|NCT03289208|18558362|P2|COMPLETED|Overall Study||8
7539343|NCT03289208|18558363|P1|COMPLETED|Overall Study||10
7539344|NCT03289208|18558361|P3|STARTED|Overall Study||11
7539345|NCT03289208|18558362|P2|STARTED|Overall Study||8
7539346|NCT03289208|18558363|P1|STARTED|Overall Study||11
7539347|NCT03288779|18558380|P1|NOT COMPLETED|Overall Study||3
7539348|NCT03288779|18558380|P1|COMPLETED|Overall Study||3
7539349|NCT03288779|18558380|P1|STARTED|Overall Study||6
7539350|NCT03287869|18558387|P2|NOT COMPLETED|Overall Study||93
7539351|NCT03287869|18558388|P1|NOT COMPLETED|Overall Study||83
7539352|NCT03287869|18558387|P2|COMPLETED|Overall Study||100
7539353|NCT03287869|18558388|P1|COMPLETED|Overall Study||105
7539354|NCT03287869|18558387|P2|Analyzed For Safety (Safety Sample)|Overall Study||184
7539355|NCT03287869|18558388|P1|Analyzed For Safety (Safety Sample)|Overall Study||184
7539356|NCT03287869|18558387|P2|STARTED|Overall Study||193
7539357|NCT03287869|18558388|P1|STARTED|Overall Study||188
7539358|NCT03287843|18558396|P2|NOT COMPLETED|Overall Study||8
7539359|NCT03287843|18558397|P1|NOT COMPLETED|Overall Study||15
7539360|NCT03287843|18558396|P2|COMPLETED|Overall Study||167
7539361|NCT03287843|18558397|P1|COMPLETED|Overall Study||160
7539362|NCT03287843|18558396|P2|Lost to Follow up|Overall Study||0
7539363|NCT03287843|18558397|P1|Lost to Follow up|Overall Study||3
7539364|NCT03287843|18558396|P2|Excluded|Overall Study|No surgery n=4 R2 resection n=2 Stage IV n=2|8
7539365|NCT03287843|18558397|P1|Excluded|Overall Study|No surgery n=5 R2 resection n=5 Stage IV n=2|12
7539366|NCT03287843|18558396|P2|STARTED|Overall Study||175
7539367|NCT03287843|18558397|P1|STARTED|Overall Study||175
7539368|NCT03287804|18558409|P1|NOT COMPLETED|Overall Study||11
7539369|NCT03287804|18558409|P1|COMPLETED|Overall Study||1
7539370|NCT03287804|18558409|P1|Received Study Treatment|Overall Study||11
7539371|NCT03287804|18558409|P1|Started Pre-conditioning Therapy|Overall Study||11
7539372|NCT03287804|18558409|P1|Leukaperesed|Overall Study||12
7539373|NCT03287804|18558409|P1|STARTED|Overall Study||12
7539374|NCT03287791|18558425|P3|NOT COMPLETED|Overall Study||36
7539375|NCT03287791|18558426|P2|NOT COMPLETED|Overall Study||36
7539376|NCT03287791|18558427|P1|NOT COMPLETED|Overall Study||32
7539377|NCT03287791|18558425|P3|COMPLETED|Overall Study||264
7539378|NCT03287791|18558426|P2|COMPLETED|Overall Study||276
7539379|NCT03287791|18558427|P1|COMPLETED|Overall Study||280
7539380|NCT03287791|18558425|P3|PP Population|Overall Study||245
7539381|NCT03287791|18558426|P2|PP Population|Overall Study||259
7539382|NCT03287791|18558427|P1|PP Population|Overall Study||262
7539383|NCT03287791|18558425|P3|mITT Population|Overall Study||283
7539384|NCT03287791|18558426|P2|mITT Population|Overall Study||291
7539385|NCT03287791|18558427|P1|mITT Population|Overall Study||291
7539386|NCT03287791|18558425|P3|Safety Population|Overall Study||291
7539387|NCT03287791|18558426|P2|Safety Population|Overall Study||297
7539388|NCT03287791|18558427|P1|Safety Population|Overall Study||306
7539389|NCT03287791|18558425|P3|STARTED|Overall Study||300
7539390|NCT03287791|18558426|P2|STARTED|Overall Study||312
7539391|NCT03287791|18558427|P1|STARTED|Overall Study||312
7539392|NCT03287622|18558440|P2|NOT COMPLETED|Overall Study||48
7539393|NCT03287622|18558441|P1|NOT COMPLETED|Overall Study||58
7539394|NCT03287622|18558440|P2|COMPLETED|Overall Study||308
7539395|NCT03287622|18558441|P1|COMPLETED|Overall Study||298
7539396|NCT03287622|18558440|P2|Sub-randomized to Nudge/NoNudge|Overall Study||266
7539397|NCT03287622|18558441|P1|Sub-randomized to Nudge/NoNudge|Overall Study||253
7539398|NCT03287622|18558440|P2|STARTED|Overall Study||356
7539399|NCT03287622|18558441|P1|STARTED|Overall Study||356
7539400|NCT03287089|18558463|P2|NOT COMPLETED|Overall Study||6
7539401|NCT03287089|18558464|P1|NOT COMPLETED|Overall Study||0
7539402|NCT03287089|18558463|P2|COMPLETED|Overall Study||76
7539403|NCT03287089|18558464|P1|COMPLETED|Overall Study||82
7539404|NCT03287089|18558463|P2|STARTED|Overall Study||82
7539405|NCT03287089|18558464|P1|STARTED|Overall Study||82
7539406|NCT03286829|18558478|P4|NOT COMPLETED|Overall Study||0
7539407|NCT03286829|18558479|P3|NOT COMPLETED|Overall Study||0
7539408|NCT03286829|18558480|P2|NOT COMPLETED|Overall Study||0
7539409|NCT03286829|18558481|P1|NOT COMPLETED|Overall Study||0
7539410|NCT03286829|18558478|P4|COMPLETED|Overall Study||15
7539411|NCT03286829|18558479|P3|COMPLETED|Overall Study||15
7539412|NCT03286829|18558480|P2|COMPLETED|Overall Study||15
7539413|NCT03286829|18558481|P1|COMPLETED|Overall Study||15
7539414|NCT03286829|18558478|P4|STARTED|Overall Study||15
7539415|NCT03286829|18558479|P3|STARTED|Overall Study||15
7539416|NCT03286829|18558480|P2|STARTED|Overall Study||15
7539417|NCT03286829|18558481|P1|STARTED|Overall Study||15
7539418|NCT03286751|18558499|P6|NOT COMPLETED|Period 6||0
7539419|NCT03286751|18558500|P5|NOT COMPLETED|Period 6||0
7539420|NCT03286751|18558501|P4|NOT COMPLETED|Period 6||0
7539421|NCT03286751|18558502|P3|NOT COMPLETED|Period 6||0
7539422|NCT03286751|18558503|P2|NOT COMPLETED|Period 6||0
7539423|NCT03286751|18558504|P1|NOT COMPLETED|Period 6||0
7539424|NCT03286751|18558499|P6|COMPLETED|Period 6||7
7539425|NCT03286751|18558500|P5|COMPLETED|Period 6||5
7539426|NCT03286751|18558501|P4|COMPLETED|Period 6||7
7539427|NCT03286751|18558502|P3|COMPLETED|Period 6||7
7539428|NCT03286751|18558503|P2|COMPLETED|Period 6||6
7539429|NCT03286751|18558504|P1|COMPLETED|Period 6||7
7539430|NCT03286751|18558499|P6|STARTED|Period 6||7
7539431|NCT03286751|18558500|P5|STARTED|Period 6||5
7539432|NCT03286751|18558501|P4|STARTED|Period 6||7
7539433|NCT03286751|18558502|P3|STARTED|Period 6||7
7539434|NCT03286751|18558503|P2|STARTED|Period 6||6
7539435|NCT03286751|18558504|P1|STARTED|Period 6||7
7539436|NCT03286751|18558499|P6|NOT COMPLETED|Washout Period 5||0
7539437|NCT03286751|18558500|P5|NOT COMPLETED|Washout Period 5||1
7539438|NCT03286751|18558501|P4|NOT COMPLETED|Washout Period 5||0
7539439|NCT03286751|18558502|P3|NOT COMPLETED|Washout Period 5||0
7539440|NCT03286751|18558503|P2|NOT COMPLETED|Washout Period 5||0
7539441|NCT03286751|18558504|P1|NOT COMPLETED|Washout Period 5||0
7539442|NCT03286751|18558499|P6|COMPLETED|Washout Period 5||7
7539443|NCT03286751|18558500|P5|COMPLETED|Washout Period 5||5
7539444|NCT03286751|18558501|P4|COMPLETED|Washout Period 5||7
7539445|NCT03286751|18558502|P3|COMPLETED|Washout Period 5||7
7539446|NCT03286751|18558503|P2|COMPLETED|Washout Period 5||6
7539447|NCT03286751|18558504|P1|COMPLETED|Washout Period 5||7
7539448|NCT03286751|18558499|P6|STARTED|Washout Period 5||7
7539449|NCT03286751|18558500|P5|STARTED|Washout Period 5||6
7539450|NCT03286751|18558501|P4|STARTED|Washout Period 5||7
7539451|NCT03286751|18558502|P3|STARTED|Washout Period 5||7
7539452|NCT03286751|18558503|P2|STARTED|Washout Period 5||6
7539453|NCT03286751|18558504|P1|STARTED|Washout Period 5||7
7539454|NCT03286751|18558499|P6|NOT COMPLETED|Period 5||0
7539455|NCT03286751|18558500|P5|NOT COMPLETED|Period 5||0
7539456|NCT03286751|18558501|P4|NOT COMPLETED|Period 5||0
7539457|NCT03286751|18558502|P3|NOT COMPLETED|Period 5||0
7539458|NCT03286751|18558503|P2|NOT COMPLETED|Period 5||0
7539459|NCT03286751|18558504|P1|NOT COMPLETED|Period 5||0
7539460|NCT03286751|18558499|P6|COMPLETED|Period 5||7
7539461|NCT03286751|18558500|P5|COMPLETED|Period 5||6
7539462|NCT03286751|18558501|P4|COMPLETED|Period 5||7
7539463|NCT03286751|18558502|P3|COMPLETED|Period 5||7
7539464|NCT03286751|18558503|P2|COMPLETED|Period 5||6
7539465|NCT03286751|18558504|P1|COMPLETED|Period 5||7
7539466|NCT03286751|18558499|P6|STARTED|Period 5||7
7539467|NCT03286751|18558500|P5|STARTED|Period 5||6
7539468|NCT03286751|18558501|P4|STARTED|Period 5||7
7539469|NCT03286751|18558502|P3|STARTED|Period 5||7
7539470|NCT03286751|18558503|P2|STARTED|Period 5||6
7539471|NCT03286751|18558504|P1|STARTED|Period 5||7
7539472|NCT03286751|18558499|P6|NOT COMPLETED|Washout Period 4||0
7539473|NCT03286751|18558500|P5|NOT COMPLETED|Washout Period 4||0
7539474|NCT03286751|18558501|P4|NOT COMPLETED|Washout Period 4||0
7539475|NCT03286751|18558502|P3|NOT COMPLETED|Washout Period 4||0
7539476|NCT03286751|18558503|P2|NOT COMPLETED|Washout Period 4||0
7539477|NCT03286751|18558504|P1|NOT COMPLETED|Washout Period 4||0
7539478|NCT03286751|18558499|P6|COMPLETED|Washout Period 4||7
7539479|NCT03286751|18558500|P5|COMPLETED|Washout Period 4||6
7539480|NCT03286751|18558501|P4|COMPLETED|Washout Period 4||7
7539481|NCT03286751|18558502|P3|COMPLETED|Washout Period 4||7
7539482|NCT03286751|18558503|P2|COMPLETED|Washout Period 4||6
7539483|NCT03286751|18558504|P1|COMPLETED|Washout Period 4||7
7539484|NCT03286751|18558499|P6|STARTED|Washout Period 4||7
7539485|NCT03286751|18558500|P5|STARTED|Washout Period 4||6
7539486|NCT03286751|18558501|P4|STARTED|Washout Period 4||7
7539487|NCT03286751|18558502|P3|STARTED|Washout Period 4||7
7539488|NCT03286751|18558503|P2|STARTED|Washout Period 4||6
7539489|NCT03286751|18558504|P1|STARTED|Washout Period 4||7
7539490|NCT03286751|18558499|P6|NOT COMPLETED|Period 4||0
7539491|NCT03286751|18558500|P5|NOT COMPLETED|Period 4||0
7539492|NCT03286751|18558501|P4|NOT COMPLETED|Period 4||0
7539493|NCT03286751|18558502|P3|NOT COMPLETED|Period 4||0
7539494|NCT03286751|18558503|P2|NOT COMPLETED|Period 4||0
7539495|NCT03286751|18558504|P1|NOT COMPLETED|Period 4||0
7539496|NCT03286751|18558499|P6|COMPLETED|Period 4||7
7539497|NCT03286751|18558500|P5|COMPLETED|Period 4||6
7539498|NCT03286751|18558501|P4|COMPLETED|Period 4||7
7539499|NCT03286751|18558502|P3|COMPLETED|Period 4||7
7539500|NCT03286751|18558503|P2|COMPLETED|Period 4||6
7539501|NCT03286751|18558504|P1|COMPLETED|Period 4||7
7539502|NCT03286751|18558499|P6|STARTED|Period 4||7
7539503|NCT03286751|18558500|P5|STARTED|Period 4||6
7539504|NCT03286751|18558501|P4|STARTED|Period 4||7
7539505|NCT03286751|18558502|P3|STARTED|Period 4||7
7539506|NCT03286751|18558503|P2|STARTED|Period 4||6
7539507|NCT03286751|18558504|P1|STARTED|Period 4||7
7539508|NCT03286751|18558499|P6|NOT COMPLETED|Washout Period 3||0
7539509|NCT03286751|18558500|P5|NOT COMPLETED|Washout Period 3||0
7539510|NCT03286751|18558501|P4|NOT COMPLETED|Washout Period 3||0
7539511|NCT03286751|18558502|P3|NOT COMPLETED|Washout Period 3||0
7539512|NCT03286751|18558503|P2|NOT COMPLETED|Washout Period 3||0
7539513|NCT03286751|18558504|P1|NOT COMPLETED|Washout Period 3||0
7539514|NCT03286751|18558499|P6|COMPLETED|Washout Period 3||7
7539515|NCT03286751|18558500|P5|COMPLETED|Washout Period 3||6
7539516|NCT03286751|18558501|P4|COMPLETED|Washout Period 3||7
7539517|NCT03286751|18558502|P3|COMPLETED|Washout Period 3||7
7539518|NCT03286751|18558503|P2|COMPLETED|Washout Period 3||6
7539519|NCT03286751|18558504|P1|COMPLETED|Washout Period 3||7
7539520|NCT03286751|18558499|P6|STARTED|Washout Period 3||7
7539521|NCT03286751|18558500|P5|STARTED|Washout Period 3||6
7539522|NCT03286751|18558501|P4|STARTED|Washout Period 3||7
7539523|NCT03286751|18558502|P3|STARTED|Washout Period 3||7
7539524|NCT03286751|18558503|P2|STARTED|Washout Period 3||6
7539525|NCT03286751|18558504|P1|STARTED|Washout Period 3||7
7539526|NCT03286751|18558499|P6|NOT COMPLETED|Period 3||0
7539527|NCT03286751|18558500|P5|NOT COMPLETED|Period 3||0
7539528|NCT03286751|18558501|P4|NOT COMPLETED|Period 3||0
7539529|NCT03286751|18558502|P3|NOT COMPLETED|Period 3||0
7539530|NCT03286751|18558503|P2|NOT COMPLETED|Period 3||0
7539531|NCT03286751|18558504|P1|NOT COMPLETED|Period 3||0
7539532|NCT03286751|18558499|P6|COMPLETED|Period 3||7
7539533|NCT03286751|18558500|P5|COMPLETED|Period 3||6
7539534|NCT03286751|18558501|P4|COMPLETED|Period 3||7
7539535|NCT03286751|18558502|P3|COMPLETED|Period 3||7
7539536|NCT03286751|18558503|P2|COMPLETED|Period 3||6
7539537|NCT03286751|18558504|P1|COMPLETED|Period 3||7
7539538|NCT03286751|18558499|P6|STARTED|Period 3||7
7539539|NCT03286751|18558500|P5|STARTED|Period 3||6
7539540|NCT03286751|18558501|P4|STARTED|Period 3||7
7539541|NCT03286751|18558502|P3|STARTED|Period 3||7
7539542|NCT03286751|18558503|P2|STARTED|Period 3||6
7539543|NCT03286751|18558504|P1|STARTED|Period 3||7
7539544|NCT03286751|18558499|P6|NOT COMPLETED|Washout Period 2||0
7539545|NCT03286751|18558500|P5|NOT COMPLETED|Washout Period 2||0
7539546|NCT03286751|18558501|P4|NOT COMPLETED|Washout Period 2||0
7539547|NCT03286751|18558502|P3|NOT COMPLETED|Washout Period 2||0
7539548|NCT03286751|18558503|P2|NOT COMPLETED|Washout Period 2||1
7539549|NCT03286751|18558504|P1|NOT COMPLETED|Washout Period 2||0
7539550|NCT03286751|18558499|P6|COMPLETED|Washout Period 2||7
7539551|NCT03286751|18558500|P5|COMPLETED|Washout Period 2||6
7539552|NCT03286751|18558501|P4|COMPLETED|Washout Period 2||7
7539553|NCT03286751|18558502|P3|COMPLETED|Washout Period 2||7
7539554|NCT03286751|18558503|P2|COMPLETED|Washout Period 2||6
7539555|NCT03286751|18558504|P1|COMPLETED|Washout Period 2||7
7539556|NCT03286751|18558499|P6|STARTED|Washout Period 2||7
7539557|NCT03286751|18558500|P5|STARTED|Washout Period 2||6
7539558|NCT03286751|18558501|P4|STARTED|Washout Period 2||7
7539559|NCT03286751|18558502|P3|STARTED|Washout Period 2||7
7539560|NCT03286751|18558503|P2|STARTED|Washout Period 2||7
7539561|NCT03286751|18558504|P1|STARTED|Washout Period 2||7
7539562|NCT03286751|18558499|P6|NOT COMPLETED|Period 2||0
7539563|NCT03286751|18558500|P5|NOT COMPLETED|Period 2||0
7539564|NCT03286751|18558501|P4|NOT COMPLETED|Period 2||0
7539565|NCT03286751|18558502|P3|NOT COMPLETED|Period 2||0
7539566|NCT03286751|18558503|P2|NOT COMPLETED|Period 2||0
7539567|NCT03286751|18558504|P1|NOT COMPLETED|Period 2||0
7539568|NCT03286751|18558499|P6|COMPLETED|Period 2||7
7539569|NCT03286751|18558500|P5|COMPLETED|Period 2||6
7539570|NCT03286751|18558501|P4|COMPLETED|Period 2||7
7539571|NCT03286751|18558502|P3|COMPLETED|Period 2||7
7539572|NCT03286751|18558503|P2|COMPLETED|Period 2||7
7539573|NCT03286751|18558504|P1|COMPLETED|Period 2||7
7539574|NCT03286751|18558499|P6|STARTED|Period 2||7
7539575|NCT03286751|18558500|P5|STARTED|Period 2||6
7539576|NCT03286751|18558501|P4|STARTED|Period 2||7
7539577|NCT03286751|18558502|P3|STARTED|Period 2||7
7539578|NCT03286751|18558503|P2|STARTED|Period 2||7
7539579|NCT03286751|18558504|P1|STARTED|Period 2||7
7539580|NCT03286751|18558499|P6|NOT COMPLETED|Washout Period 1||0
7539581|NCT03286751|18558500|P5|NOT COMPLETED|Washout Period 1||1
7539582|NCT03286751|18558501|P4|NOT COMPLETED|Washout Period 1||0
7539583|NCT03286751|18558502|P3|NOT COMPLETED|Washout Period 1||0
7539584|NCT03286751|18558503|P2|NOT COMPLETED|Washout Period 1||0
7539585|NCT03286751|18558504|P1|NOT COMPLETED|Washout Period 1||0
7539586|NCT03286751|18558499|P6|COMPLETED|Washout Period 1||7
7539587|NCT03286751|18558500|P5|COMPLETED|Washout Period 1||6
7539588|NCT03286751|18558501|P4|COMPLETED|Washout Period 1||7
7539589|NCT03286751|18558502|P3|COMPLETED|Washout Period 1||7
7539590|NCT03286751|18558503|P2|COMPLETED|Washout Period 1||7
7539591|NCT03286751|18558504|P1|COMPLETED|Washout Period 1||7
7539592|NCT03286751|18558499|P6|STARTED|Washout Period 1||7
7539593|NCT03286751|18558500|P5|STARTED|Washout Period 1||7
7539594|NCT03286751|18558501|P4|STARTED|Washout Period 1||7
7539595|NCT03286751|18558502|P3|STARTED|Washout Period 1||7
7539596|NCT03286751|18558503|P2|STARTED|Washout Period 1||7
7539597|NCT03286751|18558504|P1|STARTED|Washout Period 1||7
7539598|NCT03286751|18558499|P6|NOT COMPLETED|Period 1||0
7539599|NCT03286751|18558500|P5|NOT COMPLETED|Period 1||0
7539600|NCT03286751|18558501|P4|NOT COMPLETED|Period 1||0
7539601|NCT03286751|18558502|P3|NOT COMPLETED|Period 1||0
7539602|NCT03286751|18558503|P2|NOT COMPLETED|Period 1||0
7539603|NCT03286751|18558504|P1|NOT COMPLETED|Period 1||0
7539604|NCT03286751|18558499|P6|COMPLETED|Period 1||7
7539605|NCT03286751|18558500|P5|COMPLETED|Period 1||7
7539606|NCT03286751|18558501|P4|COMPLETED|Period 1||7
7539607|NCT03286751|18558502|P3|COMPLETED|Period 1||7
7539608|NCT03286751|18558503|P2|COMPLETED|Period 1||7
7539609|NCT03286751|18558504|P1|COMPLETED|Period 1||7
7539610|NCT03286751|18558499|P6|Received at Least One Dose of Study Drug|Period 1||7
7539611|NCT03286751|18558500|P5|Received at Least One Dose of Study Drug|Period 1||7
7539612|NCT03286751|18558501|P4|Received at Least One Dose of Study Drug|Period 1||7
7539613|NCT03286751|18558502|P3|Received at Least One Dose of Study Drug|Period 1||7
7539614|NCT03286751|18558503|P2|Received at Least One Dose of Study Drug|Period 1||7
7539615|NCT03286751|18558504|P1|Received at Least One Dose of Study Drug|Period 1||7
7539616|NCT03286751|18558499|P6|STARTED|Period 1||7
7539617|NCT03286751|18558500|P5|STARTED|Period 1||7
7539618|NCT03286751|18558501|P4|STARTED|Period 1||7
7539619|NCT03286751|18558502|P3|STARTED|Period 1||7
7539620|NCT03286751|18558503|P2|STARTED|Period 1||7
7539621|NCT03286751|18558504|P1|STARTED|Period 1||7
7539622|NCT03286400|18558524|P1|NOT COMPLETED|Overall Study||25
7539623|NCT03286400|18558524|P1|COMPLETED|Overall Study||102
7539624|NCT03286400|18558524|P1|STARTED|Overall Study||127
7539625|NCT03286283|18558537|P1|NOT COMPLETED|Overall Study||0
7539626|NCT03286283|18558537|P1|COMPLETED|Overall Study||55
7539627|NCT03286283|18558537|P1|STARTED|Overall Study||55
7539628|NCT03286218|18558553|P12|NOT COMPLETED|Treatment Phase Period 5||0
7539629|NCT03286218|18558554|P11|NOT COMPLETED|Treatment Phase Period 5||0
7539630|NCT03286218|18558555|P10|NOT COMPLETED|Treatment Phase Period 5||0
7539631|NCT03286218|18558556|P9|NOT COMPLETED|Treatment Phase Period 5||0
7539632|NCT03286218|18558557|P8|NOT COMPLETED|Treatment Phase Period 5||0
7539633|NCT03286218|18558558|P7|NOT COMPLETED|Treatment Phase Period 5||0
7539634|NCT03286218|18558559|P6|NOT COMPLETED|Treatment Phase Period 5||0
7539635|NCT03286218|18558560|P5|NOT COMPLETED|Treatment Phase Period 5||0
7539636|NCT03286218|18558561|P4|NOT COMPLETED|Treatment Phase Period 5||0
7539637|NCT03286218|18558562|P3|NOT COMPLETED|Treatment Phase Period 5||0
7539638|NCT03286218|18558563|P2|NOT COMPLETED|Treatment Phase Period 5||0
7539639|NCT03286218|18558564|P1|NOT COMPLETED|Treatment Phase Period 5||0
7539640|NCT03286218|18558553|P12|COMPLETED|Treatment Phase Period 5||4
7539641|NCT03286218|18558554|P11|COMPLETED|Treatment Phase Period 5||5
7539642|NCT03286218|18558555|P10|COMPLETED|Treatment Phase Period 5||6
7539643|NCT03286218|18558556|P9|COMPLETED|Treatment Phase Period 5||6
7539644|NCT03286218|18558557|P8|COMPLETED|Treatment Phase Period 5||6
7539645|NCT03286218|18558558|P7|COMPLETED|Treatment Phase Period 5||6
7539646|NCT03286218|18558559|P6|COMPLETED|Treatment Phase Period 5||5
7539647|NCT03286218|18558560|P5|COMPLETED|Treatment Phase Period 5||5
7539648|NCT03286218|18558561|P4|COMPLETED|Treatment Phase Period 5||5
7539649|NCT03286218|18558562|P3|COMPLETED|Treatment Phase Period 5||5
7539650|NCT03286218|18558563|P2|COMPLETED|Treatment Phase Period 5||0
7539651|NCT03286218|18558564|P1|COMPLETED|Treatment Phase Period 5||0
7539652|NCT03286218|18558553|P12|STARTED|Treatment Phase Period 5||4
7539653|NCT03286218|18558554|P11|STARTED|Treatment Phase Period 5||5
7539654|NCT03286218|18558555|P10|STARTED|Treatment Phase Period 5||6
7539655|NCT03286218|18558556|P9|STARTED|Treatment Phase Period 5||6
7539656|NCT03286218|18558557|P8|STARTED|Treatment Phase Period 5||6
7539657|NCT03286218|18558558|P7|STARTED|Treatment Phase Period 5||6
7539658|NCT03286218|18558559|P6|STARTED|Treatment Phase Period 5||5
7539659|NCT03286218|18558560|P5|STARTED|Treatment Phase Period 5||5
7539660|NCT03286218|18558561|P4|STARTED|Treatment Phase Period 5||5
7539661|NCT03286218|18558562|P3|STARTED|Treatment Phase Period 5||5
7539662|NCT03286218|18558563|P2|STARTED|Treatment Phase Period 5||0
7539663|NCT03286218|18558564|P1|STARTED|Treatment Phase Period 5||0
7539664|NCT03286218|18558553|P12|NOT COMPLETED|Treatment Phase Period 4||1
7539665|NCT03286218|18558554|P11|NOT COMPLETED|Treatment Phase Period 4||0
7539666|NCT03286218|18558555|P10|NOT COMPLETED|Treatment Phase Period 4||0
7539667|NCT03286218|18558556|P9|NOT COMPLETED|Treatment Phase Period 4||0
7539668|NCT03286218|18558557|P8|NOT COMPLETED|Treatment Phase Period 4||0
7539669|NCT03286218|18558558|P7|NOT COMPLETED|Treatment Phase Period 4||0
7539670|NCT03286218|18558559|P6|NOT COMPLETED|Treatment Phase Period 4||0
7539671|NCT03286218|18558560|P5|NOT COMPLETED|Treatment Phase Period 4||0
7539672|NCT03286218|18558561|P4|NOT COMPLETED|Treatment Phase Period 4||0
7539673|NCT03286218|18558562|P3|NOT COMPLETED|Treatment Phase Period 4||0
7539674|NCT03286218|18558563|P2|NOT COMPLETED|Treatment Phase Period 4||0
7539675|NCT03286218|18558564|P1|NOT COMPLETED|Treatment Phase Period 4||0
7539676|NCT03286218|18558553|P12|COMPLETED|Treatment Phase Period 4||4
7539677|NCT03286218|18558554|P11|COMPLETED|Treatment Phase Period 4||5
7539678|NCT03286218|18558555|P10|COMPLETED|Treatment Phase Period 4||6
7539679|NCT03286218|18558556|P9|COMPLETED|Treatment Phase Period 4||6
7539680|NCT03286218|18558557|P8|COMPLETED|Treatment Phase Period 4||6
7539681|NCT03286218|18558558|P7|COMPLETED|Treatment Phase Period 4||6
7539682|NCT03286218|18558559|P6|COMPLETED|Treatment Phase Period 4||5
7539683|NCT03286218|18558560|P5|COMPLETED|Treatment Phase Period 4||5
7539684|NCT03286218|18558561|P4|COMPLETED|Treatment Phase Period 4||5
7539685|NCT03286218|18558562|P3|COMPLETED|Treatment Phase Period 4||5
7539686|NCT03286218|18558563|P2|COMPLETED|Treatment Phase Period 4||0
7539687|NCT03286218|18558564|P1|COMPLETED|Treatment Phase Period 4||0
7539688|NCT03286218|18558553|P12|STARTED|Treatment Phase Period 4||5
7539689|NCT03286218|18558554|P11|STARTED|Treatment Phase Period 4||5
7539690|NCT03286218|18558555|P10|STARTED|Treatment Phase Period 4||6
7539691|NCT03286218|18558556|P9|STARTED|Treatment Phase Period 4||6
7539692|NCT03286218|18558557|P8|STARTED|Treatment Phase Period 4||6
7539693|NCT03286218|18558558|P7|STARTED|Treatment Phase Period 4||6
7539694|NCT03286218|18558559|P6|STARTED|Treatment Phase Period 4||5
7539695|NCT03286218|18558560|P5|STARTED|Treatment Phase Period 4||5
7539696|NCT03286218|18558561|P4|STARTED|Treatment Phase Period 4||5
7539697|NCT03286218|18558562|P3|STARTED|Treatment Phase Period 4||5
7539698|NCT03286218|18558563|P2|STARTED|Treatment Phase Period 4||0
7539699|NCT03286218|18558564|P1|STARTED|Treatment Phase Period 4||0
7539700|NCT03286218|18558553|P12|NOT COMPLETED|Treatment Phase Period 3||0
7539701|NCT03286218|18558554|P11|NOT COMPLETED|Treatment Phase Period 3||0
7539702|NCT03286218|18558555|P10|NOT COMPLETED|Treatment Phase Period 3||0
7539703|NCT03286218|18558556|P9|NOT COMPLETED|Treatment Phase Period 3||0
7539704|NCT03286218|18558557|P8|NOT COMPLETED|Treatment Phase Period 3||0
7539705|NCT03286218|18558558|P7|NOT COMPLETED|Treatment Phase Period 3||0
7539706|NCT03286218|18558559|P6|NOT COMPLETED|Treatment Phase Period 3||0
7539707|NCT03286218|18558560|P5|NOT COMPLETED|Treatment Phase Period 3||0
7539708|NCT03286218|18558561|P4|NOT COMPLETED|Treatment Phase Period 3||0
7539709|NCT03286218|18558562|P3|NOT COMPLETED|Treatment Phase Period 3||0
7539710|NCT03286218|18558563|P2|NOT COMPLETED|Treatment Phase Period 3||0
7539711|NCT03286218|18558564|P1|NOT COMPLETED|Treatment Phase Period 3||0
7539712|NCT03286218|18558553|P12|COMPLETED|Treatment Phase Period 3||5
7539713|NCT03286218|18558554|P11|COMPLETED|Treatment Phase Period 3||5
7539714|NCT03286218|18558555|P10|COMPLETED|Treatment Phase Period 3||6
7539715|NCT03286218|18558556|P9|COMPLETED|Treatment Phase Period 3||6
7539716|NCT03286218|18558557|P8|COMPLETED|Treatment Phase Period 3||6
7539717|NCT03286218|18558558|P7|COMPLETED|Treatment Phase Period 3||6
7539718|NCT03286218|18558559|P6|COMPLETED|Treatment Phase Period 3||5
7539719|NCT03286218|18558560|P5|COMPLETED|Treatment Phase Period 3||5
7539720|NCT03286218|18558561|P4|COMPLETED|Treatment Phase Period 3||5
7539721|NCT03286218|18558562|P3|COMPLETED|Treatment Phase Period 3||5
7539722|NCT03286218|18558563|P2|COMPLETED|Treatment Phase Period 3||0
7539723|NCT03286218|18558564|P1|COMPLETED|Treatment Phase Period 3||0
7539724|NCT03286218|18558553|P12|STARTED|Treatment Phase Period 3||5
7539725|NCT03286218|18558554|P11|STARTED|Treatment Phase Period 3||5
7539726|NCT03286218|18558555|P10|STARTED|Treatment Phase Period 3||6
7539727|NCT03286218|18558556|P9|STARTED|Treatment Phase Period 3||6
7539728|NCT03286218|18558557|P8|STARTED|Treatment Phase Period 3||6
7539729|NCT03286218|18558558|P7|STARTED|Treatment Phase Period 3||6
7539730|NCT03286218|18558559|P6|STARTED|Treatment Phase Period 3||5
7539731|NCT03286218|18558560|P5|STARTED|Treatment Phase Period 3||5
7539732|NCT03286218|18558561|P4|STARTED|Treatment Phase Period 3||5
7539733|NCT03286218|18558562|P3|STARTED|Treatment Phase Period 3||5
7539734|NCT03286218|18558563|P2|STARTED|Treatment Phase Period 3||0
7539735|NCT03286218|18558564|P1|STARTED|Treatment Phase Period 3||0
7539736|NCT03286218|18558553|P12|NOT COMPLETED|Treatment Phase Period 2||0
7539737|NCT03286218|18558554|P11|NOT COMPLETED|Treatment Phase Period 2||0
7539738|NCT03286218|18558555|P10|NOT COMPLETED|Treatment Phase Period 2||0
7539739|NCT03286218|18558556|P9|NOT COMPLETED|Treatment Phase Period 2||0
7539740|NCT03286218|18558557|P8|NOT COMPLETED|Treatment Phase Period 2||0
7539741|NCT03286218|18558558|P7|NOT COMPLETED|Treatment Phase Period 2||0
7539742|NCT03286218|18558559|P6|NOT COMPLETED|Treatment Phase Period 2||0
7539743|NCT03286218|18558560|P5|NOT COMPLETED|Treatment Phase Period 2||0
7539744|NCT03286218|18558561|P4|NOT COMPLETED|Treatment Phase Period 2||0
7539745|NCT03286218|18558562|P3|NOT COMPLETED|Treatment Phase Period 2||0
7539746|NCT03286218|18558563|P2|NOT COMPLETED|Treatment Phase Period 2||0
7539747|NCT03286218|18558564|P1|NOT COMPLETED|Treatment Phase Period 2||0
7539748|NCT03286218|18558553|P12|COMPLETED|Treatment Phase Period 2||5
7539749|NCT03286218|18558554|P11|COMPLETED|Treatment Phase Period 2||5
7539750|NCT03286218|18558555|P10|COMPLETED|Treatment Phase Period 2||6
7539751|NCT03286218|18558556|P9|COMPLETED|Treatment Phase Period 2||6
7539752|NCT03286218|18558557|P8|COMPLETED|Treatment Phase Period 2||6
7539753|NCT03286218|18558558|P7|COMPLETED|Treatment Phase Period 2||6
7539754|NCT03286218|18558559|P6|COMPLETED|Treatment Phase Period 2||5
7539755|NCT03286218|18558560|P5|COMPLETED|Treatment Phase Period 2||5
7539756|NCT03286218|18558561|P4|COMPLETED|Treatment Phase Period 2||5
7539757|NCT03286218|18558562|P3|COMPLETED|Treatment Phase Period 2||5
7539758|NCT03286218|18558563|P2|COMPLETED|Treatment Phase Period 2||0
7539759|NCT03286218|18558564|P1|COMPLETED|Treatment Phase Period 2||0
7539760|NCT03286218|18558553|P12|STARTED|Treatment Phase Period 2||5
7539761|NCT03286218|18558554|P11|STARTED|Treatment Phase Period 2||5
7539762|NCT03286218|18558555|P10|STARTED|Treatment Phase Period 2||6
7539763|NCT03286218|18558556|P9|STARTED|Treatment Phase Period 2||6
7539764|NCT03286218|18558557|P8|STARTED|Treatment Phase Period 2||6
7539765|NCT03286218|18558558|P7|STARTED|Treatment Phase Period 2||6
7539766|NCT03286218|18558559|P6|STARTED|Treatment Phase Period 2||5
7539767|NCT03286218|18558560|P5|STARTED|Treatment Phase Period 2||5
7539768|NCT03286218|18558561|P4|STARTED|Treatment Phase Period 2||5
7539769|NCT03286218|18558562|P3|STARTED|Treatment Phase Period 2||5
7539770|NCT03286218|18558563|P2|STARTED|Treatment Phase Period 2||0
7539771|NCT03286218|18558564|P1|STARTED|Treatment Phase Period 2||0
7539772|NCT03286218|18558553|P12|NOT COMPLETED|Treatment Phase Period 1||1
7539773|NCT03286218|18558554|P11|NOT COMPLETED|Treatment Phase Period 1||0
7539774|NCT03286218|18558555|P10|NOT COMPLETED|Treatment Phase Period 1||0
7539775|NCT03286218|18558556|P9|NOT COMPLETED|Treatment Phase Period 1||0
7539776|NCT03286218|18558557|P8|NOT COMPLETED|Treatment Phase Period 1||0
7539777|NCT03286218|18558558|P7|NOT COMPLETED|Treatment Phase Period 1||0
7539778|NCT03286218|18558559|P6|NOT COMPLETED|Treatment Phase Period 1||1
7539779|NCT03286218|18558560|P5|NOT COMPLETED|Treatment Phase Period 1||0
7539780|NCT03286218|18558561|P4|NOT COMPLETED|Treatment Phase Period 1||1
7539781|NCT03286218|18558562|P3|NOT COMPLETED|Treatment Phase Period 1||1
7539782|NCT03286218|18558563|P2|NOT COMPLETED|Treatment Phase Period 1||0
7539783|NCT03286218|18558564|P1|NOT COMPLETED|Treatment Phase Period 1||0
7539784|NCT03286218|18558553|P12|COMPLETED|Treatment Phase Period 1||5
7539785|NCT03286218|18558554|P11|COMPLETED|Treatment Phase Period 1||5
7539786|NCT03286218|18558555|P10|COMPLETED|Treatment Phase Period 1||6
7539787|NCT03286218|18558556|P9|COMPLETED|Treatment Phase Period 1||6
7539788|NCT03286218|18558557|P8|COMPLETED|Treatment Phase Period 1||6
7539789|NCT03286218|18558558|P7|COMPLETED|Treatment Phase Period 1||6
7539790|NCT03286218|18558559|P6|COMPLETED|Treatment Phase Period 1||5
7539791|NCT03286218|18558560|P5|COMPLETED|Treatment Phase Period 1||5
7539792|NCT03286218|18558561|P4|COMPLETED|Treatment Phase Period 1||5
7539793|NCT03286218|18558562|P3|COMPLETED|Treatment Phase Period 1||5
7539794|NCT03286218|18558563|P2|COMPLETED|Treatment Phase Period 1||0
7539795|NCT03286218|18558564|P1|COMPLETED|Treatment Phase Period 1||0
7539796|NCT03286218|18558553|P12|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
7539797|NCT03286218|18558554|P11|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
7539798|NCT03286218|18558555|P10|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
7539799|NCT03286218|18558556|P9|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
7539800|NCT03286218|18558557|P8|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
7539801|NCT03286218|18558558|P7|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
7539802|NCT03286218|18558559|P6|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
7539803|NCT03286218|18558560|P5|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
7539804|NCT03286218|18558561|P4|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
7539805|NCT03286218|18558562|P3|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
7539806|NCT03286218|18558563|P2|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
7539807|NCT03286218|18558564|P1|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
7539808|NCT03286218|18558553|P12|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
7539809|NCT03286218|18558554|P11|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
7539810|NCT03286218|18558555|P10|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
7539811|NCT03286218|18558556|P9|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
7539812|NCT03286218|18558557|P8|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
7539813|NCT03286218|18558558|P7|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
7539814|NCT03286218|18558559|P6|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
7539815|NCT03286218|18558560|P5|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
7539816|NCT03286218|18558561|P4|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
7539817|NCT03286218|18558562|P3|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
7539818|NCT03286218|18558563|P2|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
7539819|NCT03286218|18558564|P1|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
7539820|NCT03286218|18558553|P12|NOT COMPLETED|Qualification Phase Period 2||0
7539821|NCT03286218|18558554|P11|NOT COMPLETED|Qualification Phase Period 2||0
7539822|NCT03286218|18558555|P10|NOT COMPLETED|Qualification Phase Period 2||0
7539823|NCT03286218|18558556|P9|NOT COMPLETED|Qualification Phase Period 2||0
7539824|NCT03286218|18558557|P8|NOT COMPLETED|Qualification Phase Period 2||0
7539825|NCT03286218|18558558|P7|NOT COMPLETED|Qualification Phase Period 2||0
7539826|NCT03286218|18558559|P6|NOT COMPLETED|Qualification Phase Period 2||0
7539827|NCT03286218|18558560|P5|NOT COMPLETED|Qualification Phase Period 2||0
7539828|NCT03286218|18558561|P4|NOT COMPLETED|Qualification Phase Period 2||0
7539829|NCT03286218|18558562|P3|NOT COMPLETED|Qualification Phase Period 2||0
7539830|NCT03286218|18558563|P2|NOT COMPLETED|Qualification Phase Period 2||19
7539831|NCT03286218|18558564|P1|NOT COMPLETED|Qualification Phase Period 2||17
7539832|NCT03286218|18558553|P12|COMPLETED|Qualification Phase Period 2||0
7539833|NCT03286218|18558554|P11|COMPLETED|Qualification Phase Period 2||0
7539834|NCT03286218|18558555|P10|COMPLETED|Qualification Phase Period 2||0
7539835|NCT03286218|18558556|P9|COMPLETED|Qualification Phase Period 2||0
7539836|NCT03286218|18558557|P8|COMPLETED|Qualification Phase Period 2||0
7539837|NCT03286218|18558558|P7|COMPLETED|Qualification Phase Period 2||0
7539838|NCT03286218|18558559|P6|COMPLETED|Qualification Phase Period 2||0
7539839|NCT03286218|18558560|P5|COMPLETED|Qualification Phase Period 2||0
7539840|NCT03286218|18558561|P4|COMPLETED|Qualification Phase Period 2||0
7539841|NCT03286218|18558562|P3|COMPLETED|Qualification Phase Period 2||0
7539842|NCT03286218|18558563|P2|COMPLETED|Qualification Phase Period 2||28
7539843|NCT03286218|18558564|P1|COMPLETED|Qualification Phase Period 2||30
7539844|NCT03286218|18558553|P12|STARTED|Qualification Phase Period 2||0
7539845|NCT03286218|18558554|P11|STARTED|Qualification Phase Period 2||0
7539846|NCT03286218|18558555|P10|STARTED|Qualification Phase Period 2||0
7539847|NCT03286218|18558556|P9|STARTED|Qualification Phase Period 2||0
7539848|NCT03286218|18558557|P8|STARTED|Qualification Phase Period 2||0
7539849|NCT03286218|18558558|P7|STARTED|Qualification Phase Period 2||0
7539850|NCT03286218|18558559|P6|STARTED|Qualification Phase Period 2||0
7539851|NCT03286218|18558560|P5|STARTED|Qualification Phase Period 2||0
7539852|NCT03286218|18558561|P4|STARTED|Qualification Phase Period 2||0
7539853|NCT03286218|18558562|P3|STARTED|Qualification Phase Period 2||0
7539854|NCT03286218|18558563|P2|STARTED|Qualification Phase Period 2||47
7539855|NCT03286218|18558564|P1|STARTED|Qualification Phase Period 2||47
7539856|NCT03286218|18558553|P12|NOT COMPLETED|Qualification Phase Period 1||0
7539857|NCT03286218|18558554|P11|NOT COMPLETED|Qualification Phase Period 1||0
7539858|NCT03286218|18558555|P10|NOT COMPLETED|Qualification Phase Period 1||0
7539859|NCT03286218|18558556|P9|NOT COMPLETED|Qualification Phase Period 1||0
7539860|NCT03286218|18558557|P8|NOT COMPLETED|Qualification Phase Period 1||0
7539861|NCT03286218|18558558|P7|NOT COMPLETED|Qualification Phase Period 1||0
7539862|NCT03286218|18558559|P6|NOT COMPLETED|Qualification Phase Period 1||0
7539863|NCT03286218|18558560|P5|NOT COMPLETED|Qualification Phase Period 1||0
7539864|NCT03286218|18558561|P4|NOT COMPLETED|Qualification Phase Period 1||0
7539865|NCT03286218|18558562|P3|NOT COMPLETED|Qualification Phase Period 1||0
7539866|NCT03286218|18558563|P2|NOT COMPLETED|Qualification Phase Period 1||1
7539867|NCT03286218|18558564|P1|NOT COMPLETED|Qualification Phase Period 1||1
7539868|NCT03286218|18558553|P12|COMPLETED|Qualification Phase Period 1||0
7539869|NCT03286218|18558554|P11|COMPLETED|Qualification Phase Period 1||0
7539870|NCT03286218|18558555|P10|COMPLETED|Qualification Phase Period 1||0
7539871|NCT03286218|18558556|P9|COMPLETED|Qualification Phase Period 1||0
7539872|NCT03286218|18558557|P8|COMPLETED|Qualification Phase Period 1||0
7539873|NCT03286218|18558558|P7|COMPLETED|Qualification Phase Period 1||0
7539874|NCT03286218|18558559|P6|COMPLETED|Qualification Phase Period 1||0
7539875|NCT03286218|18558560|P5|COMPLETED|Qualification Phase Period 1||0
7539876|NCT03286218|18558561|P4|COMPLETED|Qualification Phase Period 1||0
7539877|NCT03286218|18558562|P3|COMPLETED|Qualification Phase Period 1||0
7539878|NCT03286218|18558563|P2|COMPLETED|Qualification Phase Period 1||47
7539879|NCT03286218|18558564|P1|COMPLETED|Qualification Phase Period 1||47
7539880|NCT03286218|18558553|P12|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
7539881|NCT03286218|18558554|P11|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
7539959|NCT03285542|18558664|P1|COMPLETED|Overall Study||30
7539882|NCT03286218|18558555|P10|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
7539883|NCT03286218|18558556|P9|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
7539884|NCT03286218|18558557|P8|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
7539885|NCT03286218|18558558|P7|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
7539886|NCT03286218|18558559|P6|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
7539887|NCT03286218|18558560|P5|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
7539888|NCT03286218|18558561|P4|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
7539889|NCT03286218|18558562|P3|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
7539890|NCT03286218|18558563|P2|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
7539891|NCT03286218|18558564|P1|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
7539892|NCT03286218|18558553|P12|STARTED|Qualification Phase Period 1||0
7539893|NCT03286218|18558554|P11|STARTED|Qualification Phase Period 1||0
7539894|NCT03286218|18558555|P10|STARTED|Qualification Phase Period 1||0
7539895|NCT03286218|18558556|P9|STARTED|Qualification Phase Period 1||0
7539896|NCT03286218|18558557|P8|STARTED|Qualification Phase Period 1||0
7539897|NCT03286218|18558558|P7|STARTED|Qualification Phase Period 1||0
7539898|NCT03286218|18558559|P6|STARTED|Qualification Phase Period 1||0
7539899|NCT03286218|18558560|P5|STARTED|Qualification Phase Period 1||0
7539900|NCT03286218|18558561|P4|STARTED|Qualification Phase Period 1||0
7539901|NCT03286218|18558562|P3|STARTED|Qualification Phase Period 1||0
7539902|NCT03286218|18558563|P2|STARTED|Qualification Phase Period 1||48
7539903|NCT03286218|18558564|P1|STARTED|Qualification Phase Period 1||48
7539904|NCT03285984|18558606|P1|NOT COMPLETED|Overall Study||0
7539905|NCT03285984|18558606|P1|COMPLETED|Overall Study||56
7539906|NCT03285984|18558606|P1|Received Test Product 4|Overall Study||56
7539907|NCT03285984|18558606|P1|Received Test Product 3|Overall Study||56
7539908|NCT03285984|18558606|P1|Received Test Product 2|Overall Study||56
7539909|NCT03285984|18558606|P1|Received Test Product 1|Overall Study||56
7539910|NCT03285984|18558606|P1|STARTED|Overall Study||56
7539911|NCT03285724|18558618|P1|NOT COMPLETED|Overall Study||0
7539912|NCT03285724|18558618|P1|COMPLETED|Overall Study||1
7539913|NCT03285724|18558618|P1|STARTED|Overall Study||1
7539914|NCT03285711|18558627|P4|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
7539915|NCT03285711|18558628|P3|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
7539916|NCT03285711|18558629|P2|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
7539917|NCT03285711|18558630|P1|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
7539918|NCT03285711|18558627|P4|COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
7539919|NCT03285711|18558628|P3|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
7539920|NCT03285711|18558629|P2|COMPLETED|Extended Blinded Phase (Week 32 to 52)||2
7539921|NCT03285711|18558630|P1|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
7539922|NCT03285711|18558627|P4|STARTED|Extended Blinded Phase (Week 32 to 52)||1
7539923|NCT03285711|18558628|P3|STARTED|Extended Blinded Phase (Week 32 to 52)||0
7539924|NCT03285711|18558629|P2|STARTED|Extended Blinded Phase (Week 32 to 52)||3
7539925|NCT03285711|18558630|P1|STARTED|Extended Blinded Phase (Week 32 to 52)||0
7539926|NCT03285711|18558627|P4|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
7539927|NCT03285711|18558628|P3|NOT COMPLETED|Blinded Phase (Week 16 to 32)||1
7539928|NCT03285711|18558629|P2|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
7539929|NCT03285711|18558630|P1|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
7539930|NCT03285711|18558627|P4|COMPLETED|Blinded Phase (Week 16 to 32)||1
7539931|NCT03285711|18558628|P3|COMPLETED|Blinded Phase (Week 16 to 32)||0
7539932|NCT03285711|18558629|P2|COMPLETED|Blinded Phase (Week 16 to 32)||3
7539933|NCT03285711|18558630|P1|COMPLETED|Blinded Phase (Week 16 to 32)||0
7539934|NCT03285711|18558627|P4|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from filgotinib.|1
7539935|NCT03285711|18558628|P3|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from lanraplenib.|1
7539936|NCT03285711|18558629|P2|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to lanraplenib.|3
7539937|NCT03285711|18558630|P1|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to filgotinib.|0
7539938|NCT03285711|18558627|P4|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
7539939|NCT03285711|18558628|P3|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
7539940|NCT03285711|18558629|P2|NOT COMPLETED|Blinded Phase (Up to Week 16)||1
7539941|NCT03285711|18558630|P1|NOT COMPLETED|Blinded Phase (Up to Week 16)||3
7539942|NCT03285711|18558627|P4|COMPLETED|Blinded Phase (Up to Week 16)||0
7539943|NCT03285711|18558628|P3|COMPLETED|Blinded Phase (Up to Week 16)||0
7539944|NCT03285711|18558629|P2|COMPLETED|Blinded Phase (Up to Week 16)||4
7539945|NCT03285711|18558630|P1|COMPLETED|Blinded Phase (Up to Week 16)||1
7539946|NCT03285711|18558627|P4|STARTED|Blinded Phase (Up to Week 16)||0
7539947|NCT03285711|18558628|P3|STARTED|Blinded Phase (Up to Week 16)||0
7539948|NCT03285711|18558629|P2|STARTED|Blinded Phase (Up to Week 16)||5
7539949|NCT03285711|18558630|P1|STARTED|Blinded Phase (Up to Week 16)||4
7539950|NCT03285555|18558652|P2|NOT COMPLETED|Overall Study||0
7539951|NCT03285555|18558653|P1|NOT COMPLETED|Overall Study||0
7539952|NCT03285555|18558652|P2|COMPLETED|Overall Study||30
7539953|NCT03285555|18558653|P1|COMPLETED|Overall Study||30
7539954|NCT03285555|18558652|P2|STARTED|Overall Study||30
7539955|NCT03285555|18558653|P1|STARTED|Overall Study||30
7539956|NCT03285542|18558663|P2|NOT COMPLETED|Overall Study||0
7539957|NCT03285542|18558664|P1|NOT COMPLETED|Overall Study||0
7539958|NCT03285542|18558663|P2|COMPLETED|Overall Study||30
7539960|NCT03285542|18558663|P2|STARTED|Overall Study||30
7539961|NCT03285542|18558664|P1|STARTED|Overall Study||30
7539962|NCT03285529|18558676|P2|NOT COMPLETED|Overall Study||0
7539963|NCT03285529|18558677|P1|NOT COMPLETED|Overall Study||0
7539964|NCT03285529|18558676|P2|COMPLETED|Overall Study||30
7539965|NCT03285529|18558677|P1|COMPLETED|Overall Study||30
7539966|NCT03285529|18558676|P2|STARTED|Overall Study||30
7539967|NCT03285529|18558677|P1|STARTED|Overall Study||30
7539968|NCT03285373|18558685|P4|NOT COMPLETED|Overall Study||0
7539969|NCT03285373|18558686|P3|NOT COMPLETED|Overall Study||0
7539970|NCT03285373|18558687|P2|NOT COMPLETED|Overall Study||0
7539971|NCT03285373|18558688|P1|NOT COMPLETED|Overall Study||0
7539972|NCT03285373|18558685|P4|COMPLETED|Overall Study||130
7539973|NCT03285373|18558686|P3|COMPLETED|Overall Study||266
7539974|NCT03285373|18558687|P2|COMPLETED|Overall Study||253
7539975|NCT03285373|18558688|P1|COMPLETED|Overall Study||314
7539976|NCT03285373|18558685|P4|STARTED|Overall Study||130
7539977|NCT03285373|18558686|P3|STARTED|Overall Study||266
7539978|NCT03285373|18558687|P2|STARTED|Overall Study||253
7539979|NCT03285373|18558688|P1|STARTED|Overall Study||314
7539980|NCT03285295|18558738|P5|NOT COMPLETED|Alinity s Chagas Follow-Up||0
7539981|NCT03285295|18558739|P4|NOT COMPLETED|Alinity s Chagas Follow-Up||0
7539982|NCT03285295|18558740|P3|NOT COMPLETED|Alinity s Chagas Follow-Up||0
7539983|NCT03285295|18558741|P2|NOT COMPLETED|Alinity s Chagas Follow-Up||0
7539984|NCT03285295|18558742|P1|NOT COMPLETED|Alinity s Chagas Follow-Up||13
7539985|NCT03285295|18558738|P5|COMPLETED|Alinity s Chagas Follow-Up||0
7539986|NCT03285295|18558739|P4|COMPLETED|Alinity s Chagas Follow-Up||0
7539987|NCT03285295|18558740|P3|COMPLETED|Alinity s Chagas Follow-Up||0
7539988|NCT03285295|18558741|P2|COMPLETED|Alinity s Chagas Follow-Up||0
7539989|NCT03285295|18558742|P1|COMPLETED|Alinity s Chagas Follow-Up||1
7539990|NCT03285295|18558738|P5|STARTED|Alinity s Chagas Follow-Up||0
7539991|NCT03285295|18558739|P4|STARTED|Alinity s Chagas Follow-Up||0
7539992|NCT03285295|18558740|P3|STARTED|Alinity s Chagas Follow-Up||0
7539993|NCT03285295|18558741|P2|STARTED|Alinity s Chagas Follow-Up||0
7539994|NCT03285295|18558742|P1|STARTED|Alinity s Chagas Follow-Up||14
7539995|NCT03285295|18558738|P5|NOT COMPLETED|Alinity s Chagas||0
7539996|NCT03285295|18558739|P4|NOT COMPLETED|Alinity s Chagas||0
7539997|NCT03285295|18558740|P3|NOT COMPLETED|Alinity s Chagas||0
7539998|NCT03285295|18558741|P2|NOT COMPLETED|Alinity s Chagas||0
7539999|NCT03285295|18558742|P1|NOT COMPLETED|Alinity s Chagas||219
7540000|NCT03285295|18558738|P5|COMPLETED|Alinity s Chagas||0
7540001|NCT03285295|18558739|P4|COMPLETED|Alinity s Chagas||615
7540002|NCT03285295|18558740|P3|COMPLETED|Alinity s Chagas||0
7540003|NCT03285295|18558741|P2|COMPLETED|Alinity s Chagas||320
7540004|NCT03285295|18558742|P1|COMPLETED|Alinity s Chagas||15804
7540005|NCT03285295|18558738|P5|STARTED|Alinity s Chagas||0
7540006|NCT03285295|18558739|P4|STARTED|Alinity s Chagas||615
7540007|NCT03285295|18558740|P3|STARTED|Alinity s Chagas||0
7540008|NCT03285295|18558741|P2|STARTED|Alinity s Chagas||320
7540009|NCT03285295|18558742|P1|STARTED|Alinity s Chagas||16023
7540010|NCT03285295|18558738|P5|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
7540011|NCT03285295|18558739|P4|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
7540012|NCT03285295|18558740|P3|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
7540013|NCT03285295|18558741|P2|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
7540014|NCT03285295|18558742|P1|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||14
7540015|NCT03285295|18558738|P5|COMPLETED|Alinity s Anti-HBc Follow-Up||0
7540016|NCT03285295|18558739|P4|COMPLETED|Alinity s Anti-HBc Follow-Up||0
7540017|NCT03285295|18558740|P3|COMPLETED|Alinity s Anti-HBc Follow-Up||0
7540018|NCT03285295|18558741|P2|COMPLETED|Alinity s Anti-HBc Follow-Up||0
7540019|NCT03285295|18558742|P1|COMPLETED|Alinity s Anti-HBc Follow-Up||2
7540020|NCT03285295|18558738|P5|STARTED|Alinity s Anti-HBc Follow-Up||0
7540021|NCT03285295|18558739|P4|STARTED|Alinity s Anti-HBc Follow-Up||0
7540022|NCT03285295|18558740|P3|STARTED|Alinity s Anti-HBc Follow-Up||0
7540023|NCT03285295|18558741|P2|STARTED|Alinity s Anti-HBc Follow-Up||0
7540024|NCT03285295|18558742|P1|STARTED|Alinity s Anti-HBc Follow-Up||16
7540025|NCT03285295|18558738|P5|NOT COMPLETED|Alinity s Anti-HBc||0
7540026|NCT03285295|18558739|P4|NOT COMPLETED|Alinity s Anti-HBc||0
7540027|NCT03285295|18558740|P3|NOT COMPLETED|Alinity s Anti-HBc||0
7540028|NCT03285295|18558741|P2|NOT COMPLETED|Alinity s Anti-HBc||1
7540029|NCT03285295|18558742|P1|NOT COMPLETED|Alinity s Anti-HBc||91
7540030|NCT03285295|18558738|P5|COMPLETED|Alinity s Anti-HBc||0
7540031|NCT03285295|18558739|P4|COMPLETED|Alinity s Anti-HBc||0
7540032|NCT03285295|18558740|P3|COMPLETED|Alinity s Anti-HBc||403
7540033|NCT03285295|18558741|P2|COMPLETED|Alinity s Anti-HBc||404
7540034|NCT03285295|18558742|P1|COMPLETED|Alinity s Anti-HBc||15877
7540035|NCT03285295|18558738|P5|STARTED|Alinity s Anti-HBc||0
7540036|NCT03285295|18558739|P4|STARTED|Alinity s Anti-HBc||0
7540037|NCT03285295|18558740|P3|STARTED|Alinity s Anti-HBc||403
7540038|NCT03285295|18558741|P2|STARTED|Alinity s Anti-HBc||405
7540039|NCT03285295|18558742|P1|STARTED|Alinity s Anti-HBc||15968
7540040|NCT03285295|18558738|P5|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7540041|NCT03285295|18558739|P4|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7540042|NCT03285295|18558740|P3|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7540043|NCT03285295|18558741|P2|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7540044|NCT03285295|18558742|P1|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||11
7540045|NCT03285295|18558738|P5|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7540046|NCT03285295|18558739|P4|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7540047|NCT03285295|18558740|P3|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7540048|NCT03285295|18558741|P2|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7540049|NCT03285295|18558742|P1|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||4
7540050|NCT03285295|18558738|P5|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7540051|NCT03285295|18558739|P4|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7540052|NCT03285295|18558740|P3|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7540053|NCT03285295|18558741|P2|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7540054|NCT03285295|18558742|P1|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||15
7540055|NCT03285295|18558738|P5|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
7540056|NCT03285295|18558739|P4|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
7540057|NCT03285295|18558740|P3|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
7540058|NCT03285295|18558741|P2|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
7540059|NCT03285295|18558742|P1|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||99
7540060|NCT03285295|18558738|P5|COMPLETED|Alinity s HIV Ag/Ab Combo||0
7540061|NCT03285295|18558739|P4|COMPLETED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
7540062|NCT03285295|18558740|P3|COMPLETED|Alinity s HIV Ag/Ab Combo||605
7540063|NCT03285295|18558741|P2|COMPLETED|Alinity s HIV Ag/Ab Combo||1336
7540064|NCT03285295|18558742|P1|COMPLETED|Alinity s HIV Ag/Ab Combo||16996
7540065|NCT03285295|18558738|P5|STARTED|Alinity s HIV Ag/Ab Combo||0
7540066|NCT03285295|18558739|P4|STARTED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
7540067|NCT03285295|18558740|P3|STARTED|Alinity s HIV Ag/Ab Combo||605
7540068|NCT03285295|18558741|P2|STARTED|Alinity s HIV Ag/Ab Combo||1336
7540069|NCT03285295|18558742|P1|STARTED|Alinity s HIV Ag/Ab Combo||17095
7540070|NCT03285295|18558738|P5|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
7540071|NCT03285295|18558739|P4|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
7540072|NCT03285295|18558740|P3|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
7540073|NCT03285295|18558741|P2|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
7540074|NCT03285295|18558742|P1|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||18
7540075|NCT03285295|18558738|P5|COMPLETED|Alinity s Anti-HCV Follow-Up||0
7540076|NCT03285295|18558739|P4|COMPLETED|Alinity s Anti-HCV Follow-Up||0
7540077|NCT03285295|18558740|P3|COMPLETED|Alinity s Anti-HCV Follow-Up||0
7540078|NCT03285295|18558741|P2|COMPLETED|Alinity s Anti-HCV Follow-Up||0
7540079|NCT03285295|18558742|P1|COMPLETED|Alinity s Anti-HCV Follow-Up||2
7540080|NCT03285295|18558738|P5|STARTED|Alinity s Anti-HCV Follow-Up||0
7540081|NCT03285295|18558739|P4|STARTED|Alinity s Anti-HCV Follow-Up||0
7540082|NCT03285295|18558740|P3|STARTED|Alinity s Anti-HCV Follow-Up||0
7540083|NCT03285295|18558741|P2|STARTED|Alinity s Anti-HCV Follow-Up||0
7540084|NCT03285295|18558742|P1|STARTED|Alinity s Anti-HCV Follow-Up||20
7540085|NCT03285295|18558738|P5|NOT COMPLETED|Alinity s Anti-HCV||0
7540086|NCT03285295|18558739|P4|NOT COMPLETED|Alinity s Anti-HCV||0
7540087|NCT03285295|18558740|P3|NOT COMPLETED|Alinity s Anti-HCV||0
7540088|NCT03285295|18558741|P2|NOT COMPLETED|Alinity s Anti-HCV||0
7540089|NCT03285295|18558742|P1|NOT COMPLETED|Alinity s Anti-HCV||96
7540090|NCT03285295|18558738|P5|COMPLETED|Alinity s Anti-HCV||0
7540091|NCT03285295|18558739|P4|COMPLETED|Alinity s Anti-HCV||0
7540092|NCT03285295|18558740|P3|COMPLETED|Alinity s Anti-HCV||407
7540093|NCT03285295|18558741|P2|COMPLETED|Alinity s Anti-HCV||402
7540094|NCT03285295|18558742|P1|COMPLETED|Alinity s Anti-HCV||16999
7540095|NCT03285295|18558738|P5|STARTED|Alinity s Anti-HCV||0
7540096|NCT03285295|18558739|P4|STARTED|Alinity s Anti-HCV||0
7540097|NCT03285295|18558740|P3|STARTED|Alinity s Anti-HCV||407
7540098|NCT03285295|18558741|P2|STARTED|Alinity s Anti-HCV||402
7540099|NCT03285295|18558742|P1|STARTED|Alinity s Anti-HCV||17095
7540100|NCT03285295|18558738|P5|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
7540101|NCT03285295|18558739|P4|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
7540102|NCT03285295|18558740|P3|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
7540103|NCT03285295|18558741|P2|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
7540104|NCT03285295|18558742|P1|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||4
7540105|NCT03285295|18558738|P5|COMPLETED|Alinity s HTLV I/II Follow-Up||0
7540106|NCT03285295|18558739|P4|COMPLETED|Alinity s HTLV I/II Follow-Up||0
7540107|NCT03285295|18558740|P3|COMPLETED|Alinity s HTLV I/II Follow-Up||0
7540108|NCT03285295|18558741|P2|COMPLETED|Alinity s HTLV I/II Follow-Up||0
7540109|NCT03285295|18558742|P1|COMPLETED|Alinity s HTLV I/II Follow-Up||8
7540110|NCT03285295|18558738|P5|STARTED|Alinity s HTLV I/II Follow-Up||0
7540111|NCT03285295|18558739|P4|STARTED|Alinity s HTLV I/II Follow-Up||0
7540112|NCT03285295|18558740|P3|STARTED|Alinity s HTLV I/II Follow-Up||0
7540113|NCT03285295|18558741|P2|STARTED|Alinity s HTLV I/II Follow-Up||0
7540114|NCT03285295|18558742|P1|STARTED|Alinity s HTLV I/II Follow-Up||12
7540115|NCT03285295|18558738|P5|NOT COMPLETED|Alinity s HTLV I/II||0
7540116|NCT03285295|18558739|P4|NOT COMPLETED|Alinity s HTLV I/II||0
7540117|NCT03285295|18558740|P3|NOT COMPLETED|Alinity s HTLV I/II||0
7540118|NCT03285295|18558741|P2|NOT COMPLETED|Alinity s HTLV I/II||0
7540119|NCT03285295|18558742|P1|NOT COMPLETED|Alinity s HTLV I/II||91
7540120|NCT03285295|18558738|P5|COMPLETED|Alinity s HTLV I/II||0
7540121|NCT03285295|18558739|P4|COMPLETED|Alinity s HTLV I/II||509
7540122|NCT03285295|18558740|P3|COMPLETED|Alinity s HTLV I/II||502
7540123|NCT03285295|18558741|P2|COMPLETED|Alinity s HTLV I/II||706
7540124|NCT03285295|18558742|P1|COMPLETED|Alinity s HTLV I/II||15877
7540125|NCT03285295|18558738|P5|STARTED|Alinity s HTLV I/II||0
7540126|NCT03285295|18558739|P4|STARTED|Alinity s HTLV I/II||509
7540127|NCT03285295|18558740|P3|STARTED|Alinity s HTLV I/II||502
7540128|NCT03285295|18558741|P2|STARTED|Alinity s HTLV I/II||706
7540129|NCT03285295|18558742|P1|STARTED|Alinity s HTLV I/II||15968
7540130|NCT03285295|18558738|P5|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
7540131|NCT03285295|18558739|P4|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
7540132|NCT03285295|18558740|P3|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
7540133|NCT03285295|18558741|P2|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
7540134|NCT03285295|18558742|P1|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
7540135|NCT03285295|18558738|P5|COMPLETED|Alinity s HBsAg Follow-Up||0
7540136|NCT03285295|18558739|P4|COMPLETED|Alinity s HBsAg Follow-Up||0
7540137|NCT03285295|18558740|P3|COMPLETED|Alinity s HBsAg Follow-Up||0
7540138|NCT03285295|18558741|P2|COMPLETED|Alinity s HBsAg Follow-Up||0
7540139|NCT03285295|18558742|P1|COMPLETED|Alinity s HBsAg Follow-Up||0
7540140|NCT03285295|18558738|P5|STARTED|Alinity s HBsAg Follow-Up||0
7540141|NCT03285295|18558739|P4|STARTED|Alinity s HBsAg Follow-Up||0
7540142|NCT03285295|18558740|P3|STARTED|Alinity s HBsAg Follow-Up||0
7540143|NCT03285295|18558741|P2|STARTED|Alinity s HBsAg Follow-Up||0
7540144|NCT03285295|18558742|P1|STARTED|Alinity s HBsAg Follow-Up||0
7540145|NCT03285295|18558738|P5|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
7540146|NCT03285295|18558739|P4|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
7540147|NCT03285295|18558740|P3|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
7540148|NCT03285295|18558741|P2|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
7540149|NCT03285295|18558742|P1|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
7540150|NCT03285295|18558738|P5|COMPLETED|Alinity s HBsAg Confirmatory||0
7540151|NCT03285295|18558739|P4|COMPLETED|Alinity s HBsAg Confirmatory||0
7540152|NCT03285295|18558740|P3|COMPLETED|Alinity s HBsAg Confirmatory||3
7540153|NCT03285295|18558741|P2|COMPLETED|Alinity s HBsAg Confirmatory||432
7540154|NCT03285295|18558742|P1|COMPLETED|Alinity s HBsAg Confirmatory||8
7540155|NCT03285295|18558738|P5|STARTED|Alinity s HBsAg Confirmatory||0
7540156|NCT03285295|18558739|P4|STARTED|Alinity s HBsAg Confirmatory||0
7540157|NCT03285295|18558740|P3|STARTED|Alinity s HBsAg Confirmatory||3
7540158|NCT03285295|18558741|P2|STARTED|Alinity s HBsAg Confirmatory||432
7540159|NCT03285295|18558742|P1|STARTED|Alinity s HBsAg Confirmatory||8
7540160|NCT03285295|18558738|P5|NOT COMPLETED|Alinity s HBsAg||0
7540161|NCT03285295|18558739|P4|NOT COMPLETED|Alinity s HBsAg||0
7540162|NCT03285295|18558740|P3|NOT COMPLETED|Alinity s HBsAg||0
7540163|NCT03285295|18558741|P2|NOT COMPLETED|Alinity s HBsAg||6
7540164|NCT03285295|18558742|P1|NOT COMPLETED|Alinity s HBsAg||102
7540165|NCT03285295|18558738|P5|COMPLETED|Alinity s HBsAg||51
7540166|NCT03285295|18558739|P4|COMPLETED|Alinity s HBsAg||0
7540167|NCT03285295|18558740|P3|COMPLETED|Alinity s HBsAg||403
7540168|NCT03285295|18558741|P2|COMPLETED|Alinity s HBsAg||432
7540169|NCT03285295|18558742|P1|COMPLETED|Alinity s HBsAg||16993
7540170|NCT03285295|18558738|P5|STARTED|Alinity s HBsAg||51
7540171|NCT03285295|18558739|P4|STARTED|Alinity s HBsAg||0
7540172|NCT03285295|18558740|P3|STARTED|Alinity s HBsAg||403
7540173|NCT03285295|18558741|P2|STARTED|Alinity s HBsAg||438
7540174|NCT03285295|18558742|P1|STARTED|Alinity s HBsAg||17095
7540175|NCT03284411|18558771|P1|NOT COMPLETED|Overall Study||0
7540176|NCT03284411|18558771|P1|COMPLETED|Overall Study||30
7540177|NCT03284411|18558771|P1|STARTED|Overall Study||30
7540178|NCT03284229|18558776|P1|NOT COMPLETED|Overall Study||3
7540179|NCT03284229|18558776|P1|COMPLETED|Overall Study||25
7540180|NCT03284229|18558776|P1|STARTED|Overall Study||28
7540181|NCT03283787|18558792|P3|NOT COMPLETED|Overall Study||7
7540182|NCT03283787|18558793|P2|NOT COMPLETED|Overall Study||7
7540183|NCT03283787|18558794|P1|NOT COMPLETED|Overall Study||3
7540184|NCT03283787|18558792|P3|COMPLETED|Overall Study||13
7540185|NCT03283787|18558793|P2|COMPLETED|Overall Study||13
7540186|NCT03283787|18558794|P1|COMPLETED|Overall Study||17
7540187|NCT03283787|18558792|P3|STARTED|Overall Study||20
7540188|NCT03283787|18558793|P2|STARTED|Overall Study||20
7540189|NCT03283787|18558794|P1|STARTED|Overall Study||20
7540190|NCT03283709|18558810|P2|NOT COMPLETED|Overall Study||1
7540191|NCT03283709|18558811|P1|NOT COMPLETED|Overall Study||0
7540192|NCT03283709|18558810|P2|COMPLETED|Overall Study||0
7540193|NCT03283709|18558811|P1|COMPLETED|Overall Study||0
7540194|NCT03283709|18558810|P2|STARTED|Overall Study||1
7540195|NCT03283709|18558811|P1|STARTED|Overall Study||0
7540196|NCT03283696|18558843|P2|NOT COMPLETED|Overall Study||6
7540197|NCT03283696|18558844|P1|NOT COMPLETED|Overall Study||7
7540198|NCT03283696|18558843|P2|COMPLETED|Overall Study||2
7540199|NCT03283696|18558844|P1|COMPLETED|Overall Study||9
7540200|NCT03283696|18558843|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
7540201|NCT03283696|18558844|P1|Received at Least 1 Dose of Study Drug|Overall Study||16
7540202|NCT03283696|18558843|P2|STARTED|Overall Study||8
7540203|NCT03283696|18558844|P1|STARTED|Overall Study||16
7540204|NCT03283436|18558872|P2|NOT COMPLETED|Overall Study||0
7540205|NCT03283436|18558873|P1|NOT COMPLETED|Overall Study||6
7540206|NCT03283436|18558872|P2|COMPLETED|Overall Study||50
7540207|NCT03283436|18558873|P1|COMPLETED|Overall Study||44
7540208|NCT03283436|18558872|P2|STARTED|Overall Study||50
7540209|NCT03283436|18558873|P1|STARTED|Overall Study||50
7540210|NCT03283319|18558889|P6|NOT COMPLETED|Overall Study||4
7540211|NCT03283319|18558890|P5|NOT COMPLETED|Overall Study||4
7540212|NCT03283319|18558891|P4|NOT COMPLETED|Overall Study||7
7540213|NCT03283319|18558892|P3|NOT COMPLETED|Overall Study||7
7540214|NCT03283319|18558893|P2|NOT COMPLETED|Overall Study||6
7540215|NCT03283319|18558894|P1|NOT COMPLETED|Overall Study||7
7540216|NCT03283319|18558889|P6|COMPLETED|Overall Study||57
7540217|NCT03283319|18558890|P5|COMPLETED|Overall Study||56
7540218|NCT03283319|18558891|P4|COMPLETED|Overall Study||54
7540219|NCT03283319|18558892|P3|COMPLETED|Overall Study||55
7540220|NCT03283319|18558893|P2|COMPLETED|Overall Study||54
7540221|NCT03283319|18558894|P1|COMPLETED|Overall Study||55
7540222|NCT03283319|18558889|P6|STARTED|Overall Study||61
7540223|NCT03283319|18558890|P5|STARTED|Overall Study||60
7540224|NCT03283319|18558891|P4|STARTED|Overall Study||61
7540225|NCT03283319|18558892|P3|STARTED|Overall Study||62
7540226|NCT03283319|18558893|P2|STARTED|Overall Study||60
7540227|NCT03283319|18558894|P1|STARTED|Overall Study||62
7540228|NCT03283098|18559036|P2|NOT COMPLETED|Overall Study||1
7540229|NCT03283098|18559037|P1|NOT COMPLETED|Overall Study||0
7540230|NCT03283098|18559036|P2|COMPLETED|Overall Study||24
7540231|NCT03283098|18559037|P1|COMPLETED|Overall Study||8
7540232|NCT03283098|18559036|P2|STARTED|Overall Study||25
7540233|NCT03283098|18559037|P1|STARTED|Overall Study||8
7540234|NCT03282682|18559076|P3|NOT COMPLETED|Overall Study||0
7540235|NCT03282682|18559077|P2|NOT COMPLETED|Overall Study||0
7540236|NCT03282682|18559078|P1|NOT COMPLETED|Overall Study||0
7540237|NCT03282682|18559076|P3|COMPLETED|Overall Study||8
7540238|NCT03282682|18559077|P2|COMPLETED|Overall Study||8
7540239|NCT03282682|18559078|P1|COMPLETED|Overall Study||6
7540240|NCT03282682|18559076|P3|STARTED|Overall Study||8
7540241|NCT03282682|18559077|P2|STARTED|Overall Study||8
7540242|NCT03282682|18559078|P1|STARTED|Overall Study||6
7540243|NCT03282591|18559139|P2|NOT COMPLETED|Overall Study||4
7540244|NCT03282591|18559140|P1|NOT COMPLETED|Overall Study||4
7540245|NCT03282591|18559139|P2|COMPLETED|Overall Study||89
7540246|NCT03282591|18559140|P1|COMPLETED|Overall Study||88
7540247|NCT03282591|18559139|P2|STARTED|Overall Study||93
7540248|NCT03282591|18559140|P1|STARTED|Overall Study||92
7540249|NCT03282240|18559157|P3|NOT COMPLETED|Overall Study||3
7540250|NCT03282240|18559158|P2|NOT COMPLETED|Overall Study||3
7540251|NCT03282240|18559159|P1|NOT COMPLETED|Overall Study||10
7540252|NCT03282240|18559157|P3|COMPLETED|Overall Study||447
7540253|NCT03282240|18559158|P2|COMPLETED|Overall Study||440
7540254|NCT03282240|18559159|P1|COMPLETED|Overall Study||1767
7540255|NCT03282240|18559157|P3|STARTED|Overall Study||450
7540256|NCT03282240|18559158|P2|STARTED|Overall Study||443
7540257|NCT03282240|18559159|P1|STARTED|Overall Study||1777
7540258|NCT03282227|18559211|P1|NOT COMPLETED|Overall Study||215
7540259|NCT03282227|18559211|P1|COMPLETED|Overall Study||127
7540260|NCT03282227|18559211|P1|Completed at Least 6 Months|Overall Study||257
7540261|NCT03282227|18559211|P1|STARTED|Overall Study||342
7540262|NCT03282071|18559223|P2|NOT COMPLETED|Overall Study||9
7540263|NCT03282071|18559224|P1|NOT COMPLETED|Overall Study||10
7540264|NCT03282071|18559223|P2|COMPLETED|Overall Study||60
7540265|NCT03282071|18559224|P1|COMPLETED|Overall Study||65
7540266|NCT03282071|18559223|P2|STARTED|Overall Study||69
7540267|NCT03282071|18559224|P1|STARTED|Overall Study||75
7540268|NCT03281668|18559245|P1|NOT COMPLETED|Overall Study||8
7540269|NCT03281668|18559245|P1|COMPLETED|Overall Study||21
7540270|NCT03281668|18559245|P1|STARTED|Overall Study||29
7540271|NCT03281577|18559273|P4|NOT COMPLETED|Overall Study||1
7540272|NCT03281577|18559274|P3|NOT COMPLETED|Overall Study||0
7540273|NCT03281577|18559275|P2|NOT COMPLETED|Overall Study||0
7540274|NCT03281577|18559276|P1|NOT COMPLETED|Overall Study||1
7540275|NCT03281577|18559273|P4|COMPLETED|Overall Study||6
7540276|NCT03281577|18559274|P3|COMPLETED|Overall Study||9
7540277|NCT03281577|18559275|P2|COMPLETED|Overall Study||10
7540278|NCT03281577|18559276|P1|COMPLETED|Overall Study||9
7540279|NCT03281577|18559273|P4|STARTED|Overall Study||7
7540280|NCT03281577|18559274|P3|STARTED|Overall Study||9
7540281|NCT03281577|18559275|P2|STARTED|Overall Study||10
7540282|NCT03281577|18559276|P1|STARTED|Overall Study||10
7540283|NCT03281200|18559307|P1|NOT COMPLETED|Overall Study||0
7540284|NCT03281200|18559307|P1|COMPLETED|Overall Study||172
7540285|NCT03281200|18559307|P1|STARTED|Overall Study||172
7540286|NCT03280615|18559331|P2|NOT COMPLETED|Overall Study||5
7540287|NCT03280615|18559332|P1|NOT COMPLETED|Overall Study||4
7540288|NCT03280615|18559331|P2|COMPLETED|Overall Study||45
7540289|NCT03280615|18559332|P1|COMPLETED|Overall Study||46
7540290|NCT03280615|18559331|P2|STARTED|Overall Study||50
7540291|NCT03280615|18559332|P1|STARTED|Overall Study||50
7540292|NCT03280550|18559344|P2|NOT COMPLETED|Overall Study||3
7540293|NCT03280550|18559345|P1|NOT COMPLETED|Overall Study||2
7540294|NCT03280550|18559344|P2|COMPLETED|Overall Study||69
7540295|NCT03280550|18559345|P1|COMPLETED|Overall Study||64
7540296|NCT03280550|18559344|P2|STARTED|Overall Study||72
7540297|NCT03280550|18559345|P1|STARTED|Overall Study||66
7540298|NCT03280537|18559397|P2|NOT COMPLETED|Overall Study||4
7540299|NCT03280537|18559398|P1|NOT COMPLETED|Overall Study||2
7540300|NCT03280537|18559397|P2|COMPLETED|Overall Study||58
7540301|NCT03280537|18559398|P1|COMPLETED|Overall Study||63
7540302|NCT03280537|18559397|P2|STARTED|Overall Study||62
7540303|NCT03280537|18559398|P1|STARTED|Overall Study||65
7540304|NCT03280381|18559450|P2|NOT COMPLETED|Overall Study||2
7540305|NCT03280381|18559451|P1|NOT COMPLETED|Overall Study||0
7540306|NCT03280381|18559450|P2|COMPLETED|Overall Study||97
7540307|NCT03280381|18559451|P1|COMPLETED|Overall Study||101
7540308|NCT03280381|18559450|P2|STARTED|Overall Study||99
7540309|NCT03280381|18559451|P1|STARTED|Overall Study||101
7540310|NCT03280108|18559461|P2|NOT COMPLETED|Overall Study||0
7540311|NCT03280108|18559462|P1|NOT COMPLETED|Overall Study||2
7540312|NCT03280108|18559461|P2|COMPLETED|Overall Study||114
7540313|NCT03280108|18559462|P1|COMPLETED|Overall Study||127
7540314|NCT03280108|18559461|P2|STARTED|Overall Study||114
7540315|NCT03280108|18559462|P1|STARTED|Overall Study||129
7540316|NCT03279731|18559495|P2|NOT COMPLETED|Overall Study||3
7540317|NCT03279731|18559496|P1|NOT COMPLETED|Overall Study||6
7540318|NCT03279731|18559495|P2|COMPLETED|Overall Study||14
7540319|NCT03279731|18559496|P1|COMPLETED|Overall Study||13
7540320|NCT03279731|18559495|P2|STARTED|Overall Study||17
7540321|NCT03279731|18559496|P1|STARTED|Overall Study||19
7540322|NCT03279458|18559508|P1|NOT COMPLETED|Overall Study||0
7540323|NCT03279458|18559508|P1|COMPLETED|Overall Study||40
7540324|NCT03279458|18559508|P1|STARTED|Overall Study||40
7540325|NCT03279237|18559514|P1|NOT COMPLETED|Overall Study||5
7540326|NCT03279237|18559514|P1|COMPLETED|Overall Study||20
7540327|NCT03279237|18559514|P1|Surgical Resection|Overall Study||20
7540328|NCT03279237|18559514|P1|Chemo-radiation|Overall Study||23
7540329|NCT03279237|18559514|P1|STARTED|Overall Study||25
7540330|NCT03278886|18559523|P2|NOT COMPLETED|Overall Study||1
7540331|NCT03278886|18559524|P1|NOT COMPLETED|Overall Study||0
7540332|NCT03278886|18559523|P2|COMPLETED|Overall Study||2
7540333|NCT03278886|18559524|P1|COMPLETED|Overall Study||8
7540334|NCT03278886|18559523|P2|STARTED|Overall Study||3
7540335|NCT03278886|18559524|P1|STARTED|Overall Study||8
7540336|NCT03278106|18559544|P1|NOT COMPLETED|Overall Study||1
7540337|NCT03278106|18559544|P1|COMPLETED|Overall Study||27
7540338|NCT03278106|18559544|P1|STARTED|Overall Study||28
7540339|NCT03278067|18559555|P3|NOT COMPLETED|Overall Study||0
7540340|NCT03278067|18559556|P2|NOT COMPLETED|Overall Study||0
7540341|NCT03278067|18559557|P1|NOT COMPLETED|Overall Study||0
7540342|NCT03278067|18559555|P3|COMPLETED|Overall Study||4196
7540343|NCT03278067|18559556|P2|COMPLETED|Overall Study||3310
7540344|NCT03278067|18559557|P1|COMPLETED|Overall Study||16433
7540345|NCT03278067|18559555|P3|STARTED|Overall Study||4196
7540346|NCT03278067|18559556|P2|STARTED|Overall Study||3310
7540347|NCT03278067|18559557|P1|STARTED|Overall Study||16433
7540348|NCT03278028|18559960|P2|NOT COMPLETED|Overall Study||2
7540349|NCT03278028|18559961|P1|NOT COMPLETED|Overall Study||4
7540350|NCT03278028|18559960|P2|COMPLETED|Overall Study||76
7540351|NCT03278028|18559961|P1|COMPLETED|Overall Study||77
7540352|NCT03278028|18559960|P2|STARTED|Overall Study||78
7540353|NCT03278028|18559961|P1|STARTED|Overall Study||81
7540354|NCT03277846|18559969|P2|NOT COMPLETED|Overall Study||11
7540355|NCT03277846|18559970|P1|NOT COMPLETED|Overall Study||12
7540356|NCT03277846|18559969|P2|COMPLETED|Overall Study||40
7540357|NCT03277846|18559970|P1|COMPLETED|Overall Study||38
7540358|NCT03277846|18559969|P2|STARTED|Overall Study||51
7540359|NCT03277846|18559970|P1|STARTED|Overall Study||50
7540360|NCT03277274|18559979|P3|NOT COMPLETED|Overall Study||0
7540361|NCT03277274|18559980|P2|NOT COMPLETED|Overall Study||0
7540362|NCT03277274|18559981|P1|NOT COMPLETED|Overall Study||0
7540363|NCT03277274|18559979|P3|COMPLETED|Overall Study||7
7540364|NCT03277274|18559980|P2|COMPLETED|Overall Study||10
7540365|NCT03277274|18559981|P1|COMPLETED|Overall Study||8
7540366|NCT03277274|18559979|P3|STARTED|Overall Study||7
7540367|NCT03277274|18559980|P2|STARTED|Overall Study||10
7540368|NCT03277274|18559981|P1|STARTED|Overall Study||8
7540369|NCT03277183|18560012|P2|NOT COMPLETED|Overall Study||2
7540370|NCT03277183|18560013|P1|NOT COMPLETED|Overall Study||3
7540371|NCT03277183|18560012|P2|COMPLETED|Overall Study||0
7540372|NCT03277183|18560013|P1|COMPLETED|Overall Study||0
7540373|NCT03277183|18560012|P2|STARTED|Overall Study||2
7540374|NCT03277183|18560013|P1|STARTED|Overall Study||3
7540375|NCT03277105|18560027|P2|NOT COMPLETED|Overall Study||263
7540376|NCT03277105|18560028|P1|NOT COMPLETED|Overall Study||259
7540377|NCT03277105|18560027|P2|COMPLETED|Overall Study||0
7540378|NCT03277105|18560028|P1|COMPLETED|Overall Study||0
7540379|NCT03277105|18560027|P2|Safety Analysis Set|Overall Study||260
7540380|NCT03277105|18560028|P1|Safety Analysis Set|Overall Study||258
7540381|NCT03277105|18560027|P2|STARTED|Overall Study||263
7540382|NCT03277105|18560028|P1|STARTED|Overall Study||259
7540383|NCT03276936|18560060|P2|NOT COMPLETED|Overall Study||38
7540384|NCT03276936|18560061|P1|NOT COMPLETED|Overall Study||56
7540385|NCT03276936|18560060|P2|COMPLETED|Overall Study||134
7540386|NCT03276936|18560061|P1|COMPLETED|Overall Study||276
7540387|NCT03276936|18560060|P2|STARTED|Overall Study||172
7540388|NCT03276936|18560061|P1|STARTED|Overall Study||332
7540389|NCT03276871|18560081|P2|NOT COMPLETED|Overall Study||0
7540390|NCT03276871|18560082|P1|NOT COMPLETED|Overall Study||0
7540391|NCT03276871|18560081|P2|COMPLETED|Overall Study||19
7540392|NCT03276871|18560082|P1|COMPLETED|Overall Study||21
7540393|NCT03276871|18560081|P2|STARTED|Overall Study||19
7540394|NCT03276871|18560082|P1|STARTED|Overall Study||21
7540395|NCT03276494|18560094|P1|NOT COMPLETED|Overall Study||1
7540396|NCT03276494|18560094|P1|COMPLETED|Overall Study||5
7540397|NCT03276494|18560094|P1|STARTED|Overall Study||6
7540398|NCT03276078|18560099|P1|NOT COMPLETED|Overall Study||1
7540399|NCT03276078|18560099|P1|COMPLETED|Overall Study||19
7540400|NCT03276078|18560099|P1|STARTED|Overall Study||20
7540401|NCT03276026|18560128|P2|NOT COMPLETED|Overall Study||0
7540402|NCT03276026|18560129|P1|NOT COMPLETED|Overall Study||1
7540403|NCT03276026|18560128|P2|COMPLETED|Overall Study||33
7540404|NCT03276026|18560129|P1|COMPLETED|Overall Study||34
7540405|NCT03276026|18560128|P2|STARTED|Overall Study||33
7540406|NCT03276026|18560129|P1|STARTED|Overall Study||35
7540407|NCT03275870|18560139|P1|NOT COMPLETED|Overall Study||14
7540408|NCT03275870|18560139|P1|COMPLETED|Overall Study||3
7540409|NCT03275870|18560139|P1|STARTED|Overall Study||17
7540410|NCT03275623|18560146|P2|NOT COMPLETED|Overall Study||2
7540411|NCT03275623|18560147|P1|NOT COMPLETED|Overall Study||5
7540412|NCT03275623|18560146|P2|COMPLETED|Overall Study||28
7540413|NCT03275623|18560147|P1|COMPLETED|Overall Study||25
7540414|NCT03275623|18560146|P2|STARTED|Overall Study||30
7540415|NCT03275623|18560147|P1|STARTED|Overall Study||30
7540416|NCT03274986|18560157|P2|NOT COMPLETED|Overall Study||2
7540417|NCT03274986|18560158|P1|NOT COMPLETED|Overall Study||0
7540418|NCT03274986|18560157|P2|COMPLETED|Overall Study||111
7540419|NCT03274986|18560158|P1|COMPLETED|Overall Study||107
7540420|NCT03274986|18560157|P2|Successful Implantation, as Treated|Overall Study||113
7540421|NCT03274986|18560158|P1|Successful Implantation, as Treated|Overall Study||107
7540422|NCT03274986|18560157|P2|STARTED|Overall Study||113
7540423|NCT03274986|18560158|P1|STARTED|Overall Study||107
7540424|NCT03274856|18560191|P2|NOT COMPLETED|Overall Study||0
7540425|NCT03274856|18560192|P1|NOT COMPLETED|Overall Study||0
7540426|NCT03274856|18560191|P2|COMPLETED|Overall Study||9
7540427|NCT03274856|18560192|P1|COMPLETED|Overall Study||10
7540428|NCT03274856|18560191|P2|STARTED|Overall Study||9
7540429|NCT03274856|18560192|P1|STARTED|Overall Study||10
7540430|NCT03274518|18560208|P2|NOT COMPLETED|Second Intervention||0
7540431|NCT03274518|18560209|P1|NOT COMPLETED|Second Intervention||0
7540432|NCT03274518|18560208|P2|COMPLETED|Second Intervention||8
7540433|NCT03274518|18560209|P1|COMPLETED|Second Intervention||8
7540434|NCT03274518|18560208|P2|STARTED|Second Intervention|Second intervention: patients from this group underwent online hemodiafiltration for 30 days.|8
7540435|NCT03274518|18560209|P1|STARTED|Second Intervention||8
7540436|NCT03274518|18560208|P2|NOT COMPLETED|Washout Period||0
7540437|NCT03274518|18560209|P1|NOT COMPLETED|Washout Period||0
7540438|NCT03274518|18560208|P2|COMPLETED|Washout Period||8
7540439|NCT03274518|18560209|P1|COMPLETED|Washout Period||8
7540440|NCT03274518|18560208|P2|STARTED|Washout Period|Patients returned from expanded hemodialysis to conventional hemodialysis for 15 days.|8
7540441|NCT03274518|18560209|P1|STARTED|Washout Period||8
7540442|NCT03274518|18560208|P2|NOT COMPLETED|First Intervention||0
7540443|NCT03274518|18560209|P1|NOT COMPLETED|First Intervention||0
7540444|NCT03274518|18560208|P2|COMPLETED|First Intervention||8
7540445|NCT03274518|18560209|P1|COMPLETED|First Intervention||8
7540446|NCT03274518|18560208|P2|STARTED|First Intervention|First intervention: expanded hemodialysis, for 30 days.|8
7540447|NCT03274518|18560209|P1|STARTED|First Intervention||8
7540448|NCT03274453|18560225|P4|NOT COMPLETED|Overall Study||4
7540449|NCT03274453|18560226|P3|NOT COMPLETED|Overall Study||4
7540450|NCT03274453|18560227|P2|NOT COMPLETED|Overall Study||6
7540451|NCT03274453|18560228|P1|NOT COMPLETED|Overall Study||4
7540452|NCT03274453|18560225|P4|COMPLETED|Overall Study||25
7540453|NCT03274453|18560226|P3|COMPLETED|Overall Study||28
7540454|NCT03274453|18560227|P2|COMPLETED|Overall Study||24
7540455|NCT03274453|18560228|P1|COMPLETED|Overall Study||34
7540456|NCT03274453|18560225|P4|STARTED|Overall Study||29
7540457|NCT03274453|18560226|P3|STARTED|Overall Study||32
7540458|NCT03274453|18560227|P2|STARTED|Overall Study||30
7540459|NCT03274453|18560228|P1|STARTED|Overall Study||38
7540460|NCT03274440|18560238|P6|NOT COMPLETED|Overall Study||0
7540461|NCT03274440|18560239|P5|NOT COMPLETED|Overall Study||0
7540462|NCT03274440|18560240|P4|NOT COMPLETED|Overall Study||1
7540463|NCT03274440|18560241|P3|NOT COMPLETED|Overall Study||0
7540464|NCT03274440|18560242|P2|NOT COMPLETED|Overall Study||0
7540465|NCT03274440|18560243|P1|NOT COMPLETED|Overall Study||1
7540466|NCT03274440|18560238|P6|COMPLETED|Overall Study||3
7540467|NCT03274440|18560239|P5|COMPLETED|Overall Study||1
7540468|NCT03274440|18560240|P4|COMPLETED|Overall Study||0
7540469|NCT03274440|18560241|P3|COMPLETED|Overall Study||4
7540470|NCT03274440|18560242|P2|COMPLETED|Overall Study||2
7540471|NCT03274440|18560243|P1|COMPLETED|Overall Study||2
7540472|NCT03274440|18560238|P6|STARTED|Overall Study||3
7540473|NCT03274440|18560239|P5|STARTED|Overall Study||1
7540474|NCT03274440|18560240|P4|STARTED|Overall Study||1
7540475|NCT03274440|18560241|P3|STARTED|Overall Study||4
7540476|NCT03274440|18560242|P2|STARTED|Overall Study||2
7540477|NCT03274440|18560243|P1|STARTED|Overall Study||3
7540478|NCT03274076|18560256|P4|NOT COMPLETED|24 Weeks Open Label||1
7540479|NCT03274076|18560257|P3|NOT COMPLETED|24 Weeks Open Label||2
7540480|NCT03274076|18560258|P2|NOT COMPLETED|24 Weeks Open Label||0
7540481|NCT03274076|18560259|P1|NOT COMPLETED|24 Weeks Open Label||0
7540482|NCT03274076|18560256|P4|COMPLETED|24 Weeks Open Label||3
7540483|NCT03274076|18560257|P3|COMPLETED|24 Weeks Open Label||8
7540484|NCT03274076|18560258|P2|COMPLETED|24 Weeks Open Label||0
7540485|NCT03274076|18560259|P1|COMPLETED|24 Weeks Open Label||0
7540486|NCT03274076|18560256|P4|STARTED|24 Weeks Open Label||4
7540487|NCT03274076|18560257|P3|STARTED|24 Weeks Open Label||10
7540488|NCT03274076|18560258|P2|STARTED|24 Weeks Open Label||0
7540489|NCT03274076|18560259|P1|STARTED|24 Weeks Open Label||0
7540490|NCT03274076|18560256|P4|NOT COMPLETED|24 Weeks Double Blind||0
7540491|NCT03274076|18560257|P3|NOT COMPLETED|24 Weeks Double Blind||0
7540492|NCT03274076|18560258|P2|NOT COMPLETED|24 Weeks Double Blind||1
7540493|NCT03274076|18560259|P1|NOT COMPLETED|24 Weeks Double Blind||0
7540494|NCT03274076|18560256|P4|COMPLETED|24 Weeks Double Blind||0
7540495|NCT03274076|18560257|P3|COMPLETED|24 Weeks Double Blind||0
7540496|NCT03274076|18560258|P2|COMPLETED|24 Weeks Double Blind||4
7540497|NCT03274076|18560259|P1|COMPLETED|24 Weeks Double Blind||10
7540498|NCT03274076|18560256|P4|STARTED|24 Weeks Double Blind||0
7540499|NCT03274076|18560257|P3|STARTED|24 Weeks Double Blind||0
7540500|NCT03274076|18560258|P2|STARTED|24 Weeks Double Blind||5
7540501|NCT03274076|18560259|P1|STARTED|24 Weeks Double Blind||10
7540502|NCT03273946|18560287|P1|NOT COMPLETED|Overall Study||9
7540503|NCT03273946|18560287|P1|COMPLETED|Overall Study||149
7540504|NCT03273946|18560287|P1|STARTED|Overall Study||158
7540505|NCT03273673|18560295|P2|NOT COMPLETED|Overall Study||0
7540506|NCT03273673|18560296|P1|NOT COMPLETED|Overall Study||4
7540507|NCT03273673|18560295|P2|COMPLETED|Overall Study||22
7540508|NCT03273673|18560296|P1|COMPLETED|Overall Study||14
7540509|NCT03273673|18560295|P2|STARTED|Overall Study||22
7540510|NCT03273673|18560296|P1|STARTED|Overall Study||18
7540511|NCT03273543|18560314|P2|NOT COMPLETED|Overall Study||0
7540512|NCT03273543|18560315|P1|NOT COMPLETED|Overall Study||0
7540513|NCT03273543|18560314|P2|COMPLETED|Overall Study||10
7540514|NCT03273543|18560315|P1|COMPLETED|Overall Study||10
7540515|NCT03273543|18560314|P2|STARTED|Overall Study||10
7540516|NCT03273543|18560315|P1|STARTED|Overall Study||10
7540517|NCT03273426|18560323|P2|NOT COMPLETED|Overall Study||0
7540518|NCT03273426|18560324|P1|NOT COMPLETED|Overall Study||0
7540519|NCT03273426|18560323|P2|COMPLETED|Overall Study||20
7540520|NCT03273426|18560324|P1|COMPLETED|Overall Study||20
7540521|NCT03273426|18560323|P2|STARTED|Overall Study||20
7540522|NCT03273426|18560324|P1|STARTED|Overall Study||20
7540523|NCT03273387|18560335|P2|NOT COMPLETED|Overall Study||3
7540524|NCT03273387|18560336|P1|NOT COMPLETED|Overall Study||3
7540525|NCT03273387|18560335|P2|COMPLETED|Overall Study||10
7540526|NCT03273387|18560336|P1|COMPLETED|Overall Study||10
7540527|NCT03273387|18560335|P2|STARTED|Overall Study||13
7540528|NCT03273387|18560336|P1|STARTED|Overall Study||13
7540529|NCT03273283|18560348|P2|NOT COMPLETED|Overall Study||20
7540530|NCT03273283|18560349|P1|NOT COMPLETED|Overall Study||27
7540531|NCT03273283|18560348|P2|COMPLETED|Overall Study||81
7540532|NCT03273283|18560349|P1|COMPLETED|Overall Study||72
7540533|NCT03273283|18560348|P2|STARTED|Overall Study||101
7540534|NCT03273283|18560349|P1|STARTED|Overall Study||99
7540535|NCT03273166|18560357|P1|NOT COMPLETED|Overall Study||31
7540536|NCT03273166|18560357|P1|COMPLETED|Overall Study||51
7540537|NCT03273166|18560357|P1|STARTED|Overall Study||82
7540538|NCT03273153|18560364|P2|NOT COMPLETED|Overall Study||222
7540539|NCT03273153|18560365|P1|NOT COMPLETED|Overall Study||224
7540540|NCT03273153|18560364|P2|COMPLETED|Overall Study||0
7540541|NCT03273153|18560365|P1|COMPLETED|Overall Study||0
7540542|NCT03273153|18560364|P2|STARTED|Overall Study||222
7540543|NCT03273153|18560365|P1|STARTED|Overall Study||224
7540544|NCT03272711|18560387|P2|NOT COMPLETED|Overall Study||8
7540545|NCT03272711|18560388|P1|NOT COMPLETED|Overall Study||7
7540546|NCT03272711|18560387|P2|COMPLETED|Overall Study||41
7540547|NCT03272711|18560388|P1|COMPLETED|Overall Study||44
7540548|NCT03272711|18560387|P2|STARTED|Overall Study||49
7540549|NCT03272711|18560388|P1|STARTED|Overall Study||51
7540550|NCT03272139|18560400|P2|NOT COMPLETED|Overall Study||0
7540551|NCT03272139|18560401|P1|NOT COMPLETED|Overall Study||0
7540552|NCT03272139|18560400|P2|COMPLETED|Overall Study||63
7540553|NCT03272139|18560401|P1|COMPLETED|Overall Study||63
7540554|NCT03272139|18560400|P2|STARTED|Overall Study||63
7540555|NCT03272139|18560401|P1|STARTED|Overall Study||63
7540556|NCT03271424|18560414|P3|NOT COMPLETED|April-May 2016||0
7540557|NCT03271424|18560415|P2|NOT COMPLETED|April-May 2016||0
7540558|NCT03271424|18560416|P1|NOT COMPLETED|April-May 2016||0
7540559|NCT03271424|18560414|P3|COMPLETED|April-May 2016||40
7540560|NCT03271424|18560415|P2|COMPLETED|April-May 2016||0
7540561|NCT03271424|18560416|P1|COMPLETED|April-May 2016||0
7540562|NCT03271424|18560414|P3|STARTED|April-May 2016||40
7540563|NCT03271424|18560415|P2|STARTED|April-May 2016||0
7540564|NCT03271424|18560416|P1|STARTED|April-May 2016||0
7540565|NCT03271424|18560414|P3|NOT COMPLETED|December 2015||0
7540566|NCT03271424|18560415|P2|NOT COMPLETED|December 2015||0
7540567|NCT03271424|18560416|P1|NOT COMPLETED|December 2015||0
7540568|NCT03271424|18560414|P3|COMPLETED|December 2015||0
7540569|NCT03271424|18560415|P2|COMPLETED|December 2015||35
7540570|NCT03271424|18560416|P1|COMPLETED|December 2015||0
7540571|NCT03271424|18560414|P3|STARTED|December 2015||0
7540572|NCT03271424|18560415|P2|STARTED|December 2015||35
7540573|NCT03271424|18560416|P1|STARTED|December 2015||0
7540574|NCT03271424|18560414|P3|NOT COMPLETED|November 2015||0
7540575|NCT03271424|18560415|P2|NOT COMPLETED|November 2015||0
7540576|NCT03271424|18560416|P1|NOT COMPLETED|November 2015||0
7540577|NCT03271424|18560414|P3|COMPLETED|November 2015||0
7540578|NCT03271424|18560415|P2|COMPLETED|November 2015||0
7540579|NCT03271424|18560416|P1|COMPLETED|November 2015||20
7540580|NCT03271424|18560414|P3|STARTED|November 2015||0
7540581|NCT03271424|18560415|P2|STARTED|November 2015||0
7540582|NCT03271424|18560416|P1|STARTED|November 2015||20
7540583|NCT03271307|18560431|P5|NOT COMPLETED|Overall Study||91
7540584|NCT03271307|18560432|P4|NOT COMPLETED|Overall Study||28
7540585|NCT03271307|18560433|P3|NOT COMPLETED|Overall Study||0
7540586|NCT03271307|18560434|P2|NOT COMPLETED|Overall Study||0
7540587|NCT03271307|18560435|P1|NOT COMPLETED|Overall Study||0
7540588|NCT03271307|18560431|P5|COMPLETED|Overall Study||258
7540589|NCT03271307|18560432|P4|COMPLETED|Overall Study||107
7540590|NCT03271307|18560433|P3|COMPLETED|Overall Study||2097
7540591|NCT03271307|18560434|P2|COMPLETED|Overall Study||1837
7540592|NCT03271307|18560435|P1|COMPLETED|Overall Study||1951
7540593|NCT03271307|18560431|P5|STARTED|Overall Study||349
7540594|NCT03271307|18560432|P4|STARTED|Overall Study||135
7540595|NCT03271307|18560433|P3|STARTED|Overall Study||2097
7540596|NCT03271307|18560434|P2|STARTED|Overall Study||1837
7540597|NCT03271307|18560435|P1|STARTED|Overall Study||1951
7540598|NCT03271021|18560491|P2|NOT COMPLETED|Overall Study||106
7540599|NCT03271021|18560492|P1|NOT COMPLETED|Overall Study||89
7540600|NCT03271021|18560491|P2|COMPLETED|Overall Study||644
7540601|NCT03271021|18560492|P1|COMPLETED|Overall Study||649
7540602|NCT03271021|18560491|P2|STARTED|Overall Study||750
7540603|NCT03271021|18560492|P1|STARTED|Overall Study||738
7540604|NCT03270657|18560510|P1|NOT COMPLETED|Overall Study||1
7540605|NCT03270657|18560510|P1|COMPLETED|Overall Study||4
7540606|NCT03270657|18560510|P1|STARTED|Overall Study||5
7540607|NCT03270644|18560516|P1|NOT COMPLETED|Day 4 - 10 Propranolol Reference||1
7540608|NCT03270644|18560516|P1|COMPLETED|Day 4 - 10 Propranolol Reference||42
7540609|NCT03270644|18560516|P1|Day 9 Lasmiditan + Propranolol Test|Day 4 - 10 Propranolol Reference||42
7540610|NCT03270644|18560516|P1|Received at Least One Dose of Study Drug|Day 4 - 10 Propranolol Reference||43
7540611|NCT03270644|18560516|P1|STARTED|Day 4 - 10 Propranolol Reference||43
7540612|NCT03270644|18560516|P1|NOT COMPLETED|Day 1 Lasmiditan Reference||1
7540613|NCT03270644|18560516|P1|COMPLETED|Day 1 Lasmiditan Reference||43
7540614|NCT03270644|18560516|P1|Received at Least One Dose of Study Drug|Day 1 Lasmiditan Reference||44
7540615|NCT03270644|18560516|P1|STARTED|Day 1 Lasmiditan Reference||44
7540616|NCT03270436|18560539|P2|NOT COMPLETED|6 Months Post-Intervention||51
7540617|NCT03270436|18560540|P1|NOT COMPLETED|6 Months Post-Intervention||40
7540618|NCT03270436|18560539|P2|COMPLETED|6 Months Post-Intervention||116
7540619|NCT03270436|18560540|P1|COMPLETED|6 Months Post-Intervention||173
7540620|NCT03270436|18560539|P2|STARTED|6 Months Post-Intervention||167
7540621|NCT03270436|18560540|P1|STARTED|6 Months Post-Intervention||213
7540622|NCT03270436|18560539|P2|NOT COMPLETED|Immediate Post-Intervention||56
7540623|NCT03270436|18560540|P1|NOT COMPLETED|Immediate Post-Intervention||41
7540624|NCT03270436|18560539|P2|COMPLETED|Immediate Post-Intervention||111
7540625|NCT03270436|18560540|P1|COMPLETED|Immediate Post-Intervention||172
7540626|NCT03270436|18560539|P2|STARTED|Immediate Post-Intervention||167
7540627|NCT03270436|18560540|P1|STARTED|Immediate Post-Intervention||213
7540628|NCT03270436|18560539|P2|NOT COMPLETED|Baseline||1
7540629|NCT03270436|18560540|P1|NOT COMPLETED|Baseline||1
7540630|NCT03270436|18560539|P2|COMPLETED|Baseline||166
7540631|NCT03270436|18560540|P1|COMPLETED|Baseline||212
7540632|NCT03270436|18560539|P2|STARTED|Baseline||167
7540633|NCT03270436|18560540|P1|STARTED|Baseline||213
7540634|NCT03270085|18560566|P2|NOT COMPLETED|Overall Study||0
7540635|NCT03270085|18560567|P1|NOT COMPLETED|Overall Study||1
7540636|NCT03270085|18560566|P2|COMPLETED|Overall Study||15
7540637|NCT03270085|18560567|P1|COMPLETED|Overall Study||14
7540638|NCT03270085|18560566|P2|STARTED|Overall Study||15
7540639|NCT03270085|18560567|P1|STARTED|Overall Study||15
7540640|NCT03269968|18560579|P2|NOT COMPLETED|Overall Study||0
7540641|NCT03269968|18560580|P1|NOT COMPLETED|Overall Study||0
7540642|NCT03269968|18560579|P2|COMPLETED|Overall Study||0
7540643|NCT03269968|18560580|P1|COMPLETED|Overall Study||0
7540644|NCT03269968|18560579|P2|STARTED|Overall Study||0
7540645|NCT03269968|18560580|P1|STARTED|Overall Study||0
7540646|NCT03269552|18560588|P1|NOT COMPLETED|Overall Study||2
7540647|NCT03269552|18560588|P1|COMPLETED|Overall Study||2
7540648|NCT03269552|18560588|P1|STARTED|Overall Study||4
7540649|NCT03268941|18560599|P7|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7540650|NCT03268941|18560600|P6|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7540651|NCT03268941|18560601|P5|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7540652|NCT03268941|18560602|P4|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7540653|NCT03268941|18560603|P3|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7540654|NCT03268941|18560604|P2|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7540655|NCT03268941|18560605|P1|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7540656|NCT03268941|18560599|P7|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7540657|NCT03268941|18560600|P6|COMPLETED|Part 2: Period 2: Fasted (Day 25)||6
7540658|NCT03268941|18560601|P5|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7540659|NCT03268941|18560602|P4|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7540660|NCT03268941|18560603|P3|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7540661|NCT03268941|18560604|P2|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7540662|NCT03268941|18560605|P1|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7540663|NCT03268941|18560599|P7|STARTED|Part 2: Period 2: Fasted (Day 25)||0
7540664|NCT03268941|18560600|P6|STARTED|Part 2: Period 2: Fasted (Day 25)||6
7540665|NCT03268941|18560601|P5|STARTED|Part 2: Period 2: Fasted (Day 25)||0
7540666|NCT03268941|18560602|P4|STARTED|Part 2: Period 2: Fasted (Day 25)||0
7540667|NCT03268941|18560603|P3|STARTED|Part 2: Period 2: Fasted (Day 25)||0
7540668|NCT03268941|18560604|P2|STARTED|Part 2: Period 2: Fasted (Day 25)||0
7540669|NCT03268941|18560605|P1|STARTED|Part 2: Period 2: Fasted (Day 25)||0
7540670|NCT03268941|18560599|P7|NOT COMPLETED|Part 2: Days 17 to 25||2
7540671|NCT03268941|18560600|P6|NOT COMPLETED|Part 2: Days 17 to 25||0
7540672|NCT03268941|18560601|P5|NOT COMPLETED|Part 2: Days 17 to 25||0
7540673|NCT03268941|18560602|P4|NOT COMPLETED|Part 2: Days 17 to 25||0
7540674|NCT03268941|18560603|P3|NOT COMPLETED|Part 2: Days 17 to 25||0
7540675|NCT03268941|18560604|P2|NOT COMPLETED|Part 2: Days 17 to 25||0
7540676|NCT03268941|18560605|P1|NOT COMPLETED|Part 2: Days 17 to 25||0
7540677|NCT03268941|18560599|P7|COMPLETED|Part 2: Days 17 to 25||13
7540678|NCT03268941|18560600|P6|COMPLETED|Part 2: Days 17 to 25||0
7540679|NCT03268941|18560601|P5|COMPLETED|Part 2: Days 17 to 25||6
7540680|NCT03268941|18560602|P4|COMPLETED|Part 2: Days 17 to 25||0
7540681|NCT03268941|18560603|P3|COMPLETED|Part 2: Days 17 to 25||0
7540682|NCT03268941|18560604|P2|COMPLETED|Part 2: Days 17 to 25||0
7540683|NCT03268941|18560605|P1|COMPLETED|Part 2: Days 17 to 25||0
7540684|NCT03268941|18560599|P7|Treated|Part 2: Days 17 to 25||13
7540685|NCT03268941|18560600|P6|Treated|Part 2: Days 17 to 25||0
7540686|NCT03268941|18560601|P5|Treated|Part 2: Days 17 to 25||6
7540687|NCT03268941|18560602|P4|Treated|Part 2: Days 17 to 25||0
7540688|NCT03268941|18560603|P3|Treated|Part 2: Days 17 to 25||0
7540689|NCT03268941|18560604|P2|Treated|Part 2: Days 17 to 25||0
7540690|NCT03268941|18560605|P1|Treated|Part 2: Days 17 to 25||0
7540691|NCT03268941|18560599|P7|STARTED|Part 2: Days 17 to 25||15
7540692|NCT03268941|18560600|P6|STARTED|Part 2: Days 17 to 25||0
7540693|NCT03268941|18560601|P5|STARTED|Part 2: Days 17 to 25||6
7540694|NCT03268941|18560602|P4|STARTED|Part 2: Days 17 to 25||0
7540695|NCT03268941|18560603|P3|STARTED|Part 2: Days 17 to 25||0
7540696|NCT03268941|18560604|P2|STARTED|Part 2: Days 17 to 25||0
7540697|NCT03268941|18560605|P1|STARTED|Part 2: Days 17 to 25||0
7540698|NCT03268941|18560599|P7|NOT COMPLETED|Part 1 (Days 1 to 9)||0
7540699|NCT03268941|18560600|P6|NOT COMPLETED|Part 1 (Days 1 to 9)||0
7540700|NCT03268941|18560601|P5|NOT COMPLETED|Part 1 (Days 1 to 9)||0
7540701|NCT03268941|18560602|P4|NOT COMPLETED|Part 1 (Days 1 to 9)||2
7540702|NCT03268941|18560603|P3|NOT COMPLETED|Part 1 (Days 1 to 9)||0
7540703|NCT03268941|18560604|P2|NOT COMPLETED|Part 1 (Days 1 to 9)||0
7540704|NCT03268941|18560605|P1|NOT COMPLETED|Part 1 (Days 1 to 9)||1
7540705|NCT03268941|18560599|P7|COMPLETED|Part 1 (Days 1 to 9)||0
7540706|NCT03268941|18560600|P6|COMPLETED|Part 1 (Days 1 to 9)||0
7540707|NCT03268941|18560601|P5|COMPLETED|Part 1 (Days 1 to 9)||0
7540708|NCT03268941|18560602|P4|COMPLETED|Part 1 (Days 1 to 9)||11
7540709|NCT03268941|18560603|P3|COMPLETED|Part 1 (Days 1 to 9)||12
7540710|NCT03268941|18560604|P2|COMPLETED|Part 1 (Days 1 to 9)||14
7540711|NCT03268941|18560605|P1|COMPLETED|Part 1 (Days 1 to 9)||11
7540712|NCT03268941|18560599|P7|STARTED|Part 1 (Days 1 to 9)||0
7540713|NCT03268941|18560600|P6|STARTED|Part 1 (Days 1 to 9)||0
7540714|NCT03268941|18560601|P5|STARTED|Part 1 (Days 1 to 9)||0
7540715|NCT03268941|18560602|P4|STARTED|Part 1 (Days 1 to 9)||13
7540716|NCT03268941|18560603|P3|STARTED|Part 1 (Days 1 to 9)||12
7540717|NCT03268941|18560604|P2|STARTED|Part 1 (Days 1 to 9)||14
7540718|NCT03268941|18560605|P1|STARTED|Part 1 (Days 1 to 9)||12
7540719|NCT03268746|18560667|P1|NOT COMPLETED|Overall Study||1
7540720|NCT03268746|18560667|P1|COMPLETED|Overall Study||44
7540721|NCT03268746|18560667|P1|STARTED|Overall Study||45
7540722|NCT03268590|18560689|P1|NOT COMPLETED|Overall Study||1
7540723|NCT03268590|18560689|P1|COMPLETED|Overall Study|One participant did not complete MRI due to a previously undiagnosed subdermal metal shard in scalp.|32
7540724|NCT03268590|18560689|P1|STARTED|Overall Study||33
7540725|NCT03268343|18560696|P2|NOT COMPLETED|Overall Study||0
7540726|NCT03268343|18560697|P1|NOT COMPLETED|Overall Study||0
7540727|NCT03268343|18560696|P2|COMPLETED|Overall Study||12
7540728|NCT03268343|18560697|P1|COMPLETED|Overall Study||12
7540729|NCT03268343|18560696|P2|STARTED|Overall Study||12
7540730|NCT03268343|18560697|P1|STARTED|Overall Study||12
7540731|NCT03268005|18560724|P2|NOT COMPLETED|Overall Study||14
7540732|NCT03268005|18560725|P1|NOT COMPLETED|Overall Study||15
7540733|NCT03268005|18560724|P2|COMPLETED|Overall Study||531
7540734|NCT03268005|18560725|P1|COMPLETED|Overall Study||531
7540735|NCT03268005|18560724|P2|Safety Analysis Set|Overall Study||544
7540736|NCT03268005|18560725|P1|Safety Analysis Set|Overall Study||544
7540737|NCT03268005|18560724|P2|Full Analysis Set|Overall Study||545
7540738|NCT03268005|18560725|P1|Full Analysis Set|Overall Study||546
7540739|NCT03268005|18560724|P2|STARTED|Overall Study||545
7540740|NCT03268005|18560725|P1|STARTED|Overall Study||546
7540741|NCT03267940|18560839|P6|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
7540742|NCT03267940|18560840|P5|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
7540743|NCT03267940|18560841|P4|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||22
7540744|NCT03267940|18560842|P3|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||21
7540745|NCT03267940|18560843|P2|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
7540746|NCT03267940|18560844|P1|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
7540747|NCT03267940|18560839|P6|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
7540748|NCT03267940|18560840|P5|COMPLETED|Expansion (Maximum Exposure: 421 Days)||1
7540749|NCT03267940|18560841|P4|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
7540750|NCT03267940|18560842|P3|COMPLETED|Expansion (Maximum Exposure: 421 Days)||3
7540751|NCT03267940|18560843|P2|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
7540752|NCT03267940|18560844|P1|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
7540753|NCT03267940|18560839|P6|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||10
7540754|NCT03267940|18560840|P5|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||11
7540755|NCT03267940|18560841|P4|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||22
7540756|NCT03267940|18560842|P3|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||24
7540757|NCT03267940|18560843|P2|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
7540758|NCT03267940|18560844|P1|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
7540759|NCT03267940|18560839|P6|STARTED|Expansion (Maximum Exposure: 421 Days)||10
7540760|NCT03267940|18560840|P5|STARTED|Expansion (Maximum Exposure: 421 Days)||11
7540761|NCT03267940|18560841|P4|STARTED|Expansion (Maximum Exposure: 421 Days)||22
7540762|NCT03267940|18560842|P3|STARTED|Expansion (Maximum Exposure: 421 Days)||24
7540763|NCT03267940|18560843|P2|STARTED|Expansion (Maximum Exposure: 421 Days)||0
7540764|NCT03267940|18560844|P1|STARTED|Expansion (Maximum Exposure: 421 Days)||0
7540765|NCT03267940|18560839|P6|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
7540766|NCT03267940|18560840|P5|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
7540767|NCT03267940|18560841|P4|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
7540768|NCT03267940|18560842|P3|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
7540769|NCT03267940|18560843|P2|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||7
7540770|NCT03267940|18560844|P1|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||8
7540771|NCT03267940|18560839|P6|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
7540772|NCT03267940|18560840|P5|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
7540773|NCT03267940|18560841|P4|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
7540774|NCT03267940|18560842|P3|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
7540775|NCT03267940|18560843|P2|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||2
7540776|NCT03267940|18560844|P1|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||1
7540777|NCT03267940|18560839|P6|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
7540778|NCT03267940|18560840|P5|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
7540779|NCT03267940|18560841|P4|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
7540780|NCT03267940|18560842|P3|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
7540781|NCT03267940|18560843|P2|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
7540782|NCT03267940|18560844|P1|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
7540783|NCT03267940|18560839|P6|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
7540784|NCT03267940|18560840|P5|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
7540785|NCT03267940|18560841|P4|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
7540786|NCT03267940|18560842|P3|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
7540787|NCT03267940|18560843|P2|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
7540788|NCT03267940|18560844|P1|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
7540789|NCT03267576|18560946|P2|NOT COMPLETED|Period 2: Day 44 to 71||2
7540790|NCT03267576|18560947|P1|NOT COMPLETED|Period 2: Day 44 to 71||1
7540791|NCT03267576|18560946|P2|COMPLETED|Period 2: Day 44 to 71||30
7540792|NCT03267576|18560947|P1|COMPLETED|Period 2: Day 44 to 71||30
7540793|NCT03267576|18560946|P2|STARTED|Period 2: Day 44 to 71||32
7540794|NCT03267576|18560947|P1|STARTED|Period 2: Day 44 to 71||31
7540795|NCT03267576|18560946|P2|NOT COMPLETED|Washout Period: 16 Days||0
7540796|NCT03267576|18560947|P1|NOT COMPLETED|Washout Period: 16 Days||0
7540797|NCT03267576|18560946|P2|COMPLETED|Washout Period: 16 Days||32
7540798|NCT03267576|18560947|P1|COMPLETED|Washout Period: 16 Days||31
7540799|NCT03267576|18560946|P2|STARTED|Washout Period: 16 Days||32
7540800|NCT03267576|18560947|P1|STARTED|Washout Period: 16 Days||31
7540801|NCT03267576|18560946|P2|NOT COMPLETED|Period 1: Day 0 to 27||0
7540802|NCT03267576|18560947|P1|NOT COMPLETED|Period 1: Day 0 to 27||0
7540803|NCT03267576|18560946|P2|COMPLETED|Period 1: Day 0 to 27||32
7540804|NCT03267576|18560947|P1|COMPLETED|Period 1: Day 0 to 27||31
7540805|NCT03267576|18560946|P2|STARTED|Period 1: Day 0 to 27||32
7540806|NCT03267576|18560947|P1|STARTED|Period 1: Day 0 to 27||31
7540807|NCT03267511|18560985|P4|NOT COMPLETED|Overall Study||1
7540808|NCT03267511|18560986|P3|NOT COMPLETED|Overall Study||0
7540809|NCT03267511|18560987|P2|NOT COMPLETED|Overall Study||0
7540810|NCT03267511|18560988|P1|NOT COMPLETED|Overall Study||0
7540811|NCT03267511|18560985|P4|COMPLETED|Overall Study||30
7540812|NCT03267511|18560986|P3|COMPLETED|Overall Study||30
7540813|NCT03267511|18560987|P2|COMPLETED|Overall Study||31
7540814|NCT03267511|18560988|P1|COMPLETED|Overall Study||31
7540815|NCT03267511|18560985|P4|STARTED|Overall Study||31
7540816|NCT03267511|18560986|P3|STARTED|Overall Study||30
7540817|NCT03267511|18560987|P2|STARTED|Overall Study||31
7540818|NCT03267511|18560988|P1|STARTED|Overall Study||31
7540819|NCT03267264|18561004|P4|NOT COMPLETED|Overall Study||4
7540820|NCT03267264|18561005|P3|NOT COMPLETED|Overall Study||2
7540821|NCT03267264|18561006|P2|NOT COMPLETED|Overall Study||0
7540822|NCT03267264|18561007|P1|NOT COMPLETED|Overall Study||1
7540823|NCT03267264|18561004|P4|COMPLETED|Overall Study||61
7540824|NCT03267264|18561005|P3|COMPLETED|Overall Study||66
7540825|NCT03267264|18561006|P2|COMPLETED|Overall Study||49
7540826|NCT03267264|18561007|P1|COMPLETED|Overall Study||65
7540827|NCT03267264|18561004|P4|Sequence B(Comparator)|Overall Study||32
7540828|NCT03267264|18561005|P3|Sequence B(Comparator)|Overall Study||33
7540829|NCT03267264|18561006|P2|Sequence B(Comparator)|Overall Study||24
7540830|NCT03267264|18561007|P1|Sequence B(Comparator)|Overall Study||32
7540831|NCT03267264|18561004|P4|Sequence A(Nucleus)|Overall Study||33
7540832|NCT03267264|18561005|P3|Sequence A(Nucleus)|Overall Study||33
7540833|NCT03267264|18561006|P2|Sequence A(Nucleus)|Overall Study||25
7540834|NCT03267264|18561007|P1|Sequence A(Nucleus)|Overall Study||34
7540835|NCT03267264|18561004|P4|STARTED|Overall Study||65
7540836|NCT03267264|18561005|P3|STARTED|Overall Study||68
7540837|NCT03267264|18561006|P2|STARTED|Overall Study||49
7540838|NCT03267264|18561007|P1|STARTED|Overall Study||66
7540839|NCT03267212|18561024|P2|NOT COMPLETED|Second Intervention||0
7540840|NCT03267212|18561025|P1|NOT COMPLETED|Second Intervention||0
7540841|NCT03267212|18561024|P2|COMPLETED|Second Intervention||6
7540842|NCT03267212|18561025|P1|COMPLETED|Second Intervention||4
7540843|NCT03267212|18561024|P2|STARTED|Second Intervention||6
7540844|NCT03267212|18561025|P1|STARTED|Second Intervention||4
7540845|NCT03267212|18561024|P2|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||0
7540846|NCT03267212|18561025|P1|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||1
7540847|NCT03267212|18561024|P2|COMPLETED|Washout (Min 2 Days / Max 7 Days)||6
7540848|NCT03267212|18561025|P1|COMPLETED|Washout (Min 2 Days / Max 7 Days)||4
7540849|NCT03267212|18561024|P2|STARTED|Washout (Min 2 Days / Max 7 Days)||6
7540850|NCT03267212|18561025|P1|STARTED|Washout (Min 2 Days / Max 7 Days)||5
7540851|NCT03267212|18561024|P2|NOT COMPLETED|First Intervention||3
7540852|NCT03267212|18561025|P1|NOT COMPLETED|First Intervention||1
7540853|NCT03267212|18561024|P2|COMPLETED|First Intervention||6
7540854|NCT03267212|18561025|P1|COMPLETED|First Intervention||5
7540855|NCT03267212|18561024|P2|Low SCI|First Intervention||4
7540856|NCT03267212|18561025|P1|Low SCI|First Intervention||4
7540857|NCT03267212|18561024|P2|High SCI|First Intervention||5
7540858|NCT03267212|18561025|P1|High SCI|First Intervention||2
7540859|NCT03267212|18561024|P2|STARTED|First Intervention|"First Intervention (1 day), Washout (2 days), and Second Intervention (1 day)"|9
7540860|NCT03267212|18561025|P1|STARTED|First Intervention|Non-invasive ventilation|6
7540861|NCT03266588|18561040|P3|NOT COMPLETED|Long-term Treatment Period||65
7540862|NCT03266588|18561041|P2|NOT COMPLETED|Long-term Treatment Period||240
7540863|NCT03266588|18561042|P1|NOT COMPLETED|Long-term Treatment Period||406
7540864|NCT03266588|18561040|P3|COMPLETED|Long-term Treatment Period||243
7540865|NCT03266588|18561041|P2|COMPLETED|Long-term Treatment Period||271
7540866|NCT03266588|18561042|P1|COMPLETED|Long-term Treatment Period||683
7540867|NCT03266588|18561040|P3|Treated|Long-term Treatment Period||286
7540868|NCT03266588|18561041|P2|Treated|Long-term Treatment Period||481
7540869|NCT03266588|18561042|P1|Treated|Long-term Treatment Period||1033
7540870|NCT03266588|18561040|P3|STARTED|Long-term Treatment Period||308
7540871|NCT03266588|18561041|P2|STARTED|Long-term Treatment Period||511
7540872|NCT03266588|18561042|P1|STARTED|Long-term Treatment Period||1089
7540873|NCT03266588|18561040|P3|NOT COMPLETED|Observational Period||168
7540874|NCT03266588|18561041|P2|NOT COMPLETED|Observational Period||275
7540875|NCT03266588|18561042|P1|NOT COMPLETED|Observational Period||516
7540876|NCT03266588|18561040|P3|COMPLETED|Observational Period||308
7540877|NCT03266588|18561041|P2|COMPLETED|Observational Period||511
7540878|NCT03266588|18561042|P1|COMPLETED|Observational Period||1089
7540879|NCT03266588|18561040|P3|STARTED|Observational Period||476
7540880|NCT03266588|18561041|P2|STARTED|Observational Period||786
7540881|NCT03266588|18561042|P1|STARTED|Observational Period||1605
7540882|NCT03266419|18561061|P2|NOT COMPLETED|Overall Study||0
7540883|NCT03266419|18561062|P1|NOT COMPLETED|Overall Study||0
7540884|NCT03266419|18561061|P2|COMPLETED|Overall Study||49
7540885|NCT03266419|18561062|P1|COMPLETED|Overall Study||51
7540886|NCT03266419|18561061|P2|STARTED|Overall Study||49
7540887|NCT03266419|18561062|P1|STARTED|Overall Study||51
7540888|NCT03266172|18561073|P3|NOT COMPLETED|Part C Period 6(2 Days)||0
7540889|NCT03266172|18561074|P2|NOT COMPLETED|Part C Period 6(2 Days)||0
7540890|NCT03266172|18561075|P1|NOT COMPLETED|Part C Period 6(2 Days)||0
7540891|NCT03266172|18561073|P3|COMPLETED|Part C Period 6(2 Days)||14
7540892|NCT03266172|18561074|P2|COMPLETED|Part C Period 6(2 Days)||0
7540893|NCT03266172|18561075|P1|COMPLETED|Part C Period 6(2 Days)||0
7540894|NCT03266172|18561073|P3|STARTED|Part C Period 6(2 Days)||14
7540895|NCT03266172|18561074|P2|STARTED|Part C Period 6(2 Days)||0
7540896|NCT03266172|18561075|P1|STARTED|Part C Period 6(2 Days)||0
7540897|NCT03266172|18561073|P3|NOT COMPLETED|Part C Washout Period (7 Days)||1
7540898|NCT03266172|18561074|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
7540899|NCT03266172|18561075|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
7540900|NCT03266172|18561073|P3|COMPLETED|Part C Washout Period (7 Days)||14
7540901|NCT03266172|18561074|P2|COMPLETED|Part C Washout Period (7 Days)||0
7540902|NCT03266172|18561075|P1|COMPLETED|Part C Washout Period (7 Days)||0
7540903|NCT03266172|18561073|P3|STARTED|Part C Washout Period (7 Days)||15
7540904|NCT03266172|18561074|P2|STARTED|Part C Washout Period (7 Days)||0
7540905|NCT03266172|18561075|P1|STARTED|Part C Washout Period (7 Days)||0
7540906|NCT03266172|18561073|P3|NOT COMPLETED|Part C Period 5(2 Days)||0
7540907|NCT03266172|18561074|P2|NOT COMPLETED|Part C Period 5(2 Days)||0
7540908|NCT03266172|18561075|P1|NOT COMPLETED|Part C Period 5(2 Days)||0
7540909|NCT03266172|18561073|P3|COMPLETED|Part C Period 5(2 Days)||15
7540910|NCT03266172|18561074|P2|COMPLETED|Part C Period 5(2 Days)||0
7540911|NCT03266172|18561075|P1|COMPLETED|Part C Period 5(2 Days)||0
7540912|NCT03266172|18561073|P3|STARTED|Part C Period 5(2 Days)||15
7540913|NCT03266172|18561074|P2|STARTED|Part C Period 5(2 Days)||0
7540914|NCT03266172|18561075|P1|STARTED|Part C Period 5(2 Days)||0
7540915|NCT03266172|18561073|P3|NOT COMPLETED|Part C Washout Period (7 Days)||1
7540916|NCT03266172|18561074|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
7540917|NCT03266172|18561075|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
7540918|NCT03266172|18561073|P3|COMPLETED|Part C Washout Period (7 Days)||15
7540919|NCT03266172|18561074|P2|COMPLETED|Part C Washout Period (7 Days)||0
7540920|NCT03266172|18561075|P1|COMPLETED|Part C Washout Period (7 Days)||0
7540921|NCT03266172|18561073|P3|STARTED|Part C Washout Period (7 Days)||16
7540922|NCT03266172|18561074|P2|STARTED|Part C Washout Period (7 Days)||0
7540923|NCT03266172|18561075|P1|STARTED|Part C Washout Period (7 Days)||0
7540924|NCT03266172|18561073|P3|NOT COMPLETED|Part C Period 4(2 Days)||0
7540925|NCT03266172|18561074|P2|NOT COMPLETED|Part C Period 4(2 Days)||0
7540926|NCT03266172|18561075|P1|NOT COMPLETED|Part C Period 4(2 Days)||0
7540927|NCT03266172|18561073|P3|COMPLETED|Part C Period 4(2 Days)||16
7540928|NCT03266172|18561074|P2|COMPLETED|Part C Period 4(2 Days)||0
7540929|NCT03266172|18561075|P1|COMPLETED|Part C Period 4(2 Days)||0
7540930|NCT03266172|18561073|P3|STARTED|Part C Period 4(2 Days)||16
7540931|NCT03266172|18561074|P2|STARTED|Part C Period 4(2 Days)||0
7540932|NCT03266172|18561075|P1|STARTED|Part C Period 4(2 Days)||0
7540933|NCT03266172|18561073|P3|NOT COMPLETED|Part C Washout Period (7 Days)||0
7540934|NCT03266172|18561074|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
7540935|NCT03266172|18561075|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
7540936|NCT03266172|18561073|P3|COMPLETED|Part C Washout Period (7 Days)||16
7540937|NCT03266172|18561074|P2|COMPLETED|Part C Washout Period (7 Days)||0
7540938|NCT03266172|18561075|P1|COMPLETED|Part C Washout Period (7 Days)||0
7540939|NCT03266172|18561073|P3|STARTED|Part C Washout Period (7 Days)||16
7540940|NCT03266172|18561074|P2|STARTED|Part C Washout Period (7 Days)||0
7540941|NCT03266172|18561075|P1|STARTED|Part C Washout Period (7 Days)||0
7540942|NCT03266172|18561073|P3|NOT COMPLETED|Part C Period 3(2 Days)||0
7540943|NCT03266172|18561074|P2|NOT COMPLETED|Part C Period 3(2 Days)||0
7540944|NCT03266172|18561075|P1|NOT COMPLETED|Part C Period 3(2 Days)||0
7540945|NCT03266172|18561073|P3|COMPLETED|Part C Period 3(2 Days)||16
7540946|NCT03266172|18561074|P2|COMPLETED|Part C Period 3(2 Days)||0
7540947|NCT03266172|18561075|P1|COMPLETED|Part C Period 3(2 Days)||0
7540948|NCT03266172|18561073|P3|STARTED|Part C Period 3(2 Days)|1 replacement participant enrolled|16
7540949|NCT03266172|18561074|P2|STARTED|Part C Period 3(2 Days)||0
7540950|NCT03266172|18561075|P1|STARTED|Part C Period 3(2 Days)||0
7540951|NCT03266172|18561073|P3|NOT COMPLETED|Part C Washout Period (7 Days)||0
7540952|NCT03266172|18561074|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
7540953|NCT03266172|18561075|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
7540954|NCT03266172|18561073|P3|COMPLETED|Part C Washout Period (7 Days)||15
7540955|NCT03266172|18561074|P2|COMPLETED|Part C Washout Period (7 Days)||0
7540956|NCT03266172|18561075|P1|COMPLETED|Part C Washout Period (7 Days)||0
7540957|NCT03266172|18561073|P3|STARTED|Part C Washout Period (7 Days)||15
7540958|NCT03266172|18561074|P2|STARTED|Part C Washout Period (7 Days)||0
7540959|NCT03266172|18561075|P1|STARTED|Part C Washout Period (7 Days)||0
7540960|NCT03266172|18561073|P3|NOT COMPLETED|Part C Period 2(2 Days)||0
7540961|NCT03266172|18561074|P2|NOT COMPLETED|Part C Period 2(2 Days)||0
7540962|NCT03266172|18561075|P1|NOT COMPLETED|Part C Period 2(2 Days)||0
7540963|NCT03266172|18561073|P3|COMPLETED|Part C Period 2(2 Days)||15
7540964|NCT03266172|18561074|P2|COMPLETED|Part C Period 2(2 Days)||0
7540965|NCT03266172|18561075|P1|COMPLETED|Part C Period 2(2 Days)||0
7540966|NCT03266172|18561073|P3|STARTED|Part C Period 2(2 Days)||15
7540967|NCT03266172|18561074|P2|STARTED|Part C Period 2(2 Days)||0
7540968|NCT03266172|18561075|P1|STARTED|Part C Period 2(2 Days)||0
7540969|NCT03266172|18561073|P3|NOT COMPLETED|Part C Washout Period (7 Days)||0
7540970|NCT03266172|18561074|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
7540971|NCT03266172|18561075|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
7540972|NCT03266172|18561073|P3|COMPLETED|Part C Washout Period (7 Days)||15
7540973|NCT03266172|18561074|P2|COMPLETED|Part C Washout Period (7 Days)||0
7540974|NCT03266172|18561075|P1|COMPLETED|Part C Washout Period (7 Days)||0
7540975|NCT03266172|18561073|P3|STARTED|Part C Washout Period (7 Days)||15
7540976|NCT03266172|18561074|P2|STARTED|Part C Washout Period (7 Days)||0
7540977|NCT03266172|18561075|P1|STARTED|Part C Washout Period (7 Days)||0
7540978|NCT03266172|18561073|P3|NOT COMPLETED|Part C: Period 1(2 Days)||0
7540979|NCT03266172|18561074|P2|NOT COMPLETED|Part C: Period 1(2 Days)||0
7540980|NCT03266172|18561075|P1|NOT COMPLETED|Part C: Period 1(2 Days)||0
7540981|NCT03266172|18561073|P3|COMPLETED|Part C: Period 1(2 Days)||15
7540982|NCT03266172|18561074|P2|COMPLETED|Part C: Period 1(2 Days)||0
7540983|NCT03266172|18561075|P1|COMPLETED|Part C: Period 1(2 Days)||0
7540984|NCT03266172|18561073|P3|STARTED|Part C: Period 1(2 Days)|New participants were enrolled in Part C of study|15
7540985|NCT03266172|18561074|P2|STARTED|Part C: Period 1(2 Days)|Participants from Part B did not enter Part C|0
7540986|NCT03266172|18561075|P1|STARTED|Part C: Period 1(2 Days)||0
7540987|NCT03266172|18561073|P3|NOT COMPLETED|Part B: Period 3 (4 Days)||0
7540988|NCT03266172|18561074|P2|NOT COMPLETED|Part B: Period 3 (4 Days)||0
7540989|NCT03266172|18561075|P1|NOT COMPLETED|Part B: Period 3 (4 Days)||0
7540990|NCT03266172|18561073|P3|COMPLETED|Part B: Period 3 (4 Days)||0
7540991|NCT03266172|18561074|P2|COMPLETED|Part B: Period 3 (4 Days)||6
7540992|NCT03266172|18561075|P1|COMPLETED|Part B: Period 3 (4 Days)||0
7540993|NCT03266172|18561073|P3|STARTED|Part B: Period 3 (4 Days)||0
7540994|NCT03266172|18561074|P2|STARTED|Part B: Period 3 (4 Days)|Two participants completed Washout Period but withdrew before the start of Period 3.|6
7540995|NCT03266172|18561075|P1|STARTED|Part B: Period 3 (4 Days)||0
7540996|NCT03266172|18561073|P3|NOT COMPLETED|Part B: Washout (7 Days)||0
7540997|NCT03266172|18561074|P2|NOT COMPLETED|Part B: Washout (7 Days)||2
7540998|NCT03266172|18561075|P1|NOT COMPLETED|Part B: Washout (7 Days)||0
7540999|NCT03266172|18561073|P3|COMPLETED|Part B: Washout (7 Days)||0
7541000|NCT03266172|18561074|P2|COMPLETED|Part B: Washout (7 Days)||8
7541001|NCT03266172|18561075|P1|COMPLETED|Part B: Washout (7 Days)||0
7541002|NCT03266172|18561073|P3|STARTED|Part B: Washout (7 Days)||0
7541003|NCT03266172|18561074|P2|STARTED|Part B: Washout (7 Days)||10
7541004|NCT03266172|18561075|P1|STARTED|Part B: Washout (7 Days)||0
7541005|NCT03266172|18561073|P3|NOT COMPLETED|Part B: Period 2 (4 Days)||0
7541006|NCT03266172|18561074|P2|NOT COMPLETED|Part B: Period 2 (4 Days)||0
7541007|NCT03266172|18561075|P1|NOT COMPLETED|Part B: Period 2 (4 Days)||0
7541008|NCT03266172|18561073|P3|COMPLETED|Part B: Period 2 (4 Days)||0
7541009|NCT03266172|18561074|P2|COMPLETED|Part B: Period 2 (4 Days)||10
7541010|NCT03266172|18561075|P1|COMPLETED|Part B: Period 2 (4 Days)||0
7541011|NCT03266172|18561073|P3|STARTED|Part B: Period 2 (4 Days)||0
7541012|NCT03266172|18561074|P2|STARTED|Part B: Period 2 (4 Days)||10
7541013|NCT03266172|18561075|P1|STARTED|Part B: Period 2 (4 Days)||0
7541014|NCT03266172|18561073|P3|NOT COMPLETED|Part B: Washout (7 Days)||0
7541015|NCT03266172|18561074|P2|NOT COMPLETED|Part B: Washout (7 Days)||0
7541016|NCT03266172|18561075|P1|NOT COMPLETED|Part B: Washout (7 Days)||0
7541017|NCT03266172|18561073|P3|COMPLETED|Part B: Washout (7 Days)||0
7541018|NCT03266172|18561074|P2|COMPLETED|Part B: Washout (7 Days)||10
7541019|NCT03266172|18561075|P1|COMPLETED|Part B: Washout (7 Days)||0
7541020|NCT03266172|18561073|P3|STARTED|Part B: Washout (7 Days)||0
7541021|NCT03266172|18561074|P2|STARTED|Part B: Washout (7 Days)||10
7541022|NCT03266172|18561075|P1|STARTED|Part B: Washout (7 Days)||0
7541023|NCT03266172|18561073|P3|NOT COMPLETED|Part B: Period 1 (4 Days)||0
7541024|NCT03266172|18561074|P2|NOT COMPLETED|Part B: Period 1 (4 Days)||0
7541025|NCT03266172|18561075|P1|NOT COMPLETED|Part B: Period 1 (4 Days)||0
7541026|NCT03266172|18561073|P3|COMPLETED|Part B: Period 1 (4 Days)||0
7541027|NCT03266172|18561074|P2|COMPLETED|Part B: Period 1 (4 Days)||10
7541028|NCT03266172|18561075|P1|COMPLETED|Part B: Period 1 (4 Days)||0
7541029|NCT03266172|18561073|P3|STARTED|Part B: Period 1 (4 Days)||0
7541030|NCT03266172|18561074|P2|STARTED|Part B: Period 1 (4 Days)|New participants were enrolled in Part B of study|10
7541031|NCT03266172|18561075|P1|STARTED|Part B: Period 1 (4 Days)|Participants from Part A did not enter Part B|0
7541032|NCT03266172|18561073|P3|NOT COMPLETED|Part A: Period 4 (2 Days)||0
7541033|NCT03266172|18561074|P2|NOT COMPLETED|Part A: Period 4 (2 Days)||0
7541034|NCT03266172|18561075|P1|NOT COMPLETED|Part A: Period 4 (2 Days)||0
7541035|NCT03266172|18561073|P3|COMPLETED|Part A: Period 4 (2 Days)||0
7541036|NCT03266172|18561074|P2|COMPLETED|Part A: Period 4 (2 Days)||0
7541037|NCT03266172|18561075|P1|COMPLETED|Part A: Period 4 (2 Days)||16
7541038|NCT03266172|18561073|P3|STARTED|Part A: Period 4 (2 Days)||0
7541039|NCT03266172|18561074|P2|STARTED|Part A: Period 4 (2 Days)||0
7541040|NCT03266172|18561075|P1|STARTED|Part A: Period 4 (2 Days)||16
7541041|NCT03266172|18561073|P3|NOT COMPLETED|Part A: Washout (7 Days)||0
7541042|NCT03266172|18561074|P2|NOT COMPLETED|Part A: Washout (7 Days)||0
7541043|NCT03266172|18561075|P1|NOT COMPLETED|Part A: Washout (7 Days)||0
7541044|NCT03266172|18561073|P3|COMPLETED|Part A: Washout (7 Days)||0
7541045|NCT03266172|18561074|P2|COMPLETED|Part A: Washout (7 Days)||0
7541046|NCT03266172|18561075|P1|COMPLETED|Part A: Washout (7 Days)||16
7541047|NCT03266172|18561073|P3|STARTED|Part A: Washout (7 Days)||0
7541048|NCT03266172|18561074|P2|STARTED|Part A: Washout (7 Days)||0
7541049|NCT03266172|18561075|P1|STARTED|Part A: Washout (7 Days)||16
7541050|NCT03266172|18561073|P3|NOT COMPLETED|Part A: Period 3 (2 Days)||0
7541051|NCT03266172|18561074|P2|NOT COMPLETED|Part A: Period 3 (2 Days)||0
7541052|NCT03266172|18561075|P1|NOT COMPLETED|Part A: Period 3 (2 Days)||0
7541053|NCT03266172|18561073|P3|COMPLETED|Part A: Period 3 (2 Days)||0
7541054|NCT03266172|18561074|P2|COMPLETED|Part A: Period 3 (2 Days)||0
7541055|NCT03266172|18561075|P1|COMPLETED|Part A: Period 3 (2 Days)||16
7541056|NCT03266172|18561073|P3|STARTED|Part A: Period 3 (2 Days)||0
7541057|NCT03266172|18561074|P2|STARTED|Part A: Period 3 (2 Days)||0
7541058|NCT03266172|18561075|P1|STARTED|Part A: Period 3 (2 Days)|3 replacement participants were enrolled|16
7541059|NCT03266172|18561073|P3|NOT COMPLETED|Part A: Washout (7 Days)||0
7541060|NCT03266172|18561074|P2|NOT COMPLETED|Part A: Washout (7 Days)||0
7541061|NCT03266172|18561075|P1|NOT COMPLETED|Part A: Washout (7 Days)||0
7541062|NCT03266172|18561073|P3|COMPLETED|Part A: Washout (7 Days)||0
7541063|NCT03266172|18561074|P2|COMPLETED|Part A: Washout (7 Days)||0
7541064|NCT03266172|18561075|P1|COMPLETED|Part A: Washout (7 Days)||13
7541065|NCT03266172|18561073|P3|STARTED|Part A: Washout (7 Days)||0
7541066|NCT03266172|18561074|P2|STARTED|Part A: Washout (7 Days)||0
7541067|NCT03266172|18561075|P1|STARTED|Part A: Washout (7 Days)||13
7541068|NCT03266172|18561073|P3|NOT COMPLETED|Part A: Period 2 (2 Days)||0
7541069|NCT03266172|18561074|P2|NOT COMPLETED|Part A: Period 2 (2 Days)||0
7541070|NCT03266172|18561075|P1|NOT COMPLETED|Part A: Period 2 (2 Days)||0
7541071|NCT03266172|18561073|P3|COMPLETED|Part A: Period 2 (2 Days)||0
7541072|NCT03266172|18561074|P2|COMPLETED|Part A: Period 2 (2 Days)||0
7541073|NCT03266172|18561075|P1|COMPLETED|Part A: Period 2 (2 Days)||13
7541074|NCT03266172|18561073|P3|STARTED|Part A: Period 2 (2 Days)||0
7541075|NCT03266172|18561074|P2|STARTED|Part A: Period 2 (2 Days)||0
7541076|NCT03266172|18561075|P1|STARTED|Part A: Period 2 (2 Days)||13
7541077|NCT03266172|18561073|P3|NOT COMPLETED|Part A: Washout Period (7 Days)||0
7541078|NCT03266172|18561074|P2|NOT COMPLETED|Part A: Washout Period (7 Days)||0
7541079|NCT03266172|18561075|P1|NOT COMPLETED|Part A: Washout Period (7 Days)||2
7541080|NCT03266172|18561073|P3|COMPLETED|Part A: Washout Period (7 Days)||0
7541081|NCT03266172|18561074|P2|COMPLETED|Part A: Washout Period (7 Days)||0
7541082|NCT03266172|18561075|P1|COMPLETED|Part A: Washout Period (7 Days)||13
7541083|NCT03266172|18561073|P3|STARTED|Part A: Washout Period (7 Days)||0
7541084|NCT03266172|18561074|P2|STARTED|Part A: Washout Period (7 Days)||0
7541085|NCT03266172|18561075|P1|STARTED|Part A: Washout Period (7 Days)||15
7541086|NCT03266172|18561073|P3|NOT COMPLETED|Part A: Period 1(2 Days)||0
7541087|NCT03266172|18561074|P2|NOT COMPLETED|Part A: Period 1(2 Days)||0
7541088|NCT03266172|18561075|P1|NOT COMPLETED|Part A: Period 1(2 Days)||1
7541089|NCT03266172|18561073|P3|COMPLETED|Part A: Period 1(2 Days)||0
7541090|NCT03266172|18561074|P2|COMPLETED|Part A: Period 1(2 Days)||0
7541091|NCT03266172|18561075|P1|COMPLETED|Part A: Period 1(2 Days)||15
7541092|NCT03266172|18561073|P3|STARTED|Part A: Period 1(2 Days)||0
7541093|NCT03266172|18561074|P2|STARTED|Part A: Period 1(2 Days)||0
7541094|NCT03266172|18561075|P1|STARTED|Part A: Period 1(2 Days)||16
7541095|NCT03266107|18561320|P1|NOT COMPLETED|12-Month Follow-up Visit||1
7541096|NCT03266107|18561320|P1|COMPLETED|12-Month Follow-up Visit||45
7541097|NCT03266107|18561320|P1|STARTED|12-Month Follow-up Visit||46
7541098|NCT03266107|18561320|P1|NOT COMPLETED|3-Month Follow-up Visit||1
7541099|NCT03266107|18561320|P1|COMPLETED|3-Month Follow-up Visit||46
7541100|NCT03266107|18561320|P1|STARTED|3-Month Follow-up Visit||47
7541101|NCT03266107|18561320|P1|NOT COMPLETED|Enrollment to Procedure||3
7541102|NCT03266107|18561320|P1|COMPLETED|Enrollment to Procedure||47
7541103|NCT03266107|18561320|P1|STARTED|Enrollment to Procedure||50
7541104|NCT03266094|18561332|P1|NOT COMPLETED|Overall Study||2
7541105|NCT03266094|18561332|P1|COMPLETED|Overall Study||58
7541106|NCT03266094|18561332|P1|STARTED|Overall Study||60
7541107|NCT03265938|18561350|P1|NOT COMPLETED|Overall Study||8
7541108|NCT03265938|18561350|P1|COMPLETED|Overall Study||92
7541109|NCT03265938|18561350|P1|STARTED|Overall Study||100
7541110|NCT03265600|18561363|P2|NOT COMPLETED|Overall Study||12
7541111|NCT03265600|18561364|P1|NOT COMPLETED|Overall Study||24
7541112|NCT03265600|18561363|P2|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|32
7541113|NCT03265600|18561364|P1|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|68
7541114|NCT03265600|18561363|P2|STARTED|Overall Study||44
7541115|NCT03265600|18561364|P1|STARTED|Overall Study||92
7541116|NCT03265132|18561390|P2|NOT COMPLETED|Overall Study||6
7541117|NCT03265132|18561391|P1|NOT COMPLETED|Overall Study||0
7541118|NCT03265132|18561390|P2|COMPLETED|Overall Study||0
7541119|NCT03265132|18561391|P1|COMPLETED|Overall Study||6
7541120|NCT03265132|18561390|P2|STARTED|Overall Study|One patient failed disease specific inclusion criteria and was excluded from efficacy analysis|6
7541121|NCT03265132|18561391|P1|STARTED|Overall Study||6
7541122|NCT03265119|18561489|P2|NOT COMPLETED|Overall Study||7
7541123|NCT03265119|18561490|P1|NOT COMPLETED|Overall Study||10
7541124|NCT03265119|18561489|P2|COMPLETED|Overall Study||28
7541125|NCT03265119|18561490|P1|COMPLETED|Overall Study||24
7541126|NCT03265119|18561489|P2|STARTED|Overall Study||35
7541127|NCT03265119|18561490|P1|STARTED|Overall Study||34
7541128|NCT03264456|18561498|P1|NOT COMPLETED|Overall Study||4
7541129|NCT03264456|18561498|P1|COMPLETED|Overall Study||14
7541130|NCT03264456|18561498|P1|STARTED|Overall Study||18
7541131|NCT03264248|18561505|P1|NOT COMPLETED|Overall Study||0
7541132|NCT03264248|18561505|P1|COMPLETED|Overall Study||9
7541133|NCT03264248|18561505|P1|STARTED|Overall Study||9
7541134|NCT03264157|18561514|P2|NOT COMPLETED|Overall Study||7
7541135|NCT03264157|18561515|P1|NOT COMPLETED|Overall Study||13
7541136|NCT03264157|18561514|P2|COMPLETED|Overall Study||74
7541137|NCT03264157|18561515|P1|COMPLETED|Overall Study||68
7541138|NCT03264157|18561514|P2|STARTED|Overall Study||81
7541139|NCT03264157|18561515|P1|STARTED|Overall Study||81
7541140|NCT03263806|18561533|P2|NOT COMPLETED|Overall Study||7
7541141|NCT03263806|18561534|P1|NOT COMPLETED|Overall Study||6
7541142|NCT03263806|18561533|P2|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
7541143|NCT03263806|18561534|P1|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
7541144|NCT03263806|18561533|P2|STARTED|Overall Study||7
7541145|NCT03263806|18561534|P1|STARTED|Overall Study||6
7541146|NCT03263702|18561548|P2|NOT COMPLETED|Overall Study||4
7541147|NCT03263702|18561549|P1|NOT COMPLETED|Overall Study||3
7541148|NCT03263702|18561548|P2|COMPLETED|Overall Study||22
7541149|NCT03263702|18561549|P1|COMPLETED|Overall Study||35
7541150|NCT03263702|18561548|P2|STARTED|Overall Study||26
7541151|NCT03263702|18561549|P1|STARTED|Overall Study||38
7541152|NCT03262441|18561575|P1|NOT COMPLETED|Overall Study||1
7541153|NCT03262441|18561575|P1|COMPLETED|Overall Study||4
7541154|NCT03262441|18561575|P1|STARTED|Overall Study||5
7541155|NCT03262233|18561587|P4|NOT COMPLETED|Overall Study||29
7541156|NCT03262233|18561588|P3|NOT COMPLETED|Overall Study||25
7541157|NCT03262233|18561589|P2|NOT COMPLETED|Overall Study||21
7541158|NCT03262233|18561590|P1|NOT COMPLETED|Overall Study||18
7541159|NCT03262233|18561587|P4|COMPLETED|Overall Study||32
7541160|NCT03262233|18561588|P3|COMPLETED|Overall Study||34
7541161|NCT03262233|18561589|P2|COMPLETED|Overall Study||32
7541162|NCT03262233|18561590|P1|COMPLETED|Overall Study||35
7541163|NCT03262233|18561587|P4|STARTED|Overall Study||61
7541164|NCT03262233|18561588|P3|STARTED|Overall Study||59
7541165|NCT03262233|18561589|P2|STARTED|Overall Study||53
7541166|NCT03262233|18561590|P1|STARTED|Overall Study||53
7541167|NCT03262012|18561616|P4|NOT COMPLETED|Overall Study||15
7541168|NCT03262012|18561617|P3|NOT COMPLETED|Overall Study||14
7541169|NCT03262012|18561618|P2|NOT COMPLETED|Overall Study||36
7541170|NCT03262012|18561619|P1|NOT COMPLETED|Overall Study||27
7541171|NCT03262012|18561616|P4|COMPLETED|Overall Study||54
7541172|NCT03262012|18561617|P3|COMPLETED|Overall Study||56
7541173|NCT03262012|18561618|P2|COMPLETED|Overall Study||102
7541174|NCT03262012|18561619|P1|COMPLETED|Overall Study||112
7541175|NCT03262012|18561616|P4|STARTED|Overall Study||69
7541176|NCT03262012|18561617|P3|STARTED|Overall Study||70
7541177|NCT03262012|18561618|P2|STARTED|Overall Study||138
7541178|NCT03262012|18561619|P1|STARTED|Overall Study||139
7541179|NCT03261999|18561637|P1|NOT COMPLETED|Overall Study||15
7541180|NCT03261999|18561637|P1|COMPLETED|Overall Study||129
7541181|NCT03261999|18561637|P1|PP|Overall Study||132
7541182|NCT03261999|18561637|P1|ITT|Overall Study||144
7541183|NCT03261999|18561637|P1|STARTED|Overall Study||144
7541184|NCT03261531|18561642|P1|NOT COMPLETED|Overall Study||4
7541185|NCT03261531|18561642|P1|COMPLETED|Overall Study||3
7541186|NCT03261531|18561642|P1|STARTED|Overall Study||7
7541187|NCT03261167|18561660|P2|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
7541188|NCT03261167|18561661|P1|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
7541189|NCT03261167|18561660|P2|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||40
7541190|NCT03261167|18561661|P1|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||43
7541191|NCT03261167|18561660|P2|STARTED|Open-label(Treatment cycle4,Upto Week48)||40
7541192|NCT03261167|18561661|P1|STARTED|Open-label(Treatment cycle4,Upto Week48)||43
7541282|NCT03259490|18561913|P2|STARTED|Period 2||14
7541193|NCT03261167|18561660|P2|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
7541194|NCT03261167|18561661|P1|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
7541195|NCT03261167|18561660|P2|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||55
7541196|NCT03261167|18561661|P1|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||54
7541197|NCT03261167|18561660|P2|STARTED|Open-label(Treatment cycle3,Upto Week48)||56
7541198|NCT03261167|18561661|P1|STARTED|Open-label(Treatment cycle3,Upto Week48)||55
7541199|NCT03261167|18561660|P2|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||0
7541200|NCT03261167|18561661|P1|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||2
7541201|NCT03261167|18561660|P2|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||57
7541202|NCT03261167|18561661|P1|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||58
7541203|NCT03261167|18561660|P2|STARTED|Open-label(Treatment cycle2,Upto Week48)||57
7541204|NCT03261167|18561661|P1|STARTED|Open-label(Treatment cycle2,Upto Week48)||60
7541205|NCT03261167|18561660|P2|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||4
7541206|NCT03261167|18561661|P1|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||3
7541207|NCT03261167|18561660|P2|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||57
7541208|NCT03261167|18561661|P1|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||60
7541209|NCT03261167|18561660|P2|STARTED|Double Blind(Treatment cyc1,Upto Week48)||61
7541210|NCT03261167|18561661|P1|STARTED|Double Blind(Treatment cyc1,Upto Week48)||63
7541211|NCT03260894|18561699|P2|NOT COMPLETED|Overall Study||50
7541212|NCT03260894|18561700|P1|NOT COMPLETED|Overall Study||46
7541213|NCT03260894|18561699|P2|COMPLETED|Overall Study||15
7541214|NCT03260894|18561700|P1|COMPLETED|Overall Study||18
7541215|NCT03260894|18561699|P2|All Subjects as Treated (ASaT)|Overall Study||63
7541216|NCT03260894|18561700|P1|All Subjects as Treated (ASaT)|Overall Study||64
7541217|NCT03260894|18561699|P2|Intention-to-Treat (ITT)|Overall Study||65
7541218|NCT03260894|18561700|P1|Intention-to-Treat (ITT)|Overall Study||64
7541219|NCT03260894|18561699|P2|STARTED|Overall Study||65
7541220|NCT03260894|18561700|P1|STARTED|Overall Study||64
7541221|NCT03260868|18561712|P2|NOT COMPLETED|Overall Study||3
7541222|NCT03260868|18561713|P1|NOT COMPLETED|Overall Study||3
7541223|NCT03260868|18561712|P2|COMPLETED|Overall Study||4
7541224|NCT03260868|18561713|P1|COMPLETED|Overall Study||5
7541225|NCT03260868|18561712|P2|Safety Population|Overall Study||6
7541226|NCT03260868|18561713|P1|Safety Population|Overall Study||8
7541227|NCT03260868|18561712|P2|STARTED|Overall Study||7
7541228|NCT03260868|18561713|P1|STARTED|Overall Study||8
7541229|NCT03260699|18561753|P2|NOT COMPLETED|Overall Study||2
7541230|NCT03260699|18561754|P1|NOT COMPLETED|Overall Study||0
7541231|NCT03260699|18561753|P2|COMPLETED|Overall Study||2
7541232|NCT03260699|18561754|P1|COMPLETED|Overall Study||5
7541233|NCT03260699|18561753|P2|STARTED|Overall Study||4
7541234|NCT03260699|18561754|P1|STARTED|Overall Study||5
7541235|NCT03260595|18561783|P3|NOT COMPLETED|Overall Study||0
7541236|NCT03260595|18561784|P2|NOT COMPLETED|Overall Study||0
7541237|NCT03260595|18561785|P1|NOT COMPLETED|Overall Study||0
7541238|NCT03260595|18561783|P3|COMPLETED|Overall Study||2
7541239|NCT03260595|18561784|P2|COMPLETED|Overall Study||10
7541240|NCT03260595|18561785|P1|COMPLETED|Overall Study||20
7541241|NCT03260595|18561783|P3|STARTED|Overall Study||2
7541242|NCT03260595|18561784|P2|STARTED|Overall Study||10
7541243|NCT03260595|18561785|P1|STARTED|Overall Study||20
7541244|NCT03260426|18561809|P2|NOT COMPLETED|Overall Study||0
7541245|NCT03260426|18561810|P1|NOT COMPLETED|Overall Study||0
7541246|NCT03260426|18561809|P2|COMPLETED|Overall Study||50
7541247|NCT03260426|18561810|P1|COMPLETED|Overall Study||50
7541248|NCT03260426|18561809|P2|STARTED|Overall Study||50
7541249|NCT03260426|18561810|P1|STARTED|Overall Study||50
7541250|NCT03260205|18561835|P5|NOT COMPLETED|Overall Study||14
7541251|NCT03260205|18561836|P4|NOT COMPLETED|Overall Study||7
7541252|NCT03260205|18561837|P3|NOT COMPLETED|Overall Study||11
7541253|NCT03260205|18561838|P2|NOT COMPLETED|Overall Study||8
7541254|NCT03260205|18561839|P1|NOT COMPLETED|Overall Study||9
7541255|NCT03260205|18561835|P5|COMPLETED|Overall Study||25
7541256|NCT03260205|18561836|P4|COMPLETED|Overall Study||30
7541257|NCT03260205|18561837|P3|COMPLETED|Overall Study||26
7541258|NCT03260205|18561838|P2|COMPLETED|Overall Study||32
7541259|NCT03260205|18561839|P1|COMPLETED|Overall Study||37
7541260|NCT03260205|18561835|P5|Received Treatment|Overall Study||38
7541261|NCT03260205|18561836|P4|Received Treatment|Overall Study||34
7541262|NCT03260205|18561837|P3|Received Treatment|Overall Study||35
7541263|NCT03260205|18561838|P2|Received Treatment|Overall Study||39
7541264|NCT03260205|18561839|P1|Received Treatment|Overall Study||45
7541265|NCT03260205|18561835|P5|STARTED|Overall Study||39
7541266|NCT03260205|18561836|P4|STARTED|Overall Study||37
7541267|NCT03260205|18561837|P3|STARTED|Overall Study||37
7541268|NCT03260205|18561838|P2|STARTED|Overall Study||40
7541269|NCT03260205|18561839|P1|STARTED|Overall Study||46
7541270|NCT03259555|18561902|P2|NOT COMPLETED|Overall Study||30
7541271|NCT03259555|18561903|P1|NOT COMPLETED|Overall Study||34
7541272|NCT03259555|18561902|P2|COMPLETED|Overall Study||134
7541273|NCT03259555|18561903|P1|COMPLETED|Overall Study||124
7541274|NCT03259555|18561902|P2|Received At Least 1 Dose of Study Drug|Overall Study||163
7541275|NCT03259555|18561903|P1|Received At Least 1 Dose of Study Drug|Overall Study||158
7541276|NCT03259555|18561902|P2|STARTED|Overall Study||164
7541277|NCT03259555|18561903|P1|STARTED|Overall Study||158
7541278|NCT03259490|18561913|P2|NOT COMPLETED|Period 2||0
7541279|NCT03259490|18561914|P1|NOT COMPLETED|Period 2||1
7541280|NCT03259490|18561913|P2|COMPLETED|Period 2||14
7541281|NCT03259490|18561914|P1|COMPLETED|Period 2||14
7541283|NCT03259490|18561914|P1|STARTED|Period 2||15
7541284|NCT03259490|18561913|P2|NOT COMPLETED|Period 1||1
7541285|NCT03259490|18561914|P1|NOT COMPLETED|Period 1||0
7541286|NCT03259490|18561913|P2|COMPLETED|Period 1||14
7541287|NCT03259490|18561914|P1|COMPLETED|Period 1||15
7541288|NCT03259490|18561913|P2|STARTED|Period 1||15
7541289|NCT03259490|18561914|P1|STARTED|Period 1||15
7541290|NCT03259425|18561936|P1|NOT COMPLETED|Overall Study||1
7541291|NCT03259425|18561936|P1|COMPLETED|Overall Study||6
7541292|NCT03259425|18561936|P1|Surgery|Overall Study||6
7541293|NCT03259425|18561936|P1|STARTED|Overall Study||7
7541294|NCT03259139|18561946|P6|NOT COMPLETED|Overall Study||6
7541295|NCT03259139|18561947|P5|NOT COMPLETED|Overall Study||6
7541296|NCT03259139|18561948|P4|NOT COMPLETED|Overall Study||5
7541297|NCT03259139|18561949|P3|NOT COMPLETED|Overall Study||5
7541298|NCT03259139|18561950|P2|NOT COMPLETED|Overall Study||4
7541299|NCT03259139|18561951|P1|NOT COMPLETED|Overall Study||4
7541300|NCT03259139|18561946|P6|COMPLETED|Overall Study||35
7541301|NCT03259139|18561947|P5|COMPLETED|Overall Study||35
7541302|NCT03259139|18561948|P4|COMPLETED|Overall Study||37
7541303|NCT03259139|18561949|P3|COMPLETED|Overall Study||37
7541304|NCT03259139|18561950|P2|COMPLETED|Overall Study||38
7541305|NCT03259139|18561951|P1|COMPLETED|Overall Study||38
7541306|NCT03259139|18561946|P6|Found Handgun|Overall Study||35
7541307|NCT03259139|18561947|P5|Found Handgun|Overall Study||35
7541308|NCT03259139|18561948|P4|Found Handgun|Overall Study||37
7541309|NCT03259139|18561949|P3|Found Handgun|Overall Study||37
7541310|NCT03259139|18561950|P2|Found Handgun|Overall Study||38
7541311|NCT03259139|18561951|P1|Found Handgun|Overall Study||38
7541312|NCT03259139|18561946|P6|Outlier Elimination|Overall Study||39
7541313|NCT03259139|18561947|P5|Outlier Elimination|Overall Study||39
7541314|NCT03259139|18561948|P4|Outlier Elimination|Overall Study||41
7541315|NCT03259139|18561949|P3|Outlier Elimination|Overall Study||41
7541316|NCT03259139|18561950|P2|Outlier Elimination|Overall Study||41
7541317|NCT03259139|18561951|P1|Outlier Elimination|Overall Study||41
7541318|NCT03259139|18561946|P6|Eligible|Overall Study||41
7541319|NCT03259139|18561947|P5|Eligible|Overall Study||41
7541320|NCT03259139|18561948|P4|Eligible|Overall Study||41
7541321|NCT03259139|18561949|P3|Eligible|Overall Study||41
7541322|NCT03259139|18561950|P2|Eligible|Overall Study||41
7541323|NCT03259139|18561951|P1|Eligible|Overall Study||41
7541324|NCT03259139|18561946|P6|STARTED|Overall Study||41
7541325|NCT03259139|18561947|P5|STARTED|Overall Study||41
7541326|NCT03259139|18561948|P4|STARTED|Overall Study||42
7541327|NCT03259139|18561949|P3|STARTED|Overall Study||42
7541328|NCT03259139|18561950|P2|STARTED|Overall Study||42
7541329|NCT03259139|18561951|P1|STARTED|Overall Study||42
7541330|NCT03259087|18561982|P5|NOT COMPLETED|Period 2 of Part 2||1
7541331|NCT03259087|18561983|P4|NOT COMPLETED|Period 2 of Part 2||0
7541332|NCT03259087|18561984|P3|NOT COMPLETED|Period 2 of Part 2||0
7541333|NCT03259087|18561985|P2|NOT COMPLETED|Period 2 of Part 2||0
7541334|NCT03259087|18561986|P1|NOT COMPLETED|Period 2 of Part 2||0
7541335|NCT03259087|18561982|P5|COMPLETED|Period 2 of Part 2||6
7541336|NCT03259087|18561983|P4|COMPLETED|Period 2 of Part 2||0
7541337|NCT03259087|18561984|P3|COMPLETED|Period 2 of Part 2||0
7541338|NCT03259087|18561985|P2|COMPLETED|Period 2 of Part 2||0
7541339|NCT03259087|18561986|P1|COMPLETED|Period 2 of Part 2||0
7541340|NCT03259087|18561982|P5|STARTED|Period 2 of Part 2||7
7541341|NCT03259087|18561983|P4|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
7541342|NCT03259087|18561984|P3|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
7541343|NCT03259087|18561985|P2|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
7541344|NCT03259087|18561986|P1|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
7541345|NCT03259087|18561982|P5|NOT COMPLETED|Part 1 and Period 1 of Part 2||1
7541346|NCT03259087|18561983|P4|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
7541347|NCT03259087|18561984|P3|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
7541348|NCT03259087|18561985|P2|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
7541349|NCT03259087|18561986|P1|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
7541350|NCT03259087|18561982|P5|COMPLETED|Part 1 and Period 1 of Part 2||7
7541351|NCT03259087|18561983|P4|COMPLETED|Part 1 and Period 1 of Part 2||10
7541352|NCT03259087|18561984|P3|COMPLETED|Part 1 and Period 1 of Part 2||8
7541353|NCT03259087|18561985|P2|COMPLETED|Part 1 and Period 1 of Part 2||8
7541354|NCT03259087|18561986|P1|COMPLETED|Part 1 and Period 1 of Part 2||8
7541355|NCT03259087|18561982|P5|STARTED|Part 1 and Period 1 of Part 2||8
7541356|NCT03259087|18561983|P4|STARTED|Part 1 and Period 1 of Part 2||10
7541357|NCT03259087|18561984|P3|STARTED|Part 1 and Period 1 of Part 2||8
7541358|NCT03259087|18561985|P2|STARTED|Part 1 and Period 1 of Part 2||8
7541359|NCT03259087|18561986|P1|STARTED|Part 1 and Period 1 of Part 2||8
7541360|NCT03258814|18562114|P3|NOT COMPLETED|Overall Study||10
7541361|NCT03258814|18562115|P2|NOT COMPLETED|Overall Study||3
7541362|NCT03258814|18562116|P1|NOT COMPLETED|Overall Study||4
7541363|NCT03258814|18562114|P3|COMPLETED|Overall Study||0
7541364|NCT03258814|18562115|P2|COMPLETED|Overall Study||0
7541365|NCT03258814|18562116|P1|COMPLETED|Overall Study||0
7541366|NCT03258814|18562114|P3|STARTED|Overall Study||10
7541367|NCT03258814|18562115|P2|STARTED|Overall Study||3
7541368|NCT03258814|18562116|P1|STARTED|Overall Study||4
7541369|NCT03258762|18562171|P2|NOT COMPLETED|Overall Study||1
7541370|NCT03258762|18562172|P1|NOT COMPLETED|Overall Study||0
7541371|NCT03258762|18562171|P2|COMPLETED|Overall Study||6
7541372|NCT03258762|18562172|P1|COMPLETED|Overall Study||7
7541373|NCT03258762|18562171|P2|STARTED|Overall Study||7
7541374|NCT03258762|18562172|P1|STARTED|Overall Study||7
7541375|NCT03258710|18562232|P1|NOT COMPLETED|Overall Study||3
7541376|NCT03258710|18562232|P1|COMPLETED|Overall Study||72
7541377|NCT03258710|18562232|P1|STARTED|Overall Study||75
7541378|NCT03258645|18562271|P1|NOT COMPLETED|Overall Study||0
7541379|NCT03258645|18562271|P1|COMPLETED|Overall Study||1489
7541380|NCT03258645|18562271|P1|STARTED|Overall Study||1489
7541381|NCT03257995|18562326|P6|NOT COMPLETED|Overall Study||2
7541382|NCT03257995|18562327|P5|NOT COMPLETED|Overall Study||0
7541383|NCT03257995|18562328|P4|NOT COMPLETED|Overall Study||0
7541384|NCT03257995|18562329|P3|NOT COMPLETED|Overall Study||0
7541385|NCT03257995|18562330|P2|NOT COMPLETED|Overall Study||1
7541386|NCT03257995|18562331|P1|NOT COMPLETED|Overall Study||0
7541387|NCT03257995|18562326|P6|COMPLETED|Overall Study||7
7541388|NCT03257995|18562327|P5|COMPLETED|Overall Study||9
7541389|NCT03257995|18562328|P4|COMPLETED|Overall Study||9
7541390|NCT03257995|18562329|P3|COMPLETED|Overall Study||9
7541391|NCT03257995|18562330|P2|COMPLETED|Overall Study||8
7541392|NCT03257995|18562331|P1|COMPLETED|Overall Study||9
7541393|NCT03257995|18562326|P6|STARTED|Overall Study||9
7541394|NCT03257995|18562327|P5|STARTED|Overall Study||9
7541395|NCT03257995|18562328|P4|STARTED|Overall Study||9
7541396|NCT03257995|18562329|P3|STARTED|Overall Study||9
7541397|NCT03257995|18562330|P2|STARTED|Overall Study||9
7541398|NCT03257995|18562331|P1|STARTED|Overall Study||9
7541399|NCT03257865|18562381|P2|NOT COMPLETED|Overall Study||35
7541400|NCT03257865|18562382|P1|NOT COMPLETED|Overall Study||35
7541401|NCT03257865|18562381|P2|COMPLETED|Overall Study||135
7541402|NCT03257865|18562382|P1|COMPLETED|Overall Study||128
7541403|NCT03257865|18562381|P2|Received at Least 1 Dose of Study Drug|Overall Study||170
7541404|NCT03257865|18562382|P1|Received at Least 1 Dose of Study Drug|Overall Study||162
7541405|NCT03257865|18562381|P2|STARTED|Overall Study||170
7541406|NCT03257865|18562382|P1|STARTED|Overall Study||163
7541407|NCT03257813|18562392|P2|NOT COMPLETED|Overall Study||3
7541408|NCT03257813|18562393|P1|NOT COMPLETED|Overall Study||6
7541409|NCT03257813|18562392|P2|COMPLETED|Overall Study||27
7541410|NCT03257813|18562393|P1|COMPLETED|Overall Study||24
7541411|NCT03257813|18562392|P2|STARTED|Overall Study||30
7541412|NCT03257813|18562393|P1|STARTED|Overall Study||30
7541413|NCT03257657|18562415|P2|NOT COMPLETED|Overall Study||5
7541414|NCT03257657|18562416|P1|NOT COMPLETED|Overall Study||0
7541415|NCT03257657|18562415|P2|COMPLETED|Overall Study||15
7541416|NCT03257657|18562416|P1|COMPLETED|Overall Study||22
7541417|NCT03257657|18562415|P2|STARTED|Overall Study||20
7541418|NCT03257657|18562416|P1|STARTED|Overall Study||22
7541419|NCT03257631|18562447|P4|NOT COMPLETED|Overall Study||10
7541420|NCT03257631|18562448|P3|NOT COMPLETED|Overall Study||23
7541421|NCT03257631|18562449|P2|NOT COMPLETED|Overall Study||9
7541422|NCT03257631|18562450|P1|NOT COMPLETED|Overall Study||11
7541423|NCT03257631|18562447|P4|COMPLETED|Overall Study||0
7541424|NCT03257631|18562448|P3|COMPLETED|Overall Study||0
7541425|NCT03257631|18562449|P2|COMPLETED|Overall Study||0
7541426|NCT03257631|18562450|P1|COMPLETED|Overall Study||0
7541427|NCT03257631|18562447|P4|Received Study Drug|Overall Study||10
7541428|NCT03257631|18562448|P3|Received Study Drug|Overall Study||22
7541429|NCT03257631|18562449|P2|Received Study Drug|Overall Study||9
7541430|NCT03257631|18562450|P1|Received Study Drug|Overall Study||11
7541431|NCT03257631|18562447|P4|STARTED|Overall Study||10
7541432|NCT03257631|18562448|P3|STARTED|Overall Study||23
7541433|NCT03257631|18562449|P2|STARTED|Overall Study||9
7541434|NCT03257631|18562450|P1|STARTED|Overall Study||11
7541435|NCT03257410|18562486|P2|NOT COMPLETED|Overall Study||21
7541436|NCT03257410|18562487|P1|NOT COMPLETED|Overall Study||21
7541437|NCT03257410|18562486|P2|COMPLETED|Overall Study||65
7541438|NCT03257410|18562487|P1|COMPLETED|Overall Study||65
7541439|NCT03257410|18562486|P2|STARTED|Overall Study||86
7541440|NCT03257410|18562487|P1|STARTED|Overall Study||86
7541441|NCT03257358|18562629|P2|NOT COMPLETED|Overall Study||34
7541442|NCT03257358|18562630|P1|NOT COMPLETED|Overall Study||71
7541443|NCT03257358|18562629|P2|COMPLETED|Overall Study||183
7541444|NCT03257358|18562630|P1|COMPLETED|Overall Study||94
7541445|NCT03257358|18562629|P2|Never Received Treatment|Overall Study||0
7541446|NCT03257358|18562630|P1|Never Received Treatment|Overall Study||2
7541447|NCT03257358|18562629|P2|STARTED|Overall Study||217
7541448|NCT03257358|18562630|P1|STARTED|Overall Study||165
7541449|NCT03257202|18562730|P1|NOT COMPLETED|Overall Study||0
7541450|NCT03257202|18562730|P1|COMPLETED|Overall Study||12
7541451|NCT03257202|18562730|P1|STARTED|Overall Study||12
7541452|NCT03257189|18562740|P1|NOT COMPLETED|Overall Study||0
7541453|NCT03257189|18562740|P1|COMPLETED|Overall Study||30
7541454|NCT03257189|18562740|P1|STARTED|Overall Study||30
7541455|NCT03256968|18562752|P1|NOT COMPLETED|Overall Study||0
7541456|NCT03256968|18562752|P1|COMPLETED|Overall Study||1
7541457|NCT03256968|18562752|P1|STARTED|Overall Study||1
7541458|NCT03256851|18562758|P2|NOT COMPLETED|Overall Study||0
7541459|NCT03256851|18562759|P1|NOT COMPLETED|Overall Study||1
7541460|NCT03256851|18562758|P2|COMPLETED|Overall Study||10
7541461|NCT03256851|18562759|P1|COMPLETED|Overall Study||9
7541462|NCT03256851|18562758|P2|STARTED|Overall Study||10
7541463|NCT03256851|18562759|P1|STARTED|Overall Study||10
7541464|NCT03256799|18562767|P1|NOT COMPLETED|Overall Study||0
7541465|NCT03256799|18562767|P1|COMPLETED|Overall Study||1
7541466|NCT03256799|18562767|P1|STARTED|Overall Study||1
7541467|NCT03256695|18562771|P1|NOT COMPLETED|Overall Study||39
7541468|NCT03256695|18562771|P1|COMPLETED|Overall Study||366
7541469|NCT03256695|18562771|P1|Used ABS eMDPI at Least Once|Overall Study||390
7541470|NCT03256695|18562771|P1|STARTED|Overall Study||405
7541471|NCT03256552|18562779|P1|NOT COMPLETED|Overall Study||5
7541472|NCT03256552|18562779|P1|COMPLETED|Overall Study||61
7541473|NCT03256552|18562779|P1|Placebo MDI|Overall Study||65
7541474|NCT03256552|18562779|P1|GP MDI 7.2 µg|Overall Study||62
7541475|NCT03256552|18562779|P1|GP MDI 14.4 µg|Overall Study||63
7541476|NCT03256552|18562779|P1|GP MDI 28.8 µg|Overall Study||61
7541477|NCT03256552|18562779|P1|STARTED|Overall Study||66
7541478|NCT03256526|18562804|P3|NOT COMPLETED|Overall Study||3
7541479|NCT03256526|18562805|P2|NOT COMPLETED|Overall Study||0
7541480|NCT03256526|18562806|P1|NOT COMPLETED|Overall Study||2
7541481|NCT03256526|18562804|P3|COMPLETED|Overall Study||14
7541482|NCT03256526|18562805|P2|COMPLETED|Overall Study||17
7541483|NCT03256526|18562806|P1|COMPLETED|Overall Study||17
7541484|NCT03256526|18562804|P3|STARTED|Overall Study||17
7541485|NCT03256526|18562805|P2|STARTED|Overall Study||17
7541486|NCT03256526|18562806|P1|STARTED|Overall Study||19
7541487|NCT03256253|18562826|P1|NOT COMPLETED|Overall Study||12
7541488|NCT03256253|18562826|P1|COMPLETED|Overall Study||6
7541489|NCT03256253|18562826|P1|STARTED|Overall Study||18
7541490|NCT03256162|18562832|P2|NOT COMPLETED|Overall Study||4
7541491|NCT03256162|18562833|P1|NOT COMPLETED|Overall Study||5
7541492|NCT03256162|18562832|P2|COMPLETED|Overall Study||8
7541493|NCT03256162|18562833|P1|COMPLETED|Overall Study||8
7541494|NCT03256162|18562832|P2|STARTED|Overall Study||12
7541495|NCT03256162|18562833|P1|STARTED|Overall Study||13
7541496|NCT03256136|18562855|P4|NOT COMPLETED|Overall Study||0
7541497|NCT03256136|18562856|P3|NOT COMPLETED|Overall Study||0
7541498|NCT03256136|18562857|P2|NOT COMPLETED|Overall Study||0
7541499|NCT03256136|18562858|P1|NOT COMPLETED|Overall Study||0
7541500|NCT03256136|18562855|P4|COMPLETED|Overall Study||1
7541501|NCT03256136|18562856|P3|COMPLETED|Overall Study||4
7541502|NCT03256136|18562857|P2|COMPLETED|Overall Study||1
7541503|NCT03256136|18562858|P1|COMPLETED|Overall Study||3
7541504|NCT03256136|18562855|P4|STARTED|Overall Study||1
7541505|NCT03256136|18562856|P3|STARTED|Overall Study||4
7541506|NCT03256136|18562857|P2|STARTED|Overall Study||1
7541507|NCT03256136|18562858|P1|STARTED|Overall Study||3
7541508|NCT03255980|18562888|P4|NOT COMPLETED|Overall Study||12
7541509|NCT03255980|18562889|P3|NOT COMPLETED|Overall Study||6
7541510|NCT03255980|18562890|P2|NOT COMPLETED|Overall Study||8
7541511|NCT03255980|18562891|P1|NOT COMPLETED|Overall Study||3
7541512|NCT03255980|18562888|P4|COMPLETED|Overall Study||8
7541513|NCT03255980|18562889|P3|COMPLETED|Overall Study||14
7541514|NCT03255980|18562890|P2|COMPLETED|Overall Study||12
7541515|NCT03255980|18562891|P1|COMPLETED|Overall Study||17
7541516|NCT03255980|18562888|P4|STARTED|Overall Study||20
7541517|NCT03255980|18562889|P3|STARTED|Overall Study||20
7541518|NCT03255980|18562890|P2|STARTED|Overall Study||20
7541519|NCT03255980|18562891|P1|STARTED|Overall Study||20
7541520|NCT03255902|18562901|P1|NOT COMPLETED|Overall Study||2
7541521|NCT03255902|18562901|P1|COMPLETED|Overall Study||5
7541522|NCT03255902|18562901|P1|STARTED|Overall Study||7
7541523|NCT03255824|18562908|P2|NOT COMPLETED|Overall Study||1
7541524|NCT03255824|18562909|P1|NOT COMPLETED|Overall Study||2
7541525|NCT03255824|18562908|P2|COMPLETED|Overall Study||74
7541526|NCT03255824|18562909|P1|COMPLETED|Overall Study||67
7541527|NCT03255824|18562908|P2|STARTED|Overall Study||75
7541528|NCT03255824|18562909|P1|STARTED|Overall Study||69
7541529|NCT03255733|18562937|P1|NOT COMPLETED|Overall Study||4
7541530|NCT03255733|18562937|P1|COMPLETED|Overall Study||25
7541531|NCT03255733|18562937|P1|STARTED|Overall Study||29
7541532|NCT03255655|18562944|P2|NOT COMPLETED|Overall Study||4
7541533|NCT03255655|18562945|P1|NOT COMPLETED|Overall Study||7
7541534|NCT03255655|18562944|P2|COMPLETED|Overall Study||8
7541535|NCT03255655|18562945|P1|COMPLETED|Overall Study||22
7541536|NCT03255655|18562944|P2|STARTED|Overall Study||12
7541537|NCT03255655|18562945|P1|STARTED|Overall Study||29
7541538|NCT03255382|18562955|P2|NOT COMPLETED|Overall Study||0
7541539|NCT03255382|18562956|P1|NOT COMPLETED|Overall Study||13
7541540|NCT03255382|18562955|P2|COMPLETED|Overall Study||60
7541541|NCT03255382|18562956|P1|COMPLETED|Overall Study||47
7541542|NCT03255382|18562955|P2|STARTED|Overall Study||60
7541543|NCT03255382|18562956|P1|STARTED|Overall Study||60
7541544|NCT03255291|18563130|P6|NOT COMPLETED|Overall Study||10
7541545|NCT03255291|18563131|P5|NOT COMPLETED|Overall Study||7
7541546|NCT03255291|18563132|P4|NOT COMPLETED|Overall Study||6
7541547|NCT03255291|18563133|P3|NOT COMPLETED|Overall Study||6
7541548|NCT03255291|18563134|P2|NOT COMPLETED|Overall Study||12
7541549|NCT03255291|18563135|P1|NOT COMPLETED|Overall Study||13
7541550|NCT03255291|18563130|P6|COMPLETED|Overall Study||85
7541551|NCT03255291|18563131|P5|COMPLETED|Overall Study||88
7541552|NCT03255291|18563132|P4|COMPLETED|Overall Study||84
7541553|NCT03255291|18563133|P3|COMPLETED|Overall Study||85
7541554|NCT03255291|18563134|P2|COMPLETED|Overall Study||78
7541555|NCT03255291|18563135|P1|COMPLETED|Overall Study||80
7541556|NCT03255291|18563130|P6|STARTED|Overall Study||95
7541557|NCT03255291|18563131|P5|STARTED|Overall Study||95
7541558|NCT03255291|18563132|P4|STARTED|Overall Study||90
7541559|NCT03255291|18563133|P3|STARTED|Overall Study||91
7541560|NCT03255291|18563134|P2|STARTED|Overall Study||90
7541561|NCT03255291|18563135|P1|STARTED|Overall Study||93
7541562|NCT03255187|18563168|P2|NOT COMPLETED|Period at Fourth Follow-up||0
7541563|NCT03255187|18563169|P1|NOT COMPLETED|Period at Fourth Follow-up||0
7541564|NCT03255187|18563168|P2|COMPLETED|Period at Fourth Follow-up||31
7541565|NCT03255187|18563169|P1|COMPLETED|Period at Fourth Follow-up||34
7541566|NCT03255187|18563168|P2|STARTED|Period at Fourth Follow-up||31
7541567|NCT03255187|18563169|P1|STARTED|Period at Fourth Follow-up||34
7541568|NCT03255187|18563168|P2|NOT COMPLETED|Period From Third to Fourth Follow-up||0
7541569|NCT03255187|18563169|P1|NOT COMPLETED|Period From Third to Fourth Follow-up||0
7541570|NCT03255187|18563168|P2|COMPLETED|Period From Third to Fourth Follow-up||31
7541571|NCT03255187|18563169|P1|COMPLETED|Period From Third to Fourth Follow-up||34
7541572|NCT03255187|18563168|P2|STARTED|Period From Third to Fourth Follow-up||31
7541573|NCT03255187|18563169|P1|STARTED|Period From Third to Fourth Follow-up||34
7541574|NCT03255187|18563168|P2|NOT COMPLETED|Period From Second to Third Follow-up||0
7541575|NCT03255187|18563169|P1|NOT COMPLETED|Period From Second to Third Follow-up||0
7541576|NCT03255187|18563168|P2|COMPLETED|Period From Second to Third Follow-up||31
7541577|NCT03255187|18563169|P1|COMPLETED|Period From Second to Third Follow-up||34
7541578|NCT03255187|18563168|P2|STARTED|Period From Second to Third Follow-up||31
7541579|NCT03255187|18563169|P1|STARTED|Period From Second to Third Follow-up||34
7541580|NCT03255187|18563168|P2|NOT COMPLETED|Period From First to Second Follow-up||1
7541581|NCT03255187|18563169|P1|NOT COMPLETED|Period From First to Second Follow-up||0
7541582|NCT03255187|18563168|P2|COMPLETED|Period From First to Second Follow-up||31
7541583|NCT03255187|18563169|P1|COMPLETED|Period From First to Second Follow-up||34
7541584|NCT03255187|18563168|P2|STARTED|Period From First to Second Follow-up||32
7541585|NCT03255187|18563169|P1|STARTED|Period From First to Second Follow-up||34
7541586|NCT03255187|18563168|P2|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||3
7541587|NCT03255187|18563169|P1|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||1
7541588|NCT03255187|18563168|P2|COMPLETED|Periodfrom Enrollment to First Follow-up||32
7541589|NCT03255187|18563169|P1|COMPLETED|Periodfrom Enrollment to First Follow-up||34
7541590|NCT03255187|18563168|P2|STARTED|Periodfrom Enrollment to First Follow-up||35
7541591|NCT03255187|18563169|P1|STARTED|Periodfrom Enrollment to First Follow-up||35
7541592|NCT03254719|18563209|P1|NOT COMPLETED|Overall Study||0
7541593|NCT03254719|18563209|P1|COMPLETED|Overall Study||40
7541594|NCT03254719|18563209|P1|STARTED|Overall Study||40
7541595|NCT03254602|18563228|P1|NOT COMPLETED|Overall Study||4
7541596|NCT03254602|18563228|P1|COMPLETED|Overall Study||29
7541597|NCT03254602|18563228|P1|STARTED|Overall Study||33
7541598|NCT03254459|18563236|P2|NOT COMPLETED|Overall Study||23
7541599|NCT03254459|18563237|P1|NOT COMPLETED|Overall Study||10
7541600|NCT03254459|18563236|P2|COMPLETED|Overall Study||27
7541601|NCT03254459|18563237|P1|COMPLETED|Overall Study||40
7541602|NCT03254459|18563236|P2|STARTED|Overall Study||50
7541603|NCT03254459|18563237|P1|STARTED|Overall Study||50
7541604|NCT03254147|18563255|P1|NOT COMPLETED|Overall Study||0
7541605|NCT03254147|18563255|P1|COMPLETED|Overall Study||53969
7541606|NCT03254147|18563255|P1|STARTED|Overall Study|The number of patients meeting the inclusion and exclusion criteria|53969
7541607|NCT03254134|18563262|P2|NOT COMPLETED|Overall Study||3630
7541608|NCT03254134|18563263|P1|NOT COMPLETED|Overall Study||599
7541609|NCT03254134|18563262|P2|COMPLETED|Overall Study||13115
7541610|NCT03254134|18563263|P1|COMPLETED|Overall Study||5146
7541611|NCT03254134|18563262|P2|STARTED|Overall Study||16745
7541612|NCT03254134|18563263|P1|STARTED|Overall Study||5745
7541613|NCT03252964|18563271|P1|NOT COMPLETED|Overall Study||32
7541614|NCT03252964|18563271|P1|COMPLETED|Overall Study||20
7541615|NCT03252964|18563271|P1|STARTED|Overall Study||52
7541616|NCT03252353|18563287|P2|NOT COMPLETED|Overall Study||0
7541617|NCT03252353|18563288|P1|NOT COMPLETED|Overall Study||0
7541618|NCT03252353|18563287|P2|COMPLETED|Overall Study||28
7541619|NCT03252353|18563288|P1|COMPLETED|Overall Study||28
7541620|NCT03252353|18563287|P2|STARTED|Overall Study||28
7541621|NCT03252353|18563288|P1|STARTED|Overall Study||28
7541622|NCT03252015|18563302|P4|NOT COMPLETED|Overall Study||1
7541623|NCT03252015|18563303|P3|NOT COMPLETED|Overall Study||1
7541624|NCT03252015|18563304|P2|NOT COMPLETED|Overall Study||1
7541625|NCT03252015|18563305|P1|NOT COMPLETED|Overall Study||1
7541626|NCT03252015|18563302|P4|COMPLETED|Overall Study||14
7541627|NCT03252015|18563303|P3|COMPLETED|Overall Study||14
7541628|NCT03252015|18563304|P2|COMPLETED|Overall Study||27
7541629|NCT03252015|18563305|P1|COMPLETED|Overall Study||11
7541630|NCT03252015|18563302|P4|Received at Least 1 Dose of Study Drug|Overall Study||15
7541631|NCT03252015|18563303|P3|Received at Least 1 Dose of Study Drug|Overall Study||15
7541632|NCT03252015|18563304|P2|Received at Least 1 Dose of Study Drug|Overall Study||28
7541633|NCT03252015|18563305|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
7541634|NCT03252015|18563302|P4|STARTED|Overall Study||15
7541635|NCT03252015|18563303|P3|STARTED|Overall Study||15
7541636|NCT03252015|18563304|P2|STARTED|Overall Study||28
7541637|NCT03252015|18563305|P1|STARTED|Overall Study||12
7541638|NCT03251963|18563343|P2|NOT COMPLETED|Overall Study||5
7541639|NCT03251963|18563344|P1|NOT COMPLETED|Overall Study||9
7541640|NCT03251963|18563343|P2|COMPLETED|Overall Study||61
7541641|NCT03251963|18563344|P1|COMPLETED|Overall Study||56
7541642|NCT03251963|18563343|P2|STARTED|Overall Study||66
7541643|NCT03251963|18563344|P1|STARTED|Overall Study||65
7541644|NCT03251937|18563354|P1|NOT COMPLETED|Overall Study||3
7541645|NCT03251937|18563354|P1|COMPLETED|Overall Study||37
7541646|NCT03251937|18563354|P1|STARTED|Overall Study||40
7541647|NCT03251482|18563363|P5|NOT COMPLETED|Overall Study||0
7541648|NCT03251482|18563364|P4|NOT COMPLETED|Overall Study||0
7541649|NCT03251482|18563365|P3|NOT COMPLETED|Overall Study||0
7541650|NCT03251482|18563366|P2|NOT COMPLETED|Overall Study||1
7541651|NCT03251482|18563367|P1|NOT COMPLETED|Overall Study||0
7541652|NCT03251482|18563363|P5|COMPLETED|Overall Study||63
7541653|NCT03251482|18563364|P4|COMPLETED|Overall Study||122
7541654|NCT03251482|18563365|P3|COMPLETED|Overall Study||43
7541655|NCT03251482|18563366|P2|COMPLETED|Overall Study||40
7541656|NCT03251482|18563367|P1|COMPLETED|Overall Study||39
7541657|NCT03251482|18563363|P5|Treated|Overall Study||63
7541658|NCT03251482|18563364|P4|Treated|Overall Study||122
7541659|NCT03251482|18563365|P3|Treated|Overall Study||42
7541660|NCT03251482|18563366|P2|Treated|Overall Study||40
7541661|NCT03251482|18563367|P1|Treated|Overall Study||38
7541662|NCT03251482|18563363|P5|STARTED|Overall Study||63
7541663|NCT03251482|18563364|P4|STARTED|Overall Study||122
7541664|NCT03251482|18563365|P3|STARTED|Overall Study||43
7541665|NCT03251482|18563366|P2|STARTED|Overall Study||41
7541666|NCT03251482|18563367|P1|STARTED|Overall Study||39
7541667|NCT03251326|18563439|P4|NOT COMPLETED|Overall Study||0
7541668|NCT03251326|18563440|P3|NOT COMPLETED|Overall Study||0
7541669|NCT03251326|18563441|P2|NOT COMPLETED|Overall Study||0
7541670|NCT03251326|18563442|P1|NOT COMPLETED|Overall Study||0
7541671|NCT03251326|18563439|P4|COMPLETED|Overall Study||0
7541672|NCT03251326|18563440|P3|COMPLETED|Overall Study||0
7541673|NCT03251326|18563441|P2|COMPLETED|Overall Study||0
7541674|NCT03251326|18563442|P1|COMPLETED|Overall Study||0
7541675|NCT03251326|18563439|P4|STARTED|Overall Study||0
7541676|NCT03251326|18563440|P3|STARTED|Overall Study||0
7541677|NCT03251326|18563441|P2|STARTED|Overall Study||0
7541678|NCT03251326|18563442|P1|STARTED|Overall Study||0
7541679|NCT03250845|18563452|P1|NOT COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||0
7541680|NCT03250845|18563452|P1|COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||30
7541681|NCT03250845|18563452|P1|STARTED|Multigam 10% Infusion (3-4 Weeks Later)||30
7541682|NCT03250845|18563452|P1|NOT COMPLETED|Multigam 5% Infusion (Baseline)||0
7541683|NCT03250845|18563452|P1|COMPLETED|Multigam 5% Infusion (Baseline)||30
7541684|NCT03250845|18563452|P1|STARTED|Multigam 5% Infusion (Baseline)||30
7541685|NCT03250689|18563463|P2|NOT COMPLETED|Overall Study||0
7541686|NCT03250689|18563464|P1|NOT COMPLETED|Overall Study||0
7541687|NCT03250689|18563463|P2|COMPLETED|Overall Study||14
7541688|NCT03250689|18563464|P1|COMPLETED|Overall Study||5
7541689|NCT03250689|18563463|P2|STARTED|Overall Study||14
7541690|NCT03250689|18563464|P1|STARTED|Overall Study||5
7541691|NCT03250182|18563524|P1|NOT COMPLETED|Overall Study||1
7541692|NCT03250182|18563524|P1|COMPLETED|Overall Study||29
7541693|NCT03250182|18563524|P1|STARTED|Overall Study||30
7541694|NCT03249935|18563548|P1|NOT COMPLETED|Overall Study||45
7541695|NCT03249935|18563548|P1|COMPLETED|Overall Study||55
7541696|NCT03249935|18563548|P1|STARTED|Overall Study||100
7541697|NCT03249909|18563557|P3|NOT COMPLETED|Overall Study||0
7541698|NCT03249909|18563558|P2|NOT COMPLETED|Overall Study||1
7541699|NCT03249909|18563559|P1|NOT COMPLETED|Overall Study||6
7541700|NCT03249909|18563557|P3|COMPLETED|Overall Study||16
7541701|NCT03249909|18563558|P2|COMPLETED|Overall Study||14
7541702|NCT03249909|18563559|P1|COMPLETED|Overall Study||72
7541703|NCT03249909|18563557|P3|STARTED|Overall Study||16
7541704|NCT03249909|18563558|P2|STARTED|Overall Study||15
7541705|NCT03249909|18563559|P1|STARTED|Overall Study||78
7541706|NCT03249779|18563594|P1|NOT COMPLETED|Overall Study||0
7541707|NCT03249779|18563594|P1|COMPLETED|Overall Study||8
7541708|NCT03249779|18563594|P1|STARTED|Overall Study||8
7541709|NCT03249584|18563599|P1|NOT COMPLETED|Overall Study||98
7541710|NCT03249584|18563599|P1|COMPLETED|Overall Study||2
7541711|NCT03249584|18563599|P1|Month 3 Primary Objective|Overall Study|Included the first 42 Thoracic/Lumbar RF Ablation subjects to complete Month 3|42
7541712|NCT03249584|18563599|P1|Month 3|Overall Study||46
7541713|NCT03249584|18563599|P1|STARTED|Overall Study|87 subjects in the Thoracic/Lumbar and 13 subjects in the Periacetabulum, Iliac Crest, and/or Sacrum|100
7541714|NCT03249454|18563603|P11|NOT COMPLETED|Overall Study||1
7541715|NCT03249454|18563604|P10|NOT COMPLETED|Overall Study||1
7541716|NCT03249454|18563605|P9|NOT COMPLETED|Overall Study||0
7541717|NCT03249454|18563606|P8|NOT COMPLETED|Overall Study||0
7541718|NCT03249454|18563607|P7|NOT COMPLETED|Overall Study||0
7541719|NCT03249454|18563608|P6|NOT COMPLETED|Overall Study||0
7541720|NCT03249454|18563609|P5|NOT COMPLETED|Overall Study||0
7541721|NCT03249454|18563610|P4|NOT COMPLETED|Overall Study||0
7541722|NCT03249454|18563611|P3|NOT COMPLETED|Overall Study||0
7541723|NCT03249454|18563612|P2|NOT COMPLETED|Overall Study||0
7541724|NCT03249454|18563613|P1|NOT COMPLETED|Overall Study||0
7541725|NCT03249454|18563603|P11|COMPLETED|Overall Study||0
7541726|NCT03249454|18563604|P10|COMPLETED|Overall Study||0
7541727|NCT03249454|18563605|P9|COMPLETED|Overall Study||1
7541728|NCT03249454|18563606|P8|COMPLETED|Overall Study||1
7541729|NCT03249454|18563607|P7|COMPLETED|Overall Study||1
7541730|NCT03249454|18563608|P6|COMPLETED|Overall Study||2
7541731|NCT03249454|18563609|P5|COMPLETED|Overall Study||1
7541732|NCT03249454|18563610|P4|COMPLETED|Overall Study||1
7541733|NCT03249454|18563611|P3|COMPLETED|Overall Study||2
7541734|NCT03249454|18563612|P2|COMPLETED|Overall Study||1
7541735|NCT03249454|18563613|P1|COMPLETED|Overall Study||1
7541736|NCT03249454|18563603|P11|Fifth Intervention (1 Day)|Overall Study||0
7541737|NCT03249454|18563604|P10|Fifth Intervention (1 Day)|Overall Study||0
7541738|NCT03249454|18563605|P9|Fifth Intervention (1 Day)|Overall Study||1
7541739|NCT03249454|18563606|P8|Fifth Intervention (1 Day)|Overall Study||1
7541740|NCT03249454|18563607|P7|Fifth Intervention (1 Day)|Overall Study||1
7541741|NCT03249454|18563608|P6|Fifth Intervention (1 Day)|Overall Study||2
7541742|NCT03249454|18563609|P5|Fifth Intervention (1 Day)|Overall Study||1
7541743|NCT03249454|18563610|P4|Fifth Intervention (1 Day)|Overall Study||1
7541744|NCT03249454|18563611|P3|Fifth Intervention (1 Day)|Overall Study||2
7541745|NCT03249454|18563612|P2|Fifth Intervention (1 Day)|Overall Study||1
7541746|NCT03249454|18563613|P1|Fifth Intervention (1 Day)|Overall Study||1
7541747|NCT03249454|18563603|P11|Washout (1 Week)|Overall Study||0
7541748|NCT03249454|18563604|P10|Washout (1 Week)|Overall Study||0
7541749|NCT03249454|18563605|P9|Washout (1 Week)|Overall Study||1
7541750|NCT03249454|18563606|P8|Washout (1 Week)|Overall Study||1
7541751|NCT03249454|18563607|P7|Washout (1 Week)|Overall Study||1
7541752|NCT03249454|18563608|P6|Washout (1 Week)|Overall Study||2
7541753|NCT03249454|18563609|P5|Washout (1 Week)|Overall Study||1
7541754|NCT03249454|18563610|P4|Washout (1 Week)|Overall Study||1
7541755|NCT03249454|18563611|P3|Washout (1 Week)|Overall Study||2
7541756|NCT03249454|18563612|P2|Washout (1 Week)|Overall Study||1
7541757|NCT03249454|18563613|P1|Washout (1 Week)|Overall Study||1
7541758|NCT03249454|18563603|P11|Fourth Intervention (1 Day)|Overall Study||0
7541759|NCT03249454|18563604|P10|Fourth Intervention (1 Day)|Overall Study||0
7541760|NCT03249454|18563605|P9|Fourth Intervention (1 Day)|Overall Study||1
7541761|NCT03249454|18563606|P8|Fourth Intervention (1 Day)|Overall Study||1
7541762|NCT03249454|18563607|P7|Fourth Intervention (1 Day)|Overall Study||1
7541763|NCT03249454|18563608|P6|Fourth Intervention (1 Day)|Overall Study||2
7541764|NCT03249454|18563609|P5|Fourth Intervention (1 Day)|Overall Study||1
7541765|NCT03249454|18563610|P4|Fourth Intervention (1 Day)|Overall Study||1
7541766|NCT03249454|18563611|P3|Fourth Intervention (1 Day)|Overall Study||2
7541767|NCT03249454|18563612|P2|Fourth Intervention (1 Day)|Overall Study||1
7541768|NCT03249454|18563613|P1|Fourth Intervention (1 Day)|Overall Study||1
7541769|NCT03249454|18563603|P11|Washout (1 Week)|Overall Study||0
7541770|NCT03249454|18563604|P10|Washout (1 Week)|Overall Study||0
7541771|NCT03249454|18563605|P9|Washout (1 Week)|Overall Study||1
7541772|NCT03249454|18563606|P8|Washout (1 Week)|Overall Study||1
7541773|NCT03249454|18563607|P7|Washout (1 Week)|Overall Study||1
7541774|NCT03249454|18563608|P6|Washout (1 Week)|Overall Study||2
7541775|NCT03249454|18563609|P5|Washout (1 Week)|Overall Study||1
7541776|NCT03249454|18563610|P4|Washout (1 Week)|Overall Study||1
7541777|NCT03249454|18563611|P3|Washout (1 Week)|Overall Study||2
7541778|NCT03249454|18563612|P2|Washout (1 Week)|Overall Study||1
7541779|NCT03249454|18563613|P1|Washout (1 Week)|Overall Study||1
7541780|NCT03249454|18563603|P11|Third Intervention (1 Day)|Overall Study||0
7541781|NCT03249454|18563604|P10|Third Intervention (1 Day)|Overall Study||0
7541782|NCT03249454|18563605|P9|Third Intervention (1 Day)|Overall Study||1
7541783|NCT03249454|18563606|P8|Third Intervention (1 Day)|Overall Study||1
7541784|NCT03249454|18563607|P7|Third Intervention (1 Day)|Overall Study||1
7541785|NCT03249454|18563608|P6|Third Intervention (1 Day)|Overall Study||2
7541786|NCT03249454|18563609|P5|Third Intervention (1 Day)|Overall Study||1
7541787|NCT03249454|18563610|P4|Third Intervention (1 Day)|Overall Study||1
7541788|NCT03249454|18563611|P3|Third Intervention (1 Day)|Overall Study||2
7541789|NCT03249454|18563612|P2|Third Intervention (1 Day)|Overall Study||1
7541790|NCT03249454|18563613|P1|Third Intervention (1 Day)|Overall Study||1
7541791|NCT03249454|18563603|P11|Washout (1 Week)|Overall Study||0
7541792|NCT03249454|18563604|P10|Washout (1 Week)|Overall Study||0
7541793|NCT03249454|18563605|P9|Washout (1 Week)|Overall Study||1
7541794|NCT03249454|18563606|P8|Washout (1 Week)|Overall Study||1
7541795|NCT03249454|18563607|P7|Washout (1 Week)|Overall Study||1
7541796|NCT03249454|18563608|P6|Washout (1 Week)|Overall Study||2
7541797|NCT03249454|18563609|P5|Washout (1 Week)|Overall Study||1
7541798|NCT03249454|18563610|P4|Washout (1 Week)|Overall Study||1
7541799|NCT03249454|18563611|P3|Washout (1 Week)|Overall Study||2
7541800|NCT03249454|18563612|P2|Washout (1 Week)|Overall Study||1
7541801|NCT03249454|18563613|P1|Washout (1 Week)|Overall Study||1
7541802|NCT03249454|18563603|P11|Second Intervention (1 Day)|Overall Study||0
7541803|NCT03249454|18563604|P10|Second Intervention (1 Day)|Overall Study||0
7541804|NCT03249454|18563605|P9|Second Intervention (1 Day)|Overall Study||1
7541805|NCT03249454|18563606|P8|Second Intervention (1 Day)|Overall Study||1
7541806|NCT03249454|18563607|P7|Second Intervention (1 Day)|Overall Study||1
7541807|NCT03249454|18563608|P6|Second Intervention (1 Day)|Overall Study||2
7541808|NCT03249454|18563609|P5|Second Intervention (1 Day)|Overall Study||1
7541809|NCT03249454|18563610|P4|Second Intervention (1 Day)|Overall Study||1
7541810|NCT03249454|18563611|P3|Second Intervention (1 Day)|Overall Study||2
7541811|NCT03249454|18563612|P2|Second Intervention (1 Day)|Overall Study||1
7541812|NCT03249454|18563613|P1|Second Intervention (1 Day)|Overall Study||1
7541813|NCT03249454|18563603|P11|Washout (1 Week)|Overall Study||0
7541814|NCT03249454|18563604|P10|Washout (1 Week)|Overall Study||0
7541815|NCT03249454|18563605|P9|Washout (1 Week)|Overall Study||1
7541816|NCT03249454|18563606|P8|Washout (1 Week)|Overall Study||1
7541817|NCT03249454|18563607|P7|Washout (1 Week)|Overall Study||1
7541818|NCT03249454|18563608|P6|Washout (1 Week)|Overall Study||2
7541819|NCT03249454|18563609|P5|Washout (1 Week)|Overall Study||1
7541820|NCT03249454|18563610|P4|Washout (1 Week)|Overall Study||1
7541821|NCT03249454|18563611|P3|Washout (1 Week)|Overall Study||2
7541822|NCT03249454|18563612|P2|Washout (1 Week)|Overall Study||1
7541823|NCT03249454|18563613|P1|Washout (1 Week)|Overall Study||1
7541824|NCT03249454|18563603|P11|First Intervention (1 Day)|Overall Study||0
7541825|NCT03249454|18563604|P10|First Intervention (1 Day)|Overall Study||0
7541826|NCT03249454|18563605|P9|First Intervention (1 Day)|Overall Study||1
7541827|NCT03249454|18563606|P8|First Intervention (1 Day)|Overall Study||1
7541828|NCT03249454|18563607|P7|First Intervention (1 Day)|Overall Study||1
7541829|NCT03249454|18563608|P6|First Intervention (1 Day)|Overall Study||2
7541830|NCT03249454|18563609|P5|First Intervention (1 Day)|Overall Study||1
7541831|NCT03249454|18563610|P4|First Intervention (1 Day)|Overall Study||1
7541832|NCT03249454|18563611|P3|First Intervention (1 Day)|Overall Study||2
7541833|NCT03249454|18563612|P2|First Intervention (1 Day)|Overall Study||1
7541834|NCT03249454|18563613|P1|First Intervention (1 Day)|Overall Study||1
7541835|NCT03249454|18563603|P11|STARTED|Overall Study||1
7541836|NCT03249454|18563604|P10|STARTED|Overall Study||1
7541837|NCT03249454|18563605|P9|STARTED|Overall Study||1
7541838|NCT03249454|18563606|P8|STARTED|Overall Study||1
7541839|NCT03249454|18563607|P7|STARTED|Overall Study||1
7541840|NCT03249454|18563608|P6|STARTED|Overall Study||2
7541841|NCT03249454|18563609|P5|STARTED|Overall Study||1
7541842|NCT03249454|18563610|P4|STARTED|Overall Study||1
7541843|NCT03249454|18563611|P3|STARTED|Overall Study||2
7541844|NCT03249454|18563612|P2|STARTED|Overall Study||1
7541845|NCT03249454|18563613|P1|STARTED|Overall Study||1
7541846|NCT03249272|18563636|P3|NOT COMPLETED|Overall Study||0
7541847|NCT03249272|18563637|P2|NOT COMPLETED|Overall Study||0
7541848|NCT03249272|18563638|P1|NOT COMPLETED|Overall Study||0
7541849|NCT03249272|18563636|P3|COMPLETED|Overall Study||6
7541850|NCT03249272|18563637|P2|COMPLETED|Overall Study||6
7541851|NCT03249272|18563638|P1|COMPLETED|Overall Study||19
7541852|NCT03249272|18563636|P3|STARTED|Overall Study||6
7541853|NCT03249272|18563637|P2|STARTED|Overall Study||6
7541854|NCT03249272|18563638|P1|STARTED|Overall Study||19
7541855|NCT03249116|18563661|P3|NOT COMPLETED|Overall Study||0
7541856|NCT03249116|18563662|P2|NOT COMPLETED|Overall Study||0
7541857|NCT03249116|18563663|P1|NOT COMPLETED|Overall Study||0
7541858|NCT03249116|18563661|P3|COMPLETED|Overall Study||25
7541859|NCT03249116|18563662|P2|COMPLETED|Overall Study||25
7541860|NCT03249116|18563663|P1|COMPLETED|Overall Study||25
7541861|NCT03249116|18563661|P3|STARTED|Overall Study||25
7541862|NCT03249116|18563662|P2|STARTED|Overall Study||25
7541863|NCT03249116|18563663|P1|STARTED|Overall Study||25
7541864|NCT03248947|18563683|P1|NOT COMPLETED|Overall Study||8
7541865|NCT03248947|18563683|P1|COMPLETED|Overall Study||63
7541866|NCT03248947|18563683|P1|STARTED|Overall Study||71
7541867|NCT03248882|18563701|P5|NOT COMPLETED|Overall Study||13
7541868|NCT03248882|18563702|P4|NOT COMPLETED|Overall Study||10
7541869|NCT03248882|18563703|P3|NOT COMPLETED|Overall Study||7
7541870|NCT03248882|18563704|P2|NOT COMPLETED|Overall Study||5
7541871|NCT03248882|18563705|P1|NOT COMPLETED|Overall Study||7
7541872|NCT03248882|18563701|P5|COMPLETED|Overall Study||48
7541873|NCT03248882|18563702|P4|COMPLETED|Overall Study||48
7541874|NCT03248882|18563703|P3|COMPLETED|Overall Study||55
7541875|NCT03248882|18563704|P2|COMPLETED|Overall Study||58
7541876|NCT03248882|18563705|P1|COMPLETED|Overall Study||54
7541877|NCT03248882|18563701|P5|Received Treatment|Overall Study||61
7541878|NCT03248882|18563702|P4|Received Treatment|Overall Study||58
7541879|NCT03248882|18563703|P3|Received Treatment|Overall Study||62
7541880|NCT03248882|18563704|P2|Received Treatment|Overall Study||63
7541881|NCT03248882|18563705|P1|Received Treatment|Overall Study||61
7541882|NCT03248882|18563701|P5|STARTED|Overall Study||61
7541883|NCT03248882|18563702|P4|STARTED|Overall Study||58
7541884|NCT03248882|18563703|P3|STARTED|Overall Study||62
7541885|NCT03248882|18563704|P2|STARTED|Overall Study||63
7541886|NCT03248882|18563705|P1|STARTED|Overall Study||61
7541887|NCT03248492|18563747|P5|NOT COMPLETED|Overall Study||4
7541888|NCT03248492|18563748|P4|NOT COMPLETED|Overall Study||130
7541889|NCT03248492|18563749|P3|NOT COMPLETED|Overall Study||21
7541890|NCT03248492|18563750|P2|NOT COMPLETED|Overall Study||48
7541891|NCT03248492|18563751|P1|NOT COMPLETED|Overall Study||50
7541892|NCT03248492|18563747|P5|COMPLETED|Overall Study||0
7541893|NCT03248492|18563748|P4|COMPLETED|Overall Study||0
7541894|NCT03248492|18563749|P3|COMPLETED|Overall Study||0
7541895|NCT03248492|18563750|P2|COMPLETED|Overall Study||0
7541896|NCT03248492|18563751|P1|COMPLETED|Overall Study||0
7541897|NCT03248492|18563747|P5|STARTED|Overall Study||4
7541898|NCT03248492|18563748|P4|STARTED|Overall Study||130
7541899|NCT03248492|18563749|P3|STARTED|Overall Study||21
7541900|NCT03248492|18563750|P2|STARTED|Overall Study||48
7541901|NCT03248492|18563751|P1|STARTED|Overall Study||50
7541902|NCT03248141|18563791|P2|NOT COMPLETED|Overall Study||0
7541903|NCT03248141|18563792|P1|NOT COMPLETED|Overall Study||0
7541904|NCT03248141|18563791|P2|COMPLETED|Overall Study||0
7541905|NCT03248141|18563792|P1|COMPLETED|Overall Study|Participants who were present in the study till termination were considered as completed.|11
7541906|NCT03248141|18563791|P2|STARTED|Overall Study|No enrollment occurred in this arm prior to study termination.|0
7541907|NCT03248141|18563792|P1|STARTED|Overall Study||11
7541908|NCT03247985|18563802|P2|NOT COMPLETED|Overall Study||0
7541909|NCT03247985|18563803|P1|NOT COMPLETED|Overall Study||0
7541910|NCT03247985|18563802|P2|COMPLETED|Overall Study||19
7541911|NCT03247985|18563803|P1|COMPLETED|Overall Study||19
7541912|NCT03247985|18563802|P2|STARTED|Overall Study||19
7541913|NCT03247985|18563803|P1|STARTED|Overall Study||19
7541914|NCT03247816|18563817|P1|NOT COMPLETED|Overall Study||29
7541915|NCT03247816|18563817|P1|COMPLETED|Overall Study||30
7541916|NCT03247816|18563817|P1|STARTED|Overall Study||59
7541917|NCT03247790|18563847|P1|NOT COMPLETED|Period 2: Inter-ictal Period||0
7541918|NCT03247790|18563847|P1|COMPLETED|Period 2: Inter-ictal Period||16
7541919|NCT03247790|18563847|P1|STARTED|Period 2: Inter-ictal Period||16
7541920|NCT03247790|18563847|P1|NOT COMPLETED|Period 1: Migraine Attack||0
7541921|NCT03247790|18563847|P1|COMPLETED|Period 1: Migraine Attack||16
7541922|NCT03247790|18563847|P1|Received at Least One Dose of Study Drug|Period 1: Migraine Attack||16
7541923|NCT03247790|18563847|P1|STARTED|Period 1: Migraine Attack||16
7541924|NCT03247738|18563861|P2|NOT COMPLETED|Overall Study||0
7541925|NCT03247738|18563862|P1|NOT COMPLETED|Overall Study||0
7541926|NCT03247738|18563861|P2|COMPLETED|Overall Study||25
7541927|NCT03247738|18563862|P1|COMPLETED|Overall Study||25
7541928|NCT03247738|18563861|P2|STARTED|Overall Study||25
7541929|NCT03247738|18563862|P1|STARTED|Overall Study||25
7541930|NCT03247673|18563873|P3|NOT COMPLETED|Overall Study||4
7541931|NCT03247673|18563874|P2|NOT COMPLETED|Overall Study||0
7541932|NCT03247673|18563875|P1|NOT COMPLETED|Overall Study||1
7541933|NCT03247673|18563873|P3|COMPLETED|Overall Study||44
7541934|NCT03247673|18563874|P2|COMPLETED|Overall Study||47
7541935|NCT03247673|18563875|P1|COMPLETED|Overall Study||45
7541936|NCT03247673|18563873|P3|STARTED|Overall Study||48
7541937|NCT03247673|18563874|P2|STARTED|Overall Study||47
7541938|NCT03247673|18563875|P1|STARTED|Overall Study||46
7541939|NCT03246724|18563899|P4|NOT COMPLETED|Overall Study||8
7541940|NCT03246724|18563900|P3|NOT COMPLETED|Overall Study||15
7541941|NCT03246724|18563901|P2|NOT COMPLETED|Overall Study||7
7541942|NCT03246724|18563902|P1|NOT COMPLETED|Overall Study||14
7541943|NCT03246724|18563899|P4|COMPLETED|Overall Study||44
7541944|NCT03246724|18563900|P3|COMPLETED|Overall Study||70
7541945|NCT03246724|18563901|P2|COMPLETED|Overall Study||84
7541946|NCT03246724|18563902|P1|COMPLETED|Overall Study||85
7541947|NCT03246724|18563899|P4|STARTED|Overall Study||52
7541948|NCT03246724|18563900|P3|STARTED|Overall Study||85
7541949|NCT03246724|18563901|P2|STARTED|Overall Study||91
7541950|NCT03246724|18563902|P1|STARTED|Overall Study||99
7541951|NCT03246672|18563928|P1|NOT COMPLETED|Overall Study||2
7541952|NCT03246672|18563928|P1|COMPLETED|Overall Study||28
7541953|NCT03246672|18563928|P1|Completed First Phone Call|Overall Study||29
7541954|NCT03246672|18563928|P1|STARTED|Overall Study||30
7541955|NCT03246152|18563934|P1|NOT COMPLETED|Overall Study||3
7541956|NCT03246152|18563934|P1|COMPLETED|Overall Study||28
7541957|NCT03246152|18563934|P1|STARTED|Overall Study||31
7541958|NCT03246061|18563942|P2|NOT COMPLETED|Overall Study||21
7541959|NCT03246061|18563943|P1|NOT COMPLETED|Overall Study||15
7541960|NCT03246061|18563942|P2|COMPLETED|Overall Study||53
7541961|NCT03246061|18563943|P1|COMPLETED|Overall Study||51
7541962|NCT03246061|18563942|P2|Interim Analysis|Overall Study||53
7541963|NCT03246061|18563943|P1|Interim Analysis|Overall Study||51
7541964|NCT03246061|18563942|P2|STARTED|Overall Study||74
7541965|NCT03246061|18563943|P1|STARTED|Overall Study||66
7541966|NCT03245762|18563953|P2|NOT COMPLETED|Overall Study||0
7541967|NCT03245762|18563954|P1|NOT COMPLETED|Overall Study||0
7541968|NCT03245762|18563953|P2|COMPLETED|Overall Study||5
7541969|NCT03245762|18563954|P1|COMPLETED|Overall Study||10
7541970|NCT03245762|18563953|P2|STARTED|Overall Study||5
7541971|NCT03245762|18563954|P1|STARTED|Overall Study||10
7541972|NCT03245619|18563977|P17|NOT COMPLETED|Part C (Up to 34 Days)||0
7541973|NCT03245619|18563978|P16|NOT COMPLETED|Part C (Up to 34 Days)||0
7541974|NCT03245619|18563979|P15|NOT COMPLETED|Part C (Up to 34 Days)||0
7541975|NCT03245619|18563980|P14|NOT COMPLETED|Part C (Up to 34 Days)||0
7541976|NCT03245619|18563981|P13|NOT COMPLETED|Part C (Up to 34 Days)||0
7541977|NCT03245619|18563982|P12|NOT COMPLETED|Part C (Up to 34 Days)||0
7541978|NCT03245619|18563983|P11|NOT COMPLETED|Part C (Up to 34 Days)||0
7541979|NCT03245619|18563984|P10|NOT COMPLETED|Part C (Up to 34 Days)||0
7541980|NCT03245619|18563985|P9|NOT COMPLETED|Part C (Up to 34 Days)||0
7541981|NCT03245619|18563986|P8|NOT COMPLETED|Part C (Up to 34 Days)||0
7541982|NCT03245619|18563987|P7|NOT COMPLETED|Part C (Up to 34 Days)||0
7541983|NCT03245619|18563988|P6|NOT COMPLETED|Part C (Up to 34 Days)||0
7541984|NCT03245619|18563989|P5|NOT COMPLETED|Part C (Up to 34 Days)||0
7541985|NCT03245619|18563990|P4|NOT COMPLETED|Part C (Up to 34 Days)||0
7541986|NCT03245619|18563991|P3|NOT COMPLETED|Part C (Up to 34 Days)||0
7541987|NCT03245619|18563992|P2|NOT COMPLETED|Part C (Up to 34 Days)||0
7541988|NCT03245619|18563993|P1|NOT COMPLETED|Part C (Up to 34 Days)||0
7541989|NCT03245619|18563977|P17|COMPLETED|Part C (Up to 34 Days)||0
7541990|NCT03245619|18563978|P16|COMPLETED|Part C (Up to 34 Days)||0
7541991|NCT03245619|18563979|P15|COMPLETED|Part C (Up to 34 Days)||0
7541992|NCT03245619|18563980|P14|COMPLETED|Part C (Up to 34 Days)||0
7541993|NCT03245619|18563981|P13|COMPLETED|Part C (Up to 34 Days)||0
7541994|NCT03245619|18563982|P12|COMPLETED|Part C (Up to 34 Days)||0
7541995|NCT03245619|18563983|P11|COMPLETED|Part C (Up to 34 Days)||0
7541996|NCT03245619|18563984|P10|COMPLETED|Part C (Up to 34 Days)||0
7541997|NCT03245619|18563985|P9|COMPLETED|Part C (Up to 34 Days)||0
7541998|NCT03245619|18563986|P8|COMPLETED|Part C (Up to 34 Days)||0
7541999|NCT03245619|18563987|P7|COMPLETED|Part C (Up to 34 Days)||0
7542000|NCT03245619|18563988|P6|COMPLETED|Part C (Up to 34 Days)||0
7542001|NCT03245619|18563989|P5|COMPLETED|Part C (Up to 34 Days)||0
7542002|NCT03245619|18563990|P4|COMPLETED|Part C (Up to 34 Days)||0
7542003|NCT03245619|18563991|P3|COMPLETED|Part C (Up to 34 Days)||0
7542004|NCT03245619|18563992|P2|COMPLETED|Part C (Up to 34 Days)||0
7542005|NCT03245619|18563993|P1|COMPLETED|Part C (Up to 34 Days)||0
7542006|NCT03245619|18563977|P17|STARTED|Part C (Up to 34 Days)||0
7542007|NCT03245619|18563978|P16|STARTED|Part C (Up to 34 Days)||0
7542008|NCT03245619|18563979|P15|STARTED|Part C (Up to 34 Days)||0
7542009|NCT03245619|18563980|P14|STARTED|Part C (Up to 34 Days)||0
7542010|NCT03245619|18563981|P13|STARTED|Part C (Up to 34 Days)||0
7542011|NCT03245619|18563982|P12|STARTED|Part C (Up to 34 Days)||0
7542012|NCT03245619|18563983|P11|STARTED|Part C (Up to 34 Days)||0
7542013|NCT03245619|18563984|P10|STARTED|Part C (Up to 34 Days)||0
7542014|NCT03245619|18563985|P9|STARTED|Part C (Up to 34 Days)||0
7542015|NCT03245619|18563986|P8|STARTED|Part C (Up to 34 Days)||0
7542016|NCT03245619|18563987|P7|STARTED|Part C (Up to 34 Days)||0
7542017|NCT03245619|18563988|P6|STARTED|Part C (Up to 34 Days)||0
7542018|NCT03245619|18563989|P5|STARTED|Part C (Up to 34 Days)||0
7542019|NCT03245619|18563990|P4|STARTED|Part C (Up to 34 Days)||0
7542020|NCT03245619|18563991|P3|STARTED|Part C (Up to 34 Days)||0
7542021|NCT03245619|18563992|P2|STARTED|Part C (Up to 34 Days)||0
7542022|NCT03245619|18563993|P1|STARTED|Part C (Up to 34 Days)||0
7542023|NCT03245619|18563977|P17|NOT COMPLETED|Part B (Up to 34 Days)||0
7542024|NCT03245619|18563978|P16|NOT COMPLETED|Part B (Up to 34 Days)||0
7542025|NCT03245619|18563979|P15|NOT COMPLETED|Part B (Up to 34 Days)||0
7542026|NCT03245619|18563980|P14|NOT COMPLETED|Part B (Up to 34 Days)||0
7542027|NCT03245619|18563981|P13|NOT COMPLETED|Part B (Up to 34 Days)||0
7542028|NCT03245619|18563982|P12|NOT COMPLETED|Part B (Up to 34 Days)||0
7542029|NCT03245619|18563983|P11|NOT COMPLETED|Part B (Up to 34 Days)||0
7542030|NCT03245619|18563984|P10|NOT COMPLETED|Part B (Up to 34 Days)||0
7542031|NCT03245619|18563985|P9|NOT COMPLETED|Part B (Up to 34 Days)||0
7542032|NCT03245619|18563986|P8|NOT COMPLETED|Part B (Up to 34 Days)||0
7542033|NCT03245619|18563987|P7|NOT COMPLETED|Part B (Up to 34 Days)||0
7542034|NCT03245619|18563988|P6|NOT COMPLETED|Part B (Up to 34 Days)||0
7542035|NCT03245619|18563989|P5|NOT COMPLETED|Part B (Up to 34 Days)||0
7542036|NCT03245619|18563990|P4|NOT COMPLETED|Part B (Up to 34 Days)||0
7542037|NCT03245619|18563991|P3|NOT COMPLETED|Part B (Up to 34 Days)||0
7542038|NCT03245619|18563992|P2|NOT COMPLETED|Part B (Up to 34 Days)||0
7542039|NCT03245619|18563993|P1|NOT COMPLETED|Part B (Up to 34 Days)||0
7542040|NCT03245619|18563977|P17|COMPLETED|Part B (Up to 34 Days)||0
7542041|NCT03245619|18563978|P16|COMPLETED|Part B (Up to 34 Days)||0
7542042|NCT03245619|18563979|P15|COMPLETED|Part B (Up to 34 Days)||0
7542043|NCT03245619|18563980|P14|COMPLETED|Part B (Up to 34 Days)||0
7542044|NCT03245619|18563981|P13|COMPLETED|Part B (Up to 34 Days)||0
7542045|NCT03245619|18563982|P12|COMPLETED|Part B (Up to 34 Days)||0
7542046|NCT03245619|18563983|P11|COMPLETED|Part B (Up to 34 Days)||0
7542047|NCT03245619|18563984|P10|COMPLETED|Part B (Up to 34 Days)||0
7542048|NCT03245619|18563985|P9|COMPLETED|Part B (Up to 34 Days)||0
7542049|NCT03245619|18563986|P8|COMPLETED|Part B (Up to 34 Days)||0
7542050|NCT03245619|18563987|P7|COMPLETED|Part B (Up to 34 Days)||0
7542051|NCT03245619|18563988|P6|COMPLETED|Part B (Up to 34 Days)||0
7542052|NCT03245619|18563989|P5|COMPLETED|Part B (Up to 34 Days)||0
7542053|NCT03245619|18563990|P4|COMPLETED|Part B (Up to 34 Days)||0
7542054|NCT03245619|18563991|P3|COMPLETED|Part B (Up to 34 Days)||0
7542055|NCT03245619|18563992|P2|COMPLETED|Part B (Up to 34 Days)||0
7542056|NCT03245619|18563993|P1|COMPLETED|Part B (Up to 34 Days)||0
7542057|NCT03245619|18563977|P17|STARTED|Part B (Up to 34 Days)||0
7542058|NCT03245619|18563978|P16|STARTED|Part B (Up to 34 Days)||0
7542059|NCT03245619|18563979|P15|STARTED|Part B (Up to 34 Days)||0
7542060|NCT03245619|18563980|P14|STARTED|Part B (Up to 34 Days)||0
7542061|NCT03245619|18563981|P13|STARTED|Part B (Up to 34 Days)||0
7542062|NCT03245619|18563982|P12|STARTED|Part B (Up to 34 Days)||0
7542063|NCT03245619|18563983|P11|STARTED|Part B (Up to 34 Days)||0
7542064|NCT03245619|18563984|P10|STARTED|Part B (Up to 34 Days)||0
7542065|NCT03245619|18563985|P9|STARTED|Part B (Up to 34 Days)||0
7542066|NCT03245619|18563986|P8|STARTED|Part B (Up to 34 Days)||0
7542067|NCT03245619|18563987|P7|STARTED|Part B (Up to 34 Days)||0
7542068|NCT03245619|18563988|P6|STARTED|Part B (Up to 34 Days)||0
7542069|NCT03245619|18563989|P5|STARTED|Part B (Up to 34 Days)||0
7542070|NCT03245619|18563990|P4|STARTED|Part B (Up to 34 Days)||0
7542071|NCT03245619|18563991|P3|STARTED|Part B (Up to 34 Days)||0
7542072|NCT03245619|18563992|P2|STARTED|Part B (Up to 34 Days)||0
7542073|NCT03245619|18563993|P1|STARTED|Part B (Up to 34 Days)||0
7542074|NCT03245619|18563977|P17|NOT COMPLETED|Part A (Up to Day 22)||0
7542075|NCT03245619|18563978|P16|NOT COMPLETED|Part A (Up to Day 22)||0
7542076|NCT03245619|18563979|P15|NOT COMPLETED|Part A (Up to Day 22)||0
7542077|NCT03245619|18563980|P14|NOT COMPLETED|Part A (Up to Day 22)||0
7542078|NCT03245619|18563981|P13|NOT COMPLETED|Part A (Up to Day 22)||0
7542079|NCT03245619|18563982|P12|NOT COMPLETED|Part A (Up to Day 22)||0
7542080|NCT03245619|18563983|P11|NOT COMPLETED|Part A (Up to Day 22)||0
7542081|NCT03245619|18563984|P10|NOT COMPLETED|Part A (Up to Day 22)||0
7542082|NCT03245619|18563985|P9|NOT COMPLETED|Part A (Up to Day 22)||0
7542083|NCT03245619|18563986|P8|NOT COMPLETED|Part A (Up to Day 22)||0
7542084|NCT03245619|18563987|P7|NOT COMPLETED|Part A (Up to Day 22)||0
7542085|NCT03245619|18563988|P6|NOT COMPLETED|Part A (Up to Day 22)||0
7542086|NCT03245619|18563989|P5|NOT COMPLETED|Part A (Up to Day 22)||0
7542087|NCT03245619|18563990|P4|NOT COMPLETED|Part A (Up to Day 22)||0
7542088|NCT03245619|18563991|P3|NOT COMPLETED|Part A (Up to Day 22)||6
7542089|NCT03245619|18563992|P2|NOT COMPLETED|Part A (Up to Day 22)||6
7542090|NCT03245619|18563993|P1|NOT COMPLETED|Part A (Up to Day 22)||4
7542091|NCT03245619|18563977|P17|COMPLETED|Part A (Up to Day 22)||0
7542092|NCT03245619|18563978|P16|COMPLETED|Part A (Up to Day 22)||0
7542093|NCT03245619|18563979|P15|COMPLETED|Part A (Up to Day 22)||0
7542094|NCT03245619|18563980|P14|COMPLETED|Part A (Up to Day 22)||0
7542095|NCT03245619|18563981|P13|COMPLETED|Part A (Up to Day 22)||0
7542096|NCT03245619|18563982|P12|COMPLETED|Part A (Up to Day 22)||0
7542097|NCT03245619|18563983|P11|COMPLETED|Part A (Up to Day 22)||0
7542098|NCT03245619|18563984|P10|COMPLETED|Part A (Up to Day 22)||0
7542099|NCT03245619|18563985|P9|COMPLETED|Part A (Up to Day 22)||0
7542100|NCT03245619|18563986|P8|COMPLETED|Part A (Up to Day 22)||0
7542101|NCT03245619|18563987|P7|COMPLETED|Part A (Up to Day 22)||0
7542102|NCT03245619|18563988|P6|COMPLETED|Part A (Up to Day 22)||0
7542103|NCT03245619|18563989|P5|COMPLETED|Part A (Up to Day 22)||0
7542104|NCT03245619|18563990|P4|COMPLETED|Part A (Up to Day 22)||1
7542105|NCT03245619|18563991|P3|COMPLETED|Part A (Up to Day 22)||0
7542106|NCT03245619|18563992|P2|COMPLETED|Part A (Up to Day 22)||0
7542107|NCT03245619|18563993|P1|COMPLETED|Part A (Up to Day 22)||1
7542108|NCT03245619|18563977|P17|STARTED|Part A (Up to Day 22)||0
7542109|NCT03245619|18563978|P16|STARTED|Part A (Up to Day 22)||0
7542110|NCT03245619|18563979|P15|STARTED|Part A (Up to Day 22)||0
7542111|NCT03245619|18563980|P14|STARTED|Part A (Up to Day 22)||0
7542112|NCT03245619|18563981|P13|STARTED|Part A (Up to Day 22)||0
7542113|NCT03245619|18563982|P12|STARTED|Part A (Up to Day 22)||0
7542114|NCT03245619|18563983|P11|STARTED|Part A (Up to Day 22)||0
7542115|NCT03245619|18563984|P10|STARTED|Part A (Up to Day 22)||0
7542116|NCT03245619|18563985|P9|STARTED|Part A (Up to Day 22)||0
7542117|NCT03245619|18563986|P8|STARTED|Part A (Up to Day 22)||0
7542118|NCT03245619|18563987|P7|STARTED|Part A (Up to Day 22)||0
7542119|NCT03245619|18563988|P6|STARTED|Part A (Up to Day 22)||0
7542120|NCT03245619|18563989|P5|STARTED|Part A (Up to Day 22)||0
7542121|NCT03245619|18563990|P4|STARTED|Part A (Up to Day 22)||1
7542122|NCT03245619|18563991|P3|STARTED|Part A (Up to Day 22)||6
7542123|NCT03245619|18563992|P2|STARTED|Part A (Up to Day 22)||6
7542124|NCT03245619|18563993|P1|STARTED|Part A (Up to Day 22)||5
7542125|NCT03245463|18564248|P2|NOT COMPLETED|Overall Study||0
7542126|NCT03245463|18564249|P1|NOT COMPLETED|Overall Study||0
7542127|NCT03245463|18564248|P2|COMPLETED|Overall Study||12
7542128|NCT03245463|18564249|P1|COMPLETED|Overall Study||12
7542129|NCT03245463|18564248|P2|STARTED|Overall Study||12
7542130|NCT03245463|18564249|P1|STARTED|Overall Study||12
7542131|NCT03245398|18564267|P2|NOT COMPLETED|Overall Study||0
7542132|NCT03245398|18564268|P1|NOT COMPLETED|Overall Study||1
7542133|NCT03245398|18564267|P2|COMPLETED|Overall Study||93
7542134|NCT03245398|18564268|P1|COMPLETED|Overall Study||92
7542135|NCT03245398|18564267|P2|STARTED|Overall Study||93
7542136|NCT03245398|18564268|P1|STARTED|Overall Study||93
7542137|NCT03244865|18564290|P1|NOT COMPLETED|Overall Study||0
7542138|NCT03244865|18564290|P1|COMPLETED|Overall Study||35
7542139|NCT03244865|18564290|P1|STARTED|Overall Study||35
7542140|NCT03244800|18564298|P4|NOT COMPLETED|Overall Study||2
7542141|NCT03244800|18564299|P3|NOT COMPLETED|Overall Study||0
7542142|NCT03244800|18564300|P2|NOT COMPLETED|Overall Study||1
7542143|NCT03244800|18564301|P1|NOT COMPLETED|Overall Study||0
7542144|NCT03244800|18564298|P4|COMPLETED|Overall Study||18
7542145|NCT03244800|18564299|P3|COMPLETED|Overall Study||6
7542146|NCT03244800|18564300|P2|COMPLETED|Overall Study||25
7542147|NCT03244800|18564301|P1|COMPLETED|Overall Study||13
7542148|NCT03244800|18564298|P4|STARTED|Overall Study||20
7542149|NCT03244800|18564299|P3|STARTED|Overall Study||6
7542150|NCT03244800|18564300|P2|STARTED|Overall Study||26
7542151|NCT03244800|18564301|P1|STARTED|Overall Study||13
7542152|NCT03244618|18564361|P2|NOT COMPLETED|Overall Study||9
7542153|NCT03244618|18564362|P1|NOT COMPLETED|Overall Study||7
7542154|NCT03244618|18564361|P2|COMPLETED|Overall Study||122
7542155|NCT03244618|18564362|P1|COMPLETED|Overall Study||125
7542156|NCT03244618|18564361|P2|Week 2|Overall Study||125
7542157|NCT03244618|18564362|P1|Week 2|Overall Study||128
7542158|NCT03244618|18564361|P2|STARTED|Overall Study||131
7542159|NCT03244618|18564362|P1|STARTED|Overall Study||132
7542160|NCT03243981|18564378|P1|NOT COMPLETED|Overall Study||0
7542161|NCT03243981|18564378|P1|COMPLETED|Overall Study||5
7542162|NCT03243981|18564378|P1|STARTED|Overall Study||5
7542163|NCT03243630|18564397|P1|NOT COMPLETED|Overall Study||2
7542164|NCT03243630|18564397|P1|COMPLETED|Overall Study||22
7542165|NCT03243630|18564397|P1|Green Apple and Menthol E-liquid Lower|Overall Study||21
7542166|NCT03243630|18564397|P1|Green Apple and Menthol E-liquid Higher|Overall Study||21
7542167|NCT03243630|18564397|P1|Green Apple and Menthol E-liquid Saline|Overall Study||21
7542168|NCT03243630|18564397|P1|Green Apple E-liquid Lower|Overall Study||20
7542169|NCT03243630|18564397|P1|Green Apple E-liquid Higher|Overall Study||20
7542170|NCT03243630|18564397|P1|Green Apple E-liquid Saline|Overall Study||20
7542171|NCT03243630|18564397|P1|Menthol E-liquid Lower|Overall Study||22
7542172|NCT03243630|18564397|P1|Menthol E-liquid Higher|Overall Study||22
7542173|NCT03243630|18564397|P1|Menthol E-liquid Saline|Overall Study||22
7542174|NCT03243630|18564397|P1|STARTED|Overall Study||24
7542175|NCT03243305|18564405|P1|NOT COMPLETED|Overall Study||935
7542176|NCT03243305|18564405|P1|COMPLETED|Overall Study||449
7542177|NCT03243305|18564405|P1|STARTED|Overall Study||1384
7542178|NCT03243084|18564412|P2|NOT COMPLETED|Session 2||0
7542179|NCT03243084|18564413|P1|NOT COMPLETED|Session 2||0
7542180|NCT03243084|18564412|P2|COMPLETED|Session 2||10
7542181|NCT03243084|18564413|P1|COMPLETED|Session 2||10
7542182|NCT03243084|18564412|P2|STARTED|Session 2||10
7542183|NCT03243084|18564413|P1|STARTED|Session 2||10
7542184|NCT03243084|18564412|P2|NOT COMPLETED|Washout (1-3 Weeks)||0
7542185|NCT03243084|18564413|P1|NOT COMPLETED|Washout (1-3 Weeks)||1
7542186|NCT03243084|18564412|P2|COMPLETED|Washout (1-3 Weeks)||10
7542187|NCT03243084|18564413|P1|COMPLETED|Washout (1-3 Weeks)||10
7542188|NCT03243084|18564412|P2|STARTED|Washout (1-3 Weeks)||10
7542189|NCT03243084|18564413|P1|STARTED|Washout (1-3 Weeks)||11
7542190|NCT03243084|18564412|P2|NOT COMPLETED|Session 1||0
7542191|NCT03243084|18564413|P1|NOT COMPLETED|Session 1||0
7542192|NCT03243084|18564412|P2|COMPLETED|Session 1||10
7542193|NCT03243084|18564413|P1|COMPLETED|Session 1||11
7542194|NCT03243084|18564412|P2|STARTED|Session 1||10
7542195|NCT03243084|18564413|P1|STARTED|Session 1||11
7542196|NCT03242941|18564423|P1|NOT COMPLETED|Overall Study||2
7542197|NCT03242941|18564423|P1|COMPLETED|Overall Study||14
7542198|NCT03242941|18564423|P1|STARTED|Overall Study||16
7542199|NCT03242863|18564429|P6|NOT COMPLETED|Study Week 3||0
7542200|NCT03242863|18564430|P5|NOT COMPLETED|Study Week 3||0
7542201|NCT03242863|18564431|P4|NOT COMPLETED|Study Week 3||0
7542202|NCT03242863|18564432|P3|NOT COMPLETED|Study Week 3||0
7542203|NCT03242863|18564433|P2|NOT COMPLETED|Study Week 3||0
7542204|NCT03242863|18564434|P1|NOT COMPLETED|Study Week 3||0
7542205|NCT03242863|18564429|P6|COMPLETED|Study Week 3||5
7542206|NCT03242863|18564430|P5|COMPLETED|Study Week 3||12
7542207|NCT03242863|18564431|P4|COMPLETED|Study Week 3||4
7542208|NCT03242863|18564432|P3|COMPLETED|Study Week 3||4
7542209|NCT03242863|18564433|P2|COMPLETED|Study Week 3||15
7542210|NCT03242863|18564434|P1|COMPLETED|Study Week 3||13
7542211|NCT03242863|18564429|P6|STARTED|Study Week 3||5
7542212|NCT03242863|18564430|P5|STARTED|Study Week 3||12
7542213|NCT03242863|18564431|P4|STARTED|Study Week 3||4
7542214|NCT03242863|18564432|P3|STARTED|Study Week 3||4
7542215|NCT03242863|18564433|P2|STARTED|Study Week 3||15
7542216|NCT03242863|18564434|P1|STARTED|Study Week 3||13
7542217|NCT03242863|18564429|P6|NOT COMPLETED|Study Week 2||0
7542218|NCT03242863|18564430|P5|NOT COMPLETED|Study Week 2||0
7542219|NCT03242863|18564431|P4|NOT COMPLETED|Study Week 2||0
7542220|NCT03242863|18564432|P3|NOT COMPLETED|Study Week 2||0
7542221|NCT03242863|18564433|P2|NOT COMPLETED|Study Week 2||0
7542222|NCT03242863|18564434|P1|NOT COMPLETED|Study Week 2||0
7542223|NCT03242863|18564429|P6|COMPLETED|Study Week 2||5
7542224|NCT03242863|18564430|P5|COMPLETED|Study Week 2||12
7542225|NCT03242863|18564431|P4|COMPLETED|Study Week 2||4
7542226|NCT03242863|18564432|P3|COMPLETED|Study Week 2||4
7542227|NCT03242863|18564433|P2|COMPLETED|Study Week 2||15
7542228|NCT03242863|18564434|P1|COMPLETED|Study Week 2||13
7542229|NCT03242863|18564429|P6|STARTED|Study Week 2||5
7542230|NCT03242863|18564430|P5|STARTED|Study Week 2||12
7542231|NCT03242863|18564431|P4|STARTED|Study Week 2||4
7542232|NCT03242863|18564432|P3|STARTED|Study Week 2||4
7542233|NCT03242863|18564433|P2|STARTED|Study Week 2||15
7542234|NCT03242863|18564434|P1|STARTED|Study Week 2||13
7542235|NCT03242863|18564429|P6|NOT COMPLETED|Study Week 1||0
7542236|NCT03242863|18564430|P5|NOT COMPLETED|Study Week 1||3
7542237|NCT03242863|18564431|P4|NOT COMPLETED|Study Week 1||0
7542238|NCT03242863|18564432|P3|NOT COMPLETED|Study Week 1||0
7542239|NCT03242863|18564433|P2|NOT COMPLETED|Study Week 1||1
7542240|NCT03242863|18564434|P1|NOT COMPLETED|Study Week 1||0
7542241|NCT03242863|18564429|P6|COMPLETED|Study Week 1||5
7542242|NCT03242863|18564430|P5|COMPLETED|Study Week 1||12
7542243|NCT03242863|18564431|P4|COMPLETED|Study Week 1||4
7542244|NCT03242863|18564432|P3|COMPLETED|Study Week 1||4
7542245|NCT03242863|18564433|P2|COMPLETED|Study Week 1||15
7542246|NCT03242863|18564434|P1|COMPLETED|Study Week 1||13
7542247|NCT03242863|18564429|P6|STARTED|Study Week 1||5
7542248|NCT03242863|18564430|P5|STARTED|Study Week 1||15
7542249|NCT03242863|18564431|P4|STARTED|Study Week 1||4
7542250|NCT03242863|18564432|P3|STARTED|Study Week 1||4
7542251|NCT03242863|18564433|P2|STARTED|Study Week 1||16
7542252|NCT03242863|18564434|P1|STARTED|Study Week 1||13
7542253|NCT03242590|18564451|P1|NOT COMPLETED|Overall Study||0
7542254|NCT03242590|18564451|P1|COMPLETED|Overall Study||95
7542255|NCT03242590|18564451|P1|STARTED|Overall Study||95
7542256|NCT03242434|18564457|P2|NOT COMPLETED|Overall Study||2
7542257|NCT03242434|18564458|P1|NOT COMPLETED|Overall Study||0
7542258|NCT03242434|18564457|P2|COMPLETED|Overall Study||1
7542259|NCT03242434|18564458|P1|COMPLETED|Overall Study||15
7542260|NCT03242434|18564457|P2|STARTED|Overall Study||3
7542261|NCT03242434|18564458|P1|STARTED|Overall Study||15
7542262|NCT03242408|18564466|P1|NOT COMPLETED|Overall Study||2
7542263|NCT03242408|18564466|P1|COMPLETED|Overall Study||98
7542264|NCT03242408|18564466|P1|STARTED|Overall Study||100
7542265|NCT03241927|18564470|P2|NOT COMPLETED|Overall Study||0
7542266|NCT03241927|18564471|P1|NOT COMPLETED|Overall Study||1
7542267|NCT03241927|18564470|P2|COMPLETED|Overall Study||0
7542268|NCT03241927|18564471|P1|COMPLETED|Overall Study||0
7542269|NCT03241927|18564470|P2|STARTED|Overall Study||0
7542270|NCT03241927|18564471|P1|STARTED|Overall Study||1
7542271|NCT03241862|18564491|P1|NOT COMPLETED|Overall Study||0
7542272|NCT03241862|18564491|P1|COMPLETED|Overall Study||20
7542273|NCT03241862|18564491|P1|STARTED|Overall Study||20
7542274|NCT03241810|18564498|P2|NOT COMPLETED|Overall Study||0
7542275|NCT03241810|18564499|P1|NOT COMPLETED|Overall Study||0
7542276|NCT03241810|18564498|P2|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
7542277|NCT03241810|18564499|P1|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
7542278|NCT03241810|18564498|P2|STARTED|Overall Study||11
7542279|NCT03241810|18564499|P1|STARTED|Overall Study||11
7542280|NCT03241368|18564517|P1|NOT COMPLETED|Overall Study||39
7542281|NCT03241368|18564517|P1|COMPLETED|Overall Study||119
7542282|NCT03241368|18564517|P1|STARTED|Overall Study||158
7542283|NCT03241342|18564527|P3|NOT COMPLETED|Overall Study||27
7542284|NCT03241342|18564528|P2|NOT COMPLETED|Overall Study||32
7542285|NCT03241342|18564529|P1|NOT COMPLETED|Overall Study||23
7542286|NCT03241342|18564527|P3|COMPLETED|Overall Study||138
7542287|NCT03241342|18564528|P2|COMPLETED|Overall Study||132
7542288|NCT03241342|18564529|P1|COMPLETED|Overall Study||141
7542289|NCT03241342|18564527|P3|STARTED|Overall Study||165
7542290|NCT03241342|18564528|P2|STARTED|Overall Study||164
7542291|NCT03241342|18564529|P1|STARTED|Overall Study||164
7542292|NCT03240575|18564541|P4|NOT COMPLETED|Overall Study||2
7542293|NCT03240575|18564542|P3|NOT COMPLETED|Overall Study||0
7542294|NCT03240575|18564543|P2|NOT COMPLETED|Overall Study||14
7542295|NCT03240575|18564544|P1|NOT COMPLETED|Overall Study||2
7542296|NCT03240575|18564541|P4|COMPLETED|Overall Study||3
7542297|NCT03240575|18564542|P3|COMPLETED|Overall Study||6
7542298|NCT03240575|18564543|P2|COMPLETED|Overall Study||131
7542299|NCT03240575|18564544|P1|COMPLETED|Overall Study||144
7542300|NCT03240575|18564541|P4|STARTED|Overall Study||5
7542301|NCT03240575|18564542|P3|STARTED|Overall Study||6
7542302|NCT03240575|18564543|P2|STARTED|Overall Study||145
7542303|NCT03240575|18564544|P1|STARTED|Overall Study||146
7542304|NCT03239873|18564566|P2|NOT COMPLETED|Overall Study||27
7542305|NCT03239873|18564567|P1|NOT COMPLETED|Overall Study||32
7542306|NCT03239873|18564566|P2|COMPLETED|Overall Study||273
7542307|NCT03239873|18564567|P1|COMPLETED|Overall Study||268
7542308|NCT03239873|18564566|P2|Vaccination 2|Overall Study||282
7542309|NCT03239873|18564567|P1|Vaccination 2|Overall Study||276
7542310|NCT03239873|18564566|P2|Vaccination 1|Overall Study||300
7542311|NCT03239873|18564567|P1|Vaccination 1|Overall Study||299
7542312|NCT03239873|18564566|P2|STARTED|Overall Study||300
7542313|NCT03239873|18564567|P1|STARTED|Overall Study||300
7542314|NCT03239665|18564613|P2|NOT COMPLETED|Overall Study||20
7542315|NCT03239665|18564614|P1|NOT COMPLETED|Overall Study||28
7542316|NCT03239665|18564613|P2|COMPLETED|Overall Study||140
7542317|NCT03239665|18564614|P1|COMPLETED|Overall Study||147
7542318|NCT03239665|18564613|P2|Submitted Survey Data|Overall Study||140
7542319|NCT03239665|18564614|P1|Submitted Survey Data|Overall Study||147
7542320|NCT03239665|18564613|P2|Met Inclusion Criteria|Overall Study||144
7542321|NCT03239665|18564614|P1|Met Inclusion Criteria|Overall Study||150
7542322|NCT03239665|18564613|P2|STARTED|Overall Study||160
7542323|NCT03239665|18564614|P1|STARTED|Overall Study||175
7542324|NCT03239522|18564634|P1|NOT COMPLETED|Treatment Period 2 (Up to 15 Days)||0
7542325|NCT03239522|18564634|P1|COMPLETED|Treatment Period 2 (Up to 15 Days)||6
7542326|NCT03239522|18564634|P1|STARTED|Treatment Period 2 (Up to 15 Days)||6
7542327|NCT03239522|18564634|P1|NOT COMPLETED|Washout Period (Up to 7 Days)||0
7542328|NCT03239522|18564634|P1|COMPLETED|Washout Period (Up to 7 Days)||6
7542329|NCT03239522|18564634|P1|STARTED|Washout Period (Up to 7 Days)||6
7542330|NCT03239522|18564634|P1|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
7542331|NCT03239522|18564634|P1|COMPLETED|Treatment Period 1 (Up to 7 Days)||6
7542332|NCT03239522|18564634|P1|STARTED|Treatment Period 1 (Up to 7 Days)||6
7542333|NCT03239496|18564728|P4|NOT COMPLETED|Overall Study||14
7542334|NCT03239496|18564729|P3|NOT COMPLETED|Overall Study||12
7542335|NCT03239496|18564730|P2|NOT COMPLETED|Overall Study||10
7542336|NCT03239496|18564731|P1|NOT COMPLETED|Overall Study||14
7542337|NCT03239496|18564728|P4|COMPLETED|Overall Study||203
7542338|NCT03239496|18564729|P3|COMPLETED|Overall Study||166
7542339|NCT03239496|18564730|P2|COMPLETED|Overall Study||168
7542340|NCT03239496|18564731|P1|COMPLETED|Overall Study||186
7542341|NCT03239496|18564728|P4|STARTED|Overall Study||217
7542342|NCT03239496|18564729|P3|STARTED|Overall Study||178
7542343|NCT03239496|18564730|P2|STARTED|Overall Study||178
7542344|NCT03239496|18564731|P1|STARTED|Overall Study||200
7542345|NCT03239483|18564759|P2|NOT COMPLETED|Overall Study||0
7542346|NCT03239483|18564760|P1|NOT COMPLETED|Overall Study||2
7542347|NCT03239483|18564759|P2|COMPLETED|Overall Study||9
7542348|NCT03239483|18564760|P1|COMPLETED|Overall Study||17
7542349|NCT03239483|18564759|P2|STARTED|Overall Study||9
7542350|NCT03239483|18564760|P1|STARTED|Overall Study||19
7542351|NCT03239106|18564774|P1|NOT COMPLETED|Overall Study||7
7542352|NCT03239106|18564774|P1|COMPLETED|Overall Study||3
7542353|NCT03239106|18564774|P1|STARTED|Overall Study||10
7542354|NCT03238924|18564781|P2|NOT COMPLETED|Overall Study||2
7542355|NCT03238924|18564782|P1|NOT COMPLETED|Overall Study||2
7542356|NCT03238924|18564781|P2|COMPLETED|Overall Study||7
7542357|NCT03238924|18564782|P1|COMPLETED|Overall Study||6
7542358|NCT03238924|18564781|P2|STARTED|Overall Study||9
7542359|NCT03238924|18564782|P1|STARTED|Overall Study||8
7542360|NCT03238911|18564794|P2|NOT COMPLETED|Overall Study||3
7542361|NCT03238911|18564795|P1|NOT COMPLETED|Overall Study||3
7542362|NCT03238911|18564794|P2|COMPLETED|Overall Study||58
7542363|NCT03238911|18564795|P1|COMPLETED|Overall Study||59
7542364|NCT03238911|18564794|P2|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|60
7542365|NCT03238911|18564795|P1|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|63
7542366|NCT03238911|18564794|P2|STARTED|Overall Study||61
7542367|NCT03238911|18564795|P1|STARTED|Overall Study||62
7542368|NCT03238781|18564838|P3|NOT COMPLETED|Overall Study||20
7542369|NCT03238781|18564839|P2|NOT COMPLETED|Overall Study||17
7542370|NCT03238781|18564840|P1|NOT COMPLETED|Overall Study||26
7542371|NCT03238781|18564838|P3|COMPLETED|Overall Study||82
7542372|NCT03238781|18564839|P2|COMPLETED|Overall Study||87
7542373|NCT03238781|18564840|P1|COMPLETED|Overall Study||111
7542374|NCT03238781|18564838|P3|STARTED|Overall Study||102
7542375|NCT03238781|18564839|P2|STARTED|Overall Study||104
7542376|NCT03238781|18564840|P1|STARTED|Overall Study||137
7542377|NCT03238352|18564890|P3|NOT COMPLETED|Overall Study||1
7542378|NCT03238352|18564891|P2|NOT COMPLETED|Overall Study||3
7542379|NCT03238352|18564892|P1|NOT COMPLETED|Overall Study||0
7542380|NCT03238352|18564890|P3|COMPLETED|Overall Study||22
7542381|NCT03238352|18564891|P2|COMPLETED|Overall Study||20
7542382|NCT03238352|18564892|P1|COMPLETED|Overall Study||43
7542383|NCT03238352|18564890|P3|STARTED|Overall Study||23
7542384|NCT03238352|18564891|P2|STARTED|Overall Study||23
7542385|NCT03238352|18564892|P1|STARTED|Overall Study||43
7542386|NCT03238001|18564903|P1|NOT COMPLETED|Visit 2 (Secondary Endpoint Cohort)||29
7542387|NCT03238001|18564903|P1|COMPLETED|Visit 2 (Secondary Endpoint Cohort)||403
7542388|NCT03238001|18564903|P1|STARTED|Visit 2 (Secondary Endpoint Cohort)||432
7542389|NCT03238001|18564903|P1|NOT COMPLETED|Visit 1 (Primary Endpoint Cohort)||4
7542390|NCT03238001|18564903|P1|COMPLETED|Visit 1 (Primary Endpoint Cohort)||432
7542391|NCT03238001|18564903|P1|STARTED|Visit 1 (Primary Endpoint Cohort)||436
7542392|NCT03237871|18564926|P1|NOT COMPLETED|Overall Study||6
7542393|NCT03237871|18564926|P1|COMPLETED|Overall Study||11
7542394|NCT03237871|18564926|P1|STARTED|Overall Study||17
7542395|NCT03237845|18564934|P2|NOT COMPLETED|Overall Study||50
7542396|NCT03237845|18564935|P1|NOT COMPLETED|Overall Study||56
7542397|NCT03237845|18564934|P2|COMPLETED|Overall Study||542
7542398|NCT03237845|18564935|P1|COMPLETED|Overall Study||538
7542399|NCT03237845|18564934|P2|Treated|Overall Study||543
7542400|NCT03237845|18564935|P1|Treated|Overall Study||543
7542401|NCT03237845|18564934|P2|STARTED|Overall Study||592
7542402|NCT03237845|18564935|P1|STARTED|Overall Study||594
7542403|NCT03237156|18564969|P4|NOT COMPLETED|Overall Study||0
7542404|NCT03237156|18564970|P3|NOT COMPLETED|Overall Study||0
7542405|NCT03237156|18564971|P2|NOT COMPLETED|Overall Study||0
7542406|NCT03237156|18564972|P1|NOT COMPLETED|Overall Study||0
7542407|NCT03237156|18564969|P4|COMPLETED|Overall Study||6
7542408|NCT03237156|18564970|P3|COMPLETED|Overall Study||6
7542409|NCT03237156|18564971|P2|COMPLETED|Overall Study||6
7542410|NCT03237156|18564972|P1|COMPLETED|Overall Study||6
7542411|NCT03237156|18564969|P4|STARTED|Overall Study||6
7542412|NCT03237156|18564970|P3|STARTED|Overall Study||6
7542413|NCT03237156|18564971|P2|STARTED|Overall Study||6
7542414|NCT03237156|18564972|P1|STARTED|Overall Study||6
7542415|NCT03237065|18565065|P2|NOT COMPLETED|Overall Study||4
7542416|NCT03237065|18565066|P1|NOT COMPLETED|Overall Study||4
7542417|NCT03237065|18565065|P2|COMPLETED|Overall Study||57
7542418|NCT03237065|18565066|P1|COMPLETED|Overall Study||57
7542419|NCT03237065|18565065|P2|Safety Analysis Set|Overall Study||57
7542420|NCT03237065|18565066|P1|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|62
7542421|NCT03237065|18565065|P2|STARTED|Overall Study||61
7542422|NCT03237065|18565066|P1|STARTED|Overall Study||61
7542423|NCT03237013|18565109|P3|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||37
7542424|NCT03237013|18565110|P2|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||30
7542425|NCT03237013|18565111|P1|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||43
7542426|NCT03237013|18565109|P3|COMPLETED|Immediate Post-treatment to 1-mo F/u||36
7542427|NCT03237013|18565110|P2|COMPLETED|Immediate Post-treatment to 1-mo F/u||43
7542428|NCT03237013|18565111|P1|COMPLETED|Immediate Post-treatment to 1-mo F/u||30
7542429|NCT03237013|18565109|P3|STARTED|Immediate Post-treatment to 1-mo F/u||73
7542430|NCT03237013|18565110|P2|STARTED|Immediate Post-treatment to 1-mo F/u||73
7542431|NCT03237013|18565111|P1|STARTED|Immediate Post-treatment to 1-mo F/u||73
7542432|NCT03237013|18565109|P3|NOT COMPLETED|Baseline to Immediate Post-treatment||0
7542433|NCT03237013|18565110|P2|NOT COMPLETED|Baseline to Immediate Post-treatment||0
7542434|NCT03237013|18565111|P1|NOT COMPLETED|Baseline to Immediate Post-treatment||0
7542435|NCT03237013|18565109|P3|COMPLETED|Baseline to Immediate Post-treatment||73
7542436|NCT03237013|18565110|P2|COMPLETED|Baseline to Immediate Post-treatment||73
7542437|NCT03237013|18565111|P1|COMPLETED|Baseline to Immediate Post-treatment||73
7542438|NCT03237013|18565109|P3|STARTED|Baseline to Immediate Post-treatment||73
7542439|NCT03237013|18565110|P2|STARTED|Baseline to Immediate Post-treatment||73
7542440|NCT03237013|18565111|P1|STARTED|Baseline to Immediate Post-treatment||73
7542441|NCT03236311|18565160|P2|NOT COMPLETED|Overall Study||3
7542442|NCT03236311|18565161|P1|NOT COMPLETED|Overall Study||0
7542443|NCT03236311|18565160|P2|COMPLETED|Overall Study||2
7542444|NCT03236311|18565161|P1|COMPLETED|Overall Study||5
7542445|NCT03236311|18565160|P2|STARTED|Overall Study||5
7542446|NCT03236311|18565161|P1|STARTED|Overall Study||5
7542447|NCT03236168|18565171|P1|NOT COMPLETED|Overall Study||11
7542448|NCT03236168|18565171|P1|COMPLETED|Overall Study||107
7542449|NCT03236168|18565171|P1|STARTED|Overall Study||118
7542450|NCT03235817|18565178|P3|NOT COMPLETED|Overall Study||2
7542451|NCT03235817|18565179|P2|NOT COMPLETED|Overall Study||1
7542452|NCT03235817|18565180|P1|NOT COMPLETED|Overall Study||3
7542453|NCT03235817|18565178|P3|COMPLETED|Overall Study||11
7542454|NCT03235817|18565179|P2|COMPLETED|Overall Study||12
7542455|NCT03235817|18565180|P1|COMPLETED|Overall Study||10
7542456|NCT03235817|18565178|P3|STARTED|Overall Study||13
7542457|NCT03235817|18565179|P2|STARTED|Overall Study||13
7542458|NCT03235817|18565180|P1|STARTED|Overall Study||13
7542459|NCT03235726|18565205|P10|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
7542460|NCT03235726|18565206|P9|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
7542461|NCT03235726|18565207|P8|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
7542462|NCT03235726|18565208|P7|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
7542463|NCT03235726|18565209|P6|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
7542464|NCT03235726|18565210|P5|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
7542465|NCT03235726|18565211|P4|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
7542466|NCT03235726|18565212|P3|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
7542467|NCT03235726|18565213|P2|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
7542468|NCT03235726|18565214|P1|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
7542469|NCT03235726|18565205|P10|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||8
7542470|NCT03235726|18565206|P9|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
7542471|NCT03235726|18565207|P8|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
7542472|NCT03235726|18565208|P7|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
7542473|NCT03235726|18565209|P6|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
7542474|NCT03235726|18565210|P5|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
7542475|NCT03235726|18565211|P4|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
7542476|NCT03235726|18565212|P3|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
7542477|NCT03235726|18565213|P2|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
7542478|NCT03235726|18565214|P1|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
7542479|NCT03235726|18565205|P10|STARTED|Part 2 (Cohort B - Days 1 to 14)||8
7542480|NCT03235726|18565206|P9|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
7542481|NCT03235726|18565207|P8|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
7542482|NCT03235726|18565208|P7|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
7542483|NCT03235726|18565209|P6|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
7542484|NCT03235726|18565210|P5|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
7542485|NCT03235726|18565211|P4|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
7542486|NCT03235726|18565212|P3|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
7542487|NCT03235726|18565213|P2|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
7542488|NCT03235726|18565214|P1|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
7542489|NCT03235726|18565205|P10|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
7542490|NCT03235726|18565206|P9|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
7542491|NCT03235726|18565207|P8|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
7542492|NCT03235726|18565208|P7|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
7542493|NCT03235726|18565209|P6|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
7542494|NCT03235726|18565210|P5|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
7542495|NCT03235726|18565211|P4|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
7542496|NCT03235726|18565212|P3|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
7542497|NCT03235726|18565213|P2|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
7542498|NCT03235726|18565214|P1|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
7542499|NCT03235726|18565205|P10|COMPLETED|Part 2 (Cohort A - Day 1)||0
7542500|NCT03235726|18565206|P9|COMPLETED|Part 2 (Cohort A - Day 1)||2
7542501|NCT03235726|18565207|P8|COMPLETED|Part 2 (Cohort A - Day 1)||6
7542502|NCT03235726|18565208|P7|COMPLETED|Part 2 (Cohort A - Day 1)||0
7542503|NCT03235726|18565209|P6|COMPLETED|Part 2 (Cohort A - Day 1)||0
7542504|NCT03235726|18565210|P5|COMPLETED|Part 2 (Cohort A - Day 1)||0
7542505|NCT03235726|18565211|P4|COMPLETED|Part 2 (Cohort A - Day 1)||0
7542506|NCT03235726|18565212|P3|COMPLETED|Part 2 (Cohort A - Day 1)||0
7542507|NCT03235726|18565213|P2|COMPLETED|Part 2 (Cohort A - Day 1)||0
7542508|NCT03235726|18565214|P1|COMPLETED|Part 2 (Cohort A - Day 1)||0
7542509|NCT03235726|18565205|P10|STARTED|Part 2 (Cohort A - Day 1)||0
7542510|NCT03235726|18565206|P9|STARTED|Part 2 (Cohort A - Day 1)||2
7542511|NCT03235726|18565207|P8|STARTED|Part 2 (Cohort A - Day 1)||6
7542512|NCT03235726|18565208|P7|STARTED|Part 2 (Cohort A - Day 1)||0
7542513|NCT03235726|18565209|P6|STARTED|Part 2 (Cohort A - Day 1)||0
7542514|NCT03235726|18565210|P5|STARTED|Part 2 (Cohort A - Day 1)||0
7542515|NCT03235726|18565211|P4|STARTED|Part 2 (Cohort A - Day 1)||0
7542516|NCT03235726|18565212|P3|STARTED|Part 2 (Cohort A - Day 1)||0
7542517|NCT03235726|18565213|P2|STARTED|Part 2 (Cohort A - Day 1)||0
7542518|NCT03235726|18565214|P1|STARTED|Part 2 (Cohort A - Day 1)||0
7542519|NCT03235726|18565205|P10|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542520|NCT03235726|18565206|P9|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542521|NCT03235726|18565207|P8|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542522|NCT03235726|18565208|P7|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542523|NCT03235726|18565209|P6|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542524|NCT03235726|18565210|P5|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
7542525|NCT03235726|18565211|P4|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542526|NCT03235726|18565212|P3|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542527|NCT03235726|18565213|P2|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542528|NCT03235726|18565214|P1|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542529|NCT03235726|18565205|P10|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542530|NCT03235726|18565206|P9|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542531|NCT03235726|18565207|P8|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542532|NCT03235726|18565208|P7|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||14
7542533|NCT03235726|18565209|P6|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
7542534|NCT03235726|18565210|P5|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||10
7542535|NCT03235726|18565211|P4|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542536|NCT03235726|18565212|P3|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542537|NCT03235726|18565213|P2|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542538|NCT03235726|18565214|P1|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542539|NCT03235726|18565205|P10|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542540|NCT03235726|18565206|P9|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542541|NCT03235726|18565207|P8|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542542|NCT03235726|18565208|P7|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||14
7542543|NCT03235726|18565209|P6|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||2
7542544|NCT03235726|18565210|P5|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||12
7542545|NCT03235726|18565211|P4|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542546|NCT03235726|18565212|P3|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542547|NCT03235726|18565213|P2|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542548|NCT03235726|18565214|P1|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
7542549|NCT03235726|18565205|P10|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542550|NCT03235726|18565206|P9|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542551|NCT03235726|18565207|P8|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542552|NCT03235726|18565208|P7|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542553|NCT03235726|18565209|P6|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542554|NCT03235726|18565210|P5|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542555|NCT03235726|18565211|P4|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542556|NCT03235726|18565212|P3|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542557|NCT03235726|18565213|P2|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542558|NCT03235726|18565214|P1|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542559|NCT03235726|18565205|P10|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542560|NCT03235726|18565206|P9|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542561|NCT03235726|18565207|P8|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542562|NCT03235726|18565208|P7|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542563|NCT03235726|18565209|P6|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542564|NCT03235726|18565210|P5|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542565|NCT03235726|18565211|P4|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
7542566|NCT03235726|18565212|P3|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
7542567|NCT03235726|18565213|P2|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542568|NCT03235726|18565214|P1|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542569|NCT03235726|18565205|P10|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542570|NCT03235726|18565206|P9|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542571|NCT03235726|18565207|P8|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542572|NCT03235726|18565208|P7|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542573|NCT03235726|18565209|P6|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542574|NCT03235726|18565210|P5|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542575|NCT03235726|18565211|P4|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
7542576|NCT03235726|18565212|P3|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
7542577|NCT03235726|18565213|P2|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542578|NCT03235726|18565214|P1|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
7542579|NCT03235726|18565205|P10|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
7542580|NCT03235726|18565206|P9|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
7542581|NCT03235726|18565207|P8|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
7542582|NCT03235726|18565208|P7|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
7542583|NCT03235726|18565209|P6|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
7542584|NCT03235726|18565210|P5|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
7542585|NCT03235726|18565211|P4|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
7542586|NCT03235726|18565212|P3|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
7542587|NCT03235726|18565213|P2|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
7542588|NCT03235726|18565214|P1|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
7542589|NCT03235726|18565205|P10|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
7542590|NCT03235726|18565206|P9|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
7542591|NCT03235726|18565207|P8|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
7542592|NCT03235726|18565208|P7|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
7542593|NCT03235726|18565209|P6|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
7542594|NCT03235726|18565210|P5|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
7542595|NCT03235726|18565211|P4|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||2
7542596|NCT03235726|18565212|P3|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
7542597|NCT03235726|18565213|P2|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||6
7542598|NCT03235726|18565214|P1|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
7542599|NCT03235726|18565205|P10|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
7542600|NCT03235726|18565206|P9|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
7542601|NCT03235726|18565207|P8|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
7542602|NCT03235726|18565208|P7|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
7542603|NCT03235726|18565209|P6|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
7542604|NCT03235726|18565210|P5|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
7542605|NCT03235726|18565211|P4|STARTED|Part 1 (Cohort A 120 mg - Day 3)||2
7542606|NCT03235726|18565212|P3|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
7542607|NCT03235726|18565213|P2|STARTED|Part 1 (Cohort A 120 mg - Day 3)||6
7542608|NCT03235726|18565214|P1|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
7542609|NCT03235726|18565205|P10|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
7542610|NCT03235726|18565206|P9|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
7542611|NCT03235726|18565207|P8|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
7542612|NCT03235726|18565208|P7|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
7542613|NCT03235726|18565209|P6|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
7542614|NCT03235726|18565210|P5|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
7542615|NCT03235726|18565211|P4|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
7542616|NCT03235726|18565212|P3|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
7542617|NCT03235726|18565213|P2|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
7542618|NCT03235726|18565214|P1|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
7542619|NCT03235726|18565205|P10|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
7542620|NCT03235726|18565206|P9|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
7542621|NCT03235726|18565207|P8|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
7542622|NCT03235726|18565208|P7|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
7542623|NCT03235726|18565209|P6|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
7542624|NCT03235726|18565210|P5|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
7542625|NCT03235726|18565211|P4|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||2
7542626|NCT03235726|18565212|P3|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
7542627|NCT03235726|18565213|P2|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
7542628|NCT03235726|18565214|P1|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||6
7542629|NCT03235726|18565205|P10|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
7542630|NCT03235726|18565206|P9|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
7542631|NCT03235726|18565207|P8|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
7542632|NCT03235726|18565208|P7|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
7542633|NCT03235726|18565209|P6|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
7542634|NCT03235726|18565210|P5|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
7542635|NCT03235726|18565211|P4|STARTED|Part 1 (Cohort A 60 mg - Day 1)||2
7542636|NCT03235726|18565212|P3|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
7542637|NCT03235726|18565213|P2|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
7542638|NCT03235726|18565214|P1|STARTED|Part 1 (Cohort A 60 mg - Day 1)||6
7542639|NCT03235479|18565368|P2|NOT COMPLETED|Overall Study||40
7542640|NCT03235479|18565369|P1|NOT COMPLETED|Overall Study||41
7542641|NCT03235479|18565368|P2|COMPLETED|Overall Study||540
7542642|NCT03235479|18565369|P1|COMPLETED|Overall Study||541
7542643|NCT03235479|18565368|P2|Treated|Overall Study||549
7542644|NCT03235479|18565369|P1|Treated|Overall Study||546
7542645|NCT03235479|18565368|P2|STARTED|Overall Study||580
7542646|NCT03235479|18565369|P1|STARTED|Overall Study||582
7542647|NCT03235414|18565399|P1|NOT COMPLETED|Overall Study||0
7542648|NCT03235414|18565399|P1|COMPLETED|Overall Study||101
7542649|NCT03235414|18565399|P1|STARTED|Overall Study||101
7542650|NCT03235349|18565406|P1|NOT COMPLETED|Overall Study||2
7542651|NCT03235349|18565406|P1|COMPLETED|Overall Study||158
7542652|NCT03235349|18565406|P1|STARTED|Overall Study||160
7542653|NCT03235284|18565416|P3|NOT COMPLETED|Overall Study||1
7542654|NCT03235284|18565417|P2|NOT COMPLETED|Overall Study||2
7542655|NCT03235284|18565418|P1|NOT COMPLETED|Overall Study||1
7542656|NCT03235284|18565416|P3|COMPLETED|Overall Study||14
7542657|NCT03235284|18565417|P2|COMPLETED|Overall Study||13
7542658|NCT03235284|18565418|P1|COMPLETED|Overall Study||14
7542659|NCT03235284|18565416|P3|STARTED|Overall Study||15
7542660|NCT03235284|18565417|P2|STARTED|Overall Study||15
7542661|NCT03235284|18565418|P1|STARTED|Overall Study||15
7542662|NCT03235115|18565435|P6|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
7542663|NCT03235115|18565436|P5|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
7542664|NCT03235115|18565437|P4|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
7542665|NCT03235115|18565438|P3|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
7542666|NCT03235115|18565439|P2|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
7542667|NCT03235115|18565440|P1|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
7542668|NCT03235115|18565435|P6|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||5
7542669|NCT03235115|18565436|P5|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
7542670|NCT03235115|18565437|P4|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
7542671|NCT03235115|18565438|P3|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||7
7542672|NCT03235115|18565439|P2|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
7542673|NCT03235115|18565440|P1|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||9
7542674|NCT03235115|18565435|P6|STARTED|Third Intervention ( 1 Hour, Visit 6)||5
7542675|NCT03235115|18565436|P5|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
7542676|NCT03235115|18565437|P4|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
7542677|NCT03235115|18565438|P3|STARTED|Third Intervention ( 1 Hour, Visit 6)||7
7542678|NCT03235115|18565439|P2|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
7542679|NCT03235115|18565440|P1|STARTED|Third Intervention ( 1 Hour, Visit 6)||9
7542680|NCT03235115|18565435|P6|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
7542681|NCT03235115|18565436|P5|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
7542682|NCT03235115|18565437|P4|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
7542683|NCT03235115|18565438|P3|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
7542684|NCT03235115|18565439|P2|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
7542685|NCT03235115|18565440|P1|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
7542686|NCT03235115|18565435|P6|COMPLETED|Second Intervention (1 Hour, Visit 4)||5
7542687|NCT03235115|18565436|P5|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
7542688|NCT03235115|18565437|P4|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
7542689|NCT03235115|18565438|P3|COMPLETED|Second Intervention (1 Hour, Visit 4)||7
7542690|NCT03235115|18565439|P2|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
7542691|NCT03235115|18565440|P1|COMPLETED|Second Intervention (1 Hour, Visit 4)||9
7542692|NCT03235115|18565435|P6|STARTED|Second Intervention (1 Hour, Visit 4)||5
7542693|NCT03235115|18565436|P5|STARTED|Second Intervention (1 Hour, Visit 4)||6
7542694|NCT03235115|18565437|P4|STARTED|Second Intervention (1 Hour, Visit 4)||6
7542695|NCT03235115|18565438|P3|STARTED|Second Intervention (1 Hour, Visit 4)||7
7542696|NCT03235115|18565439|P2|STARTED|Second Intervention (1 Hour, Visit 4)||6
7542697|NCT03235115|18565440|P1|STARTED|Second Intervention (1 Hour, Visit 4)||9
7542698|NCT03235115|18565435|P6|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||1
7542699|NCT03235115|18565436|P5|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
7542700|NCT03235115|18565437|P4|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
7542701|NCT03235115|18565438|P3|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
7542702|NCT03235115|18565439|P2|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
7542703|NCT03235115|18565440|P1|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
7542704|NCT03235115|18565435|P6|COMPLETED|First Intervention (1 Hour, Visit 2)||5
7542705|NCT03235115|18565436|P5|COMPLETED|First Intervention (1 Hour, Visit 2)||6
7542706|NCT03235115|18565437|P4|COMPLETED|First Intervention (1 Hour, Visit 2)||6
7542707|NCT03235115|18565438|P3|COMPLETED|First Intervention (1 Hour, Visit 2)||7
7542708|NCT03235115|18565439|P2|COMPLETED|First Intervention (1 Hour, Visit 2)||6
7542709|NCT03235115|18565440|P1|COMPLETED|First Intervention (1 Hour, Visit 2)||9
7542710|NCT03235115|18565435|P6|STARTED|First Intervention (1 Hour, Visit 2)||6
7542711|NCT03235115|18565436|P5|STARTED|First Intervention (1 Hour, Visit 2)||6
7542712|NCT03235115|18565437|P4|STARTED|First Intervention (1 Hour, Visit 2)||6
7542713|NCT03235115|18565438|P3|STARTED|First Intervention (1 Hour, Visit 2)||7
7542714|NCT03235115|18565439|P2|STARTED|First Intervention (1 Hour, Visit 2)||6
7542715|NCT03235115|18565440|P1|STARTED|First Intervention (1 Hour, Visit 2)||9
7542716|NCT03235089|18565460|P2|NOT COMPLETED|Overall Study||3
7542717|NCT03235089|18565461|P1|NOT COMPLETED|Overall Study||3
7542718|NCT03235089|18565460|P2|COMPLETED|Overall Study||28
7542719|NCT03235089|18565461|P1|COMPLETED|Overall Study||28
7542720|NCT03235089|18565460|P2|STARTED|Overall Study||31
7542721|NCT03235089|18565461|P1|STARTED|Overall Study||31
7542722|NCT03235050|18565502|P5|NOT COMPLETED|Overall Study||11
7542723|NCT03235050|18565503|P4|NOT COMPLETED|Overall Study||14
7542724|NCT03235050|18565504|P3|NOT COMPLETED|Overall Study||4
7542725|NCT03235050|18565505|P2|NOT COMPLETED|Overall Study||5
7542726|NCT03235050|18565506|P1|NOT COMPLETED|Overall Study||4
7542727|NCT03235050|18565502|P5|COMPLETED|Overall Study||245
7542728|NCT03235050|18565503|P4|COMPLETED|Overall Study||242
7542729|NCT03235050|18565504|P3|COMPLETED|Overall Study||96
7542730|NCT03235050|18565505|P2|COMPLETED|Overall Study||105
7542731|NCT03235050|18565506|P1|COMPLETED|Overall Study||108
7542732|NCT03235050|18565502|P5|STARTED|Overall Study||256
7542733|NCT03235050|18565503|P4|STARTED|Overall Study||256
7542734|NCT03235050|18565504|P3|STARTED|Overall Study||100
7542735|NCT03235050|18565505|P2|STARTED|Overall Study||110
7542736|NCT03235050|18565506|P1|STARTED|Overall Study||112
7542737|NCT03234465|18565567|P2|NOT COMPLETED|Overall Study||40
7542738|NCT03234465|18565568|P1|NOT COMPLETED|Overall Study||33
7542739|NCT03234465|18565567|P2|COMPLETED|Overall Study||60
7542740|NCT03234465|18565568|P1|COMPLETED|Overall Study||67
7542741|NCT03234465|18565567|P2|STARTED|Overall Study||100
7542742|NCT03234465|18565568|P1|STARTED|Overall Study||100
7542743|NCT03234374|18565576|P2|NOT COMPLETED|Overall Study||1
7542744|NCT03234374|18565577|P1|NOT COMPLETED|Overall Study||1
7542745|NCT03234374|18565576|P2|COMPLETED|Overall Study||16
7542746|NCT03234374|18565577|P1|COMPLETED|Overall Study||34
7542747|NCT03234374|18565576|P2|STARTED|Overall Study||17
7542748|NCT03234374|18565577|P1|STARTED|Overall Study||35
7542749|NCT03234036|18565598|P4|NOT COMPLETED|Part 2 (Up to 25 Days)||0
7542750|NCT03234036|18565599|P3|NOT COMPLETED|Part 2 (Up to 25 Days)||0
7542751|NCT03234036|18565600|P2|NOT COMPLETED|Part 2 (Up to 25 Days)||0
7542752|NCT03234036|18565601|P1|NOT COMPLETED|Part 2 (Up to 25 Days)||0
7542753|NCT03234036|18565598|P4|COMPLETED|Part 2 (Up to 25 Days)||7
7542754|NCT03234036|18565599|P3|COMPLETED|Part 2 (Up to 25 Days)||3
7542755|NCT03234036|18565600|P2|COMPLETED|Part 2 (Up to 25 Days)||0
7542756|NCT03234036|18565601|P1|COMPLETED|Part 2 (Up to 25 Days)||0
7542757|NCT03234036|18565598|P4|STARTED|Part 2 (Up to 25 Days)||7
7542758|NCT03234036|18565599|P3|STARTED|Part 2 (Up to 25 Days)||3
7542759|NCT03234036|18565600|P2|STARTED|Part 2 (Up to 25 Days)||0
7542760|NCT03234036|18565601|P1|STARTED|Part 2 (Up to 25 Days)||0
7542761|NCT03234036|18565598|P4|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
7542762|NCT03234036|18565599|P3|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
7542763|NCT03234036|18565600|P2|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
7542764|NCT03234036|18565601|P1|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
7542765|NCT03234036|18565598|P4|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
7542766|NCT03234036|18565599|P3|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
7542767|NCT03234036|18565600|P2|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
7542768|NCT03234036|18565601|P1|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
7542769|NCT03234036|18565598|P4|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
7542770|NCT03234036|18565599|P3|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
7542771|NCT03234036|18565600|P2|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
7542772|NCT03234036|18565601|P1|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
7542773|NCT03234036|18565598|P4|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
7542774|NCT03234036|18565599|P3|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
7542775|NCT03234036|18565600|P2|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
7542776|NCT03234036|18565601|P1|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
7542777|NCT03234036|18565598|P4|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
7542778|NCT03234036|18565599|P3|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
7542779|NCT03234036|18565600|P2|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
7542780|NCT03234036|18565601|P1|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
7542781|NCT03234036|18565598|P4|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
7542782|NCT03234036|18565599|P3|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
7542783|NCT03234036|18565600|P2|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
7542784|NCT03234036|18565601|P1|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
7542785|NCT03234036|18565598|P4|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
7542786|NCT03234036|18565599|P3|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
7542787|NCT03234036|18565600|P2|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
7542788|NCT03234036|18565601|P1|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
7542789|NCT03234036|18565598|P4|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
7542790|NCT03234036|18565599|P3|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
7542791|NCT03234036|18565600|P2|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
7542792|NCT03234036|18565601|P1|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
7542793|NCT03234036|18565598|P4|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
7542794|NCT03234036|18565599|P3|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
7542795|NCT03234036|18565600|P2|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
7542796|NCT03234036|18565601|P1|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
7542797|NCT03234036|18565598|P4|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
7542798|NCT03234036|18565599|P3|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
7542799|NCT03234036|18565600|P2|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
7542800|NCT03234036|18565601|P1|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
7542801|NCT03234036|18565598|P4|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
7542802|NCT03234036|18565599|P3|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
7542803|NCT03234036|18565600|P2|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
7542804|NCT03234036|18565601|P1|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
7542805|NCT03234036|18565598|P4|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
7542806|NCT03234036|18565599|P3|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
7542807|NCT03234036|18565600|P2|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
7542808|NCT03234036|18565601|P1|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
7542809|NCT03234036|18565598|P4|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
7542810|NCT03234036|18565599|P3|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
7542811|NCT03234036|18565600|P2|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
7542812|NCT03234036|18565601|P1|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
7542813|NCT03234036|18565598|P4|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
7542814|NCT03234036|18565599|P3|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
7542815|NCT03234036|18565600|P2|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
7542816|NCT03234036|18565601|P1|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
7542817|NCT03234036|18565598|P4|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
7542818|NCT03234036|18565599|P3|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
7542819|NCT03234036|18565600|P2|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
7542820|NCT03234036|18565601|P1|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
7542821|NCT03233737|18565708|P5|NOT COMPLETED|Overall Study||0
7542822|NCT03233737|18565709|P4|NOT COMPLETED|Overall Study||0
7542823|NCT03233737|18565710|P3|NOT COMPLETED|Overall Study||0
7542824|NCT03233737|18565711|P2|NOT COMPLETED|Overall Study||0
7542825|NCT03233737|18565712|P1|NOT COMPLETED|Overall Study||0
7542826|NCT03233737|18565708|P5|COMPLETED|Overall Study||26
7542827|NCT03233737|18565709|P4|COMPLETED|Overall Study||24
7542828|NCT03233737|18565710|P3|COMPLETED|Overall Study||5
7542829|NCT03233737|18565711|P2|COMPLETED|Overall Study||10
7542830|NCT03233737|18565712|P1|COMPLETED|Overall Study||10
7542831|NCT03233737|18565708|P5|STARTED|Overall Study||26
7542832|NCT03233737|18565709|P4|STARTED|Overall Study||24
7542833|NCT03233737|18565710|P3|STARTED|Overall Study||5
7542834|NCT03233737|18565711|P2|STARTED|Overall Study||10
7542835|NCT03233737|18565712|P1|STARTED|Overall Study||10
7542836|NCT03233529|18565772|P1|NOT COMPLETED|Open-Label Period (Day 15 to Day 71)||1
7542837|NCT03233529|18565772|P1|COMPLETED|Open-Label Period (Day 15 to Day 71)||38
7542838|NCT03233529|18565772|P1|STARTED|Open-Label Period (Day 15 to Day 71)||39
7542839|NCT03233529|18565772|P1|NOT COMPLETED|Double-Blind Period (Day 1 to Day 15)||1
7542840|NCT03233529|18565772|P1|COMPLETED|Double-Blind Period (Day 1 to Day 15)||39
7542841|NCT03233529|18565772|P1|STARTED|Double-Blind Period (Day 1 to Day 15)||40
7542842|NCT03233438|18565816|P2|NOT COMPLETED|Overall Study||11
7542843|NCT03233438|18565817|P1|NOT COMPLETED|Overall Study||6
7542844|NCT03233438|18565816|P2|COMPLETED|Overall Study||32
7542845|NCT03233438|18565817|P1|COMPLETED|Overall Study||42
7542846|NCT03233438|18565816|P2|STARTED|Overall Study||43
7542847|NCT03233438|18565817|P1|STARTED|Overall Study||48
7542848|NCT03233308|18565883|P1|NOT COMPLETED|Overall Study||2
7542849|NCT03233308|18565883|P1|COMPLETED|Overall Study||18
7542850|NCT03233308|18565883|P1|STARTED|Overall Study||20
7542851|NCT03233230|18565899|P4|NOT COMPLETED|Overall Study||8
7542852|NCT03233230|18565900|P3|NOT COMPLETED|Overall Study||12
7542853|NCT03233230|18565901|P2|NOT COMPLETED|Overall Study||15
7542854|NCT03233230|18565902|P1|NOT COMPLETED|Overall Study||15
7542855|NCT03233230|18565899|P4|COMPLETED|Overall Study||91
7542856|NCT03233230|18565900|P3|COMPLETED|Overall Study||84
7542857|NCT03233230|18565901|P2|COMPLETED|Overall Study||83
7542858|NCT03233230|18565902|P1|COMPLETED|Overall Study||82
7542859|NCT03233230|18565899|P4|STARTED|Overall Study||99
7542860|NCT03233230|18565900|P3|STARTED|Overall Study||96
7542861|NCT03233230|18565901|P2|STARTED|Overall Study||98
7542862|NCT03233230|18565902|P1|STARTED|Overall Study||97
7542863|NCT03233217|18566061|P5|NOT COMPLETED|Overall Study||0
7542864|NCT03233217|18566062|P4|NOT COMPLETED|Overall Study||0
7542865|NCT03233217|18566063|P3|NOT COMPLETED|Overall Study||0
7542866|NCT03233217|18566064|P2|NOT COMPLETED|Overall Study||0
7542867|NCT03233217|18566065|P1|NOT COMPLETED|Overall Study||0
7542868|NCT03233217|18566061|P5|COMPLETED|Overall Study||55
7542869|NCT03233217|18566062|P4|COMPLETED|Overall Study||55
7542870|NCT03233217|18566063|P3|COMPLETED|Overall Study||55
7542871|NCT03233217|18566064|P2|COMPLETED|Overall Study||5
7542872|NCT03233217|18566065|P1|COMPLETED|Overall Study||5
7542873|NCT03233217|18566061|P5|Per-protocol Analysis Set (PPAS)|Overall Study||54
7542874|NCT03233217|18566062|P4|Per-protocol Analysis Set (PPAS)|Overall Study||55
7542875|NCT03233217|18566063|P3|Per-protocol Analysis Set (PPAS)|Overall Study||55
7542876|NCT03233217|18566064|P2|Per-protocol Analysis Set (PPAS)|Overall Study||5
7542877|NCT03233217|18566065|P1|Per-protocol Analysis Set (PPAS)|Overall Study||5
7542878|NCT03233217|18566061|P5|Safety Analysis Set (SafAS)|Overall Study||55
7542879|NCT03233217|18566062|P4|Safety Analysis Set (SafAS)|Overall Study||55
7542880|NCT03233217|18566063|P3|Safety Analysis Set (SafAS)|Overall Study||55
7542881|NCT03233217|18566064|P2|Safety Analysis Set (SafAS)|Overall Study||5
7542882|NCT03233217|18566065|P1|Safety Analysis Set (SafAS)|Overall Study||5
7542883|NCT03233217|18566061|P5|STARTED|Overall Study||55
7542884|NCT03233217|18566062|P4|STARTED|Overall Study||55
7542885|NCT03233217|18566063|P3|STARTED|Overall Study||55
7542886|NCT03233217|18566064|P2|STARTED|Overall Study||5
7542887|NCT03233217|18566065|P1|STARTED|Overall Study||5
7542888|NCT03233009|18566094|P1|NOT COMPLETED|Overall Study||1
7542889|NCT03233009|18566094|P1|COMPLETED|Overall Study||39
7542890|NCT03233009|18566094|P1|Reference Product|Overall Study||39
7542891|NCT03233009|18566094|P1|Test Product 4|Overall Study||39
7542892|NCT03233009|18566094|P1|Test Product 3|Overall Study||39
7542893|NCT03233009|18566094|P1|Test Product 2|Overall Study||39
7542894|NCT03233009|18566094|P1|Test Product 1|Overall Study||39
7542895|NCT03233009|18566094|P1|STARTED|Overall Study||40
7542896|NCT03232983|18566137|P4|NOT COMPLETED|Period 4||0
7542897|NCT03232983|18566138|P3|NOT COMPLETED|Period 4||0
7542898|NCT03232983|18566139|P2|NOT COMPLETED|Period 4||0
7542899|NCT03232983|18566140|P1|NOT COMPLETED|Period 4||1
7542900|NCT03232983|18566137|P4|COMPLETED|Period 4||6
7542901|NCT03232983|18566138|P3|COMPLETED|Period 4||5
7542902|NCT03232983|18566139|P2|COMPLETED|Period 4||7
7542903|NCT03232983|18566140|P1|COMPLETED|Period 4||6
7542904|NCT03232983|18566137|P4|STARTED|Period 4||6
7542905|NCT03232983|18566138|P3|STARTED|Period 4||5
7542906|NCT03232983|18566139|P2|STARTED|Period 4||7
7542907|NCT03232983|18566140|P1|STARTED|Period 4||7
7542908|NCT03232983|18566137|P4|NOT COMPLETED|Washout Period 3||0
7542909|NCT03232983|18566138|P3|NOT COMPLETED|Washout Period 3||0
7542910|NCT03232983|18566139|P2|NOT COMPLETED|Washout Period 3||0
7542911|NCT03232983|18566140|P1|NOT COMPLETED|Washout Period 3||0
7542912|NCT03232983|18566137|P4|COMPLETED|Washout Period 3||6
7542913|NCT03232983|18566138|P3|COMPLETED|Washout Period 3||5
7542914|NCT03232983|18566139|P2|COMPLETED|Washout Period 3||7
7542915|NCT03232983|18566140|P1|COMPLETED|Washout Period 3||7
7542916|NCT03232983|18566137|P4|STARTED|Washout Period 3||6
7542917|NCT03232983|18566138|P3|STARTED|Washout Period 3||5
7542918|NCT03232983|18566139|P2|STARTED|Washout Period 3||7
7542919|NCT03232983|18566140|P1|STARTED|Washout Period 3||7
7542920|NCT03232983|18566137|P4|NOT COMPLETED|Period 3||0
7542921|NCT03232983|18566138|P3|NOT COMPLETED|Period 3||0
7542922|NCT03232983|18566139|P2|NOT COMPLETED|Period 3||0
7542923|NCT03232983|18566140|P1|NOT COMPLETED|Period 3||0
7542924|NCT03232983|18566137|P4|COMPLETED|Period 3||6
7542925|NCT03232983|18566138|P3|COMPLETED|Period 3||5
7542926|NCT03232983|18566139|P2|COMPLETED|Period 3||7
7542927|NCT03232983|18566140|P1|COMPLETED|Period 3||7
7542928|NCT03232983|18566137|P4|STARTED|Period 3||6
7542929|NCT03232983|18566138|P3|STARTED|Period 3||5
7542930|NCT03232983|18566139|P2|STARTED|Period 3||7
7542931|NCT03232983|18566140|P1|STARTED|Period 3||7
7542932|NCT03232983|18566137|P4|NOT COMPLETED|Washout Period 2||1
7542933|NCT03232983|18566138|P3|NOT COMPLETED|Washout Period 2||1
7542934|NCT03232983|18566139|P2|NOT COMPLETED|Washout Period 2||0
7542935|NCT03232983|18566140|P1|NOT COMPLETED|Washout Period 2||0
7542936|NCT03232983|18566137|P4|COMPLETED|Washout Period 2||6
7542937|NCT03232983|18566138|P3|COMPLETED|Washout Period 2||5
7542938|NCT03232983|18566139|P2|COMPLETED|Washout Period 2||7
7542939|NCT03232983|18566140|P1|COMPLETED|Washout Period 2||7
7542940|NCT03232983|18566137|P4|STARTED|Washout Period 2||7
7542941|NCT03232983|18566138|P3|STARTED|Washout Period 2||6
7542942|NCT03232983|18566139|P2|STARTED|Washout Period 2||7
7542943|NCT03232983|18566140|P1|STARTED|Washout Period 2||7
7542944|NCT03232983|18566137|P4|NOT COMPLETED|Period 2||0
7542945|NCT03232983|18566138|P3|NOT COMPLETED|Period 2||0
7542946|NCT03232983|18566139|P2|NOT COMPLETED|Period 2||0
7542947|NCT03232983|18566140|P1|NOT COMPLETED|Period 2||0
7542948|NCT03232983|18566137|P4|COMPLETED|Period 2||7
7542949|NCT03232983|18566138|P3|COMPLETED|Period 2||6
7542950|NCT03232983|18566139|P2|COMPLETED|Period 2||7
7542951|NCT03232983|18566140|P1|COMPLETED|Period 2||7
7542952|NCT03232983|18566137|P4|STARTED|Period 2||7
7542953|NCT03232983|18566138|P3|STARTED|Period 2||6
7542954|NCT03232983|18566139|P2|STARTED|Period 2||7
7542955|NCT03232983|18566140|P1|STARTED|Period 2||7
7542956|NCT03232983|18566137|P4|NOT COMPLETED|Washout Period 1||0
7542957|NCT03232983|18566138|P3|NOT COMPLETED|Washout Period 1||0
7542958|NCT03232983|18566139|P2|NOT COMPLETED|Washout Period 1||0
7542959|NCT03232983|18566140|P1|NOT COMPLETED|Washout Period 1||0
7542960|NCT03232983|18566137|P4|COMPLETED|Washout Period 1||7
7542961|NCT03232983|18566138|P3|COMPLETED|Washout Period 1||6
7542962|NCT03232983|18566139|P2|COMPLETED|Washout Period 1||7
7542963|NCT03232983|18566140|P1|COMPLETED|Washout Period 1||7
7542964|NCT03232983|18566137|P4|STARTED|Washout Period 1||7
7542965|NCT03232983|18566138|P3|STARTED|Washout Period 1||6
7542966|NCT03232983|18566139|P2|STARTED|Washout Period 1||7
7542967|NCT03232983|18566140|P1|STARTED|Washout Period 1||7
7542968|NCT03232983|18566137|P4|NOT COMPLETED|Period 1||0
7542969|NCT03232983|18566138|P3|NOT COMPLETED|Period 1||1
7542970|NCT03232983|18566139|P2|NOT COMPLETED|Period 1||0
7542971|NCT03232983|18566140|P1|NOT COMPLETED|Period 1||0
7542972|NCT03232983|18566137|P4|COMPLETED|Period 1||7
7542973|NCT03232983|18566138|P3|COMPLETED|Period 1||6
7542974|NCT03232983|18566139|P2|COMPLETED|Period 1||7
7542975|NCT03232983|18566140|P1|COMPLETED|Period 1||7
7542976|NCT03232983|18566137|P4|Received at Least One Dose of Study Drug|Period 1||7
7542977|NCT03232983|18566138|P3|Received at Least One Dose of Study Drug|Period 1||7
7542978|NCT03232983|18566139|P2|Received at Least One Dose of Study Drug|Period 1||7
7542979|NCT03232983|18566140|P1|Received at Least One Dose of Study Drug|Period 1||7
7542980|NCT03232983|18566137|P4|STARTED|Period 1||7
7542981|NCT03232983|18566138|P3|STARTED|Period 1||7
7542982|NCT03232983|18566139|P2|STARTED|Period 1||7
7542983|NCT03232983|18566140|P1|STARTED|Period 1||7
7542984|NCT03232892|18566153|P1|NOT COMPLETED|Overall Study||0
7542985|NCT03232892|18566153|P1|COMPLETED|Overall Study||1
7542986|NCT03232892|18566153|P1|STARTED|Overall Study||1
7542987|NCT03232827|18566161|P1|NOT COMPLETED|Flavored-very Low Sweetened||0
7542988|NCT03232827|18566161|P1|COMPLETED|Flavored-very Low Sweetened||66
7542989|NCT03232827|18566161|P1|STARTED|Flavored-very Low Sweetened||66
7542990|NCT03232827|18566161|P1|NOT COMPLETED|Unflavored-very Low Sweetened (UU)||0
7542991|NCT03232827|18566161|P1|COMPLETED|Unflavored-very Low Sweetened (UU)||66
7542992|NCT03232827|18566161|P1|STARTED|Unflavored-very Low Sweetened (UU)||66
7542993|NCT03232827|18566161|P1|NOT COMPLETED|Unflavored-sweetened (US)||0
7542994|NCT03232827|18566161|P1|COMPLETED|Unflavored-sweetened (US)||86
7542995|NCT03232827|18566161|P1|STARTED|Unflavored-sweetened (US)||86
7542996|NCT03232827|18566161|P1|NOT COMPLETED|Flavored-sweetened (FS)||0
7542997|NCT03232827|18566161|P1|COMPLETED|Flavored-sweetened (FS)||80
7542998|NCT03232827|18566161|P1|STARTED|Flavored-sweetened (FS)||80
7542999|NCT03232580|18566175|P1|NOT COMPLETED|Overall Study||0
7543000|NCT03232580|18566175|P1|COMPLETED|Overall Study||5
7543001|NCT03232580|18566175|P1|STARTED|Overall Study||5
7543002|NCT03232567|18566184|P4|NOT COMPLETED|Overall Study||0
7543003|NCT03232567|18566185|P3|NOT COMPLETED|Overall Study||0
7543004|NCT03232567|18566186|P2|NOT COMPLETED|Overall Study||1
7543005|NCT03232567|18566187|P1|NOT COMPLETED|Overall Study||0
7543006|NCT03232567|18566184|P4|COMPLETED|Overall Study||15
7543007|NCT03232567|18566185|P3|COMPLETED|Overall Study||15
7543008|NCT03232567|18566186|P2|COMPLETED|Overall Study||14
7543009|NCT03232567|18566187|P1|COMPLETED|Overall Study||15
7543010|NCT03232567|18566184|P4|STARTED|Overall Study||15
7543011|NCT03232567|18566185|P3|STARTED|Overall Study||15
7543012|NCT03232567|18566186|P2|STARTED|Overall Study||15
7543013|NCT03232567|18566187|P1|STARTED|Overall Study||15
7543014|NCT03232333|18566209|P1|NOT COMPLETED|Overall Study||15
7543015|NCT03232333|18566209|P1|COMPLETED|Overall Study||38
7543016|NCT03232333|18566209|P1|STARTED|Overall Study||53
7543017|NCT03231943|18566226|P13|NOT COMPLETED|Part 2||0
7543018|NCT03231943|18566227|P12|NOT COMPLETED|Part 2||1
7543019|NCT03231943|18566228|P11|NOT COMPLETED|Part 2||1
7543020|NCT03231943|18566229|P10|NOT COMPLETED|Part 2||0
7543021|NCT03231943|18566230|P9|NOT COMPLETED|Part 2||0
7543022|NCT03231943|18566231|P8|NOT COMPLETED|Part 2||0
7543023|NCT03231943|18566232|P7|NOT COMPLETED|Part 2||0
7543024|NCT03231943|18566233|P6|NOT COMPLETED|Part 2||0
7543025|NCT03231943|18566234|P5|NOT COMPLETED|Part 2||0
7543026|NCT03231943|18566235|P4|NOT COMPLETED|Part 2||0
7543027|NCT03231943|18566236|P3|NOT COMPLETED|Part 2||0
7543028|NCT03231943|18566237|P2|NOT COMPLETED|Part 2||0
7543029|NCT03231943|18566238|P1|NOT COMPLETED|Part 2||0
7543030|NCT03231943|18566226|P13|COMPLETED|Part 2||14
7543031|NCT03231943|18566227|P12|COMPLETED|Part 2||6
7543032|NCT03231943|18566228|P11|COMPLETED|Part 2||24
7543033|NCT03231943|18566229|P10|COMPLETED|Part 2||6
7543034|NCT03231943|18566230|P9|COMPLETED|Part 2||6
7543035|NCT03231943|18566231|P8|COMPLETED|Part 2||0
7543036|NCT03231943|18566232|P7|COMPLETED|Part 2||0
7543037|NCT03231943|18566233|P6|COMPLETED|Part 2||0
7543038|NCT03231943|18566234|P5|COMPLETED|Part 2||0
7543039|NCT03231943|18566235|P4|COMPLETED|Part 2||0
7543040|NCT03231943|18566236|P3|COMPLETED|Part 2||0
7543041|NCT03231943|18566237|P2|COMPLETED|Part 2||0
7543042|NCT03231943|18566238|P1|COMPLETED|Part 2||0
7543043|NCT03231943|18566226|P13|STARTED|Part 2||14
7543044|NCT03231943|18566227|P12|STARTED|Part 2||7
7543045|NCT03231943|18566228|P11|STARTED|Part 2||25
7543046|NCT03231943|18566229|P10|STARTED|Part 2||6
7543047|NCT03231943|18566230|P9|STARTED|Part 2||6
7543048|NCT03231943|18566231|P8|STARTED|Part 2||0
7543049|NCT03231943|18566232|P7|STARTED|Part 2||0
7543050|NCT03231943|18566233|P6|STARTED|Part 2||0
7543051|NCT03231943|18566234|P5|STARTED|Part 2||0
7543052|NCT03231943|18566235|P4|STARTED|Part 2||0
7543053|NCT03231943|18566236|P3|STARTED|Part 2||0
7543054|NCT03231943|18566237|P2|STARTED|Part 2||0
7543055|NCT03231943|18566238|P1|STARTED|Part 2||0
7543056|NCT03231943|18566226|P13|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
7543057|NCT03231943|18566227|P12|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
7543058|NCT03231943|18566228|P11|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
7543059|NCT03231943|18566229|P10|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
7543060|NCT03231943|18566230|P9|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
7543061|NCT03231943|18566231|P8|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
7543062|NCT03231943|18566232|P7|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
7543063|NCT03231943|18566233|P6|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
7543064|NCT03231943|18566234|P5|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
7543065|NCT03231943|18566235|P4|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
7543066|NCT03231943|18566236|P3|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
7543067|NCT03231943|18566237|P2|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
7543068|NCT03231943|18566238|P1|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
7543069|NCT03231943|18566226|P13|COMPLETED|Part 1 Period 4 (up to Day 60)||0
7543070|NCT03231943|18566227|P12|COMPLETED|Part 1 Period 4 (up to Day 60)||0
7543071|NCT03231943|18566228|P11|COMPLETED|Part 1 Period 4 (up to Day 60)||0
7543072|NCT03231943|18566229|P10|COMPLETED|Part 1 Period 4 (up to Day 60)||0
7543073|NCT03231943|18566230|P9|COMPLETED|Part 1 Period 4 (up to Day 60)||0
7543074|NCT03231943|18566231|P8|COMPLETED|Part 1 Period 4 (up to Day 60)||2
7543075|NCT03231943|18566232|P7|COMPLETED|Part 1 Period 4 (up to Day 60)||2
7543076|NCT03231943|18566233|P6|COMPLETED|Part 1 Period 4 (up to Day 60)||2
7543077|NCT03231943|18566234|P5|COMPLETED|Part 1 Period 4 (up to Day 60)||2
7543078|NCT03231943|18566235|P4|COMPLETED|Part 1 Period 4 (up to Day 60)||2
7543079|NCT03231943|18566236|P3|COMPLETED|Part 1 Period 4 (up to Day 60)||2
7543080|NCT03231943|18566237|P2|COMPLETED|Part 1 Period 4 (up to Day 60)||2
7543081|NCT03231943|18566238|P1|COMPLETED|Part 1 Period 4 (up to Day 60)||2
7543082|NCT03231943|18566226|P13|STARTED|Part 1 Period 4 (up to Day 60)||0
7543083|NCT03231943|18566227|P12|STARTED|Part 1 Period 4 (up to Day 60)||0
7543084|NCT03231943|18566228|P11|STARTED|Part 1 Period 4 (up to Day 60)||0
7543085|NCT03231943|18566229|P10|STARTED|Part 1 Period 4 (up to Day 60)||0
7543086|NCT03231943|18566230|P9|STARTED|Part 1 Period 4 (up to Day 60)||0
7543087|NCT03231943|18566231|P8|STARTED|Part 1 Period 4 (up to Day 60)||2
7543088|NCT03231943|18566232|P7|STARTED|Part 1 Period 4 (up to Day 60)||2
7543089|NCT03231943|18566233|P6|STARTED|Part 1 Period 4 (up to Day 60)||2
7543090|NCT03231943|18566234|P5|STARTED|Part 1 Period 4 (up to Day 60)||2
7543091|NCT03231943|18566235|P4|STARTED|Part 1 Period 4 (up to Day 60)||2
7543092|NCT03231943|18566236|P3|STARTED|Part 1 Period 4 (up to Day 60)||2
7543093|NCT03231943|18566237|P2|STARTED|Part 1 Period 4 (up to Day 60)||2
7543094|NCT03231943|18566238|P1|STARTED|Part 1 Period 4 (up to Day 60)||2
7543095|NCT03231943|18566226|P13|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
7543096|NCT03231943|18566227|P12|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
7543097|NCT03231943|18566228|P11|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
7543098|NCT03231943|18566229|P10|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
7543099|NCT03231943|18566230|P9|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
7543100|NCT03231943|18566231|P8|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
7543101|NCT03231943|18566232|P7|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
7543102|NCT03231943|18566233|P6|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
7543103|NCT03231943|18566234|P5|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
7543104|NCT03231943|18566235|P4|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
7543105|NCT03231943|18566236|P3|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
7543106|NCT03231943|18566237|P2|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
7543107|NCT03231943|18566238|P1|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||1
7543108|NCT03231943|18566226|P13|COMPLETED|Part 1, Period 3 (up to Day 45)||0
7543109|NCT03231943|18566227|P12|COMPLETED|Part 1, Period 3 (up to Day 45)||0
7543110|NCT03231943|18566228|P11|COMPLETED|Part 1, Period 3 (up to Day 45)||0
7543111|NCT03231943|18566229|P10|COMPLETED|Part 1, Period 3 (up to Day 45)||0
7543112|NCT03231943|18566230|P9|COMPLETED|Part 1, Period 3 (up to Day 45)||0
7543113|NCT03231943|18566231|P8|COMPLETED|Part 1, Period 3 (up to Day 45)||2
7543114|NCT03231943|18566232|P7|COMPLETED|Part 1, Period 3 (up to Day 45)||2
7543115|NCT03231943|18566233|P6|COMPLETED|Part 1, Period 3 (up to Day 45)||2
7543116|NCT03231943|18566234|P5|COMPLETED|Part 1, Period 3 (up to Day 45)||2
7543117|NCT03231943|18566235|P4|COMPLETED|Part 1, Period 3 (up to Day 45)||2
7543118|NCT03231943|18566236|P3|COMPLETED|Part 1, Period 3 (up to Day 45)||2
7543119|NCT03231943|18566237|P2|COMPLETED|Part 1, Period 3 (up to Day 45)||2
7543120|NCT03231943|18566238|P1|COMPLETED|Part 1, Period 3 (up to Day 45)|One participant withdrawn was replaced|1
7543121|NCT03231943|18566226|P13|STARTED|Part 1, Period 3 (up to Day 45)||0
7543122|NCT03231943|18566227|P12|STARTED|Part 1, Period 3 (up to Day 45)||0
7543123|NCT03231943|18566228|P11|STARTED|Part 1, Period 3 (up to Day 45)||0
7543124|NCT03231943|18566229|P10|STARTED|Part 1, Period 3 (up to Day 45)||0
7543125|NCT03231943|18566230|P9|STARTED|Part 1, Period 3 (up to Day 45)||0
7543126|NCT03231943|18566231|P8|STARTED|Part 1, Period 3 (up to Day 45)||2
7543127|NCT03231943|18566232|P7|STARTED|Part 1, Period 3 (up to Day 45)||2
7543128|NCT03231943|18566233|P6|STARTED|Part 1, Period 3 (up to Day 45)||2
7543129|NCT03231943|18566234|P5|STARTED|Part 1, Period 3 (up to Day 45)||2
7543130|NCT03231943|18566235|P4|STARTED|Part 1, Period 3 (up to Day 45)||2
7543131|NCT03231943|18566236|P3|STARTED|Part 1, Period 3 (up to Day 45)||2
7543132|NCT03231943|18566237|P2|STARTED|Part 1, Period 3 (up to Day 45)||2
7543133|NCT03231943|18566238|P1|STARTED|Part 1, Period 3 (up to Day 45)||2
7543134|NCT03231943|18566226|P13|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
7543135|NCT03231943|18566227|P12|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
7543136|NCT03231943|18566228|P11|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
7543137|NCT03231943|18566229|P10|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
7543138|NCT03231943|18566230|P9|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
7543139|NCT03231943|18566231|P8|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
7543140|NCT03231943|18566232|P7|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
7543141|NCT03231943|18566233|P6|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
7543142|NCT03231943|18566234|P5|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
7543143|NCT03231943|18566235|P4|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
7543144|NCT03231943|18566236|P3|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||1
7543145|NCT03231943|18566237|P2|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||2
7543146|NCT03231943|18566238|P1|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
7543147|NCT03231943|18566226|P13|COMPLETED|Part 1, Period 2 (up to Day 30)||0
7543148|NCT03231943|18566227|P12|COMPLETED|Part 1, Period 2 (up to Day 30)||0
7543149|NCT03231943|18566228|P11|COMPLETED|Part 1, Period 2 (up to Day 30)||0
7543150|NCT03231943|18566229|P10|COMPLETED|Part 1, Period 2 (up to Day 30)||0
7543151|NCT03231943|18566230|P9|COMPLETED|Part 1, Period 2 (up to Day 30)||0
7543152|NCT03231943|18566231|P8|COMPLETED|Part 1, Period 2 (up to Day 30)||2
7543153|NCT03231943|18566232|P7|COMPLETED|Part 1, Period 2 (up to Day 30)||2
7543154|NCT03231943|18566233|P6|COMPLETED|Part 1, Period 2 (up to Day 30)||2
7543155|NCT03231943|18566234|P5|COMPLETED|Part 1, Period 2 (up to Day 30)||2
7543156|NCT03231943|18566235|P4|COMPLETED|Part 1, Period 2 (up to Day 30)||2
7543157|NCT03231943|18566236|P3|COMPLETED|Part 1, Period 2 (up to Day 30)|One participant withdrawn was replaced|1
7543158|NCT03231943|18566237|P2|COMPLETED|Part 1, Period 2 (up to Day 30)|Two participants withdrawn were replaced|0
7543159|NCT03231943|18566238|P1|COMPLETED|Part 1, Period 2 (up to Day 30)||2
7543160|NCT03231943|18566226|P13|STARTED|Part 1, Period 2 (up to Day 30)||0
7543161|NCT03231943|18566227|P12|STARTED|Part 1, Period 2 (up to Day 30)||0
7543162|NCT03231943|18566228|P11|STARTED|Part 1, Period 2 (up to Day 30)||0
7543163|NCT03231943|18566229|P10|STARTED|Part 1, Period 2 (up to Day 30)||0
7543164|NCT03231943|18566230|P9|STARTED|Part 1, Period 2 (up to Day 30)||0
7543165|NCT03231943|18566231|P8|STARTED|Part 1, Period 2 (up to Day 30)||2
7543166|NCT03231943|18566232|P7|STARTED|Part 1, Period 2 (up to Day 30)||2
7543167|NCT03231943|18566233|P6|STARTED|Part 1, Period 2 (up to Day 30)||2
7543168|NCT03231943|18566234|P5|STARTED|Part 1, Period 2 (up to Day 30)||2
7543169|NCT03231943|18566235|P4|STARTED|Part 1, Period 2 (up to Day 30)||2
7543170|NCT03231943|18566236|P3|STARTED|Part 1, Period 2 (up to Day 30)||2
7543171|NCT03231943|18566237|P2|STARTED|Part 1, Period 2 (up to Day 30)||2
7543172|NCT03231943|18566238|P1|STARTED|Part 1, Period 2 (up to Day 30)||2
7543173|NCT03231943|18566226|P13|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
7543174|NCT03231943|18566227|P12|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
7543175|NCT03231943|18566228|P11|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
7543176|NCT03231943|18566229|P10|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
7543177|NCT03231943|18566230|P9|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
7543178|NCT03231943|18566231|P8|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
7543179|NCT03231943|18566232|P7|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
7543180|NCT03231943|18566233|P6|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
7543181|NCT03231943|18566234|P5|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
7543182|NCT03231943|18566235|P4|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
7543183|NCT03231943|18566236|P3|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
7543184|NCT03231943|18566237|P2|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
7543185|NCT03231943|18566238|P1|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
7543186|NCT03231943|18566226|P13|COMPLETED|Part 1, Period 1 (up to Day 15)||0
7543187|NCT03231943|18566227|P12|COMPLETED|Part 1, Period 1 (up to Day 15)||0
7543188|NCT03231943|18566228|P11|COMPLETED|Part 1, Period 1 (up to Day 15)||0
7543189|NCT03231943|18566229|P10|COMPLETED|Part 1, Period 1 (up to Day 15)||0
7543190|NCT03231943|18566230|P9|COMPLETED|Part 1, Period 1 (up to Day 15)||0
7543191|NCT03231943|18566231|P8|COMPLETED|Part 1, Period 1 (up to Day 15)||2
7543192|NCT03231943|18566232|P7|COMPLETED|Part 1, Period 1 (up to Day 15)||2
7543193|NCT03231943|18566233|P6|COMPLETED|Part 1, Period 1 (up to Day 15)||2
7543194|NCT03231943|18566234|P5|COMPLETED|Part 1, Period 1 (up to Day 15)||2
7543195|NCT03231943|18566235|P4|COMPLETED|Part 1, Period 1 (up to Day 15)||2
7543196|NCT03231943|18566236|P3|COMPLETED|Part 1, Period 1 (up to Day 15)||2
7543197|NCT03231943|18566237|P2|COMPLETED|Part 1, Period 1 (up to Day 15)||2
7543198|NCT03231943|18566238|P1|COMPLETED|Part 1, Period 1 (up to Day 15)||2
7543199|NCT03231943|18566226|P13|STARTED|Part 1, Period 1 (up to Day 15)||0
7543200|NCT03231943|18566227|P12|STARTED|Part 1, Period 1 (up to Day 15)||0
7543201|NCT03231943|18566228|P11|STARTED|Part 1, Period 1 (up to Day 15)||0
7543202|NCT03231943|18566229|P10|STARTED|Part 1, Period 1 (up to Day 15)||0
7543203|NCT03231943|18566230|P9|STARTED|Part 1, Period 1 (up to Day 15)||0
7543204|NCT03231943|18566231|P8|STARTED|Part 1, Period 1 (up to Day 15)||2
7543205|NCT03231943|18566232|P7|STARTED|Part 1, Period 1 (up to Day 15)||2
7543206|NCT03231943|18566233|P6|STARTED|Part 1, Period 1 (up to Day 15)||2
7543207|NCT03231943|18566234|P5|STARTED|Part 1, Period 1 (up to Day 15)||2
7543208|NCT03231943|18566235|P4|STARTED|Part 1, Period 1 (up to Day 15)||2
7543209|NCT03231943|18566236|P3|STARTED|Part 1, Period 1 (up to Day 15)||2
7543210|NCT03231943|18566237|P2|STARTED|Part 1, Period 1 (up to Day 15)||2
7543211|NCT03231943|18566238|P1|STARTED|Part 1, Period 1 (up to Day 15)||2
7543212|NCT03231917|18566688|P2|NOT COMPLETED|Overall Study||0
7543213|NCT03231917|18566689|P1|NOT COMPLETED|Overall Study||0
7543214|NCT03231917|18566688|P2|COMPLETED|Overall Study||61
7543215|NCT03231917|18566689|P1|COMPLETED|Overall Study||60
7543216|NCT03231917|18566688|P2|STARTED|Overall Study||61
7543217|NCT03231917|18566689|P1|STARTED|Overall Study||60
7543218|NCT03231800|18566701|P2|NOT COMPLETED|Overall Study||3
7543219|NCT03231800|18566702|P1|NOT COMPLETED|Overall Study||3
7543220|NCT03231800|18566701|P2|COMPLETED|Overall Study||44
7543221|NCT03231800|18566702|P1|COMPLETED|Overall Study||45
7543222|NCT03231800|18566701|P2|Safety Population|Overall Study||47
7543223|NCT03231800|18566702|P1|Safety Population|Overall Study||47
7543224|NCT03231800|18566701|P2|STARTED|Overall Study||47
7543225|NCT03231800|18566702|P1|STARTED|Overall Study||48
7543226|NCT03231709|18566718|P2|NOT COMPLETED|Treatment Period 2||1
7543227|NCT03231709|18566719|P1|NOT COMPLETED|Treatment Period 2||0
7543228|NCT03231709|18566718|P2|COMPLETED|Treatment Period 2||28
7543229|NCT03231709|18566719|P1|COMPLETED|Treatment Period 2||30
7543230|NCT03231709|18566718|P2|STARTED|Treatment Period 2||29
7543231|NCT03231709|18566719|P1|STARTED|Treatment Period 2||30
7543232|NCT03231709|18566718|P2|NOT COMPLETED|Treatment Period 1||1
7543233|NCT03231709|18566719|P1|NOT COMPLETED|Treatment Period 1||0
7543234|NCT03231709|18566718|P2|COMPLETED|Treatment Period 1||29
7543235|NCT03231709|18566719|P1|COMPLETED|Treatment Period 1||30
7543236|NCT03231709|18566718|P2|STARTED|Treatment Period 1||30
7543237|NCT03231709|18566719|P1|STARTED|Treatment Period 1||30
7543238|NCT03231371|18566737|P1|NOT COMPLETED|Overall Study||13
7543239|NCT03231371|18566737|P1|COMPLETED|Overall Study||9
7543240|NCT03231371|18566737|P1|Optional and Age Limited (12 Yrs+) MRI|Overall Study||9
7543241|NCT03231371|18566737|P1|STARTED|Overall Study||22
7543242|NCT03231345|18566742|P1|NOT COMPLETED|Overall Study||0
7543243|NCT03231345|18566742|P1|COMPLETED|Overall Study||35
7543244|NCT03231345|18566742|P1|STARTED|Overall Study||35
7543245|NCT03231228|18566750|P2|NOT COMPLETED|Overall Study||0
7543246|NCT03231228|18566751|P1|NOT COMPLETED|Overall Study||3
7543247|NCT03231228|18566750|P2|COMPLETED|Overall Study||28
7543248|NCT03231228|18566751|P1|COMPLETED|Overall Study||30
7543249|NCT03231228|18566750|P2|STARTED|Overall Study||28
7543250|NCT03231228|18566751|P1|STARTED|Overall Study||33
7543251|NCT03230864|18566762|P4|NOT COMPLETED|Double Blind Treatment (DBT) Period||2
7543252|NCT03230864|18566763|P3|NOT COMPLETED|Double Blind Treatment (DBT) Period||8
7543253|NCT03230864|18566764|P2|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
7543254|NCT03230864|18566765|P1|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
7543255|NCT03230864|18566762|P4|COMPLETED|Double Blind Treatment (DBT) Period||31
7543256|NCT03230864|18566763|P3|COMPLETED|Double Blind Treatment (DBT) Period||27
7543257|NCT03230864|18566764|P2|COMPLETED|Double Blind Treatment (DBT) Period||0
7543258|NCT03230864|18566765|P1|COMPLETED|Double Blind Treatment (DBT) Period||0
7543259|NCT03230864|18566762|P4|STARTED|Double Blind Treatment (DBT) Period||33
7543260|NCT03230864|18566763|P3|STARTED|Double Blind Treatment (DBT) Period||35
7543261|NCT03230864|18566764|P2|STARTED|Double Blind Treatment (DBT) Period||0
7543262|NCT03230864|18566765|P1|STARTED|Double Blind Treatment (DBT) Period||0
7543263|NCT03230864|18566762|P4|NOT COMPLETED|Prospective Confirmation (PC) Period||0
7543264|NCT03230864|18566763|P3|NOT COMPLETED|Prospective Confirmation (PC) Period||0
7543265|NCT03230864|18566764|P2|NOT COMPLETED|Prospective Confirmation (PC) Period||19
7543266|NCT03230864|18566765|P1|NOT COMPLETED|Prospective Confirmation (PC) Period||32
7543267|NCT03230864|18566762|P4|COMPLETED|Prospective Confirmation (PC) Period||0
7543268|NCT03230864|18566763|P3|COMPLETED|Prospective Confirmation (PC) Period||0
7543269|NCT03230864|18566764|P2|COMPLETED|Prospective Confirmation (PC) Period||32
7543270|NCT03230864|18566765|P1|COMPLETED|Prospective Confirmation (PC) Period||36
7543271|NCT03230864|18566762|P4|STARTED|Prospective Confirmation (PC) Period||0
7543272|NCT03230864|18566763|P3|STARTED|Prospective Confirmation (PC) Period||0
7543273|NCT03230864|18566764|P2|STARTED|Prospective Confirmation (PC) Period||51
7543274|NCT03230864|18566765|P1|STARTED|Prospective Confirmation (PC) Period||68
7543275|NCT03229486|18566783|P2|NOT COMPLETED|Overall Study||1
7543276|NCT03229486|18566784|P1|NOT COMPLETED|Overall Study||0
7543277|NCT03229486|18566783|P2|COMPLETED|Overall Study||19
7543278|NCT03229486|18566784|P1|COMPLETED|Overall Study||20
7543279|NCT03229486|18566783|P2|STARTED|Overall Study||20
7543280|NCT03229486|18566784|P1|STARTED|Overall Study||20
7543281|NCT03229252|18566805|P3|NOT COMPLETED|Overall Study||6
7543282|NCT03229252|18566806|P2|NOT COMPLETED|Overall Study||0
7543283|NCT03229252|18566807|P1|NOT COMPLETED|Overall Study||2
7543284|NCT03229252|18566805|P3|COMPLETED|Overall Study||39
7543285|NCT03229252|18566806|P2|COMPLETED|Overall Study||15
7543286|NCT03229252|18566807|P1|COMPLETED|Overall Study||29
7543287|NCT03229252|18566805|P3|STARTED|Overall Study||45
7543288|NCT03229252|18566806|P2|STARTED|Overall Study||15
7543289|NCT03229252|18566807|P1|STARTED|Overall Study||31
7543290|NCT03229109|18566825|P4|NOT COMPLETED|Overall Study||1
7543291|NCT03229109|18566826|P3|NOT COMPLETED|Overall Study||0
7543292|NCT03229109|18566827|P2|NOT COMPLETED|Overall Study||0
7543293|NCT03229109|18566828|P1|NOT COMPLETED|Overall Study||0
7543294|NCT03229109|18566825|P4|COMPLETED|Overall Study||50
7543295|NCT03229109|18566826|P3|COMPLETED|Overall Study||50
7543296|NCT03229109|18566827|P2|COMPLETED|Overall Study||50
7543297|NCT03229109|18566828|P1|COMPLETED|Overall Study||50
7543298|NCT03229109|18566825|P4|STARTED|Overall Study||51
7543299|NCT03229109|18566826|P3|STARTED|Overall Study||50
7543300|NCT03229109|18566827|P2|STARTED|Overall Study||50
7543301|NCT03229109|18566828|P1|STARTED|Overall Study||50
7543302|NCT03228836|18566838|P1|NOT COMPLETED|Overall Study||17
7543303|NCT03228836|18566838|P1|COMPLETED|Overall Study||11
7543304|NCT03228836|18566838|P1|STARTED|Overall Study||28
7543305|NCT03228433|18566850|P6|NOT COMPLETED|Overall Study||0
7543306|NCT03228433|18566851|P5|NOT COMPLETED|Overall Study||0
7543307|NCT03228433|18566852|P4|NOT COMPLETED|Overall Study||1
7543308|NCT03228433|18566853|P3|NOT COMPLETED|Overall Study||0
7543309|NCT03228433|18566854|P2|NOT COMPLETED|Overall Study||0
7543310|NCT03228433|18566855|P1|NOT COMPLETED|Overall Study||1
7543311|NCT03228433|18566850|P6|COMPLETED|Overall Study||6
7543312|NCT03228433|18566851|P5|COMPLETED|Overall Study||6
7543313|NCT03228433|18566852|P4|COMPLETED|Overall Study||5
7543314|NCT03228433|18566853|P3|COMPLETED|Overall Study||6
7543315|NCT03228433|18566854|P2|COMPLETED|Overall Study||6
7543316|NCT03228433|18566855|P1|COMPLETED|Overall Study||9
7543317|NCT03228433|18566850|P6|STARTED|Overall Study||6
7543318|NCT03228433|18566851|P5|STARTED|Overall Study||6
7543319|NCT03228433|18566852|P4|STARTED|Overall Study||6
7543320|NCT03228433|18566853|P3|STARTED|Overall Study||6
7543321|NCT03228433|18566854|P2|STARTED|Overall Study||6
7543322|NCT03228433|18566855|P1|STARTED|Overall Study||10
7543323|NCT03228212|18566930|P2|NOT COMPLETED|Period 3||0
7543324|NCT03228212|18566931|P1|NOT COMPLETED|Period 3||0
7543325|NCT03228212|18566930|P2|COMPLETED|Period 3||64
7543326|NCT03228212|18566931|P1|COMPLETED|Period 3||63
7543327|NCT03228212|18566930|P2|STARTED|Period 3||64
7543328|NCT03228212|18566931|P1|STARTED|Period 3||63
7543329|NCT03228212|18566930|P2|NOT COMPLETED|Period 2||0
7543330|NCT03228212|18566931|P1|NOT COMPLETED|Period 2||1
7543331|NCT03228212|18566930|P2|COMPLETED|Period 2||64
7543332|NCT03228212|18566931|P1|COMPLETED|Period 2||63
7543333|NCT03228212|18566930|P2|STARTED|Period 2||64
7543334|NCT03228212|18566931|P1|STARTED|Period 2||64
7543335|NCT03228212|18566930|P2|NOT COMPLETED|Period 1||1
7543336|NCT03228212|18566931|P1|NOT COMPLETED|Period 1||1
7543337|NCT03228212|18566930|P2|COMPLETED|Period 1||64
7543338|NCT03228212|18566931|P1|COMPLETED|Period 1||64
7543339|NCT03228212|18566930|P2|STARTED|Period 1||65
7543340|NCT03228212|18566931|P1|STARTED|Period 1||65
7543341|NCT03227861|18566947|P1|NOT COMPLETED|Extension Period (Week 48 to Week 96)||80
7543342|NCT03227861|18566947|P1|COMPLETED|Extension Period (Week 48 to Week 96)||0
7543343|NCT03227861|18566947|P1|STARTED|Extension Period (Week 48 to Week 96)|17 participants were not willing to enter extension study and discontinued after main study.|80
7543344|NCT03227861|18566947|P1|NOT COMPLETED|Main Study Period (Week 0 to Week 48)||12
7543345|NCT03227861|18566947|P1|COMPLETED|Main Study Period (Week 0 to Week 48)||97
7543346|NCT03227861|18566947|P1|STARTED|Main Study Period (Week 0 to Week 48)||109
7543347|NCT03227692|18566979|P2|NOT COMPLETED|Overall Study||5
7543348|NCT03227692|18566980|P1|NOT COMPLETED|Overall Study||5
7543349|NCT03227692|18566979|P2|COMPLETED|Overall Study||41
7543350|NCT03227692|18566980|P1|COMPLETED|Overall Study||42
7543351|NCT03227692|18566979|P2|STARTED|Overall Study||46
7543352|NCT03227692|18566980|P1|STARTED|Overall Study||47
7543353|NCT03227445|18567008|P4|NOT COMPLETED|Period 2 (28 Days)||3
7543354|NCT03227445|18567009|P3|NOT COMPLETED|Period 2 (28 Days)||2
7543355|NCT03227445|18567010|P2|NOT COMPLETED|Period 2 (28 Days)||1
7543356|NCT03227445|18567011|P1|NOT COMPLETED|Period 2 (28 Days)||1
7543357|NCT03227445|18567008|P4|COMPLETED|Period 2 (28 Days)||55
7543358|NCT03227445|18567009|P3|COMPLETED|Period 2 (28 Days)||57
7543359|NCT03227445|18567010|P2|COMPLETED|Period 2 (28 Days)||56
7543360|NCT03227445|18567011|P1|COMPLETED|Period 2 (28 Days)||57
7543361|NCT03227445|18567008|P4|STARTED|Period 2 (28 Days)||58
7543362|NCT03227445|18567009|P3|STARTED|Period 2 (28 Days)||59
7543363|NCT03227445|18567010|P2|STARTED|Period 2 (28 Days)||57
7543364|NCT03227445|18567011|P1|STARTED|Period 2 (28 Days)||58
7543365|NCT03227445|18567008|P4|NOT COMPLETED|Period 1 (28 Days)||2
7543366|NCT03227445|18567009|P3|NOT COMPLETED|Period 1 (28 Days)||1
7543367|NCT03227445|18567010|P2|NOT COMPLETED|Period 1 (28 Days)||2
7543368|NCT03227445|18567011|P1|NOT COMPLETED|Period 1 (28 Days)||2
7543369|NCT03227445|18567008|P4|COMPLETED|Period 1 (28 Days)||58
7543370|NCT03227445|18567009|P3|COMPLETED|Period 1 (28 Days)||59
7543371|NCT03227445|18567010|P2|COMPLETED|Period 1 (28 Days)||57
7543372|NCT03227445|18567011|P1|COMPLETED|Period 1 (28 Days)||58
7543373|NCT03227445|18567008|P4|STARTED|Period 1 (28 Days)||60
7543374|NCT03227445|18567009|P3|STARTED|Period 1 (28 Days)||60
7543375|NCT03227445|18567010|P2|STARTED|Period 1 (28 Days)||59
7543376|NCT03227445|18567011|P1|STARTED|Period 1 (28 Days)||60
7543377|NCT03226769|18567037|P2|NOT COMPLETED|Overall Study||1
7543378|NCT03226769|18567038|P1|NOT COMPLETED|Overall Study||0
7543379|NCT03226769|18567037|P2|COMPLETED|Overall Study||27
7543380|NCT03226769|18567038|P1|COMPLETED|Overall Study||29
7543381|NCT03226769|18567037|P2|STARTED|Overall Study||28
7543382|NCT03226769|18567038|P1|STARTED|Overall Study||29
7543383|NCT03226691|18567046|P1|NOT COMPLETED|Overall Study||0
7543384|NCT03226691|18567046|P1|COMPLETED|Overall Study||15
7543385|NCT03226691|18567046|P1|STARTED|Overall Study||15
7543386|NCT03226392|18567052|P2|NOT COMPLETED|Overall Study||8
7543387|NCT03226392|18567053|P1|NOT COMPLETED|Overall Study||11
7543388|NCT03226392|18567052|P2|COMPLETED|Overall Study||344
7543389|NCT03226392|18567053|P1|COMPLETED|Overall Study||341
7543390|NCT03226392|18567052|P2|FAS|Overall Study|"2 patients in the placebo were mis-randomized, not treated, not included due to technical problems"|350
7543391|NCT03226392|18567053|P1|FAS|Overall Study||352
7543392|NCT03226392|18567052|P2|STARTED|Overall Study||352
7543393|NCT03226392|18567053|P1|STARTED|Overall Study||352
7543394|NCT03226366|18567069|P4|NOT COMPLETED|Overall Study||0
7543395|NCT03226366|18567070|P3|NOT COMPLETED|Overall Study||0
7543396|NCT03226366|18567071|P2|NOT COMPLETED|Overall Study||0
7543397|NCT03226366|18567072|P1|NOT COMPLETED|Overall Study||0
7543398|NCT03226366|18567069|P4|COMPLETED|Overall Study||641
7543399|NCT03226366|18567070|P3|COMPLETED|Overall Study||1183
7543400|NCT03226366|18567071|P2|COMPLETED|Overall Study||495
7543401|NCT03226366|18567072|P1|COMPLETED|Overall Study||911
7543402|NCT03226366|18567069|P4|STARTED|Overall Study||641
7543403|NCT03226366|18567070|P3|STARTED|Overall Study||1183
7543404|NCT03226366|18567071|P2|STARTED|Overall Study||495
7543405|NCT03226366|18567072|P1|STARTED|Overall Study||911
7543406|NCT03226353|18567094|P1|NOT COMPLETED|Overall Study||6
7543407|NCT03226353|18567094|P1|COMPLETED|Overall Study|Study participants completed includes the Omafilcon A habitual wearers.|71
7543408|NCT03226353|18567094|P1|Other Habitual Lens Types|Overall Study||75
7543409|NCT03226353|18567094|P1|Habitual Wearers of Proclear 1 Day|Overall Study||2
7543410|NCT03226353|18567094|P1|STARTED|Overall Study||77
7543411|NCT03226275|18567118|P4|NOT COMPLETED|Treatment Period 2 (8 Days)||0
7543412|NCT03226275|18567119|P3|NOT COMPLETED|Treatment Period 2 (8 Days)||0
7543413|NCT03226275|18567120|P2|NOT COMPLETED|Treatment Period 2 (8 Days)||0
7543414|NCT03226275|18567121|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
7543415|NCT03226275|18567118|P4|COMPLETED|Treatment Period 2 (8 Days)||7
7543416|NCT03226275|18567119|P3|COMPLETED|Treatment Period 2 (8 Days)||7
7543417|NCT03226275|18567120|P2|COMPLETED|Treatment Period 2 (8 Days)||8
7543418|NCT03226275|18567121|P1|COMPLETED|Treatment Period 2 (8 Days)||8
7543419|NCT03226275|18567118|P4|STARTED|Treatment Period 2 (8 Days)||7
7543420|NCT03226275|18567119|P3|STARTED|Treatment Period 2 (8 Days)||7
7543421|NCT03226275|18567120|P2|STARTED|Treatment Period 2 (8 Days)||8
7543422|NCT03226275|18567121|P1|STARTED|Treatment Period 2 (8 Days)||8
7543423|NCT03226275|18567118|P4|NOT COMPLETED|Treatment Period 1 (8 Days)||1
7543424|NCT03226275|18567119|P3|NOT COMPLETED|Treatment Period 1 (8 Days)||1
7543425|NCT03226275|18567120|P2|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7543426|NCT03226275|18567121|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7543427|NCT03226275|18567118|P4|COMPLETED|Treatment Period 1 (8 Days)||7
7543428|NCT03226275|18567119|P3|COMPLETED|Treatment Period 1 (8 Days)||7
7543429|NCT03226275|18567120|P2|COMPLETED|Treatment Period 1 (8 Days)||8
7543430|NCT03226275|18567121|P1|COMPLETED|Treatment Period 1 (8 Days)||8
7543431|NCT03226275|18567118|P4|STARTED|Treatment Period 1 (8 Days)||8
7543432|NCT03226275|18567119|P3|STARTED|Treatment Period 1 (8 Days)||8
7543433|NCT03226275|18567120|P2|STARTED|Treatment Period 1 (8 Days)||8
7543434|NCT03226275|18567121|P1|STARTED|Treatment Period 1 (8 Days)||8
7543435|NCT03226249|18567167|P1|NOT COMPLETED|Survival Follow-up||30
7543436|NCT03226249|18567167|P1|COMPLETED|Survival Follow-up||0
7543437|NCT03226249|18567167|P1|STARTED|Survival Follow-up|All patients that are treated with one dose of study drug go into follow-up.|30
7543438|NCT03226249|18567167|P1|NOT COMPLETED|PEM Consolidation (1-2 Years)||29
7543439|NCT03226249|18567167|P1|COMPLETED|PEM Consolidation (1-2 Years)||0
7543440|NCT03226249|18567167|P1|STARTED|PEM Consolidation (1-2 Years)||29
7543441|NCT03226249|18567167|P1|NOT COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||1
7543442|NCT03226249|18567167|P1|COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
7543443|NCT03226249|18567167|P1|PET#4|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
7543444|NCT03226249|18567167|P1|2-4 Cycles of AVD +/- Chemo & RT|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
7543445|NCT03226249|18567167|P1|STARTED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||30
7543446|NCT03226249|18567167|P1|NOT COMPLETED|2 Cycles of AVD + PET#3||0
7543447|NCT03226249|18567167|P1|COMPLETED|2 Cycles of AVD + PET#3||30
7543448|NCT03226249|18567167|P1|PET#3|2 Cycles of AVD + PET#3||30
7543449|NCT03226249|18567167|P1|AVD Cycle 2|2 Cycles of AVD + PET#3||30
7543450|NCT03226249|18567167|P1|AVD Cycle 1|2 Cycles of AVD + PET#3||30
7543451|NCT03226249|18567167|P1|STARTED|2 Cycles of AVD + PET#3||30
7543452|NCT03226249|18567167|P1|NOT COMPLETED|PEM Induction Cycles 1-3, and PET#2||0
7543453|NCT03226249|18567167|P1|COMPLETED|PEM Induction Cycles 1-3, and PET#2||30
7543454|NCT03226249|18567167|P1|PET#2|PEM Induction Cycles 1-3, and PET#2||30
7543455|NCT03226249|18567167|P1|PEM Cycle 3|PEM Induction Cycles 1-3, and PET#2||30
7543456|NCT03226249|18567167|P1|PEM Cycle 2|PEM Induction Cycles 1-3, and PET#2||30
7543457|NCT03226249|18567167|P1|PEM Cycle 1|PEM Induction Cycles 1-3, and PET#2||30
7543458|NCT03226249|18567167|P1|STARTED|PEM Induction Cycles 1-3, and PET#2||30
7543459|NCT03226223|18567175|P2|NOT COMPLETED|Overall Study||2
7543460|NCT03226223|18567176|P1|NOT COMPLETED|Overall Study||2
7543461|NCT03226223|18567175|P2|COMPLETED|Overall Study||6
7543462|NCT03226223|18567176|P1|COMPLETED|Overall Study||8
7543463|NCT03226223|18567175|P2|STARTED|Overall Study||8
7543464|NCT03226223|18567176|P1|STARTED|Overall Study||10
7543465|NCT03225599|18567184|P1|NOT COMPLETED|Overall Study||2
7543466|NCT03225599|18567184|P1|COMPLETED|Overall Study||7
7543467|NCT03225599|18567184|P1|STARTED|Overall Study||9
7543468|NCT03225573|18567188|P1|NOT COMPLETED|Overall Study||0
7543469|NCT03225573|18567188|P1|COMPLETED|Overall Study||60
7543470|NCT03225573|18567188|P1|STARTED|Overall Study||60
7543471|NCT03225313|18567195|P3|NOT COMPLETED|Overall Study||0
7543472|NCT03225313|18567196|P2|NOT COMPLETED|Overall Study||0
7543473|NCT03225313|18567197|P1|NOT COMPLETED|Overall Study||0
7543474|NCT03225313|18567195|P3|COMPLETED|Overall Study|25 Patients|25
7543475|NCT03225313|18567196|P2|COMPLETED|Overall Study|25 Patients|25
7543476|NCT03225313|18567197|P1|COMPLETED|Overall Study|25 Patients|25
7543477|NCT03225313|18567195|P3|STARTED|Overall Study|25 Patients|25
7543478|NCT03225313|18567196|P2|STARTED|Overall Study|25 Patients|25
7543479|NCT03225313|18567197|P1|STARTED|Overall Study|25 Patients|25
7543480|NCT03225001|18567229|P1|NOT COMPLETED|Overall Study||9
7543481|NCT03225001|18567229|P1|COMPLETED|Overall Study||188
7543482|NCT03225001|18567229|P1|Valve-Implanted|Overall Study||195
7543483|NCT03225001|18567229|P1|STARTED|Overall Study||197
7543484|NCT03224598|18567237|P3|NOT COMPLETED|Overall Study||0
7543485|NCT03224598|18567238|P2|NOT COMPLETED|Overall Study||3
7543486|NCT03224598|18567239|P1|NOT COMPLETED|Overall Study||0
7543487|NCT03224598|18567237|P3|COMPLETED|Overall Study||13
7543488|NCT03224598|18567238|P2|COMPLETED|Overall Study||14
7543489|NCT03224598|18567239|P1|COMPLETED|Overall Study||9
7543490|NCT03224598|18567237|P3|STARTED|Overall Study||13
7543491|NCT03224598|18567238|P2|STARTED|Overall Study||17
7543492|NCT03224598|18567239|P1|STARTED|Overall Study||9
7543493|NCT03224390|18567249|P2|NOT COMPLETED|Overall Study||35
7543494|NCT03224390|18567250|P1|NOT COMPLETED|Overall Study||27
7543495|NCT03224390|18567249|P2|COMPLETED|Overall Study||21
7543496|NCT03224390|18567250|P1|COMPLETED|Overall Study||29
7543497|NCT03224390|18567249|P2|STARTED|Overall Study||56
7543498|NCT03224390|18567250|P1|STARTED|Overall Study||56
7543499|NCT03224325|18567265|P7|NOT COMPLETED|Overall Study||1
7543500|NCT03224325|18567266|P6|NOT COMPLETED|Overall Study||0
7543501|NCT03224325|18567267|P5|NOT COMPLETED|Overall Study||0
7543502|NCT03224325|18567268|P4|NOT COMPLETED|Overall Study||1
7543503|NCT03224325|18567269|P3|NOT COMPLETED|Overall Study||0
7543504|NCT03224325|18567270|P2|NOT COMPLETED|Overall Study||0
7543505|NCT03224325|18567271|P1|NOT COMPLETED|Overall Study||1
7543506|NCT03224325|18567265|P7|COMPLETED|Overall Study||6
7543507|NCT03224325|18567266|P6|COMPLETED|Overall Study||6
7543508|NCT03224325|18567267|P5|COMPLETED|Overall Study||6
7543509|NCT03224325|18567268|P4|COMPLETED|Overall Study||5
7543510|NCT03224325|18567269|P3|COMPLETED|Overall Study||6
7543511|NCT03224325|18567270|P2|COMPLETED|Overall Study||6
7543512|NCT03224325|18567271|P1|COMPLETED|Overall Study||12
7543513|NCT03224325|18567265|P7|STARTED|Overall Study||7
7543514|NCT03224325|18567266|P6|STARTED|Overall Study||6
7543515|NCT03224325|18567267|P5|STARTED|Overall Study||6
7543516|NCT03224325|18567268|P4|STARTED|Overall Study||6
7543517|NCT03224325|18567269|P3|STARTED|Overall Study||6
7543518|NCT03224325|18567270|P2|STARTED|Overall Study||6
7543519|NCT03224325|18567271|P1|STARTED|Overall Study||13
7543520|NCT03224130|18567334|P2|NOT COMPLETED|Overall Study||1
7543521|NCT03224130|18567335|P1|NOT COMPLETED|Overall Study||0
7543522|NCT03224130|18567334|P2|COMPLETED|Overall Study||482
7543523|NCT03224130|18567335|P1|COMPLETED|Overall Study||483
7543524|NCT03224130|18567334|P2|STARTED|Overall Study||483
7543525|NCT03224130|18567335|P1|STARTED|Overall Study||483
7543526|NCT03223909|18567356|P3|NOT COMPLETED|Overall Study||16
7543527|NCT03223909|18567357|P2|NOT COMPLETED|Overall Study||45
7543528|NCT03223909|18567358|P1|NOT COMPLETED|Overall Study||48
7543529|NCT03223909|18567356|P3|COMPLETED|Overall Study||81
7543530|NCT03223909|18567357|P2|COMPLETED|Overall Study||64
7543531|NCT03223909|18567358|P1|COMPLETED|Overall Study||72
7543532|NCT03223909|18567356|P3|STARTED|Overall Study||97
7543533|NCT03223909|18567357|P2|STARTED|Overall Study||109
7543534|NCT03223909|18567358|P1|STARTED|Overall Study||120
7543535|NCT03223662|18567387|P1|NOT COMPLETED|Overall Study||2
7543536|NCT03223662|18567387|P1|COMPLETED|Overall Study||0
7543537|NCT03223662|18567387|P1|STARTED|Overall Study||2
7543538|NCT03223337|18567401|P4|NOT COMPLETED|Part 2 (Up to 16 Days)||0
7543539|NCT03223337|18567402|P3|NOT COMPLETED|Part 2 (Up to 16 Days)||0
7543540|NCT03223337|18567403|P2|NOT COMPLETED|Part 2 (Up to 16 Days)||0
7543541|NCT03223337|18567404|P1|NOT COMPLETED|Part 2 (Up to 16 Days)||0
7543542|NCT03223337|18567401|P4|COMPLETED|Part 2 (Up to 16 Days)||9
7543543|NCT03223337|18567402|P3|COMPLETED|Part 2 (Up to 16 Days)||12
7543544|NCT03223337|18567403|P2|COMPLETED|Part 2 (Up to 16 Days)||0
7543545|NCT03223337|18567404|P1|COMPLETED|Part 2 (Up to 16 Days)||0
7543546|NCT03223337|18567401|P4|STARTED|Part 2 (Up to 16 Days)||9
7543547|NCT03223337|18567402|P3|STARTED|Part 2 (Up to 16 Days)||12
7543548|NCT03223337|18567403|P2|STARTED|Part 2 (Up to 16 Days)||0
7543549|NCT03223337|18567404|P1|STARTED|Part 2 (Up to 16 Days)||0
7543550|NCT03223337|18567401|P4|NOT COMPLETED|Part 1 (Up to 16 Days)||0
7543551|NCT03223337|18567402|P3|NOT COMPLETED|Part 1 (Up to 16 Days)||0
7543552|NCT03223337|18567403|P2|NOT COMPLETED|Part 1 (Up to 16 Days)||0
7543553|NCT03223337|18567404|P1|NOT COMPLETED|Part 1 (Up to 16 Days)||0
7543554|NCT03223337|18567401|P4|COMPLETED|Part 1 (Up to 16 Days)||0
7543555|NCT03223337|18567402|P3|COMPLETED|Part 1 (Up to 16 Days)||0
7543556|NCT03223337|18567403|P2|COMPLETED|Part 1 (Up to 16 Days)||8
7543557|NCT03223337|18567404|P1|COMPLETED|Part 1 (Up to 16 Days)||8
7543558|NCT03223337|18567401|P4|STARTED|Part 1 (Up to 16 Days)||0
7543559|NCT03223337|18567402|P3|STARTED|Part 1 (Up to 16 Days)||0
7543560|NCT03223337|18567403|P2|STARTED|Part 1 (Up to 16 Days)||8
7543561|NCT03223337|18567404|P1|STARTED|Part 1 (Up to 16 Days)||8
7543562|NCT03223246|18567472|P2|NOT COMPLETED|5-7 Days||31
7543563|NCT03223246|18567473|P1|NOT COMPLETED|5-7 Days||42
7543564|NCT03223246|18567472|P2|COMPLETED|5-7 Days||35
7543565|NCT03223246|18567473|P1|COMPLETED|5-7 Days||41
7543566|NCT03223246|18567472|P2|STARTED|5-7 Days||66
7543567|NCT03223246|18567473|P1|STARTED|5-7 Days||83
7543568|NCT03223246|18567472|P2|NOT COMPLETED|48-72 Hours||31
7543569|NCT03223246|18567473|P1|NOT COMPLETED|48-72 Hours||21
7543570|NCT03223246|18567472|P2|COMPLETED|48-72 Hours||35
7543571|NCT03223246|18567473|P1|COMPLETED|48-72 Hours||62
7543572|NCT03223246|18567472|P2|STARTED|48-72 Hours||66
7543573|NCT03223246|18567473|P1|STARTED|48-72 Hours||83
7543574|NCT03222583|18567491|P2|NOT COMPLETED|Overall Study||6
7543575|NCT03222583|18567492|P1|NOT COMPLETED|Overall Study||5
7543576|NCT03222583|18567491|P2|COMPLETED|Overall Study||177
7543577|NCT03222583|18567492|P1|COMPLETED|Overall Study||358
7543578|NCT03222583|18567491|P2|Completed Open-label Period|Overall Study||181
7543579|NCT03222583|18567492|P1|Completed Open-label Period|Overall Study||0
7543580|NCT03222583|18567491|P2|Entered Open-label Period|Overall Study||182
7543581|NCT03222583|18567492|P1|Entered Open-label Period|Overall Study||0
7543582|NCT03222583|18567491|P2|Completed Double-blind Period|Overall Study||183
7543583|NCT03222583|18567492|P1|Completed Double-blind Period|Overall Study||360
7543584|NCT03222583|18567491|P2|Received Double-blind Treatment|Overall Study||183
7543585|NCT03222583|18567492|P1|Received Double-blind Treatment|Overall Study||362
7543586|NCT03222583|18567491|P2|STARTED|Overall Study||183
7543587|NCT03222583|18567492|P1|STARTED|Overall Study||363
7543588|NCT03222505|18567505|P2|NOT COMPLETED|Overall Study||0
7543589|NCT03222505|18567506|P1|NOT COMPLETED|Overall Study||0
7543590|NCT03222505|18567505|P2|COMPLETED|Overall Study||7
7543591|NCT03222505|18567506|P1|COMPLETED|Overall Study||5
7543592|NCT03222505|18567505|P2|STARTED|Overall Study||7
7543593|NCT03222505|18567506|P1|STARTED|Overall Study||5
7543594|NCT03222427|18567516|P1|NOT COMPLETED|Overall Study||0
7543595|NCT03222427|18567516|P1|COMPLETED|Overall Study||8
7543596|NCT03222427|18567516|P1|Received One Dose of Study Drug|Overall Study||8
7543597|NCT03222427|18567516|P1|STARTED|Overall Study||8
7543598|NCT03222414|18567525|P2|NOT COMPLETED|Overall Study||0
7543599|NCT03222414|18567526|P1|NOT COMPLETED|Overall Study||0
7543600|NCT03222414|18567525|P2|COMPLETED|Overall Study||1
7543601|NCT03222414|18567526|P1|COMPLETED|Overall Study||0
7543602|NCT03222414|18567525|P2|STARTED|Overall Study||1
7543603|NCT03222414|18567526|P1|STARTED|Overall Study||0
7543604|NCT03222141|18567542|P1|NOT COMPLETED|Overall Study||18
7543605|NCT03222141|18567542|P1|COMPLETED|Overall Study||565
7543606|NCT03222141|18567542|P1|STARTED|Overall Study||583
7543607|NCT03222128|18567548|P1|NOT COMPLETED|Overall Study||106
7543608|NCT03222128|18567548|P1|COMPLETED|Overall Study||968
7543609|NCT03222128|18567548|P1|Valve-Implanted|Overall Study||1069
7543610|NCT03222128|18567548|P1|STARTED|Overall Study||1074
7543611|NCT03222037|18567553|P2|NOT COMPLETED|Period 2||0
7543612|NCT03222037|18567554|P1|NOT COMPLETED|Period 2||0
7543613|NCT03222037|18567553|P2|COMPLETED|Period 2||22
7543614|NCT03222037|18567554|P1|COMPLETED|Period 2||21
7543615|NCT03222037|18567553|P2|STARTED|Period 2||22
7543616|NCT03222037|18567554|P1|STARTED|Period 2||21
7543617|NCT03222037|18567553|P2|NOT COMPLETED|Period 1||0
7543618|NCT03222037|18567554|P1|NOT COMPLETED|Period 1||0
7543619|NCT03222037|18567553|P2|COMPLETED|Period 1||22
7543620|NCT03222037|18567554|P1|COMPLETED|Period 1||21
7543621|NCT03222037|18567553|P2|STARTED|Period 1||22
7543622|NCT03222037|18567554|P1|STARTED|Period 1||21
7543623|NCT03221764|18567562|P1|NOT COMPLETED|Overall Study||0
7543624|NCT03221764|18567562|P1|COMPLETED|Overall Study||20
7543625|NCT03221764|18567562|P1|STARTED|Overall Study||20
7543626|NCT03221738|18567568|P1|NOT COMPLETED|Overall Study||0
7543627|NCT03221738|18567568|P1|COMPLETED|Overall Study||10
7543628|NCT03221738|18567568|P1|STARTED|Overall Study||10
7543629|NCT03221660|18567574|P1|NOT COMPLETED|Overall Study||0
7543630|NCT03221660|18567574|P1|COMPLETED|Overall Study||50
7543631|NCT03221660|18567574|P1|STARTED|Overall Study||50
7543632|NCT03221192|18567579|P1|NOT COMPLETED|Overall Study||0
7543633|NCT03221192|18567579|P1|COMPLETED|Overall Study||27
7543634|NCT03221192|18567579|P1|STARTED|Overall Study||27
7543635|NCT03220737|18567625|P7|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
7543636|NCT03220737|18567626|P6|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
7543637|NCT03220737|18567627|P5|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
7543638|NCT03220737|18567628|P4|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
7543639|NCT03220737|18567629|P3|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
7543640|NCT03220737|18567630|P2|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
7543641|NCT03220737|18567631|P1|NOT COMPLETED|Long-term Follow-up (Day 365-730)||11
7543642|NCT03220737|18567625|P7|COMPLETED|Long-term Follow-up (Day 365-730)||0
7543643|NCT03220737|18567626|P6|COMPLETED|Long-term Follow-up (Day 365-730)||0
7543644|NCT03220737|18567627|P5|COMPLETED|Long-term Follow-up (Day 365-730)||0
7543645|NCT03220737|18567628|P4|COMPLETED|Long-term Follow-up (Day 365-730)||0
7543646|NCT03220737|18567629|P3|COMPLETED|Long-term Follow-up (Day 365-730)||0
7543647|NCT03220737|18567630|P2|COMPLETED|Long-term Follow-up (Day 365-730)||0
7543648|NCT03220737|18567631|P1|COMPLETED|Long-term Follow-up (Day 365-730)||62
7543649|NCT03220737|18567625|P7|STARTED|Long-term Follow-up (Day 365-730)||0
7543650|NCT03220737|18567626|P6|STARTED|Long-term Follow-up (Day 365-730)||0
7543651|NCT03220737|18567627|P5|STARTED|Long-term Follow-up (Day 365-730)|Cohort 3 subjects were not eligible for the Long-term follow-up study.|0
7543652|NCT03220737|18567628|P4|STARTED|Long-term Follow-up (Day 365-730)||0
7543653|NCT03220737|18567629|P3|STARTED|Long-term Follow-up (Day 365-730)|Cohort 2 subjects were not eligible for the Long-term follow-up study.|0
7543654|NCT03220737|18567630|P2|STARTED|Long-term Follow-up (Day 365-730)||0
7543655|NCT03220737|18567631|P1|STARTED|Long-term Follow-up (Day 365-730)|Cohort 1 subjects from the main study had to opt to be included in the Long-term follow-up study.|73
7543656|NCT03220737|18567625|P7|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
7543657|NCT03220737|18567626|P6|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
7543658|NCT03220737|18567627|P5|NOT COMPLETED|Placebo Crossover (Day 181-365)||2
7543659|NCT03220737|18567628|P4|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
7543660|NCT03220737|18567629|P3|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
7543661|NCT03220737|18567630|P2|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
7543662|NCT03220737|18567631|P1|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
7543663|NCT03220737|18567625|P7|COMPLETED|Placebo Crossover (Day 181-365)||0
7543664|NCT03220737|18567626|P6|COMPLETED|Placebo Crossover (Day 181-365)||0
7543665|NCT03220737|18567627|P5|COMPLETED|Placebo Crossover (Day 181-365)||5
7543666|NCT03220737|18567628|P4|COMPLETED|Placebo Crossover (Day 181-365)||0
7543667|NCT03220737|18567629|P3|COMPLETED|Placebo Crossover (Day 181-365)||11
7543668|NCT03220737|18567630|P2|COMPLETED|Placebo Crossover (Day 181-365)||0
7543669|NCT03220737|18567631|P1|COMPLETED|Placebo Crossover (Day 181-365)||13
7543670|NCT03220737|18567625|P7|STARTED|Placebo Crossover (Day 181-365)||0
7543671|NCT03220737|18567626|P6|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0
7543672|NCT03220737|18567627|P5|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|7
7543673|NCT03220737|18567628|P4|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0
7543674|NCT03220737|18567629|P3|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|11
7543675|NCT03220737|18567630|P2|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora.|0
7543676|NCT03220737|18567631|P1|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|13
7543677|NCT03220737|18567625|P7|NOT COMPLETED|Main Study (Day 1 - 181)||1
7543678|NCT03220737|18567626|P6|NOT COMPLETED|Main Study (Day 1 - 181)||1
7543679|NCT03220737|18567627|P5|NOT COMPLETED|Main Study (Day 1 - 181)||20
7543680|NCT03220737|18567628|P4|NOT COMPLETED|Main Study (Day 1 - 181)||3
7543681|NCT03220737|18567629|P3|NOT COMPLETED|Main Study (Day 1 - 181)||12
7543682|NCT03220737|18567630|P2|NOT COMPLETED|Main Study (Day 1 - 181)||2
7543683|NCT03220737|18567631|P1|NOT COMPLETED|Main Study (Day 1 - 181)||6
7543684|NCT03220737|18567625|P7|COMPLETED|Main Study (Day 1 - 181)||2687
7543685|NCT03220737|18567626|P6|COMPLETED|Main Study (Day 1 - 181)||25
7543686|NCT03220737|18567627|P5|COMPLETED|Main Study (Day 1 - 181)||130
7543687|NCT03220737|18567628|P4|COMPLETED|Main Study (Day 1 - 181)||24
7543688|NCT03220737|18567629|P3|COMPLETED|Main Study (Day 1 - 181)||146
7543689|NCT03220737|18567630|P2|COMPLETED|Main Study (Day 1 - 181)||24
7543690|NCT03220737|18567631|P1|COMPLETED|Main Study (Day 1 - 181)||157
7543691|NCT03220737|18567625|P7|STARTED|Main Study (Day 1 - 181)||2688
7543692|NCT03220737|18567626|P6|STARTED|Main Study (Day 1 - 181)||26
7543693|NCT03220737|18567627|P5|STARTED|Main Study (Day 1 - 181)||150
7543694|NCT03220737|18567628|P4|STARTED|Main Study (Day 1 - 181)||27
7543695|NCT03220737|18567629|P3|STARTED|Main Study (Day 1 - 181)||158
7543696|NCT03220737|18567630|P2|STARTED|Main Study (Day 1 - 181)||26
7543697|NCT03220737|18567631|P1|STARTED|Main Study (Day 1 - 181)||163
7543698|NCT03220412|18567672|P2|NOT COMPLETED|Overall Study||0
7543699|NCT03220412|18567673|P1|NOT COMPLETED|Overall Study||0
7543700|NCT03220412|18567672|P2|COMPLETED|Overall Study||50
7543701|NCT03220412|18567673|P1|COMPLETED|Overall Study||54
7543702|NCT03220412|18567672|P2|STARTED|Overall Study||50
7543703|NCT03220412|18567673|P1|STARTED|Overall Study||54
7543704|NCT03220230|18567681|P1|NOT COMPLETED|Overall Study||0
7543705|NCT03220230|18567681|P1|COMPLETED|Overall Study||4240
7543706|NCT03220230|18567681|P1|STARTED|Overall Study||4240
7543707|NCT03220204|18567694|P3|NOT COMPLETED|Overall Study||3
7543708|NCT03220204|18567695|P2|NOT COMPLETED|Overall Study||2
7543709|NCT03220204|18567696|P1|NOT COMPLETED|Overall Study||1
7543710|NCT03220204|18567694|P3|COMPLETED|Overall Study||12
7543711|NCT03220204|18567695|P2|COMPLETED|Overall Study||13
7543712|NCT03220204|18567696|P1|COMPLETED|Overall Study||14
7543713|NCT03220204|18567694|P3|STARTED|Overall Study||15
7543714|NCT03220204|18567695|P2|STARTED|Overall Study||15
7543715|NCT03220204|18567696|P1|STARTED|Overall Study||15
7543716|NCT03220048|18567746|P3|NOT COMPLETED|Overall Study||1
7543717|NCT03220048|18567747|P2|NOT COMPLETED|Overall Study||2
7543718|NCT03220048|18567748|P1|NOT COMPLETED|Overall Study||0
7543719|NCT03220048|18567746|P3|COMPLETED|Overall Study||27
7543720|NCT03220048|18567747|P2|COMPLETED|Overall Study||25
7543721|NCT03220048|18567748|P1|COMPLETED|Overall Study||11
7543722|NCT03220048|18567746|P3|STARTED|Overall Study||28
7543723|NCT03220048|18567747|P2|STARTED|Overall Study||27
7543724|NCT03220048|18567748|P1|STARTED|Overall Study||11
7543725|NCT03219723|18567771|P1|NOT COMPLETED|Overall Study||10
7543726|NCT03219723|18567771|P1|COMPLETED|Overall Study||550
7543727|NCT03219723|18567771|P1|STARTED|Overall Study||560
7543728|NCT03219320|18567780|P4|NOT COMPLETED|Overall Study||3
7543729|NCT03219320|18567781|P3|NOT COMPLETED|Overall Study||5
7543730|NCT03219320|18567782|P2|NOT COMPLETED|Overall Study||3
7543731|NCT03219320|18567783|P1|NOT COMPLETED|Overall Study||2
7543732|NCT03219320|18567780|P4|COMPLETED|Overall Study||69
7543733|NCT03219320|18567781|P3|COMPLETED|Overall Study||72
7543734|NCT03219320|18567782|P2|COMPLETED|Overall Study||74
7543735|NCT03219320|18567783|P1|COMPLETED|Overall Study||73
7543736|NCT03219320|18567780|P4|STARTED|Overall Study||72
7543737|NCT03219320|18567781|P3|STARTED|Overall Study||77
7543738|NCT03219320|18567782|P2|STARTED|Overall Study||77
7543739|NCT03219320|18567783|P1|STARTED|Overall Study||75
7543740|NCT03219294|18567803|P2|NOT COMPLETED|Overall Study||0
7543741|NCT03219294|18567804|P1|NOT COMPLETED|Overall Study||0
7543742|NCT03219294|18567803|P2|COMPLETED|Overall Study||58
7543743|NCT03219294|18567804|P1|COMPLETED|Overall Study||58
7543744|NCT03219294|18567803|P2|STARTED|Overall Study||58
7543745|NCT03219294|18567804|P1|STARTED|Overall Study||58
7543746|NCT03219216|18567814|P2|NOT COMPLETED|Overall Study||1
7543747|NCT03219216|18567815|P1|NOT COMPLETED|Overall Study||0
7543748|NCT03219216|18567814|P2|COMPLETED|Overall Study||24
7543749|NCT03219216|18567815|P1|COMPLETED|Overall Study||75
7543750|NCT03219216|18567814|P2|STARTED|Overall Study||25
7543751|NCT03219216|18567815|P1|STARTED|Overall Study||75
7543752|NCT03218592|18567824|P3|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
7543753|NCT03218592|18567825|P2|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
7543754|NCT03218592|18567826|P1|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
7543755|NCT03218592|18567824|P3|COMPLETED|Phase 3: 3 Doses Per Week||4
7543756|NCT03218592|18567825|P2|COMPLETED|Phase 3: 3 Doses Per Week||4
7543757|NCT03218592|18567826|P1|COMPLETED|Phase 3: 3 Doses Per Week||4
7543758|NCT03218592|18567824|P3|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
7543759|NCT03218592|18567825|P2|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
7543760|NCT03218592|18567826|P1|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
7543761|NCT03218592|18567824|P3|STARTED|Phase 3: 3 Doses Per Week||4
7543762|NCT03218592|18567825|P2|STARTED|Phase 3: 3 Doses Per Week||4
7543763|NCT03218592|18567826|P1|STARTED|Phase 3: 3 Doses Per Week||4
7543764|NCT03218592|18567824|P3|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
7543765|NCT03218592|18567825|P2|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
7543766|NCT03218592|18567826|P1|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
7543767|NCT03218592|18567824|P3|COMPLETED|Phase 3: 1 Dose Per Period||4
7543768|NCT03218592|18567825|P2|COMPLETED|Phase 3: 1 Dose Per Period||4
7543769|NCT03218592|18567826|P1|COMPLETED|Phase 3: 1 Dose Per Period||4
7543770|NCT03218592|18567824|P3|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
7543771|NCT03218592|18567825|P2|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
7543772|NCT03218592|18567826|P1|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
7543773|NCT03218592|18567824|P3|STARTED|Phase 3: 1 Dose Per Period||4
7543774|NCT03218592|18567825|P2|STARTED|Phase 3: 1 Dose Per Period||4
7543775|NCT03218592|18567826|P1|STARTED|Phase 3: 1 Dose Per Period||4
7543776|NCT03218592|18567824|P3|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
7543777|NCT03218592|18567825|P2|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
7543778|NCT03218592|18567826|P1|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
7543779|NCT03218592|18567824|P3|COMPLETED|Phase 3: 0 Doses Per Week||4
7543780|NCT03218592|18567825|P2|COMPLETED|Phase 3: 0 Doses Per Week||4
7543781|NCT03218592|18567826|P1|COMPLETED|Phase 3: 0 Doses Per Week||4
7543782|NCT03218592|18567824|P3|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
7543783|NCT03218592|18567825|P2|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
7543784|NCT03218592|18567826|P1|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
7543785|NCT03218592|18567824|P3|STARTED|Phase 3: 0 Doses Per Week||4
7543786|NCT03218592|18567825|P2|STARTED|Phase 3: 0 Doses Per Week||4
7543787|NCT03218592|18567826|P1|STARTED|Phase 3: 0 Doses Per Week||4
7543788|NCT03218592|18567824|P3|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
7543789|NCT03218592|18567825|P2|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
7543790|NCT03218592|18567826|P1|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
7543791|NCT03218592|18567824|P3|COMPLETED|Phase 2: Daily Doses x 28 Days||12
7543792|NCT03218592|18567825|P2|COMPLETED|Phase 2: Daily Doses x 28 Days||12
7543793|NCT03218592|18567826|P1|COMPLETED|Phase 2: Daily Doses x 28 Days||12
7543794|NCT03218592|18567824|P3|STARTED|Phase 2: Daily Doses x 28 Days||12
7543795|NCT03218592|18567825|P2|STARTED|Phase 2: Daily Doses x 28 Days||12
7543796|NCT03218592|18567826|P1|STARTED|Phase 2: Daily Doses x 28 Days||12
7543797|NCT03218592|18567824|P3|NOT COMPLETED|Phase 1: 1 Dose||0
7543798|NCT03218592|18567825|P2|NOT COMPLETED|Phase 1: 1 Dose||0
7543799|NCT03218592|18567826|P1|NOT COMPLETED|Phase 1: 1 Dose||0
7543800|NCT03218592|18567824|P3|COMPLETED|Phase 1: 1 Dose||12
7543801|NCT03218592|18567825|P2|COMPLETED|Phase 1: 1 Dose||12
7543802|NCT03218592|18567826|P1|COMPLETED|Phase 1: 1 Dose||12
7543803|NCT03218592|18567824|P3|STARTED|Phase 1: 1 Dose||12
7543804|NCT03218592|18567825|P2|STARTED|Phase 1: 1 Dose||12
7543805|NCT03218592|18567826|P1|STARTED|Phase 1: 1 Dose||12
7543806|NCT03218566|18567846|P1|NOT COMPLETED|Overall Study||9
7543807|NCT03218566|18567846|P1|COMPLETED|Overall Study||110
7543808|NCT03218566|18567846|P1|STARTED|Overall Study||119
7543809|NCT03218397|18567861|P2|NOT COMPLETED|Overall Study||29
7543810|NCT03218397|18567862|P1|NOT COMPLETED|Overall Study||23
7543811|NCT03218397|18567861|P2|COMPLETED|Overall Study||222
7543812|NCT03218397|18567862|P1|COMPLETED|Overall Study||226
7543813|NCT03218397|18567861|P2|STARTED|Overall Study||251
7543814|NCT03218397|18567862|P1|STARTED|Overall Study||249
7543815|NCT03218163|18567890|P1|NOT COMPLETED|Overall Study||0
7543816|NCT03218163|18567890|P1|COMPLETED|Overall Study||0
7543817|NCT03218163|18567890|P1|STARTED|Overall Study||0
7543818|NCT03217968|18567894|P1|NOT COMPLETED|Overall Study||11
7543819|NCT03217968|18567894|P1|COMPLETED|Overall Study||48
7543820|NCT03217968|18567894|P1|STARTED|Overall Study||59
7543821|NCT03217175|18567903|P2|NOT COMPLETED|Overall Study||1
7543822|NCT03217175|18567904|P1|NOT COMPLETED|Overall Study||4
7543823|NCT03217175|18567903|P2|COMPLETED|Overall Study||0
7543824|NCT03217175|18567904|P1|COMPLETED|Overall Study||0
7543825|NCT03217175|18567903|P2|STARTED|Overall Study||1
7543826|NCT03217175|18567904|P1|STARTED|Overall Study||4
7543827|NCT03216902|18567924|P6|NOT COMPLETED|Overall Study||3
7543828|NCT03216902|18567925|P5|NOT COMPLETED|Overall Study||1
7543829|NCT03216902|18567926|P4|NOT COMPLETED|Overall Study||0
7543830|NCT03216902|18567927|P3|NOT COMPLETED|Overall Study||1
7543831|NCT03216902|18567928|P2|NOT COMPLETED|Overall Study||1
7543832|NCT03216902|18567929|P1|NOT COMPLETED|Overall Study||2
7543833|NCT03216902|18567924|P6|COMPLETED|Overall Study||42
7543834|NCT03216902|18567925|P5|COMPLETED|Overall Study||43
7543835|NCT03216902|18567926|P4|COMPLETED|Overall Study||43
7543836|NCT03216902|18567927|P3|COMPLETED|Overall Study||42
7543837|NCT03216902|18567928|P2|COMPLETED|Overall Study||43
7543838|NCT03216902|18567929|P1|COMPLETED|Overall Study||20
7543839|NCT03216902|18567924|P6|STARTED|Overall Study||45
7543840|NCT03216902|18567925|P5|STARTED|Overall Study||44
7543841|NCT03216902|18567926|P4|STARTED|Overall Study||43
7543842|NCT03216902|18567927|P3|STARTED|Overall Study||43
7543843|NCT03216902|18567928|P2|STARTED|Overall Study||44
7543844|NCT03216902|18567929|P1|STARTED|Overall Study||22
7543845|NCT03216850|18567999|P1|NOT COMPLETED|Overall Study||6
7543846|NCT03216850|18567999|P1|COMPLETED|Overall Study|6 patients did not complete the study because of the pre-analytical error.|9
7543847|NCT03216850|18567999|P1|STARTED|Overall Study||15
7543848|NCT03216746|18568007|P4|NOT COMPLETED|Overall Study||6
7543849|NCT03216746|18568008|P3|NOT COMPLETED|Overall Study||5
7543850|NCT03216746|18568009|P2|NOT COMPLETED|Overall Study||8
7543851|NCT03216746|18568010|P1|NOT COMPLETED|Overall Study||6
7543852|NCT03216746|18568007|P4|COMPLETED|Overall Study||63
7543853|NCT03216746|18568008|P3|COMPLETED|Overall Study||63
7543854|NCT03216746|18568009|P2|COMPLETED|Overall Study||71
7543855|NCT03216746|18568010|P1|COMPLETED|Overall Study||66
7543856|NCT03216746|18568007|P4|STARTED|Overall Study||69
7543857|NCT03216746|18568008|P3|STARTED|Overall Study||68
7543858|NCT03216746|18568009|P2|STARTED|Overall Study||79
7543859|NCT03216746|18568010|P1|STARTED|Overall Study||72
7543860|NCT03216512|18568022|P2|NOT COMPLETED|Overall Study||1
7543861|NCT03216512|18568023|P1|NOT COMPLETED|Overall Study||0
7543862|NCT03216512|18568022|P2|COMPLETED|Overall Study||13
7543863|NCT03216512|18568023|P1|COMPLETED|Overall Study||17
7543864|NCT03216512|18568022|P2|STARTED|Overall Study||14
7543865|NCT03216512|18568023|P1|STARTED|Overall Study||17
7543866|NCT03216499|18568041|P1|NOT COMPLETED|Overall Study||0
7543867|NCT03216499|18568041|P1|COMPLETED|Overall Study||24
7543868|NCT03216499|18568041|P1|STARTED|Overall Study||24
7543869|NCT03216265|18568051|P3|NOT COMPLETED|Overall Study||3
7543870|NCT03216265|18568052|P2|NOT COMPLETED|Overall Study||1
7543871|NCT03216265|18568053|P1|NOT COMPLETED|Overall Study||2
7543872|NCT03216265|18568051|P3|COMPLETED|Overall Study||19
7543873|NCT03216265|18568052|P2|COMPLETED|Overall Study||21
7543874|NCT03216265|18568053|P1|COMPLETED|Overall Study||20
7543875|NCT03216265|18568051|P3|STARTED|Overall Study||22
7543876|NCT03216265|18568052|P2|STARTED|Overall Study||22
7543877|NCT03216265|18568053|P1|STARTED|Overall Study||22
7543878|NCT03216200|18568103|P1|NOT COMPLETED|Overall Study||0
7543879|NCT03216200|18568103|P1|COMPLETED|Overall Study||5
7543880|NCT03216200|18568103|P1|STARTED|Overall Study||5
7543881|NCT03215901|18568111|P3|NOT COMPLETED|Overall Study||0
7543882|NCT03215901|18568112|P2|NOT COMPLETED|Overall Study||0
7543883|NCT03215901|18568113|P1|NOT COMPLETED|Overall Study||0
7543884|NCT03215901|18568111|P3|COMPLETED|Overall Study||116
7543885|NCT03215901|18568112|P2|COMPLETED|Overall Study||112
7543886|NCT03215901|18568113|P1|COMPLETED|Overall Study||199
7543887|NCT03215901|18568111|P3|STARTED|Overall Study||116
7543888|NCT03215901|18568112|P2|STARTED|Overall Study||112
7543889|NCT03215901|18568113|P1|STARTED|Overall Study||199
7543890|NCT03215758|18568144|P2|NOT COMPLETED|Overall Study||8
7543891|NCT03215758|18568145|P1|NOT COMPLETED|Overall Study||5
7543892|NCT03215758|18568144|P2|COMPLETED|Overall Study||328
7543893|NCT03215758|18568145|P1|COMPLETED|Overall Study||334
7543894|NCT03215758|18568144|P2|STARTED|Overall Study||336
7543895|NCT03215758|18568145|P1|STARTED|Overall Study||339
7543896|NCT03215706|18568159|P2|NOT COMPLETED|Treatment Period||246
7543897|NCT03215706|18568160|P1|NOT COMPLETED|Treatment Period||342
7543898|NCT03215706|18568159|P2|COMPLETED|Treatment Period||103
7543899|NCT03215706|18568160|P1|COMPLETED|Treatment Period||16
7543900|NCT03215706|18568159|P2|STARTED|Treatment Period||349
7543901|NCT03215706|18568160|P1|STARTED|Treatment Period||358
7543902|NCT03215706|18568159|P2|NOT COMPLETED|Randomization||9
7543903|NCT03215706|18568160|P1|NOT COMPLETED|Randomization||3
7543904|NCT03215706|18568159|P2|COMPLETED|Randomization||349
7543905|NCT03215706|18568160|P1|COMPLETED|Randomization||358
7543906|NCT03215706|18568159|P2|STARTED|Randomization||358
7543907|NCT03215706|18568160|P1|STARTED|Randomization||361
7543908|NCT03214952|18568180|P1|NOT COMPLETED|Overall Study||58
7543909|NCT03214952|18568180|P1|COMPLETED|Overall Study||3125
7543910|NCT03214952|18568180|P1|STARTED|Overall Study||3183
7543911|NCT03214588|18568195|P3|NOT COMPLETED|Overall Study||2
7543912|NCT03214588|18568196|P2|NOT COMPLETED|Overall Study||1
7543913|NCT03214588|18568197|P1|NOT COMPLETED|Overall Study||1
7543914|NCT03214588|18568195|P3|COMPLETED|Overall Study||24
7543915|NCT03214588|18568196|P2|COMPLETED|Overall Study||13
7543916|NCT03214588|18568197|P1|COMPLETED|Overall Study||26
7543917|NCT03214588|18568195|P3|STARTED|Overall Study||26
7543918|NCT03214588|18568196|P2|STARTED|Overall Study||14
7543919|NCT03214588|18568197|P1|STARTED|Overall Study||27
7543920|NCT03214406|18568264|P2|NOT COMPLETED|Overall Study||15
7543921|NCT03214406|18568265|P1|NOT COMPLETED|Overall Study||10
7543922|NCT03214406|18568264|P2|COMPLETED|Overall Study||78
7543923|NCT03214406|18568265|P1|COMPLETED|Overall Study||78
7543924|NCT03214406|18568264|P2|STARTED|Overall Study||93
7543925|NCT03214406|18568265|P1|STARTED|Overall Study||88
7543926|NCT03214380|18568279|P6|NOT COMPLETED|Treatment Period||11
7543927|NCT03214380|18568280|P5|NOT COMPLETED|Treatment Period||9
7543928|NCT03214380|18568281|P4|NOT COMPLETED|Treatment Period||0
7543929|NCT03214380|18568282|P3|NOT COMPLETED|Treatment Period||16
7543930|NCT03214380|18568283|P2|NOT COMPLETED|Treatment Period||18
7543931|NCT03214380|18568284|P1|NOT COMPLETED|Treatment Period||0
7543932|NCT03214380|18568279|P6|COMPLETED|Treatment Period||71
7543933|NCT03214380|18568280|P5|COMPLETED|Treatment Period||73
7543934|NCT03214380|18568281|P4|COMPLETED|Treatment Period||0
7543935|NCT03214380|18568282|P3|COMPLETED|Treatment Period||320
7543936|NCT03214380|18568283|P2|COMPLETED|Treatment Period||319
7543937|NCT03214380|18568284|P1|COMPLETED|Treatment Period||0
7543938|NCT03214380|18568279|P6|Received at Least 1 Dose of Study Drug|Treatment Period||82
7543939|NCT03214380|18568280|P5|Received at Least 1 Dose of Study Drug|Treatment Period||82
7543940|NCT03214380|18568281|P4|Received at Least 1 Dose of Study Drug|Treatment Period||0
7543941|NCT03214380|18568282|P3|Received at Least 1 Dose of Study Drug|Treatment Period||336
7543942|NCT03214380|18568283|P2|Received at Least 1 Dose of Study Drug|Treatment Period||337
7543943|NCT03214380|18568284|P1|Received at Least 1 Dose of Study Drug|Treatment Period||0
7543944|NCT03214380|18568279|P6|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
7543945|NCT03214380|18568280|P5|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
7543946|NCT03214380|18568281|P4|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
7543947|NCT03214380|18568282|P3|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|336
7543948|NCT03214380|18568283|P2|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|337
7543949|NCT03214380|18568284|P1|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
7543950|NCT03214380|18568279|P6|NOT COMPLETED|Lead-in||0
7543951|NCT03214380|18568280|P5|NOT COMPLETED|Lead-in||0
7543952|NCT03214380|18568281|P4|NOT COMPLETED|Lead-in||19
7543953|NCT03214380|18568282|P3|NOT COMPLETED|Lead-in||0
7543954|NCT03214380|18568283|P2|NOT COMPLETED|Lead-in||0
7543955|NCT03214380|18568284|P1|NOT COMPLETED|Lead-in||77
7543956|NCT03214380|18568279|P6|COMPLETED|Lead-in||0
7543957|NCT03214380|18568280|P5|COMPLETED|Lead-in||0
7543958|NCT03214380|18568281|P4|COMPLETED|Lead-in||164
7543959|NCT03214380|18568282|P3|COMPLETED|Lead-in||0
7543960|NCT03214380|18568283|P2|COMPLETED|Lead-in||0
7543961|NCT03214380|18568284|P1|COMPLETED|Lead-in||673
7543962|NCT03214380|18568279|P6|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
7543963|NCT03214380|18568280|P5|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
7543964|NCT03214380|18568281|P4|Received at Least 1 Dose Lead-in Insulin|Lead-in||183
7543965|NCT03214380|18568282|P3|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
7543966|NCT03214380|18568283|P2|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
7543967|NCT03214380|18568284|P1|Received at Least 1 Dose Lead-in Insulin|Lead-in||750
7543968|NCT03214380|18568279|P6|STARTED|Lead-in||0
7543969|NCT03214380|18568280|P5|STARTED|Lead-in||0
7543970|NCT03214380|18568281|P4|STARTED|Lead-in||183
7543971|NCT03214380|18568282|P3|STARTED|Lead-in||0
7543972|NCT03214380|18568283|P2|STARTED|Lead-in||0
7543973|NCT03214380|18568284|P1|STARTED|Lead-in||750
7543974|NCT03214367|18568320|P8|NOT COMPLETED|Treatment Period||1
7543975|NCT03214367|18568321|P7|NOT COMPLETED|Treatment Period||2
7543976|NCT03214367|18568322|P6|NOT COMPLETED|Treatment Period||3
7543977|NCT03214367|18568323|P5|NOT COMPLETED|Treatment Period||0
7543978|NCT03214367|18568324|P4|NOT COMPLETED|Treatment Period||19
7543979|NCT03214367|18568325|P3|NOT COMPLETED|Treatment Period||33
7543980|NCT03214367|18568326|P2|NOT COMPLETED|Treatment Period||34
7543981|NCT03214367|18568327|P1|NOT COMPLETED|Treatment Period||0
7543982|NCT03214367|18568320|P8|COMPLETED|Treatment Period||21
7543983|NCT03214367|18568321|P7|COMPLETED|Treatment Period||19
7543984|NCT03214367|18568322|P6|COMPLETED|Treatment Period||28
7543985|NCT03214367|18568323|P5|COMPLETED|Treatment Period||0
7543986|NCT03214367|18568324|P4|COMPLETED|Treatment Period||310
7543987|NCT03214367|18568325|P3|COMPLETED|Treatment Period||418
7543988|NCT03214367|18568326|P2|COMPLETED|Treatment Period||408
7543989|NCT03214367|18568327|P1|COMPLETED|Treatment Period||0
7543990|NCT03214367|18568320|P8|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|22
7543991|NCT03214367|18568321|P7|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|21
7543992|NCT03214367|18568322|P6|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|31
7543993|NCT03214367|18568323|P5|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
7543994|NCT03214367|18568324|P4|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|329
7543995|NCT03214367|18568325|P3|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|451
7543996|NCT03214367|18568326|P2|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|442
7543997|NCT03214367|18568327|P1|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
7543998|NCT03214367|18568320|P8|NOT COMPLETED|Lead-in Period||0
7543999|NCT03214367|18568321|P7|NOT COMPLETED|Lead-in Period||0
7544000|NCT03214367|18568322|P6|NOT COMPLETED|Lead-in Period||0
7544001|NCT03214367|18568323|P5|NOT COMPLETED|Lead-in Period||2
7544002|NCT03214367|18568324|P4|NOT COMPLETED|Lead-in Period||0
7544003|NCT03214367|18568325|P3|NOT COMPLETED|Lead-in Period||0
7544004|NCT03214367|18568326|P2|NOT COMPLETED|Lead-in Period||0
7544005|NCT03214367|18568327|P1|NOT COMPLETED|Lead-in Period||94
7544006|NCT03214367|18568320|P8|COMPLETED|Lead-in Period||0
7544007|NCT03214367|18568321|P7|COMPLETED|Lead-in Period||0
7544008|NCT03214367|18568322|P6|COMPLETED|Lead-in Period||0
7544009|NCT03214367|18568323|P5|COMPLETED|Lead-in Period||74
7544010|NCT03214367|18568324|P4|COMPLETED|Lead-in Period||0
7544011|NCT03214367|18568325|P3|COMPLETED|Lead-in Period||0
7544012|NCT03214367|18568326|P2|COMPLETED|Lead-in Period||0
7544013|NCT03214367|18568327|P1|COMPLETED|Lead-in Period||1222
7544014|NCT03214367|18568320|P8|STARTED|Lead-in Period||0
7544015|NCT03214367|18568321|P7|STARTED|Lead-in Period||0
7544016|NCT03214367|18568322|P6|STARTED|Lead-in Period||0
7544017|NCT03214367|18568323|P5|STARTED|Lead-in Period||76
7544018|NCT03214367|18568324|P4|STARTED|Lead-in Period||0
7544019|NCT03214367|18568325|P3|STARTED|Lead-in Period||0
7544020|NCT03214367|18568326|P2|STARTED|Lead-in Period||0
7544021|NCT03214367|18568327|P1|STARTED|Lead-in Period||1316
7544022|NCT03214224|18568372|P1|NOT COMPLETED|Overall Study||9
7544023|NCT03214224|18568372|P1|COMPLETED|Overall Study|3 therapists enrolled. 3 ctrls enrolled (not incl. in analysis). 3 pts enr. but not completed.|40
7544024|NCT03214224|18568372|P1|STARTED|Overall Study|Subjects did both standard and remote assessments in the validation study. Total enrollment 49.|49
7544025|NCT03214094|18568381|P1|NOT COMPLETED|Overall Study||60
7544026|NCT03214094|18568381|P1|COMPLETED|Overall Study||1059
7544027|NCT03214094|18568381|P1|STARTED|Overall Study||1119
7544028|NCT03214081|18568389|P1|NOT COMPLETED|Overall Study||63
7544029|NCT03214081|18568389|P1|COMPLETED|Overall Study||1174
7544030|NCT03214081|18568389|P1|STARTED|Overall Study||1237
7544031|NCT03213626|18568404|P1|NOT COMPLETED|Overall Study||7
7544032|NCT03213626|18568404|P1|COMPLETED|Overall Study||0
7544033|NCT03213626|18568404|P1|STARTED|Overall Study||7
7544034|NCT03213509|18568414|P2|NOT COMPLETED|Overall Study||5
7544035|NCT03213509|18568415|P1|NOT COMPLETED|Overall Study||4
7544036|NCT03213509|18568414|P2|COMPLETED|Overall Study||85
7544037|NCT03213509|18568415|P1|COMPLETED|Overall Study||76
7544038|NCT03213509|18568414|P2|STARTED|Overall Study||90
7544039|NCT03213509|18568415|P1|STARTED|Overall Study||80
7544040|NCT03213405|18568430|P4|NOT COMPLETED|Overall Study||0
7544041|NCT03213405|18568431|P3|NOT COMPLETED|Overall Study||0
7544042|NCT03213405|18568432|P2|NOT COMPLETED|Overall Study||0
7544043|NCT03213405|18568433|P1|NOT COMPLETED|Overall Study||0
7544044|NCT03213405|18568430|P4|COMPLETED|Overall Study||6
7544045|NCT03213405|18568431|P3|COMPLETED|Overall Study||6
7544046|NCT03213405|18568432|P2|COMPLETED|Overall Study||6
7544047|NCT03213405|18568433|P1|COMPLETED|Overall Study||6
7544048|NCT03213405|18568430|P4|STARTED|Overall Study||6
7544049|NCT03213405|18568431|P3|STARTED|Overall Study||6
7544050|NCT03213405|18568432|P2|STARTED|Overall Study||6
7544051|NCT03213405|18568433|P1|STARTED|Overall Study||6
7544052|NCT03213366|18568445|P2|NOT COMPLETED|Overall Study||4
7544053|NCT03213366|18568446|P1|NOT COMPLETED|Overall Study||9
7544054|NCT03213366|18568445|P2|COMPLETED|Overall Study||67
7544055|NCT03213366|18568446|P1|COMPLETED|Overall Study||72
7544056|NCT03213366|18568445|P2|STARTED|Overall Study||71
7544057|NCT03213366|18568446|P1|STARTED|Overall Study||81
7544058|NCT03212690|18568472|P1|NOT COMPLETED|Overall Study||1
7544059|NCT03212690|18568472|P1|COMPLETED|Overall Study||56
7544060|NCT03212690|18568472|P1|STARTED|Overall Study||57
7544061|NCT03212638|18568494|P5|NOT COMPLETED|Period 5||0
7544062|NCT03212638|18568495|P4|NOT COMPLETED|Period 5||0
7544063|NCT03212638|18568496|P3|NOT COMPLETED|Period 5||0
7544064|NCT03212638|18568497|P2|NOT COMPLETED|Period 5||0
7544065|NCT03212638|18568498|P1|NOT COMPLETED|Period 5||0
7544066|NCT03212638|18568494|P5|COMPLETED|Period 5||9
7544067|NCT03212638|18568495|P4|COMPLETED|Period 5||9
7544068|NCT03212638|18568496|P3|COMPLETED|Period 5||0
7544069|NCT03212638|18568497|P2|COMPLETED|Period 5||0
7544070|NCT03212638|18568498|P1|COMPLETED|Period 5||0
7544071|NCT03212638|18568494|P5|Received at Least 1 Dose of Study Drug|Period 5||9
7544072|NCT03212638|18568495|P4|Received at Least 1 Dose of Study Drug|Period 5||9
7544073|NCT03212638|18568496|P3|Received at Least 1 Dose of Study Drug|Period 5||0
7544074|NCT03212638|18568497|P2|Received at Least 1 Dose of Study Drug|Period 5||0
7544075|NCT03212638|18568498|P1|Received at Least 1 Dose of Study Drug|Period 5||0
7544076|NCT03212638|18568494|P5|STARTED|Period 5||9
7544077|NCT03212638|18568495|P4|STARTED|Period 5||9
7544078|NCT03212638|18568496|P3|STARTED|Period 5||0
7544079|NCT03212638|18568497|P2|STARTED|Period 5||0
7544080|NCT03212638|18568498|P1|STARTED|Period 5||0
7544081|NCT03212638|18568494|P5|NOT COMPLETED|Period 4||0
7544082|NCT03212638|18568495|P4|NOT COMPLETED|Period 4||0
7544083|NCT03212638|18568496|P3|NOT COMPLETED|Period 4||0
7544084|NCT03212638|18568497|P2|NOT COMPLETED|Period 4||0
7544085|NCT03212638|18568498|P1|NOT COMPLETED|Period 4||0
7544086|NCT03212638|18568494|P5|COMPLETED|Period 4||9
7544087|NCT03212638|18568495|P4|COMPLETED|Period 4||9
7544088|NCT03212638|18568496|P3|COMPLETED|Period 4||0
7544089|NCT03212638|18568497|P2|COMPLETED|Period 4||0
7544090|NCT03212638|18568498|P1|COMPLETED|Period 4||0
7544091|NCT03212638|18568494|P5|Received at Least 1 Dose of Study Drug|Period 4||9
7544092|NCT03212638|18568495|P4|Received at Least 1 Dose of Study Drug|Period 4||9
7544093|NCT03212638|18568496|P3|Received at Least 1 Dose of Study Drug|Period 4||0
7544094|NCT03212638|18568497|P2|Received at Least 1 Dose of Study Drug|Period 4||0
7544095|NCT03212638|18568498|P1|Received at Least 1 Dose of Study Drug|Period 4||0
7544096|NCT03212638|18568494|P5|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
7544097|NCT03212638|18568495|P4|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
7544098|NCT03212638|18568496|P3|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
7544099|NCT03212638|18568497|P2|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
7544100|NCT03212638|18568498|P1|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
7544101|NCT03212638|18568494|P5|NOT COMPLETED|Period 3||0
7544102|NCT03212638|18568495|P4|NOT COMPLETED|Period 3||0
7544103|NCT03212638|18568496|P3|NOT COMPLETED|Period 3||0
7544104|NCT03212638|18568497|P2|NOT COMPLETED|Period 3||0
7544105|NCT03212638|18568498|P1|NOT COMPLETED|Period 3||0
7544106|NCT03212638|18568494|P5|COMPLETED|Period 3||0
7544107|NCT03212638|18568495|P4|COMPLETED|Period 3||0
7544108|NCT03212638|18568496|P3|COMPLETED|Period 3||8
7544109|NCT03212638|18568497|P2|COMPLETED|Period 3||8
7544110|NCT03212638|18568498|P1|COMPLETED|Period 3||8
7544111|NCT03212638|18568494|P5|Received at Least 1 Dose of Study Drug|Period 3||0
7544112|NCT03212638|18568495|P4|Received at Least 1 Dose of Study Drug|Period 3||0
7544113|NCT03212638|18568496|P3|Received at Least 1 Dose of Study Drug|Period 3||8
7544114|NCT03212638|18568497|P2|Received at Least 1 Dose of Study Drug|Period 3||8
7544115|NCT03212638|18568498|P1|Received at Least 1 Dose of Study Drug|Period 3||8
7544116|NCT03212638|18568494|P5|STARTED|Period 3||0
7544117|NCT03212638|18568495|P4|STARTED|Period 3||0
7544118|NCT03212638|18568496|P3|STARTED|Period 3||8
7544119|NCT03212638|18568497|P2|STARTED|Period 3||8
7544120|NCT03212638|18568498|P1|STARTED|Period 3||8
7544121|NCT03212638|18568494|P5|NOT COMPLETED|Period 2||0
7544122|NCT03212638|18568495|P4|NOT COMPLETED|Period 2||0
7544123|NCT03212638|18568496|P3|NOT COMPLETED|Period 2||0
7544124|NCT03212638|18568497|P2|NOT COMPLETED|Period 2||0
7544125|NCT03212638|18568498|P1|NOT COMPLETED|Period 2||0
7544126|NCT03212638|18568494|P5|COMPLETED|Period 2||0
7544127|NCT03212638|18568495|P4|COMPLETED|Period 2||0
7544128|NCT03212638|18568496|P3|COMPLETED|Period 2||8
7544129|NCT03212638|18568497|P2|COMPLETED|Period 2||8
7544130|NCT03212638|18568498|P1|COMPLETED|Period 2||8
7544131|NCT03212638|18568494|P5|Received at Least 1 Dose of Study Drug|Period 2||0
7544132|NCT03212638|18568495|P4|Received at Least 1 Dose of Study Drug|Period 2||0
7544133|NCT03212638|18568496|P3|Received at Least 1 Dose of Study Drug|Period 2||8
7544134|NCT03212638|18568497|P2|Received at Least 1 Dose of Study Drug|Period 2||8
7544135|NCT03212638|18568498|P1|Received at Least 1 Dose of Study Drug|Period 2||8
7544136|NCT03212638|18568494|P5|STARTED|Period 2||0
7544137|NCT03212638|18568495|P4|STARTED|Period 2||0
7544138|NCT03212638|18568496|P3|STARTED|Period 2||8
7544139|NCT03212638|18568497|P2|STARTED|Period 2||8
7544140|NCT03212638|18568498|P1|STARTED|Period 2||8
7544141|NCT03212638|18568494|P5|NOT COMPLETED|Period 1||0
7544142|NCT03212638|18568495|P4|NOT COMPLETED|Period 1||0
7544143|NCT03212638|18568496|P3|NOT COMPLETED|Period 1||0
7544144|NCT03212638|18568497|P2|NOT COMPLETED|Period 1||0
7544145|NCT03212638|18568498|P1|NOT COMPLETED|Period 1||0
7544146|NCT03212638|18568494|P5|COMPLETED|Period 1||0
7544147|NCT03212638|18568495|P4|COMPLETED|Period 1||0
7544148|NCT03212638|18568496|P3|COMPLETED|Period 1||8
7544149|NCT03212638|18568497|P2|COMPLETED|Period 1||8
7544150|NCT03212638|18568498|P1|COMPLETED|Period 1||8
7544151|NCT03212638|18568494|P5|Received at Least 1 Dose of Study Drug|Period 1||0
7544152|NCT03212638|18568495|P4|Received at Least 1 Dose of Study Drug|Period 1||0
7544153|NCT03212638|18568496|P3|Received at Least 1 Dose of Study Drug|Period 1||8
7544154|NCT03212638|18568497|P2|Received at Least 1 Dose of Study Drug|Period 1||8
7544155|NCT03212638|18568498|P1|Received at Least 1 Dose of Study Drug|Period 1||8
7544156|NCT03212638|18568494|P5|STARTED|Period 1||0
7544157|NCT03212638|18568495|P4|STARTED|Period 1||0
7544158|NCT03212638|18568496|P3|STARTED|Period 1||8
7544159|NCT03212638|18568497|P2|STARTED|Period 1||8
7544160|NCT03212638|18568498|P1|STARTED|Period 1||8
7544161|NCT03212521|18568520|P1|NOT COMPLETED|Overall Study||7
7544162|NCT03212521|18568520|P1|COMPLETED|Overall Study||223
7544163|NCT03212521|18568520|P1|STARTED|Overall Study||230
7544164|NCT03212365|18568529|P2|NOT COMPLETED|Overall Study||14
7544165|NCT03212365|18568530|P1|NOT COMPLETED|Overall Study||23
7544166|NCT03212365|18568529|P2|COMPLETED|Overall Study||130
7544167|NCT03212365|18568530|P1|COMPLETED|Overall Study||128
7544168|NCT03212365|18568529|P2|STARTED|Overall Study||144
7544169|NCT03212365|18568530|P1|STARTED|Overall Study||151
7544170|NCT03212326|18568542|P1|NOT COMPLETED|Overall Study||4
7544171|NCT03212326|18568542|P1|COMPLETED|Overall Study||20
7544172|NCT03212326|18568542|P1|STARTED|Overall Study||24
7544173|NCT03212261|18568547|P1|NOT COMPLETED|Overall Study||16
7544174|NCT03212261|18568547|P1|COMPLETED|Overall Study||21
7544175|NCT03212261|18568547|P1|One Month Follow-up|Overall Study|Lost to follow up (n=1)|21
7544176|NCT03212261|18568547|P1|Post-intervention Survey|Overall Study|Lost to follow up (n=4)|22
7544177|NCT03212261|18568547|P1|Program Initiation|Overall Study|Lost patients: Tech trouble no first visit (n=1), Too busy/no time (n=2), LTFU (n=1)|26
7544178|NCT03212261|18568547|P1|Baseline Completion|Overall Study|Lost patients: Technology difficulties (n=2), Family Emergency (n=1), Too busy (n=3), LTFU (n=1)|30
7544179|NCT03212261|18568547|P1|Remained Eligible|Overall Study||35
7544180|NCT03212261|18568547|P1|STARTED|Overall Study|Enrolled: eligible at time of approach and signed a consent.|37
7544181|NCT03212144|18568555|P2|NOT COMPLETED|Second Sequence (4 Weeks)||1
7544182|NCT03212144|18568556|P1|NOT COMPLETED|Second Sequence (4 Weeks)||1
7544183|NCT03212144|18568555|P2|COMPLETED|Second Sequence (4 Weeks)||0
7544184|NCT03212144|18568556|P1|COMPLETED|Second Sequence (4 Weeks)||0
7544185|NCT03212144|18568555|P2|STARTED|Second Sequence (4 Weeks)||1
7544186|NCT03212144|18568556|P1|STARTED|Second Sequence (4 Weeks)||1
7544187|NCT03212144|18568555|P2|NOT COMPLETED|Washout (4 Weeks)||0
7544188|NCT03212144|18568556|P1|NOT COMPLETED|Washout (4 Weeks)||0
7544189|NCT03212144|18568555|P2|COMPLETED|Washout (4 Weeks)||1
7544190|NCT03212144|18568556|P1|COMPLETED|Washout (4 Weeks)||1
7544191|NCT03212144|18568555|P2|STARTED|Washout (4 Weeks)||1
7544192|NCT03212144|18568556|P1|STARTED|Washout (4 Weeks)||1
7544193|NCT03212144|18568555|P2|NOT COMPLETED|First Sequence (4 Weeks)||0
7544194|NCT03212144|18568556|P1|NOT COMPLETED|First Sequence (4 Weeks)||1
7544195|NCT03212144|18568555|P2|COMPLETED|First Sequence (4 Weeks)||1
7544196|NCT03212144|18568556|P1|COMPLETED|First Sequence (4 Weeks)||1
7544197|NCT03212144|18568555|P2|STARTED|First Sequence (4 Weeks)||1
7544198|NCT03212144|18568556|P1|STARTED|First Sequence (4 Weeks)||2
7544199|NCT03211858|18568564|P2|NOT COMPLETED|Overall Study||33
7544200|NCT03211858|18568565|P1|NOT COMPLETED|Overall Study||37
7544201|NCT03211858|18568564|P2|COMPLETED|Overall Study||263
7544202|NCT03211858|18568565|P1|COMPLETED|Overall Study||264
7544203|NCT03211858|18568564|P2|Treated|Overall Study||296
7544204|NCT03211858|18568565|P1|Treated|Overall Study||301
7544205|NCT03211858|18568564|P2|STARTED|Overall Study||296
7544206|NCT03211858|18568565|P1|STARTED|Overall Study||301
7544207|NCT03211156|18568617|P2|NOT COMPLETED|Overall Study||3
7544208|NCT03211156|18568618|P1|NOT COMPLETED|Overall Study||2
7544209|NCT03211156|18568617|P2|COMPLETED|Overall Study||45
7544210|NCT03211156|18568618|P1|COMPLETED|Overall Study||47
7544211|NCT03211156|18568617|P2|Received Study Drug|Overall Study||45
7544212|NCT03211156|18568618|P1|Received Study Drug|Overall Study||47
7544213|NCT03211156|18568617|P2|STARTED|Overall Study||48
7544214|NCT03211156|18568618|P1|STARTED|Overall Study||49
7544215|NCT03211117|18568626|P2|NOT COMPLETED|Overall Study||0
7544216|NCT03211117|18568627|P1|NOT COMPLETED|Overall Study||0
7544217|NCT03211117|18568626|P2|COMPLETED|Overall Study||3
7544218|NCT03211117|18568627|P1|COMPLETED|Overall Study||0
7544219|NCT03211117|18568626|P2|STARTED|Overall Study||3
7544220|NCT03211117|18568627|P1|STARTED|Overall Study||0
7544221|NCT03210961|18568649|P15|NOT COMPLETED|Overall Study||2
7544222|NCT03210961|18568650|P14|NOT COMPLETED|Overall Study||4
7544223|NCT03210961|18568651|P13|NOT COMPLETED|Overall Study||2
7544224|NCT03210961|18568652|P12|NOT COMPLETED|Overall Study||0
7544225|NCT03210961|18568653|P11|NOT COMPLETED|Overall Study||1
7544226|NCT03210961|18568654|P10|NOT COMPLETED|Overall Study||0
7544227|NCT03210961|18568655|P9|NOT COMPLETED|Overall Study||0
7544228|NCT03210961|18568656|P8|NOT COMPLETED|Overall Study||0
7544229|NCT03210961|18568657|P7|NOT COMPLETED|Overall Study||1
7544230|NCT03210961|18568658|P6|NOT COMPLETED|Overall Study||0
7544231|NCT03210961|18568659|P5|NOT COMPLETED|Overall Study||0
7544232|NCT03210961|18568660|P4|NOT COMPLETED|Overall Study||1
7544233|NCT03210961|18568661|P3|NOT COMPLETED|Overall Study||0
7544234|NCT03210961|18568662|P2|NOT COMPLETED|Overall Study||0
7544235|NCT03210961|18568663|P1|NOT COMPLETED|Overall Study||0
7544236|NCT03210961|18568649|P15|COMPLETED|Overall Study||9
7544237|NCT03210961|18568650|P14|COMPLETED|Overall Study||11
7544238|NCT03210961|18568651|P13|COMPLETED|Overall Study||12
7544239|NCT03210961|18568652|P12|COMPLETED|Overall Study||5
7544240|NCT03210961|18568653|P11|COMPLETED|Overall Study||6
7544241|NCT03210961|18568654|P10|COMPLETED|Overall Study||6
7544242|NCT03210961|18568655|P9|COMPLETED|Overall Study||8
7544243|NCT03210961|18568656|P8|COMPLETED|Overall Study||7
7544244|NCT03210961|18568657|P7|COMPLETED|Overall Study||7
7544245|NCT03210961|18568658|P6|COMPLETED|Overall Study||6
7544246|NCT03210961|18568659|P5|COMPLETED|Overall Study||6
7544247|NCT03210961|18568660|P4|COMPLETED|Overall Study||1
7544248|NCT03210961|18568661|P3|COMPLETED|Overall Study||1
7544249|NCT03210961|18568662|P2|COMPLETED|Overall Study||9
7544250|NCT03210961|18568663|P1|COMPLETED|Overall Study||4
7544251|NCT03210961|18568649|P15|STARTED|Overall Study||11
7544252|NCT03210961|18568650|P14|STARTED|Overall Study||15
7544253|NCT03210961|18568651|P13|STARTED|Overall Study||14
7544254|NCT03210961|18568652|P12|STARTED|Overall Study||5
7544255|NCT03210961|18568653|P11|STARTED|Overall Study||7
7544256|NCT03210961|18568654|P10|STARTED|Overall Study||6
7544257|NCT03210961|18568655|P9|STARTED|Overall Study||8
7544258|NCT03210961|18568656|P8|STARTED|Overall Study||7
7544259|NCT03210961|18568657|P7|STARTED|Overall Study||8
7544260|NCT03210961|18568658|P6|STARTED|Overall Study||6
7544261|NCT03210961|18568659|P5|STARTED|Overall Study||6
7544262|NCT03210961|18568660|P4|STARTED|Overall Study||2
7544263|NCT03210961|18568661|P3|STARTED|Overall Study||1
7544264|NCT03210961|18568662|P2|STARTED|Overall Study||9
7544265|NCT03210961|18568663|P1|STARTED|Overall Study||4
7544266|NCT03210701|18569012|P1|NOT COMPLETED|Overall Study||0
7544267|NCT03210701|18569012|P1|COMPLETED|Overall Study||123
7544268|NCT03210701|18569012|P1|STARTED|Overall Study||123
7544269|NCT03210519|18569022|P2|NOT COMPLETED|Overall Study||0
7544270|NCT03210519|18569023|P1|NOT COMPLETED|Overall Study||2
7544271|NCT03210519|18569022|P2|COMPLETED|Overall Study||10
7544272|NCT03210519|18569023|P1|COMPLETED|Overall Study||9
7544273|NCT03210519|18569022|P2|STARTED|Overall Study||10
7544274|NCT03210519|18569023|P1|STARTED|Overall Study||11
7544275|NCT03210376|18569049|P2|NOT COMPLETED|Overall Study||0
7544276|NCT03210376|18569050|P1|NOT COMPLETED|Overall Study||0
7544277|NCT03210376|18569049|P2|COMPLETED|Overall Study||50
7544278|NCT03210376|18569050|P1|COMPLETED|Overall Study||50
7544279|NCT03210376|18569049|P2|STARTED|Overall Study||50
7544280|NCT03210376|18569050|P1|STARTED|Overall Study||50
7544281|NCT03210337|18569070|P2|NOT COMPLETED|Overall Study||5
7544282|NCT03210337|18569071|P1|NOT COMPLETED|Overall Study||8
7544283|NCT03210337|18569070|P2|COMPLETED|Overall Study||74
7544284|NCT03210337|18569071|P1|COMPLETED|Overall Study||70
7544285|NCT03210337|18569070|P2|STARTED|Overall Study||79
7544286|NCT03210337|18569071|P1|STARTED|Overall Study||78
7544287|NCT03210220|18569079|P2|NOT COMPLETED|Overall Study||0
7544288|NCT03210220|18569080|P1|NOT COMPLETED|Overall Study||1
7544289|NCT03210220|18569079|P2|COMPLETED|Overall Study||20
7544290|NCT03210220|18569080|P1|COMPLETED|Overall Study||19
7544291|NCT03210220|18569079|P2|STARTED|Overall Study||20
7544292|NCT03210220|18569080|P1|STARTED|Overall Study||20
7544293|NCT03210155|18569088|P2|NOT COMPLETED|Overall Study||0
7544294|NCT03210155|18569089|P1|NOT COMPLETED|Overall Study||0
7544295|NCT03210155|18569088|P2|COMPLETED|Overall Study||1
7544296|NCT03210155|18569089|P1|COMPLETED|Overall Study||0
7544297|NCT03210155|18569088|P2|STARTED|Overall Study||1
7544298|NCT03210155|18569089|P1|STARTED|Overall Study||0
7544299|NCT03209973|18569103|P1|NOT COMPLETED|Overall Study||4
7544300|NCT03209973|18569103|P1|COMPLETED|Overall Study||66
7544301|NCT03209973|18569103|P1|STARTED|Overall Study||70
7544302|NCT03209570|18569109|P2|NOT COMPLETED|Overall Study||13
7544303|NCT03209570|18569110|P1|NOT COMPLETED|Overall Study||10
7544304|NCT03209570|18569109|P2|COMPLETED|Overall Study||12
7544305|NCT03209570|18569110|P1|COMPLETED|Overall Study||14
7544306|NCT03209570|18569109|P2|STARTED|Overall Study||25
7544307|NCT03209570|18569110|P1|STARTED|Overall Study||24
7544308|NCT03209518|18569120|P1|NOT COMPLETED|Overall Study||2
7544309|NCT03209518|18569120|P1|COMPLETED|Overall Study||310
7544310|NCT03209518|18569120|P1|STARTED|Overall Study||312
7544311|NCT03209492|18569125|P1|NOT COMPLETED|Overall Study||5
7544312|NCT03209492|18569125|P1|COMPLETED|Overall Study||328
7544313|NCT03209492|18569125|P1|STARTED|Overall Study||333
7544314|NCT03208933|18569130|P1|NOT COMPLETED|Overall Study||13
7544315|NCT03208933|18569130|P1|COMPLETED|Overall Study||47
7544316|NCT03208933|18569130|P1|STARTED|Overall Study||60
7544317|NCT03208673|18569139|P1|NOT COMPLETED|Overall Study||0
7544318|NCT03208673|18569139|P1|COMPLETED|Overall Study||32
7544319|NCT03208673|18569139|P1|STARTED|Overall Study||32
7544320|NCT03208192|18569147|P2|NOT COMPLETED|Overall Study||0
7544321|NCT03208192|18569148|P1|NOT COMPLETED|Overall Study||0
7544322|NCT03208192|18569147|P2|COMPLETED|Overall Study||36
7544323|NCT03208192|18569148|P1|COMPLETED|Overall Study||32
7544324|NCT03208192|18569147|P2|STARTED|Overall Study||36
7544325|NCT03208192|18569148|P1|STARTED|Overall Study||32
7544326|NCT03208166|18569168|P2|NOT COMPLETED|Overall Study||0
7544327|NCT03208166|18569169|P1|NOT COMPLETED|Overall Study||0
7544328|NCT03208166|18569168|P2|COMPLETED|Overall Study||1
7544329|NCT03208166|18569169|P1|COMPLETED|Overall Study||1
7544330|NCT03208166|18569168|P2|STARTED|Overall Study||1
7544331|NCT03208166|18569169|P1|STARTED|Overall Study||1
7544332|NCT03208088|18569177|P10|NOT COMPLETED|Period 5||0
7544333|NCT03208088|18569178|P9|NOT COMPLETED|Period 5||0
7544334|NCT03208088|18569179|P8|NOT COMPLETED|Period 5||0
7544335|NCT03208088|18569180|P7|NOT COMPLETED|Period 5||0
7544336|NCT03208088|18569181|P6|NOT COMPLETED|Period 5||0
7544337|NCT03208088|18569182|P5|NOT COMPLETED|Period 5||0
7544338|NCT03208088|18569183|P4|NOT COMPLETED|Period 5||0
7544339|NCT03208088|18569184|P3|NOT COMPLETED|Period 5||0
7544340|NCT03208088|18569185|P2|NOT COMPLETED|Period 5||0
7544341|NCT03208088|18569186|P1|NOT COMPLETED|Period 5||0
7544342|NCT03208088|18569177|P10|COMPLETED|Period 5||9
7544343|NCT03208088|18569178|P9|COMPLETED|Period 5||7
7544344|NCT03208088|18569179|P8|COMPLETED|Period 5||10
7544345|NCT03208088|18569180|P7|COMPLETED|Period 5||8
7544346|NCT03208088|18569181|P6|COMPLETED|Period 5||9
7544347|NCT03208088|18569182|P5|COMPLETED|Period 5||9
7544348|NCT03208088|18569183|P4|COMPLETED|Period 5||7
7544349|NCT03208088|18569184|P3|COMPLETED|Period 5||10
7544350|NCT03208088|18569185|P2|COMPLETED|Period 5||9
7544351|NCT03208088|18569186|P1|COMPLETED|Period 5||10
7544352|NCT03208088|18569177|P10|STARTED|Period 5||9
7544353|NCT03208088|18569178|P9|STARTED|Period 5||7
7544354|NCT03208088|18569179|P8|STARTED|Period 5||10
7544355|NCT03208088|18569180|P7|STARTED|Period 5||8
7544356|NCT03208088|18569181|P6|STARTED|Period 5||9
7544357|NCT03208088|18569182|P5|STARTED|Period 5||9
7544358|NCT03208088|18569183|P4|STARTED|Period 5||7
7544359|NCT03208088|18569184|P3|STARTED|Period 5||10
7544360|NCT03208088|18569185|P2|STARTED|Period 5||9
7544361|NCT03208088|18569186|P1|STARTED|Period 5||10
7544362|NCT03208088|18569177|P10|NOT COMPLETED|Period 4||0
7544363|NCT03208088|18569178|P9|NOT COMPLETED|Period 4||0
7544364|NCT03208088|18569179|P8|NOT COMPLETED|Period 4||0
7544365|NCT03208088|18569180|P7|NOT COMPLETED|Period 4||0
7544366|NCT03208088|18569181|P6|NOT COMPLETED|Period 4||0
7544367|NCT03208088|18569182|P5|NOT COMPLETED|Period 4||0
7544368|NCT03208088|18569183|P4|NOT COMPLETED|Period 4||1
7544369|NCT03208088|18569184|P3|NOT COMPLETED|Period 4||0
7544370|NCT03208088|18569185|P2|NOT COMPLETED|Period 4||0
7544371|NCT03208088|18569186|P1|NOT COMPLETED|Period 4||0
7544372|NCT03208088|18569177|P10|COMPLETED|Period 4||9
7544373|NCT03208088|18569178|P9|COMPLETED|Period 4||7
7544374|NCT03208088|18569179|P8|COMPLETED|Period 4||10
7544375|NCT03208088|18569180|P7|COMPLETED|Period 4||8
7544376|NCT03208088|18569181|P6|COMPLETED|Period 4||9
7544377|NCT03208088|18569182|P5|COMPLETED|Period 4||9
7544378|NCT03208088|18569183|P4|COMPLETED|Period 4||7
7544379|NCT03208088|18569184|P3|COMPLETED|Period 4||10
7544380|NCT03208088|18569185|P2|COMPLETED|Period 4||9
7544381|NCT03208088|18569186|P1|COMPLETED|Period 4||10
7544382|NCT03208088|18569177|P10|STARTED|Period 4||9
7544383|NCT03208088|18569178|P9|STARTED|Period 4||7
7544384|NCT03208088|18569179|P8|STARTED|Period 4||10
7544385|NCT03208088|18569180|P7|STARTED|Period 4||8
7544386|NCT03208088|18569181|P6|STARTED|Period 4||9
7544387|NCT03208088|18569182|P5|STARTED|Period 4||9
7544388|NCT03208088|18569183|P4|STARTED|Period 4||8
7544389|NCT03208088|18569184|P3|STARTED|Period 4||10
7544390|NCT03208088|18569185|P2|STARTED|Period 4||9
7544391|NCT03208088|18569186|P1|STARTED|Period 4||10
7544392|NCT03208088|18569177|P10|NOT COMPLETED|Period 3||0
7544393|NCT03208088|18569178|P9|NOT COMPLETED|Period 3||0
7544394|NCT03208088|18569179|P8|NOT COMPLETED|Period 3||0
7544395|NCT03208088|18569180|P7|NOT COMPLETED|Period 3||0
7544396|NCT03208088|18569181|P6|NOT COMPLETED|Period 3||0
7544397|NCT03208088|18569182|P5|NOT COMPLETED|Period 3||0
7544398|NCT03208088|18569183|P4|NOT COMPLETED|Period 3||1
7544399|NCT03208088|18569184|P3|NOT COMPLETED|Period 3||0
7544400|NCT03208088|18569185|P2|NOT COMPLETED|Period 3||0
7544401|NCT03208088|18569186|P1|NOT COMPLETED|Period 3||0
7544402|NCT03208088|18569177|P10|COMPLETED|Period 3||9
7544403|NCT03208088|18569178|P9|COMPLETED|Period 3||7
7544404|NCT03208088|18569179|P8|COMPLETED|Period 3||10
7544405|NCT03208088|18569180|P7|COMPLETED|Period 3||8
7544406|NCT03208088|18569181|P6|COMPLETED|Period 3||9
7544407|NCT03208088|18569182|P5|COMPLETED|Period 3||9
7544408|NCT03208088|18569183|P4|COMPLETED|Period 3||8
7544409|NCT03208088|18569184|P3|COMPLETED|Period 3||10
7544410|NCT03208088|18569185|P2|COMPLETED|Period 3||9
7544411|NCT03208088|18569186|P1|COMPLETED|Period 3||10
7544412|NCT03208088|18569177|P10|STARTED|Period 3||9
7544413|NCT03208088|18569178|P9|STARTED|Period 3||7
7544414|NCT03208088|18569179|P8|STARTED|Period 3||10
7544415|NCT03208088|18569180|P7|STARTED|Period 3||8
7544416|NCT03208088|18569181|P6|STARTED|Period 3||9
7544417|NCT03208088|18569182|P5|STARTED|Period 3||9
7544418|NCT03208088|18569183|P4|STARTED|Period 3||9
7544419|NCT03208088|18569184|P3|STARTED|Period 3||10
7544420|NCT03208088|18569185|P2|STARTED|Period 3||9
7544421|NCT03208088|18569186|P1|STARTED|Period 3||10
7544422|NCT03208088|18569177|P10|NOT COMPLETED|Period 2||0
7544423|NCT03208088|18569178|P9|NOT COMPLETED|Period 2||1
7544424|NCT03208088|18569179|P8|NOT COMPLETED|Period 2||0
7544425|NCT03208088|18569180|P7|NOT COMPLETED|Period 2||0
7544426|NCT03208088|18569181|P6|NOT COMPLETED|Period 2||0
7544427|NCT03208088|18569182|P5|NOT COMPLETED|Period 2||0
7544428|NCT03208088|18569183|P4|NOT COMPLETED|Period 2||0
7544429|NCT03208088|18569184|P3|NOT COMPLETED|Period 2||0
7544430|NCT03208088|18569185|P2|NOT COMPLETED|Period 2||0
7544431|NCT03208088|18569186|P1|NOT COMPLETED|Period 2||0
7544432|NCT03208088|18569177|P10|COMPLETED|Period 2||9
7544433|NCT03208088|18569178|P9|COMPLETED|Period 2||7
7544434|NCT03208088|18569179|P8|COMPLETED|Period 2||10
7544435|NCT03208088|18569180|P7|COMPLETED|Period 2||8
7544436|NCT03208088|18569181|P6|COMPLETED|Period 2||9
7544437|NCT03208088|18569182|P5|COMPLETED|Period 2||9
7544438|NCT03208088|18569183|P4|COMPLETED|Period 2||9
7544439|NCT03208088|18569184|P3|COMPLETED|Period 2||10
7544440|NCT03208088|18569185|P2|COMPLETED|Period 2||9
7544441|NCT03208088|18569186|P1|COMPLETED|Period 2||10
7544442|NCT03208088|18569177|P10|STARTED|Period 2||9
7544443|NCT03208088|18569178|P9|STARTED|Period 2||8
7544444|NCT03208088|18569179|P8|STARTED|Period 2||10
7544445|NCT03208088|18569180|P7|STARTED|Period 2||8
7544446|NCT03208088|18569181|P6|STARTED|Period 2||9
7544447|NCT03208088|18569182|P5|STARTED|Period 2||9
7544448|NCT03208088|18569183|P4|STARTED|Period 2||9
7544449|NCT03208088|18569184|P3|STARTED|Period 2||10
7544450|NCT03208088|18569185|P2|STARTED|Period 2||9
7544451|NCT03208088|18569186|P1|STARTED|Period 2||10
7544452|NCT03208088|18569177|P10|NOT COMPLETED|Period 1||0
7544453|NCT03208088|18569178|P9|NOT COMPLETED|Period 1||0
7544454|NCT03208088|18569179|P8|NOT COMPLETED|Period 1||0
7544455|NCT03208088|18569180|P7|NOT COMPLETED|Period 1||0
7544456|NCT03208088|18569181|P6|NOT COMPLETED|Period 1||0
7544457|NCT03208088|18569182|P5|NOT COMPLETED|Period 1||0
7544458|NCT03208088|18569183|P4|NOT COMPLETED|Period 1||0
7544459|NCT03208088|18569184|P3|NOT COMPLETED|Period 1||0
7544460|NCT03208088|18569185|P2|NOT COMPLETED|Period 1||0
7544461|NCT03208088|18569186|P1|NOT COMPLETED|Period 1||0
7544462|NCT03208088|18569177|P10|COMPLETED|Period 1||9
7544463|NCT03208088|18569178|P9|COMPLETED|Period 1||8
7544464|NCT03208088|18569179|P8|COMPLETED|Period 1||10
7544465|NCT03208088|18569180|P7|COMPLETED|Period 1||8
7544466|NCT03208088|18569181|P6|COMPLETED|Period 1||9
7544467|NCT03208088|18569182|P5|COMPLETED|Period 1||9
7544468|NCT03208088|18569183|P4|COMPLETED|Period 1||9
7544469|NCT03208088|18569184|P3|COMPLETED|Period 1||10
7544470|NCT03208088|18569185|P2|COMPLETED|Period 1||9
7544471|NCT03208088|18569186|P1|COMPLETED|Period 1||10
7544472|NCT03208088|18569177|P10|STARTED|Period 1||9
7544473|NCT03208088|18569178|P9|STARTED|Period 1||8
7544474|NCT03208088|18569179|P8|STARTED|Period 1||10
7544475|NCT03208088|18569180|P7|STARTED|Period 1||8
7544476|NCT03208088|18569181|P6|STARTED|Period 1||9
7544477|NCT03208088|18569182|P5|STARTED|Period 1||9
7544478|NCT03208088|18569183|P4|STARTED|Period 1||9
7544479|NCT03208088|18569184|P3|STARTED|Period 1||10
7544480|NCT03208088|18569185|P2|STARTED|Period 1||9
7544481|NCT03208088|18569186|P1|STARTED|Period 1||10
7544482|NCT03207776|18569201|P2|NOT COMPLETED|Overall Study||0
7544483|NCT03207776|18569202|P1|NOT COMPLETED|Overall Study||0
7544484|NCT03207776|18569201|P2|COMPLETED|Overall Study||2353
7544485|NCT03207776|18569202|P1|COMPLETED|Overall Study||2479
7544486|NCT03207776|18569201|P2|STARTED|Overall Study||2353
7544487|NCT03207776|18569202|P1|STARTED|Overall Study||2479
7544488|NCT03207763|18569216|P2|NOT COMPLETED|Overall Study||0
7544489|NCT03207763|18569217|P1|NOT COMPLETED|Overall Study||1
7544490|NCT03207763|18569216|P2|COMPLETED|Overall Study||25
7544491|NCT03207763|18569217|P1|COMPLETED|Overall Study||7
7544492|NCT03207763|18569216|P2|Completed Patches 2 and 3 Study|Overall Study||23
7544493|NCT03207763|18569217|P1|Completed Patches 2 and 3 Study|Overall Study||5
7544494|NCT03207763|18569216|P2|Eligible and Opted for Patches 2 and 3|Overall Study||23
7544495|NCT03207763|18569217|P1|Eligible and Opted for Patches 2 and 3|Overall Study||5
7544496|NCT03207763|18569216|P2|STARTED|Overall Study||25
7544497|NCT03207763|18569217|P1|STARTED|Overall Study||8
7544498|NCT03207750|18569243|P2|NOT COMPLETED|Overall Study||66
7544499|NCT03207750|18569244|P1|NOT COMPLETED|Overall Study||58
7544500|NCT03207750|18569243|P2|COMPLETED|Overall Study||574
7544501|NCT03207750|18569244|P1|COMPLETED|Overall Study||574
7544502|NCT03207750|18569243|P2|STARTED|Overall Study||640
7544503|NCT03207750|18569244|P1|STARTED|Overall Study||632
7544504|NCT03207438|18569290|P4|NOT COMPLETED|Overall Study||112
7544505|NCT03207438|18569291|P3|NOT COMPLETED|Overall Study||232
7544506|NCT03207438|18569292|P2|NOT COMPLETED|Overall Study||21
7544507|NCT03207438|18569293|P1|NOT COMPLETED|Overall Study||19
7544508|NCT03207438|18569290|P4|COMPLETED|Overall Study||470
7544509|NCT03207438|18569291|P3|COMPLETED|Overall Study||643
7544510|NCT03207438|18569292|P2|COMPLETED|Overall Study||145
7544511|NCT03207438|18569293|P1|COMPLETED|Overall Study||148
7544512|NCT03207438|18569290|P4|STARTED|Overall Study||582
7544513|NCT03207438|18569291|P3|STARTED|Overall Study||875
7544514|NCT03207438|18569292|P2|STARTED|Overall Study||166
7544515|NCT03207438|18569293|P1|STARTED|Overall Study||167
7544516|NCT03207399|18569310|P1|NOT COMPLETED|Overall Study||0
7544517|NCT03207399|18569310|P1|COMPLETED|Overall Study||1
7544518|NCT03207399|18569310|P1|STARTED|Overall Study||1
7544519|NCT03207243|18569324|P2|NOT COMPLETED|Overall Study||44
7544520|NCT03207243|18569325|P1|NOT COMPLETED|Overall Study||59
7544521|NCT03207243|18569324|P2|COMPLETED|Overall Study||39
7544522|NCT03207243|18569325|P1|COMPLETED|Overall Study||23
7544523|NCT03207243|18569324|P2|STARTED|Overall Study||83
7544524|NCT03207243|18569325|P1|STARTED|Overall Study||82
7544525|NCT03207074|18569432|P1|NOT COMPLETED|Overall Study||0
7544526|NCT03207074|18569432|P1|COMPLETED|Overall Study||150
7544527|NCT03207074|18569432|P1|STARTED|Overall Study||150
7544528|NCT03206970|18569436|P1|NOT COMPLETED|Overall Study||26
7544529|NCT03206970|18569436|P1|COMPLETED|Overall Study||60
7544530|NCT03206970|18569436|P1|STARTED|Overall Study||86
7544531|NCT03206918|18569440|P1|NOT COMPLETED|Overall Study||6
7544532|NCT03206918|18569440|P1|COMPLETED|Overall Study||85
7544533|NCT03206918|18569440|P1|STARTED|Overall Study||91
7544534|NCT03206788|18569446|P2|NOT COMPLETED|Overall Study||3
7544535|NCT03206788|18569447|P1|NOT COMPLETED|Overall Study||0
7544536|NCT03206788|18569446|P2|COMPLETED|Overall Study||2
7544537|NCT03206788|18569447|P1|COMPLETED|Overall Study||2
7544538|NCT03206788|18569446|P2|STARTED|Overall Study||5
7544539|NCT03206788|18569447|P1|STARTED|Overall Study||2
7544540|NCT03206216|18569485|P2|NOT COMPLETED|Overall Study||1
7544541|NCT03206216|18569486|P1|NOT COMPLETED|Overall Study||0
7544542|NCT03206216|18569485|P2|COMPLETED|Overall Study||0
7544543|NCT03206216|18569486|P1|COMPLETED|Overall Study||0
7544544|NCT03206216|18569485|P2|STARTED|Overall Study||1
7544545|NCT03206216|18569486|P1|STARTED|Overall Study||0
7544546|NCT03205488|18569497|P3|NOT COMPLETED|Overall Study||5
7544547|NCT03205488|18569498|P2|NOT COMPLETED|Overall Study||2
7544548|NCT03205488|18569499|P1|NOT COMPLETED|Overall Study||1
7544549|NCT03205488|18569497|P3|COMPLETED|Overall Study||21
7544550|NCT03205488|18569498|P2|COMPLETED|Overall Study||23
7544551|NCT03205488|18569499|P1|COMPLETED|Overall Study||24
7544552|NCT03205488|18569497|P3|STARTED|Overall Study||26
7544553|NCT03205488|18569498|P2|STARTED|Overall Study||25
7544554|NCT03205488|18569499|P1|STARTED|Overall Study||25
7544555|NCT03205371|18569525|P12|NOT COMPLETED|Overall Study||1
7544556|NCT03205371|18569526|P11|NOT COMPLETED|Overall Study||0
7544557|NCT03205371|18569527|P10|NOT COMPLETED|Overall Study||0
7544558|NCT03205371|18569528|P9|NOT COMPLETED|Overall Study||5
7544559|NCT03205371|18569529|P8|NOT COMPLETED|Overall Study||3
7544560|NCT03205371|18569530|P7|NOT COMPLETED|Overall Study||10
7544561|NCT03205371|18569531|P6|NOT COMPLETED|Overall Study||0
7544562|NCT03205371|18569532|P5|NOT COMPLETED|Overall Study||0
7544563|NCT03205371|18569533|P4|NOT COMPLETED|Overall Study||0
7544564|NCT03205371|18569534|P3|NOT COMPLETED|Overall Study||0
7544565|NCT03205371|18569535|P2|NOT COMPLETED|Overall Study||1
7544566|NCT03205371|18569536|P1|NOT COMPLETED|Overall Study||4
7544567|NCT03205371|18569525|P12|COMPLETED|Overall Study||99
7544568|NCT03205371|18569526|P11|COMPLETED|Overall Study||100
7544569|NCT03205371|18569527|P10|COMPLETED|Overall Study||200
7544570|NCT03205371|18569528|P9|COMPLETED|Overall Study||95
7544571|NCT03205371|18569529|P8|COMPLETED|Overall Study||97
7544572|NCT03205371|18569530|P7|COMPLETED|Overall Study||190
7544573|NCT03205371|18569531|P6|COMPLETED|Overall Study||42
7544574|NCT03205371|18569532|P5|COMPLETED|Overall Study||42
7544575|NCT03205371|18569533|P4|COMPLETED|Overall Study||86
7544576|NCT03205371|18569534|P3|COMPLETED|Overall Study||53
7544577|NCT03205371|18569535|P2|COMPLETED|Overall Study||52
7544578|NCT03205371|18569536|P1|COMPLETED|Overall Study||103
7544579|NCT03205371|18569525|P12|Per-protocol Analysis Set (PPAS)|Overall Study||92
7544580|NCT03205371|18569526|P11|Per-protocol Analysis Set (PPAS)|Overall Study||96
7544581|NCT03205371|18569527|P10|Per-protocol Analysis Set (PPAS)|Overall Study||196
7544582|NCT03205371|18569528|P9|Per-protocol Analysis Set (PPAS)|Overall Study||68
7544583|NCT03205371|18569529|P8|Per-protocol Analysis Set (PPAS)|Overall Study||79
7544584|NCT03205371|18569530|P7|Per-protocol Analysis Set (PPAS)|Overall Study||155
7544585|NCT03205371|18569531|P6|Per-protocol Analysis Set (PPAS)|Overall Study||42
7544586|NCT03205371|18569532|P5|Per-protocol Analysis Set (PPAS)|Overall Study||42
7544587|NCT03205371|18569533|P4|Per-protocol Analysis Set (PPAS)|Overall Study||85
7544588|NCT03205371|18569534|P3|Per-protocol Analysis Set (PPAS)|Overall Study||50
7544589|NCT03205371|18569535|P2|Per-protocol Analysis Set (PPAS)|Overall Study||45
7544590|NCT03205371|18569536|P1|Per-protocol Analysis Set (PPAS)|Overall Study||92
7544591|NCT03205371|18569525|P12|Safety Analysis Set (SafAS)|Overall Study||99
7544592|NCT03205371|18569526|P11|Safety Analysis Set (SafAS)|Overall Study||100
7544593|NCT03205371|18569527|P10|Safety Analysis Set (SafAS)|Overall Study||200
7544594|NCT03205371|18569528|P9|Safety Analysis Set (SafAS)|Overall Study||100
7544595|NCT03205371|18569529|P8|Safety Analysis Set (SafAS)|Overall Study||100
7544596|NCT03205371|18569530|P7|Safety Analysis Set (SafAS)|Overall Study||200
7544597|NCT03205371|18569531|P6|Safety Analysis Set (SafAS)|Overall Study||42
7544598|NCT03205371|18569532|P5|Safety Analysis Set (SafAS)|Overall Study||42
7544599|NCT03205371|18569533|P4|Safety Analysis Set (SafAS)|Overall Study||86
7544600|NCT03205371|18569534|P3|Safety Analysis Set (SafAS)|Overall Study||53
7544601|NCT03205371|18569535|P2|Safety Analysis Set (SafAS)|Overall Study||52
7544602|NCT03205371|18569536|P1|Safety Analysis Set (SafAS)|Overall Study||103
7544603|NCT03205371|18569525|P12|STARTED|Overall Study||100
7544604|NCT03205371|18569526|P11|STARTED|Overall Study||100
7544605|NCT03205371|18569527|P10|STARTED|Overall Study||200
7544606|NCT03205371|18569528|P9|STARTED|Overall Study||100
7544607|NCT03205371|18569529|P8|STARTED|Overall Study||100
7544608|NCT03205371|18569530|P7|STARTED|Overall Study||200
7544609|NCT03205371|18569531|P6|STARTED|Overall Study||42
7544610|NCT03205371|18569532|P5|STARTED|Overall Study||42
7544611|NCT03205371|18569533|P4|STARTED|Overall Study||86
7544612|NCT03205371|18569534|P3|STARTED|Overall Study||53
7544613|NCT03205371|18569535|P2|STARTED|Overall Study||53
7544614|NCT03205371|18569536|P1|STARTED|Overall Study||107
7544615|NCT03205358|18569616|P2|NOT COMPLETED|Overall Study||0
7544616|NCT03205358|18569617|P1|NOT COMPLETED|Overall Study||0
7544617|NCT03205358|18569616|P2|COMPLETED|Overall Study||94
7544618|NCT03205358|18569617|P1|COMPLETED|Overall Study||94
7544619|NCT03205358|18569616|P2|STARTED|Overall Study||94
7544620|NCT03205358|18569617|P1|STARTED|Overall Study||94
7544621|NCT03205163|18569625|P2|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
7544622|NCT03205163|18569626|P1|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
7544623|NCT03205163|18569625|P2|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||9
7544624|NCT03205163|18569626|P1|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||6
7544625|NCT03205163|18569625|P2|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||9
7544626|NCT03205163|18569626|P1|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||6
7544627|NCT03205163|18569625|P2|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||9
7544628|NCT03205163|18569626|P1|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||6
7544629|NCT03205163|18569625|P2|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||0
7544630|NCT03205163|18569626|P1|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||1
7544631|NCT03205163|18569625|P2|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||9
7544632|NCT03205163|18569626|P1|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||6
7544633|NCT03205163|18569625|P2|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||9
7544634|NCT03205163|18569626|P1|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||7
7544635|NCT03205163|18569625|P2|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||9
7544636|NCT03205163|18569626|P1|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||7
7544637|NCT03204942|18569677|P3|NOT COMPLETED|Overall Study||0
7544638|NCT03204942|18569678|P2|NOT COMPLETED|Overall Study||0
7544639|NCT03204942|18569679|P1|NOT COMPLETED|Overall Study||0
7544640|NCT03204942|18569677|P3|COMPLETED|Overall Study||23
7544641|NCT03204942|18569678|P2|COMPLETED|Overall Study||23
7544642|NCT03204942|18569679|P1|COMPLETED|Overall Study||23
7544643|NCT03204942|18569677|P3|STARTED|Overall Study||23
7544644|NCT03204942|18569678|P2|STARTED|Overall Study||23
7544645|NCT03204942|18569679|P1|STARTED|Overall Study||23
7544646|NCT03204643|18569707|P2|NOT COMPLETED|Overall Study||0
7544647|NCT03204643|18569708|P1|NOT COMPLETED|Overall Study||0
7544648|NCT03204643|18569707|P2|COMPLETED|Overall Study||314
7544649|NCT03204643|18569708|P1|COMPLETED|Overall Study||323
7544650|NCT03204643|18569707|P2|STARTED|Overall Study||314
7544651|NCT03204643|18569708|P1|STARTED|Overall Study||323
7544652|NCT03204539|18569722|P2|NOT COMPLETED|Overall Study||1
7544653|NCT03204539|18569723|P1|NOT COMPLETED|Overall Study||0
7544654|NCT03204539|18569722|P2|COMPLETED|Overall Study||0
7544655|NCT03204539|18569723|P1|COMPLETED|Overall Study||0
7544656|NCT03204539|18569722|P2|STARTED|Overall Study||1
7544657|NCT03204539|18569723|P1|STARTED|Overall Study||0
7544658|NCT03204279|18569747|P2|NOT COMPLETED|Overall Study||1
7544659|NCT03204279|18569748|P1|NOT COMPLETED|Overall Study||0
7544660|NCT03204279|18569747|P2|COMPLETED|Overall Study||32
7544661|NCT03204279|18569748|P1|COMPLETED|Overall Study||34
7544662|NCT03204279|18569747|P2|STARTED|Overall Study||33
7544663|NCT03204279|18569748|P1|STARTED|Overall Study||34
7544664|NCT03203564|18569763|P4|NOT COMPLETED|Overall Study||0
7544665|NCT03203564|18569764|P3|NOT COMPLETED|Overall Study||0
7544666|NCT03203564|18569765|P2|NOT COMPLETED|Overall Study||0
7544667|NCT03203564|18569766|P1|NOT COMPLETED|Overall Study||0
7544668|NCT03203564|18569763|P4|COMPLETED|Overall Study||9
7544669|NCT03203564|18569764|P3|COMPLETED|Overall Study||8
7544670|NCT03203564|18569765|P2|COMPLETED|Overall Study||8
7544671|NCT03203564|18569766|P1|COMPLETED|Overall Study||8
7544672|NCT03203564|18569763|P4|STARTED|Overall Study||9
7544673|NCT03203564|18569764|P3|STARTED|Overall Study||8
7544674|NCT03203564|18569765|P2|STARTED|Overall Study||8
7544675|NCT03203564|18569766|P1|STARTED|Overall Study||8
7544676|NCT03203291|18569875|P1|NOT COMPLETED|Overall Study||1
7544677|NCT03203291|18569875|P1|COMPLETED|Overall Study||11
7544678|NCT03203291|18569875|P1|STARTED|Overall Study||12
7544679|NCT03202550|18569887|P2|NOT COMPLETED|Overall Study||0
7544680|NCT03202550|18569888|P1|NOT COMPLETED|Overall Study||0
7544681|NCT03202550|18569887|P2|COMPLETED|Overall Study||11
7544682|NCT03202550|18569888|P1|COMPLETED|Overall Study||13
7544683|NCT03202550|18569887|P2|STARTED|Overall Study||11
7544684|NCT03202550|18569888|P1|STARTED|Overall Study||13
7544685|NCT03202472|18569910|P1|NOT COMPLETED|Overall Study||0
7544686|NCT03202472|18569910|P1|COMPLETED|Overall Study||50
7544687|NCT03202472|18569910|P1|STARTED|Overall Study||50
7544688|NCT03201900|18569923|P1|NOT COMPLETED|Extension Phase (Up to 124 Weeks)||46
7544689|NCT03201900|18569923|P1|COMPLETED|Extension Phase (Up to 124 Weeks)||0
7544690|NCT03201900|18569923|P1|STARTED|Extension Phase (Up to 124 Weeks)|Eligible participants who completed Treatment Phase and agreed to continue in the Extension Phase.|46
7544691|NCT03201900|18569923|P1|NOT COMPLETED|Treatment Phase (Up to 62 Weeks)||37
7544692|NCT03201900|18569923|P1|COMPLETED|Treatment Phase (Up to 62 Weeks)||54
7544693|NCT03201900|18569923|P1|Treated|Treatment Phase (Up to 62 Weeks)||89
7544694|NCT03201900|18569923|P1|STARTED|Treatment Phase (Up to 62 Weeks)||91
7544695|NCT03201419|18569938|P9|NOT COMPLETED|Overall Study||2
7544696|NCT03201419|18569939|P8|NOT COMPLETED|Overall Study||1
7544697|NCT03201419|18569940|P7|NOT COMPLETED|Overall Study||6
7544698|NCT03201419|18569941|P6|NOT COMPLETED|Overall Study||1
7544699|NCT03201419|18569942|P5|NOT COMPLETED|Overall Study||1
7544700|NCT03201419|18569943|P4|NOT COMPLETED|Overall Study||0
7544701|NCT03201419|18569944|P3|NOT COMPLETED|Overall Study||2
7544702|NCT03201419|18569945|P2|NOT COMPLETED|Overall Study||3
7544703|NCT03201419|18569946|P1|NOT COMPLETED|Overall Study||8
7544704|NCT03201419|18569938|P9|COMPLETED|Overall Study||15
7544705|NCT03201419|18569939|P8|COMPLETED|Overall Study||25
7544706|NCT03201419|18569940|P7|COMPLETED|Overall Study||81
7544707|NCT03201419|18569941|P6|COMPLETED|Overall Study||33
7544708|NCT03201419|18569942|P5|COMPLETED|Overall Study||12
7544709|NCT03201419|18569943|P4|COMPLETED|Overall Study||14
7544710|NCT03201419|18569944|P3|COMPLETED|Overall Study||22
7544711|NCT03201419|18569945|P2|COMPLETED|Overall Study||24
7544712|NCT03201419|18569946|P1|COMPLETED|Overall Study||52
7544713|NCT03201419|18569938|P9|STARTED|Overall Study||17
7544714|NCT03201419|18569939|P8|STARTED|Overall Study||26
7544715|NCT03201419|18569940|P7|STARTED|Overall Study||87
7544716|NCT03201419|18569941|P6|STARTED|Overall Study||34
7544717|NCT03201419|18569942|P5|STARTED|Overall Study||13
7544718|NCT03201419|18569943|P4|STARTED|Overall Study||14
7544719|NCT03201419|18569944|P3|STARTED|Overall Study||24
7544720|NCT03201419|18569945|P2|STARTED|Overall Study||27
7544721|NCT03201419|18569946|P1|STARTED|Overall Study||60
7544722|NCT03200925|18570282|P2|NOT COMPLETED|Overall Study||0
7544723|NCT03200925|18570283|P1|NOT COMPLETED|Overall Study||0
7544724|NCT03200925|18570282|P2|COMPLETED|Overall Study||120
7544725|NCT03200925|18570283|P1|COMPLETED|Overall Study||120
7544726|NCT03200925|18570282|P2|STARTED|Overall Study||120
7544727|NCT03200925|18570283|P1|STARTED|Overall Study||120
7544728|NCT03200912|18570296|P3|NOT COMPLETED|Overall Study||4
7544729|NCT03200912|18570297|P2|NOT COMPLETED|Overall Study||3
7544730|NCT03200912|18570298|P1|NOT COMPLETED|Overall Study||4
7544731|NCT03200912|18570296|P3|COMPLETED|Overall Study||164
7544732|NCT03200912|18570297|P2|COMPLETED|Overall Study||166
7544733|NCT03200912|18570298|P1|COMPLETED|Overall Study||166
7544734|NCT03200912|18570296|P3|STARTED|Overall Study||168
7544735|NCT03200912|18570297|P2|STARTED|Overall Study||169
7544736|NCT03200912|18570298|P1|STARTED|Overall Study||170
7544737|NCT03200860|18570308|P2|NOT COMPLETED|Overall Study||0
7544738|NCT03200860|18570309|P1|NOT COMPLETED|Overall Study||1
7544739|NCT03200860|18570308|P2|COMPLETED|Overall Study||39
7544740|NCT03200860|18570309|P1|COMPLETED|Overall Study||40
7544741|NCT03200860|18570308|P2|STARTED|Overall Study||39
7544742|NCT03200860|18570309|P1|STARTED|Overall Study||41
7544743|NCT03200535|18570333|P4|NOT COMPLETED|Overall Study||0
7544744|NCT03200535|18570334|P3|NOT COMPLETED|Overall Study||0
7544745|NCT03200535|18570335|P2|NOT COMPLETED|Overall Study||0
7544746|NCT03200535|18570336|P1|NOT COMPLETED|Overall Study||0
7544747|NCT03200535|18570333|P4|COMPLETED|Overall Study||1000
7544748|NCT03200535|18570334|P3|COMPLETED|Overall Study||1862
7544749|NCT03200535|18570335|P2|COMPLETED|Overall Study||1863
7544750|NCT03200535|18570336|P1|COMPLETED|Overall Study||1863
7544751|NCT03200535|18570333|P4|STARTED|Overall Study||1000
7544752|NCT03200535|18570334|P3|STARTED|Overall Study||1862
7544753|NCT03200535|18570335|P2|STARTED|Overall Study||1863
7544754|NCT03200535|18570336|P1|STARTED|Overall Study||1863
7544755|NCT03199911|18570352|P2|NOT COMPLETED|Overall Study||6
7544756|NCT03199911|18570353|P1|NOT COMPLETED|Overall Study||7
7544757|NCT03199911|18570352|P2|COMPLETED|Overall Study||187
7544758|NCT03199911|18570353|P1|COMPLETED|Overall Study||201
7544759|NCT03199911|18570352|P2|Primary Outcome Analyzed|Overall Study||187
7544760|NCT03199911|18570353|P1|Primary Outcome Analyzed|Overall Study||201
7544761|NCT03199911|18570352|P2|Lost to Follow-up|Overall Study||5
7544762|NCT03199911|18570353|P1|Lost to Follow-up|Overall Study||5
7544763|NCT03199911|18570352|P2|Received Allocated Treatment|Overall Study||192
7544764|NCT03199911|18570353|P1|Received Allocated Treatment|Overall Study||206
7544765|NCT03199911|18570352|P2|Did Not Proceed With Surgery|Overall Study||1
7544766|NCT03199911|18570353|P1|Did Not Proceed With Surgery|Overall Study||2
7544767|NCT03199911|18570352|P2|STARTED|Overall Study||193
7544768|NCT03199911|18570353|P1|STARTED|Overall Study||208
7544769|NCT03199872|18570365|P1|NOT COMPLETED|Overall Study||0
7544770|NCT03199872|18570365|P1|COMPLETED|Overall Study||22
7544771|NCT03199872|18570365|P1|STARTED|Overall Study||22
7544772|NCT03199079|18570372|P2|NOT COMPLETED|Overall Study||0
7544773|NCT03199079|18570373|P1|NOT COMPLETED|Overall Study||0
7544774|NCT03199079|18570372|P2|COMPLETED|Overall Study||10
7544775|NCT03199079|18570373|P1|COMPLETED|Overall Study||10
7544776|NCT03199079|18570372|P2|STARTED|Overall Study||10
7544777|NCT03199079|18570373|P1|STARTED|Overall Study||10
7544778|NCT03198884|18570381|P1|NOT COMPLETED|Overall Study||0
7544779|NCT03198884|18570381|P1|COMPLETED|Overall Study||20
7544780|NCT03198884|18570381|P1|STARTED|Overall Study||20
7544781|NCT03198767|18570404|P7|NOT COMPLETED|Overall Study||0
7544782|NCT03198767|18570405|P6|NOT COMPLETED|Overall Study||0
7544783|NCT03198767|18570406|P5|NOT COMPLETED|Overall Study||0
7544784|NCT03198767|18570407|P4|NOT COMPLETED|Overall Study||6
7544785|NCT03198767|18570408|P3|NOT COMPLETED|Overall Study||0
7544786|NCT03198767|18570409|P2|NOT COMPLETED|Overall Study||0
7544787|NCT03198767|18570410|P1|NOT COMPLETED|Overall Study||0
7544788|NCT03198767|18570404|P7|COMPLETED|Overall Study||8
7544789|NCT03198767|18570405|P6|COMPLETED|Overall Study||8
7544790|NCT03198767|18570406|P5|COMPLETED|Overall Study||8
7544791|NCT03198767|18570407|P4|COMPLETED|Overall Study||0
7544792|NCT03198767|18570408|P3|COMPLETED|Overall Study||8
7544793|NCT03198767|18570409|P2|COMPLETED|Overall Study||8
7544794|NCT03198767|18570410|P1|COMPLETED|Overall Study||8
7544795|NCT03198767|18570404|P7|STARTED|Overall Study||8
7544796|NCT03198767|18570405|P6|STARTED|Overall Study||8
7544797|NCT03198767|18570406|P5|STARTED|Overall Study||8
7544798|NCT03198767|18570407|P4|STARTED|Overall Study||6
7544799|NCT03198767|18570408|P3|STARTED|Overall Study||8
7544800|NCT03198767|18570409|P2|STARTED|Overall Study||8
7544801|NCT03198767|18570410|P1|STARTED|Overall Study||8
7544802|NCT03198754|18570451|P2|NOT COMPLETED|Overall Study||8
7544803|NCT03198754|18570452|P1|NOT COMPLETED|Overall Study||11
7544804|NCT03198754|18570451|P2|COMPLETED|Overall Study||27
7544805|NCT03198754|18570452|P1|COMPLETED|Overall Study||27
7544806|NCT03198754|18570451|P2|STARTED|Overall Study||35
7544807|NCT03198754|18570452|P1|STARTED|Overall Study||38
7544808|NCT03198520|18570490|P1|NOT COMPLETED|Overall Study||6
7544809|NCT03198520|18570490|P1|COMPLETED|Overall Study||40
7544810|NCT03198520|18570490|P1|STARTED|Overall Study||46
7544811|NCT03198507|18570513|P2|NOT COMPLETED|Overall Study||0
7544812|NCT03198507|18570514|P1|NOT COMPLETED|Overall Study||1
7544813|NCT03198507|18570513|P2|COMPLETED|Overall Study||227
7544814|NCT03198507|18570514|P1|COMPLETED|Overall Study||227
7544815|NCT03198507|18570513|P2|STARTED|Overall Study||227
7544816|NCT03198507|18570514|P1|STARTED|Overall Study||228
7544817|NCT03198000|18570529|P3|NOT COMPLETED|Overall Study||0
7544818|NCT03198000|18570530|P2|NOT COMPLETED|Overall Study||0
7544819|NCT03198000|18570531|P1|NOT COMPLETED|Overall Study||0
7544820|NCT03198000|18570529|P3|COMPLETED|Overall Study||41
7544821|NCT03198000|18570530|P2|COMPLETED|Overall Study||38
7544822|NCT03198000|18570531|P1|COMPLETED|Overall Study||41
7544823|NCT03198000|18570529|P3|STARTED|Overall Study||41
7544824|NCT03198000|18570530|P2|STARTED|Overall Study||38
7544825|NCT03198000|18570531|P1|STARTED|Overall Study||41
7544826|NCT03197883|18570640|P2|NOT COMPLETED|Overall Study||6
7544827|NCT03197883|18570641|P1|NOT COMPLETED|Overall Study||3
7544828|NCT03197883|18570640|P2|COMPLETED|Overall Study||44
7544829|NCT03197883|18570641|P1|COMPLETED|Overall Study||47
7544830|NCT03197883|18570640|P2|STARTED|Overall Study||50
7544831|NCT03197883|18570641|P1|STARTED|Overall Study||50
7544832|NCT03197558|18570671|P1|NOT COMPLETED|Overall Study||1
7544833|NCT03197558|18570671|P1|COMPLETED|Overall Study||29
7544834|NCT03197558|18570671|P1|STARTED|Overall Study||30
7544835|NCT03197376|18570679|P4|NOT COMPLETED|Immune Persistence Phase||5
7544836|NCT03197376|18570680|P3|NOT COMPLETED|Immune Persistence Phase||5
7544837|NCT03197376|18570681|P2|NOT COMPLETED|Immune Persistence Phase||4
7544838|NCT03197376|18570682|P1|NOT COMPLETED|Immune Persistence Phase||5
7544839|NCT03197376|18570679|P4|COMPLETED|Immune Persistence Phase||190
7544840|NCT03197376|18570680|P3|COMPLETED|Immune Persistence Phase||123
7544841|NCT03197376|18570681|P2|COMPLETED|Immune Persistence Phase||129
7544842|NCT03197376|18570682|P1|COMPLETED|Immune Persistence Phase||127
7544843|NCT03197376|18570679|P4|STARTED|Immune Persistence Phase||195
7544844|NCT03197376|18570680|P3|STARTED|Immune Persistence Phase||128
7544845|NCT03197376|18570681|P2|STARTED|Immune Persistence Phase||133
7544846|NCT03197376|18570682|P1|STARTED|Immune Persistence Phase||132
7544847|NCT03197376|18570679|P4|NOT COMPLETED|Primary and Booster Phase||25
7544848|NCT03197376|18570680|P3|NOT COMPLETED|Primary and Booster Phase||20
7544849|NCT03197376|18570681|P2|NOT COMPLETED|Primary and Booster Phase||13
7544850|NCT03197376|18570682|P1|NOT COMPLETED|Primary and Booster Phase||15
7544851|NCT03197376|18570679|P4|COMPLETED|Primary and Booster Phase||722
7544852|NCT03197376|18570680|P3|COMPLETED|Primary and Booster Phase||480
7544853|NCT03197376|18570681|P2|COMPLETED|Primary and Booster Phase||488
7544854|NCT03197376|18570682|P1|COMPLETED|Primary and Booster Phase||487
7544855|NCT03197376|18570679|P4|Received Booster Vaccine|Primary and Booster Phase||213
7544856|NCT03197376|18570680|P3|Received Booster Vaccine|Primary and Booster Phase||139
7544857|NCT03197376|18570681|P2|Received Booster Vaccine|Primary and Booster Phase||144
7544858|NCT03197376|18570682|P1|Received Booster Vaccine|Primary and Booster Phase||145
7544859|NCT03197376|18570679|P4|Booster Cohort|Primary and Booster Phase||224
7544860|NCT03197376|18570680|P3|Booster Cohort|Primary and Booster Phase||150
7544861|NCT03197376|18570681|P2|Booster Cohort|Primary and Booster Phase||151
7544862|NCT03197376|18570682|P1|Booster Cohort|Primary and Booster Phase||150
7544863|NCT03197376|18570679|P4|Primary Reactogenicity Cohort|Primary and Booster Phase||364
7544864|NCT03197376|18570680|P3|Primary Reactogenicity Cohort|Primary and Booster Phase||257
7544865|NCT03197376|18570681|P2|Primary Reactogenicity Cohort|Primary and Booster Phase||243
7544866|NCT03197376|18570682|P1|Primary Reactogenicity Cohort|Primary and Booster Phase||251
7544867|NCT03197376|18570679|P4|Vaccinated-Dose 3|Primary and Booster Phase||731
7544868|NCT03197376|18570680|P3|Vaccinated-Dose 3|Primary and Booster Phase||490
7544869|NCT03197376|18570681|P2|Vaccinated-Dose 3|Primary and Booster Phase||493
7544870|NCT03197376|18570682|P1|Vaccinated-Dose 3|Primary and Booster Phase||492
7544871|NCT03197376|18570679|P4|Vaccinated-Dose 2|Primary and Booster Phase||738
7544872|NCT03197376|18570680|P3|Vaccinated-Dose 2|Primary and Booster Phase||491
7544873|NCT03197376|18570681|P2|Vaccinated-Dose 2|Primary and Booster Phase||495
7544874|NCT03197376|18570682|P1|Vaccinated-Dose 2|Primary and Booster Phase||495
7544875|NCT03197376|18570679|P4|Vaccinated-Dose 1|Primary and Booster Phase||747
7544876|NCT03197376|18570680|P3|Vaccinated-Dose 1|Primary and Booster Phase||500
7544877|NCT03197376|18570681|P2|Vaccinated-Dose 1|Primary and Booster Phase||501
7544878|NCT03197376|18570682|P1|Vaccinated-Dose 1|Primary and Booster Phase||502
7544879|NCT03197376|18570679|P4|STARTED|Primary and Booster Phase||747
7544880|NCT03197376|18570680|P3|STARTED|Primary and Booster Phase||500
7544881|NCT03197376|18570681|P2|STARTED|Primary and Booster Phase||501
7544882|NCT03197376|18570682|P1|STARTED|Primary and Booster Phase||502
7544883|NCT03197025|18570749|P1|NOT COMPLETED|Overall Study||0
7544884|NCT03197025|18570749|P1|COMPLETED|Overall Study||1
7544885|NCT03197025|18570749|P1|STARTED|Overall Study||1
7544886|NCT03196635|18570756|P1|NOT COMPLETED|Overall Study||1
7544887|NCT03196635|18570756|P1|COMPLETED|Overall Study||30
7544888|NCT03196635|18570756|P1|STARTED|Overall Study||31
7544889|NCT03196505|18570776|P2|NOT COMPLETED|Overall Study||26
7544890|NCT03196505|18570777|P1|NOT COMPLETED|Overall Study||26
7544891|NCT03196505|18570776|P2|COMPLETED|Overall Study||90
7544892|NCT03196505|18570777|P1|COMPLETED|Overall Study||89
7544893|NCT03196505|18570776|P2|STARTED|Overall Study||116
7544894|NCT03196505|18570777|P1|STARTED|Overall Study||115
7544895|NCT03196349|18570788|P3|NOT COMPLETED|Overall Study||13
7544896|NCT03196349|18570789|P2|NOT COMPLETED|Overall Study||14
7544897|NCT03196349|18570790|P1|NOT COMPLETED|Overall Study||17
7544898|NCT03196349|18570788|P3|COMPLETED|Overall Study||0
7544899|NCT03196349|18570789|P2|COMPLETED|Overall Study||0
7544900|NCT03196349|18570790|P1|COMPLETED|Overall Study||0
7544901|NCT03196349|18570788|P3|STARTED|Overall Study||13
7544902|NCT03196349|18570789|P2|STARTED|Overall Study||14
7544903|NCT03196349|18570790|P1|STARTED|Overall Study||17
7544904|NCT03196232|18570816|P1|NOT COMPLETED|Overall Study||0
7544905|NCT03196232|18570816|P1|COMPLETED|Overall Study||3
7544906|NCT03196232|18570816|P1|STARTED|Overall Study||3
7544907|NCT03196193|18570827|P2|NOT COMPLETED|Overall Study||0
7544908|NCT03196193|18570828|P1|NOT COMPLETED|Overall Study||3
7544909|NCT03196193|18570827|P2|COMPLETED|Overall Study||119
7544910|NCT03196193|18570828|P1|COMPLETED|Overall Study||118
7544911|NCT03196193|18570827|P2|STARTED|Overall Study||119
7544912|NCT03196193|18570828|P1|STARTED|Overall Study||121
7544913|NCT03195517|18570840|P1|NOT COMPLETED|Overall Study||0
7544914|NCT03195517|18570840|P1|COMPLETED|Overall Study||33
7544915|NCT03195517|18570840|P1|STARTED|Overall Study||33
7544916|NCT03195010|18570855|P2|NOT COMPLETED|Overall Study||0
7544917|NCT03195010|18570856|P1|NOT COMPLETED|Overall Study||0
7544918|NCT03195010|18570855|P2|COMPLETED|Overall Study||2
7544919|NCT03195010|18570856|P1|COMPLETED|Overall Study||2
7544920|NCT03195010|18570855|P2|STARTED|Overall Study||2
7544921|NCT03195010|18570856|P1|STARTED|Overall Study||2
7544922|NCT03194776|18570883|P2|NOT COMPLETED|Overall Study||0
7544923|NCT03194776|18570884|P1|NOT COMPLETED|Overall Study||0
7544924|NCT03194776|18570883|P2|COMPLETED|Overall Study||23
7544925|NCT03194776|18570884|P1|COMPLETED|Overall Study||23
7544926|NCT03194776|18570883|P2|STARTED|Overall Study||23
7544927|NCT03194776|18570884|P1|STARTED|Overall Study||23
7544928|NCT03194698|18570902|P2|NOT COMPLETED|Overall Study||0
7544929|NCT03194698|18570903|P1|NOT COMPLETED|Overall Study||0
7544930|NCT03194698|18570902|P2|COMPLETED|Overall Study||10
7544931|NCT03194698|18570903|P1|COMPLETED|Overall Study||10
7544932|NCT03194698|18570902|P2|STARTED|Overall Study||10
7544933|NCT03194698|18570903|P1|STARTED|Overall Study||10
7544934|NCT03194503|18570915|P2|NOT COMPLETED|Overall Study||0
7544935|NCT03194503|18570916|P1|NOT COMPLETED|Overall Study||0
7544936|NCT03194503|18570915|P2|COMPLETED|Overall Study||1054
7544937|NCT03194503|18570916|P1|COMPLETED|Overall Study||458
7544938|NCT03194503|18570915|P2|STARTED|Overall Study||1054
7544939|NCT03194503|18570916|P1|STARTED|Overall Study||458
7544940|NCT03194490|18570926|P2|NOT COMPLETED|Overall Study||3
7544941|NCT03194490|18570927|P1|NOT COMPLETED|Overall Study||2
7544942|NCT03194490|18570926|P2|COMPLETED|Overall Study||20
7544943|NCT03194490|18570927|P1|COMPLETED|Overall Study||18
7544944|NCT03194490|18570926|P2|STARTED|Overall Study||23
7544945|NCT03194490|18570927|P1|STARTED|Overall Study||20
7544946|NCT03194464|18570969|P1|NOT COMPLETED|Overall Study||2
7544947|NCT03194464|18570969|P1|COMPLETED|Overall Study||13
7544948|NCT03194464|18570969|P1|STARTED|Overall Study||15
7544949|NCT03194373|18570976|P1|NOT COMPLETED|Overall Study||2
7544950|NCT03194373|18570976|P1|COMPLETED|Overall Study||18
7544951|NCT03194373|18570976|P1|STARTED|Overall Study||20
7544952|NCT03194334|18570983|P3|NOT COMPLETED|3-6 Months||0
7544953|NCT03194334|18570984|P2|NOT COMPLETED|3-6 Months||0
7544954|NCT03194334|18570985|P1|NOT COMPLETED|3-6 Months||0
7544955|NCT03194334|18570983|P3|COMPLETED|3-6 Months||14
7544956|NCT03194334|18570984|P2|COMPLETED|3-6 Months||15
7544957|NCT03194334|18570985|P1|COMPLETED|3-6 Months||10
7544958|NCT03194334|18570983|P3|STARTED|3-6 Months||14
7544959|NCT03194334|18570984|P2|STARTED|3-6 Months||15
7544960|NCT03194334|18570985|P1|STARTED|3-6 Months||10
7544961|NCT03194334|18570983|P3|NOT COMPLETED|0-3 Months||1
7544962|NCT03194334|18570984|P2|NOT COMPLETED|0-3 Months||0
7544963|NCT03194334|18570985|P1|NOT COMPLETED|0-3 Months||0
7544964|NCT03194334|18570983|P3|COMPLETED|0-3 Months||14
7544965|NCT03194334|18570984|P2|COMPLETED|0-3 Months||15
7544966|NCT03194334|18570985|P1|COMPLETED|0-3 Months||10
7544967|NCT03194334|18570983|P3|STARTED|0-3 Months||15
7544968|NCT03194334|18570984|P2|STARTED|0-3 Months||15
7544969|NCT03194334|18570985|P1|STARTED|0-3 Months||10
7544970|NCT03194217|18571060|P4|NOT COMPLETED|Overall Study||4
7544971|NCT03194217|18571061|P3|NOT COMPLETED|Overall Study||4
7544972|NCT03194217|18571062|P2|NOT COMPLETED|Overall Study||3
7544973|NCT03194217|18571063|P1|NOT COMPLETED|Overall Study||0
7544974|NCT03194217|18571060|P4|COMPLETED|Overall Study||60
7544975|NCT03194217|18571061|P3|COMPLETED|Overall Study||56
7544976|NCT03194217|18571062|P2|COMPLETED|Overall Study||57
7544977|NCT03194217|18571063|P1|COMPLETED|Overall Study||60
7544978|NCT03194217|18571060|P4|STARTED|Overall Study||64
7544979|NCT03194217|18571061|P3|STARTED|Overall Study||60
7544980|NCT03194217|18571062|P2|STARTED|Overall Study||60
7544981|NCT03194217|18571063|P1|STARTED|Overall Study||60
7544982|NCT03193593|18571080|P7|NOT COMPLETED|Overall Study||4
7544983|NCT03193593|18571081|P6|NOT COMPLETED|Overall Study||3
7544984|NCT03193593|18571082|P5|NOT COMPLETED|Overall Study||1
7544985|NCT03193593|18571083|P4|NOT COMPLETED|Overall Study||0
7544986|NCT03193593|18571084|P3|NOT COMPLETED|Overall Study||1
7544987|NCT03193593|18571085|P2|NOT COMPLETED|Overall Study||1
7544988|NCT03193593|18571086|P1|NOT COMPLETED|Overall Study||4
7544989|NCT03193593|18571080|P7|COMPLETED|Overall Study||8
7544990|NCT03193593|18571081|P6|COMPLETED|Overall Study||13
7544991|NCT03193593|18571082|P5|COMPLETED|Overall Study||7
7544992|NCT03193593|18571083|P4|COMPLETED|Overall Study||4
7544993|NCT03193593|18571084|P3|COMPLETED|Overall Study||3
7544994|NCT03193593|18571085|P2|COMPLETED|Overall Study||3
7544995|NCT03193593|18571086|P1|COMPLETED|Overall Study||14
7544996|NCT03193593|18571080|P7|STARTED|Overall Study||12
7544997|NCT03193593|18571081|P6|STARTED|Overall Study||16
7544998|NCT03193593|18571082|P5|STARTED|Overall Study||8
7544999|NCT03193593|18571083|P4|STARTED|Overall Study||4
7545000|NCT03193593|18571084|P3|STARTED|Overall Study||4
7545001|NCT03193593|18571085|P2|STARTED|Overall Study||4
7545002|NCT03193593|18571086|P1|STARTED|Overall Study||18
7545003|NCT03193047|18571104|P2|NOT COMPLETED|Overall Study||0
7545004|NCT03193047|18571105|P1|NOT COMPLETED|Overall Study||2
7545005|NCT03193047|18571104|P2|COMPLETED|Overall Study||28
7545006|NCT03193047|18571105|P1|COMPLETED|Overall Study||29
7545007|NCT03193047|18571104|P2|STARTED|Overall Study||28
7545008|NCT03193047|18571105|P1|STARTED|Overall Study||31
7545009|NCT03193021|18571125|P2|NOT COMPLETED|Overall Study||1
7545010|NCT03193021|18571126|P1|NOT COMPLETED|Overall Study||1
7545011|NCT03193021|18571125|P2|COMPLETED|Overall Study||103
7545012|NCT03193021|18571126|P1|COMPLETED|Overall Study||99
7545013|NCT03193021|18571125|P2|STARTED|Overall Study||104
7545014|NCT03193021|18571126|P1|STARTED|Overall Study||100
7545015|NCT03192904|18571151|P2|NOT COMPLETED|Overall Study||2
7545016|NCT03192904|18571152|P1|NOT COMPLETED|Overall Study||3
7545017|NCT03192904|18571151|P2|COMPLETED|Overall Study||33
7545018|NCT03192904|18571152|P1|COMPLETED|Overall Study||32
7545019|NCT03192904|18571151|P2|STARTED|Overall Study||35
7545020|NCT03192904|18571152|P1|STARTED|Overall Study||35
7545021|NCT03192826|18571189|P3|NOT COMPLETED|Overall Study||0
7545022|NCT03192826|18571190|P2|NOT COMPLETED|Overall Study||0
7545023|NCT03192826|18571191|P1|NOT COMPLETED|Overall Study||0
7545024|NCT03192826|18571189|P3|COMPLETED|Overall Study||25
7545025|NCT03192826|18571190|P2|COMPLETED|Overall Study||27
7545026|NCT03192826|18571191|P1|COMPLETED|Overall Study||27
7545027|NCT03192826|18571189|P3|STARTED|Overall Study||25
7545028|NCT03192826|18571190|P2|STARTED|Overall Study||27
7545029|NCT03192826|18571191|P1|STARTED|Overall Study||27
7545030|NCT03192488|18571208|P6|NOT COMPLETED|Third Intervention (d1)||0
7545031|NCT03192488|18571209|P5|NOT COMPLETED|Third Intervention (d1)||1
7545032|NCT03192488|18571210|P4|NOT COMPLETED|Third Intervention (d1)||0
7545033|NCT03192488|18571211|P3|NOT COMPLETED|Third Intervention (d1)||0
7545034|NCT03192488|18571212|P2|NOT COMPLETED|Third Intervention (d1)||0
7545035|NCT03192488|18571213|P1|NOT COMPLETED|Third Intervention (d1)||0
7545036|NCT03192488|18571208|P6|COMPLETED|Third Intervention (d1)||0
7545037|NCT03192488|18571209|P5|COMPLETED|Third Intervention (d1)||0
7545038|NCT03192488|18571210|P4|COMPLETED|Third Intervention (d1)||1
7545039|NCT03192488|18571211|P3|COMPLETED|Third Intervention (d1)||1
7545040|NCT03192488|18571212|P2|COMPLETED|Third Intervention (d1)||5
7545041|NCT03192488|18571213|P1|COMPLETED|Third Intervention (d1)||1
7545042|NCT03192488|18571208|P6|STARTED|Third Intervention (d1)||0
7545043|NCT03192488|18571209|P5|STARTED|Third Intervention (d1)||1
7545044|NCT03192488|18571210|P4|STARTED|Third Intervention (d1)||1
7545045|NCT03192488|18571211|P3|STARTED|Third Intervention (d1)||1
7545046|NCT03192488|18571212|P2|STARTED|Third Intervention (d1)||5
7545047|NCT03192488|18571213|P1|STARTED|Third Intervention (d1)||1
7545048|NCT03192488|18571208|P6|NOT COMPLETED|Second Washout (>6d)||0
7545049|NCT03192488|18571209|P5|NOT COMPLETED|Second Washout (>6d)||0
7545050|NCT03192488|18571210|P4|NOT COMPLETED|Second Washout (>6d)||0
7545051|NCT03192488|18571211|P3|NOT COMPLETED|Second Washout (>6d)||0
7545052|NCT03192488|18571212|P2|NOT COMPLETED|Second Washout (>6d)||0
7545053|NCT03192488|18571213|P1|NOT COMPLETED|Second Washout (>6d)||0
7545054|NCT03192488|18571208|P6|COMPLETED|Second Washout (>6d)||0
7545055|NCT03192488|18571209|P5|COMPLETED|Second Washout (>6d)||1
7545056|NCT03192488|18571210|P4|COMPLETED|Second Washout (>6d)||1
7545057|NCT03192488|18571211|P3|COMPLETED|Second Washout (>6d)||1
7545058|NCT03192488|18571212|P2|COMPLETED|Second Washout (>6d)||5
7545059|NCT03192488|18571213|P1|COMPLETED|Second Washout (>6d)||1
7545060|NCT03192488|18571208|P6|STARTED|Second Washout (>6d)||0
7545061|NCT03192488|18571209|P5|STARTED|Second Washout (>6d)||1
7545062|NCT03192488|18571210|P4|STARTED|Second Washout (>6d)||1
7545063|NCT03192488|18571211|P3|STARTED|Second Washout (>6d)||1
7545064|NCT03192488|18571212|P2|STARTED|Second Washout (>6d)||5
7545065|NCT03192488|18571213|P1|STARTED|Second Washout (>6d)||1
7545066|NCT03192488|18571208|P6|NOT COMPLETED|Second Intervention (d1)||0
7545067|NCT03192488|18571209|P5|NOT COMPLETED|Second Intervention (d1)||0
7545068|NCT03192488|18571210|P4|NOT COMPLETED|Second Intervention (d1)||0
7545069|NCT03192488|18571211|P3|NOT COMPLETED|Second Intervention (d1)||0
7545070|NCT03192488|18571212|P2|NOT COMPLETED|Second Intervention (d1)||0
7545071|NCT03192488|18571213|P1|NOT COMPLETED|Second Intervention (d1)||0
7545072|NCT03192488|18571208|P6|COMPLETED|Second Intervention (d1)||0
7545073|NCT03192488|18571209|P5|COMPLETED|Second Intervention (d1)||1
7545074|NCT03192488|18571210|P4|COMPLETED|Second Intervention (d1)||1
7545075|NCT03192488|18571211|P3|COMPLETED|Second Intervention (d1)||1
7545076|NCT03192488|18571212|P2|COMPLETED|Second Intervention (d1)||5
7545077|NCT03192488|18571213|P1|COMPLETED|Second Intervention (d1)||1
7545078|NCT03192488|18571208|P6|STARTED|Second Intervention (d1)||0
7545079|NCT03192488|18571209|P5|STARTED|Second Intervention (d1)||1
7545080|NCT03192488|18571210|P4|STARTED|Second Intervention (d1)||1
7545081|NCT03192488|18571211|P3|STARTED|Second Intervention (d1)||1
7545082|NCT03192488|18571212|P2|STARTED|Second Intervention (d1)||5
7545083|NCT03192488|18571213|P1|STARTED|Second Intervention (d1)||1
7545084|NCT03192488|18571208|P6|NOT COMPLETED|First Washout (>6d)||1
7545085|NCT03192488|18571209|P5|NOT COMPLETED|First Washout (>6d)||0
7545086|NCT03192488|18571210|P4|NOT COMPLETED|First Washout (>6d)||0
7545087|NCT03192488|18571211|P3|NOT COMPLETED|First Washout (>6d)||1
7545088|NCT03192488|18571212|P2|NOT COMPLETED|First Washout (>6d)||0
7545089|NCT03192488|18571213|P1|NOT COMPLETED|First Washout (>6d)||0
7545090|NCT03192488|18571208|P6|COMPLETED|First Washout (>6d)||0
7545091|NCT03192488|18571209|P5|COMPLETED|First Washout (>6d)||1
7545092|NCT03192488|18571210|P4|COMPLETED|First Washout (>6d)||1
7545093|NCT03192488|18571211|P3|COMPLETED|First Washout (>6d)||1
7545094|NCT03192488|18571212|P2|COMPLETED|First Washout (>6d)||5
7545095|NCT03192488|18571213|P1|COMPLETED|First Washout (>6d)||1
7545096|NCT03192488|18571208|P6|STARTED|First Washout (>6d)||1
7545097|NCT03192488|18571209|P5|STARTED|First Washout (>6d)||1
7545098|NCT03192488|18571210|P4|STARTED|First Washout (>6d)||1
7545099|NCT03192488|18571211|P3|STARTED|First Washout (>6d)||2
7545100|NCT03192488|18571212|P2|STARTED|First Washout (>6d)||5
7545101|NCT03192488|18571213|P1|STARTED|First Washout (>6d)||1
7545102|NCT03192488|18571208|P6|NOT COMPLETED|First Intervention (d1)||0
7545103|NCT03192488|18571209|P5|NOT COMPLETED|First Intervention (d1)||0
7545104|NCT03192488|18571210|P4|NOT COMPLETED|First Intervention (d1)||0
7545105|NCT03192488|18571211|P3|NOT COMPLETED|First Intervention (d1)||0
7545106|NCT03192488|18571212|P2|NOT COMPLETED|First Intervention (d1)||0
7545107|NCT03192488|18571213|P1|NOT COMPLETED|First Intervention (d1)||0
7545108|NCT03192488|18571208|P6|COMPLETED|First Intervention (d1)||1
7545109|NCT03192488|18571209|P5|COMPLETED|First Intervention (d1)||1
7545110|NCT03192488|18571210|P4|COMPLETED|First Intervention (d1)||1
7545111|NCT03192488|18571211|P3|COMPLETED|First Intervention (d1)||2
7545112|NCT03192488|18571212|P2|COMPLETED|First Intervention (d1)||5
7545113|NCT03192488|18571213|P1|COMPLETED|First Intervention (d1)||1
7545114|NCT03192488|18571208|P6|STARTED|First Intervention (d1)||1
7545115|NCT03192488|18571209|P5|STARTED|First Intervention (d1)||1
7545116|NCT03192488|18571210|P4|STARTED|First Intervention (d1)||1
7545117|NCT03192488|18571211|P3|STARTED|First Intervention (d1)||2
7545118|NCT03192488|18571212|P2|STARTED|First Intervention (d1)||5
7545119|NCT03192488|18571213|P1|STARTED|First Intervention (d1)||1
7545120|NCT03192475|18571229|P2|NOT COMPLETED|Overall Study||9
7545121|NCT03192475|18571230|P1|NOT COMPLETED|Overall Study||13
7545122|NCT03192475|18571229|P2|COMPLETED|Overall Study||151
7545123|NCT03192475|18571230|P1|COMPLETED|Overall Study||149
7545124|NCT03192475|18571229|P2|STARTED|Overall Study||160
7545125|NCT03192475|18571230|P1|STARTED|Overall Study||162
7545126|NCT03192306|18571266|P2|NOT COMPLETED|Overall Study||145
7545127|NCT03192306|18571267|P1|NOT COMPLETED|Overall Study||152
7545128|NCT03192306|18571266|P2|COMPLETED|Overall Study||79
7545129|NCT03192306|18571267|P1|COMPLETED|Overall Study||75
7545130|NCT03192306|18571266|P2|Modified Intent to Treat (MITT)|Overall Study||80
7545131|NCT03192306|18571267|P1|Modified Intent to Treat (MITT)|Overall Study||76
7545132|NCT03192306|18571266|P2|STARTED|Overall Study||224
7545133|NCT03192306|18571267|P1|STARTED|Overall Study||227
7545134|NCT03192137|18571287|P2|NOT COMPLETED|Overall Study||58
7545135|NCT03192137|18571288|P1|NOT COMPLETED|Overall Study||50
7545136|NCT03192137|18571287|P2|COMPLETED|Overall Study||29
7545137|NCT03192137|18571288|P1|COMPLETED|Overall Study||123
7545138|NCT03192137|18571287|P2|STARTED|Overall Study||87
7545139|NCT03192137|18571288|P1|STARTED|Overall Study||173
7545140|NCT03191552|18571299|P3|NOT COMPLETED|Overall Study||0
7545141|NCT03191552|18571300|P2|NOT COMPLETED|Overall Study||1
7545142|NCT03191552|18571301|P1|NOT COMPLETED|Overall Study||1
7545143|NCT03191552|18571299|P3|COMPLETED|Overall Study||8
7545144|NCT03191552|18571300|P2|COMPLETED|Overall Study||8
7545145|NCT03191552|18571301|P1|COMPLETED|Overall Study||8
7545146|NCT03191552|18571299|P3|STARTED|Overall Study||8
7545147|NCT03191552|18571300|P2|STARTED|Overall Study||9
7545148|NCT03191552|18571301|P1|STARTED|Overall Study||9
7545149|NCT03191396|18571354|P2|NOT COMPLETED|Overall Study||5
7545150|NCT03191396|18571355|P1|NOT COMPLETED|Overall Study||3
7545151|NCT03191396|18571354|P2|COMPLETED|Overall Study||282
7545152|NCT03191396|18571355|P1|COMPLETED|Overall Study||287
7545153|NCT03191396|18571354|P2|STARTED|Overall Study||287
7545154|NCT03191396|18571355|P1|STARTED|Overall Study||290
7545155|NCT03190993|18571443|P2|NOT COMPLETED|Overall Study||0
7545156|NCT03190993|18571444|P1|NOT COMPLETED|Overall Study||0
7545157|NCT03190993|18571443|P2|COMPLETED|Overall Study||10
7545158|NCT03190993|18571444|P1|COMPLETED|Overall Study||10
7545159|NCT03190993|18571443|P2|STARTED|Overall Study||10
7545160|NCT03190993|18571444|P1|STARTED|Overall Study||10
7545161|NCT03190369|18571452|P2|NOT COMPLETED|Overall Study||8
7545162|NCT03190369|18571453|P1|NOT COMPLETED|Overall Study||1
7545163|NCT03190369|18571452|P2|COMPLETED|Overall Study||212
7545164|NCT03190369|18571453|P1|COMPLETED|Overall Study||219
7545165|NCT03190369|18571452|P2|Treated|Overall Study||218
7545166|NCT03190369|18571453|P1|Treated|Overall Study||220
7545167|NCT03190369|18571452|P2|STARTED|Overall Study||220
7545168|NCT03190369|18571453|P1|STARTED|Overall Study||220
7545169|NCT03190213|18571471|P1|NOT COMPLETED|Overall Study||0
7545170|NCT03190213|18571471|P1|COMPLETED|Overall Study||6
7545171|NCT03190213|18571471|P1|STARTED|Overall Study||6
7545172|NCT03190083|18571479|P1|NOT COMPLETED|Overall Study||0
7545173|NCT03190083|18571479|P1|COMPLETED|Overall Study||16
7545174|NCT03190083|18571479|P1|STARTED|Overall Study||16
7545175|NCT03190005|18571490|P7|NOT COMPLETED|Overall Study||0
7545176|NCT03190005|18571491|P6|NOT COMPLETED|Overall Study||0
7545177|NCT03190005|18571492|P5|NOT COMPLETED|Overall Study||0
7545178|NCT03190005|18571493|P4|NOT COMPLETED|Overall Study||0
7545179|NCT03190005|18571494|P3|NOT COMPLETED|Overall Study||0
7545180|NCT03190005|18571495|P2|NOT COMPLETED|Overall Study||0
7545181|NCT03190005|18571496|P1|NOT COMPLETED|Overall Study||0
7545182|NCT03190005|18571490|P7|COMPLETED|Overall Study||5
7545183|NCT03190005|18571491|P6|COMPLETED|Overall Study||5
7545184|NCT03190005|18571492|P5|COMPLETED|Overall Study||5
7545185|NCT03190005|18571493|P4|COMPLETED|Overall Study||5
7545186|NCT03190005|18571494|P3|COMPLETED|Overall Study||5
7545187|NCT03190005|18571495|P2|COMPLETED|Overall Study||5
7545188|NCT03190005|18571496|P1|COMPLETED|Overall Study||5
7545189|NCT03190005|18571490|P7|STARTED|Overall Study||5
7545190|NCT03190005|18571491|P6|STARTED|Overall Study||5
7545191|NCT03190005|18571492|P5|STARTED|Overall Study||5
7545192|NCT03190005|18571493|P4|STARTED|Overall Study||5
7545193|NCT03190005|18571494|P3|STARTED|Overall Study||5
7545194|NCT03190005|18571495|P2|STARTED|Overall Study||5
7545195|NCT03190005|18571496|P1|STARTED|Overall Study||5
7545196|NCT03189745|18571514|P2|NOT COMPLETED|Overall Study||1
7545197|NCT03189745|18571515|P1|NOT COMPLETED|Overall Study||1
7545198|NCT03189745|18571514|P2|COMPLETED|Overall Study||58
7545199|NCT03189745|18571515|P1|COMPLETED|Overall Study||169
7545200|NCT03189745|18571514|P2|STARTED|Overall Study||59
7545201|NCT03189745|18571515|P1|STARTED|Overall Study||170
7545202|NCT03189589|18571543|P2|NOT COMPLETED|Overall Study||0
7545203|NCT03189589|18571544|P1|NOT COMPLETED|Overall Study||0
7545204|NCT03189589|18571543|P2|COMPLETED|Overall Study||6
7545205|NCT03189589|18571544|P1|COMPLETED|Overall Study||6
7545206|NCT03189589|18571543|P2|STARTED|Overall Study||6
7545207|NCT03189589|18571544|P1|STARTED|Overall Study||6
7545208|NCT03189134|18571568|P1|NOT COMPLETED|Overall Study||0
7545209|NCT03189134|18571568|P1|COMPLETED|Overall Study||6
7545210|NCT03189134|18571568|P1|STARTED|Overall Study||6
7545211|NCT03188536|18571574|P1|NOT COMPLETED|Overall Study||6
7545212|NCT03188536|18571574|P1|COMPLETED|Overall Study||276
7545213|NCT03188536|18571574|P1|STARTED|Overall Study||282
7545214|NCT03188523|18571588|P4|NOT COMPLETED|Overall Study||0
7545215|NCT03188523|18571589|P3|NOT COMPLETED|Overall Study||0
7545216|NCT03188523|18571590|P2|NOT COMPLETED|Overall Study||0
7545217|NCT03188523|18571591|P1|NOT COMPLETED|Overall Study||0
7545218|NCT03188523|18571588|P4|COMPLETED|Overall Study||0
7545219|NCT03188523|18571589|P3|COMPLETED|Overall Study||0
7545220|NCT03188523|18571590|P2|COMPLETED|Overall Study||6
7545221|NCT03188523|18571591|P1|COMPLETED|Overall Study||6
7545222|NCT03188523|18571588|P4|STARTED|Overall Study||0
7545223|NCT03188523|18571589|P3|STARTED|Overall Study||0
7545224|NCT03188523|18571590|P2|STARTED|Overall Study||6
7545225|NCT03188523|18571591|P1|STARTED|Overall Study||6
7545226|NCT03188263|18571643|P2|NOT COMPLETED|Overall Study||0
7545227|NCT03188263|18571644|P1|NOT COMPLETED|Overall Study||4
7545228|NCT03188263|18571643|P2|COMPLETED|Overall Study||0
7545229|NCT03188263|18571644|P1|COMPLETED|Overall Study||6
7545230|NCT03188263|18571643|P2|STARTED|Overall Study||0
7545231|NCT03188263|18571644|P1|STARTED|Overall Study||10
7545232|NCT03188120|18571652|P1|NOT COMPLETED|Overall Study||47
7545233|NCT03188120|18571652|P1|COMPLETED|Overall Study||146
7545234|NCT03188120|18571652|P1|STARTED|Overall Study||193
7545235|NCT03188055|18571659|P6|NOT COMPLETED|Overall Study||0
7545236|NCT03188055|18571660|P5|NOT COMPLETED|Overall Study||0
7545237|NCT03188055|18571661|P4|NOT COMPLETED|Overall Study||12
7545238|NCT03188055|18571662|P3|NOT COMPLETED|Overall Study||19
7545239|NCT03188055|18571663|P2|NOT COMPLETED|Overall Study||19
7545240|NCT03188055|18571664|P1|NOT COMPLETED|Overall Study||0
7545241|NCT03188055|18571659|P6|COMPLETED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|0
7545242|NCT03188055|18571660|P5|COMPLETED|Overall Study||59
7545243|NCT03188055|18571661|P4|COMPLETED|Overall Study||26
7545244|NCT03188055|18571662|P3|COMPLETED|Overall Study||43
7545245|NCT03188055|18571663|P2|COMPLETED|Overall Study||29
7545246|NCT03188055|18571664|P1|COMPLETED|Overall Study||48
7545247|NCT03188055|18571659|P6|Family Survey 3|Overall Study||0
7545248|NCT03188055|18571660|P5|Family Survey 3|Overall Study||0
7545249|NCT03188055|18571661|P4|Family Survey 3|Overall Study||26
7545250|NCT03188055|18571662|P3|Family Survey 3|Overall Study||0
7545251|NCT03188055|18571663|P2|Family Survey 3|Overall Study||29
7545252|NCT03188055|18571664|P1|Family Survey 3|Overall Study||0
7545253|NCT03188055|18571659|P6|Family Survey 2|Overall Study||0
7545254|NCT03188055|18571660|P5|Family Survey 2|Overall Study||0
7545255|NCT03188055|18571661|P4|Family Survey 2|Overall Study||35
7545256|NCT03188055|18571662|P3|Family Survey 2|Overall Study||0
7545257|NCT03188055|18571663|P2|Family Survey 2|Overall Study||34
7545258|NCT03188055|18571664|P1|Family Survey 2|Overall Study||0
7545259|NCT03188055|18571659|P6|Family Survey 1|Overall Study||0
7545260|NCT03188055|18571660|P5|Family Survey 1|Overall Study||0
7545261|NCT03188055|18571661|P4|Family Survey 1|Overall Study||38
7545262|NCT03188055|18571662|P3|Family Survey 1|Overall Study||0
7545263|NCT03188055|18571663|P2|Family Survey 1|Overall Study||37
7545264|NCT03188055|18571664|P1|Family Survey 1|Overall Study||0
7545265|NCT03188055|18571659|P6|Nurse Survey 1|Overall Study||0
7545266|NCT03188055|18571660|P5|Nurse Survey 1|Overall Study||0
7545267|NCT03188055|18571661|P4|Nurse Survey 1|Overall Study||27
7545268|NCT03188055|18571662|P3|Nurse Survey 1|Overall Study||0
7545269|NCT03188055|18571663|P2|Nurse Survey 1|Overall Study||32
7545270|NCT03188055|18571664|P1|Nurse Survey 1|Overall Study||0
7545271|NCT03188055|18571659|P6|Patient Survey 1|Overall Study||0
7545272|NCT03188055|18571660|P5|Patient Survey 1|Overall Study||0
7545273|NCT03188055|18571661|P4|Patient Survey 1|Overall Study||13
7545274|NCT03188055|18571662|P3|Patient Survey 1|Overall Study||0
7545275|NCT03188055|18571663|P2|Patient Survey 1|Overall Study||16
7545276|NCT03188055|18571664|P1|Patient Survey 1|Overall Study||0
7545277|NCT03188055|18571659|P6|MDS Post-Intervention Survey Responses|Overall Study||134
7545278|NCT03188055|18571660|P5|MDS Post-Intervention Survey Responses|Overall Study||0
7545279|NCT03188055|18571661|P4|MDS Post-Intervention Survey Responses|Overall Study||0
7545280|NCT03188055|18571662|P3|MDS Post-Intervention Survey Responses|Overall Study||0
7545281|NCT03188055|18571663|P2|MDS Post-Intervention Survey Responses|Overall Study||0
7545282|NCT03188055|18571664|P1|MDS Post-Intervention Survey Responses|Overall Study||0
7545283|NCT03188055|18571659|P6|MDS Pre-Intervention Survey Responses|Overall Study||99
7545284|NCT03188055|18571660|P5|MDS Pre-Intervention Survey Responses|Overall Study||0
7545285|NCT03188055|18571661|P4|MDS Pre-Intervention Survey Responses|Overall Study||0
7545286|NCT03188055|18571662|P3|MDS Pre-Intervention Survey Responses|Overall Study||0
7545287|NCT03188055|18571663|P2|MDS Pre-Intervention Survey Responses|Overall Study||0
7545288|NCT03188055|18571664|P1|MDS Pre-Intervention Survey Responses|Overall Study||0
7545289|NCT03188055|18571659|P6|Patients Who Provided Self-Consent|Overall Study||0
7545290|NCT03188055|18571660|P5|Patients Who Provided Self-Consent|Overall Study||0
7545291|NCT03188055|18571661|P4|Patients Who Provided Self-Consent|Overall Study||19
7545292|NCT03188055|18571662|P3|Patients Who Provided Self-Consent|Overall Study||0
7545293|NCT03188055|18571663|P2|Patients Who Provided Self-Consent|Overall Study||24
7545294|NCT03188055|18571664|P1|Patients Who Provided Self-Consent|Overall Study||0
7545295|NCT03188055|18571659|P6|STARTED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|0
7545296|NCT03188055|18571660|P5|STARTED|Overall Study||59
7545297|NCT03188055|18571661|P4|STARTED|Overall Study|Family members consented (19/38 had patient enroll along with them as patient had DMC).|38
7545298|NCT03188055|18571662|P3|STARTED|Overall Study||62
7545299|NCT03188055|18571663|P2|STARTED|Overall Study|Family members consented (24/48 had patient enroll along with them as patient had DMC).|48
7545300|NCT03188055|18571664|P1|STARTED|Overall Study||48
7545301|NCT03187756|18571690|P1|NOT COMPLETED|Overall Study||4
7545302|NCT03187756|18571690|P1|COMPLETED|Overall Study||2
7545303|NCT03187756|18571690|P1|STARTED|Overall Study||6
7545304|NCT03187678|18571700|P1|NOT COMPLETED|Period 3 (Oral Selexipag)||0
7545305|NCT03187678|18571700|P1|COMPLETED|Period 3 (Oral Selexipag)||20
7545306|NCT03187678|18571700|P1|STARTED|Period 3 (Oral Selexipag)||20
7545307|NCT03187678|18571700|P1|NOT COMPLETED|Period 2 (Intravenous Selexipag)||0
7545308|NCT03187678|18571700|P1|COMPLETED|Period 2 (Intravenous Selexipag)||20
7545309|NCT03187678|18571700|P1|STARTED|Period 2 (Intravenous Selexipag)||20
7545310|NCT03187678|18571700|P1|NOT COMPLETED|Period 1 (Oral Selexipag)||0
7545311|NCT03187678|18571700|P1|COMPLETED|Period 1 (Oral Selexipag)||20
7545312|NCT03187678|18571700|P1|STARTED|Period 1 (Oral Selexipag)||20
7545313|NCT03187301|18571708|P7|NOT COMPLETED|Third Intervention||0
7545314|NCT03187301|18571709|P6|NOT COMPLETED|Third Intervention||0
7545315|NCT03187301|18571710|P5|NOT COMPLETED|Third Intervention||0
7545316|NCT03187301|18571711|P4|NOT COMPLETED|Third Intervention||0
7545317|NCT03187301|18571712|P3|NOT COMPLETED|Third Intervention||0
7545318|NCT03187301|18571713|P2|NOT COMPLETED|Third Intervention||0
7545319|NCT03187301|18571714|P1|NOT COMPLETED|Third Intervention||0
7545320|NCT03187301|18571708|P7|COMPLETED|Third Intervention||0
7545321|NCT03187301|18571709|P6|COMPLETED|Third Intervention||7
7545322|NCT03187301|18571710|P5|COMPLETED|Third Intervention||7
7545323|NCT03187301|18571711|P4|COMPLETED|Third Intervention||6
7545324|NCT03187301|18571712|P3|COMPLETED|Third Intervention||7
7545325|NCT03187301|18571713|P2|COMPLETED|Third Intervention||7
7545326|NCT03187301|18571714|P1|COMPLETED|Third Intervention||6
7545327|NCT03187301|18571708|P7|STARTED|Third Intervention||0
7545328|NCT03187301|18571709|P6|STARTED|Third Intervention||7
7545329|NCT03187301|18571710|P5|STARTED|Third Intervention||7
7545330|NCT03187301|18571711|P4|STARTED|Third Intervention||6
7545331|NCT03187301|18571712|P3|STARTED|Third Intervention||7
7545332|NCT03187301|18571713|P2|STARTED|Third Intervention||7
7545333|NCT03187301|18571714|P1|STARTED|Third Intervention||6
7545334|NCT03187301|18571708|P7|NOT COMPLETED|Second Washout||0
7545335|NCT03187301|18571709|P6|NOT COMPLETED|Second Washout||0
7545336|NCT03187301|18571710|P5|NOT COMPLETED|Second Washout||0
7545337|NCT03187301|18571711|P4|NOT COMPLETED|Second Washout||0
7545338|NCT03187301|18571712|P3|NOT COMPLETED|Second Washout||0
7545339|NCT03187301|18571713|P2|NOT COMPLETED|Second Washout||0
7545340|NCT03187301|18571714|P1|NOT COMPLETED|Second Washout||0
7545341|NCT03187301|18571708|P7|COMPLETED|Second Washout||0
7545342|NCT03187301|18571709|P6|COMPLETED|Second Washout||7
7545343|NCT03187301|18571710|P5|COMPLETED|Second Washout||7
7545344|NCT03187301|18571711|P4|COMPLETED|Second Washout||6
7545345|NCT03187301|18571712|P3|COMPLETED|Second Washout||7
7545346|NCT03187301|18571713|P2|COMPLETED|Second Washout||7
7545347|NCT03187301|18571714|P1|COMPLETED|Second Washout||6
7545348|NCT03187301|18571708|P7|STARTED|Second Washout||0
7545349|NCT03187301|18571709|P6|STARTED|Second Washout||7
7545350|NCT03187301|18571710|P5|STARTED|Second Washout||7
7545351|NCT03187301|18571711|P4|STARTED|Second Washout||6
7545352|NCT03187301|18571712|P3|STARTED|Second Washout||7
7545353|NCT03187301|18571713|P2|STARTED|Second Washout||7
7545354|NCT03187301|18571714|P1|STARTED|Second Washout||6
7545355|NCT03187301|18571708|P7|NOT COMPLETED|Second Intervention||0
7545356|NCT03187301|18571709|P6|NOT COMPLETED|Second Intervention||0
7545357|NCT03187301|18571710|P5|NOT COMPLETED|Second Intervention||0
7545358|NCT03187301|18571711|P4|NOT COMPLETED|Second Intervention||0
7545359|NCT03187301|18571712|P3|NOT COMPLETED|Second Intervention||0
7545360|NCT03187301|18571713|P2|NOT COMPLETED|Second Intervention||0
7545361|NCT03187301|18571714|P1|NOT COMPLETED|Second Intervention||0
7545362|NCT03187301|18571708|P7|COMPLETED|Second Intervention||0
7545363|NCT03187301|18571709|P6|COMPLETED|Second Intervention||7
7545364|NCT03187301|18571710|P5|COMPLETED|Second Intervention||7
7545365|NCT03187301|18571711|P4|COMPLETED|Second Intervention||6
7545366|NCT03187301|18571712|P3|COMPLETED|Second Intervention||7
7545367|NCT03187301|18571713|P2|COMPLETED|Second Intervention||7
7545368|NCT03187301|18571714|P1|COMPLETED|Second Intervention||6
7545369|NCT03187301|18571708|P7|STARTED|Second Intervention||0
7545370|NCT03187301|18571709|P6|STARTED|Second Intervention||7
7545371|NCT03187301|18571710|P5|STARTED|Second Intervention||7
7545372|NCT03187301|18571711|P4|STARTED|Second Intervention||6
7545373|NCT03187301|18571712|P3|STARTED|Second Intervention||7
7545374|NCT03187301|18571713|P2|STARTED|Second Intervention||7
7545375|NCT03187301|18571714|P1|STARTED|Second Intervention||6
7545376|NCT03187301|18571708|P7|NOT COMPLETED|First Washout||0
7545377|NCT03187301|18571709|P6|NOT COMPLETED|First Washout||0
7545378|NCT03187301|18571710|P5|NOT COMPLETED|First Washout||0
7545379|NCT03187301|18571711|P4|NOT COMPLETED|First Washout||0
7545380|NCT03187301|18571712|P3|NOT COMPLETED|First Washout||0
7545381|NCT03187301|18571713|P2|NOT COMPLETED|First Washout||0
7545382|NCT03187301|18571714|P1|NOT COMPLETED|First Washout||0
7545383|NCT03187301|18571708|P7|COMPLETED|First Washout||0
7545384|NCT03187301|18571709|P6|COMPLETED|First Washout||7
7545385|NCT03187301|18571710|P5|COMPLETED|First Washout||7
7545386|NCT03187301|18571711|P4|COMPLETED|First Washout||6
7545387|NCT03187301|18571712|P3|COMPLETED|First Washout||7
7545388|NCT03187301|18571713|P2|COMPLETED|First Washout||7
7545389|NCT03187301|18571714|P1|COMPLETED|First Washout||6
7545390|NCT03187301|18571708|P7|STARTED|First Washout||0
7545391|NCT03187301|18571709|P6|STARTED|First Washout||7
7545392|NCT03187301|18571710|P5|STARTED|First Washout||7
7545393|NCT03187301|18571711|P4|STARTED|First Washout||6
7545394|NCT03187301|18571712|P3|STARTED|First Washout||7
7545395|NCT03187301|18571713|P2|STARTED|First Washout||7
7545396|NCT03187301|18571714|P1|STARTED|First Washout||6
7545397|NCT03187301|18571708|P7|NOT COMPLETED|First Intervention||0
7545398|NCT03187301|18571709|P6|NOT COMPLETED|First Intervention||0
7545399|NCT03187301|18571710|P5|NOT COMPLETED|First Intervention||0
7545400|NCT03187301|18571711|P4|NOT COMPLETED|First Intervention||0
7545401|NCT03187301|18571712|P3|NOT COMPLETED|First Intervention||0
7545402|NCT03187301|18571713|P2|NOT COMPLETED|First Intervention||0
7545403|NCT03187301|18571714|P1|NOT COMPLETED|First Intervention||0
7545404|NCT03187301|18571708|P7|COMPLETED|First Intervention||0
7545405|NCT03187301|18571709|P6|COMPLETED|First Intervention||7
7545406|NCT03187301|18571710|P5|COMPLETED|First Intervention||7
7545407|NCT03187301|18571711|P4|COMPLETED|First Intervention||6
7545408|NCT03187301|18571712|P3|COMPLETED|First Intervention||7
7545409|NCT03187301|18571713|P2|COMPLETED|First Intervention||7
7545410|NCT03187301|18571714|P1|COMPLETED|First Intervention||6
7545411|NCT03187301|18571708|P7|STARTED|First Intervention||0
7545412|NCT03187301|18571709|P6|STARTED|First Intervention||7
7545413|NCT03187301|18571710|P5|STARTED|First Intervention||7
7545414|NCT03187301|18571711|P4|STARTED|First Intervention||6
7545415|NCT03187301|18571712|P3|STARTED|First Intervention||7
7545416|NCT03187301|18571713|P2|STARTED|First Intervention||7
7545417|NCT03187301|18571714|P1|STARTED|First Intervention||6
7545418|NCT03187301|18571708|P7|NOT COMPLETED|Pre-Intervention||0
7545419|NCT03187301|18571709|P6|NOT COMPLETED|Pre-Intervention||0
7545420|NCT03187301|18571710|P5|NOT COMPLETED|Pre-Intervention||0
7545421|NCT03187301|18571711|P4|NOT COMPLETED|Pre-Intervention||0
7545422|NCT03187301|18571712|P3|NOT COMPLETED|Pre-Intervention||0
7545423|NCT03187301|18571713|P2|NOT COMPLETED|Pre-Intervention||0
7545424|NCT03187301|18571714|P1|NOT COMPLETED|Pre-Intervention||1
7545425|NCT03187301|18571708|P7|COMPLETED|Pre-Intervention||0
7545426|NCT03187301|18571709|P6|COMPLETED|Pre-Intervention||7
7545427|NCT03187301|18571710|P5|COMPLETED|Pre-Intervention||7
7545428|NCT03187301|18571711|P4|COMPLETED|Pre-Intervention||6
7545429|NCT03187301|18571712|P3|COMPLETED|Pre-Intervention||7
7545430|NCT03187301|18571713|P2|COMPLETED|Pre-Intervention||7
7545431|NCT03187301|18571714|P1|COMPLETED|Pre-Intervention||6
7545432|NCT03187301|18571708|P7|STARTED|Pre-Intervention||0
7545433|NCT03187301|18571709|P6|STARTED|Pre-Intervention||7
7545434|NCT03187301|18571710|P5|STARTED|Pre-Intervention||7
7545435|NCT03187301|18571711|P4|STARTED|Pre-Intervention||6
7545436|NCT03187301|18571712|P3|STARTED|Pre-Intervention||7
7545437|NCT03187301|18571713|P2|STARTED|Pre-Intervention||7
7545438|NCT03187301|18571714|P1|STARTED|Pre-Intervention||7
7545439|NCT03187301|18571708|P7|NOT COMPLETED|Titration Period||7
7545440|NCT03187301|18571709|P6|NOT COMPLETED|Titration Period||0
7545441|NCT03187301|18571710|P5|NOT COMPLETED|Titration Period||0
7545442|NCT03187301|18571711|P4|NOT COMPLETED|Titration Period||0
7545443|NCT03187301|18571712|P3|NOT COMPLETED|Titration Period||0
7545444|NCT03187301|18571713|P2|NOT COMPLETED|Titration Period||0
7545445|NCT03187301|18571714|P1|NOT COMPLETED|Titration Period||0
7545446|NCT03187301|18571708|P7|COMPLETED|Titration Period||0
7545447|NCT03187301|18571709|P6|COMPLETED|Titration Period||7
7545448|NCT03187301|18571710|P5|COMPLETED|Titration Period||7
7545449|NCT03187301|18571711|P4|COMPLETED|Titration Period||6
7545450|NCT03187301|18571712|P3|COMPLETED|Titration Period||7
7545451|NCT03187301|18571713|P2|COMPLETED|Titration Period||7
7545452|NCT03187301|18571714|P1|COMPLETED|Titration Period||7
7545453|NCT03187301|18571708|P7|STARTED|Titration Period||7
7545454|NCT03187301|18571709|P6|STARTED|Titration Period||7
7545455|NCT03187301|18571710|P5|STARTED|Titration Period||7
7545456|NCT03187301|18571711|P4|STARTED|Titration Period||6
7545457|NCT03187301|18571712|P3|STARTED|Titration Period||7
7545458|NCT03187301|18571713|P2|STARTED|Titration Period||7
7545459|NCT03187301|18571714|P1|STARTED|Titration Period||7
7545460|NCT03187197|18571766|P3|NOT COMPLETED|Overall Study||23
7545461|NCT03187197|18571767|P2|NOT COMPLETED|Overall Study||393
7545462|NCT03187197|18571768|P1|NOT COMPLETED|Overall Study||46
7545463|NCT03187197|18571766|P3|COMPLETED|Overall Study||32
7545464|NCT03187197|18571767|P2|COMPLETED|Overall Study||704
7545465|NCT03187197|18571768|P1|COMPLETED|Overall Study||107
7545466|NCT03187197|18571766|P3|Started (Eligible Participants as FAS)|Overall Study||54
7545467|NCT03187197|18571767|P2|Started (Eligible Participants as FAS)|Overall Study||1052
7545468|NCT03187197|18571768|P1|Started (Eligible Participants as FAS)|Overall Study||139
7545469|NCT03187197|18571766|P3|STARTED|Overall Study||55
7545470|NCT03187197|18571767|P2|STARTED|Overall Study||1097
7545471|NCT03187197|18571768|P1|STARTED|Overall Study||153
7545472|NCT03187002|18571781|P2|NOT COMPLETED|Overall Study||0
7545473|NCT03187002|18571782|P1|NOT COMPLETED|Overall Study||0
7545474|NCT03187002|18571781|P2|COMPLETED|Overall Study||54
7545475|NCT03187002|18571782|P1|COMPLETED|Overall Study||55
7545476|NCT03187002|18571781|P2|STARTED|Overall Study||54
7545477|NCT03187002|18571782|P1|STARTED|Overall Study||55
7545478|NCT03186781|18571806|P6|NOT COMPLETED|Overall Study||0
7545479|NCT03186781|18571807|P5|NOT COMPLETED|Overall Study||3
7545480|NCT03186781|18571808|P4|NOT COMPLETED|Overall Study||0
7545481|NCT03186781|18571809|P3|NOT COMPLETED|Overall Study||1
7545482|NCT03186781|18571810|P2|NOT COMPLETED|Overall Study||0
7545483|NCT03186781|18571811|P1|NOT COMPLETED|Overall Study||0
7545484|NCT03186781|18571806|P6|COMPLETED|Overall Study||10
7545485|NCT03186781|18571807|P5|COMPLETED|Overall Study||7
7545486|NCT03186781|18571808|P4|COMPLETED|Overall Study||10
7545487|NCT03186781|18571809|P3|COMPLETED|Overall Study||9
7545488|NCT03186781|18571810|P2|COMPLETED|Overall Study||5
7545489|NCT03186781|18571811|P1|COMPLETED|Overall Study||5
7545490|NCT03186781|18571806|P6|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
7545491|NCT03186781|18571807|P5|Received All Product Administrations|Overall Study|2nd dose not given due to subject decision to withdraw (n=1) and lost to follow up (n=1)|8
7545492|NCT03186781|18571808|P4|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
7545493|NCT03186781|18571809|P3|Received All Product Administrations|Overall Study|2nd dose not given due to unrelated intercurrent illness (n=1) and lost to follow up (n=1)|8
7545494|NCT03186781|18571810|P2|Received All Product Administrations|Overall Study||5
7545495|NCT03186781|18571811|P1|Received All Product Administrations|Overall Study||5
7545496|NCT03186781|18571806|P6|Received First Product Administration|Overall Study||10
7545497|NCT03186781|18571807|P5|Received First Product Administration|Overall Study||10
7545498|NCT03186781|18571808|P4|Received First Product Administration|Overall Study||10
7545499|NCT03186781|18571809|P3|Received First Product Administration|Overall Study||10
7545500|NCT03186781|18571810|P2|Received First Product Administration|Overall Study||5
7545501|NCT03186781|18571811|P1|Received First Product Administration|Overall Study||5
7545502|NCT03186781|18571806|P6|STARTED|Overall Study||10
7545503|NCT03186781|18571807|P5|STARTED|Overall Study||10
7545504|NCT03186781|18571808|P4|STARTED|Overall Study||10
7545505|NCT03186781|18571809|P3|STARTED|Overall Study||10
7545506|NCT03186781|18571810|P2|STARTED|Overall Study||5
7545507|NCT03186781|18571811|P1|STARTED|Overall Study||5
7545508|NCT03186677|18571882|P5|NOT COMPLETED|Period 2||0
7545509|NCT03186677|18571883|P4|NOT COMPLETED|Period 2||0
7545510|NCT03186677|18571884|P3|NOT COMPLETED|Period 2||0
7545511|NCT03186677|18571885|P2|NOT COMPLETED|Period 2||0
7545512|NCT03186677|18571886|P1|NOT COMPLETED|Period 2||0
7545513|NCT03186677|18571882|P5|COMPLETED|Period 2||2
7545514|NCT03186677|18571883|P4|COMPLETED|Period 2||5
7545515|NCT03186677|18571884|P3|COMPLETED|Period 2||0
7545516|NCT03186677|18571885|P2|COMPLETED|Period 2||0
7545517|NCT03186677|18571886|P1|COMPLETED|Period 2||0
7545518|NCT03186677|18571882|P5|STARTED|Period 2||2
7545519|NCT03186677|18571883|P4|STARTED|Period 2||5
7545520|NCT03186677|18571884|P3|STARTED|Period 2||0
7545521|NCT03186677|18571885|P2|STARTED|Period 2||0
7545522|NCT03186677|18571886|P1|STARTED|Period 2||0
7545523|NCT03186677|18571882|P5|NOT COMPLETED|Period 1||0
7545524|NCT03186677|18571883|P4|NOT COMPLETED|Period 1||0
7545525|NCT03186677|18571884|P3|NOT COMPLETED|Period 1||0
7545526|NCT03186677|18571885|P2|NOT COMPLETED|Period 1||0
7545527|NCT03186677|18571886|P1|NOT COMPLETED|Period 1||0
7545528|NCT03186677|18571882|P5|COMPLETED|Period 1||0
7545529|NCT03186677|18571883|P4|COMPLETED|Period 1||0
7545530|NCT03186677|18571884|P3|COMPLETED|Period 1||3
7545531|NCT03186677|18571885|P2|COMPLETED|Period 1||3
7545532|NCT03186677|18571886|P1|COMPLETED|Period 1||3
7545533|NCT03186677|18571882|P5|STARTED|Period 1||0
7545534|NCT03186677|18571883|P4|STARTED|Period 1||0
7545535|NCT03186677|18571884|P3|STARTED|Period 1||3
7545536|NCT03186677|18571885|P2|STARTED|Period 1||3
7545537|NCT03186677|18571886|P1|STARTED|Period 1||3
7545538|NCT03185481|18571908|P1|NOT COMPLETED|Overall Study||5
7545539|NCT03185481|18571908|P1|COMPLETED|Overall Study||0
7545540|NCT03185481|18571908|P1|STARTED|Overall Study||5
7545541|NCT03185455|18571927|P2|NOT COMPLETED|Overall Study||0
7545542|NCT03185455|18571928|P1|NOT COMPLETED|Overall Study||0
7545543|NCT03185455|18571927|P2|COMPLETED|Overall Study||103
7545544|NCT03185455|18571928|P1|COMPLETED|Overall Study||103
7545545|NCT03185455|18571927|P2|STARTED|Overall Study||103
7545546|NCT03185455|18571928|P1|STARTED|Overall Study||103
7545547|NCT03185182|18571942|P1|NOT COMPLETED|Overall Study||0
7545548|NCT03185182|18571942|P1|COMPLETED|Overall Study||5
7545549|NCT03185182|18571942|P1|STARTED|Overall Study||5
7545550|NCT03185065|18571951|P4|NOT COMPLETED|Period 4 (6 Weeks)||1
7545551|NCT03185065|18571952|P3|NOT COMPLETED|Period 4 (6 Weeks)||1
7545552|NCT03185065|18571953|P2|NOT COMPLETED|Period 4 (6 Weeks)||1
7545553|NCT03185065|18571954|P1|NOT COMPLETED|Period 4 (6 Weeks)||0
7545554|NCT03185065|18571951|P4|COMPLETED|Period 4 (6 Weeks)||31
7545555|NCT03185065|18571952|P3|COMPLETED|Period 4 (6 Weeks)||26
7545556|NCT03185065|18571953|P2|COMPLETED|Period 4 (6 Weeks)||27
7545557|NCT03185065|18571954|P1|COMPLETED|Period 4 (6 Weeks)||31
7545558|NCT03185065|18571951|P4|STARTED|Period 4 (6 Weeks)||32
7545559|NCT03185065|18571952|P3|STARTED|Period 4 (6 Weeks)||27
7545560|NCT03185065|18571953|P2|STARTED|Period 4 (6 Weeks)||28
7545561|NCT03185065|18571954|P1|STARTED|Period 4 (6 Weeks)||31
7545562|NCT03185065|18571951|P4|NOT COMPLETED|Washout (2 Weeks)||0
7545563|NCT03185065|18571952|P3|NOT COMPLETED|Washout (2 Weeks)||2
7545564|NCT03185065|18571953|P2|NOT COMPLETED|Washout (2 Weeks)||1
7545565|NCT03185065|18571954|P1|NOT COMPLETED|Washout (2 Weeks)||0
7545566|NCT03185065|18571951|P4|COMPLETED|Washout (2 Weeks)||32
7545567|NCT03185065|18571952|P3|COMPLETED|Washout (2 Weeks)||27
7545568|NCT03185065|18571953|P2|COMPLETED|Washout (2 Weeks)||28
7545569|NCT03185065|18571954|P1|COMPLETED|Washout (2 Weeks)||31
7545570|NCT03185065|18571951|P4|STARTED|Washout (2 Weeks)||32
7545571|NCT03185065|18571952|P3|STARTED|Washout (2 Weeks)||29
7545572|NCT03185065|18571953|P2|STARTED|Washout (2 Weeks)||29
7545573|NCT03185065|18571954|P1|STARTED|Washout (2 Weeks)||31
7545574|NCT03185065|18571951|P4|NOT COMPLETED|Period 3 (6 Weeks)||0
7545575|NCT03185065|18571952|P3|NOT COMPLETED|Period 3 (6 Weeks)||2
7545576|NCT03185065|18571953|P2|NOT COMPLETED|Period 3 (6 Weeks)||0
7545577|NCT03185065|18571954|P1|NOT COMPLETED|Period 3 (6 Weeks)||0
7545578|NCT03185065|18571951|P4|COMPLETED|Period 3 (6 Weeks)||32
7545579|NCT03185065|18571952|P3|COMPLETED|Period 3 (6 Weeks)||29
7545580|NCT03185065|18571953|P2|COMPLETED|Period 3 (6 Weeks)||29
7545581|NCT03185065|18571954|P1|COMPLETED|Period 3 (6 Weeks)||31
7545582|NCT03185065|18571951|P4|STARTED|Period 3 (6 Weeks)||32
7545583|NCT03185065|18571952|P3|STARTED|Period 3 (6 Weeks)||31
7545584|NCT03185065|18571953|P2|STARTED|Period 3 (6 Weeks)||29
7545585|NCT03185065|18571954|P1|STARTED|Period 3 (6 Weeks)||31
7545586|NCT03185065|18571951|P4|NOT COMPLETED|Washout (2 Weeks)||2
7545587|NCT03185065|18571952|P3|NOT COMPLETED|Washout (2 Weeks)||1
7545588|NCT03185065|18571953|P2|NOT COMPLETED|Washout (2 Weeks)||2
7545589|NCT03185065|18571954|P1|NOT COMPLETED|Washout (2 Weeks)||1
7545590|NCT03185065|18571951|P4|COMPLETED|Washout (2 Weeks)||32
7545591|NCT03185065|18571952|P3|COMPLETED|Washout (2 Weeks)||31
7545592|NCT03185065|18571953|P2|COMPLETED|Washout (2 Weeks)||29
7545593|NCT03185065|18571954|P1|COMPLETED|Washout (2 Weeks)||31
7545594|NCT03185065|18571951|P4|STARTED|Washout (2 Weeks)||34
7545595|NCT03185065|18571952|P3|STARTED|Washout (2 Weeks)||32
7545596|NCT03185065|18571953|P2|STARTED|Washout (2 Weeks)||31
7545597|NCT03185065|18571954|P1|STARTED|Washout (2 Weeks)||32
7545598|NCT03185065|18571951|P4|NOT COMPLETED|Period 2 (6 Weeks)||1
7545599|NCT03185065|18571952|P3|NOT COMPLETED|Period 2 (6 Weeks)||0
7545600|NCT03185065|18571953|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
7545601|NCT03185065|18571954|P1|NOT COMPLETED|Period 2 (6 Weeks)||0
7545602|NCT03185065|18571951|P4|COMPLETED|Period 2 (6 Weeks)||34
7545603|NCT03185065|18571952|P3|COMPLETED|Period 2 (6 Weeks)||32
7545604|NCT03185065|18571953|P2|COMPLETED|Period 2 (6 Weeks)||31
7545605|NCT03185065|18571954|P1|COMPLETED|Period 2 (6 Weeks)||32
7545606|NCT03185065|18571951|P4|STARTED|Period 2 (6 Weeks)||35
7545607|NCT03185065|18571952|P3|STARTED|Period 2 (6 Weeks)||32
7545608|NCT03185065|18571953|P2|STARTED|Period 2 (6 Weeks)||31
7545609|NCT03185065|18571954|P1|STARTED|Period 2 (6 Weeks)||32
7545610|NCT03185065|18571951|P4|NOT COMPLETED|Washout (2 Weeks)||1
7545611|NCT03185065|18571952|P3|NOT COMPLETED|Washout (2 Weeks)||0
7545612|NCT03185065|18571953|P2|NOT COMPLETED|Washout (2 Weeks)||2
7545613|NCT03185065|18571954|P1|NOT COMPLETED|Washout (2 Weeks)||0
7545614|NCT03185065|18571951|P4|COMPLETED|Washout (2 Weeks)||35
7545615|NCT03185065|18571952|P3|COMPLETED|Washout (2 Weeks)||32
7545616|NCT03185065|18571953|P2|COMPLETED|Washout (2 Weeks)||31
7545617|NCT03185065|18571954|P1|COMPLETED|Washout (2 Weeks)||32
7545618|NCT03185065|18571951|P4|STARTED|Washout (2 Weeks)||36
7545619|NCT03185065|18571952|P3|STARTED|Washout (2 Weeks)||32
7545620|NCT03185065|18571953|P2|STARTED|Washout (2 Weeks)||33
7545621|NCT03185065|18571954|P1|STARTED|Washout (2 Weeks)||32
7545622|NCT03185065|18571951|P4|NOT COMPLETED|Period 1 (6 Weeks)||1
7545623|NCT03185065|18571952|P3|NOT COMPLETED|Period 1 (6 Weeks)||3
7545624|NCT03185065|18571953|P2|NOT COMPLETED|Period 1 (6 Weeks)||1
7545625|NCT03185065|18571954|P1|NOT COMPLETED|Period 1 (6 Weeks)||3
7545626|NCT03185065|18571951|P4|COMPLETED|Period 1 (6 Weeks)||36
7545627|NCT03185065|18571952|P3|COMPLETED|Period 1 (6 Weeks)||32
7545628|NCT03185065|18571953|P2|COMPLETED|Period 1 (6 Weeks)||33
7545629|NCT03185065|18571954|P1|COMPLETED|Period 1 (6 Weeks)||32
7545630|NCT03185065|18571951|P4|STARTED|Period 1 (6 Weeks)||37
7545631|NCT03185065|18571952|P3|STARTED|Period 1 (6 Weeks)||35
7545632|NCT03185065|18571953|P2|STARTED|Period 1 (6 Weeks)||34
7545633|NCT03185065|18571954|P1|STARTED|Period 1 (6 Weeks)||35
7545634|NCT03184987|18571979|P3|NOT COMPLETED|Overall Study||4
7545635|NCT03184987|18571980|P2|NOT COMPLETED|Overall Study||1
7545636|NCT03184987|18571981|P1|NOT COMPLETED|Overall Study||1
7545637|NCT03184987|18571979|P3|COMPLETED|Overall Study||51
7545638|NCT03184987|18571980|P2|COMPLETED|Overall Study||8
7545639|NCT03184987|18571981|P1|COMPLETED|Overall Study||46
7545640|NCT03184987|18571979|P3|STARTED|Overall Study||55
7545641|NCT03184987|18571980|P2|STARTED|Overall Study||9
7545642|NCT03184987|18571981|P1|STARTED|Overall Study||47
7545643|NCT03184701|18572046|P1|NOT COMPLETED|Overall Study||17
7545644|NCT03184701|18572046|P1|COMPLETED|Overall Study||28
7545645|NCT03184701|18572046|P1|STARTED|Overall Study||45
7545646|NCT03184519|18572050|P1|NOT COMPLETED|Overall Study||27
7545647|NCT03184519|18572050|P1|COMPLETED|Overall Study||129
7545648|NCT03184519|18572050|P1|STARTED|Overall Study||156
7545649|NCT03184441|18572054|P1|NOT COMPLETED|Overall Study||1
7545650|NCT03184441|18572054|P1|COMPLETED|Overall Study|Last subject completed study|10
7545651|NCT03184441|18572054|P1|STARTED|Overall Study||11
7545652|NCT03184428|18572062|P1|NOT COMPLETED|Overall Study||822
7545653|NCT03184428|18572062|P1|COMPLETED|Overall Study||2963
7545654|NCT03184428|18572062|P1|STARTED|Overall Study||3785
7545655|NCT03184077|18572080|P2|NOT COMPLETED|Overall Study||21
7545656|NCT03184077|18572081|P1|NOT COMPLETED|Overall Study||21
7545657|NCT03184077|18572080|P2|COMPLETED|Overall Study||131
7545658|NCT03184077|18572081|P1|COMPLETED|Overall Study||145
7545659|NCT03184077|18572080|P2|STARTED|Overall Study||152
7545660|NCT03184077|18572081|P1|STARTED|Overall Study||166
7545661|NCT03183869|18572093|P2|NOT COMPLETED|Overall Study||5
7545662|NCT03183869|18572094|P1|NOT COMPLETED|Overall Study||4
7545663|NCT03183869|18572093|P2|COMPLETED|Overall Study||2
7545664|NCT03183869|18572094|P1|COMPLETED|Overall Study||0
7545665|NCT03183869|18572093|P2|STARTED|Overall Study||7
7545666|NCT03183869|18572094|P1|STARTED|Overall Study||4
7545667|NCT03183518|18572100|P1|NOT COMPLETED|Overall Study||3
7545668|NCT03183518|18572100|P1|COMPLETED|Overall Study||33
7545669|NCT03183518|18572100|P1|Negative Control|Overall Study||36
7545670|NCT03183518|18572100|P1|Test Product|Overall Study||36
7545671|NCT03183518|18572100|P1|STARTED|Overall Study||36
7545672|NCT03183063|18572134|P3|NOT COMPLETED|Overall Study||4
7545673|NCT03183063|18572135|P2|NOT COMPLETED|Overall Study||4
7545674|NCT03183063|18572136|P1|NOT COMPLETED|Overall Study||5
7545675|NCT03183063|18572134|P3|COMPLETED|Overall Study||111
7545676|NCT03183063|18572135|P2|COMPLETED|Overall Study||0
7545677|NCT03183063|18572136|P1|COMPLETED|Overall Study||15
7545678|NCT03183063|18572134|P3|STARTED|Overall Study||115
7545679|NCT03183063|18572135|P2|STARTED|Overall Study||4
7545680|NCT03183063|18572136|P1|STARTED|Overall Study||20
7545681|NCT03182933|18572161|P2|NOT COMPLETED|Overall Study||0
7545682|NCT03182933|18572162|P1|NOT COMPLETED|Overall Study||1
7545683|NCT03182933|18572161|P2|COMPLETED|Overall Study||32
7545684|NCT03182933|18572162|P1|COMPLETED|Overall Study||31
7545685|NCT03182933|18572161|P2|STARTED|Overall Study||32
7545686|NCT03182933|18572162|P1|STARTED|Overall Study||32
7545687|NCT03182920|18572178|P3|NOT COMPLETED|Period 2||0
7545688|NCT03182920|18572179|P2|NOT COMPLETED|Period 2||0
7545689|NCT03182920|18572180|P1|NOT COMPLETED|Period 2||0
7545690|NCT03182920|18572178|P3|COMPLETED|Period 2||0
7545691|NCT03182920|18572179|P2|COMPLETED|Period 2||9
7545692|NCT03182920|18572180|P1|COMPLETED|Period 2||9
7545693|NCT03182920|18572178|P3|STARTED|Period 2|Young participants on Lasmiditan did not move to study period 2.|0
7545694|NCT03182920|18572179|P2|STARTED|Period 2||9
7545695|NCT03182920|18572180|P1|STARTED|Period 2||9
7545696|NCT03182920|18572178|P3|NOT COMPLETED|Washout Period||0
7545697|NCT03182920|18572179|P2|NOT COMPLETED|Washout Period||0
7545698|NCT03182920|18572180|P1|NOT COMPLETED|Washout Period||0
7545699|NCT03182920|18572178|P3|COMPLETED|Washout Period||0
7545700|NCT03182920|18572179|P2|COMPLETED|Washout Period||9
7545701|NCT03182920|18572180|P1|COMPLETED|Washout Period||9
7545702|NCT03182920|18572178|P3|STARTED|Washout Period||0
7545703|NCT03182920|18572179|P2|STARTED|Washout Period||9
7545704|NCT03182920|18572180|P1|STARTED|Washout Period||9
7545705|NCT03182920|18572178|P3|NOT COMPLETED|Period 1||0
7545706|NCT03182920|18572179|P2|NOT COMPLETED|Period 1||0
7545707|NCT03182920|18572180|P1|NOT COMPLETED|Period 1||0
7545708|NCT03182920|18572178|P3|COMPLETED|Period 1||17
7545709|NCT03182920|18572179|P2|COMPLETED|Period 1||9
7545710|NCT03182920|18572180|P1|COMPLETED|Period 1||9
7545711|NCT03182920|18572178|P3|STARTED|Period 1||17
7545712|NCT03182920|18572179|P2|STARTED|Period 1||9
7545713|NCT03182920|18572180|P1|STARTED|Period 1||9
7545714|NCT03182738|18572191|P2|NOT COMPLETED|Overall Study||5
7545715|NCT03182738|18572192|P1|NOT COMPLETED|Overall Study||9
7545716|NCT03182738|18572191|P2|COMPLETED|Overall Study||45
7545717|NCT03182738|18572192|P1|COMPLETED|Overall Study||41
7545718|NCT03182738|18572191|P2|STARTED|Overall Study||50
7545719|NCT03182738|18572192|P1|STARTED|Overall Study||50
7545720|NCT03182582|18572206|P2|NOT COMPLETED|Treatment 2||0
7545721|NCT03182582|18572207|P1|NOT COMPLETED|Treatment 2||0
7545722|NCT03182582|18572206|P2|COMPLETED|Treatment 2||10
7545723|NCT03182582|18572207|P1|COMPLETED|Treatment 2||12
7545724|NCT03182582|18572206|P2|STARTED|Treatment 2||10
7545725|NCT03182582|18572207|P1|STARTED|Treatment 2||12
7545726|NCT03182582|18572206|P2|NOT COMPLETED|Treatment 1||0
7545727|NCT03182582|18572207|P1|NOT COMPLETED|Treatment 1||0
7545728|NCT03182582|18572206|P2|COMPLETED|Treatment 1||10
7545729|NCT03182582|18572207|P1|COMPLETED|Treatment 1||12
7545730|NCT03182582|18572206|P2|STARTED|Treatment 1||10
7545731|NCT03182582|18572207|P1|STARTED|Treatment 1||12
7545732|NCT03181724|18572224|P2|NOT COMPLETED|Overall Study||0
7545733|NCT03181724|18572225|P1|NOT COMPLETED|Overall Study||0
7545734|NCT03181724|18572224|P2|COMPLETED|Overall Study||45
7545735|NCT03181724|18572225|P1|COMPLETED|Overall Study||45
7545736|NCT03181724|18572224|P2|STARTED|Overall Study||45
7545737|NCT03181724|18572225|P1|STARTED|Overall Study||45
7545738|NCT03181594|18572241|P1|NOT COMPLETED|Overall Study||2
7545739|NCT03181594|18572241|P1|COMPLETED|Overall Study||98
7545740|NCT03181594|18572241|P1|90-day Follow-up|Overall Study||98
7545741|NCT03181594|18572241|P1|30-day Follow-up|Overall Study||99
7545742|NCT03181594|18572241|P1|STARTED|Overall Study||100
7545743|NCT03181503|18572249|P2|NOT COMPLETED|Overall Study||3
7545744|NCT03181503|18572250|P1|NOT COMPLETED|Overall Study||7
7545745|NCT03181503|18572249|P2|COMPLETED|Overall Study||31
7545746|NCT03181503|18572250|P1|COMPLETED|Overall Study||29
7545747|NCT03181503|18572249|P2|Treated|Overall Study||34
7545748|NCT03181503|18572250|P1|Treated|Overall Study||36
7545749|NCT03181503|18572249|P2|STARTED|Overall Study||34
7545750|NCT03181503|18572250|P1|STARTED|Overall Study||36
7545751|NCT03181451|18572289|P3|NOT COMPLETED|Overall Study||0
7545752|NCT03181451|18572290|P2|NOT COMPLETED|Overall Study||2
7545753|NCT03181451|18572291|P1|NOT COMPLETED|Overall Study||0
7545754|NCT03181451|18572289|P3|COMPLETED|Overall Study||12
7545755|NCT03181451|18572290|P2|COMPLETED|Overall Study||11
7545756|NCT03181451|18572291|P1|COMPLETED|Overall Study||12
7545757|NCT03181451|18572289|P3|STARTED|Overall Study||12
7545758|NCT03181451|18572290|P2|STARTED|Overall Study||13
7545759|NCT03181451|18572291|P1|STARTED|Overall Study||12
7545760|NCT03181308|18572451|P2|NOT COMPLETED|Overall Study||0
7545761|NCT03181308|18572452|P1|NOT COMPLETED|Overall Study||0
7545762|NCT03181308|18572451|P2|COMPLETED|Overall Study||8
7545763|NCT03181308|18572452|P1|COMPLETED|Overall Study||3
7545764|NCT03181308|18572451|P2|STARTED|Overall Study||8
7545765|NCT03181308|18572452|P1|STARTED|Overall Study||3
7545766|NCT03181009|18572468|P2|NOT COMPLETED|Overall Study||2
7545767|NCT03181009|18572469|P1|NOT COMPLETED|Overall Study||0
7545768|NCT03181009|18572468|P2|COMPLETED|Overall Study||28
7545769|NCT03181009|18572469|P1|COMPLETED|Overall Study||30
7545770|NCT03181009|18572468|P2|STARTED|Overall Study||30
7545771|NCT03181009|18572469|P1|STARTED|Overall Study||30
7545772|NCT03180801|18572478|P3|NOT COMPLETED|Overall Study||10
7545773|NCT03180801|18572479|P2|NOT COMPLETED|Overall Study||12
7545774|NCT03180801|18572480|P1|NOT COMPLETED|Overall Study||8
7545775|NCT03180801|18572478|P3|COMPLETED|Overall Study||41
7545776|NCT03180801|18572479|P2|COMPLETED|Overall Study||40
7545777|NCT03180801|18572480|P1|COMPLETED|Overall Study||42
7545778|NCT03180801|18572478|P3|Intention to Treat|Overall Study||41
7545779|NCT03180801|18572479|P2|Intention to Treat|Overall Study||40
7545780|NCT03180801|18572480|P1|Intention to Treat|Overall Study||42
7545781|NCT03180801|18572478|P3|Safety Population|Overall Study||51
7545782|NCT03180801|18572479|P2|Safety Population|Overall Study||52
7545783|NCT03180801|18572480|P1|Safety Population|Overall Study||50
7545784|NCT03180801|18572478|P3|STARTED|Overall Study||51
7545785|NCT03180801|18572479|P2|STARTED|Overall Study||52
7545786|NCT03180801|18572480|P1|STARTED|Overall Study||50
7545787|NCT03180645|18572524|P3|NOT COMPLETED|Overall Study||2
7545788|NCT03180645|18572525|P2|NOT COMPLETED|Overall Study||1
7545789|NCT03180645|18572526|P1|NOT COMPLETED|Overall Study||0
7545790|NCT03180645|18572524|P3|COMPLETED|Overall Study||22
7545791|NCT03180645|18572525|P2|COMPLETED|Overall Study||23
7545792|NCT03180645|18572526|P1|COMPLETED|Overall Study||24
7545793|NCT03180645|18572524|P3|STARTED|Overall Study||24
7545794|NCT03180645|18572525|P2|STARTED|Overall Study||24
7545795|NCT03180645|18572526|P1|STARTED|Overall Study||24
7545796|NCT03180619|18572568|P3|NOT COMPLETED|Overall Study||28
7545797|NCT03180619|18572569|P2|NOT COMPLETED|Overall Study||15
7545798|NCT03180619|18572570|P1|NOT COMPLETED|Overall Study||73
7545799|NCT03180619|18572568|P3|COMPLETED|Overall Study||3
7545800|NCT03180619|18572569|P2|COMPLETED|Overall Study||0
7545801|NCT03180619|18572570|P1|COMPLETED|Overall Study||5
7545802|NCT03180619|18572568|P3|STARTED|Overall Study||31
7545803|NCT03180619|18572569|P2|STARTED|Overall Study||15
7545804|NCT03180619|18572570|P1|STARTED|Overall Study||78
7545805|NCT03180515|18572667|P1|NOT COMPLETED|Aim 3||0
7545806|NCT03180515|18572667|P1|COMPLETED|Aim 3||1
7545807|NCT03180515|18572667|P1|STARTED|Aim 3||1
7545808|NCT03180515|18572667|P1|NOT COMPLETED|Aim 2||0
7545809|NCT03180515|18572667|P1|COMPLETED|Aim 2||12
7545810|NCT03180515|18572667|P1|STARTED|Aim 2||12
7545811|NCT03180515|18572667|P1|NOT COMPLETED|Aim 1||0
7545812|NCT03180515|18572667|P1|COMPLETED|Aim 1||12
7545813|NCT03180515|18572667|P1|STARTED|Aim 1||12
7545814|NCT03180489|18572712|P2|NOT COMPLETED|Overall Study||4
7545815|NCT03180489|18572713|P1|NOT COMPLETED|Overall Study||8
7545816|NCT03180489|18572712|P2|COMPLETED|Overall Study||25
7545817|NCT03180489|18572713|P1|COMPLETED|Overall Study||25
7545818|NCT03180489|18572712|P2|STARTED|Overall Study||29
7545819|NCT03180489|18572713|P1|STARTED|Overall Study||33
7545820|NCT03180385|18572745|P2|NOT COMPLETED|Overall Study||0
7545821|NCT03180385|18572746|P1|NOT COMPLETED|Overall Study||0
7545822|NCT03180385|18572745|P2|COMPLETED|Overall Study||2
7545823|NCT03180385|18572746|P1|COMPLETED|Overall Study||0
7545824|NCT03180385|18572745|P2|STARTED|Overall Study||2
7545825|NCT03180385|18572746|P1|STARTED|Overall Study||0
7545826|NCT03180138|18572773|P3|NOT COMPLETED|Overall Study||24
7545827|NCT03180138|18572774|P2|NOT COMPLETED|Overall Study||13
7545828|NCT03180138|18572775|P1|NOT COMPLETED|Overall Study||22
7545829|NCT03180138|18572773|P3|COMPLETED|Overall Study||179
7545830|NCT03180138|18572774|P2|COMPLETED|Overall Study||188
7545831|NCT03180138|18572775|P1|COMPLETED|Overall Study||182
7545832|NCT03180138|18572773|P3|STARTED|Overall Study||203
7545833|NCT03180138|18572774|P2|STARTED|Overall Study||201
7545834|NCT03180138|18572775|P1|STARTED|Overall Study||204
7545835|NCT03179891|18572786|P2|NOT COMPLETED|Second Intervention (After 14 Days)||0
7545836|NCT03179891|18572787|P1|NOT COMPLETED|Second Intervention (After 14 Days)||0
7545837|NCT03179891|18572786|P2|COMPLETED|Second Intervention (After 14 Days)||20
7545838|NCT03179891|18572787|P1|COMPLETED|Second Intervention (After 14 Days)||11
7545839|NCT03179891|18572786|P2|STARTED|Second Intervention (After 14 Days)||20
7545840|NCT03179891|18572787|P1|STARTED|Second Intervention (After 14 Days)||11
7545841|NCT03179891|18572786|P2|NOT COMPLETED|First Intervention||2
7545842|NCT03179891|18572787|P1|NOT COMPLETED|First Intervention||2
7545843|NCT03179891|18572786|P2|COMPLETED|First Intervention||20
7545844|NCT03179891|18572787|P1|COMPLETED|First Intervention||11
7545845|NCT03179891|18572786|P2|STARTED|First Intervention||22
7545846|NCT03179891|18572787|P1|STARTED|First Intervention||13
7545847|NCT03179345|18572811|P4|NOT COMPLETED|Overall Study||2
7545848|NCT03179345|18572812|P3|NOT COMPLETED|Overall Study||1
7545849|NCT03179345|18572813|P2|NOT COMPLETED|Overall Study||1
7545850|NCT03179345|18572814|P1|NOT COMPLETED|Overall Study||0
7545851|NCT03179345|18572811|P4|COMPLETED|Overall Study||6
7545852|NCT03179345|18572812|P3|COMPLETED|Overall Study||7
7545853|NCT03179345|18572813|P2|COMPLETED|Overall Study||7
7545854|NCT03179345|18572814|P1|COMPLETED|Overall Study||8
7545855|NCT03179345|18572811|P4|Received Placebo|Overall Study||8
7545856|NCT03179345|18572812|P3|Received Placebo|Overall Study||7
7545857|NCT03179345|18572813|P2|Received Placebo|Overall Study||7
7545858|NCT03179345|18572814|P1|Received Placebo|Overall Study||8
7545859|NCT03179345|18572811|P4|Received Lyrica®|Overall Study||8
7545860|NCT03179345|18572812|P3|Received Lyrica®|Overall Study||8
7545861|NCT03179345|18572813|P2|Received Lyrica®|Overall Study||7
7545862|NCT03179345|18572814|P1|Received Lyrica®|Overall Study||8
7545863|NCT03179345|18572811|P4|Received Neurontin®|Overall Study||8
7545864|NCT03179345|18572812|P3|Received Neurontin®|Overall Study||7
7545865|NCT03179345|18572813|P2|Received Neurontin®|Overall Study||8
7545866|NCT03179345|18572814|P1|Received Neurontin®|Overall Study||8
7545867|NCT03179345|18572811|P4|Received Gralise®|Overall Study||6
7545868|NCT03179345|18572812|P3|Received Gralise®|Overall Study||7
7545869|NCT03179345|18572813|P2|Received Gralise®|Overall Study||7
7545870|NCT03179345|18572814|P1|Received Gralise®|Overall Study||8
7545871|NCT03179345|18572811|P4|STARTED|Overall Study||8
7545872|NCT03179345|18572812|P3|STARTED|Overall Study||8
7545873|NCT03179345|18572813|P2|STARTED|Overall Study||8
7545874|NCT03179345|18572814|P1|STARTED|Overall Study||8
7545875|NCT03179319|18572866|P2|NOT COMPLETED|Overall Study||0
7545876|NCT03179319|18572867|P1|NOT COMPLETED|Overall Study||6
7545877|NCT03179319|18572866|P2|COMPLETED|Overall Study||20
7545878|NCT03179319|18572867|P1|COMPLETED|Overall Study||34
7545879|NCT03179319|18572866|P2|3 Month Visit|Overall Study||20
7545880|NCT03179319|18572867|P1|3 Month Visit|Overall Study||37
7545881|NCT03179319|18572866|P2|STARTED|Overall Study||20
7545882|NCT03179319|18572867|P1|STARTED|Overall Study||40
7545883|NCT03178942|18572882|P2|NOT COMPLETED|Overall Study||2
7545884|NCT03178942|18572883|P1|NOT COMPLETED|Overall Study||3
7545885|NCT03178942|18572882|P2|COMPLETED|Overall Study||123
7545886|NCT03178942|18572883|P1|COMPLETED|Overall Study||126
7545887|NCT03178942|18572882|P2|STARTED|Overall Study||125
7545888|NCT03178942|18572883|P1|STARTED|Overall Study||129
7545889|NCT03178851|18572898|P3|NOT COMPLETED|Overall Study||52
7545890|NCT03178851|18572899|P2|NOT COMPLETED|Overall Study||11
7545891|NCT03178851|18572900|P1|NOT COMPLETED|Overall Study||92
7545892|NCT03178851|18572898|P3|COMPLETED|Overall Study||0
7545893|NCT03178851|18572899|P2|COMPLETED|Overall Study||0
7545894|NCT03178851|18572900|P1|COMPLETED|Overall Study||0
7545895|NCT03178851|18572898|P3|STARTED|Overall Study||52
7545896|NCT03178851|18572899|P2|STARTED|Overall Study||11
7545897|NCT03178851|18572900|P1|STARTED|Overall Study||92
7545898|NCT03178344|18572930|P2|NOT COMPLETED|Second Session||0
7545899|NCT03178344|18572931|P1|NOT COMPLETED|Second Session||0
7545900|NCT03178344|18572930|P2|COMPLETED|Second Session||10
7545901|NCT03178344|18572931|P1|COMPLETED|Second Session||10
7545902|NCT03178344|18572930|P2|STARTED|Second Session||10
7545903|NCT03178344|18572931|P1|STARTED|Second Session||10
7545904|NCT03178344|18572930|P2|NOT COMPLETED|Washout Period (5-9 Days)||0
7545905|NCT03178344|18572931|P1|NOT COMPLETED|Washout Period (5-9 Days)||0
7545906|NCT03178344|18572930|P2|COMPLETED|Washout Period (5-9 Days)||10
7545907|NCT03178344|18572931|P1|COMPLETED|Washout Period (5-9 Days)||10
7545908|NCT03178344|18572930|P2|STARTED|Washout Period (5-9 Days)||10
7545909|NCT03178344|18572931|P1|STARTED|Washout Period (5-9 Days)||10
7545910|NCT03178344|18572930|P2|NOT COMPLETED|First Session||0
7545911|NCT03178344|18572931|P1|NOT COMPLETED|First Session||0
7545912|NCT03178344|18572930|P2|COMPLETED|First Session||10
7545913|NCT03178344|18572931|P1|COMPLETED|First Session||10
7545914|NCT03178344|18572930|P2|STARTED|First Session||10
7545915|NCT03178344|18572931|P1|STARTED|First Session||10
7545916|NCT03178266|18572947|P2|NOT COMPLETED|Overall Study||4
7545917|NCT03178266|18572948|P1|NOT COMPLETED|Overall Study||0
7545918|NCT03178266|18572947|P2|COMPLETED|Overall Study||16
7545919|NCT03178266|18572948|P1|COMPLETED|Overall Study||21
7545920|NCT03178266|18572947|P2|STARTED|Overall Study||20
7545921|NCT03178266|18572948|P1|STARTED|Overall Study||21
7545922|NCT03178045|18572958|P2|NOT COMPLETED|Overall Study||83
7545923|NCT03178045|18572959|P1|NOT COMPLETED|Overall Study||86
7545924|NCT03178045|18572958|P2|COMPLETED|Overall Study||1314
7545925|NCT03178045|18572959|P1|COMPLETED|Overall Study||1310
7545926|NCT03178045|18572958|P2|STARTED|Overall Study||1397
7545927|NCT03178045|18572959|P1|STARTED|Overall Study||1396
7545928|NCT03177798|18572986|P2|NOT COMPLETED|Overall Study||0
7545929|NCT03177798|18572987|P1|NOT COMPLETED|Overall Study||0
7545930|NCT03177798|18572986|P2|COMPLETED|Overall Study||6
7545931|NCT03177798|18572987|P1|COMPLETED|Overall Study||5
7545932|NCT03177798|18572986|P2|Intervention 2|Overall Study||6
7545933|NCT03177798|18572987|P1|Intervention 2|Overall Study||5
7545934|NCT03177798|18572986|P2|Washout|Overall Study||6
7545935|NCT03177798|18572987|P1|Washout|Overall Study||5
7545936|NCT03177798|18572986|P2|Intervention 1|Overall Study||6
7545937|NCT03177798|18572987|P1|Intervention 1|Overall Study||5
7545938|NCT03177798|18572986|P2|STARTED|Overall Study||6
7545939|NCT03177798|18572987|P1|STARTED|Overall Study||5
7545940|NCT03177603|18572999|P4|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
7545941|NCT03177603|18573000|P3|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
7545942|NCT03177603|18573001|P2|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
7545943|NCT03177603|18573002|P1|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
7545944|NCT03177603|18572999|P4|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
7545945|NCT03177603|18573000|P3|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
7545946|NCT03177603|18573001|P2|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
7545947|NCT03177603|18573002|P1|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
7545948|NCT03177603|18572999|P4|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
7545949|NCT03177603|18573000|P3|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
7545950|NCT03177603|18573001|P2|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
7545951|NCT03177603|18573002|P1|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
7545952|NCT03177603|18572999|P4|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
7545953|NCT03177603|18573000|P3|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
7545954|NCT03177603|18573001|P2|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
7545955|NCT03177603|18573002|P1|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
7545956|NCT03177603|18572999|P4|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
7545957|NCT03177603|18573000|P3|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
7545958|NCT03177603|18573001|P2|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
7545959|NCT03177603|18573002|P1|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
7545960|NCT03177603|18572999|P4|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
7545961|NCT03177603|18573000|P3|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
7545962|NCT03177603|18573001|P2|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
7545963|NCT03177603|18573002|P1|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
7545964|NCT03177603|18572999|P4|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
7545965|NCT03177603|18573000|P3|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
7545966|NCT03177603|18573001|P2|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
7545967|NCT03177603|18573002|P1|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
7545968|NCT03177603|18572999|P4|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
7545969|NCT03177603|18573000|P3|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
7545970|NCT03177603|18573001|P2|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
7545971|NCT03177603|18573002|P1|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
7545972|NCT03177603|18572999|P4|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
7545973|NCT03177603|18573000|P3|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
7545974|NCT03177603|18573001|P2|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
7545975|NCT03177603|18573002|P1|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
7545976|NCT03177603|18572999|P4|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
7545977|NCT03177603|18573000|P3|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
7545978|NCT03177603|18573001|P2|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
7545979|NCT03177603|18573002|P1|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
7545980|NCT03177603|18572999|P4|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
7545981|NCT03177603|18573000|P3|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
7545982|NCT03177603|18573001|P2|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
7545983|NCT03177603|18573002|P1|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
7545984|NCT03177603|18572999|P4|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
7545985|NCT03177603|18573000|P3|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
7545986|NCT03177603|18573001|P2|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
7545987|NCT03177603|18573002|P1|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
7545988|NCT03177395|18573172|P4|NOT COMPLETED|Overall Study||0
7545989|NCT03177395|18573173|P3|NOT COMPLETED|Overall Study||0
7545990|NCT03177395|18573174|P2|NOT COMPLETED|Overall Study||0
7545991|NCT03177395|18573175|P1|NOT COMPLETED|Overall Study||0
7545992|NCT03177395|18573172|P4|COMPLETED|Overall Study||6
7545993|NCT03177395|18573173|P3|COMPLETED|Overall Study||6
7545994|NCT03177395|18573174|P2|COMPLETED|Overall Study||6
7545995|NCT03177395|18573175|P1|COMPLETED|Overall Study||6
7545996|NCT03177395|18573172|P4|STARTED|Overall Study||6
7545997|NCT03177395|18573173|P3|STARTED|Overall Study||6
7545998|NCT03177395|18573174|P2|STARTED|Overall Study||6
7545999|NCT03177395|18573175|P1|STARTED|Overall Study||6
7546000|NCT03176654|18573279|P2|NOT COMPLETED|Overall Study||0
7546001|NCT03176654|18573280|P1|NOT COMPLETED|Overall Study||0
7546002|NCT03176654|18573279|P2|COMPLETED|Overall Study||15
7546003|NCT03176654|18573280|P1|COMPLETED|Overall Study||13
7546004|NCT03176654|18573279|P2|STARTED|Overall Study||15
7546005|NCT03176654|18573280|P1|STARTED|Overall Study||13
7546006|NCT03176407|18573300|P1|NOT COMPLETED|Overall Study||3
7546007|NCT03176407|18573300|P1|COMPLETED|Overall Study||27
7546008|NCT03176407|18573300|P1|STARTED|Overall Study||30
7546009|NCT03176238|18573310|P2|NOT COMPLETED|Overall Study||36
7546010|NCT03176238|18573311|P1|NOT COMPLETED|Overall Study||199
7546011|NCT03176238|18573310|P2|COMPLETED|Overall Study||0
7546012|NCT03176238|18573311|P1|COMPLETED|Overall Study||0
7546013|NCT03176238|18573310|P2|STARTED|Overall Study||36
7546014|NCT03176238|18573311|P1|STARTED|Overall Study||199
7546015|NCT03175562|18573330|P1|NOT COMPLETED|Overall Study||16
7546016|NCT03175562|18573330|P1|COMPLETED|Overall Study||224
7546017|NCT03175562|18573330|P1|Negative Control|Overall Study||240
7546018|NCT03175562|18573330|P1|Test Product|Overall Study||240
7546019|NCT03175562|18573330|P1|STARTED|Overall Study||240
7546020|NCT03175172|18573355|P1|NOT COMPLETED|Overall Study||10
7546021|NCT03175172|18573355|P1|COMPLETED|Overall Study||0
7546022|NCT03175172|18573355|P1|STARTED|Overall Study||10
7546023|NCT03175120|18573365|P2|NOT COMPLETED|Overall Study||12
7546024|NCT03175120|18573366|P1|NOT COMPLETED|Overall Study||12
7546025|NCT03175120|18573365|P2|COMPLETED|Overall Study||139
7546026|NCT03175120|18573366|P1|COMPLETED|Overall Study||290
7546027|NCT03175120|18573365|P2|Safety Analysis Set (SAS)|Overall Study||151
7546028|NCT03175120|18573366|P1|Safety Analysis Set (SAS)|Overall Study||301
7546029|NCT03175120|18573365|P2|Full Analysis Set (FAS)|Overall Study||151
7546030|NCT03175120|18573366|P1|Full Analysis Set (FAS)|Overall Study||302
7546031|NCT03175120|18573365|P2|Treated|Overall Study||151
7546032|NCT03175120|18573366|P1|Treated|Overall Study||301
7546033|NCT03175120|18573365|P2|STARTED|Overall Study||151
7546034|NCT03175120|18573366|P1|STARTED|Overall Study||302
7546035|NCT03174366|18573488|P1|NOT COMPLETED|Overall Study||0
7546036|NCT03174366|18573488|P1|COMPLETED|Overall Study||7
7546037|NCT03174366|18573488|P1|STARTED|Overall Study||7
7546038|NCT03174158|18573497|P4|NOT COMPLETED|Overall Study||1
7546039|NCT03174158|18573498|P3|NOT COMPLETED|Overall Study||2
7546040|NCT03174158|18573499|P2|NOT COMPLETED|Overall Study||2
7546041|NCT03174158|18573500|P1|NOT COMPLETED|Overall Study||4
7546042|NCT03174158|18573497|P4|COMPLETED|Overall Study||38
7546043|NCT03174158|18573498|P3|COMPLETED|Overall Study||34
7546044|NCT03174158|18573499|P2|COMPLETED|Overall Study||37
7546045|NCT03174158|18573500|P1|COMPLETED|Overall Study||35
7546046|NCT03174158|18573497|P4|STARTED|Overall Study||39
7546047|NCT03174158|18573498|P3|STARTED|Overall Study||36
7546048|NCT03174158|18573499|P2|STARTED|Overall Study||39
7546049|NCT03174158|18573500|P1|STARTED|Overall Study||39
7546050|NCT03174132|18573536|P1|NOT COMPLETED|Overall Study||0
7546051|NCT03174132|18573536|P1|COMPLETED|Overall Study||70
7546052|NCT03174132|18573536|P1|STARTED|Overall Study||70
7546053|NCT03173170|18573541|P1|NOT COMPLETED|Intervention Period 2 (9 Days)||0
7546054|NCT03173170|18573541|P1|COMPLETED|Intervention Period 2 (9 Days)||10
7546055|NCT03173170|18573541|P1|STARTED|Intervention Period 2 (9 Days)||10
7546056|NCT03173170|18573541|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7546057|NCT03173170|18573541|P1|COMPLETED|Washout Period (at Least 7 Days)||10
7546058|NCT03173170|18573541|P1|STARTED|Washout Period (at Least 7 Days)||10
7546059|NCT03173170|18573541|P1|NOT COMPLETED|First Intervention Period (6 Days)||0
7546060|NCT03173170|18573541|P1|COMPLETED|First Intervention Period (6 Days)||10
7546061|NCT03173170|18573541|P1|STARTED|First Intervention Period (6 Days)||10
7546062|NCT03172702|18573550|P1|NOT COMPLETED|Overall Study||28
7546063|NCT03172702|18573550|P1|COMPLETED|Overall Study||122
7546064|NCT03172702|18573550|P1|Received Treatment in MP|Overall Study||150
7546065|NCT03172702|18573550|P1|Received Treatment in CP|Overall Study||150
7546066|NCT03172702|18573550|P1|STARTED|Overall Study||150
7546067|NCT03172520|18573571|P1|NOT COMPLETED|Overall Study||10
7546068|NCT03172520|18573571|P1|COMPLETED|Overall Study||0
7546069|NCT03172520|18573571|P1|STARTED|Overall Study||10
7546070|NCT03172494|18573578|P3|NOT COMPLETED|Overall Study||29
7546071|NCT03172494|18573579|P2|NOT COMPLETED|Overall Study||12
7546072|NCT03172494|18573580|P1|NOT COMPLETED|Overall Study||20
7546073|NCT03172494|18573578|P3|COMPLETED|Overall Study||151
7546074|NCT03172494|18573579|P2|COMPLETED|Overall Study||167
7546075|NCT03172494|18573580|P1|COMPLETED|Overall Study||341
7546076|NCT03172494|18573578|P3|Exposed|Overall Study||180
7546077|NCT03172494|18573579|P2|Exposed|Overall Study||175
7546078|NCT03172494|18573580|P1|Exposed|Overall Study||358
7546079|NCT03172494|18573578|P3|Safety Analysis Set (SAS)|Overall Study||180
7546080|NCT03172494|18573579|P2|Safety Analysis Set (SAS)|Overall Study||175
7546081|NCT03172494|18573580|P1|Safety Analysis Set (SAS)|Overall Study||358
7546082|NCT03172494|18573578|P3|Full Analysis Set (FAS)|Overall Study||180
7546083|NCT03172494|18573579|P2|Full Analysis Set (FAS)|Overall Study||179
7546084|NCT03172494|18573580|P1|Full Analysis Set (FAS)|Overall Study||361
7546085|NCT03172494|18573578|P3|STARTED|Overall Study||180
7546086|NCT03172494|18573579|P2|STARTED|Overall Study||179
7546087|NCT03172494|18573580|P1|STARTED|Overall Study||361
7546088|NCT03172481|18573763|P2|NOT COMPLETED|Double-blind||0
7546089|NCT03172481|18573764|P1|NOT COMPLETED|Double-blind||1
7546090|NCT03172481|18573763|P2|COMPLETED|Double-blind||73
7546091|NCT03172481|18573764|P1|COMPLETED|Double-blind||74
7546092|NCT03172481|18573763|P2|STARTED|Double-blind|From 148 subjects who completed the Open-label period, 73 randomly received Placebo|73
7546093|NCT03172481|18573764|P1|STARTED|Double-blind||75
7546094|NCT03172481|18573763|P2|NOT COMPLETED|Open-label||0
7546095|NCT03172481|18573764|P1|NOT COMPLETED|Open-label||8
7546096|NCT03172481|18573763|P2|COMPLETED|Open-label||0
7546097|NCT03172481|18573764|P1|COMPLETED|Open-label||148
7546098|NCT03172481|18573763|P2|STARTED|Open-label||0
7546099|NCT03172481|18573764|P1|STARTED|Open-label||156
7546100|NCT03172364|18573772|P2|NOT COMPLETED|Overall Study||1
7546101|NCT03172364|18573773|P1|NOT COMPLETED|Overall Study||2
7546102|NCT03172364|18573772|P2|COMPLETED|Overall Study||57
7546103|NCT03172364|18573773|P1|COMPLETED|Overall Study||53
7546104|NCT03172364|18573772|P2|STARTED|Overall Study||58
7546105|NCT03172364|18573773|P1|STARTED|Overall Study||55
7546106|NCT03172130|18573791|P2|NOT COMPLETED|Overall Study||1
7546107|NCT03172130|18573792|P1|NOT COMPLETED|Overall Study||3
7546108|NCT03172130|18573791|P2|COMPLETED|Overall Study||9
7546109|NCT03172130|18573792|P1|COMPLETED|Overall Study||9
7546110|NCT03172130|18573791|P2|STARTED|Overall Study||10
7546111|NCT03172130|18573792|P1|STARTED|Overall Study||12
7546112|NCT03171415|18573817|P5|NOT COMPLETED|Overall Study||2
7546113|NCT03171415|18573818|P4|NOT COMPLETED|Overall Study||0
7546114|NCT03171415|18573819|P3|NOT COMPLETED|Overall Study||0
7546115|NCT03171415|18573820|P2|NOT COMPLETED|Overall Study||0
7546116|NCT03171415|18573821|P1|NOT COMPLETED|Overall Study||0
7546117|NCT03171415|18573817|P5|COMPLETED|Overall Study||7
7546118|NCT03171415|18573818|P4|COMPLETED|Overall Study||6
7546119|NCT03171415|18573819|P3|COMPLETED|Overall Study||6
7546120|NCT03171415|18573820|P2|COMPLETED|Overall Study||6
7546121|NCT03171415|18573821|P1|COMPLETED|Overall Study||6
7546122|NCT03171415|18573817|P5|STARTED|Overall Study||9
7546123|NCT03171415|18573818|P4|STARTED|Overall Study||6
7546124|NCT03171415|18573819|P3|STARTED|Overall Study||6
7546125|NCT03171415|18573820|P2|STARTED|Overall Study||6
7546126|NCT03171415|18573821|P1|STARTED|Overall Study||6
7546127|NCT03171051|18573882|P1|NOT COMPLETED|Overall Study||0
7546128|NCT03171051|18573882|P1|COMPLETED|Overall Study||10
7546129|NCT03171051|18573882|P1|STARTED|Overall Study||10
7546130|NCT03170609|18573894|P7|NOT COMPLETED|Overall Study||1
7546131|NCT03170609|18573895|P6|NOT COMPLETED|Overall Study||2
7546132|NCT03170609|18573896|P5|NOT COMPLETED|Overall Study||1
7546133|NCT03170609|18573897|P4|NOT COMPLETED|Overall Study||2
7546134|NCT03170609|18573898|P3|NOT COMPLETED|Overall Study||6
7546135|NCT03170609|18573899|P2|NOT COMPLETED|Overall Study||2
7546136|NCT03170609|18573900|P1|NOT COMPLETED|Overall Study||3
7546137|NCT03170609|18573894|P7|COMPLETED|Overall Study||51
7546138|NCT03170609|18573895|P6|COMPLETED|Overall Study||50
7546139|NCT03170609|18573896|P5|COMPLETED|Overall Study||51
7546140|NCT03170609|18573897|P4|COMPLETED|Overall Study||50
7546141|NCT03170609|18573898|P3|COMPLETED|Overall Study||46
7546142|NCT03170609|18573899|P2|COMPLETED|Overall Study||50
7546143|NCT03170609|18573900|P1|COMPLETED|Overall Study||50
7546144|NCT03170609|18573894|P7|Vaccinated|Overall Study||52
7546145|NCT03170609|18573895|P6|Vaccinated|Overall Study||52
7546146|NCT03170609|18573896|P5|Vaccinated|Overall Study||52
7546147|NCT03170609|18573897|P4|Vaccinated|Overall Study||52
7546148|NCT03170609|18573898|P3|Vaccinated|Overall Study||52
7546149|NCT03170609|18573899|P2|Vaccinated|Overall Study||52
7546150|NCT03170609|18573900|P1|Vaccinated|Overall Study||52
7546151|NCT03170609|18573894|P7|STARTED|Overall Study||52
7546152|NCT03170609|18573895|P6|STARTED|Overall Study||52
7546153|NCT03170609|18573896|P5|STARTED|Overall Study||52
7546154|NCT03170609|18573897|P4|STARTED|Overall Study||52
7546155|NCT03170609|18573898|P3|STARTED|Overall Study||52
7546156|NCT03170609|18573899|P2|STARTED|Overall Study||52
7546157|NCT03170609|18573900|P1|STARTED|Overall Study||53
7546158|NCT03170544|18573970|P12|NOT COMPLETED|Part 4||0
7546159|NCT03170544|18573971|P11|NOT COMPLETED|Part 4||0
7546160|NCT03170544|18573972|P10|NOT COMPLETED|Part 4||0
7546161|NCT03170544|18573973|P9|NOT COMPLETED|Part 4||0
7546162|NCT03170544|18573974|P8|NOT COMPLETED|Part 4||0
7546163|NCT03170544|18573975|P7|NOT COMPLETED|Part 4||0
7546164|NCT03170544|18573976|P6|NOT COMPLETED|Part 4||0
7546165|NCT03170544|18573977|P5|NOT COMPLETED|Part 4||0
7546166|NCT03170544|18573978|P4|NOT COMPLETED|Part 4||0
7546167|NCT03170544|18573979|P3|NOT COMPLETED|Part 4||0
7546168|NCT03170544|18573980|P2|NOT COMPLETED|Part 4||0
7546169|NCT03170544|18573981|P1|NOT COMPLETED|Part 4||0
7546170|NCT03170544|18573970|P12|COMPLETED|Part 4||6
7546171|NCT03170544|18573971|P11|COMPLETED|Part 4||3
7546172|NCT03170544|18573972|P10|COMPLETED|Part 4||0
7546173|NCT03170544|18573973|P9|COMPLETED|Part 4||0
7546174|NCT03170544|18573974|P8|COMPLETED|Part 4||0
7546175|NCT03170544|18573975|P7|COMPLETED|Part 4||0
7546176|NCT03170544|18573976|P6|COMPLETED|Part 4||0
7546177|NCT03170544|18573977|P5|COMPLETED|Part 4||0
7546178|NCT03170544|18573978|P4|COMPLETED|Part 4||0
7546179|NCT03170544|18573979|P3|COMPLETED|Part 4||0
7546180|NCT03170544|18573980|P2|COMPLETED|Part 4||0
7546181|NCT03170544|18573981|P1|COMPLETED|Part 4||0
7546182|NCT03170544|18573970|P12|STARTED|Part 4||6
7546183|NCT03170544|18573971|P11|STARTED|Part 4||3
7546184|NCT03170544|18573972|P10|STARTED|Part 4||0
7546185|NCT03170544|18573973|P9|STARTED|Part 4||0
7546186|NCT03170544|18573974|P8|STARTED|Part 4||0
7546187|NCT03170544|18573975|P7|STARTED|Part 4||0
7546188|NCT03170544|18573976|P6|STARTED|Part 4||0
7546189|NCT03170544|18573977|P5|STARTED|Part 4||0
7546190|NCT03170544|18573978|P4|STARTED|Part 4||0
7546191|NCT03170544|18573979|P3|STARTED|Part 4||0
7546192|NCT03170544|18573980|P2|STARTED|Part 4||0
7546193|NCT03170544|18573981|P1|STARTED|Part 4||0
7546194|NCT03170544|18573970|P12|NOT COMPLETED|Part 3||0
7546195|NCT03170544|18573971|P11|NOT COMPLETED|Part 3||0
7546196|NCT03170544|18573972|P10|NOT COMPLETED|Part 3||0
7546197|NCT03170544|18573973|P9|NOT COMPLETED|Part 3||0
7546198|NCT03170544|18573974|P8|NOT COMPLETED|Part 3||0
7546199|NCT03170544|18573975|P7|NOT COMPLETED|Part 3||0
7546200|NCT03170544|18573976|P6|NOT COMPLETED|Part 3||0
7546201|NCT03170544|18573977|P5|NOT COMPLETED|Part 3||0
7546202|NCT03170544|18573978|P4|NOT COMPLETED|Part 3||0
7546203|NCT03170544|18573979|P3|NOT COMPLETED|Part 3||0
7546204|NCT03170544|18573980|P2|NOT COMPLETED|Part 3||0
7546205|NCT03170544|18573981|P1|NOT COMPLETED|Part 3||0
7546206|NCT03170544|18573970|P12|COMPLETED|Part 3||0
7546207|NCT03170544|18573971|P11|COMPLETED|Part 3||0
7546208|NCT03170544|18573972|P10|COMPLETED|Part 3||6
7546209|NCT03170544|18573973|P9|COMPLETED|Part 3||6
7546210|NCT03170544|18573974|P8|COMPLETED|Part 3||4
7546211|NCT03170544|18573975|P7|COMPLETED|Part 3||0
7546212|NCT03170544|18573976|P6|COMPLETED|Part 3||0
7546213|NCT03170544|18573977|P5|COMPLETED|Part 3||0
7546214|NCT03170544|18573978|P4|COMPLETED|Part 3||0
7546215|NCT03170544|18573979|P3|COMPLETED|Part 3||0
7546216|NCT03170544|18573980|P2|COMPLETED|Part 3||0
7546217|NCT03170544|18573981|P1|COMPLETED|Part 3||0
7546218|NCT03170544|18573970|P12|STARTED|Part 3||0
7546219|NCT03170544|18573971|P11|STARTED|Part 3||0
7546220|NCT03170544|18573972|P10|STARTED|Part 3||6
7546221|NCT03170544|18573973|P9|STARTED|Part 3||6
7546222|NCT03170544|18573974|P8|STARTED|Part 3||4
7546223|NCT03170544|18573975|P7|STARTED|Part 3||0
7546224|NCT03170544|18573976|P6|STARTED|Part 3||0
7546225|NCT03170544|18573977|P5|STARTED|Part 3||0
7546226|NCT03170544|18573978|P4|STARTED|Part 3||0
7546227|NCT03170544|18573979|P3|STARTED|Part 3||0
7546228|NCT03170544|18573980|P2|STARTED|Part 3||0
7546229|NCT03170544|18573981|P1|STARTED|Part 3||0
7546230|NCT03170544|18573970|P12|NOT COMPLETED|Part 2||0
7546231|NCT03170544|18573971|P11|NOT COMPLETED|Part 2||0
7546232|NCT03170544|18573972|P10|NOT COMPLETED|Part 2||0
7546233|NCT03170544|18573973|P9|NOT COMPLETED|Part 2||0
7546234|NCT03170544|18573974|P8|NOT COMPLETED|Part 2||0
7546235|NCT03170544|18573975|P7|NOT COMPLETED|Part 2||0
7546236|NCT03170544|18573976|P6|NOT COMPLETED|Part 2||0
7546237|NCT03170544|18573977|P5|NOT COMPLETED|Part 2||0
7546238|NCT03170544|18573978|P4|NOT COMPLETED|Part 2||0
7546239|NCT03170544|18573979|P3|NOT COMPLETED|Part 2||0
7546240|NCT03170544|18573980|P2|NOT COMPLETED|Part 2||0
7546241|NCT03170544|18573981|P1|NOT COMPLETED|Part 2||0
7546242|NCT03170544|18573970|P12|COMPLETED|Part 2||0
7546243|NCT03170544|18573971|P11|COMPLETED|Part 2||0
7546244|NCT03170544|18573972|P10|COMPLETED|Part 2||0
7546245|NCT03170544|18573973|P9|COMPLETED|Part 2||0
7546246|NCT03170544|18573974|P8|COMPLETED|Part 2||0
7546247|NCT03170544|18573975|P7|COMPLETED|Part 2||4
7546248|NCT03170544|18573976|P6|COMPLETED|Part 2||0
7546249|NCT03170544|18573977|P5|COMPLETED|Part 2||0
7546250|NCT03170544|18573978|P4|COMPLETED|Part 2||0
7546251|NCT03170544|18573979|P3|COMPLETED|Part 2||0
7546252|NCT03170544|18573980|P2|COMPLETED|Part 2||0
7546253|NCT03170544|18573981|P1|COMPLETED|Part 2||0
7546254|NCT03170544|18573970|P12|STARTED|Part 2||0
7546255|NCT03170544|18573971|P11|STARTED|Part 2||0
7546256|NCT03170544|18573972|P10|STARTED|Part 2||0
7546257|NCT03170544|18573973|P9|STARTED|Part 2||0
7546258|NCT03170544|18573974|P8|STARTED|Part 2||0
7546259|NCT03170544|18573975|P7|STARTED|Part 2||4
7546260|NCT03170544|18573976|P6|STARTED|Part 2||0
7546261|NCT03170544|18573977|P5|STARTED|Part 2||0
7546262|NCT03170544|18573978|P4|STARTED|Part 2||0
7546263|NCT03170544|18573979|P3|STARTED|Part 2||0
7546264|NCT03170544|18573980|P2|STARTED|Part 2||0
7546265|NCT03170544|18573981|P1|STARTED|Part 2||0
7546266|NCT03170544|18573970|P12|NOT COMPLETED|Part 1||0
7546267|NCT03170544|18573971|P11|NOT COMPLETED|Part 1||0
7546268|NCT03170544|18573972|P10|NOT COMPLETED|Part 1||0
7546269|NCT03170544|18573973|P9|NOT COMPLETED|Part 1||0
7546270|NCT03170544|18573974|P8|NOT COMPLETED|Part 1||0
7546271|NCT03170544|18573975|P7|NOT COMPLETED|Part 1||0
7546272|NCT03170544|18573976|P6|NOT COMPLETED|Part 1||0
7546273|NCT03170544|18573977|P5|NOT COMPLETED|Part 1||0
7546274|NCT03170544|18573978|P4|NOT COMPLETED|Part 1||1
7546275|NCT03170544|18573979|P3|NOT COMPLETED|Part 1||0
7546276|NCT03170544|18573980|P2|NOT COMPLETED|Part 1||0
7546277|NCT03170544|18573981|P1|NOT COMPLETED|Part 1||1
7546278|NCT03170544|18573970|P12|COMPLETED|Part 1||0
7546279|NCT03170544|18573971|P11|COMPLETED|Part 1||0
7546280|NCT03170544|18573972|P10|COMPLETED|Part 1||0
7546281|NCT03170544|18573973|P9|COMPLETED|Part 1||0
7546282|NCT03170544|18573974|P8|COMPLETED|Part 1||0
7546283|NCT03170544|18573975|P7|COMPLETED|Part 1||0
7546284|NCT03170544|18573976|P6|COMPLETED|Part 1||6
7546285|NCT03170544|18573977|P5|COMPLETED|Part 1||6
7546286|NCT03170544|18573978|P4|COMPLETED|Part 1||6
7546287|NCT03170544|18573979|P3|COMPLETED|Part 1||6
7546288|NCT03170544|18573980|P2|COMPLETED|Part 1||6
7546289|NCT03170544|18573981|P1|COMPLETED|Part 1||9
7546290|NCT03170544|18573970|P12|STARTED|Part 1||0
7546291|NCT03170544|18573971|P11|STARTED|Part 1||0
7546292|NCT03170544|18573972|P10|STARTED|Part 1||0
7546293|NCT03170544|18573973|P9|STARTED|Part 1||0
7546294|NCT03170544|18573974|P8|STARTED|Part 1||0
7546295|NCT03170544|18573975|P7|STARTED|Part 1||0
7546296|NCT03170544|18573976|P6|STARTED|Part 1||6
7546297|NCT03170544|18573977|P5|STARTED|Part 1||6
7546298|NCT03170544|18573978|P4|STARTED|Part 1||7
7546299|NCT03170544|18573979|P3|STARTED|Part 1||6
7546300|NCT03170544|18573980|P2|STARTED|Part 1||6
7546301|NCT03170544|18573981|P1|STARTED|Part 1||10
7546302|NCT03170271|18574145|P2|NOT COMPLETED|Overall Study||11
7546303|NCT03170271|18574146|P1|NOT COMPLETED|Overall Study||33
7546304|NCT03170271|18574145|P2|COMPLETED|Overall Study||218
7546305|NCT03170271|18574146|P1|COMPLETED|Overall Study||398
7546306|NCT03170271|18574145|P2|Received Treatment|Overall Study||229
7546307|NCT03170271|18574146|P1|Received Treatment|Overall Study||427
7546308|NCT03170271|18574145|P2|STARTED|Overall Study||229
7546309|NCT03170271|18574146|P1|STARTED|Overall Study||431
7546310|NCT03170232|18574174|P2|NOT COMPLETED|Overall Study||27
7546311|NCT03170232|18574175|P1|NOT COMPLETED|Overall Study||27
7546312|NCT03170232|18574174|P2|COMPLETED|Overall Study||0
7546313|NCT03170232|18574175|P1|COMPLETED|Overall Study||0
7546314|NCT03170232|18574174|P2|STARTED|Overall Study||27
7546315|NCT03170232|18574175|P1|STARTED|Overall Study||27
7546316|NCT03170219|18574221|P2|NOT COMPLETED|Overall Study||0
7546317|NCT03170219|18574222|P1|NOT COMPLETED|Overall Study||0
7546318|NCT03170219|18574221|P2|COMPLETED|Overall Study||4
7546319|NCT03170219|18574222|P1|COMPLETED|Overall Study||7
7546320|NCT03170219|18574221|P2|STARTED|Overall Study||4
7546321|NCT03170219|18574222|P1|STARTED|Overall Study||7
7546322|NCT03170193|18574253|P7|NOT COMPLETED|Overall Study||0
7546323|NCT03170193|18574254|P6|NOT COMPLETED|Overall Study||0
7546324|NCT03170193|18574255|P5|NOT COMPLETED|Overall Study||0
7546325|NCT03170193|18574256|P4|NOT COMPLETED|Overall Study||1
7546326|NCT03170193|18574257|P3|NOT COMPLETED|Overall Study||0
7546327|NCT03170193|18574258|P2|NOT COMPLETED|Overall Study||1
7546328|NCT03170193|18574259|P1|NOT COMPLETED|Overall Study||1
7546329|NCT03170193|18574253|P7|COMPLETED|Overall Study||6
7546330|NCT03170193|18574254|P6|COMPLETED|Overall Study||6
7546331|NCT03170193|18574255|P5|COMPLETED|Overall Study||6
7546332|NCT03170193|18574256|P4|COMPLETED|Overall Study||5
7546333|NCT03170193|18574257|P3|COMPLETED|Overall Study||6
7546334|NCT03170193|18574258|P2|COMPLETED|Overall Study||5
7546335|NCT03170193|18574259|P1|COMPLETED|Overall Study||11
7546336|NCT03170193|18574253|P7|STARTED|Overall Study||6
7546337|NCT03170193|18574254|P6|STARTED|Overall Study||6
7546338|NCT03170193|18574255|P5|STARTED|Overall Study||6
7546339|NCT03170193|18574256|P4|STARTED|Overall Study||6
7546340|NCT03170193|18574257|P3|STARTED|Overall Study||6
7546341|NCT03170193|18574258|P2|STARTED|Overall Study||6
7546342|NCT03170193|18574259|P1|STARTED|Overall Study||12
7546343|NCT03170154|18574328|P1|NOT COMPLETED|Overall Study||8
7546344|NCT03170154|18574328|P1|COMPLETED|Overall Study||342
7546345|NCT03170154|18574328|P1|Rotational Stability Sub-study|Overall Study||141
7546346|NCT03170154|18574328|P1|STARTED|Overall Study||350
7546347|NCT03169816|18574343|P2|NOT COMPLETED|Overall Study||13
7546348|NCT03169816|18574344|P1|NOT COMPLETED|Overall Study||27
7546349|NCT03169816|18574343|P2|COMPLETED|Overall Study||3
7546350|NCT03169816|18574344|P1|COMPLETED|Overall Study||6
7546351|NCT03169816|18574343|P2|STARTED|Overall Study||16
7546352|NCT03169816|18574344|P1|STARTED|Overall Study||33
7546353|NCT03169530|18574352|P2|NOT COMPLETED|Overall Study||17
7546354|NCT03169530|18574353|P1|NOT COMPLETED|Overall Study||15
7546355|NCT03169530|18574352|P2|COMPLETED|Overall Study||0
7546356|NCT03169530|18574353|P1|COMPLETED|Overall Study||0
7546357|NCT03169530|18574352|P2|STARTED|Overall Study||17
7546358|NCT03169530|18574353|P1|STARTED|Overall Study||15
7546359|NCT03169244|18574373|P2|NOT COMPLETED|Overall Study||4
7546360|NCT03169244|18574374|P1|NOT COMPLETED|Overall Study||5
7546361|NCT03169244|18574373|P2|COMPLETED|Overall Study||16
7546362|NCT03169244|18574374|P1|COMPLETED|Overall Study||17
7546363|NCT03169244|18574373|P2|Received Intervention|Overall Study||18
7546364|NCT03169244|18574374|P1|Received Intervention|Overall Study||22
7546365|NCT03169244|18574373|P2|Randomly Assigned|Overall Study||20
7546366|NCT03169244|18574374|P1|Randomly Assigned|Overall Study||22
7546367|NCT03169244|18574373|P2|STARTED|Overall Study||20
7546368|NCT03169244|18574374|P1|STARTED|Overall Study||22
7546369|NCT03169153|18574384|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
7546370|NCT03169153|18574385|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
7546371|NCT03169153|18574384|P2|COMPLETED|Period 2, Second 30 Days of Wear||32
7546372|NCT03169153|18574385|P1|COMPLETED|Period 2, Second 30 Days of Wear||37
7546373|NCT03169153|18574384|P2|STARTED|Period 2, Second 30 Days of Wear|One subject discontinued after completing Period 1 and was not exposed in Period 2.|34
7546374|NCT03169153|18574385|P1|STARTED|Period 2, Second 30 Days of Wear||39
7546375|NCT03169153|18574384|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||4
7546376|NCT03169153|18574385|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||3
7546377|NCT03169153|18574384|P2|COMPLETED|Period 1, First 30 Days of Wear||35
7546378|NCT03169153|18574385|P1|COMPLETED|Period 1, First 30 Days of Wear||39
7546379|NCT03169153|18574384|P2|STARTED|Period 1, First 30 Days of Wear||39
7546380|NCT03169153|18574385|P1|STARTED|Period 1, First 30 Days of Wear||42
7546381|NCT03169062|18574391|P1|NOT COMPLETED|Overall Study||0
7546382|NCT03169062|18574391|P1|COMPLETED|Overall Study||10
7546383|NCT03169062|18574391|P1|STARTED|Overall Study||10
7546384|NCT03168919|18574396|P1|NOT COMPLETED|Overall Study||2
7546385|NCT03168919|18574396|P1|COMPLETED|Overall Study||3
7546386|NCT03168919|18574396|P1|STARTED|Overall Study||5
7546387|NCT03168906|18574406|P2|NOT COMPLETED|Overall Study||6
7546388|NCT03168906|18574407|P1|NOT COMPLETED|Overall Study||6
7546389|NCT03168906|18574406|P2|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
7546390|NCT03168906|18574407|P1|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
7546391|NCT03168906|18574406|P2|STARTED|Overall Study||6
7546392|NCT03168906|18574407|P1|STARTED|Overall Study||6
7546393|NCT03168841|18574427|P1|NOT COMPLETED|Overall Study||4
7546394|NCT03168841|18574427|P1|COMPLETED|Overall Study||36
7546395|NCT03168841|18574427|P1|STARTED|Overall Study||40
7546396|NCT03168542|18574434|P3|NOT COMPLETED|Overall Study||0
7546397|NCT03168542|18574435|P2|NOT COMPLETED|Overall Study||0
7546398|NCT03168542|18574436|P1|NOT COMPLETED|Overall Study||0
7546399|NCT03168542|18574434|P3|COMPLETED|Overall Study||9
7546400|NCT03168542|18574435|P2|COMPLETED|Overall Study||5
7546401|NCT03168542|18574436|P1|COMPLETED|Overall Study||7
7546402|NCT03168542|18574434|P3|STARTED|Overall Study||9
7546403|NCT03168542|18574435|P2|STARTED|Overall Study||5
7546404|NCT03168542|18574436|P1|STARTED|Overall Study||7
7546405|NCT03168425|18574453|P2|NOT COMPLETED|Overall Study||11
7546406|NCT03168425|18574454|P1|NOT COMPLETED|Overall Study||7
7546407|NCT03168425|18574453|P2|COMPLETED|Overall Study||85
7546408|NCT03168425|18574454|P1|COMPLETED|Overall Study||87
7546409|NCT03168425|18574453|P2|STARTED|Overall Study||96
7546410|NCT03168425|18574454|P1|STARTED|Overall Study||94
7546411|NCT03168308|18574464|P2|NOT COMPLETED|Overall Study||0
7546412|NCT03168308|18574465|P1|NOT COMPLETED|Overall Study||0
7546413|NCT03168308|18574464|P2|COMPLETED|Overall Study||44
7546414|NCT03168308|18574465|P1|COMPLETED|Overall Study||48
7546415|NCT03168308|18574464|P2|STARTED|Overall Study||44
7546416|NCT03168308|18574465|P1|STARTED|Overall Study||48
7546417|NCT03168295|18574478|P5|NOT COMPLETED|Overall Study||0
7546418|NCT03168295|18574479|P4|NOT COMPLETED|Overall Study||0
7546419|NCT03168295|18574480|P3|NOT COMPLETED|Overall Study||0
7546420|NCT03168295|18574481|P2|NOT COMPLETED|Overall Study||0
7546421|NCT03168295|18574482|P1|NOT COMPLETED|Overall Study||0
7546422|NCT03168295|18574478|P5|COMPLETED|Overall Study||20
7546423|NCT03168295|18574479|P4|COMPLETED|Overall Study||4
7546424|NCT03168295|18574480|P3|COMPLETED|Overall Study||4
7546425|NCT03168295|18574481|P2|COMPLETED|Overall Study||3
7546426|NCT03168295|18574482|P1|COMPLETED|Overall Study||3
7546427|NCT03168295|18574478|P5|STARTED|Overall Study||20
7546428|NCT03168295|18574479|P4|STARTED|Overall Study||4
7546429|NCT03168295|18574480|P3|STARTED|Overall Study||4
7546430|NCT03168295|18574481|P2|STARTED|Overall Study||3
7546431|NCT03168295|18574482|P1|STARTED|Overall Study||3
7546432|NCT03168022|18574496|P2|NOT COMPLETED|Overall Study||1
7546433|NCT03168022|18574497|P1|NOT COMPLETED|Overall Study||0
7546434|NCT03168022|18574496|P2|COMPLETED|Overall Study||21
7546435|NCT03168022|18574497|P1|COMPLETED|Overall Study||21
7546436|NCT03168022|18574496|P2|STARTED|Overall Study||22
7546437|NCT03168022|18574497|P1|STARTED|Overall Study||21
7546438|NCT03167541|18574505|P2|NOT COMPLETED|Second Intervention||0
7546439|NCT03167541|18574506|P1|NOT COMPLETED|Second Intervention||0
7546440|NCT03167541|18574505|P2|COMPLETED|Second Intervention||9
7546441|NCT03167541|18574506|P1|COMPLETED|Second Intervention||9
7546442|NCT03167541|18574505|P2|STARTED|Second Intervention||9
7546443|NCT03167541|18574506|P1|STARTED|Second Intervention||9
7546444|NCT03167541|18574505|P2|NOT COMPLETED|Washout: 5-8 Days||0
7546445|NCT03167541|18574506|P1|NOT COMPLETED|Washout: 5-8 Days||0
7546446|NCT03167541|18574505|P2|COMPLETED|Washout: 5-8 Days||9
7546447|NCT03167541|18574506|P1|COMPLETED|Washout: 5-8 Days||9
7546448|NCT03167541|18574505|P2|STARTED|Washout: 5-8 Days||9
7546449|NCT03167541|18574506|P1|STARTED|Washout: 5-8 Days||9
7546450|NCT03167541|18574505|P2|NOT COMPLETED|First Intervention||0
7546451|NCT03167541|18574506|P1|NOT COMPLETED|First Intervention||0
7546452|NCT03167541|18574505|P2|COMPLETED|First Intervention||9
7546453|NCT03167541|18574506|P1|COMPLETED|First Intervention||9
7546454|NCT03167541|18574505|P2|STARTED|First Intervention||9
7546455|NCT03167541|18574506|P1|STARTED|First Intervention||9
7546456|NCT03167151|18574531|P3|NOT COMPLETED|Overall Study||1
7546457|NCT03167151|18574532|P2|NOT COMPLETED|Overall Study||1
7546458|NCT03167151|18574533|P1|NOT COMPLETED|Overall Study||1
7546459|NCT03167151|18574531|P3|COMPLETED|Overall Study||2
7546460|NCT03167151|18574532|P2|COMPLETED|Overall Study||2
7546461|NCT03167151|18574533|P1|COMPLETED|Overall Study||2
7546462|NCT03167151|18574531|P3|STARTED|Overall Study||3
7546463|NCT03167151|18574532|P2|STARTED|Overall Study||3
7546464|NCT03167151|18574533|P1|STARTED|Overall Study||3
7546465|NCT03166735|18574546|P5|NOT COMPLETED|Overall Study||4
7546466|NCT03166735|18574547|P4|NOT COMPLETED|Overall Study||1
7546467|NCT03166735|18574548|P3|NOT COMPLETED|Overall Study||3
7546468|NCT03166735|18574549|P2|NOT COMPLETED|Overall Study||3
7546469|NCT03166735|18574550|P1|NOT COMPLETED|Overall Study||1
7546470|NCT03166735|18574546|P5|COMPLETED|Overall Study||28
7546471|NCT03166735|18574547|P4|COMPLETED|Overall Study||16
7546472|NCT03166735|18574548|P3|COMPLETED|Overall Study||13
7546473|NCT03166735|18574549|P2|COMPLETED|Overall Study||13
7546474|NCT03166735|18574550|P1|COMPLETED|Overall Study||32
7546475|NCT03166735|18574546|P5|Treated|Overall Study||32
7546476|NCT03166735|18574547|P4|Treated|Overall Study||17
7546477|NCT03166735|18574548|P3|Treated|Overall Study||16
7546478|NCT03166735|18574549|P2|Treated|Overall Study||16
7546479|NCT03166735|18574550|P1|Treated|Overall Study||32
7546480|NCT03166735|18574546|P5|STARTED|Overall Study||32
7546481|NCT03166735|18574547|P4|STARTED|Overall Study||17
7546482|NCT03166735|18574548|P3|STARTED|Overall Study||16
7546483|NCT03166735|18574549|P2|STARTED|Overall Study||16
7546484|NCT03166735|18574550|P1|STARTED|Overall Study||33
7546485|NCT03166618|18574600|P2|NOT COMPLETED|Overall Study||1
7546486|NCT03166618|18574601|P1|NOT COMPLETED|Overall Study||0
7546487|NCT03166618|18574600|P2|COMPLETED|Overall Study||0
7546488|NCT03166618|18574601|P1|COMPLETED|Overall Study||0
7546489|NCT03166618|18574600|P2|STARTED|Overall Study||1
7546490|NCT03166618|18574601|P1|STARTED|Overall Study||0
7546491|NCT03166215|18574613|P3|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||2
7546492|NCT03166215|18574614|P2|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
7546493|NCT03166215|18574615|P1|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
7546494|NCT03166215|18574613|P3|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||14
7546495|NCT03166215|18574614|P2|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
7546496|NCT03166215|18574615|P1|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
7546497|NCT03166215|18574613|P3|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||16
7546498|NCT03166215|18574614|P2|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
7546499|NCT03166215|18574615|P1|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
7546500|NCT03166215|18574613|P3|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
7546501|NCT03166215|18574614|P2|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||2
7546502|NCT03166215|18574615|P1|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
7546503|NCT03166215|18574613|P3|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
7546504|NCT03166215|18574614|P2|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||12
7546505|NCT03166215|18574615|P1|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||4
7546506|NCT03166215|18574613|P3|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||0
7546507|NCT03166215|18574614|P2|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||14
7546508|NCT03166215|18574615|P1|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||4
7546509|NCT03166124|18574655|P4|NOT COMPLETED|Treatment Period 2||0
7546510|NCT03166124|18574656|P3|NOT COMPLETED|Treatment Period 2||0
7546511|NCT03166124|18574657|P2|NOT COMPLETED|Treatment Period 2||0
7546512|NCT03166124|18574658|P1|NOT COMPLETED|Treatment Period 2||0
7546513|NCT03166124|18574655|P4|COMPLETED|Treatment Period 2||20
7546514|NCT03166124|18574656|P3|COMPLETED|Treatment Period 2||17
7546515|NCT03166124|18574657|P2|COMPLETED|Treatment Period 2||18
7546516|NCT03166124|18574658|P1|COMPLETED|Treatment Period 2||20
7546517|NCT03166124|18574655|P4|STARTED|Treatment Period 2||20
7546518|NCT03166124|18574656|P3|STARTED|Treatment Period 2||17
7546519|NCT03166124|18574657|P2|STARTED|Treatment Period 2||18
7546520|NCT03166124|18574658|P1|STARTED|Treatment Period 2||20
7546521|NCT03166124|18574655|P4|NOT COMPLETED|Wash-out Period||1
7546522|NCT03166124|18574656|P3|NOT COMPLETED|Wash-out Period||1
7546523|NCT03166124|18574657|P2|NOT COMPLETED|Wash-out Period||2
7546524|NCT03166124|18574658|P1|NOT COMPLETED|Wash-out Period||0
7546525|NCT03166124|18574655|P4|COMPLETED|Wash-out Period||20
7546526|NCT03166124|18574656|P3|COMPLETED|Wash-out Period||17
7546527|NCT03166124|18574657|P2|COMPLETED|Wash-out Period||18
7546528|NCT03166124|18574658|P1|COMPLETED|Wash-out Period||20
7546529|NCT03166124|18574655|P4|STARTED|Wash-out Period||21
7546530|NCT03166124|18574656|P3|STARTED|Wash-out Period||18
7546531|NCT03166124|18574657|P2|STARTED|Wash-out Period||20
7546532|NCT03166124|18574658|P1|STARTED|Wash-out Period||20
7546533|NCT03166124|18574655|P4|NOT COMPLETED|Treatment Period 1||0
7546534|NCT03166124|18574656|P3|NOT COMPLETED|Treatment Period 1||1
7546535|NCT03166124|18574657|P2|NOT COMPLETED|Treatment Period 1||0
7546536|NCT03166124|18574658|P1|NOT COMPLETED|Treatment Period 1||0
7546537|NCT03166124|18574655|P4|COMPLETED|Treatment Period 1||21
7546538|NCT03166124|18574656|P3|COMPLETED|Treatment Period 1||18
7546539|NCT03166124|18574657|P2|COMPLETED|Treatment Period 1||20
7546540|NCT03166124|18574658|P1|COMPLETED|Treatment Period 1||20
7546541|NCT03166124|18574655|P4|Received at Least One Dose of Study Drug|Treatment Period 1||21
7546542|NCT03166124|18574656|P3|Received at Least One Dose of Study Drug|Treatment Period 1||18
7546543|NCT03166124|18574657|P2|Received at Least One Dose of Study Drug|Treatment Period 1||20
7546544|NCT03166124|18574658|P1|Received at Least One Dose of Study Drug|Treatment Period 1||20
7546545|NCT03166124|18574655|P4|STARTED|Treatment Period 1||21
7546546|NCT03166124|18574656|P3|STARTED|Treatment Period 1||19
7546547|NCT03166124|18574657|P2|STARTED|Treatment Period 1||20
7546548|NCT03166124|18574658|P1|STARTED|Treatment Period 1||20
7546549|NCT03165981|18574674|P2|NOT COMPLETED|Overall Study||4
7546550|NCT03165981|18574675|P1|NOT COMPLETED|Overall Study||11
7546551|NCT03165981|18574674|P2|COMPLETED|Overall Study||107
7546552|NCT03165981|18574675|P1|COMPLETED|Overall Study||99
7546553|NCT03165981|18574674|P2|Per Protocol Population|Overall Study||107
7546554|NCT03165981|18574675|P1|Per Protocol Population|Overall Study||99
7546555|NCT03165981|18574674|P2|STARTED|Overall Study||111
7546556|NCT03165981|18574675|P1|STARTED|Overall Study||110
7546557|NCT03165955|18574703|P1|NOT COMPLETED|Treatment||8
7546558|NCT03165955|18574703|P1|COMPLETED|Treatment||20
7546559|NCT03165955|18574703|P1|STARTED|Treatment||28
7546560|NCT03165955|18574703|P1|NOT COMPLETED|Screening/Baseline||3
7546561|NCT03165955|18574703|P1|COMPLETED|Screening/Baseline||28
7546562|NCT03165955|18574703|P1|STARTED|Screening/Baseline||31
7546563|NCT03165916|18574722|P2|NOT COMPLETED|Overall Study||0
7546564|NCT03165916|18574723|P1|NOT COMPLETED|Overall Study||0
7546565|NCT03165916|18574722|P2|COMPLETED|Overall Study||57
7546566|NCT03165916|18574723|P1|COMPLETED|Overall Study||58
7546567|NCT03165916|18574722|P2|Reconstruction Interventions|Overall Study||57
7546568|NCT03165916|18574723|P1|Reconstruction Interventions|Overall Study||59
7546569|NCT03165916|18574722|P2|STARTED|Overall Study||57
7546570|NCT03165916|18574723|P1|STARTED|Overall Study||58
7546571|NCT03165747|18574731|P2|NOT COMPLETED|Overall Study||0
7546572|NCT03165747|18574732|P1|NOT COMPLETED|Overall Study||0
7546573|NCT03165747|18574731|P2|COMPLETED|Overall Study||0
7546574|NCT03165747|18574732|P1|COMPLETED|Overall Study||0
7546575|NCT03165747|18574731|P2|STARTED|Overall Study||0
7546576|NCT03165747|18574732|P1|STARTED|Overall Study||0
7546577|NCT03165617|18574760|P2|NOT COMPLETED|Overall Study||9
7546578|NCT03165617|18574761|P1|NOT COMPLETED|Overall Study||9
7546579|NCT03165617|18574760|P2|COMPLETED|Overall Study||2247
7546580|NCT03165617|18574761|P1|COMPLETED|Overall Study||2249
7546581|NCT03165617|18574760|P2|STARTED|Overall Study||2256
7546582|NCT03165617|18574761|P1|STARTED|Overall Study||2258
7546583|NCT03165175|18574825|P2|NOT COMPLETED|Baseline to 3-month||0
7546584|NCT03165175|18574826|P1|NOT COMPLETED|Baseline to 3-month||4
7546585|NCT03165175|18574825|P2|COMPLETED|Baseline to 3-month||39
7546586|NCT03165175|18574826|P1|COMPLETED|Baseline to 3-month||31
7546587|NCT03165175|18574825|P2|STARTED|Baseline to 3-month||39
7546588|NCT03165175|18574826|P1|STARTED|Baseline to 3-month||35
7546589|NCT03165175|18574825|P2|NOT COMPLETED|1-month to 3-month||0
7546590|NCT03165175|18574826|P1|NOT COMPLETED|1-month to 3-month||6
7546591|NCT03165175|18574825|P2|COMPLETED|1-month to 3-month||39
7546592|NCT03165175|18574826|P1|COMPLETED|1-month to 3-month||35
7546593|NCT03165175|18574825|P2|STARTED|1-month to 3-month||39
7546594|NCT03165175|18574826|P1|STARTED|1-month to 3-month||41
7546595|NCT03165110|18574840|P1|NOT COMPLETED|Overall Study||1
7546596|NCT03165110|18574840|P1|COMPLETED|Overall Study||46
7546597|NCT03165110|18574840|P1|STARTED|Overall Study||47
7546598|NCT03165058|18574854|P2|NOT COMPLETED|Overall Study||0
7546599|NCT03165058|18574855|P1|NOT COMPLETED|Overall Study||0
7546600|NCT03165058|18574854|P2|COMPLETED|Overall Study||11
7546601|NCT03165058|18574855|P1|COMPLETED|Overall Study||21
7546602|NCT03165058|18574854|P2|STARTED|Overall Study||11
7546603|NCT03165058|18574855|P1|STARTED|Overall Study||21
7546604|NCT03165045|18574862|P1|NOT COMPLETED|Visit 2||182
7546605|NCT03165045|18574862|P1|COMPLETED|Visit 2||1140
7546606|NCT03165045|18574862|P1|STARTED|Visit 2||1322
7546607|NCT03165045|18574862|P1|NOT COMPLETED|Visit 1||29
7546608|NCT03165045|18574862|P1|COMPLETED|Visit 1||1322
7546609|NCT03165045|18574862|P1|STARTED|Visit 1||1351
7546610|NCT03164629|18574873|P2|NOT COMPLETED|Overall Study||0
7546611|NCT03164629|18574874|P1|NOT COMPLETED|Overall Study||0
7546612|NCT03164629|18574873|P2|COMPLETED|Overall Study||25
7546613|NCT03164629|18574874|P1|COMPLETED|Overall Study||25
7546614|NCT03164629|18574873|P2|STARTED|Overall Study||25
7546615|NCT03164629|18574874|P1|STARTED|Overall Study||25
7546616|NCT03164551|18574882|P2|NOT COMPLETED|Overall Study||16
7546617|NCT03164551|18574883|P1|NOT COMPLETED|Overall Study||29
7546618|NCT03164551|18574882|P2|COMPLETED|Overall Study||192
7546619|NCT03164551|18574883|P1|COMPLETED|Overall Study||171
7546620|NCT03164551|18574882|P2|STARTED|Overall Study||208
7546621|NCT03164551|18574883|P1|STARTED|Overall Study||200
7546622|NCT03163758|18574909|P2|NOT COMPLETED|Overall Study||7
7546623|NCT03163758|18574910|P1|NOT COMPLETED|Overall Study||8
7546624|NCT03163758|18574909|P2|COMPLETED|Overall Study||14
7546625|NCT03163758|18574910|P1|COMPLETED|Overall Study||13
7546626|NCT03163758|18574909|P2|STARTED|Overall Study||21
7546627|NCT03163758|18574910|P1|STARTED|Overall Study||21
7546628|NCT03163342|18574922|P1|NOT COMPLETED|Overall Study||0
7546629|NCT03163342|18574922|P1|COMPLETED|Overall Study||20
7546630|NCT03163342|18574922|P1|STARTED|Overall Study||20
7546631|NCT03163303|18574931|P2|NOT COMPLETED|Overall Study||0
7546632|NCT03163303|18574932|P1|NOT COMPLETED|Overall Study||0
7546633|NCT03163303|18574931|P2|COMPLETED|Overall Study||94
7546634|NCT03163303|18574932|P1|COMPLETED|Overall Study||85
7546635|NCT03163303|18574931|P2|STARTED|Overall Study||94
7546636|NCT03163303|18574932|P1|STARTED|Overall Study||85
7546637|NCT03163134|18574966|P2|NOT COMPLETED|Overall Study||0
7546638|NCT03163134|18574967|P1|NOT COMPLETED|Overall Study||0
7546639|NCT03163134|18574966|P2|COMPLETED|Overall Study||85
7546640|NCT03163134|18574967|P1|COMPLETED|Overall Study||85
7546641|NCT03163134|18574966|P2|STARTED|Overall Study||85
7546642|NCT03163134|18574967|P1|STARTED|Overall Study||85
7546643|NCT03163017|18574975|P1|NOT COMPLETED|Overall Study||0
7546644|NCT03163017|18574975|P1|COMPLETED|Overall Study||30
7546645|NCT03163017|18574975|P1|STARTED|Overall Study||30
7546646|NCT03162796|18574994|P3|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
7546647|NCT03162796|18574995|P2|NOT COMPLETED|Safety Follow-up: Week 52 - 60||2
7546648|NCT03162796|18574996|P1|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
7546649|NCT03162796|18574994|P3|COMPLETED|Safety Follow-up: Week 52 - 60||123
7546650|NCT03162796|18574995|P2|COMPLETED|Safety Follow-up: Week 52 - 60||114
7546651|NCT03162796|18574996|P1|COMPLETED|Safety Follow-up: Week 52 - 60||106
7546652|NCT03162796|18574994|P3|STARTED|Safety Follow-up: Week 52 - 60||124
7546653|NCT03162796|18574995|P2|STARTED|Safety Follow-up: Week 52 - 60||116
7546654|NCT03162796|18574996|P1|STARTED|Safety Follow-up: Week 52 - 60||107
7546655|NCT03162796|18574994|P3|NOT COMPLETED|Active Treatment Period: Week 24 - 52||1
7546656|NCT03162796|18574995|P2|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
7546657|NCT03162796|18574996|P1|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
7546658|NCT03162796|18574994|P3|COMPLETED|Active Treatment Period: Week 24 - 52||124
7546659|NCT03162796|18574995|P2|COMPLETED|Active Treatment Period: Week 24 - 52||116
7546660|NCT03162796|18574996|P1|COMPLETED|Active Treatment Period: Week 24 - 52||107
7546661|NCT03162796|18574994|P3|STARTED|Active Treatment Period: Week 24 - 52||125
7546662|NCT03162796|18574995|P2|STARTED|Active Treatment Period: Week 24 - 52||123
7546663|NCT03162796|18574996|P1|STARTED|Active Treatment Period: Week 24 - 52||114
7546664|NCT03162796|18574994|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||3
7546665|NCT03162796|18574995|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||4
7546666|NCT03162796|18574996|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||12
7546667|NCT03162796|18574994|P3|COMPLETED|Placebo Controlled Period: Week 0 - 24||125
7546668|NCT03162796|18574995|P2|COMPLETED|Placebo Controlled Period: Week 0 - 24||123
7546669|NCT03162796|18574996|P1|COMPLETED|Placebo Controlled Period: Week 0 - 24||114
7546670|NCT03162796|18574994|P3|STARTED|Placebo Controlled Period: Week 0 - 24||128
7546671|NCT03162796|18574995|P2|STARTED|Placebo Controlled Period: Week 0 - 24||127
7546672|NCT03162796|18574996|P1|STARTED|Placebo Controlled Period: Week 0 - 24||126
7546673|NCT03162614|18575306|P6|NOT COMPLETED|Overall Study||0
7546674|NCT03162614|18575307|P5|NOT COMPLETED|Overall Study||5
7546675|NCT03162614|18575308|P4|NOT COMPLETED|Overall Study||7
7546676|NCT03162614|18575309|P3|NOT COMPLETED|Overall Study||4
7546677|NCT03162614|18575310|P2|NOT COMPLETED|Overall Study||5
7546678|NCT03162614|18575311|P1|NOT COMPLETED|Overall Study||6
7546679|NCT03162614|18575306|P6|COMPLETED|Overall Study||24
7546680|NCT03162614|18575307|P5|COMPLETED|Overall Study||21
7546681|NCT03162614|18575308|P4|COMPLETED|Overall Study||19
7546682|NCT03162614|18575309|P3|COMPLETED|Overall Study||22
7546683|NCT03162614|18575310|P2|COMPLETED|Overall Study||21
7546684|NCT03162614|18575311|P1|COMPLETED|Overall Study||20
7546685|NCT03162614|18575306|P6|STARTED|Overall Study||24
7546686|NCT03162614|18575307|P5|STARTED|Overall Study||26
7546687|NCT03162614|18575308|P4|STARTED|Overall Study||26
7546688|NCT03162614|18575309|P3|STARTED|Overall Study||26
7546689|NCT03162614|18575310|P2|STARTED|Overall Study||26
7546690|NCT03162614|18575311|P1|STARTED|Overall Study||26
7546691|NCT03162458|18575405|P2|NOT COMPLETED|Overall Study||0
7546692|NCT03162458|18575406|P1|NOT COMPLETED|Overall Study||0
7546693|NCT03162458|18575405|P2|COMPLETED|Overall Study||71
7546694|NCT03162458|18575406|P1|COMPLETED|Overall Study||71
7546695|NCT03162458|18575405|P2|STARTED|Overall Study||71
7546696|NCT03162458|18575406|P1|STARTED|Overall Study||71
7546697|NCT03162354|18575432|P2|NOT COMPLETED|Overall Study||0
7546698|NCT03162354|18575433|P1|NOT COMPLETED|Overall Study||0
7546699|NCT03162354|18575432|P2|COMPLETED|Overall Study||237
7546700|NCT03162354|18575433|P1|COMPLETED|Overall Study||183
7546701|NCT03162354|18575432|P2|STARTED|Overall Study||237
7546702|NCT03162354|18575433|P1|STARTED|Overall Study||183
7546703|NCT03162328|18575464|P3|NOT COMPLETED|Study Period||1
7546704|NCT03162328|18575465|P2|NOT COMPLETED|Study Period||0
7546705|NCT03162328|18575466|P1|NOT COMPLETED|Study Period||0
7546706|NCT03162328|18575464|P3|COMPLETED|Study Period||31
7546707|NCT03162328|18575465|P2|COMPLETED|Study Period||30
7546708|NCT03162328|18575466|P1|COMPLETED|Study Period||0
7546709|NCT03162328|18575464|P3|STARTED|Study Period||32
7546710|NCT03162328|18575465|P2|STARTED|Study Period||30
7546711|NCT03162328|18575466|P1|STARTED|Study Period||0
7546712|NCT03162328|18575464|P3|NOT COMPLETED|Screening Period||0
7546713|NCT03162328|18575465|P2|NOT COMPLETED|Screening Period||0
7546714|NCT03162328|18575466|P1|NOT COMPLETED|Screening Period||22
7546715|NCT03162328|18575464|P3|COMPLETED|Screening Period||0
7546716|NCT03162328|18575465|P2|COMPLETED|Screening Period||0
7546717|NCT03162328|18575466|P1|COMPLETED|Screening Period||62
7546718|NCT03162328|18575464|P3|STARTED|Screening Period||0
7546719|NCT03162328|18575465|P2|STARTED|Screening Period||0
7546720|NCT03162328|18575466|P1|STARTED|Screening Period||84
7546721|NCT03162055|18575495|P2|NOT COMPLETED|Overall Study||43
7546722|NCT03162055|18575496|P1|NOT COMPLETED|Overall Study||62
7546723|NCT03162055|18575495|P2|COMPLETED|Overall Study||517
7546724|NCT03162055|18575496|P1|COMPLETED|Overall Study||497
7546725|NCT03162055|18575495|P2|Per Protocol (PP) Analysis Set|Overall Study||510
7546726|NCT03162055|18575496|P1|Per Protocol (PP) Analysis Set|Overall Study||506
7546727|NCT03162055|18575495|P2|Full Analysis Set (FAS)|Overall Study||552
7546728|NCT03162055|18575496|P1|Full Analysis Set (FAS)|Overall Study||552
7546729|NCT03162055|18575495|P2|Safety Analysis Set|Overall Study||552
7546730|NCT03162055|18575496|P1|Safety Analysis Set|Overall Study||552
7546731|NCT03162055|18575495|P2|Received Treatment|Overall Study||560
7546732|NCT03162055|18575496|P1|Received Treatment|Overall Study||557
7546733|NCT03162055|18575495|P2|STARTED|Overall Study||560
7546734|NCT03162055|18575496|P1|STARTED|Overall Study||559
7546735|NCT03161964|18575522|P2|NOT COMPLETED|Overall Study||1
7546736|NCT03161964|18575523|P1|NOT COMPLETED|Overall Study||0
7546737|NCT03161964|18575522|P2|COMPLETED|Overall Study||0
7546738|NCT03161964|18575523|P1|COMPLETED|Overall Study||1
7546739|NCT03161964|18575522|P2|STARTED|Overall Study||1
7546740|NCT03161964|18575523|P1|STARTED|Overall Study||1
7546741|NCT03161938|18575561|P2|NOT COMPLETED|Overall Study||0
7546742|NCT03161938|18575562|P1|NOT COMPLETED|Overall Study||0
7546743|NCT03161938|18575561|P2|COMPLETED|Overall Study||32
7546744|NCT03161938|18575562|P1|COMPLETED|Overall Study||32
7546745|NCT03161938|18575561|P2|STARTED|Overall Study||32
7546746|NCT03161938|18575562|P1|STARTED|Overall Study||32
7546747|NCT03161405|18575588|P1|NOT COMPLETED|Second Intervention Period (6 Days)||1
7546748|NCT03161405|18575588|P1|COMPLETED|Second Intervention Period (6 Days)||11
7546749|NCT03161405|18575588|P1|STARTED|Second Intervention Period (6 Days)||12
7546750|NCT03161405|18575588|P1|NOT COMPLETED|Washout Period (at Least 4 Days)||0
7546751|NCT03161405|18575588|P1|COMPLETED|Washout Period (at Least 4 Days)||12
7546752|NCT03161405|18575588|P1|STARTED|Washout Period (at Least 4 Days)||12
7546753|NCT03161405|18575588|P1|NOT COMPLETED|First Intervention Period (3 Days)||0
7546754|NCT03161405|18575588|P1|COMPLETED|First Intervention Period (3 Days)||12
7546755|NCT03161405|18575588|P1|STARTED|First Intervention Period (3 Days)||12
7546756|NCT03161327|18575599|P1|NOT COMPLETED|Overall Study||0
7546757|NCT03161327|18575599|P1|COMPLETED|Overall Study||238
7546758|NCT03161327|18575599|P1|STARTED|Overall Study||238
7546759|NCT03160898|18575608|P4|NOT COMPLETED|Overall Study||19
7546760|NCT03160898|18575609|P3|NOT COMPLETED|Overall Study||16
7546761|NCT03160898|18575610|P2|NOT COMPLETED|Overall Study||13
7546762|NCT03160898|18575611|P1|NOT COMPLETED|Overall Study||20
7546763|NCT03160898|18575608|P4|COMPLETED|Overall Study||98
7546764|NCT03160898|18575609|P3|COMPLETED|Overall Study||97
7546765|NCT03160898|18575610|P2|COMPLETED|Overall Study||100
7546766|NCT03160898|18575611|P1|COMPLETED|Overall Study||95
7546767|NCT03160898|18575608|P4|STARTED|Overall Study||117
7546768|NCT03160898|18575609|P3|STARTED|Overall Study||113
7546769|NCT03160898|18575610|P2|STARTED|Overall Study|1 patient withdrew consent before study drug dosing and was therefore excluded from safety analysis|113
7546770|NCT03160898|18575611|P1|STARTED|Overall Study||115
7546771|NCT03160885|18575634|P7|NOT COMPLETED|Maintenance Treatment Period||0
7546772|NCT03160885|18575635|P6|NOT COMPLETED|Maintenance Treatment Period||15
7546773|NCT03160885|18575636|P5|NOT COMPLETED|Maintenance Treatment Period||31
7546774|NCT03160885|18575637|P4|NOT COMPLETED|Maintenance Treatment Period||40
7546775|NCT03160885|18575638|P3|NOT COMPLETED|Maintenance Treatment Period||39
7546776|NCT03160885|18575639|P2|NOT COMPLETED|Maintenance Treatment Period||0
7546777|NCT03160885|18575640|P1|NOT COMPLETED|Maintenance Treatment Period||0
7546778|NCT03160885|18575634|P7|COMPLETED|Maintenance Treatment Period||0
7546779|NCT03160885|18575635|P6|COMPLETED|Maintenance Treatment Period||16
7546780|NCT03160885|18575636|P5|COMPLETED|Maintenance Treatment Period||15
7546781|NCT03160885|18575637|P4|COMPLETED|Maintenance Treatment Period||50
7546782|NCT03160885|18575638|P3|COMPLETED|Maintenance Treatment Period||52
7546783|NCT03160885|18575639|P2|COMPLETED|Maintenance Treatment Period||0
7546784|NCT03160885|18575640|P1|COMPLETED|Maintenance Treatment Period||0
7546785|NCT03160885|18575634|P7|STARTED|Maintenance Treatment Period||0
7546786|NCT03160885|18575635|P6|STARTED|Maintenance Treatment Period||31
7546787|NCT03160885|18575636|P5|STARTED|Maintenance Treatment Period||46
7546788|NCT03160885|18575637|P4|STARTED|Maintenance Treatment Period||90
7546789|NCT03160885|18575638|P3|STARTED|Maintenance Treatment Period||91
7546790|NCT03160885|18575639|P2|STARTED|Maintenance Treatment Period||0
7546791|NCT03160885|18575640|P1|STARTED|Maintenance Treatment Period||0
7546792|NCT03160885|18575634|P7|NOT COMPLETED|Open-label Treatment||137
7546793|NCT03160885|18575635|P6|NOT COMPLETED|Open-label Treatment||0
7546794|NCT03160885|18575636|P5|NOT COMPLETED|Open-label Treatment||0
7546795|NCT03160885|18575637|P4|NOT COMPLETED|Open-label Treatment||0
7546796|NCT03160885|18575638|P3|NOT COMPLETED|Open-label Treatment||0
7546797|NCT03160885|18575639|P2|NOT COMPLETED|Open-label Treatment||0
7546798|NCT03160885|18575640|P1|NOT COMPLETED|Open-label Treatment||0
7546799|NCT03160885|18575634|P7|COMPLETED|Open-label Treatment||423
7546800|NCT03160885|18575635|P6|COMPLETED|Open-label Treatment||0
7546801|NCT03160885|18575636|P5|COMPLETED|Open-label Treatment||0
7546802|NCT03160885|18575637|P4|COMPLETED|Open-label Treatment||0
7546803|NCT03160885|18575638|P3|COMPLETED|Open-label Treatment||0
7546804|NCT03160885|18575639|P2|COMPLETED|Open-label Treatment||0
7546805|NCT03160885|18575640|P1|COMPLETED|Open-label Treatment||0
7546806|NCT03160885|18575634|P7|STARTED|Open-label Treatment||560
7546807|NCT03160885|18575635|P6|STARTED|Open-label Treatment||0
7546808|NCT03160885|18575636|P5|STARTED|Open-label Treatment||0
7546809|NCT03160885|18575637|P4|STARTED|Open-label Treatment||0
7546810|NCT03160885|18575638|P3|STARTED|Open-label Treatment||0
7546811|NCT03160885|18575639|P2|STARTED|Open-label Treatment||0
7546812|NCT03160885|18575640|P1|STARTED|Open-label Treatment||0
7546813|NCT03160885|18575634|P7|NOT COMPLETED|Initial Treatment Period||0
7546814|NCT03160885|18575635|P6|NOT COMPLETED|Initial Treatment Period||0
7546815|NCT03160885|18575636|P5|NOT COMPLETED|Initial Treatment Period||0
7546816|NCT03160885|18575637|P4|NOT COMPLETED|Initial Treatment Period||0
7546817|NCT03160885|18575638|P3|NOT COMPLETED|Initial Treatment Period||0
7546818|NCT03160885|18575639|P2|NOT COMPLETED|Initial Treatment Period||22
7546819|NCT03160885|18575640|P1|NOT COMPLETED|Initial Treatment Period||35
7546820|NCT03160885|18575634|P7|COMPLETED|Initial Treatment Period||0
7546821|NCT03160885|18575635|P6|COMPLETED|Initial Treatment Period||0
7546822|NCT03160885|18575636|P5|COMPLETED|Initial Treatment Period||0
7546823|NCT03160885|18575637|P4|COMPLETED|Initial Treatment Period||0
7546824|NCT03160885|18575638|P3|COMPLETED|Initial Treatment Period||0
7546825|NCT03160885|18575639|P2|COMPLETED|Initial Treatment Period||179
7546826|NCT03160885|18575640|P1|COMPLETED|Initial Treatment Period||558
7546827|NCT03160885|18575634|P7|STARTED|Initial Treatment Period||0
7546828|NCT03160885|18575635|P6|STARTED|Initial Treatment Period||0
7546829|NCT03160885|18575636|P5|STARTED|Initial Treatment Period||0
7546830|NCT03160885|18575637|P4|STARTED|Initial Treatment Period||0
7546831|NCT03160885|18575638|P3|STARTED|Initial Treatment Period||0
7546832|NCT03160885|18575639|P2|STARTED|Initial Treatment Period||201
7546833|NCT03160885|18575640|P1|STARTED|Initial Treatment Period||593
7546834|NCT03160716|18575686|P1|NOT COMPLETED|Overall Study||1
7546835|NCT03160716|18575686|P1|COMPLETED|Overall Study||59
7546836|NCT03160716|18575686|P1|STARTED|Overall Study||60
7546837|NCT03160703|18575697|P4|NOT COMPLETED|Overall Study||1
7546838|NCT03160703|18575698|P3|NOT COMPLETED|Overall Study||0
7546839|NCT03160703|18575699|P2|NOT COMPLETED|Overall Study||0
7546840|NCT03160703|18575700|P1|NOT COMPLETED|Overall Study||0
7546841|NCT03160703|18575697|P4|COMPLETED|Overall Study||54
7546842|NCT03160703|18575698|P3|COMPLETED|Overall Study||55
7546843|NCT03160703|18575699|P2|COMPLETED|Overall Study||55
7546844|NCT03160703|18575700|P1|COMPLETED|Overall Study||55
7546845|NCT03160703|18575697|P4|STARTED|Overall Study||55
7546846|NCT03160703|18575698|P3|STARTED|Overall Study||55
7546847|NCT03160703|18575699|P2|STARTED|Overall Study||55
7546848|NCT03160703|18575700|P1|STARTED|Overall Study||55
7546849|NCT03160573|18575714|P4|NOT COMPLETED|Second Sequence (3 Weeks)||0
7546850|NCT03160573|18575715|P3|NOT COMPLETED|Second Sequence (3 Weeks)||0
7546851|NCT03160573|18575716|P2|NOT COMPLETED|Second Sequence (3 Weeks)||0
7546852|NCT03160573|18575717|P1|NOT COMPLETED|Second Sequence (3 Weeks)||0
7546853|NCT03160573|18575714|P4|COMPLETED|Second Sequence (3 Weeks)||23
7546854|NCT03160573|18575715|P3|COMPLETED|Second Sequence (3 Weeks)||23
7546855|NCT03160573|18575716|P2|COMPLETED|Second Sequence (3 Weeks)||23
7546856|NCT03160573|18575717|P1|COMPLETED|Second Sequence (3 Weeks)||22
7546857|NCT03160573|18575714|P4|STARTED|Second Sequence (3 Weeks)||23
7546858|NCT03160573|18575715|P3|STARTED|Second Sequence (3 Weeks)||23
7546859|NCT03160573|18575716|P2|STARTED|Second Sequence (3 Weeks)||23
7546860|NCT03160573|18575717|P1|STARTED|Second Sequence (3 Weeks)||22
7546861|NCT03160573|18575714|P4|NOT COMPLETED|Washout (2 Weeks)||0
7546862|NCT03160573|18575715|P3|NOT COMPLETED|Washout (2 Weeks)||0
7546863|NCT03160573|18575716|P2|NOT COMPLETED|Washout (2 Weeks)||0
7546864|NCT03160573|18575717|P1|NOT COMPLETED|Washout (2 Weeks)||0
7546865|NCT03160573|18575714|P4|COMPLETED|Washout (2 Weeks)||23
7546866|NCT03160573|18575715|P3|COMPLETED|Washout (2 Weeks)||23
7546867|NCT03160573|18575716|P2|COMPLETED|Washout (2 Weeks)||23
7546868|NCT03160573|18575717|P1|COMPLETED|Washout (2 Weeks)||22
7546869|NCT03160573|18575714|P4|STARTED|Washout (2 Weeks)||23
7546870|NCT03160573|18575715|P3|STARTED|Washout (2 Weeks)||23
7546871|NCT03160573|18575716|P2|STARTED|Washout (2 Weeks)||23
7546872|NCT03160573|18575717|P1|STARTED|Washout (2 Weeks)||22
7546873|NCT03160573|18575714|P4|NOT COMPLETED|First Sequence (3 Weeks)||2
7546874|NCT03160573|18575715|P3|NOT COMPLETED|First Sequence (3 Weeks)||2
7546875|NCT03160573|18575716|P2|NOT COMPLETED|First Sequence (3 Weeks)||3
7546876|NCT03160573|18575717|P1|NOT COMPLETED|First Sequence (3 Weeks)||1
7546877|NCT03160573|18575714|P4|COMPLETED|First Sequence (3 Weeks)||23
7546878|NCT03160573|18575715|P3|COMPLETED|First Sequence (3 Weeks)||23
7546879|NCT03160573|18575716|P2|COMPLETED|First Sequence (3 Weeks)||23
7546880|NCT03160573|18575717|P1|COMPLETED|First Sequence (3 Weeks)||22
7546881|NCT03160573|18575714|P4|STARTED|First Sequence (3 Weeks)||25
7546882|NCT03160573|18575715|P3|STARTED|First Sequence (3 Weeks)||25
7546883|NCT03160573|18575716|P2|STARTED|First Sequence (3 Weeks)||26
7546884|NCT03160573|18575717|P1|STARTED|First Sequence (3 Weeks)||23
7546885|NCT03160170|18575729|P2|NOT COMPLETED|Overall Study||0
7546886|NCT03160170|18575730|P1|NOT COMPLETED|Overall Study||0
7546887|NCT03160170|18575729|P2|COMPLETED|Overall Study||10
7546888|NCT03160170|18575730|P1|COMPLETED|Overall Study||10
7546889|NCT03160170|18575729|P2|STARTED|Overall Study||10
7546890|NCT03160170|18575730|P1|STARTED|Overall Study||10
7546891|NCT03160027|18575744|P4|NOT COMPLETED|Overall Study||0
7546892|NCT03160027|18575745|P3|NOT COMPLETED|Overall Study||0
7546893|NCT03160027|18575746|P2|NOT COMPLETED|Overall Study||0
7546894|NCT03160027|18575747|P1|NOT COMPLETED|Overall Study||0
7546895|NCT03160027|18575744|P4|COMPLETED|Overall Study||4
7546896|NCT03160027|18575745|P3|COMPLETED|Overall Study||6
7546897|NCT03160027|18575746|P2|COMPLETED|Overall Study||4
7546898|NCT03160027|18575747|P1|COMPLETED|Overall Study||6
7546899|NCT03160027|18575744|P4|STARTED|Overall Study||4
7546900|NCT03160027|18575745|P3|STARTED|Overall Study||6
7546901|NCT03160027|18575746|P2|STARTED|Overall Study||4
7546902|NCT03160027|18575747|P1|STARTED|Overall Study||6
7546903|NCT03159624|18575782|P2|NOT COMPLETED|Overall Study||1
7546904|NCT03159624|18575783|P1|NOT COMPLETED|Overall Study||0
7546905|NCT03159624|18575782|P2|COMPLETED|Overall Study||25
7546906|NCT03159624|18575783|P1|COMPLETED|Overall Study||21
7546907|NCT03159624|18575782|P2|STARTED|Overall Study||26
7546908|NCT03159624|18575783|P1|STARTED|Overall Study||21
7546909|NCT03159611|18575795|P2|NOT COMPLETED|Overall Study||15
7546910|NCT03159611|18575796|P1|NOT COMPLETED|Overall Study||23
7546911|NCT03159611|18575795|P2|COMPLETED|Overall Study||72
7546912|NCT03159611|18575796|P1|COMPLETED|Overall Study||72
7546913|NCT03159611|18575795|P2|STARTED|Overall Study||87
7546914|NCT03159611|18575796|P1|STARTED|Overall Study||95
7546915|NCT03159468|18575816|P6|NOT COMPLETED|Overall Study||0
7546916|NCT03159468|18575817|P5|NOT COMPLETED|Overall Study||0
7546917|NCT03159468|18575818|P4|NOT COMPLETED|Overall Study||0
7546918|NCT03159468|18575819|P3|NOT COMPLETED|Overall Study||3
7546919|NCT03159468|18575820|P2|NOT COMPLETED|Overall Study||0
7546920|NCT03159468|18575821|P1|NOT COMPLETED|Overall Study||0
7546921|NCT03159468|18575816|P6|COMPLETED|Overall Study||34
7546922|NCT03159468|18575817|P5|COMPLETED|Overall Study||34
7546923|NCT03159468|18575818|P4|COMPLETED|Overall Study||34
7546924|NCT03159468|18575819|P3|COMPLETED|Overall Study||34
7546925|NCT03159468|18575820|P2|COMPLETED|Overall Study||35
7546926|NCT03159468|18575821|P1|COMPLETED|Overall Study||35
7546927|NCT03159468|18575816|P6|STARTED|Overall Study||34
7546928|NCT03159468|18575817|P5|STARTED|Overall Study||34
7546929|NCT03159468|18575818|P4|STARTED|Overall Study||34
7546930|NCT03159468|18575819|P3|STARTED|Overall Study||37
7546931|NCT03159468|18575820|P2|STARTED|Overall Study||35
7546932|NCT03159468|18575821|P1|STARTED|Overall Study||35
7546933|NCT03159299|18575837|P2|NOT COMPLETED|Overall Study||1
7546934|NCT03159299|18575838|P1|NOT COMPLETED|Overall Study||2
7546935|NCT03159299|18575837|P2|COMPLETED|Overall Study||20
7546936|NCT03159299|18575838|P1|COMPLETED|Overall Study||24
7546937|NCT03159299|18575837|P2|STARTED|Overall Study||21
7546938|NCT03159299|18575838|P1|STARTED|Overall Study||26
7546939|NCT03159260|18575846|P2|NOT COMPLETED|Overall Study||4
7546940|NCT03159260|18575847|P1|NOT COMPLETED|Overall Study||3
7546941|NCT03159260|18575846|P2|COMPLETED|Overall Study||25
7546942|NCT03159260|18575847|P1|COMPLETED|Overall Study||25
7546943|NCT03159260|18575846|P2|STARTED|Overall Study||29
7546944|NCT03159260|18575847|P1|STARTED|Overall Study||28
7546945|NCT03159143|18575861|P1|NOT COMPLETED|Overall Study||0
7546946|NCT03159143|18575861|P1|COMPLETED|Overall Study||22
7546947|NCT03159143|18575861|P1|STARTED|Overall Study||22
7546948|NCT03159091|18575870|P2|NOT COMPLETED|Overall Study||4
7546949|NCT03159091|18575871|P1|NOT COMPLETED|Overall Study||5
7546950|NCT03159091|18575870|P2|COMPLETED|Overall Study||113
7546951|NCT03159091|18575871|P1|COMPLETED|Overall Study||116
7546952|NCT03159091|18575870|P2|STARTED|Overall Study||117
7546953|NCT03159091|18575871|P1|STARTED|Overall Study||121
7546954|NCT03158688|18575887|P2|NOT COMPLETED|Overall Study||312
7546955|NCT03158688|18575888|P1|NOT COMPLETED|Overall Study||154
7546956|NCT03158688|18575887|P2|COMPLETED|Overall Study||0
7546957|NCT03158688|18575888|P1|COMPLETED|Overall Study||0
7546958|NCT03158688|18575887|P2|Treated|Overall Study||308
7546959|NCT03158688|18575888|P1|Treated|Overall Study||153
7546960|NCT03158688|18575887|P2|STARTED|Overall Study||312
7546961|NCT03158688|18575888|P1|STARTED|Overall Study||154
7546962|NCT03158311|18575921|P3|NOT COMPLETED|Overall Study||28
7546963|NCT03158311|18575922|P2|NOT COMPLETED|Overall Study||16
7546964|NCT03158311|18575923|P1|NOT COMPLETED|Overall Study||22
7546965|NCT03158311|18575921|P3|COMPLETED|Overall Study||448
7546966|NCT03158311|18575922|P2|COMPLETED|Overall Study||460
7546967|NCT03158311|18575923|P1|COMPLETED|Overall Study||452
7546968|NCT03158311|18575921|P3|Safety Set (SAF)|Overall Study||475
7546969|NCT03158311|18575922|P2|Safety Set (SAF)|Overall Study||476
7546970|NCT03158311|18575923|P1|Safety Set (SAF)|Overall Study||474
7546971|NCT03158311|18575921|P3|Full Analysis Set (FAS)|Overall Study||475
7546972|NCT03158311|18575922|P2|Full Analysis Set (FAS)|Overall Study||476
7546973|NCT03158311|18575923|P1|Full Analysis Set (FAS)|Overall Study||474
7546974|NCT03158311|18575921|P3|STARTED|Overall Study||476
7546975|NCT03158311|18575922|P2|STARTED|Overall Study||476
7546976|NCT03158311|18575923|P1|STARTED|Overall Study||474
7546977|NCT03158285|18575955|P3|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
7546978|NCT03158285|18575956|P2|NOT COMPLETED|Active Treatment Period: Week 24 - 52||6
7546979|NCT03158285|18575957|P1|NOT COMPLETED|Active Treatment Period: Week 24 - 52||10
7546980|NCT03158285|18575955|P3|COMPLETED|Active Treatment Period: Week 24 - 52||227
7546981|NCT03158285|18575956|P2|COMPLETED|Active Treatment Period: Week 24 - 52||234
7546982|NCT03158285|18575957|P1|COMPLETED|Active Treatment Period: Week 24 - 52||228
7546983|NCT03158285|18575955|P3|STARTED|Active Treatment Period: Week 24 - 52|2 participants who discontinued without receiving study agent at and post Week 24 were not included.|234
7546984|NCT03158285|18575956|P2|STARTED|Active Treatment Period: Week 24 - 52||240
7546985|NCT03158285|18575957|P1|STARTED|Active Treatment Period: Week 24 - 52|2 participants who discontinued without receiving study agent at and post Week 24 were not included.|238
7546986|NCT03158285|18575955|P3|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||9
7546987|NCT03158285|18575956|P2|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||8
7546988|NCT03158285|18575957|P1|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||6
7546989|NCT03158285|18575955|P3|COMPLETED|Placebo-controlled Period: Week 0 - 24||236
7546990|NCT03158285|18575956|P2|COMPLETED|Placebo-controlled Period: Week 0 - 24||240
7546991|NCT03158285|18575957|P1|COMPLETED|Placebo-controlled Period: Week 0 - 24||240
7546992|NCT03158285|18575955|P3|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (159) = 38 (CNTO1959PSA3001) + 121 (CNTO1959PSA3002)|159
7546993|NCT03158285|18575956|P2|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (160) = 49 (CNTO1959PSA3001) + 111 (CNTO1959PSA3002)|160
7546994|NCT03158285|18575957|P1|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (154) = 55 (CNTO1959PSA3001) + 99 (CNTO1959PSA3002)|154
7546995|NCT03158285|18575955|P3|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (243)= 73 (CNTO1959PSA3001) + 170 (CNTO1959PSA3002)|243
7546996|NCT03158285|18575956|P2|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (230)= 72 (CNTO1959PSA3001) + 158 (CNTO1959PSA3002)|230
7546997|NCT03158285|18575957|P1|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (255) = 77 (CNTO1959PSA3001[NCT03162796]) + 178 (CNTO1959PSA3002)|255
7546998|NCT03158285|18575955|P3|STARTED|Placebo-controlled Period: Week 0 - 24||245
7546999|NCT03158285|18575956|P2|STARTED|Placebo-controlled Period: Week 0 - 24||248
7547000|NCT03158285|18575957|P1|STARTED|Placebo-controlled Period: Week 0 - 24||246
7547001|NCT03158272|18576173|P4|NOT COMPLETED|Overall Study||6
7547002|NCT03158272|18576174|P3|NOT COMPLETED|Overall Study||6
7547003|NCT03158272|18576175|P2|NOT COMPLETED|Overall Study||4
7547004|NCT03158272|18576176|P1|NOT COMPLETED|Overall Study||3
7547005|NCT03158272|18576173|P4|COMPLETED|Overall Study||0
7547006|NCT03158272|18576174|P3|COMPLETED|Overall Study||0
7547007|NCT03158272|18576175|P2|COMPLETED|Overall Study||0
7547008|NCT03158272|18576176|P1|COMPLETED|Overall Study||0
7547009|NCT03158272|18576173|P4|STARTED|Overall Study||6
7547010|NCT03158272|18576174|P3|STARTED|Overall Study||6
7547011|NCT03158272|18576175|P2|STARTED|Overall Study||4
7547012|NCT03158272|18576176|P1|STARTED|Overall Study||3
7547013|NCT03158220|18576246|P2|NOT COMPLETED|Overall Study||16
7547014|NCT03158220|18576247|P1|NOT COMPLETED|Overall Study||17
7547015|NCT03158220|18576246|P2|COMPLETED|Overall Study||626
7547016|NCT03158220|18576247|P1|COMPLETED|Overall Study||553
7547017|NCT03158220|18576246|P2|Vaccination 3|Overall Study||629
7547018|NCT03158220|18576247|P1|Vaccination 3|Overall Study||556
7547019|NCT03158220|18576246|P2|Vaccination 2|Overall Study||635
7547020|NCT03158220|18576247|P1|Vaccination 2|Overall Study||563
7547021|NCT03158220|18576246|P2|Vaccination 1|Overall Study||640
7547022|NCT03158220|18576247|P1|Vaccination 1|Overall Study||570
7547023|NCT03158220|18576246|P2|STARTED|Overall Study||642
7547024|NCT03158220|18576247|P1|STARTED|Overall Study||570
7547025|NCT03158038|18576267|P2|NOT COMPLETED|Overall Study||0
7547026|NCT03158038|18576268|P1|NOT COMPLETED|Overall Study||0
7547027|NCT03158038|18576267|P2|COMPLETED|Overall Study||60
7547028|NCT03158038|18576268|P1|COMPLETED|Overall Study||240
7547029|NCT03158038|18576267|P2|STARTED|Overall Study||60
7547030|NCT03158038|18576268|P1|STARTED|Overall Study||240
7547031|NCT03158012|18576284|P2|NOT COMPLETED|Overall Study||1
7547032|NCT03158012|18576285|P1|NOT COMPLETED|Overall Study||0
7547033|NCT03158012|18576284|P2|COMPLETED|Overall Study||6
7547034|NCT03158012|18576285|P1|COMPLETED|Overall Study||8
7547035|NCT03158012|18576284|P2|STARTED|Overall Study||7
7547036|NCT03158012|18576285|P1|STARTED|Overall Study||8
7547037|NCT03157583|18576291|P1|NOT COMPLETED|Overall Study||1
7547038|NCT03157583|18576291|P1|COMPLETED|Overall Study||7
7547039|NCT03157583|18576291|P1|STARTED|Overall Study||8
7547040|NCT03157531|18576309|P1|NOT COMPLETED|Overall Study||6
7547041|NCT03157531|18576309|P1|COMPLETED|Overall Study||91
7547042|NCT03157531|18576309|P1|Analyzed at 30 Days For MAEs|Overall Study||93
7547043|NCT03157531|18576309|P1|STARTED|Overall Study||97
7547044|NCT03157232|18576324|P1|NOT COMPLETED|Overall Study||0
7547045|NCT03157232|18576324|P1|COMPLETED|Overall Study||18
7547046|NCT03157232|18576324|P1|STARTED|Overall Study||18
7547047|NCT03156543|18576330|P2|NOT COMPLETED|Overall Study||0
7547048|NCT03156543|18576331|P1|NOT COMPLETED|Overall Study||1
7547049|NCT03156543|18576330|P2|COMPLETED|Overall Study||23
7547050|NCT03156543|18576331|P1|COMPLETED|Overall Study||8
7547051|NCT03156543|18576330|P2|STARTED|Overall Study||23
7547052|NCT03156543|18576331|P1|STARTED|Overall Study||9
7547053|NCT03155269|18576341|P2|NOT COMPLETED|Overall Study||7
7547054|NCT03155269|18576342|P1|NOT COMPLETED|Overall Study||5
7547055|NCT03155269|18576341|P2|COMPLETED|Overall Study||50
7547056|NCT03155269|18576342|P1|COMPLETED|Overall Study||52
7547057|NCT03155269|18576341|P2|STARTED|Overall Study||57
7547058|NCT03155269|18576342|P1|STARTED|Overall Study||57
7547059|NCT03155178|18576388|P4|NOT COMPLETED|Overall Study||7
7547060|NCT03155178|18576389|P3|NOT COMPLETED|Overall Study||7
7547061|NCT03155178|18576390|P2|NOT COMPLETED|Overall Study||7
7547062|NCT03155178|18576391|P1|NOT COMPLETED|Overall Study||7
7547063|NCT03155178|18576388|P4|COMPLETED|Overall Study||62
7547064|NCT03155178|18576389|P3|COMPLETED|Overall Study||62
7547065|NCT03155178|18576390|P2|COMPLETED|Overall Study||62
7547066|NCT03155178|18576391|P1|COMPLETED|Overall Study||62
7547067|NCT03155178|18576388|P4|STARTED|Overall Study||69
7547068|NCT03155178|18576389|P3|STARTED|Overall Study||69
7547069|NCT03155178|18576390|P2|STARTED|Overall Study||69
7547070|NCT03155178|18576391|P1|STARTED|Overall Study||69
7547071|NCT03154333|18576411|P2|NOT COMPLETED|Overall Study||5
7547072|NCT03154333|18576412|P1|NOT COMPLETED|Overall Study||7
7547073|NCT03154333|18576411|P2|COMPLETED|Overall Study||21
7547074|NCT03154333|18576412|P1|COMPLETED|Overall Study||21
7547075|NCT03154333|18576411|P2|STARTED|Overall Study||26
7547076|NCT03154333|18576412|P1|STARTED|Overall Study||28
7547077|NCT03154086|18576435|P15|NOT COMPLETED|Part B (Up to 25 Days)||0
7547078|NCT03154086|18576436|P14|NOT COMPLETED|Part B (Up to 25 Days)||0
7547079|NCT03154086|18576437|P13|NOT COMPLETED|Part B (Up to 25 Days)||0
7547080|NCT03154086|18576438|P12|NOT COMPLETED|Part B (Up to 25 Days)||0
7547081|NCT03154086|18576439|P11|NOT COMPLETED|Part B (Up to 25 Days)||1
7547082|NCT03154086|18576440|P10|NOT COMPLETED|Part B (Up to 25 Days)||0
7547083|NCT03154086|18576441|P9|NOT COMPLETED|Part B (Up to 25 Days)||0
7547084|NCT03154086|18576442|P8|NOT COMPLETED|Part B (Up to 25 Days)||0
7547085|NCT03154086|18576443|P7|NOT COMPLETED|Part B (Up to 25 Days)||0
7547086|NCT03154086|18576444|P6|NOT COMPLETED|Part B (Up to 25 Days)||0
7547087|NCT03154086|18576445|P5|NOT COMPLETED|Part B (Up to 25 Days)||0
7547088|NCT03154086|18576446|P4|NOT COMPLETED|Part B (Up to 25 Days)||0
7547089|NCT03154086|18576447|P3|NOT COMPLETED|Part B (Up to 25 Days)||0
7547090|NCT03154086|18576448|P2|NOT COMPLETED|Part B (Up to 25 Days)||0
7547091|NCT03154086|18576449|P1|NOT COMPLETED|Part B (Up to 25 Days)||0
7547092|NCT03154086|18576435|P15|COMPLETED|Part B (Up to 25 Days)||6
7547093|NCT03154086|18576436|P14|COMPLETED|Part B (Up to 25 Days)||6
7547094|NCT03154086|18576437|P13|COMPLETED|Part B (Up to 25 Days)||6
7547095|NCT03154086|18576438|P12|COMPLETED|Part B (Up to 25 Days)||6
7547096|NCT03154086|18576439|P11|COMPLETED|Part B (Up to 25 Days)||5
7547097|NCT03154086|18576440|P10|COMPLETED|Part B (Up to 25 Days)||10
7547098|NCT03154086|18576441|P9|COMPLETED|Part B (Up to 25 Days)||0
7547099|NCT03154086|18576442|P8|COMPLETED|Part B (Up to 25 Days)||0
7547100|NCT03154086|18576443|P7|COMPLETED|Part B (Up to 25 Days)||0
7547101|NCT03154086|18576444|P6|COMPLETED|Part B (Up to 25 Days)||0
7547102|NCT03154086|18576445|P5|COMPLETED|Part B (Up to 25 Days)||0
7547103|NCT03154086|18576446|P4|COMPLETED|Part B (Up to 25 Days)||0
7547104|NCT03154086|18576447|P3|COMPLETED|Part B (Up to 25 Days)||0
7547105|NCT03154086|18576448|P2|COMPLETED|Part B (Up to 25 Days)||0
7547106|NCT03154086|18576449|P1|COMPLETED|Part B (Up to 25 Days)||0
7547107|NCT03154086|18576435|P15|STARTED|Part B (Up to 25 Days)||6
7547108|NCT03154086|18576436|P14|STARTED|Part B (Up to 25 Days)||6
7547109|NCT03154086|18576437|P13|STARTED|Part B (Up to 25 Days)||6
7547110|NCT03154086|18576438|P12|STARTED|Part B (Up to 25 Days)||6
7547111|NCT03154086|18576439|P11|STARTED|Part B (Up to 25 Days)||6
7547112|NCT03154086|18576440|P10|STARTED|Part B (Up to 25 Days)||10
7547113|NCT03154086|18576441|P9|STARTED|Part B (Up to 25 Days)||0
7547114|NCT03154086|18576442|P8|STARTED|Part B (Up to 25 Days)||0
7547115|NCT03154086|18576443|P7|STARTED|Part B (Up to 25 Days)||0
7547116|NCT03154086|18576444|P6|STARTED|Part B (Up to 25 Days)||0
7547117|NCT03154086|18576445|P5|STARTED|Part B (Up to 25 Days)||0
7547118|NCT03154086|18576446|P4|STARTED|Part B (Up to 25 Days)||0
7547119|NCT03154086|18576447|P3|STARTED|Part B (Up to 25 Days)||0
7547120|NCT03154086|18576448|P2|STARTED|Part B (Up to 25 Days)||0
7547121|NCT03154086|18576449|P1|STARTED|Part B (Up to 25 Days)||0
7547122|NCT03154086|18576435|P15|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547123|NCT03154086|18576436|P14|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547124|NCT03154086|18576437|P13|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547125|NCT03154086|18576438|P12|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547126|NCT03154086|18576439|P11|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547127|NCT03154086|18576440|P10|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547128|NCT03154086|18576441|P9|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
7547129|NCT03154086|18576442|P8|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
7547130|NCT03154086|18576443|P7|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547131|NCT03154086|18576444|P6|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547132|NCT03154086|18576445|P5|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547133|NCT03154086|18576446|P4|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547134|NCT03154086|18576447|P3|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547135|NCT03154086|18576448|P2|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547136|NCT03154086|18576449|P1|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547137|NCT03154086|18576435|P15|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547138|NCT03154086|18576436|P14|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547139|NCT03154086|18576437|P13|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547140|NCT03154086|18576438|P12|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547141|NCT03154086|18576439|P11|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547142|NCT03154086|18576440|P10|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547143|NCT03154086|18576441|P9|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||4
7547144|NCT03154086|18576442|P8|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
7547145|NCT03154086|18576443|P7|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||2
7547146|NCT03154086|18576444|P6|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547147|NCT03154086|18576445|P5|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547148|NCT03154086|18576446|P4|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547149|NCT03154086|18576447|P3|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547150|NCT03154086|18576448|P2|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547151|NCT03154086|18576449|P1|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547152|NCT03154086|18576435|P15|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547153|NCT03154086|18576436|P14|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547154|NCT03154086|18576437|P13|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547155|NCT03154086|18576438|P12|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547156|NCT03154086|18576439|P11|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547157|NCT03154086|18576440|P10|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547158|NCT03154086|18576441|P9|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)|1 par was unwell on Day-1 of Period 2 and discontinued; hence,1 replacement was enrolled and dosed|5
7547159|NCT03154086|18576442|P8|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
7547160|NCT03154086|18576443|P7|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
7547161|NCT03154086|18576444|P6|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547162|NCT03154086|18576445|P5|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547163|NCT03154086|18576446|P4|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547164|NCT03154086|18576447|P3|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547165|NCT03154086|18576448|P2|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547166|NCT03154086|18576449|P1|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
7547167|NCT03154086|18576435|P15|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547168|NCT03154086|18576436|P14|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547169|NCT03154086|18576437|P13|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547170|NCT03154086|18576438|P12|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547171|NCT03154086|18576439|P11|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547172|NCT03154086|18576440|P10|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547173|NCT03154086|18576441|P9|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547174|NCT03154086|18576442|P8|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547175|NCT03154086|18576443|P7|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547176|NCT03154086|18576444|P6|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547177|NCT03154086|18576445|P5|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547178|NCT03154086|18576446|P4|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547179|NCT03154086|18576447|P3|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547180|NCT03154086|18576448|P2|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547181|NCT03154086|18576449|P1|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547182|NCT03154086|18576435|P15|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547183|NCT03154086|18576436|P14|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547184|NCT03154086|18576437|P13|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547185|NCT03154086|18576438|P12|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547186|NCT03154086|18576439|P11|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547187|NCT03154086|18576440|P10|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547188|NCT03154086|18576441|P9|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
7547189|NCT03154086|18576442|P8|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
7547190|NCT03154086|18576443|P7|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
7547191|NCT03154086|18576444|P6|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547192|NCT03154086|18576445|P5|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547193|NCT03154086|18576446|P4|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547194|NCT03154086|18576447|P3|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547195|NCT03154086|18576448|P2|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547196|NCT03154086|18576449|P1|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547197|NCT03154086|18576435|P15|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547198|NCT03154086|18576436|P14|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547199|NCT03154086|18576437|P13|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547200|NCT03154086|18576438|P12|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547201|NCT03154086|18576439|P11|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547202|NCT03154086|18576440|P10|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547203|NCT03154086|18576441|P9|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
7547204|NCT03154086|18576442|P8|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
7547205|NCT03154086|18576443|P7|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
7547206|NCT03154086|18576444|P6|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547207|NCT03154086|18576445|P5|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547208|NCT03154086|18576446|P4|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547209|NCT03154086|18576447|P3|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547210|NCT03154086|18576448|P2|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547211|NCT03154086|18576449|P1|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
7547212|NCT03154086|18576435|P15|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547213|NCT03154086|18576436|P14|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547214|NCT03154086|18576437|P13|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547215|NCT03154086|18576438|P12|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547216|NCT03154086|18576439|P11|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547217|NCT03154086|18576440|P10|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547218|NCT03154086|18576441|P9|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547219|NCT03154086|18576442|P8|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547220|NCT03154086|18576443|P7|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547221|NCT03154086|18576444|P6|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547222|NCT03154086|18576445|P5|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547223|NCT03154086|18576446|P4|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547224|NCT03154086|18576447|P3|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547225|NCT03154086|18576448|P2|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547226|NCT03154086|18576449|P1|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547227|NCT03154086|18576435|P15|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547228|NCT03154086|18576436|P14|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547229|NCT03154086|18576437|P13|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547230|NCT03154086|18576438|P12|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547231|NCT03154086|18576439|P11|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547232|NCT03154086|18576440|P10|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547233|NCT03154086|18576441|P9|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||4
7547234|NCT03154086|18576442|P8|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
7547235|NCT03154086|18576443|P7|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
7547236|NCT03154086|18576444|P6|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547237|NCT03154086|18576445|P5|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547238|NCT03154086|18576446|P4|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547239|NCT03154086|18576447|P3|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547240|NCT03154086|18576448|P2|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547241|NCT03154086|18576449|P1|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547242|NCT03154086|18576435|P15|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547243|NCT03154086|18576436|P14|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547244|NCT03154086|18576437|P13|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547245|NCT03154086|18576438|P12|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547246|NCT03154086|18576439|P11|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547247|NCT03154086|18576440|P10|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547248|NCT03154086|18576441|P9|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||4
7547249|NCT03154086|18576442|P8|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
7547250|NCT03154086|18576443|P7|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
7547251|NCT03154086|18576444|P6|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547252|NCT03154086|18576445|P5|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547253|NCT03154086|18576446|P4|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547254|NCT03154086|18576447|P3|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547255|NCT03154086|18576448|P2|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547256|NCT03154086|18576449|P1|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
7547257|NCT03154086|18576435|P15|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547258|NCT03154086|18576436|P14|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547259|NCT03154086|18576437|P13|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547260|NCT03154086|18576438|P12|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547261|NCT03154086|18576439|P11|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547262|NCT03154086|18576440|P10|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547263|NCT03154086|18576441|P9|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547264|NCT03154086|18576442|P8|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547265|NCT03154086|18576443|P7|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547266|NCT03154086|18576444|P6|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547267|NCT03154086|18576445|P5|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547268|NCT03154086|18576446|P4|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547269|NCT03154086|18576447|P3|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547270|NCT03154086|18576448|P2|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547271|NCT03154086|18576449|P1|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547272|NCT03154086|18576435|P15|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547273|NCT03154086|18576436|P14|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547274|NCT03154086|18576437|P13|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547275|NCT03154086|18576438|P12|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547276|NCT03154086|18576439|P11|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547277|NCT03154086|18576440|P10|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547278|NCT03154086|18576441|P9|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547279|NCT03154086|18576442|P8|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547280|NCT03154086|18576443|P7|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547281|NCT03154086|18576444|P6|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||2
7547282|NCT03154086|18576445|P5|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||6
7547283|NCT03154086|18576446|P4|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547284|NCT03154086|18576447|P3|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547285|NCT03154086|18576448|P2|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547286|NCT03154086|18576449|P1|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547287|NCT03154086|18576435|P15|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547288|NCT03154086|18576436|P14|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547289|NCT03154086|18576437|P13|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547290|NCT03154086|18576438|P12|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547291|NCT03154086|18576439|P11|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547292|NCT03154086|18576440|P10|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547293|NCT03154086|18576441|P9|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547294|NCT03154086|18576442|P8|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547295|NCT03154086|18576443|P7|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547296|NCT03154086|18576444|P6|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||2
7547297|NCT03154086|18576445|P5|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||6
7547298|NCT03154086|18576446|P4|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547299|NCT03154086|18576447|P3|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547300|NCT03154086|18576448|P2|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547301|NCT03154086|18576449|P1|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
7547302|NCT03154086|18576435|P15|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547303|NCT03154086|18576436|P14|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547304|NCT03154086|18576437|P13|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547305|NCT03154086|18576438|P12|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547306|NCT03154086|18576439|P11|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547307|NCT03154086|18576440|P10|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547308|NCT03154086|18576441|P9|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547309|NCT03154086|18576442|P8|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547310|NCT03154086|18576443|P7|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547311|NCT03154086|18576444|P6|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547312|NCT03154086|18576445|P5|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547313|NCT03154086|18576446|P4|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547314|NCT03154086|18576447|P3|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547315|NCT03154086|18576448|P2|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547316|NCT03154086|18576449|P1|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547317|NCT03154086|18576435|P15|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547318|NCT03154086|18576436|P14|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547319|NCT03154086|18576437|P13|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547320|NCT03154086|18576438|P12|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547321|NCT03154086|18576439|P11|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547322|NCT03154086|18576440|P10|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547323|NCT03154086|18576441|P9|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547324|NCT03154086|18576442|P8|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547325|NCT03154086|18576443|P7|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547326|NCT03154086|18576444|P6|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
7547327|NCT03154086|18576445|P5|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
7547328|NCT03154086|18576446|P4|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547329|NCT03154086|18576447|P3|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547330|NCT03154086|18576448|P2|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547331|NCT03154086|18576449|P1|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547332|NCT03154086|18576435|P15|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547333|NCT03154086|18576436|P14|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547334|NCT03154086|18576437|P13|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547335|NCT03154086|18576438|P12|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547336|NCT03154086|18576439|P11|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547337|NCT03154086|18576440|P10|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547338|NCT03154086|18576441|P9|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547339|NCT03154086|18576442|P8|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547340|NCT03154086|18576443|P7|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547341|NCT03154086|18576444|P6|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
7547342|NCT03154086|18576445|P5|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
7547343|NCT03154086|18576446|P4|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547344|NCT03154086|18576447|P3|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547345|NCT03154086|18576448|P2|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547346|NCT03154086|18576449|P1|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
7547347|NCT03154086|18576435|P15|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547348|NCT03154086|18576436|P14|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547349|NCT03154086|18576437|P13|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547350|NCT03154086|18576438|P12|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547351|NCT03154086|18576439|P11|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547352|NCT03154086|18576440|P10|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547353|NCT03154086|18576441|P9|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547354|NCT03154086|18576442|P8|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547355|NCT03154086|18576443|P7|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547356|NCT03154086|18576444|P6|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547357|NCT03154086|18576445|P5|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547358|NCT03154086|18576446|P4|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547359|NCT03154086|18576447|P3|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547360|NCT03154086|18576448|P2|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547361|NCT03154086|18576449|P1|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547362|NCT03154086|18576435|P15|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547363|NCT03154086|18576436|P14|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547364|NCT03154086|18576437|P13|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547365|NCT03154086|18576438|P12|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547366|NCT03154086|18576439|P11|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547367|NCT03154086|18576440|P10|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547368|NCT03154086|18576441|P9|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547369|NCT03154086|18576442|P8|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547370|NCT03154086|18576443|P7|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547371|NCT03154086|18576444|P6|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||2
7547372|NCT03154086|18576445|P5|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||6
7547373|NCT03154086|18576446|P4|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547374|NCT03154086|18576447|P3|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547375|NCT03154086|18576448|P2|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547376|NCT03154086|18576449|P1|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547377|NCT03154086|18576435|P15|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547378|NCT03154086|18576436|P14|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547379|NCT03154086|18576437|P13|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547380|NCT03154086|18576438|P12|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547381|NCT03154086|18576439|P11|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547382|NCT03154086|18576440|P10|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547383|NCT03154086|18576441|P9|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547384|NCT03154086|18576442|P8|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547385|NCT03154086|18576443|P7|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547386|NCT03154086|18576444|P6|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||2
7547387|NCT03154086|18576445|P5|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||6
7547388|NCT03154086|18576446|P4|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547389|NCT03154086|18576447|P3|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547390|NCT03154086|18576448|P2|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547391|NCT03154086|18576449|P1|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
7547392|NCT03154086|18576435|P15|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547393|NCT03154086|18576436|P14|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547394|NCT03154086|18576437|P13|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547395|NCT03154086|18576438|P12|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547396|NCT03154086|18576439|P11|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547397|NCT03154086|18576440|P10|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547398|NCT03154086|18576441|P9|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547399|NCT03154086|18576442|P8|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547400|NCT03154086|18576443|P7|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547401|NCT03154086|18576444|P6|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547402|NCT03154086|18576445|P5|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547403|NCT03154086|18576446|P4|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547404|NCT03154086|18576447|P3|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547405|NCT03154086|18576448|P2|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547406|NCT03154086|18576449|P1|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
7547407|NCT03154086|18576435|P15|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547408|NCT03154086|18576436|P14|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547409|NCT03154086|18576437|P13|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547410|NCT03154086|18576438|P12|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547411|NCT03154086|18576439|P11|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547412|NCT03154086|18576440|P10|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547413|NCT03154086|18576441|P9|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547414|NCT03154086|18576442|P8|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547415|NCT03154086|18576443|P7|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547416|NCT03154086|18576444|P6|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547417|NCT03154086|18576445|P5|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547418|NCT03154086|18576446|P4|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
7547419|NCT03154086|18576447|P3|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
7547420|NCT03154086|18576448|P2|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
7547421|NCT03154086|18576449|P1|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
7547422|NCT03154086|18576435|P15|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547423|NCT03154086|18576436|P14|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547424|NCT03154086|18576437|P13|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547425|NCT03154086|18576438|P12|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547426|NCT03154086|18576439|P11|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547427|NCT03154086|18576440|P10|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547428|NCT03154086|18576441|P9|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547429|NCT03154086|18576442|P8|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547430|NCT03154086|18576443|P7|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547431|NCT03154086|18576444|P6|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547432|NCT03154086|18576445|P5|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
7547433|NCT03154086|18576446|P4|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
7547434|NCT03154086|18576447|P3|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||1
7547435|NCT03154086|18576448|P2|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
7547436|NCT03154086|18576449|P1|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)|1 par was not dosed on day of dosing due to elevated lab; hence 1 replacement was enrolled and dosed|3
7547437|NCT03154086|18576435|P15|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547438|NCT03154086|18576436|P14|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547439|NCT03154086|18576437|P13|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547440|NCT03154086|18576438|P12|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547441|NCT03154086|18576439|P11|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547442|NCT03154086|18576440|P10|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547443|NCT03154086|18576441|P9|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547444|NCT03154086|18576442|P8|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547445|NCT03154086|18576443|P7|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547446|NCT03154086|18576444|P6|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547447|NCT03154086|18576445|P5|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547448|NCT03154086|18576446|P4|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547449|NCT03154086|18576447|P3|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
7547450|NCT03154086|18576448|P2|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547451|NCT03154086|18576449|P1|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547452|NCT03154086|18576435|P15|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547453|NCT03154086|18576436|P14|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547454|NCT03154086|18576437|P13|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547455|NCT03154086|18576438|P12|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547456|NCT03154086|18576439|P11|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547457|NCT03154086|18576440|P10|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547458|NCT03154086|18576441|P9|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547459|NCT03154086|18576442|P8|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547460|NCT03154086|18576443|P7|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547461|NCT03154086|18576444|P6|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547462|NCT03154086|18576445|P5|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547463|NCT03154086|18576446|P4|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
7547464|NCT03154086|18576447|P3|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
7547465|NCT03154086|18576448|P2|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
7547466|NCT03154086|18576449|P1|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
7547467|NCT03154086|18576435|P15|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547468|NCT03154086|18576436|P14|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547469|NCT03154086|18576437|P13|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547470|NCT03154086|18576438|P12|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547471|NCT03154086|18576439|P11|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547472|NCT03154086|18576440|P10|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547473|NCT03154086|18576441|P9|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547474|NCT03154086|18576442|P8|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547475|NCT03154086|18576443|P7|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547476|NCT03154086|18576444|P6|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547477|NCT03154086|18576445|P5|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
7547478|NCT03154086|18576446|P4|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
7547479|NCT03154086|18576447|P3|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
7547480|NCT03154086|18576448|P2|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
7547481|NCT03154086|18576449|P1|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
7547482|NCT03154086|18576435|P15|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547483|NCT03154086|18576436|P14|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547484|NCT03154086|18576437|P13|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547485|NCT03154086|18576438|P12|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547486|NCT03154086|18576439|P11|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547487|NCT03154086|18576440|P10|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547488|NCT03154086|18576441|P9|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547489|NCT03154086|18576442|P8|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547490|NCT03154086|18576443|P7|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547491|NCT03154086|18576444|P6|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547492|NCT03154086|18576445|P5|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547493|NCT03154086|18576446|P4|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547494|NCT03154086|18576447|P3|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547495|NCT03154086|18576448|P2|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547496|NCT03154086|18576449|P1|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547497|NCT03154086|18576435|P15|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547498|NCT03154086|18576436|P14|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547499|NCT03154086|18576437|P13|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547500|NCT03154086|18576438|P12|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547501|NCT03154086|18576439|P11|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547502|NCT03154086|18576440|P10|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547503|NCT03154086|18576441|P9|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547504|NCT03154086|18576442|P8|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547505|NCT03154086|18576443|P7|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547506|NCT03154086|18576444|P6|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547507|NCT03154086|18576445|P5|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547508|NCT03154086|18576446|P4|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
7547509|NCT03154086|18576447|P3|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
7547510|NCT03154086|18576448|P2|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
7547511|NCT03154086|18576449|P1|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
7547512|NCT03154086|18576435|P15|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547513|NCT03154086|18576436|P14|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547514|NCT03154086|18576437|P13|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547515|NCT03154086|18576438|P12|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547516|NCT03154086|18576439|P11|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547517|NCT03154086|18576440|P10|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547518|NCT03154086|18576441|P9|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547519|NCT03154086|18576442|P8|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547520|NCT03154086|18576443|P7|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547521|NCT03154086|18576444|P6|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547522|NCT03154086|18576445|P5|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
7547523|NCT03154086|18576446|P4|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
7547524|NCT03154086|18576447|P3|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
7547525|NCT03154086|18576448|P2|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)|One replacement par was enrolled and dosed|2
7547526|NCT03154086|18576449|P1|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
7547527|NCT03154086|18576435|P15|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547528|NCT03154086|18576436|P14|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547529|NCT03154086|18576437|P13|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547530|NCT03154086|18576438|P12|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547531|NCT03154086|18576439|P11|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547532|NCT03154086|18576440|P10|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547533|NCT03154086|18576441|P9|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547534|NCT03154086|18576442|P8|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547535|NCT03154086|18576443|P7|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547536|NCT03154086|18576444|P6|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547537|NCT03154086|18576445|P5|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547538|NCT03154086|18576446|P4|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547539|NCT03154086|18576447|P3|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547540|NCT03154086|18576448|P2|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
7547541|NCT03154086|18576449|P1|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547542|NCT03154086|18576435|P15|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547543|NCT03154086|18576436|P14|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547544|NCT03154086|18576437|P13|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547545|NCT03154086|18576438|P12|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547546|NCT03154086|18576439|P11|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547547|NCT03154086|18576440|P10|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547548|NCT03154086|18576441|P9|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547549|NCT03154086|18576442|P8|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547550|NCT03154086|18576443|P7|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547551|NCT03154086|18576444|P6|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547552|NCT03154086|18576445|P5|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547553|NCT03154086|18576446|P4|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
7547554|NCT03154086|18576447|P3|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
7547555|NCT03154086|18576448|P2|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
7547556|NCT03154086|18576449|P1|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
7547557|NCT03154086|18576435|P15|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547558|NCT03154086|18576436|P14|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547559|NCT03154086|18576437|P13|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547560|NCT03154086|18576438|P12|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547561|NCT03154086|18576439|P11|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547562|NCT03154086|18576440|P10|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547563|NCT03154086|18576441|P9|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547564|NCT03154086|18576442|P8|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547565|NCT03154086|18576443|P7|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547566|NCT03154086|18576444|P6|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547567|NCT03154086|18576445|P5|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
7547568|NCT03154086|18576446|P4|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
7547569|NCT03154086|18576447|P3|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
7547570|NCT03154086|18576448|P2|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
7547571|NCT03154086|18576449|P1|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
7547572|NCT03154086|18576435|P15|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547573|NCT03154086|18576436|P14|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547574|NCT03154086|18576437|P13|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547575|NCT03154086|18576438|P12|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547576|NCT03154086|18576439|P11|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547577|NCT03154086|18576440|P10|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547578|NCT03154086|18576441|P9|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547579|NCT03154086|18576442|P8|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547580|NCT03154086|18576443|P7|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547581|NCT03154086|18576444|P6|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547582|NCT03154086|18576445|P5|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547583|NCT03154086|18576446|P4|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547584|NCT03154086|18576447|P3|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547585|NCT03154086|18576448|P2|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547586|NCT03154086|18576449|P1|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547587|NCT03154086|18576435|P15|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547588|NCT03154086|18576436|P14|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547589|NCT03154086|18576437|P13|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547590|NCT03154086|18576438|P12|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547591|NCT03154086|18576439|P11|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547592|NCT03154086|18576440|P10|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547593|NCT03154086|18576441|P9|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547594|NCT03154086|18576442|P8|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547595|NCT03154086|18576443|P7|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547596|NCT03154086|18576444|P6|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547597|NCT03154086|18576445|P5|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547598|NCT03154086|18576446|P4|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
7547599|NCT03154086|18576447|P3|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
7547600|NCT03154086|18576448|P2|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
7547601|NCT03154086|18576449|P1|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
7547602|NCT03154086|18576435|P15|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547603|NCT03154086|18576436|P14|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547604|NCT03154086|18576437|P13|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547605|NCT03154086|18576438|P12|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547606|NCT03154086|18576439|P11|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547607|NCT03154086|18576440|P10|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547608|NCT03154086|18576441|P9|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547609|NCT03154086|18576442|P8|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547610|NCT03154086|18576443|P7|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547611|NCT03154086|18576444|P6|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547612|NCT03154086|18576445|P5|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
7547613|NCT03154086|18576446|P4|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)|One replacement participant (par) was enrolled and dosed|2
7547614|NCT03154086|18576447|P3|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
7547615|NCT03154086|18576448|P2|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
7547616|NCT03154086|18576449|P1|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
7547617|NCT03154086|18576435|P15|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547618|NCT03154086|18576436|P14|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547619|NCT03154086|18576437|P13|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547620|NCT03154086|18576438|P12|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547621|NCT03154086|18576439|P11|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547622|NCT03154086|18576440|P10|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547623|NCT03154086|18576441|P9|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547624|NCT03154086|18576442|P8|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547625|NCT03154086|18576443|P7|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547626|NCT03154086|18576444|P6|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547627|NCT03154086|18576445|P5|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547628|NCT03154086|18576446|P4|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
7547629|NCT03154086|18576447|P3|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547630|NCT03154086|18576448|P2|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547631|NCT03154086|18576449|P1|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547632|NCT03154086|18576435|P15|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547633|NCT03154086|18576436|P14|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547634|NCT03154086|18576437|P13|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547635|NCT03154086|18576438|P12|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547636|NCT03154086|18576439|P11|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547637|NCT03154086|18576440|P10|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547638|NCT03154086|18576441|P9|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547639|NCT03154086|18576442|P8|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547640|NCT03154086|18576443|P7|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547641|NCT03154086|18576444|P6|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547642|NCT03154086|18576445|P5|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547643|NCT03154086|18576446|P4|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
7547644|NCT03154086|18576447|P3|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
7547645|NCT03154086|18576448|P2|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
7547646|NCT03154086|18576449|P1|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
7547647|NCT03154086|18576435|P15|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547648|NCT03154086|18576436|P14|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547649|NCT03154086|18576437|P13|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547650|NCT03154086|18576438|P12|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547651|NCT03154086|18576439|P11|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547652|NCT03154086|18576440|P10|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547653|NCT03154086|18576441|P9|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547654|NCT03154086|18576442|P8|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547655|NCT03154086|18576443|P7|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547656|NCT03154086|18576444|P6|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547657|NCT03154086|18576445|P5|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
7547658|NCT03154086|18576446|P4|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
7547659|NCT03154086|18576447|P3|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
7547660|NCT03154086|18576448|P2|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
7547661|NCT03154086|18576449|P1|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
7547662|NCT03154086|18576435|P15|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547663|NCT03154086|18576436|P14|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547664|NCT03154086|18576437|P13|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547665|NCT03154086|18576438|P12|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547666|NCT03154086|18576439|P11|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547667|NCT03154086|18576440|P10|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547668|NCT03154086|18576441|P9|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547669|NCT03154086|18576442|P8|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547670|NCT03154086|18576443|P7|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547671|NCT03154086|18576444|P6|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547672|NCT03154086|18576445|P5|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547673|NCT03154086|18576446|P4|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547674|NCT03154086|18576447|P3|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547675|NCT03154086|18576448|P2|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547676|NCT03154086|18576449|P1|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547677|NCT03154086|18576435|P15|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547678|NCT03154086|18576436|P14|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547679|NCT03154086|18576437|P13|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547680|NCT03154086|18576438|P12|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547681|NCT03154086|18576439|P11|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547682|NCT03154086|18576440|P10|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547683|NCT03154086|18576441|P9|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547684|NCT03154086|18576442|P8|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547685|NCT03154086|18576443|P7|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547686|NCT03154086|18576444|P6|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547687|NCT03154086|18576445|P5|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547688|NCT03154086|18576446|P4|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
7547689|NCT03154086|18576447|P3|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
7547690|NCT03154086|18576448|P2|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
7547691|NCT03154086|18576449|P1|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
7547692|NCT03154086|18576435|P15|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547693|NCT03154086|18576436|P14|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547694|NCT03154086|18576437|P13|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547695|NCT03154086|18576438|P12|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547696|NCT03154086|18576439|P11|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547697|NCT03154086|18576440|P10|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547698|NCT03154086|18576441|P9|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547699|NCT03154086|18576442|P8|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547700|NCT03154086|18576443|P7|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547701|NCT03154086|18576444|P6|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547702|NCT03154086|18576445|P5|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
7547703|NCT03154086|18576446|P4|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
7547704|NCT03154086|18576447|P3|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
7547705|NCT03154086|18576448|P2|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
7547706|NCT03154086|18576449|P1|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
7547707|NCT03154047|18576849|P1|NOT COMPLETED|Overall Study||80
7547708|NCT03154047|18576849|P1|COMPLETED|Overall Study||0
7547709|NCT03154047|18576849|P1|Number of Patients Dosed|Overall Study||80
7547710|NCT03154047|18576849|P1|STARTED|Overall Study||80
7547711|NCT03153956|18576855|P2|NOT COMPLETED|Overall Study||0
7547712|NCT03153956|18576856|P1|NOT COMPLETED|Overall Study||0
7547713|NCT03153956|18576855|P2|COMPLETED|Overall Study||38
7547714|NCT03153956|18576856|P1|COMPLETED|Overall Study||39
7547715|NCT03153956|18576855|P2|STARTED|Overall Study||38
7547716|NCT03153956|18576856|P1|STARTED|Overall Study||39
7547717|NCT03152591|18576868|P2|NOT COMPLETED|Overall Study||0
7547718|NCT03152591|18576869|P1|NOT COMPLETED|Overall Study||0
7547719|NCT03152591|18576868|P2|COMPLETED|Overall Study||14
7547720|NCT03152591|18576869|P1|COMPLETED|Overall Study||15
7547721|NCT03152591|18576868|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||14
7547722|NCT03152591|18576869|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||15
7547723|NCT03152591|18576868|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||0
7547724|NCT03152591|18576869|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||14
7547725|NCT03152591|18576868|P2|STARTED|Overall Study||14
7547726|NCT03152591|18576869|P1|STARTED|Overall Study||15
7547727|NCT03152552|18576896|P5|NOT COMPLETED|Treatment Period 2 (24 Weeks)||11
7547728|NCT03152552|18576897|P4|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
7547729|NCT03152552|18576898|P3|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
7547730|NCT03152552|18576899|P2|NOT COMPLETED|Treatment Period 2 (24 Weeks)||5
7547731|NCT03152552|18576900|P1|NOT COMPLETED|Treatment Period 2 (24 Weeks)||6
7547732|NCT03152552|18576896|P5|COMPLETED|Treatment Period 2 (24 Weeks)||0
7547733|NCT03152552|18576897|P4|COMPLETED|Treatment Period 2 (24 Weeks)||0
7547734|NCT03152552|18576898|P3|COMPLETED|Treatment Period 2 (24 Weeks)||0
7547735|NCT03152552|18576899|P2|COMPLETED|Treatment Period 2 (24 Weeks)||0
7547736|NCT03152552|18576900|P1|COMPLETED|Treatment Period 2 (24 Weeks)||1
7547737|NCT03152552|18576896|P5|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|11
7547738|NCT03152552|18576897|P4|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
7547739|NCT03152552|18576898|P3|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
7547740|NCT03152552|18576899|P2|STARTED|Treatment Period 2 (24 Weeks)||5
7547741|NCT03152552|18576900|P1|STARTED|Treatment Period 2 (24 Weeks)||7
7547742|NCT03152552|18576896|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
7547743|NCT03152552|18576897|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||20
7547744|NCT03152552|18576898|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
7547745|NCT03152552|18576899|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
7547746|NCT03152552|18576900|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
7547747|NCT03152552|18576896|P5|COMPLETED|Treatment Period 1 (12 Weeks)||12
7547748|NCT03152552|18576897|P4|COMPLETED|Treatment Period 1 (12 Weeks)||10
7547749|NCT03152552|18576898|P3|COMPLETED|Treatment Period 1 (12 Weeks)||10
7547750|NCT03152552|18576899|P2|COMPLETED|Treatment Period 1 (12 Weeks)||5
7547751|NCT03152552|18576900|P1|COMPLETED|Treatment Period 1 (12 Weeks)||7
7547752|NCT03152552|18576896|P5|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||33
7547753|NCT03152552|18576897|P4|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
7547754|NCT03152552|18576898|P3|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
7547755|NCT03152552|18576899|P2|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||16
7547756|NCT03152552|18576900|P1|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||15
7547757|NCT03152552|18576896|P5|STARTED|Treatment Period 1 (12 Weeks)||33
7547758|NCT03152552|18576897|P4|STARTED|Treatment Period 1 (12 Weeks)||30
7547759|NCT03152552|18576898|P3|STARTED|Treatment Period 1 (12 Weeks)||31
7547760|NCT03152552|18576899|P2|STARTED|Treatment Period 1 (12 Weeks)||16
7547761|NCT03152552|18576900|P1|STARTED|Treatment Period 1 (12 Weeks)||15
7547762|NCT03152526|18577033|P2|NOT COMPLETED|Overall Study||1
7547763|NCT03152526|18577034|P1|NOT COMPLETED|Overall Study||0
7547764|NCT03152526|18577033|P2|COMPLETED|Overall Study|The one participant enrolled on this arm withdrew from the study early.|0
7547765|NCT03152526|18577034|P1|COMPLETED|Overall Study|No participants were enrolled on this arm.|0
7547766|NCT03152526|18577033|P2|STARTED|Overall Study|One participant was enrolled on this arm.|1
7547767|NCT03152526|18577034|P1|STARTED|Overall Study|No participants were enrolled on this arm.|0
7547768|NCT03152136|18577045|P3|NOT COMPLETED|Overall Study||1
7547769|NCT03152136|18577046|P2|NOT COMPLETED|Overall Study||0
7547770|NCT03152136|18577047|P1|NOT COMPLETED|Overall Study||3
7547771|NCT03152136|18577045|P3|COMPLETED|Overall Study||14
7547772|NCT03152136|18577046|P2|COMPLETED|Overall Study||15
7547773|NCT03152136|18577047|P1|COMPLETED|Overall Study||29
7547774|NCT03152136|18577045|P3|STARTED|Overall Study||15
7547775|NCT03152136|18577046|P2|STARTED|Overall Study||15
7547776|NCT03152136|18577047|P1|STARTED|Overall Study||32
7547777|NCT03152110|18577054|P1|NOT COMPLETED|Overall Study||3
7547778|NCT03152110|18577054|P1|COMPLETED|Overall Study||7
7547779|NCT03152110|18577054|P1|STARTED|Overall Study||10
7547780|NCT03152019|18577069|P2|NOT COMPLETED|Overall Study||1
7547781|NCT03152019|18577070|P1|NOT COMPLETED|Overall Study||0
7547782|NCT03152019|18577069|P2|COMPLETED|Overall Study||24
7547783|NCT03152019|18577070|P1|COMPLETED|Overall Study||25
7547784|NCT03152019|18577069|P2|STARTED|Overall Study||25
7547785|NCT03152019|18577070|P1|STARTED|Overall Study||25
7547786|NCT03151551|18577078|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||28
7547787|NCT03151551|18577079|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||25
7547788|NCT03151551|18577078|P2|COMPLETED|Post-Treatment Follow-Up Period||230
7547789|NCT03151551|18577079|P1|COMPLETED|Post-Treatment Follow-Up Period||240
7547790|NCT03151551|18577078|P2|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|258
7547791|NCT03151551|18577079|P1|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|265
7547792|NCT03151551|18577078|P2|NOT COMPLETED|Open-Label Treatment Period||24
7547793|NCT03151551|18577079|P1|NOT COMPLETED|Open-Label Treatment Period||18
7547794|NCT03151551|18577078|P2|COMPLETED|Open-Label Treatment Period||259
7547795|NCT03151551|18577079|P1|COMPLETED|Open-Label Treatment Period||265
7547796|NCT03151551|18577078|P2|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||219
7547797|NCT03151551|18577079|P1|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0
7547798|NCT03151551|18577078|P2|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||51
7547799|NCT03151551|18577079|P1|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0
7547800|NCT03151551|18577078|P2|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0
7547801|NCT03151551|18577079|P1|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period||218
7547802|NCT03151551|18577078|P2|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0
7547803|NCT03151551|18577079|P1|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period||49
7547804|NCT03151551|18577078|P2|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283
7547805|NCT03151551|18577079|P1|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283
7547806|NCT03151551|18577078|P2|STARTED|Open-Label Treatment Period||283
7547807|NCT03151551|18577079|P1|STARTED|Open-Label Treatment Period||283
7547808|NCT03151265|18577145|P2|NOT COMPLETED|Overall Study||0
7547809|NCT03151265|18577146|P1|NOT COMPLETED|Overall Study||0
7547810|NCT03151265|18577145|P2|COMPLETED|Overall Study||20
7547811|NCT03151265|18577146|P1|COMPLETED|Overall Study||20
7547812|NCT03151265|18577145|P2|STARTED|Overall Study||20
7547813|NCT03151265|18577146|P1|STARTED|Overall Study||20
7547814|NCT03151226|18577168|P1|NOT COMPLETED|Overall Study||3
7547815|NCT03151226|18577168|P1|COMPLETED|Overall Study||0
7547816|NCT03151226|18577168|P1|STARTED|Overall Study||3
7547817|NCT03151148|18577174|P2|NOT COMPLETED|Overall Study||0
7547818|NCT03151148|18577175|P1|NOT COMPLETED|Overall Study||2
7547819|NCT03151148|18577174|P2|COMPLETED|Overall Study||18
7547820|NCT03151148|18577175|P1|COMPLETED|Overall Study||34
7547821|NCT03151148|18577174|P2|STARTED|Overall Study||18
7547822|NCT03151148|18577175|P1|STARTED|Overall Study||36
7547823|NCT03150758|18577223|P1|NOT COMPLETED|Overall Study||0
7547824|NCT03150758|18577223|P1|COMPLETED|Overall Study||6
7547825|NCT03150758|18577223|P1|STARTED|Overall Study||6
7547826|NCT03150719|18577229|P2|NOT COMPLETED|Overall Study||2
7547827|NCT03150719|18577230|P1|NOT COMPLETED|Overall Study||1
7547828|NCT03150719|18577229|P2|COMPLETED|Overall Study||48
7547829|NCT03150719|18577230|P1|COMPLETED|Overall Study||46
7547830|NCT03150719|18577229|P2|STARTED|Overall Study||50
7547831|NCT03150719|18577230|P1|STARTED|Overall Study||47
7547832|NCT03150485|18577246|P6|NOT COMPLETED|Overall Study||0
7547833|NCT03150485|18577247|P5|NOT COMPLETED|Overall Study||0
7547834|NCT03150485|18577248|P4|NOT COMPLETED|Overall Study||0
7547835|NCT03150485|18577249|P3|NOT COMPLETED|Overall Study||0
7547836|NCT03150485|18577250|P2|NOT COMPLETED|Overall Study||1
7547837|NCT03150485|18577251|P1|NOT COMPLETED|Overall Study||0
7547838|NCT03150485|18577246|P6|COMPLETED|Overall Study||1
7547839|NCT03150485|18577247|P5|COMPLETED|Overall Study||2
7547840|NCT03150485|18577248|P4|COMPLETED|Overall Study||5
7547841|NCT03150485|18577249|P3|COMPLETED|Overall Study||4
7547842|NCT03150485|18577250|P2|COMPLETED|Overall Study||8
7547843|NCT03150485|18577251|P1|COMPLETED|Overall Study||2
7547844|NCT03150485|18577246|P6|STARTED|Overall Study||1
7547845|NCT03150485|18577247|P5|STARTED|Overall Study||2
7547846|NCT03150485|18577248|P4|STARTED|Overall Study||5
7547847|NCT03150485|18577249|P3|STARTED|Overall Study||4
7547848|NCT03150485|18577250|P2|STARTED|Overall Study||9
7547849|NCT03150485|18577251|P1|STARTED|Overall Study||2
7547850|NCT03150199|18577268|P2|NOT COMPLETED|Overall Study||0
7547851|NCT03150199|18577269|P1|NOT COMPLETED|Overall Study||0
7547852|NCT03150199|18577268|P2|COMPLETED|Overall Study||30
7547853|NCT03150199|18577269|P1|COMPLETED|Overall Study||30
7547854|NCT03150199|18577268|P2|STARTED|Overall Study||30
7547855|NCT03150199|18577269|P1|STARTED|Overall Study||30
7547856|NCT03150160|18577320|P2|NOT COMPLETED|Overall Study||0
7547857|NCT03150160|18577321|P1|NOT COMPLETED|Overall Study||0
7547858|NCT03150160|18577320|P2|COMPLETED|Overall Study||1
7547859|NCT03150160|18577321|P1|COMPLETED|Overall Study||0
7547860|NCT03150160|18577320|P2|STARTED|Overall Study||1
7547861|NCT03150160|18577321|P1|STARTED|Overall Study||0
7547862|NCT03150108|18577337|P2|NOT COMPLETED|Overall Study||0
7547863|NCT03150108|18577338|P1|NOT COMPLETED|Overall Study||0
7547864|NCT03150108|18577337|P2|COMPLETED|Overall Study||12
7547865|NCT03150108|18577338|P1|COMPLETED|Overall Study||12
7547866|NCT03150108|18577337|P2|STARTED|Overall Study||12
7547867|NCT03150108|18577338|P1|STARTED|Overall Study||12
7547868|NCT03150082|18577428|P2|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
7547869|NCT03150082|18577429|P1|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
7547870|NCT03150082|18577428|P2|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||13
7547871|NCT03150082|18577429|P1|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||12
7547872|NCT03150082|18577428|P2|STARTED|Treatment Period 2 (Up to 4 Weeks)||13
7547873|NCT03150082|18577429|P1|STARTED|Treatment Period 2 (Up to 4 Weeks)||12
7547874|NCT03150082|18577428|P2|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
7547875|NCT03150082|18577429|P1|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
7547876|NCT03150082|18577428|P2|COMPLETED|Washout Period (Up to 4 Weeks)||13
7547877|NCT03150082|18577429|P1|COMPLETED|Washout Period (Up to 4 Weeks)||12
7547878|NCT03150082|18577428|P2|STARTED|Washout Period (Up to 4 Weeks)||13
7547879|NCT03150082|18577429|P1|STARTED|Washout Period (Up to 4 Weeks)||12
7547880|NCT03150082|18577428|P2|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||0
7547881|NCT03150082|18577429|P1|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||1
7547882|NCT03150082|18577428|P2|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||13
7547883|NCT03150082|18577429|P1|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||12
7547884|NCT03150082|18577428|P2|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
7547885|NCT03150082|18577429|P1|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
7547886|NCT03149991|18577485|P2|NOT COMPLETED|Overall Study||2
7547887|NCT03149991|18577486|P1|NOT COMPLETED|Overall Study||4
7547888|NCT03149991|18577485|P2|COMPLETED|Overall Study||24
7547889|NCT03149991|18577486|P1|COMPLETED|Overall Study||21
7547890|NCT03149991|18577485|P2|Exited|Overall Study||2
7547891|NCT03149991|18577486|P1|Exited|Overall Study||4
7547892|NCT03149991|18577485|P2|Completed Primary Endpoint (Day 14)|Overall Study||24
7547893|NCT03149991|18577486|P1|Completed Primary Endpoint (Day 14)|Overall Study||25
7547894|NCT03149991|18577485|P2|STARTED|Overall Study||26
7547895|NCT03149991|18577486|P1|STARTED|Overall Study||25
7547896|NCT03149887|18577514|P2|NOT COMPLETED|Overall Study||0
7547897|NCT03149887|18577515|P1|NOT COMPLETED|Overall Study||0
7547898|NCT03149887|18577514|P2|COMPLETED|Overall Study||27
7547899|NCT03149887|18577515|P1|COMPLETED|Overall Study||27
7547900|NCT03149887|18577514|P2|STARTED|Overall Study||27
7547901|NCT03149887|18577515|P1|STARTED|Overall Study||27
7547902|NCT03149848|18577535|P1|NOT COMPLETED|Period 2 (Day 15 to Day 28)||2
7547903|NCT03149848|18577535|P1|COMPLETED|Period 2 (Day 15 to Day 28)||12
7547904|NCT03149848|18577535|P1|STARTED|Period 2 (Day 15 to Day 28)||14
7547905|NCT03149848|18577535|P1|NOT COMPLETED|Period 1 (Day 1 to Day 14)||1
7547906|NCT03149848|18577535|P1|COMPLETED|Period 1 (Day 1 to Day 14)||14
7547907|NCT03149848|18577535|P1|STARTED|Period 1 (Day 1 to Day 14)||15
7547908|NCT03149172|18577575|P3|NOT COMPLETED|Overall Study||2
7547909|NCT03149172|18577576|P2|NOT COMPLETED|Overall Study||1
7547910|NCT03149172|18577577|P1|NOT COMPLETED|Overall Study||2
7547911|NCT03149172|18577575|P3|COMPLETED|Overall Study||5
7547912|NCT03149172|18577576|P2|COMPLETED|Overall Study||5
7547913|NCT03149172|18577577|P1|COMPLETED|Overall Study||6
7547914|NCT03149172|18577575|P3|STARTED|Overall Study||7
7547915|NCT03149172|18577576|P2|STARTED|Overall Study||6
7547916|NCT03149172|18577577|P1|STARTED|Overall Study||8
7547917|NCT03149055|18577588|P1|NOT COMPLETED|Overall Study||4
7547918|NCT03149055|18577588|P1|COMPLETED|Overall Study||95
7547919|NCT03149055|18577588|P1|STARTED|Overall Study||99
7547920|NCT03149042|18577593|P1|NOT COMPLETED|Overall Study||23
7547921|NCT03149042|18577593|P1|COMPLETED|Overall Study||52
7547922|NCT03149042|18577593|P1|STARTED|Overall Study||75
7547923|NCT03148756|18577607|P2|NOT COMPLETED|Overall Study||1
7547924|NCT03148756|18577608|P1|NOT COMPLETED|Overall Study||0
7547925|NCT03148756|18577607|P2|COMPLETED|Overall Study||1
7547926|NCT03148756|18577608|P1|COMPLETED|Overall Study||0
7547927|NCT03148756|18577607|P2|STARTED|Overall Study||2
7547928|NCT03148756|18577608|P1|STARTED|Overall Study||0
7547929|NCT03148691|18577641|P3|NOT COMPLETED|Overall Study||8
7547930|NCT03148691|18577642|P2|NOT COMPLETED|Overall Study||2
7547931|NCT03148691|18577643|P1|NOT COMPLETED|Overall Study||3
7547932|NCT03148691|18577641|P3|COMPLETED|Overall Study||92
7547933|NCT03148691|18577642|P2|COMPLETED|Overall Study||101
7547934|NCT03148691|18577643|P1|COMPLETED|Overall Study||47
7547935|NCT03148691|18577641|P3|STARTED|Overall Study||100
7547936|NCT03148691|18577642|P2|STARTED|Overall Study||103
7547937|NCT03148691|18577643|P1|STARTED|Overall Study||50
7547938|NCT03148470|18577653|P2|NOT COMPLETED|Overall Study||0
7547939|NCT03148470|18577654|P1|NOT COMPLETED|Overall Study||1
7547940|NCT03148470|18577653|P2|COMPLETED|Overall Study|20 Participants completed the Tasks following cTBS-stimulation|20
7547941|NCT03148470|18577654|P1|COMPLETED|Overall Study|20 Participants completed the Tasks following iTBS-stimulation|20
7547942|NCT03148470|18577653|P2|STARTED|Overall Study|20 Participants completed the Tasks following Sham-stimulation|20
7547943|NCT03148470|18577654|P1|STARTED|Overall Study|21 Participants completed the Tasks following Sham-stimulation|21
7547944|NCT03148262|18577670|P2|NOT COMPLETED|Overall Study||1
7547945|NCT03148262|18577671|P1|NOT COMPLETED|Overall Study||3
7547946|NCT03148262|18577670|P2|COMPLETED|Overall Study||31
7547947|NCT03148262|18577671|P1|COMPLETED|Overall Study||28
7547948|NCT03148262|18577670|P2|STARTED|Overall Study||32
7547949|NCT03148262|18577671|P1|STARTED|Overall Study||31
7547950|NCT03148236|18577679|P2|NOT COMPLETED|Overall Study||0
7547951|NCT03148236|18577680|P1|NOT COMPLETED|Overall Study||0
7547952|NCT03148236|18577679|P2|COMPLETED|Overall Study||10
7547953|NCT03148236|18577680|P1|COMPLETED|Overall Study||10
7547954|NCT03148236|18577679|P2|STARTED|Overall Study||10
7547955|NCT03148236|18577680|P1|STARTED|Overall Study||10
7547956|NCT03148067|18577706|P1|NOT COMPLETED|Overall Study||4
7547957|NCT03148067|18577706|P1|COMPLETED|Overall Study||221
7547958|NCT03148067|18577706|P1|STARTED|Overall Study||225
7547959|NCT03147690|18577711|P1|NOT COMPLETED|Overall Study||3
7547960|NCT03147690|18577711|P1|COMPLETED|Overall Study||71
7547961|NCT03147690|18577711|P1|STARTED|Overall Study||74
7547962|NCT03147248|18577739|P6|NOT COMPLETED|Overall Study||31
7547963|NCT03147248|18577740|P5|NOT COMPLETED|Overall Study||26
7547964|NCT03147248|18577741|P4|NOT COMPLETED|Overall Study||2
7547965|NCT03147248|18577742|P3|NOT COMPLETED|Overall Study||2
7547966|NCT03147248|18577743|P2|NOT COMPLETED|Overall Study||2
7547967|NCT03147248|18577744|P1|NOT COMPLETED|Overall Study||1
7547968|NCT03147248|18577739|P6|COMPLETED|Overall Study||145
7547969|NCT03147248|18577740|P5|COMPLETED|Overall Study||141
7547970|NCT03147248|18577741|P4|COMPLETED|Overall Study||10
7547971|NCT03147248|18577742|P3|COMPLETED|Overall Study||10
7547972|NCT03147248|18577743|P2|COMPLETED|Overall Study||9
7547973|NCT03147248|18577744|P1|COMPLETED|Overall Study||12
7547974|NCT03147248|18577739|P6|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|176
7547975|NCT03147248|18577740|P5|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|167
7547976|NCT03147248|18577741|P4|STARTED|Overall Study|This cohort is only for Part 1.|12
7547977|NCT03147248|18577742|P3|STARTED|Overall Study|This cohort is only for Part 1.|12
7547978|NCT03147248|18577743|P2|STARTED|Overall Study|This cohort is only for Part 1.|11
7547979|NCT03147248|18577744|P1|STARTED|Overall Study|This cohort is only for Part 1.|13
7547980|NCT03146741|18577766|P1|NOT COMPLETED|Overall Study||10
7547981|NCT03146741|18577766|P1|COMPLETED|Overall Study||10
7547982|NCT03146741|18577766|P1|STARTED|Overall Study||20
7547983|NCT03146585|18577774|P3|NOT COMPLETED|Overall Study||0
7547984|NCT03146585|18577775|P2|NOT COMPLETED|Overall Study||0
7547985|NCT03146585|18577776|P1|NOT COMPLETED|Overall Study||0
7547986|NCT03146585|18577774|P3|COMPLETED|Overall Study||5
7547987|NCT03146585|18577775|P2|COMPLETED|Overall Study||10
7547988|NCT03146585|18577776|P1|COMPLETED|Overall Study||25
7547989|NCT03146585|18577774|P3|STARTED|Overall Study||5
7547990|NCT03146585|18577775|P2|STARTED|Overall Study||10
7547991|NCT03146585|18577776|P1|STARTED|Overall Study||25
7547992|NCT03146403|18577786|P2|NOT COMPLETED|Overall Study||3
7547993|NCT03146403|18577787|P1|NOT COMPLETED|Overall Study||2
7547994|NCT03146403|18577786|P2|COMPLETED|Overall Study||14
7547995|NCT03146403|18577787|P1|COMPLETED|Overall Study||14
7547996|NCT03146403|18577786|P2|STARTED|Overall Study||17
7547997|NCT03146403|18577787|P1|STARTED|Overall Study||16
7547998|NCT03145818|18577805|P4|NOT COMPLETED|Overall Study||0
7547999|NCT03145818|18577806|P3|NOT COMPLETED|Overall Study||0
7548000|NCT03145818|18577807|P2|NOT COMPLETED|Overall Study||8
7548001|NCT03145818|18577808|P1|NOT COMPLETED|Overall Study||91
7548002|NCT03145818|18577805|P4|COMPLETED|Overall Study||9
7548003|NCT03145818|18577806|P3|COMPLETED|Overall Study||10
7548004|NCT03145818|18577807|P2|COMPLETED|Overall Study||0
7548005|NCT03145818|18577808|P1|COMPLETED|Overall Study||8
7548006|NCT03145818|18577805|P4|STARTED|Overall Study||9
7548007|NCT03145818|18577806|P3|STARTED|Overall Study||10
7548008|NCT03145818|18577807|P2|STARTED|Overall Study||8
7548009|NCT03145818|18577808|P1|STARTED|Overall Study||99
7548010|NCT03145259|18577816|P1|NOT COMPLETED|Overall Study||0
7548011|NCT03145259|18577816|P1|COMPLETED|Overall Study||12
7548012|NCT03145259|18577816|P1|STARTED|Overall Study||12
7548013|NCT03145207|18577823|P1|NOT COMPLETED|Overall Study||2
7548014|NCT03145207|18577823|P1|COMPLETED|Overall Study||12
7548015|NCT03145207|18577823|P1|STARTED|Overall Study|The same 12 volunteers completed each of the seven study sessions.|14
7548016|NCT03144635|18577838|P1|NOT COMPLETED|Overall Study||80
7548017|NCT03144635|18577838|P1|COMPLETED|Overall Study||0
7548018|NCT03144635|18577838|P1|STARTED|Overall Study||80
7548019|NCT03144518|18577850|P2|NOT COMPLETED|16 Week Post-Vaccination||2
7548020|NCT03144518|18577851|P1|NOT COMPLETED|16 Week Post-Vaccination||3
7548021|NCT03144518|18577850|P2|COMPLETED|16 Week Post-Vaccination||49
7548022|NCT03144518|18577851|P1|COMPLETED|16 Week Post-Vaccination||49
7548023|NCT03144518|18577850|P2|STARTED|16 Week Post-Vaccination||51
7548024|NCT03144518|18577851|P1|STARTED|16 Week Post-Vaccination||52
7548025|NCT03144518|18577850|P2|NOT COMPLETED|4 Weeks Post-Vaccination||0
7548026|NCT03144518|18577851|P1|NOT COMPLETED|4 Weeks Post-Vaccination||1
7548027|NCT03144518|18577850|P2|COMPLETED|4 Weeks Post-Vaccination||51
7548028|NCT03144518|18577851|P1|COMPLETED|4 Weeks Post-Vaccination||51
7548029|NCT03144518|18577850|P2|STARTED|4 Weeks Post-Vaccination||51
7548030|NCT03144518|18577851|P1|STARTED|4 Weeks Post-Vaccination||52
7548031|NCT03144518|18577850|P2|NOT COMPLETED|Primary Outcome (Mood)||0
7548032|NCT03144518|18577851|P1|NOT COMPLETED|Primary Outcome (Mood)||0
7548033|NCT03144518|18577850|P2|COMPLETED|Primary Outcome (Mood)||51
7548034|NCT03144518|18577851|P1|COMPLETED|Primary Outcome (Mood)||52
7548035|NCT03144518|18577850|P2|STARTED|Primary Outcome (Mood)||51
7548036|NCT03144518|18577851|P1|STARTED|Primary Outcome (Mood)||52
7548037|NCT03144180|18577868|P2|NOT COMPLETED|Overall Study||6
7548038|NCT03144180|18577869|P1|NOT COMPLETED|Overall Study||2
7548039|NCT03144180|18577868|P2|COMPLETED|Overall Study||10
7548040|NCT03144180|18577869|P1|COMPLETED|Overall Study||14
7548041|NCT03144180|18577868|P2|STARTED|Overall Study||16
7548042|NCT03144180|18577869|P1|STARTED|Overall Study||16
7548043|NCT03143855|18577881|P2|NOT COMPLETED|Overall Study||4
7548044|NCT03143855|18577882|P1|NOT COMPLETED|Overall Study||5
7548045|NCT03143855|18577881|P2|COMPLETED|Overall Study||6
7548046|NCT03143855|18577882|P1|COMPLETED|Overall Study||12
7548047|NCT03143855|18577881|P2|STARTED|Overall Study||10
7548048|NCT03143855|18577882|P1|STARTED|Overall Study||17
7548049|NCT03143569|18577890|P2|NOT COMPLETED|Overall Study||2
7548050|NCT03143569|18577891|P1|NOT COMPLETED|Overall Study||0
7548051|NCT03143569|18577890|P2|COMPLETED|Overall Study||8
7548052|NCT03143569|18577891|P1|COMPLETED|Overall Study||10
7548053|NCT03143569|18577890|P2|STARTED|Overall Study||10
7548054|NCT03143569|18577891|P1|STARTED|Overall Study||10
7548055|NCT03143166|18577913|P1|NOT COMPLETED|Period 2 (Washout of at Least 4 Days)||1
7548056|NCT03143166|18577913|P1|COMPLETED|Period 2 (Washout of at Least 4 Days)||35
7548057|NCT03143166|18577913|P1|STARTED|Period 2 (Washout of at Least 4 Days)||36
7548058|NCT03143166|18577913|P1|NOT COMPLETED|Period 1||0
7548059|NCT03143166|18577913|P1|COMPLETED|Period 1||36
7548060|NCT03143166|18577913|P1|STARTED|Period 1||36
7548061|NCT03143101|18577932|P3|NOT COMPLETED|Overall Study||0
7548062|NCT03143101|18577933|P2|NOT COMPLETED|Overall Study||3
7548063|NCT03143101|18577934|P1|NOT COMPLETED|Overall Study||2
7548064|NCT03143101|18577932|P3|COMPLETED|Overall Study||67
7548065|NCT03143101|18577933|P2|COMPLETED|Overall Study||63
7548066|NCT03143101|18577934|P1|COMPLETED|Overall Study||65
7548067|NCT03143101|18577932|P3|STARTED|Overall Study||67
7548068|NCT03143101|18577933|P2|STARTED|Overall Study||66
7548069|NCT03143101|18577934|P1|STARTED|Overall Study||67
7548070|NCT03142932|18577989|P2|NOT COMPLETED|Overall Study||11
7548071|NCT03142932|18577990|P1|NOT COMPLETED|Overall Study||2
7548072|NCT03142932|18577989|P2|COMPLETED|Overall Study||39
7548073|NCT03142932|18577990|P1|COMPLETED|Overall Study||50
7548074|NCT03142932|18577989|P2|STARTED|Overall Study||50
7548075|NCT03142932|18577990|P1|STARTED|Overall Study||52
7548076|NCT03142750|18578006|P2|NOT COMPLETED|Overall Study||1
7548077|NCT03142750|18578007|P1|NOT COMPLETED|Overall Study||4
7548078|NCT03142750|18578006|P2|COMPLETED|Overall Study||9
7548079|NCT03142750|18578007|P1|COMPLETED|Overall Study||10
7548080|NCT03142750|18578006|P2|STARTED|Overall Study||10
7548081|NCT03142750|18578007|P1|STARTED|Overall Study||14
7548082|NCT03142451|18578020|P2|NOT COMPLETED|Overall Study||24
7548083|NCT03142451|18578021|P1|NOT COMPLETED|Overall Study||58
7548084|NCT03142451|18578020|P2|COMPLETED|Overall Study||232
7548085|NCT03142451|18578021|P1|COMPLETED|Overall Study||437
7548086|NCT03142451|18578020|P2|STARTED|Overall Study||256
7548087|NCT03142451|18578021|P1|STARTED|Overall Study||495
7548088|NCT03141931|18578041|P2|NOT COMPLETED|Overall Study||6
7548089|NCT03141931|18578042|P1|NOT COMPLETED|Overall Study||12
7548090|NCT03141931|18578041|P2|COMPLETED|Overall Study||52
7548091|NCT03141931|18578042|P1|COMPLETED|Overall Study||49
7548092|NCT03141931|18578041|P2|STARTED|Overall Study||58
7548093|NCT03141931|18578042|P1|STARTED|Overall Study||61
7548094|NCT03141788|18578062|P1|NOT COMPLETED|Overall Study||8
7548095|NCT03141788|18578062|P1|COMPLETED|Overall Study||44
7548096|NCT03141788|18578062|P1|STARTED|Overall Study||52
7548097|NCT03141528|18578079|P2|NOT COMPLETED|Overall Study||41
7548098|NCT03141528|18578080|P1|NOT COMPLETED|Overall Study||47
7548099|NCT03141528|18578079|P2|COMPLETED|Overall Study||77
7548100|NCT03141528|18578080|P1|COMPLETED|Overall Study||75
7548101|NCT03141528|18578079|P2|STARTED|Overall Study||118
7548102|NCT03141528|18578080|P1|STARTED|Overall Study||122
7548103|NCT03141372|18578122|P2|NOT COMPLETED|Overall Study||2
7548104|NCT03141372|18578123|P1|NOT COMPLETED|Overall Study||0
7548105|NCT03141372|18578122|P2|COMPLETED|Overall Study||40
7548106|NCT03141372|18578123|P1|COMPLETED|Overall Study||42
7548107|NCT03141372|18578122|P2|STARTED|Overall Study||42
7548108|NCT03141372|18578123|P1|STARTED|Overall Study||42
7548109|NCT03141307|18578143|P2|NOT COMPLETED|Follow-Up||54
7548110|NCT03141307|18578144|P1|NOT COMPLETED|Follow-Up||97
7548111|NCT03141307|18578143|P2|COMPLETED|Follow-Up||184
7548112|NCT03141307|18578144|P1|COMPLETED|Follow-Up||370
7548113|NCT03141307|18578143|P2|STARTED|Follow-Up||238
7548114|NCT03141307|18578144|P1|STARTED|Follow-Up||467
7548115|NCT03141307|18578143|P2|NOT COMPLETED|In-Hospital||2
7548116|NCT03141307|18578144|P1|NOT COMPLETED|In-Hospital||4
7548117|NCT03141307|18578143|P2|COMPLETED|In-Hospital||238
7548118|NCT03141307|18578144|P1|COMPLETED|In-Hospital||467
7548119|NCT03141307|18578143|P2|STARTED|In-Hospital||240
7548120|NCT03141307|18578144|P1|STARTED|In-Hospital||471
7548121|NCT03141151|18578162|P2|NOT COMPLETED|Overall Study||4
7548122|NCT03141151|18578163|P1|NOT COMPLETED|Overall Study||6
7548123|NCT03141151|18578162|P2|COMPLETED|Overall Study||54
7548124|NCT03141151|18578163|P1|COMPLETED|Overall Study||53
7548125|NCT03141151|18578162|P2|STARTED|Overall Study||58
7548126|NCT03141151|18578163|P1|STARTED|Overall Study||59
7548127|NCT03141086|18578181|P2|NOT COMPLETED|Overall Study||5
7548128|NCT03141086|18578182|P1|NOT COMPLETED|Overall Study||1
7548129|NCT03141086|18578181|P2|COMPLETED|Overall Study||12
7548130|NCT03141086|18578182|P1|COMPLETED|Overall Study||6
7548131|NCT03141086|18578181|P2|STARTED|Overall Study||17
7548132|NCT03141086|18578182|P1|STARTED|Overall Study||7
7548133|NCT03140631|18578211|P2|NOT COMPLETED|Overall Study||0
7548134|NCT03140631|18578212|P1|NOT COMPLETED|Overall Study||0
7548135|NCT03140631|18578211|P2|COMPLETED|Overall Study||77
7548136|NCT03140631|18578212|P1|COMPLETED|Overall Study||73
7548137|NCT03140631|18578211|P2|STARTED|Overall Study||77
7548138|NCT03140631|18578212|P1|STARTED|Overall Study||73
7548139|NCT03139604|18578222|P2|NOT COMPLETED|Overall Study||220
7548140|NCT03139604|18578223|P1|NOT COMPLETED|Overall Study||219
7548141|NCT03139604|18578222|P2|COMPLETED|Overall Study||0
7548142|NCT03139604|18578223|P1|COMPLETED|Overall Study||0
7548143|NCT03139604|18578222|P2|STARTED|Overall Study||220
7548144|NCT03139604|18578223|P1|STARTED|Overall Study||219
7548145|NCT03139578|18578235|P4|NOT COMPLETED|Period 2||0
7548146|NCT03139578|18578236|P3|NOT COMPLETED|Period 2||0
7548147|NCT03139578|18578237|P2|NOT COMPLETED|Period 2||0
7548148|NCT03139578|18578238|P1|NOT COMPLETED|Period 2||0
7548149|NCT03139578|18578235|P4|COMPLETED|Period 2||13
7548150|NCT03139578|18578236|P3|COMPLETED|Period 2||12
7548151|NCT03139578|18578237|P2|COMPLETED|Period 2||13
7548152|NCT03139578|18578238|P1|COMPLETED|Period 2||12
7548153|NCT03139578|18578235|P4|Discontinued|Period 2||0
7548154|NCT03139578|18578236|P3|Discontinued|Period 2||0
7548155|NCT03139578|18578237|P2|Discontinued|Period 2||0
7548156|NCT03139578|18578238|P1|Discontinued|Period 2||0
7548157|NCT03139578|18578235|P4|STARTED|Period 2||13
7548158|NCT03139578|18578236|P3|STARTED|Period 2||12
7548159|NCT03139578|18578237|P2|STARTED|Period 2||13
7548160|NCT03139578|18578238|P1|STARTED|Period 2||12
7548161|NCT03139578|18578235|P4|NOT COMPLETED|Period 1||0
7548162|NCT03139578|18578236|P3|NOT COMPLETED|Period 1||0
7548163|NCT03139578|18578237|P2|NOT COMPLETED|Period 1||0
7548164|NCT03139578|18578238|P1|NOT COMPLETED|Period 1||0
7548165|NCT03139578|18578235|P4|COMPLETED|Period 1||13
7548166|NCT03139578|18578236|P3|COMPLETED|Period 1||12
7548167|NCT03139578|18578237|P2|COMPLETED|Period 1||13
7548168|NCT03139578|18578238|P1|COMPLETED|Period 1||12
7548169|NCT03139578|18578235|P4|Discontinued|Period 1||0
7548170|NCT03139578|18578236|P3|Discontinued|Period 1||0
7548171|NCT03139578|18578237|P2|Discontinued|Period 1||0
7548172|NCT03139578|18578238|P1|Discontinued|Period 1||0
7548173|NCT03139578|18578235|P4|STARTED|Period 1||13
7548174|NCT03139578|18578236|P3|STARTED|Period 1||12
7548175|NCT03139578|18578237|P2|STARTED|Period 1||13
7548176|NCT03139578|18578238|P1|STARTED|Period 1||12
7548177|NCT03139552|18578272|P1|NOT COMPLETED|Overall Study||3
7548178|NCT03139552|18578272|P1|COMPLETED|Overall Study||147
7548179|NCT03139552|18578272|P1|STARTED|Overall Study||150
7548180|NCT03139448|18578315|P2|NOT COMPLETED|Overall Study||26
7548181|NCT03139448|18578316|P1|NOT COMPLETED|Overall Study||12
7548182|NCT03139448|18578315|P2|COMPLETED|Overall Study||63
7548183|NCT03139448|18578316|P1|COMPLETED|Overall Study||73
7548184|NCT03139448|18578315|P2|Intervention Started|Overall Study||70
7548185|NCT03139448|18578316|P1|Intervention Started|Overall Study||79
7548186|NCT03139448|18578315|P2|STARTED|Overall Study||89
7548187|NCT03139448|18578316|P1|STARTED|Overall Study||85
7548188|NCT03139279|18578340|P2|NOT COMPLETED|Overall Study||6
7548189|NCT03139279|18578341|P1|NOT COMPLETED|Overall Study||7
7548190|NCT03139279|18578340|P2|COMPLETED|Overall Study||50
7548191|NCT03139279|18578341|P1|COMPLETED|Overall Study||51
7548192|NCT03139279|18578340|P2|STARTED|Overall Study||56
7548193|NCT03139279|18578341|P1|STARTED|Overall Study||58
7548194|NCT03139240|18578359|P4|NOT COMPLETED|Overall Study||0
7548195|NCT03139240|18578360|P3|NOT COMPLETED|Overall Study||1
7548196|NCT03139240|18578361|P2|NOT COMPLETED|Overall Study||1
7548197|NCT03139240|18578362|P1|NOT COMPLETED|Overall Study||0
7548198|NCT03139240|18578359|P4|COMPLETED|Overall Study||38
7548199|NCT03139240|18578360|P3|COMPLETED|Overall Study||37
7548200|NCT03139240|18578361|P2|COMPLETED|Overall Study||47
7548201|NCT03139240|18578362|P1|COMPLETED|Overall Study||48
7548202|NCT03139240|18578359|P4|STARTED|Overall Study||38
7548203|NCT03139240|18578360|P3|STARTED|Overall Study||38
7548204|NCT03139240|18578361|P2|STARTED|Overall Study||48
7548205|NCT03139240|18578362|P1|STARTED|Overall Study||48
7548206|NCT03139032|18578372|P1|NOT COMPLETED|Overall Study||0
7548207|NCT03139032|18578372|P1|COMPLETED|Overall Study||1
7548208|NCT03139032|18578372|P1|STARTED|Overall Study||1
7548209|NCT03138967|18578394|P2|NOT COMPLETED|Overall Study||4
7548210|NCT03138967|18578395|P1|NOT COMPLETED|Overall Study||1
7548211|NCT03138967|18578394|P2|COMPLETED|Overall Study||24
7548212|NCT03138967|18578395|P1|COMPLETED|Overall Study||25
7548213|NCT03138967|18578394|P2|Post-operative Day(POD) 7 Follow-up|Overall Study||24
7548214|NCT03138967|18578395|P1|Post-operative Day(POD) 7 Follow-up|Overall Study||25
7548215|NCT03138967|18578394|P2|Post-operative Day(POD) 1 Follow-up|Overall Study||25
7548216|NCT03138967|18578395|P1|Post-operative Day(POD) 1 Follow-up|Overall Study||25
7548217|NCT03138967|18578394|P2|STARTED|Overall Study||28
7548218|NCT03138967|18578395|P1|STARTED|Overall Study||26
7548219|NCT03138876|18578405|P1|NOT COMPLETED|Overall Study||0
7548220|NCT03138876|18578405|P1|COMPLETED|Overall Study||20
7548221|NCT03138876|18578405|P1|STARTED|Overall Study||20
7548222|NCT03138798|18578414|P2|NOT COMPLETED|Overall Study||4
7548223|NCT03138798|18578415|P1|NOT COMPLETED|Overall Study||6
7548224|NCT03138798|18578414|P2|COMPLETED|Overall Study||171
7548225|NCT03138798|18578415|P1|COMPLETED|Overall Study||167
7548226|NCT03138798|18578414|P2|Randomized But Did Not Meet Eligibility|Overall Study||4
7548227|NCT03138798|18578415|P1|Randomized But Did Not Meet Eligibility|Overall Study||6
7548228|NCT03138798|18578414|P2|STARTED|Overall Study||175
7548229|NCT03138798|18578415|P1|STARTED|Overall Study||173
7548230|NCT03138655|18578446|P8|NOT COMPLETED|Overall Study||2
7548231|NCT03138655|18578447|P7|NOT COMPLETED|Overall Study||3
7548232|NCT03138655|18578448|P6|NOT COMPLETED|Overall Study||5
7548233|NCT03138655|18578449|P5|NOT COMPLETED|Overall Study||2
7548234|NCT03138655|18578450|P4|NOT COMPLETED|Overall Study||3
7548235|NCT03138655|18578451|P3|NOT COMPLETED|Overall Study||2
7548236|NCT03138655|18578452|P2|NOT COMPLETED|Overall Study||2
7548237|NCT03138655|18578453|P1|NOT COMPLETED|Overall Study||3
7548238|NCT03138655|18578446|P8|COMPLETED|Overall Study||10
7548239|NCT03138655|18578447|P7|COMPLETED|Overall Study||9
7548240|NCT03138655|18578448|P6|COMPLETED|Overall Study||7
7548241|NCT03138655|18578449|P5|COMPLETED|Overall Study||11
7548242|NCT03138655|18578450|P4|COMPLETED|Overall Study||7
7548243|NCT03138655|18578451|P3|COMPLETED|Overall Study||9
7548244|NCT03138655|18578452|P2|COMPLETED|Overall Study||7
7548245|NCT03138655|18578453|P1|COMPLETED|Overall Study||7
7548246|NCT03138655|18578446|P8|STARTED|Overall Study||12
7548247|NCT03138655|18578447|P7|STARTED|Overall Study||12
7548248|NCT03138655|18578448|P6|STARTED|Overall Study||12
7548249|NCT03138655|18578449|P5|STARTED|Overall Study||13
7548250|NCT03138655|18578450|P4|STARTED|Overall Study||10
7548251|NCT03138655|18578451|P3|STARTED|Overall Study||11
7548252|NCT03138655|18578452|P2|STARTED|Overall Study||9
7548253|NCT03138655|18578453|P1|STARTED|Overall Study||10
7548254|NCT03138590|18578495|P2|NOT COMPLETED|Overall Study||0
7548255|NCT03138590|18578496|P1|NOT COMPLETED|Overall Study||0
7548256|NCT03138590|18578495|P2|COMPLETED|Overall Study||10
7548257|NCT03138590|18578496|P1|COMPLETED|Overall Study||10
7548258|NCT03138590|18578495|P2|STARTED|Overall Study||10
7548259|NCT03138590|18578496|P1|STARTED|Overall Study||10
7548260|NCT03138577|18578509|P7|NOT COMPLETED|Overall Study||0
7548261|NCT03138577|18578510|P6|NOT COMPLETED|Overall Study||0
7548262|NCT03138577|18578511|P5|NOT COMPLETED|Overall Study||0
7548263|NCT03138577|18578512|P4|NOT COMPLETED|Overall Study||0
7548264|NCT03138577|18578513|P3|NOT COMPLETED|Overall Study||0
7548265|NCT03138577|18578514|P2|NOT COMPLETED|Overall Study||0
7548266|NCT03138577|18578515|P1|NOT COMPLETED|Overall Study||0
7548267|NCT03138577|18578509|P7|COMPLETED|Overall Study||3
7548268|NCT03138577|18578510|P6|COMPLETED|Overall Study||3
7548269|NCT03138577|18578511|P5|COMPLETED|Overall Study||3
7548270|NCT03138577|18578512|P4|COMPLETED|Overall Study||3
7548271|NCT03138577|18578513|P3|COMPLETED|Overall Study||3
7548272|NCT03138577|18578514|P2|COMPLETED|Overall Study||3
7548273|NCT03138577|18578515|P1|COMPLETED|Overall Study||3
7548274|NCT03138577|18578509|P7|STARTED|Overall Study||3
7548275|NCT03138577|18578510|P6|STARTED|Overall Study||3
7548276|NCT03138577|18578511|P5|STARTED|Overall Study||3
7548277|NCT03138577|18578512|P4|STARTED|Overall Study||3
7548278|NCT03138577|18578513|P3|STARTED|Overall Study||3
7548279|NCT03138577|18578514|P2|STARTED|Overall Study||3
7548280|NCT03138577|18578515|P1|STARTED|Overall Study||3
7548281|NCT03138382|18578560|P2|NOT COMPLETED|Overall Study||0
7548282|NCT03138382|18578561|P1|NOT COMPLETED|Overall Study||0
7548283|NCT03138382|18578560|P2|COMPLETED|Overall Study||10
7548284|NCT03138382|18578561|P1|COMPLETED|Overall Study||10
7548285|NCT03138382|18578560|P2|STARTED|Overall Study||10
7548286|NCT03138382|18578561|P1|STARTED|Overall Study||10
7548287|NCT03138330|18578569|P1|NOT COMPLETED|Overall Study||4
7548288|NCT03138330|18578569|P1|COMPLETED|Overall Study||91
7548289|NCT03138330|18578569|P1|STARTED|Overall Study||95
7548290|NCT03137784|18578574|P6|NOT COMPLETED|Overall Study||0
7548291|NCT03137784|18578575|P5|NOT COMPLETED|Overall Study||1
7548292|NCT03137784|18578576|P4|NOT COMPLETED|Overall Study||0
7548293|NCT03137784|18578577|P3|NOT COMPLETED|Overall Study||0
7548294|NCT03137784|18578578|P2|NOT COMPLETED|Overall Study||1
7548295|NCT03137784|18578579|P1|NOT COMPLETED|Overall Study||2
7548296|NCT03137784|18578574|P6|COMPLETED|Overall Study||25
7548297|NCT03137784|18578575|P5|COMPLETED|Overall Study||24
7548298|NCT03137784|18578576|P4|COMPLETED|Overall Study||24
7548299|NCT03137784|18578577|P3|COMPLETED|Overall Study||25
7548300|NCT03137784|18578578|P2|COMPLETED|Overall Study||24
7548301|NCT03137784|18578579|P1|COMPLETED|Overall Study||22
7548302|NCT03137784|18578574|P6|STARTED|Overall Study||25
7548303|NCT03137784|18578575|P5|STARTED|Overall Study||25
7548304|NCT03137784|18578576|P4|STARTED|Overall Study||24
7548305|NCT03137784|18578577|P3|STARTED|Overall Study||25
7548306|NCT03137784|18578578|P2|STARTED|Overall Study||25
7548307|NCT03137784|18578579|P1|STARTED|Overall Study||24
7548308|NCT03137693|18578614|P1|NOT COMPLETED|Overall Study||0
7548309|NCT03137693|18578614|P1|COMPLETED|Overall Study||20
7548310|NCT03137693|18578614|P1|STARTED|Overall Study||20
7548311|NCT03137225|18578620|P2|NOT COMPLETED|Second 4 Hour Measurement Period||0
7548312|NCT03137225|18578621|P1|NOT COMPLETED|Second 4 Hour Measurement Period||0
7548313|NCT03137225|18578620|P2|COMPLETED|Second 4 Hour Measurement Period||0
7548314|NCT03137225|18578621|P1|COMPLETED|Second 4 Hour Measurement Period||1
7548315|NCT03137225|18578620|P2|STARTED|Second 4 Hour Measurement Period||0
7548316|NCT03137225|18578621|P1|STARTED|Second 4 Hour Measurement Period||1
7548317|NCT03137225|18578620|P2|NOT COMPLETED|First 4 Hour Measurement Period||0
7548318|NCT03137225|18578621|P1|NOT COMPLETED|First 4 Hour Measurement Period||0
7548319|NCT03137225|18578620|P2|COMPLETED|First 4 Hour Measurement Period||0
7548320|NCT03137225|18578621|P1|COMPLETED|First 4 Hour Measurement Period||1
7548321|NCT03137225|18578620|P2|STARTED|First 4 Hour Measurement Period||0
7548322|NCT03137225|18578621|P1|STARTED|First 4 Hour Measurement Period||1
7548323|NCT03137173|18578635|P2|NOT COMPLETED|Overall Study||36
7548324|NCT03137173|18578636|P1|NOT COMPLETED|Overall Study||26
7548325|NCT03137173|18578635|P2|COMPLETED|Overall Study||308
7548326|NCT03137173|18578636|P1|COMPLETED|Overall Study||309
7548327|NCT03137173|18578635|P2|STARTED|Overall Study||344
7548328|NCT03137173|18578636|P1|STARTED|Overall Study||335
7548329|NCT03137069|18578652|P6|NOT COMPLETED|Overall Study||2
7548330|NCT03137069|18578653|P5|NOT COMPLETED|Overall Study||2
7548331|NCT03137069|18578654|P4|NOT COMPLETED|Overall Study||6
7548332|NCT03137069|18578655|P3|NOT COMPLETED|Overall Study||3
7548333|NCT03137069|18578656|P2|NOT COMPLETED|Overall Study||6
7548334|NCT03137069|18578657|P1|NOT COMPLETED|Overall Study||1
7548335|NCT03137069|18578652|P6|COMPLETED|Overall Study||21
7548336|NCT03137069|18578653|P5|COMPLETED|Overall Study||22
7548337|NCT03137069|18578654|P4|COMPLETED|Overall Study||17
7548338|NCT03137069|18578655|P3|COMPLETED|Overall Study||20
7548339|NCT03137069|18578656|P2|COMPLETED|Overall Study||22
7548340|NCT03137069|18578657|P1|COMPLETED|Overall Study||12
7548341|NCT03137069|18578652|P6|STARTED|Overall Study||23
7548342|NCT03137069|18578653|P5|STARTED|Overall Study||24
7548343|NCT03137069|18578654|P4|STARTED|Overall Study||23
7548344|NCT03137069|18578655|P3|STARTED|Overall Study||23
7548345|NCT03137069|18578656|P2|STARTED|Overall Study||28
7548346|NCT03137069|18578657|P1|STARTED|Overall Study||13
7548347|NCT03136861|18578700|P7|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
7548348|NCT03136861|18578701|P6|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
7548349|NCT03136861|18578702|P5|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
7548350|NCT03136861|18578703|P4|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
7548351|NCT03136861|18578704|P3|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
7548352|NCT03136861|18578705|P2|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
7548353|NCT03136861|18578706|P1|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
7548354|NCT03136861|18578700|P7|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||43
7548355|NCT03136861|18578701|P6|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
7548356|NCT03136861|18578702|P5|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||92
7548357|NCT03136861|18578703|P4|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||93
7548358|NCT03136861|18578704|P3|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||88
7548359|NCT03136861|18578705|P2|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
7548360|NCT03136861|18578706|P1|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
7548361|NCT03136861|18578700|P7|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||44
7548362|NCT03136861|18578701|P6|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
7548363|NCT03136861|18578702|P5|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
7548364|NCT03136861|18578703|P4|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
7548365|NCT03136861|18578704|P3|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||90
7548366|NCT03136861|18578705|P2|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
7548367|NCT03136861|18578706|P1|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
7548368|NCT03136861|18578700|P7|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
7548369|NCT03136861|18578701|P6|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
7548370|NCT03136861|18578702|P5|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
7548371|NCT03136861|18578703|P4|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
7548372|NCT03136861|18578704|P3|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
7548373|NCT03136861|18578705|P2|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||6
7548374|NCT03136861|18578706|P1|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||7
7548375|NCT03136861|18578700|P7|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
7548376|NCT03136861|18578701|P6|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
7548377|NCT03136861|18578702|P5|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
7548378|NCT03136861|18578703|P4|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
7548379|NCT03136861|18578704|P3|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
7548380|NCT03136861|18578705|P2|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||89
7548381|NCT03136861|18578706|P1|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||278
7548382|NCT03136861|18578700|P7|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
7548383|NCT03136861|18578701|P6|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
7548384|NCT03136861|18578702|P5|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
7548385|NCT03136861|18578703|P4|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
7548386|NCT03136861|18578704|P3|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
7548387|NCT03136861|18578705|P2|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||95
7548388|NCT03136861|18578706|P1|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||285
7548389|NCT03136484|18578721|P2|NOT COMPLETED|Overall Study||22
7548390|NCT03136484|18578722|P1|NOT COMPLETED|Overall Study||27
7548391|NCT03136484|18578721|P2|COMPLETED|Overall Study||372
7548392|NCT03136484|18578722|P1|COMPLETED|Overall Study||367
7548393|NCT03136484|18578721|P2|Exposed|Overall Study||394
7548394|NCT03136484|18578722|P1|Exposed|Overall Study||392
7548395|NCT03136484|18578721|P2|STARTED|Overall Study||394
7548396|NCT03136484|18578722|P1|STARTED|Overall Study||394
7548397|NCT03136380|18578850|P5|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
7548398|NCT03136380|18578851|P4|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
7548399|NCT03136380|18578852|P3|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
7548400|NCT03136380|18578853|P2|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
7548401|NCT03136380|18578854|P1|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
7548402|NCT03136380|18578850|P5|COMPLETED|Part 2, Period 2 (3 Days)||8
7548403|NCT03136380|18578851|P4|COMPLETED|Part 2, Period 2 (3 Days)||8
7548404|NCT03136380|18578852|P3|COMPLETED|Part 2, Period 2 (3 Days)||0
7548405|NCT03136380|18578853|P2|COMPLETED|Part 2, Period 2 (3 Days)||0
7548406|NCT03136380|18578854|P1|COMPLETED|Part 2, Period 2 (3 Days)||0
7548407|NCT03136380|18578850|P5|STARTED|Part 2, Period 2 (3 Days)||8
7548408|NCT03136380|18578851|P4|STARTED|Part 2, Period 2 (3 Days)||8
7548409|NCT03136380|18578852|P3|STARTED|Part 2, Period 2 (3 Days)||0
7548410|NCT03136380|18578853|P2|STARTED|Part 2, Period 2 (3 Days)||0
7548411|NCT03136380|18578854|P1|STARTED|Part 2, Period 2 (3 Days)||0
7548412|NCT03136380|18578850|P5|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7548413|NCT03136380|18578851|P4|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7548414|NCT03136380|18578852|P3|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7548415|NCT03136380|18578853|P2|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7548416|NCT03136380|18578854|P1|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7548417|NCT03136380|18578850|P5|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
7548418|NCT03136380|18578851|P4|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
7548419|NCT03136380|18578852|P3|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7548420|NCT03136380|18578853|P2|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7548421|NCT03136380|18578854|P1|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
7548422|NCT03136380|18578850|P5|STARTED|Part 2, Washout Period 1 (7 Days)||8
7548423|NCT03136380|18578851|P4|STARTED|Part 2, Washout Period 1 (7 Days)||8
7548424|NCT03136380|18578852|P3|STARTED|Part 2, Washout Period 1 (7 Days)||0
7548425|NCT03136380|18578853|P2|STARTED|Part 2, Washout Period 1 (7 Days)||0
7548426|NCT03136380|18578854|P1|STARTED|Part 2, Washout Period 1 (7 Days)||0
7548427|NCT03136380|18578850|P5|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
7548428|NCT03136380|18578851|P4|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
7548429|NCT03136380|18578852|P3|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
7548430|NCT03136380|18578853|P2|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
7548431|NCT03136380|18578854|P1|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
7548432|NCT03136380|18578850|P5|COMPLETED|Part 2, Period 1 (3 Days)||8
7548433|NCT03136380|18578851|P4|COMPLETED|Part 2, Period 1 (3 Days)||8
7548434|NCT03136380|18578852|P3|COMPLETED|Part 2, Period 1 (3 Days)||0
7548435|NCT03136380|18578853|P2|COMPLETED|Part 2, Period 1 (3 Days)||0
7548436|NCT03136380|18578854|P1|COMPLETED|Part 2, Period 1 (3 Days)||0
7548437|NCT03136380|18578850|P5|STARTED|Part 2, Period 1 (3 Days)||8
7548438|NCT03136380|18578851|P4|STARTED|Part 2, Period 1 (3 Days)||8
7548439|NCT03136380|18578852|P3|STARTED|Part 2, Period 1 (3 Days)||0
7548440|NCT03136380|18578853|P2|STARTED|Part 2, Period 1 (3 Days)||0
7548441|NCT03136380|18578854|P1|STARTED|Part 2, Period 1 (3 Days)||0
7548442|NCT03136380|18578850|P5|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
7548443|NCT03136380|18578851|P4|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
7548444|NCT03136380|18578852|P3|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
7548445|NCT03136380|18578853|P2|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
7548446|NCT03136380|18578854|P1|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
7548447|NCT03136380|18578850|P5|COMPLETED|Part 1, Period 3 (4 Days)||0
7548448|NCT03136380|18578851|P4|COMPLETED|Part 1, Period 3 (4 Days)||0
7548449|NCT03136380|18578852|P3|COMPLETED|Part 1, Period 3 (4 Days)||6
7548450|NCT03136380|18578853|P2|COMPLETED|Part 1, Period 3 (4 Days)||5
7548451|NCT03136380|18578854|P1|COMPLETED|Part 1, Period 3 (4 Days)||6
7548452|NCT03136380|18578850|P5|STARTED|Part 1, Period 3 (4 Days)||0
7548453|NCT03136380|18578851|P4|STARTED|Part 1, Period 3 (4 Days)||0
7548454|NCT03136380|18578852|P3|STARTED|Part 1, Period 3 (4 Days)||6
7548455|NCT03136380|18578853|P2|STARTED|Part 1, Period 3 (4 Days)||5
7548456|NCT03136380|18578854|P1|STARTED|Part 1, Period 3 (4 Days)||6
7548457|NCT03136380|18578850|P5|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7548458|NCT03136380|18578851|P4|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7548459|NCT03136380|18578852|P3|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7548460|NCT03136380|18578853|P2|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||1
7548461|NCT03136380|18578854|P1|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7548462|NCT03136380|18578850|P5|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7548463|NCT03136380|18578851|P4|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7548464|NCT03136380|18578852|P3|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
7548465|NCT03136380|18578853|P2|COMPLETED|Part 1, Washout Period 2 (7 Days)||5
7548466|NCT03136380|18578854|P1|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
7548467|NCT03136380|18578850|P5|STARTED|Part 1, Washout Period 2 (7 Days)||0
7548468|NCT03136380|18578851|P4|STARTED|Part 1, Washout Period 2 (7 Days)||0
7548469|NCT03136380|18578852|P3|STARTED|Part 1, Washout Period 2 (7 Days)||6
7548470|NCT03136380|18578853|P2|STARTED|Part 1, Washout Period 2 (7 Days)||6
7548471|NCT03136380|18578854|P1|STARTED|Part 1, Washout Period 2 (7 Days)||6
7548472|NCT03136380|18578850|P5|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
7548473|NCT03136380|18578851|P4|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
7548474|NCT03136380|18578852|P3|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
7548475|NCT03136380|18578853|P2|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
7548476|NCT03136380|18578854|P1|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
7548477|NCT03136380|18578850|P5|COMPLETED|Part 1, Period 2 (3 Days)||0
7548478|NCT03136380|18578851|P4|COMPLETED|Part 1, Period 2 (3 Days)||0
7548479|NCT03136380|18578852|P3|COMPLETED|Part 1, Period 2 (3 Days)||6
7548480|NCT03136380|18578853|P2|COMPLETED|Part 1, Period 2 (3 Days)||6
7548481|NCT03136380|18578854|P1|COMPLETED|Part 1, Period 2 (3 Days)||6
7548482|NCT03136380|18578850|P5|STARTED|Part 1, Period 2 (3 Days)||0
7548483|NCT03136380|18578851|P4|STARTED|Part 1, Period 2 (3 Days)||0
7548484|NCT03136380|18578852|P3|STARTED|Part 1, Period 2 (3 Days)||6
7548485|NCT03136380|18578853|P2|STARTED|Part 1, Period 2 (3 Days)||6
7548486|NCT03136380|18578854|P1|STARTED|Part 1, Period 2 (3 Days)||6
7548487|NCT03136380|18578850|P5|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7548488|NCT03136380|18578851|P4|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7548489|NCT03136380|18578852|P3|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7548490|NCT03136380|18578853|P2|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7548491|NCT03136380|18578854|P1|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7548492|NCT03136380|18578850|P5|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7548493|NCT03136380|18578851|P4|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7548494|NCT03136380|18578852|P3|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
7548495|NCT03136380|18578853|P2|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
7548496|NCT03136380|18578854|P1|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
7548497|NCT03136380|18578850|P5|STARTED|Part 1, Washout Period 1 (7 Days)||0
7548498|NCT03136380|18578851|P4|STARTED|Part 1, Washout Period 1 (7 Days)||0
7548499|NCT03136380|18578852|P3|STARTED|Part 1, Washout Period 1 (7 Days)||6
7548500|NCT03136380|18578853|P2|STARTED|Part 1, Washout Period 1 (7 Days)||6
7548501|NCT03136380|18578854|P1|STARTED|Part 1, Washout Period 1 (7 Days)||6
7548502|NCT03136380|18578850|P5|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
7548503|NCT03136380|18578851|P4|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
7548504|NCT03136380|18578852|P3|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
7548505|NCT03136380|18578853|P2|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
7548506|NCT03136380|18578854|P1|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
7548507|NCT03136380|18578850|P5|COMPLETED|Part 1, Period 1 (3 Days)||0
7548508|NCT03136380|18578851|P4|COMPLETED|Part 1, Period 1 (3 Days)||0
7548509|NCT03136380|18578852|P3|COMPLETED|Part 1, Period 1 (3 Days)||6
7548510|NCT03136380|18578853|P2|COMPLETED|Part 1, Period 1 (3 Days)||6
7548511|NCT03136380|18578854|P1|COMPLETED|Part 1, Period 1 (3 Days)||6
7548512|NCT03136380|18578850|P5|STARTED|Part 1, Period 1 (3 Days)||0
7548513|NCT03136380|18578851|P4|STARTED|Part 1, Period 1 (3 Days)||0
7548514|NCT03136380|18578852|P3|STARTED|Part 1, Period 1 (3 Days)||6
7548515|NCT03136380|18578853|P2|STARTED|Part 1, Period 1 (3 Days)||6
7548516|NCT03136380|18578854|P1|STARTED|Part 1, Period 1 (3 Days)||6
7548517|NCT03136328|18579027|P1|NOT COMPLETED|Overall Study||0
7548518|NCT03136328|18579027|P1|COMPLETED|Overall Study||11
7548519|NCT03136328|18579027|P1|STARTED|Overall Study||11
7548520|NCT03136198|18579035|P2|NOT COMPLETED|Overall Study||1
7548521|NCT03136198|18579036|P1|NOT COMPLETED|Overall Study||0
7548522|NCT03136198|18579035|P2|COMPLETED|Overall Study||63
7548523|NCT03136198|18579036|P1|COMPLETED|Overall Study||66
7548524|NCT03136198|18579035|P2|STARTED|Overall Study||64
7548525|NCT03136198|18579036|P1|STARTED|Overall Study||66
7548526|NCT03136159|18579044|P2|NOT COMPLETED|Overall Study||0
7548527|NCT03136159|18579045|P1|NOT COMPLETED|Overall Study||5
7548528|NCT03136159|18579044|P2|COMPLETED|Overall Study||190
7548529|NCT03136159|18579045|P1|COMPLETED|Overall Study||185
7548530|NCT03136159|18579044|P2|STARTED|Overall Study||190
7548531|NCT03136159|18579045|P1|STARTED|Overall Study||190
7548532|NCT03136107|18579051|P1|NOT COMPLETED|Overall Study||1
7548533|NCT03136107|18579051|P1|COMPLETED|Overall Study||25
7548534|NCT03136107|18579051|P1|Negative Control|Overall Study||26
7548535|NCT03136107|18579051|P1|Reference Product|Overall Study||26
7548536|NCT03136107|18579051|P1|Test Product|Overall Study||26
7548537|NCT03136107|18579051|P1|STARTED|Overall Study||26
7548538|NCT03136068|18579061|P2|NOT COMPLETED|Overall Study||1
7548539|NCT03136068|18579062|P1|NOT COMPLETED|Overall Study||2
7548540|NCT03136068|18579061|P2|COMPLETED|Overall Study||89
7548541|NCT03136068|18579062|P1|COMPLETED|Overall Study||86
7548542|NCT03136068|18579061|P2|STARTED|Overall Study||90
7548543|NCT03136068|18579062|P1|STARTED|Overall Study||88
7548544|NCT03135899|18579084|P8|NOT COMPLETED|Overall Study||0
7548545|NCT03135899|18579085|P7|NOT COMPLETED|Overall Study||1
7548546|NCT03135899|18579086|P6|NOT COMPLETED|Overall Study||2
7548547|NCT03135899|18579087|P5|NOT COMPLETED|Overall Study||0
7548548|NCT03135899|18579088|P4|NOT COMPLETED|Overall Study||0
7548549|NCT03135899|18579089|P3|NOT COMPLETED|Overall Study||0
7548550|NCT03135899|18579090|P2|NOT COMPLETED|Overall Study||0
7548551|NCT03135899|18579091|P1|NOT COMPLETED|Overall Study||0
7548552|NCT03135899|18579084|P8|COMPLETED|Overall Study||8
7548553|NCT03135899|18579085|P7|COMPLETED|Overall Study||7
7548554|NCT03135899|18579086|P6|COMPLETED|Overall Study||7
7548555|NCT03135899|18579087|P5|COMPLETED|Overall Study||8
7548556|NCT03135899|18579088|P4|COMPLETED|Overall Study||1
7548557|NCT03135899|18579089|P3|COMPLETED|Overall Study||1
7548558|NCT03135899|18579090|P2|COMPLETED|Overall Study||1
7548559|NCT03135899|18579091|P1|COMPLETED|Overall Study||1
7548560|NCT03135899|18579084|P8|STARTED|Overall Study||8
7548561|NCT03135899|18579085|P7|STARTED|Overall Study||8
7548562|NCT03135899|18579086|P6|STARTED|Overall Study||9
7548563|NCT03135899|18579087|P5|STARTED|Overall Study||8
7548564|NCT03135899|18579088|P4|STARTED|Overall Study||1
7548565|NCT03135899|18579089|P3|STARTED|Overall Study||1
7548566|NCT03135899|18579090|P2|STARTED|Overall Study||1
7548567|NCT03135899|18579091|P1|STARTED|Overall Study||1
7548568|NCT03135548|18579124|P3|NOT COMPLETED|Overall Study||3
7548569|NCT03135548|18579125|P2|NOT COMPLETED|Overall Study||4
7548570|NCT03135548|18579126|P1|NOT COMPLETED|Overall Study||5
7548571|NCT03135548|18579124|P3|COMPLETED|Overall Study||18
7548572|NCT03135548|18579125|P2|COMPLETED|Overall Study||15
7548573|NCT03135548|18579126|P1|COMPLETED|Overall Study||14
7548574|NCT03135548|18579124|P3|STARTED|Overall Study||21
7548575|NCT03135548|18579125|P2|STARTED|Overall Study||19
7548576|NCT03135548|18579126|P1|STARTED|Overall Study||19
7548577|NCT03135535|18579146|P1|NOT COMPLETED|Overall Study||0
7548578|NCT03135535|18579146|P1|COMPLETED|Overall Study||30
7548579|NCT03135535|18579146|P1|STARTED|Overall Study||30
7548580|NCT03135522|18579156|P2|NOT COMPLETED|Overall Study||0
7548581|NCT03135522|18579157|P1|NOT COMPLETED|Overall Study||1
7548582|NCT03135522|18579156|P2|COMPLETED|Overall Study||17
7548583|NCT03135522|18579157|P1|COMPLETED|Overall Study||16
7548584|NCT03135522|18579156|P2|STARTED|Overall Study||17
7548585|NCT03135522|18579157|P1|STARTED|Overall Study||17
7548586|NCT03135431|18579171|P2|NOT COMPLETED|Overall Study||0
7548587|NCT03135431|18579172|P1|NOT COMPLETED|Overall Study||2
7548588|NCT03135431|18579171|P2|COMPLETED|Overall Study||20
7548589|NCT03135431|18579172|P1|COMPLETED|Overall Study||18
7548590|NCT03135431|18579171|P2|STARTED|Overall Study||20
7548591|NCT03135431|18579172|P1|STARTED|Overall Study||20
7548592|NCT03135379|18579184|P2|NOT COMPLETED|Overall Study||3
7548593|NCT03135379|18579185|P1|NOT COMPLETED|Overall Study||1
7548594|NCT03135379|18579184|P2|COMPLETED|Overall Study||59
7548595|NCT03135379|18579185|P1|COMPLETED|Overall Study||61
7548596|NCT03135379|18579184|P2|STARTED|Overall Study||62
7548597|NCT03135379|18579185|P1|STARTED|Overall Study||62
7548598|NCT03135028|18579193|P1|NOT COMPLETED|Overall Study||9
7548599|NCT03135028|18579193|P1|COMPLETED|Overall Study||0
7548600|NCT03135028|18579193|P1|STARTED|Overall Study||9
7548601|NCT03135015|18579201|P2|NOT COMPLETED|Overall Study||0
7548602|NCT03135015|18579202|P1|NOT COMPLETED|Overall Study||2
7548603|NCT03135015|18579201|P2|COMPLETED|Overall Study||11
7548604|NCT03135015|18579202|P1|COMPLETED|Overall Study||9
7548605|NCT03135015|18579201|P2|4g Tablets|Overall Study||11
7548606|NCT03135015|18579202|P1|4g Tablets|Overall Study||9
7548607|NCT03135015|18579201|P2|2g Tablets|Overall Study||11
7548608|NCT03135015|18579202|P1|2g Tablets|Overall Study||9
7548609|NCT03135015|18579201|P2|4g Capsules|Overall Study||11
7548610|NCT03135015|18579202|P1|4g Capsules|Overall Study||9
7548611|NCT03135015|18579201|P2|2g Capsules|Overall Study||11
7548612|NCT03135015|18579202|P1|2g Capsules|Overall Study||9
7548613|NCT03135015|18579201|P2|Placebo Capsules|Overall Study||11
7548614|NCT03135015|18579202|P1|Placebo Capsules|Overall Study||9
7548615|NCT03135015|18579201|P2|Water Control|Overall Study||11
7548616|NCT03135015|18579202|P1|Water Control|Overall Study||9
7548617|NCT03135015|18579201|P2|STARTED|Overall Study||11
7548618|NCT03135015|18579202|P1|STARTED|Overall Study||11
7548619|NCT03134963|18579312|P4|NOT COMPLETED|Overall Study||0
7548620|NCT03134963|18579313|P3|NOT COMPLETED|Overall Study||0
7548621|NCT03134963|18579314|P2|NOT COMPLETED|Overall Study||0
7548622|NCT03134963|18579315|P1|NOT COMPLETED|Overall Study||0
7548623|NCT03134963|18579312|P4|COMPLETED|Overall Study||14
7548624|NCT03134963|18579313|P3|COMPLETED|Overall Study||3
7548625|NCT03134963|18579314|P2|COMPLETED|Overall Study||13
7548626|NCT03134963|18579315|P1|COMPLETED|Overall Study||12
7548627|NCT03134963|18579312|P4|STARTED|Overall Study||14
7548628|NCT03134963|18579313|P3|STARTED|Overall Study||3
7548629|NCT03134963|18579314|P2|STARTED|Overall Study||13
7548630|NCT03134963|18579315|P1|STARTED|Overall Study||12
7548631|NCT03134911|18579339|P1|NOT COMPLETED|Overall Study||34
7548632|NCT03134911|18579339|P1|COMPLETED|Overall Study||501
7548633|NCT03134911|18579339|P1|STARTED|Overall Study||535
7548634|NCT03134768|18579366|P1|NOT COMPLETED|Overall Study||0
7548635|NCT03134768|18579366|P1|COMPLETED|Overall Study||50
7548636|NCT03134768|18579366|P1|STARTED|Overall Study||50
7548637|NCT03134703|18579374|P2|NOT COMPLETED|Overall Study||2
7548638|NCT03134703|18579375|P1|NOT COMPLETED|Overall Study||6
7548639|NCT03134703|18579374|P2|COMPLETED|Overall Study||3
7548640|NCT03134703|18579375|P1|COMPLETED|Overall Study||0
7548641|NCT03134703|18579374|P2|STARTED|Overall Study||5
7548642|NCT03134703|18579375|P1|STARTED|Overall Study||6
7548643|NCT03134599|18579401|P6|NOT COMPLETED|Week 3||1
7548644|NCT03134599|18579402|P5|NOT COMPLETED|Week 3||0
7548645|NCT03134599|18579403|P4|NOT COMPLETED|Week 3||1
7548646|NCT03134599|18579404|P3|NOT COMPLETED|Week 3||0
7548647|NCT03134599|18579405|P2|NOT COMPLETED|Week 3||0
7548648|NCT03134599|18579406|P1|NOT COMPLETED|Week 3||0
7548649|NCT03134599|18579401|P6|COMPLETED|Week 3||8
7548650|NCT03134599|18579402|P5|COMPLETED|Week 3||8
7548651|NCT03134599|18579403|P4|COMPLETED|Week 3||9
7548652|NCT03134599|18579404|P3|COMPLETED|Week 3||10
7548653|NCT03134599|18579405|P2|COMPLETED|Week 3||10
7548654|NCT03134599|18579406|P1|COMPLETED|Week 3||9
7548655|NCT03134599|18579401|P6|STARTED|Week 3||9
7548656|NCT03134599|18579402|P5|STARTED|Week 3||8
7548657|NCT03134599|18579403|P4|STARTED|Week 3||10
7548658|NCT03134599|18579404|P3|STARTED|Week 3||10
7548659|NCT03134599|18579405|P2|STARTED|Week 3||10
7548660|NCT03134599|18579406|P1|STARTED|Week 3||9
7548661|NCT03134599|18579401|P6|NOT COMPLETED|Week 2||0
7548662|NCT03134599|18579402|P5|NOT COMPLETED|Week 2||1
7548663|NCT03134599|18579403|P4|NOT COMPLETED|Week 2||1
7548664|NCT03134599|18579404|P3|NOT COMPLETED|Week 2||0
7548665|NCT03134599|18579405|P2|NOT COMPLETED|Week 2||0
7548666|NCT03134599|18579406|P1|NOT COMPLETED|Week 2||1
7548667|NCT03134599|18579401|P6|COMPLETED|Week 2||9
7548668|NCT03134599|18579402|P5|COMPLETED|Week 2||8
7548669|NCT03134599|18579403|P4|COMPLETED|Week 2||10
7548670|NCT03134599|18579404|P3|COMPLETED|Week 2||10
7548671|NCT03134599|18579405|P2|COMPLETED|Week 2||10
7548672|NCT03134599|18579406|P1|COMPLETED|Week 2||9
7548673|NCT03134599|18579401|P6|STARTED|Week 2||9
7548674|NCT03134599|18579402|P5|STARTED|Week 2||9
7548675|NCT03134599|18579403|P4|STARTED|Week 2||11
7548676|NCT03134599|18579404|P3|STARTED|Week 2||10
7548677|NCT03134599|18579405|P2|STARTED|Week 2||10
7548678|NCT03134599|18579406|P1|STARTED|Week 2||10
7548679|NCT03134599|18579401|P6|NOT COMPLETED|Week 1||0
7548680|NCT03134599|18579402|P5|NOT COMPLETED|Week 1||1
7548681|NCT03134599|18579403|P4|NOT COMPLETED|Week 1||0
7548682|NCT03134599|18579404|P3|NOT COMPLETED|Week 1||0
7548683|NCT03134599|18579405|P2|NOT COMPLETED|Week 1||0
7548684|NCT03134599|18579406|P1|NOT COMPLETED|Week 1||0
7548685|NCT03134599|18579401|P6|COMPLETED|Week 1||9
7548686|NCT03134599|18579402|P5|COMPLETED|Week 1||9
7548687|NCT03134599|18579403|P4|COMPLETED|Week 1||11
7548688|NCT03134599|18579404|P3|COMPLETED|Week 1||10
7548689|NCT03134599|18579405|P2|COMPLETED|Week 1||10
7548690|NCT03134599|18579406|P1|COMPLETED|Week 1||10
7548691|NCT03134599|18579401|P6|STARTED|Week 1||9
7548692|NCT03134599|18579402|P5|STARTED|Week 1||10
7548693|NCT03134599|18579403|P4|STARTED|Week 1||11
7548694|NCT03134599|18579404|P3|STARTED|Week 1||10
7548695|NCT03134599|18579405|P2|STARTED|Week 1||10
7548696|NCT03134599|18579406|P1|STARTED|Week 1||10
7548697|NCT03134326|18579414|P1|NOT COMPLETED|Overall Study||0
7548698|NCT03134326|18579414|P1|COMPLETED|Overall Study||21
7548699|NCT03134326|18579414|P1|STARTED|Overall Study||21
7548700|NCT03134313|18579418|P1|NOT COMPLETED|Overall Study||0
7548701|NCT03134313|18579418|P1|COMPLETED|Overall Study||25
7548702|NCT03134313|18579418|P1|STARTED|Overall Study||25
7548703|NCT03134248|18579422|P6|NOT COMPLETED|Week 3||0
7548704|NCT03134248|18579423|P5|NOT COMPLETED|Week 3||0
7548705|NCT03134248|18579424|P4|NOT COMPLETED|Week 3||0
7548706|NCT03134248|18579425|P3|NOT COMPLETED|Week 3||0
7548707|NCT03134248|18579426|P2|NOT COMPLETED|Week 3||0
7548708|NCT03134248|18579427|P1|NOT COMPLETED|Week 3||0
7548709|NCT03134248|18579422|P6|COMPLETED|Week 3||9
7548710|NCT03134248|18579423|P5|COMPLETED|Week 3||9
7548711|NCT03134248|18579424|P4|COMPLETED|Week 3||7
7548712|NCT03134248|18579425|P3|COMPLETED|Week 3||9
7548713|NCT03134248|18579426|P2|COMPLETED|Week 3||8
7548714|NCT03134248|18579427|P1|COMPLETED|Week 3||7
7548715|NCT03134248|18579422|P6|STARTED|Week 3||9
7548716|NCT03134248|18579423|P5|STARTED|Week 3||9
7548717|NCT03134248|18579424|P4|STARTED|Week 3||7
7548718|NCT03134248|18579425|P3|STARTED|Week 3||9
7548719|NCT03134248|18579426|P2|STARTED|Week 3||8
7548720|NCT03134248|18579427|P1|STARTED|Week 3||7
7548721|NCT03134248|18579422|P6|NOT COMPLETED|Week 2||0
7548722|NCT03134248|18579423|P5|NOT COMPLETED|Week 2||0
7548723|NCT03134248|18579424|P4|NOT COMPLETED|Week 2||0
7548724|NCT03134248|18579425|P3|NOT COMPLETED|Week 2||0
7548725|NCT03134248|18579426|P2|NOT COMPLETED|Week 2||0
7548726|NCT03134248|18579427|P1|NOT COMPLETED|Week 2||0
7548727|NCT03134248|18579422|P6|COMPLETED|Week 2||9
7548728|NCT03134248|18579423|P5|COMPLETED|Week 2||9
7548729|NCT03134248|18579424|P4|COMPLETED|Week 2||7
7548730|NCT03134248|18579425|P3|COMPLETED|Week 2||9
7548731|NCT03134248|18579426|P2|COMPLETED|Week 2||8
7548732|NCT03134248|18579427|P1|COMPLETED|Week 2||7
7548733|NCT03134248|18579422|P6|STARTED|Week 2||9
7548734|NCT03134248|18579423|P5|STARTED|Week 2||9
7548735|NCT03134248|18579424|P4|STARTED|Week 2||7
7548736|NCT03134248|18579425|P3|STARTED|Week 2||9
7548737|NCT03134248|18579426|P2|STARTED|Week 2||8
7548738|NCT03134248|18579427|P1|STARTED|Week 2||7
7548739|NCT03134248|18579422|P6|NOT COMPLETED|Week 1||0
7548740|NCT03134248|18579423|P5|NOT COMPLETED|Week 1||0
7548741|NCT03134248|18579424|P4|NOT COMPLETED|Week 1||0
7548742|NCT03134248|18579425|P3|NOT COMPLETED|Week 1||0
7548743|NCT03134248|18579426|P2|NOT COMPLETED|Week 1||0
7548744|NCT03134248|18579427|P1|NOT COMPLETED|Week 1||0
7548745|NCT03134248|18579422|P6|COMPLETED|Week 1||9
7548746|NCT03134248|18579423|P5|COMPLETED|Week 1||9
7548747|NCT03134248|18579424|P4|COMPLETED|Week 1||7
7548748|NCT03134248|18579425|P3|COMPLETED|Week 1||9
7548749|NCT03134248|18579426|P2|COMPLETED|Week 1||8
7548750|NCT03134248|18579427|P1|COMPLETED|Week 1||7
7548751|NCT03134248|18579422|P6|STARTED|Week 1||9
7548752|NCT03134248|18579423|P5|STARTED|Week 1||9
7548753|NCT03134248|18579424|P4|STARTED|Week 1||7
7548754|NCT03134248|18579425|P3|STARTED|Week 1||9
7548755|NCT03134248|18579426|P2|STARTED|Week 1||8
7548756|NCT03134248|18579427|P1|STARTED|Week 1||7
7548757|NCT03134222|18579446|P5|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
7548758|NCT03134222|18579447|P4|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
7548759|NCT03134222|18579448|P3|NOT COMPLETED|Treatment Period (Week 12 to 48)||0
7548760|NCT03134222|18579449|P2|NOT COMPLETED|Treatment Period (Week 12 to 48)||3
7548761|NCT03134222|18579450|P1|NOT COMPLETED|Treatment Period (Week 12 to 48)||2
7548762|NCT03134222|18579446|P5|COMPLETED|Treatment Period (Week 12 to 48)||3
7548763|NCT03134222|18579447|P4|COMPLETED|Treatment Period (Week 12 to 48)||3
7548764|NCT03134222|18579448|P3|COMPLETED|Treatment Period (Week 12 to 48)||0
7548765|NCT03134222|18579449|P2|COMPLETED|Treatment Period (Week 12 to 48)||11
7548766|NCT03134222|18579450|P1|COMPLETED|Treatment Period (Week 12 to 48)||12
7548767|NCT03134222|18579446|P5|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
7548768|NCT03134222|18579447|P4|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
7548769|NCT03134222|18579448|P3|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized 1:1 to either Placebo to Lanraplenib or Placebo to Filgotinib arm.|0
7548770|NCT03134222|18579449|P2|STARTED|Treatment Period (Week 12 to 48)||14
7548771|NCT03134222|18579450|P1|STARTED|Treatment Period (Week 12 to 48)||14
7548772|NCT03134222|18579446|P5|NOT COMPLETED|Treatment Period (Up to Week 12)||0
7548773|NCT03134222|18579447|P4|NOT COMPLETED|Treatment Period (Up to Week 12)||0
7548774|NCT03134222|18579448|P3|NOT COMPLETED|Treatment Period (Up to Week 12)||2
7548775|NCT03134222|18579449|P2|NOT COMPLETED|Treatment Period (Up to Week 12)||4
7548776|NCT03134222|18579450|P1|NOT COMPLETED|Treatment Period (Up to Week 12)||5
7548777|NCT03134222|18579446|P5|COMPLETED|Treatment Period (Up to Week 12)||0
7548778|NCT03134222|18579447|P4|COMPLETED|Treatment Period (Up to Week 12)||0
7548779|NCT03134222|18579448|P3|COMPLETED|Treatment Period (Up to Week 12)||8
7548780|NCT03134222|18579449|P2|COMPLETED|Treatment Period (Up to Week 12)||14
7548781|NCT03134222|18579450|P1|COMPLETED|Treatment Period (Up to Week 12)||14
7548782|NCT03134222|18579446|P5|STARTED|Treatment Period (Up to Week 12)||0
7548783|NCT03134222|18579447|P4|STARTED|Treatment Period (Up to Week 12)||0
7548784|NCT03134222|18579448|P3|STARTED|Treatment Period (Up to Week 12)||10
7548785|NCT03134222|18579449|P2|STARTED|Treatment Period (Up to Week 12)||18
7548786|NCT03134222|18579450|P1|STARTED|Treatment Period (Up to Week 12)||19
7548787|NCT03134183|18579472|P2|NOT COMPLETED|Overall Study||1
7548788|NCT03134183|18579473|P1|NOT COMPLETED|Overall Study||1
7548789|NCT03134183|18579472|P2|COMPLETED|Overall Study||33
7548790|NCT03134183|18579473|P1|COMPLETED|Overall Study||35
7548791|NCT03134183|18579472|P2|STARTED|Overall Study||34
7548792|NCT03134183|18579473|P1|STARTED|Overall Study||36
7548793|NCT03134144|18579483|P2|NOT COMPLETED|Overall Study||0
7548794|NCT03134144|18579484|P1|NOT COMPLETED|Overall Study||0
7548795|NCT03134144|18579483|P2|COMPLETED|Overall Study||30
7548796|NCT03134144|18579484|P1|COMPLETED|Overall Study||15
7548797|NCT03134144|18579483|P2|STARTED|Overall Study||30
7548798|NCT03134144|18579484|P1|STARTED|Overall Study||15
7548799|NCT03134092|18579501|P3|NOT COMPLETED|Overall Study||0
7548800|NCT03134092|18579502|P2|NOT COMPLETED|Overall Study||0
7548801|NCT03134092|18579503|P1|NOT COMPLETED|Overall Study||0
7548802|NCT03134092|18579501|P3|COMPLETED|Overall Study||433
7548803|NCT03134092|18579502|P2|COMPLETED|Overall Study||435
7548804|NCT03134092|18579503|P1|COMPLETED|Overall Study||434
7548805|NCT03134092|18579501|P3|STARTED|Overall Study||433
7548806|NCT03134092|18579502|P2|STARTED|Overall Study||435
7548807|NCT03134092|18579503|P1|STARTED|Overall Study||434
7548808|NCT03133767|18579524|P2|NOT COMPLETED|Overall Study||25
7548809|NCT03133767|18579525|P1|NOT COMPLETED|Overall Study||38
7548810|NCT03133767|18579524|P2|COMPLETED|Overall Study||53
7548811|NCT03133767|18579525|P1|COMPLETED|Overall Study||41
7548812|NCT03133767|18579524|P2|STARTED|Overall Study||78
7548813|NCT03133767|18579525|P1|STARTED|Overall Study||79
7548814|NCT03133481|18579541|P2|NOT COMPLETED|Overall Study||4
7548815|NCT03133481|18579542|P1|NOT COMPLETED|Overall Study||0
7548816|NCT03133481|18579541|P2|COMPLETED|Overall Study||45
7548817|NCT03133481|18579542|P1|COMPLETED|Overall Study||45
7548818|NCT03133481|18579541|P2|STARTED|Overall Study||49
7548819|NCT03133481|18579542|P1|STARTED|Overall Study||45
7548820|NCT03132753|18579572|P2|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||2
7548821|NCT03132753|18579573|P1|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||6
7548822|NCT03132753|18579572|P2|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||20
7548823|NCT03132753|18579573|P1|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||13
7548824|NCT03132753|18579572|P2|STARTED|6 Month Follow-Up - 12 Month Follow-Up||22
7548825|NCT03132753|18579573|P1|STARTED|6 Month Follow-Up - 12 Month Follow-Up||19
7548826|NCT03132753|18579572|P2|NOT COMPLETED|Baseline - 6 Month Follow-Up||32
7548827|NCT03132753|18579573|P1|NOT COMPLETED|Baseline - 6 Month Follow-Up||27
7548828|NCT03132753|18579572|P2|COMPLETED|Baseline - 6 Month Follow-Up||22
7548829|NCT03132753|18579573|P1|COMPLETED|Baseline - 6 Month Follow-Up||19
7548830|NCT03132753|18579572|P2|STARTED|Baseline - 6 Month Follow-Up||54
7548831|NCT03132753|18579573|P1|STARTED|Baseline - 6 Month Follow-Up||46
7548832|NCT03132571|18579661|P2|NOT COMPLETED|Overall Study||0
7548833|NCT03132571|18579662|P1|NOT COMPLETED|Overall Study||0
7548834|NCT03132571|18579661|P2|COMPLETED|Overall Study||2
7548835|NCT03132571|18579662|P1|COMPLETED|Overall Study||3
7548836|NCT03132571|18579661|P2|STARTED|Overall Study||2
7548837|NCT03132571|18579662|P1|STARTED|Overall Study||3
7548838|NCT03132298|18579676|P2|NOT COMPLETED|Overall Study||13
7548839|NCT03132298|18579677|P1|NOT COMPLETED|Overall Study||12
7548840|NCT03132298|18579676|P2|COMPLETED|Overall Study||35
7548841|NCT03132298|18579677|P1|COMPLETED|Overall Study||36
7548842|NCT03132298|18579676|P2|STARTED|Overall Study||48
7548843|NCT03132298|18579677|P1|STARTED|Overall Study||48
7548844|NCT03132246|18579707|P1|NOT COMPLETED|Overall Study||104
7548845|NCT03132246|18579707|P1|COMPLETED|Overall Study||156
7548846|NCT03132246|18579707|P1|STARTED|Overall Study||260
7548847|NCT03132220|18579718|P2|NOT COMPLETED|Overall Study||12
7548848|NCT03132220|18579719|P1|NOT COMPLETED|Overall Study||18
7548849|NCT03132220|18579718|P2|COMPLETED|Overall Study||54
7548850|NCT03132220|18579719|P1|COMPLETED|Overall Study||47
7548851|NCT03132220|18579718|P2|Began Study Sessions|Overall Study|66 participants randomized to control arm;8 were lost to f/u prior to study start; 58 began sessions|58
7548852|NCT03132220|18579719|P1|Began Study Sessions|Overall Study|65 participants randomized to intervention arm;17 lost to f/u prior to study start;48 began sessions|48
7548853|NCT03132220|18579718|P2|STARTED|Overall Study||66
7548854|NCT03132220|18579719|P1|STARTED|Overall Study||65
7548855|NCT03131999|18579747|P2|NOT COMPLETED|Overall Study||1
7548856|NCT03131999|18579748|P1|NOT COMPLETED|Overall Study||0
7548857|NCT03131999|18579747|P2|COMPLETED|Overall Study||7
7548858|NCT03131999|18579748|P1|COMPLETED|Overall Study||8
7548859|NCT03131999|18579747|P2|STARTED|Overall Study||8
7548860|NCT03131999|18579748|P1|STARTED|Overall Study||8
7548861|NCT03131895|18579760|P4|NOT COMPLETED|Intervention Period 2 (2 Days)||0
7548862|NCT03131895|18579761|P3|NOT COMPLETED|Intervention Period 2 (2 Days)||0
7548863|NCT03131895|18579762|P2|NOT COMPLETED|Intervention Period 2 (2 Days)||1
7548864|NCT03131895|18579763|P1|NOT COMPLETED|Intervention Period 2 (2 Days)||1
7548865|NCT03131895|18579760|P4|COMPLETED|Intervention Period 2 (2 Days)||25
7548866|NCT03131895|18579761|P3|COMPLETED|Intervention Period 2 (2 Days)||26
7548867|NCT03131895|18579762|P2|COMPLETED|Intervention Period 2 (2 Days)||22
7548868|NCT03131895|18579763|P1|COMPLETED|Intervention Period 2 (2 Days)||26
7548869|NCT03131895|18579760|P4|STARTED|Intervention Period 2 (2 Days)||25
7548870|NCT03131895|18579761|P3|STARTED|Intervention Period 2 (2 Days)||26
7548871|NCT03131895|18579762|P2|STARTED|Intervention Period 2 (2 Days)||23
7548872|NCT03131895|18579763|P1|STARTED|Intervention Period 2 (2 Days)||27
7548873|NCT03131895|18579760|P4|NOT COMPLETED|Washout Period (at Least 5 Days)||5
7548874|NCT03131895|18579761|P3|NOT COMPLETED|Washout Period (at Least 5 Days)||4
7548875|NCT03131895|18579762|P2|NOT COMPLETED|Washout Period (at Least 5 Days)||5
7548876|NCT03131895|18579763|P1|NOT COMPLETED|Washout Period (at Least 5 Days)||1
7548877|NCT03131895|18579760|P4|COMPLETED|Washout Period (at Least 5 Days)||25
7548878|NCT03131895|18579761|P3|COMPLETED|Washout Period (at Least 5 Days)||26
7548879|NCT03131895|18579762|P2|COMPLETED|Washout Period (at Least 5 Days)||23
7548880|NCT03131895|18579763|P1|COMPLETED|Washout Period (at Least 5 Days)||27
7548881|NCT03131895|18579760|P4|STARTED|Washout Period (at Least 5 Days)||30
7548882|NCT03131895|18579761|P3|STARTED|Washout Period (at Least 5 Days)||30
7548883|NCT03131895|18579762|P2|STARTED|Washout Period (at Least 5 Days)||28
7548884|NCT03131895|18579763|P1|STARTED|Washout Period (at Least 5 Days)||28
7548885|NCT03131895|18579760|P4|NOT COMPLETED|Intervention Period 1 (2 Days)||0
7548886|NCT03131895|18579761|P3|NOT COMPLETED|Intervention Period 1 (2 Days)||0
7548887|NCT03131895|18579762|P2|NOT COMPLETED|Intervention Period 1 (2 Days)||0
7548888|NCT03131895|18579763|P1|NOT COMPLETED|Intervention Period 1 (2 Days)||0
7548889|NCT03131895|18579760|P4|COMPLETED|Intervention Period 1 (2 Days)||30
7548890|NCT03131895|18579761|P3|COMPLETED|Intervention Period 1 (2 Days)||30
7548891|NCT03131895|18579762|P2|COMPLETED|Intervention Period 1 (2 Days)||28
7548892|NCT03131895|18579763|P1|COMPLETED|Intervention Period 1 (2 Days)||28
7548893|NCT03131895|18579760|P4|STARTED|Intervention Period 1 (2 Days)||30
7548894|NCT03131895|18579761|P3|STARTED|Intervention Period 1 (2 Days)||30
7548895|NCT03131895|18579762|P2|STARTED|Intervention Period 1 (2 Days)||28
7548896|NCT03131895|18579763|P1|STARTED|Intervention Period 1 (2 Days)||28
7548897|NCT03131713|18579783|P2|NOT COMPLETED|Overall Study||0
7548898|NCT03131713|18579784|P1|NOT COMPLETED|Overall Study||5
7548899|NCT03131713|18579783|P2|COMPLETED|Overall Study||51
7548900|NCT03131713|18579784|P1|COMPLETED|Overall Study||45
7548901|NCT03131713|18579783|P2|STARTED|Overall Study|1 intervention subject was added on after the protocol was initiated.|51
7548902|NCT03131713|18579784|P1|STARTED|Overall Study||50
7548903|NCT03131687|18579808|P6|NOT COMPLETED|Overall Study||5
7548904|NCT03131687|18579809|P5|NOT COMPLETED|Overall Study||8
7548905|NCT03131687|18579810|P4|NOT COMPLETED|Overall Study||4
7548906|NCT03131687|18579811|P3|NOT COMPLETED|Overall Study||3
7548907|NCT03131687|18579812|P2|NOT COMPLETED|Overall Study||9
7548908|NCT03131687|18579813|P1|NOT COMPLETED|Overall Study||6
7548909|NCT03131687|18579808|P6|COMPLETED|Overall Study||49
7548910|NCT03131687|18579809|P5|COMPLETED|Overall Study||45
7548911|NCT03131687|18579810|P4|COMPLETED|Overall Study||48
7548912|NCT03131687|18579811|P3|COMPLETED|Overall Study||52
7548913|NCT03131687|18579812|P2|COMPLETED|Overall Study||44
7548914|NCT03131687|18579813|P1|COMPLETED|Overall Study||45
7548915|NCT03131687|18579808|P6|Received at Least One Dose of Study Drug|Overall Study||54
7548916|NCT03131687|18579809|P5|Received at Least One Dose of Study Drug|Overall Study||53
7548917|NCT03131687|18579810|P4|Received at Least One Dose of Study Drug|Overall Study||51
7548918|NCT03131687|18579811|P3|Received at Least One Dose of Study Drug|Overall Study||55
7548919|NCT03131687|18579812|P2|Received at Least One Dose of Study Drug|Overall Study||52
7548920|NCT03131687|18579813|P1|Received at Least One Dose of Study Drug|Overall Study||51
7548921|NCT03131687|18579808|P6|STARTED|Overall Study||54
7548922|NCT03131687|18579809|P5|STARTED|Overall Study||53
7548923|NCT03131687|18579810|P4|STARTED|Overall Study||52
7548924|NCT03131687|18579811|P3|STARTED|Overall Study||55
7548925|NCT03131687|18579812|P2|STARTED|Overall Study||53
7548926|NCT03131687|18579813|P1|STARTED|Overall Study||51
7548927|NCT03131648|18579923|P8|NOT COMPLETED|Open-label (Short Term Extension)||3
7548928|NCT03131648|18579924|P7|NOT COMPLETED|Open-label (Short Term Extension)||0
7548929|NCT03131648|18579925|P6|NOT COMPLETED|Open-label (Short Term Extension)||0
7548930|NCT03131648|18579926|P5|NOT COMPLETED|Open-label (Short Term Extension)||0
7548931|NCT03131648|18579927|P4|NOT COMPLETED|Open-label (Short Term Extension)||0
7548932|NCT03131648|18579928|P3|NOT COMPLETED|Open-label (Short Term Extension)||0
7548933|NCT03131648|18579929|P2|NOT COMPLETED|Open-label (Short Term Extension)||0
7548934|NCT03131648|18579930|P1|NOT COMPLETED|Open-label (Short Term Extension)||0
7548935|NCT03131648|18579923|P8|COMPLETED|Open-label (Short Term Extension)||62
7548936|NCT03131648|18579924|P7|COMPLETED|Open-label (Short Term Extension)||0
7548937|NCT03131648|18579925|P6|COMPLETED|Open-label (Short Term Extension)||0
7548938|NCT03131648|18579926|P5|COMPLETED|Open-label (Short Term Extension)||0
7548939|NCT03131648|18579927|P4|COMPLETED|Open-label (Short Term Extension)||0
7548940|NCT03131648|18579928|P3|COMPLETED|Open-label (Short Term Extension)||0
7548941|NCT03131648|18579929|P2|COMPLETED|Open-label (Short Term Extension)||0
7548942|NCT03131648|18579930|P1|COMPLETED|Open-label (Short Term Extension)||0
7548943|NCT03131648|18579923|P8|STARTED|Open-label (Short Term Extension)||65
7548944|NCT03131648|18579924|P7|STARTED|Open-label (Short Term Extension)||0
7548945|NCT03131648|18579925|P6|STARTED|Open-label (Short Term Extension)||0
7548946|NCT03131648|18579926|P5|STARTED|Open-label (Short Term Extension)||0
7548947|NCT03131648|18579927|P4|STARTED|Open-label (Short Term Extension)||0
7548948|NCT03131648|18579928|P3|STARTED|Open-label (Short Term Extension)||0
7548949|NCT03131648|18579929|P2|STARTED|Open-label (Short Term Extension)||0
7548950|NCT03131648|18579930|P1|STARTED|Open-label (Short Term Extension)||0
7548951|NCT03131648|18579923|P8|NOT COMPLETED|Maintenance Treatment Period||0
7548952|NCT03131648|18579924|P7|NOT COMPLETED|Maintenance Treatment Period||0
7548953|NCT03131648|18579925|P6|NOT COMPLETED|Maintenance Treatment Period||14
7548954|NCT03131648|18579926|P5|NOT COMPLETED|Maintenance Treatment Period||15
7548955|NCT03131648|18579927|P4|NOT COMPLETED|Maintenance Treatment Period||25
7548956|NCT03131648|18579928|P3|NOT COMPLETED|Maintenance Treatment Period||27
7548957|NCT03131648|18579929|P2|NOT COMPLETED|Maintenance Treatment Period||0
7548958|NCT03131648|18579930|P1|NOT COMPLETED|Maintenance Treatment Period||0
7548959|NCT03131648|18579923|P8|COMPLETED|Maintenance Treatment Period||0
7548960|NCT03131648|18579924|P7|COMPLETED|Maintenance Treatment Period||0
7548961|NCT03131648|18579925|P6|COMPLETED|Maintenance Treatment Period||15
7548962|NCT03131648|18579926|P5|COMPLETED|Maintenance Treatment Period||21
7548963|NCT03131648|18579927|P4|COMPLETED|Maintenance Treatment Period||53
7548964|NCT03131648|18579928|P3|COMPLETED|Maintenance Treatment Period||44
7548965|NCT03131648|18579929|P2|COMPLETED|Maintenance Treatment Period||0
7548966|NCT03131648|18579930|P1|COMPLETED|Maintenance Treatment Period||0
7548967|NCT03131648|18579923|P8|STARTED|Maintenance Treatment Period||0
7548968|NCT03131648|18579924|P7|STARTED|Maintenance Treatment Period||0
7548969|NCT03131648|18579925|P6|STARTED|Maintenance Treatment Period||29
7548970|NCT03131648|18579926|P5|STARTED|Maintenance Treatment Period||36
7548971|NCT03131648|18579927|P4|STARTED|Maintenance Treatment Period||78
7548972|NCT03131648|18579928|P3|STARTED|Maintenance Treatment Period||71
7548973|NCT03131648|18579929|P2|STARTED|Maintenance Treatment Period||0
7548974|NCT03131648|18579930|P1|STARTED|Maintenance Treatment Period||0
7548975|NCT03131648|18579923|P8|NOT COMPLETED|Open-label Treatment||0
7548976|NCT03131648|18579924|P7|NOT COMPLETED|Open-label Treatment||118
7548977|NCT03131648|18579925|P6|NOT COMPLETED|Open-label Treatment||0
7548978|NCT03131648|18579926|P5|NOT COMPLETED|Open-label Treatment||0
7548979|NCT03131648|18579927|P4|NOT COMPLETED|Open-label Treatment||0
7548980|NCT03131648|18579928|P3|NOT COMPLETED|Open-label Treatment||0
7548981|NCT03131648|18579929|P2|NOT COMPLETED|Open-label Treatment||0
7548982|NCT03131648|18579930|P1|NOT COMPLETED|Open-label Treatment||0
7548983|NCT03131648|18579923|P8|COMPLETED|Open-label Treatment||0
7548984|NCT03131648|18579924|P7|COMPLETED|Open-label Treatment||446
7548985|NCT03131648|18579925|P6|COMPLETED|Open-label Treatment||0
7548986|NCT03131648|18579926|P5|COMPLETED|Open-label Treatment||0
7548987|NCT03131648|18579927|P4|COMPLETED|Open-label Treatment||0
7548988|NCT03131648|18579928|P3|COMPLETED|Open-label Treatment||0
7548989|NCT03131648|18579929|P2|COMPLETED|Open-label Treatment||0
7548990|NCT03131648|18579930|P1|COMPLETED|Open-label Treatment||0
7548991|NCT03131648|18579923|P8|STARTED|Open-label Treatment||0
7548992|NCT03131648|18579924|P7|STARTED|Open-label Treatment||564
7548993|NCT03131648|18579925|P6|STARTED|Open-label Treatment||0
7548994|NCT03131648|18579926|P5|STARTED|Open-label Treatment||0
7548995|NCT03131648|18579927|P4|STARTED|Open-label Treatment||0
7548996|NCT03131648|18579928|P3|STARTED|Open-label Treatment||0
7548997|NCT03131648|18579929|P2|STARTED|Open-label Treatment||0
7548998|NCT03131648|18579930|P1|STARTED|Open-label Treatment||0
7548999|NCT03131648|18579923|P8|NOT COMPLETED|Initial Treatment Period||0
7549000|NCT03131648|18579924|P7|NOT COMPLETED|Initial Treatment Period||0
7549001|NCT03131648|18579925|P6|NOT COMPLETED|Initial Treatment Period||0
7549002|NCT03131648|18579926|P5|NOT COMPLETED|Initial Treatment Period||0
7549003|NCT03131648|18579927|P4|NOT COMPLETED|Initial Treatment Period||0
7549004|NCT03131648|18579928|P3|NOT COMPLETED|Initial Treatment Period||0
7549005|NCT03131648|18579929|P2|NOT COMPLETED|Initial Treatment Period||20
7549006|NCT03131648|18579930|P1|NOT COMPLETED|Initial Treatment Period||53
7549007|NCT03131648|18579923|P8|COMPLETED|Initial Treatment Period||0
7549008|NCT03131648|18579924|P7|COMPLETED|Initial Treatment Period||0
7549009|NCT03131648|18579925|P6|COMPLETED|Initial Treatment Period||0
7549010|NCT03131648|18579926|P5|COMPLETED|Initial Treatment Period||0
7549011|NCT03131648|18579927|P4|COMPLETED|Initial Treatment Period||0
7549012|NCT03131648|18579928|P3|COMPLETED|Initial Treatment Period||0
7549013|NCT03131648|18579929|P2|COMPLETED|Initial Treatment Period||179
7549014|NCT03131648|18579930|P1|COMPLETED|Initial Treatment Period||550
7549015|NCT03131648|18579923|P8|STARTED|Initial Treatment Period||0
7549016|NCT03131648|18579924|P7|STARTED|Initial Treatment Period||0
7549017|NCT03131648|18579925|P6|STARTED|Initial Treatment Period||0
7549018|NCT03131648|18579926|P5|STARTED|Initial Treatment Period||0
7549019|NCT03131648|18579927|P4|STARTED|Initial Treatment Period||0
7549020|NCT03131648|18579928|P3|STARTED|Initial Treatment Period||0
7549021|NCT03131648|18579929|P2|STARTED|Initial Treatment Period||199
7549022|NCT03131648|18579930|P1|STARTED|Initial Treatment Period||603
7549023|NCT03131596|18579978|P2|NOT COMPLETED|Overall Study||3
7549024|NCT03131596|18579979|P1|NOT COMPLETED|Overall Study||6
7549025|NCT03131596|18579978|P2|COMPLETED|Overall Study||97
7549026|NCT03131596|18579979|P1|COMPLETED|Overall Study||94
7549027|NCT03131596|18579978|P2|STARTED|Overall Study||100
7549028|NCT03131596|18579979|P1|STARTED|Overall Study||100
7549029|NCT03131479|18579996|P5|NOT COMPLETED|Overall Study||0
7549030|NCT03131479|18579997|P4|NOT COMPLETED|Overall Study||2
7549031|NCT03131479|18579998|P3|NOT COMPLETED|Overall Study||1
7549032|NCT03131479|18579999|P2|NOT COMPLETED|Overall Study||0
7549033|NCT03131479|18580000|P1|NOT COMPLETED|Overall Study||0
7549034|NCT03131479|18579996|P5|COMPLETED|Overall Study||10
7549035|NCT03131479|18579997|P4|COMPLETED|Overall Study||10
7549036|NCT03131479|18579998|P3|COMPLETED|Overall Study||10
7549037|NCT03131479|18579999|P2|COMPLETED|Overall Study||10
7549038|NCT03131479|18580000|P1|COMPLETED|Overall Study||10
7549039|NCT03131479|18579996|P5|Pharcodynamic Analysis Set (PD)|Overall Study||10
7549040|NCT03131479|18579997|P4|Pharcodynamic Analysis Set (PD)|Overall Study||12
7549041|NCT03131479|18579998|P3|Pharcodynamic Analysis Set (PD)|Overall Study||11
7549042|NCT03131479|18579999|P2|Pharcodynamic Analysis Set (PD)|Overall Study||10
7549043|NCT03131479|18580000|P1|Pharcodynamic Analysis Set (PD)|Overall Study||10
7549044|NCT03131479|18579996|P5|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
7549045|NCT03131479|18579997|P4|Pharmacokinetic Analysis Set (PAS)|Overall Study||12
7549046|NCT03131479|18579998|P3|Pharmacokinetic Analysis Set (PAS)|Overall Study||11
7549047|NCT03131479|18579999|P2|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
7549048|NCT03131479|18580000|P1|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
7549049|NCT03131479|18579996|P5|Safety Analysis Set (SS)|Overall Study||10
7549050|NCT03131479|18579997|P4|Safety Analysis Set (SS)|Overall Study||12
7549051|NCT03131479|18579998|P3|Safety Analysis Set (SS)|Overall Study||11
7549052|NCT03131479|18579999|P2|Safety Analysis Set (SS)|Overall Study||10
7549053|NCT03131479|18580000|P1|Safety Analysis Set (SS)|Overall Study||10
7549054|NCT03131479|18579996|P5|STARTED|Overall Study||10
7549055|NCT03131479|18579997|P4|STARTED|Overall Study||12
7549056|NCT03131479|18579998|P3|STARTED|Overall Study||11
7549057|NCT03131479|18579999|P2|STARTED|Overall Study||10
7549058|NCT03131479|18580000|P1|STARTED|Overall Study||10
7549059|NCT03131219|18580059|P2|NOT COMPLETED|Extension Period||10
7549060|NCT03131219|18580060|P1|NOT COMPLETED|Extension Period||17
7549061|NCT03131219|18580059|P2|COMPLETED|Extension Period||0
7549062|NCT03131219|18580060|P1|COMPLETED|Extension Period||0
7549063|NCT03131219|18580059|P2|Ongoing|Extension Period||10
7549064|NCT03131219|18580060|P1|Ongoing|Extension Period||16
7549151|NCT03130257|18580194|P1|NOT COMPLETED|Overall Study||1
7549065|NCT03131219|18580059|P2|Received At Least 1 Dose of Study Drug|Extension Period||10
7549066|NCT03131219|18580060|P1|Received At Least 1 Dose of Study Drug|Extension Period||17
7549067|NCT03131219|18580059|P2|STARTED|Extension Period||10
7549068|NCT03131219|18580060|P1|STARTED|Extension Period||17
7549069|NCT03131219|18580059|P2|NOT COMPLETED|Initial Evaluation Period||0
7549070|NCT03131219|18580060|P1|NOT COMPLETED|Initial Evaluation Period||4
7549071|NCT03131219|18580059|P2|COMPLETED|Initial Evaluation Period||10
7549072|NCT03131219|18580060|P1|COMPLETED|Initial Evaluation Period||17
7549073|NCT03131219|18580059|P2|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||10
7549074|NCT03131219|18580060|P1|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||21
7549075|NCT03131219|18580059|P2|STARTED|Initial Evaluation Period||10
7549076|NCT03131219|18580060|P1|STARTED|Initial Evaluation Period||21
7549077|NCT03131206|18580086|P4|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
7549078|NCT03131206|18580087|P3|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
7549079|NCT03131206|18580088|P2|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
7549080|NCT03131206|18580089|P1|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
7549081|NCT03131206|18580086|P4|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
7549082|NCT03131206|18580087|P3|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
7549083|NCT03131206|18580088|P2|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
7549084|NCT03131206|18580089|P1|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
7549085|NCT03131206|18580086|P4|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
7549086|NCT03131206|18580087|P3|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
7549087|NCT03131206|18580088|P2|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
7549088|NCT03131206|18580089|P1|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
7549089|NCT03131206|18580086|P4|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
7549090|NCT03131206|18580087|P3|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
7549091|NCT03131206|18580088|P2|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
7549092|NCT03131206|18580089|P1|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
7549093|NCT03131206|18580086|P4|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
7549094|NCT03131206|18580087|P3|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
7549095|NCT03131206|18580088|P2|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
7549096|NCT03131206|18580089|P1|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
7549097|NCT03131206|18580086|P4|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
7549098|NCT03131206|18580087|P3|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
7549099|NCT03131206|18580088|P2|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
7549100|NCT03131206|18580089|P1|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
7549101|NCT03131167|18580120|P13|NOT COMPLETED|Overall Study||0
7549102|NCT03131167|18580121|P12|NOT COMPLETED|Overall Study||0
7549103|NCT03131167|18580122|P11|NOT COMPLETED|Overall Study||0
7549104|NCT03131167|18580123|P10|NOT COMPLETED|Overall Study||0
7549105|NCT03131167|18580124|P9|NOT COMPLETED|Overall Study||0
7549106|NCT03131167|18580125|P8|NOT COMPLETED|Overall Study||0
7549107|NCT03131167|18580126|P7|NOT COMPLETED|Overall Study||0
7549108|NCT03131167|18580127|P6|NOT COMPLETED|Overall Study||1
7549109|NCT03131167|18580128|P5|NOT COMPLETED|Overall Study||0
7549110|NCT03131167|18580129|P4|NOT COMPLETED|Overall Study||0
7549111|NCT03131167|18580130|P3|NOT COMPLETED|Overall Study||0
7549112|NCT03131167|18580131|P2|NOT COMPLETED|Overall Study||0
7549113|NCT03131167|18580132|P1|NOT COMPLETED|Overall Study||0
7549114|NCT03131167|18580120|P13|COMPLETED|Overall Study||5
7549115|NCT03131167|18580121|P12|COMPLETED|Overall Study||5
7549116|NCT03131167|18580122|P11|COMPLETED|Overall Study||4
7549117|NCT03131167|18580123|P10|COMPLETED|Overall Study||5
7549118|NCT03131167|18580124|P9|COMPLETED|Overall Study||2
7549119|NCT03131167|18580125|P8|COMPLETED|Overall Study||5
7549120|NCT03131167|18580126|P7|COMPLETED|Overall Study||5
7549121|NCT03131167|18580127|P6|COMPLETED|Overall Study||4
7549122|NCT03131167|18580128|P5|COMPLETED|Overall Study||6
7549123|NCT03131167|18580129|P4|COMPLETED|Overall Study||5
7549124|NCT03131167|18580130|P3|COMPLETED|Overall Study||5
7549125|NCT03131167|18580131|P2|COMPLETED|Overall Study||5
7549126|NCT03131167|18580132|P1|COMPLETED|Overall Study||6
7549127|NCT03131167|18580120|P13|STARTED|Overall Study||5
7549128|NCT03131167|18580121|P12|STARTED|Overall Study||5
7549129|NCT03131167|18580122|P11|STARTED|Overall Study||4
7549130|NCT03131167|18580123|P10|STARTED|Overall Study||5
7549131|NCT03131167|18580124|P9|STARTED|Overall Study||2
7549132|NCT03131167|18580125|P8|STARTED|Overall Study||5
7549133|NCT03131167|18580126|P7|STARTED|Overall Study||5
7549134|NCT03131167|18580127|P6|STARTED|Overall Study||5
7549135|NCT03131167|18580128|P5|STARTED|Overall Study||6
7549136|NCT03131167|18580129|P4|STARTED|Overall Study||5
7549137|NCT03131167|18580130|P3|STARTED|Overall Study||5
7549138|NCT03131167|18580131|P2|STARTED|Overall Study||5
7549139|NCT03131167|18580132|P1|STARTED|Overall Study||6
7549140|NCT03130738|18580176|P3|NOT COMPLETED|Overall Study||6
7549141|NCT03130738|18580177|P2|NOT COMPLETED|Overall Study||2
7549142|NCT03130738|18580178|P1|NOT COMPLETED|Overall Study||3
7549143|NCT03130738|18580176|P3|COMPLETED|Overall Study||14
7549144|NCT03130738|18580177|P2|COMPLETED|Overall Study||20
7549145|NCT03130738|18580178|P1|COMPLETED|Overall Study||20
7549146|NCT03130738|18580176|P3|STARTED|Overall Study||20
7549147|NCT03130738|18580177|P2|STARTED|Overall Study||22
7549148|NCT03130738|18580178|P1|STARTED|Overall Study||23
7549149|NCT03130257|18580192|P3|NOT COMPLETED|Overall Study||2
7549150|NCT03130257|18580193|P2|NOT COMPLETED|Overall Study||0
7549152|NCT03130257|18580192|P3|COMPLETED|Overall Study||166
7549153|NCT03130257|18580193|P2|COMPLETED|Overall Study||170
7549154|NCT03130257|18580194|P1|COMPLETED|Overall Study||171
7549155|NCT03130257|18580192|P3|STARTED|Overall Study||168
7549156|NCT03130257|18580193|P2|STARTED|Overall Study||170
7549157|NCT03130257|18580194|P1|STARTED|Overall Study||172
7549158|NCT03129321|18580205|P3|NOT COMPLETED|Overall Study||55
7549159|NCT03129321|18580206|P2|NOT COMPLETED|Overall Study||109
7549160|NCT03129321|18580207|P1|NOT COMPLETED|Overall Study||98
7549161|NCT03129321|18580205|P3|COMPLETED|Overall Study||120
7549162|NCT03129321|18580206|P2|COMPLETED|Overall Study||241
7549163|NCT03129321|18580207|P1|COMPLETED|Overall Study||253
7549164|NCT03129321|18580205|P3|STARTED|Overall Study||175
7549165|NCT03129321|18580206|P2|STARTED|Overall Study||350
7549166|NCT03129321|18580207|P1|STARTED|Overall Study||351
7549167|NCT03129178|18580229|P2|NOT COMPLETED|Overall Study||2
7549168|NCT03129178|18580230|P1|NOT COMPLETED|Overall Study||1
7549169|NCT03129178|18580229|P2|COMPLETED|Overall Study||11
7549170|NCT03129178|18580230|P1|COMPLETED|Overall Study||12
7549171|NCT03129178|18580229|P2|STARTED|Overall Study||13
7549172|NCT03129178|18580230|P1|STARTED|Overall Study||13
7549173|NCT03128931|18580248|P1|NOT COMPLETED|Overall Study||4
7549174|NCT03128931|18580248|P1|COMPLETED|Overall Study||41
7549175|NCT03128931|18580248|P1|STARTED|Overall Study||45
7549176|NCT03128892|18580252|P1|NOT COMPLETED|Overall Study||3
7549177|NCT03128892|18580252|P1|COMPLETED|Overall Study||31
7549178|NCT03128892|18580252|P1|STARTED|Overall Study||34
7549179|NCT03128723|18580258|P1|NOT COMPLETED|Overall Study||2
7549180|NCT03128723|18580258|P1|COMPLETED|Overall Study||43
7549181|NCT03128723|18580258|P1|STARTED|Overall Study||45
7549182|NCT03128411|18580273|P1|NOT COMPLETED|Long Term Follow-up Phase||19
7549183|NCT03128411|18580273|P1|COMPLETED|Long Term Follow-up Phase||0
7549184|NCT03128411|18580273|P1|STARTED|Long Term Follow-up Phase|"Participants who discontinued treatment phase, entered this phase, except those were Ongoing."|19
7549185|NCT03128411|18580273|P1|NOT COMPLETED|Treatment Phase||60
7549186|NCT03128411|18580273|P1|COMPLETED|Treatment Phase||0
7549187|NCT03128411|18580273|P1|Received Treatment|Treatment Phase||60
7549188|NCT03128411|18580273|P1|STARTED|Treatment Phase||60
7549189|NCT03128372|18580312|P1|NOT COMPLETED|Overall Study||0
7549190|NCT03128372|18580312|P1|COMPLETED|Overall Study||32
7549191|NCT03128372|18580312|P1|STARTED|Overall Study||32
7549192|NCT03128307|18580316|P1|NOT COMPLETED|Overall Study||34
7549193|NCT03128307|18580316|P1|COMPLETED|Overall Study||570
7549194|NCT03128307|18580316|P1|STARTED|Overall Study||604
7549195|NCT03128099|18580324|P3|NOT COMPLETED|Overall Study||1
7549196|NCT03128099|18580325|P2|NOT COMPLETED|Overall Study||4
7549197|NCT03128099|18580326|P1|NOT COMPLETED|Overall Study||2
7549198|NCT03128099|18580324|P3|COMPLETED|Overall Study||21
7549199|NCT03128099|18580325|P2|COMPLETED|Overall Study|hour 2 training was completed by 0 participants|0
7549200|NCT03128099|18580326|P1|COMPLETED|Overall Study||19
7549201|NCT03128099|18580324|P3|Hour 2 (High Dose) Completed|Overall Study||0
7549202|NCT03128099|18580325|P2|Hour 2 (High Dose) Completed|Overall Study||0
7549203|NCT03128099|18580326|P1|Hour 2 (High Dose) Completed|Overall Study||0
7549204|NCT03128099|18580324|P3|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
7549205|NCT03128099|18580325|P2|Hour 2 (High Dose)Started|Overall Study||4
7549206|NCT03128099|18580326|P1|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
7549207|NCT03128099|18580324|P3|Hour 1 (Low Dose) Completed|Overall Study||21
7549208|NCT03128099|18580325|P2|Hour 1 (Low Dose) Completed|Overall Study||4
7549209|NCT03128099|18580326|P1|Hour 1 (Low Dose) Completed|Overall Study||19
7549210|NCT03128099|18580324|P3|Hour 1 (Low Dose) Started|Overall Study||22
7549211|NCT03128099|18580325|P2|Hour 1 (Low Dose) Started|Overall Study||4
7549212|NCT03128099|18580326|P1|Hour 1 (Low Dose) Started|Overall Study||21
7549213|NCT03128099|18580324|P3|STARTED|Overall Study||22
7549214|NCT03128099|18580325|P2|STARTED|Overall Study||4
7549215|NCT03128099|18580326|P1|STARTED|Overall Study||21
7549216|NCT03128086|18580334|P2|NOT COMPLETED|Overall Study||0
7549217|NCT03128086|18580335|P1|NOT COMPLETED|Overall Study||0
7549218|NCT03128086|18580334|P2|COMPLETED|Overall Study||44
7549219|NCT03128086|18580335|P1|COMPLETED|Overall Study||50
7549220|NCT03128086|18580334|P2|STARTED|Overall Study||44
7549221|NCT03128086|18580335|P1|STARTED|Overall Study||50
7549222|NCT03128008|18580355|P1|NOT COMPLETED|Overall Study||9
7549223|NCT03128008|18580355|P1|COMPLETED|Overall Study|9 participants are in follow up|1
7549224|NCT03128008|18580355|P1|STARTED|Overall Study||10
7549225|NCT03127956|18580360|P1|NOT COMPLETED|Overall Study||317
7549226|NCT03127956|18580360|P1|COMPLETED|Overall Study||431
7549227|NCT03127956|18580360|P1|STARTED|Overall Study||748
7549228|NCT03127943|18580364|P2|NOT COMPLETED|Second Intervention||0
7549229|NCT03127943|18580365|P1|NOT COMPLETED|Second Intervention||0
7549230|NCT03127943|18580364|P2|COMPLETED|Second Intervention||12
7549231|NCT03127943|18580365|P1|COMPLETED|Second Intervention||12
7549232|NCT03127943|18580364|P2|STARTED|Second Intervention||12
7549233|NCT03127943|18580365|P1|STARTED|Second Intervention||12
7549234|NCT03127943|18580364|P2|NOT COMPLETED|Washout (1 Week)||0
7549235|NCT03127943|18580365|P1|NOT COMPLETED|Washout (1 Week)||0
7549236|NCT03127943|18580364|P2|COMPLETED|Washout (1 Week)||12
7549237|NCT03127943|18580365|P1|COMPLETED|Washout (1 Week)||12
7549238|NCT03127943|18580364|P2|STARTED|Washout (1 Week)||12
7549239|NCT03127943|18580365|P1|STARTED|Washout (1 Week)||12
7549240|NCT03127943|18580364|P2|NOT COMPLETED|First Intervention||0
7549241|NCT03127943|18580365|P1|NOT COMPLETED|First Intervention||0
7549242|NCT03127943|18580364|P2|COMPLETED|First Intervention||12
7549243|NCT03127943|18580365|P1|COMPLETED|First Intervention||12
7549244|NCT03127943|18580364|P2|STARTED|First Intervention||12
7549245|NCT03127943|18580365|P1|STARTED|First Intervention||12
7549246|NCT03127644|18580376|P3|NOT COMPLETED|Overall Study||2
7549247|NCT03127644|18580377|P2|NOT COMPLETED|Overall Study||0
7549248|NCT03127644|18580378|P1|NOT COMPLETED|Overall Study||0
7549249|NCT03127644|18580376|P3|COMPLETED|Overall Study||31
7549250|NCT03127644|18580377|P2|COMPLETED|Overall Study||36
7549251|NCT03127644|18580378|P1|COMPLETED|Overall Study||34
7549252|NCT03127644|18580376|P3|STARTED|Overall Study||33
7549253|NCT03127644|18580377|P2|STARTED|Overall Study||36
7549254|NCT03127644|18580378|P1|STARTED|Overall Study||34
7549255|NCT03127384|18580410|P1|NOT COMPLETED|Overall Study||6
7549256|NCT03127384|18580410|P1|COMPLETED|Overall Study||43
7549257|NCT03127384|18580410|P1|Completed 3 Month Visit|Overall Study||47
7549258|NCT03127384|18580410|P1|STARTED|Overall Study||49
7549259|NCT03127228|18580418|P2|NOT COMPLETED|Overall Study||0
7549260|NCT03127228|18580419|P1|NOT COMPLETED|Overall Study||0
7549261|NCT03127228|18580418|P2|COMPLETED|Overall Study||12
7549262|NCT03127228|18580419|P1|COMPLETED|Overall Study||12
7549263|NCT03127228|18580418|P2|STARTED|Overall Study||12
7549264|NCT03127228|18580419|P1|STARTED|Overall Study||12
7549265|NCT03126682|18580433|P2|NOT COMPLETED|Overall Study||0
7549266|NCT03126682|18580434|P1|NOT COMPLETED|Overall Study||0
7549267|NCT03126682|18580433|P2|COMPLETED|Overall Study||5
7549268|NCT03126682|18580434|P1|COMPLETED|Overall Study||5
7549269|NCT03126682|18580433|P2|STARTED|Overall Study||5
7549270|NCT03126682|18580434|P1|STARTED|Overall Study||5
7549271|NCT03126539|18580446|P5|NOT COMPLETED|Overall Study||0
7549272|NCT03126539|18580447|P4|NOT COMPLETED|Overall Study||0
7549273|NCT03126539|18580448|P3|NOT COMPLETED|Overall Study||1
7549274|NCT03126539|18580449|P2|NOT COMPLETED|Overall Study||1
7549275|NCT03126539|18580450|P1|NOT COMPLETED|Overall Study||1
7549276|NCT03126539|18580446|P5|COMPLETED|Overall Study||0
7549277|NCT03126539|18580447|P4|COMPLETED|Overall Study||0
7549278|NCT03126539|18580448|P3|COMPLETED|Overall Study||8
7549279|NCT03126539|18580449|P2|COMPLETED|Overall Study||8
7549280|NCT03126539|18580450|P1|COMPLETED|Overall Study||8
7549281|NCT03126539|18580446|P5|STARTED|Overall Study||0
7549282|NCT03126539|18580447|P4|STARTED|Overall Study|Group B was not done|0
7549283|NCT03126539|18580448|P3|STARTED|Overall Study||9
7549284|NCT03126539|18580449|P2|STARTED|Overall Study||9
7549285|NCT03126539|18580450|P1|STARTED|Overall Study||9
7549286|NCT03126448|18580466|P3|NOT COMPLETED|Overall Study||10
7549287|NCT03126448|18580467|P2|NOT COMPLETED|Overall Study||8
7549288|NCT03126448|18580468|P1|NOT COMPLETED|Overall Study||13
7549289|NCT03126448|18580466|P3|COMPLETED|Overall Study||27
7549290|NCT03126448|18580467|P2|COMPLETED|Overall Study||41
7549291|NCT03126448|18580468|P1|COMPLETED|Overall Study||43
7549292|NCT03126448|18580466|P3|STARTED|Overall Study||37
7549293|NCT03126448|18580467|P2|STARTED|Overall Study||49
7549294|NCT03126448|18580468|P1|STARTED|Overall Study||56
7549295|NCT03126344|18580479|P3|NOT COMPLETED|Overall Study||5
7549296|NCT03126344|18580480|P2|NOT COMPLETED|Overall Study||0
7549297|NCT03126344|18580481|P1|NOT COMPLETED|Overall Study||0
7549298|NCT03126344|18580479|P3|COMPLETED|Overall Study||28
7549299|NCT03126344|18580480|P2|COMPLETED|Overall Study||33
7549300|NCT03126344|18580481|P1|COMPLETED|Overall Study||33
7549301|NCT03126344|18580479|P3|STARTED|Overall Study||33
7549302|NCT03126344|18580480|P2|STARTED|Overall Study||33
7549303|NCT03126344|18580481|P1|STARTED|Overall Study||33
7549304|NCT03125941|18580497|P2|NOT COMPLETED|Overall Study||2
7549305|NCT03125941|18580498|P1|NOT COMPLETED|Overall Study||1
7549306|NCT03125941|18580497|P2|COMPLETED|Overall Study||63
7549307|NCT03125941|18580498|P1|COMPLETED|Overall Study||64
7549308|NCT03125941|18580497|P2|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|2
7549309|NCT03125941|18580498|P1|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|1
7549310|NCT03125941|18580497|P2|STARTED|Overall Study||65
7549311|NCT03125941|18580498|P1|STARTED|Overall Study||65
7549312|NCT03125915|18580534|P4|NOT COMPLETED|6 Month Follow-up||3
7549313|NCT03125915|18580535|P3|NOT COMPLETED|6 Month Follow-up||6
7549314|NCT03125915|18580536|P2|NOT COMPLETED|6 Month Follow-up||3
7549315|NCT03125915|18580537|P1|NOT COMPLETED|6 Month Follow-up||7
7549316|NCT03125915|18580534|P4|COMPLETED|6 Month Follow-up||31
7549317|NCT03125915|18580535|P3|COMPLETED|6 Month Follow-up||28
7549318|NCT03125915|18580536|P2|COMPLETED|6 Month Follow-up||37
7549319|NCT03125915|18580537|P1|COMPLETED|6 Month Follow-up||25
7549320|NCT03125915|18580534|P4|STARTED|6 Month Follow-up||34
7549321|NCT03125915|18580535|P3|STARTED|6 Month Follow-up||34
7549322|NCT03125915|18580536|P2|STARTED|6 Month Follow-up||40
7549323|NCT03125915|18580537|P1|STARTED|6 Month Follow-up||32
7549324|NCT03125915|18580534|P4|NOT COMPLETED|3 Month Follow-up||2
7549325|NCT03125915|18580535|P3|NOT COMPLETED|3 Month Follow-up||4
7549326|NCT03125915|18580536|P2|NOT COMPLETED|3 Month Follow-up||4
7549327|NCT03125915|18580537|P1|NOT COMPLETED|3 Month Follow-up||6
7549328|NCT03125915|18580534|P4|COMPLETED|3 Month Follow-up||32
7549329|NCT03125915|18580535|P3|COMPLETED|3 Month Follow-up||30
7549330|NCT03125915|18580536|P2|COMPLETED|3 Month Follow-up||36
7549331|NCT03125915|18580537|P1|COMPLETED|3 Month Follow-up||26
7549332|NCT03125915|18580534|P4|STARTED|3 Month Follow-up||34
7549333|NCT03125915|18580535|P3|STARTED|3 Month Follow-up||34
7549334|NCT03125915|18580536|P2|STARTED|3 Month Follow-up||40
7549335|NCT03125915|18580537|P1|STARTED|3 Month Follow-up||32
7549336|NCT03125915|18580534|P4|NOT COMPLETED|1 Month Follow up||3
7549337|NCT03125915|18580535|P3|NOT COMPLETED|1 Month Follow up||2
7549338|NCT03125915|18580536|P2|NOT COMPLETED|1 Month Follow up||3
7549339|NCT03125915|18580537|P1|NOT COMPLETED|1 Month Follow up||3
7549340|NCT03125915|18580534|P4|COMPLETED|1 Month Follow up||31
7549341|NCT03125915|18580535|P3|COMPLETED|1 Month Follow up||32
7549342|NCT03125915|18580536|P2|COMPLETED|1 Month Follow up||37
7549343|NCT03125915|18580537|P1|COMPLETED|1 Month Follow up||29
7549344|NCT03125915|18580534|P4|STARTED|1 Month Follow up||34
7549345|NCT03125915|18580535|P3|STARTED|1 Month Follow up||34
7549346|NCT03125915|18580536|P2|STARTED|1 Month Follow up||40
7549347|NCT03125915|18580537|P1|STARTED|1 Month Follow up||32
7549348|NCT03125915|18580534|P4|NOT COMPLETED|Baseline and Intervention||0
7549349|NCT03125915|18580535|P3|NOT COMPLETED|Baseline and Intervention||0
7549350|NCT03125915|18580536|P2|NOT COMPLETED|Baseline and Intervention||0
7549351|NCT03125915|18580537|P1|NOT COMPLETED|Baseline and Intervention||0
7549352|NCT03125915|18580534|P4|COMPLETED|Baseline and Intervention||34
7549353|NCT03125915|18580535|P3|COMPLETED|Baseline and Intervention||34
7549354|NCT03125915|18580536|P2|COMPLETED|Baseline and Intervention||40
7549355|NCT03125915|18580537|P1|COMPLETED|Baseline and Intervention||32
7549356|NCT03125915|18580534|P4|STARTED|Baseline and Intervention||34
7549357|NCT03125915|18580535|P3|STARTED|Baseline and Intervention||34
7549358|NCT03125915|18580536|P2|STARTED|Baseline and Intervention||40
7549359|NCT03125915|18580537|P1|STARTED|Baseline and Intervention||32
7549360|NCT03125395|18580555|P1|NOT COMPLETED|Overall Study||10
7549361|NCT03125395|18580555|P1|COMPLETED|Overall Study||47
7549362|NCT03125395|18580555|P1|Study 116 LCI Substudy Set|Overall Study||31
7549363|NCT03125395|18580555|P1|Study 116 FAS|Overall Study||57
7549364|NCT03125395|18580555|P1|Study 115B FAS|Overall Study||60
7549365|NCT03125395|18580555|P1|STARTED|Overall Study||57
7549366|NCT03125200|18580581|P7|NOT COMPLETED|Overall Study||3
7549367|NCT03125200|18580582|P6|NOT COMPLETED|Overall Study||3
7549368|NCT03125200|18580583|P5|NOT COMPLETED|Overall Study||4
7549369|NCT03125200|18580584|P4|NOT COMPLETED|Overall Study||5
7549370|NCT03125200|18580585|P3|NOT COMPLETED|Overall Study||2
7549371|NCT03125200|18580586|P2|NOT COMPLETED|Overall Study||2
7549372|NCT03125200|18580587|P1|NOT COMPLETED|Overall Study||2
7549373|NCT03125200|18580581|P7|COMPLETED|Overall Study||0
7549374|NCT03125200|18580582|P6|COMPLETED|Overall Study||0
7549375|NCT03125200|18580583|P5|COMPLETED|Overall Study||0
7549376|NCT03125200|18580584|P4|COMPLETED|Overall Study||0
7549377|NCT03125200|18580585|P3|COMPLETED|Overall Study||0
7549378|NCT03125200|18580586|P2|COMPLETED|Overall Study||0
7549379|NCT03125200|18580587|P1|COMPLETED|Overall Study||0
7549380|NCT03125200|18580581|P7|STARTED|Overall Study||3
7549381|NCT03125200|18580582|P6|STARTED|Overall Study||3
7549382|NCT03125200|18580583|P5|STARTED|Overall Study||4
7549383|NCT03125200|18580584|P4|STARTED|Overall Study||5
7549384|NCT03125200|18580585|P3|STARTED|Overall Study||2
7549385|NCT03125200|18580586|P2|STARTED|Overall Study||2
7549386|NCT03125200|18580587|P1|STARTED|Overall Study||2
7549387|NCT03125031|18580785|P2|NOT COMPLETED|Overall Study||0
7549388|NCT03125031|18580786|P1|NOT COMPLETED|Overall Study||0
7549389|NCT03125031|18580785|P2|COMPLETED|Overall Study||44
7549390|NCT03125031|18580786|P1|COMPLETED|Overall Study||44
7549391|NCT03125031|18580785|P2|STARTED|Overall Study||44
7549392|NCT03125031|18580786|P1|STARTED|Overall Study||44
7549393|NCT03125018|18580791|P1|NOT COMPLETED|Overall Study||0
7549394|NCT03125018|18580791|P1|COMPLETED|Overall Study||13
7549395|NCT03125018|18580791|P1|STARTED|Overall Study||13
7549396|NCT03125005|18580795|P1|NOT COMPLETED|Overall Study||0
7549397|NCT03125005|18580795|P1|COMPLETED|Overall Study||51
7549398|NCT03125005|18580795|P1|STARTED|Overall Study||51
7549399|NCT03124979|18580799|P1|NOT COMPLETED|Overall Study||0
7549400|NCT03124979|18580799|P1|COMPLETED|Overall Study||13
7549401|NCT03124979|18580799|P1|STARTED|Overall Study||13
7549402|NCT03124966|18580803|P1|NOT COMPLETED|Overall Study||0
7549403|NCT03124966|18580803|P1|COMPLETED|Overall Study||118
7549404|NCT03124966|18580803|P1|STARTED|Overall Study||118
7549405|NCT03124927|18580807|P1|NOT COMPLETED|Overall Study||0
7549406|NCT03124927|18580807|P1|COMPLETED|Overall Study||25
7549407|NCT03124927|18580807|P1|STARTED|Overall Study||25
7549408|NCT03124901|18580811|P1|NOT COMPLETED|Overall Study||0
7549409|NCT03124901|18580811|P1|COMPLETED|Overall Study||147
7549410|NCT03124901|18580811|P1|STARTED|Overall Study||147
7549411|NCT03124836|18580815|P1|NOT COMPLETED|Overall Study||0
7549412|NCT03124836|18580815|P1|COMPLETED|Overall Study||28
7549413|NCT03124836|18580815|P1|STARTED|Overall Study||28
7549414|NCT03124823|18580819|P1|NOT COMPLETED|Overall Study||0
7549415|NCT03124823|18580819|P1|COMPLETED|Overall Study||11
7549416|NCT03124823|18580819|P1|STARTED|Overall Study||11
7549417|NCT03124797|18580823|P1|NOT COMPLETED|Overall Study||0
7549418|NCT03124797|18580823|P1|COMPLETED|Overall Study||18
7549419|NCT03124797|18580823|P1|STARTED|Overall Study||18
7549420|NCT03124784|18580827|P1|NOT COMPLETED|Overall Study||2
7549421|NCT03124784|18580827|P1|COMPLETED|Overall Study||25
7549422|NCT03124784|18580827|P1|STARTED|Overall Study||27
7549423|NCT03124771|18580831|P1|NOT COMPLETED|Overall Study||0
7549424|NCT03124771|18580831|P1|COMPLETED|Overall Study||132
7549425|NCT03124771|18580831|P1|STARTED|Overall Study||132
7549426|NCT03124758|18580835|P1|NOT COMPLETED|Overall Study||0
7549427|NCT03124758|18580835|P1|COMPLETED|Overall Study||354
7549428|NCT03124758|18580835|P1|STARTED|Overall Study||354
7549429|NCT03124693|18580839|P1|NOT COMPLETED|Overall Study||0
7549430|NCT03124693|18580839|P1|COMPLETED|Overall Study||90
7549431|NCT03124693|18580839|P1|STARTED|Overall Study||90
7549432|NCT03124602|18580843|P1|NOT COMPLETED|Overall Study||10
7549433|NCT03124602|18580843|P1|COMPLETED|Overall Study||25
7549434|NCT03124602|18580843|P1|STARTED|Overall Study||35
7549435|NCT03124563|18580849|P2|NOT COMPLETED|Overall Study||2
7549436|NCT03124563|18580850|P1|NOT COMPLETED|Overall Study||2
7549437|NCT03124563|18580849|P2|COMPLETED|Overall Study||29
7549438|NCT03124563|18580850|P1|COMPLETED|Overall Study||30
7549439|NCT03124563|18580849|P2|Pre-test|Overall Study||30
7549440|NCT03124563|18580850|P1|Pre-test|Overall Study||30
7549441|NCT03124563|18580849|P2|STARTED|Overall Study||31
7549442|NCT03124563|18580850|P1|STARTED|Overall Study||32
7549443|NCT03124550|18580866|P1|NOT COMPLETED|Overall Study||0
7549444|NCT03124550|18580866|P1|COMPLETED|Overall Study||18
7549445|NCT03124550|18580866|P1|STARTED|Overall Study||18
7549446|NCT03124537|18580875|P2|NOT COMPLETED|Overall Study||13
7549447|NCT03124537|18580876|P1|NOT COMPLETED|Overall Study||10
7549448|NCT03124537|18580875|P2|COMPLETED|Overall Study||32
7549449|NCT03124537|18580876|P1|COMPLETED|Overall Study||31
7549450|NCT03124537|18580875|P2|STARTED|Overall Study||45
7549451|NCT03124537|18580876|P1|STARTED|Overall Study||41
7549452|NCT03124407|18580900|P4|NOT COMPLETED|Overall Study||0
7549453|NCT03124407|18580901|P3|NOT COMPLETED|Overall Study||1
7549454|NCT03124407|18580902|P2|NOT COMPLETED|Overall Study||0
7549455|NCT03124407|18580903|P1|NOT COMPLETED|Overall Study||1
7549456|NCT03124407|18580900|P4|COMPLETED|Overall Study||20
7549457|NCT03124407|18580901|P3|COMPLETED|Overall Study||39
7549458|NCT03124407|18580902|P2|COMPLETED|Overall Study||20
7549459|NCT03124407|18580903|P1|COMPLETED|Overall Study||39
7549460|NCT03124407|18580900|P4|STARTED|Overall Study||20
7549461|NCT03124407|18580901|P3|STARTED|Overall Study||40
7549462|NCT03124407|18580902|P2|STARTED|Overall Study||20
7549463|NCT03124407|18580903|P1|STARTED|Overall Study||40
7549464|NCT03124381|18580923|P2|NOT COMPLETED|Overall Study||6
7549465|NCT03124381|18580924|P1|NOT COMPLETED|Overall Study||9
7549466|NCT03124381|18580923|P2|COMPLETED|Overall Study||55
7549467|NCT03124381|18580924|P1|COMPLETED|Overall Study||56
7549468|NCT03124381|18580923|P2|STARTED|Overall Study||61
7549469|NCT03124381|18580924|P1|STARTED|Overall Study||65
7549470|NCT03124342|18581016|P2|NOT COMPLETED|Overall Study||0
7549471|NCT03124342|18581017|P1|NOT COMPLETED|Overall Study||0
7549472|NCT03124342|18581016|P2|COMPLETED|Overall Study||121
7549473|NCT03124342|18581017|P1|COMPLETED|Overall Study||111
7549474|NCT03124342|18581016|P2|STARTED|Overall Study||121
7549475|NCT03124342|18581017|P1|STARTED|Overall Study||111
7549476|NCT03124199|18581031|P1|NOT COMPLETED|Overall Study||4
7549477|NCT03124199|18581031|P1|COMPLETED|Overall Study||36
7549478|NCT03124199|18581031|P1|STARTED|Overall Study||40
7549479|NCT03124108|18581040|P3|NOT COMPLETED|Overall Study||0
7549480|NCT03124108|18581041|P2|NOT COMPLETED|Overall Study||1
7549481|NCT03124108|18581042|P1|NOT COMPLETED|Overall Study||0
7549482|NCT03124108|18581040|P3|COMPLETED|Overall Study||15
7549483|NCT03124108|18581041|P2|COMPLETED|Overall Study||14
7549484|NCT03124108|18581042|P1|COMPLETED|Overall Study||15
7549485|NCT03124108|18581040|P3|STARTED|Overall Study||15
7549486|NCT03124108|18581041|P2|STARTED|Overall Study||15
7549487|NCT03124108|18581042|P1|STARTED|Overall Study||15
7549488|NCT03123874|18581175|P2|NOT COMPLETED|Overall Study||0
7549489|NCT03123874|18581176|P1|NOT COMPLETED|Overall Study||0
7549490|NCT03123874|18581175|P2|COMPLETED|Overall Study||25
7549491|NCT03123874|18581176|P1|COMPLETED|Overall Study||27
7549492|NCT03123874|18581175|P2|STARTED|Overall Study||25
7549493|NCT03123874|18581176|P1|STARTED|Overall Study||27
7549494|NCT03123861|18581188|P2|NOT COMPLETED|Overall Study||3
7549495|NCT03123861|18581189|P1|NOT COMPLETED|Overall Study||3
7549496|NCT03123861|18581188|P2|COMPLETED|Overall Study||20
7549497|NCT03123861|18581189|P1|COMPLETED|Overall Study||19
7549498|NCT03123861|18581188|P2|Received Intervention|Overall Study||22
7549499|NCT03123861|18581189|P1|Received Intervention|Overall Study||21
7549500|NCT03123861|18581188|P2|STARTED|Overall Study||23
7549501|NCT03123861|18581189|P1|STARTED|Overall Study||22
7549502|NCT03123848|18581201|P1|NOT COMPLETED|Overall Study||0
7549503|NCT03123848|18581201|P1|COMPLETED|Overall Study||8
7549504|NCT03123848|18581201|P1|STARTED|Overall Study||8
7549505|NCT03123614|18581225|P2|NOT COMPLETED|Overall Study||0
7549506|NCT03123614|18581226|P1|NOT COMPLETED|Overall Study||0
7549507|NCT03123614|18581225|P2|COMPLETED|Overall Study||74
7549508|NCT03123614|18581226|P1|COMPLETED|Overall Study||57
7549509|NCT03123614|18581225|P2|STARTED|Overall Study||74
7549510|NCT03123614|18581226|P1|STARTED|Overall Study||57
7549511|NCT03123471|18581240|P2|NOT COMPLETED|Apremilast Extension Phase||25
7549512|NCT03123471|18581241|P1|NOT COMPLETED|Apremilast Extension Phase||8
7549513|NCT03123471|18581240|P2|COMPLETED|Apremilast Extension Phase||140
7549514|NCT03123471|18581241|P1|COMPLETED|Apremilast Extension Phase||76
7549515|NCT03123471|18581240|P2|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||163
7549516|NCT03123471|18581241|P1|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||84
7549517|NCT03123471|18581240|P2|STARTED|Apremilast Extension Phase|3 participants completed the first phase; did not enter in extension phase|165
7549518|NCT03123471|18581241|P1|STARTED|Apremilast Extension Phase||84
7549519|NCT03123471|18581240|P2|NOT COMPLETED|Placebo-controlled Phase||33
7549520|NCT03123471|18581241|P1|NOT COMPLETED|Placebo-controlled Phase||18
7549521|NCT03123471|18581240|P2|COMPLETED|Placebo-controlled Phase||168
7549522|NCT03123471|18581241|P1|COMPLETED|Placebo-controlled Phase||84
7549523|NCT03123471|18581240|P2|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||200
7549524|NCT03123471|18581241|P1|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||102
7549525|NCT03123471|18581240|P2|STARTED|Placebo-controlled Phase||201
7549526|NCT03123471|18581241|P1|STARTED|Placebo-controlled Phase||102
7549527|NCT03123393|18581268|P2|NOT COMPLETED|Overall Study||23
7549528|NCT03123393|18581269|P1|NOT COMPLETED|Overall Study||21
7549529|NCT03123393|18581268|P2|COMPLETED|Overall Study||2
7549530|NCT03123393|18581269|P1|COMPLETED|Overall Study||3
7549531|NCT03123393|18581268|P2|STARTED|Overall Study||25
7549532|NCT03123393|18581269|P1|STARTED|Overall Study||24
7549533|NCT03123354|18581297|P1|NOT COMPLETED|Overall Study||6
7549534|NCT03123354|18581297|P1|COMPLETED|Overall Study||38
7549535|NCT03123354|18581297|P1|STARTED|Overall Study||44
7549536|NCT03123263|18581301|P1|NOT COMPLETED|Overall Study||0
7549537|NCT03123263|18581301|P1|COMPLETED|Overall Study||60
7549538|NCT03123263|18581301|P1|STARTED|Overall Study||60
7549539|NCT03123055|18581308|P1|NOT COMPLETED|Overall Study||0
7549540|NCT03123055|18581308|P1|COMPLETED|Overall Study||28
7549541|NCT03123055|18581308|P1|STARTED|Overall Study||28
7549542|NCT03122886|18581322|P2|NOT COMPLETED|Overall Study||2
7549543|NCT03122886|18581323|P1|NOT COMPLETED|Overall Study||1
7549544|NCT03122886|18581322|P2|COMPLETED|Overall Study||7
7549545|NCT03122886|18581323|P1|COMPLETED|Overall Study||9
7549546|NCT03122886|18581322|P2|STARTED|Overall Study||9
7549547|NCT03122886|18581323|P1|STARTED|Overall Study||10
7549548|NCT03122587|18581332|P3|NOT COMPLETED|Overall Study||1
7549549|NCT03122587|18581333|P2|NOT COMPLETED|Overall Study||2
7549550|NCT03122587|18581334|P1|NOT COMPLETED|Overall Study||2
7549551|NCT03122587|18581332|P3|COMPLETED|Overall Study||12
7549552|NCT03122587|18581333|P2|COMPLETED|Overall Study||10
7549553|NCT03122587|18581334|P1|COMPLETED|Overall Study||11
7549554|NCT03122587|18581332|P3|STARTED|Overall Study||13
7549555|NCT03122587|18581333|P2|STARTED|Overall Study||12
7549556|NCT03122587|18581334|P1|STARTED|Overall Study||13
7549557|NCT03122548|18581345|P1|NOT COMPLETED|Overall Study||5
7549558|NCT03122548|18581345|P1|COMPLETED|Overall Study||0
7549559|NCT03122548|18581345|P1|STARTED|Overall Study||5
7549560|NCT03122457|18581353|P1|NOT COMPLETED|Overall Study||6
7549561|NCT03122457|18581353|P1|COMPLETED|Overall Study||16
7549562|NCT03122457|18581353|P1|STARTED|Overall Study||22
7549563|NCT03122184|18581360|P2|NOT COMPLETED|Overall Study||6
7549564|NCT03122184|18581361|P1|NOT COMPLETED|Overall Study||8
7549565|NCT03122184|18581360|P2|COMPLETED|Overall Study||17
7549566|NCT03122184|18581361|P1|COMPLETED|Overall Study||16
7549567|NCT03122184|18581360|P2|STARTED|Overall Study||23
7549568|NCT03122184|18581361|P1|STARTED|Overall Study||24
7549569|NCT03122171|18581398|P1|NOT COMPLETED|Overall Study||1
7549570|NCT03122171|18581398|P1|COMPLETED|Overall Study||5
7549571|NCT03122171|18581398|P1|STARTED|Overall Study||6
7549572|NCT03122145|18581407|P2|NOT COMPLETED|Overall Study||0
7549573|NCT03122145|18581408|P1|NOT COMPLETED|Overall Study||3
7549574|NCT03122145|18581407|P2|COMPLETED|Overall Study||12
7549575|NCT03122145|18581408|P1|COMPLETED|Overall Study||34
7549576|NCT03122145|18581407|P2|STARTED|Overall Study||12
7549577|NCT03122145|18581408|P1|STARTED|Overall Study|34 participants completed the first sub study under this IRB|37
7549578|NCT03121950|18581418|P2|NOT COMPLETED|Overall Study||2
7549579|NCT03121950|18581419|P1|NOT COMPLETED|Overall Study||11
7549580|NCT03121950|18581418|P2|COMPLETED|Overall Study||1
7549581|NCT03121950|18581419|P1|COMPLETED|Overall Study||6
7549582|NCT03121950|18581418|P2|STARTED|Overall Study||3
7549583|NCT03121950|18581419|P1|STARTED|Overall Study||17
7549584|NCT03121820|18581431|P2|NOT COMPLETED|Second Period (After Washout)||0
7549585|NCT03121820|18581432|P1|NOT COMPLETED|Second Period (After Washout)||0
7549586|NCT03121820|18581431|P2|COMPLETED|Second Period (After Washout)||9
7549587|NCT03121820|18581432|P1|COMPLETED|Second Period (After Washout)||9
7549588|NCT03121820|18581431|P2|STARTED|Second Period (After Washout)||9
7549589|NCT03121820|18581432|P1|STARTED|Second Period (After Washout)||9
7549590|NCT03121820|18581431|P2|NOT COMPLETED|First Period||0
7549591|NCT03121820|18581432|P1|NOT COMPLETED|First Period||0
7549592|NCT03121820|18581431|P2|COMPLETED|First Period||9
7549593|NCT03121820|18581432|P1|COMPLETED|First Period||9
7549594|NCT03121820|18581431|P2|STARTED|First Period||9
7549595|NCT03121820|18581432|P1|STARTED|First Period||9
7549596|NCT03121612|18581442|P2|NOT COMPLETED|Overall Study||0
7549597|NCT03121612|18581443|P1|NOT COMPLETED|Overall Study||0
7549598|NCT03121612|18581442|P2|COMPLETED|Overall Study||25
7549599|NCT03121612|18581443|P1|COMPLETED|Overall Study||26
7549600|NCT03121612|18581442|P2|STARTED|Overall Study||25
7549601|NCT03121612|18581443|P1|STARTED|Overall Study||26
7549602|NCT03121365|18581487|P2|NOT COMPLETED|7 Months||8
7549603|NCT03121365|18581488|P1|NOT COMPLETED|7 Months||10
7549604|NCT03121365|18581487|P2|COMPLETED|7 Months||37
7549605|NCT03121365|18581488|P1|COMPLETED|7 Months||44
7549606|NCT03121365|18581487|P2|STARTED|7 Months||45
7549607|NCT03121365|18581488|P1|STARTED|7 Months||54
7549608|NCT03121365|18581487|P2|NOT COMPLETED|4 Months||1
7549609|NCT03121365|18581488|P1|NOT COMPLETED|4 Months||3
7549610|NCT03121365|18581487|P2|COMPLETED|4 Months||44
7549611|NCT03121365|18581488|P1|COMPLETED|4 Months||51
7549612|NCT03121365|18581487|P2|STARTED|4 Months||45
7549613|NCT03121365|18581488|P1|STARTED|4 Months||54
7549614|NCT03121365|18581487|P2|NOT COMPLETED|1 Months||3
7549615|NCT03121365|18581488|P1|NOT COMPLETED|1 Months||2
7549616|NCT03121365|18581487|P2|COMPLETED|1 Months||45
7549617|NCT03121365|18581488|P1|COMPLETED|1 Months||52
7549618|NCT03121365|18581487|P2|STARTED|1 Months||48
7549619|NCT03121365|18581488|P1|STARTED|1 Months||54
7549620|NCT03121365|18581487|P2|NOT COMPLETED|Baseline||1
7549621|NCT03121365|18581488|P1|NOT COMPLETED|Baseline||1
7549622|NCT03121365|18581487|P2|COMPLETED|Baseline||48
7549623|NCT03121365|18581488|P1|COMPLETED|Baseline||54
7549624|NCT03121365|18581487|P2|STARTED|Baseline||49
7549625|NCT03121365|18581488|P1|STARTED|Baseline||55
7549626|NCT03121144|18581516|P1|NOT COMPLETED|Overall Study||0
7549627|NCT03121144|18581516|P1|COMPLETED|Overall Study||34
7549628|NCT03121144|18581516|P1|STARTED|Overall Study||34
7549629|NCT03120676|18581520|P1|NOT COMPLETED|Overall Study||1
7549630|NCT03120676|18581520|P1|COMPLETED|Overall Study||2
7549631|NCT03120676|18581520|P1|STARTED|Overall Study||3
7549632|NCT03120520|18581528|P4|NOT COMPLETED|Overall Study||3
7549633|NCT03120520|18581529|P3|NOT COMPLETED|Overall Study||4
7549634|NCT03120520|18581530|P2|NOT COMPLETED|Overall Study||4
7549635|NCT03120520|18581531|P1|NOT COMPLETED|Overall Study||4
7549636|NCT03120520|18581528|P4|COMPLETED|Overall Study||29
7549637|NCT03120520|18581529|P3|COMPLETED|Overall Study||26
7549638|NCT03120520|18581530|P2|COMPLETED|Overall Study||27
7549639|NCT03120520|18581531|P1|COMPLETED|Overall Study||27
7549640|NCT03120520|18581528|P4|STARTED|Overall Study||32
7549641|NCT03120520|18581529|P3|STARTED|Overall Study||30
7549642|NCT03120520|18581530|P2|STARTED|Overall Study||31
7549643|NCT03120520|18581531|P1|STARTED|Overall Study||31
7549644|NCT03120351|18581555|P2|NOT COMPLETED|Overall Study||1
7549645|NCT03120351|18581556|P1|NOT COMPLETED|Overall Study||1
7549646|NCT03120351|18581555|P2|COMPLETED|Overall Study||39
7549647|NCT03120351|18581556|P1|COMPLETED|Overall Study||39
7549648|NCT03120351|18581555|P2|STARTED|Overall Study||40
7549649|NCT03120351|18581556|P1|STARTED|Overall Study||40
7549650|NCT03120013|18581562|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
7549651|NCT03120013|18581563|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
7549652|NCT03120013|18581562|P2|COMPLETED|Second Intervention (2 Weeks)||10
7549653|NCT03120013|18581563|P1|COMPLETED|Second Intervention (2 Weeks)||10
7549654|NCT03120013|18581562|P2|STARTED|Second Intervention (2 Weeks)||10
7549655|NCT03120013|18581563|P1|STARTED|Second Intervention (2 Weeks)||10
7549656|NCT03120013|18581562|P2|NOT COMPLETED|Washout (6 Months)||0
7549657|NCT03120013|18581563|P1|NOT COMPLETED|Washout (6 Months)||0
7549658|NCT03120013|18581562|P2|COMPLETED|Washout (6 Months)||10
7549659|NCT03120013|18581563|P1|COMPLETED|Washout (6 Months)||10
7549660|NCT03120013|18581562|P2|STARTED|Washout (6 Months)||10
7549661|NCT03120013|18581563|P1|STARTED|Washout (6 Months)||10
7549662|NCT03120013|18581562|P2|NOT COMPLETED|First Intervention (2 Weeks)||1
7549663|NCT03120013|18581563|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
7549664|NCT03120013|18581562|P2|COMPLETED|First Intervention (2 Weeks)||10
7549665|NCT03120013|18581563|P1|COMPLETED|First Intervention (2 Weeks)||10
7549666|NCT03120013|18581562|P2|Received Intervention|First Intervention (2 Weeks)||11
7549667|NCT03120013|18581563|P1|Received Intervention|First Intervention (2 Weeks)||10
7549668|NCT03120013|18581562|P2|STARTED|First Intervention (2 Weeks)||11
7549669|NCT03120013|18581563|P1|STARTED|First Intervention (2 Weeks)||10
7549670|NCT03119831|18581586|P3|NOT COMPLETED|Overall Study||0
7549671|NCT03119831|18581587|P2|NOT COMPLETED|Overall Study||0
7549672|NCT03119831|18581588|P1|NOT COMPLETED|Overall Study||0
7549673|NCT03119831|18581586|P3|COMPLETED|Overall Study||14
7549674|NCT03119831|18581587|P2|COMPLETED|Overall Study||14
7549675|NCT03119831|18581588|P1|COMPLETED|Overall Study||14
7549676|NCT03119831|18581586|P3|STARTED|Overall Study||14
7549677|NCT03119831|18581587|P2|STARTED|Overall Study||14
7549678|NCT03119831|18581588|P1|STARTED|Overall Study||14
7549679|NCT03119688|18581605|P1|NOT COMPLETED|Overall Study||4
7549680|NCT03119688|18581605|P1|COMPLETED|Overall Study||44
7549681|NCT03119688|18581605|P1|STARTED|Overall Study||48
7549682|NCT03119662|18581638|P2|NOT COMPLETED|Overall Study||1
7549683|NCT03119662|18581639|P1|NOT COMPLETED|Overall Study||0
7549684|NCT03119662|18581638|P2|COMPLETED|Overall Study||1
7549685|NCT03119662|18581639|P1|COMPLETED|Overall Study||2
7549686|NCT03119662|18581638|P2|STARTED|Overall Study||2
7549687|NCT03119662|18581639|P1|STARTED|Overall Study||2
7549688|NCT03119649|18581660|P5|NOT COMPLETED|Overall Study||0
7549689|NCT03119649|18581661|P4|NOT COMPLETED|Overall Study||0
7549690|NCT03119649|18581662|P3|NOT COMPLETED|Overall Study||0
7549691|NCT03119649|18581663|P2|NOT COMPLETED|Overall Study||0
7549692|NCT03119649|18581664|P1|NOT COMPLETED|Overall Study||0
7549693|NCT03119649|18581660|P5|COMPLETED|Overall Study||14
7549694|NCT03119649|18581661|P4|COMPLETED|Overall Study||14
7549695|NCT03119649|18581662|P3|COMPLETED|Overall Study||10
7549696|NCT03119649|18581663|P2|COMPLETED|Overall Study||10
7549697|NCT03119649|18581664|P1|COMPLETED|Overall Study||11
7549698|NCT03119649|18581660|P5|STARTED|Overall Study||14
7549699|NCT03119649|18581661|P4|STARTED|Overall Study||14
7549700|NCT03119649|18581662|P3|STARTED|Overall Study||10
7549701|NCT03119649|18581663|P2|STARTED|Overall Study||10
7549702|NCT03119649|18581664|P1|STARTED|Overall Study||11
7549703|NCT03119610|18581709|P2|NOT COMPLETED|Overall Study||1
7549704|NCT03119610|18581710|P1|NOT COMPLETED|Overall Study||1
7549705|NCT03119610|18581709|P2|COMPLETED|Overall Study||9
7549706|NCT03119610|18581710|P1|COMPLETED|Overall Study||12
7549707|NCT03119610|18581709|P2|STARTED|Overall Study||10
7549708|NCT03119610|18581710|P1|STARTED|Overall Study||13
7549709|NCT03119389|18581742|P2|NOT COMPLETED|Overall Study||0
7549710|NCT03119389|18581743|P1|NOT COMPLETED|Overall Study||0
7549711|NCT03119389|18581742|P2|COMPLETED|Overall Study||7627
7549712|NCT03119389|18581743|P1|COMPLETED|Overall Study||6791
7549713|NCT03119389|18581742|P2|STARTED|Overall Study||7627
7549714|NCT03119389|18581743|P1|STARTED|Overall Study||6791
7549715|NCT03119181|18581759|P2|NOT COMPLETED|Overall Study||0
7549716|NCT03119181|18581760|P1|NOT COMPLETED|Overall Study||0
7549717|NCT03119181|18581759|P2|COMPLETED|Overall Study||21
7549718|NCT03119181|18581760|P1|COMPLETED|Overall Study||19
7549719|NCT03119181|18581759|P2|STARTED|Overall Study||21
7549720|NCT03119181|18581760|P1|STARTED|Overall Study||19
7549721|NCT03119168|18581768|P2|NOT COMPLETED|Overall Study||0
7549722|NCT03119168|18581769|P1|NOT COMPLETED|Overall Study||0
7549723|NCT03119168|18581768|P2|COMPLETED|Overall Study||139
7549724|NCT03119168|18581769|P1|COMPLETED|Overall Study||129
7549725|NCT03119168|18581768|P2|STARTED|Overall Study||139
7549726|NCT03119168|18581769|P1|STARTED|Overall Study||129
7549727|NCT03119025|18581781|P1|NOT COMPLETED|Overall Study||0
7549728|NCT03119025|18581781|P1|COMPLETED|Overall Study||10
7549729|NCT03119025|18581781|P1|STARTED|Overall Study||10
7549730|NCT03118947|18581788|P1|NOT COMPLETED|Overall Study||29
7549731|NCT03118947|18581788|P1|COMPLETED|Overall Study||49
7549732|NCT03118947|18581788|P1|STARTED|Overall Study||78
7549733|NCT03118934|18581795|P6|NOT COMPLETED|Overall Study||2
7549734|NCT03118934|18581796|P5|NOT COMPLETED|Overall Study||2
7549735|NCT03118934|18581797|P4|NOT COMPLETED|Overall Study||1
7549736|NCT03118934|18581798|P3|NOT COMPLETED|Overall Study||1
7549737|NCT03118934|18581799|P2|NOT COMPLETED|Overall Study||1
7549738|NCT03118934|18581800|P1|NOT COMPLETED|Overall Study||0
7549739|NCT03118934|18581795|P6|COMPLETED|Overall Study||23
7549740|NCT03118934|18581796|P5|COMPLETED|Overall Study||27
7549741|NCT03118934|18581797|P4|COMPLETED|Overall Study||28
7549742|NCT03118934|18581798|P3|COMPLETED|Overall Study||33
7549743|NCT03118934|18581799|P2|COMPLETED|Overall Study||30
7549744|NCT03118934|18581800|P1|COMPLETED|Overall Study||34
7549745|NCT03118934|18581795|P6|Safety Analysis Set|Overall Study||25
7549746|NCT03118934|18581796|P5|Safety Analysis Set|Overall Study||26
7549747|NCT03118934|18581797|P4|Safety Analysis Set|Overall Study||29
7549748|NCT03118934|18581798|P3|Safety Analysis Set|Overall Study||34
7549749|NCT03118934|18581799|P2|Safety Analysis Set|Overall Study||29
7549750|NCT03118934|18581800|P1|Safety Analysis Set|Overall Study||34
7549751|NCT03118934|18581795|P6|STARTED|Overall Study||25
7549752|NCT03118934|18581796|P5|STARTED|Overall Study||29
7549753|NCT03118934|18581797|P4|STARTED|Overall Study||29
7549754|NCT03118934|18581798|P3|STARTED|Overall Study||34
7549755|NCT03118934|18581799|P2|STARTED|Overall Study||31
7549756|NCT03118934|18581800|P1|STARTED|Overall Study||34
7549757|NCT03118843|18581810|P1|NOT COMPLETED|Overall Study||0
7549758|NCT03118843|18581810|P1|COMPLETED|Overall Study||31
7549759|NCT03118843|18581810|P1|STARTED|Overall Study||31
7549760|NCT03118765|18581824|P5|NOT COMPLETED|Overall Study||2
7549761|NCT03118765|18581825|P4|NOT COMPLETED|Overall Study||3
7549762|NCT03118765|18581826|P3|NOT COMPLETED|Overall Study||5
7549763|NCT03118765|18581827|P2|NOT COMPLETED|Overall Study||2
7549764|NCT03118765|18581828|P1|NOT COMPLETED|Overall Study||4
7549765|NCT03118765|18581824|P5|COMPLETED|Overall Study||28
7549766|NCT03118765|18581825|P4|COMPLETED|Overall Study||29
7549767|NCT03118765|18581826|P3|COMPLETED|Overall Study||26
7549768|NCT03118765|18581827|P2|COMPLETED|Overall Study||30
7549769|NCT03118765|18581828|P1|COMPLETED|Overall Study||26
7549770|NCT03118765|18581824|P5|STARTED|Overall Study||30
7549771|NCT03118765|18581825|P4|STARTED|Overall Study||32
7549772|NCT03118765|18581826|P3|STARTED|Overall Study||31
7549773|NCT03118765|18581827|P2|STARTED|Overall Study||32
7549774|NCT03118765|18581828|P1|STARTED|Overall Study||30
7549775|NCT03118739|18581924|P2|NOT COMPLETED|Overall Study||4
7549776|NCT03118739|18581925|P1|NOT COMPLETED|Overall Study||7
7549777|NCT03118739|18581924|P2|COMPLETED|Overall Study||24
7549778|NCT03118739|18581925|P1|COMPLETED|Overall Study||25
7549779|NCT03118739|18581924|P2|Completed 24 Weeks of Treatment|Overall Study||25
7549780|NCT03118739|18581925|P1|Completed 24 Weeks of Treatment|Overall Study||24
7549781|NCT03118739|18581924|P2|Completed 12 Weeks of Treatment|Overall Study||25
7549782|NCT03118739|18581925|P1|Completed 12 Weeks of Treatment|Overall Study||26
7549783|NCT03118739|18581924|P2|STARTED|Overall Study||28
7549784|NCT03118739|18581925|P1|STARTED|Overall Study||32
7549785|NCT03118596|18582017|P2|NOT COMPLETED|Overall Study||4
7549786|NCT03118596|18582018|P1|NOT COMPLETED|Overall Study||0
7549787|NCT03118596|18582017|P2|COMPLETED|Overall Study||86
7549788|NCT03118596|18582018|P1|COMPLETED|Overall Study||90
7549789|NCT03118596|18582017|P2|Failed|Overall Study||4
7549790|NCT03118596|18582018|P1|Failed|Overall Study||0
7549791|NCT03118596|18582017|P2|Treated|Overall Study||0
7549792|NCT03118596|18582018|P1|Treated|Overall Study||2
7549793|NCT03118596|18582017|P2|STARTED|Overall Study||90
7549794|NCT03118596|18582018|P1|STARTED|Overall Study||90
7549795|NCT03118297|18582038|P2|NOT COMPLETED|Overall Study||2
7549796|NCT03118297|18582039|P1|NOT COMPLETED|Overall Study||0
7549797|NCT03118297|18582038|P2|COMPLETED|Overall Study||31
7549798|NCT03118297|18582039|P1|COMPLETED|Overall Study||32
7549799|NCT03118297|18582038|P2|STARTED|Overall Study||33
7549800|NCT03118297|18582039|P1|STARTED|Overall Study||32
7549801|NCT03117569|18582055|P2|NOT COMPLETED|Overall Study||12
7549802|NCT03117569|18582056|P1|NOT COMPLETED|Overall Study||4
7549803|NCT03117569|18582055|P2|COMPLETED|Overall Study||241
7549804|NCT03117569|18582056|P1|COMPLETED|Overall Study||123
7549805|NCT03117569|18582055|P2|STARTED|Overall Study||253
7549806|NCT03117569|18582056|P1|STARTED|Overall Study||127
7549807|NCT03117517|18582080|P2|NOT COMPLETED|Overall Study||4
7549808|NCT03117517|18582081|P1|NOT COMPLETED|Overall Study||5
7549809|NCT03117517|18582080|P2|COMPLETED|Overall Study||49
7549810|NCT03117517|18582081|P1|COMPLETED|Overall Study||48
7549811|NCT03117517|18582080|P2|STARTED|Overall Study||53
7549812|NCT03117517|18582081|P1|STARTED|Overall Study||53
7549813|NCT03117361|18582091|P1|NOT COMPLETED|Overall Study||10
7549814|NCT03117361|18582091|P1|COMPLETED|Overall Study||0
7549815|NCT03117361|18582091|P1|STARTED|Overall Study||10
7549816|NCT03117140|18582118|P4|NOT COMPLETED|Overall Study||0
7549817|NCT03117140|18582119|P3|NOT COMPLETED|Overall Study||0
7549818|NCT03117140|18582120|P2|NOT COMPLETED|Overall Study||0
7549819|NCT03117140|18582121|P1|NOT COMPLETED|Overall Study||0
7549820|NCT03117140|18582118|P4|COMPLETED|Overall Study||40
7549821|NCT03117140|18582119|P3|COMPLETED|Overall Study||40
7549822|NCT03117140|18582120|P2|COMPLETED|Overall Study||40
7549823|NCT03117140|18582121|P1|COMPLETED|Overall Study||40
7549824|NCT03117140|18582118|P4|STARTED|Overall Study||40
7549825|NCT03117140|18582119|P3|STARTED|Overall Study||40
7549826|NCT03117140|18582120|P2|STARTED|Overall Study||40
7549827|NCT03117140|18582121|P1|STARTED|Overall Study||40
7549828|NCT03116841|18582187|P1|NOT COMPLETED|Overall Study||0
7549829|NCT03116841|18582187|P1|COMPLETED|Overall Study||3
7549830|NCT03116841|18582187|P1|STARTED|Overall Study||3
7549831|NCT03116828|18582206|P2|NOT COMPLETED|Overall Study||21
7549832|NCT03116828|18582207|P1|NOT COMPLETED|Overall Study||8
7549833|NCT03116828|18582206|P2|COMPLETED|Overall Study||37
7549834|NCT03116828|18582207|P1|COMPLETED|Overall Study||36
7549835|NCT03116828|18582206|P2|STARTED|Overall Study||58
7549836|NCT03116828|18582207|P1|STARTED|Overall Study||44
7549837|NCT03116698|18582217|P4|NOT COMPLETED|Overall Study||2
7549838|NCT03116698|18582218|P3|NOT COMPLETED|Overall Study||8
7549839|NCT03116698|18582219|P2|NOT COMPLETED|Overall Study||6
7549840|NCT03116698|18582220|P1|NOT COMPLETED|Overall Study||6
7549841|NCT03116698|18582217|P4|COMPLETED|Overall Study||55
7549842|NCT03116698|18582218|P3|COMPLETED|Overall Study||54
7549843|NCT03116698|18582219|P2|COMPLETED|Overall Study||51
7549844|NCT03116698|18582220|P1|COMPLETED|Overall Study||56
7549845|NCT03116698|18582217|P4|STARTED|Overall Study||57
7549846|NCT03116698|18582218|P3|STARTED|Overall Study||62
7549847|NCT03116698|18582219|P2|STARTED|Overall Study||57
7549848|NCT03116698|18582220|P1|STARTED|Overall Study||62
7549849|NCT03115853|18582234|P1|NOT COMPLETED|Overall Study||0
7549850|NCT03115853|18582234|P1|COMPLETED|Overall Study||31
7549851|NCT03115853|18582234|P1|STARTED|Overall Study||31
7549852|NCT03115827|18582252|P1|NOT COMPLETED|Overall Study||3
7549853|NCT03115827|18582252|P1|COMPLETED|Overall Study||12
7549854|NCT03115827|18582252|P1|STARTED|Overall Study||15
7549855|NCT03115580|18582262|P2|NOT COMPLETED|Overall Study||0
7549856|NCT03115580|18582263|P1|NOT COMPLETED|Overall Study||0
7549857|NCT03115580|18582262|P2|COMPLETED|Overall Study||36
7549858|NCT03115580|18582263|P1|COMPLETED|Overall Study||35
7549859|NCT03115580|18582262|P2|STARTED|Overall Study||36
7549860|NCT03115580|18582263|P1|STARTED|Overall Study||35
7549861|NCT03115476|18582282|P3|NOT COMPLETED|LP0084-1369||162
7549862|NCT03115476|18582283|P2|NOT COMPLETED|LP0084-1369||210
7549863|NCT03115476|18582284|P1|NOT COMPLETED|LP0084-1369||191
7549864|NCT03115476|18582282|P3|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
7549865|NCT03115476|18582283|P2|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
7549866|NCT03115476|18582284|P1|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
7549867|NCT03115476|18582282|P3|STARTED|LP0084-1369||162
7549868|NCT03115476|18582283|P2|STARTED|LP0084-1369||210
7549869|NCT03115476|18582284|P1|STARTED|LP0084-1369||191
7549870|NCT03115476|18582282|P3|NOT COMPLETED|Main Trials (LP0084-119x)||0
7549871|NCT03115476|18582283|P2|NOT COMPLETED|Main Trials (LP0084-119x)||0
7549872|NCT03115476|18582284|P1|NOT COMPLETED|Main Trials (LP0084-119x)||0
7549873|NCT03115476|18582282|P3|COMPLETED|Main Trials (LP0084-119x)||409
7549874|NCT03115476|18582283|P2|COMPLETED|Main Trials (LP0084-119x)||418
7549875|NCT03115476|18582284|P1|COMPLETED|Main Trials (LP0084-119x)||407
7549876|NCT03115476|18582282|P3|STARTED|Main Trials (LP0084-119x)||409
7549877|NCT03115476|18582283|P2|STARTED|Main Trials (LP0084-119x)||418
7549878|NCT03115476|18582284|P1|STARTED|Main Trials (LP0084-119x)||407
7549879|NCT03115411|18582295|P1|NOT COMPLETED|Overall Study||0
7549880|NCT03115411|18582295|P1|COMPLETED|Overall Study||23
7549881|NCT03115411|18582295|P1|STARTED|Overall Study||23
7549882|NCT03115177|18582301|P2|NOT COMPLETED|Overall Study||0
7549883|NCT03115177|18582302|P1|NOT COMPLETED|Overall Study||0
7549884|NCT03115177|18582301|P2|COMPLETED|Overall Study||29
7549885|NCT03115177|18582302|P1|COMPLETED|Overall Study||27
7549886|NCT03115177|18582301|P2|STARTED|Overall Study||29
7549887|NCT03115177|18582302|P1|STARTED|Overall Study||27
7549888|NCT03114995|18582311|P3|NOT COMPLETED|Overall Study||0
7549889|NCT03114995|18582312|P2|NOT COMPLETED|Overall Study||1
7549890|NCT03114995|18582313|P1|NOT COMPLETED|Overall Study||1
7549891|NCT03114995|18582311|P3|COMPLETED|Overall Study||78
7549892|NCT03114995|18582312|P2|COMPLETED|Overall Study||30
7549893|NCT03114995|18582313|P1|COMPLETED|Overall Study||30
7549894|NCT03114995|18582311|P3|STARTED|Overall Study||78
7549895|NCT03114995|18582312|P2|STARTED|Overall Study||31
7549896|NCT03114995|18582313|P1|STARTED|Overall Study||31
7549897|NCT03114969|18582333|P9|NOT COMPLETED|Overall Study||2
7549898|NCT03114969|18582334|P8|NOT COMPLETED|Overall Study||0
7549899|NCT03114969|18582335|P7|NOT COMPLETED|Overall Study||1
7549900|NCT03114969|18582336|P6|NOT COMPLETED|Overall Study||1
7549901|NCT03114969|18582337|P5|NOT COMPLETED|Overall Study||0
7549902|NCT03114969|18582338|P4|NOT COMPLETED|Overall Study||2
7549903|NCT03114969|18582339|P3|NOT COMPLETED|Overall Study||4
7549904|NCT03114969|18582340|P2|NOT COMPLETED|Overall Study||0
7549905|NCT03114969|18582341|P1|NOT COMPLETED|Overall Study||0
7549906|NCT03114969|18582333|P9|COMPLETED|Overall Study||48
7549907|NCT03114969|18582334|P8|COMPLETED|Overall Study||50
7549908|NCT03114969|18582335|P7|COMPLETED|Overall Study||49
7549909|NCT03114969|18582336|P6|COMPLETED|Overall Study||48
7549910|NCT03114969|18582337|P5|COMPLETED|Overall Study||51
7549911|NCT03114969|18582338|P4|COMPLETED|Overall Study||48
7549912|NCT03114969|18582339|P3|COMPLETED|Overall Study||46
7549913|NCT03114969|18582340|P2|COMPLETED|Overall Study||50
7549914|NCT03114969|18582341|P1|COMPLETED|Overall Study||50
7549915|NCT03114969|18582333|P9|STARTED|Overall Study||50
7549916|NCT03114969|18582334|P8|STARTED|Overall Study||50
7549917|NCT03114969|18582335|P7|STARTED|Overall Study||50
7549918|NCT03114969|18582336|P6|STARTED|Overall Study||49
7549919|NCT03114969|18582337|P5|STARTED|Overall Study||51
7549920|NCT03114969|18582338|P4|STARTED|Overall Study||50
7549921|NCT03114969|18582339|P3|STARTED|Overall Study||50
7549922|NCT03114969|18582340|P2|STARTED|Overall Study||50
7549923|NCT03114969|18582341|P1|STARTED|Overall Study||50
7549924|NCT03114683|18582436|P1|NOT COMPLETED|Overall Study||44
7549925|NCT03114683|18582436|P1|COMPLETED|Overall Study||52
7549926|NCT03114683|18582436|P1|STARTED|Overall Study||96
7549927|NCT03114657|18582442|P2|NOT COMPLETED|Overall Study||407
7549928|NCT03114657|18582443|P1|NOT COMPLETED|Overall Study||399
7549929|NCT03114657|18582442|P2|COMPLETED|Overall Study||0
7549930|NCT03114657|18582443|P1|COMPLETED|Overall Study||0
7549931|NCT03114657|18582442|P2|STARTED|Overall Study||407
7549932|NCT03114657|18582443|P1|STARTED|Overall Study||399
7549933|NCT03114488|18582488|P2|NOT COMPLETED|Time Period 2||3
7549934|NCT03114488|18582489|P1|NOT COMPLETED|Time Period 2||1
7549935|NCT03114488|18582488|P2|COMPLETED|Time Period 2||19
7549936|NCT03114488|18582489|P1|COMPLETED|Time Period 2||18
7549937|NCT03114488|18582488|P2|STARTED|Time Period 2||22
7549938|NCT03114488|18582489|P1|STARTED|Time Period 2||19
7549939|NCT03114488|18582488|P2|NOT COMPLETED|Time Period 1||0
7549940|NCT03114488|18582489|P1|NOT COMPLETED|Time Period 1||0
7549941|NCT03114488|18582488|P2|COMPLETED|Time Period 1||22
7549942|NCT03114488|18582489|P1|COMPLETED|Time Period 1||19
7549943|NCT03114488|18582488|P2|STARTED|Time Period 1||22
7549944|NCT03114488|18582489|P1|STARTED|Time Period 1||19
7549945|NCT03113916|18582501|P2|NOT COMPLETED|Overall Study||12
7549946|NCT03113916|18582502|P1|NOT COMPLETED|Overall Study||11
7549947|NCT03113916|18582501|P2|COMPLETED|Overall Study||84
7549948|NCT03113916|18582502|P1|COMPLETED|Overall Study||88
7549949|NCT03113916|18582501|P2|STARTED|Overall Study||96
7549950|NCT03113916|18582502|P1|STARTED|Overall Study||99
7549951|NCT03113656|18582533|P2|NOT COMPLETED|Overall Study||0
7549952|NCT03113656|18582534|P1|NOT COMPLETED|Overall Study||0
7549953|NCT03113656|18582533|P2|COMPLETED|Overall Study||7
7549954|NCT03113656|18582534|P1|COMPLETED|Overall Study||9
7549955|NCT03113656|18582533|P2|STARTED|Overall Study||7
7549956|NCT03113656|18582534|P1|STARTED|Overall Study||9
7549957|NCT03112993|18582542|P2|NOT COMPLETED|Overall Study||0
7549958|NCT03112993|18582543|P1|NOT COMPLETED|Overall Study||0
7549959|NCT03112993|18582542|P2|COMPLETED|Overall Study||21
7549960|NCT03112993|18582543|P1|COMPLETED|Overall Study||19
7549961|NCT03112993|18582542|P2|STARTED|Overall Study||21
7549962|NCT03112993|18582543|P1|STARTED|Overall Study||19
7549963|NCT03111550|18582560|P3|NOT COMPLETED|Overall Study||3
7549964|NCT03111550|18582561|P2|NOT COMPLETED|Overall Study||2
7549965|NCT03111550|18582562|P1|NOT COMPLETED|Overall Study||4
7549966|NCT03111550|18582560|P3|COMPLETED|Overall Study||76
7549967|NCT03111550|18582561|P2|COMPLETED|Overall Study||71
7549968|NCT03111550|18582562|P1|COMPLETED|Overall Study||73
7549969|NCT03111550|18582560|P3|STARTED|Overall Study|First eye|79
7549970|NCT03111550|18582561|P2|STARTED|Overall Study|First eye|73
7549971|NCT03111550|18582562|P1|STARTED|Overall Study|First eye|77
7549972|NCT03111316|18582580|P4|NOT COMPLETED|Overall Study||0
7549973|NCT03111316|18582581|P3|NOT COMPLETED|Overall Study||0
7549974|NCT03111316|18582582|P2|NOT COMPLETED|Overall Study||0
7549975|NCT03111316|18582583|P1|NOT COMPLETED|Overall Study||0
7549976|NCT03111316|18582580|P4|COMPLETED|Overall Study||25
7549977|NCT03111316|18582581|P3|COMPLETED|Overall Study||25
7549978|NCT03111316|18582582|P2|COMPLETED|Overall Study||24
7549979|NCT03111316|18582583|P1|COMPLETED|Overall Study||26
7549980|NCT03111316|18582580|P4|STARTED|Overall Study||25
7549981|NCT03111316|18582581|P3|STARTED|Overall Study||25
7549982|NCT03111316|18582582|P2|STARTED|Overall Study||24
7549983|NCT03111316|18582583|P1|STARTED|Overall Study||26
7549984|NCT03111108|18582599|P2|NOT COMPLETED|Overall Study||1
7549985|NCT03111108|18582600|P1|NOT COMPLETED|Overall Study||1
7549986|NCT03111108|18582599|P2|COMPLETED|Overall Study||63
7549987|NCT03111108|18582600|P1|COMPLETED|Overall Study||52
7549988|NCT03111108|18582599|P2|STARTED|Overall Study||64
7549989|NCT03111108|18582600|P1|STARTED|Overall Study||53
7549990|NCT03110900|18582618|P2|NOT COMPLETED|Overall Study||1
7549991|NCT03110900|18582619|P1|NOT COMPLETED|Overall Study||1
7549992|NCT03110900|18582618|P2|COMPLETED|Overall Study||0
7549993|NCT03110900|18582619|P1|COMPLETED|Overall Study||0
7549994|NCT03110900|18582618|P2|STARTED|Overall Study||1
7549995|NCT03110900|18582619|P1|STARTED|Overall Study||1
7549996|NCT03110770|18582630|P5|NOT COMPLETED|Overall Study||123
7549997|NCT03110770|18582631|P4|NOT COMPLETED|Overall Study||133
7549998|NCT03110770|18582632|P3|NOT COMPLETED|Overall Study||2
7549999|NCT03110770|18582633|P2|NOT COMPLETED|Overall Study||0
7550000|NCT03110770|18582634|P1|NOT COMPLETED|Overall Study||6
7550001|NCT03110770|18582630|P5|COMPLETED|Overall Study||1045
7550002|NCT03110770|18582631|P4|COMPLETED|Overall Study||1037
7550003|NCT03110770|18582632|P3|COMPLETED|Overall Study||28
7550004|NCT03110770|18582633|P2|COMPLETED|Overall Study||30
7550005|NCT03110770|18582634|P1|COMPLETED|Overall Study||24
7550006|NCT03110770|18582630|P5|Received Third Product Administration|Overall Study||1107
7550007|NCT03110770|18582631|P4|Received Third Product Administration|Overall Study||1107
7550008|NCT03110770|18582632|P3|Received Third Product Administration|Overall Study||28
7550009|NCT03110770|18582633|P2|Received Third Product Administration|Overall Study||27
7550010|NCT03110770|18582634|P1|Received Third Product Administration|Overall Study||29
7550011|NCT03110770|18582630|P5|Received Second Product Administration|Overall Study||1127
7550012|NCT03110770|18582631|P4|Received Second Product Administration|Overall Study||1126
7550013|NCT03110770|18582632|P3|Received Second Product Administration|Overall Study||29
7550014|NCT03110770|18582633|P2|Received Second Product Administration|Overall Study||29
7550015|NCT03110770|18582634|P1|Received Second Product Administration|Overall Study||30
7550016|NCT03110770|18582630|P5|Received First Product Administration|Overall Study||1161
7550017|NCT03110770|18582631|P4|Received First Product Administration|Overall Study||1162
7550018|NCT03110770|18582632|P3|Received First Product Administration|Overall Study||30
7550019|NCT03110770|18582633|P2|Received First Product Administration|Overall Study||30
7550020|NCT03110770|18582634|P1|Received First Product Administration|Overall Study||30
7550021|NCT03110770|18582630|P5|STARTED|Overall Study||1168
7550022|NCT03110770|18582631|P4|STARTED|Overall Study||1170
7550023|NCT03110770|18582632|P3|STARTED|Overall Study||30
7550024|NCT03110770|18582633|P2|STARTED|Overall Study||30
7550025|NCT03110770|18582634|P1|STARTED|Overall Study||30
7550026|NCT03110692|18582679|P2|NOT COMPLETED|Overall Study||0
7550027|NCT03110692|18582680|P1|NOT COMPLETED|Overall Study||0
7550028|NCT03110692|18582679|P2|COMPLETED|Overall Study||509
7550029|NCT03110692|18582680|P1|COMPLETED|Overall Study||679
7550030|NCT03110692|18582679|P2|STARTED|Overall Study||509
7550031|NCT03110692|18582680|P1|STARTED|Overall Study||679
7550032|NCT03110601|18582686|P1|NOT COMPLETED|Stimgenics SCS Parameters||3
7550033|NCT03110601|18582686|P1|COMPLETED|Stimgenics SCS Parameters||20
7550034|NCT03110601|18582686|P1|STARTED|Stimgenics SCS Parameters||23
7550035|NCT03110601|18582686|P1|NOT COMPLETED|Washout Period||1
7550036|NCT03110601|18582686|P1|COMPLETED|Washout Period||23
7550037|NCT03110601|18582686|P1|STARTED|Washout Period||24
7550038|NCT03110601|18582686|P1|NOT COMPLETED|Conventional SCS Parameters||1
7550039|NCT03110601|18582686|P1|COMPLETED|Conventional SCS Parameters||24
7550040|NCT03110601|18582686|P1|STARTED|Conventional SCS Parameters||25
7550041|NCT03110471|18582695|P2|NOT COMPLETED|Overall Study||0
7550042|NCT03110471|18582696|P1|NOT COMPLETED|Overall Study||0
7550043|NCT03110471|18582695|P2|COMPLETED|Overall Study||30
7550044|NCT03110471|18582696|P1|COMPLETED|Overall Study||30
7550045|NCT03110471|18582695|P2|STARTED|Overall Study||30
7550046|NCT03110471|18582696|P1|STARTED|Overall Study||30
7550047|NCT03110458|18582708|P3|NOT COMPLETED|Overall Study||3
7550048|NCT03110458|18582709|P2|NOT COMPLETED|Overall Study||4
7550049|NCT03110458|18582710|P1|NOT COMPLETED|Overall Study||6
7550050|NCT03110458|18582708|P3|COMPLETED|Overall Study||31
7550051|NCT03110458|18582709|P2|COMPLETED|Overall Study||32
7550052|NCT03110458|18582710|P1|COMPLETED|Overall Study||31
7550053|NCT03110458|18582708|P3|STARTED|Overall Study||34
7550054|NCT03110458|18582709|P2|STARTED|Overall Study||36
7550055|NCT03110458|18582710|P1|STARTED|Overall Study||37
7550056|NCT03110380|18582738|P2|NOT COMPLETED|Overall Study||283
7550057|NCT03110380|18582739|P1|NOT COMPLETED|Overall Study||284
7550058|NCT03110380|18582738|P2|COMPLETED|Overall Study||0
7550059|NCT03110380|18582739|P1|COMPLETED|Overall Study||0
7550060|NCT03110380|18582738|P2|STARTED|Overall Study||283
7550061|NCT03110380|18582739|P1|STARTED|Overall Study||284
7550062|NCT03110185|18582751|P2|NOT COMPLETED|Overall Study||31
7550063|NCT03110185|18582752|P1|NOT COMPLETED|Overall Study||10
7550064|NCT03110185|18582751|P2|COMPLETED|Overall Study||33
7550065|NCT03110185|18582752|P1|COMPLETED|Overall Study||17
7550066|NCT03110185|18582751|P2|STARTED|Overall Study||64
7550067|NCT03110185|18582752|P1|STARTED|Overall Study||27
7550068|NCT03110159|18582762|P1|NOT COMPLETED|Overall Study||1
7550069|NCT03110159|18582762|P1|COMPLETED|Overall Study||0
7550070|NCT03110159|18582762|P1|STARTED|Overall Study||1
7550071|NCT03110029|18582773|P2|NOT COMPLETED|Overall Study||1
7550072|NCT03110029|18582774|P1|NOT COMPLETED|Overall Study||1
7550073|NCT03110029|18582773|P2|COMPLETED|Overall Study||5
7550074|NCT03110029|18582774|P1|COMPLETED|Overall Study||6
7550075|NCT03110029|18582773|P2|STARTED|Overall Study||6
7550076|NCT03110029|18582774|P1|STARTED|Overall Study||7
7550077|NCT03110003|18582784|P2|NOT COMPLETED|Overall Study||0
7550078|NCT03110003|18582785|P1|NOT COMPLETED|Overall Study||0
7550079|NCT03110003|18582784|P2|COMPLETED|Overall Study||24
7550080|NCT03110003|18582785|P1|COMPLETED|Overall Study||21
7550081|NCT03110003|18582784|P2|STARTED|Overall Study||24
7550082|NCT03110003|18582785|P1|STARTED|Overall Study||21
7550083|NCT03109951|18582801|P1|NOT COMPLETED|Overall Study||0
7550084|NCT03109951|18582801|P1|COMPLETED|Overall Study||187
7550085|NCT03109951|18582801|P1|STARTED|Overall Study||187
7550086|NCT03109873|18582809|P2|NOT COMPLETED|Overall Study||0
7550087|NCT03109873|18582810|P1|NOT COMPLETED|Overall Study||0
7550088|NCT03109873|18582809|P2|COMPLETED|Overall Study||4
7550089|NCT03109873|18582810|P1|COMPLETED|Overall Study||5
7550090|NCT03109873|18582809|P2|STARTED|Overall Study||4
7550091|NCT03109873|18582810|P1|STARTED|Overall Study||5
7550092|NCT03109769|18582826|P2|NOT COMPLETED|Overall Study||0
7550093|NCT03109769|18582827|P1|NOT COMPLETED|Overall Study||0
7550094|NCT03109769|18582826|P2|COMPLETED|Overall Study||22
7550095|NCT03109769|18582827|P1|COMPLETED|Overall Study||22
7550096|NCT03109769|18582826|P2|STARTED|Overall Study||22
7550097|NCT03109769|18582827|P1|STARTED|Overall Study||22
7550098|NCT03109418|18582837|P2|NOT COMPLETED|Overall Study||1
7550099|NCT03109418|18582838|P1|NOT COMPLETED|Overall Study||0
7550100|NCT03109418|18582837|P2|COMPLETED|Overall Study||3
7550101|NCT03109418|18582838|P1|COMPLETED|Overall Study||2
7550102|NCT03109418|18582837|P2|STARTED|Overall Study||4
7550103|NCT03109418|18582838|P1|STARTED|Overall Study||2
7550104|NCT03109184|18582848|P2|NOT COMPLETED|Overall Study||7
7550105|NCT03109184|18582849|P1|NOT COMPLETED|Overall Study||7
7550106|NCT03109184|18582848|P2|COMPLETED|Overall Study||52
7550107|NCT03109184|18582849|P1|COMPLETED|Overall Study||53
7550108|NCT03109184|18582848|P2|STARTED|Overall Study||59
7550109|NCT03109184|18582849|P1|STARTED|Overall Study||60
7550110|NCT03109015|18582869|P2|NOT COMPLETED|Overall Study||0
7550111|NCT03109015|18582870|P1|NOT COMPLETED|Overall Study||0
7550112|NCT03109015|18582869|P2|COMPLETED|Overall Study||3
7550113|NCT03109015|18582870|P1|COMPLETED|Overall Study||4
7550114|NCT03109015|18582869|P2|STARTED|Overall Study||3
7550115|NCT03109015|18582870|P1|STARTED|Overall Study||4
7550116|NCT03108924|18582904|P4|NOT COMPLETED|Overall Study||0
7550117|NCT03108924|18582905|P3|NOT COMPLETED|Overall Study||0
7550118|NCT03108924|18582906|P2|NOT COMPLETED|Overall Study||0
7550119|NCT03108924|18582907|P1|NOT COMPLETED|Overall Study||0
7550120|NCT03108924|18582904|P4|COMPLETED|Overall Study||6
7550121|NCT03108924|18582905|P3|COMPLETED|Overall Study||6
7550122|NCT03108924|18582906|P2|COMPLETED|Overall Study||6
7550123|NCT03108924|18582907|P1|COMPLETED|Overall Study||6
7550124|NCT03108924|18582904|P4|STARTED|Overall Study||6
7550125|NCT03108924|18582905|P3|STARTED|Overall Study||6
7550126|NCT03108924|18582906|P2|STARTED|Overall Study||6
7550127|NCT03108924|18582907|P1|STARTED|Overall Study||6
7550128|NCT03108521|18583003|P2|NOT COMPLETED|Overall Study||0
7550129|NCT03108521|18583004|P1|NOT COMPLETED|Overall Study||12
7550130|NCT03108521|18583003|P2|COMPLETED|Overall Study||36
7550131|NCT03108521|18583004|P1|COMPLETED|Overall Study||71
7550132|NCT03108521|18583003|P2|STARTED|Overall Study||36
7550133|NCT03108521|18583004|P1|STARTED|Overall Study||83
7550134|NCT03108482|18583018|P4|NOT COMPLETED|Overall Study||3
7550135|NCT03108482|18583019|P3|NOT COMPLETED|Overall Study||2
7550136|NCT03108482|18583020|P2|NOT COMPLETED|Overall Study||4
7550137|NCT03108482|18583021|P1|NOT COMPLETED|Overall Study||0
7550138|NCT03108482|18583018|P4|COMPLETED|Overall Study||86
7550139|NCT03108482|18583019|P3|COMPLETED|Overall Study||180
7550140|NCT03108482|18583020|P2|COMPLETED|Overall Study||179
7550141|NCT03108482|18583021|P1|COMPLETED|Overall Study||183
7550142|NCT03108482|18583018|P4|STARTED|Overall Study||89
7550143|NCT03108482|18583019|P3|STARTED|Overall Study||182
7550144|NCT03108482|18583020|P2|STARTED|Overall Study||183
7550145|NCT03108482|18583021|P1|STARTED|Overall Study||183
7550146|NCT03108469|18583033|P2|NOT COMPLETED|Overall Study||4
7550147|NCT03108469|18583034|P1|NOT COMPLETED|Overall Study||4
7550148|NCT03108469|18583033|P2|COMPLETED|Overall Study||11
7550149|NCT03108469|18583034|P1|COMPLETED|Overall Study||11
7550150|NCT03108469|18583033|P2|STARTED|Overall Study||15
7550151|NCT03108469|18583034|P1|STARTED|Overall Study||15
7550152|NCT03108157|18583056|P2|NOT COMPLETED|Overall Study||4
7550153|NCT03108157|18583057|P1|NOT COMPLETED|Overall Study||15
7550154|NCT03108157|18583056|P2|COMPLETED|Overall Study||172
7550155|NCT03108157|18583057|P1|COMPLETED|Overall Study||161
7550156|NCT03108157|18583056|P2|STARTED|Overall Study||176
7550157|NCT03108157|18583057|P1|STARTED|Overall Study||176
7550158|NCT03108027|18583067|P6|NOT COMPLETED|Period 3||0
7550159|NCT03108027|18583068|P5|NOT COMPLETED|Period 3||0
7550160|NCT03108027|18583069|P4|NOT COMPLETED|Period 3||0
7550161|NCT03108027|18583070|P3|NOT COMPLETED|Period 3||0
7550162|NCT03108027|18583071|P2|NOT COMPLETED|Period 3||1
7550163|NCT03108027|18583072|P1|NOT COMPLETED|Period 3||0
7550164|NCT03108027|18583067|P6|COMPLETED|Period 3||6
7550165|NCT03108027|18583068|P5|COMPLETED|Period 3||6
7550166|NCT03108027|18583069|P4|COMPLETED|Period 3||4
7550167|NCT03108027|18583070|P3|COMPLETED|Period 3||6
7550168|NCT03108027|18583071|P2|COMPLETED|Period 3||5
7550169|NCT03108027|18583072|P1|COMPLETED|Period 3||7
7550170|NCT03108027|18583067|P6|STARTED|Period 3||6
7550171|NCT03108027|18583068|P5|STARTED|Period 3||6
7550172|NCT03108027|18583069|P4|STARTED|Period 3||4
7550173|NCT03108027|18583070|P3|STARTED|Period 3||6
7550174|NCT03108027|18583071|P2|STARTED|Period 3||6
7550175|NCT03108027|18583072|P1|STARTED|Period 3||7
7550176|NCT03108027|18583067|P6|NOT COMPLETED|Period 2||0
7550177|NCT03108027|18583068|P5|NOT COMPLETED|Period 2||0
7550178|NCT03108027|18583069|P4|NOT COMPLETED|Period 2||0
7550179|NCT03108027|18583070|P3|NOT COMPLETED|Period 2||0
7550180|NCT03108027|18583071|P2|NOT COMPLETED|Period 2||0
7550181|NCT03108027|18583072|P1|NOT COMPLETED|Period 2||0
7550182|NCT03108027|18583067|P6|COMPLETED|Period 2||6
7550183|NCT03108027|18583068|P5|COMPLETED|Period 2||6
7550184|NCT03108027|18583069|P4|COMPLETED|Period 2||4
7550185|NCT03108027|18583070|P3|COMPLETED|Period 2||6
7550186|NCT03108027|18583071|P2|COMPLETED|Period 2||6
7550187|NCT03108027|18583072|P1|COMPLETED|Period 2||7
7550188|NCT03108027|18583067|P6|STARTED|Period 2||6
7550189|NCT03108027|18583068|P5|STARTED|Period 2||6
7550190|NCT03108027|18583069|P4|STARTED|Period 2||4
7550191|NCT03108027|18583070|P3|STARTED|Period 2||6
7550192|NCT03108027|18583071|P2|STARTED|Period 2||6
7550193|NCT03108027|18583072|P1|STARTED|Period 2||7
7550194|NCT03108027|18583067|P6|NOT COMPLETED|Period 1||0
7550195|NCT03108027|18583068|P5|NOT COMPLETED|Period 1||0
7550196|NCT03108027|18583069|P4|NOT COMPLETED|Period 1||2
7550197|NCT03108027|18583070|P3|NOT COMPLETED|Period 1||0
7550198|NCT03108027|18583071|P2|NOT COMPLETED|Period 1||0
7550199|NCT03108027|18583072|P1|NOT COMPLETED|Period 1||0
7550200|NCT03108027|18583067|P6|COMPLETED|Period 1||6
7550201|NCT03108027|18583068|P5|COMPLETED|Period 1||6
7550202|NCT03108027|18583069|P4|COMPLETED|Period 1||4
7550203|NCT03108027|18583070|P3|COMPLETED|Period 1||6
7550204|NCT03108027|18583071|P2|COMPLETED|Period 1||6
7550205|NCT03108027|18583072|P1|COMPLETED|Period 1||7
7550206|NCT03108027|18583067|P6|STARTED|Period 1||6
7550207|NCT03108027|18583068|P5|STARTED|Period 1||6
7550208|NCT03108027|18583069|P4|STARTED|Period 1||6
7550209|NCT03108027|18583070|P3|STARTED|Period 1||6
7550210|NCT03108027|18583071|P2|STARTED|Period 1||6
7550211|NCT03108027|18583072|P1|STARTED|Period 1||7
7550212|NCT03107754|18583088|P2|NOT COMPLETED|Overall Study||0
7550213|NCT03107754|18583089|P1|NOT COMPLETED|Overall Study||0
7550214|NCT03107754|18583088|P2|COMPLETED|Overall Study||50
7550215|NCT03107754|18583089|P1|COMPLETED|Overall Study||48
7550216|NCT03107754|18583088|P2|STARTED|Overall Study||50
7550217|NCT03107754|18583089|P1|STARTED|Overall Study||48
7550218|NCT03107715|18583099|P2|NOT COMPLETED|Overall Study||7
7550219|NCT03107715|18583100|P1|NOT COMPLETED|Overall Study||4
7550220|NCT03107715|18583099|P2|COMPLETED|Overall Study||104
7550221|NCT03107715|18583100|P1|COMPLETED|Overall Study||128
7550222|NCT03107715|18583099|P2|STARTED|Overall Study||111
7550223|NCT03107715|18583100|P1|STARTED|Overall Study||132
7550224|NCT03107611|18583115|P3|NOT COMPLETED|Overall Study||9
7550225|NCT03107611|18583116|P2|NOT COMPLETED|Overall Study||4
7550226|NCT03107611|18583117|P1|NOT COMPLETED|Overall Study||7
7550227|NCT03107611|18583115|P3|COMPLETED|Overall Study||212
7550228|NCT03107611|18583116|P2|COMPLETED|Overall Study||212
7550229|NCT03107611|18583117|P1|COMPLETED|Overall Study||210
7550230|NCT03107611|18583115|P3|Dosed|Overall Study||220
7550231|NCT03107611|18583116|P2|Dosed|Overall Study||214
7550232|NCT03107611|18583117|P1|Dosed|Overall Study||215
7550233|NCT03107611|18583115|P3|STARTED|Overall Study||221
7550234|NCT03107611|18583116|P2|STARTED|Overall Study||216
7550235|NCT03107611|18583117|P1|STARTED|Overall Study||217
7550236|NCT03107377|18583136|P2|NOT COMPLETED|Overall Study||99
7550237|NCT03107377|18583137|P1|NOT COMPLETED|Overall Study||91
7550238|NCT03107377|18583136|P2|COMPLETED|Overall Study||335
7550239|NCT03107377|18583137|P1|COMPLETED|Overall Study||335
7550240|NCT03107377|18583136|P2|STARTED|Overall Study||434
7550241|NCT03107377|18583137|P1|STARTED|Overall Study||426
7550242|NCT03107052|18583162|P3|NOT COMPLETED|Overall Study||41
7550243|NCT03107052|18583163|P2|NOT COMPLETED|Overall Study||46
7550244|NCT03107052|18583164|P1|NOT COMPLETED|Overall Study||119
7550245|NCT03107052|18583162|P3|COMPLETED|Overall Study||29
7550246|NCT03107052|18583163|P2|COMPLETED|Overall Study||14
7550247|NCT03107052|18583164|P1|COMPLETED|Overall Study||26
7550248|NCT03107052|18583162|P3|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|71
7550249|NCT03107052|18583163|P2|Safety Analysis Set|Overall Study||60
7550250|NCT03107052|18583164|P1|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|144
7550251|NCT03107052|18583162|P3|STARTED|Overall Study||70
7550252|NCT03107052|18583163|P2|STARTED|Overall Study||60
7550253|NCT03107052|18583164|P1|STARTED|Overall Study||145
7550254|NCT03107026|18583208|P3|NOT COMPLETED|Overall Study||56
7550255|NCT03107026|18583209|P2|NOT COMPLETED|Overall Study||38
7550256|NCT03107026|18583210|P1|NOT COMPLETED|Overall Study||32
7550257|NCT03107026|18583208|P3|COMPLETED|Overall Study||106
7550258|NCT03107026|18583209|P2|COMPLETED|Overall Study||123
7550259|NCT03107026|18583210|P1|COMPLETED|Overall Study||131
7550260|NCT03107026|18583208|P3|STARTED|Overall Study||162
7550261|NCT03107026|18583209|P2|STARTED|Overall Study||161
7550262|NCT03107026|18583210|P1|STARTED|Overall Study||163
7550263|NCT03106870|18583259|P2|NOT COMPLETED|Overall Study||0
7550264|NCT03106870|18583260|P1|NOT COMPLETED|Overall Study||0
7550265|NCT03106870|18583259|P2|COMPLETED|Overall Study||31
7550266|NCT03106870|18583260|P1|COMPLETED|Overall Study||31
7550267|NCT03106870|18583259|P2|STARTED|Overall Study||31
7550268|NCT03106870|18583260|P1|STARTED|Overall Study||31
7550269|NCT03106844|18583270|P1|NOT COMPLETED|Overall Study||1
7550270|NCT03106844|18583270|P1|COMPLETED|Overall Study||49
7550271|NCT03106844|18583270|P1|STARTED|Overall Study||50
7550272|NCT03106753|18583277|P2|NOT COMPLETED|Overall Study||1
7550273|NCT03106753|18583278|P1|NOT COMPLETED|Overall Study||0
7550274|NCT03106753|18583277|P2|COMPLETED|Overall Study||16
7550275|NCT03106753|18583278|P1|COMPLETED|Overall Study||17
7550276|NCT03106753|18583277|P2|STARTED|Overall Study||17
7550277|NCT03106753|18583278|P1|STARTED|Overall Study||17
7550278|NCT03106636|18583302|P2|NOT COMPLETED|Overall Study||26
7550279|NCT03106636|18583303|P1|NOT COMPLETED|Overall Study||44
7550280|NCT03106636|18583302|P2|COMPLETED|Overall Study||164
7550281|NCT03106636|18583303|P1|COMPLETED|Overall Study||182
7550282|NCT03106636|18583302|P2|STARTED|Overall Study||190
7550283|NCT03106636|18583303|P1|STARTED|Overall Study||226
7550284|NCT03106337|18583339|P1|NOT COMPLETED|Overall Study||0
7550285|NCT03106337|18583339|P1|COMPLETED|Overall Study||35
7550286|NCT03106337|18583339|P1|STARTED|Overall Study||35
7550287|NCT03106077|18583344|P2|NOT COMPLETED|Overall Study||0
7550288|NCT03106077|18583345|P1|NOT COMPLETED|Overall Study||94
7550289|NCT03106077|18583344|P2|COMPLETED|Overall Study||0
7550290|NCT03106077|18583345|P1|COMPLETED|Overall Study||2
7550291|NCT03106077|18583344|P2|STARTED|Overall Study||0
7550292|NCT03106077|18583345|P1|STARTED|Overall Study||96
7550293|NCT03105518|18583355|P1|NOT COMPLETED|Overall Study||0
7550294|NCT03105518|18583355|P1|COMPLETED|Overall Study||100
7550295|NCT03105518|18583355|P1|STARTED|Overall Study||100
7550296|NCT03105479|18583360|P7|NOT COMPLETED|Overall Study||0
7550297|NCT03105479|18583361|P6|NOT COMPLETED|Overall Study||0
7550298|NCT03105479|18583362|P5|NOT COMPLETED|Overall Study||0
7550299|NCT03105479|18583363|P4|NOT COMPLETED|Overall Study||0
7550300|NCT03105479|18583364|P3|NOT COMPLETED|Overall Study||0
7550301|NCT03105479|18583365|P2|NOT COMPLETED|Overall Study||0
7550302|NCT03105479|18583366|P1|NOT COMPLETED|Overall Study||0
7550303|NCT03105479|18583360|P7|COMPLETED|Overall Study||0
7550304|NCT03105479|18583361|P6|COMPLETED|Overall Study||0
7550305|NCT03105479|18583362|P5|COMPLETED|Overall Study||0
7550306|NCT03105479|18583363|P4|COMPLETED|Overall Study||0
7550307|NCT03105479|18583364|P3|COMPLETED|Overall Study||0
7550308|NCT03105479|18583365|P2|COMPLETED|Overall Study||0
7550309|NCT03105479|18583366|P1|COMPLETED|Overall Study||1
7550310|NCT03105479|18583360|P7|STARTED|Overall Study||0
7550311|NCT03105479|18583361|P6|STARTED|Overall Study||0
7550312|NCT03105479|18583362|P5|STARTED|Overall Study||0
7550313|NCT03105479|18583363|P4|STARTED|Overall Study||0
7550314|NCT03105479|18583364|P3|STARTED|Overall Study||0
7550315|NCT03105479|18583365|P2|STARTED|Overall Study||0
7550316|NCT03105479|18583366|P1|STARTED|Overall Study||1
7550317|NCT03105362|18583389|P1|NOT COMPLETED|Overall Study||2
7550318|NCT03105362|18583389|P1|COMPLETED|Overall Study||2
7550319|NCT03105362|18583389|P1|Completed 2 Week Questionaire|Overall Study||2
7550320|NCT03105362|18583389|P1|Completed 2 Weeks of Study|Overall Study||3
7550321|NCT03105362|18583389|P1|Completed 1 Week of Study|Overall Study||4
7550322|NCT03105362|18583389|P1|STARTED|Overall Study||4
7550323|NCT03105297|18583396|P1|NOT COMPLETED|Nasal Resistance Phase (Day 30, 31)||8
7550324|NCT03105297|18583396|P1|COMPLETED|Nasal Resistance Phase (Day 30, 31)||48
7550325|NCT03105297|18583396|P1|Treated|Nasal Resistance Phase (Day 30, 31)||55
7550326|NCT03105297|18583396|P1|STARTED|Nasal Resistance Phase (Day 30, 31)|14 participants withdrew from the study after the completion of active phase|56
7550327|NCT03105297|18583396|P1|NOT COMPLETED|Active Phase (Day 2-29)||0
7550328|NCT03105297|18583396|P1|COMPLETED|Active Phase (Day 2-29)||70
7550329|NCT03105297|18583396|P1|STARTED|Active Phase (Day 2-29)||70
7550330|NCT03105297|18583396|P1|NOT COMPLETED|Baseline Phase (Day 1)||21
7550331|NCT03105297|18583396|P1|COMPLETED|Baseline Phase (Day 1)||70
7550332|NCT03105297|18583396|P1|STARTED|Baseline Phase (Day 1)||91
7550333|NCT03104985|18583430|P2|NOT COMPLETED|Overall Study||0
7550334|NCT03104985|18583431|P1|NOT COMPLETED|Overall Study||0
7550335|NCT03104985|18583430|P2|COMPLETED|Overall Study||34
7550336|NCT03104985|18583431|P1|COMPLETED|Overall Study||34
7550337|NCT03104985|18583430|P2|STARTED|Overall Study||34
7550338|NCT03104985|18583431|P1|STARTED|Overall Study||34
7550339|NCT03104816|18583440|P3|NOT COMPLETED|Overall Study||2
7550340|NCT03104816|18583441|P2|NOT COMPLETED|Overall Study||2
7550341|NCT03104816|18583442|P1|NOT COMPLETED|Overall Study||2
7550342|NCT03104816|18583440|P3|COMPLETED|Overall Study||4
7550343|NCT03104816|18583441|P2|COMPLETED|Overall Study||9
7550344|NCT03104816|18583442|P1|COMPLETED|Overall Study||9
7550345|NCT03104816|18583440|P3|STARTED|Overall Study||6
7550346|NCT03104816|18583441|P2|STARTED|Overall Study||11
7550347|NCT03104816|18583442|P1|STARTED|Overall Study||11
7550348|NCT03104738|18583452|P2|NOT COMPLETED|Overall Study||0
7550349|NCT03104738|18583453|P1|NOT COMPLETED|Overall Study||0
7550350|NCT03104738|18583452|P2|COMPLETED|Overall Study||20
7550351|NCT03104738|18583453|P1|COMPLETED|Overall Study||20
7550352|NCT03104738|18583452|P2|STARTED|Overall Study||20
7550353|NCT03104738|18583453|P1|STARTED|Overall Study||20
7550354|NCT03104647|18583479|P1|NOT COMPLETED|Overall Study||0
7550355|NCT03104647|18583479|P1|COMPLETED|Overall Study||20
7550356|NCT03104647|18583479|P1|STARTED|Overall Study||20
7550357|NCT03104322|18583484|P1|NOT COMPLETED|Overall Study||1
7550358|NCT03104322|18583484|P1|COMPLETED|Overall Study||6
7550359|NCT03104322|18583484|P1|STARTED|Overall Study||7
7550360|NCT03104192|18583496|P4|NOT COMPLETED|Overall Study||3
7550361|NCT03104192|18583497|P3|NOT COMPLETED|Overall Study||2
7550362|NCT03104192|18583498|P2|NOT COMPLETED|Overall Study||4
7550363|NCT03104192|18583499|P1|NOT COMPLETED|Overall Study||0
7550364|NCT03104192|18583496|P4|COMPLETED|Overall Study||14
7550365|NCT03104192|18583497|P3|COMPLETED|Overall Study||14
7550366|NCT03104192|18583498|P2|COMPLETED|Overall Study||23
7550367|NCT03104192|18583499|P1|COMPLETED|Overall Study||9
7550368|NCT03104192|18583496|P4|STARTED|Overall Study||17
7550369|NCT03104192|18583497|P3|STARTED|Overall Study||16
7550370|NCT03104192|18583498|P2|STARTED|Overall Study||27
7550371|NCT03104192|18583499|P1|STARTED|Overall Study||9
7550372|NCT03103919|18583550|P2|NOT COMPLETED|Overall Study||2
7550373|NCT03103919|18583551|P1|NOT COMPLETED|Overall Study||2
7550374|NCT03103919|18583550|P2|COMPLETED|Overall Study||17
7550375|NCT03103919|18583551|P1|COMPLETED|Overall Study||18
7550376|NCT03103919|18583550|P2|STARTED|Overall Study||19
7550377|NCT03103919|18583551|P1|STARTED|Overall Study||20
7550378|NCT03103906|18583587|P2|NOT COMPLETED|Overall Study||3
7550379|NCT03103906|18583588|P1|NOT COMPLETED|Overall Study||4
7550380|NCT03103906|18583587|P2|COMPLETED|Overall Study||39
7550381|NCT03103906|18583588|P1|COMPLETED|Overall Study||36
7550382|NCT03103906|18583587|P2|STARTED|Overall Study||42
7550383|NCT03103906|18583588|P1|STARTED|Overall Study||40
7550384|NCT03103763|18583611|P3|NOT COMPLETED|Overall Study||7
7550385|NCT03103763|18583612|P2|NOT COMPLETED|Overall Study||8
7550386|NCT03103763|18583613|P1|NOT COMPLETED|Overall Study||15
7550387|NCT03103763|18583611|P3|COMPLETED|Overall Study||37
7550388|NCT03103763|18583612|P2|COMPLETED|Overall Study||36
7550389|NCT03103763|18583613|P1|COMPLETED|Overall Study||29
7550390|NCT03103763|18583611|P3|STARTED|Overall Study||44
7550391|NCT03103763|18583612|P2|STARTED|Overall Study||44
7550392|NCT03103763|18583613|P1|STARTED|Overall Study||44
7550393|NCT03103503|18583642|P1|NOT COMPLETED|Overall Study||901
7550394|NCT03103503|18583642|P1|COMPLETED|Overall Study||0
7550395|NCT03103503|18583642|P1|STARTED|Overall Study||901
7550396|NCT03103282|18583652|P1|NOT COMPLETED|Overall Study||0
7550397|NCT03103282|18583652|P1|COMPLETED|Overall Study||65
7550398|NCT03103282|18583652|P1|STARTED|Overall Study||65
7550399|NCT03103100|18583667|P3|NOT COMPLETED|Overall Study||2
7550400|NCT03103100|18583668|P2|NOT COMPLETED|Overall Study||0
7550401|NCT03103100|18583669|P1|NOT COMPLETED|Overall Study||2
7550402|NCT03103100|18583667|P3|COMPLETED|Overall Study||23
7550403|NCT03103100|18583668|P2|COMPLETED|Overall Study||25
7550404|NCT03103100|18583669|P1|COMPLETED|Overall Study||23
7550405|NCT03103100|18583667|P3|STARTED|Overall Study||25
7550406|NCT03103100|18583668|P2|STARTED|Overall Study||25
7550407|NCT03103100|18583669|P1|STARTED|Overall Study||25
7550408|NCT03103061|18583686|P1|NOT COMPLETED|Overall Study||0
7550409|NCT03103061|18583686|P1|COMPLETED|Overall Study||24
7550410|NCT03103061|18583686|P1|STARTED|Overall Study||24
7550411|NCT03102918|18583693|P2|NOT COMPLETED|Overall Study||0
7550412|NCT03102918|18583694|P1|NOT COMPLETED|Overall Study||1
7550413|NCT03102918|18583693|P2|COMPLETED|Overall Study||5
7550414|NCT03102918|18583694|P1|COMPLETED|Overall Study||4
7550415|NCT03102918|18583693|P2|STARTED|Overall Study||5
7550416|NCT03102918|18583694|P1|STARTED|Overall Study||5
7550417|NCT03102879|18583702|P2|NOT COMPLETED|Overall Study||0
7550418|NCT03102879|18583703|P1|NOT COMPLETED|Overall Study||0
7550419|NCT03102879|18583702|P2|COMPLETED|Overall Study||18
7550420|NCT03102879|18583703|P1|COMPLETED|Overall Study||18
7550421|NCT03102879|18583702|P2|STARTED|Overall Study||18
7550422|NCT03102879|18583703|P1|STARTED|Overall Study||18
7550423|NCT03102762|18583720|P2|NOT COMPLETED|Overall Study||0
7550424|NCT03102762|18583721|P1|NOT COMPLETED|Overall Study||1
7550425|NCT03102762|18583720|P2|COMPLETED|Overall Study||35
7550426|NCT03102762|18583721|P1|COMPLETED|Overall Study||34
7550427|NCT03102762|18583720|P2|STARTED|Overall Study||35
7550428|NCT03102762|18583721|P1|STARTED|Overall Study||35
7550429|NCT03102736|18583749|P2|NOT COMPLETED|Overall Study||0
7550430|NCT03102736|18583750|P1|NOT COMPLETED|Overall Study||0
7550431|NCT03102736|18583749|P2|COMPLETED|Overall Study||9
7550432|NCT03102736|18583750|P1|COMPLETED|Overall Study||7
7550433|NCT03102736|18583749|P2|STARTED|Overall Study||9
7550434|NCT03102736|18583750|P1|STARTED|Overall Study||7
7550435|NCT03102710|18583765|P3|NOT COMPLETED|Overall Study||0
7550436|NCT03102710|18583766|P2|NOT COMPLETED|Overall Study||3
7550437|NCT03102710|18583767|P1|NOT COMPLETED|Overall Study||1
7550438|NCT03102710|18583765|P3|COMPLETED|Overall Study||27
7550439|NCT03102710|18583766|P2|COMPLETED|Overall Study||27
7550440|NCT03102710|18583767|P1|COMPLETED|Overall Study||27
7550441|NCT03102710|18583765|P3|STARTED|Overall Study||27
7550442|NCT03102710|18583766|P2|STARTED|Overall Study||30
7550443|NCT03102710|18583767|P1|STARTED|Overall Study||28
7550444|NCT03102411|18583781|P1|NOT COMPLETED|Overall Study||163
7550445|NCT03102411|18583781|P1|COMPLETED|Overall Study||1718
7550446|NCT03102411|18583781|P1|STARTED|Overall Study||1881
7550447|NCT03102190|18583786|P1|NOT COMPLETED|Overall Study||0
7550448|NCT03102190|18583786|P1|COMPLETED|Overall Study||6
7550449|NCT03102190|18583786|P1|STARTED|Overall Study||6
7550450|NCT03102034|18583792|P2|NOT COMPLETED|Overall Study||0
7550451|NCT03102034|18583793|P1|NOT COMPLETED|Overall Study||1
7550452|NCT03102034|18583792|P2|COMPLETED|Overall Study||11
7550453|NCT03102034|18583793|P1|COMPLETED|Overall Study||20
7550454|NCT03102034|18583792|P2|STARTED|Overall Study||11
7550455|NCT03102034|18583793|P1|STARTED|Overall Study||21
7550456|NCT03101592|18583822|P3|NOT COMPLETED|Overall Study||118
7550457|NCT03101592|18583823|P2|NOT COMPLETED|Overall Study||170
7550458|NCT03101592|18583824|P1|NOT COMPLETED|Overall Study||111
7550459|NCT03101592|18583822|P3|COMPLETED|Overall Study||2981
7550460|NCT03101592|18583823|P2|COMPLETED|Overall Study||2726
7550461|NCT03101592|18583824|P1|COMPLETED|Overall Study||3012
7550462|NCT03101592|18583822|P3|STARTED|Overall Study||3099
7550463|NCT03101592|18583823|P2|STARTED|Overall Study||2896
7550464|NCT03101592|18583824|P1|STARTED|Overall Study||3123
7550465|NCT03101462|18583843|P2|NOT COMPLETED|Overall Study||1
7550466|NCT03101462|18583844|P1|NOT COMPLETED|Overall Study||1
7550467|NCT03101462|18583843|P2|COMPLETED|Overall Study||18
7550468|NCT03101462|18583844|P1|COMPLETED|Overall Study||18
7550469|NCT03101462|18583843|P2|STARTED|Overall Study||19
7550470|NCT03101462|18583844|P1|STARTED|Overall Study||19
7550471|NCT03101371|18583860|P2|NOT COMPLETED|Overall Study||6
7550472|NCT03101371|18583861|P1|NOT COMPLETED|Overall Study||3
7550473|NCT03101371|18583860|P2|COMPLETED|Overall Study||45
7550474|NCT03101371|18583861|P1|COMPLETED|Overall Study||45
7550475|NCT03101371|18583860|P2|STARTED|Overall Study||51
7550476|NCT03101371|18583861|P1|STARTED|Overall Study||48
7550477|NCT03101293|18583881|P2|NOT COMPLETED|Intervention Period 2||0
7550478|NCT03101293|18583882|P1|NOT COMPLETED|Intervention Period 2||0
7550479|NCT03101293|18583881|P2|COMPLETED|Intervention Period 2||8
7550480|NCT03101293|18583882|P1|COMPLETED|Intervention Period 2||6
7550481|NCT03101293|18583881|P2|STARTED|Intervention Period 2||8
7550482|NCT03101293|18583882|P1|STARTED|Intervention Period 2||6
7550483|NCT03101293|18583881|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7550484|NCT03101293|18583882|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||1
7550485|NCT03101293|18583881|P2|COMPLETED|Washout Period (at Least 7 Days)||8
7550486|NCT03101293|18583882|P1|COMPLETED|Washout Period (at Least 7 Days)||6
7550487|NCT03101293|18583881|P2|STARTED|Washout Period (at Least 7 Days)||8
7550488|NCT03101293|18583882|P1|STARTED|Washout Period (at Least 7 Days)||7
7550489|NCT03101293|18583881|P2|NOT COMPLETED|Intervention Period 1||0
7550490|NCT03101293|18583882|P1|NOT COMPLETED|Intervention Period 1||0
7550491|NCT03101293|18583881|P2|COMPLETED|Intervention Period 1||8
7550492|NCT03101293|18583882|P1|COMPLETED|Intervention Period 1||7
7550493|NCT03101293|18583881|P2|STARTED|Intervention Period 1||8
7550494|NCT03101293|18583882|P1|STARTED|Intervention Period 1||7
7550495|NCT03101267|18583897|P3|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
7550496|NCT03101267|18583898|P2|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
7550497|NCT03101267|18583899|P1|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
7550498|NCT03101267|18583897|P3|COMPLETED|Pollinosis Symptoms Survey Period||47
7550499|NCT03101267|18583898|P2|COMPLETED|Pollinosis Symptoms Survey Period||48
7550500|NCT03101267|18583899|P1|COMPLETED|Pollinosis Symptoms Survey Period||47
7550501|NCT03101267|18583897|P3|STARTED|Pollinosis Symptoms Survey Period||47
7550502|NCT03101267|18583898|P2|STARTED|Pollinosis Symptoms Survey Period||48
7550503|NCT03101267|18583899|P1|STARTED|Pollinosis Symptoms Survey Period||47
7550504|NCT03101267|18583897|P3|NOT COMPLETED|Primary Study Period||3
7550505|NCT03101267|18583898|P2|NOT COMPLETED|Primary Study Period||2
7550506|NCT03101267|18583899|P1|NOT COMPLETED|Primary Study Period||3
7550507|NCT03101267|18583897|P3|COMPLETED|Primary Study Period||47
7550508|NCT03101267|18583898|P2|COMPLETED|Primary Study Period||48
7550509|NCT03101267|18583899|P1|COMPLETED|Primary Study Period||47
7550510|NCT03101267|18583897|P3|STARTED|Primary Study Period||50
7550511|NCT03101267|18583898|P2|STARTED|Primary Study Period||50
7550512|NCT03101267|18583899|P1|STARTED|Primary Study Period||50
7550513|NCT03101150|18583954|P2|NOT COMPLETED|Overall Study||10
7550514|NCT03101150|18583955|P1|NOT COMPLETED|Overall Study||5
7550515|NCT03101150|18583954|P2|COMPLETED|Overall Study||83
7550516|NCT03101150|18583955|P1|COMPLETED|Overall Study||81
7550517|NCT03101150|18583954|P2|STARTED|Overall Study||93
7550518|NCT03101150|18583955|P1|STARTED|Overall Study||86
7550519|NCT03101033|18583967|P2|NOT COMPLETED|Overall Study||9
7550520|NCT03101033|18583968|P1|NOT COMPLETED|Overall Study||5
7550521|NCT03101033|18583967|P2|COMPLETED|Overall Study||51
7550522|NCT03101033|18583968|P1|COMPLETED|Overall Study||27
7550523|NCT03101033|18583967|P2|STARTED|Overall Study||60
7550524|NCT03101033|18583968|P1|STARTED|Overall Study||32
7550525|NCT03101020|18583990|P2|NOT COMPLETED|Overall Study||3
7550526|NCT03101020|18583991|P1|NOT COMPLETED|Overall Study||1
7550527|NCT03101020|18583990|P2|COMPLETED|Overall Study||7
7550528|NCT03101020|18583991|P1|COMPLETED|Overall Study||9
7550529|NCT03101020|18583990|P2|STARTED|Overall Study||10
7550530|NCT03101020|18583991|P1|STARTED|Overall Study||10
7550531|NCT03100968|18584005|P2|NOT COMPLETED|Overall Study||0
7550532|NCT03100968|18584006|P1|NOT COMPLETED|Overall Study||0
7550533|NCT03100968|18584005|P2|COMPLETED|Overall Study||75
7550534|NCT03100968|18584006|P1|COMPLETED|Overall Study||75
7550535|NCT03100968|18584005|P2|STARTED|Overall Study||75
7550536|NCT03100968|18584006|P1|STARTED|Overall Study||75
7550537|NCT03100942|18584026|P7|NOT COMPLETED|Placebo Arm Re-Randomized||1
7550538|NCT03100942|18584027|P6|NOT COMPLETED|Placebo Arm Re-Randomized||0
7550539|NCT03100942|18584028|P5|NOT COMPLETED|Placebo Arm Re-Randomized||0
7550540|NCT03100942|18584029|P4|NOT COMPLETED|Placebo Arm Re-Randomized||0
7550541|NCT03100942|18584030|P3|NOT COMPLETED|Placebo Arm Re-Randomized||0
7550542|NCT03100942|18584031|P2|NOT COMPLETED|Placebo Arm Re-Randomized||0
7550543|NCT03100942|18584032|P1|NOT COMPLETED|Placebo Arm Re-Randomized||0
7550544|NCT03100942|18584026|P7|COMPLETED|Placebo Arm Re-Randomized||9
7550545|NCT03100942|18584027|P6|COMPLETED|Placebo Arm Re-Randomized||12
7550546|NCT03100942|18584028|P5|COMPLETED|Placebo Arm Re-Randomized||10
7550547|NCT03100942|18584029|P4|COMPLETED|Placebo Arm Re-Randomized||0
7550548|NCT03100942|18584030|P3|COMPLETED|Placebo Arm Re-Randomized||0
7550549|NCT03100942|18584031|P2|COMPLETED|Placebo Arm Re-Randomized||0
7550550|NCT03100942|18584032|P1|COMPLETED|Placebo Arm Re-Randomized||0
7550551|NCT03100942|18584026|P7|STARTED|Placebo Arm Re-Randomized||10
7550552|NCT03100942|18584027|P6|STARTED|Placebo Arm Re-Randomized||12
7550553|NCT03100942|18584028|P5|STARTED|Placebo Arm Re-Randomized||10
7550554|NCT03100942|18584029|P4|STARTED|Placebo Arm Re-Randomized||0
7550555|NCT03100942|18584030|P3|STARTED|Placebo Arm Re-Randomized||0
7550556|NCT03100942|18584031|P2|STARTED|Placebo Arm Re-Randomized||0
7550557|NCT03100942|18584032|P1|STARTED|Placebo Arm Re-Randomized||0
7550558|NCT03100942|18584026|P7|NOT COMPLETED|Randomized Treatment Period||0
7550559|NCT03100942|18584027|P6|NOT COMPLETED|Randomized Treatment Period||0
7550560|NCT03100942|18584028|P5|NOT COMPLETED|Randomized Treatment Period||0
7550561|NCT03100942|18584029|P4|NOT COMPLETED|Randomized Treatment Period||5
7550562|NCT03100942|18584030|P3|NOT COMPLETED|Randomized Treatment Period||6
7550563|NCT03100942|18584031|P2|NOT COMPLETED|Randomized Treatment Period||9
7550564|NCT03100942|18584032|P1|NOT COMPLETED|Randomized Treatment Period||12
7550565|NCT03100942|18584026|P7|COMPLETED|Randomized Treatment Period||0
7550566|NCT03100942|18584027|P6|COMPLETED|Randomized Treatment Period||0
7550567|NCT03100942|18584028|P5|COMPLETED|Randomized Treatment Period||0
7550568|NCT03100942|18584029|P4|COMPLETED|Randomized Treatment Period||32
7550569|NCT03100942|18584030|P3|COMPLETED|Randomized Treatment Period||33
7550570|NCT03100942|18584031|P2|COMPLETED|Randomized Treatment Period||29
7550571|NCT03100942|18584032|P1|COMPLETED|Randomized Treatment Period||26
7550572|NCT03100942|18584026|P7|STARTED|Randomized Treatment Period||0
7550573|NCT03100942|18584027|P6|STARTED|Randomized Treatment Period||0
7550574|NCT03100942|18584028|P5|STARTED|Randomized Treatment Period||0
7550575|NCT03100942|18584029|P4|STARTED|Randomized Treatment Period||37
7550576|NCT03100942|18584030|P3|STARTED|Randomized Treatment Period||39
7550577|NCT03100942|18584031|P2|STARTED|Randomized Treatment Period||38
7550578|NCT03100942|18584032|P1|STARTED|Randomized Treatment Period||38
7550579|NCT03100864|18584061|P1|NOT COMPLETED|Overall Study||0
7550580|NCT03100864|18584061|P1|COMPLETED|Overall Study||8
7550581|NCT03100864|18584061|P1|STARTED|Overall Study||8
7550582|NCT03100838|18584070|P4|NOT COMPLETED|Overall Study||1
7550583|NCT03100838|18584071|P3|NOT COMPLETED|Overall Study||2
7550584|NCT03100838|18584072|P2|NOT COMPLETED|Overall Study||2
7550585|NCT03100838|18584073|P1|NOT COMPLETED|Overall Study||2
7550586|NCT03100838|18584070|P4|COMPLETED|Overall Study||15
7550587|NCT03100838|18584071|P3|COMPLETED|Overall Study||14
7550588|NCT03100838|18584072|P2|COMPLETED|Overall Study||14
7550589|NCT03100838|18584073|P1|COMPLETED|Overall Study||14
7550590|NCT03100838|18584070|P4|STARTED|Overall Study||16
7550591|NCT03100838|18584071|P3|STARTED|Overall Study||16
7550592|NCT03100838|18584072|P2|STARTED|Overall Study||16
7550593|NCT03100838|18584073|P1|STARTED|Overall Study||16
7550594|NCT03100825|18584099|P1|NOT COMPLETED|Overall Study||8
7550595|NCT03100825|18584099|P1|COMPLETED|Overall Study||86
7550596|NCT03100825|18584099|P1|STARTED|Overall Study||94
7550597|NCT03100617|18584109|P1|NOT COMPLETED|Overall Study||0
7550598|NCT03100617|18584109|P1|COMPLETED|Overall Study||6
7550599|NCT03100617|18584109|P1|STARTED|Overall Study||6
7550600|NCT03100500|18584113|P1|NOT COMPLETED|Overall Study||0
7550601|NCT03100500|18584113|P1|COMPLETED|Overall Study||51
7550602|NCT03100500|18584113|P1|STARTED|Overall Study||51
7550603|NCT03100344|18584126|P4|NOT COMPLETED|Overall Study||12
7550604|NCT03100344|18584127|P3|NOT COMPLETED|Overall Study||7
7550605|NCT03100344|18584128|P2|NOT COMPLETED|Overall Study||11
7550606|NCT03100344|18584129|P1|NOT COMPLETED|Overall Study||14
7550607|NCT03100344|18584126|P4|COMPLETED|Overall Study||45
7550608|NCT03100344|18584127|P3|COMPLETED|Overall Study||50
7550609|NCT03100344|18584128|P2|COMPLETED|Overall Study||44
7550610|NCT03100344|18584129|P1|COMPLETED|Overall Study||43
7550611|NCT03100344|18584126|P4|STARTED|Overall Study||57
7550612|NCT03100344|18584127|P3|STARTED|Overall Study||57
7550613|NCT03100344|18584128|P2|STARTED|Overall Study||55
7550614|NCT03100344|18584129|P1|STARTED|Overall Study||57
7550615|NCT03100123|18584209|P2|NOT COMPLETED|Overall Study||0
7550616|NCT03100123|18584210|P1|NOT COMPLETED|Overall Study||0
7550617|NCT03100123|18584209|P2|COMPLETED|Overall Study||1
7550618|NCT03100123|18584210|P1|COMPLETED|Overall Study||0
7550619|NCT03100123|18584209|P2|STARTED|Overall Study||1
7550620|NCT03100123|18584210|P1|STARTED|Overall Study||0
7550621|NCT03100058|18584232|P13|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||4
7550622|NCT03100058|18584233|P12|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||3
7550623|NCT03100058|18584234|P11|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||15
7550624|NCT03100058|18584235|P10|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||5
7550625|NCT03100058|18584236|P9|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
7550626|NCT03100058|18584237|P8|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
7550627|NCT03100058|18584238|P7|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
7550628|NCT03100058|18584239|P6|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
7550629|NCT03100058|18584240|P5|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
7550630|NCT03100058|18584241|P4|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
7550631|NCT03100058|18584242|P3|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
7550632|NCT03100058|18584243|P2|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
7550633|NCT03100058|18584244|P1|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
7550634|NCT03100058|18584232|P13|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||30
7550635|NCT03100058|18584233|P12|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||36
7550636|NCT03100058|18584234|P11|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||148
7550637|NCT03100058|18584235|P10|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||153
7550638|NCT03100058|18584236|P9|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
7550639|NCT03100058|18584237|P8|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
7550640|NCT03100058|18584238|P7|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
7550641|NCT03100058|18584239|P6|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
7550642|NCT03100058|18584240|P5|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
7550643|NCT03100058|18584241|P4|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
7550644|NCT03100058|18584242|P3|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
7550645|NCT03100058|18584243|P2|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
7550646|NCT03100058|18584244|P1|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
7550647|NCT03100058|18584232|P13|STARTED|Epoch 4 (Last 24 Weeks of the Study)||34
7550648|NCT03100058|18584233|P12|STARTED|Epoch 4 (Last 24 Weeks of the Study)||39
7550649|NCT03100058|18584234|P11|STARTED|Epoch 4 (Last 24 Weeks of the Study)||163
7550650|NCT03100058|18584235|P10|STARTED|Epoch 4 (Last 24 Weeks of the Study)||158
7550651|NCT03100058|18584236|P9|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
7550652|NCT03100058|18584237|P8|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
7550653|NCT03100058|18584238|P7|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
7550654|NCT03100058|18584239|P6|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
7550655|NCT03100058|18584240|P5|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
7550656|NCT03100058|18584241|P4|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
7550657|NCT03100058|18584242|P3|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
7550658|NCT03100058|18584243|P2|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
7550659|NCT03100058|18584244|P1|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
7550660|NCT03100058|18584232|P13|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
7550661|NCT03100058|18584233|P12|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
7550662|NCT03100058|18584234|P11|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
7550663|NCT03100058|18584235|P10|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
7550664|NCT03100058|18584236|P9|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||5
7550665|NCT03100058|18584237|P8|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||16
7550666|NCT03100058|18584238|P7|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||8
7550667|NCT03100058|18584239|P6|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
7550668|NCT03100058|18584240|P5|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
7550669|NCT03100058|18584241|P4|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||14
7550670|NCT03100058|18584242|P3|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||9
7550671|NCT03100058|18584243|P2|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||7
7550672|NCT03100058|18584244|P1|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||3
7550673|NCT03100058|18584232|P13|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
7550674|NCT03100058|18584233|P12|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
7550675|NCT03100058|18584234|P11|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
7550676|NCT03100058|18584235|P10|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
7550677|NCT03100058|18584236|P9|COMPLETED|Epoch 3 (24 Weeks of Treatment)||73
7550678|NCT03100058|18584237|P8|COMPLETED|Epoch 3 (24 Weeks of Treatment)||60
7550679|NCT03100058|18584238|P7|COMPLETED|Epoch 3 (24 Weeks of Treatment)||30
7550680|NCT03100058|18584239|P6|COMPLETED|Epoch 3 (24 Weeks of Treatment)||37
7550681|NCT03100058|18584240|P5|COMPLETED|Epoch 3 (24 Weeks of Treatment)||36
7550682|NCT03100058|18584241|P4|COMPLETED|Epoch 3 (24 Weeks of Treatment)||63
7550683|NCT03100058|18584242|P3|COMPLETED|Epoch 3 (24 Weeks of Treatment)||29
7550684|NCT03100058|18584243|P2|COMPLETED|Epoch 3 (24 Weeks of Treatment)||31
7550685|NCT03100058|18584244|P1|COMPLETED|Epoch 3 (24 Weeks of Treatment)||35
7550686|NCT03100058|18584232|P13|STARTED|Epoch 3 (24 Weeks of Treatment)||0
7550687|NCT03100058|18584233|P12|STARTED|Epoch 3 (24 Weeks of Treatment)||0
7550688|NCT03100058|18584234|P11|STARTED|Epoch 3 (24 Weeks of Treatment)||0
7550689|NCT03100058|18584235|P10|STARTED|Epoch 3 (24 Weeks of Treatment)||0
7550690|NCT03100058|18584236|P9|STARTED|Epoch 3 (24 Weeks of Treatment)||78
7550691|NCT03100058|18584237|P8|STARTED|Epoch 3 (24 Weeks of Treatment)||76
7550692|NCT03100058|18584238|P7|STARTED|Epoch 3 (24 Weeks of Treatment)||38
7550693|NCT03100058|18584239|P6|STARTED|Epoch 3 (24 Weeks of Treatment)||39
7550694|NCT03100058|18584240|P5|STARTED|Epoch 3 (24 Weeks of Treatment)||38
7550695|NCT03100058|18584241|P4|STARTED|Epoch 3 (24 Weeks of Treatment)||77
7550696|NCT03100058|18584242|P3|STARTED|Epoch 3 (24 Weeks of Treatment)||38
7550697|NCT03100058|18584243|P2|STARTED|Epoch 3 (24 Weeks of Treatment)||38
7550698|NCT03100058|18584244|P1|STARTED|Epoch 3 (24 Weeks of Treatment)||38
7550699|NCT03099694|18584451|P2|NOT COMPLETED|Overall Study||18
7550700|NCT03099694|18584452|P1|NOT COMPLETED|Overall Study||20
7550701|NCT03099694|18584451|P2|COMPLETED|Overall Study||152
7550702|NCT03099694|18584452|P1|COMPLETED|Overall Study||150
7550703|NCT03099694|18584451|P2|STARTED|Overall Study||170
7550704|NCT03099694|18584452|P1|STARTED|Overall Study||170
7550705|NCT03099655|18584480|P1|NOT COMPLETED|Overall Study||61
7550706|NCT03099655|18584480|P1|COMPLETED|Overall Study|6-Month visit with original 4798 lead implanted|379
7550707|NCT03099655|18584480|P1|STARTED|Overall Study||440
7550708|NCT03099538|18584491|P1|NOT COMPLETED|Overall Study||3
7550709|NCT03099538|18584491|P1|COMPLETED|Overall Study||1
7550710|NCT03099538|18584491|P1|STARTED|Overall Study||4
7550711|NCT03099369|18584503|P2|NOT COMPLETED|Overall Study||4
7550712|NCT03099369|18584504|P1|NOT COMPLETED|Overall Study||6
7550713|NCT03099369|18584503|P2|COMPLETED|Overall Study||5
7550714|NCT03099369|18584504|P1|COMPLETED|Overall Study||5
7550715|NCT03099369|18584503|P2|STARTED|Overall Study||9
7550716|NCT03099369|18584504|P1|STARTED|Overall Study||11
7550717|NCT03099187|18584516|P2|NOT COMPLETED|Overall Study||34
7550718|NCT03099187|18584517|P1|NOT COMPLETED|Overall Study||43
7550719|NCT03099187|18584516|P2|COMPLETED|Overall Study||92
7550720|NCT03099187|18584517|P1|COMPLETED|Overall Study||84
7550721|NCT03099187|18584516|P2|STARTED|Overall Study||126
7550722|NCT03099187|18584517|P1|STARTED|Overall Study||127
7550723|NCT03099161|18584566|P3|NOT COMPLETED|Overall Study||3
7550724|NCT03099161|18584567|P2|NOT COMPLETED|Overall Study||4
7550725|NCT03099161|18584568|P1|NOT COMPLETED|Overall Study||3
7550726|NCT03099161|18584566|P3|COMPLETED|Overall Study||0
7550727|NCT03099161|18584567|P2|COMPLETED|Overall Study||0
7550728|NCT03099161|18584568|P1|COMPLETED|Overall Study||0
7550729|NCT03099161|18584566|P3|STARTED|Overall Study||3
7550730|NCT03099161|18584567|P2|STARTED|Overall Study||4
7550731|NCT03099161|18584568|P1|STARTED|Overall Study||3
7550732|NCT03099096|18584585|P1|NOT COMPLETED|Overall Study||2
7550733|NCT03099096|18584585|P1|COMPLETED|Overall Study||157
7550734|NCT03099096|18584585|P1|STARTED|Overall Study||159
7550735|NCT03098979|18584598|P6|NOT COMPLETED|Overall Study||4
7550736|NCT03098979|18584599|P5|NOT COMPLETED|Overall Study||9
7550737|NCT03098979|18584600|P4|NOT COMPLETED|Overall Study||5
7550738|NCT03098979|18584601|P3|NOT COMPLETED|Overall Study||4
7550739|NCT03098979|18584602|P2|NOT COMPLETED|Overall Study||2
7550740|NCT03098979|18584603|P1|NOT COMPLETED|Overall Study||6
7550741|NCT03098979|18584598|P6|COMPLETED|Overall Study||47
7550742|NCT03098979|18584599|P5|COMPLETED|Overall Study||41
7550743|NCT03098979|18584600|P4|COMPLETED|Overall Study||46
7550744|NCT03098979|18584601|P3|COMPLETED|Overall Study||46
7550745|NCT03098979|18584602|P2|COMPLETED|Overall Study||25
7550746|NCT03098979|18584603|P1|COMPLETED|Overall Study||70
7550747|NCT03098979|18584598|P6|STARTED|Overall Study||51
7550748|NCT03098979|18584599|P5|STARTED|Overall Study||50
7550749|NCT03098979|18584600|P4|STARTED|Overall Study||51
7550750|NCT03098979|18584601|P3|STARTED|Overall Study||50
7550751|NCT03098979|18584602|P2|STARTED|Overall Study||27
7550752|NCT03098979|18584603|P1|STARTED|Overall Study||76
7550753|NCT03098966|18584641|P1|NOT COMPLETED|Overall Study||0
7550754|NCT03098966|18584641|P1|COMPLETED|Overall Study||368
7550755|NCT03098966|18584641|P1|STARTED|Overall Study||368
7550756|NCT03098745|18584647|P6|NOT COMPLETED|Day 3||0
7550757|NCT03098745|18584648|P5|NOT COMPLETED|Day 3||0
7550758|NCT03098745|18584649|P4|NOT COMPLETED|Day 3||0
7550759|NCT03098745|18584650|P3|NOT COMPLETED|Day 3||0
7550760|NCT03098745|18584651|P2|NOT COMPLETED|Day 3||0
7550761|NCT03098745|18584652|P1|NOT COMPLETED|Day 3||0
7550762|NCT03098745|18584647|P6|COMPLETED|Day 3||4
7550763|NCT03098745|18584648|P5|COMPLETED|Day 3||10
7550764|NCT03098745|18584649|P4|COMPLETED|Day 3||8
7550765|NCT03098745|18584650|P3|COMPLETED|Day 3||8
7550766|NCT03098745|18584651|P2|COMPLETED|Day 3||3
7550767|NCT03098745|18584652|P1|COMPLETED|Day 3||7
7550768|NCT03098745|18584647|P6|STARTED|Day 3||4
7550769|NCT03098745|18584648|P5|STARTED|Day 3||10
7550770|NCT03098745|18584649|P4|STARTED|Day 3||8
7550771|NCT03098745|18584650|P3|STARTED|Day 3||8
7550772|NCT03098745|18584651|P2|STARTED|Day 3||3
7550773|NCT03098745|18584652|P1|STARTED|Day 3||7
7550774|NCT03098745|18584647|P6|NOT COMPLETED|Day 2||0
7550775|NCT03098745|18584648|P5|NOT COMPLETED|Day 2||0
7550776|NCT03098745|18584649|P4|NOT COMPLETED|Day 2||0
7550777|NCT03098745|18584650|P3|NOT COMPLETED|Day 2||0
7550778|NCT03098745|18584651|P2|NOT COMPLETED|Day 2||0
7550779|NCT03098745|18584652|P1|NOT COMPLETED|Day 2||0
7550780|NCT03098745|18584647|P6|COMPLETED|Day 2||4
7550781|NCT03098745|18584648|P5|COMPLETED|Day 2||10
7550782|NCT03098745|18584649|P4|COMPLETED|Day 2||8
7550783|NCT03098745|18584650|P3|COMPLETED|Day 2||8
7550784|NCT03098745|18584651|P2|COMPLETED|Day 2||3
7550785|NCT03098745|18584652|P1|COMPLETED|Day 2||7
7550786|NCT03098745|18584647|P6|STARTED|Day 2||4
7550787|NCT03098745|18584648|P5|STARTED|Day 2||10
7550788|NCT03098745|18584649|P4|STARTED|Day 2||8
7550789|NCT03098745|18584650|P3|STARTED|Day 2||8
7550790|NCT03098745|18584651|P2|STARTED|Day 2||3
7550791|NCT03098745|18584652|P1|STARTED|Day 2||7
7550792|NCT03098745|18584647|P6|NOT COMPLETED|Day 1||0
7550793|NCT03098745|18584648|P5|NOT COMPLETED|Day 1||0
7550794|NCT03098745|18584649|P4|NOT COMPLETED|Day 1||0
7550795|NCT03098745|18584650|P3|NOT COMPLETED|Day 1||0
7550796|NCT03098745|18584651|P2|NOT COMPLETED|Day 1||0
7550797|NCT03098745|18584652|P1|NOT COMPLETED|Day 1||0
7550798|NCT03098745|18584647|P6|COMPLETED|Day 1||4
7550799|NCT03098745|18584648|P5|COMPLETED|Day 1||10
7550800|NCT03098745|18584649|P4|COMPLETED|Day 1||8
7550801|NCT03098745|18584650|P3|COMPLETED|Day 1||8
7550802|NCT03098745|18584651|P2|COMPLETED|Day 1||3
7550803|NCT03098745|18584652|P1|COMPLETED|Day 1||7
7550804|NCT03098745|18584647|P6|STARTED|Day 1||4
7550805|NCT03098745|18584648|P5|STARTED|Day 1||10
7550806|NCT03098745|18584649|P4|STARTED|Day 1||8
7550807|NCT03098745|18584650|P3|STARTED|Day 1||8
7550808|NCT03098745|18584651|P2|STARTED|Day 1||3
7550809|NCT03098745|18584652|P1|STARTED|Day 1||7
7550810|NCT03098641|18584688|P1|NOT COMPLETED|Overall Study||52
7550811|NCT03098641|18584688|P1|COMPLETED|Overall Study||220
7550812|NCT03098641|18584688|P1|STARTED|Overall Study||272
7550813|NCT03098615|18584706|P1|NOT COMPLETED|Overall Study||2
7550814|NCT03098615|18584706|P1|COMPLETED|Overall Study||17
7550815|NCT03098615|18584706|P1|STARTED|Overall Study||19
7550816|NCT03098173|18584713|P2|NOT COMPLETED|Overall Study||2
7550817|NCT03098173|18584714|P1|NOT COMPLETED|Overall Study||1
7550818|NCT03098173|18584713|P2|COMPLETED|Overall Study||79
7550819|NCT03098173|18584714|P1|COMPLETED|Overall Study||80
7550820|NCT03098173|18584713|P2|STARTED|Overall Study||81
7550821|NCT03098173|18584714|P1|STARTED|Overall Study||81
7550822|NCT03098030|18584746|P4|NOT COMPLETED|Overall Study||85
7550823|NCT03098030|18584747|P3|NOT COMPLETED|Overall Study||166
7550824|NCT03098030|18584748|P2|NOT COMPLETED|Overall Study||163
7550825|NCT03098030|18584749|P1|NOT COMPLETED|Overall Study||10
7550826|NCT03098030|18584746|P4|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|9
7550827|NCT03098030|18584747|P3|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24
7550828|NCT03098030|18584748|P2|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24
7550829|NCT03098030|18584749|P1|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|2
7550830|NCT03098030|18584746|P4|STARTED|Overall Study||94
7550831|NCT03098030|18584747|P3|STARTED|Overall Study||190
7550832|NCT03098030|18584748|P2|STARTED|Overall Study||187
7550833|NCT03098030|18584749|P1|STARTED|Overall Study||12
7550834|NCT03097861|18584770|P3|NOT COMPLETED|Overall Study||9
7550835|NCT03097861|18584771|P2|NOT COMPLETED|Overall Study||22
7550836|NCT03097861|18584772|P1|NOT COMPLETED|Overall Study||7
7550837|NCT03097861|18584770|P3|COMPLETED|Overall Study||122
7550838|NCT03097861|18584771|P2|COMPLETED|Overall Study||254
7550839|NCT03097861|18584772|P1|COMPLETED|Overall Study||138
7550840|NCT03097861|18584770|P3|Per-protocol Population (PP)|Overall Study||113
7550841|NCT03097861|18584771|P2|Per-protocol Population (PP)|Overall Study||234
7550842|NCT03097861|18584772|P1|Per-protocol Population (PP)|Overall Study||126
7550843|NCT03097861|18584770|P3|Completers|Overall Study||121
7550844|NCT03097861|18584771|P2|Completers|Overall Study||255
7550845|NCT03097861|18584772|P1|Completers|Overall Study||129
7550846|NCT03097861|18584770|P3|Modified Intent to Treat|Overall Study||130
7550847|NCT03097861|18584771|P2|Modified Intent to Treat|Overall Study||275
7550848|NCT03097861|18584772|P1|Modified Intent to Treat|Overall Study||143
7550849|NCT03097861|18584770|P3|Safety Population|Overall Study||130
7550850|NCT03097861|18584771|P2|Safety Population|Overall Study||275
7550851|NCT03097861|18584772|P1|Safety Population|Overall Study||143
7550852|NCT03097861|18584770|P3|STARTED|Overall Study||131
7550853|NCT03097861|18584771|P2|STARTED|Overall Study||276
7550854|NCT03097861|18584772|P1|STARTED|Overall Study||145
7550855|NCT03097614|18584789|P1|NOT COMPLETED|Overall Study||3
7550856|NCT03097614|18584789|P1|COMPLETED|Overall Study||54
7550857|NCT03097614|18584789|P1|STARTED|Overall Study||57
7550858|NCT03097484|18584795|P2|NOT COMPLETED|Overall Study||0
7550859|NCT03097484|18584796|P1|NOT COMPLETED|Overall Study||0
7550860|NCT03097484|18584795|P2|COMPLETED|Overall Study||19
7550861|NCT03097484|18584796|P1|COMPLETED|Overall Study||19
7550862|NCT03097484|18584795|P2|STARTED|Overall Study||19
7550863|NCT03097484|18584796|P1|STARTED|Overall Study||19
7550864|NCT03097341|18584809|P5|NOT COMPLETED|Overall Study||0
7550865|NCT03097341|18584810|P4|NOT COMPLETED|Overall Study||0
7550866|NCT03097341|18584811|P3|NOT COMPLETED|Overall Study||0
7550867|NCT03097341|18584812|P2|NOT COMPLETED|Overall Study||0
7550868|NCT03097341|18584813|P1|NOT COMPLETED|Overall Study||0
7550869|NCT03097341|18584809|P5|COMPLETED|Overall Study||5
7550870|NCT03097341|18584810|P4|COMPLETED|Overall Study||4
7550871|NCT03097341|18584811|P3|COMPLETED|Overall Study||4
7550872|NCT03097341|18584812|P2|COMPLETED|Overall Study||4
7550873|NCT03097341|18584813|P1|COMPLETED|Overall Study||4
7550874|NCT03097341|18584809|P5|STARTED|Overall Study||5
7550875|NCT03097341|18584810|P4|STARTED|Overall Study||4
7550876|NCT03097341|18584811|P3|STARTED|Overall Study||4
7550877|NCT03097341|18584812|P2|STARTED|Overall Study||4
7550878|NCT03097341|18584813|P1|STARTED|Overall Study||4
7550879|NCT03097289|18584891|P1|NOT COMPLETED|Overall Study||6
7550880|NCT03097289|18584891|P1|COMPLETED|Overall Study||26
7550881|NCT03097289|18584891|P1|STARTED|Overall Study||32
7550882|NCT03097133|18584900|P2|NOT COMPLETED|Overall Study||34
7550883|NCT03097133|18584901|P1|NOT COMPLETED|Overall Study||30
7550884|NCT03097133|18584900|P2|COMPLETED|Overall Study||81
7550885|NCT03097133|18584901|P1|COMPLETED|Overall Study||85
7550886|NCT03097133|18584900|P2|Treated|Overall Study||114
7550887|NCT03097133|18584901|P1|Treated|Overall Study||113
7550888|NCT03097133|18584900|P2|STARTED|Overall Study||115
7550889|NCT03097133|18584901|P1|STARTED|Overall Study||115
7550890|NCT03097029|18584951|P1|NOT COMPLETED|Overall Study||1
7550891|NCT03097029|18584951|P1|COMPLETED|Overall Study||14
7550892|NCT03097029|18584951|P1|STARTED|Overall Study||15
7550893|NCT03096873|18584958|P2|NOT COMPLETED|Overall Study||0
7550894|NCT03096873|18584959|P1|NOT COMPLETED|Overall Study||0
7550895|NCT03096873|18584958|P2|COMPLETED|Overall Study||20
7550896|NCT03096873|18584959|P1|COMPLETED|Overall Study||20
7550897|NCT03096873|18584958|P2|STARTED|Overall Study||20
7550898|NCT03096873|18584959|P1|STARTED|Overall Study||20
7550899|NCT03096483|18584995|P1|NOT COMPLETED|Overall Study||1
7550900|NCT03096483|18584995|P1|COMPLETED|Overall Study||11
7550901|NCT03096483|18584995|P1|STARTED|Overall Study||12
7550902|NCT03096444|18585000|P1|NOT COMPLETED|Overall Study||0
7550903|NCT03096444|18585000|P1|COMPLETED|Overall Study||13
7550904|NCT03096444|18585000|P1|STARTED|Overall Study||13
7550905|NCT03096314|18585024|P2|NOT COMPLETED|Confirmed Vitamin D Deficient||12
7550906|NCT03096314|18585025|P1|NOT COMPLETED|Confirmed Vitamin D Deficient||7
7550907|NCT03096314|18585024|P2|COMPLETED|Confirmed Vitamin D Deficient||528
7550908|NCT03096314|18585025|P1|COMPLETED|Confirmed Vitamin D Deficient||531
7550909|NCT03096314|18585024|P2|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|540
7550910|NCT03096314|18585025|P1|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|538
7550911|NCT03096314|18585024|P2|NOT COMPLETED|Screened Vitamin D Deficient||12
7550912|NCT03096314|18585025|P1|NOT COMPLETED|Screened Vitamin D Deficient||9
7550913|NCT03096314|18585024|P2|COMPLETED|Screened Vitamin D Deficient||656
7550914|NCT03096314|18585025|P1|COMPLETED|Screened Vitamin D Deficient||681
7550915|NCT03096314|18585024|P2|STARTED|Screened Vitamin D Deficient|2 randomized but not included in analysis; 1 treated but inadequate consent and 1 withdrew.|668
7550916|NCT03096314|18585025|P1|STARTED|Screened Vitamin D Deficient||690
7550917|NCT03095885|18585073|P1|NOT COMPLETED|Overall Study||0
7550918|NCT03095885|18585073|P1|COMPLETED|Overall Study||22
7550919|NCT03095885|18585073|P1|STARTED|Overall Study||22
7550920|NCT03095651|18585087|P8|NOT COMPLETED|Overall Study||0
7550921|NCT03095651|18585088|P7|NOT COMPLETED|Overall Study||0
7550922|NCT03095651|18585089|P6|NOT COMPLETED|Overall Study||1
7550923|NCT03095651|18585090|P5|NOT COMPLETED|Overall Study||0
7550924|NCT03095651|18585091|P4|NOT COMPLETED|Overall Study||1
7550925|NCT03095651|18585092|P3|NOT COMPLETED|Overall Study||0
7550926|NCT03095651|18585093|P2|NOT COMPLETED|Overall Study||1
7550927|NCT03095651|18585094|P1|NOT COMPLETED|Overall Study||1
7550928|NCT03095651|18585087|P8|COMPLETED|Overall Study||4
7550929|NCT03095651|18585088|P7|COMPLETED|Overall Study||6
7550930|NCT03095651|18585089|P6|COMPLETED|Overall Study||6
7550931|NCT03095651|18585090|P5|COMPLETED|Overall Study||0
7550932|NCT03095651|18585091|P4|COMPLETED|Overall Study||3
7550933|NCT03095651|18585092|P3|COMPLETED|Overall Study||0
7550934|NCT03095651|18585093|P2|COMPLETED|Overall Study||5
7550935|NCT03095651|18585094|P1|COMPLETED|Overall Study||5
7550936|NCT03095651|18585087|P8|STARTED|Overall Study||4
7550937|NCT03095651|18585088|P7|STARTED|Overall Study||6
7550938|NCT03095651|18585089|P6|STARTED|Overall Study||7
7550939|NCT03095651|18585090|P5|STARTED|Overall Study||0
7550940|NCT03095651|18585091|P4|STARTED|Overall Study||4
7550941|NCT03095651|18585092|P3|STARTED|Overall Study||0
7550942|NCT03095651|18585093|P2|STARTED|Overall Study||6
7550943|NCT03095651|18585094|P1|STARTED|Overall Study||6
7550944|NCT03095638|18585218|P8|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
7550945|NCT03095638|18585219|P7|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
7550946|NCT03095638|18585220|P6|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
7550947|NCT03095638|18585221|P5|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
7550948|NCT03095638|18585222|P4|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
7550949|NCT03095638|18585223|P3|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
7550950|NCT03095638|18585224|P2|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
7550951|NCT03095638|18585225|P1|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
7550952|NCT03095638|18585218|P8|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
7550953|NCT03095638|18585219|P7|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
7550954|NCT03095638|18585220|P6|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
7550955|NCT03095638|18585221|P5|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
7550956|NCT03095638|18585222|P4|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
7550957|NCT03095638|18585223|P3|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
7550958|NCT03095638|18585224|P2|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
7550959|NCT03095638|18585225|P1|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
7550960|NCT03095638|18585218|P8|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
7550961|NCT03095638|18585219|P7|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
7550962|NCT03095638|18585220|P6|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
7550963|NCT03095638|18585221|P5|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
7550964|NCT03095638|18585222|P4|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
7550965|NCT03095638|18585223|P3|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
7550966|NCT03095638|18585224|P2|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
7550967|NCT03095638|18585225|P1|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
7550968|NCT03095638|18585218|P8|NOT COMPLETED|P2: Period 3 (4 Days)||0
7550969|NCT03095638|18585219|P7|NOT COMPLETED|P2: Period 3 (4 Days)||0
7550970|NCT03095638|18585220|P6|NOT COMPLETED|P2: Period 3 (4 Days)||0
7550971|NCT03095638|18585221|P5|NOT COMPLETED|P2: Period 3 (4 Days)||0
7550972|NCT03095638|18585222|P4|NOT COMPLETED|P2: Period 3 (4 Days)||0
7550973|NCT03095638|18585223|P3|NOT COMPLETED|P2: Period 3 (4 Days)||0
7550974|NCT03095638|18585224|P2|NOT COMPLETED|P2: Period 3 (4 Days)||0
7550975|NCT03095638|18585225|P1|NOT COMPLETED|P2: Period 3 (4 Days)||0
7550976|NCT03095638|18585218|P8|COMPLETED|P2: Period 3 (4 Days)||4
7550977|NCT03095638|18585219|P7|COMPLETED|P2: Period 3 (4 Days)||4
7550978|NCT03095638|18585220|P6|COMPLETED|P2: Period 3 (4 Days)||4
7550979|NCT03095638|18585221|P5|COMPLETED|P2: Period 3 (4 Days)||4
7550980|NCT03095638|18585222|P4|COMPLETED|P2: Period 3 (4 Days)||4
7550981|NCT03095638|18585223|P3|COMPLETED|P2: Period 3 (4 Days)||4
7550982|NCT03095638|18585224|P2|COMPLETED|P2: Period 3 (4 Days)||0
7550983|NCT03095638|18585225|P1|COMPLETED|P2: Period 3 (4 Days)||0
7550984|NCT03095638|18585218|P8|STARTED|P2: Period 3 (4 Days)||4
7550985|NCT03095638|18585219|P7|STARTED|P2: Period 3 (4 Days)||4
7550986|NCT03095638|18585220|P6|STARTED|P2: Period 3 (4 Days)||4
7550987|NCT03095638|18585221|P5|STARTED|P2: Period 3 (4 Days)||4
7550988|NCT03095638|18585222|P4|STARTED|P2: Period 3 (4 Days)||4
7550989|NCT03095638|18585223|P3|STARTED|P2: Period 3 (4 Days)||4
7550990|NCT03095638|18585224|P2|STARTED|P2: Period 3 (4 Days)||0
7550991|NCT03095638|18585225|P1|STARTED|P2: Period 3 (4 Days)||0
7550992|NCT03095638|18585218|P8|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
7550993|NCT03095638|18585219|P7|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
7550994|NCT03095638|18585220|P6|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
7550995|NCT03095638|18585221|P5|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
7550996|NCT03095638|18585222|P4|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
7550997|NCT03095638|18585223|P3|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
7550998|NCT03095638|18585224|P2|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
7550999|NCT03095638|18585225|P1|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
7551000|NCT03095638|18585218|P8|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
7551001|NCT03095638|18585219|P7|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
7551002|NCT03095638|18585220|P6|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
7551003|NCT03095638|18585221|P5|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
7551004|NCT03095638|18585222|P4|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
7551005|NCT03095638|18585223|P3|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
7551006|NCT03095638|18585224|P2|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
7551007|NCT03095638|18585225|P1|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
7551008|NCT03095638|18585218|P8|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
7551009|NCT03095638|18585219|P7|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
7551010|NCT03095638|18585220|P6|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
7551011|NCT03095638|18585221|P5|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
7551012|NCT03095638|18585222|P4|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
7551013|NCT03095638|18585223|P3|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
7551014|NCT03095638|18585224|P2|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
7551015|NCT03095638|18585225|P1|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
7551016|NCT03095638|18585218|P8|NOT COMPLETED|P2: Period 2 (4 Days)||0
7551017|NCT03095638|18585219|P7|NOT COMPLETED|P2: Period 2 (4 Days)||0
7551018|NCT03095638|18585220|P6|NOT COMPLETED|P2: Period 2 (4 Days)||0
7551019|NCT03095638|18585221|P5|NOT COMPLETED|P2: Period 2 (4 Days)||0
7551020|NCT03095638|18585222|P4|NOT COMPLETED|P2: Period 2 (4 Days)||0
7551021|NCT03095638|18585223|P3|NOT COMPLETED|P2: Period 2 (4 Days)||0
7551022|NCT03095638|18585224|P2|NOT COMPLETED|P2: Period 2 (4 Days)||0
7551023|NCT03095638|18585225|P1|NOT COMPLETED|P2: Period 2 (4 Days)||0
7551024|NCT03095638|18585218|P8|COMPLETED|P2: Period 2 (4 Days)||4
7551025|NCT03095638|18585219|P7|COMPLETED|P2: Period 2 (4 Days)||4
7551026|NCT03095638|18585220|P6|COMPLETED|P2: Period 2 (4 Days)||4
7551027|NCT03095638|18585221|P5|COMPLETED|P2: Period 2 (4 Days)||4
7551028|NCT03095638|18585222|P4|COMPLETED|P2: Period 2 (4 Days)||4
7551029|NCT03095638|18585223|P3|COMPLETED|P2: Period 2 (4 Days)||4
7551030|NCT03095638|18585224|P2|COMPLETED|P2: Period 2 (4 Days)||0
7551031|NCT03095638|18585225|P1|COMPLETED|P2: Period 2 (4 Days)||0
7551032|NCT03095638|18585218|P8|STARTED|P2: Period 2 (4 Days)||4
7551033|NCT03095638|18585219|P7|STARTED|P2: Period 2 (4 Days)||4
7551034|NCT03095638|18585220|P6|STARTED|P2: Period 2 (4 Days)||4
7551035|NCT03095638|18585221|P5|STARTED|P2: Period 2 (4 Days)||4
7551036|NCT03095638|18585222|P4|STARTED|P2: Period 2 (4 Days)||4
7551037|NCT03095638|18585223|P3|STARTED|P2: Period 2 (4 Days)||4
7551038|NCT03095638|18585224|P2|STARTED|P2: Period 2 (4 Days)||0
7551039|NCT03095638|18585225|P1|STARTED|P2: Period 2 (4 Days)||0
7551040|NCT03095638|18585218|P8|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
7551041|NCT03095638|18585219|P7|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
7551042|NCT03095638|18585220|P6|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
7551043|NCT03095638|18585221|P5|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
7551044|NCT03095638|18585222|P4|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
7551045|NCT03095638|18585223|P3|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
7551046|NCT03095638|18585224|P2|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
7551047|NCT03095638|18585225|P1|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
7551048|NCT03095638|18585218|P8|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
7551049|NCT03095638|18585219|P7|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
7551050|NCT03095638|18585220|P6|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
7551051|NCT03095638|18585221|P5|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
7551052|NCT03095638|18585222|P4|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
7551053|NCT03095638|18585223|P3|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
7551054|NCT03095638|18585224|P2|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
7551055|NCT03095638|18585225|P1|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
7551056|NCT03095638|18585218|P8|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
7551057|NCT03095638|18585219|P7|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
7551058|NCT03095638|18585220|P6|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
7551059|NCT03095638|18585221|P5|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
7551060|NCT03095638|18585222|P4|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
7551061|NCT03095638|18585223|P3|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
7551062|NCT03095638|18585224|P2|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
7551063|NCT03095638|18585225|P1|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
7551064|NCT03095638|18585218|P8|NOT COMPLETED|P2: Period 1 (4 Days)||0
7551065|NCT03095638|18585219|P7|NOT COMPLETED|P2: Period 1 (4 Days)||0
7551066|NCT03095638|18585220|P6|NOT COMPLETED|P2: Period 1 (4 Days)||0
7551067|NCT03095638|18585221|P5|NOT COMPLETED|P2: Period 1 (4 Days)||0
7551068|NCT03095638|18585222|P4|NOT COMPLETED|P2: Period 1 (4 Days)||0
7551069|NCT03095638|18585223|P3|NOT COMPLETED|P2: Period 1 (4 Days)||0
7551070|NCT03095638|18585224|P2|NOT COMPLETED|P2: Period 1 (4 Days)||0
7551071|NCT03095638|18585225|P1|NOT COMPLETED|P2: Period 1 (4 Days)||0
7551072|NCT03095638|18585218|P8|COMPLETED|P2: Period 1 (4 Days)||4
7551073|NCT03095638|18585219|P7|COMPLETED|P2: Period 1 (4 Days)||4
7551074|NCT03095638|18585220|P6|COMPLETED|P2: Period 1 (4 Days)||4
7551075|NCT03095638|18585221|P5|COMPLETED|P2: Period 1 (4 Days)||4
7551076|NCT03095638|18585222|P4|COMPLETED|P2: Period 1 (4 Days)||4
7551077|NCT03095638|18585223|P3|COMPLETED|P2: Period 1 (4 Days)||4
7551078|NCT03095638|18585224|P2|COMPLETED|P2: Period 1 (4 Days)||0
7551079|NCT03095638|18585225|P1|COMPLETED|P2: Period 1 (4 Days)||0
7551080|NCT03095638|18585218|P8|STARTED|P2: Period 1 (4 Days)||4
7551081|NCT03095638|18585219|P7|STARTED|P2: Period 1 (4 Days)||4
7551082|NCT03095638|18585220|P6|STARTED|P2: Period 1 (4 Days)||4
7551083|NCT03095638|18585221|P5|STARTED|P2: Period 1 (4 Days)||4
7551084|NCT03095638|18585222|P4|STARTED|P2: Period 1 (4 Days)||4
7551085|NCT03095638|18585223|P3|STARTED|P2: Period 1 (4 Days)||4
7551086|NCT03095638|18585224|P2|STARTED|P2: Period 1 (4 Days)||0
7551087|NCT03095638|18585225|P1|STARTED|P2: Period 1 (4 Days)||0
7551088|NCT03095638|18585218|P8|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
7551089|NCT03095638|18585219|P7|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
7551171|NCT03095638|18585221|P5|COMPLETED|P1: Period 1 (4 Days)||0
7551090|NCT03095638|18585220|P6|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
7551091|NCT03095638|18585221|P5|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
7551092|NCT03095638|18585222|P4|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
7551093|NCT03095638|18585223|P3|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
7551094|NCT03095638|18585224|P2|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
7551095|NCT03095638|18585225|P1|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
7551096|NCT03095638|18585218|P8|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
7551097|NCT03095638|18585219|P7|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
7551098|NCT03095638|18585220|P6|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
7551099|NCT03095638|18585221|P5|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
7551100|NCT03095638|18585222|P4|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
7551101|NCT03095638|18585223|P3|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
7551102|NCT03095638|18585224|P2|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
7551103|NCT03095638|18585225|P1|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
7551104|NCT03095638|18585218|P8|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
7551105|NCT03095638|18585219|P7|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
7551106|NCT03095638|18585220|P6|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
7551107|NCT03095638|18585221|P5|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
7551108|NCT03095638|18585222|P4|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
7551109|NCT03095638|18585223|P3|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
7551110|NCT03095638|18585224|P2|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
7551111|NCT03095638|18585225|P1|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
7551112|NCT03095638|18585218|P8|NOT COMPLETED|P1: Period 2 (4 Days)||0
7551113|NCT03095638|18585219|P7|NOT COMPLETED|P1: Period 2 (4 Days)||0
7551114|NCT03095638|18585220|P6|NOT COMPLETED|P1: Period 2 (4 Days)||0
7551115|NCT03095638|18585221|P5|NOT COMPLETED|P1: Period 2 (4 Days)||0
7551116|NCT03095638|18585222|P4|NOT COMPLETED|P1: Period 2 (4 Days)||0
7551117|NCT03095638|18585223|P3|NOT COMPLETED|P1: Period 2 (4 Days)||0
7551118|NCT03095638|18585224|P2|NOT COMPLETED|P1: Period 2 (4 Days)||0
7551119|NCT03095638|18585225|P1|NOT COMPLETED|P1: Period 2 (4 Days)||0
7551120|NCT03095638|18585218|P8|COMPLETED|P1: Period 2 (4 Days)||0
7551121|NCT03095638|18585219|P7|COMPLETED|P1: Period 2 (4 Days)||0
7551122|NCT03095638|18585220|P6|COMPLETED|P1: Period 2 (4 Days)||0
7551123|NCT03095638|18585221|P5|COMPLETED|P1: Period 2 (4 Days)||0
7551124|NCT03095638|18585222|P4|COMPLETED|P1: Period 2 (4 Days)||0
7551125|NCT03095638|18585223|P3|COMPLETED|P1: Period 2 (4 Days)||0
7551126|NCT03095638|18585224|P2|COMPLETED|P1: Period 2 (4 Days)||7
7551127|NCT03095638|18585225|P1|COMPLETED|P1: Period 2 (4 Days)||7
7551128|NCT03095638|18585218|P8|STARTED|P1: Period 2 (4 Days)||0
7551129|NCT03095638|18585219|P7|STARTED|P1: Period 2 (4 Days)||0
7551130|NCT03095638|18585220|P6|STARTED|P1: Period 2 (4 Days)||0
7551131|NCT03095638|18585221|P5|STARTED|P1: Period 2 (4 Days)||0
7551132|NCT03095638|18585222|P4|STARTED|P1: Period 2 (4 Days)||0
7551133|NCT03095638|18585223|P3|STARTED|P1: Period 2 (4 Days)||0
7551134|NCT03095638|18585224|P2|STARTED|P1: Period 2 (4 Days)||7
7551135|NCT03095638|18585225|P1|STARTED|P1: Period 2 (4 Days)||7
7551136|NCT03095638|18585218|P8|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
7551137|NCT03095638|18585219|P7|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
7551138|NCT03095638|18585220|P6|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
7551139|NCT03095638|18585221|P5|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
7551140|NCT03095638|18585222|P4|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
7551141|NCT03095638|18585223|P3|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
7551142|NCT03095638|18585224|P2|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
7551143|NCT03095638|18585225|P1|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
7551144|NCT03095638|18585218|P8|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
7551145|NCT03095638|18585219|P7|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
7551146|NCT03095638|18585220|P6|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
7551147|NCT03095638|18585221|P5|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
7551148|NCT03095638|18585222|P4|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
7551149|NCT03095638|18585223|P3|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
7551150|NCT03095638|18585224|P2|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
7551151|NCT03095638|18585225|P1|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
7551152|NCT03095638|18585218|P8|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
7551153|NCT03095638|18585219|P7|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
7551154|NCT03095638|18585220|P6|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
7551155|NCT03095638|18585221|P5|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
7551156|NCT03095638|18585222|P4|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
7551157|NCT03095638|18585223|P3|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
7551158|NCT03095638|18585224|P2|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
7551159|NCT03095638|18585225|P1|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
7551160|NCT03095638|18585218|P8|NOT COMPLETED|P1: Period 1 (4 Days)||0
7551161|NCT03095638|18585219|P7|NOT COMPLETED|P1: Period 1 (4 Days)||0
7551162|NCT03095638|18585220|P6|NOT COMPLETED|P1: Period 1 (4 Days)||0
7551163|NCT03095638|18585221|P5|NOT COMPLETED|P1: Period 1 (4 Days)||0
7551164|NCT03095638|18585222|P4|NOT COMPLETED|P1: Period 1 (4 Days)||0
7551165|NCT03095638|18585223|P3|NOT COMPLETED|P1: Period 1 (4 Days)||0
7551166|NCT03095638|18585224|P2|NOT COMPLETED|P1: Period 1 (4 Days)||0
7551167|NCT03095638|18585225|P1|NOT COMPLETED|P1: Period 1 (4 Days)||0
7551168|NCT03095638|18585218|P8|COMPLETED|P1: Period 1 (4 Days)||0
7551169|NCT03095638|18585219|P7|COMPLETED|P1: Period 1 (4 Days)||0
7551170|NCT03095638|18585220|P6|COMPLETED|P1: Period 1 (4 Days)||0
7551172|NCT03095638|18585222|P4|COMPLETED|P1: Period 1 (4 Days)||0
7551173|NCT03095638|18585223|P3|COMPLETED|P1: Period 1 (4 Days)||0
7551174|NCT03095638|18585224|P2|COMPLETED|P1: Period 1 (4 Days)||7
7551175|NCT03095638|18585225|P1|COMPLETED|P1: Period 1 (4 Days)||7
7551176|NCT03095638|18585218|P8|STARTED|P1: Period 1 (4 Days)||0
7551177|NCT03095638|18585219|P7|STARTED|P1: Period 1 (4 Days)||0
7551178|NCT03095638|18585220|P6|STARTED|P1: Period 1 (4 Days)||0
7551179|NCT03095638|18585221|P5|STARTED|P1: Period 1 (4 Days)||0
7551180|NCT03095638|18585222|P4|STARTED|P1: Period 1 (4 Days)||0
7551181|NCT03095638|18585223|P3|STARTED|P1: Period 1 (4 Days)||0
7551182|NCT03095638|18585224|P2|STARTED|P1: Period 1 (4 Days)||7
7551183|NCT03095638|18585225|P1|STARTED|P1: Period 1 (4 Days)||7
7551184|NCT03095599|18585373|P2|NOT COMPLETED|Overall Study||0
7551185|NCT03095599|18585374|P1|NOT COMPLETED|Overall Study||3
7551186|NCT03095599|18585373|P2|COMPLETED|Overall Study||148
7551187|NCT03095599|18585374|P1|COMPLETED|Overall Study||738
7551188|NCT03095599|18585373|P2|Vaccinated|Overall Study||148
7551189|NCT03095599|18585374|P1|Vaccinated|Overall Study||740
7551190|NCT03095599|18585373|P2|Withdrawal Before Vaccination|Overall Study||0
7551191|NCT03095599|18585374|P1|Withdrawal Before Vaccination|Overall Study||1
7551192|NCT03095599|18585373|P2|STARTED|Overall Study||148
7551193|NCT03095599|18585374|P1|STARTED|Overall Study||741
7551194|NCT03095521|18585410|P2|NOT COMPLETED|Overall Study||2
7551195|NCT03095521|18585411|P1|NOT COMPLETED|Overall Study||0
7551196|NCT03095521|18585410|P2|COMPLETED|Overall Study||111
7551197|NCT03095521|18585411|P1|COMPLETED|Overall Study||115
7551198|NCT03095521|18585410|P2|Safety Population|Overall Study||113
7551199|NCT03095521|18585411|P1|Safety Population|Overall Study||115
7551200|NCT03095521|18585410|P2|Per Protocol Population PP|Overall Study||107
7551201|NCT03095521|18585411|P1|Per Protocol Population PP|Overall Study||113
7551202|NCT03095521|18585410|P2|Intent to Treat Population ITT|Overall Study||113
7551203|NCT03095521|18585411|P1|Intent to Treat Population ITT|Overall Study||115
7551204|NCT03095521|18585410|P2|STARTED|Overall Study||113
7551205|NCT03095521|18585411|P1|STARTED|Overall Study||115
7551206|NCT03095508|18585429|P2|NOT COMPLETED|Overall Study||1
7551207|NCT03095508|18585430|P1|NOT COMPLETED|Overall Study||0
7551208|NCT03095508|18585429|P2|COMPLETED|Overall Study||114
7551209|NCT03095508|18585430|P1|COMPLETED|Overall Study||114
7551210|NCT03095508|18585429|P2|ITT Population|Overall Study||115
7551211|NCT03095508|18585430|P1|ITT Population|Overall Study||114
7551212|NCT03095508|18585429|P2|Safety Population|Overall Study||115
7551213|NCT03095508|18585430|P1|Safety Population|Overall Study||114
7551214|NCT03095508|18585429|P2|Per Protocol Population|Overall Study||111
7551215|NCT03095508|18585430|P1|Per Protocol Population|Overall Study||112
7551216|NCT03095508|18585429|P2|STARTED|Overall Study||115
7551217|NCT03095508|18585430|P1|STARTED|Overall Study||114
7551218|NCT03095456|18585448|P2|NOT COMPLETED|Overall Study||8
7551219|NCT03095456|18585449|P1|NOT COMPLETED|Overall Study||4
7551220|NCT03095456|18585448|P2|COMPLETED|Overall Study||96
7551221|NCT03095456|18585449|P1|COMPLETED|Overall Study||99
7551222|NCT03095456|18585448|P2|STARTED|Overall Study||104
7551223|NCT03095456|18585449|P1|STARTED|Overall Study||103
7551224|NCT03095053|18585467|P2|NOT COMPLETED|Overall Study||0
7551225|NCT03095053|18585468|P1|NOT COMPLETED|Overall Study||29
7551226|NCT03095053|18585467|P2|COMPLETED|Overall Study||111
7551227|NCT03095053|18585468|P1|COMPLETED|Overall Study|29 excluded as blastocyst was predicted to be aneuploid|80
7551228|NCT03095053|18585467|P2|STARTED|Overall Study|All blastocysts scored morphologically|111
7551229|NCT03095053|18585468|P1|STARTED|Overall Study|All blastocysts scored morphologically PGT-A of the single best blastocyst from the cohort|109
7551230|NCT03095027|18585478|P2|NOT COMPLETED|Period 2, Second Week of Wear||0
7551231|NCT03095027|18585479|P1|NOT COMPLETED|Period 2, Second Week of Wear||1
7551232|NCT03095027|18585478|P2|COMPLETED|Period 2, Second Week of Wear||24
7551233|NCT03095027|18585479|P1|COMPLETED|Period 2, Second Week of Wear||26
7551234|NCT03095027|18585478|P2|STARTED|Period 2, Second Week of Wear||24
7551235|NCT03095027|18585479|P1|STARTED|Period 2, Second Week of Wear||27
7551236|NCT03095027|18585478|P2|NOT COMPLETED|Period 1, First Week of Wear||0
7551237|NCT03095027|18585479|P1|NOT COMPLETED|Period 1, First Week of Wear||0
7551238|NCT03095027|18585478|P2|COMPLETED|Period 1, First Week of Wear||24
7551239|NCT03095027|18585479|P1|COMPLETED|Period 1, First Week of Wear||27
7551240|NCT03095027|18585478|P2|STARTED|Period 1, First Week of Wear||24
7551241|NCT03095027|18585479|P1|STARTED|Period 1, First Week of Wear||27
7551242|NCT03094806|18585487|P2|NOT COMPLETED|Overall Study||0
7551243|NCT03094806|18585488|P1|NOT COMPLETED|Overall Study||0
7551244|NCT03094806|18585487|P2|COMPLETED|Overall Study||47
7551245|NCT03094806|18585488|P1|COMPLETED|Overall Study||44
7551246|NCT03094806|18585487|P2|STARTED|Overall Study||47
7551247|NCT03094806|18585488|P1|STARTED|Overall Study||44
7551248|NCT03094325|18585506|P1|NOT COMPLETED|Overall Study||0
7551249|NCT03094325|18585506|P1|COMPLETED|Overall Study||10
7551250|NCT03094325|18585506|P1|OPIE After Cardiopulmonary Bypass|Overall Study||10
7551251|NCT03094325|18585506|P1|TEE After Cardiopulmonary Bypass|Overall Study||10
7551252|NCT03094325|18585506|P1|OPIE Before Cardiopulmonary Bypass|Overall Study||10
7551253|NCT03094325|18585506|P1|TEE Before Cardiopulmonary Bypass|Overall Study||10
7551254|NCT03094325|18585506|P1|STARTED|Overall Study||10
7551255|NCT03094195|18585515|P8|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
7551256|NCT03094195|18585516|P7|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
7551257|NCT03094195|18585517|P6|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
7551258|NCT03094195|18585518|P5|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
7551259|NCT03094195|18585519|P4|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
7551260|NCT03094195|18585520|P3|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
7551261|NCT03094195|18585521|P2|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
7551262|NCT03094195|18585522|P1|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
7551263|NCT03094195|18585515|P8|COMPLETED|Treatment Withdrawal Period (TW)||26
7551264|NCT03094195|18585516|P7|COMPLETED|Treatment Withdrawal Period (TW)||13
7551265|NCT03094195|18585517|P6|COMPLETED|Treatment Withdrawal Period (TW)||15
7551266|NCT03094195|18585518|P5|COMPLETED|Treatment Withdrawal Period (TW)||13
7551267|NCT03094195|18585519|P4|COMPLETED|Treatment Withdrawal Period (TW)||13
7551268|NCT03094195|18585520|P3|COMPLETED|Treatment Withdrawal Period (TW)||0
7551269|NCT03094195|18585521|P2|COMPLETED|Treatment Withdrawal Period (TW)||0
7551270|NCT03094195|18585522|P1|COMPLETED|Treatment Withdrawal Period (TW)||0
7551271|NCT03094195|18585515|P8|STARTED|Treatment Withdrawal Period (TW)||26
7551272|NCT03094195|18585516|P7|STARTED|Treatment Withdrawal Period (TW)||13
7551273|NCT03094195|18585517|P6|STARTED|Treatment Withdrawal Period (TW)||15
7551274|NCT03094195|18585518|P5|STARTED|Treatment Withdrawal Period (TW)||13
7551275|NCT03094195|18585519|P4|STARTED|Treatment Withdrawal Period (TW)||13
7551276|NCT03094195|18585520|P3|STARTED|Treatment Withdrawal Period (TW)||0
7551277|NCT03094195|18585521|P2|STARTED|Treatment Withdrawal Period (TW)||0
7551278|NCT03094195|18585522|P1|STARTED|Treatment Withdrawal Period (TW)||0
7551279|NCT03094195|18585515|P8|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
7551280|NCT03094195|18585516|P7|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
7551281|NCT03094195|18585517|P6|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
7551282|NCT03094195|18585518|P5|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
7551283|NCT03094195|18585519|P4|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
7551284|NCT03094195|18585520|P3|NOT COMPLETED|Double-Blind Treatment Period (DB)||14
7551285|NCT03094195|18585521|P2|NOT COMPLETED|Double-Blind Treatment Period (DB)||13
7551286|NCT03094195|18585522|P1|NOT COMPLETED|Double-Blind Treatment Period (DB)||15
7551287|NCT03094195|18585515|P8|COMPLETED|Double-Blind Treatment Period (DB)||0
7551288|NCT03094195|18585516|P7|COMPLETED|Double-Blind Treatment Period (DB)||0
7551289|NCT03094195|18585517|P6|COMPLETED|Double-Blind Treatment Period (DB)||0
7551290|NCT03094195|18585518|P5|COMPLETED|Double-Blind Treatment Period (DB)||0
7551291|NCT03094195|18585519|P4|COMPLETED|Double-Blind Treatment Period (DB)||0
7551292|NCT03094195|18585520|P3|COMPLETED|Double-Blind Treatment Period (DB)||29
7551293|NCT03094195|18585521|P2|COMPLETED|Double-Blind Treatment Period (DB)||30
7551294|NCT03094195|18585522|P1|COMPLETED|Double-Blind Treatment Period (DB)||28
7551295|NCT03094195|18585515|P8|STARTED|Double-Blind Treatment Period (DB)||0
7551296|NCT03094195|18585516|P7|STARTED|Double-Blind Treatment Period (DB)||0
7551297|NCT03094195|18585517|P6|STARTED|Double-Blind Treatment Period (DB)||0
7551298|NCT03094195|18585518|P5|STARTED|Double-Blind Treatment Period (DB)||0
7551299|NCT03094195|18585519|P4|STARTED|Double-Blind Treatment Period (DB)||0
7551300|NCT03094195|18585520|P3|STARTED|Double-Blind Treatment Period (DB)||43
7551301|NCT03094195|18585521|P2|STARTED|Double-Blind Treatment Period (DB)||43
7551302|NCT03094195|18585522|P1|STARTED|Double-Blind Treatment Period (DB)||43
7551303|NCT03093662|18585570|P2|NOT COMPLETED|Second Intervention (3 Minutes)||0
7551304|NCT03093662|18585571|P1|NOT COMPLETED|Second Intervention (3 Minutes)||0
7551305|NCT03093662|18585570|P2|COMPLETED|Second Intervention (3 Minutes)||19
7551306|NCT03093662|18585571|P1|COMPLETED|Second Intervention (3 Minutes)||18
7551307|NCT03093662|18585570|P2|STARTED|Second Intervention (3 Minutes)||19
7551308|NCT03093662|18585571|P1|STARTED|Second Intervention (3 Minutes)||18
7551309|NCT03093662|18585570|P2|NOT COMPLETED|Washout Period (5 Minutes)||0
7551310|NCT03093662|18585571|P1|NOT COMPLETED|Washout Period (5 Minutes)||0
7551311|NCT03093662|18585570|P2|COMPLETED|Washout Period (5 Minutes)||19
7551312|NCT03093662|18585571|P1|COMPLETED|Washout Period (5 Minutes)||18
7551313|NCT03093662|18585570|P2|STARTED|Washout Period (5 Minutes)||19
7551314|NCT03093662|18585571|P1|STARTED|Washout Period (5 Minutes)||18
7551315|NCT03093662|18585570|P2|NOT COMPLETED|First Intervention (3 Minutes)||0
7551316|NCT03093662|18585571|P1|NOT COMPLETED|First Intervention (3 Minutes)||0
7551317|NCT03093662|18585570|P2|COMPLETED|First Intervention (3 Minutes)||19
7551318|NCT03093662|18585571|P1|COMPLETED|First Intervention (3 Minutes)||18
7551319|NCT03093662|18585570|P2|STARTED|First Intervention (3 Minutes)||19
7551320|NCT03093662|18585571|P1|STARTED|First Intervention (3 Minutes)||18
7551321|NCT03093415|18585580|P3|NOT COMPLETED|Enrollment to SVR12 Results||3
7551322|NCT03093415|18585581|P2|NOT COMPLETED|Enrollment to SVR12 Results||8
7551323|NCT03093415|18585582|P1|NOT COMPLETED|Enrollment to SVR12 Results||1
7551324|NCT03093415|18585580|P3|COMPLETED|Enrollment to SVR12 Results||47
7551325|NCT03093415|18585581|P2|COMPLETED|Enrollment to SVR12 Results||17
7551326|NCT03093415|18585582|P1|COMPLETED|Enrollment to SVR12 Results||24
7551327|NCT03093415|18585580|P3|STARTED|Enrollment to SVR12 Results|Prespecified 50 participants enrolled.|50
7551328|NCT03093415|18585581|P2|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25
7551329|NCT03093415|18585582|P1|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25
7551330|NCT03093415|18585580|P3|NOT COMPLETED|Assessed for Eligibility --> Enrollment||0
7551331|NCT03093415|18585581|P2|NOT COMPLETED|Assessed for Eligibility --> Enrollment||110
7551332|NCT03093415|18585582|P1|NOT COMPLETED|Assessed for Eligibility --> Enrollment||140
7551333|NCT03093415|18585580|P3|COMPLETED|Assessed for Eligibility --> Enrollment||50
7551334|NCT03093415|18585581|P2|COMPLETED|Assessed for Eligibility --> Enrollment||25
7551335|NCT03093415|18585582|P1|COMPLETED|Assessed for Eligibility --> Enrollment||25
7551336|NCT03093415|18585580|P3|STARTED|Assessed for Eligibility --> Enrollment||50
7551337|NCT03093415|18585581|P2|STARTED|Assessed for Eligibility --> Enrollment||135
7551338|NCT03093415|18585582|P1|STARTED|Assessed for Eligibility --> Enrollment||165
7551339|NCT03093350|18585605|P1|NOT COMPLETED|Overall Study||2
7551340|NCT03093350|18585605|P1|COMPLETED|Overall Study||10
7551341|NCT03093350|18585605|P1|Started Treatment|Overall Study||10
7551342|NCT03093350|18585605|P1|STARTED|Overall Study||12
7551343|NCT03093324|18585613|P2|NOT COMPLETED|Overall Study||19
7551344|NCT03093324|18585614|P1|NOT COMPLETED|Overall Study||9
7551345|NCT03093324|18585613|P2|COMPLETED|Overall Study||233
7551346|NCT03093324|18585614|P1|COMPLETED|Overall Study||245
7551347|NCT03093324|18585613|P2|Safety Population|Overall Study||251
7551348|NCT03093324|18585614|P1|Safety Population|Overall Study||253
7551349|NCT03093324|18585613|P2|STARTED|Overall Study||252
7551350|NCT03093324|18585614|P1|STARTED|Overall Study||254
7551351|NCT03093272|18585636|P1|NOT COMPLETED|Overall Study||0
7551352|NCT03093272|18585636|P1|COMPLETED|Overall Study||9
7551353|NCT03093272|18585636|P1|STARTED|Overall Study||9
7551354|NCT03093207|18585647|P2|NOT COMPLETED|Overall Study||0
7551355|NCT03093207|18585648|P1|NOT COMPLETED|Overall Study||0
7551356|NCT03093207|18585647|P2|COMPLETED|Overall Study||17
7551357|NCT03093207|18585648|P1|COMPLETED|Overall Study||17
7551358|NCT03093207|18585647|P2|STARTED|Overall Study||17
7551359|NCT03093207|18585648|P1|STARTED|Overall Study||17
7551360|NCT03093181|18585661|P3|NOT COMPLETED|Overall Study||3
7551361|NCT03093181|18585662|P2|NOT COMPLETED|Overall Study||2
7551362|NCT03093181|18585663|P1|NOT COMPLETED|Overall Study||3
7551363|NCT03093181|18585661|P3|COMPLETED|Overall Study||41
7551364|NCT03093181|18585662|P2|COMPLETED|Overall Study||42
7551365|NCT03093181|18585663|P1|COMPLETED|Overall Study||41
7551366|NCT03093181|18585661|P3|STARTED|Overall Study||44
7551367|NCT03093181|18585662|P2|STARTED|Overall Study||44
7551368|NCT03093181|18585663|P1|STARTED|Overall Study||44
7551369|NCT03093025|18585692|P3|NOT COMPLETED|Overall Study||2
7551370|NCT03093025|18585693|P2|NOT COMPLETED|Overall Study||2
7551371|NCT03093025|18585694|P1|NOT COMPLETED|Overall Study||4
7551372|NCT03093025|18585692|P3|COMPLETED|Overall Study||16
7551373|NCT03093025|18585693|P2|COMPLETED|Overall Study||15
7551374|NCT03093025|18585694|P1|COMPLETED|Overall Study||12
7551375|NCT03093025|18585692|P3|STARTED|Overall Study||18
7551376|NCT03093025|18585693|P2|STARTED|Overall Study|One participant did not take any dose of investigational product after randomization.|17
7551377|NCT03093025|18585694|P1|STARTED|Overall Study||16
7551378|NCT03092791|18585725|P8|NOT COMPLETED|Overall Study||60
7551379|NCT03092791|18585726|P7|NOT COMPLETED|Overall Study||60
7551380|NCT03092791|18585727|P6|NOT COMPLETED|Overall Study||60
7551381|NCT03092791|18585728|P5|NOT COMPLETED|Overall Study||60
7551382|NCT03092791|18585729|P4|NOT COMPLETED|Overall Study||0
7551383|NCT03092791|18585730|P3|NOT COMPLETED|Overall Study||0
7551384|NCT03092791|18585731|P2|NOT COMPLETED|Overall Study||0
7551385|NCT03092791|18585732|P1|NOT COMPLETED|Overall Study||0
7551386|NCT03092791|18585725|P8|COMPLETED|Overall Study||0
7551387|NCT03092791|18585726|P7|COMPLETED|Overall Study||0
7551388|NCT03092791|18585727|P6|COMPLETED|Overall Study||0
7551389|NCT03092791|18585728|P5|COMPLETED|Overall Study||0
7551390|NCT03092791|18585729|P4|COMPLETED|Overall Study||30
7551391|NCT03092791|18585730|P3|COMPLETED|Overall Study||30
7551392|NCT03092791|18585731|P2|COMPLETED|Overall Study||20
7551393|NCT03092791|18585732|P1|COMPLETED|Overall Study||20
7551394|NCT03092791|18585725|P8|STARTED|Overall Study||60
7551395|NCT03092791|18585726|P7|STARTED|Overall Study||60
7551396|NCT03092791|18585727|P6|STARTED|Overall Study||60
7551397|NCT03092791|18585728|P5|STARTED|Overall Study||60
7551398|NCT03092791|18585729|P4|STARTED|Overall Study||30
7551399|NCT03092791|18585730|P3|STARTED|Overall Study||30
7551400|NCT03092791|18585731|P2|STARTED|Overall Study||20
7551401|NCT03092791|18585732|P1|STARTED|Overall Study||20
7551402|NCT03092752|18585847|P1|NOT COMPLETED|Overall Study||361469
7551403|NCT03092752|18585847|P1|COMPLETED|Overall Study||162116
7551404|NCT03092752|18585847|P1|STARTED|Overall Study||523585
7551405|NCT03092726|18585912|P2|NOT COMPLETED|Overall Study||14
7551406|NCT03092726|18585913|P1|NOT COMPLETED|Overall Study||9
7551407|NCT03092726|18585912|P2|COMPLETED|Overall Study||81
7551408|NCT03092726|18585913|P1|COMPLETED|Overall Study||79
7551409|NCT03092726|18585912|P2|Treated|Overall Study||95
7551410|NCT03092726|18585913|P1|Treated|Overall Study||88
7551411|NCT03092726|18585912|P2|STARTED|Overall Study||95
7551412|NCT03092726|18585913|P1|STARTED|Overall Study||88
7551413|NCT03092479|18585939|P2|NOT COMPLETED|Overall Study||2
7551414|NCT03092479|18585940|P1|NOT COMPLETED|Overall Study||7
7551415|NCT03092479|18585939|P2|COMPLETED|Overall Study||24
7551416|NCT03092479|18585940|P1|COMPLETED|Overall Study||17
7551417|NCT03092479|18585939|P2|STARTED|Overall Study||26
7551418|NCT03092479|18585940|P1|STARTED|Overall Study||24
7551419|NCT03092375|18585962|P4|NOT COMPLETED|Overall Study||0
7551420|NCT03092375|18585963|P3|NOT COMPLETED|Overall Study||1
7551421|NCT03092375|18585964|P2|NOT COMPLETED|Overall Study||1
7551422|NCT03092375|18585965|P1|NOT COMPLETED|Overall Study||0
7551423|NCT03092375|18585962|P4|COMPLETED|Overall Study||29
7551424|NCT03092375|18585963|P3|COMPLETED|Overall Study||20
7551425|NCT03092375|18585964|P2|COMPLETED|Overall Study||48
7551426|NCT03092375|18585965|P1|COMPLETED|Overall Study||78
7551427|NCT03092375|18585962|P4|STARTED|Overall Study||29
7551428|NCT03092375|18585963|P3|STARTED|Overall Study||21
7551429|NCT03092375|18585964|P2|STARTED|Overall Study||49
7551430|NCT03092375|18585965|P1|STARTED|Overall Study||78
7551431|NCT03092219|18585993|P2|NOT COMPLETED|Overall Study||4
7551432|NCT03092219|18585994|P1|NOT COMPLETED|Overall Study||7
7551433|NCT03092219|18585993|P2|COMPLETED|Overall Study||48
7551434|NCT03092219|18585994|P1|COMPLETED|Overall Study||143
7551435|NCT03092219|18585993|P2|Pooled SAFT Population|Overall Study|2 subjects did not receive treatment at Visit 1b.|50
7551436|NCT03092219|18585994|P1|Pooled SAFT Population|Overall Study||150
7551437|NCT03092219|18585993|P2|Primary Analysis Endpoint|Overall Study||51
7551438|NCT03092219|18585994|P1|Primary Analysis Endpoint|Overall Study||150
7551439|NCT03092219|18585993|P2|Baseline / ITT Population|Overall Study|Subject randomized to No Treatment group but received treatment at Visit 1.|51
7551440|NCT03092219|18585994|P1|Baseline / ITT Population|Overall Study||150
7551441|NCT03092219|18585993|P2|STARTED|Overall Study||52
7551442|NCT03092219|18585994|P1|STARTED|Overall Study||150
7551443|NCT03091920|18586038|P3|NOT COMPLETED|Overall Study||0
7551444|NCT03091920|18586039|P2|NOT COMPLETED|Overall Study||1
7551445|NCT03091920|18586040|P1|NOT COMPLETED|Overall Study||0
7551446|NCT03091920|18586038|P3|COMPLETED|Overall Study||10
7551447|NCT03091920|18586039|P2|COMPLETED|Overall Study||9
7551448|NCT03091920|18586040|P1|COMPLETED|Overall Study||6
7551449|NCT03091920|18586038|P3|STARTED|Overall Study||10
7551450|NCT03091920|18586039|P2|STARTED|Overall Study||10
7551451|NCT03091920|18586040|P1|STARTED|Overall Study||6
7551452|NCT03091777|18586187|P3|NOT COMPLETED|Overall Study||37
7551453|NCT03091777|18586188|P2|NOT COMPLETED|Overall Study||33
7551454|NCT03091777|18586189|P1|NOT COMPLETED|Overall Study||32
7551455|NCT03091777|18586187|P3|COMPLETED|Overall Study||257
7551456|NCT03091777|18586188|P2|COMPLETED|Overall Study||255
7551457|NCT03091777|18586189|P1|COMPLETED|Overall Study||257
7551458|NCT03091777|18586187|P3|STARTED|Overall Study||294
7551459|NCT03091777|18586188|P2|STARTED|Overall Study||288
7551460|NCT03091777|18586189|P1|STARTED|Overall Study||289
7551461|NCT03091751|18586197|P1|NOT COMPLETED|Overall Study||0
7551462|NCT03091751|18586197|P1|COMPLETED|Overall Study||22
7551463|NCT03091751|18586197|P1|STARTED|Overall Study||22
7551464|NCT03091673|18586208|P2|NOT COMPLETED|Second Dose||0
7551465|NCT03091673|18586209|P1|NOT COMPLETED|Second Dose||0
7551466|NCT03091673|18586208|P2|COMPLETED|Second Dose||11
7551467|NCT03091673|18586209|P1|COMPLETED|Second Dose||0
7551468|NCT03091673|18586208|P2|STARTED|Second Dose|Only the 11 study subjects ages 12-<18 years were assigned the 1 mg dose during period 2.|11
7551469|NCT03091673|18586209|P1|STARTED|Second Dose|No subjects received the 0.5 mg dose during period 2.|0
7551470|NCT03091673|18586208|P2|NOT COMPLETED|First Dose||0
7551471|NCT03091673|18586209|P1|NOT COMPLETED|First Dose||0
7551472|NCT03091673|18586208|P2|COMPLETED|First Dose||0
7551473|NCT03091673|18586209|P1|COMPLETED|First Dose||31
7551474|NCT03091673|18586208|P2|STARTED|First Dose|All 31 subjects received the 0.5 mg dose during period 1.|0
7551475|NCT03091673|18586209|P1|STARTED|First Dose||31
7551476|NCT03091439|18586231|P2|NOT COMPLETED|Overall Study||0
7551477|NCT03091439|18586232|P1|NOT COMPLETED|Overall Study||1
7551478|NCT03091439|18586231|P2|COMPLETED|Overall Study||0
7551479|NCT03091439|18586232|P1|COMPLETED|Overall Study||0
7551480|NCT03091439|18586231|P2|STARTED|Overall Study||0
7551481|NCT03091439|18586232|P1|STARTED|Overall Study||1
7551482|NCT03091400|18586256|P2|NOT COMPLETED|Phase 2 - 6 Weeks||0
7551483|NCT03091400|18586257|P1|NOT COMPLETED|Phase 2 - 6 Weeks||0
7551484|NCT03091400|18586256|P2|COMPLETED|Phase 2 - 6 Weeks||6
7551485|NCT03091400|18586257|P1|COMPLETED|Phase 2 - 6 Weeks||4
7551486|NCT03091400|18586256|P2|STARTED|Phase 2 - 6 Weeks||6
7551487|NCT03091400|18586257|P1|STARTED|Phase 2 - 6 Weeks||4
7551488|NCT03091400|18586256|P2|NOT COMPLETED|Washout - 2 Weeks||0
7551489|NCT03091400|18586257|P1|NOT COMPLETED|Washout - 2 Weeks||1
7551490|NCT03091400|18586256|P2|COMPLETED|Washout - 2 Weeks||6
7551491|NCT03091400|18586257|P1|COMPLETED|Washout - 2 Weeks||4
7551492|NCT03091400|18586256|P2|STARTED|Washout - 2 Weeks||6
7551493|NCT03091400|18586257|P1|STARTED|Washout - 2 Weeks||5
7551494|NCT03091400|18586256|P2|NOT COMPLETED|Phase 1 - 6 Weeks||0
7551495|NCT03091400|18586257|P1|NOT COMPLETED|Phase 1 - 6 Weeks||0
7551496|NCT03091400|18586256|P2|COMPLETED|Phase 1 - 6 Weeks||6
7551497|NCT03091400|18586257|P1|COMPLETED|Phase 1 - 6 Weeks||5
7551498|NCT03091400|18586256|P2|STARTED|Phase 1 - 6 Weeks||6
7551499|NCT03091400|18586257|P1|STARTED|Phase 1 - 6 Weeks||5
7551500|NCT03091361|18586273|P1|NOT COMPLETED|Overall Study||0
7551501|NCT03091361|18586273|P1|COMPLETED|Overall Study||30
7551502|NCT03091361|18586273|P1|STARTED|Overall Study||30
7551503|NCT03091348|18586279|P2|NOT COMPLETED|Overall Study||1
7551504|NCT03091348|18586280|P1|NOT COMPLETED|Overall Study||2
7551505|NCT03091348|18586279|P2|COMPLETED|Overall Study||1
7551506|NCT03091348|18586280|P1|COMPLETED|Overall Study||0
7551507|NCT03091348|18586279|P2|STARTED|Overall Study||2
7551508|NCT03091348|18586280|P1|STARTED|Overall Study||2
7551509|NCT03091192|18586306|P2|NOT COMPLETED|Overall Study||27
7551510|NCT03091192|18586307|P1|NOT COMPLETED|Overall Study||33
7551511|NCT03091192|18586306|P2|COMPLETED|Overall Study||0
7551512|NCT03091192|18586307|P1|COMPLETED|Overall Study||0
7551513|NCT03091192|18586306|P2|STARTED|Overall Study||27
7551514|NCT03091192|18586307|P1|STARTED|Overall Study||33
7551515|NCT03091179|18586325|P2|NOT COMPLETED|Overall Study||0
7551516|NCT03091179|18586326|P1|NOT COMPLETED|Overall Study||0
7551517|NCT03091179|18586325|P2|COMPLETED|Overall Study||10
7551518|NCT03091179|18586326|P1|COMPLETED|Overall Study||10
7551519|NCT03091179|18586325|P2|STARTED|Overall Study||10
7551520|NCT03091179|18586326|P1|STARTED|Overall Study||10
7551521|NCT03090958|18586352|P1|NOT COMPLETED|Overall Study||0
7551522|NCT03090958|18586352|P1|COMPLETED|Overall Study||20
7551523|NCT03090958|18586352|P1|STARTED|Overall Study||20
7551524|NCT03090256|18586364|P1|NOT COMPLETED|Overall Study||0
7551525|NCT03090256|18586364|P1|COMPLETED|Overall Study||68
7551526|NCT03090256|18586364|P1|STARTED|Overall Study||68
7551527|NCT03090100|18586375|P2|NOT COMPLETED|Overall Study||48
7551528|NCT03090100|18586376|P1|NOT COMPLETED|Overall Study||27
7551529|NCT03090100|18586375|P2|COMPLETED|Overall Study||466
7551530|NCT03090100|18586376|P1|COMPLETED|Overall Study||507
7551531|NCT03090100|18586375|P2|Treated|Overall Study||511
7551532|NCT03090100|18586376|P1|Treated|Overall Study||534
7551533|NCT03090100|18586375|P2|STARTED|Overall Study||514
7551534|NCT03090100|18586376|P1|STARTED|Overall Study||534
7551535|NCT03089944|18586416|P1|NOT COMPLETED|Overall Study||12
7551536|NCT03089944|18586416|P1|COMPLETED|Overall Study||331
7551537|NCT03089944|18586416|P1|STARTED|Overall Study||343
7551538|NCT03089879|18586430|P3|NOT COMPLETED|Overall Study||0
7551539|NCT03089879|18586431|P2|NOT COMPLETED|Overall Study||0
7551540|NCT03089879|18586432|P1|NOT COMPLETED|Overall Study||0
7551541|NCT03089879|18586430|P3|COMPLETED|Overall Study||26
7551542|NCT03089879|18586431|P2|COMPLETED|Overall Study||2
7551543|NCT03089879|18586432|P1|COMPLETED|Overall Study||7
7551544|NCT03089879|18586430|P3|STARTED|Overall Study||26
7551545|NCT03089879|18586431|P2|STARTED|Overall Study||2
7551546|NCT03089879|18586432|P1|STARTED|Overall Study||7
7551547|NCT03089853|18586463|P2|NOT COMPLETED|Overall Study||1
7551548|NCT03089853|18586464|P1|NOT COMPLETED|Overall Study||2
7551549|NCT03089853|18586463|P2|COMPLETED|Overall Study||2
7551550|NCT03089853|18586464|P1|COMPLETED|Overall Study||2
7551551|NCT03089853|18586463|P2|STARTED|Overall Study||3
7551552|NCT03089853|18586464|P1|STARTED|Overall Study||4
7551553|NCT03089580|18586486|P1|NOT COMPLETED|Overall Study||2
7551554|NCT03089580|18586486|P1|COMPLETED|Overall Study||12
7551555|NCT03089580|18586486|P1|STARTED|Overall Study||14
7551556|NCT03089216|18586497|P4|NOT COMPLETED|Overall Study||1
7551557|NCT03089216|18586498|P3|NOT COMPLETED|Overall Study||0
7551558|NCT03089216|18586499|P2|NOT COMPLETED|Overall Study||0
7551559|NCT03089216|18586500|P1|NOT COMPLETED|Overall Study||0
7551560|NCT03089216|18586497|P4|COMPLETED|Overall Study||26
7551561|NCT03089216|18586498|P3|COMPLETED|Overall Study||27
7551562|NCT03089216|18586499|P2|COMPLETED|Overall Study||27
7551563|NCT03089216|18586500|P1|COMPLETED|Overall Study||27
7551564|NCT03089216|18586497|P4|STARTED|Overall Study||27
7551565|NCT03089216|18586498|P3|STARTED|Overall Study||27
7551566|NCT03089216|18586499|P2|STARTED|Overall Study||27
7551567|NCT03089216|18586500|P1|STARTED|Overall Study||27
7551568|NCT03088917|18586514|P1|NOT COMPLETED|Overall Study||96
7551569|NCT03088917|18586514|P1|COMPLETED|Overall Study||10
7551570|NCT03088917|18586514|P1|STARTED|Overall Study||106
7551571|NCT03088345|18586524|P2|NOT COMPLETED|Overall Study||0
7551572|NCT03088345|18586525|P1|NOT COMPLETED|Overall Study||0
7551573|NCT03088345|18586524|P2|COMPLETED|Overall Study||10
7551574|NCT03088345|18586525|P1|COMPLETED|Overall Study||10
7551575|NCT03088345|18586524|P2|STARTED|Overall Study||10
7551576|NCT03088345|18586525|P1|STARTED|Overall Study||10
7551577|NCT03088267|18586541|P2|NOT COMPLETED|Overall Study||0
7551578|NCT03088267|18586542|P1|NOT COMPLETED|Overall Study||0
7551579|NCT03088267|18586541|P2|COMPLETED|Overall Study||9
7551580|NCT03088267|18586542|P1|COMPLETED|Overall Study||9
7551581|NCT03088267|18586541|P2|STARTED|Overall Study||9
7551582|NCT03088267|18586542|P1|STARTED|Overall Study||9
7551583|NCT03088137|18586553|P2|NOT COMPLETED|Overall Study||0
7551584|NCT03088137|18586554|P1|NOT COMPLETED|Overall Study||0
7551585|NCT03088137|18586553|P2|COMPLETED|Overall Study||55
7551586|NCT03088137|18586554|P1|COMPLETED|Overall Study||55
7551587|NCT03088137|18586553|P2|STARTED|Overall Study||55
7551588|NCT03088137|18586554|P1|STARTED|Overall Study||55
7551589|NCT03087643|18586584|P2|NOT COMPLETED|Overall Study||6
7551590|NCT03087643|18586585|P1|NOT COMPLETED|Overall Study||4
7551591|NCT03087643|18586584|P2|COMPLETED|Overall Study||19
7551592|NCT03087643|18586585|P1|COMPLETED|Overall Study||22
7551593|NCT03087643|18586584|P2|STARTED|Overall Study||25
7551594|NCT03087643|18586585|P1|STARTED|Overall Study||26
7551595|NCT03087604|18586601|P2|NOT COMPLETED|Overall Study||0
7551596|NCT03087604|18586602|P1|NOT COMPLETED|Overall Study||0
7551597|NCT03087604|18586601|P2|COMPLETED|Overall Study||50
7551598|NCT03087604|18586602|P1|COMPLETED|Overall Study||50
7551599|NCT03087604|18586601|P2|STARTED|Overall Study||50
7551600|NCT03087604|18586602|P1|STARTED|Overall Study||50
7551601|NCT03087513|18586612|P1|NOT COMPLETED|Second Intervention After 3 hr Washout||2
7551602|NCT03087513|18586612|P1|COMPLETED|Second Intervention After 3 hr Washout||38
7551603|NCT03087513|18586612|P1|STARTED|Second Intervention After 3 hr Washout||40
7551604|NCT03087513|18586612|P1|NOT COMPLETED|First Intervention||0
7551605|NCT03087513|18586612|P1|COMPLETED|First Intervention||40
7551606|NCT03087513|18586612|P1|STARTED|First Intervention||40
7551607|NCT03086707|18586628|P2|NOT COMPLETED|Overall Study||0
7551608|NCT03086707|18586629|P1|NOT COMPLETED|Overall Study||0
7551609|NCT03086707|18586628|P2|COMPLETED|Overall Study||7
7551610|NCT03086707|18586629|P1|COMPLETED|Overall Study||7
7551611|NCT03086707|18586628|P2|STARTED|Overall Study||7
7551612|NCT03086707|18586629|P1|STARTED|Overall Study||7
7551613|NCT03086551|18586659|P2|NOT COMPLETED|Second Intervention||0
7551614|NCT03086551|18586660|P1|NOT COMPLETED|Second Intervention||0
7551615|NCT03086551|18586659|P2|COMPLETED|Second Intervention||1
7551616|NCT03086551|18586660|P1|COMPLETED|Second Intervention||1
7551617|NCT03086551|18586659|P2|STARTED|Second Intervention||1
7551618|NCT03086551|18586660|P1|STARTED|Second Intervention||1
7551619|NCT03086551|18586659|P2|NOT COMPLETED|Washout||3
7551620|NCT03086551|18586660|P1|NOT COMPLETED|Washout||3
7551621|NCT03086551|18586659|P2|COMPLETED|Washout||1
7551622|NCT03086551|18586660|P1|COMPLETED|Washout||1
7551623|NCT03086551|18586659|P2|STARTED|Washout||4
7551624|NCT03086551|18586660|P1|STARTED|Washout||4
7551625|NCT03086551|18586659|P2|NOT COMPLETED|First Intervention||1
7551626|NCT03086551|18586660|P1|NOT COMPLETED|First Intervention||1
7551627|NCT03086551|18586659|P2|COMPLETED|First Intervention||4
7551628|NCT03086551|18586660|P1|COMPLETED|First Intervention||4
7551629|NCT03086551|18586659|P2|STARTED|First Intervention||5
7551630|NCT03086551|18586660|P1|STARTED|First Intervention||5
7551631|NCT03086447|18586676|P2|NOT COMPLETED|Overall Study||20
7551632|NCT03086447|18586677|P1|NOT COMPLETED|Overall Study||11
7551633|NCT03086447|18586676|P2|COMPLETED|Overall Study||110
7551634|NCT03086447|18586677|P1|COMPLETED|Overall Study||121
7551635|NCT03086447|18586676|P2|STARTED|Overall Study||130
7551636|NCT03086447|18586677|P1|STARTED|Overall Study||132
7551637|NCT03086408|18586699|P2|NOT COMPLETED|Overall Study||0
7551638|NCT03086408|18586700|P1|NOT COMPLETED|Overall Study||0
7551639|NCT03086408|18586699|P2|COMPLETED|Overall Study||10
7551640|NCT03086408|18586700|P1|COMPLETED|Overall Study||10
7551641|NCT03086408|18586699|P2|STARTED|Overall Study||10
7551642|NCT03086408|18586700|P1|STARTED|Overall Study||10
7551643|NCT03086356|18586724|P1|NOT COMPLETED|Overall Study||0
7551644|NCT03086356|18586724|P1|COMPLETED|Overall Study||12
7551645|NCT03086356|18586724|P1|STARTED|Overall Study||12
7551646|NCT03086343|18586735|P2|NOT COMPLETED|Overall Study||25
7551647|NCT03086343|18586736|P1|NOT COMPLETED|Overall Study||32
7551648|NCT03086343|18586735|P2|COMPLETED|Overall Study||278
7551649|NCT03086343|18586736|P1|COMPLETED|Overall Study||277
7551650|NCT03086343|18586735|P2|STARTED|Overall Study||303
7551651|NCT03086343|18586736|P1|STARTED|Overall Study||309
7551652|NCT03086330|18586748|P2|NOT COMPLETED|Overall Study||4
7551653|NCT03086330|18586749|P1|NOT COMPLETED|Overall Study||4
7551654|NCT03086330|18586748|P2|COMPLETED|Overall Study||147
7551655|NCT03086330|18586749|P1|COMPLETED|Overall Study||147
7551656|NCT03086330|18586748|P2|Exposed|Overall Study||151
7551657|NCT03086330|18586749|P1|Exposed|Overall Study||150
7551658|NCT03086330|18586748|P2|STARTED|Overall Study||151
7551659|NCT03086330|18586749|P1|STARTED|Overall Study||151
7551660|NCT03086265|18586871|P2|NOT COMPLETED|Overall Study||0
7551661|NCT03086265|18586872|P1|NOT COMPLETED|Overall Study||0
7551662|NCT03086265|18586871|P2|COMPLETED|Overall Study||10
7551663|NCT03086265|18586872|P1|COMPLETED|Overall Study||10
7551664|NCT03086265|18586871|P2|STARTED|Overall Study||10
7551665|NCT03086265|18586872|P1|STARTED|Overall Study||10
7551666|NCT03086213|18586929|P2|NOT COMPLETED|Overall Study||0
7551667|NCT03086213|18586930|P1|NOT COMPLETED|Overall Study||0
7551668|NCT03086213|18586929|P2|COMPLETED|Overall Study||24
7551669|NCT03086213|18586930|P1|COMPLETED|Overall Study||24
7551670|NCT03086213|18586929|P2|STARTED|Overall Study||24
7551671|NCT03086213|18586930|P1|STARTED|Overall Study||24
7551672|NCT03086135|18586946|P1|NOT COMPLETED|Overall Study||3
7551673|NCT03086135|18586946|P1|COMPLETED|Overall Study||48
7551674|NCT03086135|18586946|P1|STARTED|Overall Study||51
7551675|NCT03086018|18586973|P1|NOT COMPLETED|Final Testing for End of Trial||2
7551676|NCT03086018|18586973|P1|COMPLETED|Final Testing for End of Trial||28
7551677|NCT03086018|18586973|P1|STARTED|Final Testing for End of Trial||30
7551678|NCT03086018|18586973|P1|NOT COMPLETED|Field Testing||0
7551679|NCT03086018|18586973|P1|COMPLETED|Field Testing||30
7551680|NCT03086018|18586973|P1|STARTED|Field Testing||30
7551681|NCT03085914|18586988|P7|NOT COMPLETED|Overall Study||11
7551682|NCT03085914|18586989|P6|NOT COMPLETED|Overall Study||8
7551683|NCT03085914|18586990|P5|NOT COMPLETED|Overall Study||13
7551684|NCT03085914|18586991|P4|NOT COMPLETED|Overall Study||9
7551685|NCT03085914|18586992|P3|NOT COMPLETED|Overall Study||11
7551686|NCT03085914|18586993|P2|NOT COMPLETED|Overall Study||9
7551687|NCT03085914|18586994|P1|NOT COMPLETED|Overall Study||9
7551688|NCT03085914|18586988|P7|COMPLETED|Overall Study||0
7551689|NCT03085914|18586989|P6|COMPLETED|Overall Study||0
7551690|NCT03085914|18586990|P5|COMPLETED|Overall Study||0
7551691|NCT03085914|18586991|P4|COMPLETED|Overall Study||0
7551692|NCT03085914|18586992|P3|COMPLETED|Overall Study||0
7551693|NCT03085914|18586993|P2|COMPLETED|Overall Study||0
7551694|NCT03085914|18586994|P1|COMPLETED|Overall Study||0
7551695|NCT03085914|18586988|P7|Phase 2 Mandatory Biopsy Cohort|Overall Study||0
7551696|NCT03085914|18586989|P6|Phase 2 Mandatory Biopsy Cohort|Overall Study||0
7551697|NCT03085914|18586990|P5|Phase 2 Mandatory Biopsy Cohort|Overall Study||6
7551698|NCT03085914|18586991|P4|Phase 2 Mandatory Biopsy Cohort|Overall Study||3
7551699|NCT03085914|18586992|P3|Phase 2 Mandatory Biopsy Cohort|Overall Study||3
7551700|NCT03085914|18586993|P2|Phase 2 Mandatory Biopsy Cohort|Overall Study||0
7551701|NCT03085914|18586994|P1|Phase 2 Mandatory Biopsy Cohort|Overall Study||0
7551702|NCT03085914|18586988|P7|STARTED|Overall Study||11
7551703|NCT03085914|18586989|P6|STARTED|Overall Study||8
7551704|NCT03085914|18586990|P5|STARTED|Overall Study||13
7551705|NCT03085914|18586991|P4|STARTED|Overall Study||9
7551706|NCT03085914|18586992|P3|STARTED|Overall Study||11
7551707|NCT03085914|18586993|P2|STARTED|Overall Study||9
7551708|NCT03085914|18586994|P1|STARTED|Overall Study||9
7551709|NCT03085836|18587027|P3|NOT COMPLETED|Overall Study||0
7551710|NCT03085836|18587028|P2|NOT COMPLETED|Overall Study||0
7551711|NCT03085836|18587029|P1|NOT COMPLETED|Overall Study||0
7551712|NCT03085836|18587027|P3|COMPLETED|Overall Study||10
7551713|NCT03085836|18587028|P2|COMPLETED|Overall Study||11
7551714|NCT03085836|18587029|P1|COMPLETED|Overall Study||12
7551715|NCT03085836|18587027|P3|STARTED|Overall Study||10
7551716|NCT03085836|18587028|P2|STARTED|Overall Study||11
7551717|NCT03085836|18587029|P1|STARTED|Overall Study||12
7551718|NCT03085797|18587078|P2|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||1
7551719|NCT03085797|18587079|P1|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||0
7551720|NCT03085797|18587078|P2|COMPLETED|No-treatment Follow-up Period (6 Months)||68
7551721|NCT03085797|18587079|P1|COMPLETED|No-treatment Follow-up Period (6 Months)||65
7551722|NCT03085797|18587078|P2|STARTED|No-treatment Follow-up Period (6 Months)|Only 69 Par. continued in FU to check maintenance of response after stopping treatment per protocol|69
7551723|NCT03085797|18587079|P1|STARTED|No-treatment Follow-up Period (6 Months)|Only 65 Par. continued in FU to check maintenance of response after stopping treatment per protocol|65
7551724|NCT03085797|18587078|P2|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17
7551725|NCT03085797|18587079|P1|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17
7551726|NCT03085797|18587078|P2|COMPLETED|Treatment Period (TP) (52 Weeks)||189
7551727|NCT03085797|18587079|P1|COMPLETED|Treatment Period (TP) (52 Weeks)||184
7551728|NCT03085797|18587078|P2|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||12
7551729|NCT03085797|18587079|P1|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||15
7551730|NCT03085797|18587078|P2|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||1
7551731|NCT03085797|18587079|P1|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||2
7551732|NCT03085797|18587078|P2|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1
7551733|NCT03085797|18587079|P1|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1
7551734|NCT03085797|18587078|P2|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||0
7551735|NCT03085797|18587079|P1|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||1
7551736|NCT03085797|18587078|P2|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||5
7551737|NCT03085797|18587079|P1|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||11
7551738|NCT03085797|18587078|P2|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4
7551739|NCT03085797|18587079|P1|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4
7551740|NCT03085797|18587078|P2|Not Completed IP|Treatment Period (TP) (52 Weeks)||23
7551741|NCT03085797|18587079|P1|Not Completed IP|Treatment Period (TP) (52 Weeks)||34
7551742|NCT03085797|18587078|P2|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||183
7551743|NCT03085797|18587079|P1|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||167
7551744|NCT03085797|18587078|P2|STARTED|Treatment Period (TP) (52 Weeks)||206
7551745|NCT03085797|18587079|P1|STARTED|Treatment Period (TP) (52 Weeks)||201
7551746|NCT03085238|18587101|P1|NOT COMPLETED|Overall Study||4
7551747|NCT03085238|18587101|P1|COMPLETED|Overall Study||19
7551748|NCT03085238|18587101|P1|18 Months|Overall Study||7
7551749|NCT03085238|18587101|P1|15 Months|Overall Study||11
7551750|NCT03085238|18587101|P1|12 Months|Overall Study||14
7551751|NCT03085238|18587101|P1|9 Months|Overall Study||16
7551752|NCT03085238|18587101|P1|6 Months|Overall Study||19
7551753|NCT03085238|18587101|P1|3 Months|Overall Study||22
7551754|NCT03085238|18587101|P1|1 Month|Overall Study||23
7551755|NCT03085238|18587101|P1|STARTED|Overall Study||23
7551756|NCT03085017|18587128|P2|NOT COMPLETED|Overall Study||3
7551757|NCT03085017|18587129|P1|NOT COMPLETED|Overall Study||0
7551758|NCT03085017|18587128|P2|COMPLETED|Overall Study||24
7551759|NCT03085017|18587129|P1|COMPLETED|Overall Study||30
7551760|NCT03085017|18587128|P2|STARTED|Overall Study||27
7551761|NCT03085017|18587129|P1|STARTED|Overall Study||30
7551762|NCT03084315|18587155|P2|NOT COMPLETED|Overall Study||9
7551763|NCT03084315|18587156|P1|NOT COMPLETED|Overall Study||10
7551764|NCT03084315|18587155|P2|COMPLETED|Overall Study||109
7551765|NCT03084315|18587156|P1|COMPLETED|Overall Study||106
7551766|NCT03084315|18587155|P2|STARTED|Overall Study||118
7551767|NCT03084315|18587156|P1|STARTED|Overall Study||116
7551768|NCT03083990|18587166|P2|NOT COMPLETED|Overall Study||0
7551769|NCT03083990|18587167|P1|NOT COMPLETED|Overall Study||1
7551770|NCT03083990|18587166|P2|COMPLETED|Overall Study||50
7551771|NCT03083990|18587167|P1|COMPLETED|Overall Study||49
7551772|NCT03083990|18587166|P2|STARTED|Overall Study||50
7551773|NCT03083990|18587167|P1|STARTED|Overall Study||50
7551774|NCT03083847|18587205|P10|NOT COMPLETED|Overall Study||0
7551775|NCT03083847|18587206|P9|NOT COMPLETED|Overall Study||0
7551776|NCT03083847|18587207|P8|NOT COMPLETED|Overall Study||0
7551777|NCT03083847|18587208|P7|NOT COMPLETED|Overall Study||0
7551778|NCT03083847|18587209|P6|NOT COMPLETED|Overall Study||0
7551779|NCT03083847|18587210|P5|NOT COMPLETED|Overall Study||0
7551780|NCT03083847|18587211|P4|NOT COMPLETED|Overall Study||0
7551781|NCT03083847|18587212|P3|NOT COMPLETED|Overall Study||4
7551782|NCT03083847|18587213|P2|NOT COMPLETED|Overall Study||1
7551783|NCT03083847|18587214|P1|NOT COMPLETED|Overall Study||1
7551784|NCT03083847|18587205|P10|COMPLETED|Overall Study||4
7551785|NCT03083847|18587206|P9|COMPLETED|Overall Study||2
7551786|NCT03083847|18587207|P8|COMPLETED|Overall Study||4
7551787|NCT03083847|18587208|P7|COMPLETED|Overall Study||2
7551788|NCT03083847|18587209|P6|COMPLETED|Overall Study||2
7551789|NCT03083847|18587210|P5|COMPLETED|Overall Study||8
7551790|NCT03083847|18587211|P4|COMPLETED|Overall Study||4
7551791|NCT03083847|18587212|P3|COMPLETED|Overall Study||6
7551792|NCT03083847|18587213|P2|COMPLETED|Overall Study||9
7551793|NCT03083847|18587214|P1|COMPLETED|Overall Study||8
7551794|NCT03083847|18587205|P10|STARTED|Overall Study||4
7551795|NCT03083847|18587206|P9|STARTED|Overall Study||2
7551796|NCT03083847|18587207|P8|STARTED|Overall Study||4
7551797|NCT03083847|18587208|P7|STARTED|Overall Study||2
7551798|NCT03083847|18587209|P6|STARTED|Overall Study||2
7551799|NCT03083847|18587210|P5|STARTED|Overall Study||8
7551800|NCT03083847|18587211|P4|STARTED|Overall Study||4
7551801|NCT03083847|18587212|P3|STARTED|Overall Study||10
7551802|NCT03083847|18587213|P2|STARTED|Overall Study||10
7551803|NCT03083847|18587214|P1|STARTED|Overall Study||9
7551804|NCT03083769|18587236|P2|NOT COMPLETED|Overall Study||32
7551805|NCT03083769|18587237|P1|NOT COMPLETED|Overall Study||20
7551806|NCT03083769|18587236|P2|COMPLETED|Overall Study||631
7551807|NCT03083769|18587237|P1|COMPLETED|Overall Study||819
7551808|NCT03083769|18587236|P2|STARTED|Overall Study||663
7551809|NCT03083769|18587237|P1|STARTED|Overall Study||839
7551810|NCT03083639|18587249|P2|NOT COMPLETED|Intervention Period 2 (1 Day)||0
7551811|NCT03083639|18587250|P1|NOT COMPLETED|Intervention Period 2 (1 Day)||0
7551812|NCT03083639|18587249|P2|COMPLETED|Intervention Period 2 (1 Day)||25
7551813|NCT03083639|18587250|P1|COMPLETED|Intervention Period 2 (1 Day)||25
7551814|NCT03083639|18587249|P2|STARTED|Intervention Period 2 (1 Day)||25
7551815|NCT03083639|18587250|P1|STARTED|Intervention Period 2 (1 Day)||25
7551816|NCT03083639|18587249|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||1
7551817|NCT03083639|18587250|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||1
7551818|NCT03083639|18587249|P2|COMPLETED|Washout Period (at Least 6 Days)||25
7551819|NCT03083639|18587250|P1|COMPLETED|Washout Period (at Least 6 Days)||25
7551820|NCT03083639|18587249|P2|STARTED|Washout Period (at Least 6 Days)||26
7551821|NCT03083639|18587250|P1|STARTED|Washout Period (at Least 6 Days)||26
7551822|NCT03083639|18587249|P2|NOT COMPLETED|Intervention Period 1 (1 Day)||0
7551823|NCT03083639|18587250|P1|NOT COMPLETED|Intervention Period 1 (1 Day)||0
7551824|NCT03083639|18587249|P2|COMPLETED|Intervention Period 1 (1 Day)||26
7551825|NCT03083639|18587250|P1|COMPLETED|Intervention Period 1 (1 Day)||26
7551826|NCT03083639|18587249|P2|STARTED|Intervention Period 1 (1 Day)||26
7551827|NCT03083639|18587250|P1|STARTED|Intervention Period 1 (1 Day)||26
7551828|NCT03083483|18587263|P3|NOT COMPLETED|Overall Study||3
7551829|NCT03083483|18587264|P2|NOT COMPLETED|Overall Study||2
7551830|NCT03083483|18587265|P1|NOT COMPLETED|Overall Study||4
7551831|NCT03083483|18587263|P3|COMPLETED|Overall Study||20
7551832|NCT03083483|18587264|P2|COMPLETED|Overall Study||20
7551833|NCT03083483|18587265|P1|COMPLETED|Overall Study||20
7551834|NCT03083483|18587263|P3|STARTED|Overall Study||23
7551835|NCT03083483|18587264|P2|STARTED|Overall Study||22
7551836|NCT03083483|18587265|P1|STARTED|Overall Study||24
7551837|NCT03083470|18587284|P5|NOT COMPLETED|Overall Study||2
7551838|NCT03083470|18587285|P4|NOT COMPLETED|Overall Study||0
7551839|NCT03083470|18587286|P3|NOT COMPLETED|Overall Study||0
7551840|NCT03083470|18587287|P2|NOT COMPLETED|Overall Study||0
7551841|NCT03083470|18587288|P1|NOT COMPLETED|Overall Study||0
7551842|NCT03083470|18587284|P5|COMPLETED|Overall Study||7
7551843|NCT03083470|18587285|P4|COMPLETED|Overall Study||6
7551844|NCT03083470|18587286|P3|COMPLETED|Overall Study||6
7551845|NCT03083470|18587287|P2|COMPLETED|Overall Study||6
7551846|NCT03083470|18587288|P1|COMPLETED|Overall Study||6
7551847|NCT03083470|18587284|P5|STARTED|Overall Study||9
7551848|NCT03083470|18587285|P4|STARTED|Overall Study||6
7551849|NCT03083470|18587286|P3|STARTED|Overall Study||6
7551850|NCT03083470|18587287|P2|STARTED|Overall Study||6
7551851|NCT03083470|18587288|P1|STARTED|Overall Study||6
7551852|NCT03083379|18587327|P2|NOT COMPLETED|Overall Study||0
7551853|NCT03083379|18587328|P1|NOT COMPLETED|Overall Study||0
7551854|NCT03083379|18587327|P2|COMPLETED|Overall Study||15
7551855|NCT03083379|18587328|P1|COMPLETED|Overall Study||15
7551856|NCT03083379|18587327|P2|STARTED|Overall Study||15
7551857|NCT03083379|18587328|P1|STARTED|Overall Study||15
7551858|NCT03082599|18587336|P2|NOT COMPLETED|Overall Study||0
7551859|NCT03082599|18587337|P1|NOT COMPLETED|Overall Study||1
7551860|NCT03082599|18587336|P2|COMPLETED|Overall Study||39
7551861|NCT03082599|18587337|P1|COMPLETED|Overall Study||39
7551862|NCT03082599|18587336|P2|STARTED|Overall Study||39
7551863|NCT03082599|18587337|P1|STARTED|Overall Study||40
7551864|NCT03082586|18587369|P6|NOT COMPLETED|Overall Study||0
7551865|NCT03082586|18587370|P5|NOT COMPLETED|Overall Study||0
7551866|NCT03082586|18587371|P4|NOT COMPLETED|Overall Study||0
7551867|NCT03082586|18587372|P3|NOT COMPLETED|Overall Study||0
7551868|NCT03082586|18587373|P2|NOT COMPLETED|Overall Study||0
7551869|NCT03082586|18587374|P1|NOT COMPLETED|Overall Study||0
7551870|NCT03082586|18587369|P6|COMPLETED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
7551871|NCT03082586|18587370|P5|COMPLETED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
7551872|NCT03082586|18587371|P4|COMPLETED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
7551873|NCT03082586|18587372|P3|COMPLETED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
7551874|NCT03082586|18587373|P2|COMPLETED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
7551875|NCT03082586|18587374|P1|COMPLETED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
7551876|NCT03082586|18587369|P6|STARTED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
7551877|NCT03082586|18587370|P5|STARTED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
7551878|NCT03082586|18587371|P4|STARTED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
7551879|NCT03082586|18587372|P3|STARTED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
7551970|NCT03078556|18587578|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
7551880|NCT03082586|18587373|P2|STARTED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
7551881|NCT03082586|18587374|P1|STARTED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
7551882|NCT03082196|18587396|P2|NOT COMPLETED|Overall Study||13
7551883|NCT03082196|18587397|P1|NOT COMPLETED|Overall Study||9
7551884|NCT03082196|18587396|P2|COMPLETED|Overall Study||129
7551885|NCT03082196|18587397|P1|COMPLETED|Overall Study||133
7551886|NCT03082196|18587396|P2|STARTED|Overall Study||142
7551887|NCT03082196|18587397|P1|STARTED|Overall Study||142
7551888|NCT03080961|18587409|P1|NOT COMPLETED|Overall Study||3
7551889|NCT03080961|18587409|P1|COMPLETED|Overall Study||43
7551890|NCT03080961|18587409|P1|STARTED|Overall Study||46
7551891|NCT03080493|18587420|P2|NOT COMPLETED|Overall Study||2
7551892|NCT03080493|18587421|P1|NOT COMPLETED|Overall Study||1
7551893|NCT03080493|18587420|P2|COMPLETED|Overall Study||58
7551894|NCT03080493|18587421|P1|COMPLETED|Overall Study||60
7551895|NCT03080493|18587420|P2|STARTED|Overall Study||60
7551896|NCT03080493|18587421|P1|STARTED|Overall Study||61
7551897|NCT03080454|18587437|P1|NOT COMPLETED|Anodal FU (7 Days)||4
7551898|NCT03080454|18587437|P1|COMPLETED|Anodal FU (7 Days)||19
7551899|NCT03080454|18587437|P1|STARTED|Anodal FU (7 Days)||23
7551900|NCT03080454|18587437|P1|NOT COMPLETED|Anodal Doublestim (5 Days)||1
7551901|NCT03080454|18587437|P1|COMPLETED|Anodal Doublestim (5 Days)||23
7551902|NCT03080454|18587437|P1|STARTED|Anodal Doublestim (5 Days)||24
7551903|NCT03080454|18587437|P1|NOT COMPLETED|Sham FU (7days)||0
7551904|NCT03080454|18587437|P1|COMPLETED|Sham FU (7days)||24
7551905|NCT03080454|18587437|P1|STARTED|Sham FU (7days)||24
7551906|NCT03080454|18587437|P1|NOT COMPLETED|Sham Doublestim (5days)||0
7551907|NCT03080454|18587437|P1|COMPLETED|Sham Doublestim (5days)||24
7551908|NCT03080454|18587437|P1|STARTED|Sham Doublestim (5days)||24
7551909|NCT03080454|18587437|P1|NOT COMPLETED|Baseline||2
7551910|NCT03080454|18587437|P1|COMPLETED|Baseline|Two participants (pts) dropped out after consent due to hospitalizations unrelated to the study.|24
7551911|NCT03080454|18587437|P1|STARTED|Baseline||26
7551912|NCT03079531|18587446|P1|NOT COMPLETED|Overall Study||7
7551913|NCT03079531|18587446|P1|COMPLETED|Overall Study||17
7551914|NCT03079531|18587446|P1|Attended ≥1 Post-baseline Visit|Overall Study||23
7551915|NCT03079531|18587446|P1|STARTED|Overall Study||24
7551916|NCT03079375|18587459|P3|NOT COMPLETED|Overall Study||21
7551917|NCT03079375|18587460|P2|NOT COMPLETED|Overall Study||6
7551918|NCT03079375|18587461|P1|NOT COMPLETED|Overall Study||5
7551919|NCT03079375|18587459|P3|COMPLETED|Overall Study||476
7551920|NCT03079375|18587460|P2|COMPLETED|Overall Study||493
7551921|NCT03079375|18587461|P1|COMPLETED|Overall Study||498
7551922|NCT03079375|18587459|P3|STARTED|Overall Study||497
7551923|NCT03079375|18587460|P2|STARTED|Overall Study||499
7551924|NCT03079375|18587461|P1|STARTED|Overall Study||503
7551925|NCT03078946|18587495|P2|NOT COMPLETED|Overall Study||0
7551926|NCT03078946|18587496|P1|NOT COMPLETED|Overall Study||0
7551927|NCT03078946|18587495|P2|COMPLETED|Overall Study||30
7551928|NCT03078946|18587496|P1|COMPLETED|Overall Study||30
7551929|NCT03078946|18587495|P2|STARTED|Overall Study||30
7551930|NCT03078946|18587496|P1|STARTED|Overall Study||30
7551931|NCT03078816|18587504|P1|NOT COMPLETED|Overall Study||1
7551932|NCT03078816|18587504|P1|COMPLETED|Overall Study||4
7551933|NCT03078816|18587504|P1|STARTED|Overall Study||5
7551934|NCT03078647|18587522|P3|NOT COMPLETED|Overall Study||0
7551935|NCT03078647|18587523|P2|NOT COMPLETED|Overall Study||1
7551936|NCT03078647|18587524|P1|NOT COMPLETED|Overall Study||0
7551937|NCT03078647|18587522|P3|COMPLETED|Overall Study||3
7551938|NCT03078647|18587523|P2|COMPLETED|Overall Study||10
7551939|NCT03078647|18587524|P1|COMPLETED|Overall Study||17
7551940|NCT03078647|18587522|P3|STARTED|Overall Study||3
7551941|NCT03078647|18587523|P2|STARTED|Overall Study||11
7551942|NCT03078647|18587524|P1|STARTED|Overall Study||17
7551943|NCT03078595|18587543|P2|NOT COMPLETED|Overall Study||0
7551944|NCT03078595|18587544|P1|NOT COMPLETED|Overall Study||0
7551945|NCT03078595|18587543|P2|COMPLETED|Overall Study||24
7551946|NCT03078595|18587544|P1|COMPLETED|Overall Study||24
7551947|NCT03078595|18587543|P2|STARTED|Overall Study||24
7551948|NCT03078595|18587544|P1|STARTED|Overall Study||24
7551949|NCT03078582|18587554|P2|NOT COMPLETED|Overall Study||8
7551950|NCT03078582|18587555|P1|NOT COMPLETED|Overall Study||0
7551951|NCT03078582|18587554|P2|COMPLETED|Overall Study||8
7551952|NCT03078582|18587555|P1|COMPLETED|Overall Study||10
7551953|NCT03078582|18587554|P2|STARTED|Overall Study||16
7551954|NCT03078582|18587555|P1|STARTED|Overall Study||10
7551955|NCT03078556|18587575|P4|NOT COMPLETED|Treatment Period 3 (4 Days)||0
7551956|NCT03078556|18587576|P3|NOT COMPLETED|Treatment Period 3 (4 Days)||0
7551957|NCT03078556|18587577|P2|NOT COMPLETED|Treatment Period 3 (4 Days)||0
7551958|NCT03078556|18587578|P1|NOT COMPLETED|Treatment Period 3 (4 Days)||0
7551959|NCT03078556|18587575|P4|COMPLETED|Treatment Period 3 (4 Days)||9
7551960|NCT03078556|18587576|P3|COMPLETED|Treatment Period 3 (4 Days)||7
7551961|NCT03078556|18587577|P2|COMPLETED|Treatment Period 3 (4 Days)||7
7551962|NCT03078556|18587578|P1|COMPLETED|Treatment Period 3 (4 Days)||9
7551963|NCT03078556|18587575|P4|STARTED|Treatment Period 3 (4 Days)||9
7551964|NCT03078556|18587576|P3|STARTED|Treatment Period 3 (4 Days)||7
7551965|NCT03078556|18587577|P2|STARTED|Treatment Period 3 (4 Days)||7
7551966|NCT03078556|18587578|P1|STARTED|Treatment Period 3 (4 Days)||9
7551967|NCT03078556|18587575|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
7551968|NCT03078556|18587576|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
7551969|NCT03078556|18587577|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
7551971|NCT03078556|18587575|P4|COMPLETED|Washout Period 2 (7 Days)||9
7551972|NCT03078556|18587576|P3|COMPLETED|Washout Period 2 (7 Days)||7
7551973|NCT03078556|18587577|P2|COMPLETED|Washout Period 2 (7 Days)||7
7551974|NCT03078556|18587578|P1|COMPLETED|Washout Period 2 (7 Days)||9
7551975|NCT03078556|18587575|P4|STARTED|Washout Period 2 (7 Days)||9
7551976|NCT03078556|18587576|P3|STARTED|Washout Period 2 (7 Days)||7
7551977|NCT03078556|18587577|P2|STARTED|Washout Period 2 (7 Days)||7
7551978|NCT03078556|18587578|P1|STARTED|Washout Period 2 (7 Days)||9
7551979|NCT03078556|18587575|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7551980|NCT03078556|18587576|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7551981|NCT03078556|18587577|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7551982|NCT03078556|18587578|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7551983|NCT03078556|18587575|P4|COMPLETED|Treatment Period 2 (4 Days)||37
7551984|NCT03078556|18587576|P3|COMPLETED|Treatment Period 2 (4 Days)||37
7551985|NCT03078556|18587577|P2|COMPLETED|Treatment Period 2 (4 Days)||36
7551986|NCT03078556|18587578|P1|COMPLETED|Treatment Period 2 (4 Days)||37
7551987|NCT03078556|18587575|P4|STARTED|Treatment Period 2 (4 Days)||37
7551988|NCT03078556|18587576|P3|STARTED|Treatment Period 2 (4 Days)||37
7551989|NCT03078556|18587577|P2|STARTED|Treatment Period 2 (4 Days)||36
7551990|NCT03078556|18587578|P1|STARTED|Treatment Period 2 (4 Days)||37
7551991|NCT03078556|18587575|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
7551992|NCT03078556|18587576|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
7551993|NCT03078556|18587577|P2|NOT COMPLETED|Washout Period 1 (7 Days)||2
7551994|NCT03078556|18587578|P1|NOT COMPLETED|Washout Period 1 (7 Days)||2
7551995|NCT03078556|18587575|P4|COMPLETED|Washout Period 1 (7 Days)||37
7551996|NCT03078556|18587576|P3|COMPLETED|Washout Period 1 (7 Days)||37
7551997|NCT03078556|18587577|P2|COMPLETED|Washout Period 1 (7 Days)||36
7551998|NCT03078556|18587578|P1|COMPLETED|Washout Period 1 (7 Days)||37
7551999|NCT03078556|18587575|P4|STARTED|Washout Period 1 (7 Days)||38
7552000|NCT03078556|18587576|P3|STARTED|Washout Period 1 (7 Days)||38
7552001|NCT03078556|18587577|P2|STARTED|Washout Period 1 (7 Days)||38
7552002|NCT03078556|18587578|P1|STARTED|Washout Period 1 (7 Days)||39
7552003|NCT03078556|18587575|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
7552004|NCT03078556|18587576|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
7552005|NCT03078556|18587577|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||1
7552006|NCT03078556|18587578|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
7552007|NCT03078556|18587575|P4|COMPLETED|Treatment Period 1 (4 Days)||38
7552008|NCT03078556|18587576|P3|COMPLETED|Treatment Period 1 (4 Days)||38
7552009|NCT03078556|18587577|P2|COMPLETED|Treatment Period 1 (4 Days)||38
7552010|NCT03078556|18587578|P1|COMPLETED|Treatment Period 1 (4 Days)||39
7552011|NCT03078556|18587575|P4|STARTED|Treatment Period 1 (4 Days)||38
7552012|NCT03078556|18587576|P3|STARTED|Treatment Period 1 (4 Days)||38
7552013|NCT03078556|18587577|P2|STARTED|Treatment Period 1 (4 Days)||39
7552014|NCT03078556|18587578|P1|STARTED|Treatment Period 1 (4 Days)||39
7552015|NCT03078504|18587716|P1|NOT COMPLETED|Overall Study||0
7552016|NCT03078504|18587716|P1|COMPLETED|Overall Study||6
7552017|NCT03078504|18587716|P1|STARTED|Overall Study||6
7552018|NCT03078478|18587722|P2|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||27
7552019|NCT03078478|18587723|P1|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||25
7552020|NCT03078478|18587722|P2|COMPLETED|Maintencance Period 2 (36 Weeks)||734
7552021|NCT03078478|18587723|P1|COMPLETED|Maintencance Period 2 (36 Weeks)||733
7552022|NCT03078478|18587722|P2|STARTED|Maintencance Period 2 (36 Weeks)||761
7552023|NCT03078478|18587723|P1|STARTED|Maintencance Period 2 (36 Weeks)||758
7552024|NCT03078478|18587722|P2|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||43
7552025|NCT03078478|18587723|P1|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||47
7552026|NCT03078478|18587722|P2|COMPLETED|Maintenance Period 1 (36 Weeks)||761
7552027|NCT03078478|18587723|P1|COMPLETED|Maintenance Period 1 (36 Weeks)||758
7552028|NCT03078478|18587722|P2|STARTED|Maintenance Period 1 (36 Weeks)||804
7552029|NCT03078478|18587723|P1|STARTED|Maintenance Period 1 (36 Weeks)||805
7552030|NCT03078478|18587722|P2|NOT COMPLETED|Titration Period (16 Weeks)||0
7552031|NCT03078478|18587723|P1|NOT COMPLETED|Titration Period (16 Weeks)||0
7552032|NCT03078478|18587722|P2|COMPLETED|Titration Period (16 Weeks)||804
7552033|NCT03078478|18587723|P1|COMPLETED|Titration Period (16 Weeks)||805
7552034|NCT03078478|18587722|P2|Safety Analysis Set|Titration Period (16 Weeks)||798
7552035|NCT03078478|18587723|P1|Safety Analysis Set|Titration Period (16 Weeks)||802
7552036|NCT03078478|18587722|P2|Full Analysis Set|Titration Period (16 Weeks)||804
7552037|NCT03078478|18587723|P1|Full Analysis Set|Titration Period (16 Weeks)||805
7552038|NCT03078478|18587722|P2|STARTED|Titration Period (16 Weeks)||804
7552039|NCT03078478|18587723|P1|STARTED|Titration Period (16 Weeks)||805
7552040|NCT03078270|18587761|P2|NOT COMPLETED|Overall Study||0
7552041|NCT03078270|18587762|P1|NOT COMPLETED|Overall Study||4
7552042|NCT03078270|18587761|P2|COMPLETED|Overall Study||0
7552043|NCT03078270|18587762|P1|COMPLETED|Overall Study||0
7552044|NCT03078270|18587761|P2|STARTED|Overall Study||0
7552045|NCT03078270|18587762|P1|STARTED|Overall Study||4
7552046|NCT03078127|18587771|P3|NOT COMPLETED|Third Intervention||0
7552047|NCT03078127|18587772|P2|NOT COMPLETED|Third Intervention||0
7552048|NCT03078127|18587773|P1|NOT COMPLETED|Third Intervention||0
7552049|NCT03078127|18587771|P3|COMPLETED|Third Intervention||3
7552050|NCT03078127|18587772|P2|COMPLETED|Third Intervention||3
7552051|NCT03078127|18587773|P1|COMPLETED|Third Intervention||4
7552052|NCT03078127|18587771|P3|STARTED|Third Intervention||3
7552053|NCT03078127|18587772|P2|STARTED|Third Intervention||3
7552054|NCT03078127|18587773|P1|STARTED|Third Intervention||4
7552055|NCT03078127|18587771|P3|NOT COMPLETED|Washout (3-21 Days)||0
7552056|NCT03078127|18587772|P2|NOT COMPLETED|Washout (3-21 Days)||0
7552057|NCT03078127|18587773|P1|NOT COMPLETED|Washout (3-21 Days)||0
7552058|NCT03078127|18587771|P3|COMPLETED|Washout (3-21 Days)||3
7552059|NCT03078127|18587772|P2|COMPLETED|Washout (3-21 Days)||3
7552060|NCT03078127|18587773|P1|COMPLETED|Washout (3-21 Days)||4
7552061|NCT03078127|18587771|P3|STARTED|Washout (3-21 Days)||3
7552062|NCT03078127|18587772|P2|STARTED|Washout (3-21 Days)||3
7552063|NCT03078127|18587773|P1|STARTED|Washout (3-21 Days)||4
7552064|NCT03078127|18587771|P3|NOT COMPLETED|Second Intervention||0
7552065|NCT03078127|18587772|P2|NOT COMPLETED|Second Intervention||0
7552066|NCT03078127|18587773|P1|NOT COMPLETED|Second Intervention||0
7552067|NCT03078127|18587771|P3|COMPLETED|Second Intervention||3
7552068|NCT03078127|18587772|P2|COMPLETED|Second Intervention||3
7552069|NCT03078127|18587773|P1|COMPLETED|Second Intervention||4
7552070|NCT03078127|18587771|P3|STARTED|Second Intervention||3
7552071|NCT03078127|18587772|P2|STARTED|Second Intervention||3
7552072|NCT03078127|18587773|P1|STARTED|Second Intervention||4
7552073|NCT03078127|18587771|P3|NOT COMPLETED|Washout (3-21 Days)||0
7552074|NCT03078127|18587772|P2|NOT COMPLETED|Washout (3-21 Days)||0
7552075|NCT03078127|18587773|P1|NOT COMPLETED|Washout (3-21 Days)||0
7552076|NCT03078127|18587771|P3|COMPLETED|Washout (3-21 Days)||3
7552077|NCT03078127|18587772|P2|COMPLETED|Washout (3-21 Days)||3
7552078|NCT03078127|18587773|P1|COMPLETED|Washout (3-21 Days)||4
7552079|NCT03078127|18587771|P3|STARTED|Washout (3-21 Days)||3
7552080|NCT03078127|18587772|P2|STARTED|Washout (3-21 Days)||3
7552081|NCT03078127|18587773|P1|STARTED|Washout (3-21 Days)||4
7552082|NCT03078127|18587771|P3|NOT COMPLETED|First Intervention||0
7552083|NCT03078127|18587772|P2|NOT COMPLETED|First Intervention||0
7552084|NCT03078127|18587773|P1|NOT COMPLETED|First Intervention||0
7552085|NCT03078127|18587771|P3|COMPLETED|First Intervention||3
7552086|NCT03078127|18587772|P2|COMPLETED|First Intervention||3
7552087|NCT03078127|18587773|P1|COMPLETED|First Intervention||4
7552088|NCT03078127|18587771|P3|STARTED|First Intervention||3
7552089|NCT03078127|18587772|P2|STARTED|First Intervention||3
7552090|NCT03078127|18587773|P1|STARTED|First Intervention||4
7552091|NCT03077919|18587809|P2|NOT COMPLETED|Overall Study||1
7552092|NCT03077919|18587810|P1|NOT COMPLETED|Overall Study||4
7552093|NCT03077919|18587809|P2|COMPLETED|Overall Study||38
7552094|NCT03077919|18587810|P1|COMPLETED|Overall Study||70
7552095|NCT03077919|18587809|P2|Final CAPS|Overall Study||38
7552096|NCT03077919|18587810|P1|Final CAPS|Overall Study||70
7552097|NCT03077919|18587809|P2|Week 8 Visit|Overall Study||38
7552098|NCT03077919|18587810|P1|Week 8 Visit|Overall Study||71
7552099|NCT03077919|18587809|P2|Week 6 Visit|Overall Study||38
7552100|NCT03077919|18587810|P1|Week 6 Visit|Overall Study||73
7552101|NCT03077919|18587809|P2|Week 4 Visit|Overall Study||38
7552102|NCT03077919|18587810|P1|Week 4 Visit|Overall Study||73
7552103|NCT03077919|18587809|P2|Week 2 Visit|Overall Study||39
7552104|NCT03077919|18587810|P1|Week 2 Visit|Overall Study||74
7552105|NCT03077919|18587809|P2|STARTED|Overall Study||39
7552106|NCT03077919|18587810|P1|STARTED|Overall Study||74
7552107|NCT03077893|18587840|P2|NOT COMPLETED|Overall Study||3
7552108|NCT03077893|18587841|P1|NOT COMPLETED|Overall Study||4
7552109|NCT03077893|18587840|P2|COMPLETED|Overall Study||16
7552110|NCT03077893|18587841|P1|COMPLETED|Overall Study||14
7552111|NCT03077893|18587840|P2|STARTED|Overall Study||19
7552112|NCT03077893|18587841|P1|STARTED|Overall Study||18
7552113|NCT03077724|18587870|P2|NOT COMPLETED|Overall Study||2
7552114|NCT03077724|18587871|P1|NOT COMPLETED|Overall Study||8
7552115|NCT03077724|18587870|P2|COMPLETED|Overall Study||12
7552116|NCT03077724|18587871|P1|COMPLETED|Overall Study||6
7552117|NCT03077724|18587870|P2|STARTED|Overall Study||14
7552118|NCT03077724|18587871|P1|STARTED|Overall Study||14
7552119|NCT03077711|18587883|P2|NOT COMPLETED|Overall Study||2
7552120|NCT03077711|18587884|P1|NOT COMPLETED|Overall Study||4
7552121|NCT03077711|18587883|P2|COMPLETED|Overall Study||43
7552122|NCT03077711|18587884|P1|COMPLETED|Overall Study||43
7552123|NCT03077711|18587883|P2|STARTED|Overall Study||45
7552124|NCT03077711|18587884|P1|STARTED|Overall Study||47
7552125|NCT03077659|18587903|P3|NOT COMPLETED|Overall Study||1
7552126|NCT03077659|18587904|P2|NOT COMPLETED|Overall Study||0
7552127|NCT03077659|18587905|P1|NOT COMPLETED|Overall Study||0
7552128|NCT03077659|18587903|P3|COMPLETED|Overall Study||9
7552129|NCT03077659|18587904|P2|COMPLETED|Overall Study||3
7552130|NCT03077659|18587905|P1|COMPLETED|Overall Study||3
7552131|NCT03077659|18587903|P3|STARTED|Overall Study||10
7552132|NCT03077659|18587904|P2|STARTED|Overall Study||3
7552133|NCT03077659|18587905|P1|STARTED|Overall Study||3
7552134|NCT03077607|18587936|P2|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||2
7552135|NCT03077607|18587937|P1|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||3
7552136|NCT03077607|18587936|P2|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
7552137|NCT03077607|18587937|P1|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||14
7552138|NCT03077607|18587936|P2|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
7552139|NCT03077607|18587937|P1|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
7552140|NCT03077607|18587936|P2|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
7552141|NCT03077607|18587937|P1|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
7552142|NCT03077607|18587936|P2|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
7552143|NCT03077607|18587937|P1|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
7552144|NCT03077607|18587936|P2|NOT COMPLETED|Period 1 (15 Days)||0
7552145|NCT03077607|18587937|P1|NOT COMPLETED|Period 1 (15 Days)||2
7552146|NCT03077607|18587936|P2|COMPLETED|Period 1 (15 Days)||17
7552147|NCT03077607|18587937|P1|COMPLETED|Period 1 (15 Days)||17
7552148|NCT03077607|18587936|P2|Received Talazoparib|Period 1 (15 Days)||17
7552149|NCT03077607|18587937|P1|Received Talazoparib|Period 1 (15 Days)||19
7552150|NCT03077607|18587936|P2|Treated (With Any Study Drug)|Period 1 (15 Days)||17
7552151|NCT03077607|18587937|P1|Treated (With Any Study Drug)|Period 1 (15 Days)||19
7552152|NCT03077607|18587936|P2|STARTED|Period 1 (15 Days)||17
7552153|NCT03077607|18587937|P1|STARTED|Period 1 (15 Days)||19
7552154|NCT03077438|18588005|P2|NOT COMPLETED|Overall Study||14
7552155|NCT03077438|18588006|P1|NOT COMPLETED|Overall Study||12
7552156|NCT03077438|18588005|P2|COMPLETED|Overall Study||487
7552157|NCT03077438|18588006|P1|COMPLETED|Overall Study||487
7552158|NCT03077438|18588005|P2|Safety Analysis Set (SafAS)|Overall Study||494
7552159|NCT03077438|18588006|P1|Safety Analysis Set (SafAS)|Overall Study||498
7552160|NCT03077438|18588005|P2|STARTED|Overall Study||501
7552161|NCT03077438|18588006|P1|STARTED|Overall Study||499
7552162|NCT03077165|18588028|P6|NOT COMPLETED|Overall Study||0
7552163|NCT03077165|18588029|P5|NOT COMPLETED|Overall Study||3
7552164|NCT03077165|18588030|P4|NOT COMPLETED|Overall Study||0
7552165|NCT03077165|18588031|P3|NOT COMPLETED|Overall Study||0
7552166|NCT03077165|18588032|P2|NOT COMPLETED|Overall Study||0
7552167|NCT03077165|18588033|P1|NOT COMPLETED|Overall Study||1
7552168|NCT03077165|18588028|P6|COMPLETED|Overall Study||20
7552169|NCT03077165|18588029|P5|COMPLETED|Overall Study||16
7552170|NCT03077165|18588030|P4|COMPLETED|Overall Study||19
7552171|NCT03077165|18588031|P3|COMPLETED|Overall Study||20
7552172|NCT03077165|18588032|P2|COMPLETED|Overall Study||22
7552173|NCT03077165|18588033|P1|COMPLETED|Overall Study||20
7552174|NCT03077165|18588028|P6|STARTED|Overall Study||20
7552175|NCT03077165|18588029|P5|STARTED|Overall Study||19
7552176|NCT03077165|18588030|P4|STARTED|Overall Study||19
7552177|NCT03077165|18588031|P3|STARTED|Overall Study||20
7552178|NCT03077165|18588032|P2|STARTED|Overall Study||22
7552179|NCT03077165|18588033|P1|STARTED|Overall Study||21
7552180|NCT03076996|18588047|P1|NOT COMPLETED|Overall Study||6
7552181|NCT03076996|18588047|P1|COMPLETED|Overall Study||35
7552182|NCT03076996|18588047|P1|STARTED|Overall Study||41
7552183|NCT03076983|18588056|P2|NOT COMPLETED|Overall Study||0
7552184|NCT03076983|18588057|P1|NOT COMPLETED|Overall Study||0
7552185|NCT03076983|18588056|P2|COMPLETED|Overall Study||25
7552186|NCT03076983|18588057|P1|COMPLETED|Overall Study||55
7552187|NCT03076983|18588056|P2|STARTED|Overall Study||25
7552188|NCT03076983|18588057|P1|STARTED|Overall Study||55
7552189|NCT03076970|18588073|P6|NOT COMPLETED|Washout Period 3||0
7552190|NCT03076970|18588074|P5|NOT COMPLETED|Washout Period 3||0
7552191|NCT03076970|18588075|P4|NOT COMPLETED|Washout Period 3||0
7552192|NCT03076970|18588076|P3|NOT COMPLETED|Washout Period 3||0
7552193|NCT03076970|18588077|P2|NOT COMPLETED|Washout Period 3||0
7552194|NCT03076970|18588078|P1|NOT COMPLETED|Washout Period 3||0
7552195|NCT03076970|18588073|P6|COMPLETED|Washout Period 3||6
7552196|NCT03076970|18588074|P5|COMPLETED|Washout Period 3||5
7552197|NCT03076970|18588075|P4|COMPLETED|Washout Period 3||7
7552198|NCT03076970|18588076|P3|COMPLETED|Washout Period 3||7
7552199|NCT03076970|18588077|P2|COMPLETED|Washout Period 3||7
7552200|NCT03076970|18588078|P1|COMPLETED|Washout Period 3||7
7552201|NCT03076970|18588073|P6|STARTED|Washout Period 3||6
7552202|NCT03076970|18588074|P5|STARTED|Washout Period 3||5
7552203|NCT03076970|18588075|P4|STARTED|Washout Period 3||7
7552204|NCT03076970|18588076|P3|STARTED|Washout Period 3||7
7552205|NCT03076970|18588077|P2|STARTED|Washout Period 3||7
7552206|NCT03076970|18588078|P1|STARTED|Washout Period 3||7
7552207|NCT03076970|18588073|P6|NOT COMPLETED|Period 3||1
7552208|NCT03076970|18588074|P5|NOT COMPLETED|Period 3||1
7552209|NCT03076970|18588075|P4|NOT COMPLETED|Period 3||0
7552210|NCT03076970|18588076|P3|NOT COMPLETED|Period 3||0
7552211|NCT03076970|18588077|P2|NOT COMPLETED|Period 3||0
7552212|NCT03076970|18588078|P1|NOT COMPLETED|Period 3||0
7552213|NCT03076970|18588073|P6|COMPLETED|Period 3||6
7552214|NCT03076970|18588074|P5|COMPLETED|Period 3||5
7552215|NCT03076970|18588075|P4|COMPLETED|Period 3||7
7552216|NCT03076970|18588076|P3|COMPLETED|Period 3||7
7552217|NCT03076970|18588077|P2|COMPLETED|Period 3||7
7552218|NCT03076970|18588078|P1|COMPLETED|Period 3||7
7552219|NCT03076970|18588073|P6|STARTED|Period 3||7
7552220|NCT03076970|18588074|P5|STARTED|Period 3||6
7552221|NCT03076970|18588075|P4|STARTED|Period 3||7
7552222|NCT03076970|18588076|P3|STARTED|Period 3||7
7552223|NCT03076970|18588077|P2|STARTED|Period 3||7
7552224|NCT03076970|18588078|P1|STARTED|Period 3||7
7552225|NCT03076970|18588073|P6|NOT COMPLETED|Washout Period 2||0
7552226|NCT03076970|18588074|P5|NOT COMPLETED|Washout Period 2||1
7552227|NCT03076970|18588075|P4|NOT COMPLETED|Washout Period 2||0
7552228|NCT03076970|18588076|P3|NOT COMPLETED|Washout Period 2||0
7552229|NCT03076970|18588077|P2|NOT COMPLETED|Washout Period 2||0
7552230|NCT03076970|18588078|P1|NOT COMPLETED|Washout Period 2||0
7552231|NCT03076970|18588073|P6|COMPLETED|Washout Period 2||7
7552232|NCT03076970|18588074|P5|COMPLETED|Washout Period 2||6
7552233|NCT03076970|18588075|P4|COMPLETED|Washout Period 2||7
7552234|NCT03076970|18588076|P3|COMPLETED|Washout Period 2||7
7552235|NCT03076970|18588077|P2|COMPLETED|Washout Period 2||7
7552236|NCT03076970|18588078|P1|COMPLETED|Washout Period 2||7
7552237|NCT03076970|18588073|P6|STARTED|Washout Period 2||7
7552238|NCT03076970|18588074|P5|STARTED|Washout Period 2||7
7552239|NCT03076970|18588075|P4|STARTED|Washout Period 2||7
7552240|NCT03076970|18588076|P3|STARTED|Washout Period 2||7
7552241|NCT03076970|18588077|P2|STARTED|Washout Period 2||7
7552242|NCT03076970|18588078|P1|STARTED|Washout Period 2||7
7552243|NCT03076970|18588073|P6|NOT COMPLETED|Period 2||0
7552244|NCT03076970|18588074|P5|NOT COMPLETED|Period 2||0
7552245|NCT03076970|18588075|P4|NOT COMPLETED|Period 2||0
7552246|NCT03076970|18588076|P3|NOT COMPLETED|Period 2||0
7552247|NCT03076970|18588077|P2|NOT COMPLETED|Period 2||0
7552248|NCT03076970|18588078|P1|NOT COMPLETED|Period 2||0
7552249|NCT03076970|18588073|P6|COMPLETED|Period 2||7
7552250|NCT03076970|18588074|P5|COMPLETED|Period 2||7
7552251|NCT03076970|18588075|P4|COMPLETED|Period 2||7
7552252|NCT03076970|18588076|P3|COMPLETED|Period 2||7
7552253|NCT03076970|18588077|P2|COMPLETED|Period 2||7
7552254|NCT03076970|18588078|P1|COMPLETED|Period 2||7
7552255|NCT03076970|18588073|P6|STARTED|Period 2||7
7552256|NCT03076970|18588074|P5|STARTED|Period 2||7
7552257|NCT03076970|18588075|P4|STARTED|Period 2||7
7552258|NCT03076970|18588076|P3|STARTED|Period 2||7
7552259|NCT03076970|18588077|P2|STARTED|Period 2||7
7552260|NCT03076970|18588078|P1|STARTED|Period 2||7
7552261|NCT03076970|18588073|P6|NOT COMPLETED|Washout Period 1||0
7552262|NCT03076970|18588074|P5|NOT COMPLETED|Washout Period 1||0
7552263|NCT03076970|18588075|P4|NOT COMPLETED|Washout Period 1||0
7552264|NCT03076970|18588076|P3|NOT COMPLETED|Washout Period 1||0
7552265|NCT03076970|18588077|P2|NOT COMPLETED|Washout Period 1||0
7552266|NCT03076970|18588078|P1|NOT COMPLETED|Washout Period 1||0
7552267|NCT03076970|18588073|P6|COMPLETED|Washout Period 1||7
7552268|NCT03076970|18588074|P5|COMPLETED|Washout Period 1||7
7552269|NCT03076970|18588075|P4|COMPLETED|Washout Period 1||7
7552270|NCT03076970|18588076|P3|COMPLETED|Washout Period 1||7
7552271|NCT03076970|18588077|P2|COMPLETED|Washout Period 1||7
7552272|NCT03076970|18588078|P1|COMPLETED|Washout Period 1||7
7552273|NCT03076970|18588073|P6|STARTED|Washout Period 1||7
7552274|NCT03076970|18588074|P5|STARTED|Washout Period 1||7
7552275|NCT03076970|18588075|P4|STARTED|Washout Period 1||7
7552276|NCT03076970|18588076|P3|STARTED|Washout Period 1||7
7552277|NCT03076970|18588077|P2|STARTED|Washout Period 1||7
7552278|NCT03076970|18588078|P1|STARTED|Washout Period 1||7
7552279|NCT03076970|18588073|P6|NOT COMPLETED|Period 1||0
7552280|NCT03076970|18588074|P5|NOT COMPLETED|Period 1||0
7552281|NCT03076970|18588075|P4|NOT COMPLETED|Period 1||0
7552282|NCT03076970|18588076|P3|NOT COMPLETED|Period 1||0
7552283|NCT03076970|18588077|P2|NOT COMPLETED|Period 1||0
7552284|NCT03076970|18588078|P1|NOT COMPLETED|Period 1||0
7552285|NCT03076970|18588073|P6|COMPLETED|Period 1||7
7552286|NCT03076970|18588074|P5|COMPLETED|Period 1||7
7552287|NCT03076970|18588075|P4|COMPLETED|Period 1||7
7552288|NCT03076970|18588076|P3|COMPLETED|Period 1||7
7552289|NCT03076970|18588077|P2|COMPLETED|Period 1||7
7552290|NCT03076970|18588078|P1|COMPLETED|Period 1||7
7552291|NCT03076970|18588073|P6|Received at Least 1 Dose of Study Drug|Period 1||7
7552292|NCT03076970|18588074|P5|Received at Least 1 Dose of Study Drug|Period 1||7
7552293|NCT03076970|18588075|P4|Received at Least 1 Dose of Study Drug|Period 1||7
7552294|NCT03076970|18588076|P3|Received at Least 1 Dose of Study Drug|Period 1||7
7552295|NCT03076970|18588077|P2|Received at Least 1 Dose of Study Drug|Period 1||7
7552296|NCT03076970|18588078|P1|Received at Least 1 Dose of Study Drug|Period 1||7
7552297|NCT03076970|18588073|P6|STARTED|Period 1||7
7552298|NCT03076970|18588074|P5|STARTED|Period 1||7
7552299|NCT03076970|18588075|P4|STARTED|Period 1||7
7552300|NCT03076970|18588076|P3|STARTED|Period 1||7
7552301|NCT03076970|18588077|P2|STARTED|Period 1||7
7552302|NCT03076970|18588078|P1|STARTED|Period 1||7
7552303|NCT03076515|18588130|P2|NOT COMPLETED|Overall Study||29
7552304|NCT03076515|18588131|P1|NOT COMPLETED|Overall Study||25
7552305|NCT03076515|18588130|P2|COMPLETED|Overall Study||33
7552306|NCT03076515|18588131|P1|COMPLETED|Overall Study||33
7552307|NCT03076515|18588130|P2|STARTED|Overall Study||62
7552308|NCT03076515|18588131|P1|STARTED|Overall Study||58
7552309|NCT03076359|18588139|P2|NOT COMPLETED|Overall Study||0
7552310|NCT03076359|18588140|P1|NOT COMPLETED|Overall Study||0
7552311|NCT03076359|18588139|P2|COMPLETED|Overall Study||150
7552312|NCT03076359|18588140|P1|COMPLETED|Overall Study||170
7552313|NCT03076359|18588139|P2|STARTED|Overall Study||150
7552314|NCT03076359|18588140|P1|STARTED|Overall Study||170
7552315|NCT03076190|18588150|P2|NOT COMPLETED|Overall Study||41
7552316|NCT03076190|18588151|P1|NOT COMPLETED|Overall Study||18
7552317|NCT03076190|18588150|P2|COMPLETED|Overall Study||36
7552318|NCT03076190|18588151|P1|COMPLETED|Overall Study||32
7552319|NCT03076190|18588150|P2|STARTED|Overall Study||77
7552320|NCT03076190|18588151|P1|STARTED|Overall Study||50
7552321|NCT03075904|18588164|P1|NOT COMPLETED|Overall Study||4
7552322|NCT03075904|18588164|P1|COMPLETED|Overall Study||4
7552323|NCT03075904|18588164|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
7552324|NCT03075904|18588164|P1|STARTED|Overall Study||8
7552325|NCT03075891|18588174|P2|NOT COMPLETED|Overall Study||13
7552326|NCT03075891|18588175|P1|NOT COMPLETED|Overall Study||9
7552327|NCT03075891|18588174|P2|COMPLETED|Overall Study||125
7552328|NCT03075891|18588175|P1|COMPLETED|Overall Study||126
7552329|NCT03075891|18588174|P2|STARTED|Overall Study||138
7552330|NCT03075891|18588175|P1|STARTED|Overall Study||135
7552331|NCT03075878|18588181|P1|NOT COMPLETED|Overall Study||1
7552332|NCT03075878|18588181|P1|COMPLETED|Overall Study||7
7552333|NCT03075878|18588181|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
7552334|NCT03075878|18588181|P1|STARTED|Overall Study||8
7552335|NCT03075839|18588189|P1|NOT COMPLETED|Overall Study||4
7552336|NCT03075839|18588189|P1|COMPLETED|Overall Study||29
7552337|NCT03075839|18588189|P1|STARTED|Overall Study||33
7552338|NCT03075644|18588197|P2|NOT COMPLETED|Overall Study||1
7552339|NCT03075644|18588198|P1|NOT COMPLETED|Overall Study||1
7552340|NCT03075644|18588197|P2|COMPLETED|Overall Study||45
7552341|NCT03075644|18588198|P1|COMPLETED|Overall Study||15
7552342|NCT03075644|18588197|P2|Safety Analysis Set (SAS)|Overall Study||46
7552343|NCT03075644|18588198|P1|Safety Analysis Set (SAS)|Overall Study||16
7552344|NCT03075644|18588197|P2|Full Analysis Set (FAS)|Overall Study||46
7552345|NCT03075644|18588198|P1|Full Analysis Set (FAS)|Overall Study||16
7552346|NCT03075644|18588197|P2|STARTED|Overall Study||46
7552347|NCT03075644|18588198|P1|STARTED|Overall Study||16
7552348|NCT03075553|18588259|P1|NOT COMPLETED|Overall Study||0
7552349|NCT03075553|18588259|P1|COMPLETED|Overall Study||12
7552350|NCT03075553|18588259|P1|STARTED|Overall Study||12
7552351|NCT03075527|18588268|P1|NOT COMPLETED|Overall Study||2
7552352|NCT03075527|18588268|P1|COMPLETED|Overall Study||17
7552353|NCT03075527|18588268|P1|STARTED|Overall Study||19
7552354|NCT03075449|18588272|P1|NOT COMPLETED|Overall Study||0
7552355|NCT03075449|18588272|P1|COMPLETED|Overall Study||170
7552356|NCT03075449|18588272|P1|STARTED|Overall Study||170
7552357|NCT03075410|18588292|P9|NOT COMPLETED|Part B (up to 28 Days)||0
7552358|NCT03075410|18588293|P8|NOT COMPLETED|Part B (up to 28 Days)||0
7552359|NCT03075410|18588294|P7|NOT COMPLETED|Part B (up to 28 Days)||0
7552360|NCT03075410|18588295|P6|NOT COMPLETED|Part B (up to 28 Days)||0
7552361|NCT03075410|18588296|P5|NOT COMPLETED|Part B (up to 28 Days)||0
7552362|NCT03075410|18588297|P4|NOT COMPLETED|Part B (up to 28 Days)||0
7552363|NCT03075410|18588298|P3|NOT COMPLETED|Part B (up to 28 Days)||0
7552364|NCT03075410|18588299|P2|NOT COMPLETED|Part B (up to 28 Days)||0
7552365|NCT03075410|18588300|P1|NOT COMPLETED|Part B (up to 28 Days)||0
7552366|NCT03075410|18588292|P9|COMPLETED|Part B (up to 28 Days)||8
7552367|NCT03075410|18588293|P8|COMPLETED|Part B (up to 28 Days)||7
7552368|NCT03075410|18588294|P7|COMPLETED|Part B (up to 28 Days)||4
7552369|NCT03075410|18588295|P6|COMPLETED|Part B (up to 28 Days)||0
7552370|NCT03075410|18588296|P5|COMPLETED|Part B (up to 28 Days)||0
7552371|NCT03075410|18588297|P4|COMPLETED|Part B (up to 28 Days)||0
7552372|NCT03075410|18588298|P3|COMPLETED|Part B (up to 28 Days)||0
7552373|NCT03075410|18588299|P2|COMPLETED|Part B (up to 28 Days)||0
7552374|NCT03075410|18588300|P1|COMPLETED|Part B (up to 28 Days)||0
7552375|NCT03075410|18588292|P9|STARTED|Part B (up to 28 Days)||8
7552376|NCT03075410|18588293|P8|STARTED|Part B (up to 28 Days)||7
7552377|NCT03075410|18588294|P7|STARTED|Part B (up to 28 Days)||4
7552378|NCT03075410|18588295|P6|STARTED|Part B (up to 28 Days)||0
7552379|NCT03075410|18588296|P5|STARTED|Part B (up to 28 Days)||0
7552380|NCT03075410|18588297|P4|STARTED|Part B (up to 28 Days)||0
7552381|NCT03075410|18588298|P3|STARTED|Part B (up to 28 Days)||0
7552382|NCT03075410|18588299|P2|STARTED|Part B (up to 28 Days)||0
7552383|NCT03075410|18588300|P1|STARTED|Part B (up to 28 Days)||0
7552384|NCT03075410|18588292|P9|NOT COMPLETED|Part A-Period 4 (14 Days)||0
7552385|NCT03075410|18588293|P8|NOT COMPLETED|Part A-Period 4 (14 Days)||0
7552386|NCT03075410|18588294|P7|NOT COMPLETED|Part A-Period 4 (14 Days)||0
7552387|NCT03075410|18588295|P6|NOT COMPLETED|Part A-Period 4 (14 Days)||0
7552388|NCT03075410|18588296|P5|NOT COMPLETED|Part A-Period 4 (14 Days)||0
7552389|NCT03075410|18588297|P4|NOT COMPLETED|Part A-Period 4 (14 Days)||0
7552390|NCT03075410|18588298|P3|NOT COMPLETED|Part A-Period 4 (14 Days)||0
7552391|NCT03075410|18588299|P2|NOT COMPLETED|Part A-Period 4 (14 Days)||0
7552392|NCT03075410|18588300|P1|NOT COMPLETED|Part A-Period 4 (14 Days)||0
7552393|NCT03075410|18588292|P9|COMPLETED|Part A-Period 4 (14 Days)||0
7552394|NCT03075410|18588293|P8|COMPLETED|Part A-Period 4 (14 Days)||0
7552395|NCT03075410|18588294|P7|COMPLETED|Part A-Period 4 (14 Days)||0
7552396|NCT03075410|18588295|P6|COMPLETED|Part A-Period 4 (14 Days)||1
7552397|NCT03075410|18588296|P5|COMPLETED|Part A-Period 4 (14 Days)||2
7552398|NCT03075410|18588297|P4|COMPLETED|Part A-Period 4 (14 Days)||1
7552399|NCT03075410|18588298|P3|COMPLETED|Part A-Period 4 (14 Days)||2
7552400|NCT03075410|18588299|P2|COMPLETED|Part A-Period 4 (14 Days)||1
7552401|NCT03075410|18588300|P1|COMPLETED|Part A-Period 4 (14 Days)||1
7552402|NCT03075410|18588292|P9|STARTED|Part A-Period 4 (14 Days)||0
7552403|NCT03075410|18588293|P8|STARTED|Part A-Period 4 (14 Days)||0
7552404|NCT03075410|18588294|P7|STARTED|Part A-Period 4 (14 Days)||0
7552405|NCT03075410|18588295|P6|STARTED|Part A-Period 4 (14 Days)||1
7552406|NCT03075410|18588296|P5|STARTED|Part A-Period 4 (14 Days)||2
7552407|NCT03075410|18588297|P4|STARTED|Part A-Period 4 (14 Days)||1
7552408|NCT03075410|18588298|P3|STARTED|Part A-Period 4 (14 Days)||2
7552409|NCT03075410|18588299|P2|STARTED|Part A-Period 4 (14 Days)||1
7552410|NCT03075410|18588300|P1|STARTED|Part A-Period 4 (14 Days)||1
7552411|NCT03075410|18588292|P9|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
7552412|NCT03075410|18588293|P8|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
7552413|NCT03075410|18588294|P7|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
7552414|NCT03075410|18588295|P6|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
7552415|NCT03075410|18588296|P5|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
7552416|NCT03075410|18588297|P4|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
7552417|NCT03075410|18588298|P3|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
7552418|NCT03075410|18588299|P2|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
7552419|NCT03075410|18588300|P1|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
7552420|NCT03075410|18588292|P9|COMPLETED|Part A-Washout Period 3 (14 Days)||0
7552421|NCT03075410|18588293|P8|COMPLETED|Part A-Washout Period 3 (14 Days)||0
7552422|NCT03075410|18588294|P7|COMPLETED|Part A-Washout Period 3 (14 Days)||0
7552423|NCT03075410|18588295|P6|COMPLETED|Part A-Washout Period 3 (14 Days)||1
7552424|NCT03075410|18588296|P5|COMPLETED|Part A-Washout Period 3 (14 Days)||2
7552425|NCT03075410|18588297|P4|COMPLETED|Part A-Washout Period 3 (14 Days)||1
7552426|NCT03075410|18588298|P3|COMPLETED|Part A-Washout Period 3 (14 Days)||2
7552427|NCT03075410|18588299|P2|COMPLETED|Part A-Washout Period 3 (14 Days)||1
7552428|NCT03075410|18588300|P1|COMPLETED|Part A-Washout Period 3 (14 Days)||1
7552429|NCT03075410|18588292|P9|STARTED|Part A-Washout Period 3 (14 Days)||0
7552430|NCT03075410|18588293|P8|STARTED|Part A-Washout Period 3 (14 Days)||0
7552431|NCT03075410|18588294|P7|STARTED|Part A-Washout Period 3 (14 Days)||0
7552432|NCT03075410|18588295|P6|STARTED|Part A-Washout Period 3 (14 Days)||1
7552433|NCT03075410|18588296|P5|STARTED|Part A-Washout Period 3 (14 Days)||2
7552434|NCT03075410|18588297|P4|STARTED|Part A-Washout Period 3 (14 Days)||1
7552435|NCT03075410|18588298|P3|STARTED|Part A-Washout Period 3 (14 Days)||2
7552436|NCT03075410|18588299|P2|STARTED|Part A-Washout Period 3 (14 Days)||1
7552437|NCT03075410|18588300|P1|STARTED|Part A-Washout Period 3 (14 Days)||1
7552438|NCT03075410|18588292|P9|NOT COMPLETED|Part A-Period 3 (14 Days)||0
7552439|NCT03075410|18588293|P8|NOT COMPLETED|Part A-Period 3 (14 Days)||0
7552440|NCT03075410|18588294|P7|NOT COMPLETED|Part A-Period 3 (14 Days)||0
7552441|NCT03075410|18588295|P6|NOT COMPLETED|Part A-Period 3 (14 Days)||0
7552442|NCT03075410|18588296|P5|NOT COMPLETED|Part A-Period 3 (14 Days)||0
7552443|NCT03075410|18588297|P4|NOT COMPLETED|Part A-Period 3 (14 Days)||0
7552444|NCT03075410|18588298|P3|NOT COMPLETED|Part A-Period 3 (14 Days)||0
7552445|NCT03075410|18588299|P2|NOT COMPLETED|Part A-Period 3 (14 Days)||0
7552446|NCT03075410|18588300|P1|NOT COMPLETED|Part A-Period 3 (14 Days)||1
7552447|NCT03075410|18588292|P9|COMPLETED|Part A-Period 3 (14 Days)||0
7552448|NCT03075410|18588293|P8|COMPLETED|Part A-Period 3 (14 Days)||0
7552449|NCT03075410|18588294|P7|COMPLETED|Part A-Period 3 (14 Days)||0
7552450|NCT03075410|18588295|P6|COMPLETED|Part A-Period 3 (14 Days)||1
7552451|NCT03075410|18588296|P5|COMPLETED|Part A-Period 3 (14 Days)||2
7552452|NCT03075410|18588297|P4|COMPLETED|Part A-Period 3 (14 Days)||1
7552453|NCT03075410|18588298|P3|COMPLETED|Part A-Period 3 (14 Days)||2
7552454|NCT03075410|18588299|P2|COMPLETED|Part A-Period 3 (14 Days)||1
7552455|NCT03075410|18588300|P1|COMPLETED|Part A-Period 3 (14 Days)||1
7552456|NCT03075410|18588292|P9|STARTED|Part A-Period 3 (14 Days)||0
7552457|NCT03075410|18588293|P8|STARTED|Part A-Period 3 (14 Days)||0
7552458|NCT03075410|18588294|P7|STARTED|Part A-Period 3 (14 Days)||0
7552459|NCT03075410|18588295|P6|STARTED|Part A-Period 3 (14 Days)||1
7552460|NCT03075410|18588296|P5|STARTED|Part A-Period 3 (14 Days)||2
7552461|NCT03075410|18588297|P4|STARTED|Part A-Period 3 (14 Days)||1
7552462|NCT03075410|18588298|P3|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
7552463|NCT03075410|18588299|P2|STARTED|Part A-Period 3 (14 Days)||1
7552464|NCT03075410|18588300|P1|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
7552465|NCT03075410|18588292|P9|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
7552466|NCT03075410|18588293|P8|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
7552467|NCT03075410|18588294|P7|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
7552468|NCT03075410|18588295|P6|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
7552469|NCT03075410|18588296|P5|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
7552470|NCT03075410|18588297|P4|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
7552471|NCT03075410|18588298|P3|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
7552472|NCT03075410|18588299|P2|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
7552473|NCT03075410|18588300|P1|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
7552474|NCT03075410|18588292|P9|COMPLETED|Part A-Washout Period 2 (14 Days)||0
7552475|NCT03075410|18588293|P8|COMPLETED|Part A-Washout Period 2 (14 Days)||0
7552476|NCT03075410|18588294|P7|COMPLETED|Part A-Washout Period 2 (14 Days)||0
7552477|NCT03075410|18588295|P6|COMPLETED|Part A-Washout Period 2 (14 Days)||1
7552478|NCT03075410|18588296|P5|COMPLETED|Part A-Washout Period 2 (14 Days)||2
7552479|NCT03075410|18588297|P4|COMPLETED|Part A-Washout Period 2 (14 Days)||1
7552480|NCT03075410|18588298|P3|COMPLETED|Part A-Washout Period 2 (14 Days)||1
7552481|NCT03075410|18588299|P2|COMPLETED|Part A-Washout Period 2 (14 Days)||1
7552482|NCT03075410|18588300|P1|COMPLETED|Part A-Washout Period 2 (14 Days)||1
7552483|NCT03075410|18588292|P9|STARTED|Part A-Washout Period 2 (14 Days)||0
7552484|NCT03075410|18588293|P8|STARTED|Part A-Washout Period 2 (14 Days)||0
7552485|NCT03075410|18588294|P7|STARTED|Part A-Washout Period 2 (14 Days)||0
7552486|NCT03075410|18588295|P6|STARTED|Part A-Washout Period 2 (14 Days)||1
7552487|NCT03075410|18588296|P5|STARTED|Part A-Washout Period 2 (14 Days)||2
7552488|NCT03075410|18588297|P4|STARTED|Part A-Washout Period 2 (14 Days)||1
7552489|NCT03075410|18588298|P3|STARTED|Part A-Washout Period 2 (14 Days)||1
7552490|NCT03075410|18588299|P2|STARTED|Part A-Washout Period 2 (14 Days)||1
7552491|NCT03075410|18588300|P1|STARTED|Part A-Washout Period 2 (14 Days)||1
7552492|NCT03075410|18588292|P9|NOT COMPLETED|Part A-Period 2 (14 Days)||0
7552493|NCT03075410|18588293|P8|NOT COMPLETED|Part A-Period 2 (14 Days)||0
7552494|NCT03075410|18588294|P7|NOT COMPLETED|Part A-Period 2 (14 Days)||0
7552495|NCT03075410|18588295|P6|NOT COMPLETED|Part A-Period 2 (14 Days)||0
7552496|NCT03075410|18588296|P5|NOT COMPLETED|Part A-Period 2 (14 Days)||0
7552497|NCT03075410|18588297|P4|NOT COMPLETED|Part A-Period 2 (14 Days)||0
7552498|NCT03075410|18588298|P3|NOT COMPLETED|Part A-Period 2 (14 Days)||1
7552499|NCT03075410|18588299|P2|NOT COMPLETED|Part A-Period 2 (14 Days)||0
7552500|NCT03075410|18588300|P1|NOT COMPLETED|Part A-Period 2 (14 Days)||1
7552501|NCT03075410|18588292|P9|COMPLETED|Part A-Period 2 (14 Days)||0
7552502|NCT03075410|18588293|P8|COMPLETED|Part A-Period 2 (14 Days)||0
7552503|NCT03075410|18588294|P7|COMPLETED|Part A-Period 2 (14 Days)||0
7552504|NCT03075410|18588295|P6|COMPLETED|Part A-Period 2 (14 Days)||1
7552505|NCT03075410|18588296|P5|COMPLETED|Part A-Period 2 (14 Days)||2
7552506|NCT03075410|18588297|P4|COMPLETED|Part A-Period 2 (14 Days)||1
7552507|NCT03075410|18588298|P3|COMPLETED|Part A-Period 2 (14 Days)||1
7552508|NCT03075410|18588299|P2|COMPLETED|Part A-Period 2 (14 Days)||1
7552509|NCT03075410|18588300|P1|COMPLETED|Part A-Period 2 (14 Days)||1
7552510|NCT03075410|18588292|P9|STARTED|Part A-Period 2 (14 Days)||0
7552511|NCT03075410|18588293|P8|STARTED|Part A-Period 2 (14 Days)||0
7552512|NCT03075410|18588294|P7|STARTED|Part A-Period 2 (14 Days)||0
7552513|NCT03075410|18588295|P6|STARTED|Part A-Period 2 (14 Days)||1
7552514|NCT03075410|18588296|P5|STARTED|Part A-Period 2 (14 Days)||2
7552515|NCT03075410|18588297|P4|STARTED|Part A-Period 2 (14 Days)||1
7552516|NCT03075410|18588298|P3|STARTED|Part A-Period 2 (14 Days)||2
7552517|NCT03075410|18588299|P2|STARTED|Part A-Period 2 (14 Days)||1
7552518|NCT03075410|18588300|P1|STARTED|Part A-Period 2 (14 Days)||2
7552519|NCT03075410|18588292|P9|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
7552520|NCT03075410|18588293|P8|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
7552521|NCT03075410|18588294|P7|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
7552522|NCT03075410|18588295|P6|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
7552523|NCT03075410|18588296|P5|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
7552524|NCT03075410|18588297|P4|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
7552525|NCT03075410|18588298|P3|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
7552526|NCT03075410|18588299|P2|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
7552527|NCT03075410|18588300|P1|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
7552528|NCT03075410|18588292|P9|COMPLETED|Part A-Washout Period 1 (14 Days)||0
7552529|NCT03075410|18588293|P8|COMPLETED|Part A-Washout Period 1 (14 Days)||0
7552530|NCT03075410|18588294|P7|COMPLETED|Part A-Washout Period 1 (14 Days)||0
7552531|NCT03075410|18588295|P6|COMPLETED|Part A-Washout Period 1 (14 Days)||1
7552532|NCT03075410|18588296|P5|COMPLETED|Part A-Washout Period 1 (14 Days)||2
7552533|NCT03075410|18588297|P4|COMPLETED|Part A-Washout Period 1 (14 Days)||1
7552534|NCT03075410|18588298|P3|COMPLETED|Part A-Washout Period 1 (14 Days)||2
7552535|NCT03075410|18588299|P2|COMPLETED|Part A-Washout Period 1 (14 Days)||1
7552536|NCT03075410|18588300|P1|COMPLETED|Part A-Washout Period 1 (14 Days)||2
7552537|NCT03075410|18588292|P9|STARTED|Part A-Washout Period 1 (14 Days)||0
7552538|NCT03075410|18588293|P8|STARTED|Part A-Washout Period 1 (14 Days)||0
7552539|NCT03075410|18588294|P7|STARTED|Part A-Washout Period 1 (14 Days)||0
7552540|NCT03075410|18588295|P6|STARTED|Part A-Washout Period 1 (14 Days)||1
7552541|NCT03075410|18588296|P5|STARTED|Part A-Washout Period 1 (14 Days)||2
7552542|NCT03075410|18588297|P4|STARTED|Part A-Washout Period 1 (14 Days)||1
7552543|NCT03075410|18588298|P3|STARTED|Part A-Washout Period 1 (14 Days)||2
7552544|NCT03075410|18588299|P2|STARTED|Part A-Washout Period 1 (14 Days)||1
7552545|NCT03075410|18588300|P1|STARTED|Part A-Washout Period 1 (14 Days)||2
7552546|NCT03075410|18588292|P9|NOT COMPLETED|Part A-Period 1 (14 Days)||0
7552547|NCT03075410|18588293|P8|NOT COMPLETED|Part A-Period 1 (14 Days)||0
7552548|NCT03075410|18588294|P7|NOT COMPLETED|Part A-Period 1 (14 Days)||0
7552549|NCT03075410|18588295|P6|NOT COMPLETED|Part A-Period 1 (14 Days)||0
7552550|NCT03075410|18588296|P5|NOT COMPLETED|Part A-Period 1 (14 Days)||0
7552551|NCT03075410|18588297|P4|NOT COMPLETED|Part A-Period 1 (14 Days)||0
7552552|NCT03075410|18588298|P3|NOT COMPLETED|Part A-Period 1 (14 Days)||0
7552553|NCT03075410|18588299|P2|NOT COMPLETED|Part A-Period 1 (14 Days)||0
7552554|NCT03075410|18588300|P1|NOT COMPLETED|Part A-Period 1 (14 Days)||0
7552555|NCT03075410|18588292|P9|COMPLETED|Part A-Period 1 (14 Days)||0
7552556|NCT03075410|18588293|P8|COMPLETED|Part A-Period 1 (14 Days)||0
7552557|NCT03075410|18588294|P7|COMPLETED|Part A-Period 1 (14 Days)||0
7552558|NCT03075410|18588295|P6|COMPLETED|Part A-Period 1 (14 Days)||1
7552559|NCT03075410|18588296|P5|COMPLETED|Part A-Period 1 (14 Days)||2
7552560|NCT03075410|18588297|P4|COMPLETED|Part A-Period 1 (14 Days)||1
7552561|NCT03075410|18588298|P3|COMPLETED|Part A-Period 1 (14 Days)||2
7552562|NCT03075410|18588299|P2|COMPLETED|Part A-Period 1 (14 Days)||1
7552563|NCT03075410|18588300|P1|COMPLETED|Part A-Period 1 (14 Days)||2
7552564|NCT03075410|18588292|P9|STARTED|Part A-Period 1 (14 Days)||0
7552565|NCT03075410|18588293|P8|STARTED|Part A-Period 1 (14 Days)||0
7552566|NCT03075410|18588294|P7|STARTED|Part A-Period 1 (14 Days)||0
7552567|NCT03075410|18588295|P6|STARTED|Part A-Period 1 (14 Days)||1
7552568|NCT03075410|18588296|P5|STARTED|Part A-Period 1 (14 Days)||2
7552569|NCT03075410|18588297|P4|STARTED|Part A-Period 1 (14 Days)||1
7552570|NCT03075410|18588298|P3|STARTED|Part A-Period 1 (14 Days)||2
7552571|NCT03075410|18588299|P2|STARTED|Part A-Period 1 (14 Days)||1
7552572|NCT03075410|18588300|P1|STARTED|Part A-Period 1 (14 Days)||2
7552573|NCT03075163|18588466|P2|NOT COMPLETED|Overall Study||138
7552574|NCT03075163|18588467|P1|NOT COMPLETED|Overall Study||138
7552575|NCT03075163|18588466|P2|COMPLETED|Overall Study||12
7552576|NCT03075163|18588467|P1|COMPLETED|Overall Study||12
7552577|NCT03075163|18588466|P2|STARTED|Overall Study||150
7552578|NCT03075163|18588467|P1|STARTED|Overall Study||150
7552579|NCT03074682|18588476|P3|NOT COMPLETED|Overall Study||0
7552580|NCT03074682|18588477|P2|NOT COMPLETED|Overall Study||0
7552581|NCT03074682|18588478|P1|NOT COMPLETED|Overall Study||0
7552582|NCT03074682|18588476|P3|COMPLETED|Overall Study||18
7552583|NCT03074682|18588477|P2|COMPLETED|Overall Study||18
7552584|NCT03074682|18588478|P1|COMPLETED|Overall Study||18
7552585|NCT03074682|18588476|P3|STARTED|Overall Study||18
7552586|NCT03074682|18588477|P2|STARTED|Overall Study||18
7552587|NCT03074682|18588478|P1|STARTED|Overall Study||18
7552588|NCT03074630|18588495|P1|NOT COMPLETED|Overall Study||1
7552589|NCT03074630|18588495|P1|COMPLETED|Overall Study||11
7552590|NCT03074630|18588495|P1|STARTED|Overall Study||12
7552591|NCT03074500|18588514|P3|NOT COMPLETED|Overall Study||1
7552592|NCT03074500|18588515|P2|NOT COMPLETED|Overall Study||1
7552593|NCT03074500|18588516|P1|NOT COMPLETED|Overall Study||1
7552594|NCT03074500|18588514|P3|COMPLETED|Overall Study||10
7552595|NCT03074500|18588515|P2|COMPLETED|Overall Study||10
7552596|NCT03074500|18588516|P1|COMPLETED|Overall Study||10
7552597|NCT03074500|18588514|P3|STARTED|Overall Study||11
7552598|NCT03074500|18588515|P2|STARTED|Overall Study||11
7552599|NCT03074500|18588516|P1|STARTED|Overall Study||11
7552600|NCT03074409|18588544|P2|NOT COMPLETED|Overall Study||4
7552601|NCT03074409|18588545|P1|NOT COMPLETED|Overall Study||4
7552602|NCT03074409|18588544|P2|COMPLETED|Overall Study||38
7552603|NCT03074409|18588545|P1|COMPLETED|Overall Study||37
7552604|NCT03074409|18588544|P2|STARTED|Overall Study||42
7552605|NCT03074409|18588545|P1|STARTED|Overall Study||41
7552606|NCT03074331|18588553|P1|NOT COMPLETED|Overall Study||7
7552607|NCT03074331|18588553|P1|COMPLETED|Overall Study||123
7552608|NCT03074331|18588553|P1|STARTED|Overall Study||130
7552609|NCT03074162|18588565|P6|NOT COMPLETED|Period 3||0
7552610|NCT03074162|18588566|P5|NOT COMPLETED|Period 3||1
7552611|NCT03074162|18588567|P4|NOT COMPLETED|Period 3||0
7552612|NCT03074162|18588568|P3|NOT COMPLETED|Period 3||0
7552613|NCT03074162|18588569|P2|NOT COMPLETED|Period 3||0
7552614|NCT03074162|18588570|P1|NOT COMPLETED|Period 3||1
7552615|NCT03074162|18588565|P6|COMPLETED|Period 3||7
7552616|NCT03074162|18588566|P5|COMPLETED|Period 3||7
7552617|NCT03074162|18588567|P4|COMPLETED|Period 3||8
7552618|NCT03074162|18588568|P3|COMPLETED|Period 3||6
7552619|NCT03074162|18588569|P2|COMPLETED|Period 3||8
7552620|NCT03074162|18588570|P1|COMPLETED|Period 3||7
7552621|NCT03074162|18588565|P6|STARTED|Period 3||7
7552622|NCT03074162|18588566|P5|STARTED|Period 3||8
7552623|NCT03074162|18588567|P4|STARTED|Period 3||8
7552624|NCT03074162|18588568|P3|STARTED|Period 3||6
7552625|NCT03074162|18588569|P2|STARTED|Period 3||8
7552626|NCT03074162|18588570|P1|STARTED|Period 3||8
7552627|NCT03074162|18588565|P6|NOT COMPLETED|Period 2 Including Washout 2||1
7552628|NCT03074162|18588566|P5|NOT COMPLETED|Period 2 Including Washout 2||0
7552629|NCT03074162|18588567|P4|NOT COMPLETED|Period 2 Including Washout 2||0
7552630|NCT03074162|18588568|P3|NOT COMPLETED|Period 2 Including Washout 2||1
7552631|NCT03074162|18588569|P2|NOT COMPLETED|Period 2 Including Washout 2||0
7552632|NCT03074162|18588570|P1|NOT COMPLETED|Period 2 Including Washout 2||0
7552633|NCT03074162|18588565|P6|COMPLETED|Period 2 Including Washout 2||7
7552634|NCT03074162|18588566|P5|COMPLETED|Period 2 Including Washout 2||8
7552635|NCT03074162|18588567|P4|COMPLETED|Period 2 Including Washout 2||8
7552636|NCT03074162|18588568|P3|COMPLETED|Period 2 Including Washout 2||6
7552637|NCT03074162|18588569|P2|COMPLETED|Period 2 Including Washout 2||8
7552638|NCT03074162|18588570|P1|COMPLETED|Period 2 Including Washout 2||8
7552639|NCT03074162|18588565|P6|STARTED|Period 2 Including Washout 2||8
7552640|NCT03074162|18588566|P5|STARTED|Period 2 Including Washout 2||8
7552641|NCT03074162|18588567|P4|STARTED|Period 2 Including Washout 2||8
7552642|NCT03074162|18588568|P3|STARTED|Period 2 Including Washout 2||7
7552643|NCT03074162|18588569|P2|STARTED|Period 2 Including Washout 2||8
7552644|NCT03074162|18588570|P1|STARTED|Period 2 Including Washout 2||8
7552645|NCT03074162|18588565|P6|NOT COMPLETED|Period 1 Including Washout 1||0
7552646|NCT03074162|18588566|P5|NOT COMPLETED|Period 1 Including Washout 1||0
7552647|NCT03074162|18588567|P4|NOT COMPLETED|Period 1 Including Washout 1||0
7552648|NCT03074162|18588568|P3|NOT COMPLETED|Period 1 Including Washout 1||1
7552649|NCT03074162|18588569|P2|NOT COMPLETED|Period 1 Including Washout 1||0
7552650|NCT03074162|18588570|P1|NOT COMPLETED|Period 1 Including Washout 1||0
7552651|NCT03074162|18588565|P6|COMPLETED|Period 1 Including Washout 1||8
7552652|NCT03074162|18588566|P5|COMPLETED|Period 1 Including Washout 1||8
7552653|NCT03074162|18588567|P4|COMPLETED|Period 1 Including Washout 1||8
7552654|NCT03074162|18588568|P3|COMPLETED|Period 1 Including Washout 1||7
7552655|NCT03074162|18588569|P2|COMPLETED|Period 1 Including Washout 1||8
7552656|NCT03074162|18588570|P1|COMPLETED|Period 1 Including Washout 1||8
7552657|NCT03074162|18588565|P6|STARTED|Period 1 Including Washout 1||8
7552658|NCT03074162|18588566|P5|STARTED|Period 1 Including Washout 1||8
7552659|NCT03074162|18588567|P4|STARTED|Period 1 Including Washout 1||8
7552660|NCT03074162|18588568|P3|STARTED|Period 1 Including Washout 1||8
7552661|NCT03074162|18588569|P2|STARTED|Period 1 Including Washout 1||8
7552662|NCT03074162|18588570|P1|STARTED|Period 1 Including Washout 1||8
7552663|NCT03073876|18588592|P2|NOT COMPLETED|Overall Study||0
7552664|NCT03073876|18588593|P1|NOT COMPLETED|Overall Study||0
7552665|NCT03073876|18588592|P2|COMPLETED|Overall Study||11
7552666|NCT03073876|18588593|P1|COMPLETED|Overall Study||12
7552667|NCT03073876|18588592|P2|STARTED|Overall Study||11
7552668|NCT03073876|18588593|P1|STARTED|Overall Study||12
7552669|NCT03073798|18588632|P1|NOT COMPLETED|Overall Study||2
7552670|NCT03073798|18588632|P1|COMPLETED|Overall Study||10
7552671|NCT03073798|18588632|P1|STARTED|Overall Study||12
7552672|NCT03073759|18588645|P2|NOT COMPLETED|Overall Study||0
7552673|NCT03073759|18588646|P1|NOT COMPLETED|Overall Study||0
7552674|NCT03073759|18588645|P2|COMPLETED|Overall Study||2
7552675|NCT03073759|18588646|P1|COMPLETED|Overall Study||2
7552676|NCT03073759|18588645|P2|STARTED|Overall Study||2
7552677|NCT03073759|18588646|P1|STARTED|Overall Study||2
7552678|NCT03073486|18588656|P2|NOT COMPLETED|Overall Study||44
7552679|NCT03073486|18588657|P1|NOT COMPLETED|Overall Study||88
7552680|NCT03073486|18588656|P2|COMPLETED|Overall Study||207
7552681|NCT03073486|18588657|P1|COMPLETED|Overall Study||405
7552682|NCT03073486|18588656|P2|STARTED|Overall Study||251
7552683|NCT03073486|18588657|P1|STARTED|Overall Study||493
7552684|NCT03073213|18588670|P3|NOT COMPLETED|Multiple Dose Period||1
7552685|NCT03073213|18588671|P2|NOT COMPLETED|Multiple Dose Period||0
7552686|NCT03073213|18588672|P1|NOT COMPLETED|Multiple Dose Period||0
7552687|NCT03073213|18588670|P3|COMPLETED|Multiple Dose Period||14
7552688|NCT03073213|18588671|P2|COMPLETED|Multiple Dose Period||14
7552689|NCT03073213|18588672|P1|COMPLETED|Multiple Dose Period||0
7552690|NCT03073213|18588670|P3|Participants Enrolled From Single Dose|Multiple Dose Period||2
7552691|NCT03073213|18588671|P2|Participants Enrolled From Single Dose|Multiple Dose Period||7
7552692|NCT03073213|18588672|P1|Participants Enrolled From Single Dose|Multiple Dose Period||0
7552693|NCT03073213|18588670|P3|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|15
7552694|NCT03073213|18588671|P2|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|14
7552695|NCT03073213|18588672|P1|STARTED|Multiple Dose Period||0
7552696|NCT03073213|18588670|P3|NOT COMPLETED|Single Dose Period||0
7552697|NCT03073213|18588671|P2|NOT COMPLETED|Single Dose Period||0
7552698|NCT03073213|18588672|P1|NOT COMPLETED|Single Dose Period||0
7552699|NCT03073213|18588670|P3|COMPLETED|Single Dose Period||0
7552700|NCT03073213|18588671|P2|COMPLETED|Single Dose Period||0
7552701|NCT03073213|18588672|P1|COMPLETED|Single Dose Period||12
7552702|NCT03073213|18588670|P3|STARTED|Single Dose Period||0
7552703|NCT03073213|18588671|P2|STARTED|Single Dose Period||0
7552704|NCT03073213|18588672|P1|STARTED|Single Dose Period||12
7552705|NCT03073200|18588687|P3|NOT COMPLETED|Overall Study||30
7552706|NCT03073200|18588688|P2|NOT COMPLETED|Overall Study||115
7552707|NCT03073200|18588689|P1|NOT COMPLETED|Overall Study||55
7552708|NCT03073200|18588687|P3|COMPLETED|Overall Study||0
7552709|NCT03073200|18588688|P2|COMPLETED|Overall Study||0
7552710|NCT03073200|18588689|P1|COMPLETED|Overall Study||1
7552711|NCT03073200|18588687|P3|Pts in Etanercept Approved Countries|Overall Study||30
7552712|NCT03073200|18588688|P2|Pts in Etanercept Approved Countries|Overall Study||38
7552713|NCT03073200|18588689|P1|Pts in Etanercept Approved Countries|Overall Study||19
7552714|NCT03073200|18588687|P3|STARTED|Overall Study||30
7552715|NCT03073200|18588688|P2|STARTED|Overall Study||115
7552716|NCT03073200|18588689|P1|STARTED|Overall Study||56
7552717|NCT03073148|18588727|P3|NOT COMPLETED|Overall Study||4
7552718|NCT03073148|18588728|P2|NOT COMPLETED|Overall Study||0
7552719|NCT03073148|18588729|P1|NOT COMPLETED|Overall Study||0
7552720|NCT03073148|18588727|P3|COMPLETED|Overall Study||0
7552721|NCT03073148|18588728|P2|COMPLETED|Overall Study||10
7552722|NCT03073148|18588729|P1|COMPLETED|Overall Study||21
7552723|NCT03073148|18588727|P3|STARTED|Overall Study||4
7552724|NCT03073148|18588728|P2|STARTED|Overall Study||10
7552725|NCT03073148|18588729|P1|STARTED|Overall Study||21
7552726|NCT03073109|18588751|P2|NOT COMPLETED|Overall Study||2
7552727|NCT03073109|18588752|P1|NOT COMPLETED|Overall Study||10
7552728|NCT03073109|18588751|P2|COMPLETED|Overall Study||68
7552729|NCT03073109|18588752|P1|COMPLETED|Overall Study||90
7552730|NCT03073109|18588751|P2|STARTED|Overall Study||70
7552731|NCT03073109|18588752|P1|STARTED|Overall Study||100
7552732|NCT03072875|18588780|P1|NOT COMPLETED|Overall Study||1
7552733|NCT03072875|18588780|P1|COMPLETED|Overall Study||25
7552734|NCT03072875|18588780|P1|STARTED|Overall Study||26
7552735|NCT03072732|18588787|P2|NOT COMPLETED|Overall Study||0
7552736|NCT03072732|18588788|P1|NOT COMPLETED|Overall Study||0
7552737|NCT03072732|18588787|P2|COMPLETED|Overall Study||20
7552738|NCT03072732|18588788|P1|COMPLETED|Overall Study||20
7552739|NCT03072732|18588787|P2|STARTED|Overall Study||20
7552740|NCT03072732|18588788|P1|STARTED|Overall Study||20
7552741|NCT03072719|18588796|P2|NOT COMPLETED|Overall Study||1
7552742|NCT03072719|18588797|P1|NOT COMPLETED|Overall Study||1
7552743|NCT03072719|18588796|P2|COMPLETED|Overall Study||59
7552744|NCT03072719|18588797|P1|COMPLETED|Overall Study||59
7552745|NCT03072719|18588796|P2|STARTED|Overall Study||60
7552746|NCT03072719|18588797|P1|STARTED|Overall Study||60
7552747|NCT03072550|18588807|P1|NOT COMPLETED|Overall Study||2
7552748|NCT03072550|18588807|P1|COMPLETED|Overall Study||24
7552749|NCT03072550|18588807|P1|STARTED|Overall Study||26
7552750|NCT03071887|18588811|P1|NOT COMPLETED|Overall Study||6
7552751|NCT03071887|18588811|P1|COMPLETED|Overall Study||7
7552752|NCT03071887|18588811|P1|STARTED|Overall Study||13
7552753|NCT03071744|18588816|P1|NOT COMPLETED|Overall Study||2
7552754|NCT03071744|18588816|P1|COMPLETED|Overall Study||4
7552755|NCT03071744|18588816|P1|STARTED|Overall Study||6
7552756|NCT03071276|18588822|P1|NOT COMPLETED|Overall Study||15
7552757|NCT03071276|18588822|P1|COMPLETED|Overall Study||22
7552758|NCT03071276|18588822|P1|STARTED|Overall Study||37
7552759|NCT03071263|18588830|P2|NOT COMPLETED|Overall Study||7
7552760|NCT03071263|18588831|P1|NOT COMPLETED|Overall Study||3
7552761|NCT03071263|18588830|P2|COMPLETED|Overall Study||141
7552762|NCT03071263|18588831|P1|COMPLETED|Overall Study||144
7552763|NCT03071263|18588830|P2|STARTED|Overall Study||148
7552764|NCT03071263|18588831|P1|STARTED|Overall Study||147
7552765|NCT03070964|18588855|P1|NOT COMPLETED|Overall Study||14
7552766|NCT03070964|18588855|P1|COMPLETED|Overall Study||0
7552767|NCT03070964|18588855|P1|STARTED|Overall Study||14
7552768|NCT03070782|18588866|P6|NOT COMPLETED|Overall Study||7
7552769|NCT03070782|18588867|P5|NOT COMPLETED|Overall Study||12
7552770|NCT03070782|18588868|P4|NOT COMPLETED|Overall Study||5
7552771|NCT03070782|18588869|P3|NOT COMPLETED|Overall Study||4
7552772|NCT03070782|18588870|P2|NOT COMPLETED|Overall Study||1
7552773|NCT03070782|18588871|P1|NOT COMPLETED|Overall Study||7
7552774|NCT03070782|18588866|P6|COMPLETED|Overall Study||40
7552775|NCT03070782|18588867|P5|COMPLETED|Overall Study||36
7552776|NCT03070782|18588868|P4|COMPLETED|Overall Study||43
7552777|NCT03070782|18588869|P3|COMPLETED|Overall Study||43
7552778|NCT03070782|18588870|P2|COMPLETED|Overall Study||47
7552779|NCT03070782|18588871|P1|COMPLETED|Overall Study||41
7552780|NCT03070782|18588866|P6|STARTED|Overall Study||47
7552781|NCT03070782|18588867|P5|STARTED|Overall Study||48
7552782|NCT03070782|18588868|P4|STARTED|Overall Study||48
7552783|NCT03070782|18588869|P3|STARTED|Overall Study||47
7552784|NCT03070782|18588870|P2|STARTED|Overall Study||48
7552785|NCT03070782|18588871|P1|STARTED|Overall Study||48
7552786|NCT03070730|18588942|P3|NOT COMPLETED|Overall Study||0
7552787|NCT03070730|18588943|P2|NOT COMPLETED|Overall Study||0
7552788|NCT03070730|18588944|P1|NOT COMPLETED|Overall Study||0
7552789|NCT03070730|18588942|P3|COMPLETED|Overall Study||0
7552790|NCT03070730|18588943|P2|COMPLETED|Overall Study||0
7552791|NCT03070730|18588944|P1|COMPLETED|Overall Study||0
7552792|NCT03070730|18588942|P3|STARTED|Overall Study||0
7552793|NCT03070730|18588943|P2|STARTED|Overall Study||0
7552794|NCT03070730|18588944|P1|STARTED|Overall Study||0
7552795|NCT03070548|18589075|P1|NOT COMPLETED|Overall Study||0
7552796|NCT03070548|18589075|P1|COMPLETED|Overall Study||6
7552797|NCT03070548|18589075|P1|STARTED|Overall Study||6
7552798|NCT03070483|18589111|P1|NOT COMPLETED|Overall Study||2
7552799|NCT03070483|18589111|P1|COMPLETED|Overall Study||3
7552800|NCT03070483|18589111|P1|STARTED|Overall Study||5
7552801|NCT03070470|18589126|P6|NOT COMPLETED|Overall Study||2
7552802|NCT03070470|18589127|P5|NOT COMPLETED|Overall Study||0
7552803|NCT03070470|18589128|P4|NOT COMPLETED|Overall Study||0
7552804|NCT03070470|18589129|P3|NOT COMPLETED|Overall Study||0
7552805|NCT03070470|18589130|P2|NOT COMPLETED|Overall Study||1
7552806|NCT03070470|18589131|P1|NOT COMPLETED|Overall Study||0
7552807|NCT03070470|18589126|P6|COMPLETED|Overall Study||8
7552808|NCT03070470|18589127|P5|COMPLETED|Overall Study||10
7552809|NCT03070470|18589128|P4|COMPLETED|Overall Study||10
7552810|NCT03070470|18589129|P3|COMPLETED|Overall Study||10
7552811|NCT03070470|18589130|P2|COMPLETED|Overall Study||9
7552812|NCT03070470|18589131|P1|COMPLETED|Overall Study||10
7552813|NCT03070470|18589126|P6|STARTED|Overall Study||10
7552814|NCT03070470|18589127|P5|STARTED|Overall Study||10
7552815|NCT03070470|18589128|P4|STARTED|Overall Study||10
7552816|NCT03070470|18589129|P3|STARTED|Overall Study||10
7552817|NCT03070470|18589130|P2|STARTED|Overall Study||10
7552818|NCT03070470|18589131|P1|STARTED|Overall Study||10
7552819|NCT03070431|18589158|P1|NOT COMPLETED|Overall Study||4
7552820|NCT03070431|18589158|P1|COMPLETED|Overall Study||40
7552821|NCT03070431|18589158|P1|STARTED|Overall Study||44
7552822|NCT03070236|18589173|P1|NOT COMPLETED|Overall Study||0
7552823|NCT03070236|18589173|P1|COMPLETED|Overall Study||912
7552824|NCT03070236|18589173|P1|Active Surveillance (AS) Arm|Overall Study||374
7552825|NCT03070236|18589173|P1|Guideline Concordant Care (GCC) Arm|Overall Study||538
7552826|NCT03070236|18589173|P1|STARTED|Overall Study||912
7552827|NCT03070171|18589180|P2|NOT COMPLETED|Treatment Period 4 + Washout||1
7552828|NCT03070171|18589181|P1|NOT COMPLETED|Treatment Period 4 + Washout||0
7552829|NCT03070171|18589180|P2|COMPLETED|Treatment Period 4 + Washout||78
7552830|NCT03070171|18589181|P1|COMPLETED|Treatment Period 4 + Washout||80
7552831|NCT03070171|18589180|P2|STARTED|Treatment Period 4 + Washout||79
7552832|NCT03070171|18589181|P1|STARTED|Treatment Period 4 + Washout||80
7552833|NCT03070171|18589180|P2|NOT COMPLETED|Treatment Period 3 + Washout||0
7552834|NCT03070171|18589181|P1|NOT COMPLETED|Treatment Period 3 + Washout||0
7552835|NCT03070171|18589180|P2|COMPLETED|Treatment Period 3 + Washout||79
7552836|NCT03070171|18589181|P1|COMPLETED|Treatment Period 3 + Washout||80
7552837|NCT03070171|18589180|P2|STARTED|Treatment Period 3 + Washout||79
7552838|NCT03070171|18589181|P1|STARTED|Treatment Period 3 + Washout||80
7552839|NCT03070171|18589180|P2|NOT COMPLETED|Treatment Period 2 + Washout||1
7552840|NCT03070171|18589181|P1|NOT COMPLETED|Treatment Period 2 + Washout||0
7552841|NCT03070171|18589180|P2|COMPLETED|Treatment Period 2 + Washout||79
7552842|NCT03070171|18589181|P1|COMPLETED|Treatment Period 2 + Washout||80
7552843|NCT03070171|18589180|P2|STARTED|Treatment Period 2 + Washout||80
7552844|NCT03070171|18589181|P1|STARTED|Treatment Period 2 + Washout||80
7552845|NCT03070171|18589180|P2|NOT COMPLETED|Treatment Period 1 + Washout||0
7552846|NCT03070171|18589181|P1|NOT COMPLETED|Treatment Period 1 + Washout||0
7552847|NCT03070171|18589180|P2|COMPLETED|Treatment Period 1 + Washout||80
7552848|NCT03070171|18589181|P1|COMPLETED|Treatment Period 1 + Washout||80
7552849|NCT03070171|18589180|P2|STARTED|Treatment Period 1 + Washout||80
7552850|NCT03070171|18589181|P1|STARTED|Treatment Period 1 + Washout||80
7552851|NCT03070002|18589197|P1|NOT COMPLETED|Follow up for 2 Years||1
7552852|NCT03070002|18589197|P1|COMPLETED|Follow up for 2 Years||0
7552853|NCT03070002|18589197|P1|STARTED|Follow up for 2 Years||1
7552854|NCT03070002|18589197|P1|NOT COMPLETED|3 Cycles of Treatment||0
7552855|NCT03070002|18589197|P1|COMPLETED|3 Cycles of Treatment||1
7552856|NCT03070002|18589197|P1|STARTED|3 Cycles of Treatment||1
7552857|NCT03069989|18589205|P2|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||0
7552858|NCT03069989|18589206|P1|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||1
7552859|NCT03069989|18589205|P2|COMPLETED|Dosing Period 2 (Up to 16 Days)||5
7552860|NCT03069989|18589206|P1|COMPLETED|Dosing Period 2 (Up to 16 Days)||2
7552861|NCT03069989|18589205|P2|STARTED|Dosing Period 2 (Up to 16 Days)||5
7552862|NCT03069989|18589206|P1|STARTED|Dosing Period 2 (Up to 16 Days)||3
7552863|NCT03069989|18589205|P2|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
7552864|NCT03069989|18589206|P1|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
7552865|NCT03069989|18589205|P2|COMPLETED|Wash Out Period (Up to 28 Days))||5
7552866|NCT03069989|18589206|P1|COMPLETED|Wash Out Period (Up to 28 Days))||3
7552867|NCT03069989|18589205|P2|STARTED|Wash Out Period (Up to 28 Days))||5
7552868|NCT03069989|18589206|P1|STARTED|Wash Out Period (Up to 28 Days))||3
7552869|NCT03069989|18589205|P2|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
7552870|NCT03069989|18589206|P1|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
7552871|NCT03069989|18589205|P2|COMPLETED|Dosing Period 1 (Up to 2 Days)||5
7552872|NCT03069989|18589206|P1|COMPLETED|Dosing Period 1 (Up to 2 Days)||3
7552873|NCT03069989|18589205|P2|STARTED|Dosing Period 1 (Up to 2 Days)||5
7552874|NCT03069989|18589206|P1|STARTED|Dosing Period 1 (Up to 2 Days)||3
7552875|NCT03069677|18589294|P2|NOT COMPLETED|Overall Study||3
7552876|NCT03069677|18589295|P1|NOT COMPLETED|Overall Study||3
7552877|NCT03069677|18589294|P2|COMPLETED|Overall Study||77
7552878|NCT03069677|18589295|P1|COMPLETED|Overall Study||77
7552879|NCT03069677|18589294|P2|STARTED|Overall Study||80
7552880|NCT03069677|18589295|P1|STARTED|Overall Study||80
7552881|NCT03069482|18589313|P2|NOT COMPLETED|Overall Study||1
7552882|NCT03069482|18589314|P1|NOT COMPLETED|Overall Study||1
7552883|NCT03069482|18589313|P2|COMPLETED|Overall Study||28
7552884|NCT03069482|18589314|P1|COMPLETED|Overall Study||33
7552885|NCT03069482|18589313|P2|STARTED|Overall Study||29
7552886|NCT03069482|18589314|P1|STARTED|Overall Study||34
7552887|NCT03069365|18589424|P1|NOT COMPLETED|Overall Study||1
7552888|NCT03069365|18589424|P1|COMPLETED|Overall Study||100
7552889|NCT03069365|18589424|P1|STARTED|Overall Study||101
7552890|NCT03069352|18589432|P2|NOT COMPLETED|Overall Study||40
7552891|NCT03069352|18589433|P1|NOT COMPLETED|Overall Study||12
7552892|NCT03069352|18589432|P2|COMPLETED|Overall Study||103
7552893|NCT03069352|18589433|P1|COMPLETED|Overall Study||56
7552894|NCT03069352|18589432|P2|Received Treatment|Overall Study||142
7552895|NCT03069352|18589433|P1|Received Treatment|Overall Study||68
7552896|NCT03069352|18589432|P2|STARTED|Overall Study||143
7552897|NCT03069352|18589433|P1|STARTED|Overall Study||68
7552898|NCT03069313|18589475|P1|NOT COMPLETED|Overall Study||5
7552899|NCT03069313|18589475|P1|COMPLETED|Overall Study||36
7552900|NCT03069313|18589475|P1|STARTED|Overall Study||41
7552901|NCT03068897|18589486|P4|NOT COMPLETED|Overall Study||6
7552902|NCT03068897|18589487|P3|NOT COMPLETED|Overall Study||1
7552903|NCT03068897|18589488|P2|NOT COMPLETED|Overall Study||4
7552904|NCT03068897|18589489|P1|NOT COMPLETED|Overall Study||4
7552905|NCT03068897|18589486|P4|COMPLETED|Overall Study||74
7552906|NCT03068897|18589487|P3|COMPLETED|Overall Study||79
7552907|NCT03068897|18589488|P2|COMPLETED|Overall Study||76
7552908|NCT03068897|18589489|P1|COMPLETED|Overall Study||76
7552909|NCT03068897|18589486|P4|STARTED|Overall Study||80
7552910|NCT03068897|18589487|P3|STARTED|Overall Study||80
7552911|NCT03068897|18589488|P2|STARTED|Overall Study||80
7552912|NCT03068897|18589489|P1|STARTED|Overall Study||80
7552913|NCT03068767|18589513|P2|NOT COMPLETED|Overall Study||3
7552914|NCT03068767|18589514|P1|NOT COMPLETED|Overall Study||10
7552915|NCT03068767|18589513|P2|COMPLETED|Overall Study|December 2018|71
7552916|NCT03068767|18589514|P1|COMPLETED|Overall Study|December 2018|65
7552917|NCT03068767|18589513|P2|STARTED|Overall Study|from August 2017 to September 2018|74
7552918|NCT03068767|18589514|P1|STARTED|Overall Study|from August 2017 to September 2018|75
7552919|NCT03068754|18589524|P4|NOT COMPLETED|Open Label Extension Period (OLE)||6
7552920|NCT03068754|18589525|P3|NOT COMPLETED|Open Label Extension Period (OLE)||21
7552921|NCT03068754|18589526|P2|NOT COMPLETED|Open Label Extension Period (OLE)||0
7552922|NCT03068754|18589527|P1|NOT COMPLETED|Open Label Extension Period (OLE)||0
7552923|NCT03068754|18589524|P4|COMPLETED|Open Label Extension Period (OLE)||2
7552924|NCT03068754|18589525|P3|COMPLETED|Open Label Extension Period (OLE)||4
7552925|NCT03068754|18589526|P2|COMPLETED|Open Label Extension Period (OLE)||0
7552926|NCT03068754|18589527|P1|COMPLETED|Open Label Extension Period (OLE)||0
7552927|NCT03068754|18589524|P4|Completed Treatment in OLE|Open Label Extension Period (OLE)||2
7552928|NCT03068754|18589525|P3|Completed Treatment in OLE|Open Label Extension Period (OLE)||4
7552929|NCT03068754|18589526|P2|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
7552930|NCT03068754|18589527|P1|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
7552931|NCT03068754|18589524|P4|Completed OLE Period|Open Label Extension Period (OLE)||2
7552932|NCT03068754|18589525|P3|Completed OLE Period|Open Label Extension Period (OLE)||3
7552933|NCT03068754|18589526|P2|Completed OLE Period|Open Label Extension Period (OLE)||0
7552934|NCT03068754|18589527|P1|Completed OLE Period|Open Label Extension Period (OLE)||0
7552935|NCT03068754|18589524|P4|Completed Taper|Open Label Extension Period (OLE)||7
7552936|NCT03068754|18589525|P3|Completed Taper|Open Label Extension Period (OLE)||19
7552937|NCT03068754|18589526|P2|Completed Taper|Open Label Extension Period (OLE)||0
7552938|NCT03068754|18589527|P1|Completed Taper|Open Label Extension Period (OLE)||0
7552939|NCT03068754|18589524|P4|STARTED|Open Label Extension Period (OLE)||8
7552940|NCT03068754|18589525|P3|STARTED|Open Label Extension Period (OLE)||25
7552941|NCT03068754|18589526|P2|STARTED|Open Label Extension Period (OLE)||0
7552942|NCT03068754|18589527|P1|STARTED|Open Label Extension Period (OLE)|RTP arms were not included during the OLE period|0
7552943|NCT03068754|18589524|P4|NOT COMPLETED|Randomized Treatment Period (RTP)||0
7552944|NCT03068754|18589525|P3|NOT COMPLETED|Randomized Treatment Period (RTP)||0
7552945|NCT03068754|18589526|P2|NOT COMPLETED|Randomized Treatment Period (RTP)||39
7552946|NCT03068754|18589527|P1|NOT COMPLETED|Randomized Treatment Period (RTP)||67
7552947|NCT03068754|18589524|P4|COMPLETED|Randomized Treatment Period (RTP)||0
7552948|NCT03068754|18589525|P3|COMPLETED|Randomized Treatment Period (RTP)||0
7552949|NCT03068754|18589526|P2|COMPLETED|Randomized Treatment Period (RTP)||9
7552950|NCT03068754|18589527|P1|COMPLETED|Randomized Treatment Period (RTP)||28
7552951|NCT03068754|18589524|P4|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
7552952|NCT03068754|18589525|P3|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
7552953|NCT03068754|18589526|P2|Enrolled in OLE Period|Randomized Treatment Period (RTP)||8
7552954|NCT03068754|18589527|P1|Enrolled in OLE Period|Randomized Treatment Period (RTP)||25
7552955|NCT03068754|18589524|P4|Completed RTP|Randomized Treatment Period (RTP)||0
7552956|NCT03068754|18589525|P3|Completed RTP|Randomized Treatment Period (RTP)||0
7552957|NCT03068754|18589526|P2|Completed RTP|Randomized Treatment Period (RTP)||9
7552958|NCT03068754|18589527|P1|Completed RTP|Randomized Treatment Period (RTP)||27
7552959|NCT03068754|18589524|P4|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
7552960|NCT03068754|18589525|P3|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
7552961|NCT03068754|18589526|P2|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||9
7552962|NCT03068754|18589527|P1|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||28
7552963|NCT03068754|18589524|P4|Completed Taper|Randomized Treatment Period (RTP)||0
7552964|NCT03068754|18589525|P3|Completed Taper|Randomized Treatment Period (RTP)||0
7552965|NCT03068754|18589526|P2|Completed Taper|Randomized Treatment Period (RTP)||28
7552966|NCT03068754|18589527|P1|Completed Taper|Randomized Treatment Period (RTP)||58
7552967|NCT03068754|18589524|P4|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
7552968|NCT03068754|18589525|P3|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
7552969|NCT03068754|18589526|P2|Modified ITT (mITT)|Randomized Treatment Period (RTP)||46
7552970|NCT03068754|18589527|P1|Modified ITT (mITT)|Randomized Treatment Period (RTP)||93
7552971|NCT03068754|18589524|P4|Safety Population|Randomized Treatment Period (RTP)||0
7552972|NCT03068754|18589525|P3|Safety Population|Randomized Treatment Period (RTP)||0
7552973|NCT03068754|18589526|P2|Safety Population|Randomized Treatment Period (RTP)||47
7552974|NCT03068754|18589527|P1|Safety Population|Randomized Treatment Period (RTP)||95
7552975|NCT03068754|18589524|P4|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
7552976|NCT03068754|18589525|P3|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
7552977|NCT03068754|18589526|P2|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||48
7552978|NCT03068754|18589527|P1|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||95
7552979|NCT03068754|18589524|P4|STARTED|Randomized Treatment Period (RTP)||0
7552980|NCT03068754|18589525|P3|STARTED|Randomized Treatment Period (RTP)|OLE Arms were not included during the RTP|0
7552981|NCT03068754|18589526|P2|STARTED|Randomized Treatment Period (RTP)||48
7552982|NCT03068754|18589527|P1|STARTED|Randomized Treatment Period (RTP)||95
7552983|NCT03068611|18589547|P2|NOT COMPLETED|Overall Study||25
7552984|NCT03068611|18589548|P1|NOT COMPLETED|Overall Study||31
7552985|NCT03068611|18589547|P2|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|33
7552986|NCT03068611|18589548|P1|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|30
7552987|NCT03068611|18589547|P2|STARTED|Overall Study||58
7552988|NCT03068611|18589548|P1|STARTED|Overall Study||61
7552989|NCT03068468|18589562|P4|NOT COMPLETED|Open-Label Extension Period||276
7552990|NCT03068468|18589563|P3|NOT COMPLETED|Open-Label Extension Period||140
7552991|NCT03068468|18589564|P2|NOT COMPLETED|Open-Label Extension Period||0
7552992|NCT03068468|18589565|P1|NOT COMPLETED|Open-Label Extension Period||0
7552993|NCT03068468|18589562|P4|COMPLETED|Open-Label Extension Period||0
7552994|NCT03068468|18589563|P3|COMPLETED|Open-Label Extension Period||0
7552995|NCT03068468|18589564|P2|COMPLETED|Open-Label Extension Period||0
7552996|NCT03068468|18589565|P1|COMPLETED|Open-Label Extension Period||0
7552997|NCT03068468|18589562|P4|STARTED|Open-Label Extension Period|3 participants did not enter OLE period.|276
7552998|NCT03068468|18589563|P3|STARTED|Open-Label Extension Period|4 participants did not enter OLE period.|140
7552999|NCT03068468|18589564|P2|STARTED|Open-Label Extension Period||0
7553000|NCT03068468|18589565|P1|STARTED|Open-Label Extension Period||0
7553001|NCT03068468|18589562|P4|NOT COMPLETED|Placebo-Controlled Period||0
7553002|NCT03068468|18589563|P3|NOT COMPLETED|Placebo-Controlled Period||0
7553003|NCT03068468|18589564|P2|NOT COMPLETED|Placebo-Controlled Period||45
7553004|NCT03068468|18589565|P1|NOT COMPLETED|Placebo-Controlled Period||22
7553005|NCT03068468|18589562|P4|COMPLETED|Placebo-Controlled Period||0
7553006|NCT03068468|18589563|P3|COMPLETED|Placebo-Controlled Period||0
7553007|NCT03068468|18589564|P2|COMPLETED|Placebo-Controlled Period||279
7553008|NCT03068468|18589565|P1|COMPLETED|Placebo-Controlled Period||144
7553009|NCT03068468|18589562|P4|Treated|Placebo-Controlled Period||0
7553010|NCT03068468|18589563|P3|Treated|Placebo-Controlled Period||0
7553011|NCT03068468|18589564|P2|Treated|Placebo-Controlled Period||321
7553012|NCT03068468|18589565|P1|Treated|Placebo-Controlled Period||165
7553013|NCT03068468|18589562|P4|STARTED|Placebo-Controlled Period||0
7553014|NCT03068468|18589563|P3|STARTED|Placebo-Controlled Period||0
7553015|NCT03068468|18589564|P2|STARTED|Placebo-Controlled Period||324
7553016|NCT03068468|18589565|P1|STARTED|Placebo-Controlled Period||166
7553017|NCT03068312|18589603|P2|NOT COMPLETED|Overall Study||0
7553018|NCT03068312|18589604|P1|NOT COMPLETED|Overall Study||0
7553019|NCT03068312|18589603|P2|COMPLETED|Overall Study||19
7553020|NCT03068312|18589604|P1|COMPLETED|Overall Study||19
7553021|NCT03068312|18589603|P2|STARTED|Overall Study||19
7553022|NCT03068312|18589604|P1|STARTED|Overall Study||19
7553023|NCT03068091|18589610|P1|NOT COMPLETED|Overall Study||1
7553024|NCT03068091|18589610|P1|COMPLETED|Overall Study||24
7553025|NCT03068091|18589610|P1|STARTED|Overall Study||25
7553026|NCT03067987|18589617|P2|NOT COMPLETED|Overall Study||13
7553027|NCT03067987|18589618|P1|NOT COMPLETED|Overall Study||10
7553028|NCT03067987|18589617|P2|COMPLETED|Overall Study||40
7553029|NCT03067987|18589618|P1|COMPLETED|Overall Study||40
7553030|NCT03067987|18589617|P2|STARTED|Overall Study||53
7553031|NCT03067987|18589618|P1|STARTED|Overall Study||50
7553032|NCT03067948|18589630|P1|NOT COMPLETED|Overall Study||0
7553033|NCT03067948|18589630|P1|COMPLETED|Overall Study||32
7553034|NCT03067948|18589630|P1|STARTED|Overall Study||32
7553035|NCT03067506|18589635|P1|NOT COMPLETED|Overall Study||0
7553036|NCT03067506|18589635|P1|COMPLETED|Overall Study||30
7553037|NCT03067506|18589635|P1|STARTED|Overall Study||30
7553038|NCT03067441|18589644|P2|NOT COMPLETED|Overall Study||57
7553039|NCT03067441|18589645|P1|NOT COMPLETED|Overall Study||33
7553040|NCT03067441|18589644|P2|COMPLETED|Overall Study||913
7553041|NCT03067441|18589645|P1|COMPLETED|Overall Study||459
7553042|NCT03067441|18589644|P2|STARTED|Overall Study||970
7553043|NCT03067441|18589645|P1|STARTED|Overall Study||492
7553044|NCT03066999|18589703|P2|NOT COMPLETED|Overall Study||2
7553045|NCT03066999|18589704|P1|NOT COMPLETED|Overall Study||0
7553046|NCT03066999|18589703|P2|COMPLETED|Overall Study||1
7553047|NCT03066999|18589704|P1|COMPLETED|Overall Study||2
7553048|NCT03066999|18589703|P2|STARTED|Overall Study||3
7553049|NCT03066999|18589704|P1|STARTED|Overall Study||2
7553050|NCT03066778|18589724|P2|NOT COMPLETED|Overall Study||225
7553051|NCT03066778|18589725|P1|NOT COMPLETED|Overall Study||228
7553052|NCT03066778|18589724|P2|COMPLETED|Overall Study||0
7553053|NCT03066778|18589725|P1|COMPLETED|Overall Study||0
7553054|NCT03066778|18589724|P2|Treated|Overall Study|1 participant randomized to the pembrolizumab+etoposide arm was treated with placebo+etoposide.|223
7553055|NCT03066778|18589725|P1|Treated|Overall Study|1 participant randomized to the pembrolizumab+etoposide arm was treated with placebo+etoposide.|223
7553056|NCT03066778|18589724|P2|STARTED|Overall Study||225
7553057|NCT03066778|18589725|P1|STARTED|Overall Study||228
7553058|NCT03066622|18589753|P2|NOT COMPLETED|Overall Study||26
7553059|NCT03066622|18589754|P1|NOT COMPLETED|Overall Study||26
7553060|NCT03066622|18589753|P2|COMPLETED|Overall Study||35
7553061|NCT03066622|18589754|P1|COMPLETED|Overall Study||35
7553062|NCT03066622|18589753|P2|STARTED|Overall Study||61
7553063|NCT03066622|18589754|P1|STARTED|Overall Study||61
7553064|NCT03066609|18589767|P4|NOT COMPLETED|OVERALL STUDY||5
7553065|NCT03066609|18589768|P3|NOT COMPLETED|OVERALL STUDY||4
7553066|NCT03066609|18589769|P2|NOT COMPLETED|OVERALL STUDY||8
7553067|NCT03066609|18589770|P1|NOT COMPLETED|OVERALL STUDY||10
7553068|NCT03066609|18589767|P4|COMPLETED|OVERALL STUDY||124
7553069|NCT03066609|18589768|P3|COMPLETED|OVERALL STUDY||2
7553070|NCT03066609|18589769|P2|COMPLETED|OVERALL STUDY||264
7553071|NCT03066609|18589770|P1|COMPLETED|OVERALL STUDY||126
7553072|NCT03066609|18589767|P4|STARTED|OVERALL STUDY||129
7553073|NCT03066609|18589768|P3|STARTED|OVERALL STUDY||6
7553074|NCT03066609|18589769|P2|STARTED|OVERALL STUDY||272
7553075|NCT03066609|18589770|P1|STARTED|OVERALL STUDY||136
7553076|NCT03066609|18589767|P4|NOT COMPLETED|MAINTENANCE||3
7553077|NCT03066609|18589768|P3|NOT COMPLETED|MAINTENANCE||2
7553078|NCT03066609|18589769|P2|NOT COMPLETED|MAINTENANCE||4
7553079|NCT03066609|18589770|P1|NOT COMPLETED|MAINTENANCE||7
7553080|NCT03066609|18589767|P4|COMPLETED|MAINTENANCE||126
7553081|NCT03066609|18589768|P3|COMPLETED|MAINTENANCE||2
7553082|NCT03066609|18589769|P2|COMPLETED|MAINTENANCE||266
7553083|NCT03066609|18589770|P1|COMPLETED|MAINTENANCE||127
7553084|NCT03066609|18589767|P4|STARTED|MAINTENANCE||129
7553085|NCT03066609|18589768|P3|STARTED|MAINTENANCE||4
7553086|NCT03066609|18589769|P2|STARTED|MAINTENANCE||270
7553087|NCT03066609|18589770|P1|STARTED|MAINTENANCE||134
7553088|NCT03066609|18589767|P4|NOT COMPLETED|INDUCTION||0
7553089|NCT03066609|18589768|P3|NOT COMPLETED|INDUCTION||2
7553090|NCT03066609|18589769|P2|NOT COMPLETED|INDUCTION||2
7553091|NCT03066609|18589770|P1|NOT COMPLETED|INDUCTION||2
7553092|NCT03066609|18589767|P4|COMPLETED|INDUCTION||0
7553093|NCT03066609|18589768|P3|COMPLETED|INDUCTION||133
7553094|NCT03066609|18589769|P2|COMPLETED|INDUCTION||270
7553095|NCT03066609|18589770|P1|COMPLETED|INDUCTION||134
7553096|NCT03066609|18589767|P4|STARTED|INDUCTION||0
7553097|NCT03066609|18589768|P3|STARTED|INDUCTION||135
7553098|NCT03066609|18589769|P2|STARTED|INDUCTION||272
7553099|NCT03066609|18589770|P1|STARTED|INDUCTION||136
7553100|NCT03066193|18589800|P1|NOT COMPLETED|Overall Study||1
7553101|NCT03066193|18589800|P1|COMPLETED|Overall Study||16
7553102|NCT03066193|18589800|P1|STARTED|Overall Study||17
7553103|NCT03066102|18589804|P1|NOT COMPLETED|Overall Study||0
7553104|NCT03066102|18589804|P1|COMPLETED|Overall Study||30
7553105|NCT03066102|18589804|P1|STARTED|Overall Study||30
7553106|NCT03065933|18589813|P1|NOT COMPLETED|Overall Study||5
7553107|NCT03065933|18589813|P1|COMPLETED|Overall Study||0
7553108|NCT03065933|18589813|P1|STARTED|Overall Study||5
7553109|NCT03065530|18589821|P4|NOT COMPLETED|Overall Study||2
7553110|NCT03065530|18589822|P3|NOT COMPLETED|Overall Study||1
7553111|NCT03065530|18589823|P2|NOT COMPLETED|Overall Study||1
7553112|NCT03065530|18589824|P1|NOT COMPLETED|Overall Study||2
7553113|NCT03065530|18589821|P4|COMPLETED|Overall Study||28
7553114|NCT03065530|18589822|P3|COMPLETED|Overall Study||29
7553115|NCT03065530|18589823|P2|COMPLETED|Overall Study||29
7553116|NCT03065530|18589824|P1|COMPLETED|Overall Study||28
7553117|NCT03065530|18589821|P4|STARTED|Overall Study||30
7553118|NCT03065530|18589822|P3|STARTED|Overall Study||30
7553119|NCT03065530|18589823|P2|STARTED|Overall Study||30
7553120|NCT03065530|18589824|P1|STARTED|Overall Study||30
7553121|NCT03065283|18589903|P2|NOT COMPLETED|Overall Study||0
7553122|NCT03065283|18589904|P1|NOT COMPLETED|Overall Study||0
7553123|NCT03065283|18589903|P2|COMPLETED|Overall Study||25
7553124|NCT03065283|18589904|P1|COMPLETED|Overall Study||50
7553125|NCT03065283|18589903|P2|STARTED|Overall Study||25
7553126|NCT03065283|18589904|P1|STARTED|Overall Study||50
7553127|NCT03065205|18589910|P1|NOT COMPLETED|Overall Study||12
7553128|NCT03065205|18589910|P1|COMPLETED|Overall Study||53
7553129|NCT03065205|18589910|P1|STARTED|Overall Study||65
7553130|NCT03065075|18589919|P2|NOT COMPLETED|Overall Study||0
7553131|NCT03065075|18589920|P1|NOT COMPLETED|Overall Study||0
7553132|NCT03065075|18589919|P2|COMPLETED|Overall Study||76
7553133|NCT03065075|18589920|P1|COMPLETED|Overall Study||76
7553134|NCT03065075|18589919|P2|As-treated Analysis|Overall Study||77
7553135|NCT03065075|18589920|P1|As-treated Analysis|Overall Study||69
7553136|NCT03065075|18589919|P2|Intent-to-treat Analysis|Overall Study||74
7553137|NCT03065075|18589920|P1|Intent-to-treat Analysis|Overall Study||72
7553138|NCT03065075|18589919|P2|STARTED|Overall Study||76
7553139|NCT03065075|18589920|P1|STARTED|Overall Study||76
7553140|NCT03065023|18589932|P5|NOT COMPLETED|Overall Study||0
7553141|NCT03065023|18589933|P4|NOT COMPLETED|Overall Study||3
7553142|NCT03065023|18589934|P3|NOT COMPLETED|Overall Study||1
7553143|NCT03065023|18589935|P2|NOT COMPLETED|Overall Study||2
7553144|NCT03065023|18589936|P1|NOT COMPLETED|Overall Study||2
7553145|NCT03065023|18589932|P5|COMPLETED|Overall Study||0
7553146|NCT03065023|18589933|P4|COMPLETED|Overall Study||3
7553147|NCT03065023|18589934|P3|COMPLETED|Overall Study||2
7553148|NCT03065023|18589935|P2|COMPLETED|Overall Study||1
7553149|NCT03065023|18589936|P1|COMPLETED|Overall Study||1
7553150|NCT03065023|18589932|P5|STARTED|Overall Study|Group B not started for business reasons.|0
7553151|NCT03065023|18589933|P4|STARTED|Overall Study||6
7553152|NCT03065023|18589934|P3|STARTED|Overall Study||3
7553153|NCT03065023|18589935|P2|STARTED|Overall Study||3
7553154|NCT03065023|18589936|P1|STARTED|Overall Study||3
7553155|NCT03064841|18590002|P1|NOT COMPLETED|Overall Study||17
7553156|NCT03064841|18590002|P1|COMPLETED|Overall Study||1520
7553157|NCT03064841|18590002|P1|STARTED|Overall Study||1537
7553158|NCT03064451|18590017|P1|NOT COMPLETED|Overall Study||14
7553159|NCT03064451|18590017|P1|COMPLETED|Overall Study||46
7553160|NCT03064451|18590017|P1|Safety Population|Overall Study||52
7553161|NCT03064451|18590017|P1|STARTED|Overall Study||60
7553162|NCT03064126|18590035|P4|NOT COMPLETED|Overall Study||1
7553163|NCT03064126|18590036|P3|NOT COMPLETED|Overall Study||3
7553164|NCT03064126|18590037|P2|NOT COMPLETED|Overall Study||7
7553165|NCT03064126|18590038|P1|NOT COMPLETED|Overall Study||26
7553166|NCT03064126|18590035|P4|COMPLETED|Overall Study||11
7553167|NCT03064126|18590036|P3|COMPLETED|Overall Study||49
7553168|NCT03064126|18590037|P2|COMPLETED|Overall Study||91
7553169|NCT03064126|18590038|P1|COMPLETED|Overall Study||252
7553170|NCT03064126|18590035|P4|STARTED|Overall Study||12
7553171|NCT03064126|18590036|P3|STARTED|Overall Study||52
7553172|NCT03064126|18590037|P2|STARTED|Overall Study||98
7553173|NCT03064126|18590038|P1|STARTED|Overall Study||278
7553174|NCT03064113|18590087|P4|NOT COMPLETED|Washout (7 Days)||0
7553175|NCT03064113|18590088|P3|NOT COMPLETED|Washout (7 Days)||0
7553176|NCT03064113|18590089|P2|NOT COMPLETED|Washout (7 Days)||0
7553177|NCT03064113|18590090|P1|NOT COMPLETED|Washout (7 Days)||0
7553178|NCT03064113|18590087|P4|COMPLETED|Washout (7 Days)||8
7553179|NCT03064113|18590088|P3|COMPLETED|Washout (7 Days)||8
7553180|NCT03064113|18590089|P2|COMPLETED|Washout (7 Days)||8
7553181|NCT03064113|18590090|P1|COMPLETED|Washout (7 Days)||8
7553182|NCT03064113|18590087|P4|STARTED|Washout (7 Days)||8
7553183|NCT03064113|18590088|P3|STARTED|Washout (7 Days)||8
7553184|NCT03064113|18590089|P2|STARTED|Washout (7 Days)||8
7553185|NCT03064113|18590090|P1|STARTED|Washout (7 Days)||8
7553186|NCT03064113|18590087|P4|NOT COMPLETED|Intervention 4 (2 Days)||0
7553187|NCT03064113|18590088|P3|NOT COMPLETED|Intervention 4 (2 Days)||0
7553188|NCT03064113|18590089|P2|NOT COMPLETED|Intervention 4 (2 Days)||0
7553189|NCT03064113|18590090|P1|NOT COMPLETED|Intervention 4 (2 Days)||0
7553190|NCT03064113|18590087|P4|COMPLETED|Intervention 4 (2 Days)||8
7553191|NCT03064113|18590088|P3|COMPLETED|Intervention 4 (2 Days)||8
7553192|NCT03064113|18590089|P2|COMPLETED|Intervention 4 (2 Days)||8
7553193|NCT03064113|18590090|P1|COMPLETED|Intervention 4 (2 Days)||8
7553194|NCT03064113|18590087|P4|STARTED|Intervention 4 (2 Days)||8
7553195|NCT03064113|18590088|P3|STARTED|Intervention 4 (2 Days)||8
7553196|NCT03064113|18590089|P2|STARTED|Intervention 4 (2 Days)||8
7553197|NCT03064113|18590090|P1|STARTED|Intervention 4 (2 Days)||8
7553198|NCT03064113|18590087|P4|NOT COMPLETED|Washout (7 Days)||0
7553199|NCT03064113|18590088|P3|NOT COMPLETED|Washout (7 Days)||0
7553200|NCT03064113|18590089|P2|NOT COMPLETED|Washout (7 Days)||0
7553201|NCT03064113|18590090|P1|NOT COMPLETED|Washout (7 Days)||0
7553202|NCT03064113|18590087|P4|COMPLETED|Washout (7 Days)||8
7553203|NCT03064113|18590088|P3|COMPLETED|Washout (7 Days)||8
7553204|NCT03064113|18590089|P2|COMPLETED|Washout (7 Days)||8
7553205|NCT03064113|18590090|P1|COMPLETED|Washout (7 Days)||8
7553206|NCT03064113|18590087|P4|STARTED|Washout (7 Days)||8
7553207|NCT03064113|18590088|P3|STARTED|Washout (7 Days)||8
7553208|NCT03064113|18590089|P2|STARTED|Washout (7 Days)||8
7553209|NCT03064113|18590090|P1|STARTED|Washout (7 Days)||8
7553210|NCT03064113|18590087|P4|NOT COMPLETED|Intervention 3 (2 Days)||0
7553211|NCT03064113|18590088|P3|NOT COMPLETED|Intervention 3 (2 Days)||0
7553212|NCT03064113|18590089|P2|NOT COMPLETED|Intervention 3 (2 Days)||0
7553213|NCT03064113|18590090|P1|NOT COMPLETED|Intervention 3 (2 Days)||0
7553214|NCT03064113|18590087|P4|COMPLETED|Intervention 3 (2 Days)||8
7553215|NCT03064113|18590088|P3|COMPLETED|Intervention 3 (2 Days)||8
7553216|NCT03064113|18590089|P2|COMPLETED|Intervention 3 (2 Days)||8
7553217|NCT03064113|18590090|P1|COMPLETED|Intervention 3 (2 Days)||8
7553218|NCT03064113|18590087|P4|STARTED|Intervention 3 (2 Days)||8
7553219|NCT03064113|18590088|P3|STARTED|Intervention 3 (2 Days)||8
7553220|NCT03064113|18590089|P2|STARTED|Intervention 3 (2 Days)||8
7553221|NCT03064113|18590090|P1|STARTED|Intervention 3 (2 Days)||8
7553222|NCT03064113|18590087|P4|NOT COMPLETED|Washout (7 Days)||0
7553223|NCT03064113|18590088|P3|NOT COMPLETED|Washout (7 Days)||0
7553224|NCT03064113|18590089|P2|NOT COMPLETED|Washout (7 Days)||0
7553225|NCT03064113|18590090|P1|NOT COMPLETED|Washout (7 Days)||0
7553226|NCT03064113|18590087|P4|COMPLETED|Washout (7 Days)||8
7553227|NCT03064113|18590088|P3|COMPLETED|Washout (7 Days)||8
7553228|NCT03064113|18590089|P2|COMPLETED|Washout (7 Days)||8
7553229|NCT03064113|18590090|P1|COMPLETED|Washout (7 Days)||8
7553230|NCT03064113|18590087|P4|STARTED|Washout (7 Days)||8
7553231|NCT03064113|18590088|P3|STARTED|Washout (7 Days)||8
7553232|NCT03064113|18590089|P2|STARTED|Washout (7 Days)||8
7553233|NCT03064113|18590090|P1|STARTED|Washout (7 Days)||8
7553234|NCT03064113|18590087|P4|NOT COMPLETED|Intervention 2 (2 Days)||0
7553235|NCT03064113|18590088|P3|NOT COMPLETED|Intervention 2 (2 Days)||0
7553236|NCT03064113|18590089|P2|NOT COMPLETED|Intervention 2 (2 Days)||0
7553237|NCT03064113|18590090|P1|NOT COMPLETED|Intervention 2 (2 Days)||0
7553238|NCT03064113|18590087|P4|COMPLETED|Intervention 2 (2 Days)||8
7553239|NCT03064113|18590088|P3|COMPLETED|Intervention 2 (2 Days)||8
7553240|NCT03064113|18590089|P2|COMPLETED|Intervention 2 (2 Days)||8
7553241|NCT03064113|18590090|P1|COMPLETED|Intervention 2 (2 Days)||8
7553242|NCT03064113|18590087|P4|STARTED|Intervention 2 (2 Days)||8
7553243|NCT03064113|18590088|P3|STARTED|Intervention 2 (2 Days)||8
7553244|NCT03064113|18590089|P2|STARTED|Intervention 2 (2 Days)||8
7553245|NCT03064113|18590090|P1|STARTED|Intervention 2 (2 Days)||8
7553246|NCT03064113|18590087|P4|NOT COMPLETED|Washout (7 Days)||0
7553247|NCT03064113|18590088|P3|NOT COMPLETED|Washout (7 Days)||0
7553248|NCT03064113|18590089|P2|NOT COMPLETED|Washout (7 Days)||0
7553249|NCT03064113|18590090|P1|NOT COMPLETED|Washout (7 Days)||0
7553250|NCT03064113|18590087|P4|COMPLETED|Washout (7 Days)||8
7553251|NCT03064113|18590088|P3|COMPLETED|Washout (7 Days)||8
7553252|NCT03064113|18590089|P2|COMPLETED|Washout (7 Days)||8
7553253|NCT03064113|18590090|P1|COMPLETED|Washout (7 Days)||8
7553254|NCT03064113|18590087|P4|STARTED|Washout (7 Days)||8
7553255|NCT03064113|18590088|P3|STARTED|Washout (7 Days)||8
7553256|NCT03064113|18590089|P2|STARTED|Washout (7 Days)||8
7553257|NCT03064113|18590090|P1|STARTED|Washout (7 Days)||8
7553258|NCT03064113|18590087|P4|NOT COMPLETED|Intervention 1 (2 Days)||0
7553259|NCT03064113|18590088|P3|NOT COMPLETED|Intervention 1 (2 Days)||0
7553260|NCT03064113|18590089|P2|NOT COMPLETED|Intervention 1 (2 Days)||0
7553261|NCT03064113|18590090|P1|NOT COMPLETED|Intervention 1 (2 Days)||0
7553262|NCT03064113|18590087|P4|COMPLETED|Intervention 1 (2 Days)||8
7553263|NCT03064113|18590088|P3|COMPLETED|Intervention 1 (2 Days)||8
7553264|NCT03064113|18590089|P2|COMPLETED|Intervention 1 (2 Days)||8
7553265|NCT03064113|18590090|P1|COMPLETED|Intervention 1 (2 Days)||8
7553266|NCT03064113|18590087|P4|STARTED|Intervention 1 (2 Days)||8
7553267|NCT03064113|18590088|P3|STARTED|Intervention 1 (2 Days)||8
7553268|NCT03064113|18590089|P2|STARTED|Intervention 1 (2 Days)||8
7553269|NCT03064113|18590090|P1|STARTED|Intervention 1 (2 Days)||8
7553270|NCT03063476|18590124|P1|NOT COMPLETED|Overall Study||0
7553271|NCT03063476|18590124|P1|COMPLETED|Overall Study||2
7553272|NCT03063476|18590124|P1|STARTED|Overall Study||2
7553273|NCT03063437|18590131|P2|NOT COMPLETED|Overall Study||0
7553274|NCT03063437|18590132|P1|NOT COMPLETED|Overall Study||0
7553275|NCT03063437|18590131|P2|COMPLETED|Overall Study||5
7553276|NCT03063437|18590132|P1|COMPLETED|Overall Study||4
7553277|NCT03063437|18590131|P2|STARTED|Overall Study||5
7553278|NCT03063437|18590132|P1|STARTED|Overall Study||4
7553279|NCT03063385|18590160|P2|NOT COMPLETED|Overall Study||76
7553280|NCT03063385|18590161|P1|NOT COMPLETED|Overall Study||87
7553281|NCT03063385|18590160|P2|COMPLETED|Overall Study||254
7553282|NCT03063385|18590161|P1|COMPLETED|Overall Study||243
7553283|NCT03063385|18590160|P2|12-month Follow-up|Overall Study||254
7553284|NCT03063385|18590161|P1|12-month Follow-up|Overall Study||243
7553285|NCT03063385|18590160|P2|6-month Follow-up|Overall Study||259
7553286|NCT03063385|18590161|P1|6-month Follow-up|Overall Study||265
7553287|NCT03063385|18590160|P2|3-month Follow-up|Overall Study||259
7553288|NCT03063385|18590161|P1|3-month Follow-up|Overall Study||257
7553289|NCT03063385|18590160|P2|STARTED|Overall Study||330
7553290|NCT03063385|18590161|P1|STARTED|Overall Study||330
7553291|NCT03063294|18590173|P2|NOT COMPLETED|Overall Study||0
7553292|NCT03063294|18590174|P1|NOT COMPLETED|Overall Study||0
7553293|NCT03063294|18590173|P2|COMPLETED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502
7553294|NCT03063294|18590174|P1|COMPLETED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463
7553295|NCT03063294|18590173|P2|STARTED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502
7553296|NCT03063294|18590174|P1|STARTED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463
7553297|NCT03063086|18590180|P6|NOT COMPLETED|Overall Study||1
7553298|NCT03063086|18590181|P5|NOT COMPLETED|Overall Study||0
7553299|NCT03063086|18590182|P4|NOT COMPLETED|Overall Study||3
7553300|NCT03063086|18590183|P3|NOT COMPLETED|Overall Study||1
7553301|NCT03063086|18590184|P2|NOT COMPLETED|Overall Study||1
7553302|NCT03063086|18590185|P1|NOT COMPLETED|Overall Study||3
7553303|NCT03063086|18590180|P6|COMPLETED|Overall Study||18
7553304|NCT03063086|18590181|P5|COMPLETED|Overall Study||20
7553305|NCT03063086|18590182|P4|COMPLETED|Overall Study||17
7553306|NCT03063086|18590183|P3|COMPLETED|Overall Study||17
7553307|NCT03063086|18590184|P2|COMPLETED|Overall Study||19
7553308|NCT03063086|18590185|P1|COMPLETED|Overall Study||16
7553309|NCT03063086|18590180|P6|STARTED|Overall Study||19
7553310|NCT03063086|18590181|P5|STARTED|Overall Study||20
7553311|NCT03063086|18590182|P4|STARTED|Overall Study||20
7553312|NCT03063086|18590183|P3|STARTED|Overall Study||18
7553313|NCT03063086|18590184|P2|STARTED|Overall Study||20
7553314|NCT03063086|18590185|P1|STARTED|Overall Study||19
7553315|NCT03062917|18590213|P5|NOT COMPLETED|Overall Study||0
7553316|NCT03062917|18590214|P4|NOT COMPLETED|Overall Study||0
7553317|NCT03062917|18590215|P3|NOT COMPLETED|Overall Study||0
7553318|NCT03062917|18590216|P2|NOT COMPLETED|Overall Study||0
7553319|NCT03062917|18590217|P1|NOT COMPLETED|Overall Study||0
7553320|NCT03062917|18590213|P5|COMPLETED|Overall Study||0
7553321|NCT03062917|18590214|P4|COMPLETED|Overall Study||20
7553322|NCT03062917|18590215|P3|COMPLETED|Overall Study||49
7553323|NCT03062917|18590216|P2|COMPLETED|Overall Study||51
7553324|NCT03062917|18590217|P1|COMPLETED|Overall Study||32
7553325|NCT03062917|18590213|P5|STARTED|Overall Study||0
7553326|NCT03062917|18590214|P4|STARTED|Overall Study||20
7553327|NCT03062917|18590215|P3|STARTED|Overall Study||49
7553328|NCT03062917|18590216|P2|STARTED|Overall Study||51
7553329|NCT03062917|18590217|P1|STARTED|Overall Study||32
7553330|NCT03062891|18590231|P2|NOT COMPLETED|Overall Study||38
7553331|NCT03062891|18590232|P1|NOT COMPLETED|Overall Study||52
7553332|NCT03062891|18590231|P2|COMPLETED|Overall Study||62
7553333|NCT03062891|18590232|P1|COMPLETED|Overall Study||47
7553334|NCT03062891|18590231|P2|Followup|Overall Study||62
7553335|NCT03062891|18590232|P1|Followup|Overall Study||47
7553336|NCT03062891|18590231|P2|End of Intervention|Overall Study||78
7553337|NCT03062891|18590232|P1|End of Intervention|Overall Study||67
7553338|NCT03062891|18590231|P2|Mid-intervention|Overall Study||74
7553339|NCT03062891|18590232|P1|Mid-intervention|Overall Study||68
7553340|NCT03062891|18590231|P2|STARTED|Overall Study||100
7553341|NCT03062891|18590232|P1|STARTED|Overall Study||99
7553342|NCT03062605|18590277|P2|NOT COMPLETED|Overall Study||10
7553343|NCT03062605|18590278|P1|NOT COMPLETED|Overall Study||11
7553344|NCT03062605|18590277|P2|COMPLETED|Overall Study||13
7553345|NCT03062605|18590278|P1|COMPLETED|Overall Study||14
7553346|NCT03062605|18590277|P2|STARTED|Overall Study||23
7553347|NCT03062605|18590278|P1|STARTED|Overall Study||25
7553348|NCT03062488|18590287|P3|NOT COMPLETED|Overall Study||0
7553349|NCT03062488|18590288|P2|NOT COMPLETED|Overall Study||0
7553350|NCT03062488|18590289|P1|NOT COMPLETED|Overall Study||0
7553351|NCT03062488|18590287|P3|COMPLETED|Overall Study||41
7553352|NCT03062488|18590288|P2|COMPLETED|Overall Study||51
7553353|NCT03062488|18590289|P1|COMPLETED|Overall Study||51
7553354|NCT03062488|18590287|P3|STARTED|Overall Study||41
7553355|NCT03062488|18590288|P2|STARTED|Overall Study||51
7553356|NCT03062488|18590289|P1|STARTED|Overall Study||51
7553357|NCT03062267|18590305|P2|NOT COMPLETED|Overall Study||5
7553358|NCT03062267|18590306|P1|NOT COMPLETED|Overall Study||2
7553359|NCT03062267|18590305|P2|COMPLETED|Overall Study||32
7553360|NCT03062267|18590306|P1|COMPLETED|Overall Study||10
7553361|NCT03062267|18590305|P2|STARTED|Overall Study||37
7553362|NCT03062267|18590306|P1|STARTED|Overall Study||12
7553363|NCT03062228|18590318|P1|NOT COMPLETED|Overall Study||0
7553364|NCT03062228|18590318|P1|COMPLETED|Overall Study||162
7553365|NCT03062228|18590318|P1|STARTED|Overall Study||162
7553366|NCT03061513|18590331|P2|NOT COMPLETED|Overall Study||1
7553367|NCT03061513|18590332|P1|NOT COMPLETED|Overall Study||0
7553368|NCT03061513|18590331|P2|COMPLETED|Overall Study||4
7553369|NCT03061513|18590332|P1|COMPLETED|Overall Study||6
7553370|NCT03061513|18590331|P2|STARTED|Overall Study||5
7553371|NCT03061513|18590332|P1|STARTED|Overall Study||6
7553372|NCT03061331|18590342|P2|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
7553373|NCT03061331|18590343|P1|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
7553374|NCT03061331|18590342|P2|COMPLETED|Treatment Period 2 (8 Weeks)||9
7553375|NCT03061331|18590343|P1|COMPLETED|Treatment Period 2 (8 Weeks)||8
7553376|NCT03061331|18590342|P2|STARTED|Treatment Period 2 (8 Weeks)||9
7553377|NCT03061331|18590343|P1|STARTED|Treatment Period 2 (8 Weeks)||8
7553378|NCT03061331|18590342|P2|NOT COMPLETED|Washout Period (8 Weeks)||1
7553379|NCT03061331|18590343|P1|NOT COMPLETED|Washout Period (8 Weeks)||2
7553380|NCT03061331|18590342|P2|COMPLETED|Washout Period (8 Weeks)||9
7553381|NCT03061331|18590343|P1|COMPLETED|Washout Period (8 Weeks)||8
7553382|NCT03061331|18590342|P2|STARTED|Washout Period (8 Weeks)||10
7553383|NCT03061331|18590343|P1|STARTED|Washout Period (8 Weeks)||10
7553384|NCT03061331|18590342|P2|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
7553385|NCT03061331|18590343|P1|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
7553386|NCT03061331|18590342|P2|COMPLETED|Treatment Period 1 (8 Weeks)||10
7553387|NCT03061331|18590343|P1|COMPLETED|Treatment Period 1 (8 Weeks)||10
7553388|NCT03061331|18590342|P2|STARTED|Treatment Period 1 (8 Weeks)||10
7553389|NCT03061331|18590343|P1|STARTED|Treatment Period 1 (8 Weeks)||10
7553390|NCT03061279|18590351|P2|NOT COMPLETED|Overall Study||1
7553391|NCT03061279|18590352|P1|NOT COMPLETED|Overall Study||0
7553392|NCT03061279|18590351|P2|COMPLETED|Overall Study||0
7553393|NCT03061279|18590352|P1|COMPLETED|Overall Study||0
7553394|NCT03061279|18590351|P2|STARTED|Overall Study||1
7553395|NCT03061279|18590352|P1|STARTED|Overall Study||0
7553396|NCT03061214|18590373|P3|NOT COMPLETED|Overall Study||10
7553397|NCT03061214|18590374|P2|NOT COMPLETED|Overall Study||28
7553398|NCT03061214|18590375|P1|NOT COMPLETED|Overall Study||25
7553399|NCT03061214|18590373|P3|COMPLETED|Overall Study||280
7553400|NCT03061214|18590374|P2|COMPLETED|Overall Study||262
7553401|NCT03061214|18590375|P1|COMPLETED|Overall Study||263
7553402|NCT03061214|18590373|P3|Safety Analysis Set (SAS)|Overall Study||290
7553403|NCT03061214|18590374|P2|Safety Analysis Set (SAS)|Overall Study||290
7553404|NCT03061214|18590375|P1|Safety Analysis Set (SAS)|Overall Study||287
7553405|NCT03061214|18590373|P3|Full Analysis Set (FAS)|Overall Study||290
7553406|NCT03061214|18590374|P2|Full Analysis Set (FAS)|Overall Study||290
7553407|NCT03061214|18590375|P1|Full Analysis Set (FAS)|Overall Study||288
7553408|NCT03061214|18590373|P3|Exposed|Overall Study||290
7553409|NCT03061214|18590374|P2|Exposed|Overall Study||290
7553410|NCT03061214|18590375|P1|Exposed|Overall Study||287
7553411|NCT03061214|18590373|P3|STARTED|Overall Study||290
7553412|NCT03061214|18590374|P2|STARTED|Overall Study||290
7553413|NCT03061214|18590375|P1|STARTED|Overall Study||288
7553414|NCT03061188|18590601|P4|NOT COMPLETED|On Follow-up for 3 Years||5
7553415|NCT03061188|18590602|P3|NOT COMPLETED|On Follow-up for 3 Years||5
7553416|NCT03061188|18590603|P2|NOT COMPLETED|On Follow-up for 3 Years||3
7553417|NCT03061188|18590604|P1|NOT COMPLETED|On Follow-up for 3 Years||0
7553418|NCT03061188|18590601|P4|COMPLETED|On Follow-up for 3 Years||1
7553419|NCT03061188|18590602|P3|COMPLETED|On Follow-up for 3 Years||1
7553420|NCT03061188|18590603|P2|COMPLETED|On Follow-up for 3 Years||0
7553421|NCT03061188|18590604|P1|COMPLETED|On Follow-up for 3 Years||0
7553422|NCT03061188|18590601|P4|STARTED|On Follow-up for 3 Years|Patients who receive at least one dose of study drug go into follow-up.|6
7553423|NCT03061188|18590602|P3|STARTED|On Follow-up for 3 Years|Patients who received at least one dose of study drug go into follow-up.|6
7553424|NCT03061188|18590603|P2|STARTED|On Follow-up for 3 Years||3
7553425|NCT03061188|18590604|P1|STARTED|On Follow-up for 3 Years||0
7553426|NCT03061188|18590601|P4|NOT COMPLETED|Went on to Cycle 2 and Beyond||1
7553427|NCT03061188|18590602|P3|NOT COMPLETED|Went on to Cycle 2 and Beyond||1
7553428|NCT03061188|18590603|P2|NOT COMPLETED|Went on to Cycle 2 and Beyond||0
7553429|NCT03061188|18590604|P1|NOT COMPLETED|Went on to Cycle 2 and Beyond||0
7553430|NCT03061188|18590601|P4|COMPLETED|Went on to Cycle 2 and Beyond||5
7553431|NCT03061188|18590602|P3|COMPLETED|Went on to Cycle 2 and Beyond||5
7553432|NCT03061188|18590603|P2|COMPLETED|Went on to Cycle 2 and Beyond||3
7553433|NCT03061188|18590604|P1|COMPLETED|Went on to Cycle 2 and Beyond||0
7553434|NCT03061188|18590601|P4|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5
7553435|NCT03061188|18590602|P3|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5
7553436|NCT03061188|18590603|P2|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||3
7553437|NCT03061188|18590604|P1|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||0
7553438|NCT03061188|18590601|P4|STARTED|Went on to Cycle 2 and Beyond||6
7553439|NCT03061188|18590602|P3|STARTED|Went on to Cycle 2 and Beyond||6
7553440|NCT03061188|18590603|P2|STARTED|Went on to Cycle 2 and Beyond||3
7553441|NCT03061188|18590604|P1|STARTED|Went on to Cycle 2 and Beyond||0
7553442|NCT03061188|18590601|P4|NOT COMPLETED|Completed 1st Cycle||0
7553443|NCT03061188|18590602|P3|NOT COMPLETED|Completed 1st Cycle||0
7553444|NCT03061188|18590603|P2|NOT COMPLETED|Completed 1st Cycle||0
7553445|NCT03061188|18590604|P1|NOT COMPLETED|Completed 1st Cycle||0
7553446|NCT03061188|18590601|P4|COMPLETED|Completed 1st Cycle||6
7553447|NCT03061188|18590602|P3|COMPLETED|Completed 1st Cycle||6
7553448|NCT03061188|18590603|P2|COMPLETED|Completed 1st Cycle||3
7553449|NCT03061188|18590604|P1|COMPLETED|Completed 1st Cycle||0
7553450|NCT03061188|18590601|P4|STARTED|Completed 1st Cycle||6
7553451|NCT03061188|18590602|P3|STARTED|Completed 1st Cycle||6
7553452|NCT03061188|18590603|P2|STARTED|Completed 1st Cycle||3
7553453|NCT03061188|18590604|P1|STARTED|Completed 1st Cycle||0
7553454|NCT03061175|18590626|P2|NOT COMPLETED|Followup 2 at 6 Months||7
7553455|NCT03061175|18590627|P1|NOT COMPLETED|Followup 2 at 6 Months||4
7553456|NCT03061175|18590626|P2|COMPLETED|Followup 2 at 6 Months|39 participants completed the follow-up survey out of the 46 who were sent the survey|39
7553457|NCT03061175|18590627|P1|COMPLETED|Followup 2 at 6 Months|41 participants completed the 2nd follow-up survey out of the 45 who were sent the survey|41
7553458|NCT03061175|18590626|P2|STARTED|Followup 2 at 6 Months|1 participant withdrew from the study in between the 1st and 2nd follow-up survey so only 46 sent|46
7553459|NCT03061175|18590627|P1|STARTED|Followup 2 at 6 Months|Participants who skipped the first follow-up survey were still sent the second FU survey|45
7553460|NCT03061175|18590626|P2|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||3
7553461|NCT03061175|18590627|P1|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||6
7553462|NCT03061175|18590626|P2|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|44 participants completed the follow-up survey out of the 47 who were sent the survey|44
7553463|NCT03061175|18590627|P1|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|39 participants completed the follow-up survey out of the 45 who were sent the survey|39
7553464|NCT03061175|18590626|P2|STARTED|Followup 1 at 2-4 Weeks Post-surgery||47
7553465|NCT03061175|18590627|P1|STARTED|Followup 1 at 2-4 Weeks Post-surgery|1 Participant dropped out of the study before the follow-up survey was to be sent|45
7553466|NCT03061175|18590626|P2|NOT COMPLETED|Baseline||0
7553467|NCT03061175|18590627|P1|NOT COMPLETED|Baseline||1
7553468|NCT03061175|18590626|P2|COMPLETED|Baseline||47
7553469|NCT03061175|18590627|P1|COMPLETED|Baseline||46
7553470|NCT03061175|18590626|P2|STARTED|Baseline||47
7553471|NCT03061175|18590627|P1|STARTED|Baseline||47
7553472|NCT03061097|18590651|P2|NOT COMPLETED|Overall Study||3
7553473|NCT03061097|18590652|P1|NOT COMPLETED|Overall Study||0
7553474|NCT03061097|18590651|P2|COMPLETED|Overall Study||0
7553475|NCT03061097|18590652|P1|COMPLETED|Overall Study||4
7553476|NCT03061097|18590651|P2|STARTED|Overall Study||3
7553477|NCT03061097|18590652|P1|STARTED|Overall Study||4
7553478|NCT03060759|18590666|P2|NOT COMPLETED|Overall Study||3
7553479|NCT03060759|18590667|P1|NOT COMPLETED|Overall Study||5
7553480|NCT03060759|18590666|P2|COMPLETED|Overall Study||12
7553481|NCT03060759|18590667|P1|COMPLETED|Overall Study||15
7553482|NCT03060759|18590666|P2|STARTED|Overall Study||15
7553483|NCT03060759|18590667|P1|STARTED|Overall Study||20
7553484|NCT03060551|18590673|P1|NOT COMPLETED|Overall Study||2
7553485|NCT03060551|18590673|P1|COMPLETED|Overall Study||18
7553486|NCT03060551|18590673|P1|STARTED|Overall Study||20
7553487|NCT03060512|18590694|P2|NOT COMPLETED|Overall Study||9
7553488|NCT03060512|18590695|P1|NOT COMPLETED|Overall Study||7
7553489|NCT03060512|18590694|P2|COMPLETED|Overall Study||130
7553490|NCT03060512|18590695|P1|COMPLETED|Overall Study||130
7553491|NCT03060512|18590694|P2|Treated With PEG 3350|Overall Study||138
7553492|NCT03060512|18590695|P1|Treated With PEG 3350|Overall Study||130
7553493|NCT03060512|18590694|P2|Treated With Movantik|Overall Study||135
7553494|NCT03060512|18590695|P1|Treated With Movantik|Overall Study||136
7553495|NCT03060512|18590694|P2|STARTED|Overall Study||139
7553496|NCT03060512|18590695|P1|STARTED|Overall Study||137
7553497|NCT03060486|18590712|P1|NOT COMPLETED|Overall Study||0
7553498|NCT03060486|18590712|P1|COMPLETED|Overall Study||15
7553499|NCT03060486|18590712|P1|STARTED|Overall Study||15
7553500|NCT03059901|18590718|P2|NOT COMPLETED|Overall Study||2
7553501|NCT03059901|18590719|P1|NOT COMPLETED|Overall Study||4
7553502|NCT03059901|18590718|P2|COMPLETED|Overall Study||28
7553503|NCT03059901|18590719|P1|COMPLETED|Overall Study||26
7553504|NCT03059901|18590718|P2|STARTED|Overall Study||30
7553505|NCT03059901|18590719|P1|STARTED|Overall Study||30
7553506|NCT03059810|18590725|P1|NOT COMPLETED|Overall Study||0
7553507|NCT03059810|18590725|P1|COMPLETED|Overall Study||63
7553508|NCT03059810|18590725|P1|STARTED|Overall Study||63
7553509|NCT03058991|18590732|P3|NOT COMPLETED|Overall Study||12
7553510|NCT03058991|18590733|P2|NOT COMPLETED|Overall Study||12
7553511|NCT03058991|18590734|P1|NOT COMPLETED|Overall Study||18
7553512|NCT03058991|18590732|P3|COMPLETED|Overall Study||25
7553513|NCT03058991|18590733|P2|COMPLETED|Overall Study||20
7553514|NCT03058991|18590734|P1|COMPLETED|Overall Study||21
7553515|NCT03058991|18590732|P3|1-Week Follow Up|Overall Study||28
7553516|NCT03058991|18590733|P2|1-Week Follow Up|Overall Study||27
7553517|NCT03058991|18590734|P1|1-Week Follow Up|Overall Study||23
7553518|NCT03058991|18590732|P3|STARTED|Overall Study||37
7553519|NCT03058991|18590733|P2|STARTED|Overall Study||32
7553520|NCT03058991|18590734|P1|STARTED|Overall Study||39
7553521|NCT03058705|18590760|P1|NOT COMPLETED|Overall Study||4
7553522|NCT03058705|18590760|P1|COMPLETED|Overall Study||6
7553523|NCT03058705|18590760|P1|STARTED|Overall Study||10
7553524|NCT03058692|18590766|P2|NOT COMPLETED|Overall Study||2
7553525|NCT03058692|18590767|P1|NOT COMPLETED|Overall Study||3
7553526|NCT03058692|18590766|P2|COMPLETED|Overall Study||57
7553527|NCT03058692|18590767|P1|COMPLETED|Overall Study||58
7553528|NCT03058692|18590766|P2|STARTED|Overall Study||59
7553529|NCT03058692|18590767|P1|STARTED|Overall Study||61
7553530|NCT03057704|18590881|P2|NOT COMPLETED|Overall Study||0
7553531|NCT03057704|18590882|P1|NOT COMPLETED|Overall Study||0
7553532|NCT03057704|18590881|P2|COMPLETED|Overall Study||25
7553533|NCT03057704|18590882|P1|COMPLETED|Overall Study||25
7553534|NCT03057704|18590881|P2|STARTED|Overall Study||25
7553535|NCT03057704|18590882|P1|STARTED|Overall Study||25
7553536|NCT03057613|18590892|P1|NOT COMPLETED|Overall Study||0
7553537|NCT03057613|18590892|P1|COMPLETED|Overall Study||18
7553538|NCT03057613|18590892|P1|STARTED|Overall Study||18
7553539|NCT03057496|18590896|P1|NOT COMPLETED|Overall Study||18
7553540|NCT03057496|18590896|P1|COMPLETED|Overall Study||31
7553541|NCT03057496|18590896|P1|Started Home-use Trial|Overall Study||36
7553542|NCT03057496|18590896|P1|STARTED|Overall Study||49
7553543|NCT03057366|18590904|P3|NOT COMPLETED|Part B||0
7553544|NCT03057366|18590905|P2|NOT COMPLETED|Part B||0
7553545|NCT03057366|18590906|P1|NOT COMPLETED|Part B||0
7553546|NCT03057366|18590904|P3|COMPLETED|Part B||2
7553547|NCT03057366|18590905|P2|COMPLETED|Part B||5
7553548|NCT03057366|18590906|P1|COMPLETED|Part B||0
7553549|NCT03057366|18590904|P3|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|2
7553550|NCT03057366|18590905|P2|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|5
7553551|NCT03057366|18590906|P1|STARTED|Part B||0
7553552|NCT03057366|18590904|P3|NOT COMPLETED|Part A||0
7553553|NCT03057366|18590905|P2|NOT COMPLETED|Part A||0
7553554|NCT03057366|18590906|P1|NOT COMPLETED|Part A||0
7553555|NCT03057366|18590904|P3|COMPLETED|Part A||0
7553556|NCT03057366|18590905|P2|COMPLETED|Part A||0
7553557|NCT03057366|18590906|P1|COMPLETED|Part A||8
7553558|NCT03057366|18590904|P3|STARTED|Part A||0
7553559|NCT03057366|18590905|P2|STARTED|Part A||0
7553560|NCT03057366|18590906|P1|STARTED|Part A||8
7553561|NCT03057132|18590929|P1|NOT COMPLETED|Overall Study||0
7553562|NCT03057132|18590929|P1|COMPLETED|Overall Study||1
7553563|NCT03057132|18590929|P1|STARTED|Overall Study||1
7553564|NCT03056573|18590936|P2|NOT COMPLETED|Overall Study||5
7553565|NCT03056573|18590937|P1|NOT COMPLETED|Overall Study||5
7553566|NCT03056573|18590936|P2|COMPLETED|Overall Study||14
7553567|NCT03056573|18590937|P1|COMPLETED|Overall Study||40
7553568|NCT03056573|18590936|P2|STARTED|Overall Study||19
7553569|NCT03056573|18590937|P1|STARTED|Overall Study||45
7553570|NCT03056456|18590981|P4|NOT COMPLETED|Period 4||0
7553571|NCT03056456|18590982|P3|NOT COMPLETED|Period 4||0
7553572|NCT03056456|18590983|P2|NOT COMPLETED|Period 4||0
7553573|NCT03056456|18590984|P1|NOT COMPLETED|Period 4||0
7553574|NCT03056456|18590981|P4|COMPLETED|Period 4||5
7553575|NCT03056456|18590982|P3|COMPLETED|Period 4||6
7553576|NCT03056456|18590983|P2|COMPLETED|Period 4||6
7553577|NCT03056456|18590984|P1|COMPLETED|Period 4||6
7553578|NCT03056456|18590981|P4|STARTED|Period 4|Participant deviated from 1 week maximum between consecutive periods and did not start Period 4.|5
7553579|NCT03056456|18590982|P3|STARTED|Period 4||6
7553580|NCT03056456|18590983|P2|STARTED|Period 4||6
7553581|NCT03056456|18590984|P1|STARTED|Period 4||6
7553582|NCT03056456|18590981|P4|NOT COMPLETED|Period 3||0
7553583|NCT03056456|18590982|P3|NOT COMPLETED|Period 3||0
7553584|NCT03056456|18590983|P2|NOT COMPLETED|Period 3||0
7553585|NCT03056456|18590984|P1|NOT COMPLETED|Period 3||0
7553586|NCT03056456|18590981|P4|COMPLETED|Period 3||6
7553587|NCT03056456|18590982|P3|COMPLETED|Period 3||6
7553588|NCT03056456|18590983|P2|COMPLETED|Period 3||6
7553589|NCT03056456|18590984|P1|COMPLETED|Period 3||6
7553590|NCT03056456|18590981|P4|STARTED|Period 3||6
7553591|NCT03056456|18590982|P3|STARTED|Period 3||6
7553592|NCT03056456|18590983|P2|STARTED|Period 3||6
7553593|NCT03056456|18590984|P1|STARTED|Period 3||6
7553594|NCT03056456|18590981|P4|NOT COMPLETED|Period 2||0
7553595|NCT03056456|18590982|P3|NOT COMPLETED|Period 2||0
7553596|NCT03056456|18590983|P2|NOT COMPLETED|Period 2||0
7553597|NCT03056456|18590984|P1|NOT COMPLETED|Period 2||0
7553598|NCT03056456|18590981|P4|COMPLETED|Period 2||6
7553599|NCT03056456|18590982|P3|COMPLETED|Period 2||6
7553600|NCT03056456|18590983|P2|COMPLETED|Period 2||6
7553601|NCT03056456|18590984|P1|COMPLETED|Period 2||6
7553602|NCT03056456|18590981|P4|STARTED|Period 2||6
7553603|NCT03056456|18590982|P3|STARTED|Period 2||6
7553604|NCT03056456|18590983|P2|STARTED|Period 2||6
7553605|NCT03056456|18590984|P1|STARTED|Period 2||6
7553606|NCT03056456|18590981|P4|NOT COMPLETED|Period 1||0
7553607|NCT03056456|18590982|P3|NOT COMPLETED|Period 1||0
7553608|NCT03056456|18590983|P2|NOT COMPLETED|Period 1||0
7553609|NCT03056456|18590984|P1|NOT COMPLETED|Period 1||0
7553610|NCT03056456|18590981|P4|COMPLETED|Period 1||6
7553611|NCT03056456|18590982|P3|COMPLETED|Period 1||6
7553612|NCT03056456|18590983|P2|COMPLETED|Period 1||6
7553613|NCT03056456|18590984|P1|COMPLETED|Period 1||6
7553614|NCT03056456|18590981|P4|Received One Dose of Study Drug|Period 1||6
7553615|NCT03056456|18590982|P3|Received One Dose of Study Drug|Period 1||6
7553616|NCT03056456|18590983|P2|Received One Dose of Study Drug|Period 1||6
7553617|NCT03056456|18590984|P1|Received One Dose of Study Drug|Period 1||6
7553618|NCT03056456|18590981|P4|STARTED|Period 1||6
7553619|NCT03056456|18590982|P3|STARTED|Period 1||6
7553620|NCT03056456|18590983|P2|STARTED|Period 1||6
7553621|NCT03056456|18590984|P1|STARTED|Period 1||6
7553622|NCT03056352|18590997|P1|NOT COMPLETED|Overall Study||1
7553623|NCT03056352|18590997|P1|COMPLETED|Overall Study||20
7553624|NCT03056352|18590997|P1|STARTED|Overall Study||21
7553625|NCT03056300|18591003|P1|NOT COMPLETED|Overall Study||3
7553626|NCT03056300|18591003|P1|COMPLETED|Overall Study||47
7553627|NCT03056300|18591003|P1|STARTED|Overall Study||50
7553628|NCT03056144|18591008|P1|NOT COMPLETED|Overall Study||0
7553629|NCT03056144|18591008|P1|COMPLETED|Overall Study||1
7553630|NCT03056144|18591008|P1|STARTED|Overall Study||1
7553631|NCT03056040|18591020|P2|NOT COMPLETED|Extension Period||95
7553632|NCT03056040|18591021|P1|NOT COMPLETED|Extension Period||96
7553633|NCT03056040|18591020|P2|COMPLETED|Extension Period||0
7553634|NCT03056040|18591021|P1|COMPLETED|Extension Period||0
7553635|NCT03056040|18591020|P2|Received at Least 1 Dose of Ravulizumab|Extension Period||95
7553636|NCT03056040|18591021|P1|Received at Least 1 Dose of Ravulizumab|Extension Period||96
7553637|NCT03056040|18591020|P2|STARTED|Extension Period||95
7553638|NCT03056040|18591021|P1|STARTED|Extension Period||96
7553639|NCT03056040|18591020|P2|NOT COMPLETED|Primary Evaluation Period||3
7553640|NCT03056040|18591021|P1|NOT COMPLETED|Primary Evaluation Period||1
7553641|NCT03056040|18591020|P2|COMPLETED|Primary Evaluation Period||95
7553642|NCT03056040|18591021|P1|COMPLETED|Primary Evaluation Period||96
7553643|NCT03056040|18591020|P2|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||98
7553644|NCT03056040|18591021|P1|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||97
7553645|NCT03056040|18591020|P2|STARTED|Primary Evaluation Period||98
7553646|NCT03056040|18591021|P1|STARTED|Primary Evaluation Period||97
7553647|NCT03055988|18591035|P2|NOT COMPLETED|Period 2||2
7553648|NCT03055988|18591036|P1|NOT COMPLETED|Period 2||1
7553649|NCT03055988|18591035|P2|COMPLETED|Period 2||31
7553650|NCT03055988|18591036|P1|COMPLETED|Period 2||36
7553651|NCT03055988|18591035|P2|STARTED|Period 2||33
7553652|NCT03055988|18591036|P1|STARTED|Period 2||37
7553653|NCT03055988|18591035|P2|NOT COMPLETED|Period 1||5
7553654|NCT03055988|18591036|P1|NOT COMPLETED|Period 1||1
7553655|NCT03055988|18591035|P2|COMPLETED|Period 1||33
7553656|NCT03055988|18591036|P1|COMPLETED|Period 1||37
7553657|NCT03055988|18591035|P2|STARTED|Period 1||38
7553658|NCT03055988|18591036|P1|STARTED|Period 1||38
7553659|NCT03055897|18591058|P1|NOT COMPLETED|Overall Study||0
7553660|NCT03055897|18591058|P1|COMPLETED|Overall Study||15
7553661|NCT03055897|18591058|P1|STARTED|Overall Study||15
7553662|NCT03055858|18591062|P1|NOT COMPLETED|Overall Study||6
7553663|NCT03055858|18591062|P1|COMPLETED|Overall Study||194
7553664|NCT03055858|18591062|P1|CAP Cohort|Overall Study||150
7553665|NCT03055858|18591062|P1|IDE Cohort|Overall Study||50
7553666|NCT03055858|18591062|P1|STARTED|Overall Study||200
7553667|NCT03055832|18591070|P2|NOT COMPLETED|Week 4||0
7553668|NCT03055832|18591071|P1|NOT COMPLETED|Week 4||0
7553669|NCT03055832|18591070|P2|COMPLETED|Week 4||71
7553670|NCT03055832|18591071|P1|COMPLETED|Week 4||70
7553671|NCT03055832|18591070|P2|STARTED|Week 4||71
7553672|NCT03055832|18591071|P1|STARTED|Week 4||70
7553673|NCT03055832|18591070|P2|NOT COMPLETED|Week 2||0
7553674|NCT03055832|18591071|P1|NOT COMPLETED|Week 2||1
7553675|NCT03055832|18591070|P2|COMPLETED|Week 2||71
7553676|NCT03055832|18591071|P1|COMPLETED|Week 2||70
7553677|NCT03055832|18591070|P2|STARTED|Week 2||71
7553678|NCT03055832|18591071|P1|STARTED|Week 2||71
7553679|NCT03055832|18591070|P2|NOT COMPLETED|Day 1||0
7553680|NCT03055832|18591071|P1|NOT COMPLETED|Day 1||0
7553681|NCT03055832|18591070|P2|COMPLETED|Day 1||71
7553682|NCT03055832|18591071|P1|COMPLETED|Day 1||71
7553683|NCT03055832|18591070|P2|STARTED|Day 1||71
7553684|NCT03055832|18591071|P1|STARTED|Day 1||71
7553685|NCT03055832|18591070|P2|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
7553686|NCT03055832|18591071|P1|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
7553687|NCT03055832|18591070|P2|COMPLETED|Immediately Post-Procedure (Hour 1)||71
7553688|NCT03055832|18591071|P1|COMPLETED|Immediately Post-Procedure (Hour 1)||71
7553689|NCT03055832|18591070|P2|STARTED|Immediately Post-Procedure (Hour 1)||71
7553690|NCT03055832|18591071|P1|STARTED|Immediately Post-Procedure (Hour 1)||71
7553691|NCT03055832|18591070|P2|NOT COMPLETED|Baseline||0
7553692|NCT03055832|18591071|P1|NOT COMPLETED|Baseline||0
7553693|NCT03055832|18591070|P2|COMPLETED|Baseline||71
7553694|NCT03055832|18591071|P1|COMPLETED|Baseline||71
7553695|NCT03055832|18591070|P2|STARTED|Baseline||71
7553696|NCT03055832|18591071|P1|STARTED|Baseline||71
7553697|NCT03055806|18591131|P4|NOT COMPLETED|Overall Study||15
7553698|NCT03055806|18591132|P3|NOT COMPLETED|Overall Study||13
7553699|NCT03055806|18591133|P2|NOT COMPLETED|Overall Study||7
7553700|NCT03055806|18591134|P1|NOT COMPLETED|Overall Study||6
7553701|NCT03055806|18591131|P4|COMPLETED|Overall Study||57
7553702|NCT03055806|18591132|P3|COMPLETED|Overall Study||58
7553703|NCT03055806|18591133|P2|COMPLETED|Overall Study||41
7553704|NCT03055806|18591134|P1|COMPLETED|Overall Study||42
7553705|NCT03055806|18591131|P4|STARTED|Overall Study||72
7553706|NCT03055806|18591132|P3|STARTED|Overall Study||71
7553707|NCT03055806|18591133|P2|STARTED|Overall Study||48
7553708|NCT03055806|18591134|P1|STARTED|Overall Study||48
7553709|NCT03055650|18591176|P1|NOT COMPLETED|Overall Study||0
7553710|NCT03055650|18591176|P1|COMPLETED|Overall Study||30
7553711|NCT03055650|18591176|P1|STARTED|Overall Study||30
7553712|NCT03055624|18591183|P1|NOT COMPLETED|Overall Study||9
7553713|NCT03055624|18591183|P1|COMPLETED|Overall Study||0
7553714|NCT03055624|18591183|P1|STARTED|Overall Study||9
7553715|NCT03055494|18591194|P2|NOT COMPLETED|Overall Study||1
7553716|NCT03055494|18591195|P1|NOT COMPLETED|Overall Study||10
7553717|NCT03055494|18591194|P2|COMPLETED|Overall Study||27
7553718|NCT03055494|18591195|P1|COMPLETED|Overall Study||44
7553719|NCT03055494|18591194|P2|STARTED|Overall Study||28
7553720|NCT03055494|18591195|P1|STARTED|Overall Study||54
7553721|NCT03055338|18591226|P3|NOT COMPLETED|Overall Study||12
7553722|NCT03055338|18591227|P2|NOT COMPLETED|Overall Study||11
7553723|NCT03055338|18591228|P1|NOT COMPLETED|Overall Study||18
7553724|NCT03055338|18591226|P3|COMPLETED|Overall Study||77
7553725|NCT03055338|18591227|P2|COMPLETED|Overall Study||34
7553726|NCT03055338|18591228|P1|COMPLETED|Overall Study||72
7553727|NCT03055338|18591226|P3|STARTED|Overall Study||89
7553728|NCT03055338|18591227|P2|STARTED|Overall Study||45
7553729|NCT03055338|18591228|P1|STARTED|Overall Study||90
7553730|NCT03055260|18591247|P2|NOT COMPLETED|Overall Study||0
7553731|NCT03055260|18591248|P1|NOT COMPLETED|Overall Study||1
7553732|NCT03055260|18591247|P2|COMPLETED|Overall Study||0
7553733|NCT03055260|18591248|P1|COMPLETED|Overall Study||7
7553734|NCT03055260|18591247|P2|STARTED|Overall Study||0
7553735|NCT03055260|18591248|P1|STARTED|Overall Study||8
7553736|NCT03055221|18591256|P1|NOT COMPLETED|Overall Study||16
7553737|NCT03055221|18591256|P1|COMPLETED|Overall Study||0
7553738|NCT03055221|18591256|P1|STARTED|Overall Study||16
7553739|NCT03055195|18591263|P2|NOT COMPLETED|Overall Study||14
7553740|NCT03055195|18591264|P1|NOT COMPLETED|Overall Study||12
7553741|NCT03055195|18591263|P2|COMPLETED|Overall Study||4
7553742|NCT03055195|18591264|P1|COMPLETED|Overall Study||4
7553743|NCT03055195|18591263|P2|STARTED|Overall Study||18
7553744|NCT03055195|18591264|P1|STARTED|Overall Study||16
7553745|NCT03055156|18591318|P2|NOT COMPLETED|Overall Study||0
7553746|NCT03055156|18591319|P1|NOT COMPLETED|Overall Study||0
7553747|NCT03055156|18591318|P2|COMPLETED|Overall Study||273
7553748|NCT03055156|18591319|P1|COMPLETED|Overall Study||281
7553749|NCT03055156|18591318|P2|STARTED|Overall Study||273
7553750|NCT03055156|18591319|P1|STARTED|Overall Study||281
7553751|NCT03055000|18591356|P3|NOT COMPLETED|Overall Study||0
7553752|NCT03055000|18591357|P2|NOT COMPLETED|Overall Study||0
7553753|NCT03055000|18591358|P1|NOT COMPLETED|Overall Study||0
7553754|NCT03055000|18591356|P3|COMPLETED|Overall Study||16
7553755|NCT03055000|18591357|P2|COMPLETED|Overall Study||17
7553756|NCT03055000|18591358|P1|COMPLETED|Overall Study||16
7553757|NCT03055000|18591356|P3|STARTED|Overall Study||16
7553758|NCT03055000|18591357|P2|STARTED|Overall Study||17
7553759|NCT03055000|18591358|P1|STARTED|Overall Study||16
7553760|NCT03054922|18591444|P3|NOT COMPLETED|Overall Study||0
7553761|NCT03054922|18591445|P2|NOT COMPLETED|Overall Study||0
7553762|NCT03054922|18591446|P1|NOT COMPLETED|Overall Study||0
7553763|NCT03054922|18591444|P3|COMPLETED|Overall Study||20
7553764|NCT03054922|18591445|P2|COMPLETED|Overall Study||19
7553765|NCT03054922|18591446|P1|COMPLETED|Overall Study||20
7553766|NCT03054922|18591444|P3|STARTED|Overall Study||20
7553767|NCT03054922|18591445|P2|STARTED|Overall Study||19
7553768|NCT03054922|18591446|P1|STARTED|Overall Study||20
7553769|NCT03054857|18591468|P2|NOT COMPLETED|Overall Study||0
7553770|NCT03054857|18591469|P1|NOT COMPLETED|Overall Study||1
7553771|NCT03054857|18591468|P2|COMPLETED|Overall Study||50
7553772|NCT03054857|18591469|P1|COMPLETED|Overall Study||49
7553773|NCT03054857|18591468|P2|STARTED|Overall Study||50
7553774|NCT03054857|18591469|P1|STARTED|Overall Study||50
7553775|NCT03054844|18591485|P2|NOT COMPLETED|Overall Study||1
7553776|NCT03054844|18591486|P1|NOT COMPLETED|Overall Study||3
7553777|NCT03054844|18591485|P2|COMPLETED|Overall Study||26
7553778|NCT03054844|18591486|P1|COMPLETED|Overall Study||25
7553779|NCT03054844|18591485|P2|STARTED|Overall Study||27
7553780|NCT03054844|18591486|P1|STARTED|Overall Study||28
7553781|NCT03054805|18591505|P3|NOT COMPLETED|Overall Study||2
7553782|NCT03054805|18591506|P2|NOT COMPLETED|Overall Study||10
7553783|NCT03054805|18591507|P1|NOT COMPLETED|Overall Study||16
7553784|NCT03054805|18591505|P3|COMPLETED|Overall Study||42
7553785|NCT03054805|18591506|P2|COMPLETED|Overall Study||41
7553786|NCT03054805|18591507|P1|COMPLETED|Overall Study||42
7553787|NCT03054805|18591505|P3|STARTED|Overall Study||44
7553788|NCT03054805|18591506|P2|STARTED|Overall Study||51
7553789|NCT03054805|18591507|P1|STARTED|Overall Study||58
7553790|NCT03054740|18591517|P2|NOT COMPLETED|Overall Study||0
7553791|NCT03054740|18591518|P1|NOT COMPLETED|Overall Study||0
7553792|NCT03054740|18591517|P2|COMPLETED|Overall Study||15
7553793|NCT03054740|18591518|P1|COMPLETED|Overall Study||15
7553794|NCT03054740|18591517|P2|STARTED|Overall Study||15
7553795|NCT03054740|18591518|P1|STARTED|Overall Study||15
7553796|NCT03054649|18591532|P2|NOT COMPLETED|Overall Study||0
7553797|NCT03054649|18591533|P1|NOT COMPLETED|Overall Study||0
7553798|NCT03054649|18591532|P2|COMPLETED|Overall Study||27
7553799|NCT03054649|18591533|P1|COMPLETED|Overall Study||27
7553800|NCT03054649|18591532|P2|STARTED|Overall Study||27
7553801|NCT03054649|18591533|P1|STARTED|Overall Study||27
7553802|NCT03054506|18591590|P3|NOT COMPLETED|Overall Study||0
7553803|NCT03054506|18591591|P2|NOT COMPLETED|Overall Study||0
7553804|NCT03054506|18591592|P1|NOT COMPLETED|Overall Study||1
7553805|NCT03054506|18591590|P3|COMPLETED|Overall Study||9
7553806|NCT03054506|18591591|P2|COMPLETED|Overall Study||11
7553807|NCT03054506|18591592|P1|COMPLETED|Overall Study||19
7553808|NCT03054506|18591590|P3|STARTED|Overall Study||9
7553809|NCT03054506|18591591|P2|STARTED|Overall Study||11
7553810|NCT03054506|18591592|P1|STARTED|Overall Study||20
7553811|NCT03054428|18591636|P3|NOT COMPLETED|Overall Study||79
7553812|NCT03054428|18591637|P2|NOT COMPLETED|Overall Study||80
7553813|NCT03054428|18591638|P1|NOT COMPLETED|Overall Study||83
7553814|NCT03054428|18591636|P3|COMPLETED|Overall Study||3
7553815|NCT03054428|18591637|P2|COMPLETED|Overall Study||4
7553816|NCT03054428|18591638|P1|COMPLETED|Overall Study||2
7553817|NCT03054428|18591636|P3|Completed Week 28 (End of Study)|Overall Study||3
7553818|NCT03054428|18591637|P2|Completed Week 28 (End of Study)|Overall Study||4
7553819|NCT03054428|18591638|P1|Completed Week 28 (End of Study)|Overall Study||2
7553820|NCT03054428|18591636|P3|Completed Wk 16 End of Treatment (EOT)|Overall Study||79
7553821|NCT03054428|18591637|P2|Completed Wk 16 End of Treatment (EOT)|Overall Study||81
7553822|NCT03054428|18591638|P1|Completed Wk 16 End of Treatment (EOT)|Overall Study||80
7553823|NCT03054428|18591636|P3|STARTED|Overall Study||82
7553824|NCT03054428|18591637|P2|STARTED|Overall Study||84
7553825|NCT03054428|18591638|P1|STARTED|Overall Study||85
7553826|NCT03054103|18591706|P3|NOT COMPLETED|Overall Study||0
7553827|NCT03054103|18591707|P2|NOT COMPLETED|Overall Study||0
7553828|NCT03054103|18591708|P1|NOT COMPLETED|Overall Study||0
7553829|NCT03054103|18591706|P3|COMPLETED|Overall Study||35
7553830|NCT03054103|18591707|P2|COMPLETED|Overall Study||29
7553831|NCT03054103|18591708|P1|COMPLETED|Overall Study||41
7553832|NCT03054103|18591706|P3|STARTED|Overall Study||35
7553833|NCT03054103|18591707|P2|STARTED|Overall Study||29
7553834|NCT03054103|18591708|P1|STARTED|Overall Study||41
7553835|NCT03054077|18591727|P2|NOT COMPLETED|Overall Study||0
7553836|NCT03054077|18591728|P1|NOT COMPLETED|Overall Study||0
7553837|NCT03054077|18591727|P2|COMPLETED|Overall Study||12
7553838|NCT03054077|18591728|P1|COMPLETED|Overall Study||12
7553839|NCT03054077|18591727|P2|STARTED|Overall Study||12
7553840|NCT03054077|18591728|P1|STARTED|Overall Study||12
7553841|NCT03054064|18591734|P1|NOT COMPLETED|Overall Study||6
7553842|NCT03054064|18591734|P1|COMPLETED|Overall Study||42
7553843|NCT03054064|18591734|P1|Screen Failure|Overall Study||2
7553844|NCT03054064|18591734|P1|STARTED|Overall Study||48
7553845|NCT03054051|18591744|P2|NOT COMPLETED|Overall Study||0
7553846|NCT03054051|18591745|P1|NOT COMPLETED|Overall Study||0
7553847|NCT03054051|18591744|P2|COMPLETED|Overall Study||30
7553848|NCT03054051|18591745|P1|COMPLETED|Overall Study||30
7553849|NCT03054051|18591744|P2|STARTED|Overall Study||30
7553850|NCT03054051|18591745|P1|STARTED|Overall Study||30
7553851|NCT03053960|18591774|P1|NOT COMPLETED|Overall Study||0
7553852|NCT03053960|18591774|P1|COMPLETED|Overall Study||8
7553853|NCT03053960|18591774|P1|STARTED|Overall Study||8
7553854|NCT03053518|18591779|P1|NOT COMPLETED|Overall Study||10
7553855|NCT03053518|18591779|P1|COMPLETED|Overall Study||12
7553856|NCT03053518|18591779|P1|STARTED|Overall Study||22
7553857|NCT03053492|18591785|P2|NOT COMPLETED|Overall Study||6
7553858|NCT03053492|18591786|P1|NOT COMPLETED|Overall Study||8
7553859|NCT03053492|18591785|P2|COMPLETED|Overall Study||27
7553860|NCT03053492|18591786|P1|COMPLETED|Overall Study||25
7553861|NCT03053492|18591785|P2|STARTED|Overall Study||33
7553862|NCT03053492|18591786|P1|STARTED|Overall Study||33
7553863|NCT03053427|18591800|P2|NOT COMPLETED|Overall Study||16
7553864|NCT03053427|18591801|P1|NOT COMPLETED|Overall Study||13
7553865|NCT03053427|18591800|P2|COMPLETED|Overall Study||173
7553866|NCT03053427|18591801|P1|COMPLETED|Overall Study||173
7553867|NCT03053427|18591800|P2|STARTED|Overall Study||189
7553868|NCT03053427|18591801|P1|STARTED|Overall Study||186
7553869|NCT03053401|18591825|P2|NOT COMPLETED|Overall Study||0
7553870|NCT03053401|18591826|P1|NOT COMPLETED|Overall Study||0
7553871|NCT03053401|18591825|P2|COMPLETED|Overall Study||26
7553872|NCT03053401|18591826|P1|COMPLETED|Overall Study||26
7553873|NCT03053401|18591825|P2|STARTED|Overall Study||26
7553874|NCT03053401|18591826|P1|STARTED|Overall Study||26
7553875|NCT03053180|18591836|P1|NOT COMPLETED|Overall Study||1
7553876|NCT03053180|18591836|P1|COMPLETED|Overall Study||59
7553877|NCT03053180|18591836|P1|STARTED|Overall Study||60
7553878|NCT03053063|18591848|P4|NOT COMPLETED|Open-Label Phase||23
7553879|NCT03053063|18591849|P3|NOT COMPLETED|Open-Label Phase||0
7553880|NCT03053063|18591850|P2|NOT COMPLETED|Open-Label Phase||0
7553881|NCT03053063|18591851|P1|NOT COMPLETED|Open-Label Phase||0
7553882|NCT03053063|18591848|P4|COMPLETED|Open-Label Phase||0
7553883|NCT03053063|18591849|P3|COMPLETED|Open-Label Phase||0
7553884|NCT03053063|18591850|P2|COMPLETED|Open-Label Phase||0
7553885|NCT03053063|18591851|P1|COMPLETED|Open-Label Phase||0
7553886|NCT03053063|18591848|P4|STARTED|Open-Label Phase|Participants who experienced a hepatic clinical event had the option to roll over into the OL Phase.|23
7553887|NCT03053063|18591849|P3|STARTED|Open-Label Phase||0
7553888|NCT03053063|18591850|P2|STARTED|Open-Label Phase||0
7553889|NCT03053063|18591851|P1|STARTED|Open-Label Phase||0
7553890|NCT03053063|18591848|P4|NOT COMPLETED|Randomized Phase||0
7553891|NCT03053063|18591849|P3|NOT COMPLETED|Randomized Phase||174
7553892|NCT03053063|18591850|P2|NOT COMPLETED|Randomized Phase||354
7553893|NCT03053063|18591851|P1|NOT COMPLETED|Randomized Phase||355
7553894|NCT03053063|18591848|P4|COMPLETED|Randomized Phase||0
7553895|NCT03053063|18591849|P3|COMPLETED|Randomized Phase||0
7553896|NCT03053063|18591850|P2|COMPLETED|Randomized Phase||0
7553897|NCT03053063|18591851|P1|COMPLETED|Randomized Phase||0
7553898|NCT03053063|18591848|P4|STARTED|Randomized Phase||0
7553899|NCT03053063|18591849|P3|STARTED|Randomized Phase||174
7553900|NCT03053063|18591850|P2|STARTED|Randomized Phase||354
7553901|NCT03053063|18591851|P1|STARTED|Randomized Phase||355
7553902|NCT03053050|18591881|P4|NOT COMPLETED|Open-label Phase||99
7553903|NCT03053050|18591882|P3|NOT COMPLETED|Open-label Phase||0
7553904|NCT03053050|18591883|P2|NOT COMPLETED|Open-label Phase||0
7553905|NCT03053050|18591884|P1|NOT COMPLETED|Open-label Phase||0
7553906|NCT03053050|18591881|P4|COMPLETED|Open-label Phase||0
7553907|NCT03053050|18591882|P3|COMPLETED|Open-label Phase||0
7553908|NCT03053050|18591883|P2|COMPLETED|Open-label Phase||0
7553909|NCT03053050|18591884|P1|COMPLETED|Open-label Phase||0
7553910|NCT03053050|18591881|P4|STARTED|Open-label Phase|Participants with hepatic clinical event or progression to cirrhosis had option to go into OL Phase.|99
7553911|NCT03053050|18591882|P3|STARTED|Open-label Phase||0
7553912|NCT03053050|18591883|P2|STARTED|Open-label Phase||0
7553913|NCT03053050|18591884|P1|STARTED|Open-label Phase||0
7553914|NCT03053050|18591881|P4|NOT COMPLETED|Randomized Phase||0
7553915|NCT03053050|18591882|P3|NOT COMPLETED|Randomized Phase||161
7553916|NCT03053050|18591883|P2|NOT COMPLETED|Randomized Phase||323
7553917|NCT03053050|18591884|P1|NOT COMPLETED|Randomized Phase||324
7553918|NCT03053050|18591881|P4|COMPLETED|Randomized Phase||0
7553919|NCT03053050|18591882|P3|COMPLETED|Randomized Phase||0
7553920|NCT03053050|18591883|P2|COMPLETED|Randomized Phase||0
7553921|NCT03053050|18591884|P1|COMPLETED|Randomized Phase||0
7553922|NCT03053050|18591881|P4|STARTED|Randomized Phase||0
7553923|NCT03053050|18591882|P3|STARTED|Randomized Phase||161
7553924|NCT03053050|18591883|P2|STARTED|Randomized Phase||323
7553925|NCT03053050|18591884|P1|STARTED|Randomized Phase||324
7553926|NCT03052972|18591916|P2|NOT COMPLETED|Overall Study||0
7553927|NCT03052972|18591917|P1|NOT COMPLETED|Overall Study||0
7553928|NCT03052972|18591916|P2|COMPLETED|Overall Study||5
7553929|NCT03052972|18591917|P1|COMPLETED|Overall Study||18
7553930|NCT03052972|18591916|P2|STARTED|Overall Study||5
7553931|NCT03052972|18591917|P1|STARTED|Overall Study||18
7553932|NCT03052764|18591928|P2|NOT COMPLETED|Open-Label Re-Treatment Period||0
7553933|NCT03052764|18591929|P1|NOT COMPLETED|Open-Label Re-Treatment Period||0
7553934|NCT03052764|18591928|P2|COMPLETED|Open-Label Re-Treatment Period||33
7553935|NCT03052764|18591929|P1|COMPLETED|Open-Label Re-Treatment Period||58
7553936|NCT03052764|18591928|P2|STARTED|Open-Label Re-Treatment Period||33
7553937|NCT03052764|18591929|P1|STARTED|Open-Label Re-Treatment Period||58
7553938|NCT03052764|18591928|P2|NOT COMPLETED|Double-Blind Treatment Period||3
7553939|NCT03052764|18591929|P1|NOT COMPLETED|Double-Blind Treatment Period||10
7553940|NCT03052764|18591928|P2|COMPLETED|Double-Blind Treatment Period||37
7553941|NCT03052764|18591929|P1|COMPLETED|Double-Blind Treatment Period||70
7553942|NCT03052764|18591928|P2|mITT|Double-Blind Treatment Period||39
7553943|NCT03052764|18591929|P1|mITT|Double-Blind Treatment Period||78
7553944|NCT03052764|18591928|P2|STARTED|Double-Blind Treatment Period||40
7553945|NCT03052764|18591929|P1|STARTED|Double-Blind Treatment Period||80
7553946|NCT03052725|18591949|P2|NOT COMPLETED|Overall Study||150
7553947|NCT03052725|18591950|P1|NOT COMPLETED|Overall Study||148
7553948|NCT03052725|18591949|P2|COMPLETED|Overall Study||47
7553949|NCT03052725|18591950|P1|COMPLETED|Overall Study||46
7553950|NCT03052725|18591949|P2|Safety Analysis Set|Overall Study||196
7553951|NCT03052725|18591950|P1|Safety Analysis Set|Overall Study||194
7553952|NCT03052725|18591949|P2|STARTED|Overall Study||197
7553953|NCT03052725|18591950|P1|STARTED|Overall Study||194
7553954|NCT03052530|18591987|P1|NOT COMPLETED|Overall Study||0
7553955|NCT03052530|18591987|P1|COMPLETED|Overall Study||61
7553956|NCT03052530|18591987|P1|STARTED|Overall Study||61
7553957|NCT03052517|18591997|P3|NOT COMPLETED|Overall Study||328
7553958|NCT03052517|18591998|P2|NOT COMPLETED|Overall Study||1014
7553959|NCT03052517|18591999|P1|NOT COMPLETED|Overall Study||1017
7553960|NCT03052517|18591997|P3|COMPLETED|Overall Study||32
7553961|NCT03052517|18591998|P2|COMPLETED|Overall Study||71
7553962|NCT03052517|18591999|P1|COMPLETED|Overall Study||76
7553963|NCT03052517|18591997|P3|Safety Set (SAF)|Overall Study|One patient in QAW039 150 mg group received placebo and was included in the placebo group in the SAF|361
7553964|NCT03052517|18591998|P2|Safety Set (SAF)|Overall Study|One patient had no treatment administered and thus was excluded from the SAF|1084
7553965|NCT03052517|18591999|P1|Safety Set (SAF)|Overall Study|One patient received placebo. This patient was not included in QAW039 150 mg group in the SAF|1092
7553966|NCT03052517|18591997|P3|STARTED|Overall Study||360
7553967|NCT03052517|18591998|P2|STARTED|Overall Study||1085
7553968|NCT03052517|18591999|P1|STARTED|Overall Study||1093
7553969|NCT03052426|18592043|P3|NOT COMPLETED|Overall Study||1
7553970|NCT03052426|18592044|P2|NOT COMPLETED|Overall Study||1
7553971|NCT03052426|18592045|P1|NOT COMPLETED|Overall Study||2
7553972|NCT03052426|18592043|P3|COMPLETED|Overall Study||5
7553973|NCT03052426|18592044|P2|COMPLETED|Overall Study||5
7553974|NCT03052426|18592045|P1|COMPLETED|Overall Study||4
7553975|NCT03052426|18592043|P3|STARTED|Overall Study||6
7553976|NCT03052426|18592044|P2|STARTED|Overall Study||6
7553977|NCT03052426|18592045|P1|STARTED|Overall Study||6
7553978|NCT03052322|18592060|P2|NOT COMPLETED|Overall Study||32
7553979|NCT03052322|18592061|P1|NOT COMPLETED|Overall Study||21
7553980|NCT03052322|18592060|P2|COMPLETED|Overall Study||113
7553981|NCT03052322|18592061|P1|COMPLETED|Overall Study||122
7553982|NCT03052322|18592060|P2|STARTED|Overall Study||145
7553983|NCT03052322|18592061|P1|STARTED|Overall Study||143
7553984|NCT03052257|18592113|P2|NOT COMPLETED|Overall Study||3
7553985|NCT03052257|18592114|P1|NOT COMPLETED|Overall Study||5
7553986|NCT03052257|18592113|P2|COMPLETED|Overall Study||97
7553987|NCT03052257|18592114|P1|COMPLETED|Overall Study||95
7553988|NCT03052257|18592113|P2|STARTED|Overall Study||100
7553989|NCT03052257|18592114|P1|STARTED|Overall Study||100
7553990|NCT03051646|18592122|P2|NOT COMPLETED|Overall Study||0
7553991|NCT03051646|18592123|P1|NOT COMPLETED|Overall Study||0
7553992|NCT03051646|18592122|P2|COMPLETED|Overall Study||6
7553993|NCT03051646|18592123|P1|COMPLETED|Overall Study||6
7553994|NCT03051646|18592122|P2|STARTED|Overall Study||6
7553995|NCT03051646|18592123|P1|STARTED|Overall Study||6
7553996|NCT03051633|18592133|P2|NOT COMPLETED|Overall Study||7
7553997|NCT03051633|18592134|P1|NOT COMPLETED|Overall Study||93
7553998|NCT03051633|18592133|P2|COMPLETED|Overall Study||179
7553999|NCT03051633|18592134|P1|COMPLETED|Overall Study||249
7554000|NCT03051633|18592133|P2|STARTED|Overall Study||186
7554001|NCT03051633|18592134|P1|STARTED|Overall Study||342
7554002|NCT03051607|18592144|P1|NOT COMPLETED|Overall Study||66
7554003|NCT03051607|18592144|P1|COMPLETED|Overall Study||0
7554004|NCT03051607|18592144|P1|STARTED|Overall Study||66
7554005|NCT03051217|18592154|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||1
7554006|NCT03051217|18592155|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||2
7554007|NCT03051217|18592156|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
7554008|NCT03051217|18592157|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
7554009|NCT03051217|18592158|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
7554010|NCT03051217|18592159|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
7554011|NCT03051217|18592160|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
7554012|NCT03051217|18592154|P7|COMPLETED|Maintenance Period (Week 16 to Week 52)||19
7554013|NCT03051217|18592155|P6|COMPLETED|Maintenance Period (Week 16 to Week 52)||24
7554014|NCT03051217|18592156|P5|COMPLETED|Maintenance Period (Week 16 to Week 52)||48
7554015|NCT03051217|18592157|P4|COMPLETED|Maintenance Period (Week 16 to Week 52)||20
7554016|NCT03051217|18592158|P3|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
7554017|NCT03051217|18592159|P2|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
7554018|NCT03051217|18592160|P1|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
7554019|NCT03051217|18592154|P7|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
7554020|NCT03051217|18592155|P6|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||7
7554021|NCT03051217|18592156|P5|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
7554022|NCT03051217|18592157|P4|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||21
7554023|NCT03051217|18592158|P3|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
7554024|NCT03051217|18592159|P2|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
7554025|NCT03051217|18592160|P1|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
7554026|NCT03051217|18592154|P7|STARTED|Maintenance Period (Week 16 to Week 52)||20
7554027|NCT03051217|18592155|P6|STARTED|Maintenance Period (Week 16 to Week 52)||26
7554028|NCT03051217|18592156|P5|STARTED|Maintenance Period (Week 16 to Week 52)||51
7554029|NCT03051217|18592157|P4|STARTED|Maintenance Period (Week 16 to Week 52)||23
7554030|NCT03051217|18592158|P3|STARTED|Maintenance Period (Week 16 to Week 52)||0
7554031|NCT03051217|18592159|P2|STARTED|Maintenance Period (Week 16 to Week 52)||0
7554032|NCT03051217|18592160|P1|STARTED|Maintenance Period (Week 16 to Week 52)||0
7554033|NCT03051217|18592154|P7|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7554034|NCT03051217|18592155|P6|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7554035|NCT03051217|18592156|P5|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7554036|NCT03051217|18592157|P4|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7554037|NCT03051217|18592158|P3|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
7554038|NCT03051217|18592159|P2|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
7554039|NCT03051217|18592160|P1|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
7554040|NCT03051217|18592154|P7|COMPLETED|Initial Period (Week 0 to Week 16)||0
7554041|NCT03051217|18592155|P6|COMPLETED|Initial Period (Week 0 to Week 16)||0
7554042|NCT03051217|18592156|P5|COMPLETED|Initial Period (Week 0 to Week 16)||0
7554043|NCT03051217|18592157|P4|COMPLETED|Initial Period (Week 0 to Week 16)||0
7554044|NCT03051217|18592158|P3|COMPLETED|Initial Period (Week 0 to Week 16)||51
7554045|NCT03051217|18592159|P2|COMPLETED|Initial Period (Week 0 to Week 16)||46
7554046|NCT03051217|18592160|P1|COMPLETED|Initial Period (Week 0 to Week 16)||23
7554047|NCT03051217|18592154|P7|STARTED|Initial Period (Week 0 to Week 16)||0
7554048|NCT03051217|18592155|P6|STARTED|Initial Period (Week 0 to Week 16)||0
7554049|NCT03051217|18592156|P5|STARTED|Initial Period (Week 0 to Week 16)||0
7554050|NCT03051217|18592157|P4|STARTED|Initial Period (Week 0 to Week 16)||0
7554051|NCT03051217|18592158|P3|STARTED|Initial Period (Week 0 to Week 16)||53
7554052|NCT03051217|18592159|P2|STARTED|Initial Period (Week 0 to Week 16)||48
7554053|NCT03051217|18592160|P1|STARTED|Initial Period (Week 0 to Week 16)||26
7554054|NCT03051165|18592189|P1|NOT COMPLETED|Overall Study||13
7554055|NCT03051165|18592189|P1|COMPLETED|Overall Study||0
7554056|NCT03051165|18592189|P1|Completed Some Day 137 Assessments|Overall Study||0
7554057|NCT03051165|18592189|P1|Began HGNS Treatment Withdrawal|Overall Study||0
7554058|NCT03051165|18592189|P1|Completed Some Day 105 Assessments|Overall Study||1
7554059|NCT03051165|18592189|P1|Completed Some Baseline Assessments|Overall Study||1
7554060|NCT03051165|18592189|P1|STARTED|Overall Study||13
7554061|NCT03051100|18592203|P2|NOT COMPLETED|Overall Study||0
7554062|NCT03051100|18592204|P1|NOT COMPLETED|Overall Study||1
7554063|NCT03051100|18592203|P2|COMPLETED|Overall Study||43
7554064|NCT03051100|18592204|P1|COMPLETED|Overall Study||19
7554065|NCT03051100|18592203|P2|STARTED|Overall Study||43
7554066|NCT03051100|18592204|P1|STARTED|Overall Study||20
7554067|NCT03050918|18592220|P2|NOT COMPLETED|Overall Study||0
7554068|NCT03050918|18592221|P1|NOT COMPLETED|Overall Study||0
7554069|NCT03050918|18592220|P2|COMPLETED|Overall Study||1520
7554070|NCT03050918|18592221|P1|COMPLETED|Overall Study||1534
7554071|NCT03050918|18592220|P2|STARTED|Overall Study||1520
7554072|NCT03050918|18592221|P1|STARTED|Overall Study||1534
7554073|NCT03050775|18592243|P2|NOT COMPLETED|Overall Study||0
7554074|NCT03050775|18592244|P1|NOT COMPLETED|Overall Study||0
7554075|NCT03050775|18592243|P2|COMPLETED|Overall Study||35
7554076|NCT03050775|18592244|P1|COMPLETED|Overall Study||35
7554077|NCT03050775|18592243|P2|STARTED|Overall Study||35
7554078|NCT03050775|18592244|P1|STARTED|Overall Study||35
7554079|NCT03050697|18592262|P1|NOT COMPLETED|Overall Study||0
7554080|NCT03050697|18592262|P1|COMPLETED|Overall Study||12
7554081|NCT03050697|18592262|P1|STARTED|Overall Study||12
7554082|NCT03050619|18592299|P6|NOT COMPLETED|Overall Study||0
7554083|NCT03050619|18592300|P5|NOT COMPLETED|Overall Study||0
7554084|NCT03050619|18592301|P4|NOT COMPLETED|Overall Study||0
7554085|NCT03050619|18592302|P3|NOT COMPLETED|Overall Study||0
7554086|NCT03050619|18592303|P2|NOT COMPLETED|Overall Study||0
7554087|NCT03050619|18592304|P1|NOT COMPLETED|Overall Study||0
7554088|NCT03050619|18592299|P6|COMPLETED|Overall Study||1351
7554089|NCT03050619|18592300|P5|COMPLETED|Overall Study||6079
7554090|NCT03050619|18592301|P4|COMPLETED|Overall Study||14007
7554091|NCT03050619|18592302|P3|COMPLETED|Overall Study||6416
7554092|NCT03050619|18592303|P2|COMPLETED|Overall Study||3926
7554093|NCT03050619|18592304|P1|COMPLETED|Overall Study||129
7554094|NCT03050619|18592299|P6|STARTED|Overall Study||1351
7554095|NCT03050619|18592300|P5|STARTED|Overall Study||6079
7554096|NCT03050619|18592301|P4|STARTED|Overall Study||14007
7554097|NCT03050619|18592302|P3|STARTED|Overall Study||6416
7554098|NCT03050619|18592303|P2|STARTED|Overall Study||3926
7554099|NCT03050619|18592304|P1|STARTED|Overall Study||129
7554100|NCT03050541|18592441|P3|NOT COMPLETED|Overall Study||8
7554101|NCT03050541|18592442|P2|NOT COMPLETED|Overall Study||8
7554102|NCT03050541|18592443|P1|NOT COMPLETED|Overall Study||8
7554103|NCT03050541|18592441|P3|COMPLETED|Overall Study||20
7554104|NCT03050541|18592442|P2|COMPLETED|Overall Study||20
7554105|NCT03050541|18592443|P1|COMPLETED|Overall Study||20
7554106|NCT03050541|18592441|P3|STARTED|Overall Study||28
7554107|NCT03050541|18592442|P2|STARTED|Overall Study||28
7554108|NCT03050541|18592443|P1|STARTED|Overall Study||28
7554109|NCT03050398|18592454|P1|NOT COMPLETED|Overall Study||8
7554110|NCT03050398|18592454|P1|COMPLETED|Overall Study||0
7554111|NCT03050398|18592454|P1|STARTED|Overall Study||8
7554112|NCT03050372|18592459|P2|NOT COMPLETED|Second Intervention (Nights #4 and #5)||1
7554113|NCT03050372|18592460|P1|NOT COMPLETED|Second Intervention (Nights #4 and #5)||0
7554203|NCT03049488|18592639|P3|Received Optional Second Dose|Overall Study||11
7554114|NCT03050372|18592459|P2|COMPLETED|Second Intervention (Nights #4 and #5)|N=1 subject (blind only broken after double-blind analysis) moved out off State; lost to study|5
7554115|NCT03050372|18592460|P1|COMPLETED|Second Intervention (Nights #4 and #5)||5
7554116|NCT03050372|18592459|P2|STARTED|Second Intervention (Nights #4 and #5)||6
7554117|NCT03050372|18592460|P1|STARTED|Second Intervention (Nights #4 and #5)||5
7554118|NCT03050372|18592459|P2|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
7554119|NCT03050372|18592460|P1|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
7554120|NCT03050372|18592459|P2|COMPLETED|First Intervention (Nights #2 and #3)||6
7554121|NCT03050372|18592460|P1|COMPLETED|First Intervention (Nights #2 and #3)||5
7554122|NCT03050372|18592459|P2|STARTED|First Intervention (Nights #2 and #3)||6
7554123|NCT03050372|18592460|P1|STARTED|First Intervention (Nights #2 and #3)||5
7554124|NCT03050372|18592459|P2|NOT COMPLETED|Adaptation Night (Night #1 PSG)||0
7554125|NCT03050372|18592460|P1|NOT COMPLETED|Adaptation Night (Night #1 PSG)||1
7554126|NCT03050372|18592459|P2|COMPLETED|Adaptation Night (Night #1 PSG)||6
7554127|NCT03050372|18592460|P1|COMPLETED|Adaptation Night (Night #1 PSG)|N=1 subject removed from study due to mild sleep apnea during adaptation night|5
7554128|NCT03050372|18592459|P2|STARTED|Adaptation Night (Night #1 PSG)||6
7554129|NCT03050372|18592460|P1|STARTED|Adaptation Night (Night #1 PSG)||6
7554130|NCT03050359|18592483|P2|NOT COMPLETED|Overall Study||20
7554131|NCT03050359|18592484|P1|NOT COMPLETED|Overall Study||17
7554132|NCT03050359|18592483|P2|COMPLETED|Overall Study||248
7554133|NCT03050359|18592484|P1|COMPLETED|Overall Study||248
7554134|NCT03050359|18592483|P2|STARTED|Overall Study||268
7554135|NCT03050359|18592484|P1|STARTED|Overall Study||265
7554136|NCT03050320|18592498|P2|NOT COMPLETED|Overall Study||1
7554137|NCT03050320|18592499|P1|NOT COMPLETED|Overall Study||1
7554138|NCT03050320|18592498|P2|COMPLETED|Overall Study||21
7554139|NCT03050320|18592499|P1|COMPLETED|Overall Study||20
7554140|NCT03050320|18592498|P2|STARTED|Overall Study||22
7554141|NCT03050320|18592499|P1|STARTED|Overall Study||21
7554142|NCT03050294|18592533|P4|NOT COMPLETED|Overall Study||0
7554143|NCT03050294|18592534|P3|NOT COMPLETED|Overall Study||0
7554144|NCT03050294|18592535|P2|NOT COMPLETED|Overall Study||0
7554145|NCT03050294|18592536|P1|NOT COMPLETED|Overall Study||0
7554146|NCT03050294|18592533|P4|COMPLETED|Overall Study||6
7554147|NCT03050294|18592534|P3|COMPLETED|Overall Study||6
7554148|NCT03050294|18592535|P2|COMPLETED|Overall Study||6
7554149|NCT03050294|18592536|P1|COMPLETED|Overall Study||6
7554150|NCT03050294|18592533|P4|STARTED|Overall Study||6
7554151|NCT03050294|18592534|P3|STARTED|Overall Study||6
7554152|NCT03050294|18592535|P2|STARTED|Overall Study||6
7554153|NCT03050294|18592536|P1|STARTED|Overall Study||6
7554154|NCT03050216|18592558|P1|NOT COMPLETED|Overall Study||0
7554155|NCT03050216|18592558|P1|COMPLETED|Overall Study||8
7554156|NCT03050216|18592558|P1|STARTED|Overall Study||8
7554157|NCT03050203|18592570|P2|NOT COMPLETED|Overall Study||0
7554158|NCT03050203|18592571|P1|NOT COMPLETED|Overall Study||0
7554159|NCT03050203|18592570|P2|COMPLETED|Overall Study||18
7554160|NCT03050203|18592571|P1|COMPLETED|Overall Study||19
7554161|NCT03050203|18592570|P2|STARTED|Overall Study||18
7554162|NCT03050203|18592571|P1|STARTED|Overall Study||19
7554163|NCT03049852|18592580|P3|NOT COMPLETED|Overall Study||0
7554164|NCT03049852|18592581|P2|NOT COMPLETED|Overall Study||1
7554165|NCT03049852|18592582|P1|NOT COMPLETED|Overall Study||0
7554166|NCT03049852|18592580|P3|COMPLETED|Overall Study||26
7554167|NCT03049852|18592581|P2|COMPLETED|Overall Study||24
7554168|NCT03049852|18592582|P1|COMPLETED|Overall Study||24
7554169|NCT03049852|18592580|P3|STARTED|Overall Study||26
7554170|NCT03049852|18592581|P2|STARTED|Overall Study||25
7554171|NCT03049852|18592582|P1|STARTED|Overall Study||24
7554172|NCT03049748|18592594|P2|NOT COMPLETED|Overall Study||6
7554173|NCT03049748|18592595|P1|NOT COMPLETED|Overall Study||4
7554174|NCT03049748|18592594|P2|COMPLETED|Overall Study||14
7554175|NCT03049748|18592595|P1|COMPLETED|Overall Study||16
7554176|NCT03049748|18592594|P2|STARTED|Overall Study||20
7554177|NCT03049748|18592595|P1|STARTED|Overall Study||20
7554178|NCT03049501|18592613|P2|NOT COMPLETED|Overall Study||29
7554179|NCT03049501|18592614|P1|NOT COMPLETED|Overall Study||22
7554180|NCT03049501|18592613|P2|COMPLETED|Overall Study||92
7554181|NCT03049501|18592614|P1|COMPLETED|Overall Study||101
7554182|NCT03049501|18592613|P2|12 Month Follow up|Overall Study||92
7554183|NCT03049501|18592614|P1|12 Month Follow up|Overall Study||101
7554184|NCT03049501|18592613|P2|6 Month Follow up|Overall Study||91
7554185|NCT03049501|18592614|P1|6 Month Follow up|Overall Study||107
7554186|NCT03049501|18592613|P2|STARTED|Overall Study||121
7554187|NCT03049501|18592614|P1|STARTED|Overall Study||123
7554188|NCT03049488|18592636|P6|NOT COMPLETED|Overall Study||0
7554189|NCT03049488|18592637|P5|NOT COMPLETED|Overall Study||2
7554190|NCT03049488|18592638|P4|NOT COMPLETED|Overall Study||2
7554191|NCT03049488|18592639|P3|NOT COMPLETED|Overall Study||0
7554192|NCT03049488|18592640|P2|NOT COMPLETED|Overall Study||2
7554193|NCT03049488|18592641|P1|NOT COMPLETED|Overall Study||2
7554194|NCT03049488|18592636|P6|COMPLETED|Overall Study||15
7554195|NCT03049488|18592637|P5|COMPLETED|Overall Study||13
7554196|NCT03049488|18592638|P4|COMPLETED|Overall Study||13
7554197|NCT03049488|18592639|P3|COMPLETED|Overall Study||20
7554198|NCT03049488|18592640|P2|COMPLETED|Overall Study||13
7554199|NCT03049488|18592641|P1|COMPLETED|Overall Study||13
7554200|NCT03049488|18592636|P6|Received Optional Second Dose|Overall Study||10
7554201|NCT03049488|18592637|P5|Received Optional Second Dose|Overall Study||11
7554202|NCT03049488|18592638|P4|Received Optional Second Dose|Overall Study||9
7554204|NCT03049488|18592640|P2|Received Optional Second Dose|Overall Study||11
7554205|NCT03049488|18592641|P1|Received Optional Second Dose|Overall Study||10
7554206|NCT03049488|18592636|P6|Received First Product Administration|Overall Study||15
7554207|NCT03049488|18592637|P5|Received First Product Administration|Overall Study||15
7554208|NCT03049488|18592638|P4|Received First Product Administration|Overall Study||15
7554209|NCT03049488|18592639|P3|Received First Product Administration|Overall Study||20
7554210|NCT03049488|18592640|P2|Received First Product Administration|Overall Study||15
7554211|NCT03049488|18592641|P1|Received First Product Administration|Overall Study||15
7554212|NCT03049488|18592636|P6|STARTED|Overall Study||15
7554213|NCT03049488|18592637|P5|STARTED|Overall Study||15
7554214|NCT03049488|18592638|P4|STARTED|Overall Study||15
7554215|NCT03049488|18592639|P3|STARTED|Overall Study||20
7554216|NCT03049488|18592640|P2|STARTED|Overall Study||15
7554217|NCT03049488|18592641|P1|STARTED|Overall Study||15
7554218|NCT03049280|18592724|P1|NOT COMPLETED|Overall Study||1
7554219|NCT03049280|18592724|P1|COMPLETED|Overall Study||32
7554220|NCT03049280|18592724|P1|STARTED|Overall Study||33
7554221|NCT03048747|18592730|P1|NOT COMPLETED|Overall Study||5
7554222|NCT03048747|18592730|P1|COMPLETED|Overall Study||11
7554223|NCT03048747|18592730|P1|STARTED|Overall Study||16
7554224|NCT03048500|18592735|P1|NOT COMPLETED|Follow up for 3 Years||16
7554225|NCT03048500|18592735|P1|COMPLETED|Follow up for 3 Years||0
7554226|NCT03048500|18592735|P1|STARTED|Follow up for 3 Years|1 patient died whilst on study.|16
7554227|NCT03048500|18592735|P1|NOT COMPLETED|Reached 1st Response/Continued Treatment||7
7554228|NCT03048500|18592735|P1|COMPLETED|Reached 1st Response/Continued Treatment||9
7554229|NCT03048500|18592735|P1|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||9
7554230|NCT03048500|18592735|P1|Assessed for First Response|Reached 1st Response/Continued Treatment||16
7554231|NCT03048500|18592735|P1|STARTED|Reached 1st Response/Continued Treatment||16
7554232|NCT03048500|18592735|P1|NOT COMPLETED|2 Cycles of Treatment||1
7554233|NCT03048500|18592735|P1|COMPLETED|2 Cycles of Treatment||16
7554234|NCT03048500|18592735|P1|Attempted 2nd Cycle|2 Cycles of Treatment||16
7554235|NCT03048500|18592735|P1|Attempted 1st Cycle|2 Cycles of Treatment||17
7554236|NCT03048500|18592735|P1|STARTED|2 Cycles of Treatment||17
7554237|NCT03048383|18592743|P3|NOT COMPLETED|Overall Study||12
7554238|NCT03048383|18592744|P2|NOT COMPLETED|Overall Study||8
7554239|NCT03048383|18592745|P1|NOT COMPLETED|Overall Study||13
7554240|NCT03048383|18592743|P3|COMPLETED|Overall Study||10
7554241|NCT03048383|18592744|P2|COMPLETED|Overall Study||13
7554242|NCT03048383|18592745|P1|COMPLETED|Overall Study||15
7554243|NCT03048383|18592743|P3|STARTED|Overall Study||22
7554244|NCT03048383|18592744|P2|STARTED|Overall Study||21
7554245|NCT03048383|18592745|P1|STARTED|Overall Study||28
7554246|NCT03048058|18592758|P2|NOT COMPLETED|Overall Study||4
7554247|NCT03048058|18592759|P1|NOT COMPLETED|Overall Study||4
7554248|NCT03048058|18592758|P2|COMPLETED|Overall Study||6
7554249|NCT03048058|18592759|P1|COMPLETED|Overall Study||6
7554250|NCT03048058|18592758|P2|STARTED|Overall Study||10
7554251|NCT03048058|18592759|P1|STARTED|Overall Study||10
7554252|NCT03048006|18592777|P1|NOT COMPLETED|Overall Study||0
7554253|NCT03048006|18592777|P1|COMPLETED|Overall Study||44456
7554254|NCT03048006|18592777|P1|STARTED|Overall Study||44456
7554255|NCT03047720|18592785|P2|NOT COMPLETED|Second Intervention (6weeks)||0
7554256|NCT03047720|18592786|P1|NOT COMPLETED|Second Intervention (6weeks)||0
7554257|NCT03047720|18592785|P2|COMPLETED|Second Intervention (6weeks)||0
7554258|NCT03047720|18592786|P1|COMPLETED|Second Intervention (6weeks)||0
7554259|NCT03047720|18592785|P2|STARTED|Second Intervention (6weeks)||0
7554260|NCT03047720|18592786|P1|STARTED|Second Intervention (6weeks)||0
7554261|NCT03047720|18592785|P2|NOT COMPLETED|First Intervention (6weeks)||0
7554262|NCT03047720|18592786|P1|NOT COMPLETED|First Intervention (6weeks)||7
7554263|NCT03047720|18592785|P2|COMPLETED|First Intervention (6weeks)||0
7554264|NCT03047720|18592786|P1|COMPLETED|First Intervention (6weeks)||5
7554265|NCT03047720|18592785|P2|STARTED|First Intervention (6weeks)||0
7554266|NCT03047720|18592786|P1|STARTED|First Intervention (6weeks)||12
7554267|NCT03047551|18592800|P2|NOT COMPLETED|Overall Study||3
7554268|NCT03047551|18592801|P1|NOT COMPLETED|Overall Study||2
7554269|NCT03047551|18592800|P2|COMPLETED|Overall Study||312
7554270|NCT03047551|18592801|P1|COMPLETED|Overall Study||317
7554271|NCT03047551|18592800|P2|STARTED|Overall Study||315
7554272|NCT03047551|18592801|P1|STARTED|Overall Study||319
7554273|NCT03047447|18592812|P3|NOT COMPLETED|Overall Study||0
7554274|NCT03047447|18592813|P2|NOT COMPLETED|Overall Study||0
7554275|NCT03047447|18592814|P1|NOT COMPLETED|Overall Study||0
7554276|NCT03047447|18592812|P3|COMPLETED|Overall Study||10
7554277|NCT03047447|18592813|P2|COMPLETED|Overall Study||10
7554278|NCT03047447|18592814|P1|COMPLETED|Overall Study||10
7554279|NCT03047447|18592812|P3|STARTED|Overall Study||10
7554280|NCT03047447|18592813|P2|STARTED|Overall Study||10
7554281|NCT03047447|18592814|P1|STARTED|Overall Study||10
7554282|NCT03047174|18592836|P2|NOT COMPLETED|Overall Study||2
7554283|NCT03047174|18592837|P1|NOT COMPLETED|Overall Study||19
7554284|NCT03047174|18592836|P2|COMPLETED|Overall Study||27
7554285|NCT03047174|18592837|P1|COMPLETED|Overall Study||9
7554286|NCT03047174|18592836|P2|STARTED|Overall Study||29
7554287|NCT03047174|18592837|P1|STARTED|Overall Study||28
7554288|NCT03046472|18592867|P2|NOT COMPLETED|Overall Study||0
7554289|NCT03046472|18592868|P1|NOT COMPLETED|Overall Study||0
7554290|NCT03046472|18592867|P2|COMPLETED|Overall Study||17
7554291|NCT03046472|18592868|P1|COMPLETED|Overall Study||33
7554292|NCT03046472|18592867|P2|STARTED|Overall Study||17
7554293|NCT03046472|18592868|P1|STARTED|Overall Study||33
7554294|NCT03046446|18592878|P1|NOT COMPLETED|Overall Study||59
7554295|NCT03046446|18592878|P1|COMPLETED|Overall Study||149
7554296|NCT03046446|18592878|P1|Completed at Week 52|Overall Study||133
7554297|NCT03046446|18592878|P1|Completed at Week 24|Overall Study||6
7554298|NCT03046446|18592878|P1|Completed at Week 12|Overall Study||10
7554299|NCT03046446|18592878|P1|Second Injection|Overall Study||179
7554300|NCT03046446|18592878|P1|STARTED|Overall Study||208
7554301|NCT03046225|18592888|P2|NOT COMPLETED|Overall Study||0
7554302|NCT03046225|18592889|P1|NOT COMPLETED|Overall Study||0
7554303|NCT03046225|18592888|P2|COMPLETED|Overall Study||13
7554304|NCT03046225|18592889|P1|COMPLETED|Overall Study||13
7554305|NCT03046225|18592888|P2|STARTED|Overall Study||13
7554306|NCT03046225|18592889|P1|STARTED|Overall Study||13
7554307|NCT03046212|18592901|P2|NOT COMPLETED|Overall Study||0
7554308|NCT03046212|18592902|P1|NOT COMPLETED|Overall Study||0
7554309|NCT03046212|18592901|P2|COMPLETED|Overall Study||15
7554310|NCT03046212|18592902|P1|COMPLETED|Overall Study||15
7554311|NCT03046212|18592901|P2|STARTED|Overall Study||15
7554312|NCT03046212|18592902|P1|STARTED|Overall Study||15
7554313|NCT03045926|18592912|P1|NOT COMPLETED|Overall Study||0
7554314|NCT03045926|18592912|P1|COMPLETED|Overall Study||35
7554315|NCT03045926|18592912|P1|STARTED|Overall Study||35
7554316|NCT03045887|18592941|P10|NOT COMPLETED|Part B (14 Days)||0
7554317|NCT03045887|18592942|P9|NOT COMPLETED|Part B (14 Days)||0
7554318|NCT03045887|18592943|P8|NOT COMPLETED|Part B (14 Days)||0
7554319|NCT03045887|18592944|P7|NOT COMPLETED|Part B (14 Days)||0
7554320|NCT03045887|18592945|P6|NOT COMPLETED|Part B (14 Days)||0
7554321|NCT03045887|18592946|P5|NOT COMPLETED|Part B (14 Days)||0
7554322|NCT03045887|18592947|P4|NOT COMPLETED|Part B (14 Days)||0
7554323|NCT03045887|18592948|P3|NOT COMPLETED|Part B (14 Days)||0
7554324|NCT03045887|18592949|P2|NOT COMPLETED|Part B (14 Days)||0
7554325|NCT03045887|18592950|P1|NOT COMPLETED|Part B (14 Days)||0
7554326|NCT03045887|18592941|P10|COMPLETED|Part B (14 Days)||9
7554327|NCT03045887|18592942|P9|COMPLETED|Part B (14 Days)||3
7554328|NCT03045887|18592943|P8|COMPLETED|Part B (14 Days)||0
7554329|NCT03045887|18592944|P7|COMPLETED|Part B (14 Days)||0
7554330|NCT03045887|18592945|P6|COMPLETED|Part B (14 Days)||0
7554331|NCT03045887|18592946|P5|COMPLETED|Part B (14 Days)||0
7554332|NCT03045887|18592947|P4|COMPLETED|Part B (14 Days)||0
7554333|NCT03045887|18592948|P3|COMPLETED|Part B (14 Days)||0
7554334|NCT03045887|18592949|P2|COMPLETED|Part B (14 Days)||0
7554335|NCT03045887|18592950|P1|COMPLETED|Part B (14 Days)||0
7554336|NCT03045887|18592941|P10|STARTED|Part B (14 Days)||9
7554337|NCT03045887|18592942|P9|STARTED|Part B (14 Days)||3
7554338|NCT03045887|18592943|P8|STARTED|Part B (14 Days)||0
7554339|NCT03045887|18592944|P7|STARTED|Part B (14 Days)||0
7554340|NCT03045887|18592945|P6|STARTED|Part B (14 Days)||0
7554341|NCT03045887|18592946|P5|STARTED|Part B (14 Days)||0
7554342|NCT03045887|18592947|P4|STARTED|Part B (14 Days)||0
7554343|NCT03045887|18592948|P3|STARTED|Part B (14 Days)||0
7554344|NCT03045887|18592949|P2|STARTED|Part B (14 Days)||0
7554345|NCT03045887|18592950|P1|STARTED|Part B (14 Days)||0
7554346|NCT03045887|18592941|P10|NOT COMPLETED|Part A, Period 3 (1 Day)||0
7554347|NCT03045887|18592942|P9|NOT COMPLETED|Part A, Period 3 (1 Day)||0
7554348|NCT03045887|18592943|P8|NOT COMPLETED|Part A, Period 3 (1 Day)||0
7554349|NCT03045887|18592944|P7|NOT COMPLETED|Part A, Period 3 (1 Day)||0
7554350|NCT03045887|18592945|P6|NOT COMPLETED|Part A, Period 3 (1 Day)||0
7554351|NCT03045887|18592946|P5|NOT COMPLETED|Part A, Period 3 (1 Day)||0
7554352|NCT03045887|18592947|P4|NOT COMPLETED|Part A, Period 3 (1 Day)||0
7554353|NCT03045887|18592948|P3|NOT COMPLETED|Part A, Period 3 (1 Day)||0
7554354|NCT03045887|18592949|P2|NOT COMPLETED|Part A, Period 3 (1 Day)||0
7554355|NCT03045887|18592950|P1|NOT COMPLETED|Part A, Period 3 (1 Day)||0
7554356|NCT03045887|18592941|P10|COMPLETED|Part A, Period 3 (1 Day)||0
7554357|NCT03045887|18592942|P9|COMPLETED|Part A, Period 3 (1 Day)||0
7554358|NCT03045887|18592943|P8|COMPLETED|Part A, Period 3 (1 Day)||4
7554359|NCT03045887|18592944|P7|COMPLETED|Part A, Period 3 (1 Day)||4
7554360|NCT03045887|18592945|P6|COMPLETED|Part A, Period 3 (1 Day)||4
7554361|NCT03045887|18592946|P5|COMPLETED|Part A, Period 3 (1 Day)||4
7554362|NCT03045887|18592947|P4|COMPLETED|Part A, Period 3 (1 Day)||2
7554363|NCT03045887|18592948|P3|COMPLETED|Part A, Period 3 (1 Day)||4
7554364|NCT03045887|18592949|P2|COMPLETED|Part A, Period 3 (1 Day)||4
7554365|NCT03045887|18592950|P1|COMPLETED|Part A, Period 3 (1 Day)||3
7554366|NCT03045887|18592941|P10|STARTED|Part A, Period 3 (1 Day)||0
7554367|NCT03045887|18592942|P9|STARTED|Part A, Period 3 (1 Day)||0
7554368|NCT03045887|18592943|P8|STARTED|Part A, Period 3 (1 Day)||4
7554369|NCT03045887|18592944|P7|STARTED|Part A, Period 3 (1 Day)||4
7554370|NCT03045887|18592945|P6|STARTED|Part A, Period 3 (1 Day)||4
7554371|NCT03045887|18592946|P5|STARTED|Part A, Period 3 (1 Day)||4
7554372|NCT03045887|18592947|P4|STARTED|Part A, Period 3 (1 Day)||2
7554373|NCT03045887|18592948|P3|STARTED|Part A, Period 3 (1 Day)||4
7554374|NCT03045887|18592949|P2|STARTED|Part A, Period 3 (1 Day)||4
7554375|NCT03045887|18592950|P1|STARTED|Part A, Period 3 (1 Day)||3
7554376|NCT03045887|18592941|P10|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
7554377|NCT03045887|18592942|P9|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
7554378|NCT03045887|18592943|P8|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
7554379|NCT03045887|18592944|P7|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
7554380|NCT03045887|18592945|P6|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
7554381|NCT03045887|18592946|P5|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
7554382|NCT03045887|18592947|P4|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
7554383|NCT03045887|18592948|P3|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||1
7554384|NCT03045887|18592949|P2|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
7554385|NCT03045887|18592950|P1|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
7554386|NCT03045887|18592941|P10|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
7554387|NCT03045887|18592942|P9|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
7554388|NCT03045887|18592943|P8|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
7554389|NCT03045887|18592944|P7|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
7554390|NCT03045887|18592945|P6|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
7554391|NCT03045887|18592946|P5|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
7554392|NCT03045887|18592947|P4|COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
7554393|NCT03045887|18592948|P3|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
7554394|NCT03045887|18592949|P2|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
7554395|NCT03045887|18592950|P1|COMPLETED|Part A,Washout Period 2 (4 Weeks)||3
7554396|NCT03045887|18592941|P10|STARTED|Part A,Washout Period 2 (4 Weeks)||0
7554397|NCT03045887|18592942|P9|STARTED|Part A,Washout Period 2 (4 Weeks)||0
7554398|NCT03045887|18592943|P8|STARTED|Part A,Washout Period 2 (4 Weeks)||4
7554399|NCT03045887|18592944|P7|STARTED|Part A,Washout Period 2 (4 Weeks)||4
7554400|NCT03045887|18592945|P6|STARTED|Part A,Washout Period 2 (4 Weeks)||4
7554401|NCT03045887|18592946|P5|STARTED|Part A,Washout Period 2 (4 Weeks)||4
7554402|NCT03045887|18592947|P4|STARTED|Part A,Washout Period 2 (4 Weeks)||4
7554403|NCT03045887|18592948|P3|STARTED|Part A,Washout Period 2 (4 Weeks)||5
7554404|NCT03045887|18592949|P2|STARTED|Part A,Washout Period 2 (4 Weeks)||4
7554405|NCT03045887|18592950|P1|STARTED|Part A,Washout Period 2 (4 Weeks)||3
7554406|NCT03045887|18592941|P10|NOT COMPLETED|Part A, Period 2 (1 Day)||0
7554407|NCT03045887|18592942|P9|NOT COMPLETED|Part A, Period 2 (1 Day)||0
7554408|NCT03045887|18592943|P8|NOT COMPLETED|Part A, Period 2 (1 Day)||0
7554409|NCT03045887|18592944|P7|NOT COMPLETED|Part A, Period 2 (1 Day)||0
7554410|NCT03045887|18592945|P6|NOT COMPLETED|Part A, Period 2 (1 Day)||0
7554411|NCT03045887|18592946|P5|NOT COMPLETED|Part A, Period 2 (1 Day)||0
7554412|NCT03045887|18592947|P4|NOT COMPLETED|Part A, Period 2 (1 Day)||0
7554413|NCT03045887|18592948|P3|NOT COMPLETED|Part A, Period 2 (1 Day)||0
7554414|NCT03045887|18592949|P2|NOT COMPLETED|Part A, Period 2 (1 Day)||0
7554415|NCT03045887|18592950|P1|NOT COMPLETED|Part A, Period 2 (1 Day)||1
7554416|NCT03045887|18592941|P10|COMPLETED|Part A, Period 2 (1 Day)||0
7554417|NCT03045887|18592942|P9|COMPLETED|Part A, Period 2 (1 Day)||0
7554418|NCT03045887|18592943|P8|COMPLETED|Part A, Period 2 (1 Day)||4
7554419|NCT03045887|18592944|P7|COMPLETED|Part A, Period 2 (1 Day)||4
7554420|NCT03045887|18592945|P6|COMPLETED|Part A, Period 2 (1 Day)||4
7554421|NCT03045887|18592946|P5|COMPLETED|Part A, Period 2 (1 Day)||4
7554422|NCT03045887|18592947|P4|COMPLETED|Part A, Period 2 (1 Day)||4
7554423|NCT03045887|18592948|P3|COMPLETED|Part A, Period 2 (1 Day)||5
7554424|NCT03045887|18592949|P2|COMPLETED|Part A, Period 2 (1 Day)||4
7554425|NCT03045887|18592950|P1|COMPLETED|Part A, Period 2 (1 Day)||3
7554426|NCT03045887|18592941|P10|STARTED|Part A, Period 2 (1 Day)||0
7554427|NCT03045887|18592942|P9|STARTED|Part A, Period 2 (1 Day)||0
7554428|NCT03045887|18592943|P8|STARTED|Part A, Period 2 (1 Day)||4
7554429|NCT03045887|18592944|P7|STARTED|Part A, Period 2 (1 Day)||4
7554430|NCT03045887|18592945|P6|STARTED|Part A, Period 2 (1 Day)||4
7554431|NCT03045887|18592946|P5|STARTED|Part A, Period 2 (1 Day)||4
7554432|NCT03045887|18592947|P4|STARTED|Part A, Period 2 (1 Day)||4
7554433|NCT03045887|18592948|P3|STARTED|Part A, Period 2 (1 Day)||5
7554434|NCT03045887|18592949|P2|STARTED|Part A, Period 2 (1 Day)||4
7554435|NCT03045887|18592950|P1|STARTED|Part A, Period 2 (1 Day)||4
7554436|NCT03045887|18592941|P10|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
7554437|NCT03045887|18592942|P9|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
7554438|NCT03045887|18592943|P8|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
7554439|NCT03045887|18592944|P7|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
7554440|NCT03045887|18592945|P6|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
7554441|NCT03045887|18592946|P5|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
7554442|NCT03045887|18592947|P4|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||1
7554443|NCT03045887|18592948|P3|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
7554444|NCT03045887|18592949|P2|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
7554445|NCT03045887|18592950|P1|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||3
7554446|NCT03045887|18592941|P10|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
7554447|NCT03045887|18592942|P9|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
7554448|NCT03045887|18592943|P8|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
7554449|NCT03045887|18592944|P7|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
7554450|NCT03045887|18592945|P6|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
7554451|NCT03045887|18592946|P5|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
7554452|NCT03045887|18592947|P4|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
7554453|NCT03045887|18592948|P3|COMPLETED|Part A,Washout Period 1(4 Weeks)||5
7554454|NCT03045887|18592949|P2|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
7554455|NCT03045887|18592950|P1|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
7554456|NCT03045887|18592941|P10|STARTED|Part A,Washout Period 1(4 Weeks)||0
7554457|NCT03045887|18592942|P9|STARTED|Part A,Washout Period 1(4 Weeks)||0
7554458|NCT03045887|18592943|P8|STARTED|Part A,Washout Period 1(4 Weeks)||4
7554459|NCT03045887|18592944|P7|STARTED|Part A,Washout Period 1(4 Weeks)||4
7554460|NCT03045887|18592945|P6|STARTED|Part A,Washout Period 1(4 Weeks)||4
7554461|NCT03045887|18592946|P5|STARTED|Part A,Washout Period 1(4 Weeks)||4
7554462|NCT03045887|18592947|P4|STARTED|Part A,Washout Period 1(4 Weeks)||5
7554463|NCT03045887|18592948|P3|STARTED|Part A,Washout Period 1(4 Weeks)||5
7554464|NCT03045887|18592949|P2|STARTED|Part A,Washout Period 1(4 Weeks)||4
7554465|NCT03045887|18592950|P1|STARTED|Part A,Washout Period 1(4 Weeks)||7
7554466|NCT03045887|18592941|P10|NOT COMPLETED|Part A, Period (1 Day)||0
7554467|NCT03045887|18592942|P9|NOT COMPLETED|Part A, Period (1 Day)||0
7554468|NCT03045887|18592943|P8|NOT COMPLETED|Part A, Period (1 Day)||0
7554469|NCT03045887|18592944|P7|NOT COMPLETED|Part A, Period (1 Day)||0
7554470|NCT03045887|18592945|P6|NOT COMPLETED|Part A, Period (1 Day)||0
7554471|NCT03045887|18592946|P5|NOT COMPLETED|Part A, Period (1 Day)||0
7554472|NCT03045887|18592947|P4|NOT COMPLETED|Part A, Period (1 Day)||0
7554473|NCT03045887|18592948|P3|NOT COMPLETED|Part A, Period (1 Day)||0
7554474|NCT03045887|18592949|P2|NOT COMPLETED|Part A, Period (1 Day)||0
7554475|NCT03045887|18592950|P1|NOT COMPLETED|Part A, Period (1 Day)||0
7554476|NCT03045887|18592941|P10|COMPLETED|Part A, Period (1 Day)||0
7554477|NCT03045887|18592942|P9|COMPLETED|Part A, Period (1 Day)||0
7554478|NCT03045887|18592943|P8|COMPLETED|Part A, Period (1 Day)||4
7554479|NCT03045887|18592944|P7|COMPLETED|Part A, Period (1 Day)||4
7554480|NCT03045887|18592945|P6|COMPLETED|Part A, Period (1 Day)||4
7554481|NCT03045887|18592946|P5|COMPLETED|Part A, Period (1 Day)||4
7554482|NCT03045887|18592947|P4|COMPLETED|Part A, Period (1 Day)||5
7554483|NCT03045887|18592948|P3|COMPLETED|Part A, Period (1 Day)||5
7554484|NCT03045887|18592949|P2|COMPLETED|Part A, Period (1 Day)||4
7554485|NCT03045887|18592950|P1|COMPLETED|Part A, Period (1 Day)||7
7554486|NCT03045887|18592941|P10|STARTED|Part A, Period (1 Day)||0
7554487|NCT03045887|18592942|P9|STARTED|Part A, Period (1 Day)||0
7554488|NCT03045887|18592943|P8|STARTED|Part A, Period (1 Day)||4
7554489|NCT03045887|18592944|P7|STARTED|Part A, Period (1 Day)||4
7554490|NCT03045887|18592945|P6|STARTED|Part A, Period (1 Day)||4
7554491|NCT03045887|18592946|P5|STARTED|Part A, Period (1 Day)||4
7554492|NCT03045887|18592947|P4|STARTED|Part A, Period (1 Day)||5
7554493|NCT03045887|18592948|P3|STARTED|Part A, Period (1 Day)||5
7554494|NCT03045887|18592949|P2|STARTED|Part A, Period (1 Day)||4
7554495|NCT03045887|18592950|P1|STARTED|Part A, Period (1 Day)||7
7554496|NCT03045861|18593092|P4|NOT COMPLETED|Part B (Up to 10 Days)||0
7554497|NCT03045861|18593093|P3|NOT COMPLETED|Part B (Up to 10 Days)||0
7554498|NCT03045861|18593094|P2|NOT COMPLETED|Part B (Up to 10 Days)||0
7554499|NCT03045861|18593095|P1|NOT COMPLETED|Part B (Up to 10 Days)||0
7554500|NCT03045861|18593092|P4|COMPLETED|Part B (Up to 10 Days)||8
7554501|NCT03045861|18593093|P3|COMPLETED|Part B (Up to 10 Days)||0
7554502|NCT03045861|18593094|P2|COMPLETED|Part B (Up to 10 Days)||8
7554503|NCT03045861|18593095|P1|COMPLETED|Part B (Up to 10 Days)||7
7554504|NCT03045861|18593092|P4|STARTED|Part B (Up to 10 Days)||8
7554505|NCT03045861|18593093|P3|STARTED|Part B (Up to 10 Days)||0
7554506|NCT03045861|18593094|P2|STARTED|Part B (Up to 10 Days)||8
7554507|NCT03045861|18593095|P1|STARTED|Part B (Up to 10 Days)||7
7554508|NCT03045861|18593092|P4|NOT COMPLETED|Part A (Up to 10 Days)||0
7554509|NCT03045861|18593093|P3|NOT COMPLETED|Part A (Up to 10 Days)||0
7554510|NCT03045861|18593094|P2|NOT COMPLETED|Part A (Up to 10 Days)||0
7554511|NCT03045861|18593095|P1|NOT COMPLETED|Part A (Up to 10 Days)||0
7554512|NCT03045861|18593092|P4|COMPLETED|Part A (Up to 10 Days)||0
7554513|NCT03045861|18593093|P3|COMPLETED|Part A (Up to 10 Days)||10
7554514|NCT03045861|18593094|P2|COMPLETED|Part A (Up to 10 Days)||0
7554515|NCT03045861|18593095|P1|COMPLETED|Part A (Up to 10 Days)||0
7554516|NCT03045861|18593092|P4|STARTED|Part A (Up to 10 Days)||0
7554517|NCT03045861|18593093|P3|STARTED|Part A (Up to 10 Days)||10
7554518|NCT03045861|18593094|P2|STARTED|Part A (Up to 10 Days)||0
7554519|NCT03045861|18593095|P1|STARTED|Part A (Up to 10 Days)||0
7554520|NCT03045809|18593221|P1|NOT COMPLETED|Overall Study||0
7554521|NCT03045809|18593221|P1|COMPLETED|Overall Study||705
7554522|NCT03045809|18593221|P1|Attended an Additional Visit (if Needed)|Overall Study|(only if needed, for medical follow-up, to complete study procedures, or to report adverse events).|51
7554523|NCT03045809|18593221|P1|STARTED|Overall Study||705
7554524|NCT03045653|18593228|P1|NOT COMPLETED|Overall Study||0
7554525|NCT03045653|18593228|P1|COMPLETED|Overall Study||30
7554526|NCT03045653|18593228|P1|STARTED|Overall Study||30
7554527|NCT03045302|18593232|P1|NOT COMPLETED|Overall Study||1
7554528|NCT03045302|18593232|P1|COMPLETED|Overall Study||3
7554529|NCT03045302|18593232|P1|STARTED|Overall Study||4
7554530|NCT03045081|18593238|P2|NOT COMPLETED|Overall Study||11
7554531|NCT03045081|18593239|P1|NOT COMPLETED|Overall Study||6
7554532|NCT03045081|18593238|P2|COMPLETED|Overall Study||37
7554533|NCT03045081|18593239|P1|COMPLETED|Overall Study||45
7554534|NCT03045081|18593238|P2|STARTED|Overall Study||48
7554535|NCT03045081|18593239|P1|STARTED|Overall Study||51
7554536|NCT03044886|18593258|P3|NOT COMPLETED|Overall Study||12
7554537|NCT03044886|18593259|P2|NOT COMPLETED|Overall Study||10
7554538|NCT03044886|18593260|P1|NOT COMPLETED|Overall Study||15
7554539|NCT03044886|18593258|P3|COMPLETED|Overall Study||108
7554540|NCT03044886|18593259|P2|COMPLETED|Overall Study||110
7554541|NCT03044886|18593260|P1|COMPLETED|Overall Study||105
7554542|NCT03044886|18593258|P3|STARTED|Overall Study||120
7554543|NCT03044886|18593259|P2|STARTED|Overall Study||120
7554544|NCT03044886|18593260|P1|STARTED|Overall Study||120
7554545|NCT03044730|18593301|P1|NOT COMPLETED|On Follow-up for 2 Years||25
7554546|NCT03044730|18593301|P1|COMPLETED|On Follow-up for 2 Years||4
7554547|NCT03044730|18593301|P1|STARTED|On Follow-up for 2 Years||29
7554548|NCT03044730|18593301|P1|NOT COMPLETED|Cycles 4 and Beyond||10
7554549|NCT03044730|18593301|P1|COMPLETED|Cycles 4 and Beyond||16
7554550|NCT03044730|18593301|P1|Went on to Cycle 5 and Beyond|Cycles 4 and Beyond||16
7554551|NCT03044730|18593301|P1|Started Cycle 4|Cycles 4 and Beyond||20
7554552|NCT03044730|18593301|P1|Assessed for Cycle 4|Cycles 4 and Beyond||26
7554553|NCT03044730|18593301|P1|STARTED|Cycles 4 and Beyond||26
7554554|NCT03044730|18593301|P1|NOT COMPLETED|3 Cycles of Pembro + Capecitab||4
7554555|NCT03044730|18593301|P1|COMPLETED|3 Cycles of Pembro + Capecitab||26
7554556|NCT03044730|18593301|P1|Attempted Cycle 3|3 Cycles of Pembro + Capecitab||26
7554557|NCT03044730|18593301|P1|Attempted Cycle 2|3 Cycles of Pembro + Capecitab||28
7554558|NCT03044730|18593301|P1|Attempted Cycle 1|3 Cycles of Pembro + Capecitab||30
7554559|NCT03044730|18593301|P1|STARTED|3 Cycles of Pembro + Capecitab||30
7554560|NCT03044691|18593312|P2|NOT COMPLETED|Overall Study||0
7554561|NCT03044691|18593313|P1|NOT COMPLETED|Overall Study||0
7554562|NCT03044691|18593312|P2|COMPLETED|Overall Study||84
7554563|NCT03044691|18593313|P1|COMPLETED|Overall Study||0
7554564|NCT03044691|18593312|P2|STARTED|Overall Study||84
7554565|NCT03044691|18593313|P1|STARTED|Overall Study||0
7554566|NCT03044574|18593321|P2|NOT COMPLETED|Overall Study||45
7554567|NCT03044574|18593322|P1|NOT COMPLETED|Overall Study||37
7554568|NCT03044574|18593321|P2|COMPLETED|Overall Study||158
7554569|NCT03044574|18593322|P1|COMPLETED|Overall Study||167
7554570|NCT03044574|18593321|P2|180 Days After Surgery|Overall Study||158
7554571|NCT03044574|18593322|P1|180 Days After Surgery|Overall Study||167
7554572|NCT03044574|18593321|P2|30 Days After Surgery|Overall Study||194
7554573|NCT03044574|18593322|P1|30 Days After Surgery|Overall Study||193
7554574|NCT03044574|18593321|P2|Inpatient Period|Overall Study||203
7554575|NCT03044574|18593322|P1|Inpatient Period|Overall Study||204
7554576|NCT03044574|18593321|P2|STARTED|Overall Study||203
7554577|NCT03044574|18593322|P1|STARTED|Overall Study||204
7554578|NCT03044431|18593348|P1|NOT COMPLETED|Overall Study||59
7554579|NCT03044431|18593348|P1|COMPLETED|Overall Study||148
7554580|NCT03044431|18593348|P1|STARTED|Overall Study||207
7554581|NCT03044353|18593361|P3|NOT COMPLETED|Overall Study||0
7554582|NCT03044353|18593362|P2|NOT COMPLETED|Overall Study||1
7554583|NCT03044353|18593363|P1|NOT COMPLETED|Overall Study||0
7554584|NCT03044353|18593361|P3|COMPLETED|Overall Study||0
7554585|NCT03044353|18593362|P2|COMPLETED|Overall Study||0
7554586|NCT03044353|18593363|P1|COMPLETED|Overall Study||6
7554587|NCT03044353|18593361|P3|STARTED|Overall Study|No participant was enrolled in Group-3 due to early termination of the study.|0
7554588|NCT03044353|18593362|P2|STARTED|Overall Study||1
7554589|NCT03044353|18593363|P1|STARTED|Overall Study||6
7554590|NCT03044197|18593446|P2|NOT COMPLETED|Overall Study||1
7554591|NCT03044197|18593447|P1|NOT COMPLETED|Overall Study||3
7554592|NCT03044197|18593446|P2|COMPLETED|Overall Study||11
7554593|NCT03044197|18593447|P1|COMPLETED|Overall Study||9
7554594|NCT03044197|18593446|P2|STARTED|Overall Study||12
7554595|NCT03044197|18593447|P1|STARTED|Overall Study||12
7554596|NCT03044106|18593457|P2|NOT COMPLETED|Visit 2||0
7554597|NCT03044106|18593458|P1|NOT COMPLETED|Visit 2||0
7554598|NCT03044106|18593457|P2|COMPLETED|Visit 2||20
7554599|NCT03044106|18593458|P1|COMPLETED|Visit 2||22
7554600|NCT03044106|18593457|P2|STARTED|Visit 2||20
7554601|NCT03044106|18593458|P1|STARTED|Visit 2||22
7554602|NCT03044106|18593457|P2|NOT COMPLETED|Washout (1 Week)||2
7554603|NCT03044106|18593458|P1|NOT COMPLETED|Washout (1 Week)||0
7554604|NCT03044106|18593457|P2|COMPLETED|Washout (1 Week)||20
7554605|NCT03044106|18593458|P1|COMPLETED|Washout (1 Week)||22
7554606|NCT03044106|18593457|P2|STARTED|Washout (1 Week)||22
7554607|NCT03044106|18593458|P1|STARTED|Washout (1 Week)||22
7554608|NCT03044106|18593457|P2|NOT COMPLETED|Visit 1||0
7554609|NCT03044106|18593458|P1|NOT COMPLETED|Visit 1||0
7554610|NCT03044106|18593457|P2|COMPLETED|Visit 1||22
7554611|NCT03044106|18593458|P1|COMPLETED|Visit 1||22
7554612|NCT03044106|18593457|P2|STARTED|Visit 1||22
7554613|NCT03044106|18593458|P1|STARTED|Visit 1||22
7554614|NCT03044028|18593475|P3|NOT COMPLETED|Overall Study||0
7554615|NCT03044028|18593476|P2|NOT COMPLETED|Overall Study||10
7554616|NCT03044028|18593477|P1|NOT COMPLETED|Overall Study||10
7554617|NCT03044028|18593475|P3|COMPLETED|Overall Study||22
7554618|NCT03044028|18593476|P2|COMPLETED|Overall Study||12
7554619|NCT03044028|18593477|P1|COMPLETED|Overall Study||12
7554620|NCT03044028|18593475|P3|STARTED|Overall Study||22
7554621|NCT03044028|18593476|P2|STARTED|Overall Study||22
7554622|NCT03044028|18593477|P1|STARTED|Overall Study||22
7554623|NCT03043885|18593513|P4|NOT COMPLETED|Overall Study||0
7554624|NCT03043885|18593514|P3|NOT COMPLETED|Overall Study||0
7554625|NCT03043885|18593515|P2|NOT COMPLETED|Overall Study||0
7554626|NCT03043885|18593516|P1|NOT COMPLETED|Overall Study||0
7554627|NCT03043885|18593513|P4|COMPLETED|Overall Study||10
7554628|NCT03043885|18593514|P3|COMPLETED|Overall Study||10
7554629|NCT03043885|18593515|P2|COMPLETED|Overall Study||10
7554630|NCT03043885|18593516|P1|COMPLETED|Overall Study||10
7554631|NCT03043885|18593513|P4|STARTED|Overall Study||10
7554632|NCT03043885|18593514|P3|STARTED|Overall Study||10
7554633|NCT03043885|18593515|P2|STARTED|Overall Study||10
7554634|NCT03043885|18593516|P1|STARTED|Overall Study||10
7554635|NCT03043651|18593530|P1|NOT COMPLETED|Overall Study||48
7554636|NCT03043651|18593530|P1|COMPLETED|Overall Study||0
7554637|NCT03043651|18593530|P1|STARTED|Overall Study||48
7554638|NCT03043599|18593534|P1|NOT COMPLETED|Overall Study||0
7554639|NCT03043599|18593534|P1|COMPLETED|Overall Study||21
7554640|NCT03043599|18593534|P1|STARTED|Overall Study||21
7554641|NCT03043560|18593542|P2|NOT COMPLETED|Overall Study||3
7554642|NCT03043560|18593543|P1|NOT COMPLETED|Overall Study||1
7554643|NCT03043560|18593542|P2|COMPLETED|Overall Study||21
7554644|NCT03043560|18593543|P1|COMPLETED|Overall Study||20
7554645|NCT03043560|18593542|P2|STARTED|Overall Study||24
7554646|NCT03043560|18593543|P1|STARTED|Overall Study||21
7554647|NCT03043534|18593567|P2|NOT COMPLETED|Overall Study||0
7554648|NCT03043534|18593568|P1|NOT COMPLETED|Overall Study||0
7554649|NCT03043534|18593567|P2|COMPLETED|Overall Study||14
7554650|NCT03043534|18593568|P1|COMPLETED|Overall Study||15
7554651|NCT03043534|18593567|P2|STARTED|Overall Study||14
7554652|NCT03043534|18593568|P1|STARTED|Overall Study||15
7554653|NCT03043365|18593584|P2|NOT COMPLETED|Week 16 to Week 24||0
7554654|NCT03043365|18593585|P1|NOT COMPLETED|Week 16 to Week 24||0
7554655|NCT03043365|18593584|P2|COMPLETED|Week 16 to Week 24||14
7554656|NCT03043365|18593585|P1|COMPLETED|Week 16 to Week 24||16
7554657|NCT03043365|18593584|P2|STARTED|Week 16 to Week 24||14
7554658|NCT03043365|18593585|P1|STARTED|Week 16 to Week 24||16
7554659|NCT03043365|18593584|P2|NOT COMPLETED|Week 8 to Week 16 - Washout Period||0
7554660|NCT03043365|18593585|P1|NOT COMPLETED|Week 8 to Week 16 - Washout Period||1
7554661|NCT03043365|18593584|P2|COMPLETED|Week 8 to Week 16 - Washout Period||14
7554662|NCT03043365|18593585|P1|COMPLETED|Week 8 to Week 16 - Washout Period||16
7554663|NCT03043365|18593584|P2|STARTED|Week 8 to Week 16 - Washout Period||14
7554664|NCT03043365|18593585|P1|STARTED|Week 8 to Week 16 - Washout Period||17
7554665|NCT03043365|18593584|P2|NOT COMPLETED|Weeks 0 to Week 8||3
7554666|NCT03043365|18593585|P1|NOT COMPLETED|Weeks 0 to Week 8||3
7554667|NCT03043365|18593584|P2|COMPLETED|Weeks 0 to Week 8||14
7554668|NCT03043365|18593585|P1|COMPLETED|Weeks 0 to Week 8||17
7554669|NCT03043365|18593584|P2|STARTED|Weeks 0 to Week 8||17
7554670|NCT03043365|18593585|P1|STARTED|Weeks 0 to Week 8||20
7554671|NCT03043274|18593598|P2|NOT COMPLETED|Overall Study||1
7554672|NCT03043274|18593599|P1|NOT COMPLETED|Overall Study||0
7554673|NCT03043274|18593598|P2|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|9
7554674|NCT03043274|18593599|P1|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|13
7554675|NCT03043274|18593598|P2|STARTED|Overall Study||10
7554676|NCT03043274|18593599|P1|STARTED|Overall Study||13
7554677|NCT03043105|18593615|P1|NOT COMPLETED|Overall Study||0
7554678|NCT03043105|18593615|P1|COMPLETED|Overall Study||25
7554679|NCT03043105|18593615|P1|STARTED|Overall Study||25
7554680|NCT03043079|18593627|P3|NOT COMPLETED|Overall Study||0
7554681|NCT03043079|18593628|P2|NOT COMPLETED|Overall Study||0
7554682|NCT03043079|18593629|P1|NOT COMPLETED|Overall Study||0
7554683|NCT03043079|18593627|P3|COMPLETED|Overall Study||10
7554684|NCT03043079|18593628|P2|COMPLETED|Overall Study||14
7554685|NCT03043079|18593629|P1|COMPLETED|Overall Study||21
7554686|NCT03043079|18593627|P3|STARTED|Overall Study||10
7554687|NCT03043079|18593628|P2|STARTED|Overall Study||14
7554688|NCT03043079|18593629|P1|STARTED|Overall Study||21
7554689|NCT03042910|18593639|P1|NOT COMPLETED|Overall Study||7
7554690|NCT03042910|18593639|P1|COMPLETED|Overall Study||31
7554691|NCT03042910|18593639|P1|Treated|Overall Study||37
7554692|NCT03042910|18593639|P1|STARTED|Overall Study||38
7554693|NCT03042780|18593662|P1|NOT COMPLETED|Overall Study||0
7554694|NCT03042780|18593662|P1|COMPLETED|Overall Study||2
7554695|NCT03042780|18593662|P1|STARTED|Overall Study||2
7554696|NCT03042715|18593668|P1|NOT COMPLETED|Overall Study||1
7554697|NCT03042715|18593668|P1|COMPLETED|Overall Study||5
7554698|NCT03042715|18593668|P1|STARTED|Overall Study||6
7554699|NCT03042702|18593672|P1|NOT COMPLETED|Overall Study||0
7554700|NCT03042702|18593672|P1|COMPLETED|Overall Study||2
7554701|NCT03042702|18593672|P1|STARTED|Overall Study||2
7554702|NCT03042559|18593683|P2|NOT COMPLETED|Overall Study||1
7554703|NCT03042559|18593684|P1|NOT COMPLETED|Overall Study||1
7554704|NCT03042559|18593683|P2|COMPLETED|Overall Study||20
7554705|NCT03042559|18593684|P1|COMPLETED|Overall Study||21
7554706|NCT03042559|18593683|P2|STARTED|Overall Study||21
7554707|NCT03042559|18593684|P1|STARTED|Overall Study||22
7554708|NCT03042299|18593746|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
7554709|NCT03042299|18593747|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
7554710|NCT03042299|18593746|P2|COMPLETED|Intervention Period 2 (6 Days)||7
7554711|NCT03042299|18593747|P1|COMPLETED|Intervention Period 2 (6 Days)||7
7554712|NCT03042299|18593746|P2|STARTED|Intervention Period 2 (6 Days)||7
7554713|NCT03042299|18593747|P1|STARTED|Intervention Period 2 (6 Days)||7
7554714|NCT03042299|18593746|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||0
7554715|NCT03042299|18593747|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||0
7554716|NCT03042299|18593746|P2|COMPLETED|Washout Period (at Least 6 Days)||7
7554717|NCT03042299|18593747|P1|COMPLETED|Washout Period (at Least 6 Days)||7
7554718|NCT03042299|18593746|P2|STARTED|Washout Period (at Least 6 Days)||7
7554719|NCT03042299|18593747|P1|STARTED|Washout Period (at Least 6 Days)||7
7554720|NCT03042299|18593746|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
7554721|NCT03042299|18593747|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
7554722|NCT03042299|18593746|P2|COMPLETED|Intervention Period 1 (6 Days)||7
7554723|NCT03042299|18593747|P1|COMPLETED|Intervention Period 1 (6 Days)||7
7554724|NCT03042299|18593746|P2|STARTED|Intervention Period 1 (6 Days)||7
7554725|NCT03042299|18593747|P1|STARTED|Intervention Period 1 (6 Days)||7
7554726|NCT03041909|18593776|P3|NOT COMPLETED|Overall Study||0
7554727|NCT03041909|18593777|P2|NOT COMPLETED|Overall Study||0
7554728|NCT03041909|18593778|P1|NOT COMPLETED|Overall Study||0
7554729|NCT03041909|18593776|P3|COMPLETED|Overall Study||1
7554730|NCT03041909|18593777|P2|COMPLETED|Overall Study||1
7554731|NCT03041909|18593778|P1|COMPLETED|Overall Study||3
7554732|NCT03041909|18593776|P3|STARTED|Overall Study||1
7554733|NCT03041909|18593777|P2|STARTED|Overall Study||1
7554734|NCT03041909|18593778|P1|STARTED|Overall Study||3
7554735|NCT03041896|18593799|P4|NOT COMPLETED|Overall Study||3
7554736|NCT03041896|18593800|P3|NOT COMPLETED|Overall Study||63
7554737|NCT03041896|18593801|P2|NOT COMPLETED|Overall Study||0
7554738|NCT03041896|18593802|P1|NOT COMPLETED|Overall Study||0
7554739|NCT03041896|18593799|P4|COMPLETED|Overall Study||253
7554740|NCT03041896|18593800|P3|COMPLETED|Overall Study||2236
7554741|NCT03041896|18593801|P2|COMPLETED|Overall Study||1009
7554742|NCT03041896|18593802|P1|COMPLETED|Overall Study||1486
7554743|NCT03041896|18593799|P4|STARTED|Overall Study||256
7554744|NCT03041896|18593800|P3|STARTED|Overall Study||2299
7554745|NCT03041896|18593801|P2|STARTED|Overall Study||1009
7554746|NCT03041896|18593802|P1|STARTED|Overall Study||1486
7554747|NCT03041792|18593819|P2|NOT COMPLETED|Overall Study||3
7554748|NCT03041792|18593820|P1|NOT COMPLETED|Overall Study||4
7554749|NCT03041792|18593819|P2|COMPLETED|Overall Study||26
7554750|NCT03041792|18593820|P1|COMPLETED|Overall Study||28
7554751|NCT03041792|18593819|P2|Received Treatment|Overall Study||28
7554752|NCT03041792|18593820|P1|Received Treatment|Overall Study||32
7554753|NCT03041792|18593819|P2|STARTED|Overall Study||29
7554754|NCT03041792|18593820|P1|STARTED|Overall Study||32
7554755|NCT03041467|18593844|P2|NOT COMPLETED|Overall Study||160
7554756|NCT03041467|18593845|P1|NOT COMPLETED|Overall Study||170
7554757|NCT03041467|18593844|P2|COMPLETED|Overall Study||0
7554758|NCT03041467|18593845|P1|COMPLETED|Overall Study||0
7554759|NCT03041467|18593844|P2|STARTED|Overall Study||160
7554760|NCT03041467|18593845|P1|STARTED|Overall Study||170
7554761|NCT03041441|18593875|P1|NOT COMPLETED|Overall Study||2
7554762|NCT03041441|18593875|P1|COMPLETED|Overall Study||3
7554763|NCT03041441|18593875|P1|STARTED|Overall Study||5
7554764|NCT03041298|18593883|P1|NOT COMPLETED|Overall Study||0
7554765|NCT03041298|18593883|P1|COMPLETED|Overall Study||1537
7554766|NCT03041298|18593883|P1|STARTED|Overall Study||1537
7554767|NCT03041181|18593893|P2|NOT COMPLETED|Overall Study||2
7554768|NCT03041181|18593894|P1|NOT COMPLETED|Overall Study||1
7554769|NCT03041181|18593893|P2|COMPLETED|Overall Study||0
7554770|NCT03041181|18593894|P1|COMPLETED|Overall Study||0
7554771|NCT03041181|18593893|P2|STARTED|Overall Study||2
7554772|NCT03041181|18593894|P1|STARTED|Overall Study||1
7554773|NCT03041116|18593910|P2|NOT COMPLETED|Open-label||37
7554774|NCT03041116|18593911|P1|NOT COMPLETED|Open-label||41
7554775|NCT03041116|18593910|P2|COMPLETED|Open-label||0
7554776|NCT03041116|18593911|P1|COMPLETED|Open-label||0
7554777|NCT03041116|18593910|P2|Received At Least 1 Dose of Study Drug|Open-label||37
7554778|NCT03041116|18593911|P1|Received At Least 1 Dose of Study Drug|Open-label||41
7554779|NCT03041116|18593910|P2|STARTED|Open-label||37
7554780|NCT03041116|18593911|P1|STARTED|Open-label||41
7554781|NCT03041116|18593910|P2|NOT COMPLETED|Double-blind||6
7554782|NCT03041116|18593911|P1|NOT COMPLETED|Double-blind||0
7554783|NCT03041116|18593910|P2|COMPLETED|Double-blind||37
7554784|NCT03041116|18593911|P1|COMPLETED|Double-blind||41
7554785|NCT03041116|18593910|P2|Received at Least 1 Dose of Study Drug|Double-blind||43
7554786|NCT03041116|18593911|P1|Received at Least 1 Dose of Study Drug|Double-blind||41
7554787|NCT03041116|18593910|P2|STARTED|Double-blind||43
7554788|NCT03041116|18593911|P1|STARTED|Double-blind||41
7554789|NCT03041090|18593927|P2|NOT COMPLETED|Overall Study||3
7554790|NCT03041090|18593928|P1|NOT COMPLETED|Overall Study||0
7554791|NCT03041090|18593927|P2|COMPLETED|Overall Study|3 consented subjects in the dynamic arm were not included in analysis due to technical errors.|21
7554792|NCT03041090|18593928|P1|COMPLETED|Overall Study||109
7554793|NCT03041090|18593927|P2|STARTED|Overall Study||24
7554794|NCT03041090|18593928|P1|STARTED|Overall Study||109
7554795|NCT03040713|18593938|P1|NOT COMPLETED|Overall Study||3
7554796|NCT03040713|18593938|P1|COMPLETED|Overall Study||13
7554797|NCT03040713|18593938|P1|STARTED|Overall Study||16
7554798|NCT03040687|18593946|P3|NOT COMPLETED|Overall Study||0
7554799|NCT03040687|18593947|P2|NOT COMPLETED|Overall Study||0
7554800|NCT03040687|18593948|P1|NOT COMPLETED|Overall Study||1
7554801|NCT03040687|18593946|P3|COMPLETED|Overall Study||20
7554802|NCT03040687|18593947|P2|COMPLETED|Overall Study||20
7554803|NCT03040687|18593948|P1|COMPLETED|Overall Study||19
7554804|NCT03040687|18593946|P3|STARTED|Overall Study||20
7554805|NCT03040687|18593947|P2|STARTED|Overall Study||20
7554806|NCT03040687|18593948|P1|STARTED|Overall Study||20
7554807|NCT03040479|18593962|P3|NOT COMPLETED|Overall Study||0
7554808|NCT03040479|18593963|P2|NOT COMPLETED|Overall Study||0
7554809|NCT03040479|18593964|P1|NOT COMPLETED|Overall Study||0
7554810|NCT03040479|18593962|P3|COMPLETED|Overall Study||8
7554811|NCT03040479|18593963|P2|COMPLETED|Overall Study||8
7554812|NCT03040479|18593964|P1|COMPLETED|Overall Study||8
7554813|NCT03040479|18593962|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
7554814|NCT03040479|18593963|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
7554815|NCT03040479|18593964|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
7554816|NCT03040479|18593962|P3|STARTED|Overall Study||8
7554817|NCT03040479|18593963|P2|STARTED|Overall Study||8
7554818|NCT03040479|18593964|P1|STARTED|Overall Study||8
7554819|NCT03040466|18593992|P2|NOT COMPLETED|Overall Study||0
7554820|NCT03040466|18593993|P1|NOT COMPLETED|Overall Study||0
7554821|NCT03040466|18593992|P2|COMPLETED|Overall Study||115
7554822|NCT03040466|18593993|P1|COMPLETED|Overall Study||65
7554823|NCT03040466|18593992|P2|STARTED|Overall Study||115
7554824|NCT03040466|18593993|P1|STARTED|Overall Study||65
7554825|NCT03040362|18594003|P1|NOT COMPLETED|Overall Study||0
7554826|NCT03040362|18594003|P1|COMPLETED|Overall Study||8
7554827|NCT03040362|18594003|P1|Received at Least 1dose of Study Drug|Overall Study||8
7554828|NCT03040362|18594003|P1|STARTED|Overall Study||8
7554829|NCT03040336|18594017|P2|NOT COMPLETED|Overall Study||3
7554830|NCT03040336|18594018|P1|NOT COMPLETED|Overall Study||3
7554831|NCT03040336|18594017|P2|COMPLETED|Overall Study||4
7554832|NCT03040336|18594018|P1|COMPLETED|Overall Study||7
7554833|NCT03040336|18594017|P2|STARTED|Overall Study||7
7554834|NCT03040336|18594018|P1|STARTED|Overall Study||10
7554835|NCT03040323|18594050|P2|NOT COMPLETED|Overall Study||0
7554836|NCT03040323|18594051|P1|NOT COMPLETED|Overall Study||0
7554837|NCT03040323|18594050|P2|COMPLETED|Overall Study||0
7554838|NCT03040323|18594051|P1|COMPLETED|Overall Study||0
7554839|NCT03040323|18594050|P2|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
7554840|NCT03040323|18594051|P1|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
7554841|NCT03040011|18594062|P3|NOT COMPLETED|Primary Outcome Follow Up||1
7554842|NCT03040011|18594063|P2|NOT COMPLETED|Primary Outcome Follow Up||1
7554843|NCT03040011|18594064|P1|NOT COMPLETED|Primary Outcome Follow Up||4
7554844|NCT03040011|18594062|P3|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
7554845|NCT03040011|18594063|P2|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
7554846|NCT03040011|18594064|P1|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for four patients|21
7554847|NCT03040011|18594062|P3|STARTED|Primary Outcome Follow Up||25
7554848|NCT03040011|18594063|P2|STARTED|Primary Outcome Follow Up||25
7554849|NCT03040011|18594064|P1|STARTED|Primary Outcome Follow Up||25
7554850|NCT03040011|18594062|P3|NOT COMPLETED|Received Randomized Study Intervention||0
7554851|NCT03040011|18594063|P2|NOT COMPLETED|Received Randomized Study Intervention||0
7554852|NCT03040011|18594064|P1|NOT COMPLETED|Received Randomized Study Intervention||0
7554853|NCT03040011|18594062|P3|COMPLETED|Received Randomized Study Intervention||25
7554854|NCT03040011|18594063|P2|COMPLETED|Received Randomized Study Intervention||25
7554855|NCT03040011|18594064|P1|COMPLETED|Received Randomized Study Intervention||25
7554856|NCT03040011|18594062|P3|STARTED|Received Randomized Study Intervention||25
7554857|NCT03040011|18594063|P2|STARTED|Received Randomized Study Intervention||25
7554858|NCT03040011|18594064|P1|STARTED|Received Randomized Study Intervention||25
7554859|NCT03039738|18594131|P2|NOT COMPLETED|Overall Study||0
7554860|NCT03039738|18594132|P1|NOT COMPLETED|Overall Study||54
7554861|NCT03039738|18594131|P2|COMPLETED|Overall Study||0
7554862|NCT03039738|18594132|P1|COMPLETED|Overall Study||152
7554863|NCT03039738|18594131|P2|STARTED|Overall Study|This arm did not initiate. The study was terminated following the completion of the telemetry phase.|0
7554864|NCT03039738|18594132|P1|STARTED|Overall Study||206
7554865|NCT03039699|18594154|P2|NOT COMPLETED|Overall Study||35
7554866|NCT03039699|18594155|P1|NOT COMPLETED|Overall Study||22
7554867|NCT03039699|18594154|P2|COMPLETED|Overall Study||97
7554868|NCT03039699|18594155|P1|COMPLETED|Overall Study||105
7554869|NCT03039699|18594154|P2|STARTED|Overall Study||132
7554870|NCT03039699|18594155|P1|STARTED|Overall Study||127
7554871|NCT03039686|18594178|P3|NOT COMPLETED|Open Label Period||42
7554872|NCT03039686|18594179|P2|NOT COMPLETED|Open Label Period||38
7554873|NCT03039686|18594180|P1|NOT COMPLETED|Open Label Period||0
7554874|NCT03039686|18594178|P3|COMPLETED|Open Label Period||0
7554875|NCT03039686|18594179|P2|COMPLETED|Open Label Period||0
7554876|NCT03039686|18594180|P1|COMPLETED|Open Label Period||0
7554877|NCT03039686|18594178|P3|Completed DB, Did Not Start OL|Open Label Period||3
7554878|NCT03039686|18594179|P2|Completed DB, Did Not Start OL|Open Label Period||2
7554879|NCT03039686|18594180|P1|Completed DB, Did Not Start OL|Open Label Period||2
7554880|NCT03039686|18594178|P3|STARTED|Open Label Period|13 DB placebo participants switched to the RO High Dose for the open-label phase.|42
7554881|NCT03039686|18594179|P2|STARTED|Open Label Period|14 DB placebo participants switched to the RO Low Dose for the open-label phase.|38
7554882|NCT03039686|18594180|P1|STARTED|Open Label Period|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
7554883|NCT03039686|18594178|P3|NOT COMPLETED|Double-blind Period||23
7554884|NCT03039686|18594179|P2|NOT COMPLETED|Double-blind Period||29
7554885|NCT03039686|18594180|P1|NOT COMPLETED|Double-blind Period||27
7554886|NCT03039686|18594178|P3|COMPLETED|Double-blind Period||32
7554887|NCT03039686|18594179|P2|COMPLETED|Double-blind Period||26
7554888|NCT03039686|18594180|P1|COMPLETED|Double-blind Period||29
7554889|NCT03039686|18594178|P3|STARTED|Double-blind Period||55
7554890|NCT03039686|18594179|P2|STARTED|Double-blind Period||55
7554891|NCT03039686|18594180|P1|STARTED|Double-blind Period||56
7554892|NCT03039621|18594246|P2|NOT COMPLETED|Overall Study||16
7554893|NCT03039621|18594247|P1|NOT COMPLETED|Overall Study||12
7554894|NCT03039621|18594246|P2|COMPLETED|Overall Study||128
7554895|NCT03039621|18594247|P1|COMPLETED|Overall Study||131
7554896|NCT03039621|18594246|P2|STARTED|Overall Study||144
7554897|NCT03039621|18594247|P1|STARTED|Overall Study||143
7554898|NCT03039569|18594271|P2|NOT COMPLETED|Overall Study||4
7554899|NCT03039569|18594272|P1|NOT COMPLETED|Overall Study||5
7554900|NCT03039569|18594271|P2|COMPLETED|Overall Study||35
7554901|NCT03039569|18594272|P1|COMPLETED|Overall Study||35
7554902|NCT03039569|18594271|P2|STARTED|Overall Study||39
7554903|NCT03039569|18594272|P1|STARTED|Overall Study||40
7554904|NCT03039543|18594302|P2|NOT COMPLETED|Overall Study||3
7554905|NCT03039543|18594303|P1|NOT COMPLETED|Overall Study||1
7554906|NCT03039543|18594302|P2|COMPLETED|Overall Study||51
7554907|NCT03039543|18594303|P1|COMPLETED|Overall Study||53
7554908|NCT03039543|18594302|P2|STARTED|Overall Study||54
7554909|NCT03039543|18594303|P1|STARTED|Overall Study||54
7554910|NCT03039283|18594317|P1|NOT COMPLETED|Overall Study||2
7554911|NCT03039283|18594317|P1|COMPLETED|Overall Study||160
7554912|NCT03039283|18594317|P1|STARTED|Overall Study||162
7554913|NCT03039192|18594328|P2|NOT COMPLETED|Overall Study||30
7554914|NCT03039192|18594329|P1|NOT COMPLETED|Overall Study||32
7554915|NCT03039192|18594328|P2|COMPLETED|Overall Study||84
7554916|NCT03039192|18594329|P1|COMPLETED|Overall Study||80
7554917|NCT03039192|18594328|P2|Treated|Overall Study||113
7554918|NCT03039192|18594329|P1|Treated|Overall Study||112
7554919|NCT03039192|18594328|P2|STARTED|Overall Study||114
7554920|NCT03039192|18594329|P1|STARTED|Overall Study||112
7554921|NCT03039179|18594381|P2|NOT COMPLETED|Overall Study||0
7554922|NCT03039179|18594382|P1|NOT COMPLETED|Overall Study||0
7554923|NCT03039179|18594381|P2|COMPLETED|Overall Study||42
7554924|NCT03039179|18594382|P1|COMPLETED|Overall Study||38
7554925|NCT03039179|18594381|P2|STARTED|Overall Study||42
7554926|NCT03039179|18594382|P1|STARTED|Overall Study||38
7554927|NCT03039088|18594392|P2|NOT COMPLETED|Overall Study||0
7554928|NCT03039088|18594393|P1|NOT COMPLETED|Overall Study||0
7554929|NCT03039088|18594392|P2|COMPLETED|Overall Study||316
7554930|NCT03039088|18594393|P1|COMPLETED|Overall Study||192
7554931|NCT03039088|18594392|P2|STARTED|Overall Study||316
7554932|NCT03039088|18594393|P1|STARTED|Overall Study||192
7554933|NCT03038867|18594401|P2|NOT COMPLETED|Overall Study||0
7554934|NCT03038867|18594402|P1|NOT COMPLETED|Overall Study||0
7554935|NCT03038867|18594401|P2|COMPLETED|Overall Study||32
7554936|NCT03038867|18594402|P1|COMPLETED|Overall Study||37
7554937|NCT03038867|18594401|P2|STARTED|Overall Study||32
7554938|NCT03038867|18594402|P1|STARTED|Overall Study||37
7554939|NCT03038815|18594518|P2|NOT COMPLETED|Intervention 2, 1 Hour||0
7554940|NCT03038815|18594519|P1|NOT COMPLETED|Intervention 2, 1 Hour||0
7554941|NCT03038815|18594518|P2|COMPLETED|Intervention 2, 1 Hour||10
7554942|NCT03038815|18594519|P1|COMPLETED|Intervention 2, 1 Hour||10
7554943|NCT03038815|18594518|P2|STARTED|Intervention 2, 1 Hour||10
7554944|NCT03038815|18594519|P1|STARTED|Intervention 2, 1 Hour||10
7554945|NCT03038815|18594518|P2|NOT COMPLETED|Intervention 1, 1 Hour||0
7554946|NCT03038815|18594519|P1|NOT COMPLETED|Intervention 1, 1 Hour||0
7554947|NCT03038815|18594518|P2|COMPLETED|Intervention 1, 1 Hour||10
7554948|NCT03038815|18594519|P1|COMPLETED|Intervention 1, 1 Hour||10
7554949|NCT03038815|18594518|P2|STARTED|Intervention 1, 1 Hour||10
7554950|NCT03038815|18594519|P1|STARTED|Intervention 1, 1 Hour||10
7554951|NCT03038815|18594518|P2|NOT COMPLETED|Controll Condition, 1 Hour||0
7554952|NCT03038815|18594519|P1|NOT COMPLETED|Controll Condition, 1 Hour||0
7554953|NCT03038815|18594518|P2|COMPLETED|Controll Condition, 1 Hour||10
7554954|NCT03038815|18594519|P1|COMPLETED|Controll Condition, 1 Hour||10
7554955|NCT03038815|18594518|P2|STARTED|Controll Condition, 1 Hour||10
7554956|NCT03038815|18594519|P1|STARTED|Controll Condition, 1 Hour||10
7554957|NCT03038126|18594531|P2|NOT COMPLETED|Overall Study||4
7554958|NCT03038126|18594532|P1|NOT COMPLETED|Overall Study||9
7554959|NCT03038126|18594531|P2|COMPLETED|Overall Study||51
7554960|NCT03038126|18594532|P1|COMPLETED|Overall Study||54
7554961|NCT03038126|18594531|P2|STARTED|Overall Study||55
7554962|NCT03038126|18594532|P1|STARTED|Overall Study||63
7554963|NCT03038113|18594556|P14|NOT COMPLETED|Overall Study||1
7554964|NCT03038113|18594557|P13|NOT COMPLETED|Overall Study||0
7554965|NCT03038113|18594558|P12|NOT COMPLETED|Overall Study||0
7554966|NCT03038113|18594559|P11|NOT COMPLETED|Overall Study||0
7554967|NCT03038113|18594560|P10|NOT COMPLETED|Overall Study||0
7554968|NCT03038113|18594561|P9|NOT COMPLETED|Overall Study||0
7554969|NCT03038113|18594562|P8|NOT COMPLETED|Overall Study||0
7554970|NCT03038113|18594563|P7|NOT COMPLETED|Overall Study||1
7554971|NCT03038113|18594564|P6|NOT COMPLETED|Overall Study||0
7554972|NCT03038113|18594565|P5|NOT COMPLETED|Overall Study||0
7554973|NCT03038113|18594566|P4|NOT COMPLETED|Overall Study||0
7554974|NCT03038113|18594567|P3|NOT COMPLETED|Overall Study||1
7554975|NCT03038113|18594568|P2|NOT COMPLETED|Overall Study||0
7554976|NCT03038113|18594569|P1|NOT COMPLETED|Overall Study||0
7554977|NCT03038113|18594556|P14|COMPLETED|Overall Study||14
7554978|NCT03038113|18594557|P13|COMPLETED|Overall Study||4
7554979|NCT03038113|18594558|P12|COMPLETED|Overall Study||7
7554980|NCT03038113|18594559|P11|COMPLETED|Overall Study||14
7554981|NCT03038113|18594560|P10|COMPLETED|Overall Study||6
7554982|NCT03038113|18594561|P9|COMPLETED|Overall Study||7
7554983|NCT03038113|18594562|P8|COMPLETED|Overall Study||6
7554984|NCT03038113|18594563|P7|COMPLETED|Overall Study||11
7554985|NCT03038113|18594564|P6|COMPLETED|Overall Study||8
7554986|NCT03038113|18594565|P5|COMPLETED|Overall Study||8
7554987|NCT03038113|18594566|P4|COMPLETED|Overall Study||8
7554988|NCT03038113|18594567|P3|COMPLETED|Overall Study||7
7554989|NCT03038113|18594568|P2|COMPLETED|Overall Study||8
7554990|NCT03038113|18594569|P1|COMPLETED|Overall Study||8
7554991|NCT03038113|18594556|P14|STARTED|Overall Study||15
7554992|NCT03038113|18594557|P13|STARTED|Overall Study||4
7554993|NCT03038113|18594558|P12|STARTED|Overall Study||7
7554994|NCT03038113|18594559|P11|STARTED|Overall Study||14
7554995|NCT03038113|18594560|P10|STARTED|Overall Study||6
7554996|NCT03038113|18594561|P9|STARTED|Overall Study||7
7554997|NCT03038113|18594562|P8|STARTED|Overall Study||6
7554998|NCT03038113|18594563|P7|STARTED|Overall Study||12
7554999|NCT03038113|18594564|P6|STARTED|Overall Study||8
7555000|NCT03038113|18594565|P5|STARTED|Overall Study||8
7555001|NCT03038113|18594566|P4|STARTED|Overall Study||8
7555002|NCT03038113|18594567|P3|STARTED|Overall Study||8
7555003|NCT03038113|18594568|P2|STARTED|Overall Study||8
7555004|NCT03038113|18594569|P1|STARTED|Overall Study||8
7555005|NCT03037983|18594780|P2|NOT COMPLETED|Overall Study||0
7555006|NCT03037983|18594781|P1|NOT COMPLETED|Overall Study||0
7555007|NCT03037983|18594780|P2|COMPLETED|Overall Study||4
7555008|NCT03037983|18594781|P1|COMPLETED|Overall Study||5
7555009|NCT03037983|18594780|P2|STARTED|Overall Study||4
7555010|NCT03037983|18594781|P1|STARTED|Overall Study||5
7555011|NCT03037905|18594795|P2|NOT COMPLETED|Overall Study||0
7555012|NCT03037905|18594796|P1|NOT COMPLETED|Overall Study||0
7555013|NCT03037905|18594795|P2|COMPLETED|Overall Study||50
7555014|NCT03037905|18594796|P1|COMPLETED|Overall Study||50
7555015|NCT03037905|18594795|P2|STARTED|Overall Study||50
7555016|NCT03037905|18594796|P1|STARTED|Overall Study||50
7555017|NCT03037619|18594810|P2|NOT COMPLETED|Overall Study||1
7555018|NCT03037619|18594811|P1|NOT COMPLETED|Overall Study||0
7555019|NCT03037619|18594810|P2|COMPLETED|Overall Study|7 participants and 7 buddies|14
7555020|NCT03037619|18594811|P1|COMPLETED|Overall Study||8
7555021|NCT03037619|18594810|P2|STARTED|Overall Study|8 participants and 7 buddies|15
7555022|NCT03037619|18594811|P1|STARTED|Overall Study||8
7555023|NCT03037580|18594825|P2|NOT COMPLETED|Overall Study||16
7555024|NCT03037580|18594826|P1|NOT COMPLETED|Overall Study||16
7555025|NCT03037580|18594825|P2|COMPLETED|Overall Study||27
7555026|NCT03037580|18594826|P1|COMPLETED|Overall Study||25
7555027|NCT03037580|18594825|P2|STARTED|Overall Study||43
7555028|NCT03037580|18594826|P1|STARTED|Overall Study||41
7555029|NCT03037541|18594840|P2|NOT COMPLETED|Overall Study||0
7555030|NCT03037541|18594841|P1|NOT COMPLETED|Overall Study||0
7555031|NCT03037541|18594840|P2|COMPLETED|Overall Study||30
7555032|NCT03037541|18594841|P1|COMPLETED|Overall Study||30
7555033|NCT03037541|18594840|P2|STARTED|Overall Study||30
7555034|NCT03037541|18594841|P1|STARTED|Overall Study||30
7555035|NCT03037489|18594851|P2|NOT COMPLETED|Overall Study||0
7555036|NCT03037489|18594852|P1|NOT COMPLETED|Overall Study||7
7555037|NCT03037489|18594851|P2|COMPLETED|Overall Study||4
7555038|NCT03037489|18594852|P1|COMPLETED|Overall Study||39
7555039|NCT03037489|18594851|P2|STARTED|Overall Study||4
7555040|NCT03037489|18594852|P1|STARTED|Overall Study||46
7555041|NCT03037307|18594858|P6|NOT COMPLETED|Period 3||0
7555042|NCT03037307|18594859|P5|NOT COMPLETED|Period 3||0
7555043|NCT03037307|18594860|P4|NOT COMPLETED|Period 3||0
7555044|NCT03037307|18594861|P3|NOT COMPLETED|Period 3||0
7555045|NCT03037307|18594862|P2|NOT COMPLETED|Period 3||0
7555046|NCT03037307|18594863|P1|NOT COMPLETED|Period 3||0
7555047|NCT03037307|18594858|P6|COMPLETED|Period 3||8
7555048|NCT03037307|18594859|P5|COMPLETED|Period 3||7
7555049|NCT03037307|18594860|P4|COMPLETED|Period 3||6
7555050|NCT03037307|18594861|P3|COMPLETED|Period 3||8
7555051|NCT03037307|18594862|P2|COMPLETED|Period 3||7
7555052|NCT03037307|18594863|P1|COMPLETED|Period 3||7
7555053|NCT03037307|18594858|P6|STARTED|Period 3||8
7555054|NCT03037307|18594859|P5|STARTED|Period 3||7
7555055|NCT03037307|18594860|P4|STARTED|Period 3||6
7555056|NCT03037307|18594861|P3|STARTED|Period 3||8
7555057|NCT03037307|18594862|P2|STARTED|Period 3||7
7555058|NCT03037307|18594863|P1|STARTED|Period 3||7
7555059|NCT03037307|18594858|P6|NOT COMPLETED|Wash Out Period 2||0
7555060|NCT03037307|18594859|P5|NOT COMPLETED|Wash Out Period 2||0
7555061|NCT03037307|18594860|P4|NOT COMPLETED|Wash Out Period 2||0
7555062|NCT03037307|18594861|P3|NOT COMPLETED|Wash Out Period 2||0
7555063|NCT03037307|18594862|P2|NOT COMPLETED|Wash Out Period 2||0
7555064|NCT03037307|18594863|P1|NOT COMPLETED|Wash Out Period 2||0
7555065|NCT03037307|18594858|P6|COMPLETED|Wash Out Period 2||8
7555066|NCT03037307|18594859|P5|COMPLETED|Wash Out Period 2||7
7555067|NCT03037307|18594860|P4|COMPLETED|Wash Out Period 2||6
7555068|NCT03037307|18594861|P3|COMPLETED|Wash Out Period 2||8
7555069|NCT03037307|18594862|P2|COMPLETED|Wash Out Period 2||7
7555070|NCT03037307|18594863|P1|COMPLETED|Wash Out Period 2||7
7555071|NCT03037307|18594858|P6|STARTED|Wash Out Period 2||8
7555072|NCT03037307|18594859|P5|STARTED|Wash Out Period 2||7
7555073|NCT03037307|18594860|P4|STARTED|Wash Out Period 2||6
7555074|NCT03037307|18594861|P3|STARTED|Wash Out Period 2||8
7555075|NCT03037307|18594862|P2|STARTED|Wash Out Period 2||7
7555076|NCT03037307|18594863|P1|STARTED|Wash Out Period 2||7
7555077|NCT03037307|18594858|P6|NOT COMPLETED|Period 2||0
7555078|NCT03037307|18594859|P5|NOT COMPLETED|Period 2||0
7555079|NCT03037307|18594860|P4|NOT COMPLETED|Period 2||0
7555080|NCT03037307|18594861|P3|NOT COMPLETED|Period 2||0
7555081|NCT03037307|18594862|P2|NOT COMPLETED|Period 2||0
7555082|NCT03037307|18594863|P1|NOT COMPLETED|Period 2||0
7555083|NCT03037307|18594858|P6|COMPLETED|Period 2||8
7555084|NCT03037307|18594859|P5|COMPLETED|Period 2||7
7555085|NCT03037307|18594860|P4|COMPLETED|Period 2||6
7555086|NCT03037307|18594861|P3|COMPLETED|Period 2||8
7555087|NCT03037307|18594862|P2|COMPLETED|Period 2||7
7555088|NCT03037307|18594863|P1|COMPLETED|Period 2||7
7555089|NCT03037307|18594858|P6|STARTED|Period 2||8
7555090|NCT03037307|18594859|P5|STARTED|Period 2||7
7555091|NCT03037307|18594860|P4|STARTED|Period 2||6
7555092|NCT03037307|18594861|P3|STARTED|Period 2||8
7555093|NCT03037307|18594862|P2|STARTED|Period 2||7
7555094|NCT03037307|18594863|P1|STARTED|Period 2||7
7555095|NCT03037307|18594858|P6|NOT COMPLETED|Wash Out Period 1||0
7555096|NCT03037307|18594859|P5|NOT COMPLETED|Wash Out Period 1||0
7555097|NCT03037307|18594860|P4|NOT COMPLETED|Wash Out Period 1||0
7555098|NCT03037307|18594861|P3|NOT COMPLETED|Wash Out Period 1||0
7555099|NCT03037307|18594862|P2|NOT COMPLETED|Wash Out Period 1||0
7555100|NCT03037307|18594863|P1|NOT COMPLETED|Wash Out Period 1||0
7555101|NCT03037307|18594858|P6|COMPLETED|Wash Out Period 1||8
7555102|NCT03037307|18594859|P5|COMPLETED|Wash Out Period 1||7
7555103|NCT03037307|18594860|P4|COMPLETED|Wash Out Period 1||6
7555104|NCT03037307|18594861|P3|COMPLETED|Wash Out Period 1||8
7555105|NCT03037307|18594862|P2|COMPLETED|Wash Out Period 1||7
7555106|NCT03037307|18594863|P1|COMPLETED|Wash Out Period 1||7
7555107|NCT03037307|18594858|P6|STARTED|Wash Out Period 1||8
7555108|NCT03037307|18594859|P5|STARTED|Wash Out Period 1||7
7555109|NCT03037307|18594860|P4|STARTED|Wash Out Period 1||6
7555110|NCT03037307|18594861|P3|STARTED|Wash Out Period 1||8
7555111|NCT03037307|18594862|P2|STARTED|Wash Out Period 1||7
7555112|NCT03037307|18594863|P1|STARTED|Wash Out Period 1||7
7555113|NCT03037307|18594858|P6|NOT COMPLETED|Period 1||0
7555114|NCT03037307|18594859|P5|NOT COMPLETED|Period 1||0
7555115|NCT03037307|18594860|P4|NOT COMPLETED|Period 1||1
7555116|NCT03037307|18594861|P3|NOT COMPLETED|Period 1||0
7555117|NCT03037307|18594862|P2|NOT COMPLETED|Period 1||0
7555118|NCT03037307|18594863|P1|NOT COMPLETED|Period 1||0
7555119|NCT03037307|18594858|P6|COMPLETED|Period 1||8
7555120|NCT03037307|18594859|P5|COMPLETED|Period 1||7
7555121|NCT03037307|18594860|P4|COMPLETED|Period 1||6
7555122|NCT03037307|18594861|P3|COMPLETED|Period 1||8
7555123|NCT03037307|18594862|P2|COMPLETED|Period 1||7
7555124|NCT03037307|18594863|P1|COMPLETED|Period 1||7
7555125|NCT03037307|18594858|P6|STARTED|Period 1||8
7555126|NCT03037307|18594859|P5|STARTED|Period 1||7
7555127|NCT03037307|18594860|P4|STARTED|Period 1||7
7555128|NCT03037307|18594861|P3|STARTED|Period 1||8
7555129|NCT03037307|18594862|P2|STARTED|Period 1||7
7555130|NCT03037307|18594863|P1|STARTED|Period 1||7
7555131|NCT03037203|18594876|P3|NOT COMPLETED|Overall Study||1
7555132|NCT03037203|18594877|P2|NOT COMPLETED|Overall Study||2
7555133|NCT03037203|18594878|P1|NOT COMPLETED|Overall Study||1
7555134|NCT03037203|18594876|P3|COMPLETED|Overall Study||9
7555135|NCT03037203|18594877|P2|COMPLETED|Overall Study||26
7555136|NCT03037203|18594878|P1|COMPLETED|Overall Study||27
7555137|NCT03037203|18594876|P3|STARTED|Overall Study||10
7555138|NCT03037203|18594877|P2|STARTED|Overall Study||28
7555139|NCT03037203|18594878|P1|STARTED|Overall Study||28
7555140|NCT03036852|18594902|P1|NOT COMPLETED|Overall Study||6
7555141|NCT03036852|18594902|P1|COMPLETED|Overall Study||53
7555142|NCT03036852|18594902|P1|STARTED|Overall Study||59
7555143|NCT03036839|18594959|P3|NOT COMPLETED|Overall Study||5
7555144|NCT03036839|18594960|P2|NOT COMPLETED|Overall Study||0
7555145|NCT03036839|18594961|P1|NOT COMPLETED|Overall Study||3
7555146|NCT03036839|18594959|P3|COMPLETED|Overall Study||14
7555147|NCT03036839|18594960|P2|COMPLETED|Overall Study||31
7555148|NCT03036839|18594961|P1|COMPLETED|Overall Study||42
7555149|NCT03036839|18594959|P3|STARTED|Overall Study||19
7555150|NCT03036839|18594960|P2|STARTED|Overall Study||31
7555151|NCT03036839|18594961|P1|STARTED|Overall Study||45
7555152|NCT03036735|18595011|P1|NOT COMPLETED|Overall Study||10
7555153|NCT03036735|18595011|P1|COMPLETED|Overall Study||0
7555154|NCT03036735|18595011|P1|STARTED|Overall Study||10
7555155|NCT03036384|18595019|P10|NOT COMPLETED|Overall Study||0
7555156|NCT03036384|18595020|P9|NOT COMPLETED|Overall Study||0
7555157|NCT03036384|18595021|P8|NOT COMPLETED|Overall Study||0
7555158|NCT03036384|18595022|P7|NOT COMPLETED|Overall Study||0
7555159|NCT03036384|18595023|P6|NOT COMPLETED|Overall Study||0
7555160|NCT03036384|18595024|P5|NOT COMPLETED|Overall Study||0
7555161|NCT03036384|18595025|P4|NOT COMPLETED|Overall Study||0
7555162|NCT03036384|18595026|P3|NOT COMPLETED|Overall Study||0
7555163|NCT03036384|18595027|P2|NOT COMPLETED|Overall Study||0
7555164|NCT03036384|18595028|P1|NOT COMPLETED|Overall Study||0
7555165|NCT03036384|18595019|P10|COMPLETED|Overall Study||4
7555166|NCT03036384|18595020|P9|COMPLETED|Overall Study||4
7555167|NCT03036384|18595021|P8|COMPLETED|Overall Study||4
7555168|NCT03036384|18595022|P7|COMPLETED|Overall Study||4
7555169|NCT03036384|18595023|P6|COMPLETED|Overall Study||4
7555170|NCT03036384|18595024|P5|COMPLETED|Overall Study||4
7555171|NCT03036384|18595025|P4|COMPLETED|Overall Study||4
7555172|NCT03036384|18595026|P3|COMPLETED|Overall Study||4
7555173|NCT03036384|18595027|P2|COMPLETED|Overall Study||4
7555174|NCT03036384|18595028|P1|COMPLETED|Overall Study||4
7555175|NCT03036384|18595019|P10|STARTED|Overall Study||4
7555176|NCT03036384|18595020|P9|STARTED|Overall Study||4
7555177|NCT03036384|18595021|P8|STARTED|Overall Study||4
7555178|NCT03036384|18595022|P7|STARTED|Overall Study||4
7555179|NCT03036384|18595023|P6|STARTED|Overall Study||4
7555180|NCT03036384|18595024|P5|STARTED|Overall Study||4
7555181|NCT03036384|18595025|P4|STARTED|Overall Study||4
7555182|NCT03036384|18595026|P3|STARTED|Overall Study||4
7555183|NCT03036384|18595027|P2|STARTED|Overall Study||4
7555184|NCT03036384|18595028|P1|STARTED|Overall Study||4
7555185|NCT03036293|18595074|P4|NOT COMPLETED|Overall Study||1
7555186|NCT03036293|18595075|P3|NOT COMPLETED|Overall Study||1
7555187|NCT03036293|18595076|P2|NOT COMPLETED|Overall Study||3
7555188|NCT03036293|18595077|P1|NOT COMPLETED|Overall Study||1
7555189|NCT03036293|18595074|P4|COMPLETED|Overall Study||64
7555190|NCT03036293|18595075|P3|COMPLETED|Overall Study||130
7555191|NCT03036293|18595076|P2|COMPLETED|Overall Study||64
7555192|NCT03036293|18595077|P1|COMPLETED|Overall Study||126
7555193|NCT03036293|18595074|P4|STARTED|Overall Study||65
7555194|NCT03036293|18595075|P3|STARTED|Overall Study||131
7555195|NCT03036293|18595076|P2|STARTED|Overall Study||67
7555196|NCT03036293|18595077|P1|STARTED|Overall Study||127
7555197|NCT03036215|18595105|P2|NOT COMPLETED|Overall Study||3
7555198|NCT03036215|18595106|P1|NOT COMPLETED|Overall Study||2
7555199|NCT03036215|18595105|P2|COMPLETED|Overall Study||36
7555200|NCT03036215|18595106|P1|COMPLETED|Overall Study||39
7555201|NCT03036215|18595105|P2|STARTED|Overall Study||39
7555202|NCT03036215|18595106|P1|STARTED|Overall Study||41
7555203|NCT03036163|18595123|P7|NOT COMPLETED|Overall Study||0
7555204|NCT03036163|18595124|P6|NOT COMPLETED|Overall Study||0
7555205|NCT03036163|18595125|P5|NOT COMPLETED|Overall Study||0
7555206|NCT03036163|18595126|P4|NOT COMPLETED|Overall Study||0
7555207|NCT03036163|18595127|P3|NOT COMPLETED|Overall Study||0
7555208|NCT03036163|18595128|P2|NOT COMPLETED|Overall Study||0
7555209|NCT03036163|18595129|P1|NOT COMPLETED|Overall Study||0
7555210|NCT03036163|18595123|P7|COMPLETED|Overall Study||5
7555211|NCT03036163|18595124|P6|COMPLETED|Overall Study||5
7555212|NCT03036163|18595125|P5|COMPLETED|Overall Study||6
7555213|NCT03036163|18595126|P4|COMPLETED|Overall Study||6
7555214|NCT03036163|18595127|P3|COMPLETED|Overall Study||6
7555215|NCT03036163|18595128|P2|COMPLETED|Overall Study||6
7555216|NCT03036163|18595129|P1|COMPLETED|Overall Study||6
7555217|NCT03036163|18595123|P7|STARTED|Overall Study||5
7555218|NCT03036163|18595124|P6|STARTED|Overall Study||5
7555219|NCT03036163|18595125|P5|STARTED|Overall Study||6
7555220|NCT03036163|18595126|P4|STARTED|Overall Study||6
7555221|NCT03036163|18595127|P3|STARTED|Overall Study||6
7555222|NCT03036163|18595128|P2|STARTED|Overall Study||6
7555223|NCT03036163|18595129|P1|STARTED|Overall Study||6
7555224|NCT03036124|18595220|P2|NOT COMPLETED|Overall Study||6
7555225|NCT03036124|18595221|P1|NOT COMPLETED|Overall Study||5
7555226|NCT03036124|18595220|P2|COMPLETED|Overall Study||2365
7555227|NCT03036124|18595221|P1|COMPLETED|Overall Study||2368
7555228|NCT03036124|18595220|P2|STARTED|Overall Study||2371
7555229|NCT03036124|18595221|P1|STARTED|Overall Study||2373
7555230|NCT03036072|18595239|P2|NOT COMPLETED|Overall Study||3
7555231|NCT03036072|18595240|P1|NOT COMPLETED|Overall Study||0
7555232|NCT03036072|18595239|P2|COMPLETED|Overall Study||10
7555233|NCT03036072|18595240|P1|COMPLETED|Overall Study||12
7555234|NCT03036072|18595239|P2|STARTED|Overall Study||13
7555235|NCT03036072|18595240|P1|STARTED|Overall Study||12
7555236|NCT03035955|18595250|P2|NOT COMPLETED|Overall Study||1
7555237|NCT03035955|18595251|P1|NOT COMPLETED|Overall Study||1
7555238|NCT03035955|18595250|P2|COMPLETED|Overall Study||9
7555239|NCT03035955|18595251|P1|COMPLETED|Overall Study||9
7555240|NCT03035955|18595250|P2|STARTED|Overall Study||10
7555241|NCT03035955|18595251|P1|STARTED|Overall Study||10
7555242|NCT03035942|18595260|P3|NOT COMPLETED|Overall Study||5
7555243|NCT03035942|18595261|P2|NOT COMPLETED|Overall Study||4
7555244|NCT03035942|18595262|P1|NOT COMPLETED|Overall Study||8
7555245|NCT03035942|18595260|P3|COMPLETED|Overall Study||40
7555246|NCT03035942|18595261|P2|COMPLETED|Overall Study||41
7555247|NCT03035942|18595262|P1|COMPLETED|Overall Study||37
7555248|NCT03035942|18595260|P3|STARTED|Overall Study||45
7555249|NCT03035942|18595261|P2|STARTED|Overall Study||45
7555250|NCT03035942|18595262|P1|STARTED|Overall Study||45
7555251|NCT03035929|18595279|P1|NOT COMPLETED|Overall Study||0
7555252|NCT03035929|18595279|P1|COMPLETED|Overall Study||10
7555253|NCT03035929|18595279|P1|STARTED|Overall Study||10
7555254|NCT03035916|18595291|P3|NOT COMPLETED|Overall Study||0
7555255|NCT03035916|18595292|P2|NOT COMPLETED|Overall Study||2
7555256|NCT03035916|18595293|P1|NOT COMPLETED|Overall Study||0
7555257|NCT03035916|18595291|P3|COMPLETED|Overall Study||31
7555258|NCT03035916|18595292|P2|COMPLETED|Overall Study||28
7555259|NCT03035916|18595293|P1|COMPLETED|Overall Study||30
7555260|NCT03035916|18595291|P3|STARTED|Overall Study||31
7555261|NCT03035916|18595292|P2|STARTED|Overall Study||30
7555262|NCT03035916|18595293|P1|STARTED|Overall Study||30
7555263|NCT03035864|18595342|P2|NOT COMPLETED|Follow-up Period||4
7555264|NCT03035864|18595343|P1|NOT COMPLETED|Follow-up Period||11
7555265|NCT03035864|18595342|P2|COMPLETED|Follow-up Period||55
7555266|NCT03035864|18595343|P1|COMPLETED|Follow-up Period||105
7555267|NCT03035864|18595342|P2|STARTED|Follow-up Period||59
7555268|NCT03035864|18595343|P1|STARTED|Follow-up Period||116
7555269|NCT03035864|18595342|P2|NOT COMPLETED|Treatment Period||1
7555270|NCT03035864|18595343|P1|NOT COMPLETED|Treatment Period||4
7555271|NCT03035864|18595342|P2|COMPLETED|Treatment Period||59
7555272|NCT03035864|18595343|P1|COMPLETED|Treatment Period||116
7555273|NCT03035864|18595342|P2|STARTED|Treatment Period||60
7555274|NCT03035864|18595343|P1|STARTED|Treatment Period||120
7555275|NCT03035760|18595364|P5|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
7555276|NCT03035760|18595365|P4|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
7555277|NCT03035760|18595366|P3|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
7555278|NCT03035760|18595367|P2|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
7555279|NCT03035760|18595368|P1|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
7555280|NCT03035760|18595364|P5|COMPLETED|Second Intervention - 7 Days Follow-up||6
7555281|NCT03035760|18595365|P4|COMPLETED|Second Intervention - 7 Days Follow-up||6
7555282|NCT03035760|18595366|P3|COMPLETED|Second Intervention - 7 Days Follow-up||0
7555283|NCT03035760|18595367|P2|COMPLETED|Second Intervention - 7 Days Follow-up||0
7555284|NCT03035760|18595368|P1|COMPLETED|Second Intervention - 7 Days Follow-up||0
7555285|NCT03035760|18595364|P5|STARTED|Second Intervention - 7 Days Follow-up||6
7555286|NCT03035760|18595365|P4|STARTED|Second Intervention - 7 Days Follow-up||6
7555287|NCT03035760|18595366|P3|STARTED|Second Intervention - 7 Days Follow-up||0
7555288|NCT03035760|18595367|P2|STARTED|Second Intervention - 7 Days Follow-up||0
7555289|NCT03035760|18595368|P1|STARTED|Second Intervention - 7 Days Follow-up||0
7555290|NCT03035760|18595364|P5|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
7555291|NCT03035760|18595365|P4|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
7555292|NCT03035760|18595366|P3|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
7555293|NCT03035760|18595367|P2|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
7555294|NCT03035760|18595368|P1|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
7555295|NCT03035760|18595364|P5|COMPLETED|First Intervention - 10/7 Days Follow-up||6
7555296|NCT03035760|18595365|P4|COMPLETED|First Intervention - 10/7 Days Follow-up||6
7555297|NCT03035760|18595366|P3|COMPLETED|First Intervention - 10/7 Days Follow-up||8
7555298|NCT03035760|18595367|P2|COMPLETED|First Intervention - 10/7 Days Follow-up||8
7555299|NCT03035760|18595368|P1|COMPLETED|First Intervention - 10/7 Days Follow-up||8
7555300|NCT03035760|18595364|P5|STARTED|First Intervention - 10/7 Days Follow-up||6
7555301|NCT03035760|18595365|P4|STARTED|First Intervention - 10/7 Days Follow-up||6
7555302|NCT03035760|18595366|P3|STARTED|First Intervention - 10/7 Days Follow-up||8
7555303|NCT03035760|18595367|P2|STARTED|First Intervention - 10/7 Days Follow-up||8
7555304|NCT03035760|18595368|P1|STARTED|First Intervention - 10/7 Days Follow-up||8
7555305|NCT03035708|18595398|P2|NOT COMPLETED|Overall Study||11
7555306|NCT03035708|18595399|P1|NOT COMPLETED|Overall Study||4
7555307|NCT03035708|18595398|P2|COMPLETED|Overall Study||13
7555308|NCT03035708|18595399|P1|COMPLETED|Overall Study||19
7555309|NCT03035708|18595398|P2|STARTED|Overall Study||24
7555310|NCT03035708|18595399|P1|STARTED|Overall Study||23
7555311|NCT03035487|18595413|P1|NOT COMPLETED|Overall Study||0
7555312|NCT03035487|18595413|P1|COMPLETED|Overall Study||9
7555313|NCT03035487|18595413|P1|STARTED|Overall Study||9
7555314|NCT03035032|18595417|P1|NOT COMPLETED|Overall Study||43
7555315|NCT03035032|18595417|P1|COMPLETED|Overall Study||64
7555316|NCT03035032|18595417|P1|STARTED|Overall Study||107
7555317|NCT03034967|18595438|P6|NOT COMPLETED|Overall Study||15
7555318|NCT03034967|18595439|P5|NOT COMPLETED|Overall Study||14
7555319|NCT03034967|18595440|P4|NOT COMPLETED|Overall Study||11
7555320|NCT03034967|18595441|P3|NOT COMPLETED|Overall Study||13
7555321|NCT03034967|18595442|P2|NOT COMPLETED|Overall Study||5
7555322|NCT03034967|18595443|P1|NOT COMPLETED|Overall Study||14
7555323|NCT03034967|18595438|P6|COMPLETED|Overall Study||87
7555324|NCT03034967|18595439|P5|COMPLETED|Overall Study||88
7555325|NCT03034967|18595440|P4|COMPLETED|Overall Study||92
7555326|NCT03034967|18595441|P3|COMPLETED|Overall Study||90
7555327|NCT03034967|18595442|P2|COMPLETED|Overall Study||97
7555328|NCT03034967|18595443|P1|COMPLETED|Overall Study||88
7555329|NCT03034967|18595438|P6|STARTED|Overall Study||102
7555330|NCT03034967|18595439|P5|STARTED|Overall Study||102
7555331|NCT03034967|18595440|P4|STARTED|Overall Study||103
7555332|NCT03034967|18595441|P3|STARTED|Overall Study||103
7555333|NCT03034967|18595442|P2|STARTED|Overall Study||102
7555334|NCT03034967|18595443|P1|STARTED|Overall Study||102
7555335|NCT03034954|18595641|P2|NOT COMPLETED|Overall Study||0
7555336|NCT03034954|18595642|P1|NOT COMPLETED|Overall Study||1
7555337|NCT03034954|18595641|P2|COMPLETED|Overall Study||21
7555338|NCT03034954|18595642|P1|COMPLETED|Overall Study||20
7555339|NCT03034954|18595641|P2|STARTED|Overall Study||21
7555340|NCT03034954|18595642|P1|STARTED|Overall Study||21
7555341|NCT03034928|18595694|P4|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
7555342|NCT03034928|18595695|P3|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
7555343|NCT03034928|18595696|P2|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
7555344|NCT03034928|18595697|P1|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
7555345|NCT03034928|18595694|P4|COMPLETED|Period 2, Second 2 Hours of Wear||8
7555346|NCT03034928|18595695|P3|COMPLETED|Period 2, Second 2 Hours of Wear||9
7555347|NCT03034928|18595696|P2|COMPLETED|Period 2, Second 2 Hours of Wear||8
7555348|NCT03034928|18595697|P1|COMPLETED|Period 2, Second 2 Hours of Wear||8
7555349|NCT03034928|18595694|P4|STARTED|Period 2, Second 2 Hours of Wear||8
7555350|NCT03034928|18595695|P3|STARTED|Period 2, Second 2 Hours of Wear||9
7555351|NCT03034928|18595696|P2|STARTED|Period 2, Second 2 Hours of Wear||8
7555352|NCT03034928|18595697|P1|STARTED|Period 2, Second 2 Hours of Wear||8
7555353|NCT03034928|18595694|P4|NOT COMPLETED|Washout Period Between Lens Wear||0
7555354|NCT03034928|18595695|P3|NOT COMPLETED|Washout Period Between Lens Wear||0
7555355|NCT03034928|18595696|P2|NOT COMPLETED|Washout Period Between Lens Wear||0
7555356|NCT03034928|18595697|P1|NOT COMPLETED|Washout Period Between Lens Wear||0
7555357|NCT03034928|18595694|P4|COMPLETED|Washout Period Between Lens Wear||8
7555358|NCT03034928|18595695|P3|COMPLETED|Washout Period Between Lens Wear||9
7555359|NCT03034928|18595696|P2|COMPLETED|Washout Period Between Lens Wear||8
7555360|NCT03034928|18595697|P1|COMPLETED|Washout Period Between Lens Wear||8
7555361|NCT03034928|18595694|P4|STARTED|Washout Period Between Lens Wear||8
7555362|NCT03034928|18595695|P3|STARTED|Washout Period Between Lens Wear||9
7555363|NCT03034928|18595696|P2|STARTED|Washout Period Between Lens Wear||8
7555364|NCT03034928|18595697|P1|STARTED|Washout Period Between Lens Wear||8
7555365|NCT03034928|18595694|P4|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
7555366|NCT03034928|18595695|P3|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
7555367|NCT03034928|18595696|P2|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
7555368|NCT03034928|18595697|P1|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
7555369|NCT03034928|18595694|P4|COMPLETED|Period 1, First 2 Hours of Wear||8
7555370|NCT03034928|18595695|P3|COMPLETED|Period 1, First 2 Hours of Wear||9
7555371|NCT03034928|18595696|P2|COMPLETED|Period 1, First 2 Hours of Wear||8
7555372|NCT03034928|18595697|P1|COMPLETED|Period 1, First 2 Hours of Wear||8
7555373|NCT03034928|18595694|P4|STARTED|Period 1, First 2 Hours of Wear||8
7555374|NCT03034928|18595695|P3|STARTED|Period 1, First 2 Hours of Wear||9
7555375|NCT03034928|18595696|P2|STARTED|Period 1, First 2 Hours of Wear||8
7555376|NCT03034928|18595697|P1|STARTED|Period 1, First 2 Hours of Wear||8
7555377|NCT03034915|18595709|P3|NOT COMPLETED|Overall Study||126
7555378|NCT03034915|18595710|P2|NOT COMPLETED|Overall Study||154
7555379|NCT03034915|18595711|P1|NOT COMPLETED|Overall Study||95
7555380|NCT03034915|18595709|P3|COMPLETED|Overall Study||683
7555381|NCT03034915|18595710|P2|COMPLETED|Overall Study||650
7555382|NCT03034915|18595711|P1|COMPLETED|Overall Study||717
7555383|NCT03034915|18595709|P3|STARTED|Overall Study||809
7555384|NCT03034915|18595710|P2|STARTED|Overall Study||804
7555385|NCT03034915|18595711|P1|STARTED|Overall Study||812
7555386|NCT03034772|18595751|P2|NOT COMPLETED|Overall Study||2
7555387|NCT03034772|18595752|P1|NOT COMPLETED|Overall Study||0
7555388|NCT03034772|18595751|P2|COMPLETED|Overall Study||23
7555389|NCT03034772|18595752|P1|COMPLETED|Overall Study||27
7555390|NCT03034772|18595751|P2|STARTED|Overall Study||25
7555391|NCT03034772|18595752|P1|STARTED|Overall Study||27
7555392|NCT03034577|18595768|P2|NOT COMPLETED|Overall Study||35
7555393|NCT03034577|18595769|P1|NOT COMPLETED|Overall Study||31
7555394|NCT03034577|18595768|P2|COMPLETED|Overall Study||140
7555395|NCT03034577|18595769|P1|COMPLETED|Overall Study||144
7555396|NCT03034577|18595768|P2|STARTED|Overall Study||175
7555397|NCT03034577|18595769|P1|STARTED|Overall Study||175
7555398|NCT03034460|18595787|P2|NOT COMPLETED|Overall Study||3
7555399|NCT03034460|18595788|P1|NOT COMPLETED|Overall Study||3
7555400|NCT03034460|18595787|P2|COMPLETED|Overall Study||19
7555401|NCT03034460|18595788|P1|COMPLETED|Overall Study||45
7555402|NCT03034460|18595787|P2|STARTED|Overall Study||22
7555403|NCT03034460|18595788|P1|STARTED|Overall Study||48
7555404|NCT03034057|18595830|P1|NOT COMPLETED|Overall Study||55
7555405|NCT03034057|18595830|P1|COMPLETED|Overall Study||114
7555406|NCT03034057|18595830|P1|STARTED|Overall Study||169
7555407|NCT03034044|18595836|P1|NOT COMPLETED|Overall Study||1
7555408|NCT03034044|18595836|P1|COMPLETED|Overall Study||105
7555409|NCT03034044|18595836|P1|Received Xyntha|Overall Study||105
7555410|NCT03034044|18595836|P1|STARTED|Overall Study||106
7555411|NCT03033745|18595859|P3|NOT COMPLETED|Overall Study||2
7555412|NCT03033745|18595860|P2|NOT COMPLETED|Overall Study||1
7555413|NCT03033745|18595861|P1|NOT COMPLETED|Overall Study||1
7555414|NCT03033745|18595859|P3|COMPLETED|Overall Study||14
7555415|NCT03033745|18595860|P2|COMPLETED|Overall Study||17
7555416|NCT03033745|18595861|P1|COMPLETED|Overall Study||14
7555417|NCT03033745|18595859|P3|STARTED|Overall Study||16
7555418|NCT03033745|18595860|P2|STARTED|Overall Study||18
7555419|NCT03033745|18595861|P1|STARTED|Overall Study||15
7555420|NCT03033511|18595896|P2|NOT COMPLETED|Overall Study||0
7555421|NCT03033511|18595897|P1|NOT COMPLETED|Overall Study||0
7555422|NCT03033511|18595896|P2|COMPLETED|Overall Study||372
7555423|NCT03033511|18595897|P1|COMPLETED|Overall Study||376
7555424|NCT03033511|18595896|P2|STARTED|Overall Study||372
7555425|NCT03033511|18595897|P1|STARTED|Overall Study||376
7555426|NCT03033134|18595909|P2|NOT COMPLETED|Overall Study||12
7555427|NCT03033134|18595910|P1|NOT COMPLETED|Overall Study||42
7555428|NCT03033134|18595909|P2|COMPLETED|Overall Study||0
7555429|NCT03033134|18595910|P1|COMPLETED|Overall Study||0
7555430|NCT03033134|18595909|P2|6-month Primary Endpoints|Overall Study||12
7555431|NCT03033134|18595910|P1|6-month Primary Endpoints|Overall Study||42
7555432|NCT03033134|18595909|P2|STARTED|Overall Study||12
7555433|NCT03033134|18595910|P1|STARTED|Overall Study||42
7555434|NCT03032965|18595932|P2|NOT COMPLETED|Overall Study||0
7555435|NCT03032965|18595933|P1|NOT COMPLETED|Overall Study||0
7555436|NCT03032965|18595932|P2|COMPLETED|Overall Study||68
7555437|NCT03032965|18595933|P1|COMPLETED|Overall Study||61
7555438|NCT03032965|18595932|P2|STARTED|Overall Study||68
7555439|NCT03032965|18595933|P1|STARTED|Overall Study||61
7555440|NCT03032523|18595957|P2|NOT COMPLETED|Overall Study||2
7555441|NCT03032523|18595958|P1|NOT COMPLETED|Overall Study||3
7555442|NCT03032523|18595957|P2|COMPLETED|Overall Study||4
7555443|NCT03032523|18595958|P1|COMPLETED|Overall Study||12
7555444|NCT03032523|18595957|P2|STARTED|Overall Study||6
7555445|NCT03032523|18595958|P1|STARTED|Overall Study||15
7555446|NCT03032510|18595970|P2|NOT COMPLETED|Overall Study||18
7555447|NCT03032510|18595971|P1|NOT COMPLETED|Overall Study||27
7555448|NCT03032510|18595970|P2|COMPLETED|Overall Study||584
7555449|NCT03032510|18595971|P1|COMPLETED|Overall Study||576
7555450|NCT03032510|18595970|P2|STARTED|Overall Study||602
7555451|NCT03032510|18595971|P1|STARTED|Overall Study||603
7555452|NCT03032393|18595983|P2|NOT COMPLETED|Overall Study||0
7555453|NCT03032393|18595984|P1|NOT COMPLETED|Overall Study||0
7555454|NCT03032393|18595983|P2|COMPLETED|Overall Study||15
7555455|NCT03032393|18595984|P1|COMPLETED|Overall Study||15
7555456|NCT03032393|18595983|P2|STARTED|Overall Study||15
7555457|NCT03032393|18595984|P1|STARTED|Overall Study||15
7555458|NCT03032380|18595992|P2|NOT COMPLETED|Overall Study||40
7555459|NCT03032380|18595993|P1|NOT COMPLETED|Overall Study||42
7555460|NCT03032380|18595992|P2|COMPLETED|Overall Study||112
7555461|NCT03032380|18595993|P1|COMPLETED|Overall Study||106
7555462|NCT03032380|18595992|P2|Received Treatment|Overall Study||150
7555463|NCT03032380|18595993|P1|Received Treatment|Overall Study||148
7555464|NCT03032380|18595992|P2|STARTED|Overall Study||152
7555465|NCT03032380|18595993|P1|STARTED|Overall Study||148
7555466|NCT03032263|18596025|P2|NOT COMPLETED|Overall Study||0
7555467|NCT03032263|18596026|P1|NOT COMPLETED|Overall Study||0
7555468|NCT03032263|18596025|P2|COMPLETED|Overall Study||6
7555469|NCT03032263|18596026|P1|COMPLETED|Overall Study||6
7555470|NCT03032263|18596025|P2|STARTED|Overall Study||6
7555471|NCT03032263|18596026|P1|STARTED|Overall Study||6
7555472|NCT03031899|18596040|P1|NOT COMPLETED|Overall Study||2
7555473|NCT03031899|18596040|P1|COMPLETED|Overall Study||25
7555474|NCT03031899|18596040|P1|STARTED|Overall Study||27
7555475|NCT03031795|18596050|P2|NOT COMPLETED|Overall Study||1
7555476|NCT03031795|18596051|P1|NOT COMPLETED|Overall Study||0
7555477|NCT03031795|18596050|P2|COMPLETED|Overall Study||35
7555478|NCT03031795|18596051|P1|COMPLETED|Overall Study||35
7555479|NCT03031795|18596050|P2|STARTED|Overall Study||36
7555480|NCT03031795|18596051|P1|STARTED|Overall Study||35
7555481|NCT03031678|18596057|P1|NOT COMPLETED|Overall Study||1
7555482|NCT03031678|18596057|P1|COMPLETED|Overall Study||49
7555483|NCT03031678|18596057|P1|CI Alone Test Condition Complete|Overall Study||10
7555484|NCT03031678|18596057|P1|EAS Test Condition Complete|Overall Study||39
7555485|NCT03031678|18596057|P1|STARTED|Overall Study||50
7555486|NCT03031496|18596066|P2|NOT COMPLETED|Period 2||0
7555487|NCT03031496|18596067|P1|NOT COMPLETED|Period 2||0
7555488|NCT03031496|18596066|P2|COMPLETED|Period 2||19
7555489|NCT03031496|18596067|P1|COMPLETED|Period 2||19
7555490|NCT03031496|18596066|P2|STARTED|Period 2||19
7555491|NCT03031496|18596067|P1|STARTED|Period 2||19
7555492|NCT03031496|18596066|P2|NOT COMPLETED|Period 1||2
7555493|NCT03031496|18596067|P1|NOT COMPLETED|Period 1||2
7555494|NCT03031496|18596066|P2|COMPLETED|Period 1||19
7555495|NCT03031496|18596067|P1|COMPLETED|Period 1||19
7555496|NCT03031496|18596066|P2|STARTED|Period 1||21
7555497|NCT03031496|18596067|P1|STARTED|Period 1||21
7555498|NCT03031431|18596103|P1|NOT COMPLETED|Overall Study||1
7555499|NCT03031431|18596103|P1|COMPLETED|Overall Study||129
7555500|NCT03031431|18596103|P1|STARTED|Overall Study||130
7555501|NCT03031340|18596112|P2|NOT COMPLETED|Overall Study||1
7555502|NCT03031340|18596113|P1|NOT COMPLETED|Overall Study||2
7555503|NCT03031340|18596112|P2|COMPLETED|Overall Study||0
7555504|NCT03031340|18596113|P1|COMPLETED|Overall Study||0
7555505|NCT03031340|18596112|P2|STARTED|Overall Study||1
7555506|NCT03031340|18596113|P1|STARTED|Overall Study||2
7555507|NCT03030989|18596131|P2|NOT COMPLETED|Overall Study||14
7555508|NCT03030989|18596132|P1|NOT COMPLETED|Overall Study||12
7555509|NCT03030989|18596131|P2|COMPLETED|Overall Study||15
7555510|NCT03030989|18596132|P1|COMPLETED|Overall Study||9
7555511|NCT03030989|18596131|P2|STARTED|Overall Study||29
7555512|NCT03030989|18596132|P1|STARTED|Overall Study||21
7555513|NCT03030638|18596148|P8|NOT COMPLETED|Overall Study||0
7555514|NCT03030638|18596149|P7|NOT COMPLETED|Overall Study||0
7555515|NCT03030638|18596150|P6|NOT COMPLETED|Overall Study||0
7555516|NCT03030638|18596151|P5|NOT COMPLETED|Overall Study||0
7555517|NCT03030638|18596152|P4|NOT COMPLETED|Overall Study||0
7555518|NCT03030638|18596153|P3|NOT COMPLETED|Overall Study||0
7555519|NCT03030638|18596154|P2|NOT COMPLETED|Overall Study||0
7555520|NCT03030638|18596155|P1|NOT COMPLETED|Overall Study||0
7555521|NCT03030638|18596148|P8|COMPLETED|Overall Study||127
7555522|NCT03030638|18596149|P7|COMPLETED|Overall Study||364
7555523|NCT03030638|18596150|P6|COMPLETED|Overall Study||1592
7555524|NCT03030638|18596151|P5|COMPLETED|Overall Study||696
7555525|NCT03030638|18596152|P4|COMPLETED|Overall Study||6406
7555526|NCT03030638|18596153|P3|COMPLETED|Overall Study||1712
7555527|NCT03030638|18596154|P2|COMPLETED|Overall Study||1841
7555528|NCT03030638|18596155|P1|COMPLETED|Overall Study||1386
7555529|NCT03030638|18596148|P8|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
7555530|NCT03030638|18596149|P7|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
7555531|NCT03030638|18596150|P6|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
7555532|NCT03030638|18596151|P5|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
7555533|NCT03030638|18596152|P4|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
7555534|NCT03030638|18596153|P3|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
7555535|NCT03030638|18596154|P2|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||636
7555536|NCT03030638|18596155|P1|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||372
7555537|NCT03030638|18596148|P8|STARTED|Overall Study||127
7555538|NCT03030638|18596149|P7|STARTED|Overall Study||364
7555539|NCT03030638|18596150|P6|STARTED|Overall Study||1592
7555540|NCT03030638|18596151|P5|STARTED|Overall Study||696
7555541|NCT03030638|18596152|P4|STARTED|Overall Study||6406
7555542|NCT03030638|18596153|P3|STARTED|Overall Study||1712
7555543|NCT03030638|18596154|P2|STARTED|Overall Study||1841
7555544|NCT03030638|18596155|P1|STARTED|Overall Study||1386
7555545|NCT03030599|18596185|P3|NOT COMPLETED|Open-label Extension||0
7555546|NCT03030599|18596186|P2|NOT COMPLETED|Open-label Extension||0
7555547|NCT03030599|18596187|P1|NOT COMPLETED|Open-label Extension||7
7555548|NCT03030599|18596185|P3|COMPLETED|Open-label Extension||0
7555549|NCT03030599|18596186|P2|COMPLETED|Open-label Extension||0
7555550|NCT03030599|18596187|P1|COMPLETED|Open-label Extension||67
7555551|NCT03030599|18596185|P3|STARTED|Open-label Extension||0
7555552|NCT03030599|18596186|P2|STARTED|Open-label Extension||0
7555553|NCT03030599|18596187|P1|STARTED|Open-label Extension||74
7555554|NCT03030599|18596185|P3|NOT COMPLETED|Double Blind Randomized Withdrawal||8
7555555|NCT03030599|18596186|P2|NOT COMPLETED|Double Blind Randomized Withdrawal||0
7555556|NCT03030599|18596187|P1|NOT COMPLETED|Double Blind Randomized Withdrawal||0
7555557|NCT03030599|18596185|P3|COMPLETED|Double Blind Randomized Withdrawal||59
7555558|NCT03030599|18596186|P2|COMPLETED|Double Blind Randomized Withdrawal||69
7555559|NCT03030599|18596187|P1|COMPLETED|Double Blind Randomized Withdrawal||0
7555560|NCT03030599|18596185|P3|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|67
7555561|NCT03030599|18596186|P2|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|69
7555562|NCT03030599|18596187|P1|STARTED|Double Blind Randomized Withdrawal||0
7555563|NCT03030599|18596185|P3|NOT COMPLETED|Stable Dose||0
7555564|NCT03030599|18596186|P2|NOT COMPLETED|Stable Dose||0
7555565|NCT03030599|18596187|P1|NOT COMPLETED|Stable Dose||5
7555566|NCT03030599|18596185|P3|COMPLETED|Stable Dose||0
7555567|NCT03030599|18596186|P2|COMPLETED|Stable Dose||0
7555568|NCT03030599|18596187|P1|COMPLETED|Stable Dose||144
7555569|NCT03030599|18596185|P3|STARTED|Stable Dose||0
7555570|NCT03030599|18596186|P2|STARTED|Stable Dose||0
7555571|NCT03030599|18596187|P1|STARTED|Stable Dose|149 subjects of the 201 entered the Stable Dose Period. Of those subjects, 136 were randomized.|149
7555572|NCT03030599|18596185|P3|NOT COMPLETED|Open Label Treatment and Titration||0
7555573|NCT03030599|18596186|P2|NOT COMPLETED|Open Label Treatment and Titration||0
7555574|NCT03030599|18596187|P1|NOT COMPLETED|Open Label Treatment and Titration||46
7555575|NCT03030599|18596185|P3|COMPLETED|Open Label Treatment and Titration||0
7555576|NCT03030599|18596186|P2|COMPLETED|Open Label Treatment and Titration||0
7555577|NCT03030599|18596187|P1|COMPLETED|Open Label Treatment and Titration||155
7555578|NCT03030599|18596185|P3|STARTED|Open Label Treatment and Titration||0
7555579|NCT03030599|18596186|P2|STARTED|Open Label Treatment and Titration||0
7555580|NCT03030599|18596187|P1|STARTED|Open Label Treatment and Titration||201
7555581|NCT03030183|18596203|P1|NOT COMPLETED|Overall Study||0
7555582|NCT03030183|18596203|P1|COMPLETED|Overall Study||3
7555583|NCT03030183|18596203|P1|STARTED|Overall Study||3
7555584|NCT03029988|18596213|P1|NOT COMPLETED|Overall Study||0
7555585|NCT03029988|18596213|P1|COMPLETED|Overall Study||3
7555586|NCT03029988|18596213|P1|STARTED|Overall Study||3
7555587|NCT03029832|18596220|P2|NOT COMPLETED|Overall Study||1
7555588|NCT03029832|18596221|P1|NOT COMPLETED|Overall Study||4
7555589|NCT03029832|18596220|P2|COMPLETED|Overall Study||0
7555590|NCT03029832|18596221|P1|COMPLETED|Overall Study||0
7555591|NCT03029832|18596220|P2|STARTED|Overall Study||1
7555592|NCT03029832|18596221|P1|STARTED|Overall Study||4
7555593|NCT03029819|18596251|P2|NOT COMPLETED|Overall Study||6
7555594|NCT03029819|18596252|P1|NOT COMPLETED|Overall Study||3
7555595|NCT03029819|18596251|P2|COMPLETED|Overall Study||33
7555596|NCT03029819|18596252|P1|COMPLETED|Overall Study||30
7555597|NCT03029819|18596251|P2|STARTED|Overall Study||39
7555598|NCT03029819|18596252|P1|STARTED|Overall Study||33
7555599|NCT03029780|18596266|P2|NOT COMPLETED|Overall Study||11
7555600|NCT03029780|18596267|P1|NOT COMPLETED|Overall Study||6
7555601|NCT03029780|18596266|P2|COMPLETED|Overall Study||41
7555602|NCT03029780|18596267|P1|COMPLETED|Overall Study||46
7555603|NCT03029780|18596266|P2|STARTED|Overall Study||52
7555604|NCT03029780|18596267|P1|STARTED|Overall Study||52
7555605|NCT03029715|18596281|P2|NOT COMPLETED|Overall Study||0
7555606|NCT03029715|18596282|P1|NOT COMPLETED|Overall Study||0
7555607|NCT03029715|18596281|P2|COMPLETED|Overall Study||50
7555608|NCT03029715|18596282|P1|COMPLETED|Overall Study||50
7555609|NCT03029715|18596281|P2|STARTED|Overall Study||50
7555610|NCT03029715|18596282|P1|STARTED|Overall Study||50
7555611|NCT03029650|18596290|P2|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
7555612|NCT03029650|18596291|P1|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
7555613|NCT03029650|18596290|P2|COMPLETED|2nd Intervention (3 - 6 Days)||10
7555614|NCT03029650|18596291|P1|COMPLETED|2nd Intervention (3 - 6 Days)||13
7555615|NCT03029650|18596290|P2|STARTED|2nd Intervention (3 - 6 Days)||10
7555616|NCT03029650|18596291|P1|STARTED|2nd Intervention (3 - 6 Days)||13
7555617|NCT03029650|18596290|P2|NOT COMPLETED|Washout (1 Week)||2
7555618|NCT03029650|18596291|P1|NOT COMPLETED|Washout (1 Week)||1
7555619|NCT03029650|18596290|P2|COMPLETED|Washout (1 Week)||10
7555620|NCT03029650|18596291|P1|COMPLETED|Washout (1 Week)||13
7555621|NCT03029650|18596290|P2|STARTED|Washout (1 Week)||12
7555622|NCT03029650|18596291|P1|STARTED|Washout (1 Week)||14
7555623|NCT03029650|18596290|P2|NOT COMPLETED|First Intervention (3 - 6 Days)||0
7555624|NCT03029650|18596291|P1|NOT COMPLETED|First Intervention (3 - 6 Days)||0
7555625|NCT03029650|18596290|P2|COMPLETED|First Intervention (3 - 6 Days)||12
7555626|NCT03029650|18596291|P1|COMPLETED|First Intervention (3 - 6 Days)||14
7555627|NCT03029650|18596290|P2|STARTED|First Intervention (3 - 6 Days)||12
7555628|NCT03029650|18596291|P1|STARTED|First Intervention (3 - 6 Days)|More subjects not enrolled after consent in other group leaving uneven number.|14
7555629|NCT03029624|18596306|P1|NOT COMPLETED|Overall Study||5
7555630|NCT03029624|18596306|P1|COMPLETED|Overall Study||41
7555631|NCT03029624|18596306|P1|Primary Endpoint (3 Months)|Overall Study||44
7555632|NCT03029624|18596306|P1|STARTED|Overall Study||46
7555633|NCT03029234|18596313|P1|NOT COMPLETED|Overall Study||67
7555634|NCT03029234|18596313|P1|COMPLETED|Overall Study||59
7555635|NCT03029234|18596313|P1|Received Carfilzomib|Overall Study||123
7555636|NCT03029234|18596313|P1|STARTED|Overall Study||126
7555637|NCT03029091|18596340|P2|NOT COMPLETED|Overall Study||0
7555638|NCT03029091|18596341|P1|NOT COMPLETED|Overall Study||0
7555639|NCT03029091|18596340|P2|COMPLETED|Overall Study||7
7555640|NCT03029091|18596341|P1|COMPLETED|Overall Study||8
7555641|NCT03029091|18596340|P2|STARTED|Overall Study||7
7555642|NCT03029091|18596341|P1|STARTED|Overall Study||8
7555643|NCT03029000|18596367|P1|NOT COMPLETED|Overall Study||0
7555644|NCT03029000|18596367|P1|COMPLETED|Overall Study||1
7555645|NCT03029000|18596367|P1|STARTED|Overall Study||1
7555646|NCT03028987|18596380|P2|NOT COMPLETED|Overall Study||0
7555647|NCT03028987|18596381|P1|NOT COMPLETED|Overall Study||0
7555648|NCT03028987|18596380|P2|COMPLETED|Overall Study||5
7555649|NCT03028987|18596381|P1|COMPLETED|Overall Study||5
7555650|NCT03028987|18596380|P2|STARTED|Overall Study||5
7555651|NCT03028987|18596381|P1|STARTED|Overall Study||5
7555652|NCT03028974|18596394|P7|NOT COMPLETED|2017-2018||0
7555653|NCT03028974|18596395|P6|NOT COMPLETED|2017-2018||0
7555654|NCT03028974|18596396|P5|NOT COMPLETED|2017-2018||0
7555655|NCT03028974|18596397|P4|NOT COMPLETED|2017-2018||0
7555656|NCT03028974|18596398|P3|NOT COMPLETED|2017-2018||0
7555657|NCT03028974|18596399|P2|NOT COMPLETED|2017-2018||0
7555658|NCT03028974|18596400|P1|NOT COMPLETED|2017-2018||0
7555659|NCT03028974|18596394|P7|COMPLETED|2017-2018||5
7555660|NCT03028974|18596395|P6|COMPLETED|2017-2018||0
7555661|NCT03028974|18596396|P5|COMPLETED|2017-2018||0
7555662|NCT03028974|18596397|P4|COMPLETED|2017-2018||5
7555663|NCT03028974|18596398|P3|COMPLETED|2017-2018||0
7555664|NCT03028974|18596399|P2|COMPLETED|2017-2018||0
7555665|NCT03028974|18596400|P1|COMPLETED|2017-2018||0
7555666|NCT03028974|18596394|P7|STARTED|2017-2018|5 new participants were enrolled.|5
7555667|NCT03028974|18596395|P6|STARTED|2017-2018||0
7555668|NCT03028974|18596396|P5|STARTED|2017-2018||0
7555669|NCT03028974|18596397|P4|STARTED|2017-2018||5
7555670|NCT03028974|18596398|P3|STARTED|2017-2018||0
7555671|NCT03028974|18596399|P2|STARTED|2017-2018||0
7555672|NCT03028974|18596400|P1|STARTED|2017-2018||0
7555673|NCT03028974|18596394|P7|NOT COMPLETED|2016-2017||0
7555674|NCT03028974|18596395|P6|NOT COMPLETED|2016-2017||0
7555675|NCT03028974|18596396|P5|NOT COMPLETED|2016-2017||0
7555676|NCT03028974|18596397|P4|NOT COMPLETED|2016-2017||0
7555677|NCT03028974|18596398|P3|NOT COMPLETED|2016-2017||0
7555678|NCT03028974|18596399|P2|NOT COMPLETED|2016-2017||0
7555679|NCT03028974|18596400|P1|NOT COMPLETED|2016-2017||0
7555680|NCT03028974|18596394|P7|COMPLETED|2016-2017|18 participants did not continue to the next period.|18
7555681|NCT03028974|18596395|P6|COMPLETED|2016-2017||0
7555682|NCT03028974|18596396|P5|COMPLETED|2016-2017|2 participants did not continue to the next period|2
7555683|NCT03028974|18596397|P4|COMPLETED|2016-2017||4
7555684|NCT03028974|18596398|P3|COMPLETED|2016-2017||0
7555685|NCT03028974|18596399|P2|COMPLETED|2016-2017||0
7555686|NCT03028974|18596400|P1|COMPLETED|2016-2017||0
7555687|NCT03028974|18596394|P7|STARTED|2016-2017|18 new participants were enrolled.|18
7555688|NCT03028974|18596395|P6|STARTED|2016-2017||0
7555689|NCT03028974|18596396|P5|STARTED|2016-2017|2 new participants were enrolled.|2
7555690|NCT03028974|18596397|P4|STARTED|2016-2017|1 new participant was enrolled.|4
7555691|NCT03028974|18596398|P3|STARTED|2016-2017||0
7555692|NCT03028974|18596399|P2|STARTED|2016-2017||0
7555693|NCT03028974|18596400|P1|STARTED|2016-2017||0
7555694|NCT03028974|18596394|P7|NOT COMPLETED|2015-2016||0
7555695|NCT03028974|18596395|P6|NOT COMPLETED|2015-2016||0
7555696|NCT03028974|18596396|P5|NOT COMPLETED|2015-2016||0
7555697|NCT03028974|18596397|P4|NOT COMPLETED|2015-2016||0
7555698|NCT03028974|18596398|P3|NOT COMPLETED|2015-2016||0
7555699|NCT03028974|18596399|P2|NOT COMPLETED|2015-2016||0
7555700|NCT03028974|18596400|P1|NOT COMPLETED|2015-2016||0
7555701|NCT03028974|18596394|P7|COMPLETED|2015-2016|20 participants did not continue to the next period.|20
7555702|NCT03028974|18596395|P6|COMPLETED|2015-2016|14 participants did not continue to the next period.|14
7555703|NCT03028974|18596396|P5|COMPLETED|2015-2016||0
7555704|NCT03028974|18596397|P4|COMPLETED|2015-2016|3 participants did not continue to the next period. 1 Participant returned in period 4 (2017-2018).|6
7555705|NCT03028974|18596398|P3|COMPLETED|2015-2016||0
7555706|NCT03028974|18596399|P2|COMPLETED|2015-2016||0
7555707|NCT03028974|18596400|P1|COMPLETED|2015-2016||0
7555708|NCT03028974|18596394|P7|STARTED|2015-2016|11 new participants were enrolled; 9 subjects switched from Group F.|20
7555709|NCT03028974|18596395|P6|STARTED|2015-2016|10 new participants were enrolled; 4 subjects switched from Group G.|14
7555710|NCT03028974|18596396|P5|STARTED|2015-2016||0
7555711|NCT03028974|18596397|P4|STARTED|2015-2016|One participant joined from Group A, 2 new were enrolled.|6
7555712|NCT03028974|18596398|P3|STARTED|2015-2016||0
7555713|NCT03028974|18596399|P2|STARTED|2015-2016||0
7555714|NCT03028974|18596400|P1|STARTED|2015-2016||0
7555715|NCT03028974|18596394|P7|NOT COMPLETED|2014-2015||0
7555716|NCT03028974|18596395|P6|NOT COMPLETED|2014-2015||0
7555717|NCT03028974|18596396|P5|NOT COMPLETED|2014-2015||0
7555718|NCT03028974|18596397|P4|NOT COMPLETED|2014-2015||0
7555719|NCT03028974|18596398|P3|NOT COMPLETED|2014-2015||0
7555720|NCT03028974|18596399|P2|NOT COMPLETED|2014-2015||0
7555721|NCT03028974|18596400|P1|NOT COMPLETED|2014-2015||0
7555722|NCT03028974|18596394|P7|COMPLETED|2014-2015|13 participants did not continue to the next period.|13
7555723|NCT03028974|18596395|P6|COMPLETED|2014-2015|2 participants did not continue to the next period.|11
7555724|NCT03028974|18596396|P5|COMPLETED|2014-2015||0
7555725|NCT03028974|18596397|P4|COMPLETED|2014-2015||3
7555726|NCT03028974|18596398|P3|COMPLETED|2014-2015||0
7555727|NCT03028974|18596399|P2|COMPLETED|2014-2015||0
7555728|NCT03028974|18596400|P1|COMPLETED|2014-2015||1
7555729|NCT03028974|18596394|P7|STARTED|2014-2015||13
7555730|NCT03028974|18596395|P6|STARTED|2014-2015||11
7555731|NCT03028974|18596396|P5|STARTED|2014-2015||0
7555732|NCT03028974|18596397|P4|STARTED|2014-2015||3
7555733|NCT03028974|18596398|P3|STARTED|2014-2015||0
7555734|NCT03028974|18596399|P2|STARTED|2014-2015||0
7555735|NCT03028974|18596400|P1|STARTED|2014-2015||1
7555736|NCT03028896|18596419|P2|NOT COMPLETED|Overall Study||0
7555737|NCT03028896|18596420|P1|NOT COMPLETED|Overall Study||3
7555738|NCT03028896|18596419|P2|COMPLETED|Overall Study||66
7555739|NCT03028896|18596420|P1|COMPLETED|Overall Study||63
7555740|NCT03028896|18596419|P2|STARTED|Overall Study||66
7555741|NCT03028896|18596420|P1|STARTED|Overall Study||66
7555742|NCT03028870|18596436|P4|NOT COMPLETED|Overall Study||9
7555743|NCT03028870|18596437|P3|NOT COMPLETED|Overall Study||16
7555744|NCT03028870|18596438|P2|NOT COMPLETED|Overall Study||10
7555745|NCT03028870|18596439|P1|NOT COMPLETED|Overall Study||17
7555746|NCT03028870|18596436|P4|COMPLETED|Overall Study||65
7555747|NCT03028870|18596437|P3|COMPLETED|Overall Study||60
7555748|NCT03028870|18596438|P2|COMPLETED|Overall Study||57
7555749|NCT03028870|18596439|P1|COMPLETED|Overall Study||57
7555750|NCT03028870|18596436|P4|STARTED|Overall Study||74
7555751|NCT03028870|18596437|P3|STARTED|Overall Study||76
7555752|NCT03028870|18596438|P2|STARTED|Overall Study||67
7555753|NCT03028870|18596439|P1|STARTED|Overall Study||74
7555754|NCT03028636|18596517|P1|NOT COMPLETED|Overall Study||6
7555755|NCT03028636|18596517|P1|COMPLETED|Overall Study||11
7555756|NCT03028636|18596517|P1|STARTED|Overall Study||17
7555757|NCT03028467|18596530|P4|NOT COMPLETED|Overall Study||0
7555758|NCT03028467|18596531|P3|NOT COMPLETED|Overall Study||0
7555759|NCT03028467|18596532|P2|NOT COMPLETED|Overall Study||0
7555760|NCT03028467|18596533|P1|NOT COMPLETED|Overall Study||0
7555761|NCT03028467|18596530|P4|COMPLETED|Overall Study||4
7555762|NCT03028467|18596531|P3|COMPLETED|Overall Study||4
7555763|NCT03028467|18596532|P2|COMPLETED|Overall Study||3
7555764|NCT03028467|18596533|P1|COMPLETED|Overall Study||4
7555765|NCT03028467|18596530|P4|STARTED|Overall Study||4
7555766|NCT03028467|18596531|P3|STARTED|Overall Study||4
7555767|NCT03028467|18596532|P2|STARTED|Overall Study||3
7555768|NCT03028467|18596533|P1|STARTED|Overall Study||4
7555769|NCT03028363|18596597|P2|NOT COMPLETED|Overall Study||33
7555770|NCT03028363|18596598|P1|NOT COMPLETED|Overall Study||78
7555771|NCT03028363|18596597|P2|COMPLETED|Overall Study||228
7555772|NCT03028363|18596598|P1|COMPLETED|Overall Study||420
7555773|NCT03028363|18596597|P2|STARTED|Overall Study||261
7555774|NCT03028363|18596598|P1|STARTED|Overall Study||498
7555775|NCT03028324|18596608|P1|NOT COMPLETED|Overall Study||0
7555776|NCT03028324|18596608|P1|COMPLETED|Overall Study||4
7555777|NCT03028324|18596608|P1|STARTED|Overall Study||4
7555778|NCT03028220|18596615|P2|NOT COMPLETED|Overall Study||0
7555779|NCT03028220|18596616|P1|NOT COMPLETED|Overall Study||0
7555780|NCT03028220|18596615|P2|COMPLETED|Overall Study||20
7555781|NCT03028220|18596616|P1|COMPLETED|Overall Study||20
7555782|NCT03028220|18596615|P2|STARTED|Overall Study||20
7555783|NCT03028220|18596616|P1|STARTED|Overall Study||20
7555784|NCT03028142|18596644|P6|NOT COMPLETED|Overall Study||1
7555785|NCT03028142|18596645|P5|NOT COMPLETED|Overall Study||1
7555786|NCT03028142|18596646|P4|NOT COMPLETED|Overall Study||0
7555787|NCT03028142|18596647|P3|NOT COMPLETED|Overall Study||0
7555788|NCT03028142|18596648|P2|NOT COMPLETED|Overall Study||1
7555789|NCT03028142|18596649|P1|NOT COMPLETED|Overall Study||1
7555790|NCT03028142|18596644|P6|COMPLETED|Overall Study||3
7555791|NCT03028142|18596645|P5|COMPLETED|Overall Study||5
7555792|NCT03028142|18596646|P4|COMPLETED|Overall Study||4
7555793|NCT03028142|18596647|P3|COMPLETED|Overall Study||6
7555794|NCT03028142|18596648|P2|COMPLETED|Overall Study||4
7555795|NCT03028142|18596649|P1|COMPLETED|Overall Study||4
7555796|NCT03028142|18596644|P6|STARTED|Overall Study||4
7555797|NCT03028142|18596645|P5|STARTED|Overall Study||6
7555798|NCT03028142|18596646|P4|STARTED|Overall Study||4
7555799|NCT03028142|18596647|P3|STARTED|Overall Study||6
7555800|NCT03028142|18596648|P2|STARTED|Overall Study||5
7555801|NCT03028142|18596649|P1|STARTED|Overall Study||5
7555802|NCT03028129|18596668|P2|NOT COMPLETED|Overall Study||87
7555803|NCT03028129|18596669|P1|NOT COMPLETED|Overall Study||126
7555804|NCT03028129|18596668|P2|COMPLETED|Overall Study||122
7555805|NCT03028129|18596669|P1|COMPLETED|Overall Study||132
7555806|NCT03028129|18596668|P2|STARTED|Overall Study||209
7555807|NCT03028129|18596669|P1|STARTED|Overall Study||258
7555808|NCT03028025|18596677|P2|NOT COMPLETED|Overall Study||1
7555809|NCT03028025|18596678|P1|NOT COMPLETED|Overall Study||3
7555810|NCT03028025|18596677|P2|COMPLETED|Overall Study||93
7555811|NCT03028025|18596678|P1|COMPLETED|Overall Study||87
7555812|NCT03028025|18596677|P2|STARTED|Overall Study||94
7555813|NCT03028025|18596678|P1|STARTED|Overall Study||90
7555814|NCT03028012|18596689|P3|NOT COMPLETED|Overall Study||3
7555815|NCT03028012|18596690|P2|NOT COMPLETED|Overall Study||3
7555816|NCT03028012|18596691|P1|NOT COMPLETED|Overall Study||2
7555817|NCT03028012|18596689|P3|COMPLETED|Overall Study||0
7555818|NCT03028012|18596690|P2|COMPLETED|Overall Study||0
7555819|NCT03028012|18596691|P1|COMPLETED|Overall Study||2
7555820|NCT03028012|18596689|P3|STARTED|Overall Study||3
7555821|NCT03028012|18596690|P2|STARTED|Overall Study||3
7555822|NCT03028012|18596691|P1|STARTED|Overall Study||4
7555823|NCT03027661|18596707|P2|NOT COMPLETED|Overall Study||0
7555824|NCT03027661|18596708|P1|NOT COMPLETED|Overall Study||0
7555825|NCT03027661|18596707|P2|COMPLETED|Overall Study||21
7555826|NCT03027661|18596708|P1|COMPLETED|Overall Study||20
7555827|NCT03027661|18596707|P2|STARTED|Overall Study||21
7555828|NCT03027661|18596708|P1|STARTED|Overall Study||20
7555829|NCT03026803|18596716|P1|NOT COMPLETED|Overall Study||0
7555830|NCT03026803|18596716|P1|COMPLETED|Overall Study||4
7555831|NCT03026803|18596716|P1|STARTED|Overall Study||4
7555832|NCT03026556|18596723|P3|NOT COMPLETED|Overall Study||0
7555833|NCT03026556|18596724|P2|NOT COMPLETED|Overall Study||0
7555834|NCT03026556|18596725|P1|NOT COMPLETED|Overall Study||0
7555835|NCT03026556|18596723|P3|COMPLETED|Overall Study||12594
7555836|NCT03026556|18596724|P2|COMPLETED|Overall Study||17177
7555837|NCT03026556|18596725|P1|COMPLETED|Overall Study||12763
7555838|NCT03026556|18596723|P3|STARTED|Overall Study||12594
7555839|NCT03026556|18596724|P2|STARTED|Overall Study||17177
7555840|NCT03026556|18596725|P1|STARTED|Overall Study||12763
7555841|NCT03026530|18596784|P2|NOT COMPLETED|Overall Study||29
7555842|NCT03026530|18596785|P1|NOT COMPLETED|Overall Study||21
7555843|NCT03026530|18596784|P2|COMPLETED|Overall Study||71
7555844|NCT03026530|18596785|P1|COMPLETED|Overall Study||79
7555845|NCT03026530|18596784|P2|STARTED|Overall Study||100
7555846|NCT03026530|18596785|P1|STARTED|Overall Study||100
7555847|NCT03026283|18596793|P8|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
7555848|NCT03026283|18596794|P7|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
7555849|NCT03026283|18596795|P6|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
7555850|NCT03026283|18596796|P5|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
7555851|NCT03026283|18596797|P4|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
7555852|NCT03026283|18596798|P3|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
7555853|NCT03026283|18596799|P2|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
7555854|NCT03026283|18596800|P1|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
7555855|NCT03026283|18596793|P8|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
7555856|NCT03026283|18596794|P7|COMPLETED|Optimal Care/ICA Diagnostic Cath||21
7555857|NCT03026283|18596795|P6|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
7555858|NCT03026283|18596796|P5|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
7555859|NCT03026283|18596797|P4|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
7555860|NCT03026283|18596798|P3|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
7555861|NCT03026283|18596799|P2|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
7555862|NCT03026283|18596800|P1|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
7555863|NCT03026283|18596793|P8|STARTED|Optimal Care/ICA Diagnostic Cath||0
7555864|NCT03026283|18596794|P7|STARTED|Optimal Care/ICA Diagnostic Cath||21
7555865|NCT03026283|18596795|P6|STARTED|Optimal Care/ICA Diagnostic Cath||0
7555866|NCT03026283|18596796|P5|STARTED|Optimal Care/ICA Diagnostic Cath||0
7555867|NCT03026283|18596797|P4|STARTED|Optimal Care/ICA Diagnostic Cath||0
7555868|NCT03026283|18596798|P3|STARTED|Optimal Care/ICA Diagnostic Cath||0
7555869|NCT03026283|18596799|P2|STARTED|Optimal Care/ICA Diagnostic Cath||0
7555870|NCT03026283|18596800|P1|STARTED|Optimal Care/ICA Diagnostic Cath||0
7555871|NCT03026283|18596793|P8|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
7555872|NCT03026283|18596794|P7|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
7555873|NCT03026283|18596795|P6|NOT COMPLETED|Optimal Care/Stress Test/ICA||28
7555874|NCT03026283|18596796|P5|NOT COMPLETED|Optimal Care/Stress Test/ICA||38
7555875|NCT03026283|18596797|P4|NOT COMPLETED|Optimal Care/Stress Test/ICA||20
7555876|NCT03026283|18596798|P3|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
7555877|NCT03026283|18596799|P2|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
7555878|NCT03026283|18596800|P1|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
7555879|NCT03026283|18596793|P8|COMPLETED|Optimal Care/Stress Test/ICA||0
7555880|NCT03026283|18596794|P7|COMPLETED|Optimal Care/Stress Test/ICA||0
7555881|NCT03026283|18596795|P6|COMPLETED|Optimal Care/Stress Test/ICA||73
7555882|NCT03026283|18596796|P5|COMPLETED|Optimal Care/Stress Test/ICA||14
7555883|NCT03026283|18596797|P4|COMPLETED|Optimal Care/Stress Test/ICA||108
7555884|NCT03026283|18596798|P3|COMPLETED|Optimal Care/Stress Test/ICA||0
7555885|NCT03026283|18596799|P2|COMPLETED|Optimal Care/Stress Test/ICA||0
7555886|NCT03026283|18596800|P1|COMPLETED|Optimal Care/Stress Test/ICA||0
7555887|NCT03026283|18596793|P8|STARTED|Optimal Care/Stress Test/ICA||0
7555888|NCT03026283|18596794|P7|STARTED|Optimal Care/Stress Test/ICA||0
7555889|NCT03026283|18596795|P6|STARTED|Optimal Care/Stress Test/ICA||101
7555890|NCT03026283|18596796|P5|STARTED|Optimal Care/Stress Test/ICA||52
7555891|NCT03026283|18596797|P4|STARTED|Optimal Care/Stress Test/ICA||128
7555892|NCT03026283|18596798|P3|STARTED|Optimal Care/Stress Test/ICA||0
7555893|NCT03026283|18596799|P2|STARTED|Optimal Care/Stress Test/ICA||0
7555894|NCT03026283|18596800|P1|STARTED|Optimal Care/Stress Test/ICA||0
7555895|NCT03026283|18596793|P8|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
7555896|NCT03026283|18596794|P7|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
7555897|NCT03026283|18596795|P6|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
7555898|NCT03026283|18596796|P5|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
7555899|NCT03026283|18596797|P4|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
7555900|NCT03026283|18596798|P3|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||15
7555901|NCT03026283|18596799|P2|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||3
7555902|NCT03026283|18596800|P1|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
7555903|NCT03026283|18596793|P8|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
7555904|NCT03026283|18596794|P7|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
7555905|NCT03026283|18596795|P6|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
7555906|NCT03026283|18596796|P5|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
7555907|NCT03026283|18596797|P4|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
7555908|NCT03026283|18596798|P3|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||265
7555909|NCT03026283|18596799|P2|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||286
7555910|NCT03026283|18596800|P1|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
7555911|NCT03026283|18596793|P8|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
7555912|NCT03026283|18596794|P7|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
7555913|NCT03026283|18596795|P6|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
7555914|NCT03026283|18596796|P5|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
7555915|NCT03026283|18596797|P4|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
7555916|NCT03026283|18596798|P3|STARTED|Optimal Medical Care/FFR-CT Diagnosis||280
7555917|NCT03026283|18596799|P2|STARTED|Optimal Medical Care/FFR-CT Diagnosis||289
7555918|NCT03026283|18596800|P1|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
7555919|NCT03026283|18596793|P8|NOT COMPLETED|CCTA Diagnosis||0
7555920|NCT03026283|18596794|P7|NOT COMPLETED|CCTA Diagnosis||0
7555921|NCT03026283|18596795|P6|NOT COMPLETED|CCTA Diagnosis||0
7555922|NCT03026283|18596796|P5|NOT COMPLETED|CCTA Diagnosis||0
7555923|NCT03026283|18596797|P4|NOT COMPLETED|CCTA Diagnosis||0
7555924|NCT03026283|18596798|P3|NOT COMPLETED|CCTA Diagnosis||0
7555925|NCT03026283|18596799|P2|NOT COMPLETED|CCTA Diagnosis||0
7555926|NCT03026283|18596800|P1|NOT COMPLETED|CCTA Diagnosis||14
7555927|NCT03026283|18596793|P8|COMPLETED|CCTA Diagnosis||0
7555928|NCT03026283|18596794|P7|COMPLETED|CCTA Diagnosis||0
7555929|NCT03026283|18596795|P6|COMPLETED|CCTA Diagnosis||0
7555930|NCT03026283|18596796|P5|COMPLETED|CCTA Diagnosis||0
7555931|NCT03026283|18596797|P4|COMPLETED|CCTA Diagnosis||0
7555932|NCT03026283|18596798|P3|COMPLETED|CCTA Diagnosis||0
7555933|NCT03026283|18596799|P2|COMPLETED|CCTA Diagnosis||0
7555934|NCT03026283|18596800|P1|COMPLETED|CCTA Diagnosis||572
7555935|NCT03026283|18596793|P8|STARTED|CCTA Diagnosis||0
7555936|NCT03026283|18596794|P7|STARTED|CCTA Diagnosis||0
7555937|NCT03026283|18596795|P6|STARTED|CCTA Diagnosis||0
7555938|NCT03026283|18596796|P5|STARTED|CCTA Diagnosis||0
7555939|NCT03026283|18596797|P4|STARTED|CCTA Diagnosis||0
7555940|NCT03026283|18596798|P3|STARTED|CCTA Diagnosis||0
7555941|NCT03026283|18596799|P2|STARTED|CCTA Diagnosis||0
7555942|NCT03026283|18596800|P1|STARTED|CCTA Diagnosis||586
7555943|NCT03026257|18596821|P6|NOT COMPLETED|Overall Study||0
7555944|NCT03026257|18596822|P5|NOT COMPLETED|Overall Study||1
7555945|NCT03026257|18596823|P4|NOT COMPLETED|Overall Study||1
7555946|NCT03026257|18596824|P3|NOT COMPLETED|Overall Study||0
7555947|NCT03026257|18596825|P2|NOT COMPLETED|Overall Study||1
7555948|NCT03026257|18596826|P1|NOT COMPLETED|Overall Study||6
7555949|NCT03026257|18596821|P6|COMPLETED|Overall Study||46
7555950|NCT03026257|18596822|P5|COMPLETED|Overall Study||22
7555951|NCT03026257|18596823|P4|COMPLETED|Overall Study||24
7555952|NCT03026257|18596824|P3|COMPLETED|Overall Study||34
7555953|NCT03026257|18596825|P2|COMPLETED|Overall Study||63
7555954|NCT03026257|18596826|P1|COMPLETED|Overall Study||54
7555955|NCT03026257|18596821|P6|Treated|Overall Study||47
7555956|NCT03026257|18596822|P5|Treated|Overall Study||23
7555957|NCT03026257|18596823|P4|Treated|Overall Study||24
7555958|NCT03026257|18596824|P3|Treated|Overall Study||35
7555959|NCT03026257|18596825|P2|Treated|Overall Study||65
7555960|NCT03026257|18596826|P1|Treated|Overall Study||58
7555961|NCT03026257|18596821|P6|STARTED|Overall Study||46
7555962|NCT03026257|18596822|P5|STARTED|Overall Study||23
7555963|NCT03026257|18596823|P4|STARTED|Overall Study||25
7555964|NCT03026257|18596824|P3|STARTED|Overall Study||34
7555965|NCT03026257|18596825|P2|STARTED|Overall Study||64
7555966|NCT03026257|18596826|P1|STARTED|Overall Study||60
7555967|NCT03026166|18596842|P2|NOT COMPLETED|Overall Study||12
7555968|NCT03026166|18596843|P1|NOT COMPLETED|Overall Study||30
7555969|NCT03026166|18596842|P2|COMPLETED|Overall Study||0
7555970|NCT03026166|18596843|P1|COMPLETED|Overall Study||0
7555971|NCT03026166|18596842|P2|STARTED|Overall Study||12
7555972|NCT03026166|18596843|P1|STARTED|Overall Study||30
7555973|NCT03026088|18596859|P1|NOT COMPLETED|Overall Study||20
7555974|NCT03026088|18596859|P1|COMPLETED|Overall Study||0
7555975|NCT03026088|18596859|P1|STARTED|Overall Study||20
7555976|NCT03026075|18596883|P1|NOT COMPLETED|Overall Study||1
7555977|NCT03026075|18596883|P1|COMPLETED|Overall Study||46
7555978|NCT03026075|18596883|P1|STARTED|Overall Study||47
7555979|NCT03025945|18596889|P2|NOT COMPLETED|Overall Study||0
7555980|NCT03025945|18596890|P1|NOT COMPLETED|Overall Study||0
7555981|NCT03025945|18596889|P2|COMPLETED|Overall Study||331
7555982|NCT03025945|18596890|P1|COMPLETED|Overall Study||331
7555983|NCT03025945|18596889|P2|STARTED|Overall Study||331
7555984|NCT03025945|18596890|P1|STARTED|Overall Study||331
7555985|NCT03025217|18596896|P1|NOT COMPLETED|Overall Study||4
7555986|NCT03025217|18596896|P1|COMPLETED|Overall Study||27
7555987|NCT03025217|18596896|P1|STARTED|Overall Study||31
7555988|NCT03024970|18596901|P2|NOT COMPLETED|Second Intervention||0
7555989|NCT03024970|18596902|P1|NOT COMPLETED|Second Intervention||1
7555990|NCT03024970|18596901|P2|COMPLETED|Second Intervention||38
7555991|NCT03024970|18596902|P1|COMPLETED|Second Intervention||32
7555992|NCT03024970|18596901|P2|STARTED|Second Intervention||38
7555993|NCT03024970|18596902|P1|STARTED|Second Intervention||33
7555994|NCT03024970|18596901|P2|NOT COMPLETED|First Intervention||0
7555995|NCT03024970|18596902|P1|NOT COMPLETED|First Intervention||1
7555996|NCT03024970|18596901|P2|COMPLETED|First Intervention||38
7555997|NCT03024970|18596902|P1|COMPLETED|First Intervention||33
7555998|NCT03024970|18596901|P2|STARTED|First Intervention||38
7555999|NCT03024970|18596902|P1|STARTED|First Intervention||34
7556000|NCT03024606|18596980|P2|NOT COMPLETED|Overall Study||10
7556001|NCT03024606|18596981|P1|NOT COMPLETED|Overall Study||9
7556002|NCT03024606|18596980|P2|COMPLETED|Overall Study||16
7556003|NCT03024606|18596981|P1|COMPLETED|Overall Study||14
7556004|NCT03024606|18596980|P2|STARTED|Overall Study||26
7556005|NCT03024606|18596981|P1|STARTED|Overall Study||23
7556006|NCT03024112|18596989|P2|NOT COMPLETED|Overall Study||0
7556007|NCT03024112|18596990|P1|NOT COMPLETED|Overall Study||7
7556008|NCT03024112|18596989|P2|COMPLETED|Overall Study||26
7556009|NCT03024112|18596990|P1|COMPLETED|Overall Study||18
7556010|NCT03024112|18596989|P2|STARTED|Overall Study||26
7556011|NCT03024112|18596990|P1|STARTED|Overall Study||25
7556012|NCT03023891|18597002|P1|NOT COMPLETED|Overall Study||0
7556013|NCT03023891|18597002|P1|COMPLETED|Overall Study||18
7556014|NCT03023891|18597002|P1|STARTED|Overall Study||18
7556015|NCT03023878|18597009|P1|NOT COMPLETED|Long Term Follow-Up Period||2
7556016|NCT03023878|18597009|P1|COMPLETED|Long Term Follow-Up Period||26
7556017|NCT03023878|18597009|P1|STARTED|Long Term Follow-Up Period||28
7556018|NCT03023878|18597009|P1|NOT COMPLETED|Treatment Period||3
7556019|NCT03023878|18597009|P1|COMPLETED|Treatment Period||25
7556020|NCT03023878|18597009|P1|Started Cycle 2|Treatment Period||11
7556021|NCT03023878|18597009|P1|Started Cycle 1|Treatment Period||28
7556022|NCT03023878|18597009|P1|STARTED|Treatment Period||28
7556023|NCT03023878|18597009|P1|NOT COMPLETED|Between Run-In and Treatment Periods||2
7556024|NCT03023878|18597009|P1|COMPLETED|Between Run-In and Treatment Periods||28
7556025|NCT03023878|18597009|P1|STARTED|Between Run-In and Treatment Periods||30
7556026|NCT03023878|18597009|P1|NOT COMPLETED|Pre-Study Run-In Period||17
7556027|NCT03023878|18597009|P1|COMPLETED|Pre-Study Run-In Period||30
7556028|NCT03023878|18597009|P1|STARTED|Pre-Study Run-In Period||47
7556029|NCT03023709|18597024|P2|NOT COMPLETED|Overall Study||0
7556030|NCT03023709|18597025|P1|NOT COMPLETED|Overall Study||0
7556031|NCT03023709|18597024|P2|COMPLETED|Overall Study||0
7556032|NCT03023709|18597025|P1|COMPLETED|Overall Study||3
7556033|NCT03023709|18597024|P2|STARTED|Overall Study||0
7556034|NCT03023709|18597025|P1|STARTED|Overall Study||3
7556035|NCT03023683|18597035|P2|NOT COMPLETED|Overall Study||1
7556036|NCT03023683|18597036|P1|NOT COMPLETED|Overall Study||0
7556037|NCT03023683|18597035|P2|COMPLETED|Overall Study||17
7556038|NCT03023683|18597036|P1|COMPLETED|Overall Study||0
7556039|NCT03023683|18597035|P2|STARTED|Overall Study||18
7556040|NCT03023683|18597036|P1|STARTED|Overall Study||0
7556041|NCT03023553|18597046|P2|NOT COMPLETED|Overall Study||1
7556042|NCT03023553|18597047|P1|NOT COMPLETED|Overall Study||0
7556043|NCT03023553|18597046|P2|COMPLETED|Overall Study||8
7556044|NCT03023553|18597047|P1|COMPLETED|Overall Study||4
7556045|NCT03023553|18597046|P2|STARTED|Overall Study||9
7556046|NCT03023553|18597047|P1|STARTED|Overall Study||4
7556047|NCT03023488|18597055|P1|NOT COMPLETED|Overall Study||0
7556048|NCT03023488|18597055|P1|COMPLETED|Overall Study||46
7556049|NCT03023488|18597055|P1|STARTED|Overall Study||46
7556050|NCT03023423|18597071|P3|NOT COMPLETED|Overall Study||46
7556051|NCT03023423|18597072|P2|NOT COMPLETED|Overall Study||46
7556052|NCT03023423|18597073|P1|NOT COMPLETED|Overall Study||7
7556053|NCT03023423|18597071|P3|COMPLETED|Overall Study||0
7556054|NCT03023423|18597072|P2|COMPLETED|Overall Study||0
7556055|NCT03023423|18597073|P1|COMPLETED|Overall Study||0
7556056|NCT03023423|18597071|P3|Crossover From Atezo to Dara + Atezo|Overall Study||0
7556057|NCT03023423|18597072|P2|Crossover From Atezo to Dara + Atezo|Overall Study|Participants who met crossover eligibility criteria entered to Dara + Atezo arm.|8
7556058|NCT03023423|18597073|P1|Crossover From Atezo to Dara + Atezo|Overall Study||0
7556059|NCT03023423|18597071|P3|Treated|Overall Study||44
7556060|NCT03023423|18597072|P2|Treated|Overall Study||44
7556061|NCT03023423|18597073|P1|Treated|Overall Study||7
7556062|NCT03023423|18597071|P3|STARTED|Overall Study||46
7556063|NCT03023423|18597072|P2|STARTED|Overall Study||46
7556064|NCT03023423|18597073|P1|STARTED|Overall Study||7
7556065|NCT03023176|18597103|P1|NOT COMPLETED|Overall Study||0
7556066|NCT03023176|18597103|P1|COMPLETED|Overall Study||20
7556067|NCT03023176|18597103|P1|STARTED|Overall Study||20
7556068|NCT03023137|18597110|P2|NOT COMPLETED|Overall Study||9
7556069|NCT03023137|18597111|P1|NOT COMPLETED|Overall Study||4
7556070|NCT03023137|18597110|P2|COMPLETED|Overall Study||162
7556071|NCT03023137|18597111|P1|COMPLETED|Overall Study||174
7556072|NCT03023137|18597110|P2|STARTED|Overall Study||171
7556073|NCT03023137|18597111|P1|STARTED|Overall Study||178
7556074|NCT03022981|18597140|P3|NOT COMPLETED|Overall Study||6
7556075|NCT03022981|18597141|P2|NOT COMPLETED|Overall Study||4
7556076|NCT03022981|18597142|P1|NOT COMPLETED|Overall Study||6
7556077|NCT03022981|18597140|P3|COMPLETED|Overall Study||35
7556078|NCT03022981|18597141|P2|COMPLETED|Overall Study||69
7556079|NCT03022981|18597142|P1|COMPLETED|Overall Study||96
7556080|NCT03022981|18597140|P3|Participated in PK Lead-in (PKL) Phase|Overall Study|All 19 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|19
7556081|NCT03022981|18597141|P2|Participated in PK Lead-in (PKL) Phase|Overall Study|All 20 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|20
7556082|NCT03022981|18597142|P1|Participated in PK Lead-in (PKL) Phase|Overall Study|All 17 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|17
7556083|NCT03022981|18597140|P3|STARTED|Overall Study||41
7556084|NCT03022981|18597141|P2|STARTED|Overall Study||73
7556085|NCT03022981|18597142|P1|STARTED|Overall Study||102
7556086|NCT03022916|18597218|P4|NOT COMPLETED|Overall Study||0
7556087|NCT03022916|18597219|P3|NOT COMPLETED|Overall Study||0
7556088|NCT03022916|18597220|P2|NOT COMPLETED|Overall Study||0
7556089|NCT03022916|18597221|P1|NOT COMPLETED|Overall Study||0
7556090|NCT03022916|18597218|P4|COMPLETED|Overall Study||5
7556091|NCT03022916|18597219|P3|COMPLETED|Overall Study||5
7556092|NCT03022916|18597220|P2|COMPLETED|Overall Study||5
7556093|NCT03022916|18597221|P1|COMPLETED|Overall Study||5
7556094|NCT03022916|18597218|P4|Nail Polish, Top Coat|Overall Study||5
7556095|NCT03022916|18597219|P3|Nail Polish, Top Coat|Overall Study||5
7556096|NCT03022916|18597220|P2|Nail Polish, Top Coat|Overall Study||5
7556097|NCT03022916|18597221|P1|Nail Polish, Top Coat|Overall Study||5
7556098|NCT03022916|18597218|P4|Nail Polish, Base Coat|Overall Study||5
7556099|NCT03022916|18597219|P3|Nail Polish, Base Coat|Overall Study||5
7556100|NCT03022916|18597220|P2|Nail Polish, Base Coat|Overall Study||5
7556101|NCT03022916|18597221|P1|Nail Polish, Base Coat|Overall Study||5
7556102|NCT03022916|18597218|P4|Nail Polish|Overall Study||5
7556103|NCT03022916|18597219|P3|Nail Polish|Overall Study||5
7556104|NCT03022916|18597220|P2|Nail Polish|Overall Study||5
7556105|NCT03022916|18597221|P1|Nail Polish|Overall Study||5
7556106|NCT03022916|18597218|P4|STARTED|Overall Study||5
7556107|NCT03022916|18597219|P3|STARTED|Overall Study||5
7556108|NCT03022916|18597220|P2|STARTED|Overall Study||5
7556109|NCT03022916|18597221|P1|STARTED|Overall Study||5
7556110|NCT03022799|18597241|P13|NOT COMPLETED|Overall Study||0
7556111|NCT03022799|18597242|P12|NOT COMPLETED|Overall Study||0
7556112|NCT03022799|18597243|P11|NOT COMPLETED|Overall Study||1
7556113|NCT03022799|18597244|P10|NOT COMPLETED|Overall Study||1
7556114|NCT03022799|18597245|P9|NOT COMPLETED|Overall Study||0
7556115|NCT03022799|18597246|P8|NOT COMPLETED|Overall Study||0
7556116|NCT03022799|18597247|P7|NOT COMPLETED|Overall Study||0
7556117|NCT03022799|18597248|P6|NOT COMPLETED|Overall Study||0
7556118|NCT03022799|18597249|P5|NOT COMPLETED|Overall Study||0
7556119|NCT03022799|18597250|P4|NOT COMPLETED|Overall Study||0
7556120|NCT03022799|18597251|P3|NOT COMPLETED|Overall Study||0
7556121|NCT03022799|18597252|P2|NOT COMPLETED|Overall Study||0
7556122|NCT03022799|18597253|P1|NOT COMPLETED|Overall Study||0
7556123|NCT03022799|18597241|P13|COMPLETED|Overall Study||10
7556124|NCT03022799|18597242|P12|COMPLETED|Overall Study||6
7556125|NCT03022799|18597243|P11|COMPLETED|Overall Study||5
7556126|NCT03022799|18597244|P10|COMPLETED|Overall Study||5
7556127|NCT03022799|18597245|P9|COMPLETED|Overall Study||6
7556128|NCT03022799|18597246|P8|COMPLETED|Overall Study||6
7556129|NCT03022799|18597247|P7|COMPLETED|Overall Study||12
7556130|NCT03022799|18597248|P6|COMPLETED|Overall Study||6
7556131|NCT03022799|18597249|P5|COMPLETED|Overall Study||6
7556132|NCT03022799|18597250|P4|COMPLETED|Overall Study||6
7556133|NCT03022799|18597251|P3|COMPLETED|Overall Study||6
7556134|NCT03022799|18597252|P2|COMPLETED|Overall Study||6
7556135|NCT03022799|18597253|P1|COMPLETED|Overall Study||6
7556136|NCT03022799|18597241|P13|STARTED|Overall Study||10
7556137|NCT03022799|18597242|P12|STARTED|Overall Study||6
7556138|NCT03022799|18597243|P11|STARTED|Overall Study||6
7556139|NCT03022799|18597244|P10|STARTED|Overall Study||6
7556140|NCT03022799|18597245|P9|STARTED|Overall Study||6
7556141|NCT03022799|18597246|P8|STARTED|Overall Study||6
7556142|NCT03022799|18597247|P7|STARTED|Overall Study||12
7556143|NCT03022799|18597248|P6|STARTED|Overall Study||6
7556144|NCT03022799|18597249|P5|STARTED|Overall Study||6
7556145|NCT03022799|18597250|P4|STARTED|Overall Study||6
7556146|NCT03022799|18597251|P3|STARTED|Overall Study||6
7556147|NCT03022799|18597252|P2|STARTED|Overall Study||6
7556148|NCT03022799|18597253|P1|STARTED|Overall Study||6
7556149|NCT03022630|18597450|P2|NOT COMPLETED|Overall Study||12
7556150|NCT03022630|18597451|P1|NOT COMPLETED|Overall Study||9
7556151|NCT03022630|18597450|P2|COMPLETED|Overall Study||20
7556152|NCT03022630|18597451|P1|COMPLETED|Overall Study||22
7556153|NCT03022630|18597450|P2|STARTED|Overall Study||32
7556154|NCT03022630|18597451|P1|STARTED|Overall Study||31
7556155|NCT03022526|18597501|P2|NOT COMPLETED|Overall Study||5
7556156|NCT03022526|18597502|P1|NOT COMPLETED|Overall Study||10
7556157|NCT03022526|18597501|P2|COMPLETED|Overall Study||25
7556158|NCT03022526|18597502|P1|COMPLETED|Overall Study||21
7556159|NCT03022526|18597501|P2|STARTED|Overall Study||30
7556160|NCT03022526|18597502|P1|STARTED|Overall Study||31
7556161|NCT03022435|18597541|P5|NOT COMPLETED|Overall Study||0
7556162|NCT03022435|18597542|P4|NOT COMPLETED|Overall Study||0
7556163|NCT03022435|18597543|P3|NOT COMPLETED|Overall Study||0
7556164|NCT03022435|18597544|P2|NOT COMPLETED|Overall Study||0
7556165|NCT03022435|18597545|P1|NOT COMPLETED|Overall Study||0
7556166|NCT03022435|18597541|P5|COMPLETED|Overall Study||3
7556167|NCT03022435|18597542|P4|COMPLETED|Overall Study||3
7556168|NCT03022435|18597543|P3|COMPLETED|Overall Study||6
7556169|NCT03022435|18597544|P2|COMPLETED|Overall Study||5
7556170|NCT03022435|18597545|P1|COMPLETED|Overall Study||5
7556171|NCT03022435|18597541|P5|STARTED|Overall Study||3
7556172|NCT03022435|18597542|P4|STARTED|Overall Study||3
7556173|NCT03022435|18597543|P3|STARTED|Overall Study||6
7556174|NCT03022435|18597544|P2|STARTED|Overall Study||5
7556175|NCT03022435|18597545|P1|STARTED|Overall Study||5
7556176|NCT03022422|18597568|P6|NOT COMPLETED|Overall Study||0
7556177|NCT03022422|18597569|P5|NOT COMPLETED|Overall Study||0
7556178|NCT03022422|18597570|P4|NOT COMPLETED|Overall Study||0
7556179|NCT03022422|18597571|P3|NOT COMPLETED|Overall Study||3
7556180|NCT03022422|18597572|P2|NOT COMPLETED|Overall Study||0
7556181|NCT03022422|18597573|P1|NOT COMPLETED|Overall Study||0
7556182|NCT03022422|18597568|P6|COMPLETED|Overall Study||5
7556183|NCT03022422|18597569|P5|COMPLETED|Overall Study||5
7556184|NCT03022422|18597570|P4|COMPLETED|Overall Study||12
7556185|NCT03022422|18597571|P3|COMPLETED|Overall Study||20
7556186|NCT03022422|18597572|P2|COMPLETED|Overall Study||10
7556187|NCT03022422|18597573|P1|COMPLETED|Overall Study||8
7556188|NCT03022422|18597568|P6|STARTED|Overall Study||5
7556189|NCT03022422|18597569|P5|STARTED|Overall Study||5
7556190|NCT03022422|18597570|P4|STARTED|Overall Study||12
7556191|NCT03022422|18597571|P3|STARTED|Overall Study||23
7556192|NCT03022422|18597572|P2|STARTED|Overall Study||10
7556193|NCT03022422|18597573|P1|STARTED|Overall Study||8
7556194|NCT03022396|18597599|P6|NOT COMPLETED|Overall Study||0
7556195|NCT03022396|18597600|P5|NOT COMPLETED|Overall Study||0
7556196|NCT03022396|18597601|P4|NOT COMPLETED|Overall Study||0
7556197|NCT03022396|18597602|P3|NOT COMPLETED|Overall Study||0
7556198|NCT03022396|18597603|P2|NOT COMPLETED|Overall Study||0
7556199|NCT03022396|18597604|P1|NOT COMPLETED|Overall Study||0
7556200|NCT03022396|18597599|P6|COMPLETED|Overall Study||8
7556201|NCT03022396|18597600|P5|COMPLETED|Overall Study||14
7556202|NCT03022396|18597601|P4|COMPLETED|Overall Study||20
7556203|NCT03022396|18597602|P3|COMPLETED|Overall Study||10
7556204|NCT03022396|18597603|P2|COMPLETED|Overall Study||14
7556205|NCT03022396|18597604|P1|COMPLETED|Overall Study||16
7556206|NCT03022396|18597599|P6|STARTED|Overall Study||8
7556207|NCT03022396|18597600|P5|STARTED|Overall Study||14
7556208|NCT03022396|18597601|P4|STARTED|Overall Study||20
7556209|NCT03022396|18597602|P3|STARTED|Overall Study||10
7556210|NCT03022396|18597603|P2|STARTED|Overall Study||14
7556211|NCT03022396|18597604|P1|STARTED|Overall Study||16
7556212|NCT03022370|18597628|P2|NOT COMPLETED|Overall Study||121
7556213|NCT03022370|18597629|P1|NOT COMPLETED|Overall Study||180
7556214|NCT03022370|18597628|P2|COMPLETED|Overall Study||553
7556215|NCT03022370|18597629|P1|COMPLETED|Overall Study||497
7556216|NCT03022370|18597628|P2|STARTED|Overall Study||674
7556217|NCT03022370|18597629|P1|STARTED|Overall Study||677
7556218|NCT03022084|18597705|P2|NOT COMPLETED|Overall Study||3
7556219|NCT03022084|18597706|P1|NOT COMPLETED|Overall Study||2
7556220|NCT03022084|18597705|P2|COMPLETED|Overall Study||29
7556221|NCT03022084|18597706|P1|COMPLETED|Overall Study||27
7556222|NCT03022084|18597705|P2|STARTED|Overall Study||32
7556223|NCT03022084|18597706|P1|STARTED|Overall Study||29
7556224|NCT03022045|18597714|P2|NOT COMPLETED|Overall Study||2
7556225|NCT03022045|18597715|P1|NOT COMPLETED|Overall Study||1
7556226|NCT03022045|18597714|P2|COMPLETED|Overall Study||6
7556227|NCT03022045|18597715|P1|COMPLETED|Overall Study||8
7556228|NCT03022045|18597714|P2|STARTED|Overall Study||8
7556229|NCT03022045|18597715|P1|STARTED|Overall Study||9
7556230|NCT03021759|18597732|P3|NOT COMPLETED|Overall Study||0
7556231|NCT03021759|18597733|P2|NOT COMPLETED|Overall Study||0
7556232|NCT03021759|18597734|P1|NOT COMPLETED|Overall Study||0
7556233|NCT03021759|18597732|P3|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1465
7556234|NCT03021759|18597733|P2|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1743
7556235|NCT03021759|18597734|P1|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1566
7556236|NCT03021759|18597732|P3|STARTED|Overall Study||1465
7556237|NCT03021759|18597733|P2|STARTED|Overall Study||1743
7556238|NCT03021759|18597734|P1|STARTED|Overall Study||1566
7556239|NCT03021668|18597744|P2|NOT COMPLETED|Overall Study||1
7556240|NCT03021668|18597745|P1|NOT COMPLETED|Overall Study||0
7556241|NCT03021668|18597744|P2|COMPLETED|Overall Study||61
7556242|NCT03021668|18597745|P1|COMPLETED|Overall Study||62
7556243|NCT03021668|18597744|P2|STARTED|Overall Study||62
7556244|NCT03021668|18597745|P1|STARTED|Overall Study||62
7556245|NCT03021642|18597757|P2|NOT COMPLETED|Treatment Period 2 (Day 22)||0
7556246|NCT03021642|18597758|P1|NOT COMPLETED|Treatment Period 2 (Day 22)||0
7556247|NCT03021642|18597757|P2|COMPLETED|Treatment Period 2 (Day 22)||11
7556248|NCT03021642|18597758|P1|COMPLETED|Treatment Period 2 (Day 22)||11
7556249|NCT03021642|18597757|P2|STARTED|Treatment Period 2 (Day 22)||11
7556250|NCT03021642|18597758|P1|STARTED|Treatment Period 2 (Day 22)||11
7556251|NCT03021642|18597757|P2|NOT COMPLETED|Washout Period (21 Days)||1
7556252|NCT03021642|18597758|P1|NOT COMPLETED|Washout Period (21 Days)||1
7556253|NCT03021642|18597757|P2|COMPLETED|Washout Period (21 Days)||11
7556254|NCT03021642|18597758|P1|COMPLETED|Washout Period (21 Days)||11
7556255|NCT03021642|18597757|P2|STARTED|Washout Period (21 Days)||12
7556256|NCT03021642|18597758|P1|STARTED|Washout Period (21 Days)||12
7556257|NCT03021642|18597757|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
7556258|NCT03021642|18597758|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
7556259|NCT03021642|18597757|P2|COMPLETED|Treatment Period 1 (Day 1)||12
7556260|NCT03021642|18597758|P1|COMPLETED|Treatment Period 1 (Day 1)||12
7556261|NCT03021642|18597757|P2|STARTED|Treatment Period 1 (Day 1)||12
7556262|NCT03021642|18597758|P1|STARTED|Treatment Period 1 (Day 1)||12
7556263|NCT03021564|18597798|P2|NOT COMPLETED|Overall Study||468
7556264|NCT03021564|18597799|P1|NOT COMPLETED|Overall Study||84
7556265|NCT03021564|18597798|P2|COMPLETED|Overall Study||89
7556266|NCT03021564|18597799|P1|COMPLETED|Overall Study||36
7556267|NCT03021564|18597798|P2|STARTED|Overall Study||557
7556268|NCT03021564|18597799|P1|STARTED|Overall Study||120
7556269|NCT03021538|18597825|P2|NOT COMPLETED|Overall Study||0
7556270|NCT03021538|18597826|P1|NOT COMPLETED|Overall Study||0
7556271|NCT03021538|18597825|P2|COMPLETED|Overall Study||7
7556272|NCT03021538|18597826|P1|COMPLETED|Overall Study||6
7556273|NCT03021538|18597825|P2|STARTED|Overall Study||7
7556274|NCT03021538|18597826|P1|STARTED|Overall Study||6
7556275|NCT03021343|18597834|P2|NOT COMPLETED|Overall Study||7
7556276|NCT03021343|18597835|P1|NOT COMPLETED|Overall Study||5
7556277|NCT03021343|18597834|P2|COMPLETED|Overall Study||174
7556278|NCT03021343|18597835|P1|COMPLETED|Overall Study||174
7556279|NCT03021343|18597834|P2|STARTED|Overall Study||181
7556280|NCT03021343|18597835|P1|STARTED|Overall Study||179
7556281|NCT03021304|18597843|P1|NOT COMPLETED|Overall Study||1
7556282|NCT03021304|18597843|P1|COMPLETED|Overall Study||55
7556283|NCT03021304|18597843|P1|STARTED|Overall Study||56
7556284|NCT03021265|18597848|P1|NOT COMPLETED|Overall Study||122
7556285|NCT03021265|18597848|P1|COMPLETED|Overall Study||554
7556286|NCT03021265|18597848|P1|STARTED|Overall Study||676
7556287|NCT03021187|18597858|P4|NOT COMPLETED|Overall Study||9
7556288|NCT03021187|18597859|P3|NOT COMPLETED|Overall Study||6
7556289|NCT03021187|18597860|P2|NOT COMPLETED|Overall Study||9
7556290|NCT03021187|18597861|P1|NOT COMPLETED|Overall Study||10
7556291|NCT03021187|18597858|P4|COMPLETED|Overall Study||175
7556292|NCT03021187|18597859|P3|COMPLETED|Overall Study||175
7556293|NCT03021187|18597860|P2|COMPLETED|Overall Study||173
7556294|NCT03021187|18597861|P1|COMPLETED|Overall Study||174
7556295|NCT03021187|18597858|P4|Safety Analysis Set (SAS)|Overall Study||184
7556296|NCT03021187|18597859|P3|Safety Analysis Set (SAS)|Overall Study||181
7556297|NCT03021187|18597860|P2|Safety Analysis Set (SAS)|Overall Study||181
7556298|NCT03021187|18597861|P1|Safety Analysis Set (SAS)|Overall Study||184
7556299|NCT03021187|18597858|P4|Full Analysis Set (FAS)|Overall Study||184
7556300|NCT03021187|18597859|P3|Full Analysis Set (FAS)|Overall Study||181
7556301|NCT03021187|18597860|P2|Full Analysis Set (FAS)|Overall Study||182
7556302|NCT03021187|18597861|P1|Full Analysis Set (FAS)|Overall Study||184
7556303|NCT03021187|18597858|P4|Exposed|Overall Study||184
7556304|NCT03021187|18597859|P3|Exposed|Overall Study||181
7556305|NCT03021187|18597860|P2|Exposed|Overall Study||181
7556306|NCT03021187|18597861|P1|Exposed|Overall Study||184
7556307|NCT03021187|18597858|P4|STARTED|Overall Study||184
7556308|NCT03021187|18597859|P3|STARTED|Overall Study||181
7556309|NCT03021187|18597860|P2|STARTED|Overall Study||182
7556310|NCT03021187|18597861|P1|STARTED|Overall Study||184
7556311|NCT03021018|18598017|P3|NOT COMPLETED|Overall Study||0
7556312|NCT03021018|18598018|P2|NOT COMPLETED|Overall Study||0
7556313|NCT03021018|18598019|P1|NOT COMPLETED|Overall Study||2
7556314|NCT03021018|18598017|P3|COMPLETED|Overall Study||15
7556315|NCT03021018|18598018|P2|COMPLETED|Overall Study||15
7556316|NCT03021018|18598019|P1|COMPLETED|Overall Study||14
7556317|NCT03021018|18598017|P3|STARTED|Overall Study||15
7556318|NCT03021018|18598018|P2|STARTED|Overall Study||15
7556319|NCT03021018|18598019|P1|STARTED|Overall Study||16
7556320|NCT03021005|18598050|P2|NOT COMPLETED|Overall Study||26
7556321|NCT03021005|18598051|P1|NOT COMPLETED|Overall Study||39
7556322|NCT03021005|18598050|P2|COMPLETED|Overall Study||72
7556323|NCT03021005|18598051|P1|COMPLETED|Overall Study||63
7556324|NCT03021005|18598050|P2|STARTED|Overall Study||98
7556325|NCT03021005|18598051|P1|STARTED|Overall Study||102
7556326|NCT03020992|18598057|P1|NOT COMPLETED|Overall Study||6
7556327|NCT03020992|18598057|P1|COMPLETED|Overall Study||83
7556328|NCT03020992|18598057|P1|STARTED|Overall Study||89
7556329|NCT03020745|18598100|P10|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
7556330|NCT03020745|18598101|P9|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||3
7556331|NCT03020745|18598102|P8|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
7556332|NCT03020745|18598103|P7|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
7556333|NCT03020745|18598104|P6|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||1
7556334|NCT03020745|18598105|P5|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
7556335|NCT03020745|18598106|P4|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
7556336|NCT03020745|18598107|P3|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
7556337|NCT03020745|18598108|P2|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
7556338|NCT03020745|18598109|P1|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
7556339|NCT03020745|18598100|P10|COMPLETED|Part 2:Optional FU (Up to 450 Days)||15
7556340|NCT03020745|18598101|P9|COMPLETED|Part 2:Optional FU (Up to 450 Days)||10
7556341|NCT03020745|18598102|P8|COMPLETED|Part 2:Optional FU (Up to 450 Days)||17
7556342|NCT03020745|18598103|P7|COMPLETED|Part 2:Optional FU (Up to 450 Days)||5
7556343|NCT03020745|18598104|P6|COMPLETED|Part 2:Optional FU (Up to 450 Days)||9
7556344|NCT03020745|18598105|P5|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
7556345|NCT03020745|18598106|P4|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
7556346|NCT03020745|18598107|P3|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
7556347|NCT03020745|18598108|P2|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
7556348|NCT03020745|18598109|P1|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
7556349|NCT03020745|18598100|P10|STARTED|Part 2:Optional FU (Up to 450 Days)||15
7556350|NCT03020745|18598101|P9|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant did not enter into optional follow-up period|13
7556351|NCT03020745|18598102|P8|STARTED|Part 2:Optional FU (Up to 450 Days)|2 participants didn't enter into optional follow-up period.|17
7556352|NCT03020745|18598103|P7|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant didn't enter into optional follow-up period.|5
7556353|NCT03020745|18598104|P6|STARTED|Part 2:Optional FU (Up to 450 Days)||10
7556354|NCT03020745|18598105|P5|STARTED|Part 2:Optional FU (Up to 450 Days)||0
7556355|NCT03020745|18598106|P4|STARTED|Part 2:Optional FU (Up to 450 Days)||0
7556356|NCT03020745|18598107|P3|STARTED|Part 2:Optional FU (Up to 450 Days)||0
7556357|NCT03020745|18598108|P2|STARTED|Part 2:Optional FU (Up to 450 Days)||0
7556358|NCT03020745|18598109|P1|STARTED|Part 2:Optional FU (Up to 450 Days)||0
7556359|NCT03020745|18598100|P10|NOT COMPLETED|Part 2 (Up to 169 Days)||0
7556360|NCT03020745|18598101|P9|NOT COMPLETED|Part 2 (Up to 169 Days)||1
7556361|NCT03020745|18598102|P8|NOT COMPLETED|Part 2 (Up to 169 Days)||1
7556362|NCT03020745|18598103|P7|NOT COMPLETED|Part 2 (Up to 169 Days)||0
7556363|NCT03020745|18598104|P6|NOT COMPLETED|Part 2 (Up to 169 Days)||0
7556364|NCT03020745|18598105|P5|NOT COMPLETED|Part 2 (Up to 169 Days)||0
7556365|NCT03020745|18598106|P4|NOT COMPLETED|Part 2 (Up to 169 Days)||0
7556366|NCT03020745|18598107|P3|NOT COMPLETED|Part 2 (Up to 169 Days)||0
7556367|NCT03020745|18598108|P2|NOT COMPLETED|Part 2 (Up to 169 Days)||0
7556368|NCT03020745|18598109|P1|NOT COMPLETED|Part 2 (Up to 169 Days)||0
7556369|NCT03020745|18598100|P10|COMPLETED|Part 2 (Up to 169 Days)||15
7556370|NCT03020745|18598101|P9|COMPLETED|Part 2 (Up to 169 Days)||14
7556371|NCT03020745|18598102|P8|COMPLETED|Part 2 (Up to 169 Days)||19
7556372|NCT03020745|18598103|P7|COMPLETED|Part 2 (Up to 169 Days)||6
7556373|NCT03020745|18598104|P6|COMPLETED|Part 2 (Up to 169 Days)||10
7556374|NCT03020745|18598105|P5|COMPLETED|Part 2 (Up to 169 Days)||0
7556375|NCT03020745|18598106|P4|COMPLETED|Part 2 (Up to 169 Days)||0
7556376|NCT03020745|18598107|P3|COMPLETED|Part 2 (Up to 169 Days)||0
7556377|NCT03020745|18598108|P2|COMPLETED|Part 2 (Up to 169 Days)||0
7556378|NCT03020745|18598109|P1|COMPLETED|Part 2 (Up to 169 Days)||0
7556379|NCT03020745|18598100|P10|STARTED|Part 2 (Up to 169 Days)||15
7556380|NCT03020745|18598101|P9|STARTED|Part 2 (Up to 169 Days)||15
7556381|NCT03020745|18598102|P8|STARTED|Part 2 (Up to 169 Days)||20
7556382|NCT03020745|18598103|P7|STARTED|Part 2 (Up to 169 Days)||6
7556383|NCT03020745|18598104|P6|STARTED|Part 2 (Up to 169 Days)||10
7556384|NCT03020745|18598105|P5|STARTED|Part 2 (Up to 169 Days)||0
7556385|NCT03020745|18598106|P4|STARTED|Part 2 (Up to 169 Days)||0
7556386|NCT03020745|18598107|P3|STARTED|Part 2 (Up to 169 Days)||0
7556387|NCT03020745|18598108|P2|STARTED|Part 2 (Up to 169 Days)||0
7556388|NCT03020745|18598109|P1|STARTED|Part 2 (Up to 169 Days)||0
7556389|NCT03020745|18598100|P10|NOT COMPLETED|Part 1 (Up to 60 Days)||0
7556390|NCT03020745|18598101|P9|NOT COMPLETED|Part 1 (Up to 60 Days)||0
7556391|NCT03020745|18598102|P8|NOT COMPLETED|Part 1 (Up to 60 Days)||0
7556392|NCT03020745|18598103|P7|NOT COMPLETED|Part 1 (Up to 60 Days)||0
7556393|NCT03020745|18598104|P6|NOT COMPLETED|Part 1 (Up to 60 Days)||0
7556394|NCT03020745|18598105|P5|NOT COMPLETED|Part 1 (Up to 60 Days)||0
7556395|NCT03020745|18598106|P4|NOT COMPLETED|Part 1 (Up to 60 Days)||0
7556396|NCT03020745|18598107|P3|NOT COMPLETED|Part 1 (Up to 60 Days)||0
7556397|NCT03020745|18598108|P2|NOT COMPLETED|Part 1 (Up to 60 Days)||0
7556398|NCT03020745|18598109|P1|NOT COMPLETED|Part 1 (Up to 60 Days)||0
7556399|NCT03020745|18598100|P10|COMPLETED|Part 1 (Up to 60 Days)||0
7556400|NCT03020745|18598101|P9|COMPLETED|Part 1 (Up to 60 Days)||0
7556401|NCT03020745|18598102|P8|COMPLETED|Part 1 (Up to 60 Days)||0
7556402|NCT03020745|18598103|P7|COMPLETED|Part 1 (Up to 60 Days)||0
7556403|NCT03020745|18598104|P6|COMPLETED|Part 1 (Up to 60 Days)||0
7556404|NCT03020745|18598105|P5|COMPLETED|Part 1 (Up to 60 Days)||0
7556405|NCT03020745|18598106|P4|COMPLETED|Part 1 (Up to 60 Days)||6
7556406|NCT03020745|18598107|P3|COMPLETED|Part 1 (Up to 60 Days)||0
7556407|NCT03020745|18598108|P2|COMPLETED|Part 1 (Up to 60 Days)||3
7556408|NCT03020745|18598109|P1|COMPLETED|Part 1 (Up to 60 Days)||3
7556409|NCT03020745|18598100|P10|STARTED|Part 1 (Up to 60 Days)||0
7556410|NCT03020745|18598101|P9|STARTED|Part 1 (Up to 60 Days)||0
7556411|NCT03020745|18598102|P8|STARTED|Part 1 (Up to 60 Days)||0
7556412|NCT03020745|18598103|P7|STARTED|Part 1 (Up to 60 Days)||0
7556413|NCT03020745|18598104|P6|STARTED|Part 1 (Up to 60 Days)||0
7556414|NCT03020745|18598105|P5|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
7556415|NCT03020745|18598106|P4|STARTED|Part 1 (Up to 60 Days)||6
7556416|NCT03020745|18598107|P3|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
7556417|NCT03020745|18598108|P2|STARTED|Part 1 (Up to 60 Days)||3
7556418|NCT03020745|18598109|P1|STARTED|Part 1 (Up to 60 Days)||3
7556419|NCT03020719|18598449|P2|NOT COMPLETED|Overall Study||2
7556420|NCT03020719|18598450|P1|NOT COMPLETED|Overall Study||0
7556421|NCT03020719|18598449|P2|COMPLETED|Overall Study||28
7556422|NCT03020719|18598450|P1|COMPLETED|Overall Study||30
7556423|NCT03020719|18598449|P2|STARTED|Overall Study||30
7556424|NCT03020719|18598450|P1|STARTED|Overall Study||30
7556425|NCT03020576|18598470|P2|NOT COMPLETED|Overall Study||2
7556426|NCT03020576|18598471|P1|NOT COMPLETED|Overall Study||1
7556427|NCT03020576|18598470|P2|COMPLETED|Overall Study||14
7556428|NCT03020576|18598471|P1|COMPLETED|Overall Study||14
7556429|NCT03020576|18598470|P2|STARTED|Overall Study||16
7556430|NCT03020576|18598471|P1|STARTED|Overall Study||15
7556431|NCT03020537|18598493|P2|NOT COMPLETED|Overall Study||0
7556432|NCT03020537|18598494|P1|NOT COMPLETED|Overall Study||0
7556433|NCT03020537|18598493|P2|COMPLETED|Overall Study||7
7556434|NCT03020537|18598494|P1|COMPLETED|Overall Study||1
7556435|NCT03020537|18598493|P2|STARTED|Overall Study||7
7556436|NCT03020537|18598494|P1|STARTED|Overall Study||1
7556437|NCT03020524|18598505|P3|NOT COMPLETED|Overall Study||0
7556438|NCT03020524|18598506|P2|NOT COMPLETED|Overall Study||0
7556439|NCT03020524|18598507|P1|NOT COMPLETED|Overall Study||0
7556440|NCT03020524|18598505|P3|COMPLETED|Overall Study||3
7556441|NCT03020524|18598506|P2|COMPLETED|Overall Study||3
7556442|NCT03020524|18598507|P1|COMPLETED|Overall Study||3
7556443|NCT03020524|18598505|P3|STARTED|Overall Study||3
7556444|NCT03020524|18598506|P2|STARTED|Overall Study||3
7556445|NCT03020524|18598507|P1|STARTED|Overall Study||3
7556446|NCT03020498|18598518|P3|NOT COMPLETED|Overall Study||0
7556447|NCT03020498|18598519|P2|NOT COMPLETED|Overall Study||3
7556448|NCT03020498|18598520|P1|NOT COMPLETED|Overall Study||0
7556449|NCT03020498|18598518|P3|COMPLETED|Overall Study||36
7556450|NCT03020498|18598519|P2|COMPLETED|Overall Study||38
7556451|NCT03020498|18598520|P1|COMPLETED|Overall Study||14
7556452|NCT03020498|18598518|P3|STARTED|Overall Study||36
7556453|NCT03020498|18598519|P2|STARTED|Overall Study||41
7556454|NCT03020498|18598520|P1|STARTED|Overall Study||14
7556455|NCT03020472|18598531|P1|NOT COMPLETED|Overall Study||0
7556456|NCT03020472|18598531|P1|COMPLETED|Overall Study||6
7556457|NCT03020472|18598531|P1|STARTED|Overall Study||6
7556458|NCT03020446|18598537|P1|NOT COMPLETED|Overall Study||3
7556459|NCT03020446|18598537|P1|COMPLETED|Overall Study||0
7556460|NCT03020446|18598537|P1|STARTED|Overall Study||3
7556461|NCT03020160|18598545|P2|NOT COMPLETED|Overall Study||41
7556462|NCT03020160|18598546|P1|NOT COMPLETED|Overall Study||7
7556463|NCT03020160|18598545|P2|COMPLETED|Overall Study||0
7556464|NCT03020160|18598546|P1|COMPLETED|Overall Study||0
7556465|NCT03020160|18598545|P2|Completed 24 Weeks in the Study|Overall Study||41
7556466|NCT03020160|18598546|P1|Completed 24 Weeks in the Study|Overall Study||7
7556467|NCT03020160|18598545|P2|STARTED|Overall Study||41
7556468|NCT03020160|18598546|P1|STARTED|Overall Study||7
7556469|NCT03020095|18598599|P1|NOT COMPLETED|Overall Study||1
7556470|NCT03020095|18598599|P1|COMPLETED|Overall Study||37
7556471|NCT03020095|18598599|P1|STARTED|Overall Study||38
7556472|NCT03020069|18598605|P2|NOT COMPLETED|Overall Study||1
7556473|NCT03020069|18598606|P1|NOT COMPLETED|Overall Study||0
7556474|NCT03020069|18598605|P2|COMPLETED|Overall Study||3
7556475|NCT03020069|18598606|P1|COMPLETED|Overall Study||9
7556476|NCT03020069|18598605|P2|STARTED|Overall Study||4
7556477|NCT03020069|18598606|P1|STARTED|Overall Study||9
7556478|NCT03020004|18598618|P1|NOT COMPLETED|Overall Study||1
7556479|NCT03020004|18598618|P1|COMPLETED|Overall Study||69
7556480|NCT03020004|18598618|P1|STARTED|Overall Study||70
7556481|NCT03019783|18598624|P2|NOT COMPLETED|Overall Study||0
7556482|NCT03019783|18598625|P1|NOT COMPLETED|Overall Study||0
7556483|NCT03019783|18598624|P2|COMPLETED|Overall Study||31
7556484|NCT03019783|18598625|P1|COMPLETED|Overall Study||29
7556485|NCT03019783|18598624|P2|STARTED|Overall Study||31
7556486|NCT03019783|18598625|P1|STARTED|Overall Study||29
7556487|NCT03019744|18598635|P2|NOT COMPLETED|Overall Study||8
7556488|NCT03019744|18598636|P1|NOT COMPLETED|Overall Study||6
7556489|NCT03019744|18598635|P2|COMPLETED|Overall Study||36
7556490|NCT03019744|18598636|P1|COMPLETED|Overall Study||32
7556491|NCT03019744|18598635|P2|STARTED|Overall Study||44
7556492|NCT03019744|18598636|P1|STARTED|Overall Study||38
7556493|NCT03019627|18598652|P2|NOT COMPLETED|Overall Study||8
7556494|NCT03019627|18598653|P1|NOT COMPLETED|Overall Study||15
7556495|NCT03019627|18598652|P2|COMPLETED|Overall Study||42
7556496|NCT03019627|18598653|P1|COMPLETED|Overall Study||85
7556497|NCT03019627|18598652|P2|STARTED|Overall Study||50
7556498|NCT03019627|18598653|P1|STARTED|Overall Study||100
7556499|NCT03019549|18598669|P1|NOT COMPLETED|Period 2||5
7556500|NCT03019549|18598669|P1|COMPLETED|Period 2||26
7556501|NCT03019549|18598669|P1|Received at Least 1 Dose of Study Drug|Period 2||29
7556502|NCT03019549|18598669|P1|STARTED|Period 2||31
7556503|NCT03019549|18598669|P1|NOT COMPLETED|Washout||11
7556504|NCT03019549|18598669|P1|COMPLETED|Washout||31
7556505|NCT03019549|18598669|P1|STARTED|Washout||42
7556506|NCT03019549|18598669|P1|NOT COMPLETED|Period 1||0
7556507|NCT03019549|18598669|P1|COMPLETED|Period 1||42
7556508|NCT03019549|18598669|P1|Received 1 Dose of Study Drug|Period 1||42
7556509|NCT03019549|18598669|P1|STARTED|Period 1||42
7556510|NCT03019458|18598682|P2|NOT COMPLETED|Overall Study||1
7556511|NCT03019458|18598683|P1|NOT COMPLETED|Overall Study||0
7556512|NCT03019458|18598682|P2|COMPLETED|Overall Study||25
7556513|NCT03019458|18598683|P1|COMPLETED|Overall Study||24
7556514|NCT03019458|18598682|P2|STARTED|Overall Study||26
7556515|NCT03019458|18598683|P1|STARTED|Overall Study||24
7556516|NCT03018938|18598697|P2|NOT COMPLETED|Overall Study||85
7556517|NCT03018938|18598698|P1|NOT COMPLETED|Overall Study||66
7556518|NCT03018938|18598697|P2|COMPLETED|Overall Study||325
7556519|NCT03018938|18598698|P1|COMPLETED|Overall Study||338
7556520|NCT03018938|18598697|P2|Received at Least 1 Dose of Study Drug|Overall Study||410
7556521|NCT03018938|18598698|P1|Received at Least 1 Dose of Study Drug|Overall Study||404
7556522|NCT03018938|18598697|P2|STARTED|Overall Study||410
7556523|NCT03018938|18598698|P1|STARTED|Overall Study||404
7556524|NCT03018691|18598737|P3|NOT COMPLETED|Overall Study||7
7556525|NCT03018691|18598738|P2|NOT COMPLETED|Overall Study||1
7556526|NCT03018691|18598739|P1|NOT COMPLETED|Overall Study||2
7556527|NCT03018691|18598737|P3|COMPLETED|Overall Study||17
7556528|NCT03018691|18598738|P2|COMPLETED|Overall Study||24
7556529|NCT03018691|18598739|P1|COMPLETED|Overall Study||22
7556530|NCT03018691|18598737|P3|STARTED|Overall Study||24
7556531|NCT03018691|18598738|P2|STARTED|Overall Study||25
7556532|NCT03018691|18598739|P1|STARTED|Overall Study||24
7556533|NCT03018340|18598775|P2|NOT COMPLETED|Overall Study||30
7556534|NCT03018340|18598776|P1|NOT COMPLETED|Overall Study||8
7556535|NCT03018340|18598775|P2|COMPLETED|Overall Study||125
7556536|NCT03018340|18598776|P1|COMPLETED|Overall Study||44
7556537|NCT03018340|18598775|P2|STARTED|Overall Study||155
7556538|NCT03018340|18598776|P1|STARTED|Overall Study||52
7556539|NCT03018223|18598826|P1|NOT COMPLETED|Overall Study||0
7556540|NCT03018223|18598826|P1|COMPLETED|Overall Study||32
7556541|NCT03018223|18598826|P1|STARTED|Overall Study||32
7556542|NCT03018106|18598835|P2|NOT COMPLETED|Overall Study||1
7556543|NCT03018106|18598836|P1|NOT COMPLETED|Overall Study||0
7556544|NCT03018106|18598835|P2|COMPLETED|Overall Study||0
7556545|NCT03018106|18598836|P1|COMPLETED|Overall Study||0
7556546|NCT03018106|18598835|P2|STARTED|Overall Study||1
7556547|NCT03018106|18598836|P1|STARTED|Overall Study||0
7556548|NCT03018028|18598849|P5|NOT COMPLETED|Overall Study||0
7556549|NCT03018028|18598850|P4|NOT COMPLETED|Overall Study||2
7556550|NCT03018028|18598851|P3|NOT COMPLETED|Overall Study||1
7556551|NCT03018028|18598852|P2|NOT COMPLETED|Overall Study||0
7556552|NCT03018028|18598853|P1|NOT COMPLETED|Overall Study||3
7556553|NCT03018028|18598849|P5|COMPLETED|Overall Study||49
7556554|NCT03018028|18598850|P4|COMPLETED|Overall Study||46
7556555|NCT03018028|18598851|P3|COMPLETED|Overall Study||47
7556556|NCT03018028|18598852|P2|COMPLETED|Overall Study||49
7556557|NCT03018028|18598853|P1|COMPLETED|Overall Study||46
7556558|NCT03018028|18598849|P5|Safety Analysis Set (SAS)|Overall Study||49
7556559|NCT03018028|18598850|P4|Safety Analysis Set (SAS)|Overall Study||48
7556560|NCT03018028|18598851|P3|Safety Analysis Set (SAS)|Overall Study||48
7556561|NCT03018028|18598852|P2|Safety Analysis Set (SAS)|Overall Study||49
7556562|NCT03018028|18598853|P1|Safety Analysis Set (SAS)|Overall Study||49
7556563|NCT03018028|18598849|P5|Full Analysis Set (FAS)|Overall Study||49
7556564|NCT03018028|18598850|P4|Full Analysis Set (FAS)|Overall Study||48
7556565|NCT03018028|18598851|P3|Full Analysis Set (FAS)|Overall Study||48
7556566|NCT03018028|18598852|P2|Full Analysis Set (FAS)|Overall Study||49
7556567|NCT03018028|18598853|P1|Full Analysis Set (FAS)|Overall Study||49
7556568|NCT03018028|18598849|P5|STARTED|Overall Study||49
7556569|NCT03018028|18598850|P4|STARTED|Overall Study||48
7556570|NCT03018028|18598851|P3|STARTED|Overall Study||48
7556571|NCT03018028|18598852|P2|STARTED|Overall Study||49
7556572|NCT03018028|18598853|P1|STARTED|Overall Study||49
7556573|NCT03017937|18599098|P1|NOT COMPLETED|Overall Study||0
7556574|NCT03017937|18599098|P1|COMPLETED|Overall Study||155
7556575|NCT03017937|18599098|P1|STARTED|Overall Study||155
7556576|NCT03017846|18599103|P1|NOT COMPLETED|Overall Study||5
7556577|NCT03017846|18599103|P1|COMPLETED|Overall Study||25
7556578|NCT03017846|18599103|P1|STARTED|Overall Study||30
7556579|NCT03017612|18599111|P1|NOT COMPLETED|Overall Study||2
7556580|NCT03017612|18599111|P1|COMPLETED|Overall Study||11
7556581|NCT03017612|18599111|P1|STARTED|Overall Study||13
7556582|NCT03017261|18599119|P1|NOT COMPLETED|12 Month Follow up||47
7556583|NCT03017261|18599119|P1|COMPLETED|12 Month Follow up|1 failed to compete 12M imaging so only 58 have 12M data for KSS Objective Score.|59
7556584|NCT03017261|18599119|P1|STARTED|12 Month Follow up||106
7556585|NCT03017261|18599119|P1|NOT COMPLETED|6 Month Follow up||9
7556586|NCT03017261|18599119|P1|COMPLETED|6 Month Follow up||106
7556587|NCT03017261|18599119|P1|STARTED|6 Month Follow up||115
7556588|NCT03017261|18599119|P1|NOT COMPLETED|3 Month Follow up||0
7556589|NCT03017261|18599119|P1|COMPLETED|3 Month Follow up|1 failed to compete 3M imaging so only 114 have 3M data for tibial slope and KSS Objective Score.|115
7556590|NCT03017261|18599119|P1|STARTED|3 Month Follow up||115
7556591|NCT03017261|18599119|P1|NOT COMPLETED|6 Week Follow up||0
7556592|NCT03017261|18599119|P1|COMPLETED|6 Week Follow up||115
7556593|NCT03017261|18599119|P1|STARTED|6 Week Follow up||115
7556594|NCT03017235|18599156|P2|NOT COMPLETED|Overall Study||14
7556595|NCT03017235|18599157|P1|NOT COMPLETED|Overall Study||12
7556596|NCT03017235|18599156|P2|COMPLETED|Overall Study||447
7556597|NCT03017235|18599157|P1|COMPLETED|Overall Study||444
7556598|NCT03017235|18599156|P2|STARTED|Overall Study||461
7556599|NCT03017235|18599157|P1|STARTED|Overall Study||456
7556600|NCT03017040|18599207|P2|NOT COMPLETED|Overall Study||1
7556601|NCT03017040|18599208|P1|NOT COMPLETED|Overall Study||1
7556602|NCT03017040|18599207|P2|COMPLETED|Overall Study||0
7556603|NCT03017040|18599208|P1|COMPLETED|Overall Study||0
7556604|NCT03017040|18599207|P2|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
7556605|NCT03017040|18599208|P1|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
7556606|NCT03016325|18599223|P5|NOT COMPLETED|182-Day Follow-Up Period||12
7556607|NCT03016325|18599224|P4|NOT COMPLETED|182-Day Follow-Up Period||13
7556608|NCT03016325|18599225|P3|NOT COMPLETED|182-Day Follow-Up Period||11
7556609|NCT03016325|18599226|P2|NOT COMPLETED|182-Day Follow-Up Period||4
7556610|NCT03016325|18599227|P1|NOT COMPLETED|182-Day Follow-Up Period||4
7556611|NCT03016325|18599223|P5|COMPLETED|182-Day Follow-Up Period||60
7556612|NCT03016325|18599224|P4|COMPLETED|182-Day Follow-Up Period||58
7556613|NCT03016325|18599225|P3|COMPLETED|182-Day Follow-Up Period||60
7556614|NCT03016325|18599226|P2|COMPLETED|182-Day Follow-Up Period||45
7556615|NCT03016325|18599227|P1|COMPLETED|182-Day Follow-Up Period||44
7556616|NCT03016325|18599223|P5|STARTED|182-Day Follow-Up Period||72
7556617|NCT03016325|18599224|P4|STARTED|182-Day Follow-Up Period||71
7556618|NCT03016325|18599225|P3|STARTED|182-Day Follow-Up Period||71
7556619|NCT03016325|18599226|P2|STARTED|182-Day Follow-Up Period||49
7556620|NCT03016325|18599227|P1|STARTED|182-Day Follow-Up Period||48
7556621|NCT03016325|18599223|P5|NOT COMPLETED|32-Day Follow-Up Period||8
7556622|NCT03016325|18599224|P4|NOT COMPLETED|32-Day Follow-Up Period||8
7556623|NCT03016325|18599225|P3|NOT COMPLETED|32-Day Follow-Up Period||9
7556624|NCT03016325|18599226|P2|NOT COMPLETED|32-Day Follow-Up Period||2
7556625|NCT03016325|18599227|P1|NOT COMPLETED|32-Day Follow-Up Period||4
7556626|NCT03016325|18599223|P5|COMPLETED|32-Day Follow-Up Period||64
7556627|NCT03016325|18599224|P4|COMPLETED|32-Day Follow-Up Period||63
7556628|NCT03016325|18599225|P3|COMPLETED|32-Day Follow-Up Period||62
7556629|NCT03016325|18599226|P2|COMPLETED|32-Day Follow-Up Period||47
7556630|NCT03016325|18599227|P1|COMPLETED|32-Day Follow-Up Period||44
7556631|NCT03016325|18599223|P5|STARTED|32-Day Follow-Up Period||72
7556632|NCT03016325|18599224|P4|STARTED|32-Day Follow-Up Period||71
7556633|NCT03016325|18599225|P3|STARTED|32-Day Follow-Up Period||71
7556634|NCT03016325|18599226|P2|STARTED|32-Day Follow-Up Period||49
7556635|NCT03016325|18599227|P1|STARTED|32-Day Follow-Up Period||48
7556636|NCT03016325|18599223|P5|NOT COMPLETED|Treatment Period||2
7556637|NCT03016325|18599224|P4|NOT COMPLETED|Treatment Period||0
7556638|NCT03016325|18599225|P3|NOT COMPLETED|Treatment Period||1
7556639|NCT03016325|18599226|P2|NOT COMPLETED|Treatment Period||1
7556640|NCT03016325|18599227|P1|NOT COMPLETED|Treatment Period||0
7556641|NCT03016325|18599223|P5|COMPLETED|Treatment Period||70
7556642|NCT03016325|18599224|P4|COMPLETED|Treatment Period||71
7556643|NCT03016325|18599225|P3|COMPLETED|Treatment Period||70
7556644|NCT03016325|18599226|P2|COMPLETED|Treatment Period||48
7556645|NCT03016325|18599227|P1|COMPLETED|Treatment Period||48
7556646|NCT03016325|18599223|P5|STARTED|Treatment Period||72
7556647|NCT03016325|18599224|P4|STARTED|Treatment Period||71
7556648|NCT03016325|18599225|P3|STARTED|Treatment Period||71
7556649|NCT03016325|18599226|P2|STARTED|Treatment Period||49
7556650|NCT03016325|18599227|P1|STARTED|Treatment Period||48
7556651|NCT03016078|18599369|P1|NOT COMPLETED|Overall Study||2
7556652|NCT03016078|18599369|P1|COMPLETED|Overall Study||19
7556653|NCT03016078|18599369|P1|STARTED|Overall Study||21
7556654|NCT03015649|18599380|P1|NOT COMPLETED|Overall Study||0
7556655|NCT03015649|18599380|P1|COMPLETED|Overall Study||34
7556656|NCT03015649|18599380|P1|STARTED|Overall Study||34
7556657|NCT03015220|18599388|P4|NOT COMPLETED|Overall Study||2
7556658|NCT03015220|18599389|P3|NOT COMPLETED|Overall Study||3
7556659|NCT03015220|18599390|P2|NOT COMPLETED|Overall Study||2
7556660|NCT03015220|18599391|P1|NOT COMPLETED|Overall Study||3
7556661|NCT03015220|18599388|P4|COMPLETED|Overall Study||63
7556662|NCT03015220|18599389|P3|COMPLETED|Overall Study||127
7556663|NCT03015220|18599390|P2|COMPLETED|Overall Study||130
7556664|NCT03015220|18599391|P1|COMPLETED|Overall Study||128
7556665|NCT03015220|18599388|P4|Safety Analysis Set (SAS)|Overall Study||65
7556666|NCT03015220|18599389|P3|Safety Analysis Set (SAS)|Overall Study||130
7556667|NCT03015220|18599390|P2|Safety Analysis Set (SAS)|Overall Study||132
7556668|NCT03015220|18599391|P1|Safety Analysis Set (SAS)|Overall Study||131
7556669|NCT03015220|18599388|P4|Full Analysis Set (FAS)|Overall Study||65
7556670|NCT03015220|18599389|P3|Full Analysis Set (FAS)|Overall Study||130
7556671|NCT03015220|18599390|P2|Full Analysis Set (FAS)|Overall Study||132
7556672|NCT03015220|18599391|P1|Full Analysis Set (FAS)|Overall Study||131
7556673|NCT03015220|18599388|P4|STARTED|Overall Study||65
7556674|NCT03015220|18599389|P3|STARTED|Overall Study||130
7556675|NCT03015220|18599390|P2|STARTED|Overall Study||132
7556676|NCT03015220|18599391|P1|STARTED|Overall Study||131
7556677|NCT03015181|18599536|P7|NOT COMPLETED|Overall Study||1
7556678|NCT03015181|18599537|P6|NOT COMPLETED|Overall Study||1
7556679|NCT03015181|18599538|P5|NOT COMPLETED|Overall Study||0
7556680|NCT03015181|18599539|P4|NOT COMPLETED|Overall Study||0
7556681|NCT03015181|18599540|P3|NOT COMPLETED|Overall Study||0
7556682|NCT03015181|18599541|P2|NOT COMPLETED|Overall Study||0
7556683|NCT03015181|18599542|P1|NOT COMPLETED|Overall Study||1
7556684|NCT03015181|18599536|P7|COMPLETED|Overall Study|Group 7 subject who received only 1 dose was withdrawn after unrelated intercurrent illness resolved|4
7556685|NCT03015181|18599537|P6|COMPLETED|Overall Study|Group 6 subject who received only 1 dose chose to withdraw from study after the first administration|4
7556686|NCT03015181|18599538|P5|COMPLETED|Overall Study||3
7556687|NCT03015181|18599539|P4|COMPLETED|Overall Study||3
7556688|NCT03015181|18599540|P3|COMPLETED|Overall Study||3
7556689|NCT03015181|18599541|P2|COMPLETED|Overall Study||3
7556690|NCT03015181|18599542|P1|COMPLETED|Overall Study||3
7556691|NCT03015181|18599536|P7|Discontinued VRC07-523LS Administrations|Overall Study|One Group 7 subject received only 1 of 3 scheduled doses due to an unrelated intercurrent illness|1
7556692|NCT03015181|18599537|P6|Discontinued VRC07-523LS Administrations|Overall Study|One Group 6 subject received only 1 of 3 scheduled doses prior to withdrawing from the study|1
7556693|NCT03015181|18599538|P5|Discontinued VRC07-523LS Administrations|Overall Study||0
7556694|NCT03015181|18599539|P4|Discontinued VRC07-523LS Administrations|Overall Study||0
7556695|NCT03015181|18599540|P3|Discontinued VRC07-523LS Administrations|Overall Study||0
7556696|NCT03015181|18599541|P2|Discontinued VRC07-523LS Administrations|Overall Study||0
7556697|NCT03015181|18599542|P1|Discontinued VRC07-523LS Administrations|Overall Study|One Group 1 subject decided not to receive the VRC07-523LS infusion|1
7556698|NCT03015181|18599536|P7|Received VRC07-523LS Per Protocol|Overall Study||4
7556699|NCT03015181|18599537|P6|Received VRC07-523LS Per Protocol|Overall Study||4
7556700|NCT03015181|18599538|P5|Received VRC07-523LS Per Protocol|Overall Study||3
7556701|NCT03015181|18599539|P4|Received VRC07-523LS Per Protocol|Overall Study||3
7556702|NCT03015181|18599540|P3|Received VRC07-523LS Per Protocol|Overall Study||3
7556703|NCT03015181|18599541|P2|Received VRC07-523LS Per Protocol|Overall Study||3
7556704|NCT03015181|18599542|P1|Received VRC07-523LS Per Protocol|Overall Study||3
7556705|NCT03015181|18599536|P7|STARTED|Overall Study||5
7556706|NCT03015181|18599537|P6|STARTED|Overall Study||5
7556707|NCT03015181|18599538|P5|STARTED|Overall Study||3
7556708|NCT03015181|18599539|P4|STARTED|Overall Study||3
7556709|NCT03015181|18599540|P3|STARTED|Overall Study||3
7556710|NCT03015181|18599541|P2|STARTED|Overall Study||3
7556711|NCT03015181|18599542|P1|STARTED|Overall Study||4
7556712|NCT03015142|18599653|P1|NOT COMPLETED|Overall Study||1
7556713|NCT03015142|18599653|P1|COMPLETED|Overall Study||20
7556714|NCT03015142|18599653|P1|STARTED|Overall Study||21
7556715|NCT03014700|18599668|P2|NOT COMPLETED|Overall Study||1
7556716|NCT03014700|18599669|P1|NOT COMPLETED|Overall Study||5
7556717|NCT03014700|18599668|P2|COMPLETED|Overall Study||29
7556718|NCT03014700|18599669|P1|COMPLETED|Overall Study||25
7556719|NCT03014700|18599668|P2|STARTED|Overall Study||30
7556720|NCT03014700|18599669|P1|STARTED|Overall Study||30
7556721|NCT03014674|18599688|P3|NOT COMPLETED|Overall Study||0
7556722|NCT03014674|18599689|P2|NOT COMPLETED|Overall Study||0
7556723|NCT03014674|18599690|P1|NOT COMPLETED|Overall Study||1
7556724|NCT03014674|18599688|P3|COMPLETED|Overall Study||80
7556725|NCT03014674|18599689|P2|COMPLETED|Overall Study||79
7556726|NCT03014674|18599690|P1|COMPLETED|Overall Study||84
7556727|NCT03014674|18599688|P3|STARTED|Overall Study||80
7556728|NCT03014674|18599689|P2|STARTED|Overall Study||79
7556729|NCT03014674|18599690|P1|STARTED|Overall Study||85
7556730|NCT03014492|18599754|P2|NOT COMPLETED|Overall Study||0
7556731|NCT03014492|18599755|P1|NOT COMPLETED|Overall Study||0
7556732|NCT03014492|18599754|P2|COMPLETED|Overall Study||28
7556733|NCT03014492|18599755|P1|COMPLETED|Overall Study||44
7556734|NCT03014492|18599754|P2|STARTED|Overall Study||28
7556735|NCT03014492|18599755|P1|STARTED|Overall Study||44
7556736|NCT03014479|18599765|P2|NOT COMPLETED|Overall Study||4
7556737|NCT03014479|18599766|P1|NOT COMPLETED|Overall Study||0
7556738|NCT03014479|18599765|P2|COMPLETED|Overall Study||105
7556739|NCT03014479|18599766|P1|COMPLETED|Overall Study||110
7556740|NCT03014479|18599765|P2|STARTED|Overall Study||109
7556741|NCT03014479|18599766|P1|STARTED|Overall Study||110
7556742|NCT03014453|18599812|P1|NOT COMPLETED|Overall Study||71
7556743|NCT03014453|18599812|P1|COMPLETED|Overall Study||116
7556744|NCT03014453|18599812|P1|STARTED|Overall Study||187
7556745|NCT03014206|18599816|P1|NOT COMPLETED|Overall Study||12
7556746|NCT03014206|18599816|P1|COMPLETED|Overall Study||684
7556747|NCT03014206|18599816|P1|STARTED|Overall Study||696
7556748|NCT03014180|18599820|P1|NOT COMPLETED|Overall Study||2
7556749|NCT03014180|18599820|P1|COMPLETED|Overall Study||58
7556750|NCT03014180|18599820|P1|STARTED|Overall Study||60
7556751|NCT03014011|18599829|P2|NOT COMPLETED|Second Intervention||0
7556752|NCT03014011|18599830|P1|NOT COMPLETED|Second Intervention||0
7556753|NCT03014011|18599829|P2|COMPLETED|Second Intervention||13
7556754|NCT03014011|18599830|P1|COMPLETED|Second Intervention||12
7556755|NCT03014011|18599829|P2|STARTED|Second Intervention||13
7556756|NCT03014011|18599830|P1|STARTED|Second Intervention||12
7556757|NCT03014011|18599829|P2|NOT COMPLETED|Washout||0
7556758|NCT03014011|18599830|P1|NOT COMPLETED|Washout||1
7556759|NCT03014011|18599829|P2|COMPLETED|Washout||13
7556760|NCT03014011|18599830|P1|COMPLETED|Washout||12
7556761|NCT03014011|18599829|P2|STARTED|Washout||13
7556762|NCT03014011|18599830|P1|STARTED|Washout||13
7556763|NCT03014011|18599829|P2|NOT COMPLETED|First Intervention||0
7556764|NCT03014011|18599830|P1|NOT COMPLETED|First Intervention||1
7556765|NCT03014011|18599829|P2|COMPLETED|First Intervention||13
7556766|NCT03014011|18599830|P1|COMPLETED|First Intervention||13
7556767|NCT03014011|18599829|P2|STARTED|First Intervention||13
7556768|NCT03014011|18599830|P1|STARTED|First Intervention||14
7556769|NCT03013985|18599838|P2|NOT COMPLETED|Overall Study||19
7556770|NCT03013985|18599839|P1|NOT COMPLETED|Overall Study||16
7556771|NCT03013985|18599838|P2|COMPLETED|Overall Study||84
7556772|NCT03013985|18599839|P1|COMPLETED|Overall Study||92
7556773|NCT03013985|18599838|P2|STARTED|Overall Study||103
7556774|NCT03013985|18599839|P1|STARTED|Overall Study||108
7556775|NCT03012841|18599871|P2|NOT COMPLETED|Overall Study||21
7556776|NCT03012841|18599872|P1|NOT COMPLETED|Overall Study||20
7556777|NCT03012841|18599871|P2|COMPLETED|Overall Study||0
7556778|NCT03012841|18599872|P1|COMPLETED|Overall Study||145
7556779|NCT03012841|18599871|P2|STARTED|Overall Study||21
7556780|NCT03012841|18599872|P1|STARTED|Overall Study||165
7556781|NCT03012828|18599886|P6|NOT COMPLETED|Overall Study||2
7556782|NCT03012828|18599887|P5|NOT COMPLETED|Overall Study||2
7556783|NCT03012828|18599888|P4|NOT COMPLETED|Overall Study||0
7556784|NCT03012828|18599889|P3|NOT COMPLETED|Overall Study||2
7556785|NCT03012828|18599890|P2|NOT COMPLETED|Overall Study||0
7556786|NCT03012828|18599891|P1|NOT COMPLETED|Overall Study||1
7556787|NCT03012828|18599886|P6|COMPLETED|Overall Study||8
7556788|NCT03012828|18599887|P5|COMPLETED|Overall Study||8
7556789|NCT03012828|18599888|P4|COMPLETED|Overall Study||10
7556790|NCT03012828|18599889|P3|COMPLETED|Overall Study||8
7556791|NCT03012828|18599890|P2|COMPLETED|Overall Study||10
7556792|NCT03012828|18599891|P1|COMPLETED|Overall Study||9
7556793|NCT03012828|18599886|P6|STARTED|Overall Study||10
7556794|NCT03012828|18599887|P5|STARTED|Overall Study||10
7556795|NCT03012828|18599888|P4|STARTED|Overall Study||10
7556796|NCT03012828|18599889|P3|STARTED|Overall Study||10
7556797|NCT03012828|18599890|P2|STARTED|Overall Study||10
7556798|NCT03012828|18599891|P1|STARTED|Overall Study||10
7556799|NCT03012334|18599934|P10|NOT COMPLETED|Period 5||0
7556800|NCT03012334|18599935|P9|NOT COMPLETED|Period 5||0
7556801|NCT03012334|18599936|P8|NOT COMPLETED|Period 5||0
7556802|NCT03012334|18599937|P7|NOT COMPLETED|Period 5||0
7556803|NCT03012334|18599938|P6|NOT COMPLETED|Period 5||0
7556804|NCT03012334|18599939|P5|NOT COMPLETED|Period 5||0
7556805|NCT03012334|18599940|P4|NOT COMPLETED|Period 5||0
7556806|NCT03012334|18599941|P3|NOT COMPLETED|Period 5||0
7556807|NCT03012334|18599942|P2|NOT COMPLETED|Period 5||0
7556808|NCT03012334|18599943|P1|NOT COMPLETED|Period 5||0
7556809|NCT03012334|18599934|P10|COMPLETED|Period 5||8
7556810|NCT03012334|18599935|P9|COMPLETED|Period 5||8
7556811|NCT03012334|18599936|P8|COMPLETED|Period 5||8
7556812|NCT03012334|18599937|P7|COMPLETED|Period 5||8
7556813|NCT03012334|18599938|P6|COMPLETED|Period 5||9
7556814|NCT03012334|18599939|P5|COMPLETED|Period 5||9
7556815|NCT03012334|18599940|P4|COMPLETED|Period 5||9
7556816|NCT03012334|18599941|P3|COMPLETED|Period 5||8
7556817|NCT03012334|18599942|P2|COMPLETED|Period 5||8
7556818|NCT03012334|18599943|P1|COMPLETED|Period 5||9
7556819|NCT03012334|18599934|P10|STARTED|Period 5||8
7556820|NCT03012334|18599935|P9|STARTED|Period 5||8
7556821|NCT03012334|18599936|P8|STARTED|Period 5||8
7556822|NCT03012334|18599937|P7|STARTED|Period 5||8
7556823|NCT03012334|18599938|P6|STARTED|Period 5||9
7556824|NCT03012334|18599939|P5|STARTED|Period 5||9
7556825|NCT03012334|18599940|P4|STARTED|Period 5||9
7556826|NCT03012334|18599941|P3|STARTED|Period 5||8
7556827|NCT03012334|18599942|P2|STARTED|Period 5||8
7556828|NCT03012334|18599943|P1|STARTED|Period 5||9
7556829|NCT03012334|18599934|P10|NOT COMPLETED|Period 4||0
7556830|NCT03012334|18599935|P9|NOT COMPLETED|Period 4||1
7556831|NCT03012334|18599936|P8|NOT COMPLETED|Period 4||0
7556832|NCT03012334|18599937|P7|NOT COMPLETED|Period 4||1
7556833|NCT03012334|18599938|P6|NOT COMPLETED|Period 4||0
7556834|NCT03012334|18599939|P5|NOT COMPLETED|Period 4||0
7556835|NCT03012334|18599940|P4|NOT COMPLETED|Period 4||0
7556836|NCT03012334|18599941|P3|NOT COMPLETED|Period 4||0
7556837|NCT03012334|18599942|P2|NOT COMPLETED|Period 4||0
7556838|NCT03012334|18599943|P1|NOT COMPLETED|Period 4||0
7556839|NCT03012334|18599934|P10|COMPLETED|Period 4||8
7556840|NCT03012334|18599935|P9|COMPLETED|Period 4||8
7556841|NCT03012334|18599936|P8|COMPLETED|Period 4||8
7556842|NCT03012334|18599937|P7|COMPLETED|Period 4||8
7556843|NCT03012334|18599938|P6|COMPLETED|Period 4||9
7556844|NCT03012334|18599939|P5|COMPLETED|Period 4||9
7556845|NCT03012334|18599940|P4|COMPLETED|Period 4||9
7556846|NCT03012334|18599941|P3|COMPLETED|Period 4||8
7556847|NCT03012334|18599942|P2|COMPLETED|Period 4||8
7556848|NCT03012334|18599943|P1|COMPLETED|Period 4||9
7556849|NCT03012334|18599934|P10|STARTED|Period 4||8
7556850|NCT03012334|18599935|P9|STARTED|Period 4||9
7556851|NCT03012334|18599936|P8|STARTED|Period 4||8
7556852|NCT03012334|18599937|P7|STARTED|Period 4||9
7556853|NCT03012334|18599938|P6|STARTED|Period 4||9
7556854|NCT03012334|18599939|P5|STARTED|Period 4||9
7556855|NCT03012334|18599940|P4|STARTED|Period 4||9
7556856|NCT03012334|18599941|P3|STARTED|Period 4||8
7556857|NCT03012334|18599942|P2|STARTED|Period 4||8
7556858|NCT03012334|18599943|P1|STARTED|Period 4||9
7556859|NCT03012334|18599934|P10|NOT COMPLETED|Period 3||0
7556860|NCT03012334|18599935|P9|NOT COMPLETED|Period 3||0
7556861|NCT03012334|18599936|P8|NOT COMPLETED|Period 3||0
7556862|NCT03012334|18599937|P7|NOT COMPLETED|Period 3||0
7556863|NCT03012334|18599938|P6|NOT COMPLETED|Period 3||0
7556864|NCT03012334|18599939|P5|NOT COMPLETED|Period 3||0
7556865|NCT03012334|18599940|P4|NOT COMPLETED|Period 3||0
7556866|NCT03012334|18599941|P3|NOT COMPLETED|Period 3||0
7556867|NCT03012334|18599942|P2|NOT COMPLETED|Period 3||0
7556868|NCT03012334|18599943|P1|NOT COMPLETED|Period 3||0
7556869|NCT03012334|18599934|P10|COMPLETED|Period 3||8
7556870|NCT03012334|18599935|P9|COMPLETED|Period 3||9
7556871|NCT03012334|18599936|P8|COMPLETED|Period 3||8
7556872|NCT03012334|18599937|P7|COMPLETED|Period 3||9
7556873|NCT03012334|18599938|P6|COMPLETED|Period 3||9
7556874|NCT03012334|18599939|P5|COMPLETED|Period 3||9
7556875|NCT03012334|18599940|P4|COMPLETED|Period 3||9
7556876|NCT03012334|18599941|P3|COMPLETED|Period 3||8
7556877|NCT03012334|18599942|P2|COMPLETED|Period 3||8
7556878|NCT03012334|18599943|P1|COMPLETED|Period 3||9
7556879|NCT03012334|18599934|P10|STARTED|Period 3||8
7556880|NCT03012334|18599935|P9|STARTED|Period 3||9
7556881|NCT03012334|18599936|P8|STARTED|Period 3||8
7556882|NCT03012334|18599937|P7|STARTED|Period 3||9
7556883|NCT03012334|18599938|P6|STARTED|Period 3||9
7556884|NCT03012334|18599939|P5|STARTED|Period 3||9
7556885|NCT03012334|18599940|P4|STARTED|Period 3||9
7556886|NCT03012334|18599941|P3|STARTED|Period 3||8
7556887|NCT03012334|18599942|P2|STARTED|Period 3||8
7556888|NCT03012334|18599943|P1|STARTED|Period 3||9
7556889|NCT03012334|18599934|P10|NOT COMPLETED|Period 2||0
7556890|NCT03012334|18599935|P9|NOT COMPLETED|Period 2||0
7556891|NCT03012334|18599936|P8|NOT COMPLETED|Period 2||1
7556892|NCT03012334|18599937|P7|NOT COMPLETED|Period 2||0
7556893|NCT03012334|18599938|P6|NOT COMPLETED|Period 2||0
7556894|NCT03012334|18599939|P5|NOT COMPLETED|Period 2||0
7556895|NCT03012334|18599940|P4|NOT COMPLETED|Period 2||0
7556896|NCT03012334|18599941|P3|NOT COMPLETED|Period 2||1
7556897|NCT03012334|18599942|P2|NOT COMPLETED|Period 2||1
7556898|NCT03012334|18599943|P1|NOT COMPLETED|Period 2||0
7556899|NCT03012334|18599934|P10|COMPLETED|Period 2||8
7556900|NCT03012334|18599935|P9|COMPLETED|Period 2||9
7556901|NCT03012334|18599936|P8|COMPLETED|Period 2||8
7556902|NCT03012334|18599937|P7|COMPLETED|Period 2||9
7556903|NCT03012334|18599938|P6|COMPLETED|Period 2||9
7556904|NCT03012334|18599939|P5|COMPLETED|Period 2||9
7556905|NCT03012334|18599940|P4|COMPLETED|Period 2||9
7556906|NCT03012334|18599941|P3|COMPLETED|Period 2||8
7556907|NCT03012334|18599942|P2|COMPLETED|Period 2||8
7556908|NCT03012334|18599943|P1|COMPLETED|Period 2||9
7556909|NCT03012334|18599934|P10|STARTED|Period 2||8
7556910|NCT03012334|18599935|P9|STARTED|Period 2||9
7556911|NCT03012334|18599936|P8|STARTED|Period 2||9
7556912|NCT03012334|18599937|P7|STARTED|Period 2||9
7556913|NCT03012334|18599938|P6|STARTED|Period 2||9
7556914|NCT03012334|18599939|P5|STARTED|Period 2||9
7556915|NCT03012334|18599940|P4|STARTED|Period 2||9
7556916|NCT03012334|18599941|P3|STARTED|Period 2||9
7556917|NCT03012334|18599942|P2|STARTED|Period 2||9
7556918|NCT03012334|18599943|P1|STARTED|Period 2||9
7556919|NCT03012334|18599934|P10|NOT COMPLETED|Period 1||1
7556920|NCT03012334|18599935|P9|NOT COMPLETED|Period 1||0
7556921|NCT03012334|18599936|P8|NOT COMPLETED|Period 1||0
7556922|NCT03012334|18599937|P7|NOT COMPLETED|Period 1||0
7556923|NCT03012334|18599938|P6|NOT COMPLETED|Period 1||0
7556924|NCT03012334|18599939|P5|NOT COMPLETED|Period 1||0
7556925|NCT03012334|18599940|P4|NOT COMPLETED|Period 1||0
7556926|NCT03012334|18599941|P3|NOT COMPLETED|Period 1||0
7556927|NCT03012334|18599942|P2|NOT COMPLETED|Period 1||0
7556928|NCT03012334|18599943|P1|NOT COMPLETED|Period 1||0
7556929|NCT03012334|18599934|P10|COMPLETED|Period 1||8
7556930|NCT03012334|18599935|P9|COMPLETED|Period 1||9
7556931|NCT03012334|18599936|P8|COMPLETED|Period 1||9
7556932|NCT03012334|18599937|P7|COMPLETED|Period 1||9
7556933|NCT03012334|18599938|P6|COMPLETED|Period 1||9
7556934|NCT03012334|18599939|P5|COMPLETED|Period 1||9
7556935|NCT03012334|18599940|P4|COMPLETED|Period 1||9
7556936|NCT03012334|18599941|P3|COMPLETED|Period 1||9
7556937|NCT03012334|18599942|P2|COMPLETED|Period 1||9
7556938|NCT03012334|18599943|P1|COMPLETED|Period 1||9
7556939|NCT03012334|18599934|P10|STARTED|Period 1||9
7556940|NCT03012334|18599935|P9|STARTED|Period 1||9
7556941|NCT03012334|18599936|P8|STARTED|Period 1||9
7556942|NCT03012334|18599937|P7|STARTED|Period 1||9
7556943|NCT03012334|18599938|P6|STARTED|Period 1||9
7556944|NCT03012334|18599939|P5|STARTED|Period 1||9
7556945|NCT03012334|18599940|P4|STARTED|Period 1||9
7556946|NCT03012334|18599941|P3|STARTED|Period 1||9
7556947|NCT03012334|18599942|P2|STARTED|Period 1||9
7556948|NCT03012334|18599943|P1|STARTED|Period 1||9
7556949|NCT03012191|18599993|P3|NOT COMPLETED|Overall Study||0
7556950|NCT03012191|18599994|P2|NOT COMPLETED|Overall Study||0
7556951|NCT03012191|18599995|P1|NOT COMPLETED|Overall Study||0
7556952|NCT03012191|18599993|P3|COMPLETED|Overall Study||2
7556953|NCT03012191|18599994|P2|COMPLETED|Overall Study||2
7556954|NCT03012191|18599995|P1|COMPLETED|Overall Study||2
7556955|NCT03012191|18599993|P3|STARTED|Overall Study||2
7556956|NCT03012191|18599994|P2|STARTED|Overall Study||2
7556957|NCT03012191|18599995|P1|STARTED|Overall Study||2
7556958|NCT03012061|18600013|P3|NOT COMPLETED|Overall Study||8
7556959|NCT03012061|18600014|P2|NOT COMPLETED|Overall Study||9
7556960|NCT03012061|18600015|P1|NOT COMPLETED|Overall Study||6
7556961|NCT03012061|18600013|P3|COMPLETED|Overall Study||131
7556962|NCT03012061|18600014|P2|COMPLETED|Overall Study||130
7556963|NCT03012061|18600015|P1|COMPLETED|Overall Study||137
7556964|NCT03012061|18600013|P3|STARTED|Overall Study||139
7556965|NCT03012061|18600014|P2|STARTED|Overall Study||139
7556966|NCT03012061|18600015|P1|STARTED|Overall Study||143
7556967|NCT03011840|18600040|P2|NOT COMPLETED|Overall Study||21
7556968|NCT03011840|18600041|P1|NOT COMPLETED|Overall Study||0
7556969|NCT03011840|18600040|P2|COMPLETED|Overall Study||196
7556970|NCT03011840|18600041|P1|COMPLETED|Overall Study||232
7556971|NCT03011840|18600040|P2|STARTED|Overall Study||217
7556972|NCT03011840|18600041|P1|STARTED|Overall Study||232
7556973|NCT03011099|18600051|P2|NOT COMPLETED|Overall Study||2
7556974|NCT03011099|18600052|P1|NOT COMPLETED|Overall Study||0
7556975|NCT03011099|18600051|P2|COMPLETED|Overall Study||3
7556976|NCT03011099|18600052|P1|COMPLETED|Overall Study||6
7556977|NCT03011099|18600051|P2|STARTED|Overall Study||5
7556978|NCT03011099|18600052|P1|STARTED|Overall Study||6
7556979|NCT03011034|18600078|P2|NOT COMPLETED|Overall Study||0
7556980|NCT03011034|18600079|P1|NOT COMPLETED|Overall Study||1
7556981|NCT03011034|18600078|P2|COMPLETED|Overall Study||33
7556982|NCT03011034|18600079|P1|COMPLETED|Overall Study||0
7556983|NCT03011034|18600078|P2|STARTED|Overall Study||33
7556984|NCT03011034|18600079|P1|STARTED|Overall Study||1
7556985|NCT03010800|18600109|P2|NOT COMPLETED|Cross Over||0
7556986|NCT03010800|18600110|P1|NOT COMPLETED|Cross Over||0
7556987|NCT03010800|18600109|P2|COMPLETED|Cross Over||4
7556988|NCT03010800|18600110|P1|COMPLETED|Cross Over||4
7556989|NCT03010800|18600109|P2|STARTED|Cross Over||4
7556990|NCT03010800|18600110|P1|STARTED|Cross Over||4
7556991|NCT03010800|18600109|P2|NOT COMPLETED|Initial Assignment||0
7556992|NCT03010800|18600110|P1|NOT COMPLETED|Initial Assignment||0
7556993|NCT03010800|18600109|P2|COMPLETED|Initial Assignment||4
7556994|NCT03010800|18600110|P1|COMPLETED|Initial Assignment||4
7556995|NCT03010800|18600109|P2|STARTED|Initial Assignment||4
7556996|NCT03010800|18600110|P1|STARTED|Initial Assignment||4
7556997|NCT03010631|18600120|P4|NOT COMPLETED|Cohort 2||0
7556998|NCT03010631|18600121|P3|NOT COMPLETED|Cohort 2||0
7556999|NCT03010631|18600122|P2|NOT COMPLETED|Cohort 2||0
7557000|NCT03010631|18600123|P1|NOT COMPLETED|Cohort 2||0
7557001|NCT03010631|18600120|P4|COMPLETED|Cohort 2||7
7557002|NCT03010631|18600121|P3|COMPLETED|Cohort 2||7
7557003|NCT03010631|18600122|P2|COMPLETED|Cohort 2||0
7557004|NCT03010631|18600123|P1|COMPLETED|Cohort 2||0
7557005|NCT03010631|18600120|P4|STARTED|Cohort 2||7
7557006|NCT03010631|18600121|P3|STARTED|Cohort 2|New participants were enrolled for Cohort 2|7
7557007|NCT03010631|18600122|P2|STARTED|Cohort 2||0
7557008|NCT03010631|18600123|P1|STARTED|Cohort 2||0
7557009|NCT03010631|18600120|P4|NOT COMPLETED|Cohort 1||0
7557010|NCT03010631|18600121|P3|NOT COMPLETED|Cohort 1||0
7557011|NCT03010631|18600122|P2|NOT COMPLETED|Cohort 1||0
7557012|NCT03010631|18600123|P1|NOT COMPLETED|Cohort 1||4
7557013|NCT03010631|18600120|P4|COMPLETED|Cohort 1||0
7557014|NCT03010631|18600121|P3|COMPLETED|Cohort 1||0
7557015|NCT03010631|18600122|P2|COMPLETED|Cohort 1||17
7557016|NCT03010631|18600123|P1|COMPLETED|Cohort 1||14
7557017|NCT03010631|18600120|P4|STARTED|Cohort 1||0
7557018|NCT03010631|18600121|P3|STARTED|Cohort 1||0
7557019|NCT03010631|18600122|P2|STARTED|Cohort 1||17
7557020|NCT03010631|18600123|P1|STARTED|Cohort 1||18
7557021|NCT03010501|18600141|P6|NOT COMPLETED|Study Week 3||0
7557022|NCT03010501|18600142|P5|NOT COMPLETED|Study Week 3||0
7557023|NCT03010501|18600143|P4|NOT COMPLETED|Study Week 3||1
7557024|NCT03010501|18600144|P3|NOT COMPLETED|Study Week 3||0
7557025|NCT03010501|18600145|P2|NOT COMPLETED|Study Week 3||0
7557026|NCT03010501|18600146|P1|NOT COMPLETED|Study Week 3||0
7557027|NCT03010501|18600141|P6|COMPLETED|Study Week 3||11
7557028|NCT03010501|18600142|P5|COMPLETED|Study Week 3||7
7557029|NCT03010501|18600143|P4|COMPLETED|Study Week 3||4
7557030|NCT03010501|18600144|P3|COMPLETED|Study Week 3||7
7557031|NCT03010501|18600145|P2|COMPLETED|Study Week 3||14
7557032|NCT03010501|18600146|P1|COMPLETED|Study Week 3||7
7557033|NCT03010501|18600141|P6|STARTED|Study Week 3||11
7557034|NCT03010501|18600142|P5|STARTED|Study Week 3||7
7557035|NCT03010501|18600143|P4|STARTED|Study Week 3||5
7557036|NCT03010501|18600144|P3|STARTED|Study Week 3||7
7557037|NCT03010501|18600145|P2|STARTED|Study Week 3||14
7557038|NCT03010501|18600146|P1|STARTED|Study Week 3||7
7557039|NCT03010501|18600141|P6|NOT COMPLETED|Study Week 2||0
7557040|NCT03010501|18600142|P5|NOT COMPLETED|Study Week 2||0
7557041|NCT03010501|18600143|P4|NOT COMPLETED|Study Week 2||0
7557042|NCT03010501|18600144|P3|NOT COMPLETED|Study Week 2||0
7557043|NCT03010501|18600145|P2|NOT COMPLETED|Study Week 2||0
7557044|NCT03010501|18600146|P1|NOT COMPLETED|Study Week 2||0
7557045|NCT03010501|18600141|P6|COMPLETED|Study Week 2||11
7557046|NCT03010501|18600142|P5|COMPLETED|Study Week 2||7
7557047|NCT03010501|18600143|P4|COMPLETED|Study Week 2||5
7557048|NCT03010501|18600144|P3|COMPLETED|Study Week 2||7
7557049|NCT03010501|18600145|P2|COMPLETED|Study Week 2||14
7557050|NCT03010501|18600146|P1|COMPLETED|Study Week 2||7
7557051|NCT03010501|18600141|P6|STARTED|Study Week 2||11
7557052|NCT03010501|18600142|P5|STARTED|Study Week 2||7
7557053|NCT03010501|18600143|P4|STARTED|Study Week 2||5
7557054|NCT03010501|18600144|P3|STARTED|Study Week 2||7
7557055|NCT03010501|18600145|P2|STARTED|Study Week 2||14
7557056|NCT03010501|18600146|P1|STARTED|Study Week 2||7
7557057|NCT03010501|18600141|P6|NOT COMPLETED|Study Week 1||0
7557058|NCT03010501|18600142|P5|NOT COMPLETED|Study Week 1||0
7557059|NCT03010501|18600143|P4|NOT COMPLETED|Study Week 1||2
7557060|NCT03010501|18600144|P3|NOT COMPLETED|Study Week 1||0
7557061|NCT03010501|18600145|P2|NOT COMPLETED|Study Week 1||1
7557062|NCT03010501|18600146|P1|NOT COMPLETED|Study Week 1||2
7557063|NCT03010501|18600141|P6|COMPLETED|Study Week 1||11
7557064|NCT03010501|18600142|P5|COMPLETED|Study Week 1||7
7557065|NCT03010501|18600143|P4|COMPLETED|Study Week 1||5
7557066|NCT03010501|18600144|P3|COMPLETED|Study Week 1||7
7557067|NCT03010501|18600145|P2|COMPLETED|Study Week 1||14
7557068|NCT03010501|18600146|P1|COMPLETED|Study Week 1||7
7557069|NCT03010501|18600141|P6|STARTED|Study Week 1||11
7557070|NCT03010501|18600142|P5|STARTED|Study Week 1||7
7557071|NCT03010501|18600143|P4|STARTED|Study Week 1||7
7557072|NCT03010501|18600144|P3|STARTED|Study Week 1||7
7557073|NCT03010501|18600145|P2|STARTED|Study Week 1||15
7557074|NCT03010501|18600146|P1|STARTED|Study Week 1||9
7557075|NCT03010423|18600160|P1|NOT COMPLETED|Overall Study||8
7557076|NCT03010423|18600160|P1|COMPLETED|Overall Study||0
7557077|NCT03010423|18600160|P1|STARTED|Overall Study||8
7557078|NCT03010254|18600173|P2|NOT COMPLETED|Overall Study||5
7557079|NCT03010254|18600174|P1|NOT COMPLETED|Overall Study||7
7557080|NCT03010254|18600173|P2|COMPLETED|Overall Study||118
7557081|NCT03010254|18600174|P1|COMPLETED|Overall Study||152
7557082|NCT03010254|18600173|P2|Successful Implantation|Overall Study||120
7557083|NCT03010254|18600174|P1|Successful Implantation|Overall Study||156
7557084|NCT03010254|18600173|P2|Attempted Implantation|Overall Study||120
7557085|NCT03010254|18600174|P1|Attempted Implantation|Overall Study||156
7557086|NCT03010254|18600173|P2|STARTED|Overall Study||123
7557087|NCT03010254|18600174|P1|STARTED|Overall Study||159
7557088|NCT03010137|18600201|P2|NOT COMPLETED|Overall Study||0
7557089|NCT03010137|18600202|P1|NOT COMPLETED|Overall Study||0
7557090|NCT03010137|18600201|P2|COMPLETED|Overall Study||15
7557091|NCT03010137|18600202|P1|COMPLETED|Overall Study||15
7557092|NCT03010137|18600201|P2|STARTED|Overall Study||15
7557093|NCT03010137|18600202|P1|STARTED|Overall Study||15
7557094|NCT03009162|18600218|P2|NOT COMPLETED|Overall Study||0
7557095|NCT03009162|18600219|P1|NOT COMPLETED|Overall Study||0
7557096|NCT03009162|18600218|P2|COMPLETED|Overall Study||8
7557097|NCT03009162|18600219|P1|COMPLETED|Overall Study||8
7557098|NCT03009162|18600218|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
7557099|NCT03009162|18600219|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
7557100|NCT03009162|18600218|P2|STARTED|Overall Study||8
7557101|NCT03009162|18600219|P1|STARTED|Overall Study||8
7557102|NCT03008889|18600241|P2|NOT COMPLETED|Overall Study||0
7557103|NCT03008889|18600242|P1|NOT COMPLETED|Overall Study||0
7557104|NCT03008889|18600241|P2|COMPLETED|Overall Study||1
7557105|NCT03008889|18600242|P1|COMPLETED|Overall Study||1
7557106|NCT03008889|18600241|P2|STARTED|Overall Study||1
7557107|NCT03008889|18600242|P1|STARTED|Overall Study||1
7557108|NCT03008837|18600267|P2|NOT COMPLETED|Overall Study||4
7557109|NCT03008837|18600268|P1|NOT COMPLETED|Overall Study||3
7557110|NCT03008837|18600267|P2|COMPLETED|Overall Study||5
7557111|NCT03008837|18600268|P1|COMPLETED|Overall Study||9
7557112|NCT03008837|18600267|P2|STARTED|Overall Study||9
7557113|NCT03008837|18600268|P1|STARTED|Overall Study||12
7557114|NCT03008707|18600286|P2|NOT COMPLETED|Overall Study||0
7557115|NCT03008707|18600287|P1|NOT COMPLETED|Overall Study||0
7557116|NCT03008707|18600286|P2|COMPLETED|Overall Study||38
7557117|NCT03008707|18600287|P1|COMPLETED|Overall Study||28
7557118|NCT03008707|18600286|P2|STARTED|Overall Study||38
7557119|NCT03008707|18600287|P1|STARTED|Overall Study||28
7557120|NCT03008213|18600307|P1|NOT COMPLETED|Overall Study||0
7557121|NCT03008213|18600307|P1|COMPLETED|Overall Study||1
7557122|NCT03008213|18600307|P1|STARTED|Overall Study||1
7557123|NCT03008174|18600313|P2|NOT COMPLETED|Overall Study||4
7557124|NCT03008174|18600314|P1|NOT COMPLETED|Overall Study||3
7557125|NCT03008174|18600313|P2|COMPLETED|Overall Study||6
7557126|NCT03008174|18600314|P1|COMPLETED|Overall Study||7
7557127|NCT03008174|18600313|P2|STARTED|Overall Study||10
7557128|NCT03008174|18600314|P1|STARTED|Overall Study||10
7557129|NCT03007966|18600342|P2|NOT COMPLETED|Overall Study||0
7557130|NCT03007966|18600343|P1|NOT COMPLETED|Overall Study||1
7557131|NCT03007966|18600342|P2|COMPLETED|Overall Study||30
7557132|NCT03007966|18600343|P1|COMPLETED|Overall Study||29
7557133|NCT03007966|18600342|P2|STARTED|Overall Study||30
7557134|NCT03007966|18600343|P1|STARTED|Overall Study||30
7557135|NCT03007719|18600375|P2|NOT COMPLETED|Overall Study||0
7557136|NCT03007719|18600376|P1|NOT COMPLETED|Overall Study||0
7557137|NCT03007719|18600375|P2|COMPLETED|Overall Study||4
7557138|NCT03007719|18600376|P1|COMPLETED|Overall Study||0
7557139|NCT03007719|18600375|P2|STARTED|Overall Study||4
7557140|NCT03007719|18600376|P1|STARTED|Overall Study||0
7557141|NCT03007472|18600384|P1|NOT COMPLETED|Overall Study||5
7557142|NCT03007472|18600384|P1|COMPLETED|Overall Study||91
7557143|NCT03007472|18600384|P1|STARTED|Overall Study||96
7557144|NCT03007394|18600392|P2|NOT COMPLETED|Overall Study||63
7557145|NCT03007394|18600393|P1|NOT COMPLETED|Overall Study||27
7557146|NCT03007394|18600392|P2|COMPLETED|Overall Study||91
7557147|NCT03007394|18600393|P1|COMPLETED|Overall Study||91
7557148|NCT03007394|18600392|P2|STARTED|Overall Study||154
7557149|NCT03007394|18600393|P1|STARTED|Overall Study||118
7557150|NCT03007225|18600403|P2|NOT COMPLETED|Overall Study||0
7557151|NCT03007225|18600404|P1|NOT COMPLETED|Overall Study||0
7557152|NCT03007225|18600403|P2|COMPLETED|Overall Study||25
7557153|NCT03007225|18600404|P1|COMPLETED|Overall Study||25
7557154|NCT03007225|18600403|P2|STARTED|Overall Study|followed up for at least 6 months after TACE|25
7557155|NCT03007225|18600404|P1|STARTED|Overall Study|Followed up for at least 6 months after DEB TACE|25
7557156|NCT03006926|18600412|P2|NOT COMPLETED|Overall Study||98
7557157|NCT03006926|18600413|P1|NOT COMPLETED|Overall Study||0
7557158|NCT03006926|18600412|P2|COMPLETED|Overall Study||0
7557159|NCT03006926|18600413|P1|COMPLETED|Overall Study||6
7557160|NCT03006926|18600412|P2|STARTED|Overall Study||98
7557161|NCT03006926|18600413|P1|STARTED|Overall Study||6
7557162|NCT03006562|18600433|P2|NOT COMPLETED|Overall Study||1
7557163|NCT03006562|18600434|P1|NOT COMPLETED|Overall Study||0
7557164|NCT03006562|18600433|P2|COMPLETED|Overall Study||249
7557165|NCT03006562|18600434|P1|COMPLETED|Overall Study||251
7557166|NCT03006562|18600433|P2|Voluntary Ultrasound at 30 Days|Overall Study||137
7557167|NCT03006562|18600434|P1|Voluntary Ultrasound at 30 Days|Overall Study||141
7557168|NCT03006562|18600433|P2|STARTED|Overall Study||250
7557169|NCT03006562|18600434|P1|STARTED|Overall Study||251
7557170|NCT03006471|18600454|P2|NOT COMPLETED|Overall Study||2
7557171|NCT03006471|18600455|P1|NOT COMPLETED|Overall Study||2
7557172|NCT03006471|18600454|P2|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
7557173|NCT03006471|18600455|P1|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
7557174|NCT03006471|18600454|P2|STARTED|Overall Study||15
7557175|NCT03006471|18600455|P1|STARTED|Overall Study||15
7557176|NCT03006458|18600525|P2|NOT COMPLETED|Second Intervention||0
7557177|NCT03006458|18600526|P1|NOT COMPLETED|Second Intervention||0
7557178|NCT03006458|18600525|P2|COMPLETED|Second Intervention||10
7557179|NCT03006458|18600526|P1|COMPLETED|Second Intervention||14
7557180|NCT03006458|18600525|P2|STARTED|Second Intervention||10
7557181|NCT03006458|18600526|P1|STARTED|Second Intervention||14
7557182|NCT03006458|18600525|P2|NOT COMPLETED|First Intervention||3
7557183|NCT03006458|18600526|P1|NOT COMPLETED|First Intervention||0
7557184|NCT03006458|18600525|P2|COMPLETED|First Intervention||7
7557185|NCT03006458|18600526|P1|COMPLETED|First Intervention||14
7557186|NCT03006458|18600525|P2|STARTED|First Intervention||10
7557187|NCT03006458|18600526|P1|STARTED|First Intervention||14
7557188|NCT03006341|18600568|P4|NOT COMPLETED|Overall Study||10685
7557189|NCT03006341|18600569|P3|NOT COMPLETED|Overall Study||30993
7557190|NCT03006341|18600570|P2|NOT COMPLETED|Overall Study||67505
7557191|NCT03006341|18600571|P1|NOT COMPLETED|Overall Study||25069
7557192|NCT03006341|18600568|P4|COMPLETED|Overall Study||637
7557193|NCT03006341|18600569|P3|COMPLETED|Overall Study||1602
7557194|NCT03006341|18600570|P2|COMPLETED|Overall Study||2566
7557195|NCT03006341|18600571|P1|COMPLETED|Overall Study||1130
7557196|NCT03006341|18600568|P4|STARTED|Overall Study||11322
7557197|NCT03006341|18600569|P3|STARTED|Overall Study||32595
7557198|NCT03006341|18600570|P2|STARTED|Overall Study||70071
7557199|NCT03006341|18600571|P1|STARTED|Overall Study||26199
7557200|NCT03005288|18600615|P2|NOT COMPLETED|Overall Study||8
7557201|NCT03005288|18600616|P1|NOT COMPLETED|Overall Study||12
7557202|NCT03005288|18600615|P2|COMPLETED|Overall Study||31
7557203|NCT03005288|18600616|P1|COMPLETED|Overall Study||27
7557204|NCT03005288|18600615|P2|Pharmacodynamics (PD) Analysis Set|Overall Study|Two subjects were excluded due to protocol deviations.|36
7557205|NCT03005288|18600616|P1|Pharmacodynamics (PD) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
7557206|NCT03005288|18600615|P2|Pharmacokinetics (PK) Analysis Set|Overall Study|PK samples were only obtained and evaluated for subjects treated with BYM338.|0
7557207|NCT03005288|18600616|P1|Pharmacokinetics (PK) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
7557208|NCT03005288|18600615|P2|Safety Analysis Set|Overall Study||38
7557209|NCT03005288|18600616|P1|Safety Analysis Set|Overall Study||37
7557210|NCT03005288|18600615|P2|STARTED|Overall Study||39
7557211|NCT03005288|18600616|P1|STARTED|Overall Study||39
7557212|NCT03005067|18600648|P2|NOT COMPLETED|Overall Study||7
7557213|NCT03005067|18600649|P1|NOT COMPLETED|Overall Study||10
7557214|NCT03005067|18600648|P2|COMPLETED|Overall Study||74
7557215|NCT03005067|18600649|P1|COMPLETED|Overall Study||80
7557216|NCT03005067|18600648|P2|STARTED|Overall Study||81
7557217|NCT03005067|18600649|P1|STARTED|Overall Study||90
7557218|NCT03005041|18600661|P2|NOT COMPLETED|Period 2||0
7557219|NCT03005041|18600662|P1|NOT COMPLETED|Period 2||0
7557220|NCT03005041|18600661|P2|COMPLETED|Period 2||27
7557221|NCT03005041|18600662|P1|COMPLETED|Period 2||28
7557222|NCT03005041|18600661|P2|STARTED|Period 2||27
7557223|NCT03005041|18600662|P1|STARTED|Period 2||28
7557224|NCT03005041|18600661|P2|NOT COMPLETED|Washout Period 1||0
7557225|NCT03005041|18600662|P1|NOT COMPLETED|Washout Period 1||0
7557226|NCT03005041|18600661|P2|COMPLETED|Washout Period 1||27
7557227|NCT03005041|18600662|P1|COMPLETED|Washout Period 1||28
7557228|NCT03005041|18600661|P2|STARTED|Washout Period 1||27
7557229|NCT03005041|18600662|P1|STARTED|Washout Period 1||28
7557230|NCT03005041|18600661|P2|NOT COMPLETED|Period 1||0
7557231|NCT03005041|18600662|P1|NOT COMPLETED|Period 1||0
7557232|NCT03005041|18600661|P2|COMPLETED|Period 1||27
7557233|NCT03005041|18600662|P1|COMPLETED|Period 1||28
7557234|NCT03005041|18600661|P2|STARTED|Period 1||27
7557235|NCT03005041|18600662|P1|STARTED|Period 1||28
7557236|NCT03004924|18600677|P3|NOT COMPLETED|Overall Study||28
7557237|NCT03004924|18600678|P2|NOT COMPLETED|Overall Study||14
7557238|NCT03004924|18600679|P1|NOT COMPLETED|Overall Study||27
7557239|NCT03004924|18600677|P3|COMPLETED|Overall Study||293
7557240|NCT03004924|18600678|P2|COMPLETED|Overall Study||94
7557241|NCT03004924|18600679|P1|COMPLETED|Overall Study||297
7557242|NCT03004924|18600677|P3|STARTED|Overall Study||321
7557243|NCT03004924|18600678|P2|STARTED|Overall Study||108
7557244|NCT03004924|18600679|P1|STARTED|Overall Study||324
7557245|NCT03004911|18600731|P2|NOT COMPLETED|Overall Study||3
7557246|NCT03004911|18600732|P1|NOT COMPLETED|Overall Study||1
7557247|NCT03004911|18600731|P2|COMPLETED|Overall Study||17
7557248|NCT03004911|18600732|P1|COMPLETED|Overall Study||19
7557249|NCT03004911|18600731|P2|STARTED|Overall Study||20
7557250|NCT03004911|18600732|P1|STARTED|Overall Study||20
7557251|NCT03004846|18600750|P3|NOT COMPLETED|Part B (Up to 14 Weeks)||0
7557252|NCT03004846|18600751|P2|NOT COMPLETED|Part B (Up to 14 Weeks)||0
7557253|NCT03004846|18600752|P1|NOT COMPLETED|Part B (Up to 14 Weeks)||0
7557254|NCT03004846|18600750|P3|COMPLETED|Part B (Up to 14 Weeks)||0
7557255|NCT03004846|18600751|P2|COMPLETED|Part B (Up to 14 Weeks)||0
7557256|NCT03004846|18600752|P1|COMPLETED|Part B (Up to 14 Weeks)||0
7557257|NCT03004846|18600750|P3|STARTED|Part B (Up to 14 Weeks)||0
7557258|NCT03004846|18600751|P2|STARTED|Part B (Up to 14 Weeks)||0
7557259|NCT03004846|18600752|P1|STARTED|Part B (Up to 14 Weeks)||0
7557260|NCT03004846|18600750|P3|NOT COMPLETED|Part A (Up to 14 Weeks)||0
7557261|NCT03004846|18600751|P2|NOT COMPLETED|Part A (Up to 14 Weeks)||0
7557262|NCT03004846|18600752|P1|NOT COMPLETED|Part A (Up to 14 Weeks)||0
7557263|NCT03004846|18600750|P3|COMPLETED|Part A (Up to 14 Weeks)||0
7557264|NCT03004846|18600751|P2|COMPLETED|Part A (Up to 14 Weeks)||0
7557265|NCT03004846|18600752|P1|COMPLETED|Part A (Up to 14 Weeks)||8
7557266|NCT03004846|18600750|P3|STARTED|Part A (Up to 14 Weeks)||0
7557267|NCT03004846|18600751|P2|STARTED|Part A (Up to 14 Weeks)||0
7557268|NCT03004846|18600752|P1|STARTED|Part A (Up to 14 Weeks)||8
7557269|NCT03004638|18600804|P6|NOT COMPLETED|Overall Study||0
7557270|NCT03004638|18600805|P5|NOT COMPLETED|Overall Study||0
7557271|NCT03004638|18600806|P4|NOT COMPLETED|Overall Study||0
7557272|NCT03004638|18600807|P3|NOT COMPLETED|Overall Study||0
7557273|NCT03004638|18600808|P2|NOT COMPLETED|Overall Study||0
7557274|NCT03004638|18600809|P1|NOT COMPLETED|Overall Study||0
7557275|NCT03004638|18600804|P6|COMPLETED|Overall Study||7
7557276|NCT03004638|18600805|P5|COMPLETED|Overall Study||1
7557277|NCT03004638|18600806|P4|COMPLETED|Overall Study||6
7557278|NCT03004638|18600807|P3|COMPLETED|Overall Study||6
7557279|NCT03004638|18600808|P2|COMPLETED|Overall Study||6
7557280|NCT03004638|18600809|P1|COMPLETED|Overall Study||6
7557281|NCT03004638|18600804|P6|STARTED|Overall Study||7
7557282|NCT03004638|18600805|P5|STARTED|Overall Study||1
7557283|NCT03004638|18600806|P4|STARTED|Overall Study||6
7557284|NCT03004638|18600807|P3|STARTED|Overall Study||6
7557285|NCT03004638|18600808|P2|STARTED|Overall Study||6
7557286|NCT03004638|18600809|P1|STARTED|Overall Study||6
7557287|NCT03004534|18600915|P1|NOT COMPLETED|Overall Study||0
7557288|NCT03004534|18600915|P1|COMPLETED|Overall Study||36
7557289|NCT03004534|18600915|P1|STARTED|Overall Study||36
7557290|NCT03004469|18600923|P3|NOT COMPLETED|Overall Study||25
7557291|NCT03004469|18600924|P2|NOT COMPLETED|Overall Study||49
7557292|NCT03004469|18600925|P1|NOT COMPLETED|Overall Study||61
7557293|NCT03004469|18600923|P3|COMPLETED|Overall Study||60
7557294|NCT03004469|18600924|P2|COMPLETED|Overall Study||135
7557295|NCT03004469|18600925|P1|COMPLETED|Overall Study||128
7557296|NCT03004469|18600923|P3|STARTED|Overall Study||85
7557297|NCT03004469|18600924|P2|STARTED|Overall Study||184
7557298|NCT03004469|18600925|P1|STARTED|Overall Study||189
7557299|NCT03003793|18600959|P2|NOT COMPLETED|Overall Study||0
7557300|NCT03003793|18600960|P1|NOT COMPLETED|Overall Study||0
7557301|NCT03003793|18600959|P2|COMPLETED|Overall Study||16
7557302|NCT03003793|18600960|P1|COMPLETED|Overall Study||16
7557303|NCT03003793|18600959|P2|STARTED|Overall Study||16
7557304|NCT03003793|18600960|P1|STARTED|Overall Study||16
7557305|NCT03003520|18600968|P2|NOT COMPLETED|Follow-up||3
7557306|NCT03003520|18600969|P1|NOT COMPLETED|Follow-up||14
7557307|NCT03003520|18600968|P2|COMPLETED|Follow-up||0
7557308|NCT03003520|18600969|P1|COMPLETED|Follow-up||0
7557309|NCT03003520|18600968|P2|STARTED|Follow-up||3
7557310|NCT03003520|18600969|P1|STARTED|Follow-up||14
7557311|NCT03003520|18600968|P2|NOT COMPLETED|Consolidation||1
7557312|NCT03003520|18600969|P1|NOT COMPLETED|Consolidation||24
7557313|NCT03003520|18600968|P2|COMPLETED|Consolidation||2
7557314|NCT03003520|18600969|P1|COMPLETED|Consolidation||1
7557315|NCT03003520|18600968|P2|STARTED|Consolidation||3
7557316|NCT03003520|18600969|P1|STARTED|Consolidation||25
7557317|NCT03003520|18600968|P2|NOT COMPLETED|Induction||0
7557318|NCT03003520|18600969|P1|NOT COMPLETED|Induction||13
7557319|NCT03003520|18600968|P2|COMPLETED|Induction||3
7557320|NCT03003520|18600969|P1|COMPLETED|Induction||30
7557321|NCT03003520|18600968|P2|Efficacy Evaluable Population|Induction||3
7557322|NCT03003520|18600969|P1|Efficacy Evaluable Population|Induction||37
7557323|NCT03003520|18600968|P2|Safety Population|Induction||3
7557324|NCT03003520|18600969|P1|Safety Population|Induction||43
7557325|NCT03003520|18600968|P2|STARTED|Induction||3
7557326|NCT03003520|18600969|P1|STARTED|Induction||43
7557327|NCT03003494|18600987|P1|NOT COMPLETED|Overall Study||28
7557328|NCT03003494|18600987|P1|COMPLETED|Overall Study||278
7557329|NCT03003494|18600987|P1|STARTED|Overall Study||306
7557330|NCT03003390|18600998|P2|NOT COMPLETED|Overall Study||0
7557331|NCT03003390|18600999|P1|NOT COMPLETED|Overall Study||4
7557332|NCT03003390|18600998|P2|COMPLETED|Overall Study||24
7557333|NCT03003390|18600999|P1|COMPLETED|Overall Study||23
7557334|NCT03003390|18600998|P2|STARTED|Overall Study||24
7557335|NCT03003390|18600999|P1|STARTED|Overall Study||27
7557336|NCT03003000|18601027|P3|NOT COMPLETED|Overall Study||5
7557337|NCT03003000|18601028|P2|NOT COMPLETED|Overall Study||4
7557338|NCT03003000|18601029|P1|NOT COMPLETED|Overall Study||5
7557339|NCT03003000|18601027|P3|COMPLETED|Overall Study||251
7557340|NCT03003000|18601028|P2|COMPLETED|Overall Study||249
7557341|NCT03003000|18601029|P1|COMPLETED|Overall Study||121
7557342|NCT03003000|18601027|P3|STARTED|Overall Study||256
7557343|NCT03003000|18601028|P2|STARTED|Overall Study||253
7557344|NCT03003000|18601029|P1|STARTED|Overall Study||126
7557345|NCT03002974|18601058|P3|NOT COMPLETED|Overall Study||18
7557346|NCT03002974|18601059|P2|NOT COMPLETED|Overall Study||16
7557347|NCT03002974|18601060|P1|NOT COMPLETED|Overall Study||20
7557348|NCT03002974|18601058|P3|COMPLETED|Overall Study||36
7557349|NCT03002974|18601059|P2|COMPLETED|Overall Study||40
7557350|NCT03002974|18601060|P1|COMPLETED|Overall Study||35
7557351|NCT03002974|18601058|P3|Safety Population|Overall Study||52
7557352|NCT03002974|18601059|P2|Safety Population|Overall Study||55
7557353|NCT03002974|18601060|P1|Safety Population|Overall Study||54
7557354|NCT03002974|18601058|P3|Intention To Treat Populatio|Overall Study||54
7557355|NCT03002974|18601059|P2|Intention To Treat Populatio|Overall Study||56
7557356|NCT03002974|18601060|P1|Intention To Treat Populatio|Overall Study||55
7557357|NCT03002974|18601058|P3|STARTED|Overall Study||54
7557358|NCT03002974|18601059|P2|STARTED|Overall Study||56
7557359|NCT03002974|18601060|P1|STARTED|Overall Study||55
7557360|NCT03002818|18601131|P1|NOT COMPLETED|Overall Study||1
7557361|NCT03002818|18601131|P1|COMPLETED|Overall Study||40
7557362|NCT03002818|18601131|P1|STARTED|Overall Study||41
7557363|NCT03002753|18601145|P3|NOT COMPLETED|Second Randomization (Re-randomization)||0
7557364|NCT03002753|18601146|P2|NOT COMPLETED|Second Randomization (Re-randomization)||1
7557365|NCT03002753|18601147|P1|NOT COMPLETED|Second Randomization (Re-randomization)||0
7557366|NCT03002753|18601145|P3|COMPLETED|Second Randomization (Re-randomization)||0
7557367|NCT03002753|18601146|P2|COMPLETED|Second Randomization (Re-randomization)||9
7557368|NCT03002753|18601147|P1|COMPLETED|Second Randomization (Re-randomization)||11
7557369|NCT03002753|18601145|P3|STARTED|Second Randomization (Re-randomization)||0
7557370|NCT03002753|18601146|P2|STARTED|Second Randomization (Re-randomization)||10
7557371|NCT03002753|18601147|P1|STARTED|Second Randomization (Re-randomization)||11
7557372|NCT03002753|18601145|P3|NOT COMPLETED|First Randomization||0
7557373|NCT03002753|18601146|P2|NOT COMPLETED|First Randomization||1
7557374|NCT03002753|18601147|P1|NOT COMPLETED|First Randomization||1
7557375|NCT03002753|18601145|P3|COMPLETED|First Randomization||21
7557376|NCT03002753|18601146|P2|COMPLETED|First Randomization||11
7557377|NCT03002753|18601147|P1|COMPLETED|First Randomization||9
7557378|NCT03002753|18601145|P3|STARTED|First Randomization||21
7557379|NCT03002753|18601146|P2|STARTED|First Randomization||12
7557380|NCT03002753|18601147|P1|STARTED|First Randomization||10
7557381|NCT03002623|18601157|P2|NOT COMPLETED|Overall Study||1
7557382|NCT03002623|18601158|P1|NOT COMPLETED|Overall Study||2
7557383|NCT03002623|18601157|P2|COMPLETED|Overall Study||2
7557384|NCT03002623|18601158|P1|COMPLETED|Overall Study||2
7557385|NCT03002623|18601157|P2|STARTED|Overall Study||3
7557386|NCT03002623|18601158|P1|STARTED|Overall Study||4
7557387|NCT03002610|18601175|P3|NOT COMPLETED|Overall Study||13
7557388|NCT03002610|18601176|P2|NOT COMPLETED|Overall Study||25
7557389|NCT03002610|18601177|P1|NOT COMPLETED|Overall Study||6
7557390|NCT03002610|18601175|P3|COMPLETED|Overall Study||21
7557391|NCT03002610|18601176|P2|COMPLETED|Overall Study||25
7557392|NCT03002610|18601177|P1|COMPLETED|Overall Study||18
7557393|NCT03002610|18601175|P3|STARTED|Overall Study||34
7557394|NCT03002610|18601176|P2|STARTED|Overall Study||50
7557395|NCT03002610|18601177|P1|STARTED|Overall Study||24
7557396|NCT03002454|18601194|P1|NOT COMPLETED|Overall Study||0
7557397|NCT03002454|18601194|P1|COMPLETED|Overall Study||4
7557398|NCT03002454|18601194|P1|STARTED|Overall Study||4
7557399|NCT03002311|18601201|P2|NOT COMPLETED|Overall Study||30
7557400|NCT03002311|18601202|P1|NOT COMPLETED|Overall Study||19
7557401|NCT03002311|18601201|P2|COMPLETED|Overall Study||150
7557402|NCT03002311|18601202|P1|COMPLETED|Overall Study||128
7557403|NCT03002311|18601201|P2|STARTED|Overall Study||180
7557404|NCT03002311|18601202|P1|STARTED|Overall Study||147
7557405|NCT03002194|18601210|P1|NOT COMPLETED|Overall Study||10
7557406|NCT03002194|18601210|P1|COMPLETED|Overall Study||38
7557407|NCT03002194|18601210|P1|STARTED|Overall Study||48
7557408|NCT03002077|18601216|P1|NOT COMPLETED|Overall Study||438
7557409|NCT03002077|18601216|P1|COMPLETED|Overall Study||179
7557410|NCT03002077|18601216|P1|STARTED|Overall Study||617
7557411|NCT03002038|18601224|P2|NOT COMPLETED|Overall Study||7
7557412|NCT03002038|18601225|P1|NOT COMPLETED|Overall Study||11
7557413|NCT03002038|18601224|P2|COMPLETED|Overall Study||33
7557414|NCT03002038|18601225|P1|COMPLETED|Overall Study||35
7557415|NCT03002038|18601224|P2|STARTED|Overall Study||40
7557416|NCT03002038|18601225|P1|STARTED|Overall Study||46
7557417|NCT03002012|18601237|P2|NOT COMPLETED|Overall Study||0
7557418|NCT03002012|18601238|P1|NOT COMPLETED|Overall Study||0
7557419|NCT03002012|18601237|P2|COMPLETED|Overall Study||11
7557420|NCT03002012|18601238|P1|COMPLETED|Overall Study||11
7557421|NCT03002012|18601237|P2|STARTED|Overall Study||11
7557422|NCT03002012|18601238|P1|STARTED|Overall Study||11
7557423|NCT03001778|18601260|P2|NOT COMPLETED|Overall Study||0
7557424|NCT03001778|18601261|P1|NOT COMPLETED|Overall Study||0
7557425|NCT03001778|18601260|P2|COMPLETED|Overall Study||46
7557426|NCT03001778|18601261|P1|COMPLETED|Overall Study||21
7557427|NCT03001778|18601260|P2|STARTED|Overall Study||46
7557428|NCT03001778|18601261|P1|STARTED|Overall Study||21
7557429|NCT03001674|18601269|P2|NOT COMPLETED|Overall Study||0
7557430|NCT03001674|18601270|P1|NOT COMPLETED|Overall Study||0
7557431|NCT03001674|18601269|P2|COMPLETED|Overall Study||5
7557432|NCT03001674|18601270|P1|COMPLETED|Overall Study||10
7557433|NCT03001674|18601269|P2|STARTED|Overall Study||5
7557434|NCT03001674|18601270|P1|STARTED|Overall Study||10
7557435|NCT03001557|18601281|P5|NOT COMPLETED|Overall Study||0
7557436|NCT03001557|18601282|P4|NOT COMPLETED|Overall Study||0
7557437|NCT03001557|18601283|P3|NOT COMPLETED|Overall Study||1
7557438|NCT03001557|18601284|P2|NOT COMPLETED|Overall Study||0
7557439|NCT03001557|18601285|P1|NOT COMPLETED|Overall Study||0
7557440|NCT03001557|18601281|P5|COMPLETED|Overall Study||12
7557441|NCT03001557|18601282|P4|COMPLETED|Overall Study||13
7557442|NCT03001557|18601283|P3|COMPLETED|Overall Study||13
7557443|NCT03001557|18601284|P2|COMPLETED|Overall Study||12
7557444|NCT03001557|18601285|P1|COMPLETED|Overall Study||12
7557445|NCT03001557|18601281|P5|Treated|Overall Study||12
7557446|NCT03001557|18601282|P4|Treated|Overall Study||13
7557447|NCT03001557|18601283|P3|Treated|Overall Study||13
7557448|NCT03001557|18601284|P2|Treated|Overall Study||12
7557449|NCT03001557|18601285|P1|Treated|Overall Study||12
7557450|NCT03001557|18601281|P5|STARTED|Overall Study||12
7557451|NCT03001557|18601282|P4|STARTED|Overall Study||13
7557452|NCT03001557|18601283|P3|STARTED|Overall Study||14
7557453|NCT03001557|18601284|P2|STARTED|Overall Study||12
7557454|NCT03001557|18601285|P1|STARTED|Overall Study||12
7557455|NCT03001453|18601554|P2|NOT COMPLETED|Overall Study||0
7557456|NCT03001453|18601555|P1|NOT COMPLETED|Overall Study||0
7557457|NCT03001453|18601554|P2|COMPLETED|Overall Study||57
7557458|NCT03001453|18601555|P1|COMPLETED|Overall Study||50
7557459|NCT03001453|18601554|P2|STARTED|Overall Study||57
7557460|NCT03001453|18601555|P1|STARTED|Overall Study||50
7557461|NCT03001258|18601572|P3|NOT COMPLETED|Overall Study||0
7557462|NCT03001258|18601573|P2|NOT COMPLETED|Overall Study||0
7557463|NCT03001258|18601574|P1|NOT COMPLETED|Overall Study||0
7557464|NCT03001258|18601572|P3|COMPLETED|Overall Study||485
7557465|NCT03001258|18601573|P2|COMPLETED|Overall Study||751
7557466|NCT03001258|18601574|P1|COMPLETED|Overall Study||765
7557467|NCT03001258|18601572|P3|STARTED|Overall Study||485
7557468|NCT03001258|18601573|P2|STARTED|Overall Study||751
7557469|NCT03001258|18601574|P1|STARTED|Overall Study||765
7557470|NCT03001219|18601584|P2|NOT COMPLETED|Extension Period Analysis||45
7557471|NCT03001219|18601585|P1|NOT COMPLETED|Extension Period Analysis||5
7557472|NCT03001219|18601584|P2|COMPLETED|Extension Period Analysis||52
7557473|NCT03001219|18601585|P1|COMPLETED|Extension Period Analysis||4
7557474|NCT03001219|18601584|P2|STARTED|Extension Period Analysis||97
7557475|NCT03001219|18601585|P1|STARTED|Extension Period Analysis||9
7557476|NCT03001219|18601584|P2|NOT COMPLETED|Proof of Concept||7
7557477|NCT03001219|18601585|P1|NOT COMPLETED|Proof of Concept||2
7557478|NCT03001219|18601584|P2|COMPLETED|Proof of Concept||65
7557479|NCT03001219|18601585|P1|COMPLETED|Proof of Concept||35
7557480|NCT03001219|18601584|P2|STARTED|Proof of Concept||72
7557481|NCT03001219|18601585|P1|STARTED|Proof of Concept||37
7557482|NCT03001076|18601646|P2|NOT COMPLETED|Overall Study||5
7557483|NCT03001076|18601647|P1|NOT COMPLETED|Overall Study||7
7557484|NCT03001076|18601646|P2|COMPLETED|Overall Study||176
7557485|NCT03001076|18601647|P1|COMPLETED|Overall Study||81
7557486|NCT03001076|18601646|P2|STARTED|Overall Study||181
7557487|NCT03001076|18601647|P1|STARTED|Overall Study||88
7557488|NCT03001011|18601681|P2|NOT COMPLETED|Overall Study||21
7557489|NCT03001011|18601682|P1|NOT COMPLETED|Overall Study||27
7557490|NCT03001011|18601681|P2|COMPLETED|Overall Study||80
7557491|NCT03001011|18601682|P1|COMPLETED|Overall Study||74
7557492|NCT03001011|18601681|P2|STARTED|Overall Study||101
7557493|NCT03001011|18601682|P1|STARTED|Overall Study||101
7557494|NCT03000686|18601716|P4|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
7557495|NCT03000686|18601717|P3|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
7557496|NCT03000686|18601718|P2|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
7557497|NCT03000686|18601719|P1|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
7557498|NCT03000686|18601716|P4|COMPLETED|Part 2, Period 2 (1 Day)||3
7557499|NCT03000686|18601717|P3|COMPLETED|Part 2, Period 2 (1 Day)||3
7557500|NCT03000686|18601718|P2|COMPLETED|Part 2, Period 2 (1 Day)||0
7557501|NCT03000686|18601719|P1|COMPLETED|Part 2, Period 2 (1 Day)||0
7557502|NCT03000686|18601716|P4|STARTED|Part 2, Period 2 (1 Day)||3
7557503|NCT03000686|18601717|P3|STARTED|Part 2, Period 2 (1 Day)||3
7557504|NCT03000686|18601718|P2|STARTED|Part 2, Period 2 (1 Day)||0
7557505|NCT03000686|18601719|P1|STARTED|Part 2, Period 2 (1 Day)||0
7557506|NCT03000686|18601716|P4|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
7557507|NCT03000686|18601717|P3|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
7557508|NCT03000686|18601718|P2|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
7557509|NCT03000686|18601719|P1|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
7557510|NCT03000686|18601716|P4|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
7557511|NCT03000686|18601717|P3|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
7557512|NCT03000686|18601718|P2|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
7557513|NCT03000686|18601719|P1|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
7557514|NCT03000686|18601716|P4|STARTED|Part 2, Wash-out (Up to 14 Days)||3
7557515|NCT03000686|18601717|P3|STARTED|Part 2, Wash-out (Up to 14 Days)||3
7557516|NCT03000686|18601718|P2|STARTED|Part 2, Wash-out (Up to 14 Days)||0
7557517|NCT03000686|18601719|P1|STARTED|Part 2, Wash-out (Up to 14 Days)||0
7557518|NCT03000686|18601716|P4|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
7557519|NCT03000686|18601717|P3|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
7557520|NCT03000686|18601718|P2|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
7557521|NCT03000686|18601719|P1|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
7557522|NCT03000686|18601716|P4|COMPLETED|Part 2, Period 1 (1 Day)||3
7557523|NCT03000686|18601717|P3|COMPLETED|Part 2, Period 1 (1 Day)||3
7557524|NCT03000686|18601718|P2|COMPLETED|Part 2, Period 1 (1 Day)||0
7557525|NCT03000686|18601719|P1|COMPLETED|Part 2, Period 1 (1 Day)||0
7557526|NCT03000686|18601716|P4|STARTED|Part 2, Period 1 (1 Day)||3
7557527|NCT03000686|18601717|P3|STARTED|Part 2, Period 1 (1 Day)||3
7557528|NCT03000686|18601718|P2|STARTED|Part 2, Period 1 (1 Day)||0
7557529|NCT03000686|18601719|P1|STARTED|Part 2, Period 1 (1 Day)||0
7557530|NCT03000686|18601716|P4|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
7557531|NCT03000686|18601717|P3|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
7557532|NCT03000686|18601718|P2|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
7557533|NCT03000686|18601719|P1|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
7557534|NCT03000686|18601716|P4|COMPLETED|Part 1, Period 2 (1 Day)||0
7557535|NCT03000686|18601717|P3|COMPLETED|Part 1, Period 2 (1 Day)||0
7557536|NCT03000686|18601718|P2|COMPLETED|Part 1, Period 2 (1 Day)||5
7557537|NCT03000686|18601719|P1|COMPLETED|Part 1, Period 2 (1 Day)||5
7557538|NCT03000686|18601716|P4|STARTED|Part 1, Period 2 (1 Day)||0
7557539|NCT03000686|18601717|P3|STARTED|Part 1, Period 2 (1 Day)||0
7557540|NCT03000686|18601718|P2|STARTED|Part 1, Period 2 (1 Day)||5
7557541|NCT03000686|18601719|P1|STARTED|Part 1, Period 2 (1 Day)||5
7557542|NCT03000686|18601716|P4|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
7557543|NCT03000686|18601717|P3|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
7557544|NCT03000686|18601718|P2|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
7557545|NCT03000686|18601719|P1|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
7557546|NCT03000686|18601716|P4|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
7557547|NCT03000686|18601717|P3|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
7557548|NCT03000686|18601718|P2|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
7557549|NCT03000686|18601719|P1|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
7557550|NCT03000686|18601716|P4|STARTED|Part 1, Wash-out (Up to 14 Days)||0
7557551|NCT03000686|18601717|P3|STARTED|Part 1, Wash-out (Up to 14 Days)||0
7557552|NCT03000686|18601718|P2|STARTED|Part 1, Wash-out (Up to 14 Days)||5
7557553|NCT03000686|18601719|P1|STARTED|Part 1, Wash-out (Up to 14 Days)||5
7557554|NCT03000686|18601716|P4|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
7557555|NCT03000686|18601717|P3|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
7557556|NCT03000686|18601718|P2|NOT COMPLETED|Part 1, Period 1 (1 Day)||1
7557557|NCT03000686|18601719|P1|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
7557558|NCT03000686|18601716|P4|COMPLETED|Part 1, Period 1 (1 Day)||0
7557559|NCT03000686|18601717|P3|COMPLETED|Part 1, Period 1 (1 Day)||0
7557560|NCT03000686|18601718|P2|COMPLETED|Part 1, Period 1 (1 Day)||5
7557561|NCT03000686|18601719|P1|COMPLETED|Part 1, Period 1 (1 Day)||5
7557562|NCT03000686|18601716|P4|STARTED|Part 1, Period 1 (1 Day)||0
7557563|NCT03000686|18601717|P3|STARTED|Part 1, Period 1 (1 Day)||0
7557564|NCT03000686|18601718|P2|STARTED|Part 1, Period 1 (1 Day)||6
7557565|NCT03000686|18601719|P1|STARTED|Part 1, Period 1 (1 Day)||5
7557566|NCT03000673|18601789|P4|NOT COMPLETED|Overall Study||0
7557567|NCT03000673|18601790|P3|NOT COMPLETED|Overall Study||0
7557568|NCT03000673|18601791|P2|NOT COMPLETED|Overall Study||0
7557569|NCT03000673|18601792|P1|NOT COMPLETED|Overall Study||1
7557570|NCT03000673|18601789|P4|COMPLETED|Overall Study||9
7557571|NCT03000673|18601790|P3|COMPLETED|Overall Study||7
7557572|NCT03000673|18601791|P2|COMPLETED|Overall Study||9
7557573|NCT03000673|18601792|P1|COMPLETED|Overall Study||6
7557574|NCT03000673|18601789|P4|STARTED|Overall Study||9
7557575|NCT03000673|18601790|P3|STARTED|Overall Study||7
7557576|NCT03000673|18601791|P2|STARTED|Overall Study||9
7557577|NCT03000673|18601792|P1|STARTED|Overall Study||7
7557578|NCT03000608|18601874|P2|NOT COMPLETED|Overall Study||4
7557579|NCT03000608|18601875|P1|NOT COMPLETED|Overall Study||6
7557580|NCT03000608|18601874|P2|COMPLETED|Overall Study||19
7557581|NCT03000608|18601875|P1|COMPLETED|Overall Study||40
7557582|NCT03000608|18601874|P2|STARTED|Overall Study||23
7557583|NCT03000608|18601875|P1|STARTED|Overall Study||46
7557584|NCT03000569|18601885|P2|NOT COMPLETED|Overall Study||0
7557585|NCT03000569|18601886|P1|NOT COMPLETED|Overall Study||1
7557586|NCT03000569|18601885|P2|COMPLETED|Overall Study||14
7557587|NCT03000569|18601886|P1|COMPLETED|Overall Study||14
7557588|NCT03000569|18601885|P2|STARTED|Overall Study||14
7557589|NCT03000569|18601886|P1|STARTED|Overall Study||15
7557590|NCT03000530|18602021|P3|NOT COMPLETED|Overall Study||4
7557591|NCT03000530|18602022|P2|NOT COMPLETED|Overall Study||5
7557592|NCT03000530|18602023|P1|NOT COMPLETED|Overall Study||0
7557593|NCT03000530|18602021|P3|COMPLETED|Overall Study||41
7557594|NCT03000530|18602022|P2|COMPLETED|Overall Study||39
7557595|NCT03000530|18602023|P1|COMPLETED|Overall Study||13
7557596|NCT03000530|18602021|P3|STARTED|Overall Study||45
7557597|NCT03000530|18602022|P2|STARTED|Overall Study||44
7557598|NCT03000530|18602023|P1|STARTED|Overall Study||13
7557599|NCT03000452|18602221|P1|NOT COMPLETED|Follow-Up Period||7
7557600|NCT03000452|18602221|P1|COMPLETED|Follow-Up Period||10
7557601|NCT03000452|18602221|P1|STARTED|Follow-Up Period|1 participant died in Cycle 1 due to PD prior to evaluation.|17
7557602|NCT03000452|18602221|P1|NOT COMPLETED|Treatment Period||18
7557603|NCT03000452|18602221|P1|COMPLETED|Treatment Period||0
7557604|NCT03000452|18602221|P1|STARTED|Treatment Period||18
7557605|NCT03000309|18602237|P1|NOT COMPLETED|Overall Study||1
7557606|NCT03000309|18602237|P1|COMPLETED|Overall Study||19
7557607|NCT03000309|18602237|P1|STARTED|Overall Study||20
7557608|NCT03000283|18602257|P1|NOT COMPLETED|Overall Study||0
7557609|NCT03000283|18602257|P1|COMPLETED|Overall Study||7
7557610|NCT03000283|18602257|P1|STARTED|Overall Study||7
7557611|NCT03000088|18602268|P2|NOT COMPLETED|Overall Study||0
7557612|NCT03000088|18602269|P1|NOT COMPLETED|Overall Study||0
7557613|NCT03000088|18602268|P2|COMPLETED|Overall Study||70
7557614|NCT03000088|18602269|P1|COMPLETED|Overall Study||70
7557615|NCT03000088|18602268|P2|STARTED|Overall Study||70
7557616|NCT03000088|18602269|P1|STARTED|Overall Study||70
7557617|NCT03000075|18602278|P7|NOT COMPLETED|Part B||1
7557618|NCT03000075|18602279|P6|NOT COMPLETED|Part B||2
7557619|NCT03000075|18602280|P5|NOT COMPLETED|Part B||1
7557620|NCT03000075|18602281|P4|NOT COMPLETED|Part B||0
7557621|NCT03000075|18602282|P3|NOT COMPLETED|Part B||0
7557622|NCT03000075|18602283|P2|NOT COMPLETED|Part B||0
7557623|NCT03000075|18602284|P1|NOT COMPLETED|Part B||0
7557624|NCT03000075|18602278|P7|COMPLETED|Part B||54
7557625|NCT03000075|18602279|P6|COMPLETED|Part B||56
7557626|NCT03000075|18602280|P5|COMPLETED|Part B||26
7557627|NCT03000075|18602281|P4|COMPLETED|Part B||27
7557628|NCT03000075|18602282|P3|COMPLETED|Part B||0
7557629|NCT03000075|18602283|P2|COMPLETED|Part B||0
7557630|NCT03000075|18602284|P1|COMPLETED|Part B||0
7557631|NCT03000075|18602278|P7|STARTED|Part B|Participants who received risankizumab 150 mg in Part A received risankizumab 150 mg in Part B|55
7557632|NCT03000075|18602279|P6|STARTED|Part B|Participants who received risankizumab 75 mg in Part A received risankizumab 75 mg in Part B|58
7557633|NCT03000075|18602280|P5|STARTED|Part B|Participants who received placebo in Part A received risankizumab 150 mg in Part B|27
7557634|NCT03000075|18602281|P4|STARTED|Part B|Participants who received placebo in Part A received risankizumab 75 mg in Part B|27
7557635|NCT03000075|18602282|P3|STARTED|Part B||0
7557636|NCT03000075|18602283|P2|STARTED|Part B||0
7557637|NCT03000075|18602284|P1|STARTED|Part B||0
7557638|NCT03000075|18602278|P7|NOT COMPLETED|Part A||0
7557639|NCT03000075|18602279|P6|NOT COMPLETED|Part A||0
7557640|NCT03000075|18602280|P5|NOT COMPLETED|Part A||0
7557641|NCT03000075|18602281|P4|NOT COMPLETED|Part A||0
7557642|NCT03000075|18602282|P3|NOT COMPLETED|Part A||0
7557643|NCT03000075|18602283|P2|NOT COMPLETED|Part A||0
7557644|NCT03000075|18602284|P1|NOT COMPLETED|Part A||4
7557645|NCT03000075|18602278|P7|COMPLETED|Part A||0
7557646|NCT03000075|18602279|P6|COMPLETED|Part A||0
7557647|NCT03000075|18602280|P5|COMPLETED|Part A||0
7557648|NCT03000075|18602281|P4|COMPLETED|Part A||0
7557649|NCT03000075|18602282|P3|COMPLETED|Part A||55
7557650|NCT03000075|18602283|P2|COMPLETED|Part A||58
7557651|NCT03000075|18602284|P1|COMPLETED|Part A||54
7557652|NCT03000075|18602278|P7|STARTED|Part A||0
7557653|NCT03000075|18602279|P6|STARTED|Part A||0
7557654|NCT03000075|18602280|P5|STARTED|Part A||0
7557655|NCT03000075|18602281|P4|STARTED|Part A||0
7557656|NCT03000075|18602282|P3|STARTED|Part A||55
7557657|NCT03000075|18602283|P2|STARTED|Part A||58
7557658|NCT03000075|18602284|P1|STARTED|Part A||58
7557659|NCT02999763|18602328|P1|NOT COMPLETED|Overall Study||12
7557660|NCT02999763|18602328|P1|COMPLETED|Overall Study||58
7557661|NCT02999763|18602328|P1|STARTED|Overall Study||70
7557662|NCT02999672|18602337|P2|NOT COMPLETED|Overall Study||7
7557663|NCT02999672|18602338|P1|NOT COMPLETED|Overall Study||13
7557664|NCT02999672|18602337|P2|COMPLETED|Overall Study||0
7557665|NCT02999672|18602338|P1|COMPLETED|Overall Study||0
7557666|NCT02999672|18602337|P2|STARTED|Overall Study||7
7557667|NCT02999672|18602338|P1|STARTED|Overall Study||13
7557668|NCT02999633|18602354|P1|NOT COMPLETED|Overall Study||14
7557669|NCT02999633|18602354|P1|COMPLETED|Overall Study||0
7557670|NCT02999633|18602354|P1|STARTED|Overall Study||14
7557671|NCT02999178|18602364|P2|NOT COMPLETED|Overall Study||100
7557672|NCT02999178|18602365|P1|NOT COMPLETED|Overall Study||114
7557673|NCT02999178|18602364|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|231
7557674|NCT02999178|18602365|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|218
7557675|NCT02999178|18602364|P2|STARTED|Overall Study||331
7557676|NCT02999178|18602365|P1|STARTED|Overall Study||332
7557677|NCT02999100|18602415|P6|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
7557678|NCT02999100|18602416|P5|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
7557679|NCT02999100|18602417|P4|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
7557680|NCT02999100|18602418|P3|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
7557681|NCT02999100|18602419|P2|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
7557682|NCT02999100|18602420|P1|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
7557683|NCT02999100|18602415|P6|COMPLETED|Part 2 (Day 14): Dosing Session 2||2
7557684|NCT02999100|18602416|P5|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
7557685|NCT02999100|18602417|P4|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
7557686|NCT02999100|18602418|P3|COMPLETED|Part 2 (Day 14): Dosing Session 2||4
7557687|NCT02999100|18602419|P2|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
7557688|NCT02999100|18602420|P1|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
7557689|NCT02999100|18602415|P6|STARTED|Part 2 (Day 14): Dosing Session 2||2
7557690|NCT02999100|18602416|P5|STARTED|Part 2 (Day 14): Dosing Session 2||3
7557691|NCT02999100|18602417|P4|STARTED|Part 2 (Day 14): Dosing Session 2||3
7557692|NCT02999100|18602418|P3|STARTED|Part 2 (Day 14): Dosing Session 2||4
7557693|NCT02999100|18602419|P2|STARTED|Part 2 (Day 14): Dosing Session 2||0
7557694|NCT02999100|18602420|P1|STARTED|Part 2 (Day 14): Dosing Session 2||0
7557695|NCT02999100|18602415|P6|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
7557696|NCT02999100|18602416|P5|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
7557697|NCT02999100|18602417|P4|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
7557698|NCT02999100|18602418|P3|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
7557699|NCT02999100|18602419|P2|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
7557700|NCT02999100|18602420|P1|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
7557701|NCT02999100|18602415|P6|COMPLETED|Part 2 (Day 1): Dosing Session 1||2
7557702|NCT02999100|18602416|P5|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
7557703|NCT02999100|18602417|P4|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
7557704|NCT02999100|18602418|P3|COMPLETED|Part 2 (Day 1): Dosing Session 1||4
7557705|NCT02999100|18602419|P2|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
7557706|NCT02999100|18602420|P1|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
7557707|NCT02999100|18602415|P6|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
7557708|NCT02999100|18602416|P5|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
7557709|NCT02999100|18602417|P4|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
7557710|NCT02999100|18602418|P3|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|5
7557711|NCT02999100|18602419|P2|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
7557712|NCT02999100|18602420|P1|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
7557713|NCT02999100|18602415|P6|NOT COMPLETED|Part 1 (up to 15 Days)||0
7557714|NCT02999100|18602416|P5|NOT COMPLETED|Part 1 (up to 15 Days)||0
7557715|NCT02999100|18602417|P4|NOT COMPLETED|Part 1 (up to 15 Days)||0
7557716|NCT02999100|18602418|P3|NOT COMPLETED|Part 1 (up to 15 Days)||0
7557717|NCT02999100|18602419|P2|NOT COMPLETED|Part 1 (up to 15 Days)||1
7557718|NCT02999100|18602420|P1|NOT COMPLETED|Part 1 (up to 15 Days)||0
7557719|NCT02999100|18602415|P6|COMPLETED|Part 1 (up to 15 Days)||0
7557720|NCT02999100|18602416|P5|COMPLETED|Part 1 (up to 15 Days)||0
7557721|NCT02999100|18602417|P4|COMPLETED|Part 1 (up to 15 Days)||0
7557722|NCT02999100|18602418|P3|COMPLETED|Part 1 (up to 15 Days)||0
7557723|NCT02999100|18602419|P2|COMPLETED|Part 1 (up to 15 Days)||7
7557724|NCT02999100|18602420|P1|COMPLETED|Part 1 (up to 15 Days)||9
7557725|NCT02999100|18602415|P6|STARTED|Part 1 (up to 15 Days)||0
7557726|NCT02999100|18602416|P5|STARTED|Part 1 (up to 15 Days)||0
7557727|NCT02999100|18602417|P4|STARTED|Part 1 (up to 15 Days)||0
7557728|NCT02999100|18602418|P3|STARTED|Part 1 (up to 15 Days)||0
7557729|NCT02999100|18602419|P2|STARTED|Part 1 (up to 15 Days)||8
7557730|NCT02999100|18602420|P1|STARTED|Part 1 (up to 15 Days)||9
7557731|NCT02998996|18602588|P6|NOT COMPLETED|Overall Study||0
7557732|NCT02998996|18602589|P5|NOT COMPLETED|Overall Study||1
7557733|NCT02998996|18602590|P4|NOT COMPLETED|Overall Study||0
7557734|NCT02998996|18602591|P3|NOT COMPLETED|Overall Study||1
7557735|NCT02998996|18602592|P2|NOT COMPLETED|Overall Study||1
7557736|NCT02998996|18602593|P1|NOT COMPLETED|Overall Study||0
7557737|NCT02998996|18602588|P6|COMPLETED|Overall Study||19
7557738|NCT02998996|18602589|P5|COMPLETED|Overall Study||17
7557739|NCT02998996|18602590|P4|COMPLETED|Overall Study||18
7557740|NCT02998996|18602591|P3|COMPLETED|Overall Study||35
7557741|NCT02998996|18602592|P2|COMPLETED|Overall Study||34
7557742|NCT02998996|18602593|P1|COMPLETED|Overall Study||36
7557743|NCT02998996|18602588|P6|STARTED|Overall Study||19
7557744|NCT02998996|18602589|P5|STARTED|Overall Study||18
7557745|NCT02998996|18602590|P4|STARTED|Overall Study||18
7557746|NCT02998996|18602591|P3|STARTED|Overall Study||36
7557747|NCT02998996|18602592|P2|STARTED|Overall Study||35
7557748|NCT02998996|18602593|P1|STARTED|Overall Study||36
7557749|NCT02998684|18602613|P2|NOT COMPLETED|Overall Study||1
7557750|NCT02998684|18602614|P1|NOT COMPLETED|Overall Study||3
7557751|NCT02998684|18602613|P2|COMPLETED|Overall Study||6
7557752|NCT02998684|18602614|P1|COMPLETED|Overall Study||4
7557753|NCT02998684|18602613|P2|STARTED|Overall Study||7
7557754|NCT02998684|18602614|P1|STARTED|Overall Study||7
7557755|NCT02998671|18602627|P5|NOT COMPLETED|Period 2||0
7557756|NCT02998671|18602628|P4|NOT COMPLETED|Period 2||4
7557757|NCT02998671|18602629|P3|NOT COMPLETED|Period 2||1
7557758|NCT02998671|18602630|P2|NOT COMPLETED|Period 2||7
7557759|NCT02998671|18602631|P1|NOT COMPLETED|Period 2||3
7557760|NCT02998671|18602627|P5|COMPLETED|Period 2||0
7557761|NCT02998671|18602628|P4|COMPLETED|Period 2||4
7557762|NCT02998671|18602629|P3|COMPLETED|Period 2||5
7557763|NCT02998671|18602630|P2|COMPLETED|Period 2||3
7557764|NCT02998671|18602631|P1|COMPLETED|Period 2||14
7557765|NCT02998671|18602627|P5|STARTED|Period 2||0
7557766|NCT02998671|18602628|P4|STARTED|Period 2||8
7557767|NCT02998671|18602629|P3|STARTED|Period 2||6
7557768|NCT02998671|18602630|P2|STARTED|Period 2||10
7557769|NCT02998671|18602631|P1|STARTED|Period 2||17
7557770|NCT02998671|18602627|P5|NOT COMPLETED|Period 1||4
7557771|NCT02998671|18602628|P4|NOT COMPLETED|Period 1||0
7557772|NCT02998671|18602629|P3|NOT COMPLETED|Period 1||0
7557773|NCT02998671|18602630|P2|NOT COMPLETED|Period 1||3
7557774|NCT02998671|18602631|P1|NOT COMPLETED|Period 1||4
7557775|NCT02998671|18602627|P5|COMPLETED|Period 1||0
7557776|NCT02998671|18602628|P4|COMPLETED|Period 1||8
7557777|NCT02998671|18602629|P3|COMPLETED|Period 1||6
7557778|NCT02998671|18602630|P2|COMPLETED|Period 1||10
7557779|NCT02998671|18602631|P1|COMPLETED|Period 1||17
7557780|NCT02998671|18602627|P5|STARTED|Period 1||4
7557781|NCT02998671|18602628|P4|STARTED|Period 1||8
7557782|NCT02998671|18602629|P3|STARTED|Period 1||6
7557783|NCT02998671|18602630|P2|STARTED|Period 1||13
7557784|NCT02998671|18602631|P1|STARTED|Period 1||21
7557785|NCT02998554|18602676|P2|NOT COMPLETED|Overall Study||11
7557786|NCT02998554|18602677|P1|NOT COMPLETED|Overall Study||11
7557787|NCT02998554|18602676|P2|COMPLETED|Overall Study||66
7557788|NCT02998554|18602677|P1|COMPLETED|Overall Study||68
7557789|NCT02998554|18602676|P2|STARTED|Overall Study||77
7557790|NCT02998554|18602677|P1|STARTED|Overall Study||79
7557791|NCT02998541|18602708|P3|NOT COMPLETED|Overall Study||6
7557792|NCT02998541|18602709|P2|NOT COMPLETED|Overall Study||9
7557793|NCT02998541|18602710|P1|NOT COMPLETED|Overall Study||8
7557794|NCT02998541|18602708|P3|COMPLETED|Overall Study||37
7557795|NCT02998541|18602709|P2|COMPLETED|Overall Study||81
7557796|NCT02998541|18602710|P1|COMPLETED|Overall Study||78
7557797|NCT02998541|18602708|P3|STARTED|Overall Study||43
7557798|NCT02998541|18602709|P2|STARTED|Overall Study||90
7557799|NCT02998541|18602710|P1|STARTED|Overall Study||86
7557800|NCT02998476|18602765|P2|NOT COMPLETED|Overall Study||5
7557801|NCT02998476|18602766|P1|NOT COMPLETED|Overall Study||55
7557802|NCT02998476|18602765|P2|COMPLETED|Overall Study||0
7557803|NCT02998476|18602766|P1|COMPLETED|Overall Study||0
7557804|NCT02998476|18602765|P2|STARTED|Overall Study||5
7557805|NCT02998476|18602766|P1|STARTED|Overall Study||55
7557806|NCT02998021|18602776|P2|NOT COMPLETED|Overall Study||2
7557807|NCT02998021|18602777|P1|NOT COMPLETED|Overall Study||3
7557808|NCT02998021|18602776|P2|COMPLETED|Overall Study||0
7557809|NCT02998021|18602777|P1|COMPLETED|Overall Study||5
7557810|NCT02998021|18602776|P2|STARTED|Overall Study||2
7557811|NCT02998021|18602777|P1|STARTED|Overall Study||8
7557812|NCT02997904|18602803|P2|NOT COMPLETED|Overall Study||0
7557813|NCT02997904|18602804|P1|NOT COMPLETED|Overall Study||0
7557814|NCT02997904|18602803|P2|COMPLETED|Overall Study||49
7557815|NCT02997904|18602804|P1|COMPLETED|Overall Study||51
7557816|NCT02997904|18602803|P2|STARTED|Overall Study||49
7557817|NCT02997904|18602804|P1|STARTED|Overall Study||51
7557818|NCT02997735|18602816|P2|NOT COMPLETED|Overall Study||0
7557819|NCT02997735|18602817|P1|NOT COMPLETED|Overall Study||0
7557820|NCT02997735|18602816|P2|COMPLETED|Overall Study||251
7557821|NCT02997735|18602817|P1|COMPLETED|Overall Study||233
7557822|NCT02997735|18602816|P2|STARTED|Overall Study||251
7557823|NCT02997735|18602817|P1|STARTED|Overall Study||233
7557824|NCT02997722|18602841|P2|NOT COMPLETED|Overall Study||0
7557825|NCT02997722|18602842|P1|NOT COMPLETED|Overall Study||0
7557826|NCT02997722|18602841|P2|COMPLETED|Overall Study||1
7557827|NCT02997722|18602842|P1|COMPLETED|Overall Study||3
7557828|NCT02997722|18602841|P2|STARTED|Overall Study||1
7557829|NCT02997722|18602842|P1|STARTED|Overall Study||3
7557830|NCT02997163|18602852|P4|NOT COMPLETED|Overall Study||1
7557831|NCT02997163|18602853|P3|NOT COMPLETED|Overall Study||0
7557832|NCT02997163|18602854|P2|NOT COMPLETED|Overall Study||0
7557833|NCT02997163|18602855|P1|NOT COMPLETED|Overall Study||1
7557834|NCT02997163|18602852|P4|COMPLETED|Overall Study||7
7557835|NCT02997163|18602853|P3|COMPLETED|Overall Study||8
7557836|NCT02997163|18602854|P2|COMPLETED|Overall Study||9
7557837|NCT02997163|18602855|P1|COMPLETED|Overall Study||8
7557838|NCT02997163|18602852|P4|STARTED|Overall Study||8
7557839|NCT02997163|18602853|P3|STARTED|Overall Study||8
7557840|NCT02997163|18602854|P2|STARTED|Overall Study||9
7557841|NCT02997163|18602855|P1|STARTED|Overall Study||9
7557842|NCT02996968|18602987|P2|NOT COMPLETED|Overall Study||0
7557843|NCT02996968|18602988|P1|NOT COMPLETED|Overall Study||1
7557844|NCT02996968|18602987|P2|COMPLETED|Overall Study||79
7557845|NCT02996968|18602988|P1|COMPLETED|Overall Study||78
7557846|NCT02996968|18602987|P2|STARTED|Overall Study||79
7557847|NCT02996968|18602988|P1|STARTED|Overall Study||79
7557848|NCT02996682|18602996|P2|NOT COMPLETED|Overall Study||3
7557849|NCT02996682|18602997|P1|NOT COMPLETED|Overall Study||0
7557850|NCT02996682|18602996|P2|COMPLETED|Overall Study||48
7557851|NCT02996682|18602997|P1|COMPLETED|Overall Study||51
7557852|NCT02996682|18602996|P2|STARTED|Overall Study||51
7557853|NCT02996682|18602997|P1|STARTED|Overall Study||51
7557854|NCT02996591|18603021|P2|NOT COMPLETED|Overall Study||0
7557855|NCT02996591|18603022|P1|NOT COMPLETED|Overall Study||0
7557856|NCT02996591|18603021|P2|COMPLETED|Overall Study||18
7557857|NCT02996591|18603022|P1|COMPLETED|Overall Study||18
7557858|NCT02996591|18603021|P2|STARTED|Overall Study||18
7557859|NCT02996591|18603022|P1|STARTED|Overall Study||18
7557860|NCT02996500|18603076|P6|NOT COMPLETED|Overall Study||4
7557861|NCT02996500|18603077|P5|NOT COMPLETED|Overall Study||5
7557862|NCT02996500|18603078|P4|NOT COMPLETED|Overall Study||4
7557863|NCT02996500|18603079|P3|NOT COMPLETED|Overall Study||10
7557864|NCT02996500|18603080|P2|NOT COMPLETED|Overall Study||1
7557865|NCT02996500|18603081|P1|NOT COMPLETED|Overall Study||8
7557866|NCT02996500|18603076|P6|COMPLETED|Overall Study||44
7557867|NCT02996500|18603077|P5|COMPLETED|Overall Study||45
7557868|NCT02996500|18603078|P4|COMPLETED|Overall Study||46
7557869|NCT02996500|18603079|P3|COMPLETED|Overall Study||29
7557870|NCT02996500|18603080|P2|COMPLETED|Overall Study||42
7557871|NCT02996500|18603081|P1|COMPLETED|Overall Study||31
7557872|NCT02996500|18603076|P6|STARTED|Overall Study||48
7557873|NCT02996500|18603077|P5|STARTED|Overall Study||50
7557874|NCT02996500|18603078|P4|STARTED|Overall Study||50
7557875|NCT02996500|18603079|P3|STARTED|Overall Study||39
7557876|NCT02996500|18603080|P2|STARTED|Overall Study||43
7557877|NCT02996500|18603081|P1|STARTED|Overall Study||39
7557878|NCT02996474|18603264|P1|NOT COMPLETED|Overall Study||5
7557879|NCT02996474|18603264|P1|COMPLETED|Overall Study||5
7557880|NCT02996474|18603264|P1|STARTED|Overall Study||10
7557881|NCT02996448|18603268|P1|NOT COMPLETED|Overall Study||3
7557882|NCT02996448|18603268|P1|COMPLETED|Overall Study||0
7557883|NCT02996448|18603268|P1|STARTED|Overall Study||3
7557884|NCT02996097|18603274|P2|NOT COMPLETED|Overall Study||11
7557885|NCT02996097|18603275|P1|NOT COMPLETED|Overall Study||11
7557886|NCT02996097|18603274|P2|COMPLETED|Overall Study||19
7557887|NCT02996097|18603275|P1|COMPLETED|Overall Study||19
7557888|NCT02996097|18603274|P2|Per Protocol Population|Overall Study||22
7557889|NCT02996097|18603275|P1|Per Protocol Population|Overall Study||22
7557890|NCT02996097|18603274|P2|STARTED|Overall Study||30
7557891|NCT02996097|18603275|P1|STARTED|Overall Study||30
7557892|NCT02995980|18603282|P1|NOT COMPLETED|Overall Study||14
7557893|NCT02995980|18603282|P1|COMPLETED|Overall Study||114
7557894|NCT02995980|18603282|P1|STARTED|Overall Study||128
7557895|NCT02995967|18603293|P2|NOT COMPLETED|Overall Study||0
7557896|NCT02995967|18603294|P1|NOT COMPLETED|Overall Study||0
7557897|NCT02995967|18603293|P2|COMPLETED|Overall Study||2
7557898|NCT02995967|18603294|P1|COMPLETED|Overall Study||1
7557899|NCT02995967|18603293|P2|STARTED|Overall Study||2
7557900|NCT02995967|18603294|P1|STARTED|Overall Study||1
7557901|NCT02994979|18603320|P2|NOT COMPLETED|Overall Study||0
7557902|NCT02994979|18603321|P1|NOT COMPLETED|Overall Study||0
7557903|NCT02994979|18603320|P2|COMPLETED|Overall Study||105
7557904|NCT02994979|18603321|P1|COMPLETED|Overall Study||114
7557905|NCT02994979|18603320|P2|STARTED|Overall Study||105
7557906|NCT02994979|18603321|P1|STARTED|Overall Study||114
7557907|NCT02994940|18603335|P2|NOT COMPLETED|Overall Study||1
7557908|NCT02994940|18603336|P1|NOT COMPLETED|Overall Study||7
7557909|NCT02994940|18603335|P2|COMPLETED|Overall Study||36
7557910|NCT02994940|18603336|P1|COMPLETED|Overall Study||30
7557911|NCT02994940|18603335|P2|STARTED|Overall Study||37
7557912|NCT02994940|18603336|P1|STARTED|Overall Study||37
7557913|NCT02994732|18603348|P1|NOT COMPLETED|Overall Study||0
7557914|NCT02994732|18603348|P1|COMPLETED|Overall Study|All subjects were discharged from the clinic by Jan 24, 2017|6
7557915|NCT02994732|18603348|P1|STARTED|Overall Study|All subjects entered clinic on January 11, 2017|6
7557916|NCT02994251|18603362|P1|NOT COMPLETED|Overall Study||0
7557917|NCT02994251|18603362|P1|COMPLETED|Overall Study||0
7557918|NCT02994251|18603362|P1|STARTED|Overall Study||0
7557919|NCT02994108|18603374|P2|NOT COMPLETED|Phase 2 Assessment||7
7557920|NCT02994108|18603375|P1|NOT COMPLETED|Phase 2 Assessment||9
7557921|NCT02994108|18603374|P2|COMPLETED|Phase 2 Assessment||69
7557922|NCT02994108|18603375|P1|COMPLETED|Phase 2 Assessment||63
7557923|NCT02994108|18603374|P2|STARTED|Phase 2 Assessment||76
7557924|NCT02994108|18603375|P1|STARTED|Phase 2 Assessment||72
7557925|NCT02994108|18603374|P2|NOT COMPLETED|Phase 1 Assessment||3
7557926|NCT02994108|18603375|P1|NOT COMPLETED|Phase 1 Assessment||5
7557927|NCT02994108|18603374|P2|COMPLETED|Phase 1 Assessment||73
7557928|NCT02994108|18603375|P1|COMPLETED|Phase 1 Assessment||67
7557929|NCT02994108|18603374|P2|STARTED|Phase 1 Assessment||76
7557930|NCT02994108|18603375|P1|STARTED|Phase 1 Assessment||72
7557931|NCT02994108|18603374|P2|NOT COMPLETED|Intervention Messages||0
7557932|NCT02994108|18603375|P1|NOT COMPLETED|Intervention Messages||2
7557933|NCT02994108|18603374|P2|COMPLETED|Intervention Messages||76
7557934|NCT02994108|18603375|P1|COMPLETED|Intervention Messages||72
7557935|NCT02994108|18603374|P2|STARTED|Intervention Messages||76
7557936|NCT02994108|18603375|P1|STARTED|Intervention Messages||74
7557937|NCT02994056|18603407|P1|NOT COMPLETED|Overall Study||9
7557938|NCT02994056|18603407|P1|COMPLETED|Overall Study||23
7557939|NCT02994056|18603407|P1|STARTED|Overall Study||32
7557940|NCT02993926|18603441|P3|NOT COMPLETED|Follow-Up Phase||0
7557941|NCT02993926|18603442|P2|NOT COMPLETED|Follow-Up Phase||0
7557942|NCT02993926|18603443|P1|NOT COMPLETED|Follow-Up Phase||0
7557943|NCT02993926|18603441|P3|COMPLETED|Follow-Up Phase||26
7557944|NCT02993926|18603442|P2|COMPLETED|Follow-Up Phase||44
7557945|NCT02993926|18603443|P1|COMPLETED|Follow-Up Phase||0
7557946|NCT02993926|18603441|P3|STARTED|Follow-Up Phase||26
7557947|NCT02993926|18603442|P2|STARTED|Follow-Up Phase||44
7557948|NCT02993926|18603443|P1|STARTED|Follow-Up Phase||0
7557949|NCT02993926|18603441|P3|NOT COMPLETED|Enantone Treatment Phase||0
7557950|NCT02993926|18603442|P2|NOT COMPLETED|Enantone Treatment Phase||0
7557951|NCT02993926|18603443|P1|NOT COMPLETED|Enantone Treatment Phase||32
7557952|NCT02993926|18603441|P3|COMPLETED|Enantone Treatment Phase||0
7557953|NCT02993926|18603442|P2|COMPLETED|Enantone Treatment Phase||0
7557954|NCT02993926|18603443|P1|COMPLETED|Enantone Treatment Phase||76
7557955|NCT02993926|18603441|P3|STARTED|Enantone Treatment Phase||0
7557956|NCT02993926|18603442|P2|STARTED|Enantone Treatment Phase||0
7557957|NCT02993926|18603443|P1|STARTED|Enantone Treatment Phase||108
7557958|NCT02993783|18603475|P2|NOT COMPLETED|Overall Study||9
7557959|NCT02993783|18603476|P1|NOT COMPLETED|Overall Study||6
7557960|NCT02993783|18603475|P2|COMPLETED|Overall Study||0
7557961|NCT02993783|18603476|P1|COMPLETED|Overall Study||2
7557962|NCT02993783|18603475|P2|STARTED|Overall Study||9
7557963|NCT02993783|18603476|P1|STARTED|Overall Study||8
7557964|NCT02993757|18603508|P2|NOT COMPLETED|Overall Study||178
7557965|NCT02993757|18603509|P1|NOT COMPLETED|Overall Study||164
7557966|NCT02993757|18603508|P2|COMPLETED|Overall Study||84
7557967|NCT02993757|18603509|P1|COMPLETED|Overall Study||102
7557968|NCT02993757|18603508|P2|Safety Analysis Set (SafAS)|Overall Study||260
7557969|NCT02993757|18603509|P1|Safety Analysis Set (SafAS)|Overall Study||263
7557970|NCT02993757|18603508|P2|STARTED|Overall Study||262
7557971|NCT02993757|18603509|P1|STARTED|Overall Study||266
7557972|NCT02993471|18603541|P1|NOT COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||2
7557973|NCT02993471|18603541|P1|COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||26
7557974|NCT02993471|18603541|P1|Received at Least 1 Dose of Study Drug|Period 2 (Drug Cocktail + Ixekizumab)||27
7557975|NCT02993471|18603541|P1|STARTED|Period 2 (Drug Cocktail + Ixekizumab)||28
7557976|NCT02993471|18603541|P1|NOT COMPLETED|Period 1 (Drug Cocktail)||0
7557977|NCT02993471|18603541|P1|COMPLETED|Period 1 (Drug Cocktail)||28
7557978|NCT02993471|18603541|P1|Received at Least 1 Dose of Study Drug|Period 1 (Drug Cocktail)||28
7557979|NCT02993471|18603541|P1|STARTED|Period 1 (Drug Cocktail)||28
7557980|NCT02993445|18603577|P2|NOT COMPLETED|Second Intervention (5 Mins)||0
7557981|NCT02993445|18603578|P1|NOT COMPLETED|Second Intervention (5 Mins)||0
7557982|NCT02993445|18603577|P2|COMPLETED|Second Intervention (5 Mins)||5
7557983|NCT02993445|18603578|P1|COMPLETED|Second Intervention (5 Mins)||6
7557984|NCT02993445|18603577|P2|STARTED|Second Intervention (5 Mins)||5
7557985|NCT02993445|18603578|P1|STARTED|Second Intervention (5 Mins)||6
7557986|NCT02993445|18603577|P2|NOT COMPLETED|Washout (2 Weeks)||0
7557987|NCT02993445|18603578|P1|NOT COMPLETED|Washout (2 Weeks)||0
7557988|NCT02993445|18603577|P2|COMPLETED|Washout (2 Weeks)||5
7557989|NCT02993445|18603578|P1|COMPLETED|Washout (2 Weeks)||6
7557990|NCT02993445|18603577|P2|STARTED|Washout (2 Weeks)||5
7557991|NCT02993445|18603578|P1|STARTED|Washout (2 Weeks)||6
7557992|NCT02993445|18603577|P2|NOT COMPLETED|First Intervention (5 Minutes)||0
7557993|NCT02993445|18603578|P1|NOT COMPLETED|First Intervention (5 Minutes)||0
7557994|NCT02993445|18603577|P2|COMPLETED|First Intervention (5 Minutes)||5
7557995|NCT02993445|18603578|P1|COMPLETED|First Intervention (5 Minutes)||6
7557996|NCT02993445|18603577|P2|STARTED|First Intervention (5 Minutes)||5
7557997|NCT02993445|18603578|P1|STARTED|First Intervention (5 Minutes)||6
7557998|NCT02993302|18603588|P2|NOT COMPLETED|Overall Study||0
7557999|NCT02993302|18603589|P1|NOT COMPLETED|Overall Study||0
7558000|NCT02993302|18603588|P2|COMPLETED|Overall Study||12
7558001|NCT02993302|18603589|P1|COMPLETED|Overall Study||13
7558002|NCT02993302|18603588|P2|STARTED|Overall Study||12
7558003|NCT02993302|18603589|P1|STARTED|Overall Study||13
7558004|NCT02993250|18603603|P2|NOT COMPLETED|Overall Study||1
7558005|NCT02993250|18603604|P1|NOT COMPLETED|Overall Study||0
7558006|NCT02993250|18603603|P2|COMPLETED|Overall Study||10
7558007|NCT02993250|18603604|P1|COMPLETED|Overall Study||22
7558008|NCT02993250|18603603|P2|STARTED|Overall Study||11
7558009|NCT02993250|18603604|P1|STARTED|Overall Study||22
7558010|NCT02992691|18603624|P1|NOT COMPLETED|Overall Study||3
7558011|NCT02992691|18603624|P1|COMPLETED|Overall Study||53
7558012|NCT02992691|18603624|P1|Received Negative Control|Overall Study||55
7558013|NCT02992691|18603624|P1|Received Positive Control|Overall Study||55
7558014|NCT02992691|18603624|P1|Received Test Product 3|Overall Study||52
7558015|NCT02992691|18603624|P1|Received Test Product 2|Overall Study||55
7558016|NCT02992691|18603624|P1|Received Test Product 1|Overall Study||55
7558017|NCT02992691|18603624|P1|STARTED|Overall Study||56
7558018|NCT02992418|18603643|P2|NOT COMPLETED|Overall Study||342
7558019|NCT02992418|18603644|P1|NOT COMPLETED|Overall Study||346
7558020|NCT02992418|18603643|P2|COMPLETED|Overall Study||0
7558021|NCT02992418|18603644|P1|COMPLETED|Overall Study||0
7558022|NCT02992418|18603643|P2|Safety Analysis Set (SafAS)|Overall Study||342
7558023|NCT02992418|18603644|P1|Safety Analysis Set (SafAS)|Overall Study||338
7558024|NCT02992418|18603643|P2|STARTED|Overall Study||342
7558025|NCT02992418|18603644|P1|STARTED|Overall Study||346
7558026|NCT02992288|18603684|P6|NOT COMPLETED|Overall Study||13
7558027|NCT02992288|18603685|P5|NOT COMPLETED|Overall Study||8
7558028|NCT02992288|18603686|P4|NOT COMPLETED|Overall Study||9
7558029|NCT02992288|18603687|P3|NOT COMPLETED|Overall Study||7
7558030|NCT02992288|18603688|P2|NOT COMPLETED|Overall Study||5
7558031|NCT02992288|18603689|P1|NOT COMPLETED|Overall Study||17
7558032|NCT02992288|18603684|P6|COMPLETED|Overall Study||59
7558033|NCT02992288|18603685|P5|COMPLETED|Overall Study||61
7558034|NCT02992288|18603686|P4|COMPLETED|Overall Study||64
7558035|NCT02992288|18603687|P3|COMPLETED|Overall Study||63
7558036|NCT02992288|18603688|P2|COMPLETED|Overall Study||32
7558037|NCT02992288|18603689|P1|COMPLETED|Overall Study||89
7558038|NCT02992288|18603684|P6|Treated|Overall Study||72
7558039|NCT02992288|18603685|P5|Treated|Overall Study||69
7558040|NCT02992288|18603686|P4|Treated|Overall Study||72
7558041|NCT02992288|18603687|P3|Treated|Overall Study||70
7558042|NCT02992288|18603688|P2|Treated|Overall Study||37
7558043|NCT02992288|18603689|P1|Treated|Overall Study||106
7558044|NCT02992288|18603684|P6|STARTED|Overall Study||72
7558045|NCT02992288|18603685|P5|STARTED|Overall Study||69
7558046|NCT02992288|18603686|P4|STARTED|Overall Study||73
7558047|NCT02992288|18603687|P3|STARTED|Overall Study||70
7558048|NCT02992288|18603688|P2|STARTED|Overall Study||37
7558049|NCT02992288|18603689|P1|STARTED|Overall Study||106
7558050|NCT02992236|18603747|P2|NOT COMPLETED|Overall Study||0
7558051|NCT02992236|18603748|P1|NOT COMPLETED|Overall Study||0
7558052|NCT02992236|18603747|P2|COMPLETED|Overall Study||8
7558053|NCT02992236|18603748|P1|COMPLETED|Overall Study||8
7558054|NCT02992236|18603747|P2|STARTED|Overall Study||8
7558055|NCT02992236|18603748|P1|STARTED|Overall Study||8
7558056|NCT02992197|18603760|P2|NOT COMPLETED|Overall Study||7
7558057|NCT02992197|18603761|P1|NOT COMPLETED|Overall Study||11
7558058|NCT02992197|18603760|P2|COMPLETED|Overall Study||103
7558059|NCT02992197|18603761|P1|COMPLETED|Overall Study||99
7558060|NCT02992197|18603760|P2|STARTED|Overall Study||110
7558061|NCT02992197|18603761|P1|STARTED|Overall Study||110
7558062|NCT02992132|18603774|P3|NOT COMPLETED|Overall Study||7
7558063|NCT02992132|18603775|P2|NOT COMPLETED|Overall Study||8
7558064|NCT02992132|18603776|P1|NOT COMPLETED|Overall Study||13
7558065|NCT02992132|18603774|P3|COMPLETED|Overall Study||29
7558066|NCT02992132|18603775|P2|COMPLETED|Overall Study||27
7558067|NCT02992132|18603776|P1|COMPLETED|Overall Study||27
7558068|NCT02992132|18603774|P3|STARTED|Overall Study||36
7558069|NCT02992132|18603775|P2|STARTED|Overall Study||35
7558070|NCT02992132|18603776|P1|STARTED|Overall Study||40
7558071|NCT02992119|18603794|P7|NOT COMPLETED|Overall Study||3
7558072|NCT02992119|18603795|P6|NOT COMPLETED|Overall Study||0
7558073|NCT02992119|18603796|P5|NOT COMPLETED|Overall Study||0
7558074|NCT02992119|18603797|P4|NOT COMPLETED|Overall Study||0
7558075|NCT02992119|18603798|P3|NOT COMPLETED|Overall Study||1
7558076|NCT02992119|18603799|P2|NOT COMPLETED|Overall Study||1
7558077|NCT02992119|18603800|P1|NOT COMPLETED|Overall Study||2
7558078|NCT02992119|18603794|P7|COMPLETED|Overall Study||28
7558079|NCT02992119|18603795|P6|COMPLETED|Overall Study||30
7558080|NCT02992119|18603796|P5|COMPLETED|Overall Study||30
7558081|NCT02992119|18603797|P4|COMPLETED|Overall Study||30
7558082|NCT02992119|18603798|P3|COMPLETED|Overall Study||29
7558083|NCT02992119|18603799|P2|COMPLETED|Overall Study||20
7558084|NCT02992119|18603800|P1|COMPLETED|Overall Study||19
7558085|NCT02992119|18603794|P7|STARTED|Overall Study||31
7558086|NCT02992119|18603795|P6|STARTED|Overall Study||30
7558087|NCT02992119|18603796|P5|STARTED|Overall Study||30
7558088|NCT02992119|18603797|P4|STARTED|Overall Study||30
7558089|NCT02992119|18603798|P3|STARTED|Overall Study||30
7558090|NCT02992119|18603799|P2|STARTED|Overall Study||21
7558091|NCT02992119|18603800|P1|STARTED|Overall Study||21
7558092|NCT02992067|18603851|P1|NOT COMPLETED|Overall Study||0
7558093|NCT02992067|18603851|P1|COMPLETED|Overall Study||359
7558094|NCT02992067|18603851|P1|STARTED|Overall Study||359
7558095|NCT02991898|18603855|P1|NOT COMPLETED|Overall Study||0
7558096|NCT02991898|18603855|P1|COMPLETED|Overall Study||3
7558097|NCT02991898|18603855|P1|STARTED|Overall Study||3
7558098|NCT02991859|18603889|P17|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558099|NCT02991859|18603890|P16|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558100|NCT02991859|18603891|P15|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558101|NCT02991859|18603892|P14|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558102|NCT02991859|18603893|P13|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558103|NCT02991859|18603894|P12|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558104|NCT02991859|18603895|P11|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558105|NCT02991859|18603896|P10|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558106|NCT02991859|18603897|P9|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558107|NCT02991859|18603898|P8|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558108|NCT02991859|18603899|P7|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558109|NCT02991859|18603900|P6|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558110|NCT02991859|18603901|P5|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558111|NCT02991859|18603902|P4|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558112|NCT02991859|18603903|P3|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558113|NCT02991859|18603904|P2|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558114|NCT02991859|18603905|P1|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558115|NCT02991859|18603889|P17|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558116|NCT02991859|18603890|P16|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558117|NCT02991859|18603891|P15|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558118|NCT02991859|18603892|P14|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558119|NCT02991859|18603893|P13|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
7558120|NCT02991859|18603894|P12|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
7558121|NCT02991859|18603895|P11|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
7558122|NCT02991859|18603896|P10|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
7558123|NCT02991859|18603897|P9|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
7558124|NCT02991859|18603898|P8|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
7558125|NCT02991859|18603899|P7|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
7558126|NCT02991859|18603900|P6|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
7558127|NCT02991859|18603901|P5|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
7558128|NCT02991859|18603902|P4|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
7558129|NCT02991859|18603903|P3|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
7558130|NCT02991859|18603904|P2|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
7558131|NCT02991859|18603905|P1|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
7558132|NCT02991859|18603889|P17|STARTED|Period2,Escalation Phase5,Upto Day 112||0
7558133|NCT02991859|18603890|P16|STARTED|Period2,Escalation Phase5,Upto Day 112||0
7558134|NCT02991859|18603891|P15|STARTED|Period2,Escalation Phase5,Upto Day 112||0
7558135|NCT02991859|18603892|P14|STARTED|Period2,Escalation Phase5,Upto Day 112||0
7558136|NCT02991859|18603893|P13|STARTED|Period2,Escalation Phase5,Upto Day 112||0
7558137|NCT02991859|18603894|P12|STARTED|Period2,Escalation Phase5,Upto Day 112||2
7558138|NCT02991859|18603895|P11|STARTED|Period2,Escalation Phase5,Upto Day 112||2
7558139|NCT02991859|18603896|P10|STARTED|Period2,Escalation Phase5,Upto Day 112||2
7558140|NCT02991859|18603897|P9|STARTED|Period2,Escalation Phase5,Upto Day 112||1
7558141|NCT02991859|18603898|P8|STARTED|Period2,Escalation Phase5,Upto Day 112||2
7558142|NCT02991859|18603899|P7|STARTED|Period2,Escalation Phase5,Upto Day 112||2
7558143|NCT02991859|18603900|P6|STARTED|Period2,Escalation Phase5,Upto Day 112||1
7558144|NCT02991859|18603901|P5|STARTED|Period2,Escalation Phase5,Upto Day 112||2
7558145|NCT02991859|18603902|P4|STARTED|Period2,Escalation Phase5,Upto Day 112||2
7558146|NCT02991859|18603903|P3|STARTED|Period2,Escalation Phase5,Upto Day 112||2
7558147|NCT02991859|18603904|P2|STARTED|Period2,Escalation Phase5,Upto Day 112||2
7558148|NCT02991859|18603905|P1|STARTED|Period2,Escalation Phase5,Upto Day 112||2
7558149|NCT02991859|18603889|P17|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
7558150|NCT02991859|18603890|P16|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
7558151|NCT02991859|18603891|P15|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
7558152|NCT02991859|18603892|P14|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
7558153|NCT02991859|18603893|P13|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
7558154|NCT02991859|18603894|P12|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
7558155|NCT02991859|18603895|P11|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
7558156|NCT02991859|18603896|P10|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
7558157|NCT02991859|18603897|P9|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
7558158|NCT02991859|18603898|P8|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
7558159|NCT02991859|18603899|P7|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
7558160|NCT02991859|18603900|P6|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
7558161|NCT02991859|18603901|P5|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
7558162|NCT02991859|18603902|P4|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
7558163|NCT02991859|18603903|P3|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
7558164|NCT02991859|18603904|P2|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
7558165|NCT02991859|18603905|P1|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
7558166|NCT02991859|18603889|P17|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
7558167|NCT02991859|18603890|P16|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
7558168|NCT02991859|18603891|P15|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
7558169|NCT02991859|18603892|P14|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
7558170|NCT02991859|18603893|P13|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
7558171|NCT02991859|18603894|P12|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
7558172|NCT02991859|18603895|P11|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
7558173|NCT02991859|18603896|P10|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
7558174|NCT02991859|18603897|P9|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
7558175|NCT02991859|18603898|P8|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
7558176|NCT02991859|18603899|P7|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
7558177|NCT02991859|18603900|P6|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
7558178|NCT02991859|18603901|P5|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
7558179|NCT02991859|18603902|P4|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
7558180|NCT02991859|18603903|P3|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
7558181|NCT02991859|18603904|P2|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
7558182|NCT02991859|18603905|P1|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
7558183|NCT02991859|18603889|P17|STARTED|Period2, Escalation Phase4, Upto Day 105||0
7558184|NCT02991859|18603890|P16|STARTED|Period2, Escalation Phase4, Upto Day 105||0
7558185|NCT02991859|18603891|P15|STARTED|Period2, Escalation Phase4, Upto Day 105||0
7558186|NCT02991859|18603892|P14|STARTED|Period2, Escalation Phase4, Upto Day 105||0
7558187|NCT02991859|18603893|P13|STARTED|Period2, Escalation Phase4, Upto Day 105||0
7558188|NCT02991859|18603894|P12|STARTED|Period2, Escalation Phase4, Upto Day 105||2
7558189|NCT02991859|18603895|P11|STARTED|Period2, Escalation Phase4, Upto Day 105||2
7558190|NCT02991859|18603896|P10|STARTED|Period2, Escalation Phase4, Upto Day 105||2
7558191|NCT02991859|18603897|P9|STARTED|Period2, Escalation Phase4, Upto Day 105||2
7558192|NCT02991859|18603898|P8|STARTED|Period2, Escalation Phase4, Upto Day 105||2
7558193|NCT02991859|18603899|P7|STARTED|Period2, Escalation Phase4, Upto Day 105||2
7558194|NCT02991859|18603900|P6|STARTED|Period2, Escalation Phase4, Upto Day 105||1
7558195|NCT02991859|18603901|P5|STARTED|Period2, Escalation Phase4, Upto Day 105||2
7558196|NCT02991859|18603902|P4|STARTED|Period2, Escalation Phase4, Upto Day 105||2
7558197|NCT02991859|18603903|P3|STARTED|Period2, Escalation Phase4, Upto Day 105||2
7558198|NCT02991859|18603904|P2|STARTED|Period2, Escalation Phase4, Upto Day 105||2
7558199|NCT02991859|18603905|P1|STARTED|Period2, Escalation Phase4, Upto Day 105||2
7558200|NCT02991859|18603889|P17|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558201|NCT02991859|18603890|P16|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558202|NCT02991859|18603891|P15|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558203|NCT02991859|18603892|P14|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558204|NCT02991859|18603893|P13|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558205|NCT02991859|18603894|P12|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558206|NCT02991859|18603895|P11|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558207|NCT02991859|18603896|P10|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558208|NCT02991859|18603897|P9|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558209|NCT02991859|18603898|P8|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558210|NCT02991859|18603899|P7|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558211|NCT02991859|18603900|P6|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558212|NCT02991859|18603901|P5|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558213|NCT02991859|18603902|P4|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558214|NCT02991859|18603903|P3|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558215|NCT02991859|18603904|P2|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558216|NCT02991859|18603905|P1|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558217|NCT02991859|18603889|P17|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558218|NCT02991859|18603890|P16|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558219|NCT02991859|18603891|P15|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558220|NCT02991859|18603892|P14|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558221|NCT02991859|18603893|P13|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
7558222|NCT02991859|18603894|P12|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
7558223|NCT02991859|18603895|P11|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
7558224|NCT02991859|18603896|P10|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
7558225|NCT02991859|18603897|P9|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
7558226|NCT02991859|18603898|P8|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
7558227|NCT02991859|18603899|P7|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
7558228|NCT02991859|18603900|P6|COMPLETED|Period2, Escalation Phase3, Upto Day 98||1
7558229|NCT02991859|18603901|P5|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
7558230|NCT02991859|18603902|P4|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
7558231|NCT02991859|18603903|P3|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
7558232|NCT02991859|18603904|P2|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
7558233|NCT02991859|18603905|P1|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
7558234|NCT02991859|18603889|P17|STARTED|Period2, Escalation Phase3, Upto Day 98||0
7558235|NCT02991859|18603890|P16|STARTED|Period2, Escalation Phase3, Upto Day 98||0
7558236|NCT02991859|18603891|P15|STARTED|Period2, Escalation Phase3, Upto Day 98||0
7558237|NCT02991859|18603892|P14|STARTED|Period2, Escalation Phase3, Upto Day 98||0
7558238|NCT02991859|18603893|P13|STARTED|Period2, Escalation Phase3, Upto Day 98||0
7558239|NCT02991859|18603894|P12|STARTED|Period2, Escalation Phase3, Upto Day 98||2
7558240|NCT02991859|18603895|P11|STARTED|Period2, Escalation Phase3, Upto Day 98||2
7558241|NCT02991859|18603896|P10|STARTED|Period2, Escalation Phase3, Upto Day 98||2
7558242|NCT02991859|18603897|P9|STARTED|Period2, Escalation Phase3, Upto Day 98||2
7558243|NCT02991859|18603898|P8|STARTED|Period2, Escalation Phase3, Upto Day 98||2
7558244|NCT02991859|18603899|P7|STARTED|Period2, Escalation Phase3, Upto Day 98||2
7558245|NCT02991859|18603900|P6|STARTED|Period2, Escalation Phase3, Upto Day 98||1
7558246|NCT02991859|18603901|P5|STARTED|Period2, Escalation Phase3, Upto Day 98||2
7558247|NCT02991859|18603902|P4|STARTED|Period2, Escalation Phase3, Upto Day 98||2
7558248|NCT02991859|18603903|P3|STARTED|Period2, Escalation Phase3, Upto Day 98||2
7558249|NCT02991859|18603904|P2|STARTED|Period2, Escalation Phase3, Upto Day 98||2
7558250|NCT02991859|18603905|P1|STARTED|Period2, Escalation Phase3, Upto Day 98||2
7558251|NCT02991859|18603889|P17|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558252|NCT02991859|18603890|P16|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558253|NCT02991859|18603891|P15|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558254|NCT02991859|18603892|P14|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558255|NCT02991859|18603893|P13|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558256|NCT02991859|18603894|P12|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558257|NCT02991859|18603895|P11|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558258|NCT02991859|18603896|P10|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558259|NCT02991859|18603897|P9|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558260|NCT02991859|18603898|P8|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558261|NCT02991859|18603899|P7|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558262|NCT02991859|18603900|P6|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558263|NCT02991859|18603901|P5|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558264|NCT02991859|18603902|P4|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558265|NCT02991859|18603903|P3|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558266|NCT02991859|18603904|P2|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558267|NCT02991859|18603905|P1|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558268|NCT02991859|18603889|P17|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558269|NCT02991859|18603890|P16|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558270|NCT02991859|18603891|P15|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558271|NCT02991859|18603892|P14|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558272|NCT02991859|18603893|P13|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
7558273|NCT02991859|18603894|P12|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
7558274|NCT02991859|18603895|P11|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
7558275|NCT02991859|18603896|P10|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
7558276|NCT02991859|18603897|P9|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
7558277|NCT02991859|18603898|P8|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
7558278|NCT02991859|18603899|P7|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
7558279|NCT02991859|18603900|P6|COMPLETED|Period2, Escalation Phase2, Upto Day 91||1
7558280|NCT02991859|18603901|P5|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
7558281|NCT02991859|18603902|P4|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
7558282|NCT02991859|18603903|P3|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
7558283|NCT02991859|18603904|P2|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
7558284|NCT02991859|18603905|P1|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
7558285|NCT02991859|18603889|P17|STARTED|Period2, Escalation Phase2, Upto Day 91||0
7558286|NCT02991859|18603890|P16|STARTED|Period2, Escalation Phase2, Upto Day 91||0
7558287|NCT02991859|18603891|P15|STARTED|Period2, Escalation Phase2, Upto Day 91||0
7558288|NCT02991859|18603892|P14|STARTED|Period2, Escalation Phase2, Upto Day 91||0
7558289|NCT02991859|18603893|P13|STARTED|Period2, Escalation Phase2, Upto Day 91||0
7558290|NCT02991859|18603894|P12|STARTED|Period2, Escalation Phase2, Upto Day 91||2
7558291|NCT02991859|18603895|P11|STARTED|Period2, Escalation Phase2, Upto Day 91||2
7558292|NCT02991859|18603896|P10|STARTED|Period2, Escalation Phase2, Upto Day 91||2
7558293|NCT02991859|18603897|P9|STARTED|Period2, Escalation Phase2, Upto Day 91||2
7558294|NCT02991859|18603898|P8|STARTED|Period2, Escalation Phase2, Upto Day 91||2
7558295|NCT02991859|18603899|P7|STARTED|Period2, Escalation Phase2, Upto Day 91||2
7558296|NCT02991859|18603900|P6|STARTED|Period2, Escalation Phase2, Upto Day 91||1
7558297|NCT02991859|18603901|P5|STARTED|Period2, Escalation Phase2, Upto Day 91||2
7558298|NCT02991859|18603902|P4|STARTED|Period2, Escalation Phase2, Upto Day 91||2
7558299|NCT02991859|18603903|P3|STARTED|Period2, Escalation Phase2, Upto Day 91||2
7558300|NCT02991859|18603904|P2|STARTED|Period2, Escalation Phase2, Upto Day 91||2
7558301|NCT02991859|18603905|P1|STARTED|Period2, Escalation Phase2, Upto Day 91||2
7558302|NCT02991859|18603889|P17|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558303|NCT02991859|18603890|P16|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558304|NCT02991859|18603891|P15|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558305|NCT02991859|18603892|P14|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558306|NCT02991859|18603893|P13|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558307|NCT02991859|18603894|P12|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558308|NCT02991859|18603895|P11|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558309|NCT02991859|18603896|P10|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558310|NCT02991859|18603897|P9|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558311|NCT02991859|18603898|P8|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558312|NCT02991859|18603899|P7|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558313|NCT02991859|18603900|P6|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558314|NCT02991859|18603901|P5|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558315|NCT02991859|18603902|P4|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558316|NCT02991859|18603903|P3|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558317|NCT02991859|18603904|P2|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558318|NCT02991859|18603905|P1|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558319|NCT02991859|18603889|P17|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558320|NCT02991859|18603890|P16|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558321|NCT02991859|18603891|P15|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558322|NCT02991859|18603892|P14|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558323|NCT02991859|18603893|P13|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
7558324|NCT02991859|18603894|P12|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
7558325|NCT02991859|18603895|P11|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
7558326|NCT02991859|18603896|P10|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
7558327|NCT02991859|18603897|P9|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
7558328|NCT02991859|18603898|P8|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
7558329|NCT02991859|18603899|P7|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
7558330|NCT02991859|18603900|P6|COMPLETED|Period2, Escalation Phase1, Upto Day 84||1
7558331|NCT02991859|18603901|P5|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
7558332|NCT02991859|18603902|P4|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
7558333|NCT02991859|18603903|P3|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
7558334|NCT02991859|18603904|P2|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
7558335|NCT02991859|18603905|P1|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
7558336|NCT02991859|18603889|P17|STARTED|Period2, Escalation Phase1, Upto Day 84||0
7558337|NCT02991859|18603890|P16|STARTED|Period2, Escalation Phase1, Upto Day 84||0
7558338|NCT02991859|18603891|P15|STARTED|Period2, Escalation Phase1, Upto Day 84||0
7558339|NCT02991859|18603892|P14|STARTED|Period2, Escalation Phase1, Upto Day 84||0
7558340|NCT02991859|18603893|P13|STARTED|Period2, Escalation Phase1, Upto Day 84||0
7558341|NCT02991859|18603894|P12|STARTED|Period2, Escalation Phase1, Upto Day 84||2
7558342|NCT02991859|18603895|P11|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par cont in P2 Esc 1 insteadP1 Esc 5, was not withdrawn|2
7558343|NCT02991859|18603896|P10|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par directly entered into Period 2, Esc 1|2
7558344|NCT02991859|18603897|P9|STARTED|Period2, Escalation Phase1, Upto Day 84||2
7558345|NCT02991859|18603898|P8|STARTED|Period2, Escalation Phase1, Upto Day 84||2
7558346|NCT02991859|18603899|P7|STARTED|Period2, Escalation Phase1, Upto Day 84||2
7558347|NCT02991859|18603900|P6|STARTED|Period2, Escalation Phase1, Upto Day 84||1
7558348|NCT02991859|18603901|P5|STARTED|Period2, Escalation Phase1, Upto Day 84||2
7558349|NCT02991859|18603902|P4|STARTED|Period2, Escalation Phase1, Upto Day 84||2
7558350|NCT02991859|18603903|P3|STARTED|Period2, Escalation Phase1, Upto Day 84||2
7558351|NCT02991859|18603904|P2|STARTED|Period2, Escalation Phase1, Upto Day 84||2
7558352|NCT02991859|18603905|P1|STARTED|Period2, Escalation Phase1, Upto Day 84||2
7558353|NCT02991859|18603889|P17|NOT COMPLETED|Wash Out, Up to Day 77||0
7558354|NCT02991859|18603890|P16|NOT COMPLETED|Wash Out, Up to Day 77||0
7558355|NCT02991859|18603891|P15|NOT COMPLETED|Wash Out, Up to Day 77||0
7558356|NCT02991859|18603892|P14|NOT COMPLETED|Wash Out, Up to Day 77||0
7558357|NCT02991859|18603893|P13|NOT COMPLETED|Wash Out, Up to Day 77||0
7558358|NCT02991859|18603894|P12|NOT COMPLETED|Wash Out, Up to Day 77||0
7558359|NCT02991859|18603895|P11|NOT COMPLETED|Wash Out, Up to Day 77||0
7558360|NCT02991859|18603896|P10|NOT COMPLETED|Wash Out, Up to Day 77||1
7558361|NCT02991859|18603897|P9|NOT COMPLETED|Wash Out, Up to Day 77||0
7558362|NCT02991859|18603898|P8|NOT COMPLETED|Wash Out, Up to Day 77||0
7558363|NCT02991859|18603899|P7|NOT COMPLETED|Wash Out, Up to Day 77||0
7558364|NCT02991859|18603900|P6|NOT COMPLETED|Wash Out, Up to Day 77||1
7558365|NCT02991859|18603901|P5|NOT COMPLETED|Wash Out, Up to Day 77||0
7558366|NCT02991859|18603902|P4|NOT COMPLETED|Wash Out, Up to Day 77||0
7558367|NCT02991859|18603903|P3|NOT COMPLETED|Wash Out, Up to Day 77||0
7558368|NCT02991859|18603904|P2|NOT COMPLETED|Wash Out, Up to Day 77||0
7558369|NCT02991859|18603905|P1|NOT COMPLETED|Wash Out, Up to Day 77||0
7558370|NCT02991859|18603889|P17|COMPLETED|Wash Out, Up to Day 77||0
7558371|NCT02991859|18603890|P16|COMPLETED|Wash Out, Up to Day 77||0
7558372|NCT02991859|18603891|P15|COMPLETED|Wash Out, Up to Day 77||0
7558373|NCT02991859|18603892|P14|COMPLETED|Wash Out, Up to Day 77||0
7558374|NCT02991859|18603893|P13|COMPLETED|Wash Out, Up to Day 77||0
7558375|NCT02991859|18603894|P12|COMPLETED|Wash Out, Up to Day 77||2
7558376|NCT02991859|18603895|P11|COMPLETED|Wash Out, Up to Day 77||1
7558377|NCT02991859|18603896|P10|COMPLETED|Wash Out, Up to Day 77||1
7558378|NCT02991859|18603897|P9|COMPLETED|Wash Out, Up to Day 77||2
7558379|NCT02991859|18603898|P8|COMPLETED|Wash Out, Up to Day 77||2
7558380|NCT02991859|18603899|P7|COMPLETED|Wash Out, Up to Day 77||2
7558381|NCT02991859|18603900|P6|COMPLETED|Wash Out, Up to Day 77||1
7558382|NCT02991859|18603901|P5|COMPLETED|Wash Out, Up to Day 77||2
7558383|NCT02991859|18603902|P4|COMPLETED|Wash Out, Up to Day 77||2
7558384|NCT02991859|18603903|P3|COMPLETED|Wash Out, Up to Day 77||2
7558385|NCT02991859|18603904|P2|COMPLETED|Wash Out, Up to Day 77||2
7558386|NCT02991859|18603905|P1|COMPLETED|Wash Out, Up to Day 77||2
7558387|NCT02991859|18603889|P17|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
7558388|NCT02991859|18603890|P16|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
7558389|NCT02991859|18603891|P15|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
7558390|NCT02991859|18603892|P14|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
7558391|NCT02991859|18603893|P13|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
7558392|NCT02991859|18603894|P12|STARTED|Wash Out, Up to Day 77||2
7558393|NCT02991859|18603895|P11|STARTED|Wash Out, Up to Day 77||1
7558394|NCT02991859|18603896|P10|STARTED|Wash Out, Up to Day 77||2
7558395|NCT02991859|18603897|P9|STARTED|Wash Out, Up to Day 77||2
7558396|NCT02991859|18603898|P8|STARTED|Wash Out, Up to Day 77||2
7558397|NCT02991859|18603899|P7|STARTED|Wash Out, Up to Day 77||2
7558398|NCT02991859|18603900|P6|STARTED|Wash Out, Up to Day 77||2
7558399|NCT02991859|18603901|P5|STARTED|Wash Out, Up to Day 77||2
7558400|NCT02991859|18603902|P4|STARTED|Wash Out, Up to Day 77||2
7558401|NCT02991859|18603903|P3|STARTED|Wash Out, Up to Day 77||2
7558402|NCT02991859|18603904|P2|STARTED|Wash Out, Up to Day 77||2
7558403|NCT02991859|18603905|P1|STARTED|Wash Out, Up to Day 77||2
7558404|NCT02991859|18603889|P17|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
7558405|NCT02991859|18603890|P16|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
7558406|NCT02991859|18603891|P15|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
7558407|NCT02991859|18603892|P14|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
7558408|NCT02991859|18603893|P13|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
7558409|NCT02991859|18603894|P12|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
7558410|NCT02991859|18603895|P11|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
7558411|NCT02991859|18603896|P10|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
7558412|NCT02991859|18603897|P9|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
7558413|NCT02991859|18603898|P8|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
7558414|NCT02991859|18603899|P7|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
7558415|NCT02991859|18603900|P6|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
7558416|NCT02991859|18603901|P5|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
7558417|NCT02991859|18603902|P4|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
7558418|NCT02991859|18603903|P3|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
7558419|NCT02991859|18603904|P2|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
7558420|NCT02991859|18603905|P1|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
7558421|NCT02991859|18603889|P17|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
7558422|NCT02991859|18603890|P16|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
7558423|NCT02991859|18603891|P15|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
7558424|NCT02991859|18603892|P14|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
7558425|NCT02991859|18603893|P13|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
7558426|NCT02991859|18603894|P12|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
7558427|NCT02991859|18603895|P11|COMPLETED|Period1, Escalation Phase5, Upto Day35||1
7558428|NCT02991859|18603896|P10|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
7558429|NCT02991859|18603897|P9|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
7558430|NCT02991859|18603898|P8|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
7558431|NCT02991859|18603899|P7|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
7558432|NCT02991859|18603900|P6|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
7558433|NCT02991859|18603901|P5|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
7558434|NCT02991859|18603902|P4|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
7558435|NCT02991859|18603903|P3|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
7558436|NCT02991859|18603904|P2|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
7558437|NCT02991859|18603905|P1|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
7558438|NCT02991859|18603889|P17|STARTED|Period1, Escalation Phase5, Upto Day35||3
7558439|NCT02991859|18603890|P16|STARTED|Period1, Escalation Phase5, Upto Day35||3
7558440|NCT02991859|18603891|P15|STARTED|Period1, Escalation Phase5, Upto Day35||6
7558441|NCT02991859|18603892|P14|STARTED|Period1, Escalation Phase5, Upto Day35||6
7558442|NCT02991859|18603893|P13|STARTED|Period1, Escalation Phase5, Upto Day35||6
7558443|NCT02991859|18603894|P12|STARTED|Period1, Escalation Phase5, Upto Day35||2
7558444|NCT02991859|18603895|P11|STARTED|Period1, Escalation Phase5, Upto Day35|1 participant did not enter Esc Phase 5, and was not withdrawn|1
7558445|NCT02991859|18603896|P10|STARTED|Period1, Escalation Phase5, Upto Day35||2
7558446|NCT02991859|18603897|P9|STARTED|Period1, Escalation Phase5, Upto Day35||2
7558447|NCT02991859|18603898|P8|STARTED|Period1, Escalation Phase5, Upto Day35||2
7558448|NCT02991859|18603899|P7|STARTED|Period1, Escalation Phase5, Upto Day35||2
7558449|NCT02991859|18603900|P6|STARTED|Period1, Escalation Phase5, Upto Day35||2
7558450|NCT02991859|18603901|P5|STARTED|Period1, Escalation Phase5, Upto Day35||2
7558451|NCT02991859|18603902|P4|STARTED|Period1, Escalation Phase5, Upto Day35||2
7558452|NCT02991859|18603903|P3|STARTED|Period1, Escalation Phase5, Upto Day35||2
7558453|NCT02991859|18603904|P2|STARTED|Period1, Escalation Phase5, Upto Day35||2
7558454|NCT02991859|18603905|P1|STARTED|Period1, Escalation Phase5, Upto Day35||2
7558455|NCT02991859|18603889|P17|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
7558456|NCT02991859|18603890|P16|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
7558457|NCT02991859|18603891|P15|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
7558458|NCT02991859|18603892|P14|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
7558459|NCT02991859|18603893|P13|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
7558460|NCT02991859|18603894|P12|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
7558461|NCT02991859|18603895|P11|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
7558462|NCT02991859|18603896|P10|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
7558463|NCT02991859|18603897|P9|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
7558464|NCT02991859|18603898|P8|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
7558465|NCT02991859|18603899|P7|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
7558466|NCT02991859|18603900|P6|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
7558467|NCT02991859|18603901|P5|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
7558468|NCT02991859|18603902|P4|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
7558469|NCT02991859|18603903|P3|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
7558470|NCT02991859|18603904|P2|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
7558471|NCT02991859|18603905|P1|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
7558472|NCT02991859|18603889|P17|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
7558473|NCT02991859|18603890|P16|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
7558474|NCT02991859|18603891|P15|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
7558475|NCT02991859|18603892|P14|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
7558476|NCT02991859|18603893|P13|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
7558477|NCT02991859|18603894|P12|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
7558478|NCT02991859|18603895|P11|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
7558479|NCT02991859|18603896|P10|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
7558480|NCT02991859|18603897|P9|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
7558481|NCT02991859|18603898|P8|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
7558482|NCT02991859|18603899|P7|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
7558483|NCT02991859|18603900|P6|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
7558484|NCT02991859|18603901|P5|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
7558485|NCT02991859|18603902|P4|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
7558486|NCT02991859|18603903|P3|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
7558487|NCT02991859|18603904|P2|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
7558488|NCT02991859|18603905|P1|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
7558489|NCT02991859|18603889|P17|STARTED|Period1, Escalation Phase4, Upto Day28||3
7558490|NCT02991859|18603890|P16|STARTED|Period1, Escalation Phase4, Upto Day28||3
7558491|NCT02991859|18603891|P15|STARTED|Period1, Escalation Phase4, Upto Day28||6
7558492|NCT02991859|18603892|P14|STARTED|Period1, Escalation Phase4, Upto Day28||6
7558493|NCT02991859|18603893|P13|STARTED|Period1, Escalation Phase4, Upto Day28||6
7558494|NCT02991859|18603894|P12|STARTED|Period1, Escalation Phase4, Upto Day28||2
7558495|NCT02991859|18603895|P11|STARTED|Period1, Escalation Phase4, Upto Day28||2
7558496|NCT02991859|18603896|P10|STARTED|Period1, Escalation Phase4, Upto Day28||2
7558497|NCT02991859|18603897|P9|STARTED|Period1, Escalation Phase4, Upto Day28||2
7558498|NCT02991859|18603898|P8|STARTED|Period1, Escalation Phase4, Upto Day28||2
7558499|NCT02991859|18603899|P7|STARTED|Period1, Escalation Phase4, Upto Day28||2
7558500|NCT02991859|18603900|P6|STARTED|Period1, Escalation Phase4, Upto Day28|1 Par completed Phase 3 did not enter Phase 4|2
7558501|NCT02991859|18603901|P5|STARTED|Period1, Escalation Phase4, Upto Day28||2
7558502|NCT02991859|18603902|P4|STARTED|Period1, Escalation Phase4, Upto Day28||2
7558503|NCT02991859|18603903|P3|STARTED|Period1, Escalation Phase4, Upto Day28||2
7558504|NCT02991859|18603904|P2|STARTED|Period1, Escalation Phase4, Upto Day28||2
7558505|NCT02991859|18603905|P1|STARTED|Period1, Escalation Phase4, Upto Day28||2
7558506|NCT02991859|18603889|P17|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
7558507|NCT02991859|18603890|P16|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
7558508|NCT02991859|18603891|P15|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
7558509|NCT02991859|18603892|P14|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
7558510|NCT02991859|18603893|P13|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
7558511|NCT02991859|18603894|P12|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
7558512|NCT02991859|18603895|P11|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
7558513|NCT02991859|18603896|P10|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
7558514|NCT02991859|18603897|P9|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
7558515|NCT02991859|18603898|P8|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
7558516|NCT02991859|18603899|P7|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
7558517|NCT02991859|18603900|P6|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
7558518|NCT02991859|18603901|P5|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
7558519|NCT02991859|18603902|P4|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
7558520|NCT02991859|18603903|P3|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
7558521|NCT02991859|18603904|P2|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
7558522|NCT02991859|18603905|P1|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
7558523|NCT02991859|18603889|P17|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
7558524|NCT02991859|18603890|P16|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
7558525|NCT02991859|18603891|P15|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
7558526|NCT02991859|18603892|P14|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
7558527|NCT02991859|18603893|P13|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
7558528|NCT02991859|18603894|P12|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
7558529|NCT02991859|18603895|P11|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
7558530|NCT02991859|18603896|P10|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
7558531|NCT02991859|18603897|P9|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
7558532|NCT02991859|18603898|P8|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
7558533|NCT02991859|18603899|P7|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
7558534|NCT02991859|18603900|P6|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
7558535|NCT02991859|18603901|P5|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
7558536|NCT02991859|18603902|P4|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
7558537|NCT02991859|18603903|P3|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
7558538|NCT02991859|18603904|P2|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
7558539|NCT02991859|18603905|P1|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
7558540|NCT02991859|18603889|P17|STARTED|Period1, Escalation Phase3, Upto Day21||3
7558541|NCT02991859|18603890|P16|STARTED|Period1, Escalation Phase3, Upto Day21||3
7558542|NCT02991859|18603891|P15|STARTED|Period1, Escalation Phase3, Upto Day21||6
7558543|NCT02991859|18603892|P14|STARTED|Period1, Escalation Phase3, Upto Day21||7
7558544|NCT02991859|18603893|P13|STARTED|Period1, Escalation Phase3, Upto Day21||7
7558545|NCT02991859|18603894|P12|STARTED|Period1, Escalation Phase3, Upto Day21||2
7558546|NCT02991859|18603895|P11|STARTED|Period1, Escalation Phase3, Upto Day21||2
7558547|NCT02991859|18603896|P10|STARTED|Period1, Escalation Phase3, Upto Day21||2
7558548|NCT02991859|18603897|P9|STARTED|Period1, Escalation Phase3, Upto Day21||2
7558549|NCT02991859|18603898|P8|STARTED|Period1, Escalation Phase3, Upto Day21||2
7558550|NCT02991859|18603899|P7|STARTED|Period1, Escalation Phase3, Upto Day21||2
7558551|NCT02991859|18603900|P6|STARTED|Period1, Escalation Phase3, Upto Day21||3
7558552|NCT02991859|18603901|P5|STARTED|Period1, Escalation Phase3, Upto Day21||2
7558553|NCT02991859|18603902|P4|STARTED|Period1, Escalation Phase3, Upto Day21||2
7558554|NCT02991859|18603903|P3|STARTED|Period1, Escalation Phase3, Upto Day21||2
7558555|NCT02991859|18603904|P2|STARTED|Period1, Escalation Phase3, Upto Day21||2
7558556|NCT02991859|18603905|P1|STARTED|Period1, Escalation Phase3, Upto Day21||2
7558557|NCT02991859|18603889|P17|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
7558558|NCT02991859|18603890|P16|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
7558559|NCT02991859|18603891|P15|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
7558560|NCT02991859|18603892|P14|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
7558561|NCT02991859|18603893|P13|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
7558562|NCT02991859|18603894|P12|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
7558563|NCT02991859|18603895|P11|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
7558564|NCT02991859|18603896|P10|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
7558565|NCT02991859|18603897|P9|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
7558566|NCT02991859|18603898|P8|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
7558567|NCT02991859|18603899|P7|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
7558568|NCT02991859|18603900|P6|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
7558569|NCT02991859|18603901|P5|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
7558570|NCT02991859|18603902|P4|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
7558571|NCT02991859|18603903|P3|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
7558572|NCT02991859|18603904|P2|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
7558573|NCT02991859|18603905|P1|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
7558574|NCT02991859|18603889|P17|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
7558575|NCT02991859|18603890|P16|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
7558576|NCT02991859|18603891|P15|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||6
7558577|NCT02991859|18603892|P14|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
7558578|NCT02991859|18603893|P13|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
7558579|NCT02991859|18603894|P12|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
7558580|NCT02991859|18603895|P11|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
7558581|NCT02991859|18603896|P10|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
7558582|NCT02991859|18603897|P9|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
7558583|NCT02991859|18603898|P8|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
7558584|NCT02991859|18603899|P7|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
7558585|NCT02991859|18603900|P6|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
7558586|NCT02991859|18603901|P5|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
7558587|NCT02991859|18603902|P4|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
7558588|NCT02991859|18603903|P3|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
7558589|NCT02991859|18603904|P2|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
7558590|NCT02991859|18603905|P1|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
7558591|NCT02991859|18603889|P17|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
7558592|NCT02991859|18603890|P16|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
7558593|NCT02991859|18603891|P15|STARTED|Period 1,Escalation Phase2,Upto Day 14||6
7558594|NCT02991859|18603892|P14|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
7558595|NCT02991859|18603893|P13|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
7558596|NCT02991859|18603894|P12|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
7558597|NCT02991859|18603895|P11|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
7558598|NCT02991859|18603896|P10|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
7558599|NCT02991859|18603897|P9|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
7558600|NCT02991859|18603898|P8|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
7558601|NCT02991859|18603899|P7|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
7558602|NCT02991859|18603900|P6|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
7558603|NCT02991859|18603901|P5|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
7558604|NCT02991859|18603902|P4|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
7558605|NCT02991859|18603903|P3|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
7558606|NCT02991859|18603904|P2|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
7558607|NCT02991859|18603905|P1|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
7558608|NCT02991859|18603889|P17|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
7558609|NCT02991859|18603890|P16|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
7558610|NCT02991859|18603891|P15|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
7558611|NCT02991859|18603892|P14|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
7558612|NCT02991859|18603893|P13|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
7558613|NCT02991859|18603894|P12|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
7558614|NCT02991859|18603895|P11|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
7558615|NCT02991859|18603896|P10|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
7558616|NCT02991859|18603897|P9|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
7558617|NCT02991859|18603898|P8|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
7558618|NCT02991859|18603899|P7|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
7558619|NCT02991859|18603900|P6|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
7558620|NCT02991859|18603901|P5|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
7558621|NCT02991859|18603902|P4|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
7558622|NCT02991859|18603903|P3|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
7558623|NCT02991859|18603904|P2|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
7558624|NCT02991859|18603905|P1|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
7558625|NCT02991859|18603889|P17|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
7558626|NCT02991859|18603890|P16|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
7558627|NCT02991859|18603891|P15|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||6
7558628|NCT02991859|18603892|P14|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
7558629|NCT02991859|18603893|P13|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
7558630|NCT02991859|18603894|P12|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
7558631|NCT02991859|18603895|P11|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
7558632|NCT02991859|18603896|P10|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
7558633|NCT02991859|18603897|P9|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
7558634|NCT02991859|18603898|P8|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
7558635|NCT02991859|18603899|P7|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
7558636|NCT02991859|18603900|P6|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
7558637|NCT02991859|18603901|P5|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
7558638|NCT02991859|18603902|P4|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
7558639|NCT02991859|18603903|P3|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
7558640|NCT02991859|18603904|P2|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
7558641|NCT02991859|18603905|P1|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
7558642|NCT02991859|18603889|P17|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
7558643|NCT02991859|18603890|P16|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
7558644|NCT02991859|18603891|P15|STARTED|Period 1,Escalation Phase 1,Upto Day 7||6
7558645|NCT02991859|18603892|P14|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
7558646|NCT02991859|18603893|P13|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
7558647|NCT02991859|18603894|P12|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
7558648|NCT02991859|18603895|P11|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
7558649|NCT02991859|18603896|P10|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
7558650|NCT02991859|18603897|P9|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
7558651|NCT02991859|18603898|P8|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
7558652|NCT02991859|18603899|P7|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
7558653|NCT02991859|18603900|P6|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
7558654|NCT02991859|18603901|P5|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
7558655|NCT02991859|18603902|P4|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
7558656|NCT02991859|18603903|P3|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
7558657|NCT02991859|18603904|P2|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
7558658|NCT02991859|18603905|P1|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
7558659|NCT02991820|18604150|P2|NOT COMPLETED|Overall Study||0
7558660|NCT02991820|18604151|P1|NOT COMPLETED|Overall Study||0
7558661|NCT02991820|18604150|P2|COMPLETED|Overall Study||31
7558662|NCT02991820|18604151|P1|COMPLETED|Overall Study||12
7558663|NCT02991820|18604150|P2|STARTED|Overall Study||31
7558664|NCT02991820|18604151|P1|STARTED|Overall Study||12
7558665|NCT02991729|18604161|P2|NOT COMPLETED|Overall Study||0
7558666|NCT02991729|18604162|P1|NOT COMPLETED|Overall Study||0
7558667|NCT02991729|18604161|P2|COMPLETED|Overall Study||92
7558668|NCT02991729|18604162|P1|COMPLETED|Overall Study||105
7558669|NCT02991729|18604161|P2|STARTED|Overall Study||92
7558670|NCT02991729|18604162|P1|STARTED|Overall Study||105
7558671|NCT02991599|18604176|P2|NOT COMPLETED|Overall Study||37
7558672|NCT02991599|18604177|P1|NOT COMPLETED|Overall Study||38
7558673|NCT02991599|18604176|P2|COMPLETED|Overall Study||61
7558674|NCT02991599|18604177|P1|COMPLETED|Overall Study||60
7558675|NCT02991599|18604176|P2|STARTED|Overall Study||98
7558676|NCT02991599|18604177|P1|STARTED|Overall Study||98
7558677|NCT02991430|18604200|P3|NOT COMPLETED|Post-treatment Observation Period||5
7558678|NCT02991430|18604201|P2|NOT COMPLETED|Post-treatment Observation Period||6
7558679|NCT02991430|18604202|P1|NOT COMPLETED|Post-treatment Observation Period||3
7558680|NCT02991430|18604200|P3|COMPLETED|Post-treatment Observation Period||5
7558681|NCT02991430|18604201|P2|COMPLETED|Post-treatment Observation Period||2
7558682|NCT02991430|18604202|P1|COMPLETED|Post-treatment Observation Period||4
7558683|NCT02991430|18604200|P3|STARTED|Post-treatment Observation Period||10
7558684|NCT02991430|18604201|P2|STARTED|Post-treatment Observation Period||8
7558685|NCT02991430|18604202|P1|STARTED|Post-treatment Observation Period||7
7558686|NCT02991430|18604200|P3|NOT COMPLETED|Treatment Period 2||4
7558687|NCT02991430|18604201|P2|NOT COMPLETED|Treatment Period 2||3
7558688|NCT02991430|18604202|P1|NOT COMPLETED|Treatment Period 2||6
7558689|NCT02991430|18604200|P3|COMPLETED|Treatment Period 2||10
7558690|NCT02991430|18604201|P2|COMPLETED|Treatment Period 2||8
7558691|NCT02991430|18604202|P1|COMPLETED|Treatment Period 2||7
7558692|NCT02991430|18604200|P3|STARTED|Treatment Period 2||14
7558693|NCT02991430|18604201|P2|STARTED|Treatment Period 2||11
7558694|NCT02991430|18604202|P1|STARTED|Treatment Period 2||13
7558695|NCT02991430|18604200|P3|NOT COMPLETED|Treatment Period 1||2
7558696|NCT02991430|18604201|P2|NOT COMPLETED|Treatment Period 1||4
7558697|NCT02991430|18604202|P1|NOT COMPLETED|Treatment Period 1||1
7558698|NCT02991430|18604200|P3|COMPLETED|Treatment Period 1||14
7558699|NCT02991430|18604201|P2|COMPLETED|Treatment Period 1||11
7558700|NCT02991430|18604202|P1|COMPLETED|Treatment Period 1||13
7558701|NCT02991430|18604200|P3|STARTED|Treatment Period 1||16
7558702|NCT02991430|18604201|P2|STARTED|Treatment Period 1||15
7558703|NCT02991430|18604202|P1|STARTED|Treatment Period 1||14
7558704|NCT02991118|18604239|P2|NOT COMPLETED|Overall Study||32
7558705|NCT02991118|18604240|P1|NOT COMPLETED|Overall Study||7
7558706|NCT02991118|18604239|P2|COMPLETED|Overall Study||490
7558707|NCT02991118|18604240|P1|COMPLETED|Overall Study||250
7558708|NCT02991118|18604239|P2|STARTED|Overall Study||522
7558709|NCT02991118|18604240|P1|STARTED|Overall Study||257
7558710|NCT02991040|18604284|P1|NOT COMPLETED|Overall Study||4
7558711|NCT02991040|18604284|P1|COMPLETED|Overall Study||96
7558712|NCT02991040|18604284|P1|STARTED|Overall Study||100
7558713|NCT02990910|18604299|P2|NOT COMPLETED|Overall Study||10
7558714|NCT02990910|18604300|P1|NOT COMPLETED|Overall Study||6
7558715|NCT02990910|18604299|P2|COMPLETED|Overall Study||130
7558716|NCT02990910|18604300|P1|COMPLETED|Overall Study||134
7558717|NCT02990910|18604299|P2|STARTED|Overall Study||140
7558718|NCT02990910|18604300|P1|STARTED|Overall Study||140
7558719|NCT02990338|18604310|P2|NOT COMPLETED|Overall Study||89
7558720|NCT02990338|18604311|P1|NOT COMPLETED|Overall Study||118
7558721|NCT02990338|18604310|P2|COMPLETED|Overall Study||65
7558722|NCT02990338|18604311|P1|COMPLETED|Overall Study||35
7558723|NCT02990338|18604310|P2|Ongoing|Overall Study||65
7558724|NCT02990338|18604311|P1|Ongoing|Overall Study||35
7558725|NCT02990338|18604310|P2|Treated|Overall Study||152
7558726|NCT02990338|18604311|P1|Treated|Overall Study||149
7558727|NCT02990338|18604310|P2|STARTED|Overall Study||154
7558728|NCT02990338|18604311|P1|STARTED|Overall Study||153
7558729|NCT02990000|18604359|P2|NOT COMPLETED|Overall Study||34
7558730|NCT02990000|18604360|P1|NOT COMPLETED|Overall Study||36
7558731|NCT02990000|18604359|P2|COMPLETED|Overall Study|99 patients provided naturalistic treatment data and were included in analyses|99
7558732|NCT02990000|18604360|P1|COMPLETED|Overall Study|119 patients provided naturalistic treatment data and were included in analyses|119
7558733|NCT02990000|18604359|P2|Begin Treatment|Overall Study|99 Scientifically Matched patients actually began treatment (attended at least one session)|99
7558734|NCT02990000|18604360|P1|Begin Treatment|Overall Study|119 Pragmatic Match patients actually began treatment (attended at least 1 session)|119
7558735|NCT02990000|18604359|P2|STARTED|Overall Study|133 patients were randomly assigned to the Scientific Match condition|133
7558736|NCT02990000|18604360|P1|STARTED|Overall Study|155 patients were randomly assigned to the Pragmatic Match condition|155
7558737|NCT02989805|18604380|P2|NOT COMPLETED|Overall Study||4
7558738|NCT02989805|18604381|P1|NOT COMPLETED|Overall Study||6
7558739|NCT02989805|18604380|P2|COMPLETED|Overall Study||162
7558740|NCT02989805|18604381|P1|COMPLETED|Overall Study||154
7558741|NCT02989805|18604380|P2|STARTED|Overall Study||166
7558742|NCT02989805|18604381|P1|STARTED|Overall Study||160
7558743|NCT02989727|18604397|P4|NOT COMPLETED|Overall Study||0
7558744|NCT02989727|18604398|P3|NOT COMPLETED|Overall Study||0
7558745|NCT02989727|18604399|P2|NOT COMPLETED|Overall Study||0
7558746|NCT02989727|18604400|P1|NOT COMPLETED|Overall Study||0
7558747|NCT02989727|18604397|P4|COMPLETED|Overall Study||30
7558748|NCT02989727|18604398|P3|COMPLETED|Overall Study||30
7558749|NCT02989727|18604399|P2|COMPLETED|Overall Study||44
7558750|NCT02989727|18604400|P1|COMPLETED|Overall Study||46
7558751|NCT02989727|18604397|P4|STARTED|Overall Study||30
7558752|NCT02989727|18604398|P3|STARTED|Overall Study||30
7558753|NCT02989727|18604399|P2|STARTED|Overall Study||44
7558754|NCT02989727|18604400|P1|STARTED|Overall Study||46
7558755|NCT02989714|18604476|P1|NOT COMPLETED|Overall Study||1
7558756|NCT02989714|18604476|P1|COMPLETED|Overall Study||12
7558757|NCT02989714|18604476|P1|Started Nivolumab|Overall Study||12
7558758|NCT02989714|18604476|P1|STARTED|Overall Study||13
7558759|NCT02989649|18604482|P1|NOT COMPLETED|Overall Study||420
7558760|NCT02989649|18604482|P1|COMPLETED|Overall Study||173
7558761|NCT02989649|18604482|P1|Eligible to Enter Into Treatment Period|Overall Study||509
7558762|NCT02989649|18604482|P1|Started But Not Treated|Overall Study||84
7558763|NCT02989649|18604482|P1|STARTED|Overall Study||593
7558764|NCT02989610|18604494|P1|NOT COMPLETED|Overall Study||39
7558765|NCT02989610|18604494|P1|COMPLETED|Overall Study||195
7558766|NCT02989610|18604494|P1|STARTED|Overall Study||234
7558767|NCT02989545|18604500|P1|NOT COMPLETED|Treatment Period - Anal Tape Provided||0
7558768|NCT02989545|18604500|P1|COMPLETED|Treatment Period - Anal Tape Provided||20
7558769|NCT02989545|18604500|P1|STARTED|Treatment Period - Anal Tape Provided||20
7558770|NCT02989545|18604500|P1|NOT COMPLETED|Control Period - no Intervention||0
7558771|NCT02989545|18604500|P1|COMPLETED|Control Period - no Intervention||20
7558772|NCT02989545|18604500|P1|STARTED|Control Period - no Intervention||20
7558773|NCT02989389|18604524|P10|NOT COMPLETED|Period 3||0
7558774|NCT02989389|18604525|P9|NOT COMPLETED|Period 3||0
7558775|NCT02989389|18604526|P8|NOT COMPLETED|Period 3||0
7558776|NCT02989389|18604527|P7|NOT COMPLETED|Period 3||0
7558777|NCT02989389|18604528|P6|NOT COMPLETED|Period 3||0
7558778|NCT02989389|18604529|P5|NOT COMPLETED|Period 3||0
7558779|NCT02989389|18604530|P4|NOT COMPLETED|Period 3||0
7558780|NCT02989389|18604531|P3|NOT COMPLETED|Period 3||0
7558781|NCT02989389|18604532|P2|NOT COMPLETED|Period 3||0
7558782|NCT02989389|18604533|P1|NOT COMPLETED|Period 3||0
7558783|NCT02989389|18604524|P10|COMPLETED|Period 3||0
7558784|NCT02989389|18604525|P9|COMPLETED|Period 3||0
7558785|NCT02989389|18604526|P8|COMPLETED|Period 3||0
7558786|NCT02989389|18604527|P7|COMPLETED|Period 3||0
7558787|NCT02989389|18604528|P6|COMPLETED|Period 3||3
7558788|NCT02989389|18604529|P5|COMPLETED|Period 3||3
7558789|NCT02989389|18604530|P4|COMPLETED|Period 3||3
7558790|NCT02989389|18604531|P3|COMPLETED|Period 3||3
7558791|NCT02989389|18604532|P2|COMPLETED|Period 3||3
7558792|NCT02989389|18604533|P1|COMPLETED|Period 3||3
7558793|NCT02989389|18604524|P10|STARTED|Period 3||0
7558794|NCT02989389|18604525|P9|STARTED|Period 3||0
7558795|NCT02989389|18604526|P8|STARTED|Period 3||0
7558796|NCT02989389|18604527|P7|STARTED|Period 3||0
7558797|NCT02989389|18604528|P6|STARTED|Period 3||3
7558798|NCT02989389|18604529|P5|STARTED|Period 3||3
7558799|NCT02989389|18604530|P4|STARTED|Period 3||3
7558800|NCT02989389|18604531|P3|STARTED|Period 3||3
7558801|NCT02989389|18604532|P2|STARTED|Period 3||3
7558802|NCT02989389|18604533|P1|STARTED|Period 3||3
7558803|NCT02989389|18604524|P10|NOT COMPLETED|Period 2||0
7558804|NCT02989389|18604525|P9|NOT COMPLETED|Period 2||0
7558805|NCT02989389|18604526|P8|NOT COMPLETED|Period 2||0
7558806|NCT02989389|18604527|P7|NOT COMPLETED|Period 2||0
7558807|NCT02989389|18604528|P6|NOT COMPLETED|Period 2||0
7558808|NCT02989389|18604529|P5|NOT COMPLETED|Period 2||0
7558809|NCT02989389|18604530|P4|NOT COMPLETED|Period 2||0
7558810|NCT02989389|18604531|P3|NOT COMPLETED|Period 2||0
7558811|NCT02989389|18604532|P2|NOT COMPLETED|Period 2||0
7558812|NCT02989389|18604533|P1|NOT COMPLETED|Period 2||0
7558813|NCT02989389|18604524|P10|COMPLETED|Period 2||0
7558814|NCT02989389|18604525|P9|COMPLETED|Period 2||0
7558815|NCT02989389|18604526|P8|COMPLETED|Period 2||0
7558816|NCT02989389|18604527|P7|COMPLETED|Period 2||0
7558817|NCT02989389|18604528|P6|COMPLETED|Period 2||3
7558818|NCT02989389|18604529|P5|COMPLETED|Period 2||3
7558819|NCT02989389|18604530|P4|COMPLETED|Period 2||3
7558820|NCT02989389|18604531|P3|COMPLETED|Period 2||3
7558821|NCT02989389|18604532|P2|COMPLETED|Period 2||3
7558822|NCT02989389|18604533|P1|COMPLETED|Period 2||3
7558823|NCT02989389|18604524|P10|STARTED|Period 2|Part B was planned as a single period study.|0
7558824|NCT02989389|18604525|P9|STARTED|Period 2|Part B was planned as a single period study.|0
7558825|NCT02989389|18604526|P8|STARTED|Period 2|Part B was planned as a single period study.|0
7558826|NCT02989389|18604527|P7|STARTED|Period 2|Part B was planned as a single period study.|0
7558827|NCT02989389|18604528|P6|STARTED|Period 2||3
7558828|NCT02989389|18604529|P5|STARTED|Period 2||3
7558829|NCT02989389|18604530|P4|STARTED|Period 2||3
7558830|NCT02989389|18604531|P3|STARTED|Period 2||3
7558831|NCT02989389|18604532|P2|STARTED|Period 2||3
7558832|NCT02989389|18604533|P1|STARTED|Period 2||3
7558833|NCT02989389|18604524|P10|NOT COMPLETED|Period 1||0
7558834|NCT02989389|18604525|P9|NOT COMPLETED|Period 1||1
7558835|NCT02989389|18604526|P8|NOT COMPLETED|Period 1||0
7558836|NCT02989389|18604527|P7|NOT COMPLETED|Period 1||0
7558837|NCT02989389|18604528|P6|NOT COMPLETED|Period 1||0
7558838|NCT02989389|18604529|P5|NOT COMPLETED|Period 1||0
7558839|NCT02989389|18604530|P4|NOT COMPLETED|Period 1||0
7558840|NCT02989389|18604531|P3|NOT COMPLETED|Period 1||0
7558841|NCT02989389|18604532|P2|NOT COMPLETED|Period 1||1
7558842|NCT02989389|18604533|P1|NOT COMPLETED|Period 1||0
7558843|NCT02989389|18604524|P10|COMPLETED|Period 1||6
7558844|NCT02989389|18604525|P9|COMPLETED|Period 1||5
7558845|NCT02989389|18604526|P8|COMPLETED|Period 1||5
7558846|NCT02989389|18604527|P7|COMPLETED|Period 1||6
7558847|NCT02989389|18604528|P6|COMPLETED|Period 1||3
7558848|NCT02989389|18604529|P5|COMPLETED|Period 1||3
7558849|NCT02989389|18604530|P4|COMPLETED|Period 1||3
7558850|NCT02989389|18604531|P3|COMPLETED|Period 1||3
7558851|NCT02989389|18604532|P2|COMPLETED|Period 1||3
7558852|NCT02989389|18604533|P1|COMPLETED|Period 1||3
7558853|NCT02989389|18604524|P10|Received at Least 1 Dose of Study Drug|Period 1||6
7558854|NCT02989389|18604525|P9|Received at Least 1 Dose of Study Drug|Period 1||6
7558855|NCT02989389|18604526|P8|Received at Least 1 Dose of Study Drug|Period 1||5
7558856|NCT02989389|18604527|P7|Received at Least 1 Dose of Study Drug|Period 1||6
7558857|NCT02989389|18604528|P6|Received at Least 1 Dose of Study Drug|Period 1||3
7558858|NCT02989389|18604529|P5|Received at Least 1 Dose of Study Drug|Period 1||3
7558859|NCT02989389|18604530|P4|Received at Least 1 Dose of Study Drug|Period 1||3
7558860|NCT02989389|18604531|P3|Received at Least 1 Dose of Study Drug|Period 1||3
7558861|NCT02989389|18604532|P2|Received at Least 1 Dose of Study Drug|Period 1||4
7558862|NCT02989389|18604533|P1|Received at Least 1 Dose of Study Drug|Period 1||3
7558863|NCT02989389|18604524|P10|STARTED|Period 1||6
7558864|NCT02989389|18604525|P9|STARTED|Period 1||6
7558865|NCT02989389|18604526|P8|STARTED|Period 1||5
7558866|NCT02989389|18604527|P7|STARTED|Period 1||6
7558867|NCT02989389|18604528|P6|STARTED|Period 1||3
7558868|NCT02989389|18604529|P5|STARTED|Period 1||3
7558869|NCT02989389|18604530|P4|STARTED|Period 1||3
7558870|NCT02989389|18604531|P3|STARTED|Period 1||3
7558871|NCT02989389|18604532|P2|STARTED|Period 1||4
7558872|NCT02989389|18604533|P1|STARTED|Period 1||3
7558873|NCT02989168|18604599|P2|NOT COMPLETED|Overall Study||3
7558874|NCT02989168|18604600|P1|NOT COMPLETED|Overall Study||4
7558875|NCT02989168|18604599|P2|COMPLETED|Overall Study||0
7558876|NCT02989168|18604600|P1|COMPLETED|Overall Study||7
7558877|NCT02989168|18604599|P2|STARTED|Overall Study||3
7558878|NCT02989168|18604600|P1|STARTED|Overall Study||11
7558879|NCT02988882|18604622|P2|NOT COMPLETED|Overall Study||2
7558880|NCT02988882|18604623|P1|NOT COMPLETED|Overall Study||3
7558881|NCT02988882|18604622|P2|COMPLETED|Overall Study||40
7558882|NCT02988882|18604623|P1|COMPLETED|Overall Study||41
7558883|NCT02988882|18604622|P2|STARTED|Overall Study||42
7558884|NCT02988882|18604623|P1|STARTED|Overall Study||44
7558885|NCT02988856|18604633|P1|NOT COMPLETED|Overall Study||3
7558886|NCT02988856|18604633|P1|COMPLETED|Overall Study||8
7558887|NCT02988856|18604633|P1|STARTED|Overall Study||11
7558888|NCT02988843|18604639|P1|NOT COMPLETED|Overall Study||0
7558889|NCT02988843|18604639|P1|COMPLETED|Overall Study||1
7558890|NCT02988843|18604639|P1|STARTED|Overall Study||1
7558891|NCT02988622|18604646|P1|NOT COMPLETED|Overall Study||17
7558892|NCT02988622|18604646|P1|COMPLETED|Overall Study||83
7558893|NCT02988622|18604646|P1|STARTED|Overall Study||100
7558894|NCT02988349|18604670|P2|NOT COMPLETED|Overall Study||0
7558895|NCT02988349|18604671|P1|NOT COMPLETED|Overall Study||0
7558896|NCT02988349|18604670|P2|COMPLETED|Overall Study||21
7558897|NCT02988349|18604671|P1|COMPLETED|Overall Study||21
7558898|NCT02988349|18604670|P2|STARTED|Overall Study||21
7558899|NCT02988349|18604671|P1|STARTED|Overall Study||21
7558900|NCT02988219|18604681|P2|NOT COMPLETED|Overall Study||3
7558901|NCT02988219|18604682|P1|NOT COMPLETED|Overall Study||1
7558902|NCT02988219|18604681|P2|COMPLETED|Overall Study||22
7558903|NCT02988219|18604682|P1|COMPLETED|Overall Study||24
7558904|NCT02988219|18604681|P2|STARTED|Overall Study||25
7558905|NCT02988219|18604682|P1|STARTED|Overall Study||25
7558906|NCT02988193|18604692|P2|NOT COMPLETED|Overall Study||0
7558907|NCT02988193|18604693|P1|NOT COMPLETED|Overall Study||0
7558908|NCT02988193|18604692|P2|COMPLETED|Overall Study||16
7558909|NCT02988193|18604693|P1|COMPLETED|Overall Study||12
7558910|NCT02988193|18604692|P2|STARTED|Overall Study||16
7558911|NCT02988193|18604693|P1|STARTED|Overall Study||12
7558912|NCT02988115|18604701|P2|NOT COMPLETED|Overall Study||4
7558913|NCT02988115|18604702|P1|NOT COMPLETED|Overall Study||14
7558914|NCT02988115|18604701|P2|COMPLETED|Overall Study||107
7558915|NCT02988115|18604702|P1|COMPLETED|Overall Study||220
7558916|NCT02988115|18604701|P2|STARTED|Overall Study||111
7558917|NCT02988115|18604702|P1|STARTED|Overall Study||234
7558918|NCT02988050|18604718|P2|NOT COMPLETED|Overall Study||0
7558919|NCT02988050|18604719|P1|NOT COMPLETED|Overall Study||0
7558920|NCT02988050|18604718|P2|COMPLETED|Overall Study||30
7558921|NCT02988050|18604719|P1|COMPLETED|Overall Study||30
7558922|NCT02988050|18604718|P2|STARTED|Overall Study||30
7558923|NCT02988050|18604719|P1|STARTED|Overall Study||30
7558924|NCT02987972|18604728|P3|NOT COMPLETED|Overall Study||42
7558925|NCT02987972|18604729|P2|NOT COMPLETED|Overall Study||45
7558926|NCT02987972|18604730|P1|NOT COMPLETED|Overall Study||43
7558927|NCT02987972|18604728|P3|COMPLETED|Overall Study||308
7558928|NCT02987972|18604729|P2|COMPLETED|Overall Study||305
7558929|NCT02987972|18604730|P1|COMPLETED|Overall Study||308
7558930|NCT02987972|18604728|P3|Vaccination 4|Overall Study||311
7558931|NCT02987972|18604729|P2|Vaccination 4|Overall Study||306
7558932|NCT02987972|18604730|P1|Vaccination 4|Overall Study||310
7558933|NCT02987972|18604728|P3|Vaccination 3|Overall Study||332
7558934|NCT02987972|18604729|P2|Vaccination 3|Overall Study||331
7558935|NCT02987972|18604730|P1|Vaccination 3|Overall Study||330
7558936|NCT02987972|18604728|P3|Vaccination 2|Overall Study||335
7558937|NCT02987972|18604729|P2|Vaccination 2|Overall Study||335
7558938|NCT02987972|18604730|P1|Vaccination 2|Overall Study||333
7558939|NCT02987972|18604728|P3|Vaccination 1|Overall Study||347
7558940|NCT02987972|18604729|P2|Vaccination 1|Overall Study||347
7558941|NCT02987972|18604730|P1|Vaccination 1|Overall Study||350
7558942|NCT02987972|18604728|P3|STARTED|Overall Study||350
7558943|NCT02987972|18604729|P2|STARTED|Overall Study||350
7558944|NCT02987972|18604730|P1|STARTED|Overall Study||351
7558945|NCT02987868|18604759|P2|NOT COMPLETED|Second Intervention||0
7558946|NCT02987868|18604760|P1|NOT COMPLETED|Second Intervention||0
7558947|NCT02987868|18604759|P2|COMPLETED|Second Intervention||8
7558948|NCT02987868|18604760|P1|COMPLETED|Second Intervention||8
7558949|NCT02987868|18604759|P2|STARTED|Second Intervention||8
7558950|NCT02987868|18604760|P1|STARTED|Second Intervention||8
7558951|NCT02987868|18604759|P2|NOT COMPLETED|Wash Out Period 1 Week||0
7558952|NCT02987868|18604760|P1|NOT COMPLETED|Wash Out Period 1 Week||0
7558953|NCT02987868|18604759|P2|COMPLETED|Wash Out Period 1 Week||8
7558954|NCT02987868|18604760|P1|COMPLETED|Wash Out Period 1 Week||8
7558955|NCT02987868|18604759|P2|STARTED|Wash Out Period 1 Week||8
7558956|NCT02987868|18604760|P1|STARTED|Wash Out Period 1 Week||8
7558957|NCT02987868|18604759|P2|NOT COMPLETED|First Intervention||0
7558958|NCT02987868|18604760|P1|NOT COMPLETED|First Intervention||0
7558959|NCT02987868|18604759|P2|COMPLETED|First Intervention||8
7558960|NCT02987868|18604760|P1|COMPLETED|First Intervention||8
7558961|NCT02987868|18604759|P2|STARTED|First Intervention||8
7558962|NCT02987868|18604760|P1|STARTED|First Intervention||8
7558963|NCT02987660|18604768|P2|NOT COMPLETED|Overall Study||10
7558964|NCT02987660|18604769|P1|NOT COMPLETED|Overall Study||10
7558965|NCT02987660|18604768|P2|COMPLETED|Overall Study||0
7558966|NCT02987660|18604769|P1|COMPLETED|Overall Study||0
7558967|NCT02987660|18604768|P2|STARTED|Overall Study||10
7558968|NCT02987660|18604769|P1|STARTED|Overall Study||10
7558969|NCT02987621|18604779|P2|NOT COMPLETED|Overall Study||0
7558970|NCT02987621|18604780|P1|NOT COMPLETED|Overall Study||0
7558971|NCT02987621|18604779|P2|COMPLETED|Overall Study||7
7558972|NCT02987621|18604780|P1|COMPLETED|Overall Study||7
7558973|NCT02987621|18604779|P2|STARTED|Overall Study||7
7558974|NCT02987621|18604780|P1|STARTED|Overall Study||7
7558975|NCT02987543|18604793|P4|NOT COMPLETED|Overall Study||48
7558976|NCT02987543|18604794|P3|NOT COMPLETED|Overall Study||94
7558977|NCT02987543|18604795|P2|NOT COMPLETED|Overall Study||83
7558978|NCT02987543|18604796|P1|NOT COMPLETED|Overall Study||162
7558979|NCT02987543|18604793|P4|COMPLETED|Overall Study||0
7558980|NCT02987543|18604794|P3|COMPLETED|Overall Study||0
7558981|NCT02987543|18604795|P2|COMPLETED|Overall Study||0
7558982|NCT02987543|18604796|P1|COMPLETED|Overall Study||0
7558983|NCT02987543|18604793|P4|STARTED|Overall Study||48
7558984|NCT02987543|18604794|P3|STARTED|Overall Study||94
7558985|NCT02987543|18604795|P2|STARTED|Overall Study||83
7558986|NCT02987543|18604796|P1|STARTED|Overall Study||162
7558987|NCT02987374|18604810|P1|NOT COMPLETED|Overall Study||0
7558988|NCT02987374|18604810|P1|COMPLETED|Overall Study||10
7558989|NCT02987374|18604810|P1|STARTED|Overall Study||10
7558990|NCT02987231|18604817|P2|NOT COMPLETED|Overall Study||0
7558991|NCT02987231|18604818|P1|NOT COMPLETED|Overall Study||0
7558992|NCT02987231|18604817|P2|COMPLETED|Overall Study||30
7558993|NCT02987231|18604818|P1|COMPLETED|Overall Study||30
7558994|NCT02987231|18604817|P2|STARTED|Overall Study||30
7558995|NCT02987231|18604818|P1|STARTED|Overall Study||30
7558996|NCT02987205|18604826|P1|NOT COMPLETED|Overall Study||4
7558997|NCT02987205|18604826|P1|COMPLETED|Overall Study|Treatment is bilateral, subject lost to Restylane AE was lost to further Revanesse Ultra treatment|159
7558998|NCT02987205|18604826|P1|Treated - Bilateral NLF Injection|Overall Study||163
7558999|NCT02987205|18604826|P1|STARTED|Overall Study||163
7559000|NCT02986958|18604836|P2|NOT COMPLETED|Overall Study||0
7559001|NCT02986958|18604837|P1|NOT COMPLETED|Overall Study||0
7559002|NCT02986958|18604836|P2|COMPLETED|Overall Study||44
7559003|NCT02986958|18604837|P1|COMPLETED|Overall Study||49
7559004|NCT02986958|18604836|P2|STARTED|Overall Study||44
7559005|NCT02986958|18604837|P1|STARTED|Overall Study||49
7559006|NCT02986854|18604860|P3|NOT COMPLETED|Overall Study||3
7559007|NCT02986854|18604861|P2|NOT COMPLETED|Overall Study||12
7559008|NCT02986854|18604862|P1|NOT COMPLETED|Overall Study||3
7559009|NCT02986854|18604860|P3|COMPLETED|Overall Study||97
7559010|NCT02986854|18604861|P2|COMPLETED|Overall Study||288
7559011|NCT02986854|18604862|P1|COMPLETED|Overall Study||298
7559012|NCT02986854|18604860|P3|STARTED|Overall Study||100
7559013|NCT02986854|18604861|P2|STARTED|Overall Study||300
7559014|NCT02986854|18604862|P1|STARTED|Overall Study||301
7559015|NCT02986711|18604937|P2|NOT COMPLETED|Overall Study||10
7559016|NCT02986711|18604938|P1|NOT COMPLETED|Overall Study||8
7559017|NCT02986711|18604937|P2|COMPLETED|Overall Study||70
7559018|NCT02986711|18604938|P1|COMPLETED|Overall Study||70
7559019|NCT02986711|18604937|P2|STARTED|Overall Study||80
7559020|NCT02986711|18604938|P1|STARTED|Overall Study||78
7559021|NCT02986373|18604946|P1|NOT COMPLETED|Overall Study||39
7559022|NCT02986373|18604946|P1|COMPLETED|Overall Study||106
7559023|NCT02986373|18604946|P1|STARTED|Overall Study||145
7559024|NCT02986282|18604981|P1|NOT COMPLETED|Overall Study||16
7559025|NCT02986282|18604981|P1|COMPLETED|Overall Study||99
7559026|NCT02986282|18604981|P1|STARTED|Overall Study||115
7559027|NCT02986139|18604988|P2|NOT COMPLETED|Overall Study||4
7559028|NCT02986139|18604989|P1|NOT COMPLETED|Overall Study||1
7559029|NCT02986139|18604988|P2|COMPLETED|Overall Study||51
7559030|NCT02986139|18604989|P1|COMPLETED|Overall Study||55
7559031|NCT02986139|18604988|P2|Received Etanercept|Overall Study||53
7559032|NCT02986139|18604989|P1|Received Etanercept|Overall Study||56
7559033|NCT02986139|18604988|P2|STARTED|Overall Study||55
7559034|NCT02986139|18604989|P1|STARTED|Overall Study||56
7559035|NCT02985996|18605006|P5|NOT COMPLETED|Overall Study||0
7559036|NCT02985996|18605007|P4|NOT COMPLETED|Overall Study||0
7559037|NCT02985996|18605008|P3|NOT COMPLETED|Overall Study||1
7559038|NCT02985996|18605009|P2|NOT COMPLETED|Overall Study||1
7559039|NCT02985996|18605010|P1|NOT COMPLETED|Overall Study||0
7559040|NCT02985996|18605006|P5|COMPLETED|Overall Study||9
7559041|NCT02985996|18605007|P4|COMPLETED|Overall Study||7
7559042|NCT02985996|18605008|P3|COMPLETED|Overall Study||9
7559043|NCT02985996|18605009|P2|COMPLETED|Overall Study||7
7559044|NCT02985996|18605010|P1|COMPLETED|Overall Study||5
7559045|NCT02985996|18605006|P5|STARTED|Overall Study||9
7559046|NCT02985996|18605007|P4|STARTED|Overall Study||7
7559047|NCT02985996|18605008|P3|STARTED|Overall Study||10
7559048|NCT02985996|18605009|P2|STARTED|Overall Study||8
7559049|NCT02985996|18605010|P1|STARTED|Overall Study||5
7559050|NCT02985840|18605124|P2|NOT COMPLETED|Overall Study||0
7559051|NCT02985840|18605125|P1|NOT COMPLETED|Overall Study||0
7559052|NCT02985840|18605124|P2|COMPLETED|Overall Study||63
7559053|NCT02985840|18605125|P1|COMPLETED|Overall Study||64
7559054|NCT02985840|18605124|P2|STARTED|Overall Study||63
7559055|NCT02985840|18605125|P1|STARTED|Overall Study||64
7559056|NCT02985827|18605135|P2|NOT COMPLETED|Overall Study||0
7559057|NCT02985827|18605136|P1|NOT COMPLETED|Overall Study||0
7559058|NCT02985827|18605135|P2|COMPLETED|Overall Study||15
7559059|NCT02985827|18605136|P1|COMPLETED|Overall Study||33
7559060|NCT02985827|18605135|P2|STARTED|Overall Study||15
7559061|NCT02985827|18605136|P1|STARTED|Overall Study||33
7559062|NCT02985684|18605144|P1|NOT COMPLETED|6-Month Closure Success Evaluation||8
7559063|NCT02985684|18605144|P1|COMPLETED|6-Month Closure Success Evaluation||112
7559064|NCT02985684|18605144|P1|STARTED|6-Month Closure Success Evaluation||120
7559065|NCT02985684|18605144|P1|NOT COMPLETED|6-Month Clinical Success Evaluation||5
7559066|NCT02985684|18605144|P1|COMPLETED|6-Month Clinical Success Evaluation||120
7559067|NCT02985684|18605144|P1|STARTED|6-Month Clinical Success Evaluation||125
7559068|NCT02985398|18605155|P1|NOT COMPLETED|Overall Study||22
7559069|NCT02985398|18605155|P1|COMPLETED|Overall Study||106
7559070|NCT02985398|18605155|P1|Participants Treated|Overall Study||128
7559071|NCT02985398|18605155|P1|STARTED|Overall Study||128
7559072|NCT02984995|18605173|P2|NOT COMPLETED|Overall Study||3
7559073|NCT02984995|18605174|P1|NOT COMPLETED|Overall Study||25
7559074|NCT02984995|18605173|P2|COMPLETED|Overall Study||0
7559075|NCT02984995|18605174|P1|COMPLETED|Overall Study||9
7559076|NCT02984995|18605173|P2|STARTED|Overall Study||3
7559077|NCT02984995|18605174|P1|STARTED|Overall Study||34
7559078|NCT02984982|18605221|P2|NOT COMPLETED|Overall Study||10
7559079|NCT02984982|18605222|P1|NOT COMPLETED|Overall Study||8
7559080|NCT02984982|18605221|P2|COMPLETED|Overall Study||94
7559081|NCT02984982|18605222|P1|COMPLETED|Overall Study||94
7559082|NCT02984982|18605221|P2|Treated|Overall Study||103
7559083|NCT02984982|18605222|P1|Treated|Overall Study||102
7559084|NCT02984982|18605221|P2|STARTED|Overall Study||104
7559085|NCT02984982|18605222|P1|STARTED|Overall Study||102
7559086|NCT02984943|18605274|P1|NOT COMPLETED|Overall Study||4
7559087|NCT02984943|18605274|P1|COMPLETED|Overall Study||10
7559088|NCT02984943|18605274|P1|STARTED|Overall Study||14
7559089|NCT02984878|18605319|P2|NOT COMPLETED|Overall Study||0
7559090|NCT02984878|18605320|P1|NOT COMPLETED|Overall Study||0
7559091|NCT02984878|18605319|P2|COMPLETED|Overall Study||41
7559092|NCT02984878|18605320|P1|COMPLETED|Overall Study||30
7559093|NCT02984878|18605319|P2|STARTED|Overall Study||41
7559094|NCT02984878|18605320|P1|STARTED|Overall Study||30
7559095|NCT02984709|18605332|P2|NOT COMPLETED|Overall Study||0
7559096|NCT02984709|18605333|P1|NOT COMPLETED|Overall Study||0
7559097|NCT02984709|18605332|P2|COMPLETED|Overall Study||24
7559098|NCT02984709|18605333|P1|COMPLETED|Overall Study||24
7559099|NCT02984709|18605332|P2|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
7559100|NCT02984709|18605333|P1|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
7559101|NCT02984644|18605357|P2|NOT COMPLETED|Overall Study||0
7559102|NCT02984644|18605358|P1|NOT COMPLETED|Overall Study||0
7559103|NCT02984644|18605357|P2|COMPLETED|Overall Study||10
7559104|NCT02984644|18605358|P1|COMPLETED|Overall Study||20
7559105|NCT02984644|18605357|P2|STARTED|Overall Study||10
7559106|NCT02984644|18605358|P1|STARTED|Overall Study||20
7559107|NCT02984267|18605388|P2|NOT COMPLETED|Overall Study||1
7559108|NCT02984267|18605389|P1|NOT COMPLETED|Overall Study||1
7559109|NCT02984267|18605388|P2|COMPLETED|Overall Study||9
7559110|NCT02984267|18605389|P1|COMPLETED|Overall Study||7
7559111|NCT02984267|18605388|P2|STARTED|Overall Study||10
7559112|NCT02984267|18605389|P1|STARTED|Overall Study||8
7559113|NCT02983981|18605413|P1|NOT COMPLETED|Overall Study||0
7559114|NCT02983981|18605413|P1|COMPLETED|Overall Study||20
7559115|NCT02983981|18605413|P1|STARTED|Overall Study||20
7559116|NCT02983877|18605420|P1|NOT COMPLETED|Overall Study||0
7559117|NCT02983877|18605420|P1|COMPLETED|Overall Study||38
7559118|NCT02983877|18605420|P1|STARTED|Overall Study||38
7559119|NCT02983825|18605427|P1|NOT COMPLETED|Overall Study||3
7559120|NCT02983825|18605427|P1|COMPLETED|Overall Study|Of 12 subjects starting intervention, 3 met specified stopping critieria|9
7559121|NCT02983825|18605427|P1|STARTED|Overall Study|Of 21 enrolled subjects, 9 became ineligible for between consent and intervention|12
7559122|NCT02983617|18605434|P2|NOT COMPLETED|Overall Study||30
7559123|NCT02983617|18605435|P1|NOT COMPLETED|Overall Study||6
7559124|NCT02983617|18605434|P2|COMPLETED|Overall Study||0
7559125|NCT02983617|18605435|P1|COMPLETED|Overall Study||0
7559126|NCT02983617|18605434|P2|STARTED|Overall Study||30
7559127|NCT02983617|18605435|P1|STARTED|Overall Study||6
7559128|NCT02983604|18605453|P4|NOT COMPLETED|Overall Study||0
7559129|NCT02983604|18605454|P3|NOT COMPLETED|Overall Study||1
7559130|NCT02983604|18605455|P2|NOT COMPLETED|Overall Study||0
7559131|NCT02983604|18605456|P1|NOT COMPLETED|Overall Study||0
7559132|NCT02983604|18605453|P4|COMPLETED|Overall Study||3
7559133|NCT02983604|18605454|P3|COMPLETED|Overall Study||3
7559134|NCT02983604|18605455|P2|COMPLETED|Overall Study||3
7559135|NCT02983604|18605456|P1|COMPLETED|Overall Study||4
7559136|NCT02983604|18605453|P4|STARTED|Overall Study||3
7559137|NCT02983604|18605454|P3|STARTED|Overall Study||4
7559138|NCT02983604|18605455|P2|STARTED|Overall Study||3
7559139|NCT02983604|18605456|P1|STARTED|Overall Study||4
7559140|NCT02983448|18605494|P2|NOT COMPLETED|Overall Study||0
7559141|NCT02983448|18605495|P1|NOT COMPLETED|Overall Study||0
7559142|NCT02983448|18605494|P2|COMPLETED|Overall Study||12
7559143|NCT02983448|18605495|P1|COMPLETED|Overall Study||12
7559144|NCT02983448|18605494|P2|STARTED|Overall Study||12
7559145|NCT02983448|18605495|P1|STARTED|Overall Study||12
7559146|NCT02983305|18605505|P2|NOT COMPLETED|Overall Study||0
7559147|NCT02983305|18605506|P1|NOT COMPLETED|Overall Study||2
7559148|NCT02983305|18605505|P2|COMPLETED|Overall Study||10
7559149|NCT02983305|18605506|P1|COMPLETED|Overall Study||10
7559150|NCT02983305|18605505|P2|STARTED|Overall Study||10
7559151|NCT02983305|18605506|P1|STARTED|Overall Study||12
7559152|NCT02983227|18605516|P2|NOT COMPLETED|Overall Study||14
7559153|NCT02983227|18605517|P1|NOT COMPLETED|Overall Study||59
7559154|NCT02983227|18605516|P2|COMPLETED|Overall Study||72
7559155|NCT02983227|18605517|P1|COMPLETED|Overall Study||351
7559156|NCT02983227|18605516|P2|STARTED|Overall Study||86
7559157|NCT02983227|18605517|P1|STARTED|Overall Study||410
7559158|NCT02983058|18605577|P2|NOT COMPLETED|Overall Study||3
7559159|NCT02983058|18605578|P1|NOT COMPLETED|Overall Study||5
7559160|NCT02983058|18605577|P2|COMPLETED|Overall Study||2
7559161|NCT02983058|18605578|P1|COMPLETED|Overall Study||2
7559162|NCT02983058|18605577|P2|STARTED|Overall Study||5
7559163|NCT02983058|18605578|P1|STARTED|Overall Study||7
7559164|NCT02982928|18605588|P1|NOT COMPLETED|Overall Study||0
7559165|NCT02982928|18605588|P1|COMPLETED|Overall Study||11
7559166|NCT02982928|18605588|P1|STARTED|Overall Study||11
7559167|NCT02982863|18605597|P5|NOT COMPLETED|Overall Study||492
7559168|NCT02982863|18605598|P4|NOT COMPLETED|Overall Study||1400
7559169|NCT02982863|18605599|P3|NOT COMPLETED|Overall Study||1852
7559170|NCT02982863|18605600|P2|NOT COMPLETED|Overall Study||4261
7559171|NCT02982863|18605601|P1|NOT COMPLETED|Overall Study||809
7559172|NCT02982863|18605597|P5|COMPLETED|Overall Study||2268
7559173|NCT02982863|18605598|P4|COMPLETED|Overall Study||8758
7559174|NCT02982863|18605599|P3|COMPLETED|Overall Study||11386
7559175|NCT02982863|18605600|P2|COMPLETED|Overall Study||12484
7559176|NCT02982863|18605601|P1|COMPLETED|Overall Study||4936
7559177|NCT02982863|18605597|P5|STARTED|Overall Study||2760
7559178|NCT02982863|18605598|P4|STARTED|Overall Study||10158
7559179|NCT02982863|18605599|P3|STARTED|Overall Study||13238
7559180|NCT02982863|18605600|P2|STARTED|Overall Study||16745
7559181|NCT02982863|18605601|P1|STARTED|Overall Study||5745
7559182|NCT02982720|18605658|P1|NOT COMPLETED|Overall Study||4
7559183|NCT02982720|18605658|P1|COMPLETED|Overall Study||0
7559184|NCT02982720|18605658|P1|STARTED|Overall Study||4
7559185|NCT02982239|18605668|P2|NOT COMPLETED|Overall Study||2
7559186|NCT02982239|18605669|P1|NOT COMPLETED|Overall Study||3
7559187|NCT02982239|18605668|P2|COMPLETED|Overall Study||18
7559188|NCT02982239|18605669|P1|COMPLETED|Overall Study||17
7559189|NCT02982239|18605668|P2|STARTED|Overall Study||20
7559190|NCT02982239|18605669|P1|STARTED|Overall Study||20
7559191|NCT02982187|18605685|P8|NOT COMPLETED|Overall Study||0
7559192|NCT02982187|18605686|P7|NOT COMPLETED|Overall Study||1
7559193|NCT02982187|18605687|P6|NOT COMPLETED|Overall Study||0
7559194|NCT02982187|18605688|P5|NOT COMPLETED|Overall Study||0
7559195|NCT02982187|18605689|P4|NOT COMPLETED|Overall Study||0
7559196|NCT02982187|18605690|P3|NOT COMPLETED|Overall Study||0
7559197|NCT02982187|18605691|P2|NOT COMPLETED|Overall Study||0
7559198|NCT02982187|18605692|P1|NOT COMPLETED|Overall Study||0
7559199|NCT02982187|18605685|P8|COMPLETED|Overall Study||20
7559200|NCT02982187|18605686|P7|COMPLETED|Overall Study||19
7559201|NCT02982187|18605687|P6|COMPLETED|Overall Study||20
7559202|NCT02982187|18605688|P5|COMPLETED|Overall Study||20
7559203|NCT02982187|18605689|P4|COMPLETED|Overall Study||20
7559204|NCT02982187|18605690|P3|COMPLETED|Overall Study||20
7559205|NCT02982187|18605691|P2|COMPLETED|Overall Study||20
7559206|NCT02982187|18605692|P1|COMPLETED|Overall Study||20
7559207|NCT02982187|18605685|P8|STARTED|Overall Study||20
7559208|NCT02982187|18605686|P7|STARTED|Overall Study||20
7559209|NCT02982187|18605687|P6|STARTED|Overall Study||20
7559210|NCT02982187|18605688|P5|STARTED|Overall Study||20
7559211|NCT02982187|18605689|P4|STARTED|Overall Study||20
7559212|NCT02982187|18605690|P3|STARTED|Overall Study||20
7559213|NCT02982187|18605691|P2|STARTED|Overall Study||20
7559214|NCT02982187|18605692|P1|STARTED|Overall Study||20
7559215|NCT02982018|18605742|P2|NOT COMPLETED|Overall Study||3
7559216|NCT02982018|18605743|P1|NOT COMPLETED|Overall Study||5
7559217|NCT02982018|18605742|P2|COMPLETED|Overall Study||61
7559218|NCT02982018|18605743|P1|COMPLETED|Overall Study||62
7559219|NCT02982018|18605742|P2|STARTED|Overall Study||64
7559220|NCT02982018|18605743|P1|STARTED|Overall Study||67
7559221|NCT02981602|18605762|P5|NOT COMPLETED|Overall Study||0
7559222|NCT02981602|18605763|P4|NOT COMPLETED|Overall Study||1
7559223|NCT02981602|18605764|P3|NOT COMPLETED|Overall Study||0
7559224|NCT02981602|18605765|P2|NOT COMPLETED|Overall Study||0
7559225|NCT02981602|18605766|P1|NOT COMPLETED|Overall Study||0
7559226|NCT02981602|18605762|P5|COMPLETED|Overall Study||2
7559227|NCT02981602|18605763|P4|COMPLETED|Overall Study||4
7559228|NCT02981602|18605764|P3|COMPLETED|Overall Study||6
7559229|NCT02981602|18605765|P2|COMPLETED|Overall Study||12
7559230|NCT02981602|18605766|P1|COMPLETED|Overall Study||6
7559231|NCT02981602|18605762|P5|STARTED|Overall Study||2
7559232|NCT02981602|18605763|P4|STARTED|Overall Study||5
7559233|NCT02981602|18605764|P3|STARTED|Overall Study||6
7559234|NCT02981602|18605765|P2|STARTED|Overall Study||12
7559235|NCT02981602|18605766|P1|STARTED|Overall Study||6
7559236|NCT02981524|18605946|P1|NOT COMPLETED|Overall Study||17
7559237|NCT02981524|18605946|P1|COMPLETED|Overall Study||0
7559238|NCT02981524|18605946|P1|STARTED|Overall Study||17
7559239|NCT02981342|18605958|P4|NOT COMPLETED|Overall Study||14
7559240|NCT02981342|18605959|P3|NOT COMPLETED|Overall Study||13
7559241|NCT02981342|18605960|P2|NOT COMPLETED|Overall Study||11
7559242|NCT02981342|18605961|P1|NOT COMPLETED|Overall Study||0
7559243|NCT02981342|18605958|P4|COMPLETED|Overall Study||19
7559244|NCT02981342|18605959|P3|COMPLETED|Overall Study||20
7559245|NCT02981342|18605960|P2|COMPLETED|Overall Study||22
7559246|NCT02981342|18605961|P1|COMPLETED|Overall Study||7
7559247|NCT02981342|18605958|P4|Received at Least One Dose of Study Drug|Overall Study||26
7559248|NCT02981342|18605959|P3|Received at Least One Dose of Study Drug|Overall Study||33
7559249|NCT02981342|18605960|P2|Received at Least One Dose of Study Drug|Overall Study||32
7559250|NCT02981342|18605961|P1|Received at Least One Dose of Study Drug|Overall Study||7
7559251|NCT02981342|18605958|P4|STARTED|Overall Study||33
7559252|NCT02981342|18605959|P3|STARTED|Overall Study||33
7559253|NCT02981342|18605960|P2|STARTED|Overall Study||33
7559254|NCT02981342|18605961|P1|STARTED|Overall Study||7
7559255|NCT02980978|18606004|P2|NOT COMPLETED|Overall Study||8
7559256|NCT02980978|18606005|P1|NOT COMPLETED|Overall Study||6
7559257|NCT02980978|18606004|P2|COMPLETED|Overall Study||50
7559258|NCT02980978|18606005|P1|COMPLETED|Overall Study||54
7559259|NCT02980978|18606004|P2|STARTED|Overall Study||58
7559260|NCT02980978|18606005|P1|STARTED|Overall Study||60
7559261|NCT02980783|18606019|P1|NOT COMPLETED|Overall Study||1
7559262|NCT02980783|18606019|P1|COMPLETED|Overall Study||52
7559263|NCT02980783|18606019|P1|STARTED|Overall Study||53
7559264|NCT02980601|18606032|P2|NOT COMPLETED|Overall Study||3
7559265|NCT02980601|18606033|P1|NOT COMPLETED|Overall Study||5
7559266|NCT02980601|18606032|P2|COMPLETED|Overall Study||1
7559267|NCT02980601|18606033|P1|COMPLETED|Overall Study||1
7559268|NCT02980601|18606032|P2|STARTED|Overall Study||4
7559269|NCT02980601|18606033|P1|STARTED|Overall Study||6
7559270|NCT02980523|18606126|P5|NOT COMPLETED|Overall Study||10
7559271|NCT02980523|18606127|P4|NOT COMPLETED|Overall Study||9
7559272|NCT02980523|18606128|P3|NOT COMPLETED|Overall Study||6
7559273|NCT02980523|18606129|P2|NOT COMPLETED|Overall Study||11
7559274|NCT02980523|18606130|P1|NOT COMPLETED|Overall Study||3
7559275|NCT02980523|18606126|P5|COMPLETED|Overall Study||20
7559276|NCT02980523|18606127|P4|COMPLETED|Overall Study||21
7559277|NCT02980523|18606128|P3|COMPLETED|Overall Study||24
7559278|NCT02980523|18606129|P2|COMPLETED|Overall Study||19
7559279|NCT02980523|18606130|P1|COMPLETED|Overall Study||27
7559280|NCT02980523|18606126|P5|STARTED|Overall Study||30
7559281|NCT02980523|18606127|P4|STARTED|Overall Study||30
7559282|NCT02980523|18606128|P3|STARTED|Overall Study||30
7559283|NCT02980523|18606129|P2|STARTED|Overall Study||30
7559284|NCT02980523|18606130|P1|STARTED|Overall Study||30
7559285|NCT02980224|18606174|P2|NOT COMPLETED|Overall Study||3
7559286|NCT02980224|18606175|P1|NOT COMPLETED|Overall Study||4
7559287|NCT02980224|18606174|P2|COMPLETED|Overall Study||88
7559288|NCT02980224|18606175|P1|COMPLETED|Overall Study||85
7559289|NCT02980224|18606174|P2|STARTED|Overall Study||91
7559290|NCT02980224|18606175|P1|STARTED|Overall Study||89
7559291|NCT02980211|18606185|P1|NOT COMPLETED|Overall Study||0
7559292|NCT02980211|18606185|P1|COMPLETED|Overall Study||17
7559293|NCT02980211|18606185|P1|STARTED|Overall Study||17
7559294|NCT02980133|18606193|P4|NOT COMPLETED|Overall Study||6
7559295|NCT02980133|18606194|P3|NOT COMPLETED|Overall Study||7
7559296|NCT02980133|18606195|P2|NOT COMPLETED|Overall Study||5
7559297|NCT02980133|18606196|P1|NOT COMPLETED|Overall Study||7
7559298|NCT02980133|18606193|P4|COMPLETED|Overall Study||205
7559299|NCT02980133|18606194|P3|COMPLETED|Overall Study||203
7559300|NCT02980133|18606195|P2|COMPLETED|Overall Study||206
7559301|NCT02980133|18606196|P1|COMPLETED|Overall Study||202
7559302|NCT02980133|18606193|P4|Received at Least 1 Dose of Study Drug|Overall Study||211
7559303|NCT02980133|18606194|P3|Received at Least 1 Dose of Study Drug|Overall Study||208
7559304|NCT02980133|18606195|P2|Received at Least 1 Dose of Study Drug|Overall Study||211
7559305|NCT02980133|18606196|P1|Received at Least 1 Dose of Study Drug|Overall Study||209
7559306|NCT02980133|18606193|P4|STARTED|Overall Study||211
7559307|NCT02980133|18606194|P3|STARTED|Overall Study||210
7559308|NCT02980133|18606195|P2|STARTED|Overall Study||211
7559309|NCT02980133|18606196|P1|STARTED|Overall Study||209
7559310|NCT02980107|18606234|P2|NOT COMPLETED|Overall Study||62
7559311|NCT02980107|18606235|P1|NOT COMPLETED|Overall Study||51
7559312|NCT02980107|18606234|P2|COMPLETED|Overall Study||45
7559313|NCT02980107|18606235|P1|COMPLETED|Overall Study||54
7559314|NCT02980107|18606234|P2|STARTED|Overall Study||107
7559315|NCT02980107|18606235|P1|STARTED|Overall Study||105
7559316|NCT02980042|18606249|P2|NOT COMPLETED|Overall Study||0
7559317|NCT02980042|18606250|P1|NOT COMPLETED|Overall Study||7
7559318|NCT02980042|18606249|P2|COMPLETED|Overall Study||100
7559319|NCT02980042|18606250|P1|COMPLETED|Overall Study|All 100 subjects completed their Week 24 infusion. 7 subjects did not complete the 12 month visit.|93
7559320|NCT02980042|18606249|P2|STARTED|Overall Study||100
7559321|NCT02980042|18606250|P1|STARTED|Overall Study||100
7559322|NCT02979899|18606269|P2|NOT COMPLETED|Overall Study||0
7559323|NCT02979899|18606270|P1|NOT COMPLETED|Overall Study||0
7559324|NCT02979899|18606269|P2|COMPLETED|Overall Study||64
7559325|NCT02979899|18606270|P1|COMPLETED|Overall Study||64
7559326|NCT02979899|18606269|P2|STARTED|Overall Study||64
7559327|NCT02979899|18606270|P1|STARTED|Overall Study||64
7559328|NCT02979639|18606282|P1|NOT COMPLETED|Overall Study||14
7559329|NCT02979639|18606282|P1|COMPLETED|Overall Study||387
7559330|NCT02979639|18606282|P1|STARTED|Overall Study||401
7559331|NCT02979613|18606314|P2|NOT COMPLETED|Open-Label Extension (OLE) Phase||6
7559332|NCT02979613|18606315|P1|NOT COMPLETED|Open-Label Extension (OLE) Phase||3
7559333|NCT02979613|18606314|P2|COMPLETED|Open-Label Extension (OLE) Phase||231
7559334|NCT02979613|18606315|P1|COMPLETED|Open-Label Extension (OLE) Phase||232
7559335|NCT02979613|18606314|P2|STARTED|Open-Label Extension (OLE) Phase||237
7559336|NCT02979613|18606315|P1|STARTED|Open-Label Extension (OLE) Phase||235
7559337|NCT02979613|18606314|P2|NOT COMPLETED|Double-Blind Phase||8
7559338|NCT02979613|18606315|P1|NOT COMPLETED|Double-Blind Phase||10
7559339|NCT02979613|18606314|P2|COMPLETED|Double-Blind Phase||237
7559340|NCT02979613|18606315|P1|COMPLETED|Double-Blind Phase||235
7559341|NCT02979613|18606314|P2|STARTED|Double-Blind Phase||245
7559342|NCT02979613|18606315|P1|STARTED|Double-Blind Phase||245
7559343|NCT02979535|18606375|P2|NOT COMPLETED|Overall Study||101
7559344|NCT02979535|18606376|P1|NOT COMPLETED|Overall Study||95
7559345|NCT02979535|18606375|P2|COMPLETED|Overall Study||140
7559346|NCT02979535|18606376|P1|COMPLETED|Overall Study||144
7559347|NCT02979535|18606375|P2|Safety Analysis Set|Overall Study||241
7559348|NCT02979535|18606376|P1|Safety Analysis Set|Overall Study||237
7559349|NCT02979535|18606375|P2|STARTED|Overall Study||241
7559350|NCT02979535|18606376|P1|STARTED|Overall Study||239
7559351|NCT02979444|18606413|P3|NOT COMPLETED|Overall Study||10
7559352|NCT02979444|18606414|P2|NOT COMPLETED|Overall Study||17
7559353|NCT02979444|18606415|P1|NOT COMPLETED|Overall Study||23
7559354|NCT02979444|18606413|P3|COMPLETED|Overall Study||149
7559355|NCT02979444|18606414|P2|COMPLETED|Overall Study||293
7559356|NCT02979444|18606415|P1|COMPLETED|Overall Study||382
7559357|NCT02979444|18606413|P3|STARTED|Overall Study||159
7559358|NCT02979444|18606414|P2|STARTED|Overall Study||310
7559359|NCT02979444|18606415|P1|STARTED|Overall Study||405
7559360|NCT02979431|18606439|P4|NOT COMPLETED|Overall Study||1
7559361|NCT02979431|18606440|P3|NOT COMPLETED|Overall Study||2
7559362|NCT02979431|18606441|P2|NOT COMPLETED|Overall Study||2
7559363|NCT02979431|18606442|P1|NOT COMPLETED|Overall Study||4
7559364|NCT02979431|18606439|P4|COMPLETED|Overall Study||44
7559365|NCT02979431|18606440|P3|COMPLETED|Overall Study||43
7559366|NCT02979431|18606441|P2|COMPLETED|Overall Study||44
7559367|NCT02979431|18606442|P1|COMPLETED|Overall Study||40
7559368|NCT02979431|18606439|P4|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 9.0 mg/kg|46
7559369|NCT02979431|18606440|P3|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 6.0 mg/kg|44
7559370|NCT02979431|18606441|P2|Included in the Safety Population|Overall Study||45
7559371|NCT02979431|18606442|P1|Included in the Safety Population|Overall Study||40
7559372|NCT02979431|18606439|P4|Included in the mITT Population|Overall Study||45
7559373|NCT02979431|18606440|P3|Included in the mITT Population|Overall Study||43
7559374|NCT02979431|18606441|P2|Included in the mITT Population|Overall Study||45
7559375|NCT02979431|18606442|P1|Included in the mITT Population|Overall Study||42
7559376|NCT02979431|18606439|P4|STARTED|Overall Study||45
7559377|NCT02979431|18606440|P3|STARTED|Overall Study||45
7559378|NCT02979431|18606441|P2|STARTED|Overall Study||46
7559379|NCT02979431|18606442|P1|STARTED|Overall Study||44
7559380|NCT02979301|18606494|P2|NOT COMPLETED|Overall Study||0
7559381|NCT02979301|18606495|P1|NOT COMPLETED|Overall Study||1
7559382|NCT02979301|18606494|P2|COMPLETED|Overall Study||11
7559383|NCT02979301|18606495|P1|COMPLETED|Overall Study||10
7559384|NCT02979301|18606494|P2|STARTED|Overall Study||11
7559385|NCT02979301|18606495|P1|STARTED|Overall Study||11
7559386|NCT02979262|18606503|P2|NOT COMPLETED|Overall Study||9
7559387|NCT02979262|18606504|P1|NOT COMPLETED|Overall Study||12
7559388|NCT02979262|18606503|P2|COMPLETED|Overall Study||20
7559389|NCT02979262|18606504|P1|COMPLETED|Overall Study||21
7559390|NCT02979262|18606503|P2|Received Allocated Intervention|Overall Study||27
7559391|NCT02979262|18606504|P1|Received Allocated Intervention|Overall Study||30
7559392|NCT02979262|18606503|P2|STARTED|Overall Study||29
7559393|NCT02979262|18606504|P1|STARTED|Overall Study||33
7559394|NCT02979249|18606520|P1|NOT COMPLETED|Overall Study||6
7559395|NCT02979249|18606520|P1|COMPLETED|Overall Study||10
7559396|NCT02979249|18606520|P1|STARTED|Overall Study||16
7559397|NCT02979197|18606528|P3|NOT COMPLETED|Overall Study||0
7559398|NCT02979197|18606529|P2|NOT COMPLETED|Overall Study||4
7559399|NCT02979197|18606530|P1|NOT COMPLETED|Overall Study||4
7559400|NCT02979197|18606528|P3|COMPLETED|Overall Study||8
7559401|NCT02979197|18606529|P2|COMPLETED|Overall Study||45
7559402|NCT02979197|18606530|P1|COMPLETED|Overall Study||44
7559403|NCT02979197|18606528|P3|STARTED|Overall Study||8
7559404|NCT02979197|18606529|P2|STARTED|Overall Study||49
7559405|NCT02979197|18606530|P1|STARTED|Overall Study||48
7559406|NCT02979054|18606558|P2|NOT COMPLETED|Overall Study||0
7559407|NCT02979054|18606559|P1|NOT COMPLETED|Overall Study||0
7559408|NCT02979054|18606558|P2|COMPLETED|Overall Study||64
7559409|NCT02979054|18606559|P1|COMPLETED|Overall Study||71
7559410|NCT02979054|18606558|P2|STARTED|Overall Study||64
7559411|NCT02979054|18606559|P1|STARTED|Overall Study||71
7559412|NCT02978833|18606573|P2|NOT COMPLETED|Overall Study||1
7559413|NCT02978833|18606574|P1|NOT COMPLETED|Overall Study||1
7559414|NCT02978833|18606573|P2|COMPLETED|Overall Study||0
7559415|NCT02978833|18606574|P1|COMPLETED|Overall Study||0
7559416|NCT02978833|18606573|P2|STARTED|Overall Study||1
7559417|NCT02978833|18606574|P1|STARTED|Overall Study||1
7559418|NCT02978508|18606592|P2|NOT COMPLETED|Overall Study||0
7559419|NCT02978508|18606593|P1|NOT COMPLETED|Overall Study||0
7559420|NCT02978508|18606592|P2|COMPLETED|Overall Study||70
7559421|NCT02978508|18606593|P1|COMPLETED|Overall Study||70
7559422|NCT02978508|18606592|P2|STARTED|Overall Study||70
7559423|NCT02978508|18606593|P1|STARTED|Overall Study||70
7559424|NCT02978417|18606603|P2|NOT COMPLETED|Overall Study||2
7559425|NCT02978417|18606604|P1|NOT COMPLETED|Overall Study||2
7559426|NCT02978417|18606603|P2|COMPLETED|Overall Study||3
7559427|NCT02978417|18606604|P1|COMPLETED|Overall Study||3
7559428|NCT02978417|18606603|P2|STARTED|Overall Study||5
7559429|NCT02978417|18606604|P1|STARTED|Overall Study||5
7559430|NCT02978339|18606638|P1|NOT COMPLETED|Overall Study||0
7559431|NCT02978339|18606638|P1|COMPLETED|Overall Study||15
7559432|NCT02978339|18606638|P1|STARTED|Overall Study||15
7559433|NCT02978157|18606650|P2|NOT COMPLETED|Overall Study||0
7559434|NCT02978157|18606651|P1|NOT COMPLETED|Overall Study||0
7559435|NCT02978157|18606650|P2|COMPLETED|Overall Study||50
7559436|NCT02978157|18606651|P1|COMPLETED|Overall Study||52
7559437|NCT02978157|18606650|P2|STARTED|Overall Study||50
7559438|NCT02978157|18606651|P1|STARTED|Overall Study||52
7559439|NCT02977572|18606659|P2|NOT COMPLETED|Overall Study||2
7559440|NCT02977572|18606660|P1|NOT COMPLETED|Overall Study||2
7559441|NCT02977572|18606659|P2|COMPLETED|Overall Study||54
7559442|NCT02977572|18606660|P1|COMPLETED|Overall Study||56
7559443|NCT02977572|18606659|P2|STARTED|Overall Study||56
7559444|NCT02977572|18606660|P1|STARTED|Overall Study||58
7559445|NCT02977507|18606682|P2|NOT COMPLETED|Overall Study||0
7559446|NCT02977507|18606683|P1|NOT COMPLETED|Overall Study||2
7559447|NCT02977507|18606682|P2|COMPLETED|Overall Study||10
7559448|NCT02977507|18606683|P1|COMPLETED|Overall Study||6
7559449|NCT02977507|18606682|P2|STARTED|Overall Study||10
7559450|NCT02977507|18606683|P1|STARTED|Overall Study||8
7559451|NCT02976519|18606713|P7|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||1
7559452|NCT02976519|18606714|P6|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
7559453|NCT02976519|18606715|P5|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
7559454|NCT02976519|18606716|P4|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
7559455|NCT02976519|18606717|P3|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
7559456|NCT02976519|18606718|P2|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
7559457|NCT02976519|18606719|P1|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
7559458|NCT02976519|18606713|P7|COMPLETED|Treatment Period 2 (Part 2 Only)||9
7559459|NCT02976519|18606714|P6|COMPLETED|Treatment Period 2 (Part 2 Only)||12
7559460|NCT02976519|18606715|P5|COMPLETED|Treatment Period 2 (Part 2 Only)||0
7559461|NCT02976519|18606716|P4|COMPLETED|Treatment Period 2 (Part 2 Only)||0
7559462|NCT02976519|18606717|P3|COMPLETED|Treatment Period 2 (Part 2 Only)||0
7559463|NCT02976519|18606718|P2|COMPLETED|Treatment Period 2 (Part 2 Only)||0
7559464|NCT02976519|18606719|P1|COMPLETED|Treatment Period 2 (Part 2 Only)||0
7559465|NCT02976519|18606713|P7|STARTED|Treatment Period 2 (Part 2 Only)||10
7559466|NCT02976519|18606714|P6|STARTED|Treatment Period 2 (Part 2 Only)||12
7559467|NCT02976519|18606715|P5|STARTED|Treatment Period 2 (Part 2 Only)||0
7559468|NCT02976519|18606716|P4|STARTED|Treatment Period 2 (Part 2 Only)||0
7559469|NCT02976519|18606717|P3|STARTED|Treatment Period 2 (Part 2 Only)||0
7559470|NCT02976519|18606718|P2|STARTED|Treatment Period 2 (Part 2 Only)||0
7559471|NCT02976519|18606719|P1|STARTED|Treatment Period 2 (Part 2 Only)||0
7559472|NCT02976519|18606713|P7|NOT COMPLETED|Wash-out Period (Part 2 Only)||2
7559473|NCT02976519|18606714|P6|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
7559474|NCT02976519|18606715|P5|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
7559475|NCT02976519|18606716|P4|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
7559476|NCT02976519|18606717|P3|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
7559477|NCT02976519|18606718|P2|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
7559478|NCT02976519|18606719|P1|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
7559479|NCT02976519|18606713|P7|COMPLETED|Wash-out Period (Part 2 Only)||10
7559480|NCT02976519|18606714|P6|COMPLETED|Wash-out Period (Part 2 Only)||12
7559481|NCT02976519|18606715|P5|COMPLETED|Wash-out Period (Part 2 Only)||0
7559482|NCT02976519|18606716|P4|COMPLETED|Wash-out Period (Part 2 Only)||0
7559483|NCT02976519|18606717|P3|COMPLETED|Wash-out Period (Part 2 Only)||0
7559484|NCT02976519|18606718|P2|COMPLETED|Wash-out Period (Part 2 Only)||0
7559485|NCT02976519|18606719|P1|COMPLETED|Wash-out Period (Part 2 Only)||0
7559486|NCT02976519|18606713|P7|STARTED|Wash-out Period (Part 2 Only)||12
7559487|NCT02976519|18606714|P6|STARTED|Wash-out Period (Part 2 Only)||12
7559488|NCT02976519|18606715|P5|STARTED|Wash-out Period (Part 2 Only)||0
7559489|NCT02976519|18606716|P4|STARTED|Wash-out Period (Part 2 Only)||0
7559490|NCT02976519|18606717|P3|STARTED|Wash-out Period (Part 2 Only)||0
7559491|NCT02976519|18606718|P2|STARTED|Wash-out Period (Part 2 Only)||0
7559492|NCT02976519|18606719|P1|STARTED|Wash-out Period (Part 2 Only)||0
7559493|NCT02976519|18606713|P7|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
7559494|NCT02976519|18606714|P6|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
7559495|NCT02976519|18606715|P5|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
7559496|NCT02976519|18606716|P4|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
7559497|NCT02976519|18606717|P3|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
7559498|NCT02976519|18606718|P2|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
7559499|NCT02976519|18606719|P1|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
7559500|NCT02976519|18606713|P7|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
7559501|NCT02976519|18606714|P6|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
7559502|NCT02976519|18606715|P5|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
7559503|NCT02976519|18606716|P4|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
7559504|NCT02976519|18606717|P3|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
7559505|NCT02976519|18606718|P2|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
7559506|NCT02976519|18606719|P1|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
7559507|NCT02976519|18606713|P7|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
7559508|NCT02976519|18606714|P6|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
7559509|NCT02976519|18606715|P5|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
7559510|NCT02976519|18606716|P4|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
7559511|NCT02976519|18606717|P3|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
7559512|NCT02976519|18606718|P2|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
7559513|NCT02976519|18606719|P1|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
7559514|NCT02976181|18606743|P1|NOT COMPLETED|Overall Study||1
7559515|NCT02976181|18606743|P1|COMPLETED|Overall Study||112
7559516|NCT02976181|18606743|P1|STARTED|Overall Study||113
7559517|NCT02976103|18606750|P2|NOT COMPLETED|Overall Study||8
7559518|NCT02976103|18606751|P1|NOT COMPLETED|Overall Study||13
7559519|NCT02976103|18606750|P2|COMPLETED|Overall Study|64 participants answered final (T3 questionnaire)|64
7559520|NCT02976103|18606751|P1|COMPLETED|Overall Study|54 participants answered final (T3) questionnaire|54
7559521|NCT02976103|18606750|P2|STARTED|Overall Study||72
7559522|NCT02976103|18606751|P1|STARTED|Overall Study||67
7559523|NCT02975973|18606806|P4|NOT COMPLETED|Overall Study||0
7559524|NCT02975973|18606807|P3|NOT COMPLETED|Overall Study||1
7559525|NCT02975973|18606808|P2|NOT COMPLETED|Overall Study||1
7559526|NCT02975973|18606809|P1|NOT COMPLETED|Overall Study||1
7559527|NCT02975973|18606806|P4|COMPLETED|Overall Study||4
7559528|NCT02975973|18606807|P3|COMPLETED|Overall Study||0
7559529|NCT02975973|18606808|P2|COMPLETED|Overall Study||1
7559530|NCT02975973|18606809|P1|COMPLETED|Overall Study||0
7559531|NCT02975973|18606806|P4|STARTED|Overall Study||4
7559532|NCT02975973|18606807|P3|STARTED|Overall Study||1
7559533|NCT02975973|18606808|P2|STARTED|Overall Study||2
7559534|NCT02975973|18606809|P1|STARTED|Overall Study||1
7559535|NCT02975804|18606833|P2|NOT COMPLETED|Overall Study||0
7559536|NCT02975804|18606834|P1|NOT COMPLETED|Overall Study||0
7559537|NCT02975804|18606833|P2|COMPLETED|Overall Study||9
7559538|NCT02975804|18606834|P1|COMPLETED|Overall Study||9
7559539|NCT02975804|18606833|P2|STARTED|Overall Study||9
7559540|NCT02975804|18606834|P1|STARTED|Overall Study||9
7559541|NCT02975700|18606872|P1|NOT COMPLETED|Overall Study||6
7559542|NCT02975700|18606872|P1|COMPLETED|Overall Study||0
7559543|NCT02975700|18606872|P1|STARTED|Overall Study||6
7559544|NCT02975557|18606893|P3|NOT COMPLETED|Overall Study||1
7559545|NCT02975557|18606894|P2|NOT COMPLETED|Overall Study||3
7559546|NCT02975557|18606895|P1|NOT COMPLETED|Overall Study||1
7559547|NCT02975557|18606893|P3|COMPLETED|Overall Study||5
7559548|NCT02975557|18606894|P2|COMPLETED|Overall Study||2
7559549|NCT02975557|18606895|P1|COMPLETED|Overall Study||3
7559550|NCT02975557|18606893|P3|STARTED|Overall Study||6
7559551|NCT02975557|18606894|P2|STARTED|Overall Study||5
7559552|NCT02975557|18606895|P1|STARTED|Overall Study||4
7559553|NCT02975336|18606907|P4|NOT COMPLETED|Overall Study||33
7559554|NCT02975336|18606908|P3|NOT COMPLETED|Overall Study||27
7559555|NCT02975336|18606909|P2|NOT COMPLETED|Overall Study||29
7559556|NCT02975336|18606910|P1|NOT COMPLETED|Overall Study||32
7559557|NCT02975336|18606907|P4|COMPLETED|Overall Study||84
7559558|NCT02975336|18606908|P3|COMPLETED|Overall Study||90
7559559|NCT02975336|18606909|P2|COMPLETED|Overall Study||89
7559560|NCT02975336|18606910|P1|COMPLETED|Overall Study||85
7559561|NCT02975336|18606907|P4|STARTED|Overall Study||117
7559562|NCT02975336|18606908|P3|STARTED|Overall Study||117
7559563|NCT02975336|18606909|P2|STARTED|Overall Study||118
7559564|NCT02975336|18606910|P1|STARTED|Overall Study||117
7559565|NCT02975206|18607143|P3|NOT COMPLETED|Overall Study||17
7559566|NCT02975206|18607144|P2|NOT COMPLETED|Overall Study||17
7559567|NCT02975206|18607145|P1|NOT COMPLETED|Overall Study||27
7559568|NCT02975206|18607143|P3|COMPLETED|Overall Study||145
7559569|NCT02975206|18607144|P2|COMPLETED|Overall Study||144
7559570|NCT02975206|18607145|P1|COMPLETED|Overall Study||134
7559571|NCT02975206|18607143|P3|STARTED|Overall Study||162
7559572|NCT02975206|18607144|P2|STARTED|Overall Study||161
7559573|NCT02975206|18607145|P1|STARTED|Overall Study||161
7559574|NCT02974868|18607162|P4|NOT COMPLETED|Cross-Over Extension (COE) Period||0
7559575|NCT02974868|18607163|P3|NOT COMPLETED|Cross-Over Extension (COE) Period||3
7559576|NCT02974868|18607164|P2|NOT COMPLETED|Cross-Over Extension (COE) Period||1
7559577|NCT02974868|18607165|P1|NOT COMPLETED|Cross-Over Extension (COE) Period||2
7559578|NCT02974868|18607162|P4|COMPLETED|Cross-Over Extension (COE) Period||3
7559579|NCT02974868|18607163|P3|COMPLETED|Cross-Over Extension (COE) Period||8
7559580|NCT02974868|18607164|P2|COMPLETED|Cross-Over Extension (COE) Period||1
7559581|NCT02974868|18607165|P1|COMPLETED|Cross-Over Extension (COE) Period||5
7559582|NCT02974868|18607162|P4|STARTED|Cross-Over Extension (COE) Period||3
7559583|NCT02974868|18607163|P3|STARTED|Cross-Over Extension (COE) Period||11
7559584|NCT02974868|18607164|P2|STARTED|Cross-Over Extension (COE) Period||2
7559585|NCT02974868|18607165|P1|STARTED|Cross-Over Extension (COE) Period||7
7559586|NCT02974868|18607162|P4|NOT COMPLETED|Single-Blind Extension (SBE) Period||6
7559587|NCT02974868|18607163|P3|NOT COMPLETED|Single-Blind Extension (SBE) Period||11
7559588|NCT02974868|18607164|P2|NOT COMPLETED|Single-Blind Extension (SBE) Period||1
7559589|NCT02974868|18607165|P1|NOT COMPLETED|Single-Blind Extension (SBE) Period||2
7559590|NCT02974868|18607162|P4|COMPLETED|Single-Blind Extension (SBE) Period||23
7559591|NCT02974868|18607163|P3|COMPLETED|Single-Blind Extension (SBE) Period||27
7559592|NCT02974868|18607164|P2|COMPLETED|Single-Blind Extension (SBE) Period||11
7559593|NCT02974868|18607165|P1|COMPLETED|Single-Blind Extension (SBE) Period||15
7559594|NCT02974868|18607162|P4|STARTED|Single-Blind Extension (SBE) Period||29
7559595|NCT02974868|18607163|P3|STARTED|Single-Blind Extension (SBE) Period||38
7559596|NCT02974868|18607164|P2|STARTED|Single-Blind Extension (SBE) Period||12
7559597|NCT02974868|18607165|P1|STARTED|Single-Blind Extension (SBE) Period||17
7559598|NCT02974868|18607162|P4|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||12
7559599|NCT02974868|18607163|P3|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||3
7559600|NCT02974868|18607164|P2|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||9
7559601|NCT02974868|18607165|P1|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||4
7559602|NCT02974868|18607162|P4|COMPLETED|Initial 24-Week Treatment Period (TP)||35
7559603|NCT02974868|18607163|P3|COMPLETED|Initial 24-Week Treatment Period (TP)||45
7559604|NCT02974868|18607164|P2|COMPLETED|Initial 24-Week Treatment Period (TP)||14
7559605|NCT02974868|18607165|P1|COMPLETED|Initial 24-Week Treatment Period (TP)||20
7559606|NCT02974868|18607162|P4|STARTED|Initial 24-Week Treatment Period (TP)||47
7559607|NCT02974868|18607163|P3|STARTED|Initial 24-Week Treatment Period (TP)||48
7559608|NCT02974868|18607164|P2|STARTED|Initial 24-Week Treatment Period (TP)||23
7559609|NCT02974868|18607165|P1|STARTED|Initial 24-Week Treatment Period (TP)||24
7559610|NCT02974855|18607287|P4|NOT COMPLETED|Overall Study||1
7559611|NCT02974855|18607288|P3|NOT COMPLETED|Overall Study||0
7559612|NCT02974855|18607289|P2|NOT COMPLETED|Overall Study||1
7559613|NCT02974855|18607290|P1|NOT COMPLETED|Overall Study||0
7559614|NCT02974855|18607287|P4|COMPLETED|Overall Study||6
7559615|NCT02974855|18607288|P3|COMPLETED|Overall Study||6
7559616|NCT02974855|18607289|P2|COMPLETED|Overall Study||5
7559617|NCT02974855|18607290|P1|COMPLETED|Overall Study||7
7559618|NCT02974855|18607287|P4|STARTED|Overall Study||7
7559619|NCT02974855|18607288|P3|STARTED|Overall Study||6
7559620|NCT02974855|18607289|P2|STARTED|Overall Study||6
7559621|NCT02974855|18607290|P1|STARTED|Overall Study||7
7559622|NCT02974842|18607476|P1|NOT COMPLETED|Overall Study||8
7559623|NCT02974842|18607476|P1|COMPLETED|Overall Study||42
7559624|NCT02974842|18607476|P1|STARTED|Overall Study|Participants|50
7559625|NCT02974686|18607482|P2|NOT COMPLETED|Overall Study||0
7559626|NCT02974686|18607483|P1|NOT COMPLETED|Overall Study||0
7559627|NCT02974686|18607482|P2|COMPLETED|Overall Study||0
7559628|NCT02974686|18607483|P1|COMPLETED|Overall Study||0
7559629|NCT02974686|18607482|P2|STARTED|Overall Study||0
7559630|NCT02974686|18607483|P1|STARTED|Overall Study||0
7559631|NCT02974634|18607495|P2|NOT COMPLETED|Overall Study||21
7559632|NCT02974634|18607496|P1|NOT COMPLETED|Overall Study||28
7559633|NCT02974634|18607495|P2|COMPLETED|Overall Study||89
7559634|NCT02974634|18607496|P1|COMPLETED|Overall Study||78
7559635|NCT02974634|18607495|P2|STARTED|Overall Study||110
7559636|NCT02974634|18607496|P1|STARTED|Overall Study||106
7559637|NCT02974543|18607506|P2|NOT COMPLETED|Overall Study||0
7559638|NCT02974543|18607507|P1|NOT COMPLETED|Overall Study||1
7559639|NCT02974543|18607506|P2|COMPLETED|Overall Study||10
7559640|NCT02974543|18607507|P1|COMPLETED|Overall Study||10
7559641|NCT02974543|18607506|P2|Began Crossover Assignment|Overall Study||10
7559642|NCT02974543|18607507|P1|Began Crossover Assignment|Overall Study||10
7559643|NCT02974543|18607506|P2|Began Washout Period|Overall Study||10
7559644|NCT02974543|18607507|P1|Began Washout Period|Overall Study||10
7559645|NCT02974543|18607506|P2|STARTED|Overall Study||10
7559646|NCT02974543|18607507|P1|STARTED|Overall Study||11
7559647|NCT02974296|18607529|P2|NOT COMPLETED|Overall Study||1
7559648|NCT02974296|18607530|P1|NOT COMPLETED|Overall Study||0
7559649|NCT02974296|18607529|P2|COMPLETED|Overall Study||22
7559650|NCT02974296|18607530|P1|COMPLETED|Overall Study||10
7559651|NCT02974296|18607529|P2|STARTED|Overall Study||23
7559652|NCT02974296|18607530|P1|STARTED|Overall Study||10
7559653|NCT02974153|18607541|P3|NOT COMPLETED|Overall Study||50
7559654|NCT02974153|18607542|P2|NOT COMPLETED|Overall Study||48
7559655|NCT02974153|18607543|P1|NOT COMPLETED|Overall Study||52
7559656|NCT02974153|18607541|P3|COMPLETED|Overall Study||325
7559657|NCT02974153|18607542|P2|COMPLETED|Overall Study||324
7559658|NCT02974153|18607543|P1|COMPLETED|Overall Study||322
7559659|NCT02974153|18607541|P3|Participants Treated|Overall Study||366
7559660|NCT02974153|18607542|P2|Participants Treated|Overall Study||356
7559661|NCT02974153|18607543|P1|Participants Treated|Overall Study||350
7559662|NCT02974153|18607541|P3|STARTED|Overall Study||375
7559663|NCT02974153|18607542|P2|STARTED|Overall Study||372
7559664|NCT02974153|18607543|P1|STARTED|Overall Study||374
7559665|NCT02974140|18607629|P1|NOT COMPLETED|Overall Study||39
7559666|NCT02974140|18607629|P1|COMPLETED|Overall Study||0
7559667|NCT02974140|18607629|P1|Manual (Fellow Eye)|Overall Study||38
7559668|NCT02974140|18607629|P1|CRS (Left or Right Eye)|Overall Study||38
7559669|NCT02974140|18607629|P1|STARTED|Overall Study||39
7559670|NCT02974114|18607645|P3|NOT COMPLETED|Overall Study||2
7559671|NCT02974114|18607646|P2|NOT COMPLETED|Overall Study||1
7559672|NCT02974114|18607647|P1|NOT COMPLETED|Overall Study||0
7559673|NCT02974114|18607645|P3|COMPLETED|Overall Study||6
7559674|NCT02974114|18607646|P2|COMPLETED|Overall Study||6
7559675|NCT02974114|18607647|P1|COMPLETED|Overall Study||6
7559676|NCT02974114|18607645|P3|STARTED|Overall Study||8
7559677|NCT02974114|18607646|P2|STARTED|Overall Study||7
7559678|NCT02974114|18607647|P1|STARTED|Overall Study||6
7559679|NCT02974088|18607690|P2|NOT COMPLETED|Overall Study||3
7559680|NCT02974088|18607691|P1|NOT COMPLETED|Overall Study||0
7559681|NCT02974088|18607690|P2|COMPLETED|Overall Study|Nurse left without notice and took CRFs and data for 2 subjects.|21
7559682|NCT02974088|18607691|P1|COMPLETED|Overall Study||23
7559683|NCT02974088|18607690|P2|STARTED|Overall Study||24
7559684|NCT02974088|18607691|P1|STARTED|Overall Study||23
7559685|NCT02973802|18607697|P1|NOT COMPLETED|Overall Study||2
7559686|NCT02973802|18607697|P1|COMPLETED|Overall Study||10
7559687|NCT02973802|18607697|P1|STARTED|Overall Study||12
7559688|NCT02973503|18607711|P1|NOT COMPLETED|Overall Study||0
7559689|NCT02973503|18607711|P1|COMPLETED|Overall Study||117
7559690|NCT02973503|18607711|P1|STARTED|Overall Study||117
7559691|NCT02973477|18607724|P2|NOT COMPLETED|Second Intervention||0
7559692|NCT02973477|18607725|P1|NOT COMPLETED|Second Intervention||1
7559693|NCT02973477|18607724|P2|COMPLETED|Second Intervention||24
7559694|NCT02973477|18607725|P1|COMPLETED|Second Intervention||17
7559695|NCT02973477|18607724|P2|STARTED|Second Intervention||24
7559696|NCT02973477|18607725|P1|STARTED|Second Intervention||18
7559697|NCT02973477|18607724|P2|NOT COMPLETED|Washout||0
7559698|NCT02973477|18607725|P1|NOT COMPLETED|Washout||1
7559699|NCT02973477|18607724|P2|COMPLETED|Washout||24
7559700|NCT02973477|18607725|P1|COMPLETED|Washout||18
7559701|NCT02973477|18607724|P2|STARTED|Washout||24
7559702|NCT02973477|18607725|P1|STARTED|Washout||19
7559703|NCT02973477|18607724|P2|NOT COMPLETED|First Intervention||2
7559704|NCT02973477|18607725|P1|NOT COMPLETED|First Intervention||0
7559705|NCT02973477|18607724|P2|COMPLETED|First Intervention||24
7559706|NCT02973477|18607725|P1|COMPLETED|First Intervention||19
7559707|NCT02973477|18607724|P2|STARTED|First Intervention||26
7559708|NCT02973477|18607725|P1|STARTED|First Intervention||19
7559709|NCT02973438|18607742|P4|NOT COMPLETED|Second Treatment Session (4 Days)||0
7559710|NCT02973438|18607743|P3|NOT COMPLETED|Second Treatment Session (4 Days)||0
7559711|NCT02973438|18607744|P2|NOT COMPLETED|Second Treatment Session (4 Days)||0
7559712|NCT02973438|18607745|P1|NOT COMPLETED|Second Treatment Session (4 Days)||0
7559713|NCT02973438|18607742|P4|COMPLETED|Second Treatment Session (4 Days)||1
7559714|NCT02973438|18607743|P3|COMPLETED|Second Treatment Session (4 Days)||2
7559715|NCT02973438|18607744|P2|COMPLETED|Second Treatment Session (4 Days)||1
7559716|NCT02973438|18607745|P1|COMPLETED|Second Treatment Session (4 Days)||2
7559717|NCT02973438|18607742|P4|STARTED|Second Treatment Session (4 Days)||1
7559718|NCT02973438|18607743|P3|STARTED|Second Treatment Session (4 Days)||2
7559719|NCT02973438|18607744|P2|STARTED|Second Treatment Session (4 Days)||1
7559720|NCT02973438|18607745|P1|STARTED|Second Treatment Session (4 Days)||2
7559721|NCT02973438|18607742|P4|NOT COMPLETED|Washout (Three Weeks)||0
7559722|NCT02973438|18607743|P3|NOT COMPLETED|Washout (Three Weeks)||0
7559723|NCT02973438|18607744|P2|NOT COMPLETED|Washout (Three Weeks)||0
7559724|NCT02973438|18607745|P1|NOT COMPLETED|Washout (Three Weeks)||0
7559725|NCT02973438|18607742|P4|COMPLETED|Washout (Three Weeks)||1
7559726|NCT02973438|18607743|P3|COMPLETED|Washout (Three Weeks)||2
7559727|NCT02973438|18607744|P2|COMPLETED|Washout (Three Weeks)||1
7559728|NCT02973438|18607745|P1|COMPLETED|Washout (Three Weeks)||2
7559729|NCT02973438|18607742|P4|STARTED|Washout (Three Weeks)||1
7559730|NCT02973438|18607743|P3|STARTED|Washout (Three Weeks)||2
7559731|NCT02973438|18607744|P2|STARTED|Washout (Three Weeks)||1
7559732|NCT02973438|18607745|P1|STARTED|Washout (Three Weeks)||2
7559733|NCT02973438|18607742|P4|NOT COMPLETED|First Treatment Session (4 Days)||0
7559734|NCT02973438|18607743|P3|NOT COMPLETED|First Treatment Session (4 Days)||0
7559735|NCT02973438|18607744|P2|NOT COMPLETED|First Treatment Session (4 Days)||0
7559736|NCT02973438|18607745|P1|NOT COMPLETED|First Treatment Session (4 Days)||0
7559737|NCT02973438|18607742|P4|COMPLETED|First Treatment Session (4 Days)||1
7559738|NCT02973438|18607743|P3|COMPLETED|First Treatment Session (4 Days)||2
7559739|NCT02973438|18607744|P2|COMPLETED|First Treatment Session (4 Days)||1
7559740|NCT02973438|18607745|P1|COMPLETED|First Treatment Session (4 Days)||2
7559741|NCT02973438|18607742|P4|STARTED|First Treatment Session (4 Days)||1
7559742|NCT02973438|18607743|P3|STARTED|First Treatment Session (4 Days)||2
7559743|NCT02973438|18607744|P2|STARTED|First Treatment Session (4 Days)||1
7559744|NCT02973438|18607745|P1|STARTED|First Treatment Session (4 Days)||2
7559745|NCT02973100|18607763|P4|NOT COMPLETED|Overall Study||7
7559746|NCT02973100|18607764|P3|NOT COMPLETED|Overall Study||4
7559747|NCT02973100|18607765|P2|NOT COMPLETED|Overall Study||8
7559748|NCT02973100|18607766|P1|NOT COMPLETED|Overall Study||7
7559749|NCT02973100|18607763|P4|COMPLETED|Overall Study||69
7559750|NCT02973100|18607764|P3|COMPLETED|Overall Study||75
7559751|NCT02973100|18607765|P2|COMPLETED|Overall Study||73
7559752|NCT02973100|18607766|P1|COMPLETED|Overall Study||75
7559753|NCT02973100|18607763|P4|Received at Least 1 Dose of Study Drug|Overall Study||76
7559754|NCT02973100|18607764|P3|Received at Least 1 Dose of Study Drug|Overall Study||79
7559755|NCT02973100|18607765|P2|Received at Least 1 Dose of Study Drug|Overall Study||81
7559756|NCT02973100|18607766|P1|Received at Least 1 Dose of Study Drug|Overall Study||81
7559757|NCT02973100|18607763|P4|STARTED|Overall Study||76
7559758|NCT02973100|18607764|P3|STARTED|Overall Study||79
7559759|NCT02973100|18607765|P2|STARTED|Overall Study||81
7559760|NCT02973100|18607766|P1|STARTED|Overall Study||82
7559761|NCT02973048|18607804|P2|NOT COMPLETED|Overall Study||3
7559762|NCT02973048|18607805|P1|NOT COMPLETED|Overall Study||1
7559763|NCT02973048|18607804|P2|COMPLETED|Overall Study||17
7559764|NCT02973048|18607805|P1|COMPLETED|Overall Study||19
7559765|NCT02973048|18607804|P2|STARTED|Overall Study||20
7559766|NCT02973048|18607805|P1|STARTED|Overall Study||20
7559767|NCT02972658|18607857|P4|NOT COMPLETED|Overall Study||131
7559768|NCT02972658|18607858|P3|NOT COMPLETED|Overall Study||75
7559769|NCT02972658|18607859|P2|NOT COMPLETED|Overall Study||138
7559770|NCT02972658|18607860|P1|NOT COMPLETED|Overall Study||76
7559771|NCT02972658|18607857|P4|COMPLETED|Overall Study||0
7559772|NCT02972658|18607858|P3|COMPLETED|Overall Study||0
7559773|NCT02972658|18607859|P2|COMPLETED|Overall Study|"1 participant was incorrectly marked as Completed rather than study terminated by Sponsor."|1
7559774|NCT02972658|18607860|P1|COMPLETED|Overall Study||0
7559775|NCT02972658|18607857|P4|Received at Least 1 Dose of Study Drug|Overall Study||131
7559776|NCT02972658|18607858|P3|Received at Least 1 Dose of Study Drug|Overall Study||74
7559777|NCT02972658|18607859|P2|Received at Least 1 Dose of Study Drug|Overall Study||139
7559778|NCT02972658|18607860|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
7559779|NCT02972658|18607857|P4|STARTED|Overall Study||131
7559780|NCT02972658|18607858|P3|STARTED|Overall Study||75
7559781|NCT02972658|18607859|P2|STARTED|Overall Study||139
7559782|NCT02972658|18607860|P1|STARTED|Overall Study||76
7559783|NCT02972632|18607890|P1|NOT COMPLETED|Overall Study||17
7559784|NCT02972632|18607890|P1|COMPLETED|Overall Study||106
7559785|NCT02972632|18607890|P1|Safety Analysis Set|Overall Study||122
7559786|NCT02972632|18607890|P1|STARTED|Overall Study||123
7559787|NCT02972554|18607903|P2|NOT COMPLETED|Overall Study||0
7559788|NCT02972554|18607904|P1|NOT COMPLETED|Overall Study||0
7559789|NCT02972554|18607903|P2|COMPLETED|Overall Study||48
7559790|NCT02972554|18607904|P1|COMPLETED|Overall Study||44
7559791|NCT02972554|18607903|P2|STARTED|Overall Study||48
7559792|NCT02972554|18607904|P1|STARTED|Overall Study||44
7559793|NCT02972515|18607920|P1|NOT COMPLETED|Overall Study||78
7559794|NCT02972515|18607920|P1|COMPLETED|Overall Study||88
7559795|NCT02972515|18607920|P1|STARTED|Overall Study||166
7559796|NCT02972502|18607929|P2|NOT COMPLETED|Overall Study||2
7559797|NCT02972502|18607930|P1|NOT COMPLETED|Overall Study||4
7559798|NCT02972502|18607929|P2|COMPLETED|Overall Study||29
7559799|NCT02972502|18607930|P1|COMPLETED|Overall Study||31
7559800|NCT02972502|18607929|P2|STARTED|Overall Study||31
7559801|NCT02972502|18607930|P1|STARTED|Overall Study||35
7559802|NCT02972359|18607940|P1|NOT COMPLETED|Overall Study||71
7559803|NCT02972359|18607940|P1|COMPLETED|Overall Study||247
7559804|NCT02972359|18607940|P1|STARTED|Overall Study||318
7559805|NCT02972242|18607953|P2|NOT COMPLETED|Overall Study||0
7559806|NCT02972242|18607954|P1|NOT COMPLETED|Overall Study||1
7559807|NCT02972242|18607953|P2|COMPLETED|Overall Study||93
7559808|NCT02972242|18607954|P1|COMPLETED|Overall Study||81
7559809|NCT02972242|18607953|P2|STARTED|Overall Study||93
7559810|NCT02972242|18607954|P1|STARTED|Overall Study||82
7559811|NCT02971839|18607981|P5|NOT COMPLETED|Overall Study||0
7559812|NCT02971839|18607982|P4|NOT COMPLETED|Overall Study||0
7559813|NCT02971839|18607983|P3|NOT COMPLETED|Overall Study||0
7559814|NCT02971839|18607984|P2|NOT COMPLETED|Overall Study||0
7559815|NCT02971839|18607985|P1|NOT COMPLETED|Overall Study||0
7559816|NCT02971839|18607981|P5|COMPLETED|Overall Study||3
7559817|NCT02971839|18607982|P4|COMPLETED|Overall Study||2
7559818|NCT02971839|18607983|P3|COMPLETED|Overall Study||2
7559819|NCT02971839|18607984|P2|COMPLETED|Overall Study||2
7559820|NCT02971839|18607985|P1|COMPLETED|Overall Study||2
7559821|NCT02971839|18607981|P5|STARTED|Overall Study||3
7559822|NCT02971839|18607982|P4|STARTED|Overall Study||2
7559823|NCT02971839|18607983|P3|STARTED|Overall Study||2
7559824|NCT02971839|18607984|P2|STARTED|Overall Study||2
7559825|NCT02971839|18607985|P1|STARTED|Overall Study||2
7559826|NCT02971670|18608011|P4|NOT COMPLETED|Overall Study||2
7559827|NCT02971670|18608012|P3|NOT COMPLETED|Overall Study||1
7559828|NCT02971670|18608013|P2|NOT COMPLETED|Overall Study||1
7559829|NCT02971670|18608014|P1|NOT COMPLETED|Overall Study||4
7559830|NCT02971670|18608011|P4|COMPLETED|Overall Study||1
7559831|NCT02971670|18608012|P3|COMPLETED|Overall Study||4
7559832|NCT02971670|18608013|P2|COMPLETED|Overall Study||1
7559833|NCT02971670|18608014|P1|COMPLETED|Overall Study||9
7559834|NCT02971670|18608011|P4|STARTED|Overall Study||3
7559835|NCT02971670|18608012|P3|STARTED|Overall Study||5
7559836|NCT02971670|18608013|P2|STARTED|Overall Study||2
7559837|NCT02971670|18608014|P1|STARTED|Overall Study||13
7559838|NCT02971631|18608032|P2|NOT COMPLETED|Second Intervention - One Day||0
7559839|NCT02971631|18608033|P1|NOT COMPLETED|Second Intervention - One Day||0
7559840|NCT02971631|18608032|P2|COMPLETED|Second Intervention - One Day||2
7559841|NCT02971631|18608033|P1|COMPLETED|Second Intervention - One Day||3
7559842|NCT02971631|18608032|P2|STARTED|Second Intervention - One Day||2
7559843|NCT02971631|18608033|P1|STARTED|Second Intervention - One Day||3
7559844|NCT02971631|18608032|P2|NOT COMPLETED|First Intervention - One Day||0
7559845|NCT02971631|18608033|P1|NOT COMPLETED|First Intervention - One Day||0
7559846|NCT02971631|18608032|P2|COMPLETED|First Intervention - One Day||2
7559847|NCT02971631|18608033|P1|COMPLETED|First Intervention - One Day||3
7559848|NCT02971631|18608032|P2|STARTED|First Intervention - One Day||2
7559849|NCT02971631|18608033|P1|STARTED|First Intervention - One Day||3
7559850|NCT02971605|18608053|P1|NOT COMPLETED|Overall Study||1
7559851|NCT02971605|18608053|P1|COMPLETED|Overall Study||12
7559852|NCT02971605|18608053|P1|STARTED|Overall Study||13
7559853|NCT02971488|18608068|P1|NOT COMPLETED|Overall Study||0
7559854|NCT02971488|18608068|P1|COMPLETED|Overall Study||529
7559855|NCT02971488|18608068|P1|STARTED|Overall Study||529
7559856|NCT02971293|18608078|P1|NOT COMPLETED|Overall Study||11
7559857|NCT02971293|18608078|P1|COMPLETED|Overall Study||31
7559858|NCT02971293|18608078|P1|STARTED|Overall Study||42
7559859|NCT02971202|18608167|P3|NOT COMPLETED|Overall Study||1
7559860|NCT02971202|18608168|P2|NOT COMPLETED|Overall Study||0
7559861|NCT02971202|18608169|P1|NOT COMPLETED|Overall Study||2
7559862|NCT02971202|18608167|P3|COMPLETED|Overall Study||10
7559863|NCT02971202|18608168|P2|COMPLETED|Overall Study||10
7559864|NCT02971202|18608169|P1|COMPLETED|Overall Study||10
7559865|NCT02971202|18608167|P3|Started Study|Overall Study||10
7559866|NCT02971202|18608168|P2|Started Study|Overall Study||10
7559867|NCT02971202|18608169|P1|Started Study|Overall Study||11
7559868|NCT02971202|18608167|P3|STARTED|Overall Study||11
7559869|NCT02971202|18608168|P2|STARTED|Overall Study||10
7559870|NCT02971202|18608169|P1|STARTED|Overall Study||12
7559871|NCT02971163|18608185|P2|NOT COMPLETED|Overall Study||2
7559872|NCT02971163|18608186|P1|NOT COMPLETED|Overall Study||4
7559873|NCT02971163|18608185|P2|COMPLETED|Overall Study||24
7559874|NCT02971163|18608186|P1|COMPLETED|Overall Study||20
7559875|NCT02971163|18608185|P2|STARTED|Overall Study||26
7559876|NCT02971163|18608186|P1|STARTED|Overall Study||24
7559877|NCT02971007|18608209|P3|NOT COMPLETED|Overall Study||1
7559878|NCT02971007|18608210|P2|NOT COMPLETED|Overall Study||3
7559879|NCT02971007|18608211|P1|NOT COMPLETED|Overall Study||2
7559880|NCT02971007|18608209|P3|COMPLETED|Overall Study||45
7559881|NCT02971007|18608210|P2|COMPLETED|Overall Study||42
7559882|NCT02971007|18608211|P1|COMPLETED|Overall Study||44
7559883|NCT02971007|18608209|P3|STARTED|Overall Study||46
7559884|NCT02971007|18608210|P2|STARTED|Overall Study||45
7559885|NCT02971007|18608211|P1|STARTED|Overall Study||46
7559886|NCT02970981|18608228|P1|NOT COMPLETED|Overall Study||0
7559887|NCT02970981|18608228|P1|COMPLETED|Overall Study||16
7559888|NCT02970981|18608228|P1|STARTED|Overall Study||16
7559889|NCT02970812|18608234|P2|NOT COMPLETED|Overall Study||2
7559890|NCT02970812|18608235|P1|NOT COMPLETED|Overall Study||8
7559891|NCT02970812|18608234|P2|COMPLETED|Overall Study||28
7559892|NCT02970812|18608235|P1|COMPLETED|Overall Study||22
7559893|NCT02970812|18608234|P2|STARTED|Overall Study||30
7559894|NCT02970812|18608235|P1|STARTED|Overall Study||30
7559895|NCT02970669|18608243|P2|NOT COMPLETED|Open-label Period||2
7559896|NCT02970669|18608244|P1|NOT COMPLETED|Open-label Period||4
7559897|NCT02970669|18608243|P2|COMPLETED|Open-label Period||62
7559898|NCT02970669|18608244|P1|COMPLETED|Open-label Period||58
7559899|NCT02970669|18608243|P2|STARTED|Open-label Period||64
7559900|NCT02970669|18608244|P1|STARTED|Open-label Period||62
7559901|NCT02970669|18608243|P2|NOT COMPLETED|Double-blind Period||6
7559902|NCT02970669|18608244|P1|NOT COMPLETED|Double-blind Period||8
7559903|NCT02970669|18608243|P2|COMPLETED|Double-blind Period||64
7559904|NCT02970669|18608244|P1|COMPLETED|Double-blind Period||62
7559905|NCT02970669|18608243|P2|STARTED|Double-blind Period||70
7559906|NCT02970669|18608244|P1|STARTED|Double-blind Period||70
7559907|NCT02970552|18608264|P2|NOT COMPLETED|Overall Study||3
7559908|NCT02970552|18608265|P1|NOT COMPLETED|Overall Study||3
7559909|NCT02970552|18608264|P2|COMPLETED|Overall Study||67
7559910|NCT02970552|18608265|P1|COMPLETED|Overall Study||67
7559911|NCT02970552|18608264|P2|STARTED|Overall Study||70
7559912|NCT02970552|18608265|P1|STARTED|Overall Study||70
7559913|NCT02970422|18608293|P1|NOT COMPLETED|Overall Study||0
7559914|NCT02970422|18608293|P1|COMPLETED|Overall Study||200
7559915|NCT02970422|18608293|P1|STARTED|Overall Study||200
7559916|NCT02970305|18608398|P2|NOT COMPLETED|Overall Study||28
7559917|NCT02970305|18608399|P1|NOT COMPLETED|Overall Study||29
7559918|NCT02970305|18608398|P2|COMPLETED|Overall Study||174
7559919|NCT02970305|18608399|P1|COMPLETED|Overall Study||172
7559920|NCT02970305|18608398|P2|STARTED|Overall Study||202
7559921|NCT02970305|18608399|P1|STARTED|Overall Study||201
7559922|NCT02970292|18608431|P2|NOT COMPLETED|Overall Study||8
7559923|NCT02970292|18608432|P1|NOT COMPLETED|Overall Study||24
7559924|NCT02970292|18608431|P2|COMPLETED|Overall Study||190
7559925|NCT02970292|18608432|P1|COMPLETED|Overall Study||174
7559926|NCT02970292|18608431|P2|STARTED|Overall Study||198
7559927|NCT02970292|18608432|P1|STARTED|Overall Study||198
7559928|NCT02970162|18608456|P2|NOT COMPLETED|Overall Study||0
7559929|NCT02970162|18608457|P1|NOT COMPLETED|Overall Study||0
7559930|NCT02970162|18608456|P2|COMPLETED|Overall Study||13
7559931|NCT02970162|18608457|P1|COMPLETED|Overall Study||13
7559932|NCT02970162|18608456|P2|STARTED|Overall Study||13
7559933|NCT02970162|18608457|P1|STARTED|Overall Study||13
7559934|NCT02970032|18608469|P1|NOT COMPLETED|Real Time Heparin Dose Adjustment||0
7559935|NCT02970032|18608469|P1|COMPLETED|Real Time Heparin Dose Adjustment||20
7559936|NCT02970032|18608469|P1|STARTED|Real Time Heparin Dose Adjustment||20
7559937|NCT02970032|18608469|P1|NOT COMPLETED|Standard Heparin Dose||0
7559938|NCT02970032|18608469|P1|COMPLETED|Standard Heparin Dose||20
7559939|NCT02970032|18608469|P1|STARTED|Standard Heparin Dose||20
7559940|NCT02969928|18608477|P2|NOT COMPLETED|Overall Study||0
7559941|NCT02969928|18608478|P1|NOT COMPLETED|Overall Study||0
7559942|NCT02969928|18608477|P2|COMPLETED|Overall Study||23
7559943|NCT02969928|18608478|P1|COMPLETED|Overall Study||23
7559944|NCT02969928|18608477|P2|STARTED|Overall Study||23
7559945|NCT02969928|18608478|P1|STARTED|Overall Study||23
7559946|NCT02969876|18608492|P1|NOT COMPLETED|Overall Study||0
7559947|NCT02969876|18608492|P1|COMPLETED|Overall Study||2
7559948|NCT02969876|18608492|P1|STARTED|Overall Study||2
7559949|NCT02969863|18608498|P6|NOT COMPLETED|Overall Study||0
7559950|NCT02969863|18608499|P5|NOT COMPLETED|Overall Study||0
7559951|NCT02969863|18608500|P4|NOT COMPLETED|Overall Study||0
7559952|NCT02969863|18608501|P3|NOT COMPLETED|Overall Study||0
7559953|NCT02969863|18608502|P2|NOT COMPLETED|Overall Study||0
7559954|NCT02969863|18608503|P1|NOT COMPLETED|Overall Study||1
7559955|NCT02969863|18608498|P6|COMPLETED|Overall Study||4
7559956|NCT02969863|18608499|P5|COMPLETED|Overall Study||4
7559957|NCT02969863|18608500|P4|COMPLETED|Overall Study||4
7559958|NCT02969863|18608501|P3|COMPLETED|Overall Study||4
7559959|NCT02969863|18608502|P2|COMPLETED|Overall Study||4
7559960|NCT02969863|18608503|P1|COMPLETED|Overall Study||3
7559961|NCT02969863|18608498|P6|STARTED|Overall Study||4
7559962|NCT02969863|18608499|P5|STARTED|Overall Study||4
7559963|NCT02969863|18608500|P4|STARTED|Overall Study||4
7559964|NCT02969863|18608501|P3|STARTED|Overall Study||4
7559965|NCT02969863|18608502|P2|STARTED|Overall Study||4
7559966|NCT02969863|18608503|P1|STARTED|Overall Study||4
7559967|NCT02969655|18608519|P2|NOT COMPLETED|Overall Study||15
7559968|NCT02969655|18608520|P1|NOT COMPLETED|Overall Study||21
7559969|NCT02969655|18608519|P2|COMPLETED|Overall Study||120
7559970|NCT02969655|18608520|P1|COMPLETED|Overall Study||115
7559971|NCT02969655|18608519|P2|STARTED|Overall Study||135
7559972|NCT02969655|18608520|P1|STARTED|Overall Study||136
7559973|NCT02969590|18608555|P3|NOT COMPLETED|Treatment Period 2||0
7559974|NCT02969590|18608556|P2|NOT COMPLETED|Treatment Period 2||0
7559975|NCT02969590|18608557|P1|NOT COMPLETED|Treatment Period 2||0
7559976|NCT02969590|18608555|P3|COMPLETED|Treatment Period 2||2
7559977|NCT02969590|18608556|P2|COMPLETED|Treatment Period 2||2
7559978|NCT02969590|18608557|P1|COMPLETED|Treatment Period 2||0
7559979|NCT02969590|18608555|P3|STARTED|Treatment Period 2||2
7559980|NCT02969590|18608556|P2|STARTED|Treatment Period 2||2
7559981|NCT02969590|18608557|P1|STARTED|Treatment Period 2||0
7559982|NCT02969590|18608555|P3|NOT COMPLETED|Treatment Period 1||0
7559983|NCT02969590|18608556|P2|NOT COMPLETED|Treatment Period 1||0
7559984|NCT02969590|18608557|P1|NOT COMPLETED|Treatment Period 1||0
7559985|NCT02969590|18608555|P3|COMPLETED|Treatment Period 1||2
7559986|NCT02969590|18608556|P2|COMPLETED|Treatment Period 1||2
7559987|NCT02969590|18608557|P1|COMPLETED|Treatment Period 1||0
7559988|NCT02969590|18608555|P3|STARTED|Treatment Period 1||2
7559989|NCT02969590|18608556|P2|STARTED|Treatment Period 1||2
7559990|NCT02969590|18608557|P1|STARTED|Treatment Period 1||0
7559991|NCT02969590|18608555|P3|NOT COMPLETED|Screening Period||0
7559992|NCT02969590|18608556|P2|NOT COMPLETED|Screening Period||0
7559993|NCT02969590|18608557|P1|NOT COMPLETED|Screening Period||1
7559994|NCT02969590|18608555|P3|COMPLETED|Screening Period||0
7559995|NCT02969590|18608556|P2|COMPLETED|Screening Period||0
7559996|NCT02969590|18608557|P1|COMPLETED|Screening Period||4
7559997|NCT02969590|18608555|P3|STARTED|Screening Period||0
7559998|NCT02969590|18608556|P2|STARTED|Screening Period||0
7559999|NCT02969590|18608557|P1|STARTED|Screening Period||5
7560000|NCT02969525|18608580|P12|NOT COMPLETED|Dose-Blind Period||2
7560001|NCT02969525|18608581|P11|NOT COMPLETED|Dose-Blind Period||2
7560002|NCT02969525|18608582|P10|NOT COMPLETED|Dose-Blind Period||3
7560003|NCT02969525|18608583|P9|NOT COMPLETED|Dose-Blind Period||1
7560004|NCT02969525|18608584|P8|NOT COMPLETED|Dose-Blind Period||0
7560005|NCT02969525|18608585|P7|NOT COMPLETED|Dose-Blind Period||2
7560006|NCT02969525|18608586|P6|NOT COMPLETED|Dose-Blind Period||0
7560007|NCT02969525|18608587|P5|NOT COMPLETED|Dose-Blind Period||0
7560008|NCT02969525|18608588|P4|NOT COMPLETED|Dose-Blind Period||0
7560009|NCT02969525|18608589|P3|NOT COMPLETED|Dose-Blind Period||0
7560010|NCT02969525|18608590|P2|NOT COMPLETED|Dose-Blind Period||0
7560011|NCT02969525|18608591|P1|NOT COMPLETED|Dose-Blind Period||0
7560012|NCT02969525|18608580|P12|COMPLETED|Dose-Blind Period||39
7560013|NCT02969525|18608581|P11|COMPLETED|Dose-Blind Period||38
7560014|NCT02969525|18608582|P10|COMPLETED|Dose-Blind Period||34
7560015|NCT02969525|18608583|P9|COMPLETED|Dose-Blind Period||18
7560016|NCT02969525|18608584|P8|COMPLETED|Dose-Blind Period||22
7560017|NCT02969525|18608585|P7|COMPLETED|Dose-Blind Period||18
7560018|NCT02969525|18608586|P6|COMPLETED|Dose-Blind Period||20
7560019|NCT02969525|18608587|P5|COMPLETED|Dose-Blind Period||0
7560020|NCT02969525|18608588|P4|COMPLETED|Dose-Blind Period||0
7560021|NCT02969525|18608589|P3|COMPLETED|Dose-Blind Period||0
7560022|NCT02969525|18608590|P2|COMPLETED|Dose-Blind Period||0
7560023|NCT02969525|18608591|P1|COMPLETED|Dose-Blind Period||0
7560024|NCT02969525|18608580|P12|STARTED|Dose-Blind Period||41
7560025|NCT02969525|18608581|P11|STARTED|Dose-Blind Period||40
7560026|NCT02969525|18608582|P10|STARTED|Dose-Blind Period||37
7560027|NCT02969525|18608583|P9|STARTED|Dose-Blind Period||19
7560028|NCT02969525|18608584|P8|STARTED|Dose-Blind Period||22
7560029|NCT02969525|18608585|P7|STARTED|Dose-Blind Period||20
7560030|NCT02969525|18608586|P6|STARTED|Dose-Blind Period||20
7560031|NCT02969525|18608587|P5|STARTED|Dose-Blind Period||0
7560032|NCT02969525|18608588|P4|STARTED|Dose-Blind Period||0
7560033|NCT02969525|18608589|P3|STARTED|Dose-Blind Period||0
7560034|NCT02969525|18608590|P2|STARTED|Dose-Blind Period||0
7560035|NCT02969525|18608591|P1|STARTED|Dose-Blind Period||0
7560036|NCT02969525|18608580|P12|NOT COMPLETED|Double-Blind Period||0
7560037|NCT02969525|18608581|P11|NOT COMPLETED|Double-Blind Period||0
7560038|NCT02969525|18608582|P10|NOT COMPLETED|Double-Blind Period||0
7560039|NCT02969525|18608583|P9|NOT COMPLETED|Double-Blind Period||0
7560040|NCT02969525|18608584|P8|NOT COMPLETED|Double-Blind Period||0
7560041|NCT02969525|18608585|P7|NOT COMPLETED|Double-Blind Period||0
7560042|NCT02969525|18608586|P6|NOT COMPLETED|Double-Blind Period||0
7560043|NCT02969525|18608587|P5|NOT COMPLETED|Double-Blind Period||0
7560044|NCT02969525|18608588|P4|NOT COMPLETED|Double-Blind Period||4
7560045|NCT02969525|18608589|P3|NOT COMPLETED|Double-Blind Period||1
7560046|NCT02969525|18608590|P2|NOT COMPLETED|Double-Blind Period||0
7560047|NCT02969525|18608591|P1|NOT COMPLETED|Double-Blind Period||2
7560048|NCT02969525|18608580|P12|COMPLETED|Double-Blind Period||0
7560049|NCT02969525|18608581|P11|COMPLETED|Double-Blind Period||0
7560050|NCT02969525|18608582|P10|COMPLETED|Double-Blind Period||0
7560051|NCT02969525|18608583|P9|COMPLETED|Double-Blind Period||0
7560052|NCT02969525|18608584|P8|COMPLETED|Double-Blind Period||0
7560053|NCT02969525|18608585|P7|COMPLETED|Double-Blind Period||0
7560054|NCT02969525|18608586|P6|COMPLETED|Double-Blind Period||0
7560055|NCT02969525|18608587|P5|COMPLETED|Double-Blind Period||41
7560056|NCT02969525|18608588|P4|COMPLETED|Double-Blind Period||37
7560057|NCT02969525|18608589|P3|COMPLETED|Double-Blind Period||40
7560058|NCT02969525|18608590|P2|COMPLETED|Double-Blind Period||41
7560059|NCT02969525|18608591|P1|COMPLETED|Double-Blind Period||40
7560060|NCT02969525|18608580|P12|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
7560061|NCT02969525|18608581|P11|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
7560062|NCT02969525|18608582|P10|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
7560063|NCT02969525|18608583|P9|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
7560064|NCT02969525|18608584|P8|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
7560065|NCT02969525|18608585|P7|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
7560066|NCT02969525|18608586|P6|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
7560067|NCT02969525|18608587|P5|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41
7560068|NCT02969525|18608588|P4|Completed Wk12 and Started Dose-Blind|Double-Blind Period||37
7560069|NCT02969525|18608589|P3|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40
7560070|NCT02969525|18608590|P2|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41
7560071|NCT02969525|18608591|P1|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40
7560072|NCT02969525|18608580|P12|Completed Double-Blind Period|Double-Blind Period||0
7560073|NCT02969525|18608581|P11|Completed Double-Blind Period|Double-Blind Period||0
7560074|NCT02969525|18608582|P10|Completed Double-Blind Period|Double-Blind Period||0
7560075|NCT02969525|18608583|P9|Completed Double-Blind Period|Double-Blind Period||0
7560076|NCT02969525|18608584|P8|Completed Double-Blind Period|Double-Blind Period||0
7560077|NCT02969525|18608585|P7|Completed Double-Blind Period|Double-Blind Period||0
7560078|NCT02969525|18608586|P6|Completed Double-Blind Period|Double-Blind Period||0
7560079|NCT02969525|18608587|P5|Completed Double-Blind Period|Double-Blind Period||41
7560080|NCT02969525|18608588|P4|Completed Double-Blind Period|Double-Blind Period||39
7560081|NCT02969525|18608589|P3|Completed Double-Blind Period|Double-Blind Period||40
7560082|NCT02969525|18608590|P2|Completed Double-Blind Period|Double-Blind Period||41
7560083|NCT02969525|18608591|P1|Completed Double-Blind Period|Double-Blind Period||42
7560084|NCT02969525|18608580|P12|STARTED|Double-Blind Period||0
7560085|NCT02969525|18608581|P11|STARTED|Double-Blind Period||0
7560086|NCT02969525|18608582|P10|STARTED|Double-Blind Period||0
7560087|NCT02969525|18608583|P9|STARTED|Double-Blind Period||0
7560088|NCT02969525|18608584|P8|STARTED|Double-Blind Period||0
7560089|NCT02969525|18608585|P7|STARTED|Double-Blind Period||0
7560090|NCT02969525|18608586|P6|STARTED|Double-Blind Period||0
7560091|NCT02969525|18608587|P5|STARTED|Double-Blind Period||41
7560092|NCT02969525|18608588|P4|STARTED|Double-Blind Period||41
7560093|NCT02969525|18608589|P3|STARTED|Double-Blind Period||41
7560094|NCT02969525|18608590|P2|STARTED|Double-Blind Period||41
7560095|NCT02969525|18608591|P1|STARTED|Double-Blind Period||42
7560096|NCT02969421|18608731|P2|NOT COMPLETED|Overall Study||0
7560097|NCT02969421|18608732|P1|NOT COMPLETED|Overall Study||0
7560098|NCT02969421|18608731|P2|COMPLETED|Overall Study||33
7560099|NCT02969421|18608732|P1|COMPLETED|Overall Study||33
7560100|NCT02969421|18608731|P2|STARTED|Overall Study||33
7560101|NCT02969421|18608732|P1|STARTED|Overall Study||33
7560102|NCT02969408|18608742|P1|NOT COMPLETED|Overall Study||16
7560103|NCT02969408|18608742|P1|COMPLETED|Overall Study||381
7560104|NCT02969408|18608742|P1|Used ABS eMDPI at Least Once|Overall Study||370
7560105|NCT02969408|18608742|P1|STARTED|Overall Study||397
7560106|NCT02969356|18608750|P1|NOT COMPLETED|Overall Study||23
7560107|NCT02969356|18608750|P1|COMPLETED|Overall Study||134
7560108|NCT02969356|18608750|P1|Intent-to-Treat (ITT) Population|Overall Study||153
7560109|NCT02969356|18608750|P1|STARTED|Overall Study||157
7560110|NCT02969317|18608768|P1|NOT COMPLETED|Overall Study||0
7560111|NCT02969317|18608768|P1|COMPLETED|Overall Study||12
7560112|NCT02969317|18608768|P1|STARTED|Overall Study||12
7560113|NCT02969187|18608793|P2|NOT COMPLETED|Overall Study||13
7560114|NCT02969187|18608794|P1|NOT COMPLETED|Overall Study||12
7560115|NCT02969187|18608793|P2|COMPLETED|Overall Study||50
7560116|NCT02969187|18608794|P1|COMPLETED|Overall Study||51
7560117|NCT02969187|18608793|P2|STARTED|Overall Study||63
7560118|NCT02969187|18608794|P1|STARTED|Overall Study||63
7560119|NCT02969044|18608806|P2|NOT COMPLETED|Overall Study||6
7560120|NCT02969044|18608807|P1|NOT COMPLETED|Overall Study||5
7560121|NCT02969044|18608806|P2|COMPLETED|Overall Study||22
7560122|NCT02969044|18608807|P1|COMPLETED|Overall Study||37
7560123|NCT02969044|18608806|P2|STARTED|Overall Study||28
7560124|NCT02969044|18608807|P1|STARTED|Overall Study||42
7560125|NCT02969031|18608849|P2|NOT COMPLETED|Completed and Analyzed||0
7560126|NCT02969031|18608850|P1|NOT COMPLETED|Completed and Analyzed||0
7560127|NCT02969031|18608849|P2|COMPLETED|Completed and Analyzed||12
7560128|NCT02969031|18608850|P1|COMPLETED|Completed and Analyzed||15
7560129|NCT02969031|18608849|P2|STARTED|Completed and Analyzed||12
7560130|NCT02969031|18608850|P1|STARTED|Completed and Analyzed||15
7560131|NCT02969031|18608849|P2|NOT COMPLETED|Collection of Follow-Up Recordings||0
7560132|NCT02969031|18608850|P1|NOT COMPLETED|Collection of Follow-Up Recordings||0
7560133|NCT02969031|18608849|P2|COMPLETED|Collection of Follow-Up Recordings||12
7560134|NCT02969031|18608850|P1|COMPLETED|Collection of Follow-Up Recordings||15
7560135|NCT02969031|18608849|P2|STARTED|Collection of Follow-Up Recordings||12
7560136|NCT02969031|18608850|P1|STARTED|Collection of Follow-Up Recordings||15
7560137|NCT02969031|18608849|P2|NOT COMPLETED|Collection of Follow-Up Surveys||2
7560138|NCT02969031|18608850|P1|NOT COMPLETED|Collection of Follow-Up Surveys||0
7560139|NCT02969031|18608849|P2|COMPLETED|Collection of Follow-Up Surveys||12
7560140|NCT02969031|18608850|P1|COMPLETED|Collection of Follow-Up Surveys||15
7560141|NCT02969031|18608849|P2|STARTED|Collection of Follow-Up Surveys||14
7560142|NCT02969031|18608850|P1|STARTED|Collection of Follow-Up Surveys||15
7560143|NCT02969031|18608849|P2|NOT COMPLETED|Completed Intervention||4
7560144|NCT02969031|18608850|P1|NOT COMPLETED|Completed Intervention||7
7560145|NCT02969031|18608849|P2|COMPLETED|Completed Intervention||14
7560146|NCT02969031|18608850|P1|COMPLETED|Completed Intervention||15
7560147|NCT02969031|18608849|P2|STARTED|Completed Intervention||18
7560148|NCT02969031|18608850|P1|STARTED|Completed Intervention||22
7560149|NCT02969031|18608849|P2|NOT COMPLETED|Collection of Baseline Recordings||5
7560150|NCT02969031|18608850|P1|NOT COMPLETED|Collection of Baseline Recordings||12
7560151|NCT02969031|18608849|P2|COMPLETED|Collection of Baseline Recordings||18
7560152|NCT02969031|18608850|P1|COMPLETED|Collection of Baseline Recordings||22
7560153|NCT02969031|18608849|P2|STARTED|Collection of Baseline Recordings||23
7560154|NCT02969031|18608850|P1|STARTED|Collection of Baseline Recordings||34
7560155|NCT02969031|18608849|P2|NOT COMPLETED|Collection of Baseline Surveys||52
7560156|NCT02969031|18608850|P1|NOT COMPLETED|Collection of Baseline Surveys||39
7560157|NCT02969031|18608849|P2|COMPLETED|Collection of Baseline Surveys||23
7560158|NCT02969031|18608850|P1|COMPLETED|Collection of Baseline Surveys||34
7560159|NCT02969031|18608849|P2|STARTED|Collection of Baseline Surveys||75
7560160|NCT02969031|18608850|P1|STARTED|Collection of Baseline Surveys||73
7560161|NCT02969031|18608849|P2|NOT COMPLETED|Enrolled and Randomized||0
7560162|NCT02969031|18608850|P1|NOT COMPLETED|Enrolled and Randomized||0
7560163|NCT02969031|18608849|P2|COMPLETED|Enrolled and Randomized||75
7560164|NCT02969031|18608850|P1|COMPLETED|Enrolled and Randomized||73
7560165|NCT02969031|18608849|P2|STARTED|Enrolled and Randomized||75
7560166|NCT02969031|18608850|P1|STARTED|Enrolled and Randomized||73
7560167|NCT02969018|18608866|P8|NOT COMPLETED|Overall Study||7
7560168|NCT02969018|18608867|P7|NOT COMPLETED|Overall Study||8
7560169|NCT02969018|18608868|P6|NOT COMPLETED|Overall Study||8
7560170|NCT02969018|18608869|P5|NOT COMPLETED|Overall Study||2
7560171|NCT02969018|18608870|P4|NOT COMPLETED|Overall Study||5
7560172|NCT02969018|18608871|P3|NOT COMPLETED|Overall Study||6
7560173|NCT02969018|18608872|P2|NOT COMPLETED|Overall Study||8
7560174|NCT02969018|18608873|P1|NOT COMPLETED|Overall Study||4
7560175|NCT02969018|18608866|P8|COMPLETED|Overall Study||16
7560176|NCT02969018|18608867|P7|COMPLETED|Overall Study||22
7560177|NCT02969018|18608868|P6|COMPLETED|Overall Study||17
7560178|NCT02969018|18608869|P5|COMPLETED|Overall Study||27
7560179|NCT02969018|18608870|P4|COMPLETED|Overall Study||20
7560180|NCT02969018|18608871|P3|COMPLETED|Overall Study||20
7560181|NCT02969018|18608872|P2|COMPLETED|Overall Study||21
7560182|NCT02969018|18608873|P1|COMPLETED|Overall Study||21
7560183|NCT02969018|18608866|P8|STARTED|Overall Study||23
7560184|NCT02969018|18608867|P7|STARTED|Overall Study||30
7560185|NCT02969018|18608868|P6|STARTED|Overall Study||25
7560186|NCT02969018|18608869|P5|STARTED|Overall Study||29
7560187|NCT02969018|18608870|P4|STARTED|Overall Study||25
7560188|NCT02969018|18608871|P3|STARTED|Overall Study||26
7560189|NCT02969018|18608872|P2|STARTED|Overall Study||29
7560190|NCT02969018|18608873|P1|STARTED|Overall Study||25
7560191|NCT02968992|18608992|P2|NOT COMPLETED|Overall Study||1
7560192|NCT02968992|18608993|P1|NOT COMPLETED|Overall Study||0
7560193|NCT02968992|18608992|P2|COMPLETED|Overall Study||17
7560194|NCT02968992|18608993|P1|COMPLETED|Overall Study||18
7560195|NCT02968992|18608992|P2|STARTED|Overall Study||18
7560196|NCT02968992|18608993|P1|STARTED|Overall Study||18
7560197|NCT02968979|18609013|P1|NOT COMPLETED|Overall Study||8
7560198|NCT02968979|18609013|P1|COMPLETED|Overall Study|This cross-sectional study had only 1 visit.|531
7560199|NCT02968979|18609013|P1|STARTED|Overall Study||539
7560200|NCT02968914|18609101|P2|NOT COMPLETED|Overall Study||0
7560201|NCT02968914|18609102|P1|NOT COMPLETED|Overall Study||0
7560202|NCT02968914|18609101|P2|COMPLETED|Overall Study||90
7560203|NCT02968914|18609102|P1|COMPLETED|Overall Study||90
7560204|NCT02968914|18609101|P2|STARTED|Overall Study||90
7560205|NCT02968914|18609102|P1|STARTED|Overall Study||90
7560206|NCT02968758|18609126|P2|NOT COMPLETED|Overall Study||0
7560207|NCT02968758|18609127|P1|NOT COMPLETED|Overall Study||0
7560208|NCT02968758|18609126|P2|COMPLETED|Overall Study||1664
7560209|NCT02968758|18609127|P1|COMPLETED|Overall Study||797
7560210|NCT02968758|18609126|P2|STARTED|Overall Study||1664
7560211|NCT02968758|18609127|P1|STARTED|Overall Study||797
7560212|NCT02968576|18609138|P2|NOT COMPLETED|Overall Study||1
7560213|NCT02968576|18609139|P1|NOT COMPLETED|Overall Study||0
7560214|NCT02968576|18609138|P2|COMPLETED|Overall Study||13
7560215|NCT02968576|18609139|P1|COMPLETED|Overall Study||11
7560216|NCT02968576|18609138|P2|STARTED|Overall Study||14
7560217|NCT02968576|18609139|P1|STARTED|Overall Study||11
7560218|NCT02968563|18609146|P2|NOT COMPLETED|Overall Study||23
7560219|NCT02968563|18609147|P1|NOT COMPLETED|Overall Study||1
7560220|NCT02968563|18609146|P2|COMPLETED|Overall Study||7
7560221|NCT02968563|18609147|P1|COMPLETED|Overall Study||4
7560222|NCT02968563|18609146|P2|STARTED|Overall Study||30
7560223|NCT02968563|18609147|P1|STARTED|Overall Study||5
7560224|NCT02968433|18609161|P1|NOT COMPLETED|Overall Study||1
7560225|NCT02968433|18609161|P1|COMPLETED|Overall Study||15
7560226|NCT02968433|18609161|P1|STARTED|Overall Study||16
7560227|NCT02968368|18609176|P2|NOT COMPLETED|Open Label Phase||14
7560228|NCT02968368|18609177|P1|NOT COMPLETED|Open Label Phase||19
7560229|NCT02968368|18609176|P2|COMPLETED|Open Label Phase||25
7560230|NCT02968368|18609177|P1|COMPLETED|Open Label Phase||67
7560231|NCT02968368|18609176|P2|STARTED|Open Label Phase||39
7560232|NCT02968368|18609177|P1|STARTED|Open Label Phase||86
7560233|NCT02968368|18609176|P2|NOT COMPLETED|Double Blind Phase||17
7560234|NCT02968368|18609177|P1|NOT COMPLETED|Double Blind Phase||21
7560235|NCT02968368|18609176|P2|COMPLETED|Double Blind Phase||39
7560236|NCT02968368|18609177|P1|COMPLETED|Double Blind Phase||90
7560237|NCT02968368|18609176|P2|STARTED|Double Blind Phase||56
7560238|NCT02968368|18609177|P1|STARTED|Double Blind Phase||111
7560239|NCT02968277|18609210|P3|NOT COMPLETED|Overall Study||0
7560240|NCT02968277|18609211|P2|NOT COMPLETED|Overall Study||0
7560241|NCT02968277|18609212|P1|NOT COMPLETED|Overall Study||0
7560242|NCT02968277|18609210|P3|COMPLETED|Overall Study||13
7560243|NCT02968277|18609211|P2|COMPLETED|Overall Study||7
7560244|NCT02968277|18609212|P1|COMPLETED|Overall Study||10
7560245|NCT02968277|18609210|P3|STARTED|Overall Study||13
7560246|NCT02968277|18609211|P2|STARTED|Overall Study||7
7560247|NCT02968277|18609212|P1|STARTED|Overall Study||10
7560248|NCT02968173|18609238|P1|NOT COMPLETED|Overall Study||1
7560249|NCT02968173|18609238|P1|COMPLETED|Overall Study||49
7560250|NCT02968173|18609238|P1|STARTED|Overall Study||50
7560251|NCT02968134|18609250|P1|NOT COMPLETED|Overall Study||0
7560252|NCT02968134|18609250|P1|COMPLETED|Overall Study||8
7560253|NCT02968134|18609250|P1|STARTED|Overall Study||8
7560254|NCT02967991|18609255|P2|NOT COMPLETED|Overall Study||0
7560255|NCT02967991|18609256|P1|NOT COMPLETED|Overall Study||0
7560256|NCT02967991|18609255|P2|COMPLETED|Overall Study||10
7560257|NCT02967991|18609256|P1|COMPLETED|Overall Study||10
7560258|NCT02967991|18609255|P2|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
7560259|NCT02967991|18609256|P1|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
7560260|NCT02967679|18609275|P1|NOT COMPLETED|Overall Study||1
7560261|NCT02967679|18609275|P1|COMPLETED|Overall Study||14
7560262|NCT02967679|18609275|P1|STARTED|Overall Study||15
7560263|NCT02967562|18609296|P2|NOT COMPLETED|Overall Study||1
7560264|NCT02967562|18609297|P1|NOT COMPLETED|Overall Study||2
7560265|NCT02967562|18609296|P2|COMPLETED|Overall Study||30
7560266|NCT02967562|18609297|P1|COMPLETED|Overall Study||30
7560267|NCT02967562|18609296|P2|STARTED|Overall Study||31
7560268|NCT02967562|18609297|P1|STARTED|Overall Study||32
7560269|NCT02967510|18609311|P4|NOT COMPLETED|Overall Study||8
7560270|NCT02967510|18609312|P3|NOT COMPLETED|Overall Study||7
7560271|NCT02967510|18609313|P2|NOT COMPLETED|Overall Study||3
7560272|NCT02967510|18609314|P1|NOT COMPLETED|Overall Study||4
7560273|NCT02967510|18609311|P4|COMPLETED|Overall Study||63
7560274|NCT02967510|18609312|P3|COMPLETED|Overall Study||65
7560275|NCT02967510|18609313|P2|COMPLETED|Overall Study||67
7560276|NCT02967510|18609314|P1|COMPLETED|Overall Study||66
7560277|NCT02967510|18609311|P4|STARTED|Overall Study||71
7560278|NCT02967510|18609312|P3|STARTED|Overall Study||72
7560279|NCT02967510|18609313|P2|STARTED|Overall Study||70
7560280|NCT02967510|18609314|P1|STARTED|Overall Study||70
7560281|NCT02967458|18609440|P1|NOT COMPLETED|Overall Study||0
7560282|NCT02967458|18609440|P1|COMPLETED|Overall Study||55
7560283|NCT02967458|18609440|P1|STARTED|Overall Study||55
7560284|NCT02967393|18609448|P2|NOT COMPLETED|Overall Study||0
7560285|NCT02967393|18609449|P1|NOT COMPLETED|Overall Study||0
7560286|NCT02967393|18609448|P2|COMPLETED|Overall Study||20
7560287|NCT02967393|18609449|P1|COMPLETED|Overall Study||20
7560288|NCT02967393|18609448|P2|STARTED|Overall Study||20
7560289|NCT02967393|18609449|P1|STARTED|Overall Study||20
7560290|NCT02967367|18609474|P1|NOT COMPLETED|Overall Study||14
7560291|NCT02967367|18609474|P1|COMPLETED|Overall Study||22
7560292|NCT02967367|18609474|P1|STARTED|Overall Study||36
7560293|NCT02967354|18609487|P5|NOT COMPLETED|Overall Study||0
7560294|NCT02967354|18609488|P4|NOT COMPLETED|Overall Study||0
7560295|NCT02967354|18609489|P3|NOT COMPLETED|Overall Study||0
7560296|NCT02967354|18609490|P2|NOT COMPLETED|Overall Study||0
7560297|NCT02967354|18609491|P1|NOT COMPLETED|Overall Study||0
7560298|NCT02967354|18609487|P5|COMPLETED|Overall Study||8
7560299|NCT02967354|18609488|P4|COMPLETED|Overall Study||7
7560300|NCT02967354|18609489|P3|COMPLETED|Overall Study||9
7560301|NCT02967354|18609490|P2|COMPLETED|Overall Study||7
7560302|NCT02967354|18609491|P1|COMPLETED|Overall Study||8
7560303|NCT02967354|18609487|P5|STARTED|Overall Study||8
7560304|NCT02967354|18609488|P4|STARTED|Overall Study||7
7560305|NCT02967354|18609489|P3|STARTED|Overall Study||9
7560306|NCT02967354|18609490|P2|STARTED|Overall Study||7
7560307|NCT02967354|18609491|P1|STARTED|Overall Study||8
7560308|NCT02967055|18609523|P1|NOT COMPLETED|Overall Study||49
7560309|NCT02967055|18609523|P1|COMPLETED|Overall Study||5
7560310|NCT02967055|18609523|P1|Completed 4 Week Follow-up Visit|Overall Study||8
7560311|NCT02967055|18609523|P1|Enrolled|Overall Study|Enrolled|9
7560312|NCT02967055|18609523|P1|In-person Screening|Overall Study||14
7560313|NCT02967055|18609523|P1|STARTED|Overall Study|Assessed for eligibility|54
7560314|NCT02967016|18609531|P2|NOT COMPLETED|Overall Study||0
7560315|NCT02967016|18609532|P1|NOT COMPLETED|Overall Study||0
7560316|NCT02967016|18609531|P2|COMPLETED|Overall Study||25
7560317|NCT02967016|18609532|P1|COMPLETED|Overall Study||25
7560318|NCT02967016|18609531|P2|STARTED|Overall Study||25
7560319|NCT02967016|18609532|P1|STARTED|Overall Study||25
7560320|NCT02966795|18609544|P2|NOT COMPLETED|Overall Study||1
7560321|NCT02966795|18609545|P1|NOT COMPLETED|Overall Study||0
7560322|NCT02966795|18609544|P2|COMPLETED|Overall Study||60
7560323|NCT02966795|18609545|P1|COMPLETED|Overall Study||23
7560324|NCT02966795|18609544|P2|STARTED|Overall Study||61
7560325|NCT02966795|18609545|P1|STARTED|Overall Study||23
7560326|NCT02966509|18609556|P2|NOT COMPLETED|End of Life Utilization and Cost 15month||48
7560327|NCT02966509|18609557|P1|NOT COMPLETED|End of Life Utilization and Cost 15month||45
7560328|NCT02966509|18609556|P2|COMPLETED|End of Life Utilization and Cost 15month||60
7560329|NCT02966509|18609557|P1|COMPLETED|End of Life Utilization and Cost 15month||60
7560330|NCT02966509|18609556|P2|STARTED|End of Life Utilization and Cost 15month||108
7560331|NCT02966509|18609557|P1|STARTED|End of Life Utilization and Cost 15month||105
7560332|NCT02966509|18609556|P2|NOT COMPLETED|End of Life Utilization and Cost 6 Month||75
7560333|NCT02966509|18609557|P1|NOT COMPLETED|End of Life Utilization and Cost 6 Month||69
7560334|NCT02966509|18609556|P2|COMPLETED|End of Life Utilization and Cost 6 Month||33
7560335|NCT02966509|18609557|P1|COMPLETED|End of Life Utilization and Cost 6 Month||36
7560336|NCT02966509|18609556|P2|STARTED|End of Life Utilization and Cost 6 Month||108
7560337|NCT02966509|18609557|P1|STARTED|End of Life Utilization and Cost 6 Month||105
7560338|NCT02966509|18609556|P2|NOT COMPLETED|15-Month Utilization and Cost||0
7560339|NCT02966509|18609557|P1|NOT COMPLETED|15-Month Utilization and Cost||0
7560340|NCT02966509|18609556|P2|COMPLETED|15-Month Utilization and Cost||108
7560341|NCT02966509|18609557|P1|COMPLETED|15-Month Utilization and Cost||105
7560342|NCT02966509|18609556|P2|STARTED|15-Month Utilization and Cost||108
7560343|NCT02966509|18609557|P1|STARTED|15-Month Utilization and Cost||105
7560344|NCT02966509|18609556|P2|NOT COMPLETED|6-Month Utilization and Cost||0
7560345|NCT02966509|18609557|P1|NOT COMPLETED|6-Month Utilization and Cost||0
7560346|NCT02966509|18609556|P2|COMPLETED|6-Month Utilization and Cost||108
7560347|NCT02966509|18609557|P1|COMPLETED|6-Month Utilization and Cost||105
7560348|NCT02966509|18609556|P2|STARTED|6-Month Utilization and Cost||108
7560349|NCT02966509|18609557|P1|STARTED|6-Month Utilization and Cost||105
7560350|NCT02966509|18609556|P2|NOT COMPLETED|6 Month Satisfaction Survey||48
7560351|NCT02966509|18609557|P1|NOT COMPLETED|6 Month Satisfaction Survey||47
7560352|NCT02966509|18609556|P2|COMPLETED|6 Month Satisfaction Survey||60
7560353|NCT02966509|18609557|P1|COMPLETED|6 Month Satisfaction Survey||58
7560354|NCT02966509|18609556|P2|STARTED|6 Month Satisfaction Survey||108
7560355|NCT02966509|18609557|P1|STARTED|6 Month Satisfaction Survey||105
7560356|NCT02966509|18609556|P2|NOT COMPLETED|6 Month Satisfaction Decision Survey||31
7560357|NCT02966509|18609557|P1|NOT COMPLETED|6 Month Satisfaction Decision Survey||25
7560358|NCT02966509|18609556|P2|COMPLETED|6 Month Satisfaction Decision Survey||77
7560359|NCT02966509|18609557|P1|COMPLETED|6 Month Satisfaction Decision Survey||80
7560360|NCT02966509|18609556|P2|STARTED|6 Month Satisfaction Decision Survey||108
7560361|NCT02966509|18609557|P1|STARTED|6 Month Satisfaction Decision Survey||105
7560362|NCT02966509|18609556|P2|NOT COMPLETED|Baseline Satisfaction Survey||7
7560363|NCT02966509|18609557|P1|NOT COMPLETED|Baseline Satisfaction Survey||4
7560364|NCT02966509|18609556|P2|COMPLETED|Baseline Satisfaction Survey||101
7560365|NCT02966509|18609557|P1|COMPLETED|Baseline Satisfaction Survey||101
7560366|NCT02966509|18609556|P2|STARTED|Baseline Satisfaction Survey||108
7560367|NCT02966509|18609557|P1|STARTED|Baseline Satisfaction Survey||105
7560368|NCT02966353|18609581|P1|NOT COMPLETED|Overall Study||22
7560369|NCT02966353|18609581|P1|COMPLETED|Overall Study||29
7560370|NCT02966353|18609581|P1|Completed After Data Cutoff|Overall Study||1
7560371|NCT02966353|18609581|P1|STARTED|Overall Study||51
7560372|NCT02966340|18609590|P2|NOT COMPLETED|Overall Study||3
7560373|NCT02966340|18609591|P1|NOT COMPLETED|Overall Study||3
7560374|NCT02966340|18609590|P2|COMPLETED|Overall Study||30
7560375|NCT02966340|18609591|P1|COMPLETED|Overall Study||34
7560376|NCT02966340|18609590|P2|STARTED|Overall Study||33
7560377|NCT02966340|18609591|P1|STARTED|Overall Study||37
7560378|NCT02966275|18609599|P1|NOT COMPLETED|Overall Study||0
7560379|NCT02966275|18609599|P1|COMPLETED|Overall Study||10
7560380|NCT02966275|18609599|P1|STARTED|Overall Study||10
7560381|NCT02966223|18609634|P1|NOT COMPLETED|Overall Study||15
7560382|NCT02966223|18609634|P1|COMPLETED|Overall Study||5
7560383|NCT02966223|18609634|P1|STARTED|Overall Study||20
7560384|NCT02966015|18609642|P2|NOT COMPLETED|Test Period||0
7560385|NCT02966015|18609643|P1|NOT COMPLETED|Test Period||0
7560386|NCT02966015|18609642|P2|COMPLETED|Test Period||55
7560387|NCT02966015|18609643|P1|COMPLETED|Test Period||87
7560388|NCT02966015|18609642|P2|STARTED|Test Period||55
7560389|NCT02966015|18609643|P1|STARTED|Test Period||87
7560390|NCT02966015|18609642|P2|NOT COMPLETED|Inclusion Visit||3
7560391|NCT02966015|18609643|P1|NOT COMPLETED|Inclusion Visit||8
7560392|NCT02966015|18609642|P2|COMPLETED|Inclusion Visit||55
7560393|NCT02966015|18609643|P1|COMPLETED|Inclusion Visit||87
7560394|NCT02966015|18609642|P2|STARTED|Inclusion Visit||58
7560395|NCT02966015|18609643|P1|STARTED|Inclusion Visit||95
7560396|NCT02966002|18609649|P1|NOT COMPLETED|Overall Study||4
7560397|NCT02966002|18609649|P1|COMPLETED|Overall Study||5
7560398|NCT02966002|18609649|P1|STARTED|Overall Study||9
7560399|NCT02965924|18609656|P1|NOT COMPLETED|Overall Study||0
7560400|NCT02965924|18609656|P1|COMPLETED|Overall Study||20
7560401|NCT02965924|18609656|P1|STARTED|Overall Study||20
7560402|NCT02965846|18609664|P3|NOT COMPLETED|Overall Study||33
7560403|NCT02965846|18609665|P2|NOT COMPLETED|Overall Study||5
7560404|NCT02965846|18609666|P1|NOT COMPLETED|Overall Study||5
7560405|NCT02965846|18609664|P3|COMPLETED|Overall Study||0
7560406|NCT02965846|18609665|P2|COMPLETED|Overall Study||0
7560407|NCT02965846|18609666|P1|COMPLETED|Overall Study||0
7560408|NCT02965846|18609664|P3|STARTED|Overall Study||33
7560409|NCT02965846|18609665|P2|STARTED|Overall Study||5
7560410|NCT02965846|18609666|P1|STARTED|Overall Study||5
7560411|NCT02965833|18609674|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
7560412|NCT02965833|18609675|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
7560413|NCT02965833|18609674|P2|COMPLETED|Period 2, Second 30 Days of Wear||52
7560414|NCT02965833|18609675|P1|COMPLETED|Period 2, Second 30 Days of Wear||62
7560415|NCT02965833|18609674|P2|STARTED|Period 2, Second 30 Days of Wear||52
7560416|NCT02965833|18609675|P1|STARTED|Period 2, Second 30 Days of Wear||64
7560417|NCT02965833|18609674|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||2
7560418|NCT02965833|18609675|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||3
7560419|NCT02965833|18609674|P2|COMPLETED|Period 1, First 30 Days of Wear||52
7560420|NCT02965833|18609675|P1|COMPLETED|Period 1, First 30 Days of Wear||64
7560421|NCT02965833|18609674|P2|STARTED|Period 1, First 30 Days of Wear||54
7560422|NCT02965833|18609675|P1|STARTED|Period 1, First 30 Days of Wear||67
7560423|NCT02965820|18609681|P2|NOT COMPLETED|Period 2, Second 30 Days||1
7560424|NCT02965820|18609682|P1|NOT COMPLETED|Period 2, Second 30 Days||1
7560425|NCT02965820|18609681|P2|COMPLETED|Period 2, Second 30 Days||61
7560426|NCT02965820|18609682|P1|COMPLETED|Period 2, Second 30 Days||57
7560427|NCT02965820|18609681|P2|STARTED|Period 2, Second 30 Days||62
7560428|NCT02965820|18609682|P1|STARTED|Period 2, Second 30 Days|One subject discontinued due to an AE after completion of Period 1 but before beginning Period 2.|58
7560429|NCT02965820|18609681|P2|NOT COMPLETED|Period 1, First 30 Days||0
7560430|NCT02965820|18609682|P1|NOT COMPLETED|Period 1, First 30 Days||0
7560431|NCT02965820|18609681|P2|COMPLETED|Period 1, First 30 Days||62
7560432|NCT02965820|18609682|P1|COMPLETED|Period 1, First 30 Days||59
7560433|NCT02965820|18609681|P2|STARTED|Period 1, First 30 Days||62
7560434|NCT02965820|18609682|P1|STARTED|Period 1, First 30 Days||59
7560435|NCT02965729|18609691|P3|NOT COMPLETED|Overall Study||11
7560436|NCT02965729|18609692|P2|NOT COMPLETED|Overall Study||3
7560437|NCT02965729|18609693|P1|NOT COMPLETED|Overall Study||7
7560438|NCT02965729|18609691|P3|COMPLETED|Overall Study||45
7560439|NCT02965729|18609692|P2|COMPLETED|Overall Study||22
7560440|NCT02965729|18609693|P1|COMPLETED|Overall Study||17
7560441|NCT02965729|18609691|P3|STARTED|Overall Study||56
7560442|NCT02965729|18609692|P2|STARTED|Overall Study||25
7560443|NCT02965729|18609693|P1|STARTED|Overall Study||24
7560444|NCT02965599|18609721|P2|NOT COMPLETED|Overall Study||0
7560445|NCT02965599|18609722|P1|NOT COMPLETED|Overall Study||1
7560446|NCT02965599|18609721|P2|COMPLETED|Overall Study||1
7560447|NCT02965599|18609722|P1|COMPLETED|Overall Study||1
7560448|NCT02965599|18609721|P2|STARTED|Overall Study||1
7560449|NCT02965599|18609722|P1|STARTED|Overall Study||2
7560450|NCT02965534|18609784|P2|NOT COMPLETED|Overall Study||0
7560451|NCT02965534|18609785|P1|NOT COMPLETED|Overall Study||0
7560452|NCT02965534|18609784|P2|COMPLETED|Overall Study||55
7560453|NCT02965534|18609785|P1|COMPLETED|Overall Study||45
7560454|NCT02965534|18609784|P2|STARTED|Overall Study|test period: 14 days with each test glasses|55
7560455|NCT02965534|18609785|P1|STARTED|Overall Study|test period: 14 days with each test glasses|45
7560456|NCT02965456|18609801|P2|NOT COMPLETED|Overall Study||43
7560457|NCT02965456|18609802|P1|NOT COMPLETED|Overall Study||71
7560458|NCT02965456|18609801|P2|COMPLETED|Overall Study||364
7560459|NCT02965456|18609802|P1|COMPLETED|Overall Study||342
7560460|NCT02965456|18609801|P2|Safety Population|Overall Study||398
7560461|NCT02965456|18609802|P1|Safety Population|Overall Study||389
7560462|NCT02965456|18609801|P2|Intent-to-treat (ITT) Population|Overall Study||407
7560463|NCT02965456|18609802|P1|Intent-to-treat (ITT) Population|Overall Study||413
7560464|NCT02965456|18609801|P2|STARTED|Overall Study||407
7560465|NCT02965456|18609802|P1|STARTED|Overall Study||413
7560466|NCT02965144|18609816|P1|NOT COMPLETED|Overall Study||0
7560467|NCT02965144|18609816|P1|COMPLETED|Overall Study||13
7560468|NCT02965144|18609816|P1|STARTED|Overall Study||13
7560469|NCT02964910|18609826|P2|NOT COMPLETED|Overall Study||44
7560470|NCT02964910|18609827|P1|NOT COMPLETED|Overall Study||43
7560471|NCT02964910|18609826|P2|COMPLETED|Overall Study||196
7560472|NCT02964910|18609827|P1|COMPLETED|Overall Study||192
7560473|NCT02964910|18609826|P2|STARTED|Overall Study||240
7560474|NCT02964910|18609827|P1|STARTED|Overall Study||235
7560475|NCT02964767|18609853|P2|NOT COMPLETED|Overall Study||0
7560476|NCT02964767|18609854|P1|NOT COMPLETED|Overall Study||0
7560477|NCT02964767|18609853|P2|COMPLETED|Overall Study||48
7560478|NCT02964767|18609854|P1|COMPLETED|Overall Study||171
7560479|NCT02964767|18609853|P2|STARTED|Overall Study||48
7560480|NCT02964767|18609854|P1|STARTED|Overall Study||171
7560481|NCT02964416|18609863|P2|NOT COMPLETED|Overall Study||0
7560482|NCT02964416|18609864|P1|NOT COMPLETED|Overall Study||1
7560483|NCT02964416|18609863|P2|COMPLETED|Overall Study||41
7560484|NCT02964416|18609864|P1|COMPLETED|Overall Study||38
7560485|NCT02964416|18609863|P2|STARTED|Overall Study||41
7560486|NCT02964416|18609864|P1|STARTED|Overall Study||39
7560487|NCT02964338|18609893|P3|NOT COMPLETED|Overall Study||19
7560488|NCT02964338|18609894|P2|NOT COMPLETED|Overall Study||24
7560489|NCT02964338|18609895|P1|NOT COMPLETED|Overall Study||17
7560490|NCT02964338|18609893|P3|COMPLETED|Overall Study||68
7560491|NCT02964338|18609894|P2|COMPLETED|Overall Study||64
7560492|NCT02964338|18609895|P1|COMPLETED|Overall Study||67
7560493|NCT02964338|18609893|P3|Full Analysis Set|Overall Study||87
7560494|NCT02964338|18609894|P2|Full Analysis Set|Overall Study||86
7560495|NCT02964338|18609895|P1|Full Analysis Set|Overall Study||81
7560496|NCT02964338|18609893|P3|Safety Analysis Set|Overall Study||87
7560497|NCT02964338|18609894|P2|Safety Analysis Set|Overall Study||88
7560498|NCT02964338|18609895|P1|Safety Analysis Set|Overall Study||83
7560499|NCT02964338|18609893|P3|STARTED|Overall Study||87
7560500|NCT02964338|18609894|P2|STARTED|Overall Study||88
7560501|NCT02964338|18609895|P1|STARTED|Overall Study||84
7560502|NCT02964312|18609939|P1|NOT COMPLETED|Overall Study||64
7560503|NCT02964312|18609939|P1|COMPLETED|Overall Study||102
7560504|NCT02964312|18609939|P1|24-Month Follow-up|Overall Study||102
7560505|NCT02964312|18609939|P1|18-Month Follow-up|Overall Study||112
7560506|NCT02964312|18609939|P1|12-Month Follow-up|Overall Study||139
7560507|NCT02964312|18609939|P1|6-Month Follow-up|Overall Study||152
7560508|NCT02964312|18609939|P1|3-Month Follow-up|Overall Study||159
7560509|NCT02964312|18609939|P1|1-Month Follow-up|Overall Study||164
7560510|NCT02964312|18609939|P1|STARTED|Overall Study||166
7560511|NCT02964247|18609950|P2|NOT COMPLETED|Overall Study||2
7560512|NCT02964247|18609951|P1|NOT COMPLETED|Overall Study||3
7560513|NCT02964247|18609950|P2|COMPLETED|Overall Study||98
7560514|NCT02964247|18609951|P1|COMPLETED|Overall Study||200
7560515|NCT02964247|18609950|P2|Exposed to Trial Product|Overall Study||100
7560516|NCT02964247|18609951|P1|Exposed to Trial Product|Overall Study||202
7560517|NCT02964247|18609950|P2|STARTED|Overall Study||100
7560518|NCT02964247|18609951|P1|STARTED|Overall Study||203
7560519|NCT02964234|18610009|P2|NOT COMPLETED|Overall Study||13
7560520|NCT02964234|18610010|P1|NOT COMPLETED|Overall Study||22
7560521|NCT02964234|18610009|P2|COMPLETED|Overall Study||56
7560522|NCT02964234|18610010|P1|COMPLETED|Overall Study||54
7560523|NCT02964234|18610009|P2|STARTED|Overall Study||69
7560524|NCT02964234|18610010|P1|STARTED|Overall Study||76
7560525|NCT02964078|18610020|P1|NOT COMPLETED|Overall Study||0
7560526|NCT02964078|18610020|P1|COMPLETED|Overall Study||27
7560527|NCT02964078|18610020|P1|STARTED|Overall Study||27
7560528|NCT02963987|18610026|P2|NOT COMPLETED|Second Intervention Period||0
7560529|NCT02963987|18610027|P1|NOT COMPLETED|Second Intervention Period||0
7560530|NCT02963987|18610026|P2|COMPLETED|Second Intervention Period||19
7560531|NCT02963987|18610027|P1|COMPLETED|Second Intervention Period||31
7560532|NCT02963987|18610026|P2|STARTED|Second Intervention Period||19
7560533|NCT02963987|18610027|P1|STARTED|Second Intervention Period||31
7560534|NCT02963987|18610026|P2|NOT COMPLETED|First Intervention Period||0
7560535|NCT02963987|18610027|P1|NOT COMPLETED|First Intervention Period||0
7560536|NCT02963987|18610026|P2|COMPLETED|First Intervention Period||19
7560537|NCT02963987|18610027|P1|COMPLETED|First Intervention Period||31
7560538|NCT02963987|18610026|P2|STARTED|First Intervention Period||19
7560539|NCT02963987|18610027|P1|STARTED|First Intervention Period||31
7560540|NCT02963935|18610039|P2|NOT COMPLETED|Overall Study||37
7560541|NCT02963935|18610040|P1|NOT COMPLETED|Overall Study||28
7560542|NCT02963935|18610039|P2|COMPLETED|Overall Study||103
7560543|NCT02963935|18610040|P1|COMPLETED|Overall Study||114
7560544|NCT02963935|18610039|P2|STARTED|Overall Study||140
7560545|NCT02963935|18610040|P1|STARTED|Overall Study||142
7560546|NCT02963922|18610148|P2|NOT COMPLETED|Overall Study||30
7560547|NCT02963922|18610149|P1|NOT COMPLETED|Overall Study||32
7560548|NCT02963922|18610148|P2|COMPLETED|Overall Study||168
7560549|NCT02963922|18610149|P1|COMPLETED|Overall Study||166
7560550|NCT02963922|18610148|P2|STARTED|Overall Study||198
7560551|NCT02963922|18610149|P1|STARTED|Overall Study||198
7560552|NCT02963701|18610247|P2|NOT COMPLETED|Period 2 (2 Days)||0
7560553|NCT02963701|18610248|P1|NOT COMPLETED|Period 2 (2 Days)||0
7560554|NCT02963701|18610247|P2|COMPLETED|Period 2 (2 Days)||28
7560555|NCT02963701|18610248|P1|COMPLETED|Period 2 (2 Days)||27
7560556|NCT02963701|18610247|P2|STARTED|Period 2 (2 Days)||28
7560557|NCT02963701|18610248|P1|STARTED|Period 2 (2 Days)||27
7560558|NCT02963701|18610247|P2|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||0
7560559|NCT02963701|18610248|P1|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||1
7560560|NCT02963701|18610247|P2|COMPLETED|Period 1 (Including Washout) (2 Days)||28
7560561|NCT02963701|18610248|P1|COMPLETED|Period 1 (Including Washout) (2 Days)|One subject withdrawn from the study after period 1|27
7560562|NCT02963701|18610247|P2|STARTED|Period 1 (Including Washout) (2 Days)||28
7560563|NCT02963701|18610248|P1|STARTED|Period 1 (Including Washout) (2 Days)||28
7560564|NCT02963597|18610280|P2|NOT COMPLETED|Overall Study||0
7560565|NCT02963597|18610281|P1|NOT COMPLETED|Overall Study||0
7560566|NCT02963597|18610280|P2|COMPLETED|Overall Study||11
7560567|NCT02963597|18610281|P1|COMPLETED|Overall Study||10
7560568|NCT02963597|18610280|P2|STARTED|Overall Study||11
7560569|NCT02963597|18610281|P1|STARTED|Overall Study||10
7560570|NCT02963506|18610308|P13|NOT COMPLETED|Dose-Blind Period||7
7560571|NCT02963506|18610309|P12|NOT COMPLETED|Dose-Blind Period||2
7560572|NCT02963506|18610310|P11|NOT COMPLETED|Dose-Blind Period||1
7560573|NCT02963506|18610311|P10|NOT COMPLETED|Dose-Blind Period||4
7560574|NCT02963506|18610312|P9|NOT COMPLETED|Dose-Blind Period||3
7560575|NCT02963506|18610313|P8|NOT COMPLETED|Dose-Blind Period||5
7560576|NCT02963506|18610314|P7|NOT COMPLETED|Dose-Blind Period||5
7560577|NCT02963506|18610315|P6|NOT COMPLETED|Dose-Blind Period||4
7560578|NCT02963506|18610316|P5|NOT COMPLETED|Dose-Blind Period||0
7560579|NCT02963506|18610317|P4|NOT COMPLETED|Dose-Blind Period||0
7560580|NCT02963506|18610318|P3|NOT COMPLETED|Dose-Blind Period||0
7560581|NCT02963506|18610319|P2|NOT COMPLETED|Dose-Blind Period||0
7560582|NCT02963506|18610320|P1|NOT COMPLETED|Dose-Blind Period||0
7560583|NCT02963506|18610308|P13|COMPLETED|Dose-Blind Period||54
7560584|NCT02963506|18610309|P12|COMPLETED|Dose-Blind Period||56
7560585|NCT02963506|18610310|P11|COMPLETED|Dose-Blind Period||24
7560586|NCT02963506|18610311|P10|COMPLETED|Dose-Blind Period||30
7560587|NCT02963506|18610312|P9|COMPLETED|Dose-Blind Period||24
7560588|NCT02963506|18610313|P8|COMPLETED|Dose-Blind Period||26
7560589|NCT02963506|18610314|P7|COMPLETED|Dose-Blind Period||31
7560590|NCT02963506|18610315|P6|COMPLETED|Dose-Blind Period||20
7560591|NCT02963506|18610316|P5|COMPLETED|Dose-Blind Period||0
7560592|NCT02963506|18610317|P4|COMPLETED|Dose-Blind Period||0
7560593|NCT02963506|18610318|P3|COMPLETED|Dose-Blind Period||0
7560594|NCT02963506|18610319|P2|COMPLETED|Dose-Blind Period||0
7560595|NCT02963506|18610320|P1|COMPLETED|Dose-Blind Period||0
7560596|NCT02963506|18610308|P13|STARTED|Dose-Blind Period||61
7560597|NCT02963506|18610309|P12|STARTED|Dose-Blind Period||58
7560598|NCT02963506|18610310|P11|STARTED|Dose-Blind Period||25
7560599|NCT02963506|18610311|P10|STARTED|Dose-Blind Period||34
7560600|NCT02963506|18610312|P9|STARTED|Dose-Blind Period||27
7560601|NCT02963506|18610313|P8|STARTED|Dose-Blind Period||31
7560602|NCT02963506|18610314|P7|STARTED|Dose-Blind Period||36
7560603|NCT02963506|18610315|P6|STARTED|Dose-Blind Period||24
7560604|NCT02963506|18610316|P5|STARTED|Dose-Blind Period||0
7560605|NCT02963506|18610317|P4|STARTED|Dose-Blind Period||0
7560606|NCT02963506|18610318|P3|STARTED|Dose-Blind Period||0
7560607|NCT02963506|18610319|P2|STARTED|Dose-Blind Period||0
7560608|NCT02963506|18610320|P1|STARTED|Dose-Blind Period||0
7560609|NCT02963506|18610308|P13|NOT COMPLETED|Double-Blind Period||0
7560610|NCT02963506|18610309|P12|NOT COMPLETED|Double-Blind Period||0
7560611|NCT02963506|18610310|P11|NOT COMPLETED|Double-Blind Period||0
7560612|NCT02963506|18610311|P10|NOT COMPLETED|Double-Blind Period||0
7560613|NCT02963506|18610312|P9|NOT COMPLETED|Double-Blind Period||0
7560614|NCT02963506|18610313|P8|NOT COMPLETED|Double-Blind Period||0
7560615|NCT02963506|18610314|P7|NOT COMPLETED|Double-Blind Period||0
7560616|NCT02963506|18610315|P6|NOT COMPLETED|Double-Blind Period||0
7560617|NCT02963506|18610316|P5|NOT COMPLETED|Double-Blind Period||0
7560618|NCT02963506|18610317|P4|NOT COMPLETED|Double-Blind Period||2
7560619|NCT02963506|18610318|P3|NOT COMPLETED|Double-Blind Period||2
7560620|NCT02963506|18610319|P2|NOT COMPLETED|Double-Blind Period||3
7560621|NCT02963506|18610320|P1|NOT COMPLETED|Double-Blind Period||0
7560622|NCT02963506|18610308|P13|COMPLETED|Double-Blind Period||0
7560623|NCT02963506|18610309|P12|COMPLETED|Double-Blind Period||0
7560624|NCT02963506|18610310|P11|COMPLETED|Double-Blind Period||0
7560625|NCT02963506|18610311|P10|COMPLETED|Double-Blind Period||0
7560626|NCT02963506|18610312|P9|COMPLETED|Double-Blind Period||0
7560627|NCT02963506|18610313|P8|COMPLETED|Double-Blind Period||0
7560628|NCT02963506|18610314|P7|COMPLETED|Double-Blind Period||0
7560629|NCT02963506|18610315|P6|COMPLETED|Double-Blind Period||0
7560630|NCT02963506|18610316|P5|COMPLETED|Double-Blind Period||61
7560631|NCT02963506|18610317|P4|COMPLETED|Double-Blind Period||58
7560632|NCT02963506|18610318|P3|COMPLETED|Double-Blind Period||59
7560633|NCT02963506|18610319|P2|COMPLETED|Double-Blind Period||58
7560634|NCT02963506|18610320|P1|COMPLETED|Double-Blind Period||60
7560635|NCT02963506|18610308|P13|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
7560636|NCT02963506|18610309|P12|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
7560637|NCT02963506|18610310|P11|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
7560638|NCT02963506|18610311|P10|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
7560639|NCT02963506|18610312|P9|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
7560640|NCT02963506|18610313|P8|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
7560641|NCT02963506|18610314|P7|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
7560642|NCT02963506|18610315|P6|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
7560643|NCT02963506|18610316|P5|Completed Week 12 - Started Dose-Blind|Double-Blind Period||61
7560644|NCT02963506|18610317|P4|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58
7560645|NCT02963506|18610318|P3|Completed Week 12 - Started Dose-Blind|Double-Blind Period||59
7560646|NCT02963506|18610319|P2|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58
7560647|NCT02963506|18610320|P1|Completed Week 12 - Started Dose-Blind|Double-Blind Period||60
7560648|NCT02963506|18610308|P13|Completed Double-Blind Period|Double-Blind Period||0
7560649|NCT02963506|18610309|P12|Completed Double-Blind Period|Double-Blind Period||0
7560650|NCT02963506|18610310|P11|Completed Double-Blind Period|Double-Blind Period||0
7560651|NCT02963506|18610311|P10|Completed Double-Blind Period|Double-Blind Period||0
7560652|NCT02963506|18610312|P9|Completed Double-Blind Period|Double-Blind Period||0
7560653|NCT02963506|18610313|P8|Completed Double-Blind Period|Double-Blind Period||0
7560654|NCT02963506|18610314|P7|Completed Double-Blind Period|Double-Blind Period||0
7560655|NCT02963506|18610315|P6|Completed Double-Blind Period|Double-Blind Period||0
7560656|NCT02963506|18610316|P5|Completed Double-Blind Period|Double-Blind Period||61
7560657|NCT02963506|18610317|P4|Completed Double-Blind Period|Double-Blind Period||58
7560658|NCT02963506|18610318|P3|Completed Double-Blind Period|Double-Blind Period||59
7560659|NCT02963506|18610319|P2|Completed Double-Blind Period|Double-Blind Period||59
7560660|NCT02963506|18610320|P1|Completed Double-Blind Period|Double-Blind Period||60
7560661|NCT02963506|18610308|P13|STARTED|Double-Blind Period||0
7560662|NCT02963506|18610309|P12|STARTED|Double-Blind Period||0
7560663|NCT02963506|18610310|P11|STARTED|Double-Blind Period||0
7560664|NCT02963506|18610311|P10|STARTED|Double-Blind Period||0
7560665|NCT02963506|18610312|P9|STARTED|Double-Blind Period||0
7560666|NCT02963506|18610313|P8|STARTED|Double-Blind Period||0
7560667|NCT02963506|18610314|P7|STARTED|Double-Blind Period||0
7560668|NCT02963506|18610315|P6|STARTED|Double-Blind Period||0
7560669|NCT02963506|18610316|P5|STARTED|Double-Blind Period||61
7560670|NCT02963506|18610317|P4|STARTED|Double-Blind Period||60
7560671|NCT02963506|18610318|P3|STARTED|Double-Blind Period||61
7560672|NCT02963506|18610319|P2|STARTED|Double-Blind Period||61
7560673|NCT02963506|18610320|P1|STARTED|Double-Blind Period||60
7560674|NCT02963311|18610372|P1|NOT COMPLETED|Overall Study||5
7560675|NCT02963311|18610372|P1|COMPLETED|Overall Study||4
7560676|NCT02963311|18610372|P1|STARTED|Overall Study||9
7560677|NCT02962960|18610399|P3|NOT COMPLETED|Overall Study||0
7560678|NCT02962960|18610400|P2|NOT COMPLETED|Overall Study||2
7560679|NCT02962960|18610401|P1|NOT COMPLETED|Overall Study||3
7560680|NCT02962960|18610399|P3|COMPLETED|Overall Study||9
7560681|NCT02962960|18610400|P2|COMPLETED|Overall Study||11
7560682|NCT02962960|18610401|P1|COMPLETED|Overall Study||11
7560683|NCT02962960|18610399|P3|STARTED|Overall Study||9
7560684|NCT02962960|18610400|P2|STARTED|Overall Study||13
7560685|NCT02962960|18610401|P1|STARTED|Overall Study||14
7560686|NCT02962934|18610474|P2|NOT COMPLETED|Overall Study||0
7560687|NCT02962934|18610475|P1|NOT COMPLETED|Overall Study||0
7560688|NCT02962934|18610474|P2|COMPLETED|Overall Study||6
7560689|NCT02962934|18610475|P1|COMPLETED|Overall Study||12
7560690|NCT02962934|18610474|P2|STARTED|Overall Study||6
7560691|NCT02962934|18610475|P1|STARTED|Overall Study||12
7560692|NCT02962908|18610485|P4|NOT COMPLETED|Overall Study||3
7560693|NCT02962908|18610486|P3|NOT COMPLETED|Overall Study||0
7560694|NCT02962908|18610487|P2|NOT COMPLETED|Overall Study||8
7560695|NCT02962908|18610488|P1|NOT COMPLETED|Overall Study||0
7560696|NCT02962908|18610485|P4|COMPLETED|Overall Study||24
7560697|NCT02962908|18610486|P3|COMPLETED|Overall Study||32
7560698|NCT02962908|18610487|P2|COMPLETED|Overall Study||50
7560699|NCT02962908|18610488|P1|COMPLETED|Overall Study||58
7560700|NCT02962908|18610485|P4|STARTED|Overall Study||27
7560701|NCT02962908|18610486|P3|STARTED|Overall Study||32
7560702|NCT02962908|18610487|P2|STARTED|Overall Study||58
7560703|NCT02962908|18610488|P1|STARTED|Overall Study||58
7560704|NCT02962882|18610552|P1|NOT COMPLETED|Overall Study||36
7560705|NCT02962882|18610552|P1|COMPLETED|Overall Study||14
7560706|NCT02962882|18610552|P1|STARTED|Overall Study||50
7560707|NCT02962687|18610563|P2|NOT COMPLETED|Overall Study||8
7560708|NCT02962687|18610564|P1|NOT COMPLETED|Overall Study||10
7560709|NCT02962687|18610563|P2|COMPLETED|Overall Study|This number represents 16 dyads (1 Veteran and 1 caregiver in each dyad)|32
7560710|NCT02962687|18610564|P1|COMPLETED|Overall Study|This number represents 15 dyads (1 Veteran and 1 caregiver in each dyad)|30
7560711|NCT02962687|18610563|P2|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
7560712|NCT02962687|18610564|P1|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
7560713|NCT02962648|18610588|P1|NOT COMPLETED|Overall Study||9
7560714|NCT02962648|18610588|P1|COMPLETED|Overall Study||94
7560715|NCT02962648|18610588|P1|STARTED|Overall Study||103
7560716|NCT02962609|18610602|P2|NOT COMPLETED|Overall Study||0
7560717|NCT02962609|18610603|P1|NOT COMPLETED|Overall Study||0
7560718|NCT02962609|18610602|P2|COMPLETED|Overall Study||42
7560719|NCT02962609|18610603|P1|COMPLETED|Overall Study||38
7560720|NCT02962609|18610602|P2|STARTED|Overall Study||42
7560721|NCT02962609|18610603|P1|STARTED|Overall Study||38
7560722|NCT02962427|18610615|P2|NOT COMPLETED|Overall Study||0
7560723|NCT02962427|18610616|P1|NOT COMPLETED|Overall Study||0
7560724|NCT02962427|18610615|P2|COMPLETED|Overall Study||1
7560725|NCT02962427|18610616|P1|COMPLETED|Overall Study||3
7560726|NCT02962427|18610615|P2|STARTED|Overall Study||1
7560727|NCT02962427|18610616|P1|STARTED|Overall Study||3
7560728|NCT02962284|18610626|P2|NOT COMPLETED|Overall Study||3
7560729|NCT02962284|18610627|P1|NOT COMPLETED|Overall Study||5
7560730|NCT02962284|18610626|P2|COMPLETED|Overall Study||8
7560731|NCT02962284|18610627|P1|COMPLETED|Overall Study||4
7560732|NCT02962284|18610626|P2|STARTED|Overall Study||11
7560733|NCT02962284|18610627|P1|STARTED|Overall Study||9
7560734|NCT02961946|18610646|P3|NOT COMPLETED|Overall Study||0
7560735|NCT02961946|18610647|P2|NOT COMPLETED|Overall Study||0
7560736|NCT02961946|18610648|P1|NOT COMPLETED|Overall Study||0
7560737|NCT02961946|18610646|P3|COMPLETED|Overall Study||66
7560738|NCT02961946|18610647|P2|COMPLETED|Overall Study||66
7560739|NCT02961946|18610648|P1|COMPLETED|Overall Study||66
7560740|NCT02961946|18610646|P3|STARTED|Overall Study||66
7560741|NCT02961946|18610647|P2|STARTED|Overall Study||66
7560742|NCT02961946|18610648|P1|STARTED|Overall Study||66
7560743|NCT02961920|18610658|P2|NOT COMPLETED|Overall Study||1
7560744|NCT02961920|18610659|P1|NOT COMPLETED|Overall Study||1
7560745|NCT02961920|18610658|P2|COMPLETED|Overall Study||24
7560746|NCT02961920|18610659|P1|COMPLETED|Overall Study||24
7560747|NCT02961920|18610658|P2|STARTED|Overall Study||25
7560748|NCT02961920|18610659|P1|STARTED|Overall Study||25
7560749|NCT02961894|18610665|P1|NOT COMPLETED|Overall Study||0
7560750|NCT02961894|18610665|P1|COMPLETED|Overall Study||121
7560751|NCT02961894|18610665|P1|STARTED|Overall Study||121
7560752|NCT02961790|18610687|P4|NOT COMPLETED|Overall Study||5
7560753|NCT02961790|18610688|P3|NOT COMPLETED|Overall Study||6
7560754|NCT02961790|18610689|P2|NOT COMPLETED|Overall Study||11
7560755|NCT02961790|18610690|P1|NOT COMPLETED|Overall Study||15
7560756|NCT02961790|18610687|P4|COMPLETED|Overall Study||20
7560757|NCT02961790|18610688|P3|COMPLETED|Overall Study||18
7560758|NCT02961790|18610689|P2|COMPLETED|Overall Study||40
7560759|NCT02961790|18610690|P1|COMPLETED|Overall Study||35
7560760|NCT02961790|18610687|P4|STARTED|Overall Study||25
7560761|NCT02961790|18610688|P3|STARTED|Overall Study||24
7560762|NCT02961790|18610689|P2|STARTED|Overall Study||51
7560763|NCT02961790|18610690|P1|STARTED|Overall Study||50
7560764|NCT02961764|18610713|P2|NOT COMPLETED|Overall Study||25
7560765|NCT02961764|18610714|P1|NOT COMPLETED|Overall Study||39
7560766|NCT02961764|18610713|P2|COMPLETED|Overall Study||128
7560767|NCT02961764|18610714|P1|COMPLETED|Overall Study||121
7560768|NCT02961764|18610713|P2|STARTED|Overall Study||153
7560769|NCT02961764|18610714|P1|STARTED|Overall Study||160
7560770|NCT02961751|18610788|P1|NOT COMPLETED|Overall Study||15
7560771|NCT02961751|18610788|P1|COMPLETED|Overall Study||196
7560772|NCT02961751|18610788|P1|STARTED|Overall Study||211
7560773|NCT02961244|18610801|P2|NOT COMPLETED|Overall Study||9
7560774|NCT02961244|18610802|P1|NOT COMPLETED|Overall Study||1
7560775|NCT02961244|18610801|P2|COMPLETED|Overall Study||55
7560776|NCT02961244|18610802|P1|COMPLETED|Overall Study||63
7560777|NCT02961244|18610801|P2|Patients Excluded During Randomization|Overall Study||1
7560778|NCT02961244|18610802|P1|Patients Excluded During Randomization|Overall Study||0
7560779|NCT02961244|18610801|P2|STARTED|Overall Study||64
7560780|NCT02961244|18610802|P1|STARTED|Overall Study||64
7560781|NCT02961218|18610812|P2|NOT COMPLETED|Overall Study||5
7560782|NCT02961218|18610813|P1|NOT COMPLETED|Overall Study||3
7560783|NCT02961218|18610812|P2|COMPLETED|Overall Study||19
7560784|NCT02961218|18610813|P1|COMPLETED|Overall Study||22
7560785|NCT02961218|18610812|P2|Primary PD Analysis Set|Overall Study||24
7560786|NCT02961218|18610813|P1|Primary PD Analysis Set|Overall Study||25
7560787|NCT02961218|18610812|P2|Pharmacokinetics (PK) Analysis Set|Overall Study|Placebo patients were excluded from the PK analyses|0
7560788|NCT02961218|18610813|P1|Pharmacokinetics (PK) Analysis Set|Overall Study||25
7560789|NCT02961218|18610812|P2|Safety Analysis Set|Overall Study||24
7560790|NCT02961218|18610813|P1|Safety Analysis Set|Overall Study||25
7560791|NCT02961218|18610812|P2|STARTED|Overall Study||24
7560792|NCT02961218|18610813|P1|STARTED|Overall Study||25
7560793|NCT02961062|18610850|P2|NOT COMPLETED|Overall Study||0
7560794|NCT02961062|18610851|P1|NOT COMPLETED|Overall Study||0
7560795|NCT02961062|18610850|P2|COMPLETED|Overall Study||20
7560796|NCT02961062|18610851|P1|COMPLETED|Overall Study||20
7560797|NCT02961062|18610850|P2|STARTED|Overall Study||20
7560798|NCT02961062|18610851|P1|STARTED|Overall Study||20
7560799|NCT02960997|18610867|P2|NOT COMPLETED|Follow-up Period, 4 Weeks||0
7560800|NCT02960997|18610868|P1|NOT COMPLETED|Follow-up Period, 4 Weeks||0
7560801|NCT02960997|18610867|P2|COMPLETED|Follow-up Period, 4 Weeks||4
7560802|NCT02960997|18610868|P1|COMPLETED|Follow-up Period, 4 Weeks||4
7560803|NCT02960997|18610867|P2|STARTED|Follow-up Period, 4 Weeks||4
7560804|NCT02960997|18610868|P1|STARTED|Follow-up Period, 4 Weeks||4
7560805|NCT02960997|18610867|P2|NOT COMPLETED|Second Treatment, 12 Weeks||0
7560806|NCT02960997|18610868|P1|NOT COMPLETED|Second Treatment, 12 Weeks||0
7560807|NCT02960997|18610867|P2|COMPLETED|Second Treatment, 12 Weeks||4
7560808|NCT02960997|18610868|P1|COMPLETED|Second Treatment, 12 Weeks||4
7560809|NCT02960997|18610867|P2|STARTED|Second Treatment, 12 Weeks||4
7560810|NCT02960997|18610868|P1|STARTED|Second Treatment, 12 Weeks||4
7560811|NCT02960997|18610867|P2|NOT COMPLETED|Washout Period, 4 Weeks||0
7560812|NCT02960997|18610868|P1|NOT COMPLETED|Washout Period, 4 Weeks||0
7560813|NCT02960997|18610867|P2|COMPLETED|Washout Period, 4 Weeks||4
7560814|NCT02960997|18610868|P1|COMPLETED|Washout Period, 4 Weeks||4
7560815|NCT02960997|18610867|P2|STARTED|Washout Period, 4 Weeks||4
7560816|NCT02960997|18610868|P1|STARTED|Washout Period, 4 Weeks||4
7560817|NCT02960997|18610867|P2|NOT COMPLETED|First Intervention, 12 Weeks||0
7560818|NCT02960997|18610868|P1|NOT COMPLETED|First Intervention, 12 Weeks||0
7560819|NCT02960997|18610867|P2|COMPLETED|First Intervention, 12 Weeks||4
7560820|NCT02960997|18610868|P1|COMPLETED|First Intervention, 12 Weeks||4
7560821|NCT02960997|18610867|P2|STARTED|First Intervention, 12 Weeks||4
7560822|NCT02960997|18610868|P1|STARTED|First Intervention, 12 Weeks||4
7560823|NCT02960893|18610893|P2|NOT COMPLETED|Extension Phase (48-week)||13
7560824|NCT02960893|18610894|P1|NOT COMPLETED|Extension Phase (48-week)||14
7560825|NCT02960893|18610893|P2|COMPLETED|Extension Phase (48-week)||54
7560826|NCT02960893|18610894|P1|COMPLETED|Extension Phase (48-week)||50
7560827|NCT02960893|18610893|P2|STARTED|Extension Phase (48-week)|One participant in placebo arm who completed Randomization Phase did not continue to Extension Phase|67
7560828|NCT02960893|18610894|P1|STARTED|Extension Phase (48-week)||64
7560829|NCT02960893|18610893|P2|NOT COMPLETED|Randomization Phase (8-week)||2
7560830|NCT02960893|18610894|P1|NOT COMPLETED|Randomization Phase (8-week)||7
7560831|NCT02960893|18610893|P2|COMPLETED|Randomization Phase (8-week)||68
7560832|NCT02960893|18610894|P1|COMPLETED|Randomization Phase (8-week)||64
7560833|NCT02960893|18610893|P2|STARTED|Randomization Phase (8-week)||70
7560834|NCT02960893|18610894|P1|STARTED|Randomization Phase (8-week)||71
7560835|NCT02960854|18610912|P2|NOT COMPLETED|Overall Study||9
7560836|NCT02960854|18610913|P1|NOT COMPLETED|Overall Study||7
7560837|NCT02960854|18610912|P2|COMPLETED|Overall Study||7
7560838|NCT02960854|18610913|P1|COMPLETED|Overall Study||8
7560839|NCT02960854|18610912|P2|STARTED|Overall Study||16
7560840|NCT02960854|18610913|P1|STARTED|Overall Study||15
7560841|NCT02960295|18610943|P1|NOT COMPLETED|Overall Study||0
7560842|NCT02960295|18610943|P1|COMPLETED|Overall Study||10
7560843|NCT02960295|18610943|P1|STARTED|Overall Study||10
7560844|NCT02960217|18610952|P2|NOT COMPLETED|Open-Label Extension Phase||13
7560845|NCT02960217|18610953|P1|NOT COMPLETED|Open-Label Extension Phase||20
7560846|NCT02960217|18610952|P2|COMPLETED|Open-Label Extension Phase||0
7560847|NCT02960217|18610953|P1|COMPLETED|Open-Label Extension Phase||0
7560848|NCT02960217|18610952|P2|STARTED|Open-Label Extension Phase|5 participants completed the double blind period but did not continue in the open label period.|13
7560849|NCT02960217|18610953|P1|STARTED|Open-Label Extension Phase||20
7560850|NCT02960217|18610952|P2|NOT COMPLETED|Maintenance Phase: Treatment Period 2||3
7560851|NCT02960217|18610953|P1|NOT COMPLETED|Maintenance Phase: Treatment Period 2||1
7560852|NCT02960217|18610952|P2|COMPLETED|Maintenance Phase: Treatment Period 2||18
7560853|NCT02960217|18610953|P1|COMPLETED|Maintenance Phase: Treatment Period 2||20
7560854|NCT02960217|18610952|P2|STARTED|Maintenance Phase: Treatment Period 2||21
7560855|NCT02960217|18610953|P1|STARTED|Maintenance Phase: Treatment Period 2||21
7560856|NCT02960217|18610952|P2|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
7560857|NCT02960217|18610953|P1|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
7560858|NCT02960217|18610952|P2|COMPLETED|Maintenance Phase: Crossover Washout||21
7560859|NCT02960217|18610953|P1|COMPLETED|Maintenance Phase: Crossover Washout||21
7560860|NCT02960217|18610952|P2|STARTED|Maintenance Phase: Crossover Washout||21
7560861|NCT02960217|18610953|P1|STARTED|Maintenance Phase: Crossover Washout||21
7560862|NCT02960217|18610952|P2|NOT COMPLETED|Maintenance Phase: Treatment Period 1||0
7560863|NCT02960217|18610953|P1|NOT COMPLETED|Maintenance Phase: Treatment Period 1||1
7560864|NCT02960217|18610952|P2|COMPLETED|Maintenance Phase: Treatment Period 1||21
7560865|NCT02960217|18610953|P1|COMPLETED|Maintenance Phase: Treatment Period 1||21
7560866|NCT02960217|18610952|P2|STARTED|Maintenance Phase: Treatment Period 1||21
7560867|NCT02960217|18610953|P1|STARTED|Maintenance Phase: Treatment Period 1||22
7560868|NCT02959996|18611007|P2|NOT COMPLETED|Overall Study||0
7560869|NCT02959996|18611008|P1|NOT COMPLETED|Overall Study||0
7560870|NCT02959996|18611007|P2|COMPLETED|Overall Study||39
7560871|NCT02959996|18611008|P1|COMPLETED|Overall Study||40
7560872|NCT02959996|18611007|P2|STARTED|Overall Study||39
7560873|NCT02959996|18611008|P1|STARTED|Overall Study||40
7560874|NCT02959983|18611032|P2|NOT COMPLETED|Overall Study||25
7560875|NCT02959983|18611033|P1|NOT COMPLETED|Overall Study||26
7560876|NCT02959983|18611032|P2|COMPLETED|Overall Study||149
7560877|NCT02959983|18611033|P1|COMPLETED|Overall Study||146
7560878|NCT02959983|18611032|P2|STARTED|Overall Study||174
7560879|NCT02959983|18611033|P1|STARTED|Overall Study||172
7560880|NCT02959970|18611047|P2|NOT COMPLETED|Overall Study||7
7560881|NCT02959970|18611048|P1|NOT COMPLETED|Overall Study||2
7560882|NCT02959970|18611047|P2|COMPLETED|Overall Study||76
7560883|NCT02959970|18611048|P1|COMPLETED|Overall Study||15
7560884|NCT02959970|18611047|P2|STARTED|Overall Study||83
7560885|NCT02959970|18611048|P1|STARTED|Overall Study||17
7560886|NCT02959892|18611082|P2|NOT COMPLETED|Overall Study||1
7560887|NCT02959892|18611083|P1|NOT COMPLETED|Overall Study||1
7560888|NCT02959892|18611082|P2|COMPLETED|Overall Study||5
7560889|NCT02959892|18611083|P1|COMPLETED|Overall Study||5
7560890|NCT02959892|18611082|P2|STARTED|Overall Study||6
7560891|NCT02959892|18611083|P1|STARTED|Overall Study||6
7560892|NCT02959866|18611091|P1|NOT COMPLETED|Overall Study||1
7560893|NCT02959866|18611091|P1|COMPLETED|Overall Study||58
7560894|NCT02959866|18611091|P1|Telephone Interview at 1 Month Follow-up|Overall Study||59
7560895|NCT02959866|18611091|P1|STARTED|Overall Study||59
7560896|NCT02959853|18611098|P2|NOT COMPLETED|Overall Study||2
7560897|NCT02959853|18611099|P1|NOT COMPLETED|Overall Study||4
7560898|NCT02959853|18611098|P2|COMPLETED|Overall Study||10
7560899|NCT02959853|18611099|P1|COMPLETED|Overall Study||7
7560900|NCT02959853|18611098|P2|STARTED|Overall Study||12
7560901|NCT02959853|18611099|P1|STARTED|Overall Study||11
7560902|NCT02959840|18611118|P3|NOT COMPLETED|Overall Study||0
7560903|NCT02959840|18611119|P2|NOT COMPLETED|Overall Study||0
7560904|NCT02959840|18611120|P1|NOT COMPLETED|Overall Study||0
7560905|NCT02959840|18611118|P3|COMPLETED|Overall Study||60
7560906|NCT02959840|18611119|P2|COMPLETED|Overall Study||60
7560907|NCT02959840|18611120|P1|COMPLETED|Overall Study||60
7560908|NCT02959840|18611118|P3|STARTED|Overall Study||60
7560909|NCT02959840|18611119|P2|STARTED|Overall Study||60
7560910|NCT02959840|18611120|P1|STARTED|Overall Study||60
7560911|NCT02959827|18611161|P1|NOT COMPLETED|Overall Study||0
7560912|NCT02959827|18611161|P1|COMPLETED|Overall Study||2320
7560913|NCT02959827|18611161|P1|STARTED|Overall Study||2320
7560914|NCT02959814|18611180|P1|NOT COMPLETED|Overall Study||57
7560915|NCT02959814|18611180|P1|COMPLETED|Overall Study|17-10-2017|272
7560916|NCT02959814|18611180|P1|STARTED|Overall Study|22-02-2017|329
7560917|NCT02959437|18611203|P4|NOT COMPLETED|Overall Study||0
7560918|NCT02959437|18611204|P3|NOT COMPLETED|Overall Study||0
7560919|NCT02959437|18611205|P2|NOT COMPLETED|Overall Study||8
7560920|NCT02959437|18611206|P1|NOT COMPLETED|Overall Study||62
7560921|NCT02959437|18611203|P4|COMPLETED|Overall Study||0
7560922|NCT02959437|18611204|P3|COMPLETED|Overall Study||0
7560923|NCT02959437|18611205|P2|COMPLETED|Overall Study||0
7560924|NCT02959437|18611206|P1|COMPLETED|Overall Study||0
7560925|NCT02959437|18611203|P4|STARTED|Overall Study||0
7560926|NCT02959437|18611204|P3|STARTED|Overall Study||0
7560927|NCT02959437|18611205|P2|STARTED|Overall Study||8
7560928|NCT02959437|18611206|P1|STARTED|Overall Study||62
7560929|NCT02959307|18611220|P2|NOT COMPLETED|Phase 2||0
7560930|NCT02959307|18611221|P1|NOT COMPLETED|Phase 2||2
7560931|NCT02959307|18611220|P2|COMPLETED|Phase 2||10
7560932|NCT02959307|18611221|P1|COMPLETED|Phase 2||26
7560933|NCT02959307|18611220|P2|STARTED|Phase 2|This group is decreased as those in sham were re-randomized to sham or NIR.|10
7560934|NCT02959307|18611221|P1|STARTED|Phase 2|This group is increased as those in sham were re-randomized to sham or NIR.|28
7560935|NCT02959307|18611220|P2|NOT COMPLETED|Phase 1||8
7560936|NCT02959307|18611221|P1|NOT COMPLETED|Phase 1||3
7560937|NCT02959307|18611220|P2|COMPLETED|Phase 1||23
7560938|NCT02959307|18611221|P1|COMPLETED|Phase 1||15
7560939|NCT02959307|18611220|P2|STARTED|Phase 1||31
7560940|NCT02959307|18611221|P1|STARTED|Phase 1||18
7560941|NCT02959190|18611239|P4|NOT COMPLETED|Post Treatment Follow Up||0
7560942|NCT02959190|18611240|P3|NOT COMPLETED|Post Treatment Follow Up||1
7560943|NCT02959190|18611241|P2|NOT COMPLETED|Post Treatment Follow Up||1
7560944|NCT02959190|18611242|P1|NOT COMPLETED|Post Treatment Follow Up||3
7560945|NCT02959190|18611239|P4|COMPLETED|Post Treatment Follow Up||32
7560946|NCT02959190|18611240|P3|COMPLETED|Post Treatment Follow Up||31
7560947|NCT02959190|18611241|P2|COMPLETED|Post Treatment Follow Up||119
7560948|NCT02959190|18611242|P1|COMPLETED|Post Treatment Follow Up||114
7560949|NCT02959190|18611239|P4|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
7560950|NCT02959190|18611240|P3|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
7560951|NCT02959190|18611241|P2|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|120
7560952|NCT02959190|18611242|P1|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|117
7560953|NCT02959190|18611239|P4|NOT COMPLETED|Open Label||6
7560954|NCT02959190|18611240|P3|NOT COMPLETED|Open Label||4
7560955|NCT02959190|18611241|P2|NOT COMPLETED|Open Label||16
7560956|NCT02959190|18611242|P1|NOT COMPLETED|Open Label||7
7560957|NCT02959190|18611239|P4|COMPLETED|Open Label||27
7560958|NCT02959190|18611240|P3|COMPLETED|Open Label||28
7560959|NCT02959190|18611241|P2|COMPLETED|Open Label||110
7560960|NCT02959190|18611242|P1|COMPLETED|Open Label||113
7560961|NCT02959190|18611239|P4|Placebo/ 240mg Galcanezumab - EM|Open Label||0
7560962|NCT02959190|18611240|P3|Placebo/ 240mg Galcanezumab - EM|Open Label||0
7560963|NCT02959190|18611241|P2|Placebo/ 240mg Galcanezumab - EM|Open Label||64
7560964|NCT02959190|18611242|P1|Placebo/ 240mg Galcanezumab - EM|Open Label||0
7560965|NCT02959190|18611239|P4|Placebo/ 120mg Galcanezumab - EM|Open Label||0
7560966|NCT02959190|18611240|P3|Placebo/ 120mg Galcanezumab - EM|Open Label||0
7560967|NCT02959190|18611241|P2|Placebo/ 120mg Galcanezumab - EM|Open Label||0
7560968|NCT02959190|18611242|P1|Placebo/ 120mg Galcanezumab - EM|Open Label||62
7560969|NCT02959190|18611239|P4|240mg/240mg Galcanezumab - EM|Open Label||0
7560970|NCT02959190|18611240|P3|240mg/240mg Galcanezumab - EM|Open Label||0
7560971|NCT02959190|18611241|P2|240mg/240mg Galcanezumab - EM|Open Label||62
7560972|NCT02959190|18611242|P1|240mg/240mg Galcanezumab - EM|Open Label||0
7560973|NCT02959190|18611239|P4|120mg/120mg Galcanezumab - EM|Open Label||0
7560974|NCT02959190|18611240|P3|120mg/120mg Galcanezumab - EM|Open Label||0
7560975|NCT02959190|18611241|P2|120mg/120mg Galcanezumab - EM|Open Label||0
7560976|NCT02959190|18611242|P1|120mg/120mg Galcanezumab - EM|Open Label||58
7560977|NCT02959190|18611239|P4|Received at Least 1 Dose of Study Drug|Open Label||33
7560978|NCT02959190|18611240|P3|Received at Least 1 Dose of Study Drug|Open Label||32
7560979|NCT02959190|18611241|P2|Received at Least 1 Dose of Study Drug|Open Label||126
7560980|NCT02959190|18611242|P1|Received at Least 1 Dose of Study Drug|Open Label||120
7560981|NCT02959190|18611239|P4|STARTED|Open Label||33
7560982|NCT02959190|18611240|P3|STARTED|Open Label||32
7560983|NCT02959190|18611241|P2|STARTED|Open Label||126
7560984|NCT02959190|18611242|P1|STARTED|Open Label||120
7560985|NCT02959177|18611335|P3|NOT COMPLETED|Follow-up Post Treatment Phase||2
7560986|NCT02959177|18611336|P2|NOT COMPLETED|Follow-up Post Treatment Phase||1
7560987|NCT02959177|18611337|P1|NOT COMPLETED|Follow-up Post Treatment Phase||1
7560988|NCT02959177|18611335|P3|COMPLETED|Follow-up Post Treatment Phase||98
7560989|NCT02959177|18611336|P2|COMPLETED|Follow-up Post Treatment Phase||51
7560990|NCT02959177|18611337|P1|COMPLETED|Follow-up Post Treatment Phase||51
7560991|NCT02959177|18611335|P3|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|100
7560992|NCT02959177|18611336|P2|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
7560993|NCT02959177|18611337|P1|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
7560994|NCT02959177|18611335|P3|NOT COMPLETED|Double-Blind Treatment Phase||5
7560995|NCT02959177|18611336|P2|NOT COMPLETED|Double-Blind Treatment Phase||3
7560996|NCT02959177|18611337|P1|NOT COMPLETED|Double-Blind Treatment Phase||11
7560997|NCT02959177|18611335|P3|COMPLETED|Double-Blind Treatment Phase||225
7560998|NCT02959177|18611336|P2|COMPLETED|Double-Blind Treatment Phase||111
7560999|NCT02959177|18611337|P1|COMPLETED|Double-Blind Treatment Phase||104
7561000|NCT02959177|18611335|P3|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||230
7561001|NCT02959177|18611336|P2|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||114
7561002|NCT02959177|18611337|P1|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||115
7561003|NCT02959177|18611335|P3|STARTED|Double-Blind Treatment Phase||230
7561004|NCT02959177|18611336|P2|STARTED|Double-Blind Treatment Phase||114
7561005|NCT02959177|18611337|P1|STARTED|Double-Blind Treatment Phase||115
7561006|NCT02959138|18611392|P3|NOT COMPLETED|Overall Study||0
7561007|NCT02959138|18611393|P2|NOT COMPLETED|Overall Study||1
7561008|NCT02959138|18611394|P1|NOT COMPLETED|Overall Study||0
7561009|NCT02959138|18611392|P3|COMPLETED|Overall Study||16
7561010|NCT02959138|18611393|P2|COMPLETED|Overall Study||9
7561011|NCT02959138|18611394|P1|COMPLETED|Overall Study||10
7561012|NCT02959138|18611392|P3|STARTED|Overall Study||16
7561013|NCT02959138|18611393|P2|STARTED|Overall Study||10
7561014|NCT02959138|18611394|P1|STARTED|Overall Study||10
7561015|NCT02958995|18611419|P2|NOT COMPLETED|Overall Study||0
7561016|NCT02958995|18611420|P1|NOT COMPLETED|Overall Study||0
7561017|NCT02958995|18611419|P2|COMPLETED|Overall Study||107495
7561018|NCT02958995|18611420|P1|COMPLETED|Overall Study||2630666
7561019|NCT02958995|18611419|P2|STARTED|Overall Study||107495
7561020|NCT02958995|18611420|P1|STARTED|Overall Study||2630666
7561021|NCT02958982|18611439|P11|NOT COMPLETED|Proof of Concept Study||0
7561022|NCT02958982|18611440|P10|NOT COMPLETED|Proof of Concept Study||0
7561023|NCT02958982|18611441|P9|NOT COMPLETED|Proof of Concept Study||0
7561024|NCT02958982|18611442|P8|NOT COMPLETED|Proof of Concept Study||0
7561025|NCT02958982|18611443|P7|NOT COMPLETED|Proof of Concept Study||0
7561026|NCT02958982|18611444|P6|NOT COMPLETED|Proof of Concept Study||0
7561027|NCT02958982|18611445|P5|NOT COMPLETED|Proof of Concept Study||0
7561028|NCT02958982|18611446|P4|NOT COMPLETED|Proof of Concept Study||0
7561029|NCT02958982|18611447|P3|NOT COMPLETED|Proof of Concept Study||0
7561030|NCT02958982|18611448|P2|NOT COMPLETED|Proof of Concept Study||0
7561031|NCT02958982|18611449|P1|NOT COMPLETED|Proof of Concept Study||0
7561032|NCT02958982|18611439|P11|COMPLETED|Proof of Concept Study||1
7561033|NCT02958982|18611440|P10|COMPLETED|Proof of Concept Study||0
7561034|NCT02958982|18611441|P9|COMPLETED|Proof of Concept Study||0
7561035|NCT02958982|18611442|P8|COMPLETED|Proof of Concept Study||0
7561036|NCT02958982|18611443|P7|COMPLETED|Proof of Concept Study||0
7561037|NCT02958982|18611444|P6|COMPLETED|Proof of Concept Study||0
7561038|NCT02958982|18611445|P5|COMPLETED|Proof of Concept Study||0
7561039|NCT02958982|18611446|P4|COMPLETED|Proof of Concept Study||0
7561040|NCT02958982|18611447|P3|COMPLETED|Proof of Concept Study||0
7561041|NCT02958982|18611448|P2|COMPLETED|Proof of Concept Study||0
7561042|NCT02958982|18611449|P1|COMPLETED|Proof of Concept Study||0
7561043|NCT02958982|18611439|P11|STARTED|Proof of Concept Study||1
7561044|NCT02958982|18611440|P10|STARTED|Proof of Concept Study||0
7561045|NCT02958982|18611441|P9|STARTED|Proof of Concept Study||0
7561046|NCT02958982|18611442|P8|STARTED|Proof of Concept Study||0
7561047|NCT02958982|18611443|P7|STARTED|Proof of Concept Study||0
7561048|NCT02958982|18611444|P6|STARTED|Proof of Concept Study||0
7561049|NCT02958982|18611445|P5|STARTED|Proof of Concept Study||0
7561050|NCT02958982|18611446|P4|STARTED|Proof of Concept Study||0
7561051|NCT02958982|18611447|P3|STARTED|Proof of Concept Study||0
7561052|NCT02958982|18611448|P2|STARTED|Proof of Concept Study||0
7561053|NCT02958982|18611449|P1|STARTED|Proof of Concept Study||0
7561054|NCT02958982|18611439|P11|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
7561055|NCT02958982|18611440|P10|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
7561056|NCT02958982|18611441|P9|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
7561057|NCT02958982|18611442|P8|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
7561058|NCT02958982|18611443|P7|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
7561059|NCT02958982|18611444|P6|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
7561060|NCT02958982|18611445|P5|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
7561061|NCT02958982|18611446|P4|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
7561062|NCT02958982|18611447|P3|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
7561063|NCT02958982|18611448|P2|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
7561064|NCT02958982|18611449|P1|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
7561065|NCT02958982|18611439|P11|COMPLETED|Cohort 3: 400 mg in MAD Study||0
7561066|NCT02958982|18611440|P10|COMPLETED|Cohort 3: 400 mg in MAD Study||6
7561067|NCT02958982|18611441|P9|COMPLETED|Cohort 3: 400 mg in MAD Study||0
7561068|NCT02958982|18611442|P8|COMPLETED|Cohort 3: 400 mg in MAD Study||0
7561069|NCT02958982|18611443|P7|COMPLETED|Cohort 3: 400 mg in MAD Study||2
7561070|NCT02958982|18611444|P6|COMPLETED|Cohort 3: 400 mg in MAD Study||0
7561071|NCT02958982|18611445|P5|COMPLETED|Cohort 3: 400 mg in MAD Study||0
7561072|NCT02958982|18611446|P4|COMPLETED|Cohort 3: 400 mg in MAD Study||0
7561073|NCT02958982|18611447|P3|COMPLETED|Cohort 3: 400 mg in MAD Study||0
7561074|NCT02958982|18611448|P2|COMPLETED|Cohort 3: 400 mg in MAD Study||0
7561075|NCT02958982|18611449|P1|COMPLETED|Cohort 3: 400 mg in MAD Study||0
7561076|NCT02958982|18611439|P11|STARTED|Cohort 3: 400 mg in MAD Study||0
7561077|NCT02958982|18611440|P10|STARTED|Cohort 3: 400 mg in MAD Study||6
7561078|NCT02958982|18611441|P9|STARTED|Cohort 3: 400 mg in MAD Study||0
7561079|NCT02958982|18611442|P8|STARTED|Cohort 3: 400 mg in MAD Study||0
7561080|NCT02958982|18611443|P7|STARTED|Cohort 3: 400 mg in MAD Study||2
7561081|NCT02958982|18611444|P6|STARTED|Cohort 3: 400 mg in MAD Study||0
7561082|NCT02958982|18611445|P5|STARTED|Cohort 3: 400 mg in MAD Study||0
7561083|NCT02958982|18611446|P4|STARTED|Cohort 3: 400 mg in MAD Study||0
7561084|NCT02958982|18611447|P3|STARTED|Cohort 3: 400 mg in MAD Study||0
7561085|NCT02958982|18611448|P2|STARTED|Cohort 3: 400 mg in MAD Study||0
7561086|NCT02958982|18611449|P1|STARTED|Cohort 3: 400 mg in MAD Study||0
7561087|NCT02958982|18611439|P11|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
7561088|NCT02958982|18611440|P10|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
7561089|NCT02958982|18611441|P9|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
7561090|NCT02958982|18611442|P8|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
7561091|NCT02958982|18611443|P7|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
7561092|NCT02958982|18611444|P6|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
7561093|NCT02958982|18611445|P5|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
7561094|NCT02958982|18611446|P4|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
7561095|NCT02958982|18611447|P3|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
7561096|NCT02958982|18611448|P2|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
7561097|NCT02958982|18611449|P1|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
7561098|NCT02958982|18611439|P11|COMPLETED|Cohort 2: 100 mg in MAD Study||0
7561099|NCT02958982|18611440|P10|COMPLETED|Cohort 2: 100 mg in MAD Study||0
7561100|NCT02958982|18611441|P9|COMPLETED|Cohort 2: 100 mg in MAD Study||6
7561101|NCT02958982|18611442|P8|COMPLETED|Cohort 2: 100 mg in MAD Study||0
7561102|NCT02958982|18611443|P7|COMPLETED|Cohort 2: 100 mg in MAD Study||2
7561103|NCT02958982|18611444|P6|COMPLETED|Cohort 2: 100 mg in MAD Study||0
7561104|NCT02958982|18611445|P5|COMPLETED|Cohort 2: 100 mg in MAD Study||0
7561105|NCT02958982|18611446|P4|COMPLETED|Cohort 2: 100 mg in MAD Study||0
7561106|NCT02958982|18611447|P3|COMPLETED|Cohort 2: 100 mg in MAD Study||0
7561107|NCT02958982|18611448|P2|COMPLETED|Cohort 2: 100 mg in MAD Study||0
7561108|NCT02958982|18611449|P1|COMPLETED|Cohort 2: 100 mg in MAD Study||0
7561109|NCT02958982|18611439|P11|STARTED|Cohort 2: 100 mg in MAD Study||0
7561110|NCT02958982|18611440|P10|STARTED|Cohort 2: 100 mg in MAD Study||0
7561111|NCT02958982|18611441|P9|STARTED|Cohort 2: 100 mg in MAD Study||6
7561112|NCT02958982|18611442|P8|STARTED|Cohort 2: 100 mg in MAD Study||0
7561113|NCT02958982|18611443|P7|STARTED|Cohort 2: 100 mg in MAD Study||2
7561114|NCT02958982|18611444|P6|STARTED|Cohort 2: 100 mg in MAD Study||0
7561115|NCT02958982|18611445|P5|STARTED|Cohort 2: 100 mg in MAD Study||0
7561116|NCT02958982|18611446|P4|STARTED|Cohort 2: 100 mg in MAD Study||0
7561117|NCT02958982|18611447|P3|STARTED|Cohort 2: 100 mg in MAD Study||0
7561118|NCT02958982|18611448|P2|STARTED|Cohort 2: 100 mg in MAD Study||0
7561119|NCT02958982|18611449|P1|STARTED|Cohort 2: 100 mg in MAD Study||0
7561120|NCT02958982|18611439|P11|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
7561121|NCT02958982|18611440|P10|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
7561122|NCT02958982|18611441|P9|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
7561123|NCT02958982|18611442|P8|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
7561124|NCT02958982|18611443|P7|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
7561125|NCT02958982|18611444|P6|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
7561126|NCT02958982|18611445|P5|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
7561127|NCT02958982|18611446|P4|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
7561128|NCT02958982|18611447|P3|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
7561129|NCT02958982|18611448|P2|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
7561130|NCT02958982|18611449|P1|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
7561131|NCT02958982|18611439|P11|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
7561132|NCT02958982|18611440|P10|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
7561133|NCT02958982|18611441|P9|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
7561134|NCT02958982|18611442|P8|COMPLETED|Cohort 1 : 25 mg in MAD Study||6
7561135|NCT02958982|18611443|P7|COMPLETED|Cohort 1 : 25 mg in MAD Study||2
7561136|NCT02958982|18611444|P6|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
7561137|NCT02958982|18611445|P5|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
7561138|NCT02958982|18611446|P4|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
7561139|NCT02958982|18611447|P3|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
7561140|NCT02958982|18611448|P2|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
7561141|NCT02958982|18611449|P1|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
7561142|NCT02958982|18611439|P11|STARTED|Cohort 1 : 25 mg in MAD Study||0
7561143|NCT02958982|18611440|P10|STARTED|Cohort 1 : 25 mg in MAD Study||0
7561144|NCT02958982|18611441|P9|STARTED|Cohort 1 : 25 mg in MAD Study||0
7561145|NCT02958982|18611442|P8|STARTED|Cohort 1 : 25 mg in MAD Study||6
7561146|NCT02958982|18611443|P7|STARTED|Cohort 1 : 25 mg in MAD Study||2
7561147|NCT02958982|18611444|P6|STARTED|Cohort 1 : 25 mg in MAD Study||0
7561148|NCT02958982|18611445|P5|STARTED|Cohort 1 : 25 mg in MAD Study||0
7561149|NCT02958982|18611446|P4|STARTED|Cohort 1 : 25 mg in MAD Study||0
7561150|NCT02958982|18611447|P3|STARTED|Cohort 1 : 25 mg in MAD Study||0
7561151|NCT02958982|18611448|P2|STARTED|Cohort 1 : 25 mg in MAD Study||0
7561152|NCT02958982|18611449|P1|STARTED|Cohort 1 : 25 mg in MAD Study||0
7561153|NCT02958982|18611439|P11|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
7561154|NCT02958982|18611440|P10|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
7561155|NCT02958982|18611441|P9|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
7561156|NCT02958982|18611442|P8|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
7561157|NCT02958982|18611443|P7|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
7561158|NCT02958982|18611444|P6|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
7561159|NCT02958982|18611445|P5|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
7561160|NCT02958982|18611446|P4|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
7561161|NCT02958982|18611447|P3|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
7561162|NCT02958982|18611448|P2|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
7561163|NCT02958982|18611449|P1|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
7561164|NCT02958982|18611439|P11|COMPLETED|Cohort 5: 400 mg in SAD Study||0
7561165|NCT02958982|18611440|P10|COMPLETED|Cohort 5: 400 mg in SAD Study||0
7561166|NCT02958982|18611441|P9|COMPLETED|Cohort 5: 400 mg in SAD Study||0
7561167|NCT02958982|18611442|P8|COMPLETED|Cohort 5: 400 mg in SAD Study||0
7561168|NCT02958982|18611443|P7|COMPLETED|Cohort 5: 400 mg in SAD Study||0
7561169|NCT02958982|18611444|P6|COMPLETED|Cohort 5: 400 mg in SAD Study||6
7561170|NCT02958982|18611445|P5|COMPLETED|Cohort 5: 400 mg in SAD Study||0
7561171|NCT02958982|18611446|P4|COMPLETED|Cohort 5: 400 mg in SAD Study||0
7561172|NCT02958982|18611447|P3|COMPLETED|Cohort 5: 400 mg in SAD Study||0
7561173|NCT02958982|18611448|P2|COMPLETED|Cohort 5: 400 mg in SAD Study||0
7561174|NCT02958982|18611449|P1|COMPLETED|Cohort 5: 400 mg in SAD Study||2
7561175|NCT02958982|18611439|P11|STARTED|Cohort 5: 400 mg in SAD Study||0
7561176|NCT02958982|18611440|P10|STARTED|Cohort 5: 400 mg in SAD Study||0
7561177|NCT02958982|18611441|P9|STARTED|Cohort 5: 400 mg in SAD Study||0
7561178|NCT02958982|18611442|P8|STARTED|Cohort 5: 400 mg in SAD Study||0
7561179|NCT02958982|18611443|P7|STARTED|Cohort 5: 400 mg in SAD Study||0
7561180|NCT02958982|18611444|P6|STARTED|Cohort 5: 400 mg in SAD Study||6
7561181|NCT02958982|18611445|P5|STARTED|Cohort 5: 400 mg in SAD Study||0
7561182|NCT02958982|18611446|P4|STARTED|Cohort 5: 400 mg in SAD Study||0
7561183|NCT02958982|18611447|P3|STARTED|Cohort 5: 400 mg in SAD Study||0
7561184|NCT02958982|18611448|P2|STARTED|Cohort 5: 400 mg in SAD Study||0
7561185|NCT02958982|18611449|P1|STARTED|Cohort 5: 400 mg in SAD Study||2
7561186|NCT02958982|18611439|P11|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
7561187|NCT02958982|18611440|P10|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
7561188|NCT02958982|18611441|P9|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
7561189|NCT02958982|18611442|P8|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
7561190|NCT02958982|18611443|P7|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
7561191|NCT02958982|18611444|P6|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
7561192|NCT02958982|18611445|P5|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
7561193|NCT02958982|18611446|P4|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
7561194|NCT02958982|18611447|P3|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
7561195|NCT02958982|18611448|P2|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
7561196|NCT02958982|18611449|P1|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
7561197|NCT02958982|18611439|P11|COMPLETED|Cohort 4: 200 mg in SAD Study||0
7561198|NCT02958982|18611440|P10|COMPLETED|Cohort 4: 200 mg in SAD Study||0
7561199|NCT02958982|18611441|P9|COMPLETED|Cohort 4: 200 mg in SAD Study||0
7561200|NCT02958982|18611442|P8|COMPLETED|Cohort 4: 200 mg in SAD Study||0
7561201|NCT02958982|18611443|P7|COMPLETED|Cohort 4: 200 mg in SAD Study||0
7561202|NCT02958982|18611444|P6|COMPLETED|Cohort 4: 200 mg in SAD Study||0
7561203|NCT02958982|18611445|P5|COMPLETED|Cohort 4: 200 mg in SAD Study||6
7561204|NCT02958982|18611446|P4|COMPLETED|Cohort 4: 200 mg in SAD Study||0
7561205|NCT02958982|18611447|P3|COMPLETED|Cohort 4: 200 mg in SAD Study||0
7561206|NCT02958982|18611448|P2|COMPLETED|Cohort 4: 200 mg in SAD Study||0
7561207|NCT02958982|18611449|P1|COMPLETED|Cohort 4: 200 mg in SAD Study||2
7561208|NCT02958982|18611439|P11|STARTED|Cohort 4: 200 mg in SAD Study||0
7561209|NCT02958982|18611440|P10|STARTED|Cohort 4: 200 mg in SAD Study||0
7561210|NCT02958982|18611441|P9|STARTED|Cohort 4: 200 mg in SAD Study||0
7561211|NCT02958982|18611442|P8|STARTED|Cohort 4: 200 mg in SAD Study||0
7561212|NCT02958982|18611443|P7|STARTED|Cohort 4: 200 mg in SAD Study||0
7561213|NCT02958982|18611444|P6|STARTED|Cohort 4: 200 mg in SAD Study||0
7561214|NCT02958982|18611445|P5|STARTED|Cohort 4: 200 mg in SAD Study||6
7561215|NCT02958982|18611446|P4|STARTED|Cohort 4: 200 mg in SAD Study||0
7561216|NCT02958982|18611447|P3|STARTED|Cohort 4: 200 mg in SAD Study||0
7561217|NCT02958982|18611448|P2|STARTED|Cohort 4: 200 mg in SAD Study||0
7561218|NCT02958982|18611449|P1|STARTED|Cohort 4: 200 mg in SAD Study||2
7561219|NCT02958982|18611439|P11|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
7561220|NCT02958982|18611440|P10|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
7561221|NCT02958982|18611441|P9|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
7561222|NCT02958982|18611442|P8|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
7561223|NCT02958982|18611443|P7|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
7561224|NCT02958982|18611444|P6|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
7561225|NCT02958982|18611445|P5|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
7561226|NCT02958982|18611446|P4|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
7561227|NCT02958982|18611447|P3|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
7561228|NCT02958982|18611448|P2|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
7561229|NCT02958982|18611449|P1|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
7561230|NCT02958982|18611439|P11|COMPLETED|Cohort 3: 100 mg in SAD Study||0
7561231|NCT02958982|18611440|P10|COMPLETED|Cohort 3: 100 mg in SAD Study||0
7561232|NCT02958982|18611441|P9|COMPLETED|Cohort 3: 100 mg in SAD Study||0
7561233|NCT02958982|18611442|P8|COMPLETED|Cohort 3: 100 mg in SAD Study||0
7561234|NCT02958982|18611443|P7|COMPLETED|Cohort 3: 100 mg in SAD Study||0
7561235|NCT02958982|18611444|P6|COMPLETED|Cohort 3: 100 mg in SAD Study||0
7561236|NCT02958982|18611445|P5|COMPLETED|Cohort 3: 100 mg in SAD Study||0
7561237|NCT02958982|18611446|P4|COMPLETED|Cohort 3: 100 mg in SAD Study||4
7561238|NCT02958982|18611447|P3|COMPLETED|Cohort 3: 100 mg in SAD Study||0
7561239|NCT02958982|18611448|P2|COMPLETED|Cohort 3: 100 mg in SAD Study||0
7561240|NCT02958982|18611449|P1|COMPLETED|Cohort 3: 100 mg in SAD Study||2
7561241|NCT02958982|18611439|P11|STARTED|Cohort 3: 100 mg in SAD Study||0
7561242|NCT02958982|18611440|P10|STARTED|Cohort 3: 100 mg in SAD Study||0
7561243|NCT02958982|18611441|P9|STARTED|Cohort 3: 100 mg in SAD Study||0
7561244|NCT02958982|18611442|P8|STARTED|Cohort 3: 100 mg in SAD Study||0
7561245|NCT02958982|18611443|P7|STARTED|Cohort 3: 100 mg in SAD Study||0
7561246|NCT02958982|18611444|P6|STARTED|Cohort 3: 100 mg in SAD Study||0
7561247|NCT02958982|18611445|P5|STARTED|Cohort 3: 100 mg in SAD Study||0
7561248|NCT02958982|18611446|P4|STARTED|Cohort 3: 100 mg in SAD Study||4
7561249|NCT02958982|18611447|P3|STARTED|Cohort 3: 100 mg in SAD Study||0
7561250|NCT02958982|18611448|P2|STARTED|Cohort 3: 100 mg in SAD Study||0
7561251|NCT02958982|18611449|P1|STARTED|Cohort 3: 100 mg in SAD Study||2
7561252|NCT02958982|18611439|P11|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
7561253|NCT02958982|18611440|P10|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
7561254|NCT02958982|18611441|P9|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
7561255|NCT02958982|18611442|P8|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
7561256|NCT02958982|18611443|P7|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
7561257|NCT02958982|18611444|P6|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
7561258|NCT02958982|18611445|P5|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
7561259|NCT02958982|18611446|P4|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
7561260|NCT02958982|18611447|P3|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
7561261|NCT02958982|18611448|P2|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
7561262|NCT02958982|18611449|P1|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
7561263|NCT02958982|18611439|P11|COMPLETED|Cohort 2: 50 mg in SAD Study||0
7561264|NCT02958982|18611440|P10|COMPLETED|Cohort 2: 50 mg in SAD Study||0
7561265|NCT02958982|18611441|P9|COMPLETED|Cohort 2: 50 mg in SAD Study||0
7561266|NCT02958982|18611442|P8|COMPLETED|Cohort 2: 50 mg in SAD Study||0
7561267|NCT02958982|18611443|P7|COMPLETED|Cohort 2: 50 mg in SAD Study||0
7561268|NCT02958982|18611444|P6|COMPLETED|Cohort 2: 50 mg in SAD Study||0
7561269|NCT02958982|18611445|P5|COMPLETED|Cohort 2: 50 mg in SAD Study||0
7561270|NCT02958982|18611446|P4|COMPLETED|Cohort 2: 50 mg in SAD Study||0
7561271|NCT02958982|18611447|P3|COMPLETED|Cohort 2: 50 mg in SAD Study||4
7561272|NCT02958982|18611448|P2|COMPLETED|Cohort 2: 50 mg in SAD Study||0
7561273|NCT02958982|18611449|P1|COMPLETED|Cohort 2: 50 mg in SAD Study||2
7561274|NCT02958982|18611439|P11|STARTED|Cohort 2: 50 mg in SAD Study||0
7561275|NCT02958982|18611440|P10|STARTED|Cohort 2: 50 mg in SAD Study||0
7561276|NCT02958982|18611441|P9|STARTED|Cohort 2: 50 mg in SAD Study||0
7561277|NCT02958982|18611442|P8|STARTED|Cohort 2: 50 mg in SAD Study||0
7561278|NCT02958982|18611443|P7|STARTED|Cohort 2: 50 mg in SAD Study||0
7561279|NCT02958982|18611444|P6|STARTED|Cohort 2: 50 mg in SAD Study||0
7561280|NCT02958982|18611445|P5|STARTED|Cohort 2: 50 mg in SAD Study||0
7561281|NCT02958982|18611446|P4|STARTED|Cohort 2: 50 mg in SAD Study||0
7561282|NCT02958982|18611447|P3|STARTED|Cohort 2: 50 mg in SAD Study||4
7561283|NCT02958982|18611448|P2|STARTED|Cohort 2: 50 mg in SAD Study||0
7561284|NCT02958982|18611449|P1|STARTED|Cohort 2: 50 mg in SAD Study||2
7561285|NCT02958982|18611439|P11|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
7561286|NCT02958982|18611440|P10|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
7561287|NCT02958982|18611441|P9|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
7561288|NCT02958982|18611442|P8|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
7561289|NCT02958982|18611443|P7|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
7561290|NCT02958982|18611444|P6|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
7561291|NCT02958982|18611445|P5|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
7561292|NCT02958982|18611446|P4|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
7561293|NCT02958982|18611447|P3|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
7561294|NCT02958982|18611448|P2|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
7561295|NCT02958982|18611449|P1|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
7561296|NCT02958982|18611439|P11|COMPLETED|Cohort 1: 25 mg in SAD Study||0
7561297|NCT02958982|18611440|P10|COMPLETED|Cohort 1: 25 mg in SAD Study||0
7561298|NCT02958982|18611441|P9|COMPLETED|Cohort 1: 25 mg in SAD Study||0
7561299|NCT02958982|18611442|P8|COMPLETED|Cohort 1: 25 mg in SAD Study||0
7561300|NCT02958982|18611443|P7|COMPLETED|Cohort 1: 25 mg in SAD Study||0
7561301|NCT02958982|18611444|P6|COMPLETED|Cohort 1: 25 mg in SAD Study||0
7561302|NCT02958982|18611445|P5|COMPLETED|Cohort 1: 25 mg in SAD Study||0
7561303|NCT02958982|18611446|P4|COMPLETED|Cohort 1: 25 mg in SAD Study||0
7561304|NCT02958982|18611447|P3|COMPLETED|Cohort 1: 25 mg in SAD Study||0
7561305|NCT02958982|18611448|P2|COMPLETED|Cohort 1: 25 mg in SAD Study||3
7561306|NCT02958982|18611449|P1|COMPLETED|Cohort 1: 25 mg in SAD Study||1
7561307|NCT02958982|18611439|P11|STARTED|Cohort 1: 25 mg in SAD Study||0
7561308|NCT02958982|18611440|P10|STARTED|Cohort 1: 25 mg in SAD Study||0
7561309|NCT02958982|18611441|P9|STARTED|Cohort 1: 25 mg in SAD Study||0
7561310|NCT02958982|18611442|P8|STARTED|Cohort 1: 25 mg in SAD Study||0
7561311|NCT02958982|18611443|P7|STARTED|Cohort 1: 25 mg in SAD Study||0
7561312|NCT02958982|18611444|P6|STARTED|Cohort 1: 25 mg in SAD Study||0
7561313|NCT02958982|18611445|P5|STARTED|Cohort 1: 25 mg in SAD Study||0
7561314|NCT02958982|18611446|P4|STARTED|Cohort 1: 25 mg in SAD Study||0
7561315|NCT02958982|18611447|P3|STARTED|Cohort 1: 25 mg in SAD Study||0
7561316|NCT02958982|18611448|P2|STARTED|Cohort 1: 25 mg in SAD Study||3
7561317|NCT02958982|18611449|P1|STARTED|Cohort 1: 25 mg in SAD Study||1
7561318|NCT02958969|18611495|P1|NOT COMPLETED|Overall Study||0
7561319|NCT02958969|18611495|P1|COMPLETED|Overall Study||50
7561320|NCT02958969|18611495|P1|STARTED|Overall Study||50
7561321|NCT02958956|18611504|P2|NOT COMPLETED|Overall Study||0
7561322|NCT02958956|18611505|P1|NOT COMPLETED|Overall Study||0
7561323|NCT02958956|18611504|P2|COMPLETED|Overall Study||198317
7561324|NCT02958956|18611505|P1|COMPLETED|Overall Study||38190
7561325|NCT02958956|18611504|P2|STARTED|Overall Study||198317
7561326|NCT02958956|18611505|P1|STARTED|Overall Study||38190
7561327|NCT02958826|18611520|P2|NOT COMPLETED|Overall Study||0
7561328|NCT02958826|18611521|P1|NOT COMPLETED|Overall Study||0
7561329|NCT02958826|18611520|P2|COMPLETED|Overall Study||80
7561330|NCT02958826|18611521|P1|COMPLETED|Overall Study||80
7561331|NCT02958826|18611520|P2|STARTED|Overall Study||80
7561332|NCT02958826|18611521|P1|STARTED|Overall Study||80
7561333|NCT02958787|18611531|P1|NOT COMPLETED|Overall Study||0
7561334|NCT02958787|18611531|P1|COMPLETED|Overall Study||135
7561335|NCT02958787|18611531|P1|STARTED|Overall Study||135
7561336|NCT02958553|18611535|P1|NOT COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||0
7561337|NCT02958553|18611535|P1|COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||2
7561338|NCT02958553|18611535|P1|STARTED|Phase II, 7th Visit -12 Month emPOWER FU||2
7561339|NCT02958553|18611535|P1|NOT COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
7561340|NCT02958553|18611535|P1|COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
7561341|NCT02958553|18611535|P1|STARTED|Phase II, 6th Visit -6 Month emPOWER FU||4
7561342|NCT02958553|18611535|P1|NOT COMPLETED|Phase II, 5th Visit -Crossover Visit||0
7561343|NCT02958553|18611535|P1|COMPLETED|Phase II, 5th Visit -Crossover Visit||4
7561344|NCT02958553|18611535|P1|STARTED|Phase II, 5th Visit -Crossover Visit||4
7561345|NCT02958553|18611535|P1|NOT COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||3
7561346|NCT02958553|18611535|P1|COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||4
7561347|NCT02958553|18611535|P1|STARTED|Phase II, 4th Visit -3 Month emPOWER FU|Only 4 subjects started Phase II of the study. Phase II was optional per protocol.|7
7561348|NCT02958553|18611535|P1|NOT COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||1
7561349|NCT02958553|18611535|P1|COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||7
7561350|NCT02958553|18611535|P1|STARTED|Phase I, 3rd Visit -2 Week emPOWER FU||8
7561351|NCT02958553|18611535|P1|NOT COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||0
7561352|NCT02958553|18611535|P1|COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||8
7561353|NCT02958553|18611535|P1|STARTED|Phase I, 2nd Visit -Fitted With emPOWER||8
7561354|NCT02958553|18611535|P1|NOT COMPLETED|Phase I, 1st Visit -Passive Prosthesis||0
7561355|NCT02958553|18611535|P1|COMPLETED|Phase I, 1st Visit -Passive Prosthesis||8
7561356|NCT02958553|18611535|P1|STARTED|Phase I, 1st Visit -Passive Prosthesis||8
7561357|NCT02958345|18611558|P2|NOT COMPLETED|Overall Study||1
7561358|NCT02958345|18611559|P1|NOT COMPLETED|Overall Study||1
7561359|NCT02958345|18611558|P2|COMPLETED|Overall Study||13
7561360|NCT02958345|18611559|P1|COMPLETED|Overall Study||13
7561361|NCT02958345|18611558|P2|STARTED|Overall Study||14
7561362|NCT02958345|18611559|P1|STARTED|Overall Study||14
7561363|NCT02958267|18611569|P2|NOT COMPLETED|Follow-up Visits||1
7561364|NCT02958267|18611570|P1|NOT COMPLETED|Follow-up Visits||2
7561365|NCT02958267|18611569|P2|COMPLETED|Follow-up Visits||14
7561366|NCT02958267|18611570|P1|COMPLETED|Follow-up Visits||13
7561367|NCT02958267|18611569|P2|12 Month Follow-up|Follow-up Visits||14
7561368|NCT02958267|18611570|P1|12 Month Follow-up|Follow-up Visits||13
7561369|NCT02958267|18611569|P2|6 Month Follow-up|Follow-up Visits||14
7561370|NCT02958267|18611570|P1|6 Month Follow-up|Follow-up Visits||14
7561371|NCT02958267|18611569|P2|3 Month Follow-up|Follow-up Visits||15
7561372|NCT02958267|18611570|P1|3 Month Follow-up|Follow-up Visits||15
7561373|NCT02958267|18611569|P2|STARTED|Follow-up Visits||15
7561374|NCT02958267|18611570|P1|STARTED|Follow-up Visits||15
7561375|NCT02958267|18611569|P2|NOT COMPLETED|Enrollment to Actual Treatment Complete||0
7561376|NCT02958267|18611570|P1|NOT COMPLETED|Enrollment to Actual Treatment Complete||2
7561377|NCT02958267|18611569|P2|COMPLETED|Enrollment to Actual Treatment Complete||15
7561378|NCT02958267|18611570|P1|COMPLETED|Enrollment to Actual Treatment Complete||15
7561379|NCT02958267|18611569|P2|STARTED|Enrollment to Actual Treatment Complete||15
7561380|NCT02958267|18611570|P1|STARTED|Enrollment to Actual Treatment Complete||17
7561381|NCT02958267|18611569|P2|NOT COMPLETED|Enrollment||0
7561382|NCT02958267|18611570|P1|NOT COMPLETED|Enrollment||0
7561383|NCT02958267|18611569|P2|COMPLETED|Enrollment||15
7561384|NCT02958267|18611570|P1|COMPLETED|Enrollment||17
7561385|NCT02958267|18611569|P2|STARTED|Enrollment||15
7561386|NCT02958267|18611570|P1|STARTED|Enrollment||17
7561387|NCT02957942|18611582|P2|NOT COMPLETED|Overall Study||7
7561388|NCT02957942|18611583|P1|NOT COMPLETED|Overall Study||0
7561389|NCT02957942|18611582|P2|COMPLETED|Overall Study||6
7561390|NCT02957942|18611583|P1|COMPLETED|Overall Study||7
7561391|NCT02957942|18611582|P2|STARTED|Overall Study|7 healthy individuals were recruited as control; 6 were recruited for practicing experiment details.|13
7561392|NCT02957942|18611583|P1|STARTED|Overall Study||7
7561393|NCT02957747|18611599|P2|NOT COMPLETED|Overall Study||8
7561394|NCT02957747|18611600|P1|NOT COMPLETED|Overall Study||10
7561395|NCT02957747|18611599|P2|COMPLETED|Overall Study||69
7561396|NCT02957747|18611600|P1|COMPLETED|Overall Study||66
7561397|NCT02957747|18611599|P2|STARTED|Overall Study||77
7561398|NCT02957747|18611600|P1|STARTED|Overall Study||76
7561399|NCT02957331|18611628|P2|NOT COMPLETED|Overall Study||0
7561400|NCT02957331|18611629|P1|NOT COMPLETED|Overall Study||1
7561401|NCT02957331|18611628|P2|COMPLETED|Overall Study||12
7561402|NCT02957331|18611629|P1|COMPLETED|Overall Study||13
7561403|NCT02957331|18611628|P2|STARTED|Overall Study||12
7561404|NCT02957331|18611629|P1|STARTED|Overall Study||14
7561405|NCT02957305|18611639|P2|NOT COMPLETED|Overall Study||0
7561406|NCT02957305|18611640|P1|NOT COMPLETED|Overall Study||0
7561407|NCT02957305|18611639|P2|COMPLETED|Overall Study||105
7561408|NCT02957305|18611640|P1|COMPLETED|Overall Study||106
7561409|NCT02957305|18611639|P2|STARTED|Overall Study||105
7561410|NCT02957305|18611640|P1|STARTED|Overall Study||106
7561411|NCT02956967|18611648|P1|NOT COMPLETED|Overall Study||48
7561412|NCT02956967|18611648|P1|COMPLETED|Overall Study||123
7561413|NCT02956967|18611648|P1|STARTED|Overall Study||171
7561414|NCT02956837|18611675|P4|NOT COMPLETED|Overall Study||3
7561415|NCT02956837|18611676|P3|NOT COMPLETED|Overall Study||2
7561416|NCT02956837|18611677|P2|NOT COMPLETED|Overall Study||3
7561417|NCT02956837|18611678|P1|NOT COMPLETED|Overall Study||0
7561418|NCT02956837|18611675|P4|COMPLETED|Overall Study||99
7561419|NCT02956837|18611676|P3|COMPLETED|Overall Study||97
7561420|NCT02956837|18611677|P2|COMPLETED|Overall Study||96
7561421|NCT02956837|18611678|P1|COMPLETED|Overall Study||100
7561422|NCT02956837|18611675|P4|STARTED|Overall Study||102
7561423|NCT02956837|18611676|P3|STARTED|Overall Study||99
7561424|NCT02956837|18611677|P2|STARTED|Overall Study||99
7561425|NCT02956837|18611678|P1|STARTED|Overall Study||100
7561426|NCT02956746|18611772|P4|NOT COMPLETED|Overall Study||4
7561427|NCT02956746|18611773|P3|NOT COMPLETED|Overall Study||6
7561428|NCT02956746|18611774|P2|NOT COMPLETED|Overall Study||3
7561429|NCT02956746|18611775|P1|NOT COMPLETED|Overall Study||2
7561430|NCT02956746|18611772|P4|COMPLETED|Overall Study||38
7561431|NCT02956746|18611773|P3|COMPLETED|Overall Study||36
7561432|NCT02956746|18611774|P2|COMPLETED|Overall Study||37
7561433|NCT02956746|18611775|P1|COMPLETED|Overall Study||38
7561434|NCT02956746|18611772|P4|STARTED|Overall Study||42
7561435|NCT02956746|18611773|P3|STARTED|Overall Study||42
7561436|NCT02956746|18611774|P2|STARTED|Overall Study||40
7561437|NCT02956746|18611775|P1|STARTED|Overall Study||40
7561438|NCT02956629|18611813|P6|NOT COMPLETED|Overall Study||1
7561439|NCT02956629|18611814|P5|NOT COMPLETED|Overall Study||0
7561440|NCT02956629|18611815|P4|NOT COMPLETED|Overall Study||1
7561441|NCT02956629|18611816|P3|NOT COMPLETED|Overall Study||4
7561442|NCT02956629|18611817|P2|NOT COMPLETED|Overall Study||6
7561443|NCT02956629|18611818|P1|NOT COMPLETED|Overall Study||5
7561444|NCT02956629|18611813|P6|COMPLETED|Overall Study||21
7561445|NCT02956629|18611814|P5|COMPLETED|Overall Study||18
7561446|NCT02956629|18611815|P4|COMPLETED|Overall Study||55
7561447|NCT02956629|18611816|P3|COMPLETED|Overall Study||57
7561448|NCT02956629|18611817|P2|COMPLETED|Overall Study||41
7561449|NCT02956629|18611818|P1|COMPLETED|Overall Study||73
7561450|NCT02956629|18611813|P6|STARTED|Overall Study||22
7561451|NCT02956629|18611814|P5|STARTED|Overall Study||18
7561452|NCT02956629|18611815|P4|STARTED|Overall Study||56
7561453|NCT02956629|18611816|P3|STARTED|Overall Study||61
7561454|NCT02956629|18611817|P2|STARTED|Overall Study||47
7561455|NCT02956629|18611818|P1|STARTED|Overall Study||78
7561456|NCT02956616|18611882|P2|NOT COMPLETED|Overall Study||0
7561457|NCT02956616|18611883|P1|NOT COMPLETED|Overall Study||0
7561458|NCT02956616|18611882|P2|COMPLETED|Overall Study||60
7561459|NCT02956616|18611883|P1|COMPLETED|Overall Study||58
7561460|NCT02956616|18611882|P2|STARTED|Overall Study||60
7561461|NCT02956616|18611883|P1|STARTED|Overall Study||58
7561462|NCT02956460|18611897|P2|NOT COMPLETED|Lens 2||0
7561463|NCT02956460|18611898|P1|NOT COMPLETED|Lens 2||0
7561464|NCT02956460|18611897|P2|COMPLETED|Lens 2||34
7561465|NCT02956460|18611898|P1|COMPLETED|Lens 2||29
7561466|NCT02956460|18611897|P2|STARTED|Lens 2||34
7561467|NCT02956460|18611898|P1|STARTED|Lens 2||29
7561468|NCT02956460|18611897|P2|NOT COMPLETED|Lens 1||0
7561469|NCT02956460|18611898|P1|NOT COMPLETED|Lens 1||1
7561470|NCT02956460|18611897|P2|COMPLETED|Lens 1||34
7561471|NCT02956460|18611898|P1|COMPLETED|Lens 1||29
7561472|NCT02956460|18611897|P2|STARTED|Lens 1||34
7561473|NCT02956460|18611898|P1|STARTED|Lens 1||30
7561474|NCT02956278|18611927|P3|NOT COMPLETED|Overall Study||0
7561475|NCT02956278|18611928|P2|NOT COMPLETED|Overall Study||2
7561476|NCT02956278|18611929|P1|NOT COMPLETED|Overall Study||6
7561477|NCT02956278|18611927|P3|COMPLETED|Overall Study||3
7561478|NCT02956278|18611928|P2|COMPLETED|Overall Study||7
7561479|NCT02956278|18611929|P1|COMPLETED|Overall Study||9
7561480|NCT02956278|18611927|P3|STARTED|Overall Study||3
7561481|NCT02956278|18611928|P2|STARTED|Overall Study||9
7561482|NCT02956278|18611929|P1|STARTED|Overall Study||15
7561483|NCT02956122|18611943|P1|NOT COMPLETED|Overall Study||0
7561484|NCT02956122|18611943|P1|COMPLETED|Overall Study||1
7561485|NCT02956122|18611943|P1|STARTED|Overall Study||1
7561486|NCT02956070|18611996|P2|NOT COMPLETED|Overall Study||0
7561487|NCT02956070|18611997|P1|NOT COMPLETED|Overall Study||0
7561488|NCT02956070|18611996|P2|COMPLETED|Overall Study||35
7561489|NCT02956070|18611997|P1|COMPLETED|Overall Study||35
7561490|NCT02956070|18611996|P2|STARTED|Overall Study||35
7561491|NCT02956070|18611997|P1|STARTED|Overall Study||35
7561492|NCT02956057|18612013|P6|NOT COMPLETED|Overall Study||17
7561493|NCT02956057|18612014|P5|NOT COMPLETED|Overall Study||5
7561494|NCT02956057|18612015|P4|NOT COMPLETED|Overall Study||15
7561495|NCT02956057|18612016|P3|NOT COMPLETED|Overall Study||8
7561496|NCT02956057|18612017|P2|NOT COMPLETED|Overall Study||12
7561497|NCT02956057|18612018|P1|NOT COMPLETED|Overall Study||14
7561498|NCT02956057|18612013|P6|COMPLETED|Overall Study||157
7561499|NCT02956057|18612014|P5|COMPLETED|Overall Study||169
7561500|NCT02956057|18612015|P4|COMPLETED|Overall Study||159
7561501|NCT02956057|18612016|P3|COMPLETED|Overall Study||166
7561502|NCT02956057|18612017|P2|COMPLETED|Overall Study||162
7561503|NCT02956057|18612018|P1|COMPLETED|Overall Study||160
7561504|NCT02956057|18612013|P6|STARTED|Overall Study||174
7561505|NCT02956057|18612014|P5|STARTED|Overall Study||174
7561506|NCT02956057|18612015|P4|STARTED|Overall Study||174
7561507|NCT02956057|18612016|P3|STARTED|Overall Study||174
7561508|NCT02956057|18612017|P2|STARTED|Overall Study||174
7561509|NCT02956057|18612018|P1|STARTED|Overall Study||174
7561510|NCT02956005|18612038|P1|NOT COMPLETED|Overall Study||16
7561511|NCT02956005|18612038|P1|COMPLETED|Overall Study||2
7561512|NCT02956005|18612038|P1|STARTED|Overall Study||18
7561513|NCT02955797|18612047|P4|NOT COMPLETED|Overall Study||2
7561514|NCT02955797|18612048|P3|NOT COMPLETED|Overall Study||0
7561515|NCT02955797|18612049|P2|NOT COMPLETED|Overall Study||3
7561516|NCT02955797|18612050|P1|NOT COMPLETED|Overall Study||3
7561517|NCT02955797|18612047|P4|COMPLETED|Overall Study||101
7561518|NCT02955797|18612048|P3|COMPLETED|Overall Study||203
7561519|NCT02955797|18612049|P2|COMPLETED|Overall Study||303
7561520|NCT02955797|18612050|P1|COMPLETED|Overall Study||303
7561521|NCT02955797|18612047|P4|Per Protocol Analysis Set (PPAS)|Overall Study||99
7561522|NCT02955797|18612048|P3|Per Protocol Analysis Set (PPAS)|Overall Study||198
7561523|NCT02955797|18612049|P2|Per Protocol Analysis Set (PPAS)|Overall Study||296
7561524|NCT02955797|18612050|P1|Per Protocol Analysis Set (PPAS)|Overall Study||293
7561525|NCT02955797|18612047|P4|Safety Analysis Set (SafAS)|Overall Study||102
7561526|NCT02955797|18612048|P3|Safety Analysis Set (SafAS)|Overall Study||203
7561527|NCT02955797|18612049|P2|Safety Analysis Set (SafAS)|Overall Study||306
7561528|NCT02955797|18612050|P1|Safety Analysis Set (SafAS)|Overall Study||303
7561529|NCT02955797|18612047|P4|STARTED|Overall Study||103
7561530|NCT02955797|18612048|P3|STARTED|Overall Study||203
7561531|NCT02955797|18612049|P2|STARTED|Overall Study||306
7561532|NCT02955797|18612050|P1|STARTED|Overall Study||306
7561533|NCT02955212|18612068|P2|NOT COMPLETED|Overall Study||12
7561534|NCT02955212|18612069|P1|NOT COMPLETED|Overall Study||16
7561535|NCT02955212|18612068|P2|COMPLETED|Overall Study||157
7561536|NCT02955212|18612069|P1|COMPLETED|Overall Study||153
7561537|NCT02955212|18612068|P2|STARTED|Overall Study||169
7561538|NCT02955212|18612069|P1|STARTED|Overall Study||169
7561539|NCT02955186|18612095|P2|NOT COMPLETED|Overall Study||2
7561540|NCT02955186|18612096|P1|NOT COMPLETED|Overall Study||7
7561541|NCT02955186|18612095|P2|COMPLETED|Overall Study||15
7561542|NCT02955186|18612096|P1|COMPLETED|Overall Study||26
7561543|NCT02955186|18612095|P2|STARTED|Overall Study||17
7561544|NCT02955186|18612096|P1|STARTED|Overall Study||33
7561545|NCT02955147|18612108|P1|NOT COMPLETED|Overall Study||0
7561546|NCT02955147|18612108|P1|COMPLETED|Overall Study||13
7561547|NCT02955147|18612108|P1|STARTED|Overall Study||13
7561548|NCT02954952|18612118|P3|NOT COMPLETED|Overall Study||0
7561549|NCT02954952|18612119|P2|NOT COMPLETED|Overall Study||1
7561550|NCT02954952|18612120|P1|NOT COMPLETED|Overall Study||1
7561551|NCT02954952|18612118|P3|COMPLETED|Overall Study||3
7561552|NCT02954952|18612119|P2|COMPLETED|Overall Study||4
7561553|NCT02954952|18612120|P1|COMPLETED|Overall Study||35
7561554|NCT02954952|18612118|P3|STARTED|Overall Study||3
7561555|NCT02954952|18612119|P2|STARTED|Overall Study||5
7561556|NCT02954952|18612120|P1|STARTED|Overall Study||36
7561557|NCT02954887|18612128|P1|NOT COMPLETED|Overall Study||7
7561558|NCT02954887|18612128|P1|COMPLETED|Overall Study||2
7561559|NCT02954887|18612128|P1|STARTED|Overall Study||9
7561560|NCT02954848|18612157|P2|NOT COMPLETED|Overall Study||5
7561561|NCT02954848|18612158|P1|NOT COMPLETED|Overall Study||2
7561562|NCT02954848|18612157|P2|COMPLETED|Overall Study||234
7561563|NCT02954848|18612158|P1|COMPLETED|Overall Study||243
7561564|NCT02954848|18612157|P2|Treated|Overall Study||238
7561565|NCT02954848|18612158|P1|Treated|Overall Study||245
7561566|NCT02954848|18612157|P2|STARTED|Overall Study||239
7561567|NCT02954848|18612158|P1|STARTED|Overall Study||245
7561568|NCT02954653|18612218|P9|NOT COMPLETED|Overall Study||0
7561569|NCT02954653|18612219|P8|NOT COMPLETED|Overall Study||0
7561570|NCT02954653|18612220|P7|NOT COMPLETED|Overall Study||0
7561571|NCT02954653|18612221|P6|NOT COMPLETED|Overall Study||0
7561572|NCT02954653|18612222|P5|NOT COMPLETED|Overall Study||0
7561573|NCT02954653|18612223|P4|NOT COMPLETED|Overall Study||0
7561574|NCT02954653|18612224|P3|NOT COMPLETED|Overall Study||0
7561575|NCT02954653|18612225|P2|NOT COMPLETED|Overall Study||3
7561576|NCT02954653|18612226|P1|NOT COMPLETED|Overall Study||4
7561577|NCT02954653|18612218|P9|COMPLETED|Overall Study||0
7561578|NCT02954653|18612219|P8|COMPLETED|Overall Study||0
7561579|NCT02954653|18612220|P7|COMPLETED|Overall Study||0
7561580|NCT02954653|18612221|P6|COMPLETED|Overall Study||0
7561581|NCT02954653|18612222|P5|COMPLETED|Overall Study||0
7561582|NCT02954653|18612223|P4|COMPLETED|Overall Study||0
7561583|NCT02954653|18612224|P3|COMPLETED|Overall Study||0
7561584|NCT02954653|18612225|P2|COMPLETED|Overall Study||1
7561585|NCT02954653|18612226|P1|COMPLETED|Overall Study||0
7561586|NCT02954653|18612218|P9|Received Treatment|Overall Study||0
7561587|NCT02954653|18612219|P8|Received Treatment|Overall Study||0
7561588|NCT02954653|18612220|P7|Received Treatment|Overall Study||0
7561589|NCT02954653|18612221|P6|Received Treatment|Overall Study||0
7561590|NCT02954653|18612222|P5|Received Treatment|Overall Study||0
7561591|NCT02954653|18612223|P4|Received Treatment|Overall Study||0
7561592|NCT02954653|18612224|P3|Received Treatment|Overall Study||0
7561593|NCT02954653|18612225|P2|Received Treatment|Overall Study||4
7561594|NCT02954653|18612226|P1|Received Treatment|Overall Study||3
7561595|NCT02954653|18612218|P9|STARTED|Overall Study|No participants were enrolled in this arm.|0
7561596|NCT02954653|18612219|P8|STARTED|Overall Study|No participants were enrolled in this arm.|0
7561597|NCT02954653|18612220|P7|STARTED|Overall Study|No participants were enrolled in this arm.|0
7561598|NCT02954653|18612221|P6|STARTED|Overall Study|No participants were enrolled in this arm.|0
7561599|NCT02954653|18612222|P5|STARTED|Overall Study|No participants were enrolled in this arm.|0
7561600|NCT02954653|18612223|P4|STARTED|Overall Study|No participants were enrolled in this arm.|0
7561601|NCT02954653|18612224|P3|STARTED|Overall Study|No participants were enrolled in this arm.|0
7561602|NCT02954653|18612225|P2|STARTED|Overall Study||4
7561603|NCT02954653|18612226|P1|STARTED|Overall Study||4
7561604|NCT02954601|18612345|P4|NOT COMPLETED|Third Intervention (Five Days)||0
7561605|NCT02954601|18612346|P3|NOT COMPLETED|Third Intervention (Five Days)||0
7561606|NCT02954601|18612347|P2|NOT COMPLETED|Third Intervention (Five Days)||0
7561607|NCT02954601|18612348|P1|NOT COMPLETED|Third Intervention (Five Days)||0
7561608|NCT02954601|18612345|P4|COMPLETED|Third Intervention (Five Days)||8
7561609|NCT02954601|18612346|P3|COMPLETED|Third Intervention (Five Days)||6
7561610|NCT02954601|18612347|P2|COMPLETED|Third Intervention (Five Days)||8
7561611|NCT02954601|18612348|P1|COMPLETED|Third Intervention (Five Days)||9
7561612|NCT02954601|18612345|P4|STARTED|Third Intervention (Five Days)||8
7561613|NCT02954601|18612346|P3|STARTED|Third Intervention (Five Days)||6
7561614|NCT02954601|18612347|P2|STARTED|Third Intervention (Five Days)||8
7561615|NCT02954601|18612348|P1|STARTED|Third Intervention (Five Days)||9
7561616|NCT02954601|18612345|P4|NOT COMPLETED|Second Intervention (Five Days)||0
7561617|NCT02954601|18612346|P3|NOT COMPLETED|Second Intervention (Five Days)||0
7561618|NCT02954601|18612347|P2|NOT COMPLETED|Second Intervention (Five Days)||0
7561619|NCT02954601|18612348|P1|NOT COMPLETED|Second Intervention (Five Days)||0
7561620|NCT02954601|18612345|P4|COMPLETED|Second Intervention (Five Days)||6
7561621|NCT02954601|18612346|P3|COMPLETED|Second Intervention (Five Days)||8
7561622|NCT02954601|18612347|P2|COMPLETED|Second Intervention (Five Days)||6
7561623|NCT02954601|18612348|P1|COMPLETED|Second Intervention (Five Days)||11
7561624|NCT02954601|18612345|P4|STARTED|Second Intervention (Five Days)||6
7561625|NCT02954601|18612346|P3|STARTED|Second Intervention (Five Days)||8
7561626|NCT02954601|18612347|P2|STARTED|Second Intervention (Five Days)||6
7561627|NCT02954601|18612348|P1|STARTED|Second Intervention (Five Days)||11
7561628|NCT02954601|18612345|P4|NOT COMPLETED|First Intervention (Five Days)||0
7561629|NCT02954601|18612346|P3|NOT COMPLETED|First Intervention (Five Days)||1
7561630|NCT02954601|18612347|P2|NOT COMPLETED|First Intervention (Five Days)||0
7561631|NCT02954601|18612348|P1|NOT COMPLETED|First Intervention (Five Days)||0
7561632|NCT02954601|18612345|P4|COMPLETED|First Intervention (Five Days)||7
7561633|NCT02954601|18612346|P3|COMPLETED|First Intervention (Five Days)||7
7561634|NCT02954601|18612347|P2|COMPLETED|First Intervention (Five Days)||6
7561635|NCT02954601|18612348|P1|COMPLETED|First Intervention (Five Days)||11
7561636|NCT02954601|18612345|P4|STARTED|First Intervention (Five Days)||7
7561637|NCT02954601|18612346|P3|STARTED|First Intervention (Five Days)||8
7561638|NCT02954601|18612347|P2|STARTED|First Intervention (Five Days)||6
7561639|NCT02954601|18612348|P1|STARTED|First Intervention (Five Days)||11
7561640|NCT02954575|18612370|P1|NOT COMPLETED|Overall Study||3
7561641|NCT02954575|18612370|P1|COMPLETED|Overall Study||54
7561642|NCT02954575|18612370|P1|SURG Population|Overall Study||1
7561643|NCT02954575|18612370|P1|PK Population|Overall Study||21
7561644|NCT02954575|18612370|P1|PP Population|Overall Study||52
7561645|NCT02954575|18612370|P1|FAS Population|Overall Study||55
7561646|NCT02954575|18612370|P1|SAF Population|Overall Study||55
7561647|NCT02954575|18612370|P1|Received Treatment|Overall Study||55
7561648|NCT02954575|18612370|P1|STARTED|Overall Study||57
7561649|NCT02954354|18612390|P3|NOT COMPLETED|Overall Study||16
7561650|NCT02954354|18612391|P2|NOT COMPLETED|Overall Study||20
7561651|NCT02954354|18612392|P1|NOT COMPLETED|Overall Study||34
7561652|NCT02954354|18612390|P3|COMPLETED|Overall Study||498
7561653|NCT02954354|18612391|P2|COMPLETED|Overall Study||290
7561654|NCT02954354|18612392|P1|COMPLETED|Overall Study||578
7561655|NCT02954354|18612390|P3|Intention to Treat Infected Population|Overall Study||377
7561656|NCT02954354|18612391|P2|Intention to Treat Infected Population|Overall Study||231
7561657|NCT02954354|18612392|P1|Intention to Treat Infected Population|Overall Study||456
7561658|NCT02954354|18612390|P3|Received Study Drug|Overall Study||513
7561659|NCT02954354|18612391|P2|Received Study Drug|Overall Study||309
7561660|NCT02954354|18612392|P1|Received Study Drug|Overall Study||610
7561661|NCT02954354|18612390|P3|STARTED|Overall Study||514
7561662|NCT02954354|18612391|P2|STARTED|Overall Study||310
7561663|NCT02954354|18612392|P1|STARTED|Overall Study||612
7561664|NCT02954198|18612478|P2|NOT COMPLETED|Overall Study||0
7561665|NCT02954198|18612479|P1|NOT COMPLETED|Overall Study||0
7561666|NCT02954198|18612478|P2|COMPLETED|Overall Study||20
7561667|NCT02954198|18612479|P1|COMPLETED|Overall Study||20
7561668|NCT02954198|18612478|P2|STARTED|Overall Study||20
7561669|NCT02954198|18612479|P1|STARTED|Overall Study||20
7561670|NCT02954172|18612493|P2|NOT COMPLETED|Overall Study||3
7561671|NCT02954172|18612494|P1|NOT COMPLETED|Overall Study||6
7561672|NCT02954172|18612493|P2|COMPLETED|Overall Study||221
7561673|NCT02954172|18612494|P1|COMPLETED|Overall Study||220
7561674|NCT02954172|18612493|P2|STARTED|Overall Study||224
7561675|NCT02954172|18612494|P1|STARTED|Overall Study||226
7561676|NCT02954159|18612506|P2|NOT COMPLETED|Overall Study||1
7561677|NCT02954159|18612507|P1|NOT COMPLETED|Overall Study||1
7561678|NCT02954159|18612506|P2|COMPLETED|Overall Study||1
7561679|NCT02954159|18612507|P1|COMPLETED|Overall Study||1
7561680|NCT02954159|18612506|P2|STARTED|Overall Study||2
7561681|NCT02954159|18612507|P1|STARTED|Overall Study||2
7561682|NCT02953938|18612521|P2|NOT COMPLETED|Overall Study||2
7561683|NCT02953938|18612522|P1|NOT COMPLETED|Overall Study||1
7561684|NCT02953938|18612521|P2|COMPLETED|Overall Study||28
7561685|NCT02953938|18612522|P1|COMPLETED|Overall Study||28
7561686|NCT02953938|18612521|P2|STARTED|Overall Study||30
7561687|NCT02953938|18612522|P1|STARTED|Overall Study||29
7561688|NCT02953886|18612537|P1|NOT COMPLETED|Overall Study||0
7561689|NCT02953886|18612537|P1|COMPLETED|Overall Study||20
7561690|NCT02953886|18612537|P1|STARTED|Overall Study||20
7561691|NCT02953873|18612543|P1|NOT COMPLETED|Overall Study||0
7561692|NCT02953873|18612543|P1|COMPLETED|Overall Study||25
7561693|NCT02953873|18612543|P1|STARTED|Overall Study||25
7561694|NCT02953821|18612553|P2|NOT COMPLETED|Overall Study||13
7561695|NCT02953821|18612554|P1|NOT COMPLETED|Overall Study||15
7561696|NCT02953821|18612553|P2|COMPLETED|Overall Study||73
7561697|NCT02953821|18612554|P1|COMPLETED|Overall Study||71
7561698|NCT02953821|18612553|P2|Completed Study Treatment (Week 24)|Overall Study||76
7561699|NCT02953821|18612554|P1|Completed Study Treatment (Week 24)|Overall Study||73
7561700|NCT02953821|18612553|P2|Completed Week 16 Visit|Overall Study||77
7561701|NCT02953821|18612554|P1|Completed Week 16 Visit|Overall Study||76
7561702|NCT02953821|18612553|P2|Per Protocol (PP) Population|Overall Study||75
7561703|NCT02953821|18612554|P1|Per Protocol (PP) Population|Overall Study||72
7561704|NCT02953821|18612553|P2|Modified Intent to Treat (mITT) Populati|Overall Study||84
7561705|NCT02953821|18612554|P1|Modified Intent to Treat (mITT) Populati|Overall Study||85
7561706|NCT02953821|18612553|P2|Safety Population|Overall Study||86
7561707|NCT02953821|18612554|P1|Safety Population|Overall Study||86
7561708|NCT02953821|18612553|P2|STARTED|Overall Study||86
7561709|NCT02953821|18612554|P1|STARTED|Overall Study||86
7561710|NCT02953678|18612572|P1|NOT COMPLETED|Overall Study||60
7561711|NCT02953678|18612572|P1|COMPLETED|Overall Study||11
7561712|NCT02953678|18612572|P1|Participants Continuing in Study|Overall Study||19
7561713|NCT02953678|18612572|P1|Participants Discontinued From Study|Overall Study||41
7561714|NCT02953678|18612572|P1|STARTED|Overall Study||71
7561715|NCT02953561|18612581|P1|NOT COMPLETED|Overall Study||0
7561716|NCT02953561|18612581|P1|COMPLETED|Overall Study||19
7561717|NCT02953561|18612581|P1|STARTED|Overall Study||19
7561718|NCT02953548|18612588|P2|NOT COMPLETED|Overall Study||0
7561719|NCT02953548|18612589|P1|NOT COMPLETED|Overall Study||0
7561720|NCT02953548|18612588|P2|COMPLETED|Overall Study||4
7561721|NCT02953548|18612589|P1|COMPLETED|Overall Study||5
7561722|NCT02953548|18612588|P2|STARTED|Overall Study||4
7561723|NCT02953548|18612589|P1|STARTED|Overall Study||5
7561724|NCT02953418|18612611|P1|NOT COMPLETED|Overall Study||0
7561725|NCT02953418|18612611|P1|COMPLETED|Overall Study||34
7561726|NCT02953418|18612611|P1|STARTED|Overall Study||34
7561727|NCT02953314|18612620|P2|NOT COMPLETED|Overall Study||3
7561728|NCT02953314|18612621|P1|NOT COMPLETED|Overall Study||0
7561729|NCT02953314|18612620|P2|COMPLETED|Overall Study||67
7561730|NCT02953314|18612621|P1|COMPLETED|Overall Study||13
7561731|NCT02953314|18612620|P2|STARTED|Overall Study||70
7561732|NCT02953314|18612621|P1|STARTED|Overall Study||13
7561733|NCT02952898|18612647|P3|NOT COMPLETED|Overall Study||15
7561734|NCT02952898|18612648|P2|NOT COMPLETED|Overall Study||19
7561735|NCT02952898|18612649|P1|NOT COMPLETED|Overall Study||22
7561736|NCT02952898|18612647|P3|COMPLETED|Overall Study||209
7561737|NCT02952898|18612648|P2|COMPLETED|Overall Study||202
7561738|NCT02952898|18612649|P1|COMPLETED|Overall Study||198
7561739|NCT02952898|18612647|P3|STARTED|Overall Study||224
7561740|NCT02952898|18612648|P2|STARTED|Overall Study||221
7561741|NCT02952898|18612649|P1|STARTED|Overall Study||220
7561742|NCT02952872|18612673|P16|NOT COMPLETED|Overall Study||0
7561743|NCT02952872|18612674|P15|NOT COMPLETED|Overall Study||0
7561744|NCT02952872|18612675|P14|NOT COMPLETED|Overall Study||0
7561745|NCT02952872|18612676|P13|NOT COMPLETED|Overall Study||0
7561746|NCT02952872|18612677|P12|NOT COMPLETED|Overall Study||0
7561747|NCT02952872|18612678|P11|NOT COMPLETED|Overall Study||0
7561748|NCT02952872|18612679|P10|NOT COMPLETED|Overall Study||0
7561749|NCT02952872|18612680|P9|NOT COMPLETED|Overall Study||0
7561750|NCT02952872|18612681|P8|NOT COMPLETED|Overall Study||0
7561751|NCT02952872|18612682|P7|NOT COMPLETED|Overall Study||0
7561752|NCT02952872|18612683|P6|NOT COMPLETED|Overall Study||0
7561753|NCT02952872|18612684|P5|NOT COMPLETED|Overall Study||0
7561754|NCT02952872|18612685|P4|NOT COMPLETED|Overall Study||0
7561755|NCT02952872|18612686|P3|NOT COMPLETED|Overall Study||0
7561756|NCT02952872|18612687|P2|NOT COMPLETED|Overall Study||0
7561757|NCT02952872|18612688|P1|NOT COMPLETED|Overall Study||0
7561758|NCT02952872|18612673|P16|COMPLETED|Overall Study||23
7561759|NCT02952872|18612674|P15|COMPLETED|Overall Study||22
7561760|NCT02952872|18612675|P14|COMPLETED|Overall Study||22
7561761|NCT02952872|18612676|P13|COMPLETED|Overall Study||22
7561762|NCT02952872|18612677|P12|COMPLETED|Overall Study||22
7561763|NCT02952872|18612678|P11|COMPLETED|Overall Study||23
7561764|NCT02952872|18612679|P10|COMPLETED|Overall Study||22
7561765|NCT02952872|18612680|P9|COMPLETED|Overall Study||22
7561766|NCT02952872|18612681|P8|COMPLETED|Overall Study||21
7561767|NCT02952872|18612682|P7|COMPLETED|Overall Study||22
7561768|NCT02952872|18612683|P6|COMPLETED|Overall Study||21
7561769|NCT02952872|18612684|P5|COMPLETED|Overall Study||22
7561770|NCT02952872|18612685|P4|COMPLETED|Overall Study||22
7561771|NCT02952872|18612686|P3|COMPLETED|Overall Study||22
7561772|NCT02952872|18612687|P2|COMPLETED|Overall Study||22
7561773|NCT02952872|18612688|P1|COMPLETED|Overall Study||22
7561774|NCT02952872|18612673|P16|STARTED|Overall Study||23
7561775|NCT02952872|18612674|P15|STARTED|Overall Study||22
7561776|NCT02952872|18612675|P14|STARTED|Overall Study||22
7561777|NCT02952872|18612676|P13|STARTED|Overall Study||22
7561778|NCT02952872|18612677|P12|STARTED|Overall Study||22
7561779|NCT02952872|18612678|P11|STARTED|Overall Study||23
7561780|NCT02952872|18612679|P10|STARTED|Overall Study||22
7561781|NCT02952872|18612680|P9|STARTED|Overall Study||22
7561782|NCT02952872|18612681|P8|STARTED|Overall Study||21
7561783|NCT02952872|18612682|P7|STARTED|Overall Study||22
7561784|NCT02952872|18612683|P6|STARTED|Overall Study||21
7561785|NCT02952872|18612684|P5|STARTED|Overall Study||22
7561786|NCT02952872|18612685|P4|STARTED|Overall Study||22
7561787|NCT02952872|18612686|P3|STARTED|Overall Study||22
7561788|NCT02952872|18612687|P2|STARTED|Overall Study||22
7561789|NCT02952872|18612688|P1|STARTED|Overall Study||22
7561790|NCT02952820|18612773|P3|NOT COMPLETED|Active Treatment Period (6 Months)||31
7561791|NCT02952820|18612774|P2|NOT COMPLETED|Active Treatment Period (6 Months)||38
7561792|NCT02952820|18612775|P1|NOT COMPLETED|Active Treatment Period (6 Months)||0
7561793|NCT02952820|18612773|P3|COMPLETED|Active Treatment Period (6 Months)||321
7561794|NCT02952820|18612774|P2|COMPLETED|Active Treatment Period (6 Months)||346
7561795|NCT02952820|18612775|P1|COMPLETED|Active Treatment Period (6 Months)||0
7561796|NCT02952820|18612773|P3|STARTED|Active Treatment Period (6 Months)||352
7561797|NCT02952820|18612774|P2|STARTED|Active Treatment Period (6 Months)||384
7561798|NCT02952820|18612775|P1|STARTED|Active Treatment Period (6 Months)|Participants from Placebo were re-randomized to Lemborexant 5 mg and Lemborexant 10 mg.|0
7561799|NCT02952820|18612773|P3|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||88
7561800|NCT02952820|18612774|P2|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||69
7561801|NCT02952820|18612775|P1|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||64
7561802|NCT02952820|18612773|P3|COMPLETED|Placebo-Controlled Treatment (6 Months)||235
7561803|NCT02952820|18612774|P2|COMPLETED|Placebo-Controlled Treatment (6 Months)||254
7561804|NCT02952820|18612775|P1|COMPLETED|Placebo-Controlled Treatment (6 Months)||261
7561805|NCT02952820|18612773|P3|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
7561806|NCT02952820|18612774|P2|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
7561807|NCT02952820|18612775|P1|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||319
7561808|NCT02952820|18612773|P3|Treated|Placebo-Controlled Treatment (6 Months)||319
7561809|NCT02952820|18612774|P2|Treated|Placebo-Controlled Treatment (6 Months)||319
7561810|NCT02952820|18612775|P1|Treated|Placebo-Controlled Treatment (6 Months)||321
7561811|NCT02952820|18612773|P3|STARTED|Placebo-Controlled Treatment (6 Months)||323
7561812|NCT02952820|18612774|P2|STARTED|Placebo-Controlled Treatment (6 Months)||323
7561813|NCT02952820|18612775|P1|STARTED|Placebo-Controlled Treatment (6 Months)||325
7561814|NCT02952313|18612835|P1|NOT COMPLETED|Long-term Follow-up||32
7561815|NCT02952313|18612835|P1|COMPLETED|Long-term Follow-up||75
7561816|NCT02952313|18612835|P1|18-Month|Long-term Follow-up||79
7561817|NCT02952313|18612835|P1|12-Month|Long-term Follow-up||93
7561818|NCT02952313|18612835|P1|STARTED|Long-term Follow-up||107
7561819|NCT02952313|18612835|P1|NOT COMPLETED|Primary Endpoint||7
7561820|NCT02952313|18612835|P1|COMPLETED|Primary Endpoint||106
7561821|NCT02952313|18612835|P1|6 Months|Primary Endpoint||106
7561822|NCT02952313|18612835|P1|STARTED|Primary Endpoint||113
7561823|NCT02952261|18612846|P2|NOT COMPLETED|Overall Study||5
7561824|NCT02952261|18612847|P1|NOT COMPLETED|Overall Study||5
7561825|NCT02952261|18612846|P2|COMPLETED|Overall Study||95
7561826|NCT02952261|18612847|P1|COMPLETED|Overall Study||95
7561827|NCT02952261|18612846|P2|STARTED|Overall Study||100
7561828|NCT02952261|18612847|P1|STARTED|Overall Study||100
7561829|NCT02951988|18612862|P4|NOT COMPLETED|Double-Blind Treatment Period||115
7561830|NCT02951988|18612863|P3|NOT COMPLETED|Double-Blind Treatment Period||101
7561831|NCT02951988|18612864|P2|NOT COMPLETED|Double-Blind Treatment Period||101
7561832|NCT02951988|18612865|P1|NOT COMPLETED|Double-Blind Treatment Period||0
7561833|NCT02951988|18612862|P4|COMPLETED|Double-Blind Treatment Period||85
7561834|NCT02951988|18612863|P3|COMPLETED|Double-Blind Treatment Period||101
7561835|NCT02951988|18612864|P2|COMPLETED|Double-Blind Treatment Period||101
7561836|NCT02951988|18612865|P1|COMPLETED|Double-Blind Treatment Period||0
7561837|NCT02951988|18612862|P4|STARTED|Double-Blind Treatment Period||200
7561838|NCT02951988|18612863|P3|STARTED|Double-Blind Treatment Period||202
7561839|NCT02951988|18612864|P2|STARTED|Double-Blind Treatment Period||202
7561840|NCT02951988|18612865|P1|STARTED|Double-Blind Treatment Period||0
7561841|NCT02951988|18612862|P4|NOT COMPLETED|Open-Label Treatment Period||0
7561842|NCT02951988|18612863|P3|NOT COMPLETED|Open-Label Treatment Period||0
7561843|NCT02951988|18612864|P2|NOT COMPLETED|Open-Label Treatment Period||0
7561844|NCT02951988|18612865|P1|NOT COMPLETED|Open-Label Treatment Period||248
7561845|NCT02951988|18612862|P4|COMPLETED|Open-Label Treatment Period||0
7561846|NCT02951988|18612863|P3|COMPLETED|Open-Label Treatment Period||0
7561847|NCT02951988|18612864|P2|COMPLETED|Open-Label Treatment Period||0
7561848|NCT02951988|18612865|P1|COMPLETED|Open-Label Treatment Period||1056
7561849|NCT02951988|18612862|P4|STARTED|Open-Label Treatment Period||0
7561850|NCT02951988|18612863|P3|STARTED|Open-Label Treatment Period||0
7561851|NCT02951988|18612864|P2|STARTED|Open-Label Treatment Period||0
7561852|NCT02951988|18612865|P1|STARTED|Open-Label Treatment Period||1304
7561853|NCT02951884|18612883|P3|NOT COMPLETED|Overall Study||0
7561854|NCT02951884|18612884|P2|NOT COMPLETED|Overall Study||0
7561855|NCT02951884|18612885|P1|NOT COMPLETED|Overall Study||0
7561856|NCT02951884|18612883|P3|COMPLETED|Overall Study||1
7561857|NCT02951884|18612884|P2|COMPLETED|Overall Study||1
7561858|NCT02951884|18612885|P1|COMPLETED|Overall Study||0
7561859|NCT02951884|18612883|P3|STARTED|Overall Study||1
7561860|NCT02951884|18612884|P2|STARTED|Overall Study||1
7561861|NCT02951884|18612885|P1|STARTED|Overall Study||0
7561862|NCT02951819|18612898|P2|NOT COMPLETED|Overall Study||14
7561863|NCT02951819|18612899|P1|NOT COMPLETED|Overall Study||87
7561864|NCT02951819|18612898|P2|COMPLETED|Overall Study||0
7561865|NCT02951819|18612899|P1|COMPLETED|Overall Study||0
7561866|NCT02951819|18612898|P2|Treated|Overall Study||14
7561867|NCT02951819|18612899|P1|Treated|Overall Study||86
7561868|NCT02951819|18612898|P2|STARTED|Overall Study||14
7561869|NCT02951819|18612899|P1|STARTED|Overall Study||87
7561870|NCT02951780|18612930|P9|NOT COMPLETED|Period 3||0
7561871|NCT02951780|18612931|P8|NOT COMPLETED|Period 3||0
7561872|NCT02951780|18612932|P7|NOT COMPLETED|Period 3||0
7561873|NCT02951780|18612933|P6|NOT COMPLETED|Period 3||0
7561874|NCT02951780|18612934|P5|NOT COMPLETED|Period 3||0
7561875|NCT02951780|18612935|P4|NOT COMPLETED|Period 3||0
7561876|NCT02951780|18612936|P3|NOT COMPLETED|Period 3||0
7561877|NCT02951780|18612937|P2|NOT COMPLETED|Period 3||0
7561878|NCT02951780|18612938|P1|NOT COMPLETED|Period 3||0
7561879|NCT02951780|18612930|P9|COMPLETED|Period 3||2
7561880|NCT02951780|18612931|P8|COMPLETED|Period 3||1
7561881|NCT02951780|18612932|P7|COMPLETED|Period 3||2
7561882|NCT02951780|18612933|P6|COMPLETED|Period 3||3
7561883|NCT02951780|18612934|P5|COMPLETED|Period 3||2
7561884|NCT02951780|18612935|P4|COMPLETED|Period 3||2
7561885|NCT02951780|18612936|P3|COMPLETED|Period 3||3
7561886|NCT02951780|18612937|P2|COMPLETED|Period 3||2
7561887|NCT02951780|18612938|P1|COMPLETED|Period 3||3
7561888|NCT02951780|18612930|P9|STARTED|Period 3||2
7561889|NCT02951780|18612931|P8|STARTED|Period 3||1
7561890|NCT02951780|18612932|P7|STARTED|Period 3||2
7561891|NCT02951780|18612933|P6|STARTED|Period 3||3
7561892|NCT02951780|18612934|P5|STARTED|Period 3||2
7561893|NCT02951780|18612935|P4|STARTED|Period 3||2
7561894|NCT02951780|18612936|P3|STARTED|Period 3||3
7561895|NCT02951780|18612937|P2|STARTED|Period 3||2
7561896|NCT02951780|18612938|P1|STARTED|Period 3||3
7561897|NCT02951780|18612930|P9|NOT COMPLETED|Period 2||0
7561898|NCT02951780|18612931|P8|NOT COMPLETED|Period 2||1
7561899|NCT02951780|18612932|P7|NOT COMPLETED|Period 2||0
7561900|NCT02951780|18612933|P6|NOT COMPLETED|Period 2||0
7561901|NCT02951780|18612934|P5|NOT COMPLETED|Period 2||0
7561902|NCT02951780|18612935|P4|NOT COMPLETED|Period 2||0
7561903|NCT02951780|18612936|P3|NOT COMPLETED|Period 2||0
7561904|NCT02951780|18612937|P2|NOT COMPLETED|Period 2||0
7561905|NCT02951780|18612938|P1|NOT COMPLETED|Period 2||0
7561906|NCT02951780|18612930|P9|COMPLETED|Period 2||2
7561907|NCT02951780|18612931|P8|COMPLETED|Period 2||1
7561908|NCT02951780|18612932|P7|COMPLETED|Period 2||2
7561909|NCT02951780|18612933|P6|COMPLETED|Period 2||3
7561910|NCT02951780|18612934|P5|COMPLETED|Period 2||2
7561911|NCT02951780|18612935|P4|COMPLETED|Period 2||2
7561912|NCT02951780|18612936|P3|COMPLETED|Period 2||3
7561913|NCT02951780|18612937|P2|COMPLETED|Period 2||2
7561914|NCT02951780|18612938|P1|COMPLETED|Period 2||3
7561915|NCT02951780|18612930|P9|STARTED|Period 2||2
7561916|NCT02951780|18612931|P8|STARTED|Period 2||2
7561917|NCT02951780|18612932|P7|STARTED|Period 2||2
7561918|NCT02951780|18612933|P6|STARTED|Period 2||3
7561919|NCT02951780|18612934|P5|STARTED|Period 2||2
7561920|NCT02951780|18612935|P4|STARTED|Period 2||2
7561921|NCT02951780|18612936|P3|STARTED|Period 2||3
7561922|NCT02951780|18612937|P2|STARTED|Period 2||2
7561923|NCT02951780|18612938|P1|STARTED|Period 2||3
7561924|NCT02951780|18612930|P9|NOT COMPLETED|Period 1||0
7561925|NCT02951780|18612931|P8|NOT COMPLETED|Period 1||1
7561926|NCT02951780|18612932|P7|NOT COMPLETED|Period 1||0
7561927|NCT02951780|18612933|P6|NOT COMPLETED|Period 1||0
7561928|NCT02951780|18612934|P5|NOT COMPLETED|Period 1||0
7561929|NCT02951780|18612935|P4|NOT COMPLETED|Period 1||1
7561930|NCT02951780|18612936|P3|NOT COMPLETED|Period 1||0
7561931|NCT02951780|18612937|P2|NOT COMPLETED|Period 1||0
7561932|NCT02951780|18612938|P1|NOT COMPLETED|Period 1||0
7561933|NCT02951780|18612930|P9|COMPLETED|Period 1||2
7561934|NCT02951780|18612931|P8|COMPLETED|Period 1||2
7561935|NCT02951780|18612932|P7|COMPLETED|Period 1||2
7561936|NCT02951780|18612933|P6|COMPLETED|Period 1||3
7561937|NCT02951780|18612934|P5|COMPLETED|Period 1||2
7561938|NCT02951780|18612935|P4|COMPLETED|Period 1||2
7561939|NCT02951780|18612936|P3|COMPLETED|Period 1||3
7561940|NCT02951780|18612937|P2|COMPLETED|Period 1||2
7561941|NCT02951780|18612938|P1|COMPLETED|Period 1||3
7561942|NCT02951780|18612930|P9|STARTED|Period 1||2
7561943|NCT02951780|18612931|P8|STARTED|Period 1||3
7561944|NCT02951780|18612932|P7|STARTED|Period 1||2
7561945|NCT02951780|18612933|P6|STARTED|Period 1||3
7561946|NCT02951780|18612934|P5|STARTED|Period 1||2
7561947|NCT02951780|18612935|P4|STARTED|Period 1||3
7561948|NCT02951780|18612936|P3|STARTED|Period 1||3
7561949|NCT02951780|18612937|P2|STARTED|Period 1||2
7561950|NCT02951780|18612938|P1|STARTED|Period 1||3
7561951|NCT02951767|18613003|P1|NOT COMPLETED|Overall Study||119
7561952|NCT02951767|18613003|P1|COMPLETED|Overall Study||0
7561953|NCT02951767|18613003|P1|STARTED|Overall Study||119
7561954|NCT02951702|18613022|P2|NOT COMPLETED|Overall Study||0
7561955|NCT02951702|18613023|P1|NOT COMPLETED|Overall Study||0
7561956|NCT02951702|18613022|P2|COMPLETED|Overall Study||17
7561957|NCT02951702|18613023|P1|COMPLETED|Overall Study||34
7561958|NCT02951702|18613022|P2|STARTED|Overall Study||17
7561959|NCT02951702|18613023|P1|STARTED|Overall Study||34
7561960|NCT02951533|18613035|P3|NOT COMPLETED|Part III (Week 64 Through Week 100)||2
7561961|NCT02951533|18613036|P2|NOT COMPLETED|Part III (Week 64 Through Week 100)||0
7561962|NCT02951533|18613037|P1|NOT COMPLETED|Part III (Week 64 Through Week 100)||4
7561963|NCT02951533|18613035|P3|COMPLETED|Part III (Week 64 Through Week 100)||10
7561964|NCT02951533|18613036|P2|COMPLETED|Part III (Week 64 Through Week 100)||0
7561965|NCT02951533|18613037|P1|COMPLETED|Part III (Week 64 Through Week 100)||32
7561966|NCT02951533|18613035|P3|STARTED|Part III (Week 64 Through Week 100)|8 participants were not eligible to enter Part III.|12
7561967|NCT02951533|18613036|P2|STARTED|Part III (Week 64 Through Week 100)|10 participants in the FAE group were not eligible to enter Part III.|0
7561968|NCT02951533|18613037|P1|STARTED|Part III (Week 64 Through Week 100)|18 participants were not eligible to enter Part III.|36
7561969|NCT02951533|18613035|P3|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||0
7561970|NCT02951533|18613036|P2|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||4
7561971|NCT02951533|18613037|P1|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||1
7561972|NCT02951533|18613035|P3|COMPLETED|Part IIb (Week 32 Through Week 56)||20
7561973|NCT02951533|18613036|P2|COMPLETED|Part IIb (Week 32 Through Week 56)||10
7561974|NCT02951533|18613037|P1|COMPLETED|Part IIb (Week 32 Through Week 56)||54
7561975|NCT02951533|18613035|P3|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in FAE group, 20 PASI 75 non-responders switched to GUS group.|20
7561976|NCT02951533|18613036|P2|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in the FAE group, 14 PASI 75 responders remained on FAE treatment.|14
7561977|NCT02951533|18613037|P1|STARTED|Part IIb (Week 32 Through Week 56)||55
7561978|NCT02951533|18613035|P3|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||0
7561979|NCT02951533|18613036|P2|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
7561980|NCT02951533|18613037|P1|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
7561981|NCT02951533|18613035|P3|COMPLETED|Part IIa (Week 24 Through Week 32)||0
7561982|NCT02951533|18613036|P2|COMPLETED|Part IIa (Week 24 Through Week 32)||34
7561983|NCT02951533|18613037|P1|COMPLETED|Part IIa (Week 24 Through Week 32)||55
7561984|NCT02951533|18613035|P3|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||0
7561985|NCT02951533|18613036|P2|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||20
7561986|NCT02951533|18613037|P1|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||1
7561987|NCT02951533|18613035|P3|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||0
7561988|NCT02951533|18613036|P2|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||14
7561989|NCT02951533|18613037|P1|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||54
7561990|NCT02951533|18613035|P3|STARTED|Part IIa (Week 24 Through Week 32)||0
7561991|NCT02951533|18613036|P2|STARTED|Part IIa (Week 24 Through Week 32)|1 participant did not sign informed consent form (ICF) for Study Part II but completed Study Part I.|35
7561992|NCT02951533|18613037|P1|STARTED|Part IIa (Week 24 Through Week 32)||56
7561993|NCT02951533|18613035|P3|NOT COMPLETED|Part I (Week 0 Through Week 24)||0
7561994|NCT02951533|18613036|P2|NOT COMPLETED|Part I (Week 0 Through Week 24)||23
7561995|NCT02951533|18613037|P1|NOT COMPLETED|Part I (Week 0 Through Week 24)||4
7561996|NCT02951533|18613035|P3|COMPLETED|Part I (Week 0 Through Week 24)||0
7561997|NCT02951533|18613036|P2|COMPLETED|Part I (Week 0 Through Week 24)||36
7561998|NCT02951533|18613037|P1|COMPLETED|Part I (Week 0 Through Week 24)||56
7561999|NCT02951533|18613035|P3|Treated|Part I (Week 0 Through Week 24)||0
7562000|NCT02951533|18613036|P2|Treated|Part I (Week 0 Through Week 24)||58
7562001|NCT02951533|18613037|P1|Treated|Part I (Week 0 Through Week 24)||60
7562002|NCT02951533|18613035|P3|STARTED|Part I (Week 0 Through Week 24)||0
7562003|NCT02951533|18613036|P2|STARTED|Part I (Week 0 Through Week 24)||59
7562004|NCT02951533|18613037|P1|STARTED|Part I (Week 0 Through Week 24)||60
7562005|NCT02951481|18613136|P2|NOT COMPLETED|Overall Study||0
7562006|NCT02951481|18613137|P1|NOT COMPLETED|Overall Study||0
7562007|NCT02951481|18613136|P2|COMPLETED|Overall Study||172
7562008|NCT02951481|18613137|P1|COMPLETED|Overall Study||231
7562009|NCT02951481|18613136|P2|STARTED|Overall Study||172
7562010|NCT02951481|18613137|P1|STARTED|Overall Study||231
7562011|NCT02951429|18613159|P2|NOT COMPLETED|Overall Study||83
7562012|NCT02951429|18613160|P1|NOT COMPLETED|Overall Study||72
7562013|NCT02951429|18613159|P2|COMPLETED|Overall Study||6
7562014|NCT02951429|18613160|P1|COMPLETED|Overall Study||16
7562015|NCT02951429|18613159|P2|STARTED|Overall Study||89
7562016|NCT02951429|18613160|P1|STARTED|Overall Study||88
7562017|NCT02951351|18613220|P2|NOT COMPLETED|Overall Study||0
7562018|NCT02951351|18613221|P1|NOT COMPLETED|Overall Study||0
7562019|NCT02951351|18613220|P2|COMPLETED|Overall Study||17
7562020|NCT02951351|18613221|P1|COMPLETED|Overall Study||19
7562021|NCT02951351|18613220|P2|STARTED|Overall Study||17
7562022|NCT02951351|18613221|P1|STARTED|Overall Study||19
7562023|NCT02951312|18613245|P4|NOT COMPLETED|Study Part 2||0
7562024|NCT02951312|18613246|P3|NOT COMPLETED|Study Part 2||0
7562025|NCT02951312|18613247|P2|NOT COMPLETED|Study Part 2||0
7562026|NCT02951312|18613248|P1|NOT COMPLETED|Study Part 2||0
7562027|NCT02951312|18613245|P4|COMPLETED|Study Part 2||6
7562028|NCT02951312|18613246|P3|COMPLETED|Study Part 2||6
7562029|NCT02951312|18613247|P2|COMPLETED|Study Part 2||0
7562030|NCT02951312|18613248|P1|COMPLETED|Study Part 2||0
7562031|NCT02951312|18613245|P4|STARTED|Study Part 2||6
7562032|NCT02951312|18613246|P3|STARTED|Study Part 2||6
7562033|NCT02951312|18613247|P2|STARTED|Study Part 2||0
7562034|NCT02951312|18613248|P1|STARTED|Study Part 2||0
7562035|NCT02951312|18613245|P4|NOT COMPLETED|Study Part 1||0
7562036|NCT02951312|18613246|P3|NOT COMPLETED|Study Part 1||0
7562037|NCT02951312|18613247|P2|NOT COMPLETED|Study Part 1||0
7562038|NCT02951312|18613248|P1|NOT COMPLETED|Study Part 1||0
7562039|NCT02951312|18613245|P4|COMPLETED|Study Part 1||0
7562040|NCT02951312|18613246|P3|COMPLETED|Study Part 1||0
7562041|NCT02951312|18613247|P2|COMPLETED|Study Part 1||6
7562042|NCT02951312|18613248|P1|COMPLETED|Study Part 1||6
7562043|NCT02951312|18613245|P4|STARTED|Study Part 1||0
7562044|NCT02951312|18613246|P3|STARTED|Study Part 1||0
7562045|NCT02951312|18613247|P2|STARTED|Study Part 1||6
7562046|NCT02951312|18613248|P1|STARTED|Study Part 1||6
7562047|NCT02951273|18613368|P1|NOT COMPLETED|Overall Study||3
7562048|NCT02951273|18613368|P1|COMPLETED|Overall Study||27
7562049|NCT02951273|18613368|P1|STARTED|Overall Study||30
7562050|NCT02951182|18613389|P6|NOT COMPLETED|Overall Study||0
7562051|NCT02951182|18613390|P5|NOT COMPLETED|Overall Study||0
7562052|NCT02951182|18613391|P4|NOT COMPLETED|Overall Study||0
7562053|NCT02951182|18613392|P3|NOT COMPLETED|Overall Study||0
7562054|NCT02951182|18613393|P2|NOT COMPLETED|Overall Study||0
7562055|NCT02951182|18613394|P1|NOT COMPLETED|Overall Study||0
7562056|NCT02951182|18613389|P6|COMPLETED|Overall Study||20
7562057|NCT02951182|18613390|P5|COMPLETED|Overall Study||6
7562058|NCT02951182|18613391|P4|COMPLETED|Overall Study||18
7562059|NCT02951182|18613392|P3|COMPLETED|Overall Study||9
7562060|NCT02951182|18613393|P2|COMPLETED|Overall Study||9
7562061|NCT02951182|18613394|P1|COMPLETED|Overall Study||11
7562062|NCT02951182|18613389|P6|STARTED|Overall Study||20
7562063|NCT02951182|18613390|P5|STARTED|Overall Study||6
7562064|NCT02951182|18613391|P4|STARTED|Overall Study||18
7562065|NCT02951182|18613392|P3|STARTED|Overall Study||9
7562066|NCT02951182|18613393|P2|STARTED|Overall Study||9
7562067|NCT02951182|18613394|P1|STARTED|Overall Study||11
7562068|NCT02951156|18613436|P3|NOT COMPLETED|Overall Study||10
7562069|NCT02951156|18613437|P2|NOT COMPLETED|Overall Study||9
7562070|NCT02951156|18613438|P1|NOT COMPLETED|Overall Study||9
7562071|NCT02951156|18613436|P3|COMPLETED|Overall Study||1
7562072|NCT02951156|18613437|P2|COMPLETED|Overall Study||0
7562073|NCT02951156|18613438|P1|COMPLETED|Overall Study||0
7562074|NCT02951156|18613436|P3|STARTED|Overall Study||11
7562075|NCT02951156|18613437|P2|STARTED|Overall Study||9
7562076|NCT02951156|18613438|P1|STARTED|Overall Study||9
7562077|NCT02951052|18613498|P2|NOT COMPLETED|Overall Study||18
7562078|NCT02951052|18613499|P1|NOT COMPLETED|Overall Study||27
7562079|NCT02951052|18613498|P2|COMPLETED|Overall Study||290
7562080|NCT02951052|18613499|P1|COMPLETED|Overall Study||281
7562081|NCT02951052|18613498|P2|STARTED|Overall Study||308
7562082|NCT02951052|18613499|P1|STARTED|Overall Study||308
7562083|NCT02950896|18613663|P1|NOT COMPLETED|Overall Study||0
7562084|NCT02950896|18613663|P1|COMPLETED|Overall Study||4
7562085|NCT02950896|18613663|P1|STARTED|Overall Study||4
7562086|NCT02950831|18613667|P1|NOT COMPLETED|Overall Study||9
7562087|NCT02950831|18613667|P1|COMPLETED|Overall Study||18
7562088|NCT02950831|18613667|P1|8 Weeks Follow up|Overall Study||19
7562089|NCT02950831|18613667|P1|4 Week Follow up|Overall Study||20
7562090|NCT02950831|18613667|P1|Permanent Implant|Overall Study||20
7562091|NCT02950831|18613667|P1|Complete Trial|Overall Study||26
7562092|NCT02950831|18613667|P1|STARTED|Overall Study||27
7562093|NCT02950753|18613692|P2|NOT COMPLETED|Overall Study||0
7562094|NCT02950753|18613693|P1|NOT COMPLETED|Overall Study||0
7562095|NCT02950753|18613692|P2|COMPLETED|Overall Study||15
7562096|NCT02950753|18613693|P1|COMPLETED|Overall Study||15
7562097|NCT02950753|18613692|P2|STARTED|Overall Study||15
7562098|NCT02950753|18613693|P1|STARTED|Overall Study||15
7562099|NCT02950545|18613709|P6|NOT COMPLETED|Session 3 (70 Minutes)||1
7562100|NCT02950545|18613710|P5|NOT COMPLETED|Session 3 (70 Minutes)||0
7562101|NCT02950545|18613711|P4|NOT COMPLETED|Session 3 (70 Minutes)||0
7562102|NCT02950545|18613712|P3|NOT COMPLETED|Session 3 (70 Minutes)||0
7562103|NCT02950545|18613713|P2|NOT COMPLETED|Session 3 (70 Minutes)||0
7562104|NCT02950545|18613714|P1|NOT COMPLETED|Session 3 (70 Minutes)||0
7562105|NCT02950545|18613709|P6|COMPLETED|Session 3 (70 Minutes)||7
7562106|NCT02950545|18613710|P5|COMPLETED|Session 3 (70 Minutes)||7
7562107|NCT02950545|18613711|P4|COMPLETED|Session 3 (70 Minutes)||7
7562108|NCT02950545|18613712|P3|COMPLETED|Session 3 (70 Minutes)||7
7562109|NCT02950545|18613713|P2|COMPLETED|Session 3 (70 Minutes)||9
7562110|NCT02950545|18613714|P1|COMPLETED|Session 3 (70 Minutes)||7
7562111|NCT02950545|18613709|P6|STARTED|Session 3 (70 Minutes)||8
7562112|NCT02950545|18613710|P5|STARTED|Session 3 (70 Minutes)||7
7562113|NCT02950545|18613711|P4|STARTED|Session 3 (70 Minutes)||7
7562114|NCT02950545|18613712|P3|STARTED|Session 3 (70 Minutes)||7
7562115|NCT02950545|18613713|P2|STARTED|Session 3 (70 Minutes)||9
7562116|NCT02950545|18613714|P1|STARTED|Session 3 (70 Minutes)||7
7562117|NCT02950545|18613709|P6|NOT COMPLETED|Washout 2 (5 Minutes)||0
7562118|NCT02950545|18613710|P5|NOT COMPLETED|Washout 2 (5 Minutes)||0
7562119|NCT02950545|18613711|P4|NOT COMPLETED|Washout 2 (5 Minutes)||0
7562120|NCT02950545|18613712|P3|NOT COMPLETED|Washout 2 (5 Minutes)||0
7562121|NCT02950545|18613713|P2|NOT COMPLETED|Washout 2 (5 Minutes)||0
7562122|NCT02950545|18613714|P1|NOT COMPLETED|Washout 2 (5 Minutes)||1
7562123|NCT02950545|18613709|P6|COMPLETED|Washout 2 (5 Minutes)||8
7562124|NCT02950545|18613710|P5|COMPLETED|Washout 2 (5 Minutes)||7
7562125|NCT02950545|18613711|P4|COMPLETED|Washout 2 (5 Minutes)||7
7562126|NCT02950545|18613712|P3|COMPLETED|Washout 2 (5 Minutes)||7
7562127|NCT02950545|18613713|P2|COMPLETED|Washout 2 (5 Minutes)||9
7562128|NCT02950545|18613714|P1|COMPLETED|Washout 2 (5 Minutes)||7
7562129|NCT02950545|18613709|P6|STARTED|Washout 2 (5 Minutes)||8
7562130|NCT02950545|18613710|P5|STARTED|Washout 2 (5 Minutes)||7
7562131|NCT02950545|18613711|P4|STARTED|Washout 2 (5 Minutes)||7
7562132|NCT02950545|18613712|P3|STARTED|Washout 2 (5 Minutes)||7
7562133|NCT02950545|18613713|P2|STARTED|Washout 2 (5 Minutes)||9
7562134|NCT02950545|18613714|P1|STARTED|Washout 2 (5 Minutes)||8
7562135|NCT02950545|18613709|P6|NOT COMPLETED|Session 2 (70 Minutes)||0
7562136|NCT02950545|18613710|P5|NOT COMPLETED|Session 2 (70 Minutes)||1
7562137|NCT02950545|18613711|P4|NOT COMPLETED|Session 2 (70 Minutes)||0
7562138|NCT02950545|18613712|P3|NOT COMPLETED|Session 2 (70 Minutes)||0
7562139|NCT02950545|18613713|P2|NOT COMPLETED|Session 2 (70 Minutes)||0
7562140|NCT02950545|18613714|P1|NOT COMPLETED|Session 2 (70 Minutes)||0
7562141|NCT02950545|18613709|P6|COMPLETED|Session 2 (70 Minutes)||8
7562142|NCT02950545|18613710|P5|COMPLETED|Session 2 (70 Minutes)||7
7562143|NCT02950545|18613711|P4|COMPLETED|Session 2 (70 Minutes)||7
7562144|NCT02950545|18613712|P3|COMPLETED|Session 2 (70 Minutes)||7
7562145|NCT02950545|18613713|P2|COMPLETED|Session 2 (70 Minutes)||9
7562146|NCT02950545|18613714|P1|COMPLETED|Session 2 (70 Minutes)||8
7562147|NCT02950545|18613709|P6|STARTED|Session 2 (70 Minutes)||8
7562148|NCT02950545|18613710|P5|STARTED|Session 2 (70 Minutes)||8
7562149|NCT02950545|18613711|P4|STARTED|Session 2 (70 Minutes)||7
7562150|NCT02950545|18613712|P3|STARTED|Session 2 (70 Minutes)||7
7562151|NCT02950545|18613713|P2|STARTED|Session 2 (70 Minutes)||9
7562152|NCT02950545|18613714|P1|STARTED|Session 2 (70 Minutes)||8
7562153|NCT02950545|18613709|P6|NOT COMPLETED|Washout 1 (5 Minutes)||1
7562154|NCT02950545|18613710|P5|NOT COMPLETED|Washout 1 (5 Minutes)||0
7562155|NCT02950545|18613711|P4|NOT COMPLETED|Washout 1 (5 Minutes)||1
7562156|NCT02950545|18613712|P3|NOT COMPLETED|Washout 1 (5 Minutes)||0
7562157|NCT02950545|18613713|P2|NOT COMPLETED|Washout 1 (5 Minutes)||0
7562158|NCT02950545|18613714|P1|NOT COMPLETED|Washout 1 (5 Minutes)||1
7562159|NCT02950545|18613709|P6|COMPLETED|Washout 1 (5 Minutes)||8
7562160|NCT02950545|18613710|P5|COMPLETED|Washout 1 (5 Minutes)||8
7562161|NCT02950545|18613711|P4|COMPLETED|Washout 1 (5 Minutes)||7
7562162|NCT02950545|18613712|P3|COMPLETED|Washout 1 (5 Minutes)||7
7562163|NCT02950545|18613713|P2|COMPLETED|Washout 1 (5 Minutes)||9
7562164|NCT02950545|18613714|P1|COMPLETED|Washout 1 (5 Minutes)||8
7562165|NCT02950545|18613709|P6|STARTED|Washout 1 (5 Minutes)||9
7562166|NCT02950545|18613710|P5|STARTED|Washout 1 (5 Minutes)||8
7562167|NCT02950545|18613711|P4|STARTED|Washout 1 (5 Minutes)||8
7562168|NCT02950545|18613712|P3|STARTED|Washout 1 (5 Minutes)||7
7562169|NCT02950545|18613713|P2|STARTED|Washout 1 (5 Minutes)||9
7562170|NCT02950545|18613714|P1|STARTED|Washout 1 (5 Minutes)||9
7562171|NCT02950545|18613709|P6|NOT COMPLETED|Session 1 (70 Minutes)||1
7562172|NCT02950545|18613710|P5|NOT COMPLETED|Session 1 (70 Minutes)||0
7562173|NCT02950545|18613711|P4|NOT COMPLETED|Session 1 (70 Minutes)||0
7562174|NCT02950545|18613712|P3|NOT COMPLETED|Session 1 (70 Minutes)||0
7562175|NCT02950545|18613713|P2|NOT COMPLETED|Session 1 (70 Minutes)||0
7562176|NCT02950545|18613714|P1|NOT COMPLETED|Session 1 (70 Minutes)||0
7562177|NCT02950545|18613709|P6|COMPLETED|Session 1 (70 Minutes)||9
7562178|NCT02950545|18613710|P5|COMPLETED|Session 1 (70 Minutes)||8
7562179|NCT02950545|18613711|P4|COMPLETED|Session 1 (70 Minutes)||8
7562180|NCT02950545|18613712|P3|COMPLETED|Session 1 (70 Minutes)||7
7562181|NCT02950545|18613713|P2|COMPLETED|Session 1 (70 Minutes)||9
7562182|NCT02950545|18613714|P1|COMPLETED|Session 1 (70 Minutes)||9
7562183|NCT02950545|18613709|P6|STARTED|Session 1 (70 Minutes)||10
7562184|NCT02950545|18613710|P5|STARTED|Session 1 (70 Minutes)||8
7562185|NCT02950545|18613711|P4|STARTED|Session 1 (70 Minutes)||8
7562186|NCT02950545|18613712|P3|STARTED|Session 1 (70 Minutes)||7
7562187|NCT02950545|18613713|P2|STARTED|Session 1 (70 Minutes)||9
7562188|NCT02950545|18613714|P1|STARTED|Session 1 (70 Minutes)||9
7562189|NCT02950480|18613723|P2|NOT COMPLETED|Overall Study||0
7562190|NCT02950480|18613724|P1|NOT COMPLETED|Overall Study||1
7562191|NCT02950480|18613723|P2|COMPLETED|Overall Study||2
7562192|NCT02950480|18613724|P1|COMPLETED|Overall Study||1
7562193|NCT02950480|18613723|P2|STARTED|Overall Study||2
7562194|NCT02950480|18613724|P1|STARTED|Overall Study||2
7562195|NCT02950025|18613736|P2|NOT COMPLETED|Overall Study||0
7562196|NCT02950025|18613737|P1|NOT COMPLETED|Overall Study||0
7562197|NCT02950025|18613736|P2|COMPLETED|Overall Study||3
7562198|NCT02950025|18613737|P1|COMPLETED|Overall Study||2
7562199|NCT02950025|18613736|P2|STARTED|Overall Study||3
7562200|NCT02950025|18613737|P1|STARTED|Overall Study||2
7562201|NCT02949947|18613757|P2|NOT COMPLETED|Overall Study||1
7562202|NCT02949947|18613758|P1|NOT COMPLETED|Overall Study||1
7562203|NCT02949947|18613757|P2|COMPLETED|Overall Study||1
7562204|NCT02949947|18613758|P1|COMPLETED|Overall Study||0
7562205|NCT02949947|18613757|P2|STARTED|Overall Study||2
7562206|NCT02949947|18613758|P1|STARTED|Overall Study||1
7562207|NCT02949921|18613766|P2|NOT COMPLETED|Overall Study||0
7562208|NCT02949921|18613767|P1|NOT COMPLETED|Overall Study||0
7562209|NCT02949921|18613766|P2|COMPLETED|Overall Study||10
7562210|NCT02949921|18613767|P1|COMPLETED|Overall Study||10
7562211|NCT02949921|18613766|P2|STARTED|Overall Study||10
7562212|NCT02949921|18613767|P1|STARTED|Overall Study||10
7562213|NCT02949908|18613791|P1|NOT COMPLETED|Overall Study||2
7562214|NCT02949908|18613791|P1|COMPLETED|Overall Study||0
7562215|NCT02949908|18613791|P1|STARTED|Overall Study||2
7562216|NCT02949674|18613814|P3|NOT COMPLETED|Overall Study||0
7562217|NCT02949674|18613815|P2|NOT COMPLETED|Overall Study||0
7562218|NCT02949674|18613816|P1|NOT COMPLETED|Overall Study||0
7562219|NCT02949674|18613814|P3|COMPLETED|Overall Study||31
7562220|NCT02949674|18613815|P2|COMPLETED|Overall Study||31
7562221|NCT02949674|18613816|P1|COMPLETED|Overall Study||31
7562222|NCT02949674|18613814|P3|STARTED|Overall Study||31
7562223|NCT02949674|18613815|P2|STARTED|Overall Study||31
7562224|NCT02949674|18613816|P1|STARTED|Overall Study||31
7562225|NCT02949518|18613826|P2|NOT COMPLETED|Overall Study||2
7562226|NCT02949518|18613827|P1|NOT COMPLETED|Overall Study||3
7562227|NCT02949518|18613826|P2|COMPLETED|Overall Study||26
7562228|NCT02949518|18613827|P1|COMPLETED|Overall Study||25
7562229|NCT02949518|18613826|P2|STARTED|Overall Study||28
7562230|NCT02949518|18613827|P1|STARTED|Overall Study||28
7562231|NCT02949271|18613855|P2|NOT COMPLETED|Overall Study||30
7562232|NCT02949271|18613856|P1|NOT COMPLETED|Overall Study||29
7562233|NCT02949271|18613855|P2|COMPLETED|Overall Study||59
7562234|NCT02949271|18613856|P1|COMPLETED|Overall Study||61
7562235|NCT02949271|18613855|P2|STARTED|Overall Study||89
7562236|NCT02949271|18613856|P1|STARTED|Overall Study||90
7562237|NCT02949219|18613882|P1|NOT COMPLETED|Overall Study||1
7562238|NCT02949219|18613882|P1|COMPLETED|Overall Study||40
7562239|NCT02949219|18613882|P1|STARTED|Overall Study||41
7562240|NCT02949141|18613889|P1|NOT COMPLETED|Overall Study||0
7562241|NCT02949141|18613889|P1|COMPLETED|Overall Study||62
7562242|NCT02949141|18613889|P1|STARTED|Overall Study||62
7562243|NCT02949128|18613896|P1|NOT COMPLETED|Extension Period||2
7562244|NCT02949128|18613896|P1|COMPLETED|Extension Period||47
7562245|NCT02949128|18613896|P1|Received At Least 1 Dose of Study Drug|Extension Period||47
7562246|NCT02949128|18613896|P1|STARTED|Extension Period||49
7562247|NCT02949128|18613896|P1|NOT COMPLETED|Initial Evaluation Period||9
7562248|NCT02949128|18613896|P1|COMPLETED|Initial Evaluation Period||49
7562249|NCT02949128|18613896|P1|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||58
7562250|NCT02949128|18613896|P1|STARTED|Initial Evaluation Period||58
7562251|NCT02949011|18613913|P3|NOT COMPLETED|Overall Study||42
7562252|NCT02949011|18613914|P2|NOT COMPLETED|Overall Study||34
7562253|NCT02949011|18613915|P1|NOT COMPLETED|Overall Study||33
7562254|NCT02949011|18613913|P3|COMPLETED|Overall Study||683
7562255|NCT02949011|18613914|P2|COMPLETED|Overall Study||695
7562256|NCT02949011|18613915|P1|COMPLETED|Overall Study||697
7562257|NCT02949011|18613913|P3|Intention to Treat Infected Population|Overall Study||389
7562258|NCT02949011|18613914|P2|Intention to Treat Infected Population|Overall Study||386
7562259|NCT02949011|18613915|P1|Intention to Treat Infected Population|Overall Study||388
7562260|NCT02949011|18613913|P3|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|722
7562261|NCT02949011|18613914|P2|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|728
7562262|NCT02949011|18613915|P1|Received Study Drug|Overall Study||728
7562263|NCT02949011|18613913|P3|STARTED|Overall Study||725
7562264|NCT02949011|18613914|P2|STARTED|Overall Study||729
7562265|NCT02949011|18613915|P1|STARTED|Overall Study||730
7562266|NCT02948634|18613985|P2|NOT COMPLETED|Overall Study||2
7562267|NCT02948634|18613986|P1|NOT COMPLETED|Overall Study||10
7562268|NCT02948634|18613985|P2|COMPLETED|Overall Study||9
7562269|NCT02948634|18613986|P1|COMPLETED|Overall Study||7
7562270|NCT02948634|18613985|P2|STARTED|Overall Study||11
7562271|NCT02948634|18613986|P1|STARTED|Overall Study||17
7562272|NCT02948582|18613996|P6|NOT COMPLETED|Wshout Period 6||0
7562273|NCT02948582|18613997|P5|NOT COMPLETED|Wshout Period 6||0
7562274|NCT02948582|18613998|P4|NOT COMPLETED|Wshout Period 6||0
7562275|NCT02948582|18613999|P3|NOT COMPLETED|Wshout Period 6||0
7562276|NCT02948582|18614000|P2|NOT COMPLETED|Wshout Period 6||0
7562277|NCT02948582|18614001|P1|NOT COMPLETED|Wshout Period 6||0
7562278|NCT02948582|18613996|P6|COMPLETED|Wshout Period 6||6
7562279|NCT02948582|18613997|P5|COMPLETED|Wshout Period 6||7
7562280|NCT02948582|18613998|P4|COMPLETED|Wshout Period 6||6
7562281|NCT02948582|18613999|P3|COMPLETED|Wshout Period 6||6
7562282|NCT02948582|18614000|P2|COMPLETED|Wshout Period 6||4
7562283|NCT02948582|18614001|P1|COMPLETED|Wshout Period 6||6
7562284|NCT02948582|18613996|P6|STARTED|Wshout Period 6||6
7562285|NCT02948582|18613997|P5|STARTED|Wshout Period 6||7
7562286|NCT02948582|18613998|P4|STARTED|Wshout Period 6||6
7562287|NCT02948582|18613999|P3|STARTED|Wshout Period 6||6
7562288|NCT02948582|18614000|P2|STARTED|Wshout Period 6||4
7562289|NCT02948582|18614001|P1|STARTED|Wshout Period 6||6
7562290|NCT02948582|18613996|P6|NOT COMPLETED|Treatment Period 6||0
7562291|NCT02948582|18613997|P5|NOT COMPLETED|Treatment Period 6||0
7562292|NCT02948582|18613998|P4|NOT COMPLETED|Treatment Period 6||0
7562293|NCT02948582|18613999|P3|NOT COMPLETED|Treatment Period 6||0
7562294|NCT02948582|18614000|P2|NOT COMPLETED|Treatment Period 6||0
7562295|NCT02948582|18614001|P1|NOT COMPLETED|Treatment Period 6||0
7562296|NCT02948582|18613996|P6|COMPLETED|Treatment Period 6||6
7562297|NCT02948582|18613997|P5|COMPLETED|Treatment Period 6||7
7562298|NCT02948582|18613998|P4|COMPLETED|Treatment Period 6||6
7562299|NCT02948582|18613999|P3|COMPLETED|Treatment Period 6||6
7562300|NCT02948582|18614000|P2|COMPLETED|Treatment Period 6||4
7562301|NCT02948582|18614001|P1|COMPLETED|Treatment Period 6||6
7562302|NCT02948582|18613996|P6|STARTED|Treatment Period 6||6
7562303|NCT02948582|18613997|P5|STARTED|Treatment Period 6||7
7562304|NCT02948582|18613998|P4|STARTED|Treatment Period 6||6
7562305|NCT02948582|18613999|P3|STARTED|Treatment Period 6||6
7562306|NCT02948582|18614000|P2|STARTED|Treatment Period 6||4
7562307|NCT02948582|18614001|P1|STARTED|Treatment Period 6||6
7562308|NCT02948582|18613996|P6|NOT COMPLETED|Washout Period 5||0
7562309|NCT02948582|18613997|P5|NOT COMPLETED|Washout Period 5||0
7562310|NCT02948582|18613998|P4|NOT COMPLETED|Washout Period 5||0
7562311|NCT02948582|18613999|P3|NOT COMPLETED|Washout Period 5||0
7562312|NCT02948582|18614000|P2|NOT COMPLETED|Washout Period 5||0
7562313|NCT02948582|18614001|P1|NOT COMPLETED|Washout Period 5||0
7562314|NCT02948582|18613996|P6|COMPLETED|Washout Period 5||6
7562315|NCT02948582|18613997|P5|COMPLETED|Washout Period 5||7
7562316|NCT02948582|18613998|P4|COMPLETED|Washout Period 5||6
7562317|NCT02948582|18613999|P3|COMPLETED|Washout Period 5||6
7562318|NCT02948582|18614000|P2|COMPLETED|Washout Period 5||4
7562319|NCT02948582|18614001|P1|COMPLETED|Washout Period 5||6
7562320|NCT02948582|18613996|P6|STARTED|Washout Period 5||6
7562321|NCT02948582|18613997|P5|STARTED|Washout Period 5||7
7562322|NCT02948582|18613998|P4|STARTED|Washout Period 5||6
7562323|NCT02948582|18613999|P3|STARTED|Washout Period 5||6
7562324|NCT02948582|18614000|P2|STARTED|Washout Period 5||4
7562325|NCT02948582|18614001|P1|STARTED|Washout Period 5||6
7562326|NCT02948582|18613996|P6|NOT COMPLETED|Treatment Period 5||0
7562327|NCT02948582|18613997|P5|NOT COMPLETED|Treatment Period 5||0
7562328|NCT02948582|18613998|P4|NOT COMPLETED|Treatment Period 5||0
7562329|NCT02948582|18613999|P3|NOT COMPLETED|Treatment Period 5||0
7562330|NCT02948582|18614000|P2|NOT COMPLETED|Treatment Period 5||0
7562331|NCT02948582|18614001|P1|NOT COMPLETED|Treatment Period 5||0
7562332|NCT02948582|18613996|P6|COMPLETED|Treatment Period 5||6
7562333|NCT02948582|18613997|P5|COMPLETED|Treatment Period 5||7
7562334|NCT02948582|18613998|P4|COMPLETED|Treatment Period 5||6
7562335|NCT02948582|18613999|P3|COMPLETED|Treatment Period 5||6
7562336|NCT02948582|18614000|P2|COMPLETED|Treatment Period 5||4
7562337|NCT02948582|18614001|P1|COMPLETED|Treatment Period 5||6
7562338|NCT02948582|18613996|P6|STARTED|Treatment Period 5||6
7562339|NCT02948582|18613997|P5|STARTED|Treatment Period 5||7
7562340|NCT02948582|18613998|P4|STARTED|Treatment Period 5||6
7562341|NCT02948582|18613999|P3|STARTED|Treatment Period 5||6
7562342|NCT02948582|18614000|P2|STARTED|Treatment Period 5||4
7562343|NCT02948582|18614001|P1|STARTED|Treatment Period 5||6
7562344|NCT02948582|18613996|P6|NOT COMPLETED|Washout Period 4||0
7562345|NCT02948582|18613997|P5|NOT COMPLETED|Washout Period 4||0
7562346|NCT02948582|18613998|P4|NOT COMPLETED|Washout Period 4||0
7562347|NCT02948582|18613999|P3|NOT COMPLETED|Washout Period 4||1
7562348|NCT02948582|18614000|P2|NOT COMPLETED|Washout Period 4||0
7562349|NCT02948582|18614001|P1|NOT COMPLETED|Washout Period 4||1
7562350|NCT02948582|18613996|P6|COMPLETED|Washout Period 4||6
7562351|NCT02948582|18613997|P5|COMPLETED|Washout Period 4||7
7562352|NCT02948582|18613998|P4|COMPLETED|Washout Period 4||6
7562353|NCT02948582|18613999|P3|COMPLETED|Washout Period 4||6
7562354|NCT02948582|18614000|P2|COMPLETED|Washout Period 4||4
7562355|NCT02948582|18614001|P1|COMPLETED|Washout Period 4||6
7562356|NCT02948582|18613996|P6|STARTED|Washout Period 4||6
7562357|NCT02948582|18613997|P5|STARTED|Washout Period 4||7
7562358|NCT02948582|18613998|P4|STARTED|Washout Period 4||6
7562359|NCT02948582|18613999|P3|STARTED|Washout Period 4||7
7562360|NCT02948582|18614000|P2|STARTED|Washout Period 4||4
7562361|NCT02948582|18614001|P1|STARTED|Washout Period 4||7
7562362|NCT02948582|18613996|P6|NOT COMPLETED|Treatment Period 4||0
7562363|NCT02948582|18613997|P5|NOT COMPLETED|Treatment Period 4||0
7562364|NCT02948582|18613998|P4|NOT COMPLETED|Treatment Period 4||0
7562365|NCT02948582|18613999|P3|NOT COMPLETED|Treatment Period 4||0
7562366|NCT02948582|18614000|P2|NOT COMPLETED|Treatment Period 4||0
7562367|NCT02948582|18614001|P1|NOT COMPLETED|Treatment Period 4||0
7562368|NCT02948582|18613996|P6|COMPLETED|Treatment Period 4||6
7562369|NCT02948582|18613997|P5|COMPLETED|Treatment Period 4||7
7562370|NCT02948582|18613998|P4|COMPLETED|Treatment Period 4||6
7562371|NCT02948582|18613999|P3|COMPLETED|Treatment Period 4||7
7562372|NCT02948582|18614000|P2|COMPLETED|Treatment Period 4||4
7562373|NCT02948582|18614001|P1|COMPLETED|Treatment Period 4||7
7562374|NCT02948582|18613996|P6|STARTED|Treatment Period 4||6
7562375|NCT02948582|18613997|P5|STARTED|Treatment Period 4||7
7562376|NCT02948582|18613998|P4|STARTED|Treatment Period 4||6
7562377|NCT02948582|18613999|P3|STARTED|Treatment Period 4||7
7562378|NCT02948582|18614000|P2|STARTED|Treatment Period 4||4
7562379|NCT02948582|18614001|P1|STARTED|Treatment Period 4||7
7562380|NCT02948582|18613996|P6|NOT COMPLETED|Washout Period 3||0
7562381|NCT02948582|18613997|P5|NOT COMPLETED|Washout Period 3||0
7562382|NCT02948582|18613998|P4|NOT COMPLETED|Washout Period 3||0
7562383|NCT02948582|18613999|P3|NOT COMPLETED|Washout Period 3||0
7562384|NCT02948582|18614000|P2|NOT COMPLETED|Washout Period 3||0
7562385|NCT02948582|18614001|P1|NOT COMPLETED|Washout Period 3||0
7562386|NCT02948582|18613996|P6|COMPLETED|Washout Period 3||6
7562387|NCT02948582|18613997|P5|COMPLETED|Washout Period 3||7
7562388|NCT02948582|18613998|P4|COMPLETED|Washout Period 3||6
7562389|NCT02948582|18613999|P3|COMPLETED|Washout Period 3||7
7562390|NCT02948582|18614000|P2|COMPLETED|Washout Period 3||4
7562391|NCT02948582|18614001|P1|COMPLETED|Washout Period 3||7
7562392|NCT02948582|18613996|P6|STARTED|Washout Period 3||6
7562393|NCT02948582|18613997|P5|STARTED|Washout Period 3||7
7562394|NCT02948582|18613998|P4|STARTED|Washout Period 3||6
7562395|NCT02948582|18613999|P3|STARTED|Washout Period 3||7
7562396|NCT02948582|18614000|P2|STARTED|Washout Period 3||4
7562397|NCT02948582|18614001|P1|STARTED|Washout Period 3||7
7562398|NCT02948582|18613996|P6|NOT COMPLETED|Treatment Period 3||0
7562399|NCT02948582|18613997|P5|NOT COMPLETED|Treatment Period 3||0
7562400|NCT02948582|18613998|P4|NOT COMPLETED|Treatment Period 3||0
7562401|NCT02948582|18613999|P3|NOT COMPLETED|Treatment Period 3||0
7562402|NCT02948582|18614000|P2|NOT COMPLETED|Treatment Period 3||0
7562403|NCT02948582|18614001|P1|NOT COMPLETED|Treatment Period 3||0
7562404|NCT02948582|18613996|P6|COMPLETED|Treatment Period 3||6
7562405|NCT02948582|18613997|P5|COMPLETED|Treatment Period 3||7
7562406|NCT02948582|18613998|P4|COMPLETED|Treatment Period 3||6
7562407|NCT02948582|18613999|P3|COMPLETED|Treatment Period 3||7
7562408|NCT02948582|18614000|P2|COMPLETED|Treatment Period 3||4
7562409|NCT02948582|18614001|P1|COMPLETED|Treatment Period 3||7
7562410|NCT02948582|18613996|P6|STARTED|Treatment Period 3||6
7562411|NCT02948582|18613997|P5|STARTED|Treatment Period 3||7
7562412|NCT02948582|18613998|P4|STARTED|Treatment Period 3||6
7562413|NCT02948582|18613999|P3|STARTED|Treatment Period 3||7
7562414|NCT02948582|18614000|P2|STARTED|Treatment Period 3||4
7562415|NCT02948582|18614001|P1|STARTED|Treatment Period 3||7
7562416|NCT02948582|18613996|P6|NOT COMPLETED|Washout Period 2||0
7562417|NCT02948582|18613997|P5|NOT COMPLETED|Washout Period 2||0
7562418|NCT02948582|18613998|P4|NOT COMPLETED|Washout Period 2||1
7562419|NCT02948582|18613999|P3|NOT COMPLETED|Washout Period 2||0
7562420|NCT02948582|18614000|P2|NOT COMPLETED|Washout Period 2||1
7562421|NCT02948582|18614001|P1|NOT COMPLETED|Washout Period 2||0
7562422|NCT02948582|18613996|P6|COMPLETED|Washout Period 2||6
7562423|NCT02948582|18613997|P5|COMPLETED|Washout Period 2||7
7562424|NCT02948582|18613998|P4|COMPLETED|Washout Period 2||6
7562425|NCT02948582|18613999|P3|COMPLETED|Washout Period 2||7
7562426|NCT02948582|18614000|P2|COMPLETED|Washout Period 2||4
7562427|NCT02948582|18614001|P1|COMPLETED|Washout Period 2||7
7562428|NCT02948582|18613996|P6|STARTED|Washout Period 2||6
7562429|NCT02948582|18613997|P5|STARTED|Washout Period 2||7
7562430|NCT02948582|18613998|P4|STARTED|Washout Period 2||7
7562431|NCT02948582|18613999|P3|STARTED|Washout Period 2||7
7562432|NCT02948582|18614000|P2|STARTED|Washout Period 2||5
7562433|NCT02948582|18614001|P1|STARTED|Washout Period 2||7
7562434|NCT02948582|18613996|P6|NOT COMPLETED|Treatment Period 2||0
7562435|NCT02948582|18613997|P5|NOT COMPLETED|Treatment Period 2||0
7562436|NCT02948582|18613998|P4|NOT COMPLETED|Treatment Period 2||0
7562437|NCT02948582|18613999|P3|NOT COMPLETED|Treatment Period 2||0
7562438|NCT02948582|18614000|P2|NOT COMPLETED|Treatment Period 2||0
7562439|NCT02948582|18614001|P1|NOT COMPLETED|Treatment Period 2||0
7562440|NCT02948582|18613996|P6|COMPLETED|Treatment Period 2||6
7562441|NCT02948582|18613997|P5|COMPLETED|Treatment Period 2||7
7562442|NCT02948582|18613998|P4|COMPLETED|Treatment Period 2||7
7562443|NCT02948582|18613999|P3|COMPLETED|Treatment Period 2||7
7562444|NCT02948582|18614000|P2|COMPLETED|Treatment Period 2||5
7562445|NCT02948582|18614001|P1|COMPLETED|Treatment Period 2||7
7562446|NCT02948582|18613996|P6|STARTED|Treatment Period 2||6
7562447|NCT02948582|18613997|P5|STARTED|Treatment Period 2||7
7562448|NCT02948582|18613998|P4|STARTED|Treatment Period 2||7
7562449|NCT02948582|18613999|P3|STARTED|Treatment Period 2||7
7562450|NCT02948582|18614000|P2|STARTED|Treatment Period 2||5
7562451|NCT02948582|18614001|P1|STARTED|Treatment Period 2||7
7562452|NCT02948582|18613996|P6|NOT COMPLETED|Washout Period 1||1
7562453|NCT02948582|18613997|P5|NOT COMPLETED|Washout Period 1||0
7562454|NCT02948582|18613998|P4|NOT COMPLETED|Washout Period 1||0
7562455|NCT02948582|18613999|P3|NOT COMPLETED|Washout Period 1||0
7562456|NCT02948582|18614000|P2|NOT COMPLETED|Washout Period 1||2
7562457|NCT02948582|18614001|P1|NOT COMPLETED|Washout Period 1||0
7562458|NCT02948582|18613996|P6|COMPLETED|Washout Period 1||6
7562459|NCT02948582|18613997|P5|COMPLETED|Washout Period 1||7
7562460|NCT02948582|18613998|P4|COMPLETED|Washout Period 1||7
7562461|NCT02948582|18613999|P3|COMPLETED|Washout Period 1||7
7562462|NCT02948582|18614000|P2|COMPLETED|Washout Period 1||5
7562463|NCT02948582|18614001|P1|COMPLETED|Washout Period 1||7
7562464|NCT02948582|18613996|P6|STARTED|Washout Period 1||7
7562465|NCT02948582|18613997|P5|STARTED|Washout Period 1||7
7562466|NCT02948582|18613998|P4|STARTED|Washout Period 1||7
7562467|NCT02948582|18613999|P3|STARTED|Washout Period 1||7
7562468|NCT02948582|18614000|P2|STARTED|Washout Period 1||7
7562469|NCT02948582|18614001|P1|STARTED|Washout Period 1||7
7562470|NCT02948582|18613996|P6|NOT COMPLETED|Treatment Period 1||0
7562471|NCT02948582|18613997|P5|NOT COMPLETED|Treatment Period 1||0
7562472|NCT02948582|18613998|P4|NOT COMPLETED|Treatment Period 1||0
7562473|NCT02948582|18613999|P3|NOT COMPLETED|Treatment Period 1||0
7562474|NCT02948582|18614000|P2|NOT COMPLETED|Treatment Period 1||0
7562475|NCT02948582|18614001|P1|NOT COMPLETED|Treatment Period 1||0
7562476|NCT02948582|18613996|P6|COMPLETED|Treatment Period 1||7
7562477|NCT02948582|18613997|P5|COMPLETED|Treatment Period 1||7
7562478|NCT02948582|18613998|P4|COMPLETED|Treatment Period 1||7
7562479|NCT02948582|18613999|P3|COMPLETED|Treatment Period 1||7
7562480|NCT02948582|18614000|P2|COMPLETED|Treatment Period 1||7
7562481|NCT02948582|18614001|P1|COMPLETED|Treatment Period 1||7
7562482|NCT02948582|18613996|P6|STARTED|Treatment Period 1||7
7562483|NCT02948582|18613997|P5|STARTED|Treatment Period 1||7
7562484|NCT02948582|18613998|P4|STARTED|Treatment Period 1||7
7562485|NCT02948582|18613999|P3|STARTED|Treatment Period 1||7
7562486|NCT02948582|18614000|P2|STARTED|Treatment Period 1||7
7562487|NCT02948582|18614001|P1|STARTED|Treatment Period 1||7
7562488|NCT02948257|18614094|P1|NOT COMPLETED|Overall Study||0
7562489|NCT02948257|18614094|P1|COMPLETED|Overall Study||52
7562490|NCT02948257|18614094|P1|STARTED|Overall Study||52
7562491|NCT02947997|18614104|P1|NOT COMPLETED|Overall Study||0
7562492|NCT02947997|18614104|P1|COMPLETED|Overall Study||4
7562493|NCT02947997|18614104|P1|STARTED|Overall Study||4
7562494|NCT02947984|18614110|P2|NOT COMPLETED|Overall Study||0
7562495|NCT02947984|18614111|P1|NOT COMPLETED|Overall Study||0
7562496|NCT02947984|18614110|P2|COMPLETED|Overall Study||22
7562497|NCT02947984|18614111|P1|COMPLETED|Overall Study||22
7562498|NCT02947984|18614110|P2|STARTED|Overall Study||22
7562499|NCT02947984|18614111|P1|STARTED|Overall Study||22
7562500|NCT02947100|18614123|P1|NOT COMPLETED|Overall Study||4
7562501|NCT02947100|18614123|P1|COMPLETED|Overall Study||0
7562502|NCT02947100|18614123|P1|STARTED|Overall Study||4
7562503|NCT02947022|18614131|P1|NOT COMPLETED|Overall Study||1
7562504|NCT02947022|18614131|P1|COMPLETED|Overall Study||0
7562505|NCT02947022|18614131|P1|STARTED|Overall Study||1
7562506|NCT02946918|18614152|P2|NOT COMPLETED|Overall Study||3
7562507|NCT02946918|18614153|P1|NOT COMPLETED|Overall Study||1
7562508|NCT02946918|18614152|P2|COMPLETED|Overall Study||5
7562509|NCT02946918|18614153|P1|COMPLETED|Overall Study||5
7562510|NCT02946918|18614152|P2|STARTED|Overall Study||8
7562511|NCT02946918|18614153|P1|STARTED|Overall Study||6
7562512|NCT02946580|18614167|P2|NOT COMPLETED|Overall Study||5
7562513|NCT02946580|18614168|P1|NOT COMPLETED|Overall Study||1
7562514|NCT02946580|18614167|P2|COMPLETED|Overall Study||20
7562515|NCT02946580|18614168|P1|COMPLETED|Overall Study||27
7562516|NCT02946580|18614167|P2|STARTED|Overall Study||25
7562517|NCT02946580|18614168|P1|STARTED|Overall Study||28
7562518|NCT02946515|18614186|P2|NOT COMPLETED|Overall Study||1
7562519|NCT02946515|18614187|P1|NOT COMPLETED|Overall Study||2
7562520|NCT02946515|18614186|P2|COMPLETED|Overall Study||21
7562521|NCT02946515|18614187|P1|COMPLETED|Overall Study||20
7562522|NCT02946515|18614186|P2|STARTED|Overall Study||22
7562523|NCT02946515|18614187|P1|STARTED|Overall Study||22
7562524|NCT02946489|18614193|P1|NOT COMPLETED|Overall Study||0
7562525|NCT02946489|18614193|P1|COMPLETED|Overall Study||8
7562526|NCT02946489|18614193|P1|STARTED|Overall Study||8
7562527|NCT02946463|18614200|P2|NOT COMPLETED|Extension Period||119
7562528|NCT02946463|18614201|P1|NOT COMPLETED|Extension Period||124
7562529|NCT02946463|18614200|P2|COMPLETED|Extension Period||0
7562530|NCT02946463|18614201|P1|COMPLETED|Extension Period||0
7562531|NCT02946463|18614200|P2|Received at Least 1 Dose of Ravulizumab|Extension Period||119
7562532|NCT02946463|18614201|P1|Received at Least 1 Dose of Ravulizumab|Extension Period||124
7562533|NCT02946463|18614200|P2|STARTED|Extension Period||119
7562534|NCT02946463|18614201|P1|STARTED|Extension Period||124
7562535|NCT02946463|18614200|P2|NOT COMPLETED|Primary Evaluation Period||2
7562536|NCT02946463|18614201|P1|NOT COMPLETED|Primary Evaluation Period||0
7562537|NCT02946463|18614200|P2|COMPLETED|Primary Evaluation Period||119
7562538|NCT02946463|18614201|P1|COMPLETED|Primary Evaluation Period||125
7562539|NCT02946463|18614200|P2|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||121
7562540|NCT02946463|18614201|P1|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||125
7562541|NCT02946463|18614200|P2|STARTED|Primary Evaluation Period||121
7562542|NCT02946463|18614201|P1|STARTED|Primary Evaluation Period||125
7562543|NCT02946385|18614223|P6|NOT COMPLETED|Overall Study||1
7562544|NCT02946385|18614224|P5|NOT COMPLETED|Overall Study||2
7562545|NCT02946385|18614225|P4|NOT COMPLETED|Overall Study||0
7562546|NCT02946385|18614226|P3|NOT COMPLETED|Overall Study||3
7562547|NCT02946385|18614227|P2|NOT COMPLETED|Overall Study||0
7562548|NCT02946385|18614228|P1|NOT COMPLETED|Overall Study||0
7562549|NCT02946385|18614223|P6|COMPLETED|Overall Study||76
7562550|NCT02946385|18614224|P5|COMPLETED|Overall Study||99
7562551|NCT02946385|18614225|P4|COMPLETED|Overall Study||74
7562552|NCT02946385|18614226|P3|COMPLETED|Overall Study||96
7562553|NCT02946385|18614227|P2|COMPLETED|Overall Study||127
7562554|NCT02946385|18614228|P1|COMPLETED|Overall Study||126
7562555|NCT02946385|18614223|P6|STARTED|Overall Study||77
7562556|NCT02946385|18614224|P5|STARTED|Overall Study||101
7562557|NCT02946385|18614225|P4|STARTED|Overall Study||74
7562558|NCT02946385|18614226|P3|STARTED|Overall Study||99
7562559|NCT02946385|18614227|P2|STARTED|Overall Study||127
7562560|NCT02946385|18614228|P1|STARTED|Overall Study||126
7562561|NCT02946229|18614312|P1|NOT COMPLETED|Overall Study||0
7562562|NCT02946229|18614312|P1|COMPLETED|Overall Study||142
7562563|NCT02946229|18614312|P1|STARTED|Overall Study||142
7562564|NCT02946021|18614318|P2|NOT COMPLETED|Overall Study||0
7562565|NCT02946021|18614319|P1|NOT COMPLETED|Overall Study||0
7562566|NCT02946021|18614318|P2|COMPLETED|Overall Study||5
7562567|NCT02946021|18614319|P1|COMPLETED|Overall Study||6
7562568|NCT02946021|18614318|P2|STARTED|Overall Study||5
7562569|NCT02946021|18614319|P1|STARTED|Overall Study||6
7562570|NCT02945657|18614331|P1|NOT COMPLETED|Overall Study||4
7562571|NCT02945657|18614331|P1|COMPLETED|Overall Study||28
7562572|NCT02945657|18614331|P1|STARTED|Overall Study||32
7562573|NCT02945410|18614354|P6|NOT COMPLETED|Intervention 3 (5 Days)||0
7562574|NCT02945410|18614355|P5|NOT COMPLETED|Intervention 3 (5 Days)||0
7562575|NCT02945410|18614356|P4|NOT COMPLETED|Intervention 3 (5 Days)||0
7562576|NCT02945410|18614357|P3|NOT COMPLETED|Intervention 3 (5 Days)||0
7562577|NCT02945410|18614358|P2|NOT COMPLETED|Intervention 3 (5 Days)||0
7562578|NCT02945410|18614359|P1|NOT COMPLETED|Intervention 3 (5 Days)||0
7562579|NCT02945410|18614354|P6|COMPLETED|Intervention 3 (5 Days)||0
7562580|NCT02945410|18614355|P5|COMPLETED|Intervention 3 (5 Days)||1
7562581|NCT02945410|18614356|P4|COMPLETED|Intervention 3 (5 Days)||3
7562582|NCT02945410|18614357|P3|COMPLETED|Intervention 3 (5 Days)||0
7562583|NCT02945410|18614358|P2|COMPLETED|Intervention 3 (5 Days)||1
7562584|NCT02945410|18614359|P1|COMPLETED|Intervention 3 (5 Days)||2
7562585|NCT02945410|18614354|P6|STARTED|Intervention 3 (5 Days)||0
7562586|NCT02945410|18614355|P5|STARTED|Intervention 3 (5 Days)||1
7562587|NCT02945410|18614356|P4|STARTED|Intervention 3 (5 Days)||3
7562588|NCT02945410|18614357|P3|STARTED|Intervention 3 (5 Days)||0
7562589|NCT02945410|18614358|P2|STARTED|Intervention 3 (5 Days)||1
7562590|NCT02945410|18614359|P1|STARTED|Intervention 3 (5 Days)||2
7562591|NCT02945410|18614354|P6|NOT COMPLETED|Washout 2 (14 Days)||0
7562592|NCT02945410|18614355|P5|NOT COMPLETED|Washout 2 (14 Days)||0
7562593|NCT02945410|18614356|P4|NOT COMPLETED|Washout 2 (14 Days)||0
7562594|NCT02945410|18614357|P3|NOT COMPLETED|Washout 2 (14 Days)||0
7562595|NCT02945410|18614358|P2|NOT COMPLETED|Washout 2 (14 Days)||0
7562596|NCT02945410|18614359|P1|NOT COMPLETED|Washout 2 (14 Days)||0
7562597|NCT02945410|18614354|P6|COMPLETED|Washout 2 (14 Days)||0
7562598|NCT02945410|18614355|P5|COMPLETED|Washout 2 (14 Days)||1
7562599|NCT02945410|18614356|P4|COMPLETED|Washout 2 (14 Days)||3
7562600|NCT02945410|18614357|P3|COMPLETED|Washout 2 (14 Days)||0
7562601|NCT02945410|18614358|P2|COMPLETED|Washout 2 (14 Days)||1
7562602|NCT02945410|18614359|P1|COMPLETED|Washout 2 (14 Days)||2
7562603|NCT02945410|18614354|P6|STARTED|Washout 2 (14 Days)||0
7562604|NCT02945410|18614355|P5|STARTED|Washout 2 (14 Days)||1
7562605|NCT02945410|18614356|P4|STARTED|Washout 2 (14 Days)||3
7562606|NCT02945410|18614357|P3|STARTED|Washout 2 (14 Days)||0
7562607|NCT02945410|18614358|P2|STARTED|Washout 2 (14 Days)||1
7562608|NCT02945410|18614359|P1|STARTED|Washout 2 (14 Days)||2
7562609|NCT02945410|18614354|P6|NOT COMPLETED|Intervention 2 (5 Days)||0
7562610|NCT02945410|18614355|P5|NOT COMPLETED|Intervention 2 (5 Days)||0
7562611|NCT02945410|18614356|P4|NOT COMPLETED|Intervention 2 (5 Days)||0
7562612|NCT02945410|18614357|P3|NOT COMPLETED|Intervention 2 (5 Days)||0
7562613|NCT02945410|18614358|P2|NOT COMPLETED|Intervention 2 (5 Days)||0
7562614|NCT02945410|18614359|P1|NOT COMPLETED|Intervention 2 (5 Days)||0
7562615|NCT02945410|18614354|P6|COMPLETED|Intervention 2 (5 Days)||0
7562616|NCT02945410|18614355|P5|COMPLETED|Intervention 2 (5 Days)||1
7562617|NCT02945410|18614356|P4|COMPLETED|Intervention 2 (5 Days)||3
7562618|NCT02945410|18614357|P3|COMPLETED|Intervention 2 (5 Days)||0
7562619|NCT02945410|18614358|P2|COMPLETED|Intervention 2 (5 Days)||1
7562620|NCT02945410|18614359|P1|COMPLETED|Intervention 2 (5 Days)||2
7562621|NCT02945410|18614354|P6|STARTED|Intervention 2 (5 Days)||0
7562622|NCT02945410|18614355|P5|STARTED|Intervention 2 (5 Days)||1
7562623|NCT02945410|18614356|P4|STARTED|Intervention 2 (5 Days)||3
7562624|NCT02945410|18614357|P3|STARTED|Intervention 2 (5 Days)||0
7562625|NCT02945410|18614358|P2|STARTED|Intervention 2 (5 Days)||1
7562626|NCT02945410|18614359|P1|STARTED|Intervention 2 (5 Days)||2
7562627|NCT02945410|18614354|P6|NOT COMPLETED|Washout 1 (14 Days)||0
7562628|NCT02945410|18614355|P5|NOT COMPLETED|Washout 1 (14 Days)||1
7562629|NCT02945410|18614356|P4|NOT COMPLETED|Washout 1 (14 Days)||0
7562630|NCT02945410|18614357|P3|NOT COMPLETED|Washout 1 (14 Days)||2
7562631|NCT02945410|18614358|P2|NOT COMPLETED|Washout 1 (14 Days)||0
7562632|NCT02945410|18614359|P1|NOT COMPLETED|Washout 1 (14 Days)||0
7562633|NCT02945410|18614354|P6|COMPLETED|Washout 1 (14 Days)||0
7562634|NCT02945410|18614355|P5|COMPLETED|Washout 1 (14 Days)||1
7562635|NCT02945410|18614356|P4|COMPLETED|Washout 1 (14 Days)||3
7562636|NCT02945410|18614357|P3|COMPLETED|Washout 1 (14 Days)||0
7562637|NCT02945410|18614358|P2|COMPLETED|Washout 1 (14 Days)||1
7562638|NCT02945410|18614359|P1|COMPLETED|Washout 1 (14 Days)||2
7562639|NCT02945410|18614354|P6|STARTED|Washout 1 (14 Days)||0
7562640|NCT02945410|18614355|P5|STARTED|Washout 1 (14 Days)||2
7562641|NCT02945410|18614356|P4|STARTED|Washout 1 (14 Days)||3
7562642|NCT02945410|18614357|P3|STARTED|Washout 1 (14 Days)||2
7562643|NCT02945410|18614358|P2|STARTED|Washout 1 (14 Days)||1
7562644|NCT02945410|18614359|P1|STARTED|Washout 1 (14 Days)||2
7562645|NCT02945410|18614354|P6|NOT COMPLETED|Intervention 1 (5 Days)||1
7562646|NCT02945410|18614355|P5|NOT COMPLETED|Intervention 1 (5 Days)||0
7562647|NCT02945410|18614356|P4|NOT COMPLETED|Intervention 1 (5 Days)||0
7562648|NCT02945410|18614357|P3|NOT COMPLETED|Intervention 1 (5 Days)||0
7562649|NCT02945410|18614358|P2|NOT COMPLETED|Intervention 1 (5 Days)||3
7562650|NCT02945410|18614359|P1|NOT COMPLETED|Intervention 1 (5 Days)||1
7562651|NCT02945410|18614354|P6|COMPLETED|Intervention 1 (5 Days)||0
7562652|NCT02945410|18614355|P5|COMPLETED|Intervention 1 (5 Days)||2
7562653|NCT02945410|18614356|P4|COMPLETED|Intervention 1 (5 Days)||3
7562654|NCT02945410|18614357|P3|COMPLETED|Intervention 1 (5 Days)||2
7562655|NCT02945410|18614358|P2|COMPLETED|Intervention 1 (5 Days)||1
7562656|NCT02945410|18614359|P1|COMPLETED|Intervention 1 (5 Days)||2
7562657|NCT02945410|18614354|P6|STARTED|Intervention 1 (5 Days)||1
7562658|NCT02945410|18614355|P5|STARTED|Intervention 1 (5 Days)||2
7562659|NCT02945410|18614356|P4|STARTED|Intervention 1 (5 Days)||3
7562660|NCT02945410|18614357|P3|STARTED|Intervention 1 (5 Days)||2
7562661|NCT02945410|18614358|P2|STARTED|Intervention 1 (5 Days)||4
7562662|NCT02945410|18614359|P1|STARTED|Intervention 1 (5 Days)||3
7562663|NCT02945254|18614390|P2|NOT COMPLETED|Overall Study||0
7562664|NCT02945254|18614391|P1|NOT COMPLETED|Overall Study||2
7562665|NCT02945254|18614390|P2|COMPLETED|Overall Study||10
7562666|NCT02945254|18614391|P1|COMPLETED|Overall Study||8
7562667|NCT02945254|18614390|P2|STARTED|Overall Study||10
7562668|NCT02945254|18614391|P1|STARTED|Overall Study||10
7562669|NCT02945150|18614399|P1|NOT COMPLETED|Overall Study||0
7562670|NCT02945150|18614399|P1|COMPLETED|Overall Study||8
7562671|NCT02945150|18614399|P1|SVR12|Overall Study||8
7562672|NCT02945150|18614399|P1|STARTED|Overall Study||8
7562673|NCT02945046|18614407|P3|NOT COMPLETED|Overall Study||15
7562674|NCT02945046|18614408|P2|NOT COMPLETED|Overall Study||13
7562675|NCT02945046|18614409|P1|NOT COMPLETED|Overall Study||13
7562676|NCT02945046|18614407|P3|COMPLETED|Overall Study||40
7562677|NCT02945046|18614408|P2|COMPLETED|Overall Study||42
7562678|NCT02945046|18614409|P1|COMPLETED|Overall Study||46
7562679|NCT02945046|18614407|P3|Full Analysis Set|Overall Study||55
7562680|NCT02945046|18614408|P2|Full Analysis Set|Overall Study||53
7562681|NCT02945046|18614409|P1|Full Analysis Set|Overall Study||57
7562682|NCT02945046|18614407|P3|Safety Analysis Set|Overall Study||55
7562683|NCT02945046|18614408|P2|Safety Analysis Set|Overall Study||55
7562684|NCT02945046|18614409|P1|Safety Analysis Set|Overall Study||59
7562685|NCT02945046|18614407|P3|STARTED|Overall Study||55
7562686|NCT02945046|18614408|P2|STARTED|Overall Study||55
7562687|NCT02945046|18614409|P1|STARTED|Overall Study||59
7562688|NCT02944968|18614462|P1|NOT COMPLETED|Overall Study||3
7562689|NCT02944968|18614462|P1|COMPLETED|Overall Study||48
7562690|NCT02944968|18614462|P1|STARTED|Overall Study||51
7562691|NCT02944656|18614469|P2|NOT COMPLETED|Overall Study||10
7562692|NCT02944656|18614470|P1|NOT COMPLETED|Overall Study||10
7562693|NCT02944656|18614469|P2|COMPLETED|Overall Study||47
7562694|NCT02944656|18614470|P1|COMPLETED|Overall Study||47
7562695|NCT02944656|18614469|P2|Completed Day 1 Follow up|Overall Study||47
7562696|NCT02944656|18614470|P1|Completed Day 1 Follow up|Overall Study||47
7562697|NCT02944656|18614469|P2|Completed Procedure Day|Overall Study||57
7562698|NCT02944656|18614470|P1|Completed Procedure Day|Overall Study||54
7562699|NCT02944656|18614469|P2|STARTED|Overall Study||57
7562700|NCT02944656|18614470|P1|STARTED|Overall Study||57
7562701|NCT02944565|18614498|P1|NOT COMPLETED|Overall Study||0
7562702|NCT02944565|18614498|P1|COMPLETED|Overall Study||28
7562703|NCT02944565|18614498|P1|STARTED|Overall Study||28
7562704|NCT02944513|18614506|P2|NOT COMPLETED|Overall Study||1
7562705|NCT02944513|18614507|P1|NOT COMPLETED|Overall Study||4
7562706|NCT02944513|18614506|P2|COMPLETED|Overall Study||32
7562707|NCT02944513|18614507|P1|COMPLETED|Overall Study||31
7562708|NCT02944513|18614506|P2|STARTED|Overall Study||33
7562709|NCT02944513|18614507|P1|STARTED|Overall Study||35
7562710|NCT02944461|18614523|P1|NOT COMPLETED|Overall Study||5
7562711|NCT02944461|18614523|P1|COMPLETED|Overall Study||15
7562712|NCT02944461|18614523|P1|STARTED|Overall Study||20
7562713|NCT02944448|18614532|P2|NOT COMPLETED|Overall Study||24
7562714|NCT02944448|18614533|P1|NOT COMPLETED|Overall Study||89
7562715|NCT02944448|18614532|P2|COMPLETED|Overall Study||136
7562716|NCT02944448|18614533|P1|COMPLETED|Overall Study||227
7562717|NCT02944448|18614532|P2|STARTED|Overall Study||160
7562718|NCT02944448|18614533|P1|STARTED|Overall Study||316
7562719|NCT02944383|18614560|P3|NOT COMPLETED|Overall Study||1
7562720|NCT02944383|18614561|P2|NOT COMPLETED|Overall Study||0
7562721|NCT02944383|18614562|P1|NOT COMPLETED|Overall Study||1
7562722|NCT02944383|18614560|P3|COMPLETED|Overall Study||30
7562723|NCT02944383|18614561|P2|COMPLETED|Overall Study||30
7562724|NCT02944383|18614562|P1|COMPLETED|Overall Study||29
7562725|NCT02944383|18614560|P3|STARTED|Overall Study||31
7562726|NCT02944383|18614561|P2|STARTED|Overall Study||30
7562727|NCT02944383|18614562|P1|STARTED|Overall Study||30
7562728|NCT02943941|18614717|P1|NOT COMPLETED|Overall Study||0
7562729|NCT02943941|18614717|P1|COMPLETED|Overall Study||16
7562730|NCT02943941|18614717|P1|STARTED|Overall Study||16
7562731|NCT02943668|18614723|P1|NOT COMPLETED|Overall Study||1
7562732|NCT02943668|18614723|P1|COMPLETED|Overall Study||1
7562733|NCT02943668|18614723|P1|STARTED|Overall Study||2
7562734|NCT02943577|18614734|P2|NOT COMPLETED|Overall Study||5
7562735|NCT02943577|18614735|P1|NOT COMPLETED|Overall Study||5
7562736|NCT02943577|18614734|P2|COMPLETED|Overall Study||201
7562737|NCT02943577|18614735|P1|COMPLETED|Overall Study||204
7562738|NCT02943577|18614734|P2|STARTED|Overall Study||206
7562739|NCT02943577|18614735|P1|STARTED|Overall Study||209
7562740|NCT02943564|18614750|P3|NOT COMPLETED|Overall Study||9
7562741|NCT02943564|18614751|P2|NOT COMPLETED|Overall Study||13
7562742|NCT02943564|18614752|P1|NOT COMPLETED|Overall Study||10
7562743|NCT02943564|18614750|P3|COMPLETED|Overall Study||201
7562744|NCT02943564|18614751|P2|COMPLETED|Overall Study||198
7562745|NCT02943564|18614752|P1|COMPLETED|Overall Study||207
7562746|NCT02943564|18614750|P3|Non-Responder|Overall Study||133
7562747|NCT02943564|18614751|P2|Non-Responder|Overall Study||134
7562748|NCT02943564|18614752|P1|Non-Responder|Overall Study||134
7562749|NCT02943564|18614750|P3|Responder|Overall Study||77
7562750|NCT02943564|18614751|P2|Responder|Overall Study||77
7562751|NCT02943564|18614752|P1|Responder|Overall Study||83
7562752|NCT02943564|18614750|P3|STARTED|Overall Study||210
7562753|NCT02943564|18614751|P2|STARTED|Overall Study||211
7562754|NCT02943564|18614752|P1|STARTED|Overall Study||217
7562755|NCT02943499|18614765|P2|NOT COMPLETED|Overall Study||5
7562756|NCT02943499|18614766|P1|NOT COMPLETED|Overall Study||7
7562757|NCT02943499|18614765|P2|COMPLETED|Overall Study||34
7562758|NCT02943499|18614766|P1|COMPLETED|Overall Study||34
7562759|NCT02943499|18614765|P2|STARTED|Overall Study||39
7562760|NCT02943499|18614766|P1|STARTED|Overall Study||41
7562761|NCT02943473|18614772|P1|NOT COMPLETED|Overall Study||6
7562762|NCT02943473|18614772|P1|COMPLETED|Overall Study||3
7562763|NCT02943473|18614772|P1|STARTED|Overall Study||9
7562764|NCT02943460|18614779|P3|NOT COMPLETED|Open Label Extension (OLE)||9
7562765|NCT02943460|18614780|P2|NOT COMPLETED|Open Label Extension (OLE)||18
7562766|NCT02943460|18614781|P1|NOT COMPLETED|Open Label Extension (OLE)||19
7562767|NCT02943460|18614779|P3|COMPLETED|Open Label Extension (OLE)||0
7562768|NCT02943460|18614780|P2|COMPLETED|Open Label Extension (OLE)||0
7562769|NCT02943460|18614781|P1|COMPLETED|Open Label Extension (OLE)||0
7562770|NCT02943460|18614779|P3|STARTED|Open Label Extension (OLE)|1 participant who discontinued study drug in the Blinded Phase did not enter the OLE Phase.|9
7562771|NCT02943460|18614780|P2|STARTED|Open Label Extension (OLE)|1 participant completed the Blinded Study Phase, but did not continue in the OLE Phase.|18
7562772|NCT02943460|18614781|P1|STARTED|Open Label Extension (OLE)||19
7562773|NCT02943460|18614779|P3|NOT COMPLETED|Blinded Study||0
7562774|NCT02943460|18614780|P2|NOT COMPLETED|Blinded Study||1
7562775|NCT02943460|18614781|P1|NOT COMPLETED|Blinded Study||3
7562776|NCT02943460|18614779|P3|COMPLETED|Blinded Study|1 participant discontinued from study drug in the Blinded Phase, but did not discontinue the study.|10
7562777|NCT02943460|18614780|P2|COMPLETED|Blinded Study||19
7562778|NCT02943460|18614781|P1|COMPLETED|Blinded Study||19
7562779|NCT02943460|18614779|P3|STARTED|Blinded Study||10
7562780|NCT02943460|18614780|P2|STARTED|Blinded Study||20
7562781|NCT02943460|18614781|P1|STARTED|Blinded Study||22
7562782|NCT02943447|18614799|P3|NOT COMPLETED|Open-Label Extension Phase||10
7562783|NCT02943447|18614800|P2|NOT COMPLETED|Open-Label Extension Phase||25
7562784|NCT02943447|18614801|P1|NOT COMPLETED|Open-Label Extension Phase||18
7562785|NCT02943447|18614799|P3|COMPLETED|Open-Label Extension Phase||2
7562786|NCT02943447|18614800|P2|COMPLETED|Open-Label Extension Phase||3
7562787|NCT02943447|18614801|P1|COMPLETED|Open-Label Extension Phase||5
7562788|NCT02943447|18614799|P3|STARTED|Open-Label Extension Phase||12
7562789|NCT02943447|18614800|P2|STARTED|Open-Label Extension Phase||28
7562790|NCT02943447|18614801|P1|STARTED|Open-Label Extension Phase||23
7562791|NCT02943447|18614799|P3|NOT COMPLETED|Blinded Study Phase||1
7562792|NCT02943447|18614800|P2|NOT COMPLETED|Blinded Study Phase||2
7562793|NCT02943447|18614801|P1|NOT COMPLETED|Blinded Study Phase||5
7562794|NCT02943447|18614799|P3|COMPLETED|Blinded Study Phase||12
7562795|NCT02943447|18614800|P2|COMPLETED|Blinded Study Phase||28
7562796|NCT02943447|18614801|P1|COMPLETED|Blinded Study Phase||23
7562797|NCT02943447|18614799|P3|STARTED|Blinded Study Phase||13
7562798|NCT02943447|18614800|P2|STARTED|Blinded Study Phase||30
7562799|NCT02943447|18614801|P1|STARTED|Blinded Study Phase||28
7562800|NCT02943226|18614823|P2|NOT COMPLETED|Overall Study||0
7562801|NCT02943226|18614824|P1|NOT COMPLETED|Overall Study||0
7562802|NCT02943226|18614823|P2|COMPLETED|Overall Study||30
7562803|NCT02943226|18614824|P1|COMPLETED|Overall Study||31
7562804|NCT02943226|18614823|P2|STARTED|Overall Study||30
7562805|NCT02943226|18614824|P1|STARTED|Overall Study||31
7562806|NCT02943213|18614840|P1|NOT COMPLETED|Treatment Period 2||0
7562807|NCT02943213|18614840|P1|COMPLETED|Treatment Period 2||20
7562808|NCT02943213|18614840|P1|STARTED|Treatment Period 2||20
7562809|NCT02943213|18614840|P1|NOT COMPLETED|Treatment Period 1||0
7562810|NCT02943213|18614840|P1|COMPLETED|Treatment Period 1||20
7562811|NCT02943213|18614840|P1|STARTED|Treatment Period 1||20
7562812|NCT02943096|18614870|P2|NOT COMPLETED|Overall Study||1
7562813|NCT02943096|18614871|P1|NOT COMPLETED|Overall Study||0
7562814|NCT02943096|18614870|P2|COMPLETED|Overall Study||2
7562815|NCT02943096|18614871|P1|COMPLETED|Overall Study||3
7562816|NCT02943096|18614870|P2|STARTED|Overall Study||3
7562817|NCT02943096|18614871|P1|STARTED|Overall Study||3
7562818|NCT02942771|18614890|P5|NOT COMPLETED|Overall Study||4
7562819|NCT02942771|18614891|P4|NOT COMPLETED|Overall Study||0
7562820|NCT02942771|18614892|P3|NOT COMPLETED|Overall Study||0
7562821|NCT02942771|18614893|P2|NOT COMPLETED|Overall Study||0
7562822|NCT02942771|18614894|P1|NOT COMPLETED|Overall Study||3
7562823|NCT02942771|18614890|P5|COMPLETED|Overall Study||4
7562824|NCT02942771|18614891|P4|COMPLETED|Overall Study||6
7562825|NCT02942771|18614892|P3|COMPLETED|Overall Study||6
7562826|NCT02942771|18614893|P2|COMPLETED|Overall Study||6
7562827|NCT02942771|18614894|P1|COMPLETED|Overall Study||6
7562828|NCT02942771|18614890|P5|STARTED|Overall Study||8
7562829|NCT02942771|18614891|P4|STARTED|Overall Study||6
7562830|NCT02942771|18614892|P3|STARTED|Overall Study||6
7562831|NCT02942771|18614893|P2|STARTED|Overall Study||6
7562832|NCT02942771|18614894|P1|STARTED|Overall Study||9
7562833|NCT02942654|18614936|P2|NOT COMPLETED|Period 2||0
7562834|NCT02942654|18614937|P1|NOT COMPLETED|Period 2||0
7562835|NCT02942654|18614936|P2|COMPLETED|Period 2||16
7562836|NCT02942654|18614937|P1|COMPLETED|Period 2||16
7562837|NCT02942654|18614936|P2|STARTED|Period 2||16
7562838|NCT02942654|18614937|P1|STARTED|Period 2||16
7562839|NCT02942654|18614936|P2|NOT COMPLETED|Washout||0
7562840|NCT02942654|18614937|P1|NOT COMPLETED|Washout||0
7562841|NCT02942654|18614936|P2|COMPLETED|Washout||16
7562842|NCT02942654|18614937|P1|COMPLETED|Washout||16
7562843|NCT02942654|18614936|P2|STARTED|Washout||16
7562844|NCT02942654|18614937|P1|STARTED|Washout||16
7562845|NCT02942654|18614936|P2|NOT COMPLETED|Period 1||0
7562846|NCT02942654|18614937|P1|NOT COMPLETED|Period 1||0
7562847|NCT02942654|18614936|P2|COMPLETED|Period 1||16
7562848|NCT02942654|18614937|P1|COMPLETED|Period 1||16
7562849|NCT02942654|18614936|P2|Received at Least 1 Dose of Study Drug|Period 1||16
7562850|NCT02942654|18614937|P1|Received at Least 1 Dose of Study Drug|Period 1||16
7562851|NCT02942654|18614936|P2|STARTED|Period 1||16
7562852|NCT02942654|18614937|P1|STARTED|Period 1||16
7562853|NCT02942576|18614947|P2|NOT COMPLETED|Overall Study||23
7562854|NCT02942576|18614948|P1|NOT COMPLETED|Overall Study||46
7562855|NCT02942576|18614947|P2|COMPLETED|Overall Study||174
7562856|NCT02942576|18614948|P1|COMPLETED|Overall Study||359
7562857|NCT02942576|18614947|P2|STARTED|Overall Study||197
7562858|NCT02942576|18614948|P1|STARTED|Overall Study||405
7562859|NCT02942485|18614962|P2|NOT COMPLETED|Overall Study||0
7562860|NCT02942485|18614963|P1|NOT COMPLETED|Overall Study||1
7562861|NCT02942485|18614962|P2|COMPLETED|Overall Study||1
7562862|NCT02942485|18614963|P1|COMPLETED|Overall Study||6
7562863|NCT02942485|18614962|P2|STARTED|Overall Study||1
7562864|NCT02942485|18614963|P1|STARTED|Overall Study||7
7562865|NCT02942407|18614975|P2|NOT COMPLETED|Overall Study||24
7562866|NCT02942407|18614976|P1|NOT COMPLETED|Overall Study||26
7562867|NCT02942407|18614975|P2|COMPLETED|Overall Study||48
7562868|NCT02942407|18614976|P1|COMPLETED|Overall Study||56
7562869|NCT02942407|18614975|P2|STARTED|Overall Study||72
7562870|NCT02942407|18614976|P1|STARTED|Overall Study||82
7562871|NCT02942160|18615004|P1|NOT COMPLETED|Overall Study||103
7562872|NCT02942160|18615004|P1|COMPLETED|Overall Study|EN3835 Treated Participants in EN3835-202 Completed|156
7562873|NCT02942160|18615004|P1|EN3835 Treated Subjects in EN3835-202|Overall Study|EN3835 Treated Participants in EN3835-202 Started|200
7562874|NCT02942160|18615004|P1|EN3835-202 Participants|Overall Study|Observation Phase Completed|222
7562875|NCT02942160|18615004|P1|STARTED|Overall Study|Observation Phase prior to open-label treatment phase|259
7562876|NCT02942017|18615038|P2|NOT COMPLETED|Overall Study||6
7562877|NCT02942017|18615039|P1|NOT COMPLETED|Overall Study||2
7562878|NCT02942017|18615038|P2|COMPLETED|Overall Study||48
7562879|NCT02942017|18615039|P1|COMPLETED|Overall Study||52
7562880|NCT02942017|18615038|P2|Treated|Overall Study||51
7562881|NCT02942017|18615039|P1|Treated|Overall Study||53
7562882|NCT02942017|18615038|P2|STARTED|Overall Study||54
7562883|NCT02942017|18615039|P1|STARTED|Overall Study||54
7562884|NCT02942004|18615070|P3|NOT COMPLETED|Overall Study||9
7562885|NCT02942004|18615071|P2|NOT COMPLETED|Overall Study||12
7562886|NCT02942004|18615072|P1|NOT COMPLETED|Overall Study||4
7562887|NCT02942004|18615070|P3|COMPLETED|Overall Study||36
7562888|NCT02942004|18615071|P2|COMPLETED|Overall Study||35
7562889|NCT02942004|18615072|P1|COMPLETED|Overall Study||42
7562890|NCT02942004|18615070|P3|Participants Who Received Study Drug|Overall Study||41
7562891|NCT02942004|18615071|P2|Participants Who Received Study Drug|Overall Study||38
7562892|NCT02942004|18615072|P1|Participants Who Received Study Drug|Overall Study||43
7562893|NCT02942004|18615070|P3|STARTED|Overall Study||45
7562894|NCT02942004|18615071|P2|STARTED|Overall Study||47
7562895|NCT02942004|18615072|P1|STARTED|Overall Study||46
7562896|NCT02941692|18615115|P2|NOT COMPLETED|Overall Study||0
7562897|NCT02941692|18615116|P1|NOT COMPLETED|Overall Study||0
7562898|NCT02941692|18615115|P2|COMPLETED|Overall Study||34
7562899|NCT02941692|18615116|P1|COMPLETED|Overall Study||32
7562900|NCT02941692|18615115|P2|STARTED|Overall Study||34
7562901|NCT02941692|18615116|P1|STARTED|Overall Study||32
7562902|NCT02941640|18615128|P4|NOT COMPLETED|Overall Study||0
7562903|NCT02941640|18615129|P3|NOT COMPLETED|Overall Study||0
7562904|NCT02941640|18615130|P2|NOT COMPLETED|Overall Study||0
7562905|NCT02941640|18615131|P1|NOT COMPLETED|Overall Study||0
7562906|NCT02941640|18615128|P4|COMPLETED|Overall Study||30
7562907|NCT02941640|18615129|P3|COMPLETED|Overall Study||30
7562908|NCT02941640|18615130|P2|COMPLETED|Overall Study||30
7562909|NCT02941640|18615131|P1|COMPLETED|Overall Study||30
7562910|NCT02941640|18615128|P4|STARTED|Overall Study||30
7562911|NCT02941640|18615129|P3|STARTED|Overall Study||30
7562912|NCT02941640|18615130|P2|STARTED|Overall Study||30
7562913|NCT02941640|18615131|P1|STARTED|Overall Study||30
7562914|NCT02941614|18615163|P2|NOT COMPLETED|Overall Study||246
7562915|NCT02941614|18615164|P1|NOT COMPLETED|Overall Study||141
7562916|NCT02941614|18615163|P2|COMPLETED|Overall Study||446
7562917|NCT02941614|18615164|P1|COMPLETED|Overall Study||603
7562918|NCT02941614|18615163|P2|STARTED|Overall Study||692
7562919|NCT02941614|18615164|P1|STARTED|Overall Study||744
7562920|NCT02941146|18615184|P1|NOT COMPLETED|Overall Study||0
7562921|NCT02941146|18615184|P1|COMPLETED|Overall Study||15
7562922|NCT02941146|18615184|P1|STARTED|Overall Study||15
7562923|NCT02940886|18615192|P2|NOT COMPLETED|Overall Study||54
7562924|NCT02940886|18615193|P1|NOT COMPLETED|Overall Study||102
7562925|NCT02940886|18615192|P2|COMPLETED|Overall Study||449
7562926|NCT02940886|18615193|P1|COMPLETED|Overall Study||907
7562927|NCT02940886|18615192|P2|Safety Analysis Set|Overall Study||494
7562928|NCT02940886|18615193|P1|Safety Analysis Set|Overall Study||989
7562929|NCT02940886|18615192|P2|STARTED|Overall Study|Intention-to-treat analysis set included 503 subjects, safety analysis set included 494 subjects.|503
7562930|NCT02940886|18615193|P1|STARTED|Overall Study|Intention-to-treat analysis set included 1009 subjects, safety analysis set included 989 subjects.|1009
7562931|NCT02940860|18615239|P2|NOT COMPLETED|Overall Study||35
7562932|NCT02940860|18615240|P1|NOT COMPLETED|Overall Study||56
7562933|NCT02940860|18615239|P2|COMPLETED|Overall Study||476
7562934|NCT02940860|18615240|P1|COMPLETED|Overall Study||971
7562935|NCT02940860|18615239|P2|STARTED|Overall Study||511
7562936|NCT02940860|18615240|P1|STARTED|Overall Study||1027
7562937|NCT02940691|18615284|P1|NOT COMPLETED|Overall Study||6
7562938|NCT02940691|18615284|P1|COMPLETED|Overall Study||26
7562939|NCT02940691|18615284|P1|STARTED|Overall Study||32
7562940|NCT02940626|18615293|P2|NOT COMPLETED|Overall Study||35
7562941|NCT02940626|18615294|P1|NOT COMPLETED|Overall Study||47
7562942|NCT02940626|18615293|P2|COMPLETED|Overall Study||43
7562943|NCT02940626|18615294|P1|COMPLETED|Overall Study||30
7562944|NCT02940626|18615293|P2|Completed Through Study Day 22|Overall Study||49
7562945|NCT02940626|18615294|P1|Completed Through Study Day 22|Overall Study||42
7562946|NCT02940626|18615293|P2|Received Study Treatment|Overall Study||77
7562947|NCT02940626|18615294|P1|Received Study Treatment|Overall Study||77
7562948|NCT02940626|18615293|P2|Randomized Into Treatment Sub-study|Overall Study||1
7562949|NCT02940626|18615294|P1|Randomized Into Treatment Sub-study|Overall Study||0
7562950|NCT02940626|18615293|P2|Randomized Into Primary Prevention Study|Overall Study||77
7562951|NCT02940626|18615294|P1|Randomized Into Primary Prevention Study|Overall Study||77
7562952|NCT02940626|18615293|P2|STARTED|Overall Study||78
7562953|NCT02940626|18615294|P1|STARTED|Overall Study||77
7562954|NCT02940574|18615316|P2|NOT COMPLETED|1-year Follow-up||4
7562955|NCT02940574|18615317|P1|NOT COMPLETED|1-year Follow-up||3
7562956|NCT02940574|18615316|P2|COMPLETED|1-year Follow-up||14
7562957|NCT02940574|18615317|P1|COMPLETED|1-year Follow-up||18
7562958|NCT02940574|18615316|P2|STARTED|1-year Follow-up||18
7562959|NCT02940574|18615317|P1|STARTED|1-year Follow-up||21
7562960|NCT02940574|18615316|P2|NOT COMPLETED|From Study Start to 1-month Follow-up||0
7562961|NCT02940574|18615317|P1|NOT COMPLETED|From Study Start to 1-month Follow-up||1
7562962|NCT02940574|18615316|P2|COMPLETED|From Study Start to 1-month Follow-up|All participants completed, but data from 1 participant was not included in analyses.|18
7562963|NCT02940574|18615317|P1|COMPLETED|From Study Start to 1-month Follow-up|Discontinued intervention (N=1): self-termination unrelated to treatment|21
7562964|NCT02940574|18615316|P2|STARTED|From Study Start to 1-month Follow-up||18
7562965|NCT02940574|18615317|P1|STARTED|From Study Start to 1-month Follow-up||22
7562966|NCT02940522|18615355|P2|NOT COMPLETED|Overall Study||2
7562967|NCT02940522|18615356|P1|NOT COMPLETED|Overall Study||2
7562968|NCT02940522|18615355|P2|COMPLETED|Overall Study||59
7562969|NCT02940522|18615356|P1|COMPLETED|Overall Study||57
7562970|NCT02940522|18615355|P2|STARTED|Overall Study||61
7562971|NCT02940522|18615356|P1|STARTED|Overall Study||59
7562972|NCT02940327|18615372|P1|NOT COMPLETED|Overall Study||0
7562973|NCT02940327|18615372|P1|COMPLETED|Overall Study||24
7562974|NCT02940327|18615372|P1|STARTED|Overall Study||24
7562975|NCT02940249|18615435|P1|NOT COMPLETED|Overall Study||4
7562976|NCT02940249|18615435|P1|COMPLETED|Overall Study||30
7562977|NCT02940249|18615435|P1|STARTED|Overall Study||34
7562978|NCT02939950|18615447|P2|NOT COMPLETED|Overall Study||81
7562979|NCT02939950|18615448|P1|NOT COMPLETED|Overall Study||66
7562980|NCT02939950|18615447|P2|COMPLETED|Overall Study||329
7562981|NCT02939950|18615448|P1|COMPLETED|Overall Study||340
7562982|NCT02939950|18615447|P2|Eligible at Baseline|Overall Study||402
7562983|NCT02939950|18615448|P1|Eligible at Baseline|Overall Study||403
7562984|NCT02939950|18615447|P2|Dispensed the Assigned Lenses|Overall Study||410
7562985|NCT02939950|18615448|P1|Dispensed the Assigned Lenses|Overall Study||405
7562986|NCT02939950|18615447|P2|STARTED|Overall Study||410
7562987|NCT02939950|18615448|P1|STARTED|Overall Study||406
7562988|NCT02939937|18615458|P2|NOT COMPLETED|Overall Study||3
7562989|NCT02939937|18615459|P1|NOT COMPLETED|Overall Study||6
7562990|NCT02939937|18615458|P2|COMPLETED|Overall Study||47
7562991|NCT02939937|18615459|P1|COMPLETED|Overall Study||15
7562992|NCT02939937|18615458|P2|STARTED|Overall Study|3 patients excluded from study|50
7562993|NCT02939937|18615459|P1|STARTED|Overall Study|5 patients had drug reaction and 1 patient excluded from study,|21
7562994|NCT02939716|18615473|P6|NOT COMPLETED|Overall Study||1
7562995|NCT02939716|18615474|P5|NOT COMPLETED|Overall Study||1
7562996|NCT02939716|18615475|P4|NOT COMPLETED|Overall Study||1
7562997|NCT02939716|18615476|P3|NOT COMPLETED|Overall Study||0
7562998|NCT02939716|18615477|P2|NOT COMPLETED|Overall Study||0
7562999|NCT02939716|18615478|P1|NOT COMPLETED|Overall Study||0
7563000|NCT02939716|18615473|P6|COMPLETED|Overall Study||2
7563001|NCT02939716|18615474|P5|COMPLETED|Overall Study||2
7563002|NCT02939716|18615475|P4|COMPLETED|Overall Study||2
7563003|NCT02939716|18615476|P3|COMPLETED|Overall Study||3
7563004|NCT02939716|18615477|P2|COMPLETED|Overall Study||3
7563005|NCT02939716|18615478|P1|COMPLETED|Overall Study||3
7563006|NCT02939716|18615473|P6|STARTED|Overall Study||3
7563007|NCT02939716|18615474|P5|STARTED|Overall Study||3
7563008|NCT02939716|18615475|P4|STARTED|Overall Study||3
7563009|NCT02939716|18615476|P3|STARTED|Overall Study||3
7563010|NCT02939716|18615477|P2|STARTED|Overall Study||3
7563011|NCT02939716|18615478|P1|STARTED|Overall Study||3
7563012|NCT02939599|18615503|P2|NOT COMPLETED|Overall Study||2
7563013|NCT02939599|18615504|P1|NOT COMPLETED|Overall Study||3
7563014|NCT02939599|18615503|P2|COMPLETED|Overall Study||0
7563015|NCT02939599|18615504|P1|COMPLETED|Overall Study||0
7563016|NCT02939599|18615503|P2|STARTED|Overall Study||2
7563017|NCT02939599|18615504|P1|STARTED|Overall Study||3
7563018|NCT02939560|18615518|P1|NOT COMPLETED|Overall Study||3
7563019|NCT02939560|18615518|P1|COMPLETED|Overall Study||10
7563020|NCT02939560|18615518|P1|STARTED|Overall Study||13
7563021|NCT02939326|18615535|P8|NOT COMPLETED|Overall Study||0
7563022|NCT02939326|18615536|P7|NOT COMPLETED|Overall Study||0
7563023|NCT02939326|18615537|P6|NOT COMPLETED|Overall Study||0
7563024|NCT02939326|18615538|P5|NOT COMPLETED|Overall Study||0
7563025|NCT02939326|18615539|P4|NOT COMPLETED|Overall Study||0
7563026|NCT02939326|18615540|P3|NOT COMPLETED|Overall Study||0
7563027|NCT02939326|18615541|P2|NOT COMPLETED|Overall Study||0
7563028|NCT02939326|18615542|P1|NOT COMPLETED|Overall Study||0
7563029|NCT02939326|18615535|P8|COMPLETED|Overall Study||5
7563030|NCT02939326|18615536|P7|COMPLETED|Overall Study||5
7563031|NCT02939326|18615537|P6|COMPLETED|Overall Study||5
7563032|NCT02939326|18615538|P5|COMPLETED|Overall Study||5
7563033|NCT02939326|18615539|P4|COMPLETED|Overall Study||5
7563034|NCT02939326|18615540|P3|COMPLETED|Overall Study||5
7563035|NCT02939326|18615541|P2|COMPLETED|Overall Study||5
7563036|NCT02939326|18615542|P1|COMPLETED|Overall Study||7
7563037|NCT02939326|18615535|P8|STARTED|Overall Study||5
7563038|NCT02939326|18615536|P7|STARTED|Overall Study||5
7563039|NCT02939326|18615537|P6|STARTED|Overall Study||5
7563040|NCT02939326|18615538|P5|STARTED|Overall Study||5
7563041|NCT02939326|18615539|P4|STARTED|Overall Study||5
7563042|NCT02939326|18615540|P3|STARTED|Overall Study||5
7563043|NCT02939326|18615541|P2|STARTED|Overall Study||5
7563044|NCT02939326|18615542|P1|STARTED|Overall Study||7
7563045|NCT02939170|18615562|P2|NOT COMPLETED|Overall Study||0
7563046|NCT02939170|18615563|P1|NOT COMPLETED|Overall Study||0
7563047|NCT02939170|18615562|P2|COMPLETED|Overall Study||40
7563048|NCT02939170|18615563|P1|COMPLETED|Overall Study||40
7563049|NCT02939170|18615562|P2|STARTED|Overall Study||40
7563050|NCT02939170|18615563|P1|STARTED|Overall Study||40
7563051|NCT02939131|18615576|P2|NOT COMPLETED|Overall Study||9
7563052|NCT02939131|18615577|P1|NOT COMPLETED|Overall Study||11
7563053|NCT02939131|18615576|P2|COMPLETED|Overall Study||66
7563054|NCT02939131|18615577|P1|COMPLETED|Overall Study||70
7563055|NCT02939131|18615576|P2|Week 24 Visit|Overall Study||72
7563056|NCT02939131|18615577|P1|Week 24 Visit|Overall Study|These are the numbers still on study at week 24|74
7563057|NCT02939131|18615576|P2|STARTED|Overall Study||75
7563058|NCT02939131|18615577|P1|STARTED|Overall Study|One additional site in the COMB-R group withdrew prior to the start of participant enrollment.|81
7563059|NCT02939079|18615595|P2|NOT COMPLETED|Overall Study||5
7563060|NCT02939079|18615596|P1|NOT COMPLETED|Overall Study||4
7563061|NCT02939079|18615595|P2|COMPLETED|Overall Study||20
7563062|NCT02939079|18615596|P1|COMPLETED|Overall Study||21
7563063|NCT02939079|18615595|P2|STARTED|Overall Study||25
7563064|NCT02939079|18615596|P1|STARTED|Overall Study||25
7563065|NCT02939014|18615626|P2|NOT COMPLETED|Overall Study||9
7563066|NCT02939014|18615627|P1|NOT COMPLETED|Overall Study||30
7563067|NCT02939014|18615626|P2|COMPLETED|Overall Study||0
7563068|NCT02939014|18615627|P1|COMPLETED|Overall Study||0
7563069|NCT02939014|18615626|P2|STARTED|Overall Study||9
7563070|NCT02939014|18615627|P1|STARTED|Overall Study||30
7563071|NCT02938949|18615656|P2|NOT COMPLETED|Overall Study||0
7563072|NCT02938949|18615657|P1|NOT COMPLETED|Overall Study||0
7563073|NCT02938949|18615656|P2|COMPLETED|Overall Study||10
7563074|NCT02938949|18615657|P1|COMPLETED|Overall Study||10
7563075|NCT02938949|18615656|P2|STARTED|Overall Study||10
7563076|NCT02938949|18615657|P1|STARTED|Overall Study||10
7563077|NCT02938585|18615671|P4|NOT COMPLETED|Overall Study||5
7563078|NCT02938585|18615672|P3|NOT COMPLETED|Overall Study||0
7563079|NCT02938585|18615673|P2|NOT COMPLETED|Overall Study||1
7563080|NCT02938585|18615674|P1|NOT COMPLETED|Overall Study||0
7563081|NCT02938585|18615671|P4|COMPLETED|Overall Study||10
7563082|NCT02938585|18615672|P3|COMPLETED|Overall Study||11
7563083|NCT02938585|18615673|P2|COMPLETED|Overall Study||32
7563084|NCT02938585|18615674|P1|COMPLETED|Overall Study||9
7563085|NCT02938585|18615671|P4|Exposed to On-demand Regimen|Overall Study||8
7563086|NCT02938585|18615672|P3|Exposed to On-demand Regimen|Overall Study||1
7563087|NCT02938585|18615673|P2|Exposed to On-demand Regimen|Overall Study||7
7563088|NCT02938585|18615674|P1|Exposed to On-demand Regimen|Overall Study||1
7563089|NCT02938585|18615671|P4|Exposed to Prophylaxis Regimen|Overall Study||12
7563090|NCT02938585|18615672|P3|Exposed to Prophylaxis Regimen|Overall Study||11
7563091|NCT02938585|18615673|P2|Exposed to Prophylaxis Regimen|Overall Study||31
7563092|NCT02938585|18615674|P1|Exposed to Prophylaxis Regimen|Overall Study||9
7563093|NCT02938585|18615671|P4|STARTED|Overall Study||15
7563094|NCT02938585|18615672|P3|STARTED|Overall Study||11
7563095|NCT02938585|18615673|P2|STARTED|Overall Study||33
7563096|NCT02938585|18615674|P1|STARTED|Overall Study||9
7563097|NCT02938520|18615838|P2|NOT COMPLETED|Overall Study||283
7563098|NCT02938520|18615839|P1|NOT COMPLETED|Overall Study||283
7563099|NCT02938520|18615838|P2|COMPLETED|Overall Study||0
7563100|NCT02938520|18615839|P1|COMPLETED|Overall Study||0
7563101|NCT02938520|18615838|P2|STARTED|Overall Study||283
7563102|NCT02938520|18615839|P1|STARTED|Overall Study||283
7563103|NCT02938494|18615968|P4|NOT COMPLETED|Overall Study||4
7563104|NCT02938494|18615969|P3|NOT COMPLETED|Overall Study||4
7563105|NCT02938494|18615970|P2|NOT COMPLETED|Overall Study||9
7563106|NCT02938494|18615971|P1|NOT COMPLETED|Overall Study||4
7563107|NCT02938494|18615968|P4|COMPLETED|Overall Study||31
7563108|NCT02938494|18615969|P3|COMPLETED|Overall Study||30
7563109|NCT02938494|18615970|P2|COMPLETED|Overall Study||63
7563110|NCT02938494|18615971|P1|COMPLETED|Overall Study||65
7563111|NCT02938494|18615968|P4|STARTED|Overall Study||35
7563112|NCT02938494|18615969|P3|STARTED|Overall Study||34
7563113|NCT02938494|18615970|P2|STARTED|Overall Study||72
7563114|NCT02938494|18615971|P1|STARTED|Overall Study||69
7563115|NCT02938169|18615990|P4|NOT COMPLETED|Overall Study||3
7563116|NCT02938169|18615991|P3|NOT COMPLETED|Overall Study||5
7563117|NCT02938169|18615992|P2|NOT COMPLETED|Overall Study||2
7563118|NCT02938169|18615993|P1|NOT COMPLETED|Overall Study||2
7563119|NCT02938169|18615990|P4|COMPLETED|Overall Study||12
7563120|NCT02938169|18615991|P3|COMPLETED|Overall Study||10
7563121|NCT02938169|18615992|P2|COMPLETED|Overall Study||13
7563122|NCT02938169|18615993|P1|COMPLETED|Overall Study||13
7563123|NCT02938169|18615990|P4|STARTED|Overall Study||15
7563124|NCT02938169|18615991|P3|STARTED|Overall Study||15
7563125|NCT02938169|18615992|P2|STARTED|Overall Study||15
7563126|NCT02938169|18615993|P1|STARTED|Overall Study||15
7563127|NCT02938052|18616019|P1|NOT COMPLETED|Overall Study||0
7563128|NCT02938052|18616019|P1|COMPLETED|Overall Study||10
7563129|NCT02938052|18616019|P1|STARTED|Overall Study||10
7563130|NCT02938013|18616042|P3|NOT COMPLETED|Overall Study||0
7563131|NCT02938013|18616043|P2|NOT COMPLETED|Overall Study||0
7563132|NCT02938013|18616044|P1|NOT COMPLETED|Overall Study||0
7563133|NCT02938013|18616042|P3|COMPLETED|Overall Study||5
7563134|NCT02938013|18616043|P2|COMPLETED|Overall Study||5
7563135|NCT02938013|18616044|P1|COMPLETED|Overall Study||5
7563136|NCT02938013|18616042|P3|STARTED|Overall Study||5
7563137|NCT02938013|18616043|P2|STARTED|Overall Study||5
7563138|NCT02938013|18616044|P1|STARTED|Overall Study||5
7563139|NCT02937870|18616061|P1|NOT COMPLETED|Overall Study||3
7563140|NCT02937870|18616061|P1|COMPLETED|Overall Study||20
7563141|NCT02937870|18616061|P1|Received no Adhesive|Overall Study||20
7563142|NCT02937870|18616061|P1|Received Positive Control Adhesive|Overall Study||21
7563143|NCT02937870|18616061|P1|Received Test Adhesive 2|Overall Study||22
7563144|NCT02937870|18616061|P1|Received Test Adhesive 1|Overall Study||21
7563145|NCT02937870|18616061|P1|STARTED|Overall Study||23
7563146|NCT02937766|18616079|P2|NOT COMPLETED|Overall Study||0
7563147|NCT02937766|18616080|P1|NOT COMPLETED|Overall Study||7
7563148|NCT02937766|18616079|P2|COMPLETED|Overall Study||30
7563149|NCT02937766|18616080|P1|COMPLETED|Overall Study||23
7563150|NCT02937766|18616079|P2|STARTED|Overall Study||30
7563151|NCT02937766|18616080|P1|STARTED|Overall Study||30
7563152|NCT02937740|18616092|P2|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||2
7563153|NCT02937740|18616093|P1|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||1
7563154|NCT02937740|18616092|P2|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||15
7563155|NCT02937740|18616093|P1|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||12
7563156|NCT02937740|18616092|P2|STARTED|Uptitrated to TID on Day 90 for 30 Days||17
7563157|NCT02937740|18616093|P1|STARTED|Uptitrated to TID on Day 90 for 30 Days||13
7563158|NCT02937740|18616092|P2|NOT COMPLETED|BID for 90 Days, 22 mg/Day||31
7563159|NCT02937740|18616093|P1|NOT COMPLETED|BID for 90 Days, 22 mg/Day||5
7563160|NCT02937740|18616092|P2|COMPLETED|BID for 90 Days, 22 mg/Day||62
7563161|NCT02937740|18616093|P1|COMPLETED|BID for 90 Days, 22 mg/Day||19
7563162|NCT02937740|18616092|P2|STARTED|BID for 90 Days, 22 mg/Day||93
7563163|NCT02937740|18616093|P1|STARTED|BID for 90 Days, 22 mg/Day||24
7563164|NCT02937701|18616109|P5|NOT COMPLETED|Week 22 to Week 50||9
7563165|NCT02937701|18616110|P4|NOT COMPLETED|Week 22 to Week 50||8
7563166|NCT02937701|18616111|P3|NOT COMPLETED|Week 22 to Week 50||32
7563167|NCT02937701|18616112|P2|NOT COMPLETED|Week 22 to Week 50||0
7563168|NCT02937701|18616113|P1|NOT COMPLETED|Week 22 to Week 50||0
7563169|NCT02937701|18616109|P5|COMPLETED|Week 22 to Week 50||110
7563170|NCT02937701|18616110|P4|COMPLETED|Week 22 to Week 50||113
7563171|NCT02937701|18616111|P3|COMPLETED|Week 22 to Week 50||212
7563172|NCT02937701|18616112|P2|COMPLETED|Week 22 to Week 50||0
7563173|NCT02937701|18616113|P1|COMPLETED|Week 22 to Week 50||0
7563174|NCT02937701|18616109|P5|STARTED|Week 22 to Week 50||119
7563175|NCT02937701|18616110|P4|STARTED|Week 22 to Week 50||121
7563176|NCT02937701|18616111|P3|STARTED|Week 22 to Week 50||244
7563177|NCT02937701|18616112|P2|STARTED|Week 22 to Week 50||0
7563178|NCT02937701|18616113|P1|STARTED|Week 22 to Week 50||0
7563179|NCT02937701|18616109|P5|NOT COMPLETED|Day 1 to Week 22||0
7563180|NCT02937701|18616110|P4|NOT COMPLETED|Day 1 to Week 22||0
7563181|NCT02937701|18616111|P3|NOT COMPLETED|Day 1 to Week 22||0
7563182|NCT02937701|18616112|P2|NOT COMPLETED|Day 1 to Week 22||39
7563183|NCT02937701|18616113|P1|NOT COMPLETED|Day 1 to Week 22||35
7563184|NCT02937701|18616109|P5|COMPLETED|Day 1 to Week 22||0
7563185|NCT02937701|18616110|P4|COMPLETED|Day 1 to Week 22||0
7563186|NCT02937701|18616111|P3|COMPLETED|Day 1 to Week 22||0
7563187|NCT02937701|18616112|P2|COMPLETED|Day 1 to Week 22||240
7563188|NCT02937701|18616113|P1|COMPLETED|Day 1 to Week 22||244
7563189|NCT02937701|18616109|P5|Received Treatment|Day 1 to Week 22||0
7563190|NCT02937701|18616110|P4|Received Treatment|Day 1 to Week 22||0
7563191|NCT02937701|18616111|P3|Received Treatment|Day 1 to Week 22||0
7563192|NCT02937701|18616112|P2|Received Treatment|Day 1 to Week 22||278
7563193|NCT02937701|18616113|P1|Received Treatment|Day 1 to Week 22||278
7563194|NCT02937701|18616109|P5|STARTED|Day 1 to Week 22||0
7563195|NCT02937701|18616110|P4|STARTED|Day 1 to Week 22||0
7563196|NCT02937701|18616111|P3|STARTED|Day 1 to Week 22||0
7563197|NCT02937701|18616112|P2|STARTED|Day 1 to Week 22||279
7563198|NCT02937701|18616113|P1|STARTED|Day 1 to Week 22||279
7563199|NCT02937636|18616144|P2|NOT COMPLETED|Overall Study||2
7563200|NCT02937636|18616145|P1|NOT COMPLETED|Overall Study||3
7563201|NCT02937636|18616144|P2|COMPLETED|Overall Study||63
7563202|NCT02937636|18616145|P1|COMPLETED|Overall Study||60
7563203|NCT02937636|18616144|P2|STARTED|Overall Study||65
7563204|NCT02937636|18616145|P1|STARTED|Overall Study||63
7563205|NCT02937623|18616159|P2|NOT COMPLETED|Overall Study||0
7563206|NCT02937623|18616160|P1|NOT COMPLETED|Overall Study||0
7563207|NCT02937623|18616159|P2|COMPLETED|Overall Study||60
7563208|NCT02937623|18616160|P1|COMPLETED|Overall Study||60
7563209|NCT02937623|18616159|P2|STARTED|Overall Study||60
7563210|NCT02937623|18616160|P1|STARTED|Overall Study||60
7563211|NCT02937584|18616172|P2|NOT COMPLETED|Period 2||0
7563212|NCT02937584|18616173|P1|NOT COMPLETED|Period 2||0
7563213|NCT02937584|18616172|P2|COMPLETED|Period 2||9
7563214|NCT02937584|18616173|P1|COMPLETED|Period 2||10
7563215|NCT02937584|18616172|P2|STARTED|Period 2||9
7563216|NCT02937584|18616173|P1|STARTED|Period 2||10
7563217|NCT02937584|18616172|P2|NOT COMPLETED|Washout||1
7563218|NCT02937584|18616173|P1|NOT COMPLETED|Washout||0
7563219|NCT02937584|18616172|P2|COMPLETED|Washout||9
7563220|NCT02937584|18616173|P1|COMPLETED|Washout||10
7563221|NCT02937584|18616172|P2|STARTED|Washout||10
7563222|NCT02937584|18616173|P1|STARTED|Washout||10
7563223|NCT02937584|18616172|P2|NOT COMPLETED|Period 1||2
7563224|NCT02937584|18616173|P1|NOT COMPLETED|Period 1||1
7563225|NCT02937584|18616172|P2|COMPLETED|Period 1||10
7563226|NCT02937584|18616173|P1|COMPLETED|Period 1||10
7563227|NCT02937584|18616172|P2|STARTED|Period 1||12
7563228|NCT02937584|18616173|P1|STARTED|Period 1||11
7563229|NCT02937558|18616191|P2|NOT COMPLETED|Open-label Phase||0
7563230|NCT02937558|18616192|P1|NOT COMPLETED|Open-label Phase||0
7563231|NCT02937558|18616191|P2|COMPLETED|Open-label Phase||0
7563232|NCT02937558|18616192|P1|COMPLETED|Open-label Phase||5
7563233|NCT02937558|18616191|P2|STARTED|Open-label Phase||0
7563234|NCT02937558|18616192|P1|STARTED|Open-label Phase||5
7563235|NCT02937558|18616191|P2|NOT COMPLETED|Double-blind Phase||0
7563236|NCT02937558|18616192|P1|NOT COMPLETED|Double-blind Phase||0
7563237|NCT02937558|18616191|P2|COMPLETED|Double-blind Phase||2
7563238|NCT02937558|18616192|P1|COMPLETED|Double-blind Phase||3
7563239|NCT02937558|18616191|P2|STARTED|Double-blind Phase||2
7563240|NCT02937558|18616192|P1|STARTED|Double-blind Phase||3
7563241|NCT02937506|18616207|P2|NOT COMPLETED|Overall Study||0
7563242|NCT02937506|18616208|P1|NOT COMPLETED|Overall Study||0
7563243|NCT02937506|18616207|P2|COMPLETED|Overall Study||300
7563244|NCT02937506|18616208|P1|COMPLETED|Overall Study||300
7563245|NCT02937506|18616207|P2|STARTED|Overall Study||300
7563246|NCT02937506|18616208|P1|STARTED|Overall Study||300
7563247|NCT02937168|18616214|P3|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
7563248|NCT02937168|18616215|P2|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
7563249|NCT02937168|18616216|P1|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
7563250|NCT02937168|18616214|P3|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
7563251|NCT02937168|18616215|P2|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
7563252|NCT02937168|18616216|P1|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
7563253|NCT02937168|18616214|P3|STARTED|Double-Blind Treatment Period (6 Weeks)||0
7563254|NCT02937168|18616215|P2|STARTED|Double-Blind Treatment Period (6 Weeks)||0
7563255|NCT02937168|18616216|P1|STARTED|Double-Blind Treatment Period (6 Weeks)||0
7563256|NCT02937168|18616214|P3|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
7563257|NCT02937168|18616215|P2|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
7563258|NCT02937168|18616216|P1|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
7563259|NCT02937168|18616214|P3|COMPLETED|PET/CT Screening Period (21 Days)||0
7563260|NCT02937168|18616215|P2|COMPLETED|PET/CT Screening Period (21 Days)||0
7563261|NCT02937168|18616216|P1|COMPLETED|PET/CT Screening Period (21 Days)||5
7563262|NCT02937168|18616214|P3|STARTED|PET/CT Screening Period (21 Days)||0
7563263|NCT02937168|18616215|P2|STARTED|PET/CT Screening Period (21 Days)||0
7563264|NCT02937168|18616216|P1|STARTED|PET/CT Screening Period (21 Days)||5
7563265|NCT02936999|18616234|P1|NOT COMPLETED|Overall Study||0
7563266|NCT02936999|18616234|P1|COMPLETED|Overall Study||8
7563267|NCT02936999|18616234|P1|STARTED|Overall Study||8
7563268|NCT02936869|18616244|P2|NOT COMPLETED|Overall Study||5
7563269|NCT02936869|18616245|P1|NOT COMPLETED|Overall Study||2
7563270|NCT02936869|18616244|P2|COMPLETED|Overall Study||98
7563271|NCT02936869|18616245|P1|COMPLETED|Overall Study||102
7563272|NCT02936869|18616244|P2|STARTED|Overall Study||103
7563273|NCT02936869|18616245|P1|STARTED|Overall Study||104
7563274|NCT02936648|18616253|P1|NOT COMPLETED|Overall Study||0
7563275|NCT02936648|18616253|P1|COMPLETED|Overall Study||2209
7563276|NCT02936648|18616253|P1|STARTED|Overall Study||2209
7563277|NCT02936479|18616257|P1|NOT COMPLETED|Overall Study||0
7563278|NCT02936479|18616257|P1|COMPLETED|Overall Study||1
7563279|NCT02936479|18616257|P1|STARTED|Overall Study||1
7563280|NCT02936076|18616263|P2|NOT COMPLETED|Overall Study||4
7563281|NCT02936076|18616264|P1|NOT COMPLETED|Overall Study||6
7563282|NCT02936076|18616263|P2|COMPLETED|Overall Study||20
7563283|NCT02936076|18616264|P1|COMPLETED|Overall Study||19
7563284|NCT02936076|18616263|P2|STARTED|Overall Study||24
7563285|NCT02936076|18616264|P1|STARTED|Overall Study||25
7563286|NCT02936037|18616278|P2|NOT COMPLETED|Open Label Extension||10
7563287|NCT02936037|18616279|P1|NOT COMPLETED|Open Label Extension||0
7563288|NCT02936037|18616278|P2|COMPLETED|Open Label Extension||518
7563289|NCT02936037|18616279|P1|COMPLETED|Open Label Extension||0
7563290|NCT02936037|18616278|P2|STARTED|Open Label Extension||528
7563291|NCT02936037|18616279|P1|STARTED|Open Label Extension||0
7563292|NCT02936037|18616278|P2|NOT COMPLETED|Double-Blind Treatment Period||65
7563293|NCT02936037|18616279|P1|NOT COMPLETED|Double-Blind Treatment Period||49
7563294|NCT02936037|18616278|P2|COMPLETED|Double-Blind Treatment Period||261
7563295|NCT02936037|18616279|P1|COMPLETED|Double-Blind Treatment Period||267
7563296|NCT02936037|18616278|P2|STARTED|Double-Blind Treatment Period||326
7563297|NCT02936037|18616279|P1|STARTED|Double-Blind Treatment Period||316
7563298|NCT02935894|18616285|P1|NOT COMPLETED|Overall Study||1
7563299|NCT02935894|18616285|P1|COMPLETED|Overall Study||13
7563300|NCT02935894|18616285|P1|STARTED|Overall Study||14
7563301|NCT02935842|18616300|P4|NOT COMPLETED|Testing and Therapy Period 3||1
7563302|NCT02935842|18616301|P3|NOT COMPLETED|Testing and Therapy Period 3||5
7563303|NCT02935842|18616302|P2|NOT COMPLETED|Testing and Therapy Period 3||4
7563304|NCT02935842|18616303|P1|NOT COMPLETED|Testing and Therapy Period 3||3
7563305|NCT02935842|18616300|P4|COMPLETED|Testing and Therapy Period 3||17
7563306|NCT02935842|18616301|P3|COMPLETED|Testing and Therapy Period 3||1
7563307|NCT02935842|18616302|P2|COMPLETED|Testing and Therapy Period 3||2
7563308|NCT02935842|18616303|P1|COMPLETED|Testing and Therapy Period 3||3
7563309|NCT02935842|18616300|P4|STARTED|Testing and Therapy Period 3|HC received no interventions. They have only been tested at BL, 4 Weeks and 6 Months.|18
7563310|NCT02935842|18616301|P3|STARTED|Testing and Therapy Period 3||6
7563311|NCT02935842|18616302|P2|STARTED|Testing and Therapy Period 3||6
7563312|NCT02935842|18616303|P1|STARTED|Testing and Therapy Period 3||6
7563313|NCT02935842|18616300|P4|NOT COMPLETED|Testing and Therapy Period 2||0
7563314|NCT02935842|18616301|P3|NOT COMPLETED|Testing and Therapy Period 2||0
7563315|NCT02935842|18616302|P2|NOT COMPLETED|Testing and Therapy Period 2||0
7563316|NCT02935842|18616303|P1|NOT COMPLETED|Testing and Therapy Period 2||2
7563317|NCT02935842|18616300|P4|COMPLETED|Testing and Therapy Period 2||0
7563318|NCT02935842|18616301|P3|COMPLETED|Testing and Therapy Period 2||6
7563319|NCT02935842|18616302|P2|COMPLETED|Testing and Therapy Period 2||6
7563320|NCT02935842|18616303|P1|COMPLETED|Testing and Therapy Period 2||6
7563321|NCT02935842|18616300|P4|STARTED|Testing and Therapy Period 2|Due to limited staff capacity, HC have only been included in the final tranche.|0
7563322|NCT02935842|18616301|P3|STARTED|Testing and Therapy Period 2||6
7563323|NCT02935842|18616302|P2|STARTED|Testing and Therapy Period 2||6
7563324|NCT02935842|18616303|P1|STARTED|Testing and Therapy Period 2||8
7563325|NCT02935842|18616300|P4|NOT COMPLETED|Testing and Therapy Period 1||0
7563326|NCT02935842|18616301|P3|NOT COMPLETED|Testing and Therapy Period 1||0
7563327|NCT02935842|18616302|P2|NOT COMPLETED|Testing and Therapy Period 1||0
7563328|NCT02935842|18616303|P1|NOT COMPLETED|Testing and Therapy Period 1||0
7563329|NCT02935842|18616300|P4|COMPLETED|Testing and Therapy Period 1||0
7563330|NCT02935842|18616301|P3|COMPLETED|Testing and Therapy Period 1||6
7563331|NCT02935842|18616302|P2|COMPLETED|Testing and Therapy Period 1||6
7563332|NCT02935842|18616303|P1|COMPLETED|Testing and Therapy Period 1||8
7563333|NCT02935842|18616300|P4|STARTED|Testing and Therapy Period 1|Due to limited staff capacity, HC have only been included in the final tranche.|0
7563334|NCT02935842|18616301|P3|STARTED|Testing and Therapy Period 1||6
7563335|NCT02935842|18616302|P2|STARTED|Testing and Therapy Period 1||6
7563336|NCT02935842|18616303|P1|STARTED|Testing and Therapy Period 1||8
7563337|NCT02935738|18616341|P4|NOT COMPLETED|Overall Study||5
7563338|NCT02935738|18616342|P3|NOT COMPLETED|Overall Study||1
7563339|NCT02935738|18616343|P2|NOT COMPLETED|Overall Study||21
7563340|NCT02935738|18616344|P1|NOT COMPLETED|Overall Study||17
7563341|NCT02935738|18616341|P4|COMPLETED|Overall Study||48
7563342|NCT02935738|18616342|P3|COMPLETED|Overall Study||46
7563343|NCT02935738|18616343|P2|COMPLETED|Overall Study||53
7563344|NCT02935738|18616344|P1|COMPLETED|Overall Study||50
7563345|NCT02935738|18616341|P4|STARTED|Overall Study||53
7563346|NCT02935738|18616342|P3|STARTED|Overall Study||47
7563347|NCT02935738|18616343|P2|STARTED|Overall Study||74
7563348|NCT02935738|18616344|P1|STARTED|Overall Study||67
7563349|NCT02935699|18616356|P2|NOT COMPLETED|Overall Study||0
7563350|NCT02935699|18616357|P1|NOT COMPLETED|Overall Study||0
7563351|NCT02935699|18616356|P2|COMPLETED|Overall Study||135
7563352|NCT02935699|18616357|P1|COMPLETED|Overall Study||127
7563353|NCT02935699|18616356|P2|STARTED|Overall Study||135
7563354|NCT02935699|18616357|P1|STARTED|Overall Study||127
7563355|NCT02935673|18616372|P3|NOT COMPLETED|Overall Study||0
7563356|NCT02935673|18616373|P2|NOT COMPLETED|Overall Study||3
7563357|NCT02935673|18616374|P1|NOT COMPLETED|Overall Study||1
7563358|NCT02935673|18616372|P3|COMPLETED|Overall Study||6
7563359|NCT02935673|18616373|P2|COMPLETED|Overall Study||24
7563360|NCT02935673|18616374|P1|COMPLETED|Overall Study||15
7563361|NCT02935673|18616372|P3|STARTED|Overall Study||6
7563362|NCT02935673|18616373|P2|STARTED|Overall Study||27
7563363|NCT02935673|18616374|P1|STARTED|Overall Study||16
7563364|NCT02935595|18616496|P1|NOT COMPLETED|Overall Study||1
7563365|NCT02935595|18616496|P1|COMPLETED|Overall Study||4
7563366|NCT02935595|18616496|P1|STARTED|Overall Study||5
7563367|NCT02935543|18616507|P1|NOT COMPLETED|Overall Study||0
7563368|NCT02935543|18616507|P1|COMPLETED|Overall Study||1
7563369|NCT02935543|18616507|P1|STARTED|Overall Study||1
7563370|NCT02935192|18616519|P2|NOT COMPLETED|Overall Study||4
7563371|NCT02935192|18616520|P1|NOT COMPLETED|Overall Study||8
7563372|NCT02935192|18616519|P2|COMPLETED|Overall Study||156
7563373|NCT02935192|18616520|P1|COMPLETED|Overall Study||312
7563374|NCT02935192|18616519|P2|Received Vaccine/Placebo|Overall Study||156
7563375|NCT02935192|18616520|P1|Received Vaccine/Placebo|Overall Study||312
7563376|NCT02935192|18616519|P2|STARTED|Overall Study|156 subjects were included in the Full Protocol Analysis because 4 withdrew without getting product.|160
7563377|NCT02935192|18616520|P1|STARTED|Overall Study|312 subjects were included in the Full Protocol Analysis because 8 withdrew without getting product.|320
7563378|NCT02935179|18616544|P2|NOT COMPLETED|Overall Study||1
7563379|NCT02935179|18616545|P1|NOT COMPLETED|Overall Study||1
7563380|NCT02935179|18616544|P2|COMPLETED|Overall Study||29
7563381|NCT02935179|18616545|P1|COMPLETED|Overall Study||29
7563382|NCT02935179|18616544|P2|STARTED|Overall Study||30
7563383|NCT02935179|18616545|P1|STARTED|Overall Study||30
7563384|NCT02935088|18616553|P1|NOT COMPLETED|Overall Study||102
7563385|NCT02935088|18616553|P1|COMPLETED|Overall Study||2115
7563386|NCT02935088|18616553|P1|STARTED|Overall Study||2217
7563387|NCT02935062|18616568|P3|NOT COMPLETED|Overall Study||0
7563388|NCT02935062|18616569|P2|NOT COMPLETED|Overall Study||0
7563389|NCT02935062|18616570|P1|NOT COMPLETED|Overall Study||0
7563390|NCT02935062|18616568|P3|COMPLETED|Overall Study||8
7563391|NCT02935062|18616569|P2|COMPLETED|Overall Study||8
7563392|NCT02935062|18616570|P1|COMPLETED|Overall Study||8
7563393|NCT02935062|18616568|P3|STARTED|Overall Study||8
7563394|NCT02935062|18616569|P2|STARTED|Overall Study||8
7563395|NCT02935062|18616570|P1|STARTED|Overall Study||8
7563396|NCT02935036|18616583|P2|NOT COMPLETED|Overall Study||11
7563397|NCT02935036|18616584|P1|NOT COMPLETED|Overall Study||10
7563398|NCT02935036|18616583|P2|COMPLETED|Overall Study||136
7563399|NCT02935036|18616584|P1|COMPLETED|Overall Study||137
7563400|NCT02935036|18616583|P2|STARTED|Overall Study||147
7563401|NCT02935036|18616584|P1|STARTED|Overall Study||147
7563402|NCT02934932|18616594|P1|NOT COMPLETED|Overall Study||3
7563403|NCT02934932|18616594|P1|COMPLETED|Overall Study||6
7563404|NCT02934932|18616594|P1|STARTED|Overall Study||9
7563405|NCT02934698|18616603|P1|NOT COMPLETED|Overall Study||0
7563406|NCT02934698|18616603|P1|COMPLETED|Overall Study||2
7563407|NCT02934698|18616603|P1|STARTED|Overall Study||2
7563408|NCT02934347|18616611|P2|NOT COMPLETED|Overall Study||0
7563409|NCT02934347|18616612|P1|NOT COMPLETED|Overall Study||0
7563410|NCT02934347|18616611|P2|COMPLETED|Overall Study||407
7563411|NCT02934347|18616612|P1|COMPLETED|Overall Study||374
7563412|NCT02934347|18616611|P2|STARTED|Overall Study||407
7563413|NCT02934347|18616612|P1|STARTED|Overall Study||374
7563414|NCT02934191|18616626|P2|NOT COMPLETED|Overall Study||0
7563415|NCT02934191|18616627|P1|NOT COMPLETED|Overall Study||0
7563416|NCT02934191|18616626|P2|COMPLETED|Overall Study||85
7563417|NCT02934191|18616627|P1|COMPLETED|Overall Study||87
7563418|NCT02934191|18616626|P2|STARTED|Overall Study||85
7563419|NCT02934191|18616627|P1|STARTED|Overall Study||87
7563420|NCT02934178|18616637|P2|NOT COMPLETED|Received Vaccination 3||0
7563421|NCT02934178|18616638|P1|NOT COMPLETED|Received Vaccination 3||1
7563422|NCT02934178|18616637|P2|COMPLETED|Received Vaccination 3||3
7563423|NCT02934178|18616638|P1|COMPLETED|Received Vaccination 3||11
7563424|NCT02934178|18616637|P2|STARTED|Received Vaccination 3||3
7563425|NCT02934178|18616638|P1|STARTED|Received Vaccination 3||12
7563426|NCT02934178|18616637|P2|NOT COMPLETED|Received Vaccination 2||1
7563427|NCT02934178|18616638|P1|NOT COMPLETED|Received Vaccination 2||0
7563428|NCT02934178|18616637|P2|COMPLETED|Received Vaccination 2||3
7563429|NCT02934178|18616638|P1|COMPLETED|Received Vaccination 2||12
7563430|NCT02934178|18616637|P2|STARTED|Received Vaccination 2||4
7563431|NCT02934178|18616638|P1|STARTED|Received Vaccination 2||12
7563432|NCT02934178|18616637|P2|NOT COMPLETED|Received Vaccination 1||0
7563433|NCT02934178|18616638|P1|NOT COMPLETED|Received Vaccination 1||0
7563434|NCT02934178|18616637|P2|COMPLETED|Received Vaccination 1||4
7563435|NCT02934178|18616638|P1|COMPLETED|Received Vaccination 1||12
7563436|NCT02934178|18616637|P2|STARTED|Received Vaccination 1||4
7563437|NCT02934178|18616638|P1|STARTED|Received Vaccination 1||12
7563438|NCT02933879|18616733|P3|NOT COMPLETED|Overall Study||17
7563439|NCT02933879|18616734|P2|NOT COMPLETED|Overall Study||14
7563440|NCT02933879|18616735|P1|NOT COMPLETED|Overall Study||16
7563441|NCT02933879|18616733|P3|COMPLETED|Overall Study||41
7563442|NCT02933879|18616734|P2|COMPLETED|Overall Study||48
7563443|NCT02933879|18616735|P1|COMPLETED|Overall Study||48
7563444|NCT02933879|18616733|P3|STARTED|Overall Study||58
7563445|NCT02933879|18616734|P2|STARTED|Overall Study||62
7563446|NCT02933879|18616735|P1|STARTED|Overall Study||64
7563447|NCT02933866|18616771|P2|NOT COMPLETED|Overall Study||9
7563448|NCT02933866|18616772|P1|NOT COMPLETED|Overall Study||12
7563449|NCT02933866|18616771|P2|COMPLETED|Overall Study||176
7563450|NCT02933866|18616772|P1|COMPLETED|Overall Study||174
7563451|NCT02933866|18616771|P2|STARTED|Overall Study||185
7563452|NCT02933866|18616772|P1|STARTED|Overall Study||186
7563453|NCT02933528|18616778|P1|NOT COMPLETED|Overall Study||2
7563454|NCT02933528|18616778|P1|COMPLETED|Overall Study||22
7563455|NCT02933528|18616778|P1|STARTED|Overall Study||24
7563456|NCT02933502|18616782|P1|NOT COMPLETED|Overall Study||0
7563457|NCT02933502|18616782|P1|COMPLETED|Overall Study||3
7563458|NCT02933502|18616782|P1|STARTED|Overall Study||3
7563459|NCT02933476|18616786|P1|NOT COMPLETED|Overall Study||0
7563460|NCT02933476|18616786|P1|COMPLETED|Overall Study||5
7563461|NCT02933476|18616786|P1|STARTED|Overall Study||5
7563462|NCT02933450|18616795|P2|NOT COMPLETED|Overall Study||8
7563463|NCT02933450|18616796|P1|NOT COMPLETED|Overall Study||5
7563464|NCT02933450|18616795|P2|COMPLETED|Overall Study||15
7563465|NCT02933450|18616796|P1|COMPLETED|Overall Study||15
7563466|NCT02933450|18616795|P2|STARTED|Overall Study||23
7563467|NCT02933450|18616796|P1|STARTED|Overall Study||20
7563468|NCT02933060|18616806|P2|NOT COMPLETED|Overall Study||1
7563469|NCT02933060|18616807|P1|NOT COMPLETED|Overall Study||0
7563470|NCT02933060|18616806|P2|COMPLETED|Overall Study||24
7563471|NCT02933060|18616807|P1|COMPLETED|Overall Study||25
7563472|NCT02933060|18616806|P2|STARTED|Overall Study||25
7563473|NCT02933060|18616807|P1|STARTED|Overall Study||25
7563474|NCT02933034|18616831|P1|NOT COMPLETED|Overall Study||9
7563475|NCT02933034|18616831|P1|COMPLETED|Overall Study||24
7563476|NCT02933034|18616831|P1|Received Both MEMRI and DEMRI Scans|Overall Study||24
7563477|NCT02933034|18616831|P1|STARTED|Overall Study||33
7563478|NCT02932943|18616848|P2|NOT COMPLETED|Overall Study||7
7563479|NCT02932943|18616849|P1|NOT COMPLETED|Overall Study||5
7563480|NCT02932943|18616848|P2|COMPLETED|Overall Study||224
7563481|NCT02932943|18616849|P1|COMPLETED|Overall Study||222
7563482|NCT02932943|18616848|P2|STARTED|Overall Study||231
7563483|NCT02932943|18616849|P1|STARTED|Overall Study||227
7563484|NCT02932904|18616865|P4|NOT COMPLETED|Overall Study||14
7563485|NCT02932904|18616866|P3|NOT COMPLETED|Overall Study||23
7563486|NCT02932904|18616867|P2|NOT COMPLETED|Overall Study||18
7563487|NCT02932904|18616868|P1|NOT COMPLETED|Overall Study||16
7563488|NCT02932904|18616865|P4|COMPLETED|Overall Study||79
7563489|NCT02932904|18616866|P3|COMPLETED|Overall Study||68
7563490|NCT02932904|18616867|P2|COMPLETED|Overall Study||67
7563491|NCT02932904|18616868|P1|COMPLETED|Overall Study||76
7563492|NCT02932904|18616865|P4|Treated|Overall Study||91
7563493|NCT02932904|18616866|P3|Treated|Overall Study||91
7563494|NCT02932904|18616867|P2|Treated|Overall Study||84
7563495|NCT02932904|18616868|P1|Treated|Overall Study||91
7563496|NCT02932904|18616865|P4|STARTED|Overall Study||93
7563497|NCT02932904|18616866|P3|STARTED|Overall Study||91
7563498|NCT02932904|18616867|P2|STARTED|Overall Study||85
7563499|NCT02932904|18616868|P1|STARTED|Overall Study||92
7563500|NCT02932891|18616903|P1|NOT COMPLETED|Overall Study||4
7563501|NCT02932891|18616903|P1|COMPLETED|Overall Study||24
7563502|NCT02932891|18616903|P1|STARTED|Overall Study||28
7563503|NCT02932878|18616909|P2|NOT COMPLETED|Overall Study||1
7563504|NCT02932878|18616910|P1|NOT COMPLETED|Overall Study||2
7563505|NCT02932878|18616909|P2|COMPLETED|Overall Study||0
7563506|NCT02932878|18616910|P1|COMPLETED|Overall Study||13
7563507|NCT02932878|18616909|P2|STARTED|Overall Study||1
7563508|NCT02932878|18616910|P1|STARTED|Overall Study||15
7563509|NCT02932787|18616918|P2|NOT COMPLETED|Overall Study||0
7563510|NCT02932787|18616919|P1|NOT COMPLETED|Overall Study||0
7563511|NCT02932787|18616918|P2|COMPLETED|Overall Study||9
7563512|NCT02932787|18616919|P1|COMPLETED|Overall Study||22
7563513|NCT02932787|18616918|P2|STARTED|Overall Study||9
7563514|NCT02932787|18616919|P1|STARTED|Overall Study||22
7563515|NCT02932462|18616931|P2|NOT COMPLETED|Overall Study||13
7563516|NCT02932462|18616932|P1|NOT COMPLETED|Overall Study||7
7563517|NCT02932462|18616931|P2|COMPLETED|Overall Study||176
7563518|NCT02932462|18616932|P1|COMPLETED|Overall Study||177
7563519|NCT02932462|18616931|P2|STARTED|Overall Study||189
7563520|NCT02932462|18616932|P1|STARTED|Overall Study||184
7563521|NCT02932306|18616944|P2|NOT COMPLETED|Overall Study||77
7563522|NCT02932306|18616945|P1|NOT COMPLETED|Overall Study||68
7563523|NCT02932306|18616944|P2|COMPLETED|Overall Study||337
7563524|NCT02932306|18616945|P1|COMPLETED|Overall Study||338
7563525|NCT02932306|18616944|P2|Safety Population|Overall Study||385
7563526|NCT02932306|18616945|P1|Safety Population|Overall Study||378
7563527|NCT02932306|18616944|P2|Intent-to-treat (ITT) Population|Overall Study||414
7563528|NCT02932306|18616945|P1|Intent-to-treat (ITT) Population|Overall Study||406
7563529|NCT02932306|18616944|P2|STARTED|Overall Study||414
7563530|NCT02932306|18616945|P1|STARTED|Overall Study||406
7563531|NCT02932267|18616959|P1|NOT COMPLETED|Overall Study||8
7563532|NCT02932267|18616959|P1|COMPLETED|Overall Study||42
7563533|NCT02932267|18616959|P1|STARTED|Overall Study||50
7563534|NCT02932228|18616965|P2|NOT COMPLETED|Overall Study||28
7563535|NCT02932228|18616966|P1|NOT COMPLETED|Overall Study||10
7563536|NCT02932228|18616965|P2|COMPLETED|Overall Study||405
7563537|NCT02932228|18616966|P1|COMPLETED|Overall Study||140
7563538|NCT02932228|18616965|P2|STARTED|Overall Study||433
7563539|NCT02932228|18616966|P1|STARTED|Overall Study||150
7563540|NCT02931838|18616991|P6|NOT COMPLETED|Overall Study||2
7563541|NCT02931838|18616992|P5|NOT COMPLETED|Overall Study||6
7563542|NCT02931838|18616993|P4|NOT COMPLETED|Overall Study||3
7563543|NCT02931838|18616994|P3|NOT COMPLETED|Overall Study||8
7563544|NCT02931838|18616995|P2|NOT COMPLETED|Overall Study||10
7563545|NCT02931838|18616996|P1|NOT COMPLETED|Overall Study||14
7563546|NCT02931838|18616991|P6|COMPLETED|Overall Study||42
7563547|NCT02931838|18616992|P5|COMPLETED|Overall Study||39
7563548|NCT02931838|18616993|P4|COMPLETED|Overall Study||42
7563549|NCT02931838|18616994|P3|COMPLETED|Overall Study||36
7563550|NCT02931838|18616995|P2|COMPLETED|Overall Study||34
7563551|NCT02931838|18616996|P1|COMPLETED|Overall Study||31
7563552|NCT02931838|18616991|P6|STARTED|Overall Study||44
7563553|NCT02931838|18616992|P5|STARTED|Overall Study||45
7563554|NCT02931838|18616993|P4|STARTED|Overall Study||45
7563555|NCT02931838|18616994|P3|STARTED|Overall Study||44
7563556|NCT02931838|18616995|P2|STARTED|Overall Study||44
7563557|NCT02931838|18616996|P1|STARTED|Overall Study||45
7563558|NCT02931396|18617047|P2|NOT COMPLETED|Overall Study||0
7563559|NCT02931396|18617048|P1|NOT COMPLETED|Overall Study||5
7563560|NCT02931396|18617047|P2|COMPLETED|Overall Study||10
7563561|NCT02931396|18617048|P1|COMPLETED|Overall Study||5
7563562|NCT02931396|18617047|P2|STARTED|Overall Study||10
7563563|NCT02931396|18617048|P1|STARTED|Overall Study||10
7563564|NCT02931253|18617060|P2|NOT COMPLETED|Overall Study||0
7563565|NCT02931253|18617061|P1|NOT COMPLETED|Overall Study||0
7563566|NCT02931253|18617060|P2|COMPLETED|Overall Study||4
7563567|NCT02931253|18617061|P1|COMPLETED|Overall Study||2
7563568|NCT02931253|18617060|P2|STARTED|Overall Study||4
7563569|NCT02931253|18617061|P1|STARTED|Overall Study||2
7563570|NCT02931045|18617083|P2|NOT COMPLETED|Overall Study||2
7563571|NCT02931045|18617084|P1|NOT COMPLETED|Overall Study||3
7563572|NCT02931045|18617083|P2|COMPLETED|Overall Study||28
7563573|NCT02931045|18617084|P1|COMPLETED|Overall Study||27
7563574|NCT02931045|18617083|P2|STARTED|Overall Study||30
7563575|NCT02931045|18617084|P1|STARTED|Overall Study||30
7563576|NCT02930980|18617090|P1|NOT COMPLETED|Overall Study||0
7563577|NCT02930980|18617090|P1|COMPLETED|Overall Study||43
7563578|NCT02930980|18617090|P1|STARTED|Overall Study||43
7563579|NCT02930837|18617094|P1|NOT COMPLETED|Overall Study||12
7563580|NCT02930837|18617094|P1|COMPLETED|Overall Study|Completed the trial|108
7563581|NCT02930837|18617094|P1|STARTED|Overall Study|Started are treated patients|120
7563582|NCT02930590|18617104|P6|NOT COMPLETED|Third Intervention (2 Hours)||0
7563583|NCT02930590|18617105|P5|NOT COMPLETED|Third Intervention (2 Hours)||0
7563584|NCT02930590|18617106|P4|NOT COMPLETED|Third Intervention (2 Hours)||0
7563585|NCT02930590|18617107|P3|NOT COMPLETED|Third Intervention (2 Hours)||0
7563586|NCT02930590|18617108|P2|NOT COMPLETED|Third Intervention (2 Hours)||0
7563587|NCT02930590|18617109|P1|NOT COMPLETED|Third Intervention (2 Hours)||0
7563588|NCT02930590|18617104|P6|COMPLETED|Third Intervention (2 Hours)||2
7563589|NCT02930590|18617105|P5|COMPLETED|Third Intervention (2 Hours)||2
7563590|NCT02930590|18617106|P4|COMPLETED|Third Intervention (2 Hours)||2
7563591|NCT02930590|18617107|P3|COMPLETED|Third Intervention (2 Hours)||3
7563592|NCT02930590|18617108|P2|COMPLETED|Third Intervention (2 Hours)||3
7563593|NCT02930590|18617109|P1|COMPLETED|Third Intervention (2 Hours)||3
7563594|NCT02930590|18617104|P6|STARTED|Third Intervention (2 Hours)||2
7563595|NCT02930590|18617105|P5|STARTED|Third Intervention (2 Hours)||2
7563596|NCT02930590|18617106|P4|STARTED|Third Intervention (2 Hours)||2
7563597|NCT02930590|18617107|P3|STARTED|Third Intervention (2 Hours)||3
7563598|NCT02930590|18617108|P2|STARTED|Third Intervention (2 Hours)||3
7563599|NCT02930590|18617109|P1|STARTED|Third Intervention (2 Hours)||3
7563600|NCT02930590|18617104|P6|NOT COMPLETED|Second Intervention (2 Hours)||0
7563601|NCT02930590|18617105|P5|NOT COMPLETED|Second Intervention (2 Hours)||0
7563602|NCT02930590|18617106|P4|NOT COMPLETED|Second Intervention (2 Hours)||0
7563603|NCT02930590|18617107|P3|NOT COMPLETED|Second Intervention (2 Hours)||0
7563604|NCT02930590|18617108|P2|NOT COMPLETED|Second Intervention (2 Hours)||0
7563605|NCT02930590|18617109|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
7563606|NCT02930590|18617104|P6|COMPLETED|Second Intervention (2 Hours)||2
7563607|NCT02930590|18617105|P5|COMPLETED|Second Intervention (2 Hours)||2
7563608|NCT02930590|18617106|P4|COMPLETED|Second Intervention (2 Hours)||2
7563609|NCT02930590|18617107|P3|COMPLETED|Second Intervention (2 Hours)||3
7563610|NCT02930590|18617108|P2|COMPLETED|Second Intervention (2 Hours)||3
7563611|NCT02930590|18617109|P1|COMPLETED|Second Intervention (2 Hours)||3
7563612|NCT02930590|18617104|P6|STARTED|Second Intervention (2 Hours)||2
7563613|NCT02930590|18617105|P5|STARTED|Second Intervention (2 Hours)||2
7563614|NCT02930590|18617106|P4|STARTED|Second Intervention (2 Hours)||2
7563615|NCT02930590|18617107|P3|STARTED|Second Intervention (2 Hours)||3
7563616|NCT02930590|18617108|P2|STARTED|Second Intervention (2 Hours)||3
7563617|NCT02930590|18617109|P1|STARTED|Second Intervention (2 Hours)||3
7563618|NCT02930590|18617104|P6|NOT COMPLETED|First Intervention (2 Hours)||0
7563619|NCT02930590|18617105|P5|NOT COMPLETED|First Intervention (2 Hours)||0
7563620|NCT02930590|18617106|P4|NOT COMPLETED|First Intervention (2 Hours)||0
7563621|NCT02930590|18617107|P3|NOT COMPLETED|First Intervention (2 Hours)||0
7563622|NCT02930590|18617108|P2|NOT COMPLETED|First Intervention (2 Hours)||0
7563623|NCT02930590|18617109|P1|NOT COMPLETED|First Intervention (2 Hours)||0
7563624|NCT02930590|18617104|P6|COMPLETED|First Intervention (2 Hours)||2
7563625|NCT02930590|18617105|P5|COMPLETED|First Intervention (2 Hours)||2
7563626|NCT02930590|18617106|P4|COMPLETED|First Intervention (2 Hours)||2
7563627|NCT02930590|18617107|P3|COMPLETED|First Intervention (2 Hours)||3
7563628|NCT02930590|18617108|P2|COMPLETED|First Intervention (2 Hours)||3
7563629|NCT02930590|18617109|P1|COMPLETED|First Intervention (2 Hours)||3
7563630|NCT02930590|18617104|P6|STARTED|First Intervention (2 Hours)||2
7563631|NCT02930590|18617105|P5|STARTED|First Intervention (2 Hours)||2
7563632|NCT02930590|18617106|P4|STARTED|First Intervention (2 Hours)||2
7563633|NCT02930590|18617107|P3|STARTED|First Intervention (2 Hours)||3
7563634|NCT02930590|18617108|P2|STARTED|First Intervention (2 Hours)||3
7563635|NCT02930590|18617109|P1|STARTED|First Intervention (2 Hours)||3
7563636|NCT02930226|18617390|P6|NOT COMPLETED|Overall Study||0
7563637|NCT02930226|18617391|P5|NOT COMPLETED|Overall Study||1
7563638|NCT02930226|18617392|P4|NOT COMPLETED|Overall Study||0
7563639|NCT02930226|18617393|P3|NOT COMPLETED|Overall Study||0
7563640|NCT02930226|18617394|P2|NOT COMPLETED|Overall Study||0
7563641|NCT02930226|18617395|P1|NOT COMPLETED|Overall Study||0
7563642|NCT02930226|18617390|P6|COMPLETED|Overall Study||4
7563643|NCT02930226|18617391|P5|COMPLETED|Overall Study||3
7563644|NCT02930226|18617392|P4|COMPLETED|Overall Study||4
7563645|NCT02930226|18617393|P3|COMPLETED|Overall Study||4
7563646|NCT02930226|18617394|P2|COMPLETED|Overall Study||4
7563647|NCT02930226|18617395|P1|COMPLETED|Overall Study||4
7563648|NCT02930226|18617390|P6|STARTED|Overall Study||4
7563649|NCT02930226|18617391|P5|STARTED|Overall Study||4
7563650|NCT02930226|18617392|P4|STARTED|Overall Study||4
7563651|NCT02930226|18617393|P3|STARTED|Overall Study||4
7563652|NCT02930226|18617394|P2|STARTED|Overall Study||4
7563653|NCT02930226|18617395|P1|STARTED|Overall Study||4
7563654|NCT02930174|18617431|P2|NOT COMPLETED|Overall Study||0
7563655|NCT02930174|18617432|P1|NOT COMPLETED|Overall Study||0
7563656|NCT02930174|18617431|P2|COMPLETED|Overall Study||8
7563657|NCT02930174|18617432|P1|COMPLETED|Overall Study||12
7563658|NCT02930174|18617431|P2|STARTED|Overall Study||8
7563659|NCT02930174|18617432|P1|STARTED|Overall Study||12
7563660|NCT02930018|18617449|P2|NOT COMPLETED|Overall Study||3
7563661|NCT02930018|18617450|P1|NOT COMPLETED|Overall Study||6
7563662|NCT02930018|18617449|P2|COMPLETED|Overall Study||546
7563663|NCT02930018|18617450|P1|COMPLETED|Overall Study||550
7563664|NCT02930018|18617449|P2|STARTED|Overall Study||549
7563665|NCT02930018|18617450|P1|STARTED|Overall Study||556
7563666|NCT02930005|18617474|P2|NOT COMPLETED|Overall Study||5
7563667|NCT02930005|18617475|P1|NOT COMPLETED|Overall Study||1
7563668|NCT02930005|18617474|P2|COMPLETED|Overall Study||1
7563669|NCT02930005|18617475|P1|COMPLETED|Overall Study||1
7563670|NCT02930005|18617474|P2|Completed 2 Weeks|Overall Study||2
7563671|NCT02930005|18617475|P1|Completed 2 Weeks|Overall Study||2
7563672|NCT02930005|18617474|P2|STARTED|Overall Study||6
7563673|NCT02930005|18617475|P1|STARTED|Overall Study||2
7563674|NCT02929823|18617486|P3|NOT COMPLETED|Overall Study||4
7563675|NCT02929823|18617487|P2|NOT COMPLETED|Overall Study||6
7563676|NCT02929823|18617488|P1|NOT COMPLETED|Overall Study||3
7563677|NCT02929823|18617486|P3|COMPLETED|Overall Study||38
7563678|NCT02929823|18617487|P2|COMPLETED|Overall Study||40
7563679|NCT02929823|18617488|P1|COMPLETED|Overall Study||39
7563680|NCT02929823|18617486|P3|STARTED|Overall Study||42
7563681|NCT02929823|18617487|P2|STARTED|Overall Study||46
7563682|NCT02929823|18617488|P1|STARTED|Overall Study||42
7563683|NCT02929667|18617498|P2|NOT COMPLETED|Overall Study||0
7563684|NCT02929667|18617499|P1|NOT COMPLETED|Overall Study||0
7563685|NCT02929667|18617498|P2|COMPLETED|Overall Study||11
7563686|NCT02929667|18617499|P1|COMPLETED|Overall Study||11
7563687|NCT02929667|18617498|P2|STARTED|Overall Study||11
7563688|NCT02929667|18617499|P1|STARTED|Overall Study||11
7563689|NCT02929498|18617515|P3|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
7563690|NCT02929498|18617516|P2|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
7563691|NCT02929498|18617517|P1|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
7563692|NCT02929498|18617515|P3|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
7563693|NCT02929498|18617516|P2|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
7563694|NCT02929498|18617517|P1|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
7563695|NCT02929498|18617515|P3|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
7563696|NCT02929498|18617516|P2|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
7563697|NCT02929498|18617517|P1|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
7563698|NCT02929498|18617515|P3|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
7563699|NCT02929498|18617516|P2|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
7563700|NCT02929498|18617517|P1|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||5
7563701|NCT02929498|18617515|P3|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
7563702|NCT02929498|18617516|P2|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
7563703|NCT02929498|18617517|P1|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
7563704|NCT02929498|18617515|P3|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
7563705|NCT02929498|18617516|P2|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
7563706|NCT02929498|18617517|P1|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||5
7563707|NCT02929407|18617611|P1|NOT COMPLETED|Overall Study||1
7563708|NCT02929407|18617611|P1|COMPLETED|Overall Study||3
7563709|NCT02929407|18617611|P1|STARTED|Overall Study||4
7563710|NCT02928770|18617626|P1|NOT COMPLETED|Overall Study||2
7563711|NCT02928770|18617626|P1|COMPLETED|Overall Study||30
7563712|NCT02928770|18617626|P1|STARTED|Overall Study||32
7563713|NCT02928536|18617630|P1|NOT COMPLETED|Overall Study||0
7563714|NCT02928536|18617630|P1|COMPLETED|Overall Study||11902
7563715|NCT02928536|18617630|P1|STARTED|Overall Study||11902
7563716|NCT02928380|18617637|P6|NOT COMPLETED|Period 3||0
7563717|NCT02928380|18617638|P5|NOT COMPLETED|Period 3||0
7563718|NCT02928380|18617639|P4|NOT COMPLETED|Period 3||0
7563719|NCT02928380|18617640|P3|NOT COMPLETED|Period 3||0
7563720|NCT02928380|18617641|P2|NOT COMPLETED|Period 3||0
7563721|NCT02928380|18617642|P1|NOT COMPLETED|Period 3||0
7563722|NCT02928380|18617637|P6|COMPLETED|Period 3||14
7563723|NCT02928380|18617638|P5|COMPLETED|Period 3||14
7563724|NCT02928380|18617639|P4|COMPLETED|Period 3||14
7563725|NCT02928380|18617640|P3|COMPLETED|Period 3||14
7563726|NCT02928380|18617641|P2|COMPLETED|Period 3||14
7563727|NCT02928380|18617642|P1|COMPLETED|Period 3||13
7563728|NCT02928380|18617637|P6|STARTED|Period 3||14
7563729|NCT02928380|18617638|P5|STARTED|Period 3||14
7563730|NCT02928380|18617639|P4|STARTED|Period 3||14
7563731|NCT02928380|18617640|P3|STARTED|Period 3||14
7563732|NCT02928380|18617641|P2|STARTED|Period 3||14
7563733|NCT02928380|18617642|P1|STARTED|Period 3||13
7563734|NCT02928380|18617637|P6|NOT COMPLETED|Wash Out Period 2||0
7563735|NCT02928380|18617638|P5|NOT COMPLETED|Wash Out Period 2||0
7563736|NCT02928380|18617639|P4|NOT COMPLETED|Wash Out Period 2||0
7563737|NCT02928380|18617640|P3|NOT COMPLETED|Wash Out Period 2||0
7563738|NCT02928380|18617641|P2|NOT COMPLETED|Wash Out Period 2||0
7563739|NCT02928380|18617642|P1|NOT COMPLETED|Wash Out Period 2||0
7563740|NCT02928380|18617637|P6|COMPLETED|Wash Out Period 2||14
7563741|NCT02928380|18617638|P5|COMPLETED|Wash Out Period 2||14
7563742|NCT02928380|18617639|P4|COMPLETED|Wash Out Period 2||14
7563743|NCT02928380|18617640|P3|COMPLETED|Wash Out Period 2||14
7563744|NCT02928380|18617641|P2|COMPLETED|Wash Out Period 2||14
7563745|NCT02928380|18617642|P1|COMPLETED|Wash Out Period 2||13
7563746|NCT02928380|18617637|P6|STARTED|Wash Out Period 2||14
7563747|NCT02928380|18617638|P5|STARTED|Wash Out Period 2||14
7563748|NCT02928380|18617639|P4|STARTED|Wash Out Period 2||14
7563749|NCT02928380|18617640|P3|STARTED|Wash Out Period 2||14
7563750|NCT02928380|18617641|P2|STARTED|Wash Out Period 2||14
7563751|NCT02928380|18617642|P1|STARTED|Wash Out Period 2||13
7563752|NCT02928380|18617637|P6|NOT COMPLETED|Period 2||0
7563753|NCT02928380|18617638|P5|NOT COMPLETED|Period 2||0
7563754|NCT02928380|18617639|P4|NOT COMPLETED|Period 2||0
7563755|NCT02928380|18617640|P3|NOT COMPLETED|Period 2||0
7563756|NCT02928380|18617641|P2|NOT COMPLETED|Period 2||0
7563757|NCT02928380|18617642|P1|NOT COMPLETED|Period 2||0
7563758|NCT02928380|18617637|P6|COMPLETED|Period 2||14
7563759|NCT02928380|18617638|P5|COMPLETED|Period 2||14
7563760|NCT02928380|18617639|P4|COMPLETED|Period 2||14
7563761|NCT02928380|18617640|P3|COMPLETED|Period 2||14
7563762|NCT02928380|18617641|P2|COMPLETED|Period 2||14
7563763|NCT02928380|18617642|P1|COMPLETED|Period 2||13
7563764|NCT02928380|18617637|P6|STARTED|Period 2||14
7563765|NCT02928380|18617638|P5|STARTED|Period 2||14
7563766|NCT02928380|18617639|P4|STARTED|Period 2||14
7563767|NCT02928380|18617640|P3|STARTED|Period 2||14
7563768|NCT02928380|18617641|P2|STARTED|Period 2||14
7563769|NCT02928380|18617642|P1|STARTED|Period 2||13
7563770|NCT02928380|18617637|P6|NOT COMPLETED|Wash Out Period 1||0
7563771|NCT02928380|18617638|P5|NOT COMPLETED|Wash Out Period 1||0
7563772|NCT02928380|18617639|P4|NOT COMPLETED|Wash Out Period 1||0
7563773|NCT02928380|18617640|P3|NOT COMPLETED|Wash Out Period 1||0
7563774|NCT02928380|18617641|P2|NOT COMPLETED|Wash Out Period 1||0
7563775|NCT02928380|18617642|P1|NOT COMPLETED|Wash Out Period 1||0
7563776|NCT02928380|18617637|P6|COMPLETED|Wash Out Period 1||14
7563777|NCT02928380|18617638|P5|COMPLETED|Wash Out Period 1||14
7563778|NCT02928380|18617639|P4|COMPLETED|Wash Out Period 1||14
7563779|NCT02928380|18617640|P3|COMPLETED|Wash Out Period 1||14
7563780|NCT02928380|18617641|P2|COMPLETED|Wash Out Period 1||14
7563781|NCT02928380|18617642|P1|COMPLETED|Wash Out Period 1||13
7563782|NCT02928380|18617637|P6|STARTED|Wash Out Period 1||14
7563783|NCT02928380|18617638|P5|STARTED|Wash Out Period 1||14
7563784|NCT02928380|18617639|P4|STARTED|Wash Out Period 1||14
7563785|NCT02928380|18617640|P3|STARTED|Wash Out Period 1||14
7563786|NCT02928380|18617641|P2|STARTED|Wash Out Period 1||14
7563787|NCT02928380|18617642|P1|STARTED|Wash Out Period 1||13
7563788|NCT02928380|18617637|P6|NOT COMPLETED|Period 1||0
7563789|NCT02928380|18617638|P5|NOT COMPLETED|Period 1||0
7563790|NCT02928380|18617639|P4|NOT COMPLETED|Period 1||0
7563791|NCT02928380|18617640|P3|NOT COMPLETED|Period 1||0
7563792|NCT02928380|18617641|P2|NOT COMPLETED|Period 1||0
7563793|NCT02928380|18617642|P1|NOT COMPLETED|Period 1||0
7563794|NCT02928380|18617637|P6|COMPLETED|Period 1||14
7563795|NCT02928380|18617638|P5|COMPLETED|Period 1||14
7563796|NCT02928380|18617639|P4|COMPLETED|Period 1||14
7563797|NCT02928380|18617640|P3|COMPLETED|Period 1||14
7563798|NCT02928380|18617641|P2|COMPLETED|Period 1||14
7563799|NCT02928380|18617642|P1|COMPLETED|Period 1||13
7563800|NCT02928380|18617637|P6|STARTED|Period 1||14
7563801|NCT02928380|18617638|P5|STARTED|Period 1||14
7563802|NCT02928380|18617639|P4|STARTED|Period 1||14
7563803|NCT02928380|18617640|P3|STARTED|Period 1||14
7563804|NCT02928380|18617641|P2|STARTED|Period 1||14
7563805|NCT02928380|18617642|P1|STARTED|Period 1||13
7563806|NCT02928224|18617666|P4|NOT COMPLETED|Overall Study||221
7563807|NCT02928224|18617667|P3|NOT COMPLETED|Overall Study||220
7563808|NCT02928224|18617668|P2|NOT COMPLETED|Overall Study||224
7563809|NCT02928224|18617669|P1|NOT COMPLETED|Overall Study||37
7563810|NCT02928224|18617666|P4|COMPLETED|Overall Study||0
7563811|NCT02928224|18617667|P3|COMPLETED|Overall Study||0
7563812|NCT02928224|18617668|P2|COMPLETED|Overall Study||0
7563813|NCT02928224|18617669|P1|COMPLETED|Overall Study||0
7563814|NCT02928224|18617666|P4|STARTED|Overall Study||221
7563815|NCT02928224|18617667|P3|STARTED|Overall Study||220
7563816|NCT02928224|18617668|P2|STARTED|Overall Study||224
7563817|NCT02928224|18617669|P1|STARTED|Overall Study||37
7563818|NCT02928029|18617773|P2|NOT COMPLETED|Overall Study||4
7563819|NCT02928029|18617774|P1|NOT COMPLETED|Overall Study||3
7563820|NCT02928029|18617773|P2|COMPLETED|Overall Study||0
7563821|NCT02928029|18617774|P1|COMPLETED|Overall Study||0
7563822|NCT02928029|18617773|P2|STARTED|Overall Study||4
7563823|NCT02928029|18617774|P1|STARTED|Overall Study||3
7563824|NCT02927938|18617788|P4|NOT COMPLETED|Overall Study||7
7563825|NCT02927938|18617789|P3|NOT COMPLETED|Overall Study||4
7563826|NCT02927938|18617790|P2|NOT COMPLETED|Overall Study||6
7563827|NCT02927938|18617791|P1|NOT COMPLETED|Overall Study||1
7563828|NCT02927938|18617788|P4|COMPLETED|Overall Study||0
7563829|NCT02927938|18617789|P3|COMPLETED|Overall Study||0
7563830|NCT02927938|18617790|P2|COMPLETED|Overall Study||0
7563831|NCT02927938|18617791|P1|COMPLETED|Overall Study||0
7563832|NCT02927938|18617788|P4|STARTED|Overall Study||7
7563833|NCT02927938|18617789|P3|STARTED|Overall Study||4
7563834|NCT02927938|18617790|P2|STARTED|Overall Study||6
7563835|NCT02927938|18617791|P1|STARTED|Overall Study||1
7563836|NCT02927834|18617802|P3|NOT COMPLETED|Overall Study||2
7563837|NCT02927834|18617803|P2|NOT COMPLETED|Overall Study||2
7563838|NCT02927834|18617804|P1|NOT COMPLETED|Overall Study||1
7563839|NCT02927834|18617802|P3|COMPLETED|Overall Study||6
7563840|NCT02927834|18617803|P2|COMPLETED|Overall Study||6
7563841|NCT02927834|18617804|P1|COMPLETED|Overall Study||7
7563842|NCT02927834|18617802|P3|STARTED|Overall Study||8
7563843|NCT02927834|18617803|P2|STARTED|Overall Study||8
7563844|NCT02927834|18617804|P1|STARTED|Overall Study||8
7563845|NCT02927795|18617818|P1|NOT COMPLETED|Overall Study||23
7563846|NCT02927795|18617818|P1|COMPLETED|Overall Study||234
7563847|NCT02927795|18617818|P1|Treated|Overall Study||253
7563848|NCT02927795|18617818|P1|STARTED|Overall Study||257
7563849|NCT02927639|18617829|P2|NOT COMPLETED|Overall Study||69
7563850|NCT02927639|18617830|P1|NOT COMPLETED|Overall Study||73
7563851|NCT02927639|18617829|P2|COMPLETED|Overall Study||13
7563852|NCT02927639|18617830|P1|COMPLETED|Overall Study||10
7563853|NCT02927639|18617829|P2|STARTED|Overall Study|1 subj was inadvertently enrolled in another interventional study just before enrolling so removed.|82
7563854|NCT02927639|18617830|P1|STARTED|Overall Study||83
7563855|NCT02927457|18617838|P2|NOT COMPLETED|Overall Study||0
7563856|NCT02927457|18617839|P1|NOT COMPLETED|Overall Study||0
7563857|NCT02927457|18617838|P2|COMPLETED|Overall Study||11
7563858|NCT02927457|18617839|P1|COMPLETED|Overall Study||0
7563859|NCT02927457|18617838|P2|STARTED|Overall Study||11
7563860|NCT02927457|18617839|P1|STARTED|Overall Study||0
7563861|NCT02927431|18617874|P3|NOT COMPLETED|Overall Study||1
7563862|NCT02927431|18617875|P2|NOT COMPLETED|Overall Study||0
7563863|NCT02927431|18617876|P1|NOT COMPLETED|Overall Study||0
7563864|NCT02927431|18617874|P3|COMPLETED|Overall Study||3
7563865|NCT02927431|18617875|P2|COMPLETED|Overall Study||4
7563866|NCT02927431|18617876|P1|COMPLETED|Overall Study||2
7563867|NCT02927431|18617874|P3|STARTED|Overall Study||4
7563868|NCT02927431|18617875|P2|STARTED|Overall Study||4
7563869|NCT02927431|18617876|P1|STARTED|Overall Study||2
7563870|NCT02927366|18617954|P2|NOT COMPLETED|Overall Study||0
7563871|NCT02927366|18617955|P1|NOT COMPLETED|Overall Study||2
7563872|NCT02927366|18617954|P2|COMPLETED|Overall Study||2
7563873|NCT02927366|18617955|P1|COMPLETED|Overall Study||4
7563874|NCT02927366|18617954|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||0
7563875|NCT02927366|18617955|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||4
7563876|NCT02927366|18617954|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||2
7563877|NCT02927366|18617955|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||6
7563878|NCT02927366|18617954|P2|STARTED|Overall Study||2
7563879|NCT02927366|18617955|P1|STARTED|Overall Study||6
7563880|NCT02927327|18617989|P2|NOT COMPLETED|Overall Study||0
7563881|NCT02927327|18617990|P1|NOT COMPLETED|Overall Study||0
7563882|NCT02927327|18617989|P2|COMPLETED|Overall Study||31
7563883|NCT02927327|18617990|P1|COMPLETED|Overall Study||30
7563884|NCT02927327|18617989|P2|STARTED|Overall Study||31
7563885|NCT02927327|18617990|P1|STARTED|Overall Study||30
7563886|NCT02927223|18618002|P1|NOT COMPLETED|Overall Study||0
7563887|NCT02927223|18618002|P1|COMPLETED|Overall Study||6
7563888|NCT02927223|18618002|P1|STARTED|Overall Study||6
7563889|NCT02927171|18618010|P2|NOT COMPLETED|Overall Study||1
7563890|NCT02927171|18618011|P1|NOT COMPLETED|Overall Study||0
7563891|NCT02927171|18618010|P2|COMPLETED|Overall Study||50
7563892|NCT02927171|18618011|P1|COMPLETED|Overall Study||53
7563893|NCT02927171|18618010|P2|STARTED|Overall Study||51
7563894|NCT02927171|18618011|P1|STARTED|Overall Study||53
7563895|NCT02926833|18618025|P4|NOT COMPLETED|Overall Study||23
7563896|NCT02926833|18618026|P3|NOT COMPLETED|Overall Study||7
7563897|NCT02926833|18618027|P2|NOT COMPLETED|Overall Study||4
7563898|NCT02926833|18618028|P1|NOT COMPLETED|Overall Study||3
7563899|NCT02926833|18618025|P4|COMPLETED|Overall Study||0
7563900|NCT02926833|18618026|P3|COMPLETED|Overall Study||0
7563901|NCT02926833|18618027|P2|COMPLETED|Overall Study||0
7563902|NCT02926833|18618028|P1|COMPLETED|Overall Study||0
7563903|NCT02926833|18618025|P4|STARTED|Overall Study||23
7563904|NCT02926833|18618026|P3|STARTED|Overall Study||7
7563905|NCT02926833|18618027|P2|STARTED|Overall Study||4
7563906|NCT02926833|18618028|P1|STARTED|Overall Study||3
7563907|NCT02926638|18618084|P2|NOT COMPLETED|Overall Study||5
7563908|NCT02926638|18618085|P1|NOT COMPLETED|Overall Study||4
7563909|NCT02926638|18618084|P2|COMPLETED|Overall Study||0
7563910|NCT02926638|18618085|P1|COMPLETED|Overall Study||0
7563911|NCT02926638|18618084|P2|Eligible|Overall Study||5
7563912|NCT02926638|18618085|P1|Eligible|Overall Study||3
7563913|NCT02926638|18618084|P2|STARTED|Overall Study||5
7563914|NCT02926638|18618085|P1|STARTED|Overall Study||4
7563915|NCT02926573|18618099|P2|NOT COMPLETED|Overall Study||9
7563916|NCT02926573|18618100|P1|NOT COMPLETED|Overall Study||11
7563917|NCT02926573|18618099|P2|COMPLETED|Overall Study||46
7563918|NCT02926573|18618100|P1|COMPLETED|Overall Study||44
7563919|NCT02926573|18618099|P2|STARTED|Overall Study||55
7563920|NCT02926573|18618100|P1|STARTED|Overall Study||55
7563921|NCT02926209|18618118|P2|NOT COMPLETED|Training Cohort - First Patients||0
7563922|NCT02926209|18618119|P1|NOT COMPLETED|Training Cohort - First Patients||0
7563923|NCT02926209|18618118|P2|COMPLETED|Training Cohort - First Patients||0
7563924|NCT02926209|18618119|P1|COMPLETED|Training Cohort - First Patients||20
7563925|NCT02926209|18618118|P2|STARTED|Training Cohort - First Patients||0
7563926|NCT02926209|18618119|P1|STARTED|Training Cohort - First Patients||20
7563927|NCT02926209|18618118|P2|NOT COMPLETED|Study Cohort||0
7563928|NCT02926209|18618119|P1|NOT COMPLETED|Study Cohort||1
7563929|NCT02926209|18618118|P2|COMPLETED|Study Cohort||37
7563930|NCT02926209|18618119|P1|COMPLETED|Study Cohort||41
7563931|NCT02926209|18618118|P2|STARTED|Study Cohort||37
7563932|NCT02926209|18618119|P1|STARTED|Study Cohort|Training cohort patients Aer-O-Scope as first followed by a conventional colonoscopy|42
7563933|NCT02925923|18618132|P2|NOT COMPLETED|Overall Study||2
7563934|NCT02925923|18618133|P1|NOT COMPLETED|Overall Study||0
7563935|NCT02925923|18618132|P2|COMPLETED|Overall Study||48
7563936|NCT02925923|18618133|P1|COMPLETED|Overall Study||50
7563937|NCT02925923|18618132|P2|STARTED|Overall Study||50
7563938|NCT02925923|18618133|P1|STARTED|Overall Study||50
7563939|NCT02925858|18618163|P2|NOT COMPLETED|Overall Study||0
7563940|NCT02925858|18618164|P1|NOT COMPLETED|Overall Study||0
7563941|NCT02925858|18618163|P2|COMPLETED|Overall Study||38
7563942|NCT02925858|18618164|P1|COMPLETED|Overall Study||42
7563943|NCT02925858|18618163|P2|STARTED|Overall Study||38
7563944|NCT02925858|18618164|P1|STARTED|Overall Study||42
7563945|NCT02925741|18618190|P2|NOT COMPLETED|Overall Study||0
7563946|NCT02925741|18618191|P1|NOT COMPLETED|Overall Study||11
7563947|NCT02925741|18618190|P2|COMPLETED|Overall Study||1706
7563948|NCT02925741|18618191|P1|COMPLETED|Overall Study||1626
7563949|NCT02925741|18618190|P2|STARTED|Overall Study||1706
7563950|NCT02925741|18618191|P1|STARTED|Overall Study||1637
7563951|NCT02925611|18618203|P2|NOT COMPLETED|Overall Study||0
7563952|NCT02925611|18618204|P1|NOT COMPLETED|Overall Study||0
7563953|NCT02925611|18618203|P2|COMPLETED|Overall Study||30
7563954|NCT02925611|18618204|P1|COMPLETED|Overall Study||30
7563955|NCT02925611|18618203|P2|STARTED|Overall Study||30
7563956|NCT02925611|18618204|P1|STARTED|Overall Study||30
7563957|NCT02925494|18618224|P4|NOT COMPLETED|Post-Treatment Follow-Up Period||50
7563958|NCT02925494|18618225|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||24
7563959|NCT02925494|18618226|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||10
7563960|NCT02925494|18618227|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||14
7563961|NCT02925494|18618224|P4|COMPLETED|Post-Treatment Follow-Up Period||134
7563962|NCT02925494|18618225|P3|COMPLETED|Post-Treatment Follow-Up Period||64
7563963|NCT02925494|18618226|P2|COMPLETED|Post-Treatment Follow-Up Period||37
7563964|NCT02925494|18618227|P1|COMPLETED|Post-Treatment Follow-Up Period||40
7563965|NCT02925494|18618224|P4|STARTED|Post-Treatment Follow-Up Period||184
7563966|NCT02925494|18618225|P3|STARTED|Post-Treatment Follow-Up Period||88
7563967|NCT02925494|18618226|P2|STARTED|Post-Treatment Follow-Up Period||47
7563968|NCT02925494|18618227|P1|STARTED|Post-Treatment Follow-Up Period||54
7563969|NCT02925494|18618224|P4|NOT COMPLETED|Treatment Period||36
7563970|NCT02925494|18618225|P3|NOT COMPLETED|Treatment Period||19
7563971|NCT02925494|18618226|P2|NOT COMPLETED|Treatment Period||15
7563972|NCT02925494|18618227|P1|NOT COMPLETED|Treatment Period||9
7563973|NCT02925494|18618224|P4|COMPLETED|Treatment Period||182
7563974|NCT02925494|18618225|P3|COMPLETED|Treatment Period||79
7563975|NCT02925494|18618226|P2|COMPLETED|Treatment Period||43
7563976|NCT02925494|18618227|P1|COMPLETED|Treatment Period||50
7563977|NCT02925494|18618224|P4|STARTED|Treatment Period||218
7563978|NCT02925494|18618225|P3|STARTED|Treatment Period||98
7563979|NCT02925494|18618226|P2|STARTED|Treatment Period||58
7563980|NCT02925494|18618227|P1|STARTED|Treatment Period||59
7563981|NCT02925403|18618255|P2|NOT COMPLETED|Overall Study||1
7563982|NCT02925403|18618256|P1|NOT COMPLETED|Overall Study||0
7563983|NCT02925403|18618255|P2|COMPLETED|Overall Study||4
7563984|NCT02925403|18618256|P1|COMPLETED|Overall Study||8
7563985|NCT02925403|18618255|P2|STARTED|Overall Study||5
7563986|NCT02925403|18618256|P1|STARTED|Overall Study||8
7563987|NCT02925312|18618270|P2|NOT COMPLETED|Overall Study||0
7563988|NCT02925312|18618271|P1|NOT COMPLETED|Overall Study||27
7563989|NCT02925312|18618270|P2|COMPLETED|Overall Study||294
7563990|NCT02925312|18618271|P1|COMPLETED|Overall Study||98
7563991|NCT02925312|18618270|P2|STARTED|Overall Study||294
7563992|NCT02925312|18618271|P1|STARTED|Overall Study||125
7563993|NCT02925117|18618287|P12|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
7563994|NCT02925117|18618288|P11|NOT COMPLETED|Period 2 (Weeks 16 - 88)||8
7563995|NCT02925117|18618289|P10|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
7563996|NCT02925117|18618290|P9|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
7563997|NCT02925117|18618291|P8|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
7563998|NCT02925117|18618292|P7|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
7563999|NCT02925117|18618293|P6|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
7564000|NCT02925117|18618294|P5|NOT COMPLETED|Period 2 (Weeks 16 - 88)||2
7564001|NCT02925117|18618295|P4|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
7564002|NCT02925117|18618296|P3|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
7564003|NCT02925117|18618297|P2|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
7564004|NCT02925117|18618298|P1|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
7564005|NCT02925117|18618287|P12|COMPLETED|Period 2 (Weeks 16 - 88)||14
7564006|NCT02925117|18618288|P11|COMPLETED|Period 2 (Weeks 16 - 88)||11
7564007|NCT02925117|18618289|P10|COMPLETED|Period 2 (Weeks 16 - 88)||12
7564008|NCT02925117|18618290|P9|COMPLETED|Period 2 (Weeks 16 - 88)||13
7564009|NCT02925117|18618291|P8|COMPLETED|Period 2 (Weeks 16 - 88)||11
7564010|NCT02925117|18618292|P7|COMPLETED|Period 2 (Weeks 16 - 88)||9
7564011|NCT02925117|18618293|P6|COMPLETED|Period 2 (Weeks 16 - 88)||5
7564012|NCT02925117|18618294|P5|COMPLETED|Period 2 (Weeks 16 - 88)||8
7564013|NCT02925117|18618295|P4|COMPLETED|Period 2 (Weeks 16 - 88)||0
7564014|NCT02925117|18618296|P3|COMPLETED|Period 2 (Weeks 16 - 88)||0
7564015|NCT02925117|18618297|P2|COMPLETED|Period 2 (Weeks 16 - 88)||0
7564016|NCT02925117|18618298|P1|COMPLETED|Period 2 (Weeks 16 - 88)||0
7564017|NCT02925117|18618287|P12|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||4
7564018|NCT02925117|18618288|P11|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||14
7564019|NCT02925117|18618289|P10|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
7564020|NCT02925117|18618290|P9|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||17
7564021|NCT02925117|18618291|P8|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
7564022|NCT02925117|18618292|P7|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||13
7564023|NCT02925117|18618293|P6|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||1
7564024|NCT02925117|18618294|P5|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||8
7564025|NCT02925117|18618295|P4|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
7564026|NCT02925117|18618296|P3|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
7564027|NCT02925117|18618297|P2|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
7564028|NCT02925117|18618298|P1|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
7564029|NCT02925117|18618287|P12|STARTED|Period 2 (Weeks 16 - 88)||19
7564030|NCT02925117|18618288|P11|STARTED|Period 2 (Weeks 16 - 88)||19
7564031|NCT02925117|18618289|P10|STARTED|Period 2 (Weeks 16 - 88)||18
7564032|NCT02925117|18618290|P9|STARTED|Period 2 (Weeks 16 - 88)||19
7564033|NCT02925117|18618291|P8|STARTED|Period 2 (Weeks 16 - 88)||16
7564034|NCT02925117|18618292|P7|STARTED|Period 2 (Weeks 16 - 88)||15
7564035|NCT02925117|18618293|P6|STARTED|Period 2 (Weeks 16 - 88)||10
7564036|NCT02925117|18618294|P5|STARTED|Period 2 (Weeks 16 - 88)||10
7564037|NCT02925117|18618295|P4|STARTED|Period 2 (Weeks 16 - 88)||0
7564038|NCT02925117|18618296|P3|STARTED|Period 2 (Weeks 16 - 88)||0
7564039|NCT02925117|18618297|P2|STARTED|Period 2 (Weeks 16 - 88)||0
7564040|NCT02925117|18618298|P1|STARTED|Period 2 (Weeks 16 - 88)||0
7564041|NCT02925117|18618287|P12|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
7564042|NCT02925117|18618288|P11|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
7564043|NCT02925117|18618289|P10|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
7564044|NCT02925117|18618290|P9|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
7564045|NCT02925117|18618291|P8|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
7564046|NCT02925117|18618292|P7|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
7564047|NCT02925117|18618293|P6|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
7564048|NCT02925117|18618294|P5|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
7564049|NCT02925117|18618295|P4|NOT COMPLETED|Period 1 (Weeks 0 - 16)||3
7564050|NCT02925117|18618296|P3|NOT COMPLETED|Period 1 (Weeks 0 - 16)||5
7564051|NCT02925117|18618297|P2|NOT COMPLETED|Period 1 (Weeks 0 - 16)||11
7564052|NCT02925117|18618298|P1|NOT COMPLETED|Period 1 (Weeks 0 - 16)||18
7564053|NCT02925117|18618287|P12|COMPLETED|Period 1 (Weeks 0 - 16)||0
7564054|NCT02925117|18618288|P11|COMPLETED|Period 1 (Weeks 0 - 16)||0
7564055|NCT02925117|18618289|P10|COMPLETED|Period 1 (Weeks 0 - 16)||0
7564056|NCT02925117|18618290|P9|COMPLETED|Period 1 (Weeks 0 - 16)||0
7564057|NCT02925117|18618291|P8|COMPLETED|Period 1 (Weeks 0 - 16)||0
7564058|NCT02925117|18618292|P7|COMPLETED|Period 1 (Weeks 0 - 16)||0
7564059|NCT02925117|18618293|P6|COMPLETED|Period 1 (Weeks 0 - 16)||0
7564060|NCT02925117|18618294|P5|COMPLETED|Period 1 (Weeks 0 - 16)||0
7564061|NCT02925117|18618295|P4|COMPLETED|Period 1 (Weeks 0 - 16)||39
7564062|NCT02925117|18618296|P3|COMPLETED|Period 1 (Weeks 0 - 16)||37
7564063|NCT02925117|18618297|P2|COMPLETED|Period 1 (Weeks 0 - 16)||31
7564064|NCT02925117|18618298|P1|COMPLETED|Period 1 (Weeks 0 - 16)||23
7564065|NCT02925117|18618287|P12|Received Treatment|Period 1 (Weeks 0 - 16)||0
7564066|NCT02925117|18618288|P11|Received Treatment|Period 1 (Weeks 0 - 16)||0
7564067|NCT02925117|18618289|P10|Received Treatment|Period 1 (Weeks 0 - 16)||0
7564068|NCT02925117|18618290|P9|Received Treatment|Period 1 (Weeks 0 - 16)||0
7564069|NCT02925117|18618291|P8|Received Treatment|Period 1 (Weeks 0 - 16)||0
7564070|NCT02925117|18618292|P7|Received Treatment|Period 1 (Weeks 0 - 16)||0
7564071|NCT02925117|18618293|P6|Received Treatment|Period 1 (Weeks 0 - 16)||0
7564072|NCT02925117|18618294|P5|Received Treatment|Period 1 (Weeks 0 - 16)||0
7564073|NCT02925117|18618295|P4|Received Treatment|Period 1 (Weeks 0 - 16)||42
7564074|NCT02925117|18618296|P3|Received Treatment|Period 1 (Weeks 0 - 16)||42
7564075|NCT02925117|18618297|P2|Received Treatment|Period 1 (Weeks 0 - 16)||42
7564076|NCT02925117|18618298|P1|Received Treatment|Period 1 (Weeks 0 - 16)||40
7564077|NCT02925117|18618287|P12|STARTED|Period 1 (Weeks 0 - 16)||0
7564078|NCT02925117|18618288|P11|STARTED|Period 1 (Weeks 0 - 16)||0
7564079|NCT02925117|18618289|P10|STARTED|Period 1 (Weeks 0 - 16)||0
7564080|NCT02925117|18618290|P9|STARTED|Period 1 (Weeks 0 - 16)||0
7564081|NCT02925117|18618291|P8|STARTED|Period 1 (Weeks 0 - 16)||0
7564082|NCT02925117|18618292|P7|STARTED|Period 1 (Weeks 0 - 16)||0
7564083|NCT02925117|18618293|P6|STARTED|Period 1 (Weeks 0 - 16)||0
7564084|NCT02925117|18618294|P5|STARTED|Period 1 (Weeks 0 - 16)||0
7564085|NCT02925117|18618295|P4|STARTED|Period 1 (Weeks 0 - 16)||42
7564086|NCT02925117|18618296|P3|STARTED|Period 1 (Weeks 0 - 16)||42
7564087|NCT02925117|18618297|P2|STARTED|Period 1 (Weeks 0 - 16)||42
7564088|NCT02925117|18618298|P1|STARTED|Period 1 (Weeks 0 - 16)||41
7564089|NCT02925078|18618398|P2|NOT COMPLETED|Overall Study||3
7564090|NCT02925078|18618399|P1|NOT COMPLETED|Overall Study||1
7564091|NCT02925078|18618398|P2|COMPLETED|Overall Study||13
7564092|NCT02925078|18618399|P1|COMPLETED|Overall Study||13
7564093|NCT02925078|18618398|P2|STARTED|Overall Study||16
7564094|NCT02925078|18618399|P1|STARTED|Overall Study||14
7564095|NCT02924883|18618409|P2|NOT COMPLETED|Overall Study||133
7564096|NCT02924883|18618410|P1|NOT COMPLETED|Overall Study||69
7564097|NCT02924883|18618409|P2|COMPLETED|Overall Study||0
7564098|NCT02924883|18618410|P1|COMPLETED|Overall Study||0
7564099|NCT02924883|18618409|P2|STARTED|Overall Study||133
7564100|NCT02924883|18618410|P1|STARTED|Overall Study||69
7564101|NCT02924688|18618435|P6|NOT COMPLETED|Overall Study||24
7564102|NCT02924688|18618436|P5|NOT COMPLETED|Overall Study||23
7564103|NCT02924688|18618437|P4|NOT COMPLETED|Overall Study||28
7564104|NCT02924688|18618438|P3|NOT COMPLETED|Overall Study||23
7564105|NCT02924688|18618439|P2|NOT COMPLETED|Overall Study||31
7564106|NCT02924688|18618440|P1|NOT COMPLETED|Overall Study||33
7564107|NCT02924688|18618435|P6|COMPLETED|Overall Study||384
7564108|NCT02924688|18618436|P5|COMPLETED|Overall Study||381
7564109|NCT02924688|18618437|P4|COMPLETED|Overall Study||378
7564110|NCT02924688|18618438|P3|COMPLETED|Overall Study||383
7564111|NCT02924688|18618439|P2|COMPLETED|Overall Study||374
7564112|NCT02924688|18618440|P1|COMPLETED|Overall Study||374
7564113|NCT02924688|18618435|P6|STARTED|Overall Study||408
7564114|NCT02924688|18618436|P5|STARTED|Overall Study||404
7564115|NCT02924688|18618437|P4|STARTED|Overall Study||406
7564116|NCT02924688|18618438|P3|STARTED|Overall Study||406
7564117|NCT02924688|18618439|P2|STARTED|Overall Study||405
7564118|NCT02924688|18618440|P1|STARTED|Overall Study||407
7564119|NCT02924428|18618510|P2|NOT COMPLETED|Overall Study||5
7564120|NCT02924428|18618511|P1|NOT COMPLETED|Overall Study||4
7564121|NCT02924428|18618510|P2|COMPLETED|Overall Study||14
7564122|NCT02924428|18618511|P1|COMPLETED|Overall Study||16
7564123|NCT02924428|18618510|P2|STARTED|Overall Study||19
7564124|NCT02924428|18618511|P1|STARTED|Overall Study||20
7564125|NCT02924350|18618533|P2|NOT COMPLETED|Overall Study||2
7564126|NCT02924350|18618534|P1|NOT COMPLETED|Overall Study||0
7564127|NCT02924350|18618533|P2|COMPLETED|Overall Study||100
7564128|NCT02924350|18618534|P1|COMPLETED|Overall Study||102
7564129|NCT02924350|18618533|P2|STARTED|Overall Study||102
7564130|NCT02924350|18618534|P1|STARTED|Overall Study||102
7564131|NCT02924051|18618546|P2|NOT COMPLETED|Overall Study||9
7564132|NCT02924051|18618547|P1|NOT COMPLETED|Overall Study||1
7564133|NCT02924051|18618546|P2|COMPLETED|Overall Study||97
7564134|NCT02924051|18618547|P1|COMPLETED|Overall Study||81
7564135|NCT02924051|18618546|P2|STARTED|Overall Study||106
7564136|NCT02924051|18618547|P1|STARTED|Overall Study||82
7564137|NCT02923921|18618559|P2|NOT COMPLETED|Overall Study||57
7564138|NCT02923921|18618560|P1|NOT COMPLETED|Overall Study||53
7564139|NCT02923921|18618559|P2|COMPLETED|Overall Study||227
7564140|NCT02923921|18618560|P1|COMPLETED|Overall Study||230
7564141|NCT02923921|18618559|P2|Safety Population|Overall Study||251
7564142|NCT02923921|18618560|P1|Safety Population|Overall Study||278
7564143|NCT02923921|18618559|P2|Received at Least 1 Dose of Study Drug|Overall Study||251
7564144|NCT02923921|18618560|P1|Received at Least 1 Dose of Study Drug|Overall Study||278
7564145|NCT02923921|18618559|P2|STARTED|Overall Study||284
7564146|NCT02923921|18618560|P1|STARTED|Overall Study||283
7564147|NCT02923895|18618578|P2|NOT COMPLETED|Overall Study||0
7564148|NCT02923895|18618579|P1|NOT COMPLETED|Overall Study||0
7564149|NCT02923895|18618578|P2|COMPLETED|Overall Study||95
7564150|NCT02923895|18618579|P1|COMPLETED|Overall Study||97
7564151|NCT02923895|18618578|P2|STARTED|Overall Study||95
7564152|NCT02923895|18618579|P1|STARTED|Overall Study||97
7564153|NCT02923830|18618593|P2|NOT COMPLETED|Overall Study||15
7564154|NCT02923830|18618594|P1|NOT COMPLETED|Overall Study||13
7564155|NCT02923830|18618593|P2|COMPLETED|Overall Study|Study terminated|0
7564156|NCT02923830|18618594|P1|COMPLETED|Overall Study|Study terminated|0
7564157|NCT02923830|18618593|P2|STARTED|Overall Study||15
7564158|NCT02923830|18618594|P1|STARTED|Overall Study||13
7564159|NCT02923427|18618614|P2|NOT COMPLETED|Overall Study||2
7564160|NCT02923427|18618615|P1|NOT COMPLETED|Overall Study||4
7564161|NCT02923427|18618614|P2|COMPLETED|Overall Study|"The reasons:
~n = 2 Convert to Laparotomy"|55
7564162|NCT02923427|18618615|P1|COMPLETED|Overall Study|"The reasons:
~n= 2 Convert to Laparotomy n=1 Desaturation n=1 LMA-S can not be placed"|51
7564163|NCT02923427|18618614|P2|STARTED|Overall Study||57
7564164|NCT02923427|18618615|P1|STARTED|Overall Study||55
7564165|NCT02923349|18618642|P7|NOT COMPLETED|Overall Study||3
7564166|NCT02923349|18618643|P6|NOT COMPLETED|Overall Study||7
7564167|NCT02923349|18618644|P5|NOT COMPLETED|Overall Study||19
7564168|NCT02923349|18618645|P4|NOT COMPLETED|Overall Study||16
7564169|NCT02923349|18618646|P3|NOT COMPLETED|Overall Study||17
7564170|NCT02923349|18618647|P2|NOT COMPLETED|Overall Study||4
7564171|NCT02923349|18618648|P1|NOT COMPLETED|Overall Study||4
7564172|NCT02923349|18618642|P7|COMPLETED|Overall Study||1
7564173|NCT02923349|18618643|P6|COMPLETED|Overall Study||5
7564174|NCT02923349|18618644|P5|COMPLETED|Overall Study||4
7564175|NCT02923349|18618645|P4|COMPLETED|Overall Study||2
7564176|NCT02923349|18618646|P3|COMPLETED|Overall Study||5
7564177|NCT02923349|18618647|P2|COMPLETED|Overall Study||0
7564178|NCT02923349|18618648|P1|COMPLETED|Overall Study||0
7564179|NCT02923349|18618642|P7|STARTED|Overall Study||4
7564180|NCT02923349|18618643|P6|STARTED|Overall Study||12
7564181|NCT02923349|18618644|P5|STARTED|Overall Study||23
7564182|NCT02923349|18618645|P4|STARTED|Overall Study||18
7564183|NCT02923349|18618646|P3|STARTED|Overall Study||22
7564184|NCT02923349|18618647|P2|STARTED|Overall Study||4
7564185|NCT02923349|18618648|P1|STARTED|Overall Study||4
7564186|NCT02923271|18618722|P2|NOT COMPLETED|Overall Study||2
7564187|NCT02923271|18618723|P1|NOT COMPLETED|Overall Study||8
7564188|NCT02923271|18618722|P2|COMPLETED|Overall Study||14
7564189|NCT02923271|18618723|P1|COMPLETED|Overall Study||10
7564190|NCT02923271|18618722|P2|STARTED|Overall Study||16
7564191|NCT02923271|18618723|P1|STARTED|Overall Study||18
7564192|NCT02923245|18618733|P2|NOT COMPLETED|Overall Study||1
7564193|NCT02923245|18618734|P1|NOT COMPLETED|Overall Study||2
7564194|NCT02923245|18618733|P2|COMPLETED|Overall Study||59
7564195|NCT02923245|18618734|P1|COMPLETED|Overall Study||58
7564196|NCT02923245|18618733|P2|STARTED|Overall Study||60
7564197|NCT02923245|18618734|P1|STARTED|Overall Study||60
7564198|NCT02923115|18618757|P6|NOT COMPLETED|Overall Study||0
7564199|NCT02923115|18618758|P5|NOT COMPLETED|Overall Study||5
7564200|NCT02923115|18618759|P4|NOT COMPLETED|Overall Study||2
7564201|NCT02923115|18618760|P3|NOT COMPLETED|Overall Study||3
7564202|NCT02923115|18618761|P2|NOT COMPLETED|Overall Study||1
7564203|NCT02923115|18618762|P1|NOT COMPLETED|Overall Study||0
7564204|NCT02923115|18618757|P6|COMPLETED|Overall Study||38
7564205|NCT02923115|18618758|P5|COMPLETED|Overall Study||17
7564206|NCT02923115|18618759|P4|COMPLETED|Overall Study||21
7564207|NCT02923115|18618760|P3|COMPLETED|Overall Study||20
7564208|NCT02923115|18618761|P2|COMPLETED|Overall Study||15
7564209|NCT02923115|18618762|P1|COMPLETED|Overall Study||12
7564210|NCT02923115|18618757|P6|Treated|Overall Study||38
7564211|NCT02923115|18618758|P5|Treated|Overall Study||17
7564212|NCT02923115|18618759|P4|Treated|Overall Study||22
7564213|NCT02923115|18618760|P3|Treated|Overall Study||20
7564214|NCT02923115|18618761|P2|Treated|Overall Study||16
7564215|NCT02923115|18618762|P1|Treated|Overall Study||12
7564216|NCT02923115|18618757|P6|STARTED|Overall Study||38
7564217|NCT02923115|18618758|P5|STARTED|Overall Study||22
7564218|NCT02923115|18618759|P4|STARTED|Overall Study||23
7564219|NCT02923115|18618760|P3|STARTED|Overall Study||23
7564220|NCT02923115|18618761|P2|STARTED|Overall Study||16
7564221|NCT02923115|18618762|P1|STARTED|Overall Study||12
7564222|NCT02922985|18618805|P2|NOT COMPLETED|Overall Study||0
7564223|NCT02922985|18618806|P1|NOT COMPLETED|Overall Study||0
7564224|NCT02922985|18618805|P2|COMPLETED|Overall Study||60
7564225|NCT02922985|18618806|P1|COMPLETED|Overall Study||60
7564226|NCT02922985|18618805|P2|STARTED|Overall Study||60
7564227|NCT02922985|18618806|P1|STARTED|Overall Study||60
7564228|NCT02922959|18618832|P2|NOT COMPLETED|Overall Study||17
7564229|NCT02922959|18618833|P1|NOT COMPLETED|Overall Study||19
7564230|NCT02922959|18618832|P2|COMPLETED|Overall Study||23
7564231|NCT02922959|18618833|P1|COMPLETED|Overall Study||21
7564232|NCT02922959|18618832|P2|12 Months|Overall Study|n=23 (57.5%)|23
7564233|NCT02922959|18618833|P1|12 Months|Overall Study|n=21 (52.5%)|21
7564234|NCT02922959|18618832|P2|6 Months|Overall Study|n=30 (75.0%)|30
7564235|NCT02922959|18618833|P1|6 Months|Overall Study|n=28 (70.0%)|28
7564236|NCT02922959|18618832|P2|3 Months|Overall Study|n=31 (77.5%)|31
7564237|NCT02922959|18618833|P1|3 Months|Overall Study|n=35 (87.5%)|35
7564238|NCT02922959|18618832|P2|3 Weeks|Overall Study|n=36 (90.0%)|36
7564239|NCT02922959|18618833|P1|3 Weeks|Overall Study|n=38 (95.0%)|38
7564240|NCT02922959|18618832|P2|STARTED|Overall Study||40
7564241|NCT02922959|18618833|P1|STARTED|Overall Study||40
7564242|NCT02922868|18618847|P2|NOT COMPLETED|Overall Study||0
7564243|NCT02922868|18618848|P1|NOT COMPLETED|Overall Study||0
7564244|NCT02922868|18618847|P2|COMPLETED|Overall Study||30
7564245|NCT02922868|18618848|P1|COMPLETED|Overall Study||30
7564246|NCT02922868|18618847|P2|STARTED|Overall Study||30
7564247|NCT02922868|18618848|P1|STARTED|Overall Study||30
7564248|NCT02922738|18618868|P2|NOT COMPLETED|Overall Study||0
7564249|NCT02922738|18618869|P1|NOT COMPLETED|Overall Study||0
7564250|NCT02922738|18618868|P2|COMPLETED|Overall Study||290
7564251|NCT02922738|18618869|P1|COMPLETED|Overall Study||175
7564252|NCT02922738|18618868|P2|STARTED|Overall Study|275 patients and 15 providers|290
7564253|NCT02922738|18618869|P1|STARTED|Overall Study|158 patients and 17 providers|175
7564254|NCT02922582|18618881|P4|NOT COMPLETED|Overall Study||0
7564255|NCT02922582|18618882|P3|NOT COMPLETED|Overall Study||0
7564256|NCT02922582|18618883|P2|NOT COMPLETED|Overall Study||1
7564257|NCT02922582|18618884|P1|NOT COMPLETED|Overall Study||0
7564258|NCT02922582|18618881|P4|COMPLETED|Overall Study||4
7564259|NCT02922582|18618882|P3|COMPLETED|Overall Study||4
7564260|NCT02922582|18618883|P2|COMPLETED|Overall Study||3
7564261|NCT02922582|18618884|P1|COMPLETED|Overall Study||4
7564262|NCT02922582|18618881|P4|STARTED|Overall Study||4
7564263|NCT02922582|18618882|P3|STARTED|Overall Study||4
7564264|NCT02922582|18618883|P2|STARTED|Overall Study||4
7564265|NCT02922582|18618884|P1|STARTED|Overall Study||4
7564266|NCT02922153|18618944|P2|NOT COMPLETED|Overall Study||2
7564267|NCT02922153|18618945|P1|NOT COMPLETED|Overall Study||10
7564268|NCT02922153|18618944|P2|COMPLETED|Overall Study||17
7564269|NCT02922153|18618945|P1|COMPLETED|Overall Study||55
7564270|NCT02922153|18618944|P2|STARTED|Overall Study||19
7564271|NCT02922153|18618945|P1|STARTED|Overall Study||65
7564272|NCT02921841|18618969|P2|NOT COMPLETED|Overall Study||13
7564273|NCT02921841|18618970|P1|NOT COMPLETED|Overall Study||16
7564274|NCT02921841|18618969|P2|COMPLETED|Overall Study||44
7564275|NCT02921841|18618970|P1|COMPLETED|Overall Study||52
7564276|NCT02921841|18618969|P2|STARTED|Overall Study||57
7564277|NCT02921841|18618970|P1|STARTED|Overall Study||68
7564278|NCT02921750|18619004|P2|NOT COMPLETED|Overall Study||11
7564279|NCT02921750|18619005|P1|NOT COMPLETED|Overall Study||9
7564280|NCT02921750|18619004|P2|COMPLETED|Overall Study||113
7564281|NCT02921750|18619005|P1|COMPLETED|Overall Study||115
7564282|NCT02921750|18619004|P2|Subgroup Followed for 24 Weeks (PP)|Overall Study||36
7564283|NCT02921750|18619005|P1|Subgroup Followed for 24 Weeks (PP)|Overall Study||19
7564284|NCT02921750|18619004|P2|Subgroup Followed for 24 Weeks (ITT)|Overall Study||40
7564285|NCT02921750|18619005|P1|Subgroup Followed for 24 Weeks (ITT)|Overall Study||35
7564286|NCT02921750|18619004|P2|Completed 6 Weeks Follow-up (PP)|Overall Study||104
7564287|NCT02921750|18619005|P1|Completed 6 Weeks Follow-up (PP)|Overall Study||97
7564288|NCT02921750|18619004|P2|Per Protocol (PP)|Overall Study||107
7564289|NCT02921750|18619005|P1|Per Protocol (PP)|Overall Study||100
7564290|NCT02921750|18619004|P2|Intention to Treat (ITT)|Overall Study||123
7564291|NCT02921750|18619005|P1|Intention to Treat (ITT)|Overall Study||122
7564292|NCT02921750|18619004|P2|STARTED|Overall Study||124
7564293|NCT02921750|18619005|P1|STARTED|Overall Study||124
7564294|NCT02921490|18619025|P1|NOT COMPLETED|Overall Study||0
7564295|NCT02921490|18619025|P1|COMPLETED|Overall Study||10
7564296|NCT02921490|18619025|P1|STARTED|Overall Study||10
7564297|NCT02921425|18619036|P1|NOT COMPLETED|Overall Study||9
7564298|NCT02921425|18619036|P1|COMPLETED|Overall Study||38
7564299|NCT02921425|18619036|P1|Second Visit|Overall Study|Participants had to wear an accelerometer and make entries into their PHR over the previous 7 days.|47
7564300|NCT02921425|18619036|P1|STARTED|Overall Study||47
7564301|NCT02921412|18619050|P1|NOT COMPLETED|Overall Study||0
7564302|NCT02921412|18619050|P1|COMPLETED|Overall Study||36
7564303|NCT02921412|18619050|P1|STARTED|Overall Study||36
7564304|NCT02921386|18619073|P1|NOT COMPLETED|Sequence E: FDA High Fat Breakfast||0
7564305|NCT02921386|18619073|P1|COMPLETED|Sequence E: FDA High Fat Breakfast||18
7564306|NCT02921386|18619073|P1|STARTED|Sequence E: FDA High Fat Breakfast||18
7564307|NCT02921386|18619073|P1|NOT COMPLETED|Sequence D: 45 g Fat Breakfast||0
7564308|NCT02921386|18619073|P1|COMPLETED|Sequence D: 45 g Fat Breakfast||18
7564309|NCT02921386|18619073|P1|STARTED|Sequence D: 45 g Fat Breakfast||18
7564310|NCT02921386|18619073|P1|NOT COMPLETED|Sequence C: 30 g Fat Breakfast||0
7564311|NCT02921386|18619073|P1|COMPLETED|Sequence C: 30 g Fat Breakfast||18
7564312|NCT02921386|18619073|P1|STARTED|Sequence C: 30 g Fat Breakfast||18
7564313|NCT02921386|18619073|P1|NOT COMPLETED|Sequence B: 15 g Fat Breakfast||0
7564314|NCT02921386|18619073|P1|COMPLETED|Sequence B: 15 g Fat Breakfast||18
7564315|NCT02921386|18619073|P1|STARTED|Sequence B: 15 g Fat Breakfast||18
7564316|NCT02921386|18619073|P1|NOT COMPLETED|Sequence A: Fasting||0
7564317|NCT02921386|18619073|P1|COMPLETED|Sequence A: Fasting||18
7564318|NCT02921386|18619073|P1|STARTED|Sequence A: Fasting||18
7564319|NCT02921295|18619096|P1|NOT COMPLETED|Conventional Prostheses||0
7564320|NCT02921295|18619096|P1|COMPLETED|Conventional Prostheses||1
7564321|NCT02921295|18619096|P1|STARTED|Conventional Prostheses||1
7564322|NCT02921295|18619096|P1|NOT COMPLETED|Sidekicks||0
7564323|NCT02921295|18619096|P1|COMPLETED|Sidekicks||1
7564324|NCT02921295|18619096|P1|STARTED|Sidekicks||1
7564325|NCT02921087|18619108|P2|NOT COMPLETED|Overall Study||1
7564326|NCT02921087|18619109|P1|NOT COMPLETED|Overall Study||0
7564327|NCT02921087|18619108|P2|COMPLETED|Overall Study|One subject dropped out prior to 1 week of lens wear while wearing the control lens (lens 1).|10
7564328|NCT02921087|18619109|P1|COMPLETED|Overall Study||12
7564329|NCT02921087|18619108|P2|STARTED|Overall Study||11
7564330|NCT02921087|18619109|P1|STARTED|Overall Study||12
7564331|NCT02921061|18619129|P1|NOT COMPLETED|Overall Study||0
7564332|NCT02921061|18619129|P1|COMPLETED|Overall Study||28
7564333|NCT02921061|18619129|P1|STARTED|Overall Study||28
7564334|NCT02920983|18619138|P6|NOT COMPLETED|Dispense 3||0
7564335|NCT02920983|18619139|P5|NOT COMPLETED|Dispense 3||1
7564336|NCT02920983|18619140|P4|NOT COMPLETED|Dispense 3||0
7564337|NCT02920983|18619141|P3|NOT COMPLETED|Dispense 3||0
7564338|NCT02920983|18619142|P2|NOT COMPLETED|Dispense 3||1
7564339|NCT02920983|18619143|P1|NOT COMPLETED|Dispense 3||1
7564340|NCT02920983|18619138|P6|COMPLETED|Dispense 3||7
7564341|NCT02920983|18619139|P5|COMPLETED|Dispense 3||12
7564342|NCT02920983|18619140|P4|COMPLETED|Dispense 3||6
7564343|NCT02920983|18619141|P3|COMPLETED|Dispense 3||7
7564344|NCT02920983|18619142|P2|COMPLETED|Dispense 3||9
7564345|NCT02920983|18619143|P1|COMPLETED|Dispense 3||7
7564346|NCT02920983|18619138|P6|STARTED|Dispense 3||7
7564347|NCT02920983|18619139|P5|STARTED|Dispense 3||13
7564348|NCT02920983|18619140|P4|STARTED|Dispense 3||6
7564349|NCT02920983|18619141|P3|STARTED|Dispense 3||7
7564350|NCT02920983|18619142|P2|STARTED|Dispense 3||10
7564351|NCT02920983|18619143|P1|STARTED|Dispense 3||8
7564352|NCT02920983|18619138|P6|NOT COMPLETED|Dispense 2||0
7564353|NCT02920983|18619139|P5|NOT COMPLETED|Dispense 2||1
7564354|NCT02920983|18619140|P4|NOT COMPLETED|Dispense 2||0
7564355|NCT02920983|18619141|P3|NOT COMPLETED|Dispense 2||0
7564356|NCT02920983|18619142|P2|NOT COMPLETED|Dispense 2||0
7564357|NCT02920983|18619143|P1|NOT COMPLETED|Dispense 2||1
7564358|NCT02920983|18619138|P6|COMPLETED|Dispense 2||7
7564359|NCT02920983|18619139|P5|COMPLETED|Dispense 2||12
7564360|NCT02920983|18619140|P4|COMPLETED|Dispense 2||6
7564361|NCT02920983|18619141|P3|COMPLETED|Dispense 2||7
7564362|NCT02920983|18619142|P2|COMPLETED|Dispense 2||10
7564363|NCT02920983|18619143|P1|COMPLETED|Dispense 2||7
7564364|NCT02920983|18619138|P6|STARTED|Dispense 2||7
7564365|NCT02920983|18619139|P5|STARTED|Dispense 2||13
7564366|NCT02920983|18619140|P4|STARTED|Dispense 2||6
7564367|NCT02920983|18619141|P3|STARTED|Dispense 2||7
7564368|NCT02920983|18619142|P2|STARTED|Dispense 2||10
7564369|NCT02920983|18619143|P1|STARTED|Dispense 2||8
7564370|NCT02920983|18619138|P6|NOT COMPLETED|Dispense 1||0
7564371|NCT02920983|18619139|P5|NOT COMPLETED|Dispense 1||1
7564372|NCT02920983|18619140|P4|NOT COMPLETED|Dispense 1||0
7564373|NCT02920983|18619141|P3|NOT COMPLETED|Dispense 1||0
7564374|NCT02920983|18619142|P2|NOT COMPLETED|Dispense 1||0
7564375|NCT02920983|18619143|P1|NOT COMPLETED|Dispense 1||0
7564376|NCT02920983|18619138|P6|COMPLETED|Dispense 1||7
7564377|NCT02920983|18619139|P5|COMPLETED|Dispense 1||12
7564378|NCT02920983|18619140|P4|COMPLETED|Dispense 1||6
7564379|NCT02920983|18619141|P3|COMPLETED|Dispense 1||7
7564380|NCT02920983|18619142|P2|COMPLETED|Dispense 1||10
7564381|NCT02920983|18619143|P1|COMPLETED|Dispense 1||8
7564382|NCT02920983|18619138|P6|STARTED|Dispense 1||7
7564383|NCT02920983|18619139|P5|STARTED|Dispense 1||13
7564384|NCT02920983|18619140|P4|STARTED|Dispense 1||6
7564385|NCT02920983|18619141|P3|STARTED|Dispense 1||7
7564386|NCT02920983|18619142|P2|STARTED|Dispense 1||10
7564387|NCT02920983|18619143|P1|STARTED|Dispense 1||8
7564388|NCT02920970|18619172|P2|NOT COMPLETED|Second Intervention||0
7564389|NCT02920970|18619173|P1|NOT COMPLETED|Second Intervention||1
7564390|NCT02920970|18619172|P2|COMPLETED|Second Intervention||30
7564391|NCT02920970|18619173|P1|COMPLETED|Second Intervention||37
7564392|NCT02920970|18619172|P2|STARTED|Second Intervention||30
7564393|NCT02920970|18619173|P1|STARTED|Second Intervention||38
7564394|NCT02920970|18619172|P2|NOT COMPLETED|First Intervention||2
7564395|NCT02920970|18619173|P1|NOT COMPLETED|First Intervention||0
7564396|NCT02920970|18619172|P2|COMPLETED|First Intervention||30
7564397|NCT02920970|18619173|P1|COMPLETED|First Intervention||38
7564398|NCT02920970|18619172|P2|STARTED|First Intervention||32
7564399|NCT02920970|18619173|P1|STARTED|First Intervention||38
7564400|NCT02920957|18619199|P2|NOT COMPLETED|Second Intervention: 1 Month||1
7564401|NCT02920957|18619200|P1|NOT COMPLETED|Second Intervention: 1 Month||0
7564402|NCT02920957|18619199|P2|COMPLETED|Second Intervention: 1 Month||40
7564403|NCT02920957|18619200|P1|COMPLETED|Second Intervention: 1 Month||42
7564404|NCT02920957|18619199|P2|STARTED|Second Intervention: 1 Month||41
7564405|NCT02920957|18619200|P1|STARTED|Second Intervention: 1 Month||42
7564406|NCT02920957|18619199|P2|NOT COMPLETED|First Intervention : 1 Month||0
7564407|NCT02920957|18619200|P1|NOT COMPLETED|First Intervention : 1 Month||4
7564408|NCT02920957|18619199|P2|COMPLETED|First Intervention : 1 Month||41
7564409|NCT02920957|18619200|P1|COMPLETED|First Intervention : 1 Month||42
7564410|NCT02920957|18619199|P2|STARTED|First Intervention : 1 Month||41
7564411|NCT02920957|18619200|P1|STARTED|First Intervention : 1 Month||46
7564412|NCT02920918|18619254|P2|NOT COMPLETED|Overall Study||0
7564413|NCT02920918|18619255|P1|NOT COMPLETED|Overall Study||0
7564414|NCT02920918|18619254|P2|COMPLETED|Overall Study||19
7564415|NCT02920918|18619255|P1|COMPLETED|Overall Study||17
7564416|NCT02920918|18619254|P2|STARTED|Overall Study||19
7564417|NCT02920918|18619255|P1|STARTED|Overall Study||17
7564418|NCT02920749|18619267|P4|NOT COMPLETED|Overall Study||0
7564419|NCT02920749|18619268|P3|NOT COMPLETED|Overall Study||0
7564420|NCT02920749|18619269|P2|NOT COMPLETED|Overall Study||0
7564421|NCT02920749|18619270|P1|NOT COMPLETED|Overall Study||0
7564422|NCT02920749|18619267|P4|COMPLETED|Overall Study||30
7564423|NCT02920749|18619268|P3|COMPLETED|Overall Study||30
7564424|NCT02920749|18619269|P2|COMPLETED|Overall Study||30
7564425|NCT02920749|18619270|P1|COMPLETED|Overall Study||30
7564426|NCT02920749|18619267|P4|STARTED|Overall Study||30
7564427|NCT02920749|18619268|P3|STARTED|Overall Study||30
7564428|NCT02920749|18619269|P2|STARTED|Overall Study||30
7564429|NCT02920749|18619270|P1|STARTED|Overall Study||30
7564430|NCT02920476|18619284|P1|NOT COMPLETED|Overall Study||1
7564431|NCT02920476|18619284|P1|COMPLETED|Overall Study||3
7564432|NCT02920476|18619284|P1|STARTED|Overall Study||4
7564433|NCT02920450|18619289|P4|NOT COMPLETED|Overall Study||0
7564434|NCT02920450|18619290|P3|NOT COMPLETED|Overall Study||0
7564435|NCT02920450|18619291|P2|NOT COMPLETED|Overall Study||0
7564436|NCT02920450|18619292|P1|NOT COMPLETED|Overall Study||2
7564437|NCT02920450|18619289|P4|COMPLETED|Overall Study||0
7564438|NCT02920450|18619290|P3|COMPLETED|Overall Study||0
7564439|NCT02920450|18619291|P2|COMPLETED|Overall Study||0
7564440|NCT02920450|18619292|P1|COMPLETED|Overall Study||1
7564441|NCT02920450|18619289|P4|STARTED|Overall Study||0
7564442|NCT02920450|18619290|P3|STARTED|Overall Study||0
7564443|NCT02920450|18619291|P2|STARTED|Overall Study||0
7564444|NCT02920450|18619292|P1|STARTED|Overall Study||3
7564445|NCT02920242|18619303|P3|NOT COMPLETED|Overall Study||1
7564446|NCT02920242|18619304|P2|NOT COMPLETED|Overall Study||0
7564447|NCT02920242|18619305|P1|NOT COMPLETED|Overall Study||2
7564448|NCT02920242|18619303|P3|COMPLETED|Overall Study||3
7564449|NCT02920242|18619304|P2|COMPLETED|Overall Study||11
7564450|NCT02920242|18619305|P1|COMPLETED|Overall Study||11
7564451|NCT02920242|18619303|P3|Safety Set|Overall Study||4
7564452|NCT02920242|18619304|P2|Safety Set|Overall Study||11
7564453|NCT02920242|18619305|P1|Safety Set|Overall Study||12
7564454|NCT02920242|18619303|P3|STARTED|Overall Study||4
7564455|NCT02920242|18619304|P2|STARTED|Overall Study||11
7564456|NCT02920242|18619305|P1|STARTED|Overall Study||13
7564457|NCT02920177|18619333|P2|NOT COMPLETED|Overall Study||2
7564458|NCT02920177|18619334|P1|NOT COMPLETED|Overall Study||2
7564459|NCT02920177|18619333|P2|COMPLETED|Overall Study||0
7564460|NCT02920177|18619334|P1|COMPLETED|Overall Study||0
7564461|NCT02920177|18619333|P2|STARTED|Overall Study||2
7564462|NCT02920177|18619334|P1|STARTED|Overall Study||2
7564463|NCT02919995|18619354|P6|NOT COMPLETED|Overall Study||1
7564464|NCT02919995|18619355|P5|NOT COMPLETED|Overall Study||0
7564465|NCT02919995|18619356|P4|NOT COMPLETED|Overall Study||0
7564466|NCT02919995|18619357|P3|NOT COMPLETED|Overall Study||0
7564467|NCT02919995|18619358|P2|NOT COMPLETED|Overall Study||0
7564468|NCT02919995|18619359|P1|NOT COMPLETED|Overall Study||0
7564469|NCT02919995|18619354|P6|COMPLETED|Overall Study||1
7564470|NCT02919995|18619355|P5|COMPLETED|Overall Study||1
7564471|NCT02919995|18619356|P4|COMPLETED|Overall Study||2
7564472|NCT02919995|18619357|P3|COMPLETED|Overall Study||2
7564473|NCT02919995|18619358|P2|COMPLETED|Overall Study||2
7564474|NCT02919995|18619359|P1|COMPLETED|Overall Study||1
7564475|NCT02919995|18619354|P6|STARTED|Overall Study||2
7564476|NCT02919995|18619355|P5|STARTED|Overall Study||1
7564477|NCT02919995|18619356|P4|STARTED|Overall Study||2
7564478|NCT02919995|18619357|P3|STARTED|Overall Study||2
7564479|NCT02919995|18619358|P2|STARTED|Overall Study||2
7564480|NCT02919995|18619359|P1|STARTED|Overall Study||1
7564481|NCT02919826|18619386|P2|NOT COMPLETED|Overall Study||2
7564482|NCT02919826|18619387|P1|NOT COMPLETED|Overall Study||0
7564483|NCT02919826|18619386|P2|COMPLETED|Overall Study||8
7564484|NCT02919826|18619387|P1|COMPLETED|Overall Study||10
7564485|NCT02919826|18619386|P2|STARTED|Overall Study||10
7564486|NCT02919826|18619387|P1|STARTED|Overall Study||10
7564487|NCT02919813|18619403|P2|NOT COMPLETED|Overall Study||0
7564488|NCT02919813|18619404|P1|NOT COMPLETED|Overall Study||0
7564489|NCT02919813|18619403|P2|COMPLETED|Overall Study||17
7564490|NCT02919813|18619404|P1|COMPLETED|Overall Study||14
7564491|NCT02919813|18619403|P2|STARTED|Overall Study||17
7564492|NCT02919813|18619404|P1|STARTED|Overall Study||14
7564493|NCT02919761|18619422|P3|NOT COMPLETED|Part 2: Double-blind||21
7564494|NCT02919761|18619423|P2|NOT COMPLETED|Part 2: Double-blind||6
7564495|NCT02919761|18619424|P1|NOT COMPLETED|Part 2: Double-blind||0
7564496|NCT02919761|18619422|P3|COMPLETED|Part 2: Double-blind||56
7564497|NCT02919761|18619423|P2|COMPLETED|Part 2: Double-blind||71
7564498|NCT02919761|18619424|P1|COMPLETED|Part 2: Double-blind||0
7564499|NCT02919761|18619422|P3|Per Protocol Population|Part 2: Double-blind||73
7564500|NCT02919761|18619423|P2|Per Protocol Population|Part 2: Double-blind||76
7564501|NCT02919761|18619424|P1|Per Protocol Population|Part 2: Double-blind||0
7564502|NCT02919761|18619422|P3|mITT Population|Part 2: Double-blind||76
7564503|NCT02919761|18619423|P2|mITT Population|Part 2: Double-blind||77
7564504|NCT02919761|18619424|P1|mITT Population|Part 2: Double-blind||0
7564505|NCT02919761|18619422|P3|Safety Population|Part 2: Double-blind||77
7564506|NCT02919761|18619423|P2|Safety Population|Part 2: Double-blind||77
7564507|NCT02919761|18619424|P1|Safety Population|Part 2: Double-blind||0
7564508|NCT02919761|18619422|P3|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive placebo for an additional 12 weeks in Part 2|77
7564509|NCT02919761|18619423|P2|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive Acthar for an additional 12 weeks in Part 2|77
7564510|NCT02919761|18619424|P1|STARTED|Part 2: Double-blind|154 of the original Part 1 participants continued to Part 2, randomized to Acthar or placebo|0
7564511|NCT02919761|18619422|P3|NOT COMPLETED|Part 1: Open Label||0
7564512|NCT02919761|18619423|P2|NOT COMPLETED|Part 1: Open Label||0
7564513|NCT02919761|18619424|P1|NOT COMPLETED|Part 1: Open Label||24
7564514|NCT02919761|18619422|P3|COMPLETED|Part 1: Open Label||0
7564515|NCT02919761|18619423|P2|COMPLETED|Part 1: Open Label||0
7564516|NCT02919761|18619424|P1|COMPLETED|Part 1: Open Label||235
7564517|NCT02919761|18619422|P3|Per Protocol Population|Part 1: Open Label||0
7564518|NCT02919761|18619423|P2|Per Protocol Population|Part 1: Open Label||0
7564519|NCT02919761|18619424|P1|Per Protocol Population|Part 1: Open Label||236
7564520|NCT02919761|18619422|P3|Safety Population|Part 1: Open Label||0
7564521|NCT02919761|18619423|P2|Safety Population|Part 1: Open Label||0
7564522|NCT02919761|18619424|P1|Safety Population|Part 1: Open Label||259
7564523|NCT02919761|18619422|P3|mITT Population|Part 1: Open Label||0
7564524|NCT02919761|18619423|P2|mITT Population|Part 1: Open Label||0
7564525|NCT02919761|18619424|P1|mITT Population|Part 1: Open Label||259
7564526|NCT02919761|18619422|P3|STARTED|Part 1: Open Label||0
7564527|NCT02919761|18619423|P2|STARTED|Part 1: Open Label|Part 2 Blinded groups were not evaluated as such during Part 1|0
7564528|NCT02919761|18619424|P1|STARTED|Part 1: Open Label||259
7564529|NCT02919696|18619452|P2|NOT COMPLETED|Overall Study||5
7564530|NCT02919696|18619453|P1|NOT COMPLETED|Overall Study||4
7564531|NCT02919696|18619452|P2|COMPLETED|Overall Study||9
7564532|NCT02919696|18619453|P1|COMPLETED|Overall Study||8
7564533|NCT02919696|18619452|P2|Progressive Disease|Overall Study||9
7564534|NCT02919696|18619453|P1|Progressive Disease|Overall Study||7
7564535|NCT02919696|18619452|P2|Death On Treatment|Overall Study||0
7564536|NCT02919696|18619453|P1|Death On Treatment|Overall Study||1
7564537|NCT02919696|18619452|P2|PK 150 mg Abemaciclib Dose|Overall Study||2
7564538|NCT02919696|18619453|P1|PK 150 mg Abemaciclib Dose|Overall Study||0
7564539|NCT02919696|18619452|P2|PK 100 mg Abemaciclib Dose|Overall Study||0
7564540|NCT02919696|18619453|P1|PK 100 mg Abemaciclib Dose|Overall Study||5
7564541|NCT02919696|18619452|P2|Received at Least One Dose of Study Drug|Overall Study||13
7564542|NCT02919696|18619453|P1|Received at Least One Dose of Study Drug|Overall Study||12
7564543|NCT02919696|18619452|P2|STARTED|Overall Study||14
7564544|NCT02919696|18619453|P1|STARTED|Overall Study||12
7564545|NCT02919683|18619475|P2|NOT COMPLETED|Post-Surgery Follow-Up||2
7564546|NCT02919683|18619476|P1|NOT COMPLETED|Post-Surgery Follow-Up||3
7564547|NCT02919683|18619475|P2|COMPLETED|Post-Surgery Follow-Up||13
7564548|NCT02919683|18619476|P1|COMPLETED|Post-Surgery Follow-Up||12
7564549|NCT02919683|18619475|P2|STARTED|Post-Surgery Follow-Up||15
7564550|NCT02919683|18619476|P1|STARTED|Post-Surgery Follow-Up||15
7564551|NCT02919683|18619475|P2|NOT COMPLETED|Pre-Surgery Intervention||0
7564552|NCT02919683|18619476|P1|NOT COMPLETED|Pre-Surgery Intervention||0
7564553|NCT02919683|18619475|P2|COMPLETED|Pre-Surgery Intervention||15
7564554|NCT02919683|18619476|P1|COMPLETED|Pre-Surgery Intervention||15
7564555|NCT02919683|18619475|P2|STARTED|Pre-Surgery Intervention||15
7564556|NCT02919683|18619476|P1|STARTED|Pre-Surgery Intervention||15
7564557|NCT02919657|18619482|P2|NOT COMPLETED|Overall Study||0
7564558|NCT02919657|18619483|P1|NOT COMPLETED|Overall Study||0
7564559|NCT02919657|18619482|P2|COMPLETED|Overall Study|completed with the same initial 10 participants|10
7564560|NCT02919657|18619483|P1|COMPLETED|Overall Study|completed with the same initial 10 participants|10
7564561|NCT02919657|18619482|P2|STARTED|Overall Study|10 Participants|10
7564562|NCT02919657|18619483|P1|STARTED|Overall Study|10 Participants|10
7564563|NCT02919618|18619489|P1|NOT COMPLETED|Overall Study||1
7564564|NCT02919618|18619489|P1|COMPLETED|Overall Study||18
7564565|NCT02919618|18619489|P1|Primary Efficacy Endpoint (6 Months)|Overall Study||18
7564566|NCT02919618|18619489|P1|Primary Safety Endpoint (</=90 Days)|Overall Study||19
7564567|NCT02919618|18619489|P1|STARTED|Overall Study||19
7564568|NCT02919423|18619508|P2|NOT COMPLETED|Overall Study||9
7564569|NCT02919423|18619509|P1|NOT COMPLETED|Overall Study||2
7564570|NCT02919423|18619508|P2|COMPLETED|Overall Study||16
7564571|NCT02919423|18619509|P1|COMPLETED|Overall Study||4
7564572|NCT02919423|18619508|P2|STARTED|Overall Study||25
7564573|NCT02919423|18619509|P1|STARTED|Overall Study||6
7564574|NCT02919267|18619519|P4|NOT COMPLETED|Overall Study||4
7564575|NCT02919267|18619520|P3|NOT COMPLETED|Overall Study||3
7564576|NCT02919267|18619521|P2|NOT COMPLETED|Overall Study||3
7564577|NCT02919267|18619522|P1|NOT COMPLETED|Overall Study||0
7564578|NCT02919267|18619519|P4|COMPLETED|Overall Study||10
7564579|NCT02919267|18619520|P3|COMPLETED|Overall Study||10
7564580|NCT02919267|18619521|P2|COMPLETED|Overall Study||9
7564581|NCT02919267|18619522|P1|COMPLETED|Overall Study||10
7564582|NCT02919267|18619519|P4|STARTED|Overall Study||14
7564583|NCT02919267|18619520|P3|STARTED|Overall Study||13
7564584|NCT02919267|18619521|P2|STARTED|Overall Study||12
7564585|NCT02919267|18619522|P1|STARTED|Overall Study||10
7564586|NCT02919111|18619532|P1|NOT COMPLETED|Overall Study||0
7564587|NCT02919111|18619532|P1|COMPLETED|Overall Study||299
7564588|NCT02919111|18619532|P1|STARTED|Overall Study||299
7564589|NCT02919007|18619552|P1|NOT COMPLETED|Overall Study||0
7564590|NCT02919007|18619552|P1|COMPLETED|Overall Study||25
7564591|NCT02919007|18619552|P1|STARTED|Overall Study||25
7564592|NCT02918773|18619558|P2|NOT COMPLETED|Overall Study||0
7564593|NCT02918773|18619559|P1|NOT COMPLETED|Overall Study||0
7564594|NCT02918773|18619558|P2|COMPLETED|Overall Study||11
7564595|NCT02918773|18619559|P1|COMPLETED|Overall Study||11
7564596|NCT02918773|18619558|P2|STARTED|Overall Study||11
7564597|NCT02918773|18619559|P1|STARTED|Overall Study||11
7564598|NCT02918669|18619570|P1|NOT COMPLETED|Overall Study||4
7564599|NCT02918669|18619570|P1|COMPLETED|Overall Study||8
7564600|NCT02918669|18619570|P1|STARTED|Overall Study||12
7564601|NCT02918656|18619580|P3|NOT COMPLETED|Overall Study||0
7564602|NCT02918656|18619581|P2|NOT COMPLETED|Overall Study||0
7564603|NCT02918656|18619582|P1|NOT COMPLETED|Overall Study||0
7564604|NCT02918656|18619580|P3|COMPLETED|Overall Study||57
7564605|NCT02918656|18619581|P2|COMPLETED|Overall Study||60
7564606|NCT02918656|18619582|P1|COMPLETED|Overall Study||54
7564607|NCT02918656|18619580|P3|STARTED|Overall Study||57
7564608|NCT02918656|18619581|P2|STARTED|Overall Study||60
7564609|NCT02918656|18619582|P1|STARTED|Overall Study||54
7564610|NCT02918630|18619601|P2|NOT COMPLETED|Overall Study||0
7564611|NCT02918630|18619602|P1|NOT COMPLETED|Overall Study||0
7564612|NCT02918630|18619601|P2|COMPLETED|Overall Study||3
7564613|NCT02918630|18619602|P1|COMPLETED|Overall Study||4
7564614|NCT02918630|18619601|P2|STARTED|Overall Study||3
7564615|NCT02918630|18619602|P1|STARTED|Overall Study||4
7564616|NCT02918617|18619625|P9|NOT COMPLETED|Overall Study||0
7564617|NCT02918617|18619626|P8|NOT COMPLETED|Overall Study||1
7564618|NCT02918617|18619627|P7|NOT COMPLETED|Overall Study||0
7564619|NCT02918617|18619628|P6|NOT COMPLETED|Overall Study||0
7564620|NCT02918617|18619629|P5|NOT COMPLETED|Overall Study||0
7564621|NCT02918617|18619630|P4|NOT COMPLETED|Overall Study||0
7564622|NCT02918617|18619631|P3|NOT COMPLETED|Overall Study||3
7564623|NCT02918617|18619632|P2|NOT COMPLETED|Overall Study||0
7564624|NCT02918617|18619633|P1|NOT COMPLETED|Overall Study||1
7564625|NCT02918617|18619625|P9|COMPLETED|Overall Study||26
7564626|NCT02918617|18619626|P8|COMPLETED|Overall Study||25
7564627|NCT02918617|18619627|P7|COMPLETED|Overall Study||22
7564628|NCT02918617|18619628|P6|COMPLETED|Overall Study||20
7564629|NCT02918617|18619629|P5|COMPLETED|Overall Study||24
7564630|NCT02918617|18619630|P4|COMPLETED|Overall Study||22
7564631|NCT02918617|18619631|P3|COMPLETED|Overall Study||19
7564632|NCT02918617|18619632|P2|COMPLETED|Overall Study||20
7564633|NCT02918617|18619633|P1|COMPLETED|Overall Study||20
7564634|NCT02918617|18619625|P9|STARTED|Overall Study||26
7564635|NCT02918617|18619626|P8|STARTED|Overall Study||26
7564636|NCT02918617|18619627|P7|STARTED|Overall Study||22
7564637|NCT02918617|18619628|P6|STARTED|Overall Study||20
7564638|NCT02918617|18619629|P5|STARTED|Overall Study||24
7564639|NCT02918617|18619630|P4|STARTED|Overall Study||22
7564640|NCT02918617|18619631|P3|STARTED|Overall Study||22
7564641|NCT02918617|18619632|P2|STARTED|Overall Study||20
7564642|NCT02918617|18619633|P1|STARTED|Overall Study||21
7564643|NCT02918552|18619682|P2|NOT COMPLETED|Overall Study||2
7564644|NCT02918552|18619683|P1|NOT COMPLETED|Overall Study||1
7564645|NCT02918552|18619682|P2|COMPLETED|Overall Study||6
7564646|NCT02918552|18619683|P1|COMPLETED|Overall Study||6
7564647|NCT02918552|18619682|P2|STARTED|Overall Study||8
7564648|NCT02918552|18619683|P1|STARTED|Overall Study||7
7564649|NCT02918396|18619720|P3|NOT COMPLETED|Overall Study||0
7564650|NCT02918396|18619721|P2|NOT COMPLETED|Overall Study||0
7564651|NCT02918396|18619722|P1|NOT COMPLETED|Overall Study||0
7564652|NCT02918396|18619720|P3|COMPLETED|Overall Study||2
7564653|NCT02918396|18619721|P2|COMPLETED|Overall Study||1
7564654|NCT02918396|18619722|P1|COMPLETED|Overall Study||2
7564655|NCT02918396|18619720|P3|STARTED|Overall Study||2
7564656|NCT02918396|18619721|P2|STARTED|Overall Study||1
7564657|NCT02918396|18619722|P1|STARTED|Overall Study||2
7564658|NCT02918357|18619730|P1|NOT COMPLETED|Overall Study||0
7564659|NCT02918357|18619730|P1|COMPLETED|Overall Study||385
7564660|NCT02918357|18619730|P1|PET/CT Scan|Overall Study||385
7564661|NCT02918357|18619730|P1|Investigational Drug Administration|Overall Study||385
7564662|NCT02918357|18619730|P1|STARTED|Overall Study||385
7564663|NCT02918318|18619759|P5|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||1
7564664|NCT02918318|18619760|P4|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
7564665|NCT02918318|18619761|P3|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
7564666|NCT02918318|18619762|P2|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
7564667|NCT02918318|18619763|P1|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
7564668|NCT02918318|18619759|P5|COMPLETED|Open Label Follow-up Phase: 4 Weeks||47
7564669|NCT02918318|18619760|P4|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
7564670|NCT02918318|18619761|P3|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
7564671|NCT02918318|18619762|P2|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
7564672|NCT02918318|18619763|P1|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
7564673|NCT02918318|18619759|P5|STARTED|Open Label Follow-up Phase: 4 Weeks||48
7564674|NCT02918318|18619760|P4|STARTED|Open Label Follow-up Phase: 4 Weeks||0
7564675|NCT02918318|18619761|P3|STARTED|Open Label Follow-up Phase: 4 Weeks||0
7564676|NCT02918318|18619762|P2|STARTED|Open Label Follow-up Phase: 4 Weeks||0
7564677|NCT02918318|18619763|P1|STARTED|Open Label Follow-up Phase: 4 Weeks||0
7564678|NCT02918318|18619759|P5|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||1
7564679|NCT02918318|18619760|P4|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
7564680|NCT02918318|18619761|P3|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
7564681|NCT02918318|18619762|P2|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
7564682|NCT02918318|18619763|P1|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
7564683|NCT02918318|18619759|P5|COMPLETED|Open Label Treatment Phase: 4 Weeks||47
7564684|NCT02918318|18619760|P4|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
7564685|NCT02918318|18619761|P3|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
7564686|NCT02918318|18619762|P2|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
7564687|NCT02918318|18619763|P1|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
7564688|NCT02918318|18619759|P5|STARTED|Open Label Treatment Phase: 4 Weeks||48
7564689|NCT02918318|18619760|P4|STARTED|Open Label Treatment Phase: 4 Weeks||0
7564690|NCT02918318|18619761|P3|STARTED|Open Label Treatment Phase: 4 Weeks||0
7564691|NCT02918318|18619762|P2|STARTED|Open Label Treatment Phase: 4 Weeks||0
7564692|NCT02918318|18619763|P1|STARTED|Open Label Treatment Phase: 4 Weeks||0
7564693|NCT02918318|18619759|P5|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
7564694|NCT02918318|18619760|P4|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||2
7564695|NCT02918318|18619761|P3|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
7564696|NCT02918318|18619762|P2|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||3
7564697|NCT02918318|18619763|P1|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
7564698|NCT02918318|18619759|P5|COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
7564699|NCT02918318|18619760|P4|COMPLETED|Posttreatment Phase: Up to 24 Weeks||25
7564700|NCT02918318|18619761|P3|COMPLETED|Posttreatment Phase: Up to 24 Weeks||16
7564701|NCT02918318|18619762|P2|COMPLETED|Posttreatment Phase: Up to 24 Weeks||8
7564702|NCT02918318|18619763|P1|COMPLETED|Posttreatment Phase: Up to 24 Weeks||12
7564703|NCT02918318|18619759|P5|STARTED|Posttreatment Phase: Up to 24 Weeks||0
7564704|NCT02918318|18619760|P4|STARTED|Posttreatment Phase: Up to 24 Weeks||27
7564705|NCT02918318|18619761|P3|STARTED|Posttreatment Phase: Up to 24 Weeks||17
7564706|NCT02918318|18619762|P2|STARTED|Posttreatment Phase: Up to 24 Weeks||11
7564707|NCT02918318|18619763|P1|STARTED|Posttreatment Phase: Up to 24 Weeks||13
7564708|NCT02918318|18619759|P5|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
7564709|NCT02918318|18619760|P4|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||3
7564710|NCT02918318|18619761|P3|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
7564711|NCT02918318|18619762|P2|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
7564712|NCT02918318|18619763|P1|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
7564713|NCT02918318|18619759|P5|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
7564714|NCT02918318|18619760|P4|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||50
7564715|NCT02918318|18619761|P3|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||23
7564716|NCT02918318|18619762|P2|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||28
7564717|NCT02918318|18619763|P1|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||26
7564718|NCT02918318|18619759|P5|STARTED|Double-blind Follow-up Phase: 4 Weeks||0
7564719|NCT02918318|18619760|P4|STARTED|Double-blind Follow-up Phase: 4 Weeks||53
7564720|NCT02918318|18619761|P3|STARTED|Double-blind Follow-up Phase: 4 Weeks||24
7564721|NCT02918318|18619762|P2|STARTED|Double-blind Follow-up Phase: 4 Weeks||28
7564722|NCT02918318|18619763|P1|STARTED|Double-blind Follow-up Phase: 4 Weeks||27
7564723|NCT02918318|18619759|P5|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||0
7564724|NCT02918318|18619760|P4|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||8
7564725|NCT02918318|18619761|P3|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
7564726|NCT02918318|18619762|P2|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||7
7564727|NCT02918318|18619763|P1|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
7564728|NCT02918318|18619759|P5|COMPLETED|Double-blind Induction Phase: 4 Weeks||0
7564729|NCT02918318|18619760|P4|COMPLETED|Double-blind Induction Phase: 4 Weeks||72
7564730|NCT02918318|18619761|P3|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
7564731|NCT02918318|18619762|P2|COMPLETED|Double-blind Induction Phase: 4 Weeks||33
7564732|NCT02918318|18619763|P1|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
7564733|NCT02918318|18619759|P5|Responders|Double-blind Induction Phase: 4 Weeks||0
7564734|NCT02918318|18619760|P4|Responders|Double-blind Induction Phase: 4 Weeks||27
7564735|NCT02918318|18619761|P3|Responders|Double-blind Induction Phase: 4 Weeks||17
7564736|NCT02918318|18619762|P2|Responders|Double-blind Induction Phase: 4 Weeks||11
7564737|NCT02918318|18619763|P1|Responders|Double-blind Induction Phase: 4 Weeks||13
7564738|NCT02918318|18619759|P5|STARTED|Double-blind Induction Phase: 4 Weeks||0
7564739|NCT02918318|18619760|P4|STARTED|Double-blind Induction Phase: 4 Weeks||80
7564740|NCT02918318|18619761|P3|STARTED|Double-blind Induction Phase: 4 Weeks||41
7564741|NCT02918318|18619762|P2|STARTED|Double-blind Induction Phase: 4 Weeks||40
7564742|NCT02918318|18619763|P1|STARTED|Double-blind Induction Phase: 4 Weeks||41
7564743|NCT02918279|18619824|P2|NOT COMPLETED|Overall Study||23
7564744|NCT02918279|18619825|P1|NOT COMPLETED|Overall Study||13
7564745|NCT02918279|18619824|P2|COMPLETED|Overall Study||103
7564746|NCT02918279|18619825|P1|COMPLETED|Overall Study||112
7564747|NCT02918279|18619824|P2|Safety Analysis Set|Overall Study||126
7564748|NCT02918279|18619825|P1|Safety Analysis Set|Overall Study||125
7564749|NCT02918279|18619824|P2|Full Analysis Set|Overall Study||126
7564750|NCT02918279|18619825|P1|Full Analysis Set|Overall Study||125
7564751|NCT02918279|18619824|P2|STARTED|Overall Study||126
7564752|NCT02918279|18619825|P1|STARTED|Overall Study||125
7564753|NCT02918266|18619961|P11|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564754|NCT02918266|18619962|P10|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564755|NCT02918266|18619963|P9|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564756|NCT02918266|18619964|P8|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564757|NCT02918266|18619965|P7|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564758|NCT02918266|18619966|P6|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564759|NCT02918266|18619967|P5|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564760|NCT02918266|18619968|P4|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564761|NCT02918266|18619969|P3|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564762|NCT02918266|18619970|P2|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564763|NCT02918266|18619971|P1|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564764|NCT02918266|18619961|P11|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564765|NCT02918266|18619962|P10|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564766|NCT02918266|18619963|P9|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564767|NCT02918266|18619964|P8|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564768|NCT02918266|18619965|P7|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564769|NCT02918266|18619966|P6|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564770|NCT02918266|18619967|P5|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564771|NCT02918266|18619968|P4|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564772|NCT02918266|18619969|P3|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564773|NCT02918266|18619970|P2|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564774|NCT02918266|18619971|P1|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
7564775|NCT02918266|18619961|P11|STARTED|Part 2: Intervention Period 5 (2 Days)||0
7564776|NCT02918266|18619962|P10|STARTED|Part 2: Intervention Period 5 (2 Days)||0
7564777|NCT02918266|18619963|P9|STARTED|Part 2: Intervention Period 5 (2 Days)||0
7564778|NCT02918266|18619964|P8|STARTED|Part 2: Intervention Period 5 (2 Days)||0
7564779|NCT02918266|18619965|P7|STARTED|Part 2: Intervention Period 5 (2 Days)||0
7564780|NCT02918266|18619966|P6|STARTED|Part 2: Intervention Period 5 (2 Days)||0
7564781|NCT02918266|18619967|P5|STARTED|Part 2: Intervention Period 5 (2 Days)||0
7564782|NCT02918266|18619968|P4|STARTED|Part 2: Intervention Period 5 (2 Days)||0
7564783|NCT02918266|18619969|P3|STARTED|Part 2: Intervention Period 5 (2 Days)||0
7564784|NCT02918266|18619970|P2|STARTED|Part 2: Intervention Period 5 (2 Days)||0
7564785|NCT02918266|18619971|P1|STARTED|Part 2: Intervention Period 5 (2 Days)||0
7564786|NCT02918266|18619961|P11|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564787|NCT02918266|18619962|P10|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564788|NCT02918266|18619963|P9|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564789|NCT02918266|18619964|P8|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564790|NCT02918266|18619965|P7|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564791|NCT02918266|18619966|P6|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564792|NCT02918266|18619967|P5|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564793|NCT02918266|18619968|P4|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564794|NCT02918266|18619969|P3|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564795|NCT02918266|18619970|P2|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564796|NCT02918266|18619971|P1|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564797|NCT02918266|18619961|P11|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564798|NCT02918266|18619962|P10|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564799|NCT02918266|18619963|P9|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564800|NCT02918266|18619964|P8|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564801|NCT02918266|18619965|P7|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564802|NCT02918266|18619966|P6|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564803|NCT02918266|18619967|P5|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564804|NCT02918266|18619968|P4|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564805|NCT02918266|18619969|P3|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564806|NCT02918266|18619970|P2|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564807|NCT02918266|18619971|P1|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
7564808|NCT02918266|18619961|P11|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
7564809|NCT02918266|18619962|P10|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
7564810|NCT02918266|18619963|P9|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
7564811|NCT02918266|18619964|P8|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
7564812|NCT02918266|18619965|P7|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
7564813|NCT02918266|18619966|P6|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
7564814|NCT02918266|18619967|P5|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
7564815|NCT02918266|18619968|P4|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
7564816|NCT02918266|18619969|P3|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
7564817|NCT02918266|18619970|P2|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
7564818|NCT02918266|18619971|P1|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
7564819|NCT02918266|18619961|P11|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564820|NCT02918266|18619962|P10|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564821|NCT02918266|18619963|P9|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564822|NCT02918266|18619964|P8|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564823|NCT02918266|18619965|P7|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564824|NCT02918266|18619966|P6|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564825|NCT02918266|18619967|P5|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564826|NCT02918266|18619968|P4|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564827|NCT02918266|18619969|P3|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564828|NCT02918266|18619970|P2|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564829|NCT02918266|18619971|P1|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564830|NCT02918266|18619961|P11|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564831|NCT02918266|18619962|P10|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564832|NCT02918266|18619963|P9|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564833|NCT02918266|18619964|P8|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564834|NCT02918266|18619965|P7|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564835|NCT02918266|18619966|P6|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564836|NCT02918266|18619967|P5|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564837|NCT02918266|18619968|P4|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564838|NCT02918266|18619969|P3|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564839|NCT02918266|18619970|P2|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564840|NCT02918266|18619971|P1|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
7564841|NCT02918266|18619961|P11|STARTED|Part 2: Intervention Period 4 (2 Days)||0
7564842|NCT02918266|18619962|P10|STARTED|Part 2: Intervention Period 4 (2 Days)||0
7564843|NCT02918266|18619963|P9|STARTED|Part 2: Intervention Period 4 (2 Days)||0
7564844|NCT02918266|18619964|P8|STARTED|Part 2: Intervention Period 4 (2 Days)||0
7564845|NCT02918266|18619965|P7|STARTED|Part 2: Intervention Period 4 (2 Days)||0
7564846|NCT02918266|18619966|P6|STARTED|Part 2: Intervention Period 4 (2 Days)||0
7564847|NCT02918266|18619967|P5|STARTED|Part 2: Intervention Period 4 (2 Days)||0
7564848|NCT02918266|18619968|P4|STARTED|Part 2: Intervention Period 4 (2 Days)||0
7564849|NCT02918266|18619969|P3|STARTED|Part 2: Intervention Period 4 (2 Days)||0
7564850|NCT02918266|18619970|P2|STARTED|Part 2: Intervention Period 4 (2 Days)||0
7564851|NCT02918266|18619971|P1|STARTED|Part 2: Intervention Period 4 (2 Days)||0
7564852|NCT02918266|18619961|P11|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564853|NCT02918266|18619962|P10|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564854|NCT02918266|18619963|P9|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564855|NCT02918266|18619964|P8|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564856|NCT02918266|18619965|P7|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564857|NCT02918266|18619966|P6|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564858|NCT02918266|18619967|P5|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564859|NCT02918266|18619968|P4|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564860|NCT02918266|18619969|P3|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564861|NCT02918266|18619970|P2|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564862|NCT02918266|18619971|P1|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564863|NCT02918266|18619961|P11|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564864|NCT02918266|18619962|P10|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564865|NCT02918266|18619963|P9|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564866|NCT02918266|18619964|P8|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564867|NCT02918266|18619965|P7|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564868|NCT02918266|18619966|P6|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564869|NCT02918266|18619967|P5|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564870|NCT02918266|18619968|P4|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564871|NCT02918266|18619969|P3|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564872|NCT02918266|18619970|P2|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564873|NCT02918266|18619971|P1|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
7564874|NCT02918266|18619961|P11|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
7564875|NCT02918266|18619962|P10|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
7564876|NCT02918266|18619963|P9|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
7564877|NCT02918266|18619964|P8|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
7564878|NCT02918266|18619965|P7|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
7564879|NCT02918266|18619966|P6|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
7564880|NCT02918266|18619967|P5|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
7564881|NCT02918266|18619968|P4|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
7564882|NCT02918266|18619969|P3|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
7564883|NCT02918266|18619970|P2|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
7564884|NCT02918266|18619971|P1|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
7564885|NCT02918266|18619961|P11|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564886|NCT02918266|18619962|P10|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564887|NCT02918266|18619963|P9|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564888|NCT02918266|18619964|P8|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564889|NCT02918266|18619965|P7|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564890|NCT02918266|18619966|P6|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564891|NCT02918266|18619967|P5|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564892|NCT02918266|18619968|P4|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564893|NCT02918266|18619969|P3|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564894|NCT02918266|18619970|P2|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564895|NCT02918266|18619971|P1|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564896|NCT02918266|18619961|P11|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564897|NCT02918266|18619962|P10|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564898|NCT02918266|18619963|P9|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564899|NCT02918266|18619964|P8|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564900|NCT02918266|18619965|P7|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564901|NCT02918266|18619966|P6|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564902|NCT02918266|18619967|P5|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564903|NCT02918266|18619968|P4|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564904|NCT02918266|18619969|P3|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564905|NCT02918266|18619970|P2|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564906|NCT02918266|18619971|P1|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
7564907|NCT02918266|18619961|P11|STARTED|Part 2: Intervention Period 3 (2 Days)||0
7564908|NCT02918266|18619962|P10|STARTED|Part 2: Intervention Period 3 (2 Days)||0
7564909|NCT02918266|18619963|P9|STARTED|Part 2: Intervention Period 3 (2 Days)||0
7564910|NCT02918266|18619964|P8|STARTED|Part 2: Intervention Period 3 (2 Days)||0
7564911|NCT02918266|18619965|P7|STARTED|Part 2: Intervention Period 3 (2 Days)||0
7564912|NCT02918266|18619966|P6|STARTED|Part 2: Intervention Period 3 (2 Days)||0
7564913|NCT02918266|18619967|P5|STARTED|Part 2: Intervention Period 3 (2 Days)||0
7564914|NCT02918266|18619968|P4|STARTED|Part 2: Intervention Period 3 (2 Days)||0
7564915|NCT02918266|18619969|P3|STARTED|Part 2: Intervention Period 3 (2 Days)||0
7564916|NCT02918266|18619970|P2|STARTED|Part 2: Intervention Period 3 (2 Days)||0
7564917|NCT02918266|18619971|P1|STARTED|Part 2: Intervention Period 3 (2 Days)||0
7564918|NCT02918266|18619961|P11|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564919|NCT02918266|18619962|P10|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564920|NCT02918266|18619963|P9|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564921|NCT02918266|18619964|P8|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564922|NCT02918266|18619965|P7|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564923|NCT02918266|18619966|P6|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564924|NCT02918266|18619967|P5|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564925|NCT02918266|18619968|P4|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564926|NCT02918266|18619969|P3|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564927|NCT02918266|18619970|P2|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564928|NCT02918266|18619971|P1|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564929|NCT02918266|18619961|P11|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564930|NCT02918266|18619962|P10|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564931|NCT02918266|18619963|P9|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564932|NCT02918266|18619964|P8|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564933|NCT02918266|18619965|P7|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564934|NCT02918266|18619966|P6|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564935|NCT02918266|18619967|P5|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564936|NCT02918266|18619968|P4|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564937|NCT02918266|18619969|P3|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564938|NCT02918266|18619970|P2|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564939|NCT02918266|18619971|P1|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
7564940|NCT02918266|18619961|P11|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
7564941|NCT02918266|18619962|P10|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
7564942|NCT02918266|18619963|P9|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
7564943|NCT02918266|18619964|P8|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
7564944|NCT02918266|18619965|P7|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
7564945|NCT02918266|18619966|P6|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
7564946|NCT02918266|18619967|P5|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
7564947|NCT02918266|18619968|P4|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
7564948|NCT02918266|18619969|P3|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
7564949|NCT02918266|18619970|P2|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
7564950|NCT02918266|18619971|P1|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
7564951|NCT02918266|18619961|P11|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564952|NCT02918266|18619962|P10|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564953|NCT02918266|18619963|P9|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564954|NCT02918266|18619964|P8|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564955|NCT02918266|18619965|P7|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564956|NCT02918266|18619966|P6|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564957|NCT02918266|18619967|P5|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564958|NCT02918266|18619968|P4|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564959|NCT02918266|18619969|P3|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564960|NCT02918266|18619970|P2|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564961|NCT02918266|18619971|P1|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564962|NCT02918266|18619961|P11|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564963|NCT02918266|18619962|P10|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564964|NCT02918266|18619963|P9|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564965|NCT02918266|18619964|P8|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564966|NCT02918266|18619965|P7|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564967|NCT02918266|18619966|P6|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564968|NCT02918266|18619967|P5|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564969|NCT02918266|18619968|P4|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564970|NCT02918266|18619969|P3|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564971|NCT02918266|18619970|P2|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564972|NCT02918266|18619971|P1|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
7564973|NCT02918266|18619961|P11|STARTED|Part 2: Intervention Period 2 (2 Days)||0
7564974|NCT02918266|18619962|P10|STARTED|Part 2: Intervention Period 2 (2 Days)||0
7564975|NCT02918266|18619963|P9|STARTED|Part 2: Intervention Period 2 (2 Days)||0
7564976|NCT02918266|18619964|P8|STARTED|Part 2: Intervention Period 2 (2 Days)||0
7564977|NCT02918266|18619965|P7|STARTED|Part 2: Intervention Period 2 (2 Days)||0
7564978|NCT02918266|18619966|P6|STARTED|Part 2: Intervention Period 2 (2 Days)||0
7564979|NCT02918266|18619967|P5|STARTED|Part 2: Intervention Period 2 (2 Days)||0
7564980|NCT02918266|18619968|P4|STARTED|Part 2: Intervention Period 2 (2 Days)||0
7564981|NCT02918266|18619969|P3|STARTED|Part 2: Intervention Period 2 (2 Days)||0
7564982|NCT02918266|18619970|P2|STARTED|Part 2: Intervention Period 2 (2 Days)||0
7564983|NCT02918266|18619971|P1|STARTED|Part 2: Intervention Period 2 (2 Days)||0
7564984|NCT02918266|18619961|P11|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7564985|NCT02918266|18619962|P10|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7564986|NCT02918266|18619963|P9|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7564987|NCT02918266|18619964|P8|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7564988|NCT02918266|18619965|P7|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7564989|NCT02918266|18619966|P6|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7564990|NCT02918266|18619967|P5|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7564991|NCT02918266|18619968|P4|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7564992|NCT02918266|18619969|P3|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7564993|NCT02918266|18619970|P2|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7564994|NCT02918266|18619971|P1|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7564995|NCT02918266|18619961|P11|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7564996|NCT02918266|18619962|P10|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7564997|NCT02918266|18619963|P9|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7564998|NCT02918266|18619964|P8|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7564999|NCT02918266|18619965|P7|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7565000|NCT02918266|18619966|P6|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7565001|NCT02918266|18619967|P5|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7565002|NCT02918266|18619968|P4|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7565003|NCT02918266|18619969|P3|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7565004|NCT02918266|18619970|P2|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7565005|NCT02918266|18619971|P1|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
7565006|NCT02918266|18619961|P11|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
7565007|NCT02918266|18619962|P10|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
7565008|NCT02918266|18619963|P9|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
7565009|NCT02918266|18619964|P8|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
7565010|NCT02918266|18619965|P7|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
7565011|NCT02918266|18619966|P6|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
7565012|NCT02918266|18619967|P5|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
7565013|NCT02918266|18619968|P4|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
7565014|NCT02918266|18619969|P3|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
7565015|NCT02918266|18619970|P2|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
7565016|NCT02918266|18619971|P1|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
7565017|NCT02918266|18619961|P11|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
7565018|NCT02918266|18619962|P10|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
7565019|NCT02918266|18619963|P9|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
7565020|NCT02918266|18619964|P8|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
7565021|NCT02918266|18619965|P7|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
7565022|NCT02918266|18619966|P6|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
7565023|NCT02918266|18619967|P5|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
7565024|NCT02918266|18619968|P4|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
7565025|NCT02918266|18619969|P3|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
7565026|NCT02918266|18619970|P2|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
7565027|NCT02918266|18619971|P1|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
7565028|NCT02918266|18619961|P11|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
7565029|NCT02918266|18619962|P10|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
7565030|NCT02918266|18619963|P9|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
7565031|NCT02918266|18619964|P8|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
7565032|NCT02918266|18619965|P7|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
7565033|NCT02918266|18619966|P6|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
7565034|NCT02918266|18619967|P5|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
7565035|NCT02918266|18619968|P4|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
7565036|NCT02918266|18619969|P3|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
7565037|NCT02918266|18619970|P2|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
7565038|NCT02918266|18619971|P1|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
7565039|NCT02918266|18619961|P11|STARTED|Part 2: Intervention Period 1 (2 Days)||1
7565040|NCT02918266|18619962|P10|STARTED|Part 2: Intervention Period 1 (2 Days)||1
7565041|NCT02918266|18619963|P9|STARTED|Part 2: Intervention Period 1 (2 Days)||2
7565042|NCT02918266|18619964|P8|STARTED|Part 2: Intervention Period 1 (2 Days)||1
7565043|NCT02918266|18619965|P7|STARTED|Part 2: Intervention Period 1 (2 Days)||2
7565044|NCT02918266|18619966|P6|STARTED|Part 2: Intervention Period 1 (2 Days)||1
7565045|NCT02918266|18619967|P5|STARTED|Part 2: Intervention Period 1 (2 Days)||1
7565046|NCT02918266|18619968|P4|STARTED|Part 2: Intervention Period 1 (2 Days)||1
7565047|NCT02918266|18619969|P3|STARTED|Part 2: Intervention Period 1 (2 Days)||1
7565048|NCT02918266|18619970|P2|STARTED|Part 2: Intervention Period 1 (2 Days)||1
7565049|NCT02918266|18619971|P1|STARTED|Part 2: Intervention Period 1 (2 Days)||0
7565050|NCT02918266|18619961|P11|NOT COMPLETED|Part 1||0
7565051|NCT02918266|18619962|P10|NOT COMPLETED|Part 1||0
7565052|NCT02918266|18619963|P9|NOT COMPLETED|Part 1||0
7565053|NCT02918266|18619964|P8|NOT COMPLETED|Part 1||0
7565054|NCT02918266|18619965|P7|NOT COMPLETED|Part 1||0
7565055|NCT02918266|18619966|P6|NOT COMPLETED|Part 1||0
7565056|NCT02918266|18619967|P5|NOT COMPLETED|Part 1||0
7565057|NCT02918266|18619968|P4|NOT COMPLETED|Part 1||0
7565058|NCT02918266|18619969|P3|NOT COMPLETED|Part 1||0
7565059|NCT02918266|18619970|P2|NOT COMPLETED|Part 1||0
7565060|NCT02918266|18619971|P1|NOT COMPLETED|Part 1||0
7565061|NCT02918266|18619961|P11|COMPLETED|Part 1||0
7565062|NCT02918266|18619962|P10|COMPLETED|Part 1||0
7565063|NCT02918266|18619963|P9|COMPLETED|Part 1||0
7565064|NCT02918266|18619964|P8|COMPLETED|Part 1||0
7565065|NCT02918266|18619965|P7|COMPLETED|Part 1||0
7565066|NCT02918266|18619966|P6|COMPLETED|Part 1||0
7565067|NCT02918266|18619967|P5|COMPLETED|Part 1||0
7565068|NCT02918266|18619968|P4|COMPLETED|Part 1||0
7565069|NCT02918266|18619969|P3|COMPLETED|Part 1||0
7565070|NCT02918266|18619970|P2|COMPLETED|Part 1||0
7565071|NCT02918266|18619971|P1|COMPLETED|Part 1||6
7565072|NCT02918266|18619961|P11|STARTED|Part 1||0
7565073|NCT02918266|18619962|P10|STARTED|Part 1||0
7565074|NCT02918266|18619963|P9|STARTED|Part 1||0
7565075|NCT02918266|18619964|P8|STARTED|Part 1||0
7565076|NCT02918266|18619965|P7|STARTED|Part 1||0
7565077|NCT02918266|18619966|P6|STARTED|Part 1||0
7565078|NCT02918266|18619967|P5|STARTED|Part 1||0
7565079|NCT02918266|18619968|P4|STARTED|Part 1||0
7565080|NCT02918266|18619969|P3|STARTED|Part 1||0
7565081|NCT02918266|18619970|P2|STARTED|Part 1||0
7565082|NCT02918266|18619971|P1|STARTED|Part 1||6
7565083|NCT02918097|18620070|P1|NOT COMPLETED|Overall Study||20
7565084|NCT02918097|18620070|P1|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|58
7565085|NCT02918097|18620070|P1|STARTED|Overall Study||78
7565086|NCT02918071|18620076|P1|NOT COMPLETED|Overall Study||3
7565087|NCT02918071|18620076|P1|COMPLETED|Overall Study||118
7565088|NCT02918071|18620076|P1|STARTED|Overall Study||121
7565089|NCT02917941|18620086|P1|NOT COMPLETED|Survival Follow-up Period||5
7565090|NCT02917941|18620086|P1|COMPLETED|Survival Follow-up Period||26
7565091|NCT02917941|18620086|P1|STARTED|Survival Follow-up Period||31
7565092|NCT02917941|18620086|P1|NOT COMPLETED|Treatment Period||24
7565093|NCT02917941|18620086|P1|COMPLETED|Treatment Period||10
7565094|NCT02917941|18620086|P1|STARTED|Treatment Period||34
7565095|NCT02917642|18620100|P2|NOT COMPLETED|Overall Study||0
7565096|NCT02917642|18620101|P1|NOT COMPLETED|Overall Study||0
7565097|NCT02917642|18620100|P2|COMPLETED|Overall Study||25
7565098|NCT02917642|18620101|P1|COMPLETED|Overall Study||25
7565099|NCT02917642|18620100|P2|STARTED|Overall Study||25
7565100|NCT02917642|18620101|P1|STARTED|Overall Study||25
7565101|NCT02917603|18620111|P2|NOT COMPLETED|Overall Study||4
7565102|NCT02917603|18620112|P1|NOT COMPLETED|Overall Study||1
7565103|NCT02917603|18620111|P2|COMPLETED|Overall Study||16
7565104|NCT02917603|18620112|P1|COMPLETED|Overall Study||19
7565105|NCT02917603|18620111|P2|STARTED|Overall Study||20
7565106|NCT02917603|18620112|P1|STARTED|Overall Study||20
7565107|NCT02917447|18620126|P2|NOT COMPLETED|Overall Study||3
7565108|NCT02917447|18620127|P1|NOT COMPLETED|Overall Study||7
7565109|NCT02917447|18620126|P2|COMPLETED|Overall Study||48
7565110|NCT02917447|18620127|P1|COMPLETED|Overall Study||44
7565111|NCT02917447|18620126|P2|STARTED|Overall Study||51
7565112|NCT02917447|18620127|P1|STARTED|Overall Study||51
7565113|NCT02917265|18620139|P2|NOT COMPLETED|Overall Study||0
7565114|NCT02917265|18620140|P1|NOT COMPLETED|Overall Study||2
7565115|NCT02917265|18620139|P2|COMPLETED|Overall Study||2
7565116|NCT02917265|18620140|P1|COMPLETED|Overall Study||3
7565117|NCT02917265|18620139|P2|STARTED|Overall Study||2
7565118|NCT02917265|18620140|P1|STARTED|Overall Study||5
7565119|NCT02916927|18620156|P2|NOT COMPLETED|Overall Study||3
7565120|NCT02916927|18620157|P1|NOT COMPLETED|Overall Study||1
7565121|NCT02916927|18620156|P2|COMPLETED|Overall Study|1 participant was in radiology for the 45 and 60 minute time points.|28
7565122|NCT02916927|18620157|P1|COMPLETED|Overall Study||30
7565123|NCT02916927|18620156|P2|Received Study Drug|Overall Study||29
7565124|NCT02916927|18620157|P1|Received Study Drug|Overall Study||31
7565125|NCT02916927|18620156|P2|STARTED|Overall Study||31
7565126|NCT02916927|18620157|P1|STARTED|Overall Study||31
7565127|NCT02916745|18620171|P1|NOT COMPLETED|Overall Study||0
7565128|NCT02916745|18620171|P1|COMPLETED|Overall Study||5
7565129|NCT02916745|18620171|P1|STARTED|Overall Study||5
7565130|NCT02916563|18620201|P1|NOT COMPLETED|Overall Study||0
7565131|NCT02916563|18620201|P1|COMPLETED|Overall Study||50
7565132|NCT02916563|18620201|P1|STARTED|Overall Study||50
7565133|NCT02916498|18620207|P2|NOT COMPLETED|Second Intervention, 21 Days||0
7565134|NCT02916498|18620208|P1|NOT COMPLETED|Second Intervention, 21 Days||0
7565135|NCT02916498|18620207|P2|COMPLETED|Second Intervention, 21 Days||4
7565136|NCT02916498|18620208|P1|COMPLETED|Second Intervention, 21 Days||2
7565137|NCT02916498|18620207|P2|STARTED|Second Intervention, 21 Days||4
7565138|NCT02916498|18620208|P1|STARTED|Second Intervention, 21 Days||2
7565139|NCT02916498|18620207|P2|NOT COMPLETED|First Intervention, 21 Days||0
7565140|NCT02916498|18620208|P1|NOT COMPLETED|First Intervention, 21 Days||0
7565141|NCT02916498|18620207|P2|COMPLETED|First Intervention, 21 Days||4
7565142|NCT02916498|18620208|P1|COMPLETED|First Intervention, 21 Days||2
7565143|NCT02916498|18620207|P2|STARTED|First Intervention, 21 Days||4
7565144|NCT02916498|18620208|P1|STARTED|First Intervention, 21 Days||2
7565145|NCT02916433|18620216|P2|NOT COMPLETED|Overall Study||0
7565146|NCT02916433|18620217|P1|NOT COMPLETED|Overall Study||2
7565147|NCT02916433|18620216|P2|COMPLETED|Overall Study||2
7565148|NCT02916433|18620217|P1|COMPLETED|Overall Study||1
7565149|NCT02916433|18620216|P2|STARTED|Overall Study||2
7565150|NCT02916433|18620217|P1|STARTED|Overall Study||3
7565151|NCT02916407|18620228|P2|NOT COMPLETED|Overall Study||0
7565152|NCT02916407|18620229|P1|NOT COMPLETED|Overall Study||0
7565153|NCT02916407|18620228|P2|COMPLETED|Overall Study||28
7565154|NCT02916407|18620229|P1|COMPLETED|Overall Study||28
7565155|NCT02916407|18620228|P2|STARTED|Overall Study||28
7565156|NCT02916407|18620229|P1|STARTED|Overall Study||28
7565157|NCT02915978|18620240|P3|NOT COMPLETED|Overall Study||0
7565158|NCT02915978|18620241|P2|NOT COMPLETED|Overall Study||1
7565159|NCT02915978|18620242|P1|NOT COMPLETED|Overall Study||2
7565160|NCT02915978|18620240|P3|COMPLETED|Overall Study||15
7565161|NCT02915978|18620241|P2|COMPLETED|Overall Study||14
7565162|NCT02915978|18620242|P1|COMPLETED|Overall Study||13
7565163|NCT02915978|18620240|P3|STARTED|Overall Study||15
7565164|NCT02915978|18620241|P2|STARTED|Overall Study||15
7565165|NCT02915978|18620242|P1|STARTED|Overall Study||15
7565166|NCT02915874|18620294|P2|NOT COMPLETED|Overall Study||6
7565167|NCT02915874|18620295|P1|NOT COMPLETED|Overall Study||6
7565168|NCT02915874|18620294|P2|COMPLETED|Overall Study||22
7565169|NCT02915874|18620295|P1|COMPLETED|Overall Study||38
7565170|NCT02915874|18620294|P2|Week 6 Follow Up|Overall Study||26
7565171|NCT02915874|18620295|P1|Week 6 Follow Up|Overall Study||41
7565172|NCT02915874|18620294|P2|STARTED|Overall Study||28
7565173|NCT02915874|18620295|P1|STARTED|Overall Study||44
7565174|NCT02915835|18620315|P2|NOT COMPLETED|Overall Study||1
7565175|NCT02915835|18620316|P1|NOT COMPLETED|Overall Study||1
7565176|NCT02915835|18620315|P2|COMPLETED|Overall Study||7
7565177|NCT02915835|18620316|P1|COMPLETED|Overall Study||8
7565178|NCT02915835|18620315|P2|STARTED|Overall Study||8
7565179|NCT02915835|18620316|P1|STARTED|Overall Study||9
7565180|NCT02915783|18620440|P1|NOT COMPLETED|Overall Study||14
7565181|NCT02915783|18620440|P1|COMPLETED|Overall Study||17
7565182|NCT02915783|18620440|P1|STARTED|Overall Study||31
7565183|NCT02915705|18620448|P2|NOT COMPLETED|Long Term Extension Period||0
7565184|NCT02915705|18620449|P1|NOT COMPLETED|Long Term Extension Period||0
7565185|NCT02915705|18620448|P2|COMPLETED|Long Term Extension Period||25
7565186|NCT02915705|18620449|P1|COMPLETED|Long Term Extension Period||26
7565187|NCT02915705|18620448|P2|STARTED|Long Term Extension Period|4 participants did not enter the extension period|25
7565188|NCT02915705|18620449|P1|STARTED|Long Term Extension Period|6 participants did not enter the extension period|26
7565189|NCT02915705|18620448|P2|NOT COMPLETED|Treatment Period||0
7565190|NCT02915705|18620449|P1|NOT COMPLETED|Treatment Period||0
7565191|NCT02915705|18620448|P2|COMPLETED|Treatment Period||29
7565192|NCT02915705|18620449|P1|COMPLETED|Treatment Period||32
7565193|NCT02915705|18620448|P2|Completed Week 64|Treatment Period||29
7565194|NCT02915705|18620449|P1|Completed Week 64|Treatment Period||32
7565195|NCT02915705|18620448|P2|Completed Week 40|Treatment Period||29
7565196|NCT02915705|18620449|P1|Completed Week 40|Treatment Period||32
7565197|NCT02915705|18620448|P2|STARTED|Treatment Period||29
7565198|NCT02915705|18620449|P1|STARTED|Treatment Period||32
7565199|NCT02915302|18620522|P2|NOT COMPLETED|Overall Study||78
7565200|NCT02915302|18620523|P1|NOT COMPLETED|Overall Study||65
7565201|NCT02915302|18620522|P2|COMPLETED|Overall Study||917
7565202|NCT02915302|18620523|P1|COMPLETED|Overall Study||890
7565203|NCT02915302|18620522|P2|Vaccinated (Safety Analysis Set)|Overall Study||992
7565204|NCT02915302|18620523|P1|Vaccinated (Safety Analysis Set)|Overall Study||949
7565205|NCT02915302|18620522|P2|STARTED|Overall Study||995
7565206|NCT02915302|18620523|P1|STARTED|Overall Study||955
7565207|NCT02915159|18620535|P2|NOT COMPLETED|Overall Study||8
7565208|NCT02915159|18620536|P1|NOT COMPLETED|Overall Study||11
7565209|NCT02915159|18620535|P2|COMPLETED|Overall Study||87
7565210|NCT02915159|18620536|P1|COMPLETED|Overall Study||81
7565211|NCT02915159|18620535|P2|STARTED|Overall Study||95
7565212|NCT02915159|18620536|P1|STARTED|Overall Study||92
7565213|NCT02915029|18620622|P2|NOT COMPLETED|Overall Study||14
7565214|NCT02915029|18620623|P1|NOT COMPLETED|Overall Study||13
7565215|NCT02915029|18620622|P2|COMPLETED|Overall Study||48
7565216|NCT02915029|18620623|P1|COMPLETED|Overall Study||50
7565217|NCT02915029|18620622|P2|STARTED|Overall Study||62
7565218|NCT02915029|18620623|P1|STARTED|Overall Study||63
7565219|NCT02915016|18620675|P8|NOT COMPLETED|Overall Study||4
7565220|NCT02915016|18620676|P7|NOT COMPLETED|Overall Study||12
7565221|NCT02915016|18620677|P6|NOT COMPLETED|Overall Study||6
7565222|NCT02915016|18620678|P5|NOT COMPLETED|Overall Study||7
7565223|NCT02915016|18620679|P4|NOT COMPLETED|Overall Study||4
7565224|NCT02915016|18620680|P3|NOT COMPLETED|Overall Study||8
7565225|NCT02915016|18620681|P2|NOT COMPLETED|Overall Study||3
7565226|NCT02915016|18620682|P1|NOT COMPLETED|Overall Study||7
7565227|NCT02915016|18620675|P8|COMPLETED|Overall Study||20
7565228|NCT02915016|18620676|P7|COMPLETED|Overall Study||38
7565229|NCT02915016|18620677|P6|COMPLETED|Overall Study||44
7565230|NCT02915016|18620678|P5|COMPLETED|Overall Study||43
7565231|NCT02915016|18620679|P4|COMPLETED|Overall Study||26
7565232|NCT02915016|18620680|P3|COMPLETED|Overall Study||42
7565233|NCT02915016|18620681|P2|COMPLETED|Overall Study||47
7565234|NCT02915016|18620682|P1|COMPLETED|Overall Study||23
7565235|NCT02915016|18620675|P8|Month 6.5 Immunogenicity Timepoint|Overall Study||21
7565236|NCT02915016|18620676|P7|Month 6.5 Immunogenicity Timepoint|Overall Study||42
7565237|NCT02915016|18620677|P6|Month 6.5 Immunogenicity Timepoint|Overall Study||42
7565238|NCT02915016|18620678|P5|Month 6.5 Immunogenicity Timepoint|Overall Study||43
7565239|NCT02915016|18620679|P4|Month 6.5 Immunogenicity Timepoint|Overall Study||26
7565240|NCT02915016|18620680|P3|Month 6.5 Immunogenicity Timepoint|Overall Study||46
7565241|NCT02915016|18620681|P2|Month 6.5 Immunogenicity Timepoint|Overall Study||49
7565242|NCT02915016|18620682|P1|Month 6.5 Immunogenicity Timepoint|Overall Study||23
7565243|NCT02915016|18620675|P8|STARTED|Overall Study||24
7565244|NCT02915016|18620676|P7|STARTED|Overall Study||50
7565245|NCT02915016|18620677|P6|STARTED|Overall Study||50
7565246|NCT02915016|18620678|P5|STARTED|Overall Study||50
7565247|NCT02915016|18620679|P4|STARTED|Overall Study||30
7565248|NCT02915016|18620680|P3|STARTED|Overall Study||50
7565249|NCT02915016|18620681|P2|STARTED|Overall Study||50
7565250|NCT02915016|18620682|P1|STARTED|Overall Study||30
7565251|NCT02914795|18620894|P2|NOT COMPLETED|Overall Study||0
7565252|NCT02914795|18620895|P1|NOT COMPLETED|Overall Study||0
7565253|NCT02914795|18620894|P2|COMPLETED|Overall Study||22
7565254|NCT02914795|18620895|P1|COMPLETED|Overall Study||77
7565255|NCT02914795|18620894|P2|STARTED|Overall Study||22
7565256|NCT02914795|18620895|P1|STARTED|Overall Study||77
7565257|NCT02914548|18620906|P3|NOT COMPLETED|Overall Study||20
7565258|NCT02914548|18620907|P2|NOT COMPLETED|Overall Study||14
7565259|NCT02914548|18620908|P1|NOT COMPLETED|Overall Study||21
7565260|NCT02914548|18620906|P3|COMPLETED|Overall Study||46
7565261|NCT02914548|18620907|P2|COMPLETED|Overall Study||53
7565262|NCT02914548|18620908|P1|COMPLETED|Overall Study||46
7565263|NCT02914548|18620906|P3|STARTED|Overall Study||66
7565264|NCT02914548|18620907|P2|STARTED|Overall Study||67
7565265|NCT02914548|18620908|P1|STARTED|Overall Study||67
7565266|NCT02914457|18620939|P1|NOT COMPLETED|Overall Study||6
7565267|NCT02914457|18620939|P1|COMPLETED|Overall Study|Subjects who completed electrophysiological study with analyzable data|25
7565268|NCT02914457|18620939|P1|STARTED|Overall Study||31
7565269|NCT02914275|18620949|P2|NOT COMPLETED|Overall Study||42
7565270|NCT02914275|18620950|P1|NOT COMPLETED|Overall Study||121
7565271|NCT02914275|18620949|P2|COMPLETED|Overall Study||521
7565272|NCT02914275|18620950|P1|COMPLETED|Overall Study||1566
7565273|NCT02914275|18620949|P2|Included in Clinical Database / FAS|Overall Study||563
7565274|NCT02914275|18620950|P1|Included in Clinical Database / FAS|Overall Study||1684
7565275|NCT02914275|18620949|P2|STARTED|Overall Study||563
7565276|NCT02914275|18620950|P1|STARTED|Overall Study||1687
7565277|NCT02914236|18620982|P1|NOT COMPLETED|Overall Study||1
7565278|NCT02914236|18620982|P1|COMPLETED|Overall Study||49
7565279|NCT02914236|18620982|P1|26-week Follow-up Visit|Overall Study||49
7565280|NCT02914236|18620982|P1|12-week Follow-up Visit|Overall Study||50
7565281|NCT02914236|18620982|P1|4-week Follow-up Visit|Overall Study||50
7565282|NCT02914236|18620982|P1|STARTED|Overall Study||50
7565283|NCT02914210|18620992|P2|NOT COMPLETED|Overall Study||9
7565284|NCT02914210|18620993|P1|NOT COMPLETED|Overall Study||10
7565285|NCT02914210|18620992|P2|COMPLETED|Overall Study||144
7565286|NCT02914210|18620993|P1|COMPLETED|Overall Study||143
7565287|NCT02914210|18620992|P2|STARTED|Overall Study||153
7565288|NCT02914210|18620993|P1|STARTED|Overall Study||153
7565289|NCT02914184|18621028|P4|NOT COMPLETED|Overall Study||11
7565290|NCT02914184|18621029|P3|NOT COMPLETED|Overall Study||17
7565291|NCT02914184|18621030|P2|NOT COMPLETED|Overall Study||13
7565292|NCT02914184|18621031|P1|NOT COMPLETED|Overall Study||14
7565293|NCT02914184|18621028|P4|COMPLETED|Overall Study||391
7565294|NCT02914184|18621029|P3|COMPLETED|Overall Study||385
7565295|NCT02914184|18621030|P2|COMPLETED|Overall Study||383
7565296|NCT02914184|18621031|P1|COMPLETED|Overall Study||386
7565297|NCT02914184|18621028|P4|STARTED|Overall Study||402
7565298|NCT02914184|18621029|P3|STARTED|Overall Study||402
7565299|NCT02914184|18621030|P2|STARTED|Overall Study||396
7565300|NCT02914184|18621031|P1|STARTED|Overall Study||400
7565301|NCT02914132|18621070|P1|NOT COMPLETED|Overall Study||0
7565302|NCT02914132|18621070|P1|COMPLETED|Overall Study||15
7565303|NCT02914132|18621070|P1|STARTED|Overall Study||15
7565304|NCT02914119|18621075|P1|NOT COMPLETED|Overall Study||0
7565305|NCT02914119|18621075|P1|COMPLETED|Overall Study||30430
7565306|NCT02914119|18621075|P1|STARTED|Overall Study||30430
7565307|NCT02913326|18621088|P2|NOT COMPLETED|Overall Study||2
7565308|NCT02913326|18621089|P1|NOT COMPLETED|Overall Study||1
7565309|NCT02913326|18621088|P2|COMPLETED|Overall Study||58
7565310|NCT02913326|18621089|P1|COMPLETED|Overall Study||59
7565311|NCT02913326|18621088|P2|STARTED|Overall Study||60
7565312|NCT02913326|18621089|P1|STARTED|Overall Study||60
7565313|NCT02913222|18621111|P2|NOT COMPLETED|Overall Study||2
7565314|NCT02913222|18621112|P1|NOT COMPLETED|Overall Study||1
7565315|NCT02913222|18621111|P2|COMPLETED|Overall Study||21
7565316|NCT02913222|18621112|P1|COMPLETED|Overall Study||22
7565317|NCT02913222|18621111|P2|STARTED|Overall Study||23
7565318|NCT02913222|18621112|P1|STARTED|Overall Study||23
7565319|NCT02913105|18621137|P3|NOT COMPLETED|Overall Study||7
7565320|NCT02913105|18621138|P2|NOT COMPLETED|Overall Study||5
7565321|NCT02913105|18621139|P1|NOT COMPLETED|Overall Study||15
7565322|NCT02913105|18621137|P3|COMPLETED|Overall Study||33
7565323|NCT02913105|18621138|P2|COMPLETED|Overall Study||39
7565324|NCT02913105|18621139|P1|COMPLETED|Overall Study||22
7565325|NCT02913105|18621137|P3|STARTED|Overall Study||40
7565326|NCT02913105|18621138|P2|STARTED|Overall Study||44
7565327|NCT02913105|18621139|P1|STARTED|Overall Study||37
7565328|NCT02912650|18621192|P4|NOT COMPLETED|Overall Study||5
7565329|NCT02912650|18621193|P3|NOT COMPLETED|Overall Study||2
7565330|NCT02912650|18621194|P2|NOT COMPLETED|Overall Study||0
7565331|NCT02912650|18621195|P1|NOT COMPLETED|Overall Study||1
7565332|NCT02912650|18621192|P4|COMPLETED|Overall Study||160
7565333|NCT02912650|18621193|P3|COMPLETED|Overall Study||173
7565334|NCT02912650|18621194|P2|COMPLETED|Overall Study||172
7565335|NCT02912650|18621195|P1|COMPLETED|Overall Study||55
7565336|NCT02912650|18621192|P4|STARTED|Overall Study||165
7565337|NCT02912650|18621193|P3|STARTED|Overall Study||175
7565338|NCT02912650|18621194|P2|STARTED|Overall Study||172
7565339|NCT02912650|18621195|P1|STARTED|Overall Study||56
7565340|NCT02912468|18621279|P2|NOT COMPLETED|Overall Study||5
7565341|NCT02912468|18621280|P1|NOT COMPLETED|Overall Study||9
7565342|NCT02912468|18621279|P2|COMPLETED|Overall Study||138
7565343|NCT02912468|18621280|P1|COMPLETED|Overall Study||124
7565344|NCT02912468|18621279|P2|Safety Population|Overall Study||143
7565345|NCT02912468|18621280|P1|Safety Population|Overall Study||132
7565346|NCT02912468|18621279|P2|Treated|Overall Study||142
7565347|NCT02912468|18621280|P1|Treated|Overall Study||133
7565348|NCT02912468|18621279|P2|STARTED|Overall Study||143
7565349|NCT02912468|18621280|P1|STARTED|Overall Study||133
7565350|NCT02912455|18621359|P2|NOT COMPLETED|Overall Study||3
7565351|NCT02912455|18621360|P1|NOT COMPLETED|Overall Study||2
7565352|NCT02912455|18621359|P2|COMPLETED|Overall Study||2
7565353|NCT02912455|18621360|P1|COMPLETED|Overall Study||9
7565354|NCT02912455|18621359|P2|STARTED|Overall Study||5
7565355|NCT02912455|18621360|P1|STARTED|Overall Study||11
7565356|NCT02912364|18621398|P2|NOT COMPLETED|Treatment 2||0
7565357|NCT02912364|18621399|P1|NOT COMPLETED|Treatment 2||1
7565358|NCT02912364|18621398|P2|COMPLETED|Treatment 2||11
7565359|NCT02912364|18621399|P1|COMPLETED|Treatment 2||12
7565360|NCT02912364|18621398|P2|Received Intervention|Treatment 2||11
7565361|NCT02912364|18621399|P1|Received Intervention|Treatment 2||12
7565362|NCT02912364|18621398|P2|STARTED|Treatment 2||11
7565363|NCT02912364|18621399|P1|STARTED|Treatment 2||13
7565364|NCT02912364|18621398|P2|NOT COMPLETED|Washout Period||0
7565365|NCT02912364|18621399|P1|NOT COMPLETED|Washout Period||0
7565366|NCT02912364|18621398|P2|COMPLETED|Washout Period||11
7565367|NCT02912364|18621399|P1|COMPLETED|Washout Period||13
7565368|NCT02912364|18621398|P2|STARTED|Washout Period||11
7565369|NCT02912364|18621399|P1|STARTED|Washout Period||13
7565370|NCT02912364|18621398|P2|NOT COMPLETED|Treatment 1||12
7565371|NCT02912364|18621399|P1|NOT COMPLETED|Treatment 1||10
7565372|NCT02912364|18621398|P2|COMPLETED|Treatment 1||11
7565373|NCT02912364|18621399|P1|COMPLETED|Treatment 1||13
7565374|NCT02912364|18621398|P2|Received Intervention|Treatment 1||18
7565375|NCT02912364|18621399|P1|Received Intervention|Treatment 1||18
7565376|NCT02912364|18621398|P2|STARTED|Treatment 1||23
7565377|NCT02912364|18621399|P1|STARTED|Treatment 1||23
7565378|NCT02912195|18621418|P2|NOT COMPLETED|Overall Study||0
7565379|NCT02912195|18621419|P1|NOT COMPLETED|Overall Study||0
7565380|NCT02912195|18621418|P2|COMPLETED|Overall Study||16
7565381|NCT02912195|18621419|P1|COMPLETED|Overall Study||16
7565382|NCT02912195|18621418|P2|STARTED|Overall Study||16
7565383|NCT02912195|18621419|P1|STARTED|Overall Study||16
7565384|NCT02911948|18621455|P2|NOT COMPLETED|Overall Study||7
7565385|NCT02911948|18621456|P1|NOT COMPLETED|Overall Study||0
7565386|NCT02911948|18621455|P2|COMPLETED|Overall Study||98
7565387|NCT02911948|18621456|P1|COMPLETED|Overall Study||105
7565388|NCT02911948|18621455|P2|STARTED|Overall Study||105
7565389|NCT02911948|18621456|P1|STARTED|Overall Study||105
7565390|NCT02911922|18621518|P2|NOT COMPLETED|Overall Study||0
7565391|NCT02911922|18621519|P1|NOT COMPLETED|Overall Study||0
7565392|NCT02911922|18621518|P2|COMPLETED|Overall Study||0
7565393|NCT02911922|18621519|P1|COMPLETED|Overall Study||1
7565394|NCT02911922|18621518|P2|STARTED|Overall Study||0
7565395|NCT02911922|18621519|P1|STARTED|Overall Study||1
7565396|NCT02911909|18621539|P2|NOT COMPLETED|Overall Study||3
7565397|NCT02911909|18621540|P1|NOT COMPLETED|Overall Study||2
7565398|NCT02911909|18621539|P2|COMPLETED|Overall Study|No Data was obtained in the study group.|0
7565399|NCT02911909|18621540|P1|COMPLETED|Overall Study||2
7565400|NCT02911909|18621539|P2|STARTED|Overall Study||3
7565401|NCT02911909|18621540|P1|STARTED|Overall Study||4
7565402|NCT02911857|18621569|P3|NOT COMPLETED|Overall Study||0
7565403|NCT02911857|18621570|P2|NOT COMPLETED|Overall Study||0
7565404|NCT02911857|18621571|P1|NOT COMPLETED|Overall Study||0
7565405|NCT02911857|18621569|P3|COMPLETED|Overall Study||1
7565406|NCT02911857|18621570|P2|COMPLETED|Overall Study||1
7565407|NCT02911857|18621571|P1|COMPLETED|Overall Study||2
7565408|NCT02911857|18621569|P3|STARTED|Overall Study||1
7565409|NCT02911857|18621570|P2|STARTED|Overall Study||1
7565410|NCT02911857|18621571|P1|STARTED|Overall Study||2
7565411|NCT02911844|18621579|P1|NOT COMPLETED|Overall Study||0
7565412|NCT02911844|18621579|P1|COMPLETED|Overall Study||5
7565413|NCT02911844|18621579|P1|STARTED|Overall Study||5
7565414|NCT02911818|18621589|P5|NOT COMPLETED|12 Week Extension Study||1
7565415|NCT02911818|18621590|P4|NOT COMPLETED|12 Week Extension Study||0
7565416|NCT02911818|18621591|P3|NOT COMPLETED|12 Week Extension Study||0
7565417|NCT02911818|18621592|P2|NOT COMPLETED|12 Week Extension Study||0
7565418|NCT02911818|18621593|P1|NOT COMPLETED|12 Week Extension Study||0
7565419|NCT02911818|18621589|P5|COMPLETED|12 Week Extension Study||22
7565420|NCT02911818|18621590|P4|COMPLETED|12 Week Extension Study||22
7565421|NCT02911818|18621591|P3|COMPLETED|12 Week Extension Study||0
7565422|NCT02911818|18621592|P2|COMPLETED|12 Week Extension Study||0
7565423|NCT02911818|18621593|P1|COMPLETED|12 Week Extension Study||0
7565424|NCT02911818|18621589|P5|STARTED|12 Week Extension Study||23
7565425|NCT02911818|18621590|P4|STARTED|12 Week Extension Study||22
7565426|NCT02911818|18621591|P3|STARTED|12 Week Extension Study||0
7565427|NCT02911818|18621592|P2|STARTED|12 Week Extension Study||0
7565428|NCT02911818|18621593|P1|STARTED|12 Week Extension Study||0
7565429|NCT02911818|18621589|P5|NOT COMPLETED|52 Week Study||0
7565430|NCT02911818|18621590|P4|NOT COMPLETED|52 Week Study||0
7565431|NCT02911818|18621591|P3|NOT COMPLETED|52 Week Study||4
7565432|NCT02911818|18621592|P2|NOT COMPLETED|52 Week Study||5
7565433|NCT02911818|18621593|P1|NOT COMPLETED|52 Week Study||4
7565434|NCT02911818|18621589|P5|COMPLETED|52 Week Study||0
7565435|NCT02911818|18621590|P4|COMPLETED|52 Week Study||0
7565436|NCT02911818|18621591|P3|COMPLETED|52 Week Study||46
7565437|NCT02911818|18621592|P2|COMPLETED|52 Week Study||45
7565438|NCT02911818|18621593|P1|COMPLETED|52 Week Study||46
7565439|NCT02911818|18621589|P5|STARTED|52 Week Study||0
7565440|NCT02911818|18621590|P4|STARTED|52 Week Study||0
7565441|NCT02911818|18621591|P3|STARTED|52 Week Study||50
7565442|NCT02911818|18621592|P2|STARTED|52 Week Study||50
7565443|NCT02911818|18621593|P1|STARTED|52 Week Study||50
7565444|NCT02911753|18621688|P3|NOT COMPLETED|Overall Study||0
7565445|NCT02911753|18621689|P2|NOT COMPLETED|Overall Study||3
7565446|NCT02911753|18621690|P1|NOT COMPLETED|Overall Study||3
7565447|NCT02911753|18621688|P3|COMPLETED|Overall Study||10
7565448|NCT02911753|18621689|P2|COMPLETED|Overall Study||16
7565449|NCT02911753|18621690|P1|COMPLETED|Overall Study||18
7565450|NCT02911753|18621688|P3|STARTED|Overall Study||10
7565451|NCT02911753|18621689|P2|STARTED|Overall Study||19
7565452|NCT02911753|18621690|P1|STARTED|Overall Study||21
7565453|NCT02911688|18621718|P2|NOT COMPLETED|Second Intervention||0
7565454|NCT02911688|18621719|P1|NOT COMPLETED|Second Intervention||0
7565455|NCT02911688|18621718|P2|COMPLETED|Second Intervention||7
7565456|NCT02911688|18621719|P1|COMPLETED|Second Intervention||8
7565457|NCT02911688|18621718|P2|STARTED|Second Intervention||7
7565458|NCT02911688|18621719|P1|STARTED|Second Intervention||8
7565459|NCT02911688|18621718|P2|NOT COMPLETED|Washout||2
7565460|NCT02911688|18621719|P1|NOT COMPLETED|Washout||1
7565461|NCT02911688|18621718|P2|COMPLETED|Washout||7
7565462|NCT02911688|18621719|P1|COMPLETED|Washout||8
7565463|NCT02911688|18621718|P2|STARTED|Washout||9
7565464|NCT02911688|18621719|P1|STARTED|Washout||9
7565465|NCT02911688|18621718|P2|NOT COMPLETED|First Intervention||0
7565466|NCT02911688|18621719|P1|NOT COMPLETED|First Intervention||0
7565467|NCT02911688|18621718|P2|COMPLETED|First Intervention||9
7565468|NCT02911688|18621719|P1|COMPLETED|First Intervention||9
7565469|NCT02911688|18621718|P2|Received Intervention|First Intervention||9
7565470|NCT02911688|18621719|P1|Received Intervention|First Intervention||9
7565471|NCT02911688|18621718|P2|STARTED|First Intervention||9
7565472|NCT02911688|18621719|P1|STARTED|First Intervention||9
7565473|NCT02911519|18621743|P2|NOT COMPLETED|Overall Study||4
7565474|NCT02911519|18621744|P1|NOT COMPLETED|Overall Study||2
7565475|NCT02911519|18621743|P2|COMPLETED|Overall Study||82
7565476|NCT02911519|18621744|P1|COMPLETED|Overall Study||88
7565477|NCT02911519|18621743|P2|STARTED|Overall Study||86
7565478|NCT02911519|18621744|P1|STARTED|Overall Study||90
7565479|NCT02911324|18621766|P2|NOT COMPLETED|Overall Study||1
7565480|NCT02911324|18621767|P1|NOT COMPLETED|Overall Study||3
7565481|NCT02911324|18621766|P2|COMPLETED|Overall Study||6
7565482|NCT02911324|18621767|P1|COMPLETED|Overall Study||6
7565483|NCT02911324|18621766|P2|STARTED|Overall Study||7
7565484|NCT02911324|18621767|P1|STARTED|Overall Study||9
7565485|NCT02910739|18621776|P4|NOT COMPLETED|Overall Study||0
7565486|NCT02910739|18621777|P3|NOT COMPLETED|Overall Study||0
7565487|NCT02910739|18621778|P2|NOT COMPLETED|Overall Study||0
7565488|NCT02910739|18621779|P1|NOT COMPLETED|Overall Study||1
7565489|NCT02910739|18621776|P4|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
7565490|NCT02910739|18621777|P3|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
7565491|NCT02910739|18621778|P2|COMPLETED|Overall Study||8
7565492|NCT02910739|18621779|P1|COMPLETED|Overall Study||7
7565493|NCT02910739|18621776|P4|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
7565494|NCT02910739|18621777|P3|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
7565495|NCT02910739|18621778|P2|STARTED|Overall Study||8
7565496|NCT02910739|18621779|P1|STARTED|Overall Study||8
7565497|NCT02910713|18621805|P1|NOT COMPLETED|Overall Study||42
7565498|NCT02910713|18621805|P1|COMPLETED|Overall Study|Completed=Completed both Intranasal and Extranasal applications.|143
7565499|NCT02910713|18621805|P1|Safety Population: Entered CAE|Overall Study||171
7565500|NCT02910713|18621805|P1|STARTED|Overall Study||185
7565501|NCT02910362|18621814|P2|NOT COMPLETED|Overall Study||0
7565502|NCT02910362|18621815|P1|NOT COMPLETED|Overall Study||0
7565503|NCT02910362|18621814|P2|COMPLETED|Overall Study||7
7565504|NCT02910362|18621815|P1|COMPLETED|Overall Study||8
7565505|NCT02910362|18621814|P2|STARTED|Overall Study||7
7565506|NCT02910362|18621815|P1|STARTED|Overall Study||8
7565507|NCT02910167|18621821|P1|NOT COMPLETED|Overall Study||19
7565508|NCT02910167|18621821|P1|COMPLETED|Overall Study||341
7565509|NCT02910167|18621821|P1|STARTED|Overall Study||360
7565510|NCT02910102|18621831|P2|NOT COMPLETED|Overall Study||0
7565511|NCT02910102|18621832|P1|NOT COMPLETED|Overall Study||0
7565512|NCT02910102|18621831|P2|COMPLETED|Overall Study||17
7565513|NCT02910102|18621832|P1|COMPLETED|Overall Study||21
7565514|NCT02910102|18621831|P2|Per-Protocol Population|Overall Study||17
7565515|NCT02910102|18621832|P1|Per-Protocol Population|Overall Study||20
7565516|NCT02910102|18621831|P2|Intent to Treat (ITT) Population|Overall Study||17
7565517|NCT02910102|18621832|P1|Intent to Treat (ITT) Population|Overall Study||21
7565518|NCT02910102|18621831|P2|Safety Population|Overall Study||17
7565519|NCT02910102|18621832|P1|Safety Population|Overall Study||21
7565520|NCT02910102|18621831|P2|STARTED|Overall Study||17
7565521|NCT02910102|18621832|P1|STARTED|Overall Study||21
7565522|NCT02910089|18621846|P2|NOT COMPLETED|Overall Study||16
7565523|NCT02910089|18621847|P1|NOT COMPLETED|Overall Study||22
7565524|NCT02910089|18621846|P2|COMPLETED|Overall Study|16 Patients ineligible (2.3%)|684
7565525|NCT02910089|18621847|P1|COMPLETED|Overall Study|22 patients ineligible (3.1%)|678
7565526|NCT02910089|18621846|P2|STARTED|Overall Study|Patients allocated to control|700
7565527|NCT02910089|18621847|P1|STARTED|Overall Study|Patients allocated to intervention|700
7565528|NCT02910011|18621859|P1|NOT COMPLETED|Overall Study||2
7565529|NCT02910011|18621859|P1|COMPLETED|Overall Study||13
7565530|NCT02910011|18621859|P1|STARTED|Overall Study||15
7565531|NCT02909959|18621867|P2|NOT COMPLETED|Overall Study||0
7565532|NCT02909959|18621868|P1|NOT COMPLETED|Overall Study||0
7565533|NCT02909959|18621867|P2|COMPLETED|Overall Study||24
7565534|NCT02909959|18621868|P1|COMPLETED|Overall Study||24
7565535|NCT02909959|18621867|P2|STARTED|Overall Study||24
7565536|NCT02909959|18621868|P1|STARTED|Overall Study||24
7565537|NCT02909907|18621968|P2|NOT COMPLETED|Overall Study||1
7565538|NCT02909907|18621969|P1|NOT COMPLETED|Overall Study||0
7565539|NCT02909907|18621968|P2|COMPLETED|Overall Study||9
7565540|NCT02909907|18621969|P1|COMPLETED|Overall Study||10
7565541|NCT02909907|18621968|P2|STARTED|Overall Study||10
7565542|NCT02909907|18621969|P1|STARTED|Overall Study||10
7565543|NCT02909764|18621993|P2|NOT COMPLETED|Overall Study||0
7565544|NCT02909764|18621994|P1|NOT COMPLETED|Overall Study||0
7565545|NCT02909764|18621993|P2|COMPLETED|Overall Study||20
7565546|NCT02909764|18621994|P1|COMPLETED|Overall Study||19
7565547|NCT02909764|18621993|P2|STARTED|Overall Study||20
7565548|NCT02909764|18621994|P1|STARTED|Overall Study||19
7565549|NCT02909504|18622010|P1|NOT COMPLETED|Overall Study||12
7565550|NCT02909504|18622010|P1|COMPLETED|Overall Study||12
7565551|NCT02909504|18622010|P1|STARTED|Overall Study||24
7565552|NCT02909439|18622017|P2|NOT COMPLETED|Overall Study||0
7565553|NCT02909439|18622018|P1|NOT COMPLETED|Overall Study||0
7565554|NCT02909439|18622017|P2|COMPLETED|Overall Study||31
7565555|NCT02909439|18622018|P1|COMPLETED|Overall Study||31
7565556|NCT02909439|18622017|P2|STARTED|Overall Study||31
7565557|NCT02909439|18622018|P1|STARTED|Overall Study||31
7565558|NCT02909153|18622047|P5|NOT COMPLETED|Overall Study||0
7565559|NCT02909153|18622048|P4|NOT COMPLETED|Overall Study||0
7565560|NCT02909153|18622049|P3|NOT COMPLETED|Overall Study||0
7565561|NCT02909153|18622050|P2|NOT COMPLETED|Overall Study||1
7565562|NCT02909153|18622051|P1|NOT COMPLETED|Overall Study||0
7565563|NCT02909153|18622047|P5|COMPLETED|Overall Study||6
7565564|NCT02909153|18622048|P4|COMPLETED|Overall Study||6
7565565|NCT02909153|18622049|P3|COMPLETED|Overall Study||6
7565566|NCT02909153|18622050|P2|COMPLETED|Overall Study||5
7565567|NCT02909153|18622051|P1|COMPLETED|Overall Study||6
7565568|NCT02909153|18622047|P5|Triferic in Extraneal PD Solution|Overall Study||6
7565569|NCT02909153|18622048|P4|Triferic in Extraneal PD Solution|Overall Study||6
7565570|NCT02909153|18622049|P3|Triferic in Extraneal PD Solution|Overall Study||0
7565571|NCT02909153|18622050|P2|Triferic in Extraneal PD Solution|Overall Study||0
7565572|NCT02909153|18622051|P1|Triferic in Extraneal PD Solution|Overall Study||0
7565573|NCT02909153|18622047|P5|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
7565574|NCT02909153|18622048|P4|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
7565575|NCT02909153|18622049|P3|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
7565576|NCT02909153|18622050|P2|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||5
7565577|NCT02909153|18622051|P1|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
7565578|NCT02909153|18622047|P5|Triferic in Dianeal PD Solution|Overall Study||0
7565579|NCT02909153|18622048|P4|Triferic in Dianeal PD Solution|Overall Study||0
7565580|NCT02909153|18622049|P3|Triferic in Dianeal PD Solution|Overall Study||6
7565581|NCT02909153|18622050|P2|Triferic in Dianeal PD Solution|Overall Study||6
7565582|NCT02909153|18622051|P1|Triferic in Dianeal PD Solution|Overall Study||6
7565583|NCT02909153|18622047|P5|STARTED|Overall Study||6
7565584|NCT02909153|18622048|P4|STARTED|Overall Study||6
7565585|NCT02909153|18622049|P3|STARTED|Overall Study||6
7565586|NCT02909153|18622050|P2|STARTED|Overall Study||6
7565587|NCT02909153|18622051|P1|STARTED|Overall Study||6
7565588|NCT02909140|18622096|P3|NOT COMPLETED|Overall Study||0
7565589|NCT02909140|18622097|P2|NOT COMPLETED|Overall Study||0
7565590|NCT02909140|18622098|P1|NOT COMPLETED|Overall Study||0
7565591|NCT02909140|18622096|P3|COMPLETED|Overall Study||0
7565592|NCT02909140|18622097|P2|COMPLETED|Overall Study||2
7565593|NCT02909140|18622098|P1|COMPLETED|Overall Study||0
7565594|NCT02909140|18622096|P3|STARTED|Overall Study||0
7565595|NCT02909140|18622097|P2|STARTED|Overall Study||2
7565596|NCT02909140|18622098|P1|STARTED|Overall Study||0
7565597|NCT02909101|18622141|P2|NOT COMPLETED|Overall Study||1
7565598|NCT02909101|18622142|P1|NOT COMPLETED|Overall Study||1
7565599|NCT02909101|18622141|P2|COMPLETED|Overall Study||28
7565600|NCT02909101|18622142|P1|COMPLETED|Overall Study||28
7565601|NCT02909101|18622141|P2|STARTED|Overall Study||29
7565602|NCT02909101|18622142|P1|STARTED|Overall Study||29
7565603|NCT02908880|18622160|P1|NOT COMPLETED|Overall Study||27
7565604|NCT02908880|18622160|P1|COMPLETED|Overall Study|Subjects within the Primary Analysis Cohort that completed all follow-up time points.|236
7565605|NCT02908880|18622160|P1|STARTED|Overall Study|Subjects within the Primary Analysis Cohort that received the MANTA Device|263
7565606|NCT02908841|18622170|P2|NOT COMPLETED|Overall Study||0
7565607|NCT02908841|18622171|P1|NOT COMPLETED|Overall Study||4
7565608|NCT02908841|18622170|P2|COMPLETED|Overall Study||12
7565609|NCT02908841|18622171|P1|COMPLETED|Overall Study||6
7565610|NCT02908841|18622170|P2|STARTED|Overall Study||12
7565611|NCT02908841|18622171|P1|STARTED|Overall Study||10
7565612|NCT02908672|18622189|P2|NOT COMPLETED|Overall Study||256
7565613|NCT02908672|18622190|P1|NOT COMPLETED|Overall Study||258
7565614|NCT02908672|18622189|P2|COMPLETED|Overall Study||0
7565615|NCT02908672|18622190|P1|COMPLETED|Overall Study||0
7565616|NCT02908672|18622189|P2|STARTED|Overall Study||256
7565617|NCT02908672|18622190|P1|STARTED|Overall Study||258
7565618|NCT02908620|18622226|P4|NOT COMPLETED|Overall Study||0
7565619|NCT02908620|18622227|P3|NOT COMPLETED|Overall Study||0
7565620|NCT02908620|18622228|P2|NOT COMPLETED|Overall Study||0
7565621|NCT02908620|18622229|P1|NOT COMPLETED|Overall Study||0
7565622|NCT02908620|18622226|P4|COMPLETED|Overall Study||10
7565623|NCT02908620|18622227|P3|COMPLETED|Overall Study||10
7565624|NCT02908620|18622228|P2|COMPLETED|Overall Study||10
7565625|NCT02908620|18622229|P1|COMPLETED|Overall Study||10
7565626|NCT02908620|18622226|P4|STARTED|Overall Study||10
7565627|NCT02908620|18622227|P3|STARTED|Overall Study||10
7565628|NCT02908620|18622228|P2|STARTED|Overall Study||10
7565629|NCT02908620|18622229|P1|STARTED|Overall Study||10
7565630|NCT02908529|18622263|P2|NOT COMPLETED|Overall Study||2
7565631|NCT02908529|18622264|P1|NOT COMPLETED|Overall Study||0
7565632|NCT02908529|18622263|P2|COMPLETED|Overall Study||10
7565633|NCT02908529|18622264|P1|COMPLETED|Overall Study||10
7565634|NCT02908529|18622263|P2|STARTED|Overall Study||12
7565635|NCT02908529|18622264|P1|STARTED|Overall Study||10
7565636|NCT02908516|18622274|P2|NOT COMPLETED|Overall Study||3
7565637|NCT02908516|18622275|P1|NOT COMPLETED|Overall Study||3
7565638|NCT02908516|18622274|P2|COMPLETED|Overall Study||0
7565639|NCT02908516|18622275|P1|COMPLETED|Overall Study||0
7565640|NCT02908516|18622274|P2|STARTED|Overall Study||3
7565641|NCT02908516|18622275|P1|STARTED|Overall Study||3
7565642|NCT02908464|18622291|P2|NOT COMPLETED|Overall Study||3
7565643|NCT02908464|18622292|P1|NOT COMPLETED|Overall Study||2
7565644|NCT02908464|18622291|P2|COMPLETED|Overall Study||20
7565645|NCT02908464|18622292|P1|COMPLETED|Overall Study||20
7565646|NCT02908464|18622291|P2|STARTED|Overall Study||23
7565647|NCT02908464|18622292|P1|STARTED|Overall Study||22
7565648|NCT02908347|18622313|P2|NOT COMPLETED|Overall Study||1
7565649|NCT02908347|18622314|P1|NOT COMPLETED|Overall Study||1
7565650|NCT02908347|18622313|P2|COMPLETED|Overall Study||22
7565651|NCT02908347|18622314|P1|COMPLETED|Overall Study||22
7565652|NCT02908347|18622313|P2|STARTED|Overall Study||23
7565653|NCT02908347|18622314|P1|STARTED|Overall Study||23
7565654|NCT02908269|18622365|P3|NOT COMPLETED|Overall Study||0
7565655|NCT02908269|18622366|P2|NOT COMPLETED|Overall Study||0
7565656|NCT02908269|18622367|P1|NOT COMPLETED|Overall Study||0
7565657|NCT02908269|18622365|P3|COMPLETED|Overall Study||60
7565658|NCT02908269|18622366|P2|COMPLETED|Overall Study||60
7565659|NCT02908269|18622367|P1|COMPLETED|Overall Study||60
7565660|NCT02908269|18622365|P3|STARTED|Overall Study||60
7565661|NCT02908269|18622366|P2|STARTED|Overall Study||60
7565662|NCT02908269|18622367|P1|STARTED|Overall Study||60
7565663|NCT02908178|18622385|P4|NOT COMPLETED|Overall Study||6819
7565664|NCT02908178|18622386|P3|NOT COMPLETED|Overall Study||0
7565665|NCT02908178|18622387|P2|NOT COMPLETED|Overall Study||8388
7565666|NCT02908178|18622388|P1|NOT COMPLETED|Overall Study||0
7565667|NCT02908178|18622385|P4|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|3965
7565668|NCT02908178|18622386|P3|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|1992
7565669|NCT02908178|18622387|P2|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|4718
7565670|NCT02908178|18622388|P1|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|2409
7565671|NCT02908178|18622385|P4|STARTED|Overall Study|The sample prior to Mahalanobis matching.|10784
7565672|NCT02908178|18622386|P3|STARTED|Overall Study|The sample prior to Mahalanobis matching.|1992
7565673|NCT02908178|18622387|P2|STARTED|Overall Study|The sample prior to Mahalanobis matching.|13106
7565674|NCT02908178|18622388|P1|STARTED|Overall Study|The sample prior to Mahalanobis matching.|2409
7565675|NCT02908100|18622410|P3|NOT COMPLETED|Overall Study||21
7565676|NCT02908100|18622411|P2|NOT COMPLETED|Overall Study||21
7565677|NCT02908100|18622412|P1|NOT COMPLETED|Overall Study||23
7565678|NCT02908100|18622410|P3|COMPLETED|Overall Study||66
7565679|NCT02908100|18622411|P2|COMPLETED|Overall Study||66
7565680|NCT02908100|18622412|P1|COMPLETED|Overall Study||63
7565681|NCT02908100|18622410|P3|STARTED|Overall Study||87
7565682|NCT02908100|18622411|P2|STARTED|Overall Study||87
7565683|NCT02908100|18622412|P1|STARTED|Overall Study||86
7565684|NCT02907892|18622448|P2|NOT COMPLETED|Overall Study||40
7565685|NCT02907892|18622449|P1|NOT COMPLETED|Overall Study||27
7565686|NCT02907892|18622448|P2|COMPLETED|Overall Study||236
7565687|NCT02907892|18622449|P1|COMPLETED|Overall Study||250
7565688|NCT02907892|18622448|P2|STARTED|Overall Study||276
7565689|NCT02907892|18622449|P1|STARTED|Overall Study||277
7565690|NCT02907814|18622457|P2|NOT COMPLETED|Overall Study||0
7565691|NCT02907814|18622458|P1|NOT COMPLETED|Overall Study||6
7565692|NCT02907814|18622457|P2|COMPLETED|Overall Study||0
7565693|NCT02907814|18622458|P1|COMPLETED|Overall Study||0
7565694|NCT02907814|18622457|P2|STARTED|Overall Study||0
7565695|NCT02907814|18622458|P1|STARTED|Overall Study||6
7565696|NCT02907619|18622469|P3|NOT COMPLETED|Overall Study||20
7565697|NCT02907619|18622470|P2|NOT COMPLETED|Overall Study||20
7565698|NCT02907619|18622471|P1|NOT COMPLETED|Overall Study||19
7565699|NCT02907619|18622469|P3|COMPLETED|Overall Study||0
7565700|NCT02907619|18622470|P2|COMPLETED|Overall Study||0
7565701|NCT02907619|18622471|P1|COMPLETED|Overall Study||0
7565702|NCT02907619|18622469|P3|Received Treatment|Overall Study||20
7565703|NCT02907619|18622470|P2|Received Treatment|Overall Study||20
7565704|NCT02907619|18622471|P1|Received Treatment|Overall Study||19
7565705|NCT02907619|18622469|P3|STARTED|Overall Study||20
7565706|NCT02907619|18622470|P2|STARTED|Overall Study||20
7565707|NCT02907619|18622471|P1|STARTED|Overall Study||19
7565708|NCT02907489|18622678|P2|NOT COMPLETED|Overall Study||1
7565709|NCT02907489|18622679|P1|NOT COMPLETED|Overall Study||2
7565710|NCT02907489|18622678|P2|COMPLETED|Overall Study||41
7565711|NCT02907489|18622679|P1|COMPLETED|Overall Study||40
7565712|NCT02907489|18622678|P2|STARTED|Overall Study||42
7565713|NCT02907489|18622679|P1|STARTED|Overall Study||42
7565714|NCT02907463|18622687|P1|NOT COMPLETED|Overall Study||37
7565715|NCT02907463|18622687|P1|COMPLETED|Overall Study||243
7565716|NCT02907463|18622687|P1|Per Protocol Cohort|Overall Study||276
7565717|NCT02907463|18622687|P1|Enrolled Cohort|Overall Study||280
7565718|NCT02907463|18622687|P1|STARTED|Overall Study||280
7565719|NCT02907268|18622759|P2|NOT COMPLETED|Overall Study||0
7565720|NCT02907268|18622760|P1|NOT COMPLETED|Overall Study||0
7565721|NCT02907268|18622759|P2|COMPLETED|Overall Study||5
7565722|NCT02907268|18622760|P1|COMPLETED|Overall Study||5
7565723|NCT02907268|18622759|P2|STARTED|Overall Study||5
7565724|NCT02907268|18622760|P1|STARTED|Overall Study||5
7565725|NCT02907216|18622769|P2|NOT COMPLETED|Overall Study||1
7565726|NCT02907216|18622770|P1|NOT COMPLETED|Overall Study||1
7565727|NCT02907216|18622769|P2|COMPLETED|Overall Study||144
7565728|NCT02907216|18622770|P1|COMPLETED|Overall Study||146
7565729|NCT02907216|18622769|P2|STARTED|Overall Study||145
7565730|NCT02907216|18622770|P1|STARTED|Overall Study||147
7565731|NCT02907073|18622805|P3|NOT COMPLETED|Overall Study||0
7565732|NCT02907073|18622806|P2|NOT COMPLETED|Overall Study||0
7565733|NCT02907073|18622807|P1|NOT COMPLETED|Overall Study||0
7565734|NCT02907073|18622805|P3|COMPLETED|Overall Study||0
7565735|NCT02907073|18622806|P2|COMPLETED|Overall Study||0
7565736|NCT02907073|18622807|P1|COMPLETED|Overall Study||8
7565737|NCT02907073|18622805|P3|STARTED|Overall Study||0
7565738|NCT02907073|18622806|P2|STARTED|Overall Study||0
7565739|NCT02907073|18622807|P1|STARTED|Overall Study||8
7565740|NCT02906930|18622822|P4|NOT COMPLETED|Overall Study||8
7565741|NCT02906930|18622823|P3|NOT COMPLETED|Overall Study||12
7565742|NCT02906930|18622824|P2|NOT COMPLETED|Overall Study||14
7565743|NCT02906930|18622825|P1|NOT COMPLETED|Overall Study||6
7565744|NCT02906930|18622822|P4|COMPLETED|Overall Study||170
7565745|NCT02906930|18622823|P3|COMPLETED|Overall Study||163
7565746|NCT02906930|18622824|P2|COMPLETED|Overall Study||161
7565747|NCT02906930|18622825|P1|COMPLETED|Overall Study||169
7565748|NCT02906930|18622822|P4|Safety Analysis Set (SAS)|Overall Study||178
7565749|NCT02906930|18622823|P3|Safety Analysis Set (SAS)|Overall Study||175
7565750|NCT02906930|18622824|P2|Safety Analysis Set (SAS)|Overall Study||175
7565751|NCT02906930|18622825|P1|Safety Analysis Set (SAS)|Overall Study||175
7565752|NCT02906930|18622822|P4|Full Analysis Set (FAS)|Overall Study||178
7565753|NCT02906930|18622823|P3|Full Analysis Set (FAS)|Overall Study||175
7565754|NCT02906930|18622824|P2|Full Analysis Set (FAS)|Overall Study||175
7565755|NCT02906930|18622825|P1|Full Analysis Set (FAS)|Overall Study||175
7565756|NCT02906930|18622822|P4|STARTED|Overall Study||178
7565757|NCT02906930|18622823|P3|STARTED|Overall Study||175
7565758|NCT02906930|18622824|P2|STARTED|Overall Study||175
7565759|NCT02906930|18622825|P1|STARTED|Overall Study||175
7565760|NCT02906917|18623018|P2|NOT COMPLETED|Intensification Period (Week 26-38)||7
7565761|NCT02906917|18623019|P1|NOT COMPLETED|Intensification Period (Week 26-38)||9
7565762|NCT02906917|18623018|P2|COMPLETED|Intensification Period (Week 26-38)||247
7565763|NCT02906917|18623019|P1|COMPLETED|Intensification Period (Week 26-38)||252
7565764|NCT02906917|18623018|P2|STARTED|Intensification Period (Week 26-38)||254
7565765|NCT02906917|18623019|P1|STARTED|Intensification Period (Week 26-38)||261
7565766|NCT02906917|18623018|P2|NOT COMPLETED|Initiation Period (Week 0-26)||11
7565767|NCT02906917|18623019|P1|NOT COMPLETED|Initiation Period (Week 0-26)||6
7565768|NCT02906917|18623018|P2|COMPLETED|Initiation Period (Week 0-26)||254
7565769|NCT02906917|18623019|P1|COMPLETED|Initiation Period (Week 0-26)||261
7565770|NCT02906917|18623018|P2|Exposed|Initiation Period (Week 0-26)||263
7565771|NCT02906917|18623019|P1|Exposed|Initiation Period (Week 0-26)||265
7565772|NCT02906917|18623018|P2|STARTED|Initiation Period (Week 0-26)||265
7565773|NCT02906917|18623019|P1|STARTED|Initiation Period (Week 0-26)||267
7565774|NCT02906813|18623050|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7565775|NCT02906813|18623051|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7565776|NCT02906813|18623052|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7565777|NCT02906813|18623050|P3|COMPLETED|Intervention Period 3 (3 Days)||3
7565778|NCT02906813|18623051|P2|COMPLETED|Intervention Period 3 (3 Days)||3
7565779|NCT02906813|18623052|P1|COMPLETED|Intervention Period 3 (3 Days)||3
7565780|NCT02906813|18623050|P3|STARTED|Intervention Period 3 (3 Days)||3
7565781|NCT02906813|18623051|P2|STARTED|Intervention Period 3 (3 Days)||3
7565782|NCT02906813|18623052|P1|STARTED|Intervention Period 3 (3 Days)||3
7565783|NCT02906813|18623050|P3|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
7565784|NCT02906813|18623051|P2|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
7565785|NCT02906813|18623052|P1|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
7565786|NCT02906813|18623050|P3|COMPLETED|Washout Period 2 (at Least 3 Days)||3
7565787|NCT02906813|18623051|P2|COMPLETED|Washout Period 2 (at Least 3 Days)||3
7565788|NCT02906813|18623052|P1|COMPLETED|Washout Period 2 (at Least 3 Days)||3
7565789|NCT02906813|18623050|P3|STARTED|Washout Period 2 (at Least 3 Days)||3
7565790|NCT02906813|18623051|P2|STARTED|Washout Period 2 (at Least 3 Days)||3
7565791|NCT02906813|18623052|P1|STARTED|Washout Period 2 (at Least 3 Days)||3
7565792|NCT02906813|18623050|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7565793|NCT02906813|18623051|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7565794|NCT02906813|18623052|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7565795|NCT02906813|18623050|P3|COMPLETED|Intervention Period 2 (3 Days)||3
7565796|NCT02906813|18623051|P2|COMPLETED|Intervention Period 2 (3 Days)||3
7565797|NCT02906813|18623052|P1|COMPLETED|Intervention Period 2 (3 Days)||3
7565798|NCT02906813|18623050|P3|STARTED|Intervention Period 2 (3 Days)||3
7565799|NCT02906813|18623051|P2|STARTED|Intervention Period 2 (3 Days)||3
7565800|NCT02906813|18623052|P1|STARTED|Intervention Period 2 (3 Days)||3
7565801|NCT02906813|18623050|P3|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
7565802|NCT02906813|18623051|P2|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
7565803|NCT02906813|18623052|P1|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
7565804|NCT02906813|18623050|P3|COMPLETED|Washout Period 1 (at Least 3 Days)||3
7565805|NCT02906813|18623051|P2|COMPLETED|Washout Period 1 (at Least 3 Days)||3
7565806|NCT02906813|18623052|P1|COMPLETED|Washout Period 1 (at Least 3 Days)||3
7565807|NCT02906813|18623050|P3|STARTED|Washout Period 1 (at Least 3 Days)||3
7565808|NCT02906813|18623051|P2|STARTED|Washout Period 1 (at Least 3 Days)||3
7565809|NCT02906813|18623052|P1|STARTED|Washout Period 1 (at Least 3 Days)||3
7565810|NCT02906813|18623050|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
7565811|NCT02906813|18623051|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
7565812|NCT02906813|18623052|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
7565813|NCT02906813|18623050|P3|COMPLETED|Intervention Period 1 (3 Days)||3
7565814|NCT02906813|18623051|P2|COMPLETED|Intervention Period 1 (3 Days)||3
7565815|NCT02906813|18623052|P1|COMPLETED|Intervention Period 1 (3 Days)||3
7565816|NCT02906813|18623050|P3|STARTED|Intervention Period 1 (3 Days)||3
7565817|NCT02906813|18623051|P2|STARTED|Intervention Period 1 (3 Days)||3
7565818|NCT02906813|18623052|P1|STARTED|Intervention Period 1 (3 Days)||3
7565819|NCT02906709|18623080|P2|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||0
7565820|NCT02906709|18623081|P1|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||5
7565821|NCT02906709|18623080|P2|COMPLETED|Phase B (Extension, Week 17 to Week 52)||58
7565822|NCT02906709|18623081|P1|COMPLETED|Phase B (Extension, Week 17 to Week 52)||117
7565823|NCT02906709|18623080|P2|STARTED|Phase B (Extension, Week 17 to Week 52)||58
7565824|NCT02906709|18623081|P1|STARTED|Phase B (Extension, Week 17 to Week 52)||122
7565825|NCT02906709|18623080|P2|NOT COMPLETED|Phase A (Week 0 to Week 16)||3
7565826|NCT02906709|18623081|P1|NOT COMPLETED|Phase A (Week 0 to Week 16)||1
7565827|NCT02906709|18623080|P2|COMPLETED|Phase A (Week 0 to Week 16)||58
7565828|NCT02906709|18623081|P1|COMPLETED|Phase A (Week 0 to Week 16)||122
7565829|NCT02906709|18623080|P2|STARTED|Phase A (Week 0 to Week 16)||61
7565830|NCT02906709|18623081|P1|STARTED|Phase A (Week 0 to Week 16)||123
7565831|NCT02906696|18623113|P1|NOT COMPLETED|Overall Study||0
7565832|NCT02906696|18623113|P1|COMPLETED|Overall Study||8
7565833|NCT02906696|18623113|P1|STARTED|Overall Study||8
7565834|NCT02906670|18623135|P10|NOT COMPLETED|Cohort 5P, QW||0
7565835|NCT02906670|18623136|P9|NOT COMPLETED|Cohort 5P, QW||0
7565836|NCT02906670|18623137|P8|NOT COMPLETED|Cohort 5P, QW||0
7565837|NCT02906670|18623138|P7|NOT COMPLETED|Cohort 5P, QW||0
7565838|NCT02906670|18623139|P6|NOT COMPLETED|Cohort 5P, QW||0
7565839|NCT02906670|18623140|P5|NOT COMPLETED|Cohort 5P, QW||3
7565840|NCT02906670|18623141|P4|NOT COMPLETED|Cohort 5P, QW||0
7565841|NCT02906670|18623142|P3|NOT COMPLETED|Cohort 5P, QW||0
7565842|NCT02906670|18623143|P2|NOT COMPLETED|Cohort 5P, QW||0
7565843|NCT02906670|18623144|P1|NOT COMPLETED|Cohort 5P, QW||0
7565844|NCT02906670|18623135|P10|COMPLETED|Cohort 5P, QW||0
7565845|NCT02906670|18623136|P9|COMPLETED|Cohort 5P, QW||0
7565846|NCT02906670|18623137|P8|COMPLETED|Cohort 5P, QW||0
7565847|NCT02906670|18623138|P7|COMPLETED|Cohort 5P, QW||0
7565848|NCT02906670|18623139|P6|COMPLETED|Cohort 5P, QW||0
7565849|NCT02906670|18623140|P5|COMPLETED|Cohort 5P, QW||0
7565850|NCT02906670|18623141|P4|COMPLETED|Cohort 5P, QW||0
7565851|NCT02906670|18623142|P3|COMPLETED|Cohort 5P, QW||0
7565852|NCT02906670|18623143|P2|COMPLETED|Cohort 5P, QW||0
7565853|NCT02906670|18623144|P1|COMPLETED|Cohort 5P, QW||0
7565854|NCT02906670|18623135|P10|STARTED|Cohort 5P, QW||0
7565855|NCT02906670|18623136|P9|STARTED|Cohort 5P, QW||0
7565856|NCT02906670|18623137|P8|STARTED|Cohort 5P, QW||0
7565857|NCT02906670|18623138|P7|STARTED|Cohort 5P, QW||0
7565858|NCT02906670|18623139|P6|STARTED|Cohort 5P, QW||0
7565859|NCT02906670|18623140|P5|STARTED|Cohort 5P, QW||3
7565860|NCT02906670|18623141|P4|STARTED|Cohort 5P, QW||0
7565861|NCT02906670|18623142|P3|STARTED|Cohort 5P, QW||0
7565862|NCT02906670|18623143|P2|STARTED|Cohort 5P, QW||0
7565863|NCT02906670|18623144|P1|STARTED|Cohort 5P, QW||0
7565864|NCT02906670|18623135|P10|NOT COMPLETED|Cohort 7P, Q2W||3
7565865|NCT02906670|18623136|P9|NOT COMPLETED|Cohort 7P, Q2W||0
7565866|NCT02906670|18623137|P8|NOT COMPLETED|Cohort 7P, Q2W||0
7565867|NCT02906670|18623138|P7|NOT COMPLETED|Cohort 7P, Q2W||0
7565868|NCT02906670|18623139|P6|NOT COMPLETED|Cohort 7P, Q2W||0
7565869|NCT02906670|18623140|P5|NOT COMPLETED|Cohort 7P, Q2W||0
7565870|NCT02906670|18623141|P4|NOT COMPLETED|Cohort 7P, Q2W||0
7565871|NCT02906670|18623142|P3|NOT COMPLETED|Cohort 7P, Q2W||0
7565872|NCT02906670|18623143|P2|NOT COMPLETED|Cohort 7P, Q2W||0
7565873|NCT02906670|18623144|P1|NOT COMPLETED|Cohort 7P, Q2W||0
7565874|NCT02906670|18623135|P10|COMPLETED|Cohort 7P, Q2W||0
7565875|NCT02906670|18623136|P9|COMPLETED|Cohort 7P, Q2W||0
7565876|NCT02906670|18623137|P8|COMPLETED|Cohort 7P, Q2W||0
7565877|NCT02906670|18623138|P7|COMPLETED|Cohort 7P, Q2W||0
7565878|NCT02906670|18623139|P6|COMPLETED|Cohort 7P, Q2W||0
7565879|NCT02906670|18623140|P5|COMPLETED|Cohort 7P, Q2W||0
7565880|NCT02906670|18623141|P4|COMPLETED|Cohort 7P, Q2W||0
7565881|NCT02906670|18623142|P3|COMPLETED|Cohort 7P, Q2W||0
7565882|NCT02906670|18623143|P2|COMPLETED|Cohort 7P, Q2W||0
7565883|NCT02906670|18623144|P1|COMPLETED|Cohort 7P, Q2W||0
7565884|NCT02906670|18623135|P10|STARTED|Cohort 7P, Q2W||3
7565885|NCT02906670|18623136|P9|STARTED|Cohort 7P, Q2W||0
7565886|NCT02906670|18623137|P8|STARTED|Cohort 7P, Q2W||0
7565887|NCT02906670|18623138|P7|STARTED|Cohort 7P, Q2W||0
7565888|NCT02906670|18623139|P6|STARTED|Cohort 7P, Q2W||0
7565889|NCT02906670|18623140|P5|STARTED|Cohort 7P, Q2W||0
7565890|NCT02906670|18623141|P4|STARTED|Cohort 7P, Q2W||0
7565891|NCT02906670|18623142|P3|STARTED|Cohort 7P, Q2W||0
7565892|NCT02906670|18623143|P2|STARTED|Cohort 7P, Q2W||0
7565893|NCT02906670|18623144|P1|STARTED|Cohort 7P, Q2W||0
7565894|NCT02906670|18623135|P10|NOT COMPLETED|Cohort 4P, QW||0
7565895|NCT02906670|18623136|P9|NOT COMPLETED|Cohort 4P, QW||0
7565896|NCT02906670|18623137|P8|NOT COMPLETED|Cohort 4P, QW||0
7565897|NCT02906670|18623138|P7|NOT COMPLETED|Cohort 4P, QW||0
7565898|NCT02906670|18623139|P6|NOT COMPLETED|Cohort 4P, QW||0
7565899|NCT02906670|18623140|P5|NOT COMPLETED|Cohort 4P, QW||0
7565900|NCT02906670|18623141|P4|NOT COMPLETED|Cohort 4P, QW||3
7565901|NCT02906670|18623142|P3|NOT COMPLETED|Cohort 4P, QW||0
7565902|NCT02906670|18623143|P2|NOT COMPLETED|Cohort 4P, QW||0
7565903|NCT02906670|18623144|P1|NOT COMPLETED|Cohort 4P, QW||0
7565904|NCT02906670|18623135|P10|COMPLETED|Cohort 4P, QW||0
7565905|NCT02906670|18623136|P9|COMPLETED|Cohort 4P, QW||0
7565906|NCT02906670|18623137|P8|COMPLETED|Cohort 4P, QW||0
7565907|NCT02906670|18623138|P7|COMPLETED|Cohort 4P, QW||0
7565908|NCT02906670|18623139|P6|COMPLETED|Cohort 4P, QW||0
7565909|NCT02906670|18623140|P5|COMPLETED|Cohort 4P, QW||0
7565910|NCT02906670|18623141|P4|COMPLETED|Cohort 4P, QW||0
7565911|NCT02906670|18623142|P3|COMPLETED|Cohort 4P, QW||0
7565912|NCT02906670|18623143|P2|COMPLETED|Cohort 4P, QW||0
7565913|NCT02906670|18623144|P1|COMPLETED|Cohort 4P, QW||0
7565914|NCT02906670|18623135|P10|STARTED|Cohort 4P, QW||0
7565915|NCT02906670|18623136|P9|STARTED|Cohort 4P, QW||0
7565916|NCT02906670|18623137|P8|STARTED|Cohort 4P, QW||0
7565917|NCT02906670|18623138|P7|STARTED|Cohort 4P, QW||0
7565918|NCT02906670|18623139|P6|STARTED|Cohort 4P, QW||0
7565919|NCT02906670|18623140|P5|STARTED|Cohort 4P, QW||0
7565920|NCT02906670|18623141|P4|STARTED|Cohort 4P, QW||3
7565921|NCT02906670|18623142|P3|STARTED|Cohort 4P, QW||0
7565922|NCT02906670|18623143|P2|STARTED|Cohort 4P, QW||0
7565923|NCT02906670|18623144|P1|STARTED|Cohort 4P, QW||0
7565924|NCT02906670|18623135|P10|NOT COMPLETED|Cohort 6P, Q2W||0
7565925|NCT02906670|18623136|P9|NOT COMPLETED|Cohort 6P, Q2W||4
7565926|NCT02906670|18623137|P8|NOT COMPLETED|Cohort 6P, Q2W||0
7565927|NCT02906670|18623138|P7|NOT COMPLETED|Cohort 6P, Q2W||0
7565928|NCT02906670|18623139|P6|NOT COMPLETED|Cohort 6P, Q2W||0
7565929|NCT02906670|18623140|P5|NOT COMPLETED|Cohort 6P, Q2W||0
7565930|NCT02906670|18623141|P4|NOT COMPLETED|Cohort 6P, Q2W||0
7565931|NCT02906670|18623142|P3|NOT COMPLETED|Cohort 6P, Q2W||0
7565932|NCT02906670|18623143|P2|NOT COMPLETED|Cohort 6P, Q2W||0
7565933|NCT02906670|18623144|P1|NOT COMPLETED|Cohort 6P, Q2W||0
7565934|NCT02906670|18623135|P10|COMPLETED|Cohort 6P, Q2W||0
7565935|NCT02906670|18623136|P9|COMPLETED|Cohort 6P, Q2W||0
7565936|NCT02906670|18623137|P8|COMPLETED|Cohort 6P, Q2W||0
7565937|NCT02906670|18623138|P7|COMPLETED|Cohort 6P, Q2W||0
7565938|NCT02906670|18623139|P6|COMPLETED|Cohort 6P, Q2W||0
7565939|NCT02906670|18623140|P5|COMPLETED|Cohort 6P, Q2W||0
7565940|NCT02906670|18623141|P4|COMPLETED|Cohort 6P, Q2W||0
7565941|NCT02906670|18623142|P3|COMPLETED|Cohort 6P, Q2W||0
7565942|NCT02906670|18623143|P2|COMPLETED|Cohort 6P, Q2W||0
7565943|NCT02906670|18623144|P1|COMPLETED|Cohort 6P, Q2W||0
7565944|NCT02906670|18623135|P10|STARTED|Cohort 6P, Q2W||0
7565945|NCT02906670|18623136|P9|STARTED|Cohort 6P, Q2W||4
7565946|NCT02906670|18623137|P8|STARTED|Cohort 6P, Q2W||0
7565947|NCT02906670|18623138|P7|STARTED|Cohort 6P, Q2W||0
7565948|NCT02906670|18623139|P6|STARTED|Cohort 6P, Q2W||0
7565949|NCT02906670|18623140|P5|STARTED|Cohort 6P, Q2W||0
7565950|NCT02906670|18623141|P4|STARTED|Cohort 6P, Q2W||0
7565951|NCT02906670|18623142|P3|STARTED|Cohort 6P, Q2W||0
7565952|NCT02906670|18623143|P2|STARTED|Cohort 6P, Q2W||0
7565953|NCT02906670|18623144|P1|STARTED|Cohort 6P, Q2W||0
7565954|NCT02906670|18623135|P10|NOT COMPLETED|Cohort 5P, Q2W||0
7565955|NCT02906670|18623136|P9|NOT COMPLETED|Cohort 5P, Q2W||0
7565956|NCT02906670|18623137|P8|NOT COMPLETED|Cohort 5P, Q2W||3
7565957|NCT02906670|18623138|P7|NOT COMPLETED|Cohort 5P, Q2W||0
7565958|NCT02906670|18623139|P6|NOT COMPLETED|Cohort 5P, Q2W||0
7565959|NCT02906670|18623140|P5|NOT COMPLETED|Cohort 5P, Q2W||0
7565960|NCT02906670|18623141|P4|NOT COMPLETED|Cohort 5P, Q2W||0
7565961|NCT02906670|18623142|P3|NOT COMPLETED|Cohort 5P, Q2W||0
7565962|NCT02906670|18623143|P2|NOT COMPLETED|Cohort 5P, Q2W||0
7565963|NCT02906670|18623144|P1|NOT COMPLETED|Cohort 5P, Q2W||0
7565964|NCT02906670|18623135|P10|COMPLETED|Cohort 5P, Q2W||0
7565965|NCT02906670|18623136|P9|COMPLETED|Cohort 5P, Q2W||0
7565966|NCT02906670|18623137|P8|COMPLETED|Cohort 5P, Q2W||0
7565967|NCT02906670|18623138|P7|COMPLETED|Cohort 5P, Q2W||0
7565968|NCT02906670|18623139|P6|COMPLETED|Cohort 5P, Q2W||0
7565969|NCT02906670|18623140|P5|COMPLETED|Cohort 5P, Q2W||0
7565970|NCT02906670|18623141|P4|COMPLETED|Cohort 5P, Q2W||0
7565971|NCT02906670|18623142|P3|COMPLETED|Cohort 5P, Q2W||0
7565972|NCT02906670|18623143|P2|COMPLETED|Cohort 5P, Q2W||0
7565973|NCT02906670|18623144|P1|COMPLETED|Cohort 5P, Q2W||0
7565974|NCT02906670|18623135|P10|STARTED|Cohort 5P, Q2W||0
7565975|NCT02906670|18623136|P9|STARTED|Cohort 5P, Q2W||0
7565976|NCT02906670|18623137|P8|STARTED|Cohort 5P, Q2W||3
7565977|NCT02906670|18623138|P7|STARTED|Cohort 5P, Q2W||0
7565978|NCT02906670|18623139|P6|STARTED|Cohort 5P, Q2W||0
7565979|NCT02906670|18623140|P5|STARTED|Cohort 5P, Q2W||0
7565980|NCT02906670|18623141|P4|STARTED|Cohort 5P, Q2W||0
7565981|NCT02906670|18623142|P3|STARTED|Cohort 5P, Q2W||0
7565982|NCT02906670|18623143|P2|STARTED|Cohort 5P, Q2W||0
7565983|NCT02906670|18623144|P1|STARTED|Cohort 5P, Q2W||0
7565984|NCT02906670|18623135|P10|NOT COMPLETED|Cohort 5, Q2W||0
7565985|NCT02906670|18623136|P9|NOT COMPLETED|Cohort 5, Q2W||0
7565986|NCT02906670|18623137|P8|NOT COMPLETED|Cohort 5, Q2W||0
7565987|NCT02906670|18623138|P7|NOT COMPLETED|Cohort 5, Q2W||7
7565988|NCT02906670|18623139|P6|NOT COMPLETED|Cohort 5, Q2W||0
7565989|NCT02906670|18623140|P5|NOT COMPLETED|Cohort 5, Q2W||0
7565990|NCT02906670|18623141|P4|NOT COMPLETED|Cohort 5, Q2W||0
7565991|NCT02906670|18623142|P3|NOT COMPLETED|Cohort 5, Q2W||0
7565992|NCT02906670|18623143|P2|NOT COMPLETED|Cohort 5, Q2W||0
7565993|NCT02906670|18623144|P1|NOT COMPLETED|Cohort 5, Q2W||0
7565994|NCT02906670|18623135|P10|COMPLETED|Cohort 5, Q2W||0
7565995|NCT02906670|18623136|P9|COMPLETED|Cohort 5, Q2W||0
7565996|NCT02906670|18623137|P8|COMPLETED|Cohort 5, Q2W||0
7565997|NCT02906670|18623138|P7|COMPLETED|Cohort 5, Q2W||0
7565998|NCT02906670|18623139|P6|COMPLETED|Cohort 5, Q2W||0
7565999|NCT02906670|18623140|P5|COMPLETED|Cohort 5, Q2W||0
7566000|NCT02906670|18623141|P4|COMPLETED|Cohort 5, Q2W||0
7566001|NCT02906670|18623142|P3|COMPLETED|Cohort 5, Q2W||0
7566002|NCT02906670|18623143|P2|COMPLETED|Cohort 5, Q2W||0
7566003|NCT02906670|18623144|P1|COMPLETED|Cohort 5, Q2W||0
7566004|NCT02906670|18623135|P10|STARTED|Cohort 5, Q2W||0
7566005|NCT02906670|18623136|P9|STARTED|Cohort 5, Q2W||0
7566006|NCT02906670|18623137|P8|STARTED|Cohort 5, Q2W||0
7566007|NCT02906670|18623138|P7|STARTED|Cohort 5, Q2W||7
7566008|NCT02906670|18623139|P6|STARTED|Cohort 5, Q2W||0
7566009|NCT02906670|18623140|P5|STARTED|Cohort 5, Q2W||0
7566010|NCT02906670|18623141|P4|STARTED|Cohort 5, Q2W||0
7566011|NCT02906670|18623142|P3|STARTED|Cohort 5, Q2W||0
7566012|NCT02906670|18623143|P2|STARTED|Cohort 5, Q2W||0
7566013|NCT02906670|18623144|P1|STARTED|Cohort 5, Q2W||0
7566014|NCT02906670|18623135|P10|NOT COMPLETED|Cohort 4, Q2W||0
7566015|NCT02906670|18623136|P9|NOT COMPLETED|Cohort 4, Q2W||0
7566016|NCT02906670|18623137|P8|NOT COMPLETED|Cohort 4, Q2W||0
7566017|NCT02906670|18623138|P7|NOT COMPLETED|Cohort 4, Q2W||0
7566018|NCT02906670|18623139|P6|NOT COMPLETED|Cohort 4, Q2W||3
7566019|NCT02906670|18623140|P5|NOT COMPLETED|Cohort 4, Q2W||0
7566020|NCT02906670|18623141|P4|NOT COMPLETED|Cohort 4, Q2W||0
7566021|NCT02906670|18623142|P3|NOT COMPLETED|Cohort 4, Q2W||0
7566022|NCT02906670|18623143|P2|NOT COMPLETED|Cohort 4, Q2W||0
7566023|NCT02906670|18623144|P1|NOT COMPLETED|Cohort 4, Q2W||0
7566024|NCT02906670|18623135|P10|COMPLETED|Cohort 4, Q2W||0
7566025|NCT02906670|18623136|P9|COMPLETED|Cohort 4, Q2W||0
7566026|NCT02906670|18623137|P8|COMPLETED|Cohort 4, Q2W||0
7566027|NCT02906670|18623138|P7|COMPLETED|Cohort 4, Q2W||0
7566028|NCT02906670|18623139|P6|COMPLETED|Cohort 4, Q2W||0
7566029|NCT02906670|18623140|P5|COMPLETED|Cohort 4, Q2W||0
7566030|NCT02906670|18623141|P4|COMPLETED|Cohort 4, Q2W||0
7566031|NCT02906670|18623142|P3|COMPLETED|Cohort 4, Q2W||0
7566032|NCT02906670|18623143|P2|COMPLETED|Cohort 4, Q2W||0
7566033|NCT02906670|18623144|P1|COMPLETED|Cohort 4, Q2W||0
7566034|NCT02906670|18623135|P10|STARTED|Cohort 4, Q2W||0
7566035|NCT02906670|18623136|P9|STARTED|Cohort 4, Q2W||0
7566036|NCT02906670|18623137|P8|STARTED|Cohort 4, Q2W||0
7566037|NCT02906670|18623138|P7|STARTED|Cohort 4, Q2W||0
7566038|NCT02906670|18623139|P6|STARTED|Cohort 4, Q2W||3
7566039|NCT02906670|18623140|P5|STARTED|Cohort 4, Q2W||0
7566040|NCT02906670|18623141|P4|STARTED|Cohort 4, Q2W||0
7566041|NCT02906670|18623142|P3|STARTED|Cohort 4, Q2W||0
7566042|NCT02906670|18623143|P2|STARTED|Cohort 4, Q2W||0
7566043|NCT02906670|18623144|P1|STARTED|Cohort 4, Q2W||0
7566044|NCT02906670|18623135|P10|NOT COMPLETED|Cohort 3, QW||0
7566045|NCT02906670|18623136|P9|NOT COMPLETED|Cohort 3, QW||0
7566046|NCT02906670|18623137|P8|NOT COMPLETED|Cohort 3, QW||0
7566047|NCT02906670|18623138|P7|NOT COMPLETED|Cohort 3, QW||0
7566048|NCT02906670|18623139|P6|NOT COMPLETED|Cohort 3, QW||0
7566049|NCT02906670|18623140|P5|NOT COMPLETED|Cohort 3, QW||0
7566050|NCT02906670|18623141|P4|NOT COMPLETED|Cohort 3, QW||0
7566051|NCT02906670|18623142|P3|NOT COMPLETED|Cohort 3, QW||4
7566052|NCT02906670|18623143|P2|NOT COMPLETED|Cohort 3, QW||0
7566053|NCT02906670|18623144|P1|NOT COMPLETED|Cohort 3, QW||0
7566054|NCT02906670|18623135|P10|COMPLETED|Cohort 3, QW||0
7566055|NCT02906670|18623136|P9|COMPLETED|Cohort 3, QW||0
7566056|NCT02906670|18623137|P8|COMPLETED|Cohort 3, QW||0
7566057|NCT02906670|18623138|P7|COMPLETED|Cohort 3, QW||0
7566058|NCT02906670|18623139|P6|COMPLETED|Cohort 3, QW||0
7566059|NCT02906670|18623140|P5|COMPLETED|Cohort 3, QW||0
7566060|NCT02906670|18623141|P4|COMPLETED|Cohort 3, QW||0
7566061|NCT02906670|18623142|P3|COMPLETED|Cohort 3, QW||0
7566062|NCT02906670|18623143|P2|COMPLETED|Cohort 3, QW||0
7566063|NCT02906670|18623144|P1|COMPLETED|Cohort 3, QW||0
7566064|NCT02906670|18623135|P10|STARTED|Cohort 3, QW||0
7566065|NCT02906670|18623136|P9|STARTED|Cohort 3, QW||0
7566066|NCT02906670|18623137|P8|STARTED|Cohort 3, QW||0
7566067|NCT02906670|18623138|P7|STARTED|Cohort 3, QW||0
7566068|NCT02906670|18623139|P6|STARTED|Cohort 3, QW||0
7566069|NCT02906670|18623140|P5|STARTED|Cohort 3, QW||0
7566070|NCT02906670|18623141|P4|STARTED|Cohort 3, QW||0
7566071|NCT02906670|18623142|P3|STARTED|Cohort 3, QW||4
7566072|NCT02906670|18623143|P2|STARTED|Cohort 3, QW||0
7566073|NCT02906670|18623144|P1|STARTED|Cohort 3, QW||0
7566074|NCT02906670|18623135|P10|NOT COMPLETED|Cohort 2, QW||0
7566075|NCT02906670|18623136|P9|NOT COMPLETED|Cohort 2, QW||0
7566076|NCT02906670|18623137|P8|NOT COMPLETED|Cohort 2, QW||0
7566077|NCT02906670|18623138|P7|NOT COMPLETED|Cohort 2, QW||0
7566078|NCT02906670|18623139|P6|NOT COMPLETED|Cohort 2, QW||0
7566079|NCT02906670|18623140|P5|NOT COMPLETED|Cohort 2, QW||0
7566080|NCT02906670|18623141|P4|NOT COMPLETED|Cohort 2, QW||0
7566081|NCT02906670|18623142|P3|NOT COMPLETED|Cohort 2, QW||0
7566082|NCT02906670|18623143|P2|NOT COMPLETED|Cohort 2, QW||1
7566083|NCT02906670|18623144|P1|NOT COMPLETED|Cohort 2, QW||0
7566084|NCT02906670|18623135|P10|COMPLETED|Cohort 2, QW||0
7566085|NCT02906670|18623136|P9|COMPLETED|Cohort 2, QW||0
7566086|NCT02906670|18623137|P8|COMPLETED|Cohort 2, QW||0
7566087|NCT02906670|18623138|P7|COMPLETED|Cohort 2, QW||0
7566088|NCT02906670|18623139|P6|COMPLETED|Cohort 2, QW||0
7566089|NCT02906670|18623140|P5|COMPLETED|Cohort 2, QW||0
7566090|NCT02906670|18623141|P4|COMPLETED|Cohort 2, QW||0
7566091|NCT02906670|18623142|P3|COMPLETED|Cohort 2, QW||0
7566092|NCT02906670|18623143|P2|COMPLETED|Cohort 2, QW||0
7566093|NCT02906670|18623144|P1|COMPLETED|Cohort 2, QW||0
7566094|NCT02906670|18623135|P10|STARTED|Cohort 2, QW||0
7566095|NCT02906670|18623136|P9|STARTED|Cohort 2, QW||0
7566096|NCT02906670|18623137|P8|STARTED|Cohort 2, QW||0
7566097|NCT02906670|18623138|P7|STARTED|Cohort 2, QW||0
7566098|NCT02906670|18623139|P6|STARTED|Cohort 2, QW||0
7566099|NCT02906670|18623140|P5|STARTED|Cohort 2, QW||0
7566100|NCT02906670|18623141|P4|STARTED|Cohort 2, QW||0
7566101|NCT02906670|18623142|P3|STARTED|Cohort 2, QW||0
7566102|NCT02906670|18623143|P2|STARTED|Cohort 2, QW||1
7566103|NCT02906670|18623144|P1|STARTED|Cohort 2, QW||0
7566104|NCT02906670|18623135|P10|NOT COMPLETED|Cohort 1, QW||0
7566105|NCT02906670|18623136|P9|NOT COMPLETED|Cohort 1, QW||0
7566106|NCT02906670|18623137|P8|NOT COMPLETED|Cohort 1, QW||0
7566107|NCT02906670|18623138|P7|NOT COMPLETED|Cohort 1, QW||0
7566108|NCT02906670|18623139|P6|NOT COMPLETED|Cohort 1, QW||0
7566109|NCT02906670|18623140|P5|NOT COMPLETED|Cohort 1, QW||0
7566110|NCT02906670|18623141|P4|NOT COMPLETED|Cohort 1, QW||0
7566111|NCT02906670|18623142|P3|NOT COMPLETED|Cohort 1, QW||0
7566112|NCT02906670|18623143|P2|NOT COMPLETED|Cohort 1, QW||0
7566113|NCT02906670|18623144|P1|NOT COMPLETED|Cohort 1, QW||1
7566114|NCT02906670|18623135|P10|COMPLETED|Cohort 1, QW||0
7566115|NCT02906670|18623136|P9|COMPLETED|Cohort 1, QW||0
7566116|NCT02906670|18623137|P8|COMPLETED|Cohort 1, QW||0
7566117|NCT02906670|18623138|P7|COMPLETED|Cohort 1, QW||0
7566118|NCT02906670|18623139|P6|COMPLETED|Cohort 1, QW||0
7566119|NCT02906670|18623140|P5|COMPLETED|Cohort 1, QW||0
7566120|NCT02906670|18623141|P4|COMPLETED|Cohort 1, QW||0
7566121|NCT02906670|18623142|P3|COMPLETED|Cohort 1, QW||0
7566122|NCT02906670|18623143|P2|COMPLETED|Cohort 1, QW||0
7566123|NCT02906670|18623144|P1|COMPLETED|Cohort 1, QW||0
7566124|NCT02906670|18623135|P10|STARTED|Cohort 1, QW||0
7566125|NCT02906670|18623136|P9|STARTED|Cohort 1, QW||0
7566126|NCT02906670|18623137|P8|STARTED|Cohort 1, QW||0
7566127|NCT02906670|18623138|P7|STARTED|Cohort 1, QW||0
7566128|NCT02906670|18623139|P6|STARTED|Cohort 1, QW||0
7566129|NCT02906670|18623140|P5|STARTED|Cohort 1, QW||0
7566130|NCT02906670|18623141|P4|STARTED|Cohort 1, QW||0
7566131|NCT02906670|18623142|P3|STARTED|Cohort 1, QW||0
7566132|NCT02906670|18623143|P2|STARTED|Cohort 1, QW||0
7566133|NCT02906670|18623144|P1|STARTED|Cohort 1, QW||1
7566134|NCT02906644|18623261|P2|NOT COMPLETED|Weeks 3 to 14||11
7566135|NCT02906644|18623262|P1|NOT COMPLETED|Weeks 3 to 14||16
7566136|NCT02906644|18623261|P2|COMPLETED|Weeks 3 to 14||16
7566137|NCT02906644|18623262|P1|COMPLETED|Weeks 3 to 14||14
7566138|NCT02906644|18623261|P2|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||16
7566139|NCT02906644|18623262|P1|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||14
7566140|NCT02906644|18623261|P2|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|20
7566141|NCT02906644|18623262|P1|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|17
7566142|NCT02906644|18623261|P2|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|27
7566143|NCT02906644|18623262|P1|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|30
7566144|NCT02906644|18623261|P2|NOT COMPLETED|First 2 Weeks||3
7566145|NCT02906644|18623262|P1|NOT COMPLETED|First 2 Weeks||1
7566146|NCT02906644|18623261|P2|COMPLETED|First 2 Weeks||27
7566147|NCT02906644|18623262|P1|COMPLETED|First 2 Weeks||30
7566148|NCT02906644|18623261|P2|STARTED|First 2 Weeks||30
7566149|NCT02906644|18623262|P1|STARTED|First 2 Weeks||31
7566150|NCT02906579|18623278|P1|NOT COMPLETED|Overall Study||2
7566151|NCT02906579|18623278|P1|COMPLETED|Overall Study||9
7566152|NCT02906579|18623278|P1|Completed Cycle 6 (50 mg IW-1973)|Overall Study||9
7566153|NCT02906579|18623278|P1|Completed Cycle 5 (40 mg IW-1973)|Overall Study||9
7566154|NCT02906579|18623278|P1|Completed Cycle 4 (30 mg IW-1973)|Overall Study||10
7566155|NCT02906579|18623278|P1|Completed Cycle 3 (20 mg IW-1973)|Overall Study||11
7566156|NCT02906579|18623278|P1|Completed Cycle 2 (10 mg IW-1973)|Overall Study||11
7566157|NCT02906579|18623278|P1|Completed Cycle 1 (Placebo)|Overall Study||11
7566158|NCT02906579|18623278|P1|STARTED|Overall Study||11
7566159|NCT02906566|18623465|P2|NOT COMPLETED|Overall Study||0
7566160|NCT02906566|18623466|P1|NOT COMPLETED|Overall Study||3
7566161|NCT02906566|18623465|P2|COMPLETED|Overall Study||10
7566162|NCT02906566|18623466|P1|COMPLETED|Overall Study||21
7566163|NCT02906566|18623465|P2|STARTED|Overall Study||10
7566164|NCT02906566|18623466|P1|STARTED|Overall Study||24
7566165|NCT02906358|18623482|P2|NOT COMPLETED|Overall Study||22
7566166|NCT02906358|18623483|P1|NOT COMPLETED|Overall Study||22
7566167|NCT02906358|18623482|P2|COMPLETED|Overall Study||31
7566168|NCT02906358|18623483|P1|COMPLETED|Overall Study||36
7566169|NCT02906358|18623482|P2|Completed 3 Month Measures|Overall Study||33
7566170|NCT02906358|18623483|P1|Completed 3 Month Measures|Overall Study||36
7566171|NCT02906358|18623482|P2|STARTED|Overall Study||53
7566172|NCT02906358|18623483|P1|STARTED|Overall Study||58
7566173|NCT02905981|18623511|P1|NOT COMPLETED|Overall Study||1
7566174|NCT02905981|18623511|P1|COMPLETED|Overall Study||0
7566175|NCT02905981|18623511|P1|STARTED|Overall Study||1
7566176|NCT02905825|18623517|P1|NOT COMPLETED|Overall Study||12
7566177|NCT02905825|18623517|P1|COMPLETED|Overall Study||41
7566178|NCT02905825|18623517|P1|STARTED|Overall Study||53
7566179|NCT02905331|18623525|P3|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
7566180|NCT02905331|18623526|P2|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||8
7566181|NCT02905331|18623527|P1|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
7566182|NCT02905331|18623525|P3|COMPLETED|Active Treatment and Follow up (wk16-40)||13
7566183|NCT02905331|18623526|P2|COMPLETED|Active Treatment and Follow up (wk16-40)||53
7566184|NCT02905331|18623527|P1|COMPLETED|Active Treatment and Follow up (wk16-40)||0
7566185|NCT02905331|18623525|P3|STARTED|Active Treatment and Follow up (wk16-40)||13
7566186|NCT02905331|18623526|P2|STARTED|Active Treatment and Follow up (wk16-40)||61
7566187|NCT02905331|18623527|P1|STARTED|Active Treatment and Follow up (wk16-40)||0
7566188|NCT02905331|18623525|P3|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
7566189|NCT02905331|18623526|P2|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||1
7566190|NCT02905331|18623527|P1|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||3
7566191|NCT02905331|18623525|P3|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
7566192|NCT02905331|18623526|P2|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||61
7566193|NCT02905331|18623527|P1|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||13
7566194|NCT02905331|18623525|P3|STARTED|Placebo Controlled Period(Week[wk] 0-16)||0
7566195|NCT02905331|18623526|P2|STARTED|Placebo Controlled Period(Week[wk] 0-16)||62
7566196|NCT02905331|18623527|P1|STARTED|Placebo Controlled Period(Week[wk] 0-16)||16
7566197|NCT02905266|18623555|P2|NOT COMPLETED|Maintenance Phase Part 2||8
7566198|NCT02905266|18623556|P1|NOT COMPLETED|Maintenance Phase Part 2||12
7566199|NCT02905266|18623555|P2|COMPLETED|Maintenance Phase Part 2||14
7566200|NCT02905266|18623556|P1|COMPLETED|Maintenance Phase Part 2||8
7566201|NCT02905266|18623555|P2|STARTED|Maintenance Phase Part 2||22
7566202|NCT02905266|18623556|P1|STARTED|Maintenance Phase Part 2||20
7566203|NCT02905266|18623555|P2|NOT COMPLETED|Transition From Part 1 to Part 2||8
7566204|NCT02905266|18623556|P1|NOT COMPLETED|Transition From Part 1 to Part 2||4
7566205|NCT02905266|18623555|P2|COMPLETED|Transition From Part 1 to Part 2||22
7566206|NCT02905266|18623556|P1|COMPLETED|Transition From Part 1 to Part 2||20
7566207|NCT02905266|18623555|P2|STARTED|Transition From Part 1 to Part 2||30
7566208|NCT02905266|18623556|P1|STARTED|Transition From Part 1 to Part 2||24
7566209|NCT02905266|18623555|P2|NOT COMPLETED|Treatment Phase Part 1||23
7566210|NCT02905266|18623556|P1|NOT COMPLETED|Treatment Phase Part 1||29
7566211|NCT02905266|18623555|P2|COMPLETED|Treatment Phase Part 1||30
7566212|NCT02905266|18623556|P1|COMPLETED|Treatment Phase Part 1||24
7566213|NCT02905266|18623555|P2|STARTED|Treatment Phase Part 1||53
7566214|NCT02905266|18623556|P1|STARTED|Treatment Phase Part 1||53
7566215|NCT02905149|18623584|P2|NOT COMPLETED|Overall Study||0
7566216|NCT02905149|18623585|P1|NOT COMPLETED|Overall Study||2
7566217|NCT02905149|18623584|P2|COMPLETED|Overall Study||30
7566218|NCT02905149|18623585|P1|COMPLETED|Overall Study||28
7566219|NCT02905149|18623584|P2|STARTED|Overall Study||30
7566220|NCT02905149|18623585|P1|STARTED|Overall Study||30
7566221|NCT02905006|18623603|P6|NOT COMPLETED|Overall Study||4
7566222|NCT02905006|18623604|P5|NOT COMPLETED|Overall Study||3
7566223|NCT02905006|18623605|P4|NOT COMPLETED|Overall Study||6
7566224|NCT02905006|18623606|P3|NOT COMPLETED|Overall Study||5
7566225|NCT02905006|18623607|P2|NOT COMPLETED|Overall Study||3
7566226|NCT02905006|18623608|P1|NOT COMPLETED|Overall Study||5
7566227|NCT02905006|18623603|P6|COMPLETED|Overall Study||39
7566228|NCT02905006|18623604|P5|COMPLETED|Overall Study||40
7566229|NCT02905006|18623605|P4|COMPLETED|Overall Study||34
7566230|NCT02905006|18623606|P3|COMPLETED|Overall Study||38
7566231|NCT02905006|18623607|P2|COMPLETED|Overall Study||36
7566232|NCT02905006|18623608|P1|COMPLETED|Overall Study||37
7566233|NCT02905006|18623603|P6|Entered Safety Follow-up Period|Overall Study||3
7566234|NCT02905006|18623604|P5|Entered Safety Follow-up Period|Overall Study||1
7566235|NCT02905006|18623605|P4|Entered Safety Follow-up Period|Overall Study||2
7566236|NCT02905006|18623606|P3|Entered Safety Follow-up Period|Overall Study||4
7566237|NCT02905006|18623607|P2|Entered Safety Follow-up Period|Overall Study||4
7566238|NCT02905006|18623608|P1|Entered Safety Follow-up Period|Overall Study||4
7566239|NCT02905006|18623603|P6|Enrolled in Extension Study (PS0011)|Overall Study||40
7566240|NCT02905006|18623604|P5|Enrolled in Extension Study (PS0011)|Overall Study||42
7566241|NCT02905006|18623605|P4|Enrolled in Extension Study (PS0011)|Overall Study||38
7566242|NCT02905006|18623606|P3|Enrolled in Extension Study (PS0011)|Overall Study||39
7566243|NCT02905006|18623607|P2|Enrolled in Extension Study (PS0011)|Overall Study||35
7566244|NCT02905006|18623608|P1|Enrolled in Extension Study (PS0011)|Overall Study||38
7566245|NCT02905006|18623603|P6|Completed Treatment Period|Overall Study||39
7566246|NCT02905006|18623604|P5|Completed Treatment Period|Overall Study||40
7566247|NCT02905006|18623605|P4|Completed Treatment Period|Overall Study||34
7566248|NCT02905006|18623606|P3|Completed Treatment Period|Overall Study||38
7566249|NCT02905006|18623607|P2|Completed Treatment Period|Overall Study||36
7566250|NCT02905006|18623608|P1|Completed Treatment Period|Overall Study||37
7566251|NCT02905006|18623603|P6|STARTED|Overall Study||43
7566252|NCT02905006|18623604|P5|STARTED|Overall Study||43
7566253|NCT02905006|18623605|P4|STARTED|Overall Study||40
7566254|NCT02905006|18623606|P3|STARTED|Overall Study||43
7566255|NCT02905006|18623607|P2|STARTED|Overall Study||39
7566256|NCT02905006|18623608|P1|STARTED|Overall Study||42
7566257|NCT02904915|18623824|P2|NOT COMPLETED|Overall Study||0
7566258|NCT02904915|18623825|P1|NOT COMPLETED|Overall Study||0
7566259|NCT02904915|18623824|P2|COMPLETED|Overall Study||25
7566260|NCT02904915|18623825|P1|COMPLETED|Overall Study||25
7566261|NCT02904915|18623824|P2|STARTED|Overall Study||25
7566262|NCT02904915|18623825|P1|STARTED|Overall Study||25
7566263|NCT02904902|18623835|P1|NOT COMPLETED|Overall Study||1
7566264|NCT02904902|18623835|P1|COMPLETED|Overall Study||14
7566265|NCT02904902|18623835|P1|STARTED|Overall Study||15
7566266|NCT02904356|18623842|P1|NOT COMPLETED|Overall Study||0
7566267|NCT02904356|18623842|P1|COMPLETED|Overall Study||2
7566268|NCT02904356|18623842|P1|STARTED|Overall Study||2
7566269|NCT02904265|18623848|P2|NOT COMPLETED|Overall Study||2
7566270|NCT02904265|18623849|P1|NOT COMPLETED|Overall Study||1
7566271|NCT02904265|18623848|P2|COMPLETED|Overall Study||0
7566272|NCT02904265|18623849|P1|COMPLETED|Overall Study||0
7566273|NCT02904265|18623848|P2|STARTED|Overall Study|Study closed due to only 3 participants recruited|2
7566274|NCT02904265|18623849|P1|STARTED|Overall Study|Study closed due to only 3 participants recruited|1
7566275|NCT02904096|18623857|P2|NOT COMPLETED|Overall Study||21
7566276|NCT02904096|18623858|P1|NOT COMPLETED|Overall Study||19
7566277|NCT02904096|18623857|P2|COMPLETED|Overall Study||105
7566278|NCT02904096|18623858|P1|COMPLETED|Overall Study||111
7566279|NCT02904096|18623857|P2|STARTED|Overall Study||126
7566280|NCT02904096|18623858|P1|STARTED|Overall Study||130
7566281|NCT02904057|18623884|P2|NOT COMPLETED|Overall Study||0
7566282|NCT02904057|18623885|P1|NOT COMPLETED|Overall Study||0
7566283|NCT02904057|18623884|P2|COMPLETED|Overall Study||10
7566284|NCT02904057|18623885|P1|COMPLETED|Overall Study||19
7566285|NCT02904057|18623884|P2|STARTED|Overall Study||10
7566286|NCT02904057|18623885|P1|STARTED|Overall Study||19
7566287|NCT02903966|18623894|P2|NOT COMPLETED|Part B (Day 44 to 112)||2
7566288|NCT02903966|18623895|P1|NOT COMPLETED|Part B (Day 44 to 112)||0
7566289|NCT02903966|18623894|P2|COMPLETED|Part B (Day 44 to 112)||22
7566290|NCT02903966|18623895|P1|COMPLETED|Part B (Day 44 to 112)||11
7566291|NCT02903966|18623894|P2|STARTED|Part B (Day 44 to 112)||24
7566292|NCT02903966|18623895|P1|STARTED|Part B (Day 44 to 112)||11
7566293|NCT02903966|18623894|P2|NOT COMPLETED|Part A (Day 1 to 43)||0
7566294|NCT02903966|18623895|P1|NOT COMPLETED|Part A (Day 1 to 43)||1
7566295|NCT02903966|18623894|P2|COMPLETED|Part A (Day 1 to 43)||24
7566296|NCT02903966|18623895|P1|COMPLETED|Part A (Day 1 to 43)||11
7566297|NCT02903966|18623894|P2|STARTED|Part A (Day 1 to 43)||24
7566298|NCT02903966|18623895|P1|STARTED|Part A (Day 1 to 43)||12
7566299|NCT02903836|18623964|P3|NOT COMPLETED|Overall Study||4
7566300|NCT02903836|18623965|P2|NOT COMPLETED|Overall Study||4
7566301|NCT02903836|18623966|P1|NOT COMPLETED|Overall Study||3
7566302|NCT02903836|18623964|P3|COMPLETED|Overall Study||73
7566303|NCT02903836|18623965|P2|COMPLETED|Overall Study||69
7566304|NCT02903836|18623966|P1|COMPLETED|Overall Study||71
7566305|NCT02903836|18623964|P3|STARTED|Overall Study||77
7566306|NCT02903836|18623965|P2|STARTED|Overall Study||73
7566307|NCT02903836|18623966|P1|STARTED|Overall Study||74
7566308|NCT02903420|18623977|P1|NOT COMPLETED|Overall Study||3
7566309|NCT02903420|18623977|P1|COMPLETED|Overall Study||25
7566310|NCT02903420|18623977|P1|STARTED|Overall Study||28
7566311|NCT02903407|18623985|P2|NOT COMPLETED|Overall Study||0
7566312|NCT02903407|18623986|P1|NOT COMPLETED|Overall Study||0
7566313|NCT02903407|18623985|P2|COMPLETED|Overall Study||3
7566314|NCT02903407|18623986|P1|COMPLETED|Overall Study||4
7566315|NCT02903407|18623985|P2|STARTED|Overall Study||3
7566316|NCT02903407|18623986|P1|STARTED|Overall Study||4
7566317|NCT02903394|18624018|P2|NOT COMPLETED|Overall Study||0
7566318|NCT02903394|18624019|P1|NOT COMPLETED|Overall Study||0
7566319|NCT02903394|18624018|P2|COMPLETED|Overall Study||50
7566320|NCT02903394|18624019|P1|COMPLETED|Overall Study||5
7566321|NCT02903394|18624018|P2|STARTED|Overall Study||50
7566322|NCT02903394|18624019|P1|STARTED|Overall Study||5
7566323|NCT02903238|18624029|P1|NOT COMPLETED|Overall Study||4
7566324|NCT02903238|18624029|P1|COMPLETED|Overall Study||17
7566325|NCT02903238|18624029|P1|STARTED|Overall Study||21
7566326|NCT02903121|18624040|P2|NOT COMPLETED|Overall Study||14
7566327|NCT02903121|18624041|P1|NOT COMPLETED|Overall Study||23
7566328|NCT02903121|18624040|P2|COMPLETED|Overall Study||38
7566329|NCT02903121|18624041|P1|COMPLETED|Overall Study||34
7566330|NCT02903121|18624040|P2|STARTED|Overall Study||52
7566331|NCT02903121|18624041|P1|STARTED|Overall Study||57
7566332|NCT02903030|18624055|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
7566333|NCT02903030|18624056|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
7566334|NCT02903030|18624055|P2|COMPLETED|Second Intervention (8 Weeks)||4
7566335|NCT02903030|18624056|P1|COMPLETED|Second Intervention (8 Weeks)||6
7566336|NCT02903030|18624055|P2|STARTED|Second Intervention (8 Weeks)||4
7566337|NCT02903030|18624056|P1|STARTED|Second Intervention (8 Weeks)||6
7566338|NCT02903030|18624055|P2|NOT COMPLETED|Washout (3 Weeks)||0
7566339|NCT02903030|18624056|P1|NOT COMPLETED|Washout (3 Weeks)||0
7566340|NCT02903030|18624055|P2|COMPLETED|Washout (3 Weeks)||4
7566341|NCT02903030|18624056|P1|COMPLETED|Washout (3 Weeks)||6
7566342|NCT02903030|18624055|P2|STARTED|Washout (3 Weeks)||4
7566343|NCT02903030|18624056|P1|STARTED|Washout (3 Weeks)||6
7566344|NCT02903030|18624055|P2|NOT COMPLETED|First Intervention (8 Weeks)||1
7566345|NCT02903030|18624056|P1|NOT COMPLETED|First Intervention (8 Weeks)||2
7566346|NCT02903030|18624055|P2|COMPLETED|First Intervention (8 Weeks)||4
7566347|NCT02903030|18624056|P1|COMPLETED|First Intervention (8 Weeks)||6
7566348|NCT02903030|18624055|P2|Received Intervention|First Intervention (8 Weeks)||4
7566349|NCT02903030|18624056|P1|Received Intervention|First Intervention (8 Weeks)||6
7566350|NCT02903030|18624055|P2|STARTED|First Intervention (8 Weeks)||5
7566351|NCT02903030|18624056|P1|STARTED|First Intervention (8 Weeks)||8
7566352|NCT02902965|18624074|P1|NOT COMPLETED|Overall Study||10
7566353|NCT02902965|18624074|P1|COMPLETED|Overall Study||64
7566354|NCT02902965|18624074|P1|STARTED|Overall Study||74
7566355|NCT02902913|18624084|P1|NOT COMPLETED|Overall Study||0
7566356|NCT02902913|18624084|P1|COMPLETED|Overall Study||9
7566357|NCT02902913|18624084|P1|Ibuprofen (400mg)|Overall Study||9
7566358|NCT02902913|18624084|P1|Washout (7 Days)|Overall Study||9
7566359|NCT02902913|18624084|P1|Third Intervention (1 Day)|Overall Study||9
7566360|NCT02902913|18624084|P1|Washout (7 Days)|Overall Study||9
7566361|NCT02902913|18624084|P1|Second Intervention (1 Day)|Overall Study||9
7566362|NCT02902913|18624084|P1|Washout (7 Days)|Overall Study||9
7566363|NCT02902913|18624084|P1|First Intervention (1 Day)|Overall Study||9
7566364|NCT02902913|18624084|P1|STARTED|Overall Study||9
7566365|NCT02902809|18624092|P1|NOT COMPLETED|Overall Study||28
7566366|NCT02902809|18624092|P1|COMPLETED|Overall Study||0
7566367|NCT02902809|18624092|P1|Treatment Completed|Overall Study||2
7566368|NCT02902809|18624092|P1|Treatment Received|Overall Study||28
7566369|NCT02902809|18624092|P1|STARTED|Overall Study||28
7566370|NCT02902770|18624103|P3|NOT COMPLETED|Overall Study||0
7566371|NCT02902770|18624104|P2|NOT COMPLETED|Overall Study||0
7566372|NCT02902770|18624105|P1|NOT COMPLETED|Overall Study||0
7566373|NCT02902770|18624103|P3|COMPLETED|Overall Study||50
7566374|NCT02902770|18624104|P2|COMPLETED|Overall Study||50
7566375|NCT02902770|18624105|P1|COMPLETED|Overall Study||50
7566376|NCT02902770|18624103|P3|STARTED|Overall Study||50
7566377|NCT02902770|18624104|P2|STARTED|Overall Study||50
7566378|NCT02902770|18624105|P1|STARTED|Overall Study||50
7566379|NCT02902237|18624113|P1|NOT COMPLETED|Overall Study||0
7566380|NCT02902237|18624113|P1|COMPLETED|Overall Study|STUDY INITIATION: 2017 03 29, 1st Patient In, STUDY COMPLETION: 2019 11 05, Date of Study End|17
7566381|NCT02902237|18624113|P1|STARTED|Overall Study||17
7566382|NCT02902172|18624126|P2|NOT COMPLETED|Overall Study||0
7566383|NCT02902172|18624127|P1|NOT COMPLETED|Overall Study||0
7566384|NCT02902172|18624126|P2|COMPLETED|Overall Study||20
7566385|NCT02902172|18624127|P1|COMPLETED|Overall Study||16
7566386|NCT02902172|18624126|P2|STARTED|Overall Study||20
7566387|NCT02902172|18624127|P1|STARTED|Overall Study||16
7566388|NCT02902146|18624137|P2|NOT COMPLETED|Overall Study||0
7566389|NCT02902146|18624138|P1|NOT COMPLETED|Overall Study||0
7566390|NCT02902146|18624137|P2|COMPLETED|Overall Study||376
7566391|NCT02902146|18624138|P1|COMPLETED|Overall Study||381
7566392|NCT02902146|18624137|P2|STARTED|Overall Study||376
7566393|NCT02902146|18624138|P1|STARTED|Overall Study||381
7566394|NCT02902081|18624152|P1|NOT COMPLETED|Overall Study||0
7566395|NCT02902081|18624152|P1|COMPLETED|Overall Study||38
7566396|NCT02902081|18624152|P1|STARTED|Overall Study||38
7566397|NCT02901951|18624160|P1|NOT COMPLETED|Overall Study||0
7566398|NCT02901951|18624160|P1|COMPLETED|Overall Study||103
7566399|NCT02901951|18624160|P1|STARTED|Overall Study||103
7566400|NCT02901249|18624171|P1|NOT COMPLETED|Overall Study||25
7566401|NCT02901249|18624171|P1|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|43
7566402|NCT02901249|18624171|P1|STARTED|Overall Study||68
7566403|NCT02901080|18624177|P1|NOT COMPLETED|Overall Study||49
7566404|NCT02901080|18624177|P1|COMPLETED|Overall Study||112
7566405|NCT02901080|18624177|P1|STARTED|Overall Study||161
7566406|NCT02901054|18624184|P1|NOT COMPLETED|Overall Study||4
7566407|NCT02901054|18624184|P1|COMPLETED|Overall Study||15
7566408|NCT02901054|18624184|P1|STARTED|Overall Study|19 consented, 3 withdrew prior to intervention, 1 received study drug but surgery was cancelled.|19
7566409|NCT02900781|18624190|P2|NOT COMPLETED|Overall Study||5
7566410|NCT02900781|18624191|P1|NOT COMPLETED|Overall Study||4
7566411|NCT02900781|18624190|P2|COMPLETED|Overall Study||0
7566412|NCT02900781|18624191|P1|COMPLETED|Overall Study||0
7566413|NCT02900781|18624190|P2|STARTED|Overall Study||5
7566414|NCT02900781|18624191|P1|STARTED|Overall Study||4
7566415|NCT02900378|18624199|P2|NOT COMPLETED|Treatment Phase||0
7566416|NCT02900378|18624200|P1|NOT COMPLETED|Treatment Phase||0
7566417|NCT02900378|18624199|P2|COMPLETED|Treatment Phase||310
7566418|NCT02900378|18624200|P1|COMPLETED|Treatment Phase||309
7566419|NCT02900378|18624199|P2|Full Analysis Set|Treatment Phase||302
7566420|NCT02900378|18624200|P1|Full Analysis Set|Treatment Phase||302
7566421|NCT02900378|18624199|P2|STARTED|Treatment Phase||310
7566422|NCT02900378|18624200|P1|STARTED|Treatment Phase||309
7566423|NCT02900378|18624199|P2|NOT COMPLETED|Randomization (Visit 2)||28
7566424|NCT02900378|18624200|P1|NOT COMPLETED|Randomization (Visit 2)||23
7566425|NCT02900378|18624199|P2|COMPLETED|Randomization (Visit 2)||283
7566426|NCT02900378|18624200|P1|COMPLETED|Randomization (Visit 2)||287
7566427|NCT02900378|18624199|P2|STARTED|Randomization (Visit 2)||311
7566428|NCT02900378|18624200|P1|STARTED|Randomization (Visit 2)||310
7566429|NCT02900170|18624244|P1|NOT COMPLETED|Overall Study||8
7566430|NCT02900170|18624244|P1|COMPLETED|Overall Study||0
7566431|NCT02900170|18624244|P1|STARTED|Overall Study||8
7566432|NCT02900092|18624248|P1|NOT COMPLETED|Overall Study||1
7566433|NCT02900092|18624248|P1|COMPLETED|Overall Study||9
7566434|NCT02900092|18624248|P1|STARTED|Overall Study||10
7566435|NCT02899988|18624256|P11|NOT COMPLETED|Follow-Up (16 Weeks)||0
7566436|NCT02899988|18624257|P10|NOT COMPLETED|Follow-Up (16 Weeks)||0
7566437|NCT02899988|18624258|P9|NOT COMPLETED|Follow-Up (16 Weeks)||0
7566438|NCT02899988|18624259|P8|NOT COMPLETED|Follow-Up (16 Weeks)||0
7566439|NCT02899988|18624260|P7|NOT COMPLETED|Follow-Up (16 Weeks)||0
7566440|NCT02899988|18624261|P6|NOT COMPLETED|Follow-Up (16 Weeks)||0
7566441|NCT02899988|18624262|P5|NOT COMPLETED|Follow-Up (16 Weeks)||0
7566442|NCT02899988|18624263|P4|NOT COMPLETED|Follow-Up (16 Weeks)||0
7566443|NCT02899988|18624264|P3|NOT COMPLETED|Follow-Up (16 Weeks)||0
7566444|NCT02899988|18624265|P2|NOT COMPLETED|Follow-Up (16 Weeks)||0
7566445|NCT02899988|18624266|P1|NOT COMPLETED|Follow-Up (16 Weeks)||0
7566446|NCT02899988|18624256|P11|COMPLETED|Follow-Up (16 Weeks)||0
7566447|NCT02899988|18624257|P10|COMPLETED|Follow-Up (16 Weeks)||2
7566448|NCT02899988|18624258|P9|COMPLETED|Follow-Up (16 Weeks)||6
7566449|NCT02899988|18624259|P8|COMPLETED|Follow-Up (16 Weeks)||3
7566450|NCT02899988|18624260|P7|COMPLETED|Follow-Up (16 Weeks)||3
7566451|NCT02899988|18624261|P6|COMPLETED|Follow-Up (16 Weeks)||4
7566452|NCT02899988|18624262|P5|COMPLETED|Follow-Up (16 Weeks)||2
7566453|NCT02899988|18624263|P4|COMPLETED|Follow-Up (16 Weeks)||0
7566454|NCT02899988|18624264|P3|COMPLETED|Follow-Up (16 Weeks)||0
7566455|NCT02899988|18624265|P2|COMPLETED|Follow-Up (16 Weeks)||0
7566456|NCT02899988|18624266|P1|COMPLETED|Follow-Up (16 Weeks)||0
7566457|NCT02899988|18624256|P11|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|0
7566458|NCT02899988|18624257|P10|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
7566459|NCT02899988|18624258|P9|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|6
7566460|NCT02899988|18624259|P8|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
7566461|NCT02899988|18624260|P7|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
7566462|NCT02899988|18624261|P6|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|4
7566463|NCT02899988|18624262|P5|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
7566464|NCT02899988|18624263|P4|STARTED|Follow-Up (16 Weeks)||0
7566465|NCT02899988|18624264|P3|STARTED|Follow-Up (16 Weeks)||0
7566466|NCT02899988|18624265|P2|STARTED|Follow-Up (16 Weeks)||0
7566467|NCT02899988|18624266|P1|STARTED|Follow-Up (16 Weeks)||0
7566468|NCT02899988|18624256|P11|NOT COMPLETED|Maintenance Period (88 Weeks)||2
7566469|NCT02899988|18624257|P10|NOT COMPLETED|Maintenance Period (88 Weeks)||2
7566470|NCT02899988|18624258|P9|NOT COMPLETED|Maintenance Period (88 Weeks)||4
7566471|NCT02899988|18624259|P8|NOT COMPLETED|Maintenance Period (88 Weeks)||5
7566472|NCT02899988|18624260|P7|NOT COMPLETED|Maintenance Period (88 Weeks)||4
7566473|NCT02899988|18624261|P6|NOT COMPLETED|Maintenance Period (88 Weeks)||3
7566474|NCT02899988|18624262|P5|NOT COMPLETED|Maintenance Period (88 Weeks)||2
7566475|NCT02899988|18624263|P4|NOT COMPLETED|Maintenance Period (88 Weeks)||0
7566476|NCT02899988|18624264|P3|NOT COMPLETED|Maintenance Period (88 Weeks)||0
7566477|NCT02899988|18624265|P2|NOT COMPLETED|Maintenance Period (88 Weeks)||0
7566478|NCT02899988|18624266|P1|NOT COMPLETED|Maintenance Period (88 Weeks)||0
7566479|NCT02899988|18624256|P11|COMPLETED|Maintenance Period (88 Weeks)||13
7566480|NCT02899988|18624257|P10|COMPLETED|Maintenance Period (88 Weeks)||19
7566481|NCT02899988|18624258|P9|COMPLETED|Maintenance Period (88 Weeks)||30
7566482|NCT02899988|18624259|P8|COMPLETED|Maintenance Period (88 Weeks)||45
7566483|NCT02899988|18624260|P7|COMPLETED|Maintenance Period (88 Weeks)||30
7566484|NCT02899988|18624261|P6|COMPLETED|Maintenance Period (88 Weeks)||27
7566485|NCT02899988|18624262|P5|COMPLETED|Maintenance Period (88 Weeks)||13
7566486|NCT02899988|18624263|P4|COMPLETED|Maintenance Period (88 Weeks)||0
7566487|NCT02899988|18624264|P3|COMPLETED|Maintenance Period (88 Weeks)||0
7566488|NCT02899988|18624265|P2|COMPLETED|Maintenance Period (88 Weeks)||0
7566489|NCT02899988|18624266|P1|COMPLETED|Maintenance Period (88 Weeks)||0
7566490|NCT02899988|18624256|P11|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
7566491|NCT02899988|18624257|P10|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||17
7566492|NCT02899988|18624258|P9|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||24
7566493|NCT02899988|18624259|P8|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||42
7566494|NCT02899988|18624260|P7|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||26
7566495|NCT02899988|18624261|P6|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||18
7566496|NCT02899988|18624262|P5|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||9
7566497|NCT02899988|18624263|P4|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||13
7566498|NCT02899988|18624264|P3|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
7566499|NCT02899988|18624265|P2|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
7566500|NCT02899988|18624266|P1|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
7566501|NCT02899988|18624256|P11|Rescue Participants|Maintenance Period (88 Weeks)||0
7566502|NCT02899988|18624257|P10|Rescue Participants|Maintenance Period (88 Weeks)||0
7566503|NCT02899988|18624258|P9|Rescue Participants|Maintenance Period (88 Weeks)||0
7566504|NCT02899988|18624259|P8|Rescue Participants|Maintenance Period (88 Weeks)||0
7566505|NCT02899988|18624260|P7|Rescue Participants|Maintenance Period (88 Weeks)||0
7566506|NCT02899988|18624261|P6|Rescue Participants|Maintenance Period (88 Weeks)||0
7566507|NCT02899988|18624262|P5|Rescue Participants|Maintenance Period (88 Weeks)||0
7566508|NCT02899988|18624263|P4|Rescue Participants|Maintenance Period (88 Weeks)|In PRN not regaining ≥ PASI 90 after 3 consecutive doses of drug or have < PASI 50 after 1 dose.|10
7566509|NCT02899988|18624264|P3|Rescue Participants|Maintenance Period (88 Weeks)||0
7566510|NCT02899988|18624265|P2|Rescue Participants|Maintenance Period (88 Weeks)||0
7566511|NCT02899988|18624266|P1|Rescue Participants|Maintenance Period (88 Weeks)||0
7566512|NCT02899988|18624256|P11|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction arm.|15
7566513|NCT02899988|18624257|P10|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction arm.|21
7566514|NCT02899988|18624258|P9|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction arm.|34
7566515|NCT02899988|18624259|P8|STARTED|Maintenance Period (88 Weeks)|Participants received placebo during induction period.|50
7566516|NCT02899988|18624260|P7|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction period.|34
7566517|NCT02899988|18624261|P6|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction period.|30
7566518|NCT02899988|18624262|P5|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction period.|15
7566519|NCT02899988|18624263|P4|STARTED|Maintenance Period (88 Weeks)||0
7566520|NCT02899988|18624264|P3|STARTED|Maintenance Period (88 Weeks)|No participants received 100 mg mirikizumab Q8W in both induction and maintenance.|0
7566521|NCT02899988|18624265|P2|STARTED|Maintenance Period (88 Weeks)|No participants received 30 mg mirikizumab Q8W in both induction and maintenance.|0
7566522|NCT02899988|18624266|P1|STARTED|Maintenance Period (88 Weeks)|No participants received placebo during maintenance period.|0
7566523|NCT02899988|18624256|P11|NOT COMPLETED|Induction Period (16 Weeks)||0
7566524|NCT02899988|18624257|P10|NOT COMPLETED|Induction Period (16 Weeks)||0
7566525|NCT02899988|18624258|P9|NOT COMPLETED|Induction Period (16 Weeks)||0
7566526|NCT02899988|18624259|P8|NOT COMPLETED|Induction Period (16 Weeks)||0
7566527|NCT02899988|18624260|P7|NOT COMPLETED|Induction Period (16 Weeks)||0
7566528|NCT02899988|18624261|P6|NOT COMPLETED|Induction Period (16 Weeks)||0
7566529|NCT02899988|18624262|P5|NOT COMPLETED|Induction Period (16 Weeks)||0
7566530|NCT02899988|18624263|P4|NOT COMPLETED|Induction Period (16 Weeks)||2
7566531|NCT02899988|18624264|P3|NOT COMPLETED|Induction Period (16 Weeks)||0
7566532|NCT02899988|18624265|P2|NOT COMPLETED|Induction Period (16 Weeks)||2
7566533|NCT02899988|18624266|P1|NOT COMPLETED|Induction Period (16 Weeks)||2
7566534|NCT02899988|18624256|P11|COMPLETED|Induction Period (16 Weeks)||0
7566535|NCT02899988|18624257|P10|COMPLETED|Induction Period (16 Weeks)||0
7566536|NCT02899988|18624258|P9|COMPLETED|Induction Period (16 Weeks)||0
7566537|NCT02899988|18624259|P8|COMPLETED|Induction Period (16 Weeks)||0
7566538|NCT02899988|18624260|P7|COMPLETED|Induction Period (16 Weeks)||0
7566539|NCT02899988|18624261|P6|COMPLETED|Induction Period (16 Weeks)||0
7566540|NCT02899988|18624262|P5|COMPLETED|Induction Period (16 Weeks)||0
7566541|NCT02899988|18624263|P4|COMPLETED|Induction Period (16 Weeks)||49
7566542|NCT02899988|18624264|P3|COMPLETED|Induction Period (16 Weeks)||51
7566543|NCT02899988|18624265|P2|COMPLETED|Induction Period (16 Weeks)||49
7566544|NCT02899988|18624266|P1|COMPLETED|Induction Period (16 Weeks)||50
7566545|NCT02899988|18624256|P11|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
7566546|NCT02899988|18624257|P10|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
7566547|NCT02899988|18624258|P9|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
7566548|NCT02899988|18624259|P8|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
7566549|NCT02899988|18624260|P7|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
7566550|NCT02899988|18624261|P6|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
7566551|NCT02899988|18624262|P5|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
7566552|NCT02899988|18624263|P4|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
7566553|NCT02899988|18624264|P3|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
7566554|NCT02899988|18624265|P2|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
7566555|NCT02899988|18624266|P1|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||52
7566556|NCT02899988|18624256|P11|STARTED|Induction Period (16 Weeks)||0
7566557|NCT02899988|18624257|P10|STARTED|Induction Period (16 Weeks)||0
7566558|NCT02899988|18624258|P9|STARTED|Induction Period (16 Weeks)||0
7566559|NCT02899988|18624259|P8|STARTED|Induction Period (16 Weeks)||0
7566560|NCT02899988|18624260|P7|STARTED|Induction Period (16 Weeks)||0
7566561|NCT02899988|18624261|P6|STARTED|Induction Period (16 Weeks)||0
7566562|NCT02899988|18624262|P5|STARTED|Induction Period (16 Weeks)||0
7566563|NCT02899988|18624263|P4|STARTED|Induction Period (16 Weeks)||51
7566564|NCT02899988|18624264|P3|STARTED|Induction Period (16 Weeks)||51
7566565|NCT02899988|18624265|P2|STARTED|Induction Period (16 Weeks)||51
7566566|NCT02899988|18624266|P1|STARTED|Induction Period (16 Weeks)||52
7566567|NCT02899962|18624325|P3|NOT COMPLETED|Maintenance Phase||153
7566568|NCT02899962|18624326|P2|NOT COMPLETED|Maintenance Phase||141
7566569|NCT02899962|18624327|P1|NOT COMPLETED|Maintenance Phase||0
7566570|NCT02899962|18624325|P3|COMPLETED|Maintenance Phase||120
7566571|NCT02899962|18624326|P2|COMPLETED|Maintenance Phase||131
7566572|NCT02899962|18624327|P1|COMPLETED|Maintenance Phase||0
7566573|NCT02899962|18624325|P3|STARTED|Maintenance Phase||273
7566574|NCT02899962|18624326|P2|STARTED|Maintenance Phase||272
7566575|NCT02899962|18624327|P1|STARTED|Maintenance Phase||0
7566576|NCT02899962|18624325|P3|NOT COMPLETED|Open-label Phase||0
7566577|NCT02899962|18624326|P2|NOT COMPLETED|Open-label Phase||0
7566578|NCT02899962|18624327|P1|NOT COMPLETED|Open-label Phase||27
7566579|NCT02899962|18624325|P3|COMPLETED|Open-label Phase||0
7566580|NCT02899962|18624326|P2|COMPLETED|Open-label Phase||0
7566581|NCT02899962|18624327|P1|COMPLETED|Open-label Phase||623
7566582|NCT02899962|18624325|P3|STARTED|Open-label Phase||0
7566583|NCT02899962|18624326|P2|STARTED|Open-label Phase||0
7566584|NCT02899962|18624327|P1|STARTED|Open-label Phase||650
7566585|NCT02899884|18624338|P1|NOT COMPLETED|Overall Study||0
7566586|NCT02899884|18624338|P1|COMPLETED|Overall Study||3765
7566587|NCT02899884|18624338|P1|STARTED|Overall Study||3765
7566588|NCT02899689|18624352|P2|NOT COMPLETED|Overall Study||2
7566589|NCT02899689|18624353|P1|NOT COMPLETED|Overall Study||0
7566590|NCT02899689|18624352|P2|COMPLETED|Overall Study||208
7566591|NCT02899689|18624353|P1|COMPLETED|Overall Study||209
7566592|NCT02899689|18624352|P2|STARTED|Overall Study||210
7566593|NCT02899689|18624353|P1|STARTED|Overall Study||209
7566594|NCT02899377|18624377|P2|NOT COMPLETED|Overall Study||0
7566595|NCT02899377|18624378|P1|NOT COMPLETED|Overall Study||1
7566596|NCT02899377|18624377|P2|COMPLETED|Overall Study||12
7566597|NCT02899377|18624378|P1|COMPLETED|Overall Study||12
7566598|NCT02899377|18624377|P2|STARTED|Overall Study||12
7566599|NCT02899377|18624378|P1|STARTED|Overall Study||13
7566600|NCT02899338|18624411|P2|NOT COMPLETED|Overall Study||2
7566601|NCT02899338|18624412|P1|NOT COMPLETED|Overall Study||3
7566602|NCT02899338|18624411|P2|COMPLETED|Overall Study||79
7566603|NCT02899338|18624412|P1|COMPLETED|Overall Study||78
7566604|NCT02899338|18624411|P2|STARTED|Overall Study||81
7566605|NCT02899338|18624412|P1|STARTED|Overall Study||81
7566606|NCT02899156|18624426|P2|NOT COMPLETED|Overall Study||1
7566607|NCT02899156|18624427|P1|NOT COMPLETED|Overall Study||1
7566608|NCT02899156|18624426|P2|COMPLETED|Overall Study||10
7566609|NCT02899156|18624427|P1|COMPLETED|Overall Study||10
7566610|NCT02899156|18624426|P2|STARTED|Overall Study||11
7566611|NCT02899156|18624427|P1|STARTED|Overall Study||11
7566612|NCT02898974|18624447|P2|NOT COMPLETED|Overall Study||0
7566613|NCT02898974|18624448|P1|NOT COMPLETED|Overall Study||0
7566614|NCT02898974|18624447|P2|COMPLETED|Overall Study||9
7566615|NCT02898974|18624448|P1|COMPLETED|Overall Study||13
7566616|NCT02898974|18624447|P2|STARTED|Overall Study||9
7566617|NCT02898974|18624448|P1|STARTED|Overall Study||13
7566618|NCT02898740|18624460|P2|NOT COMPLETED|Overall Study||0
7566619|NCT02898740|18624461|P1|NOT COMPLETED|Overall Study||0
7566620|NCT02898740|18624460|P2|COMPLETED|Overall Study||19
7566621|NCT02898740|18624461|P1|COMPLETED|Overall Study||21
7566622|NCT02898740|18624460|P2|STARTED|Overall Study||19
7566623|NCT02898740|18624461|P1|STARTED|Overall Study||21
7566624|NCT02898662|18624469|P2|NOT COMPLETED|Overall Study||28
7566625|NCT02898662|18624470|P1|NOT COMPLETED|Overall Study||29
7566626|NCT02898662|18624469|P2|COMPLETED|Overall Study||13
7566627|NCT02898662|18624470|P1|COMPLETED|Overall Study||11
7566628|NCT02898662|18624469|P2|Completed Treatment|Overall Study||29
7566629|NCT02898662|18624470|P1|Completed Treatment|Overall Study||25
7566630|NCT02898662|18624469|P2|STARTED|Overall Study||41
7566631|NCT02898662|18624470|P1|STARTED|Overall Study||40
7566632|NCT02898597|18624494|P2|NOT COMPLETED|Overall Study||12
7566633|NCT02898597|18624495|P1|NOT COMPLETED|Overall Study||4
7566634|NCT02898597|18624494|P2|COMPLETED|Overall Study||12
7566635|NCT02898597|18624495|P1|COMPLETED|Overall Study||21
7566636|NCT02898597|18624494|P2|STARTED|Overall Study||24
7566637|NCT02898597|18624495|P1|STARTED|Overall Study||25
7566638|NCT02898454|18624504|P3|NOT COMPLETED|Overall Study||6
7566639|NCT02898454|18624505|P2|NOT COMPLETED|Overall Study||5
7566640|NCT02898454|18624506|P1|NOT COMPLETED|Overall Study||17
7566641|NCT02898454|18624504|P3|COMPLETED|Overall Study||144
7566642|NCT02898454|18624505|P2|COMPLETED|Overall Study||140
7566643|NCT02898454|18624506|P1|COMPLETED|Overall Study||136
7566644|NCT02898454|18624504|P3|Safety Population|Overall Study||149
7566645|NCT02898454|18624505|P2|Safety Population|Overall Study|1 randomized to dupilumab q2w arm received 1dose of placebo: counted in 300 mg q2w then q4w arm.|148
7566646|NCT02898454|18624506|P1|Safety Population|Overall Study|2 participants randomized to placebo received 1 dose of dupilumab:counted in 300 mg q2w then q4w arm|150
7566647|NCT02898454|18624504|P3|Treated|Overall Study||150
7566648|NCT02898454|18624505|P2|Treated|Overall Study||145
7566649|NCT02898454|18624506|P1|Treated|Overall Study||152
7566650|NCT02898454|18624504|P3|Intent-to-Treat (ITT) Population|Overall Study||150
7566651|NCT02898454|18624505|P2|Intent-to-Treat (ITT) Population|Overall Study||145
7566652|NCT02898454|18624506|P1|Intent-to-Treat (ITT) Population|Overall Study||153
7566653|NCT02898454|18624504|P3|STARTED|Overall Study||150
7566654|NCT02898454|18624505|P2|STARTED|Overall Study||145
7566655|NCT02898454|18624506|P1|STARTED|Overall Study||153
7566656|NCT02898116|18624619|P1|NOT COMPLETED|Overall Study||2
7566657|NCT02898116|18624619|P1|COMPLETED|Overall Study||0
7566658|NCT02898116|18624619|P1|STARTED|Overall Study||2
7566659|NCT02897349|18624627|P2|NOT COMPLETED|Overall Study||6
7566660|NCT02897349|18624628|P1|NOT COMPLETED|Overall Study||5
7566661|NCT02897349|18624627|P2|COMPLETED|Overall Study||98
7566662|NCT02897349|18624628|P1|COMPLETED|Overall Study||97
7566663|NCT02897349|18624627|P2|STARTED|Overall Study||104
7566664|NCT02897349|18624628|P1|STARTED|Overall Study||102
7566665|NCT02897141|18624650|P2|NOT COMPLETED|Overall Study||1
7566666|NCT02897141|18624651|P1|NOT COMPLETED|Overall Study||2
7566667|NCT02897141|18624650|P2|COMPLETED|Overall Study||39
7566668|NCT02897141|18624651|P1|COMPLETED|Overall Study||38
7566669|NCT02897141|18624650|P2|STARTED|Overall Study||40
7566670|NCT02897141|18624651|P1|STARTED|Overall Study||40
7566671|NCT02897115|18624670|P2|NOT COMPLETED|Overall Study||8
7566672|NCT02897115|18624671|P1|NOT COMPLETED|Overall Study||11
7566673|NCT02897115|18624670|P2|COMPLETED|Overall Study||0
7566674|NCT02897115|18624671|P1|COMPLETED|Overall Study||3
7566675|NCT02897115|18624670|P2|STARTED|Overall Study||8
7566676|NCT02897115|18624671|P1|STARTED|Overall Study||14
7566677|NCT02896907|18624741|P1|NOT COMPLETED|Overall Study||0
7566678|NCT02896907|18624741|P1|COMPLETED|Overall Study||8
7566679|NCT02896907|18624741|P1|STARTED|Overall Study||8
7566680|NCT02896855|18624748|P2|NOT COMPLETED|Overall Study||122
7566681|NCT02896855|18624749|P1|NOT COMPLETED|Overall Study||121
7566682|NCT02896855|18624748|P2|COMPLETED|Overall Study||0
7566683|NCT02896855|18624749|P1|COMPLETED|Overall Study||0
7566684|NCT02896855|18624748|P2|Received Any Study Treatment|Overall Study||122
7566685|NCT02896855|18624749|P1|Received Any Study Treatment|Overall Study||120
7566686|NCT02896855|18624748|P2|STARTED|Overall Study||122
7566687|NCT02896855|18624749|P1|STARTED|Overall Study||121
7566688|NCT02896595|18624781|P2|NOT COMPLETED|Overall Study||0
7566689|NCT02896595|18624782|P1|NOT COMPLETED|Overall Study||0
7566690|NCT02896595|18624781|P2|COMPLETED|Overall Study||50
7566691|NCT02896595|18624782|P1|COMPLETED|Overall Study||50
7566692|NCT02896595|18624781|P2|STARTED|Overall Study||50
7566693|NCT02896595|18624782|P1|STARTED|Overall Study||50
7566694|NCT02896569|18624832|P2|NOT COMPLETED|Overall Study||5
7566695|NCT02896569|18624833|P1|NOT COMPLETED|Overall Study||4
7566696|NCT02896569|18624832|P2|COMPLETED|Overall Study||19
7566697|NCT02896569|18624833|P1|COMPLETED|Overall Study||21
7566698|NCT02896569|18624832|P2|STARTED|Overall Study||24
7566699|NCT02896569|18624833|P1|STARTED|Overall Study||25
7566700|NCT02896400|18624867|P16|NOT COMPLETED|Biochemical Verification at 3 Months||57
7566701|NCT02896400|18624868|P15|NOT COMPLETED|Biochemical Verification at 3 Months||55
7566702|NCT02896400|18624869|P14|NOT COMPLETED|Biochemical Verification at 3 Months||48
7566703|NCT02896400|18624870|P13|NOT COMPLETED|Biochemical Verification at 3 Months||53
7566704|NCT02896400|18624871|P12|NOT COMPLETED|Biochemical Verification at 3 Months||41
7566705|NCT02896400|18624872|P11|NOT COMPLETED|Biochemical Verification at 3 Months||55
7566706|NCT02896400|18624873|P10|NOT COMPLETED|Biochemical Verification at 3 Months||53
7566707|NCT02896400|18624874|P9|NOT COMPLETED|Biochemical Verification at 3 Months||45
7566708|NCT02896400|18624875|P8|NOT COMPLETED|Biochemical Verification at 3 Months||49
7566709|NCT02896400|18624876|P7|NOT COMPLETED|Biochemical Verification at 3 Months||51
7566710|NCT02896400|18624877|P6|NOT COMPLETED|Biochemical Verification at 3 Months||49
7566711|NCT02896400|18624878|P5|NOT COMPLETED|Biochemical Verification at 3 Months||45
7566712|NCT02896400|18624879|P4|NOT COMPLETED|Biochemical Verification at 3 Months||41
7566713|NCT02896400|18624880|P3|NOT COMPLETED|Biochemical Verification at 3 Months||47
7566714|NCT02896400|18624881|P2|NOT COMPLETED|Biochemical Verification at 3 Months||48
7566715|NCT02896400|18624882|P1|NOT COMPLETED|Biochemical Verification at 3 Months||46
7566716|NCT02896400|18624867|P16|COMPLETED|Biochemical Verification at 3 Months||6
7566717|NCT02896400|18624868|P15|COMPLETED|Biochemical Verification at 3 Months||7
7566718|NCT02896400|18624869|P14|COMPLETED|Biochemical Verification at 3 Months||12
7566719|NCT02896400|18624870|P13|COMPLETED|Biochemical Verification at 3 Months||10
7566720|NCT02896400|18624871|P12|COMPLETED|Biochemical Verification at 3 Months||19
7566721|NCT02896400|18624872|P11|COMPLETED|Biochemical Verification at 3 Months||5
7566722|NCT02896400|18624873|P10|COMPLETED|Biochemical Verification at 3 Months||8
7566723|NCT02896400|18624874|P9|COMPLETED|Biochemical Verification at 3 Months||15
7566724|NCT02896400|18624875|P8|COMPLETED|Biochemical Verification at 3 Months||14
7566725|NCT02896400|18624876|P7|COMPLETED|Biochemical Verification at 3 Months||11
7566726|NCT02896400|18624877|P6|COMPLETED|Biochemical Verification at 3 Months||11
7566727|NCT02896400|18624878|P5|COMPLETED|Biochemical Verification at 3 Months||9
7566728|NCT02896400|18624879|P4|COMPLETED|Biochemical Verification at 3 Months||14
7566729|NCT02896400|18624880|P3|COMPLETED|Biochemical Verification at 3 Months||13
7566730|NCT02896400|18624881|P2|COMPLETED|Biochemical Verification at 3 Months||15
7566731|NCT02896400|18624882|P1|COMPLETED|Biochemical Verification at 3 Months||14
7566732|NCT02896400|18624867|P16|STARTED|Biochemical Verification at 3 Months||63
7566733|NCT02896400|18624868|P15|STARTED|Biochemical Verification at 3 Months||62
7566734|NCT02896400|18624869|P14|STARTED|Biochemical Verification at 3 Months||60
7566735|NCT02896400|18624870|P13|STARTED|Biochemical Verification at 3 Months||63
7566736|NCT02896400|18624871|P12|STARTED|Biochemical Verification at 3 Months||60
7566737|NCT02896400|18624872|P11|STARTED|Biochemical Verification at 3 Months||60
7566738|NCT02896400|18624873|P10|STARTED|Biochemical Verification at 3 Months||61
7566739|NCT02896400|18624874|P9|STARTED|Biochemical Verification at 3 Months||60
7566740|NCT02896400|18624875|P8|STARTED|Biochemical Verification at 3 Months||63
7566741|NCT02896400|18624876|P7|STARTED|Biochemical Verification at 3 Months||62
7566742|NCT02896400|18624877|P6|STARTED|Biochemical Verification at 3 Months||60
7566743|NCT02896400|18624878|P5|STARTED|Biochemical Verification at 3 Months||54
7566744|NCT02896400|18624879|P4|STARTED|Biochemical Verification at 3 Months||55
7566745|NCT02896400|18624880|P3|STARTED|Biochemical Verification at 3 Months||60
7566746|NCT02896400|18624881|P2|STARTED|Biochemical Verification at 3 Months||63
7566747|NCT02896400|18624882|P1|STARTED|Biochemical Verification at 3 Months||60
7566748|NCT02896400|18624867|P16|NOT COMPLETED|3 Month Follow-up||2
7566749|NCT02896400|18624868|P15|NOT COMPLETED|3 Month Follow-up||4
7566750|NCT02896400|18624869|P14|NOT COMPLETED|3 Month Follow-up||6
7566751|NCT02896400|18624870|P13|NOT COMPLETED|3 Month Follow-up||3
7566752|NCT02896400|18624871|P12|NOT COMPLETED|3 Month Follow-up||6
7566753|NCT02896400|18624872|P11|NOT COMPLETED|3 Month Follow-up||6
7566754|NCT02896400|18624873|P10|NOT COMPLETED|3 Month Follow-up||5
7566755|NCT02896400|18624874|P9|NOT COMPLETED|3 Month Follow-up||6
7566756|NCT02896400|18624875|P8|NOT COMPLETED|3 Month Follow-up||3
7566757|NCT02896400|18624876|P7|NOT COMPLETED|3 Month Follow-up||4
7566758|NCT02896400|18624877|P6|NOT COMPLETED|3 Month Follow-up||6
7566759|NCT02896400|18624878|P5|NOT COMPLETED|3 Month Follow-up||12
7566760|NCT02896400|18624879|P4|NOT COMPLETED|3 Month Follow-up||11
7566761|NCT02896400|18624880|P3|NOT COMPLETED|3 Month Follow-up||6
7566762|NCT02896400|18624881|P2|NOT COMPLETED|3 Month Follow-up||3
7566763|NCT02896400|18624882|P1|NOT COMPLETED|3 Month Follow-up||6
7566764|NCT02896400|18624867|P16|COMPLETED|3 Month Follow-up||63
7566765|NCT02896400|18624868|P15|COMPLETED|3 Month Follow-up||62
7566766|NCT02896400|18624869|P14|COMPLETED|3 Month Follow-up||60
7566767|NCT02896400|18624870|P13|COMPLETED|3 Month Follow-up||63
7566768|NCT02896400|18624871|P12|COMPLETED|3 Month Follow-up||60
7566769|NCT02896400|18624872|P11|COMPLETED|3 Month Follow-up||60
7566770|NCT02896400|18624873|P10|COMPLETED|3 Month Follow-up||61
7566771|NCT02896400|18624874|P9|COMPLETED|3 Month Follow-up||60
7566772|NCT02896400|18624875|P8|COMPLETED|3 Month Follow-up||63
7566773|NCT02896400|18624876|P7|COMPLETED|3 Month Follow-up||62
7566774|NCT02896400|18624877|P6|COMPLETED|3 Month Follow-up||60
7566775|NCT02896400|18624878|P5|COMPLETED|3 Month Follow-up||54
7566776|NCT02896400|18624879|P4|COMPLETED|3 Month Follow-up||55
7566777|NCT02896400|18624880|P3|COMPLETED|3 Month Follow-up||60
7566778|NCT02896400|18624881|P2|COMPLETED|3 Month Follow-up||63
7566779|NCT02896400|18624882|P1|COMPLETED|3 Month Follow-up||60
7566780|NCT02896400|18624867|P16|STARTED|3 Month Follow-up||65
7566781|NCT02896400|18624868|P15|STARTED|3 Month Follow-up||66
7566782|NCT02896400|18624869|P14|STARTED|3 Month Follow-up||66
7566783|NCT02896400|18624870|P13|STARTED|3 Month Follow-up||66
7566784|NCT02896400|18624871|P12|STARTED|3 Month Follow-up||66
7566785|NCT02896400|18624872|P11|STARTED|3 Month Follow-up||66
7566786|NCT02896400|18624873|P10|STARTED|3 Month Follow-up||66
7566787|NCT02896400|18624874|P9|STARTED|3 Month Follow-up||66
7566788|NCT02896400|18624875|P8|STARTED|3 Month Follow-up||66
7566789|NCT02896400|18624876|P7|STARTED|3 Month Follow-up||66
7566790|NCT02896400|18624877|P6|STARTED|3 Month Follow-up||66
7566791|NCT02896400|18624878|P5|STARTED|3 Month Follow-up||66
7566792|NCT02896400|18624879|P4|STARTED|3 Month Follow-up||66
7566793|NCT02896400|18624880|P3|STARTED|3 Month Follow-up||66
7566794|NCT02896400|18624881|P2|STARTED|3 Month Follow-up||66
7566795|NCT02896400|18624882|P1|STARTED|3 Month Follow-up||66
7566796|NCT02896400|18624867|P16|NOT COMPLETED|1 Month Follow-up||3
7566797|NCT02896400|18624868|P15|NOT COMPLETED|1 Month Follow-up||1
7566798|NCT02896400|18624869|P14|NOT COMPLETED|1 Month Follow-up||4
7566799|NCT02896400|18624870|P13|NOT COMPLETED|1 Month Follow-up||3
7566800|NCT02896400|18624871|P12|NOT COMPLETED|1 Month Follow-up||5
7566801|NCT02896400|18624872|P11|NOT COMPLETED|1 Month Follow-up||5
7566802|NCT02896400|18624873|P10|NOT COMPLETED|1 Month Follow-up||7
7566803|NCT02896400|18624874|P9|NOT COMPLETED|1 Month Follow-up||4
7566804|NCT02896400|18624875|P8|NOT COMPLETED|1 Month Follow-up||6
7566805|NCT02896400|18624876|P7|NOT COMPLETED|1 Month Follow-up||5
7566806|NCT02896400|18624877|P6|NOT COMPLETED|1 Month Follow-up||6
7566807|NCT02896400|18624878|P5|NOT COMPLETED|1 Month Follow-up||9
7566808|NCT02896400|18624879|P4|NOT COMPLETED|1 Month Follow-up||8
7566809|NCT02896400|18624880|P3|NOT COMPLETED|1 Month Follow-up||5
7566810|NCT02896400|18624881|P2|NOT COMPLETED|1 Month Follow-up||7
7566811|NCT02896400|18624882|P1|NOT COMPLETED|1 Month Follow-up||7
7566812|NCT02896400|18624867|P16|COMPLETED|1 Month Follow-up||63
7566813|NCT02896400|18624868|P15|COMPLETED|1 Month Follow-up||65
7566814|NCT02896400|18624869|P14|COMPLETED|1 Month Follow-up||62
7566815|NCT02896400|18624870|P13|COMPLETED|1 Month Follow-up||63
7566816|NCT02896400|18624871|P12|COMPLETED|1 Month Follow-up||61
7566817|NCT02896400|18624872|P11|COMPLETED|1 Month Follow-up||61
7566818|NCT02896400|18624873|P10|COMPLETED|1 Month Follow-up||59
7566819|NCT02896400|18624874|P9|COMPLETED|1 Month Follow-up||62
7566820|NCT02896400|18624875|P8|COMPLETED|1 Month Follow-up||60
7566821|NCT02896400|18624876|P7|COMPLETED|1 Month Follow-up||61
7566822|NCT02896400|18624877|P6|COMPLETED|1 Month Follow-up||60
7566823|NCT02896400|18624878|P5|COMPLETED|1 Month Follow-up||57
7566824|NCT02896400|18624879|P4|COMPLETED|1 Month Follow-up||58
7566825|NCT02896400|18624880|P3|COMPLETED|1 Month Follow-up||61
7566826|NCT02896400|18624881|P2|COMPLETED|1 Month Follow-up||59
7566827|NCT02896400|18624882|P1|COMPLETED|1 Month Follow-up||59
7566828|NCT02896400|18624867|P16|STARTED|1 Month Follow-up||66
7566829|NCT02896400|18624868|P15|STARTED|1 Month Follow-up||66
7566830|NCT02896400|18624869|P14|STARTED|1 Month Follow-up||66
7566831|NCT02896400|18624870|P13|STARTED|1 Month Follow-up||66
7566832|NCT02896400|18624871|P12|STARTED|1 Month Follow-up||66
7566833|NCT02896400|18624872|P11|STARTED|1 Month Follow-up||66
7566834|NCT02896400|18624873|P10|STARTED|1 Month Follow-up||66
7566835|NCT02896400|18624874|P9|STARTED|1 Month Follow-up||66
7566836|NCT02896400|18624875|P8|STARTED|1 Month Follow-up||66
7566837|NCT02896400|18624876|P7|STARTED|1 Month Follow-up||66
7566838|NCT02896400|18624877|P6|STARTED|1 Month Follow-up||66
7566839|NCT02896400|18624878|P5|STARTED|1 Month Follow-up||66
7566840|NCT02896400|18624879|P4|STARTED|1 Month Follow-up||66
7566841|NCT02896400|18624880|P3|STARTED|1 Month Follow-up||66
7566842|NCT02896400|18624881|P2|STARTED|1 Month Follow-up||66
7566843|NCT02896400|18624882|P1|STARTED|1 Month Follow-up||66
7566844|NCT02896400|18624867|P16|NOT COMPLETED|Baseline||0
7566845|NCT02896400|18624868|P15|NOT COMPLETED|Baseline||0
7566846|NCT02896400|18624869|P14|NOT COMPLETED|Baseline||0
7566847|NCT02896400|18624870|P13|NOT COMPLETED|Baseline||0
7566848|NCT02896400|18624871|P12|NOT COMPLETED|Baseline||0
7566849|NCT02896400|18624872|P11|NOT COMPLETED|Baseline||0
7566850|NCT02896400|18624873|P10|NOT COMPLETED|Baseline||0
7566851|NCT02896400|18624874|P9|NOT COMPLETED|Baseline||0
7566852|NCT02896400|18624875|P8|NOT COMPLETED|Baseline||0
7566853|NCT02896400|18624876|P7|NOT COMPLETED|Baseline||0
7566854|NCT02896400|18624877|P6|NOT COMPLETED|Baseline||0
7566855|NCT02896400|18624878|P5|NOT COMPLETED|Baseline||0
7566856|NCT02896400|18624879|P4|NOT COMPLETED|Baseline||0
7566857|NCT02896400|18624880|P3|NOT COMPLETED|Baseline||0
7566858|NCT02896400|18624881|P2|NOT COMPLETED|Baseline||0
7566859|NCT02896400|18624882|P1|NOT COMPLETED|Baseline||0
7566860|NCT02896400|18624867|P16|COMPLETED|Baseline||66
7566861|NCT02896400|18624868|P15|COMPLETED|Baseline||66
7566862|NCT02896400|18624869|P14|COMPLETED|Baseline||66
7566863|NCT02896400|18624870|P13|COMPLETED|Baseline||66
7566864|NCT02896400|18624871|P12|COMPLETED|Baseline||66
7566865|NCT02896400|18624872|P11|COMPLETED|Baseline||66
7566866|NCT02896400|18624873|P10|COMPLETED|Baseline||66
7566867|NCT02896400|18624874|P9|COMPLETED|Baseline||66
7566868|NCT02896400|18624875|P8|COMPLETED|Baseline||66
7566869|NCT02896400|18624876|P7|COMPLETED|Baseline||66
7566870|NCT02896400|18624877|P6|COMPLETED|Baseline||66
7566871|NCT02896400|18624878|P5|COMPLETED|Baseline||66
7566872|NCT02896400|18624879|P4|COMPLETED|Baseline||66
7566873|NCT02896400|18624880|P3|COMPLETED|Baseline||66
7566874|NCT02896400|18624881|P2|COMPLETED|Baseline||66
7566875|NCT02896400|18624882|P1|COMPLETED|Baseline||66
7566876|NCT02896400|18624867|P16|STARTED|Baseline||66
7566877|NCT02896400|18624868|P15|STARTED|Baseline||66
7566878|NCT02896400|18624869|P14|STARTED|Baseline||66
7566879|NCT02896400|18624870|P13|STARTED|Baseline||66
7566880|NCT02896400|18624871|P12|STARTED|Baseline||66
7566881|NCT02896400|18624872|P11|STARTED|Baseline||66
7566882|NCT02896400|18624873|P10|STARTED|Baseline||66
7566883|NCT02896400|18624874|P9|STARTED|Baseline||66
7566884|NCT02896400|18624875|P8|STARTED|Baseline||66
7566885|NCT02896400|18624876|P7|STARTED|Baseline||66
7566886|NCT02896400|18624877|P6|STARTED|Baseline||66
7566887|NCT02896400|18624878|P5|STARTED|Baseline||66
7566888|NCT02896400|18624879|P4|STARTED|Baseline||66
7566889|NCT02896400|18624880|P3|STARTED|Baseline||66
7566890|NCT02896400|18624881|P2|STARTED|Baseline||66
7566891|NCT02896400|18624882|P1|STARTED|Baseline||66
7566892|NCT02896361|18624908|P3|NOT COMPLETED|Third Intervention (2 Weeks)||0
7566893|NCT02896361|18624909|P2|NOT COMPLETED|Third Intervention (2 Weeks)||1
7566894|NCT02896361|18624910|P1|NOT COMPLETED|Third Intervention (2 Weeks)||1
7566895|NCT02896361|18624908|P3|COMPLETED|Third Intervention (2 Weeks)||8
7566896|NCT02896361|18624909|P2|COMPLETED|Third Intervention (2 Weeks)||9
7566897|NCT02896361|18624910|P1|COMPLETED|Third Intervention (2 Weeks)||8
7566898|NCT02896361|18624908|P3|STARTED|Third Intervention (2 Weeks)||8
7566899|NCT02896361|18624909|P2|STARTED|Third Intervention (2 Weeks)||10
7566900|NCT02896361|18624910|P1|STARTED|Third Intervention (2 Weeks)||9
7566901|NCT02896361|18624908|P3|NOT COMPLETED|Second Intervention (2 Weeks)||0
7566902|NCT02896361|18624909|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
7566903|NCT02896361|18624910|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
7566904|NCT02896361|18624908|P3|COMPLETED|Second Intervention (2 Weeks)||8
7566905|NCT02896361|18624909|P2|COMPLETED|Second Intervention (2 Weeks)||10
7566906|NCT02896361|18624910|P1|COMPLETED|Second Intervention (2 Weeks)||9
7566907|NCT02896361|18624908|P3|STARTED|Second Intervention (2 Weeks)||8
7566908|NCT02896361|18624909|P2|STARTED|Second Intervention (2 Weeks)||10
7566909|NCT02896361|18624910|P1|STARTED|Second Intervention (2 Weeks)||9
7566910|NCT02896361|18624908|P3|NOT COMPLETED|First Intervention (2 Weeks)||0
7566911|NCT02896361|18624909|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
7566912|NCT02896361|18624910|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
7566913|NCT02896361|18624908|P3|COMPLETED|First Intervention (2 Weeks)||8
7566914|NCT02896361|18624909|P2|COMPLETED|First Intervention (2 Weeks)||10
7566915|NCT02896361|18624910|P1|COMPLETED|First Intervention (2 Weeks)||9
7566916|NCT02896361|18624908|P3|STARTED|First Intervention (2 Weeks)||8
7566917|NCT02896361|18624909|P2|STARTED|First Intervention (2 Weeks)||10
7566918|NCT02896361|18624910|P1|STARTED|First Intervention (2 Weeks)||9
7566919|NCT02896296|18624928|P1|NOT COMPLETED|Overall Study||42
7566920|NCT02896296|18624928|P1|COMPLETED|Overall Study||166
7566921|NCT02896296|18624928|P1|STARTED|Overall Study||208
7566922|NCT02896127|18624936|P2|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||5
7566923|NCT02896127|18624937|P1|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||4
7566924|NCT02896127|18624936|P2|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|134
7566925|NCT02896127|18624937|P1|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|276
7566926|NCT02896127|18624936|P2|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|139
7567017|NCT02892344|18625366|P1|COMPLETED|Overall Study||394
7566927|NCT02896127|18624937|P1|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|280
7566928|NCT02896127|18624936|P2|NOT COMPLETED|COMPLETED WEEK 52||11
7566929|NCT02896127|18624937|P1|NOT COMPLETED|COMPLETED WEEK 52||27
7566930|NCT02896127|18624936|P2|COMPLETED|COMPLETED WEEK 52||142
7566931|NCT02896127|18624937|P1|COMPLETED|COMPLETED WEEK 52||278
7566932|NCT02896127|18624936|P2|STARTED|COMPLETED WEEK 52|Includes participants originally assigned to placebo and switched to AIN457150 mg after Wk 16.|153
7566933|NCT02896127|18624937|P1|STARTED|COMPLETED WEEK 52||305
7566934|NCT02895347|18624959|P2|NOT COMPLETED|Overall Study||1
7566935|NCT02895347|18624960|P1|NOT COMPLETED|Overall Study||3
7566936|NCT02895347|18624959|P2|COMPLETED|Overall Study||19
7566937|NCT02895347|18624960|P1|COMPLETED|Overall Study||17
7566938|NCT02895347|18624959|P2|STARTED|Overall Study||20
7566939|NCT02895347|18624960|P1|STARTED|Overall Study||20
7566940|NCT02895295|18624972|P3|NOT COMPLETED|Overall Study||92
7566941|NCT02895295|18624973|P2|NOT COMPLETED|Overall Study||94
7566942|NCT02895295|18624974|P1|NOT COMPLETED|Overall Study||71
7566943|NCT02895295|18624972|P3|COMPLETED|Overall Study||299
7566944|NCT02895295|18624973|P2|COMPLETED|Overall Study||316
7566945|NCT02895295|18624974|P1|COMPLETED|Overall Study||313
7566946|NCT02895295|18624972|P3|STARTED|Overall Study||391
7566947|NCT02895295|18624973|P2|STARTED|Overall Study||410
7566948|NCT02895295|18624974|P1|STARTED|Overall Study||384
7566949|NCT02895035|18624991|P2|NOT COMPLETED|Overall Study||12
7566950|NCT02895035|18624992|P1|NOT COMPLETED|Overall Study||5
7566951|NCT02895035|18624991|P2|COMPLETED|Overall Study||24
7566952|NCT02895035|18624992|P1|COMPLETED|Overall Study||18
7566953|NCT02895035|18624991|P2|STARTED|Overall Study||36
7566954|NCT02895035|18624992|P1|STARTED|Overall Study||23
7566955|NCT02894840|18625008|P4|NOT COMPLETED|Overall Study||0
7566956|NCT02894840|18625009|P3|NOT COMPLETED|Overall Study||3
7566957|NCT02894840|18625010|P2|NOT COMPLETED|Overall Study||0
7566958|NCT02894840|18625011|P1|NOT COMPLETED|Overall Study||1
7566959|NCT02894840|18625008|P4|COMPLETED|Overall Study||100
7566960|NCT02894840|18625009|P3|COMPLETED|Overall Study||197
7566961|NCT02894840|18625010|P2|COMPLETED|Overall Study||20
7566962|NCT02894840|18625011|P1|COMPLETED|Overall Study||19
7566963|NCT02894840|18625008|P4|STARTED|Overall Study||100
7566964|NCT02894840|18625009|P3|STARTED|Overall Study||200
7566965|NCT02894840|18625010|P2|STARTED|Overall Study||20
7566966|NCT02894840|18625011|P1|STARTED|Overall Study||20
7566967|NCT02893878|18625036|P3|NOT COMPLETED|Overall Study||0
7566968|NCT02893878|18625037|P2|NOT COMPLETED|Overall Study||0
7566969|NCT02893878|18625038|P1|NOT COMPLETED|Overall Study||0
7566970|NCT02893878|18625036|P3|COMPLETED|Overall Study||3178
7566971|NCT02893878|18625037|P2|COMPLETED|Overall Study||2295
7566972|NCT02893878|18625038|P1|COMPLETED|Overall Study||13861
7566973|NCT02893878|18625036|P3|STARTED|Overall Study||3178
7566974|NCT02893878|18625037|P2|STARTED|Overall Study||2295
7566975|NCT02893878|18625038|P1|STARTED|Overall Study||13861
7566976|NCT02892734|18625283|P1|NOT COMPLETED|Follow up for 2 Years||3
7566977|NCT02892734|18625283|P1|COMPLETED|Follow up for 2 Years||0
7566978|NCT02892734|18625283|P1|STARTED|Follow up for 2 Years||3
7566979|NCT02892734|18625283|P1|NOT COMPLETED|Treatment on Study||2
7566980|NCT02892734|18625283|P1|COMPLETED|Treatment on Study||1
7566981|NCT02892734|18625283|P1|Went on to Start Cycle 2|Treatment on Study||1
7566982|NCT02892734|18625283|P1|Completed 1st Cycle/Response at 12 Weeks|Treatment on Study||1
7566983|NCT02892734|18625283|P1|STARTED|Treatment on Study||3
7566984|NCT02892513|18625293|P2|NOT COMPLETED|Overall Study||1
7566985|NCT02892513|18625294|P1|NOT COMPLETED|Overall Study||0
7566986|NCT02892513|18625293|P2|COMPLETED|Overall Study|Discontinued intervention early = 6; excluded from analysis = 1|24
7566987|NCT02892513|18625294|P1|COMPLETED|Overall Study|Discontinued intervention early = 5; excluded from analysis = 0|28
7566988|NCT02892513|18625293|P2|STARTED|Overall Study|did not receive allocated intervention = 1 (withdrew per participant request)|25
7566989|NCT02892513|18625294|P1|STARTED|Overall Study||28
7566990|NCT02892500|18625302|P2|NOT COMPLETED|Overall Study||0
7566991|NCT02892500|18625303|P1|NOT COMPLETED|Overall Study||0
7566992|NCT02892500|18625302|P2|COMPLETED|Overall Study||0
7566993|NCT02892500|18625303|P1|COMPLETED|Overall Study||0
7566994|NCT02892500|18625302|P2|STARTED|Overall Study||0
7566995|NCT02892500|18625303|P1|STARTED|Overall Study||0
7566996|NCT02892448|18625314|P3|NOT COMPLETED|Overall Study||1
7566997|NCT02892448|18625315|P2|NOT COMPLETED|Overall Study||2
7566998|NCT02892448|18625316|P1|NOT COMPLETED|Overall Study||2
7566999|NCT02892448|18625314|P3|COMPLETED|Overall Study||10
7567000|NCT02892448|18625315|P2|COMPLETED|Overall Study||10
7567001|NCT02892448|18625316|P1|COMPLETED|Overall Study||10
7567002|NCT02892448|18625314|P3|STARTED|Overall Study||11
7567003|NCT02892448|18625315|P2|STARTED|Overall Study||12
7567004|NCT02892448|18625316|P1|STARTED|Overall Study||12
7567005|NCT02892422|18625336|P1|NOT COMPLETED|Overall Study||210
7567006|NCT02892422|18625336|P1|COMPLETED|Overall Study||318
7567007|NCT02892422|18625336|P1|STARTED|Overall Study|528 participants were enrolled, 524 from study 16159A and 4 from study 16323A|528
7567008|NCT02892409|18625342|P2|NOT COMPLETED|Overall Study||1
7567009|NCT02892409|18625343|P1|NOT COMPLETED|Overall Study||3
7567010|NCT02892409|18625342|P2|COMPLETED|Overall Study||14
7567011|NCT02892409|18625343|P1|COMPLETED|Overall Study||12
7567012|NCT02892409|18625342|P2|STARTED|Overall Study||15
7567013|NCT02892409|18625343|P1|STARTED|Overall Study||15
7567014|NCT02892344|18625365|P2|NOT COMPLETED|Overall Study||21
7567015|NCT02892344|18625366|P1|NOT COMPLETED|Overall Study||4
7567016|NCT02892344|18625365|P2|COMPLETED|Overall Study||383
7567018|NCT02892344|18625365|P2|Full Analysis Set|Overall Study||399
7567019|NCT02892344|18625366|P1|Full Analysis Set|Overall Study||395
7567020|NCT02892344|18625365|P2|STARTED|Overall Study||404
7567021|NCT02892344|18625366|P1|STARTED|Overall Study||398
7567022|NCT02892110|18625402|P2|NOT COMPLETED|Overall Study||12
7567023|NCT02892110|18625403|P1|NOT COMPLETED|Overall Study||13
7567024|NCT02892110|18625402|P2|COMPLETED|Overall Study||25
7567025|NCT02892110|18625403|P1|COMPLETED|Overall Study||22
7567026|NCT02892110|18625402|P2|STARTED|Overall Study||37
7567027|NCT02892110|18625403|P1|STARTED|Overall Study||35
7567028|NCT02892019|18625415|P2|NOT COMPLETED|Overall Study||3
7567029|NCT02892019|18625416|P1|NOT COMPLETED|Overall Study||1
7567030|NCT02892019|18625415|P2|COMPLETED|Overall Study||36
7567031|NCT02892019|18625416|P1|COMPLETED|Overall Study||40
7567032|NCT02892019|18625415|P2|STARTED|Overall Study||39
7567033|NCT02892019|18625416|P1|STARTED|Overall Study||41
7567034|NCT02891863|18625438|P1|NOT COMPLETED|Overall Study||0
7567035|NCT02891863|18625438|P1|COMPLETED|Overall Study||9
7567036|NCT02891863|18625438|P1|STARTED|Overall Study||9
7567037|NCT02891629|18625445|P2|NOT COMPLETED|Overall Study||1
7567038|NCT02891629|18625446|P1|NOT COMPLETED|Overall Study||0
7567039|NCT02891629|18625445|P2|COMPLETED|Overall Study||4
7567040|NCT02891629|18625446|P1|COMPLETED|Overall Study||10
7567041|NCT02891629|18625445|P2|STARTED|Overall Study||5
7567042|NCT02891629|18625446|P1|STARTED|Overall Study||10
7567043|NCT02891408|18625461|P7|NOT COMPLETED|Overall Study||0
7567044|NCT02891408|18625462|P6|NOT COMPLETED|Overall Study||0
7567045|NCT02891408|18625463|P5|NOT COMPLETED|Overall Study||0
7567046|NCT02891408|18625464|P4|NOT COMPLETED|Overall Study||0
7567047|NCT02891408|18625465|P3|NOT COMPLETED|Overall Study||1
7567048|NCT02891408|18625466|P2|NOT COMPLETED|Overall Study||0
7567049|NCT02891408|18625467|P1|NOT COMPLETED|Overall Study||0
7567050|NCT02891408|18625461|P7|COMPLETED|Overall Study||10
7567051|NCT02891408|18625462|P6|COMPLETED|Overall Study||10
7567052|NCT02891408|18625463|P5|COMPLETED|Overall Study||10
7567053|NCT02891408|18625464|P4|COMPLETED|Overall Study||10
7567054|NCT02891408|18625465|P3|COMPLETED|Overall Study||13
7567055|NCT02891408|18625466|P2|COMPLETED|Overall Study||10
7567056|NCT02891408|18625467|P1|COMPLETED|Overall Study||10
7567057|NCT02891408|18625461|P7|STARTED|Overall Study||10
7567058|NCT02891408|18625462|P6|STARTED|Overall Study||10
7567059|NCT02891408|18625463|P5|STARTED|Overall Study||10
7567060|NCT02891408|18625464|P4|STARTED|Overall Study||10
7567061|NCT02891408|18625465|P3|STARTED|Overall Study||14
7567062|NCT02891408|18625466|P2|STARTED|Overall Study||10
7567063|NCT02891408|18625467|P1|STARTED|Overall Study||10
7567064|NCT02891200|18625580|P2|NOT COMPLETED|Overall Study||49
7567065|NCT02891200|18625581|P1|NOT COMPLETED|Overall Study||42
7567066|NCT02891200|18625580|P2|COMPLETED|Overall Study||98
7567067|NCT02891200|18625581|P1|COMPLETED|Overall Study||103
7567068|NCT02891200|18625580|P2|STARTED|Overall Study||147
7567069|NCT02891200|18625581|P1|STARTED|Overall Study||145
7567070|NCT02891174|18625609|P2|NOT COMPLETED|Second Intervention (24 Hours)||7
7567071|NCT02891174|18625610|P1|NOT COMPLETED|Second Intervention (24 Hours)||6
7567072|NCT02891174|18625609|P2|COMPLETED|Second Intervention (24 Hours)||3
7567073|NCT02891174|18625610|P1|COMPLETED|Second Intervention (24 Hours)||11
7567074|NCT02891174|18625609|P2|STARTED|Second Intervention (24 Hours)||10
7567075|NCT02891174|18625610|P1|STARTED|Second Intervention (24 Hours)||17
7567076|NCT02891174|18625609|P2|NOT COMPLETED|First Intervention (24 Hours)||13
7567077|NCT02891174|18625610|P1|NOT COMPLETED|First Intervention (24 Hours)||3
7567078|NCT02891174|18625609|P2|COMPLETED|First Intervention (24 Hours)||10
7567079|NCT02891174|18625610|P1|COMPLETED|First Intervention (24 Hours)||17
7567080|NCT02891174|18625609|P2|Received First Intervention|First Intervention (24 Hours)||18
7567081|NCT02891174|18625610|P1|Received First Intervention|First Intervention (24 Hours)||19
7567082|NCT02891174|18625609|P2|STARTED|First Intervention (24 Hours)||23
7567083|NCT02891174|18625610|P1|STARTED|First Intervention (24 Hours)||20
7567084|NCT02891070|18625624|P2|NOT COMPLETED|Overall Study||8
7567085|NCT02891070|18625625|P1|NOT COMPLETED|Overall Study||10
7567086|NCT02891070|18625624|P2|COMPLETED|Overall Study||106
7567087|NCT02891070|18625625|P1|COMPLETED|Overall Study||100
7567088|NCT02891070|18625624|P2|STARTED|Overall Study||114
7567089|NCT02891070|18625625|P1|STARTED|Overall Study||110
7567090|NCT02890992|18625651|P8|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
7567091|NCT02890992|18625652|P7|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
7567092|NCT02890992|18625653|P6|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
7567093|NCT02890992|18625654|P5|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
7567094|NCT02890992|18625655|P4|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
7567095|NCT02890992|18625656|P3|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
7567096|NCT02890992|18625657|P2|NOT COMPLETED|130 Weeks Open-Label Extension Period||3
7567097|NCT02890992|18625658|P1|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
7567098|NCT02890992|18625651|P8|COMPLETED|130 Weeks Open-Label Extension Period||4
7567099|NCT02890992|18625652|P7|COMPLETED|130 Weeks Open-Label Extension Period||5
7567100|NCT02890992|18625653|P6|COMPLETED|130 Weeks Open-Label Extension Period||5
7567101|NCT02890992|18625654|P5|COMPLETED|130 Weeks Open-Label Extension Period||6
7567102|NCT02890992|18625655|P4|COMPLETED|130 Weeks Open-Label Extension Period||6
7567103|NCT02890992|18625656|P3|COMPLETED|130 Weeks Open-Label Extension Period||4
7567104|NCT02890992|18625657|P2|COMPLETED|130 Weeks Open-Label Extension Period||3
7567105|NCT02890992|18625658|P1|COMPLETED|130 Weeks Open-Label Extension Period||3
7567184|NCT02888756|18625921|P3|COMPLETED|Analytical Treatment Interruption||3
7567106|NCT02890992|18625651|P8|Treated|130 Weeks Open-Label Extension Period||4
7567107|NCT02890992|18625652|P7|Treated|130 Weeks Open-Label Extension Period||5
7567108|NCT02890992|18625653|P6|Treated|130 Weeks Open-Label Extension Period||5
7567109|NCT02890992|18625654|P5|Treated|130 Weeks Open-Label Extension Period||6
7567110|NCT02890992|18625655|P4|Treated|130 Weeks Open-Label Extension Period||6
7567111|NCT02890992|18625656|P3|Treated|130 Weeks Open-Label Extension Period||4
7567112|NCT02890992|18625657|P2|Treated|130 Weeks Open-Label Extension Period||6
7567113|NCT02890992|18625658|P1|Treated|130 Weeks Open-Label Extension Period||3
7567114|NCT02890992|18625651|P8|STARTED|130 Weeks Open-Label Extension Period||5
7567115|NCT02890992|18625652|P7|STARTED|130 Weeks Open-Label Extension Period||6
7567116|NCT02890992|18625653|P6|STARTED|130 Weeks Open-Label Extension Period||5
7567117|NCT02890992|18625654|P5|STARTED|130 Weeks Open-Label Extension Period||6
7567118|NCT02890992|18625655|P4|STARTED|130 Weeks Open-Label Extension Period||6
7567119|NCT02890992|18625656|P3|STARTED|130 Weeks Open-Label Extension Period||4
7567120|NCT02890992|18625657|P2|STARTED|130 Weeks Open-Label Extension Period||6
7567121|NCT02890992|18625658|P1|STARTED|130 Weeks Open-Label Extension Period|3 participants from Open-Label Dose Finding Period (OLDFI) entered in OLE period.|3
7567122|NCT02890992|18625651|P8|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
7567123|NCT02890992|18625652|P7|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
7567124|NCT02890992|18625653|P6|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
7567125|NCT02890992|18625654|P5|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
7567126|NCT02890992|18625655|P4|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
7567127|NCT02890992|18625656|P3|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
7567128|NCT02890992|18625657|P2|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
7567129|NCT02890992|18625658|P1|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
7567130|NCT02890992|18625651|P8|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
7567131|NCT02890992|18625652|P7|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
7567132|NCT02890992|18625653|P6|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
7567133|NCT02890992|18625654|P5|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
7567134|NCT02890992|18625655|P4|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
7567135|NCT02890992|18625656|P3|COMPLETED|12 Weeks Open-Label Dose Finding Period||4
7567136|NCT02890992|18625657|P2|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
7567137|NCT02890992|18625658|P1|COMPLETED|12 Weeks Open-Label Dose Finding Period|Out of 4 participants, 3 participants entered into the open-label extension (OLE) period.|4
7567138|NCT02890992|18625651|P8|Treated|12 Weeks Open-Label Dose Finding Period||5
7567139|NCT02890992|18625652|P7|Treated|12 Weeks Open-Label Dose Finding Period||6
7567140|NCT02890992|18625653|P6|Treated|12 Weeks Open-Label Dose Finding Period||5
7567141|NCT02890992|18625654|P5|Treated|12 Weeks Open-Label Dose Finding Period||6
7567142|NCT02890992|18625655|P4|Treated|12 Weeks Open-Label Dose Finding Period||6
7567143|NCT02890992|18625656|P3|Treated|12 Weeks Open-Label Dose Finding Period||4
7567144|NCT02890992|18625657|P2|Treated|12 Weeks Open-Label Dose Finding Period||6
7567145|NCT02890992|18625658|P1|Treated|12 Weeks Open-Label Dose Finding Period||4
7567146|NCT02890992|18625651|P8|STARTED|12 Weeks Open-Label Dose Finding Period||5
7567147|NCT02890992|18625652|P7|STARTED|12 Weeks Open-Label Dose Finding Period||6
7567148|NCT02890992|18625653|P6|STARTED|12 Weeks Open-Label Dose Finding Period||5
7567149|NCT02890992|18625654|P5|STARTED|12 Weeks Open-Label Dose Finding Period||6
7567150|NCT02890992|18625655|P4|STARTED|12 Weeks Open-Label Dose Finding Period||6
7567151|NCT02890992|18625656|P3|STARTED|12 Weeks Open-Label Dose Finding Period||4
7567152|NCT02890992|18625657|P2|STARTED|12 Weeks Open-Label Dose Finding Period||6
7567153|NCT02890992|18625658|P1|STARTED|12 Weeks Open-Label Dose Finding Period||4
7567154|NCT02890381|18625826|P2|NOT COMPLETED|Overall Study||0
7567155|NCT02890381|18625827|P1|NOT COMPLETED|Overall Study||0
7567156|NCT02890381|18625826|P2|COMPLETED|Overall Study||6
7567157|NCT02890381|18625827|P1|COMPLETED|Overall Study||11
7567158|NCT02890381|18625826|P2|STARTED|Overall Study||6
7567159|NCT02890381|18625827|P1|STARTED|Overall Study||11
7567160|NCT02890355|18625855|P2|NOT COMPLETED|Overall Study||58
7567161|NCT02890355|18625856|P1|NOT COMPLETED|Overall Study||59
7567162|NCT02890355|18625855|P2|COMPLETED|Overall Study||0
7567163|NCT02890355|18625856|P1|COMPLETED|Overall Study||0
7567164|NCT02890355|18625855|P2|Treated & Assessed for AEs|Overall Study||50
7567165|NCT02890355|18625856|P1|Treated & Assessed for AEs|Overall Study||56
7567166|NCT02890355|18625855|P2|STARTED|Overall Study||58
7567167|NCT02890355|18625856|P1|STARTED|Overall Study||59
7567168|NCT02890303|18625872|P1|NOT COMPLETED|Overall Study||0
7567169|NCT02890303|18625872|P1|COMPLETED|Overall Study||100
7567170|NCT02890303|18625872|P1|STARTED|Overall Study||100
7567171|NCT02889900|18625876|P1|NOT COMPLETED|Overall Study||57
7567172|NCT02889900|18625876|P1|COMPLETED|Overall Study|Patients ongoing in study at primary analysis data cut off (DCO)|5
7567173|NCT02889900|18625876|P1|Received Treatment|Overall Study||60
7567174|NCT02889900|18625876|P1|STARTED|Overall Study||62
7567175|NCT02889861|18625888|P1|NOT COMPLETED|Overall Study||2
7567176|NCT02889861|18625888|P1|COMPLETED|Overall Study||1
7567177|NCT02889861|18625888|P1|STARTED|Overall Study||3
7567178|NCT02889289|18625909|P1|NOT COMPLETED|Overall Study||0
7567179|NCT02889289|18625909|P1|COMPLETED|Overall Study||1
7567180|NCT02889289|18625909|P1|STARTED|Overall Study||1
7567181|NCT02888756|18625921|P3|NOT COMPLETED|Analytical Treatment Interruption||5
7567182|NCT02888756|18625922|P2|NOT COMPLETED|Analytical Treatment Interruption||6
7567183|NCT02888756|18625923|P1|NOT COMPLETED|Analytical Treatment Interruption||10
7567185|NCT02888756|18625922|P2|COMPLETED|Analytical Treatment Interruption||3
7567186|NCT02888756|18625923|P1|COMPLETED|Analytical Treatment Interruption||5
7567187|NCT02888756|18625921|P3|STARTED|Analytical Treatment Interruption||8
7567188|NCT02888756|18625922|P2|STARTED|Analytical Treatment Interruption||9
7567189|NCT02888756|18625923|P1|STARTED|Analytical Treatment Interruption||15
7567190|NCT02888756|18625921|P3|NOT COMPLETED|Vaccination Period||0
7567191|NCT02888756|18625922|P2|NOT COMPLETED|Vaccination Period||0
7567192|NCT02888756|18625923|P1|NOT COMPLETED|Vaccination Period||0
7567193|NCT02888756|18625921|P3|COMPLETED|Vaccination Period||8
7567194|NCT02888756|18625922|P2|COMPLETED|Vaccination Period||9
7567195|NCT02888756|18625923|P1|COMPLETED|Vaccination Period||16
7567196|NCT02888756|18625921|P3|STARTED|Vaccination Period||8
7567197|NCT02888756|18625922|P2|STARTED|Vaccination Period||9
7567198|NCT02888756|18625923|P1|STARTED|Vaccination Period||16
7567199|NCT02888691|18625964|P2|NOT COMPLETED|Second Intervention Period||2
7567200|NCT02888691|18625965|P1|NOT COMPLETED|Second Intervention Period||0
7567201|NCT02888691|18625964|P2|COMPLETED|Second Intervention Period||3
7567202|NCT02888691|18625965|P1|COMPLETED|Second Intervention Period||7
7567203|NCT02888691|18625964|P2|STARTED|Second Intervention Period||5
7567204|NCT02888691|18625965|P1|STARTED|Second Intervention Period|This is a cross-over study. Therefore starters does not necessarily equal completers of period 1.|7
7567205|NCT02888691|18625964|P2|NOT COMPLETED|First Intervention Period||0
7567206|NCT02888691|18625965|P1|NOT COMPLETED|First Intervention Period||1
7567207|NCT02888691|18625964|P2|COMPLETED|First Intervention Period||7
7567208|NCT02888691|18625965|P1|COMPLETED|First Intervention Period||6
7567209|NCT02888691|18625964|P2|STARTED|First Intervention Period||7
7567210|NCT02888691|18625965|P1|STARTED|First Intervention Period||7
7567211|NCT02888171|18626063|P2|NOT COMPLETED|Overall Study||4
7567212|NCT02888171|18626064|P1|NOT COMPLETED|Overall Study||5
7567213|NCT02888171|18626063|P2|COMPLETED|Overall Study||26
7567214|NCT02888171|18626064|P1|COMPLETED|Overall Study||25
7567215|NCT02888171|18626063|P2|STARTED|Overall Study||30
7567216|NCT02888171|18626064|P1|STARTED|Overall Study||30
7567217|NCT02888093|18626080|P2|NOT COMPLETED|Overall Study||2
7567218|NCT02888093|18626081|P1|NOT COMPLETED|Overall Study||2
7567219|NCT02888093|18626080|P2|COMPLETED|Overall Study||20
7567220|NCT02888093|18626081|P1|COMPLETED|Overall Study||20
7567221|NCT02888093|18626080|P2|STARTED|Overall Study||22
7567222|NCT02888093|18626081|P1|STARTED|Overall Study||22
7567223|NCT02888080|18626093|P2|NOT COMPLETED|Overall Study||5
7567224|NCT02888080|18626094|P1|NOT COMPLETED|Overall Study||2
7567225|NCT02888080|18626093|P2|COMPLETED|Overall Study||15
7567226|NCT02888080|18626094|P1|COMPLETED|Overall Study||18
7567227|NCT02888080|18626093|P2|STARTED|Overall Study||20
7567228|NCT02888080|18626094|P1|STARTED|Overall Study||20
7567229|NCT02887989|18626120|P2|NOT COMPLETED|Overall Study||11
7567230|NCT02887989|18626121|P1|NOT COMPLETED|Overall Study||9
7567231|NCT02887989|18626120|P2|COMPLETED|Overall Study||59
7567232|NCT02887989|18626121|P1|COMPLETED|Overall Study||61
7567233|NCT02887989|18626120|P2|STARTED|Overall Study||70
7567234|NCT02887989|18626121|P1|STARTED|Overall Study||70
7567235|NCT02887521|18626133|P2|NOT COMPLETED|Overall Study||3
7567236|NCT02887521|18626134|P1|NOT COMPLETED|Overall Study||0
7567237|NCT02887521|18626133|P2|COMPLETED|Overall Study||2
7567238|NCT02887521|18626134|P1|COMPLETED|Overall Study||4
7567239|NCT02887521|18626133|P2|STARTED|Overall Study||5
7567240|NCT02887521|18626134|P1|STARTED|Overall Study||4
7567241|NCT02887404|18626148|P2|NOT COMPLETED|Overall Study||0
7567242|NCT02887404|18626149|P1|NOT COMPLETED|Overall Study||0
7567243|NCT02887404|18626148|P2|COMPLETED|Overall Study||149
7567244|NCT02887404|18626149|P1|COMPLETED|Overall Study||150
7567245|NCT02887404|18626148|P2|STARTED|Overall Study||149
7567246|NCT02887404|18626149|P1|STARTED|Overall Study||150
7567247|NCT02887183|18626197|P1|NOT COMPLETED|Overall Study||141
7567248|NCT02887183|18626197|P1|COMPLETED|Overall Study||654
7567249|NCT02887183|18626197|P1|Full Analysis Set|Overall Study||794
7567250|NCT02887183|18626197|P1|STARTED|Overall Study||795
7567251|NCT02886923|18626210|P2|NOT COMPLETED|Period 2||0
7567252|NCT02886923|18626211|P1|NOT COMPLETED|Period 2||0
7567253|NCT02886923|18626210|P2|COMPLETED|Period 2||11
7567254|NCT02886923|18626211|P1|COMPLETED|Period 2||12
7567255|NCT02886923|18626210|P2|STARTED|Period 2||11
7567256|NCT02886923|18626211|P1|STARTED|Period 2||12
7567257|NCT02886923|18626210|P2|NOT COMPLETED|Period 1||0
7567258|NCT02886923|18626211|P1|NOT COMPLETED|Period 1||0
7567259|NCT02886923|18626210|P2|COMPLETED|Period 1||11
7567260|NCT02886923|18626211|P1|COMPLETED|Period 1||12
7567261|NCT02886923|18626210|P2|STARTED|Period 1||11
7567262|NCT02886923|18626211|P1|STARTED|Period 1||12
7567263|NCT02886715|18626224|P3|NOT COMPLETED|Overall Study||20
7567264|NCT02886715|18626225|P2|NOT COMPLETED|Overall Study||55
7567265|NCT02886715|18626226|P1|NOT COMPLETED|Overall Study||64
7567266|NCT02886715|18626224|P3|COMPLETED|Overall Study||203
7567267|NCT02886715|18626225|P2|COMPLETED|Overall Study||390
7567268|NCT02886715|18626226|P1|COMPLETED|Overall Study||378
7567269|NCT02886715|18626224|P3|Per Protocol (PP) Population|Overall Study||176
7567270|NCT02886715|18626225|P2|Per Protocol (PP) Population|Overall Study||351
7567271|NCT02886715|18626226|P1|Per Protocol (PP) Population|Overall Study||346
7567272|NCT02886715|18626224|P3|Modified ITT (mITT)|Overall Study||217
7567273|NCT02886715|18626225|P2|Modified ITT (mITT)|Overall Study||418
7567274|NCT02886715|18626226|P1|Modified ITT (mITT)|Overall Study||421
7567275|NCT02886715|18626224|P3|STARTED|Overall Study||223
7567276|NCT02886715|18626225|P2|STARTED|Overall Study||445
7567277|NCT02886715|18626226|P1|STARTED|Overall Study||442
7567278|NCT02886702|18626243|P3|NOT COMPLETED|Overall Study||53
7567279|NCT02886702|18626244|P2|NOT COMPLETED|Overall Study||51
7567280|NCT02886702|18626245|P1|NOT COMPLETED|Overall Study||48
7567281|NCT02886702|18626243|P3|COMPLETED|Overall Study||232
7567282|NCT02886702|18626244|P2|COMPLETED|Overall Study||235
7567283|NCT02886702|18626245|P1|COMPLETED|Overall Study||236
7567284|NCT02886702|18626243|P3|Per-Protocol Population (PP)|Overall Study||201
7567285|NCT02886702|18626244|P2|Per-Protocol Population (PP)|Overall Study||209
7567286|NCT02886702|18626245|P1|Per-Protocol Population (PP)|Overall Study||208
7567287|NCT02886702|18626243|P3|Modified Intent-to Treat (mITT)|Overall Study||275
7567288|NCT02886702|18626244|P2|Modified Intent-to Treat (mITT)|Overall Study||266
7567289|NCT02886702|18626245|P1|Modified Intent-to Treat (mITT)|Overall Study||263
7567290|NCT02886702|18626243|P3|STARTED|Overall Study||285
7567291|NCT02886702|18626244|P2|STARTED|Overall Study||286
7567292|NCT02886702|18626245|P1|STARTED|Overall Study||284
7567293|NCT02886624|18626259|P1|NOT COMPLETED|48-week Post Treatment Follow-up||1
7567294|NCT02886624|18626259|P1|COMPLETED|48-week Post Treatment Follow-up||28
7567295|NCT02886624|18626259|P1|STARTED|48-week Post Treatment Follow-up||29
7567296|NCT02886624|18626259|P1|NOT COMPLETED|12-week Post Treatment Follow-up||1
7567297|NCT02886624|18626259|P1|COMPLETED|12-week Post Treatment Follow-up||29
7567298|NCT02886624|18626259|P1|STARTED|12-week Post Treatment Follow-up||30
7567299|NCT02886624|18626259|P1|NOT COMPLETED|8-week Treatment||0
7567300|NCT02886624|18626259|P1|COMPLETED|8-week Treatment||30
7567301|NCT02886624|18626259|P1|STARTED|8-week Treatment||30
7567302|NCT02886338|18626268|P1|NOT COMPLETED|Overall Study||1
7567303|NCT02886338|18626268|P1|COMPLETED|Overall Study||9
7567304|NCT02886338|18626268|P1|STARTED|Overall Study||10
7567305|NCT02886234|18626274|P2|NOT COMPLETED|Overall Study||2
7567306|NCT02886234|18626275|P1|NOT COMPLETED|Overall Study||0
7567307|NCT02886234|18626274|P2|COMPLETED|Overall Study||22
7567308|NCT02886234|18626275|P1|COMPLETED|Overall Study||20
7567309|NCT02886234|18626274|P2|STARTED|Overall Study||24
7567310|NCT02886234|18626275|P1|STARTED|Overall Study||20
7567311|NCT02885636|18626297|P2|NOT COMPLETED|Overall Study||0
7567312|NCT02885636|18626298|P1|NOT COMPLETED|Overall Study||0
7567313|NCT02885636|18626297|P2|COMPLETED|Overall Study||15
7567314|NCT02885636|18626298|P1|COMPLETED|Overall Study||15
7567315|NCT02885636|18626297|P2|STARTED|Overall Study||15
7567316|NCT02885636|18626298|P1|STARTED|Overall Study||15
7567317|NCT02885506|18626340|P10|NOT COMPLETED|Part B||0
7567318|NCT02885506|18626341|P9|NOT COMPLETED|Part B||0
7567319|NCT02885506|18626342|P8|NOT COMPLETED|Part B||0
7567320|NCT02885506|18626343|P7|NOT COMPLETED|Part B||0
7567321|NCT02885506|18626344|P6|NOT COMPLETED|Part B||0
7567322|NCT02885506|18626345|P5|NOT COMPLETED|Part B||0
7567323|NCT02885506|18626346|P4|NOT COMPLETED|Part B||0
7567324|NCT02885506|18626347|P3|NOT COMPLETED|Part B||0
7567325|NCT02885506|18626348|P2|NOT COMPLETED|Part B||0
7567326|NCT02885506|18626349|P1|NOT COMPLETED|Part B||0
7567327|NCT02885506|18626340|P10|COMPLETED|Part B||4
7567328|NCT02885506|18626341|P9|COMPLETED|Part B||4
7567329|NCT02885506|18626342|P8|COMPLETED|Part B||0
7567330|NCT02885506|18626343|P7|COMPLETED|Part B||0
7567331|NCT02885506|18626344|P6|COMPLETED|Part B||0
7567332|NCT02885506|18626345|P5|COMPLETED|Part B||0
7567333|NCT02885506|18626346|P4|COMPLETED|Part B||0
7567334|NCT02885506|18626347|P3|COMPLETED|Part B||0
7567335|NCT02885506|18626348|P2|COMPLETED|Part B||0
7567336|NCT02885506|18626349|P1|COMPLETED|Part B||0
7567337|NCT02885506|18626340|P10|STARTED|Part B||4
7567338|NCT02885506|18626341|P9|STARTED|Part B||4
7567339|NCT02885506|18626342|P8|STARTED|Part B||0
7567340|NCT02885506|18626343|P7|STARTED|Part B||0
7567341|NCT02885506|18626344|P6|STARTED|Part B||0
7567342|NCT02885506|18626345|P5|STARTED|Part B||0
7567343|NCT02885506|18626346|P4|STARTED|Part B||0
7567344|NCT02885506|18626347|P3|STARTED|Part B||0
7567345|NCT02885506|18626348|P2|STARTED|Part B||0
7567346|NCT02885506|18626349|P1|STARTED|Part B||0
7567347|NCT02885506|18626340|P10|NOT COMPLETED|Part A||0
7567348|NCT02885506|18626341|P9|NOT COMPLETED|Part A||0
7567349|NCT02885506|18626342|P8|NOT COMPLETED|Part A||0
7567350|NCT02885506|18626343|P7|NOT COMPLETED|Part A||0
7567351|NCT02885506|18626344|P6|NOT COMPLETED|Part A||0
7567352|NCT02885506|18626345|P5|NOT COMPLETED|Part A||0
7567353|NCT02885506|18626346|P4|NOT COMPLETED|Part A||0
7567354|NCT02885506|18626347|P3|NOT COMPLETED|Part A||0
7567355|NCT02885506|18626348|P2|NOT COMPLETED|Part A||0
7567356|NCT02885506|18626349|P1|NOT COMPLETED|Part A||0
7567357|NCT02885506|18626340|P10|COMPLETED|Part A||0
7567358|NCT02885506|18626341|P9|COMPLETED|Part A||0
7567359|NCT02885506|18626342|P8|COMPLETED|Part A||14
7567360|NCT02885506|18626343|P7|COMPLETED|Part A||6
7567361|NCT02885506|18626344|P6|COMPLETED|Part A||6
7567362|NCT02885506|18626345|P5|COMPLETED|Part A||6
7567363|NCT02885506|18626346|P4|COMPLETED|Part A||6
7567364|NCT02885506|18626347|P3|COMPLETED|Part A||6
7567365|NCT02885506|18626348|P2|COMPLETED|Part A||6
7567366|NCT02885506|18626349|P1|COMPLETED|Part A||6
7567367|NCT02885506|18626340|P10|STARTED|Part A||0
7567368|NCT02885506|18626341|P9|STARTED|Part A||0
7567369|NCT02885506|18626342|P8|STARTED|Part A||14
7567370|NCT02885506|18626343|P7|STARTED|Part A||6
7567371|NCT02885506|18626344|P6|STARTED|Part A||6
7567372|NCT02885506|18626345|P5|STARTED|Part A||6
7567373|NCT02885506|18626346|P4|STARTED|Part A||6
7567374|NCT02885506|18626347|P3|STARTED|Part A||6
7567375|NCT02885506|18626348|P2|STARTED|Part A||6
7567376|NCT02885506|18626349|P1|STARTED|Part A||6
7567377|NCT02885246|18626441|P1|NOT COMPLETED|Overall Study||0
7567378|NCT02885246|18626441|P1|COMPLETED|Overall Study||1839
7567379|NCT02885246|18626441|P1|STARTED|Overall Study||1839
7567380|NCT02885181|18626457|P4|NOT COMPLETED|Overall Study||3
7567381|NCT02885181|18626458|P3|NOT COMPLETED|Overall Study||0
7567382|NCT02885181|18626459|P2|NOT COMPLETED|Overall Study||1
7567383|NCT02885181|18626460|P1|NOT COMPLETED|Overall Study||0
7567384|NCT02885181|18626457|P4|COMPLETED|Overall Study||19
7567385|NCT02885181|18626458|P3|COMPLETED|Overall Study||21
7567386|NCT02885181|18626459|P2|COMPLETED|Overall Study||19
7567387|NCT02885181|18626460|P1|COMPLETED|Overall Study||20
7567388|NCT02885181|18626457|P4|STARTED|Overall Study||22
7567389|NCT02885181|18626458|P3|STARTED|Overall Study||21
7567390|NCT02885181|18626459|P2|STARTED|Overall Study||20
7567391|NCT02885181|18626460|P1|STARTED|Overall Study||20
7567392|NCT02885025|18626490|P4|NOT COMPLETED|Overall Study||0
7567393|NCT02885025|18626491|P3|NOT COMPLETED|Overall Study||0
7567394|NCT02885025|18626492|P2|NOT COMPLETED|Overall Study||2
7567395|NCT02885025|18626493|P1|NOT COMPLETED|Overall Study||0
7567396|NCT02885025|18626490|P4|COMPLETED|Overall Study||8
7567397|NCT02885025|18626491|P3|COMPLETED|Overall Study||9
7567398|NCT02885025|18626492|P2|COMPLETED|Overall Study||12
7567399|NCT02885025|18626493|P1|COMPLETED|Overall Study||16
7567400|NCT02885025|18626490|P4|STARTED|Overall Study||8
7567401|NCT02885025|18626491|P3|STARTED|Overall Study||9
7567402|NCT02885025|18626492|P2|STARTED|Overall Study||14
7567403|NCT02885025|18626493|P1|STARTED|Overall Study||16
7567404|NCT02885012|18626533|P2|NOT COMPLETED|Overall Study||0
7567405|NCT02885012|18626534|P1|NOT COMPLETED|Overall Study||0
7567406|NCT02885012|18626533|P2|COMPLETED|Overall Study||2
7567407|NCT02885012|18626534|P1|COMPLETED|Overall Study||1
7567408|NCT02885012|18626533|P2|STARTED|Overall Study||2
7567409|NCT02885012|18626534|P1|STARTED|Overall Study||1
7567410|NCT02884492|18626546|P2|NOT COMPLETED|Overall Study||0
7567411|NCT02884492|18626547|P1|NOT COMPLETED|Overall Study||0
7567412|NCT02884492|18626546|P2|COMPLETED|Overall Study||10
7567413|NCT02884492|18626547|P1|COMPLETED|Overall Study||7
7567414|NCT02884492|18626546|P2|STARTED|Overall Study||10
7567415|NCT02884492|18626547|P1|STARTED|Overall Study||7
7567416|NCT02884427|18626556|P3|NOT COMPLETED|Overall Study||0
7567417|NCT02884427|18626557|P2|NOT COMPLETED|Overall Study||0
7567418|NCT02884427|18626558|P1|NOT COMPLETED|Overall Study||0
7567419|NCT02884427|18626556|P3|COMPLETED|Overall Study||50
7567420|NCT02884427|18626557|P2|COMPLETED|Overall Study||52
7567421|NCT02884427|18626558|P1|COMPLETED|Overall Study||48
7567422|NCT02884427|18626556|P3|STARTED|Overall Study||50
7567423|NCT02884427|18626557|P2|STARTED|Overall Study||52
7567424|NCT02884427|18626558|P1|STARTED|Overall Study||48
7567425|NCT02884089|18626572|P4|NOT COMPLETED|Follow-up Visit||1
7567426|NCT02884089|18626573|P3|NOT COMPLETED|Follow-up Visit||0
7567427|NCT02884089|18626574|P2|NOT COMPLETED|Follow-up Visit||0
7567428|NCT02884089|18626575|P1|NOT COMPLETED|Follow-up Visit||1
7567429|NCT02884089|18626572|P4|COMPLETED|Follow-up Visit||6
7567430|NCT02884089|18626573|P3|COMPLETED|Follow-up Visit||7
7567431|NCT02884089|18626574|P2|COMPLETED|Follow-up Visit||6
7567432|NCT02884089|18626575|P1|COMPLETED|Follow-up Visit||6
7567433|NCT02884089|18626572|P4|STARTED|Follow-up Visit||7
7567434|NCT02884089|18626573|P3|STARTED|Follow-up Visit||7
7567435|NCT02884089|18626574|P2|STARTED|Follow-up Visit||6
7567436|NCT02884089|18626575|P1|STARTED|Follow-up Visit||7
7567437|NCT02884089|18626572|P4|NOT COMPLETED|Period 4||0
7567438|NCT02884089|18626573|P3|NOT COMPLETED|Period 4||0
7567439|NCT02884089|18626574|P2|NOT COMPLETED|Period 4||1
7567440|NCT02884089|18626575|P1|NOT COMPLETED|Period 4||1
7567441|NCT02884089|18626572|P4|COMPLETED|Period 4||7
7567442|NCT02884089|18626573|P3|COMPLETED|Period 4||7
7567443|NCT02884089|18626574|P2|COMPLETED|Period 4||6
7567444|NCT02884089|18626575|P1|COMPLETED|Period 4||7
7567445|NCT02884089|18626572|P4|STARTED|Period 4||7
7567446|NCT02884089|18626573|P3|STARTED|Period 4||7
7567447|NCT02884089|18626574|P2|STARTED|Period 4||7
7567448|NCT02884089|18626575|P1|STARTED|Period 4||8
7567449|NCT02884089|18626572|P4|NOT COMPLETED|Washout Period 3||1
7567450|NCT02884089|18626573|P3|NOT COMPLETED|Washout Period 3||1
7567451|NCT02884089|18626574|P2|NOT COMPLETED|Washout Period 3||0
7567452|NCT02884089|18626575|P1|NOT COMPLETED|Washout Period 3||0
7567453|NCT02884089|18626572|P4|COMPLETED|Washout Period 3||7
7567454|NCT02884089|18626573|P3|COMPLETED|Washout Period 3||7
7567455|NCT02884089|18626574|P2|COMPLETED|Washout Period 3||7
7567456|NCT02884089|18626575|P1|COMPLETED|Washout Period 3||8
7567457|NCT02884089|18626572|P4|STARTED|Washout Period 3||8
7567458|NCT02884089|18626573|P3|STARTED|Washout Period 3||8
7567459|NCT02884089|18626574|P2|STARTED|Washout Period 3||7
7567460|NCT02884089|18626575|P1|STARTED|Washout Period 3||8
7567461|NCT02884089|18626572|P4|NOT COMPLETED|Period 3||0
7567462|NCT02884089|18626573|P3|NOT COMPLETED|Period 3||1
7567463|NCT02884089|18626574|P2|NOT COMPLETED|Period 3||0
7567464|NCT02884089|18626575|P1|NOT COMPLETED|Period 3||0
7567465|NCT02884089|18626572|P4|COMPLETED|Period 3||8
7567466|NCT02884089|18626573|P3|COMPLETED|Period 3||8
7567467|NCT02884089|18626574|P2|COMPLETED|Period 3||7
7567468|NCT02884089|18626575|P1|COMPLETED|Period 3||8
7567469|NCT02884089|18626572|P4|STARTED|Period 3||8
7567470|NCT02884089|18626573|P3|STARTED|Period 3||9
7567471|NCT02884089|18626574|P2|STARTED|Period 3||7
7567472|NCT02884089|18626575|P1|STARTED|Period 3||8
7567473|NCT02884089|18626572|P4|NOT COMPLETED|Washout Period 2||0
7567474|NCT02884089|18626573|P3|NOT COMPLETED|Washout Period 2||0
7567475|NCT02884089|18626574|P2|NOT COMPLETED|Washout Period 2||0
7567476|NCT02884089|18626575|P1|NOT COMPLETED|Washout Period 2||0
7567477|NCT02884089|18626572|P4|COMPLETED|Washout Period 2||8
7567478|NCT02884089|18626573|P3|COMPLETED|Washout Period 2||9
7567479|NCT02884089|18626574|P2|COMPLETED|Washout Period 2||7
7567480|NCT02884089|18626575|P1|COMPLETED|Washout Period 2||8
7567481|NCT02884089|18626572|P4|STARTED|Washout Period 2||8
7567482|NCT02884089|18626573|P3|STARTED|Washout Period 2||9
7567483|NCT02884089|18626574|P2|STARTED|Washout Period 2||7
7567484|NCT02884089|18626575|P1|STARTED|Washout Period 2||8
7567485|NCT02884089|18626572|P4|NOT COMPLETED|Period 2||0
7567486|NCT02884089|18626573|P3|NOT COMPLETED|Period 2||0
7567487|NCT02884089|18626574|P2|NOT COMPLETED|Period 2||0
7567488|NCT02884089|18626575|P1|NOT COMPLETED|Period 2||1
7567489|NCT02884089|18626572|P4|COMPLETED|Period 2||8
7567490|NCT02884089|18626573|P3|COMPLETED|Period 2||9
7567491|NCT02884089|18626574|P2|COMPLETED|Period 2||7
7567492|NCT02884089|18626575|P1|COMPLETED|Period 2||8
7567493|NCT02884089|18626572|P4|STARTED|Period 2||8
7567494|NCT02884089|18626573|P3|STARTED|Period 2||9
7567495|NCT02884089|18626574|P2|STARTED|Period 2||7
7567496|NCT02884089|18626575|P1|STARTED|Period 2||9
7567497|NCT02884089|18626572|P4|NOT COMPLETED|Washout Period 1||1
7567498|NCT02884089|18626573|P3|NOT COMPLETED|Washout Period 1||0
7567499|NCT02884089|18626574|P2|NOT COMPLETED|Washout Period 1||2
7567500|NCT02884089|18626575|P1|NOT COMPLETED|Washout Period 1||0
7567501|NCT02884089|18626572|P4|COMPLETED|Washout Period 1||8
7567502|NCT02884089|18626573|P3|COMPLETED|Washout Period 1||9
7567503|NCT02884089|18626574|P2|COMPLETED|Washout Period 1||7
7567504|NCT02884089|18626575|P1|COMPLETED|Washout Period 1||9
7567505|NCT02884089|18626572|P4|STARTED|Washout Period 1||9
7567506|NCT02884089|18626573|P3|STARTED|Washout Period 1||9
7567507|NCT02884089|18626574|P2|STARTED|Washout Period 1||9
7567508|NCT02884089|18626575|P1|STARTED|Washout Period 1||9
7567509|NCT02884089|18626572|P4|NOT COMPLETED|Period 1||0
7567510|NCT02884089|18626573|P3|NOT COMPLETED|Period 1||0
7567511|NCT02884089|18626574|P2|NOT COMPLETED|Period 1||2
7567512|NCT02884089|18626575|P1|NOT COMPLETED|Period 1||2
7567513|NCT02884089|18626572|P4|COMPLETED|Period 1||9
7567514|NCT02884089|18626573|P3|COMPLETED|Period 1||9
7567515|NCT02884089|18626574|P2|COMPLETED|Period 1||9
7567516|NCT02884089|18626575|P1|COMPLETED|Period 1||9
7567517|NCT02884089|18626572|P4|Received at Least One Dose of Study Drug|Period 1||9
7567518|NCT02884089|18626573|P3|Received at Least One Dose of Study Drug|Period 1||9
7567519|NCT02884089|18626574|P2|Received at Least One Dose of Study Drug|Period 1||11
7567520|NCT02884089|18626575|P1|Received at Least One Dose of Study Drug|Period 1||11
7567521|NCT02884089|18626572|P4|STARTED|Period 1||9
7567522|NCT02884089|18626573|P3|STARTED|Period 1||9
7567523|NCT02884089|18626574|P2|STARTED|Period 1||11
7567524|NCT02884089|18626575|P1|STARTED|Period 1||11
7567525|NCT02883452|18626595|P6|NOT COMPLETED|Overall Study||15
7567526|NCT02883452|18626596|P5|NOT COMPLETED|Overall Study||11
7567527|NCT02883452|18626597|P4|NOT COMPLETED|Overall Study||2
7567528|NCT02883452|18626598|P3|NOT COMPLETED|Overall Study||5
7567529|NCT02883452|18626599|P2|NOT COMPLETED|Overall Study||2
7567530|NCT02883452|18626600|P1|NOT COMPLETED|Overall Study||5
7567531|NCT02883452|18626595|P6|COMPLETED|Overall Study||50
7567532|NCT02883452|18626596|P5|COMPLETED|Overall Study||55
7567533|NCT02883452|18626597|P4|COMPLETED|Overall Study||6
7567534|NCT02883452|18626598|P3|COMPLETED|Overall Study||7
7567535|NCT02883452|18626599|P2|COMPLETED|Overall Study||9
7567536|NCT02883452|18626600|P1|COMPLETED|Overall Study||8
7567537|NCT02883452|18626595|P6|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|65
7567538|NCT02883452|18626596|P5|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|66
7567539|NCT02883452|18626597|P4|STARTED|Overall Study|This cohort is only for Part 1.|8
7567540|NCT02883452|18626598|P3|STARTED|Overall Study|This cohort is only for Part 1.|12
7567541|NCT02883452|18626599|P2|STARTED|Overall Study|This cohort is only for Part 1.|11
7567542|NCT02883452|18626600|P1|STARTED|Overall Study|This cohort is only for Part 1.|13
7567543|NCT02883244|18626628|P2|NOT COMPLETED|Overall Study||1
7567544|NCT02883244|18626629|P1|NOT COMPLETED|Overall Study||0
7567545|NCT02883244|18626628|P2|COMPLETED|Overall Study||25
7567546|NCT02883244|18626629|P1|COMPLETED|Overall Study||24
7567547|NCT02883244|18626628|P2|STARTED|Overall Study||26
7567548|NCT02883244|18626629|P1|STARTED|Overall Study||24
7567549|NCT02882854|18626647|P2|NOT COMPLETED|Overall Study||3
7567550|NCT02882854|18626648|P1|NOT COMPLETED|Overall Study||1
7567551|NCT02882854|18626647|P2|COMPLETED|Overall Study||41
7567552|NCT02882854|18626648|P1|COMPLETED|Overall Study||39
7567553|NCT02882854|18626647|P2|STARTED|Overall Study||44
7567554|NCT02882854|18626648|P1|STARTED|Overall Study||40
7567555|NCT02882711|18626670|P1|NOT COMPLETED|Overall Study||4
7567556|NCT02882711|18626670|P1|COMPLETED|Overall Study||2
7567557|NCT02882711|18626670|P1|STARTED|Overall Study||6
7567558|NCT02882633|18626678|P2|NOT COMPLETED|Overall Study||0
7567559|NCT02882633|18626679|P1|NOT COMPLETED|Overall Study||2
7567560|NCT02882633|18626678|P2|COMPLETED|Overall Study||25
7567561|NCT02882633|18626679|P1|COMPLETED|Overall Study||23
7567562|NCT02882633|18626678|P2|STARTED|Overall Study||25
7567563|NCT02882633|18626679|P1|STARTED|Overall Study||25
7567564|NCT02882152|18626691|P2|NOT COMPLETED|Overall Study||0
7567565|NCT02882152|18626692|P1|NOT COMPLETED|Overall Study||1
7567566|NCT02882152|18626691|P2|COMPLETED|Overall Study||20
7567567|NCT02882152|18626692|P1|COMPLETED|Overall Study||19
7567568|NCT02882152|18626691|P2|STARTED|Overall Study||20
7567569|NCT02882152|18626692|P1|STARTED|Overall Study||20
7567570|NCT02881957|18626702|P2|NOT COMPLETED|Overall Study||4
7567571|NCT02881957|18626703|P1|NOT COMPLETED|Overall Study||3
7567572|NCT02881957|18626702|P2|COMPLETED|Overall Study||134
7567573|NCT02881957|18626703|P1|COMPLETED|Overall Study||133
7567574|NCT02881957|18626702|P2|STARTED|Overall Study||138
7567575|NCT02881957|18626703|P1|STARTED|Overall Study||136
7567576|NCT02881840|18626727|P1|NOT COMPLETED|Overall Study||0
7567577|NCT02881840|18626727|P1|COMPLETED|Overall Study||6
7567578|NCT02881840|18626727|P1|STARTED|Overall Study||6
7567579|NCT02881775|18626731|P2|NOT COMPLETED|Second Intervention (1-Hour Session)||0
7567580|NCT02881775|18626732|P1|NOT COMPLETED|Second Intervention (1-Hour Session)||0
7567581|NCT02881775|18626731|P2|COMPLETED|Second Intervention (1-Hour Session)||7
7567582|NCT02881775|18626732|P1|COMPLETED|Second Intervention (1-Hour Session)||9
7567583|NCT02881775|18626731|P2|STARTED|Second Intervention (1-Hour Session)||7
7567584|NCT02881775|18626732|P1|STARTED|Second Intervention (1-Hour Session)||9
7567585|NCT02881775|18626731|P2|NOT COMPLETED|Washout (1 Week)||0
7567586|NCT02881775|18626732|P1|NOT COMPLETED|Washout (1 Week)||0
7567587|NCT02881775|18626731|P2|COMPLETED|Washout (1 Week)||7
7567588|NCT02881775|18626732|P1|COMPLETED|Washout (1 Week)||9
7567589|NCT02881775|18626731|P2|STARTED|Washout (1 Week)||7
7567590|NCT02881775|18626732|P1|STARTED|Washout (1 Week)||9
7567591|NCT02881775|18626731|P2|NOT COMPLETED|First Intervention (1-hr Session)||0
7567592|NCT02881775|18626732|P1|NOT COMPLETED|First Intervention (1-hr Session)||0
7567593|NCT02881775|18626731|P2|COMPLETED|First Intervention (1-hr Session)||7
7567594|NCT02881775|18626732|P1|COMPLETED|First Intervention (1-hr Session)||9
7567595|NCT02881775|18626731|P2|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|7
7567596|NCT02881775|18626732|P1|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|9
7567597|NCT02881775|18626731|P2|NOT COMPLETED|Baseline||0
7567598|NCT02881775|18626732|P1|NOT COMPLETED|Baseline||0
7567599|NCT02881775|18626731|P2|COMPLETED|Baseline||9
7567600|NCT02881775|18626732|P1|COMPLETED|Baseline||11
7567601|NCT02881775|18626731|P2|STARTED|Baseline||9
7567602|NCT02881775|18626732|P1|STARTED|Baseline||11
7567603|NCT02881658|18626754|P2|NOT COMPLETED|Overall Study||5
7567604|NCT02881658|18626755|P1|NOT COMPLETED|Overall Study||2
7567605|NCT02881658|18626754|P2|COMPLETED|Overall Study||96
7567606|NCT02881658|18626755|P1|COMPLETED|Overall Study||98
7567607|NCT02881658|18626754|P2|STARTED|Overall Study||101
7567608|NCT02881658|18626755|P1|STARTED|Overall Study||100
7567609|NCT02881567|18626789|P1|NOT COMPLETED|Overall Study||18
7567610|NCT02881567|18626789|P1|COMPLETED|Overall Study||23
7567611|NCT02881567|18626789|P1|STARTED|Overall Study||41
7567612|NCT02881112|18626801|P1|NOT COMPLETED|Overall Study||28
7567613|NCT02881112|18626801|P1|COMPLETED|Overall Study||152
7567614|NCT02881112|18626801|P1|STARTED|Overall Study||180
7567615|NCT02881047|18626805|P1|NOT COMPLETED|Overall Study||2
7567616|NCT02881047|18626805|P1|COMPLETED|Overall Study||6
7567617|NCT02881047|18626805|P1|STARTED|Overall Study||8
7567618|NCT02881008|18626817|P6|NOT COMPLETED|Overall Study||0
7567619|NCT02881008|18626818|P5|NOT COMPLETED|Overall Study||0
7567620|NCT02881008|18626819|P4|NOT COMPLETED|Overall Study||0
7567621|NCT02881008|18626820|P3|NOT COMPLETED|Overall Study||0
7567622|NCT02881008|18626821|P2|NOT COMPLETED|Overall Study||0
7567623|NCT02881008|18626822|P1|NOT COMPLETED|Overall Study||0
7567624|NCT02881008|18626817|P6|COMPLETED|Overall Study||8
7567625|NCT02881008|18626818|P5|COMPLETED|Overall Study||8
7567626|NCT02881008|18626819|P4|COMPLETED|Overall Study||8
7567627|NCT02881008|18626820|P3|COMPLETED|Overall Study||8
7567628|NCT02881008|18626821|P2|COMPLETED|Overall Study||8
7567629|NCT02881008|18626822|P1|COMPLETED|Overall Study||8
7567630|NCT02881008|18626817|P6|STARTED|Overall Study||8
7567631|NCT02881008|18626818|P5|STARTED|Overall Study||8
7567632|NCT02881008|18626819|P4|STARTED|Overall Study||8
7567633|NCT02881008|18626820|P3|STARTED|Overall Study||8
7567634|NCT02881008|18626821|P2|STARTED|Overall Study||8
7567635|NCT02881008|18626822|P1|STARTED|Overall Study||8
7567636|NCT02880865|18626857|P2|NOT COMPLETED|Overall Study||3
7567637|NCT02880865|18626858|P1|NOT COMPLETED|Overall Study||1
7567638|NCT02880865|18626857|P2|COMPLETED|Overall Study||311
7567639|NCT02880865|18626858|P1|COMPLETED|Overall Study||313
7567640|NCT02880865|18626857|P2|Received MMR Dose 2|Overall Study||311
7567641|NCT02880865|18626858|P1|Received MMR Dose 2|Overall Study||313
7567642|NCT02880865|18626857|P2|Received CD-JEV|Overall Study||309
7567643|NCT02880865|18626858|P1|Received CD-JEV|Overall Study||314
7567644|NCT02880865|18626857|P2|Received MMR Dose 1|Overall Study||314
7567645|NCT02880865|18626858|P1|Received MMR Dose 1|Overall Study||314
7567646|NCT02880865|18626857|P2|STARTED|Overall Study||314
7567647|NCT02880865|18626858|P1|STARTED|Overall Study||314
7567648|NCT02880852|18626913|P1|NOT COMPLETED|Overall Study||0
7567649|NCT02880852|18626913|P1|COMPLETED|Overall Study||20
7567650|NCT02880852|18626913|P1|STARTED|Overall Study||20
7567651|NCT02880761|18626941|P2|NOT COMPLETED|Overall Study||21
7567652|NCT02880761|18626942|P1|NOT COMPLETED|Overall Study||16
7567653|NCT02880761|18626941|P2|COMPLETED|Overall Study||85
7567654|NCT02880761|18626942|P1|COMPLETED|Overall Study||87
7567655|NCT02880761|18626941|P2|STARTED|Overall Study||106
7567656|NCT02880761|18626942|P1|STARTED|Overall Study||103
7567657|NCT02880514|18626952|P2|NOT COMPLETED|Overall Study||0
7567658|NCT02880514|18626953|P1|NOT COMPLETED|Overall Study||0
7567659|NCT02880514|18626952|P2|COMPLETED|Overall Study||50
7567660|NCT02880514|18626953|P1|COMPLETED|Overall Study||50
7567661|NCT02880514|18626952|P2|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the control group|50
7567662|NCT02880514|18626953|P1|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the treatment group|50
7567663|NCT02880475|18626962|P2|NOT COMPLETED|Overall Study||0
7567664|NCT02880475|18626963|P1|NOT COMPLETED|Overall Study||0
7567665|NCT02880475|18626962|P2|COMPLETED|Overall Study||17
7567666|NCT02880475|18626963|P1|COMPLETED|Overall Study||13
7567667|NCT02880475|18626962|P2|STARTED|Overall Study||17
7567668|NCT02880475|18626963|P1|STARTED|Overall Study||13
7567669|NCT02880254|18627097|P2|NOT COMPLETED|Overall Study||10
7567670|NCT02880254|18627098|P1|NOT COMPLETED|Overall Study||9
7567671|NCT02880254|18627097|P2|COMPLETED|Overall Study||4
7567672|NCT02880254|18627098|P1|COMPLETED|Overall Study||4
7567673|NCT02880254|18627097|P2|STARTED|Overall Study||14
7567674|NCT02880254|18627098|P1|STARTED|Overall Study||13
7567675|NCT02880228|18627106|P1|NOT COMPLETED|Overall Study||0
7567676|NCT02880228|18627106|P1|COMPLETED|Overall Study||11
7567677|NCT02880228|18627106|P1|STARTED|Overall Study||11
7567678|NCT02880189|18627114|P1|NOT COMPLETED|Overall Study||0
7567679|NCT02880189|18627114|P1|COMPLETED|Overall Study||21
7567680|NCT02880189|18627114|P1|STARTED|Overall Study||21
7567681|NCT02880137|18627119|P1|NOT COMPLETED|Overall Study||0
7567682|NCT02880137|18627119|P1|COMPLETED|Overall Study||36
7567683|NCT02880137|18627119|P1|STARTED|Overall Study||36
7567684|NCT02879812|18627125|P2|NOT COMPLETED|Overall Study||1451
7567685|NCT02879812|18627126|P1|NOT COMPLETED|Overall Study||1217
7567686|NCT02879812|18627125|P2|COMPLETED|Overall Study||21029
7567687|NCT02879812|18627126|P1|COMPLETED|Overall Study||22153
7567688|NCT02879812|18627125|P2|STARTED|Overall Study||22480
7567689|NCT02879812|18627126|P1|STARTED|Overall Study||23370
7567690|NCT02879747|18627145|P3|NOT COMPLETED|Overall Study||2
7567691|NCT02879747|18627146|P2|NOT COMPLETED|Overall Study||6
7567692|NCT02879747|18627147|P1|NOT COMPLETED|Overall Study||4
7567693|NCT02879747|18627145|P3|COMPLETED|Overall Study||31
7567694|NCT02879747|18627146|P2|COMPLETED|Overall Study||32
7567695|NCT02879747|18627147|P1|COMPLETED|Overall Study||23
7567696|NCT02879747|18627145|P3|STARTED|Overall Study||33
7567697|NCT02879747|18627146|P2|STARTED|Overall Study||38
7567698|NCT02879747|18627147|P1|STARTED|Overall Study||27
7567699|NCT02879032|18627164|P1|NOT COMPLETED|Overall Study||0
7567700|NCT02879032|18627164|P1|COMPLETED|Overall Study||130
7567701|NCT02879032|18627164|P1|STARTED|Overall Study||130
7567702|NCT02878590|18627170|P1|NOT COMPLETED|Overall Study||2
7567703|NCT02878590|18627170|P1|COMPLETED|Overall Study||10
7567704|NCT02878590|18627170|P1|STARTED|Overall Study||12
7567705|NCT02878486|18627176|P2|NOT COMPLETED|Overall Study||0
7567706|NCT02878486|18627177|P1|NOT COMPLETED|Overall Study||0
7567707|NCT02878486|18627176|P2|COMPLETED|Overall Study||3
7567708|NCT02878486|18627177|P1|COMPLETED|Overall Study||3
7567709|NCT02878486|18627176|P2|STARTED|Overall Study||3
7567710|NCT02878486|18627177|P1|STARTED|Overall Study||3
7567711|NCT02878382|18627193|P2|NOT COMPLETED|Overall Study||0
7567712|NCT02878382|18627194|P1|NOT COMPLETED|Overall Study||0
7567713|NCT02878382|18627193|P2|COMPLETED|Overall Study||20
7567714|NCT02878382|18627194|P1|COMPLETED|Overall Study||20
7567715|NCT02878382|18627193|P2|STARTED|Overall Study|otal 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
7567716|NCT02878382|18627194|P1|STARTED|Overall Study|total 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
7567717|NCT02878330|18627208|P2|NOT COMPLETED|Overall Study||56
7567718|NCT02878330|18627209|P1|NOT COMPLETED|Overall Study||29
7567719|NCT02878330|18627208|P2|COMPLETED|Overall Study||913
7567720|NCT02878330|18627209|P1|COMPLETED|Overall Study||455
7567721|NCT02878330|18627208|P2|STARTED|Overall Study||969
7567722|NCT02878330|18627209|P1|STARTED|Overall Study||484
7567723|NCT02878213|18627225|P1|NOT COMPLETED|Overall Study||3
7567724|NCT02878213|18627225|P1|COMPLETED|Overall Study||36
7567725|NCT02878213|18627225|P1|STARTED|Overall Study||39
7567726|NCT02877927|18627232|P2|NOT COMPLETED|Overall Study||57
7567727|NCT02877927|18627233|P1|NOT COMPLETED|Overall Study||54
7567728|NCT02877927|18627232|P2|COMPLETED|Overall Study||310
7567729|NCT02877927|18627233|P1|COMPLETED|Overall Study||314
7567730|NCT02877927|18627232|P2|STARTED|Overall Study||367
7567731|NCT02877927|18627233|P1|STARTED|Overall Study||368
7567732|NCT02877732|18627245|P2|NOT COMPLETED|Overall Study||6
7567733|NCT02877732|18627246|P1|NOT COMPLETED|Overall Study||6
7567734|NCT02877732|18627245|P2|COMPLETED|Overall Study||0
7567735|NCT02877732|18627246|P1|COMPLETED|Overall Study||0
7567736|NCT02877732|18627245|P2|STARTED|Overall Study||6
7567737|NCT02877732|18627246|P1|STARTED|Overall Study||6
7567738|NCT02877680|18627264|P2|NOT COMPLETED|Overall Study||1
7567739|NCT02877680|18627265|P1|NOT COMPLETED|Overall Study||1
7567740|NCT02877680|18627264|P2|COMPLETED|Overall Study||24
7567741|NCT02877680|18627265|P1|COMPLETED|Overall Study||54
7567742|NCT02877680|18627264|P2|STARTED|Overall Study||25
7567743|NCT02877680|18627265|P1|STARTED|Overall Study||55
7567744|NCT02877485|18627306|P2|NOT COMPLETED|Overall Study||0
7567745|NCT02877485|18627307|P1|NOT COMPLETED|Overall Study||0
7567746|NCT02877485|18627306|P2|COMPLETED|Overall Study||20
7567747|NCT02877485|18627307|P1|COMPLETED|Overall Study||22
7567748|NCT02877485|18627306|P2|STARTED|Overall Study||20
7567749|NCT02877485|18627307|P1|STARTED|Overall Study||22
7567750|NCT02877095|18627316|P2|NOT COMPLETED|Overall Study||0
7567751|NCT02877095|18627317|P1|NOT COMPLETED|Overall Study||0
7567752|NCT02877095|18627316|P2|COMPLETED|Overall Study||20
7567753|NCT02877095|18627317|P1|COMPLETED|Overall Study||20
7567754|NCT02877095|18627316|P2|STARTED|Overall Study||20
7567755|NCT02877095|18627317|P1|STARTED|Overall Study|First patient enrolled 1/9/17.|20
7567756|NCT02877082|18627323|P1|NOT COMPLETED|Overall Study||5
7567757|NCT02877082|18627323|P1|COMPLETED|Overall Study||0
7567758|NCT02877082|18627323|P1|STARTED|Overall Study||5
7567759|NCT02877004|18627334|P3|NOT COMPLETED|Overall Study||1
7567760|NCT02877004|18627335|P2|NOT COMPLETED|Overall Study||0
7567761|NCT02877004|18627336|P1|NOT COMPLETED|Overall Study||0
7567762|NCT02877004|18627334|P3|COMPLETED|Overall Study||19
7567763|NCT02877004|18627335|P2|COMPLETED|Overall Study||20
7567764|NCT02877004|18627336|P1|COMPLETED|Overall Study||20
7567765|NCT02877004|18627334|P3|STARTED|Overall Study||20
7567766|NCT02877004|18627335|P2|STARTED|Overall Study||20
7567767|NCT02877004|18627336|P1|STARTED|Overall Study||20
7567768|NCT02876926|18627350|P3|NOT COMPLETED|Overall Study||20
7567769|NCT02876926|18627351|P2|NOT COMPLETED|Overall Study||19
7567770|NCT02876926|18627352|P1|NOT COMPLETED|Overall Study||18
7567771|NCT02876926|18627350|P3|COMPLETED|Overall Study||2
7567772|NCT02876926|18627351|P2|COMPLETED|Overall Study||3
7567773|NCT02876926|18627352|P1|COMPLETED|Overall Study||3
7567774|NCT02876926|18627350|P3|STARTED|Overall Study||22
7567775|NCT02876926|18627351|P2|STARTED|Overall Study||22
7567776|NCT02876926|18627352|P1|STARTED|Overall Study||21
7567777|NCT02876900|18627369|P3|NOT COMPLETED|Overall Study||44
7567778|NCT02876900|18627370|P2|NOT COMPLETED|Overall Study||48
7567779|NCT02876900|18627371|P1|NOT COMPLETED|Overall Study||39
7567780|NCT02876900|18627369|P3|COMPLETED|Overall Study||162
7567781|NCT02876900|18627370|P2|COMPLETED|Overall Study||158
7567782|NCT02876900|18627371|P1|COMPLETED|Overall Study||166
7567783|NCT02876900|18627369|P3|STARTED|Overall Study||206
7567784|NCT02876900|18627370|P2|STARTED|Overall Study||206
7567785|NCT02876900|18627371|P1|STARTED|Overall Study||205
7567786|NCT02876887|18627384|P2|NOT COMPLETED|Overall Study||0
7567787|NCT02876887|18627385|P1|NOT COMPLETED|Overall Study||4
7567788|NCT02876887|18627384|P2|COMPLETED|Overall Study||21
7567789|NCT02876887|18627385|P1|COMPLETED|Overall Study||19
7567790|NCT02876887|18627384|P2|STARTED|Overall Study||21
7567791|NCT02876887|18627385|P1|STARTED|Overall Study||23
7567792|NCT02876757|18627405|P2|NOT COMPLETED|Overall Study||0
7567793|NCT02876757|18627406|P1|NOT COMPLETED|Overall Study||0
7567794|NCT02876757|18627405|P2|COMPLETED|Overall Study||93197
7567795|NCT02876757|18627406|P1|COMPLETED|Overall Study||93197
7567796|NCT02876757|18627405|P2|STARTED|Overall Study||93197
7567797|NCT02876757|18627406|P1|STARTED|Overall Study||93197
7567798|NCT02876601|18627420|P4|NOT COMPLETED|Second Intervention (24 Hours)||0
7567799|NCT02876601|18627421|P3|NOT COMPLETED|Second Intervention (24 Hours)||0
7567800|NCT02876601|18627422|P2|NOT COMPLETED|Second Intervention (24 Hours)||0
7567801|NCT02876601|18627423|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
7567802|NCT02876601|18627420|P4|COMPLETED|Second Intervention (24 Hours)||2
7567803|NCT02876601|18627421|P3|COMPLETED|Second Intervention (24 Hours)||1
7567804|NCT02876601|18627422|P2|COMPLETED|Second Intervention (24 Hours)||8
7567805|NCT02876601|18627423|P1|COMPLETED|Second Intervention (24 Hours)||8
7567806|NCT02876601|18627420|P4|STARTED|Second Intervention (24 Hours)||2
7567807|NCT02876601|18627421|P3|STARTED|Second Intervention (24 Hours)||1
7567808|NCT02876601|18627422|P2|STARTED|Second Intervention (24 Hours)||8
7567809|NCT02876601|18627423|P1|STARTED|Second Intervention (24 Hours)||8
7567810|NCT02876601|18627420|P4|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
7567811|NCT02876601|18627421|P3|NOT COMPLETED|Washout (Minimum of 6 Weeks)||1
7567812|NCT02876601|18627422|P2|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
7567813|NCT02876601|18627423|P1|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
7567814|NCT02876601|18627420|P4|COMPLETED|Washout (Minimum of 6 Weeks)||2
7567815|NCT02876601|18627421|P3|COMPLETED|Washout (Minimum of 6 Weeks)||1
7567816|NCT02876601|18627422|P2|COMPLETED|Washout (Minimum of 6 Weeks)||8
7567817|NCT02876601|18627423|P1|COMPLETED|Washout (Minimum of 6 Weeks)||8
7567818|NCT02876601|18627420|P4|STARTED|Washout (Minimum of 6 Weeks)||2
7567819|NCT02876601|18627421|P3|STARTED|Washout (Minimum of 6 Weeks)||2
7567820|NCT02876601|18627422|P2|STARTED|Washout (Minimum of 6 Weeks)||8
7567821|NCT02876601|18627423|P1|STARTED|Washout (Minimum of 6 Weeks)||8
7567822|NCT02876601|18627420|P4|NOT COMPLETED|First Intervention (24 Hours)||0
7567823|NCT02876601|18627421|P3|NOT COMPLETED|First Intervention (24 Hours)||0
7567824|NCT02876601|18627422|P2|NOT COMPLETED|First Intervention (24 Hours)||0
7567825|NCT02876601|18627423|P1|NOT COMPLETED|First Intervention (24 Hours)||0
7567826|NCT02876601|18627420|P4|COMPLETED|First Intervention (24 Hours)||2
7567827|NCT02876601|18627421|P3|COMPLETED|First Intervention (24 Hours)||2
7567828|NCT02876601|18627422|P2|COMPLETED|First Intervention (24 Hours)||8
7567829|NCT02876601|18627423|P1|COMPLETED|First Intervention (24 Hours)||8
7567830|NCT02876601|18627420|P4|STARTED|First Intervention (24 Hours)||2
7567831|NCT02876601|18627421|P3|STARTED|First Intervention (24 Hours)||2
7567832|NCT02876601|18627422|P2|STARTED|First Intervention (24 Hours)||8
7567833|NCT02876601|18627423|P1|STARTED|First Intervention (24 Hours)||8
7567834|NCT02876575|18627473|P1|NOT COMPLETED|Overall Study||0
7567835|NCT02876575|18627473|P1|COMPLETED|Overall Study||48
7567836|NCT02876575|18627473|P1|STARTED|Overall Study||48
7567837|NCT02876159|18627489|P2|NOT COMPLETED|Overall Study||0
7567838|NCT02876159|18627490|P1|NOT COMPLETED|Overall Study||0
7567839|NCT02876159|18627489|P2|COMPLETED|Overall Study||10
7567840|NCT02876159|18627490|P1|COMPLETED|Overall Study||10
7567841|NCT02876159|18627489|P2|STARTED|Overall Study||10
7567842|NCT02876159|18627490|P1|STARTED|Overall Study||10
7567843|NCT02876055|18627509|P3|NOT COMPLETED|Overall Study||0
7567844|NCT02876055|18627510|P2|NOT COMPLETED|Overall Study||0
7567845|NCT02876055|18627511|P1|NOT COMPLETED|Overall Study||0
7567846|NCT02876055|18627509|P3|COMPLETED|Overall Study||42
7567847|NCT02876055|18627510|P2|COMPLETED|Overall Study||41
7567848|NCT02876055|18627511|P1|COMPLETED|Overall Study||42
7567849|NCT02876055|18627509|P3|STARTED|Overall Study||42
7567850|NCT02876055|18627510|P2|STARTED|Overall Study||41
7567851|NCT02876055|18627511|P1|STARTED|Overall Study||42
7567852|NCT02875977|18627521|P2|NOT COMPLETED|Overall Study||29
7567853|NCT02875977|18627522|P1|NOT COMPLETED|Overall Study||42
7567854|NCT02875977|18627521|P2|COMPLETED|Overall Study||71
7567855|NCT02875977|18627522|P1|COMPLETED|Overall Study||58
7567856|NCT02875977|18627521|P2|STARTED|Overall Study||100
7567857|NCT02875977|18627522|P1|STARTED|Overall Study||100
7567858|NCT02875834|18627540|P4|NOT COMPLETED|Randomized Treatment Phase||9
7567859|NCT02875834|18627541|P3|NOT COMPLETED|Randomized Treatment Phase||11
7567860|NCT02875834|18627542|P2|NOT COMPLETED|Randomized Treatment Phase||14
7567861|NCT02875834|18627543|P1|NOT COMPLETED|Randomized Treatment Phase||0
7567862|NCT02875834|18627540|P4|COMPLETED|Randomized Treatment Phase||41
7567863|NCT02875834|18627541|P3|COMPLETED|Randomized Treatment Phase||88
7567864|NCT02875834|18627542|P2|COMPLETED|Randomized Treatment Phase||85
7567865|NCT02875834|18627543|P1|COMPLETED|Randomized Treatment Phase||0
7567866|NCT02875834|18627540|P4|STARTED|Randomized Treatment Phase|50 subjects were randomized in placebo group in RTP.|50
7567867|NCT02875834|18627541|P3|STARTED|Randomized Treatment Phase|99 subjects were randomized in 10g QD group in RTP.|99
7567868|NCT02875834|18627542|P2|STARTED|Randomized Treatment Phase|99 subjects were randomized in 5g QD group in RTP.|99
7567869|NCT02875834|18627543|P1|STARTED|Randomized Treatment Phase|No subjects were randomized in 10g TID group in RTP.|0
7567870|NCT02875834|18627540|P4|NOT COMPLETED|Open-label Phase||0
7567871|NCT02875834|18627541|P3|NOT COMPLETED|Open-label Phase||0
7567872|NCT02875834|18627542|P2|NOT COMPLETED|Open-label Phase||0
7567873|NCT02875834|18627543|P1|NOT COMPLETED|Open-label Phase||7
7567874|NCT02875834|18627540|P4|COMPLETED|Open-label Phase||0
7567875|NCT02875834|18627541|P3|COMPLETED|Open-label Phase||0
7567876|NCT02875834|18627542|P2|COMPLETED|Open-label Phase||0
7567877|NCT02875834|18627543|P1|COMPLETED|Open-label Phase||260
7567878|NCT02875834|18627540|P4|STARTED|Open-label Phase||0
7567879|NCT02875834|18627541|P3|STARTED|Open-label Phase||0
7567880|NCT02875834|18627542|P2|STARTED|Open-label Phase||0
7567881|NCT02875834|18627543|P1|STARTED|Open-label Phase||267
7567882|NCT02875613|18627601|P1|NOT COMPLETED|Overall Study||1
7567883|NCT02875613|18627601|P1|COMPLETED|Overall Study||4
7567884|NCT02875613|18627601|P1|STARTED|Overall Study||5
7567885|NCT02875366|18627607|P2|NOT COMPLETED|Overall Study||3
7567886|NCT02875366|18627608|P1|NOT COMPLETED|Overall Study||0
7567887|NCT02875366|18627607|P2|COMPLETED|Overall Study||31
7567888|NCT02875366|18627608|P1|COMPLETED|Overall Study||36
7567889|NCT02875366|18627607|P2|STARTED|Overall Study||34
7567890|NCT02875366|18627608|P1|STARTED|Overall Study||36
7567891|NCT02875340|18627660|P1|NOT COMPLETED|Overall Study||8
7567892|NCT02875340|18627660|P1|COMPLETED|Overall Study|No patients completed 6 months of continuous treatment|0
7567893|NCT02875340|18627660|P1|STARTED|Overall Study||8
7567894|NCT02875067|18627682|P1|NOT COMPLETED|Overall Study||6
7567895|NCT02875067|18627682|P1|COMPLETED|Overall Study||0
7567896|NCT02875067|18627682|P1|STARTED|Overall Study||6
7567897|NCT02875028|18627697|P2|NOT COMPLETED|Second Intervention (24 Hours)||0
7567898|NCT02875028|18627698|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
7567899|NCT02875028|18627697|P2|COMPLETED|Second Intervention (24 Hours)||7
7567900|NCT02875028|18627698|P1|COMPLETED|Second Intervention (24 Hours)||8
7567901|NCT02875028|18627697|P2|STARTED|Second Intervention (24 Hours)||7
7567902|NCT02875028|18627698|P1|STARTED|Second Intervention (24 Hours)||8
7567903|NCT02875028|18627697|P2|NOT COMPLETED|Washout Period||1
7567904|NCT02875028|18627698|P1|NOT COMPLETED|Washout Period||0
7567905|NCT02875028|18627697|P2|COMPLETED|Washout Period||7
7567906|NCT02875028|18627698|P1|COMPLETED|Washout Period||8
7567907|NCT02875028|18627697|P2|STARTED|Washout Period||8
7567908|NCT02875028|18627698|P1|STARTED|Washout Period||8
7567909|NCT02875028|18627697|P2|NOT COMPLETED|First Intervention (24 Hours)||0
7567910|NCT02875028|18627698|P1|NOT COMPLETED|First Intervention (24 Hours)||0
7567911|NCT02875028|18627697|P2|COMPLETED|First Intervention (24 Hours)||8
7567912|NCT02875028|18627698|P1|COMPLETED|First Intervention (24 Hours)||8
7567913|NCT02875028|18627697|P2|STARTED|First Intervention (24 Hours)||8
7567914|NCT02875028|18627698|P1|STARTED|First Intervention (24 Hours)||8
7567915|NCT02874924|18627729|P3|NOT COMPLETED|Overall Study||0
7567916|NCT02874924|18627730|P2|NOT COMPLETED|Overall Study||0
7567917|NCT02874924|18627731|P1|NOT COMPLETED|Overall Study||3
7567918|NCT02874924|18627729|P3|COMPLETED|Overall Study||6
7567919|NCT02874924|18627730|P2|COMPLETED|Overall Study||14
7567920|NCT02874924|18627731|P1|COMPLETED|Overall Study||11
7567921|NCT02874924|18627729|P3|STARTED|Overall Study||6
7567922|NCT02874924|18627730|P2|STARTED|Overall Study||14
7567923|NCT02874924|18627731|P1|STARTED|Overall Study||14
7567924|NCT02874846|18627753|P2|NOT COMPLETED|Overall Study||0
7567925|NCT02874846|18627754|P1|NOT COMPLETED|Overall Study||0
7567926|NCT02874846|18627753|P2|COMPLETED|Overall Study||4
7567927|NCT02874846|18627754|P1|COMPLETED|Overall Study||8
7567928|NCT02874846|18627753|P2|STARTED|Overall Study||4
7567929|NCT02874846|18627754|P1|STARTED|Overall Study||8
7567930|NCT02874794|18627764|P2|NOT COMPLETED|Overall Study||11
7567931|NCT02874794|18627765|P1|NOT COMPLETED|Overall Study||7
7567932|NCT02874794|18627764|P2|COMPLETED|Overall Study||221
7567933|NCT02874794|18627765|P1|COMPLETED|Overall Study||226
7567934|NCT02874794|18627764|P2|STARTED|Overall Study||232
7567935|NCT02874794|18627765|P1|STARTED|Overall Study||233
7567936|NCT02874742|18627797|P3|NOT COMPLETED|Overall Study||16
7567937|NCT02874742|18627798|P2|NOT COMPLETED|Overall Study||104
7567938|NCT02874742|18627799|P1|NOT COMPLETED|Overall Study||103
7567939|NCT02874742|18627797|P3|COMPLETED|Overall Study||0
7567940|NCT02874742|18627798|P2|COMPLETED|Overall Study||0
7567941|NCT02874742|18627799|P1|COMPLETED|Overall Study||0
7567942|NCT02874742|18627797|P3|Safety|Overall Study||16
7567943|NCT02874742|18627798|P2|Safety|Overall Study||99
7567944|NCT02874742|18627799|P1|Safety|Overall Study||102
7567945|NCT02874742|18627797|P3|STARTED|Overall Study||16
7567946|NCT02874742|18627798|P2|STARTED|Overall Study||104
7567947|NCT02874742|18627799|P1|STARTED|Overall Study||103
7567948|NCT02874534|18627853|P2|NOT COMPLETED|Overall Study||11
7567949|NCT02874534|18627854|P1|NOT COMPLETED|Overall Study||8
7567950|NCT02874534|18627853|P2|COMPLETED|Overall Study||15
7567951|NCT02874534|18627854|P1|COMPLETED|Overall Study||23
7567952|NCT02874534|18627853|P2|STARTED|Overall Study||26
7567953|NCT02874534|18627854|P1|STARTED|Overall Study||31
7567954|NCT02874404|18627862|P1|NOT COMPLETED|Overall Study||0
7567955|NCT02874404|18627862|P1|COMPLETED|Overall Study||13
7567956|NCT02874404|18627862|P1|STARTED|Overall Study||13
7567957|NCT02874066|18627868|P1|NOT COMPLETED|Overall Study||0
7567958|NCT02874066|18627868|P1|COMPLETED|Overall Study||46
7567959|NCT02874066|18627868|P1|STARTED|Overall Study||46
7567960|NCT02873923|18627876|P1|NOT COMPLETED|Overall Study||0
7567961|NCT02873923|18627876|P1|COMPLETED|Overall Study||2846
7567962|NCT02873923|18627876|P1|STARTED|Overall Study||2846
7567963|NCT02873754|18627883|P1|NOT COMPLETED|Overall Study||6
7567964|NCT02873754|18627883|P1|COMPLETED|Overall Study||5
7567965|NCT02873754|18627883|P1|STARTED|Overall Study||11
7567966|NCT02873702|18627900|P4|NOT COMPLETED|Maintenance Period (up to Month 6)||2
7567967|NCT02873702|18627901|P3|NOT COMPLETED|Maintenance Period (up to Month 6)||7
7567968|NCT02873702|18627902|P2|NOT COMPLETED|Maintenance Period (up to Month 6)||0
7567969|NCT02873702|18627903|P1|NOT COMPLETED|Maintenance Period (up to Month 6)||0
7567970|NCT02873702|18627900|P4|COMPLETED|Maintenance Period (up to Month 6)||6
7567971|NCT02873702|18627901|P3|COMPLETED|Maintenance Period (up to Month 6)||1
7567972|NCT02873702|18627902|P2|COMPLETED|Maintenance Period (up to Month 6)||0
7567973|NCT02873702|18627903|P1|COMPLETED|Maintenance Period (up to Month 6)||0
7567974|NCT02873702|18627900|P4|STARTED|Maintenance Period (up to Month 6)||8
7567975|NCT02873702|18627901|P3|STARTED|Maintenance Period (up to Month 6)||8
7567976|NCT02873702|18627902|P2|STARTED|Maintenance Period (up to Month 6)||0
7567977|NCT02873702|18627903|P1|STARTED|Maintenance Period (up to Month 6)||0
7567978|NCT02873702|18627900|P4|NOT COMPLETED|Healing Period (up to Week 8)||0
7567979|NCT02873702|18627901|P3|NOT COMPLETED|Healing Period (up to Week 8)||0
7567980|NCT02873702|18627902|P2|NOT COMPLETED|Healing Period (up to Week 8)||1
7567981|NCT02873702|18627903|P1|NOT COMPLETED|Healing Period (up to Week 8)||1
7567982|NCT02873702|18627900|P4|COMPLETED|Healing Period (up to Week 8)||0
7567983|NCT02873702|18627901|P3|COMPLETED|Healing Period (up to Week 8)||0
7567984|NCT02873702|18627902|P2|COMPLETED|Healing Period (up to Week 8)||16
7567985|NCT02873702|18627903|P1|COMPLETED|Healing Period (up to Week 8)||19
7567986|NCT02873702|18627900|P4|STARTED|Healing Period (up to Week 8)||0
7567987|NCT02873702|18627901|P3|STARTED|Healing Period (up to Week 8)||0
7567988|NCT02873702|18627902|P2|STARTED|Healing Period (up to Week 8)||17
7567989|NCT02873702|18627903|P1|STARTED|Healing Period (up to Week 8)||20
7567990|NCT02873689|18627915|P2|NOT COMPLETED|Overall Study||5
7567991|NCT02873689|18627916|P1|NOT COMPLETED|Overall Study||7
7567992|NCT02873689|18627915|P2|COMPLETED|Overall Study||103
7567993|NCT02873689|18627916|P1|COMPLETED|Overall Study||102
7567994|NCT02873689|18627915|P2|Treated|Overall Study||107
7567995|NCT02873689|18627916|P1|Treated|Overall Study||108
7567996|NCT02873689|18627915|P2|STARTED|Overall Study||108
7567997|NCT02873689|18627916|P1|STARTED|Overall Study||109
7567998|NCT02873585|18627924|P1|NOT COMPLETED|Overall Study||0
7567999|NCT02873585|18627924|P1|COMPLETED|Overall Study||32
7568000|NCT02873585|18627924|P1|STARTED|Overall Study||32
7568001|NCT02873481|18627939|P2|NOT COMPLETED|Overall Study||0
7568002|NCT02873481|18627940|P1|NOT COMPLETED|Overall Study||0
7568003|NCT02873481|18627939|P2|COMPLETED|Overall Study||17
7568004|NCT02873481|18627940|P1|COMPLETED|Overall Study||15
7568005|NCT02873481|18627939|P2|STARTED|Overall Study||17
7568006|NCT02873481|18627940|P1|STARTED|Overall Study||15
7568007|NCT02873429|18627957|P2|NOT COMPLETED|16 Weeks||2
7568008|NCT02873429|18627958|P1|NOT COMPLETED|16 Weeks||5
7568009|NCT02873429|18627957|P2|COMPLETED|16 Weeks||96
7568010|NCT02873429|18627958|P1|COMPLETED|16 Weeks||100
7568011|NCT02873429|18627957|P2|STARTED|16 Weeks|1 Conv. participant Missed 6-8 week but was eligible for 16 week|98
7568012|NCT02873429|18627958|P1|STARTED|16 Weeks|10 CAM participants Missed 6-8 week but are eligible for 16 week|105
7568013|NCT02873429|18627957|P2|NOT COMPLETED|6-8 Weeks||1
7568014|NCT02873429|18627958|P1|NOT COMPLETED|6-8 Weeks||10
7568015|NCT02873429|18627957|P2|COMPLETED|6-8 Weeks||97
7568016|NCT02873429|18627958|P1|COMPLETED|6-8 Weeks||95
7568105|NCT02873104|18628269|P1|COMPLETED|Overall Study||46
7568017|NCT02873429|18627957|P2|STARTED|6-8 Weeks|2 Con. participants not eligible to complete follow ups because they did not continue treatment.|98
7568018|NCT02873429|18627958|P1|STARTED|6-8 Weeks|4 CAM participants not eligible to complete follow ups because they did not continue treatment.|105
7568019|NCT02873429|18627957|P2|NOT COMPLETED|Baseline||0
7568020|NCT02873429|18627958|P1|NOT COMPLETED|Baseline||0
7568021|NCT02873429|18627957|P2|COMPLETED|Baseline||100
7568022|NCT02873429|18627958|P1|COMPLETED|Baseline||109
7568023|NCT02873429|18627957|P2|STARTED|Baseline||100
7568024|NCT02873429|18627958|P1|STARTED|Baseline||109
7568025|NCT02873377|18627970|P2|NOT COMPLETED|Period Title 3: 6 Months Follow up||23
7568026|NCT02873377|18627971|P1|NOT COMPLETED|Period Title 3: 6 Months Follow up||15
7568027|NCT02873377|18627970|P2|COMPLETED|Period Title 3: 6 Months Follow up||46
7568028|NCT02873377|18627971|P1|COMPLETED|Period Title 3: 6 Months Follow up||50
7568029|NCT02873377|18627970|P2|STARTED|Period Title 3: 6 Months Follow up||69
7568030|NCT02873377|18627971|P1|STARTED|Period Title 3: 6 Months Follow up||65
7568031|NCT02873377|18627970|P2|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
7568032|NCT02873377|18627971|P1|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
7568033|NCT02873377|18627970|P2|COMPLETED|Period Title 2: 3 Months Follow up||47
7568034|NCT02873377|18627971|P1|COMPLETED|Period Title 2: 3 Months Follow up||43
7568035|NCT02873377|18627970|P2|STARTED|Period Title 2: 3 Months Follow up||69
7568036|NCT02873377|18627971|P1|STARTED|Period Title 2: 3 Months Follow up||65
7568037|NCT02873377|18627970|P2|NOT COMPLETED|Period 1: Enrollment||0
7568038|NCT02873377|18627971|P1|NOT COMPLETED|Period 1: Enrollment||0
7568039|NCT02873377|18627970|P2|COMPLETED|Period 1: Enrollment||69
7568040|NCT02873377|18627971|P1|COMPLETED|Period 1: Enrollment||65
7568041|NCT02873377|18627970|P2|STARTED|Period 1: Enrollment||69
7568042|NCT02873377|18627971|P1|STARTED|Period 1: Enrollment||65
7568043|NCT02873286|18627995|P5|NOT COMPLETED|Booster Substudy||0
7568044|NCT02873286|18627996|P4|NOT COMPLETED|Booster Substudy||0
7568045|NCT02873286|18627997|P3|NOT COMPLETED|Booster Substudy||0
7568046|NCT02873286|18627998|P2|NOT COMPLETED|Booster Substudy||0
7568047|NCT02873286|18627999|P1|NOT COMPLETED|Booster Substudy||0
7568048|NCT02873286|18627995|P5|COMPLETED|Booster Substudy||0
7568049|NCT02873286|18627996|P4|COMPLETED|Booster Substudy||0
7568050|NCT02873286|18627997|P3|COMPLETED|Booster Substudy||45
7568051|NCT02873286|18627998|P2|COMPLETED|Booster Substudy||0
7568052|NCT02873286|18627999|P1|COMPLETED|Booster Substudy||43
7568053|NCT02873286|18627995|P5|STARTED|Booster Substudy||0
7568054|NCT02873286|18627996|P4|STARTED|Booster Substudy||0
7568055|NCT02873286|18627997|P3|STARTED|Booster Substudy||45
7568056|NCT02873286|18627998|P2|STARTED|Booster Substudy||0
7568057|NCT02873286|18627999|P1|STARTED|Booster Substudy||43
7568058|NCT02873286|18627995|P5|NOT COMPLETED|Main Study||2
7568059|NCT02873286|18627996|P4|NOT COMPLETED|Main Study||1
7568060|NCT02873286|18627997|P3|NOT COMPLETED|Main Study||2
7568061|NCT02873286|18627998|P2|NOT COMPLETED|Main Study||5
7568062|NCT02873286|18627999|P1|NOT COMPLETED|Main Study||2
7568063|NCT02873286|18627995|P5|COMPLETED|Main Study||81
7568064|NCT02873286|18627996|P4|COMPLETED|Main Study||89
7568065|NCT02873286|18627997|P3|COMPLETED|Main Study||78
7568066|NCT02873286|18627998|P2|COMPLETED|Main Study||84
7568067|NCT02873286|18627999|P1|COMPLETED|Main Study||76
7568068|NCT02873286|18627995|P5|STARTED|Main Study||83
7568069|NCT02873286|18627996|P4|STARTED|Main Study||90
7568070|NCT02873286|18627997|P3|STARTED|Main Study||80
7568071|NCT02873286|18627998|P2|STARTED|Main Study||89
7568072|NCT02873286|18627999|P1|STARTED|Main Study||78
7568073|NCT02873221|18628229|P3|NOT COMPLETED|Safety Follow-up Period||14
7568074|NCT02873221|18628230|P2|NOT COMPLETED|Safety Follow-up Period||17
7568075|NCT02873221|18628231|P1|NOT COMPLETED|Safety Follow-up Period||7
7568076|NCT02873221|18628229|P3|COMPLETED|Safety Follow-up Period||350
7568077|NCT02873221|18628230|P2|COMPLETED|Safety Follow-up Period||339
7568078|NCT02873221|18628231|P1|COMPLETED|Safety Follow-up Period||343
7568079|NCT02873221|18628229|P3|STARTED|Safety Follow-up Period||364
7568080|NCT02873221|18628230|P2|STARTED|Safety Follow-up Period||356
7568081|NCT02873221|18628231|P1|STARTED|Safety Follow-up Period||350
7568082|NCT02873221|18628229|P3|NOT COMPLETED|Treatment Period||105
7568083|NCT02873221|18628230|P2|NOT COMPLETED|Treatment Period||126
7568084|NCT02873221|18628231|P1|NOT COMPLETED|Treatment Period||88
7568085|NCT02873221|18628229|P3|COMPLETED|Treatment Period||315
7568086|NCT02873221|18628230|P2|COMPLETED|Treatment Period||291
7568087|NCT02873221|18628231|P1|COMPLETED|Treatment Period||329
7568088|NCT02873221|18628229|P3|Safety Population: Received Study Drug|Treatment Period||409
7568089|NCT02873221|18628230|P2|Safety Population: Received Study Drug|Treatment Period||404
7568090|NCT02873221|18628231|P1|Safety Population: Received Study Drug|Treatment Period||417
7568091|NCT02873221|18628229|P3|STARTED|Treatment Period||420
7568092|NCT02873221|18628230|P2|STARTED|Treatment Period||417
7568093|NCT02873221|18628231|P1|STARTED|Treatment Period||417
7568094|NCT02873195|18628253|P2|NOT COMPLETED|Overall Study||0
7568095|NCT02873195|18628254|P1|NOT COMPLETED|Overall Study||5
7568096|NCT02873195|18628253|P2|COMPLETED|Overall Study||46
7568097|NCT02873195|18628254|P1|COMPLETED|Overall Study||82
7568098|NCT02873195|18628253|P2|Never Began Treatment (Cancel)|Overall Study||0
7568099|NCT02873195|18628254|P1|Never Began Treatment (Cancel)|Overall Study||1
7568100|NCT02873195|18628253|P2|STARTED|Overall Study||46
7568101|NCT02873195|18628254|P1|STARTED|Overall Study||87
7568102|NCT02873104|18628268|P2|NOT COMPLETED|Overall Study||0
7568103|NCT02873104|18628269|P1|NOT COMPLETED|Overall Study||1
7568104|NCT02873104|18628268|P2|COMPLETED|Overall Study||23
7568106|NCT02873104|18628268|P2|STARTED|Overall Study||23
7568107|NCT02873104|18628269|P1|STARTED|Overall Study||47
7568108|NCT02872935|18628283|P2|NOT COMPLETED|Overall Study||1
7568109|NCT02872935|18628284|P1|NOT COMPLETED|Overall Study||0
7568110|NCT02872935|18628283|P2|COMPLETED|Overall Study|One subject consented but did no proceed with the study.|10
7568111|NCT02872935|18628284|P1|COMPLETED|Overall Study||11
7568112|NCT02872935|18628283|P2|STARTED|Overall Study||11
7568113|NCT02872935|18628284|P1|STARTED|Overall Study||11
7568114|NCT02872909|18628294|P2|NOT COMPLETED|Overall Study||0
7568115|NCT02872909|18628295|P1|NOT COMPLETED|Overall Study||0
7568116|NCT02872909|18628294|P2|COMPLETED|Overall Study||18
7568117|NCT02872909|18628295|P1|COMPLETED|Overall Study||32
7568118|NCT02872909|18628294|P2|STARTED|Overall Study||18
7568119|NCT02872909|18628295|P1|STARTED|Overall Study||32
7568120|NCT02872311|18628312|P5|NOT COMPLETED|Overall Study||0
7568121|NCT02872311|18628313|P4|NOT COMPLETED|Overall Study||0
7568122|NCT02872311|18628314|P3|NOT COMPLETED|Overall Study||1
7568123|NCT02872311|18628315|P2|NOT COMPLETED|Overall Study||2
7568124|NCT02872311|18628316|P1|NOT COMPLETED|Overall Study||4
7568125|NCT02872311|18628312|P5|COMPLETED|Overall Study||20
7568126|NCT02872311|18628313|P4|COMPLETED|Overall Study||20
7568127|NCT02872311|18628314|P3|COMPLETED|Overall Study||19
7568128|NCT02872311|18628315|P2|COMPLETED|Overall Study||58
7568129|NCT02872311|18628316|P1|COMPLETED|Overall Study||55
7568130|NCT02872311|18628312|P5|STARTED|Overall Study||20
7568131|NCT02872311|18628313|P4|STARTED|Overall Study||20
7568132|NCT02872311|18628314|P3|STARTED|Overall Study||20
7568133|NCT02872311|18628315|P2|STARTED|Overall Study||60
7568134|NCT02872311|18628316|P1|STARTED|Overall Study||59
7568135|NCT02872285|18628377|P2|NOT COMPLETED|Overall Study||2
7568136|NCT02872285|18628378|P1|NOT COMPLETED|Overall Study||5
7568137|NCT02872285|18628377|P2|COMPLETED|Overall Study||9
7568138|NCT02872285|18628378|P1|COMPLETED|Overall Study||17
7568139|NCT02872285|18628377|P2|STARTED|Overall Study||11
7568140|NCT02872285|18628378|P1|STARTED|Overall Study||22
7568141|NCT02872103|18628394|P2|NOT COMPLETED|Cycle 2-4||1
7568142|NCT02872103|18628395|P1|NOT COMPLETED|Cycle 2-4||2
7568143|NCT02872103|18628394|P2|COMPLETED|Cycle 2-4||37
7568144|NCT02872103|18628395|P1|COMPLETED|Cycle 2-4||81
7568145|NCT02872103|18628394|P2|STARTED|Cycle 2-4|1 subject withdrawn in Cycle 1|38
7568146|NCT02872103|18628395|P1|STARTED|Cycle 2-4||83
7568147|NCT02872103|18628394|P2|NOT COMPLETED|Cycle 1||1
7568148|NCT02872103|18628395|P1|NOT COMPLETED|Cycle 1||0
7568149|NCT02872103|18628394|P2|COMPLETED|Cycle 1||38
7568150|NCT02872103|18628395|P1|COMPLETED|Cycle 1||83
7568151|NCT02872103|18628394|P2|STARTED|Cycle 1||39
7568152|NCT02872103|18628395|P1|STARTED|Cycle 1||83
7568153|NCT02872012|18628424|P5|NOT COMPLETED|Overall Study||0
7568154|NCT02872012|18628425|P4|NOT COMPLETED|Overall Study||0
7568155|NCT02872012|18628426|P3|NOT COMPLETED|Overall Study||0
7568156|NCT02872012|18628427|P2|NOT COMPLETED|Overall Study||0
7568157|NCT02872012|18628428|P1|NOT COMPLETED|Overall Study||1
7568158|NCT02872012|18628424|P5|COMPLETED|Overall Study||5
7568159|NCT02872012|18628425|P4|COMPLETED|Overall Study||3
7568160|NCT02872012|18628426|P3|COMPLETED|Overall Study||4
7568161|NCT02872012|18628427|P2|COMPLETED|Overall Study||7
7568162|NCT02872012|18628428|P1|COMPLETED|Overall Study||3
7568163|NCT02872012|18628424|P5|STARTED|Overall Study||5
7568164|NCT02872012|18628425|P4|STARTED|Overall Study||3
7568165|NCT02872012|18628426|P3|STARTED|Overall Study||4
7568166|NCT02872012|18628427|P2|STARTED|Overall Study||7
7568167|NCT02872012|18628428|P1|STARTED|Overall Study||4
7568168|NCT02871739|18628446|P4|NOT COMPLETED|Overall Study||2
7568169|NCT02871739|18628447|P3|NOT COMPLETED|Overall Study||0
7568170|NCT02871739|18628448|P2|NOT COMPLETED|Overall Study||2
7568171|NCT02871739|18628449|P1|NOT COMPLETED|Overall Study||3
7568172|NCT02871739|18628446|P4|COMPLETED|Overall Study||5
7568173|NCT02871739|18628447|P3|COMPLETED|Overall Study||4
7568174|NCT02871739|18628448|P2|COMPLETED|Overall Study||4
7568175|NCT02871739|18628449|P1|COMPLETED|Overall Study||3
7568176|NCT02871739|18628446|P4|Complete Final Survey|Overall Study||5
7568177|NCT02871739|18628447|P3|Complete Final Survey|Overall Study||4
7568178|NCT02871739|18628448|P2|Complete Final Survey|Overall Study||4
7568179|NCT02871739|18628449|P1|Complete Final Survey|Overall Study||3
7568180|NCT02871739|18628446|P4|Completed Second SPI|Overall Study||5
7568181|NCT02871739|18628447|P3|Completed Second SPI|Overall Study||4
7568182|NCT02871739|18628448|P2|Completed Second SPI|Overall Study||4
7568183|NCT02871739|18628449|P1|Completed Second SPI|Overall Study||3
7568184|NCT02871739|18628446|P4|Completed First SPI|Overall Study||6
7568185|NCT02871739|18628447|P3|Completed First SPI|Overall Study||4
7568186|NCT02871739|18628448|P2|Completed First SPI|Overall Study||5
7568187|NCT02871739|18628449|P1|Completed First SPI|Overall Study||3
7568188|NCT02871739|18628446|P4|STARTED|Overall Study||7
7568189|NCT02871739|18628447|P3|STARTED|Overall Study||4
7568190|NCT02871739|18628448|P2|STARTED|Overall Study||6
7568191|NCT02871739|18628449|P1|STARTED|Overall Study||6
7568192|NCT02871635|18628461|P2|NOT COMPLETED|Overall Study||19
7568193|NCT02871635|18628462|P1|NOT COMPLETED|Overall Study||18
7568194|NCT02871635|18628461|P2|COMPLETED|Overall Study||56
7568195|NCT02871635|18628462|P1|COMPLETED|Overall Study||54
7568196|NCT02871635|18628461|P2|STARTED|Overall Study||75
7568197|NCT02871635|18628462|P1|STARTED|Overall Study||72
7568198|NCT02871570|18628488|P2|NOT COMPLETED|Overall Study||0
7568199|NCT02871570|18628489|P1|NOT COMPLETED|Overall Study||0
7568200|NCT02871570|18628488|P2|COMPLETED|Overall Study||8
7568201|NCT02871570|18628489|P1|COMPLETED|Overall Study||8
7568202|NCT02871570|18628488|P2|STARTED|Overall Study||8
7568203|NCT02871570|18628489|P1|STARTED|Overall Study||8
7568204|NCT02871479|18628520|P3|NOT COMPLETED|Overall Study||0
7568205|NCT02871479|18628521|P2|NOT COMPLETED|Overall Study||3
7568206|NCT02871479|18628522|P1|NOT COMPLETED|Overall Study||3
7568207|NCT02871479|18628520|P3|COMPLETED|Overall Study||11
7568208|NCT02871479|18628521|P2|COMPLETED|Overall Study||21
7568209|NCT02871479|18628522|P1|COMPLETED|Overall Study||33
7568210|NCT02871479|18628520|P3|STARTED|Overall Study||11
7568211|NCT02871479|18628521|P2|STARTED|Overall Study||24
7568212|NCT02871479|18628522|P1|STARTED|Overall Study||36
7568213|NCT02871440|18628536|P3|NOT COMPLETED|Overall Study||0
7568214|NCT02871440|18628537|P2|NOT COMPLETED|Overall Study||0
7568215|NCT02871440|18628538|P1|NOT COMPLETED|Overall Study||0
7568216|NCT02871440|18628536|P3|COMPLETED|Overall Study||15
7568217|NCT02871440|18628537|P2|COMPLETED|Overall Study||13
7568218|NCT02871440|18628538|P1|COMPLETED|Overall Study||12
7568219|NCT02871440|18628536|P3|STARTED|Overall Study||15
7568220|NCT02871440|18628537|P2|STARTED|Overall Study||13
7568221|NCT02871440|18628538|P1|STARTED|Overall Study||12
7568222|NCT02871375|18628552|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
7568223|NCT02871375|18628553|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
7568224|NCT02871375|18628552|P2|COMPLETED|Period 2, Second 14 Days of Wear||76
7568225|NCT02871375|18628553|P1|COMPLETED|Period 2, Second 14 Days of Wear||89
7568226|NCT02871375|18628552|P2|STARTED|Period 2, Second 14 Days of Wear||76
7568227|NCT02871375|18628553|P1|STARTED|Period 2, Second 14 Days of Wear||89
7568228|NCT02871375|18628552|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||1
7568229|NCT02871375|18628553|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||0
7568230|NCT02871375|18628552|P2|COMPLETED|Period 1, First 14 Days of Wear||76
7568231|NCT02871375|18628553|P1|COMPLETED|Period 1, First 14 Days of Wear||89
7568232|NCT02871375|18628552|P2|STARTED|Period 1, First 14 Days of Wear||77
7568233|NCT02871375|18628553|P1|STARTED|Period 1, First 14 Days of Wear||89
7568234|NCT02871128|18628565|P3|NOT COMPLETED|Overall Study||1
7568235|NCT02871128|18628566|P2|NOT COMPLETED|Overall Study||1
7568236|NCT02871128|18628567|P1|NOT COMPLETED|Overall Study||0
7568237|NCT02871128|18628565|P3|COMPLETED|Overall Study||15
7568238|NCT02871128|18628566|P2|COMPLETED|Overall Study||19
7568239|NCT02871128|18628567|P1|COMPLETED|Overall Study||20
7568240|NCT02871128|18628565|P3|STARTED|Overall Study||16
7568241|NCT02871128|18628566|P2|STARTED|Overall Study||20
7568242|NCT02871128|18628567|P1|STARTED|Overall Study||20
7568243|NCT02871011|18628580|P2|NOT COMPLETED|Overall Study||0
7568244|NCT02871011|18628581|P1|NOT COMPLETED|Overall Study||0
7568245|NCT02871011|18628580|P2|COMPLETED|Overall Study||13
7568246|NCT02871011|18628581|P1|COMPLETED|Overall Study||7
7568247|NCT02871011|18628580|P2|STARTED|Overall Study||13
7568248|NCT02871011|18628581|P1|STARTED|Overall Study||7
7568249|NCT02870933|18628599|P2|NOT COMPLETED|Overall Study||2
7568250|NCT02870933|18628600|P1|NOT COMPLETED|Overall Study||2
7568251|NCT02870933|18628599|P2|COMPLETED|Overall Study||13
7568252|NCT02870933|18628600|P1|COMPLETED|Overall Study||13
7568253|NCT02870933|18628599|P2|STARTED|Overall Study||15
7568254|NCT02870933|18628600|P1|STARTED|Overall Study||15
7568255|NCT02870283|18628625|P3|NOT COMPLETED|Overall Study||19
7568256|NCT02870283|18628626|P2|NOT COMPLETED|Overall Study||9
7568257|NCT02870283|18628627|P1|NOT COMPLETED|Overall Study||3
7568258|NCT02870283|18628625|P3|COMPLETED|Overall Study||15
7568259|NCT02870283|18628626|P2|COMPLETED|Overall Study||26
7568260|NCT02870283|18628627|P1|COMPLETED|Overall Study||35
7568261|NCT02870283|18628625|P3|STARTED|Overall Study||34
7568262|NCT02870283|18628626|P2|STARTED|Overall Study||35
7568263|NCT02870283|18628627|P1|STARTED|Overall Study||38
7568264|NCT02870205|18628645|P4|NOT COMPLETED|Overall Study||7
7568265|NCT02870205|18628646|P3|NOT COMPLETED|Overall Study||7
7568266|NCT02870205|18628647|P2|NOT COMPLETED|Overall Study||5
7568267|NCT02870205|18628648|P1|NOT COMPLETED|Overall Study||10
7568268|NCT02870205|18628645|P4|COMPLETED|Overall Study||287
7568269|NCT02870205|18628646|P3|COMPLETED|Overall Study||287
7568270|NCT02870205|18628647|P2|COMPLETED|Overall Study||289
7568271|NCT02870205|18628648|P1|COMPLETED|Overall Study||284
7568272|NCT02870205|18628645|P4|STARTED|Overall Study||294
7568273|NCT02870205|18628646|P3|STARTED|Overall Study||294
7568274|NCT02870205|18628647|P2|STARTED|Overall Study||294
7568275|NCT02870205|18628648|P1|STARTED|Overall Study||294
7568276|NCT02870101|18628658|P1|NOT COMPLETED|Overall Study||169
7568277|NCT02870101|18628658|P1|COMPLETED|Overall Study||2598
7568278|NCT02870101|18628658|P1|STARTED|Overall Study||2767
7568279|NCT02869893|18628673|P1|NOT COMPLETED|Overall Study||7
7568280|NCT02869893|18628673|P1|COMPLETED|Overall Study||50
7568281|NCT02869893|18628673|P1|STARTED|Overall Study||57
7568282|NCT02869451|18628679|P1|NOT COMPLETED|Overall Study||0
7568283|NCT02869451|18628679|P1|COMPLETED|Overall Study||5
7568284|NCT02869451|18628679|P1|STARTED|Overall Study||5
7568285|NCT02869438|18628703|P2|NOT COMPLETED|Overall Study||2
7568286|NCT02869438|18628704|P1|NOT COMPLETED|Overall Study||3
7568287|NCT02869438|18628703|P2|COMPLETED|Overall Study||113
7568288|NCT02869438|18628704|P1|COMPLETED|Overall Study||115
7568289|NCT02869438|18628703|P2|STARTED|Overall Study||115
7568290|NCT02869438|18628704|P1|STARTED|Overall Study||118
7568291|NCT02868892|18628752|P1|NOT COMPLETED|Overall Study||6
7568292|NCT02868892|18628752|P1|COMPLETED|Overall Study||0
7568293|NCT02868892|18628752|P1|STARTED|Overall Study||6
7568294|NCT02868554|18628761|P3|NOT COMPLETED|Overall Study||1
7568295|NCT02868554|18628762|P2|NOT COMPLETED|Overall Study||0
7568296|NCT02868554|18628763|P1|NOT COMPLETED|Overall Study||3
7568297|NCT02868554|18628761|P3|COMPLETED|Overall Study||11
7568298|NCT02868554|18628762|P2|COMPLETED|Overall Study||12
7568299|NCT02868554|18628763|P1|COMPLETED|Overall Study||7
7568300|NCT02868554|18628761|P3|STARTED|Overall Study||12
7568301|NCT02868554|18628762|P2|STARTED|Overall Study||12
7568302|NCT02868554|18628763|P1|STARTED|Overall Study||10
7568303|NCT02868281|18628788|P2|NOT COMPLETED|Overall Study||44
7568304|NCT02868281|18628789|P1|NOT COMPLETED|Overall Study||43
7568305|NCT02868281|18628788|P2|COMPLETED|Overall Study||234
7568306|NCT02868281|18628789|P1|COMPLETED|Overall Study||209
7568307|NCT02868281|18628788|P2|STARTED|Overall Study||278
7568308|NCT02868281|18628789|P1|STARTED|Overall Study||252
7568309|NCT02868242|18628811|P1|NOT COMPLETED|Overall Study||0
7568310|NCT02868242|18628811|P1|COMPLETED|Overall Study||19
7568311|NCT02868242|18628811|P1|STARTED|Overall Study||19
7568312|NCT02868216|18628823|P2|NOT COMPLETED|Overall Study||6
7568313|NCT02868216|18628824|P1|NOT COMPLETED|Overall Study||8
7568314|NCT02868216|18628823|P2|COMPLETED|Overall Study||41
7568315|NCT02868216|18628824|P1|COMPLETED|Overall Study||35
7568316|NCT02868216|18628823|P2|STARTED|Overall Study||47
7568317|NCT02868216|18628824|P1|STARTED|Overall Study||43
7568318|NCT02867995|18628832|P2|NOT COMPLETED|Overall Study||3
7568319|NCT02867995|18628833|P1|NOT COMPLETED|Overall Study||0
7568320|NCT02867995|18628832|P2|COMPLETED|Overall Study|Total patients completed|27
7568321|NCT02867995|18628833|P1|COMPLETED|Overall Study|Total patients completed|9
7568322|NCT02867995|18628832|P2|STARTED|Overall Study|Total patients consented|30
7568323|NCT02867995|18628833|P1|STARTED|Overall Study|Total patients consented|9
7568324|NCT02867709|18628852|P3|NOT COMPLETED|Safety Follow-up Period||14
7568325|NCT02867709|18628853|P2|NOT COMPLETED|Safety Follow-up Period||15
7568326|NCT02867709|18628854|P1|NOT COMPLETED|Safety Follow-up Period||11
7568327|NCT02867709|18628852|P3|COMPLETED|Safety Follow-up Period||473
7568328|NCT02867709|18628853|P2|COMPLETED|Safety Follow-up Period||459
7568329|NCT02867709|18628854|P1|COMPLETED|Safety Follow-up Period||482
7568330|NCT02867709|18628852|P3|STARTED|Safety Follow-up Period||487
7568331|NCT02867709|18628853|P2|STARTED|Safety Follow-up Period||474
7568332|NCT02867709|18628854|P1|STARTED|Safety Follow-up Period||493
7568333|NCT02867709|18628852|P3|NOT COMPLETED|Treatment Period||75
7568334|NCT02867709|18628853|P2|NOT COMPLETED|Treatment Period||87
7568335|NCT02867709|18628854|P1|NOT COMPLETED|Treatment Period||70
7568336|NCT02867709|18628852|P3|COMPLETED|Treatment Period||487
7568337|NCT02867709|18628853|P2|COMPLETED|Treatment Period||474
7568338|NCT02867709|18628854|P1|COMPLETED|Treatment Period||493
7568339|NCT02867709|18628852|P3|Safety Population: Received Study Drug|Treatment Period||488
7568340|NCT02867709|18628853|P2|Safety Population: Received Study Drug|Treatment Period||478
7568341|NCT02867709|18628854|P1|Safety Population: Received Study Drug|Treatment Period||499
7568342|NCT02867709|18628852|P3|STARTED|Treatment Period||562
7568343|NCT02867709|18628853|P2|STARTED|Treatment Period||561
7568344|NCT02867709|18628854|P1|STARTED|Treatment Period||563
7568345|NCT02867605|18628883|P1|NOT COMPLETED|Overall Study||0
7568346|NCT02867605|18628883|P1|COMPLETED|Overall Study||20
7568347|NCT02867605|18628883|P1|STARTED|Overall Study||20
7568348|NCT02867202|18628935|P2|NOT COMPLETED|Overall Study||32
7568349|NCT02867202|18628936|P1|NOT COMPLETED|Overall Study||21
7568350|NCT02867202|18628935|P2|COMPLETED|Overall Study||56
7568351|NCT02867202|18628936|P1|COMPLETED|Overall Study||62
7568352|NCT02867202|18628935|P2|STARTED|Overall Study||88
7568353|NCT02867202|18628936|P1|STARTED|Overall Study||83
7568354|NCT02867163|18628942|P1|NOT COMPLETED|Overall Study||0
7568355|NCT02867163|18628942|P1|COMPLETED|Overall Study||25
7568356|NCT02867163|18628942|P1|STARTED|Overall Study||25
7568357|NCT02867150|18628946|P1|NOT COMPLETED|Overall Study||0
7568358|NCT02867150|18628946|P1|COMPLETED|Overall Study||58
7568359|NCT02867150|18628946|P1|STARTED|Overall Study||58
7568360|NCT02867059|18628952|P2|NOT COMPLETED|Overall Study||2
7568361|NCT02867059|18628953|P1|NOT COMPLETED|Overall Study||0
7568362|NCT02867059|18628952|P2|COMPLETED|Overall Study||8
7568363|NCT02867059|18628953|P1|COMPLETED|Overall Study||7
7568364|NCT02867059|18628952|P2|STARTED|Overall Study||10
7568365|NCT02867059|18628953|P1|STARTED|Overall Study||7
7568366|NCT02866942|18628961|P1|NOT COMPLETED|Overall Study||1
7568367|NCT02866942|18628961|P1|COMPLETED|Overall Study||478
7568368|NCT02866942|18628961|P1|STARTED|Overall Study||479
7568369|NCT02866695|18628966|P1|NOT COMPLETED|Overall Study||2
7568370|NCT02866695|18628966|P1|COMPLETED|Overall Study||18
7568371|NCT02866695|18628966|P1|STARTED|Overall Study||20
7568372|NCT02866643|18628974|P2|NOT COMPLETED|Overall Study||12
7568373|NCT02866643|18628975|P1|NOT COMPLETED|Overall Study||13
7568374|NCT02866643|18628974|P2|COMPLETED|Overall Study||35
7568375|NCT02866643|18628975|P1|COMPLETED|Overall Study||35
7568376|NCT02866643|18628974|P2|Per Protocol Population|Overall Study||35
7568377|NCT02866643|18628975|P1|Per Protocol Population|Overall Study||35
7568378|NCT02866643|18628974|P2|Intent-to-Treat (ITT) Population|Overall Study||39
7568379|NCT02866643|18628975|P1|Intent-to-Treat (ITT) Population|Overall Study||38
7568380|NCT02866643|18628974|P2|STARTED|Overall Study||47
7568381|NCT02866643|18628975|P1|STARTED|Overall Study||48
7568382|NCT02866175|18628983|P2|NOT COMPLETED|Overall Study||175
7568383|NCT02866175|18628984|P1|NOT COMPLETED|Overall Study||135
7568384|NCT02866175|18628983|P2|COMPLETED|Overall Study||580
7568385|NCT02866175|18628984|P1|COMPLETED|Overall Study||616
7568386|NCT02866175|18628983|P2|STARTED|Overall Study||755
7568387|NCT02866175|18628984|P1|STARTED|Overall Study||751
7568388|NCT02865915|18629004|P2|NOT COMPLETED|Overall Study||30
7568389|NCT02865915|18629005|P1|NOT COMPLETED|Overall Study||25
7568390|NCT02865915|18629004|P2|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
7568391|NCT02865915|18629005|P1|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
7568392|NCT02865915|18629004|P2|STARTED|Overall Study||30
7568393|NCT02865915|18629005|P1|STARTED|Overall Study||25
7568394|NCT02865720|18629015|P2|NOT COMPLETED|Overall Study||0
7568395|NCT02865720|18629016|P1|NOT COMPLETED|Overall Study||0
7568396|NCT02865720|18629015|P2|COMPLETED|Overall Study||8
7568397|NCT02865720|18629016|P1|COMPLETED|Overall Study||0
7568398|NCT02865720|18629015|P2|STARTED|Overall Study||8
7568399|NCT02865720|18629016|P1|STARTED|Overall Study||0
7568400|NCT02865590|18629041|P2|NOT COMPLETED|Overall Study||0
7568401|NCT02865590|18629042|P1|NOT COMPLETED|Overall Study||0
7568402|NCT02865590|18629041|P2|COMPLETED|Overall Study||8
7568403|NCT02865590|18629042|P1|COMPLETED|Overall Study||8
7568404|NCT02865590|18629041|P2|STARTED|Overall Study||8
7568405|NCT02865590|18629042|P1|STARTED|Overall Study||8
7568406|NCT02865499|18629048|P1|NOT COMPLETED|12 Weeks||0
7568407|NCT02865499|18629048|P1|COMPLETED|12 Weeks||6
7568408|NCT02865499|18629048|P1|STARTED|12 Weeks||6
7568409|NCT02865499|18629048|P1|NOT COMPLETED|8 Weeks||0
7568410|NCT02865499|18629048|P1|COMPLETED|8 Weeks||6
7568411|NCT02865499|18629048|P1|STARTED|8 Weeks||6
7568412|NCT02865499|18629048|P1|NOT COMPLETED|Baseline||2
7568413|NCT02865499|18629048|P1|COMPLETED|Baseline||6
7568414|NCT02865499|18629048|P1|STARTED|Baseline||8
7568415|NCT02865395|18629055|P3|NOT COMPLETED|Overall Study||7
7568416|NCT02865395|18629056|P2|NOT COMPLETED|Overall Study||10
7568417|NCT02865395|18629057|P1|NOT COMPLETED|Overall Study||6
7568418|NCT02865395|18629055|P3|COMPLETED|Overall Study|Data Not Collected|0
7568419|NCT02865395|18629056|P2|COMPLETED|Overall Study|Data Not Collected|0
7568420|NCT02865395|18629057|P1|COMPLETED|Overall Study|Data Not Collected|0
7568421|NCT02865395|18629055|P3|STARTED|Overall Study||7
7568422|NCT02865395|18629056|P2|STARTED|Overall Study||10
7568423|NCT02865395|18629057|P1|STARTED|Overall Study||6
7568424|NCT02865343|18629070|P2|NOT COMPLETED|Overall Study||2
7568425|NCT02865343|18629071|P1|NOT COMPLETED|Overall Study||0
7568426|NCT02865343|18629070|P2|COMPLETED|Overall Study||3
7568427|NCT02865343|18629071|P1|COMPLETED|Overall Study||6
7568428|NCT02865343|18629070|P2|STARTED|Overall Study||5
7568429|NCT02865343|18629071|P1|STARTED|Overall Study||6
7568430|NCT02865083|18629083|P2|NOT COMPLETED|Overall Study||1
7568431|NCT02865083|18629084|P1|NOT COMPLETED|Overall Study||3
7568432|NCT02865083|18629083|P2|COMPLETED|Overall Study||0
7568433|NCT02865083|18629084|P1|COMPLETED|Overall Study||0
7568434|NCT02865083|18629083|P2|STARTED|Overall Study||1
7568435|NCT02865083|18629084|P1|STARTED|Overall Study||3
7568436|NCT02864732|18629104|P2|NOT COMPLETED|Overall Study||2
7568437|NCT02864732|18629105|P1|NOT COMPLETED|Overall Study||2
7568438|NCT02864732|18629104|P2|COMPLETED|Overall Study||13
7568439|NCT02864732|18629105|P1|COMPLETED|Overall Study||13
7568440|NCT02864732|18629104|P2|STARTED|Overall Study||15
7568441|NCT02864732|18629105|P1|STARTED|Overall Study||15
7568442|NCT02864706|18629122|P2|NOT COMPLETED|Overall Study||0
7568443|NCT02864706|18629123|P1|NOT COMPLETED|Overall Study||0
7568444|NCT02864706|18629122|P2|COMPLETED|Overall Study||47
7568445|NCT02864706|18629123|P1|COMPLETED|Overall Study||48
7568446|NCT02864706|18629122|P2|Intent to Treat|Overall Study||47
7568447|NCT02864706|18629123|P1|Intent to Treat|Overall Study||46
7568448|NCT02864706|18629122|P2|Safety Set|Overall Study||47
7568449|NCT02864706|18629123|P1|Safety Set|Overall Study||48
7568450|NCT02864706|18629122|P2|STARTED|Overall Study||47
7568451|NCT02864706|18629123|P1|STARTED|Overall Study||48
7568452|NCT02864394|18629145|P2|NOT COMPLETED|Overall Study||212
7568453|NCT02864394|18629146|P1|NOT COMPLETED|Overall Study||213
7568454|NCT02864394|18629145|P2|COMPLETED|Overall Study||0
7568455|NCT02864394|18629146|P1|COMPLETED|Overall Study||0
7568456|NCT02864394|18629145|P2|Treated|Overall Study||198
7568457|NCT02864394|18629146|P1|Treated|Overall Study||213
7568458|NCT02864394|18629145|P2|STARTED|Overall Study||212
7568459|NCT02864394|18629146|P1|STARTED|Overall Study||213
7568460|NCT02864381|18629172|P2|NOT COMPLETED|Overall Study||72
7568461|NCT02864381|18629173|P1|NOT COMPLETED|Overall Study||72
7568462|NCT02864381|18629172|P2|COMPLETED|Overall Study||0
7568463|NCT02864381|18629173|P1|COMPLETED|Overall Study||0
7568464|NCT02864381|18629172|P2|STARTED|Overall Study||72
7568465|NCT02864381|18629173|P1|STARTED|Overall Study||72
7568466|NCT02864342|18629191|P2|NOT COMPLETED|Overall Study||19
7568467|NCT02864342|18629192|P1|NOT COMPLETED|Overall Study||15
7568468|NCT02864342|18629191|P2|COMPLETED|Overall Study||49
7568469|NCT02864342|18629192|P1|COMPLETED|Overall Study||55
7568470|NCT02864342|18629191|P2|Full Analysis Set (FAS)|Overall Study||67
7568471|NCT02864342|18629192|P1|Full Analysis Set (FAS)|Overall Study||70
7568472|NCT02864342|18629191|P2|STARTED|Overall Study||68
7568473|NCT02864342|18629192|P1|STARTED|Overall Study||70
7568474|NCT02864316|18629209|P2|NOT COMPLETED|Overall Study||2
7568475|NCT02864316|18629210|P1|NOT COMPLETED|Overall Study||2
7568476|NCT02864316|18629209|P2|COMPLETED|Overall Study||0
7568477|NCT02864316|18629210|P1|COMPLETED|Overall Study||0
7568478|NCT02864316|18629209|P2|STARTED|Overall Study||2
7568479|NCT02864316|18629210|P1|STARTED|Overall Study||2
7568480|NCT02864069|18629229|P3|NOT COMPLETED|Overall Study||8
7568481|NCT02864069|18629230|P2|NOT COMPLETED|Overall Study||8
7568482|NCT02864069|18629231|P1|NOT COMPLETED|Overall Study||6
7568483|NCT02864069|18629229|P3|COMPLETED|Overall Study||13
7568484|NCT02864069|18629230|P2|COMPLETED|Overall Study||5
7568485|NCT02864069|18629231|P1|COMPLETED|Overall Study||12
7568486|NCT02864069|18629229|P3|STARTED|Overall Study||21
7568487|NCT02864069|18629230|P2|STARTED|Overall Study||13
7568488|NCT02864069|18629231|P1|STARTED|Overall Study||18
7568489|NCT02863575|18629248|P3|NOT COMPLETED|Overall Study||1
7568490|NCT02863575|18629249|P2|NOT COMPLETED|Overall Study||2
7568491|NCT02863575|18629250|P1|NOT COMPLETED|Overall Study||1
7568492|NCT02863575|18629248|P3|COMPLETED|Overall Study||51
7568493|NCT02863575|18629249|P2|COMPLETED|Overall Study||159
7568494|NCT02863575|18629250|P1|COMPLETED|Overall Study||160
7568495|NCT02863575|18629248|P3|STARTED|Overall Study||52
7568496|NCT02863575|18629249|P2|STARTED|Overall Study||161
7568497|NCT02863575|18629250|P1|STARTED|Overall Study||161
7568498|NCT02863419|18629302|P3|NOT COMPLETED|Overall Study||8
7568499|NCT02863419|18629303|P2|NOT COMPLETED|Overall Study||10
7568500|NCT02863419|18629304|P1|NOT COMPLETED|Overall Study||8
7568501|NCT02863419|18629302|P3|COMPLETED|Overall Study||134
7568502|NCT02863419|18629303|P2|COMPLETED|Overall Study||274
7568503|NCT02863419|18629304|P1|COMPLETED|Overall Study||277
7568504|NCT02863419|18629302|P3|Safety Analysis Set (SAS)|Overall Study||142
7568505|NCT02863419|18629303|P2|Safety Analysis Set (SAS)|Overall Study||284
7568506|NCT02863419|18629304|P1|Safety Analysis Set (SAS)|Overall Study||285
7568507|NCT02863419|18629302|P3|Full Analysis Set (FAS)|Overall Study||142
7568508|NCT02863419|18629303|P2|Full Analysis Set (FAS)|Overall Study||284
7568509|NCT02863419|18629304|P1|Full Analysis Set (FAS)|Overall Study||285
7568510|NCT02863419|18629302|P3|STARTED|Overall Study||142
7568511|NCT02863419|18629303|P2|STARTED|Overall Study||284
7568512|NCT02863419|18629304|P1|STARTED|Overall Study||285
7568513|NCT02863328|18629421|P2|NOT COMPLETED|Overall Study||23
7568514|NCT02863328|18629422|P1|NOT COMPLETED|Overall Study||11
7568515|NCT02863328|18629421|P2|COMPLETED|Overall Study||387
7568516|NCT02863328|18629422|P1|COMPLETED|Overall Study||400
7568517|NCT02863328|18629421|P2|Safety Analysis Set (SAS)|Overall Study||409
7568518|NCT02863328|18629422|P1|Safety Analysis Set (SAS)|Overall Study||410
7568519|NCT02863328|18629421|P2|Full Analysis Set (FAS)|Overall Study||410
7568520|NCT02863328|18629422|P1|Full Analysis Set (FAS)|Overall Study||411
7568521|NCT02863328|18629421|P2|STARTED|Overall Study||410
7568522|NCT02863328|18629422|P1|STARTED|Overall Study||411
7568523|NCT02863289|18629519|P1|NOT COMPLETED|Overall Study||83
7568524|NCT02863289|18629519|P1|COMPLETED|Overall Study|Study completed on 01/03/2017, 35 study participants have returned the questionnaire.|35
7568525|NCT02863289|18629519|P1|STARTED|Overall Study|Study started on 01/11/2016, with 118 study participants.|118
7568526|NCT02863263|18629526|P2|NOT COMPLETED|Overall Study||1
7568527|NCT02863263|18629527|P1|NOT COMPLETED|Overall Study||1
7568528|NCT02863263|18629526|P2|COMPLETED|Overall Study||1
7568529|NCT02863263|18629527|P1|COMPLETED|Overall Study||2
7568530|NCT02863263|18629526|P2|STARTED|Overall Study||2
7568531|NCT02863263|18629527|P1|STARTED|Overall Study||3
7568532|NCT02863198|18629549|P2|NOT COMPLETED|Overall Study||0
7568533|NCT02863198|18629550|P1|NOT COMPLETED|Overall Study||0
7568534|NCT02863198|18629549|P2|COMPLETED|Overall Study||60
7568535|NCT02863198|18629550|P1|COMPLETED|Overall Study||60
7568536|NCT02863198|18629549|P2|STARTED|Overall Study||60
7568537|NCT02863198|18629550|P1|STARTED|Overall Study||60
7568538|NCT02862912|18629568|P2|NOT COMPLETED|Overall Study||0
7568539|NCT02862912|18629569|P1|NOT COMPLETED|Overall Study||1
7568540|NCT02862912|18629568|P2|COMPLETED|Overall Study||20
7568541|NCT02862912|18629569|P1|COMPLETED|Overall Study||22
7568542|NCT02862912|18629568|P2|STARTED|Overall Study||20
7568543|NCT02862912|18629569|P1|STARTED|Overall Study||23
7568544|NCT02862730|18629579|P7|NOT COMPLETED|Fourth Intervention (84 Hours)||0
7568545|NCT02862730|18629580|P6|NOT COMPLETED|Fourth Intervention (84 Hours)||0
7568546|NCT02862730|18629581|P5|NOT COMPLETED|Fourth Intervention (84 Hours)||0
7568547|NCT02862730|18629582|P4|NOT COMPLETED|Fourth Intervention (84 Hours)||0
7568548|NCT02862730|18629583|P3|NOT COMPLETED|Fourth Intervention (84 Hours)||0
7568549|NCT02862730|18629584|P2|NOT COMPLETED|Fourth Intervention (84 Hours)||0
7568550|NCT02862730|18629585|P1|NOT COMPLETED|Fourth Intervention (84 Hours)||0
7568551|NCT02862730|18629579|P7|COMPLETED|Fourth Intervention (84 Hours)||1
7568552|NCT02862730|18629580|P6|COMPLETED|Fourth Intervention (84 Hours)||1
7568553|NCT02862730|18629581|P5|COMPLETED|Fourth Intervention (84 Hours)||4
7568554|NCT02862730|18629582|P4|COMPLETED|Fourth Intervention (84 Hours)||4
7568555|NCT02862730|18629583|P3|COMPLETED|Fourth Intervention (84 Hours)||6
7568556|NCT02862730|18629584|P2|COMPLETED|Fourth Intervention (84 Hours)||1
7568557|NCT02862730|18629585|P1|COMPLETED|Fourth Intervention (84 Hours)||3
7568558|NCT02862730|18629579|P7|STARTED|Fourth Intervention (84 Hours)||1
7568559|NCT02862730|18629580|P6|STARTED|Fourth Intervention (84 Hours)||1
7568560|NCT02862730|18629581|P5|STARTED|Fourth Intervention (84 Hours)||4
7568561|NCT02862730|18629582|P4|STARTED|Fourth Intervention (84 Hours)||4
7568562|NCT02862730|18629583|P3|STARTED|Fourth Intervention (84 Hours)||6
7568563|NCT02862730|18629584|P2|STARTED|Fourth Intervention (84 Hours)||1
7568564|NCT02862730|18629585|P1|STARTED|Fourth Intervention (84 Hours)||3
7568565|NCT02862730|18629579|P7|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
7568566|NCT02862730|18629580|P6|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
7568567|NCT02862730|18629581|P5|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
7568568|NCT02862730|18629582|P4|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
7568569|NCT02862730|18629583|P3|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
7568570|NCT02862730|18629584|P2|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
7568571|NCT02862730|18629585|P1|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
7568572|NCT02862730|18629579|P7|COMPLETED|Fourth Rest Period (7-45 Days)||1
7568573|NCT02862730|18629580|P6|COMPLETED|Fourth Rest Period (7-45 Days)||1
7568574|NCT02862730|18629581|P5|COMPLETED|Fourth Rest Period (7-45 Days)||4
7568575|NCT02862730|18629582|P4|COMPLETED|Fourth Rest Period (7-45 Days)||4
7568576|NCT02862730|18629583|P3|COMPLETED|Fourth Rest Period (7-45 Days)||6
7568577|NCT02862730|18629584|P2|COMPLETED|Fourth Rest Period (7-45 Days)||1
7568578|NCT02862730|18629585|P1|COMPLETED|Fourth Rest Period (7-45 Days)||3
7568579|NCT02862730|18629579|P7|STARTED|Fourth Rest Period (7-45 Days)||1
7568580|NCT02862730|18629580|P6|STARTED|Fourth Rest Period (7-45 Days)||1
7568581|NCT02862730|18629581|P5|STARTED|Fourth Rest Period (7-45 Days)||4
7568582|NCT02862730|18629582|P4|STARTED|Fourth Rest Period (7-45 Days)||4
7568583|NCT02862730|18629583|P3|STARTED|Fourth Rest Period (7-45 Days)||6
7568584|NCT02862730|18629584|P2|STARTED|Fourth Rest Period (7-45 Days)||1
7568585|NCT02862730|18629585|P1|STARTED|Fourth Rest Period (7-45 Days)||3
7568586|NCT02862730|18629579|P7|NOT COMPLETED|Third Intervention (84 Hours)||0
7568587|NCT02862730|18629580|P6|NOT COMPLETED|Third Intervention (84 Hours)||0
7568588|NCT02862730|18629581|P5|NOT COMPLETED|Third Intervention (84 Hours)||0
7568589|NCT02862730|18629582|P4|NOT COMPLETED|Third Intervention (84 Hours)||1
7568590|NCT02862730|18629583|P3|NOT COMPLETED|Third Intervention (84 Hours)||0
7568591|NCT02862730|18629584|P2|NOT COMPLETED|Third Intervention (84 Hours)||0
7568592|NCT02862730|18629585|P1|NOT COMPLETED|Third Intervention (84 Hours)||0
7568593|NCT02862730|18629579|P7|COMPLETED|Third Intervention (84 Hours)||1
7568594|NCT02862730|18629580|P6|COMPLETED|Third Intervention (84 Hours)||1
7568595|NCT02862730|18629581|P5|COMPLETED|Third Intervention (84 Hours)||4
7568596|NCT02862730|18629582|P4|COMPLETED|Third Intervention (84 Hours)||4
7568597|NCT02862730|18629583|P3|COMPLETED|Third Intervention (84 Hours)||6
7568598|NCT02862730|18629584|P2|COMPLETED|Third Intervention (84 Hours)||1
7568599|NCT02862730|18629585|P1|COMPLETED|Third Intervention (84 Hours)||3
7568600|NCT02862730|18629579|P7|STARTED|Third Intervention (84 Hours)||1
7568601|NCT02862730|18629580|P6|STARTED|Third Intervention (84 Hours)||1
7568602|NCT02862730|18629581|P5|STARTED|Third Intervention (84 Hours)||4
7568603|NCT02862730|18629582|P4|STARTED|Third Intervention (84 Hours)||5
7568604|NCT02862730|18629583|P3|STARTED|Third Intervention (84 Hours)||6
7568605|NCT02862730|18629584|P2|STARTED|Third Intervention (84 Hours)||1
7568606|NCT02862730|18629585|P1|STARTED|Third Intervention (84 Hours)||3
7568607|NCT02862730|18629579|P7|NOT COMPLETED|Third Rest Period (7-45 Days)||0
7568608|NCT02862730|18629580|P6|NOT COMPLETED|Third Rest Period (7-45 Days)||0
7568609|NCT02862730|18629581|P5|NOT COMPLETED|Third Rest Period (7-45 Days)||1
7568610|NCT02862730|18629582|P4|NOT COMPLETED|Third Rest Period (7-45 Days)||0
7568611|NCT02862730|18629583|P3|NOT COMPLETED|Third Rest Period (7-45 Days)||1
7568612|NCT02862730|18629584|P2|NOT COMPLETED|Third Rest Period (7-45 Days)||0
7568613|NCT02862730|18629585|P1|NOT COMPLETED|Third Rest Period (7-45 Days)||0
7568614|NCT02862730|18629579|P7|COMPLETED|Third Rest Period (7-45 Days)||1
7568615|NCT02862730|18629580|P6|COMPLETED|Third Rest Period (7-45 Days)||1
7568616|NCT02862730|18629581|P5|COMPLETED|Third Rest Period (7-45 Days)||4
7568617|NCT02862730|18629582|P4|COMPLETED|Third Rest Period (7-45 Days)||5
7568618|NCT02862730|18629583|P3|COMPLETED|Third Rest Period (7-45 Days)||6
7568619|NCT02862730|18629584|P2|COMPLETED|Third Rest Period (7-45 Days)||1
7568620|NCT02862730|18629585|P1|COMPLETED|Third Rest Period (7-45 Days)||3
7568621|NCT02862730|18629579|P7|STARTED|Third Rest Period (7-45 Days)||1
7568622|NCT02862730|18629580|P6|STARTED|Third Rest Period (7-45 Days)||1
7568623|NCT02862730|18629581|P5|STARTED|Third Rest Period (7-45 Days)||5
7568624|NCT02862730|18629582|P4|STARTED|Third Rest Period (7-45 Days)||5
7568625|NCT02862730|18629583|P3|STARTED|Third Rest Period (7-45 Days)||7
7568626|NCT02862730|18629584|P2|STARTED|Third Rest Period (7-45 Days)||1
7568627|NCT02862730|18629585|P1|STARTED|Third Rest Period (7-45 Days)||3
7568628|NCT02862730|18629579|P7|NOT COMPLETED|Second Intervention (84 Hours)||0
7568629|NCT02862730|18629580|P6|NOT COMPLETED|Second Intervention (84 Hours)||0
7568630|NCT02862730|18629581|P5|NOT COMPLETED|Second Intervention (84 Hours)||0
7568631|NCT02862730|18629582|P4|NOT COMPLETED|Second Intervention (84 Hours)||0
7568632|NCT02862730|18629583|P3|NOT COMPLETED|Second Intervention (84 Hours)||0
7568633|NCT02862730|18629584|P2|NOT COMPLETED|Second Intervention (84 Hours)||0
7568634|NCT02862730|18629585|P1|NOT COMPLETED|Second Intervention (84 Hours)||1
7568635|NCT02862730|18629579|P7|COMPLETED|Second Intervention (84 Hours)||1
7568636|NCT02862730|18629580|P6|COMPLETED|Second Intervention (84 Hours)||1
7568637|NCT02862730|18629581|P5|COMPLETED|Second Intervention (84 Hours)||5
7568638|NCT02862730|18629582|P4|COMPLETED|Second Intervention (84 Hours)||5
7568639|NCT02862730|18629583|P3|COMPLETED|Second Intervention (84 Hours)||7
7568640|NCT02862730|18629584|P2|COMPLETED|Second Intervention (84 Hours)||1
7568641|NCT02862730|18629585|P1|COMPLETED|Second Intervention (84 Hours)||3
7568642|NCT02862730|18629579|P7|STARTED|Second Intervention (84 Hours)||1
7568643|NCT02862730|18629580|P6|STARTED|Second Intervention (84 Hours)||1
7568644|NCT02862730|18629581|P5|STARTED|Second Intervention (84 Hours)||5
7568645|NCT02862730|18629582|P4|STARTED|Second Intervention (84 Hours)||5
7568646|NCT02862730|18629583|P3|STARTED|Second Intervention (84 Hours)||7
7568647|NCT02862730|18629584|P2|STARTED|Second Intervention (84 Hours)||1
7568648|NCT02862730|18629585|P1|STARTED|Second Intervention (84 Hours)||4
7568649|NCT02862730|18629579|P7|NOT COMPLETED|Second Rest Period (7-45 Days)||0
7568650|NCT02862730|18629580|P6|NOT COMPLETED|Second Rest Period (7-45 Days)||0
7568651|NCT02862730|18629581|P5|NOT COMPLETED|Second Rest Period (7-45 Days)||0
7568652|NCT02862730|18629582|P4|NOT COMPLETED|Second Rest Period (7-45 Days)||0
7568653|NCT02862730|18629583|P3|NOT COMPLETED|Second Rest Period (7-45 Days)||0
7568654|NCT02862730|18629584|P2|NOT COMPLETED|Second Rest Period (7-45 Days)||0
7568655|NCT02862730|18629585|P1|NOT COMPLETED|Second Rest Period (7-45 Days)||0
7568656|NCT02862730|18629579|P7|COMPLETED|Second Rest Period (7-45 Days)||1
7568657|NCT02862730|18629580|P6|COMPLETED|Second Rest Period (7-45 Days)||1
7568658|NCT02862730|18629581|P5|COMPLETED|Second Rest Period (7-45 Days)||5
7568659|NCT02862730|18629582|P4|COMPLETED|Second Rest Period (7-45 Days)||5
7568660|NCT02862730|18629583|P3|COMPLETED|Second Rest Period (7-45 Days)||7
7568661|NCT02862730|18629584|P2|COMPLETED|Second Rest Period (7-45 Days)||1
7568662|NCT02862730|18629585|P1|COMPLETED|Second Rest Period (7-45 Days)||4
7568663|NCT02862730|18629579|P7|STARTED|Second Rest Period (7-45 Days)||1
7568664|NCT02862730|18629580|P6|STARTED|Second Rest Period (7-45 Days)||1
7568665|NCT02862730|18629581|P5|STARTED|Second Rest Period (7-45 Days)||5
7568666|NCT02862730|18629582|P4|STARTED|Second Rest Period (7-45 Days)||5
7568667|NCT02862730|18629583|P3|STARTED|Second Rest Period (7-45 Days)||7
7568668|NCT02862730|18629584|P2|STARTED|Second Rest Period (7-45 Days)||1
7568669|NCT02862730|18629585|P1|STARTED|Second Rest Period (7-45 Days)||4
7568670|NCT02862730|18629579|P7|NOT COMPLETED|First Intervention (84 Hours)||0
7568671|NCT02862730|18629580|P6|NOT COMPLETED|First Intervention (84 Hours)||0
7568672|NCT02862730|18629581|P5|NOT COMPLETED|First Intervention (84 Hours)||0
7568673|NCT02862730|18629582|P4|NOT COMPLETED|First Intervention (84 Hours)||0
7568674|NCT02862730|18629583|P3|NOT COMPLETED|First Intervention (84 Hours)||0
7568675|NCT02862730|18629584|P2|NOT COMPLETED|First Intervention (84 Hours)||0
7568676|NCT02862730|18629585|P1|NOT COMPLETED|First Intervention (84 Hours)||0
7568677|NCT02862730|18629579|P7|COMPLETED|First Intervention (84 Hours)||1
7568678|NCT02862730|18629580|P6|COMPLETED|First Intervention (84 Hours)||1
7568679|NCT02862730|18629581|P5|COMPLETED|First Intervention (84 Hours)||5
7568680|NCT02862730|18629582|P4|COMPLETED|First Intervention (84 Hours)||5
7568681|NCT02862730|18629583|P3|COMPLETED|First Intervention (84 Hours)||7
7568682|NCT02862730|18629584|P2|COMPLETED|First Intervention (84 Hours)||1
7568683|NCT02862730|18629585|P1|COMPLETED|First Intervention (84 Hours)||4
7568684|NCT02862730|18629579|P7|STARTED|First Intervention (84 Hours)||1
7568685|NCT02862730|18629580|P6|STARTED|First Intervention (84 Hours)||1
7568686|NCT02862730|18629581|P5|STARTED|First Intervention (84 Hours)||5
7568687|NCT02862730|18629582|P4|STARTED|First Intervention (84 Hours)||5
7568688|NCT02862730|18629583|P3|STARTED|First Intervention (84 Hours)||7
7568689|NCT02862730|18629584|P2|STARTED|First Intervention (84 Hours)||1
7568690|NCT02862730|18629585|P1|STARTED|First Intervention (84 Hours)||4
7568691|NCT02862730|18629579|P7|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
7568692|NCT02862730|18629580|P6|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
7568693|NCT02862730|18629581|P5|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
7568694|NCT02862730|18629582|P4|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
7568695|NCT02862730|18629583|P3|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
7568696|NCT02862730|18629584|P2|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
7568697|NCT02862730|18629585|P1|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
7568698|NCT02862730|18629579|P7|COMPLETED|First Rest Period (1-12 Weeks)||1
7568699|NCT02862730|18629580|P6|COMPLETED|First Rest Period (1-12 Weeks)||1
7568700|NCT02862730|18629581|P5|COMPLETED|First Rest Period (1-12 Weeks)||5
7568701|NCT02862730|18629582|P4|COMPLETED|First Rest Period (1-12 Weeks)||5
7568702|NCT02862730|18629583|P3|COMPLETED|First Rest Period (1-12 Weeks)||7
7568703|NCT02862730|18629584|P2|COMPLETED|First Rest Period (1-12 Weeks)||1
7568704|NCT02862730|18629585|P1|COMPLETED|First Rest Period (1-12 Weeks)||4
7568705|NCT02862730|18629579|P7|STARTED|First Rest Period (1-12 Weeks)||1
7568706|NCT02862730|18629580|P6|STARTED|First Rest Period (1-12 Weeks)||1
7568707|NCT02862730|18629581|P5|STARTED|First Rest Period (1-12 Weeks)||5
7568708|NCT02862730|18629582|P4|STARTED|First Rest Period (1-12 Weeks)||5
7568709|NCT02862730|18629583|P3|STARTED|First Rest Period (1-12 Weeks)||7
7568710|NCT02862730|18629584|P2|STARTED|First Rest Period (1-12 Weeks)||1
7568711|NCT02862730|18629585|P1|STARTED|First Rest Period (1-12 Weeks)||4
7568712|NCT02862730|18629579|P7|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
7568713|NCT02862730|18629580|P6|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
7568714|NCT02862730|18629581|P5|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
7568715|NCT02862730|18629582|P4|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
7568716|NCT02862730|18629583|P3|NOT COMPLETED|Tslim Training Visit (2 Weeks)||1
7568717|NCT02862730|18629584|P2|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
7568718|NCT02862730|18629585|P1|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
7568719|NCT02862730|18629579|P7|COMPLETED|Tslim Training Visit (2 Weeks)||1
7568720|NCT02862730|18629580|P6|COMPLETED|Tslim Training Visit (2 Weeks)||1
7568721|NCT02862730|18629581|P5|COMPLETED|Tslim Training Visit (2 Weeks)||5
7568722|NCT02862730|18629582|P4|COMPLETED|Tslim Training Visit (2 Weeks)||5
7568723|NCT02862730|18629583|P3|COMPLETED|Tslim Training Visit (2 Weeks)||7
7568724|NCT02862730|18629584|P2|COMPLETED|Tslim Training Visit (2 Weeks)||1
7568725|NCT02862730|18629585|P1|COMPLETED|Tslim Training Visit (2 Weeks)||4
7568726|NCT02862730|18629579|P7|STARTED|Tslim Training Visit (2 Weeks)||1
7568727|NCT02862730|18629580|P6|STARTED|Tslim Training Visit (2 Weeks)||1
7568728|NCT02862730|18629581|P5|STARTED|Tslim Training Visit (2 Weeks)||5
7568729|NCT02862730|18629582|P4|STARTED|Tslim Training Visit (2 Weeks)||5
7568730|NCT02862730|18629583|P3|STARTED|Tslim Training Visit (2 Weeks)||8
7568731|NCT02862730|18629584|P2|STARTED|Tslim Training Visit (2 Weeks)||1
7568732|NCT02862730|18629585|P1|STARTED|Tslim Training Visit (2 Weeks)||4
7568733|NCT02862600|18629640|P1|NOT COMPLETED|Period 2--Perhexiline-high Target Range||7
7568734|NCT02862600|18629640|P1|COMPLETED|Period 2--Perhexiline-high Target Range|Study terminated on April 26, 2017 due to lack of efficacy in first 15 subjects completing Period 2.|15
7568735|NCT02862600|18629640|P1|STARTED|Period 2--Perhexiline-high Target Range|First subject completed Period 1 and moved into Period 2 perhexiline dosing on October 17, 2016|22
7568736|NCT02862600|18629640|P1|NOT COMPLETED|Period 1--Perhexiline-low Target Range||13
7568737|NCT02862600|18629640|P1|COMPLETED|Period 1--Perhexiline-low Target Range|Study terminated on April 26, 2017 due to lack of efficacy.|22
7568738|NCT02862600|18629640|P1|STARTED|Period 1--Perhexiline-low Target Range|First subject underwent baseline functional assessment and perhexiline dosing on August 22, 2016|35
7568739|NCT02862574|18629650|P3|NOT COMPLETED|Open-Label Treatment Period||1
7568740|NCT02862574|18629651|P2|NOT COMPLETED|Open-Label Treatment Period||3
7568741|NCT02862574|18629652|P1|NOT COMPLETED|Open-Label Treatment Period||2
7568742|NCT02862574|18629650|P3|COMPLETED|Open-Label Treatment Period||0
7568743|NCT02862574|18629651|P2|COMPLETED|Open-Label Treatment Period||0
7568744|NCT02862574|18629652|P1|COMPLETED|Open-Label Treatment Period||0
7568745|NCT02862574|18629650|P3|STARTED|Open-Label Treatment Period||1
7568746|NCT02862574|18629651|P2|STARTED|Open-Label Treatment Period||3
7568747|NCT02862574|18629652|P1|STARTED|Open-Label Treatment Period||2
7568748|NCT02862574|18629650|P3|NOT COMPLETED|Double-Blind Treatment Period||4
7568749|NCT02862574|18629651|P2|NOT COMPLETED|Double-Blind Treatment Period||2
7568750|NCT02862574|18629652|P1|NOT COMPLETED|Double-Blind Treatment Period||3
7568751|NCT02862574|18629650|P3|COMPLETED|Double-Blind Treatment Period||1
7568752|NCT02862574|18629651|P2|COMPLETED|Double-Blind Treatment Period||3
7568753|NCT02862574|18629652|P1|COMPLETED|Double-Blind Treatment Period||2
7568754|NCT02862574|18629650|P3|STARTED|Double-Blind Treatment Period||5
7568755|NCT02862574|18629651|P2|STARTED|Double-Blind Treatment Period||5
7568756|NCT02862574|18629652|P1|STARTED|Double-Blind Treatment Period||5
7568757|NCT02862548|18629672|P2|NOT COMPLETED|Open-Label Extension Phase||24
7568758|NCT02862548|18629673|P1|NOT COMPLETED|Open-Label Extension Phase||26
7568759|NCT02862548|18629672|P2|COMPLETED|Open-Label Extension Phase||0
7568760|NCT02862548|18629673|P1|COMPLETED|Open-Label Extension Phase||0
7568761|NCT02862548|18629672|P2|STARTED|Open-Label Extension Phase||24
7568762|NCT02862548|18629673|P1|STARTED|Open-Label Extension Phase||26
7568763|NCT02862548|18629672|P2|NOT COMPLETED|Open-Label Phase||1
7568764|NCT02862548|18629673|P1|NOT COMPLETED|Open-Label Phase||0
7568765|NCT02862548|18629672|P2|COMPLETED|Open-Label Phase||24
7568766|NCT02862548|18629673|P1|COMPLETED|Open-Label Phase||26
7568767|NCT02862548|18629672|P2|STARTED|Open-Label Phase||25
7568768|NCT02862548|18629673|P1|STARTED|Open-Label Phase||26
7568769|NCT02862535|18629701|P4|NOT COMPLETED|Overall Study||11
7568770|NCT02862535|18629702|P3|NOT COMPLETED|Overall Study||10
7568771|NCT02862535|18629703|P2|NOT COMPLETED|Overall Study||6
7568772|NCT02862535|18629704|P1|NOT COMPLETED|Overall Study||9
7568773|NCT02862535|18629701|P4|COMPLETED|Overall Study||0
7568774|NCT02862535|18629702|P3|COMPLETED|Overall Study||0
7568775|NCT02862535|18629703|P2|COMPLETED|Overall Study||0
7568776|NCT02862535|18629704|P1|COMPLETED|Overall Study||0
7568777|NCT02862535|18629701|P4|STARTED|Overall Study||11
7568778|NCT02862535|18629702|P3|STARTED|Overall Study||10
7568779|NCT02862535|18629703|P2|STARTED|Overall Study||6
7568780|NCT02862535|18629704|P1|STARTED|Overall Study||9
7568781|NCT02862106|18629732|P2|NOT COMPLETED|Overall Study||6
7568782|NCT02862106|18629733|P1|NOT COMPLETED|Overall Study||38
7568783|NCT02862106|18629732|P2|COMPLETED|Overall Study||20
7568784|NCT02862106|18629733|P1|COMPLETED|Overall Study||145
7568785|NCT02862106|18629732|P2|STARTED|Overall Study||26
7568786|NCT02862106|18629733|P1|STARTED|Overall Study||183
7568787|NCT02861937|18629794|P3|NOT COMPLETED|Overall Study||0
7568788|NCT02861937|18629795|P2|NOT COMPLETED|Overall Study||0
7568789|NCT02861937|18629796|P1|NOT COMPLETED|Overall Study||0
7568790|NCT02861937|18629794|P3|COMPLETED|Overall Study||12
7568791|NCT02861937|18629795|P2|COMPLETED|Overall Study||12
7568792|NCT02861937|18629796|P1|COMPLETED|Overall Study||10
7568793|NCT02861937|18629794|P3|STARTED|Overall Study||12
7568794|NCT02861937|18629795|P2|STARTED|Overall Study||12
7568795|NCT02861937|18629796|P1|STARTED|Overall Study||10
7568796|NCT02861807|18629818|P2|NOT COMPLETED|Overall Study||14
7568797|NCT02861807|18629819|P1|NOT COMPLETED|Overall Study||12
7568798|NCT02861807|18629818|P2|COMPLETED|Overall Study||23
7568799|NCT02861807|18629819|P1|COMPLETED|Overall Study||35
7568800|NCT02861807|18629818|P2|Attended 2-month Follow-up|Overall Study||20
7568801|NCT02861807|18629819|P1|Attended 2-month Follow-up|Overall Study||32
7568802|NCT02861807|18629818|P2|Attended Post-treatment Assessment|Overall Study||18
7568803|NCT02861807|18629819|P1|Attended Post-treatment Assessment|Overall Study||34
7568804|NCT02861807|18629818|P2|STARTED|Overall Study||37
7568805|NCT02861807|18629819|P1|STARTED|Overall Study||47
7568806|NCT02861664|18629835|P2|NOT COMPLETED|Overall Study||1
7568807|NCT02861664|18629836|P1|NOT COMPLETED|Overall Study||0
7568808|NCT02861664|18629835|P2|COMPLETED|Overall Study||67
7568809|NCT02861664|18629836|P1|COMPLETED|Overall Study||67
7568810|NCT02861664|18629835|P2|STARTED|Overall Study||68
7568811|NCT02861664|18629836|P1|STARTED|Overall Study||67
7568812|NCT02861534|18629848|P2|NOT COMPLETED|Overall Study||587
7568813|NCT02861534|18629849|P1|NOT COMPLETED|Overall Study||574
7568814|NCT02861534|18629848|P2|COMPLETED|Overall Study||1937
7568815|NCT02861534|18629849|P1|COMPLETED|Overall Study||1952
7568816|NCT02861534|18629848|P2|Treated|Overall Study||2515
7568817|NCT02861534|18629849|P1|Treated|Overall Study||2519
7568818|NCT02861534|18629848|P2|STARTED|Overall Study||2524
7568819|NCT02861534|18629849|P1|STARTED|Overall Study||2526
7568820|NCT02861131|18629875|P2|NOT COMPLETED|Overall Study||0
7568821|NCT02861131|18629876|P1|NOT COMPLETED|Overall Study||0
7568822|NCT02861131|18629875|P2|COMPLETED|Overall Study||100
7568823|NCT02861131|18629876|P1|COMPLETED|Overall Study||100
7568824|NCT02861131|18629875|P2|STARTED|Overall Study||100
7568825|NCT02861131|18629876|P1|STARTED|Overall Study||100
7568826|NCT02861118|18629894|P2|NOT COMPLETED|Overall Study||0
7568827|NCT02861118|18629895|P1|NOT COMPLETED|Overall Study||0
7568828|NCT02861118|18629894|P2|COMPLETED|Overall Study||116
7568829|NCT02861118|18629895|P1|COMPLETED|Overall Study||194
7568830|NCT02861118|18629894|P2|STARTED|Overall Study||116
7568831|NCT02861118|18629895|P1|STARTED|Overall Study||194
7568832|NCT02860845|18629909|P2|NOT COMPLETED|Overall Study||1
7568833|NCT02860845|18629910|P1|NOT COMPLETED|Overall Study||2
7568834|NCT02860845|18629909|P2|COMPLETED|Overall Study||23
7568835|NCT02860845|18629910|P1|COMPLETED|Overall Study||22
7568836|NCT02860845|18629909|P2|Analyzed Patients|Overall Study||23
7568837|NCT02860845|18629910|P1|Analyzed Patients|Overall Study||22
7568838|NCT02860845|18629909|P2|STARTED|Overall Study||24
7568839|NCT02860845|18629910|P1|STARTED|Overall Study||24
7568840|NCT02860507|18629926|P2|NOT COMPLETED|Overall Study||0
7568841|NCT02860507|18629927|P1|NOT COMPLETED|Overall Study||0
7568842|NCT02860507|18629926|P2|COMPLETED|Overall Study||25
7568843|NCT02860507|18629927|P1|COMPLETED|Overall Study||25
7568844|NCT02860507|18629926|P2|STARTED|Overall Study||25
7568845|NCT02860507|18629927|P1|STARTED|Overall Study||25
7568846|NCT02860169|18629937|P1|NOT COMPLETED|Part C||1
7568847|NCT02860169|18629937|P1|COMPLETED|Part C||47
7568848|NCT02860169|18629937|P1|Participants With Cold and Flu|Part C||42
7568849|NCT02860169|18629937|P1|Healthy Participants|Part C||6
7568850|NCT02860169|18629937|P1|STARTED|Part C||48
7568851|NCT02860169|18629937|P1|NOT COMPLETED|Part B||11
7568852|NCT02860169|18629937|P1|COMPLETED|Part B||9
7568853|NCT02860169|18629937|P1|Participants With Cold and Flu|Part B||10
7568854|NCT02860169|18629937|P1|Healthy Participants|Part B||10
7568855|NCT02860169|18629937|P1|STARTED|Part B||20
7568856|NCT02860169|18629937|P1|NOT COMPLETED|Part A||11
7568857|NCT02860169|18629937|P1|COMPLETED|Part A||35
7568858|NCT02860169|18629937|P1|Participants With Cold and Flu|Part A||0
7568859|NCT02860169|18629937|P1|Healthy Participants|Part A||46
7568860|NCT02860169|18629937|P1|STARTED|Part A||46
7568861|NCT02859597|18629955|P2|NOT COMPLETED|Overall Study||0
7568862|NCT02859597|18629956|P1|NOT COMPLETED|Overall Study||0
7568863|NCT02859597|18629955|P2|COMPLETED|Overall Study|September 2018|19
7568864|NCT02859597|18629956|P1|COMPLETED|Overall Study|September 2018|22
7568865|NCT02859597|18629955|P2|STARTED|Overall Study|Started Dec 2016|19
7568866|NCT02859597|18629956|P1|STARTED|Overall Study|started Dec 2016|22
7568867|NCT02859454|18629966|P1|NOT COMPLETED|Overall Study||1
7568868|NCT02859454|18629966|P1|COMPLETED|Overall Study||12
7568869|NCT02859454|18629966|P1|STARTED|Overall Study||13
7568870|NCT02859441|18629977|P1|NOT COMPLETED|Overall Study||0
7568871|NCT02859441|18629977|P1|COMPLETED|Overall Study||3
7568872|NCT02859441|18629977|P1|STARTED|Overall Study||3
7568873|NCT02859246|18630022|P1|NOT COMPLETED|Overall Study||5
7568874|NCT02859246|18630022|P1|COMPLETED|Overall Study|10 subjects completed the study|10
7568875|NCT02859246|18630022|P1|STARTED|Overall Study|15 subjects were enrolled into study|15
7568876|NCT02858726|18630031|P4|NOT COMPLETED|Overall Study||3
7568877|NCT02858726|18630032|P3|NOT COMPLETED|Overall Study||11
7568878|NCT02858726|18630033|P2|NOT COMPLETED|Overall Study||7
7568879|NCT02858726|18630034|P1|NOT COMPLETED|Overall Study||5
7568880|NCT02858726|18630031|P4|COMPLETED|Overall Study||42
7568881|NCT02858726|18630032|P3|COMPLETED|Overall Study||33
7568882|NCT02858726|18630033|P2|COMPLETED|Overall Study||35
7568883|NCT02858726|18630034|P1|COMPLETED|Overall Study||39
7568884|NCT02858726|18630031|P4|STARTED|Overall Study||45
7568885|NCT02858726|18630032|P3|STARTED|Overall Study||44
7568886|NCT02858726|18630033|P2|STARTED|Overall Study||42
7568887|NCT02858726|18630034|P1|STARTED|Overall Study||44
7568888|NCT02858713|18630050|P2|NOT COMPLETED|Overall Study||5
7568889|NCT02858713|18630051|P1|NOT COMPLETED|Overall Study||7
7568890|NCT02858713|18630050|P2|COMPLETED|Overall Study||61
7568891|NCT02858713|18630051|P1|COMPLETED|Overall Study||61
7568892|NCT02858713|18630050|P2|STARTED|Overall Study||66
7568893|NCT02858713|18630051|P1|STARTED|Overall Study||68
7568894|NCT02858492|18630065|P4|NOT COMPLETED|Overall Study||6
7568895|NCT02858492|18630066|P3|NOT COMPLETED|Overall Study||0
7568896|NCT02858492|18630067|P2|NOT COMPLETED|Overall Study||1
7568897|NCT02858492|18630068|P1|NOT COMPLETED|Overall Study||0
7568898|NCT02858492|18630065|P4|COMPLETED|Overall Study||22
7568899|NCT02858492|18630066|P3|COMPLETED|Overall Study||5
7568900|NCT02858492|18630067|P2|COMPLETED|Overall Study||14
7568901|NCT02858492|18630068|P1|COMPLETED|Overall Study||3
7568902|NCT02858492|18630065|P4|STARTED|Overall Study||28
7568903|NCT02858492|18630066|P3|STARTED|Overall Study||5
7568904|NCT02858492|18630067|P2|STARTED|Overall Study||15
7568905|NCT02858492|18630068|P1|STARTED|Overall Study||3
7568906|NCT02858440|18630244|P1|NOT COMPLETED|Overall Study||12
7568907|NCT02858440|18630244|P1|COMPLETED|Overall Study||223
7568908|NCT02858440|18630244|P1|STARTED|Overall Study||235
7568909|NCT02858401|18630277|P7|NOT COMPLETED|Overall Study||0
7568910|NCT02858401|18630278|P6|NOT COMPLETED|Overall Study||1
7568911|NCT02858401|18630279|P5|NOT COMPLETED|Overall Study||0
7568912|NCT02858401|18630280|P4|NOT COMPLETED|Overall Study||0
7568913|NCT02858401|18630281|P3|NOT COMPLETED|Overall Study||0
7568914|NCT02858401|18630282|P2|NOT COMPLETED|Overall Study||1
7568915|NCT02858401|18630283|P1|NOT COMPLETED|Overall Study||0
7568916|NCT02858401|18630277|P7|COMPLETED|Overall Study||12
7568917|NCT02858401|18630278|P6|COMPLETED|Overall Study||5
7568918|NCT02858401|18630279|P5|COMPLETED|Overall Study||6
7568919|NCT02858401|18630280|P4|COMPLETED|Overall Study||6
7568920|NCT02858401|18630281|P3|COMPLETED|Overall Study||6
7568921|NCT02858401|18630282|P2|COMPLETED|Overall Study||5
7568922|NCT02858401|18630283|P1|COMPLETED|Overall Study||6
7568923|NCT02858401|18630277|P7|STARTED|Overall Study||12
7568924|NCT02858401|18630278|P6|STARTED|Overall Study||6
7568925|NCT02858401|18630279|P5|STARTED|Overall Study||6
7568926|NCT02858401|18630280|P4|STARTED|Overall Study||6
7568927|NCT02858401|18630281|P3|STARTED|Overall Study||6
7568928|NCT02858401|18630282|P2|STARTED|Overall Study||6
7568929|NCT02858401|18630283|P1|STARTED|Overall Study||6
7568930|NCT02858362|18630694|P3|NOT COMPLETED|Overall Study||3
7568931|NCT02858362|18630695|P2|NOT COMPLETED|Overall Study||1
7568932|NCT02858362|18630696|P1|NOT COMPLETED|Overall Study||2
7568933|NCT02858362|18630694|P3|COMPLETED|Overall Study||0
7568934|NCT02858362|18630695|P2|COMPLETED|Overall Study||9
7568935|NCT02858362|18630696|P1|COMPLETED|Overall Study||28
7568936|NCT02858362|18630694|P3|Did Not Enter Extension Phase|Overall Study||0
7568937|NCT02858362|18630695|P2|Did Not Enter Extension Phase|Overall Study||2
7568938|NCT02858362|18630696|P1|Did Not Enter Extension Phase|Overall Study||1
7568939|NCT02858362|18630694|P3|STARTED|Overall Study||3
7568940|NCT02858362|18630695|P2|STARTED|Overall Study||10
7568941|NCT02858362|18630696|P1|STARTED|Overall Study||30
7568942|NCT02858349|18630731|P1|NOT COMPLETED|Overall Study||0
7568943|NCT02858349|18630731|P1|COMPLETED|Overall Study||10
7568944|NCT02858349|18630731|P1|STARTED|Overall Study||10
7568945|NCT02858180|18630737|P2|NOT COMPLETED|Overall Study||2
7568946|NCT02858180|18630738|P1|NOT COMPLETED|Overall Study||0
7568947|NCT02858180|18630737|P2|COMPLETED|Overall Study|Completed a 12-week course of therapy.|3
7568948|NCT02858180|18630738|P1|COMPLETED|Overall Study|Completed a 12-week course of therapy.|10
7568949|NCT02858180|18630737|P2|STARTED|Overall Study||5
7568950|NCT02858180|18630738|P1|STARTED|Overall Study||10
7568951|NCT02858050|18630752|P2|NOT COMPLETED|Overall Study||0
7568952|NCT02858050|18630753|P1|NOT COMPLETED|Overall Study||0
7568953|NCT02858050|18630752|P2|COMPLETED|Overall Study||20
7568954|NCT02858050|18630753|P1|COMPLETED|Overall Study||20
7568955|NCT02858050|18630752|P2|STARTED|Overall Study||20
7568956|NCT02858050|18630753|P1|STARTED|Overall Study||20
7568957|NCT02857816|18630759|P1|NOT COMPLETED|Overall Study||38
7568958|NCT02857816|18630759|P1|COMPLETED|Overall Study||116
7568959|NCT02857816|18630759|P1|Subjects Qualified and Treated With PTNM|Overall Study||120
7568960|NCT02857816|18630759|P1|STARTED|Overall Study||154
7568961|NCT02857426|18630767|P2|NOT COMPLETED|Follow-up||6
7568962|NCT02857426|18630768|P1|NOT COMPLETED|Follow-up||10
7568963|NCT02857426|18630767|P2|COMPLETED|Follow-up||13
7568964|NCT02857426|18630768|P1|COMPLETED|Follow-up||37
7568965|NCT02857426|18630767|P2|STARTED|Follow-up||19
7568966|NCT02857426|18630768|P1|STARTED|Follow-up||47
7568967|NCT02857426|18630767|P2|NOT COMPLETED|Treatment||17
7568968|NCT02857426|18630768|P1|NOT COMPLETED|Treatment||46
7568969|NCT02857426|18630767|P2|COMPLETED|Treatment||2
7568970|NCT02857426|18630768|P1|COMPLETED|Treatment||1
7568971|NCT02857426|18630767|P2|STARTED|Treatment||19
7568972|NCT02857426|18630768|P1|STARTED|Treatment||47
7568973|NCT02857283|18630784|P2|NOT COMPLETED|Second Exposure||0
7568974|NCT02857283|18630785|P1|NOT COMPLETED|Second Exposure||0
7568975|NCT02857283|18630784|P2|COMPLETED|Second Exposure||7
7568976|NCT02857283|18630785|P1|COMPLETED|Second Exposure||7
7568977|NCT02857283|18630784|P2|STARTED|Second Exposure||7
7568978|NCT02857283|18630785|P1|STARTED|Second Exposure||7
7568979|NCT02857283|18630784|P2|NOT COMPLETED|Washout (2 Weeks)||0
7568980|NCT02857283|18630785|P1|NOT COMPLETED|Washout (2 Weeks)||0
7568981|NCT02857283|18630784|P2|COMPLETED|Washout (2 Weeks)||7
7568982|NCT02857283|18630785|P1|COMPLETED|Washout (2 Weeks)||7
7568983|NCT02857283|18630784|P2|STARTED|Washout (2 Weeks)||7
7568984|NCT02857283|18630785|P1|STARTED|Washout (2 Weeks)||7
7568985|NCT02857283|18630784|P2|NOT COMPLETED|First Exposure||0
7568986|NCT02857283|18630785|P1|NOT COMPLETED|First Exposure||1
7568987|NCT02857283|18630784|P2|COMPLETED|First Exposure||7
7568988|NCT02857283|18630785|P1|COMPLETED|First Exposure||7
7568989|NCT02857283|18630784|P2|STARTED|First Exposure||7
7568990|NCT02857283|18630785|P1|STARTED|First Exposure||8
7568991|NCT02856880|18630819|P1|NOT COMPLETED|Overall Study||1
7568992|NCT02856880|18630819|P1|COMPLETED|Overall Study||44
7568993|NCT02856880|18630819|P1|Received SLS Negative Control|Overall Study||44
7568994|NCT02856880|18630819|P1|Received Non-SLS Negative Control|Overall Study||44
7568995|NCT02856880|18630819|P1|Received Positive Control|Overall Study||45
7568996|NCT02856880|18630819|P1|Received Test Zinc Non-IPMP|Overall Study||44
7568997|NCT02856880|18630819|P1|Received Test Zinc-IPMP|Overall Study||44
7568998|NCT02856880|18630819|P1|STARTED|Overall Study||45
7568999|NCT02856828|18630845|P2|NOT COMPLETED|Overall Study||0
7569000|NCT02856828|18630846|P1|NOT COMPLETED|Overall Study||0
7569001|NCT02856828|18630845|P2|COMPLETED|Overall Study||3
7569002|NCT02856828|18630846|P1|COMPLETED|Overall Study||2
7569003|NCT02856828|18630845|P2|STARTED|Overall Study||3
7569004|NCT02856828|18630846|P1|STARTED|Overall Study||2
7569005|NCT02856555|18630863|P3|NOT COMPLETED|Overall Study||0
7569006|NCT02856555|18630864|P2|NOT COMPLETED|Overall Study||4
7569007|NCT02856555|18630865|P1|NOT COMPLETED|Overall Study||5
7569008|NCT02856555|18630863|P3|COMPLETED|Overall Study||26
7569009|NCT02856555|18630864|P2|COMPLETED|Overall Study||46
7569010|NCT02856555|18630865|P1|COMPLETED|Overall Study||46
7569011|NCT02856555|18630863|P3|STARTED|Overall Study||26
7569012|NCT02856555|18630864|P2|STARTED|Overall Study||50
7569013|NCT02856555|18630865|P1|STARTED|Overall Study||51
7569014|NCT02856282|18630873|P1|NOT COMPLETED|Overall Study||1
7569015|NCT02856282|18630873|P1|COMPLETED|Overall Study||45
7569016|NCT02856282|18630873|P1|STARTED|Overall Study||46
7569017|NCT02856035|18630883|P1|NOT COMPLETED|Overall Study||0
7569018|NCT02856035|18630883|P1|COMPLETED|Overall Study||4
7569019|NCT02856035|18630883|P1|STARTED|Overall Study||4
7569020|NCT02855567|18630890|P2|NOT COMPLETED|Overall Study||0
7569021|NCT02855567|18630891|P1|NOT COMPLETED|Overall Study||0
7569022|NCT02855567|18630890|P2|COMPLETED|Overall Study||56
7569023|NCT02855567|18630891|P1|COMPLETED|Overall Study||54
7569024|NCT02855567|18630890|P2|STARTED|Overall Study||56
7569025|NCT02855567|18630891|P1|STARTED|Overall Study||54
7569026|NCT02855541|18630905|P1|NOT COMPLETED|Overall Study||4
7569027|NCT02855541|18630905|P1|COMPLETED|Overall Study||21
7569028|NCT02855541|18630905|P1|STARTED|Overall Study||25
7569029|NCT02855450|18630918|P2|NOT COMPLETED|Overall Study||0
7569030|NCT02855450|18630919|P1|NOT COMPLETED|Overall Study||5
7569031|NCT02855450|18630918|P2|COMPLETED|Overall Study||20
7569032|NCT02855450|18630919|P1|COMPLETED|Overall Study||35
7569033|NCT02855450|18630918|P2|STARTED|Overall Study||20
7569034|NCT02855450|18630919|P1|STARTED|Overall Study||40
7569035|NCT02855437|18630927|P2|NOT COMPLETED|Phase 2||1
7569036|NCT02855437|18630928|P1|NOT COMPLETED|Phase 2||1
7569037|NCT02855437|18630927|P2|COMPLETED|Phase 2||18
7569038|NCT02855437|18630928|P1|COMPLETED|Phase 2||20
7569039|NCT02855437|18630927|P2|STARTED|Phase 2||19
7569040|NCT02855437|18630928|P1|STARTED|Phase 2||21
7569041|NCT02855437|18630927|P2|NOT COMPLETED|Crossover Period (Same Day)||0
7569042|NCT02855437|18630928|P1|NOT COMPLETED|Crossover Period (Same Day)||0
7569043|NCT02855437|18630927|P2|COMPLETED|Crossover Period (Same Day)||19
7569044|NCT02855437|18630928|P1|COMPLETED|Crossover Period (Same Day)||21
7569045|NCT02855437|18630927|P2|STARTED|Crossover Period (Same Day)||19
7569046|NCT02855437|18630928|P1|STARTED|Crossover Period (Same Day)||21
7569047|NCT02855437|18630927|P2|NOT COMPLETED|Phase 1||2
7569048|NCT02855437|18630928|P1|NOT COMPLETED|Phase 1||2
7569049|NCT02855437|18630927|P2|COMPLETED|Phase 1||19
7569050|NCT02855437|18630928|P1|COMPLETED|Phase 1||21
7569051|NCT02855437|18630927|P2|STARTED|Phase 1||21
7569052|NCT02855437|18630928|P1|STARTED|Phase 1||23
7569053|NCT02855411|18630936|P1|NOT COMPLETED|Overall Study||35
7569054|NCT02855411|18630936|P1|COMPLETED|Overall Study||0
7569055|NCT02855411|18630936|P1|Assigned to Study Treatment|Overall Study||0
7569056|NCT02855411|18630936|P1|STARTED|Overall Study||35
7569057|NCT02855359|18630958|P4|NOT COMPLETED|Overall Study||0
7569058|NCT02855359|18630959|P3|NOT COMPLETED|Overall Study||0
7569059|NCT02855359|18630960|P2|NOT COMPLETED|Overall Study||13
7569060|NCT02855359|18630961|P1|NOT COMPLETED|Overall Study||11
7569061|NCT02855359|18630958|P4|COMPLETED|Overall Study||0
7569062|NCT02855359|18630959|P3|COMPLETED|Overall Study||0
7569063|NCT02855359|18630960|P2|COMPLETED|Overall Study||0
7569064|NCT02855359|18630961|P1|COMPLETED|Overall Study||0
7569065|NCT02855359|18630958|P4|STARTED|Overall Study||0
7569066|NCT02855359|18630959|P3|STARTED|Overall Study||0
7569067|NCT02855359|18630960|P2|STARTED|Overall Study||13
7569068|NCT02855359|18630961|P1|STARTED|Overall Study||11
7569069|NCT02855086|18630995|P2|NOT COMPLETED|Overall Study||0
7569070|NCT02855086|18630996|P1|NOT COMPLETED|Overall Study||0
7569071|NCT02855086|18630995|P2|COMPLETED|Overall Study||1
7569072|NCT02855086|18630996|P1|COMPLETED|Overall Study||2
7569073|NCT02855086|18630995|P2|STARTED|Overall Study||1
7569074|NCT02855086|18630996|P1|STARTED|Overall Study||2
7569075|NCT02854800|18631007|P3|NOT COMPLETED|Overall Study||6
7569076|NCT02854800|18631008|P2|NOT COMPLETED|Overall Study||13
7569077|NCT02854800|18631009|P1|NOT COMPLETED|Overall Study||20
7569078|NCT02854800|18631007|P3|COMPLETED|Overall Study||8
7569079|NCT02854800|18631008|P2|COMPLETED|Overall Study||15
7569080|NCT02854800|18631009|P1|COMPLETED|Overall Study||12
7569081|NCT02854800|18631007|P3|STARTED|Overall Study||14
7569082|NCT02854800|18631008|P2|STARTED|Overall Study||28
7569083|NCT02854800|18631009|P1|STARTED|Overall Study||32
7569084|NCT02854631|18631049|P2|NOT COMPLETED|Overall Study||15
7569085|NCT02854631|18631050|P1|NOT COMPLETED|Overall Study||26
7569086|NCT02854631|18631049|P2|COMPLETED|Overall Study||37
7569087|NCT02854631|18631050|P1|COMPLETED|Overall Study||26
7569088|NCT02854631|18631049|P2|STARTED|Overall Study||52
7569089|NCT02854631|18631050|P1|STARTED|Overall Study||52
7569090|NCT02854605|18631111|P3|NOT COMPLETED|Overall Study||4
7569091|NCT02854605|18631112|P2|NOT COMPLETED|Overall Study||7
7569092|NCT02854605|18631113|P1|NOT COMPLETED|Overall Study||3
7569093|NCT02854605|18631111|P3|COMPLETED|Overall Study||24
7569094|NCT02854605|18631112|P2|COMPLETED|Overall Study||49
7569095|NCT02854605|18631113|P1|COMPLETED|Overall Study||53
7569096|NCT02854605|18631111|P3|STARTED|Overall Study||28
7569097|NCT02854605|18631112|P2|STARTED|Overall Study||56
7569098|NCT02854605|18631113|P1|STARTED|Overall Study||56
7569099|NCT02854540|18631124|P1|NOT COMPLETED|Overall Study||2
7569100|NCT02854540|18631124|P1|COMPLETED|Overall Study||11
7569101|NCT02854540|18631124|P1|STARTED|Overall Study||13
7569102|NCT02854527|18631143|P10|NOT COMPLETED|Overall Study||0
7569103|NCT02854527|18631144|P9|NOT COMPLETED|Overall Study||0
7569104|NCT02854527|18631145|P8|NOT COMPLETED|Overall Study||0
7569105|NCT02854527|18631146|P7|NOT COMPLETED|Overall Study||0
7569106|NCT02854527|18631147|P6|NOT COMPLETED|Overall Study||0
7569107|NCT02854527|18631148|P5|NOT COMPLETED|Overall Study||1
7569108|NCT02854527|18631149|P4|NOT COMPLETED|Overall Study||1
7569109|NCT02854527|18631150|P3|NOT COMPLETED|Overall Study||0
7569110|NCT02854527|18631151|P2|NOT COMPLETED|Overall Study||0
7569111|NCT02854527|18631152|P1|NOT COMPLETED|Overall Study||0
7569112|NCT02854527|18631143|P10|COMPLETED|Overall Study||3
7569113|NCT02854527|18631144|P9|COMPLETED|Overall Study||3
7569114|NCT02854527|18631145|P8|COMPLETED|Overall Study||3
7569115|NCT02854527|18631146|P7|COMPLETED|Overall Study||3
7569116|NCT02854527|18631147|P6|COMPLETED|Overall Study||3
7569117|NCT02854527|18631148|P5|COMPLETED|Overall Study||2
7569118|NCT02854527|18631149|P4|COMPLETED|Overall Study||2
7569119|NCT02854527|18631150|P3|COMPLETED|Overall Study||3
7569120|NCT02854527|18631151|P2|COMPLETED|Overall Study||3
7569121|NCT02854527|18631152|P1|COMPLETED|Overall Study||3
7569122|NCT02854527|18631143|P10|Received T|Overall Study||3
7569123|NCT02854527|18631144|P9|Received T|Overall Study||3
7569124|NCT02854527|18631145|P8|Received T|Overall Study||3
7569125|NCT02854527|18631146|P7|Received T|Overall Study||3
7569126|NCT02854527|18631147|P6|Received T|Overall Study||3
7569127|NCT02854527|18631148|P5|Received T|Overall Study||2
7569128|NCT02854527|18631149|P4|Received T|Overall Study||2
7569129|NCT02854527|18631150|P3|Received T|Overall Study||3
7569130|NCT02854527|18631151|P2|Received T|Overall Study||3
7569131|NCT02854527|18631152|P1|Received T|Overall Study||3
7569132|NCT02854527|18631143|P10|Received R4|Overall Study||3
7569133|NCT02854527|18631144|P9|Received R4|Overall Study||3
7569134|NCT02854527|18631145|P8|Received R4|Overall Study||3
7569135|NCT02854527|18631146|P7|Received R4|Overall Study||3
7569136|NCT02854527|18631147|P6|Received R4|Overall Study||3
7569137|NCT02854527|18631148|P5|Received R4|Overall Study||3
7569138|NCT02854527|18631149|P4|Received R4|Overall Study||2
7569139|NCT02854527|18631150|P3|Received R4|Overall Study||3
7569140|NCT02854527|18631151|P2|Received R4|Overall Study||3
7569141|NCT02854527|18631152|P1|Received R4|Overall Study||3
7569142|NCT02854527|18631143|P10|Received R3|Overall Study||3
7569143|NCT02854527|18631144|P9|Received R3|Overall Study||3
7569144|NCT02854527|18631145|P8|Received R3|Overall Study||3
7569145|NCT02854527|18631146|P7|Received R3|Overall Study||3
7569146|NCT02854527|18631147|P6|Received R3|Overall Study||3
7569147|NCT02854527|18631148|P5|Received R3|Overall Study||3
7569148|NCT02854527|18631149|P4|Received R3|Overall Study||2
7569149|NCT02854527|18631150|P3|Received R3|Overall Study||3
7569150|NCT02854527|18631151|P2|Received R3|Overall Study||3
7569151|NCT02854527|18631152|P1|Received R3|Overall Study||3
7569152|NCT02854527|18631143|P10|Received R2|Overall Study||3
7569153|NCT02854527|18631144|P9|Received R2|Overall Study||3
7569154|NCT02854527|18631145|P8|Received R2|Overall Study||3
7569155|NCT02854527|18631146|P7|Received R2|Overall Study||3
7569156|NCT02854527|18631147|P6|Received R2|Overall Study||3
7569157|NCT02854527|18631148|P5|Received R2|Overall Study||3
7569158|NCT02854527|18631149|P4|Received R2|Overall Study||3
7569159|NCT02854527|18631150|P3|Received R2|Overall Study||3
7569160|NCT02854527|18631151|P2|Received R2|Overall Study||3
7569161|NCT02854527|18631152|P1|Received R2|Overall Study||3
7569162|NCT02854527|18631143|P10|Received R1|Overall Study||3
7569163|NCT02854527|18631144|P9|Received R1|Overall Study||3
7569164|NCT02854527|18631145|P8|Received R1|Overall Study||3
7569165|NCT02854527|18631146|P7|Received R1|Overall Study||3
7569166|NCT02854527|18631147|P6|Received R1|Overall Study||3
7569167|NCT02854527|18631148|P5|Received R1|Overall Study||2
7569168|NCT02854527|18631149|P4|Received R1|Overall Study||2
7569169|NCT02854527|18631150|P3|Received R1|Overall Study||3
7569170|NCT02854527|18631151|P2|Received R1|Overall Study||3
7569171|NCT02854527|18631152|P1|Received R1|Overall Study||3
7569172|NCT02854527|18631143|P10|STARTED|Overall Study||3
7569173|NCT02854527|18631144|P9|STARTED|Overall Study||3
7569174|NCT02854527|18631145|P8|STARTED|Overall Study||3
7569175|NCT02854527|18631146|P7|STARTED|Overall Study||3
7569176|NCT02854527|18631147|P6|STARTED|Overall Study||3
7569177|NCT02854527|18631148|P5|STARTED|Overall Study||3
7569178|NCT02854527|18631149|P4|STARTED|Overall Study||3
7569179|NCT02854527|18631150|P3|STARTED|Overall Study||3
7569180|NCT02854527|18631151|P2|STARTED|Overall Study||3
7569181|NCT02854527|18631152|P1|STARTED|Overall Study||3
7569182|NCT02854059|18631185|P2|NOT COMPLETED|Overall Study||0
7569183|NCT02854059|18631186|P1|NOT COMPLETED|Overall Study||0
7569184|NCT02854059|18631185|P2|COMPLETED|Overall Study||0
7569185|NCT02854059|18631186|P1|COMPLETED|Overall Study||2
7569186|NCT02854059|18631185|P2|STARTED|Overall Study||0
7569187|NCT02854059|18631186|P1|STARTED|Overall Study||2
7569188|NCT02853929|18631210|P2|NOT COMPLETED|Overall Study||4
7569189|NCT02853929|18631211|P1|NOT COMPLETED|Overall Study||11
7569190|NCT02853929|18631210|P2|COMPLETED|Overall Study||277
7569191|NCT02853929|18631211|P1|COMPLETED|Overall Study||259
7569192|NCT02853929|18631210|P2|Vaccinated|Overall Study||277
7569193|NCT02853929|18631211|P1|Vaccinated|Overall Study||263
7569194|NCT02853929|18631210|P2|STARTED|Overall Study||281
7569195|NCT02853929|18631211|P1|STARTED|Overall Study||270
7569196|NCT02853435|18631252|P6|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
7569197|NCT02853435|18631253|P5|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
7569198|NCT02853435|18631254|P4|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
7569199|NCT02853435|18631255|P3|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
7569200|NCT02853435|18631256|P2|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
7569201|NCT02853435|18631257|P1|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
7569202|NCT02853435|18631252|P6|COMPLETED|Part 3, Period 3 (3 Days)||2
7569203|NCT02853435|18631253|P5|COMPLETED|Part 3, Period 3 (3 Days)||9
7569204|NCT02853435|18631254|P4|COMPLETED|Part 3, Period 3 (3 Days)||0
7569205|NCT02853435|18631255|P3|COMPLETED|Part 3, Period 3 (3 Days)||0
7569206|NCT02853435|18631256|P2|COMPLETED|Part 3, Period 3 (3 Days)||0
7569207|NCT02853435|18631257|P1|COMPLETED|Part 3, Period 3 (3 Days)||0
7569208|NCT02853435|18631252|P6|STARTED|Part 3, Period 3 (3 Days)||2
7569209|NCT02853435|18631253|P5|STARTED|Part 3, Period 3 (3 Days)||9
7569210|NCT02853435|18631254|P4|STARTED|Part 3, Period 3 (3 Days)||0
7569211|NCT02853435|18631255|P3|STARTED|Part 3, Period 3 (3 Days)||0
7569212|NCT02853435|18631256|P2|STARTED|Part 3, Period 3 (3 Days)||0
7569213|NCT02853435|18631257|P1|STARTED|Part 3, Period 3 (3 Days)||0
7569214|NCT02853435|18631252|P6|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
7569215|NCT02853435|18631253|P5|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||1
7569216|NCT02853435|18631254|P4|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
7569217|NCT02853435|18631255|P3|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
7569218|NCT02853435|18631256|P2|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
7569219|NCT02853435|18631257|P1|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
7569220|NCT02853435|18631252|P6|COMPLETED|Part 3, Washout Period 2 (3 Days)||2
7569221|NCT02853435|18631253|P5|COMPLETED|Part 3, Washout Period 2 (3 Days)||9
7569222|NCT02853435|18631254|P4|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
7569223|NCT02853435|18631255|P3|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
7569224|NCT02853435|18631256|P2|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
7569225|NCT02853435|18631257|P1|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
7569226|NCT02853435|18631252|P6|STARTED|Part 3, Washout Period 2 (3 Days)||2
7569227|NCT02853435|18631253|P5|STARTED|Part 3, Washout Period 2 (3 Days)||10
7569228|NCT02853435|18631254|P4|STARTED|Part 3, Washout Period 2 (3 Days)||0
7569229|NCT02853435|18631255|P3|STARTED|Part 3, Washout Period 2 (3 Days)||0
7569230|NCT02853435|18631256|P2|STARTED|Part 3, Washout Period 2 (3 Days)||0
7569231|NCT02853435|18631257|P1|STARTED|Part 3, Washout Period 2 (3 Days)||0
7569232|NCT02853435|18631252|P6|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
7569233|NCT02853435|18631253|P5|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
7569234|NCT02853435|18631254|P4|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
7569235|NCT02853435|18631255|P3|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
7569236|NCT02853435|18631256|P2|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
7569237|NCT02853435|18631257|P1|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
7569238|NCT02853435|18631252|P6|COMPLETED|Part 3, Period 2 (3 Days)||2
7569239|NCT02853435|18631253|P5|COMPLETED|Part 3, Period 2 (3 Days)||10
7569240|NCT02853435|18631254|P4|COMPLETED|Part 3, Period 2 (3 Days)||0
7569241|NCT02853435|18631255|P3|COMPLETED|Part 3, Period 2 (3 Days)||0
7569242|NCT02853435|18631256|P2|COMPLETED|Part 3, Period 2 (3 Days)||0
7569243|NCT02853435|18631257|P1|COMPLETED|Part 3, Period 2 (3 Days)||0
7569244|NCT02853435|18631252|P6|STARTED|Part 3, Period 2 (3 Days)||2
7569245|NCT02853435|18631253|P5|STARTED|Part 3, Period 2 (3 Days)||10
7569246|NCT02853435|18631254|P4|STARTED|Part 3, Period 2 (3 Days)||0
7569247|NCT02853435|18631255|P3|STARTED|Part 3, Period 2 (3 Days)||0
7569248|NCT02853435|18631256|P2|STARTED|Part 3, Period 2 (3 Days)||0
7569249|NCT02853435|18631257|P1|STARTED|Part 3, Period 2 (3 Days)||0
7569250|NCT02853435|18631252|P6|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
7569251|NCT02853435|18631253|P5|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
7569252|NCT02853435|18631254|P4|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
7569253|NCT02853435|18631255|P3|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
7569254|NCT02853435|18631256|P2|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
7569255|NCT02853435|18631257|P1|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
7569256|NCT02853435|18631252|P6|COMPLETED|Part 3, Washout Period 1 (3 Days)||2
7569257|NCT02853435|18631253|P5|COMPLETED|Part 3, Washout Period 1 (3 Days)||10
7569258|NCT02853435|18631254|P4|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
7569259|NCT02853435|18631255|P3|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
7569260|NCT02853435|18631256|P2|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
7569261|NCT02853435|18631257|P1|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
7569262|NCT02853435|18631252|P6|STARTED|Part 3, Washout Period 1 (3 Days)||2
7569263|NCT02853435|18631253|P5|STARTED|Part 3, Washout Period 1 (3 Days)||10
7569264|NCT02853435|18631254|P4|STARTED|Part 3, Washout Period 1 (3 Days)||0
7569265|NCT02853435|18631255|P3|STARTED|Part 3, Washout Period 1 (3 Days)||0
7569266|NCT02853435|18631256|P2|STARTED|Part 3, Washout Period 1 (3 Days)||0
7569267|NCT02853435|18631257|P1|STARTED|Part 3, Washout Period 1 (3 Days)||0
7569268|NCT02853435|18631252|P6|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
7569269|NCT02853435|18631253|P5|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
7569270|NCT02853435|18631254|P4|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
7569271|NCT02853435|18631255|P3|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
7569272|NCT02853435|18631256|P2|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
7569273|NCT02853435|18631257|P1|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
7569274|NCT02853435|18631252|P6|COMPLETED|Part 3, Period 1 (3 Days)||2
7569275|NCT02853435|18631253|P5|COMPLETED|Part 3, Period 1 (3 Days)||10
7569276|NCT02853435|18631254|P4|COMPLETED|Part 3, Period 1 (3 Days)||0
7569277|NCT02853435|18631255|P3|COMPLETED|Part 3, Period 1 (3 Days)||0
7569278|NCT02853435|18631256|P2|COMPLETED|Part 3, Period 1 (3 Days)||0
7569279|NCT02853435|18631257|P1|COMPLETED|Part 3, Period 1 (3 Days)||0
7569280|NCT02853435|18631252|P6|STARTED|Part 3, Period 1 (3 Days)||2
7569281|NCT02853435|18631253|P5|STARTED|Part 3, Period 1 (3 Days)||10
7569282|NCT02853435|18631254|P4|STARTED|Part 3, Period 1 (3 Days)||0
7569283|NCT02853435|18631255|P3|STARTED|Part 3, Period 1 (3 Days)||0
7569284|NCT02853435|18631256|P2|STARTED|Part 3, Period 1 (3 Days)||0
7569285|NCT02853435|18631257|P1|STARTED|Part 3, Period 1 (3 Days)||0
7569286|NCT02853435|18631252|P6|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
7569287|NCT02853435|18631253|P5|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
7569288|NCT02853435|18631254|P4|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
7569289|NCT02853435|18631255|P3|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
7569290|NCT02853435|18631256|P2|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
7569291|NCT02853435|18631257|P1|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
7569292|NCT02853435|18631252|P6|COMPLETED|Part 2, Period 2 (3 Days)||0
7569293|NCT02853435|18631253|P5|COMPLETED|Part 2, Period 2 (3 Days)||0
7569294|NCT02853435|18631254|P4|COMPLETED|Part 2, Period 2 (3 Days)||10
7569295|NCT02853435|18631255|P3|COMPLETED|Part 2, Period 2 (3 Days)||0
7569296|NCT02853435|18631256|P2|COMPLETED|Part 2, Period 2 (3 Days)||0
7569297|NCT02853435|18631257|P1|COMPLETED|Part 2, Period 2 (3 Days)||0
7569298|NCT02853435|18631252|P6|STARTED|Part 2, Period 2 (3 Days)||0
7569299|NCT02853435|18631253|P5|STARTED|Part 2, Period 2 (3 Days)||0
7569300|NCT02853435|18631254|P4|STARTED|Part 2, Period 2 (3 Days)||10
7569301|NCT02853435|18631255|P3|STARTED|Part 2, Period 2 (3 Days)||0
7569302|NCT02853435|18631256|P2|STARTED|Part 2, Period 2 (3 Days)||0
7569303|NCT02853435|18631257|P1|STARTED|Part 2, Period 2 (3 Days)||0
7569304|NCT02853435|18631252|P6|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
7569305|NCT02853435|18631253|P5|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
7569306|NCT02853435|18631254|P4|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
7569307|NCT02853435|18631255|P3|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
7569308|NCT02853435|18631256|P2|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
7569309|NCT02853435|18631257|P1|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
7569310|NCT02853435|18631252|P6|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
7569311|NCT02853435|18631253|P5|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
7569312|NCT02853435|18631254|P4|COMPLETED|Part 2, Washout Period 1 (3 Days)||10
7569313|NCT02853435|18631255|P3|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
7569314|NCT02853435|18631256|P2|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
7569315|NCT02853435|18631257|P1|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
7569316|NCT02853435|18631252|P6|STARTED|Part 2, Washout Period 1 (3 Days)||0
7569317|NCT02853435|18631253|P5|STARTED|Part 2, Washout Period 1 (3 Days)||0
7569318|NCT02853435|18631254|P4|STARTED|Part 2, Washout Period 1 (3 Days)||10
7569319|NCT02853435|18631255|P3|STARTED|Part 2, Washout Period 1 (3 Days)||0
7569320|NCT02853435|18631256|P2|STARTED|Part 2, Washout Period 1 (3 Days)||0
7569321|NCT02853435|18631257|P1|STARTED|Part 2, Washout Period 1 (3 Days)||0
7569322|NCT02853435|18631252|P6|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
7569323|NCT02853435|18631253|P5|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
7569324|NCT02853435|18631254|P4|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
7569325|NCT02853435|18631255|P3|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
7569326|NCT02853435|18631256|P2|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
7569327|NCT02853435|18631257|P1|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
7569328|NCT02853435|18631252|P6|COMPLETED|Part 2, Period 1 (3 Days)||0
7569329|NCT02853435|18631253|P5|COMPLETED|Part 2, Period 1 (3 Days)||0
7569330|NCT02853435|18631254|P4|COMPLETED|Part 2, Period 1 (3 Days)||10
7569331|NCT02853435|18631255|P3|COMPLETED|Part 2, Period 1 (3 Days)||0
7569332|NCT02853435|18631256|P2|COMPLETED|Part 2, Period 1 (3 Days)||0
7569333|NCT02853435|18631257|P1|COMPLETED|Part 2, Period 1 (3 Days)||0
7569334|NCT02853435|18631252|P6|STARTED|Part 2, Period 1 (3 Days)||0
7569335|NCT02853435|18631253|P5|STARTED|Part 2, Period 1 (3 Days)||0
7569336|NCT02853435|18631254|P4|STARTED|Part 2, Period 1 (3 Days)||10
7569337|NCT02853435|18631255|P3|STARTED|Part 2, Period 1 (3 Days)||0
7569338|NCT02853435|18631256|P2|STARTED|Part 2, Period 1 (3 Days)||0
7569339|NCT02853435|18631257|P1|STARTED|Part 2, Period 1 (3 Days)||0
7569340|NCT02853435|18631252|P6|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
7569341|NCT02853435|18631253|P5|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
7569342|NCT02853435|18631254|P4|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
7569343|NCT02853435|18631255|P3|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
7569344|NCT02853435|18631256|P2|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
7569345|NCT02853435|18631257|P1|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
7569346|NCT02853435|18631252|P6|COMPLETED|Part 1a, Period 3 (3 Days)||0
7569347|NCT02853435|18631253|P5|COMPLETED|Part 1a, Period 3 (3 Days)||0
7569348|NCT02853435|18631254|P4|COMPLETED|Part 1a, Period 3 (3 Days)||0
7569349|NCT02853435|18631255|P3|COMPLETED|Part 1a, Period 3 (3 Days)||8
7569350|NCT02853435|18631256|P2|COMPLETED|Part 1a, Period 3 (3 Days)||9
7569351|NCT02853435|18631257|P1|COMPLETED|Part 1a, Period 3 (3 Days)||9
7569352|NCT02853435|18631252|P6|STARTED|Part 1a, Period 3 (3 Days)||0
7569353|NCT02853435|18631253|P5|STARTED|Part 1a, Period 3 (3 Days)||0
7569354|NCT02853435|18631254|P4|STARTED|Part 1a, Period 3 (3 Days)||0
7569355|NCT02853435|18631255|P3|STARTED|Part 1a, Period 3 (3 Days)||8
7569356|NCT02853435|18631256|P2|STARTED|Part 1a, Period 3 (3 Days)||9
7569357|NCT02853435|18631257|P1|STARTED|Part 1a, Period 3 (3 Days)||9
7569358|NCT02853435|18631252|P6|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
7569359|NCT02853435|18631253|P5|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
7569360|NCT02853435|18631254|P4|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
7569361|NCT02853435|18631255|P3|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
7569362|NCT02853435|18631256|P2|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
7569363|NCT02853435|18631257|P1|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
7569364|NCT02853435|18631252|P6|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
7569365|NCT02853435|18631253|P5|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
7569366|NCT02853435|18631254|P4|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
7569367|NCT02853435|18631255|P3|COMPLETED|Part 1a, Washout Period 2 (3 Days)||8
7569368|NCT02853435|18631256|P2|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
7569369|NCT02853435|18631257|P1|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
7569370|NCT02853435|18631252|P6|STARTED|Part 1a, Washout Period 2 (3 Days)||0
7569371|NCT02853435|18631253|P5|STARTED|Part 1a, Washout Period 2 (3 Days)||0
7569372|NCT02853435|18631254|P4|STARTED|Part 1a, Washout Period 2 (3 Days)||0
7569373|NCT02853435|18631255|P3|STARTED|Part 1a, Washout Period 2 (3 Days)||8
7569374|NCT02853435|18631256|P2|STARTED|Part 1a, Washout Period 2 (3 Days)||9
7569375|NCT02853435|18631257|P1|STARTED|Part 1a, Washout Period 2 (3 Days)||9
7569376|NCT02853435|18631252|P6|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
7569377|NCT02853435|18631253|P5|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
7569378|NCT02853435|18631254|P4|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
7569379|NCT02853435|18631255|P3|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
7569380|NCT02853435|18631256|P2|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
7569381|NCT02853435|18631257|P1|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
7569382|NCT02853435|18631252|P6|COMPLETED|Part 1a, Period 2 (3 Days)||0
7569383|NCT02853435|18631253|P5|COMPLETED|Part 1a, Period 2 (3 Days)||0
7569384|NCT02853435|18631254|P4|COMPLETED|Part 1a, Period 2 (3 Days)||0
7569385|NCT02853435|18631255|P3|COMPLETED|Part 1a, Period 2 (3 Days)||8
7569386|NCT02853435|18631256|P2|COMPLETED|Part 1a, Period 2 (3 Days)||9
7569387|NCT02853435|18631257|P1|COMPLETED|Part 1a, Period 2 (3 Days)||9
7569388|NCT02853435|18631252|P6|STARTED|Part 1a, Period 2 (3 Days)||0
7569389|NCT02853435|18631253|P5|STARTED|Part 1a, Period 2 (3 Days)||0
7569390|NCT02853435|18631254|P4|STARTED|Part 1a, Period 2 (3 Days)||0
7569391|NCT02853435|18631255|P3|STARTED|Part 1a, Period 2 (3 Days)||8
7569392|NCT02853435|18631256|P2|STARTED|Part 1a, Period 2 (3 Days)||9
7569393|NCT02853435|18631257|P1|STARTED|Part 1a, Period 2 (3 Days)||9
7569394|NCT02853435|18631252|P6|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
7569395|NCT02853435|18631253|P5|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
7569396|NCT02853435|18631254|P4|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
7569397|NCT02853435|18631255|P3|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
7569398|NCT02853435|18631256|P2|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
7569399|NCT02853435|18631257|P1|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
7569400|NCT02853435|18631252|P6|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
7569401|NCT02853435|18631253|P5|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
7569402|NCT02853435|18631254|P4|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
7569403|NCT02853435|18631255|P3|COMPLETED|Part 1a, Washout Period 1 (3 Days)||8
7569404|NCT02853435|18631256|P2|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
7569405|NCT02853435|18631257|P1|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
7569406|NCT02853435|18631252|P6|STARTED|Part 1a, Washout Period 1 (3 Days)||0
7569407|NCT02853435|18631253|P5|STARTED|Part 1a, Washout Period 1 (3 Days)||0
7569408|NCT02853435|18631254|P4|STARTED|Part 1a, Washout Period 1 (3 Days)||0
7569409|NCT02853435|18631255|P3|STARTED|Part 1a, Washout Period 1 (3 Days)||8
7569410|NCT02853435|18631256|P2|STARTED|Part 1a, Washout Period 1 (3 Days)||9
7569411|NCT02853435|18631257|P1|STARTED|Part 1a, Washout Period 1 (3 Days)||9
7569412|NCT02853435|18631252|P6|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
7569413|NCT02853435|18631253|P5|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
7569414|NCT02853435|18631254|P4|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
7569415|NCT02853435|18631255|P3|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
7569416|NCT02853435|18631256|P2|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
7569417|NCT02853435|18631257|P1|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
7569418|NCT02853435|18631252|P6|COMPLETED|Part 1a, Period 1 (3 Days)||0
7569419|NCT02853435|18631253|P5|COMPLETED|Part 1a, Period 1 (3 Days)||0
7569420|NCT02853435|18631254|P4|COMPLETED|Part 1a, Period 1 (3 Days)||0
7569421|NCT02853435|18631255|P3|COMPLETED|Part 1a, Period 1 (3 Days)||8
7569422|NCT02853435|18631256|P2|COMPLETED|Part 1a, Period 1 (3 Days)||9
7569423|NCT02853435|18631257|P1|COMPLETED|Part 1a, Period 1 (3 Days)||9
7569424|NCT02853435|18631252|P6|STARTED|Part 1a, Period 1 (3 Days)||0
7569425|NCT02853435|18631253|P5|STARTED|Part 1a, Period 1 (3 Days)||0
7569426|NCT02853435|18631254|P4|STARTED|Part 1a, Period 1 (3 Days)||0
7569427|NCT02853435|18631255|P3|STARTED|Part 1a, Period 1 (3 Days)||8
7569428|NCT02853435|18631256|P2|STARTED|Part 1a, Period 1 (3 Days)||9
7569429|NCT02853435|18631257|P1|STARTED|Part 1a, Period 1 (3 Days)||9
7569430|NCT02853331|18631567|P2|NOT COMPLETED|Overall Study||429
7569431|NCT02853331|18631568|P1|NOT COMPLETED|Overall Study||432
7569432|NCT02853331|18631567|P2|COMPLETED|Overall Study||0
7569433|NCT02853331|18631568|P1|COMPLETED|Overall Study||0
7569434|NCT02853331|18631567|P2|Treated|Overall Study||425
7569435|NCT02853331|18631568|P1|Treated|Overall Study||429
7569436|NCT02853331|18631567|P2|STARTED|Overall Study||429
7569437|NCT02853331|18631568|P1|STARTED|Overall Study||432
7569438|NCT02853318|18631600|P1|NOT COMPLETED|Overall Study||1
7569439|NCT02853318|18631600|P1|COMPLETED|Overall Study||39
7569440|NCT02853318|18631600|P1|STARTED|Overall Study||40
7569441|NCT02853123|18631608|P2|NOT COMPLETED|Treatment Period 2||0
7569442|NCT02853123|18631609|P1|NOT COMPLETED|Treatment Period 2||0
7569443|NCT02853123|18631608|P2|COMPLETED|Treatment Period 2||48
7569444|NCT02853123|18631609|P1|COMPLETED|Treatment Period 2||51
7569445|NCT02853123|18631608|P2|STARTED|Treatment Period 2||48
7569446|NCT02853123|18631609|P1|STARTED|Treatment Period 2||51
7569447|NCT02853123|18631608|P2|NOT COMPLETED|Washout Period||3
7569448|NCT02853123|18631609|P1|NOT COMPLETED|Washout Period||1
7569449|NCT02853123|18631608|P2|COMPLETED|Washout Period||48
7569450|NCT02853123|18631609|P1|COMPLETED|Washout Period||51
7569451|NCT02853123|18631608|P2|STARTED|Washout Period||51
7569452|NCT02853123|18631609|P1|STARTED|Washout Period||52
7569453|NCT02853123|18631608|P2|NOT COMPLETED|Treatment Period 1||3
7569454|NCT02853123|18631609|P1|NOT COMPLETED|Treatment Period 1||0
7569455|NCT02853123|18631608|P2|COMPLETED|Treatment Period 1||51
7569456|NCT02853123|18631609|P1|COMPLETED|Treatment Period 1||52
7569457|NCT02853123|18631608|P2|STARTED|Treatment Period 1||54
7569458|NCT02853123|18631609|P1|STARTED|Treatment Period 1||52
7569459|NCT02853032|18631632|P2|NOT COMPLETED|Overall Study||3
7569460|NCT02853032|18631633|P1|NOT COMPLETED|Overall Study||9
7569461|NCT02853032|18631632|P2|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|56
7569462|NCT02853032|18631633|P1|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|51
7569463|NCT02853032|18631632|P2|STARTED|Overall Study||59
7569464|NCT02853032|18631633|P1|STARTED|Overall Study||60
7569465|NCT02852434|18631709|P2|NOT COMPLETED|Overall Study||1
7569466|NCT02852434|18631710|P1|NOT COMPLETED|Overall Study||2
7569467|NCT02852434|18631709|P2|COMPLETED|Overall Study||35
7569468|NCT02852434|18631710|P1|COMPLETED|Overall Study||34
7569469|NCT02852434|18631709|P2|STARTED|Overall Study||36
7569470|NCT02852434|18631710|P1|STARTED|Overall Study||36
7569471|NCT02852265|18631726|P2|NOT COMPLETED|6-month Follow-up||0
7569472|NCT02852265|18631727|P1|NOT COMPLETED|6-month Follow-up||0
7569473|NCT02852265|18631726|P2|COMPLETED|6-month Follow-up||9
7569474|NCT02852265|18631727|P1|COMPLETED|6-month Follow-up||9
7569475|NCT02852265|18631726|P2|STARTED|6-month Follow-up||9
7569476|NCT02852265|18631727|P1|STARTED|6-month Follow-up||9
7569477|NCT02852265|18631726|P2|NOT COMPLETED|3-month Follow-up||1
7569478|NCT02852265|18631727|P1|NOT COMPLETED|3-month Follow-up||1
7569479|NCT02852265|18631726|P2|COMPLETED|3-month Follow-up||9
7569480|NCT02852265|18631727|P1|COMPLETED|3-month Follow-up||9
7569481|NCT02852265|18631726|P2|STARTED|3-month Follow-up||10
7569482|NCT02852265|18631727|P1|STARTED|3-month Follow-up||10
7569483|NCT02852265|18631726|P2|NOT COMPLETED|1-month Follow-up||0
7569484|NCT02852265|18631727|P1|NOT COMPLETED|1-month Follow-up||0
7569485|NCT02852265|18631726|P2|COMPLETED|1-month Follow-up||10
7569486|NCT02852265|18631727|P1|COMPLETED|1-month Follow-up||10
7569487|NCT02852265|18631726|P2|STARTED|1-month Follow-up||10
7569488|NCT02852265|18631727|P1|STARTED|1-month Follow-up||10
7569489|NCT02851823|18631743|P1|NOT COMPLETED|Overall Study||0
7569490|NCT02851823|18631743|P1|COMPLETED|Overall Study||25
7569491|NCT02851823|18631743|P1|3 Months|Overall Study||25
7569492|NCT02851823|18631743|P1|1 Month|Overall Study||25
7569493|NCT02851823|18631743|P1|STARTED|Overall Study||25
7569494|NCT02851108|18631753|P2|NOT COMPLETED|Overall Study||1
7569495|NCT02851108|18631754|P1|NOT COMPLETED|Overall Study||8
7569496|NCT02851108|18631753|P2|COMPLETED|Overall Study||49
7569497|NCT02851108|18631754|P1|COMPLETED|Overall Study||42
7569498|NCT02851108|18631753|P2|STARTED|Overall Study||50
7569499|NCT02851108|18631754|P1|STARTED|Overall Study||50
7569500|NCT02851069|18631760|P1|NOT COMPLETED|Overall Study||6
7569501|NCT02851069|18631760|P1|COMPLETED|Overall Study||59
7569502|NCT02851069|18631760|P1|STARTED|Overall Study||65
7569503|NCT02850978|18631782|P1|NOT COMPLETED|Overall Study||426
7569504|NCT02850978|18631782|P1|COMPLETED|Overall Study||909
7569505|NCT02850978|18631782|P1|Treated|Overall Study||1308
7569506|NCT02850978|18631782|P1|Case Report Form (CRF) Collected|Overall Study||1308
7569507|NCT02850978|18631782|P1|STARTED|Overall Study||1335
7569508|NCT02850965|18631789|P2|NOT COMPLETED|Overall Study||25
7569509|NCT02850965|18631790|P1|NOT COMPLETED|Overall Study||18
7569510|NCT02850965|18631789|P2|COMPLETED|Overall Study||134
7569511|NCT02850965|18631790|P1|COMPLETED|Overall Study||141
7569512|NCT02850965|18631789|P2|Treated|Overall Study||158
7569513|NCT02850965|18631790|P1|Treated|Overall Study||159
7569514|NCT02850965|18631789|P2|STARTED|Overall Study||159
7569515|NCT02850965|18631790|P1|STARTED|Overall Study||159
7569516|NCT02850276|18631806|P1|NOT COMPLETED|Overall Study||61
7569517|NCT02850276|18631806|P1|COMPLETED|Overall Study||15
7569518|NCT02850276|18631806|P1|STARTED|Overall Study||76
7569519|NCT02850159|18631819|P2|NOT COMPLETED|Overall Study||0
7569520|NCT02850159|18631820|P1|NOT COMPLETED|Overall Study||0
7569521|NCT02850159|18631819|P2|COMPLETED|Overall Study||16
7569522|NCT02850159|18631820|P1|COMPLETED|Overall Study||16
7569523|NCT02850159|18631819|P2|STARTED|Overall Study||16
7569524|NCT02850159|18631820|P1|STARTED|Overall Study||16
7569525|NCT02850068|18631826|P1|NOT COMPLETED|Overall Study||20
7569526|NCT02850068|18631826|P1|COMPLETED|Overall Study||0
7569527|NCT02850068|18631826|P1|STARTED|Overall Study||20
7569528|NCT02849990|18631833|P1|NOT COMPLETED|Overall Study||2
7569529|NCT02849990|18631833|P1|COMPLETED|Overall Study||20
7569530|NCT02849990|18631833|P1|STARTED|Overall Study||22
7569531|NCT02849938|18631845|P2|NOT COMPLETED|Overall Study||0
7569532|NCT02849938|18631846|P1|NOT COMPLETED|Overall Study||0
7569533|NCT02849938|18631845|P2|COMPLETED|Overall Study||15
7569534|NCT02849938|18631846|P1|COMPLETED|Overall Study||9
7569535|NCT02849938|18631845|P2|STARTED|Overall Study||15
7569536|NCT02849938|18631846|P1|STARTED|Overall Study||9
7569537|NCT02849704|18631858|P2|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
7569538|NCT02849704|18631859|P1|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||3
7569539|NCT02849704|18631858|P2|COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
7569540|NCT02849704|18631859|P1|COMPLETED|Assessment on PERT - CP Subj - 16 Days||21
7569541|NCT02849704|18631858|P2|STARTED|Assessment on PERT - CP Subj - 16 Days||0
7569542|NCT02849704|18631859|P1|STARTED|Assessment on PERT - CP Subj - 16 Days||24
7569543|NCT02849704|18631858|P2|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
7569544|NCT02849704|18631859|P1|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
7569545|NCT02849704|18631858|P2|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
7569546|NCT02849704|18631859|P1|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
7569547|NCT02849704|18631858|P2|STARTED|Baseline Assessments - All Subj - 7 Days||24
7569548|NCT02849704|18631859|P1|STARTED|Baseline Assessments - All Subj - 7 Days||24
7569549|NCT02849704|18631858|P2|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
7569550|NCT02849704|18631859|P1|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
7569551|NCT02849704|18631858|P2|COMPLETED|Washout Period - CP Subj on PERT - 3days||0
7569552|NCT02849704|18631859|P1|COMPLETED|Washout Period - CP Subj on PERT - 3days||11
7569553|NCT02849704|18631858|P2|STARTED|Washout Period - CP Subj on PERT - 3days||0
7569554|NCT02849704|18631859|P1|STARTED|Washout Period - CP Subj on PERT - 3days||11
7569555|NCT02849678|18631874|P2|NOT COMPLETED|Overall Study||6
7569556|NCT02849678|18631875|P1|NOT COMPLETED|Overall Study||3
7569557|NCT02849678|18631874|P2|COMPLETED|Overall Study||18
7569558|NCT02849678|18631875|P1|COMPLETED|Overall Study||17
7569559|NCT02849678|18631874|P2|STARTED|Overall Study||24
7569560|NCT02849678|18631875|P1|STARTED|Overall Study||20
7569561|NCT02849626|18631895|P2|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||3
7569562|NCT02849626|18631896|P1|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||11
7569563|NCT02849626|18631895|P2|COMPLETED|Extension Phase A (up to 29 Weeks)||17
7569564|NCT02849626|18631896|P1|COMPLETED|Extension Phase A (up to 29 Weeks)||105
7569565|NCT02849626|18631895|P2|STARTED|Extension Phase A (up to 29 Weeks)||20
7569566|NCT02849626|18631896|P1|STARTED|Extension Phase A (up to 29 Weeks)||116
7569567|NCT02849626|18631895|P2|NOT COMPLETED|Core Phase (up to 23 Weeks)||7
7569568|NCT02849626|18631896|P1|NOT COMPLETED|Core Phase (up to 23 Weeks)||27
7569569|NCT02849626|18631895|P2|COMPLETED|Core Phase (up to 23 Weeks)||24
7569570|NCT02849626|18631896|P1|COMPLETED|Core Phase (up to 23 Weeks)||122
7569571|NCT02849626|18631895|P2|STARTED|Core Phase (up to 23 Weeks)||31
7569572|NCT02849626|18631896|P1|STARTED|Core Phase (up to 23 Weeks)||149
7569573|NCT02849509|18631959|P3|NOT COMPLETED|Overall Study||85
7569574|NCT02849509|18631960|P2|NOT COMPLETED|Overall Study||166
7569575|NCT02849509|18631961|P1|NOT COMPLETED|Overall Study||90
7569576|NCT02849509|18631959|P3|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|258
7569577|NCT02849509|18631960|P2|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|425
7569578|NCT02849509|18631961|P1|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|289
7569579|NCT02849509|18631959|P3|STARTED|Overall Study||343
7569580|NCT02849509|18631960|P2|STARTED|Overall Study||591
7569581|NCT02849509|18631961|P1|STARTED|Overall Study||379
7569582|NCT02849418|18631990|P6|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
7569583|NCT02849418|18631991|P5|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
7569584|NCT02849418|18631992|P4|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
7569585|NCT02849418|18631993|P3|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
7569586|NCT02849418|18631994|P2|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
7569587|NCT02849418|18631995|P1|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
7569588|NCT02849418|18631990|P6|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||3
7569589|NCT02849418|18631991|P5|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||5
7569590|NCT02849418|18631992|P4|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
7569591|NCT02849418|18631993|P3|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
7569592|NCT02849418|18631994|P2|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
7569593|NCT02849418|18631995|P1|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
7569594|NCT02849418|18631990|P6|STARTED|Open-label(3rd Treatment-Week 12 to 48)||3
7569595|NCT02849418|18631991|P5|STARTED|Open-label(3rd Treatment-Week 12 to 48)||5
7569596|NCT02849418|18631992|P4|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
7569597|NCT02849418|18631993|P3|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
7569598|NCT02849418|18631994|P2|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
7569599|NCT02849418|18631995|P1|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
7569600|NCT02849418|18631990|P6|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
7569601|NCT02849418|18631991|P5|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
7569602|NCT02849418|18631992|P4|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
7569603|NCT02849418|18631993|P3|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
7569604|NCT02849418|18631994|P2|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
7569605|NCT02849418|18631995|P1|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
7569606|NCT02849418|18631990|P6|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
7569607|NCT02849418|18631991|P5|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
7569608|NCT02849418|18631992|P4|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||6
7569609|NCT02849418|18631993|P3|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||10
7569610|NCT02849418|18631994|P2|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
7569611|NCT02849418|18631995|P1|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
7569612|NCT02849418|18631990|P6|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
7569613|NCT02849418|18631991|P5|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
7569614|NCT02849418|18631992|P4|STARTED|Open-label(2nd Treatment-Week 12 to 48)||6
7569615|NCT02849418|18631993|P3|STARTED|Open-label(2nd Treatment-Week 12 to 48)||10
7569616|NCT02849418|18631994|P2|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
7569617|NCT02849418|18631995|P1|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
7569618|NCT02849418|18631990|P6|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
7569619|NCT02849418|18631991|P5|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
7569620|NCT02849418|18631992|P4|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
7569621|NCT02849418|18631993|P3|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
7569622|NCT02849418|18631994|P2|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
7569623|NCT02849418|18631995|P1|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
7569624|NCT02849418|18631990|P6|COMPLETED|Double-blinded (Up to 48 Weeks)||0
7569625|NCT02849418|18631991|P5|COMPLETED|Double-blinded (Up to 48 Weeks)||0
7569626|NCT02849418|18631992|P4|COMPLETED|Double-blinded (Up to 48 Weeks)||0
7569627|NCT02849418|18631993|P3|COMPLETED|Double-blinded (Up to 48 Weeks)||0
7569628|NCT02849418|18631994|P2|COMPLETED|Double-blinded (Up to 48 Weeks)||11
7569629|NCT02849418|18631995|P1|COMPLETED|Double-blinded (Up to 48 Weeks)||10
7569630|NCT02849418|18631990|P6|STARTED|Double-blinded (Up to 48 Weeks)||0
7569631|NCT02849418|18631991|P5|STARTED|Double-blinded (Up to 48 Weeks)||0
7569632|NCT02849418|18631992|P4|STARTED|Double-blinded (Up to 48 Weeks)||0
7569633|NCT02849418|18631993|P3|STARTED|Double-blinded (Up to 48 Weeks)||0
7569634|NCT02849418|18631994|P2|STARTED|Double-blinded (Up to 48 Weeks)||11
7569635|NCT02849418|18631995|P1|STARTED|Double-blinded (Up to 48 Weeks)||10
7569636|NCT02849184|18632145|P2|NOT COMPLETED|Overall Study||0
7569637|NCT02849184|18632146|P1|NOT COMPLETED|Overall Study||0
7569638|NCT02849184|18632145|P2|COMPLETED|Overall Study||42
7569639|NCT02849184|18632146|P1|COMPLETED|Overall Study||40
7569640|NCT02849184|18632145|P2|STARTED|Overall Study||42
7569641|NCT02849184|18632146|P1|STARTED|Overall Study||40
7569642|NCT02849080|18632168|P4|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
7569643|NCT02849080|18632169|P3|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||1
7569644|NCT02849080|18632170|P2|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
7569645|NCT02849080|18632171|P1|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||3
7569646|NCT02849080|18632168|P4|COMPLETED|Extension Phase: 53 - 104 Weeks||98
7569647|NCT02849080|18632169|P3|COMPLETED|Extension Phase: 53 - 104 Weeks||99
7569648|NCT02849080|18632170|P2|COMPLETED|Extension Phase: 53 - 104 Weeks||0
7569649|NCT02849080|18632171|P1|COMPLETED|Extension Phase: 53 - 104 Weeks||182
7569650|NCT02849080|18632168|P4|Exposed|Extension Phase: 53 - 104 Weeks||97
7569651|NCT02849080|18632169|P3|Exposed|Extension Phase: 53 - 104 Weeks||100
7569652|NCT02849080|18632170|P2|Exposed|Extension Phase: 53 - 104 Weeks||0
7569653|NCT02849080|18632171|P1|Exposed|Extension Phase: 53 - 104 Weeks||184
7569654|NCT02849080|18632168|P4|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|98
7569655|NCT02849080|18632169|P3|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|100
7569656|NCT02849080|18632170|P2|STARTED|Extension Phase: 53 - 104 Weeks||0
7569657|NCT02849080|18632171|P1|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|185
7569658|NCT02849080|18632168|P4|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
7569659|NCT02849080|18632169|P3|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
7569660|NCT02849080|18632170|P2|NOT COMPLETED|Main Phase: 0 - 52 Weeks||7
7569661|NCT02849080|18632171|P1|NOT COMPLETED|Main Phase: 0 - 52 Weeks||12
7569662|NCT02849080|18632168|P4|COMPLETED|Main Phase: 0 - 52 Weeks||0
7569663|NCT02849080|18632169|P3|COMPLETED|Main Phase: 0 - 52 Weeks||0
7569664|NCT02849080|18632170|P2|COMPLETED|Main Phase: 0 - 52 Weeks||244
7569665|NCT02849080|18632171|P1|COMPLETED|Main Phase: 0 - 52 Weeks||241
7569666|NCT02849080|18632168|P4|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
7569667|NCT02849080|18632169|P3|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
7569668|NCT02849080|18632170|P2|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||250
7569669|NCT02849080|18632171|P1|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||253
7569670|NCT02849080|18632168|P4|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
7569671|NCT02849080|18632169|P3|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
7569672|NCT02849080|18632170|P2|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||251
7569673|NCT02849080|18632171|P1|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||253
7569674|NCT02849080|18632168|P4|Exposed|Main Phase: 0 - 52 Weeks||0
7569675|NCT02849080|18632169|P3|Exposed|Main Phase: 0 - 52 Weeks||0
7569676|NCT02849080|18632170|P2|Exposed|Main Phase: 0 - 52 Weeks||250
7569677|NCT02849080|18632171|P1|Exposed|Main Phase: 0 - 52 Weeks||253
7569678|NCT02849080|18632168|P4|STARTED|Main Phase: 0 - 52 Weeks||0
7569679|NCT02849080|18632169|P3|STARTED|Main Phase: 0 - 52 Weeks||0
7569680|NCT02849080|18632170|P2|STARTED|Main Phase: 0 - 52 Weeks||251
7569681|NCT02849080|18632171|P1|STARTED|Main Phase: 0 - 52 Weeks||253
7569682|NCT02848729|18632298|P2|NOT COMPLETED|Overall Study||11
7569683|NCT02848729|18632299|P1|NOT COMPLETED|Overall Study||16
7569684|NCT02848729|18632298|P2|COMPLETED|Overall Study||12
7569685|NCT02848729|18632299|P1|COMPLETED|Overall Study||11
7569686|NCT02848729|18632298|P2|Safety Population|Overall Study||23
7569687|NCT02848729|18632299|P1|Safety Population|Overall Study||27
7569688|NCT02848729|18632298|P2|Per Protocol Population|Overall Study||11
7569689|NCT02848729|18632299|P1|Per Protocol Population|Overall Study||11
7569690|NCT02848729|18632298|P2|STARTED|Overall Study||23
7569691|NCT02848729|18632299|P1|STARTED|Overall Study||27
7569692|NCT02848664|18632316|P1|NOT COMPLETED|Overall Study||4
7569693|NCT02848664|18632316|P1|COMPLETED|Overall Study||7
7569694|NCT02848664|18632316|P1|STARTED|Overall Study||11
7569695|NCT02848651|18632324|P1|NOT COMPLETED|Overall Study||106
7569696|NCT02848651|18632324|P1|COMPLETED|Overall Study||47
7569697|NCT02848651|18632324|P1|Received Treatment|Overall Study||152
7569698|NCT02848651|18632324|P1|STARTED|Overall Study||153
7569699|NCT02848599|18632353|P2|NOT COMPLETED|Overall Study||9
7569700|NCT02848599|18632354|P1|NOT COMPLETED|Overall Study||7
7569701|NCT02848599|18632353|P2|COMPLETED|Overall Study||35
7569702|NCT02848599|18632354|P1|COMPLETED|Overall Study||35
7569703|NCT02848599|18632353|P2|STARTED|Overall Study||44
7569704|NCT02848599|18632354|P1|STARTED|Overall Study||42
7569705|NCT02848326|18632376|P6|NOT COMPLETED|Safety Follow-up Period||5
7569706|NCT02848326|18632377|P5|NOT COMPLETED|Safety Follow-up Period||1
7569707|NCT02848326|18632378|P4|NOT COMPLETED|Safety Follow-up Period||0
7569708|NCT02848326|18632379|P3|NOT COMPLETED|Safety Follow-up Period||3
7569709|NCT02848326|18632380|P2|NOT COMPLETED|Safety Follow-up Period||1
7569710|NCT02848326|18632381|P1|NOT COMPLETED|Safety Follow-up Period||4
7569711|NCT02848326|18632376|P6|COMPLETED|Safety Follow-up Period||77
7569712|NCT02848326|18632377|P5|COMPLETED|Safety Follow-up Period||76
7569713|NCT02848326|18632378|P4|COMPLETED|Safety Follow-up Period||169
7569714|NCT02848326|18632379|P3|COMPLETED|Safety Follow-up Period||153
7569715|NCT02848326|18632380|P2|COMPLETED|Safety Follow-up Period||83
7569716|NCT02848326|18632381|P1|COMPLETED|Safety Follow-up Period||157
7569717|NCT02848326|18632376|P6|STARTED|Safety Follow-up Period||82
7569718|NCT02848326|18632377|P5|STARTED|Safety Follow-up Period||77
7569719|NCT02848326|18632378|P4|STARTED|Safety Follow-up Period||169
7569720|NCT02848326|18632379|P3|STARTED|Safety Follow-up Period||156
7569721|NCT02848326|18632380|P2|STARTED|Safety Follow-up Period||84
7569722|NCT02848326|18632381|P1|STARTED|Safety Follow-up Period||161
7569723|NCT02848326|18632376|P6|NOT COMPLETED|Treatment Period||20
7569724|NCT02848326|18632377|P5|NOT COMPLETED|Treatment Period||19
7569725|NCT02848326|18632378|P4|NOT COMPLETED|Treatment Period||23
7569726|NCT02848326|18632379|P3|NOT COMPLETED|Treatment Period||36
7569727|NCT02848326|18632380|P2|NOT COMPLETED|Treatment Period||14
7569728|NCT02848326|18632381|P1|NOT COMPLETED|Treatment Period||38
7569729|NCT02848326|18632376|P6|COMPLETED|Treatment Period||73
7569730|NCT02848326|18632377|P5|COMPLETED|Treatment Period||70
7569731|NCT02848326|18632378|P4|COMPLETED|Treatment Period||164
7569732|NCT02848326|18632379|P3|COMPLETED|Treatment Period||149
7569733|NCT02848326|18632380|P2|COMPLETED|Treatment Period||80
7569734|NCT02848326|18632381|P1|COMPLETED|Treatment Period||148
7569735|NCT02848326|18632376|P6|Safety Population: Received Study Drug|Treatment Period||91
7569736|NCT02848326|18632377|P5|Safety Population: Received Study Drug|Treatment Period||86
7569737|NCT02848326|18632378|P4|Safety Population: Received Study Drug|Treatment Period||186
7569738|NCT02848326|18632379|P3|Safety Population: Received Study Drug|Treatment Period||183
7569739|NCT02848326|18632380|P2|Safety Population: Received Study Drug|Treatment Period||93
7569740|NCT02848326|18632381|P1|Safety Population: Received Study Drug|Treatment Period||186
7569741|NCT02848326|18632376|P6|STARTED|Treatment Period||93
7569742|NCT02848326|18632377|P5|STARTED|Treatment Period||89
7569743|NCT02848326|18632378|P4|STARTED|Treatment Period||187
7569744|NCT02848326|18632379|P3|STARTED|Treatment Period||185
7569745|NCT02848326|18632380|P2|STARTED|Treatment Period||94
7569746|NCT02848326|18632381|P1|STARTED|Treatment Period||186
7569747|NCT02848313|18632415|P2|NOT COMPLETED|Overall Study||4
7569748|NCT02848313|18632416|P1|NOT COMPLETED|Overall Study||3
7569749|NCT02848313|18632415|P2|COMPLETED|Overall Study||15
7569750|NCT02848313|18632416|P1|COMPLETED|Overall Study||18
7569751|NCT02848313|18632415|P2|STARTED|Overall Study||19
7569752|NCT02848313|18632416|P1|STARTED|Overall Study||21
7569753|NCT02848222|18632451|P3|NOT COMPLETED|Overall Study||0
7569754|NCT02848222|18632452|P2|NOT COMPLETED|Overall Study||1
7569755|NCT02848222|18632453|P1|NOT COMPLETED|Overall Study||7
7569756|NCT02848222|18632451|P3|COMPLETED|Overall Study||17
7569757|NCT02848222|18632452|P2|COMPLETED|Overall Study||17
7569758|NCT02848222|18632453|P1|COMPLETED|Overall Study||18
7569759|NCT02848222|18632451|P3|STARTED|Overall Study||17
7569760|NCT02848222|18632452|P2|STARTED|Overall Study||18
7569761|NCT02848222|18632453|P1|STARTED|Overall Study||25
7569762|NCT02847858|18632463|P2|NOT COMPLETED|Overall Study||269
7569763|NCT02847858|18632464|P1|NOT COMPLETED|Overall Study||401
7569764|NCT02847858|18632463|P2|COMPLETED|Overall Study||398
7569765|NCT02847858|18632464|P1|COMPLETED|Overall Study||292
7569766|NCT02847858|18632463|P2|STARTED|Overall Study||667
7569767|NCT02847858|18632464|P1|STARTED|Overall Study||693
7569768|NCT02847650|18632490|P2|NOT COMPLETED|Overall Study||6
7569769|NCT02847650|18632491|P1|NOT COMPLETED|Overall Study||4
7569770|NCT02847650|18632490|P2|COMPLETED|Overall Study||22
7569771|NCT02847650|18632491|P1|COMPLETED|Overall Study||25
7569772|NCT02847650|18632490|P2|STARTED|Overall Study||28
7569773|NCT02847650|18632491|P1|STARTED|Overall Study||29
7569774|NCT02847637|18632515|P4|NOT COMPLETED|Overall Study||63
7569775|NCT02847637|18632516|P3|NOT COMPLETED|Overall Study||35
7569776|NCT02847637|18632517|P2|NOT COMPLETED|Overall Study||35
7569777|NCT02847637|18632518|P1|NOT COMPLETED|Overall Study||17
7569778|NCT02847637|18632515|P4|COMPLETED|Overall Study||0
7569779|NCT02847637|18632516|P3|COMPLETED|Overall Study||0
7569780|NCT02847637|18632517|P2|COMPLETED|Overall Study||1
7569781|NCT02847637|18632518|P1|COMPLETED|Overall Study||1
7569782|NCT02847637|18632515|P4|Completed 24 Weeks Emicizumab Treatment|Overall Study||58
7569783|NCT02847637|18632516|P3|Completed 24 Weeks Emicizumab Treatment|Overall Study||34
7569784|NCT02847637|18632517|P2|Completed 24 Weeks Emicizumab Treatment|Overall Study||35
7569785|NCT02847637|18632518|P1|Completed 24 Weeks Emicizumab Treatment|Overall Study|Participants started on 24 weeks No Prophylaxis first before switching to emicizumab.|1
7569786|NCT02847637|18632515|P4|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
7569787|NCT02847637|18632516|P3|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
7569788|NCT02847637|18632517|P2|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
7569789|NCT02847637|18632518|P1|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||16
7569790|NCT02847637|18632515|P4|Completed 24 Weeks on No Prophylaxis|Overall Study||0
7569791|NCT02847637|18632516|P3|Completed 24 Weeks on No Prophylaxis|Overall Study||0
7569792|NCT02847637|18632517|P2|Completed 24 Weeks on No Prophylaxis|Overall Study||0
7569793|NCT02847637|18632518|P1|Completed 24 Weeks on No Prophylaxis|Overall Study|One participant switched to emicizumab prior to completing 24 weeks No Prophylaxis (at 23.5 weeks).|16
7569794|NCT02847637|18632515|P4|STARTED|Overall Study||63
7569795|NCT02847637|18632516|P3|STARTED|Overall Study||35
7569796|NCT02847637|18632517|P2|STARTED|Overall Study||36
7569797|NCT02847637|18632518|P1|STARTED|Overall Study||18
7569798|NCT02847494|18632632|P2|NOT COMPLETED|Overall Study||5
7569799|NCT02847494|18632633|P1|NOT COMPLETED|Overall Study||8
7569800|NCT02847494|18632632|P2|COMPLETED|Overall Study||106
7569801|NCT02847494|18632633|P1|COMPLETED|Overall Study||101
7569802|NCT02847494|18632632|P2|STARTED|Overall Study||111
7569803|NCT02847494|18632633|P1|STARTED|Overall Study||109
7569804|NCT02847260|18632643|P1|NOT COMPLETED|Overall Study||7
7569805|NCT02847260|18632643|P1|COMPLETED|Overall Study||32
7569806|NCT02847260|18632643|P1|STARTED|Overall Study||39
7569807|NCT02847182|18632657|P2|NOT COMPLETED|Overall Study||1
7569808|NCT02847182|18632658|P1|NOT COMPLETED|Overall Study||0
7569809|NCT02847182|18632657|P2|COMPLETED|Overall Study||60
7569810|NCT02847182|18632658|P1|COMPLETED|Overall Study||119
7569811|NCT02847182|18632657|P2|Second Intervention (6 Months)|Overall Study||119
7569812|NCT02847182|18632658|P1|Second Intervention (6 Months)|Overall Study||61
7569813|NCT02847182|18632657|P2|First Intervention (6 Months)|Overall Study||61
7569814|NCT02847182|18632658|P1|First Intervention (6 Months)|Overall Study||119
7569815|NCT02847182|18632657|P2|STARTED|Overall Study||61
7569816|NCT02847182|18632658|P1|STARTED|Overall Study||119
7569817|NCT02847169|18632734|P2|NOT COMPLETED|Second Intervention (1 Week)||0
7569818|NCT02847169|18632735|P1|NOT COMPLETED|Second Intervention (1 Week)||0
7569819|NCT02847169|18632734|P2|COMPLETED|Second Intervention (1 Week)||15
7569820|NCT02847169|18632735|P1|COMPLETED|Second Intervention (1 Week)||15
7569821|NCT02847169|18632734|P2|STARTED|Second Intervention (1 Week)||15
7569822|NCT02847169|18632735|P1|STARTED|Second Intervention (1 Week)||15
7569823|NCT02847169|18632734|P2|NOT COMPLETED|First Intervention (1 Week)||0
7569824|NCT02847169|18632735|P1|NOT COMPLETED|First Intervention (1 Week)||0
7569825|NCT02847169|18632734|P2|COMPLETED|First Intervention (1 Week)||15
7569826|NCT02847169|18632735|P1|COMPLETED|First Intervention (1 Week)||15
7569827|NCT02847169|18632734|P2|STARTED|First Intervention (1 Week)||15
7569828|NCT02847169|18632735|P1|STARTED|First Intervention (1 Week)||15
7569829|NCT02846792|18632769|P1|NOT COMPLETED|Overall Study||0
7569830|NCT02846792|18632769|P1|COMPLETED|Overall Study||5
7569831|NCT02846792|18632769|P1|STARTED|Overall Study||5
7569832|NCT02846779|18632782|P3|NOT COMPLETED|Overall Study||138
7569833|NCT02846779|18632783|P2|NOT COMPLETED|Overall Study||127
7569834|NCT02846779|18632784|P1|NOT COMPLETED|Overall Study||139
7569835|NCT02846779|18632782|P3|COMPLETED|Overall Study||1862
7569836|NCT02846779|18632783|P2|COMPLETED|Overall Study||1873
7569837|NCT02846779|18632784|P1|COMPLETED|Overall Study||1861
7569838|NCT02846779|18632782|P3|STARTED|Overall Study||2000
7569839|NCT02846779|18632783|P2|STARTED|Overall Study||2000
7569840|NCT02846779|18632784|P1|STARTED|Overall Study||2000
7569841|NCT02846740|18632809|P2|NOT COMPLETED|Overall Study||1
7569842|NCT02846740|18632810|P1|NOT COMPLETED|Overall Study||0
7569843|NCT02846740|18632809|P2|COMPLETED|Overall Study||14
7569844|NCT02846740|18632810|P1|COMPLETED|Overall Study||15
7569845|NCT02846740|18632809|P2|STARTED|Overall Study||15
7569846|NCT02846740|18632810|P1|STARTED|Overall Study||15
7569847|NCT02846714|18632820|P1|NOT COMPLETED|Overall Study||6
7569848|NCT02846714|18632820|P1|COMPLETED|Overall Study||36
7569849|NCT02846714|18632820|P1|STARTED|Overall Study||42
7569850|NCT02846558|18632840|P4|NOT COMPLETED|Overall Study||2
7569851|NCT02846558|18632841|P3|NOT COMPLETED|Overall Study||2
7569852|NCT02846558|18632842|P2|NOT COMPLETED|Overall Study||4
7569853|NCT02846558|18632843|P1|NOT COMPLETED|Overall Study||8
7569854|NCT02846558|18632840|P4|COMPLETED|Overall Study||11
7569855|NCT02846558|18632841|P3|COMPLETED|Overall Study||12
7569856|NCT02846558|18632842|P2|COMPLETED|Overall Study||8
7569857|NCT02846558|18632843|P1|COMPLETED|Overall Study||7
7569858|NCT02846558|18632840|P4|3 Month Study Visit|Overall Study||11
7569859|NCT02846558|18632841|P3|3 Month Study Visit|Overall Study||12
7569860|NCT02846558|18632842|P2|3 Month Study Visit|Overall Study||8
7569861|NCT02846558|18632843|P1|3 Month Study Visit|Overall Study||7
7569862|NCT02846558|18632840|P4|Baseline Study Visit|Overall Study||12
7569863|NCT02846558|18632841|P3|Baseline Study Visit|Overall Study||14
7569864|NCT02846558|18632842|P2|Baseline Study Visit|Overall Study||9
7569865|NCT02846558|18632843|P1|Baseline Study Visit|Overall Study||10
7569866|NCT02846558|18632840|P4|STARTED|Overall Study||13
7569867|NCT02846558|18632841|P3|STARTED|Overall Study||14
7569868|NCT02846558|18632842|P2|STARTED|Overall Study||12
7569869|NCT02846558|18632843|P1|STARTED|Overall Study||15
7569870|NCT02846415|18632881|P2|NOT COMPLETED|Overall Study||1
7569871|NCT02846415|18632882|P1|NOT COMPLETED|Overall Study||3
7569872|NCT02846415|18632881|P2|COMPLETED|Overall Study||11
7569873|NCT02846415|18632882|P1|COMPLETED|Overall Study||15
7569874|NCT02846415|18632881|P2|STARTED|Overall Study||12
7569875|NCT02846415|18632882|P1|STARTED|Overall Study||18
7569876|NCT02846324|18632896|P4|NOT COMPLETED|Overall Study||0
7569877|NCT02846324|18632897|P3|NOT COMPLETED|Overall Study||4
7569878|NCT02846324|18632898|P2|NOT COMPLETED|Overall Study||0
7569879|NCT02846324|18632899|P1|NOT COMPLETED|Overall Study||2
7569880|NCT02846324|18632896|P4|COMPLETED|Overall Study||10
7569881|NCT02846324|18632897|P3|COMPLETED|Overall Study||10
7569882|NCT02846324|18632898|P2|COMPLETED|Overall Study||6
7569883|NCT02846324|18632899|P1|COMPLETED|Overall Study||7
7569884|NCT02846324|18632896|P4|Completed Study Treatment|Overall Study||10
7569885|NCT02846324|18632897|P3|Completed Study Treatment|Overall Study||11
7569886|NCT02846324|18632898|P2|Completed Study Treatment|Overall Study||5
7569887|NCT02846324|18632899|P1|Completed Study Treatment|Overall Study||7
7569888|NCT02846324|18632896|P4|STARTED|Overall Study||10
7569889|NCT02846324|18632897|P3|STARTED|Overall Study||14
7569890|NCT02846324|18632898|P2|STARTED|Overall Study||6
7569891|NCT02846324|18632899|P1|STARTED|Overall Study||9
7569892|NCT02846233|18632931|P2|NOT COMPLETED|Overall Study||2
7569893|NCT02846233|18632932|P1|NOT COMPLETED|Overall Study||2
7569894|NCT02846233|18632931|P2|COMPLETED|Overall Study||8
7569895|NCT02846233|18632932|P1|COMPLETED|Overall Study||10
7569896|NCT02846233|18632931|P2|STARTED|Overall Study||10
7569897|NCT02846233|18632932|P1|STARTED|Overall Study||12
7569898|NCT02845752|18632954|P2|NOT COMPLETED|Second Intervention (7 Days)||0
7569899|NCT02845752|18632955|P1|NOT COMPLETED|Second Intervention (7 Days)||0
7569900|NCT02845752|18632954|P2|COMPLETED|Second Intervention (7 Days)||7
7569901|NCT02845752|18632955|P1|COMPLETED|Second Intervention (7 Days)||7
7569902|NCT02845752|18632954|P2|STARTED|Second Intervention (7 Days)||7
7569903|NCT02845752|18632955|P1|STARTED|Second Intervention (7 Days)||7
7569904|NCT02845752|18632954|P2|NOT COMPLETED|Washout (14 Days)||0
7569905|NCT02845752|18632955|P1|NOT COMPLETED|Washout (14 Days)||0
7569906|NCT02845752|18632954|P2|COMPLETED|Washout (14 Days)||7
7569907|NCT02845752|18632955|P1|COMPLETED|Washout (14 Days)||7
7569908|NCT02845752|18632954|P2|STARTED|Washout (14 Days)||7
7569909|NCT02845752|18632955|P1|STARTED|Washout (14 Days)||7
7569910|NCT02845752|18632954|P2|NOT COMPLETED|First Intervention (7 Days)||0
7569911|NCT02845752|18632955|P1|NOT COMPLETED|First Intervention (7 Days)||0
7569912|NCT02845752|18632954|P2|COMPLETED|First Intervention (7 Days)||7
7569913|NCT02845752|18632955|P1|COMPLETED|First Intervention (7 Days)||7
7569914|NCT02845752|18632954|P2|STARTED|First Intervention (7 Days)||7
7569915|NCT02845752|18632955|P1|STARTED|First Intervention (7 Days)||7
7569916|NCT02845700|18632989|P2|NOT COMPLETED|Month 1 Follow-Up||0
7569917|NCT02845700|18632990|P1|NOT COMPLETED|Month 1 Follow-Up||0
7569918|NCT02845700|18632989|P2|COMPLETED|Month 1 Follow-Up||4
7569919|NCT02845700|18632990|P1|COMPLETED|Month 1 Follow-Up||2
7569920|NCT02845700|18632989|P2|STARTED|Month 1 Follow-Up|2 participants withdrew after completing the Intervention 2 Appointment|4
7569921|NCT02845700|18632990|P1|STARTED|Month 1 Follow-Up|3 participants withdrew after completing the Intervention 2 Appointment|2
7569922|NCT02845700|18632989|P2|NOT COMPLETED|Intervention Session 2||0
7569923|NCT02845700|18632990|P1|NOT COMPLETED|Intervention Session 2||0
7569924|NCT02845700|18632989|P2|COMPLETED|Intervention Session 2||6
7569925|NCT02845700|18632990|P1|COMPLETED|Intervention Session 2||5
7569926|NCT02845700|18632989|P2|STARTED|Intervention Session 2||6
7569927|NCT02845700|18632990|P1|STARTED|Intervention Session 2||5
7569928|NCT02845700|18632989|P2|NOT COMPLETED|Intervention Session 1||0
7569929|NCT02845700|18632990|P1|NOT COMPLETED|Intervention Session 1||0
7569930|NCT02845700|18632989|P2|COMPLETED|Intervention Session 1||6
7569931|NCT02845700|18632990|P1|COMPLETED|Intervention Session 1||5
7569932|NCT02845700|18632989|P2|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|6
7569933|NCT02845700|18632990|P1|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|5
7569934|NCT02845700|18632989|P2|NOT COMPLETED|Baseline Appointment||0
7569935|NCT02845700|18632990|P1|NOT COMPLETED|Baseline Appointment||0
7569936|NCT02845700|18632989|P2|COMPLETED|Baseline Appointment||7
7569937|NCT02845700|18632990|P1|COMPLETED|Baseline Appointment||6
7569938|NCT02845700|18632989|P2|STARTED|Baseline Appointment||7
7569939|NCT02845700|18632990|P1|STARTED|Baseline Appointment||6
7569940|NCT02845674|18633006|P2|NOT COMPLETED|Overall Study||50
7569941|NCT02845674|18633007|P1|NOT COMPLETED|Overall Study||18
7569942|NCT02845674|18633006|P2|COMPLETED|Overall Study||79
7569943|NCT02845674|18633007|P1|COMPLETED|Overall Study||111
7569944|NCT02845674|18633006|P2|STARTED|Overall Study||129
7569945|NCT02845674|18633007|P1|STARTED|Overall Study||129
7569946|NCT02845375|18633016|P3|NOT COMPLETED|Overall Study||1
7569947|NCT02845375|18633017|P2|NOT COMPLETED|Overall Study||2
7569948|NCT02845375|18633018|P1|NOT COMPLETED|Overall Study||1
7569949|NCT02845375|18633016|P3|COMPLETED|Overall Study||12
7569950|NCT02845375|18633017|P2|COMPLETED|Overall Study||12
7569951|NCT02845375|18633018|P1|COMPLETED|Overall Study||12
7569952|NCT02845375|18633016|P3|STARTED|Overall Study||13
7569953|NCT02845375|18633017|P2|STARTED|Overall Study||14
7569954|NCT02845375|18633018|P1|STARTED|Overall Study||13
7569955|NCT02845336|18633031|P2|NOT COMPLETED|Overall Study||1
7569956|NCT02845336|18633032|P1|NOT COMPLETED|Overall Study||5
7569957|NCT02845336|18633031|P2|COMPLETED|Overall Study||0
7569958|NCT02845336|18633032|P1|COMPLETED|Overall Study||1
7569959|NCT02845336|18633031|P2|STARTED|Overall Study||1
7569960|NCT02845336|18633032|P1|STARTED|Overall Study||6
7569961|NCT02844998|18633059|P3|NOT COMPLETED|Overall Study||4
7569962|NCT02844998|18633060|P2|NOT COMPLETED|Overall Study||4
7569963|NCT02844998|18633061|P1|NOT COMPLETED|Overall Study||7
7569964|NCT02844998|18633059|P3|COMPLETED|Overall Study||35
7569965|NCT02844998|18633060|P2|COMPLETED|Overall Study||35
7569966|NCT02844998|18633061|P1|COMPLETED|Overall Study||35
7569967|NCT02844998|18633059|P3|STARTED|Overall Study||39
7569968|NCT02844998|18633060|P2|STARTED|Overall Study||39
7569969|NCT02844998|18633061|P1|STARTED|Overall Study||42
7569970|NCT02844946|18633074|P2|NOT COMPLETED|Overall Study||0
7569971|NCT02844946|18633075|P1|NOT COMPLETED|Overall Study||7
7569972|NCT02844946|18633074|P2|COMPLETED|Overall Study||12
7569973|NCT02844946|18633075|P1|COMPLETED|Overall Study||20
7569974|NCT02844946|18633074|P2|STARTED|Overall Study||12
7569975|NCT02844946|18633075|P1|STARTED|Overall Study||27
7569976|NCT02844920|18633093|P1|NOT COMPLETED|Overall Study||2
7569977|NCT02844920|18633093|P1|COMPLETED|Overall Study|Participants with completed the follow-up|35
7569978|NCT02844920|18633093|P1|Completed, Eval. Data, Opposing Fibroids|Overall Study|Participants with completed the follow-up, evaluable hysteroscopy videos, and opposing fibroids|6
7569979|NCT02844920|18633093|P1|Completed With Evaluable Videos|Overall Study|Participants with completed the follow-up and evaluable hysteroscopy videos|34
7569980|NCT02844920|18633093|P1|Completed Without Evaluable Videos|Overall Study|Participants with completed the follow-up but without evaluable hysteroscopy videos|1
7569981|NCT02844920|18633093|P1|STARTED|Overall Study||37
7569982|NCT02844569|18633100|P2|NOT COMPLETED|Overall Study||0
7569983|NCT02844569|18633101|P1|NOT COMPLETED|Overall Study||0
7569984|NCT02844569|18633100|P2|COMPLETED|Overall Study||12
7569985|NCT02844569|18633101|P1|COMPLETED|Overall Study||12
7569986|NCT02844569|18633100|P2|STARTED|Overall Study||12
7569987|NCT02844569|18633101|P1|STARTED|Overall Study||12
7569988|NCT02844543|18633111|P1|NOT COMPLETED|Overall Study||5
7569989|NCT02844543|18633111|P1|COMPLETED|Overall Study||150
7569990|NCT02844543|18633111|P1|STARTED|Overall Study||155
7569991|NCT02843659|18633121|P3|NOT COMPLETED|Overall Study||5
7569992|NCT02843659|18633122|P2|NOT COMPLETED|Overall Study||6
7569993|NCT02843659|18633123|P1|NOT COMPLETED|Overall Study||4
7569994|NCT02843659|18633121|P3|COMPLETED|Overall Study||2
7569995|NCT02843659|18633122|P2|COMPLETED|Overall Study||0
7569996|NCT02843659|18633123|P1|COMPLETED|Overall Study||1
7569997|NCT02843659|18633121|P3|STARTED|Overall Study||7
7569998|NCT02843659|18633122|P2|STARTED|Overall Study||6
7569999|NCT02843659|18633123|P1|STARTED|Overall Study||5
7570000|NCT02843529|18633190|P2|NOT COMPLETED|Overall Study||21
7570001|NCT02843529|18633191|P1|NOT COMPLETED|Overall Study||31
7570002|NCT02843529|18633190|P2|COMPLETED|Overall Study||283
7570003|NCT02843529|18633191|P1|COMPLETED|Overall Study||213
7570004|NCT02843529|18633190|P2|STARTED|Overall Study||304
7570005|NCT02843529|18633191|P1|STARTED|Overall Study||244
7570006|NCT02843178|18633201|P4|NOT COMPLETED|Overall Study||4
7570007|NCT02843178|18633202|P3|NOT COMPLETED|Overall Study||7
7570008|NCT02843178|18633203|P2|NOT COMPLETED|Overall Study||8
7570009|NCT02843178|18633204|P1|NOT COMPLETED|Overall Study||8
7570010|NCT02843178|18633201|P4|COMPLETED|Overall Study||87
7570011|NCT02843178|18633202|P3|COMPLETED|Overall Study||85
7570012|NCT02843178|18633203|P2|COMPLETED|Overall Study||82
7570013|NCT02843178|18633204|P1|COMPLETED|Overall Study||78
7570014|NCT02843178|18633201|P4|STARTED|Overall Study||91
7570015|NCT02843178|18633202|P3|STARTED|Overall Study||92
7570016|NCT02843178|18633203|P2|STARTED|Overall Study||90
7570017|NCT02843178|18633204|P1|STARTED|Overall Study||86
7570018|NCT02842866|18633244|P2|NOT COMPLETED|Overall Study||3
7570019|NCT02842866|18633245|P1|NOT COMPLETED|Overall Study||7
7570020|NCT02842866|18633244|P2|COMPLETED|Overall Study||452
7570021|NCT02842866|18633245|P1|COMPLETED|Overall Study||444
7570022|NCT02842866|18633244|P2|Vaccinated|Overall Study||453
7570023|NCT02842866|18633245|P1|Vaccinated|Overall Study||448
7570024|NCT02842866|18633244|P2|STARTED|Overall Study||455
7570025|NCT02842866|18633245|P1|STARTED|Overall Study||451
7570026|NCT02842853|18633257|P4|NOT COMPLETED|Overall Study||24
7570027|NCT02842853|18633258|P3|NOT COMPLETED|Overall Study||21
7570028|NCT02842853|18633259|P2|NOT COMPLETED|Overall Study||34
7570029|NCT02842853|18633260|P1|NOT COMPLETED|Overall Study||23
7570030|NCT02842853|18633257|P4|COMPLETED|Overall Study||617
7570031|NCT02842853|18633258|P3|COMPLETED|Overall Study||885
7570032|NCT02842853|18633259|P2|COMPLETED|Overall Study||861
7570033|NCT02842853|18633260|P1|COMPLETED|Overall Study||879
7570034|NCT02842853|18633257|P4|Safety Analysis Set (SafAS)|Overall Study||635
7570035|NCT02842853|18633258|P3|Safety Analysis Set (SafAS)|Overall Study||898
7570036|NCT02842853|18633259|P2|Safety Analysis Set (SafAS)|Overall Study||883
7570037|NCT02842853|18633260|P1|Safety Analysis Set (SafAS)|Overall Study||895
7570038|NCT02842853|18633257|P4|Vaccinated|Overall Study||636
7570039|NCT02842853|18633258|P3|Vaccinated|Overall Study||900
7570040|NCT02842853|18633259|P2|Vaccinated|Overall Study||886
7570041|NCT02842853|18633260|P1|Vaccinated|Overall Study||895
7570042|NCT02842853|18633257|P4|STARTED|Overall Study||641
7570043|NCT02842853|18633258|P3|STARTED|Overall Study||906
7570044|NCT02842853|18633259|P2|STARTED|Overall Study||895
7570045|NCT02842853|18633260|P1|STARTED|Overall Study||902
7570046|NCT02842736|18633280|P1|NOT COMPLETED|Overall Study||41
7570047|NCT02842736|18633280|P1|COMPLETED|Overall Study|36 Month Visit Completed|201
7570048|NCT02842736|18633280|P1|24 Month Visit Performed|Overall Study||210
7570049|NCT02842736|18633280|P1|Known Month 12 Outcome|Overall Study||230
7570050|NCT02842736|18633280|P1|STARTED|Overall Study|Treated|242
7570051|NCT02842242|18633300|P2|NOT COMPLETED|Overall Study||0
7570052|NCT02842242|18633301|P1|NOT COMPLETED|Overall Study||1
7570053|NCT02842242|18633300|P2|COMPLETED|Overall Study||10
7570054|NCT02842242|18633301|P1|COMPLETED|Overall Study||10
7570055|NCT02842242|18633300|P2|STARTED|Overall Study||10
7570056|NCT02842242|18633301|P1|STARTED|Overall Study||11
7570057|NCT02842151|18633323|P1|NOT COMPLETED|Overall Study||2
7570058|NCT02842151|18633323|P1|COMPLETED|Overall Study||148
7570059|NCT02842151|18633323|P1|STARTED|Overall Study||150
7570060|NCT02842086|18633331|P2|NOT COMPLETED|Overall Study||493
7570061|NCT02842086|18633332|P1|NOT COMPLETED|Overall Study||544
7570062|NCT02842086|18633331|P2|COMPLETED|Overall Study||2206
7570063|NCT02842086|18633332|P1|COMPLETED|Overall Study||2156
7570064|NCT02842086|18633331|P2|STARTED|Overall Study||2699
7570065|NCT02842086|18633332|P1|STARTED|Overall Study||2700
7570066|NCT02842073|18633368|P1|NOT COMPLETED|Overall Study||1
7570067|NCT02842073|18633368|P1|COMPLETED|Overall Study||11
7570068|NCT02842073|18633368|P1|STARTED|Overall Study||12
7570069|NCT02842060|18633378|P2|NOT COMPLETED|Overall Study||0
7570070|NCT02842060|18633379|P1|NOT COMPLETED|Overall Study||0
7570071|NCT02842060|18633378|P2|COMPLETED|Overall Study||60
7570072|NCT02842060|18633379|P1|COMPLETED|Overall Study||120
7570073|NCT02842060|18633378|P2|STARTED|Overall Study||60
7570074|NCT02842060|18633379|P1|STARTED|Overall Study||120
7570075|NCT02841787|18633394|P3|NOT COMPLETED|Overall Study||0
7570076|NCT02841787|18633395|P2|NOT COMPLETED|Overall Study||4
7570077|NCT02841787|18633396|P1|NOT COMPLETED|Overall Study||3
7570078|NCT02841787|18633394|P3|COMPLETED|Overall Study||12
7570079|NCT02841787|18633395|P2|COMPLETED|Overall Study||19
7570080|NCT02841787|18633396|P1|COMPLETED|Overall Study||9
7570081|NCT02841787|18633394|P3|STARTED|Overall Study||12
7570082|NCT02841787|18633395|P2|STARTED|Overall Study||23
7570083|NCT02841787|18633396|P1|STARTED|Overall Study||12
7570084|NCT02841709|18633410|P5|NOT COMPLETED|5th Intervention||2
7570085|NCT02841709|18633411|P4|NOT COMPLETED|5th Intervention||0
7570086|NCT02841709|18633412|P3|NOT COMPLETED|5th Intervention||0
7570087|NCT02841709|18633413|P2|NOT COMPLETED|5th Intervention||0
7570088|NCT02841709|18633414|P1|NOT COMPLETED|5th Intervention||2
7570089|NCT02841709|18633410|P5|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 5.|9
7570090|NCT02841709|18633411|P4|COMPLETED|5th Intervention||12
7570091|NCT02841709|18633412|P3|COMPLETED|5th Intervention||12
7570092|NCT02841709|18633413|P2|COMPLETED|5th Intervention||11
7570093|NCT02841709|18633414|P1|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 1.|10
7570094|NCT02841709|18633410|P5|STARTED|5th Intervention||11
7570095|NCT02841709|18633411|P4|STARTED|5th Intervention||12
7570096|NCT02841709|18633412|P3|STARTED|5th Intervention||12
7570097|NCT02841709|18633413|P2|STARTED|5th Intervention||11
7570098|NCT02841709|18633414|P1|STARTED|5th Intervention||12
7570099|NCT02841709|18633410|P5|NOT COMPLETED|Washout Period 4||0
7570100|NCT02841709|18633411|P4|NOT COMPLETED|Washout Period 4||0
7570101|NCT02841709|18633412|P3|NOT COMPLETED|Washout Period 4||0
7570102|NCT02841709|18633413|P2|NOT COMPLETED|Washout Period 4||0
7570103|NCT02841709|18633414|P1|NOT COMPLETED|Washout Period 4||0
7570104|NCT02841709|18633410|P5|COMPLETED|Washout Period 4||11
7570105|NCT02841709|18633411|P4|COMPLETED|Washout Period 4||12
7570106|NCT02841709|18633412|P3|COMPLETED|Washout Period 4||12
7570107|NCT02841709|18633413|P2|COMPLETED|Washout Period 4||11
7570108|NCT02841709|18633414|P1|COMPLETED|Washout Period 4||12
7570109|NCT02841709|18633410|P5|STARTED|Washout Period 4||11
7570110|NCT02841709|18633411|P4|STARTED|Washout Period 4||12
7570111|NCT02841709|18633412|P3|STARTED|Washout Period 4||12
7570112|NCT02841709|18633413|P2|STARTED|Washout Period 4||11
7570113|NCT02841709|18633414|P1|STARTED|Washout Period 4||12
7570114|NCT02841709|18633410|P5|NOT COMPLETED|4th Intervention||0
7570115|NCT02841709|18633411|P4|NOT COMPLETED|4th Intervention||0
7570116|NCT02841709|18633412|P3|NOT COMPLETED|4th Intervention||0
7570117|NCT02841709|18633413|P2|NOT COMPLETED|4th Intervention||0
7570118|NCT02841709|18633414|P1|NOT COMPLETED|4th Intervention||0
7570119|NCT02841709|18633410|P5|COMPLETED|4th Intervention||11
7570120|NCT02841709|18633411|P4|COMPLETED|4th Intervention||12
7570121|NCT02841709|18633412|P3|COMPLETED|4th Intervention||12
7570122|NCT02841709|18633413|P2|COMPLETED|4th Intervention||11
7570123|NCT02841709|18633414|P1|COMPLETED|4th Intervention||12
7570124|NCT02841709|18633410|P5|STARTED|4th Intervention||11
7570125|NCT02841709|18633411|P4|STARTED|4th Intervention||12
7570126|NCT02841709|18633412|P3|STARTED|4th Intervention||12
7570127|NCT02841709|18633413|P2|STARTED|4th Intervention||11
7570128|NCT02841709|18633414|P1|STARTED|4th Intervention||12
7570129|NCT02841709|18633410|P5|NOT COMPLETED|Washout Period 3||0
7570130|NCT02841709|18633411|P4|NOT COMPLETED|Washout Period 3||0
7570131|NCT02841709|18633412|P3|NOT COMPLETED|Washout Period 3||0
7570132|NCT02841709|18633413|P2|NOT COMPLETED|Washout Period 3||0
7570133|NCT02841709|18633414|P1|NOT COMPLETED|Washout Period 3||0
7570134|NCT02841709|18633410|P5|COMPLETED|Washout Period 3||11
7570135|NCT02841709|18633411|P4|COMPLETED|Washout Period 3||12
7570136|NCT02841709|18633412|P3|COMPLETED|Washout Period 3||12
7570137|NCT02841709|18633413|P2|COMPLETED|Washout Period 3||11
7570138|NCT02841709|18633414|P1|COMPLETED|Washout Period 3||12
7570139|NCT02841709|18633410|P5|STARTED|Washout Period 3||11
7570140|NCT02841709|18633411|P4|STARTED|Washout Period 3||12
7570141|NCT02841709|18633412|P3|STARTED|Washout Period 3||12
7570142|NCT02841709|18633413|P2|STARTED|Washout Period 3||11
7570143|NCT02841709|18633414|P1|STARTED|Washout Period 3||12
7570144|NCT02841709|18633410|P5|NOT COMPLETED|3rd Intervention||0
7570145|NCT02841709|18633411|P4|NOT COMPLETED|3rd Intervention||0
7570146|NCT02841709|18633412|P3|NOT COMPLETED|3rd Intervention||0
7570147|NCT02841709|18633413|P2|NOT COMPLETED|3rd Intervention||0
7570148|NCT02841709|18633414|P1|NOT COMPLETED|3rd Intervention||0
7570149|NCT02841709|18633410|P5|COMPLETED|3rd Intervention||11
7570150|NCT02841709|18633411|P4|COMPLETED|3rd Intervention||12
7570151|NCT02841709|18633412|P3|COMPLETED|3rd Intervention||12
7570152|NCT02841709|18633413|P2|COMPLETED|3rd Intervention||11
7570153|NCT02841709|18633414|P1|COMPLETED|3rd Intervention||12
7570154|NCT02841709|18633410|P5|STARTED|3rd Intervention||11
7570155|NCT02841709|18633411|P4|STARTED|3rd Intervention||12
7570156|NCT02841709|18633412|P3|STARTED|3rd Intervention||12
7570157|NCT02841709|18633413|P2|STARTED|3rd Intervention||11
7570158|NCT02841709|18633414|P1|STARTED|3rd Intervention||12
7570159|NCT02841709|18633410|P5|NOT COMPLETED|Washout Period 2||0
7570160|NCT02841709|18633411|P4|NOT COMPLETED|Washout Period 2||0
7570161|NCT02841709|18633412|P3|NOT COMPLETED|Washout Period 2||0
7570162|NCT02841709|18633413|P2|NOT COMPLETED|Washout Period 2||0
7570163|NCT02841709|18633414|P1|NOT COMPLETED|Washout Period 2||0
7570164|NCT02841709|18633410|P5|COMPLETED|Washout Period 2||11
7570165|NCT02841709|18633411|P4|COMPLETED|Washout Period 2||12
7570166|NCT02841709|18633412|P3|COMPLETED|Washout Period 2||12
7570167|NCT02841709|18633413|P2|COMPLETED|Washout Period 2||11
7570168|NCT02841709|18633414|P1|COMPLETED|Washout Period 2||12
7570169|NCT02841709|18633410|P5|STARTED|Washout Period 2||11
7570170|NCT02841709|18633411|P4|STARTED|Washout Period 2||12
7570171|NCT02841709|18633412|P3|STARTED|Washout Period 2||12
7570172|NCT02841709|18633413|P2|STARTED|Washout Period 2||11
7570173|NCT02841709|18633414|P1|STARTED|Washout Period 2||12
7570174|NCT02841709|18633410|P5|NOT COMPLETED|2nd Intervention||0
7570175|NCT02841709|18633411|P4|NOT COMPLETED|2nd Intervention||0
7570176|NCT02841709|18633412|P3|NOT COMPLETED|2nd Intervention||0
7570177|NCT02841709|18633413|P2|NOT COMPLETED|2nd Intervention||0
7570178|NCT02841709|18633414|P1|NOT COMPLETED|2nd Intervention||0
7570179|NCT02841709|18633410|P5|COMPLETED|2nd Intervention||11
7570180|NCT02841709|18633411|P4|COMPLETED|2nd Intervention||12
7570181|NCT02841709|18633412|P3|COMPLETED|2nd Intervention||12
7570182|NCT02841709|18633413|P2|COMPLETED|2nd Intervention||11
7570183|NCT02841709|18633414|P1|COMPLETED|2nd Intervention||12
7570184|NCT02841709|18633410|P5|STARTED|2nd Intervention||11
7570185|NCT02841709|18633411|P4|STARTED|2nd Intervention||12
7570186|NCT02841709|18633412|P3|STARTED|2nd Intervention||12
7570187|NCT02841709|18633413|P2|STARTED|2nd Intervention||11
7570188|NCT02841709|18633414|P1|STARTED|2nd Intervention||12
7570189|NCT02841709|18633410|P5|NOT COMPLETED|Washout Period 1||0
7570190|NCT02841709|18633411|P4|NOT COMPLETED|Washout Period 1||0
7570191|NCT02841709|18633412|P3|NOT COMPLETED|Washout Period 1||0
7570192|NCT02841709|18633413|P2|NOT COMPLETED|Washout Period 1||0
7570193|NCT02841709|18633414|P1|NOT COMPLETED|Washout Period 1||0
7570194|NCT02841709|18633410|P5|COMPLETED|Washout Period 1||11
7570195|NCT02841709|18633411|P4|COMPLETED|Washout Period 1||12
7570196|NCT02841709|18633412|P3|COMPLETED|Washout Period 1||12
7570197|NCT02841709|18633413|P2|COMPLETED|Washout Period 1||11
7570198|NCT02841709|18633414|P1|COMPLETED|Washout Period 1||12
7570199|NCT02841709|18633410|P5|STARTED|Washout Period 1||11
7570200|NCT02841709|18633411|P4|STARTED|Washout Period 1||12
7570201|NCT02841709|18633412|P3|STARTED|Washout Period 1||12
7570202|NCT02841709|18633413|P2|STARTED|Washout Period 1||11
7570203|NCT02841709|18633414|P1|STARTED|Washout Period 1||12
7570204|NCT02841709|18633410|P5|NOT COMPLETED|1st Intervention||0
7570205|NCT02841709|18633411|P4|NOT COMPLETED|1st Intervention||0
7570206|NCT02841709|18633412|P3|NOT COMPLETED|1st Intervention||0
7570207|NCT02841709|18633413|P2|NOT COMPLETED|1st Intervention||0
7570208|NCT02841709|18633414|P1|NOT COMPLETED|1st Intervention||0
7570209|NCT02841709|18633410|P5|COMPLETED|1st Intervention||11
7570210|NCT02841709|18633411|P4|COMPLETED|1st Intervention||12
7570211|NCT02841709|18633412|P3|COMPLETED|1st Intervention||12
7570212|NCT02841709|18633413|P2|COMPLETED|1st Intervention||11
7570213|NCT02841709|18633414|P1|COMPLETED|1st Intervention||12
7570214|NCT02841709|18633410|P5|STARTED|1st Intervention||11
7570215|NCT02841709|18633411|P4|STARTED|1st Intervention||12
7570216|NCT02841709|18633412|P3|STARTED|1st Intervention||12
7570217|NCT02841709|18633413|P2|STARTED|1st Intervention||11
7570218|NCT02841709|18633414|P1|STARTED|1st Intervention||12
7570219|NCT02841449|18633434|P2|NOT COMPLETED|Overall Study||0
7570220|NCT02841449|18633435|P1|NOT COMPLETED|Overall Study||0
7570221|NCT02841449|18633434|P2|COMPLETED|Overall Study||9
7570222|NCT02841449|18633435|P1|COMPLETED|Overall Study||7
7570223|NCT02841449|18633434|P2|STARTED|Overall Study||9
7570224|NCT02841449|18633435|P1|STARTED|Overall Study||7
7570225|NCT02841267|18633462|P3|NOT COMPLETED|Extension Study||0
7570226|NCT02841267|18633463|P2|NOT COMPLETED|Extension Study||0
7570227|NCT02841267|18633464|P1|NOT COMPLETED|Extension Study||0
7570228|NCT02841267|18633462|P3|COMPLETED|Extension Study||6
7570229|NCT02841267|18633463|P2|COMPLETED|Extension Study||6
7570230|NCT02841267|18633464|P1|COMPLETED|Extension Study||4
7570231|NCT02841267|18633462|P3|STARTED|Extension Study|Cohort 3 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 24 weeks.|6
7570232|NCT02841267|18633463|P2|STARTED|Extension Study|Cohort 2 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 40 weeks.|6
7570233|NCT02841267|18633464|P1|STARTED|Extension Study|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
7570234|NCT02841267|18633462|P3|NOT COMPLETED|Treatment Period||0
7570235|NCT02841267|18633463|P2|NOT COMPLETED|Treatment Period||0
7570236|NCT02841267|18633464|P1|NOT COMPLETED|Treatment Period||0
7570237|NCT02841267|18633462|P3|COMPLETED|Treatment Period||8
7570238|NCT02841267|18633463|P2|COMPLETED|Treatment Period||7
7570239|NCT02841267|18633464|P1|COMPLETED|Treatment Period||4
7570240|NCT02841267|18633462|P3|STARTED|Treatment Period||8
7570241|NCT02841267|18633463|P2|STARTED|Treatment Period||7
7570242|NCT02841267|18633464|P1|STARTED|Treatment Period|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
7570243|NCT02841267|18633462|P3|NOT COMPLETED|Lead-in (Untreated)||0
7570244|NCT02841267|18633463|P2|NOT COMPLETED|Lead-in (Untreated)||0
7570245|NCT02841267|18633464|P1|NOT COMPLETED|Lead-in (Untreated)||0
7570246|NCT02841267|18633462|P3|COMPLETED|Lead-in (Untreated)||8
7570247|NCT02841267|18633463|P2|COMPLETED|Lead-in (Untreated)||7
7570248|NCT02841267|18633464|P1|COMPLETED|Lead-in (Untreated)||4
7570249|NCT02841267|18633462|P3|STARTED|Lead-in (Untreated)||8
7570250|NCT02841267|18633463|P2|STARTED|Lead-in (Untreated)||7
7570251|NCT02841267|18633464|P1|STARTED|Lead-in (Untreated)||4
7570252|NCT02841241|18633507|P1|NOT COMPLETED|Overall Study||0
7570253|NCT02841241|18633507|P1|COMPLETED|Overall Study||7
7570254|NCT02841241|18633507|P1|STARTED|Overall Study||7
7570255|NCT02841189|18633518|P1|NOT COMPLETED|Overall Study||35
7570256|NCT02841189|18633518|P1|COMPLETED|Overall Study||65
7570257|NCT02841189|18633518|P1|STARTED|Overall Study||100
7570258|NCT02841046|18633524|P2|NOT COMPLETED|Overall Study||0
7570259|NCT02841046|18633525|P1|NOT COMPLETED|Overall Study||0
7570260|NCT02841046|18633524|P2|COMPLETED|Overall Study||25
7570261|NCT02841046|18633525|P1|COMPLETED|Overall Study||25
7570262|NCT02841046|18633524|P2|STARTED|Overall Study||25
7570263|NCT02841046|18633525|P1|STARTED|Overall Study||25
7570264|NCT02840916|18633533|P2|NOT COMPLETED|Overall Study||3
7570265|NCT02840916|18633534|P1|NOT COMPLETED|Overall Study||1
7570266|NCT02840916|18633533|P2|COMPLETED|Overall Study||30
7570267|NCT02840916|18633534|P1|COMPLETED|Overall Study||32
7570268|NCT02840916|18633533|P2|STARTED|Overall Study||33
7570269|NCT02840916|18633534|P1|STARTED|Overall Study||33
7570270|NCT02840721|18633544|P1|NOT COMPLETED|Follow-Up||7
7570271|NCT02840721|18633544|P1|COMPLETED|Follow-Up||42
7570272|NCT02840721|18633544|P1|STARTED|Follow-Up||49
7570273|NCT02840721|18633544|P1|NOT COMPLETED|Treatment Period||1
7570274|NCT02840721|18633544|P1|COMPLETED|Treatment Period||49
7570275|NCT02840721|18633544|P1|STARTED|Treatment Period||50
7570276|NCT02840461|18633566|P3|NOT COMPLETED|Overall Study||14
7570277|NCT02840461|18633567|P2|NOT COMPLETED|Overall Study||22
7570278|NCT02840461|18633568|P1|NOT COMPLETED|Overall Study||23
7570279|NCT02840461|18633566|P3|COMPLETED|Overall Study||100
7570280|NCT02840461|18633567|P2|COMPLETED|Overall Study||235
7570281|NCT02840461|18633568|P1|COMPLETED|Overall Study||236
7570282|NCT02840461|18633566|P3|STARTED|Overall Study||114
7570283|NCT02840461|18633567|P2|STARTED|Overall Study||257
7570284|NCT02840461|18633568|P1|STARTED|Overall Study||259
7570285|NCT02840253|18633579|P1|NOT COMPLETED|Overall Study||4
7570286|NCT02840253|18633579|P1|COMPLETED|Overall Study||19
7570287|NCT02840253|18633579|P1|STARTED|Overall Study||23
7570288|NCT02839902|18633586|P2|NOT COMPLETED|Overall Study||0
7570289|NCT02839902|18633587|P1|NOT COMPLETED|Overall Study||0
7570290|NCT02839902|18633586|P2|COMPLETED|Overall Study||29
7570291|NCT02839902|18633587|P1|COMPLETED|Overall Study||24
7570292|NCT02839902|18633586|P2|STARTED|Overall Study||29
7570293|NCT02839902|18633587|P1|STARTED|Overall Study||24
7570294|NCT02839889|18633625|P2|NOT COMPLETED|Open-Label Period||1
7570295|NCT02839889|18633626|P1|NOT COMPLETED|Open-Label Period||0
7570296|NCT02839889|18633625|P2|COMPLETED|Open-Label Period||4
7570297|NCT02839889|18633626|P1|COMPLETED|Open-Label Period||0
7570298|NCT02839889|18633625|P2|STARTED|Open-Label Period||5
7570299|NCT02839889|18633626|P1|STARTED|Open-Label Period||0
7570300|NCT02839889|18633625|P2|NOT COMPLETED|Randomization Period||0
7570301|NCT02839889|18633626|P1|NOT COMPLETED|Randomization Period||0
7570302|NCT02839889|18633625|P2|COMPLETED|Randomization Period||3
7570303|NCT02839889|18633626|P1|COMPLETED|Randomization Period||2
7570304|NCT02839889|18633625|P2|STARTED|Randomization Period||3
7570305|NCT02839889|18633626|P1|STARTED|Randomization Period||2
7570306|NCT02839876|18633664|P2|NOT COMPLETED|Overall Study||11
7570307|NCT02839876|18633665|P1|NOT COMPLETED|Overall Study||10
7570308|NCT02839876|18633664|P2|COMPLETED|Overall Study||29
7570309|NCT02839876|18633665|P1|COMPLETED|Overall Study||31
7570310|NCT02839876|18633664|P2|STARTED|Overall Study||40
7570311|NCT02839876|18633665|P1|STARTED|Overall Study||41
7570312|NCT02839798|18633727|P1|NOT COMPLETED|Overall Study||2
7570313|NCT02839798|18633727|P1|COMPLETED|Overall Study||4
7570314|NCT02839798|18633727|P1|STARTED|Overall Study||6
7570315|NCT02839772|18633735|P2|NOT COMPLETED|Overall Study||0
7570316|NCT02839772|18633736|P1|NOT COMPLETED|Overall Study||1
7570317|NCT02839772|18633735|P2|COMPLETED|Overall Study||96
7570318|NCT02839772|18633736|P1|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96
7570319|NCT02839772|18633735|P2|STARTED|Overall Study||96
7570320|NCT02839772|18633736|P1|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97
7570321|NCT02839746|18633773|P1|NOT COMPLETED|Overall Study||12
7570322|NCT02839746|18633773|P1|COMPLETED|Overall Study||659
7570323|NCT02839746|18633773|P1|STARTED|Overall Study||671
7570324|NCT02839681|18633787|P1|NOT COMPLETED|Overall Study||2
7570325|NCT02839681|18633787|P1|COMPLETED|Overall Study||0
7570326|NCT02839681|18633787|P1|STARTED|Overall Study||2
7570327|NCT02839330|18633800|P4|NOT COMPLETED|Overall Study||51
7570328|NCT02839330|18633801|P3|NOT COMPLETED|Overall Study||48
7570329|NCT02839330|18633802|P2|NOT COMPLETED|Overall Study||58
7570330|NCT02839330|18633803|P1|NOT COMPLETED|Overall Study||58
7570331|NCT02839330|18633800|P4|COMPLETED|Overall Study||747
7570332|NCT02839330|18633801|P3|COMPLETED|Overall Study||747
7570333|NCT02839330|18633802|P2|COMPLETED|Overall Study||741
7570334|NCT02839330|18633803|P1|COMPLETED|Overall Study||746
7570335|NCT02839330|18633800|P4|Exposed|Overall Study||797
7570336|NCT02839330|18633801|P3|Exposed|Overall Study||793
7570337|NCT02839330|18633802|P2|Exposed|Overall Study||797
7570338|NCT02839330|18633803|P1|Exposed|Overall Study||804
7570339|NCT02839330|18633800|P4|STARTED|Overall Study||798
7570340|NCT02839330|18633801|P3|STARTED|Overall Study||795
7570341|NCT02839330|18633802|P2|STARTED|Overall Study||799
7570342|NCT02839330|18633803|P1|STARTED|Overall Study||804
7570343|NCT02839200|18633838|P6|NOT COMPLETED|Overall Study||1
7570344|NCT02839200|18633839|P5|NOT COMPLETED|Overall Study||2
7570345|NCT02839200|18633840|P4|NOT COMPLETED|Overall Study||0
7570346|NCT02839200|18633841|P3|NOT COMPLETED|Overall Study||1
7570347|NCT02839200|18633842|P2|NOT COMPLETED|Overall Study||1
7570348|NCT02839200|18633843|P1|NOT COMPLETED|Overall Study||4
7570349|NCT02839200|18633838|P6|COMPLETED|Overall Study||59
7570350|NCT02839200|18633839|P5|COMPLETED|Overall Study||58
7570351|NCT02839200|18633840|P4|COMPLETED|Overall Study||61
7570352|NCT02839200|18633841|P3|COMPLETED|Overall Study||59
7570353|NCT02839200|18633842|P2|COMPLETED|Overall Study||58
7570354|NCT02839200|18633843|P1|COMPLETED|Overall Study||56
7570355|NCT02839200|18633838|P6|STARTED|Overall Study||60
7570356|NCT02839200|18633839|P5|STARTED|Overall Study||60
7570357|NCT02839200|18633840|P4|STARTED|Overall Study||61
7570358|NCT02839200|18633841|P3|STARTED|Overall Study||60
7570359|NCT02839200|18633842|P2|STARTED|Overall Study||59
7570360|NCT02839200|18633843|P1|STARTED|Overall Study||60
7570361|NCT02838901|18633877|P2|NOT COMPLETED|Overall Study||2
7570362|NCT02838901|18633878|P1|NOT COMPLETED|Overall Study||2
7570363|NCT02838901|18633877|P2|COMPLETED|Overall Study||7
7570364|NCT02838901|18633878|P1|COMPLETED|Overall Study||7
7570365|NCT02838901|18633877|P2|STARTED|Overall Study||9
7570366|NCT02838901|18633878|P1|STARTED|Overall Study||9
7570367|NCT02838420|18633908|P2|NOT COMPLETED|Overall Study||62
7570368|NCT02838420|18633909|P1|NOT COMPLETED|Overall Study||125
7570369|NCT02838420|18633908|P2|COMPLETED|Overall Study||0
7570370|NCT02838420|18633909|P1|COMPLETED|Overall Study||0
7570371|NCT02838420|18633908|P2|STARTED|Overall Study||62
7570372|NCT02838420|18633909|P1|STARTED|Overall Study||125
7570373|NCT02838407|18633923|P1|NOT COMPLETED|Overall Study||0
7570374|NCT02838407|18633923|P1|COMPLETED|Overall Study||197
7570375|NCT02838407|18633923|P1|STARTED|Overall Study||197
7570376|NCT02838134|18633972|P2|NOT COMPLETED|Overall Study||3
7570377|NCT02838134|18633973|P1|NOT COMPLETED|Overall Study||2
7570378|NCT02838134|18633972|P2|COMPLETED|Overall Study||48
7570379|NCT02838134|18633973|P1|COMPLETED|Overall Study||48
7570380|NCT02838134|18633972|P2|STARTED|Overall Study||51
7570381|NCT02838134|18633973|P1|STARTED|Overall Study||50
7570382|NCT02838017|18634005|P2|NOT COMPLETED|Overall Study||11
7570383|NCT02838017|18634006|P1|NOT COMPLETED|Overall Study||14
7570384|NCT02838017|18634005|P2|COMPLETED|Overall Study||241
7570385|NCT02838017|18634006|P1|COMPLETED|Overall Study||238
7570386|NCT02838017|18634005|P2|STARTED|Overall Study||252
7570387|NCT02838017|18634006|P1|STARTED|Overall Study||252
7570388|NCT02837952|18634024|P2|NOT COMPLETED|Overall Study||6
7570389|NCT02837952|18634025|P1|NOT COMPLETED|Overall Study||5
7570390|NCT02837952|18634024|P2|COMPLETED|Overall Study||76
7570391|NCT02837952|18634025|P1|COMPLETED|Overall Study||36
7570392|NCT02837952|18634024|P2|STARTED|Overall Study||82
7570393|NCT02837952|18634025|P1|STARTED|Overall Study||41
7570394|NCT02837913|18634039|P2|NOT COMPLETED|Overall Study||0
7570395|NCT02837913|18634040|P1|NOT COMPLETED|Overall Study||0
7570396|NCT02837913|18634039|P2|COMPLETED|Overall Study||9
7570397|NCT02837913|18634040|P1|COMPLETED|Overall Study||10
7570398|NCT02837913|18634039|P2|STARTED|Overall Study||9
7570399|NCT02837913|18634040|P1|STARTED|Overall Study||10
7570400|NCT02837731|18634062|P2|NOT COMPLETED|Analysis||0
7570401|NCT02837731|18634063|P1|NOT COMPLETED|Analysis||0
7570402|NCT02837731|18634062|P2|COMPLETED|Analysis||41
7570403|NCT02837731|18634063|P1|COMPLETED|Analysis||83
7570404|NCT02837731|18634062|P2|STARTED|Analysis||41
7570405|NCT02837731|18634063|P1|STARTED|Analysis||83
7570406|NCT02837731|18634062|P2|NOT COMPLETED|Follow-up||0
7570407|NCT02837731|18634063|P1|NOT COMPLETED|Follow-up||0
7570408|NCT02837731|18634062|P2|COMPLETED|Follow-up||41
7570409|NCT02837731|18634063|P1|COMPLETED|Follow-up||83
7570410|NCT02837731|18634062|P2|STARTED|Follow-up||41
7570411|NCT02837731|18634063|P1|STARTED|Follow-up||83
7570412|NCT02837731|18634062|P2|NOT COMPLETED|Allocation||7
7570413|NCT02837731|18634063|P1|NOT COMPLETED|Allocation||19
7570414|NCT02837731|18634062|P2|COMPLETED|Allocation||41
7570415|NCT02837731|18634063|P1|COMPLETED|Allocation||83
7570416|NCT02837731|18634062|P2|STARTED|Allocation||48
7570417|NCT02837731|18634063|P1|STARTED|Allocation||102
7570418|NCT02837328|18634095|P2|NOT COMPLETED|Overall Study||0
7570419|NCT02837328|18634096|P1|NOT COMPLETED|Overall Study||0
7570420|NCT02837328|18634095|P2|COMPLETED|Overall Study||30
7570421|NCT02837328|18634096|P1|COMPLETED|Overall Study||29
7570422|NCT02837328|18634095|P2|STARTED|Overall Study||30
7570423|NCT02837328|18634096|P1|STARTED|Overall Study||29
7570424|NCT02837237|18634104|P1|NOT COMPLETED|Overall Study||0
7570425|NCT02837237|18634104|P1|COMPLETED|Overall Study||11
7570426|NCT02837237|18634104|P1|STARTED|Overall Study||11
7570427|NCT02837029|18634111|P3|NOT COMPLETED|2 Year Follow-up||0
7570428|NCT02837029|18634112|P2|NOT COMPLETED|2 Year Follow-up||7
7570429|NCT02837029|18634113|P1|NOT COMPLETED|2 Year Follow-up||6
7570430|NCT02837029|18634111|P3|COMPLETED|2 Year Follow-up||0
7570431|NCT02837029|18634112|P2|COMPLETED|2 Year Follow-up||0
7570432|NCT02837029|18634113|P1|COMPLETED|2 Year Follow-up||0
7570433|NCT02837029|18634111|P3|STARTED|2 Year Follow-up||0
7570434|NCT02837029|18634112|P2|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|7
7570435|NCT02837029|18634113|P1|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|6
7570436|NCT02837029|18634111|P3|NOT COMPLETED|Cycle 2 and Beyond||0
7570437|NCT02837029|18634112|P2|NOT COMPLETED|Cycle 2 and Beyond||0
7570438|NCT02837029|18634113|P1|NOT COMPLETED|Cycle 2 and Beyond||1
7570439|NCT02837029|18634111|P3|COMPLETED|Cycle 2 and Beyond||0
7570440|NCT02837029|18634112|P2|COMPLETED|Cycle 2 and Beyond||6
7570441|NCT02837029|18634113|P1|COMPLETED|Cycle 2 and Beyond||5
7570442|NCT02837029|18634111|P3|STARTED|Cycle 2 and Beyond||0
7570443|NCT02837029|18634112|P2|STARTED|Cycle 2 and Beyond||6
7570444|NCT02837029|18634113|P1|STARTED|Cycle 2 and Beyond||6
7570445|NCT02837029|18634111|P3|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||0
7570446|NCT02837029|18634112|P2|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||3
7570447|NCT02837029|18634113|P1|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||2
7570448|NCT02837029|18634111|P3|COMPLETED|Cycle 1 (DLT Monitoring Period)||0
7570449|NCT02837029|18634112|P2|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
7570450|NCT02837029|18634113|P1|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
7570451|NCT02837029|18634111|P3|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||0
7570452|NCT02837029|18634112|P2|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||7
7570453|NCT02837029|18634113|P1|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||6
7570454|NCT02837029|18634111|P3|STARTED|Cycle 1 (DLT Monitoring Period)||0
7570455|NCT02837029|18634112|P2|STARTED|Cycle 1 (DLT Monitoring Period)||9
7570456|NCT02837029|18634113|P1|STARTED|Cycle 1 (DLT Monitoring Period)||8
7570457|NCT02837029|18634111|P3|NOT COMPLETED|Induction Treatment With Y90||0
7570458|NCT02837029|18634112|P2|NOT COMPLETED|Induction Treatment With Y90||0
7570459|NCT02837029|18634113|P1|NOT COMPLETED|Induction Treatment With Y90||0
7570460|NCT02837029|18634111|P3|COMPLETED|Induction Treatment With Y90||0
7570461|NCT02837029|18634112|P2|COMPLETED|Induction Treatment With Y90||9
7570462|NCT02837029|18634113|P1|COMPLETED|Induction Treatment With Y90||8
7570463|NCT02837029|18634111|P3|STARTED|Induction Treatment With Y90||0
7570464|NCT02837029|18634112|P2|STARTED|Induction Treatment With Y90||9
7570465|NCT02837029|18634113|P1|STARTED|Induction Treatment With Y90||8
7570466|NCT02837029|18634111|P3|NOT COMPLETED|Screening||0
7570467|NCT02837029|18634112|P2|NOT COMPLETED|Screening||3
7570468|NCT02837029|18634113|P1|NOT COMPLETED|Screening||7
7570469|NCT02837029|18634111|P3|COMPLETED|Screening||0
7570470|NCT02837029|18634112|P2|COMPLETED|Screening||9
7570471|NCT02837029|18634113|P1|COMPLETED|Screening||8
7570472|NCT02837029|18634111|P3|STARTED|Screening||0
7570473|NCT02837029|18634112|P2|STARTED|Screening||12
7570474|NCT02837029|18634113|P1|STARTED|Screening||15
7570475|NCT02836990|18634122|P2|NOT COMPLETED|Overall Study||0
7570476|NCT02836990|18634123|P1|NOT COMPLETED|Overall Study||0
7570477|NCT02836990|18634122|P2|COMPLETED|Overall Study||55
7570478|NCT02836990|18634123|P1|COMPLETED|Overall Study||50
7570479|NCT02836990|18634122|P2|STARTED|Overall Study||55
7570480|NCT02836990|18634123|P1|STARTED|Overall Study||50
7570481|NCT02836652|18634135|P2|NOT COMPLETED|Overall Study||19
7570482|NCT02836652|18634136|P1|NOT COMPLETED|Overall Study||18
7570483|NCT02836652|18634135|P2|COMPLETED|Overall Study||18
7570484|NCT02836652|18634136|P1|COMPLETED|Overall Study||17
7570485|NCT02836652|18634135|P2|As-treated Population|Overall Study||34
7570486|NCT02836652|18634136|P1|As-treated Population|Overall Study||31
7570487|NCT02836652|18634135|P2|STARTED|Overall Study||37
7570488|NCT02836652|18634136|P1|STARTED|Overall Study||35
7570489|NCT02836613|18634150|P2|NOT COMPLETED|Overall Study||3
7570490|NCT02836613|18634151|P1|NOT COMPLETED|Overall Study||1
7570491|NCT02836613|18634150|P2|COMPLETED|Overall Study||77
7570492|NCT02836613|18634151|P1|COMPLETED|Overall Study||79
7570493|NCT02836613|18634150|P2|STARTED|Overall Study||80
7570494|NCT02836613|18634151|P1|STARTED|Overall Study||80
7570495|NCT02836496|18634165|P2|NOT COMPLETED|Overall Study||2
7570496|NCT02836496|18634166|P1|NOT COMPLETED|Overall Study||2
7570497|NCT02836496|18634165|P2|COMPLETED|Overall Study||52
7570498|NCT02836496|18634166|P1|COMPLETED|Overall Study||52
7570499|NCT02836496|18634165|P2|STARTED|Overall Study||54
7570500|NCT02836496|18634166|P1|STARTED|Overall Study||54
7570501|NCT02836249|18634182|P2|NOT COMPLETED|Overall Study||58
7570502|NCT02836249|18634183|P1|NOT COMPLETED|Overall Study||123
7570503|NCT02836249|18634182|P2|COMPLETED|Overall Study||0
7570504|NCT02836249|18634183|P1|COMPLETED|Overall Study||0
7570505|NCT02836249|18634182|P2|STARTED|Overall Study||58
7570506|NCT02836249|18634183|P1|STARTED|Overall Study||123
7570507|NCT02836236|18634201|P2|NOT COMPLETED|Overall Study||50
7570508|NCT02836236|18634202|P1|NOT COMPLETED|Overall Study||105
7570509|NCT02836236|18634201|P2|COMPLETED|Overall Study||0
7570510|NCT02836236|18634202|P1|COMPLETED|Overall Study||0
7570511|NCT02836236|18634201|P2|STARTED|Overall Study||50
7570512|NCT02836236|18634202|P1|STARTED|Overall Study||105
7570513|NCT02835820|18634218|P2|NOT COMPLETED|Overall Study||3
7570514|NCT02835820|18634219|P1|NOT COMPLETED|Overall Study||0
7570515|NCT02835820|18634218|P2|COMPLETED|Overall Study||7
7570516|NCT02835820|18634219|P1|COMPLETED|Overall Study||7
7570517|NCT02835820|18634218|P2|Baseline Screen (OGTT)|Overall Study||7
7570518|NCT02835820|18634219|P1|Baseline Screen (OGTT)|Overall Study||7
7570519|NCT02835820|18634218|P2|STARTED|Overall Study||10
7570520|NCT02835820|18634219|P1|STARTED|Overall Study||7
7570521|NCT02835690|18634266|P3|NOT COMPLETED|Overall Study||15
7570522|NCT02835690|18634267|P2|NOT COMPLETED|Overall Study||15
7570523|NCT02835690|18634268|P1|NOT COMPLETED|Overall Study||14
7570524|NCT02835690|18634266|P3|COMPLETED|Overall Study||0
7570525|NCT02835690|18634267|P2|COMPLETED|Overall Study||0
7570526|NCT02835690|18634268|P1|COMPLETED|Overall Study||0
7570527|NCT02835690|18634266|P3|Treated|Overall Study||15
7570528|NCT02835690|18634267|P2|Treated|Overall Study||13
7570529|NCT02835690|18634268|P1|Treated|Overall Study||14
7570530|NCT02835690|18634266|P3|STARTED|Overall Study||15
7570531|NCT02835690|18634267|P2|STARTED|Overall Study||15
7570532|NCT02835690|18634268|P1|STARTED|Overall Study||14
7570533|NCT02835677|18634321|P1|NOT COMPLETED|Overall Study||0
7570534|NCT02835677|18634321|P1|COMPLETED|Overall Study||25
7570535|NCT02835677|18634321|P1|STARTED|Overall Study||25
7570536|NCT02835495|18634331|P2|NOT COMPLETED|Overall Study||2
7570537|NCT02835495|18634332|P1|NOT COMPLETED|Overall Study||5
7570538|NCT02835495|18634331|P2|COMPLETED|Overall Study||23
7570539|NCT02835495|18634332|P1|COMPLETED|Overall Study||21
7570540|NCT02835495|18634331|P2|Intervention Start|Overall Study||25
7570541|NCT02835495|18634332|P1|Intervention Start|Overall Study||25
7570542|NCT02835495|18634331|P2|STARTED|Overall Study||25
7570543|NCT02835495|18634332|P1|STARTED|Overall Study|26 randomized, however, one had to withdraw pre-intervention initiation due to cancer diagnosis.|26
7570544|NCT02835339|18634358|P2|NOT COMPLETED|Overall Study||16
7570545|NCT02835339|18634359|P1|NOT COMPLETED|Overall Study||13
7570546|NCT02835339|18634358|P2|COMPLETED|Overall Study||19
7570547|NCT02835339|18634359|P1|COMPLETED|Overall Study||18
7570548|NCT02835339|18634358|P2|STARTED|Overall Study||35
7570549|NCT02835339|18634359|P1|STARTED|Overall Study||31
7570550|NCT02835274|18634371|P2|NOT COMPLETED|Overall Study||0
7570551|NCT02835274|18634372|P1|NOT COMPLETED|Overall Study||0
7570552|NCT02835274|18634371|P2|COMPLETED|Overall Study||6
7570553|NCT02835274|18634372|P1|COMPLETED|Overall Study||6
7570554|NCT02835274|18634371|P2|STARTED|Overall Study||6
7570555|NCT02835274|18634372|P1|STARTED|Overall Study||6
7570556|NCT02835092|18634381|P3|NOT COMPLETED|Overall Study||3
7570557|NCT02835092|18634382|P2|NOT COMPLETED|Overall Study||8
7570558|NCT02835092|18634383|P1|NOT COMPLETED|Overall Study||3
7570559|NCT02835092|18634381|P3|COMPLETED|Overall Study||64
7570560|NCT02835092|18634382|P2|COMPLETED|Overall Study||57
7570561|NCT02835092|18634383|P1|COMPLETED|Overall Study||63
7570562|NCT02835092|18634381|P3|STARTED|Overall Study||67
7570563|NCT02835092|18634382|P2|STARTED|Overall Study||65
7570564|NCT02835092|18634383|P1|STARTED|Overall Study||66
7570565|NCT02834819|18634393|P2|NOT COMPLETED|Overall Study||0
7570566|NCT02834819|18634394|P1|NOT COMPLETED|Overall Study||5
7570567|NCT02834819|18634393|P2|COMPLETED|Overall Study||9
7570568|NCT02834819|18634394|P1|COMPLETED|Overall Study||4
7570569|NCT02834819|18634393|P2|STARTED|Overall Study||9
7570570|NCT02834819|18634394|P1|STARTED|Overall Study||9
7570571|NCT02834806|18634414|P1|NOT COMPLETED|Overall Study||0
7570572|NCT02834806|18634414|P1|COMPLETED|Overall Study||58
7570573|NCT02834806|18634414|P1|STARTED|Overall Study||58
7570574|NCT02834663|18634418|P1|NOT COMPLETED|Overall Study||0
7570575|NCT02834663|18634418|P1|COMPLETED|Overall Study|Unit means the eye. One eye was included per patient|25
7570576|NCT02834663|18634418|P1|STARTED|Overall Study|Unit means the eye. One eye was included per patient|25
7570577|NCT02834624|18634438|P2|NOT COMPLETED|Overall Study||0
7570578|NCT02834624|18634439|P1|NOT COMPLETED|Overall Study||0
7570579|NCT02834624|18634438|P2|COMPLETED|Overall Study||15
7570580|NCT02834624|18634439|P1|COMPLETED|Overall Study||15
7570581|NCT02834624|18634438|P2|STARTED|Overall Study||15
7570582|NCT02834624|18634439|P1|STARTED|Overall Study||15
7570583|NCT02834247|18634453|P4|NOT COMPLETED|Dose Expansion Phase||17
7570584|NCT02834247|18634454|P3|NOT COMPLETED|Dose Expansion Phase||0
7570585|NCT02834247|18634455|P2|NOT COMPLETED|Dose Expansion Phase||0
7570586|NCT02834247|18634456|P1|NOT COMPLETED|Dose Expansion Phase||0
7570587|NCT02834247|18634453|P4|COMPLETED|Dose Expansion Phase||0
7570588|NCT02834247|18634454|P3|COMPLETED|Dose Expansion Phase||0
7570589|NCT02834247|18634455|P2|COMPLETED|Dose Expansion Phase||0
7570590|NCT02834247|18634456|P1|COMPLETED|Dose Expansion Phase||0
7570591|NCT02834247|18634453|P4|STARTED|Dose Expansion Phase||17
7570592|NCT02834247|18634454|P3|STARTED|Dose Expansion Phase||0
7570593|NCT02834247|18634455|P2|STARTED|Dose Expansion Phase||0
7570594|NCT02834247|18634456|P1|STARTED|Dose Expansion Phase||0
7570595|NCT02834247|18634453|P4|NOT COMPLETED|Dose Escalation Phase||0
7570596|NCT02834247|18634454|P3|NOT COMPLETED|Dose Escalation Phase||5
7570597|NCT02834247|18634455|P2|NOT COMPLETED|Dose Escalation Phase||11
7570598|NCT02834247|18634456|P1|NOT COMPLETED|Dose Escalation Phase||8
7570599|NCT02834247|18634453|P4|COMPLETED|Dose Escalation Phase||0
7570600|NCT02834247|18634454|P3|COMPLETED|Dose Escalation Phase||0
7570601|NCT02834247|18634455|P2|COMPLETED|Dose Escalation Phase||0
7570602|NCT02834247|18634456|P1|COMPLETED|Dose Escalation Phase||0
7570603|NCT02834247|18634453|P4|STARTED|Dose Escalation Phase||0
7570604|NCT02834247|18634454|P3|STARTED|Dose Escalation Phase||5
7570605|NCT02834247|18634455|P2|STARTED|Dose Escalation Phase||11
7570606|NCT02834247|18634456|P1|STARTED|Dose Escalation Phase||8
7570607|NCT02833974|18634485|P2|NOT COMPLETED|Overall Study||3
7570608|NCT02833974|18634486|P1|NOT COMPLETED|Overall Study||1
7570609|NCT02833974|18634485|P2|COMPLETED|Overall Study||19
7570610|NCT02833974|18634486|P1|COMPLETED|Overall Study||13
7570611|NCT02833974|18634485|P2|STARTED|Overall Study||22
7570612|NCT02833974|18634486|P1|STARTED|Overall Study||14
7570613|NCT02833948|18634512|P2|NOT COMPLETED|Overall Study||18
7570614|NCT02833948|18634513|P1|NOT COMPLETED|Overall Study||15
7570615|NCT02833948|18634512|P2|COMPLETED|Overall Study||97
7570616|NCT02833948|18634513|P1|COMPLETED|Overall Study||101
7570617|NCT02833948|18634512|P2|STARTED|Overall Study||115
7570618|NCT02833948|18634513|P1|STARTED|Overall Study||116
7570619|NCT02833922|18634537|P1|NOT COMPLETED|Overall Study||382
7570620|NCT02833922|18634537|P1|COMPLETED|Overall Study||336
7570621|NCT02833922|18634537|P1|STARTED|Overall Study||718
7570622|NCT02833857|18634545|P1|NOT COMPLETED|Overall Study||0
7570623|NCT02833857|18634545|P1|COMPLETED|Overall Study||11
7570624|NCT02833857|18634545|P1|STARTED|Overall Study||11
7570625|NCT02833844|18634572|P2|NOT COMPLETED|Overall Study||7
7570626|NCT02833844|18634573|P1|NOT COMPLETED|Overall Study||2
7570627|NCT02833844|18634572|P2|COMPLETED|Overall Study|completed double-blind period|303
7570628|NCT02833844|18634573|P1|COMPLETED|Overall Study|completed double-blind period|155
7570629|NCT02833844|18634572|P2|Randomized and Treated|Overall Study||307
7570630|NCT02833844|18634573|P1|Randomized and Treated|Overall Study||157
7570631|NCT02833844|18634572|P2|STARTED|Overall Study||310
7570632|NCT02833844|18634573|P1|STARTED|Overall Study||157
7570633|NCT02833415|18634601|P2|NOT COMPLETED|Overall Study||3
7570634|NCT02833415|18634602|P1|NOT COMPLETED|Overall Study||2
7570635|NCT02833415|18634601|P2|COMPLETED|Overall Study||17
7570636|NCT02833415|18634602|P1|COMPLETED|Overall Study||18
7570637|NCT02833415|18634601|P2|STARTED|Overall Study||20
7570638|NCT02833415|18634602|P1|STARTED|Overall Study||20
7570639|NCT02833350|18634615|P7|NOT COMPLETED|Overall Study||5
7570640|NCT02833350|18634616|P6|NOT COMPLETED|Overall Study||1
7570641|NCT02833350|18634617|P5|NOT COMPLETED|Overall Study||3
7570642|NCT02833350|18634618|P4|NOT COMPLETED|Overall Study||8
7570643|NCT02833350|18634619|P3|NOT COMPLETED|Overall Study||8
7570644|NCT02833350|18634620|P2|NOT COMPLETED|Overall Study||9
7570645|NCT02833350|18634621|P1|NOT COMPLETED|Overall Study||3
7570646|NCT02833350|18634615|P7|COMPLETED|Overall Study||44
7570647|NCT02833350|18634616|P6|COMPLETED|Overall Study||48
7570648|NCT02833350|18634617|P5|COMPLETED|Overall Study||108
7570649|NCT02833350|18634618|P4|COMPLETED|Overall Study||102
7570650|NCT02833350|18634619|P3|COMPLETED|Overall Study||102
7570651|NCT02833350|18634620|P2|COMPLETED|Overall Study||100
7570652|NCT02833350|18634621|P1|COMPLETED|Overall Study||37
7570653|NCT02833350|18634615|P7|Randomized|Overall Study||50
7570654|NCT02833350|18634616|P6|Randomized|Overall Study||48
7570655|NCT02833350|18634617|P5|Randomized|Overall Study||111
7570656|NCT02833350|18634618|P4|Randomized|Overall Study||110
7570657|NCT02833350|18634619|P3|Randomized|Overall Study||110
7570658|NCT02833350|18634620|P2|Randomized|Overall Study||109
7570659|NCT02833350|18634621|P1|Randomized|Overall Study||40
7570660|NCT02833350|18634615|P7|STARTED|Overall Study||49
7570661|NCT02833350|18634616|P6|STARTED|Overall Study||49
7570662|NCT02833350|18634617|P5|STARTED|Overall Study||111
7570663|NCT02833350|18634618|P4|STARTED|Overall Study||110
7570664|NCT02833350|18634619|P3|STARTED|Overall Study||110
7570665|NCT02833350|18634620|P2|STARTED|Overall Study||109
7570666|NCT02833350|18634621|P1|STARTED|Overall Study||40
7570667|NCT02833337|18634822|P1|NOT COMPLETED|Overall Study||0
7570668|NCT02833337|18634822|P1|COMPLETED|Overall Study||180
7570669|NCT02833337|18634822|P1|STARTED|Overall Study||180
7570670|NCT02833077|18634828|P2|NOT COMPLETED|Overall Study||8
7570671|NCT02833077|18634829|P1|NOT COMPLETED|Overall Study||17
7570672|NCT02833077|18634828|P2|COMPLETED|Overall Study|Includes participants who completed the study but did not receive the optional treatment.|40
7570673|NCT02833077|18634829|P1|COMPLETED|Overall Study||127
7570674|NCT02833077|18634828|P2|Participants Treated|Overall Study||38
7570675|NCT02833077|18634829|P1|Participants Treated|Overall Study||144
7570676|NCT02833077|18634828|P2|STARTED|Overall Study||48
7570677|NCT02833077|18634829|P1|STARTED|Overall Study||144
7570678|NCT02832674|18634841|P1|NOT COMPLETED|Overall Study||5
7570679|NCT02832674|18634841|P1|COMPLETED|Overall Study||67
7570680|NCT02832674|18634841|P1|STARTED|Overall Study||72
7570681|NCT02832375|18634852|P2|NOT COMPLETED|Overall Study||0
7570682|NCT02832375|18634853|P1|NOT COMPLETED|Overall Study||2
7570683|NCT02832375|18634852|P2|COMPLETED|Overall Study||121
7570684|NCT02832375|18634853|P1|COMPLETED|Overall Study||119
7570685|NCT02832375|18634852|P2|STARTED|Overall Study||121
7570686|NCT02832375|18634853|P1|STARTED|Overall Study||121
7570687|NCT02832284|18634863|P1|NOT COMPLETED|Overall Study||0
7570688|NCT02832284|18634863|P1|COMPLETED|Overall Study||23
7570689|NCT02832284|18634863|P1|STARTED|Overall Study||23
7570690|NCT02832167|18634871|P1|NOT COMPLETED|Treatment Period 2||83
7570691|NCT02832167|18634871|P1|COMPLETED|Treatment Period 2||20
7570692|NCT02832167|18634871|P1|STARTED|Treatment Period 2||103
7570693|NCT02832167|18634871|P1|NOT COMPLETED|Transition From Period 1 to Period 2||7
7570694|NCT02832167|18634871|P1|COMPLETED|Transition From Period 1 to Period 2||103
7570695|NCT02832167|18634871|P1|STARTED|Transition From Period 1 to Period 2||110
7570696|NCT02832167|18634871|P1|NOT COMPLETED|Treatment Period 1||129
7570697|NCT02832167|18634871|P1|COMPLETED|Treatment Period 1||110
7570698|NCT02832167|18634871|P1|STARTED|Treatment Period 1||239
7570699|NCT02832154|18634882|P1|NOT COMPLETED|Overall Study||0
7570700|NCT02832154|18634882|P1|COMPLETED|Overall Study||43
7570701|NCT02832154|18634882|P1|STARTED|Overall Study||43
7570702|NCT02832115|18634897|P2|NOT COMPLETED|Overall Study||0
7570703|NCT02832115|18634898|P1|NOT COMPLETED|Overall Study||0
7570704|NCT02832115|18634897|P2|COMPLETED|Overall Study||52
7570705|NCT02832115|18634898|P1|COMPLETED|Overall Study||48
7570706|NCT02832115|18634897|P2|STARTED|Overall Study||52
7570707|NCT02832115|18634898|P1|STARTED|Overall Study||48
7570708|NCT02831855|18634912|P3|NOT COMPLETED|Double Blind Phase (24 Weeks)||19
7570709|NCT02831855|18634913|P2|NOT COMPLETED|Double Blind Phase (24 Weeks)||29
7570710|NCT02831855|18634914|P1|NOT COMPLETED|Double Blind Phase (24 Weeks)||0
7570711|NCT02831855|18634912|P3|COMPLETED|Double Blind Phase (24 Weeks)||247
7570712|NCT02831855|18634913|P2|COMPLETED|Double Blind Phase (24 Weeks)||238
7570713|NCT02831855|18634914|P1|COMPLETED|Double Blind Phase (24 Weeks)||0
7570714|NCT02831855|18634912|P3|Treated|Double Blind Phase (24 Weeks)||266
7570715|NCT02831855|18634913|P2|Treated|Double Blind Phase (24 Weeks)||264
7570716|NCT02831855|18634914|P1|Treated|Double Blind Phase (24 Weeks)||0
7570717|NCT02831855|18634912|P3|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase. .|266
7570718|NCT02831855|18634913|P2|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase.|267
7570719|NCT02831855|18634914|P1|STARTED|Double Blind Phase (24 Weeks)||0
7570720|NCT02831855|18634912|P3|NOT COMPLETED|Open Label Phase (24 Weeks)||0
7570721|NCT02831855|18634913|P2|NOT COMPLETED|Open Label Phase (24 Weeks)||0
7570722|NCT02831855|18634914|P1|NOT COMPLETED|Open Label Phase (24 Weeks)||71
7570723|NCT02831855|18634912|P3|COMPLETED|Open Label Phase (24 Weeks)||0
7570724|NCT02831855|18634913|P2|COMPLETED|Open Label Phase (24 Weeks)||0
7570725|NCT02831855|18634914|P1|COMPLETED|Open Label Phase (24 Weeks)||623
7570726|NCT02831855|18634912|P3|STARTED|Open Label Phase (24 Weeks)||0
7570727|NCT02831855|18634913|P2|STARTED|Open Label Phase (24 Weeks)||0
7570728|NCT02831855|18634914|P1|STARTED|Open Label Phase (24 Weeks)||694
7570729|NCT02831764|18634975|P2|NOT COMPLETED|Overall Study||359
7570730|NCT02831764|18634976|P1|NOT COMPLETED|Overall Study||360
7570731|NCT02831764|18634975|P2|COMPLETED|Overall Study||0
7570732|NCT02831764|18634976|P1|COMPLETED|Overall Study||0
7570733|NCT02831764|18634975|P2|STARTED|Overall Study||359
7570734|NCT02831764|18634976|P1|STARTED|Overall Study||360
7570735|NCT02831673|18635040|P2|NOT COMPLETED|Overall Study||358
7570736|NCT02831673|18635041|P1|NOT COMPLETED|Overall Study||356
7570737|NCT02831673|18635040|P2|COMPLETED|Overall Study||0
7570738|NCT02831673|18635041|P1|COMPLETED|Overall Study||0
7570739|NCT02831673|18635040|P2|STARTED|Overall Study||358
7570740|NCT02831673|18635041|P1|STARTED|Overall Study||356
7570741|NCT02831660|18635103|P1|NOT COMPLETED|Overall Study||0
7570742|NCT02831660|18635103|P1|COMPLETED|Overall Study||1
7570743|NCT02831660|18635103|P1|STARTED|Overall Study||1
7570744|NCT02831569|18635107|P1|NOT COMPLETED|Overall Study||0
7570745|NCT02831569|18635107|P1|COMPLETED|Overall Study||80
7570746|NCT02831569|18635107|P1|STARTED|Overall Study||80
7570747|NCT02831387|18635114|P2|NOT COMPLETED|Overall Study||2
7570748|NCT02831387|18635115|P1|NOT COMPLETED|Overall Study||1
7570749|NCT02831387|18635114|P2|COMPLETED|Overall Study||22
7570750|NCT02831387|18635115|P1|COMPLETED|Overall Study||22
7570751|NCT02831387|18635114|P2|STARTED|Overall Study||24
7570752|NCT02831387|18635115|P1|STARTED|Overall Study||23
7570753|NCT02831257|18635133|P1|NOT COMPLETED|Overall Study||12
7570754|NCT02831257|18635133|P1|COMPLETED|Overall Study||6
7570755|NCT02831257|18635133|P1|STARTED|Overall Study||18
7570756|NCT02830893|18635147|P2|NOT COMPLETED|Overall Study||3
7570757|NCT02830893|18635148|P1|NOT COMPLETED|Overall Study||1
7570758|NCT02830893|18635147|P2|COMPLETED|Overall Study||8
7570759|NCT02830893|18635148|P1|COMPLETED|Overall Study||11
7570760|NCT02830893|18635147|P2|STARTED|Overall Study||11
7570761|NCT02830893|18635148|P1|STARTED|Overall Study||12
7570762|NCT02830880|18635160|P1|NOT COMPLETED|Overall Study||3
7570763|NCT02830880|18635160|P1|COMPLETED|Overall Study||4
7570764|NCT02830880|18635160|P1|Completed Visit After Cyle 1|Overall Study||7
7570765|NCT02830880|18635160|P1|STARTED|Overall Study||7
7570766|NCT02830438|18635169|P1|NOT COMPLETED|Overall Study||0
7570767|NCT02830438|18635169|P1|COMPLETED|Overall Study||8
7570768|NCT02830438|18635169|P1|STARTED|Overall Study||8
7570769|NCT02830087|18635179|P6|NOT COMPLETED|Overall Study||3
7570770|NCT02830087|18635180|P5|NOT COMPLETED|Overall Study||3
7570771|NCT02830087|18635181|P4|NOT COMPLETED|Overall Study||3
7570772|NCT02830087|18635182|P3|NOT COMPLETED|Overall Study||4
7570773|NCT02830087|18635183|P2|NOT COMPLETED|Overall Study||4
7570774|NCT02830087|18635184|P1|NOT COMPLETED|Overall Study||4
7570775|NCT02830087|18635179|P6|COMPLETED|Overall Study||0
7570776|NCT02830087|18635180|P5|COMPLETED|Overall Study||0
7570777|NCT02830087|18635181|P4|COMPLETED|Overall Study||0
7570778|NCT02830087|18635182|P3|COMPLETED|Overall Study||0
7570779|NCT02830087|18635183|P2|COMPLETED|Overall Study||0
7570780|NCT02830087|18635184|P1|COMPLETED|Overall Study||0
7570781|NCT02830087|18635179|P6|STARTED|Overall Study||3
7570782|NCT02830087|18635180|P5|STARTED|Overall Study||3
7570783|NCT02830087|18635181|P4|STARTED|Overall Study||3
7570784|NCT02830087|18635182|P3|STARTED|Overall Study||4
7570785|NCT02830087|18635183|P2|STARTED|Overall Study||4
7570786|NCT02830087|18635184|P1|STARTED|Overall Study||4
7570787|NCT02829996|18635251|P5|NOT COMPLETED|Overall Study||0
7570788|NCT02829996|18635252|P4|NOT COMPLETED|Overall Study||0
7570789|NCT02829996|18635253|P3|NOT COMPLETED|Overall Study||0
7570790|NCT02829996|18635254|P2|NOT COMPLETED|Overall Study||0
7570791|NCT02829996|18635255|P1|NOT COMPLETED|Overall Study||1
7570792|NCT02829996|18635251|P5|COMPLETED|Overall Study||42
7570793|NCT02829996|18635252|P4|COMPLETED|Overall Study||41
7570794|NCT02829996|18635253|P3|COMPLETED|Overall Study||40
7570795|NCT02829996|18635254|P2|COMPLETED|Overall Study||39
7570796|NCT02829996|18635255|P1|COMPLETED|Overall Study||38
7570797|NCT02829996|18635251|P5|STARTED|Overall Study||42
7570798|NCT02829996|18635252|P4|STARTED|Overall Study||41
7570799|NCT02829996|18635253|P3|STARTED|Overall Study||40
7570800|NCT02829996|18635254|P2|STARTED|Overall Study||39
7570801|NCT02829996|18635255|P1|STARTED|Overall Study||39
7570802|NCT02829983|18635269|P2|NOT COMPLETED|Overall Study||0
7570803|NCT02829983|18635270|P1|NOT COMPLETED|Overall Study||0
7570804|NCT02829983|18635269|P2|COMPLETED|Overall Study||20
7570805|NCT02829983|18635270|P1|COMPLETED|Overall Study||20
7570806|NCT02829983|18635269|P2|STARTED|Overall Study||20
7570807|NCT02829983|18635270|P1|STARTED|Overall Study||20
7570808|NCT02829944|18635280|P2|NOT COMPLETED|Overall Study||7
7570809|NCT02829944|18635281|P1|NOT COMPLETED|Overall Study||6
7570810|NCT02829944|18635280|P2|COMPLETED|Overall Study||33
7570811|NCT02829944|18635281|P1|COMPLETED|Overall Study||38
7570812|NCT02829944|18635280|P2|STARTED|Overall Study||40
7570813|NCT02829944|18635281|P1|STARTED|Overall Study||44
7570814|NCT02829918|18635331|P1|NOT COMPLETED|Overall Study||8
7570815|NCT02829918|18635331|P1|COMPLETED|Overall Study||46
7570816|NCT02829918|18635331|P1|STARTED|Overall Study||54
7570817|NCT02829775|18635336|P1|NOT COMPLETED|Overall Study||5
7570818|NCT02829775|18635336|P1|COMPLETED|Overall Study||4
7570819|NCT02829775|18635336|P1|STARTED|Overall Study||9
7570820|NCT02829463|18635343|P2|NOT COMPLETED|Overall Study||0
7570821|NCT02829463|18635344|P1|NOT COMPLETED|Overall Study||0
7570822|NCT02829463|18635343|P2|COMPLETED|Overall Study||62
7570823|NCT02829463|18635344|P1|COMPLETED|Overall Study||59
7570824|NCT02829463|18635343|P2|STARTED|Overall Study||62
7570825|NCT02829463|18635344|P1|STARTED|Overall Study||59
7570826|NCT02829320|18635350|P1|NOT COMPLETED|Overall Study||0
7570827|NCT02829320|18635350|P1|COMPLETED|Overall Study||28
7570828|NCT02829320|18635350|P1|STARTED|Overall Study||28
7570829|NCT02829307|18635387|P1|NOT COMPLETED|Overall Study||0
7570830|NCT02829307|18635387|P1|COMPLETED|Overall Study||8
7570831|NCT02829307|18635387|P1|STARTED|Overall Study||8
7570832|NCT02829294|18635410|P1|NOT COMPLETED|Overall Study||0
7570833|NCT02829294|18635410|P1|COMPLETED|Overall Study||19
7570834|NCT02829294|18635410|P1|STARTED|Overall Study||19
7570835|NCT02829138|18635418|P2|NOT COMPLETED|Overall Study||0
7570836|NCT02829138|18635419|P1|NOT COMPLETED|Overall Study||1
7570837|NCT02829138|18635418|P2|COMPLETED|Overall Study||28
7570838|NCT02829138|18635419|P1|COMPLETED|Overall Study||28
7570839|NCT02829138|18635418|P2|STARTED|Overall Study||28
7570840|NCT02829138|18635419|P1|STARTED|Overall Study||29
7570841|NCT02829034|18635431|P2|NOT COMPLETED|Overall Study||2
7570842|NCT02829034|18635432|P1|NOT COMPLETED|Overall Study||5
7570843|NCT02829034|18635431|P2|COMPLETED|Overall Study||6
7570844|NCT02829034|18635432|P1|COMPLETED|Overall Study||9
7570845|NCT02829034|18635431|P2|STARTED|Overall Study||8
7570846|NCT02829034|18635432|P1|STARTED|Overall Study||14
7570847|NCT02828982|18635442|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
7570848|NCT02828982|18635443|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
7570849|NCT02828982|18635442|P2|COMPLETED|Second Intervention (3 Weeks)||6
7570850|NCT02828982|18635443|P1|COMPLETED|Second Intervention (3 Weeks)||4
7570851|NCT02828982|18635442|P2|Received Intervention|Second Intervention (3 Weeks)||6
7570852|NCT02828982|18635443|P1|Received Intervention|Second Intervention (3 Weeks)||4
7570853|NCT02828982|18635442|P2|STARTED|Second Intervention (3 Weeks)||6
7570854|NCT02828982|18635443|P1|STARTED|Second Intervention (3 Weeks)||4
7570855|NCT02828982|18635442|P2|NOT COMPLETED|First Intervention (3 Weeks)||1
7570856|NCT02828982|18635443|P1|NOT COMPLETED|First Intervention (3 Weeks)||1
7570857|NCT02828982|18635442|P2|COMPLETED|First Intervention (3 Weeks)||6
7570858|NCT02828982|18635443|P1|COMPLETED|First Intervention (3 Weeks)||4
7570859|NCT02828982|18635442|P2|Received Intervention|First Intervention (3 Weeks)||7
7570860|NCT02828982|18635443|P1|Received Intervention|First Intervention (3 Weeks)||5
7570861|NCT02828982|18635442|P2|STARTED|First Intervention (3 Weeks)||7
7570862|NCT02828982|18635443|P1|STARTED|First Intervention (3 Weeks)||5
7570863|NCT02828917|18635459|P1|NOT COMPLETED|Overall Study||0
7570864|NCT02828917|18635459|P1|COMPLETED|Overall Study||104
7570865|NCT02828917|18635459|P1|STARTED|Overall Study||104
7570866|NCT02828644|18635465|P2|NOT COMPLETED|Overall Study||22
7570867|NCT02828644|18635466|P1|NOT COMPLETED|Overall Study||23
7570868|NCT02828644|18635465|P2|COMPLETED|Overall Study||65
7570869|NCT02828644|18635466|P1|COMPLETED|Overall Study||65
7570870|NCT02828644|18635465|P2|STARTED|Overall Study||87
7570871|NCT02828644|18635466|P1|STARTED|Overall Study||88
7570872|NCT02828436|18635473|P2|NOT COMPLETED|Period 2||0
7570873|NCT02828436|18635474|P1|NOT COMPLETED|Period 2||8
7570874|NCT02828436|18635473|P2|COMPLETED|Period 2||0
7570875|NCT02828436|18635474|P1|COMPLETED|Period 2||1
7570876|NCT02828436|18635473|P2|STARTED|Period 2||0
7570877|NCT02828436|18635474|P1|STARTED|Period 2||9
7570878|NCT02828436|18635473|P2|NOT COMPLETED|Period 1||4
7570879|NCT02828436|18635474|P1|NOT COMPLETED|Period 1||0
7570880|NCT02828436|18635473|P2|COMPLETED|Period 1||5
7570881|NCT02828436|18635474|P1|COMPLETED|Period 1||0
7570882|NCT02828436|18635473|P2|STARTED|Period 1||9
7570883|NCT02828436|18635474|P1|STARTED|Period 1||0
7570884|NCT02828241|18635482|P2|NOT COMPLETED|Overall Study||2
7570885|NCT02828241|18635483|P1|NOT COMPLETED|Overall Study||8
7570886|NCT02828241|18635482|P2|COMPLETED|Overall Study||21
7570887|NCT02828241|18635483|P1|COMPLETED|Overall Study||30
7570888|NCT02828241|18635482|P2|STARTED|Overall Study||23
7570889|NCT02828241|18635483|P1|STARTED|Overall Study||38
7570890|NCT02828137|18635496|P3|NOT COMPLETED|Overall Study||0
7570891|NCT02828137|18635497|P2|NOT COMPLETED|Overall Study||0
7570892|NCT02828137|18635498|P1|NOT COMPLETED|Overall Study||0
7570893|NCT02828137|18635496|P3|COMPLETED|Overall Study||41
7570894|NCT02828137|18635497|P2|COMPLETED|Overall Study||41
7570895|NCT02828137|18635498|P1|COMPLETED|Overall Study||41
7570896|NCT02828137|18635496|P3|STARTED|Overall Study||41
7570897|NCT02828137|18635497|P2|STARTED|Overall Study||41
7570898|NCT02828137|18635498|P1|STARTED|Overall Study||41
7570899|NCT02828124|18635510|P4|NOT COMPLETED|Overall Study||6
7570900|NCT02828124|18635511|P3|NOT COMPLETED|Overall Study||1
7570901|NCT02828124|18635512|P2|NOT COMPLETED|Overall Study||2
7570902|NCT02828124|18635513|P1|NOT COMPLETED|Overall Study||1
7570903|NCT02828124|18635510|P4|COMPLETED|Overall Study||0
7570904|NCT02828124|18635511|P3|COMPLETED|Overall Study||0
7570905|NCT02828124|18635512|P2|COMPLETED|Overall Study||0
7570906|NCT02828124|18635513|P1|COMPLETED|Overall Study||0
7570907|NCT02828124|18635510|P4|STARTED|Overall Study||6
7570908|NCT02828124|18635511|P3|STARTED|Overall Study||1
7570909|NCT02828124|18635512|P2|STARTED|Overall Study||2
7570910|NCT02828124|18635513|P1|STARTED|Overall Study||1
7570911|NCT02828111|18635628|P5|NOT COMPLETED|Overall Study||1
7570912|NCT02828111|18635629|P4|NOT COMPLETED|Overall Study||1
7570913|NCT02828111|18635630|P3|NOT COMPLETED|Overall Study||2
7570914|NCT02828111|18635631|P2|NOT COMPLETED|Overall Study||0
7570915|NCT02828111|18635632|P1|NOT COMPLETED|Overall Study||0
7570916|NCT02828111|18635628|P5|COMPLETED|Overall Study||11
7570917|NCT02828111|18635629|P4|COMPLETED|Overall Study||5
7570918|NCT02828111|18635630|P3|COMPLETED|Overall Study||4
7570919|NCT02828111|18635631|P2|COMPLETED|Overall Study||6
7570920|NCT02828111|18635632|P1|COMPLETED|Overall Study||6
7570921|NCT02828111|18635628|P5|Received at Least 1 Dose of Study Drug|Overall Study||12
7570922|NCT02828111|18635629|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
7570923|NCT02828111|18635630|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
7570924|NCT02828111|18635631|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
7570925|NCT02828111|18635632|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
7570926|NCT02828111|18635628|P5|STARTED|Overall Study||12
7570927|NCT02828111|18635629|P4|STARTED|Overall Study||6
7570928|NCT02828111|18635630|P3|STARTED|Overall Study||6
7570929|NCT02828111|18635631|P2|STARTED|Overall Study||6
7570930|NCT02828111|18635632|P1|STARTED|Overall Study||6
7570931|NCT02828020|18635693|P3|NOT COMPLETED|Safety Follow-up Period||19
7570932|NCT02828020|18635694|P2|NOT COMPLETED|Safety Follow-up Period||18
7570933|NCT02828020|18635695|P1|NOT COMPLETED|Safety Follow-up Period||20
7570934|NCT02828020|18635693|P3|COMPLETED|Safety Follow-up Period||461
7570935|NCT02828020|18635694|P2|COMPLETED|Safety Follow-up Period||440
7570936|NCT02828020|18635695|P1|COMPLETED|Safety Follow-up Period||460
7570937|NCT02828020|18635693|P3|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
7570938|NCT02828020|18635694|P2|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|458
7570939|NCT02828020|18635695|P1|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
7570940|NCT02828020|18635693|P3|NOT COMPLETED|Treatment Period||78
7570941|NCT02828020|18635694|P2|NOT COMPLETED|Treatment Period||99
7570942|NCT02828020|18635695|P1|NOT COMPLETED|Treatment Period||80
7570943|NCT02828020|18635693|P3|COMPLETED|Treatment Period||479
7570944|NCT02828020|18635694|P2|COMPLETED|Treatment Period||457
7570945|NCT02828020|18635695|P1|COMPLETED|Treatment Period||479
7570946|NCT02828020|18635693|P3|Safety Population: Received Study Drug|Treatment Period||485
7570947|NCT02828020|18635694|P2|Safety Population: Received Study Drug|Treatment Period||466
7570948|NCT02828020|18635695|P1|Safety Population: Received Study Drug|Treatment Period||485
7570949|NCT02828020|18635693|P3|STARTED|Treatment Period||557
7570950|NCT02828020|18635694|P2|STARTED|Treatment Period||556
7570951|NCT02828020|18635695|P1|STARTED|Treatment Period||559
7570952|NCT02827708|18635726|P2|NOT COMPLETED|Overall Study||5
7570953|NCT02827708|18635727|P1|NOT COMPLETED|Overall Study||5
7570954|NCT02827708|18635726|P2|COMPLETED|Overall Study||156
7570955|NCT02827708|18635727|P1|COMPLETED|Overall Study||158
7570956|NCT02827708|18635726|P2|Safety Analysis Set (SAS)|Overall Study||161
7570957|NCT02827708|18635727|P1|Safety Analysis Set (SAS)|Overall Study||163
7570958|NCT02827708|18635726|P2|Full Analysis Set (FAS)|Overall Study||161
7570959|NCT02827708|18635727|P1|Full Analysis Set (FAS)|Overall Study||163
7570960|NCT02827708|18635726|P2|STARTED|Overall Study||161
7570961|NCT02827708|18635727|P1|STARTED|Overall Study||163
7570962|NCT02827500|18635806|P2|NOT COMPLETED|Overall Study||7
7570963|NCT02827500|18635807|P1|NOT COMPLETED|Overall Study||19
7570964|NCT02827500|18635806|P2|COMPLETED|Overall Study||45
7570965|NCT02827500|18635807|P1|COMPLETED|Overall Study||33
7570966|NCT02827500|18635806|P2|STARTED|Overall Study||52
7570967|NCT02827500|18635807|P1|STARTED|Overall Study||52
7570968|NCT02826798|18635828|P5|NOT COMPLETED|Overall Study||0
7570969|NCT02826798|18635829|P4|NOT COMPLETED|Overall Study||1
7570970|NCT02826798|18635830|P3|NOT COMPLETED|Overall Study||0
7570971|NCT02826798|18635831|P2|NOT COMPLETED|Overall Study||1
7570972|NCT02826798|18635832|P1|NOT COMPLETED|Overall Study||0
7570973|NCT02826798|18635828|P5|COMPLETED|Overall Study||26
7570974|NCT02826798|18635829|P4|COMPLETED|Overall Study||24
7570975|NCT02826798|18635830|P3|COMPLETED|Overall Study||26
7570976|NCT02826798|18635831|P2|COMPLETED|Overall Study||25
7570977|NCT02826798|18635832|P1|COMPLETED|Overall Study||25
7570978|NCT02826798|18635828|P5|STARTED|Overall Study||26
7570979|NCT02826798|18635829|P4|STARTED|Overall Study||25
7570980|NCT02826798|18635830|P3|STARTED|Overall Study||26
7570981|NCT02826798|18635831|P2|STARTED|Overall Study||26
7570982|NCT02826798|18635832|P1|STARTED|Overall Study||25
7570983|NCT02826694|18635881|P2|NOT COMPLETED|Overall Study||0
7570984|NCT02826694|18635882|P1|NOT COMPLETED|Overall Study||0
7570985|NCT02826694|18635881|P2|COMPLETED|Overall Study||45
7570986|NCT02826694|18635882|P1|COMPLETED|Overall Study||61
7570987|NCT02826694|18635881|P2|Control Group|Overall Study||15
7570988|NCT02826694|18635882|P1|Control Group|Overall Study||20
7570989|NCT02826694|18635881|P2|Decision Group|Overall Study||30
7570990|NCT02826694|18635882|P1|Decision Group|Overall Study||41
7570991|NCT02826694|18635881|P2|STARTED|Overall Study||45
7570992|NCT02826694|18635882|P1|STARTED|Overall Study||61
7570993|NCT02826603|18635894|P2|NOT COMPLETED|Overall Study||64
7570994|NCT02826603|18635895|P1|NOT COMPLETED|Overall Study||61
7570995|NCT02826603|18635894|P2|COMPLETED|Overall Study||488
7570996|NCT02826603|18635895|P1|COMPLETED|Overall Study||489
7570997|NCT02826603|18635894|P2|STARTED|Overall Study||552
7570998|NCT02826603|18635895|P1|STARTED|Overall Study||550
7570999|NCT02826551|18635922|P2|NOT COMPLETED|Overall Study||0
7571000|NCT02826551|18635923|P1|NOT COMPLETED|Overall Study||0
7571001|NCT02826551|18635922|P2|COMPLETED|Overall Study||12
7571002|NCT02826551|18635923|P1|COMPLETED|Overall Study||11
7571003|NCT02826551|18635922|P2|STARTED|Overall Study||12
7571004|NCT02826551|18635923|P1|STARTED|Overall Study||11
7571005|NCT02826421|18635935|P4|NOT COMPLETED|Overall Study||2
7571006|NCT02826421|18635936|P3|NOT COMPLETED|Overall Study||2
7571007|NCT02826421|18635937|P2|NOT COMPLETED|Overall Study||3
7571008|NCT02826421|18635938|P1|NOT COMPLETED|Overall Study||3
7571009|NCT02826421|18635935|P4|COMPLETED|Overall Study||28
7571010|NCT02826421|18635936|P3|COMPLETED|Overall Study||26
7571011|NCT02826421|18635937|P2|COMPLETED|Overall Study||26
7571012|NCT02826421|18635938|P1|COMPLETED|Overall Study||19
7571013|NCT02826421|18635935|P4|Treated|Overall Study||28
7571014|NCT02826421|18635936|P3|Treated|Overall Study||26
7571015|NCT02826421|18635937|P2|Treated|Overall Study||26
7571016|NCT02826421|18635938|P1|Treated|Overall Study||19
7571017|NCT02826421|18635935|P4|STARTED|Overall Study||30
7571018|NCT02826421|18635936|P3|STARTED|Overall Study||28
7571019|NCT02826421|18635937|P2|STARTED|Overall Study||29
7571020|NCT02826421|18635938|P1|STARTED|Overall Study||22
7571021|NCT02825992|18635950|P1|NOT COMPLETED|Overall Study||8
7571022|NCT02825992|18635950|P1|COMPLETED|Overall Study||121
7571023|NCT02825992|18635950|P1|STARTED|Overall Study|The procedure was terminated for clinical reasons in 2 patients, therefore only 127 were treated.|129
7571024|NCT02825966|18635962|P1|NOT COMPLETED|Overall Study||0
7571025|NCT02825966|18635962|P1|COMPLETED|Overall Study||35
7571026|NCT02825966|18635962|P1|STARTED|Overall Study||35
7571027|NCT02825680|18635971|P2|NOT COMPLETED|Overall Study||16
7571028|NCT02825680|18635972|P1|NOT COMPLETED|Overall Study||0
7571029|NCT02825680|18635971|P2|COMPLETED|Overall Study||39
7571030|NCT02825680|18635972|P1|COMPLETED|Overall Study||82
7571031|NCT02825680|18635971|P2|STARTED|Overall Study||55
7571032|NCT02825680|18635972|P1|STARTED|Overall Study||82
7571033|NCT02825550|18635978|P1|NOT COMPLETED|Overall Study||1
7571034|NCT02825550|18635978|P1|COMPLETED|Overall Study||12
7571035|NCT02825550|18635978|P1|STARTED|Overall Study||13
7571036|NCT02825251|18635986|P2|NOT COMPLETED|Overall Study||6
7571037|NCT02825251|18635987|P1|NOT COMPLETED|Overall Study||3
7571038|NCT02825251|18635986|P2|COMPLETED|Overall Study||230
7571039|NCT02825251|18635987|P1|COMPLETED|Overall Study||233
7571040|NCT02825251|18635986|P2|STARTED|Overall Study||236
7571041|NCT02825251|18635987|P1|STARTED|Overall Study||236
7571042|NCT02825212|18636173|P1|NOT COMPLETED|Overall Study||0
7571043|NCT02825212|18636173|P1|COMPLETED|Overall Study||10
7571044|NCT02825212|18636173|P1|STARTED|Overall Study||10
7571045|NCT02825043|18636178|P1|NOT COMPLETED|Overall Study||4
7571046|NCT02825043|18636178|P1|COMPLETED|Overall Study||2
7571047|NCT02825043|18636178|P1|STARTED|Overall Study||6
7571048|NCT02824913|18636185|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7571049|NCT02824913|18636186|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7571050|NCT02824913|18636185|P2|COMPLETED|Second Intervention (1 Day)||0
7571051|NCT02824913|18636186|P1|COMPLETED|Second Intervention (1 Day)||1
7571052|NCT02824913|18636185|P2|STARTED|Second Intervention (1 Day)||0
7571053|NCT02824913|18636186|P1|STARTED|Second Intervention (1 Day)||1
7571054|NCT02824913|18636185|P2|NOT COMPLETED|Washout (7-14 Days)||0
7571055|NCT02824913|18636186|P1|NOT COMPLETED|Washout (7-14 Days)||0
7571056|NCT02824913|18636185|P2|COMPLETED|Washout (7-14 Days)||0
7571057|NCT02824913|18636186|P1|COMPLETED|Washout (7-14 Days)||1
7571058|NCT02824913|18636185|P2|STARTED|Washout (7-14 Days)||0
7571059|NCT02824913|18636186|P1|STARTED|Washout (7-14 Days)||1
7571060|NCT02824913|18636185|P2|NOT COMPLETED|First Intervention (1 Day)||0
7571061|NCT02824913|18636186|P1|NOT COMPLETED|First Intervention (1 Day)||0
7571062|NCT02824913|18636185|P2|COMPLETED|First Intervention (1 Day)||0
7571063|NCT02824913|18636186|P1|COMPLETED|First Intervention (1 Day)|Only one subject was enrolled in the study and received both study treatments.|1
7571064|NCT02824913|18636185|P2|STARTED|First Intervention (1 Day)||0
7571065|NCT02824913|18636186|P1|STARTED|First Intervention (1 Day)||1
7571066|NCT02824562|18636200|P2|NOT COMPLETED|Overall Study||5
7571067|NCT02824562|18636201|P1|NOT COMPLETED|Overall Study||3
7571068|NCT02824562|18636200|P2|COMPLETED|Overall Study||17
7571069|NCT02824562|18636201|P1|COMPLETED|Overall Study||19
7571070|NCT02824562|18636200|P2|STARTED|Overall Study||22
7571071|NCT02824562|18636201|P1|STARTED|Overall Study||22
7571072|NCT02824432|18636210|P2|NOT COMPLETED|Overall Study||0
7571073|NCT02824432|18636211|P1|NOT COMPLETED|Overall Study||1
7571074|NCT02824432|18636210|P2|COMPLETED|Overall Study||19
7571075|NCT02824432|18636211|P1|COMPLETED|Overall Study||17
7571076|NCT02824432|18636210|P2|STARTED|Overall Study||19
7571077|NCT02824432|18636211|P1|STARTED|Overall Study||18
7571078|NCT02824224|18636287|P2|NOT COMPLETED|Overall Study||1
7571079|NCT02824224|18636288|P1|NOT COMPLETED|Overall Study||2
7571080|NCT02824224|18636287|P2|COMPLETED|Overall Study||17
7571081|NCT02824224|18636288|P1|COMPLETED|Overall Study||17
7571082|NCT02824224|18636287|P2|STARTED|Overall Study||18
7571083|NCT02824224|18636288|P1|STARTED|Overall Study||19
7571084|NCT02824198|18636308|P2|NOT COMPLETED|Overall Study||3
7571085|NCT02824198|18636309|P1|NOT COMPLETED|Overall Study||15
7571086|NCT02824198|18636308|P2|COMPLETED|Overall Study||26
7571087|NCT02824198|18636309|P1|COMPLETED|Overall Study||74
7571088|NCT02824198|18636308|P2|STARTED|Overall Study||29
7571089|NCT02824198|18636309|P1|STARTED|Overall Study||89
7571090|NCT02823964|18636339|P1|NOT COMPLETED|Overall Study||5
7571091|NCT02823964|18636339|P1|COMPLETED|Overall Study||20
7571092|NCT02823964|18636339|P1|STARTED|Overall Study||25
7571093|NCT02823600|18636343|P1|NOT COMPLETED|Overall Study||0
7571094|NCT02823600|18636343|P1|COMPLETED|Overall Study||68
7571095|NCT02823600|18636343|P1|STARTED|Overall Study||68
7571096|NCT02823470|18636353|P2|NOT COMPLETED|Overall Study||15
7571097|NCT02823470|18636354|P1|NOT COMPLETED|Overall Study||9
7571098|NCT02823470|18636353|P2|COMPLETED|Overall Study||0
7571099|NCT02823470|18636354|P1|COMPLETED|Overall Study||0
7571100|NCT02823470|18636353|P2|STARTED|Overall Study||15
7571101|NCT02823470|18636354|P1|STARTED|Overall Study||9
7571102|NCT02823431|18636368|P2|NOT COMPLETED|Overall Study||0
7571103|NCT02823431|18636369|P1|NOT COMPLETED|Overall Study||0
7571104|NCT02823431|18636368|P2|COMPLETED|Overall Study||12
7571105|NCT02823431|18636369|P1|COMPLETED|Overall Study||11
7571106|NCT02823431|18636368|P2|STARTED|Overall Study||12
7571107|NCT02823431|18636369|P1|STARTED|Overall Study||11
7571108|NCT02823080|18636383|P2|NOT COMPLETED|Overall Study||0
7571109|NCT02823080|18636384|P1|NOT COMPLETED|Overall Study||0
7571110|NCT02823080|18636383|P2|COMPLETED|Overall Study||24
7571111|NCT02823080|18636384|P1|COMPLETED|Overall Study||24
7571112|NCT02823080|18636383|P2|STARTED|Overall Study||24
7571113|NCT02823080|18636384|P1|STARTED|Overall Study||24
7571114|NCT02822950|18636402|P1|NOT COMPLETED|Overall Study||0
7571115|NCT02822950|18636402|P1|COMPLETED|Overall Study||10
7571116|NCT02822950|18636402|P1|STARTED|Overall Study||10
7571117|NCT02822885|18636410|P1|NOT COMPLETED|Overall Study||0
7571118|NCT02822885|18636410|P1|COMPLETED|Overall Study||70
7571119|NCT02822885|18636410|P1|STARTED|Overall Study||70
7571120|NCT02822794|18636422|P2|NOT COMPLETED|Overall Study||0
7571121|NCT02822794|18636423|P1|NOT COMPLETED|Overall Study||1
7571122|NCT02822794|18636422|P2|COMPLETED|Overall Study||60
7571123|NCT02822794|18636423|P1|COMPLETED|Overall Study||56
7571124|NCT02822794|18636422|P2|STARTED|Overall Study||60
7571125|NCT02822794|18636423|P1|STARTED|Overall Study||57
7571126|NCT02822612|18636486|P5|NOT COMPLETED|Overall Study||0
7571127|NCT02822612|18636487|P4|NOT COMPLETED|Overall Study||0
7571128|NCT02822612|18636488|P3|NOT COMPLETED|Overall Study||0
7571129|NCT02822612|18636489|P2|NOT COMPLETED|Overall Study||0
7571130|NCT02822612|18636490|P1|NOT COMPLETED|Overall Study||0
7571131|NCT02822612|18636486|P5|COMPLETED|Overall Study||15
7571132|NCT02822612|18636487|P4|COMPLETED|Overall Study||4
7571133|NCT02822612|18636488|P3|COMPLETED|Overall Study||14
7571134|NCT02822612|18636489|P2|COMPLETED|Overall Study||13
7571135|NCT02822612|18636490|P1|COMPLETED|Overall Study||14
7571136|NCT02822612|18636486|P5|STARTED|Overall Study||15
7571137|NCT02822612|18636487|P4|STARTED|Overall Study||4
7571138|NCT02822612|18636488|P3|STARTED|Overall Study||14
7571139|NCT02822612|18636489|P2|STARTED|Overall Study||13
7571140|NCT02822612|18636490|P1|STARTED|Overall Study||14
7571141|NCT02822287|18636512|P1|NOT COMPLETED|Overall Study||0
7571142|NCT02822287|18636512|P1|COMPLETED|Overall Study||57
7571143|NCT02822287|18636512|P1|STARTED|Overall Study||57
7571144|NCT02822235|18636524|P2|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||2
7571145|NCT02822235|18636525|P1|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||11
7571146|NCT02822235|18636524|P2|COMPLETED|Prospective Phase (Day 1 up to Month 12)||34
7571147|NCT02822235|18636525|P1|COMPLETED|Prospective Phase (Day 1 up to Month 12)||107
7571148|NCT02822235|18636524|P2|STARTED|Prospective Phase (Day 1 up to Month 12)||36
7571149|NCT02822235|18636525|P1|STARTED|Prospective Phase (Day 1 up to Month 12)||118
7571150|NCT02822235|18636524|P2|NOT COMPLETED|Cross-sectional Phase (Day 1)||107
7571151|NCT02822235|18636525|P1|NOT COMPLETED|Cross-sectional Phase (Day 1)||146
7571152|NCT02822235|18636524|P2|COMPLETED|Cross-sectional Phase (Day 1)||36
7571153|NCT02822235|18636525|P1|COMPLETED|Cross-sectional Phase (Day 1)||118
7571154|NCT02822235|18636524|P2|STARTED|Cross-sectional Phase (Day 1)||143
7571155|NCT02822235|18636525|P1|STARTED|Cross-sectional Phase (Day 1)||264
7571156|NCT02822222|18636580|P2|NOT COMPLETED|Overall Study||0
7571157|NCT02822222|18636581|P1|NOT COMPLETED|Overall Study||1
7571158|NCT02822222|18636580|P2|COMPLETED|Overall Study||6
7571159|NCT02822222|18636581|P1|COMPLETED|Overall Study||15
7571160|NCT02822222|18636580|P2|STARTED|Overall Study||6
7571161|NCT02822222|18636581|P1|STARTED|Overall Study||16
7571162|NCT02821962|18636631|P2|NOT COMPLETED|Overall Study||0
7571163|NCT02821962|18636632|P1|NOT COMPLETED|Overall Study||2
7571164|NCT02821962|18636631|P2|COMPLETED|Overall Study||21
7571165|NCT02821962|18636632|P1|COMPLETED|Overall Study||17
7571166|NCT02821962|18636631|P2|STARTED|Overall Study||21
7571167|NCT02821962|18636632|P1|STARTED|Overall Study||19
7571168|NCT02821910|18636676|P6|NOT COMPLETED|Overall Study||1
7571169|NCT02821910|18636677|P5|NOT COMPLETED|Overall Study||0
7571170|NCT02821910|18636678|P4|NOT COMPLETED|Overall Study||0
7571171|NCT02821910|18636679|P3|NOT COMPLETED|Overall Study||2
7571172|NCT02821910|18636680|P2|NOT COMPLETED|Overall Study||0
7571173|NCT02821910|18636681|P1|NOT COMPLETED|Overall Study||1
7571174|NCT02821910|18636676|P6|COMPLETED|Overall Study||7
7571175|NCT02821910|18636677|P5|COMPLETED|Overall Study||7
7571176|NCT02821910|18636678|P4|COMPLETED|Overall Study||10
7571177|NCT02821910|18636679|P3|COMPLETED|Overall Study||8
7571178|NCT02821910|18636680|P2|COMPLETED|Overall Study||8
7571179|NCT02821910|18636681|P1|COMPLETED|Overall Study||6
7571180|NCT02821910|18636676|P6|STARTED|Overall Study||8
7571181|NCT02821910|18636677|P5|STARTED|Overall Study||7
7571182|NCT02821910|18636678|P4|STARTED|Overall Study||10
7571183|NCT02821910|18636679|P3|STARTED|Overall Study||10
7571184|NCT02821910|18636680|P2|STARTED|Overall Study||8
7571185|NCT02821910|18636681|P1|STARTED|Overall Study||7
7571186|NCT02821819|18636743|P1|NOT COMPLETED|Overall Study||1
7571187|NCT02821819|18636743|P1|COMPLETED|Overall Study||14
7571188|NCT02821819|18636743|P1|STARTED|Overall Study||15
7571189|NCT02821715|18636748|P6|NOT COMPLETED|Overall Study||0
7571190|NCT02821715|18636749|P5|NOT COMPLETED|Overall Study||0
7571191|NCT02821715|18636750|P4|NOT COMPLETED|Overall Study||0
7571192|NCT02821715|18636751|P3|NOT COMPLETED|Overall Study||0
7571193|NCT02821715|18636752|P2|NOT COMPLETED|Overall Study||0
7571194|NCT02821715|18636753|P1|NOT COMPLETED|Overall Study||1
7571195|NCT02821715|18636748|P6|COMPLETED|Overall Study||9
7571196|NCT02821715|18636749|P5|COMPLETED|Overall Study||6
7571197|NCT02821715|18636750|P4|COMPLETED|Overall Study||9
7571198|NCT02821715|18636751|P3|COMPLETED|Overall Study||8
7571199|NCT02821715|18636752|P2|COMPLETED|Overall Study||8
7571200|NCT02821715|18636753|P1|COMPLETED|Overall Study||7
7571201|NCT02821715|18636748|P6|STARTED|Overall Study||9
7571202|NCT02821715|18636749|P5|STARTED|Overall Study||6
7571203|NCT02821715|18636750|P4|STARTED|Overall Study||9
7571204|NCT02821715|18636751|P3|STARTED|Overall Study||8
7571205|NCT02821715|18636752|P2|STARTED|Overall Study||8
7571206|NCT02821715|18636753|P1|STARTED|Overall Study||8
7571207|NCT02821455|18636797|P1|NOT COMPLETED|Overall Study||0
7571208|NCT02821455|18636797|P1|COMPLETED|Overall Study||19
7571209|NCT02821455|18636797|P1|STARTED|Overall Study||19
7571210|NCT02821403|18636804|P2|NOT COMPLETED|"Third Intervention (1 Month)"||0
7571211|NCT02821403|18636805|P1|NOT COMPLETED|"Third Intervention (1 Month)"||0
7571212|NCT02821403|18636804|P2|COMPLETED|"Third Intervention (1 Month)"||40
7571213|NCT02821403|18636805|P1|COMPLETED|"Third Intervention (1 Month)"||40
7571214|NCT02821403|18636804|P2|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14
7571215|NCT02821403|18636805|P1|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13
7571216|NCT02821403|18636804|P2|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
7571217|NCT02821403|18636805|P1|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
7571218|NCT02821403|18636804|P2|Used Clear Lens|"Third Intervention (1 Month)"||13
7571219|NCT02821403|18636805|P1|Used Clear Lens|"Third Intervention (1 Month)"||14
7571220|NCT02821403|18636804|P2|STARTED|"Third Intervention (1 Month)"||40
7571221|NCT02821403|18636805|P1|STARTED|"Third Intervention (1 Month)"||40
7571222|NCT02821403|18636804|P2|NOT COMPLETED|"Second Intervention (1 Month)"||0
7571223|NCT02821403|18636805|P1|NOT COMPLETED|"Second Intervention (1 Month)"||0
7571224|NCT02821403|18636804|P2|COMPLETED|"Second Intervention (1 Month)"||40
7571225|NCT02821403|18636805|P1|COMPLETED|"Second Intervention (1 Month)"||40
7571226|NCT02821403|18636804|P2|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
7571227|NCT02821403|18636805|P1|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
7571228|NCT02821403|18636804|P2|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13
7571229|NCT02821403|18636805|P1|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14
7571230|NCT02821403|18636804|P2|Used Clear Lens|"Second Intervention (1 Month)"||14
7571231|NCT02821403|18636805|P1|Used Clear Lens|"Second Intervention (1 Month)"||13
7571232|NCT02821403|18636804|P2|STARTED|"Second Intervention (1 Month)"||40
7571233|NCT02821403|18636805|P1|STARTED|"Second Intervention (1 Month)"||40
7571234|NCT02821403|18636804|P2|NOT COMPLETED|"First Intervention (1 Month)"||0
7571235|NCT02821403|18636805|P1|NOT COMPLETED|"First Intervention (1 Month)"||0
7571236|NCT02821403|18636804|P2|COMPLETED|"First Intervention (1 Month)"||40
7571237|NCT02821403|18636805|P1|COMPLETED|"First Intervention (1 Month)"||40
7571238|NCT02821403|18636804|P2|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13
7571239|NCT02821403|18636805|P1|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14
7571240|NCT02821403|18636804|P2|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14
7571241|NCT02821403|18636805|P1|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13
7571242|NCT02821403|18636804|P2|Used Clear Lens|"First Intervention (1 Month)"||13
7571243|NCT02821403|18636805|P1|Used Clear Lens|"First Intervention (1 Month)"||13
7571244|NCT02821403|18636804|P2|STARTED|"First Intervention (1 Month)"||40
7571245|NCT02821403|18636805|P1|STARTED|"First Intervention (1 Month)"||40
7571246|NCT02821338|18636823|P2|NOT COMPLETED|Overall Study||2
7571247|NCT02821338|18636824|P1|NOT COMPLETED|Overall Study||3
7571248|NCT02821338|18636823|P2|COMPLETED|Overall Study|13 out of 15 subjects assigned to Sequence 2 completed the study, and provided two data points.|13
7571249|NCT02821338|18636824|P1|COMPLETED|Overall Study|12 out of 15 subjects assigned to Sequence 1 completed the study, and provided two data points.|12
7571250|NCT02821338|18636823|P2|STARTED|Overall Study||15
7571251|NCT02821338|18636824|P1|STARTED|Overall Study||15
7571252|NCT02821000|18636840|P1|NOT COMPLETED|Overall Study||103
7571253|NCT02821000|18636840|P1|COMPLETED|Overall Study||0
7571254|NCT02821000|18636840|P1|Treated|Overall Study||103
7571255|NCT02821000|18636840|P1|STARTED|Overall Study||103
7571256|NCT02820870|18636865|P2|NOT COMPLETED|Post Intervention||0
7571257|NCT02820870|18636866|P1|NOT COMPLETED|Post Intervention||0
7571258|NCT02820870|18636865|P2|COMPLETED|Post Intervention||28
7571259|NCT02820870|18636866|P1|COMPLETED|Post Intervention||15
7571260|NCT02820870|18636865|P2|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
7571261|NCT02820870|18636866|P1|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
7571262|NCT02820870|18636865|P2|NOT COMPLETED|Intervention||0
7571263|NCT02820870|18636866|P1|NOT COMPLETED|Intervention||0
7571264|NCT02820870|18636865|P2|COMPLETED|Intervention||28
7571265|NCT02820870|18636866|P1|COMPLETED|Intervention||15
7571266|NCT02820870|18636865|P2|STARTED|Intervention||28
7571267|NCT02820870|18636866|P1|STARTED|Intervention||15
7571268|NCT02820870|18636865|P2|NOT COMPLETED|Before Intervention||0
7571269|NCT02820870|18636866|P1|NOT COMPLETED|Before Intervention||0
7571270|NCT02820870|18636865|P2|COMPLETED|Before Intervention||28
7571271|NCT02820870|18636866|P1|COMPLETED|Before Intervention||15
7571272|NCT02820870|18636865|P2|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
7571273|NCT02820870|18636866|P1|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
7571274|NCT02820844|18636878|P6|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||1
7571275|NCT02820844|18636879|P5|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||2
7571276|NCT02820844|18636880|P4|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
7571277|NCT02820844|18636881|P3|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
7571278|NCT02820844|18636882|P2|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
7571279|NCT02820844|18636883|P1|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
7571280|NCT02820844|18636878|P6|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||42
7571281|NCT02820844|18636879|P5|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||54
7571282|NCT02820844|18636880|P4|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
7571283|NCT02820844|18636881|P3|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
7571284|NCT02820844|18636882|P2|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
7571285|NCT02820844|18636883|P1|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
7571286|NCT02820844|18636878|P6|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||43
7571287|NCT02820844|18636879|P5|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||56
7571288|NCT02820844|18636880|P4|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
7571289|NCT02820844|18636881|P3|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
7571290|NCT02820844|18636882|P2|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
7571291|NCT02820844|18636883|P1|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
7571292|NCT02820844|18636878|P6|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
7571293|NCT02820844|18636879|P5|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
7571294|NCT02820844|18636880|P4|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||4
7571295|NCT02820844|18636881|P3|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||9
7571296|NCT02820844|18636882|P2|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
7571297|NCT02820844|18636883|P1|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
7571298|NCT02820844|18636878|P6|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
7571299|NCT02820844|18636879|P5|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
7571300|NCT02820844|18636880|P4|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||84
7571301|NCT02820844|18636881|P3|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||99
7571302|NCT02820844|18636882|P2|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
7571303|NCT02820844|18636883|P1|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
7571304|NCT02820844|18636878|P6|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
7571305|NCT02820844|18636879|P5|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
7571306|NCT02820844|18636880|P4|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||88
7571307|NCT02820844|18636881|P3|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||108
7571308|NCT02820844|18636882|P2|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
7571309|NCT02820844|18636883|P1|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
7571310|NCT02820844|18636878|P6|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
7571311|NCT02820844|18636879|P5|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
7571312|NCT02820844|18636880|P4|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
7571313|NCT02820844|18636881|P3|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
7571314|NCT02820844|18636882|P2|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||9
7571315|NCT02820844|18636883|P1|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||5
7571316|NCT02820844|18636878|P6|COMPLETED|Double-blinded (Up to 48 Weeks)||0
7571317|NCT02820844|18636879|P5|COMPLETED|Double-blinded (Up to 48 Weeks)||0
7571318|NCT02820844|18636880|P4|COMPLETED|Double-blinded (Up to 48 Weeks)||0
7571319|NCT02820844|18636881|P3|COMPLETED|Double-blinded (Up to 48 Weeks)||0
7571320|NCT02820844|18636882|P2|COMPLETED|Double-blinded (Up to 48 Weeks)||115
7571321|NCT02820844|18636883|P1|COMPLETED|Double-blinded (Up to 48 Weeks)||119
7571322|NCT02820844|18636878|P6|STARTED|Double-blinded (Up to 48 Weeks)||0
7571323|NCT02820844|18636879|P5|STARTED|Double-blinded (Up to 48 Weeks)||0
7571324|NCT02820844|18636880|P4|STARTED|Double-blinded (Up to 48 Weeks)||0
7571325|NCT02820844|18636881|P3|STARTED|Double-blinded (Up to 48 Weeks)||0
7571326|NCT02820844|18636882|P2|STARTED|Double-blinded (Up to 48 Weeks)||124
7571327|NCT02820844|18636883|P1|STARTED|Double-blinded (Up to 48 Weeks)||124
7571328|NCT02820597|18637097|P1|NOT COMPLETED|Overall Study||12
7571329|NCT02820597|18637097|P1|COMPLETED|Overall Study|12 participants were lost to follow-up.|15
7571330|NCT02820597|18637097|P1|180-day Post Treatment|Overall Study|3 participants missed the 180-day visit, 3 participants were lost to follow-up.|21
7571331|NCT02820597|18637097|P1|90-day Post Treatment|Overall Study|2 participants missed the 90-day visit, 1 participant was lost to follow-up.|24
7571332|NCT02820597|18637097|P1|30-day Post Treatment|Overall Study||27
7571333|NCT02820597|18637097|P1|7-day Post Treatment|Overall Study||27
7571334|NCT02820597|18637097|P1|1-day Post Treatment|Overall Study||27
7571335|NCT02820597|18637097|P1|STARTED|Overall Study||27
7571336|NCT02820324|18637110|P5|NOT COMPLETED|Overall Study||3
7571337|NCT02820324|18637111|P4|NOT COMPLETED|Overall Study||3
7571338|NCT02820324|18637112|P3|NOT COMPLETED|Overall Study||3
7571339|NCT02820324|18637113|P2|NOT COMPLETED|Overall Study||3
7571340|NCT02820324|18637114|P1|NOT COMPLETED|Overall Study||2
7571341|NCT02820324|18637110|P5|COMPLETED|Overall Study||80
7571342|NCT02820324|18637111|P4|COMPLETED|Overall Study||79
7571343|NCT02820324|18637112|P3|COMPLETED|Overall Study||79
7571344|NCT02820324|18637113|P2|COMPLETED|Overall Study||79
7571345|NCT02820324|18637114|P1|COMPLETED|Overall Study||76
7571346|NCT02820324|18637110|P5|Treated With Study Medication|Overall Study||83
7571347|NCT02820324|18637111|P4|Treated With Study Medication|Overall Study||81
7571348|NCT02820324|18637112|P3|Treated With Study Medication|Overall Study||80
7571349|NCT02820324|18637113|P2|Treated With Study Medication|Overall Study||80
7571350|NCT02820324|18637114|P1|Treated With Study Medication|Overall Study||77
7571351|NCT02820324|18637110|P5|STARTED|Overall Study||83
7571352|NCT02820324|18637111|P4|STARTED|Overall Study||82
7571353|NCT02820324|18637112|P3|STARTED|Overall Study||82
7571354|NCT02820324|18637113|P2|STARTED|Overall Study||82
7571355|NCT02820324|18637114|P1|STARTED|Overall Study||78
7571356|NCT02820038|18637148|P4|NOT COMPLETED|Overall Study||22
7571357|NCT02820038|18637149|P3|NOT COMPLETED|Overall Study||5
7571358|NCT02820038|18637150|P2|NOT COMPLETED|Overall Study||25
7571359|NCT02820038|18637151|P1|NOT COMPLETED|Overall Study||10
7571360|NCT02820038|18637148|P4|COMPLETED|Overall Study||44
7571361|NCT02820038|18637149|P3|COMPLETED|Overall Study||60
7571362|NCT02820038|18637150|P2|COMPLETED|Overall Study||52
7571363|NCT02820038|18637151|P1|COMPLETED|Overall Study||68
7571364|NCT02820038|18637148|P4|STARTED|Overall Study||66
7571365|NCT02820038|18637149|P3|STARTED|Overall Study||65
7571366|NCT02820038|18637150|P2|STARTED|Overall Study||77
7571367|NCT02820038|18637151|P1|STARTED|Overall Study||78
7571368|NCT02819908|18637255|P2|NOT COMPLETED|Overall Study||0
7571369|NCT02819908|18637256|P1|NOT COMPLETED|Overall Study||0
7571370|NCT02819908|18637255|P2|COMPLETED|Overall Study||13
7571371|NCT02819908|18637256|P1|COMPLETED|Overall Study||12
7571372|NCT02819908|18637255|P2|STARTED|Overall Study||13
7571373|NCT02819908|18637256|P1|STARTED|Overall Study||12
7571374|NCT02819804|18637278|P1|NOT COMPLETED|Follow-up for 1 Year||0
7571375|NCT02819804|18637278|P1|COMPLETED|Follow-up for 1 Year||1
7571376|NCT02819804|18637278|P1|STARTED|Follow-up for 1 Year||1
7571377|NCT02819804|18637278|P1|NOT COMPLETED|Start Cycle 2 and Beyond||0
7571378|NCT02819804|18637278|P1|COMPLETED|Start Cycle 2 and Beyond||0
7571379|NCT02819804|18637278|P1|STARTED|Start Cycle 2 and Beyond||0
7571380|NCT02819804|18637278|P1|NOT COMPLETED|Complete Cycle 1 (28 Days)||1
7571381|NCT02819804|18637278|P1|COMPLETED|Complete Cycle 1 (28 Days)||0
7571382|NCT02819804|18637278|P1|STARTED|Complete Cycle 1 (28 Days)||1
7571383|NCT02819726|18637285|P4|NOT COMPLETED|Part B (All Participants)||2
7571384|NCT02819726|18637286|P3|NOT COMPLETED|Part B (All Participants)||4
7571385|NCT02819726|18637287|P2|NOT COMPLETED|Part B (All Participants)||2
7571386|NCT02819726|18637288|P1|NOT COMPLETED|Part B (All Participants)||3
7571387|NCT02819726|18637285|P4|COMPLETED|Part B (All Participants)||36
7571388|NCT02819726|18637286|P3|COMPLETED|Part B (All Participants)||35
7571389|NCT02819726|18637287|P2|COMPLETED|Part B (All Participants)||68
7571390|NCT02819726|18637288|P1|COMPLETED|Part B (All Participants)||70
7571391|NCT02819726|18637285|P4|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|38
7571392|NCT02819726|18637286|P3|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|39
7571393|NCT02819726|18637287|P2|STARTED|Part B (All Participants)|18 participants completing Part A were not eligible for Part B|70
7571394|NCT02819726|18637288|P1|STARTED|Part B (All Participants)|19 participants who completed Part A were not eligible for Part B|73
7571395|NCT02819726|18637285|P4|NOT COMPLETED|Part A (All Participants)||0
7571396|NCT02819726|18637286|P3|NOT COMPLETED|Part A (All Participants)||11
7571397|NCT02819726|18637287|P2|NOT COMPLETED|Part A (All Participants)||10
7571398|NCT02819726|18637288|P1|NOT COMPLETED|Part A (All Participants)||6
7571399|NCT02819726|18637285|P4|COMPLETED|Part A (All Participants)||0
7571400|NCT02819726|18637286|P3|COMPLETED|Part A (All Participants)||87
7571401|NCT02819726|18637287|P2|COMPLETED|Part A (All Participants)||88
7571402|NCT02819726|18637288|P1|COMPLETED|Part A (All Participants)||92
7571403|NCT02819726|18637285|P4|STARTED|Part A (All Participants)||0
7571404|NCT02819726|18637286|P3|STARTED|Part A (All Participants)||98
7571405|NCT02819726|18637287|P2|STARTED|Part A (All Participants)||98
7571406|NCT02819726|18637288|P1|STARTED|Part A (All Participants)||98
7571407|NCT02819557|18637398|P1|NOT COMPLETED|Overall Study||0
7571408|NCT02819557|18637398|P1|COMPLETED|Overall Study||14
7571409|NCT02819557|18637398|P1|Evaluable Population|Overall Study||14
7571410|NCT02819557|18637398|P1|Pharmacokinetics (PK) Population|Overall Study||14
7571411|NCT02819557|18637398|P1|Safety Population|Overall Study||14
7571412|NCT02819557|18637398|P1|STARTED|Overall Study||14
7571413|NCT02819310|18637415|P1|NOT COMPLETED|Overall Study||109
7571414|NCT02819310|18637415|P1|COMPLETED|Overall Study||221
7571415|NCT02819310|18637415|P1|STARTED|Overall Study||330
7571416|NCT02819297|18637421|P2|NOT COMPLETED|Overall Study||52
7571417|NCT02819297|18637422|P1|NOT COMPLETED|Overall Study||60
7571418|NCT02819297|18637421|P2|COMPLETED|Overall Study||252
7571419|NCT02819297|18637422|P1|COMPLETED|Overall Study||239
7571420|NCT02819297|18637421|P2|STARTED|Overall Study||304
7571421|NCT02819297|18637422|P1|STARTED|Overall Study||299
7571422|NCT02819284|18637430|P2|NOT COMPLETED|Overall Study||5
7571423|NCT02819284|18637431|P1|NOT COMPLETED|Overall Study||5
7571424|NCT02819284|18637430|P2|COMPLETED|Overall Study||448
7571425|NCT02819284|18637431|P1|COMPLETED|Overall Study||447
7571426|NCT02819284|18637430|P2|STARTED|Overall Study||453
7571427|NCT02819284|18637431|P1|STARTED|Overall Study||452
7571428|NCT02819011|18637465|P2|NOT COMPLETED|Overall Study||5
7571429|NCT02819011|18637466|P1|NOT COMPLETED|Overall Study||7
7571430|NCT02819011|18637465|P2|COMPLETED|Overall Study||17
7571431|NCT02819011|18637466|P1|COMPLETED|Overall Study||15
7571432|NCT02819011|18637465|P2|STARTED|Overall Study||22
7571433|NCT02819011|18637466|P1|STARTED|Overall Study||22
7571434|NCT02818998|18637496|P3|NOT COMPLETED|Overall Study||18
7571435|NCT02818998|18637497|P2|NOT COMPLETED|Overall Study||16
7571436|NCT02818998|18637498|P1|NOT COMPLETED|Overall Study||18
7571437|NCT02818998|18637496|P3|COMPLETED|Overall Study||136
7571438|NCT02818998|18637497|P2|COMPLETED|Overall Study||138
7571439|NCT02818998|18637498|P1|COMPLETED|Overall Study||137
7571440|NCT02818998|18637496|P3|Completed Week 52 Visit|Overall Study||140
7571441|NCT02818998|18637497|P2|Completed Week 52 Visit|Overall Study||146
7571442|NCT02818998|18637498|P1|Completed Week 52 Visit|Overall Study||144
7571443|NCT02818998|18637496|P3|STARTED|Overall Study||154
7571444|NCT02818998|18637497|P2|STARTED|Overall Study||154
7571445|NCT02818998|18637498|P1|STARTED|Overall Study||155
7571446|NCT02818946|18637524|P1|NOT COMPLETED|Overall Study||0
7571447|NCT02818946|18637524|P1|COMPLETED|Overall Study||30
7571448|NCT02818946|18637524|P1|STARTED|Overall Study||30
7571449|NCT02818920|18637531|P1|NOT COMPLETED|Overall Study||18
7571450|NCT02818920|18637531|P1|COMPLETED|Overall Study||12
7571451|NCT02818920|18637531|P1|Received Adjuvant Therapy|Overall Study||17
7571452|NCT02818920|18637531|P1|Completed Surgery|Overall Study||25
7571453|NCT02818920|18637531|P1|STARTED|Overall Study||30
7571454|NCT02818777|18637535|P1|NOT COMPLETED|Overall Study||3
7571455|NCT02818777|18637535|P1|COMPLETED|Overall Study||10
7571456|NCT02818777|18637535|P1|STARTED|Overall Study|The number of baseline participants was 13.|13
7571457|NCT02818569|18637563|P2|NOT COMPLETED|Overall Study||0
7571458|NCT02818569|18637564|P1|NOT COMPLETED|Overall Study||0
7571459|NCT02818569|18637563|P2|COMPLETED|Overall Study||7
7571460|NCT02818569|18637564|P1|COMPLETED|Overall Study||8
7571461|NCT02818569|18637563|P2|STARTED|Overall Study||7
7571462|NCT02818569|18637564|P1|STARTED|Overall Study||8
7571463|NCT02818244|18637582|P4|NOT COMPLETED|Overall Study||0
7571464|NCT02818244|18637583|P3|NOT COMPLETED|Overall Study||0
7571465|NCT02818244|18637584|P2|NOT COMPLETED|Overall Study||0
7571466|NCT02818244|18637585|P1|NOT COMPLETED|Overall Study||0
7571467|NCT02818244|18637582|P4|COMPLETED|Overall Study||25
7571468|NCT02818244|18637583|P3|COMPLETED|Overall Study||25
7571469|NCT02818244|18637584|P2|COMPLETED|Overall Study||25
7571470|NCT02818244|18637585|P1|COMPLETED|Overall Study||25
7571471|NCT02818244|18637582|P4|STARTED|Overall Study||25
7571472|NCT02818244|18637583|P3|STARTED|Overall Study||25
7571473|NCT02818244|18637584|P2|STARTED|Overall Study||25
7571474|NCT02818244|18637585|P1|STARTED|Overall Study||25
7571475|NCT02818114|18637595|P1|NOT COMPLETED|Overall Study||1
7571476|NCT02818114|18637595|P1|COMPLETED|Overall Study||7
7571477|NCT02818114|18637595|P1|STARTED|Overall Study||8
7571478|NCT02818036|18637602|P2|NOT COMPLETED|Overall Study||0
7571479|NCT02818036|18637603|P1|NOT COMPLETED|Overall Study||2
7571480|NCT02818036|18637602|P2|COMPLETED|Overall Study||40
7571481|NCT02818036|18637603|P1|COMPLETED|Overall Study||40
7571482|NCT02818036|18637602|P2|STARTED|Overall Study||40
7571483|NCT02818036|18637603|P1|STARTED|Overall Study||42
7571484|NCT02817841|18637611|P1|NOT COMPLETED|Overall Study||848
7571485|NCT02817841|18637611|P1|COMPLETED|Overall Study||1016
7571486|NCT02817841|18637611|P1|STARTED|Overall Study||1864
7571487|NCT02817828|18637638|P1|NOT COMPLETED|Overall Study||335
7571488|NCT02817828|18637638|P1|COMPLETED|Overall Study||1218
7571489|NCT02817828|18637638|P1|STARTED|Overall Study||1553
7571490|NCT02817763|18637664|P2|NOT COMPLETED|Overall Study||0
7571491|NCT02817763|18637665|P1|NOT COMPLETED|Overall Study||0
7571492|NCT02817763|18637664|P2|COMPLETED|Overall Study||20
7571493|NCT02817763|18637665|P1|COMPLETED|Overall Study||20
7571494|NCT02817763|18637664|P2|STARTED|Overall Study||20
7571495|NCT02817763|18637665|P1|STARTED|Overall Study||20
7571496|NCT02817594|18637673|P1|NOT COMPLETED|Overall Study||3
7571497|NCT02817594|18637673|P1|COMPLETED|Overall Study||48
7571498|NCT02817594|18637673|P1|Received Treatment|Overall Study||50
7571499|NCT02817594|18637673|P1|STARTED|Overall Study||51
7571500|NCT02817555|18637694|P2|NOT COMPLETED|Overall Study||5
7571501|NCT02817555|18637695|P1|NOT COMPLETED|Overall Study||3
7571502|NCT02817555|18637694|P2|COMPLETED|Overall Study||21
7571503|NCT02817555|18637695|P1|COMPLETED|Overall Study||21
7571504|NCT02817555|18637694|P2|STARTED|Overall Study||26
7571505|NCT02817555|18637695|P1|STARTED|Overall Study||24
7571506|NCT02817516|18637715|P4|NOT COMPLETED|Overall Study||0
7571507|NCT02817516|18637716|P3|NOT COMPLETED|Overall Study||1
7571508|NCT02817516|18637717|P2|NOT COMPLETED|Overall Study||0
7571509|NCT02817516|18637718|P1|NOT COMPLETED|Overall Study||0
7571510|NCT02817516|18637715|P4|COMPLETED|Overall Study||6
7571511|NCT02817516|18637716|P3|COMPLETED|Overall Study||5
7571512|NCT02817516|18637717|P2|COMPLETED|Overall Study||6
7571513|NCT02817516|18637718|P1|COMPLETED|Overall Study||6
7571514|NCT02817516|18637715|P4|STARTED|Overall Study||6
7571515|NCT02817516|18637716|P3|STARTED|Overall Study||6
7571516|NCT02817516|18637717|P2|STARTED|Overall Study||6
7571517|NCT02817516|18637718|P1|STARTED|Overall Study||6
7571518|NCT02817087|18637755|P2|NOT COMPLETED|Overall Study||0
7571519|NCT02817087|18637756|P1|NOT COMPLETED|Overall Study||2
7571520|NCT02817087|18637755|P2|COMPLETED|Overall Study||15
7571521|NCT02817087|18637756|P1|COMPLETED|Overall Study|1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns|14
7571522|NCT02817087|18637755|P2|STARTED|Overall Study||15
7571523|NCT02817087|18637756|P1|STARTED|Overall Study||16
7571524|NCT02816723|18637776|P2|NOT COMPLETED|Overall Study||2
7571525|NCT02816723|18637777|P1|NOT COMPLETED|Overall Study||6
7571526|NCT02816723|18637776|P2|COMPLETED|Overall Study||28
7571527|NCT02816723|18637777|P1|COMPLETED|Overall Study||24
7571528|NCT02816723|18637776|P2|STARTED|Overall Study||30
7571529|NCT02816723|18637777|P1|STARTED|Overall Study||30
7571530|NCT02816710|18637790|P3|NOT COMPLETED|Overall Study||7
7571531|NCT02816710|18637791|P2|NOT COMPLETED|Overall Study||3
7571532|NCT02816710|18637792|P1|NOT COMPLETED|Overall Study||4
7571533|NCT02816710|18637790|P3|COMPLETED|Overall Study||29
7571534|NCT02816710|18637791|P2|COMPLETED|Overall Study||35
7571535|NCT02816710|18637792|P1|COMPLETED|Overall Study||34
7571536|NCT02816710|18637790|P3|STARTED|Overall Study||36
7571537|NCT02816710|18637791|P2|STARTED|Overall Study||38
7571538|NCT02816710|18637792|P1|STARTED|Overall Study||38
7571539|NCT02816398|18637827|P1|NOT COMPLETED|Overall Study||14
7571540|NCT02816398|18637827|P1|COMPLETED|Overall Study||12
7571541|NCT02816398|18637827|P1|STARTED|Overall Study||26
7571542|NCT02816346|18637839|P5|NOT COMPLETED|Overall Study||0
7571543|NCT02816346|18637840|P4|NOT COMPLETED|Overall Study||0
7571544|NCT02816346|18637841|P3|NOT COMPLETED|Overall Study||0
7571545|NCT02816346|18637842|P2|NOT COMPLETED|Overall Study||0
7571546|NCT02816346|18637843|P1|NOT COMPLETED|Overall Study||0
7571547|NCT02816346|18637839|P5|COMPLETED|Overall Study||16
7571548|NCT02816346|18637840|P4|COMPLETED|Overall Study||10
7571549|NCT02816346|18637841|P3|COMPLETED|Overall Study||10
7571550|NCT02816346|18637842|P2|COMPLETED|Overall Study||10
7571551|NCT02816346|18637843|P1|COMPLETED|Overall Study||10
7571552|NCT02816346|18637839|P5|STARTED|Overall Study||16
7571553|NCT02816346|18637840|P4|STARTED|Overall Study||10
7571554|NCT02816346|18637841|P3|STARTED|Overall Study||10
7571555|NCT02816346|18637842|P2|STARTED|Overall Study||10
7571556|NCT02816346|18637843|P1|STARTED|Overall Study||10
7571557|NCT02816138|18637885|P1|NOT COMPLETED|Overall Study||1
7571558|NCT02816138|18637885|P1|COMPLETED|Overall Study||14
7571559|NCT02816138|18637885|P1|STARTED|Overall Study||15
7571560|NCT02815982|18637902|P4|NOT COMPLETED|Overall Study||0
7571561|NCT02815982|18637903|P3|NOT COMPLETED|Overall Study||0
7571562|NCT02815982|18637904|P2|NOT COMPLETED|Overall Study||0
7571563|NCT02815982|18637905|P1|NOT COMPLETED|Overall Study||0
7571564|NCT02815982|18637902|P4|COMPLETED|Overall Study||26
7571565|NCT02815982|18637903|P3|COMPLETED|Overall Study||27
7571566|NCT02815982|18637904|P2|COMPLETED|Overall Study||26
7571567|NCT02815982|18637905|P1|COMPLETED|Overall Study||27
7571568|NCT02815982|18637902|P4|STARTED|Overall Study||26
7571569|NCT02815982|18637903|P3|STARTED|Overall Study||27
7571570|NCT02815982|18637904|P2|STARTED|Overall Study||26
7571571|NCT02815982|18637905|P1|STARTED|Overall Study||27
7571572|NCT02815735|18637931|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
7571573|NCT02815735|18637932|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
7571574|NCT02815735|18637931|P2|COMPLETED|Second Intervention (4 Weeks)||37
7571575|NCT02815735|18637932|P1|COMPLETED|Second Intervention (4 Weeks)||33
7571576|NCT02815735|18637931|P2|STARTED|Second Intervention (4 Weeks)||37
7571577|NCT02815735|18637932|P1|STARTED|Second Intervention (4 Weeks)||34
7571578|NCT02815735|18637931|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
7571579|NCT02815735|18637932|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
7571580|NCT02815735|18637931|P2|COMPLETED|First Intervention (4 Weeks)||37
7571581|NCT02815735|18637932|P1|COMPLETED|First Intervention (4 Weeks)||34
7571582|NCT02815735|18637931|P2|STARTED|First Intervention (4 Weeks)||38
7571583|NCT02815735|18637932|P1|STARTED|First Intervention (4 Weeks)||36
7571584|NCT02815709|18637952|P5|NOT COMPLETED|Overall Study||10
7571585|NCT02815709|18637953|P4|NOT COMPLETED|Overall Study||8
7571586|NCT02815709|18637954|P3|NOT COMPLETED|Overall Study||7
7571587|NCT02815709|18637955|P2|NOT COMPLETED|Overall Study||8
7571588|NCT02815709|18637956|P1|NOT COMPLETED|Overall Study||7
7571589|NCT02815709|18637952|P5|COMPLETED|Overall Study|Completed Study|74
7571590|NCT02815709|18637953|P4|COMPLETED|Overall Study|Completed Study|76
7571591|NCT02815709|18637954|P3|COMPLETED|Overall Study|Completed Study|75
7571592|NCT02815709|18637955|P2|COMPLETED|Overall Study|Completed Study|78
7571593|NCT02815709|18637956|P1|COMPLETED|Overall Study|Completed Study|75
7571594|NCT02815709|18637952|P5|Treated With Study Medication|Overall Study||76
7571595|NCT02815709|18637953|P4|Treated With Study Medication|Overall Study||79
7571596|NCT02815709|18637954|P3|Treated With Study Medication|Overall Study||79
7571597|NCT02815709|18637955|P2|Treated With Study Medication|Overall Study||79
7571598|NCT02815709|18637956|P1|Treated With Study Medication|Overall Study||76
7571599|NCT02815709|18637952|P5|STARTED|Overall Study||84
7571600|NCT02815709|18637953|P4|STARTED|Overall Study||84
7571601|NCT02815709|18637954|P3|STARTED|Overall Study||82
7571602|NCT02815709|18637955|P2|STARTED|Overall Study||86
7571603|NCT02815709|18637956|P1|STARTED|Overall Study||82
7571604|NCT02815670|18637986|P1|NOT COMPLETED|Overall Study||1
7571605|NCT02815670|18637986|P1|COMPLETED|Overall Study||0
7571606|NCT02815670|18637986|P1|STARTED|Overall Study||1
7571607|NCT02815644|18637999|P2|NOT COMPLETED|Treatment Period 2||0
7571608|NCT02815644|18638000|P1|NOT COMPLETED|Treatment Period 2||0
7571609|NCT02815644|18637999|P2|COMPLETED|Treatment Period 2||11
7571610|NCT02815644|18638000|P1|COMPLETED|Treatment Period 2||11
7571611|NCT02815644|18637999|P2|STARTED|Treatment Period 2||11
7571612|NCT02815644|18638000|P1|STARTED|Treatment Period 2||11
7571613|NCT02815644|18637999|P2|NOT COMPLETED|Treatment Period 1 + Washout||0
7571614|NCT02815644|18638000|P1|NOT COMPLETED|Treatment Period 1 + Washout||0
7571615|NCT02815644|18637999|P2|COMPLETED|Treatment Period 1 + Washout||11
7571616|NCT02815644|18638000|P1|COMPLETED|Treatment Period 1 + Washout||11
7571617|NCT02815644|18637999|P2|STARTED|Treatment Period 1 + Washout||11
7571618|NCT02815644|18638000|P1|STARTED|Treatment Period 1 + Washout||11
7571619|NCT02815397|18638018|P1|NOT COMPLETED|Overall Study||2
7571620|NCT02815397|18638018|P1|COMPLETED|Overall Study||0
7571621|NCT02815397|18638018|P1|STARTED|Overall Study||2
7571622|NCT02815293|18638028|P3|NOT COMPLETED|Overall Study||18
7571623|NCT02815293|18638029|P2|NOT COMPLETED|Overall Study||8
7571624|NCT02815293|18638030|P1|NOT COMPLETED|Overall Study||10
7571625|NCT02815293|18638028|P3|COMPLETED|Overall Study||0
7571626|NCT02815293|18638029|P2|COMPLETED|Overall Study||0
7571627|NCT02815293|18638030|P1|COMPLETED|Overall Study||0
7571628|NCT02815293|18638028|P3|STARTED|Overall Study||18
7571629|NCT02815293|18638029|P2|STARTED|Overall Study||8
7571630|NCT02815293|18638030|P1|STARTED|Overall Study||10
7571631|NCT02815280|18638040|P2|NOT COMPLETED|Open-Label Phase||44
7571632|NCT02815280|18638041|P1|NOT COMPLETED|Open-Label Phase||87
7571633|NCT02815280|18638040|P2|COMPLETED|Open-Label Phase||73
7571634|NCT02815280|18638041|P1|COMPLETED|Open-Label Phase||169
7571635|NCT02815280|18638040|P2|STARTED|Open-Label Phase||117
7571636|NCT02815280|18638041|P1|STARTED|Open-Label Phase||256
7571637|NCT02815280|18638040|P2|NOT COMPLETED|Double-Blind Phase||25
7571638|NCT02815280|18638041|P1|NOT COMPLETED|Double-Blind Phase||36
7571639|NCT02815280|18638040|P2|COMPLETED|Double-Blind Phase||137
7571640|NCT02815280|18638041|P1|COMPLETED|Double-Blind Phase||297
7571641|NCT02815280|18638040|P2|STARTED|Double-Blind Phase||162
7571642|NCT02815280|18638041|P1|STARTED|Double-Blind Phase||333
7571643|NCT02815267|18638061|P2|NOT COMPLETED|Open-Label Phase||41
7571644|NCT02815267|18638062|P1|NOT COMPLETED|Open-Label Phase||71
7571645|NCT02815267|18638061|P2|COMPLETED|Open-Label Phase||50
7571646|NCT02815267|18638062|P1|COMPLETED|Open-Label Phase||122
7571647|NCT02815267|18638061|P2|STARTED|Open-Label Phase||91
7571648|NCT02815267|18638062|P1|STARTED|Open-Label Phase||193
7571649|NCT02815267|18638061|P2|NOT COMPLETED|Double-Blind Phase||31
7571650|NCT02815267|18638062|P1|NOT COMPLETED|Double-Blind Phase||33
7571651|NCT02815267|18638061|P2|COMPLETED|Double-Blind Phase||128
7571652|NCT02815267|18638062|P1|COMPLETED|Double-Blind Phase||274
7571653|NCT02815267|18638061|P2|STARTED|Double-Blind Phase||159
7571654|NCT02815267|18638062|P1|STARTED|Double-Blind Phase||307
7571655|NCT02814890|18638082|P2|NOT COMPLETED|Overall Study||2
7571656|NCT02814890|18638083|P1|NOT COMPLETED|Overall Study||3
7571657|NCT02814890|18638082|P2|COMPLETED|Overall Study||30
7571658|NCT02814890|18638083|P1|COMPLETED|Overall Study||30
7571659|NCT02814890|18638082|P2|STARTED|Overall Study||32
7571660|NCT02814890|18638083|P1|STARTED|Overall Study||33
7571661|NCT02814656|18638099|P4|NOT COMPLETED|Overall Study||0
7571662|NCT02814656|18638100|P3|NOT COMPLETED|Overall Study||0
7571663|NCT02814656|18638101|P2|NOT COMPLETED|Overall Study||0
7571664|NCT02814656|18638102|P1|NOT COMPLETED|Overall Study||0
7571665|NCT02814656|18638099|P4|COMPLETED|Overall Study||6
7571666|NCT02814656|18638100|P3|COMPLETED|Overall Study||6
7571667|NCT02814656|18638101|P2|COMPLETED|Overall Study||6
7571668|NCT02814656|18638102|P1|COMPLETED|Overall Study||6
7571669|NCT02814656|18638099|P4|STARTED|Overall Study||6
7571670|NCT02814656|18638100|P3|STARTED|Overall Study||6
7571671|NCT02814656|18638101|P2|STARTED|Overall Study||6
7571672|NCT02814656|18638102|P1|STARTED|Overall Study||6
7571673|NCT02814643|18638202|P2|NOT COMPLETED|Overall Study||3
7571674|NCT02814643|18638203|P1|NOT COMPLETED|Overall Study||1
7571675|NCT02814643|18638202|P2|COMPLETED|Overall Study||49
7571676|NCT02814643|18638203|P1|COMPLETED|Overall Study||50
7571677|NCT02814643|18638202|P2|STARTED|Overall Study||52
7571678|NCT02814643|18638203|P1|STARTED|Overall Study||51
7571679|NCT02814565|18638227|P2|NOT COMPLETED|Overall Study||2
7571680|NCT02814565|18638228|P1|NOT COMPLETED|Overall Study||1
7571681|NCT02814565|18638227|P2|COMPLETED|Overall Study||88
7571682|NCT02814565|18638228|P1|COMPLETED|Overall Study||89
7571683|NCT02814565|18638227|P2|STARTED|Overall Study||90
7571684|NCT02814565|18638228|P1|STARTED|Overall Study||90
7571685|NCT02814448|18638257|P5|NOT COMPLETED|Overall Study||2
7571686|NCT02814448|18638258|P4|NOT COMPLETED|Overall Study||0
7571687|NCT02814448|18638259|P3|NOT COMPLETED|Overall Study||1
7571688|NCT02814448|18638260|P2|NOT COMPLETED|Overall Study||0
7571689|NCT02814448|18638261|P1|NOT COMPLETED|Overall Study||0
7571690|NCT02814448|18638257|P5|COMPLETED|Overall Study||26
7571691|NCT02814448|18638258|P4|COMPLETED|Overall Study||25
7571692|NCT02814448|18638259|P3|COMPLETED|Overall Study||25
7571693|NCT02814448|18638260|P2|COMPLETED|Overall Study||24
7571694|NCT02814448|18638261|P1|COMPLETED|Overall Study||27
7571695|NCT02814448|18638257|P5|STARTED|Overall Study||28
7571696|NCT02814448|18638258|P4|STARTED|Overall Study||25
7571697|NCT02814448|18638259|P3|STARTED|Overall Study||26
7571698|NCT02814448|18638260|P2|STARTED|Overall Study||24
7571699|NCT02814448|18638261|P1|STARTED|Overall Study||27
7571700|NCT02814279|18638280|P2|NOT COMPLETED|Overall Study||0
7571701|NCT02814279|18638281|P1|NOT COMPLETED|Overall Study||0
7571702|NCT02814279|18638280|P2|COMPLETED|Overall Study||21
7571703|NCT02814279|18638281|P1|COMPLETED|Overall Study||21
7571704|NCT02814279|18638280|P2|STARTED|Overall Study||21
7571705|NCT02814279|18638281|P1|STARTED|Overall Study||21
7571706|NCT02814227|18638289|P1|NOT COMPLETED|Overall Study||0
7571707|NCT02814227|18638289|P1|COMPLETED|Overall Study||52
7571708|NCT02814227|18638289|P1|STARTED|Overall Study||52
7571709|NCT02814175|18638298|P6|NOT COMPLETED|Part 2||6
7571710|NCT02814175|18638299|P5|NOT COMPLETED|Part 2||2
7571711|NCT02814175|18638300|P4|NOT COMPLETED|Part 2||4
7571712|NCT02814175|18638301|P3|NOT COMPLETED|Part 2||0
7571713|NCT02814175|18638302|P2|NOT COMPLETED|Part 2||0
7571714|NCT02814175|18638303|P1|NOT COMPLETED|Part 2||0
7571715|NCT02814175|18638298|P6|COMPLETED|Part 2||57
7571716|NCT02814175|18638299|P5|COMPLETED|Part 2||52
7571717|NCT02814175|18638300|P4|COMPLETED|Part 2||91
7571718|NCT02814175|18638301|P3|COMPLETED|Part 2||15
7571719|NCT02814175|18638302|P2|COMPLETED|Part 2||0
7571720|NCT02814175|18638303|P1|COMPLETED|Part 2||0
7571721|NCT02814175|18638298|P6|STARTED|Part 2||63
7571722|NCT02814175|18638299|P5|STARTED|Part 2||54
7571723|NCT02814175|18638300|P4|STARTED|Part 2||95
7571724|NCT02814175|18638301|P3|STARTED|Part 2||15
7571725|NCT02814175|18638302|P2|STARTED|Part 2||0
7571726|NCT02814175|18638303|P1|STARTED|Part 2||0
7571727|NCT02814175|18638298|P6|NOT COMPLETED|Part 1||0
7571728|NCT02814175|18638299|P5|NOT COMPLETED|Part 1||0
7571729|NCT02814175|18638300|P4|NOT COMPLETED|Part 1||0
7571730|NCT02814175|18638301|P3|NOT COMPLETED|Part 1||0
7571731|NCT02814175|18638302|P2|NOT COMPLETED|Part 1||6
7571732|NCT02814175|18638303|P1|NOT COMPLETED|Part 1||12
7571733|NCT02814175|18638298|P6|COMPLETED|Part 1||0
7571734|NCT02814175|18638299|P5|COMPLETED|Part 1||0
7571735|NCT02814175|18638300|P4|COMPLETED|Part 1||0
7571736|NCT02814175|18638301|P3|COMPLETED|Part 1||0
7571737|NCT02814175|18638302|P2|COMPLETED|Part 1||117
7571738|NCT02814175|18638303|P1|COMPLETED|Part 1||110
7571739|NCT02814175|18638298|P6|STARTED|Part 1||0
7571740|NCT02814175|18638299|P5|STARTED|Part 1||0
7571741|NCT02814175|18638300|P4|STARTED|Part 1||0
7571742|NCT02814175|18638301|P3|STARTED|Part 1||0
7571743|NCT02814175|18638302|P2|STARTED|Part 1||123
7571744|NCT02814175|18638303|P1|STARTED|Part 1||122
7571745|NCT02813694|18638341|P2|NOT COMPLETED|Overall Study||14
7571746|NCT02813694|18638342|P1|NOT COMPLETED|Overall Study||17
7571747|NCT02813694|18638341|P2|COMPLETED|Overall Study|Completed Study (Late Follow Up Assessment)|354
7571748|NCT02813694|18638342|P1|COMPLETED|Overall Study||353
7571749|NCT02813694|18638341|P2|STARTED|Overall Study|Intent to Treat Analysis Set|368
7571750|NCT02813694|18638342|P1|STARTED|Overall Study|Intent to Treat Analysis Set|370
7571751|NCT02813681|18638355|P3|NOT COMPLETED|Overall Study||0
7571752|NCT02813681|18638356|P2|NOT COMPLETED|Overall Study||6
7571753|NCT02813681|18638357|P1|NOT COMPLETED|Overall Study||5
7571754|NCT02813681|18638355|P3|COMPLETED|Overall Study||19
7571755|NCT02813681|18638356|P2|COMPLETED|Overall Study||28
7571756|NCT02813681|18638357|P1|COMPLETED|Overall Study||22
7571757|NCT02813681|18638355|P3|STARTED|Overall Study||19
7571758|NCT02813681|18638356|P2|STARTED|Overall Study||34
7571759|NCT02813681|18638357|P1|STARTED|Overall Study||27
7571760|NCT02813577|18638378|P1|NOT COMPLETED|Overall Study||4
7571761|NCT02813577|18638378|P1|COMPLETED|Overall Study|Study was terminated and only some results at 1 month follow up are available.|0
7571762|NCT02813577|18638378|P1|STARTED|Overall Study||4
7571763|NCT02813551|18638396|P2|NOT COMPLETED|Overall Study||2
7571764|NCT02813551|18638397|P1|NOT COMPLETED|Overall Study||1
7571765|NCT02813551|18638396|P2|COMPLETED|Overall Study||57
7571766|NCT02813551|18638397|P1|COMPLETED|Overall Study||58
7571767|NCT02813551|18638396|P2|STARTED|Overall Study||59
7571768|NCT02813551|18638397|P1|STARTED|Overall Study||59
7571769|NCT02813473|18638423|P1|NOT COMPLETED|Overall Study||0
7571770|NCT02813473|18638423|P1|COMPLETED|Overall Study||223
7571771|NCT02813473|18638423|P1|STARTED|Overall Study||223
7571772|NCT02813265|18638429|P2|NOT COMPLETED|Overall Study||3
7571773|NCT02813265|18638430|P1|NOT COMPLETED|Overall Study||4
7571774|NCT02813265|18638429|P2|COMPLETED|Overall Study||453
7571775|NCT02813265|18638430|P1|COMPLETED|Overall Study||455
7571776|NCT02813265|18638429|P2|STARTED|Overall Study||456
7571777|NCT02813265|18638430|P1|STARTED|Overall Study||459
7571778|NCT02813070|18638463|P3|NOT COMPLETED|Overall Study||11
7571779|NCT02813070|18638464|P2|NOT COMPLETED|Overall Study||3
7571780|NCT02813070|18638465|P1|NOT COMPLETED|Overall Study||3
7571781|NCT02813070|18638463|P3|COMPLETED|Overall Study||25
7571782|NCT02813070|18638464|P2|COMPLETED|Overall Study||20
7571783|NCT02813070|18638465|P1|COMPLETED|Overall Study||25
7571784|NCT02813070|18638463|P3|Treated (Safety Population)|Overall Study||25
7571785|NCT02813070|18638464|P2|Treated (Safety Population)|Overall Study||20
7571786|NCT02813070|18638465|P1|Treated (Safety Population)|Overall Study||25
7571787|NCT02813070|18638463|P3|STARTED|Overall Study||36
7571788|NCT02813070|18638464|P2|STARTED|Overall Study||23
7571789|NCT02813070|18638465|P1|STARTED|Overall Study||28
7571790|NCT02812342|18638474|P1|NOT COMPLETED|Overall Study||0
7571791|NCT02812342|18638474|P1|COMPLETED|Overall Study||10
7571792|NCT02812342|18638474|P1|STARTED|Overall Study||10
7571793|NCT02812238|18638479|P2|NOT COMPLETED|Second Intervention||1
7571794|NCT02812238|18638480|P1|NOT COMPLETED|Second Intervention||0
7571795|NCT02812238|18638479|P2|COMPLETED|Second Intervention||18
7571796|NCT02812238|18638480|P1|COMPLETED|Second Intervention||18
7571797|NCT02812238|18638479|P2|STARTED|Second Intervention||19
7571798|NCT02812238|18638480|P1|STARTED|Second Intervention||18
7571799|NCT02812238|18638479|P2|NOT COMPLETED|First Intervention||0
7571800|NCT02812238|18638480|P1|NOT COMPLETED|First Intervention||1
7571801|NCT02812238|18638479|P2|COMPLETED|First Intervention||19
7571802|NCT02812238|18638480|P1|COMPLETED|First Intervention||18
7571803|NCT02812238|18638479|P2|STARTED|First Intervention||19
7571804|NCT02812238|18638480|P1|STARTED|First Intervention||19
7571805|NCT02812186|18638488|P2|NOT COMPLETED|Period 2||0
7571806|NCT02812186|18638489|P1|NOT COMPLETED|Period 2||0
7571807|NCT02812186|18638488|P2|COMPLETED|Period 2||24
7571808|NCT02812186|18638489|P1|COMPLETED|Period 2||29
7571809|NCT02812186|18638488|P2|STARTED|Period 2||24
7571810|NCT02812186|18638489|P1|STARTED|Period 2||29
7571811|NCT02812186|18638488|P2|NOT COMPLETED|Period 1||15
7571812|NCT02812186|18638489|P1|NOT COMPLETED|Period 1||11
7571813|NCT02812186|18638488|P2|COMPLETED|Period 1||24
7571814|NCT02812186|18638489|P1|COMPLETED|Period 1||29
7571815|NCT02812186|18638488|P2|STARTED|Period 1||39
7571816|NCT02812186|18638489|P1|STARTED|Period 1||40
7571817|NCT02811965|18638499|P1|NOT COMPLETED|Overall Study||0
7571818|NCT02811965|18638499|P1|COMPLETED|Overall Study||21
7571819|NCT02811965|18638499|P1|STARTED|Overall Study||21
7571820|NCT02811913|18638522|P1|NOT COMPLETED|Overall Study||4
7571821|NCT02811913|18638522|P1|COMPLETED|Overall Study||16
7571822|NCT02811913|18638522|P1|STARTED|Overall Study||20
7571823|NCT02811640|18638533|P1|NOT COMPLETED|Overall Study||2
7571824|NCT02811640|18638533|P1|COMPLETED|Overall Study||10
7571825|NCT02811640|18638533|P1|STARTED|Overall Study||12
7571826|NCT02811445|18638539|P2|NOT COMPLETED|Overall Study||0
7571827|NCT02811445|18638540|P1|NOT COMPLETED|Overall Study||0
7571828|NCT02811445|18638539|P2|COMPLETED|Overall Study||11
7571829|NCT02811445|18638540|P1|COMPLETED|Overall Study||18
7571830|NCT02811445|18638539|P2|STARTED|Overall Study||11
7571831|NCT02811445|18638540|P1|STARTED|Overall Study||18
7571832|NCT02811419|18638554|P2|NOT COMPLETED|Overall Study||13
7571833|NCT02811419|18638555|P1|NOT COMPLETED|Overall Study||12
7571834|NCT02811419|18638554|P2|COMPLETED|Overall Study||358
7571835|NCT02811419|18638555|P1|COMPLETED|Overall Study||357
7571836|NCT02811419|18638554|P2|STARTED|Overall Study||371
7571837|NCT02811419|18638555|P1|STARTED|Overall Study||369
7571838|NCT02811302|18638563|P1|NOT COMPLETED|Overall Study||213
7571839|NCT02811302|18638563|P1|COMPLETED|Overall Study||1282
7571840|NCT02811302|18638563|P1|STARTED|Overall Study||1495
7571841|NCT02811159|18638568|P1|NOT COMPLETED|Treatment Course 2||0
7571842|NCT02811159|18638568|P1|COMPLETED|Treatment Course 2||4
7571843|NCT02811159|18638568|P1|STARTED|Treatment Course 2|Not all participants who completed the Treatment Course 1 entered the Treatment Course 2.|4
7571844|NCT02811159|18638568|P1|NOT COMPLETED|Treatment Course 1||1
7571845|NCT02811159|18638568|P1|COMPLETED|Treatment Course 1||19
7571846|NCT02811159|18638568|P1|STARTED|Treatment Course 1||20
7571847|NCT02810873|18638585|P2|NOT COMPLETED|Overall Study||0
7571848|NCT02810873|18638586|P1|NOT COMPLETED|Overall Study||0
7571849|NCT02810873|18638585|P2|COMPLETED|Overall Study||13
7571850|NCT02810873|18638586|P1|COMPLETED|Overall Study||6
7571851|NCT02810873|18638585|P2|STARTED|Overall Study||13
7571852|NCT02810873|18638586|P1|STARTED|Overall Study||6
7571853|NCT02810509|18638596|P2|NOT COMPLETED|Overall Study||0
7571854|NCT02810509|18638597|P1|NOT COMPLETED|Overall Study||0
7571855|NCT02810509|18638596|P2|COMPLETED|Overall Study||1230
7571856|NCT02810509|18638597|P1|COMPLETED|Overall Study||584
7571857|NCT02810509|18638596|P2|STARTED|Overall Study||1230
7571858|NCT02810509|18638597|P1|STARTED|Overall Study||584
7571859|NCT02810457|18638607|P2|NOT COMPLETED|Overall Study||329
7571860|NCT02810457|18638608|P1|NOT COMPLETED|Overall Study||327
7571861|NCT02810457|18638607|P2|COMPLETED|Overall Study||38
7571862|NCT02810457|18638608|P1|COMPLETED|Overall Study||37
7571863|NCT02810457|18638607|P2|STARTED|Overall Study|366 patients received study treatment|367
7571864|NCT02810457|18638608|P1|STARTED|Overall Study|362 patients received study treatment|364
7571865|NCT02810327|18638630|P2|NOT COMPLETED|Overall Study||7
7571866|NCT02810327|18638631|P1|NOT COMPLETED|Overall Study||7
7571867|NCT02810327|18638630|P2|COMPLETED|Overall Study||34
7571868|NCT02810327|18638631|P1|COMPLETED|Overall Study||69
7571869|NCT02810327|18638630|P2|STARTED|Overall Study||41
7571870|NCT02810327|18638631|P1|STARTED|Overall Study||76
7571871|NCT02809976|18638637|P1|NOT COMPLETED|Overall Study||2
7571872|NCT02809976|18638637|P1|COMPLETED|Overall Study||9
7571873|NCT02809976|18638637|P1|STARTED|Overall Study||11
7571874|NCT02809911|18638649|P2|NOT COMPLETED|Overall Study||0
7571875|NCT02809911|18638650|P1|NOT COMPLETED|Overall Study||0
7571962|NCT02808312|18638914|P2|NOT COMPLETED|Overall Study||0
7571876|NCT02809911|18638649|P2|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19
7571877|NCT02809911|18638650|P1|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22
7571878|NCT02809911|18638649|P2|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19
7571879|NCT02809911|18638650|P1|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22
7571880|NCT02809859|18638658|P1|NOT COMPLETED|Overall Study||14
7571881|NCT02809859|18638658|P1|COMPLETED|Overall Study||125
7571882|NCT02809859|18638658|P1|STARTED|Overall Study||139
7571883|NCT02809846|18638668|P2|NOT COMPLETED|Overall Study||7
7571884|NCT02809846|18638669|P1|NOT COMPLETED|Overall Study||9
7571885|NCT02809846|18638668|P2|COMPLETED|Overall Study||9
7571886|NCT02809846|18638669|P1|COMPLETED|Overall Study||8
7571887|NCT02809846|18638668|P2|STARTED|Overall Study||16
7571888|NCT02809846|18638669|P1|STARTED|Overall Study||17
7571889|NCT02809833|18638675|P1|NOT COMPLETED|Overall Study||300
7571890|NCT02809833|18638675|P1|COMPLETED|Overall Study||550
7571891|NCT02809833|18638675|P1|STARTED|Overall Study||850
7571892|NCT02809430|18638749|P1|NOT COMPLETED|Overall Study||38
7571893|NCT02809430|18638749|P1|COMPLETED|Overall Study||52
7571894|NCT02809430|18638749|P1|Stopped CPAP During Inpatient Rehabilitation|Overall Study|10 of 62 participants stopped CPAP after the run-in and prior to discharge from IPR|10
7571895|NCT02809430|18638749|P1|Failed 3-night run-in Because no Evidence of Obstructive Sleep Apnea|Overall Study|14 with CPAP < 3 hours, 5 without evidence of OSA, 9 with evidence of central or complex sleep apnea|28
7571896|NCT02809430|18638749|P1|STARTED|Overall Study||90
7571897|NCT02809183|18638765|P6|NOT COMPLETED|Overall Study||0
7571898|NCT02809183|18638766|P5|NOT COMPLETED|Overall Study||0
7571899|NCT02809183|18638767|P4|NOT COMPLETED|Overall Study||0
7571900|NCT02809183|18638768|P3|NOT COMPLETED|Overall Study||0
7571901|NCT02809183|18638769|P2|NOT COMPLETED|Overall Study||0
7571902|NCT02809183|18638770|P1|NOT COMPLETED|Overall Study||0
7571903|NCT02809183|18638765|P6|COMPLETED|Overall Study||28
7571904|NCT02809183|18638766|P5|COMPLETED|Overall Study||6
7571905|NCT02809183|18638767|P4|COMPLETED|Overall Study||26
7571906|NCT02809183|18638768|P3|COMPLETED|Overall Study||25
7571907|NCT02809183|18638769|P2|COMPLETED|Overall Study||25
7571908|NCT02809183|18638770|P1|COMPLETED|Overall Study||25
7571909|NCT02809183|18638765|P6|STARTED|Overall Study||28
7571910|NCT02809183|18638766|P5|STARTED|Overall Study||6
7571911|NCT02809183|18638767|P4|STARTED|Overall Study||26
7571912|NCT02809183|18638768|P3|STARTED|Overall Study||25
7571913|NCT02809183|18638769|P2|STARTED|Overall Study||25
7571914|NCT02809183|18638770|P1|STARTED|Overall Study||25
7571915|NCT02809118|18638807|P3|NOT COMPLETED|Overall Study||1
7571916|NCT02809118|18638808|P2|NOT COMPLETED|Overall Study||1
7571917|NCT02809118|18638809|P1|NOT COMPLETED|Overall Study||0
7571918|NCT02809118|18638807|P3|COMPLETED|Overall Study||18
7571919|NCT02809118|18638808|P2|COMPLETED|Overall Study||18
7571920|NCT02809118|18638809|P1|COMPLETED|Overall Study||18
7571921|NCT02809118|18638807|P3|STARTED|Overall Study||19
7571922|NCT02809118|18638808|P2|STARTED|Overall Study||19
7571923|NCT02809118|18638809|P1|STARTED|Overall Study||18
7571924|NCT02809053|18638822|P2|NOT COMPLETED|Overall Study||6
7571925|NCT02809053|18638823|P1|NOT COMPLETED|Overall Study||7
7571926|NCT02809053|18638822|P2|COMPLETED|Overall Study||152
7571927|NCT02809053|18638823|P1|COMPLETED|Overall Study||150
7571928|NCT02809053|18638822|P2|Completed Treatment|Overall Study||156
7571929|NCT02809053|18638823|P1|Completed Treatment|Overall Study||156
7571930|NCT02809053|18638822|P2|STARTED|Overall Study||158
7571931|NCT02809053|18638823|P1|STARTED|Overall Study||157
7571932|NCT02808975|18638869|P2|NOT COMPLETED|Overall Study||19
7571933|NCT02808975|18638870|P1|NOT COMPLETED|Overall Study||22
7571934|NCT02808975|18638869|P2|COMPLETED|Overall Study||84
7571935|NCT02808975|18638870|P1|COMPLETED|Overall Study||81
7571936|NCT02808975|18638869|P2|STARTED|Overall Study||103
7571937|NCT02808975|18638870|P1|STARTED|Overall Study||103
7571938|NCT02808390|18638887|P3|NOT COMPLETED|Overall Study||3
7571939|NCT02808390|18638888|P2|NOT COMPLETED|Overall Study||6
7571940|NCT02808390|18638889|P1|NOT COMPLETED|Overall Study||2
7571941|NCT02808390|18638887|P3|COMPLETED|Overall Study||4
7571942|NCT02808390|18638888|P2|COMPLETED|Overall Study||2
7571943|NCT02808390|18638889|P1|COMPLETED|Overall Study||2
7571944|NCT02808390|18638887|P3|STARTED|Overall Study||7
7571945|NCT02808390|18638888|P2|STARTED|Overall Study||8
7571946|NCT02808390|18638889|P1|STARTED|Overall Study||4
7571947|NCT02808338|18638897|P1|NOT COMPLETED|Take Home Period||0
7571948|NCT02808338|18638897|P1|COMPLETED|Take Home Period||13
7571949|NCT02808338|18638897|P1|STARTED|Take Home Period||13
7571950|NCT02808338|18638897|P1|NOT COMPLETED|Overnight In-lab Polysomonography||2
7571951|NCT02808338|18638897|P1|COMPLETED|Overnight In-lab Polysomonography||13
7571952|NCT02808338|18638897|P1|ResMed S9 VPAP Adapt|Overnight In-lab Polysomonography||12
7571953|NCT02808338|18638897|P1|Philips BiPAP AutoSV Advanced System One|Overnight In-lab Polysomonography||12
7571954|NCT02808338|18638897|P1|ResMed S7 VPAP Adapt|Overnight In-lab Polysomonography||13
7571955|NCT02808338|18638897|P1|Modified Philips BiPAP ASV|Overnight In-lab Polysomonography||13
7571956|NCT02808338|18638897|P1|STARTED|Overnight In-lab Polysomonography||15
7571957|NCT02808338|18638897|P1|NOT COMPLETED|Screening||10
7571958|NCT02808338|18638897|P1|COMPLETED|Screening||15
7571959|NCT02808338|18638897|P1|STARTED|Screening||25
7571960|NCT02808312|18638912|P4|NOT COMPLETED|Overall Study||1
7571961|NCT02808312|18638913|P3|NOT COMPLETED|Overall Study||0
7571963|NCT02808312|18638915|P1|NOT COMPLETED|Overall Study||0
7571964|NCT02808312|18638912|P4|COMPLETED|Overall Study||26
7571965|NCT02808312|18638913|P3|COMPLETED|Overall Study||10
7571966|NCT02808312|18638914|P2|COMPLETED|Overall Study||10
7571967|NCT02808312|18638915|P1|COMPLETED|Overall Study||10
7571968|NCT02808312|18638912|P4|STARTED|Overall Study||27
7571969|NCT02808312|18638913|P3|STARTED|Overall Study||10
7571970|NCT02808312|18638914|P2|STARTED|Overall Study||10
7571971|NCT02808312|18638915|P1|STARTED|Overall Study||10
7571972|NCT02808130|18639028|P6|NOT COMPLETED|Overall Study||0
7571973|NCT02808130|18639029|P5|NOT COMPLETED|Overall Study||0
7571974|NCT02808130|18639030|P4|NOT COMPLETED|Overall Study||0
7571975|NCT02808130|18639031|P3|NOT COMPLETED|Overall Study||0
7571976|NCT02808130|18639032|P2|NOT COMPLETED|Overall Study||0
7571977|NCT02808130|18639033|P1|NOT COMPLETED|Overall Study||0
7571978|NCT02808130|18639028|P6|COMPLETED|Overall Study||15
7571979|NCT02808130|18639029|P5|COMPLETED|Overall Study||15
7571980|NCT02808130|18639030|P4|COMPLETED|Overall Study||15
7571981|NCT02808130|18639031|P3|COMPLETED|Overall Study||15
7571982|NCT02808130|18639032|P2|COMPLETED|Overall Study||15
7571983|NCT02808130|18639033|P1|COMPLETED|Overall Study||15
7571984|NCT02808130|18639028|P6|STARTED|Overall Study||15
7571985|NCT02808130|18639029|P5|STARTED|Overall Study||15
7571986|NCT02808130|18639030|P4|STARTED|Overall Study||15
7571987|NCT02808130|18639031|P3|STARTED|Overall Study||15
7571988|NCT02808130|18639032|P2|STARTED|Overall Study||15
7571989|NCT02808130|18639033|P1|STARTED|Overall Study||15
7571990|NCT02808052|18639062|P3|NOT COMPLETED|Overall Study||0
7571991|NCT02808052|18639063|P2|NOT COMPLETED|Overall Study||0
7571992|NCT02808052|18639064|P1|NOT COMPLETED|Overall Study||0
7571993|NCT02808052|18639062|P3|COMPLETED|Overall Study||2
7571994|NCT02808052|18639063|P2|COMPLETED|Overall Study||3
7571995|NCT02808052|18639064|P1|COMPLETED|Overall Study||4
7571996|NCT02808052|18639062|P3|STARTED|Overall Study||2
7571997|NCT02808052|18639063|P2|STARTED|Overall Study||3
7571998|NCT02808052|18639064|P1|STARTED|Overall Study||4
7571999|NCT02807948|18639072|P2|NOT COMPLETED|Overall Study||0
7572000|NCT02807948|18639073|P1|NOT COMPLETED|Overall Study||1
7572001|NCT02807948|18639072|P2|COMPLETED|Overall Study||57
7572002|NCT02807948|18639073|P1|COMPLETED|Overall Study||131
7572003|NCT02807948|18639072|P2|STARTED|Overall Study||57
7572004|NCT02807948|18639073|P1|STARTED|Overall Study||132
7572005|NCT02807623|18639081|P3|NOT COMPLETED|Overall Study||23
7572006|NCT02807623|18639082|P2|NOT COMPLETED|Overall Study||21
7572007|NCT02807623|18639083|P1|NOT COMPLETED|Overall Study||23
7572008|NCT02807623|18639081|P3|COMPLETED|Overall Study||79
7572009|NCT02807623|18639082|P2|COMPLETED|Overall Study||79
7572010|NCT02807623|18639083|P1|COMPLETED|Overall Study||75
7572011|NCT02807623|18639081|P3|STARTED|Overall Study||102
7572012|NCT02807623|18639082|P2|STARTED|Overall Study||100
7572013|NCT02807623|18639083|P1|STARTED|Overall Study||98
7572014|NCT02807402|18639110|P1|NOT COMPLETED|Overall Study||6
7572015|NCT02807402|18639110|P1|COMPLETED|Overall Study||516
7572016|NCT02807402|18639110|P1|STARTED|Overall Study||522
7572017|NCT02807376|18639148|P2|NOT COMPLETED|Overall Study||1
7572018|NCT02807376|18639149|P1|NOT COMPLETED|Overall Study||3
7572019|NCT02807376|18639148|P2|COMPLETED|Overall Study||130
7572020|NCT02807376|18639149|P1|COMPLETED|Overall Study||136
7572021|NCT02807376|18639148|P2|STARTED|Overall Study||131
7572022|NCT02807376|18639149|P1|STARTED|Overall Study||139
7572023|NCT02807259|18639159|P2|NOT COMPLETED|Endline (3 Months)||87
7572024|NCT02807259|18639160|P1|NOT COMPLETED|Endline (3 Months)||35
7572025|NCT02807259|18639159|P2|COMPLETED|Endline (3 Months)||259
7572026|NCT02807259|18639160|P1|COMPLETED|Endline (3 Months)||288
7572027|NCT02807259|18639159|P2|STARTED|Endline (3 Months)||346
7572028|NCT02807259|18639160|P1|STARTED|Endline (3 Months)||323
7572029|NCT02807259|18639159|P2|NOT COMPLETED|Midline (3 Months)||34
7572030|NCT02807259|18639160|P1|NOT COMPLETED|Midline (3 Months)||30
7572031|NCT02807259|18639159|P2|COMPLETED|Midline (3 Months)||189
7572032|NCT02807259|18639160|P1|COMPLETED|Midline (3 Months)||322
7572033|NCT02807259|18639159|P2|STARTED|Midline (3 Months)||223
7572034|NCT02807259|18639160|P1|STARTED|Midline (3 Months)||352
7572035|NCT02807259|18639159|P2|NOT COMPLETED|Baseline (3 Months)||112
7572036|NCT02807259|18639160|P1|NOT COMPLETED|Baseline (3 Months)||77
7572037|NCT02807259|18639159|P2|COMPLETED|Baseline (3 Months)||292
7572038|NCT02807259|18639160|P1|COMPLETED|Baseline (3 Months)||328
7572039|NCT02807259|18639159|P2|STARTED|Baseline (3 Months)||404
7572040|NCT02807259|18639160|P1|STARTED|Baseline (3 Months)||405
7572041|NCT02806986|18639178|P1|NOT COMPLETED|Treatment Stage 2||5
7572042|NCT02806986|18639178|P1|COMPLETED|Treatment Stage 2||55
7572043|NCT02806986|18639178|P1|STARTED|Treatment Stage 2||60
7572044|NCT02806986|18639178|P1|NOT COMPLETED|Treatment Stage 1||1
7572045|NCT02806986|18639178|P1|COMPLETED|Treatment Stage 1||60
7572046|NCT02806986|18639178|P1|STARTED|Treatment Stage 1||61
7572047|NCT02806973|18639198|P4|NOT COMPLETED|Period 4||0
7572048|NCT02806973|18639199|P3|NOT COMPLETED|Period 4||0
7572049|NCT02806973|18639200|P2|NOT COMPLETED|Period 4||0
7572050|NCT02806973|18639201|P1|NOT COMPLETED|Period 4||0
7572051|NCT02806973|18639198|P4|COMPLETED|Period 4||3
7572052|NCT02806973|18639199|P3|COMPLETED|Period 4||6
7572053|NCT02806973|18639200|P2|COMPLETED|Period 4||6
7572054|NCT02806973|18639201|P1|COMPLETED|Period 4||8
7572055|NCT02806973|18639198|P4|STARTED|Period 4||3
7572056|NCT02806973|18639199|P3|STARTED|Period 4||6
7572057|NCT02806973|18639200|P2|STARTED|Period 4||6
7572058|NCT02806973|18639201|P1|STARTED|Period 4||8
7572059|NCT02806973|18639198|P4|NOT COMPLETED|Period 3||3
7572060|NCT02806973|18639199|P3|NOT COMPLETED|Period 3||1
7572061|NCT02806973|18639200|P2|NOT COMPLETED|Period 3||0
7572062|NCT02806973|18639201|P1|NOT COMPLETED|Period 3||0
7572063|NCT02806973|18639198|P4|COMPLETED|Period 3||3
7572064|NCT02806973|18639199|P3|COMPLETED|Period 3||6
7572065|NCT02806973|18639200|P2|COMPLETED|Period 3||6
7572066|NCT02806973|18639201|P1|COMPLETED|Period 3||8
7572067|NCT02806973|18639198|P4|STARTED|Period 3||6
7572068|NCT02806973|18639199|P3|STARTED|Period 3||7
7572069|NCT02806973|18639200|P2|STARTED|Period 3||6
7572070|NCT02806973|18639201|P1|STARTED|Period 3||8
7572071|NCT02806973|18639198|P4|NOT COMPLETED|Period 2||0
7572072|NCT02806973|18639199|P3|NOT COMPLETED|Period 2||0
7572073|NCT02806973|18639200|P2|NOT COMPLETED|Period 2||0
7572074|NCT02806973|18639201|P1|NOT COMPLETED|Period 2||0
7572075|NCT02806973|18639198|P4|COMPLETED|Period 2||6
7572076|NCT02806973|18639199|P3|COMPLETED|Period 2||7
7572077|NCT02806973|18639200|P2|COMPLETED|Period 2||6
7572078|NCT02806973|18639201|P1|COMPLETED|Period 2||8
7572079|NCT02806973|18639198|P4|STARTED|Period 2||6
7572080|NCT02806973|18639199|P3|STARTED|Period 2||7
7572081|NCT02806973|18639200|P2|STARTED|Period 2||6
7572082|NCT02806973|18639201|P1|STARTED|Period 2||8
7572083|NCT02806973|18639198|P4|NOT COMPLETED|Period 1||2
7572084|NCT02806973|18639199|P3|NOT COMPLETED|Period 1||1
7572085|NCT02806973|18639200|P2|NOT COMPLETED|Period 1||2
7572086|NCT02806973|18639201|P1|NOT COMPLETED|Period 1||0
7572087|NCT02806973|18639198|P4|COMPLETED|Period 1||6
7572088|NCT02806973|18639199|P3|COMPLETED|Period 1||7
7572089|NCT02806973|18639200|P2|COMPLETED|Period 1||6
7572090|NCT02806973|18639201|P1|COMPLETED|Period 1||8
7572091|NCT02806973|18639198|P4|STARTED|Period 1||8
7572092|NCT02806973|18639199|P3|STARTED|Period 1||8
7572093|NCT02806973|18639200|P2|STARTED|Period 1||8
7572094|NCT02806973|18639201|P1|STARTED|Period 1||8
7572095|NCT02806960|18639235|P4|NOT COMPLETED|Period 4||0
7572096|NCT02806960|18639236|P3|NOT COMPLETED|Period 4||0
7572097|NCT02806960|18639237|P2|NOT COMPLETED|Period 4||0
7572098|NCT02806960|18639238|P1|NOT COMPLETED|Period 4||0
7572099|NCT02806960|18639235|P4|COMPLETED|Period 4||0
7572100|NCT02806960|18639236|P3|COMPLETED|Period 4||0
7572101|NCT02806960|18639237|P2|COMPLETED|Period 4||0
7572102|NCT02806960|18639238|P1|COMPLETED|Period 4||0
7572103|NCT02806960|18639235|P4|STARTED|Period 4||0
7572104|NCT02806960|18639236|P3|STARTED|Period 4||0
7572105|NCT02806960|18639237|P2|STARTED|Period 4||0
7572106|NCT02806960|18639238|P1|STARTED|Period 4||0
7572107|NCT02806960|18639235|P4|NOT COMPLETED|Period 3||0
7572108|NCT02806960|18639236|P3|NOT COMPLETED|Period 3||0
7572109|NCT02806960|18639237|P2|NOT COMPLETED|Period 3||0
7572110|NCT02806960|18639238|P1|NOT COMPLETED|Period 3||0
7572111|NCT02806960|18639235|P4|COMPLETED|Period 3||0
7572112|NCT02806960|18639236|P3|COMPLETED|Period 3||0
7572113|NCT02806960|18639237|P2|COMPLETED|Period 3||0
7572114|NCT02806960|18639238|P1|COMPLETED|Period 3||0
7572115|NCT02806960|18639235|P4|STARTED|Period 3||0
7572116|NCT02806960|18639236|P3|STARTED|Period 3||0
7572117|NCT02806960|18639237|P2|STARTED|Period 3||0
7572118|NCT02806960|18639238|P1|STARTED|Period 3||0
7572119|NCT02806960|18639235|P4|NOT COMPLETED|Period 2||0
7572120|NCT02806960|18639236|P3|NOT COMPLETED|Period 2||0
7572121|NCT02806960|18639237|P2|NOT COMPLETED|Period 2||0
7572122|NCT02806960|18639238|P1|NOT COMPLETED|Period 2||0
7572123|NCT02806960|18639235|P4|COMPLETED|Period 2||0
7572124|NCT02806960|18639236|P3|COMPLETED|Period 2||0
7572125|NCT02806960|18639237|P2|COMPLETED|Period 2||0
7572126|NCT02806960|18639238|P1|COMPLETED|Period 2||0
7572127|NCT02806960|18639235|P4|STARTED|Period 2||0
7572128|NCT02806960|18639236|P3|STARTED|Period 2||0
7572129|NCT02806960|18639237|P2|STARTED|Period 2||0
7572130|NCT02806960|18639238|P1|STARTED|Period 2||0
7572131|NCT02806960|18639235|P4|NOT COMPLETED|Period 1||3
7572132|NCT02806960|18639236|P3|NOT COMPLETED|Period 1||3
7572133|NCT02806960|18639237|P2|NOT COMPLETED|Period 1||3
7572134|NCT02806960|18639238|P1|NOT COMPLETED|Period 1||3
7572135|NCT02806960|18639235|P4|COMPLETED|Period 1||0
7572136|NCT02806960|18639236|P3|COMPLETED|Period 1||0
7572137|NCT02806960|18639237|P2|COMPLETED|Period 1||0
7572138|NCT02806960|18639238|P1|COMPLETED|Period 1||0
7572139|NCT02806960|18639235|P4|STARTED|Period 1||3
7572140|NCT02806960|18639236|P3|STARTED|Period 1||3
7572141|NCT02806960|18639237|P2|STARTED|Period 1||3
7572142|NCT02806960|18639238|P1|STARTED|Period 1||3
7572143|NCT02806947|18639274|P2|NOT COMPLETED|Overall Study||1
7572144|NCT02806947|18639275|P1|NOT COMPLETED|Overall Study||5
7572145|NCT02806947|18639274|P2|COMPLETED|Overall Study||63
7572146|NCT02806947|18639275|P1|COMPLETED|Overall Study||53
7572147|NCT02806947|18639274|P2|STARTED|Overall Study||64
7572148|NCT02806947|18639275|P1|STARTED|Overall Study||58
7572149|NCT02806895|18639305|P2|NOT COMPLETED|Overall Study||0
7572150|NCT02806895|18639306|P1|NOT COMPLETED|Overall Study||1
7572151|NCT02806895|18639305|P2|COMPLETED|Overall Study||17
7572152|NCT02806895|18639306|P1|COMPLETED|Overall Study||16
7572153|NCT02806895|18639305|P2|STARTED|Overall Study||17
7572154|NCT02806895|18639306|P1|STARTED|Overall Study||17
7572155|NCT02806869|18639346|P2|NOT COMPLETED|Second Intervention (1 Day)||2
7572156|NCT02806869|18639347|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7572157|NCT02806869|18639346|P2|COMPLETED|Second Intervention (1 Day)||5
7572158|NCT02806869|18639347|P1|COMPLETED|Second Intervention (1 Day)||7
7572159|NCT02806869|18639346|P2|STARTED|Second Intervention (1 Day)||7
7572160|NCT02806869|18639347|P1|STARTED|Second Intervention (1 Day)||7
7572161|NCT02806869|18639346|P2|NOT COMPLETED|Washout (7 Days)||0
7572162|NCT02806869|18639347|P1|NOT COMPLETED|Washout (7 Days)||0
7572163|NCT02806869|18639346|P2|COMPLETED|Washout (7 Days)||7
7572164|NCT02806869|18639347|P1|COMPLETED|Washout (7 Days)||7
7572165|NCT02806869|18639346|P2|STARTED|Washout (7 Days)||7
7572166|NCT02806869|18639347|P1|STARTED|Washout (7 Days)||7
7572167|NCT02806869|18639346|P2|NOT COMPLETED|First Intervention (1 Day)||12
7572168|NCT02806869|18639347|P1|NOT COMPLETED|First Intervention (1 Day)||11
7572169|NCT02806869|18639346|P2|COMPLETED|First Intervention (1 Day)||12
7572170|NCT02806869|18639347|P1|COMPLETED|First Intervention (1 Day)||13
7572171|NCT02806869|18639346|P2|STARTED|First Intervention (1 Day)||24
7572172|NCT02806869|18639347|P1|STARTED|First Intervention (1 Day)||24
7572173|NCT02806726|18639357|P1|NOT COMPLETED|Overall Study||1
7572174|NCT02806726|18639357|P1|COMPLETED|Overall Study|Subjects were treated contralaterally|6
7572175|NCT02806726|18639357|P1|STARTED|Overall Study|Subjects were treated contralaterally|7
7572176|NCT02806713|18639366|P2|NOT COMPLETED|Overall Study||2
7572177|NCT02806713|18639367|P1|NOT COMPLETED|Overall Study||2
7572178|NCT02806713|18639366|P2|COMPLETED|Overall Study||44
7572179|NCT02806713|18639367|P1|COMPLETED|Overall Study||44
7572180|NCT02806713|18639366|P2|STARTED|Overall Study||46
7572181|NCT02806713|18639367|P1|STARTED|Overall Study||46
7572182|NCT02806544|18639375|P1|NOT COMPLETED|Overall Study||4
7572183|NCT02806544|18639375|P1|COMPLETED|Overall Study||31
7572184|NCT02806544|18639375|P1|STARTED|Overall Study||35
7572185|NCT02806505|18639386|P2|NOT COMPLETED|Overall Study||11
7572186|NCT02806505|18639387|P1|NOT COMPLETED|Overall Study||10
7572187|NCT02806505|18639386|P2|COMPLETED|Overall Study||32
7572188|NCT02806505|18639387|P1|COMPLETED|Overall Study||28
7572189|NCT02806505|18639386|P2|STARTED|Overall Study||43
7572190|NCT02806505|18639387|P1|STARTED|Overall Study||38
7572191|NCT02806414|18639397|P1|NOT COMPLETED|Overall Study||2
7572192|NCT02806414|18639397|P1|COMPLETED|Overall Study||13
7572193|NCT02806414|18639397|P1|STARTED|Overall Study||15
7572194|NCT02806232|18639411|P9|NOT COMPLETED|Overall Study||0
7572195|NCT02806232|18639412|P8|NOT COMPLETED|Overall Study||0
7572196|NCT02806232|18639413|P7|NOT COMPLETED|Overall Study||0
7572197|NCT02806232|18639414|P6|NOT COMPLETED|Overall Study||2
7572198|NCT02806232|18639415|P5|NOT COMPLETED|Overall Study||2
7572199|NCT02806232|18639416|P4|NOT COMPLETED|Overall Study||0
7572200|NCT02806232|18639417|P3|NOT COMPLETED|Overall Study||1
7572201|NCT02806232|18639418|P2|NOT COMPLETED|Overall Study||4
7572202|NCT02806232|18639419|P1|NOT COMPLETED|Overall Study||1
7572203|NCT02806232|18639411|P9|COMPLETED|Overall Study||4
7572204|NCT02806232|18639412|P8|COMPLETED|Overall Study||20
7572205|NCT02806232|18639413|P7|COMPLETED|Overall Study||60
7572206|NCT02806232|18639414|P6|COMPLETED|Overall Study||58
7572207|NCT02806232|18639415|P5|COMPLETED|Overall Study||58
7572208|NCT02806232|18639416|P4|COMPLETED|Overall Study||60
7572209|NCT02806232|18639417|P3|COMPLETED|Overall Study||59
7572210|NCT02806232|18639418|P2|COMPLETED|Overall Study||56
7572211|NCT02806232|18639419|P1|COMPLETED|Overall Study||59
7572212|NCT02806232|18639411|P9|STARTED|Overall Study||4
7572213|NCT02806232|18639412|P8|STARTED|Overall Study||20
7572214|NCT02806232|18639413|P7|STARTED|Overall Study||60
7572215|NCT02806232|18639414|P6|STARTED|Overall Study||60
7572216|NCT02806232|18639415|P5|STARTED|Overall Study||60
7572217|NCT02806232|18639416|P4|STARTED|Overall Study||60
7572218|NCT02806232|18639417|P3|STARTED|Overall Study||60
7572219|NCT02806232|18639418|P2|STARTED|Overall Study||60
7572220|NCT02806232|18639419|P1|STARTED|Overall Study||60
7572221|NCT02806024|18639459|P2|NOT COMPLETED|Overall Study||2
7572222|NCT02806024|18639460|P1|NOT COMPLETED|Overall Study||1
7572223|NCT02806024|18639459|P2|COMPLETED|Overall Study||5
7572224|NCT02806024|18639460|P1|COMPLETED|Overall Study||6
7572225|NCT02806024|18639459|P2|STARTED|Overall Study||7
7572226|NCT02806024|18639460|P1|STARTED|Overall Study||7
7572227|NCT02805907|18639470|P2|NOT COMPLETED|Overall Study||3
7572228|NCT02805907|18639471|P1|NOT COMPLETED|Overall Study||3
7572229|NCT02805907|18639470|P2|COMPLETED|Overall Study||53
7572230|NCT02805907|18639471|P1|COMPLETED|Overall Study||53
7572231|NCT02805907|18639470|P2|STARTED|Overall Study||56
7572232|NCT02805907|18639471|P1|STARTED|Overall Study||56
7572233|NCT02805790|18639485|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
7572234|NCT02805790|18639486|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
7572235|NCT02805790|18639485|P2|COMPLETED|Second Intervention (4 Weeks)||15
7572236|NCT02805790|18639486|P1|COMPLETED|Second Intervention (4 Weeks)||14
7572237|NCT02805790|18639485|P2|STARTED|Second Intervention (4 Weeks)||16
7572238|NCT02805790|18639486|P1|STARTED|Second Intervention (4 Weeks)||14
7572239|NCT02805790|18639485|P2|NOT COMPLETED|Washout (4 Weeks)||0
7572240|NCT02805790|18639486|P1|NOT COMPLETED|Washout (4 Weeks)||0
7572241|NCT02805790|18639485|P2|COMPLETED|Washout (4 Weeks)||16
7572242|NCT02805790|18639486|P1|COMPLETED|Washout (4 Weeks)||14
7572243|NCT02805790|18639485|P2|STARTED|Washout (4 Weeks)||16
7572244|NCT02805790|18639486|P1|STARTED|Washout (4 Weeks)||14
7572245|NCT02805790|18639485|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
7572246|NCT02805790|18639486|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
7572247|NCT02805790|18639485|P2|COMPLETED|First Intervention (4 Weeks)||16
7572248|NCT02805790|18639486|P1|COMPLETED|First Intervention (4 Weeks)||14
7572249|NCT02805790|18639485|P2|STARTED|First Intervention (4 Weeks)||16
7572250|NCT02805790|18639486|P1|STARTED|First Intervention (4 Weeks)||14
7572251|NCT02805647|18639512|P2|NOT COMPLETED|Overall Study||0
7572252|NCT02805647|18639513|P1|NOT COMPLETED|Overall Study||0
7572253|NCT02805647|18639512|P2|COMPLETED|Overall Study|after laboratory tests|122
7572254|NCT02805647|18639513|P1|COMPLETED|Overall Study|after laboratory tests|100
7572255|NCT02805647|18639512|P2|STARTED|Overall Study|at the moment of submision|122
7572256|NCT02805647|18639513|P1|STARTED|Overall Study|at the moment of submision|100
7572257|NCT02804750|18639521|P2|NOT COMPLETED|Period 4||5
7572258|NCT02804750|18639522|P1|NOT COMPLETED|Period 4||0
7572259|NCT02804750|18639521|P2|COMPLETED|Period 4||7
7572260|NCT02804750|18639522|P1|COMPLETED|Period 4||0
7572261|NCT02804750|18639521|P2|STARTED|Period 4|One participant completed Period 3 but did not start Period 4 due to a pre-scheduled surgery.|12
7572262|NCT02804750|18639522|P1|STARTED|Period 4|Per-protocol, Group 1 did not participate in Period 4.|0
7572263|NCT02804750|18639521|P2|NOT COMPLETED|Period 3||2
7572264|NCT02804750|18639522|P1|NOT COMPLETED|Period 3||0
7572265|NCT02804750|18639521|P2|COMPLETED|Period 3||13
7572266|NCT02804750|18639522|P1|COMPLETED|Period 3||16
7572267|NCT02804750|18639521|P2|STARTED|Period 3||15
7572268|NCT02804750|18639522|P1|STARTED|Period 3||16
7572269|NCT02804750|18639521|P2|NOT COMPLETED|Period 2||0
7572270|NCT02804750|18639522|P1|NOT COMPLETED|Period 2||1
7572271|NCT02804750|18639521|P2|COMPLETED|Period 2||15
7572272|NCT02804750|18639522|P1|COMPLETED|Period 2||16
7572273|NCT02804750|18639521|P2|STARTED|Period 2||15
7572274|NCT02804750|18639522|P1|STARTED|Period 2||17
7572275|NCT02804750|18639521|P2|NOT COMPLETED|Period 1||3
7572276|NCT02804750|18639522|P1|NOT COMPLETED|Period 1||0
7572277|NCT02804750|18639521|P2|COMPLETED|Period 1||15
7572278|NCT02804750|18639522|P1|COMPLETED|Period 1||17
7572279|NCT02804750|18639521|P2|STARTED|Period 1||18
7572280|NCT02804750|18639522|P1|STARTED|Period 1||17
7572281|NCT02804594|18639538|P2|NOT COMPLETED|Overall Study||0
7572282|NCT02804594|18639539|P1|NOT COMPLETED|Overall Study||0
7572283|NCT02804594|18639538|P2|COMPLETED|Overall Study||5
7572284|NCT02804594|18639539|P1|COMPLETED|Overall Study||10
7572285|NCT02804594|18639538|P2|STARTED|Overall Study||5
7572286|NCT02804594|18639539|P1|STARTED|Overall Study||10
7572287|NCT02804399|18639549|P2|NOT COMPLETED|Period 2||1
7572288|NCT02804399|18639550|P1|NOT COMPLETED|Period 2||0
7572289|NCT02804399|18639549|P2|COMPLETED|Period 2||11
7572290|NCT02804399|18639550|P1|COMPLETED|Period 2||0
7572291|NCT02804399|18639549|P2|STARTED|Period 2||12
7572292|NCT02804399|18639550|P1|STARTED|Period 2||0
7572293|NCT02804399|18639549|P2|NOT COMPLETED|Washout Period at Least 10 Days||0
7572294|NCT02804399|18639550|P1|NOT COMPLETED|Washout Period at Least 10 Days||0
7572295|NCT02804399|18639549|P2|COMPLETED|Washout Period at Least 10 Days||0
7572296|NCT02804399|18639550|P1|COMPLETED|Washout Period at Least 10 Days||12
7572297|NCT02804399|18639549|P2|STARTED|Washout Period at Least 10 Days||0
7572298|NCT02804399|18639550|P1|STARTED|Washout Period at Least 10 Days||12
7572299|NCT02804399|18639549|P2|NOT COMPLETED|Period 1||0
7572300|NCT02804399|18639550|P1|NOT COMPLETED|Period 1||0
7572301|NCT02804399|18639549|P2|COMPLETED|Period 1||0
7572302|NCT02804399|18639550|P1|COMPLETED|Period 1||12
7572303|NCT02804399|18639549|P2|STARTED|Period 1||0
7572304|NCT02804399|18639550|P1|STARTED|Period 1||12
7572305|NCT02803749|18639601|P2|NOT COMPLETED|Overall Study||0
7572306|NCT02803749|18639602|P1|NOT COMPLETED|Overall Study||5
7572307|NCT02803749|18639601|P2|COMPLETED|Overall Study||4
7572308|NCT02803749|18639602|P1|COMPLETED|Overall Study||12
7572309|NCT02803749|18639601|P2|STARTED|Overall Study||4
7572310|NCT02803749|18639602|P1|STARTED|Overall Study||17
7572311|NCT02803580|18639622|P1|NOT COMPLETED|Overall Study||36
7572312|NCT02803580|18639622|P1|COMPLETED|Overall Study||173
7572313|NCT02803580|18639622|P1|STARTED|Overall Study||209
7572314|NCT02803138|18639661|P1|NOT COMPLETED|Overall Study||70
7572315|NCT02803138|18639661|P1|COMPLETED|Overall Study||166
7572316|NCT02803138|18639661|P1|STARTED|Overall Study||236
7572317|NCT02802878|18639677|P2|NOT COMPLETED|Overall Study||3
7572318|NCT02802878|18639678|P1|NOT COMPLETED|Overall Study||4
7572319|NCT02802878|18639677|P2|COMPLETED|Overall Study||18
7572320|NCT02802878|18639678|P1|COMPLETED|Overall Study||17
7572321|NCT02802878|18639677|P2|STARTED|Overall Study||21
7572322|NCT02802878|18639678|P1|STARTED|Overall Study||21
7572323|NCT02802865|18639694|P2|NOT COMPLETED|Overall Study||2
7572324|NCT02802865|18639695|P1|NOT COMPLETED|Overall Study||1
7572325|NCT02802865|18639694|P2|COMPLETED|Overall Study||33
7572326|NCT02802865|18639695|P1|COMPLETED|Overall Study||34
7572327|NCT02802865|18639694|P2|STARTED|Overall Study||35
7572328|NCT02802865|18639695|P1|STARTED|Overall Study||35
7572329|NCT02802592|18639717|P1|NOT COMPLETED|Overall Study||4
7572330|NCT02802592|18639717|P1|COMPLETED|Overall Study||0
7572331|NCT02802592|18639717|P1|STARTED|Overall Study||4
7572332|NCT02802514|18639728|P4|NOT COMPLETED|Session 2 (Up to Day 8)||0
7572333|NCT02802514|18639729|P3|NOT COMPLETED|Session 2 (Up to Day 8)||0
7572334|NCT02802514|18639730|P2|NOT COMPLETED|Session 2 (Up to Day 8)||0
7572335|NCT02802514|18639731|P1|NOT COMPLETED|Session 2 (Up to Day 8)||0
7572336|NCT02802514|18639728|P4|COMPLETED|Session 2 (Up to Day 8)||1
7572337|NCT02802514|18639729|P3|COMPLETED|Session 2 (Up to Day 8)||1
7572338|NCT02802514|18639730|P2|COMPLETED|Session 2 (Up to Day 8)||1
7572339|NCT02802514|18639731|P1|COMPLETED|Session 2 (Up to Day 8)||1
7572340|NCT02802514|18639728|P4|STARTED|Session 2 (Up to Day 8)||1
7572341|NCT02802514|18639729|P3|STARTED|Session 2 (Up to Day 8)||1
7572342|NCT02802514|18639730|P2|STARTED|Session 2 (Up to Day 8)||1
7572343|NCT02802514|18639731|P1|STARTED|Session 2 (Up to Day 8)||1
7572344|NCT02802514|18639728|P4|NOT COMPLETED|Wash Out Period (up to Week 9)||0
7572345|NCT02802514|18639729|P3|NOT COMPLETED|Wash Out Period (up to Week 9)||0
7572346|NCT02802514|18639730|P2|NOT COMPLETED|Wash Out Period (up to Week 9)||0
7572347|NCT02802514|18639731|P1|NOT COMPLETED|Wash Out Period (up to Week 9)||0
7572348|NCT02802514|18639728|P4|COMPLETED|Wash Out Period (up to Week 9)||1
7572349|NCT02802514|18639729|P3|COMPLETED|Wash Out Period (up to Week 9)||1
7572350|NCT02802514|18639730|P2|COMPLETED|Wash Out Period (up to Week 9)||1
7572351|NCT02802514|18639731|P1|COMPLETED|Wash Out Period (up to Week 9)||1
7572352|NCT02802514|18639728|P4|STARTED|Wash Out Period (up to Week 9)||1
7572353|NCT02802514|18639729|P3|STARTED|Wash Out Period (up to Week 9)||1
7572354|NCT02802514|18639730|P2|STARTED|Wash Out Period (up to Week 9)||1
7572355|NCT02802514|18639731|P1|STARTED|Wash Out Period (up to Week 9)||1
7572356|NCT02802514|18639728|P4|NOT COMPLETED|Session 1 (up to Day 8)||0
7572357|NCT02802514|18639729|P3|NOT COMPLETED|Session 1 (up to Day 8)||0
7572358|NCT02802514|18639730|P2|NOT COMPLETED|Session 1 (up to Day 8)||0
7572359|NCT02802514|18639731|P1|NOT COMPLETED|Session 1 (up to Day 8)||0
7572360|NCT02802514|18639728|P4|COMPLETED|Session 1 (up to Day 8)||1
7572361|NCT02802514|18639729|P3|COMPLETED|Session 1 (up to Day 8)||1
7572362|NCT02802514|18639730|P2|COMPLETED|Session 1 (up to Day 8)||1
7572363|NCT02802514|18639731|P1|COMPLETED|Session 1 (up to Day 8)||1
7572364|NCT02802514|18639728|P4|STARTED|Session 1 (up to Day 8)||1
7572365|NCT02802514|18639729|P3|STARTED|Session 1 (up to Day 8)||1
7572366|NCT02802514|18639730|P2|STARTED|Session 1 (up to Day 8)||1
7572367|NCT02802514|18639731|P1|STARTED|Session 1 (up to Day 8)||1
7572368|NCT02802501|18639807|P3|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
7572369|NCT02802501|18639808|P2|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
7572370|NCT02802501|18639809|P1|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
7572371|NCT02802501|18639807|P3|COMPLETED|Open-Label (Day 180 to Day 195)||26
7572372|NCT02802501|18639808|P2|COMPLETED|Open-Label (Day 180 to Day 195)||12
7572373|NCT02802501|18639809|P1|COMPLETED|Open-Label (Day 180 to Day 195)||6
7572374|NCT02802501|18639807|P3|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|26
7572375|NCT02802501|18639808|P2|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|12
7572376|NCT02802501|18639809|P1|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|6
7572377|NCT02802501|18639807|P3|NOT COMPLETED|Double-blind (Up to Day 180)||0
7572378|NCT02802501|18639808|P2|NOT COMPLETED|Double-blind (Up to Day 180)||0
7572379|NCT02802501|18639809|P1|NOT COMPLETED|Double-blind (Up to Day 180)||0
7572380|NCT02802501|18639807|P3|COMPLETED|Double-blind (Up to Day 180)||50
7572381|NCT02802501|18639808|P2|COMPLETED|Double-blind (Up to Day 180)||50
7572382|NCT02802501|18639809|P1|COMPLETED|Double-blind (Up to Day 180)||50
7572383|NCT02802501|18639807|P3|STARTED|Double-blind (Up to Day 180)||50
7572384|NCT02802501|18639808|P2|STARTED|Double-blind (Up to Day 180)||50
7572385|NCT02802501|18639809|P1|STARTED|Double-blind (Up to Day 180)||50
7572386|NCT02802449|18639875|P2|NOT COMPLETED|Overall Study||17
7572387|NCT02802449|18639876|P1|NOT COMPLETED|Overall Study||9
7572388|NCT02802449|18639875|P2|COMPLETED|Overall Study||202
7572389|NCT02802449|18639876|P1|COMPLETED|Overall Study||102
7572390|NCT02802449|18639875|P2|STARTED|Overall Study||219
7572391|NCT02802449|18639876|P1|STARTED|Overall Study||111
7572392|NCT02802345|18639894|P2|NOT COMPLETED|Overall Study||30
7572393|NCT02802345|18639895|P1|NOT COMPLETED|Overall Study||32
7572394|NCT02802345|18639894|P2|COMPLETED|Overall Study||108
7572395|NCT02802345|18639895|P1|COMPLETED|Overall Study||104
7572396|NCT02802345|18639894|P2|Treated|Overall Study||137
7572397|NCT02802345|18639895|P1|Treated|Overall Study||136
7572398|NCT02802345|18639894|P2|STARTED|Overall Study||138
7572399|NCT02802345|18639895|P1|STARTED|Overall Study||136
7572400|NCT02802319|18639911|P2|NOT COMPLETED|Overall Study||5
7572401|NCT02802319|18639912|P1|NOT COMPLETED|Overall Study||2
7572402|NCT02802319|18639911|P2|COMPLETED|Overall Study||17
7572403|NCT02802319|18639912|P1|COMPLETED|Overall Study||20
7572404|NCT02802319|18639911|P2|STARTED|Overall Study||22
7572405|NCT02802319|18639912|P1|STARTED|Overall Study||22
7572406|NCT02802241|18639924|P4|NOT COMPLETED|Overall Study||26
7572407|NCT02802241|18639925|P3|NOT COMPLETED|Overall Study||48
7572408|NCT02802241|18639926|P2|NOT COMPLETED|Overall Study||26
7572409|NCT02802241|18639927|P1|NOT COMPLETED|Overall Study||29
7572410|NCT02802241|18639924|P4|COMPLETED|Overall Study||72
7572411|NCT02802241|18639925|P3|COMPLETED|Overall Study|Not included in primary analysis|0
7572412|NCT02802241|18639926|P2|COMPLETED|Overall Study||71
7572413|NCT02802241|18639927|P1|COMPLETED|Overall Study||68
7572414|NCT02802241|18639924|P4|Planned Analysis|Overall Study||87
7572415|NCT02802241|18639925|P3|Planned Analysis|Overall Study|Not included in primary analysis|0
7572416|NCT02802241|18639926|P2|Planned Analysis|Overall Study||86
7572417|NCT02802241|18639927|P1|Planned Analysis|Overall Study||89
7572418|NCT02802241|18639924|P4|STARTED|Overall Study||98
7572419|NCT02802241|18639925|P3|STARTED|Overall Study||48
7572420|NCT02802241|18639926|P2|STARTED|Overall Study||97
7572421|NCT02802241|18639927|P1|STARTED|Overall Study||97
7572422|NCT02802111|18639939|P2|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
7572423|NCT02802111|18639940|P1|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
7572424|NCT02802111|18639939|P2|COMPLETED|Second Intervention (5 Min of Drug)||12
7572425|NCT02802111|18639940|P1|COMPLETED|Second Intervention (5 Min of Drug)||12
7572426|NCT02802111|18639939|P2|STARTED|Second Intervention (5 Min of Drug)||12
7572427|NCT02802111|18639940|P1|STARTED|Second Intervention (5 Min of Drug)||12
7572428|NCT02802111|18639939|P2|NOT COMPLETED|Washout (4 Hours)||0
7572429|NCT02802111|18639940|P1|NOT COMPLETED|Washout (4 Hours)||0
7572430|NCT02802111|18639939|P2|COMPLETED|Washout (4 Hours)||12
7572431|NCT02802111|18639940|P1|COMPLETED|Washout (4 Hours)||12
7572432|NCT02802111|18639939|P2|STARTED|Washout (4 Hours)||12
7572433|NCT02802111|18639940|P1|STARTED|Washout (4 Hours)||12
7572434|NCT02802111|18639939|P2|NOT COMPLETED|First Intervention (5 Min of Drug)||0
7572435|NCT02802111|18639940|P1|NOT COMPLETED|First Intervention (5 Min of Drug)||0
7572436|NCT02802111|18639939|P2|COMPLETED|First Intervention (5 Min of Drug)||12
7572437|NCT02802111|18639940|P1|COMPLETED|First Intervention (5 Min of Drug)||12
7572438|NCT02802111|18639939|P2|STARTED|First Intervention (5 Min of Drug)||12
7572439|NCT02802111|18639940|P1|STARTED|First Intervention (5 Min of Drug)||12
7572440|NCT02801942|18639950|P2|NOT COMPLETED|Overall Study||0
7572441|NCT02801942|18639951|P1|NOT COMPLETED|Overall Study||0
7572442|NCT02801942|18639950|P2|COMPLETED|Overall Study||10
7572443|NCT02801942|18639951|P1|COMPLETED|Overall Study||12
7572444|NCT02801942|18639950|P2|STARTED|Overall Study||10
7572445|NCT02801942|18639951|P1|STARTED|Overall Study||12
7572446|NCT02801877|18640075|P4|NOT COMPLETED|Overall Study||0
7572447|NCT02801877|18640076|P3|NOT COMPLETED|Overall Study||6
7572448|NCT02801877|18640077|P2|NOT COMPLETED|Overall Study||1
7572449|NCT02801877|18640078|P1|NOT COMPLETED|Overall Study||3
7572450|NCT02801877|18640075|P4|COMPLETED|Overall Study||76
7572451|NCT02801877|18640076|P3|COMPLETED|Overall Study||70
7572452|NCT02801877|18640077|P2|COMPLETED|Overall Study||74
7572453|NCT02801877|18640078|P1|COMPLETED|Overall Study||71
7572454|NCT02801877|18640075|P4|STARTED|Overall Study||76
7572455|NCT02801877|18640076|P3|STARTED|Overall Study||76
7572456|NCT02801877|18640077|P2|STARTED|Overall Study||75
7572457|NCT02801877|18640078|P1|STARTED|Overall Study||74
7572458|NCT02801669|18640098|P2|NOT COMPLETED|Overall Study||152
7572459|NCT02801669|18640099|P1|NOT COMPLETED|Overall Study||151
7572460|NCT02801669|18640098|P2|COMPLETED|Overall Study||340
7572461|NCT02801669|18640099|P1|COMPLETED|Overall Study||341
7572462|NCT02801669|18640098|P2|Received at Least 1 Dose of Study Drug|Overall Study||490
7572463|NCT02801669|18640099|P1|Received at Least 1 Dose of Study Drug|Overall Study||492
7572464|NCT02801669|18640098|P2|STARTED|Overall Study||492
7572465|NCT02801669|18640099|P1|STARTED|Overall Study||492
7572466|NCT02801617|18640126|P2|NOT COMPLETED|Overall Study||6
7572467|NCT02801617|18640127|P1|NOT COMPLETED|Overall Study||2
7572468|NCT02801617|18640126|P2|COMPLETED|Overall Study||50
7572469|NCT02801617|18640127|P1|COMPLETED|Overall Study||49
7572470|NCT02801617|18640126|P2|STARTED|Overall Study||56
7572471|NCT02801617|18640127|P1|STARTED|Overall Study||51
7572472|NCT02801578|18640145|P1|NOT COMPLETED|Overall Study||2
7572473|NCT02801578|18640145|P1|COMPLETED|Overall Study||9
7572474|NCT02801578|18640145|P1|STARTED|Overall Study||11
7572475|NCT02801396|18640149|P6|NOT COMPLETED|Period 3||0
7572476|NCT02801396|18640150|P5|NOT COMPLETED|Period 3||0
7572477|NCT02801396|18640151|P4|NOT COMPLETED|Period 3||0
7572478|NCT02801396|18640152|P3|NOT COMPLETED|Period 3||0
7572479|NCT02801396|18640153|P2|NOT COMPLETED|Period 3||0
7572480|NCT02801396|18640154|P1|NOT COMPLETED|Period 3||0
7572481|NCT02801396|18640149|P6|COMPLETED|Period 3||17
7572482|NCT02801396|18640150|P5|COMPLETED|Period 3||16
7572483|NCT02801396|18640151|P4|COMPLETED|Period 3||16
7572484|NCT02801396|18640152|P3|COMPLETED|Period 3||17
7572485|NCT02801396|18640153|P2|COMPLETED|Period 3||17
7572486|NCT02801396|18640154|P1|COMPLETED|Period 3||17
7572487|NCT02801396|18640149|P6|STARTED|Period 3||17
7572488|NCT02801396|18640150|P5|STARTED|Period 3||16
7572489|NCT02801396|18640151|P4|STARTED|Period 3||16
7572490|NCT02801396|18640152|P3|STARTED|Period 3||17
7572491|NCT02801396|18640153|P2|STARTED|Period 3||17
7572492|NCT02801396|18640154|P1|STARTED|Period 3||17
7572493|NCT02801396|18640149|P6|NOT COMPLETED|Period 2||0
7572494|NCT02801396|18640150|P5|NOT COMPLETED|Period 2||0
7572495|NCT02801396|18640151|P4|NOT COMPLETED|Period 2||0
7572496|NCT02801396|18640152|P3|NOT COMPLETED|Period 2||0
7572497|NCT02801396|18640153|P2|NOT COMPLETED|Period 2||0
7572498|NCT02801396|18640154|P1|NOT COMPLETED|Period 2||0
7572499|NCT02801396|18640149|P6|COMPLETED|Period 2||17
7572500|NCT02801396|18640150|P5|COMPLETED|Period 2||16
7572501|NCT02801396|18640151|P4|COMPLETED|Period 2||16
7572502|NCT02801396|18640152|P3|COMPLETED|Period 2||17
7572503|NCT02801396|18640153|P2|COMPLETED|Period 2||17
7572504|NCT02801396|18640154|P1|COMPLETED|Period 2||17
7572505|NCT02801396|18640149|P6|STARTED|Period 2||17
7572506|NCT02801396|18640150|P5|STARTED|Period 2||16
7572507|NCT02801396|18640151|P4|STARTED|Period 2||16
7572508|NCT02801396|18640152|P3|STARTED|Period 2||17
7572509|NCT02801396|18640153|P2|STARTED|Period 2||17
7572510|NCT02801396|18640154|P1|STARTED|Period 2||17
7572511|NCT02801396|18640149|P6|NOT COMPLETED|Period 1||0
7572512|NCT02801396|18640150|P5|NOT COMPLETED|Period 1||1
7572513|NCT02801396|18640151|P4|NOT COMPLETED|Period 1||0
7572514|NCT02801396|18640152|P3|NOT COMPLETED|Period 1||0
7572515|NCT02801396|18640153|P2|NOT COMPLETED|Period 1||0
7572516|NCT02801396|18640154|P1|NOT COMPLETED|Period 1||0
7572517|NCT02801396|18640149|P6|COMPLETED|Period 1||17
7572518|NCT02801396|18640150|P5|COMPLETED|Period 1||16
7572519|NCT02801396|18640151|P4|COMPLETED|Period 1||16
7572520|NCT02801396|18640152|P3|COMPLETED|Period 1||17
7572521|NCT02801396|18640153|P2|COMPLETED|Period 1||17
7572522|NCT02801396|18640154|P1|COMPLETED|Period 1||17
7572523|NCT02801396|18640149|P6|STARTED|Period 1||17
7572524|NCT02801396|18640150|P5|STARTED|Period 1||17
7572525|NCT02801396|18640151|P4|STARTED|Period 1||16
7572526|NCT02801396|18640152|P3|STARTED|Period 1||17
7572527|NCT02801396|18640153|P2|STARTED|Period 1||17
7572528|NCT02801396|18640154|P1|STARTED|Period 1||17
7572529|NCT02801370|18640173|P2|NOT COMPLETED|Overall Study||0
7572530|NCT02801370|18640174|P1|NOT COMPLETED|Overall Study||7
7572531|NCT02801370|18640173|P2|COMPLETED|Overall Study||132
7572532|NCT02801370|18640174|P1|COMPLETED|Overall Study||123
7572533|NCT02801370|18640173|P2|STARTED|Overall Study||132
7572534|NCT02801370|18640174|P1|STARTED|Overall Study||130
7572535|NCT02801006|18640182|P2|NOT COMPLETED|Lens 2||0
7572536|NCT02801006|18640183|P1|NOT COMPLETED|Lens 2||0
7572537|NCT02801006|18640182|P2|COMPLETED|Lens 2||19
7572538|NCT02801006|18640183|P1|COMPLETED|Lens 2||22
7572539|NCT02801006|18640182|P2|STARTED|Lens 2||19
7572540|NCT02801006|18640183|P1|STARTED|Lens 2||22
7572541|NCT02801006|18640182|P2|NOT COMPLETED|Lens 1||0
7572542|NCT02801006|18640183|P1|NOT COMPLETED|Lens 1||0
7572543|NCT02801006|18640182|P2|COMPLETED|Lens 1||19
7572544|NCT02801006|18640183|P1|COMPLETED|Lens 1||22
7572545|NCT02801006|18640182|P2|STARTED|Lens 1||19
7572546|NCT02801006|18640183|P1|STARTED|Lens 1||22
7572547|NCT02800928|18640199|P2|NOT COMPLETED|Overall Study||2
7572548|NCT02800928|18640200|P1|NOT COMPLETED|Overall Study||2
7572549|NCT02800928|18640199|P2|COMPLETED|Overall Study||6
7572550|NCT02800928|18640200|P1|COMPLETED|Overall Study||7
7572551|NCT02800928|18640199|P2|STARTED|Overall Study||8
7572552|NCT02800928|18640200|P1|STARTED|Overall Study||9
7572553|NCT02800642|18640208|P1|NOT COMPLETED|Overall Study||25
7572554|NCT02800642|18640208|P1|COMPLETED|Overall Study||137
7572555|NCT02800642|18640208|P1|STARTED|Overall Study||162
7572556|NCT02800356|18640221|P1|NOT COMPLETED|Overall Study||0
7572557|NCT02800356|18640221|P1|COMPLETED|Overall Study||20
7572558|NCT02800356|18640221|P1|STARTED|Overall Study||20
7572559|NCT02800213|18640232|P2|NOT COMPLETED|Second Intervention||0
7572560|NCT02800213|18640233|P1|NOT COMPLETED|Second Intervention||0
7572561|NCT02800213|18640232|P2|COMPLETED|Second Intervention||35
7572562|NCT02800213|18640233|P1|COMPLETED|Second Intervention||35
7572563|NCT02800213|18640232|P2|STARTED|Second Intervention||35
7572564|NCT02800213|18640233|P1|STARTED|Second Intervention||35
7572565|NCT02800213|18640232|P2|NOT COMPLETED|First Intervention||0
7572566|NCT02800213|18640233|P1|NOT COMPLETED|First Intervention||0
7572567|NCT02800213|18640232|P2|COMPLETED|First Intervention||35
7572568|NCT02800213|18640233|P1|COMPLETED|First Intervention||35
7572569|NCT02800213|18640232|P2|STARTED|First Intervention||35
7572570|NCT02800213|18640233|P1|STARTED|First Intervention||35
7572571|NCT02800148|18640242|P3|NOT COMPLETED|Overall Study||25
7572572|NCT02800148|18640243|P2|NOT COMPLETED|Overall Study||20
7572573|NCT02800148|18640244|P1|NOT COMPLETED|Overall Study||25
7572574|NCT02800148|18640242|P3|COMPLETED|Overall Study||194
7572575|NCT02800148|18640243|P2|COMPLETED|Overall Study||204
7572576|NCT02800148|18640244|P1|COMPLETED|Overall Study||199
7572577|NCT02800148|18640242|P3|STARTED|Overall Study||219
7572578|NCT02800148|18640243|P2|STARTED|Overall Study||224
7572579|NCT02800148|18640244|P1|STARTED|Overall Study||224
7572580|NCT02799784|18640252|P2|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||3
7572581|NCT02799784|18640253|P1|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||1
7572582|NCT02799784|18640252|P2|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||115
7572583|NCT02799784|18640253|P1|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||110
7572584|NCT02799784|18640252|P2|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||118
7572585|NCT02799784|18640253|P1|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||111
7572586|NCT02799784|18640252|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
7572587|NCT02799784|18640253|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
7572588|NCT02799784|18640252|P2|COMPLETED|Washout Period (3 Weeks)||118
7572589|NCT02799784|18640253|P1|COMPLETED|Washout Period (3 Weeks)||111
7572590|NCT02799784|18640252|P2|STARTED|Washout Period (3 Weeks)||118
7572591|NCT02799784|18640253|P1|STARTED|Washout Period (3 Weeks)||111
7572592|NCT02799784|18640252|P2|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||1
7572593|NCT02799784|18640253|P1|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||6
7572594|NCT02799784|18640252|P2|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||118
7572595|NCT02799784|18640253|P1|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||111
7572596|NCT02799784|18640252|P2|STARTED|Treatment Period 1 (TP1- 8 Weeks)||119
7572597|NCT02799784|18640253|P1|STARTED|Treatment Period 1 (TP1- 8 Weeks)||117
7572598|NCT02799472|18640261|P2|NOT COMPLETED|Overall Study||5
7572599|NCT02799472|18640262|P1|NOT COMPLETED|Overall Study||4
7572600|NCT02799472|18640261|P2|COMPLETED|Overall Study||23
7572601|NCT02799472|18640262|P1|COMPLETED|Overall Study||7
7572602|NCT02799472|18640261|P2|STARTED|Overall Study||28
7572603|NCT02799472|18640262|P1|STARTED|Overall Study||11
7572604|NCT02799381|18640322|P2|NOT COMPLETED|Overall Study||3
7572605|NCT02799381|18640323|P1|NOT COMPLETED|Overall Study||4
7572606|NCT02799381|18640322|P2|COMPLETED|Overall Study||25
7572607|NCT02799381|18640323|P1|COMPLETED|Overall Study||29
7572608|NCT02799381|18640322|P2|STARTED|Overall Study||28
7572609|NCT02799381|18640323|P1|STARTED|Overall Study||33
7572610|NCT02799082|18640343|P2|NOT COMPLETED|Overall Study||4
7572611|NCT02799082|18640344|P1|NOT COMPLETED|Overall Study||4
7572612|NCT02799082|18640343|P2|COMPLETED|Overall Study||77
7572613|NCT02799082|18640344|P1|COMPLETED|Overall Study||37
7572614|NCT02799082|18640343|P2|STARTED|Overall Study||81
7572615|NCT02799082|18640344|P1|STARTED|Overall Study||41
7572616|NCT02799069|18640381|P3|NOT COMPLETED|Overall Study||7
7572617|NCT02799069|18640382|P2|NOT COMPLETED|Overall Study||7
7572618|NCT02799069|18640383|P1|NOT COMPLETED|Overall Study||8
7572619|NCT02799069|18640381|P3|COMPLETED|Overall Study||240
7572620|NCT02799069|18640382|P2|COMPLETED|Overall Study||241
7572621|NCT02799069|18640383|P1|COMPLETED|Overall Study||68
7572622|NCT02799069|18640381|P3|ITT/Safety|Overall Study|1 subject received medication without Illumination and thus was excluded from ITT/safety population|246
7572623|NCT02799069|18640382|P2|ITT/Safety|Overall Study||248
7572624|NCT02799069|18640383|P1|ITT/Safety|Overall Study||76
7572625|NCT02799069|18640381|P3|STARTED|Overall Study||247
7572626|NCT02799069|18640382|P2|STARTED|Overall Study||248
7572627|NCT02799069|18640383|P1|STARTED|Overall Study||76
7572628|NCT02798978|18640500|P7|NOT COMPLETED|Part 2 (45 Days)||0
7572629|NCT02798978|18640501|P6|NOT COMPLETED|Part 2 (45 Days)||0
7572630|NCT02798978|18640502|P5|NOT COMPLETED|Part 2 (45 Days)||0
7572631|NCT02798978|18640503|P4|NOT COMPLETED|Part 2 (45 Days)||0
7572632|NCT02798978|18640504|P3|NOT COMPLETED|Part 2 (45 Days)||0
7572633|NCT02798978|18640505|P2|NOT COMPLETED|Part 2 (45 Days)||0
7572634|NCT02798978|18640506|P1|NOT COMPLETED|Part 2 (45 Days)||0
7572635|NCT02798978|18640500|P7|COMPLETED|Part 2 (45 Days)||0
7572636|NCT02798978|18640501|P6|COMPLETED|Part 2 (45 Days)||0
7572637|NCT02798978|18640502|P5|COMPLETED|Part 2 (45 Days)||0
7572638|NCT02798978|18640503|P4|COMPLETED|Part 2 (45 Days)||0
7572639|NCT02798978|18640504|P3|COMPLETED|Part 2 (45 Days)||0
7572640|NCT02798978|18640505|P2|COMPLETED|Part 2 (45 Days)||0
7572641|NCT02798978|18640506|P1|COMPLETED|Part 2 (45 Days)||0
7572642|NCT02798978|18640500|P7|STARTED|Part 2 (45 Days)||0
7572643|NCT02798978|18640501|P6|STARTED|Part 2 (45 Days)||0
7572644|NCT02798978|18640502|P5|STARTED|Part 2 (45 Days)||0
7572645|NCT02798978|18640503|P4|STARTED|Part 2 (45 Days)||0
7572646|NCT02798978|18640504|P3|STARTED|Part 2 (45 Days)||0
7572647|NCT02798978|18640505|P2|STARTED|Part 2 (45 Days)||0
7572648|NCT02798978|18640506|P1|STARTED|Part 2 (45 Days)||0
7572649|NCT02798978|18640500|P7|NOT COMPLETED|Part 1 (30 Days)||0
7572650|NCT02798978|18640501|P6|NOT COMPLETED|Part 1 (30 Days)||0
7572651|NCT02798978|18640502|P5|NOT COMPLETED|Part 1 (30 Days)||0
7572652|NCT02798978|18640503|P4|NOT COMPLETED|Part 1 (30 Days)||0
7572653|NCT02798978|18640504|P3|NOT COMPLETED|Part 1 (30 Days)||0
7572654|NCT02798978|18640505|P2|NOT COMPLETED|Part 1 (30 Days)||0
7572655|NCT02798978|18640506|P1|NOT COMPLETED|Part 1 (30 Days)||0
7572656|NCT02798978|18640500|P7|COMPLETED|Part 1 (30 Days)||0
7572657|NCT02798978|18640501|P6|COMPLETED|Part 1 (30 Days)||6
7572658|NCT02798978|18640502|P5|COMPLETED|Part 1 (30 Days)||6
7572659|NCT02798978|18640503|P4|COMPLETED|Part 1 (30 Days)||6
7572660|NCT02798978|18640504|P3|COMPLETED|Part 1 (30 Days)||6
7572661|NCT02798978|18640505|P2|COMPLETED|Part 1 (30 Days)||6
7572662|NCT02798978|18640506|P1|COMPLETED|Part 1 (30 Days)||10
7572663|NCT02798978|18640500|P7|STARTED|Part 1 (30 Days)||0
7572664|NCT02798978|18640501|P6|STARTED|Part 1 (30 Days)||6
7572665|NCT02798978|18640502|P5|STARTED|Part 1 (30 Days)||6
7572666|NCT02798978|18640503|P4|STARTED|Part 1 (30 Days)||6
7572667|NCT02798978|18640504|P3|STARTED|Part 1 (30 Days)||6
7572668|NCT02798978|18640505|P2|STARTED|Part 1 (30 Days)||6
7572669|NCT02798978|18640506|P1|STARTED|Part 1 (30 Days)||10
7572670|NCT02798952|18640709|P1|NOT COMPLETED|Overall Study||0
7572671|NCT02798952|18640709|P1|COMPLETED|Overall Study||302
7572672|NCT02798952|18640709|P1|STARTED|Overall Study||302
7572673|NCT02798861|18640721|P1|NOT COMPLETED|Overall Study||23
7572674|NCT02798861|18640721|P1|COMPLETED|Overall Study||137
7572675|NCT02798861|18640721|P1|STARTED|Overall Study||160
7572676|NCT02798835|18640729|P3|NOT COMPLETED|Overall Study||3
7572677|NCT02798835|18640730|P2|NOT COMPLETED|Overall Study||0
7572678|NCT02798835|18640731|P1|NOT COMPLETED|Overall Study||0
7572679|NCT02798835|18640729|P3|COMPLETED|Overall Study||57
7572680|NCT02798835|18640730|P2|COMPLETED|Overall Study||60
7572681|NCT02798835|18640731|P1|COMPLETED|Overall Study||60
7572682|NCT02798835|18640729|P3|STARTED|Overall Study||60
7572683|NCT02798835|18640730|P2|STARTED|Overall Study||60
7572684|NCT02798835|18640731|P1|STARTED|Overall Study||60
7572685|NCT02798380|18640766|P1|NOT COMPLETED|Overall Study||0
7572686|NCT02798380|18640766|P1|COMPLETED|Overall Study||30
7572687|NCT02798380|18640766|P1|STARTED|Overall Study||30
7572688|NCT02798354|18640773|P3|NOT COMPLETED|Third Intervention Period||0
7572689|NCT02798354|18640774|P2|NOT COMPLETED|Third Intervention Period||0
7572690|NCT02798354|18640775|P1|NOT COMPLETED|Third Intervention Period||0
7572691|NCT02798354|18640773|P3|COMPLETED|Third Intervention Period||2715
7572692|NCT02798354|18640774|P2|COMPLETED|Third Intervention Period||1010
7572693|NCT02798354|18640775|P1|COMPLETED|Third Intervention Period||746
7572694|NCT02798354|18640773|P3|Intervention Data Error 3|Third Intervention Period||1248
7572695|NCT02798354|18640774|P2|Intervention Data Error 3|Third Intervention Period||390
7572696|NCT02798354|18640775|P1|Intervention Data Error 3|Third Intervention Period||327
7572697|NCT02798354|18640773|P3|Control Data Error 3|Third Intervention Period||1467
7572698|NCT02798354|18640774|P2|Control Data Error 3|Third Intervention Period||620
7572699|NCT02798354|18640775|P1|Control Data Error 3|Third Intervention Period||419
7572700|NCT02798354|18640773|P3|STARTED|Third Intervention Period||2715
7572701|NCT02798354|18640774|P2|STARTED|Third Intervention Period||1010
7572702|NCT02798354|18640775|P1|STARTED|Third Intervention Period||746
7572703|NCT02798354|18640773|P3|NOT COMPLETED|Second Intervention Period||0
7572704|NCT02798354|18640774|P2|NOT COMPLETED|Second Intervention Period||0
7572705|NCT02798354|18640775|P1|NOT COMPLETED|Second Intervention Period||0
7572706|NCT02798354|18640773|P3|COMPLETED|Second Intervention Period||1368
7572707|NCT02798354|18640774|P2|COMPLETED|Second Intervention Period||1047
7572708|NCT02798354|18640775|P1|COMPLETED|Second Intervention Period||2617
7572709|NCT02798354|18640773|P3|Intervention Data Error 2|Second Intervention Period||700
7572710|NCT02798354|18640774|P2|Intervention Data Error 2|Second Intervention Period||454
7572711|NCT02798354|18640775|P1|Intervention Data Error 2|Second Intervention Period||1239
7572712|NCT02798354|18640773|P3|Control Data Error 2|Second Intervention Period||668
7572713|NCT02798354|18640774|P2|Control Data Error 2|Second Intervention Period||593
7572714|NCT02798354|18640775|P1|Control Data Error 2|Second Intervention Period||1378
7572715|NCT02798354|18640773|P3|STARTED|Second Intervention Period||1368
7572716|NCT02798354|18640774|P2|STARTED|Second Intervention Period||1047
7572717|NCT02798354|18640775|P1|STARTED|Second Intervention Period||2617
7572718|NCT02798354|18640773|P3|NOT COMPLETED|First Intervention Period||0
7572719|NCT02798354|18640774|P2|NOT COMPLETED|First Intervention Period||0
7572720|NCT02798354|18640775|P1|NOT COMPLETED|First Intervention Period||0
7572721|NCT02798354|18640773|P3|COMPLETED|First Intervention Period||990
7572722|NCT02798354|18640774|P2|COMPLETED|First Intervention Period||2176
7572723|NCT02798354|18640775|P1|COMPLETED|First Intervention Period||1184
7572724|NCT02798354|18640773|P3|Intervention Data Error 1|First Intervention Period||645
7572725|NCT02798354|18640774|P2|Intervention Data Error 1|First Intervention Period||1627
7572726|NCT02798354|18640775|P1|Intervention Data Error 1|First Intervention Period||744
7572727|NCT02798354|18640773|P3|Control Data Error 1|First Intervention Period||345
7572728|NCT02798354|18640774|P2|Control Data Error 1|First Intervention Period||549
7572729|NCT02798354|18640775|P1|Control Data Error 1|First Intervention Period||440
7572730|NCT02798354|18640773|P3|STARTED|First Intervention Period||990
7572731|NCT02798354|18640774|P2|STARTED|First Intervention Period||2176
7572732|NCT02798354|18640775|P1|STARTED|First Intervention Period||1184
7572733|NCT02798315|18640797|P1|NOT COMPLETED|Overall Study||1
7572734|NCT02798315|18640797|P1|COMPLETED|Overall Study||39
7572735|NCT02798315|18640797|P1|STARTED|Overall Study||40
7572736|NCT02798289|18640811|P1|NOT COMPLETED|Overall Study||0
7572737|NCT02798289|18640811|P1|COMPLETED|Overall Study||55
7572738|NCT02798289|18640811|P1|STARTED|Overall Study||55
7572739|NCT02797821|18640818|P3|NOT COMPLETED|Overall Study||0
7572740|NCT02797821|18640819|P2|NOT COMPLETED|Overall Study||0
7572741|NCT02797821|18640820|P1|NOT COMPLETED|Overall Study||0
7572742|NCT02797821|18640818|P3|COMPLETED|Overall Study||9
7572743|NCT02797821|18640819|P2|COMPLETED|Overall Study||10
7572744|NCT02797821|18640820|P1|COMPLETED|Overall Study||8
7572745|NCT02797821|18640818|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
7572746|NCT02797821|18640819|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
7572747|NCT02797821|18640820|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
7572748|NCT02797821|18640818|P3|STARTED|Overall Study||9
7572749|NCT02797821|18640819|P2|STARTED|Overall Study||10
7572750|NCT02797821|18640820|P1|STARTED|Overall Study||8
7572751|NCT02797678|18640831|P4|NOT COMPLETED|Sub-Study||0
7572752|NCT02797678|18640832|P3|NOT COMPLETED|Sub-Study||0
7572753|NCT02797678|18640833|P2|NOT COMPLETED|Sub-Study||0
7572754|NCT02797678|18640834|P1|NOT COMPLETED|Sub-Study||0
7572755|NCT02797678|18640831|P4|COMPLETED|Sub-Study||9
7572756|NCT02797678|18640832|P3|COMPLETED|Sub-Study||0
7572757|NCT02797678|18640833|P2|COMPLETED|Sub-Study||0
7572758|NCT02797678|18640834|P1|COMPLETED|Sub-Study||0
7572759|NCT02797678|18640831|P4|STARTED|Sub-Study||9
7572760|NCT02797678|18640832|P3|STARTED|Sub-Study||0
7572761|NCT02797678|18640833|P2|STARTED|Sub-Study||0
7572762|NCT02797678|18640834|P1|STARTED|Sub-Study||0
7572763|NCT02797678|18640831|P4|NOT COMPLETED|Second Intervention (5 Nights)||0
7572764|NCT02797678|18640832|P3|NOT COMPLETED|Second Intervention (5 Nights)||1
7572765|NCT02797678|18640833|P2|NOT COMPLETED|Second Intervention (5 Nights)||0
7572766|NCT02797678|18640834|P1|NOT COMPLETED|Second Intervention (5 Nights)||0
7572767|NCT02797678|18640831|P4|COMPLETED|Second Intervention (5 Nights)||0
7572768|NCT02797678|18640832|P3|COMPLETED|Second Intervention (5 Nights)||16
7572769|NCT02797678|18640833|P2|COMPLETED|Second Intervention (5 Nights)||19
7572770|NCT02797678|18640834|P1|COMPLETED|Second Intervention (5 Nights)||0
7572771|NCT02797678|18640831|P4|STARTED|Second Intervention (5 Nights)||0
7572772|NCT02797678|18640832|P3|STARTED|Second Intervention (5 Nights)||17
7572773|NCT02797678|18640833|P2|STARTED|Second Intervention (5 Nights)||19
7572774|NCT02797678|18640834|P1|STARTED|Second Intervention (5 Nights)||0
7572775|NCT02797678|18640831|P4|NOT COMPLETED|Washout||0
7572776|NCT02797678|18640832|P3|NOT COMPLETED|Washout||0
7572777|NCT02797678|18640833|P2|NOT COMPLETED|Washout||0
7572778|NCT02797678|18640834|P1|NOT COMPLETED|Washout||0
7572779|NCT02797678|18640831|P4|COMPLETED|Washout||0
7572780|NCT02797678|18640832|P3|COMPLETED|Washout||17
7572781|NCT02797678|18640833|P2|COMPLETED|Washout||19
7572782|NCT02797678|18640834|P1|COMPLETED|Washout||0
7572783|NCT02797678|18640831|P4|STARTED|Washout||0
7572784|NCT02797678|18640832|P3|STARTED|Washout||17
7572785|NCT02797678|18640833|P2|STARTED|Washout||19
7572786|NCT02797678|18640834|P1|STARTED|Washout||0
7572787|NCT02797678|18640831|P4|NOT COMPLETED|First Intervention (5 Nights)||0
7572788|NCT02797678|18640832|P3|NOT COMPLETED|First Intervention (5 Nights)||0
7572789|NCT02797678|18640833|P2|NOT COMPLETED|First Intervention (5 Nights)||1
7572790|NCT02797678|18640834|P1|NOT COMPLETED|First Intervention (5 Nights)||0
7572791|NCT02797678|18640831|P4|COMPLETED|First Intervention (5 Nights)||0
7572792|NCT02797678|18640832|P3|COMPLETED|First Intervention (5 Nights)||17
7572793|NCT02797678|18640833|P2|COMPLETED|First Intervention (5 Nights)||19
7572794|NCT02797678|18640834|P1|COMPLETED|First Intervention (5 Nights)||0
7572795|NCT02797678|18640831|P4|STARTED|First Intervention (5 Nights)||0
7572796|NCT02797678|18640832|P3|STARTED|First Intervention (5 Nights)||17
7572797|NCT02797678|18640833|P2|STARTED|First Intervention (5 Nights)||20
7572798|NCT02797678|18640834|P1|STARTED|First Intervention (5 Nights)||0
7572799|NCT02797678|18640831|P4|NOT COMPLETED|Screening Phase||0
7572800|NCT02797678|18640832|P3|NOT COMPLETED|Screening Phase||0
7572801|NCT02797678|18640833|P2|NOT COMPLETED|Screening Phase||0
7572802|NCT02797678|18640834|P1|NOT COMPLETED|Screening Phase||25
7572803|NCT02797678|18640831|P4|COMPLETED|Screening Phase||0
7572804|NCT02797678|18640832|P3|COMPLETED|Screening Phase||0
7572805|NCT02797678|18640833|P2|COMPLETED|Screening Phase||0
7572806|NCT02797678|18640834|P1|COMPLETED|Screening Phase||37
7572807|NCT02797678|18640831|P4|STARTED|Screening Phase||0
7572808|NCT02797678|18640832|P3|STARTED|Screening Phase||0
7572809|NCT02797678|18640833|P2|STARTED|Screening Phase||0
7572810|NCT02797678|18640834|P1|STARTED|Screening Phase||62
7572811|NCT02797613|18640851|P2|NOT COMPLETED|Overall Study||0
7572812|NCT02797613|18640852|P1|NOT COMPLETED|Overall Study||0
7572813|NCT02797613|18640851|P2|COMPLETED|Overall Study||55
7572814|NCT02797613|18640852|P1|COMPLETED|Overall Study||55
7572815|NCT02797613|18640851|P2|STARTED|Overall Study||55
7572816|NCT02797613|18640852|P1|STARTED|Overall Study||55
7572817|NCT02797522|18640869|P11|NOT COMPLETED|Overall Study||1
7572818|NCT02797522|18640870|P10|NOT COMPLETED|Overall Study||4
7572819|NCT02797522|18640871|P9|NOT COMPLETED|Overall Study||2
7572820|NCT02797522|18640872|P8|NOT COMPLETED|Overall Study||4
7572821|NCT02797522|18640873|P7|NOT COMPLETED|Overall Study||0
7572822|NCT02797522|18640874|P6|NOT COMPLETED|Overall Study||0
7572823|NCT02797522|18640875|P5|NOT COMPLETED|Overall Study||0
7572824|NCT02797522|18640876|P4|NOT COMPLETED|Overall Study||0
7572825|NCT02797522|18640877|P3|NOT COMPLETED|Overall Study||0
7572826|NCT02797522|18640878|P2|NOT COMPLETED|Overall Study||0
7572827|NCT02797522|18640879|P1|NOT COMPLETED|Overall Study||0
7572828|NCT02797522|18640869|P11|COMPLETED|Overall Study||0
7572829|NCT02797522|18640870|P10|COMPLETED|Overall Study||0
7572830|NCT02797522|18640871|P9|COMPLETED|Overall Study||0
7572831|NCT02797522|18640872|P8|COMPLETED|Overall Study||0
7572832|NCT02797522|18640873|P7|COMPLETED|Overall Study||12
7572833|NCT02797522|18640874|P6|COMPLETED|Overall Study||4
7572834|NCT02797522|18640875|P5|COMPLETED|Overall Study||4
7572835|NCT02797522|18640876|P4|COMPLETED|Overall Study||4
7572836|NCT02797522|18640877|P3|COMPLETED|Overall Study||4
7572837|NCT02797522|18640878|P2|COMPLETED|Overall Study||4
7572838|NCT02797522|18640879|P1|COMPLETED|Overall Study||4
7572839|NCT02797522|18640869|P11|STARTED|Overall Study||1
7572840|NCT02797522|18640870|P10|STARTED|Overall Study||4
7572841|NCT02797522|18640871|P9|STARTED|Overall Study||2
7572842|NCT02797522|18640872|P8|STARTED|Overall Study||4
7572843|NCT02797522|18640873|P7|STARTED|Overall Study||12
7572844|NCT02797522|18640874|P6|STARTED|Overall Study||4
7572845|NCT02797522|18640875|P5|STARTED|Overall Study||4
7572846|NCT02797522|18640876|P4|STARTED|Overall Study||4
7572847|NCT02797522|18640877|P3|STARTED|Overall Study||4
7572848|NCT02797522|18640878|P2|STARTED|Overall Study||4
7572849|NCT02797522|18640879|P1|STARTED|Overall Study||4
7572850|NCT02797132|18640985|P1|NOT COMPLETED|Part B (24 Weeks)||3
7572851|NCT02797132|18640985|P1|COMPLETED|Part B (24 Weeks)||57
7572852|NCT02797132|18640985|P1|Part B (>=14 kg Weight)|Part B (24 Weeks)||41
7572853|NCT02797132|18640985|P1|Part B (<14 kg Weight)|Part B (24 Weeks)||19
7572854|NCT02797132|18640985|P1|STARTED|Part B (24 Weeks)|Participants from Part A may have participated in Part B.|60
7572855|NCT02797132|18640985|P1|NOT COMPLETED|Part A (15 Days)||1
7572856|NCT02797132|18640985|P1|COMPLETED|Part A (15 Days)||11
7572857|NCT02797132|18640985|P1|Part A (>=14 kg Weight)|Part A (15 Days)||8
7572858|NCT02797132|18640985|P1|Part A (<14 kg Weight)|Part A (15 Days)||4
7572859|NCT02797132|18640985|P1|STARTED|Part A (15 Days)||12
7572860|NCT02797080|18641037|P1|NOT COMPLETED|Overall Study||2
7572861|NCT02797080|18641037|P1|COMPLETED|Overall Study||36
7572862|NCT02797080|18641037|P1|STARTED|Overall Study||38
7572863|NCT02797054|18641044|P3|NOT COMPLETED|Follow-up||285
7572864|NCT02797054|18641045|P2|NOT COMPLETED|Follow-up||228
7572865|NCT02797054|18641046|P1|NOT COMPLETED|Follow-up||209
7572866|NCT02797054|18641044|P3|COMPLETED|Follow-up||150
7572867|NCT02797054|18641045|P2|COMPLETED|Follow-up||155
7572868|NCT02797054|18641046|P1|COMPLETED|Follow-up||178
7572869|NCT02797054|18641044|P3|STARTED|Follow-up||435
7572870|NCT02797054|18641045|P2|STARTED|Follow-up||383
7572871|NCT02797054|18641046|P1|STARTED|Follow-up||387
7572872|NCT02797054|18641044|P3|NOT COMPLETED|Post-test||348
7572873|NCT02797054|18641045|P2|NOT COMPLETED|Post-test||11
7572874|NCT02797054|18641046|P1|NOT COMPLETED|Post-test||7
7572875|NCT02797054|18641044|P3|COMPLETED|Post-test||87
7572876|NCT02797054|18641045|P2|COMPLETED|Post-test||372
7572877|NCT02797054|18641046|P1|COMPLETED|Post-test||380
7572878|NCT02797054|18641044|P3|STARTED|Post-test||435
7572879|NCT02797054|18641045|P2|STARTED|Post-test||383
7572880|NCT02797054|18641046|P1|STARTED|Post-test||387
7572881|NCT02796963|18641079|P4|NOT COMPLETED|Overall Study||72
7572882|NCT02796963|18641080|P3|NOT COMPLETED|Overall Study||69
7572883|NCT02796963|18641081|P2|NOT COMPLETED|Overall Study||76
7572884|NCT02796963|18641082|P1|NOT COMPLETED|Overall Study||89
7572885|NCT02796963|18641079|P4|COMPLETED|Overall Study||282
7572886|NCT02796963|18641080|P3|COMPLETED|Overall Study||247
7572887|NCT02796963|18641081|P2|COMPLETED|Overall Study||252
7572888|NCT02796963|18641082|P1|COMPLETED|Overall Study||294
7572889|NCT02796963|18641079|P4|HIV Sero Converted|Overall Study||19
7572890|NCT02796963|18641080|P3|HIV Sero Converted|Overall Study||11
7572891|NCT02796963|18641081|P2|HIV Sero Converted|Overall Study||19
7572892|NCT02796963|18641082|P1|HIV Sero Converted|Overall Study||19
7572893|NCT02796963|18641079|P4|Fourth Follow up|Overall Study||263
7572894|NCT02796963|18641080|P3|Fourth Follow up|Overall Study||236
7572895|NCT02796963|18641081|P2|Fourth Follow up|Overall Study||233
7572896|NCT02796963|18641082|P1|Fourth Follow up|Overall Study||275
7572897|NCT02796963|18641079|P4|Third Follow up|Overall Study||286
7572898|NCT02796963|18641080|P3|Third Follow up|Overall Study||245
7572899|NCT02796963|18641081|P2|Third Follow up|Overall Study||237
7572900|NCT02796963|18641082|P1|Third Follow up|Overall Study||276
7572901|NCT02796963|18641079|P4|Second Follow up|Overall Study||293
7572902|NCT02796963|18641080|P3|Second Follow up|Overall Study||255
7572903|NCT02796963|18641081|P2|Second Follow up|Overall Study||260
7572904|NCT02796963|18641082|P1|Second Follow up|Overall Study||280
7572905|NCT02796963|18641079|P4|First Follow up|Overall Study||291
7572906|NCT02796963|18641080|P3|First Follow up|Overall Study||257
7572907|NCT02796963|18641081|P2|First Follow up|Overall Study||279
7572908|NCT02796963|18641082|P1|First Follow up|Overall Study||293
7572909|NCT02796963|18641079|P4|STARTED|Overall Study||354
7572910|NCT02796963|18641080|P3|STARTED|Overall Study||316
7572911|NCT02796963|18641081|P2|STARTED|Overall Study||328
7572912|NCT02796963|18641082|P1|STARTED|Overall Study||383
7572913|NCT02796924|18641144|P1|NOT COMPLETED|Overall Study||0
7572914|NCT02796924|18641144|P1|COMPLETED|Overall Study||10
7572915|NCT02796924|18641144|P1|STARTED|Overall Study||10
7572916|NCT02796677|18641152|P4|NOT COMPLETED|Overall Study||74
7572917|NCT02796677|18641153|P3|NOT COMPLETED|Overall Study||53
7572918|NCT02796677|18641154|P2|NOT COMPLETED|Overall Study||73
7572919|NCT02796677|18641155|P1|NOT COMPLETED|Overall Study||38
7572920|NCT02796677|18641152|P4|COMPLETED|Overall Study||405
7572921|NCT02796677|18641153|P3|COMPLETED|Overall Study||267
7572922|NCT02796677|18641154|P2|COMPLETED|Overall Study||405
7572923|NCT02796677|18641155|P1|COMPLETED|Overall Study||279
7572924|NCT02796677|18641152|P4|Completed Treatment and Follow-up|Overall Study||403
7572925|NCT02796677|18641153|P3|Completed Treatment and Follow-up|Overall Study||267
7572926|NCT02796677|18641154|P2|Completed Treatment and Follow-up|Overall Study||405
7572927|NCT02796677|18641155|P1|Completed Treatment and Follow-up|Overall Study||279
7572928|NCT02796677|18641152|P4|STARTED|Overall Study||479
7572929|NCT02796677|18641153|P3|STARTED|Overall Study||320
7572930|NCT02796677|18641154|P2|STARTED|Overall Study||478
7572931|NCT02796677|18641155|P1|STARTED|Overall Study||317
7572932|NCT02796651|18641179|P1|NOT COMPLETED|Overall Study||26
7572933|NCT02796651|18641179|P1|COMPLETED|Overall Study||106
7572934|NCT02796651|18641179|P1|Placebo (Lactose Monohydrate)|Overall Study||38
7572935|NCT02796651|18641179|P1|Perforomist 40 μg|Overall Study||108
7572936|NCT02796651|18641179|P1|Perforomist 20 μg|Overall Study||118
7572937|NCT02796651|18641179|P1|Formoterol Fumarate (FF) 24 μg|Overall Study||105
7572938|NCT02796651|18641179|P1|Formoterol Fumarate (FF) 12 μg|Overall Study||121
7572939|NCT02796651|18641179|P1|Formoterol Fumarate (FF) 6 μg|Overall Study||107
7572940|NCT02796651|18641179|P1|STARTED|Overall Study||132
7572941|NCT02796560|18641210|P2|NOT COMPLETED|Overall Study||2
7572942|NCT02796560|18641211|P1|NOT COMPLETED|Overall Study||4
7572943|NCT02796560|18641210|P2|COMPLETED|Overall Study||36
7572944|NCT02796560|18641211|P1|COMPLETED|Overall Study||34
7572945|NCT02796560|18641210|P2|STARTED|Overall Study||38
7572946|NCT02796560|18641211|P1|STARTED|Overall Study||38
7572947|NCT02796352|18641219|P1|NOT COMPLETED|Overall Study||0
7572948|NCT02796352|18641219|P1|COMPLETED|Overall Study||1
7572949|NCT02796352|18641219|P1|STARTED|Overall Study||1
7572950|NCT02796300|18641228|P2|NOT COMPLETED|Overall Study||0
7572951|NCT02796300|18641229|P1|NOT COMPLETED|Overall Study||0
7572952|NCT02796300|18641228|P2|COMPLETED|Overall Study||22
7572953|NCT02796300|18641229|P1|COMPLETED|Overall Study||10
7572954|NCT02796300|18641228|P2|STARTED|Overall Study||22
7572955|NCT02796300|18641229|P1|STARTED|Overall Study||10
7572956|NCT02796274|18641241|P1|NOT COMPLETED|Overall Study||0
7572957|NCT02796274|18641241|P1|COMPLETED|Overall Study||219
7572958|NCT02796274|18641241|P1|STARTED|Overall Study||219
7572959|NCT02796092|18641247|P2|NOT COMPLETED|Overall Study||0
7572960|NCT02796092|18641248|P1|NOT COMPLETED|Overall Study||0
7572961|NCT02796092|18641247|P2|COMPLETED|Overall Study||50
7572962|NCT02796092|18641248|P1|COMPLETED|Overall Study||50
7572963|NCT02796092|18641247|P2|STARTED|Overall Study||50
7572964|NCT02796092|18641248|P1|STARTED|Overall Study||50
7572965|NCT02795832|18641286|P6|NOT COMPLETED|Overall Study||3
7572966|NCT02795832|18641287|P5|NOT COMPLETED|Overall Study||0
7572967|NCT02795832|18641288|P4|NOT COMPLETED|Overall Study||0
7572968|NCT02795832|18641289|P3|NOT COMPLETED|Overall Study||0
7572969|NCT02795832|18641290|P2|NOT COMPLETED|Overall Study||0
7572970|NCT02795832|18641291|P1|NOT COMPLETED|Overall Study||0
7572971|NCT02795832|18641286|P6|COMPLETED|Overall Study||7
7572972|NCT02795832|18641287|P5|COMPLETED|Overall Study||20
7572973|NCT02795832|18641288|P4|COMPLETED|Overall Study||3
7572974|NCT02795832|18641289|P3|COMPLETED|Overall Study||8
7572975|NCT02795832|18641290|P2|COMPLETED|Overall Study||4
7572976|NCT02795832|18641291|P1|COMPLETED|Overall Study||8
7572977|NCT02795832|18641286|P6|STARTED|Overall Study||10
7572978|NCT02795832|18641287|P5|STARTED|Overall Study||20
7572979|NCT02795832|18641288|P4|STARTED|Overall Study||3
7572980|NCT02795832|18641289|P3|STARTED|Overall Study||8
7572981|NCT02795832|18641290|P2|STARTED|Overall Study||4
7572982|NCT02795832|18641291|P1|STARTED|Overall Study||8
7572983|NCT02795819|18641325|P7|NOT COMPLETED|Overall Study||0
7572984|NCT02795819|18641326|P6|NOT COMPLETED|Overall Study||0
7572985|NCT02795819|18641327|P5|NOT COMPLETED|Overall Study||0
7572986|NCT02795819|18641328|P4|NOT COMPLETED|Overall Study||0
7572987|NCT02795819|18641329|P3|NOT COMPLETED|Overall Study||0
7572988|NCT02795819|18641330|P2|NOT COMPLETED|Overall Study||0
7572989|NCT02795819|18641331|P1|NOT COMPLETED|Overall Study||0
7572990|NCT02795819|18641325|P7|COMPLETED|Overall Study||0
7572991|NCT02795819|18641326|P6|COMPLETED|Overall Study||0
7572992|NCT02795819|18641327|P5|COMPLETED|Overall Study||0
7572993|NCT02795819|18641328|P4|COMPLETED|Overall Study||0
7572994|NCT02795819|18641329|P3|COMPLETED|Overall Study||0
7572995|NCT02795819|18641330|P2|COMPLETED|Overall Study||6
7572996|NCT02795819|18641331|P1|COMPLETED|Overall Study||0
7572997|NCT02795819|18641325|P7|STARTED|Overall Study||0
7572998|NCT02795819|18641326|P6|STARTED|Overall Study||0
7572999|NCT02795819|18641327|P5|STARTED|Overall Study||0
7573000|NCT02795819|18641328|P4|STARTED|Overall Study||0
7573001|NCT02795819|18641329|P3|STARTED|Overall Study||0
7573002|NCT02795819|18641330|P2|STARTED|Overall Study||6
7573003|NCT02795819|18641331|P1|STARTED|Overall Study||0
7573004|NCT02795780|18641357|P2|NOT COMPLETED|Overall Study||0
7573005|NCT02795780|18641358|P1|NOT COMPLETED|Overall Study||0
7573006|NCT02795780|18641357|P2|COMPLETED|Overall Study||54
7573007|NCT02795780|18641358|P1|COMPLETED|Overall Study||25
7573008|NCT02795780|18641357|P2|STARTED|Overall Study||54
7573009|NCT02795780|18641358|P1|STARTED|Overall Study||25
7573010|NCT02795767|18641369|P3|NOT COMPLETED|Overall Study||10
7573011|NCT02795767|18641370|P2|NOT COMPLETED|Overall Study||10
7573012|NCT02795767|18641371|P1|NOT COMPLETED|Overall Study||68
7573013|NCT02795767|18641369|P3|COMPLETED|Overall Study||0
7573014|NCT02795767|18641370|P2|COMPLETED|Overall Study||0
7573015|NCT02795767|18641371|P1|COMPLETED|Overall Study||0
7573016|NCT02795767|18641369|P3|Discontinued From Study Treatment|Overall Study||1
7573017|NCT02795767|18641370|P2|Discontinued From Study Treatment|Overall Study||0
7573018|NCT02795767|18641371|P1|Discontinued From Study Treatment|Overall Study||2
7573019|NCT02795767|18641369|P3|Completed 52 Weeks in Study|Overall Study||0
7573020|NCT02795767|18641370|P2|Completed 52 Weeks in Study|Overall Study||0
7573021|NCT02795767|18641371|P1|Completed 52 Weeks in Study|Overall Study||59
7573022|NCT02795767|18641369|P3|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
7573023|NCT02795767|18641370|P2|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
7573024|NCT02795767|18641371|P1|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
7573025|NCT02795767|18641369|P3|STARTED|Overall Study||10
7573026|NCT02795767|18641370|P2|STARTED|Overall Study||10
7573027|NCT02795767|18641371|P1|STARTED|Overall Study||68
7573028|NCT02794974|18641492|P2|NOT COMPLETED|Overall Study||1
7573029|NCT02794974|18641493|P1|NOT COMPLETED|Overall Study||0
7573030|NCT02794974|18641492|P2|COMPLETED|Overall Study||14
7573031|NCT02794974|18641493|P1|COMPLETED|Overall Study||14
7573032|NCT02794974|18641492|P2|STARTED|Overall Study||15
7573033|NCT02794974|18641493|P1|STARTED|Overall Study||14
7573034|NCT02794870|18641509|P2|NOT COMPLETED|Overall Study||0
7573035|NCT02794870|18641510|P1|NOT COMPLETED|Overall Study||2
7573036|NCT02794870|18641509|P2|COMPLETED|Overall Study||11
7573037|NCT02794870|18641510|P1|COMPLETED|Overall Study||20
7573038|NCT02794870|18641509|P2|Received Inoculation|Overall Study||11
7573039|NCT02794870|18641510|P1|Received Inoculation|Overall Study||21
7573040|NCT02794870|18641509|P2|STARTED|Overall Study||11
7573041|NCT02794870|18641510|P1|STARTED|Overall Study||22
7573042|NCT02794844|18641536|P1|NOT COMPLETED|Overall Study||5
7573043|NCT02794844|18641536|P1|COMPLETED|Overall Study||23
7573044|NCT02794844|18641536|P1|STARTED|Overall Study||28
7573045|NCT02794766|18641547|P3|NOT COMPLETED|Overall Study||1
7573046|NCT02794766|18641548|P2|NOT COMPLETED|Overall Study||0
7573047|NCT02794766|18641549|P1|NOT COMPLETED|Overall Study||0
7573048|NCT02794766|18641547|P3|COMPLETED|Overall Study||14
7573049|NCT02794766|18641548|P2|COMPLETED|Overall Study||15
7573050|NCT02794766|18641549|P1|COMPLETED|Overall Study||15
7573051|NCT02794766|18641547|P3|STARTED|Overall Study||15
7573052|NCT02794766|18641548|P2|STARTED|Overall Study||15
7573053|NCT02794766|18641549|P1|STARTED|Overall Study||15
7573054|NCT02794727|18641569|P3|NOT COMPLETED|Overall Study||1
7573055|NCT02794727|18641570|P2|NOT COMPLETED|Overall Study||0
7573056|NCT02794727|18641571|P1|NOT COMPLETED|Overall Study||0
7573057|NCT02794727|18641569|P3|COMPLETED|Overall Study||44
7573058|NCT02794727|18641570|P2|COMPLETED|Overall Study||46
7573059|NCT02794727|18641571|P1|COMPLETED|Overall Study||44
7573060|NCT02794727|18641569|P3|STARTED|Overall Study||45
7573061|NCT02794727|18641570|P2|STARTED|Overall Study||46
7573062|NCT02794727|18641571|P1|STARTED|Overall Study||44
7573063|NCT02794597|18641580|P2|NOT COMPLETED|Overall Study||0
7573064|NCT02794597|18641581|P1|NOT COMPLETED|Overall Study||0
7573065|NCT02794597|18641580|P2|COMPLETED|Overall Study||56
7573066|NCT02794597|18641581|P1|COMPLETED|Overall Study||63
7573067|NCT02794597|18641580|P2|STARTED|Overall Study||56
7573068|NCT02794597|18641581|P1|STARTED|Overall Study||63
7573069|NCT02794480|18641607|P4|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
7573070|NCT02794480|18641608|P3|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
7573071|NCT02794480|18641609|P2|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
7573072|NCT02794480|18641610|P1|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
7573073|NCT02794480|18641607|P4|COMPLETED|Period 2: Treatment Period 2 (28 Days)||77
7573074|NCT02794480|18641608|P3|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
7573075|NCT02794480|18641609|P2|COMPLETED|Period 2: Treatment Period 2 (28 Days)||80
7573076|NCT02794480|18641610|P1|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
7573077|NCT02794480|18641607|P4|STARTED|Period 2: Treatment Period 2 (28 Days)||78
7573078|NCT02794480|18641608|P3|STARTED|Period 2: Treatment Period 2 (28 Days)||79
7573079|NCT02794480|18641609|P2|STARTED|Period 2: Treatment Period 2 (28 Days)||80
7573080|NCT02794480|18641610|P1|STARTED|Period 2: Treatment Period 2 (28 Days)||80
7573081|NCT02794480|18641607|P4|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||3
7573082|NCT02794480|18641608|P3|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
7573083|NCT02794480|18641609|P2|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
7573084|NCT02794480|18641610|P1|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||0
7573085|NCT02794480|18641607|P4|COMPLETED|Period 1: Treatment Period 1 (28 Days)||78
7573086|NCT02794480|18641608|P3|COMPLETED|Period 1: Treatment Period 1 (28 Days)||79
7573087|NCT02794480|18641609|P2|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
7573088|NCT02794480|18641610|P1|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
7573089|NCT02794480|18641607|P4|STARTED|Period 1: Treatment Period 1 (28 Days)||81
7573090|NCT02794480|18641608|P3|STARTED|Period 1: Treatment Period 1 (28 Days)||81
7573091|NCT02794480|18641609|P2|STARTED|Period 1: Treatment Period 1 (28 Days)||82
7573092|NCT02794480|18641610|P1|STARTED|Period 1: Treatment Period 1 (28 Days)||80
7573093|NCT02794441|18641630|P2|NOT COMPLETED|Overall Study||0
7573094|NCT02794441|18641631|P1|NOT COMPLETED|Overall Study||1
7573095|NCT02794441|18641630|P2|COMPLETED|Overall Study||5
7573096|NCT02794441|18641631|P1|COMPLETED|Overall Study||6
7573097|NCT02794441|18641630|P2|STARTED|Overall Study||5
7573098|NCT02794441|18641631|P1|STARTED|Overall Study||7
7573099|NCT02794246|18641653|P1|NOT COMPLETED|Overall Study||6
7573100|NCT02794246|18641653|P1|COMPLETED|Overall Study||0
7573101|NCT02794246|18641653|P1|Treated|Overall Study||3
7573102|NCT02794246|18641653|P1|STARTED|Overall Study||6
7573103|NCT02794207|18641659|P2|NOT COMPLETED|Overall Study||0
7573104|NCT02794207|18641660|P1|NOT COMPLETED|Overall Study||0
7573105|NCT02794207|18641659|P2|COMPLETED|Overall Study||54
7573106|NCT02794207|18641660|P1|COMPLETED|Overall Study||32
7573107|NCT02794207|18641659|P2|STARTED|Overall Study||54
7573108|NCT02794207|18641660|P1|STARTED|Overall Study||32
7573109|NCT02794103|18641665|P1|NOT COMPLETED|Overall Study||3
7573110|NCT02794103|18641665|P1|COMPLETED|Overall Study||15
7573111|NCT02794103|18641665|P1|STARTED|Overall Study||18
7573112|NCT02793947|18641676|P2|NOT COMPLETED|Overall Study||5
7573113|NCT02793947|18641677|P1|NOT COMPLETED|Overall Study||2
7573114|NCT02793947|18641676|P2|COMPLETED|Overall Study||50
7573115|NCT02793947|18641677|P1|COMPLETED|Overall Study||45
7573116|NCT02793947|18641676|P2|STARTED|Overall Study||55
7573117|NCT02793947|18641677|P1|STARTED|Overall Study||47
7573118|NCT02793856|18641691|P4|NOT COMPLETED|Overall Study||0
7573119|NCT02793856|18641692|P3|NOT COMPLETED|Overall Study||0
7573120|NCT02793856|18641693|P2|NOT COMPLETED|Overall Study||0
7573121|NCT02793856|18641694|P1|NOT COMPLETED|Overall Study||0
7573122|NCT02793856|18641691|P4|COMPLETED|Overall Study||3
7573123|NCT02793856|18641692|P3|COMPLETED|Overall Study||3
7573124|NCT02793856|18641693|P2|COMPLETED|Overall Study||4
7573125|NCT02793856|18641694|P1|COMPLETED|Overall Study||2
7573126|NCT02793856|18641691|P4|STARTED|Overall Study||3
7573127|NCT02793856|18641692|P3|STARTED|Overall Study||3
7573128|NCT02793856|18641693|P2|STARTED|Overall Study||4
7573129|NCT02793856|18641694|P1|STARTED|Overall Study||2
7573130|NCT02793817|18641738|P2|NOT COMPLETED|Overall Study||5
7573131|NCT02793817|18641739|P1|NOT COMPLETED|Overall Study||3
7573132|NCT02793817|18641738|P2|COMPLETED|Overall Study||254
7573133|NCT02793817|18641739|P1|COMPLETED|Overall Study||258
7573134|NCT02793817|18641738|P2|STARTED|Overall Study||259
7573135|NCT02793817|18641739|P1|STARTED|Overall Study||261
7573136|NCT02793674|18641759|P2|NOT COMPLETED|Overall Study||0
7573137|NCT02793674|18641760|P1|NOT COMPLETED|Overall Study||0
7573138|NCT02793674|18641759|P2|COMPLETED|Overall Study||12
7573139|NCT02793674|18641760|P1|COMPLETED|Overall Study||9
7573140|NCT02793674|18641759|P2|STARTED|Overall Study||12
7573141|NCT02793674|18641760|P1|STARTED|Overall Study||9
7573142|NCT02793232|18641781|P9|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
7573143|NCT02793232|18641782|P8|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
7573144|NCT02793232|18641783|P7|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
7573145|NCT02793232|18641784|P6|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
7573146|NCT02793232|18641785|P5|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
7573147|NCT02793232|18641786|P4|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
7573148|NCT02793232|18641787|P3|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
7573149|NCT02793232|18641788|P2|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
7573150|NCT02793232|18641789|P1|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
7573151|NCT02793232|18641781|P9|COMPLETED|Period 4 (Part A: 5 Days)||0
7573152|NCT02793232|18641782|P8|COMPLETED|Period 4 (Part A: 5 Days)||0
7573153|NCT02793232|18641783|P7|COMPLETED|Period 4 (Part A: 5 Days)||0
7573154|NCT02793232|18641784|P6|COMPLETED|Period 4 (Part A: 5 Days)||0
7573155|NCT02793232|18641785|P5|COMPLETED|Period 4 (Part A: 5 Days)||0
7573156|NCT02793232|18641786|P4|COMPLETED|Period 4 (Part A: 5 Days)||2
7573157|NCT02793232|18641787|P3|COMPLETED|Period 4 (Part A: 5 Days)||2
7573158|NCT02793232|18641788|P2|COMPLETED|Period 4 (Part A: 5 Days)||2
7573159|NCT02793232|18641789|P1|COMPLETED|Period 4 (Part A: 5 Days)||2
7573160|NCT02793232|18641781|P9|STARTED|Period 4 (Part A: 5 Days)||0
7573161|NCT02793232|18641782|P8|STARTED|Period 4 (Part A: 5 Days)||0
7573162|NCT02793232|18641783|P7|STARTED|Period 4 (Part A: 5 Days)||0
7573163|NCT02793232|18641784|P6|STARTED|Period 4 (Part A: 5 Days)||0
7573164|NCT02793232|18641785|P5|STARTED|Period 4 (Part A: 5 Days)||0
7573165|NCT02793232|18641786|P4|STARTED|Period 4 (Part A: 5 Days)||2
7573166|NCT02793232|18641787|P3|STARTED|Period 4 (Part A: 5 Days)||2
7573167|NCT02793232|18641788|P2|STARTED|Period 4 (Part A: 5 Days)||2
7573168|NCT02793232|18641789|P1|STARTED|Period 4 (Part A: 5 Days)||2
7573169|NCT02793232|18641781|P9|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
7573170|NCT02793232|18641782|P8|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
7573171|NCT02793232|18641783|P7|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
7573172|NCT02793232|18641784|P6|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
7573173|NCT02793232|18641785|P5|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
7573174|NCT02793232|18641786|P4|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
7573175|NCT02793232|18641787|P3|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
7573176|NCT02793232|18641788|P2|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
7573177|NCT02793232|18641789|P1|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
7573178|NCT02793232|18641781|P9|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
7573179|NCT02793232|18641782|P8|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
7573180|NCT02793232|18641783|P7|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
7573181|NCT02793232|18641784|P6|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
7573182|NCT02793232|18641785|P5|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
7573183|NCT02793232|18641786|P4|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
7573184|NCT02793232|18641787|P3|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
7573185|NCT02793232|18641788|P2|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
7573186|NCT02793232|18641789|P1|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
7573187|NCT02793232|18641781|P9|STARTED|Washout Period 3(Part A:at Least 10days)||0
7573188|NCT02793232|18641782|P8|STARTED|Washout Period 3(Part A:at Least 10days)||0
7573189|NCT02793232|18641783|P7|STARTED|Washout Period 3(Part A:at Least 10days)||0
7573190|NCT02793232|18641784|P6|STARTED|Washout Period 3(Part A:at Least 10days)||0
7573191|NCT02793232|18641785|P5|STARTED|Washout Period 3(Part A:at Least 10days)||0
7573192|NCT02793232|18641786|P4|STARTED|Washout Period 3(Part A:at Least 10days)||2
7573193|NCT02793232|18641787|P3|STARTED|Washout Period 3(Part A:at Least 10days)||2
7573194|NCT02793232|18641788|P2|STARTED|Washout Period 3(Part A:at Least 10days)||2
7573195|NCT02793232|18641789|P1|STARTED|Washout Period 3(Part A:at Least 10days)||2
7573196|NCT02793232|18641781|P9|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
7573197|NCT02793232|18641782|P8|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
7573198|NCT02793232|18641783|P7|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
7573199|NCT02793232|18641784|P6|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
7573200|NCT02793232|18641785|P5|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
7573201|NCT02793232|18641786|P4|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
7573202|NCT02793232|18641787|P3|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
7573203|NCT02793232|18641788|P2|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
7573204|NCT02793232|18641789|P1|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
7573205|NCT02793232|18641781|P9|COMPLETED|Period 3 (Part A: 5 Days)||0
7573206|NCT02793232|18641782|P8|COMPLETED|Period 3 (Part A: 5 Days)||0
7573207|NCT02793232|18641783|P7|COMPLETED|Period 3 (Part A: 5 Days)||0
7573208|NCT02793232|18641784|P6|COMPLETED|Period 3 (Part A: 5 Days)||0
7573209|NCT02793232|18641785|P5|COMPLETED|Period 3 (Part A: 5 Days)||0
7573210|NCT02793232|18641786|P4|COMPLETED|Period 3 (Part A: 5 Days)||2
7573211|NCT02793232|18641787|P3|COMPLETED|Period 3 (Part A: 5 Days)||2
7573212|NCT02793232|18641788|P2|COMPLETED|Period 3 (Part A: 5 Days)||2
7573213|NCT02793232|18641789|P1|COMPLETED|Period 3 (Part A: 5 Days)||2
7573214|NCT02793232|18641781|P9|STARTED|Period 3 (Part A: 5 Days)||0
7573215|NCT02793232|18641782|P8|STARTED|Period 3 (Part A: 5 Days)||0
7573216|NCT02793232|18641783|P7|STARTED|Period 3 (Part A: 5 Days)||0
7573217|NCT02793232|18641784|P6|STARTED|Period 3 (Part A: 5 Days)||0
7573218|NCT02793232|18641785|P5|STARTED|Period 3 (Part A: 5 Days)||0
7573219|NCT02793232|18641786|P4|STARTED|Period 3 (Part A: 5 Days)||2
7573220|NCT02793232|18641787|P3|STARTED|Period 3 (Part A: 5 Days)||2
7573221|NCT02793232|18641788|P2|STARTED|Period 3 (Part A: 5 Days)||2
7573222|NCT02793232|18641789|P1|STARTED|Period 3 (Part A: 5 Days)||2
7573223|NCT02793232|18641781|P9|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
7573224|NCT02793232|18641782|P8|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
7573225|NCT02793232|18641783|P7|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
7573226|NCT02793232|18641784|P6|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
7573227|NCT02793232|18641785|P5|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
7573228|NCT02793232|18641786|P4|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
7573229|NCT02793232|18641787|P3|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
7573230|NCT02793232|18641788|P2|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
7573231|NCT02793232|18641789|P1|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
7573232|NCT02793232|18641781|P9|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
7573233|NCT02793232|18641782|P8|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
7573234|NCT02793232|18641783|P7|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
7573235|NCT02793232|18641784|P6|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
7573236|NCT02793232|18641785|P5|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
7573237|NCT02793232|18641786|P4|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
7573238|NCT02793232|18641787|P3|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
7573239|NCT02793232|18641788|P2|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
7573240|NCT02793232|18641789|P1|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
7573241|NCT02793232|18641781|P9|STARTED|Washout Period 2(Part A:at Least 10days)||0
7573242|NCT02793232|18641782|P8|STARTED|Washout Period 2(Part A:at Least 10days)||0
7573243|NCT02793232|18641783|P7|STARTED|Washout Period 2(Part A:at Least 10days)||0
7573244|NCT02793232|18641784|P6|STARTED|Washout Period 2(Part A:at Least 10days)||0
7573245|NCT02793232|18641785|P5|STARTED|Washout Period 2(Part A:at Least 10days)||0
7573246|NCT02793232|18641786|P4|STARTED|Washout Period 2(Part A:at Least 10days)||2
7573247|NCT02793232|18641787|P3|STARTED|Washout Period 2(Part A:at Least 10days)||2
7573248|NCT02793232|18641788|P2|STARTED|Washout Period 2(Part A:at Least 10days)||2
7573249|NCT02793232|18641789|P1|STARTED|Washout Period 2(Part A:at Least 10days)||2
7573250|NCT02793232|18641781|P9|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
7573251|NCT02793232|18641782|P8|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
7573252|NCT02793232|18641783|P7|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
7573253|NCT02793232|18641784|P6|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
7573254|NCT02793232|18641785|P5|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
7573255|NCT02793232|18641786|P4|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
7573256|NCT02793232|18641787|P3|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
7573257|NCT02793232|18641788|P2|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
7573258|NCT02793232|18641789|P1|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
7573259|NCT02793232|18641781|P9|COMPLETED|Period 2 (Part A: 5 Days)||0
7573260|NCT02793232|18641782|P8|COMPLETED|Period 2 (Part A: 5 Days)||0
7573261|NCT02793232|18641783|P7|COMPLETED|Period 2 (Part A: 5 Days)||0
7573262|NCT02793232|18641784|P6|COMPLETED|Period 2 (Part A: 5 Days)||0
7573263|NCT02793232|18641785|P5|COMPLETED|Period 2 (Part A: 5 Days)||0
7573264|NCT02793232|18641786|P4|COMPLETED|Period 2 (Part A: 5 Days)||2
7573265|NCT02793232|18641787|P3|COMPLETED|Period 2 (Part A: 5 Days)||2
7573266|NCT02793232|18641788|P2|COMPLETED|Period 2 (Part A: 5 Days)||2
7573267|NCT02793232|18641789|P1|COMPLETED|Period 2 (Part A: 5 Days)||2
7573268|NCT02793232|18641781|P9|STARTED|Period 2 (Part A: 5 Days)||0
7573269|NCT02793232|18641782|P8|STARTED|Period 2 (Part A: 5 Days)||0
7573270|NCT02793232|18641783|P7|STARTED|Period 2 (Part A: 5 Days)||0
7573271|NCT02793232|18641784|P6|STARTED|Period 2 (Part A: 5 Days)||0
7573272|NCT02793232|18641785|P5|STARTED|Period 2 (Part A: 5 Days)||0
7573273|NCT02793232|18641786|P4|STARTED|Period 2 (Part A: 5 Days)||2
7573274|NCT02793232|18641787|P3|STARTED|Period 2 (Part A: 5 Days)||2
7573275|NCT02793232|18641788|P2|STARTED|Period 2 (Part A: 5 Days)||2
7573276|NCT02793232|18641789|P1|STARTED|Period 2 (Part A: 5 Days)||2
7573277|NCT02793232|18641781|P9|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
7573278|NCT02793232|18641782|P8|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
7573279|NCT02793232|18641783|P7|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
7573280|NCT02793232|18641784|P6|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
7573281|NCT02793232|18641785|P5|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
7573282|NCT02793232|18641786|P4|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
7573283|NCT02793232|18641787|P3|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
7573284|NCT02793232|18641788|P2|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
7573285|NCT02793232|18641789|P1|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
7573286|NCT02793232|18641781|P9|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
7573287|NCT02793232|18641782|P8|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
7573288|NCT02793232|18641783|P7|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
7573289|NCT02793232|18641784|P6|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
7573290|NCT02793232|18641785|P5|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
7573291|NCT02793232|18641786|P4|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
7573292|NCT02793232|18641787|P3|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
7573293|NCT02793232|18641788|P2|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
7573294|NCT02793232|18641789|P1|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
7573295|NCT02793232|18641781|P9|STARTED|Washout Period 1(Part A:at Least 10days)||0
7573296|NCT02793232|18641782|P8|STARTED|Washout Period 1(Part A:at Least 10days)||0
7573297|NCT02793232|18641783|P7|STARTED|Washout Period 1(Part A:at Least 10days)||0
7573298|NCT02793232|18641784|P6|STARTED|Washout Period 1(Part A:at Least 10days)||0
7573299|NCT02793232|18641785|P5|STARTED|Washout Period 1(Part A:at Least 10days)||0
7573300|NCT02793232|18641786|P4|STARTED|Washout Period 1(Part A:at Least 10days)||2
7573301|NCT02793232|18641787|P3|STARTED|Washout Period 1(Part A:at Least 10days)||2
7573302|NCT02793232|18641788|P2|STARTED|Washout Period 1(Part A:at Least 10days)||2
7573303|NCT02793232|18641789|P1|STARTED|Washout Period 1(Part A:at Least 10days)||2
7573304|NCT02793232|18641781|P9|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
7573305|NCT02793232|18641782|P8|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
7573306|NCT02793232|18641783|P7|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
7573307|NCT02793232|18641784|P6|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
7573308|NCT02793232|18641785|P5|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
7573309|NCT02793232|18641786|P4|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
7573310|NCT02793232|18641787|P3|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
7573311|NCT02793232|18641788|P2|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
7573312|NCT02793232|18641789|P1|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
7573313|NCT02793232|18641781|P9|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
7573314|NCT02793232|18641782|P8|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
7573315|NCT02793232|18641783|P7|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
7573316|NCT02793232|18641784|P6|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||12
7573317|NCT02793232|18641785|P5|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||6
7573318|NCT02793232|18641786|P4|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
7573319|NCT02793232|18641787|P3|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
7573320|NCT02793232|18641788|P2|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
7573321|NCT02793232|18641789|P1|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
7573322|NCT02793232|18641781|P9|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||8
7573323|NCT02793232|18641782|P8|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
7573324|NCT02793232|18641783|P7|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||9
7573325|NCT02793232|18641784|P6|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||12
7573326|NCT02793232|18641785|P5|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||7
7573327|NCT02793232|18641786|P4|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
7573328|NCT02793232|18641787|P3|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
7573329|NCT02793232|18641788|P2|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
7573330|NCT02793232|18641789|P1|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
7573331|NCT02793154|18641974|P3|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
7573332|NCT02793154|18641975|P2|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
7573333|NCT02793154|18641976|P1|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
7573334|NCT02793154|18641974|P3|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
7573335|NCT02793154|18641975|P2|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
7573336|NCT02793154|18641976|P1|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
7573337|NCT02793154|18641974|P3|STARTED|Part B (Parallel Group-up to 84 Days)||0
7573338|NCT02793154|18641975|P2|STARTED|Part B (Parallel Group-up to 84 Days)||0
7573339|NCT02793154|18641976|P1|STARTED|Part B (Parallel Group-up to 84 Days)||0
7573340|NCT02793154|18641974|P3|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
7573341|NCT02793154|18641975|P2|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
7573342|NCT02793154|18641976|P1|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
7573343|NCT02793154|18641974|P3|COMPLETED|Part A (Single Group-up to 12 Days)||0
7573344|NCT02793154|18641975|P2|COMPLETED|Part A (Single Group-up to 12 Days)||0
7573345|NCT02793154|18641976|P1|COMPLETED|Part A (Single Group-up to 12 Days)||4
7573346|NCT02793154|18641974|P3|STARTED|Part A (Single Group-up to 12 Days)||0
7573347|NCT02793154|18641975|P2|STARTED|Part A (Single Group-up to 12 Days)||0
7573348|NCT02793154|18641976|P1|STARTED|Part A (Single Group-up to 12 Days)||4
7573349|NCT02793128|18642042|P1|NOT COMPLETED|Overall Study||9
7573350|NCT02793128|18642042|P1|COMPLETED|Overall Study||62
7573351|NCT02793128|18642042|P1|STARTED|Overall Study||71
7573352|NCT02792829|18642064|P8|NOT COMPLETED|Treatment Period 2||2
7573353|NCT02792829|18642065|P7|NOT COMPLETED|Treatment Period 2||1
7573354|NCT02792829|18642066|P6|NOT COMPLETED|Treatment Period 2||0
7573355|NCT02792829|18642067|P5|NOT COMPLETED|Treatment Period 2||1
7573356|NCT02792829|18642068|P4|NOT COMPLETED|Treatment Period 2||0
7573357|NCT02792829|18642069|P3|NOT COMPLETED|Treatment Period 2||0
7573358|NCT02792829|18642070|P2|NOT COMPLETED|Treatment Period 2||1
7573359|NCT02792829|18642071|P1|NOT COMPLETED|Treatment Period 2||0
7573360|NCT02792829|18642064|P8|COMPLETED|Treatment Period 2||8
7573361|NCT02792829|18642065|P7|COMPLETED|Treatment Period 2||9
7573362|NCT02792829|18642066|P6|COMPLETED|Treatment Period 2||5
7573363|NCT02792829|18642067|P5|COMPLETED|Treatment Period 2||4
7573364|NCT02792829|18642068|P4|COMPLETED|Treatment Period 2||5
7573365|NCT02792829|18642069|P3|COMPLETED|Treatment Period 2||5
7573366|NCT02792829|18642070|P2|COMPLETED|Treatment Period 2||9
7573367|NCT02792829|18642071|P1|COMPLETED|Treatment Period 2||10
7573368|NCT02792829|18642064|P8|STARTED|Treatment Period 2||10
7573369|NCT02792829|18642065|P7|STARTED|Treatment Period 2||10
7573370|NCT02792829|18642066|P6|STARTED|Treatment Period 2||5
7573371|NCT02792829|18642067|P5|STARTED|Treatment Period 2||5
7573372|NCT02792829|18642068|P4|STARTED|Treatment Period 2||5
7573373|NCT02792829|18642069|P3|STARTED|Treatment Period 2||5
7573374|NCT02792829|18642070|P2|STARTED|Treatment Period 2||10
7573375|NCT02792829|18642071|P1|STARTED|Treatment Period 2||10
7573376|NCT02792829|18642064|P8|NOT COMPLETED|Wash Out Period||0
7573377|NCT02792829|18642065|P7|NOT COMPLETED|Wash Out Period||0
7573378|NCT02792829|18642066|P6|NOT COMPLETED|Wash Out Period||0
7573379|NCT02792829|18642067|P5|NOT COMPLETED|Wash Out Period||0
7573380|NCT02792829|18642068|P4|NOT COMPLETED|Wash Out Period||0
7573381|NCT02792829|18642069|P3|NOT COMPLETED|Wash Out Period||0
7573382|NCT02792829|18642070|P2|NOT COMPLETED|Wash Out Period||0
7573383|NCT02792829|18642071|P1|NOT COMPLETED|Wash Out Period||0
7573384|NCT02792829|18642064|P8|COMPLETED|Wash Out Period||10
7573385|NCT02792829|18642065|P7|COMPLETED|Wash Out Period||10
7573386|NCT02792829|18642066|P6|COMPLETED|Wash Out Period||5
7573387|NCT02792829|18642067|P5|COMPLETED|Wash Out Period||5
7573388|NCT02792829|18642068|P4|COMPLETED|Wash Out Period||5
7573389|NCT02792829|18642069|P3|COMPLETED|Wash Out Period||5
7573390|NCT02792829|18642070|P2|COMPLETED|Wash Out Period||10
7573391|NCT02792829|18642071|P1|COMPLETED|Wash Out Period||10
7573392|NCT02792829|18642064|P8|STARTED|Wash Out Period||10
7573393|NCT02792829|18642065|P7|STARTED|Wash Out Period||10
7573394|NCT02792829|18642066|P6|STARTED|Wash Out Period||5
7573395|NCT02792829|18642067|P5|STARTED|Wash Out Period||5
7573396|NCT02792829|18642068|P4|STARTED|Wash Out Period||5
7573397|NCT02792829|18642069|P3|STARTED|Wash Out Period||5
7573398|NCT02792829|18642070|P2|STARTED|Wash Out Period||10
7573399|NCT02792829|18642071|P1|STARTED|Wash Out Period||10
7573400|NCT02792829|18642064|P8|NOT COMPLETED|Treatment Period 1||0
7573401|NCT02792829|18642065|P7|NOT COMPLETED|Treatment Period 1||0
7573402|NCT02792829|18642066|P6|NOT COMPLETED|Treatment Period 1||0
7573403|NCT02792829|18642067|P5|NOT COMPLETED|Treatment Period 1||0
7573404|NCT02792829|18642068|P4|NOT COMPLETED|Treatment Period 1||0
7573405|NCT02792829|18642069|P3|NOT COMPLETED|Treatment Period 1||0
7573406|NCT02792829|18642070|P2|NOT COMPLETED|Treatment Period 1||0
7573407|NCT02792829|18642071|P1|NOT COMPLETED|Treatment Period 1||0
7573408|NCT02792829|18642064|P8|COMPLETED|Treatment Period 1||10
7573409|NCT02792829|18642065|P7|COMPLETED|Treatment Period 1||10
7573410|NCT02792829|18642066|P6|COMPLETED|Treatment Period 1||5
7573411|NCT02792829|18642067|P5|COMPLETED|Treatment Period 1||5
7573412|NCT02792829|18642068|P4|COMPLETED|Treatment Period 1||5
7573413|NCT02792829|18642069|P3|COMPLETED|Treatment Period 1||5
7573414|NCT02792829|18642070|P2|COMPLETED|Treatment Period 1||10
7573415|NCT02792829|18642071|P1|COMPLETED|Treatment Period 1||10
7573416|NCT02792829|18642064|P8|STARTED|Treatment Period 1||10
7573417|NCT02792829|18642065|P7|STARTED|Treatment Period 1||10
7573418|NCT02792829|18642066|P6|STARTED|Treatment Period 1||5
7573419|NCT02792829|18642067|P5|STARTED|Treatment Period 1||5
7573420|NCT02792829|18642068|P4|STARTED|Treatment Period 1||5
7573421|NCT02792829|18642069|P3|STARTED|Treatment Period 1||5
7573422|NCT02792829|18642070|P2|STARTED|Treatment Period 1||10
7573423|NCT02792829|18642071|P1|STARTED|Treatment Period 1||10
7573424|NCT02792777|18642179|P2|NOT COMPLETED|Overall Study||0
7573425|NCT02792777|18642180|P1|NOT COMPLETED|Overall Study||7
7573426|NCT02792777|18642179|P2|COMPLETED|Overall Study||52
7573427|NCT02792777|18642180|P1|COMPLETED|Overall Study||89
7573428|NCT02792777|18642179|P2|STARTED|Overall Study||52
7573429|NCT02792777|18642180|P1|STARTED|Overall Study||96
7573430|NCT02792699|18642196|P3|NOT COMPLETED|Overall Study||10
7573431|NCT02792699|18642197|P2|NOT COMPLETED|Overall Study||10
7573432|NCT02792699|18642198|P1|NOT COMPLETED|Overall Study||9
7573433|NCT02792699|18642196|P3|COMPLETED|Overall Study||93
7573434|NCT02792699|18642197|P2|COMPLETED|Overall Study||94
7573435|NCT02792699|18642198|P1|COMPLETED|Overall Study||95
7573436|NCT02792699|18642196|P3|Received Second Infusion of Second Dose|Overall Study||93
7573437|NCT02792699|18642197|P2|Received Second Infusion of Second Dose|Overall Study||99
7573438|NCT02792699|18642198|P1|Received Second Infusion of Second Dose|Overall Study||97
7573439|NCT02792699|18642196|P3|Received First Infusion of Second Dose|Overall Study||95
7573440|NCT02792699|18642197|P2|Received First Infusion of Second Dose|Overall Study||99
7573441|NCT02792699|18642198|P1|Received First Infusion of Second Dose|Overall Study||97
7573442|NCT02792699|18642196|P3|Received Second Infusion of First Dose|Overall Study||99
7573443|NCT02792699|18642197|P2|Received Second Infusion of First Dose|Overall Study||103
7573444|NCT02792699|18642198|P1|Received Second Infusion of First Dose|Overall Study||102
7573445|NCT02792699|18642196|P3|Received First Infusion of First Dose|Overall Study||103
7573446|NCT02792699|18642197|P2|Received First Infusion of First Dose|Overall Study||104
7573447|NCT02792699|18642198|P1|Received First Infusion of First Dose|Overall Study||104
7573448|NCT02792699|18642196|P3|STARTED|Overall Study||103
7573449|NCT02792699|18642197|P2|STARTED|Overall Study||104
7573450|NCT02792699|18642198|P1|STARTED|Overall Study||104
7573451|NCT02792517|18642279|P1|NOT COMPLETED|Overall Study||20
7573452|NCT02792517|18642279|P1|COMPLETED|Overall Study||21
7573453|NCT02792517|18642279|P1|Received Erenumab|Overall Study||24
7573454|NCT02792517|18642279|P1|STARTED|Overall Study||41
7573455|NCT02792231|18642295|P2|NOT COMPLETED|Overall Study||85
7573456|NCT02792231|18642296|P1|NOT COMPLETED|Overall Study||84
7573457|NCT02792231|18642295|P2|COMPLETED|Overall Study||389
7573458|NCT02792231|18642296|P1|COMPLETED|Overall Study||397
7573459|NCT02792231|18642295|P2|Off Study Drug at Interim Cut Off|Overall Study||19
7573460|NCT02792231|18642296|P1|Off Study Drug at Interim Cut Off|Overall Study||14
7573461|NCT02792231|18642295|P2|On Study Drug at Interim Cut Off|Overall Study||370
7573462|NCT02792231|18642296|P1|On Study Drug at Interim Cut Off|Overall Study||383
7573463|NCT02792231|18642295|P2|STARTED|Overall Study||474
7573464|NCT02792231|18642296|P1|STARTED|Overall Study||481
7573465|NCT02792218|18642318|P2|NOT COMPLETED|Overall Study||86
7573466|NCT02792218|18642319|P1|NOT COMPLETED|Overall Study||49
7573467|NCT02792218|18642318|P2|COMPLETED|Overall Study||376
7573468|NCT02792218|18642319|P1|COMPLETED|Overall Study||416
7573469|NCT02792218|18642318|P2|Off Study Drug at Interim Cut Off|Overall Study||17
7573470|NCT02792218|18642319|P1|Off Study Drug at Interim Cut Off|Overall Study||16
7573471|NCT02792218|18642318|P2|On Study Drug at Interim Cut Off|Overall Study||359
7573472|NCT02792218|18642319|P1|On Study Drug at Interim Cut Off|Overall Study||400
7573473|NCT02792218|18642318|P2|STARTED|Overall Study||462
7573474|NCT02792218|18642319|P1|STARTED|Overall Study||465
7573475|NCT02792062|18642345|P6|NOT COMPLETED|Intervention Period 3 (6 Days)||0
7573476|NCT02792062|18642346|P5|NOT COMPLETED|Intervention Period 3 (6 Days)||0
7573477|NCT02792062|18642347|P4|NOT COMPLETED|Intervention Period 3 (6 Days)||0
7573478|NCT02792062|18642348|P3|NOT COMPLETED|Intervention Period 3 (6 Days)||0
7573479|NCT02792062|18642349|P2|NOT COMPLETED|Intervention Period 3 (6 Days)||0
7573480|NCT02792062|18642350|P1|NOT COMPLETED|Intervention Period 3 (6 Days)||0
7573481|NCT02792062|18642345|P6|COMPLETED|Intervention Period 3 (6 Days)||2
7573482|NCT02792062|18642346|P5|COMPLETED|Intervention Period 3 (6 Days)||2
7573483|NCT02792062|18642347|P4|COMPLETED|Intervention Period 3 (6 Days)||2
7573484|NCT02792062|18642348|P3|COMPLETED|Intervention Period 3 (6 Days)||2
7573485|NCT02792062|18642349|P2|COMPLETED|Intervention Period 3 (6 Days)||2
7573486|NCT02792062|18642350|P1|COMPLETED|Intervention Period 3 (6 Days)||1
7573487|NCT02792062|18642345|P6|STARTED|Intervention Period 3 (6 Days)||2
7573488|NCT02792062|18642346|P5|STARTED|Intervention Period 3 (6 Days)||2
7573489|NCT02792062|18642347|P4|STARTED|Intervention Period 3 (6 Days)||2
7573490|NCT02792062|18642348|P3|STARTED|Intervention Period 3 (6 Days)||2
7573491|NCT02792062|18642349|P2|STARTED|Intervention Period 3 (6 Days)||2
7573492|NCT02792062|18642350|P1|STARTED|Intervention Period 3 (6 Days)||1
7573493|NCT02792062|18642345|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7573494|NCT02792062|18642346|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7573495|NCT02792062|18642347|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7573496|NCT02792062|18642348|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7573497|NCT02792062|18642349|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7573498|NCT02792062|18642350|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||1
7573499|NCT02792062|18642345|P6|COMPLETED|Washout Period (at Least 14 Days)||2
7573500|NCT02792062|18642346|P5|COMPLETED|Washout Period (at Least 14 Days)||2
7573501|NCT02792062|18642347|P4|COMPLETED|Washout Period (at Least 14 Days)||2
7573502|NCT02792062|18642348|P3|COMPLETED|Washout Period (at Least 14 Days)||2
7573503|NCT02792062|18642349|P2|COMPLETED|Washout Period (at Least 14 Days)||2
7573504|NCT02792062|18642350|P1|COMPLETED|Washout Period (at Least 14 Days)||1
7573505|NCT02792062|18642345|P6|STARTED|Washout Period (at Least 14 Days)||2
7573506|NCT02792062|18642346|P5|STARTED|Washout Period (at Least 14 Days)||2
7573507|NCT02792062|18642347|P4|STARTED|Washout Period (at Least 14 Days)||2
7573508|NCT02792062|18642348|P3|STARTED|Washout Period (at Least 14 Days)||2
7573509|NCT02792062|18642349|P2|STARTED|Washout Period (at Least 14 Days)||2
7573510|NCT02792062|18642350|P1|STARTED|Washout Period (at Least 14 Days)||2
7573511|NCT02792062|18642345|P6|NOT COMPLETED|Intervention Period 2 (6 Days)||0
7573512|NCT02792062|18642346|P5|NOT COMPLETED|Intervention Period 2 (6 Days)||0
7573513|NCT02792062|18642347|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
7573514|NCT02792062|18642348|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
7573515|NCT02792062|18642349|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
7573516|NCT02792062|18642350|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
7573517|NCT02792062|18642345|P6|COMPLETED|Intervention Period 2 (6 Days)||2
7573518|NCT02792062|18642346|P5|COMPLETED|Intervention Period 2 (6 Days)||2
7573519|NCT02792062|18642347|P4|COMPLETED|Intervention Period 2 (6 Days)||2
7573520|NCT02792062|18642348|P3|COMPLETED|Intervention Period 2 (6 Days)||2
7573521|NCT02792062|18642349|P2|COMPLETED|Intervention Period 2 (6 Days)||2
7573522|NCT02792062|18642350|P1|COMPLETED|Intervention Period 2 (6 Days)||2
7573523|NCT02792062|18642345|P6|STARTED|Intervention Period 2 (6 Days)||2
7573524|NCT02792062|18642346|P5|STARTED|Intervention Period 2 (6 Days)||2
7573525|NCT02792062|18642347|P4|STARTED|Intervention Period 2 (6 Days)||2
7573526|NCT02792062|18642348|P3|STARTED|Intervention Period 2 (6 Days)||2
7573527|NCT02792062|18642349|P2|STARTED|Intervention Period 2 (6 Days)||2
7573528|NCT02792062|18642350|P1|STARTED|Intervention Period 2 (6 Days)||2
7573529|NCT02792062|18642345|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7573530|NCT02792062|18642346|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7573531|NCT02792062|18642347|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7573532|NCT02792062|18642348|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7573533|NCT02792062|18642349|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7573534|NCT02792062|18642350|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7573535|NCT02792062|18642345|P6|COMPLETED|Washout Period (at Least 14 Days)||2
7573536|NCT02792062|18642346|P5|COMPLETED|Washout Period (at Least 14 Days)||2
7573537|NCT02792062|18642347|P4|COMPLETED|Washout Period (at Least 14 Days)||2
7573538|NCT02792062|18642348|P3|COMPLETED|Washout Period (at Least 14 Days)||2
7573539|NCT02792062|18642349|P2|COMPLETED|Washout Period (at Least 14 Days)||2
7573540|NCT02792062|18642350|P1|COMPLETED|Washout Period (at Least 14 Days)||2
7573541|NCT02792062|18642345|P6|STARTED|Washout Period (at Least 14 Days)||2
7573542|NCT02792062|18642346|P5|STARTED|Washout Period (at Least 14 Days)||2
7573543|NCT02792062|18642347|P4|STARTED|Washout Period (at Least 14 Days)||2
7573544|NCT02792062|18642348|P3|STARTED|Washout Period (at Least 14 Days)||2
7573545|NCT02792062|18642349|P2|STARTED|Washout Period (at Least 14 Days)||2
7573546|NCT02792062|18642350|P1|STARTED|Washout Period (at Least 14 Days)||2
7573547|NCT02792062|18642345|P6|NOT COMPLETED|Intervention Period 1 (6 Days)||0
7573548|NCT02792062|18642346|P5|NOT COMPLETED|Intervention Period 1 (6 Days)||0
7573549|NCT02792062|18642347|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
7573550|NCT02792062|18642348|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
7573551|NCT02792062|18642349|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
7573552|NCT02792062|18642350|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
7573553|NCT02792062|18642345|P6|COMPLETED|Intervention Period 1 (6 Days)||2
7573554|NCT02792062|18642346|P5|COMPLETED|Intervention Period 1 (6 Days)||2
7573555|NCT02792062|18642347|P4|COMPLETED|Intervention Period 1 (6 Days)||2
7573556|NCT02792062|18642348|P3|COMPLETED|Intervention Period 1 (6 Days)||2
7573557|NCT02792062|18642349|P2|COMPLETED|Intervention Period 1 (6 Days)||2
7573558|NCT02792062|18642350|P1|COMPLETED|Intervention Period 1 (6 Days)||2
7573559|NCT02792062|18642345|P6|STARTED|Intervention Period 1 (6 Days)||2
7573560|NCT02792062|18642346|P5|STARTED|Intervention Period 1 (6 Days)||2
7573561|NCT02792062|18642347|P4|STARTED|Intervention Period 1 (6 Days)||2
7573562|NCT02792062|18642348|P3|STARTED|Intervention Period 1 (6 Days)||2
7573563|NCT02792062|18642349|P2|STARTED|Intervention Period 1 (6 Days)||2
7573564|NCT02792062|18642350|P1|STARTED|Intervention Period 1 (6 Days)||2
7573565|NCT02792049|18642384|P2|NOT COMPLETED|Overall Study||0
7573566|NCT02792049|18642385|P1|NOT COMPLETED|Overall Study||0
7573567|NCT02792049|18642384|P2|COMPLETED|Overall Study||35
7573568|NCT02792049|18642385|P1|COMPLETED|Overall Study||35
7573569|NCT02792049|18642384|P2|STARTED|Overall Study||35
7573570|NCT02792049|18642385|P1|STARTED|Overall Study||35
7573571|NCT02791945|18642401|P2|NOT COMPLETED|Overall Study||2
7573572|NCT02791945|18642402|P1|NOT COMPLETED|Overall Study||2
7573573|NCT02791945|18642401|P2|COMPLETED|Overall Study||14
7573574|NCT02791945|18642402|P1|COMPLETED|Overall Study||12
7573575|NCT02791945|18642401|P2|STARTED|Overall Study||16
7573576|NCT02791945|18642402|P1|STARTED|Overall Study||14
7573577|NCT02791906|18642414|P2|NOT COMPLETED|Overall Study||1
7573578|NCT02791906|18642415|P1|NOT COMPLETED|Overall Study||2
7573579|NCT02791906|18642414|P2|COMPLETED|Overall Study||2
7573580|NCT02791906|18642415|P1|COMPLETED|Overall Study||2
7573581|NCT02791906|18642414|P2|STARTED|Overall Study||3
7573582|NCT02791906|18642415|P1|STARTED|Overall Study||4
7573583|NCT02791763|18642432|P3|NOT COMPLETED|Overall Study||13
7573584|NCT02791763|18642433|P2|NOT COMPLETED|Overall Study||37
7573585|NCT02791763|18642434|P1|NOT COMPLETED|Overall Study||38
7573586|NCT02791763|18642432|P3|COMPLETED|Overall Study||43
7573587|NCT02791763|18642433|P2|COMPLETED|Overall Study||113
7573588|NCT02791763|18642434|P1|COMPLETED|Overall Study||111
7573589|NCT02791763|18642432|P3|STARTED|Overall Study||56
7573590|NCT02791763|18642433|P2|STARTED|Overall Study||150
7573591|NCT02791763|18642434|P1|STARTED|Overall Study||149
7573592|NCT02791659|18642553|P2|NOT COMPLETED|Overall Study||1
7573593|NCT02791659|18642554|P1|NOT COMPLETED|Overall Study||0
7573594|NCT02791659|18642553|P2|COMPLETED|Overall Study||27
7573595|NCT02791659|18642554|P1|COMPLETED|Overall Study||27
7573596|NCT02791659|18642553|P2|STARTED|Overall Study||28
7573597|NCT02791659|18642554|P1|STARTED|Overall Study||27
7573598|NCT02791516|18642562|P2|NOT COMPLETED|Overall Study||1
7573599|NCT02791516|18642563|P1|NOT COMPLETED|Overall Study||1
7573600|NCT02791516|18642562|P2|COMPLETED|Overall Study||33
7573601|NCT02791516|18642563|P1|COMPLETED|Overall Study||32
7573602|NCT02791516|18642562|P2|Completed 6-month Treatment Period|Overall Study||33
7573603|NCT02791516|18642563|P1|Completed 6-month Treatment Period|Overall Study||33
7573604|NCT02791516|18642562|P2|STARTED|Overall Study||34
7573605|NCT02791516|18642563|P1|STARTED|Overall Study||33
7573606|NCT02791490|18642575|P2|NOT COMPLETED|Overall Study||8
7573607|NCT02791490|18642576|P1|NOT COMPLETED|Overall Study||3
7573608|NCT02791490|18642575|P2|COMPLETED|Overall Study||221
7573609|NCT02791490|18642576|P1|COMPLETED|Overall Study||226
7573610|NCT02791490|18642575|P2|STARTED|Overall Study||229
7573611|NCT02791490|18642576|P1|STARTED|Overall Study||229
7573612|NCT02791438|18642596|P2|NOT COMPLETED|Treatment Period||1
7573613|NCT02791438|18642597|P1|NOT COMPLETED|Treatment Period||3
7573614|NCT02791438|18642596|P2|COMPLETED|Treatment Period||4
7573615|NCT02791438|18642597|P1|COMPLETED|Treatment Period||19
7573616|NCT02791438|18642596|P2|STARTED|Treatment Period||5
7573617|NCT02791438|18642597|P1|STARTED|Treatment Period||22
7573618|NCT02791438|18642596|P2|NOT COMPLETED|Run-In Period||0
7573619|NCT02791438|18642597|P1|NOT COMPLETED|Run-In Period||0
7573620|NCT02791438|18642596|P2|COMPLETED|Run-In Period||5
7573621|NCT02791438|18642597|P1|COMPLETED|Run-In Period||22
7573622|NCT02791438|18642596|P2|STARTED|Run-In Period||5
7573623|NCT02791438|18642597|P1|STARTED|Run-In Period||22
7573624|NCT02791308|18642626|P3|NOT COMPLETED|Overall Study||17
7573625|NCT02791308|18642627|P2|NOT COMPLETED|Overall Study||9
7573626|NCT02791308|18642628|P1|NOT COMPLETED|Overall Study||10
7573627|NCT02791308|18642626|P3|COMPLETED|Overall Study||179
7573628|NCT02791308|18642627|P2|COMPLETED|Overall Study||187
7573629|NCT02791308|18642628|P1|COMPLETED|Overall Study||185
7573630|NCT02791308|18642626|P3|STARTED|Overall Study||196
7573631|NCT02791308|18642627|P2|STARTED|Overall Study||196
7573632|NCT02791308|18642628|P1|STARTED|Overall Study||195
7573633|NCT02791269|18642638|P2|NOT COMPLETED|Overall Study||1
7573634|NCT02791269|18642639|P1|NOT COMPLETED|Overall Study||0
7573635|NCT02791269|18642638|P2|COMPLETED|Overall Study||19
7573636|NCT02791269|18642639|P1|COMPLETED|Overall Study||4
7573637|NCT02791269|18642638|P2|STARTED|Overall Study||20
7573638|NCT02791269|18642639|P1|STARTED|Overall Study||4
7573639|NCT02790788|18642655|P2|NOT COMPLETED|Overall Study||0
7573640|NCT02790788|18642656|P1|NOT COMPLETED|Overall Study||0
7573641|NCT02790788|18642655|P2|COMPLETED|Overall Study||54
7573642|NCT02790788|18642656|P1|COMPLETED|Overall Study||46
7573643|NCT02790788|18642655|P2|STARTED|Overall Study||54
7573644|NCT02790788|18642656|P1|STARTED|Overall Study||46
7573645|NCT02790736|18642708|P2|NOT COMPLETED|Overall Study||0
7573646|NCT02790736|18642709|P1|NOT COMPLETED|Overall Study||0
7573647|NCT02790736|18642708|P2|COMPLETED|Overall Study||1
7573648|NCT02790736|18642709|P1|COMPLETED|Overall Study||5
7573649|NCT02790736|18642708|P2|STARTED|Overall Study||1
7573650|NCT02790736|18642709|P1|STARTED|Overall Study||5
7573651|NCT02790606|18642717|P1|NOT COMPLETED|Overall Study||35
7573652|NCT02790606|18642717|P1|COMPLETED|Overall Study||75
7573653|NCT02790606|18642717|P1|STARTED|Overall Study||110
7573654|NCT02790463|18642734|P2|NOT COMPLETED|Overall Study||309
7573655|NCT02790463|18642735|P1|NOT COMPLETED|Overall Study||0
7573656|NCT02790463|18642734|P2|COMPLETED|Overall Study||372
7573657|NCT02790463|18642735|P1|COMPLETED|Overall Study||782
7573658|NCT02790463|18642734|P2|STARTED|Overall Study||681
7573659|NCT02790463|18642735|P1|STARTED|Overall Study||782
7573660|NCT02790281|18642743|P1|NOT COMPLETED|Overall Study||0
7573661|NCT02790281|18642743|P1|COMPLETED|Overall Study||33
7573662|NCT02790281|18642743|P1|STARTED|Overall Study||33
7573663|NCT02790073|18642749|P1|NOT COMPLETED|Overall Study||3
7573664|NCT02790073|18642749|P1|COMPLETED|Overall Study||11
7573665|NCT02790073|18642749|P1|STARTED|Overall Study||14
7573666|NCT02789410|18642757|P2|NOT COMPLETED|Overall Study||0
7573667|NCT02789410|18642758|P1|NOT COMPLETED|Overall Study||0
7573668|NCT02789410|18642757|P2|COMPLETED|Overall Study||68
7573669|NCT02789410|18642758|P1|COMPLETED|Overall Study||66
7573670|NCT02789410|18642757|P2|STARTED|Overall Study||68
7573671|NCT02789410|18642758|P1|STARTED|Overall Study||66
7573672|NCT02789176|18642772|P4|NOT COMPLETED|Overall Study||1
7573673|NCT02789176|18642773|P3|NOT COMPLETED|Overall Study||10
7573674|NCT02789176|18642774|P2|NOT COMPLETED|Overall Study||2
7573675|NCT02789176|18642775|P1|NOT COMPLETED|Overall Study||8
7573676|NCT02789176|18642772|P4|COMPLETED|Overall Study||53
7573677|NCT02789176|18642773|P3|COMPLETED|Overall Study||85
7573678|NCT02789176|18642774|P2|COMPLETED|Overall Study||53
7573679|NCT02789176|18642775|P1|COMPLETED|Overall Study||91
7573680|NCT02789176|18642772|P4|STARTED|Overall Study||54
7573681|NCT02789176|18642773|P3|STARTED|Overall Study||95
7573682|NCT02789176|18642774|P2|STARTED|Overall Study||55
7573683|NCT02789176|18642775|P1|STARTED|Overall Study||99
7573684|NCT02789111|18642799|P2|NOT COMPLETED|Overall Study||4
7573685|NCT02789111|18642800|P1|NOT COMPLETED|Overall Study||1
7573686|NCT02789111|18642799|P2|COMPLETED|Overall Study||21
7573687|NCT02789111|18642800|P1|COMPLETED|Overall Study||23
7573688|NCT02789111|18642799|P2|STARTED|Overall Study||25
7573689|NCT02789111|18642800|P1|STARTED|Overall Study||24
7573690|NCT02788747|18642811|P3|NOT COMPLETED|Overall Study||0
7573691|NCT02788747|18642812|P2|NOT COMPLETED|Overall Study||0
7573692|NCT02788747|18642813|P1|NOT COMPLETED|Overall Study||1
7573693|NCT02788747|18642811|P3|COMPLETED|Overall Study||24
7573694|NCT02788747|18642812|P2|COMPLETED|Overall Study||24
7573695|NCT02788747|18642813|P1|COMPLETED|Overall Study||22
7573696|NCT02788747|18642811|P3|STARTED|Overall Study||24
7573697|NCT02788747|18642812|P2|STARTED|Overall Study||24
7573698|NCT02788747|18642813|P1|STARTED|Overall Study||23
7573699|NCT02788656|18642883|P2|NOT COMPLETED|Overall Study||0
7573700|NCT02788656|18642884|P1|NOT COMPLETED|Overall Study||1
7573701|NCT02788656|18642883|P2|COMPLETED|Overall Study||2
7573702|NCT02788656|18642884|P1|COMPLETED|Overall Study||1
7573703|NCT02788656|18642883|P2|STARTED|Overall Study||2
7573704|NCT02788656|18642884|P1|STARTED|Overall Study||2
7573705|NCT02788513|18642909|P5|NOT COMPLETED|Overall Study||5
7573706|NCT02788513|18642910|P4|NOT COMPLETED|Overall Study||6
7573707|NCT02788513|18642911|P3|NOT COMPLETED|Overall Study||8
7573708|NCT02788513|18642912|P2|NOT COMPLETED|Overall Study||8
7573709|NCT02788513|18642913|P1|NOT COMPLETED|Overall Study||9
7573710|NCT02788513|18642909|P5|COMPLETED|Overall Study||115
7573711|NCT02788513|18642910|P4|COMPLETED|Overall Study||117
7573712|NCT02788513|18642911|P3|COMPLETED|Overall Study||114
7573713|NCT02788513|18642912|P2|COMPLETED|Overall Study||114
7573714|NCT02788513|18642913|P1|COMPLETED|Overall Study||114
7573715|NCT02788513|18642909|P5|STARTED|Overall Study||120
7573716|NCT02788513|18642910|P4|STARTED|Overall Study||123
7573717|NCT02788513|18642911|P3|STARTED|Overall Study||122
7573718|NCT02788513|18642912|P2|STARTED|Overall Study||122
7573719|NCT02788513|18642913|P1|STARTED|Overall Study||123
7573720|NCT02788474|18642937|P2|NOT COMPLETED|Open Label Treatment Period||12
7573721|NCT02788474|18642938|P1|NOT COMPLETED|Open Label Treatment Period||32
7573722|NCT02788474|18642937|P2|COMPLETED|Open Label Treatment Period||100
7573723|NCT02788474|18642938|P1|COMPLETED|Open Label Treatment Period||189
7573724|NCT02788474|18642937|P2|STARTED|Open Label Treatment Period||112
7573725|NCT02788474|18642938|P1|STARTED|Open Label Treatment Period||221
7573726|NCT02788474|18642937|P2|NOT COMPLETED|Double Blind Treatment Period||4
7573727|NCT02788474|18642938|P1|NOT COMPLETED|Double Blind Treatment Period||10
7573728|NCT02788474|18642937|P2|COMPLETED|Double Blind Treatment Period||112
7573729|NCT02788474|18642938|P1|COMPLETED|Double Blind Treatment Period||221
7573730|NCT02788474|18642937|P2|Treated|Double Blind Treatment Period||116
7573731|NCT02788474|18642938|P1|Treated|Double Blind Treatment Period||230
7573732|NCT02788474|18642937|P2|STARTED|Double Blind Treatment Period||116
7573733|NCT02788474|18642938|P1|STARTED|Double Blind Treatment Period||231
7573734|NCT02788357|18642953|P2|NOT COMPLETED|Overall Study||0
7573735|NCT02788357|18642954|P1|NOT COMPLETED|Overall Study||3
7573736|NCT02788357|18642953|P2|COMPLETED|Overall Study||6
7573737|NCT02788357|18642954|P1|COMPLETED|Overall Study||3
7573738|NCT02788357|18642953|P2|STARTED|Overall Study||6
7573739|NCT02788357|18642954|P1|STARTED|Overall Study||6
7573740|NCT02788279|18642969|P3|NOT COMPLETED|Overall Study||90
7573741|NCT02788279|18642970|P2|NOT COMPLETED|Overall Study||183
7573742|NCT02788279|18642971|P1|NOT COMPLETED|Overall Study||90
7573743|NCT02788279|18642969|P3|COMPLETED|Overall Study||0
7573744|NCT02788279|18642970|P2|COMPLETED|Overall Study||0
7573745|NCT02788279|18642971|P1|COMPLETED|Overall Study||0
7573746|NCT02788279|18642969|P3|Modified ITT Population|Overall Study||61
7573747|NCT02788279|18642970|P2|Modified ITT Population|Overall Study||125
7573748|NCT02788279|18642971|P1|Modified ITT Population|Overall Study||57
7573749|NCT02788279|18642969|P3|Received Treatment (Safety Population)|Overall Study||90
7573750|NCT02788279|18642970|P2|Received Treatment (Safety Population)|Overall Study||179
7573751|NCT02788279|18642971|P1|Received Treatment (Safety Population)|Overall Study||80
7573752|NCT02788279|18642969|P3|STARTED|Overall Study||90
7573753|NCT02788279|18642970|P2|STARTED|Overall Study||183
7573754|NCT02788279|18642971|P1|STARTED|Overall Study||90
7573755|NCT02788201|18643008|P6|NOT COMPLETED|Overall Study||3
7573756|NCT02788201|18643009|P5|NOT COMPLETED|Overall Study||0
7573757|NCT02788201|18643010|P4|NOT COMPLETED|Overall Study||1
7573758|NCT02788201|18643011|P3|NOT COMPLETED|Overall Study||1
7573759|NCT02788201|18643012|P2|NOT COMPLETED|Overall Study||1
7573760|NCT02788201|18643013|P1|NOT COMPLETED|Overall Study||1
7573761|NCT02788201|18643008|P6|COMPLETED|Overall Study||0
7573762|NCT02788201|18643009|P5|COMPLETED|Overall Study||1
7573763|NCT02788201|18643010|P4|COMPLETED|Overall Study||0
7573764|NCT02788201|18643011|P3|COMPLETED|Overall Study||0
7573765|NCT02788201|18643012|P2|COMPLETED|Overall Study||0
7573766|NCT02788201|18643013|P1|COMPLETED|Overall Study||0
7573767|NCT02788201|18643008|P6|Did Not Start Treatment|Overall Study||3
7573768|NCT02788201|18643009|P5|Did Not Start Treatment|Overall Study||0
7573769|NCT02788201|18643010|P4|Did Not Start Treatment|Overall Study||0
7573770|NCT02788201|18643011|P3|Did Not Start Treatment|Overall Study||0
7573771|NCT02788201|18643012|P2|Did Not Start Treatment|Overall Study||0
7573772|NCT02788201|18643013|P1|Did Not Start Treatment|Overall Study||0
7573773|NCT02788201|18643008|P6|STARTED|Overall Study||3
7573774|NCT02788201|18643009|P5|STARTED|Overall Study||1
7573775|NCT02788201|18643010|P4|STARTED|Overall Study||1
7573776|NCT02788201|18643011|P3|STARTED|Overall Study||1
7573777|NCT02788201|18643012|P2|STARTED|Overall Study||1
7573778|NCT02788201|18643013|P1|STARTED|Overall Study||1
7573779|NCT02788188|18643044|P7|NOT COMPLETED|Overall Study||0
7573780|NCT02788188|18643045|P6|NOT COMPLETED|Overall Study||0
7573781|NCT02788188|18643046|P5|NOT COMPLETED|Overall Study||0
7573782|NCT02788188|18643047|P4|NOT COMPLETED|Overall Study||0
7573783|NCT02788188|18643048|P3|NOT COMPLETED|Overall Study||0
7573784|NCT02788188|18643049|P2|NOT COMPLETED|Overall Study||0
7573785|NCT02788188|18643050|P1|NOT COMPLETED|Overall Study||0
7573786|NCT02788188|18643044|P7|COMPLETED|Overall Study||10
7573787|NCT02788188|18643045|P6|COMPLETED|Overall Study||8
7573788|NCT02788188|18643046|P5|COMPLETED|Overall Study||8
7573789|NCT02788188|18643047|P4|COMPLETED|Overall Study||4
7573790|NCT02788188|18643048|P3|COMPLETED|Overall Study||4
7573791|NCT02788188|18643049|P2|COMPLETED|Overall Study||2
7573792|NCT02788188|18643050|P1|COMPLETED|Overall Study||2
7573793|NCT02788188|18643044|P7|STARTED|Overall Study||10
7573794|NCT02788188|18643045|P6|STARTED|Overall Study||8
7573795|NCT02788188|18643046|P5|STARTED|Overall Study||8
7573796|NCT02788188|18643047|P4|STARTED|Overall Study||4
7573797|NCT02788188|18643048|P3|STARTED|Overall Study||4
7573798|NCT02788188|18643049|P2|STARTED|Overall Study||2
7573799|NCT02788188|18643050|P1|STARTED|Overall Study||2
7573800|NCT02788175|18643066|P1|NOT COMPLETED|Overall Study||13
7573801|NCT02788175|18643066|P1|COMPLETED|Overall Study||13
7573802|NCT02788175|18643066|P1|Received Study Agent|Overall Study||20
7573803|NCT02788175|18643066|P1|STARTED|Overall Study||26
7573804|NCT02788097|18643073|P2|NOT COMPLETED|Overall Study||0
7573805|NCT02788097|18643074|P1|NOT COMPLETED|Overall Study||0
7573806|NCT02788097|18643073|P2|COMPLETED|Overall Study||69
7573807|NCT02788097|18643074|P1|COMPLETED|Overall Study||61
7573808|NCT02788097|18643073|P2|STARTED|Overall Study||69
7573809|NCT02788097|18643074|P1|STARTED|Overall Study||61
7573810|NCT02787863|18643088|P8|NOT COMPLETED|Overall Study||0
7573811|NCT02787863|18643089|P7|NOT COMPLETED|Overall Study||0
7573812|NCT02787863|18643090|P6|NOT COMPLETED|Overall Study||0
7573813|NCT02787863|18643091|P5|NOT COMPLETED|Overall Study||0
7573814|NCT02787863|18643092|P4|NOT COMPLETED|Overall Study||0
7573815|NCT02787863|18643093|P3|NOT COMPLETED|Overall Study||2
7573816|NCT02787863|18643094|P2|NOT COMPLETED|Overall Study||1
7573817|NCT02787863|18643095|P1|NOT COMPLETED|Overall Study||1
7573818|NCT02787863|18643088|P8|COMPLETED|Overall Study||27
7573819|NCT02787863|18643089|P7|COMPLETED|Overall Study||25
7573820|NCT02787863|18643090|P6|COMPLETED|Overall Study||18
7573821|NCT02787863|18643091|P5|COMPLETED|Overall Study||32
7573822|NCT02787863|18643092|P4|COMPLETED|Overall Study||25
7573823|NCT02787863|18643093|P3|COMPLETED|Overall Study||23
7573824|NCT02787863|18643094|P2|COMPLETED|Overall Study||33
7573825|NCT02787863|18643095|P1|COMPLETED|Overall Study||32
7573826|NCT02787863|18643088|P8|4 Years After Vaccination|Overall Study||27
7573827|NCT02787863|18643089|P7|4 Years After Vaccination|Overall Study||25
7573828|NCT02787863|18643090|P6|4 Years After Vaccination|Overall Study||18
7573829|NCT02787863|18643091|P5|4 Years After Vaccination|Overall Study||32
7573830|NCT02787863|18643092|P4|4 Years After Vaccination|Overall Study||25
7573831|NCT02787863|18643093|P3|4 Years After Vaccination|Overall Study||23
7573832|NCT02787863|18643094|P2|4 Years After Vaccination|Overall Study||33
7573833|NCT02787863|18643095|P1|4 Years After Vaccination|Overall Study||32
7573834|NCT02787863|18643088|P8|1 Year After Vaccination|Overall Study||27
7573835|NCT02787863|18643089|P7|1 Year After Vaccination|Overall Study||25
7573836|NCT02787863|18643090|P6|1 Year After Vaccination|Overall Study||18
7573837|NCT02787863|18643091|P5|1 Year After Vaccination|Overall Study||32
7573838|NCT02787863|18643092|P4|1 Year After Vaccination|Overall Study||25
7573839|NCT02787863|18643093|P3|1 Year After Vaccination|Overall Study||23
7573840|NCT02787863|18643094|P2|1 Year After Vaccination|Overall Study||33
7573841|NCT02787863|18643095|P1|1 Year After Vaccination|Overall Study||32
7573842|NCT02787863|18643088|P8|STARTED|Overall Study||27
7573843|NCT02787863|18643089|P7|STARTED|Overall Study||25
7573844|NCT02787863|18643090|P6|STARTED|Overall Study||18
7573845|NCT02787863|18643091|P5|STARTED|Overall Study||32
7573846|NCT02787863|18643092|P4|STARTED|Overall Study||25
7573847|NCT02787863|18643093|P3|STARTED|Overall Study||25
7573848|NCT02787863|18643094|P2|STARTED|Overall Study||34
7573849|NCT02787863|18643095|P1|STARTED|Overall Study||33
7573850|NCT02787694|18643155|P1|NOT COMPLETED|Overall Study||5
7573851|NCT02787694|18643155|P1|COMPLETED|Overall Study||17
7573852|NCT02787694|18643155|P1|STARTED|Overall Study||22
7573853|NCT02787681|18643159|P1|NOT COMPLETED|Overall Study||2
7573854|NCT02787681|18643159|P1|COMPLETED|Overall Study||69
7573855|NCT02787681|18643159|P1|STARTED|Overall Study||71
7573856|NCT02787655|18643165|P2|NOT COMPLETED|Overall Study||12
7573857|NCT02787655|18643166|P1|NOT COMPLETED|Overall Study||11
7573858|NCT02787655|18643165|P2|COMPLETED|Overall Study||26
7573859|NCT02787655|18643166|P1|COMPLETED|Overall Study||29
7573860|NCT02787655|18643165|P2|STARTED|Overall Study||38
7573861|NCT02787655|18643166|P1|STARTED|Overall Study||40
7573862|NCT02787564|18643174|P2|NOT COMPLETED|Overall Study||2
7573863|NCT02787564|18643175|P1|NOT COMPLETED|Overall Study||7
7573864|NCT02787564|18643174|P2|COMPLETED|Overall Study|n=12 food bank users; n=15 non-food bank users|27
7573865|NCT02787564|18643175|P1|COMPLETED|Overall Study|n=12 food bank users; n=13 non-food bank users|25
7573866|NCT02787564|18643174|P2|STARTED|Overall Study||29
7573867|NCT02787564|18643175|P1|STARTED|Overall Study||32
7573868|NCT02787551|18643193|P2|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
7573869|NCT02787551|18643194|P1|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||9
7573870|NCT02787551|18643193|P2|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
7573871|NCT02787551|18643194|P1|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||197
7573872|NCT02787551|18643193|P2|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)||0
7573873|NCT02787551|18643194|P1|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)|Participants who completed core period and met eligibility criteria for extension period.|206
7573874|NCT02787551|18643193|P2|NOT COMPLETED|Core Period: 26 Weeks||11
7573875|NCT02787551|18643194|P1|NOT COMPLETED|Core Period: 26 Weeks||27
7573876|NCT02787551|18643193|P2|COMPLETED|Core Period: 26 Weeks||246
7573877|NCT02787551|18643194|P1|COMPLETED|Core Period: 26 Weeks|Out of 230 participants, 206 participants entered in single arm extension period.|230
7573878|NCT02787551|18643193|P2|Treated|Core Period: 26 Weeks||256
7573879|NCT02787551|18643194|P1|Treated|Core Period: 26 Weeks||255
7573880|NCT02787551|18643193|P2|STARTED|Core Period: 26 Weeks||257
7573881|NCT02787551|18643194|P1|STARTED|Core Period: 26 Weeks||257
7573882|NCT02787304|18643230|P4|NOT COMPLETED|Overall Study||34
7573883|NCT02787304|18643231|P3|NOT COMPLETED|Overall Study||41
7573884|NCT02787304|18643232|P2|NOT COMPLETED|Overall Study||38
7573885|NCT02787304|18643233|P1|NOT COMPLETED|Overall Study||36
7573886|NCT02787304|18643230|P4|COMPLETED|Overall Study||15
7573887|NCT02787304|18643231|P3|COMPLETED|Overall Study||8
7573888|NCT02787304|18643232|P2|COMPLETED|Overall Study||12
7573889|NCT02787304|18643233|P1|COMPLETED|Overall Study||13
7573890|NCT02787304|18643230|P4|STARTED|Overall Study||49
7573891|NCT02787304|18643231|P3|STARTED|Overall Study||49
7573892|NCT02787304|18643232|P2|STARTED|Overall Study|One subject was randomized and received 1 dose of study drug but withdrew from the study.|50
7573893|NCT02787304|18643233|P1|STARTED|Overall Study||49
7573894|NCT02787291|18643279|P1|NOT COMPLETED|Overall Study||0
7573895|NCT02787291|18643279|P1|COMPLETED|Overall Study||227
7573896|NCT02787291|18643279|P1|STARTED|Overall Study||227
7573897|NCT02787083|18643287|P2|NOT COMPLETED|Overall Study||2
7573898|NCT02787083|18643288|P1|NOT COMPLETED|Overall Study||3
7573899|NCT02787083|18643287|P2|COMPLETED|Overall Study||3
7573900|NCT02787083|18643288|P1|COMPLETED|Overall Study||1
7573901|NCT02787083|18643287|P2|STARTED|Overall Study||5
7573902|NCT02787083|18643288|P1|STARTED|Overall Study||4
7573903|NCT02787057|18643298|P2|NOT COMPLETED|Overall Study||0
7573904|NCT02787057|18643299|P1|NOT COMPLETED|Overall Study||0
7573905|NCT02787057|18643298|P2|COMPLETED|Overall Study||40
7573906|NCT02787057|18643299|P1|COMPLETED|Overall Study||40
7573907|NCT02787057|18643298|P2|STARTED|Overall Study||40
7573908|NCT02787057|18643299|P1|STARTED|Overall Study||40
7573909|NCT02786953|18643313|P2|NOT COMPLETED|Overall Study||1
7573910|NCT02786953|18643314|P1|NOT COMPLETED|Overall Study||3
7573911|NCT02786953|18643313|P2|COMPLETED|Overall Study||18
7573912|NCT02786953|18643314|P1|COMPLETED|Overall Study||17
7573913|NCT02786953|18643313|P2|A1C 3 Month|Overall Study||17
7573914|NCT02786953|18643314|P1|A1C 3 Month|Overall Study||15
7573915|NCT02786953|18643313|P2|3 Month Parent Survey Completed|Overall Study||18
7573916|NCT02786953|18643314|P1|3 Month Parent Survey Completed|Overall Study||17
7573917|NCT02786953|18643313|P2|3 Month Teen Survey Completed|Overall Study||18
7573918|NCT02786953|18643314|P1|3 Month Teen Survey Completed|Overall Study||17
7573919|NCT02786953|18643313|P2|Session 3 Completed|Overall Study||0
7573920|NCT02786953|18643314|P1|Session 3 Completed|Overall Study||16
7573921|NCT02786953|18643313|P2|Session 2 Completed|Overall Study||0
7573922|NCT02786953|18643314|P1|Session 2 Completed|Overall Study||16
7573923|NCT02786953|18643313|P2|Session 1 Completed|Overall Study||0
7573924|NCT02786953|18643314|P1|Session 1 Completed|Overall Study||17
7573925|NCT02786953|18643313|P2|A1C Data Baseline|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
7573926|NCT02786953|18643314|P1|A1C Data Baseline|Overall Study||20
7573927|NCT02786953|18643313|P2|Actigraph Data Complete|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|17
7573928|NCT02786953|18643314|P1|Actigraph Data Complete|Overall Study||14
7573929|NCT02786953|18643313|P2|Baseline Parent Survey Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
7573930|NCT02786953|18643314|P1|Baseline Parent Survey Completed|Overall Study||20
7573931|NCT02786953|18643313|P2|Baseline Teen Survey Data Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
7573932|NCT02786953|18643314|P1|Baseline Teen Survey Data Completed|Overall Study||20
7573933|NCT02786953|18643313|P2|STARTED|Overall Study||19
7573934|NCT02786953|18643314|P1|STARTED|Overall Study||20
7573935|NCT02786927|18643336|P1|NOT COMPLETED|Overall Study||5
7573936|NCT02786927|18643336|P1|COMPLETED|Overall Study||207
7573937|NCT02786927|18643336|P1|STARTED|Overall Study||212
7573938|NCT02786901|18643346|P3|NOT COMPLETED|Overall Study||41
7573939|NCT02786901|18643347|P2|NOT COMPLETED|Overall Study||56
7573940|NCT02786901|18643348|P1|NOT COMPLETED|Overall Study||77
7573941|NCT02786901|18643346|P3|COMPLETED|Overall Study||159
7573942|NCT02786901|18643347|P2|COMPLETED|Overall Study||145
7573943|NCT02786901|18643348|P1|COMPLETED|Overall Study||122
7573944|NCT02786901|18643346|P3|STARTED|Overall Study||200
7573945|NCT02786901|18643347|P2|STARTED|Overall Study||201
7573946|NCT02786901|18643348|P1|STARTED|Overall Study||199
7573947|NCT02786836|18643377|P1|NOT COMPLETED|Overall Study||14
7573948|NCT02786836|18643377|P1|COMPLETED|Overall Study||62
7573949|NCT02786836|18643377|P1|Eligible Patients Enrolled Into the Stud|Overall Study||76
7573950|NCT02786836|18643377|P1|STARTED|Overall Study||76
7573951|NCT02786810|18643383|P1|NOT COMPLETED|Overall Study||0
7573952|NCT02786810|18643383|P1|COMPLETED|Overall Study||10
7573953|NCT02786810|18643383|P1|STARTED|Overall Study||10
7573954|NCT02786771|18643390|P2|NOT COMPLETED|Overall Study||6
7573955|NCT02786771|18643391|P1|NOT COMPLETED|Overall Study||10
7573956|NCT02786771|18643390|P2|COMPLETED|Overall Study||56
7573957|NCT02786771|18643391|P1|COMPLETED|Overall Study||53
7573958|NCT02786771|18643390|P2|STARTED|Overall Study||62
7573959|NCT02786771|18643391|P1|STARTED|Overall Study||63
7573960|NCT02786719|18643397|P1|NOT COMPLETED|Overall Study||1
7573961|NCT02786719|18643397|P1|COMPLETED|Overall Study||12
7573962|NCT02786719|18643397|P1|STARTED|Overall Study||13
7573963|NCT02786537|18643409|P6|NOT COMPLETED|As Treated||7
7573964|NCT02786537|18643410|P5|NOT COMPLETED|As Treated||12
7573965|NCT02786537|18643411|P4|NOT COMPLETED|As Treated||35
7573966|NCT02786537|18643412|P3|NOT COMPLETED|As Treated||0
7573967|NCT02786537|18643413|P2|NOT COMPLETED|As Treated||62
7573968|NCT02786537|18643414|P1|NOT COMPLETED|As Treated||6
7573969|NCT02786537|18643409|P6|COMPLETED|As Treated||40
7573970|NCT02786537|18643410|P5|COMPLETED|As Treated||87
7573971|NCT02786537|18643411|P4|COMPLETED|As Treated||359
7573972|NCT02786537|18643412|P3|COMPLETED|As Treated||15
7573973|NCT02786537|18643413|P2|COMPLETED|As Treated||602
7573974|NCT02786537|18643414|P1|COMPLETED|As Treated||50
7573975|NCT02786537|18643409|P6|STARTED|As Treated||47
7573976|NCT02786537|18643410|P5|STARTED|As Treated||99
7573977|NCT02786537|18643411|P4|STARTED|As Treated||394
7573978|NCT02786537|18643412|P3|STARTED|As Treated||15
7573979|NCT02786537|18643413|P2|STARTED|As Treated||664
7573980|NCT02786537|18643414|P1|STARTED|As Treated||56
7573981|NCT02786537|18643409|P6|NOT COMPLETED|As Randomized||7
7573982|NCT02786537|18643410|P5|NOT COMPLETED|As Randomized||12
7573983|NCT02786537|18643411|P4|NOT COMPLETED|As Randomized||35
7573984|NCT02786537|18643412|P3|NOT COMPLETED|As Randomized||0
7573985|NCT02786537|18643413|P2|NOT COMPLETED|As Randomized||62
7573986|NCT02786537|18643414|P1|NOT COMPLETED|As Randomized||6
7573987|NCT02786537|18643409|P6|COMPLETED|As Randomized||41
7573988|NCT02786537|18643410|P5|COMPLETED|As Randomized||87
7573989|NCT02786537|18643411|P4|COMPLETED|As Randomized||378
7573990|NCT02786537|18643412|P3|COMPLETED|As Randomized||15
7573991|NCT02786537|18643413|P2|COMPLETED|As Randomized||582
7573992|NCT02786537|18643414|P1|COMPLETED|As Randomized||50
7573993|NCT02786537|18643409|P6|STARTED|As Randomized||48
7573994|NCT02786537|18643410|P5|STARTED|As Randomized||99
7573995|NCT02786537|18643411|P4|STARTED|As Randomized||413
7573996|NCT02786537|18643412|P3|STARTED|As Randomized||15
7573997|NCT02786537|18643413|P2|STARTED|As Randomized||644
7573998|NCT02786537|18643414|P1|STARTED|As Randomized||56
7573999|NCT02786355|18643462|P1|NOT COMPLETED|Overall Study||0
7574000|NCT02786355|18643462|P1|COMPLETED|Overall Study||35
7574001|NCT02786355|18643462|P1|STARTED|Overall Study||35
7574002|NCT02786004|18643471|P2|NOT COMPLETED|Overall Study||1
7574003|NCT02786004|18643472|P1|NOT COMPLETED|Overall Study||0
7574004|NCT02786004|18643471|P2|COMPLETED|Overall Study||9
7574005|NCT02786004|18643472|P1|COMPLETED|Overall Study||14
7574006|NCT02786004|18643471|P2|STARTED|Overall Study||10
7574007|NCT02786004|18643472|P1|STARTED|Overall Study||14
7574008|NCT02785913|18643480|P1|NOT COMPLETED|Overall Study||26
7574009|NCT02785913|18643480|P1|COMPLETED|Overall Study||0
7574010|NCT02785913|18643480|P1|STARTED|Overall Study||26
7574011|NCT02785900|18643491|P2|NOT COMPLETED|Overall Study||123
7574012|NCT02785900|18643492|P1|NOT COMPLETED|Overall Study||117
7574013|NCT02785900|18643491|P2|COMPLETED|Overall Study||0
7574014|NCT02785900|18643492|P1|COMPLETED|Overall Study||0
7574015|NCT02785900|18643491|P2|STARTED|Overall Study||123
7574016|NCT02785900|18643492|P1|STARTED|Overall Study||117
7574017|NCT02785770|18643516|P4|NOT COMPLETED|Intervention Period 4 (1 Day)||0
7574018|NCT02785770|18643517|P3|NOT COMPLETED|Intervention Period 4 (1 Day)||0
7574019|NCT02785770|18643518|P2|NOT COMPLETED|Intervention Period 4 (1 Day)||0
7574020|NCT02785770|18643519|P1|NOT COMPLETED|Intervention Period 4 (1 Day)||0
7574021|NCT02785770|18643516|P4|COMPLETED|Intervention Period 4 (1 Day)||10
7574022|NCT02785770|18643517|P3|COMPLETED|Intervention Period 4 (1 Day)||10
7574023|NCT02785770|18643518|P2|COMPLETED|Intervention Period 4 (1 Day)||10
7574024|NCT02785770|18643519|P1|COMPLETED|Intervention Period 4 (1 Day)||11
7574025|NCT02785770|18643516|P4|STARTED|Intervention Period 4 (1 Day)||10
7574026|NCT02785770|18643517|P3|STARTED|Intervention Period 4 (1 Day)||10
7574027|NCT02785770|18643518|P2|STARTED|Intervention Period 4 (1 Day)||10
7574028|NCT02785770|18643519|P1|STARTED|Intervention Period 4 (1 Day)||11
7574029|NCT02785770|18643516|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
7574030|NCT02785770|18643517|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
7574031|NCT02785770|18643518|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
7574032|NCT02785770|18643519|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
7574033|NCT02785770|18643516|P4|COMPLETED|Washout Period 3 (7 Days)||10
7574034|NCT02785770|18643517|P3|COMPLETED|Washout Period 3 (7 Days)||10
7574035|NCT02785770|18643518|P2|COMPLETED|Washout Period 3 (7 Days)||10
7574036|NCT02785770|18643519|P1|COMPLETED|Washout Period 3 (7 Days)||11
7574037|NCT02785770|18643516|P4|STARTED|Washout Period 3 (7 Days)||10
7574038|NCT02785770|18643517|P3|STARTED|Washout Period 3 (7 Days)||10
7574039|NCT02785770|18643518|P2|STARTED|Washout Period 3 (7 Days)||10
7574040|NCT02785770|18643519|P1|STARTED|Washout Period 3 (7 Days)||11
7574041|NCT02785770|18643516|P4|NOT COMPLETED|Intervention Period 3 (1 Day)||1
7574042|NCT02785770|18643517|P3|NOT COMPLETED|Intervention Period 3 (1 Day)||0
7574043|NCT02785770|18643518|P2|NOT COMPLETED|Intervention Period 3 (1 Day)||0
7574044|NCT02785770|18643519|P1|NOT COMPLETED|Intervention Period 3 (1 Day)||0
7574045|NCT02785770|18643516|P4|COMPLETED|Intervention Period 3 (1 Day)||10
7574046|NCT02785770|18643517|P3|COMPLETED|Intervention Period 3 (1 Day)||10
7574047|NCT02785770|18643518|P2|COMPLETED|Intervention Period 3 (1 Day)||10
7574048|NCT02785770|18643519|P1|COMPLETED|Intervention Period 3 (1 Day)||11
7574049|NCT02785770|18643516|P4|STARTED|Intervention Period 3 (1 Day)||11
7574050|NCT02785770|18643517|P3|STARTED|Intervention Period 3 (1 Day)||10
7574051|NCT02785770|18643518|P2|STARTED|Intervention Period 3 (1 Day)||10
7574052|NCT02785770|18643519|P1|STARTED|Intervention Period 3 (1 Day)||11
7574053|NCT02785770|18643516|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
7574054|NCT02785770|18643517|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
7574055|NCT02785770|18643518|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
7574056|NCT02785770|18643519|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
7574057|NCT02785770|18643516|P4|COMPLETED|Washout Period 2 (7 Days)||11
7574058|NCT02785770|18643517|P3|COMPLETED|Washout Period 2 (7 Days)||10
7574059|NCT02785770|18643518|P2|COMPLETED|Washout Period 2 (7 Days)||10
7574060|NCT02785770|18643519|P1|COMPLETED|Washout Period 2 (7 Days)||11
7574061|NCT02785770|18643516|P4|STARTED|Washout Period 2 (7 Days)||11
7574062|NCT02785770|18643517|P3|STARTED|Washout Period 2 (7 Days)||10
7574063|NCT02785770|18643518|P2|STARTED|Washout Period 2 (7 Days)||10
7574064|NCT02785770|18643519|P1|STARTED|Washout Period 2 (7 Days)||11
7574065|NCT02785770|18643516|P4|NOT COMPLETED|Intervention Period 2 (1 Day)||0
7574066|NCT02785770|18643517|P3|NOT COMPLETED|Intervention Period 2 (1 Day)||1
7574067|NCT02785770|18643518|P2|NOT COMPLETED|Intervention Period 2 (1 Day)||1
7574068|NCT02785770|18643519|P1|NOT COMPLETED|Intervention Period 2 (1 Day)||0
7574069|NCT02785770|18643516|P4|COMPLETED|Intervention Period 2 (1 Day)||11
7574070|NCT02785770|18643517|P3|COMPLETED|Intervention Period 2 (1 Day)||10
7574071|NCT02785770|18643518|P2|COMPLETED|Intervention Period 2 (1 Day)||10
7574072|NCT02785770|18643519|P1|COMPLETED|Intervention Period 2 (1 Day)||11
7574073|NCT02785770|18643516|P4|STARTED|Intervention Period 2 (1 Day)||11
7574074|NCT02785770|18643517|P3|STARTED|Intervention Period 2 (1 Day)||11
7574075|NCT02785770|18643518|P2|STARTED|Intervention Period 2 (1 Day)||11
7574076|NCT02785770|18643519|P1|STARTED|Intervention Period 2 (1 Day)||11
7574077|NCT02785770|18643516|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
7574078|NCT02785770|18643517|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
7574079|NCT02785770|18643518|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
7574080|NCT02785770|18643519|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
7574081|NCT02785770|18643516|P4|COMPLETED|Washout Period 1 (7 Days)||11
7574082|NCT02785770|18643517|P3|COMPLETED|Washout Period 1 (7 Days)||11
7574083|NCT02785770|18643518|P2|COMPLETED|Washout Period 1 (7 Days)||11
7574084|NCT02785770|18643519|P1|COMPLETED|Washout Period 1 (7 Days)||11
7574085|NCT02785770|18643516|P4|STARTED|Washout Period 1 (7 Days)||11
7574086|NCT02785770|18643517|P3|STARTED|Washout Period 1 (7 Days)||11
7574087|NCT02785770|18643518|P2|STARTED|Washout Period 1 (7 Days)||11
7574088|NCT02785770|18643519|P1|STARTED|Washout Period 1 (7 Days)||11
7574089|NCT02785770|18643516|P4|NOT COMPLETED|Intervention Period 1 (1 Day)||0
7574090|NCT02785770|18643517|P3|NOT COMPLETED|Intervention Period 1 (1 Day)||0
7574091|NCT02785770|18643518|P2|NOT COMPLETED|Intervention Period 1 (1 Day)||0
7574092|NCT02785770|18643519|P1|NOT COMPLETED|Intervention Period 1 (1 Day)||0
7574093|NCT02785770|18643516|P4|COMPLETED|Intervention Period 1 (1 Day)||11
7574094|NCT02785770|18643517|P3|COMPLETED|Intervention Period 1 (1 Day)||11
7574095|NCT02785770|18643518|P2|COMPLETED|Intervention Period 1 (1 Day)||11
7574096|NCT02785770|18643519|P1|COMPLETED|Intervention Period 1 (1 Day)||11
7574097|NCT02785770|18643516|P4|STARTED|Intervention Period 1 (1 Day)||11
7574098|NCT02785770|18643517|P3|STARTED|Intervention Period 1 (1 Day)||11
7574099|NCT02785770|18643518|P2|STARTED|Intervention Period 1 (1 Day)||11
7574100|NCT02785770|18643519|P1|STARTED|Intervention Period 1 (1 Day)||11
7574101|NCT02785588|18643586|P1|NOT COMPLETED|Phase2 Controlled Image &Data Collection||0
7574102|NCT02785588|18643586|P1|COMPLETED|Phase2 Controlled Image &Data Collection||5
7574103|NCT02785588|18643586|P1|STARTED|Phase2 Controlled Image &Data Collection|Phase 2 participants represent newly enrolled participants.|5
7574104|NCT02785588|18643586|P1|NOT COMPLETED|Phase 1: Initial Feasibility Assessment||2
7574105|NCT02785588|18643586|P1|COMPLETED|Phase 1: Initial Feasibility Assessment||47
7574106|NCT02785588|18643586|P1|STARTED|Phase 1: Initial Feasibility Assessment||49
7574107|NCT02785458|18643602|P2|NOT COMPLETED|3 Months||111
7574108|NCT02785458|18643603|P1|NOT COMPLETED|3 Months||128
7574109|NCT02785458|18643602|P2|COMPLETED|3 Months||293
7574110|NCT02785458|18643603|P1|COMPLETED|3 Months||315
7574111|NCT02785458|18643602|P2|STARTED|3 Months||404
7574112|NCT02785458|18643603|P1|STARTED|3 Months||443
7574113|NCT02785458|18643602|P2|NOT COMPLETED|1 Month||75
7574114|NCT02785458|18643603|P1|NOT COMPLETED|1 Month||83
7574115|NCT02785458|18643602|P2|COMPLETED|1 Month||404
7574116|NCT02785458|18643603|P1|COMPLETED|1 Month||443
7574117|NCT02785458|18643602|P2|STARTED|1 Month||479
7574118|NCT02785458|18643603|P1|STARTED|1 Month||526
7574119|NCT02785458|18643602|P2|NOT COMPLETED|Baseline||0
7574120|NCT02785458|18643603|P1|NOT COMPLETED|Baseline||0
7574121|NCT02785458|18643602|P2|COMPLETED|Baseline||479
7574122|NCT02785458|18643603|P1|COMPLETED|Baseline||526
7574123|NCT02785458|18643602|P2|STARTED|Baseline||479
7574124|NCT02785458|18643603|P1|STARTED|Baseline||526
7574125|NCT02785432|18643613|P2|NOT COMPLETED|Overall Study||0
7574126|NCT02785432|18643614|P1|NOT COMPLETED|Overall Study||0
7574127|NCT02785432|18643613|P2|COMPLETED|Overall Study||7
7574128|NCT02785432|18643614|P1|COMPLETED|Overall Study||4
7574129|NCT02785432|18643613|P2|STARTED|Overall Study||7
7574130|NCT02785432|18643614|P1|STARTED|Overall Study||4
7574131|NCT02785406|18643628|P2|NOT COMPLETED|Overall Study||0
7574132|NCT02785406|18643629|P1|NOT COMPLETED|Overall Study||0
7574133|NCT02785406|18643628|P2|COMPLETED|Overall Study||10
7574134|NCT02785406|18643629|P1|COMPLETED|Overall Study||10
7574135|NCT02785406|18643628|P2|Completed Second Week|Overall Study||10
7574136|NCT02785406|18643629|P1|Completed Second Week|Overall Study||10
7574137|NCT02785406|18643628|P2|Completed First Week|Overall Study||10
7574138|NCT02785406|18643629|P1|Completed First Week|Overall Study||10
7574139|NCT02785406|18643628|P2|STARTED|Overall Study||10
7574140|NCT02785406|18643629|P1|STARTED|Overall Study||10
7574141|NCT02785354|18643704|P3|NOT COMPLETED|Overall Study||0
7574142|NCT02785354|18643705|P2|NOT COMPLETED|Overall Study||0
7574143|NCT02785354|18643706|P1|NOT COMPLETED|Overall Study||0
7574144|NCT02785354|18643704|P3|COMPLETED|Overall Study||44653
7574145|NCT02785354|18643705|P2|COMPLETED|Overall Study||31388
7574146|NCT02785354|18643706|P1|COMPLETED|Overall Study||27060
7574147|NCT02785354|18643704|P3|STARTED|Overall Study||44653
7574148|NCT02785354|18643705|P2|STARTED|Overall Study||31388
7574149|NCT02785354|18643706|P1|STARTED|Overall Study||27060
7574150|NCT02785185|18643739|P4|NOT COMPLETED|Overall Study||0
7574151|NCT02785185|18643740|P3|NOT COMPLETED|Overall Study||2
7574152|NCT02785185|18643741|P2|NOT COMPLETED|Overall Study||1
7574153|NCT02785185|18643742|P1|NOT COMPLETED|Overall Study||1
7574154|NCT02785185|18643739|P4|COMPLETED|Overall Study||16
7574155|NCT02785185|18643740|P3|COMPLETED|Overall Study||15
7574156|NCT02785185|18643741|P2|COMPLETED|Overall Study||56
7574157|NCT02785185|18643742|P1|COMPLETED|Overall Study||59
7574158|NCT02785185|18643739|P4|STARTED|Overall Study||16
7574159|NCT02785185|18643740|P3|STARTED|Overall Study||17
7574160|NCT02785185|18643741|P2|STARTED|Overall Study||57
7574161|NCT02785185|18643742|P1|STARTED|Overall Study||60
7574162|NCT02785172|18643756|P4|NOT COMPLETED|Overall Study||0
7574163|NCT02785172|18643757|P3|NOT COMPLETED|Overall Study||1
7574164|NCT02785172|18643758|P2|NOT COMPLETED|Overall Study||1
7574165|NCT02785172|18643759|P1|NOT COMPLETED|Overall Study||0
7574166|NCT02785172|18643756|P4|COMPLETED|Overall Study||14
7574167|NCT02785172|18643757|P3|COMPLETED|Overall Study||15
7574168|NCT02785172|18643758|P2|COMPLETED|Overall Study||62
7574169|NCT02785172|18643759|P1|COMPLETED|Overall Study||61
7574170|NCT02785172|18643756|P4|STARTED|Overall Study||14
7574171|NCT02785172|18643757|P3|STARTED|Overall Study||16
7574172|NCT02785172|18643758|P2|STARTED|Overall Study||63
7574173|NCT02785172|18643759|P1|STARTED|Overall Study||61
7574174|NCT02785159|18643773|P4|NOT COMPLETED|Overall Study||3
7574175|NCT02785159|18643774|P3|NOT COMPLETED|Overall Study||3
7574176|NCT02785159|18643775|P2|NOT COMPLETED|Overall Study||13
7574177|NCT02785159|18643776|P1|NOT COMPLETED|Overall Study||11
7574178|NCT02785159|18643773|P4|COMPLETED|Overall Study||14
7574179|NCT02785159|18643774|P3|COMPLETED|Overall Study||12
7574180|NCT02785159|18643775|P2|COMPLETED|Overall Study||45
7574181|NCT02785159|18643776|P1|COMPLETED|Overall Study||51
7574182|NCT02785159|18643773|P4|STARTED|Overall Study||17
7574183|NCT02785159|18643774|P3|STARTED|Overall Study||15
7574184|NCT02785159|18643775|P2|STARTED|Overall Study||58
7574185|NCT02785159|18643776|P1|STARTED|Overall Study||62
7574186|NCT02784925|18643786|P1|NOT COMPLETED|Overall Study||0
7574187|NCT02784925|18643786|P1|COMPLETED|Overall Study||30
7574188|NCT02784925|18643786|P1|STARTED|Overall Study||30
7574189|NCT02784834|18643790|P1|NOT COMPLETED|Overall Study||1
7574190|NCT02784834|18643790|P1|COMPLETED|Overall Study||1
7574191|NCT02784834|18643790|P1|STARTED|Overall Study||2
7574192|NCT02784704|18643796|P2|NOT COMPLETED|Overall Study||9
7574193|NCT02784704|18643797|P1|NOT COMPLETED|Overall Study||13
7574194|NCT02784704|18643796|P2|COMPLETED|Overall Study||241
7574195|NCT02784704|18643797|P1|COMPLETED|Overall Study||237
7574196|NCT02784704|18643796|P2|Treated|Overall Study||249
7574197|NCT02784704|18643797|P1|Treated|Overall Study||250
7574198|NCT02784704|18643796|P2|STARTED|Overall Study||250
7574199|NCT02784704|18643797|P1|STARTED|Overall Study||250
7574200|NCT02784613|18643807|P1|NOT COMPLETED|Overall Study||2
7574201|NCT02784613|18643807|P1|COMPLETED|Overall Study||8
7574202|NCT02784613|18643807|P1|STARTED|Overall Study||10
7574203|NCT02784587|18643813|P1|NOT COMPLETED|Overall Study||0
7574204|NCT02784587|18643813|P1|COMPLETED|Overall Study||25
7574205|NCT02784587|18643813|P1|STARTED|Overall Study||25
7574206|NCT02784548|18643817|P1|NOT COMPLETED|Overall Study||0
7574207|NCT02784548|18643817|P1|COMPLETED|Overall Study||15
7574208|NCT02784548|18643817|P1|STARTED|Overall Study||15
7574209|NCT02784444|18643826|P4|NOT COMPLETED|Overall Study||13
7574210|NCT02784444|18643827|P3|NOT COMPLETED|Overall Study||12
7574211|NCT02784444|18643828|P2|NOT COMPLETED|Overall Study||9
7574212|NCT02784444|18643829|P1|NOT COMPLETED|Overall Study||16
7574213|NCT02784444|18643826|P4|COMPLETED|Overall Study||88
7574214|NCT02784444|18643827|P3|COMPLETED|Overall Study||86
7574215|NCT02784444|18643828|P2|COMPLETED|Overall Study||90
7574216|NCT02784444|18643829|P1|COMPLETED|Overall Study||78
7574217|NCT02784444|18643826|P4|STARTED|Overall Study||101
7574218|NCT02784444|18643827|P3|STARTED|Overall Study||98
7574219|NCT02784444|18643828|P2|STARTED|Overall Study||99
7574220|NCT02784444|18643829|P1|STARTED|Overall Study||94
7574221|NCT02784275|18643871|P4|NOT COMPLETED|Overall Study||1
7574222|NCT02784275|18643872|P3|NOT COMPLETED|Overall Study||1
7574223|NCT02784275|18643873|P2|NOT COMPLETED|Overall Study||0
7574224|NCT02784275|18643874|P1|NOT COMPLETED|Overall Study||1
7574225|NCT02784275|18643871|P4|COMPLETED|Overall Study||14
7574226|NCT02784275|18643872|P3|COMPLETED|Overall Study||16
7574227|NCT02784275|18643873|P2|COMPLETED|Overall Study||16
7574228|NCT02784275|18643874|P1|COMPLETED|Overall Study||15
7574229|NCT02784275|18643871|P4|STARTED|Overall Study||15
7574230|NCT02784275|18643872|P3|STARTED|Overall Study||17
7574231|NCT02784275|18643873|P2|STARTED|Overall Study||16
7574232|NCT02784275|18643874|P1|STARTED|Overall Study||16
7574233|NCT02784106|18643918|P4|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||2
7574234|NCT02784106|18643919|P3|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||3
7574235|NCT02784106|18643920|P2|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
7574236|NCT02784106|18643921|P1|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
7574237|NCT02784106|18643918|P4|COMPLETED|Open-Label Extension Period (26 Weeks)||19
7574238|NCT02784106|18643919|P3|COMPLETED|Open-Label Extension Period (26 Weeks)||15
7574239|NCT02784106|18643920|P2|COMPLETED|Open-Label Extension Period (26 Weeks)||0
7574240|NCT02784106|18643921|P1|COMPLETED|Open-Label Extension Period (26 Weeks)||0
7574241|NCT02784106|18643918|P4|STARTED|Open-Label Extension Period (26 Weeks)||21
7574242|NCT02784106|18643919|P3|STARTED|Open-Label Extension Period (26 Weeks)||18
7574243|NCT02784106|18643920|P2|STARTED|Open-Label Extension Period (26 Weeks)||0
7574244|NCT02784106|18643921|P1|STARTED|Open-Label Extension Period (26 Weeks)||0
7574245|NCT02784106|18643918|P4|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
7574246|NCT02784106|18643919|P3|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
7574247|NCT02784106|18643920|P2|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||6
7574248|NCT02784106|18643921|P1|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||8
7574249|NCT02784106|18643918|P4|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
7574250|NCT02784106|18643919|P3|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
7574251|NCT02784106|18643920|P2|COMPLETED|Double-Blind Treatment Period (12 Weeks)||27
7574252|NCT02784106|18643921|P1|COMPLETED|Double-Blind Treatment Period (12 Weeks)||24
7574253|NCT02784106|18643918|P4|STARTED|Double-Blind Treatment Period (12 Weeks)||0
7574254|NCT02784106|18643919|P3|STARTED|Double-Blind Treatment Period (12 Weeks)||0
7574255|NCT02784106|18643920|P2|STARTED|Double-Blind Treatment Period (12 Weeks)||33
7574256|NCT02784106|18643921|P1|STARTED|Double-Blind Treatment Period (12 Weeks)||32
7574257|NCT02783898|18643984|P2|NOT COMPLETED|Overall Study||1
7574258|NCT02783898|18643985|P1|NOT COMPLETED|Overall Study||1
7574259|NCT02783898|18643984|P2|COMPLETED|Overall Study||116
7574260|NCT02783898|18643985|P1|COMPLETED|Overall Study||124
7574261|NCT02783898|18643984|P2|STARTED|Overall Study||117
7574262|NCT02783898|18643985|P1|STARTED|Overall Study||125
7574263|NCT02783820|18644009|P4|NOT COMPLETED|Overall Study||0
7574264|NCT02783820|18644010|P3|NOT COMPLETED|Overall Study||0
7574265|NCT02783820|18644011|P2|NOT COMPLETED|Overall Study||0
7574266|NCT02783820|18644012|P1|NOT COMPLETED|Overall Study||0
7574267|NCT02783820|18644009|P4|COMPLETED|Overall Study||6
7574268|NCT02783820|18644010|P3|COMPLETED|Overall Study||6
7574269|NCT02783820|18644011|P2|COMPLETED|Overall Study||6
7574270|NCT02783820|18644012|P1|COMPLETED|Overall Study||6
7574271|NCT02783820|18644009|P4|STARTED|Overall Study||6
7574272|NCT02783820|18644010|P3|STARTED|Overall Study||6
7574273|NCT02783820|18644011|P2|STARTED|Overall Study||6
7574274|NCT02783820|18644012|P1|STARTED|Overall Study||6
7574275|NCT02783768|18644022|P2|NOT COMPLETED|Overall Study||0
7574276|NCT02783768|18644023|P1|NOT COMPLETED|Overall Study||1
7574277|NCT02783768|18644022|P2|COMPLETED|Overall Study||5
7574278|NCT02783768|18644023|P1|COMPLETED|Overall Study||5
7574279|NCT02783768|18644022|P2|STARTED|Overall Study||5
7574280|NCT02783768|18644023|P1|STARTED|Overall Study||6
7574281|NCT02783729|18644045|P4|NOT COMPLETED|Overall Study||9
7574282|NCT02783729|18644046|P3|NOT COMPLETED|Overall Study||8
7574283|NCT02783729|18644047|P2|NOT COMPLETED|Overall Study||17
7574284|NCT02783729|18644048|P1|NOT COMPLETED|Overall Study||10
7574285|NCT02783729|18644045|P4|COMPLETED|Overall Study||260
7574286|NCT02783729|18644046|P3|COMPLETED|Overall Study||258
7574287|NCT02783729|18644047|P2|COMPLETED|Overall Study||246
7574288|NCT02783729|18644048|P1|COMPLETED|Overall Study||198
7574289|NCT02783729|18644045|P4|STARTED|Overall Study||269
7574290|NCT02783729|18644046|P3|STARTED|Overall Study||266
7574291|NCT02783729|18644047|P2|STARTED|Overall Study||263
7574292|NCT02783729|18644048|P1|STARTED|Overall Study||208
7574293|NCT02783599|18644114|P1|NOT COMPLETED|Overall Study||40
7574294|NCT02783599|18644114|P1|COMPLETED|Overall Study||11
7574295|NCT02783599|18644114|P1|Received At Least One Dose of Study Drug|Overall Study||51
7574296|NCT02783599|18644114|P1|STARTED|Overall Study||51
7574297|NCT02783573|18644130|P3|NOT COMPLETED|Delayed-Start Period||12
7574298|NCT02783573|18644131|P2|NOT COMPLETED|Delayed-Start Period||17
7574299|NCT02783573|18644132|P1|NOT COMPLETED|Delayed-Start Period||0
7574300|NCT02783573|18644130|P3|COMPLETED|Delayed-Start Period||0
7574301|NCT02783573|18644131|P2|COMPLETED|Delayed-Start Period||0
7574302|NCT02783573|18644132|P1|COMPLETED|Delayed-Start Period||0
7574303|NCT02783573|18644130|P3|Received at Least 1 Dose of Study Drug|Delayed-Start Period||12
7574304|NCT02783573|18644131|P2|Received at Least 1 Dose of Study Drug|Delayed-Start Period||14
7574305|NCT02783573|18644132|P1|Received at Least 1 Dose of Study Drug|Delayed-Start Period||0
7574306|NCT02783573|18644130|P3|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|12
7574307|NCT02783573|18644131|P2|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|17
7574308|NCT02783573|18644132|P1|STARTED|Delayed-Start Period|Participants from placebo group were randomized to Lanabecestat 20 mg and 50 mg.|0
7574309|NCT02783573|18644130|P3|NOT COMPLETED|Placebo-Controlled Treatment Period||548
7574310|NCT02783573|18644131|P2|NOT COMPLETED|Placebo-Controlled Treatment Period||562
7574311|NCT02783573|18644132|P1|NOT COMPLETED|Placebo-Controlled Treatment Period||536
7574312|NCT02783573|18644130|P3|COMPLETED|Placebo-Controlled Treatment Period||22
7574313|NCT02783573|18644131|P2|COMPLETED|Placebo-Controlled Treatment Period||28
7574314|NCT02783573|18644132|P1|COMPLETED|Placebo-Controlled Treatment Period||26
7574315|NCT02783573|18644130|P3|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||568
7574316|NCT02783573|18644131|P2|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||588
7574317|NCT02783573|18644132|P1|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||558
7574318|NCT02783573|18644130|P3|STARTED|Placebo-Controlled Treatment Period||570
7574319|NCT02783573|18644131|P2|STARTED|Placebo-Controlled Treatment Period||590
7574320|NCT02783573|18644132|P1|STARTED|Placebo-Controlled Treatment Period||562
7574321|NCT02783443|18644188|P2|NOT COMPLETED|Overall Study||0
7574322|NCT02783443|18644189|P1|NOT COMPLETED|Overall Study||0
7574323|NCT02783443|18644188|P2|COMPLETED|Overall Study||30
7574324|NCT02783443|18644189|P1|COMPLETED|Overall Study||30
7574325|NCT02783443|18644188|P2|STARTED|Overall Study||30
7574326|NCT02783443|18644189|P1|STARTED|Overall Study||30
7574327|NCT02783170|18644197|P2|NOT COMPLETED|Overall Study||0
7574328|NCT02783170|18644198|P1|NOT COMPLETED|Overall Study||1
7574329|NCT02783170|18644197|P2|COMPLETED|Overall Study||38
7574330|NCT02783170|18644198|P1|COMPLETED|Overall Study||42
7574331|NCT02783170|18644197|P2|Safety Population|Overall Study|Excluded sub. randomized but not vaccinated. Excluded sub. randomized to seq. but got simultaneous.|38
7574332|NCT02783170|18644198|P1|Safety Population|Overall Study|Added subject randomized to sequential but got simultaneous.|42
7574333|NCT02783170|18644197|P2|STARTED|Overall Study||38
7574334|NCT02783170|18644198|P1|STARTED|Overall Study||43
7574335|NCT02783066|18644239|P1|NOT COMPLETED|Overall Study||13
7574336|NCT02783066|18644239|P1|COMPLETED|Overall Study|complete 4-week pulseflow offloading wearing test|3
7574337|NCT02783066|18644239|P1|STARTED|Overall Study||16
7574338|NCT02783027|18644255|P2|NOT COMPLETED|Overall Study||17
7574339|NCT02783027|18644256|P1|NOT COMPLETED|Overall Study||23
7574340|NCT02783027|18644255|P2|COMPLETED|Overall Study||27
7574341|NCT02783027|18644256|P1|COMPLETED|Overall Study||16
7574342|NCT02783027|18644255|P2|STARTED|Overall Study||44
7574343|NCT02783027|18644256|P1|STARTED|Overall Study||39
7574344|NCT02782923|18644270|P1|NOT COMPLETED|Overall Study||15
7574345|NCT02782923|18644270|P1|COMPLETED|Overall Study||4
7574346|NCT02782923|18644270|P1|STARTED|Overall Study||19
7574347|NCT02782676|18644276|P2|NOT COMPLETED|Overall Study||1
7574348|NCT02782676|18644277|P1|NOT COMPLETED|Overall Study||0
7574349|NCT02782676|18644276|P2|COMPLETED|Overall Study||209
7574350|NCT02782676|18644277|P1|COMPLETED|Overall Study||211
7574351|NCT02782676|18644276|P2|STARTED|Overall Study||210
7574352|NCT02782676|18644277|P1|STARTED|Overall Study||211
7574353|NCT02782377|18644305|P1|NOT COMPLETED|Overall Study||5
7574354|NCT02782377|18644305|P1|COMPLETED|Overall Study|data from five of the patients were excluded due to interpretation difficulties|35
7574355|NCT02782377|18644305|P1|STARTED|Overall Study||40
7574356|NCT02782364|18644318|P2|NOT COMPLETED|Overall Study||0
7574357|NCT02782364|18644319|P1|NOT COMPLETED|Overall Study||0
7574358|NCT02782364|18644318|P2|COMPLETED|Overall Study||18
7574359|NCT02782364|18644319|P1|COMPLETED|Overall Study||18
7574360|NCT02782364|18644318|P2|STARTED|Overall Study||18
7574361|NCT02782364|18644319|P1|STARTED|Overall Study||18
7574362|NCT02782325|18644340|P3|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||4
7574363|NCT02782325|18644341|P2|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
7574364|NCT02782325|18644342|P1|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
7574365|NCT02782325|18644340|P3|COMPLETED|Open Label FMT Period (up to 24 Weeks)||1
7574366|NCT02782325|18644341|P2|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
7574367|NCT02782325|18644342|P1|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
7574368|NCT02782325|18644340|P3|STARTED|Open Label FMT Period (up to 24 Weeks)|1 participant decided to not participate in the open label period|5
7574369|NCT02782325|18644341|P2|STARTED|Open Label FMT Period (up to 24 Weeks)||0
7574370|NCT02782325|18644342|P1|STARTED|Open Label FMT Period (up to 24 Weeks)||0
7574371|NCT02782325|18644340|P3|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
7574372|NCT02782325|18644341|P2|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||2
7574373|NCT02782325|18644342|P1|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||4
7574374|NCT02782325|18644340|P3|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
7574375|NCT02782325|18644341|P2|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
7574376|NCT02782325|18644342|P1|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
7574377|NCT02782325|18644340|P3|STARTED|Blinded FMT Treatment (up to 24 Weeks)||0
7574378|NCT02782325|18644341|P2|STARTED|Blinded FMT Treatment (up to 24 Weeks)||2
7574379|NCT02782325|18644342|P1|STARTED|Blinded FMT Treatment (up to 24 Weeks)||4
7574380|NCT02782169|18644370|P2|NOT COMPLETED|Overall Study||2
7574381|NCT02782169|18644371|P1|NOT COMPLETED|Overall Study||1
7574382|NCT02782169|18644370|P2|COMPLETED|Overall Study||52
7574383|NCT02782169|18644371|P1|COMPLETED|Overall Study||55
7574384|NCT02782169|18644370|P2|STARTED|Overall Study||54
7574385|NCT02782169|18644371|P1|STARTED|Overall Study||56
7574386|NCT02781844|18644389|P8|NOT COMPLETED|Treatment Period 2||0
7574387|NCT02781844|18644390|P7|NOT COMPLETED|Treatment Period 2||0
7574388|NCT02781844|18644391|P6|NOT COMPLETED|Treatment Period 2||0
7574389|NCT02781844|18644392|P5|NOT COMPLETED|Treatment Period 2||0
7574390|NCT02781844|18644393|P4|NOT COMPLETED|Treatment Period 2||0
7574391|NCT02781844|18644394|P3|NOT COMPLETED|Treatment Period 2||0
7574392|NCT02781844|18644395|P2|NOT COMPLETED|Treatment Period 2||0
7574393|NCT02781844|18644396|P1|NOT COMPLETED|Treatment Period 2||0
7574394|NCT02781844|18644389|P8|COMPLETED|Treatment Period 2||4
7574395|NCT02781844|18644390|P7|COMPLETED|Treatment Period 2||4
7574396|NCT02781844|18644391|P6|COMPLETED|Treatment Period 2||4
7574397|NCT02781844|18644392|P5|COMPLETED|Treatment Period 2||4
7574398|NCT02781844|18644393|P4|COMPLETED|Treatment Period 2||4
7574399|NCT02781844|18644394|P3|COMPLETED|Treatment Period 2||4
7574400|NCT02781844|18644395|P2|COMPLETED|Treatment Period 2||4
7574401|NCT02781844|18644396|P1|COMPLETED|Treatment Period 2||5
7574402|NCT02781844|18644389|P8|STARTED|Treatment Period 2||4
7574403|NCT02781844|18644390|P7|STARTED|Treatment Period 2||4
7574404|NCT02781844|18644391|P6|STARTED|Treatment Period 2||4
7574405|NCT02781844|18644392|P5|STARTED|Treatment Period 2||4
7574406|NCT02781844|18644393|P4|STARTED|Treatment Period 2||4
7574407|NCT02781844|18644394|P3|STARTED|Treatment Period 2||4
7574408|NCT02781844|18644395|P2|STARTED|Treatment Period 2||4
7574409|NCT02781844|18644396|P1|STARTED|Treatment Period 2||5
7574410|NCT02781844|18644389|P8|NOT COMPLETED|Treatment Period 1||0
7574411|NCT02781844|18644390|P7|NOT COMPLETED|Treatment Period 1||0
7574412|NCT02781844|18644391|P6|NOT COMPLETED|Treatment Period 1||1
7574413|NCT02781844|18644392|P5|NOT COMPLETED|Treatment Period 1||0
7574414|NCT02781844|18644393|P4|NOT COMPLETED|Treatment Period 1||0
7574415|NCT02781844|18644394|P3|NOT COMPLETED|Treatment Period 1||0
7574416|NCT02781844|18644395|P2|NOT COMPLETED|Treatment Period 1||0
7574417|NCT02781844|18644396|P1|NOT COMPLETED|Treatment Period 1||0
7574418|NCT02781844|18644389|P8|COMPLETED|Treatment Period 1||4
7574419|NCT02781844|18644390|P7|COMPLETED|Treatment Period 1||4
7574420|NCT02781844|18644391|P6|COMPLETED|Treatment Period 1||4
7574421|NCT02781844|18644392|P5|COMPLETED|Treatment Period 1||4
7574422|NCT02781844|18644393|P4|COMPLETED|Treatment Period 1||4
7574423|NCT02781844|18644394|P3|COMPLETED|Treatment Period 1||4
7574424|NCT02781844|18644395|P2|COMPLETED|Treatment Period 1||4
7574425|NCT02781844|18644396|P1|COMPLETED|Treatment Period 1||5
7574426|NCT02781844|18644389|P8|STARTED|Treatment Period 1||4
7574427|NCT02781844|18644390|P7|STARTED|Treatment Period 1||4
7574428|NCT02781844|18644391|P6|STARTED|Treatment Period 1||5
7574429|NCT02781844|18644392|P5|STARTED|Treatment Period 1||4
7574430|NCT02781844|18644393|P4|STARTED|Treatment Period 1||4
7574431|NCT02781844|18644394|P3|STARTED|Treatment Period 1||4
7574432|NCT02781844|18644395|P2|STARTED|Treatment Period 1||4
7574433|NCT02781844|18644396|P1|STARTED|Treatment Period 1||5
7574434|NCT02781818|18644529|P3|NOT COMPLETED|Overall Study||1
7574435|NCT02781818|18644530|P2|NOT COMPLETED|Overall Study||2
7574436|NCT02781818|18644531|P1|NOT COMPLETED|Overall Study||4
7574437|NCT02781818|18644529|P3|COMPLETED|Overall Study||16
7574438|NCT02781818|18644530|P2|COMPLETED|Overall Study||16
7574439|NCT02781818|18644531|P1|COMPLETED|Overall Study||16
7574440|NCT02781818|18644529|P3|STARTED|Overall Study||17
7574441|NCT02781818|18644530|P2|STARTED|Overall Study||18
7574442|NCT02781818|18644531|P1|STARTED|Overall Study||20
7574443|NCT02781649|18644548|P3|NOT COMPLETED|Overall Study||0
7574444|NCT02781649|18644549|P2|NOT COMPLETED|Overall Study||0
7574445|NCT02781649|18644550|P1|NOT COMPLETED|Overall Study||0
7574446|NCT02781649|18644548|P3|COMPLETED|Overall Study||3
7574447|NCT02781649|18644549|P2|COMPLETED|Overall Study||0
7574448|NCT02781649|18644550|P1|COMPLETED|Overall Study||7
7574449|NCT02781649|18644548|P3|STARTED|Overall Study||3
7574450|NCT02781649|18644549|P2|STARTED|Overall Study||0
7574451|NCT02781649|18644550|P1|STARTED|Overall Study|4 in this group had insufficient viral RNA for genotyping. They were treated as 1a|7
7574452|NCT02781571|18644576|P1|NOT COMPLETED|Overall Study||0
7574453|NCT02781571|18644576|P1|COMPLETED|Overall Study||79
7574454|NCT02781571|18644576|P1|STARTED|Overall Study||79
7574455|NCT02781558|18644597|P2|NOT COMPLETED|Overall Study||2
7574456|NCT02781558|18644598|P1|NOT COMPLETED|Overall Study||3
7574457|NCT02781558|18644597|P2|COMPLETED|Overall Study||101
7574458|NCT02781558|18644598|P1|COMPLETED|Overall Study||98
7574459|NCT02781558|18644597|P2|STARTED|Overall Study||103
7574460|NCT02781558|18644598|P1|STARTED|Overall Study||101
7574461|NCT02781454|18644637|P3|NOT COMPLETED|Overall Study||1
7574462|NCT02781454|18644638|P2|NOT COMPLETED|Overall Study||0
7574463|NCT02781454|18644639|P1|NOT COMPLETED|Overall Study||0
7574464|NCT02781454|18644637|P3|COMPLETED|Overall Study||5
7574465|NCT02781454|18644638|P2|COMPLETED|Overall Study||6
7574466|NCT02781454|18644639|P1|COMPLETED|Overall Study||8
7574467|NCT02781454|18644637|P3|STARTED|Overall Study||6
7574468|NCT02781454|18644638|P2|STARTED|Overall Study||6
7574469|NCT02781454|18644639|P1|STARTED|Overall Study||8
7574470|NCT02781324|18644685|P2|NOT COMPLETED|Overall Study||2
7574471|NCT02781324|18644686|P1|NOT COMPLETED|Overall Study||2
7574472|NCT02781324|18644685|P2|COMPLETED|Overall Study||31
7574473|NCT02781324|18644686|P1|COMPLETED|Overall Study||31
7574474|NCT02781324|18644685|P2|STARTED|Overall Study||33
7574475|NCT02781324|18644686|P1|STARTED|Overall Study||33
7574476|NCT02781311|18644715|P3|NOT COMPLETED|Overall Study||4
7574477|NCT02781311|18644716|P2|NOT COMPLETED|Overall Study||26
7574478|NCT02781311|18644717|P1|NOT COMPLETED|Overall Study||26
7574479|NCT02781311|18644715|P3|COMPLETED|Overall Study||8
7574480|NCT02781311|18644716|P2|COMPLETED|Overall Study||57
7574481|NCT02781311|18644717|P1|COMPLETED|Overall Study||48
7574482|NCT02781311|18644715|P3|mITT Population|Overall Study||11
7574483|NCT02781311|18644716|P2|mITT Population|Overall Study||78
7574484|NCT02781311|18644717|P1|mITT Population|Overall Study||70
7574485|NCT02781311|18644715|P3|Safety Population (Treated)|Overall Study||12
7574486|NCT02781311|18644716|P2|Safety Population (Treated)|Overall Study||81
7574487|NCT02781311|18644717|P1|Safety Population (Treated)|Overall Study||73
7574488|NCT02781311|18644715|P3|STARTED|Overall Study||12
7574489|NCT02781311|18644716|P2|STARTED|Overall Study||83
7574490|NCT02781311|18644717|P1|STARTED|Overall Study||74
7574491|NCT02781051|18644726|P1|NOT COMPLETED|Overall Study||2
7574492|NCT02781051|18644726|P1|COMPLETED|Overall Study||14
7574493|NCT02781051|18644726|P1|STARTED|Overall Study||16
7574494|NCT02780869|18644733|P2|NOT COMPLETED|Overall Study||9
7574495|NCT02780869|18644734|P1|NOT COMPLETED|Overall Study||13
7574496|NCT02780869|18644733|P2|COMPLETED|Overall Study||74
7574497|NCT02780869|18644734|P1|COMPLETED|Overall Study||162
7574498|NCT02780869|18644733|P2|STARTED|Overall Study||83
7574499|NCT02780869|18644734|P1|STARTED|Overall Study||175
7574500|NCT02780856|18644744|P1|NOT COMPLETED|Overall Study||1
7574501|NCT02780856|18644744|P1|COMPLETED|Overall Study||109
7574502|NCT02780856|18644744|P1|STARTED|Overall Study||110
7574503|NCT02780765|18644754|P2|NOT COMPLETED|Overall Study||0
7574504|NCT02780765|18644755|P1|NOT COMPLETED|Overall Study||0
7574505|NCT02780765|18644754|P2|COMPLETED|Overall Study||30
7574506|NCT02780765|18644755|P1|COMPLETED|Overall Study||30
7574507|NCT02780765|18644754|P2|STARTED|Overall Study||30
7574508|NCT02780765|18644755|P1|STARTED|Overall Study||30
7574509|NCT02780700|18644763|P1|NOT COMPLETED|Overall Study||1
7574510|NCT02780700|18644763|P1|COMPLETED|Overall Study||0
7574511|NCT02780700|18644763|P1|STARTED|Overall Study||1
7574512|NCT02780687|18644773|P2|NOT COMPLETED|Overall Study||8
7574513|NCT02780687|18644774|P1|NOT COMPLETED|Overall Study||34
7574514|NCT02780687|18644773|P2|COMPLETED|Overall Study||0
7574515|NCT02780687|18644774|P1|COMPLETED|Overall Study||0
7574516|NCT02780687|18644773|P2|STARTED|Overall Study||8
7574517|NCT02780687|18644774|P1|STARTED|Overall Study||34
7574518|NCT02780661|18644785|P2|NOT COMPLETED|Period 2||0
7574519|NCT02780661|18644786|P1|NOT COMPLETED|Period 2||0
7574520|NCT02780661|18644785|P2|COMPLETED|Period 2||9
7574521|NCT02780661|18644786|P1|COMPLETED|Period 2||10
7574522|NCT02780661|18644785|P2|STARTED|Period 2||9
7574523|NCT02780661|18644786|P1|STARTED|Period 2||10
7574524|NCT02780661|18644785|P2|NOT COMPLETED|Wash Out Period||0
7574525|NCT02780661|18644786|P1|NOT COMPLETED|Wash Out Period||0
7574526|NCT02780661|18644785|P2|COMPLETED|Wash Out Period||9
7574527|NCT02780661|18644786|P1|COMPLETED|Wash Out Period||10
7574528|NCT02780661|18644785|P2|STARTED|Wash Out Period||9
7574529|NCT02780661|18644786|P1|STARTED|Wash Out Period||10
7574530|NCT02780661|18644785|P2|NOT COMPLETED|Period 1||0
7574531|NCT02780661|18644786|P1|NOT COMPLETED|Period 1||0
7574532|NCT02780661|18644785|P2|COMPLETED|Period 1||9
7574533|NCT02780661|18644786|P1|COMPLETED|Period 1||10
7574534|NCT02780661|18644785|P2|STARTED|Period 1||9
7574535|NCT02780661|18644786|P1|STARTED|Period 1||10
7574536|NCT02780622|18644802|P2|NOT COMPLETED|Treatment Period 2||0
7574537|NCT02780622|18644803|P1|NOT COMPLETED|Treatment Period 2||0
7574538|NCT02780622|18644802|P2|COMPLETED|Treatment Period 2||10
7574539|NCT02780622|18644803|P1|COMPLETED|Treatment Period 2||10
7574540|NCT02780622|18644802|P2|STARTED|Treatment Period 2||10
7574541|NCT02780622|18644803|P1|STARTED|Treatment Period 2||10
7574542|NCT02780622|18644802|P2|NOT COMPLETED|Treatment Period 1||0
7574543|NCT02780622|18644803|P1|NOT COMPLETED|Treatment Period 1||0
7574544|NCT02780622|18644802|P2|COMPLETED|Treatment Period 1||10
7574545|NCT02780622|18644803|P1|COMPLETED|Treatment Period 1||10
7574546|NCT02780622|18644802|P2|STARTED|Treatment Period 1||10
7574547|NCT02780622|18644803|P1|STARTED|Treatment Period 1||10
7574548|NCT02780388|18644846|P5|NOT COMPLETED|Overall Study||0
7574549|NCT02780388|18644847|P4|NOT COMPLETED|Overall Study||0
7574550|NCT02780388|18644848|P3|NOT COMPLETED|Overall Study||0
7574551|NCT02780388|18644849|P2|NOT COMPLETED|Overall Study||2
7574552|NCT02780388|18644850|P1|NOT COMPLETED|Overall Study||1
7574553|NCT02780388|18644846|P5|COMPLETED|Overall Study||12
7574554|NCT02780388|18644847|P4|COMPLETED|Overall Study||12
7574555|NCT02780388|18644848|P3|COMPLETED|Overall Study||10
7574556|NCT02780388|18644849|P2|COMPLETED|Overall Study||6
7574557|NCT02780388|18644850|P1|COMPLETED|Overall Study||14
7574558|NCT02780388|18644846|P5|STARTED|Overall Study||12
7574559|NCT02780388|18644847|P4|STARTED|Overall Study||12
7574560|NCT02780388|18644848|P3|STARTED|Overall Study||10
7574561|NCT02780388|18644849|P2|STARTED|Overall Study||8
7574562|NCT02780388|18644850|P1|STARTED|Overall Study||15
7574563|NCT02780349|18644907|P1|NOT COMPLETED|Overall Study||2
7574564|NCT02780349|18644907|P1|COMPLETED|Overall Study||101
7574565|NCT02780349|18644907|P1|STARTED|Overall Study||103
7574566|NCT02780167|18644916|P5|NOT COMPLETED|Overall Study||17
7574567|NCT02780167|18644917|P4|NOT COMPLETED|Overall Study||19
7574568|NCT02780167|18644918|P3|NOT COMPLETED|Overall Study||24
7574569|NCT02780167|18644919|P2|NOT COMPLETED|Overall Study||22
7574570|NCT02780167|18644920|P1|NOT COMPLETED|Overall Study||28
7574571|NCT02780167|18644916|P5|COMPLETED|Overall Study||38
7574572|NCT02780167|18644917|P4|COMPLETED|Overall Study||37
7574573|NCT02780167|18644918|P3|COMPLETED|Overall Study||27
7574574|NCT02780167|18644919|P2|COMPLETED|Overall Study||27
7574575|NCT02780167|18644920|P1|COMPLETED|Overall Study||28
7574576|NCT02780167|18644916|P5|STARTED|Overall Study||55
7574577|NCT02780167|18644917|P4|STARTED|Overall Study||56
7574578|NCT02780167|18644918|P3|STARTED|Overall Study||51
7574579|NCT02780167|18644919|P2|STARTED|Overall Study||49
7574580|NCT02780167|18644920|P1|STARTED|Overall Study||56
7574581|NCT02780115|18645057|P5|NOT COMPLETED|Overall Study||1
7574582|NCT02780115|18645058|P4|NOT COMPLETED|Overall Study||1
7574583|NCT02780115|18645059|P3|NOT COMPLETED|Overall Study||1
7574584|NCT02780115|18645060|P2|NOT COMPLETED|Overall Study||1
7574585|NCT02780115|18645061|P1|NOT COMPLETED|Overall Study||0
7574586|NCT02780115|18645057|P5|COMPLETED|Overall Study||30
7574587|NCT02780115|18645058|P4|COMPLETED|Overall Study||31
7574588|NCT02780115|18645059|P3|COMPLETED|Overall Study||29
7574589|NCT02780115|18645060|P2|COMPLETED|Overall Study||29
7574590|NCT02780115|18645061|P1|COMPLETED|Overall Study||28
7574591|NCT02780115|18645057|P5|STARTED|Overall Study||31
7574592|NCT02780115|18645058|P4|STARTED|Overall Study||32
7574593|NCT02780115|18645059|P3|STARTED|Overall Study||30
7574594|NCT02780115|18645060|P2|STARTED|Overall Study||30
7574595|NCT02780115|18645061|P1|STARTED|Overall Study||28
7574596|NCT02779543|18645080|P2|NOT COMPLETED|Overall Study||0
7574597|NCT02779543|18645081|P1|NOT COMPLETED|Overall Study||0
7574598|NCT02779543|18645080|P2|COMPLETED|Overall Study||100
7574599|NCT02779543|18645081|P1|COMPLETED|Overall Study||100
7574600|NCT02779543|18645080|P2|STARTED|Overall Study||100
7574601|NCT02779543|18645081|P1|STARTED|Overall Study||100
7574602|NCT02779491|18645097|P4|NOT COMPLETED|Overall Study||2
7574603|NCT02779491|18645098|P3|NOT COMPLETED|Overall Study||1
7574604|NCT02779491|18645099|P2|NOT COMPLETED|Overall Study||1
7574605|NCT02779491|18645100|P1|NOT COMPLETED|Overall Study||0
7574606|NCT02779491|18645097|P4|COMPLETED|Overall Study||15
7574607|NCT02779491|18645098|P3|COMPLETED|Overall Study||17
7574608|NCT02779491|18645099|P2|COMPLETED|Overall Study||26
7574609|NCT02779491|18645100|P1|COMPLETED|Overall Study||32
7574610|NCT02779491|18645097|P4|STARTED|Overall Study||17
7574611|NCT02779491|18645098|P3|STARTED|Overall Study||18
7574612|NCT02779491|18645099|P2|STARTED|Overall Study||27
7574613|NCT02779491|18645100|P1|STARTED|Overall Study||32
7574614|NCT02779166|18645120|P2|NOT COMPLETED|Overall Study||0
7574615|NCT02779166|18645121|P1|NOT COMPLETED|Overall Study||0
7574616|NCT02779166|18645120|P2|COMPLETED|Overall Study||48
7574617|NCT02779166|18645121|P1|COMPLETED|Overall Study||50
7574618|NCT02779166|18645120|P2|STARTED|Overall Study||48
7574619|NCT02779166|18645121|P1|STARTED|Overall Study||50
7574620|NCT02779075|18645131|P2|NOT COMPLETED|Overall Study||3
7574621|NCT02779075|18645132|P1|NOT COMPLETED|Overall Study||2
7574622|NCT02779075|18645131|P2|COMPLETED|Overall Study||10
7574623|NCT02779075|18645132|P1|COMPLETED|Overall Study||14
7574624|NCT02779075|18645131|P2|STARTED|Overall Study||13
7574625|NCT02779075|18645132|P1|STARTED|Overall Study||16
7574626|NCT02778880|18645142|P2|NOT COMPLETED|Overall Study||3
7574627|NCT02778880|18645143|P1|NOT COMPLETED|Overall Study||1
7574628|NCT02778880|18645142|P2|COMPLETED|Overall Study||42
7574629|NCT02778880|18645143|P1|COMPLETED|Overall Study||44
7574630|NCT02778880|18645142|P2|STARTED|Overall Study||45
7574631|NCT02778880|18645143|P1|STARTED|Overall Study||45
7574632|NCT02778867|18645195|P4|NOT COMPLETED|Phase 2||2
7574633|NCT02778867|18645196|P3|NOT COMPLETED|Phase 2||1
7574634|NCT02778867|18645197|P2|NOT COMPLETED|Phase 2||0
7574635|NCT02778867|18645198|P1|NOT COMPLETED|Phase 2||0
7574636|NCT02778867|18645195|P4|COMPLETED|Phase 2||9
7574637|NCT02778867|18645196|P3|COMPLETED|Phase 2||20
7574638|NCT02778867|18645197|P2|COMPLETED|Phase 2||0
7574639|NCT02778867|18645198|P1|COMPLETED|Phase 2||0
7574640|NCT02778867|18645195|P4|STARTED|Phase 2|Optional phase for 6FED non-responders|11
7574641|NCT02778867|18645196|P3|STARTED|Phase 2|Optional phase for 1FED non-responders|21
7574642|NCT02778867|18645197|P2|STARTED|Phase 2|6FED non-responders from Phase 1 have the option to undergo SGC in Phase 2|0
7574643|NCT02778867|18645198|P1|STARTED|Phase 2|1FED non-responders from Phase 1 have the option to undergo 6FED in Phase 2|0
7574644|NCT02778867|18645195|P4|NOT COMPLETED|Phase 1||0
7574645|NCT02778867|18645196|P3|NOT COMPLETED|Phase 1||0
7574646|NCT02778867|18645197|P2|NOT COMPLETED|Phase 1||3
7574647|NCT02778867|18645198|P1|NOT COMPLETED|Phase 1||2
7574648|NCT02778867|18645195|P4|COMPLETED|Phase 1||0
7574649|NCT02778867|18645196|P3|COMPLETED|Phase 1||0
7574650|NCT02778867|18645197|P2|COMPLETED|Phase 1||59
7574651|NCT02778867|18645198|P1|COMPLETED|Phase 1||65
7574652|NCT02778867|18645195|P4|STARTED|Phase 1||0
7574653|NCT02778867|18645196|P3|STARTED|Phase 1||0
7574654|NCT02778867|18645197|P2|STARTED|Phase 1||62
7574655|NCT02778867|18645198|P1|STARTED|Phase 1||67
7574656|NCT02778555|18645219|P3|NOT COMPLETED|Overall Study||107
7574657|NCT02778555|18645220|P2|NOT COMPLETED|Overall Study||32
7574658|NCT02778555|18645221|P1|NOT COMPLETED|Overall Study||55
7574659|NCT02778555|18645219|P3|COMPLETED|Overall Study||211
7574660|NCT02778555|18645220|P2|COMPLETED|Overall Study||177
7574661|NCT02778555|18645221|P1|COMPLETED|Overall Study||131
7574662|NCT02778555|18645219|P3|STARTED|Overall Study||318
7574663|NCT02778555|18645220|P2|STARTED|Overall Study||209
7574664|NCT02778555|18645221|P1|STARTED|Overall Study||186
7574665|NCT02778204|18645233|P4|NOT COMPLETED|Overall Study||4
7574666|NCT02778204|18645234|P3|NOT COMPLETED|Overall Study||4
7574667|NCT02778204|18645235|P2|NOT COMPLETED|Overall Study||0
7574668|NCT02778204|18645236|P1|NOT COMPLETED|Overall Study||2
7574669|NCT02778204|18645233|P4|COMPLETED|Overall Study||12
7574670|NCT02778204|18645234|P3|COMPLETED|Overall Study||12
7574671|NCT02778204|18645235|P2|COMPLETED|Overall Study||7
7574672|NCT02778204|18645236|P1|COMPLETED|Overall Study||6
7574673|NCT02778204|18645233|P4|STARTED|Overall Study||16
7574674|NCT02778204|18645234|P3|STARTED|Overall Study||16
7574675|NCT02778204|18645235|P2|STARTED|Overall Study||7
7574676|NCT02778204|18645236|P1|STARTED|Overall Study||8
7574677|NCT02778152|18645280|P1|NOT COMPLETED|Overall Study||0
7574678|NCT02778152|18645280|P1|COMPLETED|Overall Study||13
7574679|NCT02778152|18645280|P1|STARTED|Overall Study||13
7574680|NCT02778113|18645285|P4|NOT COMPLETED|Study Period Four||0
7574681|NCT02778113|18645286|P3|NOT COMPLETED|Study Period Four||0
7574682|NCT02778113|18645287|P2|NOT COMPLETED|Study Period Four||0
7574683|NCT02778113|18645288|P1|NOT COMPLETED|Study Period Four||0
7574684|NCT02778113|18645285|P4|COMPLETED|Study Period Four||4
7574685|NCT02778113|18645286|P3|COMPLETED|Study Period Four||2
7574686|NCT02778113|18645287|P2|COMPLETED|Study Period Four||4
7574687|NCT02778113|18645288|P1|COMPLETED|Study Period Four||3
7574688|NCT02778113|18645285|P4|Received Study Drug|Study Period Four||4
7574689|NCT02778113|18645286|P3|Received Study Drug|Study Period Four||2
7574690|NCT02778113|18645287|P2|Received Study Drug|Study Period Four||4
7574691|NCT02778113|18645288|P1|Received Study Drug|Study Period Four||3
7574692|NCT02778113|18645285|P4|STARTED|Study Period Four||4
7574693|NCT02778113|18645286|P3|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|2
7574694|NCT02778113|18645287|P2|STARTED|Study Period Four||4
7574695|NCT02778113|18645288|P1|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|3
7574696|NCT02778113|18645285|P4|NOT COMPLETED|Study Period Three||0
7574697|NCT02778113|18645286|P3|NOT COMPLETED|Study Period Three||0
7574698|NCT02778113|18645287|P2|NOT COMPLETED|Study Period Three||0
7574699|NCT02778113|18645288|P1|NOT COMPLETED|Study Period Three||0
7574700|NCT02778113|18645285|P4|COMPLETED|Study Period Three||4
7574701|NCT02778113|18645286|P3|COMPLETED|Study Period Three||3
7574702|NCT02778113|18645287|P2|COMPLETED|Study Period Three||4
7574703|NCT02778113|18645288|P1|COMPLETED|Study Period Three||4
7574704|NCT02778113|18645285|P4|Received Study Drug|Study Period Three||4
7574705|NCT02778113|18645286|P3|Received Study Drug|Study Period Three||3
7574706|NCT02778113|18645287|P2|Received Study Drug|Study Period Three||4
7574707|NCT02778113|18645288|P1|Received Study Drug|Study Period Three||4
7574708|NCT02778113|18645285|P4|STARTED|Study Period Three||4
7574709|NCT02778113|18645286|P3|STARTED|Study Period Three|One participant completed study period two, but did not enter study period three.|3
7574710|NCT02778113|18645287|P2|STARTED|Study Period Three||4
7574711|NCT02778113|18645288|P1|STARTED|Study Period Three||4
7574712|NCT02778113|18645285|P4|NOT COMPLETED|Study Period Two||0
7574713|NCT02778113|18645286|P3|NOT COMPLETED|Study Period Two||0
7574714|NCT02778113|18645287|P2|NOT COMPLETED|Study Period Two||0
7574715|NCT02778113|18645288|P1|NOT COMPLETED|Study Period Two||0
7574716|NCT02778113|18645285|P4|COMPLETED|Study Period Two||4
7574717|NCT02778113|18645286|P3|COMPLETED|Study Period Two||4
7574718|NCT02778113|18645287|P2|COMPLETED|Study Period Two||4
7574719|NCT02778113|18645288|P1|COMPLETED|Study Period Two||4
7574720|NCT02778113|18645285|P4|Received Study Drug|Study Period Two||4
7574721|NCT02778113|18645286|P3|Received Study Drug|Study Period Two||4
7574722|NCT02778113|18645287|P2|Received Study Drug|Study Period Two||4
7574723|NCT02778113|18645288|P1|Received Study Drug|Study Period Two||4
7574724|NCT02778113|18645285|P4|STARTED|Study Period Two||4
7574725|NCT02778113|18645286|P3|STARTED|Study Period Two||4
7574726|NCT02778113|18645287|P2|STARTED|Study Period Two||4
7574727|NCT02778113|18645288|P1|STARTED|Study Period Two||4
7574728|NCT02778113|18645285|P4|NOT COMPLETED|Study Period One||0
7574729|NCT02778113|18645286|P3|NOT COMPLETED|Study Period One||0
7574730|NCT02778113|18645287|P2|NOT COMPLETED|Study Period One||0
7574731|NCT02778113|18645288|P1|NOT COMPLETED|Study Period One||0
7574732|NCT02778113|18645285|P4|COMPLETED|Study Period One||4
7574733|NCT02778113|18645286|P3|COMPLETED|Study Period One||4
7574734|NCT02778113|18645287|P2|COMPLETED|Study Period One||4
7574735|NCT02778113|18645288|P1|COMPLETED|Study Period One||4
7574736|NCT02778113|18645285|P4|Received Study Drug|Study Period One||4
7574737|NCT02778113|18645286|P3|Received Study Drug|Study Period One||4
7574738|NCT02778113|18645287|P2|Received Study Drug|Study Period One||4
7574739|NCT02778113|18645288|P1|Received Study Drug|Study Period One||4
7574740|NCT02778113|18645285|P4|STARTED|Study Period One||4
7574741|NCT02778113|18645286|P3|STARTED|Study Period One||4
7574742|NCT02778113|18645287|P2|STARTED|Study Period One||4
7574743|NCT02778113|18645288|P1|STARTED|Study Period One||4
7574744|NCT02778100|18645328|P2|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
7574745|NCT02778100|18645329|P1|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
7574746|NCT02778100|18645328|P2|COMPLETED|Period 2 (No Cold Symptoms)||0
7574747|NCT02778100|18645329|P1|COMPLETED|Period 2 (No Cold Symptoms)||17
7574836|NCT02777827|18645416|P2|STARTED|Treatment Period 5||5
7574748|NCT02778100|18645328|P2|STARTED|Period 2 (No Cold Symptoms)|Cohort 2 only administered NG to participants with a common cold who are taking oxymetazoline.|0
7574749|NCT02778100|18645329|P1|STARTED|Period 2 (No Cold Symptoms)||17
7574750|NCT02778100|18645328|P2|NOT COMPLETED|Period 1 (Common Cold)||0
7574751|NCT02778100|18645329|P1|NOT COMPLETED|Period 1 (Common Cold)||1
7574752|NCT02778100|18645328|P2|COMPLETED|Period 1 (Common Cold)||18
7574753|NCT02778100|18645329|P1|COMPLETED|Period 1 (Common Cold)||17
7574754|NCT02778100|18645328|P2|STARTED|Period 1 (Common Cold)||18
7574755|NCT02778100|18645329|P1|STARTED|Period 1 (Common Cold)||18
7574756|NCT02778074|18645360|P2|NOT COMPLETED|Overall Study||10
7574757|NCT02778074|18645361|P1|NOT COMPLETED|Overall Study||7
7574758|NCT02778074|18645360|P2|COMPLETED|Overall Study||62
7574759|NCT02778074|18645361|P1|COMPLETED|Overall Study||65
7574760|NCT02778074|18645360|P2|STARTED|Overall Study||72
7574761|NCT02778074|18645361|P1|STARTED|Overall Study||72
7574762|NCT02777944|18645369|P2|NOT COMPLETED|Overall Study||0
7574763|NCT02777944|18645370|P1|NOT COMPLETED|Overall Study||0
7574764|NCT02777944|18645369|P2|COMPLETED|Overall Study||156
7574765|NCT02777944|18645370|P1|COMPLETED|Overall Study||157
7574766|NCT02777944|18645369|P2|STARTED|Overall Study||156
7574767|NCT02777944|18645370|P1|STARTED|Overall Study||157
7574768|NCT02777931|18645382|P2|NOT COMPLETED|Overall Study||13
7574769|NCT02777931|18645383|P1|NOT COMPLETED|Overall Study||12
7574770|NCT02777931|18645382|P2|COMPLETED|Overall Study||39
7574771|NCT02777931|18645383|P1|COMPLETED|Overall Study||37
7574772|NCT02777931|18645382|P2|Modified Intent to Treat Population|Overall Study||50
7574773|NCT02777931|18645383|P1|Modified Intent to Treat Population|Overall Study||46
7574774|NCT02777931|18645382|P2|Safety Population|Overall Study||50
7574775|NCT02777931|18645383|P1|Safety Population|Overall Study||47
7574776|NCT02777931|18645382|P2|STARTED|Overall Study||52
7574777|NCT02777931|18645383|P1|STARTED|Overall Study||49
7574778|NCT02777918|18645393|P2|NOT COMPLETED|Overall Study||4
7574779|NCT02777918|18645394|P1|NOT COMPLETED|Overall Study||3
7574780|NCT02777918|18645393|P2|COMPLETED|Overall Study||43
7574781|NCT02777918|18645394|P1|COMPLETED|Overall Study||50
7574782|NCT02777918|18645393|P2|STARTED|Overall Study||47
7574783|NCT02777918|18645394|P1|STARTED|Overall Study||53
7574784|NCT02777827|18645412|P6|NOT COMPLETED|Treatment Period 6||0
7574785|NCT02777827|18645413|P5|NOT COMPLETED|Treatment Period 6||0
7574786|NCT02777827|18645414|P4|NOT COMPLETED|Treatment Period 6||0
7574787|NCT02777827|18645415|P3|NOT COMPLETED|Treatment Period 6||0
7574788|NCT02777827|18645416|P2|NOT COMPLETED|Treatment Period 6||0
7574789|NCT02777827|18645417|P1|NOT COMPLETED|Treatment Period 6||0
7574790|NCT02777827|18645412|P6|COMPLETED|Treatment Period 6||6
7574791|NCT02777827|18645413|P5|COMPLETED|Treatment Period 6||4
7574792|NCT02777827|18645414|P4|COMPLETED|Treatment Period 6||5
7574793|NCT02777827|18645415|P3|COMPLETED|Treatment Period 6||4
7574794|NCT02777827|18645416|P2|COMPLETED|Treatment Period 6||5
7574795|NCT02777827|18645417|P1|COMPLETED|Treatment Period 6||5
7574796|NCT02777827|18645412|P6|STARTED|Treatment Period 6||6
7574797|NCT02777827|18645413|P5|STARTED|Treatment Period 6||4
7574798|NCT02777827|18645414|P4|STARTED|Treatment Period 6||5
7574799|NCT02777827|18645415|P3|STARTED|Treatment Period 6||4
7574800|NCT02777827|18645416|P2|STARTED|Treatment Period 6||5
7574801|NCT02777827|18645417|P1|STARTED|Treatment Period 6||5
7574802|NCT02777827|18645412|P6|NOT COMPLETED|Washout Between Periods 5 and 6||0
7574803|NCT02777827|18645413|P5|NOT COMPLETED|Washout Between Periods 5 and 6||0
7574804|NCT02777827|18645414|P4|NOT COMPLETED|Washout Between Periods 5 and 6||0
7574805|NCT02777827|18645415|P3|NOT COMPLETED|Washout Between Periods 5 and 6||0
7574806|NCT02777827|18645416|P2|NOT COMPLETED|Washout Between Periods 5 and 6||0
7574807|NCT02777827|18645417|P1|NOT COMPLETED|Washout Between Periods 5 and 6||0
7574808|NCT02777827|18645412|P6|COMPLETED|Washout Between Periods 5 and 6||6
7574809|NCT02777827|18645413|P5|COMPLETED|Washout Between Periods 5 and 6||4
7574810|NCT02777827|18645414|P4|COMPLETED|Washout Between Periods 5 and 6||5
7574811|NCT02777827|18645415|P3|COMPLETED|Washout Between Periods 5 and 6||4
7574812|NCT02777827|18645416|P2|COMPLETED|Washout Between Periods 5 and 6||5
7574813|NCT02777827|18645417|P1|COMPLETED|Washout Between Periods 5 and 6||5
7574814|NCT02777827|18645412|P6|STARTED|Washout Between Periods 5 and 6||6
7574815|NCT02777827|18645413|P5|STARTED|Washout Between Periods 5 and 6||4
7574816|NCT02777827|18645414|P4|STARTED|Washout Between Periods 5 and 6||5
7574817|NCT02777827|18645415|P3|STARTED|Washout Between Periods 5 and 6||4
7574818|NCT02777827|18645416|P2|STARTED|Washout Between Periods 5 and 6||5
7574819|NCT02777827|18645417|P1|STARTED|Washout Between Periods 5 and 6||5
7574820|NCT02777827|18645412|P6|NOT COMPLETED|Treatment Period 5||0
7574821|NCT02777827|18645413|P5|NOT COMPLETED|Treatment Period 5||0
7574822|NCT02777827|18645414|P4|NOT COMPLETED|Treatment Period 5||0
7574823|NCT02777827|18645415|P3|NOT COMPLETED|Treatment Period 5||0
7574824|NCT02777827|18645416|P2|NOT COMPLETED|Treatment Period 5||0
7574825|NCT02777827|18645417|P1|NOT COMPLETED|Treatment Period 5||0
7574826|NCT02777827|18645412|P6|COMPLETED|Treatment Period 5||6
7574827|NCT02777827|18645413|P5|COMPLETED|Treatment Period 5||4
7574828|NCT02777827|18645414|P4|COMPLETED|Treatment Period 5||5
7574829|NCT02777827|18645415|P3|COMPLETED|Treatment Period 5||4
7574830|NCT02777827|18645416|P2|COMPLETED|Treatment Period 5||5
7574831|NCT02777827|18645417|P1|COMPLETED|Treatment Period 5||5
7574832|NCT02777827|18645412|P6|STARTED|Treatment Period 5||6
7574833|NCT02777827|18645413|P5|STARTED|Treatment Period 5||4
7574834|NCT02777827|18645414|P4|STARTED|Treatment Period 5||5
7574835|NCT02777827|18645415|P3|STARTED|Treatment Period 5||4
7574837|NCT02777827|18645417|P1|STARTED|Treatment Period 5||5
7574838|NCT02777827|18645412|P6|NOT COMPLETED|Washout Between Periods 4 and 5||0
7574839|NCT02777827|18645413|P5|NOT COMPLETED|Washout Between Periods 4 and 5||0
7574840|NCT02777827|18645414|P4|NOT COMPLETED|Washout Between Periods 4 and 5||0
7574841|NCT02777827|18645415|P3|NOT COMPLETED|Washout Between Periods 4 and 5||0
7574842|NCT02777827|18645416|P2|NOT COMPLETED|Washout Between Periods 4 and 5||0
7574843|NCT02777827|18645417|P1|NOT COMPLETED|Washout Between Periods 4 and 5||0
7574844|NCT02777827|18645412|P6|COMPLETED|Washout Between Periods 4 and 5||6
7574845|NCT02777827|18645413|P5|COMPLETED|Washout Between Periods 4 and 5||4
7574846|NCT02777827|18645414|P4|COMPLETED|Washout Between Periods 4 and 5||5
7574847|NCT02777827|18645415|P3|COMPLETED|Washout Between Periods 4 and 5||4
7574848|NCT02777827|18645416|P2|COMPLETED|Washout Between Periods 4 and 5||5
7574849|NCT02777827|18645417|P1|COMPLETED|Washout Between Periods 4 and 5||5
7574850|NCT02777827|18645412|P6|STARTED|Washout Between Periods 4 and 5||6
7574851|NCT02777827|18645413|P5|STARTED|Washout Between Periods 4 and 5||4
7574852|NCT02777827|18645414|P4|STARTED|Washout Between Periods 4 and 5||5
7574853|NCT02777827|18645415|P3|STARTED|Washout Between Periods 4 and 5||4
7574854|NCT02777827|18645416|P2|STARTED|Washout Between Periods 4 and 5||5
7574855|NCT02777827|18645417|P1|STARTED|Washout Between Periods 4 and 5||5
7574856|NCT02777827|18645412|P6|NOT COMPLETED|Treatment Period 4||0
7574857|NCT02777827|18645413|P5|NOT COMPLETED|Treatment Period 4||0
7574858|NCT02777827|18645414|P4|NOT COMPLETED|Treatment Period 4||0
7574859|NCT02777827|18645415|P3|NOT COMPLETED|Treatment Period 4||0
7574860|NCT02777827|18645416|P2|NOT COMPLETED|Treatment Period 4||0
7574861|NCT02777827|18645417|P1|NOT COMPLETED|Treatment Period 4||0
7574862|NCT02777827|18645412|P6|COMPLETED|Treatment Period 4||6
7574863|NCT02777827|18645413|P5|COMPLETED|Treatment Period 4||4
7574864|NCT02777827|18645414|P4|COMPLETED|Treatment Period 4||5
7574865|NCT02777827|18645415|P3|COMPLETED|Treatment Period 4||4
7574866|NCT02777827|18645416|P2|COMPLETED|Treatment Period 4||5
7574867|NCT02777827|18645417|P1|COMPLETED|Treatment Period 4||5
7574868|NCT02777827|18645412|P6|STARTED|Treatment Period 4||6
7574869|NCT02777827|18645413|P5|STARTED|Treatment Period 4||4
7574870|NCT02777827|18645414|P4|STARTED|Treatment Period 4||5
7574871|NCT02777827|18645415|P3|STARTED|Treatment Period 4||4
7574872|NCT02777827|18645416|P2|STARTED|Treatment Period 4||5
7574873|NCT02777827|18645417|P1|STARTED|Treatment Period 4||5
7574874|NCT02777827|18645412|P6|NOT COMPLETED|Washout Between Periods 3 and 4||0
7574875|NCT02777827|18645413|P5|NOT COMPLETED|Washout Between Periods 3 and 4||0
7574876|NCT02777827|18645414|P4|NOT COMPLETED|Washout Between Periods 3 and 4||0
7574877|NCT02777827|18645415|P3|NOT COMPLETED|Washout Between Periods 3 and 4||1
7574878|NCT02777827|18645416|P2|NOT COMPLETED|Washout Between Periods 3 and 4||0
7574879|NCT02777827|18645417|P1|NOT COMPLETED|Washout Between Periods 3 and 4||0
7574880|NCT02777827|18645412|P6|COMPLETED|Washout Between Periods 3 and 4||6
7574881|NCT02777827|18645413|P5|COMPLETED|Washout Between Periods 3 and 4||4
7574882|NCT02777827|18645414|P4|COMPLETED|Washout Between Periods 3 and 4||5
7574883|NCT02777827|18645415|P3|COMPLETED|Washout Between Periods 3 and 4||4
7574884|NCT02777827|18645416|P2|COMPLETED|Washout Between Periods 3 and 4||5
7574885|NCT02777827|18645417|P1|COMPLETED|Washout Between Periods 3 and 4||5
7574886|NCT02777827|18645412|P6|STARTED|Washout Between Periods 3 and 4||6
7574887|NCT02777827|18645413|P5|STARTED|Washout Between Periods 3 and 4||4
7574888|NCT02777827|18645414|P4|STARTED|Washout Between Periods 3 and 4||5
7574889|NCT02777827|18645415|P3|STARTED|Washout Between Periods 3 and 4||5
7574890|NCT02777827|18645416|P2|STARTED|Washout Between Periods 3 and 4||5
7574891|NCT02777827|18645417|P1|STARTED|Washout Between Periods 3 and 4||5
7574892|NCT02777827|18645412|P6|NOT COMPLETED|Treatment Period 3||0
7574893|NCT02777827|18645413|P5|NOT COMPLETED|Treatment Period 3||0
7574894|NCT02777827|18645414|P4|NOT COMPLETED|Treatment Period 3||0
7574895|NCT02777827|18645415|P3|NOT COMPLETED|Treatment Period 3||0
7574896|NCT02777827|18645416|P2|NOT COMPLETED|Treatment Period 3||0
7574897|NCT02777827|18645417|P1|NOT COMPLETED|Treatment Period 3||0
7574898|NCT02777827|18645412|P6|COMPLETED|Treatment Period 3||6
7574899|NCT02777827|18645413|P5|COMPLETED|Treatment Period 3||4
7574900|NCT02777827|18645414|P4|COMPLETED|Treatment Period 3||5
7574901|NCT02777827|18645415|P3|COMPLETED|Treatment Period 3||5
7574902|NCT02777827|18645416|P2|COMPLETED|Treatment Period 3||5
7574903|NCT02777827|18645417|P1|COMPLETED|Treatment Period 3||5
7574904|NCT02777827|18645412|P6|STARTED|Treatment Period 3||6
7574905|NCT02777827|18645413|P5|STARTED|Treatment Period 3||4
7574906|NCT02777827|18645414|P4|STARTED|Treatment Period 3||5
7574907|NCT02777827|18645415|P3|STARTED|Treatment Period 3||5
7574908|NCT02777827|18645416|P2|STARTED|Treatment Period 3||5
7574909|NCT02777827|18645417|P1|STARTED|Treatment Period 3||5
7574910|NCT02777827|18645412|P6|NOT COMPLETED|Washout Between Periods 2 and 3||0
7574911|NCT02777827|18645413|P5|NOT COMPLETED|Washout Between Periods 2 and 3||0
7574912|NCT02777827|18645414|P4|NOT COMPLETED|Washout Between Periods 2 and 3||0
7574913|NCT02777827|18645415|P3|NOT COMPLETED|Washout Between Periods 2 and 3||0
7574914|NCT02777827|18645416|P2|NOT COMPLETED|Washout Between Periods 2 and 3||0
7574915|NCT02777827|18645417|P1|NOT COMPLETED|Washout Between Periods 2 and 3||0
7574916|NCT02777827|18645412|P6|COMPLETED|Washout Between Periods 2 and 3||6
7574917|NCT02777827|18645413|P5|COMPLETED|Washout Between Periods 2 and 3||4
7574918|NCT02777827|18645414|P4|COMPLETED|Washout Between Periods 2 and 3||5
7574919|NCT02777827|18645415|P3|COMPLETED|Washout Between Periods 2 and 3||5
7574920|NCT02777827|18645416|P2|COMPLETED|Washout Between Periods 2 and 3||5
7574921|NCT02777827|18645417|P1|COMPLETED|Washout Between Periods 2 and 3||5
7574922|NCT02777827|18645412|P6|STARTED|Washout Between Periods 2 and 3||6
7574923|NCT02777827|18645413|P5|STARTED|Washout Between Periods 2 and 3||4
7574924|NCT02777827|18645414|P4|STARTED|Washout Between Periods 2 and 3||5
7574925|NCT02777827|18645415|P3|STARTED|Washout Between Periods 2 and 3||5
7574926|NCT02777827|18645416|P2|STARTED|Washout Between Periods 2 and 3||5
7574927|NCT02777827|18645417|P1|STARTED|Washout Between Periods 2 and 3||5
7574928|NCT02777827|18645412|P6|NOT COMPLETED|Treatment Period 2||0
7574929|NCT02777827|18645413|P5|NOT COMPLETED|Treatment Period 2||0
7574930|NCT02777827|18645414|P4|NOT COMPLETED|Treatment Period 2||0
7574931|NCT02777827|18645415|P3|NOT COMPLETED|Treatment Period 2||0
7574932|NCT02777827|18645416|P2|NOT COMPLETED|Treatment Period 2||0
7574933|NCT02777827|18645417|P1|NOT COMPLETED|Treatment Period 2||0
7574934|NCT02777827|18645412|P6|COMPLETED|Treatment Period 2||6
7574935|NCT02777827|18645413|P5|COMPLETED|Treatment Period 2||4
7574936|NCT02777827|18645414|P4|COMPLETED|Treatment Period 2||5
7574937|NCT02777827|18645415|P3|COMPLETED|Treatment Period 2||5
7574938|NCT02777827|18645416|P2|COMPLETED|Treatment Period 2||5
7574939|NCT02777827|18645417|P1|COMPLETED|Treatment Period 2||5
7574940|NCT02777827|18645412|P6|STARTED|Treatment Period 2||6
7574941|NCT02777827|18645413|P5|STARTED|Treatment Period 2||4
7574942|NCT02777827|18645414|P4|STARTED|Treatment Period 2||5
7574943|NCT02777827|18645415|P3|STARTED|Treatment Period 2||5
7574944|NCT02777827|18645416|P2|STARTED|Treatment Period 2||5
7574945|NCT02777827|18645417|P1|STARTED|Treatment Period 2||5
7574946|NCT02777827|18645412|P6|NOT COMPLETED|Washout Between Periods 1 and 2||0
7574947|NCT02777827|18645413|P5|NOT COMPLETED|Washout Between Periods 1 and 2||0
7574948|NCT02777827|18645414|P4|NOT COMPLETED|Washout Between Periods 1 and 2||0
7574949|NCT02777827|18645415|P3|NOT COMPLETED|Washout Between Periods 1 and 2||0
7574950|NCT02777827|18645416|P2|NOT COMPLETED|Washout Between Periods 1 and 2||0
7574951|NCT02777827|18645417|P1|NOT COMPLETED|Washout Between Periods 1 and 2||0
7574952|NCT02777827|18645412|P6|COMPLETED|Washout Between Periods 1 and 2||6
7574953|NCT02777827|18645413|P5|COMPLETED|Washout Between Periods 1 and 2||4
7574954|NCT02777827|18645414|P4|COMPLETED|Washout Between Periods 1 and 2||5
7574955|NCT02777827|18645415|P3|COMPLETED|Washout Between Periods 1 and 2||5
7574956|NCT02777827|18645416|P2|COMPLETED|Washout Between Periods 1 and 2||5
7574957|NCT02777827|18645417|P1|COMPLETED|Washout Between Periods 1 and 2||5
7574958|NCT02777827|18645412|P6|STARTED|Washout Between Periods 1 and 2||6
7574959|NCT02777827|18645413|P5|STARTED|Washout Between Periods 1 and 2||4
7574960|NCT02777827|18645414|P4|STARTED|Washout Between Periods 1 and 2||5
7574961|NCT02777827|18645415|P3|STARTED|Washout Between Periods 1 and 2||5
7574962|NCT02777827|18645416|P2|STARTED|Washout Between Periods 1 and 2||5
7574963|NCT02777827|18645417|P1|STARTED|Washout Between Periods 1 and 2||5
7574964|NCT02777827|18645412|P6|NOT COMPLETED|Treatment Period 1||0
7574965|NCT02777827|18645413|P5|NOT COMPLETED|Treatment Period 1||0
7574966|NCT02777827|18645414|P4|NOT COMPLETED|Treatment Period 1||0
7574967|NCT02777827|18645415|P3|NOT COMPLETED|Treatment Period 1||0
7574968|NCT02777827|18645416|P2|NOT COMPLETED|Treatment Period 1||0
7574969|NCT02777827|18645417|P1|NOT COMPLETED|Treatment Period 1||0
7574970|NCT02777827|18645412|P6|COMPLETED|Treatment Period 1||6
7574971|NCT02777827|18645413|P5|COMPLETED|Treatment Period 1||4
7574972|NCT02777827|18645414|P4|COMPLETED|Treatment Period 1||5
7574973|NCT02777827|18645415|P3|COMPLETED|Treatment Period 1||5
7574974|NCT02777827|18645416|P2|COMPLETED|Treatment Period 1||5
7574975|NCT02777827|18645417|P1|COMPLETED|Treatment Period 1||5
7574976|NCT02777827|18645412|P6|STARTED|Treatment Period 1||6
7574977|NCT02777827|18645413|P5|STARTED|Treatment Period 1||4
7574978|NCT02777827|18645414|P4|STARTED|Treatment Period 1||5
7574979|NCT02777827|18645415|P3|STARTED|Treatment Period 1||5
7574980|NCT02777827|18645416|P2|STARTED|Treatment Period 1||5
7574981|NCT02777827|18645417|P1|STARTED|Treatment Period 1||5
7574982|NCT02777749|18645572|P3|NOT COMPLETED|Overall Study||0
7574983|NCT02777749|18645573|P2|NOT COMPLETED|Overall Study||0
7574984|NCT02777749|18645574|P1|NOT COMPLETED|Overall Study||0
7574985|NCT02777749|18645572|P3|COMPLETED|Overall Study||51
7574986|NCT02777749|18645573|P2|COMPLETED|Overall Study||51
7574987|NCT02777749|18645574|P1|COMPLETED|Overall Study||53
7574988|NCT02777749|18645572|P3|STARTED|Overall Study||51
7574989|NCT02777749|18645573|P2|STARTED|Overall Study||51
7574990|NCT02777749|18645574|P1|STARTED|Overall Study||53
7574991|NCT02777268|18645594|P1|NOT COMPLETED|Overall Study||0
7574992|NCT02777268|18645594|P1|COMPLETED|Overall Study||16
7574993|NCT02777268|18645594|P1|STARTED|Overall Study||16
7574994|NCT02777242|18645620|P1|NOT COMPLETED|Overall Study||6
7574995|NCT02777242|18645620|P1|COMPLETED|Overall Study||59
7574996|NCT02777242|18645620|P1|STARTED|Overall Study||65
7574997|NCT02777125|18645626|P2|NOT COMPLETED|Overall Study||47
7574998|NCT02777125|18645627|P1|NOT COMPLETED|Overall Study||43
7574999|NCT02777125|18645626|P2|COMPLETED|Overall Study||445
7575000|NCT02777125|18645627|P1|COMPLETED|Overall Study||445
7575001|NCT02777125|18645626|P2|STARTED|Overall Study||492
7575002|NCT02777125|18645627|P1|STARTED|Overall Study||488
7575003|NCT02777086|18645643|P2|NOT COMPLETED|Overall Study||99
7575004|NCT02777086|18645644|P1|NOT COMPLETED|Overall Study||96
7575005|NCT02777086|18645643|P2|COMPLETED|Overall Study||151
7575006|NCT02777086|18645644|P1|COMPLETED|Overall Study||165
7575007|NCT02777086|18645643|P2|STARTED|Overall Study||250
7575008|NCT02777086|18645644|P1|STARTED|Overall Study||261
7575009|NCT02777021|18645658|P2|NOT COMPLETED|Overall Study||17
7575010|NCT02777021|18645659|P1|NOT COMPLETED|Overall Study||17
7575011|NCT02777021|18645658|P2|COMPLETED|Overall Study||77
7575012|NCT02777021|18645659|P1|COMPLETED|Overall Study||43
7575013|NCT02777021|18645658|P2|STARTED|Overall Study||94
7575014|NCT02777021|18645659|P1|STARTED|Overall Study||60
7575015|NCT02776904|18645667|P2|NOT COMPLETED|Overall Study||0
7575016|NCT02776904|18645668|P1|NOT COMPLETED|Overall Study||0
7575017|NCT02776904|18645667|P2|COMPLETED|Overall Study||46
7575018|NCT02776904|18645668|P1|COMPLETED|Overall Study||281
7575019|NCT02776904|18645667|P2|ImPACT|Overall Study|ImPACT testing for the concussed subjects was completed for the clinical assessment (not research).|46
7575020|NCT02776904|18645668|P1|ImPACT|Overall Study||21
7575021|NCT02776904|18645667|P2|Gait Assessment|Overall Study||32
7575022|NCT02776904|18645668|P1|Gait Assessment|Overall Study||178
7575023|NCT02776904|18645667|P2|STARTED|Overall Study||46
7575024|NCT02776904|18645668|P1|STARTED|Overall Study||281
7575025|NCT02776774|18645682|P1|NOT COMPLETED|Overall Study||0
7575026|NCT02776774|18645682|P1|COMPLETED|Overall Study|Total after data cleaning|91
7575027|NCT02776774|18645682|P1|STARTED|Overall Study||91
7575028|NCT02776683|18645687|P2|NOT COMPLETED|Post-switch Period||43
7575029|NCT02776683|18645688|P1|NOT COMPLETED|Post-switch Period||0
7575030|NCT02776683|18645687|P2|COMPLETED|Post-switch Period||0
7575031|NCT02776683|18645688|P1|COMPLETED|Post-switch Period||0
7575032|NCT02776683|18645687|P2|STARTED|Post-switch Period|Entered into Switch Set|43
7575033|NCT02776683|18645688|P1|STARTED|Post-switch Period||0
7575034|NCT02776683|18645687|P2|NOT COMPLETED|Pre-switch Period||0
7575035|NCT02776683|18645688|P1|NOT COMPLETED|Pre-switch Period||80
7575036|NCT02776683|18645687|P2|COMPLETED|Pre-switch Period||0
7575037|NCT02776683|18645688|P1|COMPLETED|Pre-switch Period|Entered into Switch Set|43
7575038|NCT02776683|18645687|P2|STARTED|Pre-switch Period||0
7575039|NCT02776683|18645688|P1|STARTED|Pre-switch Period|Assigned to trial medication or enrolled/treated|123
7575040|NCT02776670|18645699|P2|NOT COMPLETED|Overall Study||6
7575041|NCT02776670|18645700|P1|NOT COMPLETED|Overall Study||0
7575042|NCT02776670|18645699|P2|COMPLETED|Overall Study||108
7575043|NCT02776670|18645700|P1|COMPLETED|Overall Study||117
7575044|NCT02776670|18645699|P2|Safety Analysis Set|Overall Study||114
7575045|NCT02776670|18645700|P1|Safety Analysis Set|Overall Study||117
7575046|NCT02776670|18645699|P2|Per Protocol Analysis Set (PPS)|Overall Study||113
7575047|NCT02776670|18645700|P1|Per Protocol Analysis Set (PPS)|Overall Study||115
7575048|NCT02776670|18645699|P2|Full Analysis Set (FAS)|Overall Study||114
7575049|NCT02776670|18645700|P1|Full Analysis Set (FAS)|Overall Study||117
7575050|NCT02776670|18645699|P2|STARTED|Overall Study||114
7575051|NCT02776670|18645700|P1|STARTED|Overall Study||117
7575052|NCT02776644|18645714|P2|NOT COMPLETED|Overall Study||0
7575053|NCT02776644|18645715|P1|NOT COMPLETED|Overall Study||0
7575054|NCT02776644|18645714|P2|COMPLETED|Overall Study||126
7575055|NCT02776644|18645715|P1|COMPLETED|Overall Study||1223
7575056|NCT02776644|18645714|P2|STARTED|Overall Study||126
7575057|NCT02776644|18645715|P1|STARTED|Overall Study||1223
7575058|NCT02776553|18645757|P2|NOT COMPLETED|Overall Study||3
7575059|NCT02776553|18645758|P1|NOT COMPLETED|Overall Study||3
7575060|NCT02776553|18645757|P2|COMPLETED|Overall Study||5
7575061|NCT02776553|18645758|P1|COMPLETED|Overall Study||6
7575062|NCT02776553|18645757|P2|STARTED|Overall Study|Two subjects were eliminated for repeated hospitalizations.|8
7575063|NCT02776553|18645758|P1|STARTED|Overall Study|One subject was eliminated for repeated hospitalizations.|9
7575064|NCT02776033|18645771|P3|NOT COMPLETED|Overall Study||2
7575065|NCT02776033|18645772|P2|NOT COMPLETED|Overall Study||2
7575066|NCT02776033|18645773|P1|NOT COMPLETED|Overall Study||4
7575067|NCT02776033|18645771|P3|COMPLETED|Overall Study||22
7575068|NCT02776033|18645772|P2|COMPLETED|Overall Study||21
7575069|NCT02776033|18645773|P1|COMPLETED|Overall Study||14
7575070|NCT02776033|18645771|P3|STARTED|Overall Study||24
7575071|NCT02776033|18645772|P2|STARTED|Overall Study||23
7575072|NCT02776033|18645773|P1|STARTED|Overall Study||18
7575073|NCT02775916|18645838|P2|NOT COMPLETED|Overall Study||0
7575074|NCT02775916|18645839|P1|NOT COMPLETED|Overall Study||3
7575075|NCT02775916|18645838|P2|COMPLETED|Overall Study||10
7575076|NCT02775916|18645839|P1|COMPLETED|Overall Study||17
7575077|NCT02775916|18645838|P2|STARTED|Overall Study||10
7575078|NCT02775916|18645839|P1|STARTED|Overall Study||20
7575079|NCT02775903|18645861|P4|NOT COMPLETED|Overall Study||65
7575080|NCT02775903|18645862|P3|NOT COMPLETED|Overall Study||64
7575081|NCT02775903|18645863|P2|NOT COMPLETED|Overall Study||41
7575082|NCT02775903|18645864|P1|NOT COMPLETED|Overall Study||42
7575083|NCT02775903|18645861|P4|COMPLETED|Overall Study||0
7575084|NCT02775903|18645862|P3|COMPLETED|Overall Study||0
7575085|NCT02775903|18645863|P2|COMPLETED|Overall Study||1
7575086|NCT02775903|18645864|P1|COMPLETED|Overall Study||0
7575087|NCT02775903|18645861|P4|Received Study Treatment|Overall Study||62
7575088|NCT02775903|18645862|P3|Received Study Treatment|Overall Study||64
7575089|NCT02775903|18645863|P2|Received Study Treatment|Overall Study||41
7575090|NCT02775903|18645864|P1|Received Study Treatment|Overall Study||38
7575091|NCT02775903|18645861|P4|STARTED|Overall Study||65
7575092|NCT02775903|18645862|P3|STARTED|Overall Study||64
7575093|NCT02775903|18645863|P2|STARTED|Overall Study||42
7575094|NCT02775903|18645864|P1|STARTED|Overall Study||42
7575095|NCT02775864|18645916|P4|NOT COMPLETED|Overall Study||2084
7575096|NCT02775864|18645917|P3|NOT COMPLETED|Overall Study||1860
7575097|NCT02775864|18645918|P2|NOT COMPLETED|Overall Study||4899
7575098|NCT02775864|18645919|P1|NOT COMPLETED|Overall Study||3242
7575099|NCT02775864|18645916|P4|COMPLETED|Overall Study||10765
7575100|NCT02775864|18645917|P3|COMPLETED|Overall Study||10081
7575101|NCT02775864|18645918|P2|COMPLETED|Overall Study||26218
7575102|NCT02775864|18645919|P1|COMPLETED|Overall Study||22772
7575103|NCT02775864|18645916|P4|STARTED|Overall Study||12849
7575104|NCT02775864|18645917|P3|STARTED|Overall Study||11941
7575105|NCT02775864|18645918|P2|STARTED|Overall Study||31117
7575106|NCT02775864|18645919|P1|STARTED|Overall Study||26014
7575107|NCT02775617|18645939|P2|NOT COMPLETED|Overall Study||160
7575108|NCT02775617|18645940|P1|NOT COMPLETED|Overall Study||48
7575109|NCT02775617|18645939|P2|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 76.2% of the resident population|478
7575110|NCT02775617|18645940|P1|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 96.3% of the resident population|605
7575111|NCT02775617|18645939|P2|STARTED|Overall Study|Participants are seen at via a survey of the community. 88.9% of the resident population|638
7575112|NCT02775617|18645940|P1|STARTED|Overall Study|Participants are seen at via a survey of the community. 92.6% of the resident population|653
7575113|NCT02775435|18645952|P2|NOT COMPLETED|Overall Study||281
7575114|NCT02775435|18645953|P1|NOT COMPLETED|Overall Study||278
7575115|NCT02775435|18645952|P2|COMPLETED|Overall Study||0
7575116|NCT02775435|18645953|P1|COMPLETED|Overall Study||0
7575117|NCT02775435|18645952|P2|Switched to Pembrolizumab+Chemotherapy|Overall Study||75
7575118|NCT02775435|18645953|P1|Switched to Pembrolizumab+Chemotherapy|Overall Study||0
7575119|NCT02775435|18645952|P2|Treated|Overall Study||280
7575120|NCT02775435|18645953|P1|Treated|Overall Study||278
7575121|NCT02775435|18645952|P2|STARTED|Overall Study||281
7575122|NCT02775435|18645953|P1|STARTED|Overall Study||278
7575123|NCT02775344|18645971|P2|NOT COMPLETED|Overall Study||2
7575124|NCT02775344|18645972|P1|NOT COMPLETED|Overall Study||3
7575125|NCT02775344|18645971|P2|COMPLETED|Overall Study||38
7575126|NCT02775344|18645972|P1|COMPLETED|Overall Study||37
7575127|NCT02775344|18645971|P2|STARTED|Overall Study||40
7575128|NCT02775344|18645972|P1|STARTED|Overall Study||40
7575129|NCT02775240|18645990|P1|NOT COMPLETED|Overall Study||1
7575130|NCT02775240|18645990|P1|COMPLETED|Overall Study||17
7575131|NCT02775240|18645990|P1|Started Treatment B|Overall Study||17
7575132|NCT02775240|18645990|P1|Started Treatment A|Overall Study||18
7575133|NCT02775240|18645990|P1|STARTED|Overall Study||18
7575134|NCT02774941|18646055|P2|NOT COMPLETED|Overall Study||2
7575135|NCT02774941|18646056|P1|NOT COMPLETED|Overall Study||1
7575136|NCT02774941|18646055|P2|COMPLETED|Overall Study||108
7575137|NCT02774941|18646056|P1|COMPLETED|Overall Study||109
7575138|NCT02774941|18646055|P2|Subjects Excluded|Overall Study||2
7575139|NCT02774941|18646056|P1|Subjects Excluded|Overall Study||1
7575140|NCT02774941|18646055|P2|STARTED|Overall Study||110
7575141|NCT02774941|18646056|P1|STARTED|Overall Study||110
7575142|NCT02774850|18646066|P1|NOT COMPLETED|Overall Study||35
7575143|NCT02774850|18646066|P1|COMPLETED|Overall Study||575
7575144|NCT02774850|18646066|P1|Early Discharge Eligible at Int III|Overall Study|7 of these patients were managed as outpatients. 37 were managed as inpatients.|44
7575145|NCT02774850|18646066|P1|Intensification III|Overall Study||48
7575146|NCT02774850|18646066|P1|Early Discharge Eligible at Int II|Overall Study|56 of these patients were managed as outpatients. 229 were managed as inpatients.|285
7575147|NCT02774850|18646066|P1|Intensification II|Overall Study||342
7575148|NCT02774850|18646066|P1|Early Discharge Eligible at Int I|Overall Study|104 of these patients were managed as outpatients. 270 were managed as inpatients.|374
7575149|NCT02774850|18646066|P1|Intensification I|Overall Study||476
7575150|NCT02774850|18646066|P1|Early Discharge Eligible at Induction II|Overall Study|114 of these patients were managed as outpatients. 379 were managed as inpatients.|493
7575151|NCT02774850|18646066|P1|Induction II|Overall Study||564
7575152|NCT02774850|18646066|P1|Early Discharge Eligible at Induction I|Overall Study|24 of these patients were managed as outpatients. 252 were managed as inpatients.|276
7575153|NCT02774850|18646066|P1|Induction I|Overall Study||585
7575154|NCT02774850|18646066|P1|STARTED|Overall Study||610
7575155|NCT02774798|18646077|P3|NOT COMPLETED|Overall Study||0
7575156|NCT02774798|18646078|P2|NOT COMPLETED|Overall Study||0
7575157|NCT02774798|18646079|P1|NOT COMPLETED|Overall Study||0
7575158|NCT02774798|18646077|P3|COMPLETED|Overall Study||7
7575159|NCT02774798|18646078|P2|COMPLETED|Overall Study||17
7575160|NCT02774798|18646079|P1|COMPLETED|Overall Study||7
7575161|NCT02774798|18646077|P3|STARTED|Overall Study||7
7575162|NCT02774798|18646078|P2|STARTED|Overall Study||17
7575163|NCT02774798|18646079|P1|STARTED|Overall Study||7
7575164|NCT02774681|18646105|P1|NOT COMPLETED|Follow-Up for 3 Years||12
7575165|NCT02774681|18646105|P1|COMPLETED|Follow-Up for 3 Years||0
7575166|NCT02774681|18646105|P1|STARTED|Follow-Up for 3 Years||12
7575167|NCT02774681|18646105|P1|NOT COMPLETED|Treatment on Study||7
7575168|NCT02774681|18646105|P1|COMPLETED|Treatment on Study||5
7575169|NCT02774681|18646105|P1|Went on to Start Cycle 3|Treatment on Study||5
7575170|NCT02774681|18646105|P1|Reached 1st Response/2 Cycles|Treatment on Study||10
7575171|NCT02774681|18646105|P1|STARTED|Treatment on Study||12
7575172|NCT02774616|18646117|P3|NOT COMPLETED|Overall Study||3
7575173|NCT02774616|18646118|P2|NOT COMPLETED|Overall Study||11
7575174|NCT02774616|18646119|P1|NOT COMPLETED|Overall Study||15
7575175|NCT02774616|18646117|P3|COMPLETED|Overall Study||13
7575176|NCT02774616|18646118|P2|COMPLETED|Overall Study||156
7575177|NCT02774616|18646119|P1|COMPLETED|Overall Study||80
7575178|NCT02774616|18646117|P3|Other|Overall Study||1
7575179|NCT02774616|18646118|P2|Other|Overall Study||4
7575180|NCT02774616|18646119|P1|Other|Overall Study||2
7575181|NCT02774616|18646117|P3|Device Explanted|Overall Study||1
7575182|NCT02774616|18646118|P2|Device Explanted|Overall Study||1
7575183|NCT02774616|18646119|P1|Device Explanted|Overall Study||2
7575184|NCT02774616|18646117|P3|Lost to FU|Overall Study||0
7575185|NCT02774616|18646118|P2|Lost to FU|Overall Study||0
7575186|NCT02774616|18646119|P1|Lost to FU|Overall Study||2
7575187|NCT02774616|18646117|P3|Withdrew Consent|Overall Study||0
7575188|NCT02774616|18646118|P2|Withdrew Consent|Overall Study||3
7575189|NCT02774616|18646119|P1|Withdrew Consent|Overall Study||3
7575190|NCT02774616|18646117|P3|Died|Overall Study||1
7575191|NCT02774616|18646118|P2|Died|Overall Study||3
7575192|NCT02774616|18646119|P1|Died|Overall Study||6
7575193|NCT02774616|18646117|P3|STARTED|Overall Study||16
7575194|NCT02774616|18646118|P2|STARTED|Overall Study||167
7575195|NCT02774616|18646119|P1|STARTED|Overall Study||95
7575196|NCT02774343|18646132|P2|NOT COMPLETED|Overall Study||3
7575197|NCT02774343|18646133|P1|NOT COMPLETED|Overall Study||6
7575198|NCT02774343|18646132|P2|COMPLETED|Overall Study||12
7575199|NCT02774343|18646133|P1|COMPLETED|Overall Study||9
7575200|NCT02774343|18646132|P2|Received at Least One Capsule|Overall Study||14
7575201|NCT02774343|18646133|P1|Received at Least One Capsule|Overall Study||12
7575202|NCT02774343|18646132|P2|STARTED|Overall Study||15
7575203|NCT02774343|18646133|P1|STARTED|Overall Study||15
7575204|NCT02774278|18646169|P1|NOT COMPLETED|Overall Study||264
7575205|NCT02774278|18646169|P1|COMPLETED|Overall Study||0
7575206|NCT02774278|18646169|P1|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261
7575207|NCT02774278|18646169|P1|STARTED|Overall Study||264
7575208|NCT02774265|18646179|P2|NOT COMPLETED|Overall Study||6
7575209|NCT02774265|18646180|P1|NOT COMPLETED|Overall Study||13
7575210|NCT02774265|18646179|P2|COMPLETED|Overall Study||159
7575211|NCT02774265|18646180|P1|COMPLETED|Overall Study||151
7575212|NCT02774265|18646179|P2|STARTED|Overall Study||165
7575213|NCT02774265|18646180|P1|STARTED|Overall Study||164
7575214|NCT02774213|18646190|P1|NOT COMPLETED|Overall Study||19
7575215|NCT02774213|18646190|P1|COMPLETED|Overall Study||55
7575216|NCT02774213|18646190|P1|STARTED|Overall Study||74
7575217|NCT02774148|18646203|P2|NOT COMPLETED|Overall Study||0
7575218|NCT02774148|18646204|P1|NOT COMPLETED|Overall Study||0
7575219|NCT02774148|18646203|P2|COMPLETED|Overall Study||0
7575220|NCT02774148|18646204|P1|COMPLETED|Overall Study||0
7575221|NCT02774148|18646203|P2|STARTED|Overall Study||0
7575222|NCT02774148|18646204|P1|STARTED|Overall Study||0
7575223|NCT02773836|18646224|P6|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
7575224|NCT02773836|18646225|P5|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
7575225|NCT02773836|18646226|P4|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
7575226|NCT02773836|18646227|P3|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
7575227|NCT02773836|18646228|P2|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
7575228|NCT02773836|18646229|P1|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
7575229|NCT02773836|18646224|P6|COMPLETED|Wave 2- Post-TPD Implementation||998
7575230|NCT02773836|18646225|P5|COMPLETED|Wave 2- Post-TPD Implementation||1002
7575231|NCT02773836|18646226|P4|COMPLETED|Wave 2- Post-TPD Implementation||1010
7575232|NCT02773836|18646227|P3|COMPLETED|Wave 2- Post-TPD Implementation||1003
7575233|NCT02773836|18646228|P2|COMPLETED|Wave 2- Post-TPD Implementation||1013
7575234|NCT02773836|18646229|P1|COMPLETED|Wave 2- Post-TPD Implementation||1010
7575235|NCT02773836|18646224|P6|STARTED|Wave 2- Post-TPD Implementation||998
7575236|NCT02773836|18646225|P5|STARTED|Wave 2- Post-TPD Implementation||1002
7575237|NCT02773836|18646226|P4|STARTED|Wave 2- Post-TPD Implementation||1010
7575238|NCT02773836|18646227|P3|STARTED|Wave 2- Post-TPD Implementation||1003
7575239|NCT02773836|18646228|P2|STARTED|Wave 2- Post-TPD Implementation||1013
7575240|NCT02773836|18646229|P1|STARTED|Wave 2- Post-TPD Implementation||1010
7575241|NCT02773836|18646224|P6|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
7575242|NCT02773836|18646225|P5|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
7575243|NCT02773836|18646226|P4|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
7575244|NCT02773836|18646227|P3|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
7575245|NCT02773836|18646228|P2|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
7575246|NCT02773836|18646229|P1|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
7575247|NCT02773836|18646224|P6|COMPLETED|Wave 1- Pre-TPD Implementation||1006
7575248|NCT02773836|18646225|P5|COMPLETED|Wave 1- Pre-TPD Implementation||1000
7575249|NCT02773836|18646226|P4|COMPLETED|Wave 1- Pre-TPD Implementation||1001
7575250|NCT02773836|18646227|P3|COMPLETED|Wave 1- Pre-TPD Implementation||1001
7575251|NCT02773836|18646228|P2|COMPLETED|Wave 1- Pre-TPD Implementation||1003
7575252|NCT02773836|18646229|P1|COMPLETED|Wave 1- Pre-TPD Implementation||1000
7575253|NCT02773836|18646224|P6|STARTED|Wave 1- Pre-TPD Implementation||1006
7575254|NCT02773836|18646225|P5|STARTED|Wave 1- Pre-TPD Implementation||1000
7575255|NCT02773836|18646226|P4|STARTED|Wave 1- Pre-TPD Implementation||1001
7575256|NCT02773836|18646227|P3|STARTED|Wave 1- Pre-TPD Implementation||1001
7575257|NCT02773836|18646228|P2|STARTED|Wave 1- Pre-TPD Implementation||1003
7575258|NCT02773836|18646229|P1|STARTED|Wave 1- Pre-TPD Implementation||1000
7575259|NCT02773758|18646317|P2|NOT COMPLETED|Overall Study||0
7575260|NCT02773758|18646318|P1|NOT COMPLETED|Overall Study||0
7575261|NCT02773758|18646317|P2|COMPLETED|Overall Study||70
7575262|NCT02773758|18646318|P1|COMPLETED|Overall Study||71
7575263|NCT02773758|18646317|P2|STARTED|Overall Study||70
7575264|NCT02773758|18646318|P1|STARTED|Overall Study||71
7575265|NCT02773576|18646330|P2|NOT COMPLETED|Overall Study||0
7575266|NCT02773576|18646331|P1|NOT COMPLETED|Overall Study||0
7575267|NCT02773576|18646330|P2|COMPLETED|Overall Study||0
7575268|NCT02773576|18646331|P1|COMPLETED|Overall Study||0
7575269|NCT02773576|18646330|P2|STARTED|Overall Study||0
7575270|NCT02773576|18646331|P1|STARTED|Overall Study||0
7575271|NCT02773537|18646344|P3|NOT COMPLETED|Overall Study||4
7575272|NCT02773537|18646345|P2|NOT COMPLETED|Overall Study||1
7575273|NCT02773537|18646346|P1|NOT COMPLETED|Overall Study||0
7575274|NCT02773537|18646344|P3|COMPLETED|Overall Study||21
7575275|NCT02773537|18646345|P2|COMPLETED|Overall Study||24
7575276|NCT02773537|18646346|P1|COMPLETED|Overall Study||25
7575277|NCT02773537|18646344|P3|STARTED|Overall Study||25
7575278|NCT02773537|18646345|P2|STARTED|Overall Study||25
7575279|NCT02773537|18646346|P1|STARTED|Overall Study||25
7575280|NCT02773446|18646381|P6|NOT COMPLETED|Second Admission||0
7575281|NCT02773446|18646382|P5|NOT COMPLETED|Second Admission||0
7575282|NCT02773446|18646383|P4|NOT COMPLETED|Second Admission||0
7575283|NCT02773446|18646384|P3|NOT COMPLETED|Second Admission||0
7575284|NCT02773446|18646385|P2|NOT COMPLETED|Second Admission||0
7575285|NCT02773446|18646386|P1|NOT COMPLETED|Second Admission||0
7575286|NCT02773446|18646381|P6|COMPLETED|Second Admission||19
7575287|NCT02773446|18646382|P5|COMPLETED|Second Admission||11
7575288|NCT02773446|18646383|P4|COMPLETED|Second Admission||0
7575289|NCT02773446|18646384|P3|COMPLETED|Second Admission||0
7575290|NCT02773446|18646385|P2|COMPLETED|Second Admission||0
7575291|NCT02773446|18646386|P1|COMPLETED|Second Admission||0
7575292|NCT02773446|18646381|P6|STARTED|Second Admission||19
7575293|NCT02773446|18646382|P5|STARTED|Second Admission||11
7575294|NCT02773446|18646383|P4|STARTED|Second Admission||0
7575295|NCT02773446|18646384|P3|STARTED|Second Admission||0
7575296|NCT02773446|18646385|P2|STARTED|Second Admission||0
7575297|NCT02773446|18646386|P1|STARTED|Second Admission||0
7575298|NCT02773446|18646381|P6|NOT COMPLETED|First Admission||0
7575299|NCT02773446|18646382|P5|NOT COMPLETED|First Admission||0
7575300|NCT02773446|18646383|P4|NOT COMPLETED|First Admission||1
7575301|NCT02773446|18646384|P3|NOT COMPLETED|First Admission||0
7575302|NCT02773446|18646385|P2|NOT COMPLETED|First Admission||0
7575303|NCT02773446|18646386|P1|NOT COMPLETED|First Admission||1
7575304|NCT02773446|18646381|P6|COMPLETED|First Admission||0
7575305|NCT02773446|18646382|P5|COMPLETED|First Admission||0
7575306|NCT02773446|18646383|P4|COMPLETED|First Admission||6
7575307|NCT02773446|18646384|P3|COMPLETED|First Admission||7
7575308|NCT02773446|18646385|P2|COMPLETED|First Admission||7
7575309|NCT02773446|18646386|P1|COMPLETED|First Admission||6
7575310|NCT02773446|18646381|P6|STARTED|First Admission||0
7575311|NCT02773446|18646382|P5|STARTED|First Admission||0
7575312|NCT02773446|18646383|P4|STARTED|First Admission||7
7575313|NCT02773446|18646384|P3|STARTED|First Admission||7
7575314|NCT02773446|18646385|P2|STARTED|First Admission||7
7575315|NCT02773446|18646386|P1|STARTED|First Admission||7
7575316|NCT02773368|18646427|P2|NOT COMPLETED|Overall Study||4
7575317|NCT02773368|18646428|P1|NOT COMPLETED|Overall Study||10
7575318|NCT02773368|18646427|P2|COMPLETED|Overall Study||206
7575319|NCT02773368|18646428|P1|COMPLETED|Overall Study||200
7575320|NCT02773368|18646427|P2|Exposed|Overall Study||210
7575321|NCT02773368|18646428|P1|Exposed|Overall Study||209
7575322|NCT02773368|18646427|P2|STARTED|Overall Study||210
7575323|NCT02773368|18646428|P1|STARTED|Overall Study||210
7575324|NCT02772809|18646498|P1|NOT COMPLETED|Overall Study||6
7575325|NCT02772809|18646498|P1|COMPLETED|Overall Study||17
7575326|NCT02772809|18646498|P1|STARTED|Overall Study||23
7575327|NCT02772757|18646510|P3|NOT COMPLETED|Overall Study||5
7575328|NCT02772757|18646511|P2|NOT COMPLETED|Overall Study||3
7575329|NCT02772757|18646512|P1|NOT COMPLETED|Overall Study||1
7575330|NCT02772757|18646510|P3|COMPLETED|Overall Study||21
7575331|NCT02772757|18646511|P2|COMPLETED|Overall Study||21
7575332|NCT02772757|18646512|P1|COMPLETED|Overall Study||21
7575333|NCT02772757|18646510|P3|STARTED|Overall Study||26
7575334|NCT02772757|18646511|P2|STARTED|Overall Study||24
7575335|NCT02772757|18646512|P1|STARTED|Overall Study||22
7575336|NCT02772666|18646529|P1|NOT COMPLETED|SFT Then O-Glass||0
7575337|NCT02772666|18646529|P1|COMPLETED|SFT Then O-Glass||44
7575338|NCT02772666|18646529|P1|STARTED|SFT Then O-Glass||44
7575339|NCT02772666|18646529|P1|NOT COMPLETED|O-Glas Then SFT||0
7575340|NCT02772666|18646529|P1|COMPLETED|O-Glas Then SFT||44
7575341|NCT02772666|18646529|P1|STARTED|O-Glas Then SFT||44
7575342|NCT02772432|18646536|P2|NOT COMPLETED|Overall Study||1
7575343|NCT02772432|18646537|P1|NOT COMPLETED|Overall Study||12
7575344|NCT02772432|18646536|P2|COMPLETED|Overall Study||21
7575345|NCT02772432|18646537|P1|COMPLETED|Overall Study||19
7575346|NCT02772432|18646536|P2|STARTED|Overall Study||22
7575347|NCT02772432|18646537|P1|STARTED|Overall Study||31
7575348|NCT02771574|18646552|P5|NOT COMPLETED|Liq Avexitide (3 Days)||0
7575349|NCT02771574|18646553|P4|NOT COMPLETED|Liq Avexitide (3 Days)||0
7575350|NCT02771574|18646554|P3|NOT COMPLETED|Liq Avexitide (3 Days)||0
7575351|NCT02771574|18646555|P2|NOT COMPLETED|Liq Avexitide (3 Days)||0
7575352|NCT02771574|18646556|P1|NOT COMPLETED|Liq Avexitide (3 Days)||0
7575353|NCT02771574|18646552|P5|COMPLETED|Liq Avexitide (3 Days)||5
7575354|NCT02771574|18646553|P4|COMPLETED|Liq Avexitide (3 Days)||0
7575355|NCT02771574|18646554|P3|COMPLETED|Liq Avexitide (3 Days)||0
7575356|NCT02771574|18646555|P2|COMPLETED|Liq Avexitide (3 Days)||0
7575357|NCT02771574|18646556|P1|COMPLETED|Liq Avexitide (3 Days)||0
7575358|NCT02771574|18646552|P5|STARTED|Liq Avexitide (3 Days)||5
7575359|NCT02771574|18646553|P4|STARTED|Liq Avexitide (3 Days)||0
7575360|NCT02771574|18646554|P3|STARTED|Liq Avexitide (3 Days)||0
7575361|NCT02771574|18646555|P2|STARTED|Liq Avexitide (3 Days)||0
7575362|NCT02771574|18646556|P1|STARTED|Liq Avexitide (3 Days)||0
7575363|NCT02771574|18646552|P5|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
7575364|NCT02771574|18646553|P4|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
7575365|NCT02771574|18646554|P3|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
7575366|NCT02771574|18646555|P2|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
7575367|NCT02771574|18646556|P1|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
7575368|NCT02771574|18646552|P5|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
7575369|NCT02771574|18646553|P4|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||3
7575370|NCT02771574|18646554|P3|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
7575371|NCT02771574|18646555|P2|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
7575372|NCT02771574|18646556|P1|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
7575373|NCT02771574|18646552|P5|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
7575374|NCT02771574|18646553|P4|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||3
7575375|NCT02771574|18646554|P3|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
7575376|NCT02771574|18646555|P2|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
7575377|NCT02771574|18646556|P1|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
7575378|NCT02771574|18646552|P5|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
7575379|NCT02771574|18646553|P4|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
7575380|NCT02771574|18646554|P3|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
7575381|NCT02771574|18646555|P2|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
7575382|NCT02771574|18646556|P1|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
7575383|NCT02771574|18646552|P5|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
7575384|NCT02771574|18646553|P4|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
7575385|NCT02771574|18646554|P3|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||3
7575386|NCT02771574|18646555|P2|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
7575387|NCT02771574|18646556|P1|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
7575388|NCT02771574|18646552|P5|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
7575389|NCT02771574|18646553|P4|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
7575390|NCT02771574|18646554|P3|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||3
7575391|NCT02771574|18646555|P2|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
7575392|NCT02771574|18646556|P1|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
7575393|NCT02771574|18646552|P5|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
7575394|NCT02771574|18646553|P4|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
7575395|NCT02771574|18646554|P3|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
7575396|NCT02771574|18646555|P2|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
7575397|NCT02771574|18646556|P1|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
7575398|NCT02771574|18646552|P5|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
7575399|NCT02771574|18646553|P4|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
7575400|NCT02771574|18646554|P3|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
7575401|NCT02771574|18646555|P2|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||5
7575402|NCT02771574|18646556|P1|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
7575403|NCT02771574|18646552|P5|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
7575404|NCT02771574|18646553|P4|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
7575405|NCT02771574|18646554|P3|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
7575406|NCT02771574|18646555|P2|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||5
7575407|NCT02771574|18646556|P1|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
7575408|NCT02771574|18646552|P5|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
7575409|NCT02771574|18646553|P4|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
7575410|NCT02771574|18646554|P3|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
7575411|NCT02771574|18646555|P2|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
7575412|NCT02771574|18646556|P1|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
7575413|NCT02771574|18646552|P5|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
7575414|NCT02771574|18646553|P4|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
7575415|NCT02771574|18646554|P3|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
7575416|NCT02771574|18646555|P2|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
7575417|NCT02771574|18646556|P1|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||3
7575418|NCT02771574|18646552|P5|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
7575419|NCT02771574|18646553|P4|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
7575420|NCT02771574|18646554|P3|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
7575421|NCT02771574|18646555|P2|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
7575422|NCT02771574|18646556|P1|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||3
7575423|NCT02771522|18646595|P1|NOT COMPLETED|Overall Study||8
7575424|NCT02771522|18646595|P1|COMPLETED|Overall Study|87 teeth imaged with the Calcivis System fro 22 patients|22
7575425|NCT02771522|18646595|P1|STARTED|Overall Study|119 teeth imaged with the Calcivis System from 30 patients|30
7575426|NCT02771366|18646606|P2|NOT COMPLETED|Period 2 (Crossover)||0
7575427|NCT02771366|18646607|P1|NOT COMPLETED|Period 2 (Crossover)||2
7575428|NCT02771366|18646606|P2|COMPLETED|Period 2 (Crossover)||13
7575429|NCT02771366|18646607|P1|COMPLETED|Period 2 (Crossover)||13
7575430|NCT02771366|18646606|P2|STARTED|Period 2 (Crossover)||13
7575431|NCT02771366|18646607|P1|STARTED|Period 2 (Crossover)||15
7575432|NCT02771366|18646606|P2|NOT COMPLETED|Period 1||2
7575433|NCT02771366|18646607|P1|NOT COMPLETED|Period 1||0
7575434|NCT02771366|18646606|P2|COMPLETED|Period 1||13
7575435|NCT02771366|18646607|P1|COMPLETED|Period 1||15
7575436|NCT02771366|18646606|P2|STARTED|Period 1||15
7575437|NCT02771366|18646607|P1|STARTED|Period 1||15
7575438|NCT02771340|18646617|P3|NOT COMPLETED|Overall Study||0
7575439|NCT02771340|18646618|P2|NOT COMPLETED|Overall Study||0
7575440|NCT02771340|18646619|P1|NOT COMPLETED|Overall Study||0
7575441|NCT02771340|18646617|P3|COMPLETED|Overall Study||5
7575442|NCT02771340|18646618|P2|COMPLETED|Overall Study||3
7575443|NCT02771340|18646619|P1|COMPLETED|Overall Study||2
7575444|NCT02771340|18646617|P3|STARTED|Overall Study||5
7575445|NCT02771340|18646618|P2|STARTED|Overall Study||3
7575446|NCT02771340|18646619|P1|STARTED|Overall Study||2
7575447|NCT02771275|18646633|P1|NOT COMPLETED|Overall Study||13
7575448|NCT02771275|18646633|P1|COMPLETED|Overall Study||0
7575449|NCT02771275|18646633|P1|STARTED|Overall Study||13
7575450|NCT02771145|18646641|P1|NOT COMPLETED|Overall Study||4
7575451|NCT02771145|18646641|P1|COMPLETED|Overall Study||86
7575452|NCT02771145|18646641|P1|STARTED|Overall Study||90
7575453|NCT02771093|18646682|P2|NOT COMPLETED|Overall Study||0
7575454|NCT02771093|18646683|P1|NOT COMPLETED|Overall Study||0
7575455|NCT02771093|18646682|P2|COMPLETED|Overall Study||14
7575456|NCT02771093|18646683|P1|COMPLETED|Overall Study||13
7575457|NCT02771093|18646682|P2|STARTED|Overall Study||14
7575458|NCT02771093|18646683|P1|STARTED|Overall Study||13
7575459|NCT02770846|18646737|P2|NOT COMPLETED|Overall Study||0
7575460|NCT02770846|18646738|P1|NOT COMPLETED|Overall Study||0
7575461|NCT02770846|18646737|P2|COMPLETED|Overall Study||25
7575462|NCT02770846|18646738|P1|COMPLETED|Overall Study||25
7575463|NCT02770846|18646737|P2|STARTED|Overall Study||25
7575464|NCT02770846|18646738|P1|STARTED|Overall Study||25
7575465|NCT02770625|18646762|P1|NOT COMPLETED|Overall Study||0
7575466|NCT02770625|18646762|P1|COMPLETED|Overall Study||8
7575467|NCT02770625|18646762|P1|STARTED|Overall Study||8
7575468|NCT02770612|18646775|P1|NOT COMPLETED|Overall Study||1
7575469|NCT02770612|18646775|P1|COMPLETED|Overall Study||50
7575470|NCT02770612|18646775|P1|STARTED|Overall Study||51
7575471|NCT02770547|18646781|P2|NOT COMPLETED|Overall Study||1
7575472|NCT02770547|18646782|P1|NOT COMPLETED|Overall Study||1
7575473|NCT02770547|18646781|P2|COMPLETED|Overall Study||15
7575474|NCT02770547|18646782|P1|COMPLETED|Overall Study||15
7575475|NCT02770547|18646781|P2|STARTED|Overall Study||16
7575476|NCT02770547|18646782|P1|STARTED|Overall Study||16
7575477|NCT02770521|18646804|P6|NOT COMPLETED|Period Three||0
7575478|NCT02770521|18646805|P5|NOT COMPLETED|Period Three||0
7575479|NCT02770521|18646806|P4|NOT COMPLETED|Period Three||0
7575480|NCT02770521|18646807|P3|NOT COMPLETED|Period Three||0
7575481|NCT02770521|18646808|P2|NOT COMPLETED|Period Three||0
7575482|NCT02770521|18646809|P1|NOT COMPLETED|Period Three||0
7575483|NCT02770521|18646804|P6|COMPLETED|Period Three||9
7575484|NCT02770521|18646805|P5|COMPLETED|Period Three||2
7575485|NCT02770521|18646806|P4|COMPLETED|Period Three||2
7575486|NCT02770521|18646807|P3|COMPLETED|Period Three||2
7575487|NCT02770521|18646808|P2|COMPLETED|Period Three||0
7575488|NCT02770521|18646809|P1|COMPLETED|Period Three||0
7575489|NCT02770521|18646804|P6|Received Study Drug|Period Three||9
7575490|NCT02770521|18646805|P5|Received Study Drug|Period Three||2
7575491|NCT02770521|18646806|P4|Received Study Drug|Period Three||2
7575492|NCT02770521|18646807|P3|Received Study Drug|Period Three||2
7575493|NCT02770521|18646808|P2|Received Study Drug|Period Three||0
7575494|NCT02770521|18646809|P1|Received Study Drug|Period Three||0
7575495|NCT02770521|18646804|P6|STARTED|Period Three||9
7575496|NCT02770521|18646805|P5|STARTED|Period Three||2
7575497|NCT02770521|18646806|P4|STARTED|Period Three||2
7575498|NCT02770521|18646807|P3|STARTED|Period Three||2
7575499|NCT02770521|18646808|P2|STARTED|Period Three|Not applicable. Part A only had two periods.|0
7575500|NCT02770521|18646809|P1|STARTED|Period Three|Not applicable. Part A only had two periods.|0
7575501|NCT02770521|18646804|P6|NOT COMPLETED|Period Two||0
7575502|NCT02770521|18646805|P5|NOT COMPLETED|Period Two||0
7575503|NCT02770521|18646806|P4|NOT COMPLETED|Period Two||0
7575504|NCT02770521|18646807|P3|NOT COMPLETED|Period Two||0
7575505|NCT02770521|18646808|P2|NOT COMPLETED|Period Two||0
7575506|NCT02770521|18646809|P1|NOT COMPLETED|Period Two||0
7575507|NCT02770521|18646804|P6|COMPLETED|Period Two||9
7575508|NCT02770521|18646805|P5|COMPLETED|Period Two||2
7575509|NCT02770521|18646806|P4|COMPLETED|Period Two||2
7575510|NCT02770521|18646807|P3|COMPLETED|Period Two||2
7575511|NCT02770521|18646808|P2|COMPLETED|Period Two||4
7575512|NCT02770521|18646809|P1|COMPLETED|Period Two||4
7575513|NCT02770521|18646804|P6|Received Study Drug|Period Two||9
7575514|NCT02770521|18646805|P5|Received Study Drug|Period Two||2
7575515|NCT02770521|18646806|P4|Received Study Drug|Period Two||2
7575516|NCT02770521|18646807|P3|Received Study Drug|Period Two||2
7575517|NCT02770521|18646808|P2|Received Study Drug|Period Two||4
7575518|NCT02770521|18646809|P1|Received Study Drug|Period Two||4
7575519|NCT02770521|18646804|P6|STARTED|Period Two||9
7575520|NCT02770521|18646805|P5|STARTED|Period Two||2
7575521|NCT02770521|18646806|P4|STARTED|Period Two||2
7575522|NCT02770521|18646807|P3|STARTED|Period Two||2
7575523|NCT02770521|18646808|P2|STARTED|Period Two||4
7575524|NCT02770521|18646809|P1|STARTED|Period Two||4
7575525|NCT02770521|18646804|P6|NOT COMPLETED|Period One||0
7575526|NCT02770521|18646805|P5|NOT COMPLETED|Period One||0
7575527|NCT02770521|18646806|P4|NOT COMPLETED|Period One||0
7575528|NCT02770521|18646807|P3|NOT COMPLETED|Period One||0
7575529|NCT02770521|18646808|P2|NOT COMPLETED|Period One||0
7575530|NCT02770521|18646809|P1|NOT COMPLETED|Period One||0
7575531|NCT02770521|18646804|P6|COMPLETED|Period One||9
7575532|NCT02770521|18646805|P5|COMPLETED|Period One||2
7575533|NCT02770521|18646806|P4|COMPLETED|Period One||2
7575534|NCT02770521|18646807|P3|COMPLETED|Period One||2
7575535|NCT02770521|18646808|P2|COMPLETED|Period One||4
7575536|NCT02770521|18646809|P1|COMPLETED|Period One||4
7575537|NCT02770521|18646804|P6|Received Study Drug|Period One||9
7575538|NCT02770521|18646805|P5|Received Study Drug|Period One||2
7575539|NCT02770521|18646806|P4|Received Study Drug|Period One||2
7575540|NCT02770521|18646807|P3|Received Study Drug|Period One||2
7575541|NCT02770521|18646808|P2|Received Study Drug|Period One||4
7575542|NCT02770521|18646809|P1|Received Study Drug|Period One||4
7575543|NCT02770521|18646804|P6|STARTED|Period One||9
7575544|NCT02770521|18646805|P5|STARTED|Period One||2
7575545|NCT02770521|18646806|P4|STARTED|Period One||2
7575546|NCT02770521|18646807|P3|STARTED|Period One||2
7575547|NCT02770521|18646808|P2|STARTED|Period One||4
7575548|NCT02770521|18646809|P1|STARTED|Period One||4
7575549|NCT02770365|18646834|P3|NOT COMPLETED|Overall Study||0
7575550|NCT02770365|18646835|P2|NOT COMPLETED|Overall Study||4
7575551|NCT02770365|18646836|P1|NOT COMPLETED|Overall Study||5
7575552|NCT02770365|18646834|P3|COMPLETED|Overall Study||139
7575553|NCT02770365|18646835|P2|COMPLETED|Overall Study||275
7575554|NCT02770365|18646836|P1|COMPLETED|Overall Study||272
7575555|NCT02770365|18646834|P3|STARTED|Overall Study||139
7575556|NCT02770365|18646835|P2|STARTED|Overall Study||279
7575557|NCT02770365|18646836|P1|STARTED|Overall Study||277
7575558|NCT02770287|18646846|P1|NOT COMPLETED|Overall Study||0
7575559|NCT02770287|18646846|P1|COMPLETED|Overall Study||11
7575560|NCT02770287|18646846|P1|STARTED|Overall Study||11
7575561|NCT02770248|18646855|P2|NOT COMPLETED|Overall Study||2
7575562|NCT02770248|18646856|P1|NOT COMPLETED|Overall Study||0
7575563|NCT02770248|18646855|P2|COMPLETED|Overall Study||61
7575564|NCT02770248|18646856|P1|COMPLETED|Overall Study||62
7575565|NCT02770248|18646855|P2|STARTED|Overall Study||63
7575566|NCT02770248|18646856|P1|STARTED|Overall Study||62
7575567|NCT02770014|18646868|P1|NOT COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib||5
7575568|NCT02770014|18646868|P1|COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib|Of the 11 participants that had an activating EGFR mutation, 6 started erlotinib treatment.|6
7575569|NCT02770014|18646868|P1|STARTED|EGFR Exon 19 Pos, Treated With Erlotinib|A total of 11 participants were found to have an activating EGFR mutation (exon 19 del or L858R).|11
7575570|NCT02770014|18646868|P1|NOT COMPLETED|Plasma Genotyping||0
7575571|NCT02770014|18646868|P1|COMPLETED|Plasma Genotyping||43
7575572|NCT02770014|18646868|P1|STARTED|Plasma Genotyping||43
7575573|NCT02769858|18646874|P1|NOT COMPLETED|Overall Study||2
7575574|NCT02769858|18646874|P1|COMPLETED|Overall Study||8
7575575|NCT02769858|18646874|P1|STARTED|Overall Study||10
7575576|NCT02769702|18646880|P1|NOT COMPLETED|Overall Study||0
7575577|NCT02769702|18646880|P1|COMPLETED|Overall Study||2
7575578|NCT02769702|18646880|P1|STARTED|Overall Study||2
7575579|NCT02769624|18646885|P2|NOT COMPLETED|Overall Study||1
7575580|NCT02769624|18646886|P1|NOT COMPLETED|Overall Study||0
7575581|NCT02769624|18646885|P2|COMPLETED|Overall Study||7
7575582|NCT02769624|18646886|P1|COMPLETED|Overall Study||7
7575583|NCT02769624|18646885|P2|STARTED|Overall Study||8
7575584|NCT02769624|18646886|P1|STARTED|Overall Study||7
7575585|NCT02769442|18646904|P2|NOT COMPLETED|Overall Study||0
7575586|NCT02769442|18646905|P1|NOT COMPLETED|Overall Study||0
7575587|NCT02769442|18646904|P2|COMPLETED|Overall Study||291
7575588|NCT02769442|18646905|P1|COMPLETED|Overall Study||309
7575589|NCT02769442|18646904|P2|STARTED|Overall Study||291
7575590|NCT02769442|18646905|P1|STARTED|Overall Study||309
7575591|NCT02769312|18646915|P2|NOT COMPLETED|Follow-up||1
7575592|NCT02769312|18646916|P1|NOT COMPLETED|Follow-up||1
7575593|NCT02769312|18646915|P2|COMPLETED|Follow-up||23
7575594|NCT02769312|18646916|P1|COMPLETED|Follow-up||22
7575595|NCT02769312|18646915|P2|STARTED|Follow-up||24
7575596|NCT02769312|18646916|P1|STARTED|Follow-up||23
7575597|NCT02769312|18646915|P2|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
7575598|NCT02769312|18646916|P1|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
7575599|NCT02769312|18646915|P2|COMPLETED|Unblinded (Optional 2-4 Weeks)||23
7575600|NCT02769312|18646916|P1|COMPLETED|Unblinded (Optional 2-4 Weeks)||20
7575601|NCT02769312|18646915|P2|STARTED|Unblinded (Optional 2-4 Weeks)||24
7575602|NCT02769312|18646916|P1|STARTED|Unblinded (Optional 2-4 Weeks)|2 participants chose not to continue with the unblinded period.|21
7575603|NCT02769312|18646915|P2|NOT COMPLETED|Double-Blind (0-2 Weeks)||1
7575604|NCT02769312|18646916|P1|NOT COMPLETED|Double-Blind (0-2 Weeks)||2
7575605|NCT02769312|18646915|P2|COMPLETED|Double-Blind (0-2 Weeks)||24
7575606|NCT02769312|18646916|P1|COMPLETED|Double-Blind (0-2 Weeks)||23
7575607|NCT02769312|18646915|P2|STARTED|Double-Blind (0-2 Weeks)||25
7575608|NCT02769312|18646916|P1|STARTED|Double-Blind (0-2 Weeks)||25
7575609|NCT02769247|18646933|P4|NOT COMPLETED|Overall Study||1
7575610|NCT02769247|18646934|P3|NOT COMPLETED|Overall Study||1
7575611|NCT02769247|18646935|P2|NOT COMPLETED|Overall Study||0
7575612|NCT02769247|18646936|P1|NOT COMPLETED|Overall Study||2
7575613|NCT02769247|18646933|P4|COMPLETED|Overall Study|1 patient decided against study participation after enrollment/randomization|39
7575614|NCT02769247|18646934|P3|COMPLETED|Overall Study|1 took non-study med after enrollment/randomization, before IUD insertion (excluded from study)|39
7575615|NCT02769247|18646935|P2|COMPLETED|Overall Study||40
7575616|NCT02769247|18646936|P1|COMPLETED|Overall Study|unable to insert IUD in one patient; 1 pt decided against study participation after enrollment|38
7575617|NCT02769247|18646933|P4|STARTED|Overall Study||40
7575618|NCT02769247|18646934|P3|STARTED|Overall Study||40
7575619|NCT02769247|18646935|P2|STARTED|Overall Study||40
7575620|NCT02769247|18646936|P1|STARTED|Overall Study||40
7575621|NCT02769065|18647004|P30|NOT COMPLETED|Overall Study||0
7575622|NCT02769065|18647005|P29|NOT COMPLETED|Overall Study||0
7575623|NCT02769065|18647006|P28|NOT COMPLETED|Overall Study||0
7575624|NCT02769065|18647007|P27|NOT COMPLETED|Overall Study||0
7575625|NCT02769065|18647008|P26|NOT COMPLETED|Overall Study||0
7575626|NCT02769065|18647009|P25|NOT COMPLETED|Overall Study||0
7575627|NCT02769065|18647010|P24|NOT COMPLETED|Overall Study||0
7575628|NCT02769065|18647011|P23|NOT COMPLETED|Overall Study||0
7575629|NCT02769065|18647012|P22|NOT COMPLETED|Overall Study||0
7575630|NCT02769065|18647013|P21|NOT COMPLETED|Overall Study||0
7575631|NCT02769065|18647014|P20|NOT COMPLETED|Overall Study||0
7575632|NCT02769065|18647015|P19|NOT COMPLETED|Overall Study||0
7575633|NCT02769065|18647016|P18|NOT COMPLETED|Overall Study||0
7575634|NCT02769065|18647017|P17|NOT COMPLETED|Overall Study||0
7575635|NCT02769065|18647018|P16|NOT COMPLETED|Overall Study||0
7575636|NCT02769065|18647019|P15|NOT COMPLETED|Overall Study||0
7575637|NCT02769065|18647020|P14|NOT COMPLETED|Overall Study||0
7575638|NCT02769065|18647021|P13|NOT COMPLETED|Overall Study||0
7575639|NCT02769065|18647022|P12|NOT COMPLETED|Overall Study||0
7575640|NCT02769065|18647023|P11|NOT COMPLETED|Overall Study||1
7575641|NCT02769065|18647024|P10|NOT COMPLETED|Overall Study||0
7575642|NCT02769065|18647025|P9|NOT COMPLETED|Overall Study||0
7575643|NCT02769065|18647026|P8|NOT COMPLETED|Overall Study||0
7575644|NCT02769065|18647027|P7|NOT COMPLETED|Overall Study||1
7575645|NCT02769065|18647028|P6|NOT COMPLETED|Overall Study||0
7575646|NCT02769065|18647029|P5|NOT COMPLETED|Overall Study||0
7575647|NCT02769065|18647030|P4|NOT COMPLETED|Overall Study||0
7575648|NCT02769065|18647031|P3|NOT COMPLETED|Overall Study||0
7575649|NCT02769065|18647032|P2|NOT COMPLETED|Overall Study||0
7575650|NCT02769065|18647033|P1|NOT COMPLETED|Overall Study||1
7575651|NCT02769065|18647004|P30|COMPLETED|Overall Study||6
7575652|NCT02769065|18647005|P29|COMPLETED|Overall Study||6
7575653|NCT02769065|18647006|P28|COMPLETED|Overall Study||5
7575654|NCT02769065|18647007|P27|COMPLETED|Overall Study||9
7575655|NCT02769065|18647008|P26|COMPLETED|Overall Study||9
7575656|NCT02769065|18647009|P25|COMPLETED|Overall Study||6
7575657|NCT02769065|18647010|P24|COMPLETED|Overall Study||6
7575658|NCT02769065|18647011|P23|COMPLETED|Overall Study||4
7575659|NCT02769065|18647012|P22|COMPLETED|Overall Study||4
7575660|NCT02769065|18647013|P21|COMPLETED|Overall Study||4
7575661|NCT02769065|18647014|P20|COMPLETED|Overall Study||0
7575662|NCT02769065|18647015|P19|COMPLETED|Overall Study||5
7575663|NCT02769065|18647016|P18|COMPLETED|Overall Study||5
7575664|NCT02769065|18647017|P17|COMPLETED|Overall Study||5
7575665|NCT02769065|18647018|P16|COMPLETED|Overall Study||3
7575666|NCT02769065|18647019|P15|COMPLETED|Overall Study||6
7575667|NCT02769065|18647020|P14|COMPLETED|Overall Study||6
7575668|NCT02769065|18647021|P13|COMPLETED|Overall Study||6
7575669|NCT02769065|18647022|P12|COMPLETED|Overall Study||6
7575670|NCT02769065|18647023|P11|COMPLETED|Overall Study||5
7575671|NCT02769065|18647024|P10|COMPLETED|Overall Study||6
7575672|NCT02769065|18647025|P9|COMPLETED|Overall Study||6
7575673|NCT02769065|18647026|P8|COMPLETED|Overall Study||6
7575674|NCT02769065|18647027|P7|COMPLETED|Overall Study||6
7575675|NCT02769065|18647028|P6|COMPLETED|Overall Study||6
7575676|NCT02769065|18647029|P5|COMPLETED|Overall Study||6
7575677|NCT02769065|18647030|P4|COMPLETED|Overall Study||6
7575678|NCT02769065|18647031|P3|COMPLETED|Overall Study||6
7575679|NCT02769065|18647032|P2|COMPLETED|Overall Study||6
7575680|NCT02769065|18647033|P1|COMPLETED|Overall Study||16
7575681|NCT02769065|18647004|P30|STARTED|Overall Study||6
7575682|NCT02769065|18647005|P29|STARTED|Overall Study||6
7575683|NCT02769065|18647006|P28|STARTED|Overall Study||5
7575684|NCT02769065|18647007|P27|STARTED|Overall Study||9
7575685|NCT02769065|18647008|P26|STARTED|Overall Study||9
7575686|NCT02769065|18647009|P25|STARTED|Overall Study||6
7575687|NCT02769065|18647010|P24|STARTED|Overall Study||6
7575688|NCT02769065|18647011|P23|STARTED|Overall Study||4
7575689|NCT02769065|18647012|P22|STARTED|Overall Study||4
7575690|NCT02769065|18647013|P21|STARTED|Overall Study||4
7575691|NCT02769065|18647014|P20|STARTED|Overall Study||0
7575692|NCT02769065|18647015|P19|STARTED|Overall Study||5
7575693|NCT02769065|18647016|P18|STARTED|Overall Study||5
7575694|NCT02769065|18647017|P17|STARTED|Overall Study||5
7575695|NCT02769065|18647018|P16|STARTED|Overall Study||3
7575696|NCT02769065|18647019|P15|STARTED|Overall Study||6
7575697|NCT02769065|18647020|P14|STARTED|Overall Study||6
7575698|NCT02769065|18647021|P13|STARTED|Overall Study||6
7575699|NCT02769065|18647022|P12|STARTED|Overall Study||6
7575700|NCT02769065|18647023|P11|STARTED|Overall Study||6
7575701|NCT02769065|18647024|P10|STARTED|Overall Study||6
7575702|NCT02769065|18647025|P9|STARTED|Overall Study||6
7575703|NCT02769065|18647026|P8|STARTED|Overall Study||6
7575704|NCT02769065|18647027|P7|STARTED|Overall Study||7
7575705|NCT02769065|18647028|P6|STARTED|Overall Study||6
7575706|NCT02769065|18647029|P5|STARTED|Overall Study||6
7575707|NCT02769065|18647030|P4|STARTED|Overall Study||6
7575708|NCT02769065|18647031|P3|STARTED|Overall Study||6
7575709|NCT02769065|18647032|P2|STARTED|Overall Study||6
7575710|NCT02769065|18647033|P1|STARTED|Overall Study||17
7575711|NCT02768870|18647443|P1|NOT COMPLETED|Overall Study||26
7575712|NCT02768870|18647443|P1|COMPLETED|Overall Study||0
7575713|NCT02768870|18647443|P1|Implanted With Device|Overall Study||24
7575714|NCT02768870|18647443|P1|STARTED|Overall Study||26
7575715|NCT02768753|18647453|P2|NOT COMPLETED|Overall Study||0
7575716|NCT02768753|18647454|P1|NOT COMPLETED|Overall Study||0
7575717|NCT02768753|18647453|P2|COMPLETED|Overall Study||30
7575718|NCT02768753|18647454|P1|COMPLETED|Overall Study||30
7575719|NCT02768753|18647453|P2|STARTED|Overall Study||30
7575720|NCT02768753|18647454|P1|STARTED|Overall Study||30
7575721|NCT02768558|18647468|P2|NOT COMPLETED|Overall Study||0
7575722|NCT02768558|18647469|P1|NOT COMPLETED|Overall Study||0
7575723|NCT02768558|18647468|P2|COMPLETED|Overall Study||5
7575724|NCT02768558|18647469|P1|COMPLETED|Overall Study||3
7575725|NCT02768558|18647468|P2|Eligible|Overall Study||5
7575726|NCT02768558|18647469|P1|Eligible|Overall Study||3
7575727|NCT02768558|18647468|P2|STARTED|Overall Study||5
7575728|NCT02768558|18647469|P1|STARTED|Overall Study||3
7575729|NCT02768298|18647487|P2|NOT COMPLETED|Overall Study||7
7575730|NCT02768298|18647488|P1|NOT COMPLETED|Overall Study||4
7575731|NCT02768298|18647487|P2|COMPLETED|Overall Study||91
7575732|NCT02768298|18647488|P1|COMPLETED|Overall Study||99
7575733|NCT02768298|18647487|P2|STARTED|Overall Study||98
7575734|NCT02768298|18647488|P1|STARTED|Overall Study||103
7575735|NCT02768194|18647502|P6|NOT COMPLETED|Period 3||0
7575736|NCT02768194|18647503|P5|NOT COMPLETED|Period 3||0
7575737|NCT02768194|18647504|P4|NOT COMPLETED|Period 3||0
7575738|NCT02768194|18647505|P3|NOT COMPLETED|Period 3||0
7575739|NCT02768194|18647506|P2|NOT COMPLETED|Period 3||1
7575740|NCT02768194|18647507|P1|NOT COMPLETED|Period 3||0
7575741|NCT02768194|18647502|P6|COMPLETED|Period 3||4
7575742|NCT02768194|18647503|P5|COMPLETED|Period 3||4
7575743|NCT02768194|18647504|P4|COMPLETED|Period 3||3
7575744|NCT02768194|18647505|P3|COMPLETED|Period 3||4
7575745|NCT02768194|18647506|P2|COMPLETED|Period 3||3
7575746|NCT02768194|18647507|P1|COMPLETED|Period 3||3
7575747|NCT02768194|18647502|P6|STARTED|Period 3||4
7575748|NCT02768194|18647503|P5|STARTED|Period 3||4
7575749|NCT02768194|18647504|P4|STARTED|Period 3||3
7575750|NCT02768194|18647505|P3|STARTED|Period 3||4
7575751|NCT02768194|18647506|P2|STARTED|Period 3||4
7575752|NCT02768194|18647507|P1|STARTED|Period 3||3
7575753|NCT02768194|18647502|P6|NOT COMPLETED|Period 2||0
7575754|NCT02768194|18647503|P5|NOT COMPLETED|Period 2||0
7575755|NCT02768194|18647504|P4|NOT COMPLETED|Period 2||0
7575756|NCT02768194|18647505|P3|NOT COMPLETED|Period 2||0
7575757|NCT02768194|18647506|P2|NOT COMPLETED|Period 2||0
7575758|NCT02768194|18647507|P1|NOT COMPLETED|Period 2||1
7575759|NCT02768194|18647502|P6|COMPLETED|Period 2||4
7575760|NCT02768194|18647503|P5|COMPLETED|Period 2||4
7575761|NCT02768194|18647504|P4|COMPLETED|Period 2||3
7575762|NCT02768194|18647505|P3|COMPLETED|Period 2||4
7575763|NCT02768194|18647506|P2|COMPLETED|Period 2||4
7575764|NCT02768194|18647507|P1|COMPLETED|Period 2||3
7575765|NCT02768194|18647502|P6|STARTED|Period 2||4
7575766|NCT02768194|18647503|P5|STARTED|Period 2||4
7575767|NCT02768194|18647504|P4|STARTED|Period 2||3
7575768|NCT02768194|18647505|P3|STARTED|Period 2||4
7575769|NCT02768194|18647506|P2|STARTED|Period 2||4
7575770|NCT02768194|18647507|P1|STARTED|Period 2||4
7575771|NCT02768194|18647502|P6|NOT COMPLETED|Period 1||0
7575772|NCT02768194|18647503|P5|NOT COMPLETED|Period 1||0
7575773|NCT02768194|18647504|P4|NOT COMPLETED|Period 1||1
7575774|NCT02768194|18647505|P3|NOT COMPLETED|Period 1||0
7575775|NCT02768194|18647506|P2|NOT COMPLETED|Period 1||0
7575776|NCT02768194|18647507|P1|NOT COMPLETED|Period 1||0
7575777|NCT02768194|18647502|P6|COMPLETED|Period 1||4
7575778|NCT02768194|18647503|P5|COMPLETED|Period 1||4
7575779|NCT02768194|18647504|P4|COMPLETED|Period 1||3
7575780|NCT02768194|18647505|P3|COMPLETED|Period 1||4
7575781|NCT02768194|18647506|P2|COMPLETED|Period 1||4
7575782|NCT02768194|18647507|P1|COMPLETED|Period 1||4
7575783|NCT02768194|18647502|P6|STARTED|Period 1||4
7575784|NCT02768194|18647503|P5|STARTED|Period 1||4
7575785|NCT02768194|18647504|P4|STARTED|Period 1||4
7575786|NCT02768194|18647505|P3|STARTED|Period 1||4
7575787|NCT02768194|18647506|P2|STARTED|Period 1||4
7575788|NCT02768194|18647507|P1|STARTED|Period 1||4
7575789|NCT02768129|18647520|P2|NOT COMPLETED|Overall Study||0
7575790|NCT02768129|18647521|P1|NOT COMPLETED|Overall Study||0
7575791|NCT02768129|18647520|P2|COMPLETED|Overall Study||10
7575792|NCT02768129|18647521|P1|COMPLETED|Overall Study||11
7575793|NCT02768129|18647520|P2|STARTED|Overall Study||10
7575794|NCT02768129|18647521|P1|STARTED|Overall Study||11
7575795|NCT02768103|18647529|P1|NOT COMPLETED|Overall Study||1
7575796|NCT02768103|18647529|P1|COMPLETED|Overall Study||4
7575797|NCT02768103|18647529|P1|STARTED|Overall Study||5
7575798|NCT02767947|18647536|P2|NOT COMPLETED|Overall Study||0
7575799|NCT02767947|18647537|P1|NOT COMPLETED|Overall Study||0
7575800|NCT02767947|18647536|P2|COMPLETED|Overall Study||15
7575801|NCT02767947|18647537|P1|COMPLETED|Overall Study||60
7575802|NCT02767947|18647536|P2|Pharmacokinetic (PK) Population|Overall Study||3
7575803|NCT02767947|18647537|P1|Pharmacokinetic (PK) Population|Overall Study||12
7575804|NCT02767947|18647536|P2|Safety Population|Overall Study||15
7575805|NCT02767947|18647537|P1|Safety Population|Overall Study||60
7575806|NCT02767947|18647536|P2|STARTED|Overall Study||15
7575807|NCT02767947|18647537|P1|STARTED|Overall Study||60
7575808|NCT02767934|18647545|P1|NOT COMPLETED|Overall Study||0
7575809|NCT02767934|18647545|P1|COMPLETED|Overall Study||12
7575810|NCT02767934|18647545|P1|STARTED|Overall Study||12
7575811|NCT02767869|18647553|P2|NOT COMPLETED|Overall Study||0
7575812|NCT02767869|18647554|P1|NOT COMPLETED|Overall Study||0
7575813|NCT02767869|18647553|P2|COMPLETED|Overall Study||12
7575814|NCT02767869|18647554|P1|COMPLETED|Overall Study||12
7575815|NCT02767869|18647553|P2|STARTED|Overall Study||12
7575816|NCT02767869|18647554|P1|STARTED|Overall Study||12
7575817|NCT02767843|18647584|P1|NOT COMPLETED|Overall Study||0
7575818|NCT02767843|18647584|P1|COMPLETED|Overall Study||4
7575819|NCT02767843|18647584|P1|STARTED|Overall Study||4
7575820|NCT02767765|18647590|P1|NOT COMPLETED|Overall Study||11
7575821|NCT02767765|18647590|P1|COMPLETED|Overall Study||50
7575822|NCT02767765|18647590|P1|STARTED|Overall Study||61
7575823|NCT02767609|18647599|P1|NOT COMPLETED|Overall Study||0
7575824|NCT02767609|18647599|P1|COMPLETED|Overall Study||1
7575825|NCT02767609|18647599|P1|STARTED|Overall Study||1
7575826|NCT02767531|18647603|P2|NOT COMPLETED|Period 4||0
7575827|NCT02767531|18647604|P1|NOT COMPLETED|Period 4||0
7575828|NCT02767531|18647603|P2|COMPLETED|Period 4||1
7575829|NCT02767531|18647604|P1|COMPLETED|Period 4||1
7575830|NCT02767531|18647603|P2|STARTED|Period 4|Orlistat Therapy|1
7575831|NCT02767531|18647604|P1|STARTED|Period 4|Off Orlistat|1
7575832|NCT02767531|18647603|P2|NOT COMPLETED|Period 3||0
7575833|NCT02767531|18647604|P1|NOT COMPLETED|Period 3||0
7575834|NCT02767531|18647603|P2|COMPLETED|Period 3||1
7575835|NCT02767531|18647604|P1|COMPLETED|Period 3||1
7575836|NCT02767531|18647603|P2|STARTED|Period 3|Off Orlistat|1
7575837|NCT02767531|18647604|P1|STARTED|Period 3|Orlistat Therapy|1
7575838|NCT02767531|18647603|P2|NOT COMPLETED|Period 2||0
7575839|NCT02767531|18647604|P1|NOT COMPLETED|Period 2||0
7575840|NCT02767531|18647603|P2|COMPLETED|Period 2||1
7575841|NCT02767531|18647604|P1|COMPLETED|Period 2||1
7575842|NCT02767531|18647603|P2|STARTED|Period 2|Orlistat Therapy|1
7575843|NCT02767531|18647604|P1|STARTED|Period 2|Off Orlistat|1
7575844|NCT02767531|18647603|P2|NOT COMPLETED|Period 1||0
7575845|NCT02767531|18647604|P1|NOT COMPLETED|Period 1||0
7575846|NCT02767531|18647603|P2|COMPLETED|Period 1||1
7575847|NCT02767531|18647604|P1|COMPLETED|Period 1||1
7575848|NCT02767531|18647603|P2|STARTED|Period 1|Off Orlistat|1
7575849|NCT02767531|18647604|P1|STARTED|Period 1|Orlistat therapy|1
7575850|NCT02767427|18647612|P2|NOT COMPLETED|Overall Study||0
7575851|NCT02767427|18647613|P1|NOT COMPLETED|Overall Study||0
7575852|NCT02767427|18647612|P2|COMPLETED|Overall Study||19
7575853|NCT02767427|18647613|P1|COMPLETED|Overall Study||21
7575854|NCT02767427|18647612|P2|STARTED|Overall Study||19
7575855|NCT02767427|18647613|P1|STARTED|Overall Study||21
7575856|NCT02767388|18647622|P3|NOT COMPLETED|Overall Study||3
7575857|NCT02767388|18647623|P2|NOT COMPLETED|Overall Study||5
7575858|NCT02767388|18647624|P1|NOT COMPLETED|Overall Study||7
7575859|NCT02767388|18647622|P3|COMPLETED|Overall Study||12
7575860|NCT02767388|18647623|P2|COMPLETED|Overall Study||10
7575861|NCT02767388|18647624|P1|COMPLETED|Overall Study||8
7575862|NCT02767388|18647622|P3|STARTED|Overall Study||15
7575863|NCT02767388|18647623|P2|STARTED|Overall Study||15
7575864|NCT02767388|18647624|P1|STARTED|Overall Study||15
7575865|NCT02767271|18647643|P2|NOT COMPLETED|Overall Study||0
7575866|NCT02767271|18647644|P1|NOT COMPLETED|Overall Study||0
7575867|NCT02767271|18647643|P2|COMPLETED|Overall Study||15
7575868|NCT02767271|18647644|P1|COMPLETED|Overall Study||15
7575869|NCT02767271|18647643|P2|Pharmacokinetic Cruris (PKC) Population|Overall Study||15
7575870|NCT02767271|18647644|P1|Pharmacokinetic Cruris (PKC) Population|Overall Study||0
7575871|NCT02767271|18647643|P2|Pharmacokinetic Pedis (PKP) Population|Overall Study||0
7575872|NCT02767271|18647644|P1|Pharmacokinetic Pedis (PKP) Population|Overall Study||15
7575873|NCT02767271|18647643|P2|Safety Population|Overall Study||15
7575874|NCT02767271|18647644|P1|Safety Population|Overall Study||15
7575875|NCT02767271|18647643|P2|STARTED|Overall Study||15
7575876|NCT02767271|18647644|P1|STARTED|Overall Study||15
7575877|NCT02767128|18647654|P1|NOT COMPLETED|Overall Study||0
7575878|NCT02767128|18647654|P1|COMPLETED|Overall Study||14
7575879|NCT02767128|18647654|P1|Shohl's + Triferic Immediately|Overall Study||14
7575880|NCT02767128|18647654|P1|Shohl's + Triferic After 10 Min|Overall Study||14
7575881|NCT02767128|18647654|P1|Triferic|Overall Study||14
7575882|NCT02767128|18647654|P1|Shohl's + Fer-In-Sol|Overall Study||14
7575883|NCT02767128|18647654|P1|Fer-In-Sol|Overall Study||14
7575884|NCT02767128|18647654|P1|Baseline|Overall Study||14
7575885|NCT02767128|18647654|P1|STARTED|Overall Study||14
7575886|NCT02767011|18647682|P2|NOT COMPLETED|Overall Study||0
7575887|NCT02767011|18647683|P1|NOT COMPLETED|Overall Study||0
7575888|NCT02767011|18647682|P2|COMPLETED|Overall Study||14
7575889|NCT02767011|18647683|P1|COMPLETED|Overall Study||16
7575890|NCT02767011|18647682|P2|STARTED|Overall Study||14
7575891|NCT02767011|18647683|P1|STARTED|Overall Study||16
7575892|NCT02766907|18647707|P2|NOT COMPLETED|Overall Study||1
7575893|NCT02766907|18647708|P1|NOT COMPLETED|Overall Study||1
7575894|NCT02766907|18647707|P2|COMPLETED|Overall Study||9
7575895|NCT02766907|18647708|P1|COMPLETED|Overall Study||9
7575896|NCT02766907|18647707|P2|STARTED|Overall Study||10
7575897|NCT02766907|18647708|P1|STARTED|Overall Study||10
7575898|NCT02766777|18647716|P1|NOT COMPLETED|Overall Study||34
7575899|NCT02766777|18647716|P1|COMPLETED|Overall Study||53
7575900|NCT02766777|18647716|P1|Treated (Safety [SAF] Population)|Overall Study||87
7575901|NCT02766777|18647716|P1|STARTED|Overall Study||87
7575902|NCT02766673|18647720|P6|NOT COMPLETED|Overall Study||1
7575903|NCT02766673|18647721|P5|NOT COMPLETED|Overall Study||0
7575904|NCT02766673|18647722|P4|NOT COMPLETED|Overall Study||0
7575905|NCT02766673|18647723|P3|NOT COMPLETED|Overall Study||0
7575906|NCT02766673|18647724|P2|NOT COMPLETED|Overall Study||0
7575907|NCT02766673|18647725|P1|NOT COMPLETED|Overall Study||1
7575908|NCT02766673|18647720|P6|COMPLETED|Overall Study||3
7575909|NCT02766673|18647721|P5|COMPLETED|Overall Study||4
7575910|NCT02766673|18647722|P4|COMPLETED|Overall Study||4
7575911|NCT02766673|18647723|P3|COMPLETED|Overall Study||4
7575912|NCT02766673|18647724|P2|COMPLETED|Overall Study||4
7575913|NCT02766673|18647725|P1|COMPLETED|Overall Study||3
7575914|NCT02766673|18647720|P6|STARTED|Overall Study||4
7575915|NCT02766673|18647721|P5|STARTED|Overall Study||4
7575916|NCT02766673|18647722|P4|STARTED|Overall Study||4
7575917|NCT02766673|18647723|P3|STARTED|Overall Study||4
7575918|NCT02766673|18647724|P2|STARTED|Overall Study||4
7575919|NCT02766673|18647725|P1|STARTED|Overall Study||4
7575920|NCT02766608|18647741|P5|NOT COMPLETED|Overall Study||29
7575921|NCT02766608|18647742|P4|NOT COMPLETED|Overall Study||37
7575922|NCT02766608|18647743|P3|NOT COMPLETED|Overall Study||90
7575923|NCT02766608|18647744|P2|NOT COMPLETED|Overall Study||70
7575924|NCT02766608|18647745|P1|NOT COMPLETED|Overall Study||79
7575925|NCT02766608|18647741|P5|COMPLETED|Overall Study||190
7575926|NCT02766608|18647742|P4|COMPLETED|Overall Study||169
7575927|NCT02766608|18647743|P3|COMPLETED|Overall Study||554
7575928|NCT02766608|18647744|P2|COMPLETED|Overall Study||567
7575929|NCT02766608|18647745|P1|COMPLETED|Overall Study||576
7575930|NCT02766608|18647741|P5|STARTED|Overall Study||219
7575931|NCT02766608|18647742|P4|STARTED|Overall Study||206
7575932|NCT02766608|18647743|P3|STARTED|Overall Study||644
7575933|NCT02766608|18647744|P2|STARTED|Overall Study||637
7575934|NCT02766608|18647745|P1|STARTED|Overall Study||655
7575935|NCT02766517|18647822|P3|NOT COMPLETED|Overall Study||0
7575936|NCT02766517|18647823|P2|NOT COMPLETED|Overall Study||0
7575937|NCT02766517|18647824|P1|NOT COMPLETED|Overall Study||0
7575938|NCT02766517|18647822|P3|COMPLETED|Overall Study||9
7575939|NCT02766517|18647823|P2|COMPLETED|Overall Study||9
7575940|NCT02766517|18647824|P1|COMPLETED|Overall Study||19
7575941|NCT02766517|18647822|P3|STARTED|Overall Study||9
7575942|NCT02766517|18647823|P2|STARTED|Overall Study||9
7575943|NCT02766517|18647824|P1|STARTED|Overall Study||19
7575944|NCT02766400|18647837|P2|NOT COMPLETED|Overall Study||2
7575945|NCT02766400|18647838|P1|NOT COMPLETED|Overall Study||2
7575946|NCT02766400|18647837|P2|COMPLETED|Overall Study||20
7575947|NCT02766400|18647838|P1|COMPLETED|Overall Study||19
7575948|NCT02766400|18647837|P2|STARTED|Overall Study||22
7575949|NCT02766400|18647838|P1|STARTED|Overall Study||21
7575950|NCT02766374|18647846|P2|NOT COMPLETED|Overall Study||3
7575951|NCT02766374|18647847|P1|NOT COMPLETED|Overall Study||10
7575952|NCT02766374|18647846|P2|COMPLETED|Overall Study||30
7575953|NCT02766374|18647847|P1|COMPLETED|Overall Study||25
7575954|NCT02766374|18647846|P2|STARTED|Overall Study||33
7575955|NCT02766374|18647847|P1|STARTED|Overall Study||35
7575956|NCT02766283|18647853|P1|NOT COMPLETED|Overall Study||27
7575957|NCT02766283|18647853|P1|COMPLETED|Overall Study||816
7575958|NCT02766283|18647853|P1|STARTED|Overall Study||843
7575959|NCT02766244|18647877|P1|NOT COMPLETED|Overall Study||0
7575960|NCT02766244|18647877|P1|COMPLETED|Overall Study||3
7575961|NCT02766244|18647877|P1|STARTED|Overall Study||3
7575962|NCT02766088|18647886|P1|NOT COMPLETED|Overall Study||506
7575963|NCT02766088|18647886|P1|COMPLETED|Overall Study||344
7575964|NCT02766088|18647886|P1|STARTED|Overall Study||850
7575965|NCT02766023|18647901|P2|NOT COMPLETED|Overall Study||17
7575966|NCT02766023|18647902|P1|NOT COMPLETED|Overall Study||30
7575967|NCT02766023|18647901|P2|COMPLETED|Overall Study||59
7575968|NCT02766023|18647902|P1|COMPLETED|Overall Study||122
7575969|NCT02766023|18647901|P2|STARTED|Overall Study||76
7575970|NCT02766023|18647902|P1|STARTED|Overall Study||152
7575971|NCT02765490|18647952|P2|NOT COMPLETED|Overall Study||3
7575972|NCT02765490|18647953|P1|NOT COMPLETED|Overall Study||1
7575973|NCT02765490|18647952|P2|COMPLETED|Overall Study||179
7575974|NCT02765490|18647953|P1|COMPLETED|Overall Study||182
7575975|NCT02765490|18647952|P2|STARTED|Overall Study||182
7575976|NCT02765490|18647953|P1|STARTED|Overall Study||183
7575977|NCT02765269|18647971|P2|NOT COMPLETED|Overall Study||0
7575978|NCT02765269|18647972|P1|NOT COMPLETED|Overall Study||0
7575979|NCT02765269|18647971|P2|COMPLETED|Overall Study||21
7575980|NCT02765269|18647972|P1|COMPLETED|Overall Study||25
7575981|NCT02765269|18647971|P2|STARTED|Overall Study||21
7575982|NCT02765269|18647972|P1|STARTED|Overall Study||25
7575983|NCT02765100|18647986|P2|NOT COMPLETED|Overall Study||2
7575984|NCT02765100|18647987|P1|NOT COMPLETED|Overall Study||1
7575985|NCT02765100|18647986|P2|COMPLETED|Overall Study||10
7575986|NCT02765100|18647987|P1|COMPLETED|Overall Study||8
7575987|NCT02765100|18647986|P2|STARTED|Overall Study||12
7575988|NCT02765100|18647987|P1|STARTED|Overall Study||9
7575989|NCT02764970|18647995|P2|NOT COMPLETED|Overall Study||0
7575990|NCT02764970|18647996|P1|NOT COMPLETED|Overall Study||0
7575991|NCT02764970|18647995|P2|COMPLETED|Overall Study||47
7575992|NCT02764970|18647996|P1|COMPLETED|Overall Study||65
7575993|NCT02764970|18647995|P2|STARTED|Overall Study||47
7575994|NCT02764970|18647996|P1|STARTED|Overall Study||65
7575995|NCT02764775|18648008|P1|NOT COMPLETED|Overall Study||6
7575996|NCT02764775|18648008|P1|COMPLETED|Overall Study||8
7575997|NCT02764775|18648008|P1|STARTED|Overall Study|All 14 participants were assigned to the Headpod utilization group.|14
7575998|NCT02764697|18648012|P1|NOT COMPLETED|Overall Study||3
7575999|NCT02764697|18648012|P1|COMPLETED|Overall Study||2
7576000|NCT02764697|18648012|P1|STARTED|Overall Study||5
7576001|NCT02764229|18648017|P1|NOT COMPLETED|Overall Study||102
7576002|NCT02764229|18648017|P1|COMPLETED|Overall Study||10
7576003|NCT02764229|18648017|P1|STARTED|Overall Study||112
7576004|NCT02764190|18648023|P2|NOT COMPLETED|Overall Study||13
7576005|NCT02764190|18648024|P1|NOT COMPLETED|Overall Study||17
7576006|NCT02764190|18648023|P2|COMPLETED|Overall Study||122
7576007|NCT02764190|18648024|P1|COMPLETED|Overall Study||150
7576008|NCT02764190|18648023|P2|12 Month Follow-up|Overall Study||122
7576009|NCT02764190|18648024|P1|12 Month Follow-up|Overall Study||150
7576010|NCT02764190|18648023|P2|6 Month Follow-up|Overall Study||128
7576011|NCT02764190|18648024|P1|6 Month Follow-up|Overall Study||155
7576012|NCT02764190|18648023|P2|3 Month Follow-up|Overall Study||128
7576013|NCT02764190|18648024|P1|3 Month Follow-up|Overall Study||156
7576014|NCT02764190|18648023|P2|1 Day Follow-up|Overall Study||131
7576015|NCT02764190|18648024|P1|1 Day Follow-up|Overall Study||161
7576016|NCT02764190|18648023|P2|STARTED|Overall Study||135
7576017|NCT02764190|18648024|P1|STARTED|Overall Study||167
7576018|NCT02764164|18648068|P1|NOT COMPLETED|Overall Study||0
7576019|NCT02764164|18648068|P1|COMPLETED|Overall Study|Duration flexible up to 12mo, ended early (funding), 2 week time point achieved|1
7576020|NCT02764164|18648068|P1|STARTED|Overall Study||1
7576021|NCT02764151|18648078|P4|NOT COMPLETED|Overall Study||3
7576022|NCT02764151|18648079|P3|NOT COMPLETED|Overall Study||0
7576023|NCT02764151|18648080|P2|NOT COMPLETED|Overall Study||0
7576024|NCT02764151|18648081|P1|NOT COMPLETED|Overall Study||0
7576025|NCT02764151|18648078|P4|COMPLETED|Overall Study||5
7576026|NCT02764151|18648079|P3|COMPLETED|Overall Study||3
7576027|NCT02764151|18648080|P2|COMPLETED|Overall Study||4
7576028|NCT02764151|18648081|P1|COMPLETED|Overall Study||2
7576029|NCT02764151|18648078|P4|STARTED|Overall Study||8
7576030|NCT02764151|18648079|P3|STARTED|Overall Study||3
7576031|NCT02764151|18648080|P2|STARTED|Overall Study||4
7576032|NCT02764151|18648081|P1|STARTED|Overall Study||2
7576033|NCT02763865|18648205|P2|NOT COMPLETED|Overall Study||0
7576034|NCT02763865|18648206|P1|NOT COMPLETED|Overall Study||0
7576035|NCT02763865|18648205|P2|COMPLETED|Overall Study||5
7576036|NCT02763865|18648206|P1|COMPLETED|Overall Study||5
7576037|NCT02763865|18648205|P2|STARTED|Overall Study||5
7576038|NCT02763865|18648206|P1|STARTED|Overall Study||5
7576039|NCT02763644|18648220|P2|NOT COMPLETED|Overall Study||2
7576040|NCT02763644|18648221|P1|NOT COMPLETED|Overall Study||3
7576041|NCT02763644|18648220|P2|COMPLETED|Overall Study||2
7576042|NCT02763644|18648221|P1|COMPLETED|Overall Study||0
7576043|NCT02763644|18648220|P2|STARTED|Overall Study||4
7576044|NCT02763644|18648221|P1|STARTED|Overall Study||3
7576045|NCT02763579|18648241|P2|NOT COMPLETED|Overall Study||202
7576046|NCT02763579|18648242|P1|NOT COMPLETED|Overall Study||201
7576047|NCT02763579|18648241|P2|COMPLETED|Overall Study||0
7576048|NCT02763579|18648242|P1|COMPLETED|Overall Study||0
7576049|NCT02763579|18648241|P2|STARTED|Overall Study||202
7576050|NCT02763579|18648242|P1|STARTED|Overall Study||201
7576051|NCT02763566|18648254|P4|NOT COMPLETED|Overall Study||14
7576052|NCT02763566|18648255|P3|NOT COMPLETED|Overall Study||54
7576053|NCT02763566|18648256|P2|NOT COMPLETED|Overall Study||39
7576054|NCT02763566|18648257|P1|NOT COMPLETED|Overall Study||118
7576055|NCT02763566|18648254|P4|COMPLETED|Overall Study||39
7576056|NCT02763566|18648255|P3|COMPLETED|Overall Study||50
7576057|NCT02763566|18648256|P2|COMPLETED|Overall Study||60
7576058|NCT02763566|18648257|P1|COMPLETED|Overall Study||89
7576059|NCT02763566|18648254|P4|STARTED|Overall Study||53
7576060|NCT02763566|18648255|P3|STARTED|Overall Study||104
7576061|NCT02763566|18648256|P2|STARTED|Overall Study||99
7576062|NCT02763566|18648257|P1|STARTED|Overall Study||207
7576063|NCT02763254|18648285|P1|NOT COMPLETED|Overall Study||1
7576064|NCT02763254|18648285|P1|COMPLETED|Overall Study||0
7576065|NCT02763254|18648285|P1|STARTED|Overall Study||1
7576066|NCT02763215|18648290|P1|NOT COMPLETED|Overall Study||7
7576067|NCT02763215|18648290|P1|COMPLETED|Overall Study||57
7576068|NCT02763215|18648290|P1|STARTED|Overall Study||64
7576069|NCT02763189|18648313|P2|NOT COMPLETED|Overall Study||2
7576070|NCT02763189|18648314|P1|NOT COMPLETED|Overall Study||0
7576071|NCT02763189|18648313|P2|COMPLETED|Overall Study||2
7576072|NCT02763189|18648314|P1|COMPLETED|Overall Study||4
7576073|NCT02763189|18648313|P2|STARTED|Overall Study||4
7576074|NCT02763189|18648314|P1|STARTED|Overall Study||4
7576075|NCT02763124|18648322|P1|NOT COMPLETED|Overall Study||0
7576076|NCT02763124|18648322|P1|COMPLETED|Overall Study||18
7576077|NCT02763124|18648322|P1|STARTED|Overall Study||18
7576078|NCT02763046|18648332|P3|NOT COMPLETED|Overall Study||8
7576079|NCT02763046|18648333|P2|NOT COMPLETED|Overall Study||5
7576080|NCT02763046|18648334|P1|NOT COMPLETED|Overall Study||9
7576081|NCT02763046|18648332|P3|COMPLETED|Overall Study||62
7576082|NCT02763046|18648333|P2|COMPLETED|Overall Study||65
7576083|NCT02763046|18648334|P1|COMPLETED|Overall Study||62
7576084|NCT02763046|18648332|P3|STARTED|Overall Study||70
7576085|NCT02763046|18648333|P2|STARTED|Overall Study||70
7576086|NCT02763046|18648334|P1|STARTED|Overall Study||71
7576087|NCT02762877|18648363|P2|NOT COMPLETED|Overall Study||0
7576088|NCT02762877|18648364|P1|NOT COMPLETED|Overall Study||0
7576089|NCT02762877|18648363|P2|COMPLETED|Overall Study||19
7576090|NCT02762877|18648364|P1|COMPLETED|Overall Study||121
7576091|NCT02762877|18648363|P2|STARTED|Overall Study||19
7576092|NCT02762877|18648364|P1|STARTED|Overall Study||121
7576093|NCT02762799|18648375|P4|NOT COMPLETED|Overall Study||0
7576094|NCT02762799|18648376|P3|NOT COMPLETED|Overall Study||1
7576095|NCT02762799|18648377|P2|NOT COMPLETED|Overall Study||0
7576096|NCT02762799|18648378|P1|NOT COMPLETED|Overall Study||0
7576097|NCT02762799|18648375|P4|COMPLETED|Overall Study||12
7576098|NCT02762799|18648376|P3|COMPLETED|Overall Study||11
7576099|NCT02762799|18648377|P2|COMPLETED|Overall Study||18
7576100|NCT02762799|18648378|P1|COMPLETED|Overall Study||18
7576101|NCT02762799|18648375|P4|STARTED|Overall Study||12
7576102|NCT02762799|18648376|P3|STARTED|Overall Study||12
7576103|NCT02762799|18648377|P2|STARTED|Overall Study||18
7576104|NCT02762799|18648378|P1|STARTED|Overall Study||18
7576105|NCT02762578|18648450|P2|NOT COMPLETED|Overall Study||10
7576106|NCT02762578|18648451|P1|NOT COMPLETED|Overall Study||15
7576107|NCT02762578|18648450|P2|COMPLETED|Overall Study||172
7576108|NCT02762578|18648451|P1|COMPLETED|Overall Study||346
7576109|NCT02762578|18648450|P2|Exposed|Overall Study||181
7576110|NCT02762578|18648451|P1|Exposed|Overall Study||360
7576111|NCT02762578|18648450|P2|STARTED|Overall Study||182
7576112|NCT02762578|18648451|P1|STARTED|Overall Study||361
7576113|NCT02762500|18648553|P2|NOT COMPLETED|Overall Study||3
7576114|NCT02762500|18648554|P1|NOT COMPLETED|Overall Study||2
7576115|NCT02762500|18648553|P2|COMPLETED|Overall Study||59
7576116|NCT02762500|18648554|P1|COMPLETED|Overall Study||60
7576117|NCT02762500|18648553|P2|STARTED|Overall Study||62
7576118|NCT02762500|18648554|P1|STARTED|Overall Study||62
7576119|NCT02762370|18648574|P2|NOT COMPLETED|Overall Study||0
7576120|NCT02762370|18648575|P1|NOT COMPLETED|Overall Study||1
7576121|NCT02762370|18648574|P2|COMPLETED|Overall Study||15
7576122|NCT02762370|18648575|P1|COMPLETED|Overall Study||17
7576123|NCT02762370|18648574|P2|STARTED|Overall Study||15
7576124|NCT02762370|18648575|P1|STARTED|Overall Study||18
7576125|NCT02762331|18648595|P2|NOT COMPLETED|Overall Study||0
7576126|NCT02762331|18648596|P1|NOT COMPLETED|Overall Study||0
7576127|NCT02762331|18648595|P2|COMPLETED|Overall Study||2
7576128|NCT02762331|18648596|P1|COMPLETED|Overall Study||4
7576129|NCT02762331|18648595|P2|STARTED|Overall Study||2
7576130|NCT02762331|18648596|P1|STARTED|Overall Study||4
7576131|NCT02762084|18648615|P3|NOT COMPLETED|Overall Study||1
7576132|NCT02762084|18648616|P2|NOT COMPLETED|Overall Study||0
7576133|NCT02762084|18648617|P1|NOT COMPLETED|Overall Study||1
7576134|NCT02762084|18648615|P3|COMPLETED|Overall Study||4
7576135|NCT02762084|18648616|P2|COMPLETED|Overall Study||6
7576136|NCT02762084|18648617|P1|COMPLETED|Overall Study||5
7576137|NCT02762084|18648615|P3|By Tumor Per Protocol Population (PP)|Overall Study||4
7576138|NCT02762084|18648616|P2|By Tumor Per Protocol Population (PP)|Overall Study||6
7576139|NCT02762084|18648617|P1|By Tumor Per Protocol Population (PP)|Overall Study||6
7576140|NCT02762084|18648615|P3|Received at Least 1 Dose of Study Drug|Overall Study||5
7576141|NCT02762084|18648616|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
7576142|NCT02762084|18648617|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
7576143|NCT02762084|18648615|P3|STARTED|Overall Study||5
7576144|NCT02762084|18648616|P2|STARTED|Overall Study||6
7576145|NCT02762084|18648617|P1|STARTED|Overall Study||6
7576146|NCT02762071|18648657|P2|NOT COMPLETED|Overall Study||0
7576147|NCT02762071|18648658|P1|NOT COMPLETED|Overall Study||0
7576148|NCT02762071|18648657|P2|COMPLETED|Overall Study||54
7576149|NCT02762071|18648658|P1|COMPLETED|Overall Study||54
7576150|NCT02762071|18648657|P2|STARTED|Overall Study||54
7576151|NCT02762071|18648658|P1|STARTED|Overall Study||54
7576152|NCT02761980|18648678|P4|NOT COMPLETED|Overall Study||6
7576153|NCT02761980|18648679|P3|NOT COMPLETED|Overall Study||6
7576154|NCT02761980|18648680|P2|NOT COMPLETED|Overall Study||7
7576155|NCT02761980|18648681|P1|NOT COMPLETED|Overall Study||4
7576156|NCT02761980|18648678|P4|COMPLETED|Overall Study||81
7576157|NCT02761980|18648679|P3|COMPLETED|Overall Study||81
7576158|NCT02761980|18648680|P2|COMPLETED|Overall Study||80
7576159|NCT02761980|18648681|P1|COMPLETED|Overall Study||25
7576160|NCT02761980|18648678|P4|STARTED|Overall Study||87
7576161|NCT02761980|18648679|P3|STARTED|Overall Study||87
7576162|NCT02761980|18648680|P2|STARTED|Overall Study||87
7576163|NCT02761980|18648681|P1|STARTED|Overall Study||29
7576164|NCT02761967|18648713|P2|NOT COMPLETED|Overall Study||6
7576165|NCT02761967|18648714|P1|NOT COMPLETED|Overall Study||5
7576166|NCT02761967|18648713|P2|COMPLETED|Overall Study||64
7576167|NCT02761967|18648714|P1|COMPLETED|Overall Study||65
7576168|NCT02761967|18648713|P2|STARTED|Overall Study||70
7576169|NCT02761967|18648714|P1|STARTED|Overall Study||70
7576170|NCT02761733|18648728|P4|NOT COMPLETED|Overall Study||15
7576171|NCT02761733|18648729|P3|NOT COMPLETED|Overall Study||27
7576172|NCT02761733|18648730|P2|NOT COMPLETED|Overall Study||21
7576173|NCT02761733|18648731|P1|NOT COMPLETED|Overall Study||30
7576174|NCT02761733|18648728|P4|COMPLETED|Overall Study||45
7576175|NCT02761733|18648729|P3|COMPLETED|Overall Study||33
7576176|NCT02761733|18648730|P2|COMPLETED|Overall Study||39
7576177|NCT02761733|18648731|P1|COMPLETED|Overall Study||30
7576178|NCT02761733|18648728|P4|9/30/2015|Overall Study||50
7576179|NCT02761733|18648729|P3|9/30/2015|Overall Study||33
7576180|NCT02761733|18648730|P2|9/30/2015|Overall Study||44
7576181|NCT02761733|18648731|P1|9/30/2015|Overall Study||40
7576182|NCT02761733|18648728|P4|3/31/2015|Overall Study||50
7576183|NCT02761733|18648729|P3|3/31/2015|Overall Study||43
7576184|NCT02761733|18648730|P2|3/31/2015|Overall Study||47
7576185|NCT02761733|18648731|P1|3/31/2015|Overall Study||48
7576186|NCT02761733|18648728|P4|9/30/2014|Overall Study||55
7576187|NCT02761733|18648729|P3|9/30/2014|Overall Study||48
7576188|NCT02761733|18648730|P2|9/30/2014|Overall Study||56
7576189|NCT02761733|18648731|P1|9/30/2014|Overall Study||53
7576190|NCT02761733|18648728|P4|STARTED|Overall Study||60
7576191|NCT02761733|18648729|P3|STARTED|Overall Study||60
7576192|NCT02761733|18648730|P2|STARTED|Overall Study||60
7576193|NCT02761733|18648731|P1|STARTED|Overall Study||60
7576194|NCT02761642|18648761|P1|NOT COMPLETED|Overall Study||70
7576195|NCT02761642|18648761|P1|COMPLETED|Overall Study||130
7576196|NCT02761642|18648761|P1|Treated|Overall Study||197
7576197|NCT02761642|18648761|P1|STARTED|Overall Study||200
7576198|NCT02761629|18648774|P2|NOT COMPLETED|Overall Study||32
7576199|NCT02761629|18648775|P1|NOT COMPLETED|Overall Study||27
7576200|NCT02761629|18648774|P2|COMPLETED|Overall Study||58
7576201|NCT02761629|18648775|P1|COMPLETED|Overall Study||63
7576202|NCT02761629|18648774|P2|Treated|Overall Study||86
7576203|NCT02761629|18648775|P1|Treated|Overall Study||82
7576204|NCT02761629|18648774|P2|STARTED|Overall Study||90
7576205|NCT02761629|18648775|P1|STARTED|Overall Study||90
7576206|NCT02761252|18648798|P3|NOT COMPLETED|Overall Study||14
7576207|NCT02761252|18648799|P2|NOT COMPLETED|Overall Study||8
7576208|NCT02761252|18648800|P1|NOT COMPLETED|Overall Study||10
7576209|NCT02761252|18648798|P3|COMPLETED|Overall Study||123
7576210|NCT02761252|18648799|P2|COMPLETED|Overall Study||132
7576211|NCT02761252|18648800|P1|COMPLETED|Overall Study||133
7576212|NCT02761252|18648798|P3|STARTED|Overall Study||137
7576213|NCT02761252|18648799|P2|STARTED|Overall Study||140
7576214|NCT02761252|18648800|P1|STARTED|Overall Study||143
7576215|NCT02760927|18648822|P1|NOT COMPLETED|Overall Study||1
7576216|NCT02760927|18648822|P1|COMPLETED|Overall Study||3
7576217|NCT02760927|18648822|P1|STARTED|Overall Study||4
7576218|NCT02760862|18648832|P2|NOT COMPLETED|Overall Study||0
7576219|NCT02760862|18648833|P1|NOT COMPLETED|Overall Study||0
7576220|NCT02760862|18648832|P2|COMPLETED|Overall Study||25
7576221|NCT02760862|18648833|P1|COMPLETED|Overall Study||25
7576222|NCT02760862|18648832|P2|STARTED|Overall Study||25
7576223|NCT02760862|18648833|P1|STARTED|Overall Study||25
7576224|NCT02760810|18648839|P1|NOT COMPLETED|Overall Study||1
7576225|NCT02760810|18648839|P1|COMPLETED|Overall Study||29
7576226|NCT02760810|18648839|P1|STARTED|Overall Study||30
7576227|NCT02760654|18648847|P2|NOT COMPLETED|Overall Study||6
7576228|NCT02760654|18648848|P1|NOT COMPLETED|Overall Study||7
7576229|NCT02760654|18648847|P2|COMPLETED|Overall Study||24
7576230|NCT02760654|18648848|P1|COMPLETED|Overall Study||23
7576231|NCT02760654|18648847|P2|STARTED|Overall Study||30
7576232|NCT02760654|18648848|P1|STARTED|Overall Study||30
7576233|NCT02760602|18648874|P2|NOT COMPLETED|Overall Study||13
7576234|NCT02760602|18648875|P1|NOT COMPLETED|Overall Study||13
7576235|NCT02760602|18648874|P2|COMPLETED|Overall Study||0
7576236|NCT02760602|18648875|P1|COMPLETED|Overall Study||0
7576237|NCT02760602|18648874|P2|STARTED|Overall Study||13
7576238|NCT02760602|18648875|P1|STARTED|Overall Study||13
7576239|NCT02760368|18648916|P3|NOT COMPLETED|Overall Study||11
7576240|NCT02760368|18648917|P2|NOT COMPLETED|Overall Study||8
7576241|NCT02760368|18648918|P1|NOT COMPLETED|Overall Study||13
7576242|NCT02760368|18648916|P3|COMPLETED|Overall Study||132
7576243|NCT02760368|18648917|P2|COMPLETED|Overall Study||134
7576244|NCT02760368|18648918|P1|COMPLETED|Overall Study||130
7576245|NCT02760368|18648916|P3|STARTED|Overall Study||143
7576246|NCT02760368|18648917|P2|STARTED|Overall Study||142
7576247|NCT02760368|18648918|P1|STARTED|Overall Study||143
7576248|NCT02760277|18648942|P4|NOT COMPLETED|6.0 mg/kg/Day||0
7576249|NCT02760277|18648943|P3|NOT COMPLETED|6.0 mg/kg/Day||0
7576250|NCT02760277|18648944|P2|NOT COMPLETED|6.0 mg/kg/Day||0
7576251|NCT02760277|18648945|P1|NOT COMPLETED|6.0 mg/kg/Day||0
7576252|NCT02760277|18648942|P4|COMPLETED|6.0 mg/kg/Day||12
7576253|NCT02760277|18648943|P3|COMPLETED|6.0 mg/kg/Day||0
7576254|NCT02760277|18648944|P2|COMPLETED|6.0 mg/kg/Day||0
7576255|NCT02760277|18648945|P1|COMPLETED|6.0 mg/kg/Day||0
7576256|NCT02760277|18648942|P4|STARTED|6.0 mg/kg/Day||12
7576257|NCT02760277|18648943|P3|STARTED|6.0 mg/kg/Day||0
7576258|NCT02760277|18648944|P2|STARTED|6.0 mg/kg/Day||0
7576259|NCT02760277|18648945|P1|STARTED|6.0 mg/kg/Day||0
7576260|NCT02760277|18648942|P4|NOT COMPLETED|2.0 mg/kg/Day||0
7576261|NCT02760277|18648943|P3|NOT COMPLETED|2.0 mg/kg/Day||0
7576262|NCT02760277|18648944|P2|NOT COMPLETED|2.0 mg/kg/Day||0
7576263|NCT02760277|18648945|P1|NOT COMPLETED|2.0 mg/kg/Day||0
7576264|NCT02760277|18648942|P4|COMPLETED|2.0 mg/kg/Day||0
7576265|NCT02760277|18648943|P3|COMPLETED|2.0 mg/kg/Day||12
7576266|NCT02760277|18648944|P2|COMPLETED|2.0 mg/kg/Day||0
7576267|NCT02760277|18648945|P1|COMPLETED|2.0 mg/kg/Day||0
7576268|NCT02760277|18648942|P4|STARTED|2.0 mg/kg/Day||0
7576269|NCT02760277|18648943|P3|STARTED|2.0 mg/kg/Day||12
7576270|NCT02760277|18648944|P2|STARTED|2.0 mg/kg/Day||0
7576271|NCT02760277|18648945|P1|STARTED|2.0 mg/kg/Day||0
7576272|NCT02760277|18648942|P4|NOT COMPLETED|0.75 mg/kg/Day||0
7576273|NCT02760277|18648943|P3|NOT COMPLETED|0.75 mg/kg/Day||0
7576274|NCT02760277|18648944|P2|NOT COMPLETED|0.75 mg/kg/Day||0
7576275|NCT02760277|18648945|P1|NOT COMPLETED|0.75 mg/kg/Day||0
7576276|NCT02760277|18648942|P4|COMPLETED|0.75 mg/kg/Day||0
7576277|NCT02760277|18648943|P3|COMPLETED|0.75 mg/kg/Day||0
7576278|NCT02760277|18648944|P2|COMPLETED|0.75 mg/kg/Day||12
7576279|NCT02760277|18648945|P1|COMPLETED|0.75 mg/kg/Day||0
7576280|NCT02760277|18648942|P4|STARTED|0.75 mg/kg/Day||0
7576281|NCT02760277|18648943|P3|STARTED|0.75 mg/kg/Day||0
7576282|NCT02760277|18648944|P2|STARTED|0.75 mg/kg/Day||12
7576283|NCT02760277|18648945|P1|STARTED|0.75 mg/kg/Day||0
7576284|NCT02760277|18648942|P4|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
7576285|NCT02760277|18648943|P3|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
7576286|NCT02760277|18648944|P2|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
7576287|NCT02760277|18648945|P1|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
7576288|NCT02760277|18648942|P4|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
7576289|NCT02760277|18648943|P3|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
7576290|NCT02760277|18648944|P2|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
7576291|NCT02760277|18648945|P1|COMPLETED|Vamorolone 0.25 mg/kg/Day||12
7576292|NCT02760277|18648942|P4|STARTED|Vamorolone 0.25 mg/kg/Day||0
7576293|NCT02760277|18648943|P3|STARTED|Vamorolone 0.25 mg/kg/Day||0
7576294|NCT02760277|18648944|P2|STARTED|Vamorolone 0.25 mg/kg/Day||0
7576295|NCT02760277|18648945|P1|STARTED|Vamorolone 0.25 mg/kg/Day||12
7576296|NCT02760264|18649019|P4|NOT COMPLETED|6.0 mg/kg/Day||0
7576297|NCT02760264|18649020|P3|NOT COMPLETED|6.0 mg/kg/Day||0
7576298|NCT02760264|18649021|P2|NOT COMPLETED|6.0 mg/kg/Day||0
7576299|NCT02760264|18649022|P1|NOT COMPLETED|6.0 mg/kg/Day||0
7576300|NCT02760264|18649019|P4|COMPLETED|6.0 mg/kg/Day||12
7576301|NCT02760264|18649020|P3|COMPLETED|6.0 mg/kg/Day||0
7576302|NCT02760264|18649021|P2|COMPLETED|6.0 mg/kg/Day||0
7576303|NCT02760264|18649022|P1|COMPLETED|6.0 mg/kg/Day||0
7576304|NCT02760264|18649019|P4|STARTED|6.0 mg/kg/Day||12
7576305|NCT02760264|18649020|P3|STARTED|6.0 mg/kg/Day||0
7576306|NCT02760264|18649021|P2|STARTED|6.0 mg/kg/Day||0
7576307|NCT02760264|18649022|P1|STARTED|6.0 mg/kg/Day||0
7576308|NCT02760264|18649019|P4|NOT COMPLETED|2.0 mg/kg/Day||0
7576309|NCT02760264|18649020|P3|NOT COMPLETED|2.0 mg/kg/Day||0
7576310|NCT02760264|18649021|P2|NOT COMPLETED|2.0 mg/kg/Day||0
7576311|NCT02760264|18649022|P1|NOT COMPLETED|2.0 mg/kg/Day||0
7576312|NCT02760264|18649019|P4|COMPLETED|2.0 mg/kg/Day||0
7576313|NCT02760264|18649020|P3|COMPLETED|2.0 mg/kg/Day||12
7576314|NCT02760264|18649021|P2|COMPLETED|2.0 mg/kg/Day||0
7576315|NCT02760264|18649022|P1|COMPLETED|2.0 mg/kg/Day||0
7576316|NCT02760264|18649019|P4|STARTED|2.0 mg/kg/Day||0
7576317|NCT02760264|18649020|P3|STARTED|2.0 mg/kg/Day||12
7576318|NCT02760264|18649021|P2|STARTED|2.0 mg/kg/Day||0
7576319|NCT02760264|18649022|P1|STARTED|2.0 mg/kg/Day||0
7576320|NCT02760264|18649019|P4|NOT COMPLETED|0.75 mg/kg/Day||0
7576321|NCT02760264|18649020|P3|NOT COMPLETED|0.75 mg/kg/Day||0
7576322|NCT02760264|18649021|P2|NOT COMPLETED|0.75 mg/kg/Day||0
7576323|NCT02760264|18649022|P1|NOT COMPLETED|0.75 mg/kg/Day||0
7576324|NCT02760264|18649019|P4|COMPLETED|0.75 mg/kg/Day||0
7576325|NCT02760264|18649020|P3|COMPLETED|0.75 mg/kg/Day||0
7576326|NCT02760264|18649021|P2|COMPLETED|0.75 mg/kg/Day||12
7576327|NCT02760264|18649022|P1|COMPLETED|0.75 mg/kg/Day||0
7576328|NCT02760264|18649019|P4|STARTED|0.75 mg/kg/Day||0
7576329|NCT02760264|18649020|P3|STARTED|0.75 mg/kg/Day||0
7576330|NCT02760264|18649021|P2|STARTED|0.75 mg/kg/Day||12
7576331|NCT02760264|18649022|P1|STARTED|0.75 mg/kg/Day||0
7576332|NCT02760264|18649019|P4|NOT COMPLETED|0.25 mg/kg/Day||0
7576333|NCT02760264|18649020|P3|NOT COMPLETED|0.25 mg/kg/Day||0
7576334|NCT02760264|18649021|P2|NOT COMPLETED|0.25 mg/kg/Day||0
7576335|NCT02760264|18649022|P1|NOT COMPLETED|0.25 mg/kg/Day||0
7576336|NCT02760264|18649019|P4|COMPLETED|0.25 mg/kg/Day||0
7576337|NCT02760264|18649020|P3|COMPLETED|0.25 mg/kg/Day||0
7576338|NCT02760264|18649021|P2|COMPLETED|0.25 mg/kg/Day||0
7576339|NCT02760264|18649022|P1|COMPLETED|0.25 mg/kg/Day||12
7576340|NCT02760264|18649019|P4|STARTED|0.25 mg/kg/Day||0
7576341|NCT02760264|18649020|P3|STARTED|0.25 mg/kg/Day||0
7576342|NCT02760264|18649021|P2|STARTED|0.25 mg/kg/Day||0
7576343|NCT02760264|18649022|P1|STARTED|0.25 mg/kg/Day||12
7576344|NCT02760069|18649100|P3|NOT COMPLETED|Overall Study||1
7576345|NCT02760069|18649101|P2|NOT COMPLETED|Overall Study||1
7576346|NCT02760069|18649102|P1|NOT COMPLETED|Overall Study||0
7576347|NCT02760069|18649100|P3|COMPLETED|Overall Study||40
7576348|NCT02760069|18649101|P2|COMPLETED|Overall Study||40
7576349|NCT02760069|18649102|P1|COMPLETED|Overall Study||40
7576350|NCT02760069|18649100|P3|STARTED|Overall Study||41
7576351|NCT02760069|18649101|P2|STARTED|Overall Study||41
7576352|NCT02760069|18649102|P1|STARTED|Overall Study||40
7576353|NCT02760056|18649115|P2|NOT COMPLETED|Overall Study||0
7576354|NCT02760056|18649116|P1|NOT COMPLETED|Overall Study||0
7576355|NCT02760056|18649115|P2|COMPLETED|Overall Study||5
7576356|NCT02760056|18649116|P1|COMPLETED|Overall Study||10
7576357|NCT02760056|18649115|P2|STARTED|Overall Study||5
7576358|NCT02760056|18649116|P1|STARTED|Overall Study||10
7576359|NCT02759939|18649128|P4|NOT COMPLETED|Overall Study||1043
7576360|NCT02759939|18649129|P3|NOT COMPLETED|Overall Study||1154
7576361|NCT02759939|18649130|P2|NOT COMPLETED|Overall Study||972
7576362|NCT02759939|18649131|P1|NOT COMPLETED|Overall Study||1056
7576363|NCT02759939|18649128|P4|COMPLETED|Overall Study||203
7576364|NCT02759939|18649129|P3|COMPLETED|Overall Study||239
7576365|NCT02759939|18649130|P2|COMPLETED|Overall Study||171
7576366|NCT02759939|18649131|P1|COMPLETED|Overall Study||200
7576367|NCT02759939|18649128|P4|Consented to T2 and T3|Overall Study||564
7576368|NCT02759939|18649129|P3|Consented to T2 and T3|Overall Study||702
7576369|NCT02759939|18649130|P2|Consented to T2 and T3|Overall Study||626
7576370|NCT02759939|18649131|P1|Consented to T2 and T3|Overall Study||579
7576371|NCT02759939|18649128|P4|Analyzed at T2 and/or T3|Overall Study||304
7576372|NCT02759939|18649129|P3|Analyzed at T2 and/or T3|Overall Study||373
7576373|NCT02759939|18649130|P2|Analyzed at T2 and/or T3|Overall Study||278
7576374|NCT02759939|18649131|P1|Analyzed at T2 and/or T3|Overall Study||303
7576375|NCT02759939|18649128|P4|Eligible for T2 and T3|Overall Study||853
7576376|NCT02759939|18649129|P3|Eligible for T2 and T3|Overall Study||1022
7576377|NCT02759939|18649130|P2|Eligible for T2 and T3|Overall Study||962
7576378|NCT02759939|18649131|P1|Eligible for T2 and T3|Overall Study||935
7576379|NCT02759939|18649128|P4|Analyzed at T1|Overall Study||1244
7576380|NCT02759939|18649129|P3|Analyzed at T1|Overall Study||1388
7576381|NCT02759939|18649130|P2|Analyzed at T1|Overall Study||1141
7576382|NCT02759939|18649131|P1|Analyzed at T1|Overall Study||1245
7576383|NCT02759939|18649128|P4|STARTED|Overall Study||1246
7576384|NCT02759939|18649129|P3|STARTED|Overall Study||1393
7576385|NCT02759939|18649130|P2|STARTED|Overall Study||1143
7576386|NCT02759939|18649131|P1|STARTED|Overall Study||1256
7576387|NCT02759692|18649141|P2|NOT COMPLETED|Period 3||0
7576388|NCT02759692|18649142|P1|NOT COMPLETED|Period 3||0
7576389|NCT02759692|18649141|P2|COMPLETED|Period 3||139
7576390|NCT02759692|18649142|P1|COMPLETED|Period 3||137
7576391|NCT02759692|18649141|P2|STARTED|Period 3||139
7576392|NCT02759692|18649142|P1|STARTED|Period 3||137
7576393|NCT02759692|18649141|P2|NOT COMPLETED|Period 2||1
7576394|NCT02759692|18649142|P1|NOT COMPLETED|Period 2||1
7576395|NCT02759692|18649141|P2|COMPLETED|Period 2||139
7576396|NCT02759692|18649142|P1|COMPLETED|Period 2||137
7576397|NCT02759692|18649141|P2|STARTED|Period 2||140
7576398|NCT02759692|18649142|P1|STARTED|Period 2||138
7576399|NCT02759692|18649141|P2|NOT COMPLETED|Period 1||2
7576400|NCT02759692|18649142|P1|NOT COMPLETED|Period 1||3
7576401|NCT02759692|18649141|P2|COMPLETED|Period 1||140
7576402|NCT02759692|18649142|P1|COMPLETED|Period 1||138
7576403|NCT02759692|18649141|P2|STARTED|Period 1||142
7576404|NCT02759692|18649142|P1|STARTED|Period 1||141
7576405|NCT02759562|18649160|P2|NOT COMPLETED|Open-Label Treatment Period||2
7576406|NCT02759562|18649161|P1|NOT COMPLETED|Open-Label Treatment Period||2
7576407|NCT02759562|18649160|P2|COMPLETED|Open-Label Treatment Period||0
7576408|NCT02759562|18649161|P1|COMPLETED|Open-Label Treatment Period||0
7576409|NCT02759562|18649160|P2|STARTED|Open-Label Treatment Period||2
7576410|NCT02759562|18649161|P1|STARTED|Open-Label Treatment Period||2
7576411|NCT02759562|18649160|P2|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
7576412|NCT02759562|18649161|P1|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
7576413|NCT02759562|18649160|P2|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
7576414|NCT02759562|18649161|P1|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
7576415|NCT02759562|18649160|P2|STARTED|Double-Blind Treatment Period (8 Weeks)||3
7576416|NCT02759562|18649161|P1|STARTED|Double-Blind Treatment Period (8 Weeks)||3
7576417|NCT02759471|18649174|P1|NOT COMPLETED|Overall Study||2
7576418|NCT02759471|18649174|P1|COMPLETED|Overall Study||52
7576419|NCT02759471|18649174|P1|STARTED|Overall Study||54
7576420|NCT02759354|18649188|P4|NOT COMPLETED|Overall Study||0
7576421|NCT02759354|18649189|P3|NOT COMPLETED|Overall Study||0
7576422|NCT02759354|18649190|P2|NOT COMPLETED|Overall Study||0
7576423|NCT02759354|18649191|P1|NOT COMPLETED|Overall Study||0
7576424|NCT02759354|18649188|P4|COMPLETED|Overall Study||191
7576425|NCT02759354|18649189|P3|COMPLETED|Overall Study||181
7576426|NCT02759354|18649190|P2|COMPLETED|Overall Study||190
7576427|NCT02759354|18649191|P1|COMPLETED|Overall Study||192
7576428|NCT02759354|18649188|P4|STARTED|Overall Study||191
7576429|NCT02759354|18649189|P3|STARTED|Overall Study||181
7576430|NCT02759354|18649190|P2|STARTED|Overall Study||190
7576431|NCT02759354|18649191|P1|STARTED|Overall Study||192
7576432|NCT02759315|18649230|P5|NOT COMPLETED|Overall Study||1
7576433|NCT02759315|18649231|P4|NOT COMPLETED|Overall Study||1
7576434|NCT02759315|18649232|P3|NOT COMPLETED|Overall Study||10
7576435|NCT02759315|18649233|P2|NOT COMPLETED|Overall Study||1
7576436|NCT02759315|18649234|P1|NOT COMPLETED|Overall Study||4
7576437|NCT02759315|18649230|P5|COMPLETED|Overall Study||2
7576438|NCT02759315|18649231|P4|COMPLETED|Overall Study||19
7576439|NCT02759315|18649232|P3|COMPLETED|Overall Study||29
7576440|NCT02759315|18649233|P2|COMPLETED|Overall Study||28
7576441|NCT02759315|18649234|P1|COMPLETED|Overall Study||65
7576442|NCT02759315|18649230|P5|STARTED|Overall Study||3
7576443|NCT02759315|18649231|P4|STARTED|Overall Study||20
7576444|NCT02759315|18649232|P3|STARTED|Overall Study||39
7576445|NCT02759315|18649233|P2|STARTED|Overall Study||29
7576446|NCT02759315|18649234|P1|STARTED|Overall Study||69
7576447|NCT02759146|18649284|P7|NOT COMPLETED|Week 5-8||6
7576448|NCT02759146|18649285|P6|NOT COMPLETED|Week 5-8||6
7576449|NCT02759146|18649286|P5|NOT COMPLETED|Week 5-8||5
7576450|NCT02759146|18649287|P4|NOT COMPLETED|Week 5-8||7
7576451|NCT02759146|18649288|P3|NOT COMPLETED|Week 5-8||10
7576452|NCT02759146|18649289|P2|NOT COMPLETED|Week 5-8||5
7576453|NCT02759146|18649290|P1|NOT COMPLETED|Week 5-8||10
7576454|NCT02759146|18649284|P7|COMPLETED|Week 5-8||20
7576455|NCT02759146|18649285|P6|COMPLETED|Week 5-8||23
7576456|NCT02759146|18649286|P5|COMPLETED|Week 5-8||44
7576457|NCT02759146|18649287|P4|COMPLETED|Week 5-8||37
7576458|NCT02759146|18649288|P3|COMPLETED|Week 5-8||22
7576459|NCT02759146|18649289|P2|COMPLETED|Week 5-8||29
7576460|NCT02759146|18649290|P1|COMPLETED|Week 5-8||46
7576461|NCT02759146|18649284|P7|STARTED|Week 5-8||26
7576462|NCT02759146|18649285|P6|STARTED|Week 5-8||29
7576463|NCT02759146|18649286|P5|STARTED|Week 5-8||49
7576464|NCT02759146|18649287|P4|STARTED|Week 5-8||44
7576465|NCT02759146|18649288|P3|STARTED|Week 5-8||32
7576466|NCT02759146|18649289|P2|STARTED|Week 5-8||34
7576467|NCT02759146|18649290|P1|STARTED|Week 5-8||56
7576468|NCT02759146|18649284|P7|NOT COMPLETED|Week 1-4||1
7576469|NCT02759146|18649285|P6|NOT COMPLETED|Week 1-4||1
7576470|NCT02759146|18649286|P5|NOT COMPLETED|Week 1-4||0
7576471|NCT02759146|18649287|P4|NOT COMPLETED|Week 1-4||0
7576472|NCT02759146|18649288|P3|NOT COMPLETED|Week 1-4||1
7576473|NCT02759146|18649289|P2|NOT COMPLETED|Week 1-4||2
7576474|NCT02759146|18649290|P1|NOT COMPLETED|Week 1-4||1
7576475|NCT02759146|18649284|P7|COMPLETED|Week 1-4||26
7576476|NCT02759146|18649285|P6|COMPLETED|Week 1-4||29
7576477|NCT02759146|18649286|P5|COMPLETED|Week 1-4||49
7576478|NCT02759146|18649287|P4|COMPLETED|Week 1-4||44
7576479|NCT02759146|18649288|P3|COMPLETED|Week 1-4||32
7576480|NCT02759146|18649289|P2|COMPLETED|Week 1-4||34
7576481|NCT02759146|18649290|P1|COMPLETED|Week 1-4||56
7576482|NCT02759146|18649284|P7|STARTED|Week 1-4||27
7576483|NCT02759146|18649285|P6|STARTED|Week 1-4||30
7576484|NCT02759146|18649286|P5|STARTED|Week 1-4||49
7576485|NCT02759146|18649287|P4|STARTED|Week 1-4|One control participant could continue without the other after baseline.|44
7576486|NCT02759146|18649288|P3|STARTED|Week 1-4||33
7576487|NCT02759146|18649289|P2|STARTED|Week 1-4||36
7576488|NCT02759146|18649290|P1|STARTED|Week 1-4||57
7576489|NCT02759016|18649337|P2|NOT COMPLETED|Overall Study||3
7576490|NCT02759016|18649338|P1|NOT COMPLETED|Overall Study||4
7576491|NCT02759016|18649337|P2|COMPLETED|Overall Study||0
7576492|NCT02759016|18649338|P1|COMPLETED|Overall Study||0
7576493|NCT02759016|18649337|P2|Treated With BI 836826 and Ibrutinib|Overall Study||3
7576494|NCT02759016|18649338|P1|Treated With BI 836826 and Ibrutinib|Overall Study||3
7576495|NCT02759016|18649337|P2|STARTED|Overall Study||3
7576496|NCT02759016|18649338|P1|STARTED|Overall Study||4
7576497|NCT02758899|18649348|P2|NOT COMPLETED|Overall Study||1
7576498|NCT02758899|18649349|P1|NOT COMPLETED|Overall Study||2
7576499|NCT02758899|18649348|P2|COMPLETED|Overall Study||9
7576500|NCT02758899|18649349|P1|COMPLETED|Overall Study||9
7576501|NCT02758899|18649348|P2|STARTED|Overall Study||10
7576502|NCT02758899|18649349|P1|STARTED|Overall Study||11
7576503|NCT02758717|18649357|P1|NOT COMPLETED|Overall Study||0
7576504|NCT02758717|18649357|P1|COMPLETED|Overall Study||46
7576505|NCT02758717|18649357|P1|STARTED|Overall Study||46
7576506|NCT02758613|18649367|P4|NOT COMPLETED|Follow-up||0
7576507|NCT02758613|18649368|P3|NOT COMPLETED|Follow-up||0
7576508|NCT02758613|18649369|P2|NOT COMPLETED|Follow-up||0
7576509|NCT02758613|18649370|P1|NOT COMPLETED|Follow-up||0
7576510|NCT02758613|18649367|P4|COMPLETED|Follow-up||8
7576511|NCT02758613|18649368|P3|COMPLETED|Follow-up||8
7576512|NCT02758613|18649369|P2|COMPLETED|Follow-up||8
7576513|NCT02758613|18649370|P1|COMPLETED|Follow-up||6
7576514|NCT02758613|18649367|P4|STARTED|Follow-up||8
7576515|NCT02758613|18649368|P3|STARTED|Follow-up||8
7576516|NCT02758613|18649369|P2|STARTED|Follow-up||8
7576517|NCT02758613|18649370|P1|STARTED|Follow-up||6
7576518|NCT02758613|18649367|P4|NOT COMPLETED|Treatment||0
7576519|NCT02758613|18649368|P3|NOT COMPLETED|Treatment||1
7576520|NCT02758613|18649369|P2|NOT COMPLETED|Treatment||0
7576521|NCT02758613|18649370|P1|NOT COMPLETED|Treatment||2
7576522|NCT02758613|18649367|P4|COMPLETED|Treatment||8
7576523|NCT02758613|18649368|P3|COMPLETED|Treatment||8
7576524|NCT02758613|18649369|P2|COMPLETED|Treatment||8
7576525|NCT02758613|18649370|P1|COMPLETED|Treatment||6
7576526|NCT02758613|18649367|P4|Received at Least One Dose of Study Drug|Treatment||8
7576527|NCT02758613|18649368|P3|Received at Least One Dose of Study Drug|Treatment||9
7576528|NCT02758613|18649369|P2|Received at Least One Dose of Study Drug|Treatment||8
7576529|NCT02758613|18649370|P1|Received at Least One Dose of Study Drug|Treatment||8
7576530|NCT02758613|18649367|P4|STARTED|Treatment||8
7576531|NCT02758613|18649368|P3|STARTED|Treatment||9
7576532|NCT02758613|18649369|P2|STARTED|Treatment||8
7576533|NCT02758613|18649370|P1|STARTED|Treatment||8
7576534|NCT02758301|18649388|P2|NOT COMPLETED|Overall Study||8
7576535|NCT02758301|18649389|P1|NOT COMPLETED|Overall Study||34
7576536|NCT02758301|18649388|P2|COMPLETED|Overall Study||0
7576537|NCT02758301|18649389|P1|COMPLETED|Overall Study||70
7576538|NCT02758301|18649388|P2|STARTED|Overall Study||8
7576539|NCT02758301|18649389|P1|STARTED|Overall Study||104
7576540|NCT02758210|18649397|P1|NOT COMPLETED|Overall Study||0
7576541|NCT02758210|18649397|P1|COMPLETED|Overall Study||20
7576542|NCT02758210|18649397|P1|STARTED|Overall Study||20
7576543|NCT02758171|18649408|P2|NOT COMPLETED|Treatment Period 2||0
7576544|NCT02758171|18649409|P1|NOT COMPLETED|Treatment Period 2||0
7576545|NCT02758171|18649408|P2|COMPLETED|Treatment Period 2||28
7576546|NCT02758171|18649409|P1|COMPLETED|Treatment Period 2||26
7576547|NCT02758171|18649408|P2|STARTED|Treatment Period 2||28
7576548|NCT02758171|18649409|P1|STARTED|Treatment Period 2||26
7576549|NCT02758171|18649408|P2|NOT COMPLETED|Wash-out||0
7576550|NCT02758171|18649409|P1|NOT COMPLETED|Wash-out||2
7576551|NCT02758171|18649408|P2|COMPLETED|Wash-out||28
7576552|NCT02758171|18649409|P1|COMPLETED|Wash-out||26
7576553|NCT02758171|18649408|P2|STARTED|Wash-out||28
7576554|NCT02758171|18649409|P1|STARTED|Wash-out||28
7576555|NCT02758171|18649408|P2|NOT COMPLETED|Treatment Period 1||0
7576556|NCT02758171|18649409|P1|NOT COMPLETED|Treatment Period 1||0
7576557|NCT02758171|18649408|P2|COMPLETED|Treatment Period 1||28
7576558|NCT02758171|18649409|P1|COMPLETED|Treatment Period 1||28
7576559|NCT02758171|18649408|P2|STARTED|Treatment Period 1||28
7576560|NCT02758171|18649409|P1|STARTED|Treatment Period 1||28
7576561|NCT02758132|18649427|P2|NOT COMPLETED|Overall Study||1
7576562|NCT02758132|18649428|P1|NOT COMPLETED|Overall Study||0
7576563|NCT02758132|18649427|P2|COMPLETED|Overall Study||0
7576564|NCT02758132|18649428|P1|COMPLETED|Overall Study||0
7576565|NCT02758132|18649427|P2|STARTED|Overall Study||1
7576566|NCT02758132|18649428|P1|STARTED|Overall Study||0
7576567|NCT02758119|18649450|P2|NOT COMPLETED|Overall Study||1
7576568|NCT02758119|18649451|P1|NOT COMPLETED|Overall Study||2
7576569|NCT02758119|18649450|P2|COMPLETED|Overall Study||40
7576570|NCT02758119|18649451|P1|COMPLETED|Overall Study||39
7576571|NCT02758119|18649450|P2|STARTED|Overall Study||41
7576572|NCT02758119|18649451|P1|STARTED|Overall Study||41
7576573|NCT02757963|18649463|P1|NOT COMPLETED|Overall Study||1097
7576574|NCT02757963|18649463|P1|COMPLETED|Overall Study||561
7576575|NCT02757963|18649463|P1|STARTED|Overall Study||1658
7576576|NCT02757950|18649481|P2|NOT COMPLETED|Overall Study||11
7576577|NCT02757950|18649482|P1|NOT COMPLETED|Overall Study||4
7576578|NCT02757950|18649481|P2|COMPLETED|Overall Study||1248
7576579|NCT02757950|18649482|P1|COMPLETED|Overall Study||1199
7576580|NCT02757950|18649481|P2|STARTED|Overall Study||1259
7576581|NCT02757950|18649482|P1|STARTED|Overall Study||1203
7576582|NCT02757768|18649503|P2|NOT COMPLETED|Overall Study||28
7576583|NCT02757768|18649504|P1|NOT COMPLETED|Overall Study||33
7576584|NCT02757768|18649503|P2|COMPLETED|Overall Study||331
7576585|NCT02757768|18649504|P1|COMPLETED|Overall Study||323
7576586|NCT02757768|18649503|P2|Treated|Overall Study||354
7576587|NCT02757768|18649504|P1|Treated|Overall Study||352
7576588|NCT02757768|18649503|P2|STARTED|Overall Study||359
7576589|NCT02757768|18649504|P1|STARTED|Overall Study||356
7576590|NCT02757625|18649554|P4|NOT COMPLETED|Overall Study||0
7576591|NCT02757625|18649555|P3|NOT COMPLETED|Overall Study||2
7576592|NCT02757625|18649556|P2|NOT COMPLETED|Overall Study||0
7576593|NCT02757625|18649557|P1|NOT COMPLETED|Overall Study||0
7576594|NCT02757625|18649554|P4|COMPLETED|Overall Study||12
7576595|NCT02757625|18649555|P3|COMPLETED|Overall Study||17
7576596|NCT02757625|18649556|P2|COMPLETED|Overall Study||18
7576597|NCT02757625|18649557|P1|COMPLETED|Overall Study||14
7576598|NCT02757625|18649554|P4|STARTED|Overall Study||12
7576599|NCT02757625|18649555|P3|STARTED|Overall Study||19
7576600|NCT02757625|18649556|P2|STARTED|Overall Study||18
7576601|NCT02757625|18649557|P1|STARTED|Overall Study||14
7576602|NCT02757547|18649709|P1|NOT COMPLETED|Overall Study||0
7576603|NCT02757547|18649709|P1|COMPLETED|Overall Study||2
7576604|NCT02757547|18649709|P1|STARTED|Overall Study||2
7576605|NCT02757521|18649716|P2|NOT COMPLETED|Overall Study||0
7576606|NCT02757521|18649717|P1|NOT COMPLETED|Overall Study||1
7576607|NCT02757521|18649716|P2|COMPLETED|Overall Study||0
7576608|NCT02757521|18649717|P1|COMPLETED|Overall Study||0
7576609|NCT02757521|18649716|P2|STARTED|Overall Study||0
7576610|NCT02757521|18649717|P1|STARTED|Overall Study||1
7576611|NCT02757430|18649723|P1|NOT COMPLETED|Overall Study||12
7576612|NCT02757430|18649723|P1|COMPLETED|Overall Study|Subjects with pre-discharge visit were considered completed.|503
7576613|NCT02757430|18649723|P1|EP Mapping/Ablation Procedure|Overall Study||503
7576614|NCT02757430|18649723|P1|Baseline Visits|Overall Study||503
7576615|NCT02757430|18649723|P1|STARTED|Overall Study||515
7576616|NCT02757352|18649742|P10|NOT COMPLETED|Follow-Up Period||3
7576617|NCT02757352|18649743|P9|NOT COMPLETED|Follow-Up Period||10
7576618|NCT02757352|18649744|P8|NOT COMPLETED|Follow-Up Period||1
7576619|NCT02757352|18649745|P7|NOT COMPLETED|Follow-Up Period||1
7576620|NCT02757352|18649746|P6|NOT COMPLETED|Follow-Up Period||0
7576621|NCT02757352|18649747|P5|NOT COMPLETED|Follow-Up Period||0
7576622|NCT02757352|18649748|P4|NOT COMPLETED|Follow-Up Period||0
7576623|NCT02757352|18649749|P3|NOT COMPLETED|Follow-Up Period||0
7576624|NCT02757352|18649750|P2|NOT COMPLETED|Follow-Up Period||0
7576625|NCT02757352|18649751|P1|NOT COMPLETED|Follow-Up Period||0
7576626|NCT02757352|18649742|P10|COMPLETED|Follow-Up Period||2
7576627|NCT02757352|18649743|P9|COMPLETED|Follow-Up Period||18
7576628|NCT02757352|18649744|P8|COMPLETED|Follow-Up Period||4
7576629|NCT02757352|18649745|P7|COMPLETED|Follow-Up Period||2
7576630|NCT02757352|18649746|P6|COMPLETED|Follow-Up Period||0
7576631|NCT02757352|18649747|P5|COMPLETED|Follow-Up Period||0
7576632|NCT02757352|18649748|P4|COMPLETED|Follow-Up Period||0
7576633|NCT02757352|18649749|P3|COMPLETED|Follow-Up Period||0
7576634|NCT02757352|18649750|P2|COMPLETED|Follow-Up Period||0
7576635|NCT02757352|18649751|P1|COMPLETED|Follow-Up Period||0
7576636|NCT02757352|18649742|P10|STARTED|Follow-Up Period||5
7576637|NCT02757352|18649743|P9|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|28
7576638|NCT02757352|18649744|P8|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|5
7576639|NCT02757352|18649745|P7|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|3
7576640|NCT02757352|18649746|P6|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
7576641|NCT02757352|18649747|P5|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
7576642|NCT02757352|18649748|P4|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
7576643|NCT02757352|18649749|P3|STARTED|Follow-Up Period||0
7576644|NCT02757352|18649750|P2|STARTED|Follow-Up Period||0
7576645|NCT02757352|18649751|P1|STARTED|Follow-Up Period||0
7576646|NCT02757352|18649742|P10|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
7576647|NCT02757352|18649743|P9|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
7576648|NCT02757352|18649744|P8|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
7576649|NCT02757352|18649745|P7|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
7576650|NCT02757352|18649746|P6|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
7576651|NCT02757352|18649747|P5|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||3
7576652|NCT02757352|18649748|P4|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
7576653|NCT02757352|18649749|P3|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
7576654|NCT02757352|18649750|P2|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
7576655|NCT02757352|18649751|P1|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
7576656|NCT02757352|18649742|P10|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
7576657|NCT02757352|18649743|P9|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
7576658|NCT02757352|18649744|P8|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
7576659|NCT02757352|18649745|P7|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
7576660|NCT02757352|18649746|P6|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||35
7576661|NCT02757352|18649747|P5|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||37
7576662|NCT02757352|18649748|P4|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||55
7576663|NCT02757352|18649749|P3|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
7576664|NCT02757352|18649750|P2|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
7576665|NCT02757352|18649751|P1|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
7576666|NCT02757352|18649742|P10|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
7576667|NCT02757352|18649743|P9|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
7576668|NCT02757352|18649744|P8|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
7576669|NCT02757352|18649745|P7|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
7576670|NCT02757352|18649746|P6|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||3
7576671|NCT02757352|18649747|P5|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
7576672|NCT02757352|18649748|P4|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||2
7576673|NCT02757352|18649749|P3|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
7576674|NCT02757352|18649750|P2|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
7576675|NCT02757352|18649751|P1|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
7576676|NCT02757352|18649742|P10|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
7576677|NCT02757352|18649743|P9|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
7576678|NCT02757352|18649744|P8|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
7576679|NCT02757352|18649745|P7|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
7576680|NCT02757352|18649746|P6|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|42
7576681|NCT02757352|18649747|P5|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|40
7576682|NCT02757352|18649748|P4|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|62
7576683|NCT02757352|18649749|P3|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
7576684|NCT02757352|18649750|P2|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
7576685|NCT02757352|18649751|P1|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
7576686|NCT02757352|18649742|P10|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
7576687|NCT02757352|18649743|P9|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
7576688|NCT02757352|18649744|P8|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
7576689|NCT02757352|18649745|P7|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
7576690|NCT02757352|18649746|P6|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
7576691|NCT02757352|18649747|P5|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
7576692|NCT02757352|18649748|P4|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
7576693|NCT02757352|18649749|P3|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||46
7576694|NCT02757352|18649750|P2|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||43
7576695|NCT02757352|18649751|P1|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||63
7576696|NCT02757352|18649742|P10|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
7576697|NCT02757352|18649743|P9|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
7576698|NCT02757352|18649744|P8|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
7576699|NCT02757352|18649745|P7|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
7576700|NCT02757352|18649746|P6|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
7576701|NCT02757352|18649747|P5|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
7576702|NCT02757352|18649748|P4|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
7576703|NCT02757352|18649749|P3|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
7576704|NCT02757352|18649750|P2|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
7576705|NCT02757352|18649751|P1|COMPLETED|Double-Blind Period (Week 16 - Week 52)||34
7576706|NCT02757352|18649742|P10|STARTED|Double-Blind Period (Week 16 - Week 52)||0
7576707|NCT02757352|18649743|P9|STARTED|Double-Blind Period (Week 16 - Week 52)||0
7576708|NCT02757352|18649744|P8|STARTED|Double-Blind Period (Week 16 - Week 52)||0
7576709|NCT02757352|18649745|P7|STARTED|Double-Blind Period (Week 16 - Week 52)||0
7576710|NCT02757352|18649746|P6|STARTED|Double-Blind Period (Week 16 - Week 52)||0
7576711|NCT02757352|18649747|P5|STARTED|Double-Blind Period (Week 16 - Week 52)||0
7576712|NCT02757352|18649748|P4|STARTED|Double-Blind Period (Week 16 - Week 52)||0
7576713|NCT02757352|18649749|P3|STARTED|Double-Blind Period (Week 16 - Week 52)||98
7576714|NCT02757352|18649750|P2|STARTED|Double-Blind Period (Week 16 - Week 52)||95
7576715|NCT02757352|18649751|P1|STARTED|Double-Blind Period (Week 16 - Week 52)||97
7576716|NCT02757352|18649742|P10|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
7576717|NCT02757352|18649743|P9|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
7576718|NCT02757352|18649744|P8|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
7576719|NCT02757352|18649745|P7|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
7576720|NCT02757352|18649746|P6|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
7576721|NCT02757352|18649747|P5|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
7576722|NCT02757352|18649748|P4|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
7576723|NCT02757352|18649749|P3|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||4
7576724|NCT02757352|18649750|P2|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||1
7576725|NCT02757352|18649751|P1|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||8
7576726|NCT02757352|18649742|P10|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
7576727|NCT02757352|18649743|P9|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
7576728|NCT02757352|18649744|P8|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
7576729|NCT02757352|18649745|P7|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
7576730|NCT02757352|18649746|P6|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
7576731|NCT02757352|18649747|P5|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
7576732|NCT02757352|18649748|P4|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
7576733|NCT02757352|18649749|P3|COMPLETED|Double-Blind Period (Week 0 - Week 16)||98
7576734|NCT02757352|18649750|P2|COMPLETED|Double-Blind Period (Week 0 - Week 16)||95
7576735|NCT02757352|18649751|P1|COMPLETED|Double-Blind Period (Week 0 - Week 16)||97
7576736|NCT02757352|18649742|P10|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
7576737|NCT02757352|18649743|P9|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
7576738|NCT02757352|18649744|P8|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
7576739|NCT02757352|18649745|P7|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
7576740|NCT02757352|18649746|P6|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
7576741|NCT02757352|18649747|P5|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
7576742|NCT02757352|18649748|P4|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
7576743|NCT02757352|18649749|P3|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||102
7576744|NCT02757352|18649750|P2|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||96
7576745|NCT02757352|18649751|P1|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||104
7576746|NCT02757352|18649742|P10|STARTED|Double-Blind Period (Week 0 - Week 16)||0
7576747|NCT02757352|18649743|P9|STARTED|Double-Blind Period (Week 0 - Week 16)||0
7576748|NCT02757352|18649744|P8|STARTED|Double-Blind Period (Week 0 - Week 16)||0
7576749|NCT02757352|18649745|P7|STARTED|Double-Blind Period (Week 0 - Week 16)||0
7576750|NCT02757352|18649746|P6|STARTED|Double-Blind Period (Week 0 - Week 16)||0
7576751|NCT02757352|18649747|P5|STARTED|Double-Blind Period (Week 0 - Week 16)||0
7576752|NCT02757352|18649748|P4|STARTED|Double-Blind Period (Week 0 - Week 16)||0
7576753|NCT02757352|18649749|P3|STARTED|Double-Blind Period (Week 0 - Week 16)||102
7576754|NCT02757352|18649750|P2|STARTED|Double-Blind Period (Week 0 - Week 16)||96
7576755|NCT02757352|18649751|P1|STARTED|Double-Blind Period (Week 0 - Week 16)||105
7576756|NCT02757105|18649860|P2|NOT COMPLETED|Overall Study||11
7576757|NCT02757105|18649861|P1|NOT COMPLETED|Overall Study||12
7576758|NCT02757105|18649860|P2|COMPLETED|Overall Study||41
7576759|NCT02757105|18649861|P1|COMPLETED|Overall Study||63
7576760|NCT02757105|18649860|P2|Treated|Overall Study||51
7576761|NCT02757105|18649861|P1|Treated|Overall Study||75
7576762|NCT02757105|18649860|P2|STARTED|Overall Study||52
7576763|NCT02757105|18649861|P1|STARTED|Overall Study||75
7576764|NCT02757092|18649883|P2|NOT COMPLETED|Overall Study||0
7576765|NCT02757092|18649884|P1|NOT COMPLETED|Overall Study||0
7576766|NCT02757092|18649883|P2|COMPLETED|Overall Study|All subjects completed the study|18
7576767|NCT02757092|18649884|P1|COMPLETED|Overall Study|All subjects completed the study|18
7576768|NCT02757092|18649883|P2|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18
7576769|NCT02757092|18649884|P1|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18
7576770|NCT02757053|18649950|P2|NOT COMPLETED|Overall Study||5
7576771|NCT02757053|18649951|P1|NOT COMPLETED|Overall Study||3
7576772|NCT02757053|18649950|P2|COMPLETED|Overall Study||0
7576773|NCT02757053|18649951|P1|COMPLETED|Overall Study||0
7576774|NCT02757053|18649950|P2|STARTED|Overall Study||5
7576775|NCT02757053|18649951|P1|STARTED|Overall Study||3
7576776|NCT02756949|18649965|P2|NOT COMPLETED|Overall Study||8
7576777|NCT02756949|18649966|P1|NOT COMPLETED|Overall Study||0
7576778|NCT02756949|18649965|P2|COMPLETED|Overall Study||164
7576779|NCT02756949|18649966|P1|COMPLETED|Overall Study||181
7576780|NCT02756949|18649965|P2|STARTED|Overall Study||172
7576781|NCT02756949|18649966|P1|STARTED|Overall Study||181
7576782|NCT02756832|18649974|P1|NOT COMPLETED|Overall Study||53
7576783|NCT02756832|18649974|P1|COMPLETED|Overall Study||1356
7576784|NCT02756832|18649974|P1|Included in Efficacy and Safety Analysis|Overall Study||1399
7576785|NCT02756832|18649974|P1|Received Therapy|Overall Study||1393
7576786|NCT02756832|18649974|P1|STARTED|Overall Study||1409
7576787|NCT02756819|18649988|P1|NOT COMPLETED|Overall Study||52
7576788|NCT02756819|18649988|P1|COMPLETED|Overall Study||1893
7576789|NCT02756819|18649988|P1|Safety Analysis Set (SAS)|Overall Study|Participants who received at least one dose of Edarbi® therapy and had any follow-up data.|1934
7576790|NCT02756819|18649988|P1|Per-protocol Set (PPS)|Overall Study|Participants who were enrolled, received Edarbi® therapy and did not have major protocol deviations.|1724
7576791|NCT02756819|18649988|P1|STARTED|Overall Study||1945
7576792|NCT02756689|18650000|P2|NOT COMPLETED|Overall Study||0
7576793|NCT02756689|18650001|P1|NOT COMPLETED|Overall Study||0
7576794|NCT02756689|18650000|P2|COMPLETED|Overall Study||65
7576795|NCT02756689|18650001|P1|COMPLETED|Overall Study||64
7576796|NCT02756689|18650000|P2|STARTED|Overall Study||65
7576797|NCT02756689|18650001|P1|STARTED|Overall Study||64
7576798|NCT02756650|18650087|P1|NOT COMPLETED|Overall Study||2
7576799|NCT02756650|18650087|P1|COMPLETED|Overall Study||6
7576800|NCT02756650|18650087|P1|STARTED|Overall Study||8
7576801|NCT02756637|18650110|P2|NOT COMPLETED|Overall Study||54
7576802|NCT02756637|18650111|P1|NOT COMPLETED|Overall Study||87
7576803|NCT02756637|18650110|P2|COMPLETED|Overall Study||263
7576804|NCT02756637|18650111|P1|COMPLETED|Overall Study||230
7576805|NCT02756637|18650110|P2|Completed Curative Treatment|Overall Study||0
7576806|NCT02756637|18650111|P1|Completed Curative Treatment|Overall Study||230
7576807|NCT02756637|18650110|P2|Had NLR Value|Overall Study||263
7576808|NCT02756637|18650111|P1|Had NLR Value|Overall Study||263
7576809|NCT02756637|18650110|P2|Eligible for SWOG 8710|Overall Study||307
7576810|NCT02756637|18650111|P1|Eligible for SWOG 8710|Overall Study||307
7576811|NCT02756637|18650110|P2|STARTED|Overall Study||317
7576812|NCT02756637|18650111|P1|STARTED|Overall Study||317
7576813|NCT02756624|18650119|P2|NOT COMPLETED|Overall Study||7
7576814|NCT02756624|18650120|P1|NOT COMPLETED|Overall Study||16
7576815|NCT02756624|18650119|P2|COMPLETED|Overall Study||166
7576816|NCT02756624|18650120|P1|COMPLETED|Overall Study||327
7576817|NCT02756624|18650119|P2|STARTED|Overall Study||173
7576818|NCT02756624|18650120|P1|STARTED|Overall Study||343
7576819|NCT02756611|18650132|P1|NOT COMPLETED|Overall Study||256
7576820|NCT02756611|18650132|P1|COMPLETED|Overall Study||2
7576821|NCT02756611|18650132|P1|STARTED|Overall Study||258
7576822|NCT02756364|18650146|P3|NOT COMPLETED|Overall Study||48
7576823|NCT02756364|18650147|P2|NOT COMPLETED|Overall Study||47
7576824|NCT02756364|18650148|P1|NOT COMPLETED|Overall Study||46
7576825|NCT02756364|18650146|P3|COMPLETED|Overall Study||0
7576826|NCT02756364|18650147|P2|COMPLETED|Overall Study||0
7576827|NCT02756364|18650148|P1|COMPLETED|Overall Study||0
7576828|NCT02756364|18650146|P3|Treated Participants|Overall Study||47
7576829|NCT02756364|18650147|P2|Treated Participants|Overall Study||47
7576830|NCT02756364|18650148|P1|Treated Participants|Overall Study||46
7576831|NCT02756364|18650146|P3|STARTED|Overall Study||48
7576832|NCT02756364|18650147|P2|STARTED|Overall Study||47
7576833|NCT02756364|18650148|P1|STARTED|Overall Study||46
7576834|NCT02756351|18650173|P2|NOT COMPLETED|Overall Study||0
7576835|NCT02756351|18650174|P1|NOT COMPLETED|Overall Study||0
7576836|NCT02756351|18650173|P2|COMPLETED|Overall Study||24
7576837|NCT02756351|18650174|P1|COMPLETED|Overall Study||24
7576838|NCT02756351|18650173|P2|STARTED|Overall Study||24
7576839|NCT02756351|18650174|P1|STARTED|Overall Study||24
7576840|NCT02756338|18650182|P1|NOT COMPLETED|Overall Study||5
7576841|NCT02756338|18650182|P1|COMPLETED|Overall Study||72
7576842|NCT02756338|18650182|P1|STARTED|Overall Study||77
7576843|NCT02756182|18650191|P1|NOT COMPLETED|Overall Study||4
7576844|NCT02756182|18650191|P1|COMPLETED|Overall Study||21
7576845|NCT02756182|18650191|P1|STARTED|Overall Study||25
7576846|NCT02756078|18650206|P2|NOT COMPLETED|Period 2||7
7576847|NCT02756078|18650207|P1|NOT COMPLETED|Period 2||6
7576848|NCT02756078|18650206|P2|COMPLETED|Period 2||57
7576849|NCT02756078|18650207|P1|COMPLETED|Period 2||70
7576850|NCT02756078|18650206|P2|STARTED|Period 2||64
7576851|NCT02756078|18650207|P1|STARTED|Period 2||76
7576852|NCT02756078|18650206|P2|NOT COMPLETED|Period 1||22
7576853|NCT02756078|18650207|P1|NOT COMPLETED|Period 1||9
7576854|NCT02756078|18650206|P2|COMPLETED|Period 1||64
7576855|NCT02756078|18650207|P1|COMPLETED|Period 1||76
7576856|NCT02756078|18650206|P2|STARTED|Period 1||86
7576857|NCT02756078|18650207|P1|STARTED|Period 1||85
7576858|NCT02756013|18650225|P1|NOT COMPLETED|Overall Study||2
7576859|NCT02756013|18650225|P1|COMPLETED|Overall Study||1
7576860|NCT02756013|18650225|P1|STARTED|Overall Study||3
7576861|NCT02755935|18650230|P1|NOT COMPLETED|Overall Study||2
7576862|NCT02755935|18650230|P1|COMPLETED|Overall Study||22
7576863|NCT02755935|18650230|P1|STARTED|Overall Study||24
7576864|NCT02755831|18650237|P2|NOT COMPLETED|Overall Study||3
7576865|NCT02755831|18650238|P1|NOT COMPLETED|Overall Study||3
7576866|NCT02755831|18650237|P2|COMPLETED|Overall Study||90
7576867|NCT02755831|18650238|P1|COMPLETED|Overall Study||97
7576868|NCT02755831|18650237|P2|STARTED|Overall Study||93
7576869|NCT02755831|18650238|P1|STARTED|Overall Study||100
7576870|NCT02755818|18650254|P4|NOT COMPLETED|Overall Study||3
7576871|NCT02755818|18650255|P3|NOT COMPLETED|Overall Study||1
7576872|NCT02755818|18650256|P2|NOT COMPLETED|Overall Study||0
7576873|NCT02755818|18650257|P1|NOT COMPLETED|Overall Study||0
7576874|NCT02755818|18650254|P4|COMPLETED|Overall Study||14
7576875|NCT02755818|18650255|P3|COMPLETED|Overall Study||1
7576876|NCT02755818|18650256|P2|COMPLETED|Overall Study||2
7576877|NCT02755818|18650257|P1|COMPLETED|Overall Study||30
7576878|NCT02755818|18650254|P4|STARTED|Overall Study||17
7576879|NCT02755818|18650255|P3|STARTED|Overall Study||2
7576880|NCT02755818|18650256|P2|STARTED|Overall Study||2
7576881|NCT02755818|18650257|P1|STARTED|Overall Study||30
7576882|NCT02755805|18650293|P2|NOT COMPLETED|Overall Study||4
7576883|NCT02755805|18650294|P1|NOT COMPLETED|Overall Study||2
7576884|NCT02755805|18650293|P2|COMPLETED|Overall Study||11
7576885|NCT02755805|18650294|P1|COMPLETED|Overall Study||13
7576886|NCT02755805|18650293|P2|STARTED|Overall Study||15
7576887|NCT02755805|18650294|P1|STARTED|Overall Study||15
7576888|NCT02755649|18650309|P3|NOT COMPLETED|Overall Study||102
7576889|NCT02755649|18650310|P2|NOT COMPLETED|Overall Study||99
7576890|NCT02755649|18650311|P1|NOT COMPLETED|Overall Study||101
7576891|NCT02755649|18650309|P3|COMPLETED|Overall Study||8
7576892|NCT02755649|18650310|P2|COMPLETED|Overall Study||8
7576893|NCT02755649|18650311|P1|COMPLETED|Overall Study||7
7576894|NCT02755649|18650309|P3|Completed Study (Week 28)|Overall Study||8
7576895|NCT02755649|18650310|P2|Completed Study (Week 28)|Overall Study||8
7576896|NCT02755649|18650311|P1|Completed Study (Week 28)|Overall Study||7
7576897|NCT02755649|18650309|P3|Completed Treatment (Week 16)|Overall Study||109
7576898|NCT02755649|18650310|P2|Completed Treatment (Week 16)|Overall Study||106
7576899|NCT02755649|18650311|P1|Completed Treatment (Week 16)|Overall Study||107
7576900|NCT02755649|18650309|P3|STARTED|Overall Study||110
7576901|NCT02755649|18650310|P2|STARTED|Overall Study||107
7576902|NCT02755649|18650311|P1|STARTED|Overall Study||108
7576903|NCT02755285|18650373|P1|NOT COMPLETED|Overall Study||0
7576904|NCT02755285|18650373|P1|COMPLETED|Overall Study||20
7576905|NCT02755285|18650373|P1|STARTED|Overall Study||20
7576906|NCT02755129|18650377|P1|NOT COMPLETED|Overall Study||0
7576907|NCT02755129|18650377|P1|COMPLETED|Overall Study||15
7576908|NCT02755129|18650377|P1|STARTED|Overall Study||15
7576909|NCT02755116|18650386|P2|NOT COMPLETED|Overall Study||1
7576910|NCT02755116|18650387|P1|NOT COMPLETED|Overall Study||3
7576911|NCT02755116|18650386|P2|COMPLETED|Overall Study||69
7576912|NCT02755116|18650387|P1|COMPLETED|Overall Study||71
7576913|NCT02755116|18650386|P2|STARTED|Overall Study||70
7576914|NCT02755116|18650387|P1|STARTED|Overall Study||74
7576915|NCT02755090|18650403|P2|NOT COMPLETED|Overall Study||0
7576916|NCT02755090|18650404|P1|NOT COMPLETED|Overall Study||1
7576917|NCT02755090|18650403|P2|COMPLETED|Overall Study||20
7576918|NCT02755090|18650404|P1|COMPLETED|Overall Study||18
7576919|NCT02755090|18650403|P2|STARTED|Overall Study||20
7576920|NCT02755090|18650404|P1|STARTED|Overall Study||19
7576921|NCT02754674|18650414|P2|NOT COMPLETED|Overall Study||7
7576922|NCT02754674|18650415|P1|NOT COMPLETED|Overall Study||6
7576923|NCT02754674|18650414|P2|COMPLETED|Overall Study||26
7576924|NCT02754674|18650415|P1|COMPLETED|Overall Study||28
7576925|NCT02754674|18650414|P2|STARTED|Overall Study||33
7576926|NCT02754674|18650415|P1|STARTED|Overall Study||34
7576927|NCT02754661|18650431|P2|NOT COMPLETED|Overall Study||19
7576928|NCT02754661|18650432|P1|NOT COMPLETED|Overall Study||15
7576929|NCT02754661|18650431|P2|COMPLETED|Overall Study||141
7576930|NCT02754661|18650432|P1|COMPLETED|Overall Study||145
7576931|NCT02754661|18650431|P2|STARTED|Overall Study||160
7576932|NCT02754661|18650432|P1|STARTED|Overall Study||160
7576933|NCT02754570|18650446|P1|NOT COMPLETED|Overall Study||0
7576934|NCT02754570|18650446|P1|COMPLETED|Overall Study||27
7576935|NCT02754570|18650446|P1|Visit 3 (PGA + Pilocarpine)|Overall Study||27
7576936|NCT02754570|18650446|P1|Visits 1 and 2 (PGA Only)|Overall Study||27
7576937|NCT02754570|18650446|P1|STARTED|Overall Study||27
7576938|NCT02754492|18650456|P4|NOT COMPLETED|Overall Study||23
7576939|NCT02754492|18650457|P3|NOT COMPLETED|Overall Study||2
7576940|NCT02754492|18650458|P2|NOT COMPLETED|Overall Study||2
7576941|NCT02754492|18650459|P1|NOT COMPLETED|Overall Study||4
7576942|NCT02754492|18650456|P4|COMPLETED|Overall Study||0
7576943|NCT02754492|18650457|P3|COMPLETED|Overall Study||93
7576944|NCT02754492|18650458|P2|COMPLETED|Overall Study||93
7576945|NCT02754492|18650459|P1|COMPLETED|Overall Study||93
7576946|NCT02754492|18650456|P4|STARTED|Overall Study||23
7576947|NCT02754492|18650457|P3|STARTED|Overall Study||95
7576948|NCT02754492|18650458|P2|STARTED|Overall Study||95
7576949|NCT02754492|18650459|P1|STARTED|Overall Study||97
7576950|NCT02754440|18650475|P4|NOT COMPLETED|Overall Study||35
7576951|NCT02754440|18650476|P3|NOT COMPLETED|Overall Study||7
7576952|NCT02754440|18650477|P2|NOT COMPLETED|Overall Study||8
7576953|NCT02754440|18650478|P1|NOT COMPLETED|Overall Study||6
7576954|NCT02754440|18650475|P4|COMPLETED|Overall Study||0
7576955|NCT02754440|18650476|P3|COMPLETED|Overall Study||93
7576956|NCT02754440|18650477|P2|COMPLETED|Overall Study||93
7576957|NCT02754440|18650478|P1|COMPLETED|Overall Study||93
7576958|NCT02754440|18650475|P4|STARTED|Overall Study||35
7576959|NCT02754440|18650476|P3|STARTED|Overall Study||100
7576960|NCT02754440|18650477|P2|STARTED|Overall Study||101
7576961|NCT02754440|18650478|P1|STARTED|Overall Study||99
7576962|NCT02754427|18650492|P2|NOT COMPLETED|Overall Study||1
7576963|NCT02754427|18650493|P1|NOT COMPLETED|Overall Study||0
7576964|NCT02754427|18650492|P2|COMPLETED|Overall Study||19
7576965|NCT02754427|18650493|P1|COMPLETED|Overall Study||21
7576966|NCT02754427|18650492|P2|STARTED|Overall Study||20
7576967|NCT02754427|18650493|P1|STARTED|Overall Study||21
7576968|NCT02754310|18650507|P2|NOT COMPLETED|Overall Study||0
7576969|NCT02754310|18650508|P1|NOT COMPLETED|Overall Study||0
7576970|NCT02754310|18650507|P2|COMPLETED|Overall Study||43
7576971|NCT02754310|18650508|P1|COMPLETED|Overall Study||42
7576972|NCT02754310|18650507|P2|STARTED|Overall Study||43
7576973|NCT02754310|18650508|P1|STARTED|Overall Study||42
7576974|NCT02753946|18650530|P2|NOT COMPLETED|Overall Study||9
7576975|NCT02753946|18650531|P1|NOT COMPLETED|Overall Study||14
7576976|NCT02753946|18650530|P2|COMPLETED|Overall Study||222
7576977|NCT02753946|18650531|P1|COMPLETED|Overall Study||219
7576978|NCT02753946|18650530|P2|STARTED|Overall Study||231
7576979|NCT02753946|18650531|P1|STARTED|Overall Study||233
7576980|NCT02753920|18650543|P2|NOT COMPLETED|Overall Study||0
7576981|NCT02753920|18650544|P1|NOT COMPLETED|Overall Study||0
7576982|NCT02753920|18650543|P2|COMPLETED|Overall Study||86
7576983|NCT02753920|18650544|P1|COMPLETED|Overall Study||87
7576984|NCT02753920|18650543|P2|STARTED|Overall Study||86
7576985|NCT02753920|18650544|P1|STARTED|Overall Study||87
7576986|NCT02753881|18650557|P3|NOT COMPLETED|Overall Study||0
7576987|NCT02753881|18650558|P2|NOT COMPLETED|Overall Study||0
7576988|NCT02753881|18650559|P1|NOT COMPLETED|Overall Study||0
7576989|NCT02753881|18650557|P3|COMPLETED|Overall Study||10
7576990|NCT02753881|18650558|P2|COMPLETED|Overall Study||10
7576991|NCT02753881|18650559|P1|COMPLETED|Overall Study||10
7576992|NCT02753881|18650557|P3|STARTED|Overall Study||10
7576993|NCT02753881|18650558|P2|STARTED|Overall Study||10
7576994|NCT02753881|18650559|P1|STARTED|Overall Study||10
7576995|NCT02753842|18650591|P6|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
7576996|NCT02753842|18650592|P5|NOT COMPLETED|Third Follow-Up (Set of Condoms)||4
7576997|NCT02753842|18650593|P4|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
7576998|NCT02753842|18650594|P3|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
7576999|NCT02753842|18650595|P2|NOT COMPLETED|Third Follow-Up (Set of Condoms)||5
7577000|NCT02753842|18650596|P1|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
7577001|NCT02753842|18650591|P6|COMPLETED|Third Follow-Up (Set of Condoms)||69
7577002|NCT02753842|18650592|P5|COMPLETED|Third Follow-Up (Set of Condoms)||71
7577003|NCT02753842|18650593|P4|COMPLETED|Third Follow-Up (Set of Condoms)||70
7577004|NCT02753842|18650594|P3|COMPLETED|Third Follow-Up (Set of Condoms)||68
7577005|NCT02753842|18650595|P2|COMPLETED|Third Follow-Up (Set of Condoms)||66
7577006|NCT02753842|18650596|P1|COMPLETED|Third Follow-Up (Set of Condoms)||65
7577007|NCT02753842|18650591|P6|STARTED|Third Follow-Up (Set of Condoms)||72
7577008|NCT02753842|18650592|P5|STARTED|Third Follow-Up (Set of Condoms)||75
7577009|NCT02753842|18650593|P4|STARTED|Third Follow-Up (Set of Condoms)||76
7577010|NCT02753842|18650594|P3|STARTED|Third Follow-Up (Set of Condoms)||71
7577011|NCT02753842|18650595|P2|STARTED|Third Follow-Up (Set of Condoms)||71
7577012|NCT02753842|18650596|P1|STARTED|Third Follow-Up (Set of Condoms)||71
7577013|NCT02753842|18650591|P6|NOT COMPLETED|Second Follow-Up (Set of Condoms)||7
7577014|NCT02753842|18650592|P5|NOT COMPLETED|Second Follow-Up (Set of Condoms)||1
7577015|NCT02753842|18650593|P4|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
7577016|NCT02753842|18650594|P3|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
7577017|NCT02753842|18650595|P2|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
7577018|NCT02753842|18650596|P1|NOT COMPLETED|Second Follow-Up (Set of Condoms)||4
7577019|NCT02753842|18650591|P6|COMPLETED|Second Follow-Up (Set of Condoms)||72
7577020|NCT02753842|18650592|P5|COMPLETED|Second Follow-Up (Set of Condoms)||75
7577021|NCT02753842|18650593|P4|COMPLETED|Second Follow-Up (Set of Condoms)||76
7577022|NCT02753842|18650594|P3|COMPLETED|Second Follow-Up (Set of Condoms)||71
7577023|NCT02753842|18650595|P2|COMPLETED|Second Follow-Up (Set of Condoms)||71
7577024|NCT02753842|18650596|P1|COMPLETED|Second Follow-Up (Set of Condoms)||71
7577025|NCT02753842|18650591|P6|STARTED|Second Follow-Up (Set of Condoms)||79
7577026|NCT02753842|18650592|P5|STARTED|Second Follow-Up (Set of Condoms)||76
7577027|NCT02753842|18650593|P4|STARTED|Second Follow-Up (Set of Condoms)||81
7577028|NCT02753842|18650594|P3|STARTED|Second Follow-Up (Set of Condoms)||76
7577029|NCT02753842|18650595|P2|STARTED|Second Follow-Up (Set of Condoms)||76
7577030|NCT02753842|18650596|P1|STARTED|Second Follow-Up (Set of Condoms)||75
7577031|NCT02753842|18650591|P6|NOT COMPLETED|First Follow-Up (Set of Condoms)||5
7577032|NCT02753842|18650592|P5|NOT COMPLETED|First Follow-Up (Set of Condoms)||7
7577033|NCT02753842|18650593|P4|NOT COMPLETED|First Follow-Up (Set of Condoms)||2
7577034|NCT02753842|18650594|P3|NOT COMPLETED|First Follow-Up (Set of Condoms)||9
7577035|NCT02753842|18650595|P2|NOT COMPLETED|First Follow-Up (Set of Condoms)||8
7577036|NCT02753842|18650596|P1|NOT COMPLETED|First Follow-Up (Set of Condoms)||10
7577037|NCT02753842|18650591|P6|COMPLETED|First Follow-Up (Set of Condoms)||79
7577038|NCT02753842|18650592|P5|COMPLETED|First Follow-Up (Set of Condoms)||76
7577039|NCT02753842|18650593|P4|COMPLETED|First Follow-Up (Set of Condoms)||81
7577040|NCT02753842|18650594|P3|COMPLETED|First Follow-Up (Set of Condoms)||76
7577041|NCT02753842|18650595|P2|COMPLETED|First Follow-Up (Set of Condoms)||76
7577042|NCT02753842|18650596|P1|COMPLETED|First Follow-Up (Set of Condoms)||75
7577043|NCT02753842|18650591|P6|STARTED|First Follow-Up (Set of Condoms)||84
7577044|NCT02753842|18650592|P5|STARTED|First Follow-Up (Set of Condoms)||83
7577045|NCT02753842|18650593|P4|STARTED|First Follow-Up (Set of Condoms)||83
7577046|NCT02753842|18650594|P3|STARTED|First Follow-Up (Set of Condoms)||85
7577047|NCT02753842|18650595|P2|STARTED|First Follow-Up (Set of Condoms)||84
7577048|NCT02753842|18650596|P1|STARTED|First Follow-Up (Set of Condoms)||85
7577049|NCT02753699|18650614|P3|NOT COMPLETED|Overall Study||23
7577050|NCT02753699|18650615|P2|NOT COMPLETED|Overall Study||43
7577051|NCT02753699|18650616|P1|NOT COMPLETED|Overall Study||14
7577052|NCT02753699|18650614|P3|COMPLETED|Overall Study||139
7577053|NCT02753699|18650615|P2|COMPLETED|Overall Study||354
7577054|NCT02753699|18650616|P1|COMPLETED|Overall Study||150
7577055|NCT02753699|18650614|P3|STARTED|Overall Study||162
7577056|NCT02753699|18650615|P2|STARTED|Overall Study||397
7577057|NCT02753699|18650616|P1|STARTED|Overall Study||164
7577058|NCT02753595|18650632|P2|NOT COMPLETED|Overall Study||2
7577059|NCT02753595|18650633|P1|NOT COMPLETED|Overall Study||2
7577060|NCT02753595|18650632|P2|COMPLETED|Overall Study||7
7577061|NCT02753595|18650633|P1|COMPLETED|Overall Study||3
7577062|NCT02753595|18650632|P2|STARTED|Overall Study||9
7577063|NCT02753595|18650633|P1|STARTED|Overall Study||5
7577064|NCT02753413|18650641|P2|NOT COMPLETED|Overall Study||0
7577065|NCT02753413|18650642|P1|NOT COMPLETED|Overall Study||0
7577066|NCT02753413|18650641|P2|COMPLETED|Overall Study||51
7577067|NCT02753413|18650642|P1|COMPLETED|Overall Study||49
7577068|NCT02753413|18650641|P2|STARTED|Overall Study||51
7577069|NCT02753413|18650642|P1|STARTED|Overall Study||49
7577070|NCT02753075|18650677|P3|NOT COMPLETED|Overall Study||3
7577071|NCT02753075|18650678|P2|NOT COMPLETED|Overall Study||3
7577072|NCT02753075|18650679|P1|NOT COMPLETED|Overall Study||8
7577073|NCT02753075|18650677|P3|COMPLETED|Overall Study||78
7577074|NCT02753075|18650678|P2|COMPLETED|Overall Study||77
7577075|NCT02753075|18650679|P1|COMPLETED|Overall Study||71
7577076|NCT02753075|18650677|P3|STARTED|Overall Study||81
7577077|NCT02753075|18650678|P2|STARTED|Overall Study||80
7577078|NCT02753075|18650679|P1|STARTED|Overall Study||79
7577079|NCT02752958|18650704|P1|NOT COMPLETED|Overall Study||9
7577080|NCT02752958|18650704|P1|COMPLETED|Overall Study||66
7577081|NCT02752958|18650704|P1|STARTED|Overall Study||75
7577082|NCT02752906|18650775|P2|NOT COMPLETED|Overall Study||5
7577083|NCT02752906|18650776|P1|NOT COMPLETED|Overall Study||7
7577084|NCT02752906|18650775|P2|COMPLETED|Overall Study||402
7577085|NCT02752906|18650776|P1|COMPLETED|Overall Study||396
7577086|NCT02752906|18650775|P2|Vaccinated|Overall Study||407
7577087|NCT02752906|18650776|P1|Vaccinated|Overall Study||402
7577088|NCT02752906|18650775|P2|STARTED|Overall Study||407
7577089|NCT02752906|18650776|P1|STARTED|Overall Study||403
7577090|NCT02752880|18650790|P2|NOT COMPLETED|Overall Study||3
7577091|NCT02752880|18650791|P1|NOT COMPLETED|Overall Study||2
7577092|NCT02752880|18650790|P2|COMPLETED|Overall Study||20
7577093|NCT02752880|18650791|P1|COMPLETED|Overall Study||21
7577094|NCT02752880|18650790|P2|STARTED|Overall Study||23
7577095|NCT02752880|18650791|P1|STARTED|Overall Study||23
7577096|NCT02752802|18650801|P2|NOT COMPLETED|Overall Study||0
7577097|NCT02752802|18650802|P1|NOT COMPLETED|Overall Study||1
7577098|NCT02752802|18650801|P2|COMPLETED|Overall Study||48
7577099|NCT02752802|18650802|P1|COMPLETED|Overall Study||47
7577100|NCT02752802|18650801|P2|STARTED|Overall Study||48
7577101|NCT02752802|18650802|P1|STARTED|Overall Study||48
7577102|NCT02752776|18650814|P3|NOT COMPLETED|Overall Study||48
7577103|NCT02752776|18650815|P2|NOT COMPLETED|Overall Study||76
7577104|NCT02752776|18650816|P1|NOT COMPLETED|Overall Study||52
7577105|NCT02752776|18650814|P3|COMPLETED|Overall Study||276
7577106|NCT02752776|18650815|P2|COMPLETED|Overall Study||597
7577107|NCT02752776|18650816|P1|COMPLETED|Overall Study||611
7577108|NCT02752776|18650814|P3|STARTED|Overall Study||324
7577109|NCT02752776|18650815|P2|STARTED|Overall Study||673
7577110|NCT02752776|18650816|P1|STARTED|Overall Study||663
7577111|NCT02752633|18650862|P1|NOT COMPLETED|Overall Study||1
7577112|NCT02752633|18650862|P1|COMPLETED|Overall Study||8
7577113|NCT02752633|18650862|P1|STARTED|Overall Study||9
7577114|NCT02752490|18650868|P2|NOT COMPLETED|Overall Study||0
7577115|NCT02752490|18650869|P1|NOT COMPLETED|Overall Study||0
7577116|NCT02752490|18650868|P2|COMPLETED|Overall Study||435
7577117|NCT02752490|18650869|P1|COMPLETED|Overall Study||409
7577118|NCT02752490|18650868|P2|STARTED|Overall Study||435
7577119|NCT02752490|18650869|P1|STARTED|Overall Study||409
7577120|NCT02752256|18650891|P2|NOT COMPLETED|Overall Study||0
7577121|NCT02752256|18650892|P1|NOT COMPLETED|Overall Study||0
7577122|NCT02752256|18650891|P2|COMPLETED|Overall Study||41
7577123|NCT02752256|18650892|P1|COMPLETED|Overall Study||35
7577124|NCT02752256|18650891|P2|STARTED|Overall Study||41
7577125|NCT02752256|18650892|P1|STARTED|Overall Study||35
7577126|NCT02752087|18650900|P2|NOT COMPLETED|Follow-up||0
7577127|NCT02752087|18650901|P1|NOT COMPLETED|Follow-up||0
7577128|NCT02752087|18650900|P2|COMPLETED|Follow-up||12
7577129|NCT02752087|18650901|P1|COMPLETED|Follow-up||11
7577130|NCT02752087|18650900|P2|STARTED|Follow-up||12
7577131|NCT02752087|18650901|P1|STARTED|Follow-up||11
7577132|NCT02752087|18650900|P2|NOT COMPLETED|Study Period 4||0
7577133|NCT02752087|18650901|P1|NOT COMPLETED|Study Period 4||0
7577134|NCT02752087|18650900|P2|COMPLETED|Study Period 4||12
7577135|NCT02752087|18650901|P1|COMPLETED|Study Period 4||11
7577136|NCT02752087|18650900|P2|Received Study Drug|Study Period 4||12
7577137|NCT02752087|18650901|P1|Received Study Drug|Study Period 4||11
7577138|NCT02752087|18650900|P2|STARTED|Study Period 4||12
7577139|NCT02752087|18650901|P1|STARTED|Study Period 4||11
7577140|NCT02752087|18650900|P2|NOT COMPLETED|Washout||0
7577141|NCT02752087|18650901|P1|NOT COMPLETED|Washout||0
7577142|NCT02752087|18650900|P2|COMPLETED|Washout||12
7577143|NCT02752087|18650901|P1|COMPLETED|Washout||11
7577144|NCT02752087|18650900|P2|STARTED|Washout||12
7577145|NCT02752087|18650901|P1|STARTED|Washout||11
7577146|NCT02752087|18650900|P2|NOT COMPLETED|Study Period 3||0
7577147|NCT02752087|18650901|P1|NOT COMPLETED|Study Period 3||0
7577148|NCT02752087|18650900|P2|COMPLETED|Study Period 3||12
7577149|NCT02752087|18650901|P1|COMPLETED|Study Period 3||11
7577150|NCT02752087|18650900|P2|Received Study Drug|Study Period 3||12
7577151|NCT02752087|18650901|P1|Received Study Drug|Study Period 3||11
7577152|NCT02752087|18650900|P2|STARTED|Study Period 3||12
7577153|NCT02752087|18650901|P1|STARTED|Study Period 3||11
7577154|NCT02752087|18650900|P2|NOT COMPLETED|Washout||0
7577155|NCT02752087|18650901|P1|NOT COMPLETED|Washout||0
7577156|NCT02752087|18650900|P2|COMPLETED|Washout||12
7577157|NCT02752087|18650901|P1|COMPLETED|Washout||11
7577158|NCT02752087|18650900|P2|STARTED|Washout||12
7577159|NCT02752087|18650901|P1|STARTED|Washout||11
7577160|NCT02752087|18650900|P2|NOT COMPLETED|Study Period 2||0
7577161|NCT02752087|18650901|P1|NOT COMPLETED|Study Period 2||0
7577162|NCT02752087|18650900|P2|COMPLETED|Study Period 2||12
7577163|NCT02752087|18650901|P1|COMPLETED|Study Period 2||11
7577164|NCT02752087|18650900|P2|Received Study Drug|Study Period 2||12
7577165|NCT02752087|18650901|P1|Received Study Drug|Study Period 2||11
7577166|NCT02752087|18650900|P2|STARTED|Study Period 2||12
7577167|NCT02752087|18650901|P1|STARTED|Study Period 2||11
7577168|NCT02752087|18650900|P2|NOT COMPLETED|Washout||0
7577169|NCT02752087|18650901|P1|NOT COMPLETED|Washout||1
7577170|NCT02752087|18650900|P2|COMPLETED|Washout||12
7577171|NCT02752087|18650901|P1|COMPLETED|Washout||11
7577172|NCT02752087|18650900|P2|STARTED|Washout||12
7577173|NCT02752087|18650901|P1|STARTED|Washout||12
7577174|NCT02752087|18650900|P2|NOT COMPLETED|Study Period 1||0
7577175|NCT02752087|18650901|P1|NOT COMPLETED|Study Period 1||0
7577176|NCT02752087|18650900|P2|COMPLETED|Study Period 1||12
7577177|NCT02752087|18650901|P1|COMPLETED|Study Period 1||12
7577178|NCT02752087|18650900|P2|Received Study Drug|Study Period 1||12
7577179|NCT02752087|18650901|P1|Received Study Drug|Study Period 1||12
7577180|NCT02752087|18650900|P2|STARTED|Study Period 1||12
7577181|NCT02752087|18650901|P1|STARTED|Study Period 1||12
7577182|NCT02752074|18650911|P2|NOT COMPLETED|Overall Study||143
7577183|NCT02752074|18650912|P1|NOT COMPLETED|Overall Study||156
7577184|NCT02752074|18650911|P2|COMPLETED|Overall Study||209
7577185|NCT02752074|18650912|P1|COMPLETED|Overall Study||198
7577186|NCT02752074|18650911|P2|Treated|Overall Study||352
7577187|NCT02752074|18650912|P1|Treated|Overall Study||353
7577188|NCT02752074|18650911|P2|STARTED|Overall Study||352
7577189|NCT02752074|18650912|P1|STARTED|Overall Study||354
7577190|NCT02752048|18650937|P3|NOT COMPLETED|Overall Study||3
7577191|NCT02752048|18650938|P2|NOT COMPLETED|Overall Study||0
7577192|NCT02752048|18650939|P1|NOT COMPLETED|Overall Study||0
7577193|NCT02752048|18650937|P3|COMPLETED|Overall Study||10
7577194|NCT02752048|18650938|P2|COMPLETED|Overall Study||12
7577195|NCT02752048|18650939|P1|COMPLETED|Overall Study||11
7577196|NCT02752048|18650937|P3|STARTED|Overall Study||13
7577197|NCT02752048|18650938|P2|STARTED|Overall Study||12
7577198|NCT02752048|18650939|P1|STARTED|Overall Study||11
7577199|NCT02751983|18650958|P2|NOT COMPLETED|Three-Month Follow-Up Assessments||16
7577200|NCT02751983|18650959|P1|NOT COMPLETED|Three-Month Follow-Up Assessments||12
7577201|NCT02751983|18650958|P2|COMPLETED|Three-Month Follow-Up Assessments||19
7577202|NCT02751983|18650959|P1|COMPLETED|Three-Month Follow-Up Assessments||23
7577203|NCT02751983|18650958|P2|STARTED|Three-Month Follow-Up Assessments||35
7577204|NCT02751983|18650959|P1|STARTED|Three-Month Follow-Up Assessments||35
7577205|NCT02751983|18650958|P2|NOT COMPLETED|One-Month Follow-Up Assessments||12
7577206|NCT02751983|18650959|P1|NOT COMPLETED|One-Month Follow-Up Assessments||14
7577207|NCT02751983|18650958|P2|COMPLETED|One-Month Follow-Up Assessments||23
7577208|NCT02751983|18650959|P1|COMPLETED|One-Month Follow-Up Assessments||21
7577209|NCT02751983|18650958|P2|STARTED|One-Month Follow-Up Assessments||35
7577210|NCT02751983|18650959|P1|STARTED|One-Month Follow-Up Assessments||35
7577211|NCT02751983|18650958|P2|NOT COMPLETED|Post-Treatment Assessment||0
7577212|NCT02751983|18650959|P1|NOT COMPLETED|Post-Treatment Assessment||5
7577213|NCT02751983|18650958|P2|COMPLETED|Post-Treatment Assessment||0
7577214|NCT02751983|18650959|P1|COMPLETED|Post-Treatment Assessment||30
7577215|NCT02751983|18650958|P2|STARTED|Post-Treatment Assessment||0
7577216|NCT02751983|18650959|P1|STARTED|Post-Treatment Assessment||35
7577217|NCT02751983|18650958|P2|NOT COMPLETED|Treatment||0
7577218|NCT02751983|18650959|P1|NOT COMPLETED|Treatment||4
7577219|NCT02751983|18650958|P2|COMPLETED|Treatment||35
7577220|NCT02751983|18650959|P1|COMPLETED|Treatment||31
7577221|NCT02751983|18650958|P2|STARTED|Treatment||35
7577222|NCT02751983|18650959|P1|STARTED|Treatment||35
7577223|NCT02751983|18650958|P2|NOT COMPLETED|Baseline and Randomization||0
7577224|NCT02751983|18650959|P1|NOT COMPLETED|Baseline and Randomization||0
7577225|NCT02751983|18650958|P2|COMPLETED|Baseline and Randomization||35
7577226|NCT02751983|18650959|P1|COMPLETED|Baseline and Randomization||35
7577227|NCT02751983|18650958|P2|STARTED|Baseline and Randomization||35
7577228|NCT02751983|18650959|P1|STARTED|Baseline and Randomization||35
7577229|NCT02751931|18650980|P2|NOT COMPLETED|Overall Study||8
7577230|NCT02751931|18650981|P1|NOT COMPLETED|Overall Study||13
7577231|NCT02751931|18650980|P2|COMPLETED|Overall Study||27
7577232|NCT02751931|18650981|P1|COMPLETED|Overall Study||43
7577233|NCT02751931|18650980|P2|Treated|Overall Study||31
7577234|NCT02751931|18650981|P1|Treated|Overall Study||55
7577235|NCT02751931|18650980|P2|STARTED|Overall Study||35
7577236|NCT02751931|18650981|P1|STARTED|Overall Study||56
7577237|NCT02751879|18651055|P2|NOT COMPLETED|Overall Study||0
7577238|NCT02751879|18651056|P1|NOT COMPLETED|Overall Study||0
7577239|NCT02751879|18651055|P2|COMPLETED|Overall Study||71
7577240|NCT02751879|18651056|P1|COMPLETED|Overall Study||157
7577241|NCT02751879|18651055|P2|On Treatment at Study Completion|Overall Study||41
7577242|NCT02751879|18651056|P1|On Treatment at Study Completion|Overall Study||81
7577243|NCT02751879|18651055|P2|STARTED|Overall Study||71
7577244|NCT02751879|18651056|P1|STARTED|Overall Study||157
7577245|NCT02751580|18651069|P1|NOT COMPLETED|Overall Study||6
7577246|NCT02751580|18651069|P1|COMPLETED|Overall Study||31
7577247|NCT02751580|18651069|P1|STARTED|Overall Study||37
7577248|NCT02751450|18651082|P2|NOT COMPLETED|Overall Study||0
7577249|NCT02751450|18651083|P1|NOT COMPLETED|Overall Study||1
7577250|NCT02751450|18651082|P2|COMPLETED|Overall Study||116
7577251|NCT02751450|18651083|P1|COMPLETED|Overall Study||116
7577252|NCT02751450|18651082|P2|STARTED|Overall Study||116
7577253|NCT02751450|18651083|P1|STARTED|Overall Study||117
7577254|NCT02751424|18651104|P9|NOT COMPLETED|Part 2||0
7577255|NCT02751424|18651105|P8|NOT COMPLETED|Part 2||5
7577256|NCT02751424|18651106|P7|NOT COMPLETED|Part 2||0
7577257|NCT02751424|18651107|P6|NOT COMPLETED|Part 2||0
7577258|NCT02751424|18651108|P5|NOT COMPLETED|Part 2||0
7577259|NCT02751424|18651109|P4|NOT COMPLETED|Part 2||0
7577260|NCT02751424|18651110|P3|NOT COMPLETED|Part 2||0
7577261|NCT02751424|18651111|P2|NOT COMPLETED|Part 2||0
7577262|NCT02751424|18651112|P1|NOT COMPLETED|Part 2||0
7577263|NCT02751424|18651104|P9|COMPLETED|Part 2||3
7577264|NCT02751424|18651105|P8|COMPLETED|Part 2||6
7577265|NCT02751424|18651106|P7|COMPLETED|Part 2||0
7577266|NCT02751424|18651107|P6|COMPLETED|Part 2||0
7577267|NCT02751424|18651108|P5|COMPLETED|Part 2||0
7577268|NCT02751424|18651109|P4|COMPLETED|Part 2||0
7577269|NCT02751424|18651110|P3|COMPLETED|Part 2||0
7577270|NCT02751424|18651111|P2|COMPLETED|Part 2||0
7577271|NCT02751424|18651112|P1|COMPLETED|Part 2||0
7577272|NCT02751424|18651104|P9|STARTED|Part 2||3
7577273|NCT02751424|18651105|P8|STARTED|Part 2||11
7577274|NCT02751424|18651106|P7|STARTED|Part 2||0
7577275|NCT02751424|18651107|P6|STARTED|Part 2||0
7577276|NCT02751424|18651108|P5|STARTED|Part 2||0
7577277|NCT02751424|18651109|P4|STARTED|Part 2||0
7577278|NCT02751424|18651110|P3|STARTED|Part 2||0
7577279|NCT02751424|18651111|P2|STARTED|Part 2||0
7577280|NCT02751424|18651112|P1|STARTED|Part 2||0
7577281|NCT02751424|18651104|P9|NOT COMPLETED|Part 1||0
7577282|NCT02751424|18651105|P8|NOT COMPLETED|Part 1||0
7577283|NCT02751424|18651106|P7|NOT COMPLETED|Part 1||0
7577284|NCT02751424|18651107|P6|NOT COMPLETED|Part 1||0
7577285|NCT02751424|18651108|P5|NOT COMPLETED|Part 1||0
7577286|NCT02751424|18651109|P4|NOT COMPLETED|Part 1||0
7577287|NCT02751424|18651110|P3|NOT COMPLETED|Part 1||0
7577288|NCT02751424|18651111|P2|NOT COMPLETED|Part 1||0
7577289|NCT02751424|18651112|P1|NOT COMPLETED|Part 1||0
7577290|NCT02751424|18651104|P9|COMPLETED|Part 1||0
7577291|NCT02751424|18651105|P8|COMPLETED|Part 1||0
7577292|NCT02751424|18651106|P7|COMPLETED|Part 1||12
7577293|NCT02751424|18651107|P6|COMPLETED|Part 1||6
7577294|NCT02751424|18651108|P5|COMPLETED|Part 1||6
7577295|NCT02751424|18651109|P4|COMPLETED|Part 1||6
7577296|NCT02751424|18651110|P3|COMPLETED|Part 1||6
7577297|NCT02751424|18651111|P2|COMPLETED|Part 1||6
7577298|NCT02751424|18651112|P1|COMPLETED|Part 1||6
7577299|NCT02751424|18651104|P9|STARTED|Part 1||0
7577300|NCT02751424|18651105|P8|STARTED|Part 1||0
7577301|NCT02751424|18651106|P7|STARTED|Part 1||12
7577302|NCT02751424|18651107|P6|STARTED|Part 1||6
7577303|NCT02751424|18651108|P5|STARTED|Part 1||6
7577304|NCT02751424|18651109|P4|STARTED|Part 1||6
7577305|NCT02751424|18651110|P3|STARTED|Part 1||6
7577306|NCT02751424|18651111|P2|STARTED|Part 1||6
7577307|NCT02751424|18651112|P1|STARTED|Part 1||6
7577308|NCT02751385|18651255|P2|NOT COMPLETED|Period 2||0
7577309|NCT02751385|18651256|P1|NOT COMPLETED|Period 2||0
7577310|NCT02751385|18651255|P2|COMPLETED|Period 2||2
7577311|NCT02751385|18651256|P1|COMPLETED|Period 2||0
7577312|NCT02751385|18651255|P2|STARTED|Period 2||2
7577313|NCT02751385|18651256|P1|STARTED|Period 2||0
7577314|NCT02751385|18651255|P2|NOT COMPLETED|Period 1||0
7577315|NCT02751385|18651256|P1|NOT COMPLETED|Period 1||0
7577316|NCT02751385|18651255|P2|COMPLETED|Period 1||0
7577317|NCT02751385|18651256|P1|COMPLETED|Period 1||2
7577318|NCT02751385|18651255|P2|STARTED|Period 1||0
7577319|NCT02751385|18651256|P1|STARTED|Period 1||2
7577320|NCT02751320|18651268|P1|NOT COMPLETED|Overall Study||3
7577321|NCT02751320|18651268|P1|COMPLETED|Overall Study||42
7577322|NCT02751320|18651268|P1|Received Reference Product 3|Overall Study||28
7577323|NCT02751320|18651268|P1|Received Reference Product 2|Overall Study||28
7577324|NCT02751320|18651268|P1|Received Reference Product 1|Overall Study||29
7577325|NCT02751320|18651268|P1|Received Test Prodcut 3|Overall Study||28
7577326|NCT02751320|18651268|P1|Received Test Prodcut 2|Overall Study||28
7577327|NCT02751320|18651268|P1|Received Test Product 1|Overall Study||29
7577328|NCT02751320|18651268|P1|STARTED|Overall Study||45
7577329|NCT02750943|18651306|P2|NOT COMPLETED|Overall Study||9
7577330|NCT02750943|18651307|P1|NOT COMPLETED|Overall Study||6
7577331|NCT02750943|18651306|P2|COMPLETED|Overall Study||119
7577332|NCT02750943|18651307|P1|COMPLETED|Overall Study||119
7577333|NCT02750943|18651306|P2|STARTED|Overall Study||128
7577334|NCT02750943|18651307|P1|STARTED|Overall Study||125
7577335|NCT02750930|18651321|P1|NOT COMPLETED|Overall Study||8
7577336|NCT02750930|18651321|P1|COMPLETED|Overall Study||0
7577337|NCT02750930|18651321|P1|STARTED|Overall Study||8
7577338|NCT02750813|18651333|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
7577339|NCT02750813|18651334|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
7577340|NCT02750813|18651333|P2|COMPLETED|Period 2, Second 14 Days of Wear||120
7577341|NCT02750813|18651334|P1|COMPLETED|Period 2, Second 14 Days of Wear||124
7577342|NCT02750813|18651333|P2|STARTED|Period 2, Second 14 Days of Wear||120
7577343|NCT02750813|18651334|P1|STARTED|Period 2, Second 14 Days of Wear||124
7577344|NCT02750813|18651333|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||1
7577345|NCT02750813|18651334|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||1
7577346|NCT02750813|18651333|P2|COMPLETED|Period 1, First 14 Days of Wear||120
7577347|NCT02750813|18651334|P1|COMPLETED|Period 1, First 14 Days of Wear||124
7577348|NCT02750813|18651333|P2|STARTED|Period 1, First 14 Days of Wear||121
7577349|NCT02750813|18651334|P1|STARTED|Period 1, First 14 Days of Wear||125
7577350|NCT02750800|18651349|P1|NOT COMPLETED|Overall Study||98
7577351|NCT02750800|18651349|P1|COMPLETED|Overall Study||314
7577352|NCT02750800|18651349|P1|STARTED|Overall Study||412
7577353|NCT02750761|18651454|P6|NOT COMPLETED|Overall Study||0
7577354|NCT02750761|18651455|P5|NOT COMPLETED|Overall Study||0
7577355|NCT02750761|18651456|P4|NOT COMPLETED|Overall Study||0
7577356|NCT02750761|18651457|P3|NOT COMPLETED|Overall Study||1
7577357|NCT02750761|18651458|P2|NOT COMPLETED|Overall Study||0
7577358|NCT02750761|18651459|P1|NOT COMPLETED|Overall Study||0
7577359|NCT02750761|18651454|P6|COMPLETED|Overall Study||6
7577360|NCT02750761|18651455|P5|COMPLETED|Overall Study||6
7577361|NCT02750761|18651456|P4|COMPLETED|Overall Study||5
7577362|NCT02750761|18651457|P3|COMPLETED|Overall Study||4
7577363|NCT02750761|18651458|P2|COMPLETED|Overall Study||5
7577364|NCT02750761|18651459|P1|COMPLETED|Overall Study||5
7577365|NCT02750761|18651454|P6|STARTED|Overall Study||6
7577366|NCT02750761|18651455|P5|STARTED|Overall Study||6
7577367|NCT02750761|18651456|P4|STARTED|Overall Study||5
7577368|NCT02750761|18651457|P3|STARTED|Overall Study||5
7577369|NCT02750761|18651458|P2|STARTED|Overall Study||5
7577370|NCT02750761|18651459|P1|STARTED|Overall Study||5
7577371|NCT02750709|18651555|P6|NOT COMPLETED|Treatment Period 3||0
7577372|NCT02750709|18651556|P5|NOT COMPLETED|Treatment Period 3||0
7577373|NCT02750709|18651557|P4|NOT COMPLETED|Treatment Period 3||0
7577374|NCT02750709|18651558|P3|NOT COMPLETED|Treatment Period 3||0
7577375|NCT02750709|18651559|P2|NOT COMPLETED|Treatment Period 3||0
7577376|NCT02750709|18651560|P1|NOT COMPLETED|Treatment Period 3||0
7577377|NCT02750709|18651555|P6|COMPLETED|Treatment Period 3||3
7577378|NCT02750709|18651556|P5|COMPLETED|Treatment Period 3||4
7577379|NCT02750709|18651557|P4|COMPLETED|Treatment Period 3||4
7577380|NCT02750709|18651558|P3|COMPLETED|Treatment Period 3||4
7577381|NCT02750709|18651559|P2|COMPLETED|Treatment Period 3||4
7577382|NCT02750709|18651560|P1|COMPLETED|Treatment Period 3||4
7577383|NCT02750709|18651555|P6|STARTED|Treatment Period 3||3
7577384|NCT02750709|18651556|P5|STARTED|Treatment Period 3||4
7577385|NCT02750709|18651557|P4|STARTED|Treatment Period 3||4
7577386|NCT02750709|18651558|P3|STARTED|Treatment Period 3||4
7577387|NCT02750709|18651559|P2|STARTED|Treatment Period 3||4
7577388|NCT02750709|18651560|P1|STARTED|Treatment Period 3||4
7577389|NCT02750709|18651555|P6|NOT COMPLETED|Treatment Period 2||0
7577390|NCT02750709|18651556|P5|NOT COMPLETED|Treatment Period 2||0
7577391|NCT02750709|18651557|P4|NOT COMPLETED|Treatment Period 2||0
7577392|NCT02750709|18651558|P3|NOT COMPLETED|Treatment Period 2||0
7577393|NCT02750709|18651559|P2|NOT COMPLETED|Treatment Period 2||0
7577394|NCT02750709|18651560|P1|NOT COMPLETED|Treatment Period 2||0
7577395|NCT02750709|18651555|P6|COMPLETED|Treatment Period 2||3
7577396|NCT02750709|18651556|P5|COMPLETED|Treatment Period 2||4
7577397|NCT02750709|18651557|P4|COMPLETED|Treatment Period 2||4
7577398|NCT02750709|18651558|P3|COMPLETED|Treatment Period 2||4
7577399|NCT02750709|18651559|P2|COMPLETED|Treatment Period 2||4
7577400|NCT02750709|18651560|P1|COMPLETED|Treatment Period 2||4
7577401|NCT02750709|18651555|P6|STARTED|Treatment Period 2||3
7577402|NCT02750709|18651556|P5|STARTED|Treatment Period 2||4
7577403|NCT02750709|18651557|P4|STARTED|Treatment Period 2||4
7577404|NCT02750709|18651558|P3|STARTED|Treatment Period 2||4
7577405|NCT02750709|18651559|P2|STARTED|Treatment Period 2||4
7577406|NCT02750709|18651560|P1|STARTED|Treatment Period 2||4
7577407|NCT02750709|18651555|P6|NOT COMPLETED|Treatment Period 1||1
7577408|NCT02750709|18651556|P5|NOT COMPLETED|Treatment Period 1||0
7577409|NCT02750709|18651557|P4|NOT COMPLETED|Treatment Period 1||0
7577410|NCT02750709|18651558|P3|NOT COMPLETED|Treatment Period 1||0
7577411|NCT02750709|18651559|P2|NOT COMPLETED|Treatment Period 1||0
7577412|NCT02750709|18651560|P1|NOT COMPLETED|Treatment Period 1||0
7577413|NCT02750709|18651555|P6|COMPLETED|Treatment Period 1||3
7577414|NCT02750709|18651556|P5|COMPLETED|Treatment Period 1||4
7577415|NCT02750709|18651557|P4|COMPLETED|Treatment Period 1||4
7577416|NCT02750709|18651558|P3|COMPLETED|Treatment Period 1||4
7577417|NCT02750709|18651559|P2|COMPLETED|Treatment Period 1||4
7577418|NCT02750709|18651560|P1|COMPLETED|Treatment Period 1||4
7577419|NCT02750709|18651555|P6|STARTED|Treatment Period 1||4
7577420|NCT02750709|18651556|P5|STARTED|Treatment Period 1||4
7577421|NCT02750709|18651557|P4|STARTED|Treatment Period 1||4
7577422|NCT02750709|18651558|P3|STARTED|Treatment Period 1||4
7577423|NCT02750709|18651559|P2|STARTED|Treatment Period 1||4
7577424|NCT02750709|18651560|P1|STARTED|Treatment Period 1||4
7577425|NCT02750618|18651586|P1|NOT COMPLETED|Overall Study||1
7577426|NCT02750618|18651586|P1|COMPLETED|Overall Study||12
7577427|NCT02750618|18651586|P1|Completed Week 64|Overall Study||13
7577428|NCT02750618|18651586|P1|Completed Week 40|Overall Study||13
7577429|NCT02750618|18651586|P1|STARTED|Overall Study||13
7577430|NCT02750592|18651602|P1|NOT COMPLETED|Overall Study||5
7577431|NCT02750592|18651602|P1|COMPLETED|Overall Study||25
7577432|NCT02750592|18651602|P1|STARTED|Overall Study||30
7577433|NCT02750501|18651621|P1|NOT COMPLETED|Overall Study||8
7577434|NCT02750501|18651621|P1|COMPLETED|Overall Study||36
7577435|NCT02750501|18651621|P1|Treated|Overall Study||39
7577436|NCT02750501|18651621|P1|Enrolled|Overall Study||44
7577437|NCT02750501|18651621|P1|STARTED|Overall Study||44
7577438|NCT02750410|18651635|P2|NOT COMPLETED|Open-Label Extension Period||6
7577439|NCT02750410|18651636|P1|NOT COMPLETED|Open-Label Extension Period||6
7577440|NCT02750410|18651635|P2|COMPLETED|Open-Label Extension Period||111
7577441|NCT02750410|18651636|P1|COMPLETED|Open-Label Extension Period||31
7577442|NCT02750410|18651635|P2|STARTED|Open-Label Extension Period||117
7577443|NCT02750410|18651636|P1|STARTED|Open-Label Extension Period||37
7577444|NCT02750410|18651635|P2|NOT COMPLETED|Double-Blind Treatment Period||3
7577445|NCT02750410|18651636|P1|NOT COMPLETED|Double-Blind Treatment Period||2
7577446|NCT02750410|18651635|P2|COMPLETED|Double-Blind Treatment Period||117
7577447|NCT02750410|18651636|P1|COMPLETED|Double-Blind Treatment Period||37
7577448|NCT02750410|18651635|P2|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||120
7577449|NCT02750410|18651636|P1|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||39
7577450|NCT02750410|18651635|P2|STARTED|Double-Blind Treatment Period||120
7577451|NCT02750410|18651636|P1|STARTED|Double-Blind Treatment Period||39
7577452|NCT02750345|18651654|P6|NOT COMPLETED|Intervention 3||0
7577453|NCT02750345|18651655|P5|NOT COMPLETED|Intervention 3||0
7577454|NCT02750345|18651656|P4|NOT COMPLETED|Intervention 3||0
7577455|NCT02750345|18651657|P3|NOT COMPLETED|Intervention 3||0
7577456|NCT02750345|18651658|P2|NOT COMPLETED|Intervention 3||0
7577457|NCT02750345|18651659|P1|NOT COMPLETED|Intervention 3||0
7577458|NCT02750345|18651654|P6|COMPLETED|Intervention 3||4
7577459|NCT02750345|18651655|P5|COMPLETED|Intervention 3||3
7577460|NCT02750345|18651656|P4|COMPLETED|Intervention 3||4
7577461|NCT02750345|18651657|P3|COMPLETED|Intervention 3||4
7577462|NCT02750345|18651658|P2|COMPLETED|Intervention 3||4
7577463|NCT02750345|18651659|P1|COMPLETED|Intervention 3||4
7577464|NCT02750345|18651654|P6|STARTED|Intervention 3||4
7577465|NCT02750345|18651655|P5|STARTED|Intervention 3||3
7577466|NCT02750345|18651656|P4|STARTED|Intervention 3||4
7577467|NCT02750345|18651657|P3|STARTED|Intervention 3||4
7577468|NCT02750345|18651658|P2|STARTED|Intervention 3||4
7577469|NCT02750345|18651659|P1|STARTED|Intervention 3||4
7577470|NCT02750345|18651654|P6|NOT COMPLETED|Intervention 2||0
7577471|NCT02750345|18651655|P5|NOT COMPLETED|Intervention 2||0
7577472|NCT02750345|18651656|P4|NOT COMPLETED|Intervention 2||0
7577473|NCT02750345|18651657|P3|NOT COMPLETED|Intervention 2||0
7577474|NCT02750345|18651658|P2|NOT COMPLETED|Intervention 2||0
7577475|NCT02750345|18651659|P1|NOT COMPLETED|Intervention 2||0
7577476|NCT02750345|18651654|P6|COMPLETED|Intervention 2||4
7577477|NCT02750345|18651655|P5|COMPLETED|Intervention 2||3
7577478|NCT02750345|18651656|P4|COMPLETED|Intervention 2||4
7577479|NCT02750345|18651657|P3|COMPLETED|Intervention 2||4
7577480|NCT02750345|18651658|P2|COMPLETED|Intervention 2||4
7577481|NCT02750345|18651659|P1|COMPLETED|Intervention 2||4
7577482|NCT02750345|18651654|P6|STARTED|Intervention 2||4
7577483|NCT02750345|18651655|P5|STARTED|Intervention 2||3
7577484|NCT02750345|18651656|P4|STARTED|Intervention 2||4
7577485|NCT02750345|18651657|P3|STARTED|Intervention 2||4
7577486|NCT02750345|18651658|P2|STARTED|Intervention 2||4
7577487|NCT02750345|18651659|P1|STARTED|Intervention 2||4
7577488|NCT02750345|18651654|P6|NOT COMPLETED|Intervention 1||0
7577489|NCT02750345|18651655|P5|NOT COMPLETED|Intervention 1||1
7577490|NCT02750345|18651656|P4|NOT COMPLETED|Intervention 1||0
7577491|NCT02750345|18651657|P3|NOT COMPLETED|Intervention 1||0
7577492|NCT02750345|18651658|P2|NOT COMPLETED|Intervention 1||0
7577493|NCT02750345|18651659|P1|NOT COMPLETED|Intervention 1||0
7577494|NCT02750345|18651654|P6|COMPLETED|Intervention 1||4
7577495|NCT02750345|18651655|P5|COMPLETED|Intervention 1||3
7577496|NCT02750345|18651656|P4|COMPLETED|Intervention 1||4
7577497|NCT02750345|18651657|P3|COMPLETED|Intervention 1||4
7577498|NCT02750345|18651658|P2|COMPLETED|Intervention 1||4
7577499|NCT02750345|18651659|P1|COMPLETED|Intervention 1||4
7577500|NCT02750345|18651654|P6|STARTED|Intervention 1||4
7577501|NCT02750345|18651655|P5|STARTED|Intervention 1||4
7577502|NCT02750345|18651656|P4|STARTED|Intervention 1||4
7577503|NCT02750345|18651657|P3|STARTED|Intervention 1||4
7577504|NCT02750345|18651658|P2|STARTED|Intervention 1||4
7577505|NCT02750345|18651659|P1|STARTED|Intervention 1||4
7577506|NCT02750332|18651685|P2|NOT COMPLETED|Treatment Period 2||0
7577507|NCT02750332|18651686|P1|NOT COMPLETED|Treatment Period 2||0
7577508|NCT02750332|18651685|P2|COMPLETED|Treatment Period 2||9
7577509|NCT02750332|18651686|P1|COMPLETED|Treatment Period 2||10
7577510|NCT02750332|18651685|P2|STARTED|Treatment Period 2||9
7577511|NCT02750332|18651686|P1|STARTED|Treatment Period 2||10
7577512|NCT02750332|18651685|P2|NOT COMPLETED|Treatment Period 1||1
7577513|NCT02750332|18651686|P1|NOT COMPLETED|Treatment Period 1||0
7577514|NCT02750332|18651685|P2|COMPLETED|Treatment Period 1||9
7577515|NCT02750332|18651686|P1|COMPLETED|Treatment Period 1||10
7577516|NCT02750332|18651685|P2|STARTED|Treatment Period 1||10
7577517|NCT02750332|18651686|P1|STARTED|Treatment Period 1||10
7577518|NCT02750306|18651706|P2|NOT COMPLETED|Overall Study||2
7577519|NCT02750306|18651707|P1|NOT COMPLETED|Overall Study||6
7577520|NCT02750306|18651706|P2|COMPLETED|Overall Study||141
7577521|NCT02750306|18651707|P1|COMPLETED|Overall Study||136
7577522|NCT02750306|18651706|P2|STARTED|Overall Study||143
7577523|NCT02750306|18651707|P1|STARTED|Overall Study||142
7577524|NCT02750267|18651721|P2|NOT COMPLETED|Overall Study||0
7577525|NCT02750267|18651722|P1|NOT COMPLETED|Overall Study||0
7577526|NCT02750267|18651721|P2|COMPLETED|Overall Study||6
7577527|NCT02750267|18651722|P1|COMPLETED|Overall Study||6
7577528|NCT02750267|18651721|P2|STARTED|Overall Study||6
7577529|NCT02750267|18651722|P1|STARTED|Overall Study||6
7577530|NCT02749903|18651760|P1|NOT COMPLETED|Overall Study||0
7577531|NCT02749903|18651760|P1|COMPLETED|Overall Study||46
7577532|NCT02749903|18651760|P1|STARTED|Overall Study||46
7577533|NCT02749799|18651766|P1|NOT COMPLETED|Overall Study||8
7577534|NCT02749799|18651766|P1|COMPLETED|Overall Study||37
7577535|NCT02749799|18651766|P1|STARTED|Overall Study||45
7577536|NCT02749370|18651772|P1|NOT COMPLETED|Overall Study||14
7577537|NCT02749370|18651772|P1|COMPLETED|Overall Study||66
7577538|NCT02749370|18651772|P1|STARTED|Overall Study||80
7577539|NCT02749201|18651799|P1|NOT COMPLETED|Overall Study||0
7577540|NCT02749201|18651799|P1|COMPLETED|Overall Study||10
7577541|NCT02749201|18651799|P1|STARTED|Overall Study||10
7577542|NCT02748928|18651803|P1|NOT COMPLETED|Overall Study||0
7577543|NCT02748928|18651803|P1|COMPLETED|Overall Study||62
7577544|NCT02748928|18651803|P1|STARTED|Overall Study||62
7577545|NCT02748889|18651814|P2|NOT COMPLETED|Overall Study||0
7577546|NCT02748889|18651815|P1|NOT COMPLETED|Overall Study||0
7577547|NCT02748889|18651814|P2|COMPLETED|Overall Study||1
7577548|NCT02748889|18651815|P1|COMPLETED|Overall Study||0
7577549|NCT02748889|18651814|P2|STARTED|Overall Study||1
7577550|NCT02748889|18651815|P1|STARTED|Overall Study||0
7577551|NCT02748863|18651822|P5|NOT COMPLETED|Treatment Period 2||1
7577552|NCT02748863|18651823|P4|NOT COMPLETED|Treatment Period 2||2
7577553|NCT02748863|18651824|P3|NOT COMPLETED|Treatment Period 2||0
7577554|NCT02748863|18651825|P2|NOT COMPLETED|Treatment Period 2||3
7577555|NCT02748863|18651826|P1|NOT COMPLETED|Treatment Period 2||5
7577556|NCT02748863|18651822|P5|COMPLETED|Treatment Period 2||33
7577557|NCT02748863|18651823|P4|COMPLETED|Treatment Period 2||32
7577558|NCT02748863|18651824|P3|COMPLETED|Treatment Period 2||0
7577559|NCT02748863|18651825|P2|COMPLETED|Treatment Period 2||66
7577560|NCT02748863|18651826|P1|COMPLETED|Treatment Period 2||67
7577561|NCT02748863|18651822|P5|STARTED|Treatment Period 2||34
7577562|NCT02748863|18651823|P4|STARTED|Treatment Period 2||34
7577563|NCT02748863|18651824|P3|STARTED|Treatment Period 2||0
7577564|NCT02748863|18651825|P2|STARTED|Treatment Period 2||69
7577565|NCT02748863|18651826|P1|STARTED|Treatment Period 2||72
7577566|NCT02748863|18651822|P5|NOT COMPLETED|Treatment Period 1||0
7577567|NCT02748863|18651823|P4|NOT COMPLETED|Treatment Period 1||0
7577568|NCT02748863|18651824|P3|NOT COMPLETED|Treatment Period 1||2
7577569|NCT02748863|18651825|P2|NOT COMPLETED|Treatment Period 1||2
7577570|NCT02748863|18651826|P1|NOT COMPLETED|Treatment Period 1||0
7577571|NCT02748863|18651822|P5|COMPLETED|Treatment Period 1||0
7577572|NCT02748863|18651823|P4|COMPLETED|Treatment Period 1||0
7577573|NCT02748863|18651824|P3|COMPLETED|Treatment Period 1||69
7577574|NCT02748863|18651825|P2|COMPLETED|Treatment Period 1||69
7577575|NCT02748863|18651826|P1|COMPLETED|Treatment Period 1||72
7577576|NCT02748863|18651822|P5|STARTED|Treatment Period 1|Not applicable for this period|0
7577577|NCT02748863|18651823|P4|STARTED|Treatment Period 1|Not applicable for this period|0
7577578|NCT02748863|18651824|P3|STARTED|Treatment Period 1||71
7577579|NCT02748863|18651825|P2|STARTED|Treatment Period 1||71
7577580|NCT02748863|18651826|P1|STARTED|Treatment Period 1||72
7577581|NCT02748785|18651852|P4|NOT COMPLETED|Visit 3- Visit 4||2
7577582|NCT02748785|18651853|P3|NOT COMPLETED|Visit 3- Visit 4||2
7577583|NCT02748785|18651854|P2|NOT COMPLETED|Visit 3- Visit 4||1
7577584|NCT02748785|18651855|P1|NOT COMPLETED|Visit 3- Visit 4||1
7577585|NCT02748785|18651852|P4|COMPLETED|Visit 3- Visit 4||50
7577586|NCT02748785|18651853|P3|COMPLETED|Visit 3- Visit 4||47
7577587|NCT02748785|18651854|P2|COMPLETED|Visit 3- Visit 4||43
7577588|NCT02748785|18651855|P1|COMPLETED|Visit 3- Visit 4||53
7577589|NCT02748785|18651852|P4|STARTED|Visit 3- Visit 4||52
7577590|NCT02748785|18651853|P3|STARTED|Visit 3- Visit 4||49
7577591|NCT02748785|18651854|P2|STARTED|Visit 3- Visit 4||44
7577592|NCT02748785|18651855|P1|STARTED|Visit 3- Visit 4||54
7577593|NCT02748785|18651852|P4|NOT COMPLETED|Visit 2-Visit 3||11
7577594|NCT02748785|18651853|P3|NOT COMPLETED|Visit 2-Visit 3||8
7577595|NCT02748785|18651854|P2|NOT COMPLETED|Visit 2-Visit 3||5
7577596|NCT02748785|18651855|P1|NOT COMPLETED|Visit 2-Visit 3||5
7577597|NCT02748785|18651852|P4|COMPLETED|Visit 2-Visit 3||52
7577598|NCT02748785|18651853|P3|COMPLETED|Visit 2-Visit 3||49
7577599|NCT02748785|18651854|P2|COMPLETED|Visit 2-Visit 3||44
7577600|NCT02748785|18651855|P1|COMPLETED|Visit 2-Visit 3||54
7577601|NCT02748785|18651852|P4|STARTED|Visit 2-Visit 3||63
7577602|NCT02748785|18651853|P3|STARTED|Visit 2-Visit 3||57
7577603|NCT02748785|18651854|P2|STARTED|Visit 2-Visit 3||49
7577604|NCT02748785|18651855|P1|STARTED|Visit 2-Visit 3||59
7577605|NCT02748785|18651852|P4|NOT COMPLETED|Visit 1- Visit 2||6
7577606|NCT02748785|18651853|P3|NOT COMPLETED|Visit 1- Visit 2||14
7577607|NCT02748785|18651854|P2|NOT COMPLETED|Visit 1- Visit 2||19
7577608|NCT02748785|18651855|P1|NOT COMPLETED|Visit 1- Visit 2||10
7577609|NCT02748785|18651852|P4|COMPLETED|Visit 1- Visit 2||63
7577610|NCT02748785|18651853|P3|COMPLETED|Visit 1- Visit 2||57
7577611|NCT02748785|18651854|P2|COMPLETED|Visit 1- Visit 2||49
7577612|NCT02748785|18651855|P1|COMPLETED|Visit 1- Visit 2||59
7577613|NCT02748785|18651852|P4|STARTED|Visit 1- Visit 2||69
7577614|NCT02748785|18651853|P3|STARTED|Visit 1- Visit 2||71
7577615|NCT02748785|18651854|P2|STARTED|Visit 1- Visit 2||68
7577616|NCT02748785|18651855|P1|STARTED|Visit 1- Visit 2||69
7577617|NCT02748525|18651901|P1|NOT COMPLETED|Overall Study||11
7577618|NCT02748525|18651901|P1|COMPLETED|Overall Study|Completed 6 months follow up|39
7577619|NCT02748525|18651901|P1|Completed Study Intervention|Overall Study||50
7577620|NCT02748525|18651901|P1|STARTED|Overall Study||50
7577621|NCT02748512|18651910|P2|NOT COMPLETED|Overall Study||1
7577622|NCT02748512|18651911|P1|NOT COMPLETED|Overall Study||1
7577623|NCT02748512|18651910|P2|COMPLETED|Overall Study||11
7577624|NCT02748512|18651911|P1|COMPLETED|Overall Study||13
7577625|NCT02748512|18651910|P2|STARTED|Overall Study||12
7577626|NCT02748512|18651911|P1|STARTED|Overall Study||14
7577627|NCT02748356|18651919|P1|NOT COMPLETED|Overall Study||1
7577628|NCT02748356|18651919|P1|COMPLETED|Overall Study||6
7577629|NCT02748356|18651919|P1|STARTED|Overall Study||7
7577630|NCT02748317|18651924|P1|NOT COMPLETED|Overall Study||23
7577631|NCT02748317|18651924|P1|COMPLETED|Overall Study||73
7577632|NCT02748317|18651924|P1|STARTED|Overall Study||96
7577633|NCT02748213|18651931|P2|NOT COMPLETED|Overall Study||112
7577634|NCT02748213|18651932|P1|NOT COMPLETED|Overall Study||113
7577635|NCT02748213|18651931|P2|COMPLETED|Overall Study||0
7577636|NCT02748213|18651932|P1|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0
7577637|NCT02748213|18651931|P2|Treated|Overall Study||110
7577638|NCT02748213|18651932|P1|Treated|Overall Study||112
7577639|NCT02748213|18651931|P2|STARTED|Overall Study||112
7577640|NCT02748213|18651932|P1|STARTED|Overall Study||113
7577641|NCT02748070|18651950|P2|NOT COMPLETED|Overall Study||1
7577642|NCT02748070|18651951|P1|NOT COMPLETED|Overall Study||8
7577643|NCT02748070|18651950|P2|COMPLETED|Overall Study||39
7577644|NCT02748070|18651951|P1|COMPLETED|Overall Study||33
7577645|NCT02748070|18651950|P2|Randomized and Treated|Overall Study||40
7577646|NCT02748070|18651951|P1|Randomized and Treated|Overall Study||40
7577647|NCT02748070|18651950|P2|STARTED|Overall Study||40
7577648|NCT02748070|18651951|P1|STARTED|Overall Study||41
7577649|NCT02748057|18651961|P2|NOT COMPLETED|Overall Study||2
7577650|NCT02748057|18651962|P1|NOT COMPLETED|Overall Study||5
7577651|NCT02748057|18651961|P2|COMPLETED|Overall Study||19
7577652|NCT02748057|18651962|P1|COMPLETED|Overall Study||109
7577653|NCT02748057|18651961|P2|STARTED|Overall Study||21
7577654|NCT02748057|18651962|P1|STARTED|Overall Study||114
7577655|NCT02747628|18651975|P3|NOT COMPLETED|Overall Study||0
7577656|NCT02747628|18651976|P2|NOT COMPLETED|Overall Study||0
7577657|NCT02747628|18651977|P1|NOT COMPLETED|Overall Study||0
7577658|NCT02747628|18651975|P3|COMPLETED|Overall Study||20
7577659|NCT02747628|18651976|P2|COMPLETED|Overall Study||20
7577660|NCT02747628|18651977|P1|COMPLETED|Overall Study||20
7577661|NCT02747628|18651975|P3|STARTED|Overall Study||20
7577662|NCT02747628|18651976|P2|STARTED|Overall Study||20
7577663|NCT02747628|18651977|P1|STARTED|Overall Study||20
7577664|NCT02747615|18651987|P2|NOT COMPLETED|Overall Study||0
7577665|NCT02747615|18651988|P1|NOT COMPLETED|Overall Study||0
7577666|NCT02747615|18651987|P2|COMPLETED|Overall Study||30
7577667|NCT02747615|18651988|P1|COMPLETED|Overall Study||30
7577668|NCT02747615|18651987|P2|STARTED|Overall Study||30
7577669|NCT02747615|18651988|P1|STARTED|Overall Study||30
7577670|NCT02747433|18651998|P2|NOT COMPLETED|Overall Study||0
7577671|NCT02747433|18651999|P1|NOT COMPLETED|Overall Study||0
7577672|NCT02747433|18651998|P2|COMPLETED|Overall Study||5
7577673|NCT02747433|18651999|P1|COMPLETED|Overall Study||5
7577674|NCT02747433|18651998|P2|STARTED|Overall Study||5
7577675|NCT02747433|18651999|P1|STARTED|Overall Study||5
7577676|NCT02747186|18652029|P2|NOT COMPLETED|Second Intervention||0
7577677|NCT02747186|18652030|P1|NOT COMPLETED|Second Intervention||0
7577678|NCT02747186|18652029|P2|COMPLETED|Second Intervention||12
7577679|NCT02747186|18652030|P1|COMPLETED|Second Intervention||12
7577680|NCT02747186|18652029|P2|STARTED|Second Intervention||12
7577681|NCT02747186|18652030|P1|STARTED|Second Intervention||12
7577682|NCT02747186|18652029|P2|NOT COMPLETED|Washout (1 Week)||0
7577683|NCT02747186|18652030|P1|NOT COMPLETED|Washout (1 Week)||0
7577684|NCT02747186|18652029|P2|COMPLETED|Washout (1 Week)||12
7577685|NCT02747186|18652030|P1|COMPLETED|Washout (1 Week)||12
7577686|NCT02747186|18652029|P2|STARTED|Washout (1 Week)||12
7577687|NCT02747186|18652030|P1|STARTED|Washout (1 Week)||12
7577688|NCT02747186|18652029|P2|NOT COMPLETED|First Intervention||0
7577689|NCT02747186|18652030|P1|NOT COMPLETED|First Intervention||0
7577690|NCT02747186|18652029|P2|COMPLETED|First Intervention||12
7577691|NCT02747186|18652030|P1|COMPLETED|First Intervention||12
7577692|NCT02747186|18652029|P2|STARTED|First Intervention||12
7577693|NCT02747186|18652030|P1|STARTED|First Intervention||12
7577694|NCT02747108|18652040|P2|NOT COMPLETED|Overall Study||2
7577695|NCT02747108|18652041|P1|NOT COMPLETED|Overall Study||5
7577696|NCT02747108|18652040|P2|COMPLETED|Overall Study||60
7577697|NCT02747108|18652041|P1|COMPLETED|Overall Study||248
7577698|NCT02747108|18652040|P2|STARTED|Overall Study||62
7577699|NCT02747108|18652041|P1|STARTED|Overall Study||253
7577700|NCT02747043|18652083|P2|NOT COMPLETED|Overall Study||5
7577701|NCT02747043|18652084|P1|NOT COMPLETED|Overall Study||10
7577702|NCT02747043|18652083|P2|COMPLETED|Overall Study||123
7577703|NCT02747043|18652084|P1|COMPLETED|Overall Study||118
7577704|NCT02747043|18652083|P2|Treated|Overall Study||126
7577705|NCT02747043|18652084|P1|Treated|Overall Study||128
7577706|NCT02747043|18652083|P2|STARTED|Overall Study||128
7577707|NCT02747043|18652084|P1|STARTED|Overall Study||128
7577708|NCT02747004|18652113|P3|NOT COMPLETED|Overall Study||47
7577709|NCT02747004|18652114|P2|NOT COMPLETED|Overall Study||49
7577710|NCT02747004|18652115|P1|NOT COMPLETED|Overall Study||57
7577711|NCT02747004|18652113|P3|COMPLETED|Overall Study||30
7577712|NCT02747004|18652114|P2|COMPLETED|Overall Study||30
7577713|NCT02747004|18652115|P1|COMPLETED|Overall Study||21
7577714|NCT02747004|18652113|P3|Received at Least One Dose of Study Drug|Overall Study||77
7577715|NCT02747004|18652114|P2|Received at Least One Dose of Study Drug|Overall Study||79
7577716|NCT02747004|18652115|P1|Received at Least One Dose of Study Drug|Overall Study||78
7577717|NCT02747004|18652113|P3|STARTED|Overall Study||77
7577718|NCT02747004|18652114|P2|STARTED|Overall Study||79
7577719|NCT02747004|18652115|P1|STARTED|Overall Study||78
7577720|NCT02746991|18652145|P2|NOT COMPLETED|Overall Study||34
7577721|NCT02746991|18652146|P1|NOT COMPLETED|Overall Study||28
7577722|NCT02746991|18652145|P2|COMPLETED|Overall Study||67
7577723|NCT02746991|18652146|P1|COMPLETED|Overall Study||24
7577724|NCT02746991|18652145|P2|STARTED|Overall Study||101
7577725|NCT02746991|18652146|P1|STARTED|Overall Study||52
7577726|NCT02746809|18652154|P1|NOT COMPLETED|Baseline-6 Months||5
7577727|NCT02746809|18652154|P1|COMPLETED|Baseline-6 Months||54
7577728|NCT02746809|18652154|P1|STARTED|Baseline-6 Months||59
7577729|NCT02746809|18652154|P1|NOT COMPLETED|Baseline- 30 Days||1
7577730|NCT02746809|18652154|P1|COMPLETED|Baseline- 30 Days||59
7577731|NCT02746809|18652154|P1|STARTED|Baseline- 30 Days||60
7577732|NCT02746705|18652174|P2|NOT COMPLETED|Overall Study||2
7577733|NCT02746705|18652175|P1|NOT COMPLETED|Overall Study||2
7577734|NCT02746705|18652174|P2|COMPLETED|Overall Study||12
7577735|NCT02746705|18652175|P1|COMPLETED|Overall Study||15
7577736|NCT02746705|18652174|P2|STARTED|Overall Study||14
7577737|NCT02746705|18652175|P1|STARTED|Overall Study||17
7577738|NCT02746679|18652189|P2|NOT COMPLETED|Overall Study||6
7577739|NCT02746679|18652190|P1|NOT COMPLETED|Overall Study||4
7577740|NCT02746679|18652189|P2|COMPLETED|Overall Study||75
7577741|NCT02746679|18652190|P1|COMPLETED|Overall Study||76
7577742|NCT02746679|18652189|P2|STARTED|Overall Study||81
7577743|NCT02746679|18652190|P1|STARTED|Overall Study||80
7577744|NCT02746627|18652223|P3|NOT COMPLETED|Overall Study||1
7577745|NCT02746627|18652224|P2|NOT COMPLETED|Overall Study||1
7577746|NCT02746627|18652225|P1|NOT COMPLETED|Overall Study||1
7577747|NCT02746627|18652223|P3|COMPLETED|Overall Study||29
7577748|NCT02746627|18652224|P2|COMPLETED|Overall Study||29
7577749|NCT02746627|18652225|P1|COMPLETED|Overall Study||59
7577750|NCT02746627|18652223|P3|STARTED|Overall Study||30
7577751|NCT02746627|18652224|P2|STARTED|Overall Study||30
7577752|NCT02746627|18652225|P1|STARTED|Overall Study||60
7577753|NCT02746575|18652248|P1|NOT COMPLETED|Overall Study||50
7577754|NCT02746575|18652248|P1|COMPLETED|Overall Study||20
7577755|NCT02746575|18652248|P1|STARTED|Overall Study||70
7577756|NCT02746406|18652252|P1|NOT COMPLETED|Overall Study||0
7577757|NCT02746406|18652252|P1|COMPLETED|Overall Study||5
7577758|NCT02746406|18652252|P1|STARTED|Overall Study||5
7577759|NCT02746263|18652258|P2|NOT COMPLETED|Overall Study||0
7577760|NCT02746263|18652259|P1|NOT COMPLETED|Overall Study||0
7577761|NCT02746263|18652258|P2|COMPLETED|Overall Study||1
7577762|NCT02746263|18652259|P1|COMPLETED|Overall Study||0
7577763|NCT02746263|18652258|P2|Per Protocol Analysis Set|Overall Study||0
7577764|NCT02746263|18652259|P1|Per Protocol Analysis Set|Overall Study||0
7577765|NCT02746263|18652258|P2|STARTED|Overall Study||1
7577766|NCT02746263|18652259|P1|STARTED|Overall Study||0
7577767|NCT02746107|18652265|P1|NOT COMPLETED|Overall Study||0
7577768|NCT02746107|18652265|P1|COMPLETED|Overall Study||968
7577769|NCT02746107|18652265|P1|CHA2DS2-VASC Score = 5|Overall Study||192
7577770|NCT02746107|18652265|P1|CHA2DS2-VASC Score = 4|Overall Study||197
7577771|NCT02746107|18652265|P1|CHA2DS2-VASC Score = 3|Overall Study||195
7577772|NCT02746107|18652265|P1|CHA2DS2-VASC Score = 2|Overall Study||189
7577773|NCT02746107|18652265|P1|CHA2DS2-VASC Score = 1|Overall Study||195
7577774|NCT02746107|18652265|P1|Target=Physician|Overall Study||482
7577775|NCT02746107|18652265|P1|Target=Patient|Overall Study||486
7577776|NCT02746107|18652265|P1|5year Risk Estimate|Overall Study||485
7577777|NCT02746107|18652265|P1|1year Risk Estimate|Overall Study||483
7577778|NCT02746107|18652265|P1|1 Diagram DA|Overall Study||486
7577779|NCT02746107|18652265|P1|2 Diagrams DA|Overall Study||482
7577780|NCT02746107|18652265|P1|STARTED|Overall Study||968
7577781|NCT02745626|18652283|P3|NOT COMPLETED|Overall Study||3
7577782|NCT02745626|18652284|P2|NOT COMPLETED|Overall Study||6
7577783|NCT02745626|18652285|P1|NOT COMPLETED|Overall Study||3
7577784|NCT02745626|18652283|P3|COMPLETED|Overall Study||19
7577785|NCT02745626|18652284|P2|COMPLETED|Overall Study||16
7577786|NCT02745626|18652285|P1|COMPLETED|Overall Study||21
7577787|NCT02745626|18652283|P3|STARTED|Overall Study||22
7577788|NCT02745626|18652284|P2|STARTED|Overall Study||22
7577789|NCT02745626|18652285|P1|STARTED|Overall Study||24
7577790|NCT02745535|18652311|P1|NOT COMPLETED|Overall Study||6
7577791|NCT02745535|18652311|P1|COMPLETED|Overall Study|Completed 12 weeks of study medication per protocol|71
7577792|NCT02745535|18652311|P1|Sustained Virologic Repsonse|Overall Study|Sustained Virologic response measured 24 weeks after completing study medication|70
7577793|NCT02745535|18652311|P1|STARTED|Overall Study||77
7577794|NCT02745392|18652323|P4|NOT COMPLETED|Overall Study||0
7577795|NCT02745392|18652324|P3|NOT COMPLETED|Overall Study||0
7577796|NCT02745392|18652325|P2|NOT COMPLETED|Overall Study||1
7577797|NCT02745392|18652326|P1|NOT COMPLETED|Overall Study||0
7577798|NCT02745392|18652323|P4|COMPLETED|Overall Study||92
7577799|NCT02745392|18652324|P3|COMPLETED|Overall Study||92
7577800|NCT02745392|18652325|P2|COMPLETED|Overall Study||89
7577801|NCT02745392|18652326|P1|COMPLETED|Overall Study||91
7577802|NCT02745392|18652323|P4|STARTED|Overall Study||92
7577803|NCT02745392|18652324|P3|STARTED|Overall Study||92
7577804|NCT02745392|18652325|P2|STARTED|Overall Study||90
7577805|NCT02745392|18652326|P1|STARTED|Overall Study||91
7577806|NCT02745353|18652342|P2|NOT COMPLETED|Second Intervention (2 Weeks)||1
7577807|NCT02745353|18652343|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
7577808|NCT02745353|18652342|P2|COMPLETED|Second Intervention (2 Weeks)||0
7577809|NCT02745353|18652343|P1|COMPLETED|Second Intervention (2 Weeks)||1
7577810|NCT02745353|18652342|P2|STARTED|Second Intervention (2 Weeks)||1
7577811|NCT02745353|18652343|P1|STARTED|Second Intervention (2 Weeks)||1
7577812|NCT02745353|18652342|P2|NOT COMPLETED|Washout (3 Days)||0
7577813|NCT02745353|18652343|P1|NOT COMPLETED|Washout (3 Days)||0
7577814|NCT02745353|18652342|P2|COMPLETED|Washout (3 Days)||1
7577815|NCT02745353|18652343|P1|COMPLETED|Washout (3 Days)||1
7577816|NCT02745353|18652342|P2|STARTED|Washout (3 Days)||1
7577817|NCT02745353|18652343|P1|STARTED|Washout (3 Days)||1
7577818|NCT02745353|18652342|P2|NOT COMPLETED|First Intervention (2 Weeks)||2
7577819|NCT02745353|18652343|P1|NOT COMPLETED|First Intervention (2 Weeks)||3
7577820|NCT02745353|18652342|P2|COMPLETED|First Intervention (2 Weeks)||1
7577821|NCT02745353|18652343|P1|COMPLETED|First Intervention (2 Weeks)||1
7577822|NCT02745353|18652342|P2|STARTED|First Intervention (2 Weeks)||3
7577823|NCT02745353|18652343|P1|STARTED|First Intervention (2 Weeks)||4
7577824|NCT02745210|18652351|P2|NOT COMPLETED|Overall Study||0
7577825|NCT02745210|18652352|P1|NOT COMPLETED|Overall Study||0
7577826|NCT02745210|18652351|P2|COMPLETED|Overall Study||9
7577827|NCT02745210|18652352|P1|COMPLETED|Overall Study||0
7577828|NCT02745210|18652351|P2|STARTED|Overall Study||9
7577829|NCT02745210|18652352|P1|STARTED|Overall Study||0
7577830|NCT02745145|18652359|P3|NOT COMPLETED|Overall Study||9
7577831|NCT02745145|18652360|P2|NOT COMPLETED|Overall Study||5
7577832|NCT02745145|18652361|P1|NOT COMPLETED|Overall Study||10
7577833|NCT02745145|18652359|P3|COMPLETED|Overall Study||0
7577834|NCT02745145|18652360|P2|COMPLETED|Overall Study||0
7577835|NCT02745145|18652361|P1|COMPLETED|Overall Study||0
7577836|NCT02745145|18652359|P3|STARTED|Overall Study||9
7577837|NCT02745145|18652360|P2|STARTED|Overall Study||5
7577838|NCT02745145|18652361|P1|STARTED|Overall Study||10
7577839|NCT02745119|18652400|P4|NOT COMPLETED|Overall Study||277
7577840|NCT02745119|18652401|P3|NOT COMPLETED|Overall Study||146
7577841|NCT02745119|18652402|P2|NOT COMPLETED|Overall Study||274
7577842|NCT02745119|18652403|P1|NOT COMPLETED|Overall Study||145
7577843|NCT02745119|18652400|P4|COMPLETED|Overall Study||0
7577844|NCT02745119|18652401|P3|COMPLETED|Overall Study||0
7577845|NCT02745119|18652402|P2|COMPLETED|Overall Study||0
7577846|NCT02745119|18652403|P1|COMPLETED|Overall Study||0
7577847|NCT02745119|18652400|P4|STARTED|Overall Study||277
7577848|NCT02745119|18652401|P3|STARTED|Overall Study||146
7577849|NCT02745119|18652402|P2|STARTED|Overall Study||274
7577850|NCT02745119|18652403|P1|STARTED|Overall Study||145
7577851|NCT02744898|18652425|P1|NOT COMPLETED|Overall Study||4
7577852|NCT02744898|18652425|P1|COMPLETED|Overall Study||19
7577853|NCT02744898|18652425|P1|STARTED|Overall Study||23
7577854|NCT02744846|18652429|P1|NOT COMPLETED|10 Year Outcome Assessment||305820
7577855|NCT02744846|18652429|P1|COMPLETED|10 Year Outcome Assessment||56730
7577856|NCT02744846|18652429|P1|Exclude Ineligible Patients|10 Year Outcome Assessment|Loss to follow-up, patients not yet 9 years, or systems that only had data from 2009 to 2016 or less|305820
7577857|NCT02744846|18652429|P1|STARTED|10 Year Outcome Assessment||362550
7577858|NCT02744846|18652429|P1|NOT COMPLETED|5 Year Outcome Assessment||319189
7577859|NCT02744846|18652429|P1|COMPLETED|5 Year Outcome Assessment|Number of patients that meet eligibility criteria|362550
7577860|NCT02744846|18652429|P1|Excluded Ineligible Patients|5 Year Outcome Assessment|Includes lost to follow-up and patients that had not reached age 4 years by end of study period|319189
7577861|NCT02744846|18652429|P1|STARTED|5 Year Outcome Assessment||681739
7577862|NCT02744755|18652439|P2|NOT COMPLETED|Study Period 2||8
7577863|NCT02744755|18652440|P1|NOT COMPLETED|Study Period 2||14
7577864|NCT02744755|18652439|P2|COMPLETED|Study Period 2||158
7577865|NCT02744755|18652440|P1|COMPLETED|Study Period 2||145
7577866|NCT02744755|18652439|P2|STARTED|Study Period 2||166
7577867|NCT02744755|18652440|P1|STARTED|Study Period 2||159
7577868|NCT02744755|18652439|P2|NOT COMPLETED|Study Period 1||8
7577869|NCT02744755|18652440|P1|NOT COMPLETED|Study Period 1||14
7577870|NCT02744755|18652439|P2|COMPLETED|Study Period 1||168
7577871|NCT02744755|18652440|P1|COMPLETED|Study Period 1||163
7577872|NCT02744755|18652439|P2|STARTED|Study Period 1||176
7577873|NCT02744755|18652440|P1|STARTED|Study Period 1||177
7577874|NCT02744534|18652494|P1|NOT COMPLETED|Overall Study||0
7577875|NCT02744534|18652494|P1|COMPLETED|Overall Study||21
7577876|NCT02744534|18652494|P1|STARTED|Overall Study||21
7577877|NCT02744391|18652500|P1|NOT COMPLETED|Overall Study||14
7577878|NCT02744391|18652500|P1|COMPLETED|Overall Study||33
7577879|NCT02744391|18652500|P1|STARTED|Overall Study||47
7577880|NCT02744352|18652524|P2|NOT COMPLETED|Overall Study||0
7577881|NCT02744352|18652525|P1|NOT COMPLETED|Overall Study||0
7577882|NCT02744352|18652524|P2|COMPLETED|Overall Study||4
7577883|NCT02744352|18652525|P1|COMPLETED|Overall Study||4
7577884|NCT02744352|18652524|P2|STARTED|Overall Study||4
7577885|NCT02744352|18652525|P1|STARTED|Overall Study||4
7577886|NCT02744066|18652541|P2|NOT COMPLETED|Overall Study||5
7577887|NCT02744066|18652542|P1|NOT COMPLETED|Overall Study||0
7577888|NCT02744066|18652541|P2|COMPLETED|Overall Study||25
7577889|NCT02744066|18652542|P1|COMPLETED|Overall Study||25
7577890|NCT02744066|18652541|P2|STARTED|Overall Study||30
7577891|NCT02744066|18652542|P1|STARTED|Overall Study||25
7577892|NCT02743962|18652552|P2|NOT COMPLETED|Overall Study||0
7577893|NCT02743962|18652553|P1|NOT COMPLETED|Overall Study||1
7577894|NCT02743962|18652552|P2|COMPLETED|Overall Study||5
7577895|NCT02743962|18652553|P1|COMPLETED|Overall Study||4
7577896|NCT02743962|18652552|P2|STARTED|Overall Study||5
7577897|NCT02743962|18652553|P1|STARTED|Overall Study||5
7577898|NCT02743949|18652575|P3|NOT COMPLETED|Overall Study||3
7577899|NCT02743949|18652576|P2|NOT COMPLETED|Overall Study||1
7577900|NCT02743949|18652577|P1|NOT COMPLETED|Overall Study||4
7577901|NCT02743949|18652575|P3|COMPLETED|Overall Study||82
7577902|NCT02743949|18652576|P2|COMPLETED|Overall Study||84
7577903|NCT02743949|18652577|P1|COMPLETED|Overall Study||82
7577904|NCT02743949|18652575|P3|STARTED|Overall Study||85
7577905|NCT02743949|18652576|P2|STARTED|Overall Study||85
7577906|NCT02743949|18652577|P1|STARTED|Overall Study||86
7577907|NCT02743936|18652590|P2|NOT COMPLETED|Overall Study||0
7577908|NCT02743936|18652591|P1|NOT COMPLETED|Overall Study||0
7577909|NCT02743936|18652590|P2|COMPLETED|Overall Study||32
7577910|NCT02743936|18652591|P1|COMPLETED|Overall Study||32
7577911|NCT02743936|18652590|P2|STARTED|Overall Study||32
7577912|NCT02743936|18652591|P1|STARTED|Overall Study||32
7577913|NCT02743780|18652604|P5|NOT COMPLETED|Part 3 (7 Days)||0
7577914|NCT02743780|18652605|P4|NOT COMPLETED|Part 3 (7 Days)||0
7577915|NCT02743780|18652606|P3|NOT COMPLETED|Part 3 (7 Days)||1
7577916|NCT02743780|18652607|P2|NOT COMPLETED|Part 3 (7 Days)||0
7577917|NCT02743780|18652608|P1|NOT COMPLETED|Part 3 (7 Days)||0
7577918|NCT02743780|18652604|P5|COMPLETED|Part 3 (7 Days)||25
7577919|NCT02743780|18652605|P4|COMPLETED|Part 3 (7 Days)||0
7577920|NCT02743780|18652606|P3|COMPLETED|Part 3 (7 Days)||24
7577921|NCT02743780|18652607|P2|COMPLETED|Part 3 (7 Days)||0
7577922|NCT02743780|18652608|P1|COMPLETED|Part 3 (7 Days)||0
7577923|NCT02743780|18652604|P5|STARTED|Part 3 (7 Days)||25
7577924|NCT02743780|18652605|P4|STARTED|Part 3 (7 Days)||0
7577925|NCT02743780|18652606|P3|STARTED|Part 3 (7 Days)||25
7577926|NCT02743780|18652607|P2|STARTED|Part 3 (7 Days)||0
7577927|NCT02743780|18652608|P1|STARTED|Part 3 (7 Days)||0
7577928|NCT02743780|18652604|P5|NOT COMPLETED|Part 2 (8 Days)||0
7577929|NCT02743780|18652605|P4|NOT COMPLETED|Part 2 (8 Days)||0
7577930|NCT02743780|18652606|P3|NOT COMPLETED|Part 2 (8 Days)||0
7577931|NCT02743780|18652607|P2|NOT COMPLETED|Part 2 (8 Days)||0
7577932|NCT02743780|18652608|P1|NOT COMPLETED|Part 2 (8 Days)||0
7577933|NCT02743780|18652604|P5|COMPLETED|Part 2 (8 Days)||4
7577934|NCT02743780|18652605|P4|COMPLETED|Part 2 (8 Days)||0
7577935|NCT02743780|18652606|P3|COMPLETED|Part 2 (8 Days)||6
7577936|NCT02743780|18652607|P2|COMPLETED|Part 2 (8 Days)||6
7577937|NCT02743780|18652608|P1|COMPLETED|Part 2 (8 Days)||0
7577938|NCT02743780|18652604|P5|STARTED|Part 2 (8 Days)||4
7577939|NCT02743780|18652605|P4|STARTED|Part 2 (8 Days)||0
7577940|NCT02743780|18652606|P3|STARTED|Part 2 (8 Days)||6
7577941|NCT02743780|18652607|P2|STARTED|Part 2 (8 Days)||6
7577942|NCT02743780|18652608|P1|STARTED|Part 2 (8 Days)||0
7577943|NCT02743780|18652604|P5|NOT COMPLETED|Part 1 (3 Days)||0
7577944|NCT02743780|18652605|P4|NOT COMPLETED|Part 1 (3 Days)||0
7577945|NCT02743780|18652606|P3|NOT COMPLETED|Part 1 (3 Days)||0
7577946|NCT02743780|18652607|P2|NOT COMPLETED|Part 1 (3 Days)||0
7577947|NCT02743780|18652608|P1|NOT COMPLETED|Part 1 (3 Days)||0
7577948|NCT02743780|18652604|P5|COMPLETED|Part 1 (3 Days)||8
7577949|NCT02743780|18652605|P4|COMPLETED|Part 1 (3 Days)||6
7577950|NCT02743780|18652606|P3|COMPLETED|Part 1 (3 Days)||6
7577951|NCT02743780|18652607|P2|COMPLETED|Part 1 (3 Days)||6
7577952|NCT02743780|18652608|P1|COMPLETED|Part 1 (3 Days)||6
7577953|NCT02743780|18652604|P5|STARTED|Part 1 (3 Days)||8
7577954|NCT02743780|18652605|P4|STARTED|Part 1 (3 Days)||6
7577955|NCT02743780|18652606|P3|STARTED|Part 1 (3 Days)||6
7577956|NCT02743780|18652607|P2|STARTED|Part 1 (3 Days)||6
7577957|NCT02743780|18652608|P1|STARTED|Part 1 (3 Days)||6
7577958|NCT02743702|18652655|P2|NOT COMPLETED|Overall Study||0
7577959|NCT02743702|18652656|P1|NOT COMPLETED|Overall Study||0
7577960|NCT02743702|18652655|P2|COMPLETED|Overall Study||10
7577961|NCT02743702|18652656|P1|COMPLETED|Overall Study||11
7577962|NCT02743702|18652655|P2|STARTED|Overall Study||10
7577963|NCT02743702|18652656|P1|STARTED|Overall Study||11
7577964|NCT02743520|18652662|P1|NOT COMPLETED|Overall Study||1
7577965|NCT02743520|18652662|P1|COMPLETED|Overall Study||85
7577966|NCT02743520|18652662|P1|STARTED|Overall Study||86
7577967|NCT02743377|18652672|P2|NOT COMPLETED|Overall Study||0
7577968|NCT02743377|18652673|P1|NOT COMPLETED|Overall Study||2
7577969|NCT02743377|18652672|P2|COMPLETED|Overall Study||6
7577970|NCT02743377|18652673|P1|COMPLETED|Overall Study||7
7577971|NCT02743377|18652672|P2|Whole Body PET Baseline & Blocked|Overall Study||2
7577972|NCT02743377|18652673|P1|Whole Body PET Baseline & Blocked|Overall Study||0
7577973|NCT02743377|18652672|P2|Whole Body PET Baseline With 11C Rolipra|Overall Study||4
7577974|NCT02743377|18652673|P1|Whole Body PET Baseline With 11C Rolipra|Overall Study||5
7577975|NCT02743377|18652672|P2|Brain PET With 11C Rolipram|Overall Study||3
7577976|NCT02743377|18652673|P1|Brain PET With 11C Rolipram|Overall Study||8
7577977|NCT02743377|18652672|P2|STARTED|Overall Study||6
7577978|NCT02743377|18652673|P1|STARTED|Overall Study||9
7577979|NCT02743312|18652701|P2|NOT COMPLETED|Overall Study||0
7577980|NCT02743312|18652702|P1|NOT COMPLETED|Overall Study||0
7577981|NCT02743312|18652701|P2|COMPLETED|Overall Study||2
7577982|NCT02743312|18652702|P1|COMPLETED|Overall Study||3
7577983|NCT02743312|18652701|P2|STARTED|Overall Study||2
7577984|NCT02743312|18652702|P1|STARTED|Overall Study||3
7577985|NCT02743221|18652735|P2|NOT COMPLETED|Overall Study||60
7577986|NCT02743221|18652736|P1|NOT COMPLETED|Overall Study||56
7577987|NCT02743221|18652735|P2|COMPLETED|Overall Study||17
7577988|NCT02743221|18652736|P1|COMPLETED|Overall Study||21
7577989|NCT02743221|18652735|P2|STARTED|Overall Study||77
7577990|NCT02743221|18652736|P1|STARTED|Overall Study||77
7577991|NCT02743117|18652752|P2|NOT COMPLETED|Overall Study||1
7577992|NCT02743117|18652753|P1|NOT COMPLETED|Overall Study||1
7577993|NCT02743117|18652752|P2|COMPLETED|Overall Study||240
7577994|NCT02743117|18652753|P1|COMPLETED|Overall Study||59
7577995|NCT02743117|18652752|P2|Treated|Overall Study||241
7577996|NCT02743117|18652753|P1|Treated|Overall Study||59
7577997|NCT02743117|18652752|P2|STARTED|Overall Study||241
7577998|NCT02743117|18652753|P1|STARTED|Overall Study||60
7577999|NCT02743078|18652767|P1|NOT COMPLETED|Overall Study||0
7578000|NCT02743078|18652767|P1|COMPLETED|Overall Study||3
7578001|NCT02743078|18652767|P1|Eligible With Six-month Follow-up Data|Overall Study||3
7578002|NCT02743078|18652767|P1|Eligible Populaton|Overall Study||3
7578003|NCT02743078|18652767|P1|STARTED|Overall Study||3
7578004|NCT02742987|18652777|P2|NOT COMPLETED|Overall Study||0
7578005|NCT02742987|18652778|P1|NOT COMPLETED|Overall Study||0
7578006|NCT02742987|18652777|P2|COMPLETED|Overall Study||21
7578007|NCT02742987|18652778|P1|COMPLETED|Overall Study||21
7578008|NCT02742987|18652777|P2|STARTED|Overall Study||21
7578009|NCT02742987|18652778|P1|STARTED|Overall Study||21
7578010|NCT02742818|18652786|P2|NOT COMPLETED|Overall Study||2
7578011|NCT02742818|18652787|P1|NOT COMPLETED|Overall Study||0
7578012|NCT02742818|18652786|P2|COMPLETED|Overall Study||23
7578013|NCT02742818|18652787|P1|COMPLETED|Overall Study||25
7578014|NCT02742818|18652786|P2|STARTED|Overall Study||25
7578015|NCT02742818|18652787|P1|STARTED|Overall Study||25
7578016|NCT02742766|18652820|P19|NOT COMPLETED|Part 3 (Up to 36 Days)||0
7578017|NCT02742766|18652821|P18|NOT COMPLETED|Part 3 (Up to 36 Days)||0
7578018|NCT02742766|18652822|P17|NOT COMPLETED|Part 3 (Up to 36 Days)||0
7578019|NCT02742766|18652823|P16|NOT COMPLETED|Part 3 (Up to 36 Days)||0
7578020|NCT02742766|18652824|P15|NOT COMPLETED|Part 3 (Up to 36 Days)||0
7578021|NCT02742766|18652825|P14|NOT COMPLETED|Part 3 (Up to 36 Days)||0
7578022|NCT02742766|18652826|P13|NOT COMPLETED|Part 3 (Up to 36 Days)||0
7578023|NCT02742766|18652827|P12|NOT COMPLETED|Part 3 (Up to 36 Days)||0
7578024|NCT02742766|18652828|P11|NOT COMPLETED|Part 3 (Up to 36 Days)||0
7578025|NCT02742766|18652829|P10|NOT COMPLETED|Part 3 (Up to 36 Days)||0
7578026|NCT02742766|18652830|P9|NOT COMPLETED|Part 3 (Up to 36 Days)||0
7578027|NCT02742766|18652831|P8|NOT COMPLETED|Part 3 (Up to 36 Days)||0
7578028|NCT02742766|18652832|P7|NOT COMPLETED|Part 3 (Up to 36 Days)||0
7578029|NCT02742766|18652833|P6|NOT COMPLETED|Part 3 (Up to 36 Days)||0
7578030|NCT02742766|18652834|P5|NOT COMPLETED|Part 3 (Up to 36 Days)||0
7578031|NCT02742766|18652835|P4|NOT COMPLETED|Part 3 (Up to 36 Days)||0
7578032|NCT02742766|18652836|P3|NOT COMPLETED|Part 3 (Up to 36 Days)||0
7578033|NCT02742766|18652837|P2|NOT COMPLETED|Part 3 (Up to 36 Days)||0
7578034|NCT02742766|18652838|P1|NOT COMPLETED|Part 3 (Up to 36 Days)||0
7578035|NCT02742766|18652820|P19|COMPLETED|Part 3 (Up to 36 Days)||0
7578036|NCT02742766|18652821|P18|COMPLETED|Part 3 (Up to 36 Days)||0
7578037|NCT02742766|18652822|P17|COMPLETED|Part 3 (Up to 36 Days)||0
7578038|NCT02742766|18652823|P16|COMPLETED|Part 3 (Up to 36 Days)||0
7578039|NCT02742766|18652824|P15|COMPLETED|Part 3 (Up to 36 Days)||0
7578040|NCT02742766|18652825|P14|COMPLETED|Part 3 (Up to 36 Days)||0
7578041|NCT02742766|18652826|P13|COMPLETED|Part 3 (Up to 36 Days)||0
7578042|NCT02742766|18652827|P12|COMPLETED|Part 3 (Up to 36 Days)||0
7578043|NCT02742766|18652828|P11|COMPLETED|Part 3 (Up to 36 Days)||0
7578044|NCT02742766|18652829|P10|COMPLETED|Part 3 (Up to 36 Days)||0
7578045|NCT02742766|18652830|P9|COMPLETED|Part 3 (Up to 36 Days)||0
7578046|NCT02742766|18652831|P8|COMPLETED|Part 3 (Up to 36 Days)||0
7578047|NCT02742766|18652832|P7|COMPLETED|Part 3 (Up to 36 Days)||0
7578048|NCT02742766|18652833|P6|COMPLETED|Part 3 (Up to 36 Days)||0
7578049|NCT02742766|18652834|P5|COMPLETED|Part 3 (Up to 36 Days)||0
7578050|NCT02742766|18652835|P4|COMPLETED|Part 3 (Up to 36 Days)||0
7578051|NCT02742766|18652836|P3|COMPLETED|Part 3 (Up to 36 Days)||0
7578052|NCT02742766|18652837|P2|COMPLETED|Part 3 (Up to 36 Days)||0
7578053|NCT02742766|18652838|P1|COMPLETED|Part 3 (Up to 36 Days)||0
7578054|NCT02742766|18652820|P19|STARTED|Part 3 (Up to 36 Days)||0
7578055|NCT02742766|18652821|P18|STARTED|Part 3 (Up to 36 Days)||0
7578056|NCT02742766|18652822|P17|STARTED|Part 3 (Up to 36 Days)||0
7578057|NCT02742766|18652823|P16|STARTED|Part 3 (Up to 36 Days)||0
7578058|NCT02742766|18652824|P15|STARTED|Part 3 (Up to 36 Days)||0
7578059|NCT02742766|18652825|P14|STARTED|Part 3 (Up to 36 Days)||0
7578060|NCT02742766|18652826|P13|STARTED|Part 3 (Up to 36 Days)||0
7578061|NCT02742766|18652827|P12|STARTED|Part 3 (Up to 36 Days)||0
7578062|NCT02742766|18652828|P11|STARTED|Part 3 (Up to 36 Days)||0
7578063|NCT02742766|18652829|P10|STARTED|Part 3 (Up to 36 Days)||0
7578064|NCT02742766|18652830|P9|STARTED|Part 3 (Up to 36 Days)||0
7578065|NCT02742766|18652831|P8|STARTED|Part 3 (Up to 36 Days)||0
7578066|NCT02742766|18652832|P7|STARTED|Part 3 (Up to 36 Days)||0
7578067|NCT02742766|18652833|P6|STARTED|Part 3 (Up to 36 Days)||0
7578068|NCT02742766|18652834|P5|STARTED|Part 3 (Up to 36 Days)||0
7578069|NCT02742766|18652835|P4|STARTED|Part 3 (Up to 36 Days)||0
7578070|NCT02742766|18652836|P3|STARTED|Part 3 (Up to 36 Days)||0
7578071|NCT02742766|18652837|P2|STARTED|Part 3 (Up to 36 Days)||0
7578072|NCT02742766|18652838|P1|STARTED|Part 3 (Up to 36 Days)||0
7578073|NCT02742766|18652820|P19|NOT COMPLETED|Part 2 (Up to 22 Days)||0
7578074|NCT02742766|18652821|P18|NOT COMPLETED|Part 2 (Up to 22 Days)||0
7578075|NCT02742766|18652822|P17|NOT COMPLETED|Part 2 (Up to 22 Days)||0
7578076|NCT02742766|18652823|P16|NOT COMPLETED|Part 2 (Up to 22 Days)||1
7578077|NCT02742766|18652824|P15|NOT COMPLETED|Part 2 (Up to 22 Days)||0
7578078|NCT02742766|18652825|P14|NOT COMPLETED|Part 2 (Up to 22 Days)||6
7578079|NCT02742766|18652826|P13|NOT COMPLETED|Part 2 (Up to 22 Days)||2
7578080|NCT02742766|18652827|P12|NOT COMPLETED|Part 2 (Up to 22 Days)||0
7578081|NCT02742766|18652828|P11|NOT COMPLETED|Part 2 (Up to 22 Days)||0
7578082|NCT02742766|18652829|P10|NOT COMPLETED|Part 2 (Up to 22 Days)||0
7578083|NCT02742766|18652830|P9|NOT COMPLETED|Part 2 (Up to 22 Days)||0
7578084|NCT02742766|18652831|P8|NOT COMPLETED|Part 2 (Up to 22 Days)||0
7578085|NCT02742766|18652832|P7|NOT COMPLETED|Part 2 (Up to 22 Days)||0
7578086|NCT02742766|18652833|P6|NOT COMPLETED|Part 2 (Up to 22 Days)||0
7578087|NCT02742766|18652834|P5|NOT COMPLETED|Part 2 (Up to 22 Days)||0
7578088|NCT02742766|18652835|P4|NOT COMPLETED|Part 2 (Up to 22 Days)||0
7578089|NCT02742766|18652836|P3|NOT COMPLETED|Part 2 (Up to 22 Days)||0
7578090|NCT02742766|18652837|P2|NOT COMPLETED|Part 2 (Up to 22 Days)||0
7578091|NCT02742766|18652838|P1|NOT COMPLETED|Part 2 (Up to 22 Days)||0
7578092|NCT02742766|18652820|P19|COMPLETED|Part 2 (Up to 22 Days)||0
7578093|NCT02742766|18652821|P18|COMPLETED|Part 2 (Up to 22 Days)||0
7578094|NCT02742766|18652822|P17|COMPLETED|Part 2 (Up to 22 Days)||0
7578095|NCT02742766|18652823|P16|COMPLETED|Part 2 (Up to 22 Days)|Day 4 study medication interrupted due to an AE and eventually withdrew from study on Day 5.|5
7578096|NCT02742766|18652824|P15|COMPLETED|Part 2 (Up to 22 Days)||6
7578097|NCT02742766|18652825|P14|COMPLETED|Part 2 (Up to 22 Days)||0
7578098|NCT02742766|18652826|P13|COMPLETED|Part 2 (Up to 22 Days)||4
7578099|NCT02742766|18652827|P12|COMPLETED|Part 2 (Up to 22 Days)||0
7578100|NCT02742766|18652828|P11|COMPLETED|Part 2 (Up to 22 Days)||0
7578101|NCT02742766|18652829|P10|COMPLETED|Part 2 (Up to 22 Days)||0
7578102|NCT02742766|18652830|P9|COMPLETED|Part 2 (Up to 22 Days)||0
7578103|NCT02742766|18652831|P8|COMPLETED|Part 2 (Up to 22 Days)||0
7578104|NCT02742766|18652832|P7|COMPLETED|Part 2 (Up to 22 Days)||0
7578105|NCT02742766|18652833|P6|COMPLETED|Part 2 (Up to 22 Days)||0
7578106|NCT02742766|18652834|P5|COMPLETED|Part 2 (Up to 22 Days)||0
7578107|NCT02742766|18652835|P4|COMPLETED|Part 2 (Up to 22 Days)||0
7578108|NCT02742766|18652836|P3|COMPLETED|Part 2 (Up to 22 Days)||0
7578109|NCT02742766|18652837|P2|COMPLETED|Part 2 (Up to 22 Days)||0
7578110|NCT02742766|18652838|P1|COMPLETED|Part 2 (Up to 22 Days)||0
7578111|NCT02742766|18652820|P19|STARTED|Part 2 (Up to 22 Days)||0
7578112|NCT02742766|18652821|P18|STARTED|Part 2 (Up to 22 Days)||0
7578113|NCT02742766|18652822|P17|STARTED|Part 2 (Up to 22 Days)||0
7578114|NCT02742766|18652823|P16|STARTED|Part 2 (Up to 22 Days)||6
7578115|NCT02742766|18652824|P15|STARTED|Part 2 (Up to 22 Days)||6
7578116|NCT02742766|18652825|P14|STARTED|Part 2 (Up to 22 Days)||6
7578117|NCT02742766|18652826|P13|STARTED|Part 2 (Up to 22 Days)||6
7578118|NCT02742766|18652827|P12|STARTED|Part 2 (Up to 22 Days)||0
7578119|NCT02742766|18652828|P11|STARTED|Part 2 (Up to 22 Days)||0
7578120|NCT02742766|18652829|P10|STARTED|Part 2 (Up to 22 Days)||0
7578121|NCT02742766|18652830|P9|STARTED|Part 2 (Up to 22 Days)||0
7578122|NCT02742766|18652831|P8|STARTED|Part 2 (Up to 22 Days)||0
7578123|NCT02742766|18652832|P7|STARTED|Part 2 (Up to 22 Days)||0
7578124|NCT02742766|18652833|P6|STARTED|Part 2 (Up to 22 Days)||0
7578125|NCT02742766|18652834|P5|STARTED|Part 2 (Up to 22 Days)||0
7578126|NCT02742766|18652835|P4|STARTED|Part 2 (Up to 22 Days)||0
7578127|NCT02742766|18652836|P3|STARTED|Part 2 (Up to 22 Days)||0
7578128|NCT02742766|18652837|P2|STARTED|Part 2 (Up to 22 Days)||0
7578129|NCT02742766|18652838|P1|STARTED|Part 2 (Up to 22 Days)||0
7578130|NCT02742766|18652820|P19|NOT COMPLETED|Part 1 (Up to 8 Days)||0
7578131|NCT02742766|18652821|P18|NOT COMPLETED|Part 1 (Up to 8 Days)||0
7578132|NCT02742766|18652822|P17|NOT COMPLETED|Part 1 (Up to 8 Days)||0
7578133|NCT02742766|18652823|P16|NOT COMPLETED|Part 1 (Up to 8 Days)||0
7578134|NCT02742766|18652824|P15|NOT COMPLETED|Part 1 (Up to 8 Days)||0
7578135|NCT02742766|18652825|P14|NOT COMPLETED|Part 1 (Up to 8 Days)||0
7578136|NCT02742766|18652826|P13|NOT COMPLETED|Part 1 (Up to 8 Days)||0
7578137|NCT02742766|18652827|P12|NOT COMPLETED|Part 1 (Up to 8 Days)||0
7578138|NCT02742766|18652828|P11|NOT COMPLETED|Part 1 (Up to 8 Days)||0
7578139|NCT02742766|18652829|P10|NOT COMPLETED|Part 1 (Up to 8 Days)||0
7578140|NCT02742766|18652830|P9|NOT COMPLETED|Part 1 (Up to 8 Days)||0
7578141|NCT02742766|18652831|P8|NOT COMPLETED|Part 1 (Up to 8 Days)||0
7578142|NCT02742766|18652832|P7|NOT COMPLETED|Part 1 (Up to 8 Days)||0
7578143|NCT02742766|18652833|P6|NOT COMPLETED|Part 1 (Up to 8 Days)||0
7578144|NCT02742766|18652834|P5|NOT COMPLETED|Part 1 (Up to 8 Days)||0
7578145|NCT02742766|18652835|P4|NOT COMPLETED|Part 1 (Up to 8 Days)||0
7578146|NCT02742766|18652836|P3|NOT COMPLETED|Part 1 (Up to 8 Days)||0
7578147|NCT02742766|18652837|P2|NOT COMPLETED|Part 1 (Up to 8 Days)||0
7578148|NCT02742766|18652838|P1|NOT COMPLETED|Part 1 (Up to 8 Days)||0
7578149|NCT02742766|18652820|P19|COMPLETED|Part 1 (Up to 8 Days)||0
7578150|NCT02742766|18652821|P18|COMPLETED|Part 1 (Up to 8 Days)||0
7578151|NCT02742766|18652822|P17|COMPLETED|Part 1 (Up to 8 Days)||0
7578152|NCT02742766|18652823|P16|COMPLETED|Part 1 (Up to 8 Days)||0
7578153|NCT02742766|18652824|P15|COMPLETED|Part 1 (Up to 8 Days)||0
7578154|NCT02742766|18652825|P14|COMPLETED|Part 1 (Up to 8 Days)||0
7578155|NCT02742766|18652826|P13|COMPLETED|Part 1 (Up to 8 Days)||0
7578156|NCT02742766|18652827|P12|COMPLETED|Part 1 (Up to 8 Days)||6
7578157|NCT02742766|18652828|P11|COMPLETED|Part 1 (Up to 8 Days)||6
7578158|NCT02742766|18652829|P10|COMPLETED|Part 1 (Up to 8 Days)||0
7578159|NCT02742766|18652830|P9|COMPLETED|Part 1 (Up to 8 Days)||6
7578160|NCT02742766|18652831|P8|COMPLETED|Part 1 (Up to 8 Days)||6
7578161|NCT02742766|18652832|P7|COMPLETED|Part 1 (Up to 8 Days)||6
7578162|NCT02742766|18652833|P6|COMPLETED|Part 1 (Up to 8 Days)||6
7578163|NCT02742766|18652834|P5|COMPLETED|Part 1 (Up to 8 Days)||6
7578164|NCT02742766|18652835|P4|COMPLETED|Part 1 (Up to 8 Days)||6
7578165|NCT02742766|18652836|P3|COMPLETED|Part 1 (Up to 8 Days)||6
7578166|NCT02742766|18652837|P2|COMPLETED|Part 1 (Up to 8 Days)||6
7578167|NCT02742766|18652838|P1|COMPLETED|Part 1 (Up to 8 Days)||20
7578168|NCT02742766|18652820|P19|STARTED|Part 1 (Up to 8 Days)||0
7578169|NCT02742766|18652821|P18|STARTED|Part 1 (Up to 8 Days)||0
7578170|NCT02742766|18652822|P17|STARTED|Part 1 (Up to 8 Days)||0
7578171|NCT02742766|18652823|P16|STARTED|Part 1 (Up to 8 Days)||0
7578172|NCT02742766|18652824|P15|STARTED|Part 1 (Up to 8 Days)||0
7578173|NCT02742766|18652825|P14|STARTED|Part 1 (Up to 8 Days)||0
7578174|NCT02742766|18652826|P13|STARTED|Part 1 (Up to 8 Days)||0
7578175|NCT02742766|18652827|P12|STARTED|Part 1 (Up to 8 Days)||6
7578176|NCT02742766|18652828|P11|STARTED|Part 1 (Up to 8 Days)||6
7578177|NCT02742766|18652829|P10|STARTED|Part 1 (Up to 8 Days)||0
7578178|NCT02742766|18652830|P9|STARTED|Part 1 (Up to 8 Days)||6
7578179|NCT02742766|18652831|P8|STARTED|Part 1 (Up to 8 Days)||6
7578180|NCT02742766|18652832|P7|STARTED|Part 1 (Up to 8 Days)||6
7578181|NCT02742766|18652833|P6|STARTED|Part 1 (Up to 8 Days)||6
7578182|NCT02742766|18652834|P5|STARTED|Part 1 (Up to 8 Days)||6
7578183|NCT02742766|18652835|P4|STARTED|Part 1 (Up to 8 Days)||6
7578184|NCT02742766|18652836|P3|STARTED|Part 1 (Up to 8 Days)||6
7578185|NCT02742766|18652837|P2|STARTED|Part 1 (Up to 8 Days)||6
7578186|NCT02742766|18652838|P1|STARTED|Part 1 (Up to 8 Days)||20
7578187|NCT02742649|18653098|P5|NOT COMPLETED|Open-Label Period||1
7578188|NCT02742649|18653099|P4|NOT COMPLETED|Open-Label Period||0
7578189|NCT02742649|18653100|P3|NOT COMPLETED|Open-Label Period||0
7578190|NCT02742649|18653101|P2|NOT COMPLETED|Open-Label Period||0
7578191|NCT02742649|18653102|P1|NOT COMPLETED|Open-Label Period||0
7578192|NCT02742649|18653098|P5|COMPLETED|Open-Label Period||48
7578193|NCT02742649|18653099|P4|COMPLETED|Open-Label Period||0
7578194|NCT02742649|18653100|P3|COMPLETED|Open-Label Period||0
7578195|NCT02742649|18653101|P2|COMPLETED|Open-Label Period||0
7578196|NCT02742649|18653102|P1|COMPLETED|Open-Label Period||0
7578197|NCT02742649|18653098|P5|STARTED|Open-Label Period||49
7578198|NCT02742649|18653099|P4|STARTED|Open-Label Period||0
7578199|NCT02742649|18653100|P3|STARTED|Open-Label Period||0
7578200|NCT02742649|18653101|P2|STARTED|Open-Label Period||0
7578201|NCT02742649|18653102|P1|STARTED|Open-Label Period||0
7578202|NCT02742649|18653098|P5|NOT COMPLETED|Double-Blind Treatment Period||0
7578203|NCT02742649|18653099|P4|NOT COMPLETED|Double-Blind Treatment Period||0
7578204|NCT02742649|18653100|P3|NOT COMPLETED|Double-Blind Treatment Period||0
7578205|NCT02742649|18653101|P2|NOT COMPLETED|Double-Blind Treatment Period||1
7578206|NCT02742649|18653102|P1|NOT COMPLETED|Double-Blind Treatment Period||0
7578207|NCT02742649|18653098|P5|COMPLETED|Double-Blind Treatment Period||0
7578208|NCT02742649|18653099|P4|COMPLETED|Double-Blind Treatment Period||16
7578209|NCT02742649|18653100|P3|COMPLETED|Double-Blind Treatment Period||17
7578210|NCT02742649|18653101|P2|COMPLETED|Double-Blind Treatment Period||16
7578211|NCT02742649|18653102|P1|COMPLETED|Double-Blind Treatment Period||0
7578212|NCT02742649|18653098|P5|STARTED|Double-Blind Treatment Period||0
7578213|NCT02742649|18653099|P4|STARTED|Double-Blind Treatment Period||16
7578214|NCT02742649|18653100|P3|STARTED|Double-Blind Treatment Period||17
7578215|NCT02742649|18653101|P2|STARTED|Double-Blind Treatment Period||17
7578216|NCT02742649|18653102|P1|STARTED|Double-Blind Treatment Period||0
7578217|NCT02742649|18653098|P5|NOT COMPLETED|Pre-Randomization Washout Period||0
7578218|NCT02742649|18653099|P4|NOT COMPLETED|Pre-Randomization Washout Period||0
7578219|NCT02742649|18653100|P3|NOT COMPLETED|Pre-Randomization Washout Period||0
7578220|NCT02742649|18653101|P2|NOT COMPLETED|Pre-Randomization Washout Period||0
7578221|NCT02742649|18653102|P1|NOT COMPLETED|Pre-Randomization Washout Period||5
7578222|NCT02742649|18653098|P5|COMPLETED|Pre-Randomization Washout Period||0
7578223|NCT02742649|18653099|P4|COMPLETED|Pre-Randomization Washout Period||0
7578224|NCT02742649|18653100|P3|COMPLETED|Pre-Randomization Washout Period||0
7578225|NCT02742649|18653101|P2|COMPLETED|Pre-Randomization Washout Period||0
7578226|NCT02742649|18653102|P1|COMPLETED|Pre-Randomization Washout Period||50
7578227|NCT02742649|18653098|P5|STARTED|Pre-Randomization Washout Period||0
7578228|NCT02742649|18653099|P4|STARTED|Pre-Randomization Washout Period||0
7578229|NCT02742649|18653100|P3|STARTED|Pre-Randomization Washout Period||0
7578230|NCT02742649|18653101|P2|STARTED|Pre-Randomization Washout Period||0
7578231|NCT02742649|18653102|P1|STARTED|Pre-Randomization Washout Period||55
7578232|NCT02742532|18653130|P2|NOT COMPLETED|Overall Study||1
7578233|NCT02742532|18653131|P1|NOT COMPLETED|Overall Study||3
7578234|NCT02742532|18653130|P2|COMPLETED|Overall Study||31
7578235|NCT02742532|18653131|P1|COMPLETED|Overall Study||28
7578236|NCT02742532|18653130|P2|STARTED|Overall Study||32
7578237|NCT02742532|18653131|P1|STARTED|Overall Study||31
7578238|NCT02742519|18653141|P3|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||10
7578239|NCT02742519|18653142|P2|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
7578240|NCT02742519|18653143|P1|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
7578241|NCT02742519|18653141|P3|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
7578242|NCT02742519|18653142|P2|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
7578243|NCT02742519|18653143|P1|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
7578244|NCT02742519|18653141|P3|STARTED|Part 2 Open Label Period (32 Weeks)|Of 12 participants who completed DB period, only 10 entered OL period & 2 opted for commercial drug.|10
7578245|NCT02742519|18653142|P2|STARTED|Part 2 Open Label Period (32 Weeks)||0
7578246|NCT02742519|18653143|P1|STARTED|Part 2 Open Label Period (32 Weeks)||0
7578247|NCT02742519|18653141|P3|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
7578248|NCT02742519|18653142|P2|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
7578249|NCT02742519|18653143|P1|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
7578250|NCT02742519|18653141|P3|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
7578251|NCT02742519|18653142|P2|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||5
7578252|NCT02742519|18653143|P1|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||7
7578253|NCT02742519|18653141|P3|STARTED|Part 1 Treatment Period 2 (8 Weeks)||0
7578254|NCT02742519|18653142|P2|STARTED|Part 1 Treatment Period 2 (8 Weeks)||6
7578255|NCT02742519|18653143|P1|STARTED|Part 1 Treatment Period 2 (8 Weeks)||8
7578256|NCT02742519|18653141|P3|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
7578257|NCT02742519|18653142|P2|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
7578258|NCT02742519|18653143|P1|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
7578259|NCT02742519|18653141|P3|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
7578260|NCT02742519|18653142|P2|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||6
7578261|NCT02742519|18653143|P1|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||8
7578262|NCT02742519|18653141|P3|STARTED|Part 1 Treatment Period 1 (8 Weeks)||0
7578263|NCT02742519|18653142|P2|STARTED|Part 1 Treatment Period 1 (8 Weeks)||6
7578264|NCT02742519|18653143|P1|STARTED|Part 1 Treatment Period 1 (8 Weeks)||8
7578265|NCT02742441|18653163|P2|NOT COMPLETED|Overall Study||8
7578266|NCT02742441|18653164|P1|NOT COMPLETED|Overall Study||6
7578267|NCT02742441|18653163|P2|COMPLETED|Overall Study||196
7578268|NCT02742441|18653164|P1|COMPLETED|Overall Study||199
7578269|NCT02742441|18653163|P2|STARTED|Overall Study||204
7578270|NCT02742441|18653164|P1|STARTED|Overall Study||205
7578271|NCT02742129|18653182|P2|NOT COMPLETED|Phase 2||2
7578272|NCT02742129|18653183|P1|NOT COMPLETED|Phase 2||1
7578273|NCT02742129|18653182|P2|COMPLETED|Phase 2||48
7578274|NCT02742129|18653183|P1|COMPLETED|Phase 2||50
7578275|NCT02742129|18653182|P2|STARTED|Phase 2||50
7578276|NCT02742129|18653183|P1|STARTED|Phase 2||51
7578277|NCT02742129|18653182|P2|NOT COMPLETED|Phase 1||2
7578278|NCT02742129|18653183|P1|NOT COMPLETED|Phase 1||2
7578279|NCT02742129|18653182|P2|COMPLETED|Phase 1||50
7578280|NCT02742129|18653183|P1|COMPLETED|Phase 1||51
7578281|NCT02742129|18653182|P2|STARTED|Phase 1||52
7578282|NCT02742129|18653183|P1|STARTED|Phase 1||53
7578283|NCT02742103|18653211|P2|NOT COMPLETED|Overall Study||5
7578284|NCT02742103|18653212|P1|NOT COMPLETED|Overall Study||9
7578285|NCT02742103|18653211|P2|COMPLETED|Overall Study||23
7578286|NCT02742103|18653212|P1|COMPLETED|Overall Study||46
7578287|NCT02742103|18653211|P2|STARTED|Overall Study||28
7578288|NCT02742103|18653212|P1|STARTED|Overall Study||55
7578289|NCT02742077|18653249|P1|NOT COMPLETED|Overall Study||0
7578290|NCT02742077|18653249|P1|COMPLETED|Overall Study||20
7578291|NCT02742077|18653249|P1|STARTED|Overall Study||20
7578292|NCT02741713|18653258|P2|NOT COMPLETED|Overall Study||1
7578293|NCT02741713|18653259|P1|NOT COMPLETED|Overall Study||2
7578294|NCT02741713|18653258|P2|COMPLETED|Overall Study||19
7578295|NCT02741713|18653259|P1|COMPLETED|Overall Study||18
7578296|NCT02741713|18653258|P2|STARTED|Overall Study||20
7578297|NCT02741713|18653259|P1|STARTED|Overall Study||20
7578298|NCT02741687|18653274|P2|NOT COMPLETED|Overall Study||0
7578299|NCT02741687|18653275|P1|NOT COMPLETED|Overall Study||0
7578300|NCT02741687|18653274|P2|COMPLETED|Overall Study||44
7578301|NCT02741687|18653275|P1|COMPLETED|Overall Study||36
7578302|NCT02741687|18653274|P2|STARTED|Overall Study||44
7578303|NCT02741687|18653275|P1|STARTED|Overall Study||36
7578304|NCT02741635|18653299|P1|NOT COMPLETED|Overall Study||1
7578305|NCT02741635|18653299|P1|COMPLETED|Overall Study||14
7578306|NCT02741635|18653299|P1|STARTED|Overall Study||15
7578307|NCT02741596|18653307|P2|NOT COMPLETED|Overall Study||78
7578308|NCT02741596|18653308|P1|NOT COMPLETED|Overall Study||78
7578309|NCT02741596|18653307|P2|COMPLETED|Overall Study||25
7578310|NCT02741596|18653308|P1|COMPLETED|Overall Study||31
7578311|NCT02741596|18653307|P2|STARTED|Overall Study||103
7578312|NCT02741596|18653308|P1|STARTED|Overall Study||109
7578313|NCT02741518|18653326|P2|NOT COMPLETED|Overall Study||1
7578314|NCT02741518|18653327|P1|NOT COMPLETED|Overall Study||1
7578315|NCT02741518|18653326|P2|COMPLETED|Overall Study||10
7578316|NCT02741518|18653327|P1|COMPLETED|Overall Study||10
7578317|NCT02741518|18653326|P2|STARTED|Overall Study||11
7578318|NCT02741518|18653327|P1|STARTED|Overall Study||11
7578319|NCT02741310|18653337|P2|NOT COMPLETED|Overall Study||2
7578320|NCT02741310|18653338|P1|NOT COMPLETED|Overall Study||2
7578321|NCT02741310|18653337|P2|COMPLETED|Overall Study||20
7578322|NCT02741310|18653338|P1|COMPLETED|Overall Study||10
7578323|NCT02741310|18653337|P2|STARTED|Overall Study||22
7578324|NCT02741310|18653338|P1|STARTED|Overall Study||12
7578325|NCT02741297|18653358|P1|NOT COMPLETED|Overall Study||14
7578326|NCT02741297|18653358|P1|COMPLETED|Overall Study||59
7578327|NCT02741297|18653358|P1|STARTED|Overall Study||73
7578328|NCT02741284|18653364|P2|NOT COMPLETED|Overall Study||9
7578329|NCT02741284|18653365|P1|NOT COMPLETED|Overall Study||6
7578330|NCT02741284|18653364|P2|COMPLETED|Overall Study||48
7578331|NCT02741284|18653365|P1|COMPLETED|Overall Study||51
7578332|NCT02741284|18653364|P2|STARTED|Overall Study||57
7578333|NCT02741284|18653365|P1|STARTED|Overall Study||57
7578334|NCT02741271|18653383|P2|NOT COMPLETED|Overall Study||2
7578335|NCT02741271|18653384|P1|NOT COMPLETED|Overall Study||2
7578336|NCT02741271|18653383|P2|COMPLETED|Overall Study||88
7578337|NCT02741271|18653384|P1|COMPLETED|Overall Study||89
7578338|NCT02741271|18653383|P2|STARTED|Overall Study||90
7578339|NCT02741271|18653384|P1|STARTED|Overall Study||91
7578340|NCT02741245|18653417|P5|NOT COMPLETED|Overall Study||2
7578341|NCT02741245|18653418|P4|NOT COMPLETED|Overall Study||4
7578342|NCT02741245|18653419|P3|NOT COMPLETED|Overall Study||0
7578343|NCT02741245|18653420|P2|NOT COMPLETED|Overall Study||1
7578344|NCT02741245|18653421|P1|NOT COMPLETED|Overall Study||0
7578345|NCT02741245|18653417|P5|COMPLETED|Overall Study||70
7578346|NCT02741245|18653418|P4|COMPLETED|Overall Study||67
7578347|NCT02741245|18653419|P3|COMPLETED|Overall Study||71
7578348|NCT02741245|18653420|P2|COMPLETED|Overall Study||71
7578349|NCT02741245|18653421|P1|COMPLETED|Overall Study||35
7578350|NCT02741245|18653417|P5|STARTED|Overall Study||72
7578351|NCT02741245|18653418|P4|STARTED|Overall Study||71
7578352|NCT02741245|18653419|P3|STARTED|Overall Study||71
7578353|NCT02741245|18653420|P2|STARTED|Overall Study||72
7578354|NCT02741245|18653421|P1|STARTED|Overall Study||35
7578355|NCT02741076|18653527|P4|NOT COMPLETED|Overall Study||2
7578356|NCT02741076|18653528|P3|NOT COMPLETED|Overall Study||2
7578357|NCT02741076|18653529|P2|NOT COMPLETED|Overall Study||5
7578358|NCT02741076|18653530|P1|NOT COMPLETED|Overall Study||3
7578359|NCT02741076|18653527|P4|COMPLETED|Overall Study||2
7578360|NCT02741076|18653528|P3|COMPLETED|Overall Study||1
7578361|NCT02741076|18653529|P2|COMPLETED|Overall Study||7
7578362|NCT02741076|18653530|P1|COMPLETED|Overall Study||10
7578363|NCT02741076|18653527|P4|STARTED|Overall Study||4
7578364|NCT02741076|18653528|P3|STARTED|Overall Study||3
7578365|NCT02741076|18653529|P2|STARTED|Overall Study||12
7578366|NCT02741076|18653530|P1|STARTED|Overall Study||13
7578367|NCT02740920|18653588|P1|NOT COMPLETED|Overall Study||0
7578368|NCT02740920|18653588|P1|COMPLETED|Overall Study||9
7578369|NCT02740920|18653588|P1|STARTED|Overall Study||9
7578370|NCT02740660|18653595|P2|NOT COMPLETED|Overall Study||0
7578371|NCT02740660|18653596|P1|NOT COMPLETED|Overall Study||0
7578372|NCT02740660|18653595|P2|COMPLETED|Overall Study||6
7578373|NCT02740660|18653596|P1|COMPLETED|Overall Study||6
7578374|NCT02740660|18653595|P2|STARTED|Overall Study||6
7578375|NCT02740660|18653596|P1|STARTED|Overall Study||6
7578376|NCT02740582|18653610|P2|NOT COMPLETED|Second Intervention||3
7578377|NCT02740582|18653611|P1|NOT COMPLETED|Second Intervention||1
7578378|NCT02740582|18653610|P2|COMPLETED|Second Intervention||28
7578379|NCT02740582|18653611|P1|COMPLETED|Second Intervention||23
7578380|NCT02740582|18653610|P2|STARTED|Second Intervention||31
7578381|NCT02740582|18653611|P1|STARTED|Second Intervention||24
7578382|NCT02740582|18653610|P2|NOT COMPLETED|Washout||0
7578383|NCT02740582|18653611|P1|NOT COMPLETED|Washout||0
7578384|NCT02740582|18653610|P2|COMPLETED|Washout||31
7578385|NCT02740582|18653611|P1|COMPLETED|Washout||24
7578386|NCT02740582|18653610|P2|STARTED|Washout||31
7578387|NCT02740582|18653611|P1|STARTED|Washout||24
7578388|NCT02740582|18653610|P2|NOT COMPLETED|First Intervention||2
7578389|NCT02740582|18653611|P1|NOT COMPLETED|First Intervention||5
7578390|NCT02740582|18653610|P2|COMPLETED|First Intervention||31
7578391|NCT02740582|18653611|P1|COMPLETED|First Intervention||24
7578392|NCT02740582|18653610|P2|STARTED|First Intervention||33
7578393|NCT02740582|18653611|P1|STARTED|First Intervention||29
7578394|NCT02740413|18653617|P1|NOT COMPLETED|Overall Study||0
7578395|NCT02740413|18653617|P1|COMPLETED|Overall Study||86
7578396|NCT02740413|18653617|P1|STARTED|Overall Study||86
7578397|NCT02740049|18653655|P1|NOT COMPLETED|Overall Study||1
7578398|NCT02740049|18653655|P1|COMPLETED|Overall Study||8
7578399|NCT02740049|18653655|P1|STARTED|Overall Study||9
7578400|NCT02739997|18653661|P1|NOT COMPLETED|Overall Study||2
7578401|NCT02739997|18653661|P1|COMPLETED|Overall Study||98
7578402|NCT02739997|18653661|P1|STARTED|Overall Study||100
7578403|NCT02739984|18653675|P2|NOT COMPLETED|Overall Study||2
7578404|NCT02739984|18653676|P1|NOT COMPLETED|Overall Study||5
7578405|NCT02739984|18653675|P2|COMPLETED|Overall Study||279
7578406|NCT02739984|18653676|P1|COMPLETED|Overall Study||138
7578407|NCT02739984|18653675|P2|Received Study Drug|Overall Study||280
7578408|NCT02739984|18653676|P1|Received Study Drug|Overall Study||141
7578409|NCT02739984|18653675|P2|STARTED|Overall Study||281
7578410|NCT02739984|18653676|P1|STARTED|Overall Study||143
7578411|NCT02739828|18653724|P1|NOT COMPLETED|Overall Study||5
7578412|NCT02739828|18653724|P1|COMPLETED|Overall Study||19
7578413|NCT02739828|18653724|P1|STARTED|Overall Study||24
7578414|NCT02739789|18653760|P2|NOT COMPLETED|Second fMRI Scan||0
7578415|NCT02739789|18653761|P1|NOT COMPLETED|Second fMRI Scan||0
7578416|NCT02739789|18653760|P2|COMPLETED|Second fMRI Scan||7
7578417|NCT02739789|18653761|P1|COMPLETED|Second fMRI Scan||9
7578418|NCT02739789|18653760|P2|STARTED|Second fMRI Scan||7
7578419|NCT02739789|18653761|P1|STARTED|Second fMRI Scan||9
7578420|NCT02739789|18653760|P2|NOT COMPLETED|~1 Week Waiting Period||3
7578421|NCT02739789|18653761|P1|NOT COMPLETED|~1 Week Waiting Period||0
7578422|NCT02739789|18653760|P2|COMPLETED|~1 Week Waiting Period||7
7578423|NCT02739789|18653761|P1|COMPLETED|~1 Week Waiting Period||9
7578424|NCT02739789|18653760|P2|STARTED|~1 Week Waiting Period||10
7578425|NCT02739789|18653761|P1|STARTED|~1 Week Waiting Period||9
7578426|NCT02739789|18653760|P2|NOT COMPLETED|First fMRI Scan||0
7578427|NCT02739789|18653761|P1|NOT COMPLETED|First fMRI Scan||0
7578428|NCT02739789|18653760|P2|COMPLETED|First fMRI Scan||10
7578429|NCT02739789|18653761|P1|COMPLETED|First fMRI Scan||9
7578430|NCT02739789|18653760|P2|STARTED|First fMRI Scan||10
7578431|NCT02739789|18653761|P1|STARTED|First fMRI Scan||9
7578432|NCT02739698|18653775|P2|NOT COMPLETED|Overall Study||5
7578433|NCT02739698|18653776|P1|NOT COMPLETED|Overall Study||6
7578434|NCT02739698|18653775|P2|COMPLETED|Overall Study||16
7578435|NCT02739698|18653776|P1|COMPLETED|Overall Study||16
7578436|NCT02739698|18653775|P2|STARTED|Overall Study||21
7578437|NCT02739698|18653776|P1|STARTED|Overall Study||22
7578438|NCT02739594|18653784|P2|NOT COMPLETED|Overall Study||28
7578439|NCT02739594|18653785|P1|NOT COMPLETED|Overall Study||25
7578440|NCT02739594|18653784|P2|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15
7578441|NCT02739594|18653785|P1|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21
7578442|NCT02739594|18653784|P2|Completed at Week 96|Overall Study||10
7578443|NCT02739594|18653785|P1|Completed at Week 96|Overall Study||10
7578444|NCT02739594|18653784|P2|Completed at Week 44|Overall Study||5
7578445|NCT02739594|18653785|P1|Completed at Week 44|Overall Study||11
7578446|NCT02739594|18653784|P2|STARTED|Overall Study||43
7578447|NCT02739594|18653785|P1|STARTED|Overall Study||46
7578448|NCT02739360|18653815|P1|NOT COMPLETED|Overall Study||3
7578449|NCT02739360|18653815|P1|COMPLETED|Overall Study||0
7578450|NCT02739360|18653815|P1|STARTED|Overall Study||3
7578451|NCT02739321|18653821|P2|NOT COMPLETED|Overall Study||4
7578452|NCT02739321|18653822|P1|NOT COMPLETED|Overall Study||3
7578453|NCT02739321|18653821|P2|COMPLETED|Overall Study||18
7578454|NCT02739321|18653822|P1|COMPLETED|Overall Study||20
7578455|NCT02739321|18653821|P2|STARTED|Overall Study||22
7578456|NCT02739321|18653822|P1|STARTED|Overall Study||23
7578457|NCT02739269|18653868|P2|NOT COMPLETED|Overall Study||4
7578458|NCT02739269|18653869|P1|NOT COMPLETED|Overall Study||7
7578459|NCT02739269|18653868|P2|COMPLETED|Overall Study||96
7578460|NCT02739269|18653869|P1|COMPLETED|Overall Study||93
7578461|NCT02739269|18653868|P2|STARTED|Overall Study||100
7578462|NCT02739269|18653869|P1|STARTED|Overall Study||100
7578463|NCT02739100|18653877|P1|NOT COMPLETED|Overall Study||0
7578464|NCT02739100|18653877|P1|COMPLETED|Overall Study||13
7578465|NCT02739100|18653877|P1|Triferic 6.6. mg IV Post-dialyzer|Overall Study||13
7578466|NCT02739100|18653877|P1|Triferic 6.6 mg IV Predialyzer|Overall Study||13
7578467|NCT02739100|18653877|P1|Triferic 2 Micromolar Via Hemodialysate|Overall Study||13
7578468|NCT02739100|18653877|P1|STARTED|Overall Study||13
7578469|NCT02738879|18653896|P2|NOT COMPLETED|Overall Study||25
7578470|NCT02738879|18653897|P1|NOT COMPLETED|Overall Study||13
7578471|NCT02738879|18653896|P2|COMPLETED|Overall Study||347
7578472|NCT02738879|18653897|P1|COMPLETED|Overall Study||361
7578473|NCT02738879|18653896|P2|Treated|Overall Study||370
7578474|NCT02738879|18653897|P1|Treated|Overall Study||373
7578475|NCT02738879|18653896|P2|STARTED|Overall Study||372
7578476|NCT02738879|18653897|P1|STARTED|Overall Study||374
7578477|NCT02738853|18653931|P1|NOT COMPLETED|30 Days- 6 Months||2
7578478|NCT02738853|18653931|P1|COMPLETED|30 Days- 6 Months||57
7578479|NCT02738853|18653931|P1|STARTED|30 Days- 6 Months||59
7578480|NCT02738853|18653931|P1|NOT COMPLETED|Baseline -30 Days||1
7578481|NCT02738853|18653931|P1|COMPLETED|Baseline -30 Days||59
7578482|NCT02738853|18653931|P1|STARTED|Baseline -30 Days||60
7578483|NCT02738801|18653949|P2|NOT COMPLETED|Overall Study||2
7578484|NCT02738801|18653950|P1|NOT COMPLETED|Overall Study||1
7578485|NCT02738801|18653949|P2|COMPLETED|Overall Study||15
7578486|NCT02738801|18653950|P1|COMPLETED|Overall Study||5
7578487|NCT02738801|18653949|P2|STARTED|Overall Study||17
7578488|NCT02738801|18653950|P1|STARTED|Overall Study||6
7578489|NCT02738580|18653966|P2|NOT COMPLETED|Overall Study||4
7578490|NCT02738580|18653967|P1|NOT COMPLETED|Overall Study||4
7578491|NCT02738580|18653966|P2|COMPLETED|Overall Study|"2 cycles cancelled due to por response to stimullation
~1 patient withdrawal
~1 excluded"|52
7578492|NCT02738580|18653967|P1|COMPLETED|Overall Study|"3 cycles cancelled due to por response to stimullation.
~1 cycle cancelled due to SAE."|52
7578493|NCT02738580|18653966|P2|STARTED|Overall Study||56
7578494|NCT02738580|18653967|P1|STARTED|Overall Study|56 patients were assigned to this arms.|56
7578495|NCT02738333|18653978|P3|NOT COMPLETED|Overall Study||0
7578496|NCT02738333|18653979|P2|NOT COMPLETED|Overall Study||0
7578497|NCT02738333|18653980|P1|NOT COMPLETED|Overall Study||2
7578498|NCT02738333|18653978|P3|COMPLETED|Overall Study||25
7578499|NCT02738333|18653979|P2|COMPLETED|Overall Study||108
7578500|NCT02738333|18653980|P1|COMPLETED|Overall Study||104
7578501|NCT02738333|18653978|P3|STARTED|Overall Study||25
7578502|NCT02738333|18653979|P2|STARTED|Overall Study||108
7578503|NCT02738333|18653980|P1|STARTED|Overall Study||106
7578504|NCT02738255|18654056|P2|NOT COMPLETED|Overall Study||1
7578505|NCT02738255|18654057|P1|NOT COMPLETED|Overall Study||0
7578506|NCT02738255|18654056|P2|COMPLETED|Overall Study||14
7578507|NCT02738255|18654057|P1|COMPLETED|Overall Study||11
7578508|NCT02738255|18654056|P2|STARTED|Overall Study||15
7578509|NCT02738255|18654057|P1|STARTED|Overall Study||11
7578510|NCT02738203|18654069|P2|NOT COMPLETED|Overall Study||3
7578511|NCT02738203|18654070|P1|NOT COMPLETED|Overall Study||2
7578512|NCT02738203|18654069|P2|COMPLETED|Overall Study||107
7578513|NCT02738203|18654070|P1|COMPLETED|Overall Study||108
7578514|NCT02738203|18654069|P2|STARTED|Overall Study||110
7578515|NCT02738203|18654070|P1|STARTED|Overall Study||110
7578516|NCT02738151|18654086|P2|NOT COMPLETED|Overall Study||31
7578517|NCT02738151|18654087|P1|NOT COMPLETED|Overall Study||23
7578518|NCT02738151|18654086|P2|COMPLETED|Overall Study||432
7578519|NCT02738151|18654087|P1|COMPLETED|Overall Study||443
7578520|NCT02738151|18654086|P2|Treated|Overall Study||462
7578521|NCT02738151|18654087|P1|Treated|Overall Study||462
7578522|NCT02738151|18654086|P2|STARTED|Overall Study||463
7578523|NCT02738151|18654087|P1|STARTED|Overall Study||466
7578524|NCT02738138|18654131|P2|NOT COMPLETED|Overall Study||1
7578525|NCT02738138|18654132|P1|NOT COMPLETED|Overall Study||3
7578526|NCT02738138|18654131|P2|COMPLETED|Overall Study||15
7578527|NCT02738138|18654132|P1|COMPLETED|Overall Study||134
7578528|NCT02738138|18654131|P2|STARTED|Overall Study||16
7578529|NCT02738138|18654132|P1|STARTED|Overall Study||137
7578530|NCT02738086|18654141|P2|NOT COMPLETED|Overall Study||2
7578531|NCT02738086|18654142|P1|NOT COMPLETED|Overall Study||2
7578532|NCT02738086|18654141|P2|COMPLETED|Overall Study||13
7578533|NCT02738086|18654142|P1|COMPLETED|Overall Study||14
7578534|NCT02738086|18654141|P2|STARTED|Overall Study||15
7578535|NCT02738086|18654142|P1|STARTED|Overall Study||16
7578536|NCT02738008|18654169|P3|NOT COMPLETED|Overall Study||5
7578537|NCT02738008|18654170|P2|NOT COMPLETED|Overall Study||6
7578538|NCT02738008|18654171|P1|NOT COMPLETED|Overall Study||1
7578539|NCT02738008|18654169|P3|COMPLETED|Overall Study||0
7578540|NCT02738008|18654170|P2|COMPLETED|Overall Study||0
7578541|NCT02738008|18654171|P1|COMPLETED|Overall Study||0
7578542|NCT02738008|18654169|P3|STARTED|Overall Study||5
7578543|NCT02738008|18654170|P2|STARTED|Overall Study||6
7578544|NCT02738008|18654171|P1|STARTED|Overall Study||1
7578545|NCT02737917|18654187|P2|NOT COMPLETED|Overall Study||3
7578546|NCT02737917|18654188|P1|NOT COMPLETED|Overall Study||3
7578547|NCT02737917|18654187|P2|COMPLETED|Overall Study||100
7578548|NCT02737917|18654188|P1|COMPLETED|Overall Study||100
7578549|NCT02737917|18654187|P2|STARTED|Overall Study||103
7578550|NCT02737917|18654188|P1|STARTED|Overall Study||103
7578551|NCT02737891|18654198|P2|NOT COMPLETED|Overall Study||2
7578552|NCT02737891|18654199|P1|NOT COMPLETED|Overall Study||0
7578553|NCT02737891|18654198|P2|COMPLETED|Overall Study||28
7578554|NCT02737891|18654199|P1|COMPLETED|Overall Study||30
7578555|NCT02737891|18654198|P2|STARTED|Overall Study||30
7578556|NCT02737891|18654199|P1|STARTED|Overall Study||30
7578557|NCT02737852|18654209|P1|NOT COMPLETED|Overall Study||2
7578558|NCT02737852|18654209|P1|COMPLETED|Overall Study||30
7578559|NCT02737852|18654209|P1|STARTED|Overall Study||32
7578560|NCT02737722|18654218|P4|NOT COMPLETED|Overall Study||0
7578561|NCT02737722|18654219|P3|NOT COMPLETED|Overall Study||1
7578562|NCT02737722|18654220|P2|NOT COMPLETED|Overall Study||0
7578563|NCT02737722|18654221|P1|NOT COMPLETED|Overall Study||0
7578564|NCT02737722|18654218|P4|COMPLETED|Overall Study||6
7578565|NCT02737722|18654219|P3|COMPLETED|Overall Study||7
7578566|NCT02737722|18654220|P2|COMPLETED|Overall Study||8
7578567|NCT02737722|18654221|P1|COMPLETED|Overall Study||8
7578568|NCT02737722|18654218|P4|STARTED|Overall Study||6
7578569|NCT02737722|18654219|P3|STARTED|Overall Study||8
7578570|NCT02737722|18654220|P2|STARTED|Overall Study||8
7578571|NCT02737722|18654221|P1|STARTED|Overall Study||8
7578572|NCT02737631|18654267|P1|NOT COMPLETED|Overall Study||0
7578573|NCT02737631|18654267|P1|COMPLETED|Overall Study||222
7578574|NCT02737631|18654267|P1|STARTED|Overall Study||222
7578575|NCT02737618|18654272|P1|NOT COMPLETED|Overall Study||9
7578576|NCT02737618|18654272|P1|COMPLETED|Overall Study||34
7578577|NCT02737618|18654272|P1|STARTED|Overall Study||43
7578578|NCT02737592|18654277|P1|NOT COMPLETED|Overall Study||1
7578579|NCT02737592|18654277|P1|COMPLETED|Overall Study||33
7578580|NCT02737592|18654277|P1|STARTED|Overall Study||34
7578581|NCT02737397|18654282|P1|NOT COMPLETED|Overall Study||0
7578582|NCT02737397|18654282|P1|COMPLETED|Overall Study||13
7578583|NCT02737397|18654282|P1|Placebo|Overall Study||13
7578584|NCT02737397|18654282|P1|SJP-223|Overall Study||13
7578585|NCT02737397|18654282|P1|SJP-304|Overall Study||12
7578586|NCT02737397|18654282|P1|JMI-001|Overall Study||13
7578587|NCT02737397|18654282|P1|STARTED|Overall Study||13
7578588|NCT02737358|18654298|P2|NOT COMPLETED|Overall Study||15
7578589|NCT02737358|18654299|P1|NOT COMPLETED|Overall Study||9
7578590|NCT02737358|18654298|P2|COMPLETED|Overall Study||44
7578591|NCT02737358|18654299|P1|COMPLETED|Overall Study||46
7578592|NCT02737358|18654298|P2|STARTED|Overall Study||59
7578593|NCT02737358|18654299|P1|STARTED|Overall Study||55
7578594|NCT02737332|18654311|P2|NOT COMPLETED|Overall Study||1
7578595|NCT02737332|18654312|P1|NOT COMPLETED|Overall Study||1
7578596|NCT02737332|18654311|P2|COMPLETED|Overall Study||23
7578597|NCT02737332|18654312|P1|COMPLETED|Overall Study||28
7578598|NCT02737332|18654311|P2|STARTED|Overall Study||24
7578599|NCT02737332|18654312|P1|STARTED|Overall Study||29
7578600|NCT02737163|18654352|P1|NOT COMPLETED|Overall Study||0
7578601|NCT02737163|18654352|P1|COMPLETED|Overall Study||95
7578602|NCT02737163|18654352|P1|STARTED|Overall Study|114 encounter assessments were completed on 95 participants over 15 months|95
7578603|NCT02737072|18654362|P3|NOT COMPLETED|Overall Study||0
7578604|NCT02737072|18654363|P2|NOT COMPLETED|Overall Study||0
7578605|NCT02737072|18654364|P1|NOT COMPLETED|Overall Study||0
7578606|NCT02737072|18654362|P3|COMPLETED|Overall Study||3
7578607|NCT02737072|18654363|P2|COMPLETED|Overall Study||3
7578608|NCT02737072|18654364|P1|COMPLETED|Overall Study||3
7578609|NCT02737072|18654362|P3|Received at Least One Dose of Drug|Overall Study||3
7578610|NCT02737072|18654363|P2|Received at Least One Dose of Drug|Overall Study||3
7578611|NCT02737072|18654364|P1|Received at Least One Dose of Drug|Overall Study||3
7578612|NCT02737072|18654362|P3|STARTED|Overall Study||3
7578613|NCT02737072|18654363|P2|STARTED|Overall Study||3
7578614|NCT02737072|18654364|P1|STARTED|Overall Study||3
7578615|NCT02736955|18654388|P3|NOT COMPLETED|Overall Study||2
7578616|NCT02736955|18654389|P2|NOT COMPLETED|Overall Study||14
7578617|NCT02736955|18654390|P1|NOT COMPLETED|Overall Study||7
7578618|NCT02736955|18654388|P3|COMPLETED|Overall Study||6
7578619|NCT02736955|18654389|P2|COMPLETED|Overall Study||103
7578620|NCT02736955|18654390|P1|COMPLETED|Overall Study||29
7578621|NCT02736955|18654388|P3|STARTED|Overall Study||8
7578622|NCT02736955|18654389|P2|STARTED|Overall Study||117
7578623|NCT02736955|18654390|P1|STARTED|Overall Study||36
7578624|NCT02736890|18654406|P2|NOT COMPLETED|Crossover Next 12 Weeks||2
7578625|NCT02736890|18654407|P1|NOT COMPLETED|Crossover Next 12 Weeks||2
7578626|NCT02736890|18654406|P2|COMPLETED|Crossover Next 12 Weeks||1
7578627|NCT02736890|18654407|P1|COMPLETED|Crossover Next 12 Weeks||3
7578628|NCT02736890|18654406|P2|STARTED|Crossover Next 12 Weeks||3
7578629|NCT02736890|18654407|P1|STARTED|Crossover Next 12 Weeks||5
7578630|NCT02736890|18654406|P2|NOT COMPLETED|First 12 Weeks||0
7578631|NCT02736890|18654407|P1|NOT COMPLETED|First 12 Weeks||0
7578632|NCT02736890|18654406|P2|COMPLETED|First 12 Weeks||3
7578633|NCT02736890|18654407|P1|COMPLETED|First 12 Weeks||5
7578634|NCT02736890|18654406|P2|STARTED|First 12 Weeks||3
7578635|NCT02736890|18654407|P1|STARTED|First 12 Weeks||5
7578636|NCT02736825|18654429|P2|NOT COMPLETED|Overall Study||12
7578637|NCT02736825|18654430|P1|NOT COMPLETED|Overall Study||10
7578638|NCT02736825|18654429|P2|COMPLETED|Overall Study||123
7578639|NCT02736825|18654430|P1|COMPLETED|Overall Study||117
7578640|NCT02736825|18654429|P2|STARTED|Overall Study||135
7578641|NCT02736825|18654430|P1|STARTED|Overall Study||127
7578642|NCT02736721|18654470|P1|NOT COMPLETED|Overall Study||16
7578643|NCT02736721|18654470|P1|COMPLETED|Overall Study||25
7578644|NCT02736721|18654470|P1|STARTED|Overall Study||41
7578645|NCT02736578|18654481|P2|NOT COMPLETED|Overall Study||0
7578646|NCT02736578|18654482|P1|NOT COMPLETED|Overall Study||1
7578647|NCT02736578|18654481|P2|COMPLETED|Overall Study||2
7578648|NCT02736578|18654482|P1|COMPLETED|Overall Study||5
7578649|NCT02736578|18654481|P2|STARTED|Overall Study||2
7578650|NCT02736578|18654482|P1|STARTED|Overall Study||6
7578651|NCT02736188|18654500|P1|NOT COMPLETED|Overall Study||142
7578652|NCT02736188|18654500|P1|COMPLETED|Overall Study||0
7578653|NCT02736188|18654500|P1|STARTED|Overall Study||142
7578654|NCT02736175|18654526|P2|NOT COMPLETED|Overall Study||1
7578655|NCT02736175|18654527|P1|NOT COMPLETED|Overall Study||2
7578656|NCT02736175|18654526|P2|COMPLETED|Overall Study||221
7578657|NCT02736175|18654527|P1|COMPLETED|Overall Study||214
7578658|NCT02736175|18654526|P2|STARTED|Overall Study||222
7578659|NCT02736175|18654527|P1|STARTED|Overall Study||216
7578660|NCT02735980|18654538|P3|NOT COMPLETED|Overall Study||1
7578661|NCT02735980|18654539|P2|NOT COMPLETED|Overall Study||11
7578662|NCT02735980|18654540|P1|NOT COMPLETED|Overall Study||10
7578663|NCT02735980|18654538|P3|COMPLETED|Overall Study||14
7578664|NCT02735980|18654539|P2|COMPLETED|Overall Study||49
7578665|NCT02735980|18654540|P1|COMPLETED|Overall Study||48
7578666|NCT02735980|18654538|P3|Received at Least 1 Dose of Study Drug|Overall Study||15
7578667|NCT02735980|18654539|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
7578668|NCT02735980|18654540|P1|Received at Least 1 Dose of Study Drug|Overall Study||56
7578669|NCT02735980|18654538|P3|STARTED|Overall Study||15
7578670|NCT02735980|18654539|P2|STARTED|Overall Study||60
7578671|NCT02735980|18654540|P1|STARTED|Overall Study||58
7578672|NCT02735915|18654569|P1|NOT COMPLETED|Overall Study||11
7578673|NCT02735915|18654569|P1|COMPLETED|Overall Study||59
7578674|NCT02735915|18654569|P1|Vaccinated|Overall Study||62
7578675|NCT02735915|18654569|P1|STARTED|Overall Study||70
7578676|NCT02735642|18654590|P2|NOT COMPLETED|Overall Study||0
7578677|NCT02735642|18654591|P1|NOT COMPLETED|Overall Study||0
7578678|NCT02735642|18654590|P2|COMPLETED|Overall Study||152
7578679|NCT02735642|18654591|P1|COMPLETED|Overall Study||1046
7578680|NCT02735642|18654590|P2|STARTED|Overall Study||152
7578681|NCT02735642|18654591|P1|STARTED|Overall Study||1046
7578682|NCT02735577|18654601|P1|NOT COMPLETED|Optional 28 Days of Disulfiram Treatment||2
7578683|NCT02735577|18654601|P1|COMPLETED|Optional 28 Days of Disulfiram Treatment||4
7578684|NCT02735577|18654601|P1|STARTED|Optional 28 Days of Disulfiram Treatment||6
7578685|NCT02735577|18654601|P1|NOT COMPLETED|Disulfiram Treatment||1
7578686|NCT02735577|18654601|P1|COMPLETED|Disulfiram Treatment||6
7578687|NCT02735577|18654601|P1|STARTED|Disulfiram Treatment||7
7578688|NCT02735551|18654608|P3|NOT COMPLETED|Overall Study||0
7578689|NCT02735551|18654609|P2|NOT COMPLETED|Overall Study||0
7578690|NCT02735551|18654610|P1|NOT COMPLETED|Overall Study||0
7578691|NCT02735551|18654608|P3|COMPLETED|Overall Study||0
7578692|NCT02735551|18654609|P2|COMPLETED|Overall Study||0
7578693|NCT02735551|18654610|P1|COMPLETED|Overall Study||3
7578694|NCT02735551|18654608|P3|STARTED|Overall Study||0
7578695|NCT02735551|18654609|P2|STARTED|Overall Study||0
7578696|NCT02735551|18654610|P1|STARTED|Overall Study||3
7578697|NCT02735421|18654618|P1|NOT COMPLETED|Overall Study||13
7578698|NCT02735421|18654618|P1|COMPLETED|Overall Study||54
7578699|NCT02735421|18654618|P1|STARTED|Overall Study||67
7578700|NCT02735382|18654629|P4|NOT COMPLETED|Overall Study||0
7578701|NCT02735382|18654630|P3|NOT COMPLETED|Overall Study||0
7578702|NCT02735382|18654631|P2|NOT COMPLETED|Overall Study||0
7578703|NCT02735382|18654632|P1|NOT COMPLETED|Overall Study||0
7578704|NCT02735382|18654629|P4|COMPLETED|Overall Study||110
7578705|NCT02735382|18654630|P3|COMPLETED|Overall Study||184
7578706|NCT02735382|18654631|P2|COMPLETED|Overall Study||7155
7578707|NCT02735382|18654632|P1|COMPLETED|Overall Study||7481
7578708|NCT02735382|18654629|P4|STARTED|Overall Study||110
7578709|NCT02735382|18654630|P3|STARTED|Overall Study||184
7578710|NCT02735382|18654631|P2|STARTED|Overall Study||7155
7578711|NCT02735382|18654632|P1|STARTED|Overall Study||7481
7578712|NCT02735200|18654648|P2|NOT COMPLETED|Overall Study||5
7578713|NCT02735200|18654649|P1|NOT COMPLETED|Overall Study||8
7578714|NCT02735200|18654648|P2|COMPLETED|Overall Study||345
7578715|NCT02735200|18654649|P1|COMPLETED|Overall Study||192
7578716|NCT02735200|18654648|P2|STARTED|Overall Study||350
7578717|NCT02735200|18654649|P1|STARTED|Overall Study||200
7578718|NCT02735187|18654657|P2|NOT COMPLETED|Overall Study||1
7578719|NCT02735187|18654658|P1|NOT COMPLETED|Overall Study||4
7578720|NCT02735187|18654657|P2|COMPLETED|Overall Study||25
7578721|NCT02735187|18654658|P1|COMPLETED|Overall Study||21
7578722|NCT02735187|18654657|P2|STARTED|Overall Study||26
7578723|NCT02735187|18654658|P1|STARTED|Overall Study||25
7578724|NCT02735174|18654688|P1|NOT COMPLETED|Overall Study||0
7578725|NCT02735174|18654688|P1|COMPLETED|Overall Study||21
7578726|NCT02735174|18654688|P1|STARTED|Overall Study||21
7578727|NCT02735096|18654692|P1|NOT COMPLETED|Overall Study||1
7578728|NCT02735096|18654692|P1|COMPLETED|Overall Study||3
7578729|NCT02735096|18654692|P1|STARTED|Overall Study||4
7578730|NCT02735044|18654701|P2|NOT COMPLETED|Overall Study||23
7578731|NCT02735044|18654702|P1|NOT COMPLETED|Overall Study||16
7578732|NCT02735044|18654701|P2|COMPLETED|Overall Study||207
7578733|NCT02735044|18654702|P1|COMPLETED|Overall Study||217
7578734|NCT02735044|18654701|P2|Treated|Overall Study||228
7578735|NCT02735044|18654702|P1|Treated|Overall Study||233
7578736|NCT02735044|18654701|P2|STARTED|Overall Study||230
7578737|NCT02735044|18654702|P1|STARTED|Overall Study||233
7578738|NCT02734953|18654728|P1|NOT COMPLETED|Overall Study||0
7578739|NCT02734953|18654728|P1|COMPLETED|Overall Study||10
7578740|NCT02734953|18654728|P1|STARTED|Overall Study||10
7578741|NCT02734940|18654745|P2|NOT COMPLETED|Overall Study||0
7578742|NCT02734940|18654746|P1|NOT COMPLETED|Overall Study||0
7578743|NCT02734940|18654745|P2|COMPLETED|Overall Study||0
7578744|NCT02734940|18654746|P1|COMPLETED|Overall Study||0
7578745|NCT02734940|18654745|P2|STARTED|Overall Study||0
7578746|NCT02734940|18654746|P1|STARTED|Overall Study||0
7578747|NCT02734862|18654771|P3|NOT COMPLETED|Part B||5
7578748|NCT02734862|18654772|P2|NOT COMPLETED|Part B||7
7578749|NCT02734862|18654773|P1|NOT COMPLETED|Part B||13
7578750|NCT02734862|18654771|P3|COMPLETED|Part B||28
7578751|NCT02734862|18654772|P2|COMPLETED|Part B||14
7578752|NCT02734862|18654773|P1|COMPLETED|Part B||33
7578753|NCT02734862|18654771|P3|STARTED|Part B||33
7578754|NCT02734862|18654772|P2|STARTED|Part B||21
7578755|NCT02734862|18654773|P1|STARTED|Part B||46
7578756|NCT02734862|18654771|P3|NOT COMPLETED|Part A||14
7578757|NCT02734862|18654772|P2|NOT COMPLETED|Part A||8
7578758|NCT02734862|18654773|P1|NOT COMPLETED|Part A||12
7578759|NCT02734862|18654771|P3|COMPLETED|Part A||22
7578760|NCT02734862|18654772|P2|COMPLETED|Part A||28
7578761|NCT02734862|18654773|P1|COMPLETED|Part A||23
7578762|NCT02734862|18654771|P3|STARTED|Part A||36
7578763|NCT02734862|18654772|P2|STARTED|Part A||36
7578764|NCT02734862|18654773|P1|STARTED|Part A||35
7578765|NCT02734849|18654802|P3|NOT COMPLETED|Overall Study||1
7578766|NCT02734849|18654803|P2|NOT COMPLETED|Overall Study||0
7578767|NCT02734849|18654804|P1|NOT COMPLETED|Overall Study||3
7578768|NCT02734849|18654802|P3|COMPLETED|Overall Study||9
7578769|NCT02734849|18654803|P2|COMPLETED|Overall Study||14
7578770|NCT02734849|18654804|P1|COMPLETED|Overall Study||12
7578771|NCT02734849|18654802|P3|STARTED|Overall Study||10
7578772|NCT02734849|18654803|P2|STARTED|Overall Study||14
7578773|NCT02734849|18654804|P1|STARTED|Overall Study|One patient was randomized but never received study treatment and excluded from all analysis sets.|15
7578774|NCT02734810|18654814|P2|NOT COMPLETED|Overall Study||0
7578775|NCT02734810|18654815|P1|NOT COMPLETED|Overall Study||2
7578776|NCT02734810|18654814|P2|COMPLETED|Overall Study||0
7578777|NCT02734810|18654815|P1|COMPLETED|Overall Study||13
7578778|NCT02734810|18654814|P2|STARTED|Overall Study||0
7578779|NCT02734810|18654815|P1|STARTED|Overall Study||15
7578780|NCT02734693|18654824|P3|NOT COMPLETED|Overall Study||3
7578781|NCT02734693|18654825|P2|NOT COMPLETED|Overall Study||3
7578782|NCT02734693|18654826|P1|NOT COMPLETED|Overall Study||6
7578783|NCT02734693|18654824|P3|COMPLETED|Overall Study||17
7578784|NCT02734693|18654825|P2|COMPLETED|Overall Study||53
7578785|NCT02734693|18654826|P1|COMPLETED|Overall Study||50
7578786|NCT02734693|18654824|P3|STARTED|Overall Study||20
7578787|NCT02734693|18654825|P2|STARTED|Overall Study||56
7578788|NCT02734693|18654826|P1|STARTED|Overall Study||56
7578789|NCT02734498|18654846|P3|NOT COMPLETED|Overall Study||0
7578790|NCT02734498|18654847|P2|NOT COMPLETED|Overall Study||0
7578791|NCT02734498|18654848|P1|NOT COMPLETED|Overall Study||0
7578792|NCT02734498|18654846|P3|COMPLETED|Overall Study||0
7578793|NCT02734498|18654847|P2|COMPLETED|Overall Study||0
7578794|NCT02734498|18654848|P1|COMPLETED|Overall Study||2
7578795|NCT02734498|18654846|P3|STARTED|Overall Study||0
7578796|NCT02734498|18654847|P2|STARTED|Overall Study||0
7578797|NCT02734498|18654848|P1|STARTED|Overall Study||2
7578798|NCT02734433|18654867|P2|NOT COMPLETED|Overall Study||8
7578799|NCT02734433|18654868|P1|NOT COMPLETED|Overall Study||2
7578800|NCT02734433|18654867|P2|COMPLETED|Overall Study||0
7578801|NCT02734433|18654868|P1|COMPLETED|Overall Study||1
7578802|NCT02734433|18654867|P2|STARTED|Overall Study||8
7578803|NCT02734433|18654868|P1|STARTED|Overall Study||3
7578804|NCT02734355|18654902|P2|NOT COMPLETED|Overall Study||0
7578805|NCT02734355|18654903|P1|NOT COMPLETED|Overall Study||0
7578806|NCT02734355|18654902|P2|COMPLETED|Overall Study||30
7578807|NCT02734355|18654903|P1|COMPLETED|Overall Study||34
7578808|NCT02734355|18654902|P2|STARTED|Overall Study||30
7578809|NCT02734355|18654903|P1|STARTED|Overall Study||34
7578810|NCT02734238|18654935|P2|NOT COMPLETED|Overall Study||0
7578811|NCT02734238|18654936|P1|NOT COMPLETED|Overall Study||0
7578812|NCT02734238|18654935|P2|COMPLETED|Overall Study||24
7578813|NCT02734238|18654936|P1|COMPLETED|Overall Study||26
7578814|NCT02734238|18654935|P2|STARTED|Overall Study||24
7578815|NCT02734238|18654936|P1|STARTED|Overall Study||26
7578816|NCT02734212|18654944|P2|NOT COMPLETED|Overall Study||10
7578817|NCT02734212|18654945|P1|NOT COMPLETED|Overall Study||5
7578818|NCT02734212|18654944|P2|COMPLETED|Overall Study||18
7578819|NCT02734212|18654945|P1|COMPLETED|Overall Study||24
7578820|NCT02734212|18654944|P2|STARTED|Overall Study||28
7578821|NCT02734212|18654945|P1|STARTED|Overall Study||29
7578822|NCT02734056|18654957|P2|NOT COMPLETED|Overall Study||1
7578823|NCT02734056|18654958|P1|NOT COMPLETED|Overall Study||0
7578824|NCT02734056|18654957|P2|COMPLETED|Overall Study||49
7578825|NCT02734056|18654958|P1|COMPLETED|Overall Study||50
7578826|NCT02734056|18654957|P2|STARTED|Overall Study||50
7578827|NCT02734056|18654958|P1|STARTED|Overall Study||50
7578828|NCT02733991|18654966|P2|NOT COMPLETED|Overall Study||5
7578829|NCT02733991|18654967|P1|NOT COMPLETED|Overall Study||1
7578830|NCT02733991|18654966|P2|COMPLETED|Overall Study||72
7578831|NCT02733991|18654967|P1|COMPLETED|Overall Study||75
7578832|NCT02733991|18654966|P2|STARTED|Overall Study||77
7578833|NCT02733991|18654967|P1|STARTED|Overall Study||76
7578834|NCT02733757|18654981|P4|NOT COMPLETED|Overall Study||0
7578835|NCT02733757|18654982|P3|NOT COMPLETED|Overall Study||0
7578836|NCT02733757|18654983|P2|NOT COMPLETED|Overall Study||0
7578837|NCT02733757|18654984|P1|NOT COMPLETED|Overall Study||0
7578838|NCT02733757|18654981|P4|COMPLETED|Overall Study||20
7578839|NCT02733757|18654982|P3|COMPLETED|Overall Study||20
7578840|NCT02733757|18654983|P2|COMPLETED|Overall Study||20
7578841|NCT02733757|18654984|P1|COMPLETED|Overall Study||20
7578842|NCT02733757|18654981|P4|STARTED|Overall Study||20
7578843|NCT02733757|18654982|P3|STARTED|Overall Study||20
7578844|NCT02733757|18654983|P2|STARTED|Overall Study||20
7578845|NCT02733757|18654984|P1|STARTED|Overall Study||20
7578846|NCT02733653|18654994|P1|NOT COMPLETED|Overall Study||1
7578847|NCT02733653|18654994|P1|COMPLETED|Overall Study||49
7578848|NCT02733653|18654994|P1|STARTED|Overall Study||50
7578849|NCT02733588|18655000|P1|NOT COMPLETED|Overall Study||0
7578850|NCT02733588|18655000|P1|COMPLETED|Overall Study||7
7578851|NCT02733588|18655000|P1|STARTED|Overall Study||7
7578852|NCT02733367|18655007|P1|NOT COMPLETED|Overall Study||6
7578853|NCT02733367|18655007|P1|COMPLETED|Overall Study||12
7578854|NCT02733367|18655007|P1|STARTED|Overall Study||18
7578855|NCT02733042|18655033|P19|NOT COMPLETED|Follow-up Period||2
7578856|NCT02733042|18655034|P18|NOT COMPLETED|Follow-up Period||2
7578857|NCT02733042|18655035|P17|NOT COMPLETED|Follow-up Period||0
7578858|NCT02733042|18655036|P16|NOT COMPLETED|Follow-up Period||5
7578859|NCT02733042|18655037|P15|NOT COMPLETED|Follow-up Period||1
7578860|NCT02733042|18655038|P14|NOT COMPLETED|Follow-up Period||4
7578861|NCT02733042|18655039|P13|NOT COMPLETED|Follow-up Period||9
7578862|NCT02733042|18655040|P12|NOT COMPLETED|Follow-up Period||9
7578863|NCT02733042|18655041|P11|NOT COMPLETED|Follow-up Period||5
7578864|NCT02733042|18655042|P10|NOT COMPLETED|Follow-up Period||2
7578865|NCT02733042|18655043|P9|NOT COMPLETED|Follow-up Period||4
7578866|NCT02733042|18655044|P8|NOT COMPLETED|Follow-up Period||4
7578867|NCT02733042|18655045|P7|NOT COMPLETED|Follow-up Period||0
7578868|NCT02733042|18655046|P6|NOT COMPLETED|Follow-up Period||2
7578869|NCT02733042|18655047|P5|NOT COMPLETED|Follow-up Period||1
7578870|NCT02733042|18655048|P4|NOT COMPLETED|Follow-up Period||3
7578871|NCT02733042|18655049|P3|NOT COMPLETED|Follow-up Period||6
7578872|NCT02733042|18655050|P2|NOT COMPLETED|Follow-up Period||3
7578873|NCT02733042|18655051|P1|NOT COMPLETED|Follow-up Period||3
7578874|NCT02733042|18655033|P19|COMPLETED|Follow-up Period||0
7578875|NCT02733042|18655034|P18|COMPLETED|Follow-up Period||1
7578876|NCT02733042|18655035|P17|COMPLETED|Follow-up Period||0
7578877|NCT02733042|18655036|P16|COMPLETED|Follow-up Period||0
7578878|NCT02733042|18655037|P15|COMPLETED|Follow-up Period||0
7578879|NCT02733042|18655038|P14|COMPLETED|Follow-up Period||0
7578880|NCT02733042|18655039|P13|COMPLETED|Follow-up Period||0
7578881|NCT02733042|18655040|P12|COMPLETED|Follow-up Period||0
7578882|NCT02733042|18655041|P11|COMPLETED|Follow-up Period||0
7578883|NCT02733042|18655042|P10|COMPLETED|Follow-up Period||0
7578884|NCT02733042|18655043|P9|COMPLETED|Follow-up Period||0
7578885|NCT02733042|18655044|P8|COMPLETED|Follow-up Period||0
7578886|NCT02733042|18655045|P7|COMPLETED|Follow-up Period||0
7578887|NCT02733042|18655046|P6|COMPLETED|Follow-up Period||0
7578888|NCT02733042|18655047|P5|COMPLETED|Follow-up Period||0
7578889|NCT02733042|18655048|P4|COMPLETED|Follow-up Period||0
7578890|NCT02733042|18655049|P3|COMPLETED|Follow-up Period||0
7578891|NCT02733042|18655050|P2|COMPLETED|Follow-up Period||0
7578892|NCT02733042|18655051|P1|COMPLETED|Follow-up Period||0
7578893|NCT02733042|18655033|P19|STARTED|Follow-up Period||2
7578894|NCT02733042|18655034|P18|STARTED|Follow-up Period||3
7578895|NCT02733042|18655035|P17|STARTED|Follow-up Period||0
7578896|NCT02733042|18655036|P16|STARTED|Follow-up Period||5
7578897|NCT02733042|18655037|P15|STARTED|Follow-up Period||1
7578898|NCT02733042|18655038|P14|STARTED|Follow-up Period||4
7578899|NCT02733042|18655039|P13|STARTED|Follow-up Period||9
7578900|NCT02733042|18655040|P12|STARTED|Follow-up Period||9
7578901|NCT02733042|18655041|P11|STARTED|Follow-up Period||5
7578902|NCT02733042|18655042|P10|STARTED|Follow-up Period||2
7578903|NCT02733042|18655043|P9|STARTED|Follow-up Period||4
7578904|NCT02733042|18655044|P8|STARTED|Follow-up Period||4
7578905|NCT02733042|18655045|P7|STARTED|Follow-up Period||0
7578906|NCT02733042|18655046|P6|STARTED|Follow-up Period||2
7578907|NCT02733042|18655047|P5|STARTED|Follow-up Period||1
7578908|NCT02733042|18655048|P4|STARTED|Follow-up Period||3
7578909|NCT02733042|18655049|P3|STARTED|Follow-up Period||6
7578910|NCT02733042|18655050|P2|STARTED|Follow-up Period||3
7578911|NCT02733042|18655051|P1|STARTED|Follow-up Period||3
7578912|NCT02733042|18655033|P19|NOT COMPLETED|Treatment Period||5
7578913|NCT02733042|18655034|P18|NOT COMPLETED|Treatment Period||5
7578914|NCT02733042|18655035|P17|NOT COMPLETED|Treatment Period||2
7578915|NCT02733042|18655036|P16|NOT COMPLETED|Treatment Period||10
7578916|NCT02733042|18655037|P15|NOT COMPLETED|Treatment Period||5
7578917|NCT02733042|18655038|P14|NOT COMPLETED|Treatment Period||4
7578918|NCT02733042|18655039|P13|NOT COMPLETED|Treatment Period||9
7578919|NCT02733042|18655040|P12|NOT COMPLETED|Treatment Period||6
7578920|NCT02733042|18655041|P11|NOT COMPLETED|Treatment Period||10
7578921|NCT02733042|18655042|P10|NOT COMPLETED|Treatment Period||10
7578922|NCT02733042|18655043|P9|NOT COMPLETED|Treatment Period||5
7578923|NCT02733042|18655044|P8|NOT COMPLETED|Treatment Period||3
7578924|NCT02733042|18655045|P7|NOT COMPLETED|Treatment Period||1
7578925|NCT02733042|18655046|P6|NOT COMPLETED|Treatment Period||3
7578926|NCT02733042|18655047|P5|NOT COMPLETED|Treatment Period||4
7578927|NCT02733042|18655048|P4|NOT COMPLETED|Treatment Period||3
7578928|NCT02733042|18655049|P3|NOT COMPLETED|Treatment Period||7
7578929|NCT02733042|18655050|P2|NOT COMPLETED|Treatment Period||2
7578930|NCT02733042|18655051|P1|NOT COMPLETED|Treatment Period||3
7578931|NCT02733042|18655033|P19|COMPLETED|Treatment Period||0
7578932|NCT02733042|18655034|P18|COMPLETED|Treatment Period||0
7578933|NCT02733042|18655035|P17|COMPLETED|Treatment Period||0
7578934|NCT02733042|18655036|P16|COMPLETED|Treatment Period||0
7578935|NCT02733042|18655037|P15|COMPLETED|Treatment Period||0
7578936|NCT02733042|18655038|P14|COMPLETED|Treatment Period||1
7578937|NCT02733042|18655039|P13|COMPLETED|Treatment Period||1
7578938|NCT02733042|18655040|P12|COMPLETED|Treatment Period||4
7578939|NCT02733042|18655041|P11|COMPLETED|Treatment Period||0
7578940|NCT02733042|18655042|P10|COMPLETED|Treatment Period||0
7578941|NCT02733042|18655043|P9|COMPLETED|Treatment Period||0
7578942|NCT02733042|18655044|P8|COMPLETED|Treatment Period||1
7578943|NCT02733042|18655045|P7|COMPLETED|Treatment Period||0
7578944|NCT02733042|18655046|P6|COMPLETED|Treatment Period||0
7578945|NCT02733042|18655047|P5|COMPLETED|Treatment Period||0
7578946|NCT02733042|18655048|P4|COMPLETED|Treatment Period||0
7578947|NCT02733042|18655049|P3|COMPLETED|Treatment Period||1
7578948|NCT02733042|18655050|P2|COMPLETED|Treatment Period||1
7578949|NCT02733042|18655051|P1|COMPLETED|Treatment Period||0
7578950|NCT02733042|18655033|P19|STARTED|Treatment Period||5
7578951|NCT02733042|18655034|P18|STARTED|Treatment Period||5
7578952|NCT02733042|18655035|P17|STARTED|Treatment Period||2
7578953|NCT02733042|18655036|P16|STARTED|Treatment Period||10
7578954|NCT02733042|18655037|P15|STARTED|Treatment Period||5
7578955|NCT02733042|18655038|P14|STARTED|Treatment Period||5
7578956|NCT02733042|18655039|P13|STARTED|Treatment Period||10
7578957|NCT02733042|18655040|P12|STARTED|Treatment Period||10
7578958|NCT02733042|18655041|P11|STARTED|Treatment Period||10
7578959|NCT02733042|18655042|P10|STARTED|Treatment Period||10
7578960|NCT02733042|18655043|P9|STARTED|Treatment Period||5
7578961|NCT02733042|18655044|P8|STARTED|Treatment Period||4
7578962|NCT02733042|18655045|P7|STARTED|Treatment Period||1
7578963|NCT02733042|18655046|P6|STARTED|Treatment Period||3
7578964|NCT02733042|18655047|P5|STARTED|Treatment Period||4
7578965|NCT02733042|18655048|P4|STARTED|Treatment Period||3
7578966|NCT02733042|18655049|P3|STARTED|Treatment Period||8
7578967|NCT02733042|18655050|P2|STARTED|Treatment Period||3
7578968|NCT02733042|18655051|P1|STARTED|Treatment Period||3
7578969|NCT02732951|18655256|P2|NOT COMPLETED|Overall Study||6
7578970|NCT02732951|18655257|P1|NOT COMPLETED|Overall Study||5
7578971|NCT02732951|18655256|P2|COMPLETED|Overall Study||46
7578972|NCT02732951|18655257|P1|COMPLETED|Overall Study||48
7578973|NCT02732951|18655256|P2|STARTED|Overall Study||52
7578974|NCT02732951|18655257|P1|STARTED|Overall Study||53
7578975|NCT02732938|18655267|P3|NOT COMPLETED|Overall Study||0
7578976|NCT02732938|18655268|P2|NOT COMPLETED|Overall Study||18
7578977|NCT02732938|18655269|P1|NOT COMPLETED|Overall Study||4
7578978|NCT02732938|18655267|P3|COMPLETED|Overall Study||0
7578979|NCT02732938|18655268|P2|COMPLETED|Overall Study||0
7578980|NCT02732938|18655269|P1|COMPLETED|Overall Study||0
7578981|NCT02732938|18655267|P3|Received Treatment|Overall Study||0
7578982|NCT02732938|18655268|P2|Received Treatment|Overall Study||17
7578983|NCT02732938|18655269|P1|Received Treatment|Overall Study||4
7578984|NCT02732938|18655267|P3|STARTED|Overall Study||0
7578985|NCT02732938|18655268|P2|STARTED|Overall Study||18
7578986|NCT02732938|18655269|P1|STARTED|Overall Study||4
7578987|NCT02732912|18655315|P2|NOT COMPLETED|Overall Study||18
7578988|NCT02732912|18655316|P1|NOT COMPLETED|Overall Study||10
7578989|NCT02732912|18655315|P2|COMPLETED|Overall Study||91
7578990|NCT02732912|18655316|P1|COMPLETED|Overall Study||87
7578991|NCT02732912|18655315|P2|STARTED|Overall Study||109
7578992|NCT02732912|18655316|P1|STARTED|Overall Study||97
7578993|NCT02732899|18655332|P2|NOT COMPLETED|Overall Study||0
7578994|NCT02732899|18655333|P1|NOT COMPLETED|Overall Study||0
7578995|NCT02732899|18655332|P2|COMPLETED|Overall Study||10
7578996|NCT02732899|18655333|P1|COMPLETED|Overall Study||10
7578997|NCT02732899|18655332|P2|STARTED|Overall Study||10
7578998|NCT02732899|18655333|P1|STARTED|Overall Study||10
7578999|NCT02732639|18655341|P1|NOT COMPLETED|Overall Study||1
7579000|NCT02732639|18655341|P1|COMPLETED|Overall Study||30
7579001|NCT02732639|18655341|P1|STARTED|Overall Study||31
7579002|NCT02732600|18655354|P2|NOT COMPLETED|Overall Study||108
7579003|NCT02732600|18655355|P1|NOT COMPLETED|Overall Study||94
7579004|NCT02732600|18655354|P2|COMPLETED|Overall Study||113
7579005|NCT02732600|18655355|P1|COMPLETED|Overall Study||100
7579006|NCT02732600|18655354|P2|1-Year|Overall Study||113
7579007|NCT02732600|18655355|P1|1-Year|Overall Study||100
7579008|NCT02732600|18655354|P2|6-months|Overall Study||129
7579009|NCT02732600|18655355|P1|6-months|Overall Study||121
7579010|NCT02732600|18655354|P2|STARTED|Overall Study||221
7579011|NCT02732600|18655355|P1|STARTED|Overall Study||194
7579012|NCT02732587|18655361|P1|NOT COMPLETED|Overall Study||0
7579013|NCT02732587|18655361|P1|COMPLETED|Overall Study||5
7579014|NCT02732587|18655361|P1|STARTED|Overall Study||5
7579015|NCT02732561|18655367|P2|NOT COMPLETED|Overall Study||1
7579016|NCT02732561|18655368|P1|NOT COMPLETED|Overall Study||2
7579017|NCT02732561|18655367|P2|COMPLETED|Overall Study||4
7579018|NCT02732561|18655368|P1|COMPLETED|Overall Study||3
7579019|NCT02732561|18655367|P2|STARTED|Overall Study||5
7579020|NCT02732561|18655368|P1|STARTED|Overall Study||5
7579021|NCT02732366|18655378|P2|NOT COMPLETED|Overall Study||2
7579022|NCT02732366|18655379|P1|NOT COMPLETED|Overall Study||5
7579023|NCT02732366|18655378|P2|COMPLETED|Overall Study||21
7579024|NCT02732366|18655379|P1|COMPLETED|Overall Study||18
7579025|NCT02732366|18655378|P2|Withdrawal by Participant|Overall Study||2
7579026|NCT02732366|18655379|P1|Withdrawal by Participant|Overall Study||5
7579027|NCT02732366|18655378|P2|STARTED|Overall Study||23
7579028|NCT02732366|18655379|P1|STARTED|Overall Study||23
7579029|NCT02732327|18655394|P2|NOT COMPLETED|Overall Study||1
7579030|NCT02732327|18655395|P1|NOT COMPLETED|Overall Study||0
7579031|NCT02732327|18655394|P2|COMPLETED|Overall Study||1
7579032|NCT02732327|18655395|P1|COMPLETED|Overall Study||0
7579033|NCT02732327|18655394|P2|STARTED|Overall Study||2
7579034|NCT02732327|18655395|P1|STARTED|Overall Study||0
7579035|NCT02732210|18655403|P2|NOT COMPLETED|Overall Study||294
7579036|NCT02732210|18655404|P1|NOT COMPLETED|Overall Study||85
7579037|NCT02732210|18655403|P2|COMPLETED|Overall Study||338
7579038|NCT02732210|18655404|P1|COMPLETED|Overall Study||218
7579039|NCT02732210|18655403|P2|STARTED|Overall Study||632
7579040|NCT02732210|18655404|P1|STARTED|Overall Study||303
7579041|NCT02732145|18655424|P4|NOT COMPLETED|Overall Study||0
7579042|NCT02732145|18655425|P3|NOT COMPLETED|Overall Study||0
7579043|NCT02732145|18655426|P2|NOT COMPLETED|Overall Study||0
7579044|NCT02732145|18655427|P1|NOT COMPLETED|Overall Study||0
7579045|NCT02732145|18655424|P4|COMPLETED|Overall Study||82
7579046|NCT02732145|18655425|P3|COMPLETED|Overall Study||82
7579047|NCT02732145|18655426|P2|COMPLETED|Overall Study||82
7579048|NCT02732145|18655427|P1|COMPLETED|Overall Study||82
7579049|NCT02732145|18655424|P4|STARTED|Overall Study||82
7579050|NCT02732145|18655425|P3|STARTED|Overall Study||82
7579051|NCT02732145|18655426|P2|STARTED|Overall Study||82
7579052|NCT02732145|18655427|P1|STARTED|Overall Study||82
7579053|NCT02731833|18655555|P2|NOT COMPLETED|Overall Study||0
7579054|NCT02731833|18655556|P1|NOT COMPLETED|Overall Study||0
7579055|NCT02731833|18655555|P2|COMPLETED|Overall Study||111
7579056|NCT02731833|18655556|P1|COMPLETED|Overall Study||111
7579057|NCT02731833|18655555|P2|STARTED|Overall Study||111
7579058|NCT02731833|18655556|P1|STARTED|Overall Study||111
7579059|NCT02731820|18655570|P2|NOT COMPLETED|Overall Study||2
7579060|NCT02731820|18655571|P1|NOT COMPLETED|Overall Study||3
7579061|NCT02731820|18655570|P2|COMPLETED|Overall Study||18
7579062|NCT02731820|18655571|P1|COMPLETED|Overall Study||17
7579063|NCT02731820|18655570|P2|STARTED|Overall Study||20
7579064|NCT02731820|18655571|P1|STARTED|Overall Study||20
7579065|NCT02731755|18655583|P2|NOT COMPLETED|Second Intervention||0
7579066|NCT02731755|18655584|P1|NOT COMPLETED|Second Intervention||0
7579067|NCT02731755|18655583|P2|COMPLETED|Second Intervention||8
7579068|NCT02731755|18655584|P1|COMPLETED|Second Intervention||8
7579069|NCT02731755|18655583|P2|STARTED|Second Intervention||8
7579070|NCT02731755|18655584|P1|STARTED|Second Intervention||8
7579071|NCT02731755|18655583|P2|NOT COMPLETED|First Intervention||2
7579072|NCT02731755|18655584|P1|NOT COMPLETED|First Intervention||0
7579073|NCT02731755|18655583|P2|COMPLETED|First Intervention||8
7579074|NCT02731755|18655584|P1|COMPLETED|First Intervention||8
7579075|NCT02731755|18655583|P2|STARTED|First Intervention||10
7579076|NCT02731755|18655584|P1|STARTED|First Intervention||8
7579077|NCT02731742|18655608|P4|NOT COMPLETED|Overall Study||2
7579078|NCT02731742|18655609|P3|NOT COMPLETED|Overall Study||6
7579079|NCT02731742|18655610|P2|NOT COMPLETED|Overall Study||3
7579080|NCT02731742|18655611|P1|NOT COMPLETED|Overall Study||3
7579081|NCT02731742|18655608|P4|COMPLETED|Overall Study||0
7579082|NCT02731742|18655609|P3|COMPLETED|Overall Study||0
7579083|NCT02731742|18655610|P2|COMPLETED|Overall Study||0
7579084|NCT02731742|18655611|P1|COMPLETED|Overall Study||0
7579085|NCT02731742|18655608|P4|STARTED|Overall Study||2
7579086|NCT02731742|18655609|P3|STARTED|Overall Study||6
7579087|NCT02731742|18655610|P2|STARTED|Overall Study||3
7579088|NCT02731742|18655611|P1|STARTED|Overall Study||3
7579089|NCT02731690|18655629|P1|NOT COMPLETED|Overall Study||30
7579090|NCT02731690|18655629|P1|COMPLETED|Overall Study||12
7579091|NCT02731690|18655629|P1|STARTED|Overall Study||42
7579092|NCT02731638|18655649|P2|NOT COMPLETED|Overall Study||9
7579093|NCT02731638|18655650|P1|NOT COMPLETED|Overall Study||6
7579094|NCT02731638|18655649|P2|COMPLETED|Overall Study||26
7579095|NCT02731638|18655650|P1|COMPLETED|Overall Study||29
7579096|NCT02731638|18655649|P2|STARTED|Overall Study||35
7579097|NCT02731638|18655650|P1|STARTED|Overall Study||35
7579098|NCT02731469|18655675|P11|NOT COMPLETED|Overall Study||0
7579099|NCT02731469|18655676|P10|NOT COMPLETED|Overall Study||0
7579100|NCT02731469|18655677|P9|NOT COMPLETED|Overall Study||0
7579101|NCT02731469|18655678|P8|NOT COMPLETED|Overall Study||0
7579102|NCT02731469|18655679|P7|NOT COMPLETED|Overall Study||0
7579103|NCT02731469|18655680|P6|NOT COMPLETED|Overall Study||0
7579104|NCT02731469|18655681|P5|NOT COMPLETED|Overall Study||0
7579105|NCT02731469|18655682|P4|NOT COMPLETED|Overall Study||0
7579106|NCT02731469|18655683|P3|NOT COMPLETED|Overall Study||0
7579107|NCT02731469|18655684|P2|NOT COMPLETED|Overall Study||0
7579108|NCT02731469|18655685|P1|NOT COMPLETED|Overall Study||0
7579109|NCT02731469|18655675|P11|COMPLETED|Overall Study||6
7579110|NCT02731469|18655676|P10|COMPLETED|Overall Study||6
7579111|NCT02731469|18655677|P9|COMPLETED|Overall Study||6
7579112|NCT02731469|18655678|P8|COMPLETED|Overall Study||6
7579113|NCT02731469|18655679|P7|COMPLETED|Overall Study||3
7579114|NCT02731469|18655680|P6|COMPLETED|Overall Study||3
7579115|NCT02731469|18655681|P5|COMPLETED|Overall Study||3
7579116|NCT02731469|18655682|P4|COMPLETED|Overall Study||3
7579117|NCT02731469|18655683|P3|COMPLETED|Overall Study||3
7579118|NCT02731469|18655684|P2|COMPLETED|Overall Study||3
7579119|NCT02731469|18655685|P1|COMPLETED|Overall Study||3
7579120|NCT02731469|18655675|P11|STARTED|Overall Study||6
7579121|NCT02731469|18655676|P10|STARTED|Overall Study||6
7579122|NCT02731469|18655677|P9|STARTED|Overall Study||6
7579123|NCT02731469|18655678|P8|STARTED|Overall Study||6
7579124|NCT02731469|18655679|P7|STARTED|Overall Study||3
7579125|NCT02731469|18655680|P6|STARTED|Overall Study||3
7579126|NCT02731469|18655681|P5|STARTED|Overall Study||3
7579127|NCT02731469|18655682|P4|STARTED|Overall Study||3
7579128|NCT02731469|18655683|P3|STARTED|Overall Study||3
7579129|NCT02731469|18655684|P2|STARTED|Overall Study||3
7579130|NCT02731469|18655685|P1|STARTED|Overall Study||3
7579131|NCT02731313|18655874|P1|NOT COMPLETED|Overall Study||0
7579132|NCT02731313|18655874|P1|COMPLETED|Overall Study||367
7579133|NCT02731313|18655874|P1|STARTED|Overall Study||367
7579134|NCT02731300|18655884|P2|NOT COMPLETED|Overall Study||0
7579135|NCT02731300|18655885|P1|NOT COMPLETED|Overall Study||0
7579136|NCT02731300|18655884|P2|COMPLETED|Overall Study||7
7579137|NCT02731300|18655885|P1|COMPLETED|Overall Study||15
7579138|NCT02731300|18655884|P2|STARTED|Overall Study||7
7579139|NCT02731300|18655885|P1|STARTED|Overall Study||15
7579140|NCT02731157|18655893|P1|NOT COMPLETED|Third Standard RCE||0
7579141|NCT02731157|18655893|P1|COMPLETED|Third Standard RCE||3
7579142|NCT02731157|18655893|P1|STARTED|Third Standard RCE||3
7579143|NCT02731157|18655893|P1|NOT COMPLETED|Second Standard RCE||0
7579144|NCT02731157|18655893|P1|COMPLETED|Second Standard RCE||3
7579145|NCT02731157|18655893|P1|STARTED|Second Standard RCE||3
7579146|NCT02731157|18655893|P1|NOT COMPLETED|Third Rejuvenated RCE||0
7579147|NCT02731157|18655893|P1|COMPLETED|Third Rejuvenated RCE||3
7579148|NCT02731157|18655893|P1|STARTED|Third Rejuvenated RCE||3
7579149|NCT02731157|18655893|P1|NOT COMPLETED|Second Rejuvenated RCE||0
7579150|NCT02731157|18655893|P1|COMPLETED|Second Rejuvenated RCE||3
7579151|NCT02731157|18655893|P1|STARTED|Second Rejuvenated RCE||3
7579152|NCT02731157|18655893|P1|NOT COMPLETED|First Rejuvenated RCE||1
7579153|NCT02731157|18655893|P1|COMPLETED|First Rejuvenated RCE||3
7579154|NCT02731157|18655893|P1|STARTED|First Rejuvenated RCE||4
7579155|NCT02731157|18655893|P1|NOT COMPLETED|First Standard RCE||0
7579156|NCT02731157|18655893|P1|COMPLETED|First Standard RCE||4
7579157|NCT02731157|18655893|P1|STARTED|First Standard RCE||4
7579158|NCT02731131|18655911|P2|NOT COMPLETED|Overall Study||2
7579159|NCT02731131|18655912|P1|NOT COMPLETED|Overall Study||0
7579160|NCT02731131|18655911|P2|COMPLETED|Overall Study||4
7579161|NCT02731131|18655912|P1|COMPLETED|Overall Study||6
7579162|NCT02731131|18655911|P2|STARTED|Overall Study||6
7579163|NCT02731131|18655912|P1|STARTED|Overall Study||6
7579164|NCT02730988|18655930|P2|NOT COMPLETED|Overall Study||10
7579165|NCT02730988|18655931|P1|NOT COMPLETED|Overall Study||4
7579166|NCT02730988|18655930|P2|COMPLETED|Overall Study||39
7579167|NCT02730988|18655931|P1|COMPLETED|Overall Study||43
7579168|NCT02730988|18655930|P2|STARTED|Overall Study||49
7579169|NCT02730988|18655931|P1|STARTED|Overall Study||47
7579170|NCT02730962|18655941|P2|NOT COMPLETED|Overall Study||0
7579171|NCT02730962|18655942|P1|NOT COMPLETED|Overall Study||0
7579172|NCT02730962|18655941|P2|COMPLETED|Overall Study||5
7579173|NCT02730962|18655942|P1|COMPLETED|Overall Study||7
7579174|NCT02730962|18655941|P2|STARTED|Overall Study||5
7579175|NCT02730962|18655942|P1|STARTED|Overall Study||7
7579176|NCT02730884|18655954|P1|NOT COMPLETED|Overall Study||0
7579177|NCT02730884|18655954|P1|COMPLETED|Overall Study||3
7579178|NCT02730884|18655954|P1|STARTED|Overall Study||3
7579179|NCT02730871|18655962|P2|NOT COMPLETED|Overall Study||0
7579180|NCT02730871|18655963|P1|NOT COMPLETED|Overall Study||6
7579181|NCT02730871|18655962|P2|COMPLETED|Overall Study||67
7579182|NCT02730871|18655963|P1|COMPLETED|Overall Study||61
7579183|NCT02730871|18655962|P2|Safety Analysis Set|Overall Study||67
7579184|NCT02730871|18655963|P1|Safety Analysis Set|Overall Study||67
7579185|NCT02730871|18655962|P2|Full Analysis Set (FAS)|Overall Study||67
7579186|NCT02730871|18655963|P1|Full Analysis Set (FAS)|Overall Study||67
7579187|NCT02730871|18655962|P2|STARTED|Overall Study||67
7579188|NCT02730871|18655963|P1|STARTED|Overall Study||67
7579189|NCT02730819|18655977|P1|NOT COMPLETED|Overall Study||9
7579190|NCT02730819|18655977|P1|COMPLETED|Overall Study||10
7579191|NCT02730819|18655977|P1|Follow-up Week 20|Overall Study||10
7579192|NCT02730819|18655977|P1|Follow-up Week 16|Overall Study||11
7579193|NCT02730819|18655977|P1|Follow-up Week 12|Overall Study||11
7579194|NCT02730819|18655977|P1|Follow-up Week 8|Overall Study||14
7579195|NCT02730819|18655977|P1|Follow-up Week 4|Overall Study||16
7579196|NCT02730819|18655977|P1|Follow-up Week 2|Overall Study||15
7579197|NCT02730819|18655977|P1|STARTED|Overall Study||19
7579198|NCT02730728|18655986|P3|NOT COMPLETED|Overall Study||1
7579199|NCT02730728|18655987|P2|NOT COMPLETED|Overall Study||2
7579200|NCT02730728|18655988|P1|NOT COMPLETED|Overall Study||0
7579201|NCT02730728|18655986|P3|COMPLETED|Overall Study||52
7579202|NCT02730728|18655987|P2|COMPLETED|Overall Study||51
7579203|NCT02730728|18655988|P1|COMPLETED|Overall Study||53
7579204|NCT02730728|18655986|P3|STARTED|Overall Study||53
7579205|NCT02730728|18655987|P2|STARTED|Overall Study||53
7579206|NCT02730728|18655988|P1|STARTED|Overall Study||53
7579207|NCT02730663|18656005|P1|NOT COMPLETED|Overall Study||1
7579208|NCT02730663|18656005|P1|COMPLETED|Overall Study||35
7579209|NCT02730663|18656005|P1|STARTED|Overall Study||36
7579210|NCT02730598|18656017|P2|NOT COMPLETED|Overall Study||4
7579211|NCT02730598|18656018|P1|NOT COMPLETED|Overall Study||4
7579212|NCT02730598|18656017|P2|COMPLETED|Overall Study||10
7579213|NCT02730598|18656018|P1|COMPLETED|Overall Study||10
7579214|NCT02730598|18656017|P2|STARTED|Overall Study||14
7579215|NCT02730598|18656018|P1|STARTED|Overall Study||14
7579216|NCT02730455|18656041|P3|NOT COMPLETED|Overall Study||11
7579217|NCT02730455|18656042|P2|NOT COMPLETED|Overall Study||14
7579218|NCT02730455|18656043|P1|NOT COMPLETED|Overall Study||13
7579219|NCT02730455|18656041|P3|COMPLETED|Overall Study||81
7579220|NCT02730455|18656042|P2|COMPLETED|Overall Study||77
7579221|NCT02730455|18656043|P1|COMPLETED|Overall Study||81
7579222|NCT02730455|18656041|P3|Who Received Total Volume of Study Drug|Overall Study||89
7579223|NCT02730455|18656042|P2|Who Received Total Volume of Study Drug|Overall Study||88
7579224|NCT02730455|18656043|P1|Who Received Total Volume of Study Drug|Overall Study||90
7579225|NCT02730455|18656041|P3|Participants Dosed|Overall Study||91
7579226|NCT02730455|18656042|P2|Participants Dosed|Overall Study||88
7579227|NCT02730455|18656043|P1|Participants Dosed|Overall Study||91
7579228|NCT02730455|18656041|P3|Safety Population|Overall Study||89
7579229|NCT02730455|18656042|P2|Safety Population|Overall Study||90
7579230|NCT02730455|18656043|P1|Safety Population|Overall Study||91
7579231|NCT02730455|18656041|P3|STARTED|Overall Study||92
7579232|NCT02730455|18656042|P2|STARTED|Overall Study||91
7579233|NCT02730455|18656043|P1|STARTED|Overall Study||94
7579234|NCT02730403|18656075|P1|NOT COMPLETED|Overall Study||54
7579235|NCT02730403|18656075|P1|COMPLETED|Overall Study||157
7579236|NCT02730403|18656075|P1|STARTED|Overall Study||211
7579237|NCT02730377|18656093|P2|NOT COMPLETED|Overall Study||633
7579238|NCT02730377|18656094|P1|NOT COMPLETED|Overall Study||550
7579239|NCT02730377|18656093|P2|COMPLETED|Overall Study||362
7579240|NCT02730377|18656094|P1|COMPLETED|Overall Study||446
7579241|NCT02730377|18656093|P2|Safety Analysis Set (SAS)|Overall Study||984
7579242|NCT02730377|18656094|P1|Safety Analysis Set (SAS)|Overall Study||980
7579243|NCT02730377|18656093|P2|Full Analysis Set (FAS)|Overall Study||995
7579244|NCT02730377|18656094|P1|Full Analysis Set (FAS)|Overall Study||996
7579245|NCT02730377|18656093|P2|Treated|Overall Study||984
7579246|NCT02730377|18656094|P1|Treated|Overall Study||980
7579247|NCT02730377|18656093|P2|STARTED|Overall Study||995
7579248|NCT02730377|18656094|P1|STARTED|Overall Study||996
7579249|NCT02730351|18656144|P2|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
7579250|NCT02730351|18656145|P1|NOT COMPLETED|Treatment Period 2 (2 Weeks)||2
7579251|NCT02730351|18656144|P2|COMPLETED|Treatment Period 2 (2 Weeks)||36
7579252|NCT02730351|18656145|P1|COMPLETED|Treatment Period 2 (2 Weeks)||33
7579253|NCT02730351|18656144|P2|STARTED|Treatment Period 2 (2 Weeks)||36
7579254|NCT02730351|18656145|P1|STARTED|Treatment Period 2 (2 Weeks)||35
7579255|NCT02730351|18656144|P2|NOT COMPLETED|Wash-out Period (2 Weeks)||1
7579256|NCT02730351|18656145|P1|NOT COMPLETED|Wash-out Period (2 Weeks)||1
7579257|NCT02730351|18656144|P2|COMPLETED|Wash-out Period (2 Weeks)||36
7579258|NCT02730351|18656145|P1|COMPLETED|Wash-out Period (2 Weeks)||35
7579259|NCT02730351|18656144|P2|STARTED|Wash-out Period (2 Weeks)||37
7579260|NCT02730351|18656145|P1|STARTED|Wash-out Period (2 Weeks)||36
7579261|NCT02730351|18656144|P2|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
7579262|NCT02730351|18656145|P1|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
7579263|NCT02730351|18656144|P2|COMPLETED|Treatment Period 1 (2 Weeks)||37
7579264|NCT02730351|18656145|P1|COMPLETED|Treatment Period 1 (2 Weeks)||36
7579265|NCT02730351|18656144|P2|STARTED|Treatment Period 1 (2 Weeks)||37
7579266|NCT02730351|18656145|P1|STARTED|Treatment Period 1 (2 Weeks)||37
7579267|NCT02730260|18656159|P2|NOT COMPLETED|Overall Study||75
7579268|NCT02730260|18656160|P1|NOT COMPLETED|Overall Study||82
7579269|NCT02730260|18656159|P2|COMPLETED|Overall Study||185
7579270|NCT02730260|18656160|P1|COMPLETED|Overall Study||176
7579271|NCT02730260|18656159|P2|STARTED|Overall Study||260
7579272|NCT02730260|18656160|P1|STARTED|Overall Study||258
7579273|NCT02730247|18656166|P1|NOT COMPLETED|Overall Study||0
7579274|NCT02730247|18656166|P1|COMPLETED|Overall Study||7
7579275|NCT02730247|18656166|P1|STARTED|Overall Study||7
7579276|NCT02730208|18656179|P2|NOT COMPLETED|Overall Study||1
7579277|NCT02730208|18656180|P1|NOT COMPLETED|Overall Study||0
7579278|NCT02730208|18656179|P2|COMPLETED|Overall Study||20
7579279|NCT02730208|18656180|P1|COMPLETED|Overall Study||20
7579280|NCT02730208|18656179|P2|STARTED|Overall Study||21
7579281|NCT02730208|18656180|P1|STARTED|Overall Study||20
7579282|NCT02730195|18656188|P1|NOT COMPLETED|Overall Study||1
7579283|NCT02730195|18656188|P1|COMPLETED|Overall Study||8
7579284|NCT02730195|18656188|P1|STARTED|Overall Study||9
7579285|NCT02730169|18656198|P4|NOT COMPLETED|Overall Study||16
7579286|NCT02730169|18656199|P3|NOT COMPLETED|Overall Study||17
7579287|NCT02730169|18656200|P2|NOT COMPLETED|Overall Study||21
7579288|NCT02730169|18656201|P1|NOT COMPLETED|Overall Study||14
7579289|NCT02730169|18656198|P4|COMPLETED|Overall Study||55
7579290|NCT02730169|18656199|P3|COMPLETED|Overall Study||50
7579291|NCT02730169|18656200|P2|COMPLETED|Overall Study||45
7579292|NCT02730169|18656201|P1|COMPLETED|Overall Study||53
7579293|NCT02730169|18656198|P4|STARTED|Overall Study||71
7579294|NCT02730169|18656199|P3|STARTED|Overall Study||67
7579295|NCT02730169|18656200|P2|STARTED|Overall Study||66
7579296|NCT02730169|18656201|P1|STARTED|Overall Study||67
7579297|NCT02730130|18656261|P1|NOT COMPLETED|Overall Study||0
7579298|NCT02730130|18656261|P1|COMPLETED|Overall Study||17
7579299|NCT02730130|18656261|P1|STARTED|Overall Study||17
7579300|NCT02729909|18656269|P2|NOT COMPLETED|Overall Study||5
7579301|NCT02729909|18656270|P1|NOT COMPLETED|Overall Study||1
7579302|NCT02729909|18656269|P2|COMPLETED|Overall Study||101
7579303|NCT02729909|18656270|P1|COMPLETED|Overall Study||104
7579304|NCT02729909|18656269|P2|STARTED|Overall Study||106
7579305|NCT02729909|18656270|P1|STARTED|Overall Study||105
7579306|NCT02729896|18656289|P3|NOT COMPLETED|Overall Study||22
7579307|NCT02729896|18656290|P2|NOT COMPLETED|Overall Study||9
7579308|NCT02729896|18656291|P1|NOT COMPLETED|Overall Study||2
7579309|NCT02729896|18656289|P3|COMPLETED|Overall Study||1
7579310|NCT02729896|18656290|P2|COMPLETED|Overall Study||1
7579311|NCT02729896|18656291|P1|COMPLETED|Overall Study||1
7579312|NCT02729896|18656289|P3|STARTED|Overall Study||23
7579313|NCT02729896|18656290|P2|STARTED|Overall Study||10
7579314|NCT02729896|18656291|P1|STARTED|Overall Study||3
7579315|NCT02729831|18656336|P4|NOT COMPLETED|6 Month Follow-up||43
7579316|NCT02729831|18656337|P3|NOT COMPLETED|6 Month Follow-up||48
7579317|NCT02729831|18656338|P2|NOT COMPLETED|6 Month Follow-up||54
7579318|NCT02729831|18656339|P1|NOT COMPLETED|6 Month Follow-up||55
7579319|NCT02729831|18656336|P4|COMPLETED|6 Month Follow-up||232
7579320|NCT02729831|18656337|P3|COMPLETED|6 Month Follow-up||227
7579321|NCT02729831|18656338|P2|COMPLETED|6 Month Follow-up||238
7579322|NCT02729831|18656339|P1|COMPLETED|6 Month Follow-up||227
7579323|NCT02729831|18656336|P4|STARTED|6 Month Follow-up||275
7579324|NCT02729831|18656337|P3|STARTED|6 Month Follow-up||275
7579325|NCT02729831|18656338|P2|STARTED|6 Month Follow-up||292
7579326|NCT02729831|18656339|P1|STARTED|6 Month Follow-up||282
7579327|NCT02729831|18656336|P4|NOT COMPLETED|1 Week Post-visit||36
7579328|NCT02729831|18656337|P3|NOT COMPLETED|1 Week Post-visit||38
7579329|NCT02729831|18656338|P2|NOT COMPLETED|1 Week Post-visit||40
7579330|NCT02729831|18656339|P1|NOT COMPLETED|1 Week Post-visit||43
7579331|NCT02729831|18656336|P4|COMPLETED|1 Week Post-visit||239
7579332|NCT02729831|18656337|P3|COMPLETED|1 Week Post-visit||237
7579333|NCT02729831|18656338|P2|COMPLETED|1 Week Post-visit||252
7579334|NCT02729831|18656339|P1|COMPLETED|1 Week Post-visit||239
7579335|NCT02729831|18656336|P4|STARTED|1 Week Post-visit||275
7579336|NCT02729831|18656337|P3|STARTED|1 Week Post-visit||275
7579337|NCT02729831|18656338|P2|STARTED|1 Week Post-visit||292
7579338|NCT02729831|18656339|P1|STARTED|1 Week Post-visit||282
7579339|NCT02729831|18656336|P4|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||17
7579340|NCT02729831|18656337|P3|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||18
7579341|NCT02729831|18656338|P2|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||23
7579342|NCT02729831|18656339|P1|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||38
7579343|NCT02729831|18656336|P4|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
7579344|NCT02729831|18656337|P3|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
7579345|NCT02729831|18656338|P2|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||292
7579346|NCT02729831|18656339|P1|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||282
7579347|NCT02729831|18656336|P4|STARTED|Baseline (Post Decision Aid, Pre-visit)||292
7579348|NCT02729831|18656337|P3|STARTED|Baseline (Post Decision Aid, Pre-visit)||293
7579349|NCT02729831|18656338|P2|STARTED|Baseline (Post Decision Aid, Pre-visit)||315
7579350|NCT02729831|18656339|P1|STARTED|Baseline (Post Decision Aid, Pre-visit)||320
7579351|NCT02729753|18656367|P2|NOT COMPLETED|Overall Study||1
7579352|NCT02729753|18656368|P1|NOT COMPLETED|Overall Study||0
7579353|NCT02729753|18656367|P2|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|6
7579354|NCT02729753|18656368|P1|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|3
7579355|NCT02729753|18656367|P2|STARTED|Overall Study|First patient enrolled April 2016|7
7579356|NCT02729753|18656368|P1|STARTED|Overall Study|First patient enrolled April 2016|3
7579357|NCT02729545|18656382|P2|NOT COMPLETED|Overall Study||5
7579358|NCT02729545|18656383|P1|NOT COMPLETED|Overall Study||3
7579359|NCT02729545|18656382|P2|COMPLETED|Overall Study||25
7579360|NCT02729545|18656383|P1|COMPLETED|Overall Study||27
7579361|NCT02729545|18656382|P2|STARTED|Overall Study||30
7579362|NCT02729545|18656383|P1|STARTED|Overall Study||30
7579363|NCT02729194|18656405|P1|NOT COMPLETED|Overall Study||3
7579364|NCT02729194|18656405|P1|COMPLETED|Overall Study||13
7579365|NCT02729194|18656405|P1|STARTED|Overall Study||16
7579366|NCT02729051|18656417|P2|NOT COMPLETED|Overall Study||32
7579367|NCT02729051|18656418|P1|NOT COMPLETED|Overall Study||30
7579368|NCT02729051|18656417|P2|COMPLETED|Overall Study||496
7579369|NCT02729051|18656418|P1|COMPLETED|Overall Study||497
7579370|NCT02729051|18656417|P2|STARTED|Overall Study||528
7579371|NCT02729051|18656418|P1|STARTED|Overall Study||527
7579372|NCT02729038|18656438|P4|NOT COMPLETED|Part 2 (Up to 50 Days)||0
7579373|NCT02729038|18656439|P3|NOT COMPLETED|Part 2 (Up to 50 Days)||0
7579374|NCT02729038|18656440|P2|NOT COMPLETED|Part 2 (Up to 50 Days)||0
7579375|NCT02729038|18656441|P1|NOT COMPLETED|Part 2 (Up to 50 Days)||0
7579376|NCT02729038|18656438|P4|COMPLETED|Part 2 (Up to 50 Days)||8
7579377|NCT02729038|18656439|P3|COMPLETED|Part 2 (Up to 50 Days)||0
7579378|NCT02729038|18656440|P2|COMPLETED|Part 2 (Up to 50 Days)||0
7579379|NCT02729038|18656441|P1|COMPLETED|Part 2 (Up to 50 Days)||0
7579380|NCT02729038|18656438|P4|STARTED|Part 2 (Up to 50 Days)||8
7579381|NCT02729038|18656439|P3|STARTED|Part 2 (Up to 50 Days)||0
7579382|NCT02729038|18656440|P2|STARTED|Part 2 (Up to 50 Days)||0
7579383|NCT02729038|18656441|P1|STARTED|Part 2 (Up to 50 Days)||0
7579384|NCT02729038|18656438|P4|NOT COMPLETED|Part 1 (Up to 44 Days)||0
7579385|NCT02729038|18656439|P3|NOT COMPLETED|Part 1 (Up to 44 Days)||0
7579386|NCT02729038|18656440|P2|NOT COMPLETED|Part 1 (Up to 44 Days)||0
7579387|NCT02729038|18656441|P1|NOT COMPLETED|Part 1 (Up to 44 Days)||0
7579388|NCT02729038|18656438|P4|COMPLETED|Part 1 (Up to 44 Days)||0
7579389|NCT02729038|18656439|P3|COMPLETED|Part 1 (Up to 44 Days)||8
7579390|NCT02729038|18656440|P2|COMPLETED|Part 1 (Up to 44 Days)||8
7579391|NCT02729038|18656441|P1|COMPLETED|Part 1 (Up to 44 Days)||8
7579392|NCT02729038|18656438|P4|STARTED|Part 1 (Up to 44 Days)||0
7579393|NCT02729038|18656439|P3|STARTED|Part 1 (Up to 44 Days)||8
7579394|NCT02729038|18656440|P2|STARTED|Part 1 (Up to 44 Days)||8
7579395|NCT02729038|18656441|P1|STARTED|Part 1 (Up to 44 Days)||8
7579396|NCT02729025|18656562|P2|NOT COMPLETED|Overall Study||1
7579397|NCT02729025|18656563|P1|NOT COMPLETED|Overall Study||0
7579398|NCT02729025|18656562|P2|COMPLETED|Overall Study||64
7579399|NCT02729025|18656563|P1|COMPLETED|Overall Study||64
7579400|NCT02729025|18656562|P2|STARTED|Overall Study||65
7579401|NCT02729025|18656563|P1|STARTED|Overall Study||64
7579402|NCT02728895|18656577|P2|NOT COMPLETED|Overall Study||5
7579403|NCT02728895|18656578|P1|NOT COMPLETED|Overall Study||1
7579404|NCT02728895|18656577|P2|COMPLETED|Overall Study||16
7579405|NCT02728895|18656578|P1|COMPLETED|Overall Study||2
7579406|NCT02728895|18656577|P2|STARTED|Overall Study||21
7579407|NCT02728895|18656578|P1|STARTED|Overall Study||3
7579408|NCT02728830|18656598|P1|NOT COMPLETED|Overall Study||24
7579409|NCT02728830|18656598|P1|COMPLETED|Overall Study||15
7579410|NCT02728830|18656598|P1|STARTED|Overall Study||39
7579411|NCT02728258|18656605|P1|NOT COMPLETED|Overall Study||0
7579412|NCT02728258|18656605|P1|COMPLETED|Overall Study||11
7579413|NCT02728258|18656605|P1|STARTED|Overall Study||11
7579414|NCT02728206|18656613|P1|NOT COMPLETED|Overall Study||1
7579415|NCT02728206|18656613|P1|COMPLETED|Overall Study||8
7579416|NCT02728206|18656613|P1|STARTED|Overall Study||9
7579417|NCT02728089|18656621|P1|NOT COMPLETED|Overall Study||3
7579418|NCT02728089|18656621|P1|COMPLETED|Overall Study||112
7579419|NCT02728089|18656621|P1|Treated|Overall Study||114
7579420|NCT02728089|18656621|P1|STARTED|Overall Study||115
7579421|NCT02727894|18656638|P2|NOT COMPLETED|Overall Study||0
7579422|NCT02727894|18656639|P1|NOT COMPLETED|Overall Study||0
7579423|NCT02727894|18656638|P2|COMPLETED|Overall Study|September 2015|192
7579424|NCT02727894|18656639|P1|COMPLETED|Overall Study|September 2015|73
7579425|NCT02727894|18656638|P2|STARTED|Overall Study|March 2013|192
7579426|NCT02727894|18656639|P1|STARTED|Overall Study|March 2013|73
7579427|NCT02727842|18656655|P1|NOT COMPLETED|Overall Study||0
7579428|NCT02727842|18656655|P1|COMPLETED|Overall Study||30
7579429|NCT02727842|18656655|P1|STARTED|Overall Study||30
7579430|NCT02727816|18656659|P1|NOT COMPLETED|Overall Study||0
7579431|NCT02727816|18656659|P1|COMPLETED|Overall Study||35
7579432|NCT02727816|18656659|P1|STARTED|Overall Study||35
7579433|NCT02727777|18656709|P3|NOT COMPLETED|Overall Study||0
7579434|NCT02727777|18656710|P2|NOT COMPLETED|Overall Study||0
7579435|NCT02727777|18656711|P1|NOT COMPLETED|Overall Study||4
7579436|NCT02727777|18656709|P3|COMPLETED|Overall Study||0
7579437|NCT02727777|18656710|P2|COMPLETED|Overall Study||0
7579438|NCT02727777|18656711|P1|COMPLETED|Overall Study||0
7579439|NCT02727777|18656709|P3|STARTED|Overall Study||0
7579440|NCT02727777|18656710|P2|STARTED|Overall Study||0
7579441|NCT02727777|18656711|P1|STARTED|Overall Study||4
7579442|NCT02727751|18656725|P1|NOT COMPLETED|Overall Study||50
7579443|NCT02727751|18656725|P1|COMPLETED|Overall Study||262
7579444|NCT02727751|18656725|P1|STARTED|Overall Study||312
7579445|NCT02727660|18656732|P3|NOT COMPLETED|Overall Study||165
7579446|NCT02727660|18656733|P2|NOT COMPLETED|Overall Study||116
7579447|NCT02727660|18656734|P1|NOT COMPLETED|Overall Study||116
7579448|NCT02727660|18656732|P3|COMPLETED|Overall Study||442
7579449|NCT02727660|18656733|P2|COMPLETED|Overall Study||501
7579450|NCT02727660|18656734|P1|COMPLETED|Overall Study||503
7579451|NCT02727660|18656732|P3|STARTED|Overall Study||607
7579452|NCT02727660|18656733|P2|STARTED|Overall Study||617
7579453|NCT02727660|18656734|P1|STARTED|Overall Study||619
7579454|NCT02727322|18656753|P2|NOT COMPLETED|Overall Study||1
7579455|NCT02727322|18656754|P1|NOT COMPLETED|Overall Study||2
7579456|NCT02727322|18656753|P2|COMPLETED|Overall Study||76
7579457|NCT02727322|18656754|P1|COMPLETED|Overall Study||75
7579458|NCT02727322|18656753|P2|STARTED|Overall Study||77
7579459|NCT02727322|18656754|P1|STARTED|Overall Study||77
7579460|NCT02726971|18656766|P2|NOT COMPLETED|Overall Study||9
7579461|NCT02726971|18656767|P1|NOT COMPLETED|Overall Study||11
7579462|NCT02726971|18656766|P2|COMPLETED|Overall Study||62
7579463|NCT02726971|18656767|P1|COMPLETED|Overall Study||59
7579464|NCT02726971|18656766|P2|STARTED|Overall Study||71
7579465|NCT02726971|18656767|P1|STARTED|Overall Study||70
7579466|NCT02726945|18656780|P3|NOT COMPLETED|Overall Study||1
7579467|NCT02726945|18656781|P2|NOT COMPLETED|Overall Study||1
7579468|NCT02726945|18656782|P1|NOT COMPLETED|Overall Study||0
7579469|NCT02726945|18656780|P3|COMPLETED|Overall Study||12
7579470|NCT02726945|18656781|P2|COMPLETED|Overall Study||12
7579471|NCT02726945|18656782|P1|COMPLETED|Overall Study||13
7579472|NCT02726945|18656780|P3|STARTED|Overall Study||13
7579473|NCT02726945|18656781|P2|STARTED|Overall Study||13
7579474|NCT02726945|18656782|P1|STARTED|Overall Study||13
7579475|NCT02726789|18656793|P1|NOT COMPLETED|Overall Study||0
7579476|NCT02726789|18656793|P1|COMPLETED|Overall Study||5
7579477|NCT02726789|18656793|P1|STARTED|Overall Study||5
7579478|NCT02726620|18656802|P2|NOT COMPLETED|Through End of Study: All Interventions||0
7579479|NCT02726620|18656803|P1|NOT COMPLETED|Through End of Study: All Interventions||0
7579480|NCT02726620|18656802|P2|COMPLETED|Through End of Study: All Interventions||3234
7579481|NCT02726620|18656803|P1|COMPLETED|Through End of Study: All Interventions||0
7579482|NCT02726620|18656802|P2|Correct IOH Notifications|Through End of Study: All Interventions||2072
7579483|NCT02726620|18656803|P1|Correct IOH Notifications|Through End of Study: All Interventions||0
7579484|NCT02726620|18656802|P2|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||2793
7579485|NCT02726620|18656803|P1|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||0
7579486|NCT02726620|18656802|P2|STARTED|Through End of Study: All Interventions||3234
7579487|NCT02726620|18656803|P1|STARTED|Through End of Study: All Interventions||0
7579488|NCT02726620|18656802|P2|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
7579489|NCT02726620|18656803|P1|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
7579490|NCT02726620|18656802|P2|COMPLETED|Months 2-3: In-room Providers Randomized||1253
7579491|NCT02726620|18656803|P1|COMPLETED|Months 2-3: In-room Providers Randomized||0
7579492|NCT02726620|18656802|P2|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||825
7579493|NCT02726620|18656803|P1|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||0
7579494|NCT02726620|18656802|P2|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||1103
7579495|NCT02726620|18656803|P1|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||0
7579496|NCT02726620|18656802|P2|STARTED|Months 2-3: In-room Providers Randomized||1253
7579497|NCT02726620|18656803|P1|STARTED|Months 2-3: In-room Providers Randomized||0
7579498|NCT02726620|18656802|P2|NOT COMPLETED|Month 1: Attending Randomization||0
7579499|NCT02726620|18656803|P1|NOT COMPLETED|Month 1: Attending Randomization||0
7579500|NCT02726620|18656802|P2|COMPLETED|Month 1: Attending Randomization||485
7579501|NCT02726620|18656803|P1|COMPLETED|Month 1: Attending Randomization||0
7579502|NCT02726620|18656802|P2|Correct IOH Notifications|Month 1: Attending Randomization||313
7579503|NCT02726620|18656803|P1|Correct IOH Notifications|Month 1: Attending Randomization||0
7579504|NCT02726620|18656802|P2|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||432
7579505|NCT02726620|18656803|P1|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||0
7579506|NCT02726620|18656802|P2|STARTED|Month 1: Attending Randomization||485
7579507|NCT02726620|18656803|P1|STARTED|Month 1: Attending Randomization||0
7579508|NCT02726620|18656802|P2|NOT COMPLETED|Historic Cohort - Three Years||0
7579509|NCT02726620|18656803|P1|NOT COMPLETED|Historic Cohort - Three Years||0
7579510|NCT02726620|18656802|P2|COMPLETED|Historic Cohort - Three Years||0
7579511|NCT02726620|18656803|P1|COMPLETED|Historic Cohort - Three Years||17463
7579512|NCT02726620|18656802|P2|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||0
7579513|NCT02726620|18656803|P1|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||15624
7579514|NCT02726620|18656802|P2|STARTED|Historic Cohort - Three Years||0
7579515|NCT02726620|18656803|P1|STARTED|Historic Cohort - Three Years||17463
7579516|NCT02726451|18656901|P2|NOT COMPLETED|Overall Study||0
7579517|NCT02726451|18656902|P1|NOT COMPLETED|Overall Study||0
7579518|NCT02726451|18656901|P2|COMPLETED|Overall Study||10
7579519|NCT02726451|18656902|P1|COMPLETED|Overall Study||10
7579520|NCT02726451|18656901|P2|STARTED|Overall Study||10
7579521|NCT02726451|18656902|P1|STARTED|Overall Study||10
7579522|NCT02726399|18656916|P1|NOT COMPLETED|Overall Study||7
7579523|NCT02726399|18656916|P1|COMPLETED|Overall Study||0
7579524|NCT02726399|18656916|P1|STARTED|Overall Study||7
7579525|NCT02726178|18656922|P2|NOT COMPLETED|Overall Study||0
7579526|NCT02726178|18656923|P1|NOT COMPLETED|Overall Study||0
7579527|NCT02726178|18656922|P2|COMPLETED|Overall Study||28
7579528|NCT02726178|18656923|P1|COMPLETED|Overall Study||28
7579529|NCT02726178|18656922|P2|STARTED|Overall Study||28
7579530|NCT02726178|18656923|P1|STARTED|Overall Study||28
7579531|NCT02726113|18656933|P2|NOT COMPLETED|Genomic Analysis||2
7579532|NCT02726113|18656934|P1|NOT COMPLETED|Genomic Analysis||4
7579533|NCT02726113|18656933|P2|COMPLETED|Genomic Analysis||12
7579534|NCT02726113|18656934|P1|COMPLETED|Genomic Analysis||15
7579535|NCT02726113|18656933|P2|STARTED|Genomic Analysis||14
7579536|NCT02726113|18656934|P1|STARTED|Genomic Analysis||19
7579537|NCT02726113|18656933|P2|NOT COMPLETED|Total Enrollment||3
7579538|NCT02726113|18656934|P1|NOT COMPLETED|Total Enrollment||4
7579539|NCT02726113|18656933|P2|COMPLETED|Total Enrollment||19
7579540|NCT02726113|18656934|P1|COMPLETED|Total Enrollment||24
7579541|NCT02726113|18656933|P2|STARTED|Total Enrollment||22
7579542|NCT02726113|18656934|P1|STARTED|Total Enrollment||28
7579543|NCT02726074|18656941|P1|NOT COMPLETED|Overall Study||26
7579544|NCT02726074|18656941|P1|COMPLETED|Overall Study||80
7579545|NCT02726074|18656941|P1|Treated|Overall Study||102
7579546|NCT02726074|18656941|P1|STARTED|Overall Study||106
7579547|NCT02726022|18656953|P1|NOT COMPLETED|Overall Study||36
7579548|NCT02726022|18656953|P1|COMPLETED|Overall Study||78
7579549|NCT02726022|18656953|P1|STARTED|Overall Study||114
7579550|NCT02725866|18656962|P1|NOT COMPLETED|Overall Study||14
7579551|NCT02725866|18656962|P1|COMPLETED|Overall Study||202
7579552|NCT02725866|18656962|P1|STARTED|Overall Study||216
7579553|NCT02725801|18656975|P2|NOT COMPLETED|Overall Study||0
7579554|NCT02725801|18656976|P1|NOT COMPLETED|Overall Study||0
7579555|NCT02725801|18656975|P2|COMPLETED|Overall Study||12
7579556|NCT02725801|18656976|P1|COMPLETED|Overall Study||8
7579557|NCT02725801|18656975|P2|STARTED|Overall Study||12
7579558|NCT02725801|18656976|P1|STARTED|Overall Study||8
7579559|NCT02725788|18656986|P2|NOT COMPLETED|Overall Study||2
7579560|NCT02725788|18656987|P1|NOT COMPLETED|Overall Study||1
7579561|NCT02725788|18656986|P2|COMPLETED|Overall Study||122
7579562|NCT02725788|18656987|P1|COMPLETED|Overall Study||122
7579563|NCT02725788|18656986|P2|STARTED|Overall Study||124
7579564|NCT02725788|18656987|P1|STARTED|Overall Study||123
7579565|NCT02725710|18656995|P2|NOT COMPLETED|Overall Study||0
7579566|NCT02725710|18656996|P1|NOT COMPLETED|Overall Study||1
7579567|NCT02725710|18656995|P2|COMPLETED|Overall Study||47
7579568|NCT02725710|18656996|P1|COMPLETED|Overall Study||47
7579569|NCT02725710|18656995|P2|STARTED|Overall Study||47
7579570|NCT02725710|18656996|P1|STARTED|Overall Study||48
7579571|NCT02725671|18657024|P1|NOT COMPLETED|Overall Study||1
7579572|NCT02725671|18657024|P1|COMPLETED|Overall Study||1
7579573|NCT02725671|18657024|P1|STARTED|Overall Study||2
7579574|NCT02725645|18657033|P1|NOT COMPLETED|Overall Study||0
7579575|NCT02725645|18657033|P1|COMPLETED|Overall Study||14
7579576|NCT02725645|18657033|P1|STARTED|Overall Study||14
7579577|NCT02725593|18657039|P2|NOT COMPLETED|Long Term Extension||3
7579578|NCT02725593|18657040|P1|NOT COMPLETED|Long Term Extension||1
7579579|NCT02725593|18657039|P2|COMPLETED|Long Term Extension||24
7579580|NCT02725593|18657040|P1|COMPLETED|Long Term Extension||32
7579581|NCT02725593|18657039|P2|STARTED|Long Term Extension||27
7579582|NCT02725593|18657040|P1|STARTED|Long Term Extension|1 participant who completed Period 1 did not enter the long-term extension period.|33
7579583|NCT02725593|18657039|P2|NOT COMPLETED|Blinded Treatment Period||6
7579584|NCT02725593|18657040|P1|NOT COMPLETED|Blinded Treatment Period||5
7579585|NCT02725593|18657039|P2|COMPLETED|Blinded Treatment Period||27
7579586|NCT02725593|18657040|P1|COMPLETED|Blinded Treatment Period||34
7579587|NCT02725593|18657039|P2|Received Treatment|Blinded Treatment Period||33
7579588|NCT02725593|18657040|P1|Received Treatment|Blinded Treatment Period||39
7579589|NCT02725593|18657039|P2|STARTED|Blinded Treatment Period||33
7579590|NCT02725593|18657040|P1|STARTED|Blinded Treatment Period||39
7579591|NCT02725515|18657054|P2|NOT COMPLETED|Overall Study||35
7579592|NCT02725515|18657055|P1|NOT COMPLETED|Overall Study||25
7579593|NCT02725515|18657054|P2|COMPLETED|Overall Study||17
7579594|NCT02725515|18657055|P1|COMPLETED|Overall Study||28
7579595|NCT02725515|18657054|P2|STARTED|Overall Study||52
7579596|NCT02725515|18657055|P1|STARTED|Overall Study||53
7579597|NCT02725476|18657067|P2|NOT COMPLETED|Overall Study||1
7579598|NCT02725476|18657068|P1|NOT COMPLETED|Overall Study||3
7579599|NCT02725476|18657067|P2|COMPLETED|Overall Study||4
7579600|NCT02725476|18657068|P1|COMPLETED|Overall Study||12
7579601|NCT02725476|18657067|P2|STARTED|Overall Study||5
7579602|NCT02725476|18657068|P1|STARTED|Overall Study||15
7579603|NCT02725411|18657079|P3|NOT COMPLETED|Follow-up Period (24 Weeks)||5
7579604|NCT02725411|18657080|P2|NOT COMPLETED|Follow-up Period (24 Weeks)||11
7579605|NCT02725411|18657081|P1|NOT COMPLETED|Follow-up Period (24 Weeks)||4
7579606|NCT02725411|18657079|P3|COMPLETED|Follow-up Period (24 Weeks)||87
7579607|NCT02725411|18657080|P2|COMPLETED|Follow-up Period (24 Weeks)||82
7579608|NCT02725411|18657081|P1|COMPLETED|Follow-up Period (24 Weeks)||88
7579609|NCT02725411|18657079|P3|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
7579610|NCT02725411|18657080|P2|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|93
7579611|NCT02725411|18657081|P1|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
7579612|NCT02725411|18657079|P3|NOT COMPLETED|Treatment Period (56 Weeks)||49
7579613|NCT02725411|18657080|P2|NOT COMPLETED|Treatment Period (56 Weeks)||50
7579614|NCT02725411|18657081|P1|NOT COMPLETED|Treatment Period (56 Weeks)||30
7579615|NCT02725411|18657079|P3|COMPLETED|Treatment Period (56 Weeks)||43
7579616|NCT02725411|18657080|P2|COMPLETED|Treatment Period (56 Weeks)||43
7579617|NCT02725411|18657081|P1|COMPLETED|Treatment Period (56 Weeks)||62
7579618|NCT02725411|18657079|P3|Treated|Treatment Period (56 Weeks)||92
7579619|NCT02725411|18657080|P2|Treated|Treatment Period (56 Weeks)||93
7579620|NCT02725411|18657081|P1|Treated|Treatment Period (56 Weeks)||92
7579621|NCT02725411|18657079|P3|STARTED|Treatment Period (56 Weeks)||92
7579622|NCT02725411|18657080|P2|STARTED|Treatment Period (56 Weeks)||93
7579623|NCT02725411|18657081|P1|STARTED|Treatment Period (56 Weeks)||92
7579624|NCT02725268|18657297|P4|NOT COMPLETED|Overall Study||17
7579625|NCT02725268|18657298|P3|NOT COMPLETED|Overall Study||37
7579626|NCT02725268|18657299|P2|NOT COMPLETED|Overall Study||59
7579627|NCT02725268|18657300|P1|NOT COMPLETED|Overall Study||59
7579628|NCT02725268|18657297|P4|COMPLETED|Overall Study||3
7579629|NCT02725268|18657298|P3|COMPLETED|Overall Study||4
7579630|NCT02725268|18657299|P2|COMPLETED|Overall Study||31
7579631|NCT02725268|18657300|P1|COMPLETED|Overall Study||31
7579632|NCT02725268|18657297|P4|STARTED|Overall Study||20
7579633|NCT02725268|18657298|P3|STARTED|Overall Study||41
7579634|NCT02725268|18657299|P2|STARTED|Overall Study||90
7579635|NCT02725268|18657300|P1|STARTED|Overall Study||90
7579636|NCT02725008|18657336|P2|NOT COMPLETED|Overall Study||12
7579637|NCT02725008|18657337|P1|NOT COMPLETED|Overall Study||9
7579638|NCT02725008|18657336|P2|COMPLETED|Overall Study||39
7579639|NCT02725008|18657337|P1|COMPLETED|Overall Study||37
7579640|NCT02725008|18657336|P2|STARTED|Overall Study||51
7579641|NCT02725008|18657337|P1|STARTED|Overall Study||46
7579642|NCT02724839|18657348|P3|NOT COMPLETED|Overall Study||5
7579643|NCT02724839|18657349|P2|NOT COMPLETED|Overall Study||4
7579644|NCT02724839|18657350|P1|NOT COMPLETED|Overall Study||1
7579645|NCT02724839|18657348|P3|COMPLETED|Overall Study||6
7579646|NCT02724839|18657349|P2|COMPLETED|Overall Study||8
7579647|NCT02724839|18657350|P1|COMPLETED|Overall Study||12
7579648|NCT02724839|18657348|P3|STARTED|Overall Study||11
7579649|NCT02724839|18657349|P2|STARTED|Overall Study||12
7579650|NCT02724839|18657350|P1|STARTED|Overall Study||13
7579651|NCT02724800|18657384|P2|NOT COMPLETED|Overall Study||9
7579652|NCT02724800|18657385|P1|NOT COMPLETED|Overall Study||17
7579653|NCT02724800|18657384|P2|COMPLETED|Overall Study||22
7579654|NCT02724800|18657385|P1|COMPLETED|Overall Study||15
7579655|NCT02724800|18657384|P2|STARTED|Overall Study||31
7579656|NCT02724800|18657385|P1|STARTED|Overall Study||32
7579657|NCT02724787|18657417|P1|NOT COMPLETED|Overall Study||2
7579658|NCT02724787|18657417|P1|COMPLETED|Overall Study|22 completed treatment. 20 participants returned for post-treatment assessment.|22
7579659|NCT02724787|18657417|P1|STARTED|Overall Study||24
7579660|NCT02724644|18657427|P2|NOT COMPLETED|Overall Study||4
7579661|NCT02724644|18657428|P1|NOT COMPLETED|Overall Study||21
7579662|NCT02724644|18657427|P2|COMPLETED|Overall Study||182
7579663|NCT02724644|18657428|P1|COMPLETED|Overall Study||168
7579664|NCT02724644|18657427|P2|STARTED|Overall Study||186
7579665|NCT02724644|18657428|P1|STARTED|Overall Study||189
7579666|NCT02724449|18657456|P1|NOT COMPLETED|Overall Study||0
7579667|NCT02724449|18657456|P1|COMPLETED|Overall Study||16
7579668|NCT02724449|18657456|P1|STARTED|Overall Study||16
7579669|NCT02724111|18657462|P2|NOT COMPLETED|Overall Study||5
7579670|NCT02724111|18657463|P1|NOT COMPLETED|Overall Study||2
7579671|NCT02724111|18657462|P2|COMPLETED|Overall Study||40
7579672|NCT02724111|18657463|P1|COMPLETED|Overall Study||43
7579673|NCT02724111|18657462|P2|STARTED|Overall Study||45
7579674|NCT02724111|18657463|P1|STARTED|Overall Study||45
7579675|NCT02724033|18657486|P3|NOT COMPLETED|Overall Study||0
7579676|NCT02724033|18657487|P2|NOT COMPLETED|Overall Study||0
7579677|NCT02724033|18657488|P1|NOT COMPLETED|Overall Study||0
7579678|NCT02724033|18657486|P3|COMPLETED|Overall Study||12
7579679|NCT02724033|18657487|P2|COMPLETED|Overall Study||14
7579680|NCT02724033|18657488|P1|COMPLETED|Overall Study||11
7579681|NCT02724033|18657486|P3|STARTED|Overall Study||12
7579682|NCT02724033|18657487|P2|STARTED|Overall Study||14
7579683|NCT02724033|18657488|P1|STARTED|Overall Study||11
7579684|NCT02723916|18657498|P2|NOT COMPLETED|Overall Study||6
7579685|NCT02723916|18657499|P1|NOT COMPLETED|Overall Study||9
7579686|NCT02723916|18657498|P2|COMPLETED|Overall Study||137
7579687|NCT02723916|18657499|P1|COMPLETED|Overall Study||135
7579688|NCT02723916|18657498|P2|STARTED|Overall Study||143
7579689|NCT02723916|18657499|P1|STARTED|Overall Study||144
7579690|NCT02723786|18657515|P1|NOT COMPLETED|Overall Study||1
7579691|NCT02723786|18657515|P1|COMPLETED|Overall Study||6
7579692|NCT02723786|18657515|P1|STARTED|Overall Study||7
7579693|NCT02723630|18657543|P6|NOT COMPLETED|Intervention Period 3||0
7579694|NCT02723630|18657544|P5|NOT COMPLETED|Intervention Period 3||0
7579695|NCT02723630|18657545|P4|NOT COMPLETED|Intervention Period 3||0
7579696|NCT02723630|18657546|P3|NOT COMPLETED|Intervention Period 3||0
7579697|NCT02723630|18657547|P2|NOT COMPLETED|Intervention Period 3||1
7579698|NCT02723630|18657548|P1|NOT COMPLETED|Intervention Period 3||0
7579699|NCT02723630|18657543|P6|COMPLETED|Intervention Period 3||10
7579700|NCT02723630|18657544|P5|COMPLETED|Intervention Period 3||10
7579701|NCT02723630|18657545|P4|COMPLETED|Intervention Period 3||10
7579702|NCT02723630|18657546|P3|COMPLETED|Intervention Period 3||10
7579703|NCT02723630|18657547|P2|COMPLETED|Intervention Period 3||9
7579704|NCT02723630|18657548|P1|COMPLETED|Intervention Period 3||9
7579705|NCT02723630|18657543|P6|STARTED|Intervention Period 3||10
7579706|NCT02723630|18657544|P5|STARTED|Intervention Period 3||10
7579707|NCT02723630|18657545|P4|STARTED|Intervention Period 3||10
7579708|NCT02723630|18657546|P3|STARTED|Intervention Period 3||10
7579709|NCT02723630|18657547|P2|STARTED|Intervention Period 3||10
7579710|NCT02723630|18657548|P1|STARTED|Intervention Period 3||9
7579711|NCT02723630|18657543|P6|NOT COMPLETED|Intervention Period 2||0
7579712|NCT02723630|18657544|P5|NOT COMPLETED|Intervention Period 2||0
7579713|NCT02723630|18657545|P4|NOT COMPLETED|Intervention Period 2||0
7579714|NCT02723630|18657546|P3|NOT COMPLETED|Intervention Period 2||0
7579715|NCT02723630|18657547|P2|NOT COMPLETED|Intervention Period 2||0
7579716|NCT02723630|18657548|P1|NOT COMPLETED|Intervention Period 2||0
7579717|NCT02723630|18657543|P6|COMPLETED|Intervention Period 2||10
7579718|NCT02723630|18657544|P5|COMPLETED|Intervention Period 2||10
7579719|NCT02723630|18657545|P4|COMPLETED|Intervention Period 2||10
7579720|NCT02723630|18657546|P3|COMPLETED|Intervention Period 2||10
7579721|NCT02723630|18657547|P2|COMPLETED|Intervention Period 2||10
7579722|NCT02723630|18657548|P1|COMPLETED|Intervention Period 2||9
7579723|NCT02723630|18657543|P6|STARTED|Intervention Period 2||10
7579724|NCT02723630|18657544|P5|STARTED|Intervention Period 2||10
7579725|NCT02723630|18657545|P4|STARTED|Intervention Period 2||10
7579726|NCT02723630|18657546|P3|STARTED|Intervention Period 2||10
7579727|NCT02723630|18657547|P2|STARTED|Intervention Period 2||10
7579728|NCT02723630|18657548|P1|STARTED|Intervention Period 2||9
7579729|NCT02723630|18657543|P6|NOT COMPLETED|Intervention Period 1||0
7579730|NCT02723630|18657544|P5|NOT COMPLETED|Intervention Period 1||0
7579731|NCT02723630|18657545|P4|NOT COMPLETED|Intervention Period 1||0
7579732|NCT02723630|18657546|P3|NOT COMPLETED|Intervention Period 1||0
7579733|NCT02723630|18657547|P2|NOT COMPLETED|Intervention Period 1||0
7579734|NCT02723630|18657548|P1|NOT COMPLETED|Intervention Period 1||1
7579735|NCT02723630|18657543|P6|COMPLETED|Intervention Period 1||10
7579736|NCT02723630|18657544|P5|COMPLETED|Intervention Period 1||10
7579737|NCT02723630|18657545|P4|COMPLETED|Intervention Period 1||10
7579738|NCT02723630|18657546|P3|COMPLETED|Intervention Period 1||10
7579739|NCT02723630|18657547|P2|COMPLETED|Intervention Period 1||10
7579740|NCT02723630|18657548|P1|COMPLETED|Intervention Period 1||9
7579741|NCT02723630|18657543|P6|STARTED|Intervention Period 1||10
7579742|NCT02723630|18657544|P5|STARTED|Intervention Period 1||10
7579743|NCT02723630|18657545|P4|STARTED|Intervention Period 1||10
7579744|NCT02723630|18657546|P3|STARTED|Intervention Period 1||10
7579745|NCT02723630|18657547|P2|STARTED|Intervention Period 1||10
7579746|NCT02723630|18657548|P1|STARTED|Intervention Period 1||10
7579747|NCT02723591|18657579|P2|NOT COMPLETED|Overall Study||101
7579748|NCT02723591|18657580|P1|NOT COMPLETED|Overall Study||96
7579749|NCT02723591|18657579|P2|COMPLETED|Overall Study||198
7579750|NCT02723591|18657580|P1|COMPLETED|Overall Study||204
7579751|NCT02723591|18657579|P2|STARTED|Overall Study||299
7579752|NCT02723591|18657580|P1|STARTED|Overall Study||300
7579753|NCT02723344|18657708|P2|NOT COMPLETED|Overall Study||4
7579754|NCT02723344|18657709|P1|NOT COMPLETED|Overall Study||0
7579755|NCT02723344|18657708|P2|COMPLETED|Overall Study||12
7579756|NCT02723344|18657709|P1|COMPLETED|Overall Study||15
7579757|NCT02723344|18657708|P2|STARTED|Overall Study||16
7579758|NCT02723344|18657709|P1|STARTED|Overall Study||15
7579759|NCT02723201|18657732|P3|NOT COMPLETED|Fourth Intervention Period||0
7579760|NCT02723201|18657733|P2|NOT COMPLETED|Fourth Intervention Period||0
7579761|NCT02723201|18657734|P1|NOT COMPLETED|Fourth Intervention Period||0
7579762|NCT02723201|18657732|P3|COMPLETED|Fourth Intervention Period||0
7579763|NCT02723201|18657733|P2|COMPLETED|Fourth Intervention Period||0
7579764|NCT02723201|18657734|P1|COMPLETED|Fourth Intervention Period||9
7579765|NCT02723201|18657732|P3|STARTED|Fourth Intervention Period||0
7579766|NCT02723201|18657733|P2|STARTED|Fourth Intervention Period||0
7579767|NCT02723201|18657734|P1|STARTED|Fourth Intervention Period||9
7579768|NCT02723201|18657732|P3|NOT COMPLETED|Washout Period 3||0
7579769|NCT02723201|18657733|P2|NOT COMPLETED|Washout Period 3||0
7579770|NCT02723201|18657734|P1|NOT COMPLETED|Washout Period 3||0
7579771|NCT02723201|18657732|P3|COMPLETED|Washout Period 3||0
7579772|NCT02723201|18657733|P2|COMPLETED|Washout Period 3||0
7579773|NCT02723201|18657734|P1|COMPLETED|Washout Period 3||9
7579774|NCT02723201|18657732|P3|STARTED|Washout Period 3||0
7579775|NCT02723201|18657733|P2|STARTED|Washout Period 3||0
7579776|NCT02723201|18657734|P1|STARTED|Washout Period 3||9
7579777|NCT02723201|18657732|P3|NOT COMPLETED|Third Intervention Period||0
7579778|NCT02723201|18657733|P2|NOT COMPLETED|Third Intervention Period||0
7579779|NCT02723201|18657734|P1|NOT COMPLETED|Third Intervention Period||0
7579780|NCT02723201|18657732|P3|COMPLETED|Third Intervention Period||0
7579781|NCT02723201|18657733|P2|COMPLETED|Third Intervention Period||0
7579782|NCT02723201|18657734|P1|COMPLETED|Third Intervention Period||9
7579783|NCT02723201|18657732|P3|STARTED|Third Intervention Period||0
7579784|NCT02723201|18657733|P2|STARTED|Third Intervention Period||0
7579785|NCT02723201|18657734|P1|STARTED|Third Intervention Period||9
7579786|NCT02723201|18657732|P3|NOT COMPLETED|Washout Period 2||0
7579787|NCT02723201|18657733|P2|NOT COMPLETED|Washout Period 2||0
7579788|NCT02723201|18657734|P1|NOT COMPLETED|Washout Period 2||0
7579789|NCT02723201|18657732|P3|COMPLETED|Washout Period 2||0
7579790|NCT02723201|18657733|P2|COMPLETED|Washout Period 2||0
7579791|NCT02723201|18657734|P1|COMPLETED|Washout Period 2||9
7579792|NCT02723201|18657732|P3|STARTED|Washout Period 2||0
7579793|NCT02723201|18657733|P2|STARTED|Washout Period 2||0
7579794|NCT02723201|18657734|P1|STARTED|Washout Period 2||9
7579795|NCT02723201|18657732|P3|NOT COMPLETED|Second Intervention Period||0
7579796|NCT02723201|18657733|P2|NOT COMPLETED|Second Intervention Period||0
7579797|NCT02723201|18657734|P1|NOT COMPLETED|Second Intervention Period||2
7579798|NCT02723201|18657732|P3|COMPLETED|Second Intervention Period||7
7579799|NCT02723201|18657733|P2|COMPLETED|Second Intervention Period||7
7579800|NCT02723201|18657734|P1|COMPLETED|Second Intervention Period||9
7579801|NCT02723201|18657732|P3|STARTED|Second Intervention Period||7
7579802|NCT02723201|18657733|P2|STARTED|Second Intervention Period||7
7579803|NCT02723201|18657734|P1|STARTED|Second Intervention Period||11
7579804|NCT02723201|18657732|P3|NOT COMPLETED|Washout Period 1||0
7579805|NCT02723201|18657733|P2|NOT COMPLETED|Washout Period 1||0
7579806|NCT02723201|18657734|P1|NOT COMPLETED|Washout Period 1||0
7579807|NCT02723201|18657732|P3|COMPLETED|Washout Period 1||7
7579808|NCT02723201|18657733|P2|COMPLETED|Washout Period 1||7
7579809|NCT02723201|18657734|P1|COMPLETED|Washout Period 1||11
7579810|NCT02723201|18657732|P3|STARTED|Washout Period 1||7
7579811|NCT02723201|18657733|P2|STARTED|Washout Period 1||7
7579812|NCT02723201|18657734|P1|STARTED|Washout Period 1||11
7579813|NCT02723201|18657732|P3|NOT COMPLETED|First Intervention Period||0
7579814|NCT02723201|18657733|P2|NOT COMPLETED|First Intervention Period||0
7579815|NCT02723201|18657734|P1|NOT COMPLETED|First Intervention Period||0
7579816|NCT02723201|18657732|P3|COMPLETED|First Intervention Period||7
7579817|NCT02723201|18657733|P2|COMPLETED|First Intervention Period||7
7579818|NCT02723201|18657734|P1|COMPLETED|First Intervention Period||11
7579819|NCT02723201|18657732|P3|STARTED|First Intervention Period||7
7579820|NCT02723201|18657733|P2|STARTED|First Intervention Period||7
7579821|NCT02723201|18657734|P1|STARTED|First Intervention Period||11
7579822|NCT02723188|18657793|P3|NOT COMPLETED|Overall Study||0
7579823|NCT02723188|18657794|P2|NOT COMPLETED|Overall Study||0
7579824|NCT02723188|18657795|P1|NOT COMPLETED|Overall Study||1
7579825|NCT02723188|18657793|P3|COMPLETED|Overall Study||15
7579826|NCT02723188|18657794|P2|COMPLETED|Overall Study||15
7579827|NCT02723188|18657795|P1|COMPLETED|Overall Study||14
7579828|NCT02723188|18657793|P3|STARTED|Overall Study||15
7579829|NCT02723188|18657794|P2|STARTED|Overall Study||15
7579830|NCT02723188|18657795|P1|STARTED|Overall Study||15
7579831|NCT02723175|18657808|P2|NOT COMPLETED|Overall Study||3
7579832|NCT02723175|18657809|P1|NOT COMPLETED|Overall Study||4
7579833|NCT02723175|18657808|P2|COMPLETED|Overall Study||4
7579834|NCT02723175|18657809|P1|COMPLETED|Overall Study||4
7579835|NCT02723175|18657808|P2|STARTED|Overall Study||7
7579836|NCT02723175|18657809|P1|STARTED|Overall Study||8
7579837|NCT02723084|18657851|P2|NOT COMPLETED|Overall Study||1
7579838|NCT02723084|18657852|P1|NOT COMPLETED|Overall Study||4
7579839|NCT02723084|18657851|P2|COMPLETED|Overall Study||45
7579840|NCT02723084|18657852|P1|COMPLETED|Overall Study||86
7579841|NCT02723084|18657851|P2|STARTED|Overall Study||46
7579842|NCT02723084|18657852|P1|STARTED|Overall Study||90
7579843|NCT02722967|18657866|P3|NOT COMPLETED|Overall Study||4
7579844|NCT02722967|18657867|P2|NOT COMPLETED|Overall Study||2
7579845|NCT02722967|18657868|P1|NOT COMPLETED|Overall Study||5
7579846|NCT02722967|18657866|P3|COMPLETED|Overall Study||11
7579847|NCT02722967|18657867|P2|COMPLETED|Overall Study||10
7579848|NCT02722967|18657868|P1|COMPLETED|Overall Study||17
7579849|NCT02722967|18657866|P3|STARTED|Overall Study||15
7579850|NCT02722967|18657867|P2|STARTED|Overall Study||12
7579851|NCT02722967|18657868|P1|STARTED|Overall Study||22
7579852|NCT02722928|18657878|P2|NOT COMPLETED|Overall Study||20
7579853|NCT02722928|18657879|P1|NOT COMPLETED|Overall Study||10
7579854|NCT02722928|18657878|P2|COMPLETED|Overall Study||31
7579855|NCT02722928|18657879|P1|COMPLETED|Overall Study||39
7579856|NCT02722928|18657878|P2|STARTED|Overall Study||51
7579857|NCT02722928|18657879|P1|STARTED|Overall Study||49
7579858|NCT02722863|18657893|P1|NOT COMPLETED|Overall Study||0
7579859|NCT02722863|18657893|P1|COMPLETED|Overall Study||908
7579860|NCT02722863|18657893|P1|STARTED|Overall Study||908
7579861|NCT02722837|18657898|P1|NOT COMPLETED|Overall Study||0
7579862|NCT02722837|18657898|P1|COMPLETED|Overall Study||119
7579863|NCT02722837|18657898|P1|STARTED|Overall Study||119
7579864|NCT02722577|18657916|P1|NOT COMPLETED|Overall Study||0
7579865|NCT02722577|18657916|P1|COMPLETED|Overall Study||20
7579866|NCT02722577|18657916|P1|STARTED|Overall Study||20
7579867|NCT02722564|18657920|P1|NOT COMPLETED|Overall Study||0
7579868|NCT02722564|18657920|P1|COMPLETED|Overall Study||55
7579869|NCT02722564|18657920|P1|STARTED|Overall Study||55
7579870|NCT02722408|18657924|P1|NOT COMPLETED|Overall Study||0
7579871|NCT02722408|18657924|P1|COMPLETED|Overall Study||8
7579872|NCT02722408|18657924|P1|STARTED|Overall Study||8
7579873|NCT02722330|18657978|P1|NOT COMPLETED|Overall Study||0
7579874|NCT02722330|18657978|P1|COMPLETED|Overall Study||23
7579875|NCT02722330|18657978|P1|STARTED|Overall Study||23
7579876|NCT02722304|18658009|P5|NOT COMPLETED|Overall Study||2
7579877|NCT02722304|18658010|P4|NOT COMPLETED|Overall Study||2
7579878|NCT02722304|18658011|P3|NOT COMPLETED|Overall Study||2
7579879|NCT02722304|18658012|P2|NOT COMPLETED|Overall Study||0
7579880|NCT02722304|18658013|P1|NOT COMPLETED|Overall Study||1
7579881|NCT02722304|18658009|P5|COMPLETED|Overall Study||0
7579882|NCT02722304|18658010|P4|COMPLETED|Overall Study||0
7579883|NCT02722304|18658011|P3|COMPLETED|Overall Study||0
7579884|NCT02722304|18658012|P2|COMPLETED|Overall Study||0
7579885|NCT02722304|18658013|P1|COMPLETED|Overall Study||0
7579886|NCT02722304|18658009|P5|Treated|Overall Study||2
7579887|NCT02722304|18658010|P4|Treated|Overall Study||1
7579888|NCT02722304|18658011|P3|Treated|Overall Study||1
7579889|NCT02722304|18658012|P2|Treated|Overall Study||0
7579890|NCT02722304|18658013|P1|Treated|Overall Study||1
7579891|NCT02722304|18658009|P5|STARTED|Overall Study||2
7579892|NCT02722304|18658010|P4|STARTED|Overall Study||2
7579893|NCT02722304|18658011|P3|STARTED|Overall Study||2
7579894|NCT02722304|18658012|P2|STARTED|Overall Study||0
7579895|NCT02722304|18658013|P1|STARTED|Overall Study||1
7579896|NCT02722278|18658065|P2|NOT COMPLETED|Overall Study||7
7579897|NCT02722278|18658066|P1|NOT COMPLETED|Overall Study||12
7579898|NCT02722278|18658065|P2|COMPLETED|Overall Study||49
7579899|NCT02722278|18658066|P1|COMPLETED|Overall Study||154
7579900|NCT02722278|18658065|P2|STARTED|Overall Study||56
7579901|NCT02722278|18658066|P1|STARTED|Overall Study||166
7579902|NCT02722239|18658076|P2|NOT COMPLETED|Overall Study||0
7579903|NCT02722239|18658077|P1|NOT COMPLETED|Overall Study||0
7579904|NCT02722239|18658076|P2|COMPLETED|Overall Study||20
7579905|NCT02722239|18658077|P1|COMPLETED|Overall Study||20
7579906|NCT02722239|18658076|P2|Second Intervention (1 Day)|Overall Study||20
7579907|NCT02722239|18658077|P1|Second Intervention (1 Day)|Overall Study||20
7579908|NCT02722239|18658076|P2|Washout (7 Days)|Overall Study||20
7579909|NCT02722239|18658077|P1|Washout (7 Days)|Overall Study||20
7579910|NCT02722239|18658076|P2|First Intervention (1 Day)|Overall Study||20
7579911|NCT02722239|18658077|P1|First Intervention (1 Day)|Overall Study||20
7579912|NCT02722239|18658076|P2|STARTED|Overall Study||20
7579913|NCT02722239|18658077|P1|STARTED|Overall Study||20
7579914|NCT02722148|18658090|P1|NOT COMPLETED|Overall Study||5
7579915|NCT02722148|18658090|P1|COMPLETED|Overall Study||19
7579916|NCT02722148|18658090|P1|STARTED|Overall Study||24
7579917|NCT02722044|18658097|P1|NOT COMPLETED|Overall Study||5
7579918|NCT02722044|18658097|P1|COMPLETED|Overall Study||28
7579919|NCT02722044|18658097|P1|STARTED|Overall Study||33
7579920|NCT02721966|18658127|P5|NOT COMPLETED|Overall Study||5
7579921|NCT02721966|18658128|P4|NOT COMPLETED|Overall Study||7
7579922|NCT02721966|18658129|P3|NOT COMPLETED|Overall Study||9
7579923|NCT02721966|18658130|P2|NOT COMPLETED|Overall Study||23
7579924|NCT02721966|18658131|P1|NOT COMPLETED|Overall Study||29
7579925|NCT02721966|18658127|P5|COMPLETED|Overall Study||0
7579926|NCT02721966|18658128|P4|COMPLETED|Overall Study||73
7579927|NCT02721966|18658129|P3|COMPLETED|Overall Study||72
7579928|NCT02721966|18658130|P2|COMPLETED|Overall Study||142
7579929|NCT02721966|18658131|P1|COMPLETED|Overall Study||138
7579930|NCT02721966|18658127|P5|Completed Period 1 & Went to Period 2|Overall Study||0
7579931|NCT02721966|18658128|P4|Completed Period 1 & Went to Period 2|Overall Study||80
7579932|NCT02721966|18658129|P3|Completed Period 1 & Went to Period 2|Overall Study||81
7579933|NCT02721966|18658130|P2|Completed Period 1 & Went to Period 2|Overall Study||153
7579934|NCT02721966|18658131|P1|Completed Period 1 & Went to Period 2|Overall Study||162
7579935|NCT02721966|18658127|P5|STARTED|Overall Study||5
7579936|NCT02721966|18658128|P4|STARTED|Overall Study||80
7579937|NCT02721966|18658129|P3|STARTED|Overall Study||81
7579938|NCT02721966|18658130|P2|STARTED|Overall Study||165
7579939|NCT02721966|18658131|P1|STARTED|Overall Study||167
7579940|NCT02721875|18658171|P2|NOT COMPLETED|Overall Study||0
7579941|NCT02721875|18658172|P1|NOT COMPLETED|Overall Study||1
7579942|NCT02721875|18658171|P2|COMPLETED|Overall Study||0
7579943|NCT02721875|18658172|P1|COMPLETED|Overall Study||0
7579944|NCT02721875|18658171|P2|STARTED|Overall Study||0
7579945|NCT02721875|18658172|P1|STARTED|Overall Study||1
7579946|NCT02721641|18658185|P1|NOT COMPLETED|Overall Study||0
7579947|NCT02721641|18658185|P1|COMPLETED|Overall Study|In this continued access study, all participants were considered to have completed per protocol.|69
7579948|NCT02721641|18658185|P1|STARTED|Overall Study||69
7579949|NCT02721277|18658191|P1|NOT COMPLETED|Overall Study||0
7579950|NCT02721277|18658191|P1|COMPLETED|Overall Study||2
7579951|NCT02721277|18658191|P1|STARTED|Overall Study||2
7579952|NCT02721147|18658223|P3|NOT COMPLETED|Overall Study||0
7579953|NCT02721147|18658224|P2|NOT COMPLETED|Overall Study||0
7579954|NCT02721147|18658225|P1|NOT COMPLETED|Overall Study||2
7579955|NCT02721147|18658223|P3|COMPLETED|Overall Study||31
7579956|NCT02721147|18658224|P2|COMPLETED|Overall Study||18
7579957|NCT02721147|18658225|P1|COMPLETED|Overall Study||38
7579958|NCT02721147|18658223|P3|STARTED|Overall Study||31
7579959|NCT02721147|18658224|P2|STARTED|Overall Study||18
7579960|NCT02721147|18658225|P1|STARTED|Overall Study||40
7579961|NCT02720952|18658260|P1|NOT COMPLETED|Overall Study||0
7579962|NCT02720952|18658260|P1|COMPLETED|Overall Study||24
7579963|NCT02720952|18658260|P1|STARTED|Overall Study||24
7579964|NCT02720757|18658269|P1|NOT COMPLETED|Overall Study||18
7579965|NCT02720757|18658269|P1|COMPLETED|Overall Study||114
7579966|NCT02720757|18658269|P1|STARTED|Overall Study||132
7579967|NCT02720627|18658278|P1|NOT COMPLETED|Overall Study||0
7579968|NCT02720627|18658278|P1|COMPLETED|Overall Study||27
7579969|NCT02720627|18658278|P1|STARTED|Overall Study||27
7579970|NCT02720536|18658283|P1|NOT COMPLETED|Overall Study||19
7579971|NCT02720536|18658283|P1|COMPLETED|Overall Study||34
7579972|NCT02720536|18658283|P1|STARTED|Overall Study||53
7579973|NCT02720523|18658318|P7|NOT COMPLETED|Period 2: Long-term Extension Period||60
7579974|NCT02720523|18658319|P6|NOT COMPLETED|Period 2: Long-term Extension Period||62
7579975|NCT02720523|18658320|P5|NOT COMPLETED|Period 2: Long-term Extension Period||65
7579976|NCT02720523|18658321|P4|NOT COMPLETED|Period 2: Long-term Extension Period||0
7579977|NCT02720523|18658322|P3|NOT COMPLETED|Period 2: Long-term Extension Period||0
7579978|NCT02720523|18658323|P2|NOT COMPLETED|Period 2: Long-term Extension Period||0
7579979|NCT02720523|18658324|P1|NOT COMPLETED|Period 2: Long-term Extension Period||0
7579980|NCT02720523|18658318|P7|COMPLETED|Period 2: Long-term Extension Period||0
7579981|NCT02720523|18658319|P6|COMPLETED|Period 2: Long-term Extension Period||0
7579982|NCT02720523|18658320|P5|COMPLETED|Period 2: Long-term Extension Period||0
7579983|NCT02720523|18658321|P4|COMPLETED|Period 2: Long-term Extension Period||0
7579984|NCT02720523|18658322|P3|COMPLETED|Period 2: Long-term Extension Period||0
7579985|NCT02720523|18658323|P2|COMPLETED|Period 2: Long-term Extension Period||0
7579986|NCT02720523|18658324|P1|COMPLETED|Period 2: Long-term Extension Period||0
7579987|NCT02720523|18658318|P7|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 30 mg|60
7579988|NCT02720523|18658319|P6|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 15 mg|62
7579989|NCT02720523|18658320|P5|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 7.5 mg|65
7579990|NCT02720523|18658321|P4|STARTED|Period 2: Long-term Extension Period||0
7579991|NCT02720523|18658322|P3|STARTED|Period 2: Long-term Extension Period||0
7579992|NCT02720523|18658323|P2|STARTED|Period 2: Long-term Extension Period||0
7579993|NCT02720523|18658324|P1|STARTED|Period 2: Long-term Extension Period||0
7579994|NCT02720523|18658318|P7|NOT COMPLETED|Period 1: Placebo-controlled Period||0
7579995|NCT02720523|18658319|P6|NOT COMPLETED|Period 1: Placebo-controlled Period||0
7579996|NCT02720523|18658320|P5|NOT COMPLETED|Period 1: Placebo-controlled Period||0
7579997|NCT02720523|18658321|P4|NOT COMPLETED|Period 1: Placebo-controlled Period||6
7579998|NCT02720523|18658322|P3|NOT COMPLETED|Period 1: Placebo-controlled Period||2
7579999|NCT02720523|18658323|P2|NOT COMPLETED|Period 1: Placebo-controlled Period||0
7580000|NCT02720523|18658324|P1|NOT COMPLETED|Period 1: Placebo-controlled Period||2
7580001|NCT02720523|18658318|P7|COMPLETED|Period 1: Placebo-controlled Period||0
7580002|NCT02720523|18658319|P6|COMPLETED|Period 1: Placebo-controlled Period||0
7580003|NCT02720523|18658320|P5|COMPLETED|Period 1: Placebo-controlled Period||0
7580004|NCT02720523|18658321|P4|COMPLETED|Period 1: Placebo-controlled Period||44
7580005|NCT02720523|18658322|P3|COMPLETED|Period 1: Placebo-controlled Period||47
7580006|NCT02720523|18658323|P2|COMPLETED|Period 1: Placebo-controlled Period||49
7580007|NCT02720523|18658324|P1|COMPLETED|Period 1: Placebo-controlled Period||47
7580008|NCT02720523|18658318|P7|STARTED|Period 1: Placebo-controlled Period||0
7580009|NCT02720523|18658319|P6|STARTED|Period 1: Placebo-controlled Period||0
7580010|NCT02720523|18658320|P5|STARTED|Period 1: Placebo-controlled Period||0
7580011|NCT02720523|18658321|P4|STARTED|Period 1: Placebo-controlled Period||50
7580012|NCT02720523|18658322|P3|STARTED|Period 1: Placebo-controlled Period||49
7580013|NCT02720523|18658323|P2|STARTED|Period 1: Placebo-controlled Period||49
7580014|NCT02720523|18658324|P1|STARTED|Period 1: Placebo-controlled Period||49
7580015|NCT02720510|18658383|P2|NOT COMPLETED|Overall Study||3
7580016|NCT02720510|18658384|P1|NOT COMPLETED|Overall Study||3
7580017|NCT02720510|18658383|P2|COMPLETED|Overall Study||0
7580018|NCT02720510|18658384|P1|COMPLETED|Overall Study||0
7580019|NCT02720510|18658383|P2|STARTED|Overall Study||3
7580020|NCT02720510|18658384|P1|STARTED|Overall Study||3
7580021|NCT02720484|18658402|P1|NOT COMPLETED|Follow Up for 2 Years||6
7580022|NCT02720484|18658402|P1|COMPLETED|Follow Up for 2 Years||1
7580023|NCT02720484|18658402|P1|STARTED|Follow Up for 2 Years|All patients that receive at least one treatment on study go into follow up.|7
7580024|NCT02720484|18658402|P1|NOT COMPLETED|Treatment on Study||6
7580025|NCT02720484|18658402|P1|COMPLETED|Treatment on Study||4
7580026|NCT02720484|18658402|P1|Treated Cycle 3|Treatment on Study||4
7580027|NCT02720484|18658402|P1|Reached 1st Response/2 Cycles|Treatment on Study||7
7580028|NCT02720484|18658402|P1|STARTED|Treatment on Study||10
7580029|NCT02720224|18658410|P1|NOT COMPLETED|Overall Study||0
7580030|NCT02720224|18658410|P1|COMPLETED|Overall Study||6
7580031|NCT02720224|18658410|P1|STARTED|Overall Study||6
7580032|NCT02720198|18658434|P2|NOT COMPLETED|Overall Study||1
7580033|NCT02720198|18658435|P1|NOT COMPLETED|Overall Study||0
7580034|NCT02720198|18658434|P2|COMPLETED|Overall Study||30
7580035|NCT02720198|18658435|P1|COMPLETED|Overall Study||29
7580036|NCT02720198|18658434|P2|STARTED|Overall Study||31
7580037|NCT02720198|18658435|P1|STARTED|Overall Study||29
7580038|NCT02720107|18658461|P1|NOT COMPLETED|Overall Study||0
7580039|NCT02720107|18658461|P1|COMPLETED|Overall Study||130
7580040|NCT02720107|18658461|P1|STARTED|Overall Study||130
7580041|NCT02720081|18658470|P2|NOT COMPLETED|Overall Study||4
7580042|NCT02720081|18658471|P1|NOT COMPLETED|Overall Study||4
7580043|NCT02720081|18658470|P2|COMPLETED|Overall Study||66
7580044|NCT02720081|18658471|P1|COMPLETED|Overall Study||68
7580045|NCT02720081|18658470|P2|Treated|Overall Study||69
7580046|NCT02720081|18658471|P1|Treated|Overall Study||70
7580047|NCT02720081|18658470|P2|STARTED|Overall Study||70
7580048|NCT02720081|18658471|P1|STARTED|Overall Study||72
7580049|NCT02720042|18658527|P1|NOT COMPLETED|Overall Study||15
7580050|NCT02720042|18658527|P1|COMPLETED|Overall Study||69
7580051|NCT02720042|18658527|P1|STARTED|Overall Study||84
7580052|NCT02719938|18658544|P2|NOT COMPLETED|Overall Study||1
7580053|NCT02719938|18658545|P1|NOT COMPLETED|Overall Study||4
7580054|NCT02719938|18658544|P2|COMPLETED|Overall Study||31
7580055|NCT02719938|18658545|P1|COMPLETED|Overall Study||26
7580056|NCT02719938|18658544|P2|STARTED|Overall Study||32
7580057|NCT02719938|18658545|P1|STARTED|Overall Study||30
7580058|NCT02719743|18658568|P5|NOT COMPLETED|Overall Study||2
7580059|NCT02719743|18658569|P4|NOT COMPLETED|Overall Study||1
7580060|NCT02719743|18658570|P3|NOT COMPLETED|Overall Study||0
7580061|NCT02719743|18658571|P2|NOT COMPLETED|Overall Study||3
7580062|NCT02719743|18658572|P1|NOT COMPLETED|Overall Study||1
7580063|NCT02719743|18658568|P5|COMPLETED|Overall Study||33
7580064|NCT02719743|18658569|P4|COMPLETED|Overall Study||36
7580065|NCT02719743|18658570|P3|COMPLETED|Overall Study||38
7580066|NCT02719743|18658571|P2|COMPLETED|Overall Study||34
7580067|NCT02719743|18658572|P1|COMPLETED|Overall Study||37
7580068|NCT02719743|18658568|P5|STARTED|Overall Study||35
7580069|NCT02719743|18658569|P4|STARTED|Overall Study||37
7580070|NCT02719743|18658570|P3|STARTED|Overall Study||38
7580071|NCT02719743|18658571|P2|STARTED|Overall Study||37
7580072|NCT02719743|18658572|P1|STARTED|Overall Study||38
7580073|NCT02719639|18658699|P1|NOT COMPLETED|Overall Study||0
7580074|NCT02719639|18658699|P1|COMPLETED|Overall Study||7443
7580075|NCT02719639|18658699|P1|STARTED|Overall Study||7443
7580076|NCT02719535|18658708|P1|NOT COMPLETED|Overall Study||22
7580077|NCT02719535|18658708|P1|COMPLETED|Overall Study||37
7580078|NCT02719535|18658708|P1|STARTED|Overall Study||59
7580079|NCT02719522|18658713|P1|NOT COMPLETED|Overall Study||11
7580080|NCT02719522|18658713|P1|COMPLETED|Overall Study||193
7580081|NCT02719522|18658713|P1|STARTED|Overall Study|In 1 consented subject, device deployment was not attempted due to significant arterial stenosis.|204
7580082|NCT02719366|18658721|P2|NOT COMPLETED|Second Intervention||0
7580083|NCT02719366|18658722|P1|NOT COMPLETED|Second Intervention||0
7580084|NCT02719366|18658721|P2|COMPLETED|Second Intervention||6
7580085|NCT02719366|18658722|P1|COMPLETED|Second Intervention||6
7580086|NCT02719366|18658721|P2|STARTED|Second Intervention||6
7580087|NCT02719366|18658722|P1|STARTED|Second Intervention||6
7580088|NCT02719366|18658721|P2|NOT COMPLETED|First Intervention||0
7580089|NCT02719366|18658722|P1|NOT COMPLETED|First Intervention||0
7580090|NCT02719366|18658721|P2|COMPLETED|First Intervention||6
7580091|NCT02719366|18658722|P1|COMPLETED|First Intervention||6
7580092|NCT02719366|18658721|P2|STARTED|First Intervention||6
7580093|NCT02719366|18658722|P1|STARTED|First Intervention||6
7580094|NCT02719353|18658755|P2|NOT COMPLETED|Second Intervention||0
7580095|NCT02719353|18658756|P1|NOT COMPLETED|Second Intervention||0
7580096|NCT02719353|18658755|P2|COMPLETED|Second Intervention||6
7580097|NCT02719353|18658756|P1|COMPLETED|Second Intervention||7
7580098|NCT02719353|18658755|P2|STARTED|Second Intervention||6
7580099|NCT02719353|18658756|P1|STARTED|Second Intervention||7
7580100|NCT02719353|18658755|P2|NOT COMPLETED|First Intervention||1
7580101|NCT02719353|18658756|P1|NOT COMPLETED|First Intervention||0
7580102|NCT02719353|18658755|P2|COMPLETED|First Intervention||6
7580103|NCT02719353|18658756|P1|COMPLETED|First Intervention||7
7580104|NCT02719353|18658755|P2|STARTED|First Intervention||7
7580105|NCT02719353|18658756|P1|STARTED|First Intervention||7
7580106|NCT02719171|18658795|P5|NOT COMPLETED|Overall Study||2
7580107|NCT02719171|18658796|P4|NOT COMPLETED|Overall Study||2
7580108|NCT02719171|18658797|P3|NOT COMPLETED|Overall Study||3
7580109|NCT02719171|18658798|P2|NOT COMPLETED|Overall Study||4
7580110|NCT02719171|18658799|P1|NOT COMPLETED|Overall Study||1
7580111|NCT02719171|18658795|P5|COMPLETED|Overall Study||18
7580112|NCT02719171|18658796|P4|COMPLETED|Overall Study||37
7580113|NCT02719171|18658797|P3|COMPLETED|Overall Study||39
7580114|NCT02719171|18658798|P2|COMPLETED|Overall Study||38
7580115|NCT02719171|18658799|P1|COMPLETED|Overall Study||41
7580116|NCT02719171|18658795|P5|STARTED|Overall Study||20
7580117|NCT02719171|18658796|P4|STARTED|Overall Study||39
7580118|NCT02719171|18658797|P3|STARTED|Overall Study||42
7580119|NCT02719171|18658798|P2|STARTED|Overall Study||42
7580120|NCT02719171|18658799|P1|STARTED|Overall Study||42
7580121|NCT02719158|18658893|P3|NOT COMPLETED|Overall Study||1
7580122|NCT02719158|18658894|P2|NOT COMPLETED|Overall Study||0
7580123|NCT02719158|18658895|P1|NOT COMPLETED|Overall Study||0
7580124|NCT02719158|18658893|P3|COMPLETED|Overall Study||18
7580125|NCT02719158|18658894|P2|COMPLETED|Overall Study||38
7580126|NCT02719158|18658895|P1|COMPLETED|Overall Study||38
7580127|NCT02719158|18658893|P3|STARTED|Overall Study||19
7580128|NCT02719158|18658894|P2|STARTED|Overall Study||38
7580129|NCT02719158|18658895|P1|STARTED|Overall Study||38
7580130|NCT02719028|18658916|P4|NOT COMPLETED|Overall Study||10
7580131|NCT02719028|18658917|P3|NOT COMPLETED|Overall Study||6
7580132|NCT02719028|18658918|P2|NOT COMPLETED|Overall Study||2
7580133|NCT02719028|18658919|P1|NOT COMPLETED|Overall Study||2
7580134|NCT02719028|18658916|P4|COMPLETED|Overall Study||20
7580135|NCT02719028|18658917|P3|COMPLETED|Overall Study||24
7580136|NCT02719028|18658918|P2|COMPLETED|Overall Study||28
7580137|NCT02719028|18658919|P1|COMPLETED|Overall Study||28
7580138|NCT02719028|18658916|P4|STARTED|Overall Study||30
7580139|NCT02719028|18658917|P3|STARTED|Overall Study||30
7580140|NCT02719028|18658918|P2|STARTED|Overall Study||30
7580141|NCT02719028|18658919|P1|STARTED|Overall Study||30
7580142|NCT02718963|18658943|P2|NOT COMPLETED|Overall Study||1
7580143|NCT02718963|18658944|P1|NOT COMPLETED|Overall Study||1
7580144|NCT02718963|18658943|P2|COMPLETED|Overall Study||9
7580145|NCT02718963|18658944|P1|COMPLETED|Overall Study||9
7580146|NCT02718963|18658943|P2|STARTED|Overall Study||10
7580147|NCT02718963|18658944|P1|STARTED|Overall Study||10
7580148|NCT02718898|18658952|P7|NOT COMPLETED|Post Treatment Follow-up Period||5
7580149|NCT02718898|18658953|P6|NOT COMPLETED|Post Treatment Follow-up Period||11
7580150|NCT02718898|18658954|P5|NOT COMPLETED|Post Treatment Follow-up Period||1
7580151|NCT02718898|18658955|P4|NOT COMPLETED|Post Treatment Follow-up Period||0
7580152|NCT02718898|18658956|P3|NOT COMPLETED|Post Treatment Follow-up Period||0
7580153|NCT02718898|18658957|P2|NOT COMPLETED|Post Treatment Follow-up Period||0
7580154|NCT02718898|18658958|P1|NOT COMPLETED|Post Treatment Follow-up Period||0
7580155|NCT02718898|18658952|P7|COMPLETED|Post Treatment Follow-up Period||44
7580156|NCT02718898|18658953|P6|COMPLETED|Post Treatment Follow-up Period||67
7580157|NCT02718898|18658954|P5|COMPLETED|Post Treatment Follow-up Period||0
7580158|NCT02718898|18658955|P4|COMPLETED|Post Treatment Follow-up Period||0
7580159|NCT02718898|18658956|P3|COMPLETED|Post Treatment Follow-up Period||0
7580160|NCT02718898|18658957|P2|COMPLETED|Post Treatment Follow-up Period||0
7580161|NCT02718898|18658958|P1|COMPLETED|Post Treatment Follow-up Period||0
7580162|NCT02718898|18658952|P7|STARTED|Post Treatment Follow-up Period||49
7580163|NCT02718898|18658953|P6|STARTED|Post Treatment Follow-up Period||78
7580164|NCT02718898|18658954|P5|STARTED|Post Treatment Follow-up Period|One participant who discontinued from placebo blinded treatment had entered post-treatment follow-up|1
7580165|NCT02718898|18658955|P4|STARTED|Post Treatment Follow-up Period||0
7580166|NCT02718898|18658956|P3|STARTED|Post Treatment Follow-up Period||0
7580167|NCT02718898|18658957|P2|STARTED|Post Treatment Follow-up Period||0
7580168|NCT02718898|18658958|P1|STARTED|Post Treatment Follow-up Period||0
7580169|NCT02718898|18658952|P7|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
7580170|NCT02718898|18658953|P6|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
7580171|NCT02718898|18658954|P5|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
7580172|NCT02718898|18658955|P4|NOT COMPLETED|Open Label Treatment Period (OLTP)||10
7580173|NCT02718898|18658956|P3|NOT COMPLETED|Open Label Treatment Period (OLTP)||3
7580174|NCT02718898|18658957|P2|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
7580175|NCT02718898|18658958|P1|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
7580176|NCT02718898|18658952|P7|COMPLETED|Open Label Treatment Period (OLTP)||0
7580177|NCT02718898|18658953|P6|COMPLETED|Open Label Treatment Period (OLTP)||0
7580178|NCT02718898|18658954|P5|COMPLETED|Open Label Treatment Period (OLTP)||0
7580179|NCT02718898|18658955|P4|COMPLETED|Open Label Treatment Period (OLTP)||64
7580180|NCT02718898|18658956|P3|COMPLETED|Open Label Treatment Period (OLTP)||62
7580181|NCT02718898|18658957|P2|COMPLETED|Open Label Treatment Period (OLTP)||0
7580182|NCT02718898|18658958|P1|COMPLETED|Open Label Treatment Period (OLTP)||0
7580183|NCT02718898|18658952|P7|STARTED|Open Label Treatment Period (OLTP)||0
7580184|NCT02718898|18658953|P6|STARTED|Open Label Treatment Period (OLTP)||0
7580185|NCT02718898|18658954|P5|STARTED|Open Label Treatment Period (OLTP)||0
7580186|NCT02718898|18658955|P4|STARTED|Open Label Treatment Period (OLTP)||74
7580187|NCT02718898|18658956|P3|STARTED|Open Label Treatment Period (OLTP)||65
7580188|NCT02718898|18658957|P2|STARTED|Open Label Treatment Period (OLTP)||0
7580189|NCT02718898|18658958|P1|STARTED|Open Label Treatment Period (OLTP)||0
7580190|NCT02718898|18658952|P7|NOT COMPLETED|Blinded Treatment Period||0
7580191|NCT02718898|18658953|P6|NOT COMPLETED|Blinded Treatment Period||0
7580192|NCT02718898|18658954|P5|NOT COMPLETED|Blinded Treatment Period||0
7580193|NCT02718898|18658955|P4|NOT COMPLETED|Blinded Treatment Period||0
7580194|NCT02718898|18658956|P3|NOT COMPLETED|Blinded Treatment Period||0
7580195|NCT02718898|18658957|P2|NOT COMPLETED|Blinded Treatment Period||1
7580196|NCT02718898|18658958|P1|NOT COMPLETED|Blinded Treatment Period||9
7580197|NCT02718898|18658952|P7|COMPLETED|Blinded Treatment Period||0
7580198|NCT02718898|18658953|P6|COMPLETED|Blinded Treatment Period||0
7580199|NCT02718898|18658954|P5|COMPLETED|Blinded Treatment Period||0
7580200|NCT02718898|18658955|P4|COMPLETED|Blinded Treatment Period||0
7580201|NCT02718898|18658956|P3|COMPLETED|Blinded Treatment Period||0
7580202|NCT02718898|18658957|P2|COMPLETED|Blinded Treatment Period||74
7580203|NCT02718898|18658958|P1|COMPLETED|Blinded Treatment Period||65
7580204|NCT02718898|18658952|P7|STARTED|Blinded Treatment Period||0
7580205|NCT02718898|18658953|P6|STARTED|Blinded Treatment Period||0
7580206|NCT02718898|18658954|P5|STARTED|Blinded Treatment Period||0
7580207|NCT02718898|18658955|P4|STARTED|Blinded Treatment Period||0
7580208|NCT02718898|18658956|P3|STARTED|Blinded Treatment Period||0
7580209|NCT02718898|18658957|P2|STARTED|Blinded Treatment Period||75
7580210|NCT02718898|18658958|P1|STARTED|Blinded Treatment Period||74
7580211|NCT02718625|18658993|P2|NOT COMPLETED|Overall Study||2
7580212|NCT02718625|18658994|P1|NOT COMPLETED|Overall Study||0
7580213|NCT02718625|18658993|P2|COMPLETED|Overall Study||0
7580214|NCT02718625|18658994|P1|COMPLETED|Overall Study||1
7580215|NCT02718625|18658993|P2|STARTED|Overall Study||2
7580216|NCT02718625|18658994|P1|STARTED|Overall Study||1
7580217|NCT02718417|18659013|P3|NOT COMPLETED|Long-term Follow-up Phase||135
7580218|NCT02718417|18659014|P2|NOT COMPLETED|Long-term Follow-up Phase||112
7580219|NCT02718417|18659015|P1|NOT COMPLETED|Long-term Follow-up Phase||139
7580220|NCT02718417|18659013|P3|COMPLETED|Long-term Follow-up Phase||0
7580221|NCT02718417|18659014|P2|COMPLETED|Long-term Follow-up Phase||0
7580222|NCT02718417|18659015|P1|COMPLETED|Long-term Follow-up Phase||0
7580223|NCT02718417|18659013|P3|STARTED|Long-term Follow-up Phase|Participants not completing follow-up could also start this phase.|135
7580224|NCT02718417|18659014|P2|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|112
7580225|NCT02718417|18659015|P1|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|139
7580226|NCT02718417|18659013|P3|NOT COMPLETED|Follow-up Phase||19
7580227|NCT02718417|18659014|P2|NOT COMPLETED|Follow-up Phase||172
7580228|NCT02718417|18659015|P1|NOT COMPLETED|Follow-up Phase||135
7580229|NCT02718417|18659013|P3|COMPLETED|Follow-up Phase||20
7580230|NCT02718417|18659014|P2|COMPLETED|Follow-up Phase||91
7580231|NCT02718417|18659015|P1|COMPLETED|Follow-up Phase||103
7580232|NCT02718417|18659013|P3|STARTED|Follow-up Phase|Participants not completing OP could also start this phase.|39
7580233|NCT02718417|18659014|P2|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|263
7580234|NCT02718417|18659015|P1|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|238
7580235|NCT02718417|18659013|P3|NOT COMPLETED|Observation Phase (OP)||282
7580236|NCT02718417|18659014|P2|NOT COMPLETED|Observation Phase (OP)||0
7580237|NCT02718417|18659015|P1|NOT COMPLETED|Observation Phase (OP)||0
7580238|NCT02718417|18659013|P3|COMPLETED|Observation Phase (OP)||2
7580239|NCT02718417|18659014|P2|COMPLETED|Observation Phase (OP)||0
7580240|NCT02718417|18659015|P1|COMPLETED|Observation Phase (OP)||0
7580241|NCT02718417|18659013|P3|STARTED|Observation Phase (OP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|284
7580242|NCT02718417|18659014|P2|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
7580243|NCT02718417|18659015|P1|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
7580244|NCT02718417|18659013|P3|NOT COMPLETED|Maintenance Phase (MP)||0
7580245|NCT02718417|18659014|P2|NOT COMPLETED|Maintenance Phase (MP)||287
7580246|NCT02718417|18659015|P1|NOT COMPLETED|Maintenance Phase (MP)||266
7580247|NCT02718417|18659013|P3|COMPLETED|Maintenance Phase (MP)||0
7580248|NCT02718417|18659014|P2|COMPLETED|Maintenance Phase (MP)||1
7580249|NCT02718417|18659015|P1|COMPLETED|Maintenance Phase (MP)||1
7580250|NCT02718417|18659013|P3|STARTED|Maintenance Phase (MP)|After completing CP, participants moved to observation phase. MP was not applicable for this arm.|0
7580251|NCT02718417|18659014|P2|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|288
7580252|NCT02718417|18659015|P1|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|267
7580253|NCT02718417|18659013|P3|NOT COMPLETED|Chemotherapy Phase (CP)||46
7580254|NCT02718417|18659014|P2|NOT COMPLETED|Chemotherapy Phase (CP)||37
7580255|NCT02718417|18659015|P1|NOT COMPLETED|Chemotherapy Phase (CP)||52
7580256|NCT02718417|18659013|P3|COMPLETED|Chemotherapy Phase (CP)||289
7580257|NCT02718417|18659014|P2|COMPLETED|Chemotherapy Phase (CP)||294
7580258|NCT02718417|18659015|P1|COMPLETED|Chemotherapy Phase (CP)||280
7580259|NCT02718417|18659013|P3|Safety Population|Chemotherapy Phase (CP)||334
7580260|NCT02718417|18659014|P2|Safety Population|Chemotherapy Phase (CP)||329
7580261|NCT02718417|18659015|P1|Safety Population|Chemotherapy Phase (CP)||328
7580262|NCT02718417|18659013|P3|STARTED|Chemotherapy Phase (CP)||335
7580263|NCT02718417|18659014|P2|STARTED|Chemotherapy Phase (CP)||331
7580264|NCT02718417|18659015|P1|STARTED|Chemotherapy Phase (CP)||332
7580265|NCT02718326|18659121|P3|NOT COMPLETED|Overall Study||22
7580266|NCT02718326|18659122|P2|NOT COMPLETED|Overall Study||24
7580267|NCT02718326|18659123|P1|NOT COMPLETED|Overall Study||36
7580268|NCT02718326|18659121|P3|COMPLETED|Overall Study||112
7580269|NCT02718326|18659122|P2|COMPLETED|Overall Study||111
7580270|NCT02718326|18659123|P1|COMPLETED|Overall Study||97
7580271|NCT02718326|18659121|P3|Completed Week 52|Overall Study||124
7580272|NCT02718326|18659122|P2|Completed Week 52|Overall Study||122
7580273|NCT02718326|18659123|P1|Completed Week 52|Overall Study||109
7580274|NCT02718326|18659121|P3|STARTED|Overall Study||134
7580275|NCT02718326|18659122|P2|STARTED|Overall Study||135
7580276|NCT02718326|18659123|P1|STARTED|Overall Study||133
7580277|NCT02718248|18659154|P1|NOT COMPLETED|Overall Study||0
7580278|NCT02718248|18659154|P1|COMPLETED|Overall Study||7
7580279|NCT02718248|18659154|P1|STARTED|Overall Study||7
7580280|NCT02718157|18659170|P1|NOT COMPLETED|Overall Study||162
7580281|NCT02718157|18659170|P1|COMPLETED|Overall Study||609
7580282|NCT02718157|18659170|P1|STARTED|Overall Study||771
7580283|NCT02718118|18659179|P2|NOT COMPLETED|Overall Study||1
7580284|NCT02718118|18659180|P1|NOT COMPLETED|Overall Study||2
7580285|NCT02718118|18659179|P2|COMPLETED|Overall Study||29
7580286|NCT02718118|18659180|P1|COMPLETED|Overall Study||28
7580287|NCT02718118|18659179|P2|STARTED|Overall Study||30
7580288|NCT02718118|18659180|P1|STARTED|Overall Study||30
7580289|NCT02718040|18659214|P1|NOT COMPLETED|Overall Study||0
7580290|NCT02718040|18659214|P1|COMPLETED|Overall Study||30
7580291|NCT02718040|18659214|P1|STARTED|Overall Study||30
7580292|NCT02717949|18659229|P2|NOT COMPLETED|Overall Study||0
7580293|NCT02717949|18659230|P1|NOT COMPLETED|Overall Study||0
7580294|NCT02717949|18659229|P2|COMPLETED|Overall Study||0
7580295|NCT02717949|18659230|P1|COMPLETED|Overall Study||0
7580296|NCT02717949|18659229|P2|STARTED|Overall Study||0
7580297|NCT02717949|18659230|P1|STARTED|Overall Study||0
7580298|NCT02717754|18659244|P6|NOT COMPLETED|Overall Study||20
7580299|NCT02717754|18659245|P5|NOT COMPLETED|Overall Study||20
7580300|NCT02717754|18659246|P4|NOT COMPLETED|Overall Study||10
7580301|NCT02717754|18659247|P3|NOT COMPLETED|Overall Study||0
7580302|NCT02717754|18659248|P2|NOT COMPLETED|Overall Study||0
7580303|NCT02717754|18659249|P1|NOT COMPLETED|Overall Study||0
7580304|NCT02717754|18659244|P6|COMPLETED|Overall Study||0
7580305|NCT02717754|18659245|P5|COMPLETED|Overall Study||0
7580306|NCT02717754|18659246|P4|COMPLETED|Overall Study||0
7580307|NCT02717754|18659247|P3|COMPLETED|Overall Study||20
7580308|NCT02717754|18659248|P2|COMPLETED|Overall Study||19
7580309|NCT02717754|18659249|P1|COMPLETED|Overall Study||10
7580310|NCT02717754|18659244|P6|STARTED|Overall Study||20
7580311|NCT02717754|18659245|P5|STARTED|Overall Study||20
7580312|NCT02717754|18659246|P4|STARTED|Overall Study||10
7580313|NCT02717754|18659247|P3|STARTED|Overall Study||20
7580314|NCT02717754|18659248|P2|STARTED|Overall Study||19
7580315|NCT02717754|18659249|P1|STARTED|Overall Study||10
7580316|NCT02717494|18659280|P3|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||4
7580317|NCT02717494|18659281|P2|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
7580318|NCT02717494|18659282|P1|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
7580319|NCT02717494|18659280|P3|COMPLETED|Second Intervention (Step 2 or Step 3)||106
7580320|NCT02717494|18659281|P2|COMPLETED|Second Intervention (Step 2 or Step 3)||0
7580321|NCT02717494|18659282|P1|COMPLETED|Second Intervention (Step 2 or Step 3)||0
7580322|NCT02717494|18659280|P3|Completed Step 3|Second Intervention (Step 2 or Step 3)||4
7580323|NCT02717494|18659281|P2|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
7580324|NCT02717494|18659282|P1|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
7580325|NCT02717494|18659280|P3|Completed Step 2B|Second Intervention (Step 2 or Step 3)||50
7580326|NCT02717494|18659281|P2|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
7580327|NCT02717494|18659282|P1|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
7580328|NCT02717494|18659280|P3|Completed Step 2A|Second Intervention (Step 2 or Step 3)||52
7580329|NCT02717494|18659281|P2|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
7580330|NCT02717494|18659282|P1|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
7580331|NCT02717494|18659280|P3|STARTED|Second Intervention (Step 2 or Step 3)|One participant who completed Step 1 did not enroll in Step 2.|110
7580332|NCT02717494|18659281|P2|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
7580333|NCT02717494|18659282|P1|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
7580334|NCT02717494|18659280|P3|NOT COMPLETED|First Intervention (Step 1)||5
7580335|NCT02717494|18659281|P2|NOT COMPLETED|First Intervention (Step 1)||7
7580336|NCT02717494|18659282|P1|NOT COMPLETED|First Intervention (Step 1)||6
7580337|NCT02717494|18659280|P3|COMPLETED|First Intervention (Step 1)||111
7580338|NCT02717494|18659281|P2|COMPLETED|First Intervention (Step 1)||108
7580339|NCT02717494|18659282|P1|COMPLETED|First Intervention (Step 1)||109
7580340|NCT02717494|18659280|P3|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||4
7580341|NCT02717494|18659281|P2|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
7580342|NCT02717494|18659282|P1|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
7580343|NCT02717494|18659280|P3|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||53
7580344|NCT02717494|18659281|P2|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
7580345|NCT02717494|18659282|P1|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
7580346|NCT02717494|18659280|P3|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||53
7580347|NCT02717494|18659281|P2|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
7580348|NCT02717494|18659282|P1|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
7580349|NCT02717494|18659280|P3|STARTED|First Intervention (Step 1)||116
7580350|NCT02717494|18659281|P2|STARTED|First Intervention (Step 1)||115
7580351|NCT02717494|18659282|P1|STARTED|First Intervention (Step 1)||115
7580352|NCT02717273|18659321|P2|NOT COMPLETED|Overall Study||2
7580353|NCT02717273|18659322|P1|NOT COMPLETED|Overall Study||3
7580354|NCT02717273|18659321|P2|COMPLETED|Overall Study||48
7580355|NCT02717273|18659322|P1|COMPLETED|Overall Study||49
7580356|NCT02717273|18659321|P2|STARTED|Overall Study||50
7580357|NCT02717273|18659322|P1|STARTED|Overall Study||52
7580358|NCT02717195|18659344|P5|NOT COMPLETED|Double-blind Treatment (DBT) Period||30
7580359|NCT02717195|18659345|P4|NOT COMPLETED|Double-blind Treatment (DBT) Period||44
7580360|NCT02717195|18659346|P3|NOT COMPLETED|Double-blind Treatment (DBT) Period||37
7580361|NCT02717195|18659347|P2|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
7580362|NCT02717195|18659348|P1|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
7580363|NCT02717195|18659344|P5|COMPLETED|Double-blind Treatment (DBT) Period||200
7580364|NCT02717195|18659345|P4|COMPLETED|Double-blind Treatment (DBT) Period||188
7580365|NCT02717195|18659346|P3|COMPLETED|Double-blind Treatment (DBT) Period||198
7580366|NCT02717195|18659347|P2|COMPLETED|Double-blind Treatment (DBT) Period||0
7580367|NCT02717195|18659348|P1|COMPLETED|Double-blind Treatment (DBT) Period||0
7580368|NCT02717195|18659344|P5|STARTED|Double-blind Treatment (DBT) Period||230
7580369|NCT02717195|18659345|P4|STARTED|Double-blind Treatment (DBT) Period||232
7580370|NCT02717195|18659346|P3|STARTED|Double-blind Treatment (DBT) Period||235
7580371|NCT02717195|18659347|P2|STARTED|Double-blind Treatment (DBT) Period||0
7580372|NCT02717195|18659348|P1|STARTED|Double-blind Treatment (DBT) Period||0
7580373|NCT02717195|18659344|P5|NOT COMPLETED|Prospective Confirmation (PC) Period||0
7580374|NCT02717195|18659345|P4|NOT COMPLETED|Prospective Confirmation (PC) Period||0
7580375|NCT02717195|18659346|P3|NOT COMPLETED|Prospective Confirmation (PC) Period||0
7580376|NCT02717195|18659347|P2|NOT COMPLETED|Prospective Confirmation (PC) Period||111
7580377|NCT02717195|18659348|P1|NOT COMPLETED|Prospective Confirmation (PC) Period||290
7580378|NCT02717195|18659344|P5|COMPLETED|Prospective Confirmation (PC) Period||0
7580379|NCT02717195|18659345|P4|COMPLETED|Prospective Confirmation (PC) Period||0
7580380|NCT02717195|18659346|P3|COMPLETED|Prospective Confirmation (PC) Period||0
7580381|NCT02717195|18659347|P2|COMPLETED|Prospective Confirmation (PC) Period||276
7580382|NCT02717195|18659348|P1|COMPLETED|Prospective Confirmation (PC) Period||421
7580383|NCT02717195|18659344|P5|STARTED|Prospective Confirmation (PC) Period||0
7580384|NCT02717195|18659345|P4|STARTED|Prospective Confirmation (PC) Period||0
7580385|NCT02717195|18659346|P3|STARTED|Prospective Confirmation (PC) Period||0
7580386|NCT02717195|18659347|P2|STARTED|Prospective Confirmation (PC) Period||387
7580387|NCT02717195|18659348|P1|STARTED|Prospective Confirmation (PC) Period||711
7580388|NCT02717130|18659379|P1|NOT COMPLETED|Overall Study||7
7580389|NCT02717130|18659379|P1|COMPLETED|Overall Study||1
7580390|NCT02717130|18659379|P1|STARTED|Overall Study|Of the nine enrolled subjects, eight received study drug.|8
7580391|NCT02716987|18659389|P6|NOT COMPLETED|Overall Study||1
7580392|NCT02716987|18659390|P5|NOT COMPLETED|Overall Study||1
7580393|NCT02716987|18659391|P4|NOT COMPLETED|Overall Study||0
7580394|NCT02716987|18659392|P3|NOT COMPLETED|Overall Study||1
7580395|NCT02716987|18659393|P2|NOT COMPLETED|Overall Study||0
7580396|NCT02716987|18659394|P1|NOT COMPLETED|Overall Study||0
7580397|NCT02716987|18659389|P6|COMPLETED|Overall Study||0
7580398|NCT02716987|18659390|P5|COMPLETED|Overall Study||5
7580399|NCT02716987|18659391|P4|COMPLETED|Overall Study||2
7580400|NCT02716987|18659392|P3|COMPLETED|Overall Study||4
7580401|NCT02716987|18659393|P2|COMPLETED|Overall Study||2
7580402|NCT02716987|18659394|P1|COMPLETED|Overall Study||4
7580403|NCT02716987|18659389|P6|STARTED|Overall Study||1
7580404|NCT02716987|18659390|P5|STARTED|Overall Study||6
7580405|NCT02716987|18659391|P4|STARTED|Overall Study||2
7580406|NCT02716987|18659392|P3|STARTED|Overall Study||5
7580407|NCT02716987|18659393|P2|STARTED|Overall Study||2
7580408|NCT02716987|18659394|P1|STARTED|Overall Study||4
7580409|NCT02716896|18659460|P2|NOT COMPLETED|Overall Study||1
7580410|NCT02716896|18659461|P1|NOT COMPLETED|Overall Study||0
7580411|NCT02716896|18659460|P2|COMPLETED|Overall Study||0
7580412|NCT02716896|18659461|P1|COMPLETED|Overall Study||1
7580413|NCT02716896|18659460|P2|STARTED|Overall Study||1
7580414|NCT02716896|18659461|P1|STARTED|Overall Study||1
7580415|NCT02716818|18659481|P2|NOT COMPLETED|Overall Study||2
7580416|NCT02716818|18659482|P1|NOT COMPLETED|Overall Study||3
7580417|NCT02716818|18659481|P2|COMPLETED|Overall Study||59
7580418|NCT02716818|18659482|P1|COMPLETED|Overall Study||58
7580419|NCT02716818|18659481|P2|STARTED|Overall Study||61
7580420|NCT02716818|18659482|P1|STARTED|Overall Study||61
7580421|NCT02716805|18659512|P4|NOT COMPLETED|Overall Study||0
7580422|NCT02716805|18659513|P3|NOT COMPLETED|Overall Study||0
7580423|NCT02716805|18659514|P2|NOT COMPLETED|Overall Study||0
7580424|NCT02716805|18659515|P1|NOT COMPLETED|Overall Study||2
7580425|NCT02716805|18659512|P4|COMPLETED|Overall Study||0
7580426|NCT02716805|18659513|P3|COMPLETED|Overall Study||0
7580427|NCT02716805|18659514|P2|COMPLETED|Overall Study||0
7580428|NCT02716805|18659515|P1|COMPLETED|Overall Study||4
7580429|NCT02716805|18659512|P4|STARTED|Overall Study||0
7580430|NCT02716805|18659513|P3|STARTED|Overall Study||0
7580431|NCT02716805|18659514|P2|STARTED|Overall Study||0
7580432|NCT02716805|18659515|P1|STARTED|Overall Study||6
7580433|NCT02716779|18659523|P3|NOT COMPLETED|Combination Therapy||1
7580434|NCT02716779|18659524|P2|NOT COMPLETED|Combination Therapy||2
7580435|NCT02716779|18659525|P1|NOT COMPLETED|Combination Therapy||0
7580436|NCT02716779|18659523|P3|COMPLETED|Combination Therapy||25
7580437|NCT02716779|18659524|P2|COMPLETED|Combination Therapy||23
7580438|NCT02716779|18659525|P1|COMPLETED|Combination Therapy||14
7580439|NCT02716779|18659523|P3|STARTED|Combination Therapy||26
7580440|NCT02716779|18659524|P2|STARTED|Combination Therapy||25
7580441|NCT02716779|18659525|P1|STARTED|Combination Therapy||14
7580442|NCT02716779|18659523|P3|NOT COMPLETED|Monotherapy||1
7580443|NCT02716779|18659524|P2|NOT COMPLETED|Monotherapy||1
7580444|NCT02716779|18659525|P1|NOT COMPLETED|Monotherapy||0
7580445|NCT02716779|18659523|P3|COMPLETED|Monotherapy||26
7580446|NCT02716779|18659524|P2|COMPLETED|Monotherapy||25
7580447|NCT02716779|18659525|P1|COMPLETED|Monotherapy||14
7580448|NCT02716779|18659523|P3|STARTED|Monotherapy||27
7580449|NCT02716779|18659524|P2|STARTED|Monotherapy||26
7580450|NCT02716779|18659525|P1|STARTED|Monotherapy||14
7580451|NCT02716727|18659571|P2|NOT COMPLETED|Overall Study||0
7580452|NCT02716727|18659572|P1|NOT COMPLETED|Overall Study||0
7580453|NCT02716727|18659571|P2|COMPLETED|Overall Study||9
7580454|NCT02716727|18659572|P1|COMPLETED|Overall Study||7
7580455|NCT02716727|18659571|P2|STARTED|Overall Study||9
7580456|NCT02716727|18659572|P1|STARTED|Overall Study||7
7580457|NCT02716714|18659596|P2|NOT COMPLETED|Overall Study||2
7580458|NCT02716714|18659597|P1|NOT COMPLETED|Overall Study||12
7580459|NCT02716714|18659596|P2|COMPLETED|Overall Study||8
7580460|NCT02716714|18659597|P1|COMPLETED|Overall Study||55
7580461|NCT02716714|18659596|P2|STARTED|Overall Study||10
7580462|NCT02716714|18659597|P1|STARTED|Overall Study||67
7580463|NCT02716584|18659625|P2|NOT COMPLETED|Overall Study||5
7580464|NCT02716584|18659626|P1|NOT COMPLETED|Overall Study||8
7580465|NCT02716584|18659625|P2|COMPLETED|Overall Study||13
7580466|NCT02716584|18659626|P1|COMPLETED|Overall Study||27
7580467|NCT02716584|18659625|P2|STARTED|Overall Study||18
7580468|NCT02716584|18659626|P1|STARTED|Overall Study||35
7580469|NCT02716506|18659650|P1|NOT COMPLETED|Overall Study||1164
7580470|NCT02716506|18659650|P1|COMPLETED|Overall Study||2351
7580471|NCT02716506|18659650|P1|2 Years|Overall Study|Patients that completed the questionnaires two years after the operation.|2351
7580472|NCT02716506|18659650|P1|6 Months|Overall Study|Patients that completed the questionnaires six months after the operation.|2528
7580473|NCT02716506|18659650|P1|STARTED|Overall Study||3515
7580474|NCT02716324|18659657|P2|NOT COMPLETED|Overall Study||11
7580475|NCT02716324|18659658|P1|NOT COMPLETED|Overall Study||19
7580476|NCT02716324|18659657|P2|COMPLETED|Overall Study||143
7580477|NCT02716324|18659658|P1|COMPLETED|Overall Study||130
7580478|NCT02716324|18659657|P2|STARTED|Overall Study||154
7580479|NCT02716324|18659658|P1|STARTED|Overall Study||149
7580480|NCT02716298|18659682|P2|NOT COMPLETED|Second Intervention (1 Month)||0
7580481|NCT02716298|18659683|P1|NOT COMPLETED|Second Intervention (1 Month)||0
7580482|NCT02716298|18659682|P2|COMPLETED|Second Intervention (1 Month)||23
7580483|NCT02716298|18659683|P1|COMPLETED|Second Intervention (1 Month)||24
7580484|NCT02716298|18659682|P2|STARTED|Second Intervention (1 Month)||23
7580485|NCT02716298|18659683|P1|STARTED|Second Intervention (1 Month)||24
7580486|NCT02716298|18659682|P2|NOT COMPLETED|First Intervention (1 Month)||1
7580487|NCT02716298|18659683|P1|NOT COMPLETED|First Intervention (1 Month)||1
7580488|NCT02716298|18659682|P2|COMPLETED|First Intervention (1 Month)||23
7580489|NCT02716298|18659683|P1|COMPLETED|First Intervention (1 Month)||24
7580490|NCT02716298|18659682|P2|STARTED|First Intervention (1 Month)||24
7580491|NCT02716298|18659683|P1|STARTED|First Intervention (1 Month)||25
7580492|NCT02716194|18659701|P3|NOT COMPLETED|Period 2 - BAX 826||0
7580493|NCT02716194|18659702|P2|NOT COMPLETED|Period 2 - BAX 826||0
7580494|NCT02716194|18659703|P1|NOT COMPLETED|Period 2 - BAX 826||0
7580495|NCT02716194|18659701|P3|COMPLETED|Period 2 - BAX 826||13
7580496|NCT02716194|18659702|P2|COMPLETED|Period 2 - BAX 826||15
7580497|NCT02716194|18659703|P1|COMPLETED|Period 2 - BAX 826||10
7580498|NCT02716194|18659701|P3|STARTED|Period 2 - BAX 826||13
7580499|NCT02716194|18659702|P2|STARTED|Period 2 - BAX 826||15
7580500|NCT02716194|18659703|P1|STARTED|Period 2 - BAX 826||10
7580501|NCT02716194|18659701|P3|NOT COMPLETED|Period 1 - ADVATE||0
7580502|NCT02716194|18659702|P2|NOT COMPLETED|Period 1 - ADVATE||1
7580503|NCT02716194|18659703|P1|NOT COMPLETED|Period 1 - ADVATE||1
7580504|NCT02716194|18659701|P3|COMPLETED|Period 1 - ADVATE||13
7580505|NCT02716194|18659702|P2|COMPLETED|Period 1 - ADVATE||15
7580506|NCT02716194|18659703|P1|COMPLETED|Period 1 - ADVATE||10
7580507|NCT02716194|18659701|P3|STARTED|Period 1 - ADVATE||13
7580508|NCT02716194|18659702|P2|STARTED|Period 1 - ADVATE||16
7580509|NCT02716194|18659703|P1|STARTED|Period 1 - ADVATE||11
7580510|NCT02715804|18659783|P2|NOT COMPLETED|Overall Study||113
7580511|NCT02715804|18659784|P1|NOT COMPLETED|Overall Study||229
7580512|NCT02715804|18659783|P2|COMPLETED|Overall Study||52
7580513|NCT02715804|18659784|P1|COMPLETED|Overall Study||98
7580514|NCT02715804|18659783|P2|Safety Population|Overall Study|1 participant randomized to PAG but received AG|156
7580515|NCT02715804|18659784|P1|Safety Population|Overall Study|3 participants randomized to AG but received PAG|325
7580516|NCT02715804|18659783|P2|Received at Least 1 Dose of Study Drug|Overall Study||158
7580517|NCT02715804|18659784|P1|Received at Least 1 Dose of Study Drug|Overall Study||323
7580518|NCT02715804|18659783|P2|STARTED|Overall Study||165
7580519|NCT02715804|18659784|P1|STARTED|Overall Study||327
7580520|NCT02715765|18659807|P3|NOT COMPLETED|Overall Study||0
7580521|NCT02715765|18659808|P2|NOT COMPLETED|Overall Study||0
7580522|NCT02715765|18659809|P1|NOT COMPLETED|Overall Study||3
7580523|NCT02715765|18659807|P3|COMPLETED|Overall Study||0
7580524|NCT02715765|18659808|P2|COMPLETED|Overall Study||0
7580525|NCT02715765|18659809|P1|COMPLETED|Overall Study||0
7580526|NCT02715765|18659807|P3|STARTED|Overall Study||0
7580527|NCT02715765|18659808|P2|STARTED|Overall Study||0
7580528|NCT02715765|18659809|P1|STARTED|Overall Study||3
7580529|NCT02715726|18659822|P2|NOT COMPLETED|Overall Study||27
7580530|NCT02715726|18659823|P1|NOT COMPLETED|Overall Study||18
7580531|NCT02715726|18659822|P2|COMPLETED|Overall Study||380
7580532|NCT02715726|18659823|P1|COMPLETED|Overall Study||190
7580533|NCT02715726|18659822|P2|Safety Population|Overall Study||406
7580534|NCT02715726|18659823|P1|Safety Population|Overall Study||206
7580535|NCT02715726|18659822|P2|Treated|Overall Study||405
7580536|NCT02715726|18659823|P1|Treated|Overall Study||207
7580537|NCT02715726|18659822|P2|STARTED|Overall Study|Randomized|407
7580538|NCT02715726|18659823|P1|STARTED|Overall Study|Randomized|208
7580539|NCT02715700|18659871|P1|NOT COMPLETED|Overall Study||0
7580540|NCT02715700|18659871|P1|COMPLETED|Overall Study||14
7580541|NCT02715700|18659871|P1|STARTED|Overall Study||14
7580542|NCT02714868|18659903|P2|NOT COMPLETED|Overall Study||0
7580543|NCT02714868|18659904|P1|NOT COMPLETED|Overall Study||5
7580544|NCT02714868|18659903|P2|COMPLETED|Overall Study||35
7580545|NCT02714868|18659904|P1|COMPLETED|Overall Study||42
7580546|NCT02714868|18659903|P2|STARTED|Overall Study||35
7580547|NCT02714868|18659904|P1|STARTED|Overall Study||47
7580548|NCT02714595|18659922|P2|NOT COMPLETED|Overall Study||13
7580549|NCT02714595|18659923|P1|NOT COMPLETED|Overall Study||32
7580550|NCT02714595|18659922|P2|COMPLETED|Overall Study||38
7580551|NCT02714595|18659923|P1|COMPLETED|Overall Study||69
7580552|NCT02714595|18659922|P2|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||38
7580553|NCT02714595|18659923|P1|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||80
7580554|NCT02714595|18659922|P2|Received Treatment|Overall Study||49
7580555|NCT02714595|18659923|P1|Received Treatment|Overall Study||101
7580556|NCT02714595|18659922|P2|STARTED|Overall Study||51
7580557|NCT02714595|18659923|P1|STARTED|Overall Study||101
7580558|NCT02714504|18660171|P2|NOT COMPLETED|Overall Study||0
7580559|NCT02714504|18660172|P1|NOT COMPLETED|Overall Study||0
7580560|NCT02714504|18660171|P2|COMPLETED|Overall Study||178
7580561|NCT02714504|18660172|P1|COMPLETED|Overall Study||61
7580562|NCT02714504|18660171|P2|STARTED|Overall Study||178
7580563|NCT02714504|18660172|P1|STARTED|Overall Study||61
7580564|NCT02714426|18660180|P2|NOT COMPLETED|Overall Study||2
7580565|NCT02714426|18660181|P1|NOT COMPLETED|Overall Study||2
7580566|NCT02714426|18660180|P2|COMPLETED|Overall Study||19
7580567|NCT02714426|18660181|P1|COMPLETED|Overall Study||19
7580568|NCT02714426|18660180|P2|STARTED|Overall Study||21
7580569|NCT02714426|18660181|P1|STARTED|Overall Study||21
7580570|NCT02714400|18660197|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7580571|NCT02714400|18660198|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7580572|NCT02714400|18660197|P2|COMPLETED|Second Intervention (1 Day)||8
7580573|NCT02714400|18660198|P1|COMPLETED|Second Intervention (1 Day)||12
7580574|NCT02714400|18660197|P2|STARTED|Second Intervention (1 Day)||8
7580575|NCT02714400|18660198|P1|STARTED|Second Intervention (1 Day)||12
7580576|NCT02714400|18660197|P2|NOT COMPLETED|Washout (>4 Days)||0
7580577|NCT02714400|18660198|P1|NOT COMPLETED|Washout (>4 Days)||0
7580578|NCT02714400|18660197|P2|COMPLETED|Washout (>4 Days)||8
7580579|NCT02714400|18660198|P1|COMPLETED|Washout (>4 Days)||12
7580580|NCT02714400|18660197|P2|STARTED|Washout (>4 Days)||8
7580581|NCT02714400|18660198|P1|STARTED|Washout (>4 Days)||12
7580582|NCT02714400|18660197|P2|NOT COMPLETED|First Intervention (1 Day)||0
7580583|NCT02714400|18660198|P1|NOT COMPLETED|First Intervention (1 Day)||0
7580584|NCT02714400|18660197|P2|COMPLETED|First Intervention (1 Day)||8
7580585|NCT02714400|18660198|P1|COMPLETED|First Intervention (1 Day)||12
7580586|NCT02714400|18660197|P2|STARTED|First Intervention (1 Day)||8
7580587|NCT02714400|18660198|P1|STARTED|First Intervention (1 Day)||12
7580588|NCT02714283|18660214|P2|NOT COMPLETED|Overall Study||0
7580589|NCT02714283|18660215|P1|NOT COMPLETED|Overall Study||0
7580590|NCT02714283|18660214|P2|COMPLETED|Overall Study||6500
7580591|NCT02714283|18660215|P1|COMPLETED|Overall Study||83589
7580592|NCT02714283|18660214|P2|STARTED|Overall Study||6500
7580593|NCT02714283|18660215|P1|STARTED|Overall Study||83589
7580594|NCT02714218|18660242|P3|NOT COMPLETED|Overall Study||19
7580595|NCT02714218|18660243|P2|NOT COMPLETED|Overall Study||143
7580596|NCT02714218|18660244|P1|NOT COMPLETED|Overall Study||130
7580597|NCT02714218|18660242|P3|COMPLETED|Overall Study||8
7580598|NCT02714218|18660243|P2|COMPLETED|Overall Study||35
7580599|NCT02714218|18660244|P1|COMPLETED|Overall Study||50
7580600|NCT02714218|18660242|P3|STARTED|Overall Study||27
7580601|NCT02714218|18660243|P2|STARTED|Overall Study||178
7580602|NCT02714218|18660244|P1|STARTED|Overall Study||180
7580603|NCT02714062|18660294|P3|NOT COMPLETED|Overall Study||3
7580604|NCT02714062|18660295|P2|NOT COMPLETED|Overall Study||1
7580605|NCT02714062|18660296|P1|NOT COMPLETED|Overall Study||1
7580606|NCT02714062|18660294|P3|COMPLETED|Overall Study||10
7580607|NCT02714062|18660295|P2|COMPLETED|Overall Study||14
7580608|NCT02714062|18660296|P1|COMPLETED|Overall Study||13
7580609|NCT02714062|18660294|P3|STARTED|Overall Study||13
7580610|NCT02714062|18660295|P2|STARTED|Overall Study||15
7580611|NCT02714062|18660296|P1|STARTED|Overall Study||14
7580612|NCT02713867|18660342|P2|NOT COMPLETED|Treatment Period||150
7580613|NCT02713867|18660343|P1|NOT COMPLETED|Treatment Period||147
7580614|NCT02713867|18660342|P2|COMPLETED|Treatment Period||30
7580615|NCT02713867|18660343|P1|COMPLETED|Treatment Period||31
7580616|NCT02713867|18660342|P2|STARTED|Treatment Period||180
7580617|NCT02713867|18660343|P1|STARTED|Treatment Period||178
7580618|NCT02713867|18660342|P2|NOT COMPLETED|Randomization||3
7580619|NCT02713867|18660343|P1|NOT COMPLETED|Randomization||2
7580620|NCT02713867|18660342|P2|COMPLETED|Randomization||180
7580621|NCT02713867|18660343|P1|COMPLETED|Randomization||178
7580622|NCT02713867|18660342|P2|STARTED|Randomization||183
7580623|NCT02713867|18660343|P1|STARTED|Randomization||180
7580624|NCT02713828|18660381|P2|NOT COMPLETED|Overall Study||0
7580625|NCT02713828|18660382|P1|NOT COMPLETED|Overall Study||5
7580626|NCT02713828|18660381|P2|COMPLETED|Overall Study||0
7580627|NCT02713828|18660382|P1|COMPLETED|Overall Study||8
7580628|NCT02713828|18660381|P2|STARTED|Overall Study||0
7580629|NCT02713828|18660382|P1|STARTED|Overall Study||13
7580630|NCT02713789|18660394|P3|NOT COMPLETED|Overall Study||1
7580631|NCT02713789|18660395|P2|NOT COMPLETED|Overall Study||1
7580632|NCT02713789|18660396|P1|NOT COMPLETED|Overall Study||0
7580633|NCT02713789|18660394|P3|COMPLETED|Overall Study||7
7580634|NCT02713789|18660395|P2|COMPLETED|Overall Study||9
7580635|NCT02713789|18660396|P1|COMPLETED|Overall Study||8
7580636|NCT02713789|18660394|P3|STARTED|Overall Study||8
7580637|NCT02713789|18660395|P2|STARTED|Overall Study||10
7580638|NCT02713789|18660396|P1|STARTED|Overall Study||8
7580639|NCT02713698|18660434|P3|NOT COMPLETED|Overall Study||0
7580640|NCT02713698|18660435|P2|NOT COMPLETED|Overall Study||0
7580641|NCT02713698|18660436|P1|NOT COMPLETED|Overall Study||0
7580642|NCT02713698|18660434|P3|COMPLETED|Overall Study||20
7580643|NCT02713698|18660435|P2|COMPLETED|Overall Study||20
7580644|NCT02713698|18660436|P1|COMPLETED|Overall Study||20
7580645|NCT02713698|18660434|P3|STARTED|Overall Study||20
7580646|NCT02713698|18660435|P2|STARTED|Overall Study||20
7580647|NCT02713698|18660436|P1|STARTED|Overall Study||20
7580648|NCT02713659|18660446|P2|NOT COMPLETED|24 Month Study Visit||8
7580649|NCT02713659|18660447|P1|NOT COMPLETED|24 Month Study Visit||8
7580650|NCT02713659|18660446|P2|COMPLETED|24 Month Study Visit||44
7580651|NCT02713659|18660447|P1|COMPLETED|24 Month Study Visit||49
7580652|NCT02713659|18660446|P2|STARTED|24 Month Study Visit||52
7580653|NCT02713659|18660447|P1|STARTED|24 Month Study Visit||57
7580654|NCT02713659|18660446|P2|NOT COMPLETED|18 Month Study Visit||3
7580655|NCT02713659|18660447|P1|NOT COMPLETED|18 Month Study Visit||8
7580656|NCT02713659|18660446|P2|COMPLETED|18 Month Study Visit||50
7580657|NCT02713659|18660447|P1|COMPLETED|18 Month Study Visit||50
7580658|NCT02713659|18660446|P2|STARTED|18 Month Study Visit||53
7580659|NCT02713659|18660447|P1|STARTED|18 Month Study Visit||58
7580660|NCT02713659|18660446|P2|NOT COMPLETED|12 Month Study Visit||3
7580661|NCT02713659|18660447|P1|NOT COMPLETED|12 Month Study Visit||3
7580662|NCT02713659|18660446|P2|COMPLETED|12 Month Study Visit||52
7580663|NCT02713659|18660447|P1|COMPLETED|12 Month Study Visit||54
7580664|NCT02713659|18660446|P2|STARTED|12 Month Study Visit||55
7580665|NCT02713659|18660447|P1|STARTED|12 Month Study Visit||57
7580666|NCT02713659|18660446|P2|NOT COMPLETED|6 Month Study Visit||13
7580667|NCT02713659|18660447|P1|NOT COMPLETED|6 Month Study Visit||7
7580668|NCT02713659|18660446|P2|COMPLETED|6 Month Study Visit||47
7580669|NCT02713659|18660447|P1|COMPLETED|6 Month Study Visit||53
7580670|NCT02713659|18660446|P2|STARTED|6 Month Study Visit||60
7580671|NCT02713659|18660447|P1|STARTED|6 Month Study Visit||60
7580672|NCT02713659|18660446|P2|NOT COMPLETED|Baseline||0
7580673|NCT02713659|18660447|P1|NOT COMPLETED|Baseline||0
7580674|NCT02713659|18660446|P2|COMPLETED|Baseline||60
7580675|NCT02713659|18660447|P1|COMPLETED|Baseline||60
7580676|NCT02713659|18660446|P2|STARTED|Baseline||60
7580677|NCT02713659|18660447|P1|STARTED|Baseline||60
7580678|NCT02713594|18660459|P2|NOT COMPLETED|Overall Study||396
7580679|NCT02713594|18660460|P1|NOT COMPLETED|Overall Study||390
7580680|NCT02713594|18660459|P2|COMPLETED|Overall Study||552
7580681|NCT02713594|18660460|P1|COMPLETED|Overall Study||562
7580682|NCT02713594|18660459|P2|STARTED|Overall Study||948
7580683|NCT02713594|18660460|P1|STARTED|Overall Study||952
7580684|NCT02713542|18660472|P2|NOT COMPLETED|Overall Study||6
7580685|NCT02713542|18660473|P1|NOT COMPLETED|Overall Study||18
7580686|NCT02713542|18660472|P2|COMPLETED|Overall Study||24
7580687|NCT02713542|18660473|P1|COMPLETED|Overall Study||42
7580688|NCT02713542|18660472|P2|STARTED|Overall Study||30
7580689|NCT02713542|18660473|P1|STARTED|Overall Study||60
7580690|NCT02713529|18660486|P7|NOT COMPLETED|Overall Study||4
7580691|NCT02713529|18660487|P6|NOT COMPLETED|Overall Study||14
7580692|NCT02713529|18660488|P5|NOT COMPLETED|Overall Study||3
7580693|NCT02713529|18660489|P4|NOT COMPLETED|Overall Study||29
7580694|NCT02713529|18660490|P3|NOT COMPLETED|Overall Study||31
7580695|NCT02713529|18660491|P2|NOT COMPLETED|Overall Study||4
7580696|NCT02713529|18660492|P1|NOT COMPLETED|Overall Study||7
7580697|NCT02713529|18660486|P7|COMPLETED|Overall Study||2
7580698|NCT02713529|18660487|P6|COMPLETED|Overall Study||5
7580699|NCT02713529|18660488|P5|COMPLETED|Overall Study||1
7580700|NCT02713529|18660489|P4|COMPLETED|Overall Study||2
7580701|NCT02713529|18660490|P3|COMPLETED|Overall Study||11
7580702|NCT02713529|18660491|P2|COMPLETED|Overall Study||3
7580703|NCT02713529|18660492|P1|COMPLETED|Overall Study||1
7580704|NCT02713529|18660486|P7|STARTED|Overall Study||6
7580705|NCT02713529|18660487|P6|STARTED|Overall Study||19
7580706|NCT02713529|18660488|P5|STARTED|Overall Study||4
7580707|NCT02713529|18660489|P4|STARTED|Overall Study||31
7580708|NCT02713529|18660490|P3|STARTED|Overall Study||42
7580709|NCT02713529|18660491|P2|STARTED|Overall Study||7
7580710|NCT02713529|18660492|P1|STARTED|Overall Study||8
7580711|NCT02713490|18660574|P2|NOT COMPLETED|Overall Study||2
7580712|NCT02713490|18660575|P1|NOT COMPLETED|Overall Study||3
7580713|NCT02713490|18660574|P2|COMPLETED|Overall Study||67
7580714|NCT02713490|18660575|P1|COMPLETED|Overall Study||68
7580715|NCT02713490|18660574|P2|STARTED|Overall Study||69
7580716|NCT02713490|18660575|P1|STARTED|Overall Study||71
7580717|NCT02713425|18660589|P1|NOT COMPLETED|Overall Study||0
7580718|NCT02713425|18660589|P1|COMPLETED|Overall Study||20
7580719|NCT02713425|18660589|P1|STARTED|Overall Study||20
7580720|NCT02713256|18660594|P1|NOT COMPLETED|Overall Study||0
7580721|NCT02713256|18660594|P1|COMPLETED|Overall Study||15
7580722|NCT02713256|18660594|P1|STARTED|Overall Study||15
7580723|NCT02713243|18660602|P2|NOT COMPLETED|Overall Study||2
7580724|NCT02713243|18660603|P1|NOT COMPLETED|Overall Study||1
7580725|NCT02713243|18660602|P2|COMPLETED|Overall Study||8
7580726|NCT02713243|18660603|P1|COMPLETED|Overall Study||9
7580727|NCT02713243|18660602|P2|PK Analysis Set|Overall Study||9
7580728|NCT02713243|18660603|P1|PK Analysis Set|Overall Study||8
7580729|NCT02713243|18660602|P2|PD Analysis Set|Overall Study||10
7580730|NCT02713243|18660603|P1|PD Analysis Set|Overall Study||9
7580731|NCT02713243|18660602|P2|STARTED|Overall Study||10
7580732|NCT02713243|18660603|P1|STARTED|Overall Study||10
7580733|NCT02713230|18660621|P3|NOT COMPLETED|Overall Study||0
7580734|NCT02713230|18660622|P2|NOT COMPLETED|Overall Study||0
7580735|NCT02713230|18660623|P1|NOT COMPLETED|Overall Study||1
7580736|NCT02713230|18660621|P3|COMPLETED|Overall Study||71
7580737|NCT02713230|18660622|P2|COMPLETED|Overall Study||15
7580738|NCT02713230|18660623|P1|COMPLETED|Overall Study||68
7580739|NCT02713230|18660621|P3|STARTED|Overall Study||71
7580740|NCT02713230|18660622|P2|STARTED|Overall Study||15
7580741|NCT02713230|18660623|P1|STARTED|Overall Study||69
7580742|NCT02713204|18660639|P8|NOT COMPLETED|From Week 12 up to Week 36||4
7580743|NCT02713204|18660640|P7|NOT COMPLETED|From Week 12 up to Week 36||2
7580744|NCT02713204|18660641|P6|NOT COMPLETED|From Week 12 up to Week 36||1
7580745|NCT02713204|18660642|P5|NOT COMPLETED|From Week 12 up to Week 36||2
7580746|NCT02713204|18660643|P4|NOT COMPLETED|From Week 12 up to Week 36||4
7580747|NCT02713204|18660644|P3|NOT COMPLETED|From Week 12 up to Week 36||0
7580748|NCT02713204|18660645|P2|NOT COMPLETED|From Week 12 up to Week 36||0
7580749|NCT02713204|18660646|P1|NOT COMPLETED|From Week 12 up to Week 36||1
7580750|NCT02713204|18660639|P8|COMPLETED|From Week 12 up to Week 36||54
7580751|NCT02713204|18660640|P7|COMPLETED|From Week 12 up to Week 36||60
7580752|NCT02713204|18660641|P6|COMPLETED|From Week 12 up to Week 36||59
7580753|NCT02713204|18660642|P5|COMPLETED|From Week 12 up to Week 36||60
7580754|NCT02713204|18660643|P4|COMPLETED|From Week 12 up to Week 36||53
7580755|NCT02713204|18660644|P3|COMPLETED|From Week 12 up to Week 36||0
7580756|NCT02713204|18660645|P2|COMPLETED|From Week 12 up to Week 36||0
7580757|NCT02713204|18660646|P1|COMPLETED|From Week 12 up to Week 36||57
7580758|NCT02713204|18660639|P8|STARTED|From Week 12 up to Week 36||58
7580759|NCT02713204|18660640|P7|STARTED|From Week 12 up to Week 36||62
7580760|NCT02713204|18660641|P6|STARTED|From Week 12 up to Week 36||60
7580761|NCT02713204|18660642|P5|STARTED|From Week 12 up to Week 36||62
7580762|NCT02713204|18660643|P4|STARTED|From Week 12 up to Week 36||57
7580763|NCT02713204|18660644|P3|STARTED|From Week 12 up to Week 36||0
7580764|NCT02713204|18660645|P2|STARTED|From Week 12 up to Week 36||0
7580765|NCT02713204|18660646|P1|STARTED|From Week 12 up to Week 36||58
7580766|NCT02713204|18660639|P8|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
7580767|NCT02713204|18660640|P7|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
7580768|NCT02713204|18660641|P6|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
7580769|NCT02713204|18660642|P5|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
7580770|NCT02713204|18660643|P4|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
7580771|NCT02713204|18660644|P3|NOT COMPLETED|Baseline (Day 1) up to Week 12||2
7580772|NCT02713204|18660645|P2|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
7580773|NCT02713204|18660646|P1|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
7580774|NCT02713204|18660639|P8|COMPLETED|Baseline (Day 1) up to Week 12||0
7580775|NCT02713204|18660640|P7|COMPLETED|Baseline (Day 1) up to Week 12||0
7580776|NCT02713204|18660641|P6|COMPLETED|Baseline (Day 1) up to Week 12||0
7580777|NCT02713204|18660642|P5|COMPLETED|Baseline (Day 1) up to Week 12||0
7580778|NCT02713204|18660643|P4|COMPLETED|Baseline (Day 1) up to Week 12||0
7580779|NCT02713204|18660644|P3|COMPLETED|Baseline (Day 1) up to Week 12||181
7580780|NCT02713204|18660645|P2|COMPLETED|Baseline (Day 1) up to Week 12||121
7580781|NCT02713204|18660646|P1|COMPLETED|Baseline (Day 1) up to Week 12||59
7580782|NCT02713204|18660639|P8|STARTED|Baseline (Day 1) up to Week 12||0
7580783|NCT02713204|18660640|P7|STARTED|Baseline (Day 1) up to Week 12||0
7580784|NCT02713204|18660641|P6|STARTED|Baseline (Day 1) up to Week 12||0
7580785|NCT02713204|18660642|P5|STARTED|Baseline (Day 1) up to Week 12||0
7580786|NCT02713204|18660643|P4|STARTED|Baseline (Day 1) up to Week 12||0
7580787|NCT02713204|18660644|P3|STARTED|Baseline (Day 1) up to Week 12||183
7580788|NCT02713204|18660645|P2|STARTED|Baseline (Day 1) up to Week 12||122
7580789|NCT02713204|18660646|P1|STARTED|Baseline (Day 1) up to Week 12||60
7580790|NCT02713178|18660706|P3|NOT COMPLETED|Overall Study||5
7580791|NCT02713178|18660707|P2|NOT COMPLETED|Overall Study||4
7580792|NCT02713178|18660708|P1|NOT COMPLETED|Overall Study||1
7580793|NCT02713178|18660706|P3|COMPLETED|Overall Study||74
7580794|NCT02713178|18660707|P2|COMPLETED|Overall Study||73
7580795|NCT02713178|18660708|P1|COMPLETED|Overall Study||75
7580796|NCT02713178|18660706|P3|STARTED|Overall Study||79
7580797|NCT02713178|18660707|P2|STARTED|Overall Study||77
7580798|NCT02713178|18660708|P1|STARTED|Overall Study||76
7580799|NCT02712996|18660727|P2|NOT COMPLETED|Second Intervention (Study Days 43-84)||1
7580800|NCT02712996|18660728|P1|NOT COMPLETED|Second Intervention (Study Days 43-84)||0
7580801|NCT02712996|18660727|P2|COMPLETED|Second Intervention (Study Days 43-84)||8
7580802|NCT02712996|18660728|P1|COMPLETED|Second Intervention (Study Days 43-84)||8
7580803|NCT02712996|18660727|P2|STARTED|Second Intervention (Study Days 43-84)||9
7580804|NCT02712996|18660728|P1|STARTED|Second Intervention (Study Days 43-84)||8
7580805|NCT02712996|18660727|P2|NOT COMPLETED|First Intervention (Study Days 1-42)||0
7580806|NCT02712996|18660728|P1|NOT COMPLETED|First Intervention (Study Days 1-42)||0
7580807|NCT02712996|18660727|P2|COMPLETED|First Intervention (Study Days 1-42)||9
7580808|NCT02712996|18660728|P1|COMPLETED|First Intervention (Study Days 1-42)||8
7580809|NCT02712996|18660727|P2|STARTED|First Intervention (Study Days 1-42)||9
7580810|NCT02712996|18660728|P1|STARTED|First Intervention (Study Days 1-42)||8
7580811|NCT02712983|18660787|P9|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
7580812|NCT02712983|18660788|P8|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||3
7580813|NCT02712983|18660789|P7|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
7580814|NCT02712983|18660790|P6|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
7580815|NCT02712983|18660791|P5|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
7580816|NCT02712983|18660792|P4|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
7580817|NCT02712983|18660793|P3|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
7580818|NCT02712983|18660794|P2|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
7580819|NCT02712983|18660795|P1|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
7580820|NCT02712983|18660787|P9|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
7580821|NCT02712983|18660788|P8|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
7580822|NCT02712983|18660789|P7|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
7580823|NCT02712983|18660790|P6|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
7580824|NCT02712983|18660791|P5|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
7580825|NCT02712983|18660792|P4|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
7580826|NCT02712983|18660793|P3|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
7580827|NCT02712983|18660794|P2|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
7580828|NCT02712983|18660795|P1|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
7580829|NCT02712983|18660787|P9|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
7580830|NCT02712983|18660788|P8|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|3
7580831|NCT02712983|18660789|P7|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
7580832|NCT02712983|18660790|P6|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
7580833|NCT02712983|18660791|P5|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
7580834|NCT02712983|18660792|P4|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
7580835|NCT02712983|18660793|P3|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
7580836|NCT02712983|18660794|P2|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
7580837|NCT02712983|18660795|P1|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
7580838|NCT02712983|18660787|P9|NOT COMPLETED|Treatment Phase||2
7580839|NCT02712983|18660788|P8|NOT COMPLETED|Treatment Phase||9
7580840|NCT02712983|18660789|P7|NOT COMPLETED|Treatment Phase||9
7580841|NCT02712983|18660790|P6|NOT COMPLETED|Treatment Phase||0
7580842|NCT02712983|18660791|P5|NOT COMPLETED|Treatment Phase||4
7580843|NCT02712983|18660792|P4|NOT COMPLETED|Treatment Phase||8
7580844|NCT02712983|18660793|P3|NOT COMPLETED|Treatment Phase||1
7580845|NCT02712983|18660794|P2|NOT COMPLETED|Treatment Phase||1
7580846|NCT02712983|18660795|P1|NOT COMPLETED|Treatment Phase||5
7580847|NCT02712983|18660787|P9|COMPLETED|Treatment Phase||5
7580848|NCT02712983|18660788|P8|COMPLETED|Treatment Phase||6
7580849|NCT02712983|18660789|P7|COMPLETED|Treatment Phase||6
7580850|NCT02712983|18660790|P6|COMPLETED|Treatment Phase||7
7580851|NCT02712983|18660791|P5|COMPLETED|Treatment Phase||10
7580852|NCT02712983|18660792|P4|COMPLETED|Treatment Phase||7
7580853|NCT02712983|18660793|P3|COMPLETED|Treatment Phase||6
7580854|NCT02712983|18660794|P2|COMPLETED|Treatment Phase||12
7580855|NCT02712983|18660795|P1|COMPLETED|Treatment Phase||9
7580856|NCT02712983|18660787|P9|Pharmacokinetic Analysis Set|Treatment Phase||0
7580857|NCT02712983|18660788|P8|Pharmacokinetic Analysis Set|Treatment Phase||14
7580858|NCT02712983|18660789|P7|Pharmacokinetic Analysis Set|Treatment Phase||15
7580859|NCT02712983|18660790|P6|Pharmacokinetic Analysis Set|Treatment Phase||0
7580860|NCT02712983|18660791|P5|Pharmacokinetic Analysis Set|Treatment Phase||14
7580861|NCT02712983|18660792|P4|Pharmacokinetic Analysis Set|Treatment Phase||15
7580862|NCT02712983|18660793|P3|Pharmacokinetic Analysis Set|Treatment Phase||0
7580863|NCT02712983|18660794|P2|Pharmacokinetic Analysis Set|Treatment Phase||13
7580864|NCT02712983|18660795|P1|Pharmacokinetic Analysis Set|Treatment Phase||14
7580865|NCT02712983|18660787|P9|STARTED|Treatment Phase||7
7580866|NCT02712983|18660788|P8|STARTED|Treatment Phase||15
7580867|NCT02712983|18660789|P7|STARTED|Treatment Phase||15
7580868|NCT02712983|18660790|P6|STARTED|Treatment Phase||7
7580869|NCT02712983|18660791|P5|STARTED|Treatment Phase||14
7580870|NCT02712983|18660792|P4|STARTED|Treatment Phase||15
7580871|NCT02712983|18660793|P3|STARTED|Treatment Phase||7
7580872|NCT02712983|18660794|P2|STARTED|Treatment Phase||13
7580873|NCT02712983|18660795|P1|STARTED|Treatment Phase||14
7580874|NCT02712788|18661027|P2|NOT COMPLETED|Overall Study||0
7580875|NCT02712788|18661028|P1|NOT COMPLETED|Overall Study||2
7580876|NCT02712788|18661027|P2|COMPLETED|Overall Study||2
7580877|NCT02712788|18661028|P1|COMPLETED|Overall Study||0
7580878|NCT02712788|18661027|P2|STARTED|Overall Study||2
7580879|NCT02712788|18661028|P1|STARTED|Overall Study||2
7580880|NCT02712554|18661038|P2|NOT COMPLETED|Part B: Treatment Phase||3
7580881|NCT02712554|18661039|P1|NOT COMPLETED|Part B: Treatment Phase||0
7580882|NCT02712554|18661038|P2|COMPLETED|Part B: Treatment Phase||37
7580883|NCT02712554|18661039|P1|COMPLETED|Part B: Treatment Phase||0
7580884|NCT02712554|18661038|P2|STARTED|Part B: Treatment Phase||40
7580885|NCT02712554|18661039|P1|STARTED|Part B: Treatment Phase||0
7580886|NCT02712554|18661038|P2|NOT COMPLETED|Part B: Qualification Phase||21
7580887|NCT02712554|18661039|P1|NOT COMPLETED|Part B: Qualification Phase||0
7580888|NCT02712554|18661038|P2|COMPLETED|Part B: Qualification Phase||40
7580889|NCT02712554|18661039|P1|COMPLETED|Part B: Qualification Phase||0
7580890|NCT02712554|18661038|P2|STARTED|Part B: Qualification Phase||61
7580891|NCT02712554|18661039|P1|STARTED|Part B: Qualification Phase||0
7580892|NCT02712554|18661038|P2|NOT COMPLETED|Part A: Dose Selection Phase||0
7580893|NCT02712554|18661039|P1|NOT COMPLETED|Part A: Dose Selection Phase||0
7580894|NCT02712554|18661038|P2|COMPLETED|Part A: Dose Selection Phase|Subjects who participated in Dose Selection Phase were not eligible to participate in Part B.|0
7580895|NCT02712554|18661039|P1|COMPLETED|Part A: Dose Selection Phase||12
7580896|NCT02712554|18661038|P2|STARTED|Part A: Dose Selection Phase||0
7580897|NCT02712554|18661039|P1|STARTED|Part A: Dose Selection Phase||12
7580898|NCT02712359|18661161|P4|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
7580899|NCT02712359|18661162|P3|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
7580900|NCT02712359|18661163|P2|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
7580901|NCT02712359|18661164|P1|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
7580902|NCT02712359|18661161|P4|COMPLETED|Epoch 002: Persistence at Year 10||300
7580903|NCT02712359|18661162|P3|COMPLETED|Epoch 002: Persistence at Year 10||299
7580904|NCT02712359|18661163|P2|COMPLETED|Epoch 002: Persistence at Year 10||0
7580905|NCT02712359|18661164|P1|COMPLETED|Epoch 002: Persistence at Year 10||0
7580906|NCT02712359|18661161|P4|STARTED|Epoch 002: Persistence at Year 10||300
7580907|NCT02712359|18661162|P3|STARTED|Epoch 002: Persistence at Year 10||299
7580908|NCT02712359|18661163|P2|STARTED|Epoch 002: Persistence at Year 10||0
7580909|NCT02712359|18661164|P1|STARTED|Epoch 002: Persistence at Year 10||0
7580910|NCT02712359|18661161|P4|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
7580911|NCT02712359|18661162|P3|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
7580912|NCT02712359|18661163|P2|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
7580913|NCT02712359|18661164|P1|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
7580914|NCT02712359|18661161|P4|COMPLETED|Epoch 001: Persistence at Year 8||0
7580915|NCT02712359|18661162|P3|COMPLETED|Epoch 001: Persistence at Year 8||0
7580916|NCT02712359|18661163|P2|COMPLETED|Epoch 001: Persistence at Year 8||300
7580917|NCT02712359|18661164|P1|COMPLETED|Epoch 001: Persistence at Year 8||300
7580918|NCT02712359|18661161|P4|STARTED|Epoch 001: Persistence at Year 8||0
7580919|NCT02712359|18661162|P3|STARTED|Epoch 001: Persistence at Year 8||0
7580920|NCT02712359|18661163|P2|STARTED|Epoch 001: Persistence at Year 8||300
7580921|NCT02712359|18661164|P1|STARTED|Epoch 001: Persistence at Year 8||300
7580922|NCT02712333|18661184|P2|NOT COMPLETED|Second Period||0
7580923|NCT02712333|18661185|P1|NOT COMPLETED|Second Period||0
7580924|NCT02712333|18661184|P2|COMPLETED|Second Period||24
7580925|NCT02712333|18661185|P1|COMPLETED|Second Period||31
7580926|NCT02712333|18661184|P2|STARTED|Second Period||24
7580927|NCT02712333|18661185|P1|STARTED|Second Period||31
7580928|NCT02712333|18661184|P2|NOT COMPLETED|First Period||2
7580929|NCT02712333|18661185|P1|NOT COMPLETED|First Period||3
7580930|NCT02712333|18661184|P2|COMPLETED|First Period||24
7580931|NCT02712333|18661185|P1|COMPLETED|First Period||31
7580932|NCT02712333|18661184|P2|STARTED|First Period||26
7580933|NCT02712333|18661185|P1|STARTED|First Period||34
7580934|NCT02712320|18661203|P1|NOT COMPLETED|Overall Study||5
7580935|NCT02712320|18661203|P1|COMPLETED|Overall Study||25
7580936|NCT02712320|18661203|P1|STARTED|Overall Study||30
7580937|NCT02712099|18661213|P2|NOT COMPLETED|Overall Study||0
7580938|NCT02712099|18661214|P1|NOT COMPLETED|Overall Study||0
7580939|NCT02712099|18661213|P2|COMPLETED|Overall Study||20
7580940|NCT02712099|18661214|P1|COMPLETED|Overall Study||30
7580941|NCT02712099|18661213|P2|STARTED|Overall Study||20
7580942|NCT02712099|18661214|P1|STARTED|Overall Study||30
7580943|NCT02712047|18661230|P2|NOT COMPLETED|Treatment Period 2 (35 Days)||0
7580944|NCT02712047|18661231|P1|NOT COMPLETED|Treatment Period 2 (35 Days)||0
7580945|NCT02712047|18661230|P2|COMPLETED|Treatment Period 2 (35 Days)||13
7580946|NCT02712047|18661231|P1|COMPLETED|Treatment Period 2 (35 Days)||14
7580947|NCT02712047|18661230|P2|STARTED|Treatment Period 2 (35 Days)||13
7580948|NCT02712047|18661231|P1|STARTED|Treatment Period 2 (35 Days)||14
7580949|NCT02712047|18661230|P2|NOT COMPLETED|Washout Period (21 Days)||0
7580950|NCT02712047|18661231|P1|NOT COMPLETED|Washout Period (21 Days)||0
7580951|NCT02712047|18661230|P2|COMPLETED|Washout Period (21 Days)||13
7580952|NCT02712047|18661231|P1|COMPLETED|Washout Period (21 Days)||14
7580953|NCT02712047|18661230|P2|STARTED|Washout Period (21 Days)||13
7580954|NCT02712047|18661231|P1|STARTED|Washout Period (21 Days)||14
7580955|NCT02712047|18661230|P2|NOT COMPLETED|Treatment Period 1 (35 Days)||0
7580956|NCT02712047|18661231|P1|NOT COMPLETED|Treatment Period 1 (35 Days)||0
7580957|NCT02712047|18661230|P2|COMPLETED|Treatment Period 1 (35 Days)||13
7580958|NCT02712047|18661231|P1|COMPLETED|Treatment Period 1 (35 Days)||14
7580959|NCT02712047|18661230|P2|STARTED|Treatment Period 1 (35 Days)||13
7580960|NCT02712047|18661231|P1|STARTED|Treatment Period 1 (35 Days)||14
7580961|NCT02712008|18661246|P8|NOT COMPLETED|From Week 12 up to Week 36||4
7580962|NCT02712008|18661247|P7|NOT COMPLETED|From Week 12 up to Week 36||5
7580963|NCT02712008|18661248|P6|NOT COMPLETED|From Week 12 up to Week 36||0
7580964|NCT02712008|18661249|P5|NOT COMPLETED|From Week 12 up to Week 36||2
7580965|NCT02712008|18661250|P4|NOT COMPLETED|From Week 12 up to Week 36||2
7580966|NCT02712008|18661251|P3|NOT COMPLETED|From Week 12 up to Week 36||0
7580967|NCT02712008|18661252|P2|NOT COMPLETED|From Week 12 up to Week 36||0
7580968|NCT02712008|18661253|P1|NOT COMPLETED|From Week 12 up to Week 36||1
7580969|NCT02712008|18661246|P8|COMPLETED|From Week 12 up to Week 36||45
7580970|NCT02712008|18661247|P7|COMPLETED|From Week 12 up to Week 36||43
7580971|NCT02712008|18661248|P6|COMPLETED|From Week 12 up to Week 36||46
7580972|NCT02712008|18661249|P5|COMPLETED|From Week 12 up to Week 36||50
7580973|NCT02712008|18661250|P4|COMPLETED|From Week 12 up to Week 36||42
7580974|NCT02712008|18661251|P3|COMPLETED|From Week 12 up to Week 36||0
7580975|NCT02712008|18661252|P2|COMPLETED|From Week 12 up to Week 36||0
7580976|NCT02712008|18661253|P1|COMPLETED|From Week 12 up to Week 36||44
7580977|NCT02712008|18661246|P8|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 49 re-randomized from Aflibercept 2mg Q4 to REGN910-3 (6:2mg) Q8|49
7580978|NCT02712008|18661247|P7|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 48 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q12|48
7580979|NCT02712008|18661248|P6|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 46 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q8|46
7580980|NCT02712008|18661249|P5|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 52 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q12|52
7580981|NCT02712008|18661250|P4|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 44 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q8|44
7580982|NCT02712008|18661251|P3|STARTED|From Week 12 up to Week 36|Out of 148 that completed Week 12,143 re-randomized to Aflibercept 2mg Q8, Q12, REGN910-3 (6:2mg) Q8|0
7580983|NCT02712008|18661252|P2|STARTED|From Week 12 up to Week 36|Out of 97 participants that completed Week 12, 96 re-randomized to REGN910-3 (6:2mg) Q8 and Q12|0
7580984|NCT02712008|18661253|P1|STARTED|From Week 12 up to Week 36|Out of 46 participants that completed Week 12, 45 re-randomized for treatment from Week 12 to 36|45
7580985|NCT02712008|18661246|P8|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
7580986|NCT02712008|18661247|P7|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
7580987|NCT02712008|18661248|P6|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
7580988|NCT02712008|18661249|P5|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
7580989|NCT02712008|18661250|P4|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
7580990|NCT02712008|18661251|P3|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
7580991|NCT02712008|18661252|P2|NOT COMPLETED|Baseline (Day 1) up to Week 12||3
7580992|NCT02712008|18661253|P1|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
7580993|NCT02712008|18661246|P8|COMPLETED|Baseline (Day 1) up to Week 12||0
7580994|NCT02712008|18661247|P7|COMPLETED|Baseline (Day 1) up to Week 12||0
7580995|NCT02712008|18661248|P6|COMPLETED|Baseline (Day 1) up to Week 12||0
7580996|NCT02712008|18661249|P5|COMPLETED|Baseline (Day 1) up to Week 12||0
7580997|NCT02712008|18661250|P4|COMPLETED|Baseline (Day 1) up to Week 12||0
7580998|NCT02712008|18661251|P3|COMPLETED|Baseline (Day 1) up to Week 12||148
7580999|NCT02712008|18661252|P2|COMPLETED|Baseline (Day 1) up to Week 12||97
7581000|NCT02712008|18661253|P1|COMPLETED|Baseline (Day 1) up to Week 12||46
7581001|NCT02712008|18661246|P8|STARTED|Baseline (Day 1) up to Week 12||0
7581002|NCT02712008|18661247|P7|STARTED|Baseline (Day 1) up to Week 12||0
7581003|NCT02712008|18661248|P6|STARTED|Baseline (Day 1) up to Week 12||0
7581004|NCT02712008|18661249|P5|STARTED|Baseline (Day 1) up to Week 12||0
7581005|NCT02712008|18661250|P4|STARTED|Baseline (Day 1) up to Week 12||0
7581006|NCT02712008|18661251|P3|STARTED|Baseline (Day 1) up to Week 12||152
7581007|NCT02712008|18661252|P2|STARTED|Baseline (Day 1) up to Week 12||100
7581008|NCT02712008|18661253|P1|STARTED|Baseline (Day 1) up to Week 12||50
7581009|NCT02711995|18661285|P1|NOT COMPLETED|Second Intervention (30 Days)||0
7581010|NCT02711995|18661285|P1|COMPLETED|Second Intervention (30 Days)||7
7581011|NCT02711995|18661285|P1|STARTED|Second Intervention (30 Days)||7
7581012|NCT02711995|18661285|P1|NOT COMPLETED|Washout (90 Days)||1
7581013|NCT02711995|18661285|P1|COMPLETED|Washout (90 Days)||7
7581014|NCT02711995|18661285|P1|STARTED|Washout (90 Days)||8
7581015|NCT02711995|18661285|P1|NOT COMPLETED|First Intervention (30 Days)||0
7581016|NCT02711995|18661285|P1|COMPLETED|First Intervention (30 Days)||8
7581017|NCT02711995|18661285|P1|STARTED|First Intervention (30 Days)||8
7581018|NCT02711839|18661309|P2|NOT COMPLETED|Overall Study||10
7581019|NCT02711839|18661310|P1|NOT COMPLETED|Overall Study||4
7581020|NCT02711839|18661309|P2|COMPLETED|Overall Study||24
7581021|NCT02711839|18661310|P1|COMPLETED|Overall Study||16
7581022|NCT02711839|18661309|P2|STARTED|Overall Study||34
7581023|NCT02711839|18661310|P1|STARTED|Overall Study||20
7581024|NCT02711800|18661324|P1|NOT COMPLETED|Overall Study||2
7581025|NCT02711800|18661324|P1|COMPLETED|Overall Study||7
7581026|NCT02711800|18661324|P1|STARTED|Overall Study||9
7581027|NCT02711345|18661343|P10|NOT COMPLETED|Overall Study||12
7581028|NCT02711345|18661344|P9|NOT COMPLETED|Overall Study||6
7581029|NCT02711345|18661345|P8|NOT COMPLETED|Overall Study||6
7581030|NCT02711345|18661346|P7|NOT COMPLETED|Overall Study||12
7581031|NCT02711345|18661347|P6|NOT COMPLETED|Overall Study||6
7581032|NCT02711345|18661348|P5|NOT COMPLETED|Overall Study||8
7581033|NCT02711345|18661349|P4|NOT COMPLETED|Overall Study||4
7581034|NCT02711345|18661350|P3|NOT COMPLETED|Overall Study||6
7581035|NCT02711345|18661351|P2|NOT COMPLETED|Overall Study||3
7581036|NCT02711345|18661352|P1|NOT COMPLETED|Overall Study||2
7581037|NCT02711345|18661343|P10|COMPLETED|Overall Study||0
7581038|NCT02711345|18661344|P9|COMPLETED|Overall Study||0
7581039|NCT02711345|18661345|P8|COMPLETED|Overall Study||0
7581040|NCT02711345|18661346|P7|COMPLETED|Overall Study||0
7581041|NCT02711345|18661347|P6|COMPLETED|Overall Study||0
7581042|NCT02711345|18661348|P5|COMPLETED|Overall Study||0
7581043|NCT02711345|18661349|P4|COMPLETED|Overall Study||0
7581044|NCT02711345|18661350|P3|COMPLETED|Overall Study||0
7581045|NCT02711345|18661351|P2|COMPLETED|Overall Study||0
7581046|NCT02711345|18661352|P1|COMPLETED|Overall Study||0
7581047|NCT02711345|18661343|P10|STARTED|Overall Study||12
7581048|NCT02711345|18661344|P9|STARTED|Overall Study||6
7581049|NCT02711345|18661345|P8|STARTED|Overall Study||6
7581050|NCT02711345|18661346|P7|STARTED|Overall Study||12
7581051|NCT02711345|18661347|P6|STARTED|Overall Study||6
7581052|NCT02711345|18661348|P5|STARTED|Overall Study||8
7581053|NCT02711345|18661349|P4|STARTED|Overall Study||4
7581054|NCT02711345|18661350|P3|STARTED|Overall Study||6
7581055|NCT02711345|18661351|P2|STARTED|Overall Study||3
7581056|NCT02711345|18661352|P1|STARTED|Overall Study||2
7581057|NCT02711306|18661538|P2|NOT COMPLETED|Overall Study||2
7581058|NCT02711306|18661539|P1|NOT COMPLETED|Overall Study||2
7581059|NCT02711306|18661538|P2|COMPLETED|Overall Study||16
7581060|NCT02711306|18661539|P1|COMPLETED|Overall Study||16
7581061|NCT02711306|18661538|P2|STARTED|Overall Study||18
7581062|NCT02711306|18661539|P1|STARTED|Overall Study||18
7581063|NCT02710981|18661551|P2|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||5
7581064|NCT02710981|18661552|P1|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
7581065|NCT02710981|18661551|P2|COMPLETED|7th Ovulation Induction Cycle (5 Days)||36
7581066|NCT02710981|18661552|P1|COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
7581067|NCT02710981|18661551|P2|STARTED|7th Ovulation Induction Cycle (5 Days)||41
7581068|NCT02710981|18661552|P1|STARTED|7th Ovulation Induction Cycle (5 Days)||0
7581069|NCT02710981|18661551|P2|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
7581070|NCT02710981|18661552|P1|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||1
7581071|NCT02710981|18661551|P2|COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
7581072|NCT02710981|18661552|P1|COMPLETED|6th Ovulation Induction Cycle (5 Days)||41
7581073|NCT02710981|18661551|P2|STARTED|6th Ovulation Induction Cycle (5 Days)||0
7581074|NCT02710981|18661552|P1|STARTED|6th Ovulation Induction Cycle (5 Days)||42
7581075|NCT02710890|18661564|P2|NOT COMPLETED|Overall Study||0
7581076|NCT02710890|18661565|P1|NOT COMPLETED|Overall Study||0
7581077|NCT02710890|18661564|P2|COMPLETED|Overall Study||55
7581078|NCT02710890|18661565|P1|COMPLETED|Overall Study||48
7581079|NCT02710890|18661564|P2|STARTED|Overall Study||55
7581080|NCT02710890|18661565|P1|STARTED|Overall Study||48
7581081|NCT02710630|18661578|P5|NOT COMPLETED|Period 6||0
7581082|NCT02710630|18661579|P4|NOT COMPLETED|Period 6||0
7581083|NCT02710630|18661580|P3|NOT COMPLETED|Period 6||0
7581084|NCT02710630|18661581|P2|NOT COMPLETED|Period 6||0
7581085|NCT02710630|18661582|P1|NOT COMPLETED|Period 6||0
7581086|NCT02710630|18661578|P5|COMPLETED|Period 6||7
7581087|NCT02710630|18661579|P4|COMPLETED|Period 6||7
7581088|NCT02710630|18661580|P3|COMPLETED|Period 6||7
7581089|NCT02710630|18661581|P2|COMPLETED|Period 6||7
7581090|NCT02710630|18661582|P1|COMPLETED|Period 6||7
7581091|NCT02710630|18661578|P5|STARTED|Period 6||7
7581092|NCT02710630|18661579|P4|STARTED|Period 6||7
7581093|NCT02710630|18661580|P3|STARTED|Period 6||7
7581094|NCT02710630|18661581|P2|STARTED|Period 6||7
7581095|NCT02710630|18661582|P1|STARTED|Period 6||7
7581096|NCT02710630|18661578|P5|NOT COMPLETED|Period 5||0
7581097|NCT02710630|18661579|P4|NOT COMPLETED|Period 5||0
7581098|NCT02710630|18661580|P3|NOT COMPLETED|Period 5||0
7581099|NCT02710630|18661581|P2|NOT COMPLETED|Period 5||0
7581100|NCT02710630|18661582|P1|NOT COMPLETED|Period 5||0
7581101|NCT02710630|18661578|P5|COMPLETED|Period 5||7
7581102|NCT02710630|18661579|P4|COMPLETED|Period 5||7
7581103|NCT02710630|18661580|P3|COMPLETED|Period 5||7
7581104|NCT02710630|18661581|P2|COMPLETED|Period 5||7
7581105|NCT02710630|18661582|P1|COMPLETED|Period 5||7
7581106|NCT02710630|18661578|P5|STARTED|Period 5||7
7581107|NCT02710630|18661579|P4|STARTED|Period 5||7
7581108|NCT02710630|18661580|P3|STARTED|Period 5||7
7581109|NCT02710630|18661581|P2|STARTED|Period 5||7
7581110|NCT02710630|18661582|P1|STARTED|Period 5||7
7581111|NCT02710630|18661578|P5|NOT COMPLETED|Period 4||0
7581112|NCT02710630|18661579|P4|NOT COMPLETED|Period 4||0
7581113|NCT02710630|18661580|P3|NOT COMPLETED|Period 4||0
7581114|NCT02710630|18661581|P2|NOT COMPLETED|Period 4||0
7581115|NCT02710630|18661582|P1|NOT COMPLETED|Period 4||0
7581116|NCT02710630|18661578|P5|COMPLETED|Period 4||7
7581117|NCT02710630|18661579|P4|COMPLETED|Period 4||7
7581118|NCT02710630|18661580|P3|COMPLETED|Period 4||7
7581119|NCT02710630|18661581|P2|COMPLETED|Period 4||7
7581120|NCT02710630|18661582|P1|COMPLETED|Period 4||7
7581121|NCT02710630|18661578|P5|STARTED|Period 4||7
7581122|NCT02710630|18661579|P4|STARTED|Period 4||7
7581123|NCT02710630|18661580|P3|STARTED|Period 4||7
7581124|NCT02710630|18661581|P2|STARTED|Period 4||7
7581125|NCT02710630|18661582|P1|STARTED|Period 4||7
7581126|NCT02710630|18661578|P5|NOT COMPLETED|Period 3||0
7581127|NCT02710630|18661579|P4|NOT COMPLETED|Period 3||0
7581128|NCT02710630|18661580|P3|NOT COMPLETED|Period 3||0
7581129|NCT02710630|18661581|P2|NOT COMPLETED|Period 3||0
7581130|NCT02710630|18661582|P1|NOT COMPLETED|Period 3||0
7581131|NCT02710630|18661578|P5|COMPLETED|Period 3||7
7581132|NCT02710630|18661579|P4|COMPLETED|Period 3||7
7581133|NCT02710630|18661580|P3|COMPLETED|Period 3||7
7581134|NCT02710630|18661581|P2|COMPLETED|Period 3||7
7581135|NCT02710630|18661582|P1|COMPLETED|Period 3||7
7581136|NCT02710630|18661578|P5|STARTED|Period 3||7
7581137|NCT02710630|18661579|P4|STARTED|Period 3||7
7581138|NCT02710630|18661580|P3|STARTED|Period 3||7
7581139|NCT02710630|18661581|P2|STARTED|Period 3||7
7581140|NCT02710630|18661582|P1|STARTED|Period 3||7
7581141|NCT02710630|18661578|P5|NOT COMPLETED|Period 2||0
7581142|NCT02710630|18661579|P4|NOT COMPLETED|Period 2||0
7581143|NCT02710630|18661580|P3|NOT COMPLETED|Period 2||0
7581144|NCT02710630|18661581|P2|NOT COMPLETED|Period 2||0
7581145|NCT02710630|18661582|P1|NOT COMPLETED|Period 2||0
7581146|NCT02710630|18661578|P5|COMPLETED|Period 2||7
7581147|NCT02710630|18661579|P4|COMPLETED|Period 2||7
7581148|NCT02710630|18661580|P3|COMPLETED|Period 2||7
7581149|NCT02710630|18661581|P2|COMPLETED|Period 2||7
7581150|NCT02710630|18661582|P1|COMPLETED|Period 2||7
7581151|NCT02710630|18661578|P5|Not Treated|Period 2||0
7581152|NCT02710630|18661579|P4|Not Treated|Period 2||0
7581153|NCT02710630|18661580|P3|Not Treated|Period 2||0
7581154|NCT02710630|18661581|P2|Not Treated|Period 2||0
7581155|NCT02710630|18661582|P1|Not Treated|Period 2||1
7581156|NCT02710630|18661578|P5|STARTED|Period 2||7
7581157|NCT02710630|18661579|P4|STARTED|Period 2||7
7581158|NCT02710630|18661580|P3|STARTED|Period 2||7
7581159|NCT02710630|18661581|P2|STARTED|Period 2||7
7581160|NCT02710630|18661582|P1|STARTED|Period 2||7
7581161|NCT02710630|18661578|P5|NOT COMPLETED|Period 1||0
7581162|NCT02710630|18661579|P4|NOT COMPLETED|Period 1||0
7581163|NCT02710630|18661580|P3|NOT COMPLETED|Period 1||0
7581164|NCT02710630|18661581|P2|NOT COMPLETED|Period 1||0
7581165|NCT02710630|18661582|P1|NOT COMPLETED|Period 1||0
7581166|NCT02710630|18661578|P5|COMPLETED|Period 1||7
7581167|NCT02710630|18661579|P4|COMPLETED|Period 1||7
7581168|NCT02710630|18661580|P3|COMPLETED|Period 1||7
7581169|NCT02710630|18661581|P2|COMPLETED|Period 1||7
7581170|NCT02710630|18661582|P1|COMPLETED|Period 1||7
7581171|NCT02710630|18661578|P5|STARTED|Period 1||7
7581172|NCT02710630|18661579|P4|STARTED|Period 1||7
7581173|NCT02710630|18661580|P3|STARTED|Period 1||7
7581174|NCT02710630|18661581|P2|STARTED|Period 1||7
7581175|NCT02710630|18661582|P1|STARTED|Period 1||7
7581176|NCT02710591|18661630|P4|NOT COMPLETED|Overall Study||0
7581177|NCT02710591|18661631|P3|NOT COMPLETED|Overall Study||0
7581178|NCT02710591|18661632|P2|NOT COMPLETED|Overall Study||0
7581179|NCT02710591|18661633|P1|NOT COMPLETED|Overall Study||0
7581180|NCT02710591|18661630|P4|COMPLETED|Overall Study||5
7581181|NCT02710591|18661631|P3|COMPLETED|Overall Study||5
7581182|NCT02710591|18661632|P2|COMPLETED|Overall Study||5
7581183|NCT02710591|18661633|P1|COMPLETED|Overall Study||5
7581184|NCT02710591|18661630|P4|STARTED|Overall Study||5
7581185|NCT02710591|18661631|P3|STARTED|Overall Study||5
7581186|NCT02710591|18661632|P2|STARTED|Overall Study||5
7581187|NCT02710591|18661633|P1|STARTED|Overall Study||5
7581188|NCT02710526|18661650|P3|NOT COMPLETED|Safety Extension||0
7581189|NCT02710526|18661651|P2|NOT COMPLETED|Safety Extension||0
7581190|NCT02710526|18661652|P1|NOT COMPLETED|Safety Extension||1
7581191|NCT02710526|18661650|P3|COMPLETED|Safety Extension||0
7581192|NCT02710526|18661651|P2|COMPLETED|Safety Extension||12
7581193|NCT02710526|18661652|P1|COMPLETED|Safety Extension||14
7581194|NCT02710526|18661650|P3|STARTED|Safety Extension||0
7581195|NCT02710526|18661651|P2|STARTED|Safety Extension||12
7581196|NCT02710526|18661652|P1|STARTED|Safety Extension||15
7581197|NCT02710526|18661650|P3|NOT COMPLETED|Treatment Phase||6
7581198|NCT02710526|18661651|P2|NOT COMPLETED|Treatment Phase||4
7581199|NCT02710526|18661652|P1|NOT COMPLETED|Treatment Phase||6
7581200|NCT02710526|18661650|P3|COMPLETED|Treatment Phase||12
7581201|NCT02710526|18661651|P2|COMPLETED|Treatment Phase||16
7581202|NCT02710526|18661652|P1|COMPLETED|Treatment Phase||22
7581203|NCT02710526|18661650|P3|STARTED|Treatment Phase||18
7581204|NCT02710526|18661651|P2|STARTED|Treatment Phase||20
7581205|NCT02710526|18661652|P1|STARTED|Treatment Phase||28
7581206|NCT02710422|18661732|P2|NOT COMPLETED|Overall Study||9
7581207|NCT02710422|18661733|P1|NOT COMPLETED|Overall Study||9
7581208|NCT02710422|18661732|P2|COMPLETED|Overall Study||3
7581209|NCT02710422|18661733|P1|COMPLETED|Overall Study||3
7581210|NCT02710422|18661732|P2|12 Month Visit|Overall Study||3
7581211|NCT02710422|18661733|P1|12 Month Visit|Overall Study||3
7581212|NCT02710422|18661732|P2|9 Month Visit|Overall Study||5
7581213|NCT02710422|18661733|P1|9 Month Visit|Overall Study||5
7581214|NCT02710422|18661732|P2|6 Month Visit|Overall Study||8
7581215|NCT02710422|18661733|P1|6 Month Visit|Overall Study||7
7581216|NCT02710422|18661732|P2|3 Month Visit|Overall Study||11
7581217|NCT02710422|18661733|P1|3 Month Visit|Overall Study||9
7581218|NCT02710422|18661732|P2|STARTED|Overall Study||12
7581219|NCT02710422|18661733|P1|STARTED|Overall Study||12
7581220|NCT02710292|18661749|P2|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
7581221|NCT02710292|18661750|P1|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
7581222|NCT02710292|18661749|P2|COMPLETED|Period 2, Second 10 Days of Wear||49
7581223|NCT02710292|18661750|P1|COMPLETED|Period 2, Second 10 Days of Wear||46
7581224|NCT02710292|18661749|P2|STARTED|Period 2, Second 10 Days of Wear||49
7581225|NCT02710292|18661750|P1|STARTED|Period 2, Second 10 Days of Wear||46
7581226|NCT02710292|18661749|P2|NOT COMPLETED|Period 1, First 10 Days of Wear||3
7581227|NCT02710292|18661750|P1|NOT COMPLETED|Period 1, First 10 Days of Wear||1
7581228|NCT02710292|18661749|P2|COMPLETED|Period 1, First 10 Days of Wear||49
7581229|NCT02710292|18661750|P1|COMPLETED|Period 1, First 10 Days of Wear||46
7581230|NCT02710292|18661749|P2|STARTED|Period 1, First 10 Days of Wear||52
7581231|NCT02710292|18661750|P1|STARTED|Period 1, First 10 Days of Wear||47
7581232|NCT02710214|18661759|P2|NOT COMPLETED|Overall Study||2
7581233|NCT02710214|18661760|P1|NOT COMPLETED|Overall Study||1
7581234|NCT02710214|18661759|P2|COMPLETED|Overall Study||10
7581235|NCT02710214|18661760|P1|COMPLETED|Overall Study||11
7581236|NCT02710214|18661759|P2|STARTED|Overall Study||12
7581237|NCT02710214|18661760|P1|STARTED|Overall Study||12
7581238|NCT02710136|18661794|P2|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
7581239|NCT02710136|18661795|P1|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
7581240|NCT02710136|18661794|P2|COMPLETED|Phase 2 [Refer to Arm/Group Description]||25
7581241|NCT02710136|18661795|P1|COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
7581242|NCT02710136|18661794|P2|STARTED|Phase 2 [Refer to Arm/Group Description]||25
7581243|NCT02710136|18661795|P1|STARTED|Phase 2 [Refer to Arm/Group Description]||0
7581244|NCT02710136|18661794|P2|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
7581245|NCT02710136|18661795|P1|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
7581246|NCT02710136|18661794|P2|COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
7581247|NCT02710136|18661795|P1|COMPLETED|Phase 1b[Refer to Arm/Group Description]||4
7581248|NCT02710136|18661794|P2|STARTED|Phase 1b[Refer to Arm/Group Description]||0
7581249|NCT02710136|18661795|P1|STARTED|Phase 1b[Refer to Arm/Group Description]||4
7581250|NCT02710136|18661794|P2|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
7581251|NCT02710136|18661795|P1|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||1
7581252|NCT02710136|18661794|P2|COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
7581253|NCT02710136|18661795|P1|COMPLETED|Phase 1a[Refer to Arm/Group Description]||9
7581254|NCT02710136|18661794|P2|STARTED|Phase 1a[Refer to Arm/Group Description]||0
7581255|NCT02710136|18661795|P1|STARTED|Phase 1a[Refer to Arm/Group Description]||10
7581256|NCT02710136|18661794|P2|NOT COMPLETED|Study Enrollment||0
7581257|NCT02710136|18661795|P1|NOT COMPLETED|Study Enrollment||0
7581258|NCT02710136|18661794|P2|COMPLETED|Study Enrollment||25
7581259|NCT02710136|18661795|P1|COMPLETED|Study Enrollment||10
7581260|NCT02710136|18661794|P2|STARTED|Study Enrollment||25
7581261|NCT02710136|18661795|P1|STARTED|Study Enrollment||10
7581262|NCT02710071|18661820|P2|NOT COMPLETED|Second Intervention (6 Weeks).||2
7581263|NCT02710071|18661821|P1|NOT COMPLETED|Second Intervention (6 Weeks).||1
7581264|NCT02710071|18661820|P2|COMPLETED|Second Intervention (6 Weeks).||14
7581265|NCT02710071|18661821|P1|COMPLETED|Second Intervention (6 Weeks).||17
7581266|NCT02710071|18661820|P2|STARTED|Second Intervention (6 Weeks).||16
7581267|NCT02710071|18661821|P1|STARTED|Second Intervention (6 Weeks).||18
7581268|NCT02710071|18661820|P2|NOT COMPLETED|First Intervention (6 Weeks).||4
7581269|NCT02710071|18661821|P1|NOT COMPLETED|First Intervention (6 Weeks).||3
7581270|NCT02710071|18661820|P2|COMPLETED|First Intervention (6 Weeks).||16
7581271|NCT02710071|18661821|P1|COMPLETED|First Intervention (6 Weeks).||18
7581272|NCT02710071|18661820|P2|STARTED|First Intervention (6 Weeks).||20
7581273|NCT02710071|18661821|P1|STARTED|First Intervention (6 Weeks).||21
7581274|NCT02710071|18661820|P2|NOT COMPLETED|Placebo (2 Weeks).||0
7581275|NCT02710071|18661821|P1|NOT COMPLETED|Placebo (2 Weeks).||0
7581276|NCT02710071|18661820|P2|COMPLETED|Placebo (2 Weeks).||20
7581277|NCT02710071|18661821|P1|COMPLETED|Placebo (2 Weeks).||21
7581278|NCT02710071|18661820|P2|STARTED|Placebo (2 Weeks).||20
7581279|NCT02710071|18661821|P1|STARTED|Placebo (2 Weeks).||21
7581280|NCT02710045|18661831|P3|NOT COMPLETED|Overall Study||13
7581281|NCT02710045|18661832|P2|NOT COMPLETED|Overall Study||17
7581282|NCT02710045|18661833|P1|NOT COMPLETED|Overall Study||11
7581283|NCT02710045|18661831|P3|COMPLETED|Overall Study||68
7581284|NCT02710045|18661832|P2|COMPLETED|Overall Study||98
7581285|NCT02710045|18661833|P1|COMPLETED|Overall Study||95
7581286|NCT02710045|18661831|P3|STARTED|Overall Study||81
7581287|NCT02710045|18661832|P2|STARTED|Overall Study||115
7581288|NCT02710045|18661833|P1|STARTED|Overall Study||106
7581289|NCT02709889|18661867|P4|NOT COMPLETED|Overall Study||88
7581290|NCT02709889|18661868|P3|NOT COMPLETED|Overall Study||12
7581291|NCT02709889|18661869|P2|NOT COMPLETED|Overall Study||57
7581292|NCT02709889|18661870|P1|NOT COMPLETED|Overall Study||43
7581293|NCT02709889|18661867|P4|COMPLETED|Overall Study||0
7581294|NCT02709889|18661868|P3|COMPLETED|Overall Study||0
7581295|NCT02709889|18661869|P2|COMPLETED|Overall Study||0
7581296|NCT02709889|18661870|P1|COMPLETED|Overall Study||0
7581297|NCT02709889|18661867|P4|Other Solid Tumors|Overall Study||15
7581298|NCT02709889|18661868|P3|Other Solid Tumors|Overall Study||3
7581299|NCT02709889|18661869|P2|Other Solid Tumors|Overall Study||16
7581300|NCT02709889|18661870|P1|Other Solid Tumors|Overall Study||9
7581301|NCT02709889|18661867|P4|Glioblastoma|Overall Study||14
7581302|NCT02709889|18661868|P3|Glioblastoma|Overall Study||1
7581303|NCT02709889|18661869|P2|Glioblastoma|Overall Study||4
7581304|NCT02709889|18661870|P1|Glioblastoma|Overall Study||4
7581305|NCT02709889|18661867|P4|Medullary Thyroid Cancer|Overall Study||7
7581306|NCT02709889|18661868|P3|Medullary Thyroid Cancer|Overall Study||0
7581307|NCT02709889|18661869|P2|Medullary Thyroid Cancer|Overall Study||3
7581308|NCT02709889|18661870|P1|Medullary Thyroid Cancer|Overall Study||3
7581309|NCT02709889|18661867|P4|Malignant Melanoma|Overall Study||11
7581310|NCT02709889|18661868|P3|Malignant Melanoma|Overall Study||0
7581311|NCT02709889|18661869|P2|Malignant Melanoma|Overall Study||6
7581312|NCT02709889|18661870|P1|Malignant Melanoma|Overall Study||3
7581313|NCT02709889|18661867|P4|Other NEC|Overall Study||7
7581314|NCT02709889|18661868|P3|Other NEC|Overall Study||1
7581315|NCT02709889|18661869|P2|Other NEC|Overall Study||12
7581316|NCT02709889|18661870|P1|Other NEC|Overall Study||11
7581317|NCT02709889|18661867|P4|Gastroenteropancreatic NEC|Overall Study||23
7581318|NCT02709889|18661868|P3|Gastroenteropancreatic NEC|Overall Study||2
7581319|NCT02709889|18661869|P2|Gastroenteropancreatic NEC|Overall Study||5
7581320|NCT02709889|18661870|P1|Gastroenteropancreatic NEC|Overall Study||6
7581321|NCT02709889|18661867|P4|Neuroendocrine Prostate Cancer|Overall Study||7
7581322|NCT02709889|18661868|P3|Neuroendocrine Prostate Cancer|Overall Study||3
7581323|NCT02709889|18661869|P2|Neuroendocrine Prostate Cancer|Overall Study||7
7581324|NCT02709889|18661870|P1|Neuroendocrine Prostate Cancer|Overall Study||4
7581325|NCT02709889|18661867|P4|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
7581326|NCT02709889|18661868|P3|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||2
7581327|NCT02709889|18661869|P2|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
7581328|NCT02709889|18661870|P1|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||3
7581329|NCT02709889|18661867|P4|STARTED|Overall Study||88
7581330|NCT02709889|18661868|P3|STARTED|Overall Study||12
7581331|NCT02709889|18661869|P2|STARTED|Overall Study||57
7581332|NCT02709889|18661870|P1|STARTED|Overall Study||43
7581333|NCT02709785|18661951|P3|NOT COMPLETED|Overall Study||1
7581334|NCT02709785|18661952|P2|NOT COMPLETED|Overall Study||2
7581335|NCT02709785|18661953|P1|NOT COMPLETED|Overall Study||1
7581336|NCT02709785|18661951|P3|COMPLETED|Overall Study||27
7581337|NCT02709785|18661952|P2|COMPLETED|Overall Study||26
7581338|NCT02709785|18661953|P1|COMPLETED|Overall Study||23
7581339|NCT02709785|18661951|P3|6 Weeks|Overall Study||27
7581340|NCT02709785|18661952|P2|6 Weeks|Overall Study||26
7581341|NCT02709785|18661953|P1|6 Weeks|Overall Study||23
7581342|NCT02709785|18661951|P3|3 Weeks|Overall Study||27
7581343|NCT02709785|18661952|P2|3 Weeks|Overall Study||27
7581344|NCT02709785|18661953|P1|3 Weeks|Overall Study||23
7581345|NCT02709785|18661951|P3|STARTED|Overall Study||28
7581346|NCT02709785|18661952|P2|STARTED|Overall Study||28
7581347|NCT02709785|18661953|P1|STARTED|Overall Study||24
7581348|NCT02709746|18661978|P5|NOT COMPLETED|Phase B (Double-blind Treatment Period)||16
7581349|NCT02709746|18661979|P4|NOT COMPLETED|Phase B (Double-blind Treatment Period)||15
7581350|NCT02709746|18661980|P3|NOT COMPLETED|Phase B (Double-blind Treatment Period)||22
7581351|NCT02709746|18661981|P2|NOT COMPLETED|Phase B (Double-blind Treatment Period)||21
7581352|NCT02709746|18661982|P1|NOT COMPLETED|Phase B (Double-blind Treatment Period)||0
7581353|NCT02709746|18661978|P5|COMPLETED|Phase B (Double-blind Treatment Period)||138
7581354|NCT02709746|18661979|P4|COMPLETED|Phase B (Double-blind Treatment Period)||138
7581355|NCT02709746|18661980|P3|COMPLETED|Phase B (Double-blind Treatment Period)||140
7581356|NCT02709746|18661981|P2|COMPLETED|Phase B (Double-blind Treatment Period)||126
7581357|NCT02709746|18661982|P1|COMPLETED|Phase B (Double-blind Treatment Period)||0
7581358|NCT02709746|18661978|P5|STARTED|Phase B (Double-blind Treatment Period)||154
7581359|NCT02709746|18661979|P4|STARTED|Phase B (Double-blind Treatment Period)||153
7581360|NCT02709746|18661980|P3|STARTED|Phase B (Double-blind Treatment Period)||162
7581361|NCT02709746|18661981|P2|STARTED|Phase B (Double-blind Treatment Period)||147
7581362|NCT02709746|18661982|P1|STARTED|Phase B (Double-blind Treatment Period)||0
7581363|NCT02709746|18661978|P5|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
7581364|NCT02709746|18661979|P4|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
7581365|NCT02709746|18661980|P3|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
7581366|NCT02709746|18661981|P2|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
7581367|NCT02709746|18661982|P1|NOT COMPLETED|Phase A (Single-blind Treatment Period)||168
7581368|NCT02709746|18661978|P5|COMPLETED|Phase A (Single-blind Treatment Period)||0
7581369|NCT02709746|18661979|P4|COMPLETED|Phase A (Single-blind Treatment Period)||0
7581370|NCT02709746|18661980|P3|COMPLETED|Phase A (Single-blind Treatment Period)||0
7581371|NCT02709746|18661981|P2|COMPLETED|Phase A (Single-blind Treatment Period)||0
7581372|NCT02709746|18661982|P1|COMPLETED|Phase A (Single-blind Treatment Period)||616
7581373|NCT02709746|18661978|P5|STARTED|Phase A (Single-blind Treatment Period)||0
7581374|NCT02709746|18661979|P4|STARTED|Phase A (Single-blind Treatment Period)||0
7581375|NCT02709746|18661980|P3|STARTED|Phase A (Single-blind Treatment Period)||0
7581376|NCT02709746|18661981|P2|STARTED|Phase A (Single-blind Treatment Period)||0
7581377|NCT02709746|18661982|P1|STARTED|Phase A (Single-blind Treatment Period)||784
7581378|NCT02709577|18662104|P4|NOT COMPLETED|Overall Study||0
7581379|NCT02709577|18662105|P3|NOT COMPLETED|Overall Study||2
7581380|NCT02709577|18662106|P2|NOT COMPLETED|Overall Study||5
7581381|NCT02709577|18662107|P1|NOT COMPLETED|Overall Study||2
7581382|NCT02709577|18662104|P4|COMPLETED|Overall Study||5
7581383|NCT02709577|18662105|P3|COMPLETED|Overall Study||4
7581384|NCT02709577|18662106|P2|COMPLETED|Overall Study||8
7581385|NCT02709577|18662107|P1|COMPLETED|Overall Study||10
7581386|NCT02709577|18662104|P4|STARTED|Overall Study||5
7581387|NCT02709577|18662105|P3|STARTED|Overall Study||6
7581388|NCT02709577|18662106|P2|STARTED|Overall Study||13
7581389|NCT02709577|18662107|P1|STARTED|Overall Study||12
7581390|NCT02709538|18662122|P3|NOT COMPLETED|Overall Study||20
7581391|NCT02709538|18662123|P2|NOT COMPLETED|Overall Study||28
7581392|NCT02709538|18662124|P1|NOT COMPLETED|Overall Study||113
7581393|NCT02709538|18662122|P3|COMPLETED|Overall Study||81
7581394|NCT02709538|18662123|P2|COMPLETED|Overall Study||72
7581395|NCT02709538|18662124|P1|COMPLETED|Overall Study||287
7581396|NCT02709538|18662122|P3|STARTED|Overall Study||101
7581397|NCT02709538|18662123|P2|STARTED|Overall Study||100
7581398|NCT02709538|18662124|P1|STARTED|Overall Study||400
7581399|NCT02709486|18662135|P3|NOT COMPLETED|Overall Study||45
7581400|NCT02709486|18662136|P2|NOT COMPLETED|Overall Study||34
7581401|NCT02709486|18662137|P1|NOT COMPLETED|Overall Study||44
7581402|NCT02709486|18662135|P3|COMPLETED|Overall Study||239
7581403|NCT02709486|18662136|P2|COMPLETED|Overall Study||249
7581404|NCT02709486|18662137|P1|COMPLETED|Overall Study||238
7581405|NCT02709486|18662135|P3|STARTED|Overall Study||284
7581406|NCT02709486|18662136|P2|STARTED|Overall Study||283
7581407|NCT02709486|18662137|P1|STARTED|Overall Study||282
7581408|NCT02709369|18662328|P1|NOT COMPLETED|Overall Study||27
7581409|NCT02709369|18662328|P1|COMPLETED|Overall Study||273
7581410|NCT02709369|18662328|P1|STARTED|Overall Study||300
7581411|NCT02709330|18662362|P2|NOT COMPLETED|Overall Study||0
7581412|NCT02709330|18662363|P1|NOT COMPLETED|Overall Study||13
7581413|NCT02709330|18662362|P2|COMPLETED|Overall Study||10
7581414|NCT02709330|18662363|P1|COMPLETED|Overall Study||37
7581415|NCT02709330|18662362|P2|STARTED|Overall Study||10
7581416|NCT02709330|18662363|P1|STARTED|Overall Study||50
7581417|NCT02709096|18662377|P2|NOT COMPLETED|Overall Study||1
7581418|NCT02709096|18662378|P1|NOT COMPLETED|Overall Study||1
7581419|NCT02709096|18662377|P2|COMPLETED|Overall Study||10
7581420|NCT02709096|18662378|P1|COMPLETED|Overall Study||21
7581421|NCT02709096|18662377|P2|STARTED|Overall Study||11
7581422|NCT02709096|18662378|P1|STARTED|Overall Study||22
7581423|NCT02709083|18662384|P1|NOT COMPLETED|Overall Study||7
7581424|NCT02709083|18662384|P1|COMPLETED|Overall Study||0
7581425|NCT02709083|18662384|P1|STARTED|Overall Study||7
7581426|NCT02709005|18662397|P2|NOT COMPLETED|Overall Study||1
7581427|NCT02709005|18662398|P1|NOT COMPLETED|Overall Study||4
7581428|NCT02709005|18662397|P2|COMPLETED|Overall Study||35
7581429|NCT02709005|18662398|P1|COMPLETED|Overall Study||69
7581430|NCT02709005|18662397|P2|STARTED|Overall Study||36
7581431|NCT02709005|18662398|P1|STARTED|Overall Study||73
7581432|NCT02708966|18662428|P2|NOT COMPLETED|Overall Study||2
7581433|NCT02708966|18662429|P1|NOT COMPLETED|Overall Study||2
7581434|NCT02708966|18662428|P2|COMPLETED|Overall Study||13
7581435|NCT02708966|18662429|P1|COMPLETED|Overall Study||13
7581436|NCT02708966|18662428|P2|STARTED|Overall Study||15
7581437|NCT02708966|18662429|P1|STARTED|Overall Study||15
7581438|NCT02708862|18662471|P1|NOT COMPLETED|Overall Study||0
7581439|NCT02708862|18662471|P1|COMPLETED|Overall Study||26
7581440|NCT02708862|18662471|P1|STARTED|Overall Study||26
7581441|NCT02708849|18662480|P2|NOT COMPLETED|Overall Study||0
7581442|NCT02708849|18662481|P1|NOT COMPLETED|Overall Study||1
7581443|NCT02708849|18662480|P2|COMPLETED|Overall Study||1
7581444|NCT02708849|18662481|P1|COMPLETED|Overall Study||1
7581445|NCT02708849|18662480|P2|STARTED|Overall Study||1
7581446|NCT02708849|18662481|P1|STARTED|Overall Study||2
7581447|NCT02708745|18662493|P4|NOT COMPLETED|Overall Study||82
7581448|NCT02708745|18662494|P3|NOT COMPLETED|Overall Study||83
7581449|NCT02708745|18662495|P2|NOT COMPLETED|Overall Study||4
7581450|NCT02708745|18662496|P1|NOT COMPLETED|Overall Study||0
7581451|NCT02708745|18662493|P4|COMPLETED|Overall Study||116
7581452|NCT02708745|18662494|P3|COMPLETED|Overall Study||121
7581453|NCT02708745|18662495|P2|COMPLETED|Overall Study||65
7581454|NCT02708745|18662496|P1|COMPLETED|Overall Study||91
7581455|NCT02708745|18662493|P4|STARTED|Overall Study||198
7581456|NCT02708745|18662494|P3|STARTED|Overall Study||204
7581457|NCT02708745|18662495|P2|STARTED|Overall Study||69
7581458|NCT02708745|18662496|P1|STARTED|Overall Study||91
7581459|NCT02708524|18662512|P4|NOT COMPLETED|Overall Study||0
7581460|NCT02708524|18662513|P3|NOT COMPLETED|Overall Study||3
7581461|NCT02708524|18662514|P2|NOT COMPLETED|Overall Study||6
7581462|NCT02708524|18662515|P1|NOT COMPLETED|Overall Study||4
7581463|NCT02708524|18662512|P4|COMPLETED|Overall Study||136
7581464|NCT02708524|18662513|P3|COMPLETED|Overall Study||134
7581465|NCT02708524|18662514|P2|COMPLETED|Overall Study||130
7581466|NCT02708524|18662515|P1|COMPLETED|Overall Study||135
7581467|NCT02708524|18662512|P4|STARTED|Overall Study||136
7581468|NCT02708524|18662513|P3|STARTED|Overall Study||137
7581469|NCT02708524|18662514|P2|STARTED|Overall Study||136
7581470|NCT02708524|18662515|P1|STARTED|Overall Study||139
7581471|NCT02708498|18662569|P8|NOT COMPLETED|Overall Study||0
7581472|NCT02708498|18662570|P7|NOT COMPLETED|Overall Study||0
7581473|NCT02708498|18662571|P6|NOT COMPLETED|Overall Study||132
7581474|NCT02708498|18662572|P5|NOT COMPLETED|Overall Study||196
7581475|NCT02708498|18662573|P4|NOT COMPLETED|Overall Study||51
7581476|NCT02708498|18662574|P3|NOT COMPLETED|Overall Study||62
7581477|NCT02708498|18662575|P2|NOT COMPLETED|Overall Study||19
7581478|NCT02708498|18662576|P1|NOT COMPLETED|Overall Study||20
7581479|NCT02708498|18662569|P8|COMPLETED|Overall Study||48
7581480|NCT02708498|18662570|P7|COMPLETED|Overall Study||20
7581481|NCT02708498|18662571|P6|COMPLETED|Overall Study||198
7581482|NCT02708498|18662572|P5|COMPLETED|Overall Study||167
7581483|NCT02708498|18662573|P4|COMPLETED|Overall Study||105
7581484|NCT02708498|18662574|P3|COMPLETED|Overall Study||90
7581485|NCT02708498|18662575|P2|COMPLETED|Overall Study||21
7581486|NCT02708498|18662576|P1|COMPLETED|Overall Study||22
7581487|NCT02708498|18662569|P8|STARTED|Overall Study||48
7581488|NCT02708498|18662570|P7|STARTED|Overall Study||20
7581489|NCT02708498|18662571|P6|STARTED|Overall Study||330
7581490|NCT02708498|18662572|P5|STARTED|Overall Study||363
7581491|NCT02708498|18662573|P4|STARTED|Overall Study||156
7581492|NCT02708498|18662574|P3|STARTED|Overall Study||152
7581493|NCT02708498|18662575|P2|STARTED|Overall Study||40
7581494|NCT02708498|18662576|P1|STARTED|Overall Study||42
7581495|NCT02708485|18662604|P2|NOT COMPLETED|Overall Study||2
7581496|NCT02708485|18662605|P1|NOT COMPLETED|Overall Study||3
7581497|NCT02708485|18662604|P2|COMPLETED|Overall Study||10
7581498|NCT02708485|18662605|P1|COMPLETED|Overall Study||0
7581499|NCT02708485|18662604|P2|STARTED|Overall Study||12
7581500|NCT02708485|18662605|P1|STARTED|Overall Study||3
7581501|NCT02708433|18662613|P2|NOT COMPLETED|Second Intervention (Visit 2)||0
7581502|NCT02708433|18662614|P1|NOT COMPLETED|Second Intervention (Visit 2)||0
7581503|NCT02708433|18662613|P2|COMPLETED|Second Intervention (Visit 2)||11
7581504|NCT02708433|18662614|P1|COMPLETED|Second Intervention (Visit 2)||12
7581505|NCT02708433|18662613|P2|STARTED|Second Intervention (Visit 2)||11
7581506|NCT02708433|18662614|P1|STARTED|Second Intervention (Visit 2)||12
7581507|NCT02708433|18662613|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
7581508|NCT02708433|18662614|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
7581509|NCT02708433|18662613|P2|COMPLETED|Washout (at Least 1 Week)||11
7581510|NCT02708433|18662614|P1|COMPLETED|Washout (at Least 1 Week)||12
7581511|NCT02708433|18662613|P2|STARTED|Washout (at Least 1 Week)||11
7581512|NCT02708433|18662614|P1|STARTED|Washout (at Least 1 Week)||12
7581513|NCT02708433|18662613|P2|NOT COMPLETED|First Intervention (Visit 1)||0
7581514|NCT02708433|18662614|P1|NOT COMPLETED|First Intervention (Visit 1)||0
7581515|NCT02708433|18662613|P2|COMPLETED|First Intervention (Visit 1)||11
7581516|NCT02708433|18662614|P1|COMPLETED|First Intervention (Visit 1)||12
7581517|NCT02708433|18662613|P2|STARTED|First Intervention (Visit 1)||11
7581518|NCT02708433|18662614|P1|STARTED|First Intervention (Visit 1)||12
7581519|NCT02708355|18662625|P3|NOT COMPLETED|Overall Study||0
7581520|NCT02708355|18662626|P2|NOT COMPLETED|Overall Study||0
7581521|NCT02708355|18662627|P1|NOT COMPLETED|Overall Study||1
7581522|NCT02708355|18662625|P3|COMPLETED|Overall Study||12
7581523|NCT02708355|18662626|P2|COMPLETED|Overall Study||22
7581524|NCT02708355|18662627|P1|COMPLETED|Overall Study||20
7581525|NCT02708355|18662625|P3|STARTED|Overall Study||12
7581526|NCT02708355|18662626|P2|STARTED|Overall Study||22
7581527|NCT02708355|18662627|P1|STARTED|Overall Study||21
7581528|NCT02708290|18662640|P2|NOT COMPLETED|Overall Study||0
7581529|NCT02708290|18662641|P1|NOT COMPLETED|Overall Study||0
7581530|NCT02708290|18662640|P2|COMPLETED|Overall Study||1009
7581531|NCT02708290|18662641|P1|COMPLETED|Overall Study||1009
7581532|NCT02708290|18662640|P2|STARTED|Overall Study||1009
7581533|NCT02708290|18662641|P1|STARTED|Overall Study||1009
7581534|NCT02708277|18662649|P2|NOT COMPLETED|Overall Study||4
7581535|NCT02708277|18662650|P1|NOT COMPLETED|Overall Study||7
7581536|NCT02708277|18662649|P2|COMPLETED|Overall Study||39
7581537|NCT02708277|18662650|P1|COMPLETED|Overall Study||43
7581538|NCT02708277|18662649|P2|STARTED|Overall Study||43
7581539|NCT02708277|18662650|P1|STARTED|Overall Study||50
7581540|NCT02708238|18662665|P3|NOT COMPLETED|Overall Study||3
7581541|NCT02708238|18662666|P2|NOT COMPLETED|Overall Study||1
7581542|NCT02708238|18662667|P1|NOT COMPLETED|Overall Study||0
7581543|NCT02708238|18662665|P3|COMPLETED|Overall Study||57
7581544|NCT02708238|18662666|P2|COMPLETED|Overall Study||59
7581545|NCT02708238|18662667|P1|COMPLETED|Overall Study||60
7581546|NCT02708238|18662665|P3|STARTED|Overall Study||60
7581547|NCT02708238|18662666|P2|STARTED|Overall Study||60
7581548|NCT02708238|18662667|P1|STARTED|Overall Study||60
7581549|NCT02708212|18662680|P2|NOT COMPLETED|Overall Study||0
7581550|NCT02708212|18662681|P1|NOT COMPLETED|Overall Study||0
7581551|NCT02708212|18662680|P2|COMPLETED|Overall Study||60
7581552|NCT02708212|18662681|P1|COMPLETED|Overall Study||60
7581553|NCT02708212|18662680|P2|STARTED|Overall Study||60
7581554|NCT02708212|18662681|P1|STARTED|Overall Study||60
7581555|NCT02708186|18662693|P2|NOT COMPLETED|Overall Study||2
7581556|NCT02708186|18662694|P1|NOT COMPLETED|Overall Study||2
7581557|NCT02708186|18662693|P2|COMPLETED|Overall Study||16
7581558|NCT02708186|18662694|P1|COMPLETED|Overall Study||14
7581559|NCT02708186|18662693|P2|STARTED|Overall Study||18
7581560|NCT02708186|18662694|P1|STARTED|Overall Study||16
7581561|NCT02708121|18662702|P2|NOT COMPLETED|Overall Study||5
7581562|NCT02708121|18662703|P1|NOT COMPLETED|Overall Study||1
7581563|NCT02708121|18662702|P2|COMPLETED|Overall Study||26
7581564|NCT02708121|18662703|P1|COMPLETED|Overall Study||34
7581565|NCT02708121|18662702|P2|6 Month Weight Data Via EHR|Overall Study||13
7581566|NCT02708121|18662703|P1|6 Month Weight Data Via EHR|Overall Study||14
7581567|NCT02708121|18662702|P2|6 Month In-Person Follow Up Data|Overall Study||19
7581568|NCT02708121|18662703|P1|6 Month In-Person Follow Up Data|Overall Study||22
7581569|NCT02708121|18662702|P2|Treatment Program Use Data Available|Overall Study||24
7581570|NCT02708121|18662703|P1|Treatment Program Use Data Available|Overall Study||34
7581571|NCT02708121|18662702|P2|Provided Acceptability Data|Overall Study|This condition did not participate in acceptability survey|0
7581572|NCT02708121|18662703|P1|Provided Acceptability Data|Overall Study||20
7581573|NCT02708121|18662702|P2|STARTED|Overall Study||31
7581574|NCT02708121|18662703|P1|STARTED|Overall Study||35
7581575|NCT02708095|18662715|P3|NOT COMPLETED|Overall Study||18
7581576|NCT02708095|18662716|P2|NOT COMPLETED|Overall Study||19
7581577|NCT02708095|18662717|P1|NOT COMPLETED|Overall Study||22
7581578|NCT02708095|18662715|P3|COMPLETED|Overall Study||86
7581579|NCT02708095|18662716|P2|COMPLETED|Overall Study||86
7581580|NCT02708095|18662717|P1|COMPLETED|Overall Study||83
7581581|NCT02708095|18662715|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
7581582|NCT02708095|18662716|P2|Received at Least 1 Dose of Study Drug|Overall Study||105
7581583|NCT02708095|18662717|P1|Received at Least 1 Dose of Study Drug|Overall Study||105
7581584|NCT02708095|18662715|P3|STARTED|Overall Study||104
7581585|NCT02708095|18662716|P2|STARTED|Overall Study||105
7581586|NCT02708095|18662717|P1|STARTED|Overall Study||105
7581587|NCT02707991|18662740|P2|NOT COMPLETED|Overall Study||1
7581588|NCT02707991|18662741|P1|NOT COMPLETED|Overall Study||1
7581589|NCT02707991|18662740|P2|COMPLETED|Overall Study||34
7581590|NCT02707991|18662741|P1|COMPLETED|Overall Study||32
7581591|NCT02707991|18662740|P2|Month 6 Data Collection|Overall Study||34
7581592|NCT02707991|18662741|P1|Month 6 Data Collection|Overall Study||32
7581593|NCT02707991|18662740|P2|Day 60 Data Collectio|Overall Study||34
7581594|NCT02707991|18662741|P1|Day 60 Data Collectio|Overall Study||32
7581595|NCT02707991|18662740|P2|STARTED|Overall Study||35
7581596|NCT02707991|18662741|P1|STARTED|Overall Study||33
7581597|NCT02707965|18662758|P16|NOT COMPLETED|Overall Study||0
7581598|NCT02707965|18662759|P15|NOT COMPLETED|Overall Study||2
7581599|NCT02707965|18662760|P14|NOT COMPLETED|Overall Study||0
7581600|NCT02707965|18662761|P13|NOT COMPLETED|Overall Study||0
7581601|NCT02707965|18662762|P12|NOT COMPLETED|Overall Study||0
7581602|NCT02707965|18662763|P11|NOT COMPLETED|Overall Study||0
7581603|NCT02707965|18662764|P10|NOT COMPLETED|Overall Study||0
7581604|NCT02707965|18662765|P9|NOT COMPLETED|Overall Study||0
7581605|NCT02707965|18662766|P8|NOT COMPLETED|Overall Study||3
7581606|NCT02707965|18662767|P7|NOT COMPLETED|Overall Study||0
7581607|NCT02707965|18662768|P6|NOT COMPLETED|Overall Study||0
7581608|NCT02707965|18662769|P5|NOT COMPLETED|Overall Study||0
7581609|NCT02707965|18662770|P4|NOT COMPLETED|Overall Study||0
7581610|NCT02707965|18662771|P3|NOT COMPLETED|Overall Study||1
7581611|NCT02707965|18662772|P2|NOT COMPLETED|Overall Study||1
7581612|NCT02707965|18662773|P1|NOT COMPLETED|Overall Study||1
7581613|NCT02707965|18662758|P16|COMPLETED|Overall Study||0
7581614|NCT02707965|18662759|P15|COMPLETED|Overall Study||0
7581615|NCT02707965|18662760|P14|COMPLETED|Overall Study||2
7581616|NCT02707965|18662761|P13|COMPLETED|Overall Study||0
7581617|NCT02707965|18662762|P12|COMPLETED|Overall Study||0
7581618|NCT02707965|18662763|P11|COMPLETED|Overall Study||1
7581619|NCT02707965|18662764|P10|COMPLETED|Overall Study||0
7581620|NCT02707965|18662765|P9|COMPLETED|Overall Study||1
7581621|NCT02707965|18662766|P8|COMPLETED|Overall Study||0
7581622|NCT02707965|18662767|P7|COMPLETED|Overall Study||0
7581623|NCT02707965|18662768|P6|COMPLETED|Overall Study||1
7581624|NCT02707965|18662769|P5|COMPLETED|Overall Study||2
7581625|NCT02707965|18662770|P4|COMPLETED|Overall Study||0
7581626|NCT02707965|18662771|P3|COMPLETED|Overall Study||3
7581627|NCT02707965|18662772|P2|COMPLETED|Overall Study||1
7581628|NCT02707965|18662773|P1|COMPLETED|Overall Study||2
7581629|NCT02707965|18662758|P16|STARTED|Overall Study||0
7581630|NCT02707965|18662759|P15|STARTED|Overall Study||2
7581631|NCT02707965|18662760|P14|STARTED|Overall Study||2
7581632|NCT02707965|18662761|P13|STARTED|Overall Study||0
7581633|NCT02707965|18662762|P12|STARTED|Overall Study||0
7581634|NCT02707965|18662763|P11|STARTED|Overall Study||1
7581635|NCT02707965|18662764|P10|STARTED|Overall Study||0
7581636|NCT02707965|18662765|P9|STARTED|Overall Study||1
7581637|NCT02707965|18662766|P8|STARTED|Overall Study||3
7581638|NCT02707965|18662767|P7|STARTED|Overall Study||0
7581639|NCT02707965|18662768|P6|STARTED|Overall Study||1
7581640|NCT02707965|18662769|P5|STARTED|Overall Study||2
7581641|NCT02707965|18662770|P4|STARTED|Overall Study||0
7581642|NCT02707965|18662771|P3|STARTED|Overall Study||4
7581643|NCT02707965|18662772|P2|STARTED|Overall Study||2
7581644|NCT02707965|18662773|P1|STARTED|Overall Study||3
7581645|NCT02707952|18662825|P4|NOT COMPLETED|Overall Study||0
7581646|NCT02707952|18662826|P3|NOT COMPLETED|Overall Study||2
7581647|NCT02707952|18662827|P2|NOT COMPLETED|Overall Study||1
7581648|NCT02707952|18662828|P1|NOT COMPLETED|Overall Study||2
7581649|NCT02707952|18662825|P4|COMPLETED|Overall Study||10
7581650|NCT02707952|18662826|P3|COMPLETED|Overall Study||101
7581651|NCT02707952|18662827|P2|COMPLETED|Overall Study||52
7581652|NCT02707952|18662828|P1|COMPLETED|Overall Study||127
7581653|NCT02707952|18662825|P4|Participants Who Received Study Drug|Overall Study||10
7581654|NCT02707952|18662826|P3|Participants Who Received Study Drug|Overall Study||103
7581655|NCT02707952|18662827|P2|Participants Who Received Study Drug|Overall Study||52
7581656|NCT02707952|18662828|P1|Participants Who Received Study Drug|Overall Study||129
7581657|NCT02707952|18662825|P4|STARTED|Overall Study||10
7581658|NCT02707952|18662826|P3|STARTED|Overall Study||103
7581659|NCT02707952|18662827|P2|STARTED|Overall Study||53
7581660|NCT02707952|18662828|P1|STARTED|Overall Study||129
7581661|NCT02707640|18662849|P2|NOT COMPLETED|Overall Study||7
7581662|NCT02707640|18662850|P1|NOT COMPLETED|Overall Study||9
7581663|NCT02707640|18662849|P2|COMPLETED|Overall Study||55
7581664|NCT02707640|18662850|P1|COMPLETED|Overall Study||52
7581665|NCT02707640|18662849|P2|STARTED|Overall Study||62
7581666|NCT02707640|18662850|P1|STARTED|Overall Study||61
7581667|NCT02707601|18662870|P2|NOT COMPLETED|Overall Study||4
7581668|NCT02707601|18662871|P1|NOT COMPLETED|Overall Study||4
7581669|NCT02707601|18662870|P2|COMPLETED|Overall Study||70
7581670|NCT02707601|18662871|P1|COMPLETED|Overall Study||72
7581671|NCT02707601|18662870|P2|STARTED|Overall Study||74
7581672|NCT02707601|18662871|P1|STARTED|Overall Study||76
7581673|NCT02707523|18662888|P3|NOT COMPLETED|Overall Study||0
7581674|NCT02707523|18662889|P2|NOT COMPLETED|Overall Study||0
7581675|NCT02707523|18662890|P1|NOT COMPLETED|Overall Study||0
7581676|NCT02707523|18662888|P3|COMPLETED|Overall Study||16
7581677|NCT02707523|18662889|P2|COMPLETED|Overall Study||16
7581678|NCT02707523|18662890|P1|COMPLETED|Overall Study||16
7581679|NCT02707523|18662888|P3|STARTED|Overall Study||16
7581680|NCT02707523|18662889|P2|STARTED|Overall Study||16
7581681|NCT02707523|18662890|P1|STARTED|Overall Study||16
7581682|NCT02707432|18662930|P2|NOT COMPLETED|Overall Study||20
7581683|NCT02707432|18662931|P1|NOT COMPLETED|Overall Study||15
7581684|NCT02707432|18662930|P2|COMPLETED|Overall Study||51
7581685|NCT02707432|18662931|P1|COMPLETED|Overall Study||57
7581686|NCT02707432|18662930|P2|STARTED|Overall Study||71
7581687|NCT02707432|18662931|P1|STARTED|Overall Study||72
7581688|NCT02707172|18662941|P1|NOT COMPLETED|2nd Set of Experiment||0
7581689|NCT02707172|18662941|P1|COMPLETED|2nd Set of Experiment||28
7581690|NCT02707172|18662941|P1|STARTED|2nd Set of Experiment||28
7581691|NCT02707172|18662941|P1|NOT COMPLETED|Wash Out||0
7581692|NCT02707172|18662941|P1|COMPLETED|Wash Out||28
7581693|NCT02707172|18662941|P1|STARTED|Wash Out||28
7581694|NCT02707172|18662941|P1|NOT COMPLETED|1st Set of Experiment||0
7581695|NCT02707172|18662941|P1|COMPLETED|1st Set of Experiment||28
7581696|NCT02707172|18662941|P1|STARTED|1st Set of Experiment||28
7581697|NCT02707146|18662948|P2|NOT COMPLETED|Overall Study||3
7581698|NCT02707146|18662949|P1|NOT COMPLETED|Overall Study||0
7581699|NCT02707146|18662948|P2|COMPLETED|Overall Study||388
7581700|NCT02707146|18662949|P1|COMPLETED|Overall Study||359
7581701|NCT02707146|18662948|P2|STARTED|Overall Study||391
7581702|NCT02707146|18662949|P1|STARTED|Overall Study||359
7581703|NCT02706951|18662960|P3|NOT COMPLETED|Overall Study||10
7581704|NCT02706951|18662961|P2|NOT COMPLETED|Overall Study||16
7581705|NCT02706951|18662962|P1|NOT COMPLETED|Overall Study||14
7581706|NCT02706951|18662960|P3|COMPLETED|Overall Study||205
7581707|NCT02706951|18662961|P2|COMPLETED|Overall Study||201
7581708|NCT02706951|18662962|P1|COMPLETED|Overall Study||202
7581709|NCT02706951|18662960|P3|STARTED|Overall Study||215
7581710|NCT02706951|18662961|P2|STARTED|Overall Study||217
7581711|NCT02706951|18662962|P1|STARTED|Overall Study||216
7581712|NCT02706938|18662996|P2|NOT COMPLETED|Second Period, 6 Weeks||10
7581713|NCT02706938|18662997|P1|NOT COMPLETED|Second Period, 6 Weeks||0
7581714|NCT02706938|18662996|P2|COMPLETED|Second Period, 6 Weeks|Only data from 19 patients were finally analyzed because of missing data.|21
7581715|NCT02706938|18662997|P1|COMPLETED|Second Period, 6 Weeks|Only data from 20 patients were finally analyzed because of missing data.|21
7581716|NCT02706938|18662996|P2|STARTED|Second Period, 6 Weeks||31
7581717|NCT02706938|18662997|P1|STARTED|Second Period, 6 Weeks||21
7581718|NCT02706938|18662996|P2|NOT COMPLETED|First Period, 6 Weeks||2
7581719|NCT02706938|18662997|P1|NOT COMPLETED|First Period, 6 Weeks||11
7581720|NCT02706938|18662996|P2|COMPLETED|First Period, 6 Weeks||31
7581721|NCT02706938|18662997|P1|COMPLETED|First Period, 6 Weeks||21
7581722|NCT02706938|18662996|P2|STARTED|First Period, 6 Weeks||33
7581723|NCT02706938|18662997|P1|STARTED|First Period, 6 Weeks||32
7581724|NCT02706925|18663015|P9|NOT COMPLETED|Overall Study||0
7581725|NCT02706925|18663016|P8|NOT COMPLETED|Overall Study||0
7581726|NCT02706925|18663017|P7|NOT COMPLETED|Overall Study||0
7581727|NCT02706925|18663018|P6|NOT COMPLETED|Overall Study||0
7581728|NCT02706925|18663019|P5|NOT COMPLETED|Overall Study||0
7581729|NCT02706925|18663020|P4|NOT COMPLETED|Overall Study||0
7581730|NCT02706925|18663021|P3|NOT COMPLETED|Overall Study||0
7581731|NCT02706925|18663022|P2|NOT COMPLETED|Overall Study||0
7581732|NCT02706925|18663023|P1|NOT COMPLETED|Overall Study||0
7581733|NCT02706925|18663015|P9|COMPLETED|Overall Study||6
7581734|NCT02706925|18663016|P8|COMPLETED|Overall Study||6
7581735|NCT02706925|18663017|P7|COMPLETED|Overall Study||6
7581736|NCT02706925|18663018|P6|COMPLETED|Overall Study||5
7581737|NCT02706925|18663019|P5|COMPLETED|Overall Study||6
7581738|NCT02706925|18663020|P4|COMPLETED|Overall Study||6
7581739|NCT02706925|18663021|P3|COMPLETED|Overall Study||6
7581740|NCT02706925|18663022|P2|COMPLETED|Overall Study||6
7581741|NCT02706925|18663023|P1|COMPLETED|Overall Study||16
7581742|NCT02706925|18663015|P9|STARTED|Overall Study||6
7581743|NCT02706925|18663016|P8|STARTED|Overall Study||6
7581744|NCT02706925|18663017|P7|STARTED|Overall Study||6
7581745|NCT02706925|18663018|P6|STARTED|Overall Study||5
7581746|NCT02706925|18663019|P5|STARTED|Overall Study||6
7581747|NCT02706925|18663020|P4|STARTED|Overall Study||6
7581748|NCT02706925|18663021|P3|STARTED|Overall Study||6
7581749|NCT02706925|18663022|P2|STARTED|Overall Study||6
7581750|NCT02706925|18663023|P1|STARTED|Overall Study||16
7581751|NCT02706899|18663061|P2|NOT COMPLETED|Overall Study||6
7581752|NCT02706899|18663062|P1|NOT COMPLETED|Overall Study||13
7581753|NCT02706899|18663061|P2|COMPLETED|Overall Study||0
7581754|NCT02706899|18663062|P1|COMPLETED|Overall Study||0
7581755|NCT02706899|18663061|P2|STARTED|Overall Study||6
7581756|NCT02706899|18663062|P1|STARTED|Overall Study||13
7581757|NCT02706886|18663093|P9|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
7581758|NCT02706886|18663094|P8|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
7581759|NCT02706886|18663095|P7|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
7581760|NCT02706886|18663096|P6|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
7581761|NCT02706886|18663097|P5|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
7581762|NCT02706886|18663098|P4|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
7581763|NCT02706886|18663099|P3|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
7581764|NCT02706886|18663100|P2|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
7581765|NCT02706886|18663101|P1|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
7581766|NCT02706886|18663093|P9|COMPLETED|Part B: MAD Study Day 85-End of Study||4
7581767|NCT02706886|18663094|P8|COMPLETED|Part B: MAD Study Day 85-End of Study||8
7581768|NCT02706886|18663095|P7|COMPLETED|Part B: MAD Study Day 85-End of Study||8
7581769|NCT02706886|18663096|P6|COMPLETED|Part B: MAD Study Day 85-End of Study||0
7581770|NCT02706886|18663097|P5|COMPLETED|Part B: MAD Study Day 85-End of Study||0
7581771|NCT02706886|18663098|P4|COMPLETED|Part B: MAD Study Day 85-End of Study||0
7581772|NCT02706886|18663099|P3|COMPLETED|Part B: MAD Study Day 85-End of Study||0
7581773|NCT02706886|18663100|P2|COMPLETED|Part B: MAD Study Day 85-End of Study||0
7581774|NCT02706886|18663101|P1|COMPLETED|Part B: MAD Study Day 85-End of Study||0
7581775|NCT02706886|18663093|P9|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|4
7581776|NCT02706886|18663094|P8|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
7581777|NCT02706886|18663095|P7|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
7581778|NCT02706886|18663096|P6|STARTED|Part B: MAD Study Day 85-End of Study||0
7581779|NCT02706886|18663097|P5|STARTED|Part B: MAD Study Day 85-End of Study||0
7581780|NCT02706886|18663098|P4|STARTED|Part B: MAD Study Day 85-End of Study||0
7581781|NCT02706886|18663099|P3|STARTED|Part B: MAD Study Day 85-End of Study||0
7581782|NCT02706886|18663100|P2|STARTED|Part B: MAD Study Day 85-End of Study||0
7581783|NCT02706886|18663101|P1|STARTED|Part B: MAD Study Day 85-End of Study||0
7581784|NCT02706886|18663093|P9|NOT COMPLETED|Part B: MAD Study Days 1-85||0
7581785|NCT02706886|18663094|P8|NOT COMPLETED|Part B: MAD Study Days 1-85||0
7581786|NCT02706886|18663095|P7|NOT COMPLETED|Part B: MAD Study Days 1-85||0
7581787|NCT02706886|18663096|P6|NOT COMPLETED|Part B: MAD Study Days 1-85||0
7581788|NCT02706886|18663097|P5|NOT COMPLETED|Part B: MAD Study Days 1-85||0
7581789|NCT02706886|18663098|P4|NOT COMPLETED|Part B: MAD Study Days 1-85||0
7581790|NCT02706886|18663099|P3|NOT COMPLETED|Part B: MAD Study Days 1-85||0
7581791|NCT02706886|18663100|P2|NOT COMPLETED|Part B: MAD Study Days 1-85||0
7581792|NCT02706886|18663101|P1|NOT COMPLETED|Part B: MAD Study Days 1-85||0
7581793|NCT02706886|18663093|P9|COMPLETED|Part B: MAD Study Days 1-85||3
7581794|NCT02706886|18663094|P8|COMPLETED|Part B: MAD Study Days 1-85||7
7581795|NCT02706886|18663095|P7|COMPLETED|Part B: MAD Study Days 1-85||7
7581796|NCT02706886|18663096|P6|COMPLETED|Part B: MAD Study Days 1-85||3
7581797|NCT02706886|18663097|P5|COMPLETED|Part B: MAD Study Days 1-85||0
7581798|NCT02706886|18663098|P4|COMPLETED|Part B: MAD Study Days 1-85||0
7581799|NCT02706886|18663099|P3|COMPLETED|Part B: MAD Study Days 1-85||0
7581800|NCT02706886|18663100|P2|COMPLETED|Part B: MAD Study Days 1-85||0
7581801|NCT02706886|18663101|P1|COMPLETED|Part B: MAD Study Days 1-85||0
7581802|NCT02706886|18663093|P9|STARTED|Part B: MAD Study Days 1-85||3
7581803|NCT02706886|18663094|P8|STARTED|Part B: MAD Study Days 1-85||7
7581804|NCT02706886|18663095|P7|STARTED|Part B: MAD Study Days 1-85||7
7581805|NCT02706886|18663096|P6|STARTED|Part B: MAD Study Days 1-85||3
7581806|NCT02706886|18663097|P5|STARTED|Part B: MAD Study Days 1-85||0
7581807|NCT02706886|18663098|P4|STARTED|Part B: MAD Study Days 1-85||0
7581808|NCT02706886|18663099|P3|STARTED|Part B: MAD Study Days 1-85||0
7581809|NCT02706886|18663100|P2|STARTED|Part B: MAD Study Days 1-85||0
7581810|NCT02706886|18663101|P1|STARTED|Part B: MAD Study Days 1-85||0
7581811|NCT02706886|18663093|P9|NOT COMPLETED|Part A: SAD Period||0
7581812|NCT02706886|18663094|P8|NOT COMPLETED|Part A: SAD Period||0
7581813|NCT02706886|18663095|P7|NOT COMPLETED|Part A: SAD Period||0
7581814|NCT02706886|18663096|P6|NOT COMPLETED|Part A: SAD Period||0
7581815|NCT02706886|18663097|P5|NOT COMPLETED|Part A: SAD Period||0
7581816|NCT02706886|18663098|P4|NOT COMPLETED|Part A: SAD Period||2
7581817|NCT02706886|18663099|P3|NOT COMPLETED|Part A: SAD Period||0
7581818|NCT02706886|18663100|P2|NOT COMPLETED|Part A: SAD Period||0
7581819|NCT02706886|18663101|P1|NOT COMPLETED|Part A: SAD Period||0
7581820|NCT02706886|18663093|P9|COMPLETED|Part A: SAD Period||0
7581821|NCT02706886|18663094|P8|COMPLETED|Part A: SAD Period||0
7581822|NCT02706886|18663095|P7|COMPLETED|Part A: SAD Period||0
7581823|NCT02706886|18663096|P6|COMPLETED|Part A: SAD Period||0
7581824|NCT02706886|18663097|P5|COMPLETED|Part A: SAD Period||6
7581825|NCT02706886|18663098|P4|COMPLETED|Part A: SAD Period||4
7581826|NCT02706886|18663099|P3|COMPLETED|Part A: SAD Period||6
7581827|NCT02706886|18663100|P2|COMPLETED|Part A: SAD Period||6
7581828|NCT02706886|18663101|P1|COMPLETED|Part A: SAD Period||8
7581829|NCT02706886|18663093|P9|STARTED|Part A: SAD Period||0
7581830|NCT02706886|18663094|P8|STARTED|Part A: SAD Period||0
7581831|NCT02706886|18663095|P7|STARTED|Part A: SAD Period||0
7581832|NCT02706886|18663096|P6|STARTED|Part A: SAD Period||0
7581833|NCT02706886|18663097|P5|STARTED|Part A: SAD Period||6
7581834|NCT02706886|18663098|P4|STARTED|Part A: SAD Period||6
7581835|NCT02706886|18663099|P3|STARTED|Part A: SAD Period||6
7581836|NCT02706886|18663100|P2|STARTED|Part A: SAD Period||6
7581837|NCT02706886|18663101|P1|STARTED|Part A: SAD Period||8
7581838|NCT02706873|18663218|P4|NOT COMPLETED|Overall Study||33
7581839|NCT02706873|18663219|P3|NOT COMPLETED|Overall Study||27
7581840|NCT02706873|18663220|P2|NOT COMPLETED|Overall Study||4
7581841|NCT02706873|18663221|P1|NOT COMPLETED|Overall Study||47
7581842|NCT02706873|18663218|P4|COMPLETED|Overall Study||282
7581843|NCT02706873|18663219|P3|COMPLETED|Overall Study||290
7581844|NCT02706873|18663220|P2|COMPLETED|Overall Study||51
7581845|NCT02706873|18663221|P1|COMPLETED|Overall Study||268
7581846|NCT02706873|18663218|P4|Japan Sub-study|Overall Study||28
7581847|NCT02706873|18663219|P3|Japan Sub-study|Overall Study||27
7581848|NCT02706873|18663220|P2|Japan Sub-study|Overall Study||55
7581849|NCT02706873|18663221|P1|Japan Sub-study|Overall Study||28
7581850|NCT02706873|18663218|P4|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
7581851|NCT02706873|18663219|P3|Global Analysis Population|Overall Study|Includes 27 participants in the Japan sub-study|317
7581852|NCT02706873|18663220|P2|Global Analysis Population|Overall Study||0
7581853|NCT02706873|18663221|P1|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
7581854|NCT02706873|18663218|P4|Received Study Drug|Overall Study||314
7581855|NCT02706873|18663219|P3|Received Study Drug|Overall Study||317
7581856|NCT02706873|18663220|P2|Received Study Drug|Overall Study||55
7581857|NCT02706873|18663221|P1|Received Study Drug|Overall Study||314
7581858|NCT02706873|18663218|P4|STARTED|Overall Study||315
7581859|NCT02706873|18663219|P3|STARTED|Overall Study||317
7581860|NCT02706873|18663220|P2|STARTED|Overall Study||55
7581861|NCT02706873|18663221|P1|STARTED|Overall Study||315
7581862|NCT02706847|18663321|P4|NOT COMPLETED|Week 12 to Week 24||14
7581863|NCT02706847|18663322|P3|NOT COMPLETED|Week 12 to Week 24||4
7581864|NCT02706847|18663323|P2|NOT COMPLETED|Week 12 to Week 24||2
7581865|NCT02706847|18663324|P1|NOT COMPLETED|Week 12 to Week 24||3
7581866|NCT02706847|18663321|P4|COMPLETED|Week 12 to Week 24||135
7581867|NCT02706847|18663322|P3|COMPLETED|Week 12 to Week 24||153
7581868|NCT02706847|18663323|P2|COMPLETED|Week 12 to Week 24||74
7581869|NCT02706847|18663324|P1|COMPLETED|Week 12 to Week 24||72
7581870|NCT02706847|18663321|P4|Received Study Treatment|Week 12 to Week 24||148
7581871|NCT02706847|18663322|P3|Received Study Treatment|Week 12 to Week 24||156
7581872|NCT02706847|18663323|P2|Received Study Treatment|Week 12 to Week 24||75
7581873|NCT02706847|18663324|P1|Received Study Treatment|Week 12 to Week 24||72
7581874|NCT02706847|18663321|P4|STARTED|Week 12 to Week 24||149
7581875|NCT02706847|18663322|P3|STARTED|Week 12 to Week 24||157
7581876|NCT02706847|18663323|P2|STARTED|Week 12 to Week 24||76
7581877|NCT02706847|18663324|P1|STARTED|Week 12 to Week 24||75
7581878|NCT02706847|18663321|P4|NOT COMPLETED|Day 1 to Week 12||16
7581879|NCT02706847|18663322|P3|NOT COMPLETED|Day 1 to Week 12||8
7581880|NCT02706847|18663323|P2|NOT COMPLETED|Day 1 to Week 12||8
7581881|NCT02706847|18663324|P1|NOT COMPLETED|Day 1 to Week 12||10
7581882|NCT02706847|18663321|P4|COMPLETED|Day 1 to Week 12||149
7581883|NCT02706847|18663322|P3|COMPLETED|Day 1 to Week 12||157
7581884|NCT02706847|18663323|P2|COMPLETED|Day 1 to Week 12||76
7581885|NCT02706847|18663324|P1|COMPLETED|Day 1 to Week 12||75
7581886|NCT02706847|18663321|P4|Received Study Treatment|Day 1 to Week 12||165
7581887|NCT02706847|18663322|P3|Received Study Treatment|Day 1 to Week 12||164
7581888|NCT02706847|18663323|P2|Received Study Treatment|Day 1 to Week 12||84
7581889|NCT02706847|18663324|P1|Received Study Treatment|Day 1 to Week 12||85
7581890|NCT02706847|18663321|P4|STARTED|Day 1 to Week 12||165
7581891|NCT02706847|18663322|P3|STARTED|Day 1 to Week 12||165
7581892|NCT02706847|18663323|P2|STARTED|Day 1 to Week 12||84
7581893|NCT02706847|18663324|P1|STARTED|Day 1 to Week 12||85
7581894|NCT02706834|18663366|P11|NOT COMPLETED|Overall Study||1
7581895|NCT02706834|18663367|P10|NOT COMPLETED|Overall Study||1
7581896|NCT02706834|18663368|P9|NOT COMPLETED|Overall Study||0
7581897|NCT02706834|18663369|P8|NOT COMPLETED|Overall Study||0
7581898|NCT02706834|18663370|P7|NOT COMPLETED|Overall Study||0
7581899|NCT02706834|18663371|P6|NOT COMPLETED|Overall Study||0
7581900|NCT02706834|18663372|P5|NOT COMPLETED|Overall Study||1
7581901|NCT02706834|18663373|P4|NOT COMPLETED|Overall Study||0
7581902|NCT02706834|18663374|P3|NOT COMPLETED|Overall Study||1
7581903|NCT02706834|18663375|P2|NOT COMPLETED|Overall Study||1
7581904|NCT02706834|18663376|P1|NOT COMPLETED|Overall Study||2
7581905|NCT02706834|18663366|P11|COMPLETED|Overall Study||3
7581906|NCT02706834|18663367|P10|COMPLETED|Overall Study||3
7581907|NCT02706834|18663368|P9|COMPLETED|Overall Study||4
7581908|NCT02706834|18663369|P8|COMPLETED|Overall Study||3
7581909|NCT02706834|18663370|P7|COMPLETED|Overall Study||3
7581910|NCT02706834|18663371|P6|COMPLETED|Overall Study||3
7581911|NCT02706834|18663372|P5|COMPLETED|Overall Study||2
7581912|NCT02706834|18663373|P4|COMPLETED|Overall Study||3
7581913|NCT02706834|18663374|P3|COMPLETED|Overall Study||2
7581914|NCT02706834|18663375|P2|COMPLETED|Overall Study||2
7581915|NCT02706834|18663376|P1|COMPLETED|Overall Study|Completed = completed study drug|1
7581916|NCT02706834|18663366|P11|STARTED|Overall Study||4
7581917|NCT02706834|18663367|P10|STARTED|Overall Study||4
7581918|NCT02706834|18663368|P9|STARTED|Overall Study||4
7581919|NCT02706834|18663369|P8|STARTED|Overall Study||3
7581920|NCT02706834|18663370|P7|STARTED|Overall Study||3
7581921|NCT02706834|18663371|P6|STARTED|Overall Study||3
7581922|NCT02706834|18663372|P5|STARTED|Overall Study||3
7581923|NCT02706834|18663373|P4|STARTED|Overall Study||3
7581924|NCT02706834|18663374|P3|STARTED|Overall Study||3
7581925|NCT02706834|18663375|P2|STARTED|Overall Study||3
7581926|NCT02706834|18663376|P1|STARTED|Overall Study||3
7581927|NCT02706717|18663520|P2|NOT COMPLETED|Overall Study||11
7581928|NCT02706717|18663521|P1|NOT COMPLETED|Overall Study||1
7581929|NCT02706717|18663520|P2|COMPLETED|Overall Study||35
7581930|NCT02706717|18663521|P1|COMPLETED|Overall Study||46
7581931|NCT02706717|18663520|P2|STARTED|Overall Study|3 placebo participants never initiated study treatment.|46
7581932|NCT02706717|18663521|P1|STARTED|Overall Study||47
7581933|NCT02706691|18663585|P1|NOT COMPLETED|Overall Study||1
7581934|NCT02706691|18663585|P1|COMPLETED|Overall Study||0
7581935|NCT02706691|18663585|P1|STARTED|Overall Study||1
7581936|NCT02706483|18663592|P1|NOT COMPLETED|Overall Study||430
7581937|NCT02706483|18663592|P1|COMPLETED|Overall Study||1842
7581938|NCT02706483|18663592|P1|STARTED|Overall Study||2272
7581939|NCT02706327|18663599|P3|NOT COMPLETED|Overall Study||2
7581940|NCT02706327|18663600|P2|NOT COMPLETED|Overall Study||1
7581941|NCT02706327|18663601|P1|NOT COMPLETED|Overall Study||1
7581942|NCT02706327|18663599|P3|COMPLETED|Overall Study||21
7581943|NCT02706327|18663600|P2|COMPLETED|Overall Study||21
7581944|NCT02706327|18663601|P1|COMPLETED|Overall Study||21
7581945|NCT02706327|18663599|P3|STARTED|Overall Study||23
7581946|NCT02706327|18663600|P2|STARTED|Overall Study||22
7581947|NCT02706327|18663601|P1|STARTED|Overall Study||22
7581948|NCT02705807|18663621|P1|NOT COMPLETED|Overall Study||0
7581949|NCT02705807|18663621|P1|COMPLETED|Overall Study||10
7581950|NCT02705807|18663621|P1|STARTED|Overall Study||10
7581951|NCT02705716|18663653|P2|NOT COMPLETED|Overall Study||2
7581952|NCT02705716|18663654|P1|NOT COMPLETED|Overall Study||4
7581953|NCT02705716|18663653|P2|COMPLETED|Overall Study||68
7581954|NCT02705716|18663654|P1|COMPLETED|Overall Study||68
7581955|NCT02705716|18663653|P2|STARTED|Overall Study||70
7581956|NCT02705716|18663654|P1|STARTED|Overall Study||72
7581957|NCT02705625|18663667|P3|NOT COMPLETED|Overall Study||11
7581958|NCT02705625|18663668|P2|NOT COMPLETED|Overall Study||10
7581959|NCT02705625|18663669|P1|NOT COMPLETED|Overall Study||8
7581960|NCT02705625|18663667|P3|COMPLETED|Overall Study||69
7581961|NCT02705625|18663668|P2|COMPLETED|Overall Study||72
7581962|NCT02705625|18663669|P1|COMPLETED|Overall Study||74
7581963|NCT02705625|18663667|P3|STARTED|Overall Study||80
7581964|NCT02705625|18663668|P2|STARTED|Overall Study||82
7581965|NCT02705625|18663669|P1|STARTED|Overall Study||82
7581966|NCT02705586|18663698|P1|NOT COMPLETED|Overall Study||8
7581967|NCT02705586|18663698|P1|COMPLETED|Overall Study||5
7581968|NCT02705586|18663698|P1|STARTED|Overall Study||13
7581969|NCT02705365|18663704|P2|NOT COMPLETED|Overall Study||0
7581970|NCT02705365|18663705|P1|NOT COMPLETED|Overall Study||0
7581971|NCT02705365|18663704|P2|COMPLETED|Overall Study||800
7581972|NCT02705365|18663705|P1|COMPLETED|Overall Study||400
7581973|NCT02705365|18663704|P2|STARTED|Overall Study||800
7581974|NCT02705365|18663705|P1|STARTED|Overall Study||400
7581975|NCT02705352|18663715|P2|NOT COMPLETED|Overall Study||0
7581976|NCT02705352|18663716|P1|NOT COMPLETED|Overall Study||0
7581977|NCT02705352|18663715|P2|COMPLETED|Overall Study||0
7581978|NCT02705352|18663716|P1|COMPLETED|Overall Study||1
7581979|NCT02705352|18663715|P2|STARTED|Overall Study||0
7581980|NCT02705352|18663716|P1|STARTED|Overall Study||1
7581981|NCT02705105|18663736|P2|NOT COMPLETED|Follow-Up||110
7581982|NCT02705105|18663737|P1|NOT COMPLETED|Follow-Up||4
7581983|NCT02705105|18663736|P2|COMPLETED|Follow-Up||0
7581984|NCT02705105|18663737|P1|COMPLETED|Follow-Up||0
7581985|NCT02705105|18663736|P2|STARTED|Follow-Up||110
7581986|NCT02705105|18663737|P1|STARTED|Follow-Up||4
7581987|NCT02705105|18663736|P2|NOT COMPLETED|Treatment||109
7581988|NCT02705105|18663737|P1|NOT COMPLETED|Treatment||4
7581989|NCT02705105|18663736|P2|COMPLETED|Treatment||1
7581990|NCT02705105|18663737|P1|COMPLETED|Treatment||0
7581991|NCT02705105|18663736|P2|D/C From Follow-Up|Treatment||110
7581992|NCT02705105|18663737|P1|D/C From Follow-Up|Treatment||4
7581993|NCT02705105|18663736|P2|D/C From Treatment Phase|Treatment||107
7581994|NCT02705105|18663737|P1|D/C From Treatment Phase|Treatment||4
7581995|NCT02705105|18663736|P2|Subjects Who Were Replaced|Treatment||0
7581996|NCT02705105|18663737|P1|Subjects Who Were Replaced|Treatment||1
7581997|NCT02705105|18663736|P2|STARTED|Treatment||110
7581998|NCT02705105|18663737|P1|STARTED|Treatment||4
7581999|NCT02704702|18663763|P6|NOT COMPLETED|Overall Study||2
7582000|NCT02704702|18663764|P5|NOT COMPLETED|Overall Study||2
7582001|NCT02704702|18663765|P4|NOT COMPLETED|Overall Study||1
7582002|NCT02704702|18663766|P3|NOT COMPLETED|Overall Study||0
7582003|NCT02704702|18663767|P2|NOT COMPLETED|Overall Study||0
7582004|NCT02704702|18663768|P1|NOT COMPLETED|Overall Study||1
7582005|NCT02704702|18663763|P6|COMPLETED|Overall Study||4
7582006|NCT02704702|18663764|P5|COMPLETED|Overall Study||4
7582007|NCT02704702|18663765|P4|COMPLETED|Overall Study||5
7582008|NCT02704702|18663766|P3|COMPLETED|Overall Study||6
7582009|NCT02704702|18663767|P2|COMPLETED|Overall Study||6
7582010|NCT02704702|18663768|P1|COMPLETED|Overall Study||5
7582011|NCT02704702|18663763|P6|STARTED|Overall Study||6
7582012|NCT02704702|18663764|P5|STARTED|Overall Study||6
7582013|NCT02704702|18663765|P4|STARTED|Overall Study||6
7582014|NCT02704702|18663766|P3|STARTED|Overall Study||6
7582015|NCT02704702|18663767|P2|STARTED|Overall Study||6
7582016|NCT02704702|18663768|P1|STARTED|Overall Study||6
7582017|NCT02704689|18663800|P1|NOT COMPLETED|Overall Study||3
7582018|NCT02704689|18663800|P1|COMPLETED|Overall Study||6
7582019|NCT02704689|18663800|P1|STARTED|Overall Study||9
7582020|NCT02704143|18663817|P1|NOT COMPLETED|Overall Study||10
7582021|NCT02704143|18663817|P1|COMPLETED|Overall Study||53
7582022|NCT02704143|18663817|P1|STARTED|Overall Study||63
7582023|NCT02704104|18663826|P1|NOT COMPLETED|Overall Study||0
7582024|NCT02704104|18663826|P1|COMPLETED|Overall Study||46
7582025|NCT02704104|18663826|P1|STARTED|Overall Study||46
7582026|NCT02704091|18663842|P2|NOT COMPLETED|Overall Study||23
7582027|NCT02704091|18663843|P1|NOT COMPLETED|Overall Study||28
7582028|NCT02704091|18663842|P2|COMPLETED|Overall Study||400
7582029|NCT02704091|18663843|P1|COMPLETED|Overall Study||402
7582030|NCT02704091|18663842|P2|STARTED|Overall Study||423
7582031|NCT02704091|18663843|P1|STARTED|Overall Study||430
7582032|NCT02703987|18663865|P2|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
7582033|NCT02703987|18663866|P1|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
7582034|NCT02703987|18663865|P2|COMPLETED|Visit 4 Intervention (1 Day)||10
7582035|NCT02703987|18663866|P1|COMPLETED|Visit 4 Intervention (1 Day)||12
7582036|NCT02703987|18663865|P2|STARTED|Visit 4 Intervention (1 Day)||11
7582037|NCT02703987|18663866|P1|STARTED|Visit 4 Intervention (1 Day)||13
7582038|NCT02703987|18663865|P2|NOT COMPLETED|Washout (Minimum 5 Days)||0
7582039|NCT02703987|18663866|P1|NOT COMPLETED|Washout (Minimum 5 Days)||0
7582040|NCT02703987|18663865|P2|COMPLETED|Washout (Minimum 5 Days)||11
7582041|NCT02703987|18663866|P1|COMPLETED|Washout (Minimum 5 Days)||13
7582042|NCT02703987|18663865|P2|STARTED|Washout (Minimum 5 Days)||11
7582043|NCT02703987|18663866|P1|STARTED|Washout (Minimum 5 Days)||13
7582044|NCT02703987|18663865|P2|NOT COMPLETED|Visit 3 Intervention (1 Day)||3
7582045|NCT02703987|18663866|P1|NOT COMPLETED|Visit 3 Intervention (1 Day)||1
7582046|NCT02703987|18663865|P2|COMPLETED|Visit 3 Intervention (1 Day)||11
7582047|NCT02703987|18663866|P1|COMPLETED|Visit 3 Intervention (1 Day)||13
7582048|NCT02703987|18663865|P2|STARTED|Visit 3 Intervention (1 Day)||14
7582049|NCT02703987|18663866|P1|STARTED|Visit 3 Intervention (1 Day)||14
7582050|NCT02703948|18663876|P1|NOT COMPLETED|Overall Study||3
7582051|NCT02703948|18663876|P1|COMPLETED|Overall Study||57
7582052|NCT02703948|18663876|P1|STARTED|Overall Study||60
7582053|NCT02703909|18663884|P4|NOT COMPLETED|Overall Study||0
7582054|NCT02703909|18663885|P3|NOT COMPLETED|Overall Study||0
7582055|NCT02703909|18663886|P2|NOT COMPLETED|Overall Study||0
7582056|NCT02703909|18663887|P1|NOT COMPLETED|Overall Study||0
7582057|NCT02703909|18663884|P4|COMPLETED|Overall Study||35
7582058|NCT02703909|18663885|P3|COMPLETED|Overall Study||36
7582059|NCT02703909|18663886|P2|COMPLETED|Overall Study||37
7582060|NCT02703909|18663887|P1|COMPLETED|Overall Study||36
7582061|NCT02703909|18663884|P4|STARTED|Overall Study||35
7582062|NCT02703909|18663885|P3|STARTED|Overall Study||36
7582063|NCT02703909|18663886|P2|STARTED|Overall Study||37
7582064|NCT02703909|18663887|P1|STARTED|Overall Study||36
7582065|NCT02703636|18663903|P1|NOT COMPLETED|Overall Study||16
7582066|NCT02703636|18663903|P1|COMPLETED|Overall Study||102
7582067|NCT02703636|18663903|P1|STARTED|Overall Study||118
7582068|NCT02703532|18663918|P4|NOT COMPLETED|Overall Study||1
7582069|NCT02703532|18663919|P3|NOT COMPLETED|Overall Study||2
7582070|NCT02703532|18663920|P2|NOT COMPLETED|Overall Study||1
7582071|NCT02703532|18663921|P1|NOT COMPLETED|Overall Study||2
7582072|NCT02703532|18663918|P4|COMPLETED|Overall Study||10
7582073|NCT02703532|18663919|P3|COMPLETED|Overall Study||19
7582074|NCT02703532|18663920|P2|COMPLETED|Overall Study||10
7582075|NCT02703532|18663921|P1|COMPLETED|Overall Study||19
7582076|NCT02703532|18663918|P4|STARTED|Overall Study||11
7582077|NCT02703532|18663919|P3|STARTED|Overall Study||21
7582078|NCT02703532|18663920|P2|STARTED|Overall Study||11
7582079|NCT02703532|18663921|P1|STARTED|Overall Study||21
7582080|NCT02703467|18663959|P3|NOT COMPLETED|Overall Study||0
7582081|NCT02703467|18663960|P2|NOT COMPLETED|Overall Study||0
7582082|NCT02703467|18663961|P1|NOT COMPLETED|Overall Study||0
7582083|NCT02703467|18663959|P3|COMPLETED|Overall Study||45
7582084|NCT02703467|18663960|P2|COMPLETED|Overall Study||5
7582085|NCT02703467|18663961|P1|COMPLETED|Overall Study||20
7582086|NCT02703467|18663959|P3|STARTED|Overall Study||45
7582087|NCT02703467|18663960|P2|STARTED|Overall Study||5
7582088|NCT02703467|18663961|P1|STARTED|Overall Study||20
7582089|NCT02703454|18663983|P2|NOT COMPLETED|Overall Study||16
7582090|NCT02703454|18663984|P1|NOT COMPLETED|Overall Study||11
7582091|NCT02703454|18663983|P2|COMPLETED|Overall Study||11
7582092|NCT02703454|18663984|P1|COMPLETED|Overall Study||13
7582093|NCT02703454|18663983|P2|Treated|Overall Study||24
7582094|NCT02703454|18663984|P1|Treated|Overall Study||23
7582095|NCT02703454|18663983|P2|STARTED|Overall Study||27
7582096|NCT02703454|18663984|P1|STARTED|Overall Study||24
7582097|NCT02703350|18663992|P8|NOT COMPLETED|Part B||0
7582098|NCT02703350|18663993|P7|NOT COMPLETED|Part B||0
7582099|NCT02703350|18663994|P6|NOT COMPLETED|Part B||0
7582100|NCT02703350|18663995|P5|NOT COMPLETED|Part B||0
7582101|NCT02703350|18663996|P4|NOT COMPLETED|Part B||0
7582102|NCT02703350|18663997|P3|NOT COMPLETED|Part B||0
7582103|NCT02703350|18663998|P2|NOT COMPLETED|Part B||0
7582104|NCT02703350|18663999|P1|NOT COMPLETED|Part B||0
7582105|NCT02703350|18663992|P8|COMPLETED|Part B||15
7582106|NCT02703350|18663993|P7|COMPLETED|Part B||15
7582107|NCT02703350|18663994|P6|COMPLETED|Part B||0
7582108|NCT02703350|18663995|P5|COMPLETED|Part B||0
7582109|NCT02703350|18663996|P4|COMPLETED|Part B||0
7582110|NCT02703350|18663997|P3|COMPLETED|Part B||0
7582111|NCT02703350|18663998|P2|COMPLETED|Part B||0
7582112|NCT02703350|18663999|P1|COMPLETED|Part B||0
7582113|NCT02703350|18663992|P8|Received Study Drug|Part B||15
7582114|NCT02703350|18663993|P7|Received Study Drug|Part B||15
7582115|NCT02703350|18663994|P6|Received Study Drug|Part B||0
7582116|NCT02703350|18663995|P5|Received Study Drug|Part B||0
7582117|NCT02703350|18663996|P4|Received Study Drug|Part B||0
7582118|NCT02703350|18663997|P3|Received Study Drug|Part B||0
7582119|NCT02703350|18663998|P2|Received Study Drug|Part B||0
7582120|NCT02703350|18663999|P1|Received Study Drug|Part B||0
7582121|NCT02703350|18663992|P8|STARTED|Part B||15
7582122|NCT02703350|18663993|P7|STARTED|Part B||15
7582123|NCT02703350|18663994|P6|STARTED|Part B||0
7582124|NCT02703350|18663995|P5|STARTED|Part B||0
7582125|NCT02703350|18663996|P4|STARTED|Part B||0
7582126|NCT02703350|18663997|P3|STARTED|Part B||0
7582127|NCT02703350|18663998|P2|STARTED|Part B||0
7582128|NCT02703350|18663999|P1|STARTED|Part B||0
7582129|NCT02703350|18663992|P8|NOT COMPLETED|Period Six (Part A)||0
7582130|NCT02703350|18663993|P7|NOT COMPLETED|Period Six (Part A)||0
7582131|NCT02703350|18663994|P6|NOT COMPLETED|Period Six (Part A)||0
7582132|NCT02703350|18663995|P5|NOT COMPLETED|Period Six (Part A)||0
7582133|NCT02703350|18663996|P4|NOT COMPLETED|Period Six (Part A)||0
7582134|NCT02703350|18663997|P3|NOT COMPLETED|Period Six (Part A)||0
7582135|NCT02703350|18663998|P2|NOT COMPLETED|Period Six (Part A)||0
7582136|NCT02703350|18663999|P1|NOT COMPLETED|Period Six (Part A)||0
7582137|NCT02703350|18663992|P8|COMPLETED|Period Six (Part A)||0
7582138|NCT02703350|18663993|P7|COMPLETED|Period Six (Part A)||0
7582139|NCT02703350|18663994|P6|COMPLETED|Period Six (Part A)||5
7582140|NCT02703350|18663995|P5|COMPLETED|Period Six (Part A)||5
7582141|NCT02703350|18663996|P4|COMPLETED|Period Six (Part A)||5
7582142|NCT02703350|18663997|P3|COMPLETED|Period Six (Part A)||5
7582143|NCT02703350|18663998|P2|COMPLETED|Period Six (Part A)||5
7582144|NCT02703350|18663999|P1|COMPLETED|Period Six (Part A)||5
7582145|NCT02703350|18663992|P8|Received Study Drug|Period Six (Part A)||0
7582146|NCT02703350|18663993|P7|Received Study Drug|Period Six (Part A)||0
7582147|NCT02703350|18663994|P6|Received Study Drug|Period Six (Part A)||5
7582148|NCT02703350|18663995|P5|Received Study Drug|Period Six (Part A)||5
7582149|NCT02703350|18663996|P4|Received Study Drug|Period Six (Part A)||5
7582150|NCT02703350|18663997|P3|Received Study Drug|Period Six (Part A)||5
7582151|NCT02703350|18663998|P2|Received Study Drug|Period Six (Part A)||5
7582152|NCT02703350|18663999|P1|Received Study Drug|Period Six (Part A)||5
7582153|NCT02703350|18663992|P8|STARTED|Period Six (Part A)||0
7582154|NCT02703350|18663993|P7|STARTED|Period Six (Part A)||0
7582155|NCT02703350|18663994|P6|STARTED|Period Six (Part A)||5
7582156|NCT02703350|18663995|P5|STARTED|Period Six (Part A)||5
7582157|NCT02703350|18663996|P4|STARTED|Period Six (Part A)||5
7582158|NCT02703350|18663997|P3|STARTED|Period Six (Part A)||5
7582159|NCT02703350|18663998|P2|STARTED|Period Six (Part A)||5
7582160|NCT02703350|18663999|P1|STARTED|Period Six (Part A)||5
7582161|NCT02703350|18663992|P8|NOT COMPLETED|Period Five (Part A)||0
7582162|NCT02703350|18663993|P7|NOT COMPLETED|Period Five (Part A)||0
7582163|NCT02703350|18663994|P6|NOT COMPLETED|Period Five (Part A)||0
7582164|NCT02703350|18663995|P5|NOT COMPLETED|Period Five (Part A)||0
7582165|NCT02703350|18663996|P4|NOT COMPLETED|Period Five (Part A)||0
7582166|NCT02703350|18663997|P3|NOT COMPLETED|Period Five (Part A)||0
7582167|NCT02703350|18663998|P2|NOT COMPLETED|Period Five (Part A)||0
7582168|NCT02703350|18663999|P1|NOT COMPLETED|Period Five (Part A)||0
7582169|NCT02703350|18663992|P8|COMPLETED|Period Five (Part A)||0
7582170|NCT02703350|18663993|P7|COMPLETED|Period Five (Part A)||0
7582171|NCT02703350|18663994|P6|COMPLETED|Period Five (Part A)||5
7582172|NCT02703350|18663995|P5|COMPLETED|Period Five (Part A)||5
7582173|NCT02703350|18663996|P4|COMPLETED|Period Five (Part A)||5
7582174|NCT02703350|18663997|P3|COMPLETED|Period Five (Part A)||5
7582175|NCT02703350|18663998|P2|COMPLETED|Period Five (Part A)||5
7582176|NCT02703350|18663999|P1|COMPLETED|Period Five (Part A)||5
7582177|NCT02703350|18663992|P8|Received Study Drug|Period Five (Part A)||0
7582178|NCT02703350|18663993|P7|Received Study Drug|Period Five (Part A)||0
7582179|NCT02703350|18663994|P6|Received Study Drug|Period Five (Part A)||5
7582180|NCT02703350|18663995|P5|Received Study Drug|Period Five (Part A)||5
7582181|NCT02703350|18663996|P4|Received Study Drug|Period Five (Part A)||5
7582182|NCT02703350|18663997|P3|Received Study Drug|Period Five (Part A)||5
7582183|NCT02703350|18663998|P2|Received Study Drug|Period Five (Part A)||5
7582184|NCT02703350|18663999|P1|Received Study Drug|Period Five (Part A)||5
7582185|NCT02703350|18663992|P8|STARTED|Period Five (Part A)||0
7582186|NCT02703350|18663993|P7|STARTED|Period Five (Part A)||0
7582187|NCT02703350|18663994|P6|STARTED|Period Five (Part A)||5
7582188|NCT02703350|18663995|P5|STARTED|Period Five (Part A)||5
7582189|NCT02703350|18663996|P4|STARTED|Period Five (Part A)||5
7582190|NCT02703350|18663997|P3|STARTED|Period Five (Part A)||5
7582191|NCT02703350|18663998|P2|STARTED|Period Five (Part A)||5
7582192|NCT02703350|18663999|P1|STARTED|Period Five (Part A)||5
7582193|NCT02703350|18663992|P8|NOT COMPLETED|Period Four (Part A)||0
7582194|NCT02703350|18663993|P7|NOT COMPLETED|Period Four (Part A)||0
7582195|NCT02703350|18663994|P6|NOT COMPLETED|Period Four (Part A)||0
7582196|NCT02703350|18663995|P5|NOT COMPLETED|Period Four (Part A)||0
7582197|NCT02703350|18663996|P4|NOT COMPLETED|Period Four (Part A)||0
7582198|NCT02703350|18663997|P3|NOT COMPLETED|Period Four (Part A)||0
7582199|NCT02703350|18663998|P2|NOT COMPLETED|Period Four (Part A)||0
7582200|NCT02703350|18663999|P1|NOT COMPLETED|Period Four (Part A)||0
7582201|NCT02703350|18663992|P8|COMPLETED|Period Four (Part A)||0
7582202|NCT02703350|18663993|P7|COMPLETED|Period Four (Part A)||0
7582203|NCT02703350|18663994|P6|COMPLETED|Period Four (Part A)||5
7582204|NCT02703350|18663995|P5|COMPLETED|Period Four (Part A)||5
7582205|NCT02703350|18663996|P4|COMPLETED|Period Four (Part A)||5
7582206|NCT02703350|18663997|P3|COMPLETED|Period Four (Part A)||5
7582207|NCT02703350|18663998|P2|COMPLETED|Period Four (Part A)||5
7582208|NCT02703350|18663999|P1|COMPLETED|Period Four (Part A)||5
7582209|NCT02703350|18663992|P8|Received Study Drug|Period Four (Part A)||0
7582210|NCT02703350|18663993|P7|Received Study Drug|Period Four (Part A)||0
7582211|NCT02703350|18663994|P6|Received Study Drug|Period Four (Part A)||5
7582212|NCT02703350|18663995|P5|Received Study Drug|Period Four (Part A)||5
7582213|NCT02703350|18663996|P4|Received Study Drug|Period Four (Part A)||5
7582214|NCT02703350|18663997|P3|Received Study Drug|Period Four (Part A)||5
7582215|NCT02703350|18663998|P2|Received Study Drug|Period Four (Part A)||5
7582216|NCT02703350|18663999|P1|Received Study Drug|Period Four (Part A)||5
7582217|NCT02703350|18663992|P8|STARTED|Period Four (Part A)||0
7582218|NCT02703350|18663993|P7|STARTED|Period Four (Part A)||0
7582219|NCT02703350|18663994|P6|STARTED|Period Four (Part A)||5
7582220|NCT02703350|18663995|P5|STARTED|Period Four (Part A)||5
7582221|NCT02703350|18663996|P4|STARTED|Period Four (Part A)||5
7582222|NCT02703350|18663997|P3|STARTED|Period Four (Part A)||5
7582223|NCT02703350|18663998|P2|STARTED|Period Four (Part A)||5
7582224|NCT02703350|18663999|P1|STARTED|Period Four (Part A)||5
7582225|NCT02703350|18663992|P8|NOT COMPLETED|Period Three (Part A)||0
7582226|NCT02703350|18663993|P7|NOT COMPLETED|Period Three (Part A)||0
7582227|NCT02703350|18663994|P6|NOT COMPLETED|Period Three (Part A)||0
7582228|NCT02703350|18663995|P5|NOT COMPLETED|Period Three (Part A)||0
7582229|NCT02703350|18663996|P4|NOT COMPLETED|Period Three (Part A)||0
7582230|NCT02703350|18663997|P3|NOT COMPLETED|Period Three (Part A)||0
7582231|NCT02703350|18663998|P2|NOT COMPLETED|Period Three (Part A)||0
7582232|NCT02703350|18663999|P1|NOT COMPLETED|Period Three (Part A)||0
7582233|NCT02703350|18663992|P8|COMPLETED|Period Three (Part A)||0
7582234|NCT02703350|18663993|P7|COMPLETED|Period Three (Part A)||0
7582235|NCT02703350|18663994|P6|COMPLETED|Period Three (Part A)||5
7582236|NCT02703350|18663995|P5|COMPLETED|Period Three (Part A)||5
7582237|NCT02703350|18663996|P4|COMPLETED|Period Three (Part A)||5
7582238|NCT02703350|18663997|P3|COMPLETED|Period Three (Part A)||5
7582239|NCT02703350|18663998|P2|COMPLETED|Period Three (Part A)||5
7582240|NCT02703350|18663999|P1|COMPLETED|Period Three (Part A)||5
7582241|NCT02703350|18663992|P8|Received Study Drug|Period Three (Part A)||0
7582242|NCT02703350|18663993|P7|Received Study Drug|Period Three (Part A)||0
7582243|NCT02703350|18663994|P6|Received Study Drug|Period Three (Part A)||5
7582244|NCT02703350|18663995|P5|Received Study Drug|Period Three (Part A)||5
7582245|NCT02703350|18663996|P4|Received Study Drug|Period Three (Part A)||5
7582246|NCT02703350|18663997|P3|Received Study Drug|Period Three (Part A)||5
7582247|NCT02703350|18663998|P2|Received Study Drug|Period Three (Part A)||5
7582248|NCT02703350|18663999|P1|Received Study Drug|Period Three (Part A)||5
7582249|NCT02703350|18663992|P8|STARTED|Period Three (Part A)||0
7582250|NCT02703350|18663993|P7|STARTED|Period Three (Part A)||0
7582251|NCT02703350|18663994|P6|STARTED|Period Three (Part A)||5
7582252|NCT02703350|18663995|P5|STARTED|Period Three (Part A)||5
7582253|NCT02703350|18663996|P4|STARTED|Period Three (Part A)||5
7582254|NCT02703350|18663997|P3|STARTED|Period Three (Part A)||5
7582255|NCT02703350|18663998|P2|STARTED|Period Three (Part A)||5
7582256|NCT02703350|18663999|P1|STARTED|Period Three (Part A)||5
7582257|NCT02703350|18663992|P8|NOT COMPLETED|Period Two (Part A)||0
7582258|NCT02703350|18663993|P7|NOT COMPLETED|Period Two (Part A)||0
7582259|NCT02703350|18663994|P6|NOT COMPLETED|Period Two (Part A)||0
7582260|NCT02703350|18663995|P5|NOT COMPLETED|Period Two (Part A)||0
7582261|NCT02703350|18663996|P4|NOT COMPLETED|Period Two (Part A)||0
7582262|NCT02703350|18663997|P3|NOT COMPLETED|Period Two (Part A)||0
7582263|NCT02703350|18663998|P2|NOT COMPLETED|Period Two (Part A)||0
7582264|NCT02703350|18663999|P1|NOT COMPLETED|Period Two (Part A)||0
7582265|NCT02703350|18663992|P8|COMPLETED|Period Two (Part A)||0
7582266|NCT02703350|18663993|P7|COMPLETED|Period Two (Part A)||0
7582267|NCT02703350|18663994|P6|COMPLETED|Period Two (Part A)||5
7582268|NCT02703350|18663995|P5|COMPLETED|Period Two (Part A)||5
7582269|NCT02703350|18663996|P4|COMPLETED|Period Two (Part A)||5
7582270|NCT02703350|18663997|P3|COMPLETED|Period Two (Part A)||5
7582271|NCT02703350|18663998|P2|COMPLETED|Period Two (Part A)||5
7582272|NCT02703350|18663999|P1|COMPLETED|Period Two (Part A)||5
7582273|NCT02703350|18663992|P8|Received Study Drug|Period Two (Part A)||0
7582274|NCT02703350|18663993|P7|Received Study Drug|Period Two (Part A)||0
7582275|NCT02703350|18663994|P6|Received Study Drug|Period Two (Part A)||5
7582276|NCT02703350|18663995|P5|Received Study Drug|Period Two (Part A)||5
7582277|NCT02703350|18663996|P4|Received Study Drug|Period Two (Part A)||5
7582278|NCT02703350|18663997|P3|Received Study Drug|Period Two (Part A)||5
7582279|NCT02703350|18663998|P2|Received Study Drug|Period Two (Part A)||5
7582280|NCT02703350|18663999|P1|Received Study Drug|Period Two (Part A)||5
7582281|NCT02703350|18663992|P8|STARTED|Period Two (Part A)||0
7582282|NCT02703350|18663993|P7|STARTED|Period Two (Part A)||0
7582283|NCT02703350|18663994|P6|STARTED|Period Two (Part A)||5
7582284|NCT02703350|18663995|P5|STARTED|Period Two (Part A)||5
7582285|NCT02703350|18663996|P4|STARTED|Period Two (Part A)||5
7582286|NCT02703350|18663997|P3|STARTED|Period Two (Part A)||5
7582287|NCT02703350|18663998|P2|STARTED|Period Two (Part A)||5
7582288|NCT02703350|18663999|P1|STARTED|Period Two (Part A)||5
7582289|NCT02703350|18663992|P8|NOT COMPLETED|Period One (Part A)||0
7582290|NCT02703350|18663993|P7|NOT COMPLETED|Period One (Part A)||0
7582291|NCT02703350|18663994|P6|NOT COMPLETED|Period One (Part A)||0
7582292|NCT02703350|18663995|P5|NOT COMPLETED|Period One (Part A)||0
7582293|NCT02703350|18663996|P4|NOT COMPLETED|Period One (Part A)||0
7582294|NCT02703350|18663997|P3|NOT COMPLETED|Period One (Part A)||0
7582295|NCT02703350|18663998|P2|NOT COMPLETED|Period One (Part A)||0
7582296|NCT02703350|18663999|P1|NOT COMPLETED|Period One (Part A)||0
7582297|NCT02703350|18663992|P8|COMPLETED|Period One (Part A)||0
7582298|NCT02703350|18663993|P7|COMPLETED|Period One (Part A)||0
7582299|NCT02703350|18663994|P6|COMPLETED|Period One (Part A)||5
7582300|NCT02703350|18663995|P5|COMPLETED|Period One (Part A)||5
7582301|NCT02703350|18663996|P4|COMPLETED|Period One (Part A)||5
7582302|NCT02703350|18663997|P3|COMPLETED|Period One (Part A)||5
7582303|NCT02703350|18663998|P2|COMPLETED|Period One (Part A)||5
7582304|NCT02703350|18663999|P1|COMPLETED|Period One (Part A)||5
7582305|NCT02703350|18663992|P8|Received Study Drug|Period One (Part A)||0
7582306|NCT02703350|18663993|P7|Received Study Drug|Period One (Part A)||0
7582307|NCT02703350|18663994|P6|Received Study Drug|Period One (Part A)||5
7582308|NCT02703350|18663995|P5|Received Study Drug|Period One (Part A)||5
7582309|NCT02703350|18663996|P4|Received Study Drug|Period One (Part A)||5
7582310|NCT02703350|18663997|P3|Received Study Drug|Period One (Part A)||5
7582311|NCT02703350|18663998|P2|Received Study Drug|Period One (Part A)||5
7582312|NCT02703350|18663999|P1|Received Study Drug|Period One (Part A)||5
7582313|NCT02703350|18663992|P8|STARTED|Period One (Part A)||0
7582314|NCT02703350|18663993|P7|STARTED|Period One (Part A)||0
7582315|NCT02703350|18663994|P6|STARTED|Period One (Part A)||5
7582316|NCT02703350|18663995|P5|STARTED|Period One (Part A)||5
7582317|NCT02703350|18663996|P4|STARTED|Period One (Part A)||5
7582318|NCT02703350|18663997|P3|STARTED|Period One (Part A)||5
7582319|NCT02703350|18663998|P2|STARTED|Period One (Part A)||5
7582320|NCT02703350|18663999|P1|STARTED|Period One (Part A)||5
7582321|NCT02703337|18664019|P8|NOT COMPLETED|Part B||0
7582322|NCT02703337|18664020|P7|NOT COMPLETED|Part B||0
7582323|NCT02703337|18664021|P6|NOT COMPLETED|Part B||0
7582324|NCT02703337|18664022|P5|NOT COMPLETED|Part B||0
7582325|NCT02703337|18664023|P4|NOT COMPLETED|Part B||0
7582326|NCT02703337|18664024|P3|NOT COMPLETED|Part B||0
7582327|NCT02703337|18664025|P2|NOT COMPLETED|Part B||0
7582328|NCT02703337|18664026|P1|NOT COMPLETED|Part B||0
7582329|NCT02703337|18664019|P8|COMPLETED|Part B||14
7582330|NCT02703337|18664020|P7|COMPLETED|Part B||15
7582331|NCT02703337|18664021|P6|COMPLETED|Part B||0
7582332|NCT02703337|18664022|P5|COMPLETED|Part B||0
7582333|NCT02703337|18664023|P4|COMPLETED|Part B||0
7582334|NCT02703337|18664024|P3|COMPLETED|Part B||0
7582335|NCT02703337|18664025|P2|COMPLETED|Part B||0
7582336|NCT02703337|18664026|P1|COMPLETED|Part B||0
7582337|NCT02703337|18664019|P8|Received Study Drug|Part B||14
7582338|NCT02703337|18664020|P7|Received Study Drug|Part B||15
7582339|NCT02703337|18664021|P6|Received Study Drug|Part B||0
7582340|NCT02703337|18664022|P5|Received Study Drug|Part B||0
7582341|NCT02703337|18664023|P4|Received Study Drug|Part B||0
7582342|NCT02703337|18664024|P3|Received Study Drug|Part B||0
7582343|NCT02703337|18664025|P2|Received Study Drug|Part B||0
7582344|NCT02703337|18664026|P1|Received Study Drug|Part B||0
7582345|NCT02703337|18664019|P8|STARTED|Part B||14
7582346|NCT02703337|18664020|P7|STARTED|Part B||15
7582347|NCT02703337|18664021|P6|STARTED|Part B||0
7582348|NCT02703337|18664022|P5|STARTED|Part B||0
7582349|NCT02703337|18664023|P4|STARTED|Part B||0
7582350|NCT02703337|18664024|P3|STARTED|Part B||0
7582351|NCT02703337|18664025|P2|STARTED|Part B||0
7582352|NCT02703337|18664026|P1|STARTED|Part B||0
7582353|NCT02703337|18664019|P8|NOT COMPLETED|Period Six (Part A)||0
7582354|NCT02703337|18664020|P7|NOT COMPLETED|Period Six (Part A)||0
7582355|NCT02703337|18664021|P6|NOT COMPLETED|Period Six (Part A)||0
7582356|NCT02703337|18664022|P5|NOT COMPLETED|Period Six (Part A)||0
7582357|NCT02703337|18664023|P4|NOT COMPLETED|Period Six (Part A)||0
7582358|NCT02703337|18664024|P3|NOT COMPLETED|Period Six (Part A)||0
7582359|NCT02703337|18664025|P2|NOT COMPLETED|Period Six (Part A)||0
7582360|NCT02703337|18664026|P1|NOT COMPLETED|Period Six (Part A)||0
7582361|NCT02703337|18664019|P8|COMPLETED|Period Six (Part A)||0
7582362|NCT02703337|18664020|P7|COMPLETED|Period Six (Part A)||0
7582363|NCT02703337|18664021|P6|COMPLETED|Period Six (Part A)||5
7582364|NCT02703337|18664022|P5|COMPLETED|Period Six (Part A)||4
7582365|NCT02703337|18664023|P4|COMPLETED|Period Six (Part A)||5
7582366|NCT02703337|18664024|P3|COMPLETED|Period Six (Part A)||5
7582367|NCT02703337|18664025|P2|COMPLETED|Period Six (Part A)||5
7582368|NCT02703337|18664026|P1|COMPLETED|Period Six (Part A)||5
7582369|NCT02703337|18664019|P8|Received Study Drug|Period Six (Part A)||0
7582370|NCT02703337|18664020|P7|Received Study Drug|Period Six (Part A)||0
7582371|NCT02703337|18664021|P6|Received Study Drug|Period Six (Part A)||5
7582372|NCT02703337|18664022|P5|Received Study Drug|Period Six (Part A)||4
7582373|NCT02703337|18664023|P4|Received Study Drug|Period Six (Part A)||5
7582374|NCT02703337|18664024|P3|Received Study Drug|Period Six (Part A)||5
7582375|NCT02703337|18664025|P2|Received Study Drug|Period Six (Part A)||5
7582376|NCT02703337|18664026|P1|Received Study Drug|Period Six (Part A)||5
7582377|NCT02703337|18664019|P8|STARTED|Period Six (Part A)||0
7582378|NCT02703337|18664020|P7|STARTED|Period Six (Part A)||0
7582379|NCT02703337|18664021|P6|STARTED|Period Six (Part A)||5
7582380|NCT02703337|18664022|P5|STARTED|Period Six (Part A)||4
7582381|NCT02703337|18664023|P4|STARTED|Period Six (Part A)||5
7582382|NCT02703337|18664024|P3|STARTED|Period Six (Part A)||5
7582383|NCT02703337|18664025|P2|STARTED|Period Six (Part A)||5
7582384|NCT02703337|18664026|P1|STARTED|Period Six (Part A)||5
7582385|NCT02703337|18664019|P8|NOT COMPLETED|Period Five (Part A)||0
7582386|NCT02703337|18664020|P7|NOT COMPLETED|Period Five (Part A)||0
7582387|NCT02703337|18664021|P6|NOT COMPLETED|Period Five (Part A)||0
7582388|NCT02703337|18664022|P5|NOT COMPLETED|Period Five (Part A)||0
7582389|NCT02703337|18664023|P4|NOT COMPLETED|Period Five (Part A)||0
7582390|NCT02703337|18664024|P3|NOT COMPLETED|Period Five (Part A)||0
7582391|NCT02703337|18664025|P2|NOT COMPLETED|Period Five (Part A)||0
7582392|NCT02703337|18664026|P1|NOT COMPLETED|Period Five (Part A)||0
7582393|NCT02703337|18664019|P8|COMPLETED|Period Five (Part A)||0
7582394|NCT02703337|18664020|P7|COMPLETED|Period Five (Part A)||0
7582395|NCT02703337|18664021|P6|COMPLETED|Period Five (Part A)||5
7582396|NCT02703337|18664022|P5|COMPLETED|Period Five (Part A)||4
7582397|NCT02703337|18664023|P4|COMPLETED|Period Five (Part A)||5
7582398|NCT02703337|18664024|P3|COMPLETED|Period Five (Part A)||5
7582399|NCT02703337|18664025|P2|COMPLETED|Period Five (Part A)||5
7582400|NCT02703337|18664026|P1|COMPLETED|Period Five (Part A)||5
7582401|NCT02703337|18664019|P8|Received Study Drug|Period Five (Part A)||0
7582402|NCT02703337|18664020|P7|Received Study Drug|Period Five (Part A)||0
7582403|NCT02703337|18664021|P6|Received Study Drug|Period Five (Part A)||5
7582404|NCT02703337|18664022|P5|Received Study Drug|Period Five (Part A)||4
7582405|NCT02703337|18664023|P4|Received Study Drug|Period Five (Part A)||5
7582406|NCT02703337|18664024|P3|Received Study Drug|Period Five (Part A)||5
7582407|NCT02703337|18664025|P2|Received Study Drug|Period Five (Part A)||5
7582408|NCT02703337|18664026|P1|Received Study Drug|Period Five (Part A)||5
7582409|NCT02703337|18664019|P8|STARTED|Period Five (Part A)||0
7582410|NCT02703337|18664020|P7|STARTED|Period Five (Part A)||0
7582411|NCT02703337|18664021|P6|STARTED|Period Five (Part A)||5
7582412|NCT02703337|18664022|P5|STARTED|Period Five (Part A)||4
7582413|NCT02703337|18664023|P4|STARTED|Period Five (Part A)||5
7582414|NCT02703337|18664024|P3|STARTED|Period Five (Part A)||5
7582415|NCT02703337|18664025|P2|STARTED|Period Five (Part A)||5
7582416|NCT02703337|18664026|P1|STARTED|Period Five (Part A)||5
7582417|NCT02703337|18664019|P8|NOT COMPLETED|Period Four (Part A)||0
7582418|NCT02703337|18664020|P7|NOT COMPLETED|Period Four (Part A)||0
7582419|NCT02703337|18664021|P6|NOT COMPLETED|Period Four (Part A)||0
7582420|NCT02703337|18664022|P5|NOT COMPLETED|Period Four (Part A)||0
7582421|NCT02703337|18664023|P4|NOT COMPLETED|Period Four (Part A)||0
7582422|NCT02703337|18664024|P3|NOT COMPLETED|Period Four (Part A)||0
7582423|NCT02703337|18664025|P2|NOT COMPLETED|Period Four (Part A)||0
7582424|NCT02703337|18664026|P1|NOT COMPLETED|Period Four (Part A)||0
7582425|NCT02703337|18664019|P8|COMPLETED|Period Four (Part A)||0
7582426|NCT02703337|18664020|P7|COMPLETED|Period Four (Part A)||0
7582427|NCT02703337|18664021|P6|COMPLETED|Period Four (Part A)||5
7582428|NCT02703337|18664022|P5|COMPLETED|Period Four (Part A)||4
7582429|NCT02703337|18664023|P4|COMPLETED|Period Four (Part A)||5
7582430|NCT02703337|18664024|P3|COMPLETED|Period Four (Part A)||5
7582431|NCT02703337|18664025|P2|COMPLETED|Period Four (Part A)||5
7582432|NCT02703337|18664026|P1|COMPLETED|Period Four (Part A)||5
7582433|NCT02703337|18664019|P8|Received Study Drug|Period Four (Part A)||0
7582434|NCT02703337|18664020|P7|Received Study Drug|Period Four (Part A)||0
7582435|NCT02703337|18664021|P6|Received Study Drug|Period Four (Part A)||5
7582436|NCT02703337|18664022|P5|Received Study Drug|Period Four (Part A)||4
7582437|NCT02703337|18664023|P4|Received Study Drug|Period Four (Part A)||5
7582438|NCT02703337|18664024|P3|Received Study Drug|Period Four (Part A)||5
7582439|NCT02703337|18664025|P2|Received Study Drug|Period Four (Part A)||5
7582440|NCT02703337|18664026|P1|Received Study Drug|Period Four (Part A)||5
7582441|NCT02703337|18664019|P8|STARTED|Period Four (Part A)||0
7582442|NCT02703337|18664020|P7|STARTED|Period Four (Part A)||0
7582443|NCT02703337|18664021|P6|STARTED|Period Four (Part A)||5
7582444|NCT02703337|18664022|P5|STARTED|Period Four (Part A)||4
7582445|NCT02703337|18664023|P4|STARTED|Period Four (Part A)||5
7582446|NCT02703337|18664024|P3|STARTED|Period Four (Part A)||5
7582447|NCT02703337|18664025|P2|STARTED|Period Four (Part A)||5
7582448|NCT02703337|18664026|P1|STARTED|Period Four (Part A)||5
7582449|NCT02703337|18664019|P8|NOT COMPLETED|Period Three (Part A)||0
7582450|NCT02703337|18664020|P7|NOT COMPLETED|Period Three (Part A)||0
7582451|NCT02703337|18664021|P6|NOT COMPLETED|Period Three (Part A)||0
7582452|NCT02703337|18664022|P5|NOT COMPLETED|Period Three (Part A)||0
7582453|NCT02703337|18664023|P4|NOT COMPLETED|Period Three (Part A)||0
7582454|NCT02703337|18664024|P3|NOT COMPLETED|Period Three (Part A)||0
7582455|NCT02703337|18664025|P2|NOT COMPLETED|Period Three (Part A)||0
7582456|NCT02703337|18664026|P1|NOT COMPLETED|Period Three (Part A)||0
7582457|NCT02703337|18664019|P8|COMPLETED|Period Three (Part A)||0
7582458|NCT02703337|18664020|P7|COMPLETED|Period Three (Part A)||0
7582459|NCT02703337|18664021|P6|COMPLETED|Period Three (Part A)||5
7582460|NCT02703337|18664022|P5|COMPLETED|Period Three (Part A)||4
7582461|NCT02703337|18664023|P4|COMPLETED|Period Three (Part A)||5
7582462|NCT02703337|18664024|P3|COMPLETED|Period Three (Part A)||5
7582463|NCT02703337|18664025|P2|COMPLETED|Period Three (Part A)||5
7582464|NCT02703337|18664026|P1|COMPLETED|Period Three (Part A)||5
7582465|NCT02703337|18664019|P8|Received Study Drug|Period Three (Part A)||0
7582466|NCT02703337|18664020|P7|Received Study Drug|Period Three (Part A)||0
7582467|NCT02703337|18664021|P6|Received Study Drug|Period Three (Part A)||5
7582468|NCT02703337|18664022|P5|Received Study Drug|Period Three (Part A)||4
7582469|NCT02703337|18664023|P4|Received Study Drug|Period Three (Part A)||5
7582470|NCT02703337|18664024|P3|Received Study Drug|Period Three (Part A)||5
7582471|NCT02703337|18664025|P2|Received Study Drug|Period Three (Part A)||5
7582472|NCT02703337|18664026|P1|Received Study Drug|Period Three (Part A)||5
7582473|NCT02703337|18664019|P8|STARTED|Period Three (Part A)||0
7582474|NCT02703337|18664020|P7|STARTED|Period Three (Part A)||0
7582475|NCT02703337|18664021|P6|STARTED|Period Three (Part A)||5
7582476|NCT02703337|18664022|P5|STARTED|Period Three (Part A)||4
7582477|NCT02703337|18664023|P4|STARTED|Period Three (Part A)||5
7582478|NCT02703337|18664024|P3|STARTED|Period Three (Part A)||5
7582479|NCT02703337|18664025|P2|STARTED|Period Three (Part A)||5
7582480|NCT02703337|18664026|P1|STARTED|Period Three (Part A)||5
7582481|NCT02703337|18664019|P8|NOT COMPLETED|Period Two (Part A)||0
7582482|NCT02703337|18664020|P7|NOT COMPLETED|Period Two (Part A)||0
7582483|NCT02703337|18664021|P6|NOT COMPLETED|Period Two (Part A)||0
7582484|NCT02703337|18664022|P5|NOT COMPLETED|Period Two (Part A)||0
7582485|NCT02703337|18664023|P4|NOT COMPLETED|Period Two (Part A)||0
7582486|NCT02703337|18664024|P3|NOT COMPLETED|Period Two (Part A)||0
7582487|NCT02703337|18664025|P2|NOT COMPLETED|Period Two (Part A)||0
7582488|NCT02703337|18664026|P1|NOT COMPLETED|Period Two (Part A)||0
7582489|NCT02703337|18664019|P8|COMPLETED|Period Two (Part A)||0
7582490|NCT02703337|18664020|P7|COMPLETED|Period Two (Part A)||0
7582491|NCT02703337|18664021|P6|COMPLETED|Period Two (Part A)||5
7582492|NCT02703337|18664022|P5|COMPLETED|Period Two (Part A)||4
7582493|NCT02703337|18664023|P4|COMPLETED|Period Two (Part A)||5
7582494|NCT02703337|18664024|P3|COMPLETED|Period Two (Part A)||5
7582495|NCT02703337|18664025|P2|COMPLETED|Period Two (Part A)||5
7582496|NCT02703337|18664026|P1|COMPLETED|Period Two (Part A)||5
7582497|NCT02703337|18664019|P8|Received Study Drug|Period Two (Part A)||0
7582498|NCT02703337|18664020|P7|Received Study Drug|Period Two (Part A)||0
7582499|NCT02703337|18664021|P6|Received Study Drug|Period Two (Part A)||5
7582500|NCT02703337|18664022|P5|Received Study Drug|Period Two (Part A)||4
7582501|NCT02703337|18664023|P4|Received Study Drug|Period Two (Part A)||5
7582502|NCT02703337|18664024|P3|Received Study Drug|Period Two (Part A)||5
7582503|NCT02703337|18664025|P2|Received Study Drug|Period Two (Part A)||5
7582504|NCT02703337|18664026|P1|Received Study Drug|Period Two (Part A)||5
7582505|NCT02703337|18664019|P8|STARTED|Period Two (Part A)||0
7582506|NCT02703337|18664020|P7|STARTED|Period Two (Part A)||0
7582507|NCT02703337|18664021|P6|STARTED|Period Two (Part A)||5
7582508|NCT02703337|18664022|P5|STARTED|Period Two (Part A)||4
7582509|NCT02703337|18664023|P4|STARTED|Period Two (Part A)||5
7582510|NCT02703337|18664024|P3|STARTED|Period Two (Part A)||5
7582511|NCT02703337|18664025|P2|STARTED|Period Two (Part A)||5
7582512|NCT02703337|18664026|P1|STARTED|Period Two (Part A)||5
7582513|NCT02703337|18664019|P8|NOT COMPLETED|Period One (Part A)||0
7582514|NCT02703337|18664020|P7|NOT COMPLETED|Period One (Part A)||0
7582515|NCT02703337|18664021|P6|NOT COMPLETED|Period One (Part A)||0
7582516|NCT02703337|18664022|P5|NOT COMPLETED|Period One (Part A)||1
7582517|NCT02703337|18664023|P4|NOT COMPLETED|Period One (Part A)||0
7582518|NCT02703337|18664024|P3|NOT COMPLETED|Period One (Part A)||0
7582519|NCT02703337|18664025|P2|NOT COMPLETED|Period One (Part A)||0
7582520|NCT02703337|18664026|P1|NOT COMPLETED|Period One (Part A)||0
7582521|NCT02703337|18664019|P8|COMPLETED|Period One (Part A)||0
7582522|NCT02703337|18664020|P7|COMPLETED|Period One (Part A)||0
7582523|NCT02703337|18664021|P6|COMPLETED|Period One (Part A)||5
7582524|NCT02703337|18664022|P5|COMPLETED|Period One (Part A)||4
7582525|NCT02703337|18664023|P4|COMPLETED|Period One (Part A)||5
7582526|NCT02703337|18664024|P3|COMPLETED|Period One (Part A)||5
7582527|NCT02703337|18664025|P2|COMPLETED|Period One (Part A)||5
7582528|NCT02703337|18664026|P1|COMPLETED|Period One (Part A)||5
7582529|NCT02703337|18664019|P8|Received Study Drug|Period One (Part A)||0
7582530|NCT02703337|18664020|P7|Received Study Drug|Period One (Part A)||0
7582531|NCT02703337|18664021|P6|Received Study Drug|Period One (Part A)||5
7582532|NCT02703337|18664022|P5|Received Study Drug|Period One (Part A)||5
7582533|NCT02703337|18664023|P4|Received Study Drug|Period One (Part A)||5
7582534|NCT02703337|18664024|P3|Received Study Drug|Period One (Part A)||5
7582535|NCT02703337|18664025|P2|Received Study Drug|Period One (Part A)||5
7582536|NCT02703337|18664026|P1|Received Study Drug|Period One (Part A)||5
7582537|NCT02703337|18664019|P8|STARTED|Period One (Part A)||0
7582538|NCT02703337|18664020|P7|STARTED|Period One (Part A)||0
7582539|NCT02703337|18664021|P6|STARTED|Period One (Part A)||5
7582540|NCT02703337|18664022|P5|STARTED|Period One (Part A)||5
7582541|NCT02703337|18664023|P4|STARTED|Period One (Part A)||5
7582542|NCT02703337|18664024|P3|STARTED|Period One (Part A)||5
7582543|NCT02703337|18664025|P2|STARTED|Period One (Part A)||5
7582544|NCT02703337|18664026|P1|STARTED|Period One (Part A)||5
7582545|NCT02703324|18664046|P6|NOT COMPLETED|Period Four||0
7582546|NCT02703324|18664047|P5|NOT COMPLETED|Period Four||0
7582547|NCT02703324|18664048|P4|NOT COMPLETED|Period Four||0
7582548|NCT02703324|18664049|P3|NOT COMPLETED|Period Four||0
7582549|NCT02703324|18664050|P2|NOT COMPLETED|Period Four||0
7582550|NCT02703324|18664051|P1|NOT COMPLETED|Period Four||0
7582551|NCT02703324|18664046|P6|COMPLETED|Period Four||5
7582552|NCT02703324|18664047|P5|COMPLETED|Period Four||5
7582553|NCT02703324|18664048|P4|COMPLETED|Period Four||5
7582554|NCT02703324|18664049|P3|COMPLETED|Period Four||4
7582555|NCT02703324|18664050|P2|COMPLETED|Period Four||4
7582556|NCT02703324|18664051|P1|COMPLETED|Period Four||5
7582557|NCT02703324|18664046|P6|Received Study Drug|Period Four||5
7582558|NCT02703324|18664047|P5|Received Study Drug|Period Four||5
7582559|NCT02703324|18664048|P4|Received Study Drug|Period Four||5
7582560|NCT02703324|18664049|P3|Received Study Drug|Period Four||4
7582561|NCT02703324|18664050|P2|Received Study Drug|Period Four||4
7582562|NCT02703324|18664051|P1|Received Study Drug|Period Four||5
7582563|NCT02703324|18664046|P6|STARTED|Period Four||5
7582564|NCT02703324|18664047|P5|STARTED|Period Four||5
7582565|NCT02703324|18664048|P4|STARTED|Period Four||5
7582566|NCT02703324|18664049|P3|STARTED|Period Four||4
7582567|NCT02703324|18664050|P2|STARTED|Period Four|One participant discontinued after Period 3. Did not enter Period 4.|4
7582568|NCT02703324|18664051|P1|STARTED|Period Four||5
7582569|NCT02703324|18664046|P6|NOT COMPLETED|Period Three||0
7582570|NCT02703324|18664047|P5|NOT COMPLETED|Period Three||0
7582571|NCT02703324|18664048|P4|NOT COMPLETED|Period Three||0
7582572|NCT02703324|18664049|P3|NOT COMPLETED|Period Three||0
7582573|NCT02703324|18664050|P2|NOT COMPLETED|Period Three||0
7582574|NCT02703324|18664051|P1|NOT COMPLETED|Period Three||0
7582575|NCT02703324|18664046|P6|COMPLETED|Period Three||5
7582576|NCT02703324|18664047|P5|COMPLETED|Period Three||5
7582577|NCT02703324|18664048|P4|COMPLETED|Period Three||5
7582578|NCT02703324|18664049|P3|COMPLETED|Period Three||4
7582579|NCT02703324|18664050|P2|COMPLETED|Period Three|One participant discontinued after Period 3. Did not enter Period 4.|5
7582580|NCT02703324|18664051|P1|COMPLETED|Period Three||5
7582581|NCT02703324|18664046|P6|Received Study Drug|Period Three||5
7582582|NCT02703324|18664047|P5|Received Study Drug|Period Three||5
7582583|NCT02703324|18664048|P4|Received Study Drug|Period Three||5
7582584|NCT02703324|18664049|P3|Received Study Drug|Period Three||4
7582585|NCT02703324|18664050|P2|Received Study Drug|Period Three||5
7582586|NCT02703324|18664051|P1|Received Study Drug|Period Three||5
7582587|NCT02703324|18664046|P6|STARTED|Period Three||5
7582588|NCT02703324|18664047|P5|STARTED|Period Three||5
7582589|NCT02703324|18664048|P4|STARTED|Period Three||5
7582590|NCT02703324|18664049|P3|STARTED|Period Three||4
7582591|NCT02703324|18664050|P2|STARTED|Period Three||5
7582592|NCT02703324|18664051|P1|STARTED|Period Three||5
7582593|NCT02703324|18664046|P6|NOT COMPLETED|Period Two||0
7582594|NCT02703324|18664047|P5|NOT COMPLETED|Period Two||0
7582595|NCT02703324|18664048|P4|NOT COMPLETED|Period Two||0
7582596|NCT02703324|18664049|P3|NOT COMPLETED|Period Two||1
7582597|NCT02703324|18664050|P2|NOT COMPLETED|Period Two||0
7582598|NCT02703324|18664051|P1|NOT COMPLETED|Period Two||0
7582599|NCT02703324|18664046|P6|COMPLETED|Period Two||5
7582600|NCT02703324|18664047|P5|COMPLETED|Period Two||5
7582601|NCT02703324|18664048|P4|COMPLETED|Period Two||5
7582602|NCT02703324|18664049|P3|COMPLETED|Period Two||4
7582603|NCT02703324|18664050|P2|COMPLETED|Period Two||5
7582604|NCT02703324|18664051|P1|COMPLETED|Period Two||5
7582605|NCT02703324|18664046|P6|Received Study Drug|Period Two||5
7582606|NCT02703324|18664047|P5|Received Study Drug|Period Two||5
7582607|NCT02703324|18664048|P4|Received Study Drug|Period Two||5
7582608|NCT02703324|18664049|P3|Received Study Drug|Period Two||5
7582609|NCT02703324|18664050|P2|Received Study Drug|Period Two||5
7582610|NCT02703324|18664051|P1|Received Study Drug|Period Two||5
7582611|NCT02703324|18664046|P6|STARTED|Period Two||5
7582612|NCT02703324|18664047|P5|STARTED|Period Two||5
7582613|NCT02703324|18664048|P4|STARTED|Period Two||5
7582614|NCT02703324|18664049|P3|STARTED|Period Two||5
7582615|NCT02703324|18664050|P2|STARTED|Period Two||5
7582616|NCT02703324|18664051|P1|STARTED|Period Two||5
7582617|NCT02703324|18664046|P6|NOT COMPLETED|Period One||0
7582618|NCT02703324|18664047|P5|NOT COMPLETED|Period One||0
7582619|NCT02703324|18664048|P4|NOT COMPLETED|Period One||0
7582620|NCT02703324|18664049|P3|NOT COMPLETED|Period One||0
7582621|NCT02703324|18664050|P2|NOT COMPLETED|Period One||0
7582622|NCT02703324|18664051|P1|NOT COMPLETED|Period One||0
7582623|NCT02703324|18664046|P6|COMPLETED|Period One||5
7582624|NCT02703324|18664047|P5|COMPLETED|Period One||5
7582625|NCT02703324|18664048|P4|COMPLETED|Period One||5
7582626|NCT02703324|18664049|P3|COMPLETED|Period One||5
7582627|NCT02703324|18664050|P2|COMPLETED|Period One||5
7582628|NCT02703324|18664051|P1|COMPLETED|Period One||5
7582629|NCT02703324|18664046|P6|Received Study Drug|Period One||5
7582630|NCT02703324|18664047|P5|Received Study Drug|Period One||5
7582631|NCT02703324|18664048|P4|Received Study Drug|Period One||5
7582632|NCT02703324|18664049|P3|Received Study Drug|Period One||5
7582633|NCT02703324|18664050|P2|Received Study Drug|Period One||5
7582634|NCT02703324|18664051|P1|Received Study Drug|Period One||5
7582635|NCT02703324|18664046|P6|STARTED|Period One||5
7582636|NCT02703324|18664047|P5|STARTED|Period One||5
7582637|NCT02703324|18664048|P4|STARTED|Period One||5
7582638|NCT02703324|18664049|P3|STARTED|Period One||5
7582639|NCT02703324|18664050|P2|STARTED|Period One||5
7582640|NCT02703324|18664051|P1|STARTED|Period One||5
7582641|NCT02703311|18664060|P1|NOT COMPLETED|Overall Study||8
7582642|NCT02703311|18664060|P1|COMPLETED|Overall Study||3
7582643|NCT02703311|18664060|P1|30 Day Follow-Up Completed|Overall Study||9
7582644|NCT02703311|18664060|P1|Implanted|Overall Study||11
7582645|NCT02703311|18664060|P1|STARTED|Overall Study||11
7582646|NCT02703259|18664078|P2|NOT COMPLETED|2 Weeks Postoperative Assessment||10
7582647|NCT02703259|18664079|P1|NOT COMPLETED|2 Weeks Postoperative Assessment||10
7582648|NCT02703259|18664078|P2|COMPLETED|2 Weeks Postoperative Assessment||51
7582649|NCT02703259|18664079|P1|COMPLETED|2 Weeks Postoperative Assessment||58
7582650|NCT02703259|18664078|P2|STARTED|2 Weeks Postoperative Assessment||61
7582651|NCT02703259|18664079|P1|STARTED|2 Weeks Postoperative Assessment||68
7582652|NCT02703259|18664078|P2|NOT COMPLETED|24 Hours Postoperative Assessment||6
7582653|NCT02703259|18664079|P1|NOT COMPLETED|24 Hours Postoperative Assessment||2
7582654|NCT02703259|18664078|P2|COMPLETED|24 Hours Postoperative Assessment||61
7582655|NCT02703259|18664079|P1|COMPLETED|24 Hours Postoperative Assessment||68
7582656|NCT02703259|18664078|P2|STARTED|24 Hours Postoperative Assessment||67
7582657|NCT02703259|18664079|P1|STARTED|24 Hours Postoperative Assessment||70
7582658|NCT02702999|18664097|P2|NOT COMPLETED|Overall Study||0
7582659|NCT02702999|18664098|P1|NOT COMPLETED|Overall Study||0
7582660|NCT02702999|18664097|P2|COMPLETED|Overall Study||104
7582661|NCT02702999|18664098|P1|COMPLETED|Overall Study||102
7582662|NCT02702999|18664097|P2|STARTED|Overall Study||104
7582663|NCT02702999|18664098|P1|STARTED|Overall Study||102
7582664|NCT02702921|18664116|P2|NOT COMPLETED|Overall Study||8
7582665|NCT02702921|18664117|P1|NOT COMPLETED|Overall Study||14
7582666|NCT02702921|18664116|P2|COMPLETED|Overall Study||95
7582667|NCT02702921|18664117|P1|COMPLETED|Overall Study||84
7582668|NCT02702921|18664116|P2|STARTED|Overall Study||103
7582669|NCT02702921|18664117|P1|STARTED|Overall Study||98
7582670|NCT02702609|18664127|P2|NOT COMPLETED|Overall Study||4
7582671|NCT02702609|18664128|P1|NOT COMPLETED|Overall Study||9
7582672|NCT02702609|18664127|P2|COMPLETED|Overall Study||17
7582673|NCT02702609|18664128|P1|COMPLETED|Overall Study||15
7582674|NCT02702609|18664127|P2|Crown Delivery|Overall Study||18
7582675|NCT02702609|18664128|P1|Crown Delivery|Overall Study||16
7582676|NCT02702609|18664127|P2|Implant Placement|Overall Study||21
7582677|NCT02702609|18664128|P1|Implant Placement|Overall Study||23
7582678|NCT02702609|18664127|P2|STARTED|Overall Study||21
7582679|NCT02702609|18664128|P1|STARTED|Overall Study||24
7582680|NCT02702401|18664146|P2|NOT COMPLETED|Overall Study||135
7582681|NCT02702401|18664147|P1|NOT COMPLETED|Overall Study||278
7582682|NCT02702401|18664146|P2|COMPLETED|Overall Study||0
7582683|NCT02702401|18664147|P1|COMPLETED|Overall Study||0
7582684|NCT02702401|18664146|P2|Treated|Overall Study||135
7582685|NCT02702401|18664147|P1|Treated|Overall Study||278
7582686|NCT02702401|18664146|P2|STARTED|Overall Study||135
7582687|NCT02702401|18664147|P1|STARTED|Overall Study||278
7582688|NCT02702193|18664169|P2|NOT COMPLETED|12 Month Follow up||18
7582689|NCT02702193|18664170|P1|NOT COMPLETED|12 Month Follow up||17
7582690|NCT02702193|18664169|P2|COMPLETED|12 Month Follow up||69
7582691|NCT02702193|18664170|P1|COMPLETED|12 Month Follow up||69
7582692|NCT02702193|18664169|P2|STARTED|12 Month Follow up||87
7582693|NCT02702193|18664170|P1|STARTED|12 Month Follow up||86
7582694|NCT02702193|18664169|P2|NOT COMPLETED|8 Month Follow up||18
7582695|NCT02702193|18664170|P1|NOT COMPLETED|8 Month Follow up||15
7582696|NCT02702193|18664169|P2|COMPLETED|8 Month Follow up||69
7582697|NCT02702193|18664170|P1|COMPLETED|8 Month Follow up||71
7582698|NCT02702193|18664169|P2|STARTED|8 Month Follow up||87
7582699|NCT02702193|18664170|P1|STARTED|8 Month Follow up||86
7582700|NCT02702193|18664169|P2|NOT COMPLETED|4 Month Follow up||18
7582701|NCT02702193|18664170|P1|NOT COMPLETED|4 Month Follow up||18
7582702|NCT02702193|18664169|P2|COMPLETED|4 Month Follow up||69
7582703|NCT02702193|18664170|P1|COMPLETED|4 Month Follow up||68
7582704|NCT02702193|18664169|P2|STARTED|4 Month Follow up||87
7582705|NCT02702193|18664170|P1|STARTED|4 Month Follow up||86
7582706|NCT02702193|18664169|P2|NOT COMPLETED|Baseline Assessment/Randomization||0
7582707|NCT02702193|18664170|P1|NOT COMPLETED|Baseline Assessment/Randomization||1
7582708|NCT02702193|18664169|P2|COMPLETED|Baseline Assessment/Randomization||87
7582709|NCT02702193|18664170|P1|COMPLETED|Baseline Assessment/Randomization||85
7582710|NCT02702193|18664169|P2|STARTED|Baseline Assessment/Randomization||87
7582711|NCT02702193|18664170|P1|STARTED|Baseline Assessment/Randomization||86
7582712|NCT02702011|18664198|P4|NOT COMPLETED|Overall Study||0
7582713|NCT02702011|18664199|P3|NOT COMPLETED|Overall Study||0
7582714|NCT02702011|18664200|P2|NOT COMPLETED|Overall Study||1
7582715|NCT02702011|18664201|P1|NOT COMPLETED|Overall Study||0
7582716|NCT02702011|18664198|P4|COMPLETED|Overall Study||12
7582717|NCT02702011|18664199|P3|COMPLETED|Overall Study||12
7582718|NCT02702011|18664200|P2|COMPLETED|Overall Study||12
7582719|NCT02702011|18664201|P1|COMPLETED|Overall Study||11
7582720|NCT02702011|18664198|P4|STARTED|Overall Study|Started are the treated patients.|12
7582721|NCT02702011|18664199|P3|STARTED|Overall Study|Started are the treated patients.|12
7582722|NCT02702011|18664200|P2|STARTED|Overall Study|Started are the treated patients.|13
7582723|NCT02702011|18664201|P1|STARTED|Overall Study|Started are the treated patients.|11
7582724|NCT02701985|18664213|P2|NOT COMPLETED|Overall Study||6
7582725|NCT02701985|18664214|P1|NOT COMPLETED|Overall Study||3
7582726|NCT02701985|18664213|P2|COMPLETED|Overall Study||32
7582727|NCT02701985|18664214|P1|COMPLETED|Overall Study||34
7582728|NCT02701985|18664213|P2|STARTED|Overall Study||38
7582729|NCT02701985|18664214|P1|STARTED|Overall Study||37
7582730|NCT02701764|18664257|P2|NOT COMPLETED|Overall Study||1
7582731|NCT02701764|18664258|P1|NOT COMPLETED|Overall Study||0
7582732|NCT02701764|18664257|P2|COMPLETED|Overall Study||21
7582733|NCT02701764|18664258|P1|COMPLETED|Overall Study||21
7582734|NCT02701764|18664257|P2|STARTED|Overall Study||22
7582735|NCT02701764|18664258|P1|STARTED|Overall Study||21
7582736|NCT02701647|18664281|P3|NOT COMPLETED|Overall Study||1
7582737|NCT02701647|18664282|P2|NOT COMPLETED|Overall Study||0
7582738|NCT02701647|18664283|P1|NOT COMPLETED|Overall Study||0
7582739|NCT02701647|18664281|P3|COMPLETED|Overall Study|One participant from sham-TT withdraw due a back injury unrelated to study.|16
7582740|NCT02701647|18664282|P2|COMPLETED|Overall Study||17
7582741|NCT02701647|18664283|P1|COMPLETED|Overall Study||17
7582742|NCT02701647|18664281|P3|STARTED|Overall Study||17
7582743|NCT02701647|18664282|P2|STARTED|Overall Study||17
7582744|NCT02701647|18664283|P1|STARTED|Overall Study||17
7582745|NCT02701634|18664317|P2|NOT COMPLETED|Overall Study||31
7582746|NCT02701634|18664318|P1|NOT COMPLETED|Overall Study||32
7582747|NCT02701634|18664317|P2|COMPLETED|Overall Study||2
7582748|NCT02701634|18664318|P1|COMPLETED|Overall Study||1
7582749|NCT02701634|18664317|P2|STARTED|Overall Study||33
7582750|NCT02701634|18664318|P1|STARTED|Overall Study||33
7582751|NCT02701582|18664348|P2|NOT COMPLETED|Overall Study||0
7582752|NCT02701582|18664349|P1|NOT COMPLETED|Overall Study||2
7582753|NCT02701582|18664348|P2|COMPLETED|Overall Study||33
7582754|NCT02701582|18664349|P1|COMPLETED|Overall Study||33
7582755|NCT02701582|18664348|P2|STARTED|Overall Study||33
7582756|NCT02701582|18664349|P1|STARTED|Overall Study||35
7582757|NCT02701556|18664373|P2|NOT COMPLETED|Overall Study||20
7582758|NCT02701556|18664374|P1|NOT COMPLETED|Overall Study||23
7582759|NCT02701556|18664373|P2|COMPLETED|Overall Study||178
7582760|NCT02701556|18664374|P1|COMPLETED|Overall Study||175
7582761|NCT02701556|18664373|P2|STARTED|Overall Study||198
7582762|NCT02701556|18664374|P1|STARTED|Overall Study||198
7582763|NCT02701387|18664380|P1|NOT COMPLETED|Overall Study||0
7582764|NCT02701387|18664380|P1|COMPLETED|Overall Study||7
7582765|NCT02701387|18664380|P1|STARTED|Overall Study||7
7582766|NCT02701361|18664388|P3|NOT COMPLETED|Overall Study||2
7582767|NCT02701361|18664389|P2|NOT COMPLETED|Overall Study||3
7582768|NCT02701361|18664390|P1|NOT COMPLETED|Overall Study||9
7582769|NCT02701361|18664388|P3|COMPLETED|Overall Study||16
7582770|NCT02701361|18664389|P2|COMPLETED|Overall Study||28
7582771|NCT02701361|18664390|P1|COMPLETED|Overall Study||22
7582772|NCT02701361|18664388|P3|STARTED|Overall Study||18
7582773|NCT02701361|18664389|P2|STARTED|Overall Study||31
7582774|NCT02701361|18664390|P1|STARTED|Overall Study||31
7582775|NCT02701296|18664431|P2|NOT COMPLETED|Overall Study||2
7582776|NCT02701296|18664432|P1|NOT COMPLETED|Overall Study||0
7582860|NCT02700984|18664691|P1|NOT COMPLETED|Overall Study||15
7582777|NCT02701296|18664431|P2|COMPLETED|Overall Study|Data was incomplete for two participants their data was not included in the overall data analysis.|36
7582778|NCT02701296|18664432|P1|COMPLETED|Overall Study||42
7582779|NCT02701296|18664431|P2|STARTED|Overall Study||38
7582780|NCT02701296|18664432|P1|STARTED|Overall Study||42
7582781|NCT02701270|18664448|P4|NOT COMPLETED|Fourth Intervention at Visit 4||0
7582782|NCT02701270|18664449|P3|NOT COMPLETED|Fourth Intervention at Visit 4||0
7582783|NCT02701270|18664450|P2|NOT COMPLETED|Fourth Intervention at Visit 4||0
7582784|NCT02701270|18664451|P1|NOT COMPLETED|Fourth Intervention at Visit 4||0
7582785|NCT02701270|18664448|P4|COMPLETED|Fourth Intervention at Visit 4||3
7582786|NCT02701270|18664449|P3|COMPLETED|Fourth Intervention at Visit 4||3
7582787|NCT02701270|18664450|P2|COMPLETED|Fourth Intervention at Visit 4||3
7582788|NCT02701270|18664451|P1|COMPLETED|Fourth Intervention at Visit 4||2
7582789|NCT02701270|18664448|P4|STARTED|Fourth Intervention at Visit 4||3
7582790|NCT02701270|18664449|P3|STARTED|Fourth Intervention at Visit 4||3
7582791|NCT02701270|18664450|P2|STARTED|Fourth Intervention at Visit 4||3
7582792|NCT02701270|18664451|P1|STARTED|Fourth Intervention at Visit 4||2
7582793|NCT02701270|18664448|P4|NOT COMPLETED|Third Intervention at Visit 3||0
7582794|NCT02701270|18664449|P3|NOT COMPLETED|Third Intervention at Visit 3||0
7582795|NCT02701270|18664450|P2|NOT COMPLETED|Third Intervention at Visit 3||0
7582796|NCT02701270|18664451|P1|NOT COMPLETED|Third Intervention at Visit 3||0
7582797|NCT02701270|18664448|P4|COMPLETED|Third Intervention at Visit 3||3
7582798|NCT02701270|18664449|P3|COMPLETED|Third Intervention at Visit 3||3
7582799|NCT02701270|18664450|P2|COMPLETED|Third Intervention at Visit 3||3
7582800|NCT02701270|18664451|P1|COMPLETED|Third Intervention at Visit 3||2
7582801|NCT02701270|18664448|P4|STARTED|Third Intervention at Visit 3||3
7582802|NCT02701270|18664449|P3|STARTED|Third Intervention at Visit 3||3
7582803|NCT02701270|18664450|P2|STARTED|Third Intervention at Visit 3||3
7582804|NCT02701270|18664451|P1|STARTED|Third Intervention at Visit 3||2
7582805|NCT02701270|18664448|P4|NOT COMPLETED|Second Intervention at Visit 2||0
7582806|NCT02701270|18664449|P3|NOT COMPLETED|Second Intervention at Visit 2||0
7582807|NCT02701270|18664450|P2|NOT COMPLETED|Second Intervention at Visit 2||0
7582808|NCT02701270|18664451|P1|NOT COMPLETED|Second Intervention at Visit 2||0
7582809|NCT02701270|18664448|P4|COMPLETED|Second Intervention at Visit 2||3
7582810|NCT02701270|18664449|P3|COMPLETED|Second Intervention at Visit 2||3
7582811|NCT02701270|18664450|P2|COMPLETED|Second Intervention at Visit 2||3
7582812|NCT02701270|18664451|P1|COMPLETED|Second Intervention at Visit 2||2
7582813|NCT02701270|18664448|P4|STARTED|Second Intervention at Visit 2||3
7582814|NCT02701270|18664449|P3|STARTED|Second Intervention at Visit 2||3
7582815|NCT02701270|18664450|P2|STARTED|Second Intervention at Visit 2||3
7582816|NCT02701270|18664451|P1|STARTED|Second Intervention at Visit 2||2
7582817|NCT02701270|18664448|P4|NOT COMPLETED|First Intervention at Visit 1||0
7582818|NCT02701270|18664449|P3|NOT COMPLETED|First Intervention at Visit 1||0
7582819|NCT02701270|18664450|P2|NOT COMPLETED|First Intervention at Visit 1||0
7582820|NCT02701270|18664451|P1|NOT COMPLETED|First Intervention at Visit 1||0
7582821|NCT02701270|18664448|P4|COMPLETED|First Intervention at Visit 1||3
7582822|NCT02701270|18664449|P3|COMPLETED|First Intervention at Visit 1||3
7582823|NCT02701270|18664450|P2|COMPLETED|First Intervention at Visit 1||3
7582824|NCT02701270|18664451|P1|COMPLETED|First Intervention at Visit 1||2
7582825|NCT02701270|18664448|P4|STARTED|First Intervention at Visit 1||3
7582826|NCT02701270|18664449|P3|STARTED|First Intervention at Visit 1||3
7582827|NCT02701270|18664450|P2|STARTED|First Intervention at Visit 1||3
7582828|NCT02701270|18664451|P1|STARTED|First Intervention at Visit 1||2
7582829|NCT02701257|18664470|P5|NOT COMPLETED|Overall Study||3
7582830|NCT02701257|18664471|P4|NOT COMPLETED|Overall Study||1
7582831|NCT02701257|18664472|P3|NOT COMPLETED|Overall Study||0
7582832|NCT02701257|18664473|P2|NOT COMPLETED|Overall Study||3
7582833|NCT02701257|18664474|P1|NOT COMPLETED|Overall Study||0
7582834|NCT02701257|18664470|P5|COMPLETED|Overall Study||1
7582835|NCT02701257|18664471|P4|COMPLETED|Overall Study||3
7582836|NCT02701257|18664472|P3|COMPLETED|Overall Study||0
7582837|NCT02701257|18664473|P2|COMPLETED|Overall Study||3
7582838|NCT02701257|18664474|P1|COMPLETED|Overall Study||6
7582839|NCT02701257|18664470|P5|STARTED|Overall Study||4
7582840|NCT02701257|18664471|P4|STARTED|Overall Study||4
7582841|NCT02701257|18664472|P3|STARTED|Overall Study||0
7582842|NCT02701257|18664473|P2|STARTED|Overall Study||6
7582843|NCT02701257|18664474|P1|STARTED|Overall Study||6
7582844|NCT02701101|18664661|P1|NOT COMPLETED|Overall Study||0
7582845|NCT02701101|18664661|P1|COMPLETED|Overall Study||189
7582846|NCT02701101|18664661|P1|STARTED|Overall Study||189
7582847|NCT02701049|18664670|P3|NOT COMPLETED|Overall Study||0
7582848|NCT02701049|18664671|P2|NOT COMPLETED|Overall Study||0
7582849|NCT02701049|18664672|P1|NOT COMPLETED|Overall Study||0
7582850|NCT02701049|18664670|P3|COMPLETED|Overall Study|Total patients included in analysis|198
7582851|NCT02701049|18664671|P2|COMPLETED|Overall Study|Total patients included in analysis|342
7582852|NCT02701049|18664672|P1|COMPLETED|Overall Study|Total patients included in analysis|209
7582853|NCT02701049|18664670|P3|STARTED|Overall Study|Patients who completed a follow-up survey|198
7582854|NCT02701049|18664671|P2|STARTED|Overall Study|Patients who completed a follow-up survey|342
7582855|NCT02701049|18664672|P1|STARTED|Overall Study|Patients who completed a follow-up survey|209
7582856|NCT02700997|18664684|P1|NOT COMPLETED|Overall Study||2
7582857|NCT02700997|18664684|P1|COMPLETED|Overall Study||15
7582858|NCT02700997|18664684|P1|STARTED|Overall Study||17
7582859|NCT02700984|18664690|P2|NOT COMPLETED|Overall Study||14
7582861|NCT02700984|18664690|P2|COMPLETED|Overall Study||53
7582862|NCT02700984|18664691|P1|COMPLETED|Overall Study||200
7582863|NCT02700984|18664690|P2|STARTED|Overall Study||67
7582864|NCT02700984|18664691|P1|STARTED|Overall Study||215
7582865|NCT02700919|18664743|P3|NOT COMPLETED|Overall Study||4
7582866|NCT02700919|18664744|P2|NOT COMPLETED|Overall Study||12
7582867|NCT02700919|18664745|P1|NOT COMPLETED|Overall Study||12
7582868|NCT02700919|18664743|P3|COMPLETED|Overall Study||87
7582869|NCT02700919|18664744|P2|COMPLETED|Overall Study||85
7582870|NCT02700919|18664745|P1|COMPLETED|Overall Study||82
7582871|NCT02700919|18664743|P3|STARTED|Overall Study||91
7582872|NCT02700919|18664744|P2|STARTED|Overall Study||97
7582873|NCT02700919|18664745|P1|STARTED|Overall Study||94
7582874|NCT02700815|18664807|P4|NOT COMPLETED|Overall Study||7
7582875|NCT02700815|18664808|P3|NOT COMPLETED|Overall Study||4
7582876|NCT02700815|18664809|P2|NOT COMPLETED|Overall Study||7
7582877|NCT02700815|18664810|P1|NOT COMPLETED|Overall Study||1
7582878|NCT02700815|18664807|P4|COMPLETED|Overall Study||218
7582879|NCT02700815|18664808|P3|COMPLETED|Overall Study||219
7582880|NCT02700815|18664809|P2|COMPLETED|Overall Study||216
7582881|NCT02700815|18664810|P1|COMPLETED|Overall Study||74
7582882|NCT02700815|18664807|P4|STARTED|Overall Study||225
7582883|NCT02700815|18664808|P3|STARTED|Overall Study||223
7582884|NCT02700815|18664809|P2|STARTED|Overall Study||223
7582885|NCT02700815|18664810|P1|STARTED|Overall Study||75
7582886|NCT02700412|18664848|P1|NOT COMPLETED|Overall Study||33
7582887|NCT02700412|18664848|P1|COMPLETED|Overall Study||47
7582888|NCT02700412|18664848|P1|STARTED|Overall Study||80
7582889|NCT02700334|18664858|P2|NOT COMPLETED|Overall Study||0
7582890|NCT02700334|18664859|P1|NOT COMPLETED|Overall Study||0
7582891|NCT02700334|18664858|P2|COMPLETED|Overall Study||12
7582892|NCT02700334|18664859|P1|COMPLETED|Overall Study||12
7582893|NCT02700334|18664858|P2|STARTED|Overall Study||12
7582894|NCT02700334|18664859|P1|STARTED|Overall Study||12
7582895|NCT02699996|18664899|P2|NOT COMPLETED|Overall Study||2
7582896|NCT02699996|18664900|P1|NOT COMPLETED|Overall Study||5
7582897|NCT02699996|18664899|P2|COMPLETED|Overall Study||9
7582898|NCT02699996|18664900|P1|COMPLETED|Overall Study||15
7582899|NCT02699996|18664899|P2|STARTED|Overall Study||11
7582900|NCT02699996|18664900|P1|STARTED|Overall Study||20
7582901|NCT02699983|18664918|P2|NOT COMPLETED|Overall Study||0
7582902|NCT02699983|18664919|P1|NOT COMPLETED|Overall Study||1
7582903|NCT02699983|18664918|P2|COMPLETED|Overall Study||17
7582904|NCT02699983|18664919|P1|COMPLETED|Overall Study||17
7582905|NCT02699983|18664918|P2|STARTED|Overall Study||17
7582906|NCT02699983|18664919|P1|STARTED|Overall Study||18
7582907|NCT02699970|18664979|P1|NOT COMPLETED|Overall Study||0
7582908|NCT02699970|18664979|P1|COMPLETED|Overall Study||399
7582909|NCT02699970|18664979|P1|Inter-system|Overall Study||399
7582910|NCT02699970|18664979|P1|Intra-system|Overall Study||399
7582911|NCT02699970|18664979|P1|STARTED|Overall Study||399
7582912|NCT02699892|18664984|P1|NOT COMPLETED|Overall Study||36
7582913|NCT02699892|18664984|P1|COMPLETED|Overall Study||94
7582914|NCT02699892|18664984|P1|STARTED|Overall Study||130
7582915|NCT02699866|18664989|P1|NOT COMPLETED|Overall Study||8
7582916|NCT02699866|18664989|P1|COMPLETED|Overall Study|Last study centre close-out.|38
7582917|NCT02699866|18664989|P1|Included|Overall Study||41
7582918|NCT02699866|18664989|P1|STARTED|Overall Study|First study centre initiation.|46
7582919|NCT02699684|18664997|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
7582920|NCT02699684|18664998|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
7582921|NCT02699684|18664997|P2|COMPLETED|Period 2, Second 30 Days of Wear||38
7582922|NCT02699684|18664998|P1|COMPLETED|Period 2, Second 30 Days of Wear||36
7582923|NCT02699684|18664997|P2|STARTED|Period 2, Second 30 Days of Wear||38
7582924|NCT02699684|18664998|P1|STARTED|Period 2, Second 30 Days of Wear||37
7582925|NCT02699684|18664997|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||0
7582926|NCT02699684|18664998|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
7582927|NCT02699684|18664997|P2|COMPLETED|Period 1, First 30 Days of Wear||38
7582928|NCT02699684|18664998|P1|COMPLETED|Period 1, First 30 Days of Wear||37
7582929|NCT02699684|18664997|P2|STARTED|Period 1, First 30 Days of Wear||38
7582930|NCT02699684|18664998|P1|STARTED|Period 1, First 30 Days of Wear||37
7582931|NCT02699632|18665008|P1|NOT COMPLETED|Overall Study||2
7582932|NCT02699632|18665008|P1|COMPLETED|Overall Study||358
7582933|NCT02699632|18665008|P1|STARTED|Overall Study||360
7582934|NCT02699593|18665015|P2|NOT COMPLETED|Period 2||2
7582935|NCT02699593|18665016|P1|NOT COMPLETED|Period 2||2
7582936|NCT02699593|18665015|P2|COMPLETED|Period 2||60
7582937|NCT02699593|18665016|P1|COMPLETED|Period 2||65
7582938|NCT02699593|18665015|P2|STARTED|Period 2||62
7582939|NCT02699593|18665016|P1|STARTED|Period 2||67
7582940|NCT02699593|18665015|P2|NOT COMPLETED|Period 1||7
7582941|NCT02699593|18665016|P1|NOT COMPLETED|Period 1||5
7582942|NCT02699593|18665015|P2|COMPLETED|Period 1||62
7582943|NCT02699593|18665016|P1|COMPLETED|Period 1||67
7582944|NCT02699593|18665015|P2|STARTED|Period 1||69
7582945|NCT02699593|18665016|P1|STARTED|Period 1||72
7582946|NCT02699450|18665027|P3|NOT COMPLETED|Overall Study||15
7582947|NCT02699450|18665028|P2|NOT COMPLETED|Overall Study||5
7582948|NCT02699450|18665029|P1|NOT COMPLETED|Overall Study||15
7582949|NCT02699450|18665027|P3|COMPLETED|Overall Study||67
7582950|NCT02699450|18665028|P2|COMPLETED|Overall Study||50
7582951|NCT02699450|18665029|P1|COMPLETED|Overall Study||75
7582952|NCT02699450|18665027|P3|Completed up to Week 24|Overall Study||73
7582953|NCT02699450|18665028|P2|Completed up to Week 24|Overall Study||53
7582954|NCT02699450|18665029|P1|Completed up to Week 24|Overall Study||81
7582955|NCT02699450|18665027|P3|Received at Least One Dose of Study Drug|Overall Study||80
7582956|NCT02699450|18665028|P2|Received at Least One Dose of Study Drug|Overall Study||55
7582957|NCT02699450|18665029|P1|Received at Least One Dose of Study Drug|Overall Study||89
7582958|NCT02699450|18665027|P3|STARTED|Overall Study||82
7582959|NCT02699450|18665028|P2|STARTED|Overall Study||55
7582960|NCT02699450|18665029|P1|STARTED|Overall Study||90
7582961|NCT02699125|18665164|P2|NOT COMPLETED|Second Intervention (6 Weeks).||2
7582962|NCT02699125|18665165|P1|NOT COMPLETED|Second Intervention (6 Weeks).||7
7582963|NCT02699125|18665164|P2|COMPLETED|Second Intervention (6 Weeks).||14
7582964|NCT02699125|18665165|P1|COMPLETED|Second Intervention (6 Weeks).||11
7582965|NCT02699125|18665164|P2|STARTED|Second Intervention (6 Weeks).||16
7582966|NCT02699125|18665165|P1|STARTED|Second Intervention (6 Weeks).||18
7582967|NCT02699125|18665164|P2|NOT COMPLETED|First Intervention (6 Weeks).||0
7582968|NCT02699125|18665165|P1|NOT COMPLETED|First Intervention (6 Weeks).||0
7582969|NCT02699125|18665164|P2|COMPLETED|First Intervention (6 Weeks).||16
7582970|NCT02699125|18665165|P1|COMPLETED|First Intervention (6 Weeks).||18
7582971|NCT02699125|18665164|P2|STARTED|First Intervention (6 Weeks).||16
7582972|NCT02699125|18665165|P1|STARTED|First Intervention (6 Weeks).||18
7582973|NCT02699125|18665164|P2|NOT COMPLETED|Placebo||4
7582974|NCT02699125|18665165|P1|NOT COMPLETED|Placebo||3
7582975|NCT02699125|18665164|P2|COMPLETED|Placebo||16
7582976|NCT02699125|18665165|P1|COMPLETED|Placebo||18
7582977|NCT02699125|18665164|P2|STARTED|Placebo||20
7582978|NCT02699125|18665165|P1|STARTED|Placebo||21
7582979|NCT02699099|18665179|P3|NOT COMPLETED|Overall Study||3
7582980|NCT02699099|18665180|P2|NOT COMPLETED|Overall Study||2
7582981|NCT02699099|18665181|P1|NOT COMPLETED|Overall Study||7
7582982|NCT02699099|18665179|P3|COMPLETED|Overall Study||229
7582983|NCT02699099|18665180|P2|COMPLETED|Overall Study||234
7582984|NCT02699099|18665181|P1|COMPLETED|Overall Study||224
7582985|NCT02699099|18665179|P3|STARTED|Overall Study||232
7582986|NCT02699099|18665180|P2|STARTED|Overall Study||236
7582987|NCT02699099|18665181|P1|STARTED|Overall Study||231
7582988|NCT02698865|18665257|P2|NOT COMPLETED|Overall Study||33
7582989|NCT02698865|18665258|P1|NOT COMPLETED|Overall Study||35
7582990|NCT02698865|18665257|P2|COMPLETED|Overall Study||47
7582991|NCT02698865|18665258|P1|COMPLETED|Overall Study||105
7582992|NCT02698865|18665257|P2|Treated|Overall Study||80
7582993|NCT02698865|18665258|P1|Treated|Overall Study||140
7582994|NCT02698865|18665257|P2|STARTED|Overall Study||80
7582995|NCT02698865|18665258|P1|STARTED|Overall Study||140
7582996|NCT02698800|18665266|P2|NOT COMPLETED|Overall Study||0
7582997|NCT02698800|18665267|P1|NOT COMPLETED|Overall Study||1
7582998|NCT02698800|18665266|P2|COMPLETED|Overall Study||8
7582999|NCT02698800|18665267|P1|COMPLETED|Overall Study||6
7583000|NCT02698800|18665266|P2|STARTED|Overall Study||8
7583001|NCT02698800|18665267|P1|STARTED|Overall Study||7
7583002|NCT02698735|18665275|P1|NOT COMPLETED|Overall Study||0
7583003|NCT02698735|18665275|P1|COMPLETED|Overall Study|There are only 18 out of 20 samples because one patient declined intradermal injection intervention.|5
7583004|NCT02698735|18665275|P1|STARTED|Overall Study||5
7583005|NCT02698566|18665289|P2|NOT COMPLETED|Overall Study||0
7583006|NCT02698566|18665290|P1|NOT COMPLETED|Overall Study||0
7583007|NCT02698566|18665289|P2|COMPLETED|Overall Study||3
7583008|NCT02698566|18665290|P1|COMPLETED|Overall Study||35
7583009|NCT02698566|18665289|P2|STARTED|Overall Study||3
7583010|NCT02698566|18665290|P1|STARTED|Overall Study||35
7583011|NCT02698475|18665296|P1|NOT COMPLETED|Overall Study||5
7583012|NCT02698475|18665296|P1|COMPLETED|Overall Study||39
7583013|NCT02698475|18665296|P1|Ongoing|Overall Study||28
7583014|NCT02698475|18665296|P1|STARTED|Overall Study||44
7583015|NCT02698436|18665313|P2|NOT COMPLETED|Overall Study||7
7583016|NCT02698436|18665314|P1|NOT COMPLETED|Overall Study||7
7583017|NCT02698436|18665313|P2|COMPLETED|Overall Study||51
7583018|NCT02698436|18665314|P1|COMPLETED|Overall Study||52
7583019|NCT02698436|18665313|P2|STARTED|Overall Study||58
7583020|NCT02698436|18665314|P1|STARTED|Overall Study||59
7583021|NCT02698423|18665354|P2|NOT COMPLETED|Overall Study||24
7583022|NCT02698423|18665355|P1|NOT COMPLETED|Overall Study||19
7583023|NCT02698423|18665354|P2|COMPLETED|Overall Study||307
7583024|NCT02698423|18665355|P1|COMPLETED|Overall Study||317
7583025|NCT02698423|18665354|P2|STARTED|Overall Study||331
7583026|NCT02698423|18665355|P1|STARTED|Overall Study||336
7583027|NCT02698410|18665363|P1|NOT COMPLETED|Overall Study||4
7583028|NCT02698410|18665363|P1|COMPLETED|Overall Study||36
7583029|NCT02698410|18665363|P1|STARTED|Overall Study||40
7583030|NCT02698371|18665382|P1|NOT COMPLETED|ADU-SE (G6) Arm/Group Flow||2
7583031|NCT02698371|18665382|P1|COMPLETED|ADU-SE (G6) Arm/Group Flow||33
7583032|NCT02698371|18665382|P1|STARTED|ADU-SE (G6) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-SE (G6 Arm/group)|35
7583033|NCT02698371|18665382|P1|NOT COMPLETED|ADU-ER (G5) Arm/Group Flow||3
7583034|NCT02698371|18665382|P1|COMPLETED|ADU-ER (G5) Arm/Group Flow||32
7583035|NCT02698371|18665382|P1|STARTED|ADU-ER (G5) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-ER (G5 Arm/group)|35
7583036|NCT02698371|18665382|P1|NOT COMPLETED|FBU-SE (G4) Arm/Group Flow||3
7583037|NCT02698371|18665382|P1|COMPLETED|FBU-SE (G4) Arm/Group Flow||32
7583038|NCT02698371|18665382|P1|STARTED|FBU-SE (G4) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-SE (G4 Arm/group)|35
7583039|NCT02698371|18665382|P1|NOT COMPLETED|FBU-ER (G3) Arm/Group Flow||3
7583040|NCT02698371|18665382|P1|COMPLETED|FBU-ER (G3) Arm/Group Flow||32
7583041|NCT02698371|18665382|P1|STARTED|FBU-ER (G3) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-ER (G3 Arm/group)|35
7583042|NCT02698371|18665382|P1|NOT COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||3
7583043|NCT02698371|18665382|P1|COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||32
7583044|NCT02698371|18665382|P1|STARTED|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE-EE (G2 control Arm/group)|35
7583045|NCT02698371|18665382|P1|NOT COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||3
7583046|NCT02698371|18665382|P1|COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||32
7583047|NCT02698371|18665382|P1|STARTED|FBDC-SE (G1; Control) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE (G1control Arm/Group).|35
7583048|NCT02698371|18665382|P1|NOT COMPLETED|All Participants Flow||3
7583049|NCT02698371|18665382|P1|COMPLETED|All Participants Flow||35
7583050|NCT02698371|18665382|P1|STARTED|All Participants Flow||38
7583051|NCT02698241|18665504|P1|NOT COMPLETED|Overall Study||34
7583052|NCT02698241|18665504|P1|COMPLETED|Overall Study|Number of subjects completed the study (no early exit or death)|45
7583053|NCT02698241|18665504|P1|Baseline & Programming|Overall Study|Number of subjects that passed screening and completed baseline and programming visit|66
7583054|NCT02698241|18665504|P1|STARTED|Overall Study|Number of subjects enrolled the study|79
7583055|NCT02698189|18665511|P2|NOT COMPLETED|Overall Study||6
7583056|NCT02698189|18665512|P1|NOT COMPLETED|Overall Study||3
7583057|NCT02698189|18665511|P2|COMPLETED|Overall Study||0
7583058|NCT02698189|18665512|P1|COMPLETED|Overall Study||0
7583059|NCT02698189|18665511|P2|STARTED|Overall Study||6
7583060|NCT02698189|18665512|P1|STARTED|Overall Study||3
7583061|NCT02698176|18665542|P4|NOT COMPLETED|Overall Study||0
7583062|NCT02698176|18665543|P3|NOT COMPLETED|Overall Study||1
7583063|NCT02698176|18665544|P2|NOT COMPLETED|Overall Study||3
7583064|NCT02698176|18665545|P1|NOT COMPLETED|Overall Study||9
7583065|NCT02698176|18665542|P4|COMPLETED|Overall Study||0
7583066|NCT02698176|18665543|P3|COMPLETED|Overall Study||0
7583067|NCT02698176|18665544|P2|COMPLETED|Overall Study||0
7583068|NCT02698176|18665545|P1|COMPLETED|Overall Study||0
7583069|NCT02698176|18665542|P4|STARTED|Overall Study|No participants were enrolled in Part B.|0
7583070|NCT02698176|18665543|P3|STARTED|Overall Study||1
7583071|NCT02698176|18665544|P2|STARTED|Overall Study||3
7583072|NCT02698176|18665545|P1|STARTED|Overall Study||9
7583073|NCT02698033|18665580|P1|NOT COMPLETED|Overall Study||1
7583074|NCT02698033|18665580|P1|COMPLETED|Overall Study||6
7583075|NCT02698033|18665580|P1|STARTED|Overall Study||7
7583076|NCT02697890|18665586|P2|NOT COMPLETED|Overall Study||0
7583077|NCT02697890|18665587|P1|NOT COMPLETED|Overall Study||0
7583078|NCT02697890|18665586|P2|COMPLETED|Overall Study||14
7583079|NCT02697890|18665587|P1|COMPLETED|Overall Study||14
7583080|NCT02697890|18665586|P2|STARTED|Overall Study||14
7583081|NCT02697890|18665587|P1|STARTED|Overall Study||14
7583082|NCT02697773|18665602|P3|NOT COMPLETED|Overall Study||40
7583083|NCT02697773|18665603|P2|NOT COMPLETED|Overall Study||38
7583084|NCT02697773|18665604|P1|NOT COMPLETED|Overall Study||38
7583085|NCT02697773|18665602|P3|COMPLETED|Overall Study||193
7583086|NCT02697773|18665603|P2|COMPLETED|Overall Study||194
7583087|NCT02697773|18665604|P1|COMPLETED|Overall Study||195
7583088|NCT02697773|18665602|P3|Treated|Overall Study||233
7583089|NCT02697773|18665603|P2|Treated|Overall Study||231
7583090|NCT02697773|18665604|P1|Treated|Overall Study||232
7583091|NCT02697773|18665602|P3|STARTED|Overall Study||233
7583092|NCT02697773|18665603|P2|STARTED|Overall Study||232
7583093|NCT02697773|18665604|P1|STARTED|Overall Study||233
7583094|NCT02697435|18665785|P2|NOT COMPLETED|Overall Study||4
7583095|NCT02697435|18665786|P1|NOT COMPLETED|Overall Study||1
7583096|NCT02697435|18665785|P2|COMPLETED|Overall Study||26
7583097|NCT02697435|18665786|P1|COMPLETED|Overall Study||24
7583098|NCT02697435|18665785|P2|STARTED|Overall Study||30
7583099|NCT02697435|18665786|P1|STARTED|Overall Study||25
7583100|NCT02697292|18665796|P2|NOT COMPLETED|Overall Study||0
7583101|NCT02697292|18665797|P1|NOT COMPLETED|Overall Study||0
7583102|NCT02697292|18665796|P2|COMPLETED|Overall Study||8
7583103|NCT02697292|18665797|P1|COMPLETED|Overall Study||9
7583104|NCT02697292|18665796|P2|STARTED|Overall Study||8
7583105|NCT02697292|18665797|P1|STARTED|Overall Study||9
7583106|NCT02697240|18665805|P1|NOT COMPLETED|Overall Study||0
7583107|NCT02697240|18665805|P1|COMPLETED|Overall Study||4
7583108|NCT02697240|18665805|P1|STARTED|Overall Study||4
7583109|NCT02697214|18665814|P6|NOT COMPLETED|Overall Study||0
7583110|NCT02697214|18665815|P5|NOT COMPLETED|Overall Study||0
7583111|NCT02697214|18665816|P4|NOT COMPLETED|Overall Study||0
7583112|NCT02697214|18665817|P3|NOT COMPLETED|Overall Study||0
7583113|NCT02697214|18665818|P2|NOT COMPLETED|Overall Study||0
7583114|NCT02697214|18665819|P1|NOT COMPLETED|Overall Study||0
7583115|NCT02697214|18665814|P6|COMPLETED|Overall Study||50
7583116|NCT02697214|18665815|P5|COMPLETED|Overall Study||50
7583117|NCT02697214|18665816|P4|COMPLETED|Overall Study||24
7583118|NCT02697214|18665817|P3|COMPLETED|Overall Study||25
7583119|NCT02697214|18665818|P2|COMPLETED|Overall Study||25
7583120|NCT02697214|18665819|P1|COMPLETED|Overall Study||26
7583121|NCT02697214|18665814|P6|Heart Rate at 6mph|Overall Study||50
7583122|NCT02697214|18665815|P5|Heart Rate at 6mph|Overall Study||50
7583123|NCT02697214|18665816|P4|Heart Rate at 6mph|Overall Study||24
7583124|NCT02697214|18665817|P3|Heart Rate at 6mph|Overall Study||25
7583125|NCT02697214|18665818|P2|Heart Rate at 6mph|Overall Study||25
7583126|NCT02697214|18665819|P1|Heart Rate at 6mph|Overall Study||26
7583127|NCT02697214|18665814|P6|Heart Rate at 4mph|Overall Study||50
7583128|NCT02697214|18665815|P5|Heart Rate at 4mph|Overall Study||50
7583129|NCT02697214|18665816|P4|Heart Rate at 4mph|Overall Study||24
7583130|NCT02697214|18665817|P3|Heart Rate at 4mph|Overall Study||25
7583131|NCT02697214|18665818|P2|Heart Rate at 4mph|Overall Study||25
7583132|NCT02697214|18665819|P1|Heart Rate at 4mph|Overall Study||26
7583133|NCT02697214|18665814|P6|Heart Rate at 3mph|Overall Study||50
7583134|NCT02697214|18665815|P5|Heart Rate at 3mph|Overall Study||50
7583135|NCT02697214|18665816|P4|Heart Rate at 3mph|Overall Study||24
7583136|NCT02697214|18665817|P3|Heart Rate at 3mph|Overall Study||25
7583137|NCT02697214|18665818|P2|Heart Rate at 3mph|Overall Study||25
7583138|NCT02697214|18665819|P1|Heart Rate at 3mph|Overall Study||26
7583139|NCT02697214|18665814|P6|Heart Rate at 2mph|Overall Study||50
7583140|NCT02697214|18665815|P5|Heart Rate at 2mph|Overall Study||50
7583141|NCT02697214|18665816|P4|Heart Rate at 2mph|Overall Study||24
7583142|NCT02697214|18665817|P3|Heart Rate at 2mph|Overall Study||25
7583143|NCT02697214|18665818|P2|Heart Rate at 2mph|Overall Study||25
7583144|NCT02697214|18665819|P1|Heart Rate at 2mph|Overall Study||26
7583145|NCT02697214|18665814|P6|STARTED|Overall Study||50
7583146|NCT02697214|18665815|P5|STARTED|Overall Study||50
7583147|NCT02697214|18665816|P4|STARTED|Overall Study||24
7583148|NCT02697214|18665817|P3|STARTED|Overall Study||25
7583149|NCT02697214|18665818|P2|STARTED|Overall Study||25
7583150|NCT02697214|18665819|P1|STARTED|Overall Study||26
7583151|NCT02697188|18665829|P1|NOT COMPLETED|TE Period 5 - 800 mg BID||0
7583152|NCT02697188|18665829|P1|COMPLETED|TE Period 5 - 800 mg BID||12
7583153|NCT02697188|18665829|P1|STARTED|TE Period 5 - 800 mg BID||12
7583154|NCT02697188|18665829|P1|NOT COMPLETED|TU Period 4 - 400 BID||0
7583155|NCT02697188|18665829|P1|COMPLETED|TU Period 4 - 400 BID||12
7583156|NCT02697188|18665829|P1|STARTED|TU Period 4 - 400 BID||12
7583157|NCT02697188|18665829|P1|NOT COMPLETED|TU Period 3 - 200 mg BID||0
7583158|NCT02697188|18665829|P1|COMPLETED|TU Period 3 - 200 mg BID||12
7583159|NCT02697188|18665829|P1|STARTED|TU Period 3 - 200 mg BID||12
7583160|NCT02697188|18665829|P1|NOT COMPLETED|TU Period 2 - 200 mg QD||0
7583161|NCT02697188|18665829|P1|COMPLETED|TU Period 2 - 200 mg QD||12
7583162|NCT02697188|18665829|P1|STARTED|TU Period 2 - 200 mg QD||12
7583163|NCT02697188|18665829|P1|NOT COMPLETED|TE Period 1 - 400 mg QD||0
7583164|NCT02697188|18665829|P1|COMPLETED|TE Period 1 - 400 mg QD||12
7583165|NCT02697188|18665829|P1|STARTED|TE Period 1 - 400 mg QD||12
7583166|NCT02696967|18665842|P4|NOT COMPLETED|Overall Study||0
7583167|NCT02696967|18665843|P3|NOT COMPLETED|Overall Study||0
7583168|NCT02696967|18665844|P2|NOT COMPLETED|Overall Study||0
7583169|NCT02696967|18665845|P1|NOT COMPLETED|Overall Study||0
7583170|NCT02696967|18665842|P4|COMPLETED|Overall Study||10
7583171|NCT02696967|18665843|P3|COMPLETED|Overall Study||6
7583172|NCT02696967|18665844|P2|COMPLETED|Overall Study||6
7583173|NCT02696967|18665845|P1|COMPLETED|Overall Study||4
7583174|NCT02696967|18665842|P4|Pharmacokinetic (PK) Analysis Set|Overall Study||0
7583175|NCT02696967|18665843|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||4
7583176|NCT02696967|18665844|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||6
7583177|NCT02696967|18665845|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||4
7583178|NCT02696967|18665842|P4|STARTED|Overall Study||10
7583179|NCT02696967|18665843|P3|STARTED|Overall Study||6
7583180|NCT02696967|18665844|P2|STARTED|Overall Study||6
7583181|NCT02696967|18665845|P1|STARTED|Overall Study||4
7583182|NCT02696902|18665895|P3|NOT COMPLETED|Overall Study||28
7583183|NCT02696902|18665896|P2|NOT COMPLETED|Overall Study||4
7583184|NCT02696902|18665897|P1|NOT COMPLETED|Overall Study||22
7583185|NCT02696902|18665895|P3|COMPLETED|Overall Study||59
7583186|NCT02696902|18665896|P2|COMPLETED|Overall Study||12
7583187|NCT02696902|18665897|P1|COMPLETED|Overall Study||63
7583188|NCT02696902|18665895|P3|Treated|Overall Study||85
7583189|NCT02696902|18665896|P2|Treated|Overall Study||16
7583190|NCT02696902|18665897|P1|Treated|Overall Study||83
7583191|NCT02696902|18665895|P3|STARTED|Overall Study||87
7583192|NCT02696902|18665896|P2|STARTED|Overall Study||16
7583193|NCT02696902|18665897|P1|STARTED|Overall Study||85
7583194|NCT02696850|18665929|P2|NOT COMPLETED|Overall Study||8
7583195|NCT02696850|18665930|P1|NOT COMPLETED|Overall Study||11
7583196|NCT02696850|18665929|P2|COMPLETED|Overall Study||32
7583197|NCT02696850|18665930|P1|COMPLETED|Overall Study||29
7583198|NCT02696850|18665929|P2|STARTED|Overall Study||40
7583199|NCT02696850|18665930|P1|STARTED|Overall Study||40
7583200|NCT02696798|18665943|P3|NOT COMPLETED|Post-treatment Follow-up Period||19
7583201|NCT02696798|18665944|P2|NOT COMPLETED|Post-treatment Follow-up Period||26
7583202|NCT02696798|18665945|P1|NOT COMPLETED|Post-treatment Follow-up Period||5
7583203|NCT02696798|18665943|P3|COMPLETED|Post-treatment Follow-up Period||3
7583204|NCT02696798|18665944|P2|COMPLETED|Post-treatment Follow-up Period||8
7583205|NCT02696798|18665945|P1|COMPLETED|Post-treatment Follow-up Period||0
7583206|NCT02696798|18665943|P3|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|22
7583207|NCT02696798|18665944|P2|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|34
7583208|NCT02696798|18665945|P1|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|5
7583209|NCT02696798|18665943|P3|NOT COMPLETED|Extended Treatment Period||10
7583210|NCT02696798|18665944|P2|NOT COMPLETED|Extended Treatment Period||9
7583211|NCT02696798|18665945|P1|NOT COMPLETED|Extended Treatment Period||12
7583212|NCT02696798|18665943|P3|COMPLETED|Extended Treatment Period||80
7583213|NCT02696798|18665944|P2|COMPLETED|Extended Treatment Period||89
7583214|NCT02696798|18665945|P1|COMPLETED|Extended Treatment Period||81
7583215|NCT02696798|18665943|P3|STARTED|Extended Treatment Period||90
7583296|NCT02696317|18666185|P1|STARTED|Period 1, 10 Days of Wear||40
7583216|NCT02696798|18665944|P2|STARTED|Extended Treatment Period|1 participant completed blinded treatment period and entered post-treatment followup period directly|98
7583217|NCT02696798|18665945|P1|STARTED|Extended Treatment Period||93
7583218|NCT02696798|18665943|P3|NOT COMPLETED|Blinded Treatment Dosing Period||8
7583219|NCT02696798|18665944|P2|NOT COMPLETED|Blinded Treatment Dosing Period||15
7583220|NCT02696798|18665945|P1|NOT COMPLETED|Blinded Treatment Dosing Period||11
7583221|NCT02696798|18665943|P3|COMPLETED|Blinded Treatment Dosing Period||90
7583222|NCT02696798|18665944|P2|COMPLETED|Blinded Treatment Dosing Period||99
7583223|NCT02696798|18665945|P1|COMPLETED|Blinded Treatment Dosing Period||93
7583224|NCT02696798|18665943|P3|STARTED|Blinded Treatment Dosing Period||98
7583225|NCT02696798|18665944|P2|STARTED|Blinded Treatment Dosing Period||114
7583226|NCT02696798|18665945|P1|STARTED|Blinded Treatment Dosing Period||104
7583227|NCT02696785|18666042|P4|NOT COMPLETED|Follow-up Period||8
7583228|NCT02696785|18666043|P3|NOT COMPLETED|Follow-up Period||13
7583229|NCT02696785|18666044|P2|NOT COMPLETED|Follow-up Period||0
7583230|NCT02696785|18666045|P1|NOT COMPLETED|Follow-up Period||1
7583231|NCT02696785|18666042|P4|COMPLETED|Follow-up Period||8
7583232|NCT02696785|18666043|P3|COMPLETED|Follow-up Period||11
7583233|NCT02696785|18666044|P2|COMPLETED|Follow-up Period||0
7583234|NCT02696785|18666045|P1|COMPLETED|Follow-up Period||0
7583235|NCT02696785|18666042|P4|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|16
7583236|NCT02696785|18666043|P3|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|24
7583237|NCT02696785|18666044|P2|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|0
7583238|NCT02696785|18666045|P1|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|1
7583239|NCT02696785|18666042|P4|NOT COMPLETED|Extended Treatment Period||6
7583240|NCT02696785|18666043|P3|NOT COMPLETED|Extended Treatment Period||5
7583241|NCT02696785|18666044|P2|NOT COMPLETED|Extended Treatment Period||6
7583242|NCT02696785|18666045|P1|NOT COMPLETED|Extended Treatment Period||3
7583243|NCT02696785|18666042|P4|COMPLETED|Extended Treatment Period||72
7583244|NCT02696785|18666043|P3|COMPLETED|Extended Treatment Period||74
7583245|NCT02696785|18666044|P2|COMPLETED|Extended Treatment Period||80
7583246|NCT02696785|18666045|P1|COMPLETED|Extended Treatment Period||83
7583247|NCT02696785|18666042|P4|STARTED|Extended Treatment Period||78
7583248|NCT02696785|18666043|P3|STARTED|Extended Treatment Period||79
7583249|NCT02696785|18666044|P2|STARTED|Extended Treatment Period||86
7583250|NCT02696785|18666045|P1|STARTED|Extended Treatment Period||86
7583251|NCT02696785|18666042|P4|NOT COMPLETED|Washout Period||0
7583252|NCT02696785|18666043|P3|NOT COMPLETED|Washout Period||0
7583253|NCT02696785|18666044|P2|NOT COMPLETED|Washout Period||2
7583254|NCT02696785|18666045|P1|NOT COMPLETED|Washout Period||0
7583255|NCT02696785|18666042|P4|COMPLETED|Washout Period||0
7583256|NCT02696785|18666043|P3|COMPLETED|Washout Period||0
7583257|NCT02696785|18666044|P2|COMPLETED|Washout Period||86
7583258|NCT02696785|18666045|P1|COMPLETED|Washout Period||0
7583259|NCT02696785|18666042|P4|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
7583260|NCT02696785|18666043|P3|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
7583261|NCT02696785|18666044|P2|STARTED|Washout Period||88
7583262|NCT02696785|18666045|P1|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
7583263|NCT02696785|18666042|P4|NOT COMPLETED|Blinded Treatment Period||3
7583264|NCT02696785|18666043|P3|NOT COMPLETED|Blinded Treatment Period||4
7583265|NCT02696785|18666044|P2|NOT COMPLETED|Blinded Treatment Period||2
7583266|NCT02696785|18666045|P1|NOT COMPLETED|Blinded Treatment Period||1
7583267|NCT02696785|18666042|P4|COMPLETED|Blinded Treatment Period||78
7583268|NCT02696785|18666043|P3|COMPLETED|Blinded Treatment Period||79
7583269|NCT02696785|18666044|P2|COMPLETED|Blinded Treatment Period||88
7583270|NCT02696785|18666045|P1|COMPLETED|Blinded Treatment Period||86
7583271|NCT02696785|18666042|P4|Received at Least One Dose of Study Drug|Blinded Treatment Period||81
7583272|NCT02696785|18666043|P3|Received at Least One Dose of Study Drug|Blinded Treatment Period||83
7583273|NCT02696785|18666044|P2|Received at Least One Dose of Study Drug|Blinded Treatment Period||90
7583274|NCT02696785|18666045|P1|Received at Least One Dose of Study Drug|Blinded Treatment Period||86
7583275|NCT02696785|18666042|P4|STARTED|Blinded Treatment Period||81
7583276|NCT02696785|18666043|P3|STARTED|Blinded Treatment Period||83
7583277|NCT02696785|18666044|P2|STARTED|Blinded Treatment Period||90
7583278|NCT02696785|18666045|P1|STARTED|Blinded Treatment Period||87
7583279|NCT02696434|18666165|P2|NOT COMPLETED|Overall Study||18
7583280|NCT02696434|18666166|P1|NOT COMPLETED|Overall Study||22
7583281|NCT02696434|18666165|P2|COMPLETED|Overall Study||33
7583282|NCT02696434|18666166|P1|COMPLETED|Overall Study||28
7583283|NCT02696434|18666165|P2|STARTED|Overall Study||51
7583284|NCT02696434|18666166|P1|STARTED|Overall Study||50
7583285|NCT02696317|18666184|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
7583286|NCT02696317|18666185|P1|NOT COMPLETED|Period 2, 10 Days of Wear||1
7583287|NCT02696317|18666184|P2|COMPLETED|Period 2, 10 Days of Wear||36
7583288|NCT02696317|18666185|P1|COMPLETED|Period 2, 10 Days of Wear||39
7583289|NCT02696317|18666184|P2|STARTED|Period 2, 10 Days of Wear||36
7583290|NCT02696317|18666185|P1|STARTED|Period 2, 10 Days of Wear||40
7583291|NCT02696317|18666184|P2|NOT COMPLETED|Period 1, 10 Days of Wear||0
7583292|NCT02696317|18666185|P1|NOT COMPLETED|Period 1, 10 Days of Wear||0
7583293|NCT02696317|18666184|P2|COMPLETED|Period 1, 10 Days of Wear||36
7583294|NCT02696317|18666185|P1|COMPLETED|Period 1, 10 Days of Wear||40
7583295|NCT02696317|18666184|P2|STARTED|Period 1, 10 Days of Wear||36
7583297|NCT02696317|18666184|P2|NOT COMPLETED|Habitual, 10 Days of Wear||4
7583298|NCT02696317|18666185|P1|NOT COMPLETED|Habitual, 10 Days of Wear||2
7583299|NCT02696317|18666184|P2|COMPLETED|Habitual, 10 Days of Wear||36
7583300|NCT02696317|18666185|P1|COMPLETED|Habitual, 10 Days of Wear||40
7583301|NCT02696317|18666184|P2|STARTED|Habitual, 10 Days of Wear||40
7583302|NCT02696317|18666185|P1|STARTED|Habitual, 10 Days of Wear||42
7583303|NCT02696291|18666201|P2|NOT COMPLETED|Overall Study||0
7583304|NCT02696291|18666202|P1|NOT COMPLETED|Overall Study||0
7583305|NCT02696291|18666201|P2|COMPLETED|Overall Study||2
7583306|NCT02696291|18666202|P1|COMPLETED|Overall Study||5
7583307|NCT02696291|18666201|P2|STARTED|Overall Study||2
7583308|NCT02696291|18666202|P1|STARTED|Overall Study||5
7583309|NCT02696226|18666229|P4|NOT COMPLETED|Overall Study||0
7583310|NCT02696226|18666230|P3|NOT COMPLETED|Overall Study||2
7583311|NCT02696226|18666231|P2|NOT COMPLETED|Overall Study||0
7583312|NCT02696226|18666232|P1|NOT COMPLETED|Overall Study||1
7583313|NCT02696226|18666229|P4|COMPLETED|Overall Study||0
7583314|NCT02696226|18666230|P3|COMPLETED|Overall Study||0
7583315|NCT02696226|18666231|P2|COMPLETED|Overall Study||0
7583316|NCT02696226|18666232|P1|COMPLETED|Overall Study||0
7583317|NCT02696226|18666229|P4|STARTED|Overall Study||0
7583318|NCT02696226|18666230|P3|STARTED|Overall Study||2
7583319|NCT02696226|18666231|P2|STARTED|Overall Study||0
7583320|NCT02696226|18666232|P1|STARTED|Overall Study||1
7583321|NCT02696200|18666244|P2|NOT COMPLETED|Overall Study||0
7583322|NCT02696200|18666245|P1|NOT COMPLETED|Overall Study||0
7583323|NCT02696200|18666244|P2|COMPLETED|Overall Study||30
7583324|NCT02696200|18666245|P1|COMPLETED|Overall Study||32
7583325|NCT02696200|18666244|P2|STARTED|Overall Study||30
7583326|NCT02696200|18666245|P1|STARTED|Overall Study||32
7583327|NCT02696083|18666255|P1|NOT COMPLETED|Overall Study||6
7583328|NCT02696083|18666255|P1|COMPLETED|Overall Study||13
7583329|NCT02696083|18666255|P1|STARTED|Overall Study||19
7583330|NCT02696070|18666266|P2|NOT COMPLETED|Overall Study||2
7583331|NCT02696070|18666267|P1|NOT COMPLETED|Overall Study||1
7583332|NCT02696070|18666266|P2|COMPLETED|Overall Study||12
7583333|NCT02696070|18666267|P1|COMPLETED|Overall Study||7
7583334|NCT02696070|18666266|P2|STARTED|Overall Study||14
7583335|NCT02696070|18666267|P1|STARTED|Overall Study||8
7583336|NCT02696031|18666276|P3|NOT COMPLETED|Week 52||26
7583337|NCT02696031|18666277|P2|NOT COMPLETED|Week 52||19
7583338|NCT02696031|18666278|P1|NOT COMPLETED|Week 52||29
7583339|NCT02696031|18666276|P3|COMPLETED|Week 52||160
7583340|NCT02696031|18666277|P2|COMPLETED|Week 52||165
7583341|NCT02696031|18666278|P1|COMPLETED|Week 52||156
7583342|NCT02696031|18666276|P3|STARTED|Week 52||186
7583343|NCT02696031|18666277|P2|STARTED|Week 52||184
7583344|NCT02696031|18666278|P1|STARTED|Week 52||185
7583345|NCT02696031|18666276|P3|NOT COMPLETED|Week 24||11
7583346|NCT02696031|18666277|P2|NOT COMPLETED|Week 24||7
7583347|NCT02696031|18666278|P1|NOT COMPLETED|Week 24||10
7583348|NCT02696031|18666276|P3|COMPLETED|Week 24||175
7583349|NCT02696031|18666277|P2|COMPLETED|Week 24||177
7583350|NCT02696031|18666278|P1|COMPLETED|Week 24||175
7583351|NCT02696031|18666276|P3|STARTED|Week 24||186
7583352|NCT02696031|18666277|P2|STARTED|Week 24||184
7583353|NCT02696031|18666278|P1|STARTED|Week 24||185
7583354|NCT02695719|18666292|P2|NOT COMPLETED|Overall Study||10
7583355|NCT02695719|18666293|P1|NOT COMPLETED|Overall Study||3
7583356|NCT02695719|18666292|P2|COMPLETED|Overall Study||72
7583357|NCT02695719|18666293|P1|COMPLETED|Overall Study||71
7583358|NCT02695719|18666292|P2|STARTED|Overall Study||82
7583359|NCT02695719|18666293|P1|STARTED|Overall Study||74
7583360|NCT02695628|18666311|P1|NOT COMPLETED|Overall Study||1
7583361|NCT02695628|18666311|P1|COMPLETED|Overall Study||4
7583362|NCT02695628|18666311|P1|STARTED|Overall Study||5
7583363|NCT02695537|18666317|P1|NOT COMPLETED|Overall Study||38
7583364|NCT02695537|18666317|P1|COMPLETED|Overall Study||51
7583365|NCT02695537|18666317|P1|STARTED|Overall Study||89
7583366|NCT02695524|18666327|P2|NOT COMPLETED|Overall Study||3
7583367|NCT02695524|18666328|P1|NOT COMPLETED|Overall Study||3
7583368|NCT02695524|18666327|P2|COMPLETED|Overall Study||27
7583369|NCT02695524|18666328|P1|COMPLETED|Overall Study||27
7583370|NCT02695524|18666327|P2|STARTED|Overall Study||30
7583371|NCT02695524|18666328|P1|STARTED|Overall Study||30
7583372|NCT02695446|18666348|P1|NOT COMPLETED|Overall Study||0
7583373|NCT02695446|18666348|P1|COMPLETED|Overall Study||12
7583374|NCT02695446|18666348|P1|STARTED|Overall Study||12
7583375|NCT02695420|18666357|P4|NOT COMPLETED|Overall Study||0
7583376|NCT02695420|18666358|P3|NOT COMPLETED|Overall Study||0
7583377|NCT02695420|18666359|P2|NOT COMPLETED|Overall Study||1
7583378|NCT02695420|18666360|P1|NOT COMPLETED|Overall Study||0
7583379|NCT02695420|18666357|P4|COMPLETED|Overall Study||20
7583380|NCT02695420|18666358|P3|COMPLETED|Overall Study||19
7583381|NCT02695420|18666359|P2|COMPLETED|Overall Study||20
7583382|NCT02695420|18666360|P1|COMPLETED|Overall Study||21
7583383|NCT02695420|18666357|P4|STARTED|Overall Study||20
7583384|NCT02695420|18666358|P3|STARTED|Overall Study||19
7583385|NCT02695420|18666359|P2|STARTED|Overall Study||21
7583386|NCT02695420|18666360|P1|STARTED|Overall Study||21
7583387|NCT02695329|18666382|P2|NOT COMPLETED|Overall Study||5
7583388|NCT02695329|18666383|P1|NOT COMPLETED|Overall Study||5
7583389|NCT02695329|18666382|P2|COMPLETED|Overall Study||45
7583390|NCT02695329|18666383|P1|COMPLETED|Overall Study||45
7583391|NCT02695329|18666382|P2|STARTED|Overall Study||50
7583392|NCT02695329|18666383|P1|STARTED|Overall Study||50
7583393|NCT02695290|18666395|P1|NOT COMPLETED|Overall Study||0
7583394|NCT02695290|18666395|P1|COMPLETED|Overall Study||1
7583395|NCT02695290|18666395|P1|STARTED|Overall Study||1
7583396|NCT02694978|18666403|P2|NOT COMPLETED|Overall Study||60
7583397|NCT02694978|18666404|P1|NOT COMPLETED|Overall Study||71
7583398|NCT02694978|18666403|P2|COMPLETED|Overall Study||948
7583399|NCT02694978|18666404|P1|COMPLETED|Overall Study||935
7583400|NCT02694978|18666403|P2|Received at Least 1 Dose of Study Drug|Overall Study||1000
7583401|NCT02694978|18666404|P1|Received at Least 1 Dose of Study Drug|Overall Study||997
7583402|NCT02694978|18666403|P2|STARTED|Overall Study||1008
7583403|NCT02694978|18666404|P1|STARTED|Overall Study||1006
7583404|NCT02694835|18666418|P2|NOT COMPLETED|Overall Study||0
7583405|NCT02694835|18666419|P1|NOT COMPLETED|Overall Study||0
7583406|NCT02694835|18666418|P2|COMPLETED|Overall Study||39
7583407|NCT02694835|18666419|P1|COMPLETED|Overall Study||41
7583408|NCT02694835|18666418|P2|STARTED|Overall Study||39
7583409|NCT02694835|18666419|P1|STARTED|Overall Study||41
7583410|NCT02694757|18666425|P1|NOT COMPLETED|Overall Study||3
7583411|NCT02694757|18666425|P1|COMPLETED|Overall Study||0
7583412|NCT02694757|18666425|P1|STARTED|Overall Study||3
7583413|NCT02694744|18666431|P2|NOT COMPLETED|Overall Study||5
7583414|NCT02694744|18666432|P1|NOT COMPLETED|Overall Study||6
7583415|NCT02694744|18666431|P2|COMPLETED|Overall Study||52
7583416|NCT02694744|18666432|P1|COMPLETED|Overall Study||51
7583417|NCT02694744|18666431|P2|ITT|Overall Study||55
7583418|NCT02694744|18666432|P1|ITT|Overall Study||57
7583419|NCT02694744|18666431|P2|Safety Population|Overall Study||56
7583420|NCT02694744|18666432|P1|Safety Population|Overall Study||57
7583421|NCT02694744|18666431|P2|STARTED|Overall Study||57
7583422|NCT02694744|18666432|P1|STARTED|Overall Study||57
7583423|NCT02694718|18666440|P1|NOT COMPLETED|Overall Study||2
7583424|NCT02694718|18666440|P1|COMPLETED|Overall Study||58
7583425|NCT02694718|18666440|P1|STARTED|Overall Study||60
7583426|NCT02694601|18666450|P1|NOT COMPLETED|Overall Study||0
7583427|NCT02694601|18666450|P1|COMPLETED|Overall Study||10
7583428|NCT02694601|18666450|P1|STARTED|Overall Study||10
7583429|NCT02694562|18666458|P1|NOT COMPLETED|Overall Study||18
7583430|NCT02694562|18666458|P1|COMPLETED|Overall Study||2
7583431|NCT02694562|18666458|P1|STARTED|Overall Study||20
7583432|NCT02694549|18666467|P1|NOT COMPLETED|Overall Study||2
7583433|NCT02694549|18666467|P1|COMPLETED|Overall Study||10
7583434|NCT02694549|18666467|P1|STARTED|Overall Study||12
7583435|NCT02694536|18666473|P1|NOT COMPLETED|Overall Study||80
7583436|NCT02694536|18666473|P1|COMPLETED|Overall Study||0
7583437|NCT02694536|18666473|P1|STARTED|Overall Study||80
7583438|NCT02694523|18666484|P7|NOT COMPLETED|Part B||2
7583439|NCT02694523|18666485|P6|NOT COMPLETED|Part B||5
7583440|NCT02694523|18666486|P5|NOT COMPLETED|Part B||4
7583441|NCT02694523|18666487|P4|NOT COMPLETED|Part B||4
7583442|NCT02694523|18666488|P3|NOT COMPLETED|Part B||20
7583443|NCT02694523|18666489|P2|NOT COMPLETED|Part B||0
7583444|NCT02694523|18666490|P1|NOT COMPLETED|Part B||0
7583445|NCT02694523|18666484|P7|COMPLETED|Part B||51
7583446|NCT02694523|18666485|P6|COMPLETED|Part B||51
7583447|NCT02694523|18666486|P5|COMPLETED|Part B||34
7583448|NCT02694523|18666487|P4|COMPLETED|Part B||140
7583449|NCT02694523|18666488|P3|COMPLETED|Part B||274
7583450|NCT02694523|18666489|P2|COMPLETED|Part B||0
7583451|NCT02694523|18666490|P1|COMPLETED|Part B||0
7583452|NCT02694523|18666484|P7|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to risankizumab in Part B|53
7583453|NCT02694523|18666485|P6|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to adalimumab in Part B|56
7583454|NCT02694523|18666486|P5|STARTED|Part B|Adalimumab nonresponders in Part A switched to risankizumab in Part B|38
7583455|NCT02694523|18666487|P4|STARTED|Part B|Adalimumab responders in Part A continued to received adalimumab in Part B|144
7583456|NCT02694523|18666488|P3|STARTED|Part B|Participants who received risankizumab in Part A continued to received risankizumab in Part B|294
7583457|NCT02694523|18666489|P2|STARTED|Part B||0
7583458|NCT02694523|18666490|P1|STARTED|Part B||0
7583459|NCT02694523|18666484|P7|NOT COMPLETED|Part A||0
7583460|NCT02694523|18666485|P6|NOT COMPLETED|Part A||0
7583461|NCT02694523|18666486|P5|NOT COMPLETED|Part A||0
7583462|NCT02694523|18666487|P4|NOT COMPLETED|Part A||0
7583463|NCT02694523|18666488|P3|NOT COMPLETED|Part A||0
7583464|NCT02694523|18666489|P2|NOT COMPLETED|Part A||7
7583465|NCT02694523|18666490|P1|NOT COMPLETED|Part A||13
7583466|NCT02694523|18666484|P7|COMPLETED|Part A||0
7583467|NCT02694523|18666485|P6|COMPLETED|Part A||0
7583468|NCT02694523|18666486|P5|COMPLETED|Part A||0
7583469|NCT02694523|18666487|P4|COMPLETED|Part A||0
7583470|NCT02694523|18666488|P3|COMPLETED|Part A||0
7583471|NCT02694523|18666489|P2|COMPLETED|Part A||294
7583472|NCT02694523|18666490|P1|COMPLETED|Part A||291
7583473|NCT02694523|18666484|P7|STARTED|Part A||0
7583474|NCT02694523|18666485|P6|STARTED|Part A||0
7583475|NCT02694523|18666486|P5|STARTED|Part A||0
7583476|NCT02694523|18666487|P4|STARTED|Part A||0
7583477|NCT02694523|18666488|P3|STARTED|Part A||0
7583478|NCT02694523|18666489|P2|STARTED|Part A||301
7583479|NCT02694523|18666490|P1|STARTED|Part A||304
7583480|NCT02694445|18666514|P1|NOT COMPLETED|Overall Study||52
7583481|NCT02694445|18666514|P1|COMPLETED|Overall Study||3046
7583482|NCT02694445|18666514|P1|STARTED|Overall Study||3098
7583483|NCT02694328|18666520|P2|NOT COMPLETED|Overall Study||98
7583484|NCT02694328|18666521|P1|NOT COMPLETED|Overall Study||100
7583485|NCT02694328|18666520|P2|COMPLETED|Overall Study||176
7583486|NCT02694328|18666521|P1|COMPLETED|Overall Study||176
7583487|NCT02694328|18666520|P2|STARTED|Overall Study||274
7583488|NCT02694328|18666521|P1|STARTED|Overall Study||276
7583489|NCT02694315|18666533|P1|NOT COMPLETED|Overall Study||0
7583490|NCT02694315|18666533|P1|COMPLETED|Overall Study||200
7583491|NCT02694315|18666533|P1|STARTED|Overall Study||200
7583492|NCT02694198|18666538|P1|NOT COMPLETED|Overall Study||0
7583493|NCT02694198|18666538|P1|COMPLETED|Overall Study||135
7583494|NCT02694198|18666538|P1|STARTED|Overall Study||135
7583495|NCT02693834|18666543|P2|NOT COMPLETED|Week 2 Practice||1
7583496|NCT02693834|18666544|P1|NOT COMPLETED|Week 2 Practice||0
7583497|NCT02693834|18666543|P2|COMPLETED|Week 2 Practice||10
7583498|NCT02693834|18666544|P1|COMPLETED|Week 2 Practice||10
7583499|NCT02693834|18666543|P2|STARTED|Week 2 Practice||11
7583500|NCT02693834|18666544|P1|STARTED|Week 2 Practice||10
7583501|NCT02693834|18666543|P2|NOT COMPLETED|Week 1 Practice||0
7583502|NCT02693834|18666544|P1|NOT COMPLETED|Week 1 Practice||0
7583503|NCT02693834|18666543|P2|COMPLETED|Week 1 Practice||11
7583504|NCT02693834|18666544|P1|COMPLETED|Week 1 Practice||10
7583505|NCT02693834|18666543|P2|STARTED|Week 1 Practice|During the first week of practice, 11 participants were assigned to DAAFO group|11
7583506|NCT02693834|18666544|P1|STARTED|Week 1 Practice|During the first week of practice, 10 participants were assigned to PLS AFO group|10
7583507|NCT02693834|18666543|P2|NOT COMPLETED|Baseline Measurement||0
7583508|NCT02693834|18666544|P1|NOT COMPLETED|Baseline Measurement||2
7583509|NCT02693834|18666543|P2|COMPLETED|Baseline Measurement|10 particiapnts completed wearing DA AFO during the first week and 10 the second week (1 was lost)|11
7583510|NCT02693834|18666544|P1|COMPLETED|Baseline Measurement|10 particiapnts completed wearing PLS AFO during the first week and 10 during the second week|10
7583511|NCT02693834|18666543|P2|STARTED|Baseline Measurement|11 participants were assigned to DA AFO first group|11
7583512|NCT02693834|18666544|P1|STARTED|Baseline Measurement|10 were randomized to PLS AFO first week group (2 dropped out at baseline)|12
7583513|NCT02693743|18666554|P2|NOT COMPLETED|Overall Study||0
7583514|NCT02693743|18666555|P1|NOT COMPLETED|Overall Study||1
7583515|NCT02693743|18666554|P2|COMPLETED|Overall Study||0
7583516|NCT02693743|18666555|P1|COMPLETED|Overall Study||0
7583517|NCT02693743|18666554|P2|STARTED|Overall Study||0
7583518|NCT02693743|18666555|P1|STARTED|Overall Study||1
7583519|NCT02693704|18666565|P4|NOT COMPLETED|Overall Study||0
7583520|NCT02693704|18666566|P3|NOT COMPLETED|Overall Study||0
7583521|NCT02693704|18666567|P2|NOT COMPLETED|Overall Study||0
7583522|NCT02693704|18666568|P1|NOT COMPLETED|Overall Study||0
7583523|NCT02693704|18666565|P4|COMPLETED|Overall Study||10
7583524|NCT02693704|18666566|P3|COMPLETED|Overall Study||10
7583525|NCT02693704|18666567|P2|COMPLETED|Overall Study||10
7583526|NCT02693704|18666568|P1|COMPLETED|Overall Study||10
7583527|NCT02693704|18666565|P4|STARTED|Overall Study||10
7583528|NCT02693704|18666566|P3|STARTED|Overall Study||10
7583529|NCT02693704|18666567|P2|STARTED|Overall Study||10
7583530|NCT02693704|18666568|P1|STARTED|Overall Study||10
7583531|NCT02693691|18666586|P1|NOT COMPLETED|Extended Follow-Up (Until Last pt 12M)||24
7583532|NCT02693691|18666586|P1|COMPLETED|Extended Follow-Up (Until Last pt 12M)||160
7583533|NCT02693691|18666586|P1|STARTED|Extended Follow-Up (Until Last pt 12M)||184
7583534|NCT02693691|18666586|P1|NOT COMPLETED|Primary Endpoint Analysis (First 12M)||50
7583535|NCT02693691|18666586|P1|COMPLETED|Primary Endpoint Analysis (First 12M)||184
7583536|NCT02693691|18666586|P1|STARTED|Primary Endpoint Analysis (First 12M)||234
7583537|NCT02693418|18666598|P5|NOT COMPLETED|Overall Study||0
7583538|NCT02693418|18666599|P4|NOT COMPLETED|Overall Study||0
7583539|NCT02693418|18666600|P3|NOT COMPLETED|Overall Study||2
7583540|NCT02693418|18666601|P2|NOT COMPLETED|Overall Study||2
7583541|NCT02693418|18666602|P1|NOT COMPLETED|Overall Study||1
7583542|NCT02693418|18666598|P5|COMPLETED|Overall Study||21
7583543|NCT02693418|18666599|P4|COMPLETED|Overall Study||20
7583544|NCT02693418|18666600|P3|COMPLETED|Overall Study||19
7583545|NCT02693418|18666601|P2|COMPLETED|Overall Study||19
7583546|NCT02693418|18666602|P1|COMPLETED|Overall Study||21
7583547|NCT02693418|18666598|P5|STARTED|Overall Study||21
7583548|NCT02693418|18666599|P4|STARTED|Overall Study||20
7583549|NCT02693418|18666600|P3|STARTED|Overall Study||21
7583550|NCT02693418|18666601|P2|STARTED|Overall Study||21
7583551|NCT02693418|18666602|P1|STARTED|Overall Study||22
7583552|NCT02693171|18666619|P1|NOT COMPLETED|Overall Study||9
7583553|NCT02693171|18666619|P1|COMPLETED|Overall Study||3
7583554|NCT02693171|18666619|P1|STARTED|Overall Study|At study termination, 13 subjects had enrolled, 12 subjects received at least 1 dose of study drug.|12
7583555|NCT02693132|18666629|P3|NOT COMPLETED|Overall Study||1
7583556|NCT02693132|18666630|P2|NOT COMPLETED|Overall Study||1
7583557|NCT02693132|18666631|P1|NOT COMPLETED|Overall Study||1
7583558|NCT02693132|18666629|P3|COMPLETED|Overall Study||17
7583559|NCT02693132|18666630|P2|COMPLETED|Overall Study||16
7583560|NCT02693132|18666631|P1|COMPLETED|Overall Study||16
7583561|NCT02693132|18666629|P3|STARTED|Overall Study||18
7583562|NCT02693132|18666630|P2|STARTED|Overall Study||17
7583563|NCT02693132|18666631|P1|STARTED|Overall Study||17
7583564|NCT02693106|18666651|P1|NOT COMPLETED|Overall Study||3
7583565|NCT02693106|18666651|P1|COMPLETED|Overall Study||10
7583566|NCT02693106|18666651|P1|STARTED|Overall Study||13
7583567|NCT02693002|18666663|P2|NOT COMPLETED|Overall Study||0
7583568|NCT02693002|18666664|P1|NOT COMPLETED|Overall Study||1
7583569|NCT02693002|18666663|P2|COMPLETED|Overall Study||2
7583570|NCT02693002|18666664|P1|COMPLETED|Overall Study||1
7583571|NCT02693002|18666663|P2|STARTED|Overall Study||2
7583572|NCT02693002|18666664|P1|STARTED|Overall Study||2
7583573|NCT02692859|18666678|P2|NOT COMPLETED|Overall Study||95
7583574|NCT02692859|18666679|P1|NOT COMPLETED|Overall Study||84
7583575|NCT02692859|18666678|P2|COMPLETED|Overall Study||901
7583576|NCT02692859|18666679|P1|COMPLETED|Overall Study||912
7583577|NCT02692859|18666678|P2|STARTED|Overall Study||996
7583578|NCT02692859|18666679|P1|STARTED|Overall Study||996
7583579|NCT02692716|18666687|P2|NOT COMPLETED|Overall Study||6
7583580|NCT02692716|18666688|P1|NOT COMPLETED|Overall Study||5
7583581|NCT02692716|18666687|P2|COMPLETED|Overall Study||1586
7583582|NCT02692716|18666688|P1|COMPLETED|Overall Study||1586
7583583|NCT02692716|18666687|P2|Exposed|Overall Study||1591
7583584|NCT02692716|18666688|P1|Exposed|Overall Study||1591
7583585|NCT02692716|18666687|P2|Full Analysis Set (FAS)|Overall Study||1592
7583586|NCT02692716|18666688|P1|Full Analysis Set (FAS)|Overall Study||1591
7583587|NCT02692716|18666687|P2|STARTED|Overall Study||1592
7583588|NCT02692716|18666688|P1|STARTED|Overall Study||1591
7583589|NCT02692703|18666728|P1|NOT COMPLETED|Overall Study||2
7583590|NCT02692703|18666728|P1|COMPLETED|Overall Study||98
7583591|NCT02692703|18666728|P1|STARTED|Overall Study||100
7583592|NCT02692560|18666736|P2|NOT COMPLETED|Overall Study||6
7583593|NCT02692560|18666737|P1|NOT COMPLETED|Overall Study||0
7583594|NCT02692560|18666736|P2|COMPLETED|Overall Study||25
7583595|NCT02692560|18666737|P1|COMPLETED|Overall Study||29
7583596|NCT02692560|18666736|P2|STARTED|Overall Study||31
7583597|NCT02692560|18666737|P1|STARTED|Overall Study||29
7583598|NCT02692495|18666759|P2|NOT COMPLETED|Overall Study||0
7583599|NCT02692495|18666760|P1|NOT COMPLETED|Overall Study||0
7583600|NCT02692495|18666759|P2|COMPLETED|Overall Study||4
7583601|NCT02692495|18666760|P1|COMPLETED|Overall Study||12
7583602|NCT02692495|18666759|P2|STARTED|Overall Study||4
7583603|NCT02692495|18666760|P1|STARTED|Overall Study||12
7583604|NCT02692482|18666777|P2|NOT COMPLETED|Overall Study||4
7583605|NCT02692482|18666778|P1|NOT COMPLETED|Overall Study||3
7583606|NCT02692482|18666777|P2|COMPLETED|Overall Study||178
7583607|NCT02692482|18666778|P1|COMPLETED|Overall Study||174
7583608|NCT02692482|18666777|P2|STARTED|Overall Study||182
7583609|NCT02692482|18666778|P1|STARTED|Overall Study||177
7583610|NCT02692417|18666792|P2|NOT COMPLETED|Overall Study||1
7583611|NCT02692417|18666793|P1|NOT COMPLETED|Overall Study||6
7583612|NCT02692417|18666792|P2|COMPLETED|Overall Study||6
7583613|NCT02692417|18666793|P1|COMPLETED|Overall Study||3
7583614|NCT02692417|18666792|P2|STARTED|Overall Study||7
7583615|NCT02692417|18666793|P1|STARTED|Overall Study||9
7583616|NCT02692235|18666805|P2|NOT COMPLETED|Overall Study||3
7583617|NCT02692235|18666806|P1|NOT COMPLETED|Overall Study||3
7583618|NCT02692235|18666805|P2|COMPLETED|Overall Study||11
7583619|NCT02692235|18666806|P1|COMPLETED|Overall Study||11
7583620|NCT02692235|18666805|P2|STARTED|Overall Study||14
7583621|NCT02692235|18666806|P1|STARTED|Overall Study||14
7583622|NCT02692209|18666814|P1|NOT COMPLETED|Overall Study||0
7583623|NCT02692209|18666814|P1|COMPLETED|Overall Study||298
7583624|NCT02692209|18666814|P1|STARTED|Overall Study||298
7583625|NCT02692040|18666837|P17|NOT COMPLETED|Overall Study||0
7583626|NCT02692040|18666838|P16|NOT COMPLETED|Overall Study||1
7583627|NCT02692040|18666839|P15|NOT COMPLETED|Overall Study||1
7583628|NCT02692040|18666840|P14|NOT COMPLETED|Overall Study||3
7583629|NCT02692040|18666841|P13|NOT COMPLETED|Overall Study||1
7583630|NCT02692040|18666842|P12|NOT COMPLETED|Overall Study||0
7583631|NCT02692040|18666843|P11|NOT COMPLETED|Overall Study||0
7583632|NCT02692040|18666844|P10|NOT COMPLETED|Overall Study||0
7583633|NCT02692040|18666845|P9|NOT COMPLETED|Overall Study||0
7583634|NCT02692040|18666846|P8|NOT COMPLETED|Overall Study||0
7583635|NCT02692040|18666847|P7|NOT COMPLETED|Overall Study||0
7583636|NCT02692040|18666848|P6|NOT COMPLETED|Overall Study||0
7583637|NCT02692040|18666849|P5|NOT COMPLETED|Overall Study||0
7583638|NCT02692040|18666850|P4|NOT COMPLETED|Overall Study||0
7583639|NCT02692040|18666851|P3|NOT COMPLETED|Overall Study||0
7583640|NCT02692040|18666852|P2|NOT COMPLETED|Overall Study||0
7583641|NCT02692040|18666853|P1|NOT COMPLETED|Overall Study||0
7583642|NCT02692040|18666837|P17|COMPLETED|Overall Study||4
7583643|NCT02692040|18666838|P16|COMPLETED|Overall Study||5
7583644|NCT02692040|18666839|P15|COMPLETED|Overall Study||5
7583645|NCT02692040|18666840|P14|COMPLETED|Overall Study||3
7583646|NCT02692040|18666841|P13|COMPLETED|Overall Study||5
7583647|NCT02692040|18666842|P12|COMPLETED|Overall Study||5
7583648|NCT02692040|18666843|P11|COMPLETED|Overall Study||5
7583649|NCT02692040|18666844|P10|COMPLETED|Overall Study||4
7583650|NCT02692040|18666845|P9|COMPLETED|Overall Study||5
7583651|NCT02692040|18666846|P8|COMPLETED|Overall Study||5
7583652|NCT02692040|18666847|P7|COMPLETED|Overall Study||5
7583653|NCT02692040|18666848|P6|COMPLETED|Overall Study||5
7583654|NCT02692040|18666849|P5|COMPLETED|Overall Study||4
7583655|NCT02692040|18666850|P4|COMPLETED|Overall Study||5
7583656|NCT02692040|18666851|P3|COMPLETED|Overall Study||5
7583657|NCT02692040|18666852|P2|COMPLETED|Overall Study||4
7583658|NCT02692040|18666853|P1|COMPLETED|Overall Study||10
7583659|NCT02692040|18666837|P17|STARTED|Overall Study||4
7583660|NCT02692040|18666838|P16|STARTED|Overall Study||6
7583661|NCT02692040|18666839|P15|STARTED|Overall Study||6
7583662|NCT02692040|18666840|P14|STARTED|Overall Study||6
7583663|NCT02692040|18666841|P13|STARTED|Overall Study||6
7583664|NCT02692040|18666842|P12|STARTED|Overall Study||5
7583665|NCT02692040|18666843|P11|STARTED|Overall Study||5
7583666|NCT02692040|18666844|P10|STARTED|Overall Study||4
7583667|NCT02692040|18666845|P9|STARTED|Overall Study||5
7583668|NCT02692040|18666846|P8|STARTED|Overall Study||5
7583669|NCT02692040|18666847|P7|STARTED|Overall Study||5
7583670|NCT02692040|18666848|P6|STARTED|Overall Study||5
7583671|NCT02692040|18666849|P5|STARTED|Overall Study||4
7583672|NCT02692040|18666850|P4|STARTED|Overall Study||5
7583673|NCT02692040|18666851|P3|STARTED|Overall Study||5
7583674|NCT02692040|18666852|P2|STARTED|Overall Study||4
7583675|NCT02692040|18666853|P1|STARTED|Overall Study||10
7583676|NCT02691936|18666945|P2|NOT COMPLETED|Overall Study||5
7583677|NCT02691936|18666946|P1|NOT COMPLETED|Overall Study||2
7583678|NCT02691936|18666945|P2|COMPLETED|Overall Study||29
7583679|NCT02691936|18666946|P1|COMPLETED|Overall Study||33
7583680|NCT02691936|18666945|P2|STARTED|Overall Study||34
7583681|NCT02691936|18666946|P1|STARTED|Overall Study||35
7583682|NCT02691741|18666968|P2|NOT COMPLETED|Overall Study||7
7583683|NCT02691741|18666969|P1|NOT COMPLETED|Overall Study||1
7583684|NCT02691741|18666968|P2|COMPLETED|Overall Study||87
7583685|NCT02691741|18666969|P1|COMPLETED|Overall Study||93
7583686|NCT02691741|18666968|P2|Safety Analysis Set|Overall Study||89
7583687|NCT02691741|18666969|P1|Safety Analysis Set|Overall Study||93
7583688|NCT02691741|18666968|P2|Best-Case Analysis Set|Overall Study||85
7583689|NCT02691741|18666969|P1|Best-Case Analysis Set|Overall Study||86
7583690|NCT02691741|18666968|P2|All-Implanted Analysis Set|Overall Study||89
7583691|NCT02691741|18666969|P1|All-Implanted Analysis Set|Overall Study||93
7583692|NCT02691741|18666968|P2|STARTED|Overall Study||94
7583693|NCT02691741|18666969|P1|STARTED|Overall Study||94
7583694|NCT02691702|18667009|P11|NOT COMPLETED|Overall Study||2
7583695|NCT02691702|18667010|P10|NOT COMPLETED|Overall Study||2
7583696|NCT02691702|18667011|P9|NOT COMPLETED|Overall Study||2
7583697|NCT02691702|18667012|P8|NOT COMPLETED|Overall Study||0
7583698|NCT02691702|18667013|P7|NOT COMPLETED|Overall Study||3
7583699|NCT02691702|18667014|P6|NOT COMPLETED|Overall Study||3
7583700|NCT02691702|18667015|P5|NOT COMPLETED|Overall Study||0
7583701|NCT02691702|18667016|P4|NOT COMPLETED|Overall Study||0
7583702|NCT02691702|18667017|P3|NOT COMPLETED|Overall Study||1
7583703|NCT02691702|18667018|P2|NOT COMPLETED|Overall Study||1
7583704|NCT02691702|18667019|P1|NOT COMPLETED|Overall Study||2
7583705|NCT02691702|18667009|P11|COMPLETED|Overall Study||6
7583706|NCT02691702|18667010|P10|COMPLETED|Overall Study||6
7583707|NCT02691702|18667011|P9|COMPLETED|Overall Study||6
7583708|NCT02691702|18667012|P8|COMPLETED|Overall Study||12
7583709|NCT02691702|18667013|P7|COMPLETED|Overall Study||5
7583710|NCT02691702|18667014|P6|COMPLETED|Overall Study||5
7583711|NCT02691702|18667015|P5|COMPLETED|Overall Study||8
7583712|NCT02691702|18667016|P4|COMPLETED|Overall Study||8
7583713|NCT02691702|18667017|P3|COMPLETED|Overall Study||7
7583714|NCT02691702|18667018|P2|COMPLETED|Overall Study||10
7583715|NCT02691702|18667019|P1|COMPLETED|Overall Study||8
7583716|NCT02691702|18667009|P11|STARTED|Overall Study||8
7583717|NCT02691702|18667010|P10|STARTED|Overall Study||8
7583718|NCT02691702|18667011|P9|STARTED|Overall Study||8
7583719|NCT02691702|18667012|P8|STARTED|Overall Study||12
7583720|NCT02691702|18667013|P7|STARTED|Overall Study||8
7583721|NCT02691702|18667014|P6|STARTED|Overall Study||8
7583722|NCT02691702|18667015|P5|STARTED|Overall Study||8
7583723|NCT02691702|18667016|P4|STARTED|Overall Study||8
7583724|NCT02691702|18667017|P3|STARTED|Overall Study||8
7583725|NCT02691702|18667018|P2|STARTED|Overall Study||11
7583726|NCT02691702|18667019|P1|STARTED|Overall Study||10
7583727|NCT02691572|18667305|P2|NOT COMPLETED|Overall Study||1
7583728|NCT02691572|18667306|P1|NOT COMPLETED|Overall Study||1
7583729|NCT02691572|18667305|P2|COMPLETED|Overall Study||39
7583730|NCT02691572|18667306|P1|COMPLETED|Overall Study||39
7583731|NCT02691572|18667305|P2|STARTED|Overall Study||40
7583732|NCT02691572|18667306|P1|STARTED|Overall Study||40
7583733|NCT02691507|18667314|P2|NOT COMPLETED|Overall Study||1
7583734|NCT02691507|18667315|P1|NOT COMPLETED|Overall Study||0
7583735|NCT02691507|18667314|P2|COMPLETED|Overall Study||12
7583736|NCT02691507|18667315|P1|COMPLETED|Overall Study||40
7583737|NCT02691507|18667314|P2|STARTED|Overall Study||13
7583738|NCT02691507|18667315|P1|STARTED|Overall Study||40
7583739|NCT02691494|18667448|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||17
7583740|NCT02691494|18667449|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||7
7583741|NCT02691494|18667450|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||5
7583742|NCT02691494|18667448|P3|COMPLETED|Post-Treatment Follow-Up Period||42
7583743|NCT02691494|18667449|P2|COMPLETED|Post-Treatment Follow-Up Period||18
7583744|NCT02691494|18667450|P1|COMPLETED|Post-Treatment Follow-Up Period||9
7583745|NCT02691494|18667448|P3|STARTED|Post-Treatment Follow-Up Period||59
7583746|NCT02691494|18667449|P2|STARTED|Post-Treatment Follow-Up Period||25
7583747|NCT02691494|18667450|P1|STARTED|Post-Treatment Follow-Up Period||14
7583748|NCT02691494|18667448|P3|NOT COMPLETED|Treatment Period||41
7583749|NCT02691494|18667449|P2|NOT COMPLETED|Treatment Period||26
7583750|NCT02691494|18667450|P1|NOT COMPLETED|Treatment Period||22
7583751|NCT02691494|18667448|P3|COMPLETED|Treatment Period|completed treatment period|148
7583752|NCT02691494|18667449|P2|COMPLETED|Treatment Period|completed treatment period|69
7583753|NCT02691494|18667450|P1|COMPLETED|Treatment Period|completed treatment period|72
7583754|NCT02691494|18667448|P3|STARTED|Treatment Period||189
7583755|NCT02691494|18667449|P2|STARTED|Treatment Period||95
7583756|NCT02691494|18667450|P1|STARTED|Treatment Period||94
7583757|NCT02691468|18667478|P2|NOT COMPLETED|Overall Study||2
7583758|NCT02691468|18667479|P1|NOT COMPLETED|Overall Study||6
7583759|NCT02691468|18667478|P2|COMPLETED|Overall Study||52
7583760|NCT02691468|18667479|P1|COMPLETED|Overall Study||48
7583761|NCT02691468|18667478|P2|STARTED|Overall Study||54
7583762|NCT02691468|18667479|P1|STARTED|Overall Study||54
7583763|NCT02691416|18667489|P2|NOT COMPLETED|Overall Study||0
7583764|NCT02691416|18667490|P1|NOT COMPLETED|Overall Study||0
7583765|NCT02691416|18667489|P2|COMPLETED|Overall Study||30
7583766|NCT02691416|18667490|P1|COMPLETED|Overall Study||30
7583767|NCT02691416|18667489|P2|STARTED|Overall Study||30
7583768|NCT02691416|18667490|P1|STARTED|Overall Study||30
7583769|NCT02691260|18667514|P4|NOT COMPLETED|Overall Study||3
7583770|NCT02691260|18667515|P3|NOT COMPLETED|Overall Study||2
7583771|NCT02691260|18667516|P2|NOT COMPLETED|Overall Study||2
7583772|NCT02691260|18667517|P1|NOT COMPLETED|Overall Study||2
7583773|NCT02691260|18667514|P4|COMPLETED|Overall Study||23
7583774|NCT02691260|18667515|P3|COMPLETED|Overall Study||25
7583775|NCT02691260|18667516|P2|COMPLETED|Overall Study||24
7583776|NCT02691260|18667517|P1|COMPLETED|Overall Study||24
7583777|NCT02691260|18667514|P4|STARTED|Overall Study||26
7583778|NCT02691260|18667515|P3|STARTED|Overall Study||27
7583779|NCT02691260|18667516|P2|STARTED|Overall Study||26
7583780|NCT02691260|18667517|P1|STARTED|Overall Study||26
7583781|NCT02691143|18667529|P2|NOT COMPLETED|Overall Study||0
7583782|NCT02691143|18667530|P1|NOT COMPLETED|Overall Study||0
7583783|NCT02691143|18667529|P2|COMPLETED|Overall Study||23
7583784|NCT02691143|18667530|P1|COMPLETED|Overall Study||27
7583785|NCT02691143|18667529|P2|STARTED|Overall Study||23
7583786|NCT02691143|18667530|P1|STARTED|Overall Study||27
7583787|NCT02691013|18667540|P2|NOT COMPLETED|Overall Study||0
7583788|NCT02691013|18667541|P1|NOT COMPLETED|Overall Study||3
7583789|NCT02691013|18667540|P2|COMPLETED|Overall Study||59
7583790|NCT02691013|18667541|P1|COMPLETED|Overall Study||58
7583791|NCT02691013|18667540|P2|STARTED|Overall Study||59
7583792|NCT02691013|18667541|P1|STARTED|Overall Study||61
7583793|NCT02690974|18667555|P1|NOT COMPLETED|Overall Study||40
7583794|NCT02690974|18667555|P1|COMPLETED|Overall Study||262
7583795|NCT02690974|18667555|P1|STARTED|Overall Study||302
7583796|NCT02690948|18667568|P2|NOT COMPLETED|Overall Study||0
7583797|NCT02690948|18667569|P1|NOT COMPLETED|Overall Study||0
7583798|NCT02690948|18667568|P2|COMPLETED|Overall Study||7
7583799|NCT02690948|18667569|P1|COMPLETED|Overall Study||9
7583800|NCT02690948|18667568|P2|STARTED|Overall Study||7
7583801|NCT02690948|18667569|P1|STARTED|Overall Study||9
7583802|NCT02690935|18667587|P2|NOT COMPLETED|Overall Study||0
7583803|NCT02690935|18667588|P1|NOT COMPLETED|Overall Study||0
7583804|NCT02690935|18667587|P2|COMPLETED|Overall Study|Count of participants|51
7583805|NCT02690935|18667588|P1|COMPLETED|Overall Study|Count of participants|51
7583806|NCT02690935|18667587|P2|STARTED|Overall Study|Count of participants|51
7583807|NCT02690935|18667588|P1|STARTED|Overall Study|Count of participants|51
7583808|NCT02690727|18667596|P2|NOT COMPLETED|Overall Study||2
7583809|NCT02690727|18667597|P1|NOT COMPLETED|Overall Study||2
7583810|NCT02690727|18667596|P2|COMPLETED|Overall Study||7
7583811|NCT02690727|18667597|P1|COMPLETED|Overall Study||7
7583812|NCT02690727|18667596|P2|STARTED|Overall Study||9
7583813|NCT02690727|18667597|P1|STARTED|Overall Study||9
7583814|NCT02690701|18667609|P2|NOT COMPLETED|Treatment Period 2||5
7583815|NCT02690701|18667610|P1|NOT COMPLETED|Treatment Period 2||3
7583816|NCT02690701|18667609|P2|COMPLETED|Treatment Period 2||37
7583817|NCT02690701|18667610|P1|COMPLETED|Treatment Period 2|Completed Treatment Period 2|41
7583818|NCT02690701|18667609|P2|STARTED|Treatment Period 2||42
7583819|NCT02690701|18667610|P1|STARTED|Treatment Period 2|Completed Treatment Period 1 and continued to Treatment Period 2|44
7583820|NCT02690701|18667609|P2|NOT COMPLETED|Treatment Period 1||3
7583821|NCT02690701|18667610|P1|NOT COMPLETED|Treatment Period 1||2
7583822|NCT02690701|18667609|P2|COMPLETED|Treatment Period 1||42
7583823|NCT02690701|18667610|P1|COMPLETED|Treatment Period 1||44
7583824|NCT02690701|18667609|P2|STARTED|Treatment Period 1||45
7583825|NCT02690701|18667610|P1|STARTED|Treatment Period 1||46
7583826|NCT02690207|18667675|P1|NOT COMPLETED|Overall Study||253
7583827|NCT02690207|18667675|P1|COMPLETED|Overall Study||8434
7583828|NCT02690207|18667675|P1|STARTED|Overall Study||8687
7583829|NCT02690194|18667685|P3|NOT COMPLETED|Overall Study||0
7583830|NCT02690194|18667686|P2|NOT COMPLETED|Overall Study||4
7583831|NCT02690194|18667687|P1|NOT COMPLETED|Overall Study||1
7583832|NCT02690194|18667685|P3|COMPLETED|Overall Study||19
7583833|NCT02690194|18667686|P2|COMPLETED|Overall Study||14
7583834|NCT02690194|18667687|P1|COMPLETED|Overall Study||16
7583835|NCT02690194|18667685|P3|STARTED|Overall Study||19
7583836|NCT02690194|18667686|P2|STARTED|Overall Study||18
7583837|NCT02690194|18667687|P1|STARTED|Overall Study||17
7583838|NCT02690181|18667736|P6|NOT COMPLETED|Overall Study||0
7583839|NCT02690181|18667737|P5|NOT COMPLETED|Overall Study||0
7583840|NCT02690181|18667738|P4|NOT COMPLETED|Overall Study||0
7583841|NCT02690181|18667739|P3|NOT COMPLETED|Overall Study||0
7583842|NCT02690181|18667740|P2|NOT COMPLETED|Overall Study||0
7583843|NCT02690181|18667741|P1|NOT COMPLETED|Overall Study||0
7583844|NCT02690181|18667736|P6|COMPLETED|Overall Study||21
7583845|NCT02690181|18667737|P5|COMPLETED|Overall Study||6
7583846|NCT02690181|18667738|P4|COMPLETED|Overall Study||10
7583847|NCT02690181|18667739|P3|COMPLETED|Overall Study||15
7583848|NCT02690181|18667740|P2|COMPLETED|Overall Study||14
7583849|NCT02690181|18667741|P1|COMPLETED|Overall Study||14
7583850|NCT02690181|18667736|P6|STARTED|Overall Study||21
7583851|NCT02690181|18667737|P5|STARTED|Overall Study||6
7583852|NCT02690181|18667738|P4|STARTED|Overall Study||10
7583853|NCT02690181|18667739|P3|STARTED|Overall Study||15
7583854|NCT02690181|18667740|P2|STARTED|Overall Study||14
7583855|NCT02690181|18667741|P1|STARTED|Overall Study||14
7583856|NCT02689973|18667867|P4|NOT COMPLETED|Overall Study||53
7583857|NCT02689973|18667868|P3|NOT COMPLETED|Overall Study||72
7583858|NCT02689973|18667869|P2|NOT COMPLETED|Overall Study||49
7583859|NCT02689973|18667870|P1|NOT COMPLETED|Overall Study||54
7583860|NCT02689973|18667867|P4|COMPLETED|Overall Study||232
7583861|NCT02689973|18667868|P3|COMPLETED|Overall Study||279
7583862|NCT02689973|18667869|P2|COMPLETED|Overall Study||221
7583863|NCT02689973|18667870|P1|COMPLETED|Overall Study||257
7583864|NCT02689973|18667867|P4|STARTED|Overall Study||285
7583865|NCT02689973|18667868|P3|STARTED|Overall Study||351
7583866|NCT02689973|18667869|P2|STARTED|Overall Study||270
7583867|NCT02689973|18667870|P1|STARTED|Overall Study||311
7583868|NCT02689804|18667894|P2|NOT COMPLETED|Overall Study||0
7583869|NCT02689804|18667895|P1|NOT COMPLETED|Overall Study||2
7583870|NCT02689804|18667894|P2|COMPLETED|Overall Study||16
7583871|NCT02689804|18667895|P1|COMPLETED|Overall Study||16
7583872|NCT02689804|18667894|P2|STARTED|Overall Study||16
7583873|NCT02689804|18667895|P1|STARTED|Overall Study||18
7583874|NCT02689492|18667921|P1|NOT COMPLETED|Overall Study||86
7583875|NCT02689492|18667921|P1|COMPLETED|Overall Study||315
7583876|NCT02689492|18667921|P1|STARTED|Overall Study||401
7583877|NCT02689219|18667937|P2|NOT COMPLETED|Overall Study||7
7583878|NCT02689219|18667938|P1|NOT COMPLETED|Overall Study||11
7583879|NCT02689219|18667937|P2|COMPLETED|Overall Study||0
7583880|NCT02689219|18667938|P1|COMPLETED|Overall Study||0
7583881|NCT02689219|18667937|P2|STARTED|Overall Study||7
7583882|NCT02689219|18667938|P1|STARTED|Overall Study||11
7583883|NCT02689206|18667955|P5|NOT COMPLETED|Overall Study||8
7583884|NCT02689206|18667956|P4|NOT COMPLETED|Overall Study||4
7583885|NCT02689206|18667957|P3|NOT COMPLETED|Overall Study||4
7583886|NCT02689206|18667958|P2|NOT COMPLETED|Overall Study||1
7583887|NCT02689206|18667959|P1|NOT COMPLETED|Overall Study||3
7583888|NCT02689206|18667955|P5|COMPLETED|Overall Study||14
7583889|NCT02689206|18667956|P4|COMPLETED|Overall Study||17
7583890|NCT02689206|18667957|P3|COMPLETED|Overall Study||16
7583891|NCT02689206|18667958|P2|COMPLETED|Overall Study||19
7583892|NCT02689206|18667959|P1|COMPLETED|Overall Study||17
7583893|NCT02689206|18667955|P5|STARTED|Overall Study||22
7583894|NCT02689206|18667956|P4|STARTED|Overall Study||21
7583895|NCT02689206|18667957|P3|STARTED|Overall Study||20
7583896|NCT02689206|18667958|P2|STARTED|Overall Study||20
7583897|NCT02689206|18667959|P1|STARTED|Overall Study||20
7583898|NCT02689154|18668163|P1|NOT COMPLETED|Overall Study||0
7583899|NCT02689154|18668163|P1|COMPLETED|Overall Study||18
7583900|NCT02689154|18668163|P1|STARTED|Overall Study||18
7583901|NCT02688933|18668172|P2|NOT COMPLETED|Overall Study||37
7583902|NCT02688933|18668173|P1|NOT COMPLETED|Overall Study||29
7583903|NCT02688933|18668172|P2|COMPLETED|Overall Study||281
7583904|NCT02688933|18668173|P1|COMPLETED|Overall Study||291
7583905|NCT02688933|18668172|P2|STARTED|Overall Study||318
7583906|NCT02688933|18668173|P1|STARTED|Overall Study||320
7583907|NCT02688868|18668193|P1|NOT COMPLETED|Overall Study||4
7583908|NCT02688868|18668193|P1|COMPLETED|Overall Study||34
7583909|NCT02688868|18668193|P1|STARTED|Overall Study||38
7583910|NCT02688842|18668205|P1|NOT COMPLETED|Overall Study||0
7583911|NCT02688842|18668205|P1|COMPLETED|Overall Study||38
7583912|NCT02688842|18668205|P1|STARTED|Overall Study||38
7583913|NCT02688829|18668221|P1|NOT COMPLETED|Overall Study||2
7583914|NCT02688829|18668221|P1|COMPLETED|Overall Study||19
7583915|NCT02688829|18668221|P1|STARTED|Overall Study||21
7583916|NCT02688764|18668233|P2|NOT COMPLETED|Overall Study||17
7583917|NCT02688764|18668234|P1|NOT COMPLETED|Overall Study||40
7583918|NCT02688764|18668233|P2|COMPLETED|Overall Study||2
7583919|NCT02688764|18668234|P1|COMPLETED|Overall Study||26
7583920|NCT02688764|18668233|P2|Treated in Stage 2|Overall Study||8
7583921|NCT02688764|18668234|P1|Treated in Stage 2|Overall Study||43
7583922|NCT02688764|18668233|P2|Treated in Stage 1|Overall Study||19
7583923|NCT02688764|18668234|P1|Treated in Stage 1|Overall Study||66
7583924|NCT02688764|18668233|P2|STARTED|Overall Study||19
7583925|NCT02688764|18668234|P1|STARTED|Overall Study||66
7583926|NCT02688556|18668284|P2|NOT COMPLETED|Overall Study||12
7583927|NCT02688556|18668285|P1|NOT COMPLETED|Overall Study||25
7583928|NCT02688556|18668284|P2|COMPLETED|Overall Study||361
7583929|NCT02688556|18668285|P1|COMPLETED|Overall Study||347
7583930|NCT02688556|18668284|P2|STARTED|Overall Study||373
7583931|NCT02688556|18668285|P1|STARTED|Overall Study||372
7583932|NCT02688387|18668301|P22|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583933|NCT02688387|18668302|P21|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583934|NCT02688387|18668303|P20|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583935|NCT02688387|18668304|P19|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583936|NCT02688387|18668305|P18|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583937|NCT02688387|18668306|P17|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583938|NCT02688387|18668307|P16|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583939|NCT02688387|18668308|P15|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583940|NCT02688387|18668309|P14|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583941|NCT02688387|18668310|P13|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583942|NCT02688387|18668311|P12|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583943|NCT02688387|18668312|P11|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583944|NCT02688387|18668313|P10|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583945|NCT02688387|18668314|P9|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583946|NCT02688387|18668315|P8|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583947|NCT02688387|18668316|P7|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583948|NCT02688387|18668317|P6|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583949|NCT02688387|18668318|P5|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583950|NCT02688387|18668319|P4|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583951|NCT02688387|18668320|P3|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583952|NCT02688387|18668321|P2|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583953|NCT02688387|18668322|P1|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583954|NCT02688387|18668301|P22|COMPLETED|Part 3B, Period 4 (up to 6 Days)||8
7583955|NCT02688387|18668302|P21|COMPLETED|Part 3B, Period 4 (up to 6 Days)||6
7583956|NCT02688387|18668303|P20|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
7583957|NCT02688387|18668304|P19|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
7583958|NCT02688387|18668305|P18|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583959|NCT02688387|18668306|P17|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583960|NCT02688387|18668307|P16|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583961|NCT02688387|18668308|P15|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583962|NCT02688387|18668309|P14|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583963|NCT02688387|18668310|P13|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583964|NCT02688387|18668311|P12|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583965|NCT02688387|18668312|P11|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583966|NCT02688387|18668313|P10|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583967|NCT02688387|18668314|P9|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583968|NCT02688387|18668315|P8|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583969|NCT02688387|18668316|P7|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583970|NCT02688387|18668317|P6|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583971|NCT02688387|18668318|P5|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583972|NCT02688387|18668319|P4|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583973|NCT02688387|18668320|P3|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583974|NCT02688387|18668321|P2|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583975|NCT02688387|18668322|P1|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
7583976|NCT02688387|18668301|P22|STARTED|Part 3B, Period 4 (up to 6 Days)||8
7583977|NCT02688387|18668302|P21|STARTED|Part 3B, Period 4 (up to 6 Days)||6
7583978|NCT02688387|18668303|P20|STARTED|Part 3B, Period 4 (up to 6 Days)||7
7583979|NCT02688387|18668304|P19|STARTED|Part 3B, Period 4 (up to 6 Days)||7
7583980|NCT02688387|18668305|P18|STARTED|Part 3B, Period 4 (up to 6 Days)||0
7583981|NCT02688387|18668306|P17|STARTED|Part 3B, Period 4 (up to 6 Days)||0
7583982|NCT02688387|18668307|P16|STARTED|Part 3B, Period 4 (up to 6 Days)||0
7583983|NCT02688387|18668308|P15|STARTED|Part 3B, Period 4 (up to 6 Days)||0
7583984|NCT02688387|18668309|P14|STARTED|Part 3B, Period 4 (up to 6 Days)||0
7583985|NCT02688387|18668310|P13|STARTED|Part 3B, Period 4 (up to 6 Days)||0
7583986|NCT02688387|18668311|P12|STARTED|Part 3B, Period 4 (up to 6 Days)||0
7583987|NCT02688387|18668312|P11|STARTED|Part 3B, Period 4 (up to 6 Days)||0
7583988|NCT02688387|18668313|P10|STARTED|Part 3B, Period 4 (up to 6 Days)||0
7583989|NCT02688387|18668314|P9|STARTED|Part 3B, Period 4 (up to 6 Days)||0
7583990|NCT02688387|18668315|P8|STARTED|Part 3B, Period 4 (up to 6 Days)||0
7583991|NCT02688387|18668316|P7|STARTED|Part 3B, Period 4 (up to 6 Days)||0
7583992|NCT02688387|18668317|P6|STARTED|Part 3B, Period 4 (up to 6 Days)||0
7583993|NCT02688387|18668318|P5|STARTED|Part 3B, Period 4 (up to 6 Days)||0
7583994|NCT02688387|18668319|P4|STARTED|Part 3B, Period 4 (up to 6 Days)||0
7583995|NCT02688387|18668320|P3|STARTED|Part 3B, Period 4 (up to 6 Days)||0
7583996|NCT02688387|18668321|P2|STARTED|Part 3B, Period 4 (up to 6 Days)||0
7583997|NCT02688387|18668322|P1|STARTED|Part 3B, Period 4 (up to 6 Days)||0
7583998|NCT02688387|18668301|P22|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7583999|NCT02688387|18668302|P21|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
7584000|NCT02688387|18668303|P20|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
7584001|NCT02688387|18668304|P19|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
7584002|NCT02688387|18668305|P18|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584003|NCT02688387|18668306|P17|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584004|NCT02688387|18668307|P16|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584005|NCT02688387|18668308|P15|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584006|NCT02688387|18668309|P14|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584007|NCT02688387|18668310|P13|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584008|NCT02688387|18668311|P12|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584009|NCT02688387|18668312|P11|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584010|NCT02688387|18668313|P10|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584011|NCT02688387|18668314|P9|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584012|NCT02688387|18668315|P8|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584013|NCT02688387|18668316|P7|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584014|NCT02688387|18668317|P6|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584015|NCT02688387|18668318|P5|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584016|NCT02688387|18668319|P4|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584017|NCT02688387|18668320|P3|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584018|NCT02688387|18668321|P2|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584019|NCT02688387|18668322|P1|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584020|NCT02688387|18668301|P22|COMPLETED|Part 3B, Washout Period 3 (10 Days)||8
7584021|NCT02688387|18668302|P21|COMPLETED|Part 3B, Washout Period 3 (10 Days)||6
7584022|NCT02688387|18668303|P20|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
7584023|NCT02688387|18668304|P19|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
7584024|NCT02688387|18668305|P18|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584025|NCT02688387|18668306|P17|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584026|NCT02688387|18668307|P16|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584027|NCT02688387|18668308|P15|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584028|NCT02688387|18668309|P14|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584029|NCT02688387|18668310|P13|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584030|NCT02688387|18668311|P12|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584031|NCT02688387|18668312|P11|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584032|NCT02688387|18668313|P10|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584033|NCT02688387|18668314|P9|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584034|NCT02688387|18668315|P8|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584035|NCT02688387|18668316|P7|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584036|NCT02688387|18668317|P6|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584037|NCT02688387|18668318|P5|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584038|NCT02688387|18668319|P4|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584039|NCT02688387|18668320|P3|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584040|NCT02688387|18668321|P2|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584041|NCT02688387|18668322|P1|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
7584042|NCT02688387|18668301|P22|STARTED|Part 3B, Washout Period 3 (10 Days)||8
7584043|NCT02688387|18668302|P21|STARTED|Part 3B, Washout Period 3 (10 Days)||7
7584044|NCT02688387|18668303|P20|STARTED|Part 3B, Washout Period 3 (10 Days)||8
7584045|NCT02688387|18668304|P19|STARTED|Part 3B, Washout Period 3 (10 Days)||8
7584046|NCT02688387|18668305|P18|STARTED|Part 3B, Washout Period 3 (10 Days)||0
7584047|NCT02688387|18668306|P17|STARTED|Part 3B, Washout Period 3 (10 Days)||0
7584048|NCT02688387|18668307|P16|STARTED|Part 3B, Washout Period 3 (10 Days)||0
7584049|NCT02688387|18668308|P15|STARTED|Part 3B, Washout Period 3 (10 Days)||0
7584050|NCT02688387|18668309|P14|STARTED|Part 3B, Washout Period 3 (10 Days)||0
7584051|NCT02688387|18668310|P13|STARTED|Part 3B, Washout Period 3 (10 Days)||0
7584052|NCT02688387|18668311|P12|STARTED|Part 3B, Washout Period 3 (10 Days)||0
7584053|NCT02688387|18668312|P11|STARTED|Part 3B, Washout Period 3 (10 Days)||0
7584054|NCT02688387|18668313|P10|STARTED|Part 3B, Washout Period 3 (10 Days)||0
7584055|NCT02688387|18668314|P9|STARTED|Part 3B, Washout Period 3 (10 Days)||0
7584056|NCT02688387|18668315|P8|STARTED|Part 3B, Washout Period 3 (10 Days)||0
7584057|NCT02688387|18668316|P7|STARTED|Part 3B, Washout Period 3 (10 Days)||0
7584058|NCT02688387|18668317|P6|STARTED|Part 3B, Washout Period 3 (10 Days)||0
7584059|NCT02688387|18668318|P5|STARTED|Part 3B, Washout Period 3 (10 Days)||0
7584060|NCT02688387|18668319|P4|STARTED|Part 3B, Washout Period 3 (10 Days)||0
7584061|NCT02688387|18668320|P3|STARTED|Part 3B, Washout Period 3 (10 Days)||0
7584062|NCT02688387|18668321|P2|STARTED|Part 3B, Washout Period 3 (10 Days)||0
7584063|NCT02688387|18668322|P1|STARTED|Part 3B, Washout Period 3 (10 Days)||0
7584064|NCT02688387|18668301|P22|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584065|NCT02688387|18668302|P21|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||1
7584066|NCT02688387|18668303|P20|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584067|NCT02688387|18668304|P19|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584068|NCT02688387|18668305|P18|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584069|NCT02688387|18668306|P17|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584070|NCT02688387|18668307|P16|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584071|NCT02688387|18668308|P15|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584072|NCT02688387|18668309|P14|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584073|NCT02688387|18668310|P13|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584074|NCT02688387|18668311|P12|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584075|NCT02688387|18668312|P11|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584076|NCT02688387|18668313|P10|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584077|NCT02688387|18668314|P9|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584078|NCT02688387|18668315|P8|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584079|NCT02688387|18668316|P7|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584080|NCT02688387|18668317|P6|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584081|NCT02688387|18668318|P5|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584082|NCT02688387|18668319|P4|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584083|NCT02688387|18668320|P3|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584084|NCT02688387|18668321|P2|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584085|NCT02688387|18668322|P1|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584086|NCT02688387|18668301|P22|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
7584087|NCT02688387|18668302|P21|COMPLETED|Part 3B, Period 3 (up to 6 Days)||7
7584088|NCT02688387|18668303|P20|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
7584089|NCT02688387|18668304|P19|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
7584090|NCT02688387|18668305|P18|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584091|NCT02688387|18668306|P17|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584092|NCT02688387|18668307|P16|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584093|NCT02688387|18668308|P15|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584094|NCT02688387|18668309|P14|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584095|NCT02688387|18668310|P13|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584096|NCT02688387|18668311|P12|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584097|NCT02688387|18668312|P11|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584098|NCT02688387|18668313|P10|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584099|NCT02688387|18668314|P9|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584100|NCT02688387|18668315|P8|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584101|NCT02688387|18668316|P7|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584102|NCT02688387|18668317|P6|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584103|NCT02688387|18668318|P5|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584104|NCT02688387|18668319|P4|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584105|NCT02688387|18668320|P3|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584106|NCT02688387|18668321|P2|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584107|NCT02688387|18668322|P1|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
7584108|NCT02688387|18668301|P22|STARTED|Part 3B, Period 3 (up to 6 Days)||8
7584109|NCT02688387|18668302|P21|STARTED|Part 3B, Period 3 (up to 6 Days)||8
7584110|NCT02688387|18668303|P20|STARTED|Part 3B, Period 3 (up to 6 Days)||8
7584111|NCT02688387|18668304|P19|STARTED|Part 3B, Period 3 (up to 6 Days)||8
7584112|NCT02688387|18668305|P18|STARTED|Part 3B, Period 3 (up to 6 Days)||0
7584113|NCT02688387|18668306|P17|STARTED|Part 3B, Period 3 (up to 6 Days)||0
7584114|NCT02688387|18668307|P16|STARTED|Part 3B, Period 3 (up to 6 Days)||0
7584115|NCT02688387|18668308|P15|STARTED|Part 3B, Period 3 (up to 6 Days)||0
7584116|NCT02688387|18668309|P14|STARTED|Part 3B, Period 3 (up to 6 Days)||0
7584117|NCT02688387|18668310|P13|STARTED|Part 3B, Period 3 (up to 6 Days)||0
7584118|NCT02688387|18668311|P12|STARTED|Part 3B, Period 3 (up to 6 Days)||0
7584119|NCT02688387|18668312|P11|STARTED|Part 3B, Period 3 (up to 6 Days)||0
7584120|NCT02688387|18668313|P10|STARTED|Part 3B, Period 3 (up to 6 Days)||0
7584121|NCT02688387|18668314|P9|STARTED|Part 3B, Period 3 (up to 6 Days)||0
7584122|NCT02688387|18668315|P8|STARTED|Part 3B, Period 3 (up to 6 Days)||0
7584123|NCT02688387|18668316|P7|STARTED|Part 3B, Period 3 (up to 6 Days)||0
7584124|NCT02688387|18668317|P6|STARTED|Part 3B, Period 3 (up to 6 Days)||0
7584125|NCT02688387|18668318|P5|STARTED|Part 3B, Period 3 (up to 6 Days)||0
7584126|NCT02688387|18668319|P4|STARTED|Part 3B, Period 3 (up to 6 Days)||0
7584127|NCT02688387|18668320|P3|STARTED|Part 3B, Period 3 (up to 6 Days)||0
7584128|NCT02688387|18668321|P2|STARTED|Part 3B, Period 3 (up to 6 Days)||0
7584129|NCT02688387|18668322|P1|STARTED|Part 3B, Period 3 (up to 6 Days)||0
7584130|NCT02688387|18668301|P22|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584131|NCT02688387|18668302|P21|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584132|NCT02688387|18668303|P20|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584133|NCT02688387|18668304|P19|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584134|NCT02688387|18668305|P18|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584135|NCT02688387|18668306|P17|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584136|NCT02688387|18668307|P16|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584137|NCT02688387|18668308|P15|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584138|NCT02688387|18668309|P14|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584139|NCT02688387|18668310|P13|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584140|NCT02688387|18668311|P12|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584141|NCT02688387|18668312|P11|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584142|NCT02688387|18668313|P10|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584143|NCT02688387|18668314|P9|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584144|NCT02688387|18668315|P8|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584145|NCT02688387|18668316|P7|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584146|NCT02688387|18668317|P6|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584147|NCT02688387|18668318|P5|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584148|NCT02688387|18668319|P4|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584149|NCT02688387|18668320|P3|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584150|NCT02688387|18668321|P2|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584151|NCT02688387|18668322|P1|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584152|NCT02688387|18668301|P22|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
7584153|NCT02688387|18668302|P21|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
7584154|NCT02688387|18668303|P20|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
7584155|NCT02688387|18668304|P19|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
7584156|NCT02688387|18668305|P18|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584157|NCT02688387|18668306|P17|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584158|NCT02688387|18668307|P16|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584159|NCT02688387|18668308|P15|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584160|NCT02688387|18668309|P14|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584161|NCT02688387|18668310|P13|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584162|NCT02688387|18668311|P12|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584163|NCT02688387|18668312|P11|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584164|NCT02688387|18668313|P10|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584165|NCT02688387|18668314|P9|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584166|NCT02688387|18668315|P8|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584167|NCT02688387|18668316|P7|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584168|NCT02688387|18668317|P6|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584169|NCT02688387|18668318|P5|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584170|NCT02688387|18668319|P4|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584171|NCT02688387|18668320|P3|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584172|NCT02688387|18668321|P2|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584173|NCT02688387|18668322|P1|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
7584174|NCT02688387|18668301|P22|STARTED|Part 3B, Washout Period 2 (10 Days)||8
7584175|NCT02688387|18668302|P21|STARTED|Part 3B, Washout Period 2 (10 Days)||8
7584176|NCT02688387|18668303|P20|STARTED|Part 3B, Washout Period 2 (10 Days)||8
7584177|NCT02688387|18668304|P19|STARTED|Part 3B, Washout Period 2 (10 Days)||8
7584178|NCT02688387|18668305|P18|STARTED|Part 3B, Washout Period 2 (10 Days)||0
7584179|NCT02688387|18668306|P17|STARTED|Part 3B, Washout Period 2 (10 Days)||0
7584180|NCT02688387|18668307|P16|STARTED|Part 3B, Washout Period 2 (10 Days)||0
7584181|NCT02688387|18668308|P15|STARTED|Part 3B, Washout Period 2 (10 Days)||0
7584182|NCT02688387|18668309|P14|STARTED|Part 3B, Washout Period 2 (10 Days)||0
7584183|NCT02688387|18668310|P13|STARTED|Part 3B, Washout Period 2 (10 Days)||0
7584184|NCT02688387|18668311|P12|STARTED|Part 3B, Washout Period 2 (10 Days)||0
7584185|NCT02688387|18668312|P11|STARTED|Part 3B, Washout Period 2 (10 Days)||0
7584186|NCT02688387|18668313|P10|STARTED|Part 3B, Washout Period 2 (10 Days)||0
7584187|NCT02688387|18668314|P9|STARTED|Part 3B, Washout Period 2 (10 Days)||0
7584188|NCT02688387|18668315|P8|STARTED|Part 3B, Washout Period 2 (10 Days)||0
7584189|NCT02688387|18668316|P7|STARTED|Part 3B, Washout Period 2 (10 Days)||0
7584190|NCT02688387|18668317|P6|STARTED|Part 3B, Washout Period 2 (10 Days)||0
7584191|NCT02688387|18668318|P5|STARTED|Part 3B, Washout Period 2 (10 Days)||0
7584192|NCT02688387|18668319|P4|STARTED|Part 3B, Washout Period 2 (10 Days)||0
7584193|NCT02688387|18668320|P3|STARTED|Part 3B, Washout Period 2 (10 Days)||0
7584194|NCT02688387|18668321|P2|STARTED|Part 3B, Washout Period 2 (10 Days)||0
7584195|NCT02688387|18668322|P1|STARTED|Part 3B, Washout Period 2 (10 Days)||0
7584196|NCT02688387|18668301|P22|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584197|NCT02688387|18668302|P21|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584198|NCT02688387|18668303|P20|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584199|NCT02688387|18668304|P19|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584200|NCT02688387|18668305|P18|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584201|NCT02688387|18668306|P17|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584202|NCT02688387|18668307|P16|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584203|NCT02688387|18668308|P15|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584204|NCT02688387|18668309|P14|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584205|NCT02688387|18668310|P13|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584206|NCT02688387|18668311|P12|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584207|NCT02688387|18668312|P11|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584208|NCT02688387|18668313|P10|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584209|NCT02688387|18668314|P9|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584210|NCT02688387|18668315|P8|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584211|NCT02688387|18668316|P7|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584212|NCT02688387|18668317|P6|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584213|NCT02688387|18668318|P5|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584214|NCT02688387|18668319|P4|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584215|NCT02688387|18668320|P3|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584216|NCT02688387|18668321|P2|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584217|NCT02688387|18668322|P1|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584218|NCT02688387|18668301|P22|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
7584219|NCT02688387|18668302|P21|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
7584220|NCT02688387|18668303|P20|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
7584221|NCT02688387|18668304|P19|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
7584222|NCT02688387|18668305|P18|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584223|NCT02688387|18668306|P17|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584224|NCT02688387|18668307|P16|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584225|NCT02688387|18668308|P15|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584226|NCT02688387|18668309|P14|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584227|NCT02688387|18668310|P13|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584228|NCT02688387|18668311|P12|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584229|NCT02688387|18668312|P11|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584230|NCT02688387|18668313|P10|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584231|NCT02688387|18668314|P9|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584232|NCT02688387|18668315|P8|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584233|NCT02688387|18668316|P7|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584234|NCT02688387|18668317|P6|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584235|NCT02688387|18668318|P5|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584236|NCT02688387|18668319|P4|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584237|NCT02688387|18668320|P3|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584238|NCT02688387|18668321|P2|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584239|NCT02688387|18668322|P1|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
7584240|NCT02688387|18668301|P22|STARTED|Part 3B, Period 2 (up to 6 Days)||8
7584241|NCT02688387|18668302|P21|STARTED|Part 3B, Period 2 (up to 6 Days)||8
7584242|NCT02688387|18668303|P20|STARTED|Part 3B, Period 2 (up to 6 Days)||8
7584243|NCT02688387|18668304|P19|STARTED|Part 3B, Period 2 (up to 6 Days)||8
7584244|NCT02688387|18668305|P18|STARTED|Part 3B, Period 2 (up to 6 Days)||0
7584245|NCT02688387|18668306|P17|STARTED|Part 3B, Period 2 (up to 6 Days)||0
7584246|NCT02688387|18668307|P16|STARTED|Part 3B, Period 2 (up to 6 Days)||0
7584247|NCT02688387|18668308|P15|STARTED|Part 3B, Period 2 (up to 6 Days)||0
7584248|NCT02688387|18668309|P14|STARTED|Part 3B, Period 2 (up to 6 Days)||0
7584249|NCT02688387|18668310|P13|STARTED|Part 3B, Period 2 (up to 6 Days)||0
7584250|NCT02688387|18668311|P12|STARTED|Part 3B, Period 2 (up to 6 Days)||0
7584251|NCT02688387|18668312|P11|STARTED|Part 3B, Period 2 (up to 6 Days)||0
7584252|NCT02688387|18668313|P10|STARTED|Part 3B, Period 2 (up to 6 Days)||0
7584253|NCT02688387|18668314|P9|STARTED|Part 3B, Period 2 (up to 6 Days)||0
7584254|NCT02688387|18668315|P8|STARTED|Part 3B, Period 2 (up to 6 Days)||0
7584255|NCT02688387|18668316|P7|STARTED|Part 3B, Period 2 (up to 6 Days)||0
7584256|NCT02688387|18668317|P6|STARTED|Part 3B, Period 2 (up to 6 Days)||0
7584257|NCT02688387|18668318|P5|STARTED|Part 3B, Period 2 (up to 6 Days)||0
7584258|NCT02688387|18668319|P4|STARTED|Part 3B, Period 2 (up to 6 Days)||0
7584259|NCT02688387|18668320|P3|STARTED|Part 3B, Period 2 (up to 6 Days)||0
7584260|NCT02688387|18668321|P2|STARTED|Part 3B, Period 2 (up to 6 Days)||0
7584261|NCT02688387|18668322|P1|STARTED|Part 3B, Period 2 (up to 6 Days)||0
7584262|NCT02688387|18668301|P22|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584263|NCT02688387|18668302|P21|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584264|NCT02688387|18668303|P20|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584265|NCT02688387|18668304|P19|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584266|NCT02688387|18668305|P18|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584267|NCT02688387|18668306|P17|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584268|NCT02688387|18668307|P16|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584269|NCT02688387|18668308|P15|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584270|NCT02688387|18668309|P14|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584271|NCT02688387|18668310|P13|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584272|NCT02688387|18668311|P12|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584273|NCT02688387|18668312|P11|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584274|NCT02688387|18668313|P10|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584275|NCT02688387|18668314|P9|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584276|NCT02688387|18668315|P8|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584277|NCT02688387|18668316|P7|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584278|NCT02688387|18668317|P6|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584279|NCT02688387|18668318|P5|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584280|NCT02688387|18668319|P4|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584281|NCT02688387|18668320|P3|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584282|NCT02688387|18668321|P2|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584283|NCT02688387|18668322|P1|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584284|NCT02688387|18668301|P22|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
7584285|NCT02688387|18668302|P21|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
7584286|NCT02688387|18668303|P20|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
7584287|NCT02688387|18668304|P19|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
7584288|NCT02688387|18668305|P18|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584289|NCT02688387|18668306|P17|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584290|NCT02688387|18668307|P16|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584291|NCT02688387|18668308|P15|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584292|NCT02688387|18668309|P14|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584293|NCT02688387|18668310|P13|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584294|NCT02688387|18668311|P12|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584295|NCT02688387|18668312|P11|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584296|NCT02688387|18668313|P10|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584297|NCT02688387|18668314|P9|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584298|NCT02688387|18668315|P8|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584299|NCT02688387|18668316|P7|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584300|NCT02688387|18668317|P6|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584301|NCT02688387|18668318|P5|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584302|NCT02688387|18668319|P4|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584303|NCT02688387|18668320|P3|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584304|NCT02688387|18668321|P2|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584305|NCT02688387|18668322|P1|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
7584306|NCT02688387|18668301|P22|STARTED|Part 3B, Washout Period 1 (10 Days)||8
7584307|NCT02688387|18668302|P21|STARTED|Part 3B, Washout Period 1 (10 Days)||8
7584308|NCT02688387|18668303|P20|STARTED|Part 3B, Washout Period 1 (10 Days)||8
7584309|NCT02688387|18668304|P19|STARTED|Part 3B, Washout Period 1 (10 Days)||8
7584310|NCT02688387|18668305|P18|STARTED|Part 3B, Washout Period 1 (10 Days)||0
7584311|NCT02688387|18668306|P17|STARTED|Part 3B, Washout Period 1 (10 Days)||0
7584312|NCT02688387|18668307|P16|STARTED|Part 3B, Washout Period 1 (10 Days)||0
7584313|NCT02688387|18668308|P15|STARTED|Part 3B, Washout Period 1 (10 Days)||0
7584314|NCT02688387|18668309|P14|STARTED|Part 3B, Washout Period 1 (10 Days)||0
7584315|NCT02688387|18668310|P13|STARTED|Part 3B, Washout Period 1 (10 Days)||0
7584316|NCT02688387|18668311|P12|STARTED|Part 3B, Washout Period 1 (10 Days)||0
7584317|NCT02688387|18668312|P11|STARTED|Part 3B, Washout Period 1 (10 Days)||0
7584318|NCT02688387|18668313|P10|STARTED|Part 3B, Washout Period 1 (10 Days)||0
7584319|NCT02688387|18668314|P9|STARTED|Part 3B, Washout Period 1 (10 Days)||0
7584320|NCT02688387|18668315|P8|STARTED|Part 3B, Washout Period 1 (10 Days)||0
7584321|NCT02688387|18668316|P7|STARTED|Part 3B, Washout Period 1 (10 Days)||0
7584322|NCT02688387|18668317|P6|STARTED|Part 3B, Washout Period 1 (10 Days)||0
7584323|NCT02688387|18668318|P5|STARTED|Part 3B, Washout Period 1 (10 Days)||0
7584324|NCT02688387|18668319|P4|STARTED|Part 3B, Washout Period 1 (10 Days)||0
7584325|NCT02688387|18668320|P3|STARTED|Part 3B, Washout Period 1 (10 Days)||0
7584326|NCT02688387|18668321|P2|STARTED|Part 3B, Washout Period 1 (10 Days)||0
7584327|NCT02688387|18668322|P1|STARTED|Part 3B, Washout Period 1 (10 Days)||0
7584328|NCT02688387|18668301|P22|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584329|NCT02688387|18668302|P21|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584330|NCT02688387|18668303|P20|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584331|NCT02688387|18668304|P19|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584332|NCT02688387|18668305|P18|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584333|NCT02688387|18668306|P17|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584334|NCT02688387|18668307|P16|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584335|NCT02688387|18668308|P15|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584336|NCT02688387|18668309|P14|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584337|NCT02688387|18668310|P13|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584338|NCT02688387|18668311|P12|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584339|NCT02688387|18668312|P11|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584340|NCT02688387|18668313|P10|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584341|NCT02688387|18668314|P9|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584342|NCT02688387|18668315|P8|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584343|NCT02688387|18668316|P7|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584344|NCT02688387|18668317|P6|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584345|NCT02688387|18668318|P5|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584346|NCT02688387|18668319|P4|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584347|NCT02688387|18668320|P3|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584348|NCT02688387|18668321|P2|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584349|NCT02688387|18668322|P1|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584350|NCT02688387|18668301|P22|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
7584351|NCT02688387|18668302|P21|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
7584352|NCT02688387|18668303|P20|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
7584353|NCT02688387|18668304|P19|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
7584354|NCT02688387|18668305|P18|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584355|NCT02688387|18668306|P17|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584356|NCT02688387|18668307|P16|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584357|NCT02688387|18668308|P15|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584358|NCT02688387|18668309|P14|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584359|NCT02688387|18668310|P13|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584360|NCT02688387|18668311|P12|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584361|NCT02688387|18668312|P11|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584362|NCT02688387|18668313|P10|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584363|NCT02688387|18668314|P9|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584364|NCT02688387|18668315|P8|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584365|NCT02688387|18668316|P7|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584366|NCT02688387|18668317|P6|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584367|NCT02688387|18668318|P5|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584368|NCT02688387|18668319|P4|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584369|NCT02688387|18668320|P3|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584370|NCT02688387|18668321|P2|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584371|NCT02688387|18668322|P1|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
7584372|NCT02688387|18668301|P22|STARTED|Part 3B, Period 1 (up to 6 Days)||8
7584373|NCT02688387|18668302|P21|STARTED|Part 3B, Period 1 (up to 6 Days)||8
7584374|NCT02688387|18668303|P20|STARTED|Part 3B, Period 1 (up to 6 Days)||8
7584375|NCT02688387|18668304|P19|STARTED|Part 3B, Period 1 (up to 6 Days)||8
7584376|NCT02688387|18668305|P18|STARTED|Part 3B, Period 1 (up to 6 Days)||0
7584377|NCT02688387|18668306|P17|STARTED|Part 3B, Period 1 (up to 6 Days)||0
7584378|NCT02688387|18668307|P16|STARTED|Part 3B, Period 1 (up to 6 Days)||0
7584379|NCT02688387|18668308|P15|STARTED|Part 3B, Period 1 (up to 6 Days)||0
7584380|NCT02688387|18668309|P14|STARTED|Part 3B, Period 1 (up to 6 Days)||0
7584381|NCT02688387|18668310|P13|STARTED|Part 3B, Period 1 (up to 6 Days)||0
7584382|NCT02688387|18668311|P12|STARTED|Part 3B, Period 1 (up to 6 Days)||0
7584383|NCT02688387|18668312|P11|STARTED|Part 3B, Period 1 (up to 6 Days)||0
7584384|NCT02688387|18668313|P10|STARTED|Part 3B, Period 1 (up to 6 Days)||0
7584385|NCT02688387|18668314|P9|STARTED|Part 3B, Period 1 (up to 6 Days)||0
7584386|NCT02688387|18668315|P8|STARTED|Part 3B, Period 1 (up to 6 Days)||0
7584387|NCT02688387|18668316|P7|STARTED|Part 3B, Period 1 (up to 6 Days)||0
7584388|NCT02688387|18668317|P6|STARTED|Part 3B, Period 1 (up to 6 Days)||0
7584389|NCT02688387|18668318|P5|STARTED|Part 3B, Period 1 (up to 6 Days)||0
7584390|NCT02688387|18668319|P4|STARTED|Part 3B, Period 1 (up to 6 Days)||0
7584391|NCT02688387|18668320|P3|STARTED|Part 3B, Period 1 (up to 6 Days)||0
7584392|NCT02688387|18668321|P2|STARTED|Part 3B, Period 1 (up to 6 Days)||0
7584393|NCT02688387|18668322|P1|STARTED|Part 3B, Period 1 (up to 6 Days)||0
7584394|NCT02688387|18668301|P22|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584395|NCT02688387|18668302|P21|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584396|NCT02688387|18668303|P20|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584397|NCT02688387|18668304|P19|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584398|NCT02688387|18668305|P18|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584399|NCT02688387|18668306|P17|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584400|NCT02688387|18668307|P16|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584401|NCT02688387|18668308|P15|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584402|NCT02688387|18668309|P14|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584403|NCT02688387|18668310|P13|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584404|NCT02688387|18668311|P12|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584405|NCT02688387|18668312|P11|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584406|NCT02688387|18668313|P10|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584407|NCT02688387|18668314|P9|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584408|NCT02688387|18668315|P8|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584409|NCT02688387|18668316|P7|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584410|NCT02688387|18668317|P6|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584411|NCT02688387|18668318|P5|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584412|NCT02688387|18668319|P4|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584413|NCT02688387|18668320|P3|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584414|NCT02688387|18668321|P2|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584415|NCT02688387|18668322|P1|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584416|NCT02688387|18668301|P22|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584417|NCT02688387|18668302|P21|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584418|NCT02688387|18668303|P20|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584419|NCT02688387|18668304|P19|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584420|NCT02688387|18668305|P18|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
7584421|NCT02688387|18668306|P17|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
7584422|NCT02688387|18668307|P16|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
7584423|NCT02688387|18668308|P15|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
7584424|NCT02688387|18668309|P14|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584425|NCT02688387|18668310|P13|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584426|NCT02688387|18668311|P12|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584427|NCT02688387|18668312|P11|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584428|NCT02688387|18668313|P10|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584429|NCT02688387|18668314|P9|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584430|NCT02688387|18668315|P8|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584431|NCT02688387|18668316|P7|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584432|NCT02688387|18668317|P6|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584433|NCT02688387|18668318|P5|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584434|NCT02688387|18668319|P4|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584435|NCT02688387|18668320|P3|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584436|NCT02688387|18668321|P2|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584437|NCT02688387|18668322|P1|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
7584438|NCT02688387|18668301|P22|STARTED|Part 3A, Period 4 (up to 6 Days)||0
7584439|NCT02688387|18668302|P21|STARTED|Part 3A, Period 4 (up to 6 Days)||0
7584440|NCT02688387|18668303|P20|STARTED|Part 3A, Period 4 (up to 6 Days)||0
7584441|NCT02688387|18668304|P19|STARTED|Part 3A, Period 4 (up to 6 Days)||0
7584442|NCT02688387|18668305|P18|STARTED|Part 3A, Period 4 (up to 6 Days)||8
7584443|NCT02688387|18668306|P17|STARTED|Part 3A, Period 4 (up to 6 Days)||8
7584444|NCT02688387|18668307|P16|STARTED|Part 3A, Period 4 (up to 6 Days)||8
7584445|NCT02688387|18668308|P15|STARTED|Part 3A, Period 4 (up to 6 Days)||8
7584446|NCT02688387|18668309|P14|STARTED|Part 3A, Period 4 (up to 6 Days)||0
7584447|NCT02688387|18668310|P13|STARTED|Part 3A, Period 4 (up to 6 Days)||0
7584448|NCT02688387|18668311|P12|STARTED|Part 3A, Period 4 (up to 6 Days)||0
7584449|NCT02688387|18668312|P11|STARTED|Part 3A, Period 4 (up to 6 Days)||0
7584450|NCT02688387|18668313|P10|STARTED|Part 3A, Period 4 (up to 6 Days)||0
7584451|NCT02688387|18668314|P9|STARTED|Part 3A, Period 4 (up to 6 Days)||0
7584452|NCT02688387|18668315|P8|STARTED|Part 3A, Period 4 (up to 6 Days)||0
7584453|NCT02688387|18668316|P7|STARTED|Part 3A, Period 4 (up to 6 Days)||0
7584454|NCT02688387|18668317|P6|STARTED|Part 3A, Period 4 (up to 6 Days)||0
7584455|NCT02688387|18668318|P5|STARTED|Part 3A, Period 4 (up to 6 Days)||0
7584456|NCT02688387|18668319|P4|STARTED|Part 3A, Period 4 (up to 6 Days)||0
7584457|NCT02688387|18668320|P3|STARTED|Part 3A, Period 4 (up to 6 Days)||0
7584458|NCT02688387|18668321|P2|STARTED|Part 3A, Period 4 (up to 6 Days)||0
7584459|NCT02688387|18668322|P1|STARTED|Part 3A, Period 4 (up to 6 Days)||0
7584460|NCT02688387|18668301|P22|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584461|NCT02688387|18668302|P21|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584462|NCT02688387|18668303|P20|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584463|NCT02688387|18668304|P19|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584464|NCT02688387|18668305|P18|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584465|NCT02688387|18668306|P17|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584466|NCT02688387|18668307|P16|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584467|NCT02688387|18668308|P15|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584468|NCT02688387|18668309|P14|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584469|NCT02688387|18668310|P13|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584470|NCT02688387|18668311|P12|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584471|NCT02688387|18668312|P11|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584472|NCT02688387|18668313|P10|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584473|NCT02688387|18668314|P9|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584474|NCT02688387|18668315|P8|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584475|NCT02688387|18668316|P7|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584476|NCT02688387|18668317|P6|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584477|NCT02688387|18668318|P5|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584478|NCT02688387|18668319|P4|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584479|NCT02688387|18668320|P3|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584480|NCT02688387|18668321|P2|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584481|NCT02688387|18668322|P1|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584482|NCT02688387|18668301|P22|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584483|NCT02688387|18668302|P21|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584484|NCT02688387|18668303|P20|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584485|NCT02688387|18668304|P19|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584486|NCT02688387|18668305|P18|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
7584487|NCT02688387|18668306|P17|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
7584488|NCT02688387|18668307|P16|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
7584489|NCT02688387|18668308|P15|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
7584490|NCT02688387|18668309|P14|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584491|NCT02688387|18668310|P13|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584492|NCT02688387|18668311|P12|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584493|NCT02688387|18668312|P11|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584494|NCT02688387|18668313|P10|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584495|NCT02688387|18668314|P9|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584496|NCT02688387|18668315|P8|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584497|NCT02688387|18668316|P7|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584498|NCT02688387|18668317|P6|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584499|NCT02688387|18668318|P5|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584500|NCT02688387|18668319|P4|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584501|NCT02688387|18668320|P3|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584502|NCT02688387|18668321|P2|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584503|NCT02688387|18668322|P1|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
7584504|NCT02688387|18668301|P22|STARTED|Part 3A, Washout Period 3 (10 Days)||0
7584505|NCT02688387|18668302|P21|STARTED|Part 3A, Washout Period 3 (10 Days)||0
7584506|NCT02688387|18668303|P20|STARTED|Part 3A, Washout Period 3 (10 Days)||0
7584507|NCT02688387|18668304|P19|STARTED|Part 3A, Washout Period 3 (10 Days)||0
7584508|NCT02688387|18668305|P18|STARTED|Part 3A, Washout Period 3 (10 Days)||8
7584509|NCT02688387|18668306|P17|STARTED|Part 3A, Washout Period 3 (10 Days)||8
7584510|NCT02688387|18668307|P16|STARTED|Part 3A, Washout Period 3 (10 Days)||8
7584511|NCT02688387|18668308|P15|STARTED|Part 3A, Washout Period 3 (10 Days)||8
7584512|NCT02688387|18668309|P14|STARTED|Part 3A, Washout Period 3 (10 Days)||0
7584513|NCT02688387|18668310|P13|STARTED|Part 3A, Washout Period 3 (10 Days)||0
7584514|NCT02688387|18668311|P12|STARTED|Part 3A, Washout Period 3 (10 Days)||0
7584515|NCT02688387|18668312|P11|STARTED|Part 3A, Washout Period 3 (10 Days)||0
7584516|NCT02688387|18668313|P10|STARTED|Part 3A, Washout Period 3 (10 Days)||0
7584517|NCT02688387|18668314|P9|STARTED|Part 3A, Washout Period 3 (10 Days)||0
7584518|NCT02688387|18668315|P8|STARTED|Part 3A, Washout Period 3 (10 Days)||0
7584519|NCT02688387|18668316|P7|STARTED|Part 3A, Washout Period 3 (10 Days)||0
7584520|NCT02688387|18668317|P6|STARTED|Part 3A, Washout Period 3 (10 Days)||0
7584521|NCT02688387|18668318|P5|STARTED|Part 3A, Washout Period 3 (10 Days)||0
7584522|NCT02688387|18668319|P4|STARTED|Part 3A, Washout Period 3 (10 Days)||0
7584523|NCT02688387|18668320|P3|STARTED|Part 3A, Washout Period 3 (10 Days)||0
7584524|NCT02688387|18668321|P2|STARTED|Part 3A, Washout Period 3 (10 Days)||0
7584525|NCT02688387|18668322|P1|STARTED|Part 3A, Washout Period 3 (10 Days)||0
7584526|NCT02688387|18668301|P22|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584527|NCT02688387|18668302|P21|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584528|NCT02688387|18668303|P20|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584529|NCT02688387|18668304|P19|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584530|NCT02688387|18668305|P18|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584531|NCT02688387|18668306|P17|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584532|NCT02688387|18668307|P16|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584533|NCT02688387|18668308|P15|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584534|NCT02688387|18668309|P14|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584535|NCT02688387|18668310|P13|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584536|NCT02688387|18668311|P12|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584537|NCT02688387|18668312|P11|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584538|NCT02688387|18668313|P10|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584539|NCT02688387|18668314|P9|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584540|NCT02688387|18668315|P8|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584541|NCT02688387|18668316|P7|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584542|NCT02688387|18668317|P6|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584543|NCT02688387|18668318|P5|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584544|NCT02688387|18668319|P4|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584545|NCT02688387|18668320|P3|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584546|NCT02688387|18668321|P2|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584547|NCT02688387|18668322|P1|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584548|NCT02688387|18668301|P22|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584549|NCT02688387|18668302|P21|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584550|NCT02688387|18668303|P20|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584551|NCT02688387|18668304|P19|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584552|NCT02688387|18668305|P18|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
7584553|NCT02688387|18668306|P17|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
7584554|NCT02688387|18668307|P16|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
7584555|NCT02688387|18668308|P15|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
7584556|NCT02688387|18668309|P14|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584557|NCT02688387|18668310|P13|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584558|NCT02688387|18668311|P12|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584559|NCT02688387|18668312|P11|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584560|NCT02688387|18668313|P10|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584561|NCT02688387|18668314|P9|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584562|NCT02688387|18668315|P8|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584563|NCT02688387|18668316|P7|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584564|NCT02688387|18668317|P6|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584565|NCT02688387|18668318|P5|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584566|NCT02688387|18668319|P4|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584567|NCT02688387|18668320|P3|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584568|NCT02688387|18668321|P2|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584569|NCT02688387|18668322|P1|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
7584570|NCT02688387|18668301|P22|STARTED|Part 3A, Period 3 (up to 6 Days)||0
7584571|NCT02688387|18668302|P21|STARTED|Part 3A, Period 3 (up to 6 Days)||0
7584572|NCT02688387|18668303|P20|STARTED|Part 3A, Period 3 (up to 6 Days)||0
7584573|NCT02688387|18668304|P19|STARTED|Part 3A, Period 3 (up to 6 Days)||0
7584574|NCT02688387|18668305|P18|STARTED|Part 3A, Period 3 (up to 6 Days)||8
7584575|NCT02688387|18668306|P17|STARTED|Part 3A, Period 3 (up to 6 Days)||8
7584576|NCT02688387|18668307|P16|STARTED|Part 3A, Period 3 (up to 6 Days)||8
7584577|NCT02688387|18668308|P15|STARTED|Part 3A, Period 3 (up to 6 Days)||8
7584578|NCT02688387|18668309|P14|STARTED|Part 3A, Period 3 (up to 6 Days)||0
7584579|NCT02688387|18668310|P13|STARTED|Part 3A, Period 3 (up to 6 Days)||0
7584580|NCT02688387|18668311|P12|STARTED|Part 3A, Period 3 (up to 6 Days)||0
7584581|NCT02688387|18668312|P11|STARTED|Part 3A, Period 3 (up to 6 Days)||0
7584582|NCT02688387|18668313|P10|STARTED|Part 3A, Period 3 (up to 6 Days)||0
7584583|NCT02688387|18668314|P9|STARTED|Part 3A, Period 3 (up to 6 Days)||0
7584584|NCT02688387|18668315|P8|STARTED|Part 3A, Period 3 (up to 6 Days)||0
7584585|NCT02688387|18668316|P7|STARTED|Part 3A, Period 3 (up to 6 Days)||0
7584586|NCT02688387|18668317|P6|STARTED|Part 3A, Period 3 (up to 6 Days)||0
7584587|NCT02688387|18668318|P5|STARTED|Part 3A, Period 3 (up to 6 Days)||0
7584588|NCT02688387|18668319|P4|STARTED|Part 3A, Period 3 (up to 6 Days)||0
7584589|NCT02688387|18668320|P3|STARTED|Part 3A, Period 3 (up to 6 Days)||0
7584590|NCT02688387|18668321|P2|STARTED|Part 3A, Period 3 (up to 6 Days)||0
7584591|NCT02688387|18668322|P1|STARTED|Part 3A, Period 3 (up to 6 Days)||0
7584592|NCT02688387|18668301|P22|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584593|NCT02688387|18668302|P21|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584594|NCT02688387|18668303|P20|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584595|NCT02688387|18668304|P19|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584596|NCT02688387|18668305|P18|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584597|NCT02688387|18668306|P17|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584598|NCT02688387|18668307|P16|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584599|NCT02688387|18668308|P15|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584600|NCT02688387|18668309|P14|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584601|NCT02688387|18668310|P13|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584602|NCT02688387|18668311|P12|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584603|NCT02688387|18668312|P11|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584604|NCT02688387|18668313|P10|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584605|NCT02688387|18668314|P9|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584606|NCT02688387|18668315|P8|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584607|NCT02688387|18668316|P7|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584608|NCT02688387|18668317|P6|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584609|NCT02688387|18668318|P5|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584610|NCT02688387|18668319|P4|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584611|NCT02688387|18668320|P3|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584612|NCT02688387|18668321|P2|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584613|NCT02688387|18668322|P1|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584614|NCT02688387|18668301|P22|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584615|NCT02688387|18668302|P21|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584616|NCT02688387|18668303|P20|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584617|NCT02688387|18668304|P19|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584618|NCT02688387|18668305|P18|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
7584619|NCT02688387|18668306|P17|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
7584620|NCT02688387|18668307|P16|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
7584621|NCT02688387|18668308|P15|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
7584622|NCT02688387|18668309|P14|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584623|NCT02688387|18668310|P13|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584624|NCT02688387|18668311|P12|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584625|NCT02688387|18668312|P11|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584626|NCT02688387|18668313|P10|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584627|NCT02688387|18668314|P9|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584628|NCT02688387|18668315|P8|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584629|NCT02688387|18668316|P7|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584630|NCT02688387|18668317|P6|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584631|NCT02688387|18668318|P5|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584632|NCT02688387|18668319|P4|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584633|NCT02688387|18668320|P3|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584634|NCT02688387|18668321|P2|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584635|NCT02688387|18668322|P1|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
7584636|NCT02688387|18668301|P22|STARTED|Part 3A, Washout Period 2 (10 Days)||0
7584637|NCT02688387|18668302|P21|STARTED|Part 3A, Washout Period 2 (10 Days)||0
7584638|NCT02688387|18668303|P20|STARTED|Part 3A, Washout Period 2 (10 Days)||0
7584639|NCT02688387|18668304|P19|STARTED|Part 3A, Washout Period 2 (10 Days)||0
7584640|NCT02688387|18668305|P18|STARTED|Part 3A, Washout Period 2 (10 Days)||8
7584641|NCT02688387|18668306|P17|STARTED|Part 3A, Washout Period 2 (10 Days)||8
7584642|NCT02688387|18668307|P16|STARTED|Part 3A, Washout Period 2 (10 Days)||8
7584643|NCT02688387|18668308|P15|STARTED|Part 3A, Washout Period 2 (10 Days)||8
7584644|NCT02688387|18668309|P14|STARTED|Part 3A, Washout Period 2 (10 Days)||0
7584645|NCT02688387|18668310|P13|STARTED|Part 3A, Washout Period 2 (10 Days)||0
7584646|NCT02688387|18668311|P12|STARTED|Part 3A, Washout Period 2 (10 Days)||0
7584647|NCT02688387|18668312|P11|STARTED|Part 3A, Washout Period 2 (10 Days)||0
7584648|NCT02688387|18668313|P10|STARTED|Part 3A, Washout Period 2 (10 Days)||0
7584649|NCT02688387|18668314|P9|STARTED|Part 3A, Washout Period 2 (10 Days)||0
7584650|NCT02688387|18668315|P8|STARTED|Part 3A, Washout Period 2 (10 Days)||0
7584651|NCT02688387|18668316|P7|STARTED|Part 3A, Washout Period 2 (10 Days)||0
7584652|NCT02688387|18668317|P6|STARTED|Part 3A, Washout Period 2 (10 Days)||0
7584653|NCT02688387|18668318|P5|STARTED|Part 3A, Washout Period 2 (10 Days)||0
7584654|NCT02688387|18668319|P4|STARTED|Part 3A, Washout Period 2 (10 Days)||0
7584655|NCT02688387|18668320|P3|STARTED|Part 3A, Washout Period 2 (10 Days)||0
7584656|NCT02688387|18668321|P2|STARTED|Part 3A, Washout Period 2 (10 Days)||0
7584657|NCT02688387|18668322|P1|STARTED|Part 3A, Washout Period 2 (10 Days)||0
7584658|NCT02688387|18668301|P22|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584659|NCT02688387|18668302|P21|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584660|NCT02688387|18668303|P20|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584661|NCT02688387|18668304|P19|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584662|NCT02688387|18668305|P18|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584663|NCT02688387|18668306|P17|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584664|NCT02688387|18668307|P16|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584665|NCT02688387|18668308|P15|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584666|NCT02688387|18668309|P14|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584667|NCT02688387|18668310|P13|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584668|NCT02688387|18668311|P12|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584669|NCT02688387|18668312|P11|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584670|NCT02688387|18668313|P10|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584671|NCT02688387|18668314|P9|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584672|NCT02688387|18668315|P8|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584673|NCT02688387|18668316|P7|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584674|NCT02688387|18668317|P6|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584675|NCT02688387|18668318|P5|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584676|NCT02688387|18668319|P4|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584677|NCT02688387|18668320|P3|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584678|NCT02688387|18668321|P2|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584679|NCT02688387|18668322|P1|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584680|NCT02688387|18668301|P22|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584681|NCT02688387|18668302|P21|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584682|NCT02688387|18668303|P20|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584683|NCT02688387|18668304|P19|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584684|NCT02688387|18668305|P18|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
7584685|NCT02688387|18668306|P17|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
7584686|NCT02688387|18668307|P16|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
7584687|NCT02688387|18668308|P15|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
7584688|NCT02688387|18668309|P14|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584689|NCT02688387|18668310|P13|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584690|NCT02688387|18668311|P12|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584691|NCT02688387|18668312|P11|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584692|NCT02688387|18668313|P10|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584693|NCT02688387|18668314|P9|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584694|NCT02688387|18668315|P8|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584695|NCT02688387|18668316|P7|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584696|NCT02688387|18668317|P6|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584697|NCT02688387|18668318|P5|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584698|NCT02688387|18668319|P4|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584699|NCT02688387|18668320|P3|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584700|NCT02688387|18668321|P2|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584701|NCT02688387|18668322|P1|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
7584702|NCT02688387|18668301|P22|STARTED|Part 3A, Period 2 (up to 6 Days)||0
7584703|NCT02688387|18668302|P21|STARTED|Part 3A, Period 2 (up to 6 Days)||0
7584704|NCT02688387|18668303|P20|STARTED|Part 3A, Period 2 (up to 6 Days)||0
7584705|NCT02688387|18668304|P19|STARTED|Part 3A, Period 2 (up to 6 Days)||0
7584706|NCT02688387|18668305|P18|STARTED|Part 3A, Period 2 (up to 6 Days)||8
7584707|NCT02688387|18668306|P17|STARTED|Part 3A, Period 2 (up to 6 Days)||8
7584708|NCT02688387|18668307|P16|STARTED|Part 3A, Period 2 (up to 6 Days)||8
7584709|NCT02688387|18668308|P15|STARTED|Part 3A, Period 2 (up to 6 Days)||8
7584710|NCT02688387|18668309|P14|STARTED|Part 3A, Period 2 (up to 6 Days)||0
7584711|NCT02688387|18668310|P13|STARTED|Part 3A, Period 2 (up to 6 Days)||0
7584712|NCT02688387|18668311|P12|STARTED|Part 3A, Period 2 (up to 6 Days)||0
7584713|NCT02688387|18668312|P11|STARTED|Part 3A, Period 2 (up to 6 Days)||0
7584714|NCT02688387|18668313|P10|STARTED|Part 3A, Period 2 (up to 6 Days)||0
7584715|NCT02688387|18668314|P9|STARTED|Part 3A, Period 2 (up to 6 Days)||0
7584716|NCT02688387|18668315|P8|STARTED|Part 3A, Period 2 (up to 6 Days)||0
7584717|NCT02688387|18668316|P7|STARTED|Part 3A, Period 2 (up to 6 Days)||0
7584718|NCT02688387|18668317|P6|STARTED|Part 3A, Period 2 (up to 6 Days)||0
7584719|NCT02688387|18668318|P5|STARTED|Part 3A, Period 2 (up to 6 Days)||0
7584720|NCT02688387|18668319|P4|STARTED|Part 3A, Period 2 (up to 6 Days)||0
7584721|NCT02688387|18668320|P3|STARTED|Part 3A, Period 2 (up to 6 Days)||0
7584722|NCT02688387|18668321|P2|STARTED|Part 3A, Period 2 (up to 6 Days)||0
7584723|NCT02688387|18668322|P1|STARTED|Part 3A, Period 2 (up to 6 Days)||0
7584724|NCT02688387|18668301|P22|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584725|NCT02688387|18668302|P21|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584726|NCT02688387|18668303|P20|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584727|NCT02688387|18668304|P19|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584728|NCT02688387|18668305|P18|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584729|NCT02688387|18668306|P17|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584730|NCT02688387|18668307|P16|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584731|NCT02688387|18668308|P15|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584732|NCT02688387|18668309|P14|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584733|NCT02688387|18668310|P13|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584734|NCT02688387|18668311|P12|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584735|NCT02688387|18668312|P11|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584736|NCT02688387|18668313|P10|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584737|NCT02688387|18668314|P9|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584738|NCT02688387|18668315|P8|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584739|NCT02688387|18668316|P7|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584740|NCT02688387|18668317|P6|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584741|NCT02688387|18668318|P5|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584742|NCT02688387|18668319|P4|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584743|NCT02688387|18668320|P3|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584744|NCT02688387|18668321|P2|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584745|NCT02688387|18668322|P1|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584746|NCT02688387|18668301|P22|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584747|NCT02688387|18668302|P21|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584748|NCT02688387|18668303|P20|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584749|NCT02688387|18668304|P19|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584750|NCT02688387|18668305|P18|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
7584751|NCT02688387|18668306|P17|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
7584752|NCT02688387|18668307|P16|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
7584753|NCT02688387|18668308|P15|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
7584754|NCT02688387|18668309|P14|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584755|NCT02688387|18668310|P13|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584756|NCT02688387|18668311|P12|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584757|NCT02688387|18668312|P11|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584758|NCT02688387|18668313|P10|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584759|NCT02688387|18668314|P9|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584760|NCT02688387|18668315|P8|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584761|NCT02688387|18668316|P7|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584762|NCT02688387|18668317|P6|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584763|NCT02688387|18668318|P5|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584764|NCT02688387|18668319|P4|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584765|NCT02688387|18668320|P3|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584766|NCT02688387|18668321|P2|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584767|NCT02688387|18668322|P1|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
7584768|NCT02688387|18668301|P22|STARTED|Part 3A, Washout Period 1 (10 Days)||0
7584769|NCT02688387|18668302|P21|STARTED|Part 3A, Washout Period 1 (10 Days)||0
7584770|NCT02688387|18668303|P20|STARTED|Part 3A, Washout Period 1 (10 Days)||0
7584771|NCT02688387|18668304|P19|STARTED|Part 3A, Washout Period 1 (10 Days)||0
7584772|NCT02688387|18668305|P18|STARTED|Part 3A, Washout Period 1 (10 Days)||8
7584773|NCT02688387|18668306|P17|STARTED|Part 3A, Washout Period 1 (10 Days)||8
7584774|NCT02688387|18668307|P16|STARTED|Part 3A, Washout Period 1 (10 Days)||8
7584775|NCT02688387|18668308|P15|STARTED|Part 3A, Washout Period 1 (10 Days)||8
7584776|NCT02688387|18668309|P14|STARTED|Part 3A, Washout Period 1 (10 Days)||0
7584777|NCT02688387|18668310|P13|STARTED|Part 3A, Washout Period 1 (10 Days)||0
7584778|NCT02688387|18668311|P12|STARTED|Part 3A, Washout Period 1 (10 Days)||0
7584779|NCT02688387|18668312|P11|STARTED|Part 3A, Washout Period 1 (10 Days)||0
7584780|NCT02688387|18668313|P10|STARTED|Part 3A, Washout Period 1 (10 Days)||0
7584781|NCT02688387|18668314|P9|STARTED|Part 3A, Washout Period 1 (10 Days)||0
7584782|NCT02688387|18668315|P8|STARTED|Part 3A, Washout Period 1 (10 Days)||0
7584783|NCT02688387|18668316|P7|STARTED|Part 3A, Washout Period 1 (10 Days)||0
7584784|NCT02688387|18668317|P6|STARTED|Part 3A, Washout Period 1 (10 Days)||0
7584785|NCT02688387|18668318|P5|STARTED|Part 3A, Washout Period 1 (10 Days)||0
7584786|NCT02688387|18668319|P4|STARTED|Part 3A, Washout Period 1 (10 Days)||0
7584787|NCT02688387|18668320|P3|STARTED|Part 3A, Washout Period 1 (10 Days)||0
7584788|NCT02688387|18668321|P2|STARTED|Part 3A, Washout Period 1 (10 Days)||0
7584789|NCT02688387|18668322|P1|STARTED|Part 3A, Washout Period 1 (10 Days)||0
7584790|NCT02688387|18668301|P22|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584791|NCT02688387|18668302|P21|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584792|NCT02688387|18668303|P20|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584793|NCT02688387|18668304|P19|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584794|NCT02688387|18668305|P18|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584795|NCT02688387|18668306|P17|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584796|NCT02688387|18668307|P16|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584797|NCT02688387|18668308|P15|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||1
7584798|NCT02688387|18668309|P14|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584799|NCT02688387|18668310|P13|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584800|NCT02688387|18668311|P12|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584801|NCT02688387|18668312|P11|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584802|NCT02688387|18668313|P10|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584803|NCT02688387|18668314|P9|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584804|NCT02688387|18668315|P8|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584805|NCT02688387|18668316|P7|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584806|NCT02688387|18668317|P6|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584807|NCT02688387|18668318|P5|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584808|NCT02688387|18668319|P4|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584809|NCT02688387|18668320|P3|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584810|NCT02688387|18668321|P2|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584811|NCT02688387|18668322|P1|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584812|NCT02688387|18668301|P22|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584813|NCT02688387|18668302|P21|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584814|NCT02688387|18668303|P20|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584815|NCT02688387|18668304|P19|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584816|NCT02688387|18668305|P18|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
7584817|NCT02688387|18668306|P17|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
7584818|NCT02688387|18668307|P16|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
7584819|NCT02688387|18668308|P15|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
7584820|NCT02688387|18668309|P14|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584821|NCT02688387|18668310|P13|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584822|NCT02688387|18668311|P12|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584823|NCT02688387|18668312|P11|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584824|NCT02688387|18668313|P10|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584825|NCT02688387|18668314|P9|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584826|NCT02688387|18668315|P8|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584827|NCT02688387|18668316|P7|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584828|NCT02688387|18668317|P6|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584829|NCT02688387|18668318|P5|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584830|NCT02688387|18668319|P4|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584831|NCT02688387|18668320|P3|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584832|NCT02688387|18668321|P2|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584833|NCT02688387|18668322|P1|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
7584834|NCT02688387|18668301|P22|STARTED|Part 3A, Period 1 (up to 6 Days)||0
7584835|NCT02688387|18668302|P21|STARTED|Part 3A, Period 1 (up to 6 Days)||0
7584836|NCT02688387|18668303|P20|STARTED|Part 3A, Period 1 (up to 6 Days)||0
7584837|NCT02688387|18668304|P19|STARTED|Part 3A, Period 1 (up to 6 Days)||0
7584838|NCT02688387|18668305|P18|STARTED|Part 3A, Period 1 (up to 6 Days)||8
7584839|NCT02688387|18668306|P17|STARTED|Part 3A, Period 1 (up to 6 Days)||8
7584840|NCT02688387|18668307|P16|STARTED|Part 3A, Period 1 (up to 6 Days)||8
7584841|NCT02688387|18668308|P15|STARTED|Part 3A, Period 1 (up to 6 Days)||9
7584842|NCT02688387|18668309|P14|STARTED|Part 3A, Period 1 (up to 6 Days)||0
7584843|NCT02688387|18668310|P13|STARTED|Part 3A, Period 1 (up to 6 Days)||0
7584844|NCT02688387|18668311|P12|STARTED|Part 3A, Period 1 (up to 6 Days)||0
7584845|NCT02688387|18668312|P11|STARTED|Part 3A, Period 1 (up to 6 Days)||0
7584846|NCT02688387|18668313|P10|STARTED|Part 3A, Period 1 (up to 6 Days)||0
7584847|NCT02688387|18668314|P9|STARTED|Part 3A, Period 1 (up to 6 Days)||0
7584848|NCT02688387|18668315|P8|STARTED|Part 3A, Period 1 (up to 6 Days)||0
7584849|NCT02688387|18668316|P7|STARTED|Part 3A, Period 1 (up to 6 Days)||0
7584850|NCT02688387|18668317|P6|STARTED|Part 3A, Period 1 (up to 6 Days)||0
7584851|NCT02688387|18668318|P5|STARTED|Part 3A, Period 1 (up to 6 Days)||0
7584852|NCT02688387|18668319|P4|STARTED|Part 3A, Period 1 (up to 6 Days)||0
7584853|NCT02688387|18668320|P3|STARTED|Part 3A, Period 1 (up to 6 Days)||0
7584854|NCT02688387|18668321|P2|STARTED|Part 3A, Period 1 (up to 6 Days)||0
7584855|NCT02688387|18668322|P1|STARTED|Part 3A, Period 1 (up to 6 Days)||0
7584856|NCT02688387|18668301|P22|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584857|NCT02688387|18668302|P21|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584858|NCT02688387|18668303|P20|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584859|NCT02688387|18668304|P19|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584860|NCT02688387|18668305|P18|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584861|NCT02688387|18668306|P17|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584862|NCT02688387|18668307|P16|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584863|NCT02688387|18668308|P15|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584864|NCT02688387|18668309|P14|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584865|NCT02688387|18668310|P13|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584866|NCT02688387|18668311|P12|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584867|NCT02688387|18668312|P11|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584868|NCT02688387|18668313|P10|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584869|NCT02688387|18668314|P9|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584870|NCT02688387|18668315|P8|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584871|NCT02688387|18668316|P7|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584872|NCT02688387|18668317|P6|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584873|NCT02688387|18668318|P5|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584874|NCT02688387|18668319|P4|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584875|NCT02688387|18668320|P3|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584876|NCT02688387|18668321|P2|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584877|NCT02688387|18668322|P1|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584878|NCT02688387|18668301|P22|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584879|NCT02688387|18668302|P21|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584880|NCT02688387|18668303|P20|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584881|NCT02688387|18668304|P19|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584882|NCT02688387|18668305|P18|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584883|NCT02688387|18668306|P17|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584884|NCT02688387|18668307|P16|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584885|NCT02688387|18668308|P15|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584886|NCT02688387|18668309|P14|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
7584887|NCT02688387|18668310|P13|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
7584888|NCT02688387|18668311|P12|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
7584889|NCT02688387|18668312|P11|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
7584890|NCT02688387|18668313|P10|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584891|NCT02688387|18668314|P9|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584892|NCT02688387|18668315|P8|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584893|NCT02688387|18668316|P7|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584894|NCT02688387|18668317|P6|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584895|NCT02688387|18668318|P5|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584896|NCT02688387|18668319|P4|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584897|NCT02688387|18668320|P3|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584898|NCT02688387|18668321|P2|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584899|NCT02688387|18668322|P1|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
7584900|NCT02688387|18668301|P22|STARTED|Part 2, Period 4 (up to 6 Days)||0
7584901|NCT02688387|18668302|P21|STARTED|Part 2, Period 4 (up to 6 Days)||0
7584902|NCT02688387|18668303|P20|STARTED|Part 2, Period 4 (up to 6 Days)||0
7584903|NCT02688387|18668304|P19|STARTED|Part 2, Period 4 (up to 6 Days)||0
7584904|NCT02688387|18668305|P18|STARTED|Part 2, Period 4 (up to 6 Days)||0
7584905|NCT02688387|18668306|P17|STARTED|Part 2, Period 4 (up to 6 Days)||0
7584906|NCT02688387|18668307|P16|STARTED|Part 2, Period 4 (up to 6 Days)||0
7584907|NCT02688387|18668308|P15|STARTED|Part 2, Period 4 (up to 6 Days)||0
7584908|NCT02688387|18668309|P14|STARTED|Part 2, Period 4 (up to 6 Days)||5
7584909|NCT02688387|18668310|P13|STARTED|Part 2, Period 4 (up to 6 Days)||5
7584910|NCT02688387|18668311|P12|STARTED|Part 2, Period 4 (up to 6 Days)||5
7584911|NCT02688387|18668312|P11|STARTED|Part 2, Period 4 (up to 6 Days)||5
7584912|NCT02688387|18668313|P10|STARTED|Part 2, Period 4 (up to 6 Days)||0
7584913|NCT02688387|18668314|P9|STARTED|Part 2, Period 4 (up to 6 Days)||0
7584914|NCT02688387|18668315|P8|STARTED|Part 2, Period 4 (up to 6 Days)||0
7584915|NCT02688387|18668316|P7|STARTED|Part 2, Period 4 (up to 6 Days)||0
7584916|NCT02688387|18668317|P6|STARTED|Part 2, Period 4 (up to 6 Days)||0
7584917|NCT02688387|18668318|P5|STARTED|Part 2, Period 4 (up to 6 Days)||0
7584918|NCT02688387|18668319|P4|STARTED|Part 2, Period 4 (up to 6 Days)||0
7584919|NCT02688387|18668320|P3|STARTED|Part 2, Period 4 (up to 6 Days)||0
7584920|NCT02688387|18668321|P2|STARTED|Part 2, Period 4 (up to 6 Days)||0
7584921|NCT02688387|18668322|P1|STARTED|Part 2, Period 4 (up to 6 Days)||0
7584922|NCT02688387|18668301|P22|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584923|NCT02688387|18668302|P21|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584924|NCT02688387|18668303|P20|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584925|NCT02688387|18668304|P19|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584926|NCT02688387|18668305|P18|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584927|NCT02688387|18668306|P17|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584928|NCT02688387|18668307|P16|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584929|NCT02688387|18668308|P15|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584930|NCT02688387|18668309|P14|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584931|NCT02688387|18668310|P13|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584932|NCT02688387|18668311|P12|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584933|NCT02688387|18668312|P11|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584934|NCT02688387|18668313|P10|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584935|NCT02688387|18668314|P9|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584936|NCT02688387|18668315|P8|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584937|NCT02688387|18668316|P7|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584938|NCT02688387|18668317|P6|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584939|NCT02688387|18668318|P5|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584940|NCT02688387|18668319|P4|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584941|NCT02688387|18668320|P3|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584942|NCT02688387|18668321|P2|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584943|NCT02688387|18668322|P1|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584944|NCT02688387|18668301|P22|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584945|NCT02688387|18668302|P21|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584946|NCT02688387|18668303|P20|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584947|NCT02688387|18668304|P19|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584948|NCT02688387|18668305|P18|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584949|NCT02688387|18668306|P17|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584950|NCT02688387|18668307|P16|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584951|NCT02688387|18668308|P15|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584952|NCT02688387|18668309|P14|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
7584953|NCT02688387|18668310|P13|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
7584954|NCT02688387|18668311|P12|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
7584955|NCT02688387|18668312|P11|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
7584956|NCT02688387|18668313|P10|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584957|NCT02688387|18668314|P9|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584958|NCT02688387|18668315|P8|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584959|NCT02688387|18668316|P7|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584960|NCT02688387|18668317|P6|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584961|NCT02688387|18668318|P5|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584962|NCT02688387|18668319|P4|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584963|NCT02688387|18668320|P3|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584964|NCT02688387|18668321|P2|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584965|NCT02688387|18668322|P1|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
7584966|NCT02688387|18668301|P22|STARTED|Part 2, Washout Period 3 (10 Days)||0
7584967|NCT02688387|18668302|P21|STARTED|Part 2, Washout Period 3 (10 Days)||0
7584968|NCT02688387|18668303|P20|STARTED|Part 2, Washout Period 3 (10 Days)||0
7584969|NCT02688387|18668304|P19|STARTED|Part 2, Washout Period 3 (10 Days)||0
7584970|NCT02688387|18668305|P18|STARTED|Part 2, Washout Period 3 (10 Days)||0
7584971|NCT02688387|18668306|P17|STARTED|Part 2, Washout Period 3 (10 Days)||0
7584972|NCT02688387|18668307|P16|STARTED|Part 2, Washout Period 3 (10 Days)||0
7584973|NCT02688387|18668308|P15|STARTED|Part 2, Washout Period 3 (10 Days)||0
7584974|NCT02688387|18668309|P14|STARTED|Part 2, Washout Period 3 (10 Days)||5
7584975|NCT02688387|18668310|P13|STARTED|Part 2, Washout Period 3 (10 Days)||5
7584976|NCT02688387|18668311|P12|STARTED|Part 2, Washout Period 3 (10 Days)||5
7584977|NCT02688387|18668312|P11|STARTED|Part 2, Washout Period 3 (10 Days)||5
7584978|NCT02688387|18668313|P10|STARTED|Part 2, Washout Period 3 (10 Days)||0
7584979|NCT02688387|18668314|P9|STARTED|Part 2, Washout Period 3 (10 Days)||0
7584980|NCT02688387|18668315|P8|STARTED|Part 2, Washout Period 3 (10 Days)||0
7584981|NCT02688387|18668316|P7|STARTED|Part 2, Washout Period 3 (10 Days)||0
7584982|NCT02688387|18668317|P6|STARTED|Part 2, Washout Period 3 (10 Days)||0
7584983|NCT02688387|18668318|P5|STARTED|Part 2, Washout Period 3 (10 Days)||0
7584984|NCT02688387|18668319|P4|STARTED|Part 2, Washout Period 3 (10 Days)||0
7584985|NCT02688387|18668320|P3|STARTED|Part 2, Washout Period 3 (10 Days)||0
7584986|NCT02688387|18668321|P2|STARTED|Part 2, Washout Period 3 (10 Days)||0
7584987|NCT02688387|18668322|P1|STARTED|Part 2, Washout Period 3 (10 Days)||0
7584988|NCT02688387|18668301|P22|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7584989|NCT02688387|18668302|P21|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7584990|NCT02688387|18668303|P20|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7584991|NCT02688387|18668304|P19|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7584992|NCT02688387|18668305|P18|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7584993|NCT02688387|18668306|P17|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7584994|NCT02688387|18668307|P16|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7584995|NCT02688387|18668308|P15|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7584996|NCT02688387|18668309|P14|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7584997|NCT02688387|18668310|P13|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7584998|NCT02688387|18668311|P12|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7584999|NCT02688387|18668312|P11|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585000|NCT02688387|18668313|P10|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585001|NCT02688387|18668314|P9|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585002|NCT02688387|18668315|P8|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585003|NCT02688387|18668316|P7|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585004|NCT02688387|18668317|P6|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585005|NCT02688387|18668318|P5|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585006|NCT02688387|18668319|P4|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585007|NCT02688387|18668320|P3|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585008|NCT02688387|18668321|P2|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585009|NCT02688387|18668322|P1|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585010|NCT02688387|18668301|P22|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585011|NCT02688387|18668302|P21|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585012|NCT02688387|18668303|P20|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585013|NCT02688387|18668304|P19|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585014|NCT02688387|18668305|P18|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585015|NCT02688387|18668306|P17|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585016|NCT02688387|18668307|P16|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585017|NCT02688387|18668308|P15|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585018|NCT02688387|18668309|P14|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
7585019|NCT02688387|18668310|P13|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
7585020|NCT02688387|18668311|P12|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
7585021|NCT02688387|18668312|P11|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
7585022|NCT02688387|18668313|P10|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585023|NCT02688387|18668314|P9|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585024|NCT02688387|18668315|P8|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585025|NCT02688387|18668316|P7|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585026|NCT02688387|18668317|P6|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585027|NCT02688387|18668318|P5|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585028|NCT02688387|18668319|P4|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585029|NCT02688387|18668320|P3|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585030|NCT02688387|18668321|P2|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585031|NCT02688387|18668322|P1|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
7585032|NCT02688387|18668301|P22|STARTED|Part 2, Period 3 (up to 6 Days)||0
7585033|NCT02688387|18668302|P21|STARTED|Part 2, Period 3 (up to 6 Days)||0
7585034|NCT02688387|18668303|P20|STARTED|Part 2, Period 3 (up to 6 Days)||0
7585035|NCT02688387|18668304|P19|STARTED|Part 2, Period 3 (up to 6 Days)||0
7585036|NCT02688387|18668305|P18|STARTED|Part 2, Period 3 (up to 6 Days)||0
7585037|NCT02688387|18668306|P17|STARTED|Part 2, Period 3 (up to 6 Days)||0
7585038|NCT02688387|18668307|P16|STARTED|Part 2, Period 3 (up to 6 Days)||0
7585039|NCT02688387|18668308|P15|STARTED|Part 2, Period 3 (up to 6 Days)||0
7585040|NCT02688387|18668309|P14|STARTED|Part 2, Period 3 (up to 6 Days)||5
7585041|NCT02688387|18668310|P13|STARTED|Part 2, Period 3 (up to 6 Days)||5
7585042|NCT02688387|18668311|P12|STARTED|Part 2, Period 3 (up to 6 Days)||5
7585043|NCT02688387|18668312|P11|STARTED|Part 2, Period 3 (up to 6 Days)||5
7585044|NCT02688387|18668313|P10|STARTED|Part 2, Period 3 (up to 6 Days)||0
7585045|NCT02688387|18668314|P9|STARTED|Part 2, Period 3 (up to 6 Days)||0
7585046|NCT02688387|18668315|P8|STARTED|Part 2, Period 3 (up to 6 Days)||0
7585047|NCT02688387|18668316|P7|STARTED|Part 2, Period 3 (up to 6 Days)||0
7585048|NCT02688387|18668317|P6|STARTED|Part 2, Period 3 (up to 6 Days)||0
7585049|NCT02688387|18668318|P5|STARTED|Part 2, Period 3 (up to 6 Days)||0
7585050|NCT02688387|18668319|P4|STARTED|Part 2, Period 3 (up to 6 Days)||0
7585051|NCT02688387|18668320|P3|STARTED|Part 2, Period 3 (up to 6 Days)||0
7585052|NCT02688387|18668321|P2|STARTED|Part 2, Period 3 (up to 6 Days)||0
7585053|NCT02688387|18668322|P1|STARTED|Part 2, Period 3 (up to 6 Days)||0
7585054|NCT02688387|18668301|P22|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585055|NCT02688387|18668302|P21|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585056|NCT02688387|18668303|P20|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585057|NCT02688387|18668304|P19|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585058|NCT02688387|18668305|P18|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585059|NCT02688387|18668306|P17|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585060|NCT02688387|18668307|P16|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585061|NCT02688387|18668308|P15|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585062|NCT02688387|18668309|P14|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585063|NCT02688387|18668310|P13|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585064|NCT02688387|18668311|P12|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585065|NCT02688387|18668312|P11|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585066|NCT02688387|18668313|P10|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585067|NCT02688387|18668314|P9|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585068|NCT02688387|18668315|P8|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585069|NCT02688387|18668316|P7|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585070|NCT02688387|18668317|P6|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585071|NCT02688387|18668318|P5|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585072|NCT02688387|18668319|P4|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585073|NCT02688387|18668320|P3|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585074|NCT02688387|18668321|P2|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585075|NCT02688387|18668322|P1|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585076|NCT02688387|18668301|P22|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585077|NCT02688387|18668302|P21|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585078|NCT02688387|18668303|P20|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585079|NCT02688387|18668304|P19|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585080|NCT02688387|18668305|P18|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585081|NCT02688387|18668306|P17|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585082|NCT02688387|18668307|P16|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585083|NCT02688387|18668308|P15|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585084|NCT02688387|18668309|P14|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
7585085|NCT02688387|18668310|P13|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
7585086|NCT02688387|18668311|P12|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
7585087|NCT02688387|18668312|P11|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
7585088|NCT02688387|18668313|P10|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585089|NCT02688387|18668314|P9|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585090|NCT02688387|18668315|P8|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585091|NCT02688387|18668316|P7|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585092|NCT02688387|18668317|P6|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585093|NCT02688387|18668318|P5|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585094|NCT02688387|18668319|P4|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585095|NCT02688387|18668320|P3|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585096|NCT02688387|18668321|P2|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585097|NCT02688387|18668322|P1|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
7585098|NCT02688387|18668301|P22|STARTED|Part 2, Washout Period 2 (10 Days)||0
7585099|NCT02688387|18668302|P21|STARTED|Part 2, Washout Period 2 (10 Days)||0
7585100|NCT02688387|18668303|P20|STARTED|Part 2, Washout Period 2 (10 Days)||0
7585101|NCT02688387|18668304|P19|STARTED|Part 2, Washout Period 2 (10 Days)||0
7585102|NCT02688387|18668305|P18|STARTED|Part 2, Washout Period 2 (10 Days)||0
7585103|NCT02688387|18668306|P17|STARTED|Part 2, Washout Period 2 (10 Days)||0
7585104|NCT02688387|18668307|P16|STARTED|Part 2, Washout Period 2 (10 Days)||0
7585105|NCT02688387|18668308|P15|STARTED|Part 2, Washout Period 2 (10 Days)||0
7585106|NCT02688387|18668309|P14|STARTED|Part 2, Washout Period 2 (10 Days)||5
7585107|NCT02688387|18668310|P13|STARTED|Part 2, Washout Period 2 (10 Days)||5
7585108|NCT02688387|18668311|P12|STARTED|Part 2, Washout Period 2 (10 Days)||5
7585109|NCT02688387|18668312|P11|STARTED|Part 2, Washout Period 2 (10 Days)||5
7585110|NCT02688387|18668313|P10|STARTED|Part 2, Washout Period 2 (10 Days)||0
7585111|NCT02688387|18668314|P9|STARTED|Part 2, Washout Period 2 (10 Days)||0
7585112|NCT02688387|18668315|P8|STARTED|Part 2, Washout Period 2 (10 Days)||0
7585113|NCT02688387|18668316|P7|STARTED|Part 2, Washout Period 2 (10 Days)||0
7585114|NCT02688387|18668317|P6|STARTED|Part 2, Washout Period 2 (10 Days)||0
7585115|NCT02688387|18668318|P5|STARTED|Part 2, Washout Period 2 (10 Days)||0
7585116|NCT02688387|18668319|P4|STARTED|Part 2, Washout Period 2 (10 Days)||0
7585117|NCT02688387|18668320|P3|STARTED|Part 2, Washout Period 2 (10 Days)||0
7585118|NCT02688387|18668321|P2|STARTED|Part 2, Washout Period 2 (10 Days)||0
7585119|NCT02688387|18668322|P1|STARTED|Part 2, Washout Period 2 (10 Days)||0
7585120|NCT02688387|18668301|P22|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585121|NCT02688387|18668302|P21|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585122|NCT02688387|18668303|P20|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585123|NCT02688387|18668304|P19|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585124|NCT02688387|18668305|P18|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585125|NCT02688387|18668306|P17|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585126|NCT02688387|18668307|P16|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585127|NCT02688387|18668308|P15|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585128|NCT02688387|18668309|P14|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585129|NCT02688387|18668310|P13|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585130|NCT02688387|18668311|P12|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585131|NCT02688387|18668312|P11|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585132|NCT02688387|18668313|P10|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585133|NCT02688387|18668314|P9|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585134|NCT02688387|18668315|P8|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585135|NCT02688387|18668316|P7|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585136|NCT02688387|18668317|P6|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585137|NCT02688387|18668318|P5|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585138|NCT02688387|18668319|P4|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585139|NCT02688387|18668320|P3|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585140|NCT02688387|18668321|P2|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585141|NCT02688387|18668322|P1|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585142|NCT02688387|18668301|P22|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585143|NCT02688387|18668302|P21|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585144|NCT02688387|18668303|P20|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585145|NCT02688387|18668304|P19|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585146|NCT02688387|18668305|P18|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585147|NCT02688387|18668306|P17|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585148|NCT02688387|18668307|P16|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585149|NCT02688387|18668308|P15|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585150|NCT02688387|18668309|P14|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
7585151|NCT02688387|18668310|P13|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
7585152|NCT02688387|18668311|P12|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
7585153|NCT02688387|18668312|P11|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
7585154|NCT02688387|18668313|P10|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585155|NCT02688387|18668314|P9|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585156|NCT02688387|18668315|P8|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585157|NCT02688387|18668316|P7|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585158|NCT02688387|18668317|P6|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585159|NCT02688387|18668318|P5|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585160|NCT02688387|18668319|P4|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585161|NCT02688387|18668320|P3|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585162|NCT02688387|18668321|P2|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585163|NCT02688387|18668322|P1|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
7585164|NCT02688387|18668301|P22|STARTED|Part 2, Period 2 (up to 6 Days)||0
7585165|NCT02688387|18668302|P21|STARTED|Part 2, Period 2 (up to 6 Days)||0
7585166|NCT02688387|18668303|P20|STARTED|Part 2, Period 2 (up to 6 Days)||0
7585167|NCT02688387|18668304|P19|STARTED|Part 2, Period 2 (up to 6 Days)||0
7585168|NCT02688387|18668305|P18|STARTED|Part 2, Period 2 (up to 6 Days)||0
7585169|NCT02688387|18668306|P17|STARTED|Part 2, Period 2 (up to 6 Days)||0
7585170|NCT02688387|18668307|P16|STARTED|Part 2, Period 2 (up to 6 Days)||0
7585171|NCT02688387|18668308|P15|STARTED|Part 2, Period 2 (up to 6 Days)||0
7585172|NCT02688387|18668309|P14|STARTED|Part 2, Period 2 (up to 6 Days)||5
7585173|NCT02688387|18668310|P13|STARTED|Part 2, Period 2 (up to 6 Days)||5
7585174|NCT02688387|18668311|P12|STARTED|Part 2, Period 2 (up to 6 Days)||5
7585175|NCT02688387|18668312|P11|STARTED|Part 2, Period 2 (up to 6 Days)||5
7585176|NCT02688387|18668313|P10|STARTED|Part 2, Period 2 (up to 6 Days)||0
7585177|NCT02688387|18668314|P9|STARTED|Part 2, Period 2 (up to 6 Days)||0
7585178|NCT02688387|18668315|P8|STARTED|Part 2, Period 2 (up to 6 Days)||0
7585179|NCT02688387|18668316|P7|STARTED|Part 2, Period 2 (up to 6 Days)||0
7585180|NCT02688387|18668317|P6|STARTED|Part 2, Period 2 (up to 6 Days)||0
7585181|NCT02688387|18668318|P5|STARTED|Part 2, Period 2 (up to 6 Days)||0
7585182|NCT02688387|18668319|P4|STARTED|Part 2, Period 2 (up to 6 Days)||0
7585183|NCT02688387|18668320|P3|STARTED|Part 2, Period 2 (up to 6 Days)||0
7585184|NCT02688387|18668321|P2|STARTED|Part 2, Period 2 (up to 6 Days)||0
7585185|NCT02688387|18668322|P1|STARTED|Part 2, Period 2 (up to 6 Days)||0
7585186|NCT02688387|18668301|P22|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585187|NCT02688387|18668302|P21|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585188|NCT02688387|18668303|P20|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585189|NCT02688387|18668304|P19|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585190|NCT02688387|18668305|P18|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585191|NCT02688387|18668306|P17|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585192|NCT02688387|18668307|P16|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585193|NCT02688387|18668308|P15|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585194|NCT02688387|18668309|P14|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585195|NCT02688387|18668310|P13|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585196|NCT02688387|18668311|P12|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585197|NCT02688387|18668312|P11|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585198|NCT02688387|18668313|P10|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585199|NCT02688387|18668314|P9|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585200|NCT02688387|18668315|P8|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585201|NCT02688387|18668316|P7|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585202|NCT02688387|18668317|P6|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585203|NCT02688387|18668318|P5|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585204|NCT02688387|18668319|P4|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585205|NCT02688387|18668320|P3|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585206|NCT02688387|18668321|P2|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585207|NCT02688387|18668322|P1|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585208|NCT02688387|18668301|P22|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585209|NCT02688387|18668302|P21|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585210|NCT02688387|18668303|P20|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585211|NCT02688387|18668304|P19|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585212|NCT02688387|18668305|P18|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585213|NCT02688387|18668306|P17|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585214|NCT02688387|18668307|P16|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585215|NCT02688387|18668308|P15|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585216|NCT02688387|18668309|P14|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
7585217|NCT02688387|18668310|P13|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
7585218|NCT02688387|18668311|P12|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
7585219|NCT02688387|18668312|P11|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
7585220|NCT02688387|18668313|P10|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585221|NCT02688387|18668314|P9|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585222|NCT02688387|18668315|P8|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585223|NCT02688387|18668316|P7|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585224|NCT02688387|18668317|P6|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585225|NCT02688387|18668318|P5|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585226|NCT02688387|18668319|P4|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585227|NCT02688387|18668320|P3|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585228|NCT02688387|18668321|P2|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585229|NCT02688387|18668322|P1|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
7585230|NCT02688387|18668301|P22|STARTED|Part 2, Washout Period 1 (10 Days)||0
7585231|NCT02688387|18668302|P21|STARTED|Part 2, Washout Period 1 (10 Days)||0
7585232|NCT02688387|18668303|P20|STARTED|Part 2, Washout Period 1 (10 Days)||0
7585233|NCT02688387|18668304|P19|STARTED|Part 2, Washout Period 1 (10 Days)||0
7585234|NCT02688387|18668305|P18|STARTED|Part 2, Washout Period 1 (10 Days)||0
7585235|NCT02688387|18668306|P17|STARTED|Part 2, Washout Period 1 (10 Days)||0
7585236|NCT02688387|18668307|P16|STARTED|Part 2, Washout Period 1 (10 Days)||0
7585237|NCT02688387|18668308|P15|STARTED|Part 2, Washout Period 1 (10 Days)||0
7585238|NCT02688387|18668309|P14|STARTED|Part 2, Washout Period 1 (10 Days)||5
7585239|NCT02688387|18668310|P13|STARTED|Part 2, Washout Period 1 (10 Days)||5
7585240|NCT02688387|18668311|P12|STARTED|Part 2, Washout Period 1 (10 Days)||5
7585241|NCT02688387|18668312|P11|STARTED|Part 2, Washout Period 1 (10 Days)||5
7585242|NCT02688387|18668313|P10|STARTED|Part 2, Washout Period 1 (10 Days)||0
7585243|NCT02688387|18668314|P9|STARTED|Part 2, Washout Period 1 (10 Days)||0
7585244|NCT02688387|18668315|P8|STARTED|Part 2, Washout Period 1 (10 Days)||0
7585245|NCT02688387|18668316|P7|STARTED|Part 2, Washout Period 1 (10 Days)||0
7585246|NCT02688387|18668317|P6|STARTED|Part 2, Washout Period 1 (10 Days)||0
7585247|NCT02688387|18668318|P5|STARTED|Part 2, Washout Period 1 (10 Days)||0
7585248|NCT02688387|18668319|P4|STARTED|Part 2, Washout Period 1 (10 Days)||0
7585249|NCT02688387|18668320|P3|STARTED|Part 2, Washout Period 1 (10 Days)||0
7585250|NCT02688387|18668321|P2|STARTED|Part 2, Washout Period 1 (10 Days)||0
7585251|NCT02688387|18668322|P1|STARTED|Part 2, Washout Period 1 (10 Days)||0
7585252|NCT02688387|18668301|P22|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585253|NCT02688387|18668302|P21|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585254|NCT02688387|18668303|P20|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585255|NCT02688387|18668304|P19|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585256|NCT02688387|18668305|P18|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585257|NCT02688387|18668306|P17|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585258|NCT02688387|18668307|P16|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585259|NCT02688387|18668308|P15|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585260|NCT02688387|18668309|P14|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585261|NCT02688387|18668310|P13|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585262|NCT02688387|18668311|P12|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585263|NCT02688387|18668312|P11|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||1
7585264|NCT02688387|18668313|P10|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585265|NCT02688387|18668314|P9|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585266|NCT02688387|18668315|P8|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585267|NCT02688387|18668316|P7|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585268|NCT02688387|18668317|P6|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585269|NCT02688387|18668318|P5|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585270|NCT02688387|18668319|P4|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585271|NCT02688387|18668320|P3|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585272|NCT02688387|18668321|P2|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585273|NCT02688387|18668322|P1|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585274|NCT02688387|18668301|P22|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585275|NCT02688387|18668302|P21|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585276|NCT02688387|18668303|P20|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585277|NCT02688387|18668304|P19|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585278|NCT02688387|18668305|P18|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585279|NCT02688387|18668306|P17|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585280|NCT02688387|18668307|P16|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585281|NCT02688387|18668308|P15|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585282|NCT02688387|18668309|P14|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
7585283|NCT02688387|18668310|P13|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
7585284|NCT02688387|18668311|P12|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
7585285|NCT02688387|18668312|P11|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
7585286|NCT02688387|18668313|P10|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585287|NCT02688387|18668314|P9|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585288|NCT02688387|18668315|P8|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585289|NCT02688387|18668316|P7|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585290|NCT02688387|18668317|P6|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585291|NCT02688387|18668318|P5|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585292|NCT02688387|18668319|P4|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585293|NCT02688387|18668320|P3|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585294|NCT02688387|18668321|P2|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585295|NCT02688387|18668322|P1|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
7585296|NCT02688387|18668301|P22|STARTED|Part 2, Period 1 (up to 6 Days)||0
7585297|NCT02688387|18668302|P21|STARTED|Part 2, Period 1 (up to 6 Days)||0
7585298|NCT02688387|18668303|P20|STARTED|Part 2, Period 1 (up to 6 Days)||0
7585299|NCT02688387|18668304|P19|STARTED|Part 2, Period 1 (up to 6 Days)||0
7585300|NCT02688387|18668305|P18|STARTED|Part 2, Period 1 (up to 6 Days)||0
7585301|NCT02688387|18668306|P17|STARTED|Part 2, Period 1 (up to 6 Days)||0
7585302|NCT02688387|18668307|P16|STARTED|Part 2, Period 1 (up to 6 Days)||0
7585303|NCT02688387|18668308|P15|STARTED|Part 2, Period 1 (up to 6 Days)||0
7585304|NCT02688387|18668309|P14|STARTED|Part 2, Period 1 (up to 6 Days)||5
7585305|NCT02688387|18668310|P13|STARTED|Part 2, Period 1 (up to 6 Days)||5
7585306|NCT02688387|18668311|P12|STARTED|Part 2, Period 1 (up to 6 Days)||5
7585307|NCT02688387|18668312|P11|STARTED|Part 2, Period 1 (up to 6 Days)||6
7585308|NCT02688387|18668313|P10|STARTED|Part 2, Period 1 (up to 6 Days)||0
7585309|NCT02688387|18668314|P9|STARTED|Part 2, Period 1 (up to 6 Days)||0
7585310|NCT02688387|18668315|P8|STARTED|Part 2, Period 1 (up to 6 Days)||0
7585311|NCT02688387|18668316|P7|STARTED|Part 2, Period 1 (up to 6 Days)||0
7585312|NCT02688387|18668317|P6|STARTED|Part 2, Period 1 (up to 6 Days)||0
7585313|NCT02688387|18668318|P5|STARTED|Part 2, Period 1 (up to 6 Days)||0
7585314|NCT02688387|18668319|P4|STARTED|Part 2, Period 1 (up to 6 Days)||0
7585315|NCT02688387|18668320|P3|STARTED|Part 2, Period 1 (up to 6 Days)||0
7585316|NCT02688387|18668321|P2|STARTED|Part 2, Period 1 (up to 6 Days)||0
7585317|NCT02688387|18668322|P1|STARTED|Part 2, Period 1 (up to 6 Days)||0
7585318|NCT02688387|18668301|P22|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585319|NCT02688387|18668302|P21|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585320|NCT02688387|18668303|P20|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585321|NCT02688387|18668304|P19|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585322|NCT02688387|18668305|P18|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585323|NCT02688387|18668306|P17|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585324|NCT02688387|18668307|P16|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585325|NCT02688387|18668308|P15|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585326|NCT02688387|18668309|P14|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585327|NCT02688387|18668310|P13|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585328|NCT02688387|18668311|P12|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585329|NCT02688387|18668312|P11|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585330|NCT02688387|18668313|P10|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585331|NCT02688387|18668314|P9|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585332|NCT02688387|18668315|P8|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585333|NCT02688387|18668316|P7|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585334|NCT02688387|18668317|P6|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585335|NCT02688387|18668318|P5|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585336|NCT02688387|18668319|P4|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585337|NCT02688387|18668320|P3|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585338|NCT02688387|18668321|P2|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585339|NCT02688387|18668322|P1|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585340|NCT02688387|18668301|P22|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585341|NCT02688387|18668302|P21|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585342|NCT02688387|18668303|P20|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585343|NCT02688387|18668304|P19|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585344|NCT02688387|18668305|P18|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585345|NCT02688387|18668306|P17|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585346|NCT02688387|18668307|P16|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585347|NCT02688387|18668308|P15|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585348|NCT02688387|18668309|P14|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585349|NCT02688387|18668310|P13|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585350|NCT02688387|18668311|P12|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585351|NCT02688387|18668312|P11|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
7585352|NCT02688387|18668313|P10|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
7585353|NCT02688387|18668314|P9|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
7585354|NCT02688387|18668315|P8|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
7585355|NCT02688387|18668316|P7|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
7585356|NCT02688387|18668317|P6|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
7585357|NCT02688387|18668318|P5|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
7585358|NCT02688387|18668319|P4|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
7585359|NCT02688387|18668320|P3|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
7585360|NCT02688387|18668321|P2|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
7585361|NCT02688387|18668322|P1|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
7585362|NCT02688387|18668301|P22|STARTED|Part 1, Period 5 (up to 6 Days)||0
7585363|NCT02688387|18668302|P21|STARTED|Part 1, Period 5 (up to 6 Days)||0
7585364|NCT02688387|18668303|P20|STARTED|Part 1, Period 5 (up to 6 Days)||0
7585365|NCT02688387|18668304|P19|STARTED|Part 1, Period 5 (up to 6 Days)||0
7585366|NCT02688387|18668305|P18|STARTED|Part 1, Period 5 (up to 6 Days)||0
7585367|NCT02688387|18668306|P17|STARTED|Part 1, Period 5 (up to 6 Days)||0
7585368|NCT02688387|18668307|P16|STARTED|Part 1, Period 5 (up to 6 Days)||0
7585369|NCT02688387|18668308|P15|STARTED|Part 1, Period 5 (up to 6 Days)||0
7585370|NCT02688387|18668309|P14|STARTED|Part 1, Period 5 (up to 6 Days)||0
7585371|NCT02688387|18668310|P13|STARTED|Part 1, Period 5 (up to 6 Days)||0
7585372|NCT02688387|18668311|P12|STARTED|Part 1, Period 5 (up to 6 Days)||0
7585373|NCT02688387|18668312|P11|STARTED|Part 1, Period 5 (up to 6 Days)||0
7585374|NCT02688387|18668313|P10|STARTED|Part 1, Period 5 (up to 6 Days)||2
7585375|NCT02688387|18668314|P9|STARTED|Part 1, Period 5 (up to 6 Days)||2
7585376|NCT02688387|18668315|P8|STARTED|Part 1, Period 5 (up to 6 Days)||2
7585377|NCT02688387|18668316|P7|STARTED|Part 1, Period 5 (up to 6 Days)||2
7585378|NCT02688387|18668317|P6|STARTED|Part 1, Period 5 (up to 6 Days)||2
7585379|NCT02688387|18668318|P5|STARTED|Part 1, Period 5 (up to 6 Days)||2
7585380|NCT02688387|18668319|P4|STARTED|Part 1, Period 5 (up to 6 Days)||2
7585381|NCT02688387|18668320|P3|STARTED|Part 1, Period 5 (up to 6 Days)||2
7585382|NCT02688387|18668321|P2|STARTED|Part 1, Period 5 (up to 6 Days)||2
7585383|NCT02688387|18668322|P1|STARTED|Part 1, Period 5 (up to 6 Days)||2
7585384|NCT02688387|18668301|P22|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585385|NCT02688387|18668302|P21|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585386|NCT02688387|18668303|P20|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585387|NCT02688387|18668304|P19|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585388|NCT02688387|18668305|P18|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585389|NCT02688387|18668306|P17|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585390|NCT02688387|18668307|P16|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585391|NCT02688387|18668308|P15|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585392|NCT02688387|18668309|P14|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585393|NCT02688387|18668310|P13|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585394|NCT02688387|18668311|P12|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585395|NCT02688387|18668312|P11|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585396|NCT02688387|18668313|P10|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585397|NCT02688387|18668314|P9|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585398|NCT02688387|18668315|P8|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585399|NCT02688387|18668316|P7|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585400|NCT02688387|18668317|P6|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585401|NCT02688387|18668318|P5|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585402|NCT02688387|18668319|P4|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585403|NCT02688387|18668320|P3|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585404|NCT02688387|18668321|P2|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585405|NCT02688387|18668322|P1|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585406|NCT02688387|18668301|P22|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585407|NCT02688387|18668302|P21|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585408|NCT02688387|18668303|P20|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585409|NCT02688387|18668304|P19|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585410|NCT02688387|18668305|P18|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585411|NCT02688387|18668306|P17|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585412|NCT02688387|18668307|P16|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585413|NCT02688387|18668308|P15|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585414|NCT02688387|18668309|P14|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585415|NCT02688387|18668310|P13|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585416|NCT02688387|18668311|P12|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585417|NCT02688387|18668312|P11|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
7585418|NCT02688387|18668313|P10|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
7585419|NCT02688387|18668314|P9|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
7585420|NCT02688387|18668315|P8|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
7585421|NCT02688387|18668316|P7|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
7585422|NCT02688387|18668317|P6|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
7585423|NCT02688387|18668318|P5|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
7585424|NCT02688387|18668319|P4|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
7585425|NCT02688387|18668320|P3|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
7585426|NCT02688387|18668321|P2|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
7585427|NCT02688387|18668322|P1|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
7585428|NCT02688387|18668301|P22|STARTED|Part 1, Washout Period 4 (7 Days)||0
7585429|NCT02688387|18668302|P21|STARTED|Part 1, Washout Period 4 (7 Days)||0
7585430|NCT02688387|18668303|P20|STARTED|Part 1, Washout Period 4 (7 Days)||0
7585431|NCT02688387|18668304|P19|STARTED|Part 1, Washout Period 4 (7 Days)||0
7585432|NCT02688387|18668305|P18|STARTED|Part 1, Washout Period 4 (7 Days)||0
7585433|NCT02688387|18668306|P17|STARTED|Part 1, Washout Period 4 (7 Days)||0
7585434|NCT02688387|18668307|P16|STARTED|Part 1, Washout Period 4 (7 Days)||0
7585435|NCT02688387|18668308|P15|STARTED|Part 1, Washout Period 4 (7 Days)||0
7585436|NCT02688387|18668309|P14|STARTED|Part 1, Washout Period 4 (7 Days)||0
7585437|NCT02688387|18668310|P13|STARTED|Part 1, Washout Period 4 (7 Days)||0
7585438|NCT02688387|18668311|P12|STARTED|Part 1, Washout Period 4 (7 Days)||0
7585439|NCT02688387|18668312|P11|STARTED|Part 1, Washout Period 4 (7 Days)||0
7585440|NCT02688387|18668313|P10|STARTED|Part 1, Washout Period 4 (7 Days)||2
7585441|NCT02688387|18668314|P9|STARTED|Part 1, Washout Period 4 (7 Days)||2
7585442|NCT02688387|18668315|P8|STARTED|Part 1, Washout Period 4 (7 Days)||2
7585443|NCT02688387|18668316|P7|STARTED|Part 1, Washout Period 4 (7 Days)||2
7585444|NCT02688387|18668317|P6|STARTED|Part 1, Washout Period 4 (7 Days)||2
7585445|NCT02688387|18668318|P5|STARTED|Part 1, Washout Period 4 (7 Days)||2
7585446|NCT02688387|18668319|P4|STARTED|Part 1, Washout Period 4 (7 Days)||2
7585447|NCT02688387|18668320|P3|STARTED|Part 1, Washout Period 4 (7 Days)||2
7585448|NCT02688387|18668321|P2|STARTED|Part 1, Washout Period 4 (7 Days)||2
7585449|NCT02688387|18668322|P1|STARTED|Part 1, Washout Period 4 (7 Days)||2
7585450|NCT02688387|18668301|P22|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585451|NCT02688387|18668302|P21|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585452|NCT02688387|18668303|P20|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585453|NCT02688387|18668304|P19|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585454|NCT02688387|18668305|P18|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585455|NCT02688387|18668306|P17|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585456|NCT02688387|18668307|P16|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585457|NCT02688387|18668308|P15|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585458|NCT02688387|18668309|P14|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585459|NCT02688387|18668310|P13|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585460|NCT02688387|18668311|P12|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585461|NCT02688387|18668312|P11|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585462|NCT02688387|18668313|P10|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585463|NCT02688387|18668314|P9|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585464|NCT02688387|18668315|P8|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585465|NCT02688387|18668316|P7|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585466|NCT02688387|18668317|P6|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585467|NCT02688387|18668318|P5|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585468|NCT02688387|18668319|P4|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585469|NCT02688387|18668320|P3|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585470|NCT02688387|18668321|P2|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585471|NCT02688387|18668322|P1|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585472|NCT02688387|18668301|P22|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585473|NCT02688387|18668302|P21|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585474|NCT02688387|18668303|P20|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585475|NCT02688387|18668304|P19|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585476|NCT02688387|18668305|P18|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585477|NCT02688387|18668306|P17|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585478|NCT02688387|18668307|P16|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585479|NCT02688387|18668308|P15|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585480|NCT02688387|18668309|P14|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585481|NCT02688387|18668310|P13|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585482|NCT02688387|18668311|P12|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585483|NCT02688387|18668312|P11|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
7585484|NCT02688387|18668313|P10|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
7585485|NCT02688387|18668314|P9|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
7585486|NCT02688387|18668315|P8|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
7585487|NCT02688387|18668316|P7|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
7585488|NCT02688387|18668317|P6|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
7585489|NCT02688387|18668318|P5|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
7585490|NCT02688387|18668319|P4|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
7585491|NCT02688387|18668320|P3|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
7585492|NCT02688387|18668321|P2|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
7585493|NCT02688387|18668322|P1|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
7585494|NCT02688387|18668301|P22|STARTED|Part 1, Period 4 (up to 6 Days)||0
7585495|NCT02688387|18668302|P21|STARTED|Part 1, Period 4 (up to 6 Days)||0
7585496|NCT02688387|18668303|P20|STARTED|Part 1, Period 4 (up to 6 Days)||0
7585497|NCT02688387|18668304|P19|STARTED|Part 1, Period 4 (up to 6 Days)||0
7585498|NCT02688387|18668305|P18|STARTED|Part 1, Period 4 (up to 6 Days)||0
7585499|NCT02688387|18668306|P17|STARTED|Part 1, Period 4 (up to 6 Days)||0
7585500|NCT02688387|18668307|P16|STARTED|Part 1, Period 4 (up to 6 Days)||0
7585501|NCT02688387|18668308|P15|STARTED|Part 1, Period 4 (up to 6 Days)||0
7585502|NCT02688387|18668309|P14|STARTED|Part 1, Period 4 (up to 6 Days)||0
7585503|NCT02688387|18668310|P13|STARTED|Part 1, Period 4 (up to 6 Days)||0
7585504|NCT02688387|18668311|P12|STARTED|Part 1, Period 4 (up to 6 Days)||0
7585505|NCT02688387|18668312|P11|STARTED|Part 1, Period 4 (up to 6 Days)||0
7585506|NCT02688387|18668313|P10|STARTED|Part 1, Period 4 (up to 6 Days)||2
7585507|NCT02688387|18668314|P9|STARTED|Part 1, Period 4 (up to 6 Days)||2
7585508|NCT02688387|18668315|P8|STARTED|Part 1, Period 4 (up to 6 Days)||2
7585509|NCT02688387|18668316|P7|STARTED|Part 1, Period 4 (up to 6 Days)||2
7585510|NCT02688387|18668317|P6|STARTED|Part 1, Period 4 (up to 6 Days)||2
7585511|NCT02688387|18668318|P5|STARTED|Part 1, Period 4 (up to 6 Days)||2
7585512|NCT02688387|18668319|P4|STARTED|Part 1, Period 4 (up to 6 Days)||2
7585513|NCT02688387|18668320|P3|STARTED|Part 1, Period 4 (up to 6 Days)||2
7585514|NCT02688387|18668321|P2|STARTED|Part 1, Period 4 (up to 6 Days)||2
7585515|NCT02688387|18668322|P1|STARTED|Part 1, Period 4 (up to 6 Days)||2
7585516|NCT02688387|18668301|P22|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585517|NCT02688387|18668302|P21|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585518|NCT02688387|18668303|P20|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585519|NCT02688387|18668304|P19|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585520|NCT02688387|18668305|P18|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585521|NCT02688387|18668306|P17|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585522|NCT02688387|18668307|P16|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585523|NCT02688387|18668308|P15|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585524|NCT02688387|18668309|P14|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585525|NCT02688387|18668310|P13|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585526|NCT02688387|18668311|P12|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585527|NCT02688387|18668312|P11|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585528|NCT02688387|18668313|P10|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585529|NCT02688387|18668314|P9|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585530|NCT02688387|18668315|P8|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585531|NCT02688387|18668316|P7|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585532|NCT02688387|18668317|P6|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585533|NCT02688387|18668318|P5|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585534|NCT02688387|18668319|P4|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585535|NCT02688387|18668320|P3|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585536|NCT02688387|18668321|P2|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585537|NCT02688387|18668322|P1|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||1
7585538|NCT02688387|18668301|P22|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585539|NCT02688387|18668302|P21|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585540|NCT02688387|18668303|P20|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585541|NCT02688387|18668304|P19|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585542|NCT02688387|18668305|P18|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585543|NCT02688387|18668306|P17|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585544|NCT02688387|18668307|P16|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585545|NCT02688387|18668308|P15|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585546|NCT02688387|18668309|P14|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585547|NCT02688387|18668310|P13|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585548|NCT02688387|18668311|P12|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585549|NCT02688387|18668312|P11|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
7585550|NCT02688387|18668313|P10|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
7585551|NCT02688387|18668314|P9|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
7585552|NCT02688387|18668315|P8|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
7585553|NCT02688387|18668316|P7|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
7585554|NCT02688387|18668317|P6|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
7585555|NCT02688387|18668318|P5|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
7585556|NCT02688387|18668319|P4|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
7585557|NCT02688387|18668320|P3|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
7585558|NCT02688387|18668321|P2|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
7585559|NCT02688387|18668322|P1|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
7585560|NCT02688387|18668301|P22|STARTED|Part 1, Washout Period 3 (7 Days)||0
7585561|NCT02688387|18668302|P21|STARTED|Part 1, Washout Period 3 (7 Days)||0
7585562|NCT02688387|18668303|P20|STARTED|Part 1, Washout Period 3 (7 Days)||0
7585563|NCT02688387|18668304|P19|STARTED|Part 1, Washout Period 3 (7 Days)||0
7585564|NCT02688387|18668305|P18|STARTED|Part 1, Washout Period 3 (7 Days)||0
7585565|NCT02688387|18668306|P17|STARTED|Part 1, Washout Period 3 (7 Days)||0
7585566|NCT02688387|18668307|P16|STARTED|Part 1, Washout Period 3 (7 Days)||0
7585567|NCT02688387|18668308|P15|STARTED|Part 1, Washout Period 3 (7 Days)||0
7585568|NCT02688387|18668309|P14|STARTED|Part 1, Washout Period 3 (7 Days)||0
7585569|NCT02688387|18668310|P13|STARTED|Part 1, Washout Period 3 (7 Days)||0
7585570|NCT02688387|18668311|P12|STARTED|Part 1, Washout Period 3 (7 Days)||0
7585571|NCT02688387|18668312|P11|STARTED|Part 1, Washout Period 3 (7 Days)||0
7585572|NCT02688387|18668313|P10|STARTED|Part 1, Washout Period 3 (7 Days)||2
7585573|NCT02688387|18668314|P9|STARTED|Part 1, Washout Period 3 (7 Days)||2
7585574|NCT02688387|18668315|P8|STARTED|Part 1, Washout Period 3 (7 Days)||2
7585575|NCT02688387|18668316|P7|STARTED|Part 1, Washout Period 3 (7 Days)||2
7585576|NCT02688387|18668317|P6|STARTED|Part 1, Washout Period 3 (7 Days)||2
7585577|NCT02688387|18668318|P5|STARTED|Part 1, Washout Period 3 (7 Days)||2
7585578|NCT02688387|18668319|P4|STARTED|Part 1, Washout Period 3 (7 Days)||2
7585579|NCT02688387|18668320|P3|STARTED|Part 1, Washout Period 3 (7 Days)||2
7585580|NCT02688387|18668321|P2|STARTED|Part 1, Washout Period 3 (7 Days)||2
7585581|NCT02688387|18668322|P1|STARTED|Part 1, Washout Period 3 (7 Days)||3
7585582|NCT02688387|18668301|P22|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585583|NCT02688387|18668302|P21|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585584|NCT02688387|18668303|P20|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585585|NCT02688387|18668304|P19|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585586|NCT02688387|18668305|P18|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585587|NCT02688387|18668306|P17|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585588|NCT02688387|18668307|P16|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585589|NCT02688387|18668308|P15|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585590|NCT02688387|18668309|P14|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585591|NCT02688387|18668310|P13|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585592|NCT02688387|18668311|P12|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585593|NCT02688387|18668312|P11|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585594|NCT02688387|18668313|P10|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585595|NCT02688387|18668314|P9|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585596|NCT02688387|18668315|P8|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585597|NCT02688387|18668316|P7|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585598|NCT02688387|18668317|P6|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585599|NCT02688387|18668318|P5|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585600|NCT02688387|18668319|P4|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585601|NCT02688387|18668320|P3|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585602|NCT02688387|18668321|P2|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585603|NCT02688387|18668322|P1|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585604|NCT02688387|18668301|P22|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585605|NCT02688387|18668302|P21|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585606|NCT02688387|18668303|P20|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585607|NCT02688387|18668304|P19|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585608|NCT02688387|18668305|P18|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585609|NCT02688387|18668306|P17|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585610|NCT02688387|18668307|P16|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585611|NCT02688387|18668308|P15|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585612|NCT02688387|18668309|P14|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585613|NCT02688387|18668310|P13|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585614|NCT02688387|18668311|P12|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585615|NCT02688387|18668312|P11|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
7585616|NCT02688387|18668313|P10|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
7585617|NCT02688387|18668314|P9|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
7585618|NCT02688387|18668315|P8|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
7585619|NCT02688387|18668316|P7|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
7585620|NCT02688387|18668317|P6|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
7585621|NCT02688387|18668318|P5|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
7585622|NCT02688387|18668319|P4|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
7585623|NCT02688387|18668320|P3|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
7585624|NCT02688387|18668321|P2|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
7585625|NCT02688387|18668322|P1|COMPLETED|Part 1, Period 3 (up to 6 Days)||3
7585626|NCT02688387|18668301|P22|STARTED|Part 1, Period 3 (up to 6 Days)||0
7585627|NCT02688387|18668302|P21|STARTED|Part 1, Period 3 (up to 6 Days)||0
7585628|NCT02688387|18668303|P20|STARTED|Part 1, Period 3 (up to 6 Days)||0
7585629|NCT02688387|18668304|P19|STARTED|Part 1, Period 3 (up to 6 Days)||0
7585630|NCT02688387|18668305|P18|STARTED|Part 1, Period 3 (up to 6 Days)||0
7585631|NCT02688387|18668306|P17|STARTED|Part 1, Period 3 (up to 6 Days)||0
7585632|NCT02688387|18668307|P16|STARTED|Part 1, Period 3 (up to 6 Days)||0
7585633|NCT02688387|18668308|P15|STARTED|Part 1, Period 3 (up to 6 Days)||0
7585634|NCT02688387|18668309|P14|STARTED|Part 1, Period 3 (up to 6 Days)||0
7585635|NCT02688387|18668310|P13|STARTED|Part 1, Period 3 (up to 6 Days)||0
7585636|NCT02688387|18668311|P12|STARTED|Part 1, Period 3 (up to 6 Days)||0
7585637|NCT02688387|18668312|P11|STARTED|Part 1, Period 3 (up to 6 Days)||0
7585638|NCT02688387|18668313|P10|STARTED|Part 1, Period 3 (up to 6 Days)||2
7585639|NCT02688387|18668314|P9|STARTED|Part 1, Period 3 (up to 6 Days)||2
7585640|NCT02688387|18668315|P8|STARTED|Part 1, Period 3 (up to 6 Days)||2
7585641|NCT02688387|18668316|P7|STARTED|Part 1, Period 3 (up to 6 Days)||2
7585642|NCT02688387|18668317|P6|STARTED|Part 1, Period 3 (up to 6 Days)||2
7585643|NCT02688387|18668318|P5|STARTED|Part 1, Period 3 (up to 6 Days)||2
7585644|NCT02688387|18668319|P4|STARTED|Part 1, Period 3 (up to 6 Days)||2
7585645|NCT02688387|18668320|P3|STARTED|Part 1, Period 3 (up to 6 Days)||2
7585646|NCT02688387|18668321|P2|STARTED|Part 1, Period 3 (up to 6 Days)||2
7585647|NCT02688387|18668322|P1|STARTED|Part 1, Period 3 (up to 6 Days)||3
7585648|NCT02688387|18668301|P22|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585649|NCT02688387|18668302|P21|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585650|NCT02688387|18668303|P20|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585651|NCT02688387|18668304|P19|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585652|NCT02688387|18668305|P18|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585653|NCT02688387|18668306|P17|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585654|NCT02688387|18668307|P16|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585655|NCT02688387|18668308|P15|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585656|NCT02688387|18668309|P14|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585657|NCT02688387|18668310|P13|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585658|NCT02688387|18668311|P12|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585659|NCT02688387|18668312|P11|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585660|NCT02688387|18668313|P10|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585661|NCT02688387|18668314|P9|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585662|NCT02688387|18668315|P8|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585663|NCT02688387|18668316|P7|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585664|NCT02688387|18668317|P6|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585665|NCT02688387|18668318|P5|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585666|NCT02688387|18668319|P4|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585667|NCT02688387|18668320|P3|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585668|NCT02688387|18668321|P2|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585669|NCT02688387|18668322|P1|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585670|NCT02688387|18668301|P22|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585671|NCT02688387|18668302|P21|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585672|NCT02688387|18668303|P20|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585673|NCT02688387|18668304|P19|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585674|NCT02688387|18668305|P18|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585675|NCT02688387|18668306|P17|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585676|NCT02688387|18668307|P16|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585677|NCT02688387|18668308|P15|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585678|NCT02688387|18668309|P14|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585679|NCT02688387|18668310|P13|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585680|NCT02688387|18668311|P12|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585681|NCT02688387|18668312|P11|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
7585682|NCT02688387|18668313|P10|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
7585683|NCT02688387|18668314|P9|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
7585684|NCT02688387|18668315|P8|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
7585685|NCT02688387|18668316|P7|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
7585686|NCT02688387|18668317|P6|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
7585687|NCT02688387|18668318|P5|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
7585688|NCT02688387|18668319|P4|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
7585689|NCT02688387|18668320|P3|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
7585690|NCT02688387|18668321|P2|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
7585691|NCT02688387|18668322|P1|COMPLETED|Part 1, Washout Period 2 (7 Days)||3
7585692|NCT02688387|18668301|P22|STARTED|Part 1, Washout Period 2 (7 Days)||0
7585693|NCT02688387|18668302|P21|STARTED|Part 1, Washout Period 2 (7 Days)||0
7585694|NCT02688387|18668303|P20|STARTED|Part 1, Washout Period 2 (7 Days)||0
7585695|NCT02688387|18668304|P19|STARTED|Part 1, Washout Period 2 (7 Days)||0
7585696|NCT02688387|18668305|P18|STARTED|Part 1, Washout Period 2 (7 Days)||0
7585697|NCT02688387|18668306|P17|STARTED|Part 1, Washout Period 2 (7 Days)||0
7585698|NCT02688387|18668307|P16|STARTED|Part 1, Washout Period 2 (7 Days)||0
7585699|NCT02688387|18668308|P15|STARTED|Part 1, Washout Period 2 (7 Days)||0
7585700|NCT02688387|18668309|P14|STARTED|Part 1, Washout Period 2 (7 Days)||0
7585701|NCT02688387|18668310|P13|STARTED|Part 1, Washout Period 2 (7 Days)||0
7585702|NCT02688387|18668311|P12|STARTED|Part 1, Washout Period 2 (7 Days)||0
7585703|NCT02688387|18668312|P11|STARTED|Part 1, Washout Period 2 (7 Days)||0
7585704|NCT02688387|18668313|P10|STARTED|Part 1, Washout Period 2 (7 Days)||2
7585705|NCT02688387|18668314|P9|STARTED|Part 1, Washout Period 2 (7 Days)||2
7585706|NCT02688387|18668315|P8|STARTED|Part 1, Washout Period 2 (7 Days)||2
7585707|NCT02688387|18668316|P7|STARTED|Part 1, Washout Period 2 (7 Days)||2
7585708|NCT02688387|18668317|P6|STARTED|Part 1, Washout Period 2 (7 Days)||2
7585709|NCT02688387|18668318|P5|STARTED|Part 1, Washout Period 2 (7 Days)||2
7585710|NCT02688387|18668319|P4|STARTED|Part 1, Washout Period 2 (7 Days)||2
7585711|NCT02688387|18668320|P3|STARTED|Part 1, Washout Period 2 (7 Days)||2
7585712|NCT02688387|18668321|P2|STARTED|Part 1, Washout Period 2 (7 Days)||2
7585713|NCT02688387|18668322|P1|STARTED|Part 1, Washout Period 2 (7 Days)||3
7585714|NCT02688387|18668301|P22|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585715|NCT02688387|18668302|P21|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585716|NCT02688387|18668303|P20|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585717|NCT02688387|18668304|P19|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585718|NCT02688387|18668305|P18|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585719|NCT02688387|18668306|P17|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585720|NCT02688387|18668307|P16|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585721|NCT02688387|18668308|P15|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585722|NCT02688387|18668309|P14|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585723|NCT02688387|18668310|P13|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585724|NCT02688387|18668311|P12|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585725|NCT02688387|18668312|P11|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585726|NCT02688387|18668313|P10|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585727|NCT02688387|18668314|P9|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585728|NCT02688387|18668315|P8|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585729|NCT02688387|18668316|P7|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585730|NCT02688387|18668317|P6|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585731|NCT02688387|18668318|P5|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
7585732|NCT02688387|18668319|P4|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585733|NCT02688387|18668320|P3|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
7585734|NCT02688387|18668321|P2|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585735|NCT02688387|18668322|P1|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585736|NCT02688387|18668301|P22|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585737|NCT02688387|18668302|P21|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585738|NCT02688387|18668303|P20|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585739|NCT02688387|18668304|P19|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585740|NCT02688387|18668305|P18|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585741|NCT02688387|18668306|P17|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585742|NCT02688387|18668307|P16|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585743|NCT02688387|18668308|P15|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585744|NCT02688387|18668309|P14|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585745|NCT02688387|18668310|P13|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585746|NCT02688387|18668311|P12|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585747|NCT02688387|18668312|P11|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
7585748|NCT02688387|18668313|P10|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
7585749|NCT02688387|18668314|P9|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
7585750|NCT02688387|18668315|P8|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
7585751|NCT02688387|18668316|P7|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
7585752|NCT02688387|18668317|P6|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
7585753|NCT02688387|18668318|P5|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
7585754|NCT02688387|18668319|P4|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
7585755|NCT02688387|18668320|P3|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
7585756|NCT02688387|18668321|P2|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
7585757|NCT02688387|18668322|P1|COMPLETED|Part 1, Period 2 (up to 6 Days)||3
7585758|NCT02688387|18668301|P22|STARTED|Part 1, Period 2 (up to 6 Days)||0
7585759|NCT02688387|18668302|P21|STARTED|Part 1, Period 2 (up to 6 Days)||0
7585760|NCT02688387|18668303|P20|STARTED|Part 1, Period 2 (up to 6 Days)||0
7585761|NCT02688387|18668304|P19|STARTED|Part 1, Period 2 (up to 6 Days)||0
7585762|NCT02688387|18668305|P18|STARTED|Part 1, Period 2 (up to 6 Days)||0
7585763|NCT02688387|18668306|P17|STARTED|Part 1, Period 2 (up to 6 Days)||0
7585764|NCT02688387|18668307|P16|STARTED|Part 1, Period 2 (up to 6 Days)||0
7585765|NCT02688387|18668308|P15|STARTED|Part 1, Period 2 (up to 6 Days)||0
7585766|NCT02688387|18668309|P14|STARTED|Part 1, Period 2 (up to 6 Days)||0
7585767|NCT02688387|18668310|P13|STARTED|Part 1, Period 2 (up to 6 Days)||0
7585768|NCT02688387|18668311|P12|STARTED|Part 1, Period 2 (up to 6 Days)||0
7585769|NCT02688387|18668312|P11|STARTED|Part 1, Period 2 (up to 6 Days)||0
7585770|NCT02688387|18668313|P10|STARTED|Part 1, Period 2 (up to 6 Days)||2
7585771|NCT02688387|18668314|P9|STARTED|Part 1, Period 2 (up to 6 Days)||2
7585772|NCT02688387|18668315|P8|STARTED|Part 1, Period 2 (up to 6 Days)||2
7585773|NCT02688387|18668316|P7|STARTED|Part 1, Period 2 (up to 6 Days)||2
7585774|NCT02688387|18668317|P6|STARTED|Part 1, Period 2 (up to 6 Days)||2
7585775|NCT02688387|18668318|P5|STARTED|Part 1, Period 2 (up to 6 Days)||3
7585776|NCT02688387|18668319|P4|STARTED|Part 1, Period 2 (up to 6 Days)||2
7585777|NCT02688387|18668320|P3|STARTED|Part 1, Period 2 (up to 6 Days)||3
7585778|NCT02688387|18668321|P2|STARTED|Part 1, Period 2 (up to 6 Days)||2
7585779|NCT02688387|18668322|P1|STARTED|Part 1, Period 2 (up to 6 Days)||3
7585780|NCT02688387|18668301|P22|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585781|NCT02688387|18668302|P21|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585782|NCT02688387|18668303|P20|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585783|NCT02688387|18668304|P19|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585784|NCT02688387|18668305|P18|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585785|NCT02688387|18668306|P17|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585786|NCT02688387|18668307|P16|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585787|NCT02688387|18668308|P15|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585788|NCT02688387|18668309|P14|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585789|NCT02688387|18668310|P13|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585790|NCT02688387|18668311|P12|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585791|NCT02688387|18668312|P11|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585792|NCT02688387|18668313|P10|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585793|NCT02688387|18668314|P9|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585794|NCT02688387|18668315|P8|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585795|NCT02688387|18668316|P7|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585796|NCT02688387|18668317|P6|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585797|NCT02688387|18668318|P5|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585798|NCT02688387|18668319|P4|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585799|NCT02688387|18668320|P3|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585800|NCT02688387|18668321|P2|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||1
7585801|NCT02688387|18668322|P1|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585802|NCT02688387|18668301|P22|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585803|NCT02688387|18668302|P21|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585804|NCT02688387|18668303|P20|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585805|NCT02688387|18668304|P19|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585806|NCT02688387|18668305|P18|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585807|NCT02688387|18668306|P17|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585808|NCT02688387|18668307|P16|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585809|NCT02688387|18668308|P15|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585810|NCT02688387|18668309|P14|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585811|NCT02688387|18668310|P13|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585812|NCT02688387|18668311|P12|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585813|NCT02688387|18668312|P11|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
7585814|NCT02688387|18668313|P10|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
7585815|NCT02688387|18668314|P9|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
7585816|NCT02688387|18668315|P8|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
7585817|NCT02688387|18668316|P7|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
7585818|NCT02688387|18668317|P6|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
7585819|NCT02688387|18668318|P5|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
7585820|NCT02688387|18668319|P4|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
7585821|NCT02688387|18668320|P3|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
7585822|NCT02688387|18668321|P2|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
7585823|NCT02688387|18668322|P1|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
7585824|NCT02688387|18668301|P22|STARTED|Part 1, Washout Period 1 (7 Days)||0
7585825|NCT02688387|18668302|P21|STARTED|Part 1, Washout Period 1 (7 Days)||0
7585826|NCT02688387|18668303|P20|STARTED|Part 1, Washout Period 1 (7 Days)||0
7585827|NCT02688387|18668304|P19|STARTED|Part 1, Washout Period 1 (7 Days)||0
7585828|NCT02688387|18668305|P18|STARTED|Part 1, Washout Period 1 (7 Days)||0
7585829|NCT02688387|18668306|P17|STARTED|Part 1, Washout Period 1 (7 Days)||0
7585830|NCT02688387|18668307|P16|STARTED|Part 1, Washout Period 1 (7 Days)||0
7585831|NCT02688387|18668308|P15|STARTED|Part 1, Washout Period 1 (7 Days)||0
7585832|NCT02688387|18668309|P14|STARTED|Part 1, Washout Period 1 (7 Days)||0
7585833|NCT02688387|18668310|P13|STARTED|Part 1, Washout Period 1 (7 Days)||0
7585834|NCT02688387|18668311|P12|STARTED|Part 1, Washout Period 1 (7 Days)||0
7585835|NCT02688387|18668312|P11|STARTED|Part 1, Washout Period 1 (7 Days)||0
7585836|NCT02688387|18668313|P10|STARTED|Part 1, Washout Period 1 (7 Days)||2
7585837|NCT02688387|18668314|P9|STARTED|Part 1, Washout Period 1 (7 Days)||2
7585838|NCT02688387|18668315|P8|STARTED|Part 1, Washout Period 1 (7 Days)||2
7585839|NCT02688387|18668316|P7|STARTED|Part 1, Washout Period 1 (7 Days)||2
7585840|NCT02688387|18668317|P6|STARTED|Part 1, Washout Period 1 (7 Days)||2
7585841|NCT02688387|18668318|P5|STARTED|Part 1, Washout Period 1 (7 Days)||3
7585842|NCT02688387|18668319|P4|STARTED|Part 1, Washout Period 1 (7 Days)||2
7585843|NCT02688387|18668320|P3|STARTED|Part 1, Washout Period 1 (7 Days)||3
7585844|NCT02688387|18668321|P2|STARTED|Part 1, Washout Period 1 (7 Days)||3
7585845|NCT02688387|18668322|P1|STARTED|Part 1, Washout Period 1 (7 Days)||3
7585846|NCT02688387|18668301|P22|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585847|NCT02688387|18668302|P21|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585848|NCT02688387|18668303|P20|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585849|NCT02688387|18668304|P19|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585850|NCT02688387|18668305|P18|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585851|NCT02688387|18668306|P17|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585852|NCT02688387|18668307|P16|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585853|NCT02688387|18668308|P15|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585854|NCT02688387|18668309|P14|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585855|NCT02688387|18668310|P13|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585856|NCT02688387|18668311|P12|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585857|NCT02688387|18668312|P11|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585858|NCT02688387|18668313|P10|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585859|NCT02688387|18668314|P9|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585860|NCT02688387|18668315|P8|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585861|NCT02688387|18668316|P7|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585862|NCT02688387|18668317|P6|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585863|NCT02688387|18668318|P5|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585864|NCT02688387|18668319|P4|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
7585865|NCT02688387|18668320|P3|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
7585866|NCT02688387|18668321|P2|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585867|NCT02688387|18668322|P1|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585868|NCT02688387|18668301|P22|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585869|NCT02688387|18668302|P21|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585870|NCT02688387|18668303|P20|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585871|NCT02688387|18668304|P19|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585872|NCT02688387|18668305|P18|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585873|NCT02688387|18668306|P17|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585874|NCT02688387|18668307|P16|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585875|NCT02688387|18668308|P15|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585876|NCT02688387|18668309|P14|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585877|NCT02688387|18668310|P13|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585878|NCT02688387|18668311|P12|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585879|NCT02688387|18668312|P11|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
7585880|NCT02688387|18668313|P10|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
7585881|NCT02688387|18668314|P9|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
7585882|NCT02688387|18668315|P8|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
7585883|NCT02688387|18668316|P7|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
7585884|NCT02688387|18668317|P6|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
7585885|NCT02688387|18668318|P5|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
7585886|NCT02688387|18668319|P4|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
7585887|NCT02688387|18668320|P3|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
7585888|NCT02688387|18668321|P2|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
7585889|NCT02688387|18668322|P1|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
7585890|NCT02688387|18668301|P22|STARTED|Part 1, Period 1 (up to 6 Days)||0
7585891|NCT02688387|18668302|P21|STARTED|Part 1, Period 1 (up to 6 Days)||0
7585892|NCT02688387|18668303|P20|STARTED|Part 1, Period 1 (up to 6 Days)||0
7585893|NCT02688387|18668304|P19|STARTED|Part 1, Period 1 (up to 6 Days)||0
7585894|NCT02688387|18668305|P18|STARTED|Part 1, Period 1 (up to 6 Days)||0
7585895|NCT02688387|18668306|P17|STARTED|Part 1, Period 1 (up to 6 Days)||0
7585896|NCT02688387|18668307|P16|STARTED|Part 1, Period 1 (up to 6 Days)||0
7585897|NCT02688387|18668308|P15|STARTED|Part 1, Period 1 (up to 6 Days)||0
7585898|NCT02688387|18668309|P14|STARTED|Part 1, Period 1 (up to 6 Days)||0
7585899|NCT02688387|18668310|P13|STARTED|Part 1, Period 1 (up to 6 Days)||0
7585900|NCT02688387|18668311|P12|STARTED|Part 1, Period 1 (up to 6 Days)||0
7585901|NCT02688387|18668312|P11|STARTED|Part 1, Period 1 (up to 6 Days)||0
7585902|NCT02688387|18668313|P10|STARTED|Part 1, Period 1 (up to 6 Days)||2
7585903|NCT02688387|18668314|P9|STARTED|Part 1, Period 1 (up to 6 Days)||2
7585904|NCT02688387|18668315|P8|STARTED|Part 1, Period 1 (up to 6 Days)||2
7585905|NCT02688387|18668316|P7|STARTED|Part 1, Period 1 (up to 6 Days)||2
7585906|NCT02688387|18668317|P6|STARTED|Part 1, Period 1 (up to 6 Days)||2
7585907|NCT02688387|18668318|P5|STARTED|Part 1, Period 1 (up to 6 Days)||3
7585908|NCT02688387|18668319|P4|STARTED|Part 1, Period 1 (up to 6 Days)||3
7585909|NCT02688387|18668320|P3|STARTED|Part 1, Period 1 (up to 6 Days)||4
7585910|NCT02688387|18668321|P2|STARTED|Part 1, Period 1 (up to 6 Days)||3
7585911|NCT02688387|18668322|P1|STARTED|Part 1, Period 1 (up to 6 Days)||3
7585912|NCT02688218|18668581|P2|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
7585913|NCT02688218|18668582|P1|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
7585914|NCT02688218|18668581|P2|COMPLETED|Second Exercise Intervention (2 Hours)||6
7585915|NCT02688218|18668582|P1|COMPLETED|Second Exercise Intervention (2 Hours)||24
7585916|NCT02688218|18668581|P2|STARTED|Second Exercise Intervention (2 Hours)||6
7585917|NCT02688218|18668582|P1|STARTED|Second Exercise Intervention (2 Hours)||24
7585918|NCT02688218|18668581|P2|NOT COMPLETED|Washout (30 Minutes)||0
7585919|NCT02688218|18668582|P1|NOT COMPLETED|Washout (30 Minutes)||0
7585920|NCT02688218|18668581|P2|COMPLETED|Washout (30 Minutes)||6
7585921|NCT02688218|18668582|P1|COMPLETED|Washout (30 Minutes)||24
7585922|NCT02688218|18668581|P2|STARTED|Washout (30 Minutes)||6
7585923|NCT02688218|18668582|P1|STARTED|Washout (30 Minutes)||24
7585924|NCT02688218|18668581|P2|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
7585925|NCT02688218|18668582|P1|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
7585926|NCT02688218|18668581|P2|COMPLETED|First Exercise Intervention (2 Hours)||6
7585927|NCT02688218|18668582|P1|COMPLETED|First Exercise Intervention (2 Hours)||24
7585928|NCT02688218|18668581|P2|STARTED|First Exercise Intervention (2 Hours)||6
7585929|NCT02688218|18668582|P1|STARTED|First Exercise Intervention (2 Hours)||24
7585930|NCT02688192|18668590|P2|NOT COMPLETED|Overall Study||5
7585931|NCT02688192|18668591|P1|NOT COMPLETED|Overall Study||12
7585932|NCT02688192|18668590|P2|COMPLETED|Overall Study||19
7585933|NCT02688192|18668591|P1|COMPLETED|Overall Study||13
7585934|NCT02688192|18668590|P2|STARTED|Overall Study||24
7585935|NCT02688192|18668591|P1|STARTED|Overall Study||25
7585936|NCT02688153|18668610|P2|NOT COMPLETED|Overall Study||7
7585937|NCT02688153|18668611|P1|NOT COMPLETED|Overall Study||15
7585938|NCT02688153|18668610|P2|COMPLETED|Overall Study||51
7585939|NCT02688153|18668611|P1|COMPLETED|Overall Study||47
7585940|NCT02688153|18668610|P2|Final Randomized Arm/Group|Overall Study||61
7585941|NCT02688153|18668611|P1|Final Randomized Arm/Group|Overall Study||59
7585942|NCT02688153|18668610|P2|STARTED|Overall Study||58
7585943|NCT02688153|18668611|P1|STARTED|Overall Study||62
7585944|NCT02687919|18668671|P2|NOT COMPLETED|Overall Study||6
7585945|NCT02687919|18668672|P1|NOT COMPLETED|Overall Study||8
7585946|NCT02687919|18668671|P2|COMPLETED|Overall Study||9
7585947|NCT02687919|18668672|P1|COMPLETED|Overall Study||8
7585948|NCT02687919|18668671|P2|STARTED|Overall Study||15
7585949|NCT02687919|18668672|P1|STARTED|Overall Study||16
7585950|NCT02687815|18668702|P2|NOT COMPLETED|Overall Study||8
7585951|NCT02687815|18668703|P1|NOT COMPLETED|Overall Study||4
7585952|NCT02687815|18668702|P2|COMPLETED|Overall Study||88
7585953|NCT02687815|18668703|P1|COMPLETED|Overall Study||92
7585954|NCT02687815|18668702|P2|STARTED|Overall Study||96
7585955|NCT02687815|18668703|P1|STARTED|Overall Study||96
7585956|NCT02687542|18668720|P5|NOT COMPLETED|Overall Study||20
7585957|NCT02687542|18668721|P4|NOT COMPLETED|Overall Study||10
7585958|NCT02687542|18668722|P3|NOT COMPLETED|Overall Study||14
7585959|NCT02687542|18668723|P2|NOT COMPLETED|Overall Study||12
7585960|NCT02687542|18668724|P1|NOT COMPLETED|Overall Study||8
7585961|NCT02687542|18668720|P5|COMPLETED|Overall Study||24
7585962|NCT02687542|18668721|P4|COMPLETED|Overall Study||3
7585963|NCT02687542|18668722|P3|COMPLETED|Overall Study||1
7585964|NCT02687542|18668723|P2|COMPLETED|Overall Study||1
7585965|NCT02687542|18668724|P1|COMPLETED|Overall Study||15
7585966|NCT02687542|18668720|P5|STARTED|Overall Study||44
7585967|NCT02687542|18668721|P4|STARTED|Overall Study||13
7585968|NCT02687542|18668722|P3|STARTED|Overall Study||15
7585969|NCT02687542|18668723|P2|STARTED|Overall Study||13
7585970|NCT02687542|18668724|P1|STARTED|Overall Study||23
7585971|NCT02687529|18668798|P2|NOT COMPLETED|Overall Study||0
7585972|NCT02687529|18668799|P1|NOT COMPLETED|Overall Study||0
7585973|NCT02687529|18668798|P2|COMPLETED|Overall Study||32
7585974|NCT02687529|18668799|P1|COMPLETED|Overall Study||34
7585975|NCT02687529|18668798|P2|STARTED|Overall Study||32
7585976|NCT02687529|18668799|P1|STARTED|Overall Study||34
7585977|NCT02687412|18668807|P2|NOT COMPLETED|Overall Study||0
7585978|NCT02687412|18668808|P1|NOT COMPLETED|Overall Study||0
7585979|NCT02687412|18668807|P2|COMPLETED|Overall Study||57
7585980|NCT02687412|18668808|P1|COMPLETED|Overall Study||50
7585981|NCT02687412|18668807|P2|STARTED|Overall Study||57
7585982|NCT02687412|18668808|P1|STARTED|Overall Study||50
7585983|NCT02687217|18668836|P2|NOT COMPLETED|Overall Study||0
7585984|NCT02687217|18668837|P1|NOT COMPLETED|Overall Study||0
7585985|NCT02687217|18668836|P2|COMPLETED|Overall Study||30
7585986|NCT02687217|18668837|P1|COMPLETED|Overall Study||30
7585987|NCT02687217|18668836|P2|STARTED|Overall Study||30
7585988|NCT02687217|18668837|P1|STARTED|Overall Study||30
7585989|NCT02687191|18668853|P6|NOT COMPLETED|Overall Study||1
7585990|NCT02687191|18668854|P5|NOT COMPLETED|Overall Study||1
7585991|NCT02687191|18668855|P4|NOT COMPLETED|Overall Study||1
7585992|NCT02687191|18668856|P3|NOT COMPLETED|Overall Study||1
7585993|NCT02687191|18668857|P2|NOT COMPLETED|Overall Study||1
7585994|NCT02687191|18668858|P1|NOT COMPLETED|Overall Study||0
7585995|NCT02687191|18668853|P6|COMPLETED|Overall Study||2
7585996|NCT02687191|18668854|P5|COMPLETED|Overall Study||2
7585997|NCT02687191|18668855|P4|COMPLETED|Overall Study||5
7585998|NCT02687191|18668856|P3|COMPLETED|Overall Study||2
7585999|NCT02687191|18668857|P2|COMPLETED|Overall Study||2
7586000|NCT02687191|18668858|P1|COMPLETED|Overall Study||3
7586001|NCT02687191|18668853|P6|STARTED|Overall Study||3
7586002|NCT02687191|18668854|P5|STARTED|Overall Study||3
7586003|NCT02687191|18668855|P4|STARTED|Overall Study||6
7586004|NCT02687191|18668856|P3|STARTED|Overall Study||3
7586005|NCT02687191|18668857|P2|STARTED|Overall Study||3
7586006|NCT02687191|18668858|P1|STARTED|Overall Study||3
7586007|NCT02687165|18668992|P2|NOT COMPLETED|Overall Study||0
7586008|NCT02687165|18668993|P1|NOT COMPLETED|Overall Study||0
7586009|NCT02687165|18668992|P2|COMPLETED|Overall Study||0
7586010|NCT02687165|18668993|P1|COMPLETED|Overall Study||0
7586011|NCT02687165|18668992|P2|STARTED|Overall Study||0
7586012|NCT02687165|18668993|P1|STARTED|Overall Study||0
7586013|NCT02687139|18668999|P1|NOT COMPLETED|Overall Study||0
7586014|NCT02687139|18668999|P1|COMPLETED|Overall Study||34
7586015|NCT02687139|18668999|P1|STARTED|Overall Study||34
7586016|NCT02687126|18669004|P1|NOT COMPLETED|Data Analysis||0
7586017|NCT02687126|18669004|P1|COMPLETED|Data Analysis||106
7586018|NCT02687126|18669004|P1|STARTED|Data Analysis||106
7586019|NCT02687126|18669004|P1|NOT COMPLETED|Data Collection||0
7586020|NCT02687126|18669004|P1|COMPLETED|Data Collection||106
7586021|NCT02687126|18669004|P1|STARTED|Data Collection||106
7586022|NCT02686437|18669013|P2|NOT COMPLETED|Overall Study||8
7586023|NCT02686437|18669014|P1|NOT COMPLETED|Overall Study||3
7586024|NCT02686437|18669013|P2|COMPLETED|Overall Study||12
7586025|NCT02686437|18669014|P1|COMPLETED|Overall Study||13
7586026|NCT02686437|18669013|P2|STARTED|Overall Study||20
7586027|NCT02686437|18669014|P1|STARTED|Overall Study||16
7586028|NCT02686164|18669022|P1|NOT COMPLETED|Overall Study||3
7586029|NCT02686164|18669022|P1|COMPLETED|Overall Study||27
7586030|NCT02686164|18669022|P1|STARTED|Overall Study||30
7586031|NCT02686138|18669034|P2|NOT COMPLETED|Overall Study||65
7586032|NCT02686138|18669035|P1|NOT COMPLETED|Overall Study||74
7586033|NCT02686138|18669034|P2|COMPLETED|Overall Study||235
7586034|NCT02686138|18669035|P1|COMPLETED|Overall Study||219
7586035|NCT02686138|18669034|P2|STARTED|Overall Study||300
7586036|NCT02686138|18669035|P1|STARTED|Overall Study||293
7586037|NCT02686034|18669059|P2|NOT COMPLETED|Open Label Period 3||1
7586038|NCT02686034|18669060|P1|NOT COMPLETED|Open Label Period 3||0
7586039|NCT02686034|18669059|P2|COMPLETED|Open Label Period 3||121
7586040|NCT02686034|18669060|P1|COMPLETED|Open Label Period 3||117
7586041|NCT02686034|18669059|P2|STARTED|Open Label Period 3||122
7586042|NCT02686034|18669060|P1|STARTED|Open Label Period 3||117
7586043|NCT02686034|18669059|P2|NOT COMPLETED|Randomized Controlled Period 2||4
7586044|NCT02686034|18669060|P1|NOT COMPLETED|Randomized Controlled Period 2||5
7586045|NCT02686034|18669059|P2|COMPLETED|Randomized Controlled Period 2||122
7586046|NCT02686034|18669060|P1|COMPLETED|Randomized Controlled Period 2||117
7586047|NCT02686034|18669059|P2|STARTED|Randomized Controlled Period 2||126
7586048|NCT02686034|18669060|P1|STARTED|Randomized Controlled Period 2||122
7586049|NCT02686034|18669059|P2|NOT COMPLETED|Run-In Period 1||17
7586050|NCT02686034|18669060|P1|NOT COMPLETED|Run-In Period 1||20
7586051|NCT02686034|18669059|P2|COMPLETED|Run-In Period 1||126
7586052|NCT02686034|18669060|P1|COMPLETED|Run-In Period 1||122
7586053|NCT02686034|18669059|P2|STARTED|Run-In Period 1||143
7586054|NCT02686034|18669060|P1|STARTED|Run-In Period 1||142
7586055|NCT02685956|18669098|P2|NOT COMPLETED|Overall Study||0
7586056|NCT02685956|18669099|P1|NOT COMPLETED|Overall Study||0
7586057|NCT02685956|18669098|P2|COMPLETED|Overall Study||1978
7586058|NCT02685956|18669099|P1|COMPLETED|Overall Study||317
7586059|NCT02685956|18669098|P2|STARTED|Overall Study||1978
7586060|NCT02685956|18669099|P1|STARTED|Overall Study||317
7586061|NCT02685826|18669110|P3|NOT COMPLETED|Overall Study||21
7586062|NCT02685826|18669111|P2|NOT COMPLETED|Overall Study||10
7586063|NCT02685826|18669112|P1|NOT COMPLETED|Overall Study||25
7586064|NCT02685826|18669110|P3|COMPLETED|Overall Study||0
7586065|NCT02685826|18669111|P2|COMPLETED|Overall Study||0
7586066|NCT02685826|18669112|P1|COMPLETED|Overall Study||0
7586067|NCT02685826|18669110|P3|STARTED|Overall Study||21
7586068|NCT02685826|18669111|P2|STARTED|Overall Study||10
7586069|NCT02685826|18669112|P1|STARTED|Overall Study||25
7586070|NCT02685566|18669195|P2|NOT COMPLETED|Second Reading Session||0
7586071|NCT02685566|18669196|P1|NOT COMPLETED|Second Reading Session||0
7586072|NCT02685566|18669195|P2|COMPLETED|Second Reading Session||50
7586073|NCT02685566|18669196|P1|COMPLETED|Second Reading Session||50
7586074|NCT02685566|18669195|P2|STARTED|Second Reading Session||50
7586075|NCT02685566|18669196|P1|STARTED|Second Reading Session||50
7586076|NCT02685566|18669195|P2|NOT COMPLETED|4 Week Memory Washout Period||0
7586077|NCT02685566|18669196|P1|NOT COMPLETED|4 Week Memory Washout Period||0
7586078|NCT02685566|18669195|P2|COMPLETED|4 Week Memory Washout Period||50
7586079|NCT02685566|18669196|P1|COMPLETED|4 Week Memory Washout Period||50
7586080|NCT02685566|18669195|P2|STARTED|4 Week Memory Washout Period||50
7586081|NCT02685566|18669196|P1|STARTED|4 Week Memory Washout Period||50
7586082|NCT02685566|18669195|P2|NOT COMPLETED|First Reading Session||0
7586083|NCT02685566|18669196|P1|NOT COMPLETED|First Reading Session||0
7586084|NCT02685566|18669195|P2|COMPLETED|First Reading Session||50
7586085|NCT02685566|18669196|P1|COMPLETED|First Reading Session||50
7586086|NCT02685566|18669195|P2|STARTED|First Reading Session||50
7586087|NCT02685566|18669196|P1|STARTED|First Reading Session||50
7586088|NCT02685488|18669206|P2|NOT COMPLETED|Overall Study||1
7586089|NCT02685488|18669207|P1|NOT COMPLETED|Overall Study||0
7586090|NCT02685488|18669206|P2|COMPLETED|Overall Study||13
7586091|NCT02685488|18669207|P1|COMPLETED|Overall Study||12
7586092|NCT02685488|18669206|P2|STARTED|Overall Study||14
7586093|NCT02685488|18669207|P1|STARTED|Overall Study||12
7586094|NCT02685436|18669221|P1|NOT COMPLETED|Overall Study||14
7586095|NCT02685436|18669221|P1|COMPLETED|Overall Study|GERD positive patients by either combined MII-pH or esophageal biopsy|38
7586096|NCT02685436|18669221|P1|STARTED|Overall Study|the overall studied group|52
7586097|NCT02685293|18669225|P2|NOT COMPLETED|Treatment Period 2||0
7586098|NCT02685293|18669226|P1|NOT COMPLETED|Treatment Period 2||0
7586099|NCT02685293|18669225|P2|COMPLETED|Treatment Period 2||3
7586100|NCT02685293|18669226|P1|COMPLETED|Treatment Period 2||1
7586101|NCT02685293|18669225|P2|STARTED|Treatment Period 2||3
7586102|NCT02685293|18669226|P1|STARTED|Treatment Period 2||1
7586103|NCT02685293|18669225|P2|NOT COMPLETED|Washout Period||0
7586104|NCT02685293|18669226|P1|NOT COMPLETED|Washout Period||0
7586105|NCT02685293|18669225|P2|COMPLETED|Washout Period||3
7586106|NCT02685293|18669226|P1|COMPLETED|Washout Period||1
7586107|NCT02685293|18669225|P2|STARTED|Washout Period||3
7586108|NCT02685293|18669226|P1|STARTED|Washout Period||1
7586109|NCT02685293|18669225|P2|NOT COMPLETED|Treatment Period 1||0
7586110|NCT02685293|18669226|P1|NOT COMPLETED|Treatment Period 1||0
7586111|NCT02685293|18669225|P2|COMPLETED|Treatment Period 1||3
7586112|NCT02685293|18669226|P1|COMPLETED|Treatment Period 1||1
7586113|NCT02685293|18669225|P2|STARTED|Treatment Period 1||3
7586114|NCT02685293|18669226|P1|STARTED|Treatment Period 1||1
7586115|NCT02685202|18669260|P1|NOT COMPLETED|Overall Study||9
7586116|NCT02685202|18669260|P1|COMPLETED|Overall Study||0
7586117|NCT02685202|18669260|P1|STARTED|Overall Study||9
7586118|NCT02685072|18669268|P2|NOT COMPLETED|3-Month Follow-Up||0
7586119|NCT02685072|18669269|P1|NOT COMPLETED|3-Month Follow-Up||0
7586120|NCT02685072|18669268|P2|COMPLETED|3-Month Follow-Up||22
7586121|NCT02685072|18669269|P1|COMPLETED|3-Month Follow-Up||19
7586122|NCT02685072|18669268|P2|STARTED|3-Month Follow-Up||22
7586123|NCT02685072|18669269|P1|STARTED|3-Month Follow-Up||19
7586124|NCT02685072|18669268|P2|NOT COMPLETED|1-Month Follow-Up||0
7586125|NCT02685072|18669269|P1|NOT COMPLETED|1-Month Follow-Up||1
7586126|NCT02685072|18669268|P2|COMPLETED|1-Month Follow-Up||22
7586127|NCT02685072|18669269|P1|COMPLETED|1-Month Follow-Up||19
7586128|NCT02685072|18669268|P2|STARTED|1-Month Follow-Up||22
7586129|NCT02685072|18669269|P1|STARTED|1-Month Follow-Up||20
7586130|NCT02685072|18669268|P2|NOT COMPLETED|Treatment Period||9
7586131|NCT02685072|18669269|P1|NOT COMPLETED|Treatment Period||13
7586132|NCT02685072|18669268|P2|COMPLETED|Treatment Period||22
7586133|NCT02685072|18669269|P1|COMPLETED|Treatment Period||20
7586134|NCT02685072|18669268|P2|Completed Week 8 Visit|Treatment Period|Week 8 data were collected at the 1-month follow-up for 1 participant|22
7586135|NCT02685072|18669269|P1|Completed Week 8 Visit|Treatment Period||20
7586136|NCT02685072|18669268|P2|Completed Week 7 Visit|Treatment Period||18
7586137|NCT02685072|18669269|P1|Completed Week 7 Visit|Treatment Period||17
7586138|NCT02685072|18669268|P2|Completed Week 6 Visit|Treatment Period||19
7586139|NCT02685072|18669269|P1|Completed Week 6 Visit|Treatment Period||18
7586140|NCT02685072|18669268|P2|Completed Week 5 Visit|Treatment Period||22
7586141|NCT02685072|18669269|P1|Completed Week 5 Visit|Treatment Period||19
7586142|NCT02685072|18669268|P2|Completed Week 4 Visit|Treatment Period||23
7586143|NCT02685072|18669269|P1|Completed Week 4 Visit|Treatment Period||19
7586144|NCT02685072|18669268|P2|Completed Week 3 Visit|Treatment Period||23
7586145|NCT02685072|18669269|P1|Completed Week 3 Visit|Treatment Period||20
7586146|NCT02685072|18669268|P2|Completed Week 2 Visit|Treatment Period||26
7586147|NCT02685072|18669269|P1|Completed Week 2 Visit|Treatment Period||23
7586148|NCT02685072|18669268|P2|STARTED|Treatment Period||31
7586149|NCT02685072|18669269|P1|STARTED|Treatment Period||33
7586150|NCT02685033|18669313|P2|NOT COMPLETED|Overall Study||2
7586151|NCT02685033|18669314|P1|NOT COMPLETED|Overall Study||3
7586152|NCT02685033|18669313|P2|COMPLETED|Overall Study||8
7586153|NCT02685033|18669314|P1|COMPLETED|Overall Study||67
7586154|NCT02685033|18669313|P2|STARTED|Overall Study||10
7586155|NCT02685033|18669314|P1|STARTED|Overall Study||70
7586156|NCT02685007|18669340|P1|NOT COMPLETED|Overall Study||0
7586157|NCT02685007|18669340|P1|COMPLETED|Overall Study||131
7586158|NCT02685007|18669340|P1|STARTED|Overall Study||131
7586159|NCT02684981|18669350|P3|NOT COMPLETED|Overall Study||127
7586160|NCT02684981|18669351|P2|NOT COMPLETED|Overall Study||210
7586161|NCT02684981|18669352|P1|NOT COMPLETED|Overall Study||240
7586162|NCT02684981|18669350|P3|COMPLETED|Overall Study||2059
7586163|NCT02684981|18669351|P2|COMPLETED|Overall Study||2969
7586164|NCT02684981|18669352|P1|COMPLETED|Overall Study||3860
7586165|NCT02684981|18669350|P3|STARTED|Overall Study||2186
7586166|NCT02684981|18669351|P2|STARTED|Overall Study||3179
7586167|NCT02684981|18669352|P1|STARTED|Overall Study||4100
7586168|NCT02684942|18669388|P6|NOT COMPLETED|Overall Study||0
7586169|NCT02684942|18669389|P5|NOT COMPLETED|Overall Study||0
7586170|NCT02684942|18669390|P4|NOT COMPLETED|Overall Study||0
7586171|NCT02684942|18669391|P3|NOT COMPLETED|Overall Study||0
7586172|NCT02684942|18669392|P2|NOT COMPLETED|Overall Study||0
7586173|NCT02684942|18669393|P1|NOT COMPLETED|Overall Study||0
7586174|NCT02684942|18669388|P6|COMPLETED|Overall Study||6
7586175|NCT02684942|18669389|P5|COMPLETED|Overall Study||6
7586176|NCT02684942|18669390|P4|COMPLETED|Overall Study||7
7586177|NCT02684942|18669391|P3|COMPLETED|Overall Study||7
7586178|NCT02684942|18669392|P2|COMPLETED|Overall Study||7
7586179|NCT02684942|18669393|P1|COMPLETED|Overall Study||7
7586180|NCT02684942|18669388|P6|STARTED|Overall Study||6
7586181|NCT02684942|18669389|P5|STARTED|Overall Study||6
7586182|NCT02684942|18669390|P4|STARTED|Overall Study||7
7586183|NCT02684942|18669391|P3|STARTED|Overall Study||7
7586184|NCT02684942|18669392|P2|STARTED|Overall Study||7
7586185|NCT02684942|18669393|P1|STARTED|Overall Study||7
7586186|NCT02684630|18669409|P2|NOT COMPLETED|Overall Study||3
7586187|NCT02684630|18669410|P1|NOT COMPLETED|Overall Study||5
7586188|NCT02684630|18669409|P2|COMPLETED|Overall Study||60
7586189|NCT02684630|18669410|P1|COMPLETED|Overall Study||60
7586190|NCT02684630|18669409|P2|STARTED|Overall Study||63
7586191|NCT02684630|18669410|P1|STARTED|Overall Study||65
7586192|NCT02684604|18669420|P2|NOT COMPLETED|Overall Study||0
7586193|NCT02684604|18669421|P1|NOT COMPLETED|Overall Study||0
7586194|NCT02684604|18669420|P2|COMPLETED|Overall Study||44
7586195|NCT02684604|18669421|P1|COMPLETED|Overall Study||44
7586196|NCT02684604|18669420|P2|STARTED|Overall Study||44
7586197|NCT02684604|18669421|P1|STARTED|Overall Study||44
7586198|NCT02684591|18669429|P2|NOT COMPLETED|Overall Study||3
7586199|NCT02684591|18669430|P1|NOT COMPLETED|Overall Study||1
7586200|NCT02684591|18669429|P2|COMPLETED|Overall Study||22
7586201|NCT02684591|18669430|P1|COMPLETED|Overall Study||24
7586202|NCT02684591|18669429|P2|STARTED|Overall Study||25
7586203|NCT02684591|18669430|P1|STARTED|Overall Study||25
7586204|NCT02684435|18669438|P1|NOT COMPLETED|Overall Study||0
7586205|NCT02684435|18669438|P1|COMPLETED|Overall Study||63
7586206|NCT02684435|18669438|P1|STARTED|Overall Study||63
7586207|NCT02684396|18669452|P6|NOT COMPLETED|Overall Study||0
7586208|NCT02684396|18669453|P5|NOT COMPLETED|Overall Study||0
7586209|NCT02684396|18669454|P4|NOT COMPLETED|Overall Study||0
7586210|NCT02684396|18669455|P3|NOT COMPLETED|Overall Study||0
7586211|NCT02684396|18669456|P2|NOT COMPLETED|Overall Study||0
7586212|NCT02684396|18669457|P1|NOT COMPLETED|Overall Study||0
7586213|NCT02684396|18669452|P6|COMPLETED|Overall Study||10
7586214|NCT02684396|18669453|P5|COMPLETED|Overall Study||5
7586215|NCT02684396|18669454|P4|COMPLETED|Overall Study||6
7586216|NCT02684396|18669455|P3|COMPLETED|Overall Study||6
7586217|NCT02684396|18669456|P2|COMPLETED|Overall Study||6
7586218|NCT02684396|18669457|P1|COMPLETED|Overall Study||6
7586219|NCT02684396|18669452|P6|STARTED|Overall Study||10
7586220|NCT02684396|18669453|P5|STARTED|Overall Study||5
7586221|NCT02684396|18669454|P4|STARTED|Overall Study||6
7586222|NCT02684396|18669455|P3|STARTED|Overall Study||6
7586223|NCT02684396|18669456|P2|STARTED|Overall Study||6
7586224|NCT02684396|18669457|P1|STARTED|Overall Study||6
7586225|NCT02684370|18669512|P6|NOT COMPLETED|Part B||8
7586226|NCT02684370|18669513|P5|NOT COMPLETED|Part B||5
7586227|NCT02684370|18669514|P4|NOT COMPLETED|Part B||2
7586228|NCT02684370|18669515|P3|NOT COMPLETED|Part B||0
7586229|NCT02684370|18669516|P2|NOT COMPLETED|Part B||0
7586230|NCT02684370|18669517|P1|NOT COMPLETED|Part B||0
7586231|NCT02684370|18669512|P6|COMPLETED|Part B||289
7586232|NCT02684370|18669513|P5|COMPLETED|Part B||94
7586233|NCT02684370|18669514|P4|COMPLETED|Part B||95
7586234|NCT02684370|18669515|P3|COMPLETED|Part B||0
7586235|NCT02684370|18669516|P2|COMPLETED|Part B||0
7586236|NCT02684370|18669517|P1|COMPLETED|Part B||0
7586237|NCT02684370|18669512|P6|STARTED|Part B|2 participants who received risankizumab in Part A did not receive a dose of study drug in Part B|297
7586238|NCT02684370|18669513|P5|STARTED|Part B|Participants who received ustekinumab in Part A received ustekinumab in Part B|99
7586239|NCT02684370|18669514|P4|STARTED|Part B|1 participant who received placebo in Part A did not receive a dose of study drug in Part B|97
7586240|NCT02684370|18669515|P3|STARTED|Part B||0
7586241|NCT02684370|18669516|P2|STARTED|Part B||0
7586242|NCT02684370|18669517|P1|STARTED|Part B||0
7586243|NCT02684370|18669512|P6|NOT COMPLETED|Part A||0
7586244|NCT02684370|18669513|P5|NOT COMPLETED|Part A||0
7586245|NCT02684370|18669514|P4|NOT COMPLETED|Part A||0
7586246|NCT02684370|18669515|P3|NOT COMPLETED|Part A||5
7586247|NCT02684370|18669516|P2|NOT COMPLETED|Part A||1
7586248|NCT02684370|18669517|P1|NOT COMPLETED|Part A||4
7586249|NCT02684370|18669512|P6|COMPLETED|Part A||0
7586250|NCT02684370|18669513|P5|COMPLETED|Part A||0
7586251|NCT02684370|18669514|P4|COMPLETED|Part A||0
7586252|NCT02684370|18669515|P3|COMPLETED|Part A||299
7586253|NCT02684370|18669516|P2|COMPLETED|Part A||99
7586254|NCT02684370|18669517|P1|COMPLETED|Part A||98
7586255|NCT02684370|18669512|P6|STARTED|Part A||0
7586256|NCT02684370|18669513|P5|STARTED|Part A||0
7586257|NCT02684370|18669514|P4|STARTED|Part A||0
7586258|NCT02684370|18669515|P3|STARTED|Part A||304
7586259|NCT02684370|18669516|P2|STARTED|Part A||100
7586260|NCT02684370|18669517|P1|STARTED|Part A||102
7586261|NCT02684357|18669562|P6|NOT COMPLETED|Part B||13
7586262|NCT02684357|18669563|P5|NOT COMPLETED|Part B||4
7586263|NCT02684357|18669564|P4|NOT COMPLETED|Part B||3
7586264|NCT02684357|18669565|P3|NOT COMPLETED|Part B||0
7586265|NCT02684357|18669566|P2|NOT COMPLETED|Part B||0
7586266|NCT02684357|18669567|P1|NOT COMPLETED|Part B||0
7586267|NCT02684357|18669562|P6|COMPLETED|Part B||278
7586268|NCT02684357|18669563|P5|COMPLETED|Part B||90
7586269|NCT02684357|18669564|P4|COMPLETED|Part B||91
7586270|NCT02684357|18669565|P3|COMPLETED|Part B||0
7586271|NCT02684357|18669566|P2|COMPLETED|Part B||0
7586272|NCT02684357|18669567|P1|COMPLETED|Part B||0
7586273|NCT02684357|18669562|P6|STARTED|Part B|1 participant who received risankizumab in Part A did not receive a dose of study drug in Part B|291
7586274|NCT02684357|18669563|P5|STARTED|Part B|2 participants who received ustekinumab in Part A did not receive a dose of study drug in Part B.|94
7586275|NCT02684357|18669564|P4|STARTED|Part B|Participants who received placebo in Part A received risankizumab in Part B|94
7586276|NCT02684357|18669565|P3|STARTED|Part B||0
7586277|NCT02684357|18669566|P2|STARTED|Part B||0
7586278|NCT02684357|18669567|P1|STARTED|Part B||0
7586279|NCT02684357|18669562|P6|NOT COMPLETED|Part A||0
7586280|NCT02684357|18669563|P5|NOT COMPLETED|Part A||0
7586281|NCT02684357|18669564|P4|NOT COMPLETED|Part A||0
7586282|NCT02684357|18669565|P3|NOT COMPLETED|Part A||2
7586283|NCT02684357|18669566|P2|NOT COMPLETED|Part A||3
7586284|NCT02684357|18669567|P1|NOT COMPLETED|Part A||4
7586285|NCT02684357|18669562|P6|COMPLETED|Part A||0
7586286|NCT02684357|18669563|P5|COMPLETED|Part A||0
7586287|NCT02684357|18669564|P4|COMPLETED|Part A||0
7586288|NCT02684357|18669565|P3|COMPLETED|Part A||292
7586289|NCT02684357|18669566|P2|COMPLETED|Part A||96
7586290|NCT02684357|18669567|P1|COMPLETED|Part A||94
7586291|NCT02684357|18669562|P6|STARTED|Part A||0
7586292|NCT02684357|18669563|P5|STARTED|Part A||0
7586293|NCT02684357|18669564|P4|STARTED|Part A||0
7586294|NCT02684357|18669565|P3|STARTED|Part A||294
7586295|NCT02684357|18669566|P2|STARTED|Part A||99
7586296|NCT02684357|18669567|P1|STARTED|Part A||98
7586297|NCT02684344|18669617|P2|NOT COMPLETED|Overall Study||1
7586298|NCT02684344|18669618|P1|NOT COMPLETED|Overall Study||0
7586299|NCT02684344|18669617|P2|COMPLETED|Overall Study||3
7586300|NCT02684344|18669618|P1|COMPLETED|Overall Study||1
7586301|NCT02684344|18669617|P2|STARTED|Overall Study||4
7586302|NCT02684344|18669618|P1|STARTED|Overall Study||1
7586303|NCT02684279|18669624|P1|NOT COMPLETED|Overall Study||279
7586304|NCT02684279|18669624|P1|COMPLETED|Overall Study||249
7586305|NCT02684279|18669624|P1|STARTED|Overall Study||528
7586306|NCT02684188|18669649|P2|NOT COMPLETED|Overall Study||3
7586307|NCT02684188|18669650|P1|NOT COMPLETED|Overall Study||2
7586308|NCT02684188|18669649|P2|COMPLETED|Overall Study||47
7586309|NCT02684188|18669650|P1|COMPLETED|Overall Study||75
7586310|NCT02684188|18669649|P2|STARTED|Overall Study||50
7586311|NCT02684188|18669650|P1|STARTED|Overall Study||77
7586312|NCT02684097|18669676|P2|NOT COMPLETED|Overall Study||6
7586313|NCT02684097|18669677|P1|NOT COMPLETED|Overall Study||13
7586314|NCT02684097|18669676|P2|COMPLETED|Overall Study||1
7586315|NCT02684097|18669677|P1|COMPLETED|Overall Study||2
7586316|NCT02684097|18669676|P2|STARTED|Overall Study||7
7586317|NCT02684097|18669677|P1|STARTED|Overall Study||15
7586318|NCT02683954|18669695|P2|NOT COMPLETED|Overall Study||0
7586319|NCT02683954|18669696|P1|NOT COMPLETED|Overall Study||0
7586320|NCT02683954|18669695|P2|COMPLETED|Overall Study||30
7586321|NCT02683954|18669696|P1|COMPLETED|Overall Study||30
7586322|NCT02683954|18669695|P2|STARTED|Overall Study||30
7586323|NCT02683954|18669696|P1|STARTED|Overall Study||30
7586324|NCT02683928|18669704|P2|NOT COMPLETED|Overall Study||8
7586325|NCT02683928|18669705|P1|NOT COMPLETED|Overall Study||22
7586326|NCT02683928|18669704|P2|COMPLETED|Overall Study||8
7586327|NCT02683928|18669705|P1|COMPLETED|Overall Study||26
7586328|NCT02683928|18669704|P2|STARTED|Overall Study||16
7586329|NCT02683928|18669705|P1|STARTED|Overall Study||48
7586330|NCT02683876|18669725|P2|NOT COMPLETED|Overall Study||0
7586331|NCT02683876|18669726|P1|NOT COMPLETED|Overall Study||2
7586332|NCT02683876|18669725|P2|COMPLETED|Overall Study||22
7586333|NCT02683876|18669726|P1|COMPLETED|Overall Study||15
7586334|NCT02683876|18669725|P2|STARTED|Overall Study||22
7586335|NCT02683876|18669726|P1|STARTED|Overall Study||17
7586336|NCT02683785|18669736|P2|NOT COMPLETED|Overall Study||4
7586337|NCT02683785|18669737|P1|NOT COMPLETED|Overall Study||1
7586338|NCT02683785|18669736|P2|COMPLETED|Overall Study||18
7586339|NCT02683785|18669737|P1|COMPLETED|Overall Study||21
7586340|NCT02683785|18669736|P2|STARTED|Overall Study||22
7586341|NCT02683785|18669737|P1|STARTED|Overall Study||22
7586342|NCT02683772|18669777|P2|NOT COMPLETED|Overall Study||0
7586343|NCT02683772|18669778|P1|NOT COMPLETED|Overall Study||0
7586344|NCT02683772|18669777|P2|COMPLETED|Overall Study||23
7586345|NCT02683772|18669778|P1|COMPLETED|Overall Study||15
7586346|NCT02683772|18669777|P2|STARTED|Overall Study||23
7586347|NCT02683772|18669778|P1|STARTED|Overall Study||15
7586348|NCT02683746|18669794|P2|NOT COMPLETED|Overall Study||14
7586349|NCT02683746|18669795|P1|NOT COMPLETED|Overall Study||16
7586350|NCT02683746|18669794|P2|COMPLETED|Overall Study||140
7586351|NCT02683746|18669795|P1|COMPLETED|Overall Study||138
7586352|NCT02683746|18669794|P2|STARTED|Overall Study||154
7586353|NCT02683746|18669795|P1|STARTED|Overall Study||154
7586354|NCT02683707|18669825|P2|NOT COMPLETED|Overall Study||0
7586355|NCT02683707|18669826|P1|NOT COMPLETED|Overall Study||0
7586356|NCT02683707|18669825|P2|COMPLETED|Overall Study||107
7586357|NCT02683707|18669826|P1|COMPLETED|Overall Study||105
7586358|NCT02683707|18669825|P2|STARTED|Overall Study||107
7586359|NCT02683707|18669826|P1|STARTED|Overall Study||105
7586360|NCT02683668|18669838|P3|NOT COMPLETED|Period 3||0
7586361|NCT02683668|18669839|P2|NOT COMPLETED|Period 3||0
7586362|NCT02683668|18669840|P1|NOT COMPLETED|Period 3||0
7586363|NCT02683668|18669838|P3|COMPLETED|Period 3||43
7586364|NCT02683668|18669839|P2|COMPLETED|Period 3||0
7586365|NCT02683668|18669840|P1|COMPLETED|Period 3||0
7586366|NCT02683668|18669838|P3|STARTED|Period 3||43
7586367|NCT02683668|18669839|P2|STARTED|Period 3||0
7586368|NCT02683668|18669840|P1|STARTED|Period 3||0
7586369|NCT02683668|18669838|P3|NOT COMPLETED|Period 2||0
7586370|NCT02683668|18669839|P2|NOT COMPLETED|Period 2||1
7586371|NCT02683668|18669840|P1|NOT COMPLETED|Period 2||0
7586372|NCT02683668|18669838|P3|COMPLETED|Period 2||0
7586373|NCT02683668|18669839|P2|COMPLETED|Period 2||43
7586374|NCT02683668|18669840|P1|COMPLETED|Period 2||0
7586375|NCT02683668|18669838|P3|STARTED|Period 2||0
7586376|NCT02683668|18669839|P2|STARTED|Period 2||44
7586377|NCT02683668|18669840|P1|STARTED|Period 2||0
7586378|NCT02683668|18669838|P3|NOT COMPLETED|Period 1||0
7586379|NCT02683668|18669839|P2|NOT COMPLETED|Period 1||0
7586380|NCT02683668|18669840|P1|NOT COMPLETED|Period 1||0
7586381|NCT02683668|18669838|P3|COMPLETED|Period 1||0
7586382|NCT02683668|18669839|P2|COMPLETED|Period 1||0
7586383|NCT02683668|18669840|P1|COMPLETED|Period 1||44
7586384|NCT02683668|18669838|P3|STARTED|Period 1||0
7586385|NCT02683668|18669839|P2|STARTED|Period 1||0
7586386|NCT02683668|18669840|P1|STARTED|Period 1||44
7586387|NCT02683577|18669858|P3|NOT COMPLETED|Overall Study||0
7586388|NCT02683577|18669859|P2|NOT COMPLETED|Overall Study||0
7586389|NCT02683577|18669860|P1|NOT COMPLETED|Overall Study||0
7586390|NCT02683577|18669858|P3|COMPLETED|Overall Study||8
7586391|NCT02683577|18669859|P2|COMPLETED|Overall Study||8
7586392|NCT02683577|18669860|P1|COMPLETED|Overall Study||8
7586393|NCT02683577|18669858|P3|STARTED|Overall Study||8
7586394|NCT02683577|18669859|P2|STARTED|Overall Study||8
7586395|NCT02683577|18669860|P1|STARTED|Overall Study||8
7586396|NCT02683525|18669906|P1|NOT COMPLETED|Overall Study||8
7586397|NCT02683525|18669906|P1|COMPLETED|Overall Study||29
7586398|NCT02683525|18669906|P1|STARTED|Overall Study||37
7586399|NCT02683421|18669924|P4|NOT COMPLETED|Overall Study||0
7586400|NCT02683421|18669925|P3|NOT COMPLETED|Overall Study||0
7586401|NCT02683421|18669926|P2|NOT COMPLETED|Overall Study||0
7586402|NCT02683421|18669927|P1|NOT COMPLETED|Overall Study||0
7586403|NCT02683421|18669924|P4|COMPLETED|Overall Study||5
7586404|NCT02683421|18669925|P3|COMPLETED|Overall Study||4
7586405|NCT02683421|18669926|P2|COMPLETED|Overall Study||4
7586406|NCT02683421|18669927|P1|COMPLETED|Overall Study||5
7586407|NCT02683421|18669924|P4|STARTED|Overall Study||5
7586408|NCT02683421|18669925|P3|STARTED|Overall Study||4
7586409|NCT02683421|18669926|P2|STARTED|Overall Study||4
7586410|NCT02683421|18669927|P1|STARTED|Overall Study||5
7586411|NCT02683174|18669945|P1|NOT COMPLETED|Overall Study||0
7586412|NCT02683174|18669945|P1|COMPLETED|Overall Study||86
7586413|NCT02683174|18669945|P1|STARTED|Overall Study||86
7586414|NCT02683161|18669955|P1|NOT COMPLETED|Overall Study||0
7586415|NCT02683161|18669955|P1|COMPLETED|Overall Study||5
7586416|NCT02683161|18669955|P1|STARTED|Overall Study||5
7586417|NCT02683109|18669961|P2|NOT COMPLETED|Overall Study||0
7586418|NCT02683109|18669962|P1|NOT COMPLETED|Overall Study||1
7586419|NCT02683109|18669961|P2|COMPLETED|Overall Study||111
7586420|NCT02683109|18669962|P1|COMPLETED|Overall Study||109
7586421|NCT02683109|18669961|P2|STARTED|Overall Study||111
7586422|NCT02683109|18669962|P1|STARTED|Overall Study||110
7586423|NCT02683083|18669973|P1|NOT COMPLETED|Overall Study||0
7586424|NCT02683083|18669973|P1|COMPLETED|Overall Study||9
7586425|NCT02683083|18669973|P1|STARTED|Overall Study||9
7586426|NCT02682823|18669983|P5|NOT COMPLETED|Overall Study||1
7586427|NCT02682823|18669984|P4|NOT COMPLETED|Overall Study||1
7586428|NCT02682823|18669985|P3|NOT COMPLETED|Overall Study||1
7586429|NCT02682823|18669986|P2|NOT COMPLETED|Overall Study||1
7586430|NCT02682823|18669987|P1|NOT COMPLETED|Overall Study||0
7586431|NCT02682823|18669983|P5|COMPLETED|Overall Study||18
7586432|NCT02682823|18669984|P4|COMPLETED|Overall Study||16
7586433|NCT02682823|18669985|P3|COMPLETED|Overall Study||18
7586434|NCT02682823|18669986|P2|COMPLETED|Overall Study||18
7586435|NCT02682823|18669987|P1|COMPLETED|Overall Study||17
7586436|NCT02682823|18669983|P5|Safety Population|Overall Study|All participants who received at least one dose of study drug.|19
7586437|NCT02682823|18669984|P4|Safety Population|Overall Study|All participants who received at least one dose of study drug.|17
7586438|NCT02682823|18669985|P3|Safety Population|Overall Study|All participants who received at least one dose of study drug.|18
7586439|NCT02682823|18669986|P2|Safety Population|Overall Study|All HCPs who administered at least one dose of study drug.|19
7586440|NCT02682823|18669987|P1|Safety Population|Overall Study|All CGs who administered at least one dose of study drug.|17
7586441|NCT02682823|18669983|P5|STARTED|Overall Study||19
7586442|NCT02682823|18669984|P4|STARTED|Overall Study||17
7586443|NCT02682823|18669985|P3|STARTED|Overall Study||19
7586444|NCT02682823|18669986|P2|STARTED|Overall Study||19
7586445|NCT02682823|18669987|P1|STARTED|Overall Study||17
7586446|NCT02682602|18670023|P2|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||0
7586447|NCT02682602|18670024|P1|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||3
7586448|NCT02682602|18670023|P2|COMPLETED|Post-operative Fluoroscopy for Implanted|Nonimplanted subjects were not analyzed again for the second period, because this would be redundant|0
7586449|NCT02682602|18670024|P1|COMPLETED|Post-operative Fluoroscopy for Implanted||7
7586450|NCT02682602|18670023|P2|STARTED|Post-operative Fluoroscopy for Implanted||0
7586451|NCT02682602|18670024|P1|STARTED|Post-operative Fluoroscopy for Implanted||10
7586452|NCT02682602|18670023|P2|NOT COMPLETED|Pre-operative Diseased & Normal Hips||0
7586453|NCT02682602|18670024|P1|NOT COMPLETED|Pre-operative Diseased & Normal Hips||1
7586454|NCT02682602|18670023|P2|COMPLETED|Pre-operative Diseased & Normal Hips||10
7586455|NCT02682602|18670024|P1|COMPLETED|Pre-operative Diseased & Normal Hips||10
7586456|NCT02682602|18670023|P2|STARTED|Pre-operative Diseased & Normal Hips||10
7586457|NCT02682602|18670024|P1|STARTED|Pre-operative Diseased & Normal Hips||11
7586458|NCT02682563|18670043|P2|NOT COMPLETED|Overall Study||0
7586459|NCT02682563|18670044|P1|NOT COMPLETED|Overall Study||0
7586460|NCT02682563|18670043|P2|COMPLETED|Overall Study||20
7586461|NCT02682563|18670044|P1|COMPLETED|Overall Study||24
7586462|NCT02682563|18670043|P2|STARTED|Overall Study||20
7586463|NCT02682563|18670044|P1|STARTED|Overall Study||24
7586464|NCT02682498|18670070|P2|NOT COMPLETED|Overall Study||0
7586465|NCT02682498|18670071|P1|NOT COMPLETED|Overall Study||0
7586466|NCT02682498|18670070|P2|COMPLETED|Overall Study||20
7586467|NCT02682498|18670071|P1|COMPLETED|Overall Study||18
7586468|NCT02682498|18670070|P2|STARTED|Overall Study||20
7586469|NCT02682498|18670071|P1|STARTED|Overall Study||18
7586470|NCT02682381|18670088|P3|NOT COMPLETED|Overall Study||0
7586471|NCT02682381|18670089|P2|NOT COMPLETED|Overall Study||0
7586472|NCT02682381|18670090|P1|NOT COMPLETED|Overall Study||0
7586473|NCT02682381|18670088|P3|COMPLETED|Overall Study||9
7586474|NCT02682381|18670089|P2|COMPLETED|Overall Study||26
7586475|NCT02682381|18670090|P1|COMPLETED|Overall Study||24
7586476|NCT02682381|18670088|P3|STARTED|Overall Study||9
7586477|NCT02682381|18670089|P2|STARTED|Overall Study||26
7586478|NCT02682381|18670090|P1|STARTED|Overall Study||24
7586479|NCT02682264|18670157|P2|NOT COMPLETED|Overall Study||122
7586480|NCT02682264|18670158|P1|NOT COMPLETED|Overall Study||138
7586481|NCT02682264|18670157|P2|COMPLETED|Overall Study||168
7586482|NCT02682264|18670158|P1|COMPLETED|Overall Study||179
7586483|NCT02682264|18670157|P2|STARTED|Overall Study||290
7586484|NCT02682264|18670158|P1|STARTED|Overall Study||317
7586485|NCT02682069|18670164|P1|NOT COMPLETED|Overall Study||0
7586486|NCT02682069|18670164|P1|COMPLETED|Overall Study||30
7586487|NCT02682069|18670164|P1|STARTED|Overall Study||30
7586488|NCT02682056|18670168|P1|NOT COMPLETED|Overall Study||0
7586489|NCT02682056|18670168|P1|COMPLETED|Overall Study||15
7586490|NCT02682056|18670168|P1|STARTED|Overall Study||15
7586491|NCT02682030|18670184|P2|NOT COMPLETED|Overall Study||2
7586492|NCT02682030|18670185|P1|NOT COMPLETED|Overall Study||1
7586493|NCT02682030|18670184|P2|COMPLETED|Overall Study||2
7586494|NCT02682030|18670185|P1|COMPLETED|Overall Study||0
7586495|NCT02682030|18670184|P2|STARTED|Overall Study||4
7586496|NCT02682030|18670185|P1|STARTED|Overall Study||1
7586497|NCT02681809|18670204|P3|NOT COMPLETED|Overall Study||1
7586498|NCT02681809|18670205|P2|NOT COMPLETED|Overall Study||4
7586499|NCT02681809|18670206|P1|NOT COMPLETED|Overall Study||5
7586500|NCT02681809|18670204|P3|COMPLETED|Overall Study||8
7586501|NCT02681809|18670205|P2|COMPLETED|Overall Study||15
7586502|NCT02681809|18670206|P1|COMPLETED|Overall Study||15
7586503|NCT02681809|18670204|P3|STARTED|Overall Study||9
7586504|NCT02681809|18670205|P2|STARTED|Overall Study||19
7586505|NCT02681809|18670206|P1|STARTED|Overall Study||20
7586506|NCT02681757|18670219|P2|NOT COMPLETED|Overall Study||0
7586507|NCT02681757|18670220|P1|NOT COMPLETED|Overall Study||0
7586508|NCT02681757|18670219|P2|COMPLETED|Overall Study||49
7586509|NCT02681757|18670220|P1|COMPLETED|Overall Study||47
7586510|NCT02681757|18670219|P2|STARTED|Overall Study||49
7586511|NCT02681757|18670220|P1|STARTED|Overall Study||47
7586512|NCT02681614|18670230|P1|NOT COMPLETED|Overall Study||0
7586513|NCT02681614|18670230|P1|COMPLETED|Overall Study||5
7586514|NCT02681614|18670230|P1|STARTED|Overall Study||5
7586515|NCT02681510|18670244|P1|NOT COMPLETED|Overall Study||10
7586516|NCT02681510|18670244|P1|COMPLETED|Overall Study||26
7586517|NCT02681510|18670244|P1|STARTED|Overall Study||36
7586518|NCT02681458|18670253|P2|NOT COMPLETED|Overall Study||656
7586519|NCT02681458|18670254|P1|NOT COMPLETED|Overall Study||645
7586520|NCT02681458|18670253|P2|COMPLETED|Overall Study||62
7586521|NCT02681458|18670254|P1|COMPLETED|Overall Study||73
7586522|NCT02681458|18670253|P2|STARTED|Overall Study||718
7586523|NCT02681458|18670254|P1|STARTED|Overall Study||718
7586524|NCT02681172|18670260|P1|NOT COMPLETED|Overall Study||13
7586525|NCT02681172|18670260|P1|COMPLETED|Overall Study||205
7586526|NCT02681172|18670260|P1|Per Protocol Set|Overall Study||205
7586527|NCT02681172|18670260|P1|Full Analysis Set|Overall Study||205
7586528|NCT02681172|18670260|P1|Safety Analysis Set|Overall Study||205
7586529|NCT02681172|18670260|P1|STARTED|Overall Study||218
7586530|NCT02681094|18670274|P3|NOT COMPLETED|2 - Enrolled Participants Set||54
7586531|NCT02681094|18670275|P2|NOT COMPLETED|2 - Enrolled Participants Set||41
7586532|NCT02681094|18670276|P1|NOT COMPLETED|2 - Enrolled Participants Set||40
7586533|NCT02681094|18670274|P3|COMPLETED|2 - Enrolled Participants Set||248
7586534|NCT02681094|18670275|P2|COMPLETED|2 - Enrolled Participants Set||261
7586535|NCT02681094|18670276|P1|COMPLETED|2 - Enrolled Participants Set||261
7586536|NCT02681094|18670274|P3|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|289
7586537|NCT02681094|18670275|P2|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|284
7586538|NCT02681094|18670276|P1|Participants Completed Treatment Period|2 - Enrolled Participants Set||281
7586539|NCT02681094|18670274|P3|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
7586540|NCT02681094|18670275|P2|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
7586626|NCT02680158|18670449|P2|NOT COMPLETED|Overall Study||0
7586541|NCT02681094|18670276|P1|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|301
7586542|NCT02681094|18670274|P3|NOT COMPLETED|1 -Modified Enrolled Participants Set||53
7586543|NCT02681094|18670275|P2|NOT COMPLETED|1 -Modified Enrolled Participants Set||39
7586544|NCT02681094|18670276|P1|NOT COMPLETED|1 -Modified Enrolled Participants Set||37
7586545|NCT02681094|18670274|P3|COMPLETED|1 -Modified Enrolled Participants Set||243
7586546|NCT02681094|18670275|P2|COMPLETED|1 -Modified Enrolled Participants Set||255
7586547|NCT02681094|18670276|P1|COMPLETED|1 -Modified Enrolled Participants Set||256
7586548|NCT02681094|18670274|P3|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||283
7586549|NCT02681094|18670275|P2|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||276
7586550|NCT02681094|18670276|P1|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||273
7586551|NCT02681094|18670274|P3|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|296
7586552|NCT02681094|18670275|P2|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|294
7586553|NCT02681094|18670276|P1|STARTED|1 -Modified Enrolled Participants Set||293
7586554|NCT02680847|18670295|P3|NOT COMPLETED|Overall Study||3
7586555|NCT02680847|18670296|P2|NOT COMPLETED|Overall Study||3
7586556|NCT02680847|18670297|P1|NOT COMPLETED|Overall Study||5
7586557|NCT02680847|18670295|P3|COMPLETED|Overall Study||4
7586558|NCT02680847|18670296|P2|COMPLETED|Overall Study||6
7586559|NCT02680847|18670297|P1|COMPLETED|Overall Study||11
7586560|NCT02680847|18670295|P3|STARTED|Overall Study||7
7586561|NCT02680847|18670296|P2|STARTED|Overall Study||9
7586562|NCT02680847|18670297|P1|STARTED|Overall Study||16
7586563|NCT02680834|18670334|P2|NOT COMPLETED|Overall Study||3
7586564|NCT02680834|18670335|P1|NOT COMPLETED|Overall Study||11
7586565|NCT02680834|18670334|P2|COMPLETED|Overall Study||27
7586566|NCT02680834|18670335|P1|COMPLETED|Overall Study||15
7586567|NCT02680834|18670334|P2|STARTED|Overall Study||30
7586568|NCT02680834|18670335|P1|STARTED|Overall Study||26
7586569|NCT02680756|18670347|P2|NOT COMPLETED|Overall Study||19
7586570|NCT02680756|18670348|P1|NOT COMPLETED|Overall Study||32
7586571|NCT02680756|18670347|P2|COMPLETED|Overall Study||106
7586572|NCT02680756|18670348|P1|COMPLETED|Overall Study||93
7586573|NCT02680756|18670347|P2|Received Treatment|Overall Study||120
7586574|NCT02680756|18670348|P1|Received Treatment|Overall Study||127
7586575|NCT02680756|18670347|P2|STARTED|Overall Study||125
7586576|NCT02680756|18670348|P1|STARTED|Overall Study||125
7586577|NCT02680665|18670396|P1|NOT COMPLETED|Overall Study||5
7586578|NCT02680665|18670396|P1|COMPLETED|Overall Study||115
7586579|NCT02680665|18670396|P1|STARTED|Overall Study||120
7586580|NCT02680639|18670402|P3|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
7586581|NCT02680639|18670403|P2|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
7586582|NCT02680639|18670404|P1|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
7586583|NCT02680639|18670402|P3|COMPLETED|High Frequency Oscillation (HFO) Therapy||1
7586584|NCT02680639|18670403|P2|COMPLETED|High Frequency Oscillation (HFO) Therapy||2
7586585|NCT02680639|18670404|P1|COMPLETED|High Frequency Oscillation (HFO) Therapy||0
7586586|NCT02680639|18670402|P3|STARTED|High Frequency Oscillation (HFO) Therapy||1
7586587|NCT02680639|18670403|P2|STARTED|High Frequency Oscillation (HFO) Therapy||2
7586588|NCT02680639|18670404|P1|STARTED|High Frequency Oscillation (HFO) Therapy||0
7586589|NCT02680639|18670402|P3|NOT COMPLETED|Screening Period||0
7586590|NCT02680639|18670403|P2|NOT COMPLETED|Screening Period||0
7586591|NCT02680639|18670404|P1|NOT COMPLETED|Screening Period||7
7586592|NCT02680639|18670402|P3|COMPLETED|Screening Period||0
7586593|NCT02680639|18670403|P2|COMPLETED|Screening Period||0
7586594|NCT02680639|18670404|P1|COMPLETED|Screening Period||3
7586595|NCT02680639|18670402|P3|STARTED|Screening Period||0
7586596|NCT02680639|18670403|P2|STARTED|Screening Period||0
7586597|NCT02680639|18670404|P1|STARTED|Screening Period||10
7586598|NCT02680457|18670425|P2|NOT COMPLETED|Cross-over Intervention||0
7586599|NCT02680457|18670426|P1|NOT COMPLETED|Cross-over Intervention||0
7586600|NCT02680457|18670425|P2|COMPLETED|Cross-over Intervention||6
7586601|NCT02680457|18670426|P1|COMPLETED|Cross-over Intervention||6
7586602|NCT02680457|18670425|P2|STARTED|Cross-over Intervention||6
7586603|NCT02680457|18670426|P1|STARTED|Cross-over Intervention||6
7586604|NCT02680457|18670425|P2|NOT COMPLETED|Washout Period||0
7586605|NCT02680457|18670426|P1|NOT COMPLETED|Washout Period||0
7586606|NCT02680457|18670425|P2|COMPLETED|Washout Period||6
7586607|NCT02680457|18670426|P1|COMPLETED|Washout Period||6
7586608|NCT02680457|18670425|P2|STARTED|Washout Period||6
7586609|NCT02680457|18670426|P1|STARTED|Washout Period||6
7586610|NCT02680457|18670425|P2|NOT COMPLETED|Initial Intervention||0
7586611|NCT02680457|18670426|P1|NOT COMPLETED|Initial Intervention||0
7586612|NCT02680457|18670425|P2|COMPLETED|Initial Intervention||6
7586613|NCT02680457|18670426|P1|COMPLETED|Initial Intervention||6
7586614|NCT02680457|18670425|P2|STARTED|Initial Intervention||6
7586615|NCT02680457|18670426|P1|STARTED|Initial Intervention||6
7586616|NCT02680301|18670436|P2|NOT COMPLETED|Overall Study||1
7586617|NCT02680301|18670437|P1|NOT COMPLETED|Overall Study||0
7586618|NCT02680301|18670436|P2|COMPLETED|Overall Study||17
7586619|NCT02680301|18670437|P1|COMPLETED|Overall Study||22
7586620|NCT02680301|18670436|P2|STARTED|Overall Study||18
7586621|NCT02680301|18670437|P1|STARTED|Overall Study||22
7586622|NCT02680158|18670445|P6|NOT COMPLETED|Overall Study||0
7586623|NCT02680158|18670446|P5|NOT COMPLETED|Overall Study||0
7586624|NCT02680158|18670447|P4|NOT COMPLETED|Overall Study||0
7586625|NCT02680158|18670448|P3|NOT COMPLETED|Overall Study||0
7586627|NCT02680158|18670450|P1|NOT COMPLETED|Overall Study||0
7586628|NCT02680158|18670445|P6|COMPLETED|Overall Study||8
7586629|NCT02680158|18670446|P5|COMPLETED|Overall Study||8
7586630|NCT02680158|18670447|P4|COMPLETED|Overall Study||8
7586631|NCT02680158|18670448|P3|COMPLETED|Overall Study||8
7586632|NCT02680158|18670449|P2|COMPLETED|Overall Study||8
7586633|NCT02680158|18670450|P1|COMPLETED|Overall Study||8
7586634|NCT02680158|18670445|P6|STARTED|Overall Study||8
7586635|NCT02680158|18670446|P5|STARTED|Overall Study||8
7586636|NCT02680158|18670447|P4|STARTED|Overall Study||8
7586637|NCT02680158|18670448|P3|STARTED|Overall Study||8
7586638|NCT02680158|18670449|P2|STARTED|Overall Study||8
7586639|NCT02680158|18670450|P1|STARTED|Overall Study||8
7586640|NCT02680145|18670461|P1|NOT COMPLETED|Overall Study||11
7586641|NCT02680145|18670461|P1|COMPLETED|Overall Study||47
7586642|NCT02680145|18670461|P1|STARTED|Overall Study||58
7586643|NCT02680054|18670468|P1|NOT COMPLETED|Overall Study||11
7586644|NCT02680054|18670468|P1|COMPLETED|Overall Study||27
7586645|NCT02680054|18670468|P1|STARTED|Overall Study||38
7586646|NCT02680041|18670486|P1|NOT COMPLETED|Overall Study||10
7586647|NCT02680041|18670486|P1|COMPLETED|Overall Study||211
7586648|NCT02680041|18670486|P1|Received 18F-fluciclovine|Overall Study||213
7586649|NCT02680041|18670486|P1|STARTED|Overall Study||221
7586650|NCT02680002|18670501|P6|NOT COMPLETED|Overall Study||9
7586651|NCT02680002|18670502|P5|NOT COMPLETED|Overall Study||11
7586652|NCT02680002|18670503|P4|NOT COMPLETED|Overall Study||4
7586653|NCT02680002|18670504|P3|NOT COMPLETED|Overall Study||10
7586654|NCT02680002|18670505|P2|NOT COMPLETED|Overall Study||4
7586655|NCT02680002|18670506|P1|NOT COMPLETED|Overall Study||13
7586656|NCT02680002|18670501|P6|COMPLETED|Overall Study||61
7586657|NCT02680002|18670502|P5|COMPLETED|Overall Study||59
7586658|NCT02680002|18670503|P4|COMPLETED|Overall Study||67
7586659|NCT02680002|18670504|P3|COMPLETED|Overall Study||60
7586660|NCT02680002|18670505|P2|COMPLETED|Overall Study||66
7586661|NCT02680002|18670506|P1|COMPLETED|Overall Study||58
7586662|NCT02680002|18670501|P6|Day 201|Overall Study||61
7586663|NCT02680002|18670502|P5|Day 201|Overall Study||59
7586664|NCT02680002|18670503|P4|Day 201|Overall Study||67
7586665|NCT02680002|18670504|P3|Day 201|Overall Study||60
7586666|NCT02680002|18670505|P2|Day 201|Overall Study||66
7586667|NCT02680002|18670506|P1|Day 201|Overall Study||58
7586668|NCT02680002|18670501|P6|Day 21 (Dose 2)|Overall Study||63
7586669|NCT02680002|18670502|P5|Day 21 (Dose 2)|Overall Study||65
7586670|NCT02680002|18670503|P4|Day 21 (Dose 2)|Overall Study||69
7586671|NCT02680002|18670504|P3|Day 21 (Dose 2)|Overall Study||65
7586672|NCT02680002|18670505|P2|Day 21 (Dose 2)|Overall Study||68
7586673|NCT02680002|18670506|P1|Day 21 (Dose 2)|Overall Study||63
7586674|NCT02680002|18670501|P6|Day 0 (Dose 1)|Overall Study||68
7586675|NCT02680002|18670502|P5|Day 0 (Dose 1)|Overall Study||70
7586676|NCT02680002|18670503|P4|Day 0 (Dose 1)|Overall Study||71
7586677|NCT02680002|18670504|P3|Day 0 (Dose 1)|Overall Study||70
7586678|NCT02680002|18670505|P2|Day 0 (Dose 1)|Overall Study||70
7586679|NCT02680002|18670506|P1|Day 0 (Dose 1)|Overall Study||70
7586680|NCT02680002|18670501|P6|STARTED|Overall Study||70
7586681|NCT02680002|18670502|P5|STARTED|Overall Study||70
7586682|NCT02680002|18670503|P4|STARTED|Overall Study||71
7586683|NCT02680002|18670504|P3|STARTED|Overall Study||70
7586684|NCT02680002|18670505|P2|STARTED|Overall Study||70
7586685|NCT02680002|18670506|P1|STARTED|Overall Study||71
7586686|NCT02679976|18670622|P1|NOT COMPLETED|Overall Study||0
7586687|NCT02679976|18670622|P1|COMPLETED|Overall Study||30
7586688|NCT02679976|18670622|P1|Myopes|Overall Study||14
7586689|NCT02679976|18670622|P1|Hyperopes|Overall Study||16
7586690|NCT02679976|18670622|P1|STARTED|Overall Study||30
7586691|NCT02679911|18670631|P1|NOT COMPLETED|Overall Study||0
7586692|NCT02679911|18670631|P1|COMPLETED|Overall Study||20
7586693|NCT02679911|18670631|P1|STARTED|Overall Study|Intra-individual study|20
7586694|NCT02679807|18670640|P2|NOT COMPLETED|Overall Study||16
7586695|NCT02679807|18670641|P1|NOT COMPLETED|Overall Study||22
7586696|NCT02679807|18670640|P2|COMPLETED|Overall Study||153
7586697|NCT02679807|18670641|P1|COMPLETED|Overall Study||143
7586698|NCT02679807|18670640|P2|STARTED|Overall Study||169
7586699|NCT02679807|18670641|P1|STARTED|Overall Study||165
7586700|NCT02679755|18670649|P2|NOT COMPLETED|Overall Study||105
7586701|NCT02679755|18670650|P1|NOT COMPLETED|Overall Study||34
7586702|NCT02679755|18670649|P2|COMPLETED|Overall Study||47
7586703|NCT02679755|18670650|P1|COMPLETED|Overall Study||66
7586704|NCT02679755|18670649|P2|STARTED|Overall Study||152
7586705|NCT02679755|18670650|P1|STARTED|Overall Study||100
7586706|NCT02679729|18670692|P9|NOT COMPLETED|Overall Study||0
7586707|NCT02679729|18670693|P8|NOT COMPLETED|Overall Study||0
7586708|NCT02679729|18670694|P7|NOT COMPLETED|Overall Study||1
7586709|NCT02679729|18670695|P6|NOT COMPLETED|Overall Study||0
7586710|NCT02679729|18670696|P5|NOT COMPLETED|Overall Study||1
7586711|NCT02679729|18670697|P4|NOT COMPLETED|Overall Study||0
7586712|NCT02679729|18670698|P3|NOT COMPLETED|Overall Study||0
7586713|NCT02679729|18670699|P2|NOT COMPLETED|Overall Study||2
7586714|NCT02679729|18670700|P1|NOT COMPLETED|Overall Study||0
7586715|NCT02679729|18670692|P9|COMPLETED|Overall Study||6
7586716|NCT02679729|18670693|P8|COMPLETED|Overall Study||14
7586717|NCT02679729|18670694|P7|COMPLETED|Overall Study||5
7586718|NCT02679729|18670695|P6|COMPLETED|Overall Study||6
7586719|NCT02679729|18670696|P5|COMPLETED|Overall Study||5
7586720|NCT02679729|18670697|P4|COMPLETED|Overall Study||6
7586721|NCT02679729|18670698|P3|COMPLETED|Overall Study||6
7586722|NCT02679729|18670699|P2|COMPLETED|Overall Study||5
7586723|NCT02679729|18670700|P1|COMPLETED|Overall Study||6
7586724|NCT02679729|18670692|P9|STARTED|Overall Study||6
7586725|NCT02679729|18670693|P8|STARTED|Overall Study||14
7586726|NCT02679729|18670694|P7|STARTED|Overall Study||6
7586727|NCT02679729|18670695|P6|STARTED|Overall Study||6
7586728|NCT02679729|18670696|P5|STARTED|Overall Study||6
7586729|NCT02679729|18670697|P4|STARTED|Overall Study||6
7586730|NCT02679729|18670698|P3|STARTED|Overall Study||6
7586731|NCT02679729|18670699|P2|STARTED|Overall Study||7
7586732|NCT02679729|18670700|P1|STARTED|Overall Study||6
7586733|NCT02679690|18670804|P1|NOT COMPLETED|Overall Study||1
7586734|NCT02679690|18670804|P1|COMPLETED|Overall Study||9
7586735|NCT02679690|18670804|P1|STARTED|Overall Study||10
7586736|NCT02679573|18670812|P2|NOT COMPLETED|Overall Study||39
7586737|NCT02679573|18670813|P1|NOT COMPLETED|Overall Study||37
7586738|NCT02679573|18670812|P2|COMPLETED|Overall Study||389
7586739|NCT02679573|18670813|P1|COMPLETED|Overall Study||394
7586740|NCT02679573|18670812|P2|STARTED|Overall Study||428
7586741|NCT02679573|18670813|P1|STARTED|Overall Study||431
7586742|NCT02679469|18670829|P1|NOT COMPLETED|Overall Study||0
7586743|NCT02679469|18670829|P1|COMPLETED|Overall Study||7
7586744|NCT02679469|18670829|P1|STARTED|Overall Study||7
7586745|NCT02679287|18670837|P2|NOT COMPLETED|Phase 4||0
7586746|NCT02679287|18670838|P1|NOT COMPLETED|Phase 4||0
7586747|NCT02679287|18670837|P2|COMPLETED|Phase 4||39
7586748|NCT02679287|18670838|P1|COMPLETED|Phase 4||40
7586749|NCT02679287|18670837|P2|STARTED|Phase 4||39
7586750|NCT02679287|18670838|P1|STARTED|Phase 4||40
7586751|NCT02679287|18670837|P2|NOT COMPLETED|Period 3||1
7586752|NCT02679287|18670838|P1|NOT COMPLETED|Period 3||0
7586753|NCT02679287|18670837|P2|COMPLETED|Period 3||39
7586754|NCT02679287|18670838|P1|COMPLETED|Period 3||40
7586755|NCT02679287|18670837|P2|STARTED|Period 3||40
7586756|NCT02679287|18670838|P1|STARTED|Period 3||40
7586757|NCT02679287|18670837|P2|NOT COMPLETED|Period 2||0
7586758|NCT02679287|18670838|P1|NOT COMPLETED|Period 2||3
7586759|NCT02679287|18670837|P2|COMPLETED|Period 2||40
7586760|NCT02679287|18670838|P1|COMPLETED|Period 2||40
7586761|NCT02679287|18670837|P2|STARTED|Period 2||40
7586762|NCT02679287|18670838|P1|STARTED|Period 2||43
7586763|NCT02679287|18670837|P2|NOT COMPLETED|Period 1: Randomization-Study Session 1||6
7586764|NCT02679287|18670838|P1|NOT COMPLETED|Period 1: Randomization-Study Session 1||4
7586765|NCT02679287|18670837|P2|COMPLETED|Period 1: Randomization-Study Session 1||40
7586766|NCT02679287|18670838|P1|COMPLETED|Period 1: Randomization-Study Session 1||43
7586767|NCT02679287|18670837|P2|STARTED|Period 1: Randomization-Study Session 1||46
7586768|NCT02679287|18670838|P1|STARTED|Period 1: Randomization-Study Session 1||47
7586769|NCT02679274|18670868|P2|NOT COMPLETED|Overall Study||0
7586770|NCT02679274|18670869|P1|NOT COMPLETED|Overall Study||1
7586771|NCT02679274|18670868|P2|COMPLETED|Overall Study||1
7586772|NCT02679274|18670869|P1|COMPLETED|Overall Study||1
7586773|NCT02679274|18670868|P2|STARTED|Overall Study||1
7586774|NCT02679274|18670869|P1|STARTED|Overall Study||2
7586775|NCT02679235|18670899|P1|NOT COMPLETED|Overall Study||4
7586776|NCT02679235|18670899|P1|COMPLETED|Overall Study||11
7586777|NCT02679235|18670899|P1|STARTED|Overall Study||15
7586778|NCT02679222|18670906|P1|NOT COMPLETED|Overall Study||1
7586779|NCT02679222|18670906|P1|COMPLETED|Overall Study||9
7586780|NCT02679222|18670906|P1|STARTED|Overall Study||10
7586781|NCT02679066|18670925|P2|NOT COMPLETED|Overall Study||0
7586782|NCT02679066|18670926|P1|NOT COMPLETED|Overall Study||0
7586783|NCT02679066|18670925|P2|COMPLETED|Overall Study||100
7586784|NCT02679066|18670926|P1|COMPLETED|Overall Study||100
7586785|NCT02679066|18670925|P2|STARTED|Overall Study||100
7586786|NCT02679066|18670926|P1|STARTED|Overall Study||100
7586787|NCT02678923|18670936|P2|NOT COMPLETED|Overall Study||5
7586788|NCT02678923|18670937|P1|NOT COMPLETED|Overall Study||6
7586789|NCT02678923|18670936|P2|COMPLETED|Overall Study||62
7586790|NCT02678923|18670937|P1|COMPLETED|Overall Study||53
7586791|NCT02678923|18670936|P2|mITT Population|Overall Study||61
7586792|NCT02678923|18670937|P1|mITT Population|Overall Study||52
7586793|NCT02678923|18670936|P2|Received at Least 1 Dose of Study Drug|Overall Study||64
7586794|NCT02678923|18670937|P1|Received at Least 1 Dose of Study Drug|Overall Study||58
7586795|NCT02678923|18670936|P2|STARTED|Overall Study||67
7586796|NCT02678923|18670937|P1|STARTED|Overall Study||59
7586797|NCT02678676|18670953|P2|NOT COMPLETED|Overall Study||872
7586798|NCT02678676|18670954|P1|NOT COMPLETED|Overall Study||888
7586799|NCT02678676|18670953|P2|COMPLETED|Overall Study||907
7586800|NCT02678676|18670954|P1|COMPLETED|Overall Study||932
7586801|NCT02678676|18670953|P2|STARTED|Overall Study||1779
7586802|NCT02678676|18670954|P1|STARTED|Overall Study||1820
7586803|NCT02678442|18670964|P2|NOT COMPLETED|Second Intervention||2
7586804|NCT02678442|18670965|P1|NOT COMPLETED|Second Intervention||2
7586805|NCT02678442|18670964|P2|COMPLETED|Second Intervention||23
7586806|NCT02678442|18670965|P1|COMPLETED|Second Intervention||23
7586807|NCT02678442|18670964|P2|STARTED|Second Intervention||25
7586808|NCT02678442|18670965|P1|STARTED|Second Intervention||25
7586809|NCT02678442|18670964|P2|NOT COMPLETED|First Intervention||0
7586810|NCT02678442|18670965|P1|NOT COMPLETED|First Intervention||0
7586811|NCT02678442|18670964|P2|COMPLETED|First Intervention||25
7586812|NCT02678442|18670965|P1|COMPLETED|First Intervention||25
7586813|NCT02678442|18670964|P2|STARTED|First Intervention||25
7586814|NCT02678442|18670965|P1|STARTED|First Intervention||25
7586815|NCT02678416|18670985|P1|NOT COMPLETED|Part 2||3
7586816|NCT02678416|18670985|P1|COMPLETED|Part 2||64
7586817|NCT02678416|18670985|P1|Per Protocol Population|Part 2||64
7586818|NCT02678416|18670985|P1|Pharmacokinetic Population|Part 2||65
7586819|NCT02678416|18670985|P1|Modified Intent to Treat Population|Part 2||66
7586820|NCT02678416|18670985|P1|Treated (Safety Population)|Part 2||66
7586821|NCT02678416|18670985|P1|STARTED|Part 2|Part 2 enrolled all new participants|67
7586822|NCT02678416|18670985|P1|NOT COMPLETED|Part 1||1
7586823|NCT02678416|18670985|P1|COMPLETED|Part 1||11
7586824|NCT02678416|18670985|P1|Per Protocol Population|Part 1||8
7586825|NCT02678416|18670985|P1|Modified Intent to Treat (mITT)|Part 1||12
7586826|NCT02678416|18670985|P1|Safety Population|Part 1||12
7586827|NCT02678416|18670985|P1|STARTED|Part 1||12
7586828|NCT02678390|18671005|P2|NOT COMPLETED|MCT + AE (5 Days)||0
7586829|NCT02678390|18671006|P1|NOT COMPLETED|MCT + AE (5 Days)||0
7586830|NCT02678390|18671005|P2|COMPLETED|MCT + AE (5 Days)||9
7586831|NCT02678390|18671006|P1|COMPLETED|MCT + AE (5 Days)||10
7586832|NCT02678390|18671005|P2|STARTED|MCT + AE (5 Days)||9
7586833|NCT02678390|18671006|P1|STARTED|MCT + AE (5 Days)||10
7586834|NCT02678390|18671005|P2|NOT COMPLETED|AE (1 Day)||1
7586835|NCT02678390|18671006|P1|NOT COMPLETED|AE (1 Day)||0
7586836|NCT02678390|18671005|P2|COMPLETED|AE (1 Day)||9
7586837|NCT02678390|18671006|P1|COMPLETED|AE (1 Day)||10
7586838|NCT02678390|18671005|P2|STARTED|AE (1 Day)||10
7586839|NCT02678390|18671006|P1|STARTED|AE (1 Day)||10
7586840|NCT02678390|18671005|P2|NOT COMPLETED|MCT (5 Days)||0
7586841|NCT02678390|18671006|P1|NOT COMPLETED|MCT (5 Days)||0
7586842|NCT02678390|18671005|P2|COMPLETED|MCT (5 Days)||10
7586843|NCT02678390|18671006|P1|COMPLETED|MCT (5 Days)||10
7586844|NCT02678390|18671005|P2|STARTED|MCT (5 Days)||10
7586845|NCT02678390|18671006|P1|STARTED|MCT (5 Days)||10
7586846|NCT02678390|18671005|P2|NOT COMPLETED|Control (5 Days)||0
7586847|NCT02678390|18671006|P1|NOT COMPLETED|Control (5 Days)||0
7586848|NCT02678390|18671005|P2|COMPLETED|Control (5 Days)||10
7586849|NCT02678390|18671006|P1|COMPLETED|Control (5 Days)||10
7586850|NCT02678390|18671005|P2|STARTED|Control (5 Days)||10
7586851|NCT02678390|18671006|P1|STARTED|Control (5 Days)||10
7586852|NCT02678286|18671022|P2|NOT COMPLETED|Study Overall (28 Day Follow-Up)||4
7586853|NCT02678286|18671023|P1|NOT COMPLETED|Study Overall (28 Day Follow-Up)||6
7586854|NCT02678286|18671022|P2|COMPLETED|Study Overall (28 Day Follow-Up)||105
7586855|NCT02678286|18671023|P1|COMPLETED|Study Overall (28 Day Follow-Up)||104
7586856|NCT02678286|18671022|P2|STARTED|Study Overall (28 Day Follow-Up)||109
7586857|NCT02678286|18671023|P1|STARTED|Study Overall (28 Day Follow-Up)||110
7586858|NCT02678286|18671022|P2|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
7586859|NCT02678286|18671023|P1|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
7586860|NCT02678286|18671022|P2|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||107
7586861|NCT02678286|18671023|P1|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||108
7586862|NCT02678286|18671022|P2|STARTED|Treatment Phase (48 Hours Post-Dose 1)||109
7586863|NCT02678286|18671023|P1|STARTED|Treatment Phase (48 Hours Post-Dose 1)||110
7586864|NCT02678039|18671055|P2|NOT COMPLETED|Overall Study||0
7586865|NCT02678039|18671056|P1|NOT COMPLETED|Overall Study||0
7586866|NCT02678039|18671055|P2|COMPLETED|Overall Study||47
7586867|NCT02678039|18671056|P1|COMPLETED|Overall Study||53
7586868|NCT02678039|18671055|P2|STARTED|Overall Study||47
7586869|NCT02678039|18671056|P1|STARTED|Overall Study||53
7586870|NCT02678000|18671075|P5|NOT COMPLETED|PART 2||0
7586871|NCT02678000|18671076|P4|NOT COMPLETED|PART 2||1
7586872|NCT02678000|18671077|P3|NOT COMPLETED|PART 2||3
7586873|NCT02678000|18671078|P2|NOT COMPLETED|PART 2||0
7586874|NCT02678000|18671079|P1|NOT COMPLETED|PART 2||0
7586875|NCT02678000|18671075|P5|COMPLETED|PART 2||18
7586876|NCT02678000|18671076|P4|COMPLETED|PART 2||26
7586877|NCT02678000|18671077|P3|COMPLETED|PART 2||25
7586878|NCT02678000|18671078|P2|COMPLETED|PART 2||0
7586879|NCT02678000|18671079|P1|COMPLETED|PART 2||0
7586880|NCT02678000|18671075|P5|STARTED|PART 2||18
7586881|NCT02678000|18671076|P4|STARTED|PART 2||27
7586882|NCT02678000|18671077|P3|STARTED|PART 2||28
7586883|NCT02678000|18671078|P2|STARTED|PART 2||0
7586884|NCT02678000|18671079|P1|STARTED|PART 2||0
7586885|NCT02678000|18671075|P5|NOT COMPLETED|PART 1||0
7586886|NCT02678000|18671076|P4|NOT COMPLETED|PART 1||0
7586887|NCT02678000|18671077|P3|NOT COMPLETED|PART 1||0
7586888|NCT02678000|18671078|P2|NOT COMPLETED|PART 1||0
7586889|NCT02678000|18671079|P1|NOT COMPLETED|PART 1||0
7586890|NCT02678000|18671075|P5|COMPLETED|PART 1||0
7586891|NCT02678000|18671076|P4|COMPLETED|PART 1||0
7586892|NCT02678000|18671077|P3|COMPLETED|PART 1||0
7586893|NCT02678000|18671078|P2|COMPLETED|PART 1||4
7586894|NCT02678000|18671079|P1|COMPLETED|PART 1||7
7586895|NCT02678000|18671075|P5|STARTED|PART 1||0
7586896|NCT02678000|18671076|P4|STARTED|PART 1||0
7586897|NCT02678000|18671077|P3|STARTED|PART 1||0
7586898|NCT02678000|18671078|P2|STARTED|PART 1||4
7586899|NCT02678000|18671079|P1|STARTED|PART 1||7
7586900|NCT02677896|18671117|P2|NOT COMPLETED|Overall Study||244
7586901|NCT02677896|18671118|P1|NOT COMPLETED|Overall Study||137
7586902|NCT02677896|18671117|P2|COMPLETED|Overall Study||332
7586903|NCT02677896|18671118|P1|COMPLETED|Overall Study||437
7586904|NCT02677896|18671117|P2|Treated|Overall Study||574
7586905|NCT02677896|18671118|P1|Treated|Overall Study||572
7586906|NCT02677896|18671117|P2|STARTED|Overall Study||576
7586907|NCT02677896|18671118|P1|STARTED|Overall Study||574
7586908|NCT02677844|18671146|P7|NOT COMPLETED|Period 7||0
7586909|NCT02677844|18671147|P6|NOT COMPLETED|Period 7||0
7586910|NCT02677844|18671148|P5|NOT COMPLETED|Period 7||0
7586911|NCT02677844|18671149|P4|NOT COMPLETED|Period 7||0
7586912|NCT02677844|18671150|P3|NOT COMPLETED|Period 7||0
7586913|NCT02677844|18671151|P2|NOT COMPLETED|Period 7||0
7586914|NCT02677844|18671152|P1|NOT COMPLETED|Period 7||0
7586915|NCT02677844|18671146|P7|COMPLETED|Period 7||4
7586916|NCT02677844|18671147|P6|COMPLETED|Period 7||4
7586917|NCT02677844|18671148|P5|COMPLETED|Period 7||7
7586918|NCT02677844|18671149|P4|COMPLETED|Period 7||0
7586919|NCT02677844|18671150|P3|COMPLETED|Period 7||0
7586920|NCT02677844|18671151|P2|COMPLETED|Period 7||0
7586921|NCT02677844|18671152|P1|COMPLETED|Period 7||0
7586922|NCT02677844|18671146|P7|STARTED|Period 7||4
7586923|NCT02677844|18671147|P6|STARTED|Period 7||4
7586924|NCT02677844|18671148|P5|STARTED|Period 7||7
7586925|NCT02677844|18671149|P4|STARTED|Period 7||0
7586926|NCT02677844|18671150|P3|STARTED|Period 7||0
7586927|NCT02677844|18671151|P2|STARTED|Period 7||0
7586928|NCT02677844|18671152|P1|STARTED|Period 7||0
7586929|NCT02677844|18671146|P7|NOT COMPLETED|Period 6||0
7586930|NCT02677844|18671147|P6|NOT COMPLETED|Period 6||0
7586931|NCT02677844|18671148|P5|NOT COMPLETED|Period 6||0
7586932|NCT02677844|18671149|P4|NOT COMPLETED|Period 6||0
7586933|NCT02677844|18671150|P3|NOT COMPLETED|Period 6||0
7586934|NCT02677844|18671151|P2|NOT COMPLETED|Period 6||0
7586935|NCT02677844|18671152|P1|NOT COMPLETED|Period 6||0
7586936|NCT02677844|18671146|P7|COMPLETED|Period 6||4
7586937|NCT02677844|18671147|P6|COMPLETED|Period 6||4
7586938|NCT02677844|18671148|P5|COMPLETED|Period 6||7
7586939|NCT02677844|18671149|P4|COMPLETED|Period 6||0
7586940|NCT02677844|18671150|P3|COMPLETED|Period 6||0
7586941|NCT02677844|18671151|P2|COMPLETED|Period 6||0
7586942|NCT02677844|18671152|P1|COMPLETED|Period 6||0
7586943|NCT02677844|18671146|P7|STARTED|Period 6||4
7586944|NCT02677844|18671147|P6|STARTED|Period 6||4
7586945|NCT02677844|18671148|P5|STARTED|Period 6||7
7586946|NCT02677844|18671149|P4|STARTED|Period 6||0
7586947|NCT02677844|18671150|P3|STARTED|Period 6||0
7586948|NCT02677844|18671151|P2|STARTED|Period 6||0
7586949|NCT02677844|18671152|P1|STARTED|Period 6||0
7586950|NCT02677844|18671146|P7|NOT COMPLETED|Period 5||0
7586951|NCT02677844|18671147|P6|NOT COMPLETED|Period 5||0
7586952|NCT02677844|18671148|P5|NOT COMPLETED|Period 5||0
7586953|NCT02677844|18671149|P4|NOT COMPLETED|Period 5||0
7586954|NCT02677844|18671150|P3|NOT COMPLETED|Period 5||0
7586955|NCT02677844|18671151|P2|NOT COMPLETED|Period 5||0
7586956|NCT02677844|18671152|P1|NOT COMPLETED|Period 5||0
7586957|NCT02677844|18671146|P7|COMPLETED|Period 5||4
7586958|NCT02677844|18671147|P6|COMPLETED|Period 5||4
7586959|NCT02677844|18671148|P5|COMPLETED|Period 5||7
7586960|NCT02677844|18671149|P4|COMPLETED|Period 5||0
7586961|NCT02677844|18671150|P3|COMPLETED|Period 5||0
7586962|NCT02677844|18671151|P2|COMPLETED|Period 5||0
7586963|NCT02677844|18671152|P1|COMPLETED|Period 5||0
7586964|NCT02677844|18671146|P7|STARTED|Period 5||4
7586965|NCT02677844|18671147|P6|STARTED|Period 5||4
7586966|NCT02677844|18671148|P5|STARTED|Period 5||7
7586967|NCT02677844|18671149|P4|STARTED|Period 5||0
7586968|NCT02677844|18671150|P3|STARTED|Period 5||0
7586969|NCT02677844|18671151|P2|STARTED|Period 5||0
7586970|NCT02677844|18671152|P1|STARTED|Period 5||0
7586971|NCT02677844|18671146|P7|NOT COMPLETED|Period 4 (DDI)||0
7586972|NCT02677844|18671147|P6|NOT COMPLETED|Period 4 (DDI)||0
7586973|NCT02677844|18671148|P5|NOT COMPLETED|Period 4 (DDI)||0
7586974|NCT02677844|18671149|P4|NOT COMPLETED|Period 4 (DDI)||0
7586975|NCT02677844|18671150|P3|NOT COMPLETED|Period 4 (DDI)||0
7586976|NCT02677844|18671151|P2|NOT COMPLETED|Period 4 (DDI)||0
7586977|NCT02677844|18671152|P1|NOT COMPLETED|Period 4 (DDI)||0
7586978|NCT02677844|18671146|P7|COMPLETED|Period 4 (DDI)||4
7586979|NCT02677844|18671147|P6|COMPLETED|Period 4 (DDI)||4
7586980|NCT02677844|18671148|P5|COMPLETED|Period 4 (DDI)||7
7586981|NCT02677844|18671149|P4|COMPLETED|Period 4 (DDI)||0
7586982|NCT02677844|18671150|P3|COMPLETED|Period 4 (DDI)||0
7586983|NCT02677844|18671151|P2|COMPLETED|Period 4 (DDI)||0
7586984|NCT02677844|18671152|P1|COMPLETED|Period 4 (DDI)||0
7586985|NCT02677844|18671146|P7|STARTED|Period 4 (DDI)||4
7586986|NCT02677844|18671147|P6|STARTED|Period 4 (DDI)||4
7586987|NCT02677844|18671148|P5|STARTED|Period 4 (DDI)||7
7586988|NCT02677844|18671149|P4|STARTED|Period 4 (DDI)||0
7586989|NCT02677844|18671150|P3|STARTED|Period 4 (DDI)||0
7586990|NCT02677844|18671151|P2|STARTED|Period 4 (DDI)||0
7586991|NCT02677844|18671152|P1|STARTED|Period 4 (DDI)||0
7586992|NCT02677844|18671146|P7|NOT COMPLETED|Period 4||0
7586993|NCT02677844|18671147|P6|NOT COMPLETED|Period 4||0
7586994|NCT02677844|18671148|P5|NOT COMPLETED|Period 4||0
7586995|NCT02677844|18671149|P4|NOT COMPLETED|Period 4||0
7586996|NCT02677844|18671150|P3|NOT COMPLETED|Period 4||0
7586997|NCT02677844|18671151|P2|NOT COMPLETED|Period 4||0
7586998|NCT02677844|18671152|P1|NOT COMPLETED|Period 4||0
7586999|NCT02677844|18671146|P7|COMPLETED|Period 4||0
7587000|NCT02677844|18671147|P6|COMPLETED|Period 4||0
7587001|NCT02677844|18671148|P5|COMPLETED|Period 4||0
7587002|NCT02677844|18671149|P4|COMPLETED|Period 4||4
7587003|NCT02677844|18671150|P3|COMPLETED|Period 4||5
7587004|NCT02677844|18671151|P2|COMPLETED|Period 4||5
7587005|NCT02677844|18671152|P1|COMPLETED|Period 4||5
7587006|NCT02677844|18671146|P7|STARTED|Period 4||0
7587007|NCT02677844|18671147|P6|STARTED|Period 4||0
7587008|NCT02677844|18671148|P5|STARTED|Period 4||0
7587009|NCT02677844|18671149|P4|STARTED|Period 4||4
7587010|NCT02677844|18671150|P3|STARTED|Period 4||5
7587011|NCT02677844|18671151|P2|STARTED|Period 4||5
7587012|NCT02677844|18671152|P1|STARTED|Period 4||5
7587013|NCT02677844|18671146|P7|NOT COMPLETED|Period 3||0
7587014|NCT02677844|18671147|P6|NOT COMPLETED|Period 3||0
7587015|NCT02677844|18671148|P5|NOT COMPLETED|Period 3||0
7587016|NCT02677844|18671149|P4|NOT COMPLETED|Period 3||1
7587017|NCT02677844|18671150|P3|NOT COMPLETED|Period 3||0
7587018|NCT02677844|18671151|P2|NOT COMPLETED|Period 3||0
7587019|NCT02677844|18671152|P1|NOT COMPLETED|Period 3||0
7587020|NCT02677844|18671146|P7|COMPLETED|Period 3||0
7587021|NCT02677844|18671147|P6|COMPLETED|Period 3||0
7587022|NCT02677844|18671148|P5|COMPLETED|Period 3||0
7587023|NCT02677844|18671149|P4|COMPLETED|Period 3||4
7587024|NCT02677844|18671150|P3|COMPLETED|Period 3||5
7587025|NCT02677844|18671151|P2|COMPLETED|Period 3||5
7587026|NCT02677844|18671152|P1|COMPLETED|Period 3||5
7587027|NCT02677844|18671146|P7|STARTED|Period 3||0
7587028|NCT02677844|18671147|P6|STARTED|Period 3||0
7587029|NCT02677844|18671148|P5|STARTED|Period 3||0
7587030|NCT02677844|18671149|P4|STARTED|Period 3||5
7587031|NCT02677844|18671150|P3|STARTED|Period 3||5
7587032|NCT02677844|18671151|P2|STARTED|Period 3||5
7587033|NCT02677844|18671152|P1|STARTED|Period 3||5
7587034|NCT02677844|18671146|P7|NOT COMPLETED|Period 2||0
7587035|NCT02677844|18671147|P6|NOT COMPLETED|Period 2||0
7587036|NCT02677844|18671148|P5|NOT COMPLETED|Period 2||0
7587037|NCT02677844|18671149|P4|NOT COMPLETED|Period 2||0
7587038|NCT02677844|18671150|P3|NOT COMPLETED|Period 2||0
7587039|NCT02677844|18671151|P2|NOT COMPLETED|Period 2||0
7587040|NCT02677844|18671152|P1|NOT COMPLETED|Period 2||0
7587041|NCT02677844|18671146|P7|COMPLETED|Period 2||0
7587042|NCT02677844|18671147|P6|COMPLETED|Period 2||0
7587043|NCT02677844|18671148|P5|COMPLETED|Period 2||0
7587044|NCT02677844|18671149|P4|COMPLETED|Period 2||5
7587045|NCT02677844|18671150|P3|COMPLETED|Period 2||5
7587046|NCT02677844|18671151|P2|COMPLETED|Period 2||5
7587047|NCT02677844|18671152|P1|COMPLETED|Period 2||5
7587048|NCT02677844|18671146|P7|STARTED|Period 2||0
7587049|NCT02677844|18671147|P6|STARTED|Period 2||0
7587050|NCT02677844|18671148|P5|STARTED|Period 2||0
7587051|NCT02677844|18671149|P4|STARTED|Period 2||5
7587052|NCT02677844|18671150|P3|STARTED|Period 2||5
7587053|NCT02677844|18671151|P2|STARTED|Period 2||5
7587054|NCT02677844|18671152|P1|STARTED|Period 2||5
7587055|NCT02677844|18671146|P7|NOT COMPLETED|Period 1||0
7587056|NCT02677844|18671147|P6|NOT COMPLETED|Period 1||0
7587057|NCT02677844|18671148|P5|NOT COMPLETED|Period 1||0
7587058|NCT02677844|18671149|P4|NOT COMPLETED|Period 1||0
7587059|NCT02677844|18671150|P3|NOT COMPLETED|Period 1||0
7587060|NCT02677844|18671151|P2|NOT COMPLETED|Period 1||0
7587061|NCT02677844|18671152|P1|NOT COMPLETED|Period 1||0
7587062|NCT02677844|18671146|P7|COMPLETED|Period 1||0
7587063|NCT02677844|18671147|P6|COMPLETED|Period 1||0
7587064|NCT02677844|18671148|P5|COMPLETED|Period 1||0
7587065|NCT02677844|18671149|P4|COMPLETED|Period 1||5
7587066|NCT02677844|18671150|P3|COMPLETED|Period 1||5
7587067|NCT02677844|18671151|P2|COMPLETED|Period 1||5
7587068|NCT02677844|18671152|P1|COMPLETED|Period 1||5
7587069|NCT02677844|18671146|P7|STARTED|Period 1||0
7587070|NCT02677844|18671147|P6|STARTED|Period 1||0
7587071|NCT02677844|18671148|P5|STARTED|Period 1||0
7587072|NCT02677844|18671149|P4|STARTED|Period 1||5
7587073|NCT02677844|18671150|P3|STARTED|Period 1||5
7587074|NCT02677844|18671151|P2|STARTED|Period 1||5
7587075|NCT02677844|18671152|P1|STARTED|Period 1||5
7587076|NCT02677779|18671182|P2|NOT COMPLETED|Overall Study||0
7587077|NCT02677779|18671183|P1|NOT COMPLETED|Overall Study||0
7587078|NCT02677779|18671182|P2|COMPLETED|Overall Study||10
7587079|NCT02677779|18671183|P1|COMPLETED|Overall Study||10
7587080|NCT02677779|18671182|P2|STARTED|Overall Study||10
7587081|NCT02677779|18671183|P1|STARTED|Overall Study||10
7587082|NCT02677766|18671199|P2|NOT COMPLETED|Overall Study||3
7587083|NCT02677766|18671200|P1|NOT COMPLETED|Overall Study||5
7587084|NCT02677766|18671199|P2|COMPLETED|Overall Study||17
7587085|NCT02677766|18671200|P1|COMPLETED|Overall Study||15
7587086|NCT02677766|18671199|P2|STARTED|Overall Study||20
7587087|NCT02677766|18671200|P1|STARTED|Overall Study||20
7587088|NCT02677753|18671208|P2|NOT COMPLETED|Overall Study||0
7587089|NCT02677753|18671209|P1|NOT COMPLETED|Overall Study||1
7587090|NCT02677753|18671208|P2|COMPLETED|Overall Study||38
7587091|NCT02677753|18671209|P1|COMPLETED|Overall Study||36
7587092|NCT02677753|18671208|P2|STARTED|Overall Study||38
7587093|NCT02677753|18671209|P1|STARTED|Overall Study||37
7587094|NCT02677740|18671217|P2|NOT COMPLETED|Overall Study||0
7587095|NCT02677740|18671218|P1|NOT COMPLETED|Overall Study||0
7587096|NCT02677740|18671217|P2|COMPLETED|Overall Study||1
7587097|NCT02677740|18671218|P1|COMPLETED|Overall Study||7
7587098|NCT02677740|18671217|P2|STARTED|Overall Study||1
7587099|NCT02677740|18671218|P1|STARTED|Overall Study||7
7587100|NCT02677714|18671232|P2|NOT COMPLETED|Overall Study||0
7587101|NCT02677714|18671233|P1|NOT COMPLETED|Overall Study||2
7587102|NCT02677714|18671232|P2|COMPLETED|Overall Study||2
7587103|NCT02677714|18671233|P1|COMPLETED|Overall Study||10
7587104|NCT02677714|18671232|P2|STARTED|Overall Study||2
7587105|NCT02677714|18671233|P1|STARTED|Overall Study||12
7587106|NCT02677623|18671248|P4|NOT COMPLETED|Overall Study||0
7587107|NCT02677623|18671249|P3|NOT COMPLETED|Overall Study||0
7587108|NCT02677623|18671250|P2|NOT COMPLETED|Overall Study||0
7587109|NCT02677623|18671251|P1|NOT COMPLETED|Overall Study||0
7587110|NCT02677623|18671248|P4|COMPLETED|Overall Study||33
7587111|NCT02677623|18671249|P3|COMPLETED|Overall Study||32
7587112|NCT02677623|18671250|P2|COMPLETED|Overall Study||32
7587113|NCT02677623|18671251|P1|COMPLETED|Overall Study||33
7587114|NCT02677623|18671248|P4|STARTED|Overall Study||33
7587115|NCT02677623|18671249|P3|STARTED|Overall Study||32
7587116|NCT02677623|18671250|P2|STARTED|Overall Study||32
7587117|NCT02677623|18671251|P1|STARTED|Overall Study||33
7587118|NCT02677493|18671264|P3|NOT COMPLETED|Overall Study||3
7587119|NCT02677493|18671265|P2|NOT COMPLETED|Overall Study||2
7587120|NCT02677493|18671266|P1|NOT COMPLETED|Overall Study||11
7587121|NCT02677493|18671264|P3|COMPLETED|Overall Study||296
7587122|NCT02677493|18671265|P2|COMPLETED|Overall Study||296
7587123|NCT02677493|18671266|P1|COMPLETED|Overall Study||1186
7587124|NCT02677493|18671264|P3|STARTED|Overall Study||299
7587125|NCT02677493|18671265|P2|STARTED|Overall Study||298
7587126|NCT02677493|18671266|P1|STARTED|Overall Study||1197
7587127|NCT02677428|18671295|P2|NOT COMPLETED|Overall Study||0
7587128|NCT02677428|18671296|P1|NOT COMPLETED|Overall Study||0
7587129|NCT02677428|18671295|P2|COMPLETED|Overall Study||55
7587130|NCT02677428|18671296|P1|COMPLETED|Overall Study||63
7587131|NCT02677428|18671295|P2|STARTED|Overall Study||55
7587132|NCT02677428|18671296|P1|STARTED|Overall Study||63
7587133|NCT02677220|18671304|P1|NOT COMPLETED|Overall Study||1
7587134|NCT02677220|18671304|P1|COMPLETED|Overall Study||0
7587135|NCT02677220|18671304|P1|STARTED|Overall Study||1
7587136|NCT02677116|18671319|P9|NOT COMPLETED|Overall Study||2
7587137|NCT02677116|18671320|P8|NOT COMPLETED|Overall Study||2
7587138|NCT02677116|18671321|P7|NOT COMPLETED|Overall Study||4
7587139|NCT02677116|18671322|P6|NOT COMPLETED|Overall Study||4
7587140|NCT02677116|18671323|P5|NOT COMPLETED|Overall Study||1
7587141|NCT02677116|18671324|P4|NOT COMPLETED|Overall Study||3
7587142|NCT02677116|18671325|P3|NOT COMPLETED|Overall Study||3
7587143|NCT02677116|18671326|P2|NOT COMPLETED|Overall Study||4
7587144|NCT02677116|18671327|P1|NOT COMPLETED|Overall Study||3
7587145|NCT02677116|18671319|P9|COMPLETED|Overall Study||2
7587146|NCT02677116|18671320|P8|COMPLETED|Overall Study||2
7587147|NCT02677116|18671321|P7|COMPLETED|Overall Study||2
7587148|NCT02677116|18671322|P6|COMPLETED|Overall Study||9
7587149|NCT02677116|18671323|P5|COMPLETED|Overall Study||0
7587150|NCT02677116|18671324|P4|COMPLETED|Overall Study||7
7587151|NCT02677116|18671325|P3|COMPLETED|Overall Study||6
7587152|NCT02677116|18671326|P2|COMPLETED|Overall Study||7
7587153|NCT02677116|18671327|P1|COMPLETED|Overall Study||7
7587154|NCT02677116|18671319|P9|Progressive Disease|Overall Study||2
7587155|NCT02677116|18671320|P8|Progressive Disease|Overall Study||2
7587156|NCT02677116|18671321|P7|Progressive Disease|Overall Study||2
7587157|NCT02677116|18671322|P6|Progressive Disease|Overall Study||9
7587158|NCT02677116|18671323|P5|Progressive Disease|Overall Study||0
7587159|NCT02677116|18671324|P4|Progressive Disease|Overall Study||7
7587160|NCT02677116|18671325|P3|Progressive Disease|Overall Study||6
7587161|NCT02677116|18671326|P2|Progressive Disease|Overall Study||7
7587162|NCT02677116|18671327|P1|Progressive Disease|Overall Study||7
7587163|NCT02677116|18671319|P9|Cycle 1 Olaratumab Alone|Overall Study||4
7587164|NCT02677116|18671320|P8|Cycle 1 Olaratumab Alone|Overall Study||4
7587165|NCT02677116|18671321|P7|Cycle 1 Olaratumab Alone|Overall Study||6
7587166|NCT02677116|18671322|P6|Cycle 1 Olaratumab Alone|Overall Study||13
7587167|NCT02677116|18671323|P5|Cycle 1 Olaratumab Alone|Overall Study||1
7587168|NCT02677116|18671324|P4|Cycle 1 Olaratumab Alone|Overall Study||10
7587169|NCT02677116|18671325|P3|Cycle 1 Olaratumab Alone|Overall Study||9
7587170|NCT02677116|18671326|P2|Cycle 1 Olaratumab Alone|Overall Study||11
7587171|NCT02677116|18671327|P1|Cycle 1 Olaratumab Alone|Overall Study||10
7587172|NCT02677116|18671319|P9|STARTED|Overall Study||4
7587173|NCT02677116|18671320|P8|STARTED|Overall Study||4
7587174|NCT02677116|18671321|P7|STARTED|Overall Study||6
7587175|NCT02677116|18671322|P6|STARTED|Overall Study||13
7587176|NCT02677116|18671323|P5|STARTED|Overall Study||1
7587177|NCT02677116|18671324|P4|STARTED|Overall Study||10
7587178|NCT02677116|18671325|P3|STARTED|Overall Study||9
7587179|NCT02677116|18671326|P2|STARTED|Overall Study||11
7587180|NCT02677116|18671327|P1|STARTED|Overall Study||10
7587181|NCT02676895|18671400|P3|NOT COMPLETED|Overall Study||3
7587182|NCT02676895|18671401|P2|NOT COMPLETED|Overall Study||3
7587183|NCT02676895|18671402|P1|NOT COMPLETED|Overall Study||2
7587184|NCT02676895|18671400|P3|COMPLETED|Overall Study||21
7587185|NCT02676895|18671401|P2|COMPLETED|Overall Study||23
7587186|NCT02676895|18671402|P1|COMPLETED|Overall Study||20
7587187|NCT02676895|18671400|P3|STARTED|Overall Study||24
7587188|NCT02676895|18671401|P2|STARTED|Overall Study||26
7587189|NCT02676895|18671402|P1|STARTED|Overall Study||22
7587190|NCT02676882|18671445|P2|NOT COMPLETED|Overall Study||2
7587191|NCT02676882|18671446|P1|NOT COMPLETED|Overall Study||3
7587192|NCT02676882|18671445|P2|COMPLETED|Overall Study||5
7587193|NCT02676882|18671446|P1|COMPLETED|Overall Study||10
7587194|NCT02676882|18671445|P2|Evaluable|Overall Study||6
7587195|NCT02676882|18671446|P1|Evaluable|Overall Study||11
7587196|NCT02676882|18671445|P2|STARTED|Overall Study||7
7587197|NCT02676882|18671446|P1|STARTED|Overall Study||13
7587198|NCT02676843|18671452|P1|NOT COMPLETED|Overall Study||0
7587199|NCT02676843|18671452|P1|COMPLETED|Overall Study||7
7587200|NCT02676843|18671452|P1|STARTED|Overall Study||7
7587201|NCT02676466|18671465|P8|NOT COMPLETED|Overall Study||1
7587202|NCT02676466|18671466|P7|NOT COMPLETED|Overall Study||1
7587203|NCT02676466|18671467|P6|NOT COMPLETED|Overall Study||1
7587204|NCT02676466|18671468|P5|NOT COMPLETED|Overall Study||3
7587205|NCT02676466|18671469|P4|NOT COMPLETED|Overall Study||0
7587206|NCT02676466|18671470|P3|NOT COMPLETED|Overall Study||2
7587207|NCT02676466|18671471|P2|NOT COMPLETED|Overall Study||5
7587208|NCT02676466|18671472|P1|NOT COMPLETED|Overall Study||4
7587209|NCT02676466|18671465|P8|COMPLETED|Overall Study||13
7587210|NCT02676466|18671466|P7|COMPLETED|Overall Study||12
7587211|NCT02676466|18671467|P6|COMPLETED|Overall Study||12
7587212|NCT02676466|18671468|P5|COMPLETED|Overall Study||23
7587213|NCT02676466|18671469|P4|COMPLETED|Overall Study||17
7587214|NCT02676466|18671470|P3|COMPLETED|Overall Study||24
7587215|NCT02676466|18671471|P2|COMPLETED|Overall Study||66
7587216|NCT02676466|18671472|P1|COMPLETED|Overall Study||105
7587217|NCT02676466|18671465|P8|STARTED|Overall Study||14
7587218|NCT02676466|18671466|P7|STARTED|Overall Study||13
7587219|NCT02676466|18671467|P6|STARTED|Overall Study||13
7587220|NCT02676466|18671468|P5|STARTED|Overall Study||26
7587221|NCT02676466|18671469|P4|STARTED|Overall Study||17
7587222|NCT02676466|18671470|P3|STARTED|Overall Study||26
7587223|NCT02676466|18671471|P2|STARTED|Overall Study||71
7587224|NCT02676466|18671472|P1|STARTED|Overall Study||109
7587225|NCT02676375|18671541|P3|NOT COMPLETED|Overall Study||3
7587226|NCT02676375|18671542|P2|NOT COMPLETED|Overall Study||4
7587227|NCT02676375|18671543|P1|NOT COMPLETED|Overall Study||1
7587228|NCT02676375|18671541|P3|COMPLETED|Overall Study||11
7587229|NCT02676375|18671542|P2|COMPLETED|Overall Study||10
7587230|NCT02676375|18671543|P1|COMPLETED|Overall Study||13
7587231|NCT02676375|18671541|P3|STARTED|Overall Study||14
7587232|NCT02676375|18671542|P2|STARTED|Overall Study||14
7587233|NCT02676375|18671543|P1|STARTED|Overall Study||14
7587234|NCT02675998|18671555|P4|NOT COMPLETED|4-Week Randomized Withdrawal Period||8
7587235|NCT02675998|18671556|P3|NOT COMPLETED|4-Week Randomized Withdrawal Period||2
7587236|NCT02675998|18671557|P2|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
7587237|NCT02675998|18671558|P1|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
7587238|NCT02675998|18671555|P4|COMPLETED|4-Week Randomized Withdrawal Period||74
7587239|NCT02675998|18671556|P3|COMPLETED|4-Week Randomized Withdrawal Period||32
7587240|NCT02675998|18671557|P2|COMPLETED|4-Week Randomized Withdrawal Period||22
7587241|NCT02675998|18671558|P1|COMPLETED|4-Week Randomized Withdrawal Period||24
7587242|NCT02675998|18671555|P4|STARTED|4-Week Randomized Withdrawal Period||82
7587243|NCT02675998|18671556|P3|STARTED|4-Week Randomized Withdrawal Period||34
7587244|NCT02675998|18671557|P2|STARTED|4-Week Randomized Withdrawal Period||23
7587245|NCT02675998|18671558|P1|STARTED|4-Week Randomized Withdrawal Period||25
7587246|NCT02675998|18671555|P4|NOT COMPLETED|8-Week Treatment Period||0
7587247|NCT02675998|18671556|P3|NOT COMPLETED|8-Week Treatment Period||19
7587248|NCT02675998|18671557|P2|NOT COMPLETED|8-Week Treatment Period||19
7587249|NCT02675998|18671558|P1|NOT COMPLETED|8-Week Treatment Period||17
7587250|NCT02675998|18671555|P4|COMPLETED|8-Week Treatment Period||0
7587251|NCT02675998|18671556|P3|COMPLETED|8-Week Treatment Period||53
7587252|NCT02675998|18671557|P2|COMPLETED|8-Week Treatment Period||54
7587253|NCT02675998|18671558|P1|COMPLETED|8-Week Treatment Period||57
7587254|NCT02675998|18671555|P4|STARTED|8-Week Treatment Period||0
7587255|NCT02675998|18671556|P3|STARTED|8-Week Treatment Period||72
7587256|NCT02675998|18671557|P2|STARTED|8-Week Treatment Period||73
7587257|NCT02675998|18671558|P1|STARTED|8-Week Treatment Period||74
7587258|NCT02675907|18671574|P2|NOT COMPLETED|Study Overall||4
7587259|NCT02675907|18671575|P1|NOT COMPLETED|Study Overall||3
7587260|NCT02675907|18671574|P2|COMPLETED|Study Overall||97
7587261|NCT02675907|18671575|P1|COMPLETED|Study Overall||97
7587262|NCT02675907|18671574|P2|STARTED|Study Overall||101
7587263|NCT02675907|18671575|P1|STARTED|Study Overall||100
7587264|NCT02675907|18671574|P2|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
7587265|NCT02675907|18671575|P1|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
7587266|NCT02675907|18671574|P2|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||96
7587267|NCT02675907|18671575|P1|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||95
7587268|NCT02675907|18671574|P2|STARTED|Treatment Phase (48 Hours Post-Dose 1)||101
7587269|NCT02675907|18671575|P1|STARTED|Treatment Phase (48 Hours Post-Dose 1)||100
7587270|NCT02675764|18671607|P2|NOT COMPLETED|Overall Study||0
7587271|NCT02675764|18671608|P1|NOT COMPLETED|Overall Study||0
7587272|NCT02675764|18671607|P2|COMPLETED|Overall Study||6
7587273|NCT02675764|18671608|P1|COMPLETED|Overall Study||6
7587274|NCT02675764|18671607|P2|STARTED|Overall Study||6
7587275|NCT02675764|18671608|P1|STARTED|Overall Study||6
7587276|NCT02675751|18671620|P1|NOT COMPLETED|Overall Study||16
7587277|NCT02675751|18671620|P1|COMPLETED|Overall Study||151
7587278|NCT02675751|18671620|P1|STARTED|Overall Study||167
7587279|NCT02675634|18671624|P6|NOT COMPLETED|Test Period 3||0
7587280|NCT02675634|18671625|P5|NOT COMPLETED|Test Period 3||0
7587281|NCT02675634|18671626|P4|NOT COMPLETED|Test Period 3||0
7587282|NCT02675634|18671627|P3|NOT COMPLETED|Test Period 3||0
7587283|NCT02675634|18671628|P2|NOT COMPLETED|Test Period 3||0
7587284|NCT02675634|18671629|P1|NOT COMPLETED|Test Period 3||0
7587285|NCT02675634|18671624|P6|COMPLETED|Test Period 3||8
7587286|NCT02675634|18671625|P5|COMPLETED|Test Period 3||10
7587287|NCT02675634|18671626|P4|COMPLETED|Test Period 3||8
7587288|NCT02675634|18671627|P3|COMPLETED|Test Period 3||8
7587289|NCT02675634|18671628|P2|COMPLETED|Test Period 3||7
7587290|NCT02675634|18671629|P1|COMPLETED|Test Period 3||9
7587291|NCT02675634|18671624|P6|STARTED|Test Period 3||8
7587292|NCT02675634|18671625|P5|STARTED|Test Period 3||10
7587293|NCT02675634|18671626|P4|STARTED|Test Period 3||8
7587294|NCT02675634|18671627|P3|STARTED|Test Period 3||8
7587295|NCT02675634|18671628|P2|STARTED|Test Period 3||7
7587296|NCT02675634|18671629|P1|STARTED|Test Period 3||9
7587297|NCT02675634|18671624|P6|NOT COMPLETED|Test Period 2||1
7587298|NCT02675634|18671625|P5|NOT COMPLETED|Test Period 2||0
7587299|NCT02675634|18671626|P4|NOT COMPLETED|Test Period 2||0
7587300|NCT02675634|18671627|P3|NOT COMPLETED|Test Period 2||0
7587301|NCT02675634|18671628|P2|NOT COMPLETED|Test Period 2||0
7587302|NCT02675634|18671629|P1|NOT COMPLETED|Test Period 2||1
7587303|NCT02675634|18671624|P6|COMPLETED|Test Period 2||8
7587304|NCT02675634|18671625|P5|COMPLETED|Test Period 2||10
7587305|NCT02675634|18671626|P4|COMPLETED|Test Period 2||8
7587306|NCT02675634|18671627|P3|COMPLETED|Test Period 2||8
7587307|NCT02675634|18671628|P2|COMPLETED|Test Period 2||7
7587308|NCT02675634|18671629|P1|COMPLETED|Test Period 2||9
7587309|NCT02675634|18671624|P6|STARTED|Test Period 2||9
7587310|NCT02675634|18671625|P5|STARTED|Test Period 2||10
7587311|NCT02675634|18671626|P4|STARTED|Test Period 2||8
7587312|NCT02675634|18671627|P3|STARTED|Test Period 2||8
7587313|NCT02675634|18671628|P2|STARTED|Test Period 2||7
7587314|NCT02675634|18671629|P1|STARTED|Test Period 2||10
7587315|NCT02675634|18671624|P6|NOT COMPLETED|Test Period 1||0
7587316|NCT02675634|18671625|P5|NOT COMPLETED|Test Period 1||0
7587317|NCT02675634|18671626|P4|NOT COMPLETED|Test Period 1||1
7587318|NCT02675634|18671627|P3|NOT COMPLETED|Test Period 1||1
7587319|NCT02675634|18671628|P2|NOT COMPLETED|Test Period 1||1
7587320|NCT02675634|18671629|P1|NOT COMPLETED|Test Period 1||0
7587321|NCT02675634|18671624|P6|COMPLETED|Test Period 1||9
7587322|NCT02675634|18671625|P5|COMPLETED|Test Period 1||10
7587323|NCT02675634|18671626|P4|COMPLETED|Test Period 1||8
7587324|NCT02675634|18671627|P3|COMPLETED|Test Period 1||8
7587325|NCT02675634|18671628|P2|COMPLETED|Test Period 1||7
7587326|NCT02675634|18671629|P1|COMPLETED|Test Period 1||10
7587327|NCT02675634|18671624|P6|STARTED|Test Period 1||9
7587328|NCT02675634|18671625|P5|STARTED|Test Period 1||10
7587329|NCT02675634|18671626|P4|STARTED|Test Period 1||9
7587330|NCT02675634|18671627|P3|STARTED|Test Period 1||9
7587331|NCT02675634|18671628|P2|STARTED|Test Period 1||8
7587332|NCT02675634|18671629|P1|STARTED|Test Period 1||10
7587333|NCT02675543|18671639|P2|NOT COMPLETED|Overall Study||0
7587334|NCT02675543|18671640|P1|NOT COMPLETED|Overall Study||0
7587335|NCT02675543|18671639|P2|COMPLETED|Overall Study||20
7587336|NCT02675543|18671640|P1|COMPLETED|Overall Study||15
7587337|NCT02675543|18671639|P2|STARTED|Overall Study||20
7587338|NCT02675543|18671640|P1|STARTED|Overall Study||15
7587339|NCT02675517|18671646|P1|NOT COMPLETED|Overall Study||159
7587340|NCT02675517|18671646|P1|COMPLETED|Overall Study||1578
7587341|NCT02675517|18671646|P1|STARTED|Overall Study||1737
7587342|NCT02675426|18671658|P3|NOT COMPLETED|Overall Study||18
7587343|NCT02675426|18671659|P2|NOT COMPLETED|Overall Study||8
7587344|NCT02675426|18671660|P1|NOT COMPLETED|Overall Study||13
7587345|NCT02675426|18671658|P3|COMPLETED|Overall Study||201
7587346|NCT02675426|18671659|P2|COMPLETED|Overall Study||213
7587347|NCT02675426|18671660|P1|COMPLETED|Overall Study||208
7587348|NCT02675426|18671658|P3|Treated|Overall Study||219
7587349|NCT02675426|18671659|P2|Treated|Overall Study||221
7587350|NCT02675426|18671660|P1|Treated|Overall Study||221
7587351|NCT02675426|18671658|P3|STARTED|Overall Study||219
7587352|NCT02675426|18671659|P2|STARTED|Overall Study||221
7587353|NCT02675426|18671660|P1|STARTED|Overall Study||221
7587354|NCT02675231|18671704|P3|NOT COMPLETED|Overall Study||26
7587355|NCT02675231|18671705|P2|NOT COMPLETED|Overall Study||36
7587356|NCT02675231|18671706|P1|NOT COMPLETED|Overall Study||26
7587357|NCT02675231|18671704|P3|COMPLETED|Overall Study||53
7587358|NCT02675231|18671705|P2|COMPLETED|Overall Study||43
7587359|NCT02675231|18671706|P1|COMPLETED|Overall Study||53
7587360|NCT02675231|18671704|P3|Received at Least One Dose of Drug|Overall Study||72
7587361|NCT02675231|18671705|P2|Received at Least One Dose of Drug|Overall Study||77
7587362|NCT02675231|18671706|P1|Received at Least One Dose of Drug|Overall Study||78
7587363|NCT02675231|18671704|P3|STARTED|Overall Study||79
7587364|NCT02675231|18671705|P2|STARTED|Overall Study||79
7587365|NCT02675231|18671706|P1|STARTED|Overall Study||79
7587366|NCT02675075|18671742|P2|NOT COMPLETED|Overall Study||0
7587367|NCT02675075|18671743|P1|NOT COMPLETED|Overall Study||3
7587368|NCT02675075|18671742|P2|COMPLETED|Overall Study||19
7587369|NCT02675075|18671743|P1|COMPLETED|Overall Study||12
7587370|NCT02675075|18671742|P2|STARTED|Overall Study||19
7587371|NCT02675075|18671743|P1|STARTED|Overall Study||15
7587372|NCT02674854|18671755|P3|NOT COMPLETED|Overall Study||14
7587373|NCT02674854|18671756|P2|NOT COMPLETED|Overall Study||27
7587374|NCT02674854|18671757|P1|NOT COMPLETED|Overall Study||24
7587375|NCT02674854|18671755|P3|COMPLETED|Overall Study||236
7587376|NCT02674854|18671756|P2|COMPLETED|Overall Study||228
7587377|NCT02674854|18671757|P1|COMPLETED|Overall Study||221
7587378|NCT02674854|18671755|P3|STARTED|Overall Study||250
7587379|NCT02674854|18671756|P2|STARTED|Overall Study||255
7587380|NCT02674854|18671757|P1|STARTED|Overall Study||245
7587381|NCT02674685|18671765|P1|NOT COMPLETED|Overall Study||4
7587382|NCT02674685|18671765|P1|COMPLETED|Overall Study||233
7587383|NCT02674685|18671765|P1|STARTED|Overall Study||237
7587384|NCT02674659|18671781|P2|NOT COMPLETED|Overall Study||4
7587385|NCT02674659|18671782|P1|NOT COMPLETED|Overall Study||4
7587386|NCT02674659|18671781|P2|COMPLETED|Overall Study||40
7587387|NCT02674659|18671782|P1|COMPLETED|Overall Study||39
7587388|NCT02674659|18671781|P2|STARTED|Overall Study||44
7587389|NCT02674659|18671782|P1|STARTED|Overall Study||43
7587390|NCT02674633|18671806|P2|NOT COMPLETED|Overall Study||4
7587391|NCT02674633|18671807|P1|NOT COMPLETED|Overall Study||5
7587392|NCT02674633|18671806|P2|COMPLETED|Overall Study||164
7587393|NCT02674633|18671807|P1|COMPLETED|Overall Study||175
7587394|NCT02674633|18671806|P2|STARTED|Overall Study||168
7587395|NCT02674633|18671807|P1|STARTED|Overall Study||180
7587396|NCT02674568|18671827|P1|NOT COMPLETED|Overall Study||339
7587397|NCT02674568|18671827|P1|COMPLETED|Overall Study||0
7587398|NCT02674568|18671827|P1|DLL3 Positive|Overall Study||287
7587399|NCT02674568|18671827|P1|Delta-like Protein 3 (DLL3) High|Overall Study||238
7587400|NCT02674568|18671827|P1|STARTED|Overall Study|Enrolled and dosed.|339
7587401|NCT02674477|18671852|P2|NOT COMPLETED|Overall Study||2
7587402|NCT02674477|18671853|P1|NOT COMPLETED|Overall Study||8
7587403|NCT02674477|18671852|P2|COMPLETED|Overall Study||45
7587404|NCT02674477|18671853|P1|COMPLETED|Overall Study||40
7587405|NCT02674477|18671852|P2|STARTED|Overall Study||47
7587406|NCT02674477|18671853|P1|STARTED|Overall Study||48
7587407|NCT02674412|18671863|P2|NOT COMPLETED|Overall Study||0
7587408|NCT02674412|18671864|P1|NOT COMPLETED|Overall Study||0
7587409|NCT02674412|18671863|P2|COMPLETED|Overall Study||5
7587410|NCT02674412|18671864|P1|COMPLETED|Overall Study||5
7587411|NCT02674412|18671863|P2|STARTED|Overall Study||5
7587412|NCT02674412|18671864|P1|STARTED|Overall Study||5
7587413|NCT02674386|18671877|P3|NOT COMPLETED|Overall Study||1
7587414|NCT02674386|18671878|P2|NOT COMPLETED|Overall Study||10
7587415|NCT02674386|18671879|P1|NOT COMPLETED|Overall Study||0
7587416|NCT02674386|18671877|P3|COMPLETED|Overall Study||16
7587417|NCT02674386|18671878|P2|COMPLETED|Overall Study||107
7587418|NCT02674386|18671879|P1|COMPLETED|Overall Study||20
7587419|NCT02674386|18671877|P3|Safety Analysis Set|Overall Study||17
7587420|NCT02674386|18671878|P2|Safety Analysis Set|Overall Study||113
7587421|NCT02674386|18671879|P1|Safety Analysis Set|Overall Study||20
7587422|NCT02674386|18671877|P3|STARTED|Overall Study||17
7587423|NCT02674386|18671878|P2|STARTED|Overall Study||117
7587424|NCT02674386|18671879|P1|STARTED|Overall Study||20
7587425|NCT02674334|18671934|P2|NOT COMPLETED|Overall Study||3
7587426|NCT02674334|18671935|P1|NOT COMPLETED|Overall Study||7
7587427|NCT02674334|18671934|P2|COMPLETED|Overall Study||40
7587428|NCT02674334|18671935|P1|COMPLETED|Overall Study||40
7587429|NCT02674334|18671934|P2|STARTED|Overall Study||43
7587430|NCT02674334|18671935|P1|STARTED|Overall Study||47
7587431|NCT02674204|18671945|P2|NOT COMPLETED|Overall Study||0
7587432|NCT02674204|18671946|P1|NOT COMPLETED|Overall Study||1
7587433|NCT02674204|18671945|P2|COMPLETED|Overall Study||1
7587434|NCT02674204|18671946|P1|COMPLETED|Overall Study||0
7587435|NCT02674204|18671945|P2|STARTED|Overall Study||1
7587436|NCT02674204|18671946|P1|STARTED|Overall Study||1
7587437|NCT02674061|18671982|P2|NOT COMPLETED|Overall Study||91
7587438|NCT02674061|18671983|P1|NOT COMPLETED|Overall Study||285
7587439|NCT02674061|18671982|P2|COMPLETED|Overall Study||0
7587440|NCT02674061|18671983|P1|COMPLETED|Overall Study||0
7587441|NCT02674061|18671982|P2|STARTED|Overall Study||91
7587442|NCT02674061|18671983|P1|STARTED|Overall Study||285
7587443|NCT02673944|18672171|P1|NOT COMPLETED|Overall Study||0
7587444|NCT02673944|18672171|P1|COMPLETED|Overall Study||10
7587445|NCT02673944|18672171|P1|STARTED|Overall Study||10
7587446|NCT02673918|18672178|P2|NOT COMPLETED|Overall Study||4
7587447|NCT02673918|18672179|P1|NOT COMPLETED|Overall Study||6
7587448|NCT02673918|18672178|P2|COMPLETED|Overall Study||20
7587449|NCT02673918|18672179|P1|COMPLETED|Overall Study||29
7587450|NCT02673918|18672178|P2|STARTED|Overall Study||24
7587451|NCT02673918|18672179|P1|STARTED|Overall Study||35
7587452|NCT02673684|18672207|P2|NOT COMPLETED|Overall Study||8
7587453|NCT02673684|18672208|P1|NOT COMPLETED|Overall Study||9
7587454|NCT02673684|18672207|P2|COMPLETED|Overall Study||0
7587455|NCT02673684|18672208|P1|COMPLETED|Overall Study||0
7587456|NCT02673684|18672207|P2|STARTED|Overall Study||8
7587457|NCT02673684|18672208|P1|STARTED|Overall Study||9
7587458|NCT02673619|18672224|P4|NOT COMPLETED|Overall Study||0
7587459|NCT02673619|18672225|P3|NOT COMPLETED|Overall Study||3
7587460|NCT02673619|18672226|P2|NOT COMPLETED|Overall Study||1
7587461|NCT02673619|18672227|P1|NOT COMPLETED|Overall Study||2
7587462|NCT02673619|18672224|P4|COMPLETED|Overall Study||7
7587463|NCT02673619|18672225|P3|COMPLETED|Overall Study||23
7587464|NCT02673619|18672226|P2|COMPLETED|Overall Study||4
7587465|NCT02673619|18672227|P1|COMPLETED|Overall Study||18
7587466|NCT02673619|18672224|P4|STARTED|Overall Study||7
7587467|NCT02673619|18672225|P3|STARTED|Overall Study||26
7587468|NCT02673619|18672226|P2|STARTED|Overall Study||5
7587469|NCT02673619|18672227|P1|STARTED|Overall Study||20
7587470|NCT02673541|18672319|P2|NOT COMPLETED|Overall Study||0
7587471|NCT02673541|18672320|P1|NOT COMPLETED|Overall Study||0
7587472|NCT02673541|18672319|P2|COMPLETED|Overall Study||2
7587473|NCT02673541|18672320|P1|COMPLETED|Overall Study||3
7587474|NCT02673541|18672319|P2|STARTED|Overall Study||2
7587475|NCT02673541|18672320|P1|STARTED|Overall Study||3
7587476|NCT02673515|18672338|P2|NOT COMPLETED|Overall Study||1
7587477|NCT02673515|18672339|P1|NOT COMPLETED|Overall Study||2
7587478|NCT02673515|18672338|P2|COMPLETED|Overall Study||29
7587479|NCT02673515|18672339|P1|COMPLETED|Overall Study||28
7587480|NCT02673515|18672338|P2|STARTED|Overall Study||30
7587481|NCT02673515|18672339|P1|STARTED|Overall Study||30
7587482|NCT02673489|18672355|P2|NOT COMPLETED|Follow Up Period||2
7587483|NCT02673489|18672356|P1|NOT COMPLETED|Follow Up Period||0
7587484|NCT02673489|18672355|P2|COMPLETED|Follow Up Period||21
7587485|NCT02673489|18672356|P1|COMPLETED|Follow Up Period||50
7587486|NCT02673489|18672355|P2|STARTED|Follow Up Period||23
7587487|NCT02673489|18672356|P1|STARTED|Follow Up Period||50
7587488|NCT02673489|18672355|P2|NOT COMPLETED|Treatment Period||3
7587489|NCT02673489|18672356|P1|NOT COMPLETED|Treatment Period||5
7587490|NCT02673489|18672355|P2|COMPLETED|Treatment Period||21
7587491|NCT02673489|18672356|P1|COMPLETED|Treatment Period||49
7587492|NCT02673489|18672355|P2|STARTED|Treatment Period||24
7587493|NCT02673489|18672356|P1|STARTED|Treatment Period||54
7587494|NCT02673372|18672371|P2|NOT COMPLETED|Overall Study||0
7587495|NCT02673372|18672372|P1|NOT COMPLETED|Overall Study||0
7587496|NCT02673372|18672371|P2|COMPLETED|Overall Study||30
7587497|NCT02673372|18672372|P1|COMPLETED|Overall Study||30
7587498|NCT02673372|18672371|P2|STARTED|Overall Study||30
7587499|NCT02673372|18672372|P1|STARTED|Overall Study||30
7587500|NCT02673333|18672378|P1|NOT COMPLETED|Overall Study||0
7587501|NCT02673333|18672378|P1|COMPLETED|Overall Study||39
7587502|NCT02673333|18672378|P1|STARTED|Overall Study||39
7587503|NCT02673203|18672384|P2|NOT COMPLETED|Overall Study||0
7587504|NCT02673203|18672385|P1|NOT COMPLETED|Overall Study||0
7587505|NCT02673203|18672384|P2|COMPLETED|Overall Study||15
7587506|NCT02673203|18672385|P1|COMPLETED|Overall Study||16
7587507|NCT02673203|18672384|P2|STARTED|Overall Study||15
7587508|NCT02673203|18672385|P1|STARTED|Overall Study||16
7587509|NCT02673138|18672407|P1|NOT COMPLETED|Overall Study||0
7587510|NCT02673138|18672407|P1|COMPLETED|Overall Study||10
7587511|NCT02673138|18672407|P1|STARTED|Overall Study||10
7587512|NCT02672852|18672421|P7|NOT COMPLETED|Part B||12
7587513|NCT02672852|18672422|P6|NOT COMPLETED|Part B||11
7587514|NCT02672852|18672423|P5|NOT COMPLETED|Part B||16
7587515|NCT02672852|18672424|P4|NOT COMPLETED|Part B||0
7587516|NCT02672852|18672425|P3|NOT COMPLETED|Part B||0
7587517|NCT02672852|18672426|P2|NOT COMPLETED|Part B||0
7587518|NCT02672852|18672427|P1|NOT COMPLETED|Part B||0
7587519|NCT02672852|18672421|P7|COMPLETED|Part B||51
7587520|NCT02672852|18672422|P6|COMPLETED|Part B||100
7587521|NCT02672852|18672423|P5|COMPLETED|Part B||209
7587522|NCT02672852|18672424|P4|COMPLETED|Part B||0
7587523|NCT02672852|18672425|P3|COMPLETED|Part B||0
7587524|NCT02672852|18672426|P2|COMPLETED|Part B||0
7587525|NCT02672852|18672427|P1|COMPLETED|Part B||0
7587526|NCT02672852|18672421|P7|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|63
7587527|NCT02672852|18672422|P6|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|111
7587528|NCT02672852|18672423|P5|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|225
7587529|NCT02672852|18672424|P4|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
7587530|NCT02672852|18672425|P3|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
7587531|NCT02672852|18672426|P2|STARTED|Part B||0
7587532|NCT02672852|18672427|P1|STARTED|Part B||0
7587533|NCT02672852|18672421|P7|NOT COMPLETED|Part A2||0
7587534|NCT02672852|18672422|P6|NOT COMPLETED|Part A2||0
7587535|NCT02672852|18672423|P5|NOT COMPLETED|Part A2||0
7587536|NCT02672852|18672424|P4|NOT COMPLETED|Part A2||4
7587537|NCT02672852|18672425|P3|NOT COMPLETED|Part A2||10
7587538|NCT02672852|18672426|P2|NOT COMPLETED|Part A2||0
7587539|NCT02672852|18672427|P1|NOT COMPLETED|Part A2||0
7587540|NCT02672852|18672421|P7|COMPLETED|Part A2||0
7587541|NCT02672852|18672422|P6|COMPLETED|Part A2||0
7587542|NCT02672852|18672423|P5|COMPLETED|Part A2||0
7587543|NCT02672852|18672424|P4|COMPLETED|Part A2||399
7587544|NCT02672852|18672425|P3|COMPLETED|Part A2||83
7587545|NCT02672852|18672426|P2|COMPLETED|Part A2||0
7587546|NCT02672852|18672427|P1|COMPLETED|Part A2||0
7587547|NCT02672852|18672421|P7|STARTED|Part A2||0
7587548|NCT02672852|18672422|P6|STARTED|Part A2||0
7587549|NCT02672852|18672423|P5|STARTED|Part A2||0
7587550|NCT02672852|18672424|P4|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|403
7587551|NCT02672852|18672425|P3|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|93
7587552|NCT02672852|18672426|P2|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
7587553|NCT02672852|18672427|P1|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
7587554|NCT02672852|18672421|P7|NOT COMPLETED|Part A1||0
7587555|NCT02672852|18672422|P6|NOT COMPLETED|Part A1||0
7587556|NCT02672852|18672423|P5|NOT COMPLETED|Part A1||0
7587557|NCT02672852|18672424|P4|NOT COMPLETED|Part A1||0
7587558|NCT02672852|18672425|P3|NOT COMPLETED|Part A1||0
7587559|NCT02672852|18672426|P2|NOT COMPLETED|Part A1||4
7587560|NCT02672852|18672427|P1|NOT COMPLETED|Part A1||3
7587561|NCT02672852|18672421|P7|COMPLETED|Part A1||0
7587562|NCT02672852|18672422|P6|COMPLETED|Part A1||0
7587563|NCT02672852|18672423|P5|COMPLETED|Part A1||0
7587564|NCT02672852|18672424|P4|COMPLETED|Part A1||0
7587565|NCT02672852|18672425|P3|COMPLETED|Part A1||0
7587566|NCT02672852|18672426|P2|COMPLETED|Part A1||403
7587567|NCT02672852|18672427|P1|COMPLETED|Part A1||97
7587568|NCT02672852|18672421|P7|STARTED|Part A1||0
7587569|NCT02672852|18672422|P6|STARTED|Part A1||0
7587570|NCT02672852|18672423|P5|STARTED|Part A1||0
7587571|NCT02672852|18672424|P4|STARTED|Part A1||0
7587572|NCT02672852|18672425|P3|STARTED|Part A1||0
7587573|NCT02672852|18672426|P2|STARTED|Part A1||407
7587574|NCT02672852|18672427|P1|STARTED|Part A1||100
7587575|NCT02672553|18672458|P2|NOT COMPLETED|Overall Study||8
7587576|NCT02672553|18672459|P1|NOT COMPLETED|Overall Study||12
7587577|NCT02672553|18672458|P2|COMPLETED|Overall Study||41
7587578|NCT02672553|18672459|P1|COMPLETED|Overall Study||39
7587579|NCT02672553|18672458|P2|As Intended (AI) Randomized Arm/Group|Overall Study||48
7587580|NCT02672553|18672459|P1|As Intended (AI) Randomized Arm/Group|Overall Study||46
7587581|NCT02672553|18672458|P2|As Treated (AT) Randomized Arm/Group|Overall Study||51
7587582|NCT02672553|18672459|P1|As Treated (AT) Randomized Arm/Group|Overall Study||46
7587583|NCT02672553|18672458|P2|Intent To Treated (ITT) Randomized Arm|Overall Study|One (1) subject randomized to Control arm/group withdrew prior to study procedure|48
7587584|NCT02672553|18672459|P1|Intent To Treated (ITT) Randomized Arm|Overall Study|Two (2) subjects randomized to Edwards INTUITY were intraoperative screen failures|49
7587585|NCT02672553|18672458|P2|STARTED|Overall Study||49
7587586|NCT02672553|18672459|P1|STARTED|Overall Study||51
7587587|NCT02672514|18672521|P2|NOT COMPLETED|Overall Study||0
7587588|NCT02672514|18672522|P1|NOT COMPLETED|Overall Study||0
7587589|NCT02672514|18672521|P2|COMPLETED|Overall Study||51
7587590|NCT02672514|18672522|P1|COMPLETED|Overall Study||53
7587591|NCT02672514|18672521|P2|STARTED|Overall Study||51
7587592|NCT02672514|18672522|P1|STARTED|Overall Study||53
7587593|NCT02672423|18672531|P10|NOT COMPLETED|Period 3||0
7587594|NCT02672423|18672532|P9|NOT COMPLETED|Period 3||0
7587595|NCT02672423|18672533|P8|NOT COMPLETED|Period 3||1
7587596|NCT02672423|18672534|P7|NOT COMPLETED|Period 3||0
7587597|NCT02672423|18672535|P6|NOT COMPLETED|Period 3||1
7587598|NCT02672423|18672536|P5|NOT COMPLETED|Period 3||0
7587599|NCT02672423|18672537|P4|NOT COMPLETED|Period 3||0
7587600|NCT02672423|18672538|P3|NOT COMPLETED|Period 3||0
7587601|NCT02672423|18672539|P2|NOT COMPLETED|Period 3||0
7587602|NCT02672423|18672540|P1|NOT COMPLETED|Period 3||0
7587603|NCT02672423|18672531|P10|COMPLETED|Period 3||0
7587604|NCT02672423|18672532|P9|COMPLETED|Period 3||0
7587605|NCT02672423|18672533|P8|COMPLETED|Period 3||14
7587606|NCT02672423|18672534|P7|COMPLETED|Period 3||15
7587607|NCT02672423|18672535|P6|COMPLETED|Period 3||14
7587608|NCT02672423|18672536|P5|COMPLETED|Period 3||14
7587609|NCT02672423|18672537|P4|COMPLETED|Period 3||15
7587610|NCT02672423|18672538|P3|COMPLETED|Period 3||13
7587611|NCT02672423|18672539|P2|COMPLETED|Period 3||0
7587612|NCT02672423|18672540|P1|COMPLETED|Period 3||0
7587613|NCT02672423|18672531|P10|STARTED|Period 3|Part C was a 2-period study design.|0
7587614|NCT02672423|18672532|P9|STARTED|Period 3|Part C was a 2-period study design.|0
7587615|NCT02672423|18672533|P8|STARTED|Period 3||15
7587616|NCT02672423|18672534|P7|STARTED|Period 3||15
7587617|NCT02672423|18672535|P6|STARTED|Period 3||15
7587618|NCT02672423|18672536|P5|STARTED|Period 3||14
7587619|NCT02672423|18672537|P4|STARTED|Period 3||15
7587620|NCT02672423|18672538|P3|STARTED|Period 3||13
7587621|NCT02672423|18672539|P2|STARTED|Period 3|Part A was a 2-period study design.|0
7587622|NCT02672423|18672540|P1|STARTED|Period 3|Part A was a 2-period study design.|0
7587623|NCT02672423|18672531|P10|NOT COMPLETED|Washout 2||0
7587624|NCT02672423|18672532|P9|NOT COMPLETED|Washout 2||0
7587625|NCT02672423|18672533|P8|NOT COMPLETED|Washout 2||0
7587626|NCT02672423|18672534|P7|NOT COMPLETED|Washout 2||0
7587627|NCT02672423|18672535|P6|NOT COMPLETED|Washout 2||0
7587628|NCT02672423|18672536|P5|NOT COMPLETED|Washout 2||0
7587629|NCT02672423|18672537|P4|NOT COMPLETED|Washout 2||0
7587630|NCT02672423|18672538|P3|NOT COMPLETED|Washout 2||0
7587631|NCT02672423|18672539|P2|NOT COMPLETED|Washout 2||0
7587632|NCT02672423|18672540|P1|NOT COMPLETED|Washout 2||0
7587633|NCT02672423|18672531|P10|COMPLETED|Washout 2||12
7587634|NCT02672423|18672532|P9|COMPLETED|Washout 2||12
7587635|NCT02672423|18672533|P8|COMPLETED|Washout 2||15
7587636|NCT02672423|18672534|P7|COMPLETED|Washout 2||15
7587637|NCT02672423|18672535|P6|COMPLETED|Washout 2||15
7587638|NCT02672423|18672536|P5|COMPLETED|Washout 2||14
7587639|NCT02672423|18672537|P4|COMPLETED|Washout 2||15
7587640|NCT02672423|18672538|P3|COMPLETED|Washout 2||13
7587641|NCT02672423|18672539|P2|COMPLETED|Washout 2||7
7587642|NCT02672423|18672540|P1|COMPLETED|Washout 2||7
7587643|NCT02672423|18672531|P10|STARTED|Washout 2||12
7587644|NCT02672423|18672532|P9|STARTED|Washout 2||12
7587645|NCT02672423|18672533|P8|STARTED|Washout 2||15
7587646|NCT02672423|18672534|P7|STARTED|Washout 2||15
7587647|NCT02672423|18672535|P6|STARTED|Washout 2||15
7587648|NCT02672423|18672536|P5|STARTED|Washout 2||14
7587649|NCT02672423|18672537|P4|STARTED|Washout 2||15
7587650|NCT02672423|18672538|P3|STARTED|Washout 2||13
7587651|NCT02672423|18672539|P2|STARTED|Washout 2||7
7587652|NCT02672423|18672540|P1|STARTED|Washout 2||7
7587653|NCT02672423|18672531|P10|NOT COMPLETED|Period 2||0
7587654|NCT02672423|18672532|P9|NOT COMPLETED|Period 2||0
7587655|NCT02672423|18672533|P8|NOT COMPLETED|Period 2||0
7587656|NCT02672423|18672534|P7|NOT COMPLETED|Period 2||0
7587657|NCT02672423|18672535|P6|NOT COMPLETED|Period 2||0
7587658|NCT02672423|18672536|P5|NOT COMPLETED|Period 2||0
7587659|NCT02672423|18672537|P4|NOT COMPLETED|Period 2||0
7587660|NCT02672423|18672538|P3|NOT COMPLETED|Period 2||1
7587661|NCT02672423|18672539|P2|NOT COMPLETED|Period 2||0
7587662|NCT02672423|18672540|P1|NOT COMPLETED|Period 2||0
7587663|NCT02672423|18672531|P10|COMPLETED|Period 2||12
7587664|NCT02672423|18672532|P9|COMPLETED|Period 2||12
7587665|NCT02672423|18672533|P8|COMPLETED|Period 2||15
7587666|NCT02672423|18672534|P7|COMPLETED|Period 2||15
7587667|NCT02672423|18672535|P6|COMPLETED|Period 2||15
7587668|NCT02672423|18672536|P5|COMPLETED|Period 2||14
7587669|NCT02672423|18672537|P4|COMPLETED|Period 2||15
7587670|NCT02672423|18672538|P3|COMPLETED|Period 2||13
7587671|NCT02672423|18672539|P2|COMPLETED|Period 2||7
7587672|NCT02672423|18672540|P1|COMPLETED|Period 2||7
7587673|NCT02672423|18672531|P10|STARTED|Period 2||12
7587674|NCT02672423|18672532|P9|STARTED|Period 2||12
7587675|NCT02672423|18672533|P8|STARTED|Period 2||15
7587676|NCT02672423|18672534|P7|STARTED|Period 2||15
7587677|NCT02672423|18672535|P6|STARTED|Period 2||15
7587678|NCT02672423|18672536|P5|STARTED|Period 2||14
7587679|NCT02672423|18672537|P4|STARTED|Period 2||15
7587680|NCT02672423|18672538|P3|STARTED|Period 2||14
7587681|NCT02672423|18672539|P2|STARTED|Period 2||7
7587682|NCT02672423|18672540|P1|STARTED|Period 2||7
7587683|NCT02672423|18672531|P10|NOT COMPLETED|Washout 1||0
7587684|NCT02672423|18672532|P9|NOT COMPLETED|Washout 1||0
7587685|NCT02672423|18672533|P8|NOT COMPLETED|Washout 1||0
7587686|NCT02672423|18672534|P7|NOT COMPLETED|Washout 1||0
7587687|NCT02672423|18672535|P6|NOT COMPLETED|Washout 1||0
7587688|NCT02672423|18672536|P5|NOT COMPLETED|Washout 1||0
7587689|NCT02672423|18672537|P4|NOT COMPLETED|Washout 1||0
7587690|NCT02672423|18672538|P3|NOT COMPLETED|Washout 1||0
7587691|NCT02672423|18672539|P2|NOT COMPLETED|Washout 1||0
7587692|NCT02672423|18672540|P1|NOT COMPLETED|Washout 1||0
7587693|NCT02672423|18672531|P10|COMPLETED|Washout 1||12
7587694|NCT02672423|18672532|P9|COMPLETED|Washout 1||12
7587695|NCT02672423|18672533|P8|COMPLETED|Washout 1||15
7587696|NCT02672423|18672534|P7|COMPLETED|Washout 1||15
7587697|NCT02672423|18672535|P6|COMPLETED|Washout 1||15
7587698|NCT02672423|18672536|P5|COMPLETED|Washout 1||14
7587699|NCT02672423|18672537|P4|COMPLETED|Washout 1||15
7587700|NCT02672423|18672538|P3|COMPLETED|Washout 1||14
7587701|NCT02672423|18672539|P2|COMPLETED|Washout 1||7
7587702|NCT02672423|18672540|P1|COMPLETED|Washout 1||7
7587703|NCT02672423|18672531|P10|STARTED|Washout 1||12
7587704|NCT02672423|18672532|P9|STARTED|Washout 1||12
7587705|NCT02672423|18672533|P8|STARTED|Washout 1||15
7587706|NCT02672423|18672534|P7|STARTED|Washout 1||15
7587707|NCT02672423|18672535|P6|STARTED|Washout 1||15
7587708|NCT02672423|18672536|P5|STARTED|Washout 1||14
7587709|NCT02672423|18672537|P4|STARTED|Washout 1||15
7587710|NCT02672423|18672538|P3|STARTED|Washout 1||14
7587711|NCT02672423|18672539|P2|STARTED|Washout 1||7
7587712|NCT02672423|18672540|P1|STARTED|Washout 1||7
7587713|NCT02672423|18672531|P10|NOT COMPLETED|Period 1||0
7587714|NCT02672423|18672532|P9|NOT COMPLETED|Period 1||0
7587715|NCT02672423|18672533|P8|NOT COMPLETED|Period 1||0
7587716|NCT02672423|18672534|P7|NOT COMPLETED|Period 1||0
7587717|NCT02672423|18672535|P6|NOT COMPLETED|Period 1||0
7587718|NCT02672423|18672536|P5|NOT COMPLETED|Period 1||1
7587719|NCT02672423|18672537|P4|NOT COMPLETED|Period 1||0
7587720|NCT02672423|18672538|P3|NOT COMPLETED|Period 1||0
7587721|NCT02672423|18672539|P2|NOT COMPLETED|Period 1||0
7587722|NCT02672423|18672540|P1|NOT COMPLETED|Period 1||0
7587723|NCT02672423|18672531|P10|COMPLETED|Period 1||12
7587724|NCT02672423|18672532|P9|COMPLETED|Period 1||12
7587725|NCT02672423|18672533|P8|COMPLETED|Period 1||15
7587726|NCT02672423|18672534|P7|COMPLETED|Period 1||15
7587727|NCT02672423|18672535|P6|COMPLETED|Period 1||15
7587728|NCT02672423|18672536|P5|COMPLETED|Period 1||14
7587729|NCT02672423|18672537|P4|COMPLETED|Period 1||15
7587730|NCT02672423|18672538|P3|COMPLETED|Period 1||14
7587731|NCT02672423|18672539|P2|COMPLETED|Period 1||7
7587732|NCT02672423|18672540|P1|COMPLETED|Period 1||7
7587733|NCT02672423|18672531|P10|Received at Least One Dose of Study Drug|Period 1||12
7587734|NCT02672423|18672532|P9|Received at Least One Dose of Study Drug|Period 1||12
7587735|NCT02672423|18672533|P8|Received at Least One Dose of Study Drug|Period 1||15
7587736|NCT02672423|18672534|P7|Received at Least One Dose of Study Drug|Period 1||15
7587737|NCT02672423|18672535|P6|Received at Least One Dose of Study Drug|Period 1||15
7587738|NCT02672423|18672536|P5|Received at Least One Dose of Study Drug|Period 1||15
7587739|NCT02672423|18672537|P4|Received at Least One Dose of Study Drug|Period 1||15
7587740|NCT02672423|18672538|P3|Received at Least One Dose of Study Drug|Period 1||14
7587741|NCT02672423|18672539|P2|Received at Least One Dose of Study Drug|Period 1||7
7587742|NCT02672423|18672540|P1|Received at Least One Dose of Study Drug|Period 1||7
7587743|NCT02672423|18672531|P10|STARTED|Period 1||12
7587744|NCT02672423|18672532|P9|STARTED|Period 1||12
7587745|NCT02672423|18672533|P8|STARTED|Period 1||15
7587746|NCT02672423|18672534|P7|STARTED|Period 1||15
7587747|NCT02672423|18672535|P6|STARTED|Period 1||15
7587748|NCT02672423|18672536|P5|STARTED|Period 1||15
7587749|NCT02672423|18672537|P4|STARTED|Period 1||15
7587750|NCT02672423|18672538|P3|STARTED|Period 1||14
7587751|NCT02672423|18672539|P2|STARTED|Period 1||7
7587752|NCT02672423|18672540|P1|STARTED|Period 1||7
7587753|NCT02672176|18672565|P2|NOT COMPLETED|Overall Study||26
7587754|NCT02672176|18672566|P1|NOT COMPLETED|Overall Study||6
7587755|NCT02672176|18672565|P2|COMPLETED|Overall Study||132
7587756|NCT02672176|18672566|P1|COMPLETED|Overall Study||155
7587757|NCT02672176|18672565|P2|STARTED|Overall Study||158
7587758|NCT02672176|18672566|P1|STARTED|Overall Study||161
7587759|NCT02672111|18672602|P2|NOT COMPLETED|Overall Study||12
7587760|NCT02672111|18672603|P1|NOT COMPLETED|Overall Study||58
7587761|NCT02672111|18672602|P2|COMPLETED|Overall Study||25
7587762|NCT02672111|18672603|P1|COMPLETED|Overall Study||132
7587763|NCT02672111|18672602|P2|Completed Treatment|Overall Study||29
7587764|NCT02672111|18672603|P1|Completed Treatment|Overall Study||138
7587765|NCT02672111|18672602|P2|STARTED|Overall Study||37
7587766|NCT02672111|18672603|P1|STARTED|Overall Study||190
7587767|NCT02672033|18672625|P1|NOT COMPLETED|Overall Study||0
7587768|NCT02672033|18672625|P1|COMPLETED|Overall Study||2
7587769|NCT02672033|18672625|P1|STARTED|Overall Study||2
7587770|NCT02671760|18672635|P3|NOT COMPLETED|Overall Study||0
7587771|NCT02671760|18672636|P2|NOT COMPLETED|Overall Study||1
7587772|NCT02671760|18672637|P1|NOT COMPLETED|Overall Study||0
7587773|NCT02671760|18672635|P3|COMPLETED|Overall Study||13
7587774|NCT02671760|18672636|P2|COMPLETED|Overall Study|1 Subject could not be contacted for f/u phone call. Data included in safety and efficacy analyses.|12
7587775|NCT02671760|18672637|P1|COMPLETED|Overall Study||13
7587776|NCT02671760|18672635|P3|STARTED|Overall Study||13
7587777|NCT02671760|18672636|P2|STARTED|Overall Study||13
7587778|NCT02671760|18672637|P1|STARTED|Overall Study||13
7587779|NCT02671500|18672663|P1|NOT COMPLETED|Overall Study||14
7587780|NCT02671500|18672663|P1|COMPLETED|Overall Study||361
7587781|NCT02671500|18672663|P1|STARTED|Overall Study||375
7587782|NCT02671461|18672678|P3|NOT COMPLETED|Follow-up||1
7587783|NCT02671461|18672679|P2|NOT COMPLETED|Follow-up||1
7587784|NCT02671461|18672680|P1|NOT COMPLETED|Follow-up||1
7587785|NCT02671461|18672678|P3|COMPLETED|Follow-up||6
7587786|NCT02671461|18672679|P2|COMPLETED|Follow-up||4
7587787|NCT02671461|18672680|P1|COMPLETED|Follow-up||1
7587788|NCT02671461|18672678|P3|STARTED|Follow-up||7
7587789|NCT02671461|18672679|P2|STARTED|Follow-up||5
7587790|NCT02671461|18672680|P1|STARTED|Follow-up||2
7587791|NCT02671461|18672678|P3|NOT COMPLETED|Treatment||5
7587792|NCT02671461|18672679|P2|NOT COMPLETED|Treatment||3
7587793|NCT02671461|18672680|P1|NOT COMPLETED|Treatment||2
7587794|NCT02671461|18672678|P3|COMPLETED|Treatment||2
7587795|NCT02671461|18672679|P2|COMPLETED|Treatment||2
7587796|NCT02671461|18672680|P1|COMPLETED|Treatment||1
7587797|NCT02671461|18672678|P3|STARTED|Treatment||7
7587798|NCT02671461|18672679|P2|STARTED|Treatment||5
7587799|NCT02671461|18672680|P1|STARTED|Treatment||3
7587800|NCT02671422|18672703|P1|NOT COMPLETED|Overall Study||260
7587801|NCT02671422|18672703|P1|COMPLETED|Overall Study||0
7587802|NCT02671422|18672703|P1|Not Treated With Vargatef®|Overall Study||3
7587803|NCT02671422|18672703|P1|STARTED|Overall Study||260
7587804|NCT02671266|18672709|P2|NOT COMPLETED|Overall Study||1
7587805|NCT02671266|18672710|P1|NOT COMPLETED|Overall Study||1
7587806|NCT02671266|18672709|P2|COMPLETED|Overall Study||20
7587807|NCT02671266|18672710|P1|COMPLETED|Overall Study||19
7587808|NCT02671266|18672709|P2|Healthy Participants|Overall Study||8
7587809|NCT02671266|18672710|P1|Healthy Participants|Overall Study||8
7587810|NCT02671266|18672709|P2|OCD Participants|Overall Study||3
7587811|NCT02671266|18672710|P1|OCD Participants|Overall Study||2
7587812|NCT02671266|18672709|P2|BDD Participants|Overall Study||9
7587813|NCT02671266|18672710|P1|BDD Participants|Overall Study||9
7587814|NCT02671266|18672709|P2|STARTED|Overall Study||21
7587815|NCT02671266|18672710|P1|STARTED|Overall Study||20
7587816|NCT02671136|18672724|P2|NOT COMPLETED|Overall Study||0
7587817|NCT02671136|18672725|P1|NOT COMPLETED|Overall Study||0
7587818|NCT02671136|18672724|P2|COMPLETED|Overall Study||0
7587819|NCT02671136|18672725|P1|COMPLETED|Overall Study||3
7587820|NCT02671136|18672724|P2|STARTED|Overall Study||0
7587821|NCT02671136|18672725|P1|STARTED|Overall Study||3
7587822|NCT02671032|18672731|P1|NOT COMPLETED|Overall Study||0
7587823|NCT02671032|18672731|P1|COMPLETED|Overall Study||12
7587824|NCT02671032|18672731|P1|STARTED|Overall Study||12
7587825|NCT02670928|18672741|P2|NOT COMPLETED|Overall Study||1
7587826|NCT02670928|18672742|P1|NOT COMPLETED|Overall Study||10
7587827|NCT02670928|18672741|P2|COMPLETED|Overall Study||29
7587828|NCT02670928|18672742|P1|COMPLETED|Overall Study||90
7587829|NCT02670928|18672741|P2|STARTED|Overall Study||30
7587830|NCT02670928|18672742|P1|STARTED|Overall Study||100
7587831|NCT02670915|18672769|P3|NOT COMPLETED|Overall Study||5
7587832|NCT02670915|18672770|P2|NOT COMPLETED|Overall Study||8
7587833|NCT02670915|18672771|P1|NOT COMPLETED|Overall Study||4
7587834|NCT02670915|18672769|P3|COMPLETED|Overall Study||253
7587835|NCT02670915|18672770|P2|COMPLETED|Overall Study||251
7587836|NCT02670915|18672771|P1|COMPLETED|Overall Study||256
7587837|NCT02670915|18672769|P3|STARTED|Overall Study||258
7587838|NCT02670915|18672770|P2|STARTED|Overall Study||259
7587839|NCT02670915|18672771|P1|STARTED|Overall Study||260
7587840|NCT02670811|18673018|P2|NOT COMPLETED|Overall Study||0
7587841|NCT02670811|18673019|P1|NOT COMPLETED|Overall Study||1
7587842|NCT02670811|18673018|P2|COMPLETED|Overall Study||18
7587843|NCT02670811|18673019|P1|COMPLETED|Overall Study||17
7587844|NCT02670811|18673018|P2|STARTED|Overall Study||18
7587845|NCT02670811|18673019|P1|STARTED|Overall Study||18
7587846|NCT02670629|18673037|P2|NOT COMPLETED|Overall Study||0
7587847|NCT02670629|18673038|P1|NOT COMPLETED|Overall Study||0
7587848|NCT02670629|18673037|P2|COMPLETED|Overall Study||29
7587849|NCT02670629|18673038|P1|COMPLETED|Overall Study||29
7587850|NCT02670629|18673037|P2|STARTED|Overall Study||29
7587851|NCT02670629|18673038|P1|STARTED|Overall Study||29
7587852|NCT02670551|18673055|P3|NOT COMPLETED|Overall Study||31
7587853|NCT02670551|18673056|P2|NOT COMPLETED|Overall Study||26
7587854|NCT02670551|18673057|P1|NOT COMPLETED|Overall Study||28
7587855|NCT02670551|18673055|P3|COMPLETED|Overall Study||134
7587856|NCT02670551|18673056|P2|COMPLETED|Overall Study||134
7587857|NCT02670551|18673057|P1|COMPLETED|Overall Study||135
7587858|NCT02670551|18673055|P3|Received Treatment (Safety Population)|Overall Study||165
7587859|NCT02670551|18673056|P2|Received Treatment (Safety Population)|Overall Study||157
7587860|NCT02670551|18673057|P1|Received Treatment (Safety Population)|Overall Study||158
7587861|NCT02670551|18673055|P3|STARTED|Overall Study||165
7587862|NCT02670551|18673056|P2|STARTED|Overall Study||160
7587863|NCT02670551|18673057|P1|STARTED|Overall Study||163
7587864|NCT02670538|18673071|P3|NOT COMPLETED|Overall Study||30
7587865|NCT02670538|18673072|P2|NOT COMPLETED|Overall Study||32
7587866|NCT02670538|18673073|P1|NOT COMPLETED|Overall Study||32
7587867|NCT02670538|18673071|P3|COMPLETED|Overall Study||128
7587868|NCT02670538|18673072|P2|COMPLETED|Overall Study||136
7587869|NCT02670538|18673073|P1|COMPLETED|Overall Study||135
7587870|NCT02670538|18673071|P3|Intent-to-Treat Population|Overall Study||153
7587871|NCT02670538|18673072|P2|Intent-to-Treat Population|Overall Study||162
7587872|NCT02670538|18673073|P1|Intent-to-Treat Population|Overall Study||163
7587873|NCT02670538|18673071|P3|Safety Population : Received Study Drug|Overall Study||158
7587874|NCT02670538|18673072|P2|Safety Population : Received Study Drug|Overall Study||167
7587875|NCT02670538|18673073|P1|Safety Population : Received Study Drug|Overall Study||165
7587876|NCT02670538|18673071|P3|STARTED|Overall Study||158
7587877|NCT02670538|18673072|P2|STARTED|Overall Study||168
7587878|NCT02670538|18673073|P1|STARTED|Overall Study||167
7587879|NCT02670473|18673084|P1|NOT COMPLETED|Overall Study||1
7587880|NCT02670473|18673084|P1|COMPLETED|Overall Study||34
7587881|NCT02670473|18673084|P1|STARTED|Overall Study||35
7587882|NCT02670343|18673137|P1|NOT COMPLETED|Overall Study||0
7587883|NCT02670343|18673137|P1|COMPLETED|Overall Study||8
7587884|NCT02670343|18673137|P1|STARTED|Overall Study||8
7587885|NCT02670330|18673143|P2|NOT COMPLETED|Overall Study||77
7587886|NCT02670330|18673144|P1|NOT COMPLETED|Overall Study||75
7587887|NCT02670330|18673143|P2|COMPLETED|Overall Study||0
7587888|NCT02670330|18673144|P1|COMPLETED|Overall Study||0
7587889|NCT02670330|18673143|P2|Received At Least 1 Dose Of Study Drug|Overall Study||77
7587890|NCT02670330|18673144|P1|Received At Least 1 Dose Of Study Drug|Overall Study||75
7587891|NCT02670330|18673143|P2|STARTED|Overall Study||77
7587892|NCT02670330|18673144|P1|STARTED|Overall Study||75
7587893|NCT02670083|18673156|P2|NOT COMPLETED|Overall Study||319
7587894|NCT02670083|18673157|P1|NOT COMPLETED|Overall Study||321
7587895|NCT02670083|18673156|P2|COMPLETED|Overall Study||85
7587896|NCT02670083|18673157|P1|COMPLETED|Overall Study||88
7587897|NCT02670083|18673156|P2|STARTED|Overall Study||404
7587898|NCT02670083|18673157|P1|STARTED|Overall Study||409
7587899|NCT02669940|18673202|P2|NOT COMPLETED|Overall Study||3
7587900|NCT02669940|18673203|P1|NOT COMPLETED|Overall Study||1
7587901|NCT02669940|18673202|P2|COMPLETED|Overall Study||92
7587902|NCT02669940|18673203|P1|COMPLETED|Overall Study||62
7587903|NCT02669940|18673202|P2|STARTED|Overall Study||95
7587904|NCT02669940|18673203|P1|STARTED|Overall Study||63
7587905|NCT02669914|18673259|P3|NOT COMPLETED|Overall Study||0
7587906|NCT02669914|18673260|P2|NOT COMPLETED|Overall Study||0
7587907|NCT02669914|18673261|P1|NOT COMPLETED|Overall Study||0
7587908|NCT02669914|18673259|P3|COMPLETED|Overall Study||0
7587909|NCT02669914|18673260|P2|COMPLETED|Overall Study||0
7587910|NCT02669914|18673261|P1|COMPLETED|Overall Study||4
7587911|NCT02669914|18673259|P3|STARTED|Overall Study||0
7587912|NCT02669914|18673260|P2|STARTED|Overall Study||0
7587913|NCT02669914|18673261|P1|STARTED|Overall Study||4
7587914|NCT02669862|18673305|P3|NOT COMPLETED|Overall Study||5
7587915|NCT02669862|18673306|P2|NOT COMPLETED|Overall Study||5
7587916|NCT02669862|18673307|P1|NOT COMPLETED|Overall Study||2
7587917|NCT02669862|18673305|P3|COMPLETED|Overall Study||26
7587918|NCT02669862|18673306|P2|COMPLETED|Overall Study||29
7587919|NCT02669862|18673307|P1|COMPLETED|Overall Study||31
7587920|NCT02669862|18673305|P3|STARTED|Overall Study||31
7587921|NCT02669862|18673306|P2|STARTED|Overall Study||34
7587922|NCT02669862|18673307|P1|STARTED|Overall Study||33
7587923|NCT02669849|18673323|P3|NOT COMPLETED|Overall Study||24
7587924|NCT02669849|18673324|P2|NOT COMPLETED|Overall Study||2
7587925|NCT02669849|18673325|P1|NOT COMPLETED|Overall Study||18
7587926|NCT02669849|18673323|P3|COMPLETED|Overall Study||8
7587927|NCT02669849|18673324|P2|COMPLETED|Overall Study||4
7587928|NCT02669849|18673325|P1|COMPLETED|Overall Study||11
7587929|NCT02669849|18673323|P3|STARTED|Overall Study||32
7587930|NCT02669849|18673324|P2|STARTED|Overall Study||6
7587931|NCT02669849|18673325|P1|STARTED|Overall Study||29
7587932|NCT02669784|18673347|P2|NOT COMPLETED|Overall Study||0
7587933|NCT02669784|18673348|P1|NOT COMPLETED|Overall Study||0
7587934|NCT02669784|18673347|P2|COMPLETED|Overall Study||16
7587935|NCT02669784|18673348|P1|COMPLETED|Overall Study||18
7587936|NCT02669784|18673347|P2|STARTED|Overall Study||16
7587937|NCT02669784|18673348|P1|STARTED|Overall Study||18
7587938|NCT02669758|18673368|P1|NOT COMPLETED|Overall Study||94
7587939|NCT02669758|18673368|P1|COMPLETED|Overall Study||183
7587940|NCT02669758|18673368|P1|STARTED|Overall Study||277
7587941|NCT02669667|18673379|P7|NOT COMPLETED|Overall Study||0
7587942|NCT02669667|18673380|P6|NOT COMPLETED|Overall Study||1
7587943|NCT02669667|18673381|P5|NOT COMPLETED|Overall Study||0
7587944|NCT02669667|18673382|P4|NOT COMPLETED|Overall Study||0
7587945|NCT02669667|18673383|P3|NOT COMPLETED|Overall Study||0
7587946|NCT02669667|18673384|P2|NOT COMPLETED|Overall Study||0
7587947|NCT02669667|18673385|P1|NOT COMPLETED|Overall Study||0
7587948|NCT02669667|18673379|P7|COMPLETED|Overall Study||6
7587949|NCT02669667|18673380|P6|COMPLETED|Overall Study||5
7587950|NCT02669667|18673381|P5|COMPLETED|Overall Study||6
7587951|NCT02669667|18673382|P4|COMPLETED|Overall Study||6
7587952|NCT02669667|18673383|P3|COMPLETED|Overall Study||4
7587953|NCT02669667|18673384|P2|COMPLETED|Overall Study||4
7587954|NCT02669667|18673385|P1|COMPLETED|Overall Study||12
7587955|NCT02669667|18673379|P7|STARTED|Overall Study||6
7587956|NCT02669667|18673380|P6|STARTED|Overall Study||6
7587957|NCT02669667|18673381|P5|STARTED|Overall Study||6
7587958|NCT02669667|18673382|P4|STARTED|Overall Study||6
7587959|NCT02669667|18673383|P3|STARTED|Overall Study||4
7587960|NCT02669667|18673384|P2|STARTED|Overall Study||4
7587961|NCT02669667|18673385|P1|STARTED|Overall Study||12
7587962|NCT02669615|18673479|P1|NOT COMPLETED|Overall Study||0
7587963|NCT02669615|18673479|P1|COMPLETED|Overall Study||24
7587964|NCT02669615|18673479|P1|STARTED|Overall Study||24
7587965|NCT02669433|18673488|P3|NOT COMPLETED|Overall Study||15
7587966|NCT02669433|18673489|P2|NOT COMPLETED|Overall Study||14
7587967|NCT02669433|18673490|P1|NOT COMPLETED|Overall Study||15
7587968|NCT02669433|18673488|P3|COMPLETED|Overall Study||74
7587969|NCT02669433|18673489|P2|COMPLETED|Overall Study||75
7587970|NCT02669433|18673490|P1|COMPLETED|Overall Study||76
7587971|NCT02669433|18673488|P3|UPDRS Primary Population|Overall Study||84
7587972|NCT02669433|18673489|P2|UPDRS Primary Population|Overall Study||87
7587973|NCT02669433|18673490|P1|UPDRS Primary Population|Overall Study||87
7587974|NCT02669433|18673488|P3|Completers Population|Overall Study||69
7587975|NCT02669433|18673489|P2|Completers Population|Overall Study||72
7587976|NCT02669433|18673490|P1|Completers Population|Overall Study||73
7587977|NCT02669433|18673488|P3|Per-Protocol Population|Overall Study||82
7587978|NCT02669433|18673489|P2|Per-Protocol Population|Overall Study||79
7587979|NCT02669433|18673490|P1|Per-Protocol Population|Overall Study||78
7587980|NCT02669433|18673488|P3|Intent to Treat (ITT) Population|Overall Study||87
7587981|NCT02669433|18673489|P2|Intent to Treat (ITT) Population|Overall Study||89
7587982|NCT02669433|18673490|P1|Intent to Treat (ITT) Population|Overall Study||89
7587983|NCT02669433|18673488|P3|Safety Population|Overall Study||88
7587984|NCT02669433|18673489|P2|Safety Population|Overall Study||89
7587985|NCT02669433|18673490|P1|Safety Population|Overall Study||91
7587986|NCT02669433|18673488|P3|STARTED|Overall Study||89
7587987|NCT02669433|18673489|P2|STARTED|Overall Study||89
7587988|NCT02669433|18673490|P1|STARTED|Overall Study||91
7587989|NCT02669407|18673504|P1|NOT COMPLETED|Overall Study||3
7587990|NCT02669407|18673504|P1|COMPLETED|Overall Study||11
7587991|NCT02669407|18673504|P1|STARTED|Overall Study||14
7587992|NCT02669329|18673521|P1|NOT COMPLETED|Overall Study||0
7587993|NCT02669329|18673521|P1|COMPLETED|Overall Study||30
7587994|NCT02669329|18673521|P1|STARTED|Overall Study||30
7587995|NCT02669264|18673533|P7|NOT COMPLETED|Overall Study||5
7587996|NCT02669264|18673534|P6|NOT COMPLETED|Overall Study||6
7587997|NCT02669264|18673535|P5|NOT COMPLETED|Overall Study||5
7587998|NCT02669264|18673536|P4|NOT COMPLETED|Overall Study||3
7587999|NCT02669264|18673537|P3|NOT COMPLETED|Overall Study||3
7588000|NCT02669264|18673538|P2|NOT COMPLETED|Overall Study||6
7588001|NCT02669264|18673539|P1|NOT COMPLETED|Overall Study||5
7588002|NCT02669264|18673533|P7|COMPLETED|Overall Study||0
7588003|NCT02669264|18673534|P6|COMPLETED|Overall Study||0
7588004|NCT02669264|18673535|P5|COMPLETED|Overall Study||0
7588005|NCT02669264|18673536|P4|COMPLETED|Overall Study||1
7588006|NCT02669264|18673537|P3|COMPLETED|Overall Study||0
7588007|NCT02669264|18673538|P2|COMPLETED|Overall Study||1
7588008|NCT02669264|18673539|P1|COMPLETED|Overall Study||0
7588009|NCT02669264|18673533|P7|STARTED|Overall Study||5
7588010|NCT02669264|18673534|P6|STARTED|Overall Study||6
7588011|NCT02669264|18673535|P5|STARTED|Overall Study||5
7588012|NCT02669264|18673536|P4|STARTED|Overall Study||4
7588013|NCT02669264|18673537|P3|STARTED|Overall Study||3
7588014|NCT02669264|18673538|P2|STARTED|Overall Study||7
7588015|NCT02669264|18673539|P1|STARTED|Overall Study||5
7588016|NCT02669095|18673685|P2|NOT COMPLETED|Overall Study||3
7588017|NCT02669095|18673686|P1|NOT COMPLETED|Overall Study||1
7588018|NCT02669095|18673685|P2|COMPLETED|Overall Study||72
7588019|NCT02669095|18673686|P1|COMPLETED|Overall Study||74
7588020|NCT02669095|18673685|P2|STARTED|Overall Study||75
7588021|NCT02669095|18673686|P1|STARTED|Overall Study||75
7588022|NCT02669082|18673694|P1|NOT COMPLETED|Overall Study||1
7588023|NCT02669082|18673694|P1|COMPLETED|Overall Study||25
7588024|NCT02669082|18673694|P1|STARTED|Overall Study||26
7588025|NCT02669043|18673706|P1|NOT COMPLETED|Overall Study||4
7588026|NCT02669043|18673706|P1|COMPLETED|Overall Study||4
7588027|NCT02669043|18673706|P1|STARTED|Overall Study||8
7588028|NCT02669017|18673719|P9|NOT COMPLETED|Overall Study||25
7588029|NCT02669017|18673720|P8|NOT COMPLETED|Overall Study||62
7588030|NCT02669017|18673721|P7|NOT COMPLETED|Overall Study||11
7588031|NCT02669017|18673722|P6|NOT COMPLETED|Overall Study||19
7588032|NCT02669017|18673723|P5|NOT COMPLETED|Overall Study||12
7588033|NCT02669017|18673724|P4|NOT COMPLETED|Overall Study||4
7588034|NCT02669017|18673725|P3|NOT COMPLETED|Overall Study||2
7588035|NCT02669017|18673726|P2|NOT COMPLETED|Overall Study||2
7588036|NCT02669017|18673727|P1|NOT COMPLETED|Overall Study||1
7588037|NCT02669017|18673719|P9|COMPLETED|Overall Study||11
7588038|NCT02669017|18673720|P8|COMPLETED|Overall Study||7
7588039|NCT02669017|18673721|P7|COMPLETED|Overall Study||8
7588040|NCT02669017|18673722|P6|COMPLETED|Overall Study||7
7588041|NCT02669017|18673723|P5|COMPLETED|Overall Study||4
7588042|NCT02669017|18673724|P4|COMPLETED|Overall Study||1
7588043|NCT02669017|18673725|P3|COMPLETED|Overall Study||2
7588044|NCT02669017|18673726|P2|COMPLETED|Overall Study||2
7588045|NCT02669017|18673727|P1|COMPLETED|Overall Study||3
7588046|NCT02669017|18673719|P9|STARTED|Overall Study||36
7588047|NCT02669017|18673720|P8|STARTED|Overall Study||69
7588048|NCT02669017|18673721|P7|STARTED|Overall Study||19
7588049|NCT02669017|18673722|P6|STARTED|Overall Study||26
7588050|NCT02669017|18673723|P5|STARTED|Overall Study||16
7588051|NCT02669017|18673724|P4|STARTED|Overall Study||5
7588052|NCT02669017|18673725|P3|STARTED|Overall Study||4
7588053|NCT02669017|18673726|P2|STARTED|Overall Study||4
7588054|NCT02669017|18673727|P1|STARTED|Overall Study||4
7588055|NCT02668952|18673851|P2|NOT COMPLETED|Overall Study||0
7588056|NCT02668952|18673852|P1|NOT COMPLETED|Overall Study||0
7588057|NCT02668952|18673851|P2|COMPLETED|Overall Study||14
7588058|NCT02668952|18673852|P1|COMPLETED|Overall Study||16
7588059|NCT02668952|18673851|P2|STARTED|Overall Study||14
7588060|NCT02668952|18673852|P1|STARTED|Overall Study||16
7588061|NCT02668822|18673872|P2|NOT COMPLETED|Overall Study||9
7588062|NCT02668822|18673873|P1|NOT COMPLETED|Overall Study||9
7588063|NCT02668822|18673872|P2|COMPLETED|Overall Study||0
7588064|NCT02668822|18673873|P1|COMPLETED|Overall Study||0
7588065|NCT02668822|18673872|P2|STARTED|Overall Study||9
7588066|NCT02668822|18673873|P1|STARTED|Overall Study||9
7588067|NCT02668783|18673895|P2|NOT COMPLETED|Overall Study||12
7588068|NCT02668783|18673896|P1|NOT COMPLETED|Overall Study||13
7588069|NCT02668783|18673895|P2|COMPLETED|Overall Study||0
7588070|NCT02668783|18673896|P1|COMPLETED|Overall Study||0
7588071|NCT02668783|18673895|P2|Treated|Overall Study||11
7588072|NCT02668783|18673896|P1|Treated|Overall Study||13
7588073|NCT02668783|18673895|P2|STARTED|Overall Study||12
7588074|NCT02668783|18673896|P1|STARTED|Overall Study||13
7588075|NCT02668640|18673916|P1|NOT COMPLETED|Overall Study||14
7588076|NCT02668640|18673916|P1|COMPLETED|Overall Study||41
7588077|NCT02668640|18673916|P1|STARTED|Overall Study||55
7588078|NCT02668432|18673929|P2|NOT COMPLETED|Overall Study||0
7588079|NCT02668432|18673930|P1|NOT COMPLETED|Overall Study||0
7588080|NCT02668432|18673929|P2|COMPLETED|Overall Study||4
7588081|NCT02668432|18673930|P1|COMPLETED|Overall Study||5
7588082|NCT02668432|18673929|P2|STARTED|Overall Study||4
7588083|NCT02668432|18673930|P1|STARTED|Overall Study||5
7588084|NCT02668302|18673968|P2|NOT COMPLETED|Overall Study||0
7588085|NCT02668302|18673969|P1|NOT COMPLETED|Overall Study||1
7588086|NCT02668302|18673968|P2|COMPLETED|Overall Study||20
7588087|NCT02668302|18673969|P1|COMPLETED|Overall Study||19
7588088|NCT02668302|18673968|P2|STARTED|Overall Study||20
7588089|NCT02668302|18673969|P1|STARTED|Overall Study||20
7588090|NCT02668198|18673975|P1|NOT COMPLETED|Overall Study||0
7588091|NCT02668198|18673975|P1|COMPLETED|Overall Study||230
7588092|NCT02668198|18673975|P1|STARTED|Overall Study||230
7588093|NCT02667951|18673989|P2|NOT COMPLETED|Overall Study||23
7588094|NCT02667951|18673990|P1|NOT COMPLETED|Overall Study||21
7588095|NCT02667951|18673989|P2|COMPLETED|Overall Study||40
7588096|NCT02667951|18673990|P1|COMPLETED|Overall Study||45
7588097|NCT02667951|18673989|P2|STARTED|Overall Study||63
7588098|NCT02667951|18673990|P1|STARTED|Overall Study||66
7588099|NCT02667912|18674008|P2|NOT COMPLETED|Overall Study||3
7588100|NCT02667912|18674009|P1|NOT COMPLETED|Overall Study||5
7588101|NCT02667912|18674008|P2|COMPLETED|Overall Study||24
7588102|NCT02667912|18674009|P1|COMPLETED|Overall Study||23
7588103|NCT02667912|18674008|P2|Six Months|Overall Study||24
7588104|NCT02667912|18674009|P1|Six Months|Overall Study||27
7588105|NCT02667912|18674008|P2|STARTED|Overall Study||27
7588106|NCT02667912|18674009|P1|STARTED|Overall Study||28
7588107|NCT02667821|18674061|P1|NOT COMPLETED|Overall Study||0
7588108|NCT02667821|18674061|P1|COMPLETED|Overall Study||20
7588109|NCT02667821|18674061|P1|STARTED|Overall Study||20
7588110|NCT02667704|18674067|P1|NOT COMPLETED|Treatment Period 2||0
7588111|NCT02667704|18674067|P1|COMPLETED|Treatment Period 2||13
7588112|NCT02667704|18674067|P1|STARTED|Treatment Period 2||13
7588113|NCT02667704|18674067|P1|NOT COMPLETED|Treatment Period 1||0
7588114|NCT02667704|18674067|P1|COMPLETED|Treatment Period 1||13
7588115|NCT02667704|18674067|P1|STARTED|Treatment Period 1||13
7588116|NCT02667639|18674080|P2|NOT COMPLETED|Overall Study||0
7588117|NCT02667639|18674081|P1|NOT COMPLETED|Overall Study||0
7588118|NCT02667639|18674080|P2|COMPLETED|Overall Study||10
7588119|NCT02667639|18674081|P1|COMPLETED|Overall Study||25
7588120|NCT02667639|18674080|P2|STARTED|Overall Study||10
7588121|NCT02667639|18674081|P1|STARTED|Overall Study||25
7588122|NCT02667626|18674109|P2|NOT COMPLETED|Overall Study||1
7588123|NCT02667626|18674110|P1|NOT COMPLETED|Overall Study||0
7588124|NCT02667626|18674109|P2|COMPLETED|Overall Study||95
7588125|NCT02667626|18674110|P1|COMPLETED|Overall Study||86
7588126|NCT02667626|18674109|P2|STARTED|Overall Study||96
7588127|NCT02667626|18674110|P1|STARTED|Overall Study||86
7588128|NCT02667457|18674126|P2|NOT COMPLETED|Overall Study||2
7588129|NCT02667457|18674127|P1|NOT COMPLETED|Overall Study||1
7588130|NCT02667457|18674126|P2|COMPLETED|Overall Study||10
7588131|NCT02667457|18674127|P1|COMPLETED|Overall Study||26
7588132|NCT02667457|18674126|P2|Full Analysis Set Population (FAS)|Overall Study||10
7588133|NCT02667457|18674127|P1|Full Analysis Set Population (FAS)|Overall Study||25
7588134|NCT02667457|18674126|P2|Dosed Participants|Overall Study||10
7588135|NCT02667457|18674127|P1|Dosed Participants|Overall Study||26
7588136|NCT02667457|18674126|P2|STARTED|Overall Study||12
7588137|NCT02667457|18674127|P1|STARTED|Overall Study||27
7588138|NCT02667288|18674151|P1|NOT COMPLETED|Overall Study||13
7588139|NCT02667288|18674151|P1|COMPLETED|Overall Study||134
7588140|NCT02667288|18674151|P1|STARTED|Overall Study||147
7588141|NCT02667275|18674158|P2|NOT COMPLETED|Overall Study||15
7588142|NCT02667275|18674159|P1|NOT COMPLETED|Overall Study||11
7588143|NCT02667275|18674158|P2|COMPLETED|Overall Study||228
7588144|NCT02667275|18674159|P1|COMPLETED|Overall Study||233
7588145|NCT02667275|18674158|P2|STARTED|Overall Study||243
7588146|NCT02667275|18674159|P1|STARTED|Overall Study||244
7588147|NCT02667236|18674169|P2|NOT COMPLETED|Overall Study||1
7588148|NCT02667236|18674170|P1|NOT COMPLETED|Overall Study||3
7588149|NCT02667236|18674169|P2|COMPLETED|Overall Study||226
7588150|NCT02667236|18674170|P1|COMPLETED|Overall Study||220
7588151|NCT02667236|18674169|P2|STARTED|Overall Study||227
7588152|NCT02667236|18674170|P1|STARTED|Overall Study||223
7588153|NCT02666950|18674178|P1|NOT COMPLETED|Overall Study||0
7588154|NCT02666950|18674178|P1|COMPLETED|Overall Study||3
7588155|NCT02666950|18674178|P1|STARTED|Overall Study||3
7588156|NCT02666846|18674191|P3|NOT COMPLETED|Overall Study||0
7588157|NCT02666846|18674192|P2|NOT COMPLETED|Overall Study||0
7588158|NCT02666846|18674193|P1|NOT COMPLETED|Overall Study||0
7588159|NCT02666846|18674191|P3|COMPLETED|Overall Study||20
7588160|NCT02666846|18674192|P2|COMPLETED|Overall Study||20
7588161|NCT02666846|18674193|P1|COMPLETED|Overall Study||20
7588162|NCT02666846|18674191|P3|STARTED|Overall Study||20
7588163|NCT02666846|18674192|P2|STARTED|Overall Study||20
7588164|NCT02666846|18674193|P1|STARTED|Overall Study||20
7588165|NCT02666664|18674292|P2|NOT COMPLETED|Overall Study||84
7588166|NCT02666664|18674293|P1|NOT COMPLETED|Overall Study||36
7588167|NCT02666664|18674292|P2|COMPLETED|Overall Study||1404
7588168|NCT02666664|18674293|P1|COMPLETED|Overall Study||706
7588169|NCT02666664|18674292|P2|STARTED|Overall Study||1488
7588170|NCT02666664|18674293|P1|STARTED|Overall Study||742
7588171|NCT02666560|18674357|P2|NOT COMPLETED|Condition 2 (1 Day)||0
7588172|NCT02666560|18674358|P1|NOT COMPLETED|Condition 2 (1 Day)||0
7588173|NCT02666560|18674357|P2|COMPLETED|Condition 2 (1 Day)||11
7588174|NCT02666560|18674358|P1|COMPLETED|Condition 2 (1 Day)||8
7588175|NCT02666560|18674357|P2|STARTED|Condition 2 (1 Day)||11
7588176|NCT02666560|18674358|P1|STARTED|Condition 2 (1 Day)||8
7588177|NCT02666560|18674357|P2|NOT COMPLETED|Condition 1 (1 Day)||0
7588178|NCT02666560|18674358|P1|NOT COMPLETED|Condition 1 (1 Day)||0
7588179|NCT02666560|18674357|P2|COMPLETED|Condition 1 (1 Day)||11
7588180|NCT02666560|18674358|P1|COMPLETED|Condition 1 (1 Day)||8
7588181|NCT02666560|18674357|P2|STARTED|Condition 1 (1 Day)||11
7588182|NCT02666560|18674358|P1|STARTED|Condition 1 (1 Day)||8
7588183|NCT02666430|18674376|P2|NOT COMPLETED|Period 3||0
7588184|NCT02666430|18674377|P1|NOT COMPLETED|Period 3||1
7588185|NCT02666430|18674376|P2|COMPLETED|Period 3||58
7588186|NCT02666430|18674377|P1|COMPLETED|Period 3||61
7588187|NCT02666430|18674376|P2|STARTED|Period 3||58
7588188|NCT02666430|18674377|P1|STARTED|Period 3||62
7588189|NCT02666430|18674376|P2|NOT COMPLETED|Period 2||4
7588190|NCT02666430|18674377|P1|NOT COMPLETED|Period 2||1
7588191|NCT02666430|18674376|P2|COMPLETED|Period 2||58
7588192|NCT02666430|18674377|P1|COMPLETED|Period 2||62
7588193|NCT02666430|18674376|P2|STARTED|Period 2||62
7588194|NCT02666430|18674377|P1|STARTED|Period 2||63
7588195|NCT02666430|18674376|P2|NOT COMPLETED|Period 1||1
7588196|NCT02666430|18674377|P1|NOT COMPLETED|Period 1||1
7588197|NCT02666430|18674376|P2|COMPLETED|Period 1||62
7588198|NCT02666430|18674377|P1|COMPLETED|Period 1||63
7588199|NCT02666430|18674376|P2|STARTED|Period 1||63
7588200|NCT02666430|18674377|P1|STARTED|Period 1||64
7588201|NCT02666430|18674376|P2|NOT COMPLETED|Baseline||0
7588202|NCT02666430|18674377|P1|NOT COMPLETED|Baseline||0
7588203|NCT02666430|18674376|P2|COMPLETED|Baseline||63
7588204|NCT02666430|18674377|P1|COMPLETED|Baseline||64
7588205|NCT02666430|18674376|P2|STARTED|Baseline||63
7588206|NCT02666430|18674377|P1|STARTED|Baseline||64
7588207|NCT02666352|18674406|P3|NOT COMPLETED|Overall Study||0
7588208|NCT02666352|18674407|P2|NOT COMPLETED|Overall Study||0
7588209|NCT02666352|18674408|P1|NOT COMPLETED|Overall Study||0
7588210|NCT02666352|18674406|P3|COMPLETED|Overall Study||8
7588211|NCT02666352|18674407|P2|COMPLETED|Overall Study||8
7588212|NCT02666352|18674408|P1|COMPLETED|Overall Study||8
7588213|NCT02666352|18674406|P3|STARTED|Overall Study||8
7588214|NCT02666352|18674407|P2|STARTED|Overall Study||8
7588215|NCT02666352|18674408|P1|STARTED|Overall Study||8
7588216|NCT02666222|18674512|P1|NOT COMPLETED|Overall Study||2
7588217|NCT02666222|18674512|P1|COMPLETED|Overall Study||49
7588218|NCT02666222|18674512|P1|STARTED|Overall Study||51
7588219|NCT02665741|18674523|P3|NOT COMPLETED|Overall Study||0
7588220|NCT02665741|18674524|P2|NOT COMPLETED|Overall Study||0
7588221|NCT02665741|18674525|P1|NOT COMPLETED|Overall Study||0
7588222|NCT02665741|18674523|P3|COMPLETED|Overall Study||42
7588223|NCT02665741|18674524|P2|COMPLETED|Overall Study||42
7588224|NCT02665741|18674525|P1|COMPLETED|Overall Study||42
7588225|NCT02665741|18674523|P3|STARTED|Overall Study||42
7588226|NCT02665741|18674524|P2|STARTED|Overall Study||42
7588227|NCT02665741|18674525|P1|STARTED|Overall Study||42
7588228|NCT02665728|18674542|P1|NOT COMPLETED|Overall Study||0
7588229|NCT02665728|18674542|P1|COMPLETED|Overall Study||33
7588230|NCT02665728|18674542|P1|STARTED|Overall Study||33
7588231|NCT02665689|18674548|P2|NOT COMPLETED|Overall Study||2
7588232|NCT02665689|18674549|P1|NOT COMPLETED|Overall Study||2
7588233|NCT02665689|18674548|P2|COMPLETED|Overall Study||0
7588234|NCT02665689|18674549|P1|COMPLETED|Overall Study||0
7588235|NCT02665689|18674548|P2|STARTED|Overall Study||2
7588236|NCT02665689|18674549|P1|STARTED|Overall Study||2
7588237|NCT02665468|18674571|P2|NOT COMPLETED|Overall Study||0
7588238|NCT02665468|18674572|P1|NOT COMPLETED|Overall Study||0
7588239|NCT02665468|18674571|P2|COMPLETED|Overall Study||601
7588240|NCT02665468|18674572|P1|COMPLETED|Overall Study||595
7588241|NCT02665468|18674571|P2|STARTED|Overall Study||601
7588242|NCT02665468|18674572|P1|STARTED|Overall Study||595
7588243|NCT02665455|18674584|P1|NOT COMPLETED|Overall Study||9
7588244|NCT02665455|18674584|P1|COMPLETED|Overall Study||74
7588245|NCT02665455|18674584|P1|STARTED|Overall Study||83
7588246|NCT02665364|18674590|P2|NOT COMPLETED|Overall Study||9
7588247|NCT02665364|18674591|P1|NOT COMPLETED|Overall Study||6
7588248|NCT02665364|18674590|P2|COMPLETED|Overall Study||84
7588249|NCT02665364|18674591|P1|COMPLETED|Overall Study||85
7588250|NCT02665364|18674590|P2|STARTED|Overall Study||93
7588251|NCT02665364|18674591|P1|STARTED|Overall Study||91
7588252|NCT02665286|18674628|P3|NOT COMPLETED|Overall Study||1
7588253|NCT02665286|18674629|P2|NOT COMPLETED|Overall Study||2
7588254|NCT02665286|18674630|P1|NOT COMPLETED|Overall Study||3
7588255|NCT02665286|18674628|P3|COMPLETED|Overall Study||80
7588256|NCT02665286|18674629|P2|COMPLETED|Overall Study||78
7588257|NCT02665286|18674630|P1|COMPLETED|Overall Study||76
7588258|NCT02665286|18674628|P3|STARTED|Overall Study||81
7588259|NCT02665286|18674629|P2|STARTED|Overall Study||80
7588260|NCT02665286|18674630|P1|STARTED|Overall Study||79
7588261|NCT02665273|18674649|P2|NOT COMPLETED|Overall Study||0
7588262|NCT02665273|18674650|P1|NOT COMPLETED|Overall Study||0
7588263|NCT02665273|18674649|P2|COMPLETED|Overall Study||15
7588264|NCT02665273|18674650|P1|COMPLETED|Overall Study||13
7588265|NCT02665273|18674649|P2|STARTED|Overall Study||15
7588266|NCT02665273|18674650|P1|STARTED|Overall Study||13
7588267|NCT02665260|18674666|P4|NOT COMPLETED|Overall Study||1
7588268|NCT02665260|18674667|P3|NOT COMPLETED|Overall Study||4
7588269|NCT02665260|18674668|P2|NOT COMPLETED|Overall Study||1
7588270|NCT02665260|18674669|P1|NOT COMPLETED|Overall Study||2
7588271|NCT02665260|18674666|P4|COMPLETED|Overall Study||21
7588272|NCT02665260|18674667|P3|COMPLETED|Overall Study||21
7588273|NCT02665260|18674668|P2|COMPLETED|Overall Study||22
7588274|NCT02665260|18674669|P1|COMPLETED|Overall Study||22
7588275|NCT02665260|18674666|P4|STARTED|Overall Study||22
7588276|NCT02665260|18674667|P3|STARTED|Overall Study||25
7588277|NCT02665260|18674668|P2|STARTED|Overall Study||23
7588278|NCT02665260|18674669|P1|STARTED|Overall Study||24
7588279|NCT02665221|18674685|P2|NOT COMPLETED|Overall Study||15
7588280|NCT02665221|18674686|P1|NOT COMPLETED|Overall Study||15
7588281|NCT02665221|18674685|P2|COMPLETED|Overall Study||0
7588282|NCT02665221|18674686|P1|COMPLETED|Overall Study||0
7588283|NCT02665221|18674685|P2|STARTED|Overall Study||15
7588284|NCT02665221|18674686|P1|STARTED|Overall Study||15
7588285|NCT02664987|18674698|P1|NOT COMPLETED|Overall Study||0
7588286|NCT02664987|18674698|P1|COMPLETED|Overall Study||462
7588287|NCT02664987|18674698|P1|STARTED|Overall Study||462
7588288|NCT02664961|18674707|P1|NOT COMPLETED|Overall Study||0
7588289|NCT02664961|18674707|P1|COMPLETED|Overall Study||3
7588290|NCT02664961|18674707|P1|STARTED|Overall Study||3
7588291|NCT02664922|18674720|P4|NOT COMPLETED|Overall Study||0
7588292|NCT02664922|18674721|P3|NOT COMPLETED|Overall Study||0
7588293|NCT02664922|18674722|P2|NOT COMPLETED|Overall Study||0
7588294|NCT02664922|18674723|P1|NOT COMPLETED|Overall Study||1
7588295|NCT02664922|18674720|P4|COMPLETED|Overall Study||5
7588296|NCT02664922|18674721|P3|COMPLETED|Overall Study||7
7588297|NCT02664922|18674722|P2|COMPLETED|Overall Study||12
7588298|NCT02664922|18674723|P1|COMPLETED|Overall Study||10
7588299|NCT02664922|18674720|P4|STARTED|Overall Study||5
7588300|NCT02664922|18674721|P3|STARTED|Overall Study||7
7588301|NCT02664922|18674722|P2|STARTED|Overall Study||12
7588302|NCT02664922|18674723|P1|STARTED|Overall Study||11
7588303|NCT02664610|18674755|P2|NOT COMPLETED|Overall Study||7
7588304|NCT02664610|18674756|P1|NOT COMPLETED|Overall Study||14
7588305|NCT02664610|18674755|P2|COMPLETED|Overall Study||41
7588306|NCT02664610|18674756|P1|COMPLETED|Overall Study||32
7588307|NCT02664610|18674755|P2|STARTED|Overall Study||48
7588308|NCT02664610|18674756|P1|STARTED|Overall Study||46
7588309|NCT02664532|18674766|P2|NOT COMPLETED|Overall Study||0
7588310|NCT02664532|18674767|P1|NOT COMPLETED|Overall Study||0
7588311|NCT02664532|18674766|P2|COMPLETED|Overall Study||75
7588312|NCT02664532|18674767|P1|COMPLETED|Overall Study||75
7588313|NCT02664532|18674766|P2|STARTED|Overall Study||75
7588314|NCT02664532|18674767|P1|STARTED|Overall Study||75
7588315|NCT02664415|18674781|P2|NOT COMPLETED|Overall Study||0
7588316|NCT02664415|18674782|P1|NOT COMPLETED|Overall Study||1
7588317|NCT02664415|18674781|P2|COMPLETED|Overall Study||5
7588318|NCT02664415|18674782|P1|COMPLETED|Overall Study||13
7588319|NCT02664415|18674781|P2|STARTED|Overall Study||5
7588320|NCT02664415|18674782|P1|STARTED|Overall Study||14
7588321|NCT02664363|18674810|P1|NOT COMPLETED|Overall Study||0
7588322|NCT02664363|18674810|P1|COMPLETED|Overall Study||3
7588323|NCT02664363|18674810|P1|STARTED|Overall Study||3
7588324|NCT02664311|18674817|P2|NOT COMPLETED|Overall Study||0
7588325|NCT02664311|18674818|P1|NOT COMPLETED|Overall Study||0
7588326|NCT02664311|18674817|P2|COMPLETED|Overall Study||3
7588327|NCT02664311|18674818|P1|COMPLETED|Overall Study||6
7588328|NCT02664311|18674817|P2|STARTED|Overall Study||3
7588329|NCT02664311|18674818|P1|STARTED|Overall Study||6
7588330|NCT02664272|18674828|P1|NOT COMPLETED|Overall Study||2
7588331|NCT02664272|18674828|P1|COMPLETED|Overall Study||38
7588332|NCT02664272|18674828|P1|STARTED|Overall Study||40
7588333|NCT02664220|18674836|P2|NOT COMPLETED|Overall Study||0
7588334|NCT02664220|18674837|P1|NOT COMPLETED|Overall Study||0
7588335|NCT02664220|18674836|P2|COMPLETED|Overall Study||50
7588336|NCT02664220|18674837|P1|COMPLETED|Overall Study||50
7588337|NCT02664220|18674836|P2|STARTED|Overall Study||50
7588338|NCT02664220|18674837|P1|STARTED|Overall Study||50
7588339|NCT02664181|18674851|P2|NOT COMPLETED|Overall Study||0
7588340|NCT02664181|18674852|P1|NOT COMPLETED|Overall Study||0
7588341|NCT02664181|18674851|P2|COMPLETED|Overall Study||5
7588342|NCT02664181|18674852|P1|COMPLETED|Overall Study||8
7588343|NCT02664181|18674851|P2|STARTED|Overall Study||5
7588344|NCT02664181|18674852|P1|STARTED|Overall Study||8
7588345|NCT02663882|18674864|P2|NOT COMPLETED|Overall Study||2
7588346|NCT02663882|18674865|P1|NOT COMPLETED|Overall Study||4
7588347|NCT02663882|18674864|P2|COMPLETED|Overall Study||34
7588348|NCT02663882|18674865|P1|COMPLETED|Overall Study||35
7588349|NCT02663882|18674864|P2|STARTED|Overall Study||36
7588350|NCT02663882|18674865|P1|STARTED|Overall Study||39
7588351|NCT02663817|18674877|P1|NOT COMPLETED|Overall Study||2
7588352|NCT02663817|18674877|P1|COMPLETED|Overall Study||50
7588353|NCT02663817|18674877|P1|STARTED|Overall Study||52
7588354|NCT02663752|18674883|P1|NOT COMPLETED|Overall Study||0
7588355|NCT02663752|18674883|P1|COMPLETED|Overall Study||1
7588356|NCT02663752|18674883|P1|STARTED|Overall Study||1
7588357|NCT02663687|18674897|P5|NOT COMPLETED|Overall Study||0
7588358|NCT02663687|18674898|P4|NOT COMPLETED|Overall Study||0
7588359|NCT02663687|18674899|P3|NOT COMPLETED|Overall Study||1
7588360|NCT02663687|18674900|P2|NOT COMPLETED|Overall Study||0
7588361|NCT02663687|18674901|P1|NOT COMPLETED|Overall Study||2
7588362|NCT02663687|18674897|P5|COMPLETED|Overall Study||9
7588363|NCT02663687|18674898|P4|COMPLETED|Overall Study||9
7588364|NCT02663687|18674899|P3|COMPLETED|Overall Study||8
7588365|NCT02663687|18674900|P2|COMPLETED|Overall Study||9
7588366|NCT02663687|18674901|P1|COMPLETED|Overall Study||10
7588367|NCT02663687|18674897|P5|Treatment Period 2 (SC)|Overall Study||9
7588368|NCT02663687|18674898|P4|Treatment Period 2 (SC)|Overall Study||9
7588369|NCT02663687|18674899|P3|Treatment Period 2 (SC)|Overall Study||8
7588370|NCT02663687|18674900|P2|Treatment Period 2 (SC)|Overall Study||9
7588371|NCT02663687|18674901|P1|Treatment Period 2 (SC)|Overall Study||10
7588372|NCT02663687|18674897|P5|Treatment Period 1 (IV)|Overall Study||9
7588373|NCT02663687|18674898|P4|Treatment Period 1 (IV)|Overall Study||9
7588374|NCT02663687|18674899|P3|Treatment Period 1 (IV)|Overall Study||9
7588375|NCT02663687|18674900|P2|Treatment Period 1 (IV)|Overall Study||9
7588376|NCT02663687|18674901|P1|Treatment Period 1 (IV)|Overall Study||12
7588377|NCT02663687|18674897|P5|STARTED|Overall Study||9
7588378|NCT02663687|18674898|P4|STARTED|Overall Study||9
7588379|NCT02663687|18674899|P3|STARTED|Overall Study||9
7588380|NCT02663687|18674900|P2|STARTED|Overall Study||9
7588381|NCT02663687|18674901|P1|STARTED|Overall Study||12
7588382|NCT02663674|18674955|P2|NOT COMPLETED|Overall Study||10
7588383|NCT02663674|18674956|P1|NOT COMPLETED|Overall Study||7
7588384|NCT02663674|18674955|P2|COMPLETED|Overall Study||29
7588385|NCT02663674|18674956|P1|COMPLETED|Overall Study||26
7588386|NCT02663674|18674955|P2|STARTED|Overall Study||39
7588387|NCT02663674|18674956|P1|STARTED|Overall Study||33
7588388|NCT02663453|18675220|P2|NOT COMPLETED|Overall Study||4
7588389|NCT02663453|18675221|P1|NOT COMPLETED|Overall Study||5
7588390|NCT02663453|18675220|P2|COMPLETED|Overall Study||18
7588391|NCT02663453|18675221|P1|COMPLETED|Overall Study||17
7588392|NCT02663453|18675220|P2|STARTED|Overall Study||22
7588393|NCT02663453|18675221|P1|STARTED|Overall Study||22
7588394|NCT02663232|18675243|P1|NOT COMPLETED|Overall Study||0
7588395|NCT02663232|18675243|P1|COMPLETED|Overall Study||264
7588396|NCT02663232|18675243|P1|STARTED|Overall Study||264
7588397|NCT02663128|18675266|P6|NOT COMPLETED|Period 3||0
7588398|NCT02663128|18675267|P5|NOT COMPLETED|Period 3||0
7588399|NCT02663128|18675268|P4|NOT COMPLETED|Period 3||0
7588400|NCT02663128|18675269|P3|NOT COMPLETED|Period 3||0
7588401|NCT02663128|18675270|P2|NOT COMPLETED|Period 3||0
7588402|NCT02663128|18675271|P1|NOT COMPLETED|Period 3||0
7588403|NCT02663128|18675266|P6|COMPLETED|Period 3||3
7588404|NCT02663128|18675267|P5|COMPLETED|Period 3||2
7588405|NCT02663128|18675268|P4|COMPLETED|Period 3||3
7588406|NCT02663128|18675269|P3|COMPLETED|Period 3||3
7588407|NCT02663128|18675270|P2|COMPLETED|Period 3||3
7588408|NCT02663128|18675271|P1|COMPLETED|Period 3||3
7588409|NCT02663128|18675266|P6|STARTED|Period 3||3
7588410|NCT02663128|18675267|P5|STARTED|Period 3||2
7588411|NCT02663128|18675268|P4|STARTED|Period 3||3
7588412|NCT02663128|18675269|P3|STARTED|Period 3||3
7588413|NCT02663128|18675270|P2|STARTED|Period 3||3
7588414|NCT02663128|18675271|P1|STARTED|Period 3||3
7588415|NCT02663128|18675266|P6|NOT COMPLETED|Period 2||0
7588416|NCT02663128|18675267|P5|NOT COMPLETED|Period 2||1
7588417|NCT02663128|18675268|P4|NOT COMPLETED|Period 2||0
7588418|NCT02663128|18675269|P3|NOT COMPLETED|Period 2||0
7588419|NCT02663128|18675270|P2|NOT COMPLETED|Period 2||0
7588420|NCT02663128|18675271|P1|NOT COMPLETED|Period 2||0
7588421|NCT02663128|18675266|P6|COMPLETED|Period 2||3
7588422|NCT02663128|18675267|P5|COMPLETED|Period 2||2
7588423|NCT02663128|18675268|P4|COMPLETED|Period 2||3
7588424|NCT02663128|18675269|P3|COMPLETED|Period 2||3
7588425|NCT02663128|18675270|P2|COMPLETED|Period 2||3
7588426|NCT02663128|18675271|P1|COMPLETED|Period 2||3
7588427|NCT02663128|18675266|P6|STARTED|Period 2||3
7588428|NCT02663128|18675267|P5|STARTED|Period 2||3
7588429|NCT02663128|18675268|P4|STARTED|Period 2||3
7588430|NCT02663128|18675269|P3|STARTED|Period 2||3
7588431|NCT02663128|18675270|P2|STARTED|Period 2||3
7588432|NCT02663128|18675271|P1|STARTED|Period 2||3
7588433|NCT02663128|18675266|P6|NOT COMPLETED|Period 1||0
7588434|NCT02663128|18675267|P5|NOT COMPLETED|Period 1||0
7588435|NCT02663128|18675268|P4|NOT COMPLETED|Period 1||0
7588436|NCT02663128|18675269|P3|NOT COMPLETED|Period 1||0
7588437|NCT02663128|18675270|P2|NOT COMPLETED|Period 1||0
7588438|NCT02663128|18675271|P1|NOT COMPLETED|Period 1||0
7588439|NCT02663128|18675266|P6|COMPLETED|Period 1||3
7588440|NCT02663128|18675267|P5|COMPLETED|Period 1||3
7588441|NCT02663128|18675268|P4|COMPLETED|Period 1||3
7588442|NCT02663128|18675269|P3|COMPLETED|Period 1||3
7588443|NCT02663128|18675270|P2|COMPLETED|Period 1||3
7588444|NCT02663128|18675271|P1|COMPLETED|Period 1||3
7588445|NCT02663128|18675266|P6|Received at Least One Dose of Study Drug|Period 1||3
7588446|NCT02663128|18675267|P5|Received at Least One Dose of Study Drug|Period 1||3
7588447|NCT02663128|18675268|P4|Received at Least One Dose of Study Drug|Period 1||3
7588448|NCT02663128|18675269|P3|Received at Least One Dose of Study Drug|Period 1||3
7588449|NCT02663128|18675270|P2|Received at Least One Dose of Study Drug|Period 1||3
7588450|NCT02663128|18675271|P1|Received at Least One Dose of Study Drug|Period 1||3
7588451|NCT02663128|18675266|P6|STARTED|Period 1||3
7588452|NCT02663128|18675267|P5|STARTED|Period 1||3
7588453|NCT02663128|18675268|P4|STARTED|Period 1||3
7588454|NCT02663128|18675269|P3|STARTED|Period 1||3
7588455|NCT02663128|18675270|P2|STARTED|Period 1||3
7588456|NCT02663128|18675271|P1|STARTED|Period 1||3
7588457|NCT02662764|18675285|P1|NOT COMPLETED|Overall Study||30
7588458|NCT02662764|18675285|P1|COMPLETED|Overall Study|First 24-hours of study treatment|290
7588459|NCT02662764|18675285|P1|STARTED|Overall Study||320
7588460|NCT02662608|18675345|P1|NOT COMPLETED|Overall Study||0
7588461|NCT02662608|18675345|P1|COMPLETED|Overall Study||1
7588462|NCT02662608|18675345|P1|STARTED|Overall Study||1
7588463|NCT02662569|18675353|P4|NOT COMPLETED|Overall Study||4
7588464|NCT02662569|18675354|P3|NOT COMPLETED|Overall Study||6
7588465|NCT02662569|18675355|P2|NOT COMPLETED|Overall Study||1
7588466|NCT02662569|18675356|P1|NOT COMPLETED|Overall Study||7
7588467|NCT02662569|18675353|P4|COMPLETED|Overall Study||328
7588468|NCT02662569|18675354|P3|COMPLETED|Overall Study||321
7588469|NCT02662569|18675355|P2|COMPLETED|Overall Study||160
7588470|NCT02662569|18675356|P1|COMPLETED|Overall Study||159
7588471|NCT02662569|18675353|P4|Received Study Drug|Overall Study||332
7588472|NCT02662569|18675354|P3|Received Study Drug|Overall Study||325
7588473|NCT02662569|18675355|P2|Received Study Drug|Overall Study||160
7588474|NCT02662569|18675356|P1|Received Study Drug|Overall Study||164
7588475|NCT02662569|18675353|P4|STARTED|Overall Study||332
7588476|NCT02662569|18675354|P3|STARTED|Overall Study||327
7588477|NCT02662569|18675355|P2|STARTED|Overall Study||161
7588478|NCT02662569|18675356|P1|STARTED|Overall Study||166
7588479|NCT02662556|18675454|P1|NOT COMPLETED|Overall Study||8
7588480|NCT02662556|18675454|P1|COMPLETED|Overall Study||132
7588481|NCT02662556|18675454|P1|STARTED|Overall Study||140
7588482|NCT02662387|18675463|P2|NOT COMPLETED|Overall Study||0
7588483|NCT02662387|18675464|P1|NOT COMPLETED|Overall Study||0
7588484|NCT02662387|18675463|P2|COMPLETED|Overall Study||28
7588485|NCT02662387|18675464|P1|COMPLETED|Overall Study||27
7588486|NCT02662387|18675463|P2|STARTED|Overall Study||28
7588487|NCT02662387|18675464|P1|STARTED|Overall Study||27
7588488|NCT02662244|18675472|P1|NOT COMPLETED|Overall Study||2
7588489|NCT02662244|18675472|P1|COMPLETED|Overall Study||31
7588490|NCT02662244|18675472|P1|STARTED|Overall Study||33
7588491|NCT02662036|18675482|P2|NOT COMPLETED|Overall Study||13
7588492|NCT02662036|18675483|P1|NOT COMPLETED|Overall Study||13
7588493|NCT02662036|18675482|P2|COMPLETED|Overall Study||22
7588494|NCT02662036|18675483|P1|COMPLETED|Overall Study||22
7588495|NCT02662036|18675482|P2|STARTED|Overall Study||35
7588496|NCT02662036|18675483|P1|STARTED|Overall Study||35
7588497|NCT02661828|18675511|P2|NOT COMPLETED|Overall Study||0
7588498|NCT02661828|18675512|P1|NOT COMPLETED|Overall Study||0
7588499|NCT02661828|18675511|P2|COMPLETED|Overall Study||0
7588500|NCT02661828|18675512|P1|COMPLETED|Overall Study||1
7588501|NCT02661828|18675511|P2|STARTED|Overall Study||0
7588502|NCT02661828|18675512|P1|STARTED|Overall Study||1
7588503|NCT02661815|18675523|P4|NOT COMPLETED|Overall Study||0
7588504|NCT02661815|18675524|P3|NOT COMPLETED|Overall Study||0
7588505|NCT02661815|18675525|P2|NOT COMPLETED|Overall Study||0
7588506|NCT02661815|18675526|P1|NOT COMPLETED|Overall Study||1
7588507|NCT02661815|18675523|P4|COMPLETED|Overall Study||0
7588508|NCT02661815|18675524|P3|COMPLETED|Overall Study||0
7588509|NCT02661815|18675525|P2|COMPLETED|Overall Study||0
7588510|NCT02661815|18675526|P1|COMPLETED|Overall Study||5
7588511|NCT02661815|18675523|P4|STARTED|Overall Study||0
7588512|NCT02661815|18675524|P3|STARTED|Overall Study||0
7588513|NCT02661815|18675525|P2|STARTED|Overall Study||0
7588514|NCT02661815|18675526|P1|STARTED|Overall Study||6
7588515|NCT02661737|18675540|P1|NOT COMPLETED|Overall Study||34
7588516|NCT02661737|18675540|P1|COMPLETED|Overall Study||469
7588517|NCT02661737|18675540|P1|STARTED|Overall Study||503
7588518|NCT02661594|18675548|P4|NOT COMPLETED|Overall Study||0
7588519|NCT02661594|18675549|P3|NOT COMPLETED|Overall Study||1
7588520|NCT02661594|18675550|P2|NOT COMPLETED|Overall Study||0
7588521|NCT02661594|18675551|P1|NOT COMPLETED|Overall Study||1
7588522|NCT02661594|18675548|P4|COMPLETED|Overall Study||9
7588523|NCT02661594|18675549|P3|COMPLETED|Overall Study||9
7588524|NCT02661594|18675550|P2|COMPLETED|Overall Study||11
7588525|NCT02661594|18675551|P1|COMPLETED|Overall Study||9
7588526|NCT02661594|18675548|P4|STARTED|Overall Study||9
7588527|NCT02661594|18675549|P3|STARTED|Overall Study||10
7588528|NCT02661594|18675550|P2|STARTED|Overall Study||11
7588529|NCT02661594|18675551|P1|STARTED|Overall Study||10
7588530|NCT02661490|18675566|P5|NOT COMPLETED|Overall Study||3
7588531|NCT02661490|18675567|P4|NOT COMPLETED|Overall Study||1
7588532|NCT02661490|18675568|P3|NOT COMPLETED|Overall Study||2
7588533|NCT02661490|18675569|P2|NOT COMPLETED|Overall Study||2
7588534|NCT02661490|18675570|P1|NOT COMPLETED|Overall Study||3
7588535|NCT02661490|18675566|P5|COMPLETED|Overall Study||23
7588536|NCT02661490|18675567|P4|COMPLETED|Overall Study||71
7588537|NCT02661490|18675568|P3|COMPLETED|Overall Study||70
7588538|NCT02661490|18675569|P2|COMPLETED|Overall Study||72
7588539|NCT02661490|18675570|P1|COMPLETED|Overall Study||73
7588540|NCT02661490|18675566|P5|STARTED|Overall Study||26
7588541|NCT02661490|18675567|P4|STARTED|Overall Study||72
7588542|NCT02661490|18675568|P3|STARTED|Overall Study||72
7588543|NCT02661490|18675569|P2|STARTED|Overall Study||74
7588544|NCT02661490|18675570|P1|STARTED|Overall Study||76
7588545|NCT02661256|18675707|P1|NOT COMPLETED|Overall Study||0
7588546|NCT02661256|18675707|P1|COMPLETED|Overall Study||7
7588547|NCT02661256|18675707|P1|STARTED|Overall Study|Each participant went through arms in same order: on nCPAP then off nCPAP. 1 participant at a time.|7
7588548|NCT02661178|18675738|P15|NOT COMPLETED|Part 2||0
7588549|NCT02661178|18675739|P14|NOT COMPLETED|Part 2||0
7588550|NCT02661178|18675740|P13|NOT COMPLETED|Part 2||0
7588551|NCT02661178|18675741|P12|NOT COMPLETED|Part 2||0
7588552|NCT02661178|18675742|P11|NOT COMPLETED|Part 2||0
7588553|NCT02661178|18675743|P10|NOT COMPLETED|Part 2||0
7588554|NCT02661178|18675744|P9|NOT COMPLETED|Part 2||0
7588555|NCT02661178|18675745|P8|NOT COMPLETED|Part 2||0
7588556|NCT02661178|18675746|P7|NOT COMPLETED|Part 2||0
7588557|NCT02661178|18675747|P6|NOT COMPLETED|Part 2||0
7588558|NCT02661178|18675748|P5|NOT COMPLETED|Part 2||0
7588559|NCT02661178|18675749|P4|NOT COMPLETED|Part 2||0
7588560|NCT02661178|18675750|P3|NOT COMPLETED|Part 2||0
7588561|NCT02661178|18675751|P2|NOT COMPLETED|Part 2||0
7588562|NCT02661178|18675752|P1|NOT COMPLETED|Part 2||0
7588563|NCT02661178|18675738|P15|COMPLETED|Part 2||2
7588564|NCT02661178|18675739|P14|COMPLETED|Part 2||2
7588565|NCT02661178|18675740|P13|COMPLETED|Part 2||6
7588566|NCT02661178|18675741|P12|COMPLETED|Part 2||6
7588567|NCT02661178|18675742|P11|COMPLETED|Part 2||0
7588568|NCT02661178|18675743|P10|COMPLETED|Part 2||0
7588569|NCT02661178|18675744|P9|COMPLETED|Part 2||0
7588570|NCT02661178|18675745|P8|COMPLETED|Part 2||0
7588571|NCT02661178|18675746|P7|COMPLETED|Part 2||0
7588572|NCT02661178|18675747|P6|COMPLETED|Part 2||0
7588573|NCT02661178|18675748|P5|COMPLETED|Part 2||0
7588574|NCT02661178|18675749|P4|COMPLETED|Part 2||0
7588575|NCT02661178|18675750|P3|COMPLETED|Part 2||0
7588576|NCT02661178|18675751|P2|COMPLETED|Part 2||0
7588577|NCT02661178|18675752|P1|COMPLETED|Part 2||0
7588578|NCT02661178|18675738|P15|STARTED|Part 2||2
7588579|NCT02661178|18675739|P14|STARTED|Part 2||2
7588580|NCT02661178|18675740|P13|STARTED|Part 2||6
7588581|NCT02661178|18675741|P12|STARTED|Part 2||6
7588582|NCT02661178|18675742|P11|STARTED|Part 2||0
7588583|NCT02661178|18675743|P10|STARTED|Part 2||0
7588584|NCT02661178|18675744|P9|STARTED|Part 2||0
7588585|NCT02661178|18675745|P8|STARTED|Part 2||0
7588586|NCT02661178|18675746|P7|STARTED|Part 2||0
7588587|NCT02661178|18675747|P6|STARTED|Part 2||0
7588588|NCT02661178|18675748|P5|STARTED|Part 2||0
7588589|NCT02661178|18675749|P4|STARTED|Part 2||0
7588590|NCT02661178|18675750|P3|STARTED|Part 2||0
7588591|NCT02661178|18675751|P2|STARTED|Part 2||0
7588592|NCT02661178|18675752|P1|STARTED|Part 2||0
7588593|NCT02661178|18675738|P15|NOT COMPLETED|Part 1||0
7588594|NCT02661178|18675739|P14|NOT COMPLETED|Part 1||0
7588595|NCT02661178|18675740|P13|NOT COMPLETED|Part 1||0
7588596|NCT02661178|18675741|P12|NOT COMPLETED|Part 1||0
7588597|NCT02661178|18675742|P11|NOT COMPLETED|Part 1||0
7588598|NCT02661178|18675743|P10|NOT COMPLETED|Part 1||0
7588599|NCT02661178|18675744|P9|NOT COMPLETED|Part 1||0
7588600|NCT02661178|18675745|P8|NOT COMPLETED|Part 1||0
7588601|NCT02661178|18675746|P7|NOT COMPLETED|Part 1||0
7588602|NCT02661178|18675747|P6|NOT COMPLETED|Part 1||0
7588603|NCT02661178|18675748|P5|NOT COMPLETED|Part 1||0
7588604|NCT02661178|18675749|P4|NOT COMPLETED|Part 1||0
7588605|NCT02661178|18675750|P3|NOT COMPLETED|Part 1||0
7588606|NCT02661178|18675751|P2|NOT COMPLETED|Part 1||0
7588607|NCT02661178|18675752|P1|NOT COMPLETED|Part 1||1
7588608|NCT02661178|18675738|P15|COMPLETED|Part 1||0
7588609|NCT02661178|18675739|P14|COMPLETED|Part 1||0
7588610|NCT02661178|18675740|P13|COMPLETED|Part 1||0
7588611|NCT02661178|18675741|P12|COMPLETED|Part 1||0
7588612|NCT02661178|18675742|P11|COMPLETED|Part 1||4
7588613|NCT02661178|18675743|P10|COMPLETED|Part 1||12
7588614|NCT02661178|18675744|P9|COMPLETED|Part 1||6
7588615|NCT02661178|18675745|P8|COMPLETED|Part 1||6
7588616|NCT02661178|18675746|P7|COMPLETED|Part 1||6
7588617|NCT02661178|18675747|P6|COMPLETED|Part 1||6
7588618|NCT02661178|18675748|P5|COMPLETED|Part 1||5
7588619|NCT02661178|18675749|P4|COMPLETED|Part 1||6
7588620|NCT02661178|18675750|P3|COMPLETED|Part 1||6
7588621|NCT02661178|18675751|P2|COMPLETED|Part 1||5
7588622|NCT02661178|18675752|P1|COMPLETED|Part 1||0
7588623|NCT02661178|18675738|P15|STARTED|Part 1||0
7588624|NCT02661178|18675739|P14|STARTED|Part 1||0
7588625|NCT02661178|18675740|P13|STARTED|Part 1||0
7588626|NCT02661178|18675741|P12|STARTED|Part 1||0
7588627|NCT02661178|18675742|P11|STARTED|Part 1||4
7588628|NCT02661178|18675743|P10|STARTED|Part 1||12
7588629|NCT02661178|18675744|P9|STARTED|Part 1||6
7588630|NCT02661178|18675745|P8|STARTED|Part 1||6
7588631|NCT02661178|18675746|P7|STARTED|Part 1||6
7588632|NCT02661178|18675747|P6|STARTED|Part 1||6
7588633|NCT02661178|18675748|P5|STARTED|Part 1||5
7588634|NCT02661178|18675749|P4|STARTED|Part 1||6
7588635|NCT02661178|18675750|P3|STARTED|Part 1||6
7588636|NCT02661178|18675751|P2|STARTED|Part 1||5
7588637|NCT02661178|18675752|P1|STARTED|Part 1||1
7588638|NCT02661126|18676019|P2|NOT COMPLETED|Overall Study||0
7588639|NCT02661126|18676020|P1|NOT COMPLETED|Overall Study||0
7588640|NCT02661126|18676019|P2|COMPLETED|Overall Study||8
7588641|NCT02661126|18676020|P1|COMPLETED|Overall Study||8
7588642|NCT02661126|18676019|P2|STARTED|Overall Study||8
7588643|NCT02661126|18676020|P1|STARTED|Overall Study||8
7588644|NCT02661061|18676110|P2|NOT COMPLETED|Overall Study||2
7588645|NCT02661061|18676111|P1|NOT COMPLETED|Overall Study||2
7588646|NCT02661061|18676110|P2|COMPLETED|Overall Study||2
7588647|NCT02661061|18676111|P1|COMPLETED|Overall Study||3
7588648|NCT02661061|18676110|P2|STARTED|Overall Study||4
7588649|NCT02661061|18676111|P1|STARTED|Overall Study||5
7588650|NCT02660983|18676121|P2|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||9
7588651|NCT02660983|18676122|P1|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||3
7588652|NCT02660983|18676121|P2|COMPLETED|Open Label Extension Phase (24 Weeks)||66
7588653|NCT02660983|18676122|P1|COMPLETED|Open Label Extension Phase (24 Weeks)||83
7588654|NCT02660983|18676121|P2|Safety Set|Open Label Extension Phase (24 Weeks)||75
7588655|NCT02660983|18676122|P1|Safety Set|Open Label Extension Phase (24 Weeks)||86
7588656|NCT02660983|18676121|P2|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|75
7588657|NCT02660983|18676122|P1|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|86
7588658|NCT02660983|18676121|P2|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||26
7588659|NCT02660983|18676122|P1|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||24
7588660|NCT02660983|18676121|P2|COMPLETED|Double-blind (DB) Phase (24 Weeks)||122
7588661|NCT02660983|18676122|P1|COMPLETED|Double-blind (DB) Phase (24 Weeks)||130
7588662|NCT02660983|18676121|P2|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||147
7588663|NCT02660983|18676122|P1|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||153
7588664|NCT02660983|18676121|P2|STARTED|Double-blind (DB) Phase (24 Weeks)||148
7588665|NCT02660983|18676122|P1|STARTED|Double-blind (DB) Phase (24 Weeks)||154
7588666|NCT02660918|18676137|P2|NOT COMPLETED|Overall Study||1
7588667|NCT02660918|18676138|P1|NOT COMPLETED|Overall Study||1
7588668|NCT02660918|18676137|P2|COMPLETED|Overall Study|Age ineligible|41
7588669|NCT02660918|18676138|P1|COMPLETED|Overall Study|Age ineligible|41
7588670|NCT02660918|18676137|P2|STARTED|Overall Study||42
7588671|NCT02660918|18676138|P1|STARTED|Overall Study||42
7588672|NCT02660853|18676160|P1|NOT COMPLETED|Overall Study||0
7588673|NCT02660853|18676160|P1|COMPLETED|Overall Study||25
7588674|NCT02660853|18676160|P1|STARTED|Overall Study||25
7588675|NCT02660827|18676173|P1|NOT COMPLETED|2-6 Years Old Age Group||1
7588676|NCT02660827|18676173|P1|COMPLETED|2-6 Years Old Age Group||45
7588677|NCT02660827|18676173|P1|STARTED|2-6 Years Old Age Group||46
7588678|NCT02660827|18676173|P1|NOT COMPLETED|7-13 Years Old Age Group||0
7588679|NCT02660827|18676173|P1|COMPLETED|7-13 Years Old Age Group||105
7588680|NCT02660827|18676173|P1|STARTED|7-13 Years Old Age Group||105
7588681|NCT02660801|18676190|P2|NOT COMPLETED|Overall Study||0
7588682|NCT02660801|18676191|P1|NOT COMPLETED|Overall Study||0
7588683|NCT02660801|18676190|P2|COMPLETED|Overall Study||15
7588684|NCT02660801|18676191|P1|COMPLETED|Overall Study||11
7588685|NCT02660801|18676190|P2|STARTED|Overall Study||15
7588686|NCT02660801|18676191|P1|STARTED|Overall Study||11
7588687|NCT02660580|18676207|P5|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
7588688|NCT02660580|18676208|P4|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
7588689|NCT02660580|18676209|P3|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||18
7588690|NCT02660580|18676210|P2|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
7588691|NCT02660580|18676211|P1|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
7588692|NCT02660580|18676207|P5|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
7588693|NCT02660580|18676208|P4|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
7588694|NCT02660580|18676209|P3|COMPLETED|Extended Treatment Period(Week 16 to 52)||195
7588695|NCT02660580|18676210|P2|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
7588696|NCT02660580|18676211|P1|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
7588697|NCT02660580|18676207|P5|STARTED|Extended Treatment Period(Week 16 to 52)||101
7588698|NCT02660580|18676208|P4|STARTED|Extended Treatment Period(Week 16 to 52)||101
7588699|NCT02660580|18676209|P3|STARTED|Extended Treatment Period(Week 16 to 52)||213
7588700|NCT02660580|18676210|P2|STARTED|Extended Treatment Period(Week 16 to 52)||0
7588701|NCT02660580|18676211|P1|STARTED|Extended Treatment Period(Week 16 to 52)||0
7588702|NCT02660580|18676207|P5|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
7588703|NCT02660580|18676208|P4|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
7588704|NCT02660580|18676209|P3|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
7588705|NCT02660580|18676210|P2|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||19
7588706|NCT02660580|18676211|P1|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||9
7588707|NCT02660580|18676207|P5|COMPLETED|Core Treatment Period (Week 1 to 16)||0
7588708|NCT02660580|18676208|P4|COMPLETED|Core Treatment Period (Week 1 to 16)||0
7588709|NCT02660580|18676209|P3|COMPLETED|Core Treatment Period (Week 1 to 16)||0
7588710|NCT02660580|18676210|P2|COMPLETED|Core Treatment Period (Week 1 to 16)||202
7588711|NCT02660580|18676211|P1|COMPLETED|Core Treatment Period (Week 1 to 16)||213
7588712|NCT02660580|18676207|P5|Treated|Core Treatment Period (Week 1 to 16)||0
7588713|NCT02660580|18676208|P4|Treated|Core Treatment Period (Week 1 to 16)||0
7588714|NCT02660580|18676209|P3|Treated|Core Treatment Period (Week 1 to 16)||0
7588715|NCT02660580|18676210|P2|Treated|Core Treatment Period (Week 1 to 16)||220
7588716|NCT02660580|18676211|P1|Treated|Core Treatment Period (Week 1 to 16)||221
7588717|NCT02660580|18676207|P5|STARTED|Core Treatment Period (Week 1 to 16)||0
7588718|NCT02660580|18676208|P4|STARTED|Core Treatment Period (Week 1 to 16)||0
7588719|NCT02660580|18676209|P3|STARTED|Core Treatment Period (Week 1 to 16)||0
7588720|NCT02660580|18676210|P2|STARTED|Core Treatment Period (Week 1 to 16)||221
7588721|NCT02660580|18676211|P1|STARTED|Core Treatment Period (Week 1 to 16)||222
7588722|NCT02660528|18676320|P1|NOT COMPLETED|Overall Study||0
7588723|NCT02660528|18676320|P1|COMPLETED|Overall Study||0
7588724|NCT02660528|18676320|P1|STARTED|Overall Study||0
7588725|NCT02660242|18676326|P1|NOT COMPLETED|Glucagon Injection||1
7588726|NCT02660242|18676326|P1|COMPLETED|Glucagon Injection||15
7588727|NCT02660242|18676326|P1|STARTED|Glucagon Injection|16 participants were randomized but only 15 completed all 4 periods.|16
7588728|NCT02660242|18676326|P1|NOT COMPLETED|Glucose Tabs||1
7588729|NCT02660242|18676326|P1|COMPLETED|Glucose Tabs||15
7588730|NCT02660242|18676326|P1|STARTED|Glucose Tabs|16 participants were randomized but only 15 completed all 4 periods.|16
7588731|NCT02660242|18676326|P1|NOT COMPLETED|Basal Insulin Reduction||0
7588732|NCT02660242|18676326|P1|COMPLETED|Basal Insulin Reduction||16
7588733|NCT02660242|18676326|P1|STARTED|Basal Insulin Reduction||16
7588734|NCT02660242|18676326|P1|NOT COMPLETED|Control||0
7588735|NCT02660242|18676326|P1|COMPLETED|Control||16
7588736|NCT02660242|18676326|P1|STARTED|Control||16
7588737|NCT02660229|18676382|P2|NOT COMPLETED|Overall Study||1
7588738|NCT02660229|18676383|P1|NOT COMPLETED|Overall Study||2
7588739|NCT02660229|18676382|P2|COMPLETED|Overall Study||31
7588740|NCT02660229|18676383|P1|COMPLETED|Overall Study||32
7588741|NCT02660229|18676382|P2|Per Protocol Set|Overall Study|Withdrawal of ICF N=1, IC/EC deviation N=1, Prohibited medication N=1|29
7588742|NCT02660229|18676383|P1|Per Protocol Set|Overall Study|Adverse events N=1, Prohibited medication N=4|28
7588743|NCT02660229|18676382|P2|FAS Set|Overall Study||32
7588744|NCT02660229|18676383|P1|FAS Set|Overall Study|Oxycodone group: 1 patient was missed any efficacy assessment.|33
7588745|NCT02660229|18676382|P2|Safety Analysis Set|Overall Study||32
7588746|NCT02660229|18676383|P1|Safety Analysis Set|Overall Study||34
7588747|NCT02660229|18676382|P2|STARTED|Overall Study|Randomization|32
7588748|NCT02660229|18676383|P1|STARTED|Overall Study|Randomization|34
7588749|NCT02660112|18676395|P1|NOT COMPLETED|Overall Study||0
7588750|NCT02660112|18676395|P1|COMPLETED|Overall Study||10
7588751|NCT02660112|18676395|P1|STARTED|Overall Study||10
7588752|NCT02659787|18676400|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7588753|NCT02659787|18676401|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7588754|NCT02659787|18676400|P2|COMPLETED|Second Intervention (1 Day)||19
7588755|NCT02659787|18676401|P1|COMPLETED|Second Intervention (1 Day)||19
7588756|NCT02659787|18676400|P2|STARTED|Second Intervention (1 Day)||19
7588757|NCT02659787|18676401|P1|STARTED|Second Intervention (1 Day)||19
7588758|NCT02659787|18676400|P2|NOT COMPLETED|Washout (3 Days)||0
7588759|NCT02659787|18676401|P1|NOT COMPLETED|Washout (3 Days)||0
7588760|NCT02659787|18676400|P2|COMPLETED|Washout (3 Days)||19
7588761|NCT02659787|18676401|P1|COMPLETED|Washout (3 Days)||19
7588762|NCT02659787|18676400|P2|STARTED|Washout (3 Days)||19
7588763|NCT02659787|18676401|P1|STARTED|Washout (3 Days)||19
7588764|NCT02659787|18676400|P2|NOT COMPLETED|First Intervention (1 Day)||0
7588765|NCT02659787|18676401|P1|NOT COMPLETED|First Intervention (1 Day)||0
7588766|NCT02659787|18676400|P2|COMPLETED|First Intervention (1 Day)||19
7588767|NCT02659787|18676401|P1|COMPLETED|First Intervention (1 Day)||19
7588768|NCT02659787|18676400|P2|STARTED|First Intervention (1 Day)||19
7588769|NCT02659787|18676401|P1|STARTED|First Intervention (1 Day)||19
7588770|NCT02659709|18676407|P1|NOT COMPLETED|Overall Study||0
7588771|NCT02659709|18676407|P1|COMPLETED|Overall Study||50
7588772|NCT02659709|18676407|P1|STARTED|Overall Study||50
7588773|NCT02659631|18676424|P10|NOT COMPLETED|Overall Study||0
7588774|NCT02659631|18676425|P9|NOT COMPLETED|Overall Study||2
7588775|NCT02659631|18676426|P8|NOT COMPLETED|Overall Study||3
7588776|NCT02659631|18676427|P7|NOT COMPLETED|Overall Study||1
7588777|NCT02659631|18676428|P6|NOT COMPLETED|Overall Study||3
7588778|NCT02659631|18676429|P5|NOT COMPLETED|Overall Study||5
7588779|NCT02659631|18676430|P4|NOT COMPLETED|Overall Study||2
7588780|NCT02659631|18676431|P3|NOT COMPLETED|Overall Study||3
7588781|NCT02659631|18676432|P2|NOT COMPLETED|Overall Study||2
7588782|NCT02659631|18676433|P1|NOT COMPLETED|Overall Study||1
7588783|NCT02659631|18676424|P10|COMPLETED|Overall Study||1
7588784|NCT02659631|18676425|P9|COMPLETED|Overall Study||0
7588785|NCT02659631|18676426|P8|COMPLETED|Overall Study||0
7588786|NCT02659631|18676427|P7|COMPLETED|Overall Study||3
7588787|NCT02659631|18676428|P6|COMPLETED|Overall Study||2
7588788|NCT02659631|18676429|P5|COMPLETED|Overall Study||0
7588789|NCT02659631|18676430|P4|COMPLETED|Overall Study||0
7588790|NCT02659631|18676431|P3|COMPLETED|Overall Study||0
7588791|NCT02659631|18676432|P2|COMPLETED|Overall Study||0
7588792|NCT02659631|18676433|P1|COMPLETED|Overall Study||0
7588793|NCT02659631|18676424|P10|STARTED|Overall Study||1
7588794|NCT02659631|18676425|P9|STARTED|Overall Study||2
7588795|NCT02659631|18676426|P8|STARTED|Overall Study||3
7588796|NCT02659631|18676427|P7|STARTED|Overall Study||4
7588797|NCT02659631|18676428|P6|STARTED|Overall Study||5
7588798|NCT02659631|18676429|P5|STARTED|Overall Study||5
7588799|NCT02659631|18676430|P4|STARTED|Overall Study||2
7588800|NCT02659631|18676431|P3|STARTED|Overall Study||3
7588801|NCT02659631|18676432|P2|STARTED|Overall Study||2
7588802|NCT02659631|18676433|P1|STARTED|Overall Study||1
7588803|NCT02659540|18676567|P2|NOT COMPLETED|Overall Study||8
7588804|NCT02659540|18676568|P1|NOT COMPLETED|Overall Study||6
7588805|NCT02659540|18676567|P2|COMPLETED|Overall Study||2
7588806|NCT02659540|18676568|P1|COMPLETED|Overall Study||4
7588807|NCT02659540|18676567|P2|STARTED|Overall Study||10
7588808|NCT02659540|18676568|P1|STARTED|Overall Study||10
7588809|NCT02659501|18676584|P2|NOT COMPLETED|Overall Study||0
7588810|NCT02659501|18676585|P1|NOT COMPLETED|Overall Study||0
7588811|NCT02659501|18676584|P2|COMPLETED|Overall Study||12
7588812|NCT02659501|18676585|P1|COMPLETED|Overall Study||12
7588813|NCT02659501|18676584|P2|STARTED|Overall Study||12
7588814|NCT02659501|18676585|P1|STARTED|Overall Study||12
7588815|NCT02659098|18676599|P1|NOT COMPLETED|Overall Study||7
7588816|NCT02659098|18676599|P1|COMPLETED|Overall Study||14
7588817|NCT02659098|18676599|P1|STARTED|Overall Study||21
7588818|NCT02658877|18676630|P2|NOT COMPLETED|Overall Study||0
7588819|NCT02658877|18676631|P1|NOT COMPLETED|Overall Study||0
7588820|NCT02658877|18676630|P2|COMPLETED|Overall Study||0
7588821|NCT02658877|18676631|P1|COMPLETED|Overall Study||3
7588822|NCT02658877|18676630|P2|STARTED|Overall Study||0
7588823|NCT02658877|18676631|P1|STARTED|Overall Study||3
7588824|NCT02658851|18676657|P1|NOT COMPLETED|Overall Study||0
7588825|NCT02658851|18676657|P1|COMPLETED|Overall Study||100
7588826|NCT02658851|18676657|P1|STARTED|Overall Study||100
7588827|NCT02658487|18676661|P1|NOT COMPLETED|Overall Study||16
7588828|NCT02658487|18676661|P1|COMPLETED|Overall Study||26
7588829|NCT02658487|18676661|P1|STARTED|Overall Study||42
7588830|NCT02658461|18676674|P3|NOT COMPLETED|Overall Study||0
7588831|NCT02658461|18676675|P2|NOT COMPLETED|Overall Study||0
7588832|NCT02658461|18676676|P1|NOT COMPLETED|Overall Study||0
7588833|NCT02658461|18676674|P3|COMPLETED|Overall Study||12
7588834|NCT02658461|18676675|P2|COMPLETED|Overall Study||12
7588835|NCT02658461|18676676|P1|COMPLETED|Overall Study||12
7588836|NCT02658461|18676674|P3|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
7588837|NCT02658461|18676675|P2|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
7588838|NCT02658461|18676676|P1|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
7588839|NCT02658357|18676704|P2|NOT COMPLETED|Overall Study||0
7588840|NCT02658357|18676705|P1|NOT COMPLETED|Overall Study||0
7588841|NCT02658357|18676704|P2|COMPLETED|Overall Study||0
7588842|NCT02658357|18676705|P1|COMPLETED|Overall Study||0
7588843|NCT02658357|18676704|P2|STARTED|Overall Study||0
7588844|NCT02658357|18676705|P1|STARTED|Overall Study||0
7588845|NCT02658240|18676717|P2|NOT COMPLETED|Overall Study||0
7588846|NCT02658240|18676718|P1|NOT COMPLETED|Overall Study||0
7588847|NCT02658240|18676717|P2|COMPLETED|Overall Study||30
7588848|NCT02658240|18676718|P1|COMPLETED|Overall Study||30
7588849|NCT02658240|18676717|P2|STARTED|Overall Study||30
7588850|NCT02658240|18676718|P1|STARTED|Overall Study||30
7588851|NCT02658149|18676732|P2|NOT COMPLETED|Overall Study||0
7588852|NCT02658149|18676733|P1|NOT COMPLETED|Overall Study||1
7588853|NCT02658149|18676732|P2|COMPLETED|Overall Study||50
7588854|NCT02658149|18676733|P1|COMPLETED|Overall Study||49
7588855|NCT02658149|18676732|P2|STARTED|Overall Study||50
7588856|NCT02658149|18676733|P1|STARTED|Overall Study||50
7588857|NCT02658084|18676749|P2|NOT COMPLETED|Overall Study||0
7588858|NCT02658084|18676750|P1|NOT COMPLETED|Overall Study||2
7588859|NCT02658084|18676749|P2|COMPLETED|Overall Study||0
7588860|NCT02658084|18676750|P1|COMPLETED|Overall Study||0
7588861|NCT02658084|18676749|P2|STARTED|Overall Study||0
7588862|NCT02658084|18676750|P1|STARTED|Overall Study||2
7588863|NCT02658019|18676759|P1|NOT COMPLETED|Overall Study||1
7588864|NCT02658019|18676759|P1|COMPLETED|Overall Study||28
7588865|NCT02658019|18676759|P1|STARTED|Overall Study||29
7588866|NCT02657928|18676770|P2|NOT COMPLETED|Overall Study||0
7588867|NCT02657928|18676771|P1|NOT COMPLETED|Overall Study||0
7588868|NCT02657928|18676770|P2|COMPLETED|Overall Study||20
7588869|NCT02657928|18676771|P1|COMPLETED|Overall Study||20
7588870|NCT02657928|18676770|P2|STARTED|Overall Study||20
7588871|NCT02657928|18676771|P1|STARTED|Overall Study||20
7588872|NCT02657915|18676787|P2|NOT COMPLETED|Overall Study||0
7588873|NCT02657915|18676788|P1|NOT COMPLETED|Overall Study||0
7588874|NCT02657915|18676787|P2|COMPLETED|Overall Study||28
7588875|NCT02657915|18676788|P1|COMPLETED|Overall Study||24
7588876|NCT02657915|18676787|P2|Per-protocol Population|Overall Study||24
7588877|NCT02657915|18676788|P1|Per-protocol Population|Overall Study||23
7588878|NCT02657915|18676787|P2|Intent-to Treat (ITT) Population|Overall Study||28
7588879|NCT02657915|18676788|P1|Intent-to Treat (ITT) Population|Overall Study||24
7588880|NCT02657915|18676787|P2|STARTED|Overall Study||28
7588881|NCT02657915|18676788|P1|STARTED|Overall Study||24
7588882|NCT02657889|18676812|P4|NOT COMPLETED|Overall Study||55
7588883|NCT02657889|18676813|P3|NOT COMPLETED|Overall Study||53
7588884|NCT02657889|18676814|P2|NOT COMPLETED|Overall Study||7
7588885|NCT02657889|18676815|P1|NOT COMPLETED|Overall Study||7
7588886|NCT02657889|18676812|P4|COMPLETED|Overall Study||0
7588887|NCT02657889|18676813|P3|COMPLETED|Overall Study||0
7588888|NCT02657889|18676814|P2|COMPLETED|Overall Study||0
7588889|NCT02657889|18676815|P1|COMPLETED|Overall Study||0
7588890|NCT02657889|18676812|P4|STARTED|Overall Study||55
7588891|NCT02657889|18676813|P3|STARTED|Overall Study||53
7588892|NCT02657889|18676814|P2|STARTED|Overall Study||7
7588893|NCT02657889|18676815|P1|STARTED|Overall Study||7
7588894|NCT02657629|18676835|P2|NOT COMPLETED|Overall Study||0
7588895|NCT02657629|18676836|P1|NOT COMPLETED|Overall Study||2
7588896|NCT02657629|18676835|P2|COMPLETED|Overall Study||14
7588897|NCT02657629|18676836|P1|COMPLETED|Overall Study||12
7588898|NCT02657629|18676835|P2|STARTED|Overall Study||14
7588899|NCT02657629|18676836|P1|STARTED|Overall Study||14
7588900|NCT02657564|18676842|P1|NOT COMPLETED|Overall Study||74
7588901|NCT02657564|18676842|P1|COMPLETED|Overall Study||1163
7588902|NCT02657564|18676842|P1|STARTED|Overall Study||1237
7588903|NCT02657538|18676847|P1|NOT COMPLETED|Overall Study||4
7588904|NCT02657538|18676847|P1|COMPLETED|Overall Study||31
7588905|NCT02657538|18676847|P1|Received Visual Caries Detection + Bite|Overall Study||35
7588906|NCT02657538|18676847|P1|Received Near Infrared Transillumination|Overall Study||35
7588907|NCT02657538|18676847|P1|STARTED|Overall Study||35
7588908|NCT02657434|18676856|P2|NOT COMPLETED|Overall Study||292
7588909|NCT02657434|18676857|P1|NOT COMPLETED|Overall Study||286
7588910|NCT02657434|18676856|P2|COMPLETED|Overall Study||0
7588911|NCT02657434|18676857|P1|COMPLETED|Overall Study||0
7588912|NCT02657434|18676856|P2|STARTED|Overall Study||292
7588913|NCT02657434|18676857|P1|STARTED|Overall Study||286
7588914|NCT02657408|18676887|P2|NOT COMPLETED|Overall Study||7
7588915|NCT02657408|18676888|P1|NOT COMPLETED|Overall Study||3
7588916|NCT02657408|18676887|P2|COMPLETED|Overall Study||22
7588917|NCT02657408|18676888|P1|COMPLETED|Overall Study||25
7588918|NCT02657408|18676887|P2|STARTED|Overall Study||29
7588919|NCT02657408|18676888|P1|STARTED|Overall Study||28
7588920|NCT02657369|18676912|P1|NOT COMPLETED|Overall Study||34
7588921|NCT02657369|18676912|P1|COMPLETED|Overall Study||0
7588922|NCT02657369|18676912|P1|STARTED|Overall Study||34
7588923|NCT02657252|18676922|P2|NOT COMPLETED|Overall Study||7
7588924|NCT02657252|18676923|P1|NOT COMPLETED|Overall Study||10
7588925|NCT02657252|18676922|P2|COMPLETED|Overall Study||51
7588926|NCT02657252|18676923|P1|COMPLETED|Overall Study||47
7588927|NCT02657252|18676922|P2|STARTED|Overall Study||58
7588928|NCT02657252|18676923|P1|STARTED|Overall Study||57
7588929|NCT02657226|18676933|P1|NOT COMPLETED|Overall Study||0
7588930|NCT02657226|18676933|P1|COMPLETED|Overall Study||15724
7588931|NCT02657226|18676933|P1|STARTED|Overall Study||15724
7588932|NCT02657031|18676943|P2|NOT COMPLETED|Overall Study||2
7588933|NCT02657031|18676944|P1|NOT COMPLETED|Overall Study||1
7588934|NCT02657031|18676943|P2|COMPLETED|Overall Study||23
7588935|NCT02657031|18676944|P1|COMPLETED|Overall Study||28
7588936|NCT02657031|18676943|P2|STARTED|Overall Study||25
7588937|NCT02657031|18676944|P1|STARTED|Overall Study||29
7588938|NCT02656875|18676958|P1|NOT COMPLETED|Overall Study||70
7588939|NCT02656875|18676958|P1|COMPLETED|Overall Study||698
7588940|NCT02656875|18676958|P1|STARTED|Overall Study||768
7588941|NCT02656836|18676962|P1|NOT COMPLETED|Overall Study||3
7588942|NCT02656836|18676962|P1|COMPLETED|Overall Study||6
7588943|NCT02656836|18676962|P1|STARTED|Overall Study||9
7588944|NCT02656745|18676966|P1|NOT COMPLETED|Overall Study||0
7588945|NCT02656745|18676966|P1|COMPLETED|Overall Study||416
7588946|NCT02656745|18676966|P1|STARTED|Overall Study||416
7588947|NCT02656693|18676976|P3|NOT COMPLETED|Overall Study||3
7588948|NCT02656693|18676977|P2|NOT COMPLETED|Overall Study||2
7588949|NCT02656693|18676978|P1|NOT COMPLETED|Overall Study||1
7588950|NCT02656693|18676976|P3|COMPLETED|Overall Study||295
7588951|NCT02656693|18676977|P2|COMPLETED|Overall Study||214
7588952|NCT02656693|18676978|P1|COMPLETED|Overall Study||325
7588953|NCT02656693|18676976|P3|STARTED|Overall Study||298
7588954|NCT02656693|18676977|P2|STARTED|Overall Study||216
7588955|NCT02656693|18676978|P1|STARTED|Overall Study||326
7588956|NCT02656485|18677065|P4|NOT COMPLETED|Overall Study||2
7588957|NCT02656485|18677066|P3|NOT COMPLETED|Overall Study||2
7588958|NCT02656485|18677067|P2|NOT COMPLETED|Overall Study||3
7588959|NCT02656485|18677068|P1|NOT COMPLETED|Overall Study||2
7588960|NCT02656485|18677065|P4|COMPLETED|Overall Study||7
7588961|NCT02656485|18677066|P3|COMPLETED|Overall Study||7
7588962|NCT02656485|18677067|P2|COMPLETED|Overall Study||6
7588963|NCT02656485|18677068|P1|COMPLETED|Overall Study||7
7588964|NCT02656485|18677065|P4|STARTED|Overall Study||9
7588965|NCT02656485|18677066|P3|STARTED|Overall Study||9
7588966|NCT02656485|18677067|P2|STARTED|Overall Study||9
7588967|NCT02656485|18677068|P1|STARTED|Overall Study||9
7588968|NCT02656420|18677084|P4|NOT COMPLETED|Overall Study||0
7588969|NCT02656420|18677085|P3|NOT COMPLETED|Overall Study||0
7588970|NCT02656420|18677086|P2|NOT COMPLETED|Overall Study||1
7588971|NCT02656420|18677087|P1|NOT COMPLETED|Overall Study||0
7588972|NCT02656420|18677084|P4|COMPLETED|Overall Study||55
7588973|NCT02656420|18677085|P3|COMPLETED|Overall Study||35
7588974|NCT02656420|18677086|P2|COMPLETED|Overall Study||24
7588975|NCT02656420|18677087|P1|COMPLETED|Overall Study||55
7588976|NCT02656420|18677084|P4|STARTED|Overall Study||55
7588977|NCT02656420|18677085|P3|STARTED|Overall Study||35
7588978|NCT02656420|18677086|P2|STARTED|Overall Study||25
7588979|NCT02656420|18677087|P1|STARTED|Overall Study||55
7588980|NCT02656329|18677103|P2|NOT COMPLETED|Overall Study||157
7588981|NCT02656329|18677104|P1|NOT COMPLETED|Overall Study||164
7588982|NCT02656329|18677103|P2|COMPLETED|Overall Study||0
7588983|NCT02656329|18677104|P1|COMPLETED|Overall Study||0
7588984|NCT02656329|18677103|P2|STARTED|Overall Study||157
7588985|NCT02656329|18677104|P1|STARTED|Overall Study||164
7588986|NCT02656290|18677127|P1|NOT COMPLETED|Overall Study||26
7588987|NCT02656290|18677127|P1|COMPLETED|Overall Study||0
7588988|NCT02656290|18677127|P1|3 Year|Overall Study||6
7588989|NCT02656290|18677127|P1|2 Year|Overall Study||17
7588990|NCT02656290|18677127|P1|1 Year|Overall Study|One subject missed the 1 year follow-up visit.|25
7588991|NCT02656290|18677127|P1|STARTED|Overall Study||26
7588992|NCT02656199|18677131|P1|NOT COMPLETED|Overall Study||0
7588993|NCT02656199|18677131|P1|COMPLETED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
7588994|NCT02656199|18677131|P1|STARTED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
7588995|NCT02656173|18677137|P2|NOT COMPLETED|Overall Study||11
7588996|NCT02656173|18677138|P1|NOT COMPLETED|Overall Study||13
7588997|NCT02656173|18677137|P2|COMPLETED|Overall Study||272
7588998|NCT02656173|18677138|P1|COMPLETED|Overall Study||272
7588999|NCT02656173|18677137|P2|Received Treatment|Overall Study||282
7589000|NCT02656173|18677138|P1|Received Treatment|Overall Study||284
7589001|NCT02656173|18677137|P2|STARTED|Overall Study||283
7589002|NCT02656173|18677138|P1|STARTED|Overall Study||285
7589003|NCT02656160|18677174|P2|NOT COMPLETED|Second Study Night||0
7589004|NCT02656160|18677175|P1|NOT COMPLETED|Second Study Night||0
7589005|NCT02656160|18677174|P2|COMPLETED|Second Study Night||6
7589006|NCT02656160|18677175|P1|COMPLETED|Second Study Night||4
7589007|NCT02656160|18677174|P2|STARTED|Second Study Night||6
7589008|NCT02656160|18677175|P1|STARTED|Second Study Night|3 subjects did not return for the second study night|4
7589009|NCT02656160|18677174|P2|NOT COMPLETED|First Study Night||0
7589010|NCT02656160|18677175|P1|NOT COMPLETED|First Study Night||0
7589011|NCT02656160|18677174|P2|COMPLETED|First Study Night||6
7589012|NCT02656160|18677175|P1|COMPLETED|First Study Night||7
7589013|NCT02656160|18677174|P2|STARTED|First Study Night||6
7589014|NCT02656160|18677175|P1|STARTED|First Study Night||7
7589015|NCT02656069|18677185|P2|NOT COMPLETED|Second Intervention||1
7589016|NCT02656069|18677186|P1|NOT COMPLETED|Second Intervention||1
7589017|NCT02656069|18677185|P2|COMPLETED|Second Intervention||35
7589018|NCT02656069|18677186|P1|COMPLETED|Second Intervention||43
7589019|NCT02656069|18677185|P2|STARTED|Second Intervention||36
7589020|NCT02656069|18677186|P1|STARTED|Second Intervention||44
7589021|NCT02656069|18677185|P2|NOT COMPLETED|First Intervention||0
7589022|NCT02656069|18677186|P1|NOT COMPLETED|First Intervention||0
7589023|NCT02656069|18677185|P2|COMPLETED|First Intervention||36
7589024|NCT02656069|18677186|P1|COMPLETED|First Intervention||44
7589025|NCT02656069|18677185|P2|STARTED|First Intervention||36
7589026|NCT02656069|18677186|P1|STARTED|First Intervention||44
7589027|NCT02655887|18677210|P1|NOT COMPLETED|Overall Study||14
7589028|NCT02655887|18677210|P1|COMPLETED|Overall Study|Completed 12-month follow-up.|156
7589029|NCT02655887|18677210|P1|STARTED|Overall Study|Intent to Treat (ITT) population.|170
7589030|NCT02655679|18677229|P5|NOT COMPLETED|Overall Study||1
7589031|NCT02655679|18677230|P4|NOT COMPLETED|Overall Study||4
7589032|NCT02655679|18677231|P3|NOT COMPLETED|Overall Study||1
7589033|NCT02655679|18677232|P2|NOT COMPLETED|Overall Study||3
7589034|NCT02655679|18677233|P1|NOT COMPLETED|Overall Study||3
7589035|NCT02655679|18677229|P5|COMPLETED|Overall Study||19
7589036|NCT02655679|18677230|P4|COMPLETED|Overall Study||20
7589037|NCT02655679|18677231|P3|COMPLETED|Overall Study||19
7589038|NCT02655679|18677232|P2|COMPLETED|Overall Study||16
7589039|NCT02655679|18677233|P1|COMPLETED|Overall Study||18
7589040|NCT02655679|18677229|P5|Received Study Drug (Safety Population)|Overall Study||20
7589041|NCT02655679|18677230|P4|Received Study Drug (Safety Population)|Overall Study||24
7589042|NCT02655679|18677231|P3|Received Study Drug (Safety Population)|Overall Study||20
7589043|NCT02655679|18677232|P2|Received Study Drug (Safety Population)|Overall Study||19
7589044|NCT02655679|18677233|P1|Received Study Drug (Safety Population)|Overall Study||20
7589045|NCT02655679|18677229|P5|STARTED|Overall Study||20
7589046|NCT02655679|18677230|P4|STARTED|Overall Study||24
7589047|NCT02655679|18677231|P3|STARTED|Overall Study||20
7589048|NCT02655679|18677232|P2|STARTED|Overall Study||19
7589049|NCT02655679|18677233|P1|STARTED|Overall Study||21
7589050|NCT02655666|18677305|P1|NOT COMPLETED|Overall Study||12
7589051|NCT02655666|18677305|P1|COMPLETED|Overall Study||4
7589052|NCT02655666|18677305|P1|STARTED|Overall Study||16
7589053|NCT02655653|18677321|P2|NOT COMPLETED|Overall Study||0
7589054|NCT02655653|18677322|P1|NOT COMPLETED|Overall Study||0
7589055|NCT02655653|18677321|P2|COMPLETED|Overall Study||58
7589056|NCT02655653|18677322|P1|COMPLETED|Overall Study||56
7589057|NCT02655653|18677321|P2|STARTED|Overall Study||58
7589058|NCT02655653|18677322|P1|STARTED|Overall Study||56
7589059|NCT02655510|18677347|P3|NOT COMPLETED|Overall Study||0
7589060|NCT02655510|18677348|P2|NOT COMPLETED|Overall Study||0
7589061|NCT02655510|18677349|P1|NOT COMPLETED|Overall Study||0
7589062|NCT02655510|18677347|P3|COMPLETED|Overall Study||6
7589063|NCT02655510|18677348|P2|COMPLETED|Overall Study||6
7589064|NCT02655510|18677349|P1|COMPLETED|Overall Study||6
7589065|NCT02655510|18677347|P3|STARTED|Overall Study||6
7589066|NCT02655510|18677348|P2|STARTED|Overall Study||6
7589067|NCT02655510|18677349|P1|STARTED|Overall Study||6
7589068|NCT02655419|18677359|P2|NOT COMPLETED|Overall Study||7
7589069|NCT02655419|18677360|P1|NOT COMPLETED|Overall Study||5
7589070|NCT02655419|18677359|P2|COMPLETED|Overall Study||16
7589071|NCT02655419|18677360|P1|COMPLETED|Overall Study||12
7589072|NCT02655419|18677359|P2|Treated|Overall Study||18
7589073|NCT02655419|18677360|P1|Treated|Overall Study||16
7589074|NCT02655419|18677359|P2|STARTED|Overall Study||23
7589075|NCT02655419|18677360|P1|STARTED|Overall Study||17
7589076|NCT02655237|18677480|P2|NOT COMPLETED|Overall Study||11
7589077|NCT02655237|18677481|P1|NOT COMPLETED|Overall Study||17
7589078|NCT02655237|18677480|P2|COMPLETED|Overall Study||131
7589079|NCT02655237|18677481|P1|COMPLETED|Overall Study||122
7589080|NCT02655237|18677480|P2|STARTED|Overall Study||142
7589081|NCT02655237|18677481|P1|STARTED|Overall Study||139
7589082|NCT02655224|18677521|P2|NOT COMPLETED|Overall Study||1
7589083|NCT02655224|18677522|P1|NOT COMPLETED|Overall Study||1
7589084|NCT02655224|18677521|P2|COMPLETED|Overall Study||31
7589085|NCT02655224|18677522|P1|COMPLETED|Overall Study||32
7589086|NCT02655224|18677521|P2|STARTED|Overall Study||32
7589087|NCT02655224|18677522|P1|STARTED|Overall Study||33
7589088|NCT02655016|18677554|P2|NOT COMPLETED|Overall Study||90
7589089|NCT02655016|18677555|P1|NOT COMPLETED|Overall Study||55
7589090|NCT02655016|18677554|P2|COMPLETED|Overall Study|177 participants are ongoing in the study.|397
7589091|NCT02655016|18677555|P1|COMPLETED|Overall Study|69 participants are ongoing in the study.|191
7589092|NCT02655016|18677554|P2|Ongoing With Treatment in the Study|Overall Study||177
7589093|NCT02655016|18677555|P1|Ongoing With Treatment in the Study|Overall Study||69
7589094|NCT02655016|18677554|P2|Received Study Treatment|Overall Study|3 participants never received treatment (2 failed screening & 1 withdrew consent before first dose).|484
7589095|NCT02655016|18677555|P1|Received Study Treatment|Overall Study|2 participants never received treatment due to screen failure after randomization.|244
7589096|NCT02655016|18677554|P2|STARTED|Overall Study||487
7589097|NCT02655016|18677555|P1|STARTED|Overall Study||246
7589098|NCT02654977|18677587|P1|NOT COMPLETED|Overall Study||7
7589099|NCT02654977|18677587|P1|COMPLETED|Overall Study||4
7589100|NCT02654977|18677587|P1|STARTED|Overall Study||11
7589101|NCT02654782|18677594|P2|NOT COMPLETED|Overall Study||0
7589102|NCT02654782|18677595|P1|NOT COMPLETED|Overall Study||0
7589103|NCT02654782|18677594|P2|COMPLETED|Overall Study||5
7589104|NCT02654782|18677595|P1|COMPLETED|Overall Study||5
7589105|NCT02654782|18677594|P2|STARTED|Overall Study||5
7589106|NCT02654782|18677595|P1|STARTED|Overall Study||5
7589107|NCT02654769|18677606|P3|NOT COMPLETED|Overall Study||1
7589108|NCT02654769|18677607|P2|NOT COMPLETED|Overall Study||1
7589109|NCT02654769|18677608|P1|NOT COMPLETED|Overall Study||4
7589110|NCT02654769|18677606|P3|COMPLETED|Overall Study||142
7589111|NCT02654769|18677607|P2|COMPLETED|Overall Study||148
7589112|NCT02654769|18677608|P1|COMPLETED|Overall Study||145
7589113|NCT02654769|18677606|P3|STARTED|Overall Study||143
7589114|NCT02654769|18677607|P2|STARTED|Overall Study||149
7589115|NCT02654769|18677608|P1|STARTED|Overall Study||149
7589116|NCT02654717|18677621|P2|NOT COMPLETED|Overall Study||5
7589117|NCT02654717|18677622|P1|NOT COMPLETED|Overall Study||6
7589118|NCT02654717|18677621|P2|COMPLETED|Overall Study||50
7589119|NCT02654717|18677622|P1|COMPLETED|Overall Study||50
7589120|NCT02654717|18677621|P2|STARTED|Overall Study||55
7589121|NCT02654717|18677622|P1|STARTED|Overall Study||56
7589122|NCT02654652|18677630|P2|NOT COMPLETED|Overall Study||3
7589123|NCT02654652|18677631|P1|NOT COMPLETED|Overall Study||1
7589124|NCT02654652|18677630|P2|COMPLETED|Overall Study||18
7589125|NCT02654652|18677631|P1|COMPLETED|Overall Study||18
7589126|NCT02654652|18677630|P2|STARTED|Overall Study||21
7589127|NCT02654652|18677631|P1|STARTED|Overall Study||19
7589128|NCT02654639|18677639|P1|NOT COMPLETED|Overall Study||0
7589129|NCT02654639|18677639|P1|COMPLETED|Overall Study||4
7589130|NCT02654639|18677639|P1|STARTED|Overall Study||4
7589131|NCT02654483|18677645|P2|NOT COMPLETED|Open-label||0
7589132|NCT02654483|18677646|P1|NOT COMPLETED|Open-label||0
7589133|NCT02654483|18677645|P2|COMPLETED|Open-label||3
7589134|NCT02654483|18677646|P1|COMPLETED|Open-label||5
7589135|NCT02654483|18677645|P2|STARTED|Open-label|4 participants did not continue to open-label arm|3
7589136|NCT02654483|18677646|P1|STARTED|Open-label|2 participants did not proceed to open-label arm|5
7589137|NCT02654483|18677645|P2|NOT COMPLETED|Double-blind||0
7589138|NCT02654483|18677646|P1|NOT COMPLETED|Double-blind||0
7589139|NCT02654483|18677645|P2|COMPLETED|Double-blind||7
7589140|NCT02654483|18677646|P1|COMPLETED|Double-blind||7
7589141|NCT02654483|18677645|P2|STARTED|Double-blind||7
7589142|NCT02654483|18677646|P1|STARTED|Double-blind||7
7589143|NCT02654314|18677660|P2|NOT COMPLETED|Overall Study||0
7589144|NCT02654314|18677661|P1|NOT COMPLETED|Overall Study||0
7589145|NCT02654314|18677660|P2|COMPLETED|Overall Study||141
7589146|NCT02654314|18677661|P1|COMPLETED|Overall Study||136
7589147|NCT02654314|18677660|P2|STARTED|Overall Study||141
7589148|NCT02654314|18677661|P1|STARTED|Overall Study||136
7589149|NCT02654145|18677673|P1|NOT COMPLETED|Overall Study||7
7589150|NCT02654145|18677673|P1|COMPLETED|Overall Study||138
7589151|NCT02654145|18677673|P1|STARTED|Overall Study||145
7589152|NCT02654132|18677682|P2|NOT COMPLETED|Overall Study||46
7589153|NCT02654132|18677683|P1|NOT COMPLETED|Overall Study||36
7589154|NCT02654132|18677682|P2|COMPLETED|Overall Study||11
7589155|NCT02654132|18677683|P1|COMPLETED|Overall Study||24
7589156|NCT02654132|18677682|P2|STARTED|Overall Study||57
7589157|NCT02654132|18677683|P1|STARTED|Overall Study||60
7589158|NCT02654054|18677694|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||30
7589159|NCT02654054|18677695|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||8
7589160|NCT02654054|18677696|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||8
7589161|NCT02654054|18677694|P3|COMPLETED|Post-Treatment Follow-Up Period||29
7589162|NCT02654054|18677695|P2|COMPLETED|Post-Treatment Follow-Up Period||24
7589163|NCT02654054|18677696|P1|COMPLETED|Post-Treatment Follow-Up Period||17
7589164|NCT02654054|18677694|P3|STARTED|Post-Treatment Follow-Up Period||59
7589165|NCT02654054|18677695|P2|STARTED|Post-Treatment Follow-Up Period||32
7589166|NCT02654054|18677696|P1|STARTED|Post-Treatment Follow-Up Period||25
7589167|NCT02654054|18677694|P3|NOT COMPLETED|Treatment Period||43
7589168|NCT02654054|18677695|P2|NOT COMPLETED|Treatment Period||23
7589169|NCT02654054|18677696|P1|NOT COMPLETED|Treatment Period||19
7589170|NCT02654054|18677694|P3|COMPLETED|Treatment Period||164
7589171|NCT02654054|18677695|P2|COMPLETED|Treatment Period||81
7589172|NCT02654054|18677696|P1|COMPLETED|Treatment Period||83
7589173|NCT02654054|18677694|P3|Randomized and Treated|Treatment Period||206
7589174|NCT02654054|18677695|P2|Randomized and Treated|Treatment Period||104
7589175|NCT02654054|18677696|P1|Randomized and Treated|Treatment Period||102
7589176|NCT02654054|18677694|P3|STARTED|Treatment Period||207
7589177|NCT02654054|18677695|P2|STARTED|Treatment Period||104
7589178|NCT02654054|18677696|P1|STARTED|Treatment Period||102
7589179|NCT02654002|18677731|P9|NOT COMPLETED|Overall Study||0
7589180|NCT02654002|18677732|P8|NOT COMPLETED|Overall Study||1
7589181|NCT02654002|18677733|P7|NOT COMPLETED|Overall Study||1
7589182|NCT02654002|18677734|P6|NOT COMPLETED|Overall Study||1
7589183|NCT02654002|18677735|P5|NOT COMPLETED|Overall Study||0
7589184|NCT02654002|18677736|P4|NOT COMPLETED|Overall Study||0
7589185|NCT02654002|18677737|P3|NOT COMPLETED|Overall Study||0
7589186|NCT02654002|18677738|P2|NOT COMPLETED|Overall Study||0
7589187|NCT02654002|18677739|P1|NOT COMPLETED|Overall Study||0
7589188|NCT02654002|18677731|P9|COMPLETED|Overall Study||24
7589189|NCT02654002|18677732|P8|COMPLETED|Overall Study||11
7589190|NCT02654002|18677733|P7|COMPLETED|Overall Study||11
7589191|NCT02654002|18677734|P6|COMPLETED|Overall Study||11
7589192|NCT02654002|18677735|P5|COMPLETED|Overall Study||12
7589193|NCT02654002|18677736|P4|COMPLETED|Overall Study||12
7589194|NCT02654002|18677737|P3|COMPLETED|Overall Study||12
7589195|NCT02654002|18677738|P2|COMPLETED|Overall Study||12
7589196|NCT02654002|18677739|P1|COMPLETED|Overall Study||12
7589197|NCT02654002|18677731|P9|STARTED|Overall Study||24
7589198|NCT02654002|18677732|P8|STARTED|Overall Study||12
7589199|NCT02654002|18677733|P7|STARTED|Overall Study||12
7589200|NCT02654002|18677734|P6|STARTED|Overall Study||12
7589201|NCT02654002|18677735|P5|STARTED|Overall Study||12
7589202|NCT02654002|18677736|P4|STARTED|Overall Study||12
7589203|NCT02654002|18677737|P3|STARTED|Overall Study||12
7589204|NCT02654002|18677738|P2|STARTED|Overall Study||12
7589205|NCT02654002|18677739|P1|STARTED|Overall Study||12
7589206|NCT02653872|18677865|P1|NOT COMPLETED|Overall Study||0
7589207|NCT02653872|18677865|P1|COMPLETED|Overall Study||15
7589208|NCT02653872|18677865|P1|Treatment Period 3:|Overall Study|Participants received: itraconazole 200 mg + AZD7986.|15
7589209|NCT02653872|18677865|P1|Treatment Period 2:|Overall Study|Participants received Verapamil (240 mg; extended release formulation) + AZD7986 (25 mg).|15
7589210|NCT02653872|18677865|P1|Treatment Period 1:|Overall Study|Participants received single AZD7986 (25 mg).|15
7589211|NCT02653872|18677865|P1|STARTED|Overall Study||15
7589212|NCT02653768|18677902|P2|NOT COMPLETED|9-Month Follow-Up (Primary)||16
7589213|NCT02653768|18677903|P1|NOT COMPLETED|9-Month Follow-Up (Primary)||33
7589214|NCT02653768|18677902|P2|COMPLETED|9-Month Follow-Up (Primary)||95
7589215|NCT02653768|18677903|P1|COMPLETED|9-Month Follow-Up (Primary)|13 withdrew/refused before 9 months; others missed prior assessments but remained in study|163
7589216|NCT02653768|18677902|P2|STARTED|9-Month Follow-Up (Primary)|4 withdrew/excluded before 9 months; others missed prior assessments but remained in study|111
7589217|NCT02653768|18677903|P1|STARTED|9-Month Follow-Up (Primary)|34 withdrew/excluded before 9 months; others missed prior assessments but remained in study|196
7589218|NCT02653768|18677902|P2|NOT COMPLETED|6-Month Follow-Up||13
7589219|NCT02653768|18677903|P1|NOT COMPLETED|6-Month Follow-Up||45
7589220|NCT02653768|18677902|P2|COMPLETED|6-Month Follow-Up||100
7589221|NCT02653768|18677903|P1|COMPLETED|6-Month Follow-Up||164
7589222|NCT02653768|18677902|P2|STARTED|6-Month Follow-Up|2 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|113
7589223|NCT02653768|18677903|P1|STARTED|6-Month Follow-Up|21 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|209
7589224|NCT02653768|18677902|P2|NOT COMPLETED|3-Month Follow-Up||15
7589225|NCT02653768|18677903|P1|NOT COMPLETED|3-Month Follow-Up||66
7589226|NCT02653768|18677902|P2|COMPLETED|3-Month Follow-Up||100
7589227|NCT02653768|18677903|P1|COMPLETED|3-Month Follow-Up||164
7589228|NCT02653768|18677902|P2|STARTED|3-Month Follow-Up||115
7589229|NCT02653768|18677903|P1|STARTED|3-Month Follow-Up||230
7589230|NCT02653625|18677913|P1|NOT COMPLETED|Overall Study||4
7589231|NCT02653625|18677913|P1|COMPLETED|Overall Study||20
7589232|NCT02653625|18677913|P1|STARTED|Overall Study||24
7589233|NCT02653560|18677922|P4|NOT COMPLETED|Placebo Phase||0
7589234|NCT02653560|18677923|P3|NOT COMPLETED|Placebo Phase||0
7589235|NCT02653560|18677924|P2|NOT COMPLETED|Placebo Phase||0
7589236|NCT02653560|18677925|P1|NOT COMPLETED|Placebo Phase||0
7589237|NCT02653560|18677922|P4|COMPLETED|Placebo Phase||30
7589238|NCT02653560|18677923|P3|COMPLETED|Placebo Phase||0
7589239|NCT02653560|18677924|P2|COMPLETED|Placebo Phase||0
7589240|NCT02653560|18677925|P1|COMPLETED|Placebo Phase||0
7589241|NCT02653560|18677922|P4|STARTED|Placebo Phase||30
7589242|NCT02653560|18677923|P3|STARTED|Placebo Phase||0
7589243|NCT02653560|18677924|P2|STARTED|Placebo Phase||0
7589244|NCT02653560|18677925|P1|STARTED|Placebo Phase||0
7589245|NCT02653560|18677922|P4|NOT COMPLETED|KCl Phase||0
7589246|NCT02653560|18677923|P3|NOT COMPLETED|KCl Phase||0
7589247|NCT02653560|18677924|P2|NOT COMPLETED|KCl Phase||0
7589248|NCT02653560|18677925|P1|NOT COMPLETED|KCl Phase||0
7589249|NCT02653560|18677922|P4|COMPLETED|KCl Phase||0
7589250|NCT02653560|18677923|P3|COMPLETED|KCl Phase||30
7589251|NCT02653560|18677924|P2|COMPLETED|KCl Phase||0
7589252|NCT02653560|18677925|P1|COMPLETED|KCl Phase||0
7589253|NCT02653560|18677922|P4|STARTED|KCl Phase||0
7589254|NCT02653560|18677923|P3|STARTED|KCl Phase||30
7589255|NCT02653560|18677924|P2|STARTED|KCl Phase||0
7589256|NCT02653560|18677925|P1|STARTED|KCl Phase||0
7589257|NCT02653560|18677922|P4|NOT COMPLETED|K Citrate Phase||0
7589258|NCT02653560|18677923|P3|NOT COMPLETED|K Citrate Phase||0
7589259|NCT02653560|18677924|P2|NOT COMPLETED|K Citrate Phase||0
7589260|NCT02653560|18677925|P1|NOT COMPLETED|K Citrate Phase||0
7589261|NCT02653560|18677922|P4|COMPLETED|K Citrate Phase||0
7589262|NCT02653560|18677923|P3|COMPLETED|K Citrate Phase||0
7589263|NCT02653560|18677924|P2|COMPLETED|K Citrate Phase||30
7589264|NCT02653560|18677925|P1|COMPLETED|K Citrate Phase||0
7589265|NCT02653560|18677922|P4|STARTED|K Citrate Phase||0
7589266|NCT02653560|18677923|P3|STARTED|K Citrate Phase||0
7589267|NCT02653560|18677924|P2|STARTED|K Citrate Phase||30
7589268|NCT02653560|18677925|P1|STARTED|K Citrate Phase||0
7589269|NCT02653560|18677922|P4|NOT COMPLETED|KMgCit Phase||0
7589270|NCT02653560|18677923|P3|NOT COMPLETED|KMgCit Phase||0
7589271|NCT02653560|18677924|P2|NOT COMPLETED|KMgCit Phase||0
7589272|NCT02653560|18677925|P1|NOT COMPLETED|KMgCit Phase||0
7589273|NCT02653560|18677922|P4|COMPLETED|KMgCit Phase||0
7589274|NCT02653560|18677923|P3|COMPLETED|KMgCit Phase||0
7589275|NCT02653560|18677924|P2|COMPLETED|KMgCit Phase||0
7589276|NCT02653560|18677925|P1|COMPLETED|KMgCit Phase||30
7589277|NCT02653560|18677922|P4|STARTED|KMgCit Phase||0
7589278|NCT02653560|18677923|P3|STARTED|KMgCit Phase||0
7589279|NCT02653560|18677924|P2|STARTED|KMgCit Phase||0
7589280|NCT02653560|18677925|P1|STARTED|KMgCit Phase||30
7589281|NCT02653495|18677937|P2|NOT COMPLETED|Overall Study||0
7589282|NCT02653495|18677938|P1|NOT COMPLETED|Overall Study||12
7589283|NCT02653495|18677937|P2|COMPLETED|Overall Study||2
7589284|NCT02653495|18677938|P1|COMPLETED|Overall Study||3
7589285|NCT02653495|18677937|P2|STARTED|Overall Study||2
7589286|NCT02653495|18677938|P1|STARTED|Overall Study||15
7589287|NCT02653456|18677952|P1|NOT COMPLETED|Overall Study||5
7589288|NCT02653456|18677952|P1|COMPLETED|Overall Study||59
7589289|NCT02653456|18677952|P1|STARTED|Overall Study||64
7589290|NCT02653417|18677963|P4|NOT COMPLETED|Overall Study||5
7589291|NCT02653417|18677964|P3|NOT COMPLETED|Overall Study||3
7589292|NCT02653417|18677965|P2|NOT COMPLETED|Overall Study||2
7589293|NCT02653417|18677966|P1|NOT COMPLETED|Overall Study||1
7589294|NCT02653417|18677963|P4|COMPLETED|Overall Study||33
7589295|NCT02653417|18677964|P3|COMPLETED|Overall Study||26
7589296|NCT02653417|18677965|P2|COMPLETED|Overall Study||32
7589297|NCT02653417|18677966|P1|COMPLETED|Overall Study||37
7589298|NCT02653417|18677963|P4|STARTED|Overall Study||38
7589299|NCT02653417|18677964|P3|STARTED|Overall Study||29
7589300|NCT02653417|18677965|P2|STARTED|Overall Study||34
7589301|NCT02653417|18677966|P1|STARTED|Overall Study||38
7589302|NCT02653326|18677990|P2|NOT COMPLETED|Overall Study||7
7589303|NCT02653326|18677991|P1|NOT COMPLETED|Overall Study||10
7589304|NCT02653326|18677990|P2|COMPLETED|Overall Study||27
7589305|NCT02653326|18677991|P1|COMPLETED|Overall Study||22
7589306|NCT02653326|18677990|P2|STARTED|Overall Study||34
7589307|NCT02653326|18677991|P1|STARTED|Overall Study||32
7589308|NCT02653183|18678005|P2|NOT COMPLETED|Overall Study||4
7589309|NCT02653183|18678006|P1|NOT COMPLETED|Overall Study||4
7589310|NCT02653183|18678005|P2|COMPLETED|Overall Study||46
7589311|NCT02653183|18678006|P1|COMPLETED|Overall Study||49
7589312|NCT02653183|18678005|P2|STARTED|Overall Study||50
7589313|NCT02653183|18678006|P1|STARTED|Overall Study||53
7589314|NCT02653170|18678029|P3|NOT COMPLETED|Overall Study||18
7589315|NCT02653170|18678030|P2|NOT COMPLETED|Overall Study||16
7589316|NCT02653170|18678031|P1|NOT COMPLETED|Overall Study||17
7589317|NCT02653170|18678029|P3|COMPLETED|Overall Study||72
7589318|NCT02653170|18678030|P2|COMPLETED|Overall Study||72
7589319|NCT02653170|18678031|P1|COMPLETED|Overall Study||70
7589320|NCT02653170|18678029|P3|STARTED|Overall Study||90
7589321|NCT02653170|18678030|P2|STARTED|Overall Study||88
7589322|NCT02653170|18678031|P1|STARTED|Overall Study||87
7589323|NCT02653144|18678054|P3|NOT COMPLETED|Overall Study||0
7589324|NCT02653144|18678055|P2|NOT COMPLETED|Overall Study||0
7589325|NCT02653144|18678056|P1|NOT COMPLETED|Overall Study||0
7589326|NCT02653144|18678054|P3|COMPLETED|Overall Study||31
7589327|NCT02653144|18678055|P2|COMPLETED|Overall Study||28
7589328|NCT02653144|18678056|P1|COMPLETED|Overall Study||30
7589329|NCT02653144|18678054|P3|STARTED|Overall Study||31
7589330|NCT02653144|18678055|P2|STARTED|Overall Study||28
7589331|NCT02653144|18678056|P1|STARTED|Overall Study||30
7589332|NCT02652949|18678073|P1|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
7589333|NCT02652949|18678073|P1|COMPLETED|12-Month Follow-up Secondary Endpoint||87
7589334|NCT02652949|18678073|P1|STARTED|12-Month Follow-up Secondary Endpoint||91
7589335|NCT02652949|18678073|P1|NOT COMPLETED|6-Month Follow-up Secondary Endpoint||8
7589336|NCT02652949|18678073|P1|COMPLETED|6-Month Follow-up Secondary Endpoint||91
7589337|NCT02652949|18678073|P1|STARTED|6-Month Follow-up Secondary Endpoint|Note that 6-month follow up is not mandatory for OUS subjects.|99
7589338|NCT02652949|18678073|P1|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
7589339|NCT02652949|18678073|P1|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
7589340|NCT02652949|18678073|P1|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
7589341|NCT02652949|18678073|P1|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
7589342|NCT02652949|18678073|P1|COMPLETED|30-Day Follow-up for Primary Endpoint||86
7589343|NCT02652949|18678073|P1|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
7589344|NCT02652780|18678082|P1|NOT COMPLETED|Overall Study||0
7589345|NCT02652780|18678082|P1|COMPLETED|Overall Study||37
7589346|NCT02652780|18678082|P1|STARTED|Overall Study||37
7589347|NCT02652767|18678108|P1|NOT COMPLETED|Overall Study||4
7589348|NCT02652767|18678108|P1|COMPLETED|Overall Study||35
7589349|NCT02652767|18678108|P1|Completed Week 48|Overall Study||38
7589350|NCT02652767|18678108|P1|STARTED|Overall Study||39
7589351|NCT02652624|18678136|P2|NOT COMPLETED|Extension Phase||4
7589352|NCT02652624|18678137|P1|NOT COMPLETED|Extension Phase||4
7589353|NCT02652624|18678136|P2|COMPLETED|Extension Phase||224
7589354|NCT02652624|18678137|P1|COMPLETED|Extension Phase||227
7589355|NCT02652624|18678136|P2|STARTED|Extension Phase|3 participants completed the Randomized Phase, but did not enter the Extension Phase.|228
7589356|NCT02652624|18678137|P1|STARTED|Extension Phase||231
7589357|NCT02652624|18678136|P2|NOT COMPLETED|Randomized Phase||5
7589358|NCT02652624|18678137|P1|NOT COMPLETED|Randomized Phase||3
7589359|NCT02652624|18678136|P2|COMPLETED|Randomized Phase||231
7589360|NCT02652624|18678137|P1|COMPLETED|Randomized Phase||231
7589361|NCT02652624|18678136|P2|STARTED|Randomized Phase||236
7589362|NCT02652624|18678137|P1|STARTED|Randomized Phase||234
7589363|NCT02652481|18678149|P1|NOT COMPLETED|Phase 2||18
7589364|NCT02652481|18678149|P1|COMPLETED|Phase 2||243
7589365|NCT02652481|18678149|P1|STARTED|Phase 2||261
7589366|NCT02652481|18678149|P1|NOT COMPLETED|Phase 1||98
7589367|NCT02652481|18678149|P1|COMPLETED|Phase 1||141
7589368|NCT02652481|18678149|P1|STARTED|Phase 1||239
7589369|NCT02652468|18678157|P1|NOT COMPLETED|Overall Study||0
7589370|NCT02652468|18678157|P1|COMPLETED|Overall Study||11
7589371|NCT02652468|18678157|P1|STARTED|Overall Study||11
7589372|NCT02652416|18678165|P4|NOT COMPLETED|Overall Study||0
7589373|NCT02652416|18678166|P3|NOT COMPLETED|Overall Study||0
7589374|NCT02652416|18678167|P2|NOT COMPLETED|Overall Study||0
7589375|NCT02652416|18678168|P1|NOT COMPLETED|Overall Study||0
7589376|NCT02652416|18678165|P4|COMPLETED|Overall Study||18
7589377|NCT02652416|18678166|P3|COMPLETED|Overall Study||18
7589378|NCT02652416|18678167|P2|COMPLETED|Overall Study||18
7589379|NCT02652416|18678168|P1|COMPLETED|Overall Study||18
7589380|NCT02652416|18678165|P4|Subjects Who Participated in MD Part|Overall Study||18
7589381|NCT02652416|18678166|P3|Subjects Who Participated in MD Part|Overall Study||0
7589382|NCT02652416|18678167|P2|Subjects Who Participated in MD Part|Overall Study||0
7589383|NCT02652416|18678168|P1|Subjects Who Participated in MD Part|Overall Study||6
7589384|NCT02652416|18678165|P4|STARTED|Overall Study||18
7589385|NCT02652416|18678166|P3|STARTED|Overall Study||18
7589386|NCT02652416|18678167|P2|STARTED|Overall Study||18
7589387|NCT02652416|18678168|P1|STARTED|Overall Study||18
7589388|NCT02652390|18678199|P3|NOT COMPLETED|Overall Study||0
7589389|NCT02652390|18678200|P2|NOT COMPLETED|Overall Study||0
7589390|NCT02652390|18678201|P1|NOT COMPLETED|Overall Study||0
7589391|NCT02652390|18678199|P3|COMPLETED|Overall Study||37
7589392|NCT02652390|18678200|P2|COMPLETED|Overall Study||37
7589393|NCT02652390|18678201|P1|COMPLETED|Overall Study||37
7589394|NCT02652390|18678199|P3|STARTED|Overall Study||37
7589395|NCT02652390|18678200|P2|STARTED|Overall Study||37
7589396|NCT02652390|18678201|P1|STARTED|Overall Study||37
7589397|NCT02652260|18678225|P2|NOT COMPLETED|Overall Study||2
7589398|NCT02652260|18678226|P1|NOT COMPLETED|Overall Study||0
7589399|NCT02652260|18678225|P2|COMPLETED|Overall Study||41
7589400|NCT02652260|18678226|P1|COMPLETED|Overall Study||43
7589401|NCT02652260|18678225|P2|STARTED|Overall Study||43
7589402|NCT02652260|18678226|P1|STARTED|Overall Study||43
7589403|NCT02652221|18678262|P1|NOT COMPLETED|Overall Study||0
7589404|NCT02652221|18678262|P1|COMPLETED|Overall Study||55
7589405|NCT02652221|18678262|P1|STARTED|Overall Study||55
7589406|NCT02652208|18678271|P2|NOT COMPLETED|Overall Study||2
7589407|NCT02652208|18678272|P1|NOT COMPLETED|Overall Study||4
7589408|NCT02652208|18678271|P2|COMPLETED|Overall Study||15
7589409|NCT02652208|18678272|P1|COMPLETED|Overall Study||13
7589410|NCT02652208|18678271|P2|STARTED|Overall Study||17
7589411|NCT02652208|18678272|P1|STARTED|Overall Study||17
7589412|NCT02652156|18678285|P3|NOT COMPLETED|Overall Study||0
7589413|NCT02652156|18678286|P2|NOT COMPLETED|Overall Study||0
7589414|NCT02652156|18678287|P1|NOT COMPLETED|Overall Study||1
7589415|NCT02652156|18678285|P3|COMPLETED|Overall Study||4
7589416|NCT02652156|18678286|P2|COMPLETED|Overall Study||6
7589417|NCT02652156|18678287|P1|COMPLETED|Overall Study||3
7589418|NCT02652156|18678285|P3|STARTED|Overall Study||4
7589419|NCT02652156|18678286|P2|STARTED|Overall Study||6
7589420|NCT02652156|18678287|P1|STARTED|Overall Study||4
7589421|NCT02651987|18678315|P2|NOT COMPLETED|Overall Study||5
7589422|NCT02651987|18678316|P1|NOT COMPLETED|Overall Study||5
7589423|NCT02651987|18678315|P2|COMPLETED|Overall Study||46
7589424|NCT02651987|18678316|P1|COMPLETED|Overall Study||43
7589425|NCT02651987|18678315|P2|STARTED|Overall Study||51
7589426|NCT02651987|18678316|P1|STARTED|Overall Study||48
7589427|NCT02651922|18678357|P1|NOT COMPLETED|Overall Study||2
7589428|NCT02651922|18678357|P1|COMPLETED|Overall Study||154
7589429|NCT02651922|18678357|P1|STARTED|Overall Study||156
7589430|NCT02651688|18678377|P3|NOT COMPLETED|Overall Study||3
7589431|NCT02651688|18678378|P2|NOT COMPLETED|Overall Study||5
7589432|NCT02651688|18678379|P1|NOT COMPLETED|Overall Study||2
7589433|NCT02651688|18678377|P3|COMPLETED|Overall Study||12
7589434|NCT02651688|18678378|P2|COMPLETED|Overall Study||12
7589435|NCT02651688|18678379|P1|COMPLETED|Overall Study||16
7589436|NCT02651688|18678377|P3|STARTED|Overall Study||15
7589437|NCT02651688|18678378|P2|STARTED|Overall Study||17
7589438|NCT02651688|18678379|P1|STARTED|Overall Study||18
7589439|NCT02651584|18678446|P2|NOT COMPLETED|Overall Study||92
7589440|NCT02651584|18678447|P1|NOT COMPLETED|Overall Study||89
7589441|NCT02651584|18678446|P2|COMPLETED|Overall Study||121
7589442|NCT02651584|18678447|P1|COMPLETED|Overall Study||126
7589443|NCT02651584|18678446|P2|STARTED|Overall Study||213
7589444|NCT02651584|18678447|P1|STARTED|Overall Study||215
7589445|NCT02651467|18678462|P3|NOT COMPLETED|Overall Study||4
7589446|NCT02651467|18678463|P2|NOT COMPLETED|Overall Study||0
7589447|NCT02651467|18678464|P1|NOT COMPLETED|Overall Study||1
7589448|NCT02651467|18678462|P3|COMPLETED|Overall Study||69
7589449|NCT02651467|18678463|P2|COMPLETED|Overall Study||74
7589450|NCT02651467|18678464|P1|COMPLETED|Overall Study||73
7589451|NCT02651467|18678462|P3|STARTED|Overall Study||73
7589452|NCT02651467|18678463|P2|STARTED|Overall Study||74
7589453|NCT02651467|18678464|P1|STARTED|Overall Study||74
7589454|NCT02651415|18678483|P1|NOT COMPLETED|Overall Study||2
7589455|NCT02651415|18678483|P1|COMPLETED|Overall Study|10 patients were evaluable.|10
7589456|NCT02651415|18678483|P1|STARTED|Overall Study|12 patients were enrolled.|12
7589457|NCT02651337|18678492|P1|NOT COMPLETED|Overall Study||1
7589458|NCT02651337|18678492|P1|COMPLETED|Overall Study||4
7589459|NCT02651337|18678492|P1|STARTED|Overall Study||5
7589460|NCT02651272|18678496|P1|NOT COMPLETED|Overall Study||3
7589461|NCT02651272|18678496|P1|COMPLETED|Overall Study||1
7589462|NCT02651272|18678496|P1|STARTED|Overall Study||4
7589463|NCT02651259|18678513|P2|NOT COMPLETED|Overall Study||0
7589464|NCT02651259|18678514|P1|NOT COMPLETED|Overall Study||0
7589465|NCT02651259|18678513|P2|COMPLETED|Overall Study||25
7589466|NCT02651259|18678514|P1|COMPLETED|Overall Study||25
7589467|NCT02651259|18678513|P2|STARTED|Overall Study||25
7589468|NCT02651259|18678514|P1|STARTED|Overall Study||25
7589469|NCT02651220|18678558|P3|NOT COMPLETED|Overall Study||29
7589470|NCT02651220|18678559|P2|NOT COMPLETED|Overall Study||27
7589471|NCT02651220|18678560|P1|NOT COMPLETED|Overall Study||23
7589472|NCT02651220|18678558|P3|COMPLETED|Overall Study||300
7589473|NCT02651220|18678559|P2|COMPLETED|Overall Study||308
7589474|NCT02651220|18678560|P1|COMPLETED|Overall Study||314
7589475|NCT02651220|18678558|P3|STARTED|Overall Study||329
7589476|NCT02651220|18678559|P2|STARTED|Overall Study||335
7589477|NCT02651220|18678560|P1|STARTED|Overall Study||337
7589478|NCT02651194|18678574|P1|NOT COMPLETED|Overall Study||5
7589479|NCT02651194|18678574|P1|COMPLETED|Overall Study||99
7589480|NCT02651194|18678574|P1|STARTED|Overall Study||104
7589481|NCT02651155|18678582|P2|NOT COMPLETED|Overall Study||2
7589482|NCT02651155|18678583|P1|NOT COMPLETED|Overall Study||6
7589483|NCT02651155|18678582|P2|COMPLETED|Overall Study||103
7589484|NCT02651155|18678583|P1|COMPLETED|Overall Study||93
7589485|NCT02651155|18678582|P2|STARTED|Overall Study||105
7589486|NCT02651155|18678583|P1|STARTED|Overall Study||99
7589487|NCT02651103|18678599|P1|NOT COMPLETED|Overall Study||0
7589488|NCT02651103|18678599|P1|COMPLETED|Overall Study||30
7589489|NCT02651103|18678599|P1|STARTED|Overall Study||30
7589490|NCT02650999|18678603|P1|NOT COMPLETED|Overall Study||0
7589491|NCT02650999|18678603|P1|COMPLETED|Overall Study||12
7589492|NCT02650999|18678603|P1|STARTED|Overall Study||12
7589493|NCT02650921|18678608|P1|NOT COMPLETED|Overall Study||8
7589494|NCT02650921|18678608|P1|COMPLETED|Overall Study||84
7589495|NCT02650921|18678608|P1|STARTED|Overall Study||92
7589496|NCT02650895|18678662|P6|NOT COMPLETED|Overall Study||0
7589497|NCT02650895|18678663|P5|NOT COMPLETED|Overall Study||0
7589498|NCT02650895|18678664|P4|NOT COMPLETED|Overall Study||0
7589499|NCT02650895|18678665|P3|NOT COMPLETED|Overall Study||0
7589500|NCT02650895|18678666|P2|NOT COMPLETED|Overall Study||1
7589501|NCT02650895|18678667|P1|NOT COMPLETED|Overall Study||0
7589502|NCT02650895|18678662|P6|COMPLETED|Overall Study||6
7589503|NCT02650895|18678663|P5|COMPLETED|Overall Study||6
7589504|NCT02650895|18678664|P4|COMPLETED|Overall Study||6
7589505|NCT02650895|18678665|P3|COMPLETED|Overall Study||6
7589506|NCT02650895|18678666|P2|COMPLETED|Overall Study||5
7589507|NCT02650895|18678667|P1|COMPLETED|Overall Study||10
7589508|NCT02650895|18678662|P6|STARTED|Overall Study||6
7589509|NCT02650895|18678663|P5|STARTED|Overall Study||6
7589510|NCT02650895|18678664|P4|STARTED|Overall Study||6
7589511|NCT02650895|18678665|P3|STARTED|Overall Study||6
7589512|NCT02650895|18678666|P2|STARTED|Overall Study||6
7589513|NCT02650895|18678667|P1|STARTED|Overall Study||10
7589514|NCT02650856|18678703|P2|NOT COMPLETED|Overall Study||0
7589515|NCT02650856|18678704|P1|NOT COMPLETED|Overall Study||0
7589516|NCT02650856|18678703|P2|COMPLETED|Overall Study||21
7589517|NCT02650856|18678704|P1|COMPLETED|Overall Study||19
7589518|NCT02650856|18678703|P2|72 Hours|Overall Study||21
7589519|NCT02650856|18678704|P1|72 Hours|Overall Study||19
7589520|NCT02650856|18678703|P2|48 Hours|Overall Study||21
7589521|NCT02650856|18678704|P1|48 Hours|Overall Study||19
7589522|NCT02650856|18678703|P2|24 Hours|Overall Study||21
7589523|NCT02650856|18678704|P1|24 Hours|Overall Study||19
7589524|NCT02650856|18678703|P2|Baseline|Overall Study||21
7589525|NCT02650856|18678704|P1|Baseline|Overall Study||19
7589526|NCT02650856|18678703|P2|STARTED|Overall Study||21
7589527|NCT02650856|18678704|P1|STARTED|Overall Study||19
7589528|NCT02650466|18678714|P1|NOT COMPLETED|Overall Study||7
7589529|NCT02650466|18678714|P1|COMPLETED|Overall Study||17
7589530|NCT02650466|18678714|P1|STARTED|Overall Study||24
7589531|NCT02650440|18678722|P2|NOT COMPLETED|Overall Study||2
7589532|NCT02650440|18678723|P1|NOT COMPLETED|Overall Study||0
7589533|NCT02650440|18678722|P2|COMPLETED|Overall Study||8
7589534|NCT02650440|18678723|P1|COMPLETED|Overall Study||10
7589535|NCT02650440|18678722|P2|STARTED|Overall Study||10
7589536|NCT02650440|18678723|P1|STARTED|Overall Study||10
7589537|NCT02650219|18678741|P2|NOT COMPLETED|Overall Study||0
7589538|NCT02650219|18678742|P1|NOT COMPLETED|Overall Study||0
7589539|NCT02650219|18678741|P2|COMPLETED|Overall Study||20
7589540|NCT02650219|18678742|P1|COMPLETED|Overall Study||40
7589541|NCT02650219|18678741|P2|STARTED|Overall Study||20
7589542|NCT02650219|18678742|P1|STARTED|Overall Study||40
7589543|NCT02650193|18678755|P3|NOT COMPLETED|Overall Study||0
7589544|NCT02650193|18678756|P2|NOT COMPLETED|Overall Study||0
7589545|NCT02650193|18678757|P1|NOT COMPLETED|Overall Study||0
7589546|NCT02650193|18678755|P3|COMPLETED|Overall Study||13
7589547|NCT02650193|18678756|P2|COMPLETED|Overall Study||6
7589548|NCT02650193|18678757|P1|COMPLETED|Overall Study||6
7589549|NCT02650193|18678755|P3|STARTED|Overall Study||13
7589550|NCT02650193|18678756|P2|STARTED|Overall Study||6
7589551|NCT02650193|18678757|P1|STARTED|Overall Study||6
7589552|NCT02650128|18678844|P1|NOT COMPLETED|Overall Study||2
7589553|NCT02650128|18678844|P1|COMPLETED|Overall Study||58
7589554|NCT02650128|18678844|P1|30 Day Primary and Safety Endpoint|Overall Study||60
7589555|NCT02650128|18678844|P1|STARTED|Overall Study||60
7589556|NCT02649946|18678853|P2|NOT COMPLETED|Overall Study||15
7589557|NCT02649946|18678854|P1|NOT COMPLETED|Overall Study||12
7589558|NCT02649946|18678853|P2|COMPLETED|Overall Study||123
7589559|NCT02649946|18678854|P1|COMPLETED|Overall Study||130
7589560|NCT02649946|18678853|P2|STARTED|Overall Study||138
7589561|NCT02649946|18678854|P1|STARTED|Overall Study||142
7589562|NCT02649894|18678883|P2|NOT COMPLETED|Overall Study||11
7589563|NCT02649894|18678884|P1|NOT COMPLETED|Overall Study||44
7589564|NCT02649894|18678883|P2|COMPLETED|Overall Study||27
7589565|NCT02649894|18678884|P1|COMPLETED|Overall Study||37
7589566|NCT02649894|18678883|P2|Completed Day 30|Overall Study||35
7589567|NCT02649894|18678884|P1|Completed Day 30|Overall Study||56
7589568|NCT02649894|18678883|P2|Device Inserted|Overall Study||37
7589569|NCT02649894|18678884|P1|Device Inserted|Overall Study||77
7589570|NCT02649894|18678883|P2|STARTED|Overall Study||38
7589571|NCT02649894|18678884|P1|STARTED|Overall Study||81
7589572|NCT02649842|18678904|P1|NOT COMPLETED|Overall Study||0
7589573|NCT02649842|18678904|P1|COMPLETED|Overall Study||101
7589574|NCT02649842|18678904|P1|STARTED|Overall Study||101
7589575|NCT02649634|18678912|P2|NOT COMPLETED|Overall Study||6
7589576|NCT02649634|18678913|P1|NOT COMPLETED|Overall Study||3
7589577|NCT02649634|18678912|P2|COMPLETED|Overall Study||60
7589578|NCT02649634|18678913|P1|COMPLETED|Overall Study||66
7589579|NCT02649634|18678912|P2|STARTED|Overall Study||66
7589580|NCT02649634|18678913|P1|STARTED|Overall Study||69
7589581|NCT02649608|18678969|P7|NOT COMPLETED|Overall Study||0
7589582|NCT02649608|18678970|P6|NOT COMPLETED|Overall Study||0
7589583|NCT02649608|18678971|P5|NOT COMPLETED|Overall Study||0
7589584|NCT02649608|18678972|P4|NOT COMPLETED|Overall Study||0
7589585|NCT02649608|18678973|P3|NOT COMPLETED|Overall Study||0
7589586|NCT02649608|18678974|P2|NOT COMPLETED|Overall Study||0
7589587|NCT02649608|18678975|P1|NOT COMPLETED|Overall Study||0
7589588|NCT02649608|18678969|P7|COMPLETED|Overall Study||1
7589589|NCT02649608|18678970|P6|COMPLETED|Overall Study||2
7589590|NCT02649608|18678971|P5|COMPLETED|Overall Study||3
7589591|NCT02649608|18678972|P4|COMPLETED|Overall Study||3
7589592|NCT02649608|18678973|P3|COMPLETED|Overall Study||3
7589593|NCT02649608|18678974|P2|COMPLETED|Overall Study||1
7589594|NCT02649608|18678975|P1|COMPLETED|Overall Study||2
7589595|NCT02649608|18678969|P7|STARTED|Overall Study||1
7589596|NCT02649608|18678970|P6|STARTED|Overall Study||2
7589597|NCT02649608|18678971|P5|STARTED|Overall Study||3
7589598|NCT02649608|18678972|P4|STARTED|Overall Study||3
7589599|NCT02649608|18678973|P3|STARTED|Overall Study||3
7589600|NCT02649608|18678974|P2|STARTED|Overall Study||1
7589601|NCT02649608|18678975|P1|STARTED|Overall Study||2
7589602|NCT02649556|18679021|P4|NOT COMPLETED|Overall Study||23
7589603|NCT02649556|18679022|P3|NOT COMPLETED|Overall Study||50
7589604|NCT02649556|18679023|P2|NOT COMPLETED|Overall Study||112
7589605|NCT02649556|18679024|P1|NOT COMPLETED|Overall Study||63
7589606|NCT02649556|18679021|P4|COMPLETED|Overall Study||28
7589607|NCT02649556|18679022|P3|COMPLETED|Overall Study||102
7589608|NCT02649556|18679023|P2|COMPLETED|Overall Study||312
7589609|NCT02649556|18679024|P1|COMPLETED|Overall Study||167
7589610|NCT02649556|18679021|P4|STARTED|Overall Study||51
7589611|NCT02649556|18679022|P3|STARTED|Overall Study||152
7589612|NCT02649556|18679023|P2|STARTED|Overall Study||424
7589613|NCT02649556|18679024|P1|STARTED|Overall Study||230
7589614|NCT02649322|18679064|P2|NOT COMPLETED|Overall Study||0
7589615|NCT02649322|18679065|P1|NOT COMPLETED|Overall Study||0
7589616|NCT02649322|18679064|P2|COMPLETED|Overall Study||57
7589617|NCT02649322|18679065|P1|COMPLETED|Overall Study||58
7589618|NCT02649322|18679064|P2|STARTED|Overall Study||57
7589619|NCT02649322|18679065|P1|STARTED|Overall Study||58
7589620|NCT02649218|18679075|P1|NOT COMPLETED|Overall Study||25
7589621|NCT02649218|18679075|P1|COMPLETED|Overall Study||201
7589622|NCT02649218|18679075|P1|STARTED|Overall Study||226
7589623|NCT02649192|18679087|P6|NOT COMPLETED|Overall Study||0
7589624|NCT02649192|18679088|P5|NOT COMPLETED|Overall Study||1
7589625|NCT02649192|18679089|P4|NOT COMPLETED|Overall Study||2
7589626|NCT02649192|18679090|P3|NOT COMPLETED|Overall Study||1
7589627|NCT02649192|18679091|P2|NOT COMPLETED|Overall Study||0
7589628|NCT02649192|18679092|P1|NOT COMPLETED|Overall Study||0
7589629|NCT02649192|18679087|P6|COMPLETED|Overall Study||14
7589630|NCT02649192|18679088|P5|COMPLETED|Overall Study||11
7589631|NCT02649192|18679089|P4|COMPLETED|Overall Study||20
7589632|NCT02649192|18679090|P3|COMPLETED|Overall Study||21
7589633|NCT02649192|18679091|P2|COMPLETED|Overall Study||4
7589634|NCT02649192|18679092|P1|COMPLETED|Overall Study||5
7589635|NCT02649192|18679087|P6|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||6
7589636|NCT02649192|18679088|P5|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||5
7589637|NCT02649192|18679089|P4|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||10
7589638|NCT02649192|18679090|P3|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||11
7589639|NCT02649192|18679091|P2|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||2
7589640|NCT02649192|18679092|P1|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||3
7589641|NCT02649192|18679087|P6|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||8
7589642|NCT02649192|18679088|P5|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||7
7589643|NCT02649192|18679089|P4|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||12
7589644|NCT02649192|18679090|P3|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||11
7589645|NCT02649192|18679091|P2|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
7589646|NCT02649192|18679092|P1|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
7589647|NCT02649192|18679087|P6|STARTED|Overall Study||14
7589648|NCT02649192|18679088|P5|STARTED|Overall Study||12
7589649|NCT02649192|18679089|P4|STARTED|Overall Study||22
7589650|NCT02649192|18679090|P3|STARTED|Overall Study||22
7589651|NCT02649192|18679091|P2|STARTED|Overall Study||4
7589652|NCT02649192|18679092|P1|STARTED|Overall Study||5
7589653|NCT02648971|18679150|P2|NOT COMPLETED|Overall Study||0
7589654|NCT02648971|18679151|P1|NOT COMPLETED|Overall Study||0
7589655|NCT02648971|18679150|P2|COMPLETED|Overall Study||18
7589656|NCT02648971|18679151|P1|COMPLETED|Overall Study||18
7589657|NCT02648971|18679150|P2|STARTED|Overall Study||18
7589658|NCT02648971|18679151|P1|STARTED|Overall Study||18
7589659|NCT02648698|18679173|P2|NOT COMPLETED|Overall Study||5
7589660|NCT02648698|18679174|P1|NOT COMPLETED|Overall Study||1
7589661|NCT02648698|18679173|P2|COMPLETED|Overall Study||55
7589662|NCT02648698|18679174|P1|COMPLETED|Overall Study||59
7589663|NCT02648698|18679173|P2|STARTED|Overall Study||60
7589664|NCT02648698|18679174|P1|STARTED|Overall Study||60
7589665|NCT02648646|18679180|P1|NOT COMPLETED|Overall Study||2
7589666|NCT02648646|18679180|P1|COMPLETED|Overall Study||8
7589667|NCT02648646|18679180|P1|STARTED|Overall Study||10
7589668|NCT02648438|18679231|P3|NOT COMPLETED|Overall Study||0
7589669|NCT02648438|18679232|P2|NOT COMPLETED|Overall Study||3
7589670|NCT02648438|18679233|P1|NOT COMPLETED|Overall Study||3
7589671|NCT02648438|18679231|P3|COMPLETED|Overall Study||6
7589672|NCT02648438|18679232|P2|COMPLETED|Overall Study||9
7589673|NCT02648438|18679233|P1|COMPLETED|Overall Study||9
7589674|NCT02648438|18679231|P3|STARTED|Overall Study||6
7589675|NCT02648438|18679232|P2|STARTED|Overall Study||12
7589676|NCT02648438|18679233|P1|STARTED|Overall Study||12
7589677|NCT02648230|18679273|P1|NOT COMPLETED|Overall Study||0
7589678|NCT02648230|18679273|P1|COMPLETED|Overall Study||74
7589679|NCT02648230|18679273|P1|STARTED|Overall Study||74
7589680|NCT02648217|18679279|P2|NOT COMPLETED|Overall Study||5
7589681|NCT02648217|18679280|P1|NOT COMPLETED|Overall Study||10
7589682|NCT02648217|18679279|P2|COMPLETED|Overall Study||127
7589683|NCT02648217|18679280|P1|COMPLETED|Overall Study||121
7589684|NCT02648217|18679279|P2|Exposed|Overall Study||132
7589685|NCT02648217|18679280|P1|Exposed|Overall Study||130
7589686|NCT02648217|18679279|P2|STARTED|Overall Study||132
7589687|NCT02648217|18679280|P1|STARTED|Overall Study||131
7589688|NCT02648204|18679302|P4|NOT COMPLETED|Overall Study||16
7589689|NCT02648204|18679303|P3|NOT COMPLETED|Overall Study||13
7589690|NCT02648204|18679304|P2|NOT COMPLETED|Overall Study||21
7589691|NCT02648204|18679305|P1|NOT COMPLETED|Overall Study||22
7589692|NCT02648204|18679302|P4|COMPLETED|Overall Study||284
7589693|NCT02648204|18679303|P3|COMPLETED|Overall Study||287
7589694|NCT02648204|18679304|P2|COMPLETED|Overall Study||279
7589695|NCT02648204|18679305|P1|COMPLETED|Overall Study||279
7589696|NCT02648204|18679302|P4|Exposed|Overall Study||299
7589697|NCT02648204|18679303|P3|Exposed|Overall Study||299
7589698|NCT02648204|18679304|P2|Exposed|Overall Study||300
7589699|NCT02648204|18679305|P1|Exposed|Overall Study||301
7589700|NCT02648204|18679302|P4|STARTED|Overall Study||300
7589701|NCT02648204|18679303|P3|STARTED|Overall Study||300
7589702|NCT02648204|18679304|P2|STARTED|Overall Study||300
7589703|NCT02648204|18679305|P1|STARTED|Overall Study||301
7589704|NCT02648178|18679423|P1|NOT COMPLETED|Overall Study||9
7589705|NCT02648178|18679423|P1|COMPLETED|Overall Study||10
7589706|NCT02648178|18679423|P1|STARTED|Overall Study||19
7589707|NCT02648022|18679430|P2|NOT COMPLETED|Overall Study||0
7589708|NCT02648022|18679431|P1|NOT COMPLETED|Overall Study||0
7589709|NCT02648022|18679430|P2|COMPLETED|Overall Study||39
7589710|NCT02648022|18679431|P1|COMPLETED|Overall Study||40
7589711|NCT02648022|18679430|P2|STARTED|Overall Study||39
7589712|NCT02648022|18679431|P1|STARTED|Overall Study||40
7589713|NCT02647944|18679443|P2|NOT COMPLETED|Overall Study||3
7589714|NCT02647944|18679444|P1|NOT COMPLETED|Overall Study||2
7589715|NCT02647944|18679443|P2|COMPLETED|Overall Study||18
7589716|NCT02647944|18679444|P1|COMPLETED|Overall Study||17
7589717|NCT02647944|18679443|P2|STARTED|Overall Study||21
7589718|NCT02647944|18679444|P1|STARTED|Overall Study||19
7589719|NCT02647905|18679468|P1|NOT COMPLETED|Overall Study||3
7589720|NCT02647905|18679468|P1|COMPLETED|Overall Study||87
7589721|NCT02647905|18679468|P1|STARTED|Overall Study||90
7589722|NCT02647866|18679478|P5|NOT COMPLETED|Overall Study||8
7589723|NCT02647866|18679479|P4|NOT COMPLETED|Overall Study||6
7589724|NCT02647866|18679480|P3|NOT COMPLETED|Overall Study||5
7589725|NCT02647866|18679481|P2|NOT COMPLETED|Overall Study||4
7589726|NCT02647866|18679482|P1|NOT COMPLETED|Overall Study||5
7589727|NCT02647866|18679478|P5|COMPLETED|Overall Study||9
7589728|NCT02647866|18679479|P4|COMPLETED|Overall Study||15
7589729|NCT02647866|18679480|P3|COMPLETED|Overall Study||4
7589730|NCT02647866|18679481|P2|COMPLETED|Overall Study||6
7589731|NCT02647866|18679482|P1|COMPLETED|Overall Study||4
7589732|NCT02647866|18679478|P5|Discontinued the Study|Overall Study||8
7589733|NCT02647866|18679479|P4|Discontinued the Study|Overall Study||6
7589734|NCT02647866|18679480|P3|Discontinued the Study|Overall Study||5
7589735|NCT02647866|18679481|P2|Discontinued the Study|Overall Study||4
7589736|NCT02647866|18679482|P1|Discontinued the Study|Overall Study||5
7589737|NCT02647866|18679478|P5|Discontinued the Treatment|Overall Study||8
7589738|NCT02647866|18679479|P4|Discontinued the Treatment|Overall Study||5
7589739|NCT02647866|18679480|P3|Discontinued the Treatment|Overall Study||5
7589740|NCT02647866|18679481|P2|Discontinued the Treatment|Overall Study||5
7589741|NCT02647866|18679482|P1|Discontinued the Treatment|Overall Study||4
7589742|NCT02647866|18679478|P5|Moved From LTE to OLE Therapy|Overall Study||2
7589743|NCT02647866|18679479|P4|Moved From LTE to OLE Therapy|Overall Study||0
7589744|NCT02647866|18679480|P3|Moved From LTE to OLE Therapy|Overall Study||0
7589745|NCT02647866|18679481|P2|Moved From LTE to OLE Therapy|Overall Study||5
7589746|NCT02647866|18679482|P1|Moved From LTE to OLE Therapy|Overall Study||0
7589747|NCT02647866|18679478|P5|Completed OLE Follow-up|Overall Study||10
7589748|NCT02647866|18679479|P4|Completed OLE Follow-up|Overall Study||14
7589749|NCT02647866|18679480|P3|Completed OLE Follow-up|Overall Study||4
7589750|NCT02647866|18679481|P2|Completed OLE Follow-up|Overall Study||6
7589751|NCT02647866|18679482|P1|Completed OLE Follow-up|Overall Study||0
7589752|NCT02647866|18679478|P5|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|13
7589753|NCT02647866|18679479|P4|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|17
7589754|NCT02647866|18679480|P3|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|4
7589755|NCT02647866|18679481|P2|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy.|7
7589756|NCT02647866|18679482|P1|Completed Open-Label Extension Therapy|Overall Study||0
7589757|NCT02647866|18679478|P5|Completed LTE Follow-up|Overall Study||0
7589758|NCT02647866|18679479|P4|Completed LTE Follow-up|Overall Study||0
7589759|NCT02647866|18679480|P3|Completed LTE Follow-up|Overall Study||0
7589760|NCT02647866|18679481|P2|Completed LTE Follow-up|Overall Study||0
7589761|NCT02647866|18679482|P1|Completed LTE Follow-up|Overall Study||2
7589762|NCT02647866|18679478|P5|Completed Long-Term Extension Therapy|Overall Study||0
7589763|NCT02647866|18679479|P4|Completed Long-Term Extension Therapy|Overall Study||0
7589764|NCT02647866|18679480|P3|Completed Long-Term Extension Therapy|Overall Study||0
7589765|NCT02647866|18679481|P2|Completed Long-Term Extension Therapy|Overall Study||0
7589766|NCT02647866|18679482|P1|Completed Long-Term Extension Therapy|Overall Study|10 add'l treatments of KHK4083 (same dose as Induction Therapy) as maintenance therapy.|3
7589767|NCT02647866|18679478|P5|Completed Induction Therapy Follow-Up|Overall Study||2
7589768|NCT02647866|18679479|P4|Completed Induction Therapy Follow-Up|Overall Study||0
7589769|NCT02647866|18679480|P3|Completed Induction Therapy Follow-Up|Overall Study||2
7589770|NCT02647866|18679481|P2|Completed Induction Therapy Follow-Up|Overall Study||1
7589771|NCT02647866|18679482|P1|Completed Induction Therapy Follow-Up|Overall Study||5
7589772|NCT02647866|18679478|P5|Completed Induction Therapy|Overall Study|Subjects received Placebo for 12 weeks|17
7589773|NCT02647866|18679479|P4|Completed Induction Therapy|Overall Study|Subjects received the maximum tolerated dose of KHK4083 10.0 mg/kg for 12 weeks|19
7589774|NCT02647866|18679480|P3|Completed Induction Therapy|Overall Study|Subjects received KHK4083 10.0 mg/kg for 12 weeks|8
7589775|NCT02647866|18679481|P2|Completed Induction Therapy|Overall Study|Subjects received KHK4083 3.0 mg/kg for 12 weeks|9
7589776|NCT02647866|18679482|P1|Completed Induction Therapy|Overall Study|Subjects received KHK4083 1.0 mg/kg for 12 weeks|8
7589777|NCT02647866|18679478|P5|STARTED|Overall Study||17
7589778|NCT02647866|18679479|P4|STARTED|Overall Study||21
7589779|NCT02647866|18679480|P3|STARTED|Overall Study||9
7589780|NCT02647866|18679481|P2|STARTED|Overall Study||10
7589781|NCT02647866|18679482|P1|STARTED|Overall Study||9
7589782|NCT02647788|18679559|P2|NOT COMPLETED|Overall Study||13
7589783|NCT02647788|18679560|P1|NOT COMPLETED|Overall Study||16
7589784|NCT02647788|18679559|P2|COMPLETED|Overall Study||57
7589785|NCT02647788|18679560|P1|COMPLETED|Overall Study||54
7589786|NCT02647788|18679559|P2|STARTED|Overall Study||70
7589787|NCT02647788|18679560|P1|STARTED|Overall Study||70
7589788|NCT02647658|18679572|P2|NOT COMPLETED|Overall Study||24
7589789|NCT02647658|18679573|P1|NOT COMPLETED|Overall Study||15
7589790|NCT02647658|18679572|P2|COMPLETED|Overall Study||1069
7589791|NCT02647658|18679573|P1|COMPLETED|Overall Study||1192
7589792|NCT02647658|18679572|P2|6 Month Assessment|Overall Study||635
7589793|NCT02647658|18679573|P1|6 Month Assessment|Overall Study||658
7589794|NCT02647658|18679572|P2|STARTED|Overall Study||1093
7589795|NCT02647658|18679573|P1|STARTED|Overall Study||1207
7589796|NCT02647645|18679601|P2|NOT COMPLETED|Overall Study||1
7589797|NCT02647645|18679602|P1|NOT COMPLETED|Overall Study||2
7589798|NCT02647645|18679601|P2|COMPLETED|Overall Study||9
7589799|NCT02647645|18679602|P1|COMPLETED|Overall Study||9
7589800|NCT02647645|18679601|P2|STARTED|Overall Study||10
7589801|NCT02647645|18679602|P1|STARTED|Overall Study||11
7589802|NCT02647346|18679612|P1|NOT COMPLETED|Overall Study||3
7589803|NCT02647346|18679612|P1|COMPLETED|Overall Study||129
7589804|NCT02647346|18679612|P1|STARTED|Overall Study||132
7589805|NCT02647320|18679624|P5|NOT COMPLETED|Overall Study||17
7589806|NCT02647320|18679625|P4|NOT COMPLETED|Overall Study||10
7589807|NCT02647320|18679626|P3|NOT COMPLETED|Overall Study||15
7589808|NCT02647320|18679627|P2|NOT COMPLETED|Overall Study||11
7589809|NCT02647320|18679628|P1|NOT COMPLETED|Overall Study||12
7589810|NCT02647320|18679624|P5|COMPLETED|Overall Study||52
7589811|NCT02647320|18679625|P4|COMPLETED|Overall Study||58
7589812|NCT02647320|18679626|P3|COMPLETED|Overall Study||54
7589813|NCT02647320|18679627|P2|COMPLETED|Overall Study||35
7589814|NCT02647320|18679628|P1|COMPLETED|Overall Study||34
7589815|NCT02647320|18679624|P5|Modified Intent-to-Treat Set (mITT)|Overall Study||62
7589816|NCT02647320|18679625|P4|Modified Intent-to-Treat Set (mITT)|Overall Study||62
7589817|NCT02647320|18679626|P3|Modified Intent-to-Treat Set (mITT)|Overall Study||61
7589818|NCT02647320|18679627|P2|Modified Intent-to-Treat Set (mITT)|Overall Study||38
7589819|NCT02647320|18679628|P1|Modified Intent-to-Treat Set (mITT)|Overall Study||40
7589820|NCT02647320|18679624|P5|Safety Set|Overall Study||69
7589821|NCT02647320|18679625|P4|Safety Set|Overall Study||68
7589822|NCT02647320|18679626|P3|Safety Set|Overall Study||68
7589823|NCT02647320|18679627|P2|Safety Set|Overall Study||44
7589824|NCT02647320|18679628|P1|Safety Set|Overall Study||43
7589825|NCT02647320|18679624|P5|Inadvertently Randomized|Overall Study||0
7589826|NCT02647320|18679625|P4|Inadvertently Randomized|Overall Study||1
7589827|NCT02647320|18679626|P3|Inadvertently Randomized|Overall Study||0
7589828|NCT02647320|18679627|P2|Inadvertently Randomized|Overall Study||0
7589829|NCT02647320|18679628|P1|Inadvertently Randomized|Overall Study||0
7589830|NCT02647320|18679624|P5|STARTED|Overall Study||69
7589831|NCT02647320|18679625|P4|STARTED|Overall Study||68
7589832|NCT02647320|18679626|P3|STARTED|Overall Study||69
7589833|NCT02647320|18679627|P2|STARTED|Overall Study||46
7589834|NCT02647320|18679628|P1|STARTED|Overall Study||46
7589835|NCT02647281|18679719|P9|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||1
7589836|NCT02647281|18679720|P8|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
7589837|NCT02647281|18679721|P7|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
7589838|NCT02647281|18679722|P6|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
7589839|NCT02647281|18679723|P5|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
7589840|NCT02647281|18679724|P4|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
7589841|NCT02647281|18679725|P3|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
7589842|NCT02647281|18679726|P2|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
7589843|NCT02647281|18679727|P1|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
7589844|NCT02647281|18679719|P9|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||5
7589845|NCT02647281|18679720|P8|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
7589846|NCT02647281|18679721|P7|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
7589847|NCT02647281|18679722|P6|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
7589848|NCT02647281|18679723|P5|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
7589849|NCT02647281|18679724|P4|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
7589850|NCT02647281|18679725|P3|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
7589851|NCT02647281|18679726|P2|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
7589852|NCT02647281|18679727|P1|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
7589853|NCT02647281|18679719|P9|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
7589854|NCT02647281|18679720|P8|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
7589855|NCT02647281|18679721|P7|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
7589856|NCT02647281|18679722|P6|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
7589857|NCT02647281|18679723|P5|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
7589858|NCT02647281|18679724|P4|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
7589859|NCT02647281|18679725|P3|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
7589860|NCT02647281|18679726|P2|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
7589861|NCT02647281|18679727|P1|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
7589862|NCT02647281|18679719|P9|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
7589863|NCT02647281|18679720|P8|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
7589864|NCT02647281|18679721|P7|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
7589865|NCT02647281|18679722|P6|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
7589866|NCT02647281|18679723|P5|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
7589867|NCT02647281|18679724|P4|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
7589868|NCT02647281|18679725|P3|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
7589869|NCT02647281|18679726|P2|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
7589870|NCT02647281|18679727|P1|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
7589871|NCT02647281|18679719|P9|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
7589872|NCT02647281|18679720|P8|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
7589873|NCT02647281|18679721|P7|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
7589874|NCT02647281|18679722|P6|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
7589875|NCT02647281|18679723|P5|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
7589876|NCT02647281|18679724|P4|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
7589877|NCT02647281|18679725|P3|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
7589878|NCT02647281|18679726|P2|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
7589879|NCT02647281|18679727|P1|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||8
7589880|NCT02647281|18679719|P9|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
7589881|NCT02647281|18679720|P8|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
7589882|NCT02647281|18679721|P7|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
7589883|NCT02647281|18679722|P6|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
7589884|NCT02647281|18679723|P5|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
7589885|NCT02647281|18679724|P4|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
7589886|NCT02647281|18679725|P3|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
7589887|NCT02647281|18679726|P2|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
7589888|NCT02647281|18679727|P1|STARTED|Single-Ascending Dose(Part 1-62 Days)||8
7589889|NCT02646891|18679915|P10|NOT COMPLETED|Overall Study||5
7589890|NCT02646891|18679916|P9|NOT COMPLETED|Overall Study||10
7589891|NCT02646891|18679917|P8|NOT COMPLETED|Overall Study||13
7589892|NCT02646891|18679918|P7|NOT COMPLETED|Overall Study||9
7589893|NCT02646891|18679919|P6|NOT COMPLETED|Overall Study||0
7589894|NCT02646891|18679920|P5|NOT COMPLETED|Overall Study||0
7589895|NCT02646891|18679921|P4|NOT COMPLETED|Overall Study||0
7589896|NCT02646891|18679922|P3|NOT COMPLETED|Overall Study||1
7589897|NCT02646891|18679923|P2|NOT COMPLETED|Overall Study||1
7589898|NCT02646891|18679924|P1|NOT COMPLETED|Overall Study||2
7589899|NCT02646891|18679915|P10|COMPLETED|Overall Study||134
7589900|NCT02646891|18679916|P9|COMPLETED|Overall Study||130
7589901|NCT02646891|18679917|P8|COMPLETED|Overall Study||127
7589902|NCT02646891|18679918|P7|COMPLETED|Overall Study||130
7589903|NCT02646891|18679919|P6|COMPLETED|Overall Study||12
7589904|NCT02646891|18679920|P5|COMPLETED|Overall Study||12
7589905|NCT02646891|18679921|P4|COMPLETED|Overall Study||6
7589906|NCT02646891|18679922|P3|COMPLETED|Overall Study||11
7589907|NCT02646891|18679923|P2|COMPLETED|Overall Study||11
7589908|NCT02646891|18679924|P1|COMPLETED|Overall Study||4
7589909|NCT02646891|18679915|P10|Received at Least 1 Dose|Overall Study||139
7589910|NCT02646891|18679916|P9|Received at Least 1 Dose|Overall Study||140
7589911|NCT02646891|18679917|P8|Received at Least 1 Dose|Overall Study|One participant was randomized but determined to be ineligible pre-vaccination.|139
7589912|NCT02646891|18679918|P7|Received at Least 1 Dose|Overall Study||139
7589913|NCT02646891|18679919|P6|Received at Least 1 Dose|Overall Study||12
7589914|NCT02646891|18679920|P5|Received at Least 1 Dose|Overall Study||12
7589915|NCT02646891|18679921|P4|Received at Least 1 Dose|Overall Study||6
7589916|NCT02646891|18679922|P3|Received at Least 1 Dose|Overall Study||12
7589917|NCT02646891|18679923|P2|Received at Least 1 Dose|Overall Study||12
7589918|NCT02646891|18679924|P1|Received at Least 1 Dose|Overall Study||6
7589919|NCT02646891|18679915|P10|STARTED|Overall Study||139
7589920|NCT02646891|18679916|P9|STARTED|Overall Study||140
7589921|NCT02646891|18679917|P8|STARTED|Overall Study||140
7589922|NCT02646891|18679918|P7|STARTED|Overall Study||139
7589923|NCT02646891|18679919|P6|STARTED|Overall Study||12
7589924|NCT02646891|18679920|P5|STARTED|Overall Study||12
7589925|NCT02646891|18679921|P4|STARTED|Overall Study||6
7589926|NCT02646891|18679922|P3|STARTED|Overall Study||12
7589927|NCT02646891|18679923|P2|STARTED|Overall Study||12
7589928|NCT02646891|18679924|P1|STARTED|Overall Study||6
7589929|NCT02646826|18680052|P4|NOT COMPLETED|Overall Study||1
7589930|NCT02646826|18680053|P3|NOT COMPLETED|Overall Study||1
7589931|NCT02646826|18680054|P2|NOT COMPLETED|Overall Study||0
7589932|NCT02646826|18680055|P1|NOT COMPLETED|Overall Study||2
7589933|NCT02646826|18680052|P4|COMPLETED|Overall Study||21
7589934|NCT02646826|18680053|P3|COMPLETED|Overall Study||20
7589935|NCT02646826|18680054|P2|COMPLETED|Overall Study||22
7589936|NCT02646826|18680055|P1|COMPLETED|Overall Study||19
7589937|NCT02646826|18680052|P4|STARTED|Overall Study||22
7589938|NCT02646826|18680053|P3|STARTED|Overall Study||21
7589939|NCT02646826|18680054|P2|STARTED|Overall Study||22
7589940|NCT02646826|18680055|P1|STARTED|Overall Study||21
7589941|NCT02646761|18680079|P2|NOT COMPLETED|Overall Study||10
7589942|NCT02646761|18680080|P1|NOT COMPLETED|Overall Study||8
7589943|NCT02646761|18680079|P2|COMPLETED|Overall Study||10
7589944|NCT02646761|18680080|P1|COMPLETED|Overall Study||10
7589945|NCT02646761|18680079|P2|5-week Assessment|Overall Study||10
7589946|NCT02646761|18680080|P1|5-week Assessment|Overall Study||12
7589947|NCT02646761|18680079|P2|Baseline Assessment|Overall Study||12
7589948|NCT02646761|18680080|P1|Baseline Assessment|Overall Study||13
7589949|NCT02646761|18680079|P2|Subject Withdrew Before Baseline|Overall Study||8
7589950|NCT02646761|18680080|P1|Subject Withdrew Before Baseline|Overall Study||5
7589951|NCT02646761|18680079|P2|STARTED|Overall Study||20
7589952|NCT02646761|18680080|P1|STARTED|Overall Study||18
7589953|NCT02646566|18680098|P3|NOT COMPLETED|Overall Study||5
7589954|NCT02646566|18680099|P2|NOT COMPLETED|Overall Study||4
7589955|NCT02646566|18680100|P1|NOT COMPLETED|Overall Study||6
7589956|NCT02646566|18680098|P3|COMPLETED|Overall Study||230
7589957|NCT02646566|18680099|P2|COMPLETED|Overall Study||226
7589958|NCT02646566|18680100|P1|COMPLETED|Overall Study||231
7589959|NCT02646566|18680098|P3|STARTED|Overall Study||235
7589960|NCT02646566|18680099|P2|STARTED|Overall Study||230
7589961|NCT02646566|18680100|P1|STARTED|Overall Study||237
7589962|NCT02646449|18680140|P2|NOT COMPLETED|Overall Study||0
7589963|NCT02646449|18680141|P1|NOT COMPLETED|Overall Study||0
7589964|NCT02646449|18680140|P2|COMPLETED|Overall Study||3
7589965|NCT02646449|18680141|P1|COMPLETED|Overall Study||4
7589966|NCT02646449|18680140|P2|STARTED|Overall Study||3
7589967|NCT02646449|18680141|P1|STARTED|Overall Study||4
7589968|NCT02646332|18680151|P2|NOT COMPLETED|Overall Study||3
7589969|NCT02646332|18680152|P1|NOT COMPLETED|Overall Study||0
7589970|NCT02646332|18680151|P2|COMPLETED|Overall Study||121
7589971|NCT02646332|18680152|P1|COMPLETED|Overall Study||124
7589972|NCT02646332|18680151|P2|STARTED|Overall Study||124
7589973|NCT02646332|18680152|P1|STARTED|Overall Study||124
7589974|NCT02646124|18680160|P2|NOT COMPLETED|Overall Study||2
7589975|NCT02646124|18680161|P1|NOT COMPLETED|Overall Study||0
7589976|NCT02646124|18680160|P2|COMPLETED|Overall Study||55
7589977|NCT02646124|18680161|P1|COMPLETED|Overall Study||57
7589978|NCT02646124|18680160|P2|STARTED|Overall Study||57
7589979|NCT02646124|18680161|P1|STARTED|Overall Study||57
7589980|NCT02645760|18680177|P2|NOT COMPLETED|Overall Study||0
7589981|NCT02645760|18680178|P1|NOT COMPLETED|Overall Study||0
7589982|NCT02645760|18680177|P2|COMPLETED|Overall Study||19
7589983|NCT02645760|18680178|P1|COMPLETED|Overall Study||19
7589984|NCT02645760|18680177|P2|STARTED|Overall Study||19
7589985|NCT02645760|18680178|P1|STARTED|Overall Study||19
7589986|NCT02645617|18680190|P1|NOT COMPLETED|Overall Study||0
7589987|NCT02645617|18680190|P1|COMPLETED|Overall Study||12
7589988|NCT02645617|18680190|P1|STARTED|Overall Study||12
7589989|NCT02645409|18680197|P2|NOT COMPLETED|Overall Study||0
7589990|NCT02645409|18680198|P1|NOT COMPLETED|Overall Study||4
7589991|NCT02645409|18680197|P2|COMPLETED|Overall Study||0
7589992|NCT02645409|18680198|P1|COMPLETED|Overall Study||10
7589993|NCT02645409|18680197|P2|STARTED|Overall Study|It was decided to not continue with the Radical Nephrectomy arm of the study.|0
7589994|NCT02645409|18680198|P1|STARTED|Overall Study||14
7589995|NCT02645253|18680207|P4|NOT COMPLETED|Overall Study||0
7589996|NCT02645253|18680208|P3|NOT COMPLETED|Overall Study||0
7589997|NCT02645253|18680209|P2|NOT COMPLETED|Overall Study||0
7589998|NCT02645253|18680210|P1|NOT COMPLETED|Overall Study||0
7589999|NCT02645253|18680207|P4|COMPLETED|Overall Study||6
7590000|NCT02645253|18680208|P3|COMPLETED|Overall Study||7
7590001|NCT02645253|18680209|P2|COMPLETED|Overall Study||7
7590002|NCT02645253|18680210|P1|COMPLETED|Overall Study||7
7590003|NCT02645253|18680207|P4|STARTED|Overall Study||6
7590004|NCT02645253|18680208|P3|STARTED|Overall Study||7
7590005|NCT02645253|18680209|P2|STARTED|Overall Study||7
7590006|NCT02645253|18680210|P1|STARTED|Overall Study||7
7590007|NCT02645123|18680332|P3|NOT COMPLETED|Overall Study||0
7590008|NCT02645123|18680333|P2|NOT COMPLETED|Overall Study||0
7590009|NCT02645123|18680334|P1|NOT COMPLETED|Overall Study||0
7590010|NCT02645123|18680332|P3|COMPLETED|Overall Study||25
7590011|NCT02645123|18680333|P2|COMPLETED|Overall Study||25
7590012|NCT02645123|18680334|P1|COMPLETED|Overall Study||25
7590013|NCT02645123|18680332|P3|STARTED|Overall Study||25
7590014|NCT02645123|18680333|P2|STARTED|Overall Study||25
7590015|NCT02645123|18680334|P1|STARTED|Overall Study||25
7590016|NCT02645019|18680356|P5|NOT COMPLETED|Overall Study||0
7590017|NCT02645019|18680357|P4|NOT COMPLETED|Overall Study||0
7590018|NCT02645019|18680358|P3|NOT COMPLETED|Overall Study||0
7590019|NCT02645019|18680359|P2|NOT COMPLETED|Overall Study||0
7590020|NCT02645019|18680360|P1|NOT COMPLETED|Overall Study||0
7590021|NCT02645019|18680356|P5|COMPLETED|Overall Study||24
7590022|NCT02645019|18680357|P4|COMPLETED|Overall Study||33
7590023|NCT02645019|18680358|P3|COMPLETED|Overall Study||15
7590024|NCT02645019|18680359|P2|COMPLETED|Overall Study||15
7590025|NCT02645019|18680360|P1|COMPLETED|Overall Study||13
7590026|NCT02645019|18680356|P5|STARTED|Overall Study||24
7590027|NCT02645019|18680357|P4|STARTED|Overall Study||33
7590028|NCT02645019|18680358|P3|STARTED|Overall Study||15
7590029|NCT02645019|18680359|P2|STARTED|Overall Study||15
7590030|NCT02645019|18680360|P1|STARTED|Overall Study||13
7590031|NCT02644668|18680385|P3|NOT COMPLETED|Overall Study||3
7590032|NCT02644668|18680386|P2|NOT COMPLETED|Overall Study||0
7590033|NCT02644668|18680387|P1|NOT COMPLETED|Overall Study||2
7590034|NCT02644668|18680385|P3|COMPLETED|Overall Study||17
7590035|NCT02644668|18680386|P2|COMPLETED|Overall Study||24
7590036|NCT02644668|18680387|P1|COMPLETED|Overall Study||24
7590037|NCT02644668|18680385|P3|STARTED|Overall Study||20
7590038|NCT02644668|18680386|P2|STARTED|Overall Study||24
7590039|NCT02644668|18680387|P1|STARTED|Overall Study||26
7590040|NCT02644356|18680426|P1|NOT COMPLETED|Overall Study||2
7590041|NCT02644356|18680426|P1|COMPLETED|Overall Study|49 of the 51 consented subjects completed pre-post knowledge testing (96%)|49
7590042|NCT02644356|18680426|P1|STARTED|Overall Study||51
7590043|NCT02644343|18680436|P1|NOT COMPLETED|Overall Study||1
7590044|NCT02644343|18680436|P1|COMPLETED|Overall Study||39
7590045|NCT02644343|18680436|P1|STARTED|Overall Study||40
7590046|NCT02644278|18680444|P4|NOT COMPLETED|Overall Study||0
7590047|NCT02644278|18680445|P3|NOT COMPLETED|Overall Study||0
7590048|NCT02644278|18680446|P2|NOT COMPLETED|Overall Study||0
7590049|NCT02644278|18680447|P1|NOT COMPLETED|Overall Study||0
7590050|NCT02644278|18680444|P4|COMPLETED|Overall Study||3
7590051|NCT02644278|18680445|P3|COMPLETED|Overall Study||6
7590052|NCT02644278|18680446|P2|COMPLETED|Overall Study||3
7590053|NCT02644278|18680447|P1|COMPLETED|Overall Study||3
7590054|NCT02644278|18680444|P4|STARTED|Overall Study||3
7590055|NCT02644278|18680445|P3|STARTED|Overall Study||6
7590056|NCT02644278|18680446|P2|STARTED|Overall Study||3
7590057|NCT02644278|18680447|P1|STARTED|Overall Study||3
7590058|NCT02644122|18680513|P1|NOT COMPLETED|Overall Study||1
7590059|NCT02644122|18680513|P1|COMPLETED|Overall Study||0
7590060|NCT02644122|18680513|P1|STARTED|Overall Study||1
7590061|NCT02644109|18680523|P2|NOT COMPLETED|Overall Study||4
7590062|NCT02644109|18680524|P1|NOT COMPLETED|Overall Study||0
7590063|NCT02644109|18680523|P2|COMPLETED|Overall Study||24
7590064|NCT02644109|18680524|P1|COMPLETED|Overall Study||24
7590065|NCT02644109|18680523|P2|STARTED|Overall Study||28
7590066|NCT02644109|18680524|P1|STARTED|Overall Study||24
7590067|NCT02644096|18680532|P2|NOT COMPLETED|Overall Study||25
7590068|NCT02644096|18680533|P1|NOT COMPLETED|Overall Study||28
7590069|NCT02644096|18680532|P2|COMPLETED|Overall Study||57
7590070|NCT02644096|18680533|P1|COMPLETED|Overall Study||65
7590071|NCT02644096|18680532|P2|9 Month SF-36 Questionnaire|Overall Study||57
7590072|NCT02644096|18680533|P1|9 Month SF-36 Questionnaire|Overall Study||65
7590073|NCT02644096|18680532|P2|12 Week SF-36 Questionnaire|Overall Study||59
7590074|NCT02644096|18680533|P1|12 Week SF-36 Questionnaire|Overall Study||68
7590075|NCT02644096|18680532|P2|10 Week Interview|Overall Study||59
7590076|NCT02644096|18680533|P1|10 Week Interview|Overall Study|Not done in control group|0
7590077|NCT02644096|18680532|P2|2 Week Interview|Overall Study||68
7590078|NCT02644096|18680533|P1|2 Week Interview|Overall Study|Not done in control group|0
7590079|NCT02644096|18680532|P2|STARTED|Overall Study||82
7590080|NCT02644096|18680533|P1|STARTED|Overall Study||93
7590081|NCT02643979|18680541|P2|NOT COMPLETED|Overall Study||0
7590082|NCT02643979|18680542|P1|NOT COMPLETED|Overall Study||0
7590083|NCT02643979|18680541|P2|COMPLETED|Overall Study||11
7590084|NCT02643979|18680542|P1|COMPLETED|Overall Study||11
7590085|NCT02643979|18680541|P2|STARTED|Overall Study||11
7590086|NCT02643979|18680542|P1|STARTED|Overall Study||11
7590087|NCT02643875|18680560|P1|NOT COMPLETED|Overall Study||8
7590088|NCT02643875|18680560|P1|COMPLETED|Overall Study||28
7590089|NCT02643875|18680560|P1|Received 1.75 D|Overall Study||36
7590090|NCT02643875|18680560|P1|Received 0.75|Overall Study||36
7590091|NCT02643875|18680560|P1|STARTED|Overall Study||36
7590092|NCT02643862|18680569|P2|NOT COMPLETED|Overall Study||0
7590093|NCT02643862|18680570|P1|NOT COMPLETED|Overall Study||0
7590094|NCT02643862|18680569|P2|COMPLETED|Overall Study||12
7590095|NCT02643862|18680570|P1|COMPLETED|Overall Study||36
7590096|NCT02643862|18680569|P2|STARTED|Overall Study||12
7590097|NCT02643862|18680570|P1|STARTED|Overall Study||36
7590098|NCT02643849|18680578|P1|NOT COMPLETED|Overall Study||25
7590099|NCT02643849|18680578|P1|COMPLETED|Overall Study||82
7590100|NCT02643849|18680578|P1|STARTED|Overall Study||107
7590101|NCT02643693|18680585|P6|NOT COMPLETED|Overall Study||1
7590102|NCT02643693|18680586|P5|NOT COMPLETED|Overall Study||0
7590103|NCT02643693|18680587|P4|NOT COMPLETED|Overall Study||0
7590104|NCT02643693|18680588|P3|NOT COMPLETED|Overall Study||1
7590105|NCT02643693|18680589|P2|NOT COMPLETED|Overall Study||2
7590106|NCT02643693|18680590|P1|NOT COMPLETED|Overall Study||2
7590107|NCT02643693|18680585|P6|COMPLETED|Overall Study||3
7590108|NCT02643693|18680586|P5|COMPLETED|Overall Study||4
7590109|NCT02643693|18680587|P4|COMPLETED|Overall Study||4
7590110|NCT02643693|18680588|P3|COMPLETED|Overall Study||3
7590111|NCT02643693|18680589|P2|COMPLETED|Overall Study||2
7590112|NCT02643693|18680590|P1|COMPLETED|Overall Study||2
7590113|NCT02643693|18680585|P6|STARTED|Overall Study||4
7590114|NCT02643693|18680586|P5|STARTED|Overall Study||4
7590115|NCT02643693|18680587|P4|STARTED|Overall Study||4
7590116|NCT02643693|18680588|P3|STARTED|Overall Study||4
7590117|NCT02643693|18680589|P2|STARTED|Overall Study||4
7590118|NCT02643693|18680590|P1|STARTED|Overall Study||4
7590119|NCT02643628|18680603|P2|NOT COMPLETED|Overall Study||6
7590120|NCT02643628|18680604|P1|NOT COMPLETED|Overall Study||1
7590121|NCT02643628|18680603|P2|COMPLETED|Overall Study||17
7590122|NCT02643628|18680604|P1|COMPLETED|Overall Study||20
7590123|NCT02643628|18680603|P2|STARTED|Overall Study||23
7590124|NCT02643628|18680604|P1|STARTED|Overall Study||21
7590125|NCT02643615|18680620|P2|NOT COMPLETED|Overall Study||0
7590126|NCT02643615|18680621|P1|NOT COMPLETED|Overall Study||0
7590127|NCT02643615|18680620|P2|COMPLETED|Overall Study||11
7590128|NCT02643615|18680621|P1|COMPLETED|Overall Study||9
7590129|NCT02643615|18680620|P2|STARTED|Overall Study||11
7590130|NCT02643615|18680621|P1|STARTED|Overall Study||9
7590131|NCT02643472|18680635|P2|NOT COMPLETED|Overall Study||34
7590132|NCT02643472|18680636|P1|NOT COMPLETED|Overall Study||27
7590133|NCT02643472|18680635|P2|COMPLETED|Overall Study|One participant completed CESD-10 but not other measures at 12 months; n=115 for other measures.|116
7590134|NCT02643472|18680636|P1|COMPLETED|Overall Study||123
7590135|NCT02643472|18680635|P2|STARTED|Overall Study||150
7590136|NCT02643472|18680636|P1|STARTED|Overall Study||150
7590137|NCT02643394|18680662|P2|NOT COMPLETED|Overall Study||5
7590138|NCT02643394|18680663|P1|NOT COMPLETED|Overall Study||4
7590139|NCT02643394|18680662|P2|COMPLETED|Overall Study||50
7590140|NCT02643394|18680663|P1|COMPLETED|Overall Study||51
7590141|NCT02643394|18680662|P2|STARTED|Overall Study||55
7590142|NCT02643394|18680663|P1|STARTED|Overall Study||55
7590143|NCT02643355|18680673|P2|NOT COMPLETED|Overall Study||5
7590144|NCT02643355|18680674|P1|NOT COMPLETED|Overall Study||1
7590145|NCT02643355|18680673|P2|COMPLETED|Overall Study||30
7590146|NCT02643355|18680674|P1|COMPLETED|Overall Study||33
7590147|NCT02643355|18680673|P2|STARTED|Overall Study||35
7590148|NCT02643355|18680674|P1|STARTED|Overall Study||34
7590149|NCT02643251|18680688|P2|NOT COMPLETED|Overall Study||2
7590150|NCT02643251|18680689|P1|NOT COMPLETED|Overall Study||11
7590151|NCT02643251|18680688|P2|COMPLETED|Overall Study||67
7590152|NCT02643251|18680689|P1|COMPLETED|Overall Study||58
7590153|NCT02643251|18680688|P2|STARTED|Overall Study||69
7590154|NCT02643251|18680689|P1|STARTED|Overall Study||69
7590155|NCT02643225|18680699|P2|NOT COMPLETED|Overall Study||0
7590156|NCT02643225|18680700|P1|NOT COMPLETED|Overall Study||0
7590157|NCT02643225|18680699|P2|COMPLETED|Overall Study||40
7590158|NCT02643225|18680700|P1|COMPLETED|Overall Study||40
7590159|NCT02643225|18680699|P2|STARTED|Overall Study||40
7590160|NCT02643225|18680700|P1|STARTED|Overall Study||40
7590161|NCT02643199|18680712|P1|NOT COMPLETED|Overall Study||0
7590162|NCT02643199|18680712|P1|COMPLETED|Overall Study||90
7590163|NCT02643199|18680712|P1|STARTED|Overall Study||90
7590164|NCT02643095|18680717|P1|NOT COMPLETED|Overall Study||1
7590165|NCT02643095|18680717|P1|COMPLETED|Overall Study||21
7590166|NCT02643095|18680717|P1|STARTED|Overall Study||22
7590167|NCT02643082|18680721|P2|NOT COMPLETED|Period 2||0
7590168|NCT02643082|18680722|P1|NOT COMPLETED|Period 2||0
7590169|NCT02643082|18680721|P2|COMPLETED|Period 2||10
7590170|NCT02643082|18680722|P1|COMPLETED|Period 2||9
7590171|NCT02643082|18680721|P2|STARTED|Period 2||10
7590172|NCT02643082|18680722|P1|STARTED|Period 2||9
7590173|NCT02643082|18680721|P2|NOT COMPLETED|Washout||0
7590174|NCT02643082|18680722|P1|NOT COMPLETED|Washout||0
7590175|NCT02643082|18680721|P2|COMPLETED|Washout||10
7590176|NCT02643082|18680722|P1|COMPLETED|Washout||9
7590177|NCT02643082|18680721|P2|STARTED|Washout||10
7590178|NCT02643082|18680722|P1|STARTED|Washout||9
7590179|NCT02643082|18680721|P2|NOT COMPLETED|Period 1||0
7590180|NCT02643082|18680722|P1|NOT COMPLETED|Period 1||1
7590181|NCT02643082|18680721|P2|COMPLETED|Period 1||10
7590182|NCT02643082|18680722|P1|COMPLETED|Period 1||9
7590183|NCT02643082|18680721|P2|STARTED|Period 1||10
7590184|NCT02643082|18680722|P1|STARTED|Period 1||10
7590185|NCT02643004|18680739|P2|NOT COMPLETED|Second Intervention (One Week)||0
7590186|NCT02643004|18680740|P1|NOT COMPLETED|Second Intervention (One Week)||0
7590187|NCT02643004|18680739|P2|COMPLETED|Second Intervention (One Week)||35
7590188|NCT02643004|18680740|P1|COMPLETED|Second Intervention (One Week)||35
7590189|NCT02643004|18680739|P2|STARTED|Second Intervention (One Week)||35
7590190|NCT02643004|18680740|P1|STARTED|Second Intervention (One Week)||35
7590191|NCT02643004|18680739|P2|NOT COMPLETED|First Intervention (One Week)||0
7590192|NCT02643004|18680740|P1|NOT COMPLETED|First Intervention (One Week)||0
7590193|NCT02643004|18680739|P2|COMPLETED|First Intervention (One Week)||35
7590194|NCT02643004|18680740|P1|COMPLETED|First Intervention (One Week)||35
7590195|NCT02643004|18680739|P2|STARTED|First Intervention (One Week)||35
7590196|NCT02643004|18680740|P1|STARTED|First Intervention (One Week)||35
7590197|NCT02642991|18680780|P2|NOT COMPLETED|Second Intervention||0
7590198|NCT02642991|18680781|P1|NOT COMPLETED|Second Intervention||0
7590199|NCT02642991|18680780|P2|COMPLETED|Second Intervention||22
7590200|NCT02642991|18680781|P1|COMPLETED|Second Intervention||22
7590201|NCT02642991|18680780|P2|STARTED|Second Intervention||22
7590202|NCT02642991|18680781|P1|STARTED|Second Intervention||22
7590203|NCT02642991|18680780|P2|NOT COMPLETED|First Intervention||0
7590204|NCT02642991|18680781|P1|NOT COMPLETED|First Intervention||0
7590205|NCT02642991|18680780|P2|COMPLETED|First Intervention||22
7590206|NCT02642991|18680781|P1|COMPLETED|First Intervention||22
7590207|NCT02642991|18680780|P2|STARTED|First Intervention||22
7590208|NCT02642991|18680781|P1|STARTED|First Intervention||22
7590209|NCT02642965|18680862|P1|NOT COMPLETED|Overall Study||13
7590210|NCT02642965|18680862|P1|COMPLETED|Overall Study||25
7590211|NCT02642965|18680862|P1|STARTED|Overall Study||38
7590212|NCT02642952|18680878|P2|NOT COMPLETED|Overall Study||5
7590213|NCT02642952|18680879|P1|NOT COMPLETED|Overall Study||2
7590214|NCT02642952|18680878|P2|COMPLETED|Overall Study||25
7590215|NCT02642952|18680879|P1|COMPLETED|Overall Study||19
7590216|NCT02642952|18680878|P2|STARTED|Overall Study||30
7590217|NCT02642952|18680879|P1|STARTED|Overall Study||21
7590218|NCT02642835|18680893|P1|NOT COMPLETED|Overall Study||0
7590219|NCT02642835|18680893|P1|COMPLETED|Overall Study||48
7590220|NCT02642835|18680893|P1|STARTED|Overall Study||48
7590221|NCT02642679|18680906|P1|NOT COMPLETED|Overall Study||3
7590222|NCT02642679|18680906|P1|COMPLETED|Overall Study||16
7590223|NCT02642679|18680906|P1|STARTED|Overall Study||19
7590224|NCT02642653|18680914|P2|NOT COMPLETED|Overall Study||0
7590225|NCT02642653|18680915|P1|NOT COMPLETED|Overall Study||2
7590226|NCT02642653|18680914|P2|COMPLETED|Overall Study||16
7590227|NCT02642653|18680915|P1|COMPLETED|Overall Study||12
7590228|NCT02642653|18680914|P2|STARTED|Overall Study||16
7590229|NCT02642653|18680915|P1|STARTED|Overall Study||14
7590230|NCT02642627|18680947|P1|NOT COMPLETED|Overall Study||3
7590231|NCT02642627|18680947|P1|COMPLETED|Overall Study||39
7590232|NCT02642627|18680947|P1|STARTED|Overall Study||42
7590233|NCT02642614|18680956|P4|NOT COMPLETED|Overall Study||2
7590234|NCT02642614|18680957|P3|NOT COMPLETED|Overall Study||2
7590235|NCT02642614|18680958|P2|NOT COMPLETED|Overall Study||2
7590236|NCT02642614|18680959|P1|NOT COMPLETED|Overall Study||3
7590237|NCT02642614|18680956|P4|COMPLETED|Overall Study||28
7590238|NCT02642614|18680957|P3|COMPLETED|Overall Study||28
7590239|NCT02642614|18680958|P2|COMPLETED|Overall Study||28
7590240|NCT02642614|18680959|P1|COMPLETED|Overall Study||27
7590241|NCT02642614|18680956|P4|STARTED|Overall Study||30
7590242|NCT02642614|18680957|P3|STARTED|Overall Study||30
7590243|NCT02642614|18680958|P2|STARTED|Overall Study||30
7590244|NCT02642614|18680959|P1|STARTED|Overall Study||30
7590245|NCT02642575|18680991|P1|NOT COMPLETED|Overall Study||0
7590246|NCT02642575|18680991|P1|COMPLETED|Overall Study||67
7590247|NCT02642575|18680991|P1|STARTED|Overall Study||67
7590248|NCT02642536|18680999|P2|NOT COMPLETED|Overall Study||5
7590249|NCT02642536|18681000|P1|NOT COMPLETED|Overall Study||2
7590250|NCT02642536|18680999|P2|COMPLETED|Overall Study||18
7590251|NCT02642536|18681000|P1|COMPLETED|Overall Study||19
7590252|NCT02642536|18680999|P2|STARTED|Overall Study||23
7590253|NCT02642536|18681000|P1|STARTED|Overall Study||21
7590254|NCT02642432|18681026|P1|NOT COMPLETED|Overall Study||8
7590255|NCT02642432|18681026|P1|COMPLETED|Overall Study||138
7590256|NCT02642432|18681026|P1|STARTED|Overall Study||146
7590257|NCT02642393|18681034|P2|NOT COMPLETED|Overall Study||92
7590258|NCT02642393|18681035|P1|NOT COMPLETED|Overall Study||99
7590259|NCT02642393|18681034|P2|COMPLETED|Overall Study|"Participants who completed the study:
~On-drug: 40; In-person off-drug: 16; By telephone off-drug: 1"|57
7590260|NCT02642393|18681035|P1|COMPLETED|Overall Study|"Participants who completed the study:
~On-drug: 31; In-person off-drug:13; By telephone off-drug: 6"|50
7590261|NCT02642393|18681034|P2|STARTED|Overall Study||149
7590262|NCT02642393|18681035|P1|STARTED|Overall Study||149
7590263|NCT02642237|18681063|P2|NOT COMPLETED|Overall Study||0
7590264|NCT02642237|18681064|P1|NOT COMPLETED|Overall Study||0
7590265|NCT02642237|18681063|P2|COMPLETED|Overall Study||15
7590266|NCT02642237|18681064|P1|COMPLETED|Overall Study||15
7590267|NCT02642237|18681063|P2|STARTED|Overall Study||15
7590268|NCT02642237|18681064|P1|STARTED|Overall Study||15
7590269|NCT02642159|18681072|P2|NOT COMPLETED|Overall Study||8
7590270|NCT02642159|18681073|P1|NOT COMPLETED|Overall Study||31
7590271|NCT02642159|18681072|P2|COMPLETED|Overall Study||129
7590272|NCT02642159|18681073|P1|COMPLETED|Overall Study||245
7590273|NCT02642159|18681072|P2|ITT: Intent to Prescribe Fenofibrate|Overall Study||24
7590274|NCT02642159|18681073|P1|ITT: Intent to Prescribe Fenofibrate|Overall Study|Fenofibrate was only 'intended to prescribe' in the Alirocumab arm but not actually administered.|47
7590275|NCT02642159|18681072|P2|ITT Population|Overall Study||136
7590276|NCT02642159|18681073|P1|ITT Population|Overall Study||273
7590277|NCT02642159|18681072|P2|Treated (Safety Population)|Overall Study||137
7590278|NCT02642159|18681073|P1|Treated (Safety Population)|Overall Study||275
7590279|NCT02642159|18681072|P2|STARTED|Overall Study|Randomized|137
7590280|NCT02642159|18681073|P1|STARTED|Overall Study|Randomized|276
7590281|NCT02641912|18681125|P2|NOT COMPLETED|Overall Study||0
7590282|NCT02641912|18681126|P1|NOT COMPLETED|Overall Study||0
7590283|NCT02641912|18681125|P2|COMPLETED|Overall Study||47
7590284|NCT02641912|18681126|P1|COMPLETED|Overall Study||53
7590285|NCT02641912|18681125|P2|STARTED|Overall Study||47
7590286|NCT02641912|18681126|P1|STARTED|Overall Study||53
7590287|NCT02641730|18681197|P5|NOT COMPLETED|Observational Period (Week 60 - Week 84)||1
7590288|NCT02641730|18681198|P4|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
7590289|NCT02641730|18681199|P3|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
7590290|NCT02641730|18681200|P2|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
7590291|NCT02641730|18681201|P1|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
7590292|NCT02641730|18681197|P5|COMPLETED|Observational Period (Week 60 - Week 84)||43
7590293|NCT02641730|18681198|P4|COMPLETED|Observational Period (Week 60 - Week 84)||45
7590294|NCT02641730|18681199|P3|COMPLETED|Observational Period (Week 60 - Week 84)||24
7590295|NCT02641730|18681200|P2|COMPLETED|Observational Period (Week 60 - Week 84)||21
7590296|NCT02641730|18681201|P1|COMPLETED|Observational Period (Week 60 - Week 84)||0
7590297|NCT02641730|18681197|P5|STARTED|Observational Period (Week 60 - Week 84)||44
7590298|NCT02641730|18681198|P4|STARTED|Observational Period (Week 60 - Week 84)||45
7590299|NCT02641730|18681199|P3|STARTED|Observational Period (Week 60 - Week 84)||24
7590300|NCT02641730|18681200|P2|STARTED|Observational Period (Week 60 - Week 84)||21
7590301|NCT02641730|18681201|P1|STARTED|Observational Period (Week 60 - Week 84)||0
7590302|NCT02641730|18681197|P5|NOT COMPLETED|After Controlled Period (Week 16 - 52)||6
7590303|NCT02641730|18681198|P4|NOT COMPLETED|After Controlled Period (Week 16 - 52)||8
7590304|NCT02641730|18681199|P3|NOT COMPLETED|After Controlled Period (Week 16 - 52)||2
7590305|NCT02641730|18681200|P2|NOT COMPLETED|After Controlled Period (Week 16 - 52)||4
7590306|NCT02641730|18681201|P1|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
7590307|NCT02641730|18681197|P5|COMPLETED|After Controlled Period (Week 16 - 52)||44
7590308|NCT02641730|18681198|P4|COMPLETED|After Controlled Period (Week 16 - 52)||45
7590309|NCT02641730|18681199|P3|COMPLETED|After Controlled Period (Week 16 - 52)||24
7590310|NCT02641730|18681200|P2|COMPLETED|After Controlled Period (Week 16 - 52)||21
7590311|NCT02641730|18681201|P1|COMPLETED|After Controlled Period (Week 16 - 52)||0
7590312|NCT02641730|18681197|P5|STARTED|After Controlled Period (Week 16 - 52)||50
7590313|NCT02641730|18681198|P4|STARTED|After Controlled Period (Week 16 - 52)||53
7590314|NCT02641730|18681199|P3|STARTED|After Controlled Period (Week 16 - 52)||26
7590315|NCT02641730|18681200|P2|STARTED|After Controlled Period (Week 16 - 52)||25
7590316|NCT02641730|18681201|P1|STARTED|After Controlled Period (Week 16 - 52)||0
7590317|NCT02641730|18681197|P5|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
7590318|NCT02641730|18681198|P4|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||1
7590319|NCT02641730|18681199|P3|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
7590320|NCT02641730|18681200|P2|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
7590321|NCT02641730|18681201|P1|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
7590322|NCT02641730|18681197|P5|COMPLETED|Placebo Controlled Period (Week 0 - 16)||50
7590323|NCT02641730|18681198|P4|COMPLETED|Placebo Controlled Period (Week 0 - 16)||53
7590324|NCT02641730|18681199|P3|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
7590325|NCT02641730|18681200|P2|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
7590326|NCT02641730|18681201|P1|COMPLETED|Placebo Controlled Period (Week 0 - 16)||51
7590327|NCT02641730|18681197|P5|STARTED|Placebo Controlled Period (Week 0 - 16)||52
7590328|NCT02641730|18681198|P4|STARTED|Placebo Controlled Period (Week 0 - 16)||54
7590329|NCT02641730|18681199|P3|STARTED|Placebo Controlled Period (Week 0 - 16)||0
7590330|NCT02641730|18681200|P2|STARTED|Placebo Controlled Period (Week 0 - 16)||0
7590331|NCT02641730|18681201|P1|STARTED|Placebo Controlled Period (Week 0 - 16)||53
7590332|NCT02641587|18681305|P2|NOT COMPLETED|Ambulatory Period||0
7590333|NCT02641587|18681306|P1|NOT COMPLETED|Ambulatory Period||1
7590334|NCT02641587|18681305|P2|COMPLETED|Ambulatory Period||39
7590335|NCT02641587|18681306|P1|COMPLETED|Ambulatory Period||76
7590336|NCT02641587|18681305|P2|STARTED|Ambulatory Period||39
7590337|NCT02641587|18681306|P1|STARTED|Ambulatory Period||77
7590338|NCT02641587|18681305|P2|NOT COMPLETED|Confinement Period||1
7590339|NCT02641587|18681306|P1|NOT COMPLETED|Confinement Period||3
7590340|NCT02641587|18681305|P2|COMPLETED|Confinement Period||39
7590341|NCT02641587|18681306|P1|COMPLETED|Confinement Period||77
7590342|NCT02641587|18681305|P2|STARTED|Confinement Period||40
7590343|NCT02641587|18681306|P1|STARTED|Confinement Period||80
7590344|NCT02641561|18681331|P4|NOT COMPLETED|Overall Study||0
7590345|NCT02641561|18681332|P3|NOT COMPLETED|Overall Study||0
7590346|NCT02641561|18681333|P2|NOT COMPLETED|Overall Study||0
7590347|NCT02641561|18681334|P1|NOT COMPLETED|Overall Study||0
7590348|NCT02641561|18681331|P4|COMPLETED|Overall Study||48
7590349|NCT02641561|18681332|P3|COMPLETED|Overall Study||48
7590350|NCT02641561|18681333|P2|COMPLETED|Overall Study||48
7590351|NCT02641561|18681334|P1|COMPLETED|Overall Study||48
7590352|NCT02641561|18681331|P4|STARTED|Overall Study||48
7590353|NCT02641561|18681332|P3|STARTED|Overall Study||48
7590354|NCT02641561|18681333|P2|STARTED|Overall Study||48
7590355|NCT02641561|18681334|P1|STARTED|Overall Study||48
7590356|NCT02641522|18681420|P1|NOT COMPLETED|Overall Study||0
7590357|NCT02641522|18681420|P1|COMPLETED|Overall Study||10
7590358|NCT02641522|18681420|P1|STARTED|Overall Study||10
7590359|NCT02641392|18681427|P3|NOT COMPLETED|Overall Study||293
7590360|NCT02641392|18681428|P2|NOT COMPLETED|Overall Study||13
7590361|NCT02641392|18681429|P1|NOT COMPLETED|Overall Study||4
7590362|NCT02641392|18681427|P3|COMPLETED|Overall Study||0
7590363|NCT02641392|18681428|P2|COMPLETED|Overall Study||0
7590364|NCT02641392|18681429|P1|COMPLETED|Overall Study||0
7590365|NCT02641392|18681427|P3|STARTED|Overall Study||293
7590366|NCT02641392|18681428|P2|STARTED|Overall Study||13
7590367|NCT02641392|18681429|P1|STARTED|Overall Study||4
7590368|NCT02641379|18681448|P11|NOT COMPLETED|Overall Study||8
7590369|NCT02641379|18681449|P10|NOT COMPLETED|Overall Study||9
7590370|NCT02641379|18681450|P9|NOT COMPLETED|Overall Study||6
7590371|NCT02641379|18681451|P8|NOT COMPLETED|Overall Study||19
7590372|NCT02641379|18681452|P7|NOT COMPLETED|Overall Study||13
7590373|NCT02641379|18681453|P6|NOT COMPLETED|Overall Study||16
7590374|NCT02641379|18681454|P5|NOT COMPLETED|Overall Study||17
7590375|NCT02641379|18681455|P4|NOT COMPLETED|Overall Study||17
7590376|NCT02641379|18681456|P3|NOT COMPLETED|Overall Study||71
7590377|NCT02641379|18681457|P2|NOT COMPLETED|Overall Study||51
7590378|NCT02641379|18681458|P1|NOT COMPLETED|Overall Study||35
7590379|NCT02641379|18681448|P11|COMPLETED|Overall Study||0
7590380|NCT02641379|18681449|P10|COMPLETED|Overall Study||36
7590381|NCT02641379|18681450|P9|COMPLETED|Overall Study||36
7590382|NCT02641379|18681451|P8|COMPLETED|Overall Study||1
7590383|NCT02641379|18681452|P7|COMPLETED|Overall Study||12
7590384|NCT02641379|18681453|P6|COMPLETED|Overall Study||20
7590385|NCT02641379|18681454|P5|COMPLETED|Overall Study||0
7590386|NCT02641379|18681455|P4|COMPLETED|Overall Study||139
7590387|NCT02641379|18681456|P3|COMPLETED|Overall Study||7
7590388|NCT02641379|18681457|P2|COMPLETED|Overall Study||101
7590389|NCT02641379|18681458|P1|COMPLETED|Overall Study||107
7590390|NCT02641379|18681448|P11|STARTED|Overall Study||8
7590391|NCT02641379|18681449|P10|STARTED|Overall Study||45
7590392|NCT02641379|18681450|P9|STARTED|Overall Study||42
7590393|NCT02641379|18681451|P8|STARTED|Overall Study||20
7590394|NCT02641379|18681452|P7|STARTED|Overall Study||25
7590395|NCT02641379|18681453|P6|STARTED|Overall Study||36
7590396|NCT02641379|18681454|P5|STARTED|Overall Study||17
7590397|NCT02641379|18681455|P4|STARTED|Overall Study||156
7590398|NCT02641379|18681456|P3|STARTED|Overall Study||78
7590399|NCT02641379|18681457|P2|STARTED|Overall Study||152
7590400|NCT02641379|18681458|P1|STARTED|Overall Study||142
7590401|NCT02641249|18681523|P1|NOT COMPLETED|Overall Study||4
7590402|NCT02641249|18681523|P1|COMPLETED|Overall Study||15
7590403|NCT02641249|18681523|P1|STARTED|Overall Study||19
7590404|NCT02641080|18681534|P2|NOT COMPLETED|Overall Study||7
7590405|NCT02641080|18681535|P1|NOT COMPLETED|Overall Study||2
7590406|NCT02641080|18681534|P2|COMPLETED|Overall Study||33
7590407|NCT02641080|18681535|P1|COMPLETED|Overall Study||38
7590408|NCT02641080|18681534|P2|STARTED|Overall Study||40
7590409|NCT02641080|18681535|P1|STARTED|Overall Study||40
7590410|NCT02641067|18681549|P2|NOT COMPLETED|Overall Study||0
7590411|NCT02641067|18681550|P1|NOT COMPLETED|Overall Study||0
7590412|NCT02641067|18681549|P2|COMPLETED|Overall Study||8
7590413|NCT02641067|18681550|P1|COMPLETED|Overall Study||8
7590414|NCT02641067|18681549|P2|STARTED|Overall Study||8
7590415|NCT02641067|18681550|P1|STARTED|Overall Study||8
7590416|NCT02640807|18681573|P3|NOT COMPLETED|Overall Study||0
7590417|NCT02640807|18681574|P2|NOT COMPLETED|Overall Study||0
7590418|NCT02640807|18681575|P1|NOT COMPLETED|Overall Study||0
7590419|NCT02640807|18681573|P3|COMPLETED|Overall Study||10
7590420|NCT02640807|18681574|P2|COMPLETED|Overall Study||8
7590421|NCT02640807|18681575|P1|COMPLETED|Overall Study||9
7590422|NCT02640807|18681573|P3|STARTED|Overall Study||10
7590423|NCT02640807|18681574|P2|STARTED|Overall Study||8
7590424|NCT02640807|18681575|P1|STARTED|Overall Study||9
7590425|NCT02640755|18681591|P2|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
7590426|NCT02640755|18681592|P1|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||2
7590427|NCT02640755|18681591|P2|COMPLETED|Multiple Dose Period (Day 8 - EoS)||0
7590428|NCT02640755|18681592|P1|COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
7590429|NCT02640755|18681591|P2|STARTED|Multiple Dose Period (Day 8 - EoS)||1
7590430|NCT02640755|18681592|P1|STARTED|Multiple Dose Period (Day 8 - EoS)||3
7590431|NCT02640755|18681591|P2|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
7590432|NCT02640755|18681592|P1|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
7590433|NCT02640755|18681591|P2|COMPLETED|Single Dose Period (Day 1 - 8)||1
7590434|NCT02640755|18681592|P1|COMPLETED|Single Dose Period (Day 1 - 8)||3
7590435|NCT02640755|18681591|P2|STARTED|Single Dose Period (Day 1 - 8)||1
7590436|NCT02640755|18681592|P1|STARTED|Single Dose Period (Day 1 - 8)||3
7590437|NCT02640716|18681629|P2|NOT COMPLETED|Overall Study||9
7590438|NCT02640716|18681630|P1|NOT COMPLETED|Overall Study||7
7590439|NCT02640716|18681629|P2|COMPLETED|Overall Study||21
7590440|NCT02640716|18681630|P1|COMPLETED|Overall Study||23
7590441|NCT02640716|18681629|P2|Training Completion|Overall Study||27
7590442|NCT02640716|18681630|P1|Training Completion|Overall Study||27
7590443|NCT02640716|18681629|P2|STARTED|Overall Study||30
7590444|NCT02640716|18681630|P1|STARTED|Overall Study||30
7590445|NCT02640677|18681646|P1|NOT COMPLETED|Overall Study||2
7590446|NCT02640677|18681646|P1|COMPLETED|Overall Study||0
7590447|NCT02640677|18681646|P1|STARTED|Overall Study||2
7590448|NCT02640625|18681653|P1|NOT COMPLETED|Overall Study||1
7590449|NCT02640625|18681653|P1|COMPLETED|Overall Study||19
7590450|NCT02640625|18681653|P1|STARTED|Overall Study||20
7590451|NCT02640612|18681662|P3|NOT COMPLETED|Overall Study||6
7590452|NCT02640612|18681663|P2|NOT COMPLETED|Overall Study||14
7590453|NCT02640612|18681664|P1|NOT COMPLETED|Overall Study||22
7590454|NCT02640612|18681662|P3|COMPLETED|Overall Study||96
7590455|NCT02640612|18681663|P2|COMPLETED|Overall Study||89
7590456|NCT02640612|18681664|P1|COMPLETED|Overall Study||203
7590457|NCT02640612|18681662|P3|STARTED|Overall Study||102
7590458|NCT02640612|18681663|P2|STARTED|Overall Study||103
7590459|NCT02640612|18681664|P1|STARTED|Overall Study||225
7590460|NCT02640573|18681684|P1|NOT COMPLETED|Overall Study||1
7590461|NCT02640573|18681684|P1|COMPLETED|Overall Study||0
7590462|NCT02640573|18681684|P1|STARTED|Overall Study||1
7590463|NCT02640547|18681688|P1|NOT COMPLETED|Overall Study||11
7590464|NCT02640547|18681688|P1|COMPLETED|Overall Study||383
7590465|NCT02640547|18681688|P1|STARTED|Overall Study||394
7590466|NCT02640482|18681765|P2|NOT COMPLETED|Overall Study||0
7590467|NCT02640482|18681766|P1|NOT COMPLETED|Overall Study||3
7590468|NCT02640482|18681765|P2|COMPLETED|Overall Study||100
7590469|NCT02640482|18681766|P1|COMPLETED|Overall Study||199
7590470|NCT02640482|18681765|P2|STARTED|Overall Study||100
7590471|NCT02640482|18681766|P1|STARTED|Overall Study||202
7590472|NCT02640404|18681778|P2|NOT COMPLETED|Overall Study||0
7590473|NCT02640404|18681779|P1|NOT COMPLETED|Overall Study||2
7590474|NCT02640404|18681778|P2|COMPLETED|Overall Study||112
7590475|NCT02640404|18681779|P1|COMPLETED|Overall Study||110
7590476|NCT02640404|18681778|P2|STARTED|Overall Study||112
7590477|NCT02640404|18681779|P1|STARTED|Overall Study||112
7590478|NCT02640235|18681789|P2|NOT COMPLETED|Overall Study||14
7590479|NCT02640235|18681790|P1|NOT COMPLETED|Overall Study||14
7590480|NCT02640235|18681789|P2|COMPLETED|Overall Study||115
7590481|NCT02640235|18681790|P1|COMPLETED|Overall Study||117
7590482|NCT02640235|18681789|P2|STARTED|Overall Study||129
7590483|NCT02640235|18681790|P1|STARTED|Overall Study||131
7590484|NCT02640157|18681813|P3|NOT COMPLETED|Overall Study||10
7590485|NCT02640157|18681814|P2|NOT COMPLETED|Overall Study||5
7590486|NCT02640157|18681815|P1|NOT COMPLETED|Overall Study||13
7590487|NCT02640157|18681813|P3|COMPLETED|Overall Study||147
7590488|NCT02640157|18681814|P2|COMPLETED|Overall Study||111
7590489|NCT02640157|18681815|P1|COMPLETED|Overall Study||220
7590490|NCT02640157|18681813|P3|Discontinued Study Drug|Overall Study||3
7590491|NCT02640157|18681814|P2|Discontinued Study Drug|Overall Study||3
7590492|NCT02640157|18681815|P1|Discontinued Study Drug|Overall Study||8
7590493|NCT02640157|18681813|P3|Completed Study Drug|Overall Study||154
7590494|NCT02640157|18681814|P2|Completed Study Drug|Overall Study||112
7590495|NCT02640157|18681815|P1|Completed Study Drug|Overall Study||225
7590496|NCT02640157|18681813|P3|Received Study Drug|Overall Study||157
7590497|NCT02640157|18681814|P2|Received Study Drug|Overall Study|One participant in Arm B was randomized in error and never dispensed study drug.|115
7590498|NCT02640157|18681815|P1|Received Study Drug|Overall Study||233
7590499|NCT02640157|18681813|P3|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|157
7590500|NCT02640157|18681814|P2|STARTED|Overall Study||116
7590501|NCT02640157|18681815|P1|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|233
7590502|NCT02640053|18681834|P2|NOT COMPLETED|Overall Study||4
7590503|NCT02640053|18681835|P1|NOT COMPLETED|Overall Study||4
7590504|NCT02640053|18681834|P2|COMPLETED|Overall Study||17
7590505|NCT02640053|18681835|P1|COMPLETED|Overall Study||17
7590506|NCT02640053|18681834|P2|STARTED|Overall Study||21
7590507|NCT02640053|18681835|P1|STARTED|Overall Study||21
7590508|NCT02639910|18681857|P2|NOT COMPLETED|Overall Study||8
7590509|NCT02639910|18681858|P1|NOT COMPLETED|Overall Study||4
7590510|NCT02639910|18681857|P2|COMPLETED|Overall Study||5
7590511|NCT02639910|18681858|P1|COMPLETED|Overall Study||7
7590512|NCT02639910|18681857|P2|STARTED|Overall Study||13
7590513|NCT02639910|18681858|P1|STARTED|Overall Study||11
7590514|NCT02639637|18681875|P4|NOT COMPLETED|Overall Study||0
7590515|NCT02639637|18681876|P3|NOT COMPLETED|Overall Study||0
7590516|NCT02639637|18681877|P2|NOT COMPLETED|Overall Study||0
7590517|NCT02639637|18681878|P1|NOT COMPLETED|Overall Study||0
7590518|NCT02639637|18681875|P4|COMPLETED|Overall Study||3
7590519|NCT02639637|18681876|P3|COMPLETED|Overall Study||2
7590520|NCT02639637|18681877|P2|COMPLETED|Overall Study||6
7590521|NCT02639637|18681878|P1|COMPLETED|Overall Study||7
7590522|NCT02639637|18681875|P4|STARTED|Overall Study||3
7590523|NCT02639637|18681876|P3|STARTED|Overall Study||2
7590524|NCT02639637|18681877|P2|STARTED|Overall Study||6
7590525|NCT02639637|18681878|P1|STARTED|Overall Study||7
7590526|NCT02639559|18681942|P2|NOT COMPLETED|Overall Study||3
7590527|NCT02639559|18681943|P1|NOT COMPLETED|Overall Study||1
7590528|NCT02639559|18681942|P2|COMPLETED|Overall Study||22
7590529|NCT02639559|18681943|P1|COMPLETED|Overall Study||24
7590530|NCT02639559|18681942|P2|STARTED|Overall Study||25
7590531|NCT02639559|18681943|P1|STARTED|Overall Study||25
7590532|NCT02639494|18681969|P1|NOT COMPLETED|Overall Study||0
7590533|NCT02639494|18681969|P1|COMPLETED|Overall Study||20
7590534|NCT02639494|18681969|P1|STARTED|Overall Study||20
7590535|NCT02639429|18681986|P2|NOT COMPLETED|Overall Study||0
7590536|NCT02639429|18681987|P1|NOT COMPLETED|Overall Study||0
7590537|NCT02639429|18681986|P2|COMPLETED|Overall Study||123
7590538|NCT02639429|18681987|P1|COMPLETED|Overall Study||113
7590539|NCT02639429|18681986|P2|STARTED|Overall Study||123
7590540|NCT02639429|18681987|P1|STARTED|Overall Study||113
7590541|NCT02639390|18682023|P2|NOT COMPLETED|Overall Study||2
7590542|NCT02639390|18682024|P1|NOT COMPLETED|Overall Study||0
7590543|NCT02639390|18682023|P2|COMPLETED|Overall Study||3
7590544|NCT02639390|18682024|P1|COMPLETED|Overall Study||0
7590545|NCT02639390|18682023|P2|STARTED|Overall Study||5
7590546|NCT02639390|18682024|P1|STARTED|Overall Study||0
7590547|NCT02639351|18682045|P5|NOT COMPLETED|Overall Study||0
7590548|NCT02639351|18682046|P4|NOT COMPLETED|Overall Study||0
7590549|NCT02639351|18682047|P3|NOT COMPLETED|Overall Study||0
7590550|NCT02639351|18682048|P2|NOT COMPLETED|Overall Study||0
7590551|NCT02639351|18682049|P1|NOT COMPLETED|Overall Study||0
7590552|NCT02639351|18682045|P5|COMPLETED|Overall Study||16
7590553|NCT02639351|18682046|P4|COMPLETED|Overall Study||16
7590554|NCT02639351|18682047|P3|COMPLETED|Overall Study||16
7590555|NCT02639351|18682048|P2|COMPLETED|Overall Study||16
7590556|NCT02639351|18682049|P1|COMPLETED|Overall Study||16
7590557|NCT02639351|18682045|P5|STARTED|Overall Study||16
7590558|NCT02639351|18682046|P4|STARTED|Overall Study||16
7590559|NCT02639351|18682047|P3|STARTED|Overall Study||16
7590560|NCT02639351|18682048|P2|STARTED|Overall Study||16
7590561|NCT02639351|18682049|P1|STARTED|Overall Study||16
7590562|NCT02639338|18682398|P2|NOT COMPLETED|Overall Study||5
7590563|NCT02639338|18682399|P1|NOT COMPLETED|Overall Study||4
7590564|NCT02639338|18682398|P2|COMPLETED|Overall Study||105
7590565|NCT02639338|18682399|P1|COMPLETED|Overall Study||106
7590566|NCT02639338|18682398|P2|STARTED|Overall Study||110
7590567|NCT02639338|18682399|P1|STARTED|Overall Study||110
7590568|NCT02639286|18682417|P2|NOT COMPLETED|Overall Study||0
7590569|NCT02639286|18682418|P1|NOT COMPLETED|Overall Study||0
7590570|NCT02639286|18682417|P2|COMPLETED|Overall Study||2
7590571|NCT02639286|18682418|P1|COMPLETED|Overall Study||3
7590572|NCT02639286|18682417|P2|STARTED|Overall Study||2
7590573|NCT02639286|18682418|P1|STARTED|Overall Study||3
7590574|NCT02639247|18682444|P2|NOT COMPLETED|Overall Study||2
7590575|NCT02639247|18682445|P1|NOT COMPLETED|Overall Study||5
7590576|NCT02639247|18682444|P2|COMPLETED|Overall Study||149
7590577|NCT02639247|18682445|P1|COMPLETED|Overall Study||177
7590578|NCT02639247|18682444|P2|STARTED|Overall Study||151
7590579|NCT02639247|18682445|P1|STARTED|Overall Study||182
7590580|NCT02639182|18682463|P2|NOT COMPLETED|Overall Study||66
7590581|NCT02639182|18682464|P1|NOT COMPLETED|Overall Study||67
7590582|NCT02639182|18682463|P2|COMPLETED|Overall Study||0
7590583|NCT02639182|18682464|P1|COMPLETED|Overall Study||0
7590584|NCT02639182|18682463|P2|STARTED|Overall Study||66
7590585|NCT02639182|18682464|P1|STARTED|Overall Study||67
7590586|NCT02639052|18682497|P1|NOT COMPLETED|Overall Study||1
7590587|NCT02639052|18682497|P1|COMPLETED|Overall Study||34
7590588|NCT02639052|18682497|P1|Visit 4 (3-month Follow-up)|Overall Study||34
7590589|NCT02639052|18682497|P1|Visit 3 (1-month Follow-up)|Overall Study||35
7590590|NCT02639052|18682497|P1|Visit 2 (1-week Follow-up)|Overall Study||35
7590591|NCT02639052|18682497|P1|Visit 1 (Baseline)|Overall Study||35
7590592|NCT02639052|18682497|P1|STARTED|Overall Study||35
7590593|NCT02638974|18682513|P2|NOT COMPLETED|Overall Study||3
7590594|NCT02638974|18682514|P1|NOT COMPLETED|Overall Study||3
7590595|NCT02638974|18682513|P2|COMPLETED|Overall Study||22
7590596|NCT02638974|18682514|P1|COMPLETED|Overall Study||23
7590597|NCT02638974|18682513|P2|STARTED|Overall Study||25
7590598|NCT02638974|18682514|P1|STARTED|Overall Study||26
7590599|NCT02638948|18682534|P4|NOT COMPLETED|Overall Study||8
7590600|NCT02638948|18682535|P3|NOT COMPLETED|Overall Study||7
7590601|NCT02638948|18682536|P2|NOT COMPLETED|Overall Study||11
7590602|NCT02638948|18682537|P1|NOT COMPLETED|Overall Study||9
7590603|NCT02638948|18682534|P4|COMPLETED|Overall Study||18
7590604|NCT02638948|18682535|P3|COMPLETED|Overall Study||66
7590605|NCT02638948|18682536|P2|COMPLETED|Overall Study||62
7590606|NCT02638948|18682537|P1|COMPLETED|Overall Study||66
7590607|NCT02638948|18682534|P4|STARTED|Overall Study||26
7590608|NCT02638948|18682535|P3|STARTED|Overall Study||73
7590609|NCT02638948|18682536|P2|STARTED|Overall Study||73
7590610|NCT02638948|18682537|P1|STARTED|Overall Study||75
7590611|NCT02638623|18682624|P2|NOT COMPLETED|Overall Study||6
7590612|NCT02638623|18682625|P1|NOT COMPLETED|Overall Study||7
7590613|NCT02638623|18682624|P2|COMPLETED|Overall Study||19
7590614|NCT02638623|18682625|P1|COMPLETED|Overall Study||20
7590615|NCT02638623|18682624|P2|STARTED|Overall Study||25
7590616|NCT02638623|18682625|P1|STARTED|Overall Study||27
7590617|NCT02638597|18682643|P2|NOT COMPLETED|Overall Study||5
7590618|NCT02638597|18682644|P1|NOT COMPLETED|Overall Study||4
7590619|NCT02638597|18682643|P2|COMPLETED|Overall Study||3
7590620|NCT02638597|18682644|P1|COMPLETED|Overall Study||4
7590621|NCT02638597|18682643|P2|STARTED|Overall Study||8
7590622|NCT02638597|18682644|P1|STARTED|Overall Study||8
7590623|NCT02638493|18682655|P3|NOT COMPLETED|Overall Study||0
7590624|NCT02638493|18682656|P2|NOT COMPLETED|Overall Study||0
7590625|NCT02638493|18682657|P1|NOT COMPLETED|Overall Study||2
7590626|NCT02638493|18682655|P3|COMPLETED|Overall Study||8
7590627|NCT02638493|18682656|P2|COMPLETED|Overall Study||8
7590628|NCT02638493|18682657|P1|COMPLETED|Overall Study||8
7590629|NCT02638493|18682655|P3|STARTED|Overall Study||8
7590630|NCT02638493|18682656|P2|STARTED|Overall Study||8
7590631|NCT02638493|18682657|P1|STARTED|Overall Study|Two men were not able to provide semen samples, and thus were replaced|10
7590632|NCT02638337|18682688|P2|NOT COMPLETED|Overall Study||36
7590633|NCT02638337|18682689|P1|NOT COMPLETED|Overall Study||33
7590634|NCT02638337|18682688|P2|COMPLETED|Overall Study||279
7590635|NCT02638337|18682689|P1|COMPLETED|Overall Study||283
7590636|NCT02638337|18682688|P2|Received Treatment|Overall Study||315
7590637|NCT02638337|18682689|P1|Received Treatment|Overall Study||313
7590638|NCT02638337|18682688|P2|STARTED|Overall Study||315
7590639|NCT02638337|18682689|P1|STARTED|Overall Study||316
7590640|NCT02638259|18682773|P2|NOT COMPLETED|Treatment Period 2||11
7590641|NCT02638259|18682774|P1|NOT COMPLETED|Treatment Period 2||6
7590642|NCT02638259|18682773|P2|COMPLETED|Treatment Period 2||155
7590643|NCT02638259|18682774|P1|COMPLETED|Treatment Period 2||169
7590644|NCT02638259|18682773|P2|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (4 not eligible, 1 consent withdrawal, 1 adverse event).|166
7590645|NCT02638259|18682774|P1|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (3 not eligible, 2 consent withdrawal, 1 IP delay)|175
7590646|NCT02638259|18682773|P2|NOT COMPLETED|Treatment Period 1||18
7590647|NCT02638259|18682774|P1|NOT COMPLETED|Treatment Period 1||5
7590648|NCT02638259|18682773|P2|COMPLETED|Treatment Period 1||172
7590649|NCT02638259|18682774|P1|COMPLETED|Treatment Period 1||181
7590650|NCT02638259|18682773|P2|STARTED|Treatment Period 1||190
7590651|NCT02638259|18682774|P1|STARTED|Treatment Period 1||186
7590652|NCT02638168|18682848|P2|NOT COMPLETED|Overall Study||0
7590653|NCT02638168|18682849|P1|NOT COMPLETED|Overall Study||0
7590654|NCT02638168|18682848|P2|COMPLETED|Overall Study||0
7590655|NCT02638168|18682849|P1|COMPLETED|Overall Study||3
7590656|NCT02638168|18682848|P2|STARTED|Overall Study||0
7590657|NCT02638168|18682849|P1|STARTED|Overall Study||3
7590658|NCT02638129|18682866|P2|NOT COMPLETED|Overall Study||30
7590659|NCT02638129|18682867|P1|NOT COMPLETED|Overall Study||28
7590660|NCT02638129|18682866|P2|COMPLETED|Overall Study||0
7590661|NCT02638129|18682867|P1|COMPLETED|Overall Study||0
7590662|NCT02638129|18682866|P2|STARTED|Overall Study||30
7590663|NCT02638129|18682867|P1|STARTED|Overall Study||28
7590664|NCT02638103|18682883|P4|NOT COMPLETED|Overall Study||142
7590665|NCT02638103|18682884|P3|NOT COMPLETED|Overall Study||85
7590666|NCT02638103|18682885|P2|NOT COMPLETED|Overall Study||118
7590667|NCT02638103|18682886|P1|NOT COMPLETED|Overall Study||106
7590668|NCT02638103|18682883|P4|COMPLETED|Overall Study||383
7590669|NCT02638103|18682884|P3|COMPLETED|Overall Study||335
7590670|NCT02638103|18682885|P2|COMPLETED|Overall Study||408
7590671|NCT02638103|18682886|P1|COMPLETED|Overall Study||313
7590672|NCT02638103|18682883|P4|Full Analysis Set (FAS)|Overall Study||523
7590673|NCT02638103|18682884|P3|Full Analysis Set (FAS)|Overall Study||419
7590674|NCT02638103|18682885|P2|Full Analysis Set (FAS)|Overall Study||520
7590675|NCT02638103|18682886|P1|Full Analysis Set (FAS)|Overall Study||416
7590676|NCT02638103|18682883|P4|Safety Analysis Set|Overall Study||525
7590677|NCT02638103|18682884|P3|Safety Analysis Set|Overall Study||419
7590678|NCT02638103|18682885|P2|Safety Analysis Set|Overall Study||526
7590679|NCT02638103|18682886|P1|Safety Analysis Set|Overall Study||418
7590680|NCT02638103|18682883|P4|STARTED|Overall Study||525
7590681|NCT02638103|18682884|P3|STARTED|Overall Study||420
7590682|NCT02638103|18682885|P2|STARTED|Overall Study||526
7590683|NCT02638103|18682886|P1|STARTED|Overall Study||419
7590684|NCT02638051|18682962|P2|NOT COMPLETED|Overall Study||0
7590685|NCT02638051|18682963|P1|NOT COMPLETED|Overall Study||0
7590686|NCT02638051|18682962|P2|COMPLETED|Overall Study||130
7590687|NCT02638051|18682963|P1|COMPLETED|Overall Study||130
7590688|NCT02638051|18682962|P2|STARTED|Overall Study||130
7590689|NCT02638051|18682963|P1|STARTED|Overall Study||130
7590690|NCT02638012|18682973|P1|NOT COMPLETED|Overall Study||1
7590691|NCT02638012|18682973|P1|COMPLETED|Overall Study||7
7590692|NCT02638012|18682973|P1|STARTED|Overall Study||8
7590693|NCT02637999|18682984|P3|NOT COMPLETED|Overall Study||2
7590694|NCT02637999|18682985|P2|NOT COMPLETED|Overall Study||2
7590695|NCT02637999|18682986|P1|NOT COMPLETED|Overall Study||1
7590696|NCT02637999|18682984|P3|COMPLETED|Overall Study||6
7590697|NCT02637999|18682985|P2|COMPLETED|Overall Study||6
7590698|NCT02637999|18682986|P1|COMPLETED|Overall Study||7
7590699|NCT02637999|18682984|P3|STARTED|Overall Study||8
7590700|NCT02637999|18682985|P2|STARTED|Overall Study||8
7590701|NCT02637999|18682986|P1|STARTED|Overall Study||8
7590702|NCT02637856|18683018|P2|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||4
7590703|NCT02637856|18683019|P1|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||0
7590704|NCT02637856|18683018|P2|COMPLETED|Sub-Study (Week 72 to Week 100)||125
7590705|NCT02637856|18683019|P1|COMPLETED|Sub-Study (Week 72 to Week 100)||0
7590706|NCT02637856|18683018|P2|STARTED|Sub-Study (Week 72 to Week 100)||129
7590707|NCT02637856|18683019|P1|STARTED|Sub-Study (Week 72 to Week 100)||0
7590708|NCT02637856|18683018|P2|NOT COMPLETED|Main Study (Baseline to Week 100)||0
7590709|NCT02637856|18683019|P1|NOT COMPLETED|Main Study (Baseline to Week 100)||219
7590710|NCT02637856|18683018|P2|COMPLETED|Main Study (Baseline to Week 100)||0
7590711|NCT02637856|18683019|P1|COMPLETED|Main Study (Baseline to Week 100)||389
7590712|NCT02637856|18683018|P2|STARTED|Main Study (Baseline to Week 100)||0
7590713|NCT02637856|18683019|P1|STARTED|Main Study (Baseline to Week 100)||608
7590714|NCT02637804|18683038|P4|NOT COMPLETED|Second Intervention (1 Week)||0
7590715|NCT02637804|18683039|P3|NOT COMPLETED|Second Intervention (1 Week)||0
7590716|NCT02637804|18683040|P2|NOT COMPLETED|Second Intervention (1 Week)||0
7590717|NCT02637804|18683041|P1|NOT COMPLETED|Second Intervention (1 Week)||0
7590718|NCT02637804|18683038|P4|COMPLETED|Second Intervention (1 Week)||26
7590719|NCT02637804|18683039|P3|COMPLETED|Second Intervention (1 Week)||25
7590720|NCT02637804|18683040|P2|COMPLETED|Second Intervention (1 Week)||28
7590721|NCT02637804|18683041|P1|COMPLETED|Second Intervention (1 Week)||27
7590722|NCT02637804|18683038|P4|STARTED|Second Intervention (1 Week)||26
7590723|NCT02637804|18683039|P3|STARTED|Second Intervention (1 Week)||25
7590724|NCT02637804|18683040|P2|STARTED|Second Intervention (1 Week)||28
7590725|NCT02637804|18683041|P1|STARTED|Second Intervention (1 Week)||27
7590726|NCT02637804|18683038|P4|NOT COMPLETED|First Intervention (1 Week)||0
7590727|NCT02637804|18683039|P3|NOT COMPLETED|First Intervention (1 Week)||0
7590728|NCT02637804|18683040|P2|NOT COMPLETED|First Intervention (1 Week)||0
7590729|NCT02637804|18683041|P1|NOT COMPLETED|First Intervention (1 Week)||0
7590730|NCT02637804|18683038|P4|COMPLETED|First Intervention (1 Week)||26
7590731|NCT02637804|18683039|P3|COMPLETED|First Intervention (1 Week)||25
7590732|NCT02637804|18683040|P2|COMPLETED|First Intervention (1 Week)||28
7590733|NCT02637804|18683041|P1|COMPLETED|First Intervention (1 Week)||27
7590734|NCT02637804|18683038|P4|STARTED|First Intervention (1 Week)||26
7590735|NCT02637804|18683039|P3|STARTED|First Intervention (1 Week)||25
7590736|NCT02637804|18683040|P2|STARTED|First Intervention (1 Week)||28
7590737|NCT02637804|18683041|P1|STARTED|First Intervention (1 Week)||27
7590738|NCT02637557|18683149|P4|NOT COMPLETED|Overall Study||7
7590739|NCT02637557|18683150|P3|NOT COMPLETED|Overall Study||9
7590740|NCT02637557|18683151|P2|NOT COMPLETED|Overall Study||5
7590741|NCT02637557|18683152|P1|NOT COMPLETED|Overall Study||8
7590742|NCT02637557|18683149|P4|COMPLETED|Overall Study||62
7590743|NCT02637557|18683150|P3|COMPLETED|Overall Study||62
7590744|NCT02637557|18683151|P2|COMPLETED|Overall Study||66
7590745|NCT02637557|18683152|P1|COMPLETED|Overall Study||63
7590746|NCT02637557|18683149|P4|STARTED|Overall Study||69
7590747|NCT02637557|18683150|P3|STARTED|Overall Study||71
7590748|NCT02637557|18683151|P2|STARTED|Overall Study||71
7590749|NCT02637557|18683152|P1|STARTED|Overall Study||71
7590750|NCT02637323|18683244|P2|NOT COMPLETED|Overall Study||1
7590751|NCT02637323|18683245|P1|NOT COMPLETED|Overall Study||2
7590752|NCT02637323|18683244|P2|COMPLETED|Overall Study||17
7590753|NCT02637323|18683245|P1|COMPLETED|Overall Study||61
7590754|NCT02637323|18683244|P2|STARTED|Overall Study||18
7590755|NCT02637323|18683245|P1|STARTED|Overall Study||63
7590756|NCT02637141|18683256|P3|NOT COMPLETED|Overall Study||1
7590757|NCT02637141|18683257|P2|NOT COMPLETED|Overall Study||2
7590758|NCT02637141|18683258|P1|NOT COMPLETED|Overall Study||2
7590759|NCT02637141|18683256|P3|COMPLETED|Overall Study||19
7590760|NCT02637141|18683257|P2|COMPLETED|Overall Study||20
7590761|NCT02637141|18683258|P1|COMPLETED|Overall Study||20
7590762|NCT02637141|18683256|P3|Received Study Drug|Overall Study||19
7590763|NCT02637141|18683257|P2|Received Study Drug|Overall Study||21
7590764|NCT02637141|18683258|P1|Received Study Drug|Overall Study||22
7590765|NCT02637141|18683256|P3|STARTED|Overall Study||20
7590766|NCT02637141|18683257|P2|STARTED|Overall Study||22
7590767|NCT02637141|18683258|P1|STARTED|Overall Study||22
7590768|NCT02637063|18683293|P3|NOT COMPLETED|Overall Study||6
7590769|NCT02637063|18683294|P2|NOT COMPLETED|Overall Study||4
7590770|NCT02637063|18683295|P1|NOT COMPLETED|Overall Study||5
7590771|NCT02637063|18683293|P3|COMPLETED|Overall Study||62
7590772|NCT02637063|18683294|P2|COMPLETED|Overall Study||64
7590773|NCT02637063|18683295|P1|COMPLETED|Overall Study||62
7590774|NCT02637063|18683293|P3|STARTED|Overall Study||68
7590775|NCT02637063|18683294|P2|STARTED|Overall Study||68
7590776|NCT02637063|18683295|P1|STARTED|Overall Study||67
7590777|NCT02637037|18683323|P2|NOT COMPLETED|Overall Study||1
7590778|NCT02637037|18683324|P1|NOT COMPLETED|Overall Study||4
7590779|NCT02637037|18683323|P2|COMPLETED|Overall Study||39
7590780|NCT02637037|18683324|P1|COMPLETED|Overall Study||36
7590781|NCT02637037|18683323|P2|STARTED|Overall Study||40
7590782|NCT02637037|18683324|P1|STARTED|Overall Study||40
7590783|NCT02636907|18683390|P1|NOT COMPLETED|Extension Phase||10
7590784|NCT02636907|18683390|P1|COMPLETED|Extension Phase||62
7590785|NCT02636907|18683390|P1|STARTED|Extension Phase||72
7590786|NCT02636907|18683390|P1|NOT COMPLETED|Autoinjector Assessment Period||4
7590787|NCT02636907|18683390|P1|COMPLETED|Autoinjector Assessment Period|Completed autoinjector assessment period (Day 50).|73
7590788|NCT02636907|18683390|P1|STARTED|Autoinjector Assessment Period|Assigned to treatment.|77
7590789|NCT02636712|18683399|P1|NOT COMPLETED|Overall Study||0
7590790|NCT02636712|18683399|P1|COMPLETED|Overall Study||10
7590791|NCT02636712|18683399|P1|STARTED|Overall Study||10
7590792|NCT02636608|18683407|P1|NOT COMPLETED|Overall Study||11
7590793|NCT02636608|18683407|P1|COMPLETED|Overall Study||233
7590794|NCT02636608|18683407|P1|Received Treatment|Overall Study||243
7590795|NCT02636608|18683407|P1|STARTED|Overall Study||244
7590796|NCT02636595|18683435|P1|NOT COMPLETED|Overall Study||2
7590797|NCT02636595|18683435|P1|COMPLETED|Overall Study||119
7590798|NCT02636595|18683435|P1|STARTED|Overall Study||121
7590799|NCT02636361|18683441|P5|NOT COMPLETED|Period 5||0
7590800|NCT02636361|18683442|P4|NOT COMPLETED|Period 5||0
7590801|NCT02636361|18683443|P3|NOT COMPLETED|Period 5||0
7590802|NCT02636361|18683444|P2|NOT COMPLETED|Period 5||0
7590803|NCT02636361|18683445|P1|NOT COMPLETED|Period 5||0
7590804|NCT02636361|18683441|P5|COMPLETED|Period 5||4
7590805|NCT02636361|18683442|P4|COMPLETED|Period 5||4
7590806|NCT02636361|18683443|P3|COMPLETED|Period 5||5
7590807|NCT02636361|18683444|P2|COMPLETED|Period 5||5
7590808|NCT02636361|18683445|P1|COMPLETED|Period 5||5
7590809|NCT02636361|18683441|P5|STARTED|Period 5||4
7590810|NCT02636361|18683442|P4|STARTED|Period 5||4
7590811|NCT02636361|18683443|P3|STARTED|Period 5||5
7590812|NCT02636361|18683444|P2|STARTED|Period 5||5
7590813|NCT02636361|18683445|P1|STARTED|Period 5||5
7590814|NCT02636361|18683441|P5|NOT COMPLETED|Period 4||0
7590815|NCT02636361|18683442|P4|NOT COMPLETED|Period 4||1
7590816|NCT02636361|18683443|P3|NOT COMPLETED|Period 4||0
7590817|NCT02636361|18683444|P2|NOT COMPLETED|Period 4||0
7590818|NCT02636361|18683445|P1|NOT COMPLETED|Period 4||0
7590819|NCT02636361|18683441|P5|COMPLETED|Period 4||4
7590820|NCT02636361|18683442|P4|COMPLETED|Period 4||4
7590821|NCT02636361|18683443|P3|COMPLETED|Period 4||5
7590822|NCT02636361|18683444|P2|COMPLETED|Period 4||5
7590823|NCT02636361|18683445|P1|COMPLETED|Period 4||5
7590824|NCT02636361|18683441|P5|STARTED|Period 4||4
7590825|NCT02636361|18683442|P4|STARTED|Period 4||5
7590826|NCT02636361|18683443|P3|STARTED|Period 4||5
7590827|NCT02636361|18683444|P2|STARTED|Period 4||5
7590828|NCT02636361|18683445|P1|STARTED|Period 4||5
7590829|NCT02636361|18683441|P5|NOT COMPLETED|Period 3||0
7590830|NCT02636361|18683442|P4|NOT COMPLETED|Period 3||0
7590831|NCT02636361|18683443|P3|NOT COMPLETED|Period 3||0
7590832|NCT02636361|18683444|P2|NOT COMPLETED|Period 3||0
7590833|NCT02636361|18683445|P1|NOT COMPLETED|Period 3||0
7590834|NCT02636361|18683441|P5|COMPLETED|Period 3||4
7590835|NCT02636361|18683442|P4|COMPLETED|Period 3||5
7590836|NCT02636361|18683443|P3|COMPLETED|Period 3||5
7590837|NCT02636361|18683444|P2|COMPLETED|Period 3||5
7590838|NCT02636361|18683445|P1|COMPLETED|Period 3||5
7590839|NCT02636361|18683441|P5|STARTED|Period 3||4
7590840|NCT02636361|18683442|P4|STARTED|Period 3||5
7590841|NCT02636361|18683443|P3|STARTED|Period 3||5
7590842|NCT02636361|18683444|P2|STARTED|Period 3||5
7590843|NCT02636361|18683445|P1|STARTED|Period 3||5
7590844|NCT02636361|18683441|P5|NOT COMPLETED|Period 2||0
7590845|NCT02636361|18683442|P4|NOT COMPLETED|Period 2||0
7590846|NCT02636361|18683443|P3|NOT COMPLETED|Period 2||0
7590847|NCT02636361|18683444|P2|NOT COMPLETED|Period 2||0
7590848|NCT02636361|18683445|P1|NOT COMPLETED|Period 2||0
7590849|NCT02636361|18683441|P5|COMPLETED|Period 2||4
7590850|NCT02636361|18683442|P4|COMPLETED|Period 2||5
7590851|NCT02636361|18683443|P3|COMPLETED|Period 2||5
7590852|NCT02636361|18683444|P2|COMPLETED|Period 2||5
7590853|NCT02636361|18683445|P1|COMPLETED|Period 2||5
7590854|NCT02636361|18683441|P5|STARTED|Period 2||4
7590855|NCT02636361|18683442|P4|STARTED|Period 2||5
7590856|NCT02636361|18683443|P3|STARTED|Period 2||5
7590857|NCT02636361|18683444|P2|STARTED|Period 2||5
7590858|NCT02636361|18683445|P1|STARTED|Period 2||5
7590859|NCT02636361|18683441|P5|NOT COMPLETED|Period 1||1
7590860|NCT02636361|18683442|P4|NOT COMPLETED|Period 1||0
7590861|NCT02636361|18683443|P3|NOT COMPLETED|Period 1||0
7590862|NCT02636361|18683444|P2|NOT COMPLETED|Period 1||1
7590863|NCT02636361|18683445|P1|NOT COMPLETED|Period 1||0
7590864|NCT02636361|18683441|P5|COMPLETED|Period 1||4
7590865|NCT02636361|18683442|P4|COMPLETED|Period 1||5
7590866|NCT02636361|18683443|P3|COMPLETED|Period 1||5
7590867|NCT02636361|18683444|P2|COMPLETED|Period 1||5
7590868|NCT02636361|18683445|P1|COMPLETED|Period 1||5
7590869|NCT02636361|18683441|P5|Received at Least One Dose of Study Drug|Period 1||4
7590870|NCT02636361|18683442|P4|Received at Least One Dose of Study Drug|Period 1||5
7590871|NCT02636361|18683443|P3|Received at Least One Dose of Study Drug|Period 1||5
7590872|NCT02636361|18683444|P2|Received at Least One Dose of Study Drug|Period 1||5
7590873|NCT02636361|18683445|P1|Received at Least One Dose of Study Drug|Period 1||5
7590874|NCT02636361|18683441|P5|STARTED|Period 1||5
7590875|NCT02636361|18683442|P4|STARTED|Period 1||5
7590876|NCT02636361|18683443|P3|STARTED|Period 1||5
7590877|NCT02636361|18683444|P2|STARTED|Period 1||6
7590878|NCT02636361|18683445|P1|STARTED|Period 1||5
7590879|NCT02636283|18683464|P2|NOT COMPLETED|Overall Study||3
7590880|NCT02636283|18683465|P1|NOT COMPLETED|Overall Study||2
7590881|NCT02636283|18683464|P2|COMPLETED|Overall Study||0
7590882|NCT02636283|18683465|P1|COMPLETED|Overall Study||1
7590883|NCT02636283|18683464|P2|STARTED|Overall Study||3
7590884|NCT02636283|18683465|P1|STARTED|Overall Study||3
7590885|NCT02636049|18683479|P1|NOT COMPLETED|Overall Study||0
7590886|NCT02636049|18683479|P1|COMPLETED|Overall Study||12
7590887|NCT02636049|18683479|P1|Triferic 35 Micrograms/kg IV Push|Overall Study||12
7590888|NCT02636049|18683479|P1|Triferic 6 mg IV Over 3 Hours|Overall Study||12
7590889|NCT02636049|18683479|P1|STARTED|Overall Study||12
7590890|NCT02635984|18683493|P2|NOT COMPLETED|Overall Study||4
7590891|NCT02635984|18683494|P1|NOT COMPLETED|Overall Study||3
7590892|NCT02635984|18683493|P2|COMPLETED|Overall Study||51
7590893|NCT02635984|18683494|P1|COMPLETED|Overall Study||50
7590894|NCT02635984|18683493|P2|STARTED|Overall Study||55
7590895|NCT02635984|18683494|P1|STARTED|Overall Study||53
7590896|NCT02635880|18683514|P1|NOT COMPLETED|Overall Study||0
7590897|NCT02635880|18683514|P1|COMPLETED|Overall Study||32
7590898|NCT02635880|18683514|P1|STARTED|Overall Study||32
7590899|NCT02635828|18683519|P1|NOT COMPLETED|Overall Study||14
7590900|NCT02635828|18683519|P1|COMPLETED|Overall Study||40
7590901|NCT02635828|18683519|P1|STARTED|Overall Study||54
7590902|NCT02635646|18683526|P2|NOT COMPLETED|Overall Study||26
7590903|NCT02635646|18683527|P1|NOT COMPLETED|Overall Study||25
7590904|NCT02635646|18683526|P2|COMPLETED|Overall Study||39
7590905|NCT02635646|18683527|P1|COMPLETED|Overall Study||32
7590906|NCT02635646|18683526|P2|STARTED|Overall Study||65
7590907|NCT02635646|18683527|P1|STARTED|Overall Study||57
7590908|NCT02635542|18683543|P2|NOT COMPLETED|Overall Study||0
7590909|NCT02635542|18683544|P1|NOT COMPLETED|Overall Study||0
7590910|NCT02635542|18683543|P2|COMPLETED|Overall Study||50
7590911|NCT02635542|18683544|P1|COMPLETED|Overall Study||50
7590912|NCT02635542|18683543|P2|STARTED|Overall Study||50
7590913|NCT02635542|18683544|P1|STARTED|Overall Study||50
7590914|NCT02635425|18683554|P2|NOT COMPLETED|Overall Study||0
7590915|NCT02635425|18683555|P1|NOT COMPLETED|Overall Study||0
7590916|NCT02635425|18683554|P2|COMPLETED|Overall Study||15
7590917|NCT02635425|18683555|P1|COMPLETED|Overall Study||15
7590918|NCT02635425|18683554|P2|STARTED|Overall Study||15
7590919|NCT02635425|18683555|P1|STARTED|Overall Study||15
7590920|NCT02635347|18683563|P2|NOT COMPLETED|Overall Study||7
7590921|NCT02635347|18683564|P1|NOT COMPLETED|Overall Study||20
7590922|NCT02635347|18683563|P2|COMPLETED|Overall Study||63
7590923|NCT02635347|18683564|P1|COMPLETED|Overall Study||31
7590924|NCT02635347|18683563|P2|Analyses|Overall Study||63
7590925|NCT02635347|18683564|P1|Analyses|Overall Study||30
7590926|NCT02635347|18683563|P2|Follow up|Overall Study||63
7590927|NCT02635347|18683564|P1|Follow up|Overall Study||31
7590928|NCT02635347|18683563|P2|Protocol Completion|Overall Study||63
7590929|NCT02635347|18683564|P1|Protocol Completion|Overall Study||22
7590930|NCT02635347|18683563|P2|Enrollment|Overall Study||63
7590931|NCT02635347|18683564|P1|Enrollment|Overall Study||31
7590932|NCT02635347|18683563|P2|Screening|Overall Study||70
7590933|NCT02635347|18683564|P1|Screening|Overall Study||51
7590934|NCT02635347|18683563|P2|STARTED|Overall Study||70
7590935|NCT02635347|18683564|P1|STARTED|Overall Study||51
7590936|NCT02635204|18683595|P2|NOT COMPLETED|Overall Study||1
7590937|NCT02635204|18683596|P1|NOT COMPLETED|Overall Study||2
7590938|NCT02635204|18683595|P2|COMPLETED|Overall Study||88
7590939|NCT02635204|18683596|P1|COMPLETED|Overall Study||176
7590940|NCT02635204|18683595|P2|STARTED|Overall Study||89
7590941|NCT02635204|18683596|P1|STARTED|Overall Study||178
7590942|NCT02634983|18683606|P2|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||0
7590943|NCT02634983|18683607|P1|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||2
7590944|NCT02634983|18683606|P2|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||15
7590945|NCT02634983|18683607|P1|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||14
7590946|NCT02634983|18683606|P2|STARTED|Period 2 (Second Treatment, 8-10 Days)||15
7590947|NCT02634983|18683607|P1|STARTED|Period 2 (Second Treatment, 8-10 Days)||16
7590948|NCT02634983|18683606|P2|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
7590949|NCT02634983|18683607|P1|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
7590950|NCT02634983|18683606|P2|COMPLETED|Washout (Approximately 7-14 Days)||15
7590951|NCT02634983|18683607|P1|COMPLETED|Washout (Approximately 7-14 Days)||16
7590952|NCT02634983|18683606|P2|STARTED|Washout (Approximately 7-14 Days)||15
7590953|NCT02634983|18683607|P1|STARTED|Washout (Approximately 7-14 Days)||16
7590954|NCT02634983|18683606|P2|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
7590955|NCT02634983|18683607|P1|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
7590956|NCT02634983|18683606|P2|COMPLETED|Period One (First Treatment, 8-10 Days)||15
7590957|NCT02634983|18683607|P1|COMPLETED|Period One (First Treatment, 8-10 Days)||16
7590958|NCT02634983|18683606|P2|STARTED|Period One (First Treatment, 8-10 Days)||15
7590959|NCT02634983|18683607|P1|STARTED|Period One (First Treatment, 8-10 Days)||16
7590960|NCT02634827|18683627|P1|NOT COMPLETED|Overall Study||0
7590961|NCT02634827|18683627|P1|COMPLETED|Overall Study||1
7590962|NCT02634827|18683627|P1|STARTED|Overall Study||1
7590963|NCT02634814|18683641|P3|NOT COMPLETED|Overall Study||0
7590964|NCT02634814|18683642|P2|NOT COMPLETED|Overall Study||6
7590965|NCT02634814|18683643|P1|NOT COMPLETED|Overall Study||2
7590966|NCT02634814|18683641|P3|COMPLETED|Overall Study||29
7590967|NCT02634814|18683642|P2|COMPLETED|Overall Study||23
7590968|NCT02634814|18683643|P1|COMPLETED|Overall Study||30
7590969|NCT02634814|18683641|P3|STARTED|Overall Study||29
7590970|NCT02634814|18683642|P2|STARTED|Overall Study||29
7590971|NCT02634814|18683643|P1|STARTED|Overall Study||32
7590972|NCT02634801|18683666|P3|NOT COMPLETED|Follow-up Period||8
7590973|NCT02634801|18683667|P2|NOT COMPLETED|Follow-up Period||8
7590974|NCT02634801|18683668|P1|NOT COMPLETED|Follow-up Period||5
7590975|NCT02634801|18683666|P3|COMPLETED|Follow-up Period||38
7590976|NCT02634801|18683667|P2|COMPLETED|Follow-up Period||18
7590977|NCT02634801|18683668|P1|COMPLETED|Follow-up Period||36
7590978|NCT02634801|18683666|P3|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|46
7590979|NCT02634801|18683667|P2|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|26
7590980|NCT02634801|18683668|P1|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|41
7590981|NCT02634801|18683666|P3|NOT COMPLETED|Extension Period (Weeks 24 to 36)||2
7590982|NCT02634801|18683667|P2|NOT COMPLETED|Extension Period (Weeks 24 to 36)||1
7590983|NCT02634801|18683668|P1|NOT COMPLETED|Extension Period (Weeks 24 to 36)||3
7590984|NCT02634801|18683666|P3|COMPLETED|Extension Period (Weeks 24 to 36)||29
7590985|NCT02634801|18683667|P2|COMPLETED|Extension Period (Weeks 24 to 36)||18
7590986|NCT02634801|18683668|P1|COMPLETED|Extension Period (Weeks 24 to 36)||45
7590987|NCT02634801|18683666|P3|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|31
7590988|NCT02634801|18683667|P2|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|19
7590989|NCT02634801|18683668|P1|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|48
7590990|NCT02634801|18683666|P3|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||5
7590991|NCT02634801|18683667|P2|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||31
7590992|NCT02634801|18683668|P1|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||4
7590993|NCT02634801|18683666|P3|COMPLETED|Treatment Period (Weeks 0 to 24)||49
7590994|NCT02634801|18683667|P2|COMPLETED|Treatment Period (Weeks 0 to 24)||23
7590995|NCT02634801|18683668|P1|COMPLETED|Treatment Period (Weeks 0 to 24)||50
7590996|NCT02634801|18683666|P3|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
7590997|NCT02634801|18683667|P2|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
7590998|NCT02634801|18683668|P1|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||54
7590999|NCT02634801|18683666|P3|STARTED|Treatment Period (Weeks 0 to 24)||54
7591000|NCT02634801|18683667|P2|STARTED|Treatment Period (Weeks 0 to 24)||54
7591001|NCT02634801|18683668|P1|STARTED|Treatment Period (Weeks 0 to 24)||54
7591002|NCT02634788|18683768|P4|NOT COMPLETED|Overall Study||5
7591003|NCT02634788|18683769|P3|NOT COMPLETED|Overall Study||5
7591004|NCT02634788|18683770|P2|NOT COMPLETED|Overall Study||10
7591005|NCT02634788|18683771|P1|NOT COMPLETED|Overall Study||4
7591006|NCT02634788|18683768|P4|COMPLETED|Overall Study||77
7591007|NCT02634788|18683769|P3|COMPLETED|Overall Study||75
7591008|NCT02634788|18683770|P2|COMPLETED|Overall Study||71
7591009|NCT02634788|18683771|P1|COMPLETED|Overall Study||75
7591010|NCT02634788|18683768|P4|STARTED|Overall Study||82
7591011|NCT02634788|18683769|P3|STARTED|Overall Study||80
7591012|NCT02634788|18683770|P2|STARTED|Overall Study||81
7591013|NCT02634788|18683771|P1|STARTED|Overall Study||79
7591014|NCT02634606|18683837|P1|NOT COMPLETED|Overall Study||13
7591015|NCT02634606|18683837|P1|COMPLETED|Overall Study||0
7591016|NCT02634606|18683837|P1|STARTED|Overall Study||13
7591017|NCT02634580|18683849|P4|NOT COMPLETED|Open-label Extension Period||1
7591018|NCT02634580|18683850|P3|NOT COMPLETED|Open-label Extension Period||0
7591019|NCT02634580|18683851|P2|NOT COMPLETED|Open-label Extension Period||1
7591020|NCT02634580|18683852|P1|NOT COMPLETED|Open-label Extension Period||0
7591021|NCT02634580|18683849|P4|COMPLETED|Open-label Extension Period||20
7591022|NCT02634580|18683850|P3|COMPLETED|Open-label Extension Period||18
7591023|NCT02634580|18683851|P2|COMPLETED|Open-label Extension Period||10
7591024|NCT02634580|18683852|P1|COMPLETED|Open-label Extension Period||9
7591025|NCT02634580|18683849|P4|Received Open-label Treatment|Open-label Extension Period||20
7591026|NCT02634580|18683850|P3|Received Open-label Treatment|Open-label Extension Period||18
7591027|NCT02634580|18683851|P2|Received Open-label Treatment|Open-label Extension Period||11
7591028|NCT02634580|18683852|P1|Received Open-label Treatment|Open-label Extension Period||9
7591029|NCT02634580|18683849|P4|STARTED|Open-label Extension Period|Includes 1 participant who did not complete the double-blind period but had study visits during OLE|21
7591030|NCT02634580|18683850|P3|STARTED|Open-label Extension Period||18
7591031|NCT02634580|18683851|P2|STARTED|Open-label Extension Period||11
7591032|NCT02634580|18683852|P1|STARTED|Open-label Extension Period||9
7591033|NCT02634580|18683849|P4|NOT COMPLETED|Double-blind Treatment Period||1
7591034|NCT02634580|18683850|P3|NOT COMPLETED|Double-blind Treatment Period||1
7591035|NCT02634580|18683851|P2|NOT COMPLETED|Double-blind Treatment Period||0
7591036|NCT02634580|18683852|P1|NOT COMPLETED|Double-blind Treatment Period||1
7591037|NCT02634580|18683849|P4|COMPLETED|Double-blind Treatment Period||20
7591038|NCT02634580|18683850|P3|COMPLETED|Double-blind Treatment Period||18
7591039|NCT02634580|18683851|P2|COMPLETED|Double-blind Treatment Period||11
7591040|NCT02634580|18683852|P1|COMPLETED|Double-blind Treatment Period||9
7591041|NCT02634580|18683849|P4|STARTED|Double-blind Treatment Period||21
7591042|NCT02634580|18683850|P3|STARTED|Double-blind Treatment Period||19
7591043|NCT02634580|18683851|P2|STARTED|Double-blind Treatment Period||11
7591044|NCT02634580|18683852|P1|STARTED|Double-blind Treatment Period||10
7591045|NCT02634346|18683910|P3|NOT COMPLETED|Overall Study||23
7591046|NCT02634346|18683911|P2|NOT COMPLETED|Overall Study||14
7591047|NCT02634346|18683912|P1|NOT COMPLETED|Overall Study||12
7591048|NCT02634346|18683910|P3|COMPLETED|Overall Study||111
7591049|NCT02634346|18683911|P2|COMPLETED|Overall Study||119
7591050|NCT02634346|18683912|P1|COMPLETED|Overall Study||122
7591051|NCT02634346|18683910|P3|STARTED|Overall Study||134
7591052|NCT02634346|18683911|P2|STARTED|Overall Study||133
7591053|NCT02634346|18683912|P1|STARTED|Overall Study||134
7591054|NCT02634320|18683926|P1|NOT COMPLETED|Overall Study||16
7591055|NCT02634320|18683926|P1|COMPLETED|Overall Study||35
7591056|NCT02634320|18683926|P1|STARTED|Overall Study||51
7591057|NCT02634177|18683937|P2|NOT COMPLETED|Overall Study||12
7591058|NCT02634177|18683938|P1|NOT COMPLETED|Overall Study||11
7591059|NCT02634177|18683937|P2|COMPLETED|Overall Study||141
7591060|NCT02634177|18683938|P1|COMPLETED|Overall Study||140
7591061|NCT02634177|18683937|P2|STARTED|Overall Study||153
7591062|NCT02634177|18683938|P1|STARTED|Overall Study||151
7591063|NCT02634151|18683962|P2|NOT COMPLETED|Overall Study||2
7591064|NCT02634151|18683963|P1|NOT COMPLETED|Overall Study||1
7591065|NCT02634151|18683962|P2|COMPLETED|Overall Study||50
7591066|NCT02634151|18683963|P1|COMPLETED|Overall Study||52
7591067|NCT02634151|18683962|P2|Safety Set|Overall Study||51
7591068|NCT02634151|18683963|P1|Safety Set|Overall Study||54
7591069|NCT02634151|18683962|P2|Full Analysis Set|Overall Study||52
7591070|NCT02634151|18683963|P1|Full Analysis Set|Overall Study||53
7591071|NCT02634151|18683962|P2|STARTED|Overall Study||52
7591072|NCT02634151|18683963|P1|STARTED|Overall Study||53
7591073|NCT02634073|18684049|P4|NOT COMPLETED|Overall Study||0
7591074|NCT02634073|18684050|P3|NOT COMPLETED|Overall Study||0
7591075|NCT02634073|18684051|P2|NOT COMPLETED|Overall Study||0
7591076|NCT02634073|18684052|P1|NOT COMPLETED|Overall Study||0
7591077|NCT02634073|18684049|P4|COMPLETED|Overall Study||4
7591078|NCT02634073|18684050|P3|COMPLETED|Overall Study||4
7591079|NCT02634073|18684051|P2|COMPLETED|Overall Study||4
7591080|NCT02634073|18684052|P1|COMPLETED|Overall Study||4
7591081|NCT02634073|18684049|P4|STARTED|Overall Study||4
7591082|NCT02634073|18684050|P3|STARTED|Overall Study||4
7591083|NCT02634073|18684051|P2|STARTED|Overall Study||4
7591084|NCT02634073|18684052|P1|STARTED|Overall Study||4
7591085|NCT02633956|18684142|P4|NOT COMPLETED|Overall Study||0
7591086|NCT02633956|18684143|P3|NOT COMPLETED|Overall Study||2
7591087|NCT02633956|18684144|P2|NOT COMPLETED|Overall Study||2
7591088|NCT02633956|18684145|P1|NOT COMPLETED|Overall Study||1
7591089|NCT02633956|18684142|P4|COMPLETED|Overall Study||21
7591090|NCT02633956|18684143|P3|COMPLETED|Overall Study||20
7591091|NCT02633956|18684144|P2|COMPLETED|Overall Study||19
7591092|NCT02633956|18684145|P1|COMPLETED|Overall Study||19
7591093|NCT02633956|18684142|P4|STARTED|Overall Study||21
7591094|NCT02633956|18684143|P3|STARTED|Overall Study||22
7591095|NCT02633956|18684144|P2|STARTED|Overall Study||21
7591096|NCT02633956|18684145|P1|STARTED|Overall Study||20
7591097|NCT02633800|18684165|P2|NOT COMPLETED|Overall Study||43
7591098|NCT02633800|18684166|P1|NOT COMPLETED|Overall Study||44
7591099|NCT02633800|18684165|P2|COMPLETED|Overall Study||0
7591100|NCT02633800|18684166|P1|COMPLETED|Overall Study||0
7591101|NCT02633800|18684165|P2|STARTED|Overall Study||43
7591102|NCT02633800|18684166|P1|STARTED|Overall Study||44
7591103|NCT02633787|18684176|P1|NOT COMPLETED|Overall Study||1
7591104|NCT02633787|18684176|P1|COMPLETED|Overall Study||109
7591105|NCT02633787|18684176|P1|STARTED|Overall Study||110
7591106|NCT02633735|18684184|P2|NOT COMPLETED|Implementation Phase||0
7591107|NCT02633735|18684185|P1|NOT COMPLETED|Implementation Phase||0
7591108|NCT02633735|18684184|P2|COMPLETED|Implementation Phase||2150
7591109|NCT02633735|18684185|P1|COMPLETED|Implementation Phase||1991
7591110|NCT02633735|18684184|P2|STARTED|Implementation Phase||2150
7591111|NCT02633735|18684185|P1|STARTED|Implementation Phase||1991
7591112|NCT02633735|18684184|P2|NOT COMPLETED|Pre-implementation Phase||0
7591113|NCT02633735|18684185|P1|NOT COMPLETED|Pre-implementation Phase||0
7591114|NCT02633735|18684184|P2|COMPLETED|Pre-implementation Phase||1011
7591115|NCT02633735|18684185|P1|COMPLETED|Pre-implementation Phase||788
7591116|NCT02633735|18684184|P2|STARTED|Pre-implementation Phase||1011
7591117|NCT02633735|18684185|P1|STARTED|Pre-implementation Phase||788
7591118|NCT02633501|18684197|P6|NOT COMPLETED|Overall Study||15
7591119|NCT02633501|18684198|P5|NOT COMPLETED|Overall Study||11
7591120|NCT02633501|18684199|P4|NOT COMPLETED|Overall Study||4
7591121|NCT02633501|18684200|P3|NOT COMPLETED|Overall Study||7
7591122|NCT02633501|18684201|P2|NOT COMPLETED|Overall Study||3
7591123|NCT02633501|18684202|P1|NOT COMPLETED|Overall Study||2
7591124|NCT02633501|18684197|P6|COMPLETED|Overall Study||48
7591125|NCT02633501|18684198|P5|COMPLETED|Overall Study||53
7591126|NCT02633501|18684199|P4|COMPLETED|Overall Study||59
7591127|NCT02633501|18684200|P3|COMPLETED|Overall Study||55
7591128|NCT02633501|18684201|P2|COMPLETED|Overall Study||11
7591129|NCT02633501|18684202|P1|COMPLETED|Overall Study||12
7591130|NCT02633501|18684197|P6|STARTED|Overall Study||63
7591131|NCT02633501|18684198|P5|STARTED|Overall Study||64
7591132|NCT02633501|18684199|P4|STARTED|Overall Study||63
7591133|NCT02633501|18684200|P3|STARTED|Overall Study||62
7591134|NCT02633501|18684201|P2|STARTED|Overall Study||14
7591135|NCT02633501|18684202|P1|STARTED|Overall Study||14
7591136|NCT02633488|18684223|P2|NOT COMPLETED|Overall Study||0
7591137|NCT02633488|18684224|P1|NOT COMPLETED|Overall Study||0
7591138|NCT02633488|18684223|P2|COMPLETED|Overall Study||5
7591139|NCT02633488|18684224|P1|COMPLETED|Overall Study||6
7591140|NCT02633488|18684223|P2|STARTED|Overall Study||5
7591141|NCT02633488|18684224|P1|STARTED|Overall Study||6
7591142|NCT02633371|18684230|P1|NOT COMPLETED|Overall Study||3
7591143|NCT02633371|18684230|P1|COMPLETED|Overall Study||7
7591144|NCT02633371|18684230|P1|STARTED|Overall Study||10
7591145|NCT02633358|18684236|P2|NOT COMPLETED|Overall Study||0
7591146|NCT02633358|18684237|P1|NOT COMPLETED|Overall Study||0
7591147|NCT02633358|18684236|P2|COMPLETED|Overall Study||54
7591148|NCT02633358|18684237|P1|COMPLETED|Overall Study||87
7591149|NCT02633358|18684236|P2|STARTED|Overall Study||54
7591150|NCT02633358|18684237|P1|STARTED|Overall Study||87
7591151|NCT02633241|18684251|P1|NOT COMPLETED|Overall Study||3
7591152|NCT02633241|18684251|P1|COMPLETED|Overall Study||27
7591153|NCT02633241|18684251|P1|STARTED|Overall Study||30
7591154|NCT02633215|18684264|P2|NOT COMPLETED|Overall Study||3
7591155|NCT02633215|18684265|P1|NOT COMPLETED|Overall Study||2
7591156|NCT02633215|18684264|P2|COMPLETED|Overall Study||15
7591157|NCT02633215|18684265|P1|COMPLETED|Overall Study||16
7591158|NCT02633215|18684264|P2|STARTED|Overall Study||18
7591159|NCT02633215|18684265|P1|STARTED|Overall Study||18
7591160|NCT02633020|18684277|P2|NOT COMPLETED|Overall Study||0
7591161|NCT02633020|18684278|P1|NOT COMPLETED|Overall Study||1
7591162|NCT02633020|18684277|P2|COMPLETED|Overall Study||9
7591163|NCT02633020|18684278|P1|COMPLETED|Overall Study||18
7591164|NCT02633020|18684277|P2|STARTED|Overall Study||9
7591165|NCT02633020|18684278|P1|STARTED|Overall Study||19
7591166|NCT02632838|18684302|P2|NOT COMPLETED|Overall Study||2
7591167|NCT02632838|18684303|P1|NOT COMPLETED|Overall Study||3
7591168|NCT02632838|18684302|P2|COMPLETED|Overall Study||13
7591169|NCT02632838|18684303|P1|COMPLETED|Overall Study||12
7591170|NCT02632838|18684302|P2|STARTED|Overall Study||15
7591171|NCT02632838|18684303|P1|STARTED|Overall Study||15
7591172|NCT02632812|18684319|P2|NOT COMPLETED|Overall Study||0
7591173|NCT02632812|18684320|P1|NOT COMPLETED|Overall Study||0
7591174|NCT02632812|18684319|P2|COMPLETED|Overall Study||12
7591175|NCT02632812|18684320|P1|COMPLETED|Overall Study||12
7591176|NCT02632812|18684319|P2|STARTED|Overall Study||12
7591177|NCT02632812|18684320|P1|STARTED|Overall Study||12
7591178|NCT02632786|18684340|P2|NOT COMPLETED|Overall Study||7
7591179|NCT02632786|18684341|P1|NOT COMPLETED|Overall Study||11
7591180|NCT02632786|18684340|P2|COMPLETED|Overall Study||56
7591181|NCT02632786|18684341|P1|COMPLETED|Overall Study||55
7591182|NCT02632786|18684340|P2|Randomized and Dosed|Overall Study||63
7591183|NCT02632786|18684341|P1|Randomized and Dosed|Overall Study||66
7591184|NCT02632786|18684340|P2|Informed Consent Obtained|Overall Study||63
7591185|NCT02632786|18684341|P1|Informed Consent Obtained|Overall Study||66
7591186|NCT02632786|18684340|P2|STARTED|Overall Study||63
7591187|NCT02632786|18684341|P1|STARTED|Overall Study||66
7591188|NCT02632747|18684361|P2|NOT COMPLETED|Treatment Period 2||0
7591189|NCT02632747|18684362|P1|NOT COMPLETED|Treatment Period 2||0
7591190|NCT02632747|18684361|P2|COMPLETED|Treatment Period 2||15
7591191|NCT02632747|18684362|P1|COMPLETED|Treatment Period 2||15
7591192|NCT02632747|18684361|P2|STARTED|Treatment Period 2||15
7591193|NCT02632747|18684362|P1|STARTED|Treatment Period 2||15
7591194|NCT02632747|18684361|P2|NOT COMPLETED|Wash-out Period||0
7591195|NCT02632747|18684362|P1|NOT COMPLETED|Wash-out Period||1
7591196|NCT02632747|18684361|P2|COMPLETED|Wash-out Period||15
7591197|NCT02632747|18684362|P1|COMPLETED|Wash-out Period||15
7591198|NCT02632747|18684361|P2|STARTED|Wash-out Period||15
7591199|NCT02632747|18684362|P1|STARTED|Wash-out Period||16
7591200|NCT02632747|18684361|P2|NOT COMPLETED|Treatment Period 1||0
7591201|NCT02632747|18684362|P1|NOT COMPLETED|Treatment Period 1||0
7591202|NCT02632747|18684361|P2|COMPLETED|Treatment Period 1||15
7591203|NCT02632747|18684362|P1|COMPLETED|Treatment Period 1||16
7591204|NCT02632747|18684361|P2|STARTED|Treatment Period 1||15
7591205|NCT02632747|18684362|P1|STARTED|Treatment Period 1||16
7591206|NCT02632526|18684376|P6|NOT COMPLETED|Overall Study||0
7591207|NCT02632526|18684377|P5|NOT COMPLETED|Overall Study||0
7591208|NCT02632526|18684378|P4|NOT COMPLETED|Overall Study||0
7591209|NCT02632526|18684379|P3|NOT COMPLETED|Overall Study||0
7591210|NCT02632526|18684380|P2|NOT COMPLETED|Overall Study||0
7591211|NCT02632526|18684381|P1|NOT COMPLETED|Overall Study||0
7591212|NCT02632526|18684376|P6|COMPLETED|Overall Study||8
7591213|NCT02632526|18684377|P5|COMPLETED|Overall Study||4
7591214|NCT02632526|18684378|P4|COMPLETED|Overall Study||12
7591215|NCT02632526|18684379|P3|COMPLETED|Overall Study||24
7591216|NCT02632526|18684380|P2|COMPLETED|Overall Study||12
7591217|NCT02632526|18684381|P1|COMPLETED|Overall Study||36
7591218|NCT02632526|18684376|P6|STARTED|Overall Study||8
7591219|NCT02632526|18684377|P5|STARTED|Overall Study||4
7591220|NCT02632526|18684378|P4|STARTED|Overall Study||12
7591221|NCT02632526|18684379|P3|STARTED|Overall Study||24
7591222|NCT02632526|18684380|P2|STARTED|Overall Study||12
7591223|NCT02632526|18684381|P1|STARTED|Overall Study||36
7591224|NCT02632110|18684562|P10|NOT COMPLETED|Overall Study||1
7591225|NCT02632110|18684563|P9|NOT COMPLETED|Overall Study||1
7591226|NCT02632110|18684564|P8|NOT COMPLETED|Overall Study||3
7591227|NCT02632110|18684565|P7|NOT COMPLETED|Overall Study||3
7591228|NCT02632110|18684566|P6|NOT COMPLETED|Overall Study||1
7591229|NCT02632110|18684567|P5|NOT COMPLETED|Overall Study||1
7591230|NCT02632110|18684568|P4|NOT COMPLETED|Overall Study||0
7591231|NCT02632110|18684569|P3|NOT COMPLETED|Overall Study||0
7591232|NCT02632110|18684570|P2|NOT COMPLETED|Overall Study||1
7591233|NCT02632110|18684571|P1|NOT COMPLETED|Overall Study||1
7591234|NCT02632110|18684562|P10|COMPLETED|Overall Study||29
7591235|NCT02632110|18684563|P9|COMPLETED|Overall Study||29
7591236|NCT02632110|18684564|P8|COMPLETED|Overall Study||23
7591237|NCT02632110|18684565|P7|COMPLETED|Overall Study||23
7591238|NCT02632110|18684566|P6|COMPLETED|Overall Study||28
7591239|NCT02632110|18684567|P5|COMPLETED|Overall Study||28
7591240|NCT02632110|18684568|P4|COMPLETED|Overall Study||27
7591241|NCT02632110|18684569|P3|COMPLETED|Overall Study||27
7591242|NCT02632110|18684570|P2|COMPLETED|Overall Study||24
7591243|NCT02632110|18684571|P1|COMPLETED|Overall Study||24
7591244|NCT02632110|18684562|P10|STARTED|Overall Study||30
7591245|NCT02632110|18684563|P9|STARTED|Overall Study||30
7591246|NCT02632110|18684564|P8|STARTED|Overall Study||26
7591247|NCT02632110|18684565|P7|STARTED|Overall Study||26
7591248|NCT02632110|18684566|P6|STARTED|Overall Study||29
7591249|NCT02632110|18684567|P5|STARTED|Overall Study||29
7591250|NCT02632110|18684568|P4|STARTED|Overall Study||27
7591251|NCT02632110|18684569|P3|STARTED|Overall Study||27
7591252|NCT02632110|18684570|P2|STARTED|Overall Study||25
7591253|NCT02632110|18684571|P1|STARTED|Overall Study||25
7591254|NCT02631954|18685040|P2|NOT COMPLETED|Overall Study||0
7591255|NCT02631954|18685041|P1|NOT COMPLETED|Overall Study||0
7591256|NCT02631954|18685040|P2|COMPLETED|Overall Study||12
7591257|NCT02631954|18685041|P1|COMPLETED|Overall Study||12
7591258|NCT02631954|18685040|P2|STARTED|Overall Study||12
7591259|NCT02631954|18685041|P1|STARTED|Overall Study||12
7591260|NCT02631876|18685061|P2|NOT COMPLETED|Overall Study||63
7591261|NCT02631876|18685062|P1|NOT COMPLETED|Overall Study||119
7591262|NCT02631876|18685061|P2|COMPLETED|Overall Study||55
7591263|NCT02631876|18685062|P1|COMPLETED|Overall Study||129
7591264|NCT02631876|18685061|P2|Safety Population|Overall Study||109
7591265|NCT02631876|18685062|P1|Safety Population|Overall Study||243
7591266|NCT02631876|18685061|P2|STARTED|Overall Study||118
7591267|NCT02631876|18685062|P1|STARTED|Overall Study||248
7591268|NCT02631837|18685088|P2|NOT COMPLETED|Overall Study||0
7591269|NCT02631837|18685089|P1|NOT COMPLETED|Overall Study||0
7591270|NCT02631837|18685088|P2|COMPLETED|Overall Study||35
7591271|NCT02631837|18685089|P1|COMPLETED|Overall Study||35
7591272|NCT02631837|18685088|P2|STARTED|Overall Study||35
7591273|NCT02631837|18685089|P1|STARTED|Overall Study||35
7591274|NCT02631772|18685127|P2|NOT COMPLETED|Overall Study||0
7591275|NCT02631772|18685128|P1|NOT COMPLETED|Overall Study||0
7591276|NCT02631772|18685127|P2|COMPLETED|Overall Study||16
7591277|NCT02631772|18685128|P1|COMPLETED|Overall Study||16
7591278|NCT02631772|18685127|P2|STARTED|Overall Study||16
7591279|NCT02631772|18685128|P1|STARTED|Overall Study||16
7591280|NCT02631746|18685138|P1|NOT COMPLETED|Overall Study||3
7591281|NCT02631746|18685138|P1|COMPLETED|Overall Study||0
7591282|NCT02631746|18685138|P1|STARTED|Overall Study||3
7591283|NCT02631590|18685149|P1|NOT COMPLETED|Overall Study||0
7591284|NCT02631590|18685149|P1|COMPLETED|Overall Study||24
7591285|NCT02631590|18685149|P1|STARTED|Overall Study||24
7591286|NCT02631577|18685157|P2|NOT COMPLETED|Overall Study||4
7591287|NCT02631577|18685158|P1|NOT COMPLETED|Overall Study||1
7591288|NCT02631577|18685157|P2|COMPLETED|Overall Study||30
7591289|NCT02631577|18685158|P1|COMPLETED|Overall Study||3
7591290|NCT02631577|18685157|P2|STARTED|Overall Study||34
7591291|NCT02631577|18685158|P1|STARTED|Overall Study||4
7591292|NCT02631551|18685176|P4|NOT COMPLETED|Overall Study||11
7591293|NCT02631551|18685177|P3|NOT COMPLETED|Overall Study||11
7591294|NCT02631551|18685178|P2|NOT COMPLETED|Overall Study||19
7591295|NCT02631551|18685179|P1|NOT COMPLETED|Overall Study||13
7591296|NCT02631551|18685176|P4|COMPLETED|Overall Study||276
7591297|NCT02631551|18685177|P3|COMPLETED|Overall Study||283
7591298|NCT02631551|18685178|P2|COMPLETED|Overall Study||278
7591299|NCT02631551|18685179|P1|COMPLETED|Overall Study||289
7591300|NCT02631551|18685176|P4|STARTED|Overall Study||287
7591301|NCT02631551|18685177|P3|STARTED|Overall Study||294
7591302|NCT02631551|18685178|P2|STARTED|Overall Study||297
7591303|NCT02631551|18685179|P1|STARTED|Overall Study||302
7591304|NCT02631525|18685191|P2|NOT COMPLETED|Overall Study||0
7591305|NCT02631525|18685192|P1|NOT COMPLETED|Overall Study||0
7591306|NCT02631525|18685191|P2|COMPLETED|Overall Study||20
7591307|NCT02631525|18685192|P1|COMPLETED|Overall Study||20
7591308|NCT02631525|18685191|P2|STARTED|Overall Study||20
7591309|NCT02631525|18685192|P1|STARTED|Overall Study||20
7591310|NCT02631070|18685200|P2|NOT COMPLETED|Overall Study||76
7591311|NCT02631070|18685201|P1|NOT COMPLETED|Overall Study||112
7591312|NCT02631070|18685200|P2|COMPLETED|Overall Study||0
7591313|NCT02631070|18685201|P1|COMPLETED|Overall Study||41
7591314|NCT02631070|18685200|P2|Completed 48 Weeks of Treatment|Overall Study||12
7591315|NCT02631070|18685201|P1|Completed 48 Weeks of Treatment|Overall Study||83
7591316|NCT02631070|18685200|P2|Completed 24 Weeks of Treatment|Overall Study||68
7591317|NCT02631070|18685201|P1|Completed 24 Weeks of Treatment|Overall Study||128
7591318|NCT02631070|18685200|P2|STARTED|Overall Study||76
7591319|NCT02631070|18685201|P1|STARTED|Overall Study||153
7591320|NCT02631057|18685269|P2|NOT COMPLETED|Overall Study||0
7591321|NCT02631057|18685270|P1|NOT COMPLETED|Overall Study||0
7591322|NCT02631057|18685269|P2|COMPLETED|Overall Study||3414
7591323|NCT02631057|18685270|P1|COMPLETED|Overall Study||899
7591324|NCT02631057|18685269|P2|STARTED|Overall Study||3414
7591325|NCT02631057|18685270|P1|STARTED|Overall Study||899
7591326|NCT02630992|18685276|P1|NOT COMPLETED|Overall Study||13
7591327|NCT02630992|18685276|P1|COMPLETED|Overall Study||99
7591328|NCT02630992|18685276|P1|STARTED|Overall Study||112
7591329|NCT02630966|18685295|P2|NOT COMPLETED|Overall Study||8
7591330|NCT02630966|18685296|P1|NOT COMPLETED|Overall Study||2
7591331|NCT02630966|18685295|P2|COMPLETED|Overall Study||10
7591332|NCT02630966|18685296|P1|COMPLETED|Overall Study||14
7591333|NCT02630966|18685295|P2|STARTED|Overall Study||18
7591334|NCT02630966|18685296|P1|STARTED|Overall Study||16
7591335|NCT02630719|18685314|P2|NOT COMPLETED|Overall Study||0
7591336|NCT02630719|18685315|P1|NOT COMPLETED|Overall Study||0
7591337|NCT02630719|18685314|P2|COMPLETED|Overall Study||6
7591338|NCT02630719|18685315|P1|COMPLETED|Overall Study||4
7591339|NCT02630719|18685314|P2|STARTED|Overall Study||6
7591340|NCT02630719|18685315|P1|STARTED|Overall Study||4
7591341|NCT02630706|18685324|P3|NOT COMPLETED|Overall Study||10
7591342|NCT02630706|18685325|P2|NOT COMPLETED|Overall Study||9
7591343|NCT02630706|18685326|P1|NOT COMPLETED|Overall Study||7
7591344|NCT02630706|18685324|P3|COMPLETED|Overall Study||157
7591345|NCT02630706|18685325|P2|COMPLETED|Overall Study||160
7591346|NCT02630706|18685326|P1|COMPLETED|Overall Study||163
7591347|NCT02630706|18685324|P3|Treated|Overall Study||167
7591348|NCT02630706|18685325|P2|Treated|Overall Study||169
7591349|NCT02630706|18685326|P1|Treated|Overall Study||170
7591350|NCT02630706|18685324|P3|STARTED|Overall Study||167
7591351|NCT02630706|18685325|P2|STARTED|Overall Study||169
7591352|NCT02630706|18685326|P1|STARTED|Overall Study||170
7591353|NCT02630693|18685435|P2|NOT COMPLETED|Overall Study||1
7591354|NCT02630693|18685436|P1|NOT COMPLETED|Overall Study||0
7591355|NCT02630693|18685435|P2|COMPLETED|Overall Study||89
7591356|NCT02630693|18685436|P1|COMPLETED|Overall Study||90
7591357|NCT02630693|18685435|P2|STARTED|Overall Study||90
7591358|NCT02630693|18685436|P1|STARTED|Overall Study||90
7591359|NCT02630563|18685448|P1|NOT COMPLETED|Overall Study||1
7591360|NCT02630563|18685448|P1|COMPLETED|Overall Study||8
7591361|NCT02630563|18685448|P1|STARTED|Overall Study||9
7591362|NCT02630472|18685459|P2|NOT COMPLETED|Overall Study||0
7591363|NCT02630472|18685460|P1|NOT COMPLETED|Overall Study||10
7591364|NCT02630472|18685459|P2|COMPLETED|Overall Study||0
7591365|NCT02630472|18685460|P1|COMPLETED|Overall Study||0
7591366|NCT02630472|18685459|P2|STARTED|Overall Study||0
7591367|NCT02630472|18685460|P1|STARTED|Overall Study||10
7591368|NCT02630459|18685478|P8|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
7591369|NCT02630459|18685479|P7|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
7591370|NCT02630459|18685480|P6|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
7591371|NCT02630459|18685481|P5|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
7591372|NCT02630459|18685482|P4|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
7591373|NCT02630459|18685483|P3|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
7591374|NCT02630459|18685484|P2|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
7591375|NCT02630459|18685485|P1|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
7591376|NCT02630459|18685478|P8|COMPLETED|Optional CHU Sub-Study (During OLTP)||25
7591377|NCT02630459|18685479|P7|COMPLETED|Optional CHU Sub-Study (During OLTP)||24
7591378|NCT02630459|18685480|P6|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
7591379|NCT02630459|18685481|P5|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
7591380|NCT02630459|18685482|P4|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
7591381|NCT02630459|18685483|P3|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
7591382|NCT02630459|18685484|P2|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
7591383|NCT02630459|18685485|P1|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
7591384|NCT02630459|18685478|P8|STARTED|Optional CHU Sub-Study (During OLTP)||25
7591385|NCT02630459|18685479|P7|STARTED|Optional CHU Sub-Study (During OLTP)||24
7591386|NCT02630459|18685480|P6|STARTED|Optional CHU Sub-Study (During OLTP)||0
7591387|NCT02630459|18685481|P5|STARTED|Optional CHU Sub-Study (During OLTP)||0
7591388|NCT02630459|18685482|P4|STARTED|Optional CHU Sub-Study (During OLTP)||0
7591389|NCT02630459|18685483|P3|STARTED|Optional CHU Sub-Study (During OLTP)||0
7591390|NCT02630459|18685484|P2|STARTED|Optional CHU Sub-Study (During OLTP)||0
7591391|NCT02630459|18685485|P1|STARTED|Optional CHU Sub-Study (During OLTP)||0
7591392|NCT02630459|18685478|P8|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
7591393|NCT02630459|18685479|P7|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
7591394|NCT02630459|18685480|P6|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||4
7591395|NCT02630459|18685481|P5|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||29
7591396|NCT02630459|18685482|P4|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
7591397|NCT02630459|18685483|P3|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
7591398|NCT02630459|18685484|P2|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
7591399|NCT02630459|18685485|P1|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
7591400|NCT02630459|18685478|P8|COMPLETED|Open-Label Treatment Phase (OLTP)||0
7591401|NCT02630459|18685479|P7|COMPLETED|Open-Label Treatment Phase (OLTP)||0
7591402|NCT02630459|18685480|P6|COMPLETED|Open-Label Treatment Phase (OLTP)||69
7591403|NCT02630459|18685481|P5|COMPLETED|Open-Label Treatment Phase (OLTP)||357
7591404|NCT02630459|18685482|P4|COMPLETED|Open-Label Treatment Phase (OLTP)||0
7591405|NCT02630459|18685483|P3|COMPLETED|Open-Label Treatment Phase (OLTP)||0
7591406|NCT02630459|18685484|P2|COMPLETED|Open-Label Treatment Phase (OLTP)||0
7591407|NCT02630459|18685485|P1|COMPLETED|Open-Label Treatment Phase (OLTP)||0
7591408|NCT02630459|18685478|P8|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
7591409|NCT02630459|18685479|P7|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
7591410|NCT02630459|18685480|P6|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
7591411|NCT02630459|18685481|P5|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||116
7591412|NCT02630459|18685482|P4|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
7591413|NCT02630459|18685483|P3|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
7591414|NCT02630459|18685484|P2|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
7591415|NCT02630459|18685485|P1|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
7591416|NCT02630459|18685478|P8|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
7591417|NCT02630459|18685479|P7|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
7591418|NCT02630459|18685480|P6|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||73
7591419|NCT02630459|18685481|P5|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
7591420|NCT02630459|18685482|P4|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
7591421|NCT02630459|18685483|P3|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
7591422|NCT02630459|18685484|P2|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
7591423|NCT02630459|18685485|P1|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
7591424|NCT02630459|18685478|P8|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
7591425|NCT02630459|18685479|P7|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
7591426|NCT02630459|18685480|P6|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
7591427|NCT02630459|18685481|P5|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||270
7591428|NCT02630459|18685482|P4|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
7591429|NCT02630459|18685483|P3|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
7591430|NCT02630459|18685484|P2|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
7591431|NCT02630459|18685485|P1|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
7591432|NCT02630459|18685478|P8|STARTED|Open-Label Treatment Phase (OLTP)||0
7591433|NCT02630459|18685479|P7|STARTED|Open-Label Treatment Phase (OLTP)||0
7591434|NCT02630459|18685480|P6|STARTED|Open-Label Treatment Phase (OLTP)||73
7591435|NCT02630459|18685481|P5|STARTED|Open-Label Treatment Phase (OLTP)||386
7591436|NCT02630459|18685482|P4|STARTED|Open-Label Treatment Phase (OLTP)||0
7591437|NCT02630459|18685483|P3|STARTED|Open-Label Treatment Phase (OLTP)||0
7591438|NCT02630459|18685484|P2|STARTED|Open-Label Treatment Phase (OLTP)||0
7591439|NCT02630459|18685485|P1|STARTED|Open-Label Treatment Phase (OLTP)||0
7591440|NCT02630459|18685478|P8|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
7591441|NCT02630459|18685479|P7|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
7591442|NCT02630459|18685480|P6|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
7591443|NCT02630459|18685481|P5|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
7591444|NCT02630459|18685482|P4|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3
7591445|NCT02630459|18685483|P3|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||5
7591446|NCT02630459|18685484|P2|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||2
7591447|NCT02630459|18685485|P1|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3
7591448|NCT02630459|18685478|P8|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
7591449|NCT02630459|18685479|P7|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
7591450|NCT02630459|18685480|P6|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
7591451|NCT02630459|18685481|P5|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
7591452|NCT02630459|18685482|P4|COMPLETED|Double-Blind Treatment Phase (DBTP)||134
7591453|NCT02630459|18685483|P3|COMPLETED|Double-Blind Treatment Phase (DBTP)||130
7591454|NCT02630459|18685484|P2|COMPLETED|Double-Blind Treatment Phase (DBTP)||65
7591455|NCT02630459|18685485|P1|COMPLETED|Double-Blind Treatment Phase (DBTP)||133
7591456|NCT02630459|18685478|P8|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
7591457|NCT02630459|18685479|P7|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
7591458|NCT02630459|18685480|P6|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
7591459|NCT02630459|18685481|P5|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
7591460|NCT02630459|18685482|P4|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||137
7591461|NCT02630459|18685483|P3|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||135
7591462|NCT02630459|18685484|P2|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||66
7591463|NCT02630459|18685485|P1|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||136
7591464|NCT02630459|18685478|P8|STARTED|Double-Blind Treatment Phase (DBTP)||0
7591465|NCT02630459|18685479|P7|STARTED|Double-Blind Treatment Phase (DBTP)||0
7591466|NCT02630459|18685480|P6|STARTED|Double-Blind Treatment Phase (DBTP)||0
7591467|NCT02630459|18685481|P5|STARTED|Double-Blind Treatment Phase (DBTP)||0
7591468|NCT02630459|18685482|P4|STARTED|Double-Blind Treatment Phase (DBTP)||137
7591469|NCT02630459|18685483|P3|STARTED|Double-Blind Treatment Phase (DBTP)||135
7591470|NCT02630459|18685484|P2|STARTED|Double-Blind Treatment Phase (DBTP)||67
7591471|NCT02630459|18685485|P1|STARTED|Double-Blind Treatment Phase (DBTP)||136
7591472|NCT02630251|18685544|P4|NOT COMPLETED|Overall Study||0
7591473|NCT02630251|18685545|P3|NOT COMPLETED|Overall Study||1
7591474|NCT02630251|18685546|P2|NOT COMPLETED|Overall Study||0
7591475|NCT02630251|18685547|P1|NOT COMPLETED|Overall Study||0
7591476|NCT02630251|18685544|P4|COMPLETED|Overall Study||1
7591477|NCT02630251|18685545|P3|COMPLETED|Overall Study||0
7591478|NCT02630251|18685546|P2|COMPLETED|Overall Study||1
7591479|NCT02630251|18685547|P1|COMPLETED|Overall Study||2
7591480|NCT02630251|18685544|P4|STARTED|Overall Study||1
7591481|NCT02630251|18685545|P3|STARTED|Overall Study||1
7591482|NCT02630251|18685546|P2|STARTED|Overall Study||1
7591483|NCT02630251|18685547|P1|STARTED|Overall Study||2
7591484|NCT02630186|18685661|P1|NOT COMPLETED|Overall Study||1
7591485|NCT02630186|18685661|P1|COMPLETED|Overall Study||2
7591486|NCT02630186|18685661|P1|STARTED|Overall Study||3
7591487|NCT02629965|18685677|P2|NOT COMPLETED|Period 2||0
7591488|NCT02629965|18685678|P1|NOT COMPLETED|Period 2||1
7591489|NCT02629965|18685677|P2|COMPLETED|Period 2||90
7591490|NCT02629965|18685678|P1|COMPLETED|Period 2||87
7591491|NCT02629965|18685677|P2|STARTED|Period 2||90
7591492|NCT02629965|18685678|P1|STARTED|Period 2||88
7591493|NCT02629965|18685677|P2|NOT COMPLETED|Period 1||2
7591494|NCT02629965|18685678|P1|NOT COMPLETED|Period 1||4
7591495|NCT02629965|18685677|P2|COMPLETED|Period 1||90
7591496|NCT02629965|18685678|P1|COMPLETED|Period 1||88
7591497|NCT02629965|18685677|P2|STARTED|Period 1||92
7591498|NCT02629965|18685678|P1|STARTED|Period 1||92
7591499|NCT02629861|18685717|P3|NOT COMPLETED|Overall Study||28
7591500|NCT02629861|18685718|P2|NOT COMPLETED|Overall Study||27
7591501|NCT02629861|18685719|P1|NOT COMPLETED|Overall Study||29
7591502|NCT02629861|18685717|P3|COMPLETED|Overall Study||262
7591503|NCT02629861|18685718|P2|COMPLETED|Overall Study||264
7591504|NCT02629861|18685719|P1|COMPLETED|Overall Study||265
7591505|NCT02629861|18685717|P3|Full Analysis Set|Overall Study||287
7591506|NCT02629861|18685718|P2|Full Analysis Set|Overall Study||288
7591507|NCT02629861|18685719|P1|Full Analysis Set|Overall Study||290
7591508|NCT02629861|18685717|P3|Safety Population|Overall Study||289
7591509|NCT02629861|18685718|P2|Safety Population|Overall Study||291
7591510|NCT02629861|18685719|P1|Safety Population|Overall Study||294
7591511|NCT02629861|18685717|P3|Intent to Treat (ITT)|Overall Study||290
7591512|NCT02629861|18685718|P2|Intent to Treat (ITT)|Overall Study||291
7591513|NCT02629861|18685719|P1|Intent to Treat (ITT)|Overall Study||294
7591514|NCT02629861|18685717|P3|STARTED|Overall Study||290
7591515|NCT02629861|18685718|P2|STARTED|Overall Study||291
7591516|NCT02629861|18685719|P1|STARTED|Overall Study||294
7591517|NCT02629822|18685766|P1|NOT COMPLETED|Extension Study||6
7591518|NCT02629822|18685766|P1|COMPLETED|Extension Study||0
7591611|NCT02628873|18685924|P2|STARTED|First Test (1 Hour)||7
7591519|NCT02629822|18685766|P1|STARTED|Extension Study|Enrollment in Extension Study was voluntary.|6
7591520|NCT02629822|18685766|P1|NOT COMPLETED|Base Study||3
7591521|NCT02629822|18685766|P1|COMPLETED|Base Study||7
7591522|NCT02629822|18685766|P1|STARTED|Base Study||10
7591523|NCT02629354|18685782|P2|NOT COMPLETED|Follow-up||0
7591524|NCT02629354|18685783|P1|NOT COMPLETED|Follow-up||0
7591525|NCT02629354|18685782|P2|COMPLETED|Follow-up||18
7591526|NCT02629354|18685783|P1|COMPLETED|Follow-up||18
7591527|NCT02629354|18685782|P2|STARTED|Follow-up||18
7591528|NCT02629354|18685783|P1|STARTED|Follow-up||18
7591529|NCT02629354|18685782|P2|NOT COMPLETED|Period 2||0
7591530|NCT02629354|18685783|P1|NOT COMPLETED|Period 2||0
7591531|NCT02629354|18685782|P2|COMPLETED|Period 2||18
7591532|NCT02629354|18685783|P1|COMPLETED|Period 2||18
7591533|NCT02629354|18685782|P2|STARTED|Period 2||18
7591534|NCT02629354|18685783|P1|STARTED|Period 2||18
7591535|NCT02629354|18685782|P2|NOT COMPLETED|Washout Period||0
7591536|NCT02629354|18685783|P1|NOT COMPLETED|Washout Period||0
7591537|NCT02629354|18685782|P2|COMPLETED|Washout Period||18
7591538|NCT02629354|18685783|P1|COMPLETED|Washout Period||18
7591539|NCT02629354|18685782|P2|STARTED|Washout Period||18
7591540|NCT02629354|18685783|P1|STARTED|Washout Period||18
7591541|NCT02629354|18685782|P2|NOT COMPLETED|Period 1||0
7591542|NCT02629354|18685783|P1|NOT COMPLETED|Period 1||0
7591543|NCT02629354|18685782|P2|COMPLETED|Period 1||18
7591544|NCT02629354|18685783|P1|COMPLETED|Period 1||18
7591545|NCT02629354|18685782|P2|STARTED|Period 1||18
7591546|NCT02629354|18685783|P1|STARTED|Period 1||18
7591547|NCT02629159|18685808|P3|NOT COMPLETED|Overall Study||51
7591548|NCT02629159|18685809|P2|NOT COMPLETED|Overall Study||39
7591549|NCT02629159|18685810|P1|NOT COMPLETED|Overall Study||56
7591550|NCT02629159|18685808|P3|COMPLETED|Overall Study||600
7591551|NCT02629159|18685809|P2|COMPLETED|Overall Study||288
7591552|NCT02629159|18685810|P1|COMPLETED|Overall Study||595
7591553|NCT02629159|18685808|P3|Rescued at Week 22|Overall Study||18
7591554|NCT02629159|18685809|P2|Rescued at Week 22|Overall Study||7
7591555|NCT02629159|18685810|P1|Rescued at Week 22|Overall Study||26
7591556|NCT02629159|18685808|P3|Rescued at Week 18|Overall Study||29
7591557|NCT02629159|18685809|P2|Rescued at Week 18|Overall Study||14
7591558|NCT02629159|18685810|P1|Rescued at Week 18|Overall Study|One participant rescued at week 18 did not receive any dose of upadacitinib|48
7591559|NCT02629159|18685808|P3|Rescued at Week 14|Overall Study||78
7591560|NCT02629159|18685809|P2|Rescued at Week 14|Overall Study||56
7591561|NCT02629159|18685810|P1|Rescued at Week 14|Overall Study||231
7591562|NCT02629159|18685808|P3|Completed Week 14 on Study Drug|Overall Study||620
7591563|NCT02629159|18685809|P2|Completed Week 14 on Study Drug|Overall Study||300
7591564|NCT02629159|18685810|P1|Completed Week 14 on Study Drug|Overall Study||620
7591565|NCT02629159|18685808|P3|Received Assigned Study Drug|Overall Study|One participant received a placebo injection but no oral study drug before discontinuing the study|650
7591566|NCT02629159|18685809|P2|Received Assigned Study Drug|Overall Study||327
7591567|NCT02629159|18685810|P1|Received Assigned Study Drug|Overall Study||651
7591568|NCT02629159|18685808|P3|STARTED|Overall Study||651
7591569|NCT02629159|18685809|P2|STARTED|Overall Study||327
7591570|NCT02629159|18685810|P1|STARTED|Overall Study||651
7591571|NCT02629133|18685862|P2|NOT COMPLETED|Overall Study||2
7591572|NCT02629133|18685863|P1|NOT COMPLETED|Overall Study||4
7591573|NCT02629133|18685862|P2|COMPLETED|Overall Study||23
7591574|NCT02629133|18685863|P1|COMPLETED|Overall Study||21
7591575|NCT02629133|18685862|P2|STARTED|Overall Study||25
7591576|NCT02629133|18685863|P1|STARTED|Overall Study||25
7591577|NCT02629094|18685877|P1|NOT COMPLETED|Overall Study||0
7591578|NCT02629094|18685877|P1|COMPLETED|Overall Study||5
7591579|NCT02629094|18685877|P1|STARTED|Overall Study||5
7591580|NCT02628964|18685884|P2|NOT COMPLETED|Overall Study||1
7591581|NCT02628964|18685885|P1|NOT COMPLETED|Overall Study||0
7591582|NCT02628964|18685884|P2|COMPLETED|Overall Study||49
7591583|NCT02628964|18685885|P1|COMPLETED|Overall Study||50
7591584|NCT02628964|18685884|P2|STARTED|Overall Study||50
7591585|NCT02628964|18685885|P1|STARTED|Overall Study||50
7591586|NCT02628938|18685906|P3|NOT COMPLETED|Overall Study||4
7591587|NCT02628938|18685907|P2|NOT COMPLETED|Overall Study||2
7591588|NCT02628938|18685908|P1|NOT COMPLETED|Overall Study||5
7591589|NCT02628938|18685906|P3|COMPLETED|Overall Study||11
7591590|NCT02628938|18685907|P2|COMPLETED|Overall Study||13
7591591|NCT02628938|18685908|P1|COMPLETED|Overall Study||10
7591592|NCT02628938|18685906|P3|STARTED|Overall Study||15
7591593|NCT02628938|18685907|P2|STARTED|Overall Study||15
7591594|NCT02628938|18685908|P1|STARTED|Overall Study||15
7591595|NCT02628873|18685924|P2|NOT COMPLETED|Second Test (1 Hour)||0
7591596|NCT02628873|18685925|P1|NOT COMPLETED|Second Test (1 Hour)||1
7591597|NCT02628873|18685924|P2|COMPLETED|Second Test (1 Hour)||6
7591598|NCT02628873|18685925|P1|COMPLETED|Second Test (1 Hour)||13
7591599|NCT02628873|18685924|P2|STARTED|Second Test (1 Hour)||6
7591600|NCT02628873|18685925|P1|STARTED|Second Test (1 Hour)||14
7591601|NCT02628873|18685924|P2|NOT COMPLETED|Break (1 Hour)||1
7591602|NCT02628873|18685925|P1|NOT COMPLETED|Break (1 Hour)||0
7591603|NCT02628873|18685924|P2|COMPLETED|Break (1 Hour)||6
7591604|NCT02628873|18685925|P1|COMPLETED|Break (1 Hour)||14
7591605|NCT02628873|18685924|P2|STARTED|Break (1 Hour)||7
7591606|NCT02628873|18685925|P1|STARTED|Break (1 Hour)||14
7591607|NCT02628873|18685924|P2|NOT COMPLETED|First Test (1 Hour)||0
7591608|NCT02628873|18685925|P1|NOT COMPLETED|First Test (1 Hour)||0
7591609|NCT02628873|18685924|P2|COMPLETED|First Test (1 Hour)||7
7591610|NCT02628873|18685925|P1|COMPLETED|First Test (1 Hour)||14
7591612|NCT02628873|18685925|P1|STARTED|First Test (1 Hour)||14
7591613|NCT02628769|18685935|P2|NOT COMPLETED|Second Intervention||1
7591614|NCT02628769|18685936|P1|NOT COMPLETED|Second Intervention||2
7591615|NCT02628769|18685935|P2|COMPLETED|Second Intervention||1
7591616|NCT02628769|18685936|P1|COMPLETED|Second Intervention||0
7591617|NCT02628769|18685935|P2|STARTED|Second Intervention||2
7591618|NCT02628769|18685936|P1|STARTED|Second Intervention||2
7591619|NCT02628769|18685935|P2|NOT COMPLETED|Wash Out (28 Days)||0
7591620|NCT02628769|18685936|P1|NOT COMPLETED|Wash Out (28 Days)||0
7591621|NCT02628769|18685935|P2|COMPLETED|Wash Out (28 Days)||2
7591622|NCT02628769|18685936|P1|COMPLETED|Wash Out (28 Days)||2
7591623|NCT02628769|18685935|P2|STARTED|Wash Out (28 Days)||2
7591624|NCT02628769|18685936|P1|STARTED|Wash Out (28 Days)||2
7591625|NCT02628769|18685935|P2|NOT COMPLETED|First Intervention||1
7591626|NCT02628769|18685936|P1|NOT COMPLETED|First Intervention||1
7591627|NCT02628769|18685935|P2|COMPLETED|First Intervention||2
7591628|NCT02628769|18685936|P1|COMPLETED|First Intervention||2
7591629|NCT02628769|18685935|P2|STARTED|First Intervention||3
7591630|NCT02628769|18685936|P1|STARTED|First Intervention||3
7591631|NCT02628743|18685974|P1|NOT COMPLETED|Overall Study||131
7591632|NCT02628743|18685974|P1|COMPLETED|Overall Study||0
7591633|NCT02628743|18685974|P1|STARTED|Overall Study||131
7591634|NCT02628600|18686000|P2|NOT COMPLETED|Overall Study||32
7591635|NCT02628600|18686001|P1|NOT COMPLETED|Overall Study||24
7591636|NCT02628600|18686000|P2|COMPLETED|Overall Study||58
7591637|NCT02628600|18686001|P1|COMPLETED|Overall Study||49
7591638|NCT02628600|18686000|P2|Participant Discontinued the Study|Overall Study||32
7591639|NCT02628600|18686001|P1|Participant Discontinued the Study|Overall Study||24
7591640|NCT02628600|18686000|P2|STARTED|Overall Study||90
7591641|NCT02628600|18686001|P1|STARTED|Overall Study||73
7591642|NCT02628418|18686015|P2|NOT COMPLETED|Overall Study||2
7591643|NCT02628418|18686016|P1|NOT COMPLETED|Overall Study||1
7591644|NCT02628418|18686015|P2|COMPLETED|Overall Study||13
7591645|NCT02628418|18686016|P1|COMPLETED|Overall Study||14
7591646|NCT02628418|18686015|P2|STARTED|Overall Study||15
7591647|NCT02628418|18686016|P1|STARTED|Overall Study||15
7591648|NCT02628236|18686037|P1|NOT COMPLETED|Overall Study||0
7591649|NCT02628236|18686037|P1|COMPLETED|Overall Study||14
7591650|NCT02628236|18686037|P1|STARTED|Overall Study||14
7591651|NCT02628223|18686076|P2|NOT COMPLETED|Overall Study||2
7591652|NCT02628223|18686077|P1|NOT COMPLETED|Overall Study||0
7591653|NCT02628223|18686076|P2|COMPLETED|Overall Study||36
7591654|NCT02628223|18686077|P1|COMPLETED|Overall Study||38
7591655|NCT02628223|18686076|P2|STARTED|Overall Study||38
7591656|NCT02628223|18686077|P1|STARTED|Overall Study||38
7591657|NCT02628106|18686093|P1|NOT COMPLETED|Overall Study||0
7591658|NCT02628106|18686093|P1|COMPLETED|Overall Study||21
7591659|NCT02628106|18686093|P1|STARTED|Overall Study||21
7591660|NCT02628093|18686099|P2|NOT COMPLETED|Overall Study||0
7591661|NCT02628093|18686100|P1|NOT COMPLETED|Overall Study||0
7591662|NCT02628093|18686099|P2|COMPLETED|Overall Study||29
7591663|NCT02628093|18686100|P1|COMPLETED|Overall Study||31
7591664|NCT02628093|18686099|P2|STARTED|Overall Study||29
7591665|NCT02628093|18686100|P1|STARTED|Overall Study||31
7591666|NCT02628028|18686126|P8|NOT COMPLETED|Long-term Extension (LTE) Period||61
7591667|NCT02628028|18686127|P7|NOT COMPLETED|Long-term Extension (LTE) Period||58
7591668|NCT02628028|18686128|P6|NOT COMPLETED|Long-term Extension (LTE) Period||60
7591669|NCT02628028|18686129|P5|NOT COMPLETED|Long-term Extension (LTE) Period||0
7591670|NCT02628028|18686130|P4|NOT COMPLETED|Long-term Extension (LTE) Period||0
7591671|NCT02628028|18686131|P3|NOT COMPLETED|Long-term Extension (LTE) Period||0
7591672|NCT02628028|18686132|P2|NOT COMPLETED|Long-term Extension (LTE) Period||0
7591673|NCT02628028|18686133|P1|NOT COMPLETED|Long-term Extension (LTE) Period||0
7591674|NCT02628028|18686126|P8|COMPLETED|Long-term Extension (LTE) Period||0
7591675|NCT02628028|18686127|P7|COMPLETED|Long-term Extension (LTE) Period||0
7591676|NCT02628028|18686128|P6|COMPLETED|Long-term Extension (LTE) Period||1
7591677|NCT02628028|18686129|P5|COMPLETED|Long-term Extension (LTE) Period||0
7591678|NCT02628028|18686130|P4|COMPLETED|Long-term Extension (LTE) Period||0
7591679|NCT02628028|18686131|P3|COMPLETED|Long-term Extension (LTE) Period||0
7591680|NCT02628028|18686132|P2|COMPLETED|Long-term Extension (LTE) Period||0
7591681|NCT02628028|18686133|P1|COMPLETED|Long-term Extension (LTE) Period||0
7591682|NCT02628028|18686126|P8|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
7591683|NCT02628028|18686127|P7|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
7591684|NCT02628028|18686128|P6|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
7591685|NCT02628028|18686129|P5|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
7591686|NCT02628028|18686130|P4|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
7591687|NCT02628028|18686131|P3|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
7591688|NCT02628028|18686132|P2|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
7591689|NCT02628028|18686133|P1|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
7591690|NCT02628028|18686126|P8|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
7591691|NCT02628028|18686127|P7|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|58
7591692|NCT02628028|18686128|P6|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
7591693|NCT02628028|18686129|P5|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;42 participants completed part B placebo period,re-randomized to LTE period.|0
7591694|NCT02628028|18686130|P4|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
7591695|NCT02628028|18686131|P3|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
7591696|NCT02628028|18686132|P2|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
7591697|NCT02628028|18686133|P1|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
7591698|NCT02628028|18686126|P8|NOT COMPLETED|Dosing Period||15
7591699|NCT02628028|18686127|P7|NOT COMPLETED|Dosing Period||16
7591700|NCT02628028|18686128|P6|NOT COMPLETED|Dosing Period||14
7591701|NCT02628028|18686129|P5|NOT COMPLETED|Dosing Period||16
7591702|NCT02628028|18686130|P4|NOT COMPLETED|Dosing Period||0
7591703|NCT02628028|18686131|P3|NOT COMPLETED|Dosing Period||1
7591704|NCT02628028|18686132|P2|NOT COMPLETED|Dosing Period||0
7591705|NCT02628028|18686133|P1|NOT COMPLETED|Dosing Period||0
7591706|NCT02628028|18686126|P8|COMPLETED|Dosing Period||48
7591707|NCT02628028|18686127|P7|COMPLETED|Dosing Period||46
7591708|NCT02628028|18686128|P6|COMPLETED|Dosing Period||49
7591709|NCT02628028|18686129|P5|COMPLETED|Dosing Period||46
7591710|NCT02628028|18686130|P4|COMPLETED|Dosing Period||8
7591711|NCT02628028|18686131|P3|COMPLETED|Dosing Period||9
7591712|NCT02628028|18686132|P2|COMPLETED|Dosing Period||9
7591713|NCT02628028|18686133|P1|COMPLETED|Dosing Period||9
7591714|NCT02628028|18686126|P8|Received at Least 1dose of Study Drug|Dosing Period||63
7591715|NCT02628028|18686127|P7|Received at Least 1dose of Study Drug|Dosing Period||62
7591716|NCT02628028|18686128|P6|Received at Least 1dose of Study Drug|Dosing Period||63
7591717|NCT02628028|18686129|P5|Received at Least 1dose of Study Drug|Dosing Period||62
7591718|NCT02628028|18686130|P4|Received at Least 1dose of Study Drug|Dosing Period||8
7591719|NCT02628028|18686131|P3|Received at Least 1dose of Study Drug|Dosing Period||10
7591720|NCT02628028|18686132|P2|Received at Least 1dose of Study Drug|Dosing Period||9
7591721|NCT02628028|18686133|P1|Received at Least 1dose of Study Drug|Dosing Period||9
7591722|NCT02628028|18686126|P8|STARTED|Dosing Period||63
7591723|NCT02628028|18686127|P7|STARTED|Dosing Period||62
7591724|NCT02628028|18686128|P6|STARTED|Dosing Period||63
7591725|NCT02628028|18686129|P5|STARTED|Dosing Period||62
7591726|NCT02628028|18686130|P4|STARTED|Dosing Period||8
7591727|NCT02628028|18686131|P3|STARTED|Dosing Period||10
7591728|NCT02628028|18686132|P2|STARTED|Dosing Period||9
7591729|NCT02628028|18686133|P1|STARTED|Dosing Period||9
7591730|NCT02627963|18686177|P2|NOT COMPLETED|Overall Study||14
7591731|NCT02627963|18686178|P1|NOT COMPLETED|Overall Study||36
7591732|NCT02627963|18686177|P2|COMPLETED|Overall Study||161
7591733|NCT02627963|18686178|P1|COMPLETED|Overall Study||139
7591734|NCT02627963|18686177|P2|STARTED|Overall Study||175
7591735|NCT02627963|18686178|P1|STARTED|Overall Study||175
7591736|NCT02627924|18686188|P1|NOT COMPLETED|Overall Study||12
7591737|NCT02627924|18686188|P1|COMPLETED|Overall Study||79
7591738|NCT02627924|18686188|P1|STARTED|Overall Study||91
7591739|NCT02627794|18686205|P1|NOT COMPLETED|Overall Study||0
7591740|NCT02627794|18686205|P1|COMPLETED|Overall Study||3
7591741|NCT02627794|18686205|P1|STARTED|Overall Study||3
7591742|NCT02627144|18686218|P1|NOT COMPLETED|Overall Study||365
7591743|NCT02627144|18686218|P1|COMPLETED|Overall Study||0
7591744|NCT02627144|18686218|P1|Treated|Overall Study||359
7591745|NCT02627144|18686218|P1|STARTED|Overall Study||365
7591746|NCT02627118|18686226|P1|NOT COMPLETED|Overall Study||0
7591747|NCT02627118|18686226|P1|COMPLETED|Overall Study||10
7591748|NCT02627118|18686226|P1|STARTED|Overall Study||10
7591749|NCT02627001|18686233|P2|NOT COMPLETED|Overall Study||0
7591750|NCT02627001|18686234|P1|NOT COMPLETED|Overall Study||0
7591751|NCT02627001|18686233|P2|COMPLETED|Overall Study||14
7591752|NCT02627001|18686234|P1|COMPLETED|Overall Study||13
7591753|NCT02627001|18686233|P2|STARTED|Overall Study||14
7591754|NCT02627001|18686234|P1|STARTED|Overall Study||13
7591755|NCT02626910|18686244|P4|NOT COMPLETED|Overall Study||0
7591756|NCT02626910|18686245|P3|NOT COMPLETED|Overall Study||0
7591757|NCT02626910|18686246|P2|NOT COMPLETED|Overall Study||0
7591758|NCT02626910|18686247|P1|NOT COMPLETED|Overall Study||0
7591759|NCT02626910|18686244|P4|COMPLETED|Overall Study||10
7591760|NCT02626910|18686245|P3|COMPLETED|Overall Study||6
7591761|NCT02626910|18686246|P2|COMPLETED|Overall Study||10
7591762|NCT02626910|18686247|P1|COMPLETED|Overall Study||23
7591763|NCT02626910|18686244|P4|STARTED|Overall Study||10
7591764|NCT02626910|18686245|P3|STARTED|Overall Study||6
7591765|NCT02626910|18686246|P2|STARTED|Overall Study||10
7591766|NCT02626910|18686247|P1|STARTED|Overall Study||23
7591767|NCT02626819|18686259|P2|NOT COMPLETED|Overall Study||3
7591768|NCT02626819|18686260|P1|NOT COMPLETED|Overall Study||4
7591769|NCT02626819|18686259|P2|COMPLETED|Overall Study||20
7591770|NCT02626819|18686260|P1|COMPLETED|Overall Study||18
7591771|NCT02626819|18686259|P2|STARTED|Overall Study||23
7591772|NCT02626819|18686260|P1|STARTED|Overall Study||22
7591773|NCT02626780|18686280|P1|NOT COMPLETED|Overall Study||3
7591774|NCT02626780|18686280|P1|COMPLETED|Overall Study||4
7591775|NCT02626780|18686280|P1|Withdrew From Study|Overall Study||3
7591776|NCT02626780|18686280|P1|STARTED|Overall Study||7
7591777|NCT02626611|18686288|P3|NOT COMPLETED|Overall Study||3
7591778|NCT02626611|18686289|P2|NOT COMPLETED|Overall Study||1
7591779|NCT02626611|18686290|P1|NOT COMPLETED|Overall Study||4
7591780|NCT02626611|18686288|P3|COMPLETED|Overall Study||16
7591781|NCT02626611|18686289|P2|COMPLETED|Overall Study||20
7591782|NCT02626611|18686290|P1|COMPLETED|Overall Study||16
7591783|NCT02626611|18686288|P3|STARTED|Overall Study||19
7591784|NCT02626611|18686289|P2|STARTED|Overall Study||21
7591785|NCT02626611|18686290|P1|STARTED|Overall Study||20
7591786|NCT02626520|18686313|P2|NOT COMPLETED|Overall Study||10
7591787|NCT02626520|18686314|P1|NOT COMPLETED|Overall Study||1
7591788|NCT02626520|18686313|P2|COMPLETED|Overall Study||0
7591789|NCT02626520|18686314|P1|COMPLETED|Overall Study||0
7591790|NCT02626520|18686313|P2|STARTED|Overall Study||10
7591791|NCT02626520|18686314|P1|STARTED|Overall Study||1
7591792|NCT02626182|18686326|P2|NOT COMPLETED|Overall Study||0
7591793|NCT02626182|18686327|P1|NOT COMPLETED|Overall Study||2
7591794|NCT02626182|18686326|P2|COMPLETED|Overall Study||3
7591795|NCT02626182|18686327|P1|COMPLETED|Overall Study||9
7591796|NCT02626182|18686326|P2|STARTED|Overall Study||3
7591797|NCT02626182|18686327|P1|STARTED|Overall Study||11
7591798|NCT02626026|18686343|P6|NOT COMPLETED|Overall Study||0
7591799|NCT02626026|18686344|P5|NOT COMPLETED|Overall Study||1
7591800|NCT02626026|18686345|P4|NOT COMPLETED|Overall Study||0
7591801|NCT02626026|18686346|P3|NOT COMPLETED|Overall Study||0
7591802|NCT02626026|18686347|P2|NOT COMPLETED|Overall Study||0
7591803|NCT02626026|18686348|P1|NOT COMPLETED|Overall Study||0
7591804|NCT02626026|18686343|P6|COMPLETED|Overall Study||5
7591805|NCT02626026|18686344|P5|COMPLETED|Overall Study||16
7591806|NCT02626026|18686345|P4|COMPLETED|Overall Study||2
7591807|NCT02626026|18686346|P3|COMPLETED|Overall Study||8
7591808|NCT02626026|18686347|P2|COMPLETED|Overall Study||2
7591809|NCT02626026|18686348|P1|COMPLETED|Overall Study||8
7591810|NCT02626026|18686343|P6|STARTED|Overall Study||5
7591811|NCT02626026|18686344|P5|STARTED|Overall Study||17
7591812|NCT02626026|18686345|P4|STARTED|Overall Study||2
7591813|NCT02626026|18686346|P3|STARTED|Overall Study||8
7591814|NCT02626026|18686347|P2|STARTED|Overall Study||2
7591815|NCT02626026|18686348|P1|STARTED|Overall Study||8
7591816|NCT02626000|18686426|P1|NOT COMPLETED|Overall Study||36
7591817|NCT02626000|18686426|P1|COMPLETED|Overall Study||0
7591818|NCT02626000|18686426|P1|STARTED|Overall Study||36
7591819|NCT02625974|18686440|P2|NOT COMPLETED|Overall Study||6
7591820|NCT02625974|18686441|P1|NOT COMPLETED|Overall Study||16
7591821|NCT02625974|18686440|P2|COMPLETED|Overall Study||105
7591822|NCT02625974|18686441|P1|COMPLETED|Overall Study||203
7591823|NCT02625974|18686440|P2|Received Treatment|Overall Study||111
7591824|NCT02625974|18686441|P1|Received Treatment|Overall Study||219
7591825|NCT02625974|18686440|P2|STARTED|Overall Study||111
7591826|NCT02625974|18686441|P1|STARTED|Overall Study||219
7591827|NCT02625922|18686551|P2|NOT COMPLETED|Overall Study||2
7591828|NCT02625922|18686552|P1|NOT COMPLETED|Overall Study||2
7591829|NCT02625922|18686551|P2|COMPLETED|Overall Study||10
7591830|NCT02625922|18686552|P1|COMPLETED|Overall Study||12
7591831|NCT02625922|18686551|P2|Completed Treatment Period 2|Overall Study||8
7591832|NCT02625922|18686552|P1|Completed Treatment Period 2|Overall Study||11
7591833|NCT02625922|18686551|P2|Completed Treatment Period 1|Overall Study||10
7591834|NCT02625922|18686552|P1|Completed Treatment Period 1|Overall Study||12
7591835|NCT02625922|18686551|P2|STARTED|Overall Study||12
7591836|NCT02625922|18686552|P1|STARTED|Overall Study||14
7591837|NCT02625844|18686565|P1|NOT COMPLETED|Overall Study||0
7591838|NCT02625844|18686565|P1|COMPLETED|Overall Study||110
7591839|NCT02625844|18686565|P1|STARTED|Overall Study||110
7591840|NCT02625623|18686571|P2|NOT COMPLETED|Overall Study||1
7591841|NCT02625623|18686572|P1|NOT COMPLETED|Overall Study||9
7591842|NCT02625623|18686571|P2|COMPLETED|Overall Study||184
7591843|NCT02625623|18686572|P1|COMPLETED|Overall Study||177
7591844|NCT02625623|18686571|P2|Treated|Overall Study||184
7591845|NCT02625623|18686572|P1|Treated|Overall Study||177
7591846|NCT02625623|18686571|P2|STARTED|Overall Study||185
7591847|NCT02625623|18686572|P1|STARTED|Overall Study||186
7591848|NCT02625571|18686592|P1|NOT COMPLETED|Overall Study||3
7591849|NCT02625571|18686592|P1|COMPLETED|Overall Study||10
7591850|NCT02625571|18686592|P1|STARTED|Overall Study||13
7591851|NCT02625545|18686597|P1|NOT COMPLETED|Overall Study||0
7591852|NCT02625545|18686597|P1|COMPLETED|Overall Study||45
7591853|NCT02625545|18686597|P1|12 Month|Overall Study||45
7591854|NCT02625545|18686597|P1|6 Month|Overall Study||45
7591855|NCT02625545|18686597|P1|3 Month|Overall Study||45
7591856|NCT02625545|18686597|P1|STARTED|Overall Study||45
7591857|NCT02625428|18686613|P2|NOT COMPLETED|Overall Study||0
7591858|NCT02625428|18686614|P1|NOT COMPLETED|Overall Study||0
7591859|NCT02625428|18686613|P2|COMPLETED|Overall Study||20
7591860|NCT02625428|18686614|P1|COMPLETED|Overall Study||20
7591861|NCT02625428|18686613|P2|STARTED|Overall Study||20
7591862|NCT02625428|18686614|P1|STARTED|Overall Study||20
7591863|NCT02625402|18686624|P2|NOT COMPLETED|Overall Study||12
7591864|NCT02625402|18686625|P1|NOT COMPLETED|Overall Study||9
7591865|NCT02625402|18686624|P2|COMPLETED|Overall Study||25
7591866|NCT02625402|18686625|P1|COMPLETED|Overall Study||33
7591867|NCT02625402|18686624|P2|STARTED|Overall Study||37
7591868|NCT02625402|18686625|P1|STARTED|Overall Study||42
7591869|NCT02625324|18686635|P1|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
7591870|NCT02625324|18686635|P1|COMPLETED|12-Month Follow-up Secondary Endpoint||87
7591871|NCT02625324|18686635|P1|STARTED|12-Month Follow-up Secondary Endpoint||91
7591872|NCT02625324|18686635|P1|NOT COMPLETED|6-Month Follow-up Subject Accountability||8
7591873|NCT02625324|18686635|P1|COMPLETED|6-Month Follow-up Subject Accountability||91
7591874|NCT02625324|18686635|P1|STARTED|6-Month Follow-up Subject Accountability|Note that 6-month follow up is not mandatory for OUS subjects|99
7591875|NCT02625324|18686635|P1|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
7591876|NCT02625324|18686635|P1|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
7591877|NCT02625324|18686635|P1|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
7591878|NCT02625324|18686635|P1|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
7591879|NCT02625324|18686635|P1|COMPLETED|30-Day Follow-up for Primary Endpoint||86
7591880|NCT02625324|18686635|P1|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
7591881|NCT02625298|18686646|P2|NOT COMPLETED|Overall Study||0
7591882|NCT02625298|18686647|P1|NOT COMPLETED|Overall Study||1
7591883|NCT02625298|18686646|P2|COMPLETED|Overall Study||13
7591884|NCT02625298|18686647|P1|COMPLETED|Overall Study||10
7591885|NCT02625298|18686646|P2|STARTED|Overall Study||13
7591886|NCT02625298|18686647|P1|STARTED|Overall Study||11
7591887|NCT02625259|18686660|P5|NOT COMPLETED|Second Intervention (Day 15)||0
7591888|NCT02625259|18686661|P4|NOT COMPLETED|Second Intervention (Day 15)||0
7591889|NCT02625259|18686662|P3|NOT COMPLETED|Second Intervention (Day 15)||0
7591890|NCT02625259|18686663|P2|NOT COMPLETED|Second Intervention (Day 15)||0
7591891|NCT02625259|18686664|P1|NOT COMPLETED|Second Intervention (Day 15)||0
7591892|NCT02625259|18686660|P5|COMPLETED|Second Intervention (Day 15)||0
7591893|NCT02625259|18686661|P4|COMPLETED|Second Intervention (Day 15)||9
7591894|NCT02625259|18686662|P3|COMPLETED|Second Intervention (Day 15)||7
7591895|NCT02625259|18686663|P2|COMPLETED|Second Intervention (Day 15)||8
7591896|NCT02625259|18686664|P1|COMPLETED|Second Intervention (Day 15)||9
7591897|NCT02625259|18686660|P5|STARTED|Second Intervention (Day 15)||0
7591898|NCT02625259|18686661|P4|STARTED|Second Intervention (Day 15)||9
7591899|NCT02625259|18686662|P3|STARTED|Second Intervention (Day 15)||7
7591900|NCT02625259|18686663|P2|STARTED|Second Intervention (Day 15)||8
7591901|NCT02625259|18686664|P1|STARTED|Second Intervention (Day 15)||9
7591902|NCT02625259|18686660|P5|NOT COMPLETED|Washout (Day 2 to Day 14)||0
7591903|NCT02625259|18686661|P4|NOT COMPLETED|Washout (Day 2 to Day 14)||0
7591904|NCT02625259|18686662|P3|NOT COMPLETED|Washout (Day 2 to Day 14)||0
7591905|NCT02625259|18686663|P2|NOT COMPLETED|Washout (Day 2 to Day 14)||0
7591906|NCT02625259|18686664|P1|NOT COMPLETED|Washout (Day 2 to Day 14)||0
7591907|NCT02625259|18686660|P5|COMPLETED|Washout (Day 2 to Day 14)||0
7591908|NCT02625259|18686661|P4|COMPLETED|Washout (Day 2 to Day 14)||9
7591909|NCT02625259|18686662|P3|COMPLETED|Washout (Day 2 to Day 14)||7
7591910|NCT02625259|18686663|P2|COMPLETED|Washout (Day 2 to Day 14)||8
7591911|NCT02625259|18686664|P1|COMPLETED|Washout (Day 2 to Day 14)||9
7591912|NCT02625259|18686660|P5|STARTED|Washout (Day 2 to Day 14)||0
7591913|NCT02625259|18686661|P4|STARTED|Washout (Day 2 to Day 14)||9
7591914|NCT02625259|18686662|P3|STARTED|Washout (Day 2 to Day 14)||7
7591915|NCT02625259|18686663|P2|STARTED|Washout (Day 2 to Day 14)||8
7591916|NCT02625259|18686664|P1|STARTED|Washout (Day 2 to Day 14)||9
7591917|NCT02625259|18686660|P5|NOT COMPLETED|First Intervention (Day 1)||0
7591918|NCT02625259|18686661|P4|NOT COMPLETED|First Intervention (Day 1)||1
7591919|NCT02625259|18686662|P3|NOT COMPLETED|First Intervention (Day 1)||1
7591920|NCT02625259|18686663|P2|NOT COMPLETED|First Intervention (Day 1)||1
7591921|NCT02625259|18686664|P1|NOT COMPLETED|First Intervention (Day 1)||2
7591922|NCT02625259|18686660|P5|COMPLETED|First Intervention (Day 1)||16
7591923|NCT02625259|18686661|P4|COMPLETED|First Intervention (Day 1)||9
7591924|NCT02625259|18686662|P3|COMPLETED|First Intervention (Day 1)||7
7591925|NCT02625259|18686663|P2|COMPLETED|First Intervention (Day 1)||8
7591926|NCT02625259|18686664|P1|COMPLETED|First Intervention (Day 1)||9
7591927|NCT02625259|18686660|P5|STARTED|First Intervention (Day 1)||16
7591928|NCT02625259|18686661|P4|STARTED|First Intervention (Day 1)||10
7591929|NCT02625259|18686662|P3|STARTED|First Intervention (Day 1)||8
7591930|NCT02625259|18686663|P2|STARTED|First Intervention (Day 1)||9
7591931|NCT02625259|18686664|P1|STARTED|First Intervention (Day 1)||11
7591932|NCT02625233|18686701|P2|NOT COMPLETED|Overall Study||0
7591933|NCT02625233|18686702|P1|NOT COMPLETED|Overall Study||2
7591934|NCT02625233|18686701|P2|COMPLETED|Overall Study||56
7591935|NCT02625233|18686702|P1|COMPLETED|Overall Study||47
7591936|NCT02625233|18686701|P2|STARTED|Overall Study||56
7591937|NCT02625233|18686702|P1|STARTED|Overall Study||49
7591938|NCT02625220|18686710|P1|NOT COMPLETED|Overall Study||7
7591939|NCT02625220|18686710|P1|COMPLETED|Overall Study||163
7591940|NCT02625220|18686710|P1|STARTED|Overall Study||170
7591941|NCT02625207|18686721|P4|NOT COMPLETED|Part 2 (11 Days)||0
7591942|NCT02625207|18686722|P3|NOT COMPLETED|Part 2 (11 Days)||0
7591943|NCT02625207|18686723|P2|NOT COMPLETED|Part 2 (11 Days)||0
7591944|NCT02625207|18686724|P1|NOT COMPLETED|Part 2 (11 Days)||0
7591945|NCT02625207|18686721|P4|COMPLETED|Part 2 (11 Days)||0
7591946|NCT02625207|18686722|P3|COMPLETED|Part 2 (11 Days)||12
7591947|NCT02625207|18686723|P2|COMPLETED|Part 2 (11 Days)||0
7591948|NCT02625207|18686724|P1|COMPLETED|Part 2 (11 Days)||11
7591949|NCT02625207|18686721|P4|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
7591950|NCT02625207|18686722|P3|STARTED|Part 2 (11 Days)||12
7591951|NCT02625207|18686723|P2|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
7591952|NCT02625207|18686724|P1|STARTED|Part 2 (11 Days)||11
7591953|NCT02625207|18686721|P4|NOT COMPLETED|Part 1 (6 Days)||0
7591954|NCT02625207|18686722|P3|NOT COMPLETED|Part 1 (6 Days)||0
7591955|NCT02625207|18686723|P2|NOT COMPLETED|Part 1 (6 Days)||0
7591956|NCT02625207|18686724|P1|NOT COMPLETED|Part 1 (6 Days)||0
7591957|NCT02625207|18686721|P4|COMPLETED|Part 1 (6 Days)||12
7591958|NCT02625207|18686722|P3|COMPLETED|Part 1 (6 Days)||12
7591959|NCT02625207|18686723|P2|COMPLETED|Part 1 (6 Days)||12
7591960|NCT02625207|18686724|P1|COMPLETED|Part 1 (6 Days)||11
7591961|NCT02625207|18686721|P4|STARTED|Part 1 (6 Days)||12
7591962|NCT02625207|18686722|P3|STARTED|Part 1 (6 Days)||12
7591963|NCT02625207|18686723|P2|STARTED|Part 1 (6 Days)||12
7591964|NCT02625207|18686724|P1|STARTED|Part 1 (6 Days)||11
7591965|NCT02625181|18686813|P3|NOT COMPLETED|Overall Study||0
7591966|NCT02625181|18686814|P2|NOT COMPLETED|Overall Study||0
7591967|NCT02625181|18686815|P1|NOT COMPLETED|Overall Study||0
7591968|NCT02625181|18686813|P3|COMPLETED|Overall Study||12707
7591969|NCT02625181|18686814|P2|COMPLETED|Overall Study||12809
7591970|NCT02625181|18686815|P1|COMPLETED|Overall Study||1518
7591971|NCT02625181|18686813|P3|STARTED|Overall Study||12707
7591972|NCT02625181|18686814|P2|STARTED|Overall Study||12809
7591973|NCT02625181|18686815|P1|STARTED|Overall Study||1518
7591974|NCT02624986|18686838|P8|NOT COMPLETED|Overall Study||5
7591975|NCT02624986|18686839|P7|NOT COMPLETED|Overall Study||4
7591976|NCT02624986|18686840|P6|NOT COMPLETED|Overall Study||2
7591977|NCT02624986|18686841|P5|NOT COMPLETED|Overall Study||4
7591978|NCT02624986|18686842|P4|NOT COMPLETED|Overall Study||3
7591979|NCT02624986|18686843|P3|NOT COMPLETED|Overall Study||2
7591980|NCT02624986|18686844|P2|NOT COMPLETED|Overall Study||3
7591981|NCT02624986|18686845|P1|NOT COMPLETED|Overall Study||2
7591982|NCT02624986|18686838|P8|COMPLETED|Overall Study||0
7591983|NCT02624986|18686839|P7|COMPLETED|Overall Study||0
7591984|NCT02624986|18686840|P6|COMPLETED|Overall Study||0
7591985|NCT02624986|18686841|P5|COMPLETED|Overall Study||0
7591986|NCT02624986|18686842|P4|COMPLETED|Overall Study||0
7591987|NCT02624986|18686843|P3|COMPLETED|Overall Study||0
7591988|NCT02624986|18686844|P2|COMPLETED|Overall Study||0
7591989|NCT02624986|18686845|P1|COMPLETED|Overall Study||0
7591990|NCT02624986|18686838|P8|Received Any Study Treatment|Overall Study||5
7591991|NCT02624986|18686839|P7|Received Any Study Treatment|Overall Study||4
7591992|NCT02624986|18686840|P6|Received Any Study Treatment|Overall Study||2
7591993|NCT02624986|18686841|P5|Received Any Study Treatment|Overall Study||4
7591994|NCT02624986|18686842|P4|Received Any Study Treatment|Overall Study||3
7591995|NCT02624986|18686843|P3|Received Any Study Treatment|Overall Study||2
7591996|NCT02624986|18686844|P2|Received Any Study Treatment|Overall Study||3
7591997|NCT02624986|18686845|P1|Received Any Study Treatment|Overall Study||1
7591998|NCT02624986|18686838|P8|STARTED|Overall Study||5
7591999|NCT02624986|18686839|P7|STARTED|Overall Study||4
7592000|NCT02624986|18686840|P6|STARTED|Overall Study||2
7592001|NCT02624986|18686841|P5|STARTED|Overall Study||4
7592002|NCT02624986|18686842|P4|STARTED|Overall Study||3
7592003|NCT02624986|18686843|P3|STARTED|Overall Study||2
7592004|NCT02624986|18686844|P2|STARTED|Overall Study||3
7592005|NCT02624986|18686845|P1|STARTED|Overall Study||2
7592006|NCT02624843|18687025|P3|NOT COMPLETED|Overall Study||8
7592007|NCT02624843|18687026|P2|NOT COMPLETED|Overall Study||36
7592008|NCT02624843|18687027|P1|NOT COMPLETED|Overall Study||37
7592009|NCT02624843|18687025|P3|COMPLETED|Overall Study||16
7592010|NCT02624843|18687026|P2|COMPLETED|Overall Study||72
7592011|NCT02624843|18687027|P1|COMPLETED|Overall Study||70
7592012|NCT02624843|18687025|P3|STARTED|Overall Study||24
7592013|NCT02624843|18687026|P2|STARTED|Overall Study||108
7592014|NCT02624843|18687027|P1|STARTED|Overall Study||107
7592015|NCT02624791|18687035|P6|NOT COMPLETED|Overall Study||0
7592016|NCT02624791|18687036|P5|NOT COMPLETED|Overall Study||0
7592017|NCT02624791|18687037|P4|NOT COMPLETED|Overall Study||0
7592018|NCT02624791|18687038|P3|NOT COMPLETED|Overall Study||0
7592019|NCT02624791|18687039|P2|NOT COMPLETED|Overall Study||0
7592020|NCT02624791|18687040|P1|NOT COMPLETED|Overall Study||2
7592021|NCT02624791|18687035|P6|COMPLETED|Overall Study||2
7592022|NCT02624791|18687036|P5|COMPLETED|Overall Study||2
7592023|NCT02624791|18687037|P4|COMPLETED|Overall Study||2
7592024|NCT02624791|18687038|P3|COMPLETED|Overall Study||2
7592025|NCT02624791|18687039|P2|COMPLETED|Overall Study||1
7592026|NCT02624791|18687040|P1|COMPLETED|Overall Study||0
7592027|NCT02624791|18687035|P6|STARTED|Overall Study||2
7592028|NCT02624791|18687036|P5|STARTED|Overall Study||2
7592029|NCT02624791|18687037|P4|STARTED|Overall Study||2
7592030|NCT02624791|18687038|P3|STARTED|Overall Study||2
7592031|NCT02624791|18687039|P2|STARTED|Overall Study||1
7592032|NCT02624791|18687040|P1|STARTED|Overall Study||2
7592033|NCT02624713|18687047|P2|NOT COMPLETED|Overall Study||0
7592034|NCT02624713|18687048|P1|NOT COMPLETED|Overall Study||14
7592035|NCT02624713|18687047|P2|COMPLETED|Overall Study||81
7592036|NCT02624713|18687048|P1|COMPLETED|Overall Study||64
7592037|NCT02624713|18687047|P2|STARTED|Overall Study||81
7592038|NCT02624713|18687048|P1|STARTED|Overall Study||78
7592039|NCT02624700|18687057|P2|NOT COMPLETED|Overall Study||0
7592040|NCT02624700|18687058|P1|NOT COMPLETED|Overall Study||0
7592041|NCT02624700|18687057|P2|COMPLETED|Overall Study||4
7592042|NCT02624700|18687058|P1|COMPLETED|Overall Study||9
7592043|NCT02624700|18687057|P2|STARTED|Overall Study||4
7592044|NCT02624700|18687058|P1|STARTED|Overall Study||9
7592045|NCT02624687|18687072|P2|NOT COMPLETED|Overall Study||2
7592046|NCT02624687|18687073|P1|NOT COMPLETED|Overall Study||1
7592047|NCT02624687|18687072|P2|COMPLETED|Overall Study||12
7592048|NCT02624687|18687073|P1|COMPLETED|Overall Study||12
7592049|NCT02624687|18687072|P2|STARTED|Overall Study||14
7592050|NCT02624687|18687073|P1|STARTED|Overall Study||13
7592051|NCT02624492|18687104|P3|NOT COMPLETED|Overall Study||5
7592052|NCT02624492|18687105|P2|NOT COMPLETED|Overall Study||4
7592053|NCT02624492|18687106|P1|NOT COMPLETED|Overall Study||2
7592054|NCT02624492|18687104|P3|COMPLETED|Overall Study||3
7592055|NCT02624492|18687105|P2|COMPLETED|Overall Study||4
7592056|NCT02624492|18687106|P1|COMPLETED|Overall Study||3
7592057|NCT02624492|18687104|P3|STARTED|Overall Study||8
7592058|NCT02624492|18687105|P2|STARTED|Overall Study||8
7592059|NCT02624492|18687106|P1|STARTED|Overall Study||5
7592060|NCT02624375|18687132|P1|NOT COMPLETED|Overall Study||0
7592061|NCT02624375|18687132|P1|COMPLETED|Overall Study||10
7592062|NCT02624375|18687132|P1|STARTED|Overall Study||10
7592063|NCT02624284|18687141|P3|NOT COMPLETED|Overall Study||11
7592064|NCT02624284|18687142|P2|NOT COMPLETED|Overall Study||18
7592065|NCT02624284|18687143|P1|NOT COMPLETED|Overall Study||14
7592066|NCT02624284|18687141|P3|COMPLETED|Overall Study||36
7592067|NCT02624284|18687142|P2|COMPLETED|Overall Study||35
7592068|NCT02624284|18687143|P1|COMPLETED|Overall Study||35
7592069|NCT02624284|18687141|P3|STARTED|Overall Study||47
7592070|NCT02624284|18687142|P2|STARTED|Overall Study||53
7592071|NCT02624284|18687143|P1|STARTED|Overall Study||49
7592072|NCT02624050|18687162|P2|NOT COMPLETED|Overall Study||0
7592073|NCT02624050|18687163|P1|NOT COMPLETED|Overall Study||6
7592074|NCT02624050|18687162|P2|COMPLETED|Overall Study||25
7592075|NCT02624050|18687163|P1|COMPLETED|Overall Study||20
7592076|NCT02624050|18687162|P2|STARTED|Overall Study||25
7592077|NCT02624050|18687163|P1|STARTED|Overall Study||26
7592078|NCT02623959|18687191|P2|NOT COMPLETED|Overall Study||1
7592079|NCT02623959|18687192|P1|NOT COMPLETED|Overall Study||0
7592080|NCT02623959|18687191|P2|COMPLETED|Overall Study|due to progression|0
7592081|NCT02623959|18687192|P1|COMPLETED|Overall Study||0
7592082|NCT02623959|18687191|P2|STARTED|Overall Study||1
7592083|NCT02623959|18687192|P1|STARTED|Overall Study||0
7592084|NCT02623855|18687202|P2|NOT COMPLETED|Overall Study||16
7592085|NCT02623855|18687203|P1|NOT COMPLETED|Overall Study||10
7592086|NCT02623855|18687202|P2|COMPLETED|Overall Study||84
7592087|NCT02623855|18687203|P1|COMPLETED|Overall Study||46
7592088|NCT02623855|18687202|P2|STARTED|Overall Study||100
7592089|NCT02623855|18687203|P1|STARTED|Overall Study||56
7592090|NCT02623829|18687225|P2|NOT COMPLETED|Overall Study||1
7592091|NCT02623829|18687226|P1|NOT COMPLETED|Overall Study||1
7592092|NCT02623829|18687225|P2|COMPLETED|Overall Study||20
7592093|NCT02623829|18687226|P1|COMPLETED|Overall Study||20
7592094|NCT02623829|18687225|P2|STARTED|Overall Study||21
7592095|NCT02623829|18687226|P1|STARTED|Overall Study||21
7592096|NCT02623803|18687238|P2|NOT COMPLETED|Overall Study||0
7592097|NCT02623803|18687239|P1|NOT COMPLETED|Overall Study||0
7592098|NCT02623803|18687238|P2|COMPLETED|Overall Study||23
7592099|NCT02623803|18687239|P1|COMPLETED|Overall Study||25
7592100|NCT02623803|18687238|P2|STARTED|Overall Study||23
7592101|NCT02623803|18687239|P1|STARTED|Overall Study||25
7592102|NCT02623725|18687285|P2|NOT COMPLETED|Overall Study||6
7592103|NCT02623725|18687286|P1|NOT COMPLETED|Overall Study||16
7592104|NCT02623725|18687285|P2|COMPLETED|Overall Study||58
7592105|NCT02623725|18687286|P1|COMPLETED|Overall Study||171
7592106|NCT02623725|18687285|P2|STARTED|Overall Study||64
7592107|NCT02623725|18687286|P1|STARTED|Overall Study||187
7592108|NCT02623361|18687320|P2|NOT COMPLETED|Overall Study||2
7592109|NCT02623361|18687321|P1|NOT COMPLETED|Overall Study||0
7592110|NCT02623361|18687320|P2|COMPLETED|Overall Study||38
7592111|NCT02623361|18687321|P1|COMPLETED|Overall Study||40
7592112|NCT02623361|18687320|P2|STARTED|Overall Study||40
7592113|NCT02623361|18687321|P1|STARTED|Overall Study||40
7592114|NCT02623348|18687333|P2|NOT COMPLETED|Overall Study||2
7592115|NCT02623348|18687334|P1|NOT COMPLETED|Overall Study||3
7592116|NCT02623348|18687333|P2|COMPLETED|Overall Study||28
7592117|NCT02623348|18687334|P1|COMPLETED|Overall Study||27
7592118|NCT02623348|18687333|P2|3-month Assessment|Overall Study||26
7592119|NCT02623348|18687334|P1|3-month Assessment|Overall Study||27
7592120|NCT02623348|18687333|P2|STARTED|Overall Study||30
7592121|NCT02623348|18687334|P1|STARTED|Overall Study||30
7592122|NCT02623335|18687360|P2|NOT COMPLETED|Overall Study||36
7592123|NCT02623335|18687361|P1|NOT COMPLETED|Overall Study||27
7592124|NCT02623335|18687360|P2|COMPLETED|Overall Study||187
7592125|NCT02623335|18687361|P1|COMPLETED|Overall Study||196
7592126|NCT02623335|18687360|P2|T3 Survey (12-14 Weeks)|Overall Study||187
7592127|NCT02623335|18687361|P1|T3 Survey (12-14 Weeks)|Overall Study||196
7592128|NCT02623335|18687360|P2|T2 Survey (6-8 Weeks)|Overall Study||192
7592129|NCT02623335|18687361|P1|T2 Survey (6-8 Weeks)|Overall Study||199
7592130|NCT02623335|18687360|P2|T1 Survey (24-48 Hours)|Overall Study||214
7592131|NCT02623335|18687361|P1|T1 Survey (24-48 Hours)|Overall Study||216
7592132|NCT02623335|18687360|P2|T0 Audio Recording (Day of Consultation)|Overall Study||222
7592133|NCT02623335|18687361|P1|T0 Audio Recording (Day of Consultation)|Overall Study||223
7592134|NCT02623335|18687360|P2|STARTED|Overall Study||223
7592135|NCT02623335|18687361|P1|STARTED|Overall Study||223
7592136|NCT02623322|18687388|P3|NOT COMPLETED|Overall Study||0
7592137|NCT02623322|18687389|P2|NOT COMPLETED|Overall Study||1
7592138|NCT02623322|18687390|P1|NOT COMPLETED|Overall Study||2
7592139|NCT02623322|18687388|P3|COMPLETED|Overall Study||40
7592140|NCT02623322|18687389|P2|COMPLETED|Overall Study||40
7592141|NCT02623322|18687390|P1|COMPLETED|Overall Study||41
7592142|NCT02623322|18687388|P3|STARTED|Overall Study||40
7592143|NCT02623322|18687389|P2|STARTED|Overall Study||41
7592144|NCT02623322|18687390|P1|STARTED|Overall Study||43
7592145|NCT02623218|18687428|P5|NOT COMPLETED|Overall Study||0
7592146|NCT02623218|18687429|P4|NOT COMPLETED|Overall Study||0
7592147|NCT02623218|18687430|P3|NOT COMPLETED|Overall Study||0
7592148|NCT02623218|18687431|P2|NOT COMPLETED|Overall Study||1
7592149|NCT02623218|18687432|P1|NOT COMPLETED|Overall Study||0
7592150|NCT02623218|18687428|P5|COMPLETED|Overall Study||4
7592151|NCT02623218|18687429|P4|COMPLETED|Overall Study||4
7592152|NCT02623218|18687430|P3|COMPLETED|Overall Study||4
7592153|NCT02623218|18687431|P2|COMPLETED|Overall Study||3
7592154|NCT02623218|18687432|P1|COMPLETED|Overall Study||5
7592155|NCT02623218|18687428|P5|STARTED|Overall Study||4
7592156|NCT02623218|18687429|P4|STARTED|Overall Study||4
7592157|NCT02623218|18687430|P3|STARTED|Overall Study||4
7592158|NCT02623218|18687431|P2|STARTED|Overall Study||4
7592159|NCT02623218|18687432|P1|STARTED|Overall Study||5
7592160|NCT02622828|18687454|P1|NOT COMPLETED|Overall Study||3
7592161|NCT02622828|18687454|P1|COMPLETED|Overall Study||1
7592162|NCT02622828|18687454|P1|STARTED|Overall Study||4
7592163|NCT02622724|18687461|P2|NOT COMPLETED|Overall Study||103
7592164|NCT02622724|18687462|P1|NOT COMPLETED|Overall Study||93
7592165|NCT02622724|18687461|P2|COMPLETED|Overall Study||49
7592166|NCT02622724|18687462|P1|COMPLETED|Overall Study||51
7592167|NCT02622724|18687461|P2|Long-Term Follow-Up (Day 180)|Overall Study||74
7592168|NCT02622724|18687462|P1|Long-Term Follow-Up (Day 180)|Overall Study||73
7592169|NCT02622724|18687461|P2|Long-Term Follow-Up (Day 90)|Overall Study||101
7592170|NCT02622724|18687462|P1|Long-Term Follow-Up (Day 90)|Overall Study||96
7592171|NCT02622724|18687461|P2|Short-Term Follow-Up (Day 28)|Overall Study||115
7592172|NCT02622724|18687462|P1|Short-Term Follow-Up (Day 28)|Overall Study||105
7592173|NCT02622724|18687461|P2|Subjects Randomised|Overall Study||155
7592174|NCT02622724|18687462|P1|Subjects Randomised|Overall Study||146
7592175|NCT02622724|18687461|P2|STARTED|Overall Study||152
7592176|NCT02622724|18687462|P1|STARTED|Overall Study||144
7592177|NCT02622568|18687540|P2|NOT COMPLETED|Overall Study||5
7592178|NCT02622568|18687541|P1|NOT COMPLETED|Overall Study||5
7592179|NCT02622568|18687540|P2|COMPLETED|Overall Study||9
7592180|NCT02622568|18687541|P1|COMPLETED|Overall Study||9
7592181|NCT02622568|18687540|P2|STARTED|Overall Study||14
7592182|NCT02622568|18687541|P1|STARTED|Overall Study||14
7592183|NCT02622321|18687551|P4|NOT COMPLETED|Overall Study||7
7592184|NCT02622321|18687552|P3|NOT COMPLETED|Overall Study||49
7592185|NCT02622321|18687553|P2|NOT COMPLETED|Overall Study||18
7592186|NCT02622321|18687554|P1|NOT COMPLETED|Overall Study||35
7592187|NCT02622321|18687551|P4|COMPLETED|Overall Study||0
7592188|NCT02622321|18687552|P3|COMPLETED|Overall Study||0
7592189|NCT02622321|18687553|P2|COMPLETED|Overall Study||0
7592190|NCT02622321|18687554|P1|COMPLETED|Overall Study||0
7592191|NCT02622321|18687551|P4|Treated|Overall Study||7
7592192|NCT02622321|18687552|P3|Treated|Overall Study||49
7592193|NCT02622321|18687553|P2|Treated|Overall Study||18
7592194|NCT02622321|18687554|P1|Treated|Overall Study||34
7592195|NCT02622321|18687551|P4|STARTED|Overall Study||7
7592196|NCT02622321|18687552|P3|STARTED|Overall Study||49
7592197|NCT02622321|18687553|P2|STARTED|Overall Study||18
7592198|NCT02622321|18687554|P1|STARTED|Overall Study||35
7592199|NCT02622191|18687599|P2|NOT COMPLETED|Overall Study||0
7592200|NCT02622191|18687600|P1|NOT COMPLETED|Overall Study||0
7592201|NCT02622191|18687599|P2|COMPLETED|Overall Study||14
7592202|NCT02622191|18687600|P1|COMPLETED|Overall Study||19
7592203|NCT02622191|18687599|P2|STARTED|Overall Study||14
7592204|NCT02622191|18687600|P1|STARTED|Overall Study||19
7592205|NCT02622178|18687610|P3|NOT COMPLETED|Overall Study||0
7592206|NCT02622178|18687611|P2|NOT COMPLETED|Overall Study||0
7592207|NCT02622178|18687612|P1|NOT COMPLETED|Overall Study||0
7592208|NCT02622178|18687610|P3|COMPLETED|Overall Study||49
7592209|NCT02622178|18687611|P2|COMPLETED|Overall Study||45
7592210|NCT02622178|18687612|P1|COMPLETED|Overall Study||42
7592211|NCT02622178|18687610|P3|STARTED|Overall Study||49
7592212|NCT02622178|18687611|P2|STARTED|Overall Study||45
7592213|NCT02622178|18687612|P1|STARTED|Overall Study||42
7592214|NCT02622113|18687625|P2|NOT COMPLETED|Overall Study||10
7592215|NCT02622113|18687626|P1|NOT COMPLETED|Overall Study||5
7592216|NCT02622113|18687625|P2|COMPLETED|Overall Study||66
7592217|NCT02622113|18687626|P1|COMPLETED|Overall Study||62
7592218|NCT02622113|18687625|P2|STARTED|Overall Study||76
7592219|NCT02622113|18687626|P1|STARTED|Overall Study||67
7592220|NCT02622074|18687644|P6|NOT COMPLETED|Overall Study||0
7592221|NCT02622074|18687645|P5|NOT COMPLETED|Overall Study||1
7592222|NCT02622074|18687646|P4|NOT COMPLETED|Overall Study||1
7592223|NCT02622074|18687647|P3|NOT COMPLETED|Overall Study||0
7592224|NCT02622074|18687648|P2|NOT COMPLETED|Overall Study||1
7592225|NCT02622074|18687649|P1|NOT COMPLETED|Overall Study||4
7592226|NCT02622074|18687644|P6|COMPLETED|Overall Study||10
7592227|NCT02622074|18687645|P5|COMPLETED|Overall Study||9
7592228|NCT02622074|18687646|P4|COMPLETED|Overall Study||9
7592229|NCT02622074|18687647|P3|COMPLETED|Overall Study||10
7592230|NCT02622074|18687648|P2|COMPLETED|Overall Study||9
7592231|NCT02622074|18687649|P1|COMPLETED|Overall Study||6
7592232|NCT02622074|18687644|P6|STARTED|Overall Study||10
7592233|NCT02622074|18687645|P5|STARTED|Overall Study||10
7592234|NCT02622074|18687646|P4|STARTED|Overall Study||10
7592235|NCT02622074|18687647|P3|STARTED|Overall Study||10
7592236|NCT02622074|18687648|P2|STARTED|Overall Study||10
7592237|NCT02622074|18687649|P1|STARTED|Overall Study||10
7592238|NCT02621983|18687737|P2|NOT COMPLETED|Overall Study||11
7592239|NCT02621983|18687738|P1|NOT COMPLETED|Overall Study||12
7592240|NCT02621983|18687737|P2|COMPLETED|Overall Study||6
7592241|NCT02621983|18687738|P1|COMPLETED|Overall Study||9
7592242|NCT02621983|18687737|P2|STARTED|Overall Study||17
7592243|NCT02621983|18687738|P1|STARTED|Overall Study||21
7592244|NCT02621931|18687753|P3|NOT COMPLETED|Overall Study||36
7592245|NCT02621931|18687754|P2|NOT COMPLETED|Overall Study||27
7592246|NCT02621931|18687755|P1|NOT COMPLETED|Overall Study||33
7592247|NCT02621931|18687753|P3|COMPLETED|Overall Study||343
7592248|NCT02621931|18687754|P2|COMPLETED|Overall Study||349
7592249|NCT02621931|18687755|P1|COMPLETED|Overall Study||342
7592250|NCT02621931|18687753|P3|Full Analysis Set|Overall Study||375
7592251|NCT02621931|18687754|P2|Full Analysis Set|Overall Study||375
7592252|NCT02621931|18687755|P1|Full Analysis Set|Overall Study||371
7592253|NCT02621931|18687753|P3|Safety and ITT Populations|Overall Study||379
7592254|NCT02621931|18687754|P2|Safety and ITT Populations|Overall Study||376
7592255|NCT02621931|18687755|P1|Safety and ITT Populations|Overall Study||375
7592256|NCT02621931|18687753|P3|STARTED|Overall Study||379
7592257|NCT02621931|18687754|P2|STARTED|Overall Study||376
7592258|NCT02621931|18687755|P1|STARTED|Overall Study||375
7592259|NCT02621892|18687806|P2|NOT COMPLETED|Randomized Withdrawal Period||12
7592260|NCT02621892|18687807|P1|NOT COMPLETED|Randomized Withdrawal Period||11
7592261|NCT02621892|18687806|P2|COMPLETED|Randomized Withdrawal Period||260
7592262|NCT02621892|18687807|P1|COMPLETED|Randomized Withdrawal Period||250
7592263|NCT02621892|18687806|P2|STARTED|Randomized Withdrawal Period||272
7592264|NCT02621892|18687807|P1|STARTED|Randomized Withdrawal Period||261
7592265|NCT02621892|18687806|P2|NOT COMPLETED|Treatment Period||27
7592266|NCT02621892|18687807|P1|NOT COMPLETED|Treatment Period||46
7592267|NCT02621892|18687806|P2|COMPLETED|Treatment Period||272
7592268|NCT02621892|18687807|P1|COMPLETED|Treatment Period||261
7592269|NCT02621892|18687806|P2|STARTED|Treatment Period||299
7592270|NCT02621892|18687807|P1|STARTED|Treatment Period||307
7592271|NCT02621619|18687825|P2|NOT COMPLETED|Overall Study||0
7592272|NCT02621619|18687826|P1|NOT COMPLETED|Overall Study||0
7592273|NCT02621619|18687825|P2|COMPLETED|Overall Study||79
7592274|NCT02621619|18687826|P1|COMPLETED|Overall Study||80
7592275|NCT02621619|18687825|P2|STARTED|Overall Study||79
7592276|NCT02621619|18687826|P1|STARTED|Overall Study||80
7592277|NCT02621606|18687837|P3|NOT COMPLETED|Overall Study||0
7592278|NCT02621606|18687838|P2|NOT COMPLETED|Overall Study||1
7592279|NCT02621606|18687839|P1|NOT COMPLETED|Overall Study||0
7592280|NCT02621606|18687837|P3|COMPLETED|Overall Study||10
7592281|NCT02621606|18687838|P2|COMPLETED|Overall Study||6
7592282|NCT02621606|18687839|P1|COMPLETED|Overall Study||3
7592283|NCT02621606|18687837|P3|Treated|Overall Study||10
7592284|NCT02621606|18687838|P2|Treated|Overall Study||7
7592285|NCT02621606|18687839|P1|Treated|Overall Study||3
7592286|NCT02621606|18687837|P3|STARTED|Overall Study||10
7592287|NCT02621606|18687838|P2|STARTED|Overall Study||7
7592288|NCT02621606|18687839|P1|STARTED|Overall Study||3
7592289|NCT02621424|18687867|P2|NOT COMPLETED|Overall Study||2
7592290|NCT02621424|18687868|P1|NOT COMPLETED|Overall Study||1
7592291|NCT02621424|18687867|P2|COMPLETED|Overall Study||16
7592292|NCT02621424|18687868|P1|COMPLETED|Overall Study||13
7592293|NCT02621424|18687867|P2|STARTED|Overall Study||18
7592294|NCT02621424|18687868|P1|STARTED|Overall Study||14
7592295|NCT02621073|18687876|P2|NOT COMPLETED|Overall Study||3
7592296|NCT02621073|18687877|P1|NOT COMPLETED|Overall Study||3
7592297|NCT02621073|18687876|P2|COMPLETED|Overall Study||0
7592298|NCT02621073|18687877|P1|COMPLETED|Overall Study||1
7592299|NCT02621073|18687876|P2|STARTED|Overall Study||3
7592300|NCT02621073|18687877|P1|STARTED|Overall Study||4
7592301|NCT02621060|18687887|P2|NOT COMPLETED|Overall Study||1
7592302|NCT02621060|18687888|P1|NOT COMPLETED|Overall Study||3
7592303|NCT02621060|18687887|P2|COMPLETED|Overall Study||14
7592304|NCT02621060|18687888|P1|COMPLETED|Overall Study||12
7592305|NCT02621060|18687887|P2|STARTED|Overall Study||15
7592306|NCT02621060|18687888|P1|STARTED|Overall Study||15
7592307|NCT02621047|18687939|P3|NOT COMPLETED|Overall Study||1
7592308|NCT02621047|18687940|P2|NOT COMPLETED|Overall Study||0
7592309|NCT02621047|18687941|P1|NOT COMPLETED|Overall Study||0
7592310|NCT02621047|18687939|P3|COMPLETED|Overall Study||11
7592311|NCT02621047|18687940|P2|COMPLETED|Overall Study||8
7592312|NCT02621047|18687941|P1|COMPLETED|Overall Study||8
7592313|NCT02621047|18687939|P3|STARTED|Overall Study||12
7592314|NCT02621047|18687940|P2|STARTED|Overall Study||8
7592315|NCT02621047|18687941|P1|STARTED|Overall Study||8
7592316|NCT02621034|18688057|P3|NOT COMPLETED|Overall Study||5
7592317|NCT02621034|18688058|P2|NOT COMPLETED|Overall Study||2
7592318|NCT02621034|18688059|P1|NOT COMPLETED|Overall Study||3
7592319|NCT02621034|18688057|P3|COMPLETED|Overall Study||50
7592320|NCT02621034|18688058|P2|COMPLETED|Overall Study||50
7592321|NCT02621034|18688059|P1|COMPLETED|Overall Study||50
7592322|NCT02621034|18688057|P3|STARTED|Overall Study||55
7592323|NCT02621034|18688058|P2|STARTED|Overall Study||52
7592324|NCT02621034|18688059|P1|STARTED|Overall Study||53
7592325|NCT02620917|18688072|P1|NOT COMPLETED|Overall Study||0
7592326|NCT02620917|18688072|P1|COMPLETED|Overall Study||6623
7592327|NCT02620917|18688072|P1|STARTED|Overall Study||6623
7592328|NCT02620878|18688081|P2|NOT COMPLETED|Overall Study||0
7592329|NCT02620878|18688082|P1|NOT COMPLETED|Overall Study||0
7592330|NCT02620878|18688081|P2|COMPLETED|Overall Study||16
7592331|NCT02620878|18688082|P1|COMPLETED|Overall Study||16
7592332|NCT02620878|18688081|P2|STARTED|Overall Study||16
7592333|NCT02620878|18688082|P1|STARTED|Overall Study||16
7592334|NCT02620787|18688093|P2|NOT COMPLETED|Overall Study||0
7592335|NCT02620787|18688094|P1|NOT COMPLETED|Overall Study||2
7592336|NCT02620787|18688093|P2|COMPLETED|Overall Study||6
7592337|NCT02620787|18688094|P1|COMPLETED|Overall Study||10
7592338|NCT02620787|18688093|P2|STARTED|Overall Study||6
7592339|NCT02620787|18688094|P1|STARTED|Overall Study||12
7592340|NCT02620774|18688106|P2|NOT COMPLETED|Overall Study||0
7592341|NCT02620774|18688107|P1|NOT COMPLETED|Overall Study||0
7592342|NCT02620774|18688106|P2|COMPLETED|Overall Study||6
7592343|NCT02620774|18688107|P1|COMPLETED|Overall Study||10
7592344|NCT02620774|18688106|P2|STARTED|Overall Study||6
7592345|NCT02620774|18688107|P1|STARTED|Overall Study||10
7592346|NCT02620683|18688125|P2|NOT COMPLETED|Second Intervention (Visit 2)||0
7592347|NCT02620683|18688126|P1|NOT COMPLETED|Second Intervention (Visit 2)||0
7592348|NCT02620683|18688125|P2|COMPLETED|Second Intervention (Visit 2)||11
7592349|NCT02620683|18688126|P1|COMPLETED|Second Intervention (Visit 2)||12
7592350|NCT02620683|18688125|P2|STARTED|Second Intervention (Visit 2)||11
7592351|NCT02620683|18688126|P1|STARTED|Second Intervention (Visit 2)||12
7592352|NCT02620683|18688125|P2|NOT COMPLETED|Washout (2 Weeks)||0
7592353|NCT02620683|18688126|P1|NOT COMPLETED|Washout (2 Weeks)||0
7592354|NCT02620683|18688125|P2|COMPLETED|Washout (2 Weeks)||11
7592355|NCT02620683|18688126|P1|COMPLETED|Washout (2 Weeks)||12
7592356|NCT02620683|18688125|P2|STARTED|Washout (2 Weeks)||11
7592357|NCT02620683|18688126|P1|STARTED|Washout (2 Weeks)||12
7592358|NCT02620683|18688125|P2|NOT COMPLETED|First Intervention (Visit 1)||0
7592359|NCT02620683|18688126|P1|NOT COMPLETED|First Intervention (Visit 1)||0
7592360|NCT02620683|18688125|P2|COMPLETED|First Intervention (Visit 1)||11
7592361|NCT02620683|18688126|P1|COMPLETED|First Intervention (Visit 1)||12
7592362|NCT02620683|18688125|P2|STARTED|First Intervention (Visit 1)||11
7592363|NCT02620683|18688126|P1|STARTED|First Intervention (Visit 1)||12
7592364|NCT02620384|18688136|P2|NOT COMPLETED|Overall Study||7
7592365|NCT02620384|18688137|P1|NOT COMPLETED|Overall Study||4
7592366|NCT02620384|18688136|P2|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
7592367|NCT02620384|18688137|P1|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
7592368|NCT02620384|18688136|P2|STARTED|Overall Study||73
7592369|NCT02620384|18688137|P1|STARTED|Overall Study||70
7592370|NCT02620020|18688169|P4|NOT COMPLETED|Overall Study||26
7592371|NCT02620020|18688170|P3|NOT COMPLETED|Overall Study||25
7592372|NCT02620020|18688171|P2|NOT COMPLETED|Overall Study||35
7592373|NCT02620020|18688172|P1|NOT COMPLETED|Overall Study||44
7592374|NCT02620020|18688169|P4|COMPLETED|Overall Study||115
7592375|NCT02620020|18688170|P3|COMPLETED|Overall Study||115
7592376|NCT02620020|18688171|P2|COMPLETED|Overall Study||106
7592377|NCT02620020|18688172|P1|COMPLETED|Overall Study||97
7592378|NCT02620020|18688169|P4|Modified Intent to Treat Set (mITT)|Overall Study||140
7592379|NCT02620020|18688170|P3|Modified Intent to Treat Set (mITT)|Overall Study||139
7592380|NCT02620020|18688171|P2|Modified Intent to Treat Set (mITT)|Overall Study||139
7592381|NCT02620020|18688172|P1|Modified Intent to Treat Set (mITT)|Overall Study||140
7592382|NCT02620020|18688169|P4|STARTED|Overall Study||141
7592383|NCT02620020|18688170|P3|STARTED|Overall Study||140
7592384|NCT02620020|18688171|P2|STARTED|Overall Study||141
7592385|NCT02620020|18688172|P1|STARTED|Overall Study||141
7592386|NCT02619812|18688198|P4|NOT COMPLETED|Overall Study||2
7592387|NCT02619812|18688199|P3|NOT COMPLETED|Overall Study||1
7592388|NCT02619812|18688200|P2|NOT COMPLETED|Overall Study||0
7592389|NCT02619812|18688201|P1|NOT COMPLETED|Overall Study||0
7592390|NCT02619812|18688198|P4|COMPLETED|Overall Study||0
7592391|NCT02619812|18688199|P3|COMPLETED|Overall Study||0
7592392|NCT02619812|18688200|P2|COMPLETED|Overall Study||0
7592393|NCT02619812|18688201|P1|COMPLETED|Overall Study||0
7592394|NCT02619812|18688198|P4|STARTED|Overall Study||2
7592395|NCT02619812|18688199|P3|STARTED|Overall Study||1
7592396|NCT02619812|18688200|P2|STARTED|Overall Study||0
7592397|NCT02619812|18688201|P1|STARTED|Overall Study||0
7592398|NCT02619799|18688217|P2|NOT COMPLETED|Overall Study||0
7592399|NCT02619799|18688218|P1|NOT COMPLETED|Overall Study||0
7592400|NCT02619799|18688217|P2|COMPLETED|Overall Study||25
7592401|NCT02619799|18688218|P1|COMPLETED|Overall Study||25
7592402|NCT02619799|18688217|P2|STARTED|Overall Study||25
7592403|NCT02619799|18688218|P1|STARTED|Overall Study||25
7592404|NCT02619617|18688234|P2|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||4
7592405|NCT02619617|18688235|P1|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||0
7592406|NCT02619617|18688234|P2|COMPLETED|Period 2 SOM230 - 2nd Attack||24
7592407|NCT02619617|18688235|P1|COMPLETED|Period 2 SOM230 - 2nd Attack||0
7592408|NCT02619617|18688234|P2|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||28
7592409|NCT02619617|18688235|P1|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||0
7592410|NCT02619617|18688234|P2|STARTED|Period 2 SOM230 - 2nd Attack||28
7592411|NCT02619617|18688235|P1|STARTED|Period 2 SOM230 - 2nd Attack||0
7592412|NCT02619617|18688234|P2|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
7592413|NCT02619617|18688235|P1|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
7592414|NCT02619617|18688234|P2|COMPLETED|Period 1 Placebo - 1st AttacK||0
7592415|NCT02619617|18688235|P1|COMPLETED|Period 1 Placebo - 1st AttacK||28
7592416|NCT02619617|18688234|P2|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||0
7592417|NCT02619617|18688235|P1|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||28
7592418|NCT02619617|18688234|P2|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||0
7592419|NCT02619617|18688235|P1|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||20
7592420|NCT02619617|18688234|P2|STARTED|Period 1 Placebo - 1st AttacK||0
7592421|NCT02619617|18688235|P1|STARTED|Period 1 Placebo - 1st AttacK||28
7592422|NCT02619591|18688247|P2|NOT COMPLETED|Overall Study||121
7592423|NCT02619591|18688248|P1|NOT COMPLETED|Overall Study||139
7592424|NCT02619591|18688247|P2|COMPLETED|Overall Study||0
7592425|NCT02619591|18688248|P1|COMPLETED|Overall Study||0
7592426|NCT02619591|18688247|P2|STARTED|Overall Study||121
7592427|NCT02619591|18688248|P1|STARTED|Overall Study||139
7592428|NCT02619409|18688259|P5|NOT COMPLETED|Overall Study||0
7592429|NCT02619409|18688260|P4|NOT COMPLETED|Overall Study||0
7592430|NCT02619409|18688261|P3|NOT COMPLETED|Overall Study||0
7592431|NCT02619409|18688262|P2|NOT COMPLETED|Overall Study||0
7592432|NCT02619409|18688263|P1|NOT COMPLETED|Overall Study||0
7592433|NCT02619409|18688259|P5|COMPLETED|Overall Study||6
7592434|NCT02619409|18688260|P4|COMPLETED|Overall Study||6
7592435|NCT02619409|18688261|P3|COMPLETED|Overall Study||6
7592436|NCT02619409|18688262|P2|COMPLETED|Overall Study||6
7592437|NCT02619409|18688263|P1|COMPLETED|Overall Study||6
7592438|NCT02619409|18688259|P5|STARTED|Overall Study||6
7592439|NCT02619409|18688260|P4|STARTED|Overall Study||6
7592440|NCT02619409|18688261|P3|STARTED|Overall Study||6
7592441|NCT02619409|18688262|P2|STARTED|Overall Study||6
7592442|NCT02619409|18688263|P1|STARTED|Overall Study||6
7592443|NCT02619396|18688284|P4|NOT COMPLETED|Overall Study||0
7592444|NCT02619396|18688285|P3|NOT COMPLETED|Overall Study||0
7592445|NCT02619396|18688286|P2|NOT COMPLETED|Overall Study||0
7592446|NCT02619396|18688287|P1|NOT COMPLETED|Overall Study||0
7592447|NCT02619396|18688284|P4|COMPLETED|Overall Study||20
7592448|NCT02619396|18688285|P3|COMPLETED|Overall Study||20
7592449|NCT02619396|18688286|P2|COMPLETED|Overall Study||20
7592450|NCT02619396|18688287|P1|COMPLETED|Overall Study||20
7592451|NCT02619396|18688284|P4|STARTED|Overall Study||20
7592452|NCT02619396|18688285|P3|STARTED|Overall Study||20
7592453|NCT02619396|18688286|P2|STARTED|Overall Study||20
7592454|NCT02619396|18688287|P1|STARTED|Overall Study||20
7592455|NCT02619175|18688331|P2|NOT COMPLETED|Overall Study||0
7592456|NCT02619175|18688332|P1|NOT COMPLETED|Overall Study||2
7592457|NCT02619175|18688331|P2|COMPLETED|Overall Study||16
7592458|NCT02619175|18688332|P1|COMPLETED|Overall Study||16
7592459|NCT02619175|18688331|P2|STARTED|Overall Study||16
7592460|NCT02619175|18688332|P1|STARTED|Overall Study||18
7592461|NCT02618928|18688346|P1|NOT COMPLETED|Overall Study||58
7592462|NCT02618928|18688346|P1|COMPLETED|Overall Study||677
7592463|NCT02618928|18688346|P1|Received Treatment|Overall Study||728
7592464|NCT02618928|18688346|P1|STARTED|Overall Study||735
7592465|NCT02618915|18688379|P2|NOT COMPLETED|Overall Study||0
7592466|NCT02618915|18688380|P1|NOT COMPLETED|Overall Study||0
7592467|NCT02618915|18688379|P2|COMPLETED|Overall Study||3
7592468|NCT02618915|18688380|P1|COMPLETED|Overall Study||3
7592469|NCT02618915|18688379|P2|STARTED|Overall Study||3
7592470|NCT02618915|18688380|P1|STARTED|Overall Study||3
7592471|NCT02618772|18688406|P2|NOT COMPLETED|Overall Study||0
7592472|NCT02618772|18688407|P1|NOT COMPLETED|Overall Study||1
7592473|NCT02618772|18688406|P2|COMPLETED|Overall Study||40
7592474|NCT02618772|18688407|P1|COMPLETED|Overall Study||38
7592475|NCT02618772|18688406|P2|Withdrawal by Subject|Overall Study||0
7592476|NCT02618772|18688407|P1|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1
7592477|NCT02618772|18688406|P2|STARTED|Overall Study||40
7592478|NCT02618772|18688407|P1|STARTED|Overall Study||39
7592479|NCT02618759|18688441|P2|NOT COMPLETED|Overall Study||5
7592480|NCT02618759|18688442|P1|NOT COMPLETED|Overall Study||2
7592481|NCT02618759|18688441|P2|COMPLETED|Overall Study||54
7592482|NCT02618759|18688442|P1|COMPLETED|Overall Study||58
7592483|NCT02618759|18688441|P2|STARTED|Overall Study||59
7592484|NCT02618759|18688442|P1|STARTED|Overall Study||60
7592485|NCT02618642|18688462|P4|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
7592486|NCT02618642|18688463|P3|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
7592487|NCT02618642|18688464|P2|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
7592488|NCT02618642|18688465|P1|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
7592489|NCT02618642|18688462|P4|COMPLETED|After 10 PILER Irradiation Treatments||15
7592490|NCT02618642|18688463|P3|COMPLETED|After 10 PILER Irradiation Treatments||15
7592491|NCT02618642|18688464|P2|COMPLETED|After 10 PILER Irradiation Treatments||15
7592492|NCT02618642|18688465|P1|COMPLETED|After 10 PILER Irradiation Treatments||15
7592493|NCT02618642|18688462|P4|STARTED|After 10 PILER Irradiation Treatments||15
7592494|NCT02618642|18688463|P3|STARTED|After 10 PILER Irradiation Treatments||15
7592495|NCT02618642|18688464|P2|STARTED|After 10 PILER Irradiation Treatments||15
7592496|NCT02618642|18688465|P1|STARTED|After 10 PILER Irradiation Treatments||15
7592497|NCT02618642|18688462|P4|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
7592498|NCT02618642|18688463|P3|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
7592499|NCT02618642|18688464|P2|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
7592500|NCT02618642|18688465|P1|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
7592501|NCT02618642|18688462|P4|COMPLETED|Before 10 PILER Irradiation Treatments||15
7592502|NCT02618642|18688463|P3|COMPLETED|Before 10 PILER Irradiation Treatments||15
7592503|NCT02618642|18688464|P2|COMPLETED|Before 10 PILER Irradiation Treatments||15
7592504|NCT02618642|18688465|P1|COMPLETED|Before 10 PILER Irradiation Treatments||15
7592505|NCT02618642|18688462|P4|STARTED|Before 10 PILER Irradiation Treatments||15
7592506|NCT02618642|18688463|P3|STARTED|Before 10 PILER Irradiation Treatments||15
7592507|NCT02618642|18688464|P2|STARTED|Before 10 PILER Irradiation Treatments||15
7592508|NCT02618642|18688465|P1|STARTED|Before 10 PILER Irradiation Treatments||15
7592509|NCT02618512|18688491|P1|NOT COMPLETED|Overall Study||0
7592510|NCT02618512|18688491|P1|COMPLETED|Overall Study||3
7592511|NCT02618512|18688491|P1|STARTED|Overall Study||3
7592512|NCT02618187|18688499|P4|NOT COMPLETED|Overall Study||5
7592513|NCT02618187|18688500|P3|NOT COMPLETED|Overall Study||4
7592514|NCT02618187|18688501|P2|NOT COMPLETED|Overall Study||2
7592515|NCT02618187|18688502|P1|NOT COMPLETED|Overall Study||2
7592516|NCT02618187|18688499|P4|COMPLETED|Overall Study||12
7592517|NCT02618187|18688500|P3|COMPLETED|Overall Study||11
7592518|NCT02618187|18688501|P2|COMPLETED|Overall Study||9
7592519|NCT02618187|18688502|P1|COMPLETED|Overall Study||13
7592520|NCT02618187|18688499|P4|Completed|Overall Study||13
7592521|NCT02618187|18688500|P3|Completed|Overall Study||13
7592522|NCT02618187|18688501|P2|Completed|Overall Study||10
7592523|NCT02618187|18688502|P1|Completed|Overall Study||13
7592524|NCT02618187|18688499|P4|STARTED|Overall Study||17
7592525|NCT02618187|18688500|P3|STARTED|Overall Study||15
7592526|NCT02618187|18688501|P2|STARTED|Overall Study||11
7592527|NCT02618187|18688502|P1|STARTED|Overall Study||15
7592528|NCT02618031|18688530|P2|NOT COMPLETED|Overall Study||0
7592529|NCT02618031|18688531|P1|NOT COMPLETED|Overall Study||1
7592530|NCT02618031|18688530|P2|COMPLETED|Overall Study||11
7592531|NCT02618031|18688531|P1|COMPLETED|Overall Study||45
7592532|NCT02618031|18688530|P2|STARTED|Overall Study||11
7592533|NCT02618031|18688531|P1|STARTED|Overall Study||46
7592534|NCT02617901|18688543|P1|NOT COMPLETED|Overall Study||0
7592535|NCT02617901|18688543|P1|COMPLETED|Overall Study||20
7592536|NCT02617901|18688543|P1|STARTED|Overall Study||20
7592537|NCT02617888|18688550|P3|NOT COMPLETED|Overall Study||0
7592538|NCT02617888|18688551|P2|NOT COMPLETED|Overall Study||7
7592539|NCT02617888|18688552|P1|NOT COMPLETED|Overall Study||1
7592540|NCT02617888|18688550|P3|COMPLETED|Overall Study||127
7592541|NCT02617888|18688551|P2|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break samples.|44
7592542|NCT02617888|18688552|P1|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break sample.|49
7592543|NCT02617888|18688550|P3|STARTED|Overall Study||127
7592544|NCT02617888|18688551|P2|STARTED|Overall Study||51
7592545|NCT02617888|18688552|P1|STARTED|Overall Study||50
7592546|NCT02617784|18688561|P2|NOT COMPLETED|Overall Study||0
7592547|NCT02617784|18688562|P1|NOT COMPLETED|Overall Study||0
7592548|NCT02617784|18688561|P2|COMPLETED|Overall Study||12
7592549|NCT02617784|18688562|P1|COMPLETED|Overall Study||12
7592550|NCT02617784|18688561|P2|Second Dose Assessment Period|Overall Study||12
7592551|NCT02617784|18688562|P1|Second Dose Assessment Period|Overall Study||11
7592552|NCT02617784|18688561|P2|First Dose Assessment Period|Overall Study||12
7592553|NCT02617784|18688562|P1|First Dose Assessment Period|Overall Study||12
7592554|NCT02617784|18688561|P2|STARTED|Overall Study||12
7592555|NCT02617784|18688562|P1|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12
7592556|NCT02617667|18688613|P4|NOT COMPLETED|Overall Study||1
7592557|NCT02617667|18688614|P3|NOT COMPLETED|Overall Study||4
7592558|NCT02617667|18688615|P2|NOT COMPLETED|Overall Study||1
7592559|NCT02617667|18688616|P1|NOT COMPLETED|Overall Study||1
7592560|NCT02617667|18688613|P4|COMPLETED|Overall Study||52
7592561|NCT02617667|18688614|P3|COMPLETED|Overall Study||48
7592562|NCT02617667|18688615|P2|COMPLETED|Overall Study||50
7592563|NCT02617667|18688616|P1|COMPLETED|Overall Study||50
7592564|NCT02617667|18688613|P4|STARTED|Overall Study||53
7592565|NCT02617667|18688614|P3|STARTED|Overall Study||52
7592566|NCT02617667|18688615|P2|STARTED|Overall Study||51
7592567|NCT02617667|18688616|P1|STARTED|Overall Study||51
7592568|NCT02617628|18688630|P2|NOT COMPLETED|Overall Study||61
7592569|NCT02617628|18688631|P1|NOT COMPLETED|Overall Study||62
7592570|NCT02617628|18688630|P2|COMPLETED|Overall Study||11
7592571|NCT02617628|18688631|P1|COMPLETED|Overall Study||12
7592572|NCT02617628|18688630|P2|STARTED|Overall Study||72
7592573|NCT02617628|18688631|P1|STARTED|Overall Study||74
7592574|NCT02616900|18688639|P1|NOT COMPLETED|Overall Study||23
7592575|NCT02616900|18688639|P1|COMPLETED|Overall Study|Six participants not included in study results because of incomplete data.|51
7592576|NCT02616900|18688639|P1|Completed 3mo Trial|Overall Study||57
7592577|NCT02616900|18688639|P1|STARTED|Overall Study||74
7592578|NCT02616783|18688647|P2|NOT COMPLETED|Overall Study||2
7592579|NCT02616783|18688648|P1|NOT COMPLETED|Overall Study||6
7592580|NCT02616783|18688647|P2|COMPLETED|Overall Study||54
7592581|NCT02616783|18688648|P1|COMPLETED|Overall Study||105
7592582|NCT02616783|18688647|P2|STARTED|Overall Study||56
7592583|NCT02616783|18688648|P1|STARTED|Overall Study||111
7592584|NCT02616614|18688671|P3|NOT COMPLETED|Overall Study||29
7592585|NCT02616614|18688672|P2|NOT COMPLETED|Overall Study||60
7592586|NCT02616614|18688673|P1|NOT COMPLETED|Overall Study||65
7592587|NCT02616614|18688671|P3|COMPLETED|Overall Study||141
7592588|NCT02616614|18688672|P2|COMPLETED|Overall Study||285
7592589|NCT02616614|18688673|P1|COMPLETED|Overall Study||282
7592590|NCT02616614|18688671|P3|PP Population|Overall Study||122
7592591|NCT02616614|18688672|P2|PP Population|Overall Study||255
7592592|NCT02616614|18688673|P1|PP Population|Overall Study||253
7592593|NCT02616614|18688671|P3|mITT Population|Overall Study||160
7592594|NCT02616614|18688672|P2|mITT Population|Overall Study||325
7592595|NCT02616614|18688673|P1|mITT Population|Overall Study||325
7592596|NCT02616614|18688671|P3|Safety Population|Overall Study||161
7592597|NCT02616614|18688672|P2|Safety Population|Overall Study||328
7592598|NCT02616614|18688673|P1|Safety Population|Overall Study||329
7592599|NCT02616614|18688671|P3|STARTED|Overall Study||170
7592600|NCT02616614|18688672|P2|STARTED|Overall Study||345
7592601|NCT02616614|18688673|P1|STARTED|Overall Study||347
7592602|NCT02616601|18688690|P3|NOT COMPLETED|Overall Study||7
7592603|NCT02616601|18688691|P2|NOT COMPLETED|Overall Study||4
7592604|NCT02616601|18688692|P1|NOT COMPLETED|Overall Study||9
7592605|NCT02616601|18688690|P3|COMPLETED|Overall Study||135
7592606|NCT02616601|18688691|P2|COMPLETED|Overall Study||136
7592607|NCT02616601|18688692|P1|COMPLETED|Overall Study||131
7592608|NCT02616601|18688690|P3|PP Population|Overall Study||123
7592609|NCT02616601|18688691|P2|PP Population|Overall Study||121
7592610|NCT02616601|18688692|P1|PP Population|Overall Study||112
7592611|NCT02616601|18688690|P3|mITT Population|Overall Study||138
7592612|NCT02616601|18688691|P2|mITT Population|Overall Study||136
7592613|NCT02616601|18688692|P1|mITT Population|Overall Study||137
7592614|NCT02616601|18688690|P3|Safety Population|Overall Study||142
7592615|NCT02616601|18688691|P2|Safety Population|Overall Study||140
7592616|NCT02616601|18688692|P1|Safety Population|Overall Study||140
7592617|NCT02616601|18688690|P3|STARTED|Overall Study||142
7592618|NCT02616601|18688691|P2|STARTED|Overall Study||140
7592619|NCT02616601|18688692|P1|STARTED|Overall Study||140
7592620|NCT02616523|18688703|P3|NOT COMPLETED|Overall Study||0
7592621|NCT02616523|18688704|P2|NOT COMPLETED|Overall Study||0
7592622|NCT02616523|18688705|P1|NOT COMPLETED|Overall Study||1
7592623|NCT02616523|18688703|P3|COMPLETED|Overall Study|April 2015|20
7592624|NCT02616523|18688704|P2|COMPLETED|Overall Study|April 2015|20
7592625|NCT02616523|18688705|P1|COMPLETED|Overall Study|April 2015|19
7592626|NCT02616523|18688703|P3|STARTED|Overall Study|June 2014|20
7592627|NCT02616523|18688704|P2|STARTED|Overall Study|June 2014|20
7592628|NCT02616523|18688705|P1|STARTED|Overall Study|June 2014|20
7592629|NCT02616380|18688719|P1|NOT COMPLETED|Overall Study||3
7592630|NCT02616380|18688719|P1|COMPLETED|Overall Study||97
7592631|NCT02616380|18688719|P1|STARTED|Overall Study||100
7592632|NCT02616250|18688734|P2|NOT COMPLETED|Overall Study||9
7592633|NCT02616250|18688735|P1|NOT COMPLETED|Overall Study||10
7592634|NCT02616250|18688734|P2|COMPLETED|Overall Study||86
7592635|NCT02616250|18688735|P1|COMPLETED|Overall Study||85
7592636|NCT02616250|18688734|P2|STARTED|Overall Study||95
7592637|NCT02616250|18688735|P1|STARTED|Overall Study||95
7592638|NCT02616146|18688743|P2|NOT COMPLETED|Overall Study||504
7592639|NCT02616146|18688744|P1|NOT COMPLETED|Overall Study||1512
7592640|NCT02616146|18688743|P2|COMPLETED|Overall Study|Due to termination of study, LNG-EE reporting group received only up to 9 cycles of treatment.|0
7592641|NCT02616146|18688744|P1|COMPLETED|Overall Study|Due to termination of study, ENG-E2 reporting group received only up to 10 cycles of treatment.|0
7592642|NCT02616146|18688743|P2|STARTED|Overall Study||504
7592643|NCT02616146|18688744|P1|STARTED|Overall Study||1512
7592644|NCT02616029|18688760|P2|NOT COMPLETED|Overall Study||2
7592645|NCT02616029|18688761|P1|NOT COMPLETED|Overall Study||4
7592646|NCT02616029|18688760|P2|COMPLETED|Overall Study||26
7592647|NCT02616029|18688761|P1|COMPLETED|Overall Study||34
7592648|NCT02616029|18688760|P2|STARTED|Overall Study||28
7592649|NCT02616029|18688761|P1|STARTED|Overall Study||38
7592650|NCT02615990|18688832|P2|NOT COMPLETED|Overall Study||1
7592651|NCT02615990|18688833|P1|NOT COMPLETED|Overall Study||1
7592652|NCT02615990|18688832|P2|COMPLETED|Overall Study||0
7592653|NCT02615990|18688833|P1|COMPLETED|Overall Study||0
7592654|NCT02615990|18688832|P2|STARTED|Overall Study||1
7592655|NCT02615990|18688833|P1|STARTED|Overall Study||1
7592656|NCT02615743|18688879|P2|NOT COMPLETED|Overall Study||3
7592657|NCT02615743|18688880|P1|NOT COMPLETED|Overall Study||6
7592658|NCT02615743|18688879|P2|COMPLETED|Overall Study||17
7592659|NCT02615743|18688880|P1|COMPLETED|Overall Study||15
7592660|NCT02615743|18688879|P2|STARTED|Overall Study||20
7592661|NCT02615743|18688880|P1|STARTED|Overall Study||21
7592662|NCT02615717|18688894|P2|NOT COMPLETED|Overall Study||0
7592663|NCT02615717|18688895|P1|NOT COMPLETED|Overall Study||0
7592664|NCT02615717|18688894|P2|COMPLETED|Overall Study||3
7592665|NCT02615717|18688895|P1|COMPLETED|Overall Study||3
7592666|NCT02615717|18688894|P2|STARTED|Overall Study||3
7592667|NCT02615717|18688895|P1|STARTED|Overall Study||3
7592668|NCT02615535|18688909|P2|NOT COMPLETED|Overall Study||1
7592669|NCT02615535|18688910|P1|NOT COMPLETED|Overall Study||4
7592670|NCT02615535|18688909|P2|COMPLETED|Overall Study||10
7592671|NCT02615535|18688910|P1|COMPLETED|Overall Study||10
7592672|NCT02615535|18688909|P2|STARTED|Overall Study||11
7592673|NCT02615535|18688910|P1|STARTED|Overall Study||14
7592674|NCT02615509|18688930|P1|NOT COMPLETED|Overall Study||146
7592675|NCT02615509|18688930|P1|COMPLETED|Overall Study||201
7592676|NCT02615509|18688930|P1|STARTED|Overall Study||347
7592677|NCT02615470|18688940|P2|NOT COMPLETED|Overall Study||32
7592678|NCT02615470|18688941|P1|NOT COMPLETED|Overall Study||21
7592679|NCT02615470|18688940|P2|COMPLETED|Overall Study||30
7592680|NCT02615470|18688941|P1|COMPLETED|Overall Study||37
7592681|NCT02615470|18688940|P2|Completed the Baseline Surveys|Overall Study||47
7592682|NCT02615470|18688941|P1|Completed the Baseline Surveys|Overall Study||46
7592683|NCT02615470|18688940|P2|STARTED|Overall Study||62
7592684|NCT02615470|18688941|P1|STARTED|Overall Study||58
7592685|NCT02615249|18688951|P1|NOT COMPLETED|Overall Study||1
7592686|NCT02615249|18688951|P1|COMPLETED|Overall Study||121
7592687|NCT02615249|18688951|P1|STARTED|Overall Study||122
7592688|NCT02615158|18688961|P3|NOT COMPLETED|Overall Study||16
7592689|NCT02615158|18688962|P2|NOT COMPLETED|Overall Study||16
7592690|NCT02615158|18688963|P1|NOT COMPLETED|Overall Study||21
7592691|NCT02615158|18688961|P3|COMPLETED|Overall Study||75
7592692|NCT02615158|18688962|P2|COMPLETED|Overall Study||76
7592693|NCT02615158|18688963|P1|COMPLETED|Overall Study||73
7592694|NCT02615158|18688961|P3|STARTED|Overall Study||91
7592695|NCT02615158|18688962|P2|STARTED|Overall Study||92
7592696|NCT02615158|18688963|P1|STARTED|Overall Study||94
7592697|NCT02615145|18688992|P4|NOT COMPLETED|Overall Study||1
7592698|NCT02615145|18688993|P3|NOT COMPLETED|Overall Study||8
7592699|NCT02615145|18688994|P2|NOT COMPLETED|Overall Study||15
7592700|NCT02615145|18688995|P1|NOT COMPLETED|Overall Study||27
7592701|NCT02615145|18688992|P4|COMPLETED|Overall Study||0
7592702|NCT02615145|18688993|P3|COMPLETED|Overall Study||40
7592703|NCT02615145|18688994|P2|COMPLETED|Overall Study||263
7592704|NCT02615145|18688995|P1|COMPLETED|Overall Study||118
7592705|NCT02615145|18688992|P4|3DAA + RBV|Overall Study||0
7592706|NCT02615145|18688993|P3|3DAA + RBV|Overall Study||2
7592707|NCT02615145|18688994|P2|3DAA + RBV|Overall Study||17
7592708|NCT02615145|18688995|P1|3DAA + RBV|Overall Study||140
7592709|NCT02615145|18688992|P4|3DAA|Overall Study||0
7592710|NCT02615145|18688993|P3|3DAA|Overall Study||0
7592711|NCT02615145|18688994|P2|3DAA|Overall Study||261
7592712|NCT02615145|18688995|P1|3DAA|Overall Study||5
7592713|NCT02615145|18688992|P4|2 DAA + Ribavirin (RBV)|Overall Study||0
7592714|NCT02615145|18688993|P3|2 DAA + Ribavirin (RBV)|Overall Study||45
7592715|NCT02615145|18688994|P2|2 DAA + Ribavirin (RBV)|Overall Study||0
7592716|NCT02615145|18688995|P1|2 DAA + Ribavirin (RBV)|Overall Study||0
7592717|NCT02615145|18688992|P4|STARTED|Overall Study||1
7592718|NCT02615145|18688993|P3|STARTED|Overall Study||48
7592719|NCT02615145|18688994|P2|STARTED|Overall Study||278
7592720|NCT02615145|18688995|P1|STARTED|Overall Study||145
7592721|NCT02614924|18689071|P2|NOT COMPLETED|Overall Study||0
7592722|NCT02614924|18689072|P1|NOT COMPLETED|Overall Study||0
7592723|NCT02614924|18689071|P2|COMPLETED|Overall Study||20
7592724|NCT02614924|18689072|P1|COMPLETED|Overall Study||20
7592725|NCT02614924|18689071|P2|STARTED|Overall Study||20
7592726|NCT02614924|18689072|P1|STARTED|Overall Study||20
7592727|NCT02614898|18689082|P2|NOT COMPLETED|Overall Study||51
7592728|NCT02614898|18689083|P1|NOT COMPLETED|Overall Study||15
7592729|NCT02614898|18689082|P2|COMPLETED|Overall Study||1
7592730|NCT02614898|18689083|P1|COMPLETED|Overall Study||0
7592731|NCT02614898|18689082|P2|Safety Population|Overall Study||52
7592732|NCT02614898|18689083|P1|Safety Population|Overall Study||15
7592733|NCT02614898|18689082|P2|STARTED|Overall Study||52
7592734|NCT02614898|18689083|P1|STARTED|Overall Study||15
7592735|NCT02614794|18689095|P2|NOT COMPLETED|Overall Study||202
7592736|NCT02614794|18689096|P1|NOT COMPLETED|Overall Study||410
7592737|NCT02614794|18689095|P2|COMPLETED|Overall Study||0
7592738|NCT02614794|18689096|P1|COMPLETED|Overall Study||0
7592739|NCT02614794|18689095|P2|STARTED|Overall Study||202
7592740|NCT02614794|18689096|P1|STARTED|Overall Study||410
7592741|NCT02614729|18689130|P2|NOT COMPLETED|Overall Study||0
7592742|NCT02614729|18689131|P1|NOT COMPLETED|Overall Study||1
7592743|NCT02614729|18689130|P2|COMPLETED|Overall Study||17
7592744|NCT02614729|18689131|P1|COMPLETED|Overall Study||17
7592745|NCT02614729|18689130|P2|STARTED|Overall Study||17
7592746|NCT02614729|18689131|P1|STARTED|Overall Study||18
7592747|NCT02614703|18689151|P2|NOT COMPLETED|Overall Study||1
7592748|NCT02614703|18689152|P1|NOT COMPLETED|Overall Study||7
7592749|NCT02614703|18689151|P2|COMPLETED|Overall Study||28
7592750|NCT02614703|18689152|P1|COMPLETED|Overall Study||24
7592751|NCT02614703|18689151|P2|STARTED|Overall Study||29
7592752|NCT02614703|18689152|P1|STARTED|Overall Study||31
7592753|NCT02614690|18689161|P3|NOT COMPLETED|Overall Study||0
7592754|NCT02614690|18689162|P2|NOT COMPLETED|Overall Study||0
7592755|NCT02614690|18689163|P1|NOT COMPLETED|Overall Study||0
7592756|NCT02614690|18689161|P3|COMPLETED|Overall Study||20
7592757|NCT02614690|18689162|P2|COMPLETED|Overall Study||20
7592758|NCT02614690|18689163|P1|COMPLETED|Overall Study||20
7592759|NCT02614690|18689161|P3|STARTED|Overall Study||20
7592760|NCT02614690|18689162|P2|STARTED|Overall Study||20
7592761|NCT02614690|18689163|P1|STARTED|Overall Study||20
7592762|NCT02614586|18689189|P1|NOT COMPLETED|Overall Study||0
7592763|NCT02614586|18689189|P1|COMPLETED|Overall Study||11
7592764|NCT02614586|18689189|P1|STARTED|Overall Study||11
7592765|NCT02614560|18689196|P2|NOT COMPLETED|Overall Study||2
7592766|NCT02614560|18689197|P1|NOT COMPLETED|Overall Study||6
7592767|NCT02614560|18689196|P2|COMPLETED|Overall Study||6
7592768|NCT02614560|18689197|P1|COMPLETED|Overall Study||0
7592769|NCT02614560|18689196|P2|STARTED|Overall Study||8
7592770|NCT02614560|18689197|P1|STARTED|Overall Study||6
7592771|NCT02614469|18689214|P2|NOT COMPLETED|Period 2||0
7592772|NCT02614469|18689215|P1|NOT COMPLETED|Period 2||0
7592773|NCT02614469|18689214|P2|COMPLETED|Period 2||9
7592774|NCT02614469|18689215|P1|COMPLETED|Period 2||9
7592775|NCT02614469|18689214|P2|STARTED|Period 2||9
7592776|NCT02614469|18689215|P1|STARTED|Period 2||9
7592777|NCT02614469|18689214|P2|NOT COMPLETED|Period 1||0
7592778|NCT02614469|18689215|P1|NOT COMPLETED|Period 1||0
7592779|NCT02614469|18689214|P2|COMPLETED|Period 1||9
7592780|NCT02614469|18689215|P1|COMPLETED|Period 1||9
7592781|NCT02614469|18689214|P2|STARTED|Period 1||9
7592782|NCT02614469|18689215|P1|STARTED|Period 1||9
7592783|NCT02614287|18689245|P2|NOT COMPLETED|Post Treatment Follow-up Phase||5
7592784|NCT02614287|18689246|P1|NOT COMPLETED|Post Treatment Follow-up Phase||9
7592785|NCT02614287|18689245|P2|COMPLETED|Post Treatment Follow-up Phase||119
7592786|NCT02614287|18689246|P1|COMPLETED|Post Treatment Follow-up Phase||103
7592787|NCT02614287|18689245|P2|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|124
7592788|NCT02614287|18689246|P1|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|112
7592789|NCT02614287|18689245|P2|NOT COMPLETED|Open Label (OL) Treatment Phase||22
7592790|NCT02614287|18689246|P1|NOT COMPLETED|Open Label (OL) Treatment Phase||38
7592791|NCT02614287|18689245|P2|COMPLETED|Open Label (OL) Treatment Phase||113
7592792|NCT02614287|18689246|P1|COMPLETED|Open Label (OL) Treatment Phase||97
7592793|NCT02614287|18689245|P2|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
7592794|NCT02614287|18689246|P1|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
7592795|NCT02614287|18689245|P2|STARTED|Open Label (OL) Treatment Phase||135
7592796|NCT02614287|18689246|P1|STARTED|Open Label (OL) Treatment Phase||135
7592797|NCT02614274|18689280|P1|NOT COMPLETED|Overall Study||4
7592798|NCT02614274|18689280|P1|COMPLETED|Overall Study||5
7592799|NCT02614274|18689280|P1|STARTED|Overall Study||9
7592800|NCT02614261|18689292|P3|NOT COMPLETED|Overall Study||11
7592801|NCT02614261|18689293|P2|NOT COMPLETED|Overall Study||15
7592802|NCT02614261|18689294|P1|NOT COMPLETED|Overall Study||49
7592803|NCT02614261|18689292|P3|COMPLETED|Overall Study||266
7592804|NCT02614261|18689293|P2|COMPLETED|Overall Study||263
7592805|NCT02614261|18689294|P1|COMPLETED|Overall Study||509
7592806|NCT02614261|18689292|P3|Received at Least One Dose of Study Drug|Overall Study||277
7592807|NCT02614261|18689293|P2|Received at Least One Dose of Study Drug|Overall Study||278
7592808|NCT02614261|18689294|P1|Received at Least One Dose of Study Drug|Overall Study||558
7592809|NCT02614261|18689292|P3|STARTED|Overall Study||277
7592810|NCT02614261|18689293|P2|STARTED|Overall Study||278
7592811|NCT02614261|18689294|P1|STARTED|Overall Study||558
7592812|NCT02614222|18689333|P2|NOT COMPLETED|Overall Study||0
7592813|NCT02614222|18689334|P1|NOT COMPLETED|Overall Study||0
7592814|NCT02614222|18689333|P2|COMPLETED|Overall Study||14
7592815|NCT02614222|18689334|P1|COMPLETED|Overall Study||13
7592816|NCT02614222|18689333|P2|STARTED|Overall Study||14
7592817|NCT02614222|18689334|P1|STARTED|Overall Study||13
7592818|NCT02614196|18689360|P6|NOT COMPLETED|Post Treatment Follow-up Phase||0
7592819|NCT02614196|18689361|P5|NOT COMPLETED|Post Treatment Follow-up Phase||2
7592820|NCT02614196|18689362|P4|NOT COMPLETED|Post Treatment Follow-up Phase||1
7592821|NCT02614196|18689363|P3|NOT COMPLETED|Post Treatment Follow-up Phase||8
7592822|NCT02614196|18689364|P2|NOT COMPLETED|Post Treatment Follow-up Phase||5
7592823|NCT02614196|18689365|P1|NOT COMPLETED|Post Treatment Follow-up Phase||20
7592824|NCT02614196|18689360|P6|COMPLETED|Post Treatment Follow-up Phase||19
7592825|NCT02614196|18689361|P5|COMPLETED|Post Treatment Follow-up Phase||13
7592826|NCT02614196|18689362|P4|COMPLETED|Post Treatment Follow-up Phase||24
7592827|NCT02614196|18689363|P3|COMPLETED|Post Treatment Follow-up Phase||199
7592828|NCT02614196|18689364|P2|COMPLETED|Post Treatment Follow-up Phase||208
7592829|NCT02614196|18689365|P1|COMPLETED|Post Treatment Follow-up Phase||390
7592830|NCT02614196|18689360|P6|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|19
7592831|NCT02614196|18689361|P5|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|15
7592832|NCT02614196|18689362|P4|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|25
7592833|NCT02614196|18689363|P3|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|207
7592834|NCT02614196|18689364|P2|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|213
7592835|NCT02614196|18689365|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|410
7592836|NCT02614196|18689360|P6|NOT COMPLETED|Double Blind Treatment Phase||0
7592837|NCT02614196|18689361|P5|NOT COMPLETED|Double Blind Treatment Phase||1
7592838|NCT02614196|18689362|P4|NOT COMPLETED|Double Blind Treatment Phase||4
7592839|NCT02614196|18689363|P3|NOT COMPLETED|Double Blind Treatment Phase||31
7592840|NCT02614196|18689364|P2|NOT COMPLETED|Double Blind Treatment Phase||30
7592841|NCT02614196|18689365|P1|NOT COMPLETED|Double Blind Treatment Phase||76
7592842|NCT02614196|18689360|P6|COMPLETED|Double Blind Treatment Phase||19
7592843|NCT02614196|18689361|P5|COMPLETED|Double Blind Treatment Phase||14
7592844|NCT02614196|18689362|P4|COMPLETED|Double Blind Treatment Phase||26
7592845|NCT02614196|18689363|P3|COMPLETED|Double Blind Treatment Phase||195
7592846|NCT02614196|18689364|P2|COMPLETED|Double Blind Treatment Phase||203
7592847|NCT02614196|18689365|P1|COMPLETED|Double Blind Treatment Phase||387
7592848|NCT02614196|18689360|P6|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||19
7592849|NCT02614196|18689361|P5|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||14
7592850|NCT02614196|18689362|P4|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||30
7592851|NCT02614196|18689363|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||223
7592852|NCT02614196|18689364|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||231
7592853|NCT02614196|18689365|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||461
7592854|NCT02614196|18689360|P6|STARTED|Double Blind Treatment Phase||19
7592855|NCT02614196|18689361|P5|STARTED|Double Blind Treatment Phase||15
7592856|NCT02614196|18689362|P4|STARTED|Double Blind Treatment Phase||30
7592857|NCT02614196|18689363|P3|STARTED|Double Blind Treatment Phase||226
7592858|NCT02614196|18689364|P2|STARTED|Double Blind Treatment Phase||233
7592859|NCT02614196|18689365|P1|STARTED|Double Blind Treatment Phase||463
7592860|NCT02614183|18689411|P3|NOT COMPLETED|Post Treatment Follow-up Phase||12
7592861|NCT02614183|18689412|P2|NOT COMPLETED|Post Treatment Follow-up Phase||6
7592862|NCT02614183|18689413|P1|NOT COMPLETED|Post Treatment Follow-up Phase||18
7592863|NCT02614183|18689411|P3|COMPLETED|Post Treatment Follow-up Phase||171
7592864|NCT02614183|18689412|P2|COMPLETED|Post Treatment Follow-up Phase||179
7592865|NCT02614183|18689413|P1|COMPLETED|Post Treatment Follow-up Phase||354
7592944|NCT02613572|18689608|P1|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||1
7592866|NCT02614183|18689411|P3|Safety Population|Post Treatment Follow-up Phase|Two participants who received only 240mg loading dose prior to discontinuation moved to this group.|185
7592867|NCT02614183|18689412|P2|Safety Population|Post Treatment Follow-up Phase||183
7592868|NCT02614183|18689413|P1|Safety Population|Post Treatment Follow-up Phase||372
7592869|NCT02614183|18689411|P3|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|183
7592870|NCT02614183|18689412|P2|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|185
7592871|NCT02614183|18689413|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|372
7592872|NCT02614183|18689411|P3|NOT COMPLETED|Double Blind Treatment Phase||39
7592873|NCT02614183|18689412|P2|NOT COMPLETED|Double Blind Treatment Phase||37
7592874|NCT02614183|18689413|P1|NOT COMPLETED|Double Blind Treatment Phase||83
7592875|NCT02614183|18689411|P3|COMPLETED|Double Blind Treatment Phase||175
7592876|NCT02614183|18689412|P2|COMPLETED|Double Blind Treatment Phase||177
7592877|NCT02614183|18689413|P1|COMPLETED|Double Blind Treatment Phase||351
7592878|NCT02614183|18689411|P3|Safety Population|Double Blind Treatment Phase|Eight pts discontinued after loading dose of 240mg galcanezumab in 120mg group moved to this group.|220
7592879|NCT02614183|18689412|P2|Safety Population|Double Blind Treatment Phase|One pt randomized to placebo received galcanezumab 120mg due to dosing error moved to this group.|206
7592880|NCT02614183|18689413|P1|Safety Population|Double Blind Treatment Phase||432
7592881|NCT02614183|18689411|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||212
7592882|NCT02614183|18689412|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||213
7592883|NCT02614183|18689413|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||433
7592884|NCT02614183|18689411|P3|STARTED|Double Blind Treatment Phase||214
7592885|NCT02614183|18689412|P2|STARTED|Double Blind Treatment Phase||214
7592886|NCT02614183|18689413|P1|STARTED|Double Blind Treatment Phase||434
7592887|NCT02614131|18689457|P7|NOT COMPLETED|Overall Study||1
7592888|NCT02614131|18689458|P6|NOT COMPLETED|Overall Study||0
7592889|NCT02614131|18689459|P5|NOT COMPLETED|Overall Study||0
7592890|NCT02614131|18689460|P4|NOT COMPLETED|Overall Study||0
7592891|NCT02614131|18689461|P3|NOT COMPLETED|Overall Study||0
7592892|NCT02614131|18689462|P2|NOT COMPLETED|Overall Study||0
7592893|NCT02614131|18689463|P1|NOT COMPLETED|Overall Study||1
7592894|NCT02614131|18689457|P7|COMPLETED|Overall Study||4
7592895|NCT02614131|18689458|P6|COMPLETED|Overall Study||2
7592896|NCT02614131|18689459|P5|COMPLETED|Overall Study||8
7592897|NCT02614131|18689460|P4|COMPLETED|Overall Study||8
7592898|NCT02614131|18689461|P3|COMPLETED|Overall Study||8
7592899|NCT02614131|18689462|P2|COMPLETED|Overall Study||8
7592900|NCT02614131|18689463|P1|COMPLETED|Overall Study||10
7592901|NCT02614131|18689457|P7|Received at Least One Dose of Drug|Overall Study||5
7592902|NCT02614131|18689458|P6|Received at Least One Dose of Drug|Overall Study||2
7592903|NCT02614131|18689459|P5|Received at Least One Dose of Drug|Overall Study||8
7592904|NCT02614131|18689460|P4|Received at Least One Dose of Drug|Overall Study||8
7592905|NCT02614131|18689461|P3|Received at Least One Dose of Drug|Overall Study||8
7592906|NCT02614131|18689462|P2|Received at Least One Dose of Drug|Overall Study||8
7592907|NCT02614131|18689463|P1|Received at Least One Dose of Drug|Overall Study||11
7592908|NCT02614131|18689457|P7|STARTED|Overall Study||5
7592909|NCT02614131|18689458|P6|STARTED|Overall Study||2
7592910|NCT02614131|18689459|P5|STARTED|Overall Study||8
7592911|NCT02614131|18689460|P4|STARTED|Overall Study||8
7592912|NCT02614131|18689461|P3|STARTED|Overall Study||8
7592913|NCT02614131|18689462|P2|STARTED|Overall Study||8
7592914|NCT02614131|18689463|P1|STARTED|Overall Study||11
7592915|NCT02614079|18689494|P1|NOT COMPLETED|Overall Study||1
7592916|NCT02614079|18689494|P1|COMPLETED|Overall Study|1 participant withdrew from the study prior to completion of DSSEP testing|5
7592917|NCT02614079|18689494|P1|STARTED|Overall Study||6
7592918|NCT02613910|18689498|P1|NOT COMPLETED|Overall Study||1
7592919|NCT02613910|18689498|P1|COMPLETED|Overall Study||0
7592920|NCT02613910|18689498|P1|STARTED|Overall Study||1
7592921|NCT02613897|18689550|P3|NOT COMPLETED|Overall Study||0
7592922|NCT02613897|18689551|P2|NOT COMPLETED|Overall Study||0
7592923|NCT02613897|18689552|P1|NOT COMPLETED|Overall Study||0
7592924|NCT02613897|18689550|P3|COMPLETED|Overall Study||12
7592925|NCT02613897|18689551|P2|COMPLETED|Overall Study||22
7592926|NCT02613897|18689552|P1|COMPLETED|Overall Study||22
7592927|NCT02613897|18689550|P3|STARTED|Overall Study||12
7592928|NCT02613897|18689551|P2|STARTED|Overall Study||22
7592929|NCT02613897|18689552|P1|STARTED|Overall Study||22
7592930|NCT02613871|18689584|P1|NOT COMPLETED|Overall Study||3
7592931|NCT02613871|18689584|P1|COMPLETED|Overall Study||108
7592932|NCT02613871|18689584|P1|STARTED|Overall Study||111
7592933|NCT02613572|18689606|P3|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
7592934|NCT02613572|18689607|P2|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||1
7592935|NCT02613572|18689608|P1|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
7592936|NCT02613572|18689606|P3|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
7592937|NCT02613572|18689607|P2|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
7592938|NCT02613572|18689608|P1|COMPLETED|Phase II: Double-Blind Rand Plac Control||0
7592939|NCT02613572|18689606|P3|STARTED|Phase II: Double-Blind Rand Plac Control||26
7592940|NCT02613572|18689607|P2|STARTED|Phase II: Double-Blind Rand Plac Control||27
7592941|NCT02613572|18689608|P1|STARTED|Phase II: Double-Blind Rand Plac Control||0
7592942|NCT02613572|18689606|P3|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
7592943|NCT02613572|18689607|P2|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
7592945|NCT02613572|18689606|P3|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
7592946|NCT02613572|18689607|P2|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
7592947|NCT02613572|18689608|P1|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||14
7592948|NCT02613572|18689606|P3|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
7592949|NCT02613572|18689607|P2|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
7592950|NCT02613572|18689608|P1|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||14
7592951|NCT02613572|18689606|P3|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
7592952|NCT02613572|18689607|P2|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
7592953|NCT02613572|18689608|P1|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
7592954|NCT02613572|18689606|P3|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
7592955|NCT02613572|18689607|P2|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
7592956|NCT02613572|18689608|P1|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
7592957|NCT02613572|18689606|P3|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
7592958|NCT02613572|18689607|P2|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
7592959|NCT02613572|18689608|P1|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||15
7592960|NCT02613507|18689630|P2|NOT COMPLETED|Overall Study||164
7592961|NCT02613507|18689631|P1|NOT COMPLETED|Overall Study||288
7592962|NCT02613507|18689630|P2|COMPLETED|Overall Study||2
7592963|NCT02613507|18689631|P1|COMPLETED|Overall Study||50
7592964|NCT02613507|18689630|P2|STARTED|Overall Study||166
7592965|NCT02613507|18689631|P1|STARTED|Overall Study||338
7592966|NCT02613481|18689647|P1|NOT COMPLETED|Overall Study||9
7592967|NCT02613481|18689647|P1|COMPLETED|Overall Study||41
7592968|NCT02613481|18689647|P1|STARTED|Overall Study||50
7592969|NCT02613403|18689658|P5|NOT COMPLETED|Overall Study||0
7592970|NCT02613403|18689659|P4|NOT COMPLETED|Overall Study||0
7592971|NCT02613403|18689660|P3|NOT COMPLETED|Overall Study||0
7592972|NCT02613403|18689661|P2|NOT COMPLETED|Overall Study||1
7592973|NCT02613403|18689662|P1|NOT COMPLETED|Overall Study||2
7592974|NCT02613403|18689658|P5|COMPLETED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
7592975|NCT02613403|18689659|P4|COMPLETED|Overall Study||13
7592976|NCT02613403|18689660|P3|COMPLETED|Overall Study||9
7592977|NCT02613403|18689661|P2|COMPLETED|Overall Study||35
7592978|NCT02613403|18689662|P1|COMPLETED|Overall Study||34
7592979|NCT02613403|18689658|P5|Treated|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
7592980|NCT02613403|18689659|P4|Treated|Overall Study||13
7592981|NCT02613403|18689660|P3|Treated|Overall Study||9
7592982|NCT02613403|18689661|P2|Treated|Overall Study||36
7592983|NCT02613403|18689662|P1|Treated|Overall Study||35
7592984|NCT02613403|18689658|P5|STARTED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
7592985|NCT02613403|18689659|P4|STARTED|Overall Study||13
7592986|NCT02613403|18689660|P3|STARTED|Overall Study||9
7592987|NCT02613403|18689661|P2|STARTED|Overall Study||36
7592988|NCT02613403|18689662|P1|STARTED|Overall Study||36
7592989|NCT02613338|18689704|P1|NOT COMPLETED|Overall Study||0
7592990|NCT02613338|18689704|P1|COMPLETED|Overall Study||30
7592991|NCT02613338|18689704|P1|STARTED|Overall Study||30
7592992|NCT02613221|18689714|P1|NOT COMPLETED|Overall Study||55
7592993|NCT02613221|18689714|P1|COMPLETED|Overall Study||1
7592994|NCT02613221|18689714|P1|Safety Population: Received Study Drug|Overall Study||55
7592995|NCT02613221|18689714|P1|STARTED|Overall Study||56
7592996|NCT02613208|18689726|P1|NOT COMPLETED|Overall Study||47
7592997|NCT02613208|18689726|P1|COMPLETED|Overall Study||64
7592998|NCT02613208|18689726|P1|STARTED|Overall Study||111
7592999|NCT02613182|18689740|P1|NOT COMPLETED|Overall Study||34
7593000|NCT02613182|18689740|P1|COMPLETED|Overall Study||0
7593001|NCT02613182|18689740|P1|Number of Patients Dosed|Overall Study||34
7593002|NCT02613182|18689740|P1|STARTED|Overall Study||34
7593003|NCT02613117|18689746|P2|NOT COMPLETED|Overall Study||0
7593004|NCT02613117|18689747|P1|NOT COMPLETED|Overall Study||0
7593005|NCT02613117|18689746|P2|COMPLETED|Overall Study||47
7593006|NCT02613117|18689747|P1|COMPLETED|Overall Study||57
7593007|NCT02613117|18689746|P2|STARTED|Overall Study||47
7593008|NCT02613117|18689747|P1|STARTED|Overall Study||57
7593009|NCT02612909|18689762|P5|NOT COMPLETED|Phase 3||0
7593010|NCT02612909|18689763|P4|NOT COMPLETED|Phase 3||1
7593011|NCT02612909|18689764|P3|NOT COMPLETED|Phase 3||0
7593012|NCT02612909|18689765|P2|NOT COMPLETED|Phase 3||0
7593013|NCT02612909|18689766|P1|NOT COMPLETED|Phase 3||0
7593014|NCT02612909|18689762|P5|COMPLETED|Phase 3||525
7593015|NCT02612909|18689763|P4|COMPLETED|Phase 3||104
7593016|NCT02612909|18689764|P3|COMPLETED|Phase 3||0
7593017|NCT02612909|18689765|P2|COMPLETED|Phase 3||0
7593018|NCT02612909|18689766|P1|COMPLETED|Phase 3||0
7593019|NCT02612909|18689762|P5|Completed Day 43 Clinic Visit|Phase 3||524
7593020|NCT02612909|18689763|P4|Completed Day 43 Clinic Visit|Phase 3||104
7593021|NCT02612909|18689764|P3|Completed Day 43 Clinic Visit|Phase 3||0
7593022|NCT02612909|18689765|P2|Completed Day 43 Clinic Visit|Phase 3||0
7593023|NCT02612909|18689766|P1|Completed Day 43 Clinic Visit|Phase 3||0
7593024|NCT02612909|18689762|P5|Completed Day 29 Clinic Visit|Phase 3||525
7593025|NCT02612909|18689763|P4|Completed Day 29 Clinic Visit|Phase 3||104
7593026|NCT02612909|18689764|P3|Completed Day 29 Clinic Visit|Phase 3||0
7593027|NCT02612909|18689765|P2|Completed Day 29 Clinic Visit|Phase 3||0
7593028|NCT02612909|18689766|P1|Completed Day 29 Clinic Visit|Phase 3||0
7593029|NCT02612909|18689762|P5|Received Injection 2|Phase 3||520
7593030|NCT02612909|18689763|P4|Received Injection 2|Phase 3||103
7593031|NCT02612909|18689764|P3|Received Injection 2|Phase 3||0
7593032|NCT02612909|18689765|P2|Received Injection 2|Phase 3||0
7593033|NCT02612909|18689766|P1|Received Injection 2|Phase 3||0
7593034|NCT02612909|18689762|P5|Received Injection 1|Phase 3||525
7593035|NCT02612909|18689763|P4|Received Injection 1|Phase 3||105
7593036|NCT02612909|18689764|P3|Received Injection 1|Phase 3||0
7593037|NCT02612909|18689765|P2|Received Injection 1|Phase 3||0
7593038|NCT02612909|18689766|P1|Received Injection 1|Phase 3||0
7593039|NCT02612909|18689762|P5|STARTED|Phase 3||525
7593040|NCT02612909|18689763|P4|STARTED|Phase 3||105
7593041|NCT02612909|18689764|P3|STARTED|Phase 3||0
7593042|NCT02612909|18689765|P2|STARTED|Phase 3||0
7593043|NCT02612909|18689766|P1|STARTED|Phase 3||0
7593044|NCT02612909|18689762|P5|NOT COMPLETED|Phase 2||0
7593045|NCT02612909|18689763|P4|NOT COMPLETED|Phase 2||0
7593046|NCT02612909|18689764|P3|NOT COMPLETED|Phase 2||1
7593047|NCT02612909|18689765|P2|NOT COMPLETED|Phase 2||5
7593048|NCT02612909|18689766|P1|NOT COMPLETED|Phase 2||2
7593049|NCT02612909|18689762|P5|COMPLETED|Phase 2||0
7593050|NCT02612909|18689763|P4|COMPLETED|Phase 2||0
7593051|NCT02612909|18689764|P3|COMPLETED|Phase 2||99
7593052|NCT02612909|18689765|P2|COMPLETED|Phase 2||95
7593053|NCT02612909|18689766|P1|COMPLETED|Phase 2||98
7593054|NCT02612909|18689762|P5|Completed Day 43 Clinic Visit|Phase 2||0
7593055|NCT02612909|18689763|P4|Completed Day 43 Clinic Visit|Phase 2||0
7593056|NCT02612909|18689764|P3|Completed Day 43 Clinic Visit|Phase 2||99
7593057|NCT02612909|18689765|P2|Completed Day 43 Clinic Visit|Phase 2||94
7593058|NCT02612909|18689766|P1|Completed Day 43 Clinic Visit|Phase 2||97
7593059|NCT02612909|18689762|P5|Completed Day 29 Clinic Visit|Phase 2||0
7593060|NCT02612909|18689763|P4|Completed Day 29 Clinic Visit|Phase 2||0
7593061|NCT02612909|18689764|P3|Completed Day 29 Clinic Visit|Phase 2||99
7593062|NCT02612909|18689765|P2|Completed Day 29 Clinic Visit|Phase 2||95
7593063|NCT02612909|18689766|P1|Completed Day 29 Clinic Visit|Phase 2||98
7593064|NCT02612909|18689762|P5|Received Injection 2|Phase 2||0
7593065|NCT02612909|18689763|P4|Received Injection 2|Phase 2||0
7593066|NCT02612909|18689764|P3|Received Injection 2|Phase 2||99
7593067|NCT02612909|18689765|P2|Received Injection 2|Phase 2||95
7593068|NCT02612909|18689766|P1|Received Injection 2|Phase 2||98
7593069|NCT02612909|18689762|P5|Received Injection 1|Phase 2||0
7593070|NCT02612909|18689763|P4|Received Injection 1|Phase 2||0
7593071|NCT02612909|18689764|P3|Received Injection 1|Phase 2||100
7593072|NCT02612909|18689765|P2|Received Injection 1|Phase 2||100
7593073|NCT02612909|18689766|P1|Received Injection 1|Phase 2||100
7593074|NCT02612909|18689762|P5|STARTED|Phase 2||0
7593075|NCT02612909|18689763|P4|STARTED|Phase 2||0
7593076|NCT02612909|18689764|P3|STARTED|Phase 2||100
7593077|NCT02612909|18689765|P2|STARTED|Phase 2||100
7593078|NCT02612909|18689766|P1|STARTED|Phase 2||100
7593079|NCT02612857|18689834|P3|NOT COMPLETED|Overall Study||4
7593080|NCT02612857|18689835|P2|NOT COMPLETED|Overall Study||4
7593081|NCT02612857|18689836|P1|NOT COMPLETED|Overall Study||3
7593082|NCT02612857|18689834|P3|COMPLETED|Overall Study||6
7593083|NCT02612857|18689835|P2|COMPLETED|Overall Study||5
7593084|NCT02612857|18689836|P1|COMPLETED|Overall Study||8
7593085|NCT02612857|18689834|P3|STARTED|Overall Study||10
7593086|NCT02612857|18689835|P2|STARTED|Overall Study||9
7593087|NCT02612857|18689836|P1|STARTED|Overall Study||11
7593088|NCT02612779|18689849|P2|NOT COMPLETED|Overall Study||5
7593089|NCT02612779|18689850|P1|NOT COMPLETED|Overall Study||64
7593090|NCT02612779|18689849|P2|COMPLETED|Overall Study||1
7593091|NCT02612779|18689850|P1|COMPLETED|Overall Study||4
7593092|NCT02612779|18689849|P2|STARTED|Overall Study||6
7593093|NCT02612779|18689850|P1|STARTED|Overall Study||68
7593094|NCT02612727|18689862|P2|NOT COMPLETED|Overall Study||4
7593095|NCT02612727|18689863|P1|NOT COMPLETED|Overall Study||5
7593096|NCT02612727|18689862|P2|COMPLETED|Overall Study||83
7593097|NCT02612727|18689863|P1|COMPLETED|Overall Study||82
7593098|NCT02612727|18689862|P2|STARTED|Overall Study||87
7593099|NCT02612727|18689863|P1|STARTED|Overall Study||87
7593100|NCT02612688|18689873|P2|NOT COMPLETED|Overall Study||0
7593101|NCT02612688|18689874|P1|NOT COMPLETED|Overall Study||0
7593102|NCT02612688|18689873|P2|COMPLETED|Overall Study||70013
7593103|NCT02612688|18689874|P1|COMPLETED|Overall Study||33035
7593104|NCT02612688|18689873|P2|STARTED|Overall Study||70013
7593105|NCT02612688|18689874|P1|STARTED|Overall Study||33035
7593106|NCT02612623|18689922|P4|NOT COMPLETED|Overall Study||0
7593107|NCT02612623|18689923|P3|NOT COMPLETED|Overall Study||1
7593108|NCT02612623|18689924|P2|NOT COMPLETED|Overall Study||1
7593109|NCT02612623|18689925|P1|NOT COMPLETED|Overall Study||1
7593110|NCT02612623|18689922|P4|COMPLETED|Overall Study||4
7593111|NCT02612623|18689923|P3|COMPLETED|Overall Study||5
7593112|NCT02612623|18689924|P2|COMPLETED|Overall Study||5
7593113|NCT02612623|18689925|P1|COMPLETED|Overall Study||7
7593114|NCT02612623|18689922|P4|Treated|Overall Study||4
7593115|NCT02612623|18689923|P3|Treated|Overall Study||6
7593116|NCT02612623|18689924|P2|Treated|Overall Study||5
7593117|NCT02612623|18689925|P1|Treated|Overall Study||8
7593118|NCT02612623|18689922|P4|STARTED|Overall Study||4
7593119|NCT02612623|18689923|P3|STARTED|Overall Study||6
7593120|NCT02612623|18689924|P2|STARTED|Overall Study||6
7593121|NCT02612623|18689925|P1|STARTED|Overall Study||8
7593122|NCT02612610|18689939|P4|NOT COMPLETED|Overall Study||13
7593123|NCT02612610|18689940|P3|NOT COMPLETED|Overall Study||5
7593124|NCT02612610|18689941|P2|NOT COMPLETED|Overall Study||8
7593125|NCT02612610|18689942|P1|NOT COMPLETED|Overall Study||5
7593126|NCT02612610|18689939|P4|COMPLETED|Overall Study||50
7593127|NCT02612610|18689940|P3|COMPLETED|Overall Study||58
7593128|NCT02612610|18689941|P2|COMPLETED|Overall Study||56
7593129|NCT02612610|18689942|P1|COMPLETED|Overall Study||58
7593130|NCT02612610|18689939|P4|Treated|Overall Study||63
7593131|NCT02612610|18689940|P3|Treated|Overall Study||63
7593132|NCT02612610|18689941|P2|Treated|Overall Study||63
7593133|NCT02612610|18689942|P1|Treated|Overall Study||63
7593134|NCT02612610|18689939|P4|STARTED|Overall Study||63
7593135|NCT02612610|18689940|P3|STARTED|Overall Study||63
7593136|NCT02612610|18689941|P2|STARTED|Overall Study||64
7593137|NCT02612610|18689942|P1|STARTED|Overall Study||63
7593138|NCT02612428|18690186|P2|NOT COMPLETED|VTL-308E||7
7593139|NCT02612428|18690187|P1|NOT COMPLETED|VTL-308E||11
7593140|NCT02612428|18690186|P2|COMPLETED|VTL-308E||49
7593141|NCT02612428|18690187|P1|COMPLETED|VTL-308E||53
7593142|NCT02612428|18690186|P2|STARTED|VTL-308E||56
7593143|NCT02612428|18690187|P1|STARTED|VTL-308E||64
7593144|NCT02612428|18690186|P2|NOT COMPLETED|VTL-308||17
7593145|NCT02612428|18690187|P1|NOT COMPLETED|VTL-308||14
7593146|NCT02612428|18690186|P2|COMPLETED|VTL-308||56
7593147|NCT02612428|18690187|P1|COMPLETED|VTL-308||64
7593148|NCT02612428|18690186|P2|STARTED|VTL-308||73
7593149|NCT02612428|18690187|P1|STARTED|VTL-308||78
7593150|NCT02612285|18690197|P1|NOT COMPLETED|Overall Study||1
7593151|NCT02612285|18690197|P1|COMPLETED|Overall Study|Subject did not complete Cycle 1; no data points recorded|0
7593152|NCT02612285|18690197|P1|STARTED|Overall Study||1
7593153|NCT02612155|18690203|P2|NOT COMPLETED|Overall Study||3
7593154|NCT02612155|18690204|P1|NOT COMPLETED|Overall Study||3
7593155|NCT02612155|18690203|P2|COMPLETED|Overall Study||15
7593156|NCT02612155|18690204|P1|COMPLETED|Overall Study||14
7593157|NCT02612155|18690203|P2|STARTED|Overall Study||18
7593158|NCT02612155|18690204|P1|STARTED|Overall Study||17
7593159|NCT02612077|18690224|P1|NOT COMPLETED|Overall Study||466
7593160|NCT02612077|18690224|P1|COMPLETED|Overall Study||299
7593161|NCT02612077|18690224|P1|Efficacy Analysis Set|Overall Study||737
7593162|NCT02612077|18690224|P1|Safety Analysis Set|Overall Study||760
7593163|NCT02612077|18690224|P1|Did Not Receive Study Product|Overall Study||5
7593164|NCT02612077|18690224|P1|STARTED|Overall Study||765
7593165|NCT02612064|18690236|P2|NOT COMPLETED|Overall Study||3
7593166|NCT02612064|18690237|P1|NOT COMPLETED|Overall Study||1
7593167|NCT02612064|18690236|P2|COMPLETED|Overall Study||112
7593168|NCT02612064|18690237|P1|COMPLETED|Overall Study||114
7593169|NCT02612064|18690236|P2|STARTED|Overall Study||115
7593170|NCT02612064|18690237|P1|STARTED|Overall Study||115
7593171|NCT02611882|18690250|P3|NOT COMPLETED|Overall Study||0
7593172|NCT02611882|18690251|P2|NOT COMPLETED|Overall Study||0
7593173|NCT02611882|18690252|P1|NOT COMPLETED|Overall Study||33
7593174|NCT02611882|18690250|P3|COMPLETED|Overall Study||0
7593175|NCT02611882|18690251|P2|COMPLETED|Overall Study||150
7593176|NCT02611882|18690252|P1|COMPLETED|Overall Study||42
7593177|NCT02611882|18690250|P3|Completed Surgery Per Protocol|Overall Study||0
7593178|NCT02611882|18690251|P2|Completed Surgery Per Protocol|Overall Study||0
7593179|NCT02611882|18690252|P1|Completed Surgery Per Protocol|Overall Study||42
7593180|NCT02611882|18690250|P3|STARTED|Overall Study||0
7593181|NCT02611882|18690251|P2|STARTED|Overall Study||150
7593182|NCT02611882|18690252|P1|STARTED|Overall Study||75
7593183|NCT02611830|18690270|P4|NOT COMPLETED|Maintenance Phase||15
7593184|NCT02611830|18690271|P3|NOT COMPLETED|Maintenance Phase||31
7593185|NCT02611830|18690272|P2|NOT COMPLETED|Maintenance Phase||36
7593186|NCT02611830|18690273|P1|NOT COMPLETED|Maintenance Phase||0
7593187|NCT02611830|18690270|P4|COMPLETED|Maintenance Phase||39
7593188|NCT02611830|18690271|P3|COMPLETED|Maintenance Phase||75
7593189|NCT02611830|18690272|P2|COMPLETED|Maintenance Phase||20
7593190|NCT02611830|18690273|P1|COMPLETED|Maintenance Phase||0
7593191|NCT02611830|18690270|P4|STARTED|Maintenance Phase||54
7593192|NCT02611830|18690271|P3|STARTED|Maintenance Phase||106
7593193|NCT02611830|18690272|P2|STARTED|Maintenance Phase||56
7593194|NCT02611830|18690273|P1|STARTED|Maintenance Phase||0
7593195|NCT02611830|18690270|P4|NOT COMPLETED|OL Induction Phase||0
7593196|NCT02611830|18690271|P3|NOT COMPLETED|OL Induction Phase||0
7593197|NCT02611830|18690272|P2|NOT COMPLETED|OL Induction Phase||0
7593198|NCT02611830|18690273|P1|NOT COMPLETED|OL Induction Phase||30
7593199|NCT02611830|18690270|P4|COMPLETED|OL Induction Phase||0
7593200|NCT02611830|18690271|P3|COMPLETED|OL Induction Phase||0
7593201|NCT02611830|18690272|P2|COMPLETED|OL Induction Phase||0
7593202|NCT02611830|18690273|P1|COMPLETED|OL Induction Phase||353
7593203|NCT02611830|18690270|P4|STARTED|OL Induction Phase||0
7593204|NCT02611830|18690271|P3|STARTED|OL Induction Phase||0
7593205|NCT02611830|18690272|P2|STARTED|OL Induction Phase||0
7593206|NCT02611830|18690273|P1|STARTED|OL Induction Phase||383
7593207|NCT02611817|18690297|P3|NOT COMPLETED|Double-blind Maintenance Phase||107
7593208|NCT02611817|18690298|P2|NOT COMPLETED|Double-blind Maintenance Phase||62
7593209|NCT02611817|18690299|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
7593210|NCT02611817|18690297|P3|COMPLETED|Double-blind Maintenance Phase||168
7593211|NCT02611817|18690298|P2|COMPLETED|Double-blind Maintenance Phase||73
7593212|NCT02611817|18690299|P1|COMPLETED|Double-blind Maintenance Phase||0
7593213|NCT02611817|18690297|P3|STARTED|Double-blind Maintenance Phase||275
7593214|NCT02611817|18690298|P2|STARTED|Double-blind Maintenance Phase||135
7593215|NCT02611817|18690299|P1|STARTED|Double-blind Maintenance Phase||0
7593216|NCT02611817|18690297|P3|NOT COMPLETED|Open-label Induction Phase||0
7593217|NCT02611817|18690298|P2|NOT COMPLETED|Open-label Induction Phase||0
7593218|NCT02611817|18690299|P1|NOT COMPLETED|Open-label Induction Phase||50
7593219|NCT02611817|18690297|P3|COMPLETED|Open-label Induction Phase||0
7593220|NCT02611817|18690298|P2|COMPLETED|Open-label Induction Phase||0
7593221|NCT02611817|18690299|P1|COMPLETED|Open-label Induction Phase||594
7593222|NCT02611817|18690297|P3|STARTED|Open-label Induction Phase||0
7593223|NCT02611817|18690298|P2|STARTED|Open-label Induction Phase||0
7593224|NCT02611817|18690299|P1|STARTED|Open-label Induction Phase||644
7593225|NCT02611765|18690314|P2|NOT COMPLETED|Overall Study||6
7593226|NCT02611765|18690315|P1|NOT COMPLETED|Overall Study||2
7593227|NCT02611765|18690314|P2|COMPLETED|Overall Study||29
7593228|NCT02611765|18690315|P1|COMPLETED|Overall Study||27
7593229|NCT02611765|18690314|P2|STARTED|Overall Study||35
7593230|NCT02611765|18690315|P1|STARTED|Overall Study||29
7593231|NCT02611752|18690323|P2|NOT COMPLETED|Overall Study||1
7593232|NCT02611752|18690324|P1|NOT COMPLETED|Overall Study||0
7593233|NCT02611752|18690323|P2|COMPLETED|Overall Study||24
7593234|NCT02611752|18690324|P1|COMPLETED|Overall Study||22
7593235|NCT02611752|18690323|P2|Day11-13 Hydromorphone Challenge Injs|Overall Study||24
7593236|NCT02611752|18690324|P1|Day11-13 Hydromorphone Challenge Injs|Overall Study||22
7593237|NCT02611752|18690323|P2|Day 8-10 Hydromorphone Challenge Injs|Overall Study||24
7593238|NCT02611752|18690324|P1|Day 8-10 Hydromorphone Challenge Injs|Overall Study||22
7593239|NCT02611752|18690323|P2|Day 4-6 Hydromorphone Challenge Injs|Overall Study||24
7593240|NCT02611752|18690324|P1|Day 4-6 Hydromorphone Challenge Injs|Overall Study||22
7593241|NCT02611752|18690323|P2|Day 1-3 Hydromorphone Challenge Injs|Overall Study||25
7593242|NCT02611752|18690324|P1|Day 1-3 Hydromorphone Challenge Injs|Overall Study||22
7593243|NCT02611752|18690323|P2|STARTED|Overall Study||25
7593244|NCT02611752|18690324|P1|STARTED|Overall Study||22
7593245|NCT02611479|18690356|P1|NOT COMPLETED|Data Cleaning||2
7593246|NCT02611479|18690356|P1|COMPLETED|Data Cleaning||149
7593247|NCT02611479|18690356|P1|STARTED|Data Cleaning||151
7593248|NCT02611479|18690356|P1|NOT COMPLETED|Post-Surgery Follow-up at 1-Year||18
7593249|NCT02611479|18690356|P1|COMPLETED|Post-Surgery Follow-up at 1-Year||151
7593250|NCT02611479|18690356|P1|STARTED|Post-Surgery Follow-up at 1-Year||169
7593251|NCT02611479|18690356|P1|NOT COMPLETED|Post-Surgery Follow-up at 30-90 Days||2
7593252|NCT02611479|18690356|P1|COMPLETED|Post-Surgery Follow-up at 30-90 Days||169
7593253|NCT02611479|18690356|P1|STARTED|Post-Surgery Follow-up at 30-90 Days||171
7593254|NCT02611479|18690356|P1|NOT COMPLETED|Baseline Enrollment||13
7593255|NCT02611479|18690356|P1|COMPLETED|Baseline Enrollment||171
7593256|NCT02611479|18690356|P1|STARTED|Baseline Enrollment||184
7593257|NCT02611154|18690360|P1|NOT COMPLETED|Overall Study||0
7593258|NCT02611154|18690360|P1|COMPLETED|Overall Study||5
7593259|NCT02611154|18690360|P1|STARTED|Overall Study||5
7593260|NCT02610972|18690381|P2|NOT COMPLETED|Overall Study||0
7593261|NCT02610972|18690382|P1|NOT COMPLETED|Overall Study||0
7593262|NCT02610972|18690381|P2|COMPLETED|Overall Study||50
7593263|NCT02610972|18690382|P1|COMPLETED|Overall Study||100
7593264|NCT02610972|18690381|P2|STARTED|Overall Study||50
7593265|NCT02610972|18690382|P1|STARTED|Overall Study||100
7593266|NCT02610868|18690388|P1|NOT COMPLETED|MYOBLOC: Treatment Session 4||2
7593267|NCT02610868|18690388|P1|COMPLETED|MYOBLOC: Treatment Session 4||22
7593268|NCT02610868|18690388|P1|STARTED|MYOBLOC: Treatment Session 4||24
7593269|NCT02610868|18690388|P1|NOT COMPLETED|MYOBLOC: Treatment Session 3||7
7593270|NCT02610868|18690388|P1|COMPLETED|MYOBLOC: Treatment Session 3||43
7593271|NCT02610868|18690388|P1|STARTED|MYOBLOC: Treatment Session 3||50
7593272|NCT02610868|18690388|P1|NOT COMPLETED|MYOBLOC: Treatment Session 2||12
7593273|NCT02610868|18690388|P1|COMPLETED|MYOBLOC: Treatment Session 2||165
7593274|NCT02610868|18690388|P1|STARTED|MYOBLOC: Treatment Session 2||177
7593275|NCT02610868|18690388|P1|NOT COMPLETED|MYOBLOC: Treatment Session 1||7
7593276|NCT02610868|18690388|P1|COMPLETED|MYOBLOC: Treatment Session 1||180
7593277|NCT02610868|18690388|P1|STARTED|MYOBLOC: Treatment Session 1||187
7593278|NCT02610842|18690488|P1|NOT COMPLETED|Overall Study||5
7593279|NCT02610842|18690488|P1|COMPLETED|Overall Study||22
7593280|NCT02610842|18690488|P1|STARTED|Overall Study||27
7593281|NCT02610816|18690497|P4|NOT COMPLETED|Phase 2||6
7593282|NCT02610816|18690498|P3|NOT COMPLETED|Phase 2||11
7593283|NCT02610816|18690499|P2|NOT COMPLETED|Phase 2||0
7593284|NCT02610816|18690500|P1|NOT COMPLETED|Phase 2||0
7593285|NCT02610816|18690497|P4|COMPLETED|Phase 2||4
7593286|NCT02610816|18690498|P3|COMPLETED|Phase 2||8
7593287|NCT02610816|18690499|P2|COMPLETED|Phase 2||0
7593288|NCT02610816|18690500|P1|COMPLETED|Phase 2||0
7593289|NCT02610816|18690497|P4|STARTED|Phase 2||10
7593290|NCT02610816|18690498|P3|STARTED|Phase 2||19
7593291|NCT02610816|18690499|P2|STARTED|Phase 2||0
7593292|NCT02610816|18690500|P1|STARTED|Phase 2||0
7593293|NCT02610816|18690497|P4|NOT COMPLETED|Phase 1||0
7593294|NCT02610816|18690498|P3|NOT COMPLETED|Phase 1||0
7593295|NCT02610816|18690499|P2|NOT COMPLETED|Phase 1||8
7593296|NCT02610816|18690500|P1|NOT COMPLETED|Phase 1||4
7593297|NCT02610816|18690497|P4|COMPLETED|Phase 1||0
7593298|NCT02610816|18690498|P3|COMPLETED|Phase 1||0
7593299|NCT02610816|18690499|P2|COMPLETED|Phase 1||17
7593300|NCT02610816|18690500|P1|COMPLETED|Phase 1||34
7593301|NCT02610816|18690497|P4|STARTED|Phase 1||0
7593302|NCT02610816|18690498|P3|STARTED|Phase 1||0
7593303|NCT02610816|18690499|P2|STARTED|Phase 1||25
7593304|NCT02610816|18690500|P1|STARTED|Phase 1||38
7593305|NCT02610777|18690523|P2|NOT COMPLETED|Overall Study||22
7593306|NCT02610777|18690524|P1|NOT COMPLETED|Overall Study||21
7593307|NCT02610777|18690523|P2|COMPLETED|Overall Study||36
7593308|NCT02610777|18690524|P1|COMPLETED|Overall Study||41
7593309|NCT02610777|18690523|P2|STARTED|Overall Study||58
7593310|NCT02610777|18690524|P1|STARTED|Overall Study||62
7593311|NCT02610725|18690530|P1|NOT COMPLETED|Overall Study||206
7593312|NCT02610725|18690530|P1|COMPLETED|Overall Study||75
7593313|NCT02610725|18690530|P1|STARTED|Overall Study||281
7593314|NCT02610634|18690538|P2|NOT COMPLETED|Overall Study||0
7593315|NCT02610634|18690539|P1|NOT COMPLETED|Overall Study||0
7593316|NCT02610634|18690538|P2|COMPLETED|Overall Study||40
7593317|NCT02610634|18690539|P1|COMPLETED|Overall Study||60
7593318|NCT02610634|18690538|P2|STARTED|Overall Study||40
7593319|NCT02610634|18690539|P1|STARTED|Overall Study||60
7593320|NCT02610231|18690545|P1|NOT COMPLETED|Overall Study||60
7593321|NCT02610231|18690545|P1|COMPLETED|Overall Study||179
7593322|NCT02610231|18690545|P1|STARTED|Overall Study||239
7593323|NCT02610192|18690552|P1|NOT COMPLETED|Overall Study||9
7593324|NCT02610192|18690552|P1|COMPLETED|Overall Study||41
7593325|NCT02610192|18690552|P1|STARTED|Overall Study|52 subjects had signed consent form, but 50 subjects have been treated. 2 subjects became SF.|50
7593326|NCT02610140|18690567|P2|NOT COMPLETED|Long-term Follow-up||66
7593327|NCT02610140|18690568|P1|NOT COMPLETED|Long-term Follow-up||123
7593328|NCT02610140|18690567|P2|COMPLETED|Long-term Follow-up||0
7593329|NCT02610140|18690568|P1|COMPLETED|Long-term Follow-up||0
7593330|NCT02610140|18690567|P2|STARTED|Long-term Follow-up||66
7593331|NCT02610140|18690568|P1|STARTED|Long-term Follow-up||123
7593332|NCT02610140|18690567|P2|NOT COMPLETED|Active Follow-up||26
7593333|NCT02610140|18690568|P1|NOT COMPLETED|Active Follow-up||48
7593334|NCT02610140|18690567|P2|COMPLETED|Active Follow-up||0
7593335|NCT02610140|18690568|P1|COMPLETED|Active Follow-up||0
7593336|NCT02610140|18690567|P2|STARTED|Active Follow-up||26
7593337|NCT02610140|18690568|P1|STARTED|Active Follow-up||48
7593338|NCT02610140|18690567|P2|NOT COMPLETED|Safety Follow-up||24
7593339|NCT02610140|18690568|P1|NOT COMPLETED|Safety Follow-up||45
7593340|NCT02610140|18690567|P2|COMPLETED|Safety Follow-up||21
7593341|NCT02610140|18690568|P1|COMPLETED|Safety Follow-up||57
7593342|NCT02610140|18690567|P2|STARTED|Safety Follow-up||45
7593343|NCT02610140|18690568|P1|STARTED|Safety Follow-up||102
7593344|NCT02610140|18690567|P2|NOT COMPLETED|Randomization and Treatment Period||82
7593345|NCT02610140|18690568|P1|NOT COMPLETED|Randomization and Treatment Period||166
7593346|NCT02610140|18690567|P2|COMPLETED|Randomization and Treatment Period||0
7593347|NCT02610140|18690568|P1|COMPLETED|Randomization and Treatment Period||0
7593348|NCT02610140|18690567|P2|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|72
7593349|NCT02610140|18690568|P1|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|163
7593350|NCT02610140|18690567|P2|STARTED|Randomization and Treatment Period||82
7593351|NCT02610140|18690568|P1|STARTED|Randomization and Treatment Period||166
7593352|NCT02609984|18690600|P2|NOT COMPLETED|Overall Study||39
7593353|NCT02609984|18690601|P1|NOT COMPLETED|Overall Study||44
7593354|NCT02609984|18690600|P2|COMPLETED|Overall Study||5
7593355|NCT02609984|18690601|P1|COMPLETED|Overall Study||1
7593356|NCT02609984|18690600|P2|Treated|Overall Study||43
7593357|NCT02609984|18690601|P1|Treated|Overall Study||45
7593358|NCT02609984|18690600|P2|STARTED|Overall Study||44
7593359|NCT02609984|18690601|P1|STARTED|Overall Study||45
7593360|NCT02609841|18690635|P1|NOT COMPLETED|Overall Study||28
7593361|NCT02609841|18690635|P1|COMPLETED|Overall Study||212
7593362|NCT02609841|18690635|P1|STARTED|Overall Study||240
7593363|NCT02609672|18690643|P2|NOT COMPLETED|Overall Study||1
7593364|NCT02609672|18690644|P1|NOT COMPLETED|Overall Study||3
7593365|NCT02609672|18690643|P2|COMPLETED|Overall Study||11
7593366|NCT02609672|18690644|P1|COMPLETED|Overall Study||9
7593367|NCT02609672|18690643|P2|STARTED|Overall Study||12
7593368|NCT02609672|18690644|P1|STARTED|Overall Study||12
7593369|NCT02609659|18690678|P1|NOT COMPLETED|Overall Study||8
7593370|NCT02609659|18690678|P1|COMPLETED|Overall Study||97
7593371|NCT02609659|18690678|P1|STARTED|Overall Study||105
7593372|NCT02609633|18690688|P2|NOT COMPLETED|Overall Study||2
7593373|NCT02609633|18690689|P1|NOT COMPLETED|Overall Study||5
7593374|NCT02609633|18690688|P2|COMPLETED|Overall Study||54
7593375|NCT02609633|18690689|P1|COMPLETED|Overall Study||37
7593376|NCT02609633|18690688|P2|Full Analysis Set (FAS)|Overall Study||46
7593377|NCT02609633|18690689|P1|Full Analysis Set (FAS)|Overall Study||32
7593378|NCT02609633|18690688|P2|STARTED|Overall Study||56
7593379|NCT02609633|18690689|P1|STARTED|Overall Study||42
7593380|NCT02609607|18690716|P2|NOT COMPLETED|Overall Study||1
7593381|NCT02609607|18690717|P1|NOT COMPLETED|Overall Study||0
7593382|NCT02609607|18690716|P2|COMPLETED|Overall Study||4
7593383|NCT02609607|18690717|P1|COMPLETED|Overall Study||6
7593384|NCT02609607|18690716|P2|STARTED|Overall Study||5
7593385|NCT02609607|18690717|P1|STARTED|Overall Study||6
7593386|NCT02609399|18690741|P2|NOT COMPLETED|Influenza Season 2016-2017||5
7593387|NCT02609399|18690742|P1|NOT COMPLETED|Influenza Season 2016-2017||9
7593388|NCT02609399|18690741|P2|COMPLETED|Influenza Season 2016-2017||59
7593389|NCT02609399|18690742|P1|COMPLETED|Influenza Season 2016-2017||49
7593390|NCT02609399|18690741|P2|STARTED|Influenza Season 2016-2017||64
7593391|NCT02609399|18690742|P1|STARTED|Influenza Season 2016-2017||58
7593392|NCT02609399|18690741|P2|NOT COMPLETED|Influenza Season 2015-2016||2
7593393|NCT02609399|18690742|P1|NOT COMPLETED|Influenza Season 2015-2016||3
7593394|NCT02609399|18690741|P2|COMPLETED|Influenza Season 2015-2016||29
7593395|NCT02609399|18690742|P1|COMPLETED|Influenza Season 2015-2016||24
7593396|NCT02609399|18690741|P2|STARTED|Influenza Season 2015-2016||31
7593397|NCT02609399|18690742|P1|STARTED|Influenza Season 2015-2016||27
7593398|NCT02609308|18690756|P2|NOT COMPLETED|Overall Study||0
7593399|NCT02609308|18690757|P1|NOT COMPLETED|Overall Study||0
7593400|NCT02609308|18690756|P2|COMPLETED|Overall Study||11
7593401|NCT02609308|18690757|P1|COMPLETED|Overall Study||10
7593402|NCT02609308|18690756|P2|STARTED|Overall Study||11
7593403|NCT02609308|18690757|P1|STARTED|Overall Study||10
7593404|NCT02609204|18690767|P1|NOT COMPLETED|Overall Study||0
7593405|NCT02609204|18690767|P1|COMPLETED|Overall Study||51
7593406|NCT02609204|18690767|P1|STARTED|Overall Study||51
7593407|NCT02609178|18690772|P6|NOT COMPLETED|Third Crown||0
7593408|NCT02609178|18690773|P5|NOT COMPLETED|Third Crown||0
7593409|NCT02609178|18690774|P4|NOT COMPLETED|Third Crown||0
7593410|NCT02609178|18690775|P3|NOT COMPLETED|Third Crown||0
7593411|NCT02609178|18690776|P2|NOT COMPLETED|Third Crown||0
7593412|NCT02609178|18690777|P1|NOT COMPLETED|Third Crown||0
7593413|NCT02609178|18690772|P6|COMPLETED|Third Crown||2
7593414|NCT02609178|18690773|P5|COMPLETED|Third Crown||0
7593415|NCT02609178|18690774|P4|COMPLETED|Third Crown||2
7593416|NCT02609178|18690775|P3|COMPLETED|Third Crown||5
7593417|NCT02609178|18690776|P2|COMPLETED|Third Crown||1
7593418|NCT02609178|18690777|P1|COMPLETED|Third Crown||0
7593419|NCT02609178|18690772|P6|STARTED|Third Crown||2
7593420|NCT02609178|18690773|P5|STARTED|Third Crown||0
7593421|NCT02609178|18690774|P4|STARTED|Third Crown||2
7593422|NCT02609178|18690775|P3|STARTED|Third Crown||5
7593423|NCT02609178|18690776|P2|STARTED|Third Crown||1
7593424|NCT02609178|18690777|P1|STARTED|Third Crown||0
7593425|NCT02609178|18690772|P6|NOT COMPLETED|5-minute Washout Time||0
7593426|NCT02609178|18690773|P5|NOT COMPLETED|5-minute Washout Time||0
7593427|NCT02609178|18690774|P4|NOT COMPLETED|5-minute Washout Time||0
7593428|NCT02609178|18690775|P3|NOT COMPLETED|5-minute Washout Time||0
7593429|NCT02609178|18690776|P2|NOT COMPLETED|5-minute Washout Time||0
7593430|NCT02609178|18690777|P1|NOT COMPLETED|5-minute Washout Time||0
7593431|NCT02609178|18690772|P6|COMPLETED|5-minute Washout Time||2
7593432|NCT02609178|18690773|P5|COMPLETED|5-minute Washout Time||0
7593433|NCT02609178|18690774|P4|COMPLETED|5-minute Washout Time||2
7593434|NCT02609178|18690775|P3|COMPLETED|5-minute Washout Time||5
7593435|NCT02609178|18690776|P2|COMPLETED|5-minute Washout Time||1
7593436|NCT02609178|18690777|P1|COMPLETED|5-minute Washout Time||0
7593437|NCT02609178|18690772|P6|STARTED|5-minute Washout Time||2
7593438|NCT02609178|18690773|P5|STARTED|5-minute Washout Time||0
7593439|NCT02609178|18690774|P4|STARTED|5-minute Washout Time||2
7593440|NCT02609178|18690775|P3|STARTED|5-minute Washout Time||5
7593441|NCT02609178|18690776|P2|STARTED|5-minute Washout Time||1
7593442|NCT02609178|18690777|P1|STARTED|5-minute Washout Time||0
7593443|NCT02609178|18690772|P6|NOT COMPLETED|Second Crown||0
7593444|NCT02609178|18690773|P5|NOT COMPLETED|Second Crown||0
7593445|NCT02609178|18690774|P4|NOT COMPLETED|Second Crown||0
7593446|NCT02609178|18690775|P3|NOT COMPLETED|Second Crown||0
7593447|NCT02609178|18690776|P2|NOT COMPLETED|Second Crown||0
7593448|NCT02609178|18690777|P1|NOT COMPLETED|Second Crown||0
7593449|NCT02609178|18690772|P6|COMPLETED|Second Crown||2
7593450|NCT02609178|18690773|P5|COMPLETED|Second Crown||0
7593451|NCT02609178|18690774|P4|COMPLETED|Second Crown||2
7593452|NCT02609178|18690775|P3|COMPLETED|Second Crown||5
7593453|NCT02609178|18690776|P2|COMPLETED|Second Crown||1
7593454|NCT02609178|18690777|P1|COMPLETED|Second Crown||0
7593455|NCT02609178|18690772|P6|STARTED|Second Crown||2
7593456|NCT02609178|18690773|P5|STARTED|Second Crown||0
7593457|NCT02609178|18690774|P4|STARTED|Second Crown||2
7593458|NCT02609178|18690775|P3|STARTED|Second Crown||5
7593459|NCT02609178|18690776|P2|STARTED|Second Crown||1
7593460|NCT02609178|18690777|P1|STARTED|Second Crown||0
7593461|NCT02609178|18690772|P6|NOT COMPLETED|5-minute Washout Time||0
7593462|NCT02609178|18690773|P5|NOT COMPLETED|5-minute Washout Time||0
7593463|NCT02609178|18690774|P4|NOT COMPLETED|5-minute Washout Time||0
7593464|NCT02609178|18690775|P3|NOT COMPLETED|5-minute Washout Time||0
7593465|NCT02609178|18690776|P2|NOT COMPLETED|5-minute Washout Time||0
7593466|NCT02609178|18690777|P1|NOT COMPLETED|5-minute Washout Time||0
7593467|NCT02609178|18690772|P6|COMPLETED|5-minute Washout Time||2
7593468|NCT02609178|18690773|P5|COMPLETED|5-minute Washout Time||0
7593469|NCT02609178|18690774|P4|COMPLETED|5-minute Washout Time||2
7593470|NCT02609178|18690775|P3|COMPLETED|5-minute Washout Time||5
7593471|NCT02609178|18690776|P2|COMPLETED|5-minute Washout Time||1
7593472|NCT02609178|18690777|P1|COMPLETED|5-minute Washout Time||0
7593473|NCT02609178|18690772|P6|STARTED|5-minute Washout Time||2
7593474|NCT02609178|18690773|P5|STARTED|5-minute Washout Time||0
7593475|NCT02609178|18690774|P4|STARTED|5-minute Washout Time||2
7593476|NCT02609178|18690775|P3|STARTED|5-minute Washout Time||5
7593477|NCT02609178|18690776|P2|STARTED|5-minute Washout Time||1
7593478|NCT02609178|18690777|P1|STARTED|5-minute Washout Time||0
7593479|NCT02609178|18690772|P6|NOT COMPLETED|First Crown||0
7593480|NCT02609178|18690773|P5|NOT COMPLETED|First Crown||0
7593481|NCT02609178|18690774|P4|NOT COMPLETED|First Crown||1
7593482|NCT02609178|18690775|P3|NOT COMPLETED|First Crown||1
7593483|NCT02609178|18690776|P2|NOT COMPLETED|First Crown||0
7593484|NCT02609178|18690777|P1|NOT COMPLETED|First Crown||0
7593485|NCT02609178|18690772|P6|COMPLETED|First Crown||2
7593486|NCT02609178|18690773|P5|COMPLETED|First Crown||0
7593487|NCT02609178|18690774|P4|COMPLETED|First Crown||2
7593488|NCT02609178|18690775|P3|COMPLETED|First Crown||5
7593489|NCT02609178|18690776|P2|COMPLETED|First Crown||1
7593490|NCT02609178|18690777|P1|COMPLETED|First Crown||0
7593491|NCT02609178|18690772|P6|STARTED|First Crown||2
7593492|NCT02609178|18690773|P5|STARTED|First Crown||0
7593493|NCT02609178|18690774|P4|STARTED|First Crown||3
7593494|NCT02609178|18690775|P3|STARTED|First Crown||6
7593495|NCT02609178|18690776|P2|STARTED|First Crown||1
7593496|NCT02609178|18690777|P1|STARTED|First Crown||0
7593497|NCT02609113|18690794|P2|NOT COMPLETED|Overall Study||2
7593498|NCT02609113|18690795|P1|NOT COMPLETED|Overall Study||2
7593499|NCT02609113|18690794|P2|COMPLETED|Overall Study||9
7593500|NCT02609113|18690795|P1|COMPLETED|Overall Study||9
7593501|NCT02609113|18690794|P2|STARTED|Overall Study||11
7593502|NCT02609113|18690795|P1|STARTED|Overall Study||11
7593503|NCT02609100|18690809|P2|NOT COMPLETED|Overall Study||0
7593504|NCT02609100|18690810|P1|NOT COMPLETED|Overall Study||0
7593505|NCT02609100|18690809|P2|COMPLETED|Overall Study||2
7593506|NCT02609100|18690810|P1|COMPLETED|Overall Study||2
7593507|NCT02609100|18690809|P2|STARTED|Overall Study||2
7593508|NCT02609100|18690810|P1|STARTED|Overall Study||2
7593509|NCT02608905|18690828|P2|NOT COMPLETED|Overall Study||0
7593510|NCT02608905|18690829|P1|NOT COMPLETED|Overall Study||2
7593511|NCT02608905|18690828|P2|COMPLETED|Overall Study||10
7593512|NCT02608905|18690829|P1|COMPLETED|Overall Study||5
7593513|NCT02608905|18690828|P2|STARTED|Overall Study||10
7593514|NCT02608905|18690829|P1|STARTED|Overall Study||7
7593515|NCT02608892|18690839|P2|NOT COMPLETED|Overall Study||0
7593516|NCT02608892|18690840|P1|NOT COMPLETED|Overall Study||1
7593517|NCT02608892|18690839|P2|COMPLETED|Overall Study||49
7593518|NCT02608892|18690840|P1|COMPLETED|Overall Study||50
7593519|NCT02608892|18690839|P2|STARTED|Overall Study||49
7593520|NCT02608892|18690840|P1|STARTED|Overall Study||51
7593521|NCT02608879|18690852|P3|NOT COMPLETED|Overall Study||3
7593522|NCT02608879|18690853|P2|NOT COMPLETED|Overall Study||0
7593523|NCT02608879|18690854|P1|NOT COMPLETED|Overall Study||1
7593524|NCT02608879|18690852|P3|COMPLETED|Overall Study||0
7593525|NCT02608879|18690853|P2|COMPLETED|Overall Study||6
7593526|NCT02608879|18690854|P1|COMPLETED|Overall Study||9
7593527|NCT02608879|18690852|P3|STARTED|Overall Study||3
7593528|NCT02608879|18690853|P2|STARTED|Overall Study||6
7593529|NCT02608879|18690854|P1|STARTED|Overall Study||10
7593530|NCT02608684|18690873|P1|NOT COMPLETED|Overall Study||3
7593531|NCT02608684|18690873|P1|COMPLETED|Overall Study||18
7593532|NCT02608684|18690873|P1|STARTED|Overall Study||21
7593533|NCT02608489|18690885|P2|NOT COMPLETED|Overall Study||10
7593534|NCT02608489|18690886|P1|NOT COMPLETED|Overall Study||13
7593535|NCT02608489|18690885|P2|COMPLETED|Overall Study||33
7593536|NCT02608489|18690886|P1|COMPLETED|Overall Study||30
7593537|NCT02608489|18690885|P2|STARTED|Overall Study||43
7593538|NCT02608489|18690886|P1|STARTED|Overall Study||43
7593539|NCT02608476|18690908|P2|NOT COMPLETED|Overall Study||81
7593540|NCT02608476|18690909|P1|NOT COMPLETED|Overall Study||67
7593541|NCT02608476|18690908|P2|COMPLETED|Overall Study||282
7593542|NCT02608476|18690909|P1|COMPLETED|Overall Study||302
7593543|NCT02608476|18690908|P2|STARTED|Overall Study||363
7593544|NCT02608476|18690909|P1|STARTED|Overall Study||369
7593545|NCT02608463|18690929|P3|NOT COMPLETED|Overall Study||0
7593546|NCT02608463|18690930|P2|NOT COMPLETED|Overall Study||0
7593547|NCT02608463|18690931|P1|NOT COMPLETED|Overall Study||3
7593548|NCT02608463|18690929|P3|COMPLETED|Overall Study||0
7593549|NCT02608463|18690930|P2|COMPLETED|Overall Study||1
7593550|NCT02608463|18690931|P1|COMPLETED|Overall Study||10
7593551|NCT02608463|18690929|P3|STARTED|Overall Study|No study participants were enrolled in Part B.|0
7593552|NCT02608463|18690930|P2|STARTED|Overall Study||1
7593553|NCT02608463|18690931|P1|STARTED|Overall Study||13
7593554|NCT02608450|18690939|P2|NOT COMPLETED|Overall Study||65
7593555|NCT02608450|18690940|P1|NOT COMPLETED|Overall Study||66
7593556|NCT02608450|18690939|P2|COMPLETED|Overall Study||290
7593557|NCT02608450|18690940|P1|COMPLETED|Overall Study||287
7593558|NCT02608450|18690939|P2|STARTED|Overall Study||355
7593559|NCT02608450|18690940|P1|STARTED|Overall Study||353
7593560|NCT02608229|18690960|P2|NOT COMPLETED|Overall Study||0
7593561|NCT02608229|18690961|P1|NOT COMPLETED|Overall Study||0
7593562|NCT02608229|18690960|P2|COMPLETED|Overall Study||8
7593563|NCT02608229|18690961|P1|COMPLETED|Overall Study||10
7593564|NCT02608229|18690960|P2|450 mg BVD-523|Overall Study||6
7593565|NCT02608229|18690961|P1|450 mg BVD-523|Overall Study||0
7593566|NCT02608229|18690960|P2|600 mg BVD-523|Overall Study||2
7593567|NCT02608229|18690961|P1|600 mg BVD-523|Overall Study||10
7593568|NCT02608229|18690960|P2|STARTED|Overall Study||8
7593569|NCT02608229|18690961|P1|STARTED|Overall Study||10
7593570|NCT02608177|18690979|P2|NOT COMPLETED|Overall Study||0
7593571|NCT02608177|18690980|P1|NOT COMPLETED|Overall Study||0
7593572|NCT02608177|18690979|P2|COMPLETED|Overall Study||1
7593573|NCT02608177|18690980|P1|COMPLETED|Overall Study||2
7593574|NCT02608177|18690979|P2|STARTED|Overall Study||1
7593575|NCT02608177|18690980|P1|STARTED|Overall Study||2
7593576|NCT02608099|18691002|P2|NOT COMPLETED|Overall Study||2
7593577|NCT02608099|18691003|P1|NOT COMPLETED|Overall Study||3
7593578|NCT02608099|18691002|P2|COMPLETED|Overall Study||150
7593579|NCT02608099|18691003|P1|COMPLETED|Overall Study||145
7593580|NCT02608099|18691002|P2|Safety|Overall Study||151
7593581|NCT02608099|18691003|P1|Safety|Overall Study||149
7593582|NCT02608099|18691002|P2|STARTED|Overall Study||152
7593583|NCT02608099|18691003|P1|STARTED|Overall Study||148
7593584|NCT02607956|18691041|P2|NOT COMPLETED|Overall Study||330
7593585|NCT02607956|18691042|P1|NOT COMPLETED|Overall Study||327
7593586|NCT02607956|18691041|P2|COMPLETED|Overall Study||0
7593587|NCT02607956|18691042|P1|COMPLETED|Overall Study||0
7593588|NCT02607956|18691041|P2|STARTED|Overall Study||330
7593589|NCT02607956|18691042|P1|STARTED|Overall Study||327
7593590|NCT02607930|18691072|P2|NOT COMPLETED|Overall Study||315
7593591|NCT02607930|18691073|P1|NOT COMPLETED|Overall Study||316
7593592|NCT02607930|18691072|P2|COMPLETED|Overall Study||0
7593593|NCT02607930|18691073|P1|COMPLETED|Overall Study||0
7593594|NCT02607930|18691072|P2|STARTED|Overall Study||315
7593595|NCT02607930|18691073|P1|STARTED|Overall Study||316
7593596|NCT02607865|18691117|P4|NOT COMPLETED|Overall Study||16
7593597|NCT02607865|18691118|P3|NOT COMPLETED|Overall Study||27
7593598|NCT02607865|18691119|P2|NOT COMPLETED|Overall Study||30
7593599|NCT02607865|18691120|P1|NOT COMPLETED|Overall Study||33
7593600|NCT02607865|18691117|P4|COMPLETED|Overall Study||451
7593601|NCT02607865|18691118|P3|COMPLETED|Overall Study||438
7593602|NCT02607865|18691119|P2|COMPLETED|Overall Study||436
7593603|NCT02607865|18691120|P1|COMPLETED|Overall Study||433
7593604|NCT02607865|18691117|P4|Safety Analysis Set (SAS)|Overall Study||466
7593605|NCT02607865|18691118|P3|Safety Analysis Set (SAS)|Overall Study||465
7593606|NCT02607865|18691119|P2|Safety Analysis Set (SAS)|Overall Study||464
7593607|NCT02607865|18691120|P1|Safety Analysis Set (SAS)|Overall Study||466
7593608|NCT02607865|18691117|P4|Full Analysis Set (FAS)|Overall Study||467
7593609|NCT02607865|18691118|P3|Full Analysis Set (FAS)|Overall Study||465
7593610|NCT02607865|18691119|P2|Full Analysis Set (FAS)|Overall Study||465
7593611|NCT02607865|18691120|P1|Full Analysis Set (FAS)|Overall Study||466
7593612|NCT02607865|18691117|P4|STARTED|Overall Study||467
7593613|NCT02607865|18691118|P3|STARTED|Overall Study||465
7593614|NCT02607865|18691119|P2|STARTED|Overall Study||466
7593615|NCT02607865|18691120|P1|STARTED|Overall Study||466
7593616|NCT02607800|18691294|P2|NOT COMPLETED|Overall Study||11
7593617|NCT02607800|18691295|P1|NOT COMPLETED|Overall Study||10
7593618|NCT02607800|18691294|P2|COMPLETED|Overall Study||430
7593619|NCT02607800|18691295|P1|COMPLETED|Overall Study||492
7593620|NCT02607800|18691294|P2|STARTED|Overall Study||441
7593621|NCT02607800|18691295|P1|STARTED|Overall Study||502
7593622|NCT02607735|18691313|P3|NOT COMPLETED|Deferred Treatment Substudy||5
7593623|NCT02607735|18691314|P2|NOT COMPLETED|Deferred Treatment Substudy||0
7593624|NCT02607735|18691315|P1|NOT COMPLETED|Deferred Treatment Substudy||0
7593625|NCT02607735|18691313|P3|COMPLETED|Deferred Treatment Substudy||142
7593626|NCT02607735|18691314|P2|COMPLETED|Deferred Treatment Substudy||0
7593627|NCT02607735|18691315|P1|COMPLETED|Deferred Treatment Substudy||0
7593628|NCT02607735|18691313|P3|STARTED|Deferred Treatment Substudy||147
7593629|NCT02607735|18691314|P2|STARTED|Deferred Treatment Substudy||0
7593630|NCT02607735|18691315|P1|STARTED|Deferred Treatment Substudy||0
7593631|NCT02607735|18691313|P3|NOT COMPLETED|Primary Study||0
7593632|NCT02607735|18691314|P2|NOT COMPLETED|Primary Study||0
7593633|NCT02607735|18691315|P1|NOT COMPLETED|Primary Study||7
7593634|NCT02607735|18691313|P3|COMPLETED|Primary Study||0
7593635|NCT02607735|18691314|P2|COMPLETED|Primary Study||152
7593636|NCT02607735|18691315|P1|COMPLETED|Primary Study||257
7593637|NCT02607735|18691313|P3|STARTED|Primary Study||0
7593638|NCT02607735|18691314|P2|STARTED|Primary Study||152
7593639|NCT02607735|18691315|P1|STARTED|Primary Study||264
7593640|NCT02607618|18691337|P2|NOT COMPLETED|Overall Study||2
7593641|NCT02607618|18691338|P1|NOT COMPLETED|Overall Study||11
7593642|NCT02607618|18691337|P2|COMPLETED|Overall Study||305
7593643|NCT02607618|18691338|P1|COMPLETED|Overall Study||295
7593644|NCT02607618|18691337|P2|STARTED|Overall Study||307
7593645|NCT02607618|18691338|P1|STARTED|Overall Study||306
7593646|NCT02607306|18691349|P3|NOT COMPLETED|Overall Study||10
7593647|NCT02607306|18691350|P2|NOT COMPLETED|Overall Study||23
7593648|NCT02607306|18691351|P1|NOT COMPLETED|Overall Study||21
7593649|NCT02607306|18691349|P3|COMPLETED|Overall Study||263
7593650|NCT02607306|18691350|P2|COMPLETED|Overall Study||248
7593651|NCT02607306|18691351|P1|COMPLETED|Overall Study||254
7593652|NCT02607306|18691349|P3|STARTED|Overall Study||273
7593653|NCT02607306|18691350|P2|STARTED|Overall Study||271
7593654|NCT02607306|18691351|P1|STARTED|Overall Study||275
7593655|NCT02607280|18691473|P2|NOT COMPLETED|Overall Study||1
7593656|NCT02607280|18691474|P1|NOT COMPLETED|Overall Study||4
7593657|NCT02607280|18691473|P2|COMPLETED|Overall Study||4
7593658|NCT02607280|18691474|P1|COMPLETED|Overall Study||26
7593659|NCT02607280|18691473|P2|Received Study Drug|Overall Study||5
7593660|NCT02607280|18691474|P1|Received Study Drug|Overall Study||30
7593661|NCT02607280|18691473|P2|STARTED|Overall Study||5
7593662|NCT02607280|18691474|P1|STARTED|Overall Study||30
7593663|NCT02607254|18691483|P3|NOT COMPLETED|Overall Study||0
7593664|NCT02607254|18691484|P2|NOT COMPLETED|Overall Study||0
7593665|NCT02607254|18691485|P1|NOT COMPLETED|Overall Study||0
7593666|NCT02607254|18691483|P3|COMPLETED|Overall Study||5
7593667|NCT02607254|18691484|P2|COMPLETED|Overall Study||3
7593668|NCT02607254|18691485|P1|COMPLETED|Overall Study||3
7593669|NCT02607254|18691483|P3|STARTED|Overall Study||5
7593670|NCT02607254|18691484|P2|STARTED|Overall Study||3
7593671|NCT02607254|18691485|P1|STARTED|Overall Study||3
7593672|NCT02607228|18691509|P7|NOT COMPLETED|Overall Study||2
7593673|NCT02607228|18691510|P6|NOT COMPLETED|Overall Study||6
7593674|NCT02607228|18691511|P5|NOT COMPLETED|Overall Study||5
7593675|NCT02607228|18691512|P4|NOT COMPLETED|Overall Study||6
7593676|NCT02607228|18691513|P3|NOT COMPLETED|Overall Study||3
7593677|NCT02607228|18691514|P2|NOT COMPLETED|Overall Study||4
7593678|NCT02607228|18691515|P1|NOT COMPLETED|Overall Study||5
7593679|NCT02607228|18691509|P7|COMPLETED|Overall Study||0
7593680|NCT02607228|18691510|P6|COMPLETED|Overall Study||0
7593681|NCT02607228|18691511|P5|COMPLETED|Overall Study||0
7593682|NCT02607228|18691512|P4|COMPLETED|Overall Study||0
7593683|NCT02607228|18691513|P3|COMPLETED|Overall Study||0
7593684|NCT02607228|18691514|P2|COMPLETED|Overall Study||0
7593685|NCT02607228|18691515|P1|COMPLETED|Overall Study||0
7593686|NCT02607228|18691509|P7|STARTED|Overall Study||2
7593687|NCT02607228|18691510|P6|STARTED|Overall Study||6
7593688|NCT02607228|18691511|P5|STARTED|Overall Study||5
7593689|NCT02607228|18691512|P4|STARTED|Overall Study||6
7593690|NCT02607228|18691513|P3|STARTED|Overall Study||3
7593691|NCT02607228|18691514|P2|STARTED|Overall Study||4
7593692|NCT02607228|18691515|P1|STARTED|Overall Study||5
7593693|NCT02607124|18691594|P1|NOT COMPLETED|Overall Study||0
7593694|NCT02607124|18691594|P1|COMPLETED|Overall Study||10
7593695|NCT02607124|18691594|P1|STARTED|Overall Study|11 participants were enrolled however 1 participant withdrew before starting study treatment.|10
7593696|NCT02606903|18691603|P2|NOT COMPLETED|Overall Study||0
7593697|NCT02606903|18691604|P1|NOT COMPLETED|Overall Study||0
7593698|NCT02606903|18691603|P2|COMPLETED|Overall Study||36
7593699|NCT02606903|18691604|P1|COMPLETED|Overall Study||35
7593700|NCT02606903|18691603|P2|STARTED|Overall Study||36
7593701|NCT02606903|18691604|P1|STARTED|Overall Study||35
7593702|NCT02606877|18691618|P2|NOT COMPLETED|Overall Study||1
7593703|NCT02606877|18691619|P1|NOT COMPLETED|Overall Study||4
7593704|NCT02606877|18691618|P2|COMPLETED|Overall Study||16
7593705|NCT02606877|18691619|P1|COMPLETED|Overall Study||16
7593706|NCT02606877|18691618|P2|STARTED|Overall Study||17
7593707|NCT02606877|18691619|P1|STARTED|Overall Study||20
7593708|NCT02606838|18691633|P1|NOT COMPLETED|Overall Study||0
7593709|NCT02606838|18691633|P1|COMPLETED|Overall Study||119
7593710|NCT02606838|18691633|P1|STARTED|Overall Study||119
7593711|NCT02606734|18691641|P1|NOT COMPLETED|Overall Study||0
7593712|NCT02606734|18691641|P1|COMPLETED|Overall Study||44
7593713|NCT02606734|18691641|P1|STARTED|Overall Study||44
7593714|NCT02606708|18691645|P1|NOT COMPLETED|Overall Study||0
7593715|NCT02606708|18691645|P1|COMPLETED|Overall Study||314
7593716|NCT02606708|18691645|P1|STARTED|Overall Study||314
7593717|NCT02606643|18691658|P2|NOT COMPLETED|Overall Study||3
7593718|NCT02606643|18691659|P1|NOT COMPLETED|Overall Study||1
7593719|NCT02606643|18691658|P2|COMPLETED|Overall Study||73
7593720|NCT02606643|18691659|P1|COMPLETED|Overall Study||67
7593721|NCT02606643|18691658|P2|STARTED|Overall Study||76
7593722|NCT02606643|18691659|P1|STARTED|Overall Study||68
7593723|NCT02606604|18691671|P2|NOT COMPLETED|Overall Study||0
7593724|NCT02606604|18691672|P1|NOT COMPLETED|Overall Study||1
7593725|NCT02606604|18691671|P2|COMPLETED|Overall Study||7
7593726|NCT02606604|18691672|P1|COMPLETED|Overall Study||7
7593727|NCT02606604|18691671|P2|STARTED|Overall Study||7
7593728|NCT02606604|18691672|P1|STARTED|Overall Study||8
7593729|NCT02606500|18691698|P2|NOT COMPLETED|Overall Study||0
7593730|NCT02606500|18691699|P1|NOT COMPLETED|Overall Study||0
7593731|NCT02606500|18691698|P2|COMPLETED|Overall Study||35
7593732|NCT02606500|18691699|P1|COMPLETED|Overall Study||35
7593733|NCT02606500|18691698|P2|STARTED|Overall Study||35
7593734|NCT02606500|18691699|P1|STARTED|Overall Study||35
7593735|NCT02606279|18691717|P2|NOT COMPLETED|Overall Study||1
7593736|NCT02606279|18691718|P1|NOT COMPLETED|Overall Study||0
7593737|NCT02606279|18691717|P2|COMPLETED|Overall Study||0
7593738|NCT02606279|18691718|P1|COMPLETED|Overall Study||0
7593739|NCT02606279|18691717|P2|STARTED|Overall Study||1
7593740|NCT02606279|18691718|P1|STARTED|Overall Study||0
7593741|NCT02606253|18691733|P3|NOT COMPLETED|Overall Study||0
7593742|NCT02606253|18691734|P2|NOT COMPLETED|Overall Study||2
7593743|NCT02606253|18691735|P1|NOT COMPLETED|Overall Study||5
7593744|NCT02606253|18691733|P3|COMPLETED|Overall Study||20
7593745|NCT02606253|18691734|P2|COMPLETED|Overall Study||18
7593746|NCT02606253|18691735|P1|COMPLETED|Overall Study||15
7593747|NCT02606253|18691733|P3|STARTED|Overall Study||20
7593748|NCT02606253|18691734|P2|STARTED|Overall Study||20
7593749|NCT02606253|18691735|P1|STARTED|Overall Study||20
7593750|NCT02605993|18691798|P4|NOT COMPLETED|Extension Period||7
7593751|NCT02605993|18691799|P3|NOT COMPLETED|Extension Period||7
7593752|NCT02605993|18691800|P2|NOT COMPLETED|Extension Period||6
7593753|NCT02605993|18691801|P1|NOT COMPLETED|Extension Period||6
7593754|NCT02605993|18691798|P4|COMPLETED|Extension Period||0
7593755|NCT02605993|18691799|P3|COMPLETED|Extension Period||0
7593756|NCT02605993|18691800|P2|COMPLETED|Extension Period||0
7593757|NCT02605993|18691801|P1|COMPLETED|Extension Period||0
7593758|NCT02605993|18691798|P4|STARTED|Extension Period||7
7593759|NCT02605993|18691799|P3|STARTED|Extension Period||7
7593760|NCT02605993|18691800|P2|STARTED|Extension Period||6
7593761|NCT02605993|18691801|P1|STARTED|Extension Period||6
7593762|NCT02605993|18691798|P4|NOT COMPLETED|Treatment Period||0
7593763|NCT02605993|18691799|P3|NOT COMPLETED|Treatment Period||0
7593764|NCT02605993|18691800|P2|NOT COMPLETED|Treatment Period||0
7593765|NCT02605993|18691801|P1|NOT COMPLETED|Treatment Period||0
7593766|NCT02605993|18691798|P4|COMPLETED|Treatment Period||7
7593767|NCT02605993|18691799|P3|COMPLETED|Treatment Period||7
7593768|NCT02605993|18691800|P2|COMPLETED|Treatment Period||6
7593769|NCT02605993|18691801|P1|COMPLETED|Treatment Period||6
7593770|NCT02605993|18691798|P4|Received at Least 1 Dose of Study Drug|Treatment Period||7
7593771|NCT02605993|18691799|P3|Received at Least 1 Dose of Study Drug|Treatment Period||7
7593772|NCT02605993|18691800|P2|Received at Least 1 Dose of Study Drug|Treatment Period||6
7593773|NCT02605993|18691801|P1|Received at Least 1 Dose of Study Drug|Treatment Period||6
7593774|NCT02605993|18691798|P4|STARTED|Treatment Period||7
7593775|NCT02605993|18691799|P3|STARTED|Treatment Period||7
7593776|NCT02605993|18691800|P2|STARTED|Treatment Period||6
7593777|NCT02605993|18691801|P1|STARTED|Treatment Period||6
7593778|NCT02605954|18691837|P2|NOT COMPLETED|Overall Study||4
7593779|NCT02605954|18691838|P1|NOT COMPLETED|Overall Study||12
7593780|NCT02605954|18691837|P2|COMPLETED|Overall Study||88
7593781|NCT02605954|18691838|P1|COMPLETED|Overall Study||171
7593782|NCT02605954|18691837|P2|STARTED|Overall Study||92
7593783|NCT02605954|18691838|P1|STARTED|Overall Study||183
7593784|NCT02605928|18691855|P1|NOT COMPLETED|Overall Study||33
7593785|NCT02605928|18691855|P1|COMPLETED|Overall Study||46
7593786|NCT02605928|18691855|P1|Pivotal Phase, Statistical Phase|Overall Study||51
7593787|NCT02605928|18691855|P1|STARTED|Overall Study||79
7593788|NCT02605876|18691862|P3|NOT COMPLETED|Overall Study||0
7593789|NCT02605876|18691863|P2|NOT COMPLETED|Overall Study||0
7593790|NCT02605876|18691864|P1|NOT COMPLETED|Overall Study||0
7593791|NCT02605876|18691862|P3|COMPLETED|Overall Study||25
7593792|NCT02605876|18691863|P2|COMPLETED|Overall Study||25
7593793|NCT02605876|18691864|P1|COMPLETED|Overall Study||25
7593794|NCT02605876|18691862|P3|STARTED|Overall Study||25
7593795|NCT02605876|18691863|P2|STARTED|Overall Study||25
7593796|NCT02605876|18691864|P1|STARTED|Overall Study||25
7593797|NCT02605863|18691889|P2|NOT COMPLETED|Overall Study||0
7593798|NCT02605863|18691890|P1|NOT COMPLETED|Overall Study||0
7593799|NCT02605863|18691889|P2|COMPLETED|Overall Study||0
7593800|NCT02605863|18691890|P1|COMPLETED|Overall Study||1
7593801|NCT02605863|18691889|P2|STARTED|Overall Study||0
7593802|NCT02605863|18691890|P1|STARTED|Overall Study||1
7593803|NCT02605837|18691898|P2|NOT COMPLETED|Overall Study||11
7593804|NCT02605837|18691899|P1|NOT COMPLETED|Overall Study||11
7593805|NCT02605837|18691898|P2|COMPLETED|Overall Study||202
7593806|NCT02605837|18691899|P1|COMPLETED|Overall Study||94
7593807|NCT02605837|18691898|P2|STARTED|Overall Study||213
7593808|NCT02605837|18691899|P1|STARTED|Overall Study||105
7593809|NCT02605824|18691938|P2|NOT COMPLETED|Overall Study||0
7593810|NCT02605824|18691939|P1|NOT COMPLETED|Overall Study||1
7593811|NCT02605824|18691938|P2|COMPLETED|Overall Study||0
7593812|NCT02605824|18691939|P1|COMPLETED|Overall Study||0
7593813|NCT02605824|18691938|P2|STARTED|Overall Study||0
7593814|NCT02605824|18691939|P1|STARTED|Overall Study||1
7593815|NCT02605642|18691949|P2|NOT COMPLETED|Overall Study||21
7593816|NCT02605642|18691950|P1|NOT COMPLETED|Overall Study||96
7593817|NCT02605642|18691949|P2|COMPLETED|Overall Study||86
7593818|NCT02605642|18691950|P1|COMPLETED|Overall Study||131
7593819|NCT02605642|18691949|P2|Safety Set|Overall Study||107
7593820|NCT02605642|18691950|P1|Safety Set|Overall Study||221
7593821|NCT02605642|18691949|P2|STARTED|Overall Study||107
7593822|NCT02605642|18691950|P1|STARTED|Overall Study||227
7593823|NCT02605447|18691992|P1|NOT COMPLETED|Overall Study||102
7593824|NCT02605447|18691992|P1|COMPLETED|Overall Study||1385
7593825|NCT02605447|18691992|P1|STARTED|Overall Study||1487
7593826|NCT02605395|18691998|P2|NOT COMPLETED|Period 2, Day 8||0
7593827|NCT02605395|18691999|P1|NOT COMPLETED|Period 2, Day 8||0
7593828|NCT02605395|18691998|P2|COMPLETED|Period 2, Day 8||35
7593829|NCT02605395|18691999|P1|COMPLETED|Period 2, Day 8||35
7593830|NCT02605395|18691998|P2|STARTED|Period 2, Day 8||35
7593831|NCT02605395|18691999|P1|STARTED|Period 2, Day 8||35
7593832|NCT02605395|18691998|P2|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
7593833|NCT02605395|18691999|P1|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
7593834|NCT02605395|18691998|P2|COMPLETED|Washout Period, Day 2 to Day 7||35
7593835|NCT02605395|18691999|P1|COMPLETED|Washout Period, Day 2 to Day 7||35
7593836|NCT02605395|18691998|P2|STARTED|Washout Period, Day 2 to Day 7||35
7593837|NCT02605395|18691999|P1|STARTED|Washout Period, Day 2 to Day 7||35
7593838|NCT02605395|18691998|P2|NOT COMPLETED|Period 1, Day 1||0
7593839|NCT02605395|18691999|P1|NOT COMPLETED|Period 1, Day 1||0
7593840|NCT02605395|18691998|P2|COMPLETED|Period 1, Day 1||35
7593841|NCT02605395|18691999|P1|COMPLETED|Period 1, Day 1||35
7593842|NCT02605395|18691998|P2|STARTED|Period 1, Day 1||35
7593843|NCT02605395|18691999|P1|STARTED|Period 1, Day 1||35
7593844|NCT02605304|18692017|P2|NOT COMPLETED|Overall Study||0
7593845|NCT02605304|18692018|P1|NOT COMPLETED|Overall Study||0
7593846|NCT02605304|18692017|P2|COMPLETED|Overall Study||3
7593847|NCT02605304|18692018|P1|COMPLETED|Overall Study||4
7593848|NCT02605304|18692017|P2|STARTED|Overall Study||3
7593849|NCT02605304|18692018|P1|STARTED|Overall Study||4
7593850|NCT02605187|18692042|P4|NOT COMPLETED|Overall Study||1
7593851|NCT02605187|18692043|P3|NOT COMPLETED|Overall Study||11
7593852|NCT02605187|18692044|P2|NOT COMPLETED|Overall Study||2
7593853|NCT02605187|18692045|P1|NOT COMPLETED|Overall Study||8
7593854|NCT02605187|18692042|P4|COMPLETED|Overall Study||15
7593855|NCT02605187|18692043|P3|COMPLETED|Overall Study||72
7593856|NCT02605187|18692044|P2|COMPLETED|Overall Study||19
7593857|NCT02605187|18692045|P1|COMPLETED|Overall Study||32
7593858|NCT02605187|18692042|P4|STARTED|Overall Study||16
7593859|NCT02605187|18692043|P3|STARTED|Overall Study||83
7593860|NCT02605187|18692044|P2|STARTED|Overall Study||21
7593861|NCT02605187|18692045|P1|STARTED|Overall Study||40
7593862|NCT02605174|18692103|P7|NOT COMPLETED|Overall Study||89
7593863|NCT02605174|18692104|P6|NOT COMPLETED|Overall Study||32
7593864|NCT02605174|18692105|P5|NOT COMPLETED|Overall Study||53
7593865|NCT02605174|18692106|P4|NOT COMPLETED|Overall Study||36
7593866|NCT02605174|18692107|P3|NOT COMPLETED|Overall Study||76
7593867|NCT02605174|18692108|P2|NOT COMPLETED|Overall Study||23
7593868|NCT02605174|18692109|P1|NOT COMPLETED|Overall Study||64
7593869|NCT02605174|18692103|P7|COMPLETED|Overall Study||662
7593870|NCT02605174|18692104|P6|COMPLETED|Overall Study||217
7593871|NCT02605174|18692105|P5|COMPLETED|Overall Study||448
7593872|NCT02605174|18692106|P4|COMPLETED|Overall Study||216
7593873|NCT02605174|18692107|P3|COMPLETED|Overall Study||426
7593874|NCT02605174|18692108|P2|COMPLETED|Overall Study||226
7593875|NCT02605174|18692109|P1|COMPLETED|Overall Study||437
7593876|NCT02605174|18692103|P7|Received Optional 2nd Dose|Overall Study||361
7593877|NCT02605174|18692104|P6|Received Optional 2nd Dose|Overall Study||74
7593878|NCT02605174|18692105|P5|Received Optional 2nd Dose|Overall Study||144
7593879|NCT02605174|18692106|P4|Received Optional 2nd Dose|Overall Study||83
7593880|NCT02605174|18692107|P3|Received Optional 2nd Dose|Overall Study||177
7593881|NCT02605174|18692108|P2|Received Optional 2nd Dose|Overall Study||96
7593882|NCT02605174|18692109|P1|Received Optional 2nd Dose|Overall Study||206
7593883|NCT02605174|18692103|P7|Received at Least 1 Dose of Study Drug|Overall Study||645
7593884|NCT02605174|18692104|P6|Received at Least 1 Dose of Study Drug|Overall Study||215
7593885|NCT02605174|18692105|P5|Received at Least 1 Dose of Study Drug|Overall Study||434
7593886|NCT02605174|18692106|P4|Received at Least 1 Dose of Study Drug|Overall Study||212
7593887|NCT02605174|18692107|P3|Received at Least 1 Dose of Study Drug|Overall Study||423
7593888|NCT02605174|18692108|P2|Received at Least 1 Dose of Study Drug|Overall Study||225
7593889|NCT02605174|18692109|P1|Received at Least 1 Dose of Study Drug|Overall Study||429
7593890|NCT02605174|18692103|P7|STARTED|Overall Study||751
7593891|NCT02605174|18692104|P6|STARTED|Overall Study||249
7593892|NCT02605174|18692105|P5|STARTED|Overall Study||501
7593893|NCT02605174|18692106|P4|STARTED|Overall Study||252
7593894|NCT02605174|18692107|P3|STARTED|Overall Study||502
7593895|NCT02605174|18692108|P2|STARTED|Overall Study||249
7593896|NCT02605174|18692109|P1|STARTED|Overall Study||501
7593897|NCT02605122|18692171|P2|NOT COMPLETED|Overall Study||2
7593898|NCT02605122|18692172|P1|NOT COMPLETED|Overall Study||5
7593899|NCT02605122|18692171|P2|COMPLETED|Overall Study||22
7593900|NCT02605122|18692172|P1|COMPLETED|Overall Study||68
7593901|NCT02605122|18692171|P2|Received Study Drug|Overall Study||24
7593902|NCT02605122|18692172|P1|Received Study Drug|Overall Study||70
7593903|NCT02605122|18692171|P2|STARTED|Overall Study||24
7593904|NCT02605122|18692172|P1|STARTED|Overall Study||73
7593905|NCT02604810|18692184|P1|NOT COMPLETED|IGSC 20%, 24 Weeks||7
7593906|NCT02604810|18692184|P1|COMPLETED|IGSC 20%, 24 Weeks||42
7593907|NCT02604810|18692184|P1|STARTED|IGSC 20%, 24 Weeks||49
7593908|NCT02604810|18692184|P1|NOT COMPLETED|IGIV-C 10%, 4-5 Weeks||3
7593909|NCT02604810|18692184|P1|COMPLETED|IGIV-C 10%, 4-5 Weeks||49
7593910|NCT02604810|18692184|P1|STARTED|IGIV-C 10%, 4-5 Weeks||52
7593911|NCT02604589|18692195|P3|NOT COMPLETED|Overall Study||1
7593912|NCT02604589|18692196|P2|NOT COMPLETED|Overall Study||0
7593913|NCT02604589|18692197|P1|NOT COMPLETED|Overall Study||0
7593914|NCT02604589|18692195|P3|COMPLETED|Overall Study||1
7593915|NCT02604589|18692196|P2|COMPLETED|Overall Study||5
7593916|NCT02604589|18692197|P1|COMPLETED|Overall Study||3
7593917|NCT02604589|18692195|P3|STARTED|Overall Study||2
7593918|NCT02604589|18692196|P2|STARTED|Overall Study||5
7593919|NCT02604589|18692197|P1|STARTED|Overall Study||3
7593920|NCT02604550|18692225|P2|NOT COMPLETED|Overall Study||26
7593921|NCT02604550|18692226|P1|NOT COMPLETED|Overall Study||25
7593922|NCT02604550|18692225|P2|COMPLETED|Overall Study||33
7593923|NCT02604550|18692226|P1|COMPLETED|Overall Study||31
7593924|NCT02604550|18692225|P2|STARTED|Overall Study||59
7593925|NCT02604550|18692226|P1|STARTED|Overall Study||56
7593926|NCT02604433|18692252|P2|NOT COMPLETED|Post Treatment Follow-up Period||24
7593927|NCT02604433|18692253|P1|NOT COMPLETED|Post Treatment Follow-up Period||42
7593928|NCT02604433|18692252|P2|COMPLETED|Post Treatment Follow-up Period||0
7593929|NCT02604433|18692253|P1|COMPLETED|Post Treatment Follow-up Period||0
7593930|NCT02604433|18692252|P2|STARTED|Post Treatment Follow-up Period||24
7593931|NCT02604433|18692253|P1|STARTED|Post Treatment Follow-up Period||42
7593932|NCT02604433|18692252|P2|NOT COMPLETED|Open-Label Treatment Period||0
7593933|NCT02604433|18692253|P1|NOT COMPLETED|Open-Label Treatment Period||0
7593934|NCT02604433|18692252|P2|COMPLETED|Open-Label Treatment Period||0
7593935|NCT02604433|18692253|P1|COMPLETED|Open-Label Treatment Period||0
7593936|NCT02604433|18692252|P2|STARTED|Open-Label Treatment Period||0
7593937|NCT02604433|18692253|P1|STARTED|Open-Label Treatment Period||0
7593938|NCT02604433|18692252|P2|NOT COMPLETED|Double-blind Treatment Period||106
7593939|NCT02604433|18692253|P1|NOT COMPLETED|Double-blind Treatment Period||218
7593940|NCT02604433|18692252|P2|COMPLETED|Double-blind Treatment Period|Completed study per original protocol|6
7593941|NCT02604433|18692253|P1|COMPLETED|Double-blind Treatment Period|Completed study per original protocol|6
7593942|NCT02604433|18692252|P2|Completed 48 Weeks of Treatment|Double-blind Treatment Period||96
7593943|NCT02604433|18692253|P1|Completed 48 Weeks of Treatment|Double-blind Treatment Period||200
7593944|NCT02604433|18692252|P2|Completed 24 Weeks of Treatment|Double-blind Treatment Period||102
7593945|NCT02604433|18692253|P1|Completed 24 Weeks of Treatment|Double-blind Treatment Period||210
7593946|NCT02604433|18692252|P2|Health-Related Quality of Life Populatio|Double-blind Treatment Period||103
7593947|NCT02604433|18692253|P1|Health-Related Quality of Life Populatio|Double-blind Treatment Period||211
7593948|NCT02604433|18692252|P2|Pharmacokinetic Population|Double-blind Treatment Period|Participants did not take luspatercept.|0
7593949|NCT02604433|18692253|P1|Pharmacokinetic Population|Double-blind Treatment Period||221
7593950|NCT02604433|18692252|P2|Safety Population|Double-blind Treatment Period||109
7593951|NCT02604433|18692253|P1|Safety Population|Double-blind Treatment Period||223
7593952|NCT02604433|18692252|P2|Intent to Treat Population|Double-blind Treatment Period||112
7593953|NCT02604433|18692253|P1|Intent to Treat Population|Double-blind Treatment Period||224
7593954|NCT02604433|18692252|P2|STARTED|Double-blind Treatment Period||112
7593955|NCT02604433|18692253|P1|STARTED|Double-blind Treatment Period||224
7593956|NCT02604407|18692322|P3|NOT COMPLETED|Overall Study||16
7593957|NCT02604407|18692323|P2|NOT COMPLETED|Overall Study||12
7593958|NCT02604407|18692324|P1|NOT COMPLETED|Overall Study||11
7593959|NCT02604407|18692322|P3|COMPLETED|Overall Study||76
7593960|NCT02604407|18692323|P2|COMPLETED|Overall Study||80
7593961|NCT02604407|18692324|P1|COMPLETED|Overall Study||80
7593962|NCT02604407|18692322|P3|TREATED|Overall Study||90
7593963|NCT02604407|18692323|P2|TREATED|Overall Study||92
7593964|NCT02604407|18692324|P1|TREATED|Overall Study||89
7593965|NCT02604407|18692322|P3|STARTED|Overall Study||92
7593966|NCT02604407|18692323|P2|STARTED|Overall Study||92
7593967|NCT02604407|18692324|P1|STARTED|Overall Study||91
7593968|NCT02604342|18692337|P2|NOT COMPLETED|Overall Study||23
7593969|NCT02604342|18692338|P1|NOT COMPLETED|Overall Study||43
7593970|NCT02604342|18692337|P2|COMPLETED|Overall Study||17
7593971|NCT02604342|18692338|P1|COMPLETED|Overall Study||36
7593972|NCT02604342|18692337|P2|STARTED|Overall Study||40
7593973|NCT02604342|18692338|P1|STARTED|Overall Study||79
7593974|NCT02604264|18692390|P2|NOT COMPLETED|Intervention||242
7593975|NCT02604264|18692391|P1|NOT COMPLETED|Intervention||200
7593976|NCT02604264|18692390|P2|COMPLETED|Intervention||1225
7593977|NCT02604264|18692391|P1|COMPLETED|Intervention||1245
7593978|NCT02604264|18692390|P2|STARTED|Intervention||1467
7593979|NCT02604264|18692391|P1|STARTED|Intervention||1445
7593980|NCT02604264|18692390|P2|NOT COMPLETED|Run-In||0
7593981|NCT02604264|18692391|P1|NOT COMPLETED|Run-In||0
7593982|NCT02604264|18692390|P2|COMPLETED|Run-In||611
7593983|NCT02604264|18692391|P1|COMPLETED|Run-In||618
7593984|NCT02604264|18692390|P2|STARTED|Run-In|The 1-mo run-in period data was used to determine pre-study demographics and PBC rate.|611
7593985|NCT02604264|18692391|P1|STARTED|Run-In||618
7593986|NCT02604212|18692401|P4|NOT COMPLETED|Overall Study||3
7593987|NCT02604212|18692402|P3|NOT COMPLETED|Overall Study||4
7593988|NCT02604212|18692403|P2|NOT COMPLETED|Overall Study||1
7593989|NCT02604212|18692404|P1|NOT COMPLETED|Overall Study||2
7593990|NCT02604212|18692401|P4|COMPLETED|Overall Study||8
7593991|NCT02604212|18692402|P3|COMPLETED|Overall Study||6
7593992|NCT02604212|18692403|P2|COMPLETED|Overall Study||4
7593993|NCT02604212|18692404|P1|COMPLETED|Overall Study||4
7593994|NCT02604212|18692401|P4|STARTED|Overall Study||11
7593995|NCT02604212|18692402|P3|STARTED|Overall Study||10
7593996|NCT02604212|18692403|P2|STARTED|Overall Study||5
7593997|NCT02604212|18692404|P1|STARTED|Overall Study||6
7593998|NCT02604199|18692472|P4|NOT COMPLETED|Overall Study||3
7593999|NCT02604199|18692473|P3|NOT COMPLETED|Overall Study||0
7594000|NCT02604199|18692474|P2|NOT COMPLETED|Overall Study||3
7594001|NCT02604199|18692475|P1|NOT COMPLETED|Overall Study||0
7594002|NCT02604199|18692472|P4|COMPLETED|Overall Study||18
7594003|NCT02604199|18692473|P3|COMPLETED|Overall Study||17
7594004|NCT02604199|18692474|P2|COMPLETED|Overall Study||8
7594005|NCT02604199|18692475|P1|COMPLETED|Overall Study||9
7594006|NCT02604199|18692472|P4|STARTED|Overall Study||21
7594007|NCT02604199|18692473|P3|STARTED|Overall Study||17
7594008|NCT02604199|18692474|P2|STARTED|Overall Study||11
7594009|NCT02604199|18692475|P1|STARTED|Overall Study||9
7594010|NCT02604173|18692526|P3|NOT COMPLETED|Overall Study||0
7594011|NCT02604173|18692527|P2|NOT COMPLETED|Overall Study||0
7594012|NCT02604173|18692528|P1|NOT COMPLETED|Overall Study||0
7594013|NCT02604173|18692526|P3|COMPLETED|Overall Study||35
7594014|NCT02604173|18692527|P2|COMPLETED|Overall Study||35
7594015|NCT02604173|18692528|P1|COMPLETED|Overall Study||33
7594016|NCT02604173|18692526|P3|STARTED|Overall Study||35
7594017|NCT02604173|18692527|P2|STARTED|Overall Study||35
7594018|NCT02604173|18692528|P1|STARTED|Overall Study||33
7594019|NCT02604160|18692544|P2|NOT COMPLETED|Overall Study||2
7594020|NCT02604160|18692545|P1|NOT COMPLETED|Overall Study||0
7594021|NCT02604160|18692544|P2|COMPLETED|Overall Study||3
7594022|NCT02604160|18692545|P1|COMPLETED|Overall Study||2
7594023|NCT02604160|18692544|P2|Received at Least One Dose of Study Drug|Overall Study||5
7594024|NCT02604160|18692545|P1|Received at Least One Dose of Study Drug|Overall Study||2
7594025|NCT02604160|18692544|P2|STARTED|Overall Study||5
7594026|NCT02604160|18692545|P1|STARTED|Overall Study||2
7594027|NCT02604017|18692559|P2|NOT COMPLETED|Overall Study||8
7594028|NCT02604017|18692560|P1|NOT COMPLETED|Overall Study||6
7594029|NCT02604017|18692559|P2|COMPLETED|Overall Study||343
7594030|NCT02604017|18692560|P1|COMPLETED|Overall Study||346
7594031|NCT02604017|18692559|P2|STARTED|Overall Study||351
7594032|NCT02604017|18692560|P1|STARTED|Overall Study||352
7594033|NCT02603952|18692589|P4|NOT COMPLETED|Overall Study||1
7594034|NCT02603952|18692590|P3|NOT COMPLETED|Overall Study||0
7594035|NCT02603952|18692591|P2|NOT COMPLETED|Overall Study||0
7594036|NCT02603952|18692592|P1|NOT COMPLETED|Overall Study||1
7594037|NCT02603952|18692589|P4|COMPLETED|Overall Study||31
7594038|NCT02603952|18692590|P3|COMPLETED|Overall Study||31
7594039|NCT02603952|18692591|P2|COMPLETED|Overall Study||31
7594040|NCT02603952|18692592|P1|COMPLETED|Overall Study||31
7594041|NCT02603952|18692589|P4|Treated|Overall Study||31
7594042|NCT02603952|18692590|P3|Treated|Overall Study||31
7594043|NCT02603952|18692591|P2|Treated|Overall Study||31
7594044|NCT02603952|18692592|P1|Treated|Overall Study||32
7594045|NCT02603952|18692589|P4|STARTED|Overall Study||32
7594046|NCT02603952|18692590|P3|STARTED|Overall Study||31
7594047|NCT02603952|18692591|P2|STARTED|Overall Study||31
7594048|NCT02603952|18692592|P1|STARTED|Overall Study||32
7594049|NCT02603926|18692633|P1|NOT COMPLETED|Overall Study||0
7594050|NCT02603926|18692633|P1|COMPLETED|Overall Study||6
7594051|NCT02603926|18692633|P1|STARTED|Overall Study||6
7594052|NCT02603887|18692640|P1|NOT COMPLETED|Overall Study||6
7594053|NCT02603887|18692640|P1|COMPLETED|Overall Study||7
7594054|NCT02603887|18692640|P1|Cycle 8|Overall Study||7
7594055|NCT02603887|18692640|P1|Cycle 1|Overall Study||13
7594056|NCT02603887|18692640|P1|STARTED|Overall Study||13
7594057|NCT02603809|18692653|P6|NOT COMPLETED|Overall Study||10
7594058|NCT02603809|18692654|P5|NOT COMPLETED|Overall Study||11
7594059|NCT02603809|18692655|P4|NOT COMPLETED|Overall Study||12
7594060|NCT02603809|18692656|P3|NOT COMPLETED|Overall Study||7
7594061|NCT02603809|18692657|P2|NOT COMPLETED|Overall Study||8
7594062|NCT02603809|18692658|P1|NOT COMPLETED|Overall Study||12
7594063|NCT02603809|18692653|P6|COMPLETED|Overall Study||71
7594064|NCT02603809|18692654|P5|COMPLETED|Overall Study||70
7594065|NCT02603809|18692655|P4|COMPLETED|Overall Study||70
7594066|NCT02603809|18692656|P3|COMPLETED|Overall Study||75
7594067|NCT02603809|18692657|P2|COMPLETED|Overall Study||74
7594068|NCT02603809|18692658|P1|COMPLETED|Overall Study||70
7594069|NCT02603809|18692653|P6|Completed Study|Overall Study||75
7594070|NCT02603809|18692654|P5|Completed Study|Overall Study||78
7594071|NCT02603809|18692655|P4|Completed Study|Overall Study||76
7594072|NCT02603809|18692656|P3|Completed Study|Overall Study||79
7594073|NCT02603809|18692657|P2|Completed Study|Overall Study||79
7594074|NCT02603809|18692658|P1|Completed Study|Overall Study||75
7594075|NCT02603809|18692653|P6|Modified Per-Protocol Set|Overall Study||69
7594076|NCT02603809|18692654|P5|Modified Per-Protocol Set|Overall Study||68
7594077|NCT02603809|18692655|P4|Modified Per-Protocol Set|Overall Study||67
7594078|NCT02603809|18692656|P3|Modified Per-Protocol Set|Overall Study||71
7594079|NCT02603809|18692657|P2|Modified Per-Protocol Set|Overall Study||68
7594080|NCT02603809|18692658|P1|Modified Per-Protocol Set|Overall Study|One participant had out of analysis window blood pressure measurements.|66
7594081|NCT02603809|18692653|P6|Per-protocol Set|Overall Study||69
7594082|NCT02603809|18692654|P5|Per-protocol Set|Overall Study||68
7594083|NCT02603809|18692655|P4|Per-protocol Set|Overall Study||67
7594084|NCT02603809|18692656|P3|Per-protocol Set|Overall Study||71
7594085|NCT02603809|18692657|P2|Per-protocol Set|Overall Study||68
7594086|NCT02603809|18692658|P1|Per-protocol Set|Overall Study||67
7594087|NCT02603809|18692653|P6|STARTED|Overall Study||81
7594088|NCT02603809|18692654|P5|STARTED|Overall Study||81
7594089|NCT02603809|18692655|P4|STARTED|Overall Study||82
7594090|NCT02603809|18692656|P3|STARTED|Overall Study||82
7594091|NCT02603809|18692657|P2|STARTED|Overall Study||82
7594092|NCT02603809|18692658|P1|STARTED|Overall Study||82
7594093|NCT02603666|18692714|P1|NOT COMPLETED|Overall Study||0
7594094|NCT02603666|18692714|P1|COMPLETED|Overall Study||130
7594095|NCT02603666|18692714|P1|STARTED|Overall Study||130
7594096|NCT02603432|18692720|P2|NOT COMPLETED|Overall Study||350
7594097|NCT02603432|18692721|P1|NOT COMPLETED|Overall Study||350
7594098|NCT02603432|18692720|P2|COMPLETED|Overall Study||0
7594099|NCT02603432|18692721|P1|COMPLETED|Overall Study||0
7594100|NCT02603432|18692720|P2|STARTED|Overall Study||350
7594101|NCT02603432|18692721|P1|STARTED|Overall Study||350
7594102|NCT02603419|18692775|P6|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||3
7594103|NCT02603419|18692776|P5|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
7594104|NCT02603419|18692777|P4|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
7594105|NCT02603419|18692778|P3|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
7594106|NCT02603419|18692779|P2|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
7594107|NCT02603419|18692780|P1|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
7594108|NCT02603419|18692775|P6|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
7594109|NCT02603419|18692776|P5|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
7594110|NCT02603419|18692777|P4|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
7594111|NCT02603419|18692778|P3|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
7594112|NCT02603419|18692779|P2|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
7594113|NCT02603419|18692780|P1|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
7594114|NCT02603419|18692775|P6|STARTED|Expansion Phase:Maximum Exposure:48Weeks|Participants started expansion phase while other few participants were completing lead-in phase.|3
7594115|NCT02603419|18692776|P5|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
7594116|NCT02603419|18692777|P4|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
7594117|NCT02603419|18692778|P3|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
7594118|NCT02603419|18692779|P2|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
7594119|NCT02603419|18692780|P1|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
7594120|NCT02603419|18692775|P6|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
7594121|NCT02603419|18692776|P5|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
7594122|NCT02603419|18692777|P4|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
7594123|NCT02603419|18692778|P3|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
7594124|NCT02603419|18692779|P2|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||7
7594125|NCT02603419|18692780|P1|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
7594126|NCT02603419|18692775|P6|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
7594127|NCT02603419|18692776|P5|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
7594128|NCT02603419|18692777|P4|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
7594129|NCT02603419|18692778|P3|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
7594130|NCT02603419|18692779|P2|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
7594131|NCT02603419|18692780|P1|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
7594212|NCT02603172|18693010|P5|COMPLETED|Part A (Approximately 16 Weeks)||0
7594132|NCT02603419|18692775|P6|Treated|Lead-in Phase:Maximum Exposure:123Weeks||0
7594133|NCT02603419|18692776|P5|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
7594134|NCT02603419|18692777|P4|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
7594135|NCT02603419|18692778|P3|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
7594136|NCT02603419|18692779|P2|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
7594137|NCT02603419|18692780|P1|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
7594138|NCT02603419|18692775|P6|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||0
7594139|NCT02603419|18692776|P5|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
7594140|NCT02603419|18692777|P4|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
7594141|NCT02603419|18692778|P3|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
7594142|NCT02603419|18692779|P2|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||7
7594143|NCT02603419|18692780|P1|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
7594144|NCT02603393|18692967|P2|NOT COMPLETED|Overall Study||54
7594145|NCT02603393|18692968|P1|NOT COMPLETED|Overall Study||71
7594146|NCT02603393|18692967|P2|COMPLETED|Overall Study||472
7594147|NCT02603393|18692968|P1|COMPLETED|Overall Study||456
7594148|NCT02603393|18692967|P2|STARTED|Overall Study||526
7594149|NCT02603393|18692968|P1|STARTED|Overall Study||527
7594150|NCT02603211|18692994|P1|NOT COMPLETED|Overall Study||0
7594151|NCT02603211|18692994|P1|COMPLETED|Overall Study||20
7594152|NCT02603211|18692994|P1|STARTED|Overall Study||20
7594153|NCT02603172|18693007|P8|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
7594154|NCT02603172|18693008|P7|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
7594155|NCT02603172|18693009|P6|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
7594156|NCT02603172|18693010|P5|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
7594157|NCT02603172|18693011|P4|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
7594158|NCT02603172|18693012|P3|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
7594159|NCT02603172|18693013|P2|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
7594160|NCT02603172|18693014|P1|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
7594161|NCT02603172|18693007|P8|COMPLETED|Part C (Approximately 13 Weeks)||0
7594162|NCT02603172|18693008|P7|COMPLETED|Part C (Approximately 13 Weeks)||0
7594163|NCT02603172|18693009|P6|COMPLETED|Part C (Approximately 13 Weeks)||0
7594164|NCT02603172|18693010|P5|COMPLETED|Part C (Approximately 13 Weeks)||0
7594165|NCT02603172|18693011|P4|COMPLETED|Part C (Approximately 13 Weeks)||0
7594166|NCT02603172|18693012|P3|COMPLETED|Part C (Approximately 13 Weeks)||0
7594167|NCT02603172|18693013|P2|COMPLETED|Part C (Approximately 13 Weeks)||0
7594168|NCT02603172|18693014|P1|COMPLETED|Part C (Approximately 13 Weeks)||0
7594169|NCT02603172|18693007|P8|STARTED|Part C (Approximately 13 Weeks)||0
7594170|NCT02603172|18693008|P7|STARTED|Part C (Approximately 13 Weeks)||0
7594171|NCT02603172|18693009|P6|STARTED|Part C (Approximately 13 Weeks)||0
7594172|NCT02603172|18693010|P5|STARTED|Part C (Approximately 13 Weeks)||0
7594173|NCT02603172|18693011|P4|STARTED|Part C (Approximately 13 Weeks)||0
7594174|NCT02603172|18693012|P3|STARTED|Part C (Approximately 13 Weeks)||0
7594175|NCT02603172|18693013|P2|STARTED|Part C (Approximately 13 Weeks)||0
7594176|NCT02603172|18693014|P1|STARTED|Part C (Approximately 13 Weeks)||0
7594177|NCT02603172|18693007|P8|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
7594178|NCT02603172|18693008|P7|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
7594179|NCT02603172|18693009|P6|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
7594180|NCT02603172|18693010|P5|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
7594181|NCT02603172|18693011|P4|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
7594182|NCT02603172|18693012|P3|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
7594183|NCT02603172|18693013|P2|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
7594184|NCT02603172|18693014|P1|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
7594185|NCT02603172|18693007|P8|COMPLETED|Part B (Approximately 7 Weeks)||0
7594186|NCT02603172|18693008|P7|COMPLETED|Part B (Approximately 7 Weeks)||0
7594187|NCT02603172|18693009|P6|COMPLETED|Part B (Approximately 7 Weeks)||0
7594188|NCT02603172|18693010|P5|COMPLETED|Part B (Approximately 7 Weeks)||6
7594189|NCT02603172|18693011|P4|COMPLETED|Part B (Approximately 7 Weeks)||1
7594190|NCT02603172|18693012|P3|COMPLETED|Part B (Approximately 7 Weeks)||0
7594191|NCT02603172|18693013|P2|COMPLETED|Part B (Approximately 7 Weeks)||1
7594192|NCT02603172|18693014|P1|COMPLETED|Part B (Approximately 7 Weeks)||0
7594193|NCT02603172|18693007|P8|STARTED|Part B (Approximately 7 Weeks)||0
7594194|NCT02603172|18693008|P7|STARTED|Part B (Approximately 7 Weeks)||0
7594195|NCT02603172|18693009|P6|STARTED|Part B (Approximately 7 Weeks)||0
7594196|NCT02603172|18693010|P5|STARTED|Part B (Approximately 7 Weeks)||6
7594197|NCT02603172|18693011|P4|STARTED|Part B (Approximately 7 Weeks)||1
7594198|NCT02603172|18693012|P3|STARTED|Part B (Approximately 7 Weeks)||0
7594199|NCT02603172|18693013|P2|STARTED|Part B (Approximately 7 Weeks)||1
7594200|NCT02603172|18693014|P1|STARTED|Part B (Approximately 7 Weeks)||0
7594201|NCT02603172|18693007|P8|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
7594202|NCT02603172|18693008|P7|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
7594203|NCT02603172|18693009|P6|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
7594204|NCT02603172|18693010|P5|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
7594205|NCT02603172|18693011|P4|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
7594206|NCT02603172|18693012|P3|NOT COMPLETED|Part A (Approximately 16 Weeks)||1
7594207|NCT02603172|18693013|P2|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
7594208|NCT02603172|18693014|P1|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
7594209|NCT02603172|18693007|P8|COMPLETED|Part A (Approximately 16 Weeks)||0
7594210|NCT02603172|18693008|P7|COMPLETED|Part A (Approximately 16 Weeks)||0
7594211|NCT02603172|18693009|P6|COMPLETED|Part A (Approximately 16 Weeks)||0
7594213|NCT02603172|18693011|P4|COMPLETED|Part A (Approximately 16 Weeks)||1
7594214|NCT02603172|18693012|P3|COMPLETED|Part A (Approximately 16 Weeks)||7
7594215|NCT02603172|18693013|P2|COMPLETED|Part A (Approximately 16 Weeks)||1
7594216|NCT02603172|18693014|P1|COMPLETED|Part A (Approximately 16 Weeks)||7
7594217|NCT02603172|18693007|P8|STARTED|Part A (Approximately 16 Weeks)||0
7594218|NCT02603172|18693008|P7|STARTED|Part A (Approximately 16 Weeks)||0
7594219|NCT02603172|18693009|P6|STARTED|Part A (Approximately 16 Weeks)||0
7594220|NCT02603172|18693010|P5|STARTED|Part A (Approximately 16 Weeks)||0
7594221|NCT02603172|18693011|P4|STARTED|Part A (Approximately 16 Weeks)||1
7594222|NCT02603172|18693012|P3|STARTED|Part A (Approximately 16 Weeks)||8
7594223|NCT02603172|18693013|P2|STARTED|Part A (Approximately 16 Weeks)||1
7594224|NCT02603172|18693014|P1|STARTED|Part A (Approximately 16 Weeks)||7
7594225|NCT02603120|18693142|P2|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||11
7594226|NCT02603120|18693143|P1|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||5
7594227|NCT02603120|18693142|P2|COMPLETED|OL Extension B/F/TAF Treatment Phase||254
7594228|NCT02603120|18693143|P1|COMPLETED|OL Extension B/F/TAF Treatment Phase||254
7594229|NCT02603120|18693142|P2|STARTED|OL Extension B/F/TAF Treatment Phase||265
7594230|NCT02603120|18693143|P1|STARTED|OL Extension B/F/TAF Treatment Phase||259
7594231|NCT02603120|18693142|P2|NOT COMPLETED|Double-Blind Treatment Phase||16
7594232|NCT02603120|18693143|P1|NOT COMPLETED|Double-Blind Treatment Phase||19
7594233|NCT02603120|18693142|P2|COMPLETED|Double-Blind Treatment Phase||267
7594234|NCT02603120|18693143|P1|COMPLETED|Double-Blind Treatment Phase||265
7594235|NCT02603120|18693142|P2|STARTED|Double-Blind Treatment Phase||283
7594236|NCT02603120|18693143|P1|STARTED|Double-Blind Treatment Phase||284
7594237|NCT02603107|18693165|P2|NOT COMPLETED|Optional Extension Phase||13
7594238|NCT02603107|18693166|P1|NOT COMPLETED|Optional Extension Phase||9
7594239|NCT02603107|18693165|P2|COMPLETED|Optional Extension Phase||232
7594240|NCT02603107|18693166|P1|COMPLETED|Optional Extension Phase||263
7594241|NCT02603107|18693165|P2|STARTED|Optional Extension Phase|21 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|245
7594242|NCT02603107|18693166|P1|STARTED|Optional Extension Phase|3 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|272
7594243|NCT02603107|18693165|P2|NOT COMPLETED|Randomized Phase||21
7594244|NCT02603107|18693166|P1|NOT COMPLETED|Randomized Phase||15
7594245|NCT02603107|18693165|P2|COMPLETED|Randomized Phase||266
7594246|NCT02603107|18693166|P1|COMPLETED|Randomized Phase||275
7594247|NCT02603107|18693165|P2|STARTED|Randomized Phase||287
7594248|NCT02603107|18693166|P1|STARTED|Randomized Phase||290
7594249|NCT02602496|18693181|P3|NOT COMPLETED|Overall Study||0
7594250|NCT02602496|18693182|P2|NOT COMPLETED|Overall Study||2
7594251|NCT02602496|18693183|P1|NOT COMPLETED|Overall Study||1
7594252|NCT02602496|18693181|P3|COMPLETED|Overall Study||17
7594253|NCT02602496|18693182|P2|COMPLETED|Overall Study||18
7594254|NCT02602496|18693183|P1|COMPLETED|Overall Study||14
7594255|NCT02602496|18693181|P3|STARTED|Overall Study||17
7594256|NCT02602496|18693182|P2|STARTED|Overall Study||20
7594257|NCT02602496|18693183|P1|STARTED|Overall Study||15
7594258|NCT02602223|18693212|P1|NOT COMPLETED|Overall Study||0
7594259|NCT02602223|18693212|P1|COMPLETED|Overall Study||9
7594260|NCT02602223|18693212|P1|STARTED|Overall Study||9
7594261|NCT02602080|18693231|P3|NOT COMPLETED|Overall Study||3
7594262|NCT02602080|18693232|P2|NOT COMPLETED|Overall Study||1
7594263|NCT02602080|18693233|P1|NOT COMPLETED|Overall Study||6
7594264|NCT02602080|18693231|P3|COMPLETED|Overall Study||15
7594265|NCT02602080|18693232|P2|COMPLETED|Overall Study||15
7594266|NCT02602080|18693233|P1|COMPLETED|Overall Study||15
7594267|NCT02602080|18693231|P3|STARTED|Overall Study||18
7594268|NCT02602080|18693232|P2|STARTED|Overall Study||16
7594269|NCT02602080|18693233|P1|STARTED|Overall Study||21
7594270|NCT02601976|18693268|P1|NOT COMPLETED|Overall Study||0
7594271|NCT02601976|18693268|P1|COMPLETED|Overall Study||64
7594272|NCT02601976|18693268|P1|STARTED|Overall Study||64
7594273|NCT02601820|18693276|P1|NOT COMPLETED|1-Yr Post-Treatment (T5)||88
7594274|NCT02601820|18693276|P1|COMPLETED|1-Yr Post-Treatment (T5)|Of 1528, 88 were excluded for a missing T5 record. 1440 provided data at T5. Some outcomes missing.|1440
7594275|NCT02601820|18693276|P1|STARTED|1-Yr Post-Treatment (T5)|Of 1601, 73 were excluded at T5 due to death, withdrawal, other reason. 1528 remained in the study.|1528
7594276|NCT02601820|18693276|P1|NOT COMPLETED|12 Weeks Post-Treatment (T4)||3
7594277|NCT02601820|18693276|P1|COMPLETED|12 Weeks Post-Treatment (T4)|Of 1564, 3 were excluded for a missing T4 record. 1561 provided data at T4. Some outcomes missing.|1561
7594278|NCT02601820|18693276|P1|STARTED|12 Weeks Post-Treatment (T4)|Of 1601, 37 were excluded at T4 due to death, withdrawal, other reason. 1564 remained in the study.|1564
7594279|NCT02601820|18693276|P1|NOT COMPLETED|Late On-Treatment (T3)||49
7594280|NCT02601820|18693276|P1|COMPLETED|Late On-Treatment (T3)|Of 1573, 49 were excluded for a missing T3 record. 1524 provided data at T3. Some outcomes missing.|1524
7594281|NCT02601820|18693276|P1|STARTED|Late On-Treatment (T3)|Of 1601, 28 were excluded at T3 due to death, withdrawal, other reason. 1573 remained in the study.|1573
7594282|NCT02601820|18693276|P1|NOT COMPLETED|Early On-Treatment (T2)||51
7594283|NCT02601820|18693276|P1|COMPLETED|Early On-Treatment (T2)|Of 1584, 51 were excluded for a missing T2 record. 1533 provided data at T2. Some outcomes missing.|1533
7594284|NCT02601820|18693276|P1|STARTED|Early On-Treatment (T2)|Of 1601, 17 were excluded at T2 due to death, withdrawal, other reason. 1584 remained in the study.|1584
7594285|NCT02601820|18693276|P1|NOT COMPLETED|Pre-Treatment (T1)||0
7594286|NCT02601820|18693276|P1|COMPLETED|Pre-Treatment (T1)||1601
7594287|NCT02601820|18693276|P1|STARTED|Pre-Treatment (T1)|1601 patients were enrolled and completed Baseline PROs (T1).|1601
7594288|NCT02601625|18693305|P4|NOT COMPLETED|Overall Study||1
7594289|NCT02601625|18693306|P3|NOT COMPLETED|Overall Study||1
7594290|NCT02601625|18693307|P2|NOT COMPLETED|Overall Study||0
7594291|NCT02601625|18693308|P1|NOT COMPLETED|Overall Study||0
7594292|NCT02601625|18693305|P4|COMPLETED|Overall Study||11
7594293|NCT02601625|18693306|P3|COMPLETED|Overall Study||5
7594294|NCT02601625|18693307|P2|COMPLETED|Overall Study||6
7594295|NCT02601625|18693308|P1|COMPLETED|Overall Study||6
7594296|NCT02601625|18693305|P4|STARTED|Overall Study||12
7594297|NCT02601625|18693306|P3|STARTED|Overall Study||6
7594298|NCT02601625|18693307|P2|STARTED|Overall Study||6
7594299|NCT02601625|18693308|P1|STARTED|Overall Study||6
7594300|NCT02601573|18693361|P5|NOT COMPLETED|Overall Study||2
7594301|NCT02601573|18693362|P4|NOT COMPLETED|Overall Study||1
7594302|NCT02601573|18693363|P3|NOT COMPLETED|Overall Study||1
7594303|NCT02601573|18693364|P2|NOT COMPLETED|Overall Study||4
7594304|NCT02601573|18693365|P1|NOT COMPLETED|Overall Study||0
7594305|NCT02601573|18693361|P5|COMPLETED|Overall Study||16
7594306|NCT02601573|18693362|P4|COMPLETED|Overall Study||17
7594307|NCT02601573|18693363|P3|COMPLETED|Overall Study||16
7594308|NCT02601573|18693364|P2|COMPLETED|Overall Study||20
7594309|NCT02601573|18693365|P1|COMPLETED|Overall Study||23
7594310|NCT02601573|18693361|P5|STARTED|Overall Study|Number randomized and treated.|18
7594311|NCT02601573|18693362|P4|STARTED|Overall Study|Number randomized and treated.|18
7594312|NCT02601573|18693363|P3|STARTED|Overall Study|Number randomized and treated.|17
7594313|NCT02601573|18693364|P2|STARTED|Overall Study|Number randomized and treated.|24
7594314|NCT02601573|18693365|P1|STARTED|Overall Study|Number randomized and treated.|23
7594315|NCT02601560|18693400|P8|NOT COMPLETED|Overall Study||0
7594316|NCT02601560|18693401|P7|NOT COMPLETED|Overall Study||1
7594317|NCT02601560|18693402|P6|NOT COMPLETED|Overall Study||0
7594318|NCT02601560|18693403|P5|NOT COMPLETED|Overall Study||0
7594319|NCT02601560|18693404|P4|NOT COMPLETED|Overall Study||0
7594320|NCT02601560|18693405|P3|NOT COMPLETED|Overall Study||0
7594321|NCT02601560|18693406|P2|NOT COMPLETED|Overall Study||0
7594322|NCT02601560|18693407|P1|NOT COMPLETED|Overall Study||0
7594323|NCT02601560|18693400|P8|COMPLETED|Overall Study||6
7594324|NCT02601560|18693401|P7|COMPLETED|Overall Study||5
7594325|NCT02601560|18693402|P6|COMPLETED|Overall Study||4
7594326|NCT02601560|18693403|P5|COMPLETED|Overall Study||6
7594327|NCT02601560|18693404|P4|COMPLETED|Overall Study||6
7594328|NCT02601560|18693405|P3|COMPLETED|Overall Study||6
7594329|NCT02601560|18693406|P2|COMPLETED|Overall Study||6
7594330|NCT02601560|18693407|P1|COMPLETED|Overall Study||8
7594331|NCT02601560|18693400|P8|STARTED|Overall Study||6
7594332|NCT02601560|18693401|P7|STARTED|Overall Study||6
7594333|NCT02601560|18693402|P6|STARTED|Overall Study||4
7594334|NCT02601560|18693403|P5|STARTED|Overall Study||6
7594335|NCT02601560|18693404|P4|STARTED|Overall Study||6
7594336|NCT02601560|18693405|P3|STARTED|Overall Study||6
7594337|NCT02601560|18693406|P2|STARTED|Overall Study||6
7594338|NCT02601560|18693407|P1|STARTED|Overall Study||8
7594339|NCT02601469|18693591|P2|NOT COMPLETED|Overall Study||0
7594340|NCT02601469|18693592|P1|NOT COMPLETED|Overall Study||1
7594341|NCT02601469|18693591|P2|COMPLETED|Overall Study||1
7594342|NCT02601469|18693592|P1|COMPLETED|Overall Study||24
7594343|NCT02601469|18693591|P2|STARTED|Overall Study||1
7594344|NCT02601469|18693592|P1|STARTED|Overall Study||25
7594345|NCT02601313|18693601|P3|NOT COMPLETED|Overall Study||17
7594346|NCT02601313|18693602|P2|NOT COMPLETED|Overall Study||74
7594347|NCT02601313|18693603|P1|NOT COMPLETED|Overall Study||6
7594348|NCT02601313|18693601|P3|COMPLETED|Overall Study||0
7594349|NCT02601313|18693602|P2|COMPLETED|Overall Study||0
7594350|NCT02601313|18693603|P1|COMPLETED|Overall Study||8
7594351|NCT02601313|18693601|P3|STARTED|Overall Study||17
7594352|NCT02601313|18693602|P2|STARTED|Overall Study||74
7594353|NCT02601313|18693603|P1|STARTED|Overall Study||14
7594354|NCT02601300|18693622|P1|NOT COMPLETED|Extension Phase||17
7594355|NCT02601300|18693622|P1|COMPLETED|Extension Phase||18
7594356|NCT02601300|18693622|P1|Treated With IP|Extension Phase||34
7594357|NCT02601300|18693622|P1|STARTED|Extension Phase|3 completed induction phase; did not enter extension due to withdrawal and lack of efficacy|35
7594358|NCT02601300|18693622|P1|NOT COMPLETED|Induction Phase||3
7594359|NCT02601300|18693622|P1|COMPLETED|Induction Phase||38
7594360|NCT02601300|18693622|P1|STARTED|Induction Phase||41
7594361|NCT02601209|18693642|P9|NOT COMPLETED|Optional Crossover (Up to 2 Months)||17
7594362|NCT02601209|18693643|P8|NOT COMPLETED|Optional Crossover (Up to 2 Months)||2
7594363|NCT02601209|18693644|P7|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
7594364|NCT02601209|18693645|P6|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
7594365|NCT02601209|18693646|P5|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
7594366|NCT02601209|18693647|P4|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
7594367|NCT02601209|18693648|P3|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
7594368|NCT02601209|18693649|P2|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
7594369|NCT02601209|18693650|P1|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
7594370|NCT02601209|18693642|P9|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|26
7594371|NCT02601209|18693643|P8|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|4
7594372|NCT02601209|18693644|P7|COMPLETED|Optional Crossover (Up to 2 Months)||0
7594373|NCT02601209|18693645|P6|COMPLETED|Optional Crossover (Up to 2 Months)||0
7594374|NCT02601209|18693646|P5|COMPLETED|Optional Crossover (Up to 2 Months)||0
7594375|NCT02601209|18693647|P4|COMPLETED|Optional Crossover (Up to 2 Months)||0
7594376|NCT02601209|18693648|P3|COMPLETED|Optional Crossover (Up to 2 Months)||0
7594377|NCT02601209|18693649|P2|COMPLETED|Optional Crossover (Up to 2 Months)||0
7594378|NCT02601209|18693650|P1|COMPLETED|Optional Crossover (Up to 2 Months)||0
7594379|NCT02601209|18693642|P9|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|43
7594380|NCT02601209|18693643|P8|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|6
7594381|NCT02601209|18693644|P7|STARTED|Optional Crossover (Up to 2 Months)||0
7594382|NCT02601209|18693645|P6|STARTED|Optional Crossover (Up to 2 Months)||0
7594383|NCT02601209|18693646|P5|STARTED|Optional Crossover (Up to 2 Months)||0
7594384|NCT02601209|18693647|P4|STARTED|Optional Crossover (Up to 2 Months)||0
7594385|NCT02601209|18693648|P3|STARTED|Optional Crossover (Up to 2 Months)||0
7594386|NCT02601209|18693649|P2|STARTED|Optional Crossover (Up to 2 Months)||0
7594387|NCT02601209|18693650|P1|STARTED|Optional Crossover (Up to 2 Months)||0
7594388|NCT02601209|18693642|P9|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
7594389|NCT02601209|18693643|P8|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
7594390|NCT02601209|18693644|P7|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
7594391|NCT02601209|18693645|P6|NOT COMPLETED|Initial Treatment (Up to 4 Months)||2
7594392|NCT02601209|18693646|P5|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
7594393|NCT02601209|18693647|P4|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
7594394|NCT02601209|18693648|P3|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
7594395|NCT02601209|18693649|P2|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
7594396|NCT02601209|18693650|P1|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
7594397|NCT02601209|18693642|P9|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|43
7594398|NCT02601209|18693643|P8|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
7594399|NCT02601209|18693644|P7|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|55
7594400|NCT02601209|18693645|P6|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|13
7594401|NCT02601209|18693646|P5|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|12
7594402|NCT02601209|18693647|P4|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
7594403|NCT02601209|18693648|P3|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
7594404|NCT02601209|18693649|P2|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
7594405|NCT02601209|18693650|P1|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
7594406|NCT02601209|18693642|P9|STARTED|Initial Treatment (Up to 4 Months)|Randomized|43
7594407|NCT02601209|18693643|P8|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
7594408|NCT02601209|18693644|P7|STARTED|Initial Treatment (Up to 4 Months)|Randomized|56
7594409|NCT02601209|18693645|P6|STARTED|Initial Treatment (Up to 4 Months)|Randomized|15
7594410|NCT02601209|18693646|P5|STARTED|Initial Treatment (Up to 4 Months)|Randomized|13
7594411|NCT02601209|18693647|P4|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
7594412|NCT02601209|18693648|P3|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
7594413|NCT02601209|18693649|P2|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
7594414|NCT02601209|18693650|P1|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
7594415|NCT02601170|18693678|P2|NOT COMPLETED|Overall Study||0
7594416|NCT02601170|18693679|P1|NOT COMPLETED|Overall Study||0
7594417|NCT02601170|18693678|P2|COMPLETED|Overall Study||11
7594418|NCT02601170|18693679|P1|COMPLETED|Overall Study||11
7594419|NCT02601170|18693678|P2|STARTED|Overall Study||11
7594420|NCT02601170|18693679|P1|STARTED|Overall Study||11
7594421|NCT02600923|18693697|P1|NOT COMPLETED|Overall Study||131
7594422|NCT02600923|18693697|P1|COMPLETED|Overall Study||0
7594423|NCT02600923|18693697|P1|Treated|Overall Study||130
7594424|NCT02600923|18693697|P1|STARTED|Overall Study||131
7594425|NCT02600871|18693707|P2|NOT COMPLETED|Overall Study||10
7594426|NCT02600871|18693708|P1|NOT COMPLETED|Overall Study||13
7594427|NCT02600871|18693707|P2|COMPLETED|Overall Study|45 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
7594428|NCT02600871|18693708|P1|COMPLETED|Overall Study|51 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
7594429|NCT02600871|18693707|P2|STARTED|Overall Study||49
7594430|NCT02600871|18693708|P1|STARTED|Overall Study||52
7594431|NCT02600845|18693718|P1|NOT COMPLETED|Overall Study||18
7594432|NCT02600845|18693718|P1|COMPLETED|Overall Study||104
7594433|NCT02600845|18693718|P1|STARTED|Overall Study||122
7594434|NCT02600819|18693733|P2|NOT COMPLETED|BVY OL Extension Phase||0
7594435|NCT02600819|18693734|P1|NOT COMPLETED|BVY OL Extension Phase||0
7594436|NCT02600819|18693733|P2|COMPLETED|BVY OL Extension Phase||10
7594437|NCT02600819|18693734|P1|COMPLETED|BVY OL Extension Phase||0
7594438|NCT02600819|18693733|P2|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|10
7594439|NCT02600819|18693734|P1|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|0
7594440|NCT02600819|18693733|P2|NOT COMPLETED|GEN Phase||0
7594441|NCT02600819|18693734|P1|NOT COMPLETED|GEN Phase||16
7594442|NCT02600819|18693733|P2|COMPLETED|GEN Phase||0
7594443|NCT02600819|18693734|P1|COMPLETED|GEN Phase||39
7594444|NCT02600819|18693733|P2|STARTED|GEN Phase||0
7594445|NCT02600819|18693734|P1|STARTED|GEN Phase||55
7594446|NCT02600767|18693754|P1|NOT COMPLETED|Overall Study||5
7594447|NCT02600767|18693754|P1|COMPLETED|Overall Study||74
7594448|NCT02600767|18693754|P1|STARTED|Overall Study||79
7594449|NCT02600715|18693760|P2|NOT COMPLETED|Overall Study||0
7594450|NCT02600715|18693761|P1|NOT COMPLETED|Overall Study||0
7594451|NCT02600715|18693760|P2|COMPLETED|Overall Study||13
7594452|NCT02600715|18693761|P1|COMPLETED|Overall Study||13
7594453|NCT02600715|18693760|P2|Completed 2-week Follow-up Appointment|Overall Study||12
7594454|NCT02600715|18693761|P1|Completed 2-week Follow-up Appointment|Overall Study||13
7594455|NCT02600715|18693760|P2|Received Treatment and Suppository|Overall Study||13
7594456|NCT02600715|18693761|P1|Received Treatment and Suppository|Overall Study||13
7594457|NCT02600715|18693760|P2|Allocated to Randomization|Overall Study||13
7594458|NCT02600715|18693761|P1|Allocated to Randomization|Overall Study||13
7594459|NCT02600715|18693760|P2|STARTED|Overall Study||13
7594460|NCT02600715|18693761|P1|STARTED|Overall Study||13
7594461|NCT02600637|18693792|P2|NOT COMPLETED|Overall Study||5
7594462|NCT02600637|18693793|P1|NOT COMPLETED|Overall Study||5
7594463|NCT02600637|18693792|P2|COMPLETED|Overall Study||13
7594464|NCT02600637|18693793|P1|COMPLETED|Overall Study||14
7594465|NCT02600637|18693792|P2|STARTED|Overall Study||18
7594466|NCT02600637|18693793|P1|STARTED|Overall Study||19
7594467|NCT02600611|18693805|P2|NOT COMPLETED|Overall Study||0
7594468|NCT02600611|18693806|P1|NOT COMPLETED|Overall Study||2
7594469|NCT02600611|18693805|P2|COMPLETED|Overall Study||300
7594470|NCT02600611|18693806|P1|COMPLETED|Overall Study||298
7594471|NCT02600611|18693805|P2|STARTED|Overall Study||300
7594472|NCT02600611|18693806|P1|STARTED|Overall Study||300
7594473|NCT02600559|18693814|P1|NOT COMPLETED|Overall Study||23
7594474|NCT02600559|18693814|P1|COMPLETED|Overall Study||478
7594475|NCT02600559|18693814|P1|STARTED|Overall Study||501
7594476|NCT02600403|18693826|P3|NOT COMPLETED|Overall Study||0
7594477|NCT02600403|18693827|P2|NOT COMPLETED|Overall Study||0
7594478|NCT02600403|18693828|P1|NOT COMPLETED|Overall Study||0
7594479|NCT02600403|18693826|P3|COMPLETED|Overall Study||11
7594480|NCT02600403|18693827|P2|COMPLETED|Overall Study||6
7594481|NCT02600403|18693828|P1|COMPLETED|Overall Study||44
7594482|NCT02600403|18693826|P3|STARTED|Overall Study||11
7594483|NCT02600403|18693827|P2|STARTED|Overall Study||6
7594484|NCT02600403|18693828|P1|STARTED|Overall Study||44
7594485|NCT02600351|18693855|P4|NOT COMPLETED|Overall Study||5
7594486|NCT02600351|18693856|P3|NOT COMPLETED|Overall Study||6
7594487|NCT02600351|18693857|P2|NOT COMPLETED|Overall Study||0
7594488|NCT02600351|18693858|P1|NOT COMPLETED|Overall Study||5
7594489|NCT02600351|18693855|P4|COMPLETED|Overall Study||22
7594490|NCT02600351|18693856|P3|COMPLETED|Overall Study||20
7594491|NCT02600351|18693857|P2|COMPLETED|Overall Study||17
7594492|NCT02600351|18693858|P1|COMPLETED|Overall Study||12
7594493|NCT02600351|18693855|P4|STARTED|Overall Study||27
7594494|NCT02600351|18693856|P3|STARTED|Overall Study||26
7594495|NCT02600351|18693857|P2|STARTED|Overall Study||17
7594496|NCT02600351|18693858|P1|STARTED|Overall Study||17
7594497|NCT02600325|18693888|P1|NOT COMPLETED|Overall Study||0
7594498|NCT02600325|18693888|P1|COMPLETED|Overall Study||80
7594499|NCT02600325|18693888|P1|STARTED|Overall Study||80
7594500|NCT02599961|18693893|P1|NOT COMPLETED|Overall Study||15
7594501|NCT02599961|18693893|P1|COMPLETED|Overall Study||0
7594502|NCT02599961|18693893|P1|STARTED|Overall Study||15
7594503|NCT02599766|18693903|P1|NOT COMPLETED|Overall Study||3
7594504|NCT02599766|18693903|P1|COMPLETED|Overall Study||19
7594505|NCT02599766|18693903|P1|STARTED|Overall Study||22
7594506|NCT02599688|18693935|P1|NOT COMPLETED|Overall Study||4
7594507|NCT02599688|18693935|P1|COMPLETED|Overall Study||14
7594508|NCT02599688|18693935|P1|STARTED|Overall Study||18
7594509|NCT02599649|18693943|P4|NOT COMPLETED|Overall Study||0
7594510|NCT02599649|18693944|P3|NOT COMPLETED|Overall Study||0
7594511|NCT02599649|18693945|P2|NOT COMPLETED|Overall Study||0
7594512|NCT02599649|18693946|P1|NOT COMPLETED|Overall Study||0
7594513|NCT02599649|18693943|P4|COMPLETED|Overall Study||0
7594514|NCT02599649|18693944|P3|COMPLETED|Overall Study||8
7594515|NCT02599649|18693945|P2|COMPLETED|Overall Study||0
7594516|NCT02599649|18693946|P1|COMPLETED|Overall Study||2
7594517|NCT02599649|18693943|P4|STARTED|Overall Study||0
7594518|NCT02599649|18693944|P3|STARTED|Overall Study||8
7594519|NCT02599649|18693945|P2|STARTED|Overall Study||0
7594520|NCT02599649|18693946|P1|STARTED|Overall Study||2
7594521|NCT02599441|18693956|P1|NOT COMPLETED|Overall Study||0
7594522|NCT02599441|18693956|P1|COMPLETED|Overall Study||9
7594523|NCT02599441|18693956|P1|STARTED|Overall Study||9
7594524|NCT02599194|18693962|P1|NOT COMPLETED|Overall Study||0
7594525|NCT02599194|18693962|P1|COMPLETED|Overall Study||7
7594526|NCT02599194|18693962|P1|STARTED|Overall Study||7
7594527|NCT02599129|18693971|P2|NOT COMPLETED|Overall Study||3
7594528|NCT02599129|18693972|P1|NOT COMPLETED|Overall Study||5
7594529|NCT02599129|18693971|P2|COMPLETED|Overall Study||1
7594530|NCT02599129|18693972|P1|COMPLETED|Overall Study||2
7594531|NCT02599129|18693971|P2|STARTED|Overall Study||4
7594532|NCT02599129|18693972|P1|STARTED|Overall Study||7
7594533|NCT02598934|18693988|P2|NOT COMPLETED|Overall Study||22
7594534|NCT02598934|18693989|P1|NOT COMPLETED|Overall Study||19
7594535|NCT02598934|18693988|P2|COMPLETED|Overall Study||132
7594536|NCT02598934|18693989|P1|COMPLETED|Overall Study||135
7594537|NCT02598934|18693988|P2|STARTED|Overall Study||154
7594538|NCT02598934|18693989|P1|STARTED|Overall Study||154
7594539|NCT02598622|18694001|P2|NOT COMPLETED|Overall Study||0
7594540|NCT02598622|18694002|P1|NOT COMPLETED|Overall Study||6
7594541|NCT02598622|18694001|P2|COMPLETED|Overall Study||0
7594542|NCT02598622|18694002|P1|COMPLETED|Overall Study||2
7594543|NCT02598622|18694001|P2|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0
7594544|NCT02598622|18694002|P1|STARTED|Overall Study||8
7594545|NCT02598583|18694010|P2|NOT COMPLETED|Overall Study||0
7594546|NCT02598583|18694011|P1|NOT COMPLETED|Overall Study||0
7594547|NCT02598583|18694010|P2|COMPLETED|Overall Study||7
7594548|NCT02598583|18694011|P1|COMPLETED|Overall Study||6
7594549|NCT02598583|18694010|P2|STARTED|Overall Study||7
7594550|NCT02598583|18694011|P1|STARTED|Overall Study||6
7594551|NCT02598297|18694031|P2|NOT COMPLETED|Overall Study||24
7594552|NCT02598297|18694032|P1|NOT COMPLETED|Overall Study||25
7594553|NCT02598297|18694031|P2|COMPLETED|Overall Study||0
7594554|NCT02598297|18694032|P1|COMPLETED|Overall Study||0
7594555|NCT02598297|18694031|P2|Subjects Followed for Survival|Overall Study||0
7594556|NCT02598297|18694032|P1|Subjects Followed for Survival|Overall Study||1
7594557|NCT02598297|18694031|P2|Not Treted Wit Study Drug|Overall Study||0
7594558|NCT02598297|18694032|P1|Not Treted Wit Study Drug|Overall Study||1
7594559|NCT02598297|18694031|P2|STARTED|Overall Study||24
7594560|NCT02598297|18694032|P1|STARTED|Overall Study|One subject in the ruxolitinib arm was not treated with the study drug|25
7594561|NCT02598193|18694058|P1|NOT COMPLETED|Overall Study||16
7594562|NCT02598193|18694058|P1|COMPLETED|Overall Study||73
7594563|NCT02598193|18694058|P1|STARTED|Overall Study||89
7594564|NCT02598128|18694066|P4|NOT COMPLETED|Period C: Days 12 to 20||0
7594565|NCT02598128|18694067|P3|NOT COMPLETED|Period C: Days 12 to 20||0
7594566|NCT02598128|18694068|P2|NOT COMPLETED|Period C: Days 12 to 20||0
7594567|NCT02598128|18694069|P1|NOT COMPLETED|Period C: Days 12 to 20||0
7594568|NCT02598128|18694066|P4|COMPLETED|Period C: Days 12 to 20||33
7594569|NCT02598128|18694067|P3|COMPLETED|Period C: Days 12 to 20||0
7594570|NCT02598128|18694068|P2|COMPLETED|Period C: Days 12 to 20||0
7594571|NCT02598128|18694069|P1|COMPLETED|Period C: Days 12 to 20||0
7594572|NCT02598128|18694066|P4|STARTED|Period C: Days 12 to 20||33
7594573|NCT02598128|18694067|P3|STARTED|Period C: Days 12 to 20||0
7594574|NCT02598128|18694068|P2|STARTED|Period C: Days 12 to 20||0
7594575|NCT02598128|18694069|P1|STARTED|Period C: Days 12 to 20||0
7594576|NCT02598128|18694066|P4|NOT COMPLETED|Period B: Days 1 to 11||0
7594577|NCT02598128|18694067|P3|NOT COMPLETED|Period B: Days 1 to 11||0
7594578|NCT02598128|18694068|P2|NOT COMPLETED|Period B: Days 1 to 11||0
7594579|NCT02598128|18694069|P1|NOT COMPLETED|Period B: Days 1 to 11||0
7594580|NCT02598128|18694066|P4|COMPLETED|Period B: Days 1 to 11||0
7594581|NCT02598128|18694067|P3|COMPLETED|Period B: Days 1 to 11||16
7594582|NCT02598128|18694068|P2|COMPLETED|Period B: Days 1 to 11||17
7594583|NCT02598128|18694069|P1|COMPLETED|Period B: Days 1 to 11||0
7594584|NCT02598128|18694066|P4|STARTED|Period B: Days 1 to 11||0
7594585|NCT02598128|18694067|P3|STARTED|Period B: Days 1 to 11||16
7594586|NCT02598128|18694068|P2|STARTED|Period B: Days 1 to 11||17
7594587|NCT02598128|18694069|P1|STARTED|Period B: Days 1 to 11||0
7594588|NCT02598128|18694066|P4|NOT COMPLETED|Period A: Days -7 to -1||0
7594589|NCT02598128|18694067|P3|NOT COMPLETED|Period A: Days -7 to -1||0
7594590|NCT02598128|18694068|P2|NOT COMPLETED|Period A: Days -7 to -1||0
7594591|NCT02598128|18694069|P1|NOT COMPLETED|Period A: Days -7 to -1||1
7594592|NCT02598128|18694066|P4|COMPLETED|Period A: Days -7 to -1||0
7594593|NCT02598128|18694067|P3|COMPLETED|Period A: Days -7 to -1||0
7594594|NCT02598128|18694068|P2|COMPLETED|Period A: Days -7 to -1||0
7594595|NCT02598128|18694069|P1|COMPLETED|Period A: Days -7 to -1||33
7594596|NCT02598128|18694066|P4|STARTED|Period A: Days -7 to -1||0
7594597|NCT02598128|18694067|P3|STARTED|Period A: Days -7 to -1||0
7594598|NCT02598128|18694068|P2|STARTED|Period A: Days -7 to -1||0
7594599|NCT02598128|18694069|P1|STARTED|Period A: Days -7 to -1||34
7594600|NCT02598089|18694083|P2|NOT COMPLETED|Overall Study||0
7594601|NCT02598089|18694084|P1|NOT COMPLETED|Overall Study||0
7594602|NCT02598089|18694083|P2|COMPLETED|Overall Study||30
7594603|NCT02598089|18694084|P1|COMPLETED|Overall Study||30
7594604|NCT02598089|18694083|P2|STARTED|Overall Study||30
7594605|NCT02598089|18694084|P1|STARTED|Overall Study||30
7594606|NCT02598076|18694112|P2|NOT COMPLETED|Overall Study||3
7594607|NCT02598076|18694113|P1|NOT COMPLETED|Overall Study||2
7594608|NCT02598076|18694112|P2|COMPLETED|Overall Study||26
7594609|NCT02598076|18694113|P1|COMPLETED|Overall Study||29
7594610|NCT02598076|18694112|P2|STARTED|Overall Study||29
7594611|NCT02598076|18694113|P1|STARTED|Overall Study||31
7594612|NCT02597946|18694127|P1|NOT COMPLETED|Overall Study||18
7594613|NCT02597946|18694127|P1|COMPLETED|Overall Study||0
7594614|NCT02597946|18694127|P1|STARTED|Overall Study||18
7594615|NCT02597933|18694138|P2|NOT COMPLETED|Overall Study||51
7594616|NCT02597933|18694139|P1|NOT COMPLETED|Overall Study||38
7594617|NCT02597933|18694138|P2|COMPLETED|Overall Study||239
7594618|NCT02597933|18694139|P1|COMPLETED|Overall Study||252
7594619|NCT02597933|18694138|P2|Treated Patients|Overall Study||288
7594620|NCT02597933|18694139|P1|Treated Patients|Overall Study||288
7594621|NCT02597933|18694138|P2|STARTED|Overall Study|Started are randomised|290
7594622|NCT02597933|18694139|P1|STARTED|Overall Study|Started are randomised|290
7594623|NCT02597920|18694170|P3|NOT COMPLETED|Overall Study||6
7594624|NCT02597920|18694171|P2|NOT COMPLETED|Overall Study||84
7594625|NCT02597920|18694172|P1|NOT COMPLETED|Overall Study||41
7594626|NCT02597920|18694170|P3|COMPLETED|Overall Study||72
7594627|NCT02597920|18694171|P2|COMPLETED|Overall Study||1075
7594628|NCT02597920|18694172|P1|COMPLETED|Overall Study||544
7594629|NCT02597920|18694170|P3|STARTED|Overall Study||78
7594630|NCT02597920|18694171|P2|STARTED|Overall Study||1159
7594631|NCT02597920|18694172|P1|STARTED|Overall Study|Information about study termination is not available for 1 subject.|585
7594632|NCT02597907|18694197|P2|NOT COMPLETED|Overall Study||0
7594633|NCT02597907|18694198|P1|NOT COMPLETED|Overall Study||0
7594634|NCT02597907|18694197|P2|COMPLETED|Overall Study||44
7594635|NCT02597907|18694198|P1|COMPLETED|Overall Study||44
7594636|NCT02597907|18694197|P2|STARTED|Overall Study||44
7594637|NCT02597907|18694198|P1|STARTED|Overall Study||44
7594638|NCT02597855|18694206|P2|NOT COMPLETED|Overall Study||1
7594639|NCT02597855|18694207|P1|NOT COMPLETED|Overall Study||2
7594640|NCT02597855|18694206|P2|COMPLETED|Overall Study||13
7594641|NCT02597855|18694207|P1|COMPLETED|Overall Study||16
7594642|NCT02597855|18694206|P2|STARTED|Overall Study||14
7594643|NCT02597855|18694207|P1|STARTED|Overall Study||18
7594644|NCT02597673|18694219|P4|NOT COMPLETED|Overall Study||5
7594645|NCT02597673|18694220|P3|NOT COMPLETED|Overall Study||5
7594646|NCT02597673|18694221|P2|NOT COMPLETED|Overall Study||6
7594647|NCT02597673|18694222|P1|NOT COMPLETED|Overall Study||3
7594648|NCT02597673|18694219|P4|COMPLETED|Overall Study||25
7594649|NCT02597673|18694220|P3|COMPLETED|Overall Study||28
7594650|NCT02597673|18694221|P2|COMPLETED|Overall Study||27
7594651|NCT02597673|18694222|P1|COMPLETED|Overall Study||31
7594652|NCT02597673|18694219|P4|STARTED|Overall Study||30
7594653|NCT02597673|18694220|P3|STARTED|Overall Study||33
7594654|NCT02597673|18694221|P2|STARTED|Overall Study||33
7594655|NCT02597673|18694222|P1|STARTED|Overall Study||34
7594656|NCT02597582|18694274|P2|NOT COMPLETED|Overall Study||0
7594657|NCT02597582|18694275|P1|NOT COMPLETED|Overall Study||0
7594658|NCT02597582|18694274|P2|COMPLETED|Overall Study||20
7594659|NCT02597582|18694275|P1|COMPLETED|Overall Study||21
7594660|NCT02597582|18694274|P2|STARTED|Overall Study||20
7594661|NCT02597582|18694275|P1|STARTED|Overall Study||21
7594662|NCT02597543|18694293|P2|NOT COMPLETED|Overall Study||0
7594663|NCT02597543|18694294|P1|NOT COMPLETED|Overall Study||0
7594664|NCT02597543|18694293|P2|COMPLETED|Overall Study||8
7594665|NCT02597543|18694294|P1|COMPLETED|Overall Study||6
7594666|NCT02597543|18694293|P2|STARTED|Overall Study||8
7594667|NCT02597543|18694294|P1|STARTED|Overall Study||6
7594668|NCT02597478|18694312|P2|NOT COMPLETED|Overall Study||1
7594669|NCT02597478|18694313|P1|NOT COMPLETED|Overall Study||3
7594670|NCT02597478|18694312|P2|COMPLETED|Overall Study||17
7594671|NCT02597478|18694313|P1|COMPLETED|Overall Study||13
7594672|NCT02597478|18694312|P2|STARTED|Overall Study||18
7594673|NCT02597478|18694313|P1|STARTED|Overall Study||16
7594674|NCT02597452|18694327|P1|NOT COMPLETED|Overall Study||30
7594675|NCT02597452|18694327|P1|COMPLETED|Overall Study||486
7594676|NCT02597452|18694327|P1|STARTED|Overall Study||516
7594677|NCT02597127|18694345|P8|NOT COMPLETED|Overall Study||2
7594678|NCT02597127|18694346|P7|NOT COMPLETED|Overall Study||4
7594679|NCT02597127|18694347|P6|NOT COMPLETED|Overall Study||4
7594680|NCT02597127|18694348|P5|NOT COMPLETED|Overall Study||5
7594681|NCT02597127|18694349|P4|NOT COMPLETED|Overall Study||5
7594682|NCT02597127|18694350|P3|NOT COMPLETED|Overall Study||8
7594683|NCT02597127|18694351|P2|NOT COMPLETED|Overall Study||3
7594684|NCT02597127|18694352|P1|NOT COMPLETED|Overall Study||1
7594685|NCT02597127|18694345|P8|COMPLETED|Overall Study||60
7594686|NCT02597127|18694346|P7|COMPLETED|Overall Study||57
7594687|NCT02597127|18694347|P6|COMPLETED|Overall Study||59
7594688|NCT02597127|18694348|P5|COMPLETED|Overall Study||57
7594689|NCT02597127|18694349|P4|COMPLETED|Overall Study||60
7594690|NCT02597127|18694350|P3|COMPLETED|Overall Study||58
7594691|NCT02597127|18694351|P2|COMPLETED|Overall Study||59
7594692|NCT02597127|18694352|P1|COMPLETED|Overall Study||59
7594693|NCT02597127|18694345|P8|Treated|Overall Study||62
7594694|NCT02597127|18694346|P7|Treated|Overall Study||61
7594695|NCT02597127|18694347|P6|Treated|Overall Study||62
7594696|NCT02597127|18694348|P5|Treated|Overall Study||61
7594697|NCT02597127|18694349|P4|Treated|Overall Study||65
7594698|NCT02597127|18694350|P3|Treated|Overall Study||65
7594699|NCT02597127|18694351|P2|Treated|Overall Study||61
7594700|NCT02597127|18694352|P1|Treated|Overall Study||60
7594701|NCT02597127|18694345|P8|STARTED|Overall Study||62
7594702|NCT02597127|18694346|P7|STARTED|Overall Study||61
7594703|NCT02597127|18694347|P6|STARTED|Overall Study||63
7594704|NCT02597127|18694348|P5|STARTED|Overall Study||62
7594705|NCT02597127|18694349|P4|STARTED|Overall Study||65
7594706|NCT02597127|18694350|P3|STARTED|Overall Study||66
7594707|NCT02597127|18694351|P2|STARTED|Overall Study||62
7594708|NCT02597127|18694352|P1|STARTED|Overall Study||60
7594709|NCT02597062|18694439|P1|NOT COMPLETED|Overall Study||1
7594710|NCT02597062|18694439|P1|COMPLETED|Overall Study||75
7594711|NCT02597062|18694439|P1|STARTED|Overall Study||76
7594712|NCT02597049|18694448|P3|NOT COMPLETED|Overall Study||3
7594713|NCT02597049|18694449|P2|NOT COMPLETED|Overall Study||5
7594714|NCT02597049|18694450|P1|NOT COMPLETED|Overall Study||7
7594715|NCT02597049|18694448|P3|COMPLETED|Overall Study||137
7594716|NCT02597049|18694449|P2|COMPLETED|Overall Study||137
7594717|NCT02597049|18694450|P1|COMPLETED|Overall Study||135
7594718|NCT02597049|18694448|P3|Received at Least One Dose of Study Drug|Overall Study||140
7594719|NCT02597049|18694449|P2|Received at Least One Dose of Study Drug|Overall Study||141
7594720|NCT02597049|18694450|P1|Received at Least One Dose of Study Drug|Overall Study||142
7594721|NCT02597049|18694448|P3|STARTED|Overall Study||140
7594722|NCT02597049|18694449|P2|STARTED|Overall Study||142
7594723|NCT02597049|18694450|P1|STARTED|Overall Study||142
7594724|NCT02596971|18694491|P3|NOT COMPLETED|Overall Study||42
7594725|NCT02596971|18694492|P2|NOT COMPLETED|Overall Study||7
7594726|NCT02596971|18694493|P1|NOT COMPLETED|Overall Study||42
7594727|NCT02596971|18694491|P3|COMPLETED|Overall Study||0
7594728|NCT02596971|18694492|P2|COMPLETED|Overall Study||0
7594729|NCT02596971|18694493|P1|COMPLETED|Overall Study||0
7594730|NCT02596971|18694491|P3|STARTED|Overall Study||42
7594731|NCT02596971|18694492|P2|STARTED|Overall Study||7
7594732|NCT02596971|18694493|P1|STARTED|Overall Study||42
7594733|NCT02596958|18694522|P1|NOT COMPLETED|Overall Study||996
7594734|NCT02596958|18694522|P1|COMPLETED|Overall Study||0
7594735|NCT02596958|18694522|P1|STARTED|Overall Study||996
7594736|NCT02596945|18694534|P1|NOT COMPLETED|Overall Study||56
7594737|NCT02596945|18694534|P1|COMPLETED|Overall Study||167
7594738|NCT02596945|18694534|P1|Treated|Overall Study||220
7594739|NCT02596945|18694534|P1|STARTED|Overall Study||223
7594740|NCT02596906|18694542|P2|NOT COMPLETED|Overall Study||3
7594741|NCT02596906|18694543|P1|NOT COMPLETED|Overall Study||4
7594742|NCT02596906|18694542|P2|COMPLETED|Overall Study||7
7594743|NCT02596906|18694543|P1|COMPLETED|Overall Study||8
7594744|NCT02596906|18694542|P2|STARTED|Overall Study||10
7594745|NCT02596906|18694543|P1|STARTED|Overall Study||12
7594746|NCT02596893|18694555|P4|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
7594747|NCT02596893|18694556|P3|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
7594748|NCT02596893|18694557|P2|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
7594749|NCT02596893|18694558|P1|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
7594750|NCT02596893|18694555|P4|COMPLETED|Follow-Up Period Weeks 0 to 52||47
7594751|NCT02596893|18694556|P3|COMPLETED|Follow-Up Period Weeks 0 to 52||56
7594752|NCT02596893|18694557|P2|COMPLETED|Follow-Up Period Weeks 0 to 52||51
7594753|NCT02596893|18694558|P1|COMPLETED|Follow-Up Period Weeks 0 to 52||57
7594754|NCT02596893|18694555|P4|STARTED|Follow-Up Period Weeks 0 to 52||47
7594755|NCT02596893|18694556|P3|STARTED|Follow-Up Period Weeks 0 to 52||56
7594756|NCT02596893|18694557|P2|STARTED|Follow-Up Period Weeks 0 to 52||51
7594757|NCT02596893|18694558|P1|STARTED|Follow-Up Period Weeks 0 to 52||57
7594758|NCT02596893|18694555|P4|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||166
7594759|NCT02596893|18694556|P3|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||162
7594760|NCT02596893|18694557|P2|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||168
7594761|NCT02596893|18694558|P1|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||164
7594762|NCT02596893|18694555|P4|COMPLETED|Overall Double-Blind Period Weeks 0-52||9
7594763|NCT02596893|18694556|P3|COMPLETED|Overall Double-Blind Period Weeks 0-52||14
7594764|NCT02596893|18694557|P2|COMPLETED|Overall Double-Blind Period Weeks 0-52||8
7594765|NCT02596893|18694558|P1|COMPLETED|Overall Double-Blind Period Weeks 0-52||10
7594766|NCT02596893|18694555|P4|STARTED|Overall Double-Blind Period Weeks 0-52||175
7594767|NCT02596893|18694556|P3|STARTED|Overall Double-Blind Period Weeks 0-52||176
7594768|NCT02596893|18694557|P2|STARTED|Overall Double-Blind Period Weeks 0-52||176
7594769|NCT02596893|18694558|P1|STARTED|Overall Double-Blind Period Weeks 0-52||174
7594770|NCT02596867|18694612|P1|NOT COMPLETED|Overall Study||0
7594771|NCT02596867|18694612|P1|COMPLETED|Overall Study||2
7594772|NCT02596867|18694612|P1|2 Patients Prospectively Recruited|Overall Study||2
7594773|NCT02596867|18694612|P1|STARTED|Overall Study||2
7594774|NCT02596854|18694617|P1|NOT COMPLETED|Overall Study||8
7594775|NCT02596854|18694617|P1|COMPLETED|Overall Study||109
7594776|NCT02596854|18694617|P1|STARTED|Overall Study||117
7594777|NCT02596750|18694623|P2|NOT COMPLETED|30 Minutes||0
7594778|NCT02596750|18694624|P1|NOT COMPLETED|30 Minutes||0
7594779|NCT02596750|18694623|P2|COMPLETED|30 Minutes||21
7594780|NCT02596750|18694624|P1|COMPLETED|30 Minutes||21
7594781|NCT02596750|18694623|P2|STARTED|30 Minutes||21
7594782|NCT02596750|18694624|P1|STARTED|30 Minutes||21
7594783|NCT02596750|18694623|P2|NOT COMPLETED|10 Minutes||0
7594784|NCT02596750|18694624|P1|NOT COMPLETED|10 Minutes||0
7594785|NCT02596750|18694623|P2|COMPLETED|10 Minutes||21
7594786|NCT02596750|18694624|P1|COMPLETED|10 Minutes||21
7594787|NCT02596750|18694623|P2|STARTED|10 Minutes||21
7594788|NCT02596750|18694624|P1|STARTED|10 Minutes||21
7594789|NCT02596750|18694623|P2|NOT COMPLETED|5 Minutes||0
7594790|NCT02596750|18694624|P1|NOT COMPLETED|5 Minutes||0
7594791|NCT02596750|18694623|P2|COMPLETED|5 Minutes||21
7594792|NCT02596750|18694624|P1|COMPLETED|5 Minutes||21
7594793|NCT02596750|18694623|P2|STARTED|5 Minutes||21
7594794|NCT02596750|18694624|P1|STARTED|5 Minutes||21
7594795|NCT02596750|18694623|P2|NOT COMPLETED|2 Minutes||0
7594796|NCT02596750|18694624|P1|NOT COMPLETED|2 Minutes||0
7594797|NCT02596750|18694623|P2|COMPLETED|2 Minutes||21
7594798|NCT02596750|18694624|P1|COMPLETED|2 Minutes||21
7594799|NCT02596750|18694623|P2|STARTED|2 Minutes||21
7594800|NCT02596750|18694624|P1|STARTED|2 Minutes||21
7594801|NCT02596750|18694623|P2|NOT COMPLETED|Baseline||0
7594802|NCT02596750|18694624|P1|NOT COMPLETED|Baseline||0
7594803|NCT02596750|18694623|P2|COMPLETED|Baseline||21
7594804|NCT02596750|18694624|P1|COMPLETED|Baseline||21
7594805|NCT02596750|18694623|P2|STARTED|Baseline||21
7594806|NCT02596750|18694624|P1|STARTED|Baseline||21
7594807|NCT02596711|18694639|P3|NOT COMPLETED|Overall Study||3
7594808|NCT02596711|18694640|P2|NOT COMPLETED|Overall Study||2
7594809|NCT02596711|18694641|P1|NOT COMPLETED|Overall Study||1
7594810|NCT02596711|18694639|P3|COMPLETED|Overall Study||5
7594811|NCT02596711|18694640|P2|COMPLETED|Overall Study||6
7594812|NCT02596711|18694641|P1|COMPLETED|Overall Study||8
7594813|NCT02596711|18694639|P3|6 Month Follow-up|Overall Study||5
7594814|NCT02596711|18694640|P2|6 Month Follow-up|Overall Study||6
7594815|NCT02596711|18694641|P1|6 Month Follow-up|Overall Study||8
7594816|NCT02596711|18694639|P3|3 Month Follow-up|Overall Study||6
7594817|NCT02596711|18694640|P2|3 Month Follow-up|Overall Study||6
7594818|NCT02596711|18694641|P1|3 Month Follow-up|Overall Study||8
7594819|NCT02596711|18694639|P3|Visit 3|Overall Study||6
7594820|NCT02596711|18694640|P2|Visit 3|Overall Study||8
7594821|NCT02596711|18694641|P1|Visit 3|Overall Study||7
7594822|NCT02596711|18694639|P3|Visit 2|Overall Study||6
7594823|NCT02596711|18694640|P2|Visit 2|Overall Study||7
7594824|NCT02596711|18694641|P1|Visit 2|Overall Study||9
7594825|NCT02596711|18694639|P3|STARTED|Overall Study||8
7594826|NCT02596711|18694640|P2|STARTED|Overall Study||8
7594827|NCT02596711|18694641|P1|STARTED|Overall Study||9
7594828|NCT02596620|18694657|P2|NOT COMPLETED|Overall Study||1
7594829|NCT02596620|18694658|P1|NOT COMPLETED|Overall Study||1
7594830|NCT02596620|18694657|P2|COMPLETED|Overall Study|Completed on 30th September 2015|81
7594831|NCT02596620|18694658|P1|COMPLETED|Overall Study|Completed on 30th September 2015|81
7594832|NCT02596620|18694657|P2|STARTED|Overall Study|Started from 1st October 2013|82
7594833|NCT02596620|18694658|P1|STARTED|Overall Study|Started from 1st October 2013|82
7594834|NCT02596451|18694667|P3|NOT COMPLETED|Overall Study||14
7594835|NCT02596451|18694668|P2|NOT COMPLETED|Overall Study||18
7594836|NCT02596451|18694669|P1|NOT COMPLETED|Overall Study||4
7594837|NCT02596451|18694667|P3|COMPLETED|Overall Study||373
7594838|NCT02596451|18694668|P2|COMPLETED|Overall Study||374
7594839|NCT02596451|18694669|P1|COMPLETED|Overall Study||381
7594840|NCT02596451|18694667|P3|STARTED|Overall Study||387
7594841|NCT02596451|18694668|P2|STARTED|Overall Study||392
7594842|NCT02596451|18694669|P1|STARTED|Overall Study||385
7594843|NCT02596321|18694678|P2|NOT COMPLETED|Overall Study||0
7594844|NCT02596321|18694679|P1|NOT COMPLETED|Overall Study||3
7594845|NCT02596321|18694678|P2|COMPLETED|Overall Study||56
7594846|NCT02596321|18694679|P1|COMPLETED|Overall Study||53
7594847|NCT02596321|18694678|P2|STARTED|Overall Study||56
7594848|NCT02596321|18694679|P1|STARTED|Overall Study||56
7594849|NCT02596230|18694696|P5|NOT COMPLETED|Objective 2, One Year||78
7594850|NCT02596230|18694697|P4|NOT COMPLETED|Objective 2, One Year||58
7594851|NCT02596230|18694698|P3|NOT COMPLETED|Objective 2, One Year||98
7594852|NCT02596230|18694699|P2|NOT COMPLETED|Objective 2, One Year||68
7594853|NCT02596230|18694700|P1|NOT COMPLETED|Objective 2, One Year||0
7594854|NCT02596230|18694696|P5|COMPLETED|Objective 2, One Year||714
7594855|NCT02596230|18694697|P4|COMPLETED|Objective 2, One Year||471
7594856|NCT02596230|18694698|P3|COMPLETED|Objective 2, One Year||812
7594857|NCT02596230|18694699|P2|COMPLETED|Objective 2, One Year||710
7594858|NCT02596230|18694700|P1|COMPLETED|Objective 2, One Year||0
7594859|NCT02596230|18694696|P5|STARTED|Objective 2, One Year||792
7594860|NCT02596230|18694697|P4|STARTED|Objective 2, One Year||529
7594861|NCT02596230|18694698|P3|STARTED|Objective 2, One Year||910
7594862|NCT02596230|18694699|P2|STARTED|Objective 2, One Year||778
7594863|NCT02596230|18694700|P1|STARTED|Objective 2, One Year||0
7594864|NCT02596230|18694696|P5|NOT COMPLETED|Screening Period for Objective 2||0
7594865|NCT02596230|18694697|P4|NOT COMPLETED|Screening Period for Objective 2||846
7594866|NCT02596230|18694698|P3|NOT COMPLETED|Screening Period for Objective 2||0
7594867|NCT02596230|18694699|P2|NOT COMPLETED|Screening Period for Objective 2||228
7594868|NCT02596230|18694700|P1|NOT COMPLETED|Screening Period for Objective 2||3714
7594869|NCT02596230|18694696|P5|COMPLETED|Screening Period for Objective 2||792
7594870|NCT02596230|18694697|P4|COMPLETED|Screening Period for Objective 2||529
7594871|NCT02596230|18694698|P3|COMPLETED|Screening Period for Objective 2||910
7594872|NCT02596230|18694699|P2|COMPLETED|Screening Period for Objective 2||778
7594873|NCT02596230|18694700|P1|COMPLETED|Screening Period for Objective 2||0
7594874|NCT02596230|18694696|P5|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|792
7594875|NCT02596230|18694697|P4|STARTED|Screening Period for Objective 2||1375
7594876|NCT02596230|18694698|P3|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|910
7594877|NCT02596230|18694699|P2|STARTED|Screening Period for Objective 2||1006
7594878|NCT02596230|18694700|P1|STARTED|Screening Period for Objective 2||3714
7594879|NCT02596230|18694696|P5|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
7594880|NCT02596230|18694697|P4|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
7594881|NCT02596230|18694698|P3|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
7594882|NCT02596230|18694699|P2|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
7594883|NCT02596230|18694700|P1|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
7594884|NCT02596230|18694696|P5|COMPLETED|Objective 1, One Visit During 14 Days||0
7594885|NCT02596230|18694697|P4|COMPLETED|Objective 1, One Visit During 14 Days||1375
7594886|NCT02596230|18694698|P3|COMPLETED|Objective 1, One Visit During 14 Days||0
7594887|NCT02596230|18694699|P2|COMPLETED|Objective 1, One Visit During 14 Days||1006
7594888|NCT02596230|18694700|P1|COMPLETED|Objective 1, One Visit During 14 Days||3714
7594889|NCT02596230|18694696|P5|STARTED|Objective 1, One Visit During 14 Days||0
7594890|NCT02596230|18694697|P4|STARTED|Objective 1, One Visit During 14 Days||1375
7594891|NCT02596230|18694698|P3|STARTED|Objective 1, One Visit During 14 Days||0
7594892|NCT02596230|18694699|P2|STARTED|Objective 1, One Visit During 14 Days||1006
7594893|NCT02596230|18694700|P1|STARTED|Objective 1, One Visit During 14 Days||3714
7594894|NCT02596035|18694724|P3|NOT COMPLETED|Overall Study||1
7594895|NCT02596035|18694725|P2|NOT COMPLETED|Overall Study||44
7594896|NCT02596035|18694726|P1|NOT COMPLETED|Overall Study||86
7594897|NCT02596035|18694724|P3|COMPLETED|Overall Study||0
7594898|NCT02596035|18694725|P2|COMPLETED|Overall Study||0
7594899|NCT02596035|18694726|P1|COMPLETED|Overall Study||11
7594900|NCT02596035|18694724|P3|STARTED|Overall Study||1
7594901|NCT02596035|18694725|P2|STARTED|Overall Study||44
7594902|NCT02596035|18694726|P1|STARTED|Overall Study||97
7594903|NCT02596022|18694755|P2|NOT COMPLETED|Overall Study||0
7594904|NCT02596022|18694756|P1|NOT COMPLETED|Overall Study||0
7594905|NCT02596022|18694755|P2|COMPLETED|Overall Study||8
7594906|NCT02596022|18694756|P1|COMPLETED|Overall Study||10
7594907|NCT02596022|18694755|P2|STARTED|Overall Study||8
7594908|NCT02596022|18694756|P1|STARTED|Overall Study||10
7594909|NCT02596009|18694762|P6|NOT COMPLETED|Overall Study||0
7594910|NCT02596009|18694763|P5|NOT COMPLETED|Overall Study||0
7594911|NCT02596009|18694764|P4|NOT COMPLETED|Overall Study||0
7594912|NCT02596009|18694765|P3|NOT COMPLETED|Overall Study||0
7594913|NCT02596009|18694766|P2|NOT COMPLETED|Overall Study||1
7594914|NCT02596009|18694767|P1|NOT COMPLETED|Overall Study||0
7594915|NCT02596009|18694762|P6|COMPLETED|Overall Study||17
7594916|NCT02596009|18694763|P5|COMPLETED|Overall Study||18
7594917|NCT02596009|18694764|P4|COMPLETED|Overall Study||16
7594918|NCT02596009|18694765|P3|COMPLETED|Overall Study||16
7594919|NCT02596009|18694766|P2|COMPLETED|Overall Study||15
7594920|NCT02596009|18694767|P1|COMPLETED|Overall Study||14
7594921|NCT02596009|18694762|P6|STARTED|Overall Study||17
7594922|NCT02596009|18694763|P5|STARTED|Overall Study||18
7594923|NCT02596009|18694764|P4|STARTED|Overall Study||16
7594924|NCT02596009|18694765|P3|STARTED|Overall Study||16
7594925|NCT02596009|18694766|P2|STARTED|Overall Study||16
7594926|NCT02596009|18694767|P1|STARTED|Overall Study||14
7594927|NCT02595983|18694776|P1|NOT COMPLETED|Overall Study||4
7594928|NCT02595983|18694776|P1|COMPLETED|Overall Study||8
7594929|NCT02595983|18694776|P1|STARTED|Overall Study||12
7594930|NCT02595970|18694784|P1|NOT COMPLETED|Overall Study||20
7594931|NCT02595970|18694784|P1|COMPLETED|Overall Study|Out of 100 patients who completed treatment period 2, 20 patients completed the extension period.|100
7594932|NCT02595970|18694784|P1|STARTED|Overall Study||120
7594933|NCT02595723|18694801|P3|NOT COMPLETED|Third Intervention (4 Days)||0
7594934|NCT02595723|18694802|P2|NOT COMPLETED|Third Intervention (4 Days)||0
7594935|NCT02595723|18694803|P1|NOT COMPLETED|Third Intervention (4 Days)||0
7594936|NCT02595723|18694801|P3|COMPLETED|Third Intervention (4 Days)||7
7594937|NCT02595723|18694802|P2|COMPLETED|Third Intervention (4 Days)||5
7594938|NCT02595723|18694803|P1|COMPLETED|Third Intervention (4 Days)||6
7594939|NCT02595723|18694801|P3|STARTED|Third Intervention (4 Days)||7
7594940|NCT02595723|18694802|P2|STARTED|Third Intervention (4 Days)||5
7594941|NCT02595723|18694803|P1|STARTED|Third Intervention (4 Days)||6
7594942|NCT02595723|18694801|P3|NOT COMPLETED|Second Washout (21 Days)||0
7594943|NCT02595723|18694802|P2|NOT COMPLETED|Second Washout (21 Days)||1
7594944|NCT02595723|18694803|P1|NOT COMPLETED|Second Washout (21 Days)||0
7594945|NCT02595723|18694801|P3|COMPLETED|Second Washout (21 Days)||7
7594946|NCT02595723|18694802|P2|COMPLETED|Second Washout (21 Days)||5
7594947|NCT02595723|18694803|P1|COMPLETED|Second Washout (21 Days)||6
7594948|NCT02595723|18694801|P3|STARTED|Second Washout (21 Days)||7
7594949|NCT02595723|18694802|P2|STARTED|Second Washout (21 Days)||6
7594950|NCT02595723|18694803|P1|STARTED|Second Washout (21 Days)||6
7594951|NCT02595723|18694801|P3|NOT COMPLETED|Second Intervention (4 Days)||0
7594952|NCT02595723|18694802|P2|NOT COMPLETED|Second Intervention (4 Days)||0
7594953|NCT02595723|18694803|P1|NOT COMPLETED|Second Intervention (4 Days)||0
7594954|NCT02595723|18694801|P3|COMPLETED|Second Intervention (4 Days)||7
7594955|NCT02595723|18694802|P2|COMPLETED|Second Intervention (4 Days)||6
7594956|NCT02595723|18694803|P1|COMPLETED|Second Intervention (4 Days)||6
7594957|NCT02595723|18694801|P3|STARTED|Second Intervention (4 Days)||7
7594958|NCT02595723|18694802|P2|STARTED|Second Intervention (4 Days)||6
7594959|NCT02595723|18694803|P1|STARTED|Second Intervention (4 Days)||6
7594960|NCT02595723|18694801|P3|NOT COMPLETED|First Washout (21 Days)||0
7594961|NCT02595723|18694802|P2|NOT COMPLETED|First Washout (21 Days)||0
7594962|NCT02595723|18694803|P1|NOT COMPLETED|First Washout (21 Days)||2
7594963|NCT02595723|18694801|P3|COMPLETED|First Washout (21 Days)||7
7594964|NCT02595723|18694802|P2|COMPLETED|First Washout (21 Days)||6
7594965|NCT02595723|18694803|P1|COMPLETED|First Washout (21 Days)||6
7594966|NCT02595723|18694801|P3|STARTED|First Washout (21 Days)||7
7594967|NCT02595723|18694802|P2|STARTED|First Washout (21 Days)||6
7594968|NCT02595723|18694803|P1|STARTED|First Washout (21 Days)||8
7594969|NCT02595723|18694801|P3|NOT COMPLETED|First Intervention (4 Days)||0
7594970|NCT02595723|18694802|P2|NOT COMPLETED|First Intervention (4 Days)||0
7594971|NCT02595723|18694803|P1|NOT COMPLETED|First Intervention (4 Days)||0
7594972|NCT02595723|18694801|P3|COMPLETED|First Intervention (4 Days)||7
7594973|NCT02595723|18694802|P2|COMPLETED|First Intervention (4 Days)||6
7594974|NCT02595723|18694803|P1|COMPLETED|First Intervention (4 Days)||8
7594975|NCT02595723|18694801|P3|STARTED|First Intervention (4 Days)||7
7594976|NCT02595723|18694802|P2|STARTED|First Intervention (4 Days)||6
7594977|NCT02595723|18694803|P1|STARTED|First Intervention (4 Days)||8
7594978|NCT02595684|18694813|P2|NOT COMPLETED|Overall Study||0
7594979|NCT02595684|18694814|P1|NOT COMPLETED|Overall Study||0
7594980|NCT02595684|18694813|P2|COMPLETED|Overall Study||9
7594981|NCT02595684|18694814|P1|COMPLETED|Overall Study||9
7594982|NCT02595684|18694813|P2|STARTED|Overall Study||9
7594983|NCT02595684|18694814|P1|STARTED|Overall Study||9
7594984|NCT02595567|18694852|P1|NOT COMPLETED|Overall Study||0
7594985|NCT02595567|18694852|P1|COMPLETED|Overall Study||25
7594986|NCT02595567|18694852|P1|STARTED|Overall Study||25
7594987|NCT02595528|18694860|P4|NOT COMPLETED|Overall Study||4
7594988|NCT02595528|18694861|P3|NOT COMPLETED|Overall Study||1
7594989|NCT02595528|18694862|P2|NOT COMPLETED|Overall Study||3
7594990|NCT02595528|18694863|P1|NOT COMPLETED|Overall Study||2
7594991|NCT02595528|18694860|P4|COMPLETED|Overall Study||36
7594992|NCT02595528|18694861|P3|COMPLETED|Overall Study||41
7594993|NCT02595528|18694862|P2|COMPLETED|Overall Study||37
7594994|NCT02595528|18694863|P1|COMPLETED|Overall Study||39
7594995|NCT02595528|18694860|P4|STARTED|Overall Study||40
7594996|NCT02595528|18694861|P3|STARTED|Overall Study||42
7594997|NCT02595528|18694862|P2|STARTED|Overall Study||40
7594998|NCT02595528|18694863|P1|STARTED|Overall Study||41
7594999|NCT02595502|18694873|P2|NOT COMPLETED|Period 3||2
7595000|NCT02595502|18694874|P1|NOT COMPLETED|Period 3||1
7595001|NCT02595502|18694873|P2|COMPLETED|Period 3||136
7595002|NCT02595502|18694874|P1|COMPLETED|Period 3||140
7595003|NCT02595502|18694873|P2|STARTED|Period 3||138
7595004|NCT02595502|18694874|P1|STARTED|Period 3||141
7595005|NCT02595502|18694873|P2|NOT COMPLETED|Period 2||2
7595006|NCT02595502|18694874|P1|NOT COMPLETED|Period 2||1
7595007|NCT02595502|18694873|P2|COMPLETED|Period 2||138
7595008|NCT02595502|18694874|P1|COMPLETED|Period 2||141
7595009|NCT02595502|18694873|P2|STARTED|Period 2||140
7595010|NCT02595502|18694874|P1|STARTED|Period 2||142
7595011|NCT02595502|18694873|P2|NOT COMPLETED|Period 1||2
7595012|NCT02595502|18694874|P1|NOT COMPLETED|Period 1||1
7595013|NCT02595502|18694873|P2|COMPLETED|Period 1||140
7595014|NCT02595502|18694874|P1|COMPLETED|Period 1||142
7595015|NCT02595502|18694873|P2|STARTED|Period 1||142
7595016|NCT02595502|18694874|P1|STARTED|Period 1||143
7595017|NCT02595450|18694880|P1|NOT COMPLETED|Overall Study||81
7595018|NCT02595450|18694880|P1|COMPLETED|Overall Study||218
7595019|NCT02595450|18694880|P1|Treated|Overall Study||291
7595020|NCT02595450|18694880|P1|STARTED|Overall Study||299
7595021|NCT02595437|18694886|P1|NOT COMPLETED|Triferic Via Hemodialysate||0
7595022|NCT02595437|18694886|P1|COMPLETED|Triferic Via Hemodialysate||21
7595023|NCT02595437|18694886|P1|STARTED|Triferic Via Hemodialysate||21
7595024|NCT02595437|18694886|P1|NOT COMPLETED|Triferic Via IV||1
7595025|NCT02595437|18694886|P1|COMPLETED|Triferic Via IV||21
7595026|NCT02595437|18694886|P1|STARTED|Triferic Via IV||22
7595027|NCT02595372|18694904|P1|NOT COMPLETED|Overall Study||9
7595028|NCT02595372|18694904|P1|COMPLETED|Overall Study||33
7595029|NCT02595372|18694904|P1|STARTED|Overall Study||42
7595030|NCT02595073|18694915|P2|NOT COMPLETED|Overall Study||1
7595031|NCT02595073|18694916|P1|NOT COMPLETED|Overall Study||2
7595032|NCT02595073|18694915|P2|COMPLETED|Overall Study||62
7595033|NCT02595073|18694916|P1|COMPLETED|Overall Study||59
7595034|NCT02595073|18694915|P2|STARTED|Overall Study||63
7595035|NCT02595073|18694916|P1|STARTED|Overall Study||61
7595036|NCT02595008|18694926|P2|NOT COMPLETED|Overall Study||0
7595037|NCT02595008|18694927|P1|NOT COMPLETED|Overall Study||1
7595038|NCT02595008|18694926|P2|COMPLETED|Overall Study||4
7595039|NCT02595008|18694927|P1|COMPLETED|Overall Study||19
7595040|NCT02595008|18694926|P2|STARTED|Overall Study||4
7595041|NCT02595008|18694927|P1|STARTED|Overall Study||20
7595042|NCT02594826|18694935|P2|NOT COMPLETED|Overall Study||60
7595043|NCT02594826|18694936|P1|NOT COMPLETED|Overall Study||57
7595044|NCT02594826|18694935|P2|COMPLETED|Overall Study||298
7595045|NCT02594826|18694936|P1|COMPLETED|Overall Study||290
7595046|NCT02594826|18694935|P2|STARTED|Overall Study||358
7595047|NCT02594826|18694936|P1|STARTED|Overall Study||347
7595048|NCT02594644|18694946|P2|NOT COMPLETED|Overall Study||1
7595049|NCT02594644|18694947|P1|NOT COMPLETED|Overall Study||0
7595050|NCT02594644|18694946|P2|COMPLETED|Overall Study||15
7595051|NCT02594644|18694947|P1|COMPLETED|Overall Study||16
7595052|NCT02594644|18694946|P2|STARTED|Overall Study||16
7595053|NCT02594644|18694947|P1|STARTED|Overall Study||16
7595054|NCT02594163|18694965|P2|NOT COMPLETED|Follow-up Period||12
7595055|NCT02594163|18694966|P1|NOT COMPLETED|Follow-up Period||11
7595056|NCT02594163|18694965|P2|COMPLETED|Follow-up Period||1
7595057|NCT02594163|18694966|P1|COMPLETED|Follow-up Period||1
7595058|NCT02594163|18694965|P2|STARTED|Follow-up Period|All participants were to be followed after treatment|13
7595059|NCT02594163|18694966|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|12
7595060|NCT02594163|18694965|P2|NOT COMPLETED|Treatment Period||12
7595061|NCT02594163|18694966|P1|NOT COMPLETED|Treatment Period||7
7595062|NCT02594163|18694965|P2|COMPLETED|Treatment Period||1
7595063|NCT02594163|18694966|P1|COMPLETED|Treatment Period||5
7595064|NCT02594163|18694965|P2|STARTED|Treatment Period||13
7595065|NCT02594163|18694966|P1|STARTED|Treatment Period||12
7595066|NCT02594111|18694984|P2|NOT COMPLETED|Overall Study||0
7595067|NCT02594111|18694985|P1|NOT COMPLETED|Overall Study||0
7595068|NCT02594111|18694984|P2|COMPLETED|Overall Study||348
7595069|NCT02594111|18694985|P1|COMPLETED|Overall Study||366
7595070|NCT02594111|18694984|P2|STARTED|Overall Study||348
7595071|NCT02594111|18694985|P1|STARTED|Overall Study||366
7595072|NCT02594098|18694997|P2|NOT COMPLETED|Overall Study||13
7595073|NCT02594098|18694998|P1|NOT COMPLETED|Overall Study||26
7595074|NCT02594098|18694997|P2|COMPLETED|Overall Study||1
7595075|NCT02594098|18694998|P1|COMPLETED|Overall Study||1
7595076|NCT02594098|18694997|P2|STARTED|Overall Study||14
7595077|NCT02594098|18694998|P1|STARTED|Overall Study||27
7595078|NCT02593903|18695060|P2|NOT COMPLETED|Overall Study||1
7595079|NCT02593903|18695061|P1|NOT COMPLETED|Overall Study||0
7595080|NCT02593903|18695060|P2|COMPLETED|Overall Study||31
7595081|NCT02593903|18695061|P1|COMPLETED|Overall Study||35
7595082|NCT02593903|18695060|P2|STARTED|Overall Study||32
7595083|NCT02593903|18695061|P1|STARTED|Overall Study||35
7595084|NCT02593864|18695067|P1|NOT COMPLETED|Overall Study||6
7595085|NCT02593864|18695067|P1|COMPLETED|Overall Study||19
7595086|NCT02593864|18695067|P1|STARTED|Overall Study||25
7595087|NCT02593825|18695074|P2|NOT COMPLETED|Follow-up||0
7595088|NCT02593825|18695075|P1|NOT COMPLETED|Follow-up||0
7595089|NCT02593825|18695074|P2|COMPLETED|Follow-up||55
7595090|NCT02593825|18695075|P1|COMPLETED|Follow-up||57
7595091|NCT02593825|18695074|P2|STARTED|Follow-up||55
7595092|NCT02593825|18695075|P1|STARTED|Follow-up||57
7595093|NCT02593825|18695074|P2|NOT COMPLETED|Intervention||12
7595094|NCT02593825|18695075|P1|NOT COMPLETED|Intervention||10
7595095|NCT02593825|18695074|P2|COMPLETED|Intervention||55
7595096|NCT02593825|18695075|P1|COMPLETED|Intervention||57
7595097|NCT02593825|18695074|P2|STARTED|Intervention||67
7595098|NCT02593825|18695075|P1|STARTED|Intervention||67
7595099|NCT02593773|18695087|P1|NOT COMPLETED|Overall Study||35
7595100|NCT02593773|18695087|P1|COMPLETED|Overall Study||51
7595101|NCT02593773|18695087|P1|STARTED|Overall Study||86
7595102|NCT02593630|18695097|P1|NOT COMPLETED|Overall Study||1
7595103|NCT02593630|18695097|P1|COMPLETED|Overall Study||53
7595104|NCT02593630|18695097|P1|STARTED|Overall Study||54
7595105|NCT02593396|18695105|P2|NOT COMPLETED|Overall Study||14
7595106|NCT02593396|18695106|P1|NOT COMPLETED|Overall Study||15
7595107|NCT02593396|18695105|P2|COMPLETED|Overall Study||26
7595108|NCT02593396|18695106|P1|COMPLETED|Overall Study||25
7595109|NCT02593396|18695105|P2|At Least Done One Efficacy Assessment|Overall Study||36
7595110|NCT02593396|18695106|P1|At Least Done One Efficacy Assessment|Overall Study||36
7595111|NCT02593396|18695105|P2|STARTED|Overall Study||40
7595112|NCT02593396|18695106|P1|STARTED|Overall Study||40
7595113|NCT02593305|18695119|P3|NOT COMPLETED|Post 2||0
7595114|NCT02593305|18695120|P2|NOT COMPLETED|Post 2||0
7595115|NCT02593305|18695121|P1|NOT COMPLETED|Post 2||0
7595116|NCT02593305|18695119|P3|COMPLETED|Post 2||0
7595117|NCT02593305|18695120|P2|COMPLETED|Post 2||6
7595118|NCT02593305|18695121|P1|COMPLETED|Post 2||7
7595119|NCT02593305|18695119|P3|STARTED|Post 2||0
7595120|NCT02593305|18695120|P2|STARTED|Post 2||6
7595121|NCT02593305|18695121|P1|STARTED|Post 2||7
7595122|NCT02593305|18695119|P3|NOT COMPLETED|Baseline 2||0
7595123|NCT02593305|18695120|P2|NOT COMPLETED|Baseline 2||0
7595124|NCT02593305|18695121|P1|NOT COMPLETED|Baseline 2||0
7595125|NCT02593305|18695119|P3|COMPLETED|Baseline 2||0
7595126|NCT02593305|18695120|P2|COMPLETED|Baseline 2||6
7595127|NCT02593305|18695121|P1|COMPLETED|Baseline 2||7
7595128|NCT02593305|18695119|P3|STARTED|Baseline 2||0
7595129|NCT02593305|18695120|P2|STARTED|Baseline 2||6
7595130|NCT02593305|18695121|P1|STARTED|Baseline 2||7
7595131|NCT02593305|18695119|P3|NOT COMPLETED|Post 1||10
7595132|NCT02593305|18695120|P2|NOT COMPLETED|Post 1||0
7595133|NCT02593305|18695121|P1|NOT COMPLETED|Post 1||0
7595134|NCT02593305|18695119|P3|COMPLETED|Post 1||0
7595135|NCT02593305|18695120|P2|COMPLETED|Post 1||6
7595136|NCT02593305|18695121|P1|COMPLETED|Post 1||7
7595137|NCT02593305|18695119|P3|STARTED|Post 1||10
7595138|NCT02593305|18695120|P2|STARTED|Post 1||6
7595139|NCT02593305|18695121|P1|STARTED|Post 1||7
7595140|NCT02593305|18695119|P3|NOT COMPLETED|Baseline 1||0
7595141|NCT02593305|18695120|P2|NOT COMPLETED|Baseline 1||0
7595142|NCT02593305|18695121|P1|NOT COMPLETED|Baseline 1||0
7595143|NCT02593305|18695119|P3|COMPLETED|Baseline 1||10
7595144|NCT02593305|18695120|P2|COMPLETED|Baseline 1||6
7595145|NCT02593305|18695121|P1|COMPLETED|Baseline 1||7
7595146|NCT02593305|18695119|P3|STARTED|Baseline 1||10
7595147|NCT02593305|18695120|P2|STARTED|Baseline 1||6
7595148|NCT02593305|18695121|P1|STARTED|Baseline 1||7
7595149|NCT02593149|18695136|P2|NOT COMPLETED|Intervention||115
7595150|NCT02593149|18695137|P1|NOT COMPLETED|Intervention||116
7595151|NCT02593149|18695136|P2|COMPLETED|Intervention||845
7595152|NCT02593149|18695137|P1|COMPLETED|Intervention||826
7595153|NCT02593149|18695136|P2|STARTED|Intervention||960
7595154|NCT02593149|18695137|P1|STARTED|Intervention||942
7595155|NCT02593149|18695136|P2|NOT COMPLETED|Run-In||38
7595156|NCT02593149|18695137|P1|NOT COMPLETED|Run-In||36
7595157|NCT02593149|18695136|P2|COMPLETED|Run-In||323
7595158|NCT02593149|18695137|P1|COMPLETED|Run-In||304
7595159|NCT02593149|18695136|P2|STARTED|Run-In||361
7595160|NCT02593149|18695137|P1|STARTED|Run-In||340
7595161|NCT02593097|18695145|P2|NOT COMPLETED|Second Intervention (12 Weeks)||1
7595162|NCT02593097|18695146|P1|NOT COMPLETED|Second Intervention (12 Weeks)||3
7595163|NCT02593097|18695145|P2|COMPLETED|Second Intervention (12 Weeks)||15
7595164|NCT02593097|18695146|P1|COMPLETED|Second Intervention (12 Weeks)||9
7595165|NCT02593097|18695145|P2|STARTED|Second Intervention (12 Weeks)||16
7595166|NCT02593097|18695146|P1|STARTED|Second Intervention (12 Weeks)||12
7595167|NCT02593097|18695145|P2|NOT COMPLETED|Washout (4 Weeks)||0
7595168|NCT02593097|18695146|P1|NOT COMPLETED|Washout (4 Weeks)||0
7595169|NCT02593097|18695145|P2|COMPLETED|Washout (4 Weeks)||16
7595170|NCT02593097|18695146|P1|COMPLETED|Washout (4 Weeks)||12
7595171|NCT02593097|18695145|P2|STARTED|Washout (4 Weeks)||16
7595172|NCT02593097|18695146|P1|STARTED|Washout (4 Weeks)||12
7595173|NCT02593097|18695145|P2|NOT COMPLETED|First Intervention (12 Weeks)||4
7595174|NCT02593097|18695146|P1|NOT COMPLETED|First Intervention (12 Weeks)||2
7595175|NCT02593097|18695145|P2|COMPLETED|First Intervention (12 Weeks)||16
7595176|NCT02593097|18695146|P1|COMPLETED|First Intervention (12 Weeks)||12
7595177|NCT02593097|18695145|P2|Received Intervention|First Intervention (12 Weeks)||20
7595178|NCT02593097|18695146|P1|Received Intervention|First Intervention (12 Weeks)||14
7595179|NCT02593097|18695145|P2|STARTED|First Intervention (12 Weeks)||20
7595180|NCT02593097|18695146|P1|STARTED|First Intervention (12 Weeks)||14
7595181|NCT02593032|18695158|P2|NOT COMPLETED|Overall Study||0
7595182|NCT02593032|18695159|P1|NOT COMPLETED|Overall Study||0
7595183|NCT02593032|18695158|P2|COMPLETED|Overall Study||33
7595184|NCT02593032|18695159|P1|COMPLETED|Overall Study||17
7595185|NCT02593032|18695158|P2|STARTED|Overall Study||33
7595186|NCT02593032|18695159|P1|STARTED|Overall Study||17
7595187|NCT02592876|18695167|P2|NOT COMPLETED|Overall Study||40
7595188|NCT02592876|18695168|P1|NOT COMPLETED|Overall Study||41
7595189|NCT02592876|18695167|P2|COMPLETED|Overall Study||0
7595190|NCT02592876|18695168|P1|COMPLETED|Overall Study||0
7595191|NCT02592876|18695167|P2|Completed Treatment|Overall Study||32
7595192|NCT02592876|18695168|P1|Completed Treatment|Overall Study||34
7595193|NCT02592876|18695167|P2|Received Study Drug|Overall Study||40
7595194|NCT02592876|18695168|P1|Received Study Drug|Overall Study||40
7595195|NCT02592876|18695167|P2|STARTED|Overall Study||40
7595196|NCT02592876|18695168|P1|STARTED|Overall Study||41
7595197|NCT02592655|18695194|P1|NOT COMPLETED|Fourth Tourniquet Right Thigh.||0
7595198|NCT02592655|18695194|P1|COMPLETED|Fourth Tourniquet Right Thigh.||4
7595199|NCT02592655|18695194|P1|Tourniquet Tape 5 cm Width|Fourth Tourniquet Right Thigh.||0
7595200|NCT02592655|18695194|P1|Tourniquet Tape 10 cm Width|Fourth Tourniquet Right Thigh.||3
7595201|NCT02592655|18695194|P1|Windlass Tourniquet|Fourth Tourniquet Right Thigh.||0
7595202|NCT02592655|18695194|P1|ATS (Pneumatic)|Fourth Tourniquet Right Thigh.||1
7595203|NCT02592655|18695194|P1|STARTED|Fourth Tourniquet Right Thigh.|Only the first 4 participants received all four interventions.|4
7595204|NCT02592655|18695194|P1|NOT COMPLETED|Third Tourniquet, Left Thigh.||0
7595205|NCT02592655|18695194|P1|COMPLETED|Third Tourniquet, Left Thigh.||19
7595206|NCT02592655|18695194|P1|Tourniquet Tape 5 cm Width|Third Tourniquet, Left Thigh.||1
7595207|NCT02592655|18695194|P1|Tourniquet Tape 10 cm Width|Third Tourniquet, Left Thigh.||6
7595208|NCT02592655|18695194|P1|Windlass Tourniquet|Third Tourniquet, Left Thigh.||4
7595209|NCT02592655|18695194|P1|ATS (Pneumatic)|Third Tourniquet, Left Thigh.||8
7595210|NCT02592655|18695194|P1|STARTED|Third Tourniquet, Left Thigh.||19
7595211|NCT02592655|18695194|P1|NOT COMPLETED|Second Tourniquet Right Thigh.||0
7595212|NCT02592655|18695194|P1|COMPLETED|Second Tourniquet Right Thigh.||19
7595213|NCT02592655|18695194|P1|Tourniquet Tape 5 cm Width|Second Tourniquet Right Thigh.||1
7595214|NCT02592655|18695194|P1|Tourniquet Tape 10 cm Width|Second Tourniquet Right Thigh.||5
7595215|NCT02592655|18695194|P1|Windlass Tourniquet|Second Tourniquet Right Thigh.||8
7595216|NCT02592655|18695194|P1|ATS (Pneumatic)|Second Tourniquet Right Thigh.||5
7595217|NCT02592655|18695194|P1|STARTED|Second Tourniquet Right Thigh.||19
7595218|NCT02592655|18695194|P1|NOT COMPLETED|First Tourniquet, Left Thigh.||0
7595219|NCT02592655|18695194|P1|COMPLETED|First Tourniquet, Left Thigh.||19
7595220|NCT02592655|18695194|P1|Tourniquet Tape 5 cm Width|First Tourniquet, Left Thigh.||2
7595221|NCT02592655|18695194|P1|Tourniquet Tape 10 cm Width|First Tourniquet, Left Thigh.||5
7595222|NCT02592655|18695194|P1|Windlass Tourniquet|First Tourniquet, Left Thigh.||7
7595223|NCT02592655|18695194|P1|ATS (Pneumatic)|First Tourniquet, Left Thigh.||5
7595224|NCT02592655|18695194|P1|STARTED|First Tourniquet, Left Thigh.||19
7595225|NCT02592629|18695212|P3|NOT COMPLETED|Overall Study||0
7595226|NCT02592629|18695213|P2|NOT COMPLETED|Overall Study||0
7595227|NCT02592629|18695214|P1|NOT COMPLETED|Overall Study||0
7595228|NCT02592629|18695212|P3|COMPLETED|Overall Study||5
7595229|NCT02592629|18695213|P2|COMPLETED|Overall Study||9
7595230|NCT02592629|18695214|P1|COMPLETED|Overall Study||5
7595231|NCT02592629|18695212|P3|STARTED|Overall Study||5
7595232|NCT02592629|18695213|P2|STARTED|Overall Study||9
7595233|NCT02592629|18695214|P1|STARTED|Overall Study||5
7595234|NCT02592486|18695224|P2|NOT COMPLETED|Overall Study||5
7595235|NCT02592486|18695225|P1|NOT COMPLETED|Overall Study||0
7595236|NCT02592486|18695224|P2|COMPLETED|Overall Study||76
7595237|NCT02592486|18695225|P1|COMPLETED|Overall Study||81
7595238|NCT02592486|18695224|P2|STARTED|Overall Study||81
7595239|NCT02592486|18695225|P1|STARTED|Overall Study||81
7595240|NCT02592447|18695239|P2|NOT COMPLETED|Overall Study||1
7595241|NCT02592447|18695240|P1|NOT COMPLETED|Overall Study||2
7595242|NCT02592447|18695239|P2|COMPLETED|Overall Study||14
7595243|NCT02592447|18695240|P1|COMPLETED|Overall Study||27
7595244|NCT02592447|18695239|P2|STARTED|Overall Study||15
7595245|NCT02592447|18695240|P1|STARTED|Overall Study||29
7595246|NCT02592434|18695248|P3|NOT COMPLETED|Double Blind Phase (26 Weeks)||47
7595247|NCT02592434|18695249|P2|NOT COMPLETED|Double Blind Phase (26 Weeks)||27
7595248|NCT02592434|18695250|P1|NOT COMPLETED|Double Blind Phase (26 Weeks)||0
7595249|NCT02592434|18695248|P3|COMPLETED|Double Blind Phase (26 Weeks)||38
7595250|NCT02592434|18695249|P2|COMPLETED|Double Blind Phase (26 Weeks)||61
7595251|NCT02592434|18695250|P1|COMPLETED|Double Blind Phase (26 Weeks)||0
7595252|NCT02592434|18695248|P3|Treated|Double Blind Phase (26 Weeks)||85
7595253|NCT02592434|18695249|P2|Treated|Double Blind Phase (26 Weeks)||88
7595254|NCT02592434|18695250|P1|Treated|Double Blind Phase (26 Weeks)||0
7595255|NCT02592434|18695248|P3|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase,achieved at least a JIA ACR 30 response in OL phase.|85
7595256|NCT02592434|18695249|P2|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase, achieved at least a JIA ACR 30 response in OL phase.|88
7595257|NCT02592434|18695250|P1|STARTED|Double Blind Phase (26 Weeks)||0
7595258|NCT02592434|18695248|P3|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
7595259|NCT02592434|18695249|P2|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
7595260|NCT02592434|18695250|P1|NOT COMPLETED|Open-Label Phase (18 Weeks)||40
7595261|NCT02592434|18695248|P3|COMPLETED|Open-Label Phase (18 Weeks)||0
7595262|NCT02592434|18695249|P2|COMPLETED|Open-Label Phase (18 Weeks)||0
7595263|NCT02592434|18695250|P1|COMPLETED|Open-Label Phase (18 Weeks)||185
7595264|NCT02592434|18695248|P3|Treated|Open-Label Phase (18 Weeks)||0
7595265|NCT02592434|18695249|P2|Treated|Open-Label Phase (18 Weeks)||0
7595266|NCT02592434|18695250|P1|Treated|Open-Label Phase (18 Weeks)||225
7595267|NCT02592434|18695248|P3|STARTED|Open-Label Phase (18 Weeks)||0
7595268|NCT02592434|18695249|P2|STARTED|Open-Label Phase (18 Weeks)||0
7595269|NCT02592434|18695250|P1|STARTED|Open-Label Phase (18 Weeks)||225
7595270|NCT02592421|18695368|P2|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
7595271|NCT02592421|18695369|P1|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
7595272|NCT02592421|18695368|P2|COMPLETED|Study 3: Pancreatic Clamp Conditions||10
7595273|NCT02592421|18695369|P1|COMPLETED|Study 3: Pancreatic Clamp Conditions||20
7595274|NCT02592421|18695368|P2|STARTED|Study 3: Pancreatic Clamp Conditions||10
7595275|NCT02592421|18695369|P1|STARTED|Study 3: Pancreatic Clamp Conditions||20
7595276|NCT02592421|18695368|P2|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
7595277|NCT02592421|18695369|P1|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
7595278|NCT02592421|18695368|P2|COMPLETED|Study 2: Glucose Clamp Conditions||10
7595279|NCT02592421|18695369|P1|COMPLETED|Study 2: Glucose Clamp Conditions||20
7595280|NCT02592421|18695368|P2|STARTED|Study 2: Glucose Clamp Conditions||10
7595281|NCT02592421|18695369|P1|STARTED|Study 2: Glucose Clamp Conditions||20
7595282|NCT02592421|18695368|P2|NOT COMPLETED|Study 1||0
7595283|NCT02592421|18695369|P1|NOT COMPLETED|Study 1||0
7595284|NCT02592421|18695368|P2|COMPLETED|Study 1||10
7595285|NCT02592421|18695369|P1|COMPLETED|Study 1||20
7595286|NCT02592421|18695368|P2|STARTED|Study 1||10
7595287|NCT02592421|18695369|P1|STARTED|Study 1||20
7595288|NCT02592018|18695381|P1|NOT COMPLETED|Overall Study||2
7595289|NCT02592018|18695381|P1|COMPLETED|Overall Study||13
7595290|NCT02592018|18695381|P1|STARTED|Overall Study||15
7595291|NCT02591537|18695398|P2|NOT COMPLETED|Overall Study||0
7595292|NCT02591537|18695399|P1|NOT COMPLETED|Overall Study||0
7595293|NCT02591537|18695398|P2|COMPLETED|Overall Study||8
7595294|NCT02591537|18695399|P1|COMPLETED|Overall Study||8
7595295|NCT02591537|18695398|P2|STARTED|Overall Study||8
7595296|NCT02591537|18695399|P1|STARTED|Overall Study||8
7595297|NCT02591511|18695421|P2|NOT COMPLETED|Overall Study||0
7595298|NCT02591511|18695422|P1|NOT COMPLETED|Overall Study||0
7595299|NCT02591511|18695421|P2|COMPLETED|Overall Study||33
7595300|NCT02591511|18695422|P1|COMPLETED|Overall Study||30
7595301|NCT02591511|18695421|P2|STARTED|Overall Study||33
7595302|NCT02591511|18695422|P1|STARTED|Overall Study||30
7595303|NCT02591290|18695428|P1|NOT COMPLETED|Overall Study||2
7595304|NCT02591290|18695428|P1|COMPLETED|Overall Study||58
7595305|NCT02591290|18695428|P1|Vaccinated Dose 2|Overall Study||58
7595306|NCT02591290|18695428|P1|Vaccinated Dose 1|Overall Study||60
7595307|NCT02591290|18695428|P1|STARTED|Overall Study||60
7595308|NCT02591238|18695438|P4|NOT COMPLETED|Overall Study||3
7595309|NCT02591238|18695439|P3|NOT COMPLETED|Overall Study||0
7595310|NCT02591238|18695440|P2|NOT COMPLETED|Overall Study||1
7595311|NCT02591238|18695441|P1|NOT COMPLETED|Overall Study||1
7595312|NCT02591238|18695438|P4|COMPLETED|Overall Study||15
7595313|NCT02591238|18695439|P3|COMPLETED|Overall Study||17
7595314|NCT02591238|18695440|P2|COMPLETED|Overall Study||16
7595315|NCT02591238|18695441|P1|COMPLETED|Overall Study||15
7595316|NCT02591238|18695438|P4|STARTED|Overall Study||18
7595317|NCT02591238|18695439|P3|STARTED|Overall Study||17
7595318|NCT02591238|18695440|P2|STARTED|Overall Study||17
7595319|NCT02591238|18695441|P1|STARTED|Overall Study||16
7595320|NCT02591056|18695471|P1|NOT COMPLETED|Overall Study||0
7595321|NCT02591056|18695471|P1|COMPLETED|Overall Study||27
7595322|NCT02591056|18695471|P1|STARTED|Overall Study||27
7595323|NCT02590939|18695477|P2|NOT COMPLETED|Overall Study||2
7595324|NCT02590939|18695478|P1|NOT COMPLETED|Overall Study||5
7595325|NCT02590939|18695477|P2|COMPLETED|Overall Study||52
7595326|NCT02590939|18695478|P1|COMPLETED|Overall Study||47
7595327|NCT02590939|18695477|P2|STARTED|Overall Study||54
7595328|NCT02590939|18695478|P1|STARTED|Overall Study||52
7595329|NCT02590588|18695498|P1|NOT COMPLETED|Overall Study||1
7595330|NCT02590588|18695498|P1|COMPLETED|Overall Study||0
7595331|NCT02590588|18695498|P1|STARTED|Overall Study||1
7595332|NCT02590562|18695506|P1|NOT COMPLETED|Overall Study||6
7595333|NCT02590562|18695506|P1|COMPLETED|Overall Study||802
7595334|NCT02590562|18695506|P1|STARTED|Overall Study||808
7595335|NCT02590432|18695565|P9|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
7595336|NCT02590432|18695566|P8|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
7595337|NCT02590432|18695567|P7|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
7595338|NCT02590432|18695568|P6|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
7595339|NCT02590432|18695569|P5|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
7595340|NCT02590432|18695570|P4|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
7595341|NCT02590432|18695571|P3|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
7595342|NCT02590432|18695572|P2|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
7595343|NCT02590432|18695573|P1|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
7595344|NCT02590432|18695565|P9|COMPLETED|Dose-reduced Open Label Treatment Period||8
7595345|NCT02590432|18695566|P8|COMPLETED|Dose-reduced Open Label Treatment Period||13
7595346|NCT02590432|18695567|P7|COMPLETED|Dose-reduced Open Label Treatment Period||0
7595347|NCT02590432|18695568|P6|COMPLETED|Dose-reduced Open Label Treatment Period||0
7595348|NCT02590432|18695569|P5|COMPLETED|Dose-reduced Open Label Treatment Period||0
7595349|NCT02590432|18695570|P4|COMPLETED|Dose-reduced Open Label Treatment Period||0
7595350|NCT02590432|18695571|P3|COMPLETED|Dose-reduced Open Label Treatment Period||0
7595351|NCT02590432|18695572|P2|COMPLETED|Dose-reduced Open Label Treatment Period||0
7595352|NCT02590432|18695573|P1|COMPLETED|Dose-reduced Open Label Treatment Period||0
7595353|NCT02590432|18695565|P9|STARTED|Dose-reduced Open Label Treatment Period||26
7595354|NCT02590432|18695566|P8|STARTED|Dose-reduced Open Label Treatment Period||31
7595355|NCT02590432|18695567|P7|STARTED|Dose-reduced Open Label Treatment Period||0
7595356|NCT02590432|18695568|P6|STARTED|Dose-reduced Open Label Treatment Period||0
7595357|NCT02590432|18695569|P5|STARTED|Dose-reduced Open Label Treatment Period||0
7595358|NCT02590432|18695570|P4|STARTED|Dose-reduced Open Label Treatment Period||0
7595359|NCT02590432|18695571|P3|STARTED|Dose-reduced Open Label Treatment Period||0
7595360|NCT02590432|18695572|P2|STARTED|Dose-reduced Open Label Treatment Period||0
7595361|NCT02590432|18695573|P1|STARTED|Dose-reduced Open Label Treatment Period||0
7595362|NCT02590432|18695565|P9|NOT COMPLETED|Double-blind Treatment Period||0
7595363|NCT02590432|18695566|P8|NOT COMPLETED|Double-blind Treatment Period||0
7595364|NCT02590432|18695567|P7|NOT COMPLETED|Double-blind Treatment Period||21
7595365|NCT02590432|18695568|P6|NOT COMPLETED|Double-blind Treatment Period||26
7595366|NCT02590432|18695569|P5|NOT COMPLETED|Double-blind Treatment Period||9
7595367|NCT02590432|18695570|P4|NOT COMPLETED|Double-blind Treatment Period||15
7595368|NCT02590432|18695571|P3|NOT COMPLETED|Double-blind Treatment Period||17
7595369|NCT02590432|18695572|P2|NOT COMPLETED|Double-blind Treatment Period||0
7595370|NCT02590432|18695573|P1|NOT COMPLETED|Double-blind Treatment Period||0
7595371|NCT02590432|18695565|P9|COMPLETED|Double-blind Treatment Period||0
7595372|NCT02590432|18695566|P8|COMPLETED|Double-blind Treatment Period||0
7595373|NCT02590432|18695567|P7|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|9
7595374|NCT02590432|18695568|P6|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|6
7595375|NCT02590432|18695569|P5|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|7
7595376|NCT02590432|18695570|P4|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|3
7595377|NCT02590432|18695571|P3|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|1
7595378|NCT02590432|18695572|P2|COMPLETED|Double-blind Treatment Period||0
7595379|NCT02590432|18695573|P1|COMPLETED|Double-blind Treatment Period||0
7595380|NCT02590432|18695565|P9|STARTED|Double-blind Treatment Period||0
7595381|NCT02590432|18695566|P8|STARTED|Double-blind Treatment Period||0
7595382|NCT02590432|18695567|P7|STARTED|Double-blind Treatment Period||30
7595383|NCT02590432|18695568|P6|STARTED|Double-blind Treatment Period||32
7595384|NCT02590432|18695569|P5|STARTED|Double-blind Treatment Period||16
7595385|NCT02590432|18695570|P4|STARTED|Double-blind Treatment Period||18
7595386|NCT02590432|18695571|P3|STARTED|Double-blind Treatment Period||18
7595387|NCT02590432|18695572|P2|STARTED|Double-blind Treatment Period||0
7595388|NCT02590432|18695573|P1|STARTED|Double-blind Treatment Period||0
7595389|NCT02590432|18695565|P9|NOT COMPLETED|Open-label Treatment Period||0
7595390|NCT02590432|18695566|P8|NOT COMPLETED|Open-label Treatment Period||0
7595391|NCT02590432|18695567|P7|NOT COMPLETED|Open-label Treatment Period||0
7595392|NCT02590432|18695568|P6|NOT COMPLETED|Open-label Treatment Period||0
7595393|NCT02590432|18695569|P5|NOT COMPLETED|Open-label Treatment Period||0
7595394|NCT02590432|18695570|P4|NOT COMPLETED|Open-label Treatment Period||0
7595395|NCT02590432|18695571|P3|NOT COMPLETED|Open-label Treatment Period||0
7595396|NCT02590432|18695572|P2|NOT COMPLETED|Open-label Treatment Period||152
7595397|NCT02590432|18695573|P1|NOT COMPLETED|Open-label Treatment Period||232
7595398|NCT02590432|18695565|P9|COMPLETED|Open-label Treatment Period||0
7595399|NCT02590432|18695566|P8|COMPLETED|Open-label Treatment Period||0
7595400|NCT02590432|18695567|P7|COMPLETED|Open-label Treatment Period||0
7595401|NCT02590432|18695568|P6|COMPLETED|Open-label Treatment Period||0
7595402|NCT02590432|18695569|P5|COMPLETED|Open-label Treatment Period||0
7595403|NCT02590432|18695570|P4|COMPLETED|Open-label Treatment Period||0
7595404|NCT02590432|18695571|P3|COMPLETED|Open-label Treatment Period||0
7595405|NCT02590432|18695572|P2|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|166
7595406|NCT02590432|18695573|P1|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|276
7595407|NCT02590432|18695565|P9|STARTED|Open-label Treatment Period||0
7595408|NCT02590432|18695566|P8|STARTED|Open-label Treatment Period||0
7595409|NCT02590432|18695567|P7|STARTED|Open-label Treatment Period||0
7595410|NCT02590432|18695568|P6|STARTED|Open-label Treatment Period||0
7595411|NCT02590432|18695569|P5|STARTED|Open-label Treatment Period||0
7595412|NCT02590432|18695570|P4|STARTED|Open-label Treatment Period||0
7595413|NCT02590432|18695571|P3|STARTED|Open-label Treatment Period||0
7595414|NCT02590432|18695572|P2|STARTED|Open-label Treatment Period||318
7595415|NCT02590432|18695573|P1|STARTED|Open-label Treatment Period||508
7595416|NCT02590406|18695609|P2|NOT COMPLETED|Overall Study||1
7595417|NCT02590406|18695610|P1|NOT COMPLETED|Overall Study||1
7595418|NCT02590406|18695609|P2|COMPLETED|Overall Study||24
7595419|NCT02590406|18695610|P1|COMPLETED|Overall Study||24
7595420|NCT02590406|18695609|P2|STARTED|Overall Study||25
7595421|NCT02590406|18695610|P1|STARTED|Overall Study||25
7595422|NCT02590354|18695624|P1|NOT COMPLETED|Phase 2 - Treatment Interruption||2
7595423|NCT02590354|18695624|P1|COMPLETED|Phase 2 - Treatment Interruption||14
7595424|NCT02590354|18695624|P1|STARTED|Phase 2 - Treatment Interruption||16
7595425|NCT02590354|18695624|P1|NOT COMPLETED|Phase 1||98
7595426|NCT02590354|18695624|P1|COMPLETED|Phase 1||16
7595427|NCT02590354|18695624|P1|STARTED|Phase 1||114
7595428|NCT02590068|18695634|P2|NOT COMPLETED|Overall Study||0
7595429|NCT02590068|18695635|P1|NOT COMPLETED|Overall Study||0
7595430|NCT02590068|18695634|P2|COMPLETED|Overall Study||14
7595431|NCT02590068|18695635|P1|COMPLETED|Overall Study||0
7595432|NCT02590068|18695634|P2|STARTED|Overall Study||14
7595433|NCT02590068|18695635|P1|STARTED|Overall Study||0
7595434|NCT02590003|18695651|P2|NOT COMPLETED|Overall Study||2
7595435|NCT02590003|18695652|P1|NOT COMPLETED|Overall Study||1
7595436|NCT02590003|18695651|P2|COMPLETED|Overall Study||0
7595437|NCT02590003|18695652|P1|COMPLETED|Overall Study||0
7595438|NCT02590003|18695651|P2|STARTED|Overall Study||2
7595439|NCT02590003|18695652|P1|STARTED|Overall Study||1
7595440|NCT02589847|18695674|P2|NOT COMPLETED|Overall Study||0
7595441|NCT02589847|18695675|P1|NOT COMPLETED|Overall Study||15
7595442|NCT02589847|18695674|P2|COMPLETED|Overall Study||110
7595443|NCT02589847|18695675|P1|COMPLETED|Overall Study||136
7595444|NCT02589847|18695674|P2|STARTED|Overall Study||110
7595445|NCT02589847|18695675|P1|STARTED|Overall Study||151
7595446|NCT02589808|18695681|P1|NOT COMPLETED|Overall Study||0
7595447|NCT02589808|18695681|P1|COMPLETED|Overall Study||76
7595448|NCT02589808|18695681|P1|STARTED|Overall Study||76
7595449|NCT02589665|18695689|P10|NOT COMPLETED|Maintenance Extension Period||68
7595450|NCT02589665|18695690|P9|NOT COMPLETED|Maintenance Extension Period||0
7595451|NCT02589665|18695691|P8|NOT COMPLETED|Maintenance Extension Period||0
7595452|NCT02589665|18695692|P7|NOT COMPLETED|Maintenance Extension Period||0
7595453|NCT02589665|18695693|P6|NOT COMPLETED|Maintenance Extension Period||0
7595454|NCT02589665|18695694|P5|NOT COMPLETED|Maintenance Extension Period||0
7595455|NCT02589665|18695695|P4|NOT COMPLETED|Maintenance Extension Period||0
7595456|NCT02589665|18695696|P3|NOT COMPLETED|Maintenance Extension Period||0
7595457|NCT02589665|18695697|P2|NOT COMPLETED|Maintenance Extension Period||0
7595458|NCT02589665|18695698|P1|NOT COMPLETED|Maintenance Extension Period||0
7595459|NCT02589665|18695689|P10|COMPLETED|Maintenance Extension Period||0
7595460|NCT02589665|18695690|P9|COMPLETED|Maintenance Extension Period||0
7595461|NCT02589665|18695691|P8|COMPLETED|Maintenance Extension Period||0
7595462|NCT02589665|18695692|P7|COMPLETED|Maintenance Extension Period||0
7595463|NCT02589665|18695693|P6|COMPLETED|Maintenance Extension Period||0
7595464|NCT02589665|18695694|P5|COMPLETED|Maintenance Extension Period||0
7595465|NCT02589665|18695695|P4|COMPLETED|Maintenance Extension Period||0
7595466|NCT02589665|18695696|P3|COMPLETED|Maintenance Extension Period||0
7595467|NCT02589665|18695697|P2|COMPLETED|Maintenance Extension Period||0
7595468|NCT02589665|18695698|P1|COMPLETED|Maintenance Extension Period||0
7595469|NCT02589665|18695689|P10|STARTED|Maintenance Extension Period||68
7595470|NCT02589665|18695690|P9|STARTED|Maintenance Extension Period||0
7595471|NCT02589665|18695691|P8|STARTED|Maintenance Extension Period||0
7595472|NCT02589665|18695692|P7|STARTED|Maintenance Extension Period||0
7595473|NCT02589665|18695693|P6|STARTED|Maintenance Extension Period||0
7595474|NCT02589665|18695694|P5|STARTED|Maintenance Extension Period||0
7595475|NCT02589665|18695695|P4|STARTED|Maintenance Extension Period||0
7595476|NCT02589665|18695696|P3|STARTED|Maintenance Extension Period||0
7595477|NCT02589665|18695697|P2|STARTED|Maintenance Extension Period||0
7595478|NCT02589665|18695698|P1|STARTED|Maintenance Extension Period||0
7595479|NCT02589665|18695689|P10|NOT COMPLETED|Induction Extension Period||0
7595480|NCT02589665|18695690|P9|NOT COMPLETED|Induction Extension Period||12
7595481|NCT02589665|18695691|P8|NOT COMPLETED|Induction Extension Period||2
7595482|NCT02589665|18695692|P7|NOT COMPLETED|Induction Extension Period||0
7595483|NCT02589665|18695693|P6|NOT COMPLETED|Induction Extension Period||0
7595484|NCT02589665|18695694|P5|NOT COMPLETED|Induction Extension Period||0
7595485|NCT02589665|18695695|P4|NOT COMPLETED|Induction Extension Period||0
7595486|NCT02589665|18695696|P3|NOT COMPLETED|Induction Extension Period||0
7595487|NCT02589665|18695697|P2|NOT COMPLETED|Induction Extension Period||0
7595488|NCT02589665|18695698|P1|NOT COMPLETED|Induction Extension Period||0
7595489|NCT02589665|18695689|P10|COMPLETED|Induction Extension Period||0
7595490|NCT02589665|18695690|P9|COMPLETED|Induction Extension Period||84
7595491|NCT02589665|18695691|P8|COMPLETED|Induction Extension Period||30
7595492|NCT02589665|18695692|P7|COMPLETED|Induction Extension Period||0
7595493|NCT02589665|18695693|P6|COMPLETED|Induction Extension Period||0
7595494|NCT02589665|18695694|P5|COMPLETED|Induction Extension Period||0
7595495|NCT02589665|18695695|P4|COMPLETED|Induction Extension Period||0
7595496|NCT02589665|18695696|P3|COMPLETED|Induction Extension Period||0
7595497|NCT02589665|18695697|P2|COMPLETED|Induction Extension Period||0
7595498|NCT02589665|18695698|P1|COMPLETED|Induction Extension Period||0
7595499|NCT02589665|18695689|P10|STARTED|Induction Extension Period||0
7595500|NCT02589665|18695690|P9|STARTED|Induction Extension Period||96
7595501|NCT02589665|18695691|P8|STARTED|Induction Extension Period||32
7595502|NCT02589665|18695692|P7|STARTED|Induction Extension Period||0
7595503|NCT02589665|18695693|P6|STARTED|Induction Extension Period||0
7595504|NCT02589665|18695694|P5|STARTED|Induction Extension Period||0
7595505|NCT02589665|18695695|P4|STARTED|Induction Extension Period||0
7595506|NCT02589665|18695696|P3|STARTED|Induction Extension Period||0
7595507|NCT02589665|18695697|P2|STARTED|Induction Extension Period||0
7595508|NCT02589665|18695698|P1|STARTED|Induction Extension Period||0
7595509|NCT02589665|18695689|P10|NOT COMPLETED|Maintenance Period||0
7595510|NCT02589665|18695690|P9|NOT COMPLETED|Maintenance Period||0
7595511|NCT02589665|18695691|P8|NOT COMPLETED|Maintenance Period||0
7595512|NCT02589665|18695692|P7|NOT COMPLETED|Maintenance Period||46
7595513|NCT02589665|18695693|P6|NOT COMPLETED|Maintenance Period||47
7595514|NCT02589665|18695694|P5|NOT COMPLETED|Maintenance Period||13
7595515|NCT02589665|18695695|P4|NOT COMPLETED|Maintenance Period||0
7595516|NCT02589665|18695696|P3|NOT COMPLETED|Maintenance Period||0
7595517|NCT02589665|18695697|P2|NOT COMPLETED|Maintenance Period||0
7595518|NCT02589665|18695698|P1|NOT COMPLETED|Maintenance Period||0
7595519|NCT02589665|18695689|P10|COMPLETED|Maintenance Period||0
7595520|NCT02589665|18695690|P9|COMPLETED|Maintenance Period||0
7595521|NCT02589665|18695691|P8|COMPLETED|Maintenance Period||0
7595522|NCT02589665|18695692|P7|COMPLETED|Maintenance Period||0
7595523|NCT02589665|18695693|P6|COMPLETED|Maintenance Period||0
7595524|NCT02589665|18695694|P5|COMPLETED|Maintenance Period||0
7595525|NCT02589665|18695695|P4|COMPLETED|Maintenance Period||0
7595526|NCT02589665|18695696|P3|COMPLETED|Maintenance Period||0
7595527|NCT02589665|18695697|P2|COMPLETED|Maintenance Period||0
7595528|NCT02589665|18695698|P1|COMPLETED|Maintenance Period||0
7595529|NCT02589665|18695689|P10|STARTED|Maintenance Period||0
7595530|NCT02589665|18695690|P9|STARTED|Maintenance Period||0
7595531|NCT02589665|18695691|P8|STARTED|Maintenance Period||0
7595532|NCT02589665|18695692|P7|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|46
7595533|NCT02589665|18695693|P6|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|47
7595534|NCT02589665|18695694|P5|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|13
7595535|NCT02589665|18695695|P4|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
7595536|NCT02589665|18695696|P3|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
7595537|NCT02589665|18695697|P2|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
7595538|NCT02589665|18695698|P1|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
7595539|NCT02589665|18695689|P10|NOT COMPLETED|Induction Period||0
7595540|NCT02589665|18695690|P9|NOT COMPLETED|Induction Period||0
7595541|NCT02589665|18695691|P8|NOT COMPLETED|Induction Period||0
7595542|NCT02589665|18695692|P7|NOT COMPLETED|Induction Period||0
7595543|NCT02589665|18695693|P6|NOT COMPLETED|Induction Period||0
7595544|NCT02589665|18695694|P5|NOT COMPLETED|Induction Period||0
7595545|NCT02589665|18695695|P4|NOT COMPLETED|Induction Period||4
7595546|NCT02589665|18695696|P3|NOT COMPLETED|Induction Period||2
7595547|NCT02589665|18695697|P2|NOT COMPLETED|Induction Period||2
7595548|NCT02589665|18695698|P1|NOT COMPLETED|Induction Period||3
7595549|NCT02589665|18695689|P10|COMPLETED|Induction Period||0
7595550|NCT02589665|18695690|P9|COMPLETED|Induction Period||0
7595551|NCT02589665|18695691|P8|COMPLETED|Induction Period||0
7595552|NCT02589665|18695692|P7|COMPLETED|Induction Period||0
7595553|NCT02589665|18695693|P6|COMPLETED|Induction Period||0
7595554|NCT02589665|18695694|P5|COMPLETED|Induction Period||0
7595555|NCT02589665|18695695|P4|COMPLETED|Induction Period||57
7595556|NCT02589665|18695696|P3|COMPLETED|Induction Period||60
7595557|NCT02589665|18695697|P2|COMPLETED|Induction Period||61
7595558|NCT02589665|18695698|P1|COMPLETED|Induction Period||60
7595559|NCT02589665|18695689|P10|Received at Least One Dose of Study Drug|Induction Period||0
7595560|NCT02589665|18695690|P9|Received at Least One Dose of Study Drug|Induction Period||0
7595561|NCT02589665|18695691|P8|Received at Least One Dose of Study Drug|Induction Period||0
7595562|NCT02589665|18695692|P7|Received at Least One Dose of Study Drug|Induction Period||0
7595563|NCT02589665|18695693|P6|Received at Least One Dose of Study Drug|Induction Period||0
7595564|NCT02589665|18695694|P5|Received at Least One Dose of Study Drug|Induction Period||0
7595565|NCT02589665|18695695|P4|Received at Least One Dose of Study Drug|Induction Period||60
7595566|NCT02589665|18695696|P3|Received at Least One Dose of Study Drug|Induction Period||62
7595567|NCT02589665|18695697|P2|Received at Least One Dose of Study Drug|Induction Period||63
7595568|NCT02589665|18695698|P1|Received at Least One Dose of Study Drug|Induction Period||63
7595569|NCT02589665|18695689|P10|STARTED|Induction Period||0
7595570|NCT02589665|18695690|P9|STARTED|Induction Period||0
7595571|NCT02589665|18695691|P8|STARTED|Induction Period||0
7595572|NCT02589665|18695692|P7|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
7595573|NCT02589665|18695693|P6|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
7595574|NCT02589665|18695694|P5|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
7595575|NCT02589665|18695695|P4|STARTED|Induction Period||61
7595576|NCT02589665|18695696|P3|STARTED|Induction Period||62
7595577|NCT02589665|18695697|P2|STARTED|Induction Period||63
7595578|NCT02589665|18695698|P1|STARTED|Induction Period||63
7595579|NCT02589639|18695763|P3|NOT COMPLETED|Overall Study||4
7595580|NCT02589639|18695764|P2|NOT COMPLETED|Overall Study||10
7595581|NCT02589639|18695765|P1|NOT COMPLETED|Overall Study||10
7595582|NCT02589639|18695763|P3|COMPLETED|Overall Study||86
7595583|NCT02589639|18695764|P2|COMPLETED|Overall Study||79
7595584|NCT02589639|18695765|P1|COMPLETED|Overall Study||80
7595585|NCT02589639|18695763|P3|Treated|Overall Study||90
7595586|NCT02589639|18695764|P2|Treated|Overall Study||86
7595587|NCT02589639|18695765|P1|Treated|Overall Study||90
7595588|NCT02589639|18695763|P3|STARTED|Overall Study||90
7595589|NCT02589639|18695764|P2|STARTED|Overall Study||89
7595590|NCT02589639|18695765|P1|STARTED|Overall Study||90
7595591|NCT02589626|18695778|P2|NOT COMPLETED|Overall Study||2
7595592|NCT02589626|18695779|P1|NOT COMPLETED|Overall Study||3
7595593|NCT02589626|18695778|P2|COMPLETED|Overall Study||31
7595594|NCT02589626|18695779|P1|COMPLETED|Overall Study||29
7595595|NCT02589626|18695778|P2|STARTED|Overall Study|Entered are treated patients|33
7595596|NCT02589626|18695779|P1|STARTED|Overall Study|Entered are treated patients|32
7595597|NCT02589405|18695787|P1|NOT COMPLETED|Overall Study||4
7595598|NCT02589405|18695787|P1|COMPLETED|Overall Study||46
7595599|NCT02589405|18695787|P1|STARTED|Overall Study||50
7595600|NCT02589171|18695793|P2|NOT COMPLETED|Overall Study||5
7595601|NCT02589171|18695794|P1|NOT COMPLETED|Overall Study||7
7595602|NCT02589171|18695793|P2|COMPLETED|Overall Study||30
7595603|NCT02589171|18695794|P1|COMPLETED|Overall Study||28
7595604|NCT02589171|18695793|P2|Week 6 Follow up|Overall Study||30
7595605|NCT02589171|18695794|P1|Week 6 Follow up|Overall Study||28
7595606|NCT02589171|18695793|P2|Week 1 Follow up|Overall Study||34
7595607|NCT02589171|18695794|P1|Week 1 Follow up|Overall Study||35
7595608|NCT02589171|18695793|P2|Day 1 Follow up|Overall Study||35
7595609|NCT02589171|18695794|P1|Day 1 Follow up|Overall Study||35
7595610|NCT02589171|18695793|P2|STARTED|Overall Study||35
7595611|NCT02589171|18695794|P1|STARTED|Overall Study||35
7595612|NCT02589145|18695837|P3|NOT COMPLETED|Overall Study||0
7595613|NCT02589145|18695838|P2|NOT COMPLETED|Overall Study||0
7595614|NCT02589145|18695839|P1|NOT COMPLETED|Overall Study||0
7595615|NCT02589145|18695837|P3|COMPLETED|Overall Study||2
7595616|NCT02589145|18695838|P2|COMPLETED|Overall Study||2
7595617|NCT02589145|18695839|P1|COMPLETED|Overall Study||4
7595618|NCT02589145|18695837|P3|STARTED|Overall Study||2
7595619|NCT02589145|18695838|P2|STARTED|Overall Study||2
7595620|NCT02589145|18695839|P1|STARTED|Overall Study||4
7595621|NCT02589067|18695867|P2|NOT COMPLETED|Overall Study||6
7595622|NCT02589067|18695868|P1|NOT COMPLETED|Overall Study||5
7595623|NCT02589067|18695867|P2|COMPLETED|Overall Study||28
7595624|NCT02589067|18695868|P1|COMPLETED|Overall Study||28
7595625|NCT02589067|18695867|P2|STARTED|Overall Study||34
7595626|NCT02589067|18695868|P1|STARTED|Overall Study||33
7595627|NCT02588976|18695880|P1|NOT COMPLETED|Overall Study||0
7595628|NCT02588976|18695880|P1|COMPLETED|Overall Study||30
7595629|NCT02588976|18695880|P1|STARTED|Overall Study||30
7595630|NCT02588872|18695887|P2|NOT COMPLETED|Overall Study||0
7595631|NCT02588872|18695888|P1|NOT COMPLETED|Overall Study||0
7595632|NCT02588872|18695887|P2|COMPLETED|Overall Study||52
7595633|NCT02588872|18695888|P1|COMPLETED|Overall Study||59
7595634|NCT02588872|18695887|P2|STARTED|Overall Study||52
7595635|NCT02588872|18695888|P1|STARTED|Overall Study||59
7595636|NCT02588599|18695902|P1|NOT COMPLETED|Overall Study||0
7595637|NCT02588599|18695902|P1|COMPLETED|Overall Study||54
7595638|NCT02588599|18695902|P1|STARTED|Overall Study||54
7595639|NCT02588573|18695909|P2|NOT COMPLETED|Overall Study||0
7595640|NCT02588573|18695910|P1|NOT COMPLETED|Overall Study||0
7595641|NCT02588573|18695909|P2|COMPLETED|Overall Study||45
7595642|NCT02588573|18695910|P1|COMPLETED|Overall Study||45
7595643|NCT02588573|18695909|P2|Randomized Eye Somofilcon A|Overall Study||45
7595644|NCT02588573|18695910|P1|Randomized Eye Somofilcon A|Overall Study||45
7595645|NCT02588573|18695909|P2|Randomized Eye Etafilcon A|Overall Study||45
7595646|NCT02588573|18695910|P1|Randomized Eye Etafilcon A|Overall Study||45
7595647|NCT02588573|18695909|P2|STARTED|Overall Study||45
7595648|NCT02588573|18695910|P1|STARTED|Overall Study||45
7595649|NCT02588339|18695940|P1|NOT COMPLETED|Overall Study||3
7595650|NCT02588339|18695940|P1|COMPLETED|Overall Study||39
7595651|NCT02588339|18695940|P1|STARTED|Overall Study||42
7595652|NCT02588261|18695952|P2|NOT COMPLETED|Overall Study||263
7595653|NCT02588261|18695953|P1|NOT COMPLETED|Overall Study||267
7595654|NCT02588261|18695952|P2|COMPLETED|Overall Study||0
7595655|NCT02588261|18695953|P1|COMPLETED|Overall Study||0
7595656|NCT02588261|18695952|P2|Treated|Overall Study||262
7595657|NCT02588261|18695953|P1|Treated|Overall Study||265
7595658|NCT02588261|18695952|P2|STARTED|Overall Study||263
7595659|NCT02588261|18695953|P1|STARTED|Overall Study||267
7595660|NCT02588092|18695989|P10|NOT COMPLETED|Overall Study||3
7595661|NCT02588092|18695990|P9|NOT COMPLETED|Overall Study||6
7595662|NCT02588092|18695991|P8|NOT COMPLETED|Overall Study||4
7595663|NCT02588092|18695992|P7|NOT COMPLETED|Overall Study||3
7595664|NCT02588092|18695993|P6|NOT COMPLETED|Overall Study||3
7595665|NCT02588092|18695994|P5|NOT COMPLETED|Overall Study||3
7595666|NCT02588092|18695995|P4|NOT COMPLETED|Overall Study||3
7595667|NCT02588092|18695996|P3|NOT COMPLETED|Overall Study||3
7595668|NCT02588092|18695997|P2|NOT COMPLETED|Overall Study||3
7595669|NCT02588092|18695998|P1|NOT COMPLETED|Overall Study||4
7595670|NCT02588092|18695989|P10|COMPLETED|Overall Study||0
7595671|NCT02588092|18695990|P9|COMPLETED|Overall Study||0
7595672|NCT02588092|18695991|P8|COMPLETED|Overall Study||0
7595673|NCT02588092|18695992|P7|COMPLETED|Overall Study||0
7595674|NCT02588092|18695993|P6|COMPLETED|Overall Study||0
7595675|NCT02588092|18695994|P5|COMPLETED|Overall Study||0
7595676|NCT02588092|18695995|P4|COMPLETED|Overall Study||0
7595677|NCT02588092|18695996|P3|COMPLETED|Overall Study||0
7595678|NCT02588092|18695997|P2|COMPLETED|Overall Study||0
7595679|NCT02588092|18695998|P1|COMPLETED|Overall Study||0
7595680|NCT02588092|18695989|P10|STARTED|Overall Study||3
7595681|NCT02588092|18695990|P9|STARTED|Overall Study||6
7595682|NCT02588092|18695991|P8|STARTED|Overall Study||4
7595683|NCT02588092|18695992|P7|STARTED|Overall Study||3
7595684|NCT02588092|18695993|P6|STARTED|Overall Study||3
7595685|NCT02588092|18695994|P5|STARTED|Overall Study||3
7595686|NCT02588092|18695995|P4|STARTED|Overall Study||3
7595687|NCT02588092|18695996|P3|STARTED|Overall Study||3
7595688|NCT02588092|18695997|P2|STARTED|Overall Study||3
7595689|NCT02588092|18695998|P1|STARTED|Overall Study||4
7595690|NCT02587819|18696192|P1|NOT COMPLETED|Overall Study||2
7595691|NCT02587819|18696192|P1|COMPLETED|Overall Study||19
7595692|NCT02587819|18696192|P1|Exposed|Overall Study||21
7595693|NCT02587819|18696192|P1|STARTED|Overall Study||21
7595694|NCT02587650|18696199|P4|NOT COMPLETED|Overall Study||0
7595695|NCT02587650|18696200|P3|NOT COMPLETED|Overall Study||0
7595696|NCT02587650|18696201|P2|NOT COMPLETED|Overall Study||0
7595697|NCT02587650|18696202|P1|NOT COMPLETED|Overall Study||0
7595698|NCT02587650|18696199|P4|COMPLETED|Overall Study||0
7595699|NCT02587650|18696200|P3|COMPLETED|Overall Study||1
7595700|NCT02587650|18696201|P2|COMPLETED|Overall Study||0
7595701|NCT02587650|18696202|P1|COMPLETED|Overall Study||0
7595702|NCT02587650|18696199|P4|STARTED|Overall Study||0
7595703|NCT02587650|18696200|P3|STARTED|Overall Study||1
7595704|NCT02587650|18696201|P2|STARTED|Overall Study||0
7595705|NCT02587650|18696202|P1|STARTED|Overall Study||0
7595706|NCT02587520|18696228|P18|NOT COMPLETED|Overall Study||0
7595707|NCT02587520|18696229|P17|NOT COMPLETED|Overall Study||0
7595708|NCT02587520|18696230|P16|NOT COMPLETED|Overall Study||0
7595709|NCT02587520|18696231|P15|NOT COMPLETED|Overall Study||0
7595710|NCT02587520|18696232|P14|NOT COMPLETED|Overall Study||1
7595711|NCT02587520|18696233|P13|NOT COMPLETED|Overall Study||0
7595712|NCT02587520|18696234|P12|NOT COMPLETED|Overall Study||4
7595713|NCT02587520|18696235|P11|NOT COMPLETED|Overall Study||3
7595714|NCT02587520|18696236|P10|NOT COMPLETED|Overall Study||5
7595715|NCT02587520|18696237|P9|NOT COMPLETED|Overall Study||3
7595716|NCT02587520|18696238|P8|NOT COMPLETED|Overall Study||2
7595717|NCT02587520|18696239|P7|NOT COMPLETED|Overall Study||3
7595718|NCT02587520|18696240|P6|NOT COMPLETED|Overall Study||3
7595719|NCT02587520|18696241|P5|NOT COMPLETED|Overall Study||0
7595720|NCT02587520|18696242|P4|NOT COMPLETED|Overall Study||5
7595721|NCT02587520|18696243|P3|NOT COMPLETED|Overall Study||1
7595722|NCT02587520|18696244|P2|NOT COMPLETED|Overall Study||2
7595723|NCT02587520|18696245|P1|NOT COMPLETED|Overall Study||2
7595724|NCT02587520|18696228|P18|COMPLETED|Overall Study||78
7595725|NCT02587520|18696229|P17|COMPLETED|Overall Study||76
7595726|NCT02587520|18696230|P16|COMPLETED|Overall Study||72
7595727|NCT02587520|18696231|P15|COMPLETED|Overall Study||78
7595728|NCT02587520|18696232|P14|COMPLETED|Overall Study||73
7595729|NCT02587520|18696233|P13|COMPLETED|Overall Study||77
7595730|NCT02587520|18696234|P12|COMPLETED|Overall Study||69
7595731|NCT02587520|18696235|P11|COMPLETED|Overall Study||73
7595732|NCT02587520|18696236|P10|COMPLETED|Overall Study||71
7595733|NCT02587520|18696237|P9|COMPLETED|Overall Study||73
7595734|NCT02587520|18696238|P8|COMPLETED|Overall Study||71
7595735|NCT02587520|18696239|P7|COMPLETED|Overall Study||73
7595736|NCT02587520|18696240|P6|COMPLETED|Overall Study||72
7595737|NCT02587520|18696241|P5|COMPLETED|Overall Study||75
7595738|NCT02587520|18696242|P4|COMPLETED|Overall Study||74
7595739|NCT02587520|18696243|P3|COMPLETED|Overall Study||77
7595740|NCT02587520|18696244|P2|COMPLETED|Overall Study||69
7595741|NCT02587520|18696245|P1|COMPLETED|Overall Study||78
7595742|NCT02587520|18696228|P18|Safety Analysis Set (SafAS)|Overall Study||78
7595743|NCT02587520|18696229|P17|Safety Analysis Set (SafAS)|Overall Study||76
7595744|NCT02587520|18696230|P16|Safety Analysis Set (SafAS)|Overall Study||72
7595745|NCT02587520|18696231|P15|Safety Analysis Set (SafAS)|Overall Study||78
7595746|NCT02587520|18696232|P14|Safety Analysis Set (SafAS)|Overall Study||73
7595747|NCT02587520|18696233|P13|Safety Analysis Set (SafAS)|Overall Study||77
7595748|NCT02587520|18696234|P12|Safety Analysis Set (SafAS)|Overall Study||72
7595749|NCT02587520|18696235|P11|Safety Analysis Set (SafAS)|Overall Study||76
7595750|NCT02587520|18696236|P10|Safety Analysis Set (SafAS)|Overall Study||76
7595751|NCT02587520|18696237|P9|Safety Analysis Set (SafAS)|Overall Study||76
7595752|NCT02587520|18696238|P8|Safety Analysis Set (SafAS)|Overall Study||73
7595753|NCT02587520|18696239|P7|Safety Analysis Set (SafAS)|Overall Study||76
7595754|NCT02587520|18696240|P6|Safety Analysis Set (SafAS)|Overall Study||75
7595755|NCT02587520|18696241|P5|Safety Analysis Set (SafAS)|Overall Study||75
7595756|NCT02587520|18696242|P4|Safety Analysis Set (SafAS)|Overall Study||77
7595757|NCT02587520|18696243|P3|Safety Analysis Set (SafAS)|Overall Study||77
7595758|NCT02587520|18696244|P2|Safety Analysis Set (SafAS)|Overall Study||71
7595759|NCT02587520|18696245|P1|Safety Analysis Set (SafAS)|Overall Study||79
7595760|NCT02587520|18696228|P18|STARTED|Overall Study||78
7595761|NCT02587520|18696229|P17|STARTED|Overall Study||76
7595762|NCT02587520|18696230|P16|STARTED|Overall Study||72
7595763|NCT02587520|18696231|P15|STARTED|Overall Study||78
7595764|NCT02587520|18696232|P14|STARTED|Overall Study||74
7595765|NCT02587520|18696233|P13|STARTED|Overall Study||77
7595766|NCT02587520|18696234|P12|STARTED|Overall Study||73
7595767|NCT02587520|18696235|P11|STARTED|Overall Study||76
7595768|NCT02587520|18696236|P10|STARTED|Overall Study||76
7595769|NCT02587520|18696237|P9|STARTED|Overall Study||76
7595770|NCT02587520|18696238|P8|STARTED|Overall Study||73
7595771|NCT02587520|18696239|P7|STARTED|Overall Study||76
7595772|NCT02587520|18696240|P6|STARTED|Overall Study||75
7595773|NCT02587520|18696241|P5|STARTED|Overall Study||75
7595774|NCT02587520|18696242|P4|STARTED|Overall Study||79
7595775|NCT02587520|18696243|P3|STARTED|Overall Study||78
7595776|NCT02587520|18696244|P2|STARTED|Overall Study||71
7595777|NCT02587520|18696245|P1|STARTED|Overall Study||80
7595778|NCT02587234|18696285|P2|NOT COMPLETED|Overall Study||3
7595779|NCT02587234|18696286|P1|NOT COMPLETED|Overall Study||1
7595780|NCT02587234|18696285|P2|COMPLETED|Overall Study||7
7595781|NCT02587234|18696286|P1|COMPLETED|Overall Study||10
7595782|NCT02587234|18696285|P2|STARTED|Overall Study||10
7595783|NCT02587234|18696286|P1|STARTED|Overall Study||11
7595784|NCT02587221|18696298|P2|NOT COMPLETED|Overall Study||123
7595785|NCT02587221|18696299|P1|NOT COMPLETED|Overall Study||131
7595786|NCT02587221|18696298|P2|COMPLETED|Overall Study||3273
7595787|NCT02587221|18696299|P1|COMPLETED|Overall Study||3263
7595788|NCT02587221|18696298|P2|Treated|Overall Study||3382
7595789|NCT02587221|18696299|P1|Treated|Overall Study||3379
7595790|NCT02587221|18696298|P2|STARTED|Overall Study||3396
7595791|NCT02587221|18696299|P1|STARTED|Overall Study||3394
7595792|NCT02587143|18696345|P2|NOT COMPLETED|Overall Study||0
7595793|NCT02587143|18696346|P1|NOT COMPLETED|Overall Study||1
7595794|NCT02587143|18696345|P2|COMPLETED|Overall Study||60
7595795|NCT02587143|18696346|P1|COMPLETED|Overall Study||65
7595796|NCT02587143|18696345|P2|STARTED|Overall Study||60
7595797|NCT02587143|18696346|P1|STARTED|Overall Study||66
7595798|NCT02587117|18696354|P2|NOT COMPLETED|Overall Study||0
7595799|NCT02587117|18696355|P1|NOT COMPLETED|Overall Study||0
7595800|NCT02587117|18696354|P2|COMPLETED|Overall Study||15
7595801|NCT02587117|18696355|P1|COMPLETED|Overall Study||13
7595802|NCT02587117|18696354|P2|STARTED|Overall Study||15
7595803|NCT02587117|18696355|P1|STARTED|Overall Study||13
7595804|NCT02587065|18696363|P1|NOT COMPLETED|Overall Study||27
7595805|NCT02587065|18696363|P1|COMPLETED|Overall Study||166
7595806|NCT02587065|18696363|P1|STARTED|Overall Study||193
7595807|NCT02586974|18696379|P2|NOT COMPLETED|Overall Study||0
7595808|NCT02586974|18696380|P1|NOT COMPLETED|Overall Study||0
7595809|NCT02586974|18696379|P2|COMPLETED|Overall Study||32
7595810|NCT02586974|18696380|P1|COMPLETED|Overall Study||32
7595811|NCT02586974|18696379|P2|STARTED|Overall Study||32
7595812|NCT02586974|18696380|P1|STARTED|Overall Study||32
7595813|NCT02586909|18696392|P1|NOT COMPLETED|Overall Study||948
7595814|NCT02586909|18696392|P1|COMPLETED|Overall Study||151
7595815|NCT02586909|18696392|P1|STARTED|Overall Study||1099
7595816|NCT02586896|18696398|P2|NOT COMPLETED|Overall Study||17
7595817|NCT02586896|18696399|P1|NOT COMPLETED|Overall Study||19
7595818|NCT02586896|18696398|P2|COMPLETED|Overall Study||133
7595819|NCT02586896|18696399|P1|COMPLETED|Overall Study||131
7595820|NCT02586896|18696398|P2|3-Month Follow-up|Overall Study||123
7595821|NCT02586896|18696399|P1|3-Month Follow-up|Overall Study||126
7595822|NCT02586896|18696398|P2|STARTED|Overall Study||150
7595823|NCT02586896|18696399|P1|STARTED|Overall Study||150
7595824|NCT02586857|18696417|P2|NOT COMPLETED|Overall Study||0
7595825|NCT02586857|18696418|P1|NOT COMPLETED|Overall Study||1
7595826|NCT02586857|18696417|P2|COMPLETED|Overall Study||9
7595827|NCT02586857|18696418|P1|COMPLETED|Overall Study||14
7595828|NCT02586857|18696417|P2|Discontinued Study|Overall Study||9
7595829|NCT02586857|18696418|P1|Discontinued Study|Overall Study||14
7595830|NCT02586857|18696417|P2|Received Study Medication|Overall Study||9
7595831|NCT02586857|18696418|P1|Received Study Medication|Overall Study||15
7595832|NCT02586857|18696417|P2|Enrolled|Overall Study||9
7595833|NCT02586857|18696418|P1|Enrolled|Overall Study||15
7595834|NCT02586857|18696417|P2|STARTED|Overall Study||9
7595835|NCT02586857|18696418|P1|STARTED|Overall Study||15
7595836|NCT02586805|18696428|P4|NOT COMPLETED|Overall Study||2
7595837|NCT02586805|18696429|P3|NOT COMPLETED|Overall Study||3
7595838|NCT02586805|18696430|P2|NOT COMPLETED|Overall Study||1
7595839|NCT02586805|18696431|P1|NOT COMPLETED|Overall Study||6
7595840|NCT02586805|18696428|P4|COMPLETED|Overall Study||25
7595841|NCT02586805|18696429|P3|COMPLETED|Overall Study||26
7595842|NCT02586805|18696430|P2|COMPLETED|Overall Study||27
7595843|NCT02586805|18696431|P1|COMPLETED|Overall Study||35
7595844|NCT02586805|18696428|P4|STARTED|Overall Study||27
7595845|NCT02586805|18696429|P3|STARTED|Overall Study||29
7595846|NCT02586805|18696430|P2|STARTED|Overall Study||28
7595847|NCT02586805|18696431|P1|STARTED|Overall Study||41
7595848|NCT02586675|18696453|P1|NOT COMPLETED|Overall Study||0
7595849|NCT02586675|18696453|P1|COMPLETED|Overall Study||7
7595850|NCT02586675|18696453|P1|STARTED|Overall Study||7
7595851|NCT02586506|18696459|P1|NOT COMPLETED|Overall Study||9
7595852|NCT02586506|18696459|P1|COMPLETED|Overall Study||250
7595853|NCT02586506|18696459|P1|STARTED|Overall Study||259
7595854|NCT02586493|18696465|P1|NOT COMPLETED|Overall Study||12
7595855|NCT02586493|18696465|P1|COMPLETED|Overall Study||266
7595856|NCT02586493|18696465|P1|STARTED|Overall Study||278
7595857|NCT02586415|18696473|P2|NOT COMPLETED|Overall Study||25
7595858|NCT02586415|18696474|P1|NOT COMPLETED|Overall Study||14
7595859|NCT02586415|18696473|P2|COMPLETED|Overall Study||65
7595860|NCT02586415|18696474|P1|COMPLETED|Overall Study||78
7595861|NCT02586415|18696473|P2|Day 90 Assessment|Overall Study||65
7595862|NCT02586415|18696474|P1|Day 90 Assessment|Overall Study||78
7595863|NCT02586415|18696473|P2|Day 30 Assessment|Overall Study||70
7595864|NCT02586415|18696474|P1|Day 30 Assessment|Overall Study||81
7595865|NCT02586415|18696473|P2|24 Hour Assessment|Overall Study||90
7595866|NCT02586415|18696474|P1|24 Hour Assessment|Overall Study||91
7595867|NCT02586415|18696473|P2|STARTED|Overall Study||90
7595868|NCT02586415|18696474|P1|STARTED|Overall Study||92
7595869|NCT02586233|18696491|P7|NOT COMPLETED|Overall Study||2
7595870|NCT02586233|18696492|P6|NOT COMPLETED|Overall Study||2
7595871|NCT02586233|18696493|P5|NOT COMPLETED|Overall Study||2
7595872|NCT02586233|18696494|P4|NOT COMPLETED|Overall Study||0
7595873|NCT02586233|18696495|P3|NOT COMPLETED|Overall Study||0
7595874|NCT02586233|18696496|P2|NOT COMPLETED|Overall Study||2
7595875|NCT02586233|18696497|P1|NOT COMPLETED|Overall Study||0
7595876|NCT02586233|18696491|P7|COMPLETED|Overall Study||24
7595877|NCT02586233|18696492|P6|COMPLETED|Overall Study||16
7595878|NCT02586233|18696493|P5|COMPLETED|Overall Study||16
7595879|NCT02586233|18696494|P4|COMPLETED|Overall Study||17
7595880|NCT02586233|18696495|P3|COMPLETED|Overall Study||13
7595881|NCT02586233|18696496|P2|COMPLETED|Overall Study||5
7595882|NCT02586233|18696497|P1|COMPLETED|Overall Study||7
7595883|NCT02586233|18696491|P7|STARTED|Overall Study||26
7595884|NCT02586233|18696492|P6|STARTED|Overall Study||18
7595885|NCT02586233|18696493|P5|STARTED|Overall Study||18
7595886|NCT02586233|18696494|P4|STARTED|Overall Study||17
7595887|NCT02586233|18696495|P3|STARTED|Overall Study||13
7595888|NCT02586233|18696496|P2|STARTED|Overall Study||7
7595889|NCT02586233|18696497|P1|STARTED|Overall Study||7
7595890|NCT02586077|18696556|P1|NOT COMPLETED|Overall Study||8
7595891|NCT02586077|18696556|P1|COMPLETED|Overall Study||28
7595892|NCT02586077|18696556|P1|STARTED|Overall Study||36
7595893|NCT02586025|18696566|P2|NOT COMPLETED|Treatment-Free Follow-Up||35
7595894|NCT02586025|18696567|P1|NOT COMPLETED|Treatment-Free Follow-Up||56
7595895|NCT02586025|18696566|P2|COMPLETED|Treatment-Free Follow-Up||3
7595896|NCT02586025|18696567|P1|COMPLETED|Treatment-Free Follow-Up||3
7595897|NCT02586025|18696566|P2|STARTED|Treatment-Free Follow-Up||38
7595898|NCT02586025|18696567|P1|STARTED|Treatment-Free Follow-Up||59
7595899|NCT02586025|18696566|P2|NOT COMPLETED|Adjuvant Treatment||69
7595900|NCT02586025|18696567|P1|NOT COMPLETED|Adjuvant Treatment||139
7595901|NCT02586025|18696566|P2|COMPLETED|Adjuvant Treatment||34
7595902|NCT02586025|18696567|P1|COMPLETED|Adjuvant Treatment||69
7595903|NCT02586025|18696566|P2|Started Adjuvant HER2 Treatment|Adjuvant Treatment||99
7595904|NCT02586025|18696567|P1|Started Adjuvant HER2 Treatment|Adjuvant Treatment||204
7595905|NCT02586025|18696566|P2|Started Adjuvant FEC Treatment|Adjuvant Treatment||103
7595906|NCT02586025|18696567|P1|Started Adjuvant FEC Treatment|Adjuvant Treatment||208
7595907|NCT02586025|18696566|P2|STARTED|Adjuvant Treatment||103
7595908|NCT02586025|18696567|P1|STARTED|Adjuvant Treatment||208
7595909|NCT02586025|18696566|P2|NOT COMPLETED|Neoadjuvant Treatment||7
7595910|NCT02586025|18696567|P1|NOT COMPLETED|Neoadjuvant Treatment||11
7595911|NCT02586025|18696566|P2|COMPLETED|Neoadjuvant Treatment||103
7595912|NCT02586025|18696567|P1|COMPLETED|Neoadjuvant Treatment||208
7595913|NCT02586025|18696566|P2|Underwent Surgery|Neoadjuvant Treatment||105
7595914|NCT02586025|18696567|P1|Underwent Surgery|Neoadjuvant Treatment||210
7595915|NCT02586025|18696566|P2|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||108
7595916|NCT02586025|18696567|P1|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||214
7595917|NCT02586025|18696566|P2|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||110
7595918|NCT02586025|18696567|P1|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||218
7595919|NCT02586025|18696566|P2|STARTED|Neoadjuvant Treatment||110
7595920|NCT02586025|18696567|P1|STARTED|Neoadjuvant Treatment||219
7595921|NCT02586012|18696603|P6|NOT COMPLETED|Overall Study||3
7595922|NCT02586012|18696604|P5|NOT COMPLETED|Overall Study||1
7595923|NCT02586012|18696605|P4|NOT COMPLETED|Overall Study||2
7595924|NCT02586012|18696606|P3|NOT COMPLETED|Overall Study||1
7595925|NCT02586012|18696607|P2|NOT COMPLETED|Overall Study||3
7595926|NCT02586012|18696608|P1|NOT COMPLETED|Overall Study||1
7595927|NCT02586012|18696603|P6|COMPLETED|Overall Study||2
7595928|NCT02586012|18696604|P5|COMPLETED|Overall Study||4
7595929|NCT02586012|18696605|P4|COMPLETED|Overall Study||3
7595930|NCT02586012|18696606|P3|COMPLETED|Overall Study||4
7595931|NCT02586012|18696607|P2|COMPLETED|Overall Study||2
7595932|NCT02586012|18696608|P1|COMPLETED|Overall Study||4
7595933|NCT02586012|18696603|P6|STARTED|Overall Study||5
7595934|NCT02586012|18696604|P5|STARTED|Overall Study||5
7595935|NCT02586012|18696605|P4|STARTED|Overall Study||5
7595936|NCT02586012|18696606|P3|STARTED|Overall Study||5
7595937|NCT02586012|18696607|P2|STARTED|Overall Study||5
7595938|NCT02586012|18696608|P1|STARTED|Overall Study||5
7595939|NCT02585999|18696619|P1|NOT COMPLETED|Overall Study||2
7595940|NCT02585999|18696619|P1|COMPLETED|Overall Study|28 participants enrolled; 2 withdrew prior to starting, leaving 26 to complete study activity.|26
7595941|NCT02585999|18696619|P1|STARTED|Overall Study||28
7595942|NCT02585960|18696627|P3|NOT COMPLETED|Prophylactic Treatment Period||0
7595943|NCT02585960|18696628|P2|NOT COMPLETED|Prophylactic Treatment Period||5
7595944|NCT02585960|18696629|P1|NOT COMPLETED|Prophylactic Treatment Period||0
7595945|NCT02585960|18696627|P3|COMPLETED|Prophylactic Treatment Period||0
7595946|NCT02585960|18696628|P2|COMPLETED|Prophylactic Treatment Period||43
7595947|NCT02585960|18696629|P1|COMPLETED|Prophylactic Treatment Period||52
7595948|NCT02585960|18696627|P3|STARTED|Prophylactic Treatment Period||0
7595949|NCT02585960|18696628|P2|STARTED|Prophylactic Treatment Period||48
7595950|NCT02585960|18696629|P1|STARTED|Prophylactic Treatment Period||52
7595951|NCT02585960|18696627|P3|NOT COMPLETED|PK/Safety Assessment Period||6
7595952|NCT02585960|18696628|P2|NOT COMPLETED|PK/Safety Assessment Period||10
7595953|NCT02585960|18696629|P1|NOT COMPLETED|PK/Safety Assessment Period||5
7595954|NCT02585960|18696627|P3|COMPLETED|PK/Safety Assessment Period||0
7595955|NCT02585960|18696628|P2|COMPLETED|PK/Safety Assessment Period||48
7595956|NCT02585960|18696629|P1|COMPLETED|PK/Safety Assessment Period||52
7595957|NCT02585960|18696627|P3|Completed 2nd 6 Month Period|PK/Safety Assessment Period||0
7595958|NCT02585960|18696628|P2|Completed 2nd 6 Month Period|PK/Safety Assessment Period||48
7595959|NCT02585960|18696629|P1|Completed 2nd 6 Month Period|PK/Safety Assessment Period||52
7595960|NCT02585960|18696627|P3|Completed 1st 6 Month Period|PK/Safety Assessment Period||0
7595961|NCT02585960|18696628|P2|Completed 1st 6 Month Period|PK/Safety Assessment Period||53
7595962|NCT02585960|18696629|P1|Completed 1st 6 Month Period|PK/Safety Assessment Period||57
7595963|NCT02585960|18696627|P3|STARTED|PK/Safety Assessment Period||6
7595964|NCT02585960|18696628|P2|STARTED|PK/Safety Assessment Period||58
7595965|NCT02585960|18696629|P1|STARTED|PK/Safety Assessment Period||57
7595966|NCT02585934|18696699|P2|NOT COMPLETED|Overall Study||73
7595967|NCT02585934|18696700|P1|NOT COMPLETED|Overall Study||69
7595968|NCT02585934|18696699|P2|COMPLETED|Overall Study||581
7595969|NCT02585934|18696700|P1|COMPLETED|Overall Study||592
7595970|NCT02585934|18696699|P2|Per Protocol (PP)|Overall Study||582
7595971|NCT02585934|18696700|P1|Per Protocol (PP)|Overall Study||603
7595972|NCT02585934|18696699|P2|Intent to Treat (ITT)|Overall Study||633
7595973|NCT02585934|18696700|P1|Intent to Treat (ITT)|Overall Study||643
7595974|NCT02585934|18696699|P2|Safety Population|Overall Study||651
7595975|NCT02585934|18696700|P1|Safety Population|Overall Study||656
7595976|NCT02585934|18696699|P2|STARTED|Overall Study||654
7595977|NCT02585934|18696700|P1|STARTED|Overall Study||661
7595978|NCT02585895|18696723|P2|NOT COMPLETED|Post-primary Period||0
7595979|NCT02585895|18696724|P1|NOT COMPLETED|Post-primary Period||0
7595980|NCT02585895|18696723|P2|COMPLETED|Post-primary Period||19
7595981|NCT02585895|18696724|P1|COMPLETED|Post-primary Period||20
7595982|NCT02585895|18696723|P2|STARTED|Post-primary Period||19
7595983|NCT02585895|18696724|P1|STARTED|Post-primary Period||20
7595984|NCT02585895|18696723|P2|NOT COMPLETED|Primary Period||0
7595985|NCT02585895|18696724|P1|NOT COMPLETED|Primary Period||0
7595986|NCT02585895|18696723|P2|COMPLETED|Primary Period||19
7595987|NCT02585895|18696724|P1|COMPLETED|Primary Period||20
7595988|NCT02585895|18696723|P2|STARTED|Primary Period||19
7595989|NCT02585895|18696724|P1|STARTED|Primary Period||20
7595990|NCT02585843|18696741|P2|NOT COMPLETED|Overall Study||0
7595991|NCT02585843|18696742|P1|NOT COMPLETED|Overall Study||1
7595992|NCT02585843|18696741|P2|COMPLETED|Overall Study||10
7595993|NCT02585843|18696742|P1|COMPLETED|Overall Study||9
7595994|NCT02585843|18696741|P2|STARTED|Overall Study||10
7595995|NCT02585843|18696742|P1|STARTED|Overall Study||10
7595996|NCT02585830|18696756|P1|NOT COMPLETED|Overall Study||3
7595997|NCT02585830|18696756|P1|COMPLETED|Overall Study||22
7595998|NCT02585830|18696756|P1|STARTED|Overall Study||25
7595999|NCT02585778|18696765|P2|NOT COMPLETED|Overall Study||15
7596000|NCT02585778|18696766|P1|NOT COMPLETED|Overall Study||33
7596001|NCT02585778|18696765|P2|COMPLETED|Overall Study||157
7596002|NCT02585778|18696766|P1|COMPLETED|Overall Study||312
7596003|NCT02585778|18696765|P2|T2DM Participants|Overall Study||147
7596004|NCT02585778|18696766|P1|T2DM Participants|Overall Study||294
7596005|NCT02585778|18696765|P2|T1DM Participants|Overall Study||25
7596006|NCT02585778|18696766|P1|T1DM Participants|Overall Study||51
7596007|NCT02585778|18696765|P2|mITT Population|Overall Study||164
7596008|NCT02585778|18696766|P1|mITT Population|Overall Study||333
7596009|NCT02585778|18696765|P2|ITT Population|Overall Study||167
7596010|NCT02585778|18696766|P1|ITT Population|Overall Study||336
7596011|NCT02585778|18696765|P2|Treated (Safety Population)|Overall Study||170
7596012|NCT02585778|18696766|P1|Treated (Safety Population)|Overall Study||344
7596013|NCT02585778|18696765|P2|STARTED|Overall Study|Randomized|172
7596014|NCT02585778|18696766|P1|STARTED|Overall Study|Randomized|345
7596015|NCT02585713|18696882|P2|NOT COMPLETED|Overall Study||8
7596016|NCT02585713|18696883|P1|NOT COMPLETED|Overall Study||5
7596017|NCT02585713|18696882|P2|COMPLETED|Overall Study||142
7596018|NCT02585713|18696883|P1|COMPLETED|Overall Study||145
7596019|NCT02585713|18696882|P2|STARTED|Overall Study||150
7596020|NCT02585713|18696883|P1|STARTED|Overall Study||150
7596021|NCT02585700|18696895|P2|NOT COMPLETED|Overall Study||0
7596022|NCT02585700|18696896|P1|NOT COMPLETED|Overall Study||0
7596023|NCT02585700|18696895|P2|COMPLETED|Overall Study||30
7596024|NCT02585700|18696896|P1|COMPLETED|Overall Study||30
7596025|NCT02585700|18696895|P2|STARTED|Overall Study||30
7596026|NCT02585700|18696896|P1|STARTED|Overall Study||30
7596027|NCT02585245|18696922|P1|NOT COMPLETED|Overall Study||13
7596028|NCT02585245|18696922|P1|COMPLETED|Overall Study||594
7596029|NCT02585245|18696922|P1|STARTED|Overall Study||607
7596030|NCT02584998|18696930|P3|NOT COMPLETED|Overall Study||0
7596031|NCT02584998|18696931|P2|NOT COMPLETED|Overall Study||0
7596032|NCT02584998|18696932|P1|NOT COMPLETED|Overall Study||0
7596033|NCT02584998|18696930|P3|COMPLETED|Overall Study||261
7596034|NCT02584998|18696931|P2|COMPLETED|Overall Study||261
7596035|NCT02584998|18696932|P1|COMPLETED|Overall Study||260
7596036|NCT02584998|18696930|P3|STARTED|Overall Study||261
7596037|NCT02584998|18696931|P2|STARTED|Overall Study||261
7596038|NCT02584998|18696932|P1|STARTED|Overall Study||260
7596039|NCT02584959|18696946|P3|NOT COMPLETED|Period 2||2
7596040|NCT02584959|18696947|P2|NOT COMPLETED|Period 2||1
7596041|NCT02584959|18696948|P1|NOT COMPLETED|Period 2||6
7596042|NCT02584959|18696946|P3|COMPLETED|Period 2||13
7596043|NCT02584959|18696947|P2|COMPLETED|Period 2||24
7596044|NCT02584959|18696948|P1|COMPLETED|Period 2||22
7596045|NCT02584959|18696946|P3|STARTED|Period 2||15
7596046|NCT02584959|18696947|P2|STARTED|Period 2||25
7596047|NCT02584959|18696948|P1|STARTED|Period 2||28
7596048|NCT02584959|18696946|P3|NOT COMPLETED|Period 1||0
7596049|NCT02584959|18696947|P2|NOT COMPLETED|Period 1||4
7596050|NCT02584959|18696948|P1|NOT COMPLETED|Period 1||3
7596051|NCT02584959|18696946|P3|COMPLETED|Period 1||15
7596052|NCT02584959|18696947|P2|COMPLETED|Period 1||25
7596053|NCT02584959|18696948|P1|COMPLETED|Period 1||28
7596054|NCT02584959|18696946|P3|STARTED|Period 1||15
7596055|NCT02584959|18696947|P2|STARTED|Period 1||29
7596056|NCT02584959|18696948|P1|STARTED|Period 1||31
7596057|NCT02584868|18697005|P2|NOT COMPLETED|Overall Study||0
7596058|NCT02584868|18697006|P1|NOT COMPLETED|Overall Study||0
7596059|NCT02584868|18697005|P2|COMPLETED|Overall Study||44
7596060|NCT02584868|18697006|P1|COMPLETED|Overall Study||44
7596061|NCT02584868|18697005|P2|STARTED|Overall Study||44
7596062|NCT02584868|18697006|P1|STARTED|Overall Study||44
7596063|NCT02584855|18697076|P6|NOT COMPLETED|Post Treatment Follow-up Period||0
7596064|NCT02584855|18697077|P5|NOT COMPLETED|Post Treatment Follow-up Period||8
7596065|NCT02584855|18697078|P4|NOT COMPLETED|Post Treatment Follow-up Period||0
7596232|NCT02584257|18697325|P4|STARTED|Period 5||8
7596066|NCT02584855|18697079|P3|NOT COMPLETED|Post Treatment Follow-up Period||0
7596067|NCT02584855|18697080|P2|NOT COMPLETED|Post Treatment Follow-up Period||0
7596068|NCT02584855|18697081|P1|NOT COMPLETED|Post Treatment Follow-up Period||0
7596069|NCT02584855|18697076|P6|COMPLETED|Post Treatment Follow-up Period||12
7596070|NCT02584855|18697077|P5|COMPLETED|Post Treatment Follow-up Period||347
7596071|NCT02584855|18697078|P4|COMPLETED|Post Treatment Follow-up Period||0
7596072|NCT02584855|18697079|P3|COMPLETED|Post Treatment Follow-up Period||0
7596073|NCT02584855|18697080|P2|COMPLETED|Post Treatment Follow-up Period||0
7596074|NCT02584855|18697081|P1|COMPLETED|Post Treatment Follow-up Period||0
7596075|NCT02584855|18697076|P6|STARTED|Post Treatment Follow-up Period||12
7596076|NCT02584855|18697077|P5|STARTED|Post Treatment Follow-up Period||355
7596077|NCT02584855|18697078|P4|STARTED|Post Treatment Follow-up Period||0
7596078|NCT02584855|18697079|P3|STARTED|Post Treatment Follow-up Period||0
7596079|NCT02584855|18697080|P2|STARTED|Post Treatment Follow-up Period||0
7596080|NCT02584855|18697081|P1|STARTED|Post Treatment Follow-up Period||0
7596081|NCT02584855|18697076|P6|NOT COMPLETED|Double-Blind Withdrawal Period||0
7596082|NCT02584855|18697077|P5|NOT COMPLETED|Double-Blind Withdrawal Period||0
7596083|NCT02584855|18697078|P4|NOT COMPLETED|Double-Blind Withdrawal Period||1
7596084|NCT02584855|18697079|P3|NOT COMPLETED|Double-Blind Withdrawal Period||2
7596085|NCT02584855|18697080|P2|NOT COMPLETED|Double-Blind Withdrawal Period||15
7596086|NCT02584855|18697081|P1|NOT COMPLETED|Double-Blind Withdrawal Period||0
7596087|NCT02584855|18697076|P6|COMPLETED|Double-Blind Withdrawal Period||0
7596088|NCT02584855|18697077|P5|COMPLETED|Double-Blind Withdrawal Period||0
7596089|NCT02584855|18697078|P4|COMPLETED|Double-Blind Withdrawal Period||78
7596090|NCT02584855|18697079|P3|COMPLETED|Double-Blind Withdrawal Period||77
7596091|NCT02584855|18697080|P2|COMPLETED|Double-Blind Withdrawal Period||118
7596092|NCT02584855|18697081|P1|COMPLETED|Double-Blind Withdrawal Period||0
7596093|NCT02584855|18697076|P6|Relapsed|Double-Blind Withdrawal Period||0
7596094|NCT02584855|18697077|P5|Relapsed|Double-Blind Withdrawal Period||0
7596095|NCT02584855|18697078|P4|Relapsed|Double-Blind Withdrawal Period||30
7596096|NCT02584855|18697079|P3|Relapsed|Double-Blind Withdrawal Period||67
7596097|NCT02584855|18697080|P2|Relapsed|Double-Blind Withdrawal Period||0
7596098|NCT02584855|18697081|P1|Relapsed|Double-Blind Withdrawal Period||0
7596099|NCT02584855|18697076|P6|STARTED|Double-Blind Withdrawal Period||0
7596100|NCT02584855|18697077|P5|STARTED|Double-Blind Withdrawal Period||0
7596101|NCT02584855|18697078|P4|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
7596102|NCT02584855|18697079|P3|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
7596103|NCT02584855|18697080|P2|STARTED|Double-Blind Withdrawal Period|Participants completed open label but did not meet criteria for double-blind withdrawal period.|133
7596104|NCT02584855|18697081|P1|STARTED|Double-Blind Withdrawal Period||0
7596105|NCT02584855|18697076|P6|NOT COMPLETED|Open-Label Treatment Period||0
7596106|NCT02584855|18697077|P5|NOT COMPLETED|Open-Label Treatment Period||0
7596107|NCT02584855|18697078|P4|NOT COMPLETED|Open-Label Treatment Period||0
7596108|NCT02584855|18697079|P3|NOT COMPLETED|Open-Label Treatment Period||0
7596109|NCT02584855|18697080|P2|NOT COMPLETED|Open-Label Treatment Period||0
7596110|NCT02584855|18697081|P1|NOT COMPLETED|Open-Label Treatment Period||103
7596111|NCT02584855|18697076|P6|COMPLETED|Open-Label Treatment Period||0
7596112|NCT02584855|18697077|P5|COMPLETED|Open-Label Treatment Period||0
7596113|NCT02584855|18697078|P4|COMPLETED|Open-Label Treatment Period||0
7596114|NCT02584855|18697079|P3|COMPLETED|Open-Label Treatment Period||0
7596115|NCT02584855|18697080|P2|COMPLETED|Open-Label Treatment Period||0
7596116|NCT02584855|18697081|P1|COMPLETED|Open-Label Treatment Period||291
7596117|NCT02584855|18697076|P6|Non-randomized|Open-Label Treatment Period||0
7596118|NCT02584855|18697077|P5|Non-randomized|Open-Label Treatment Period||0
7596119|NCT02584855|18697078|P4|Non-randomized|Open-Label Treatment Period||0
7596120|NCT02584855|18697079|P3|Non-randomized|Open-Label Treatment Period||0
7596121|NCT02584855|18697080|P2|Non-randomized|Open-Label Treatment Period||0
7596122|NCT02584855|18697081|P1|Non-randomized|Open-Label Treatment Period||133
7596123|NCT02584855|18697076|P6|Met Randomization Criteria|Open-Label Treatment Period||0
7596124|NCT02584855|18697077|P5|Met Randomization Criteria|Open-Label Treatment Period||0
7596125|NCT02584855|18697078|P4|Met Randomization Criteria|Open-Label Treatment Period||0
7596126|NCT02584855|18697079|P3|Met Randomization Criteria|Open-Label Treatment Period||0
7596127|NCT02584855|18697080|P2|Met Randomization Criteria|Open-Label Treatment Period||0
7596128|NCT02584855|18697081|P1|Met Randomization Criteria|Open-Label Treatment Period||158
7596129|NCT02584855|18697076|P6|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
7596130|NCT02584855|18697077|P5|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
7596131|NCT02584855|18697078|P4|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
7596132|NCT02584855|18697079|P3|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
7596133|NCT02584855|18697080|P2|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
7596134|NCT02584855|18697081|P1|Received at Least One Dose of Study Drug|Open-Label Treatment Period||394
7596135|NCT02584855|18697076|P6|STARTED|Open-Label Treatment Period||0
7596136|NCT02584855|18697077|P5|STARTED|Open-Label Treatment Period||0
7596137|NCT02584855|18697078|P4|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
7596138|NCT02584855|18697079|P3|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
7596233|NCT02584257|18697326|P3|STARTED|Period 5||9
7596139|NCT02584855|18697080|P2|STARTED|Open-Label Treatment Period|Participants completed Open-Label Treatment Period.|0
7596140|NCT02584855|18697081|P1|STARTED|Open-Label Treatment Period||394
7596141|NCT02584790|18697115|P1|NOT COMPLETED|Overall Study||15
7596142|NCT02584790|18697115|P1|COMPLETED|Overall Study||40
7596143|NCT02584790|18697115|P1|STARTED|Overall Study||55
7596144|NCT02584725|18697124|P3|NOT COMPLETED|Overall Study||0
7596145|NCT02584725|18697125|P2|NOT COMPLETED|Overall Study||0
7596146|NCT02584725|18697126|P1|NOT COMPLETED|Overall Study||0
7596147|NCT02584725|18697124|P3|COMPLETED|Overall Study||28
7596148|NCT02584725|18697125|P2|COMPLETED|Overall Study||28
7596149|NCT02584725|18697126|P1|COMPLETED|Overall Study||28
7596150|NCT02584725|18697124|P3|STARTED|Overall Study||28
7596151|NCT02584725|18697125|P2|STARTED|Overall Study||28
7596152|NCT02584725|18697126|P1|STARTED|Overall Study||28
7596153|NCT02584686|18697169|P2|NOT COMPLETED|Overall Study||0
7596154|NCT02584686|18697170|P1|NOT COMPLETED|Overall Study||0
7596155|NCT02584686|18697169|P2|COMPLETED|Overall Study||12
7596156|NCT02584686|18697170|P1|COMPLETED|Overall Study||12
7596157|NCT02584686|18697169|P2|STARTED|Overall Study||12
7596158|NCT02584686|18697170|P1|STARTED|Overall Study||12
7596159|NCT02584673|18697198|P2|NOT COMPLETED|Overall Study||0
7596160|NCT02584673|18697199|P1|NOT COMPLETED|Overall Study||0
7596161|NCT02584673|18697198|P2|COMPLETED|Overall Study||15
7596162|NCT02584673|18697199|P1|COMPLETED|Overall Study||15
7596163|NCT02584673|18697198|P2|STARTED|Overall Study||15
7596164|NCT02584673|18697199|P1|STARTED|Overall Study||15
7596165|NCT02584660|18697213|P2|NOT COMPLETED|Overall Study||8
7596166|NCT02584660|18697214|P1|NOT COMPLETED|Overall Study||7
7596167|NCT02584660|18697213|P2|COMPLETED|Overall Study||55
7596168|NCT02584660|18697214|P1|COMPLETED|Overall Study||44
7596169|NCT02584660|18697213|P2|Treated|Overall Study||63
7596170|NCT02584660|18697214|P1|Treated|Overall Study||49
7596171|NCT02584660|18697213|P2|STARTED|Overall Study||63
7596172|NCT02584660|18697214|P1|STARTED|Overall Study||51
7596173|NCT02584504|18697233|P3|NOT COMPLETED|Open-label Treatment||8
7596174|NCT02584504|18697234|P2|NOT COMPLETED|Open-label Treatment||4
7596175|NCT02584504|18697235|P1|NOT COMPLETED|Open-label Treatment||2
7596176|NCT02584504|18697233|P3|COMPLETED|Open-label Treatment||47
7596177|NCT02584504|18697234|P2|COMPLETED|Open-label Treatment||47
7596178|NCT02584504|18697235|P1|COMPLETED|Open-label Treatment||52
7596179|NCT02584504|18697233|P3|Treated|Open-label Treatment||54
7596180|NCT02584504|18697234|P2|Treated|Open-label Treatment||50
7596181|NCT02584504|18697235|P1|Treated|Open-label Treatment||54
7596182|NCT02584504|18697233|P3|STARTED|Open-label Treatment||55
7596183|NCT02584504|18697234|P2|STARTED|Open-label Treatment||51
7596184|NCT02584504|18697235|P1|STARTED|Open-label Treatment||54
7596185|NCT02584504|18697233|P3|NOT COMPLETED|Double-blind Treatment||1
7596186|NCT02584504|18697234|P2|NOT COMPLETED|Double-blind Treatment||2
7596187|NCT02584504|18697235|P1|NOT COMPLETED|Double-blind Treatment||0
7596188|NCT02584504|18697233|P3|COMPLETED|Double-blind Treatment||55
7596189|NCT02584504|18697234|P2|COMPLETED|Double-blind Treatment||51
7596190|NCT02584504|18697235|P1|COMPLETED|Double-blind Treatment||54
7596191|NCT02584504|18697233|P3|Safety Population|Double-blind Treatment||56
7596192|NCT02584504|18697234|P2|Safety Population|Double-blind Treatment||53
7596193|NCT02584504|18697235|P1|Safety Population|Double-blind Treatment||54
7596194|NCT02584504|18697233|P3|mITT Population|Double-blind Treatment||56
7596195|NCT02584504|18697234|P2|mITT Population|Double-blind Treatment||53
7596196|NCT02584504|18697235|P1|mITT Population|Double-blind Treatment||54
7596197|NCT02584504|18697233|P3|ITT Population|Double-blind Treatment||56
7596198|NCT02584504|18697234|P2|ITT Population|Double-blind Treatment||53
7596199|NCT02584504|18697235|P1|ITT Population|Double-blind Treatment||54
7596200|NCT02584504|18697233|P3|STARTED|Double-blind Treatment|Randomized|56
7596201|NCT02584504|18697234|P2|STARTED|Double-blind Treatment|Randomized|53
7596202|NCT02584504|18697235|P1|STARTED|Double-blind Treatment|Randomized|54
7596203|NCT02584452|18697291|P2|NOT COMPLETED|Overall Study||2
7596204|NCT02584452|18697292|P1|NOT COMPLETED|Overall Study||2
7596205|NCT02584452|18697291|P2|COMPLETED|Overall Study||21
7596206|NCT02584452|18697292|P1|COMPLETED|Overall Study||32
7596207|NCT02584452|18697291|P2|STARTED|Overall Study||23
7596208|NCT02584452|18697292|P1|STARTED|Overall Study||34
7596209|NCT02584257|18697320|P9|NOT COMPLETED|Period 5||0
7596210|NCT02584257|18697321|P8|NOT COMPLETED|Period 5||0
7596211|NCT02584257|18697322|P7|NOT COMPLETED|Period 5||0
7596212|NCT02584257|18697323|P6|NOT COMPLETED|Period 5||0
7596213|NCT02584257|18697324|P5|NOT COMPLETED|Period 5||0
7596214|NCT02584257|18697325|P4|NOT COMPLETED|Period 5||0
7596215|NCT02584257|18697326|P3|NOT COMPLETED|Period 5||0
7596216|NCT02584257|18697327|P2|NOT COMPLETED|Period 5||0
7596217|NCT02584257|18697328|P1|NOT COMPLETED|Period 5||0
7596218|NCT02584257|18697320|P9|COMPLETED|Period 5||9
7596219|NCT02584257|18697321|P8|COMPLETED|Period 5||9
7596220|NCT02584257|18697322|P7|COMPLETED|Period 5||17
7596221|NCT02584257|18697323|P6|COMPLETED|Period 5||10
7596222|NCT02584257|18697324|P5|COMPLETED|Period 5||10
7596223|NCT02584257|18697325|P4|COMPLETED|Period 5||8
7596224|NCT02584257|18697326|P3|COMPLETED|Period 5||9
7596225|NCT02584257|18697327|P2|COMPLETED|Period 5||8
7596226|NCT02584257|18697328|P1|COMPLETED|Period 5||8
7596227|NCT02584257|18697320|P9|STARTED|Period 5||9
7596228|NCT02584257|18697321|P8|STARTED|Period 5||9
7596229|NCT02584257|18697322|P7|STARTED|Period 5||17
7596230|NCT02584257|18697323|P6|STARTED|Period 5||10
7596231|NCT02584257|18697324|P5|STARTED|Period 5||10
7596234|NCT02584257|18697327|P2|STARTED|Period 5||8
7596235|NCT02584257|18697328|P1|STARTED|Period 5||8
7596236|NCT02584257|18697320|P9|NOT COMPLETED|Period 4||0
7596237|NCT02584257|18697321|P8|NOT COMPLETED|Period 4||0
7596238|NCT02584257|18697322|P7|NOT COMPLETED|Period 4||0
7596239|NCT02584257|18697323|P6|NOT COMPLETED|Period 4||0
7596240|NCT02584257|18697324|P5|NOT COMPLETED|Period 4||0
7596241|NCT02584257|18697325|P4|NOT COMPLETED|Period 4||0
7596242|NCT02584257|18697326|P3|NOT COMPLETED|Period 4||0
7596243|NCT02584257|18697327|P2|NOT COMPLETED|Period 4||0
7596244|NCT02584257|18697328|P1|NOT COMPLETED|Period 4||0
7596245|NCT02584257|18697320|P9|COMPLETED|Period 4||9
7596246|NCT02584257|18697321|P8|COMPLETED|Period 4||9
7596247|NCT02584257|18697322|P7|COMPLETED|Period 4||17
7596248|NCT02584257|18697323|P6|COMPLETED|Period 4||10
7596249|NCT02584257|18697324|P5|COMPLETED|Period 4||10
7596250|NCT02584257|18697325|P4|COMPLETED|Period 4||8
7596251|NCT02584257|18697326|P3|COMPLETED|Period 4||9
7596252|NCT02584257|18697327|P2|COMPLETED|Period 4||8
7596253|NCT02584257|18697328|P1|COMPLETED|Period 4||8
7596254|NCT02584257|18697320|P9|STARTED|Period 4||9
7596255|NCT02584257|18697321|P8|STARTED|Period 4||9
7596256|NCT02584257|18697322|P7|STARTED|Period 4||17
7596257|NCT02584257|18697323|P6|STARTED|Period 4||10
7596258|NCT02584257|18697324|P5|STARTED|Period 4||10
7596259|NCT02584257|18697325|P4|STARTED|Period 4||8
7596260|NCT02584257|18697326|P3|STARTED|Period 4||9
7596261|NCT02584257|18697327|P2|STARTED|Period 4||8
7596262|NCT02584257|18697328|P1|STARTED|Period 4||8
7596263|NCT02584257|18697320|P9|NOT COMPLETED|Period 3||0
7596264|NCT02584257|18697321|P8|NOT COMPLETED|Period 3||0
7596265|NCT02584257|18697322|P7|NOT COMPLETED|Period 3||0
7596266|NCT02584257|18697323|P6|NOT COMPLETED|Period 3||0
7596267|NCT02584257|18697324|P5|NOT COMPLETED|Period 3||0
7596268|NCT02584257|18697325|P4|NOT COMPLETED|Period 3||0
7596269|NCT02584257|18697326|P3|NOT COMPLETED|Period 3||0
7596270|NCT02584257|18697327|P2|NOT COMPLETED|Period 3||0
7596271|NCT02584257|18697328|P1|NOT COMPLETED|Period 3||0
7596272|NCT02584257|18697320|P9|COMPLETED|Period 3||9
7596273|NCT02584257|18697321|P8|COMPLETED|Period 3||9
7596274|NCT02584257|18697322|P7|COMPLETED|Period 3||17
7596275|NCT02584257|18697323|P6|COMPLETED|Period 3||10
7596276|NCT02584257|18697324|P5|COMPLETED|Period 3||10
7596277|NCT02584257|18697325|P4|COMPLETED|Period 3||8
7596278|NCT02584257|18697326|P3|COMPLETED|Period 3||9
7596279|NCT02584257|18697327|P2|COMPLETED|Period 3||8
7596280|NCT02584257|18697328|P1|COMPLETED|Period 3||8
7596281|NCT02584257|18697320|P9|STARTED|Period 3||9
7596282|NCT02584257|18697321|P8|STARTED|Period 3||9
7596283|NCT02584257|18697322|P7|STARTED|Period 3||17
7596284|NCT02584257|18697323|P6|STARTED|Period 3||10
7596285|NCT02584257|18697324|P5|STARTED|Period 3||10
7596286|NCT02584257|18697325|P4|STARTED|Period 3||8
7596287|NCT02584257|18697326|P3|STARTED|Period 3||9
7596288|NCT02584257|18697327|P2|STARTED|Period 3||8
7596289|NCT02584257|18697328|P1|STARTED|Period 3||8
7596290|NCT02584257|18697320|P9|NOT COMPLETED|Period 2||0
7596291|NCT02584257|18697321|P8|NOT COMPLETED|Period 2||0
7596292|NCT02584257|18697322|P7|NOT COMPLETED|Period 2||0
7596293|NCT02584257|18697323|P6|NOT COMPLETED|Period 2||0
7596294|NCT02584257|18697324|P5|NOT COMPLETED|Period 2||0
7596295|NCT02584257|18697325|P4|NOT COMPLETED|Period 2||0
7596296|NCT02584257|18697326|P3|NOT COMPLETED|Period 2||0
7596297|NCT02584257|18697327|P2|NOT COMPLETED|Period 2||1
7596298|NCT02584257|18697328|P1|NOT COMPLETED|Period 2||1
7596299|NCT02584257|18697320|P9|COMPLETED|Period 2||9
7596300|NCT02584257|18697321|P8|COMPLETED|Period 2||9
7596301|NCT02584257|18697322|P7|COMPLETED|Period 2||17
7596302|NCT02584257|18697323|P6|COMPLETED|Period 2||10
7596303|NCT02584257|18697324|P5|COMPLETED|Period 2||10
7596304|NCT02584257|18697325|P4|COMPLETED|Period 2||8
7596305|NCT02584257|18697326|P3|COMPLETED|Period 2||9
7596306|NCT02584257|18697327|P2|COMPLETED|Period 2||8
7596307|NCT02584257|18697328|P1|COMPLETED|Period 2||8
7596308|NCT02584257|18697320|P9|STARTED|Period 2||9
7596309|NCT02584257|18697321|P8|STARTED|Period 2||9
7596310|NCT02584257|18697322|P7|STARTED|Period 2||17
7596311|NCT02584257|18697323|P6|STARTED|Period 2||10
7596312|NCT02584257|18697324|P5|STARTED|Period 2||10
7596313|NCT02584257|18697325|P4|STARTED|Period 2||8
7596314|NCT02584257|18697326|P3|STARTED|Period 2||9
7596315|NCT02584257|18697327|P2|STARTED|Period 2||9
7596316|NCT02584257|18697328|P1|STARTED|Period 2||9
7596317|NCT02584257|18697320|P9|NOT COMPLETED|Period 1||0
7596318|NCT02584257|18697321|P8|NOT COMPLETED|Period 1||0
7596319|NCT02584257|18697322|P7|NOT COMPLETED|Period 1||1
7596320|NCT02584257|18697323|P6|NOT COMPLETED|Period 1||0
7596321|NCT02584257|18697324|P5|NOT COMPLETED|Period 1||0
7596322|NCT02584257|18697325|P4|NOT COMPLETED|Period 1||0
7596323|NCT02584257|18697326|P3|NOT COMPLETED|Period 1||0
7596324|NCT02584257|18697327|P2|NOT COMPLETED|Period 1||0
7596325|NCT02584257|18697328|P1|NOT COMPLETED|Period 1||0
7596326|NCT02584257|18697320|P9|COMPLETED|Period 1||9
7596327|NCT02584257|18697321|P8|COMPLETED|Period 1||9
7596328|NCT02584257|18697322|P7|COMPLETED|Period 1||17
7596329|NCT02584257|18697323|P6|COMPLETED|Period 1||10
7596330|NCT02584257|18697324|P5|COMPLETED|Period 1||10
7596331|NCT02584257|18697325|P4|COMPLETED|Period 1||8
7596332|NCT02584257|18697326|P3|COMPLETED|Period 1||9
7596333|NCT02584257|18697327|P2|COMPLETED|Period 1||9
7596334|NCT02584257|18697328|P1|COMPLETED|Period 1||9
7596335|NCT02584257|18697320|P9|STARTED|Period 1||9
7596336|NCT02584257|18697321|P8|STARTED|Period 1||9
7596337|NCT02584257|18697322|P7|STARTED|Period 1||18
7596338|NCT02584257|18697323|P6|STARTED|Period 1||10
7596339|NCT02584257|18697324|P5|STARTED|Period 1||10
7596340|NCT02584257|18697325|P4|STARTED|Period 1||8
7596341|NCT02584257|18697326|P3|STARTED|Period 1||9
7596342|NCT02584257|18697327|P2|STARTED|Period 1||9
7596343|NCT02584257|18697328|P1|STARTED|Period 1||9
7596344|NCT02584140|18697340|P1|NOT COMPLETED|Overall Study||53
7596345|NCT02584140|18697340|P1|COMPLETED|Overall Study||83
7596346|NCT02584140|18697340|P1|STARTED|Overall Study||136
7596347|NCT02583477|18697349|P2|NOT COMPLETED|Overall Study||20
7596348|NCT02583477|18697350|P1|NOT COMPLETED|Overall Study||3
7596349|NCT02583477|18697349|P2|COMPLETED|Overall Study||0
7596350|NCT02583477|18697350|P1|COMPLETED|Overall Study||0
7596351|NCT02583477|18697349|P2|Completed Treatment|Overall Study||0
7596352|NCT02583477|18697350|P1|Completed Treatment|Overall Study||0
7596353|NCT02583477|18697349|P2|Received Treatment|Overall Study||20
7596354|NCT02583477|18697350|P1|Received Treatment|Overall Study||3
7596355|NCT02583477|18697349|P2|STARTED|Overall Study||20
7596356|NCT02583477|18697350|P1|STARTED|Overall Study||3
7596357|NCT02583425|18697370|P1|NOT COMPLETED|Treatment Period||1
7596358|NCT02583425|18697370|P1|COMPLETED|Treatment Period||9
7596359|NCT02583425|18697370|P1|STARTED|Treatment Period||10
7596360|NCT02583425|18697370|P1|NOT COMPLETED|Baseline||5
7596361|NCT02583425|18697370|P1|COMPLETED|Baseline||10
7596362|NCT02583425|18697370|P1|STARTED|Baseline||15
7596363|NCT02583425|18697370|P1|NOT COMPLETED|Screening||12
7596364|NCT02583425|18697370|P1|COMPLETED|Screening||15
7596365|NCT02583425|18697370|P1|STARTED|Screening||27
7596366|NCT02583399|18697375|P1|NOT COMPLETED|Overall Study||6
7596367|NCT02583399|18697375|P1|COMPLETED|Overall Study||24
7596368|NCT02583399|18697375|P1|STARTED|Overall Study||30
7596369|NCT02583360|18697384|P2|NOT COMPLETED|Overall Study||0
7596370|NCT02583360|18697385|P1|NOT COMPLETED|Overall Study||0
7596371|NCT02583360|18697384|P2|COMPLETED|Overall Study||49
7596372|NCT02583360|18697385|P1|COMPLETED|Overall Study||60
7596373|NCT02583360|18697384|P2|STARTED|Overall Study||49
7596374|NCT02583360|18697385|P1|STARTED|Overall Study||60
7596375|NCT02583269|18697400|P5|NOT COMPLETED|Overall Study||0
7596376|NCT02583269|18697401|P4|NOT COMPLETED|Overall Study||0
7596377|NCT02583269|18697402|P3|NOT COMPLETED|Overall Study||0
7596378|NCT02583269|18697403|P2|NOT COMPLETED|Overall Study||0
7596379|NCT02583269|18697404|P1|NOT COMPLETED|Overall Study||1
7596380|NCT02583269|18697400|P5|COMPLETED|Overall Study||6
7596381|NCT02583269|18697401|P4|COMPLETED|Overall Study||5
7596382|NCT02583269|18697402|P3|COMPLETED|Overall Study||3
7596383|NCT02583269|18697403|P2|COMPLETED|Overall Study||7
7596384|NCT02583269|18697404|P1|COMPLETED|Overall Study||2
7596385|NCT02583269|18697400|P5|STARTED|Overall Study||6
7596386|NCT02583269|18697401|P4|STARTED|Overall Study||5
7596387|NCT02583269|18697402|P3|STARTED|Overall Study||3
7596388|NCT02583269|18697403|P2|STARTED|Overall Study||7
7596389|NCT02583269|18697404|P1|STARTED|Overall Study||3
7596390|NCT02583256|18697433|P4|NOT COMPLETED|Overall Study||3
7596391|NCT02583256|18697434|P3|NOT COMPLETED|Overall Study||2
7596392|NCT02583256|18697435|P2|NOT COMPLETED|Overall Study||2
7596393|NCT02583256|18697436|P1|NOT COMPLETED|Overall Study||3
7596394|NCT02583256|18697433|P4|COMPLETED|Overall Study||390
7596395|NCT02583256|18697434|P3|COMPLETED|Overall Study||400
7596396|NCT02583256|18697435|P2|COMPLETED|Overall Study||401
7596397|NCT02583256|18697436|P1|COMPLETED|Overall Study||400
7596398|NCT02583256|18697433|P4|Exposed|Overall Study||393
7596399|NCT02583256|18697434|P3|Exposed|Overall Study||402
7596400|NCT02583256|18697435|P2|Exposed|Overall Study||403
7596401|NCT02583256|18697436|P1|Exposed|Overall Study||403
7596402|NCT02583256|18697433|P4|STARTED|Overall Study||393
7596403|NCT02583256|18697434|P3|STARTED|Overall Study||402
7596404|NCT02583256|18697435|P2|STARTED|Overall Study||403
7596405|NCT02583256|18697436|P1|STARTED|Overall Study||403
7596406|NCT02583230|18697524|P1|NOT COMPLETED|Overall Study||0
7596407|NCT02583230|18697524|P1|COMPLETED|Overall Study||11
7596408|NCT02583230|18697524|P1|STARTED|Overall Study||11
7596409|NCT02583048|18697533|P3|NOT COMPLETED|Overall Study||1
7596410|NCT02583048|18697534|P2|NOT COMPLETED|Overall Study||1
7596411|NCT02583048|18697535|P1|NOT COMPLETED|Overall Study||0
7596412|NCT02583048|18697533|P3|COMPLETED|Overall Study||27
7596413|NCT02583048|18697534|P2|COMPLETED|Overall Study||27
7596414|NCT02583048|18697535|P1|COMPLETED|Overall Study||28
7596415|NCT02583048|18697533|P3|STARTED|Overall Study||28
7596416|NCT02583048|18697534|P2|STARTED|Overall Study||28
7596417|NCT02583048|18697535|P1|STARTED|Overall Study||28
7596418|NCT02582983|18697570|P1|NOT COMPLETED|Overall Study||6
7596419|NCT02582983|18697570|P1|COMPLETED|Overall Study||17
7596420|NCT02582983|18697570|P1|STARTED|Overall Study||23
7596421|NCT02582970|18697575|P1|NOT COMPLETED|Overall Study||0
7596422|NCT02582970|18697575|P1|COMPLETED|Overall Study||40
7596423|NCT02582970|18697575|P1|STARTED|Overall Study||40
7596424|NCT02582840|18697588|P3|NOT COMPLETED|Overall Study||0
7596425|NCT02582840|18697589|P2|NOT COMPLETED|Overall Study||0
7596426|NCT02582840|18697590|P1|NOT COMPLETED|Overall Study||0
7596427|NCT02582840|18697588|P3|COMPLETED|Overall Study||14
7596428|NCT02582840|18697589|P2|COMPLETED|Overall Study||14
7596429|NCT02582840|18697590|P1|COMPLETED|Overall Study||14
7596430|NCT02582840|18697588|P3|STARTED|Overall Study||14
7596431|NCT02582840|18697589|P2|STARTED|Overall Study||14
7596432|NCT02582840|18697590|P1|STARTED|Overall Study||14
7596433|NCT02582814|18697633|P2|NOT COMPLETED|Overall Study||7
7596434|NCT02582814|18697634|P1|NOT COMPLETED|Overall Study||9
7596435|NCT02582814|18697633|P2|COMPLETED|Overall Study||68
7596436|NCT02582814|18697634|P1|COMPLETED|Overall Study||67
7596437|NCT02582814|18697633|P2|STARTED|Overall Study||75
7596438|NCT02582814|18697634|P1|STARTED|Overall Study||76
7596439|NCT02582749|18697674|P2|NOT COMPLETED|Overall Study||11
7596440|NCT02582749|18697675|P1|NOT COMPLETED|Overall Study||5
7596441|NCT02582749|18697674|P2|COMPLETED|Overall Study||0
7596442|NCT02582749|18697675|P1|COMPLETED|Overall Study||0
7596443|NCT02582749|18697674|P2|STARTED|Overall Study||11
7596444|NCT02582749|18697675|P1|STARTED|Overall Study||5
7596445|NCT02582684|18697705|P1|NOT COMPLETED|Overall Study||17
7596446|NCT02582684|18697705|P1|COMPLETED|Overall Study||105
7596447|NCT02582684|18697705|P1|STARTED|Overall Study||122
7596448|NCT02582671|18697724|P1|NOT COMPLETED|Overall Study||2
7596449|NCT02582671|18697724|P1|COMPLETED|Overall Study||99
7596450|NCT02582671|18697724|P1|STARTED|Overall Study||101
7596451|NCT02582658|18697736|P1|NOT COMPLETED|Overall Study||25
7596452|NCT02582658|18697736|P1|COMPLETED|Overall Study||146
7596453|NCT02582658|18697736|P1|STARTED|Overall Study||171
7596454|NCT02582632|18697754|P1|NOT COMPLETED|Overall Study||1
7596455|NCT02582632|18697754|P1|COMPLETED|Overall Study||165
7596456|NCT02582632|18697754|P1|STARTED|Overall Study||166
7596457|NCT02582515|18697769|P2|NOT COMPLETED|Overall Study||1
7596458|NCT02582515|18697770|P1|NOT COMPLETED|Overall Study||0
7596459|NCT02582515|18697769|P2|COMPLETED|Overall Study||10
7596460|NCT02582515|18697770|P1|COMPLETED|Overall Study||9
7596461|NCT02582515|18697769|P2|Received Study Intervention|Overall Study||10
7596462|NCT02582515|18697770|P1|Received Study Intervention|Overall Study||9
7596463|NCT02582515|18697769|P2|STARTED|Overall Study||11
7596464|NCT02582515|18697770|P1|STARTED|Overall Study||9
7596465|NCT02582255|18697778|P2|NOT COMPLETED|Overall Study||3
7596466|NCT02582255|18697779|P1|NOT COMPLETED|Overall Study||0
7596467|NCT02582255|18697778|P2|COMPLETED|Overall Study||47
7596468|NCT02582255|18697779|P1|COMPLETED|Overall Study||50
7596469|NCT02582255|18697778|P2|STARTED|Overall Study||50
7596470|NCT02582255|18697779|P1|STARTED|Overall Study||50
7596471|NCT02582242|18697792|P2|NOT COMPLETED|Overall Study||17
7596472|NCT02582242|18697793|P1|NOT COMPLETED|Overall Study||20
7596473|NCT02582242|18697792|P2|COMPLETED|Overall Study||200
7596474|NCT02582242|18697793|P1|COMPLETED|Overall Study||200
7596475|NCT02582242|18697792|P2|STARTED|Overall Study||217
7596476|NCT02582242|18697793|P1|STARTED|Overall Study||220
7596477|NCT02582216|18697833|P1|NOT COMPLETED|Overall Study||0
7596478|NCT02582216|18697833|P1|COMPLETED|Overall Study||22
7596479|NCT02582216|18697833|P1|STARTED|Overall Study||22
7596480|NCT02582151|18697840|P2|NOT COMPLETED|Overall Study||0
7596481|NCT02582151|18697841|P1|NOT COMPLETED|Overall Study||2
7596482|NCT02582151|18697840|P2|COMPLETED|Overall Study||16
7596483|NCT02582151|18697841|P1|COMPLETED|Overall Study||12
7596484|NCT02582151|18697840|P2|STARTED|Overall Study||16
7596485|NCT02582151|18697841|P1|STARTED|Overall Study||14
7596486|NCT02581995|18697857|P1|NOT COMPLETED|Overall Study||31
7596487|NCT02581995|18697857|P1|COMPLETED|Overall Study||529
7596488|NCT02581995|18697857|P1|Treated|Overall Study||560
7596489|NCT02581995|18697857|P1|STARTED|Overall Study||560
7596490|NCT02581930|18697871|P1|NOT COMPLETED|Overall Study||2
7596491|NCT02581930|18697871|P1|COMPLETED|Overall Study||16
7596492|NCT02581930|18697871|P1|STARTED|Overall Study||18
7596493|NCT02581891|18697879|P2|NOT COMPLETED|Overall Study||19
7596494|NCT02581891|18697880|P1|NOT COMPLETED|Overall Study||16
7596495|NCT02581891|18697879|P2|COMPLETED|Overall Study||117
7596496|NCT02581891|18697880|P1|COMPLETED|Overall Study||119
7596497|NCT02581891|18697879|P2|Completed Treatment|Overall Study||117
7596498|NCT02581891|18697880|P1|Completed Treatment|Overall Study||120
7596499|NCT02581891|18697879|P2|STARTED|Overall Study||136
7596500|NCT02581891|18697880|P1|STARTED|Overall Study||135
7596501|NCT02581865|18697906|P3|NOT COMPLETED|Overall Study||16
7596502|NCT02581865|18697907|P2|NOT COMPLETED|Overall Study||7
7596503|NCT02581865|18697908|P1|NOT COMPLETED|Overall Study||4
7596504|NCT02581865|18697906|P3|COMPLETED|Overall Study||26
7596505|NCT02581865|18697907|P2|COMPLETED|Overall Study||35
7596506|NCT02581865|18697908|P1|COMPLETED|Overall Study||36
7596507|NCT02581865|18697906|P3|STARTED|Overall Study||42
7596508|NCT02581865|18697907|P2|STARTED|Overall Study||42
7596509|NCT02581865|18697908|P1|STARTED|Overall Study||40
7596510|NCT02581839|18697931|P1|NOT COMPLETED|Overall Study||0
7596511|NCT02581839|18697931|P1|COMPLETED|Overall Study||9
7596512|NCT02581839|18697931|P1|STARTED|Overall Study||9
7596513|NCT02581488|18697943|P2|NOT COMPLETED|Overall Study||11
7596514|NCT02581488|18697944|P1|NOT COMPLETED|Overall Study||9
7596515|NCT02581488|18697943|P2|COMPLETED|Overall Study||40
7596516|NCT02581488|18697944|P1|COMPLETED|Overall Study||42
7596517|NCT02581488|18697943|P2|STARTED|Overall Study||51
7596518|NCT02581488|18697944|P1|STARTED|Overall Study||51
7596519|NCT02581475|18697960|P2|NOT COMPLETED|Overall Study||15
7596520|NCT02581475|18697961|P1|NOT COMPLETED|Overall Study||11
7596521|NCT02581475|18697960|P2|COMPLETED|Overall Study||178
7596522|NCT02581475|18697961|P1|COMPLETED|Overall Study||182
7596523|NCT02581475|18697960|P2|STARTED|Overall Study||193
7596524|NCT02581475|18697961|P1|STARTED|Overall Study||193
7596525|NCT02581410|18697975|P2|NOT COMPLETED|End of Study Phase||11
7596526|NCT02581410|18697976|P1|NOT COMPLETED|End of Study Phase||5
7596527|NCT02581410|18697975|P2|COMPLETED|End of Study Phase||204
7596528|NCT02581410|18697976|P1|COMPLETED|End of Study Phase||210
7596529|NCT02581410|18697975|P2|STARTED|End of Study Phase||215
7596530|NCT02581410|18697976|P1|STARTED|End of Study Phase||215
7596531|NCT02581410|18697975|P2|NOT COMPLETED|Vaccination Phase||3
7596532|NCT02581410|18697976|P1|NOT COMPLETED|Vaccination Phase||2
7596533|NCT02581410|18697975|P2|COMPLETED|Vaccination Phase||212
7596534|NCT02581410|18697976|P1|COMPLETED|Vaccination Phase||213
7596535|NCT02581410|18697975|P2|STARTED|Vaccination Phase||215
7596536|NCT02581410|18697976|P1|STARTED|Vaccination Phase||215
7596537|NCT02581345|18698006|P4|NOT COMPLETED|Part 2: Week 17 to Week 47||12
7596538|NCT02581345|18698007|P3|NOT COMPLETED|Part 2: Week 17 to Week 47||15
7596539|NCT02581345|18698008|P2|NOT COMPLETED|Part 2: Week 17 to Week 47||0
7596540|NCT02581345|18698009|P1|NOT COMPLETED|Part 2: Week 17 to Week 47||29
7596541|NCT02581345|18698006|P4|COMPLETED|Part 2: Week 17 to Week 47||119
7596542|NCT02581345|18698007|P3|COMPLETED|Part 2: Week 17 to Week 47||117
7596543|NCT02581345|18698008|P2|COMPLETED|Part 2: Week 17 to Week 47||0
7596544|NCT02581345|18698009|P1|COMPLETED|Part 2: Week 17 to Week 47||242
7596545|NCT02581345|18698006|P4|STARTED|Part 2: Week 17 to Week 47||131
7596546|NCT02581345|18698007|P3|STARTED|Part 2: Week 17 to Week 47||132
7596547|NCT02581345|18698008|P2|STARTED|Part 2: Week 17 to Week 47||0
7596548|NCT02581345|18698009|P1|STARTED|Part 2: Week 17 to Week 47||271
7596549|NCT02581345|18698006|P4|NOT COMPLETED|Part 1: up to Week 16||0
7596550|NCT02581345|18698007|P3|NOT COMPLETED|Part 1: up to Week 16||0
7596551|NCT02581345|18698008|P2|NOT COMPLETED|Part 1: up to Week 16||23
7596552|NCT02581345|18698009|P1|NOT COMPLETED|Part 1: up to Week 16||15
7596553|NCT02581345|18698006|P4|COMPLETED|Part 1: up to Week 16||0
7596554|NCT02581345|18698007|P3|COMPLETED|Part 1: up to Week 16||0
7596555|NCT02581345|18698008|P2|COMPLETED|Part 1: up to Week 16||263
7596556|NCT02581345|18698009|P1|COMPLETED|Part 1: up to Week 16||271
7596557|NCT02581345|18698006|P4|STARTED|Part 1: up to Week 16||0
7596558|NCT02581345|18698007|P3|STARTED|Part 1: up to Week 16||0
7596559|NCT02581345|18698008|P2|STARTED|Part 1: up to Week 16||286
7596560|NCT02581345|18698009|P1|STARTED|Part 1: up to Week 16||286
7596561|NCT02581202|18698111|P1|NOT COMPLETED|Overall Study||14
7596562|NCT02581202|18698111|P1|COMPLETED|Overall Study||202
7596563|NCT02581202|18698111|P1|STARTED|Overall Study||216
7596564|NCT02581189|18698150|P1|NOT COMPLETED|Overall Study||53
7596565|NCT02581189|18698150|P1|COMPLETED|Overall Study||481
7596566|NCT02581189|18698150|P1|STARTED|Overall Study||534
7596567|NCT02581163|18698164|P1|NOT COMPLETED|Overall Study||29
7596568|NCT02581163|18698164|P1|COMPLETED|Overall Study||282
7596569|NCT02581163|18698164|P1|STARTED|Overall Study||311
7596570|NCT02581137|18698178|P1|NOT COMPLETED|Overall Study||4
7596571|NCT02581137|18698178|P1|COMPLETED|Overall Study||22
7596572|NCT02581137|18698178|P1|STARTED|Overall Study||26
7596573|NCT02581111|18698185|P2|NOT COMPLETED|Overall Study||7
7596574|NCT02581111|18698186|P1|NOT COMPLETED|Overall Study||2
7596575|NCT02581111|18698185|P2|COMPLETED|Overall Study||94
7596576|NCT02581111|18698186|P1|COMPLETED|Overall Study||96
7596577|NCT02581111|18698185|P2|STARTED|Overall Study||101
7596578|NCT02581111|18698186|P1|STARTED|Overall Study||98
7596579|NCT02580877|18698198|P2|NOT COMPLETED|Overall Study||4
7596580|NCT02580877|18698199|P1|NOT COMPLETED|Overall Study||1
7596581|NCT02580877|18698198|P2|COMPLETED|Overall Study||43
7596582|NCT02580877|18698199|P1|COMPLETED|Overall Study||44
7596583|NCT02580877|18698198|P2|STARTED|Overall Study||47
7596584|NCT02580877|18698199|P1|STARTED|Overall Study||45
7596585|NCT02580799|18698207|P1|NOT COMPLETED|Overall Study||0
7596586|NCT02580799|18698207|P1|COMPLETED|Overall Study||30
7596587|NCT02580799|18698207|P1|STARTED|Overall Study||30
7596588|NCT02580591|18698233|P4|NOT COMPLETED|Overall Study||12
7596589|NCT02580591|18698234|P3|NOT COMPLETED|Overall Study||13
7596590|NCT02580591|18698235|P2|NOT COMPLETED|Overall Study||10
7596591|NCT02580591|18698236|P1|NOT COMPLETED|Overall Study||18
7596592|NCT02580591|18698233|P4|COMPLETED|Overall Study||233
7596593|NCT02580591|18698234|P3|COMPLETED|Overall Study||235
7596594|NCT02580591|18698235|P2|COMPLETED|Overall Study||232
7596595|NCT02580591|18698236|P1|COMPLETED|Overall Study||224
7596596|NCT02580591|18698233|P4|Treated|Overall Study||245
7596597|NCT02580591|18698234|P3|Treated|Overall Study||248
7596598|NCT02580591|18698235|P2|Treated|Overall Study||241
7596599|NCT02580591|18698236|P1|Treated|Overall Study||241
7596600|NCT02580591|18698233|P4|STARTED|Overall Study||245
7596601|NCT02580591|18698234|P3|STARTED|Overall Study||248
7596602|NCT02580591|18698235|P2|STARTED|Overall Study||242
7596603|NCT02580591|18698236|P1|STARTED|Overall Study||242
7596604|NCT02580357|18698269|P3|NOT COMPLETED|Overall Study||0
7596605|NCT02580357|18698270|P2|NOT COMPLETED|Overall Study||0
7596606|NCT02580357|18698271|P1|NOT COMPLETED|Overall Study||3
7596607|NCT02580357|18698269|P3|COMPLETED|Overall Study||18
7596608|NCT02580357|18698270|P2|COMPLETED|Overall Study||18
7596609|NCT02580357|18698271|P1|COMPLETED|Overall Study||15
7596610|NCT02580357|18698269|P3|STARTED|Overall Study||18
7596611|NCT02580357|18698270|P2|STARTED|Overall Study||18
7596612|NCT02580357|18698271|P1|STARTED|Overall Study||18
7596613|NCT02580318|18698282|P1|NOT COMPLETED|Overall Study||0
7596614|NCT02580318|18698282|P1|COMPLETED|Overall Study||54
7596615|NCT02580318|18698282|P1|Drinking Water (5 Minutes)|Overall Study||54
7596616|NCT02580318|18698282|P1|Drinking Water (Immediate)|Overall Study||51
7596617|NCT02580318|18698282|P1|Hyperventilation (10 Minutes)|Overall Study||54
7596618|NCT02580318|18698282|P1|Hyperventilation (5 Minutes)|Overall Study||54
7596619|NCT02580318|18698282|P1|Hyperventilation (Immediate)|Overall Study||54
7596620|NCT02580318|18698282|P1|Poor Effort|Overall Study||53
7596621|NCT02580318|18698282|P1|STARTED|Overall Study||54
7596622|NCT02580240|18698288|P2|NOT COMPLETED|Overall Study||0
7596623|NCT02580240|18698289|P1|NOT COMPLETED|Overall Study||2
7596624|NCT02580240|18698288|P2|COMPLETED|Overall Study||58
7596625|NCT02580240|18698289|P1|COMPLETED|Overall Study||60
7596626|NCT02580240|18698288|P2|STARTED|Overall Study||58
7596627|NCT02580240|18698289|P1|STARTED|Overall Study||62
7596628|NCT02580201|18698299|P2|NOT COMPLETED|Overall Study||0
7596629|NCT02580201|18698300|P1|NOT COMPLETED|Overall Study||0
7596630|NCT02580201|18698299|P2|COMPLETED|Overall Study||104
7596631|NCT02580201|18698300|P1|COMPLETED|Overall Study||50
7596632|NCT02580201|18698299|P2|STARTED|Overall Study||104
7596633|NCT02580201|18698300|P1|STARTED|Overall Study||50
7596634|NCT02580188|18698313|P2|NOT COMPLETED|Overall Study||3
7596635|NCT02580188|18698314|P1|NOT COMPLETED|Overall Study||3
7596636|NCT02580188|18698313|P2|COMPLETED|Overall Study||32
7596637|NCT02580188|18698314|P1|COMPLETED|Overall Study||32
7596638|NCT02580188|18698313|P2|STARTED|Overall Study||35
7596639|NCT02580188|18698314|P1|STARTED|Overall Study||35
7596640|NCT02580058|18698327|P3|NOT COMPLETED|Overall Study||86
7596641|NCT02580058|18698328|P2|NOT COMPLETED|Overall Study||86
7596642|NCT02580058|18698329|P1|NOT COMPLETED|Overall Study||79
7596643|NCT02580058|18698327|P3|COMPLETED|Overall Study||104
7596644|NCT02580058|18698328|P2|COMPLETED|Overall Study||102
7596645|NCT02580058|18698329|P1|COMPLETED|Overall Study||109
7596646|NCT02580058|18698327|P3|Treated|Overall Study||177
7596647|NCT02580058|18698328|P2|Treated|Overall Study||182
7596648|NCT02580058|18698329|P1|Treated|Overall Study||187
7596649|NCT02580058|18698327|P3|STARTED|Overall Study||190
7596650|NCT02580058|18698328|P2|STARTED|Overall Study||188
7596651|NCT02580058|18698329|P1|STARTED|Overall Study||188
7596652|NCT02579928|18698396|P2|NOT COMPLETED|Overall Study||0
7596653|NCT02579928|18698397|P1|NOT COMPLETED|Overall Study||1
7596654|NCT02579928|18698396|P2|COMPLETED|Overall Study||11
7596655|NCT02579928|18698397|P1|COMPLETED|Overall Study||5
7596656|NCT02579928|18698396|P2|STARTED|Overall Study||11
7596657|NCT02579928|18698397|P1|STARTED|Overall Study||6
7596658|NCT02579915|18698405|P2|NOT COMPLETED|Overall Study||5
7596659|NCT02579915|18698406|P1|NOT COMPLETED|Overall Study||10
7596660|NCT02579915|18698405|P2|COMPLETED|Overall Study||16
7596661|NCT02579915|18698406|P1|COMPLETED|Overall Study||9
7596662|NCT02579915|18698405|P2|STARTED|Overall Study||21
7596663|NCT02579915|18698406|P1|STARTED|Overall Study||19
7596664|NCT02579876|18698414|P2|NOT COMPLETED|Overall Study||0
7596665|NCT02579876|18698415|P1|NOT COMPLETED|Overall Study||1
7596666|NCT02579876|18698414|P2|COMPLETED|Overall Study||5
7596667|NCT02579876|18698415|P1|COMPLETED|Overall Study||14
7596668|NCT02579876|18698414|P2|STARTED|Overall Study||5
7596669|NCT02579876|18698415|P1|STARTED|Overall Study||15
7596670|NCT02579863|18698437|P2|NOT COMPLETED|Overall Study||154
7596671|NCT02579863|18698438|P1|NOT COMPLETED|Overall Study||156
7596672|NCT02579863|18698437|P2|COMPLETED|Overall Study||0
7596673|NCT02579863|18698438|P1|COMPLETED|Overall Study||0
7596674|NCT02579863|18698437|P2|Treated|Overall Study||148
7596675|NCT02579863|18698438|P1|Treated|Overall Study||154
7596676|NCT02579863|18698437|P2|STARTED|Overall Study||154
7596677|NCT02579863|18698438|P1|STARTED|Overall Study||156
7596678|NCT02579811|18698458|P1|NOT COMPLETED|Overall Study||0
7596679|NCT02579811|18698458|P1|COMPLETED|Overall Study||40
7596680|NCT02579811|18698458|P1|STARTED|Overall Study||40
7596681|NCT02579772|18698465|P2|NOT COMPLETED|Overall Study||2
7596682|NCT02579772|18698466|P1|NOT COMPLETED|Overall Study||2
7596683|NCT02579772|18698465|P2|COMPLETED|Overall Study||3
7596684|NCT02579772|18698466|P1|COMPLETED|Overall Study||6
7596685|NCT02579772|18698465|P2|STARTED|Overall Study||5
7596686|NCT02579772|18698466|P1|STARTED|Overall Study||8
7596687|NCT02579759|18698487|P3|NOT COMPLETED|Overall Study||21
7596688|NCT02579759|18698488|P2|NOT COMPLETED|Overall Study||64
7596689|NCT02579759|18698489|P1|NOT COMPLETED|Overall Study||24
7596690|NCT02579759|18698487|P3|COMPLETED|Overall Study||80
7596691|NCT02579759|18698488|P2|COMPLETED|Overall Study||49
7596692|NCT02579759|18698489|P1|COMPLETED|Overall Study||85
7596693|NCT02579759|18698487|P3|STARTED|Overall Study||101
7596694|NCT02579759|18698488|P2|STARTED|Overall Study||113
7596695|NCT02579759|18698489|P1|STARTED|Overall Study||109
7596696|NCT02579629|18698536|P3|NOT COMPLETED|Overall Study||2
7596697|NCT02579629|18698537|P2|NOT COMPLETED|Overall Study||1
7596698|NCT02579629|18698538|P1|NOT COMPLETED|Overall Study||2
7596699|NCT02579629|18698536|P3|COMPLETED|Overall Study||20
7596700|NCT02579629|18698537|P2|COMPLETED|Overall Study||19
7596701|NCT02579629|18698538|P1|COMPLETED|Overall Study||20
7596702|NCT02579629|18698536|P3|STARTED|Overall Study||22
7596703|NCT02579629|18698537|P2|STARTED|Overall Study||20
7596704|NCT02579629|18698538|P1|STARTED|Overall Study||22
7596705|NCT02579616|18698585|P1|NOT COMPLETED|Overall Study||3
7596706|NCT02579616|18698585|P1|COMPLETED|Overall Study||26
7596707|NCT02579616|18698585|P1|Treated|Overall Study||26
7596708|NCT02579616|18698585|P1|STARTED|Overall Study||29
7596709|NCT02579603|18698598|P2|NOT COMPLETED|Overall Study||2
7596710|NCT02579603|18698599|P1|NOT COMPLETED|Overall Study||4
7596711|NCT02579603|18698598|P2|COMPLETED|Overall Study||51
7596712|NCT02579603|18698599|P1|COMPLETED|Overall Study||48
7596713|NCT02579603|18698598|P2|Number of Patients Treated|Overall Study||53
7596714|NCT02579603|18698599|P1|Number of Patients Treated|Overall Study||51
7596715|NCT02579603|18698598|P2|STARTED|Overall Study|Started are the randomised patients|53
7596716|NCT02579603|18698599|P1|STARTED|Overall Study|Started are the randomised patients|52
7596717|NCT02579421|18698612|P4|NOT COMPLETED|Overall Study||3
7596718|NCT02579421|18698613|P3|NOT COMPLETED|Overall Study||1
7596719|NCT02579421|18698614|P2|NOT COMPLETED|Overall Study||5
7596720|NCT02579421|18698615|P1|NOT COMPLETED|Overall Study||6
7596721|NCT02579421|18698612|P4|COMPLETED|Overall Study||3
7596722|NCT02579421|18698613|P3|COMPLETED|Overall Study||5
7596723|NCT02579421|18698614|P2|COMPLETED|Overall Study||18
7596724|NCT02579421|18698615|P1|COMPLETED|Overall Study||17
7596725|NCT02579421|18698612|P4|STARTED|Overall Study||6
7596726|NCT02579421|18698613|P3|STARTED|Overall Study||6
7596727|NCT02579421|18698614|P2|STARTED|Overall Study||23
7596728|NCT02579421|18698615|P1|STARTED|Overall Study||23
7596729|NCT02579382|18698629|P4|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||5
7596730|NCT02579382|18698630|P3|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||4
7596731|NCT02579382|18698631|P2|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||7
7596732|NCT02579382|18698632|P1|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||1
7596733|NCT02579382|18698629|P4|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
7596734|NCT02579382|18698630|P3|COMPLETED|Optional Treatment Extension Phase(OTEP)||50
7596735|NCT02579382|18698631|P2|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
7596736|NCT02579382|18698632|P1|COMPLETED|Optional Treatment Extension Phase(OTEP)||26
7596737|NCT02579382|18698629|P4|STARTED|Optional Treatment Extension Phase(OTEP)|3 participants who completed the Main Study Phase did not enter the OTEP.|49
7596738|NCT02579382|18698630|P3|STARTED|Optional Treatment Extension Phase(OTEP)||54
7596739|NCT02579382|18698631|P2|STARTED|Optional Treatment Extension Phase(OTEP)|2 participants who completed the Main Study Phase did not enter the OTEP.|51
7596740|NCT02579382|18698632|P1|STARTED|Optional Treatment Extension Phase(OTEP)|1 participant who completed the Main Study Phase did not enter the OTEP.|27
7596741|NCT02579382|18698629|P4|NOT COMPLETED|Main Study Phase||3
7596742|NCT02579382|18698630|P3|NOT COMPLETED|Main Study Phase||2
7596743|NCT02579382|18698631|P2|NOT COMPLETED|Main Study Phase||0
7596744|NCT02579382|18698632|P1|NOT COMPLETED|Main Study Phase||0
7596745|NCT02579382|18698629|P4|COMPLETED|Main Study Phase||52
7596746|NCT02579382|18698630|P3|COMPLETED|Main Study Phase||54
7596747|NCT02579382|18698631|P2|COMPLETED|Main Study Phase||53
7596748|NCT02579382|18698632|P1|COMPLETED|Main Study Phase||28
7596749|NCT02579382|18698629|P4|STARTED|Main Study Phase||55
7596750|NCT02579382|18698630|P3|STARTED|Main Study Phase||56
7596751|NCT02579382|18698631|P2|STARTED|Main Study Phase||53
7596752|NCT02579382|18698632|P1|STARTED|Main Study Phase||28
7596753|NCT02579135|18698727|P2|NOT COMPLETED|Overall Study||9
7596754|NCT02579135|18698728|P1|NOT COMPLETED|Overall Study||2
7596755|NCT02579135|18698727|P2|COMPLETED|Overall Study||106
7596756|NCT02579135|18698728|P1|COMPLETED|Overall Study||105
7596757|NCT02579135|18698727|P2|STARTED|Overall Study||115
7596758|NCT02579135|18698728|P1|STARTED|Overall Study||107
7596759|NCT02579057|18698739|P2|NOT COMPLETED|Overall Study||0
7596760|NCT02579057|18698740|P1|NOT COMPLETED|Overall Study||0
7596761|NCT02579057|18698739|P2|COMPLETED|Overall Study||21
7596762|NCT02579057|18698740|P1|COMPLETED|Overall Study||19
7596763|NCT02579057|18698739|P2|STARTED|Overall Study||21
7596764|NCT02579057|18698740|P1|STARTED|Overall Study||19
7596765|NCT02578992|18698754|P2|NOT COMPLETED|Overall Study||3
7596766|NCT02578992|18698755|P1|NOT COMPLETED|Overall Study||3
7596767|NCT02578992|18698754|P2|COMPLETED|Overall Study|October 2015|62
7596768|NCT02578992|18698755|P1|COMPLETED|Overall Study|October 2015|62
7596769|NCT02578992|18698754|P2|STARTED|Overall Study|November 2014|65
7596770|NCT02578992|18698755|P1|STARTED|Overall Study|November 2014|65
7596771|NCT02578940|18698767|P1|NOT COMPLETED|Overall Study||6
7596772|NCT02578940|18698767|P1|COMPLETED|Overall Study||103
7596773|NCT02578940|18698767|P1|Received 18F-fluciclovine|Overall Study||104
7596774|NCT02578940|18698767|P1|STARTED|Overall Study||109
7596775|NCT02578862|18698776|P2|NOT COMPLETED|Overall Study||2
7596776|NCT02578862|18698777|P1|NOT COMPLETED|Overall Study||0
7596777|NCT02578862|18698776|P2|COMPLETED|Overall Study||33
7596778|NCT02578862|18698777|P1|COMPLETED|Overall Study||37
7596779|NCT02578862|18698776|P2|STARTED|Overall Study||35
7596780|NCT02578862|18698777|P1|STARTED|Overall Study||37
7596781|NCT02578745|18698795|P2|NOT COMPLETED|Overall Study||0
7596782|NCT02578745|18698796|P1|NOT COMPLETED|Overall Study||0
7596783|NCT02578745|18698795|P2|COMPLETED|Overall Study||60
7596784|NCT02578745|18698796|P1|COMPLETED|Overall Study||60
7596785|NCT02578745|18698795|P2|STARTED|Overall Study||60
7596786|NCT02578745|18698796|P1|STARTED|Overall Study||60
7596787|NCT02578706|18698815|P3|NOT COMPLETED|Overall Study||0
7596788|NCT02578706|18698816|P2|NOT COMPLETED|Overall Study||5
7596789|NCT02578706|18698817|P1|NOT COMPLETED|Overall Study||1
7596790|NCT02578706|18698815|P3|COMPLETED|Overall Study||8
7596791|NCT02578706|18698816|P2|COMPLETED|Overall Study||5
7596792|NCT02578706|18698817|P1|COMPLETED|Overall Study||8
7596793|NCT02578706|18698815|P3|STARTED|Overall Study||8
7596794|NCT02578706|18698816|P2|STARTED|Overall Study||10
7596795|NCT02578706|18698817|P1|STARTED|Overall Study||9
7596796|NCT02578680|18698896|P2|NOT COMPLETED|Overall Study||206
7596797|NCT02578680|18698897|P1|NOT COMPLETED|Overall Study||410
7596798|NCT02578680|18698896|P2|COMPLETED|Overall Study||0
7596799|NCT02578680|18698897|P1|COMPLETED|Overall Study||0
7596800|NCT02578680|18698896|P2|Switched to Pembrolizumab|Overall Study||67
7596801|NCT02578680|18698897|P1|Switched to Pembrolizumab|Overall Study||0
7596802|NCT02578680|18698896|P2|Treated|Overall Study||202
7596803|NCT02578680|18698897|P1|Treated|Overall Study||405
7596804|NCT02578680|18698896|P2|STARTED|Overall Study||206
7596805|NCT02578680|18698897|P1|STARTED|Overall Study||410
7596806|NCT02578316|18698913|P1|NOT COMPLETED|Extension Phase||6
7596807|NCT02578316|18698913|P1|COMPLETED|Extension Phase||0
7596808|NCT02578316|18698913|P1|STARTED|Extension Phase||6
7596809|NCT02578316|18698913|P1|NOT COMPLETED|Study Phase||0
7596810|NCT02578316|18698913|P1|COMPLETED|Study Phase||6
7596811|NCT02578316|18698913|P1|STARTED|Study Phase||6
7596812|NCT02578238|18698937|P1|NOT COMPLETED|Overall Study||0
7596813|NCT02578238|18698937|P1|COMPLETED|Overall Study||143
7596814|NCT02578238|18698937|P1|STARTED|Overall Study||143
7596815|NCT02578199|18698941|P1|NOT COMPLETED|Overall Study||4
7596816|NCT02578199|18698941|P1|COMPLETED|Overall Study||27
7596817|NCT02578199|18698941|P1|STARTED|Overall Study||31
7596818|NCT02578186|18698946|P2|NOT COMPLETED|Period 2 (Second of Crossover)||0
7596819|NCT02578186|18698947|P1|NOT COMPLETED|Period 2 (Second of Crossover)||0
7596820|NCT02578186|18698946|P2|COMPLETED|Period 2 (Second of Crossover)||13
7596821|NCT02578186|18698947|P1|COMPLETED|Period 2 (Second of Crossover)||12
7596822|NCT02578186|18698946|P2|STARTED|Period 2 (Second of Crossover)||13
7596823|NCT02578186|18698947|P1|STARTED|Period 2 (Second of Crossover)||12
7596824|NCT02578186|18698946|P2|NOT COMPLETED|Period 1 (First of Crossover)||5
7596825|NCT02578186|18698947|P1|NOT COMPLETED|Period 1 (First of Crossover)||5
7596826|NCT02578186|18698946|P2|COMPLETED|Period 1 (First of Crossover)||13
7596827|NCT02578186|18698947|P1|COMPLETED|Period 1 (First of Crossover)||12
7596828|NCT02578186|18698946|P2|STARTED|Period 1 (First of Crossover)||18
7596829|NCT02578186|18698947|P1|STARTED|Period 1 (First of Crossover)||17
7596830|NCT02577991|18698956|P3|NOT COMPLETED|Overall Study||0
7596831|NCT02577991|18698957|P2|NOT COMPLETED|Overall Study||2
7596832|NCT02577991|18698958|P1|NOT COMPLETED|Overall Study||3
7596833|NCT02577991|18698956|P3|COMPLETED|Overall Study||29
7596834|NCT02577991|18698957|P2|COMPLETED|Overall Study||25
7596835|NCT02577991|18698958|P1|COMPLETED|Overall Study||21
7596836|NCT02577991|18698956|P3|STARTED|Overall Study||29
7596837|NCT02577991|18698957|P2|STARTED|Overall Study||27
7596838|NCT02577991|18698958|P1|STARTED|Overall Study||24
7596839|NCT02577978|18698980|P2|NOT COMPLETED|Overall Study||4
7596840|NCT02577978|18698981|P1|NOT COMPLETED|Overall Study||7
7596841|NCT02577978|18698980|P2|COMPLETED|Overall Study||25
7596842|NCT02577978|18698981|P1|COMPLETED|Overall Study||25
7596843|NCT02577978|18698980|P2|STARTED|Overall Study||29
7596844|NCT02577978|18698981|P1|STARTED|Overall Study||32
7596845|NCT02577900|18699014|P3|NOT COMPLETED|Overall Study||0
7596846|NCT02577900|18699015|P2|NOT COMPLETED|Overall Study||0
7596847|NCT02577900|18699016|P1|NOT COMPLETED|Overall Study||0
7596848|NCT02577900|18699014|P3|COMPLETED|Overall Study||10
7596849|NCT02577900|18699015|P2|COMPLETED|Overall Study||10
7596850|NCT02577900|18699016|P1|COMPLETED|Overall Study||11
7596851|NCT02577900|18699014|P3|STARTED|Overall Study||10
7596852|NCT02577900|18699015|P2|STARTED|Overall Study||10
7596853|NCT02577900|18699016|P1|STARTED|Overall Study||11
7596854|NCT02577887|18699036|P1|NOT COMPLETED|Overall Study||298
7596855|NCT02577887|18699036|P1|COMPLETED|Overall Study||1803
7596856|NCT02577887|18699036|P1|6 Month Follow-up|Overall Study||1938
7596857|NCT02577887|18699036|P1|STARTED|Overall Study||2101
7596858|NCT02577822|18699045|P2|NOT COMPLETED|Overall Study||13
7596859|NCT02577822|18699046|P1|NOT COMPLETED|Overall Study||6
7596860|NCT02577822|18699045|P2|COMPLETED|Overall Study||20
7596861|NCT02577822|18699046|P1|COMPLETED|Overall Study||21
7596862|NCT02577822|18699045|P2|STARTED|Overall Study||33
7596863|NCT02577822|18699046|P1|STARTED|Overall Study||27
7596864|NCT02577718|18699062|P1|NOT COMPLETED|Overall Study||8
7596865|NCT02577718|18699062|P1|COMPLETED|Overall Study||52
7596866|NCT02577718|18699062|P1|STARTED|Overall Study||60
7596867|NCT02577601|18699068|P1|NOT COMPLETED|UPA+COC (1 Month)||0
7596868|NCT02577601|18699068|P1|COMPLETED|UPA+COC (1 Month)||33
7596869|NCT02577601|18699068|P1|STARTED|UPA+COC (1 Month)||33
7596870|NCT02577601|18699068|P1|NOT COMPLETED|Washout (1 Month)||0
7596871|NCT02577601|18699068|P1|COMPLETED|Washout (1 Month)||33
7596872|NCT02577601|18699068|P1|STARTED|Washout (1 Month)||33
7596873|NCT02577601|18699068|P1|NOT COMPLETED|UPA Only (1 Month)||0
7596874|NCT02577601|18699068|P1|COMPLETED|UPA Only (1 Month)||36
7596875|NCT02577601|18699068|P1|STARTED|UPA Only (1 Month)||36
7596876|NCT02577510|18699075|P2|NOT COMPLETED|Overall Study||0
7596877|NCT02577510|18699076|P1|NOT COMPLETED|Overall Study||0
7596878|NCT02577510|18699075|P2|COMPLETED|Overall Study||21
7596879|NCT02577510|18699076|P1|COMPLETED|Overall Study||21
7596880|NCT02577510|18699075|P2|STARTED|Overall Study||21
7596881|NCT02577510|18699076|P1|STARTED|Overall Study||21
7596882|NCT02577445|18699090|P2|NOT COMPLETED|Overall Study||17
7596883|NCT02577445|18699091|P1|NOT COMPLETED|Overall Study||14
7596884|NCT02577445|18699090|P2|COMPLETED|Overall Study|study terminated prematurely|0
7596885|NCT02577445|18699091|P1|COMPLETED|Overall Study|study terminated prematurely|0
7596886|NCT02577445|18699090|P2|STARTED|Overall Study||17
7596887|NCT02577445|18699091|P1|STARTED|Overall Study||14
7596888|NCT02577354|18699104|P2|NOT COMPLETED|Overall Study||13
7596889|NCT02577354|18699105|P1|NOT COMPLETED|Overall Study||15
7596890|NCT02577354|18699104|P2|COMPLETED|Overall Study||89
7596891|NCT02577354|18699105|P1|COMPLETED|Overall Study||87
7596892|NCT02577354|18699104|P2|120 Day Primary Endpoint|Overall Study||101
7596893|NCT02577354|18699105|P1|120 Day Primary Endpoint|Overall Study||100
7596894|NCT02577354|18699104|P2|STARTED|Overall Study||102
7596895|NCT02577354|18699105|P1|STARTED|Overall Study||102
7596896|NCT02577315|18699165|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7596897|NCT02577315|18699166|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7596898|NCT02577315|18699165|P2|COMPLETED|Treatment Period 2 (4 Days)||12
7596899|NCT02577315|18699166|P1|COMPLETED|Treatment Period 2 (4 Days)||12
7596900|NCT02577315|18699165|P2|STARTED|Treatment Period 2 (4 Days)||12
7596901|NCT02577315|18699166|P1|STARTED|Treatment Period 2 (4 Days)||12
7596902|NCT02577315|18699165|P2|NOT COMPLETED|Washout Period (5 Days)||0
7596903|NCT02577315|18699166|P1|NOT COMPLETED|Washout Period (5 Days)||0
7596904|NCT02577315|18699165|P2|COMPLETED|Washout Period (5 Days)||12
7596905|NCT02577315|18699166|P1|COMPLETED|Washout Period (5 Days)||12
7596906|NCT02577315|18699165|P2|STARTED|Washout Period (5 Days)||12
7596907|NCT02577315|18699166|P1|STARTED|Washout Period (5 Days)||12
7596908|NCT02577315|18699165|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||1
7596909|NCT02577315|18699166|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
7596910|NCT02577315|18699165|P2|COMPLETED|Treatment Period 1 (4 Days)||12
7596911|NCT02577315|18699166|P1|COMPLETED|Treatment Period 1 (4 Days)||12
7596912|NCT02577315|18699165|P2|STARTED|Treatment Period 1 (4 Days)||13
7596913|NCT02577315|18699166|P1|STARTED|Treatment Period 1 (4 Days)||12
7596914|NCT02577146|18699182|P1|NOT COMPLETED|Overall Study||28
7596915|NCT02577146|18699182|P1|COMPLETED|Overall Study||46
7596916|NCT02577146|18699182|P1|STARTED|Overall Study||74
7596917|NCT02577107|18699189|P2|NOT COMPLETED|Overall Study||1
7596918|NCT02577107|18699190|P1|NOT COMPLETED|Overall Study||0
7596919|NCT02577107|18699189|P2|COMPLETED|Overall Study||5
7596920|NCT02577107|18699190|P1|COMPLETED|Overall Study||6
7596921|NCT02577107|18699189|P2|STARTED|Overall Study||6
7596922|NCT02577107|18699190|P1|STARTED|Overall Study||6
7596923|NCT02577042|18699204|P2|NOT COMPLETED|Overall Study||3
7596924|NCT02577042|18699205|P1|NOT COMPLETED|Overall Study||5
7596925|NCT02577042|18699204|P2|COMPLETED|Overall Study||19
7596926|NCT02577042|18699205|P1|COMPLETED|Overall Study||15
7596927|NCT02577042|18699204|P2|STARTED|Overall Study||22
7596928|NCT02577042|18699205|P1|STARTED|Overall Study||20
7596929|NCT02577029|18699257|P8|NOT COMPLETED|Overall Study||12
7596930|NCT02577029|18699258|P7|NOT COMPLETED|Overall Study||12
7596931|NCT02577029|18699259|P6|NOT COMPLETED|Overall Study||13
7596932|NCT02577029|18699260|P5|NOT COMPLETED|Overall Study||11
7596933|NCT02577029|18699261|P4|NOT COMPLETED|Overall Study||12
7596934|NCT02577029|18699262|P3|NOT COMPLETED|Overall Study||7
7596935|NCT02577029|18699263|P2|NOT COMPLETED|Overall Study||2
7596936|NCT02577029|18699264|P1|NOT COMPLETED|Overall Study||10
7596937|NCT02577029|18699257|P8|COMPLETED|Overall Study||0
7596938|NCT02577029|18699258|P7|COMPLETED|Overall Study||0
7596939|NCT02577029|18699259|P6|COMPLETED|Overall Study||0
7596940|NCT02577029|18699260|P5|COMPLETED|Overall Study||0
7596941|NCT02577029|18699261|P4|COMPLETED|Overall Study||0
7596942|NCT02577029|18699262|P3|COMPLETED|Overall Study||0
7596943|NCT02577029|18699263|P2|COMPLETED|Overall Study||0
7596944|NCT02577029|18699264|P1|COMPLETED|Overall Study||0
7596945|NCT02577029|18699257|P8|STARTED|Overall Study||12
7596946|NCT02577029|18699258|P7|STARTED|Overall Study||12
7596947|NCT02577029|18699259|P6|STARTED|Overall Study||13
7596948|NCT02577029|18699260|P5|STARTED|Overall Study||11
7596949|NCT02577029|18699261|P4|STARTED|Overall Study||12
7596950|NCT02577029|18699262|P3|STARTED|Overall Study||7
7596951|NCT02577029|18699263|P2|STARTED|Overall Study||2
7596952|NCT02577029|18699264|P1|STARTED|Overall Study||10
7596953|NCT02577016|18699372|P2|NOT COMPLETED|Overall Study||2
7596954|NCT02577016|18699373|P1|NOT COMPLETED|Overall Study||2
7596955|NCT02577016|18699372|P2|COMPLETED|Overall Study||69
7596956|NCT02577016|18699373|P1|COMPLETED|Overall Study||68
7596957|NCT02577016|18699372|P2|STARTED|Overall Study||71
7596958|NCT02577016|18699373|P1|STARTED|Overall Study||70
7596959|NCT02577003|18699391|P2|NOT COMPLETED|Overall Study||5
7596960|NCT02577003|18699392|P1|NOT COMPLETED|Overall Study||2
7596961|NCT02577003|18699391|P2|COMPLETED|Overall Study||65
7596962|NCT02577003|18699392|P1|COMPLETED|Overall Study||71
7596963|NCT02577003|18699391|P2|STARTED|Overall Study||70
7596964|NCT02577003|18699392|P1|STARTED|Overall Study||73
7596965|NCT02576990|18699412|P2|NOT COMPLETED|Overall Study||24
7596966|NCT02576990|18699413|P1|NOT COMPLETED|Overall Study||43
7596967|NCT02576990|18699412|P2|COMPLETED|Overall Study||0
7596968|NCT02576990|18699413|P1|COMPLETED|Overall Study||13
7596969|NCT02576990|18699412|P2|Treated|Overall Study||23
7596970|NCT02576990|18699413|P1|Treated|Overall Study||53
7596971|NCT02576990|18699412|P2|STARTED|Overall Study||24
7596972|NCT02576990|18699413|P1|STARTED|Overall Study||56
7596973|NCT02576977|18699441|P2|NOT COMPLETED|Overall Study||125
7596974|NCT02576977|18699442|P1|NOT COMPLETED|Overall Study||126
7596975|NCT02576977|18699441|P2|COMPLETED|Overall Study||0
7596976|NCT02576977|18699442|P1|COMPLETED|Overall Study||0
7596977|NCT02576977|18699441|P2|Treated|Overall Study||123
7596978|NCT02576977|18699442|P1|Treated|Overall Study||122
7596979|NCT02576977|18699441|P2|STARTED|Overall Study||125
7596980|NCT02576977|18699442|P1|STARTED|Overall Study||126
7596981|NCT02576951|18699464|P4|NOT COMPLETED|Overall Study||5
7596982|NCT02576951|18699465|P3|NOT COMPLETED|Overall Study||2
7596983|NCT02576951|18699466|P2|NOT COMPLETED|Overall Study||0
7596984|NCT02576951|18699467|P1|NOT COMPLETED|Overall Study||1
7596985|NCT02576951|18699464|P4|COMPLETED|Overall Study||75
7596986|NCT02576951|18699465|P3|COMPLETED|Overall Study||78
7596987|NCT02576951|18699466|P2|COMPLETED|Overall Study||3
7596988|NCT02576951|18699467|P1|COMPLETED|Overall Study||14
7596989|NCT02576951|18699464|P4|Received at Least One Dose of Study Drug|Overall Study||80
7596990|NCT02576951|18699465|P3|Received at Least One Dose of Study Drug|Overall Study||80
7596991|NCT02576951|18699466|P2|Received at Least One Dose of Study Drug|Overall Study||3
7596992|NCT02576951|18699467|P1|Received at Least One Dose of Study Drug|Overall Study||15
7596993|NCT02576951|18699464|P4|STARTED|Overall Study||80
7596994|NCT02576951|18699465|P3|STARTED|Overall Study||80
7596995|NCT02576951|18699466|P2|STARTED|Overall Study||3
7596996|NCT02576951|18699467|P1|STARTED|Overall Study||15
7596997|NCT02576938|18699491|P3|NOT COMPLETED|Overall Study||12
7596998|NCT02576938|18699492|P2|NOT COMPLETED|Overall Study||12
7596999|NCT02576938|18699493|P1|NOT COMPLETED|Overall Study||20
7597000|NCT02576938|18699491|P3|COMPLETED|Overall Study||26
7597001|NCT02576938|18699492|P2|COMPLETED|Overall Study||25
7597002|NCT02576938|18699493|P1|COMPLETED|Overall Study||29
7597003|NCT02576938|18699491|P3|Received at Least One Dose of Study Drug|Overall Study||38
7597004|NCT02576938|18699492|P2|Received at Least One Dose of Study Drug|Overall Study||37
7597005|NCT02576938|18699493|P1|Received at Least One Dose of Study Drug|Overall Study||49
7597006|NCT02576938|18699491|P3|STARTED|Overall Study||38
7597007|NCT02576938|18699492|P2|STARTED|Overall Study||37
7597008|NCT02576938|18699493|P1|STARTED|Overall Study||49
7597009|NCT02576899|18699523|P2|NOT COMPLETED|Overall Study||13
7597010|NCT02576899|18699524|P1|NOT COMPLETED|Overall Study||11
7597011|NCT02576899|18699523|P2|COMPLETED|Overall Study||7
7597012|NCT02576899|18699524|P1|COMPLETED|Overall Study||5
7597013|NCT02576899|18699523|P2|STARTED|Overall Study||20
7597014|NCT02576899|18699524|P1|STARTED|Overall Study||16
7597015|NCT02576678|18699539|P3|NOT COMPLETED|Overall Study||5
7597016|NCT02576678|18699540|P2|NOT COMPLETED|Overall Study||1
7597017|NCT02576678|18699541|P1|NOT COMPLETED|Overall Study||5
7597018|NCT02576678|18699539|P3|COMPLETED|Overall Study||16
7597019|NCT02576678|18699540|P2|COMPLETED|Overall Study||7
7597020|NCT02576678|18699541|P1|COMPLETED|Overall Study||8
7597021|NCT02576678|18699539|P3|Pharmacokinetic (PK) Population|Overall Study||18
7597022|NCT02576678|18699540|P2|Pharmacokinetic (PK) Population|Overall Study||8
7597023|NCT02576678|18699541|P1|Pharmacokinetic (PK) Population|Overall Study||12
7597024|NCT02576678|18699539|P3|STARTED|Overall Study||21
7597025|NCT02576678|18699540|P2|STARTED|Overall Study||8
7597026|NCT02576678|18699541|P1|STARTED|Overall Study||13
7597027|NCT02576652|18699573|P1|NOT COMPLETED|Overall Study||2
7597028|NCT02576652|18699573|P1|COMPLETED|Overall Study||4
7597029|NCT02576652|18699573|P1|STARTED|Overall Study||6
7597030|NCT02576639|18699585|P5|NOT COMPLETED|Overall Study||4
7597031|NCT02576639|18699586|P4|NOT COMPLETED|Overall Study||1
7597032|NCT02576639|18699587|P3|NOT COMPLETED|Overall Study||2
7597033|NCT02576639|18699588|P2|NOT COMPLETED|Overall Study||2
7597034|NCT02576639|18699589|P1|NOT COMPLETED|Overall Study||2
7597035|NCT02576639|18699585|P5|COMPLETED|Overall Study||20
7597036|NCT02576639|18699586|P4|COMPLETED|Overall Study||25
7597037|NCT02576639|18699587|P3|COMPLETED|Overall Study||23
7597038|NCT02576639|18699588|P2|COMPLETED|Overall Study||23
7597039|NCT02576639|18699589|P1|COMPLETED|Overall Study||22
7597040|NCT02576639|18699585|P5|Safety Analysis Set|Overall Study||24
7597041|NCT02576639|18699586|P4|Safety Analysis Set|Overall Study||26
7597042|NCT02576639|18699587|P3|Safety Analysis Set|Overall Study||25
7597043|NCT02576639|18699588|P2|Safety Analysis Set|Overall Study||25
7597044|NCT02576639|18699589|P1|Safety Analysis Set|Overall Study||24
7597045|NCT02576639|18699585|P5|Pharmacokinetic Analysis Set|Overall Study||24
7597046|NCT02576639|18699586|P4|Pharmacokinetic Analysis Set|Overall Study||26
7597047|NCT02576639|18699587|P3|Pharmacokinetic Analysis Set|Overall Study||25
7597048|NCT02576639|18699588|P2|Pharmacokinetic Analysis Set|Overall Study||25
7597049|NCT02576639|18699589|P1|Pharmacokinetic Analysis Set|Overall Study||0
7597050|NCT02576639|18699585|P5|Pharmacodynamic Analysis Set|Overall Study||25
7597051|NCT02576639|18699586|P4|Pharmacodynamic Analysis Set|Overall Study||25
7597052|NCT02576639|18699587|P3|Pharmacodynamic Analysis Set|Overall Study||25
7597053|NCT02576639|18699588|P2|Pharmacodynamic Analysis Set|Overall Study||24
7597054|NCT02576639|18699589|P1|Pharmacodynamic Analysis Set|Overall Study||24
7597055|NCT02576639|18699585|P5|STARTED|Overall Study||24
7597056|NCT02576639|18699586|P4|STARTED|Overall Study||26
7597057|NCT02576639|18699587|P3|STARTED|Overall Study||25
7597058|NCT02576639|18699588|P2|STARTED|Overall Study||25
7597059|NCT02576639|18699589|P1|STARTED|Overall Study||24
7597060|NCT02576587|18699648|P2|NOT COMPLETED|Follow up Period (Case Only)||155
7597061|NCT02576587|18699649|P1|NOT COMPLETED|Follow up Period (Case Only)||117
7597062|NCT02576587|18699648|P2|COMPLETED|Follow up Period (Case Only)||0
7597063|NCT02576587|18699649|P1|COMPLETED|Follow up Period (Case Only)||44
7597064|NCT02576587|18699648|P2|Selected for Follow up|Follow up Period (Case Only)||0
7597065|NCT02576587|18699649|P1|Selected for Follow up|Follow up Period (Case Only)||61
7597066|NCT02576587|18699648|P2|STARTED|Follow up Period (Case Only)|Controls not eligible for follow-up|155
7597067|NCT02576587|18699649|P1|STARTED|Follow up Period (Case Only)|Completed baseline.|161
7597068|NCT02576587|18699648|P2|NOT COMPLETED|Baseline||1
7597069|NCT02576587|18699649|P1|NOT COMPLETED|Baseline||0
7597070|NCT02576587|18699648|P2|COMPLETED|Baseline|Baseline visit completed|155
7597071|NCT02576587|18699649|P1|COMPLETED|Baseline|Baseline visit completed|161
7597072|NCT02576587|18699648|P2|STARTED|Baseline|Total controls baseline visit|156
7597073|NCT02576587|18699649|P1|STARTED|Baseline|Total cases baseline visit|161
7597074|NCT02576535|18699667|P1|NOT COMPLETED|Overall Study||2
7597075|NCT02576535|18699667|P1|COMPLETED|Overall Study||16
7597076|NCT02576535|18699667|P1|STARTED|Overall Study||18
7597077|NCT02576509|18699678|P2|NOT COMPLETED|Follow-up Period||52
7597078|NCT02576509|18699679|P1|NOT COMPLETED|Follow-up Period||49
7597079|NCT02576509|18699678|P2|COMPLETED|Follow-up Period||311
7597080|NCT02576509|18699679|P1|COMPLETED|Follow-up Period||318
7597081|NCT02576509|18699678|P2|STARTED|Follow-up Period||363
7597082|NCT02576509|18699679|P1|STARTED|Follow-up Period||367
7597083|NCT02576509|18699678|P2|NOT COMPLETED|Treatment Period||355
7597084|NCT02576509|18699679|P1|NOT COMPLETED|Treatment Period||329
7597085|NCT02576509|18699678|P2|COMPLETED|Treatment Period||8
7597086|NCT02576509|18699679|P1|COMPLETED|Treatment Period||38
7597087|NCT02576509|18699678|P2|STARTED|Treatment Period||363
7597088|NCT02576509|18699679|P1|STARTED|Treatment Period||367
7597089|NCT02576509|18699678|P2|NOT COMPLETED|Pre-Treatment Period||9
7597090|NCT02576509|18699679|P1|NOT COMPLETED|Pre-Treatment Period||4
7597091|NCT02576509|18699678|P2|COMPLETED|Pre-Treatment Period||363
7597092|NCT02576509|18699679|P1|COMPLETED|Pre-Treatment Period||367
7597093|NCT02576509|18699678|P2|STARTED|Pre-Treatment Period||372
7597094|NCT02576509|18699679|P1|STARTED|Pre-Treatment Period||371
7597095|NCT02576249|18699695|P2|NOT COMPLETED|Overall Study||0
7597096|NCT02576249|18699696|P1|NOT COMPLETED|Overall Study||0
7597097|NCT02576249|18699695|P2|COMPLETED|Overall Study||14
7597098|NCT02576249|18699696|P1|COMPLETED|Overall Study||15
7597099|NCT02576249|18699695|P2|STARTED|Overall Study||14
7597100|NCT02576249|18699696|P1|STARTED|Overall Study||15
7597101|NCT02576145|18699708|P2|NOT COMPLETED|Overall Study||1
7597102|NCT02576145|18699709|P1|NOT COMPLETED|Overall Study||3
7597103|NCT02576145|18699708|P2|COMPLETED|Overall Study||4
7597104|NCT02576145|18699709|P1|COMPLETED|Overall Study||3
7597105|NCT02576145|18699708|P2|STARTED|Overall Study||5
7597106|NCT02576145|18699709|P1|STARTED|Overall Study||6
7597107|NCT02576067|18699747|P2|NOT COMPLETED|Overall Study||36
7597108|NCT02576067|18699748|P1|NOT COMPLETED|Overall Study||34
7597109|NCT02576067|18699747|P2|COMPLETED|Overall Study||27
7597110|NCT02576067|18699748|P1|COMPLETED|Overall Study||26
7597111|NCT02576067|18699747|P2|STARTED|Overall Study||63
7597112|NCT02576067|18699748|P1|STARTED|Overall Study||60
7597113|NCT02576054|18699758|P1|NOT COMPLETED|Overall Study||1
7597114|NCT02576054|18699758|P1|COMPLETED|Overall Study||100
7597115|NCT02576054|18699758|P1|Vaccination 3|Overall Study||100
7597116|NCT02576054|18699758|P1|Vaccination 2|Overall Study||100
7597117|NCT02576054|18699758|P1|Vaccination 1|Overall Study||100
7597118|NCT02576054|18699758|P1|STARTED|Overall Study||101
7597119|NCT02576041|18699773|P1|NOT COMPLETED|Bilastine (Active Treatement)||0
7597120|NCT02576041|18699773|P1|COMPLETED|Bilastine (Active Treatement)||18
7597121|NCT02576041|18699773|P1|STARTED|Bilastine (Active Treatement)||18
7597122|NCT02576041|18699773|P1|NOT COMPLETED|Placebo (run-in)||0
7597123|NCT02576041|18699773|P1|COMPLETED|Placebo (run-in)||18
7597124|NCT02576041|18699773|P1|STARTED|Placebo (run-in)||18
7597125|NCT02575950|18699779|P4|NOT COMPLETED|Overall Study||5
7597126|NCT02575950|18699780|P3|NOT COMPLETED|Overall Study||0
7597127|NCT02575950|18699781|P2|NOT COMPLETED|Overall Study||1
7597128|NCT02575950|18699782|P1|NOT COMPLETED|Overall Study||0
7597129|NCT02575950|18699779|P4|COMPLETED|Overall Study||20
7597130|NCT02575950|18699780|P3|COMPLETED|Overall Study||6
7597131|NCT02575950|18699781|P2|COMPLETED|Overall Study||5
7597132|NCT02575950|18699782|P1|COMPLETED|Overall Study||3
7597133|NCT02575950|18699779|P4|STARTED|Overall Study||25
7597134|NCT02575950|18699780|P3|STARTED|Overall Study||6
7597135|NCT02575950|18699781|P2|STARTED|Overall Study||6
7597136|NCT02575950|18699782|P1|STARTED|Overall Study||3
7597137|NCT02575911|18699811|P1|NOT COMPLETED|Overall Study||1
7597138|NCT02575911|18699811|P1|COMPLETED|Overall Study||29
7597139|NCT02575911|18699811|P1|STARTED|Overall Study||30
7597140|NCT02575833|18699831|P2|NOT COMPLETED|Overall Study||1
7597141|NCT02575833|18699832|P1|NOT COMPLETED|Overall Study||1
7597142|NCT02575833|18699831|P2|COMPLETED|Overall Study||44
7597143|NCT02575833|18699832|P1|COMPLETED|Overall Study||43
7597144|NCT02575833|18699831|P2|Received Study Drug|Overall Study||44
7597145|NCT02575833|18699832|P1|Received Study Drug|Overall Study||44
7597146|NCT02575833|18699831|P2|STARTED|Overall Study||45
7597147|NCT02575833|18699832|P1|STARTED|Overall Study||44
7597148|NCT02575807|18699847|P5|NOT COMPLETED|Overall Study||4
7597149|NCT02575807|18699848|P4|NOT COMPLETED|Overall Study||2
7597150|NCT02575807|18699849|P3|NOT COMPLETED|Overall Study||16
7597151|NCT02575807|18699850|P2|NOT COMPLETED|Overall Study||4
7597152|NCT02575807|18699851|P1|NOT COMPLETED|Overall Study||9
7597153|NCT02575807|18699847|P5|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
7597154|NCT02575807|18699848|P4|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
7597155|NCT02575807|18699849|P3|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
7597156|NCT02575807|18699850|P2|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
7597157|NCT02575807|18699851|P1|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
7597158|NCT02575807|18699847|P5|Treated|Overall Study||3
7597159|NCT02575807|18699848|P4|Treated|Overall Study||1
7597160|NCT02575807|18699849|P3|Treated|Overall Study||16
7597161|NCT02575807|18699850|P2|Treated|Overall Study||4
7597162|NCT02575807|18699851|P1|Treated|Overall Study||8
7597163|NCT02575807|18699847|P5|STARTED|Overall Study||4
7597164|NCT02575807|18699848|P4|STARTED|Overall Study||2
7597165|NCT02575807|18699849|P3|STARTED|Overall Study||16
7597166|NCT02575807|18699850|P2|STARTED|Overall Study||4
7597167|NCT02575807|18699851|P1|STARTED|Overall Study||9
7597168|NCT02575365|18699891|P1|NOT COMPLETED|Overall Study||4
7597169|NCT02575365|18699891|P1|COMPLETED|Overall Study||0
7597170|NCT02575365|18699891|P1|STARTED|Overall Study||4
7597171|NCT02575300|18699901|P1|NOT COMPLETED|Overall Study||0
7597172|NCT02575300|18699901|P1|COMPLETED|Overall Study||20
7597173|NCT02575300|18699901|P1|STARTED|Overall Study||20
7597174|NCT02575079|18699911|P2|NOT COMPLETED|Overall Study||0
7597175|NCT02575079|18699912|P1|NOT COMPLETED|Overall Study||6
7597176|NCT02575079|18699911|P2|COMPLETED|Overall Study||71
7597177|NCT02575079|18699912|P1|COMPLETED|Overall Study||42
7597178|NCT02575079|18699911|P2|STARTED|Overall Study||71
7597179|NCT02575079|18699912|P1|STARTED|Overall Study||48
7597180|NCT02574858|18699926|P1|NOT COMPLETED|Overall Study||0
7597181|NCT02574858|18699926|P1|COMPLETED|Overall Study||25
7597182|NCT02574858|18699926|P1|STARTED|Overall Study||25
7597183|NCT02574845|18699937|P6|NOT COMPLETED|Overall Study||1
7597184|NCT02574845|18699938|P5|NOT COMPLETED|Overall Study||1
7597185|NCT02574845|18699939|P4|NOT COMPLETED|Overall Study||0
7597186|NCT02574845|18699940|P3|NOT COMPLETED|Overall Study||0
7597187|NCT02574845|18699941|P2|NOT COMPLETED|Overall Study||1
7597188|NCT02574845|18699942|P1|NOT COMPLETED|Overall Study||0
7597189|NCT02574845|18699937|P6|COMPLETED|Overall Study||2
7597190|NCT02574845|18699938|P5|COMPLETED|Overall Study||2
7597191|NCT02574845|18699939|P4|COMPLETED|Overall Study||3
7597192|NCT02574845|18699940|P3|COMPLETED|Overall Study||3
7597193|NCT02574845|18699941|P2|COMPLETED|Overall Study||2
7597194|NCT02574845|18699942|P1|COMPLETED|Overall Study||3
7597195|NCT02574845|18699937|P6|Received R|Overall Study||3
7597196|NCT02574845|18699938|P5|Received R|Overall Study||2
7597197|NCT02574845|18699939|P4|Received R|Overall Study||3
7597198|NCT02574845|18699940|P3|Received R|Overall Study||3
7597199|NCT02574845|18699941|P2|Received R|Overall Study||2
7597200|NCT02574845|18699942|P1|Received R|Overall Study||3
7597201|NCT02574845|18699937|P6|Received T5|Overall Study||2
7597202|NCT02574845|18699938|P5|Received T5|Overall Study||3
7597203|NCT02574845|18699939|P4|Received T5|Overall Study||3
7597204|NCT02574845|18699940|P3|Received T5|Overall Study||3
7597205|NCT02574845|18699941|P2|Received T5|Overall Study||2
7597206|NCT02574845|18699942|P1|Received T5|Overall Study||3
7597207|NCT02574845|18699937|P6|Received T4|Overall Study||2
7597208|NCT02574845|18699938|P5|Received T4|Overall Study||2
7597209|NCT02574845|18699939|P4|Received T4|Overall Study||3
7597210|NCT02574845|18699940|P3|Received T4|Overall Study||3
7597211|NCT02574845|18699941|P2|Received T4|Overall Study||2
7597212|NCT02574845|18699942|P1|Received T4|Overall Study||3
7597213|NCT02574845|18699937|P6|Received T3|Overall Study||3
7597214|NCT02574845|18699938|P5|Received T3|Overall Study||2
7597215|NCT02574845|18699939|P4|Received T3|Overall Study||3
7597216|NCT02574845|18699940|P3|Received T3|Overall Study||3
7597217|NCT02574845|18699941|P2|Received T3|Overall Study||2
7597218|NCT02574845|18699942|P1|Received T3|Overall Study|one subject missed treatment period 2|2
7597219|NCT02574845|18699937|P6|Received T2|Overall Study||3
7597220|NCT02574845|18699938|P5|Received T2|Overall Study||2
7597221|NCT02574845|18699939|P4|Received T2|Overall Study||3
7597222|NCT02574845|18699940|P3|Received T2|Overall Study||3
7597223|NCT02574845|18699941|P2|Received T2|Overall Study||3
7597224|NCT02574845|18699942|P1|Received T2|Overall Study||3
7597225|NCT02574845|18699937|P6|Received T1|Overall Study|one subject missed treatment period 2|2
7597226|NCT02574845|18699938|P5|Received T1|Overall Study||2
7597227|NCT02574845|18699939|P4|Received T1|Overall Study||3
7597228|NCT02574845|18699940|P3|Received T1|Overall Study||3
7597229|NCT02574845|18699941|P2|Received T1|Overall Study||2
7597230|NCT02574845|18699942|P1|Received T1|Overall Study||3
7597231|NCT02574845|18699937|P6|STARTED|Overall Study||3
7597232|NCT02574845|18699938|P5|STARTED|Overall Study||3
7597233|NCT02574845|18699939|P4|STARTED|Overall Study||3
7597234|NCT02574845|18699940|P3|STARTED|Overall Study||3
7597235|NCT02574845|18699941|P2|STARTED|Overall Study||3
7597236|NCT02574845|18699942|P1|STARTED|Overall Study||3
7597237|NCT02574832|18699968|P1|NOT COMPLETED|Overall Study||0
7597238|NCT02574832|18699968|P1|COMPLETED|Overall Study||2
7597239|NCT02574832|18699968|P1|STARTED|Overall Study||2
7597240|NCT02574637|18699977|P10|NOT COMPLETED|Open-label (OL) Period||1
7597241|NCT02574637|18699978|P9|NOT COMPLETED|Open-label (OL) Period||2
7597242|NCT02574637|18699979|P8|NOT COMPLETED|Open-label (OL) Period||1
7597243|NCT02574637|18699980|P7|NOT COMPLETED|Open-label (OL) Period||2
7597244|NCT02574637|18699981|P6|NOT COMPLETED|Open-label (OL) Period||2
7597245|NCT02574637|18699982|P5|NOT COMPLETED|Open-label (OL) Period||0
7597246|NCT02574637|18699983|P4|NOT COMPLETED|Open-label (OL) Period||0
7597247|NCT02574637|18699984|P3|NOT COMPLETED|Open-label (OL) Period||0
7597248|NCT02574637|18699985|P2|NOT COMPLETED|Open-label (OL) Period||0
7597249|NCT02574637|18699986|P1|NOT COMPLETED|Open-label (OL) Period||0
7597250|NCT02574637|18699977|P10|COMPLETED|Open-label (OL) Period||0
7597251|NCT02574637|18699978|P9|COMPLETED|Open-label (OL) Period||1
7597252|NCT02574637|18699979|P8|COMPLETED|Open-label (OL) Period||1
7597253|NCT02574637|18699980|P7|COMPLETED|Open-label (OL) Period||1
7597254|NCT02574637|18699981|P6|COMPLETED|Open-label (OL) Period||0
7597255|NCT02574637|18699982|P5|COMPLETED|Open-label (OL) Period||0
7597256|NCT02574637|18699983|P4|COMPLETED|Open-label (OL) Period||0
7597257|NCT02574637|18699984|P3|COMPLETED|Open-label (OL) Period||0
7597258|NCT02574637|18699985|P2|COMPLETED|Open-label (OL) Period||0
7597259|NCT02574637|18699986|P1|COMPLETED|Open-label (OL) Period||0
7597260|NCT02574637|18699977|P10|STARTED|Open-label (OL) Period||1
7597261|NCT02574637|18699978|P9|STARTED|Open-label (OL) Period||3
7597262|NCT02574637|18699979|P8|STARTED|Open-label (OL) Period||2
7597263|NCT02574637|18699980|P7|STARTED|Open-label (OL) Period||3
7597264|NCT02574637|18699981|P6|STARTED|Open-label (OL) Period||2
7597265|NCT02574637|18699982|P5|STARTED|Open-label (OL) Period||0
7597266|NCT02574637|18699983|P4|STARTED|Open-label (OL) Period||0
7597267|NCT02574637|18699984|P3|STARTED|Open-label (OL) Period||0
7597268|NCT02574637|18699985|P2|STARTED|Open-label (OL) Period||0
7597269|NCT02574637|18699986|P1|STARTED|Open-label (OL) Period||0
7597270|NCT02574637|18699977|P10|NOT COMPLETED|Double-blind Period||0
7597271|NCT02574637|18699978|P9|NOT COMPLETED|Double-blind Period||0
7597272|NCT02574637|18699979|P8|NOT COMPLETED|Double-blind Period||0
7597273|NCT02574637|18699980|P7|NOT COMPLETED|Double-blind Period||0
7597274|NCT02574637|18699981|P6|NOT COMPLETED|Double-blind Period||0
7597275|NCT02574637|18699982|P5|NOT COMPLETED|Double-blind Period||2
7597276|NCT02574637|18699983|P4|NOT COMPLETED|Double-blind Period||4
7597277|NCT02574637|18699984|P3|NOT COMPLETED|Double-blind Period||7
7597278|NCT02574637|18699985|P2|NOT COMPLETED|Double-blind Period||1
7597279|NCT02574637|18699986|P1|NOT COMPLETED|Double-blind Period||3
7597280|NCT02574637|18699977|P10|COMPLETED|Double-blind Period||0
7597281|NCT02574637|18699978|P9|COMPLETED|Double-blind Period||0
7597282|NCT02574637|18699979|P8|COMPLETED|Double-blind Period||0
7597283|NCT02574637|18699980|P7|COMPLETED|Double-blind Period||0
7597284|NCT02574637|18699981|P6|COMPLETED|Double-blind Period||0
7597285|NCT02574637|18699982|P5|COMPLETED|Double-blind Period||1
7597286|NCT02574637|18699983|P4|COMPLETED|Double-blind Period||3
7597287|NCT02574637|18699984|P3|COMPLETED|Double-blind Period||2
7597288|NCT02574637|18699985|P2|COMPLETED|Double-blind Period||4
7597289|NCT02574637|18699986|P1|COMPLETED|Double-blind Period||2
7597290|NCT02574637|18699977|P10|STARTED|Double-blind Period||0
7597291|NCT02574637|18699978|P9|STARTED|Double-blind Period||0
7597292|NCT02574637|18699979|P8|STARTED|Double-blind Period||0
7597293|NCT02574637|18699980|P7|STARTED|Double-blind Period||0
7597294|NCT02574637|18699981|P6|STARTED|Double-blind Period||0
7597295|NCT02574637|18699982|P5|STARTED|Double-blind Period||3
7597296|NCT02574637|18699983|P4|STARTED|Double-blind Period||7
7597297|NCT02574637|18699984|P3|STARTED|Double-blind Period||9
7597298|NCT02574637|18699985|P2|STARTED|Double-blind Period||5
7597299|NCT02574637|18699986|P1|STARTED|Double-blind Period||5
7597300|NCT02574598|18700084|P2|NOT COMPLETED|Overall Study||0
7597301|NCT02574598|18700085|P1|NOT COMPLETED|Overall Study||0
7597302|NCT02574598|18700084|P2|COMPLETED|Overall Study||38
7597303|NCT02574598|18700085|P1|COMPLETED|Overall Study||40
7597304|NCT02574598|18700084|P2|STARTED|Overall Study||38
7597305|NCT02574598|18700085|P1|STARTED|Overall Study||40
7597306|NCT02574481|18700095|P4|NOT COMPLETED|Overall Study||0
7597307|NCT02574481|18700096|P3|NOT COMPLETED|Overall Study||3
7597308|NCT02574481|18700097|P2|NOT COMPLETED|Overall Study||14
7597309|NCT02574481|18700098|P1|NOT COMPLETED|Overall Study||27
7597310|NCT02574481|18700095|P4|COMPLETED|Overall Study||13
7597311|NCT02574481|18700096|P3|COMPLETED|Overall Study||47
7597312|NCT02574481|18700097|P2|COMPLETED|Overall Study||142
7597313|NCT02574481|18700098|P1|COMPLETED|Overall Study||282
7597314|NCT02574481|18700095|P4|STARTED|Overall Study||13
7597315|NCT02574481|18700096|P3|STARTED|Overall Study||50
7597316|NCT02574481|18700097|P2|STARTED|Overall Study||156
7597317|NCT02574481|18700098|P1|STARTED|Overall Study||309
7597318|NCT02574312|18700138|P2|NOT COMPLETED|3 Months Follow-up||0
7597319|NCT02574312|18700139|P1|NOT COMPLETED|3 Months Follow-up||1
7597320|NCT02574312|18700138|P2|COMPLETED|3 Months Follow-up||44
7597321|NCT02574312|18700139|P1|COMPLETED|3 Months Follow-up|One subject withdrew consent|43
7597322|NCT02574312|18700138|P2|STARTED|3 Months Follow-up||44
7597323|NCT02574312|18700139|P1|STARTED|3 Months Follow-up||44
7597324|NCT02574312|18700138|P2|NOT COMPLETED|Pre-Operative||0
7597325|NCT02574312|18700139|P1|NOT COMPLETED|Pre-Operative||0
7597326|NCT02574312|18700138|P2|COMPLETED|Pre-Operative||44
7597327|NCT02574312|18700139|P1|COMPLETED|Pre-Operative||44
7597328|NCT02574312|18700138|P2|STARTED|Pre-Operative||44
7597329|NCT02574312|18700139|P1|STARTED|Pre-Operative||44
7597330|NCT02574260|18700155|P1|NOT COMPLETED|Overall Study||1
7597331|NCT02574260|18700155|P1|COMPLETED|Overall Study||2
7597332|NCT02574260|18700155|P1|STARTED|Overall Study||3
7597333|NCT02574247|18700164|P3|NOT COMPLETED|Overall Study||5
7597334|NCT02574247|18700165|P2|NOT COMPLETED|Overall Study||3
7597335|NCT02574247|18700166|P1|NOT COMPLETED|Overall Study||5
7597336|NCT02574247|18700164|P3|COMPLETED|Overall Study||5
7597337|NCT02574247|18700165|P2|COMPLETED|Overall Study||5
7597338|NCT02574247|18700166|P1|COMPLETED|Overall Study||5
7597339|NCT02574247|18700164|P3|STARTED|Overall Study||10
7597340|NCT02574247|18700165|P2|STARTED|Overall Study||8
7597341|NCT02574247|18700166|P1|STARTED|Overall Study||10
7597342|NCT02573948|18700178|P1|NOT COMPLETED|Longitudinal Cohort||56
7597343|NCT02573948|18700178|P1|COMPLETED|Longitudinal Cohort||194
7597344|NCT02573948|18700178|P1|STARTED|Longitudinal Cohort|Not on ART a/o MMT. MSM and FSW were prioritized for enrolling,|250
7597345|NCT02573948|18700178|P1|NOT COMPLETED|RDS||0
7597346|NCT02573948|18700178|P1|COMPLETED|RDS||603
7597347|NCT02573948|18700178|P1|STARTED|RDS||603
7597348|NCT02573870|18700188|P2|NOT COMPLETED|Overall Study||7
7597349|NCT02573870|18700189|P1|NOT COMPLETED|Overall Study||0
7597350|NCT02573870|18700188|P2|COMPLETED|Overall Study||35
7597351|NCT02573870|18700189|P1|COMPLETED|Overall Study||20
7597352|NCT02573870|18700188|P2|STARTED|Overall Study||42
7597353|NCT02573870|18700189|P1|STARTED|Overall Study||20
7597354|NCT02573857|18700197|P2|NOT COMPLETED|Overall Study||0
7597355|NCT02573857|18700198|P1|NOT COMPLETED|Overall Study||0
7597356|NCT02573857|18700197|P2|COMPLETED|Overall Study||8
7597357|NCT02573857|18700198|P1|COMPLETED|Overall Study||8
7597358|NCT02573857|18700197|P2|STARTED|Overall Study||8
7597359|NCT02573857|18700198|P1|STARTED|Overall Study||8
7597360|NCT02573779|18700210|P2|NOT COMPLETED|Overall Study||0
7597361|NCT02573779|18700211|P1|NOT COMPLETED|Overall Study||0
7597362|NCT02573779|18700210|P2|COMPLETED|Overall Study||43
7597363|NCT02573779|18700211|P1|COMPLETED|Overall Study||74
7597364|NCT02573779|18700210|P2|STARTED|Overall Study||43
7597365|NCT02573779|18700211|P1|STARTED|Overall Study||74
7597366|NCT02573467|18700237|P4|NOT COMPLETED|Post-treatment Follow up Epoch||3
7597367|NCT02573467|18700238|P3|NOT COMPLETED|Post-treatment Follow up Epoch||10
7597368|NCT02573467|18700239|P2|NOT COMPLETED|Post-treatment Follow up Epoch||5
7597369|NCT02573467|18700240|P1|NOT COMPLETED|Post-treatment Follow up Epoch||6
7597370|NCT02573467|18700237|P4|COMPLETED|Post-treatment Follow up Epoch||44
7597371|NCT02573467|18700238|P3|COMPLETED|Post-treatment Follow up Epoch||34
7597372|NCT02573467|18700239|P2|COMPLETED|Post-treatment Follow up Epoch||41
7597373|NCT02573467|18700240|P1|COMPLETED|Post-treatment Follow up Epoch||35
7597374|NCT02573467|18700237|P4|STARTED|Post-treatment Follow up Epoch||47
7597375|NCT02573467|18700238|P3|STARTED|Post-treatment Follow up Epoch||44
7597376|NCT02573467|18700239|P2|STARTED|Post-treatment Follow up Epoch||46
7597377|NCT02573467|18700240|P1|STARTED|Post-treatment Follow up Epoch||41
7597378|NCT02573467|18700237|P4|NOT COMPLETED|Double-blind Treatment Epoch||55
7597379|NCT02573467|18700238|P3|NOT COMPLETED|Double-blind Treatment Epoch||51
7597380|NCT02573467|18700239|P2|NOT COMPLETED|Double-blind Treatment Epoch||52
7597381|NCT02573467|18700240|P1|NOT COMPLETED|Double-blind Treatment Epoch||53
7597382|NCT02573467|18700237|P4|COMPLETED|Double-blind Treatment Epoch||0
7597383|NCT02573467|18700238|P3|COMPLETED|Double-blind Treatment Epoch||0
7597384|NCT02573467|18700239|P2|COMPLETED|Double-blind Treatment Epoch||0
7597385|NCT02573467|18700240|P1|COMPLETED|Double-blind Treatment Epoch||0
7597386|NCT02573467|18700237|P4|Full Analysis Set|Double-blind Treatment Epoch||55
7597387|NCT02573467|18700238|P3|Full Analysis Set|Double-blind Treatment Epoch||51
7597388|NCT02573467|18700239|P2|Full Analysis Set|Double-blind Treatment Epoch||52
7597389|NCT02573467|18700240|P1|Full Analysis Set|Double-blind Treatment Epoch||53
7597390|NCT02573467|18700237|P4|STARTED|Double-blind Treatment Epoch||55
7597391|NCT02573467|18700238|P3|STARTED|Double-blind Treatment Epoch||51
7597392|NCT02573467|18700239|P2|STARTED|Double-blind Treatment Epoch||52
7597393|NCT02573467|18700240|P1|STARTED|Double-blind Treatment Epoch||53
7597394|NCT02573402|18700281|P2|NOT COMPLETED|Overall Study||0
7597395|NCT02573402|18700282|P1|NOT COMPLETED|Overall Study||0
7597396|NCT02573402|18700281|P2|COMPLETED|Overall Study||7
7597397|NCT02573402|18700282|P1|COMPLETED|Overall Study||12
7597398|NCT02573402|18700281|P2|STARTED|Overall Study||7
7597399|NCT02573402|18700282|P1|STARTED|Overall Study||12
7597400|NCT02573311|18700304|P2|NOT COMPLETED|Disposition for Part 2||26
7597401|NCT02573311|18700305|P1|NOT COMPLETED|Disposition for Part 2||210
7597402|NCT02573311|18700304|P2|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|127
7597403|NCT02573311|18700305|P1|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|754
7597404|NCT02573311|18700304|P2|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|153
7597405|NCT02573311|18700305|P1|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|964
7597406|NCT02573311|18700304|P2|NOT COMPLETED|Disposition for Part 1||3
7597407|NCT02573311|18700305|P1|NOT COMPLETED|Disposition for Part 1||7
7597408|NCT02573311|18700304|P2|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|361
7597409|NCT02573311|18700305|P1|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|1730
7597410|NCT02573311|18700304|P2|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|364
7597411|NCT02573311|18700305|P1|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|1737
7597412|NCT02573233|18700321|P2|NOT COMPLETED|Overall Study||0
7597413|NCT02573233|18700322|P1|NOT COMPLETED|Overall Study||0
7597414|NCT02573233|18700321|P2|COMPLETED|Overall Study||20
7597415|NCT02573233|18700322|P1|COMPLETED|Overall Study||22
7597416|NCT02573233|18700321|P2|STARTED|Overall Study||20
7597417|NCT02573233|18700322|P1|STARTED|Overall Study||22
7597418|NCT02573181|18700349|P2|NOT COMPLETED|Overall Study||0
7597419|NCT02573181|18700350|P1|NOT COMPLETED|Overall Study||0
7597420|NCT02573181|18700349|P2|COMPLETED|Overall Study||126
7597421|NCT02573181|18700350|P1|COMPLETED|Overall Study||127
7597422|NCT02573181|18700349|P2|Vaccinated|Overall Study||126
7597423|NCT02573181|18700350|P1|Vaccinated|Overall Study||127
7597424|NCT02573181|18700349|P2|STARTED|Overall Study||126
7597425|NCT02573181|18700350|P1|STARTED|Overall Study||127
7597426|NCT02573155|18700374|P2|NOT COMPLETED|Period 5||0
7597427|NCT02573155|18700375|P1|NOT COMPLETED|Period 5||0
7597428|NCT02573155|18700374|P2|COMPLETED|Period 5||28
7597429|NCT02573155|18700375|P1|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
7597430|NCT02573155|18700374|P2|STARTED|Period 5||28
7597431|NCT02573155|18700375|P1|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
7597432|NCT02573155|18700374|P2|NOT COMPLETED|Washout Between Treatment Period 4 and 5||1
7597433|NCT02573155|18700375|P1|NOT COMPLETED|Washout Between Treatment Period 4 and 5||0
7597434|NCT02573155|18700374|P2|COMPLETED|Washout Between Treatment Period 4 and 5||28
7597435|NCT02573155|18700375|P1|COMPLETED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
7597436|NCT02573155|18700374|P2|STARTED|Washout Between Treatment Period 4 and 5||29
7597437|NCT02573155|18700375|P1|STARTED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
7597438|NCT02573155|18700374|P2|NOT COMPLETED|Period 4||0
7597439|NCT02573155|18700375|P1|NOT COMPLETED|Period 4||0
7597440|NCT02573155|18700374|P2|COMPLETED|Period 4||29
7597441|NCT02573155|18700375|P1|COMPLETED|Period 4|Part 1 comprised 3 treatment periods only|0
7597442|NCT02573155|18700374|P2|STARTED|Period 4||29
7597443|NCT02573155|18700375|P1|STARTED|Period 4|Part 1 comprised 3 treatment periods only|0
7597444|NCT02573155|18700374|P2|NOT COMPLETED|Washout Between Treatment Period 3 and 4||2
7597445|NCT02573155|18700375|P1|NOT COMPLETED|Washout Between Treatment Period 3 and 4||0
7597446|NCT02573155|18700374|P2|COMPLETED|Washout Between Treatment Period 3 and 4||29
7597447|NCT02573155|18700375|P1|COMPLETED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
7597448|NCT02573155|18700374|P2|STARTED|Washout Between Treatment Period 3 and 4||31
7597449|NCT02573155|18700375|P1|STARTED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
7597450|NCT02573155|18700374|P2|NOT COMPLETED|Period 3||0
7597451|NCT02573155|18700375|P1|NOT COMPLETED|Period 3||0
7597452|NCT02573155|18700374|P2|COMPLETED|Period 3||31
7597453|NCT02573155|18700375|P1|COMPLETED|Period 3||15
7597454|NCT02573155|18700374|P2|STARTED|Period 3||31
7597455|NCT02573155|18700375|P1|STARTED|Period 3||15
7597456|NCT02573155|18700374|P2|NOT COMPLETED|Washout Between Treatment Period 2 and 3||2
7597457|NCT02573155|18700375|P1|NOT COMPLETED|Washout Between Treatment Period 2 and 3||1
7597458|NCT02573155|18700374|P2|COMPLETED|Washout Between Treatment Period 2 and 3||31
7597459|NCT02573155|18700375|P1|COMPLETED|Washout Between Treatment Period 2 and 3||15
7597460|NCT02573155|18700374|P2|STARTED|Washout Between Treatment Period 2 and 3||33
7597461|NCT02573155|18700375|P1|STARTED|Washout Between Treatment Period 2 and 3||16
7597462|NCT02573155|18700374|P2|NOT COMPLETED|Period 2||0
7597463|NCT02573155|18700375|P1|NOT COMPLETED|Period 2||0
7597464|NCT02573155|18700374|P2|COMPLETED|Period 2||33
7597465|NCT02573155|18700375|P1|COMPLETED|Period 2||16
7597466|NCT02573155|18700374|P2|STARTED|Period 2||33
7597467|NCT02573155|18700375|P1|STARTED|Period 2||16
7597468|NCT02573155|18700374|P2|NOT COMPLETED|Washout Between Treatment Period 1 and 2||5
7597469|NCT02573155|18700375|P1|NOT COMPLETED|Washout Between Treatment Period 1 and 2||0
7597470|NCT02573155|18700374|P2|COMPLETED|Washout Between Treatment Period 1 and 2||33
7597471|NCT02573155|18700375|P1|COMPLETED|Washout Between Treatment Period 1 and 2||16
7597472|NCT02573155|18700374|P2|STARTED|Washout Between Treatment Period 1 and 2||38
7597473|NCT02573155|18700375|P1|STARTED|Washout Between Treatment Period 1 and 2||16
7597474|NCT02573155|18700374|P2|NOT COMPLETED|Treatment Period 1||0
7597475|NCT02573155|18700375|P1|NOT COMPLETED|Treatment Period 1||0
7597476|NCT02573155|18700374|P2|COMPLETED|Treatment Period 1||38
7597477|NCT02573155|18700375|P1|COMPLETED|Treatment Period 1||16
7597478|NCT02573155|18700374|P2|STARTED|Treatment Period 1||38
7597479|NCT02573155|18700375|P1|STARTED|Treatment Period 1||16
7597480|NCT02573012|18700523|P2|NOT COMPLETED|Overall Study||15
7597481|NCT02573012|18700524|P1|NOT COMPLETED|Overall Study||15
7597482|NCT02573012|18700523|P2|COMPLETED|Overall Study||113
7597483|NCT02573012|18700524|P1|COMPLETED|Overall Study||116
7597484|NCT02573012|18700523|P2|STARTED|Overall Study||128
7597485|NCT02573012|18700524|P1|STARTED|Overall Study||131
7597486|NCT02572817|18700576|P2|NOT COMPLETED|Overall Study||6
7597487|NCT02572817|18700577|P1|NOT COMPLETED|Overall Study||9
7597488|NCT02572817|18700576|P2|COMPLETED|Overall Study||41
7597489|NCT02572817|18700577|P1|COMPLETED|Overall Study||82
7597490|NCT02572817|18700576|P2|STARTED|Overall Study||47
7597491|NCT02572817|18700577|P1|STARTED|Overall Study||91
7597492|NCT02572752|18700644|P3|NOT COMPLETED|Period 3 Including Washout||0
7597493|NCT02572752|18700645|P2|NOT COMPLETED|Period 3 Including Washout||0
7597494|NCT02572752|18700646|P1|NOT COMPLETED|Period 3 Including Washout||0
7597495|NCT02572752|18700644|P3|COMPLETED|Period 3 Including Washout||24
7597496|NCT02572752|18700645|P2|COMPLETED|Period 3 Including Washout||23
7597497|NCT02572752|18700646|P1|COMPLETED|Period 3 Including Washout||23
7597498|NCT02572752|18700644|P3|STARTED|Period 3 Including Washout||24
7597499|NCT02572752|18700645|P2|STARTED|Period 3 Including Washout||23
7597500|NCT02572752|18700646|P1|STARTED|Period 3 Including Washout||23
7597501|NCT02572752|18700644|P3|NOT COMPLETED|Period 2 Including Washout||0
7597502|NCT02572752|18700645|P2|NOT COMPLETED|Period 2 Including Washout||0
7597503|NCT02572752|18700646|P1|NOT COMPLETED|Period 2 Including Washout||0
7597504|NCT02572752|18700644|P3|COMPLETED|Period 2 Including Washout||24
7597505|NCT02572752|18700645|P2|COMPLETED|Period 2 Including Washout||23
7597506|NCT02572752|18700646|P1|COMPLETED|Period 2 Including Washout||23
7597507|NCT02572752|18700644|P3|STARTED|Period 2 Including Washout||24
7597508|NCT02572752|18700645|P2|STARTED|Period 2 Including Washout||23
7597509|NCT02572752|18700646|P1|STARTED|Period 2 Including Washout||23
7597510|NCT02572752|18700644|P3|NOT COMPLETED|Period 1 Including Washout||0
7597511|NCT02572752|18700645|P2|NOT COMPLETED|Period 1 Including Washout||0
7597512|NCT02572752|18700646|P1|NOT COMPLETED|Period 1 Including Washout||0
7597513|NCT02572752|18700644|P3|COMPLETED|Period 1 Including Washout||24
7597514|NCT02572752|18700645|P2|COMPLETED|Period 1 Including Washout||23
7597515|NCT02572752|18700646|P1|COMPLETED|Period 1 Including Washout||23
7597516|NCT02572752|18700644|P3|STARTED|Period 1 Including Washout||24
7597517|NCT02572752|18700645|P2|STARTED|Period 1 Including Washout||23
7597518|NCT02572752|18700646|P1|STARTED|Period 1 Including Washout||23
7597519|NCT02572609|18700661|P2|NOT COMPLETED|Period 2: Treatment Period 2||0
7597520|NCT02572609|18700662|P1|NOT COMPLETED|Period 2: Treatment Period 2||0
7597521|NCT02572609|18700661|P2|COMPLETED|Period 2: Treatment Period 2||18
7597522|NCT02572609|18700662|P1|COMPLETED|Period 2: Treatment Period 2||18
7597523|NCT02572609|18700661|P2|STARTED|Period 2: Treatment Period 2||18
7597524|NCT02572609|18700662|P1|STARTED|Period 2: Treatment Period 2||18
7597525|NCT02572609|18700661|P2|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
7597526|NCT02572609|18700662|P1|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
7597527|NCT02572609|18700661|P2|COMPLETED|Period 1: Treatment Period 1 + Washout||18
7597528|NCT02572609|18700662|P1|COMPLETED|Period 1: Treatment Period 1 + Washout||18
7597529|NCT02572609|18700661|P2|STARTED|Period 1: Treatment Period 1 + Washout||18
7597530|NCT02572609|18700662|P1|STARTED|Period 1: Treatment Period 1 + Washout||18
7597531|NCT02572570|18700670|P1|NOT COMPLETED|Overall Study||27
7597532|NCT02572570|18700670|P1|COMPLETED|Overall Study||0
7597533|NCT02572570|18700670|P1|5 Year Follow-Up|Overall Study||0
7597534|NCT02572570|18700670|P1|3 Year Follow-Up|Overall Study||5
7597535|NCT02572570|18700670|P1|2 Year Follow-Up|Overall Study||13
7597536|NCT02572570|18700670|P1|1 Year Follow-Up|Overall Study||20
7597537|NCT02572570|18700670|P1|Filtek Supreme Ultra|Overall Study||27
7597538|NCT02572570|18700670|P1|Filtek Bulk Fill Posterior|Overall Study||27
7597539|NCT02572570|18700670|P1|STARTED|Overall Study||27
7597540|NCT02572427|18700687|P2|NOT COMPLETED|Overall Study||9
7597541|NCT02572427|18700688|P1|NOT COMPLETED|Overall Study||6
7597542|NCT02572427|18700687|P2|COMPLETED|Overall Study||36
7597543|NCT02572427|18700688|P1|COMPLETED|Overall Study||31
7597544|NCT02572427|18700687|P2|STARTED|Overall Study||45
7597545|NCT02572427|18700688|P1|STARTED|Overall Study||37
7597546|NCT02572401|18700700|P4|NOT COMPLETED|Overall Study||10
7597547|NCT02572401|18700701|P3|NOT COMPLETED|Overall Study||9
7597548|NCT02572401|18700702|P2|NOT COMPLETED|Overall Study||8
7597549|NCT02572401|18700703|P1|NOT COMPLETED|Overall Study||5
7597550|NCT02572401|18700700|P4|COMPLETED|Overall Study||88
7597551|NCT02572401|18700701|P3|COMPLETED|Overall Study||89
7597552|NCT02572401|18700702|P2|COMPLETED|Overall Study||90
7597553|NCT02572401|18700703|P1|COMPLETED|Overall Study||92
7597554|NCT02572401|18700700|P4|STARTED|Overall Study||98
7597555|NCT02572401|18700701|P3|STARTED|Overall Study||98
7597556|NCT02572401|18700702|P2|STARTED|Overall Study||98
7597557|NCT02572401|18700703|P1|STARTED|Overall Study||97
7597558|NCT02572388|18700733|P4|NOT COMPLETED|Overall Study||2
7597559|NCT02572388|18700734|P3|NOT COMPLETED|Overall Study||2
7597560|NCT02572388|18700735|P2|NOT COMPLETED|Overall Study||1
7597561|NCT02572388|18700736|P1|NOT COMPLETED|Overall Study||1
7597562|NCT02572388|18700733|P4|COMPLETED|Overall Study||4
7597563|NCT02572388|18700734|P3|COMPLETED|Overall Study||8
7597564|NCT02572388|18700735|P2|COMPLETED|Overall Study||3
7597565|NCT02572388|18700736|P1|COMPLETED|Overall Study||10
7597566|NCT02572388|18700733|P4|STARTED|Overall Study||6
7597567|NCT02572388|18700734|P3|STARTED|Overall Study||10
7597568|NCT02572388|18700735|P2|STARTED|Overall Study||4
7597569|NCT02572388|18700736|P1|STARTED|Overall Study||11
7597570|NCT02572167|18700761|P3|NOT COMPLETED|Overall Study||31
7597571|NCT02572167|18700762|P2|NOT COMPLETED|Overall Study||56
7597572|NCT02572167|18700763|P1|NOT COMPLETED|Overall Study||6
7597573|NCT02572167|18700761|P3|COMPLETED|Overall Study||0
7597574|NCT02572167|18700762|P2|COMPLETED|Overall Study||0
7597575|NCT02572167|18700763|P1|COMPLETED|Overall Study||0
7597576|NCT02572167|18700761|P3|STARTED|Overall Study||31
7597577|NCT02572167|18700762|P2|STARTED|Overall Study||56
7597578|NCT02572167|18700763|P1|STARTED|Overall Study||6
7597579|NCT02572076|18700777|P1|NOT COMPLETED|Overall Study||1
7597580|NCT02572076|18700777|P1|COMPLETED|Overall Study||9
7597581|NCT02572076|18700777|P1|STARTED|Overall Study||10
7597582|NCT02571972|18700781|P1|NOT COMPLETED|Overall Study||4
7597583|NCT02571972|18700781|P1|COMPLETED|Overall Study||10
7597584|NCT02571972|18700781|P1|STARTED|Overall Study|2 patients signed consent but withdrew from the study prior to using dorzolamide-timolol drops.|14
7597585|NCT02571777|18700793|P5|NOT COMPLETED|Overall Study||36
7597586|NCT02571777|18700794|P4|NOT COMPLETED|Overall Study||37
7597587|NCT02571777|18700795|P3|NOT COMPLETED|Overall Study||41
7597588|NCT02571777|18700796|P2|NOT COMPLETED|Overall Study||38
7597589|NCT02571777|18700797|P1|NOT COMPLETED|Overall Study||39
7597590|NCT02571777|18700793|P5|COMPLETED|Overall Study||582
7597591|NCT02571777|18700794|P4|COMPLETED|Overall Study||580
7597592|NCT02571777|18700795|P3|COMPLETED|Overall Study||577
7597593|NCT02571777|18700796|P2|COMPLETED|Overall Study||582
7597594|NCT02571777|18700797|P1|COMPLETED|Overall Study||580
7597595|NCT02571777|18700793|P5|Safety Set (SAF)|Overall Study||618
7597596|NCT02571777|18700794|P4|Safety Set (SAF)|Overall Study||608
7597597|NCT02571777|18700795|P3|Safety Set (SAF)|Overall Study||613
7597598|NCT02571777|18700796|P2|Safety Set (SAF)|Overall Study||617
7597599|NCT02571777|18700797|P1|Safety Set (SAF)|Overall Study||616
7597600|NCT02571777|18700793|P5|Full Analysis Set (FAS)|Overall Study||612
7597601|NCT02571777|18700794|P4|Full Analysis Set (FAS)|Overall Study||607
7597602|NCT02571777|18700795|P3|Full Analysis Set (FAS)|Overall Study||611
7597603|NCT02571777|18700796|P2|Full Analysis Set (FAS)|Overall Study||616
7597604|NCT02571777|18700797|P1|Full Analysis Set (FAS)|Overall Study||615
7597605|NCT02571777|18700793|P5|STARTED|Overall Study||618
7597606|NCT02571777|18700794|P4|STARTED|Overall Study||617
7597607|NCT02571777|18700795|P3|STARTED|Overall Study||618
7597608|NCT02571777|18700796|P2|STARTED|Overall Study||620
7597609|NCT02571777|18700797|P1|STARTED|Overall Study||619
7597610|NCT02571634|18700924|P1|NOT COMPLETED|Overall Study||0
7597611|NCT02571634|18700924|P1|COMPLETED|Overall Study|The final subject was enrolled on this date.|23
7597612|NCT02571634|18700924|P1|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23
7597613|NCT02571452|18700934|P2|NOT COMPLETED|Overall Study 6-Month Follow-up||0
7597614|NCT02571452|18700935|P1|NOT COMPLETED|Overall Study 6-Month Follow-up||5
7597615|NCT02571452|18700934|P2|COMPLETED|Overall Study 6-Month Follow-up||0
7597616|NCT02571452|18700935|P1|COMPLETED|Overall Study 6-Month Follow-up||42
7597617|NCT02571452|18700934|P2|STARTED|Overall Study 6-Month Follow-up|Participants in the PMRT arm were not invited to complete 6-Month Follow-up.|0
7597618|NCT02571452|18700935|P1|STARTED|Overall Study 6-Month Follow-up||47
7597619|NCT02571452|18700934|P2|NOT COMPLETED|Overall Study Treatment||1
7597620|NCT02571452|18700935|P1|NOT COMPLETED|Overall Study Treatment||0
7597621|NCT02571452|18700934|P2|COMPLETED|Overall Study Treatment||45
7597622|NCT02571452|18700935|P1|COMPLETED|Overall Study Treatment||47
7597623|NCT02571452|18700934|P2|STARTED|Overall Study Treatment||46
7597624|NCT02571452|18700935|P1|STARTED|Overall Study Treatment||47
7597625|NCT02571439|18700949|P2|NOT COMPLETED|Overall Study||0
7597626|NCT02571439|18700950|P1|NOT COMPLETED|Overall Study||0
7597627|NCT02571439|18700949|P2|COMPLETED|Overall Study||21
7597628|NCT02571439|18700950|P1|COMPLETED|Overall Study||20
7597629|NCT02571439|18700949|P2|STARTED|Overall Study||21
7597630|NCT02571439|18700950|P1|STARTED|Overall Study||20
7597631|NCT02571244|18700976|P2|NOT COMPLETED|Overall Study||1
7597632|NCT02571244|18700977|P1|NOT COMPLETED|Overall Study||3
7597633|NCT02571244|18700976|P2|COMPLETED|Overall Study||21
7597634|NCT02571244|18700977|P1|COMPLETED|Overall Study||41
7597635|NCT02571244|18700976|P2|STARTED|Overall Study||22
7597636|NCT02571244|18700977|P1|STARTED|Overall Study||44
7597637|NCT02571218|18700993|P2|NOT COMPLETED|Overall Study||0
7597638|NCT02571218|18700994|P1|NOT COMPLETED|Overall Study||0
7597639|NCT02571218|18700993|P2|COMPLETED|Overall Study||41
7597640|NCT02571218|18700994|P1|COMPLETED|Overall Study||40
7597641|NCT02571218|18700993|P2|STARTED|Overall Study||41
7597642|NCT02571218|18700994|P1|STARTED|Overall Study||40
7597643|NCT02571153|18701005|P3|NOT COMPLETED|Overall Study||2
7597644|NCT02571153|18701006|P2|NOT COMPLETED|Overall Study||8
7597645|NCT02571153|18701007|P1|NOT COMPLETED|Overall Study||6
7597646|NCT02571153|18701005|P3|COMPLETED|Overall Study||43
7597647|NCT02571153|18701006|P2|COMPLETED|Overall Study||37
7597648|NCT02571153|18701007|P1|COMPLETED|Overall Study||39
7597649|NCT02571153|18701005|P3|STARTED|Overall Study||45
7597650|NCT02571153|18701006|P2|STARTED|Overall Study||45
7597651|NCT02571153|18701007|P1|STARTED|Overall Study||45
7597652|NCT02571075|18701035|P2|NOT COMPLETED|Overall Study||24
7597653|NCT02571075|18701036|P1|NOT COMPLETED|Overall Study||20
7597654|NCT02571075|18701035|P2|COMPLETED|Overall Study||26
7597655|NCT02571075|18701036|P1|COMPLETED|Overall Study||25
7597656|NCT02571075|18701035|P2|STARTED|Overall Study||50
7597657|NCT02571075|18701036|P1|STARTED|Overall Study||45
7597658|NCT02571049|18701050|P2|NOT COMPLETED|Randomization||2
7597659|NCT02571049|18701051|P1|NOT COMPLETED|Randomization||0
7597660|NCT02571049|18701050|P2|COMPLETED|Randomization||10
7597661|NCT02571049|18701051|P1|COMPLETED|Randomization||8
7597662|NCT02571049|18701050|P2|STARTED|Randomization||12
7597663|NCT02571049|18701051|P1|STARTED|Randomization||8
7597664|NCT02571049|18701050|P2|NOT COMPLETED|Screening||2
7597665|NCT02571049|18701051|P1|NOT COMPLETED|Screening||2
7597666|NCT02571049|18701050|P2|COMPLETED|Screening||12
7597667|NCT02571049|18701051|P1|COMPLETED|Screening||8
7597668|NCT02571049|18701050|P2|STARTED|Screening||14
7597669|NCT02571049|18701051|P1|STARTED|Screening||10
7597670|NCT02570750|18701059|P2|NOT COMPLETED|Overall Study||5
7597671|NCT02570750|18701060|P1|NOT COMPLETED|Overall Study||14
7597672|NCT02570750|18701059|P2|COMPLETED|Overall Study||68
7597673|NCT02570750|18701060|P1|COMPLETED|Overall Study||96
7597674|NCT02570750|18701059|P2|STARTED|Overall Study||73
7597675|NCT02570750|18701060|P1|STARTED|Overall Study||110
7597676|NCT02570711|18701078|P2|NOT COMPLETED|Overall Study||2
7597677|NCT02570711|18701079|P1|NOT COMPLETED|Overall Study||1
7597678|NCT02570711|18701078|P2|COMPLETED|Overall Study||0
7597679|NCT02570711|18701079|P1|COMPLETED|Overall Study||0
7597680|NCT02570711|18701078|P2|STARTED|Overall Study||2
7597681|NCT02570711|18701079|P1|STARTED|Overall Study||1
7597682|NCT02570425|18701087|P2|NOT COMPLETED|Visit 3||0
7597683|NCT02570425|18701088|P1|NOT COMPLETED|Visit 3||0
7597684|NCT02570425|18701087|P2|COMPLETED|Visit 3||231
7597685|NCT02570425|18701088|P1|COMPLETED|Visit 3||229
7597686|NCT02570425|18701087|P2|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231
7597687|NCT02570425|18701088|P1|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229
7597688|NCT02570425|18701087|P2|NOT COMPLETED|Visit 2||0
7597689|NCT02570425|18701088|P1|NOT COMPLETED|Visit 2||0
7597690|NCT02570425|18701087|P2|COMPLETED|Visit 2||247
7597691|NCT02570425|18701088|P1|COMPLETED|Visit 2||251
7597692|NCT02570425|18701087|P2|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247
7597693|NCT02570425|18701088|P1|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251
7597694|NCT02570425|18701087|P2|NOT COMPLETED|Visit 1||0
7597695|NCT02570425|18701088|P1|NOT COMPLETED|Visit 1||0
7597696|NCT02570425|18701087|P2|COMPLETED|Visit 1||242
7597697|NCT02570425|18701088|P1|COMPLETED|Visit 1||274
7597698|NCT02570425|18701087|P2|STARTED|Visit 1||242
7597699|NCT02570425|18701088|P1|STARTED|Visit 1||274
7597700|NCT02570295|18701137|P2|NOT COMPLETED|Overall Study||58
7597701|NCT02570295|18701138|P1|NOT COMPLETED|Overall Study||11
7597702|NCT02570295|18701137|P2|COMPLETED|Overall Study||289
7597703|NCT02570295|18701138|P1|COMPLETED|Overall Study||364
7597704|NCT02570295|18701137|P2|STARTED|Overall Study||347
7597705|NCT02570295|18701138|P1|STARTED|Overall Study||375
7597706|NCT02570165|18701167|P7|NOT COMPLETED|Overall Study||0
7597707|NCT02570165|18701168|P6|NOT COMPLETED|Overall Study||2
7597708|NCT02570165|18701169|P5|NOT COMPLETED|Overall Study||6
7597709|NCT02570165|18701170|P4|NOT COMPLETED|Overall Study||5
7597710|NCT02570165|18701171|P3|NOT COMPLETED|Overall Study||5
7597711|NCT02570165|18701172|P2|NOT COMPLETED|Overall Study||3
7597712|NCT02570165|18701173|P1|NOT COMPLETED|Overall Study||2
7597713|NCT02570165|18701167|P7|COMPLETED|Overall Study||47
7597714|NCT02570165|18701168|P6|COMPLETED|Overall Study||44
7597715|NCT02570165|18701169|P5|COMPLETED|Overall Study||41
7597716|NCT02570165|18701170|P4|COMPLETED|Overall Study||40
7597717|NCT02570165|18701171|P3|COMPLETED|Overall Study||41
7597718|NCT02570165|18701172|P2|COMPLETED|Overall Study||43
7597719|NCT02570165|18701173|P1|COMPLETED|Overall Study||44
7597720|NCT02570165|18701167|P7|STARTED|Overall Study||47
7597721|NCT02570165|18701168|P6|STARTED|Overall Study||46
7597722|NCT02570165|18701169|P5|STARTED|Overall Study||47
7597723|NCT02570165|18701170|P4|STARTED|Overall Study||45
7597724|NCT02570165|18701171|P3|STARTED|Overall Study||46
7597725|NCT02570165|18701172|P2|STARTED|Overall Study||46
7597726|NCT02570165|18701173|P1|STARTED|Overall Study||46
7597727|NCT02570152|18701196|P1|NOT COMPLETED|Overall Study||15
7597728|NCT02570152|18701196|P1|COMPLETED|Overall Study||1989
7597729|NCT02570152|18701196|P1|STARTED|Overall Study||2004
7597730|NCT02570139|18701212|P2|NOT COMPLETED|Overall Study||0
7597731|NCT02570139|18701213|P1|NOT COMPLETED|Overall Study||0
7597732|NCT02570139|18701212|P2|COMPLETED|Overall Study||21
7597733|NCT02570139|18701213|P1|COMPLETED|Overall Study||24
7597734|NCT02570139|18701212|P2|STARTED|Overall Study|21 subjects treated with SensiCare Protective Barrier|21
7597735|NCT02570139|18701213|P1|STARTED|Overall Study|24 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|24
7597736|NCT02570126|18701227|P2|NOT COMPLETED|Overall Study||9
7597737|NCT02570126|18701228|P1|NOT COMPLETED|Overall Study||6
7597738|NCT02570126|18701227|P2|COMPLETED|Overall Study||607
7597739|NCT02570126|18701228|P1|COMPLETED|Overall Study||609
7597740|NCT02570126|18701227|P2|STARTED|Overall Study||616
7597741|NCT02570126|18701228|P1|STARTED|Overall Study||615
7597742|NCT02570074|18701254|P2|NOT COMPLETED|Period 2 (Second Dosing Regimen)||0
7597743|NCT02570074|18701255|P1|NOT COMPLETED|Period 2 (Second Dosing Regimen)||1
7597744|NCT02570074|18701254|P2|COMPLETED|Period 2 (Second Dosing Regimen)||10
7597745|NCT02570074|18701255|P1|COMPLETED|Period 2 (Second Dosing Regimen)||8
7597746|NCT02570074|18701254|P2|STARTED|Period 2 (Second Dosing Regimen)||10
7597747|NCT02570074|18701255|P1|STARTED|Period 2 (Second Dosing Regimen)||9
7597748|NCT02570074|18701254|P2|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
7597749|NCT02570074|18701255|P1|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
7597750|NCT02570074|18701254|P2|COMPLETED|Period 1 (First Dosing Regimen)||10
7597751|NCT02570074|18701255|P1|COMPLETED|Period 1 (First Dosing Regimen)||9
7597752|NCT02570074|18701254|P2|STARTED|Period 1 (First Dosing Regimen)||10
7597753|NCT02570074|18701255|P1|STARTED|Period 1 (First Dosing Regimen)||9
7597754|NCT02570022|18701315|P2|NOT COMPLETED|Overall Study||0
7597755|NCT02570022|18701316|P1|NOT COMPLETED|Overall Study||0
7597756|NCT02570022|18701315|P2|COMPLETED|Overall Study||31
7597757|NCT02570022|18701316|P1|COMPLETED|Overall Study||26
7597758|NCT02570022|18701315|P2|STARTED|Overall Study||31
7597759|NCT02570022|18701316|P1|STARTED|Overall Study||26
7597760|NCT02569996|18701324|P1|NOT COMPLETED|Overall Study||55
7597761|NCT02569996|18701324|P1|COMPLETED|Overall Study||69
7597762|NCT02569996|18701324|P1|STARTED|Overall Study||124
7597763|NCT02569957|18701336|P2|NOT COMPLETED|Overall Study||1
7597764|NCT02569957|18701337|P1|NOT COMPLETED|Overall Study||0
7597765|NCT02569957|18701336|P2|COMPLETED|Overall Study||0
7597766|NCT02569957|18701337|P1|COMPLETED|Overall Study||0
7597767|NCT02569957|18701336|P2|STARTED|Overall Study||1
7597768|NCT02569957|18701337|P1|STARTED|Overall Study||0
7597769|NCT02569853|18701369|P2|NOT COMPLETED|Overall Study||14
7597770|NCT02569853|18701370|P1|NOT COMPLETED|Overall Study||20
7597771|NCT02569853|18701369|P2|COMPLETED|Overall Study||123
7597772|NCT02569853|18701370|P1|COMPLETED|Overall Study||111
7597773|NCT02569853|18701369|P2|STARTED|Overall Study||137
7597774|NCT02569853|18701370|P1|STARTED|Overall Study||131
7597775|NCT02569710|18701388|P10|NOT COMPLETED|Overall Study||0
7597776|NCT02569710|18701389|P9|NOT COMPLETED|Overall Study||1
7597777|NCT02569710|18701390|P8|NOT COMPLETED|Overall Study||0
7597778|NCT02569710|18701391|P7|NOT COMPLETED|Overall Study||2
7597779|NCT02569710|18701392|P6|NOT COMPLETED|Overall Study||1
7597780|NCT02569710|18701393|P5|NOT COMPLETED|Overall Study||1
7597781|NCT02569710|18701394|P4|NOT COMPLETED|Overall Study||0
7597782|NCT02569710|18701395|P3|NOT COMPLETED|Overall Study||0
7597783|NCT02569710|18701396|P2|NOT COMPLETED|Overall Study||0
7597784|NCT02569710|18701397|P1|NOT COMPLETED|Overall Study||1
7597785|NCT02569710|18701388|P10|COMPLETED|Overall Study||4
7597786|NCT02569710|18701389|P9|COMPLETED|Overall Study||14
7597787|NCT02569710|18701390|P8|COMPLETED|Overall Study||30
7597788|NCT02569710|18701391|P7|COMPLETED|Overall Study||12
7597789|NCT02569710|18701392|P6|COMPLETED|Overall Study||4
7597790|NCT02569710|18701393|P5|COMPLETED|Overall Study||7
7597791|NCT02569710|18701394|P4|COMPLETED|Overall Study||20
7597792|NCT02569710|18701395|P3|COMPLETED|Overall Study||20
7597793|NCT02569710|18701396|P2|COMPLETED|Overall Study||25
7597794|NCT02569710|18701397|P1|COMPLETED|Overall Study||19
7597795|NCT02569710|18701388|P10|STARTED|Overall Study||4
7597796|NCT02569710|18701389|P9|STARTED|Overall Study||15
7597797|NCT02569710|18701390|P8|STARTED|Overall Study||30
7597798|NCT02569710|18701391|P7|STARTED|Overall Study||14
7597799|NCT02569710|18701392|P6|STARTED|Overall Study||5
7597800|NCT02569710|18701393|P5|STARTED|Overall Study||8
7597801|NCT02569710|18701394|P4|STARTED|Overall Study||20
7597802|NCT02569710|18701395|P3|STARTED|Overall Study||20
7597803|NCT02569710|18701396|P2|STARTED|Overall Study||25
7597804|NCT02569710|18701397|P1|STARTED|Overall Study||20
7597805|NCT02569658|18701707|P2|NOT COMPLETED|Overall Study||1
7597806|NCT02569658|18701708|P1|NOT COMPLETED|Overall Study||1
7597807|NCT02569658|18701707|P2|COMPLETED|Overall Study||56
7597808|NCT02569658|18701708|P1|COMPLETED|Overall Study||52
7597809|NCT02569658|18701707|P2|STARTED|Overall Study||57
7597810|NCT02569658|18701708|P1|STARTED|Overall Study||53
7597811|NCT02569541|18701724|P1|NOT COMPLETED|Overall Study||21
7597812|NCT02569541|18701724|P1|COMPLETED|Overall Study||9
7597813|NCT02569541|18701724|P1|STARTED|Overall Study||30
7597814|NCT02569437|18701737|P2|NOT COMPLETED|Overall Study||14
7597815|NCT02569437|18701738|P1|NOT COMPLETED|Overall Study||12
7597816|NCT02569437|18701737|P2|COMPLETED|Overall Study||11
7597817|NCT02569437|18701738|P1|COMPLETED|Overall Study||12
7597818|NCT02569437|18701737|P2|STARTED|Overall Study||25
7597819|NCT02569437|18701738|P1|STARTED|Overall Study||24
7597820|NCT02569411|18701754|P2|NOT COMPLETED|Overall Study||64
7597821|NCT02569411|18701755|P1|NOT COMPLETED|Overall Study||65
7597822|NCT02569411|18701754|P2|COMPLETED|Overall Study||0
7597823|NCT02569411|18701755|P1|COMPLETED|Overall Study||0
7597824|NCT02569411|18701754|P2|STARTED|Overall Study||64
7597825|NCT02569411|18701755|P1|STARTED|Overall Study||65
7597826|NCT02569398|18701768|P3|NOT COMPLETED|Overall Study||183
7597827|NCT02569398|18701769|P2|NOT COMPLETED|Overall Study||189
7597828|NCT02569398|18701770|P1|NOT COMPLETED|Overall Study||185
7597829|NCT02569398|18701768|P3|COMPLETED|Overall Study||0
7597830|NCT02569398|18701769|P2|COMPLETED|Overall Study||0
7597831|NCT02569398|18701770|P1|COMPLETED|Overall Study||0
7597832|NCT02569398|18701768|P3|STARTED|Overall Study||183
7597833|NCT02569398|18701769|P2|STARTED|Overall Study||189
7597834|NCT02569398|18701770|P1|STARTED|Overall Study||185
7597835|NCT02569112|18701793|P2|NOT COMPLETED|Overall Study||0
7597836|NCT02569112|18701794|P1|NOT COMPLETED|Overall Study||0
7597837|NCT02569112|18701793|P2|COMPLETED|Overall Study|Each subject received multipolar RF with varipulse technology to only one side of their body.|10
7597838|NCT02569112|18701794|P1|COMPLETED|Overall Study||10
7597839|NCT02569112|18701793|P2|STARTED|Overall Study||10
7597840|NCT02569112|18701794|P1|STARTED|Overall Study||10
7597841|NCT02569086|18701799|P1|NOT COMPLETED|Overall Study||0
7597842|NCT02569086|18701799|P1|COMPLETED|Overall Study||22
7597843|NCT02569086|18701799|P1|STARTED|Overall Study||22
7597844|NCT02568852|18701806|P2|NOT COMPLETED|Overall Study||0
7597845|NCT02568852|18701807|P1|NOT COMPLETED|Overall Study||0
7597846|NCT02568852|18701806|P2|COMPLETED|Overall Study||25
7597847|NCT02568852|18701807|P1|COMPLETED|Overall Study||25
7597848|NCT02568852|18701806|P2|STARTED|Overall Study||25
7597849|NCT02568852|18701807|P1|STARTED|Overall Study||25
7597850|NCT02568683|18701845|P2|NOT COMPLETED|Overall Study||4
7597851|NCT02568683|18701846|P1|NOT COMPLETED|Overall Study||6
7597852|NCT02568683|18701845|P2|COMPLETED|Overall Study||0
7597853|NCT02568683|18701846|P1|COMPLETED|Overall Study||0
7597854|NCT02568683|18701845|P2|STARTED|Overall Study||4
7597855|NCT02568683|18701846|P1|STARTED|Overall Study||6
7597856|NCT02568644|18701860|P2|NOT COMPLETED|Overall Study||0
7597857|NCT02568644|18701861|P1|NOT COMPLETED|Overall Study||0
7597858|NCT02568644|18701860|P2|COMPLETED|Overall Study||30
7597859|NCT02568644|18701861|P1|COMPLETED|Overall Study||30
7597860|NCT02568644|18701860|P2|STARTED|Overall Study||30
7597861|NCT02568644|18701861|P1|STARTED|Overall Study||30
7597862|NCT02568475|18701875|P2|NOT COMPLETED|Overall Study||43
7597863|NCT02568475|18701876|P1|NOT COMPLETED|Overall Study||51
7597864|NCT02568475|18701875|P2|COMPLETED|Overall Study||52
7597865|NCT02568475|18701876|P1|COMPLETED|Overall Study||46
7597866|NCT02568475|18701875|P2|Post-test|Overall Study||82
7597867|NCT02568475|18701876|P1|Post-test|Overall Study||85
7597868|NCT02568475|18701875|P2|STARTED|Overall Study||95
7597869|NCT02568475|18701876|P1|STARTED|Overall Study||97
7597870|NCT02568397|18701890|P2|NOT COMPLETED|Period 2||2
7597871|NCT02568397|18701891|P1|NOT COMPLETED|Period 2||0
7597872|NCT02568397|18701890|P2|COMPLETED|Period 2||58
7597873|NCT02568397|18701891|P1|COMPLETED|Period 2||0
7597874|NCT02568397|18701890|P2|STARTED|Period 2|Daily doses of 50 mg LY3314814 were administered daily on Days 3 to 21 of Period 2.|60
7597875|NCT02568397|18701891|P1|STARTED|Period 2|A single oral dose of 150 mg dabigatran etexilate was administered on Day 1 of Period 1.|0
7597876|NCT02568397|18701890|P2|NOT COMPLETED|Period 1||0
7597877|NCT02568397|18701891|P1|NOT COMPLETED|Period 1||0
7597878|NCT02568397|18701890|P2|COMPLETED|Period 1||0
7597879|NCT02568397|18701891|P1|COMPLETED|Period 1||60
7597880|NCT02568397|18701890|P2|Received at Least 1 Dose of Study Drug|Period 1||0
7597881|NCT02568397|18701891|P1|Received at Least 1 Dose of Study Drug|Period 1||60
7597882|NCT02568397|18701890|P2|STARTED|Period 1||0
7597883|NCT02568397|18701891|P1|STARTED|Period 1||60
7597884|NCT02568384|18701915|P1|NOT COMPLETED|Overall Study||2
7597885|NCT02568384|18701915|P1|COMPLETED|Overall Study||43
7597886|NCT02568384|18701915|P1|STARTED|Overall Study||45
7597887|NCT02568345|18701925|P1|NOT COMPLETED|Overall Study||0
7597888|NCT02568345|18701925|P1|COMPLETED|Overall Study||31
7597889|NCT02568345|18701925|P1|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3
7597890|NCT02568345|18701925|P1|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25
7597891|NCT02568345|18701925|P1|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3
7597892|NCT02568345|18701925|P1|STARTED|Overall Study||31
7597893|NCT02568254|18701929|P6|NOT COMPLETED|Period 3||0
7597894|NCT02568254|18701930|P5|NOT COMPLETED|Period 3||1
7597895|NCT02568254|18701931|P4|NOT COMPLETED|Period 3||0
7597896|NCT02568254|18701932|P3|NOT COMPLETED|Period 3||0
7597897|NCT02568254|18701933|P2|NOT COMPLETED|Period 3||0
7597898|NCT02568254|18701934|P1|NOT COMPLETED|Period 3||0
7597899|NCT02568254|18701929|P6|COMPLETED|Period 3||12
7597900|NCT02568254|18701930|P5|COMPLETED|Period 3||11
7597901|NCT02568254|18701931|P4|COMPLETED|Period 3||12
7597902|NCT02568254|18701932|P3|COMPLETED|Period 3||12
7597903|NCT02568254|18701933|P2|COMPLETED|Period 3||12
7597904|NCT02568254|18701934|P1|COMPLETED|Period 3||13
7597905|NCT02568254|18701929|P6|STARTED|Period 3||12
7597906|NCT02568254|18701930|P5|STARTED|Period 3||12
7597907|NCT02568254|18701931|P4|STARTED|Period 3||12
7597908|NCT02568254|18701932|P3|STARTED|Period 3||12
7597909|NCT02568254|18701933|P2|STARTED|Period 3||12
7597910|NCT02568254|18701934|P1|STARTED|Period 3||13
7597911|NCT02568254|18701929|P6|NOT COMPLETED|Period 2||0
7597912|NCT02568254|18701930|P5|NOT COMPLETED|Period 2||0
7597913|NCT02568254|18701931|P4|NOT COMPLETED|Period 2||0
7597914|NCT02568254|18701932|P3|NOT COMPLETED|Period 2||1
7597915|NCT02568254|18701933|P2|NOT COMPLETED|Period 2||0
7597916|NCT02568254|18701934|P1|NOT COMPLETED|Period 2||0
7597917|NCT02568254|18701929|P6|COMPLETED|Period 2||12
7597918|NCT02568254|18701930|P5|COMPLETED|Period 2||12
7597919|NCT02568254|18701931|P4|COMPLETED|Period 2||12
7597920|NCT02568254|18701932|P3|COMPLETED|Period 2||12
7597921|NCT02568254|18701933|P2|COMPLETED|Period 2||12
7597922|NCT02568254|18701934|P1|COMPLETED|Period 2||13
7597923|NCT02568254|18701929|P6|STARTED|Period 2||12
7597924|NCT02568254|18701930|P5|STARTED|Period 2||12
7597925|NCT02568254|18701931|P4|STARTED|Period 2||12
7597926|NCT02568254|18701932|P3|STARTED|Period 2||13
7597927|NCT02568254|18701933|P2|STARTED|Period 2||12
7597928|NCT02568254|18701934|P1|STARTED|Period 2||13
7597929|NCT02568254|18701929|P6|NOT COMPLETED|Period 1||0
7597930|NCT02568254|18701930|P5|NOT COMPLETED|Period 1||0
7597931|NCT02568254|18701931|P4|NOT COMPLETED|Period 1||0
7597932|NCT02568254|18701932|P3|NOT COMPLETED|Period 1||0
7597933|NCT02568254|18701933|P2|NOT COMPLETED|Period 1||0
7597934|NCT02568254|18701934|P1|NOT COMPLETED|Period 1||0
7597935|NCT02568254|18701929|P6|COMPLETED|Period 1||12
7597936|NCT02568254|18701930|P5|COMPLETED|Period 1||12
7597937|NCT02568254|18701931|P4|COMPLETED|Period 1||12
7597938|NCT02568254|18701932|P3|COMPLETED|Period 1||13
7597939|NCT02568254|18701933|P2|COMPLETED|Period 1||12
7597940|NCT02568254|18701934|P1|COMPLETED|Period 1||13
7597941|NCT02568254|18701929|P6|STARTED|Period 1||12
7597942|NCT02568254|18701930|P5|STARTED|Period 1||12
7597943|NCT02568254|18701931|P4|STARTED|Period 1||12
7597944|NCT02568254|18701932|P3|STARTED|Period 1||13
7597945|NCT02568254|18701933|P2|STARTED|Period 1||12
7597946|NCT02568254|18701934|P1|STARTED|Period 1||13
7597947|NCT02568046|18701944|P2|NOT COMPLETED|Overall Study||3
7597948|NCT02568046|18701945|P1|NOT COMPLETED|Overall Study||5
7597949|NCT02568046|18701944|P2|COMPLETED|Overall Study||2
7597950|NCT02568046|18701945|P1|COMPLETED|Overall Study||0
7597951|NCT02568046|18701944|P2|STARTED|Overall Study||5
7597952|NCT02568046|18701945|P1|STARTED|Overall Study||5
7597953|NCT02568007|18701954|P3|NOT COMPLETED|Overall Study||0
7597954|NCT02568007|18701955|P2|NOT COMPLETED|Overall Study||0
7597955|NCT02568007|18701956|P1|NOT COMPLETED|Overall Study||0
7597956|NCT02568007|18701954|P3|COMPLETED|Overall Study||0
7597957|NCT02568007|18701955|P2|COMPLETED|Overall Study||2
7597958|NCT02568007|18701956|P1|COMPLETED|Overall Study||2
7597959|NCT02568007|18701954|P3|STARTED|Overall Study||0
7597960|NCT02568007|18701955|P2|STARTED|Overall Study||2
7597961|NCT02568007|18701956|P1|STARTED|Overall Study||2
7597962|NCT02567968|18701985|P2|NOT COMPLETED|Second Intervention||0
7597963|NCT02567968|18701986|P1|NOT COMPLETED|Second Intervention||0
7597964|NCT02567968|18701985|P2|COMPLETED|Second Intervention||4
7597965|NCT02567968|18701986|P1|COMPLETED|Second Intervention||4
7597966|NCT02567968|18701985|P2|STARTED|Second Intervention||4
7597967|NCT02567968|18701986|P1|STARTED|Second Intervention||4
7597968|NCT02567968|18701985|P2|NOT COMPLETED|Washout (2 Weeks)||0
7597969|NCT02567968|18701986|P1|NOT COMPLETED|Washout (2 Weeks)||0
7597970|NCT02567968|18701985|P2|COMPLETED|Washout (2 Weeks)||4
7597971|NCT02567968|18701986|P1|COMPLETED|Washout (2 Weeks)||4
7597972|NCT02567968|18701985|P2|STARTED|Washout (2 Weeks)||4
7597973|NCT02567968|18701986|P1|STARTED|Washout (2 Weeks)||4
7597974|NCT02567968|18701985|P2|NOT COMPLETED|First Intervention||0
7597975|NCT02567968|18701986|P1|NOT COMPLETED|First Intervention||0
7597976|NCT02567968|18701985|P2|COMPLETED|First Intervention||4
7597977|NCT02567968|18701986|P1|COMPLETED|First Intervention||4
7597978|NCT02567968|18701985|P2|STARTED|First Intervention||4
7597979|NCT02567968|18701986|P1|STARTED|First Intervention||4
7597980|NCT02567708|18702008|P2|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||3
7597981|NCT02567708|18702009|P1|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
7597982|NCT02567708|18702008|P2|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||20
7597983|NCT02567708|18702009|P1|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||22
7597984|NCT02567708|18702008|P2|STARTED|Treatment Period 2 (Up to 4 Weeks)||23
7597985|NCT02567708|18702009|P1|STARTED|Treatment Period 2 (Up to 4 Weeks)||22
7597986|NCT02567708|18702008|P2|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
7597987|NCT02567708|18702009|P1|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
7597988|NCT02567708|18702008|P2|COMPLETED|Washout Period (Up to 4 Weeks)||23
7597989|NCT02567708|18702009|P1|COMPLETED|Washout Period (Up to 4 Weeks)||22
7597990|NCT02567708|18702008|P2|STARTED|Washout Period (Up to 4 Weeks)||23
7597991|NCT02567708|18702009|P1|STARTED|Washout Period (Up to 4 Weeks)||22
7597992|NCT02567708|18702008|P2|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||3
7597993|NCT02567708|18702009|P1|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||2
7597994|NCT02567708|18702008|P2|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||23
7597995|NCT02567708|18702009|P1|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||22
7597996|NCT02567708|18702008|P2|STARTED|Treatment Period 1 (Up to 4 Weeks)||26
7597997|NCT02567708|18702009|P1|STARTED|Treatment Period 1 (Up to 4 Weeks)||24
7597998|NCT02567656|18702054|P6|NOT COMPLETED|Overall Study||0
7597999|NCT02567656|18702055|P5|NOT COMPLETED|Overall Study||0
7598000|NCT02567656|18702056|P4|NOT COMPLETED|Overall Study||0
7598001|NCT02567656|18702057|P3|NOT COMPLETED|Overall Study||2
7598002|NCT02567656|18702058|P2|NOT COMPLETED|Overall Study||1
7598003|NCT02567656|18702059|P1|NOT COMPLETED|Overall Study||1
7598004|NCT02567656|18702054|P6|COMPLETED|Overall Study||20
7598005|NCT02567656|18702055|P5|COMPLETED|Overall Study||19
7598006|NCT02567656|18702056|P4|COMPLETED|Overall Study||6
7598007|NCT02567656|18702057|P3|COMPLETED|Overall Study||3
7598008|NCT02567656|18702058|P2|COMPLETED|Overall Study||3
7598009|NCT02567656|18702059|P1|COMPLETED|Overall Study||3
7598010|NCT02567656|18702054|P6|STARTED|Overall Study||20
7598011|NCT02567656|18702055|P5|STARTED|Overall Study||19
7598012|NCT02567656|18702056|P4|STARTED|Overall Study||6
7598013|NCT02567656|18702057|P3|STARTED|Overall Study||5
7598014|NCT02567656|18702058|P2|STARTED|Overall Study||4
7598015|NCT02567656|18702059|P1|STARTED|Overall Study||4
7598016|NCT02567552|18702091|P2|NOT COMPLETED|Overall Study||1
7598017|NCT02567552|18702092|P1|NOT COMPLETED|Overall Study||0
7598018|NCT02567552|18702091|P2|COMPLETED|Overall Study|dropout by pain in the puncture site|11
7598019|NCT02567552|18702092|P1|COMPLETED|Overall Study||12
7598020|NCT02567552|18702091|P2|STARTED|Overall Study||12
7598021|NCT02567552|18702092|P1|STARTED|Overall Study||12
7598022|NCT02567188|18702122|P1|NOT COMPLETED|Overall Study||35
7598023|NCT02567188|18702122|P1|COMPLETED|Overall Study||109
7598024|NCT02567188|18702122|P1|STARTED|Overall Study||144
7598025|NCT02566889|18702153|P2|NOT COMPLETED|Overall Study||5
7598026|NCT02566889|18702154|P1|NOT COMPLETED|Overall Study||13
7598027|NCT02566889|18702153|P2|COMPLETED|Overall Study||3
7598028|NCT02566889|18702154|P1|COMPLETED|Overall Study||32
7598029|NCT02566889|18702153|P2|Cross-over to Dose Escalation Group|Overall Study||0
7598030|NCT02566889|18702154|P1|Cross-over to Dose Escalation Group|Overall Study||1
7598031|NCT02566889|18702153|P2|STARTED|Overall Study||8
7598032|NCT02566889|18702154|P1|STARTED|Overall Study||45
7598033|NCT02566785|18702172|P2|NOT COMPLETED|Overall Study||3
7598034|NCT02566785|18702173|P1|NOT COMPLETED|Overall Study||1
7598035|NCT02566785|18702172|P2|COMPLETED|Overall Study||15
7598036|NCT02566785|18702173|P1|COMPLETED|Overall Study||14
7598037|NCT02566785|18702172|P2|STARTED|Overall Study||18
7598038|NCT02566785|18702173|P1|STARTED|Overall Study||15
7598039|NCT02566759|18702200|P17|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598040|NCT02566759|18702201|P16|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598041|NCT02566759|18702202|P15|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598042|NCT02566759|18702203|P14|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598043|NCT02566759|18702204|P13|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598044|NCT02566759|18702205|P12|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598045|NCT02566759|18702206|P11|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598046|NCT02566759|18702207|P10|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598047|NCT02566759|18702208|P9|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598048|NCT02566759|18702209|P8|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598049|NCT02566759|18702210|P7|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598050|NCT02566759|18702211|P6|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598051|NCT02566759|18702212|P5|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598052|NCT02566759|18702213|P4|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598053|NCT02566759|18702214|P3|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598054|NCT02566759|18702215|P2|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598055|NCT02566759|18702216|P1|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598056|NCT02566759|18702200|P17|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
7598057|NCT02566759|18702201|P16|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
7598058|NCT02566759|18702202|P15|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
7598059|NCT02566759|18702203|P14|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598060|NCT02566759|18702204|P13|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598061|NCT02566759|18702205|P12|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598062|NCT02566759|18702206|P11|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598063|NCT02566759|18702207|P10|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598064|NCT02566759|18702208|P9|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598065|NCT02566759|18702209|P8|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598066|NCT02566759|18702210|P7|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598067|NCT02566759|18702211|P6|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598068|NCT02566759|18702212|P5|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598069|NCT02566759|18702213|P4|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598070|NCT02566759|18702214|P3|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598071|NCT02566759|18702215|P2|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598072|NCT02566759|18702216|P1|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598073|NCT02566759|18702200|P17|STARTED|Crossover Treatment (Part 4: 1 Day)||7
7598074|NCT02566759|18702201|P16|STARTED|Crossover Treatment (Part 4: 1 Day)||8
7598075|NCT02566759|18702202|P15|STARTED|Crossover Treatment (Part 4: 1 Day)||8
7598076|NCT02566759|18702203|P14|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598077|NCT02566759|18702204|P13|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598078|NCT02566759|18702205|P12|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598079|NCT02566759|18702206|P11|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598080|NCT02566759|18702207|P10|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598081|NCT02566759|18702208|P9|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598082|NCT02566759|18702209|P8|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598083|NCT02566759|18702210|P7|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598084|NCT02566759|18702211|P6|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598085|NCT02566759|18702212|P5|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598086|NCT02566759|18702213|P4|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598087|NCT02566759|18702214|P3|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598088|NCT02566759|18702215|P2|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598089|NCT02566759|18702216|P1|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598090|NCT02566759|18702200|P17|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598091|NCT02566759|18702201|P16|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598092|NCT02566759|18702202|P15|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598093|NCT02566759|18702203|P14|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598094|NCT02566759|18702204|P13|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598095|NCT02566759|18702205|P12|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598096|NCT02566759|18702206|P11|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598097|NCT02566759|18702207|P10|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598098|NCT02566759|18702208|P9|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598099|NCT02566759|18702209|P8|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598100|NCT02566759|18702210|P7|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598101|NCT02566759|18702211|P6|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598102|NCT02566759|18702212|P5|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598103|NCT02566759|18702213|P4|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598104|NCT02566759|18702214|P3|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598105|NCT02566759|18702215|P2|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598106|NCT02566759|18702216|P1|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598107|NCT02566759|18702200|P17|COMPLETED|Washout Crossover Period (Part 4:5 Days)||7
7598108|NCT02566759|18702201|P16|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
7598109|NCT02566759|18702202|P15|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
7598110|NCT02566759|18702203|P14|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598111|NCT02566759|18702204|P13|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598112|NCT02566759|18702205|P12|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598113|NCT02566759|18702206|P11|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598114|NCT02566759|18702207|P10|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598115|NCT02566759|18702208|P9|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598116|NCT02566759|18702209|P8|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598117|NCT02566759|18702210|P7|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598118|NCT02566759|18702211|P6|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598119|NCT02566759|18702212|P5|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598120|NCT02566759|18702213|P4|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598121|NCT02566759|18702214|P3|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598122|NCT02566759|18702215|P2|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598123|NCT02566759|18702216|P1|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598124|NCT02566759|18702200|P17|STARTED|Washout Crossover Period (Part 4:5 Days)||7
7598125|NCT02566759|18702201|P16|STARTED|Washout Crossover Period (Part 4:5 Days)||8
7598126|NCT02566759|18702202|P15|STARTED|Washout Crossover Period (Part 4:5 Days)||8
7598127|NCT02566759|18702203|P14|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598128|NCT02566759|18702204|P13|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598129|NCT02566759|18702205|P12|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598130|NCT02566759|18702206|P11|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598131|NCT02566759|18702207|P10|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598132|NCT02566759|18702208|P9|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598133|NCT02566759|18702209|P8|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598134|NCT02566759|18702210|P7|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598135|NCT02566759|18702211|P6|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598136|NCT02566759|18702212|P5|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598137|NCT02566759|18702213|P4|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598138|NCT02566759|18702214|P3|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598139|NCT02566759|18702215|P2|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598140|NCT02566759|18702216|P1|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598141|NCT02566759|18702200|P17|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||1
7598142|NCT02566759|18702201|P16|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598143|NCT02566759|18702202|P15|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598144|NCT02566759|18702203|P14|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598145|NCT02566759|18702204|P13|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598146|NCT02566759|18702205|P12|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598147|NCT02566759|18702206|P11|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598148|NCT02566759|18702207|P10|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598149|NCT02566759|18702208|P9|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598150|NCT02566759|18702209|P8|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598151|NCT02566759|18702210|P7|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598152|NCT02566759|18702211|P6|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598153|NCT02566759|18702212|P5|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598154|NCT02566759|18702213|P4|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598155|NCT02566759|18702214|P3|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598156|NCT02566759|18702215|P2|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598157|NCT02566759|18702216|P1|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598158|NCT02566759|18702200|P17|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
7598159|NCT02566759|18702201|P16|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
7598160|NCT02566759|18702202|P15|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
7598161|NCT02566759|18702203|P14|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598162|NCT02566759|18702204|P13|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598163|NCT02566759|18702205|P12|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598164|NCT02566759|18702206|P11|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598165|NCT02566759|18702207|P10|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598166|NCT02566759|18702208|P9|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598167|NCT02566759|18702209|P8|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598168|NCT02566759|18702210|P7|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598169|NCT02566759|18702211|P6|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598170|NCT02566759|18702212|P5|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598171|NCT02566759|18702213|P4|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598172|NCT02566759|18702214|P3|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598173|NCT02566759|18702215|P2|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598174|NCT02566759|18702216|P1|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
7598175|NCT02566759|18702200|P17|STARTED|Crossover Treatment (Part 4: 1 Day)||8
7598176|NCT02566759|18702201|P16|STARTED|Crossover Treatment (Part 4: 1 Day)||8
7598177|NCT02566759|18702202|P15|STARTED|Crossover Treatment (Part 4: 1 Day)||8
7598178|NCT02566759|18702203|P14|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598179|NCT02566759|18702204|P13|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598180|NCT02566759|18702205|P12|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598181|NCT02566759|18702206|P11|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598182|NCT02566759|18702207|P10|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598183|NCT02566759|18702208|P9|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598184|NCT02566759|18702209|P8|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598185|NCT02566759|18702210|P7|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598186|NCT02566759|18702211|P6|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598187|NCT02566759|18702212|P5|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598188|NCT02566759|18702213|P4|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598189|NCT02566759|18702214|P3|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598190|NCT02566759|18702215|P2|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598191|NCT02566759|18702216|P1|STARTED|Crossover Treatment (Part 4: 1 Day)||0
7598192|NCT02566759|18702200|P17|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598193|NCT02566759|18702201|P16|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598194|NCT02566759|18702202|P15|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598195|NCT02566759|18702203|P14|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598196|NCT02566759|18702204|P13|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598197|NCT02566759|18702205|P12|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598198|NCT02566759|18702206|P11|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598199|NCT02566759|18702207|P10|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598200|NCT02566759|18702208|P9|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598201|NCT02566759|18702209|P8|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598202|NCT02566759|18702210|P7|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598203|NCT02566759|18702211|P6|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598204|NCT02566759|18702212|P5|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598205|NCT02566759|18702213|P4|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598206|NCT02566759|18702214|P3|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598207|NCT02566759|18702215|P2|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598208|NCT02566759|18702216|P1|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598209|NCT02566759|18702200|P17|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
7598210|NCT02566759|18702201|P16|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
7598211|NCT02566759|18702202|P15|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
7598212|NCT02566759|18702203|P14|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598213|NCT02566759|18702204|P13|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598214|NCT02566759|18702205|P12|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598215|NCT02566759|18702206|P11|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598216|NCT02566759|18702207|P10|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598217|NCT02566759|18702208|P9|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598218|NCT02566759|18702209|P8|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598219|NCT02566759|18702210|P7|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598220|NCT02566759|18702211|P6|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598221|NCT02566759|18702212|P5|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598222|NCT02566759|18702213|P4|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598223|NCT02566759|18702214|P3|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598224|NCT02566759|18702215|P2|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598225|NCT02566759|18702216|P1|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
7598226|NCT02566759|18702200|P17|STARTED|Washout Crossover Period (Part 4:5 Days)||8
7598227|NCT02566759|18702201|P16|STARTED|Washout Crossover Period (Part 4:5 Days)||8
7598228|NCT02566759|18702202|P15|STARTED|Washout Crossover Period (Part 4:5 Days)||8
7598229|NCT02566759|18702203|P14|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598230|NCT02566759|18702204|P13|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598231|NCT02566759|18702205|P12|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598232|NCT02566759|18702206|P11|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598233|NCT02566759|18702207|P10|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598234|NCT02566759|18702208|P9|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598235|NCT02566759|18702209|P8|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598236|NCT02566759|18702210|P7|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598237|NCT02566759|18702211|P6|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598238|NCT02566759|18702212|P5|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598239|NCT02566759|18702213|P4|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598240|NCT02566759|18702214|P3|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598241|NCT02566759|18702215|P2|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598242|NCT02566759|18702216|P1|STARTED|Washout Crossover Period (Part 4:5 Days)||0
7598243|NCT02566759|18702200|P17|NOT COMPLETED|All Parts||0
7598244|NCT02566759|18702201|P16|NOT COMPLETED|All Parts||0
7598245|NCT02566759|18702202|P15|NOT COMPLETED|All Parts||0
7598246|NCT02566759|18702203|P14|NOT COMPLETED|All Parts||5
7598247|NCT02566759|18702204|P13|NOT COMPLETED|All Parts||1
7598248|NCT02566759|18702205|P12|NOT COMPLETED|All Parts||0
7598249|NCT02566759|18702206|P11|NOT COMPLETED|All Parts||0
7598250|NCT02566759|18702207|P10|NOT COMPLETED|All Parts||0
7598251|NCT02566759|18702208|P9|NOT COMPLETED|All Parts||0
7598252|NCT02566759|18702209|P8|NOT COMPLETED|All Parts||0
7598253|NCT02566759|18702210|P7|NOT COMPLETED|All Parts||0
7598254|NCT02566759|18702211|P6|NOT COMPLETED|All Parts||0
7598255|NCT02566759|18702212|P5|NOT COMPLETED|All Parts||0
7598256|NCT02566759|18702213|P4|NOT COMPLETED|All Parts||0
7598257|NCT02566759|18702214|P3|NOT COMPLETED|All Parts||0
7598258|NCT02566759|18702215|P2|NOT COMPLETED|All Parts||1
7598259|NCT02566759|18702216|P1|NOT COMPLETED|All Parts||0
7598260|NCT02566759|18702200|P17|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
7598261|NCT02566759|18702201|P16|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
7598262|NCT02566759|18702202|P15|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
7598263|NCT02566759|18702203|P14|COMPLETED|All Parts||0
7598264|NCT02566759|18702204|P13|COMPLETED|All Parts||0
7598265|NCT02566759|18702205|P12|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
7598266|NCT02566759|18702206|P11|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
7598267|NCT02566759|18702207|P10|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
7598268|NCT02566759|18702208|P9|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
7598269|NCT02566759|18702209|P8|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|8
7598270|NCT02566759|18702210|P7|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
7598271|NCT02566759|18702211|P6|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
7598272|NCT02566759|18702212|P5|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
7598273|NCT02566759|18702213|P4|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
7598274|NCT02566759|18702214|P3|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
7598275|NCT02566759|18702215|P2|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|5
7598276|NCT02566759|18702216|P1|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|12
7598277|NCT02566759|18702200|P17|STARTED|All Parts||8
7598278|NCT02566759|18702201|P16|STARTED|All Parts||8
7598279|NCT02566759|18702202|P15|STARTED|All Parts||8
7598280|NCT02566759|18702203|P14|STARTED|All Parts||5
7598281|NCT02566759|18702204|P13|STARTED|All Parts||1
7598282|NCT02566759|18702205|P12|STARTED|All Parts||6
7598283|NCT02566759|18702206|P11|STARTED|All Parts||6
7598284|NCT02566759|18702207|P10|STARTED|All Parts||6
7598285|NCT02566759|18702208|P9|STARTED|All Parts||6
7598286|NCT02566759|18702209|P8|STARTED|All Parts||8
7598287|NCT02566759|18702210|P7|STARTED|All Parts||6
7598288|NCT02566759|18702211|P6|STARTED|All Parts||6
7598289|NCT02566759|18702212|P5|STARTED|All Parts||6
7598290|NCT02566759|18702213|P4|STARTED|All Parts||6
7598291|NCT02566759|18702214|P3|STARTED|All Parts||6
7598292|NCT02566759|18702215|P2|STARTED|All Parts||6
7598293|NCT02566759|18702216|P1|STARTED|All Parts||12
7598294|NCT02566590|18702369|P2|NOT COMPLETED|Overall Study||0
7598295|NCT02566590|18702370|P1|NOT COMPLETED|Overall Study||0
7598296|NCT02566590|18702369|P2|COMPLETED|Overall Study||10
7598297|NCT02566590|18702370|P1|COMPLETED|Overall Study||10
7598298|NCT02566590|18702369|P2|STARTED|Overall Study||10
7598299|NCT02566590|18702370|P1|STARTED|Overall Study||10
7598300|NCT02566577|18702378|P2|NOT COMPLETED|Overall Study||2
7598301|NCT02566577|18702379|P1|NOT COMPLETED|Overall Study||3
7598302|NCT02566577|18702378|P2|COMPLETED|Overall Study||4
7598303|NCT02566577|18702379|P1|COMPLETED|Overall Study||6
7598304|NCT02566577|18702378|P2|STARTED|Overall Study||6
7598305|NCT02566577|18702379|P1|STARTED|Overall Study||9
7598306|NCT02566369|18702407|P2|NOT COMPLETED|Overall Study||61
7598307|NCT02566369|18702408|P1|NOT COMPLETED|Overall Study||72
7598308|NCT02566369|18702407|P2|COMPLETED|Overall Study||535
7598309|NCT02566369|18702408|P1|COMPLETED|Overall Study||540
7598310|NCT02566369|18702407|P2|STARTED|Overall Study||596
7598311|NCT02566369|18702408|P1|STARTED|Overall Study||612
7598312|NCT02566317|18702416|P2|NOT COMPLETED|Overall Study||62
7598313|NCT02566317|18702417|P1|NOT COMPLETED|Overall Study||29
7598314|NCT02566317|18702416|P2|COMPLETED|Overall Study||292
7598315|NCT02566317|18702417|P1|COMPLETED|Overall Study||247
7598316|NCT02566317|18702416|P2|STARTED|Overall Study||354
7598317|NCT02566317|18702417|P1|STARTED|Overall Study||276
7598318|NCT02566265|18702429|P2|NOT COMPLETED|Overall Study||6
7598319|NCT02566265|18702430|P1|NOT COMPLETED|Overall Study||9
7598320|NCT02566265|18702429|P2|COMPLETED|Overall Study||35
7598321|NCT02566265|18702430|P1|COMPLETED|Overall Study||72
7598322|NCT02566265|18702429|P2|End of Study Visit (Optional)|Overall Study||18
7598323|NCT02566265|18702430|P1|End of Study Visit (Optional)|Overall Study||38
7598324|NCT02566265|18702429|P2|30 Days Following 2nd Vaccine|Overall Study||35
7598325|NCT02566265|18702430|P1|30 Days Following 2nd Vaccine|Overall Study||72
7598326|NCT02566265|18702429|P2|Day of Second Vaccine|Overall Study||41
7598327|NCT02566265|18702430|P1|Day of Second Vaccine|Overall Study||74
7598328|NCT02566265|18702429|P2|Day 7 (+/- 2 Days) (Optional)|Overall Study||12
7598329|NCT02566265|18702430|P1|Day 7 (+/- 2 Days) (Optional)|Overall Study||19
7598330|NCT02566265|18702429|P2|STARTED|Overall Study||41
7598331|NCT02566265|18702430|P1|STARTED|Overall Study||81
7598332|NCT02566135|18702438|P2|NOT COMPLETED|Overall Study||0
7598333|NCT02566135|18702439|P1|NOT COMPLETED|Overall Study||0
7598334|NCT02566135|18702438|P2|COMPLETED|Overall Study||29
7598335|NCT02566135|18702439|P1|COMPLETED|Overall Study||29
7598336|NCT02566135|18702438|P2|STARTED|Overall Study||29
7598337|NCT02566135|18702439|P1|STARTED|Overall Study||29
7598338|NCT02566109|18702459|P1|NOT COMPLETED|Overall Study||1
7598339|NCT02566109|18702459|P1|COMPLETED|Overall Study||5
7598340|NCT02566109|18702459|P1|STARTED|Overall Study||6
7598341|NCT02566083|18702471|P2|NOT COMPLETED|Overall Study||10
7598342|NCT02566083|18702472|P1|NOT COMPLETED|Overall Study||16
7598343|NCT02566083|18702471|P2|COMPLETED|Overall Study||141
7598344|NCT02566083|18702472|P1|COMPLETED|Overall Study||198
7598345|NCT02566083|18702471|P2|STARTED|Overall Study||151
7598346|NCT02566083|18702472|P1|STARTED|Overall Study||214
7598347|NCT02566044|18702481|P3|NOT COMPLETED|Overall Study||0
7598348|NCT02566044|18702482|P2|NOT COMPLETED|Overall Study||0
7598349|NCT02566044|18702483|P1|NOT COMPLETED|Overall Study||0
7598350|NCT02566044|18702481|P3|COMPLETED|Overall Study||4
7598351|NCT02566044|18702482|P2|COMPLETED|Overall Study||6
7598352|NCT02566044|18702483|P1|COMPLETED|Overall Study||6
7598353|NCT02566044|18702481|P3|STARTED|Overall Study||4
7598354|NCT02566044|18702482|P2|STARTED|Overall Study||6
7598355|NCT02566044|18702483|P1|STARTED|Overall Study||6
7598356|NCT02566031|18702523|P2|NOT COMPLETED|Overall Study||12
7598357|NCT02566031|18702524|P1|NOT COMPLETED|Overall Study||20
7598358|NCT02566031|18702523|P2|COMPLETED|Overall Study||178
7598359|NCT02566031|18702524|P1|COMPLETED|Overall Study||169
7598360|NCT02566031|18702523|P2|STARTED|Overall Study||190
7598361|NCT02566031|18702524|P1|STARTED|Overall Study||189
7598362|NCT02566005|18702541|P2|NOT COMPLETED|Overall Study||6
7598363|NCT02566005|18702542|P1|NOT COMPLETED|Overall Study||8
7598364|NCT02566005|18702541|P2|COMPLETED|Overall Study||94
7598365|NCT02566005|18702542|P1|COMPLETED|Overall Study||92
7598366|NCT02566005|18702541|P2|STARTED|Overall Study||100
7598367|NCT02566005|18702542|P1|STARTED|Overall Study||100
7598368|NCT02565914|18702570|P1|NOT COMPLETED|Overall Study||93
7598369|NCT02565914|18702570|P1|COMPLETED|Overall Study||951
7598370|NCT02565914|18702570|P1|Safety Set|Overall Study||1042
7598371|NCT02565914|18702570|P1|STARTED|Overall Study||1044
7598372|NCT02565810|18702604|P1|NOT COMPLETED|Overall Study||1
7598373|NCT02565810|18702604|P1|COMPLETED|Overall Study||48
7598374|NCT02565810|18702604|P1|STARTED|Overall Study||49
7598375|NCT02565784|18702613|P1|NOT COMPLETED|Second Treatment||2
7598376|NCT02565784|18702613|P1|COMPLETED|Second Treatment||96
7598377|NCT02565784|18702613|P1|12 Months Follow-up|Second Treatment||96
7598378|NCT02565784|18702613|P1|6 Months Follow-up|Second Treatment||97
7598379|NCT02565784|18702613|P1|STARTED|Second Treatment||98
7598380|NCT02565784|18702613|P1|NOT COMPLETED|First Treatment||2
7598381|NCT02565784|18702613|P1|COMPLETED|First Treatment||98
7598382|NCT02565784|18702613|P1|12 Months Follow-up|First Treatment||98
7598383|NCT02565784|18702613|P1|6 Months Follow-up|First Treatment||99
7598384|NCT02565784|18702613|P1|STARTED|First Treatment||100
7598385|NCT02565706|18702625|P4|NOT COMPLETED|Overall Study||85
7598386|NCT02565706|18702626|P3|NOT COMPLETED|Overall Study||89
7598387|NCT02565706|18702627|P2|NOT COMPLETED|Overall Study||82
7598388|NCT02565706|18702628|P1|NOT COMPLETED|Overall Study||77
7598389|NCT02565706|18702625|P4|COMPLETED|Overall Study||116
7598390|NCT02565706|18702626|P3|COMPLETED|Overall Study||104
7598391|NCT02565706|18702627|P2|COMPLETED|Overall Study||90
7598392|NCT02565706|18702628|P1|COMPLETED|Overall Study||101
7598393|NCT02565706|18702625|P4|STARTED|Overall Study||201
7598394|NCT02565706|18702626|P3|STARTED|Overall Study||193
7598395|NCT02565706|18702627|P2|STARTED|Overall Study||172
7598396|NCT02565706|18702628|P1|STARTED|Overall Study||178
7598397|NCT02565628|18702700|P2|NOT COMPLETED|Overall Study||0
7598398|NCT02565628|18702701|P1|NOT COMPLETED|Overall Study||0
7598399|NCT02565628|18702700|P2|COMPLETED|Overall Study||9
7598400|NCT02565628|18702701|P1|COMPLETED|Overall Study||10
7598401|NCT02565628|18702700|P2|Received Treatment|Overall Study||9
7598402|NCT02565628|18702701|P1|Received Treatment|Overall Study||10
7598403|NCT02565628|18702700|P2|STARTED|Overall Study||9
7598404|NCT02565628|18702701|P1|STARTED|Overall Study||10
7598405|NCT02565615|18702734|P5|NOT COMPLETED|Overall Study||1601
7598406|NCT02565615|18702735|P4|NOT COMPLETED|Overall Study||3
7598407|NCT02565615|18702736|P3|NOT COMPLETED|Overall Study||0
7598408|NCT02565615|18702737|P2|NOT COMPLETED|Overall Study||36
7598409|NCT02565615|18702738|P1|NOT COMPLETED|Overall Study||3
7598410|NCT02565615|18702734|P5|COMPLETED|Overall Study||21
7598411|NCT02565615|18702735|P4|COMPLETED|Overall Study||98
7598412|NCT02565615|18702736|P3|COMPLETED|Overall Study||21
7598413|NCT02565615|18702737|P2|COMPLETED|Overall Study||3044
7598414|NCT02565615|18702738|P1|COMPLETED|Overall Study||288
7598415|NCT02565615|18702734|P5|Treated|Overall Study||1055
7598416|NCT02565615|18702735|P4|Treated|Overall Study||101
7598417|NCT02565615|18702736|P3|Treated|Overall Study||21
7598418|NCT02565615|18702737|P2|Treated|Overall Study||3080
7598419|NCT02565615|18702738|P1|Treated|Overall Study||291
7598420|NCT02565615|18702734|P5|STARTED|Overall Study||1622
7598421|NCT02565615|18702735|P4|STARTED|Overall Study||101
7598422|NCT02565615|18702736|P3|STARTED|Overall Study||21
7598423|NCT02565615|18702737|P2|STARTED|Overall Study||3080
7598424|NCT02565615|18702738|P1|STARTED|Overall Study||291
7598425|NCT02565576|18702852|P2|NOT COMPLETED|Overall Study||5
7598426|NCT02565576|18702853|P1|NOT COMPLETED|Overall Study||5
7598427|NCT02565576|18702852|P2|COMPLETED|Overall Study||17
7598428|NCT02565576|18702853|P1|COMPLETED|Overall Study||17
7598429|NCT02565576|18702852|P2|STARTED|Overall Study||22
7598430|NCT02565576|18702853|P1|STARTED|Overall Study||22
7598431|NCT02565485|18702880|P2|NOT COMPLETED|Overall Study||0
7598432|NCT02565485|18702881|P1|NOT COMPLETED|Overall Study||0
7598433|NCT02565485|18702880|P2|COMPLETED|Overall Study||137
7598434|NCT02565485|18702881|P1|COMPLETED|Overall Study||139
7598435|NCT02565485|18702880|P2|STARTED|Overall Study||137
7598436|NCT02565485|18702881|P1|STARTED|Overall Study||139
7598437|NCT02565381|18702896|P3|NOT COMPLETED|Overall Study||1
7598438|NCT02565381|18702897|P2|NOT COMPLETED|Overall Study||0
7598439|NCT02565381|18702898|P1|NOT COMPLETED|Overall Study||1
7598440|NCT02565381|18702896|P3|COMPLETED|Overall Study||24
7598441|NCT02565381|18702897|P2|COMPLETED|Overall Study||25
7598442|NCT02565381|18702898|P1|COMPLETED|Overall Study||24
7598443|NCT02565381|18702896|P3|STARTED|Overall Study||25
7598444|NCT02565381|18702897|P2|STARTED|Overall Study||25
7598445|NCT02565381|18702898|P1|STARTED|Overall Study||25
7598446|NCT02565186|18702938|P2|NOT COMPLETED|Overall Study||621
7598447|NCT02565186|18702939|P1|NOT COMPLETED|Overall Study||580
7598448|NCT02565186|18702938|P2|COMPLETED|Overall Study||504
7598449|NCT02565186|18702939|P1|COMPLETED|Overall Study||466
7598450|NCT02565186|18702938|P2|Received at Least One Dose of Study Drug|Overall Study||1039
7598451|NCT02565186|18702939|P1|Received at Least One Dose of Study Drug|Overall Study||991
7598452|NCT02565186|18702938|P2|STARTED|Overall Study||1125
7598453|NCT02565186|18702939|P1|STARTED|Overall Study||1046
7598454|NCT02565147|18702953|P2|NOT COMPLETED|Overall Study||3
7598455|NCT02565147|18702954|P1|NOT COMPLETED|Overall Study||6
7598456|NCT02565147|18702953|P2|COMPLETED|Overall Study||37
7598457|NCT02565147|18702954|P1|COMPLETED|Overall Study||32
7598458|NCT02565147|18702953|P2|Per-Protocol Population|Overall Study||36
7598459|NCT02565147|18702954|P1|Per-Protocol Population|Overall Study||28
7598460|NCT02565147|18702953|P2|Received Study Drug|Overall Study||40
7598461|NCT02565147|18702954|P1|Received Study Drug|Overall Study||38
7598462|NCT02565147|18702953|P2|STARTED|Overall Study||40
7598463|NCT02565147|18702954|P1|STARTED|Overall Study||38
7598464|NCT02565108|18702978|P2|NOT COMPLETED|Overall Study||0
7598465|NCT02565108|18702979|P1|NOT COMPLETED|Overall Study||2
7598466|NCT02565108|18702978|P2|COMPLETED|Overall Study||4
7598467|NCT02565108|18702979|P1|COMPLETED|Overall Study||14
7598468|NCT02565108|18702978|P2|Pharmacokinetic (PK) Set|Overall Study||3
7598469|NCT02565108|18702979|P1|Pharmacokinetic (PK) Set|Overall Study||10
7598470|NCT02565108|18702978|P2|Safety Set|Overall Study||4
7598471|NCT02565108|18702979|P1|Safety Set|Overall Study||16
7598472|NCT02565108|18702978|P2|STARTED|Overall Study||4
7598473|NCT02565108|18702979|P1|STARTED|Overall Study||16
7598474|NCT02564952|18702995|P1|NOT COMPLETED|Overall Study||11
7598475|NCT02564952|18702995|P1|COMPLETED|Overall Study||7
7598476|NCT02564952|18702995|P1|Completed OLE Titration Period|Overall Study||16
7598477|NCT02564952|18702995|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
7598478|NCT02564952|18702995|P1|STARTED|Overall Study||18
7598479|NCT02564926|18703001|P2|NOT COMPLETED|Overall Study||7
7598480|NCT02564926|18703002|P1|NOT COMPLETED|Overall Study||8
7598481|NCT02564926|18703001|P2|COMPLETED|Overall Study||54
7598482|NCT02564926|18703002|P1|COMPLETED|Overall Study||52
7598483|NCT02564926|18703001|P2|STARTED|Overall Study||61
7598484|NCT02564926|18703002|P1|STARTED|Overall Study||60
7598485|NCT02564887|18703040|P2|NOT COMPLETED|Overall Study||0
7598486|NCT02564887|18703041|P1|NOT COMPLETED|Overall Study||6
7598487|NCT02564887|18703040|P2|COMPLETED|Overall Study||10
7598488|NCT02564887|18703041|P1|COMPLETED|Overall Study||10
7598489|NCT02564887|18703040|P2|STARTED|Overall Study||10
7598490|NCT02564887|18703041|P1|STARTED|Overall Study||16
7598491|NCT02564718|18703059|P2|NOT COMPLETED|Overall Study||1
7598492|NCT02564718|18703060|P1|NOT COMPLETED|Overall Study||0
7598493|NCT02564718|18703059|P2|COMPLETED|Overall Study||4
7598494|NCT02564718|18703060|P1|COMPLETED|Overall Study||5
7598495|NCT02564718|18703059|P2|STARTED|Overall Study||5
7598496|NCT02564718|18703060|P1|STARTED|Overall Study||5
7598497|NCT02564497|18703090|P2|NOT COMPLETED|Overall Study||0
7598498|NCT02564497|18703091|P1|NOT COMPLETED|Overall Study||0
7598499|NCT02564497|18703090|P2|COMPLETED|Overall Study||72
7598500|NCT02564497|18703091|P1|COMPLETED|Overall Study||74
7598501|NCT02564497|18703090|P2|STARTED|Overall Study||72
7598502|NCT02564497|18703091|P1|STARTED|Overall Study||74
7598503|NCT02564432|18703109|P1|NOT COMPLETED|Overall Study||2
7598504|NCT02564432|18703109|P1|COMPLETED|Overall Study|1 patient suffered periprosthetic fracture at 8 months; 1 failed to osseointegrate|8
7598505|NCT02564432|18703109|P1|STARTED|Overall Study||10
7598506|NCT02564354|18703117|P2|NOT COMPLETED|Overall Study||0
7598507|NCT02564354|18703118|P1|NOT COMPLETED|Overall Study||0
7598508|NCT02564354|18703117|P2|COMPLETED|Overall Study||8
7598509|NCT02564354|18703118|P1|COMPLETED|Overall Study||10
7598510|NCT02564354|18703117|P2|STARTED|Overall Study||8
7598511|NCT02564354|18703118|P1|STARTED|Overall Study||10
7598512|NCT02564263|18703148|P2|NOT COMPLETED|Overall Study||314
7598513|NCT02564263|18703149|P1|NOT COMPLETED|Overall Study||314
7598514|NCT02564263|18703148|P2|COMPLETED|Overall Study||0
7598515|NCT02564263|18703149|P1|COMPLETED|Overall Study||0
7598516|NCT02564263|18703148|P2|Treated|Overall Study||296
7598517|NCT02564263|18703149|P1|Treated|Overall Study||314
7598518|NCT02564263|18703148|P2|STARTED|Overall Study||314
7598519|NCT02564263|18703149|P1|STARTED|Overall Study||314
7598520|NCT02564211|18703171|P1|NOT COMPLETED|Overall Study||4
7598521|NCT02564211|18703171|P1|COMPLETED|Overall Study||73
7598522|NCT02564211|18703171|P1|STARTED|Overall Study||77
7598523|NCT02564120|18703182|P1|NOT COMPLETED|Overall Study||446
7598524|NCT02564120|18703182|P1|COMPLETED|Overall Study||1110
7598525|NCT02564120|18703182|P1|STARTED|Overall Study||1556
7598526|NCT02564055|18703230|P6|NOT COMPLETED|Overall Study||12
7598527|NCT02564055|18703231|P5|NOT COMPLETED|Overall Study||15
7598528|NCT02564055|18703232|P4|NOT COMPLETED|Overall Study||6
7598529|NCT02564055|18703233|P3|NOT COMPLETED|Overall Study||12
7598530|NCT02564055|18703234|P2|NOT COMPLETED|Overall Study||5
7598531|NCT02564055|18703235|P1|NOT COMPLETED|Overall Study||6
7598532|NCT02564055|18703230|P6|COMPLETED|Overall Study||28
7598533|NCT02564055|18703231|P5|COMPLETED|Overall Study||27
7598534|NCT02564055|18703232|P4|COMPLETED|Overall Study||35
7598535|NCT02564055|18703233|P3|COMPLETED|Overall Study||31
7598536|NCT02564055|18703234|P2|COMPLETED|Overall Study||36
7598537|NCT02564055|18703235|P1|COMPLETED|Overall Study||34
7598538|NCT02564055|18703230|P6|STARTED|Overall Study||40
7598539|NCT02564055|18703231|P5|STARTED|Overall Study||42
7598540|NCT02564055|18703232|P4|STARTED|Overall Study||41
7598541|NCT02564055|18703233|P3|STARTED|Overall Study||43
7598542|NCT02564055|18703234|P2|STARTED|Overall Study||41
7598543|NCT02564055|18703235|P1|STARTED|Overall Study||40
7598544|NCT02564042|18703489|P6|NOT COMPLETED|Overall Study||14
7598545|NCT02564042|18703490|P5|NOT COMPLETED|Overall Study||11
7598546|NCT02564042|18703491|P4|NOT COMPLETED|Overall Study||3
7598547|NCT02564042|18703492|P3|NOT COMPLETED|Overall Study||6
7598548|NCT02564042|18703493|P2|NOT COMPLETED|Overall Study||8
7598549|NCT02564042|18703494|P1|NOT COMPLETED|Overall Study||11
7598550|NCT02564042|18703489|P6|COMPLETED|Overall Study||24
7598551|NCT02564042|18703490|P5|COMPLETED|Overall Study||26
7598552|NCT02564042|18703491|P4|COMPLETED|Overall Study||35
7598553|NCT02564042|18703492|P3|COMPLETED|Overall Study||32
7598554|NCT02564042|18703493|P2|COMPLETED|Overall Study||30
7598555|NCT02564042|18703494|P1|COMPLETED|Overall Study||27
7598556|NCT02564042|18703489|P6|STARTED|Overall Study||38
7598557|NCT02564042|18703490|P5|STARTED|Overall Study||37
7598558|NCT02564042|18703491|P4|STARTED|Overall Study||38
7598559|NCT02564042|18703492|P3|STARTED|Overall Study||38
7598560|NCT02564042|18703493|P2|STARTED|Overall Study||38
7598561|NCT02564042|18703494|P1|STARTED|Overall Study||38
7598562|NCT02564029|18703706|P1|NOT COMPLETED|Overall Study||0
7598563|NCT02564029|18703706|P1|COMPLETED|Overall Study||7
7598564|NCT02564029|18703706|P1|STARTED|Overall Study||7
7598565|NCT02564016|18703749|P2|NOT COMPLETED|Overall Study||10
7598566|NCT02564016|18703750|P1|NOT COMPLETED|Overall Study||18
7598567|NCT02564016|18703749|P2|COMPLETED|Overall Study||4
7598568|NCT02564016|18703750|P1|COMPLETED|Overall Study||4
7598569|NCT02564016|18703749|P2|STARTED|Overall Study||14
7598570|NCT02564016|18703750|P1|STARTED|Overall Study||22
7598571|NCT02563990|18703762|P2|NOT COMPLETED|Overall Study||0
7598572|NCT02563990|18703763|P1|NOT COMPLETED|Overall Study||0
7598573|NCT02563990|18703762|P2|COMPLETED|Overall Study||14
7598574|NCT02563990|18703763|P1|COMPLETED|Overall Study||12
7598575|NCT02563990|18703762|P2|STARTED|Overall Study||14
7598576|NCT02563990|18703763|P1|STARTED|Overall Study||12
7598577|NCT02563899|18703789|P4|NOT COMPLETED|Overall Study||0
7598578|NCT02563899|18703790|P3|NOT COMPLETED|Overall Study||1
7598579|NCT02563899|18703791|P2|NOT COMPLETED|Overall Study||0
7598580|NCT02563899|18703792|P1|NOT COMPLETED|Overall Study||1
7598581|NCT02563899|18703789|P4|COMPLETED|Overall Study||6
7598582|NCT02563899|18703790|P3|COMPLETED|Overall Study||9
7598583|NCT02563899|18703791|P2|COMPLETED|Overall Study||5
7598584|NCT02563899|18703792|P1|COMPLETED|Overall Study||17
7598585|NCT02563899|18703789|P4|STARTED|Overall Study||6
7598586|NCT02563899|18703790|P3|STARTED|Overall Study||10
7598587|NCT02563899|18703791|P2|STARTED|Overall Study||5
7598588|NCT02563899|18703792|P1|STARTED|Overall Study||18
7598589|NCT02563860|18703833|P1|NOT COMPLETED|Overall Study||1
7598590|NCT02563860|18703833|P1|COMPLETED|Overall Study||19
7598591|NCT02563860|18703833|P1|STARTED|Overall Study||20
7598592|NCT02563834|18703840|P2|NOT COMPLETED|Insulin Infusion (*Day 2)||0
7598593|NCT02563834|18703841|P1|NOT COMPLETED|Insulin Infusion (*Day 2)||0
7598594|NCT02563834|18703840|P2|COMPLETED|Insulin Infusion (*Day 2)||8
7598595|NCT02563834|18703841|P1|COMPLETED|Insulin Infusion (*Day 2)||10
7598596|NCT02563834|18703840|P2|STARTED|Insulin Infusion (*Day 2)||8
7598597|NCT02563834|18703841|P1|STARTED|Insulin Infusion (*Day 2)||10
7598598|NCT02563834|18703840|P2|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
7598599|NCT02563834|18703841|P1|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
7598600|NCT02563834|18703840|P2|COMPLETED|Control (Saline) Infusion (*Day 1)||8
7598601|NCT02563834|18703841|P1|COMPLETED|Control (Saline) Infusion (*Day 1)||10
7598602|NCT02563834|18703840|P2|STARTED|Control (Saline) Infusion (*Day 1)||8
7598603|NCT02563834|18703841|P1|STARTED|Control (Saline) Infusion (*Day 1)||10
7598604|NCT02563808|18703859|P2|NOT COMPLETED|Overall Study||0
7598605|NCT02563808|18703860|P1|NOT COMPLETED|Overall Study||0
7598606|NCT02563808|18703859|P2|COMPLETED|Overall Study||88
7598607|NCT02563808|18703860|P1|COMPLETED|Overall Study||96
7598608|NCT02563808|18703859|P2|STARTED|Overall Study|A total of 5 participants enrolled were not included in final data due to data collection error|88
7598609|NCT02563808|18703860|P1|STARTED|Overall Study||96
7598610|NCT02563548|18703868|P6|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||17
7598611|NCT02563548|18703869|P5|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||25
7598612|NCT02563548|18703870|P4|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
7598613|NCT02563548|18703871|P3|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
7598614|NCT02563548|18703872|P2|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
7598615|NCT02563548|18703873|P1|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
7598616|NCT02563548|18703868|P6|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
7598617|NCT02563548|18703869|P5|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
7598618|NCT02563548|18703870|P4|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
7598619|NCT02563548|18703871|P3|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
7598620|NCT02563548|18703872|P2|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
7598621|NCT02563548|18703873|P1|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
7598622|NCT02563548|18703868|P6|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||17
7598623|NCT02563548|18703869|P5|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||24
7598624|NCT02563548|18703870|P4|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
7598625|NCT02563548|18703871|P3|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
7598626|NCT02563548|18703872|P2|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
7598627|NCT02563548|18703873|P1|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
7598628|NCT02563548|18703868|P6|STARTED|Dose Expansion (Up to 60 Weeks)||17
7598629|NCT02563548|18703869|P5|STARTED|Dose Expansion (Up to 60 Weeks)||25
7598630|NCT02563548|18703870|P4|STARTED|Dose Expansion (Up to 60 Weeks)||0
7598631|NCT02563548|18703871|P3|STARTED|Dose Expansion (Up to 60 Weeks)||0
7598632|NCT02563548|18703872|P2|STARTED|Dose Expansion (Up to 60 Weeks)||0
7598633|NCT02563548|18703873|P1|STARTED|Dose Expansion (Up to 60 Weeks)||0
7598634|NCT02563548|18703868|P6|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
7598635|NCT02563548|18703869|P5|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
7598636|NCT02563548|18703870|P4|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
7598637|NCT02563548|18703871|P3|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||7
7598638|NCT02563548|18703872|P2|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
7598639|NCT02563548|18703873|P1|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||3
7598640|NCT02563548|18703868|P6|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
7598641|NCT02563548|18703869|P5|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
7598642|NCT02563548|18703870|P4|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
7598643|NCT02563548|18703871|P3|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
7598644|NCT02563548|18703872|P2|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
7598645|NCT02563548|18703873|P1|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
7598646|NCT02563548|18703868|P6|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
7598647|NCT02563548|18703869|P5|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
7598648|NCT02563548|18703870|P4|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
7598649|NCT02563548|18703871|P3|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||7
7598650|NCT02563548|18703872|P2|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
7598651|NCT02563548|18703873|P1|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||3
7598652|NCT02563548|18703868|P6|STARTED|Dose Escalation (Up to 46 Weeks)||0
7598653|NCT02563548|18703869|P5|STARTED|Dose Escalation (Up to 46 Weeks)||0
7598654|NCT02563548|18703870|P4|STARTED|Dose Escalation (Up to 46 Weeks)||2
7598655|NCT02563548|18703871|P3|STARTED|Dose Escalation (Up to 46 Weeks)||7
7598656|NCT02563548|18703872|P2|STARTED|Dose Escalation (Up to 46 Weeks)||2
7598657|NCT02563548|18703873|P1|STARTED|Dose Escalation (Up to 46 Weeks)||3
7598658|NCT02563496|18703940|P5|NOT COMPLETED|Overall Study||0
7598659|NCT02563496|18703941|P4|NOT COMPLETED|Overall Study||0
7598660|NCT02563496|18703942|P3|NOT COMPLETED|Overall Study||0
7598661|NCT02563496|18703943|P2|NOT COMPLETED|Overall Study||0
7598662|NCT02563496|18703944|P1|NOT COMPLETED|Overall Study||0
7598663|NCT02563496|18703940|P5|COMPLETED|Overall Study||19
7598664|NCT02563496|18703941|P4|COMPLETED|Overall Study||22
7598665|NCT02563496|18703942|P3|COMPLETED|Overall Study||5
7598666|NCT02563496|18703943|P2|COMPLETED|Overall Study||14
7598667|NCT02563496|18703944|P1|COMPLETED|Overall Study||0
7598668|NCT02563496|18703940|P5|STARTED|Overall Study||19
7598669|NCT02563496|18703941|P4|STARTED|Overall Study||22
7598670|NCT02563496|18703942|P3|STARTED|Overall Study||5
7598671|NCT02563496|18703943|P2|STARTED|Overall Study||14
7598672|NCT02563496|18703944|P1|STARTED|Overall Study|No participants were enrolled since they didn't meet inclusion/exclusion criteria.|0
7598673|NCT02563106|18703982|P2|NOT COMPLETED|Overall Study||29
7598674|NCT02563106|18703983|P1|NOT COMPLETED|Overall Study||34
7598675|NCT02563106|18703982|P2|COMPLETED|Overall Study||178
7598676|NCT02563106|18703983|P1|COMPLETED|Overall Study||172
7598677|NCT02563106|18703982|P2|STARTED|Overall Study||207
7598678|NCT02563106|18703983|P1|STARTED|Overall Study||206
7598679|NCT02563093|18703993|P4|NOT COMPLETED|Overall Study||0
7598680|NCT02563093|18703994|P3|NOT COMPLETED|Overall Study||0
7598681|NCT02563093|18703995|P2|NOT COMPLETED|Overall Study||0
7598682|NCT02563093|18703996|P1|NOT COMPLETED|Overall Study||0
7598683|NCT02563093|18703993|P4|COMPLETED|Overall Study||51
7598684|NCT02563093|18703994|P3|COMPLETED|Overall Study||53
7598685|NCT02563093|18703995|P2|COMPLETED|Overall Study||52
7598686|NCT02563093|18703996|P1|COMPLETED|Overall Study||52
7598687|NCT02563093|18703993|P4|STARTED|Overall Study||51
7598688|NCT02563093|18703994|P3|STARTED|Overall Study||53
7598689|NCT02563093|18703995|P2|STARTED|Overall Study||52
7598690|NCT02563093|18703996|P1|STARTED|Overall Study||52
7598691|NCT02563028|18704022|P1|NOT COMPLETED|Overall Study||2
7598692|NCT02563028|18704022|P1|COMPLETED|Overall Study||18
7598693|NCT02563028|18704022|P1|STARTED|Overall Study||20
7598694|NCT02562989|18704032|P3|NOT COMPLETED|Overall Study||0
7598695|NCT02562989|18704033|P2|NOT COMPLETED|Overall Study||0
7598696|NCT02562989|18704034|P1|NOT COMPLETED|Overall Study||0
7598697|NCT02562989|18704032|P3|COMPLETED|Overall Study||6
7598698|NCT02562989|18704033|P2|COMPLETED|Overall Study||4
7598699|NCT02562989|18704034|P1|COMPLETED|Overall Study||3
7598700|NCT02562989|18704032|P3|STARTED|Overall Study||6
7598701|NCT02562989|18704033|P2|STARTED|Overall Study||4
7598702|NCT02562989|18704034|P1|STARTED|Overall Study||3
7598703|NCT02562924|18704060|P3|NOT COMPLETED|Overall Study||4
7598704|NCT02562924|18704061|P2|NOT COMPLETED|Overall Study||11
7598705|NCT02562924|18704062|P1|NOT COMPLETED|Overall Study||1
7598706|NCT02562924|18704060|P3|COMPLETED|Overall Study||8
7598707|NCT02562924|18704061|P2|COMPLETED|Overall Study||1
7598708|NCT02562924|18704062|P1|COMPLETED|Overall Study||12
7598709|NCT02562924|18704060|P3|STARTED|Overall Study||12
7598710|NCT02562924|18704061|P2|STARTED|Overall Study||12
7598711|NCT02562924|18704062|P1|STARTED|Overall Study||13
7598712|NCT02562898|18704081|P2|NOT COMPLETED|Overall Study||0
7598713|NCT02562898|18704082|P1|NOT COMPLETED|Overall Study||0
7598714|NCT02562898|18704081|P2|COMPLETED|Overall Study||8
7598715|NCT02562898|18704082|P1|COMPLETED|Overall Study||10
7598716|NCT02562898|18704081|P2|STARTED|Overall Study||8
7598717|NCT02562898|18704082|P1|STARTED|Overall Study||10
7598718|NCT02562755|18704094|P2|NOT COMPLETED|Overall Study||72
7598719|NCT02562755|18704095|P1|NOT COMPLETED|Overall Study||73
7598720|NCT02562755|18704094|P2|COMPLETED|Overall Study||153
7598721|NCT02562755|18704095|P1|COMPLETED|Overall Study||161
7598722|NCT02562755|18704094|P2|Safety Population|Overall Study||217
7598723|NCT02562755|18704095|P1|Safety Population|Overall Study||218
7598724|NCT02562755|18704094|P2|STARTED|Overall Study||225
7598725|NCT02562755|18704095|P1|STARTED|Overall Study||234
7598726|NCT02562521|18704103|P2|NOT COMPLETED|Overall Study||0
7598727|NCT02562521|18704104|P1|NOT COMPLETED|Overall Study||0
7598728|NCT02562521|18704103|P2|COMPLETED|Overall Study||7
7598729|NCT02562521|18704104|P1|COMPLETED|Overall Study||18
7598730|NCT02562521|18704103|P2|STARTED|Overall Study||7
7598731|NCT02562521|18704104|P1|STARTED|Overall Study||18
7598732|NCT02562482|18704120|P2|NOT COMPLETED|Overall Study||16
7598733|NCT02562482|18704121|P1|NOT COMPLETED|Overall Study||21
7598734|NCT02562482|18704120|P2|COMPLETED|Overall Study||183
7598735|NCT02562482|18704121|P1|COMPLETED|Overall Study||180
7598736|NCT02562482|18704120|P2|Received 2nd Injection|Overall Study||192
7598737|NCT02562482|18704121|P1|Received 2nd Injection|Overall Study||192
7598738|NCT02562482|18704120|P2|Received 1st Injection|Overall Study||199
7598739|NCT02562482|18704121|P1|Received 1st Injection|Overall Study||197
7598740|NCT02562482|18704120|P2|STARTED|Overall Study||199
7598741|NCT02562482|18704121|P1|STARTED|Overall Study||201
7598742|NCT02561897|18704145|P2|NOT COMPLETED|Overall Study||0
7598743|NCT02561897|18704146|P1|NOT COMPLETED|Overall Study||0
7598744|NCT02561897|18704145|P2|COMPLETED|Overall Study||3
7598745|NCT02561897|18704146|P1|COMPLETED|Overall Study||2
7598746|NCT02561897|18704145|P2|STARTED|Overall Study||3
7598747|NCT02561897|18704146|P1|STARTED|Overall Study||2
7598748|NCT02561832|18704156|P2|NOT COMPLETED|Overall Study||4
7598749|NCT02561832|18704157|P1|NOT COMPLETED|Overall Study||7
7598750|NCT02561832|18704156|P2|COMPLETED|Overall Study||3
7598751|NCT02561832|18704157|P1|COMPLETED|Overall Study||1
7598752|NCT02561832|18704156|P2|INFORMED CONSENT OBTAINED|Overall Study||7
7598753|NCT02561832|18704157|P1|INFORMED CONSENT OBTAINED|Overall Study||8
7598754|NCT02561832|18704156|P2|STARTED|Overall Study||7
7598755|NCT02561832|18704157|P1|STARTED|Overall Study||8
7598756|NCT02561806|18704165|P2|NOT COMPLETED|Post-Treatment Follow-up||1
7598757|NCT02561806|18704166|P1|NOT COMPLETED|Post-Treatment Follow-up||2
7598758|NCT02561806|18704165|P2|COMPLETED|Post-Treatment Follow-up||59
7598759|NCT02561806|18704166|P1|COMPLETED|Post-Treatment Follow-up||155
7598760|NCT02561806|18704165|P2|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|60
7598761|NCT02561806|18704166|P1|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|157
7598762|NCT02561806|18704165|P2|NOT COMPLETED|Maintenance Period||8
7598763|NCT02561806|18704166|P1|NOT COMPLETED|Maintenance Period||13
7598764|NCT02561806|18704165|P2|COMPLETED|Maintenance Period||123
7598765|NCT02561806|18704166|P1|COMPLETED|Maintenance Period||151
7598766|NCT02561806|18704165|P2|STARTED|Maintenance Period||131
7598767|NCT02561806|18704166|P1|STARTED|Maintenance Period||164
7598768|NCT02561806|18704165|P2|NOT COMPLETED|Induction Period||5
7598769|NCT02561806|18704166|P1|NOT COMPLETED|Induction Period||2
7598770|NCT02561806|18704165|P2|COMPLETED|Induction Period||131
7598771|NCT02561806|18704166|P1|COMPLETED|Induction Period||164
7598772|NCT02561806|18704165|P2|Received At Least One Dose of Study Drug|Induction Period||135
7598773|NCT02561806|18704166|P1|Received At Least One Dose of Study Drug|Induction Period||166
7598774|NCT02561806|18704165|P2|STARTED|Induction Period||136
7598775|NCT02561806|18704166|P1|STARTED|Induction Period||166
7598776|NCT02561702|18704222|P2|NOT COMPLETED|Second Intervention||0
7598777|NCT02561702|18704223|P1|NOT COMPLETED|Second Intervention||0
7598778|NCT02561702|18704222|P2|COMPLETED|Second Intervention||2
7598779|NCT02561702|18704223|P1|COMPLETED|Second Intervention||2
7598780|NCT02561702|18704222|P2|STARTED|Second Intervention||2
7598781|NCT02561702|18704223|P1|STARTED|Second Intervention||2
7598782|NCT02561702|18704222|P2|NOT COMPLETED|Washout||0
7598783|NCT02561702|18704223|P1|NOT COMPLETED|Washout||0
7598784|NCT02561702|18704222|P2|COMPLETED|Washout||2
7598785|NCT02561702|18704223|P1|COMPLETED|Washout||2
7598786|NCT02561702|18704222|P2|STARTED|Washout||2
7598787|NCT02561702|18704223|P1|STARTED|Washout||2
7598788|NCT02561702|18704222|P2|NOT COMPLETED|First Intervention||0
7598789|NCT02561702|18704223|P1|NOT COMPLETED|First Intervention||0
7598790|NCT02561702|18704222|P2|COMPLETED|First Intervention||2
7598791|NCT02561702|18704223|P1|COMPLETED|First Intervention||2
7598792|NCT02561702|18704222|P2|STARTED|First Intervention||2
7598793|NCT02561702|18704223|P1|STARTED|First Intervention||2
7598794|NCT02561585|18704233|P2|NOT COMPLETED|Overall Study||5
7598795|NCT02561585|18704234|P1|NOT COMPLETED|Overall Study||3
7598796|NCT02561585|18704233|P2|COMPLETED|Overall Study||6
7598797|NCT02561585|18704234|P1|COMPLETED|Overall Study||17
7598798|NCT02561585|18704233|P2|STARTED|Overall Study||11
7598799|NCT02561585|18704234|P1|STARTED|Overall Study||20
7598800|NCT02561572|18704270|P2|NOT COMPLETED|Overall Study||2
7598801|NCT02561572|18704271|P1|NOT COMPLETED|Overall Study||2
7598802|NCT02561572|18704270|P2|COMPLETED|Overall Study||62
7598803|NCT02561572|18704271|P1|COMPLETED|Overall Study||62
7598804|NCT02561572|18704270|P2|STARTED|Overall Study||64
7598805|NCT02561572|18704271|P1|STARTED|Overall Study||64
7598806|NCT02561481|18704289|P2|NOT COMPLETED|Main Trial - Open Label Phase||0
7598807|NCT02561481|18704290|P1|NOT COMPLETED|Main Trial - Open Label Phase||13
7598808|NCT02561481|18704289|P2|COMPLETED|Main Trial - Open Label Phase||0
7598809|NCT02561481|18704290|P1|COMPLETED|Main Trial - Open Label Phase||32
7598810|NCT02561481|18704289|P2|STARTED|Main Trial - Open Label Phase||0
7598811|NCT02561481|18704290|P1|STARTED|Main Trial - Open Label Phase||45
7598812|NCT02561481|18704289|P2|NOT COMPLETED|Main Trial - Double Blind Phase||2
7598813|NCT02561481|18704290|P1|NOT COMPLETED|Main Trial - Double Blind Phase||3
7598814|NCT02561481|18704289|P2|COMPLETED|Main Trial - Double Blind Phase||23
7598815|NCT02561481|18704290|P1|COMPLETED|Main Trial - Double Blind Phase||22
7598816|NCT02561481|18704289|P2|STARTED|Main Trial - Double Blind Phase||25
7598817|NCT02561481|18704290|P1|STARTED|Main Trial - Double Blind Phase||25
7598818|NCT02561481|18704289|P2|NOT COMPLETED|Pilot Trial||0
7598819|NCT02561481|18704290|P1|NOT COMPLETED|Pilot Trial||0
7598820|NCT02561481|18704289|P2|COMPLETED|Pilot Trial||0
7598821|NCT02561481|18704290|P1|COMPLETED|Pilot Trial||10
7598822|NCT02561481|18704289|P2|STARTED|Pilot Trial||0
7598823|NCT02561481|18704290|P1|STARTED|Pilot Trial||10
7598824|NCT02561338|18704333|P5|NOT COMPLETED|Overall Study||2
7598825|NCT02561338|18704334|P4|NOT COMPLETED|Overall Study||5
7598826|NCT02561338|18704335|P3|NOT COMPLETED|Overall Study||9
7598827|NCT02561338|18704336|P2|NOT COMPLETED|Overall Study||6
7598828|NCT02561338|18704337|P1|NOT COMPLETED|Overall Study||8
7598829|NCT02561338|18704333|P5|COMPLETED|Overall Study||51
7598830|NCT02561338|18704334|P4|COMPLETED|Overall Study||46
7598831|NCT02561338|18704335|P3|COMPLETED|Overall Study||42
7598832|NCT02561338|18704336|P2|COMPLETED|Overall Study||44
7598833|NCT02561338|18704337|P1|COMPLETED|Overall Study||45
7598834|NCT02561338|18704333|P5|STARTED|Overall Study||53
7598835|NCT02561338|18704334|P4|STARTED|Overall Study||51
7598836|NCT02561338|18704335|P3|STARTED|Overall Study||51
7598837|NCT02561338|18704336|P2|STARTED|Overall Study||50
7598838|NCT02561338|18704337|P1|STARTED|Overall Study||53
7598839|NCT02561221|18704366|P2|NOT COMPLETED|Overall Study||43
7598840|NCT02561221|18704367|P1|NOT COMPLETED|Overall Study||90
7598841|NCT02561221|18704366|P2|COMPLETED|Overall Study||308
7598842|NCT02561221|18704367|P1|COMPLETED|Overall Study||362
7598843|NCT02561221|18704366|P2|Month 18|Overall Study||316
7598844|NCT02561221|18704367|P1|Month 18|Overall Study||357
7598845|NCT02561221|18704366|P2|Month 12|Overall Study||326
7598846|NCT02561221|18704367|P1|Month 12|Overall Study||365
7598847|NCT02561221|18704366|P2|Month 6|Overall Study||340
7598848|NCT02561221|18704367|P1|Month 6|Overall Study||386
7598849|NCT02561221|18704366|P2|STARTED|Overall Study||351
7598850|NCT02561221|18704367|P1|STARTED|Overall Study||452
7598851|NCT02561195|18704425|P6|NOT COMPLETED|Overall Study||10
7598852|NCT02561195|18704426|P5|NOT COMPLETED|Overall Study||28
7598853|NCT02561195|18704427|P4|NOT COMPLETED|Overall Study||26
7598854|NCT02561195|18704428|P3|NOT COMPLETED|Overall Study||6
7598855|NCT02561195|18704429|P2|NOT COMPLETED|Overall Study||22
7598856|NCT02561195|18704430|P1|NOT COMPLETED|Overall Study||23
7598857|NCT02561195|18704425|P6|COMPLETED|Overall Study||51
7598858|NCT02561195|18704426|P5|COMPLETED|Overall Study||155
7598859|NCT02561195|18704427|P4|COMPLETED|Overall Study||157
7598860|NCT02561195|18704428|P3|COMPLETED|Overall Study||55
7598861|NCT02561195|18704429|P2|COMPLETED|Overall Study||162
7598862|NCT02561195|18704430|P1|COMPLETED|Overall Study||160
7598863|NCT02561195|18704425|P6|Treated|Overall Study||61
7598864|NCT02561195|18704426|P5|Treated|Overall Study||183
7598865|NCT02561195|18704427|P4|Treated|Overall Study||183
7598866|NCT02561195|18704428|P3|Treated|Overall Study||61
7598867|NCT02561195|18704429|P2|Treated|Overall Study||184
7598868|NCT02561195|18704430|P1|Treated|Overall Study||182
7598869|NCT02561195|18704425|P6|STARTED|Overall Study||61
7598870|NCT02561195|18704426|P5|STARTED|Overall Study||183
7598871|NCT02561195|18704427|P4|STARTED|Overall Study||183
7598872|NCT02561195|18704428|P3|STARTED|Overall Study||61
7598873|NCT02561195|18704429|P2|STARTED|Overall Study||184
7598874|NCT02561195|18704430|P1|STARTED|Overall Study||183
7598875|NCT02561156|18704591|P13|NOT COMPLETED|Part 2||0
7598876|NCT02561156|18704592|P12|NOT COMPLETED|Part 2||1
7598877|NCT02561156|18704593|P11|NOT COMPLETED|Part 2||0
7598878|NCT02561156|18704594|P10|NOT COMPLETED|Part 2||0
7598879|NCT02561156|18704595|P9|NOT COMPLETED|Part 2||0
7598880|NCT02561156|18704596|P8|NOT COMPLETED|Part 2||0
7598881|NCT02561156|18704597|P7|NOT COMPLETED|Part 2||0
7598882|NCT02561156|18704598|P6|NOT COMPLETED|Part 2||0
7598883|NCT02561156|18704599|P5|NOT COMPLETED|Part 2||0
7598884|NCT02561156|18704600|P4|NOT COMPLETED|Part 2||0
7598885|NCT02561156|18704601|P3|NOT COMPLETED|Part 2||0
7598886|NCT02561156|18704602|P2|NOT COMPLETED|Part 2||0
7598887|NCT02561156|18704603|P1|NOT COMPLETED|Part 2||0
7598888|NCT02561156|18704591|P13|COMPLETED|Part 2||6
7598889|NCT02561156|18704592|P12|COMPLETED|Part 2||5
7598890|NCT02561156|18704593|P11|COMPLETED|Part 2||6
7598891|NCT02561156|18704594|P10|COMPLETED|Part 2||6
7598892|NCT02561156|18704595|P9|COMPLETED|Part 2||6
7598893|NCT02561156|18704596|P8|COMPLETED|Part 2||10
7598894|NCT02561156|18704597|P7|COMPLETED|Part 2||0
7598895|NCT02561156|18704598|P6|COMPLETED|Part 2||0
7598896|NCT02561156|18704599|P5|COMPLETED|Part 2||0
7598897|NCT02561156|18704600|P4|COMPLETED|Part 2||0
7598898|NCT02561156|18704601|P3|COMPLETED|Part 2||0
7598899|NCT02561156|18704602|P2|COMPLETED|Part 2||0
7598900|NCT02561156|18704603|P1|COMPLETED|Part 2||0
7598901|NCT02561156|18704591|P13|STARTED|Part 2||6
7598902|NCT02561156|18704592|P12|STARTED|Part 2||6
7598903|NCT02561156|18704593|P11|STARTED|Part 2||6
7598904|NCT02561156|18704594|P10|STARTED|Part 2||6
7598905|NCT02561156|18704595|P9|STARTED|Part 2||6
7598906|NCT02561156|18704596|P8|STARTED|Part 2||10
7598907|NCT02561156|18704597|P7|STARTED|Part 2||0
7598908|NCT02561156|18704598|P6|STARTED|Part 2||0
7598909|NCT02561156|18704599|P5|STARTED|Part 2||0
7598910|NCT02561156|18704600|P4|STARTED|Part 2||0
7598911|NCT02561156|18704601|P3|STARTED|Part 2||0
7598912|NCT02561156|18704602|P2|STARTED|Part 2||0
7598913|NCT02561156|18704603|P1|STARTED|Part 2||0
7598914|NCT02561156|18704591|P13|NOT COMPLETED|Part 1||0
7598915|NCT02561156|18704592|P12|NOT COMPLETED|Part 1||0
7598916|NCT02561156|18704593|P11|NOT COMPLETED|Part 1||0
7598917|NCT02561156|18704594|P10|NOT COMPLETED|Part 1||0
7598918|NCT02561156|18704595|P9|NOT COMPLETED|Part 1||0
7598919|NCT02561156|18704596|P8|NOT COMPLETED|Part 1||0
7598920|NCT02561156|18704597|P7|NOT COMPLETED|Part 1||0
7598921|NCT02561156|18704598|P6|NOT COMPLETED|Part 1||0
7598922|NCT02561156|18704599|P5|NOT COMPLETED|Part 1||0
7598923|NCT02561156|18704600|P4|NOT COMPLETED|Part 1||0
7598924|NCT02561156|18704601|P3|NOT COMPLETED|Part 1||0
7598925|NCT02561156|18704602|P2|NOT COMPLETED|Part 1||0
7598926|NCT02561156|18704603|P1|NOT COMPLETED|Part 1||0
7598927|NCT02561156|18704591|P13|COMPLETED|Part 1||0
7598928|NCT02561156|18704592|P12|COMPLETED|Part 1||0
7598929|NCT02561156|18704593|P11|COMPLETED|Part 1||0
7598930|NCT02561156|18704594|P10|COMPLETED|Part 1||0
7598931|NCT02561156|18704595|P9|COMPLETED|Part 1||0
7598932|NCT02561156|18704596|P8|COMPLETED|Part 1||0
7598933|NCT02561156|18704597|P7|COMPLETED|Part 1||6
7598934|NCT02561156|18704598|P6|COMPLETED|Part 1||6
7598935|NCT02561156|18704599|P5|COMPLETED|Part 1||6
7598936|NCT02561156|18704600|P4|COMPLETED|Part 1||6
7598937|NCT02561156|18704601|P3|COMPLETED|Part 1||6
7598938|NCT02561156|18704602|P2|COMPLETED|Part 1||6
7598939|NCT02561156|18704603|P1|COMPLETED|Part 1||12
7598940|NCT02561156|18704591|P13|STARTED|Part 1||0
7598941|NCT02561156|18704592|P12|STARTED|Part 1||0
7598942|NCT02561156|18704593|P11|STARTED|Part 1||0
7598943|NCT02561156|18704594|P10|STARTED|Part 1||0
7598944|NCT02561156|18704595|P9|STARTED|Part 1||0
7598945|NCT02561156|18704596|P8|STARTED|Part 1||0
7598946|NCT02561156|18704597|P7|STARTED|Part 1||6
7598947|NCT02561156|18704598|P6|STARTED|Part 1||6
7598948|NCT02561156|18704599|P5|STARTED|Part 1||6
7598949|NCT02561156|18704600|P4|STARTED|Part 1||6
7598950|NCT02561156|18704601|P3|STARTED|Part 1||6
7598951|NCT02561156|18704602|P2|STARTED|Part 1||6
7598952|NCT02561156|18704603|P1|STARTED|Part 1||12
7598953|NCT02561130|18704775|P2|NOT COMPLETED|Overall Study||1
7598954|NCT02561130|18704776|P1|NOT COMPLETED|Overall Study||1
7598955|NCT02561130|18704775|P2|COMPLETED|Overall Study||76
7598956|NCT02561130|18704776|P1|COMPLETED|Overall Study||76
7598957|NCT02561130|18704775|P2|STARTED|Overall Study||77
7598958|NCT02561130|18704776|P1|STARTED|Overall Study||77
7598959|NCT02561078|18704800|P2|NOT COMPLETED|Overall Study||25
7598960|NCT02561078|18704801|P1|NOT COMPLETED|Overall Study||30
7598961|NCT02561078|18704800|P2|COMPLETED|Overall Study||186
7598962|NCT02561078|18704801|P1|COMPLETED|Overall Study||179
7598963|NCT02561078|18704800|P2|Received at Least 1 Dose of Study Drug|Overall Study||210
7598964|NCT02561078|18704801|P1|Received at Least 1 Dose of Study Drug|Overall Study||208
7598965|NCT02561078|18704800|P2|STARTED|Overall Study||211
7598966|NCT02561078|18704801|P1|STARTED|Overall Study||209
7598967|NCT02560922|18704825|P2|NOT COMPLETED|Overall Study||12
7598968|NCT02560922|18704826|P1|NOT COMPLETED|Overall Study||26
7598969|NCT02560922|18704825|P2|COMPLETED|Overall Study||112
7598970|NCT02560922|18704826|P1|COMPLETED|Overall Study||98
7598971|NCT02560922|18704825|P2|STARTED|Overall Study||124
7598972|NCT02560922|18704826|P1|STARTED|Overall Study||124
7598973|NCT02560779|18704852|P2|NOT COMPLETED|Overall Study||0
7598974|NCT02560779|18704853|P1|NOT COMPLETED|Overall Study||0
7598975|NCT02560779|18704852|P2|COMPLETED|Overall Study||13
7598976|NCT02560779|18704853|P1|COMPLETED|Overall Study||14
7598977|NCT02560779|18704852|P2|STARTED|Overall Study||13
7598978|NCT02560779|18704853|P1|STARTED|Overall Study||14
7598979|NCT02560753|18704869|P4|NOT COMPLETED|Overall Study||0
7598980|NCT02560753|18704870|P3|NOT COMPLETED|Overall Study||1
7598981|NCT02560753|18704871|P2|NOT COMPLETED|Overall Study||0
7598982|NCT02560753|18704872|P1|NOT COMPLETED|Overall Study||1
7598983|NCT02560753|18704869|P4|COMPLETED|Overall Study||8
7598984|NCT02560753|18704870|P3|COMPLETED|Overall Study||9
7598985|NCT02560753|18704871|P2|COMPLETED|Overall Study||9
7598986|NCT02560753|18704872|P1|COMPLETED|Overall Study||8
7598987|NCT02560753|18704869|P4|STARTED|Overall Study||8
7598988|NCT02560753|18704870|P3|STARTED|Overall Study||10
7598989|NCT02560753|18704871|P2|STARTED|Overall Study||9
7598990|NCT02560753|18704872|P1|STARTED|Overall Study||9
7598991|NCT02560701|18704900|P2|NOT COMPLETED|Overall Study||51466
7598992|NCT02560701|18704901|P1|NOT COMPLETED|Overall Study||4543
7598993|NCT02560701|18704900|P2|COMPLETED|Overall Study||37776
7598994|NCT02560701|18704901|P1|COMPLETED|Overall Study||3517
7598995|NCT02560701|18704900|P2|Matched Cohort|Overall Study||37776
7598996|NCT02560701|18704901|P1|Matched Cohort|Overall Study||3517
7598997|NCT02560701|18704900|P2|Bipolar Diagnosis Time Constraints|Overall Study||39427
7598998|NCT02560701|18704901|P1|Bipolar Diagnosis Time Constraints|Overall Study||3533
7598999|NCT02560701|18704900|P2|Restrict to Patients Between 12 and 64|Overall Study||82367
7599000|NCT02560701|18704901|P1|Restrict to Patients Between 12 and 64|Overall Study||7598
7599001|NCT02560701|18704900|P2|Carve Out|Overall Study||88729
7599002|NCT02560701|18704901|P1|Carve Out|Overall Study||8060
7599003|NCT02560701|18704900|P2|STARTED|Overall Study||89242
7599004|NCT02560701|18704901|P1|STARTED|Overall Study||8060
7599005|NCT02560584|18704917|P1|NOT COMPLETED|Overall Study||0
7599006|NCT02560584|18704917|P1|COMPLETED|Overall Study||304
7599007|NCT02560584|18704917|P1|STARTED|Overall Study||304
7599008|NCT02560558|18704926|P2|NOT COMPLETED|Overall Study||6
7599009|NCT02560558|18704927|P1|NOT COMPLETED|Overall Study||7
7599010|NCT02560558|18704926|P2|COMPLETED|Overall Study||76
7599011|NCT02560558|18704927|P1|COMPLETED|Overall Study||77
7599012|NCT02560558|18704926|P2|STARTED|Overall Study||82
7599013|NCT02560558|18704927|P1|STARTED|Overall Study||84
7599014|NCT02560493|18704955|P2|NOT COMPLETED|Overall Study||0
7599015|NCT02560493|18704956|P1|NOT COMPLETED|Overall Study||1
7599016|NCT02560493|18704955|P2|COMPLETED|Overall Study||23
7599017|NCT02560493|18704956|P1|COMPLETED|Overall Study||22
7599018|NCT02560493|18704955|P2|STARTED|Overall Study||23
7599019|NCT02560493|18704956|P1|STARTED|Overall Study||23
7599020|NCT02560389|18704979|P3|NOT COMPLETED|Overall Study||2
7599021|NCT02560389|18704980|P2|NOT COMPLETED|Overall Study||3
7599022|NCT02560389|18704981|P1|NOT COMPLETED|Overall Study||1
7599023|NCT02560389|18704979|P3|COMPLETED|Overall Study||27
7599024|NCT02560389|18704980|P2|COMPLETED|Overall Study||25
7599025|NCT02560389|18704981|P1|COMPLETED|Overall Study||33
7599026|NCT02560389|18704979|P3|STARTED|Overall Study||29
7599027|NCT02560389|18704980|P2|STARTED|Overall Study||28
7599028|NCT02560389|18704981|P1|STARTED|Overall Study||34
7599029|NCT02560324|18704997|P2|NOT COMPLETED|Period 2 (2 Weeks)||2
7599030|NCT02560324|18704998|P1|NOT COMPLETED|Period 2 (2 Weeks)||1
7599031|NCT02560324|18704997|P2|COMPLETED|Period 2 (2 Weeks)||21
7599032|NCT02560324|18704998|P1|COMPLETED|Period 2 (2 Weeks)||22
7599033|NCT02560324|18704997|P2|STARTED|Period 2 (2 Weeks)||23
7599034|NCT02560324|18704998|P1|STARTED|Period 2 (2 Weeks)||23
7599035|NCT02560324|18704997|P2|NOT COMPLETED|Washout (2 Weeks)||2
7599036|NCT02560324|18704998|P1|NOT COMPLETED|Washout (2 Weeks)||0
7599037|NCT02560324|18704997|P2|COMPLETED|Washout (2 Weeks)||23
7599038|NCT02560324|18704998|P1|COMPLETED|Washout (2 Weeks)||23
7599039|NCT02560324|18704997|P2|STARTED|Washout (2 Weeks)||25
7599040|NCT02560324|18704998|P1|STARTED|Washout (2 Weeks)||23
7599041|NCT02560324|18704997|P2|NOT COMPLETED|Period 1 (2 Weeks)||9
7599042|NCT02560324|18704998|P1|NOT COMPLETED|Period 1 (2 Weeks)||12
7599043|NCT02560324|18704997|P2|COMPLETED|Period 1 (2 Weeks)||25
7599044|NCT02560324|18704998|P1|COMPLETED|Period 1 (2 Weeks)||23
7599045|NCT02560324|18704997|P2|STARTED|Period 1 (2 Weeks)||34
7599046|NCT02560324|18704998|P1|STARTED|Period 1 (2 Weeks)||35
7599047|NCT02560051|18705015|P3|NOT COMPLETED|Overall Study||1
7599048|NCT02560051|18705016|P2|NOT COMPLETED|Overall Study||4
7599049|NCT02560051|18705017|P1|NOT COMPLETED|Overall Study||3
7599050|NCT02560051|18705015|P3|COMPLETED|Overall Study||4
7599051|NCT02560051|18705016|P2|COMPLETED|Overall Study||4
7599052|NCT02560051|18705017|P1|COMPLETED|Overall Study||3
7599053|NCT02560051|18705015|P3|STARTED|Overall Study||5
7599054|NCT02560051|18705016|P2|STARTED|Overall Study||8
7599055|NCT02560051|18705017|P1|STARTED|Overall Study||6
7599056|NCT02560038|18705073|P1|NOT COMPLETED|Overall Study||2
7599057|NCT02560038|18705073|P1|COMPLETED|Overall Study||1
7599058|NCT02560038|18705073|P1|STARTED|Overall Study||3
7599059|NCT02560025|18705079|P1|NOT COMPLETED|Overall Study||3
7599060|NCT02560025|18705079|P1|COMPLETED|Overall Study||39
7599061|NCT02560025|18705079|P1|STARTED|Overall Study||42
7599062|NCT02560012|18705088|P1|NOT COMPLETED|Overall Study||2
7599063|NCT02560012|18705088|P1|COMPLETED|Overall Study||1
7599064|NCT02560012|18705088|P1|STARTED|Overall Study||3
7599065|NCT02559895|18705096|P4|NOT COMPLETED|Overall Study||60
7599066|NCT02559895|18705097|P3|NOT COMPLETED|Overall Study||54
7599067|NCT02559895|18705098|P2|NOT COMPLETED|Overall Study||53
7599068|NCT02559895|18705099|P1|NOT COMPLETED|Overall Study||55
7599069|NCT02559895|18705096|P4|COMPLETED|Overall Study||165
7599070|NCT02559895|18705097|P3|COMPLETED|Overall Study||170
7599071|NCT02559895|18705098|P2|COMPLETED|Overall Study||172
7599072|NCT02559895|18705099|P1|COMPLETED|Overall Study||169
7599073|NCT02559895|18705096|P4|Participants Treated|Overall Study||222
7599074|NCT02559895|18705097|P3|Participants Treated|Overall Study||223
7599075|NCT02559895|18705098|P2|Participants Treated|Overall Study||221
7599076|NCT02559895|18705099|P1|Participants Treated|Overall Study||222
7599077|NCT02559895|18705096|P4|STARTED|Overall Study||225
7599078|NCT02559895|18705097|P3|STARTED|Overall Study||224
7599079|NCT02559895|18705098|P2|STARTED|Overall Study||225
7599080|NCT02559895|18705099|P1|STARTED|Overall Study||224
7599081|NCT02559817|18705194|P5|NOT COMPLETED|Post-treatment Period||0
7599082|NCT02559817|18705195|P4|NOT COMPLETED|Post-treatment Period||0
7599083|NCT02559817|18705196|P3|NOT COMPLETED|Post-treatment Period||0
7599084|NCT02559817|18705197|P2|NOT COMPLETED|Post-treatment Period||0
7599085|NCT02559817|18705198|P1|NOT COMPLETED|Post-treatment Period||0
7599086|NCT02559817|18705194|P5|COMPLETED|Post-treatment Period||8
7599087|NCT02559817|18705195|P4|COMPLETED|Post-treatment Period||22
7599088|NCT02559817|18705196|P3|COMPLETED|Post-treatment Period||20
7599089|NCT02559817|18705197|P2|COMPLETED|Post-treatment Period||27
7599090|NCT02559817|18705198|P1|COMPLETED|Post-treatment Period||18
7599091|NCT02559817|18705194|P5|STARTED|Post-treatment Period||8
7599092|NCT02559817|18705195|P4|STARTED|Post-treatment Period||22
7599093|NCT02559817|18705196|P3|STARTED|Post-treatment Period|1 participant who did not complete the first period, entered and completed the Post-treatment Period|20
7599094|NCT02559817|18705197|P2|STARTED|Post-treatment Period||27
7599095|NCT02559817|18705198|P1|STARTED|Post-treatment Period||18
7599096|NCT02559817|18705194|P5|NOT COMPLETED|Treatment Period||0
7599097|NCT02559817|18705195|P4|NOT COMPLETED|Treatment Period||2
7599098|NCT02559817|18705196|P3|NOT COMPLETED|Treatment Period||2
7599099|NCT02559817|18705197|P2|NOT COMPLETED|Treatment Period||2
7599100|NCT02559817|18705198|P1|NOT COMPLETED|Treatment Period||1
7599101|NCT02559817|18705194|P5|COMPLETED|Treatment Period||8
7599102|NCT02559817|18705195|P4|COMPLETED|Treatment Period||22
7599103|NCT02559817|18705196|P3|COMPLETED|Treatment Period||19
7599104|NCT02559817|18705197|P2|COMPLETED|Treatment Period||27
7599105|NCT02559817|18705198|P1|COMPLETED|Treatment Period||18
7599106|NCT02559817|18705194|P5|STARTED|Treatment Period||8
7599107|NCT02559817|18705195|P4|STARTED|Treatment Period||24
7599108|NCT02559817|18705196|P3|STARTED|Treatment Period||21
7599109|NCT02559817|18705197|P2|STARTED|Treatment Period||29
7599110|NCT02559817|18705198|P1|STARTED|Treatment Period||19
7599111|NCT02559713|18705235|P1|NOT COMPLETED|Overall Study||1
7599112|NCT02559713|18705235|P1|COMPLETED|Overall Study||10
7599113|NCT02559713|18705235|P1|Pharmacokinetic Set|Overall Study||11
7599114|NCT02559713|18705235|P1|Safety Set|Overall Study||11
7599115|NCT02559713|18705235|P1|STARTED|Overall Study||11
7599116|NCT02559687|18705245|P1|NOT COMPLETED|Overall Study||121
7599117|NCT02559687|18705245|P1|COMPLETED|Overall Study||0
7599118|NCT02559687|18705245|P1|STARTED|Overall Study||121
7599119|NCT02559622|18705258|P4|NOT COMPLETED|Overall Study||3
7599120|NCT02559622|18705259|P3|NOT COMPLETED|Overall Study||2
7599121|NCT02559622|18705260|P2|NOT COMPLETED|Overall Study||5
7599122|NCT02559622|18705261|P1|NOT COMPLETED|Overall Study||1
7599123|NCT02559622|18705258|P4|COMPLETED|Overall Study||20
7599124|NCT02559622|18705259|P3|COMPLETED|Overall Study||24
7599125|NCT02559622|18705260|P2|COMPLETED|Overall Study||49
7599126|NCT02559622|18705261|P1|COMPLETED|Overall Study||47
7599127|NCT02559622|18705258|P4|STARTED|Overall Study||23
7599128|NCT02559622|18705259|P3|STARTED|Overall Study||26
7599129|NCT02559622|18705260|P2|STARTED|Overall Study||54
7599130|NCT02559622|18705261|P1|STARTED|Overall Study||48
7599131|NCT02559570|18705345|P5|NOT COMPLETED|Overall Study||2
7599132|NCT02559570|18705346|P4|NOT COMPLETED|Overall Study||3
7599133|NCT02559570|18705347|P3|NOT COMPLETED|Overall Study||2
7599134|NCT02559570|18705348|P2|NOT COMPLETED|Overall Study||2
7599135|NCT02559570|18705349|P1|NOT COMPLETED|Overall Study||2
7599136|NCT02559570|18705345|P5|COMPLETED|Overall Study||14
7599137|NCT02559570|18705346|P4|COMPLETED|Overall Study||36
7599138|NCT02559570|18705347|P3|COMPLETED|Overall Study||39
7599139|NCT02559570|18705348|P2|COMPLETED|Overall Study||34
7599140|NCT02559570|18705349|P1|COMPLETED|Overall Study||39
7599141|NCT02559570|18705345|P5|STARTED|Overall Study||16
7599142|NCT02559570|18705346|P4|STARTED|Overall Study||39
7599143|NCT02559570|18705347|P3|STARTED|Overall Study||41
7599144|NCT02559570|18705348|P2|STARTED|Overall Study||36
7599145|NCT02559570|18705349|P1|STARTED|Overall Study||41
7599146|NCT02559414|18705387|P3|NOT COMPLETED|Overall Study||2
7599147|NCT02559414|18705388|P2|NOT COMPLETED|Overall Study||2
7599148|NCT02559414|18705389|P1|NOT COMPLETED|Overall Study||1
7599149|NCT02559414|18705387|P3|COMPLETED|Overall Study||20
7599150|NCT02559414|18705388|P2|COMPLETED|Overall Study||20
7599151|NCT02559414|18705389|P1|COMPLETED|Overall Study||10
7599152|NCT02559414|18705387|P3|STARTED|Overall Study||22
7599153|NCT02559414|18705388|P2|STARTED|Overall Study||22
7599154|NCT02559414|18705389|P1|STARTED|Overall Study||11
7599155|NCT02559310|18705429|P2|NOT COMPLETED|Overall Study||19
7599156|NCT02559310|18705430|P1|NOT COMPLETED|Overall Study||27
7599157|NCT02559310|18705429|P2|COMPLETED|Overall Study||256
7599158|NCT02559310|18705430|P1|COMPLETED|Overall Study||249
7599159|NCT02559310|18705429|P2|STARTED|Overall Study||275
7599160|NCT02559310|18705430|P1|STARTED|Overall Study||276
7599161|NCT02559206|18705448|P8|NOT COMPLETED|Overall Study||9
7599162|NCT02559206|18705449|P7|NOT COMPLETED|Overall Study||6
7599163|NCT02559206|18705450|P6|NOT COMPLETED|Overall Study||14
7599164|NCT02559206|18705451|P5|NOT COMPLETED|Overall Study||12
7599165|NCT02559206|18705452|P4|NOT COMPLETED|Overall Study||14
7599166|NCT02559206|18705453|P3|NOT COMPLETED|Overall Study||9
7599167|NCT02559206|18705454|P2|NOT COMPLETED|Overall Study||12
7599168|NCT02559206|18705455|P1|NOT COMPLETED|Overall Study||8
7599169|NCT02559206|18705448|P8|COMPLETED|Overall Study||57
7599170|NCT02559206|18705449|P7|COMPLETED|Overall Study||60
7599171|NCT02559206|18705450|P6|COMPLETED|Overall Study||53
7599172|NCT02559206|18705451|P5|COMPLETED|Overall Study||55
7599173|NCT02559206|18705452|P4|COMPLETED|Overall Study||53
7599174|NCT02559206|18705453|P3|COMPLETED|Overall Study||58
7599175|NCT02559206|18705454|P2|COMPLETED|Overall Study||54
7599176|NCT02559206|18705455|P1|COMPLETED|Overall Study||58
7599177|NCT02559206|18705448|P8|STARTED|Overall Study||66
7599178|NCT02559206|18705449|P7|STARTED|Overall Study||66
7599179|NCT02559206|18705450|P6|STARTED|Overall Study||67
7599180|NCT02559206|18705451|P5|STARTED|Overall Study||67
7599181|NCT02559206|18705452|P4|STARTED|Overall Study||67
7599182|NCT02559206|18705453|P3|STARTED|Overall Study||67
7599183|NCT02559206|18705454|P2|STARTED|Overall Study||66
7599184|NCT02559206|18705455|P1|STARTED|Overall Study||66
7599185|NCT02558894|18705497|P2|NOT COMPLETED|Overall Study||33
7599186|NCT02558894|18705498|P1|NOT COMPLETED|Overall Study||32
7599187|NCT02558894|18705497|P2|COMPLETED|Overall Study||0
7599188|NCT02558894|18705498|P1|COMPLETED|Overall Study||0
7599189|NCT02558894|18705497|P2|Patients Who Received IP|Overall Study||32
7599190|NCT02558894|18705498|P1|Patients Who Received IP|Overall Study||32
7599191|NCT02558894|18705497|P2|STARTED|Overall Study||33
7599192|NCT02558894|18705498|P1|STARTED|Overall Study||32
7599193|NCT02558829|18705526|P8|NOT COMPLETED|Overall Study||3
7599194|NCT02558829|18705527|P7|NOT COMPLETED|Overall Study||1
7599195|NCT02558829|18705528|P6|NOT COMPLETED|Overall Study||2
7599196|NCT02558829|18705529|P5|NOT COMPLETED|Overall Study||2
7599197|NCT02558829|18705530|P4|NOT COMPLETED|Overall Study||2
7599198|NCT02558829|18705531|P3|NOT COMPLETED|Overall Study||3
7599199|NCT02558829|18705532|P2|NOT COMPLETED|Overall Study||3
7599200|NCT02558829|18705533|P1|NOT COMPLETED|Overall Study||1
7599201|NCT02558829|18705526|P8|COMPLETED|Overall Study||8
7599202|NCT02558829|18705527|P7|COMPLETED|Overall Study||17
7599203|NCT02558829|18705528|P6|COMPLETED|Overall Study||24
7599204|NCT02558829|18705529|P5|COMPLETED|Overall Study||16
7599205|NCT02558829|18705530|P4|COMPLETED|Overall Study||16
7599206|NCT02558829|18705531|P3|COMPLETED|Overall Study||21
7599207|NCT02558829|18705532|P2|COMPLETED|Overall Study||18
7599208|NCT02558829|18705533|P1|COMPLETED|Overall Study||20
7599209|NCT02558829|18705526|P8|STARTED|Overall Study||11
7599210|NCT02558829|18705527|P7|STARTED|Overall Study||18
7599211|NCT02558829|18705528|P6|STARTED|Overall Study||26
7599212|NCT02558829|18705529|P5|STARTED|Overall Study||18
7599213|NCT02558829|18705530|P4|STARTED|Overall Study||18
7599214|NCT02558829|18705531|P3|STARTED|Overall Study||24
7599215|NCT02558829|18705532|P2|STARTED|Overall Study||21
7599216|NCT02558829|18705533|P1|STARTED|Overall Study||21
7599217|NCT02558790|18705559|P1|NOT COMPLETED|Overall Study||7
7599218|NCT02558790|18705559|P1|COMPLETED|Overall Study||13
7599219|NCT02558790|18705559|P1|Treated|Overall Study||15
7599220|NCT02558790|18705559|P1|STARTED|Overall Study|20 subjects signed consent to participate in the study. 15 subjects began taking L-TAMS.|20
7599221|NCT02558400|18705566|P3|NOT COMPLETED|Overall Study||33
7599222|NCT02558400|18705567|P2|NOT COMPLETED|Overall Study||96
7599223|NCT02558400|18705568|P1|NOT COMPLETED|Overall Study||79
7599224|NCT02558400|18705566|P3|COMPLETED|Overall Study||203
7599225|NCT02558400|18705567|P2|COMPLETED|Overall Study||148
7599226|NCT02558400|18705568|P1|COMPLETED|Overall Study||159
7599227|NCT02558400|18705566|P3|STARTED|Overall Study||236
7599228|NCT02558400|18705567|P2|STARTED|Overall Study||244
7599229|NCT02558400|18705568|P1|STARTED|Overall Study||238
7599230|NCT02558374|18705581|P2|NOT COMPLETED|Overall Study||43
7599231|NCT02558374|18705582|P1|NOT COMPLETED|Overall Study||108
7599232|NCT02558374|18705581|P2|COMPLETED|Overall Study||314
7599233|NCT02558374|18705582|P1|COMPLETED|Overall Study||243
7599234|NCT02558374|18705581|P2|STARTED|Overall Study||357
7599235|NCT02558374|18705582|P1|STARTED|Overall Study||351
7599236|NCT02558231|18705592|P2|NOT COMPLETED|Overall Study||124
7599237|NCT02558231|18705593|P1|NOT COMPLETED|Overall Study||123
7599238|NCT02558231|18705592|P2|COMPLETED|Overall Study||0
7599239|NCT02558231|18705593|P1|COMPLETED|Overall Study||0
7599240|NCT02558231|18705592|P2|Treated|Overall Study||123
7599241|NCT02558231|18705593|P1|Treated|Overall Study||123
7599242|NCT02558231|18705592|P2|STARTED|Overall Study||124
7599243|NCT02558231|18705593|P1|STARTED|Overall Study||123
7599244|NCT02557698|18705619|P2|NOT COMPLETED|Overall Study||0
7599245|NCT02557698|18705620|P1|NOT COMPLETED|Overall Study||0
7599246|NCT02557698|18705619|P2|COMPLETED|Overall Study||30
7599247|NCT02557698|18705620|P1|COMPLETED|Overall Study||30
7599248|NCT02557698|18705619|P2|STARTED|Overall Study||30
7599249|NCT02557698|18705620|P1|STARTED|Overall Study||30
7599250|NCT02557646|18705684|P1|NOT COMPLETED|Overall Study||276
7599251|NCT02557646|18705684|P1|COMPLETED|Overall Study||417
7599252|NCT02557646|18705684|P1|STARTED|Overall Study||693
7599253|NCT02557555|18705702|P1|NOT COMPLETED|Overall Study||0
7599254|NCT02557555|18705702|P1|COMPLETED|Overall Study||100
7599255|NCT02557555|18705702|P1|STARTED|Overall Study||100
7599256|NCT02557516|18705711|P4|NOT COMPLETED|Overall Study||9
7599257|NCT02557516|18705712|P3|NOT COMPLETED|Overall Study||4
7599258|NCT02557516|18705713|P2|NOT COMPLETED|Overall Study||5
7599259|NCT02557516|18705714|P1|NOT COMPLETED|Overall Study||1
7599260|NCT02557516|18705711|P4|COMPLETED|Overall Study||0
7599261|NCT02557516|18705712|P3|COMPLETED|Overall Study||0
7599262|NCT02557516|18705713|P2|COMPLETED|Overall Study||1
7599263|NCT02557516|18705714|P1|COMPLETED|Overall Study||2
7599264|NCT02557516|18705711|P4|STARTED|Overall Study||9
7599265|NCT02557516|18705712|P3|STARTED|Overall Study||4
7599266|NCT02557516|18705713|P2|STARTED|Overall Study||6
7599267|NCT02557516|18705714|P1|STARTED|Overall Study||3
7599268|NCT02557399|18705735|P2|NOT COMPLETED|Overall Study||8
7599269|NCT02557399|18705736|P1|NOT COMPLETED|Overall Study||7
7599270|NCT02557399|18705735|P2|COMPLETED|Overall Study||169
7599271|NCT02557399|18705736|P1|COMPLETED|Overall Study||165
7599272|NCT02557399|18705735|P2|STARTED|Overall Study||177
7599273|NCT02557399|18705736|P1|STARTED|Overall Study||172
7599274|NCT02557100|18705771|P3|NOT COMPLETED|Cumulative Abatacept Period||4
7599275|NCT02557100|18705772|P2|NOT COMPLETED|Cumulative Abatacept Period||0
7599276|NCT02557100|18705773|P1|NOT COMPLETED|Cumulative Abatacept Period||0
7599277|NCT02557100|18705771|P3|COMPLETED|Cumulative Abatacept Period||72
7599278|NCT02557100|18705772|P2|COMPLETED|Cumulative Abatacept Period||0
7599279|NCT02557100|18705773|P1|COMPLETED|Cumulative Abatacept Period||0
7599280|NCT02557100|18705771|P3|STARTED|Cumulative Abatacept Period||76
7599281|NCT02557100|18705772|P2|STARTED|Cumulative Abatacept Period||0
7599282|NCT02557100|18705773|P1|STARTED|Cumulative Abatacept Period||0
7599283|NCT02557100|18705771|P3|NOT COMPLETED|Transition to Open Label||0
7599284|NCT02557100|18705772|P2|NOT COMPLETED|Transition to Open Label||36
7599285|NCT02557100|18705773|P1|NOT COMPLETED|Transition to Open Label||40
7599286|NCT02557100|18705771|P3|COMPLETED|Transition to Open Label||0
7599287|NCT02557100|18705772|P2|COMPLETED|Transition to Open Label||0
7599288|NCT02557100|18705773|P1|COMPLETED|Transition to Open Label||0
7599289|NCT02557100|18705771|P3|STARTED|Transition to Open Label||0
7599290|NCT02557100|18705772|P2|STARTED|Transition to Open Label||36
7599291|NCT02557100|18705773|P1|STARTED|Transition to Open Label||40
7599292|NCT02557100|18705771|P3|NOT COMPLETED|Single Blind Treatment Period||0
7599293|NCT02557100|18705772|P2|NOT COMPLETED|Single Blind Treatment Period||4
7599294|NCT02557100|18705773|P1|NOT COMPLETED|Single Blind Treatment Period||0
7599295|NCT02557100|18705771|P3|COMPLETED|Single Blind Treatment Period||0
7599296|NCT02557100|18705772|P2|COMPLETED|Single Blind Treatment Period||36
7599297|NCT02557100|18705773|P1|COMPLETED|Single Blind Treatment Period||40
7599298|NCT02557100|18705771|P3|STARTED|Single Blind Treatment Period||0
7599299|NCT02557100|18705772|P2|STARTED|Single Blind Treatment Period||40
7599300|NCT02557100|18705773|P1|STARTED|Single Blind Treatment Period||40
7599301|NCT02557035|18705801|P2|NOT COMPLETED|Overall Study||9
7599302|NCT02557035|18705802|P1|NOT COMPLETED|Overall Study||7
7599303|NCT02557035|18705801|P2|COMPLETED|Overall Study||206
7599304|NCT02557035|18705802|P1|COMPLETED|Overall Study||218
7599305|NCT02557035|18705801|P2|STARTED|Overall Study||215
7599306|NCT02557035|18705802|P1|STARTED|Overall Study||225
7599307|NCT02556918|18705826|P2|NOT COMPLETED|Overall Study||10
7599308|NCT02556918|18705827|P1|NOT COMPLETED|Overall Study||9
7599309|NCT02556918|18705826|P2|COMPLETED|Overall Study||91
7599310|NCT02556918|18705827|P1|COMPLETED|Overall Study||91
7599311|NCT02556918|18705826|P2|STARTED|Overall Study||101
7599312|NCT02556918|18705827|P1|STARTED|Overall Study||100
7599313|NCT02556801|18705887|P4|NOT COMPLETED|Overall Study||5
7599314|NCT02556801|18705888|P3|NOT COMPLETED|Overall Study||4
7599315|NCT02556801|18705889|P2|NOT COMPLETED|Overall Study||7
7599316|NCT02556801|18705890|P1|NOT COMPLETED|Overall Study||2
7599317|NCT02556801|18705887|P4|COMPLETED|Overall Study||37
7599318|NCT02556801|18705888|P3|COMPLETED|Overall Study||38
7599319|NCT02556801|18705889|P2|COMPLETED|Overall Study||35
7599320|NCT02556801|18705890|P1|COMPLETED|Overall Study||40
7599321|NCT02556801|18705887|P4|STARTED|Overall Study||42
7599322|NCT02556801|18705888|P3|STARTED|Overall Study||42
7599323|NCT02556801|18705889|P2|STARTED|Overall Study||42
7599324|NCT02556801|18705890|P1|STARTED|Overall Study||42
7599325|NCT02556788|18705942|P2|NOT COMPLETED|Overall Study||37
7599326|NCT02556788|18705943|P1|NOT COMPLETED|Overall Study||44
7599327|NCT02556788|18705942|P2|COMPLETED|Overall Study||573
7599328|NCT02556788|18705943|P1|COMPLETED|Overall Study||558
7599329|NCT02556788|18705942|P2|STARTED|Overall Study||610
7599330|NCT02556788|18705943|P1|STARTED|Overall Study||602
7599331|NCT02556632|18705952|P3|NOT COMPLETED|Overall Study||9
7599332|NCT02556632|18705953|P2|NOT COMPLETED|Overall Study||6
7599333|NCT02556632|18705954|P1|NOT COMPLETED|Overall Study||5
7599334|NCT02556632|18705952|P3|COMPLETED|Overall Study||53
7599335|NCT02556632|18705953|P2|COMPLETED|Overall Study||59
7599336|NCT02556632|18705954|P1|COMPLETED|Overall Study||59
7599337|NCT02556632|18705952|P3|STARTED|Overall Study||62
7599338|NCT02556632|18705953|P2|STARTED|Overall Study||65
7599339|NCT02556632|18705954|P1|STARTED|Overall Study||64
7599340|NCT02556554|18705971|P5|NOT COMPLETED|Overall Study||0
7599341|NCT02556554|18705972|P4|NOT COMPLETED|Overall Study||0
7599342|NCT02556554|18705973|P3|NOT COMPLETED|Overall Study||4
7599343|NCT02556554|18705974|P2|NOT COMPLETED|Overall Study||1
7599344|NCT02556554|18705975|P1|NOT COMPLETED|Overall Study||0
7599345|NCT02556554|18705971|P5|COMPLETED|Overall Study||14
7599346|NCT02556554|18705972|P4|COMPLETED|Overall Study||12
7599347|NCT02556554|18705973|P3|COMPLETED|Overall Study||15
7599348|NCT02556554|18705974|P2|COMPLETED|Overall Study||13
7599349|NCT02556554|18705975|P1|COMPLETED|Overall Study||8
7599350|NCT02556554|18705971|P5|STARTED|Overall Study||14
7599351|NCT02556554|18705972|P4|STARTED|Overall Study||12
7599352|NCT02556554|18705973|P3|STARTED|Overall Study||19
7599353|NCT02556554|18705974|P2|STARTED|Overall Study||14
7599354|NCT02556554|18705975|P1|STARTED|Overall Study||8
7599355|NCT02556333|18705990|P1|NOT COMPLETED|Overall Study||0
7599356|NCT02556333|18705990|P1|COMPLETED|Overall Study||1
7599357|NCT02556333|18705990|P1|STARTED|Overall Study||1
7599358|NCT02556307|18705994|P1|NOT COMPLETED|Overall Study||53
7599359|NCT02556307|18705994|P1|COMPLETED|Overall Study||217
7599360|NCT02556307|18705994|P1|Treated|Overall Study||268
7599361|NCT02556307|18705994|P1|STARTED|Overall Study||270
7599362|NCT02556255|18706004|P1|NOT COMPLETED|Overall Study||4
7599363|NCT02556255|18706004|P1|COMPLETED|Overall Study||46
7599364|NCT02556255|18706004|P1|STARTED|Overall Study||50
7599365|NCT02556203|18706019|P2|NOT COMPLETED|Overall Study||26
7599366|NCT02556203|18706020|P1|NOT COMPLETED|Overall Study||27
7599367|NCT02556203|18706019|P2|COMPLETED|Overall Study||792
7599368|NCT02556203|18706020|P1|COMPLETED|Overall Study||799
7599369|NCT02556203|18706019|P2|Received Treatment|Overall Study||807
7599370|NCT02556203|18706020|P1|Received Treatment|Overall Study||801
7599371|NCT02556203|18706019|P2|STARTED|Overall Study||818
7599372|NCT02556203|18706020|P1|STARTED|Overall Study||826
7599373|NCT02556177|18706042|P2|NOT COMPLETED|Overall Study||61
7599374|NCT02556177|18706043|P1|NOT COMPLETED|Overall Study||283
7599375|NCT02556177|18706042|P2|COMPLETED|Overall Study||91
7599376|NCT02556177|18706043|P1|COMPLETED|Overall Study||42
7599377|NCT02556177|18706042|P2|STARTED|Overall Study||152
7599378|NCT02556177|18706043|P1|STARTED|Overall Study||325
7599379|NCT02556138|18706051|P1|NOT COMPLETED|Overall Study||1
7599380|NCT02556138|18706051|P1|COMPLETED|Overall Study|One patient withdrew from the study due to intolerance of the balloon after 1 month.|7
7599381|NCT02556138|18706051|P1|STARTED|Overall Study||8
7599382|NCT02556112|18706060|P3|NOT COMPLETED|Overall Study||12
7599383|NCT02556112|18706061|P2|NOT COMPLETED|Overall Study||17
7599384|NCT02556112|18706062|P1|NOT COMPLETED|Overall Study||10
7599385|NCT02556112|18706060|P3|COMPLETED|Overall Study||30
7599386|NCT02556112|18706061|P2|COMPLETED|Overall Study||23
7599387|NCT02556112|18706062|P1|COMPLETED|Overall Study||30
7599388|NCT02556112|18706060|P3|STARTED|Overall Study||42
7599389|NCT02556112|18706061|P2|STARTED|Overall Study||40
7599390|NCT02556112|18706062|P1|STARTED|Overall Study||40
7599391|NCT02555878|18706087|P2|NOT COMPLETED|Overall Study||150
7599392|NCT02555878|18706088|P1|NOT COMPLETED|Overall Study||166
7599393|NCT02555878|18706087|P2|COMPLETED|Overall Study||270
7599394|NCT02555878|18706088|P1|COMPLETED|Overall Study||255
7599395|NCT02555878|18706087|P2|Treated|Overall Study||405
7599396|NCT02555878|18706088|P1|Treated|Overall Study||404
7599397|NCT02555878|18706087|P2|STARTED|Overall Study||420
7599398|NCT02555878|18706088|P1|STARTED|Overall Study||421
7599399|NCT02555722|18706120|P2|NOT COMPLETED|Month 3||0
7599400|NCT02555722|18706121|P1|NOT COMPLETED|Month 3||0
7599401|NCT02555722|18706120|P2|COMPLETED|Month 3||29
7599402|NCT02555722|18706121|P1|COMPLETED|Month 3||54
7599403|NCT02555722|18706120|P2|STARTED|Month 3||29
7599404|NCT02555722|18706121|P1|STARTED|Month 3||54
7599405|NCT02555722|18706120|P2|NOT COMPLETED|Month 2||0
7599406|NCT02555722|18706121|P1|NOT COMPLETED|Month 2||4
7599407|NCT02555722|18706120|P2|COMPLETED|Month 2||29
7599408|NCT02555722|18706121|P1|COMPLETED|Month 2||54
7599409|NCT02555722|18706120|P2|STARTED|Month 2||29
7599410|NCT02555722|18706121|P1|STARTED|Month 2||58
7599411|NCT02555722|18706120|P2|NOT COMPLETED|Month 1||0
7599412|NCT02555722|18706121|P1|NOT COMPLETED|Month 1||1
7599413|NCT02555722|18706120|P2|COMPLETED|Month 1||29
7599414|NCT02555722|18706121|P1|COMPLETED|Month 1||58
7599415|NCT02555722|18706120|P2|STARTED|Month 1||29
7599416|NCT02555722|18706121|P1|STARTED|Month 1||59
7599417|NCT02555722|18706120|P2|NOT COMPLETED|Week 2||1
7599418|NCT02555722|18706121|P1|NOT COMPLETED|Week 2||1
7599419|NCT02555722|18706120|P2|COMPLETED|Week 2||29
7599420|NCT02555722|18706121|P1|COMPLETED|Week 2||59
7599421|NCT02555722|18706120|P2|STARTED|Week 2||30
7599422|NCT02555722|18706121|P1|STARTED|Week 2||60
7599423|NCT02555722|18706120|P2|NOT COMPLETED|Week 1||0
7599424|NCT02555722|18706121|P1|NOT COMPLETED|Week 1||0
7599425|NCT02555722|18706120|P2|COMPLETED|Week 1||30
7599426|NCT02555722|18706121|P1|COMPLETED|Week 1||60
7599427|NCT02555722|18706120|P2|STARTED|Week 1||30
7599428|NCT02555722|18706121|P1|STARTED|Week 1||60
7599429|NCT02555722|18706120|P2|NOT COMPLETED|Lens Dispensed||0
7599430|NCT02555722|18706121|P1|NOT COMPLETED|Lens Dispensed||0
7599431|NCT02555722|18706120|P2|COMPLETED|Lens Dispensed||30
7599432|NCT02555722|18706121|P1|COMPLETED|Lens Dispensed||60
7599433|NCT02555722|18706120|P2|STARTED|Lens Dispensed||30
7599434|NCT02555722|18706121|P1|STARTED|Lens Dispensed||60
7599435|NCT02555683|18706306|P3|NOT COMPLETED|Overall Study||29
7599436|NCT02555683|18706307|P2|NOT COMPLETED|Overall Study||17
7599437|NCT02555683|18706308|P1|NOT COMPLETED|Overall Study||19
7599438|NCT02555683|18706306|P3|COMPLETED|Overall Study||269
7599439|NCT02555683|18706307|P2|COMPLETED|Overall Study||278
7599440|NCT02555683|18706308|P1|COMPLETED|Overall Study||282
7599441|NCT02555683|18706306|P3|FAS/SAF: Overall Population|Overall Study||298
7599442|NCT02555683|18706307|P2|FAS/SAF: Overall Population|Overall Study||293
7599443|NCT02555683|18706308|P1|FAS/SAF: Overall Population|Overall Study||299
7599444|NCT02555683|18706306|P3|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
7599445|NCT02555683|18706307|P2|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
7599446|NCT02555683|18706308|P1|FAS/SAF: High Eosinophil Subpopulation|Overall Study||200
7599447|NCT02555683|18706306|P3|STARTED|Overall Study||298
7599448|NCT02555683|18706307|P2|STARTED|Overall Study||295
7599449|NCT02555683|18706308|P1|STARTED|Overall Study||301
7599450|NCT02555657|18706339|P2|NOT COMPLETED|Overall Study||310
7599451|NCT02555657|18706340|P1|NOT COMPLETED|Overall Study||312
7599452|NCT02555657|18706339|P2|COMPLETED|Overall Study||0
7599453|NCT02555657|18706340|P1|COMPLETED|Overall Study||0
7599454|NCT02555657|18706339|P2|Treated|Overall Study||292
7599455|NCT02555657|18706340|P1|Treated|Overall Study||309
7599456|NCT02555657|18706339|P2|STARTED|Overall Study||310
7599457|NCT02555657|18706340|P1|STARTED|Overall Study||312
7599458|NCT02555631|18706378|P1|NOT COMPLETED|Overall Study||4
7599459|NCT02555631|18706378|P1|COMPLETED|Overall Study||25
7599460|NCT02555631|18706378|P1|STARTED|Overall Study||29
7599461|NCT02555618|18706387|P2|NOT COMPLETED|Overall Study||0
7599462|NCT02555618|18706388|P1|NOT COMPLETED|Overall Study||1
7599463|NCT02555618|18706387|P2|COMPLETED|Overall Study||200
7599464|NCT02555618|18706388|P1|COMPLETED|Overall Study||199
7599465|NCT02555618|18706387|P2|STARTED|Overall Study||200
7599466|NCT02555618|18706388|P1|STARTED|Overall Study||200
7599467|NCT02555371|18706430|P5|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||3
7599468|NCT02555371|18706431|P4|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||4
7599469|NCT02555371|18706432|P3|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
7599470|NCT02555371|18706433|P2|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
7599471|NCT02555371|18706434|P1|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
7599472|NCT02555371|18706430|P5|COMPLETED|PartD(OL: 52W Post-randomization PartC)||42
7599473|NCT02555371|18706431|P4|COMPLETED|PartD(OL: 52W Post-randomization PartC)||80
7599474|NCT02555371|18706432|P3|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
7599475|NCT02555371|18706433|P2|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
7599476|NCT02555371|18706434|P1|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
7599477|NCT02555371|18706430|P5|STARTED|PartD(OL: 52W Post-randomization PartC)||45
7599478|NCT02555371|18706431|P4|STARTED|PartD(OL: 52W Post-randomization PartC)||84
7599479|NCT02555371|18706432|P3|STARTED|PartD(OL: 52W Post-randomization PartC)||0
7599480|NCT02555371|18706433|P2|STARTED|PartD(OL: 52W Post-randomization PartC)||0
7599481|NCT02555371|18706434|P1|STARTED|PartD(OL: 52W Post-randomization PartC)||0
7599482|NCT02555371|18706430|P5|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
7599483|NCT02555371|18706431|P4|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
7599484|NCT02555371|18706432|P3|NOT COMPLETED|Part C (DB Period: Up to 52W)||48
7599485|NCT02555371|18706433|P2|NOT COMPLETED|Part C (DB Period: Up to 52W)||89
7599486|NCT02555371|18706434|P1|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
7599487|NCT02555371|18706430|P5|COMPLETED|Part C (DB Period: Up to 52W)||0
7599488|NCT02555371|18706431|P4|COMPLETED|Part C (DB Period: Up to 52W)||0
7599489|NCT02555371|18706432|P3|COMPLETED|Part C (DB Period: Up to 52W)||96
7599490|NCT02555371|18706433|P2|COMPLETED|Part C (DB Period: Up to 52W)||62
7599491|NCT02555371|18706434|P1|COMPLETED|Part C (DB Period: Up to 52W)||0
7599492|NCT02555371|18706430|P5|STARTED|Part C (DB Period: Up to 52W)||0
7599493|NCT02555371|18706431|P4|STARTED|Part C (DB Period: Up to 52W)||0
7599494|NCT02555371|18706432|P3|STARTED|Part C (DB Period: Up to 52W)||144
7599495|NCT02555371|18706433|P2|STARTED|Part C (DB Period: Up to 52W)||151
7599496|NCT02555371|18706434|P1|STARTED|Part C (DB Period: Up to 52W)||0
7599497|NCT02555371|18706430|P5|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
7599498|NCT02555371|18706431|P4|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
7599499|NCT02555371|18706432|P3|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
7599500|NCT02555371|18706433|P2|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
7599501|NCT02555371|18706434|P1|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||11
7599502|NCT02555371|18706430|P5|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
7599503|NCT02555371|18706431|P4|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
7599504|NCT02555371|18706432|P3|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
7599505|NCT02555371|18706433|P2|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
7599506|NCT02555371|18706434|P1|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||295
7599507|NCT02555371|18706430|P5|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
7599508|NCT02555371|18706431|P4|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
7599509|NCT02555371|18706432|P3|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
7599510|NCT02555371|18706433|P2|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
7599511|NCT02555371|18706434|P1|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||306
7599512|NCT02555306|18706453|P4|NOT COMPLETED|Overall Study||0
7599513|NCT02555306|18706454|P3|NOT COMPLETED|Overall Study||0
7599514|NCT02555306|18706455|P2|NOT COMPLETED|Overall Study||0
7599515|NCT02555306|18706456|P1|NOT COMPLETED|Overall Study||0
7599516|NCT02555306|18706453|P4|COMPLETED|Overall Study||3
7599517|NCT02555306|18706454|P3|COMPLETED|Overall Study||3
7599518|NCT02555306|18706455|P2|COMPLETED|Overall Study||3
7599519|NCT02555306|18706456|P1|COMPLETED|Overall Study||3
7599520|NCT02555306|18706453|P4|STARTED|Overall Study||3
7599521|NCT02555306|18706454|P3|STARTED|Overall Study||3
7599522|NCT02555306|18706455|P2|STARTED|Overall Study||3
7599523|NCT02555306|18706456|P1|STARTED|Overall Study||3
7599524|NCT02555228|18706472|P2|NOT COMPLETED|Overall Study||0
7599525|NCT02555228|18706473|P1|NOT COMPLETED|Overall Study||0
7599526|NCT02555228|18706472|P2|COMPLETED|Overall Study|29th October 2015|27
7599527|NCT02555228|18706473|P1|COMPLETED|Overall Study|19th November 2015|27
7599528|NCT02555228|18706472|P2|STARTED|Overall Study|14th August 2015|27
7599529|NCT02555228|18706473|P1|STARTED|Overall Study|20th August 2015|27
7599530|NCT02555215|18706485|P1|NOT COMPLETED|Overall Study||3
7599531|NCT02555215|18706485|P1|COMPLETED|Overall Study||17
7599532|NCT02555215|18706485|P1|STARTED|Overall Study||20
7599533|NCT02555098|18706496|P2|NOT COMPLETED|Second Intervention||0
7599534|NCT02555098|18706497|P1|NOT COMPLETED|Second Intervention||0
7599535|NCT02555098|18706496|P2|COMPLETED|Second Intervention||11
7599536|NCT02555098|18706497|P1|COMPLETED|Second Intervention||12
7599537|NCT02555098|18706496|P2|STARTED|Second Intervention||11
7599538|NCT02555098|18706497|P1|STARTED|Second Intervention||12
7599539|NCT02555098|18706496|P2|NOT COMPLETED|First Intervention||0
7599540|NCT02555098|18706497|P1|NOT COMPLETED|First Intervention||0
7599541|NCT02555098|18706496|P2|COMPLETED|First Intervention||11
7599542|NCT02555098|18706497|P1|COMPLETED|First Intervention||12
7599543|NCT02555098|18706496|P2|STARTED|First Intervention||11
7599544|NCT02555098|18706497|P1|STARTED|First Intervention||12
7599545|NCT02554981|18706517|P1|NOT COMPLETED|Overall Study||5
7599546|NCT02554981|18706517|P1|COMPLETED|Overall Study||46
7599547|NCT02554981|18706517|P1|STARTED|Overall Study||51
7599548|NCT02554929|18706543|P2|NOT COMPLETED|Overall Study||12
7599549|NCT02554929|18706544|P1|NOT COMPLETED|Overall Study||6
7599550|NCT02554929|18706543|P2|COMPLETED|Overall Study||32
7599551|NCT02554929|18706544|P1|COMPLETED|Overall Study||40
7599552|NCT02554929|18706543|P2|Per Protocol 6 Month Follow-up|Overall Study||32
7599553|NCT02554929|18706544|P1|Per Protocol 6 Month Follow-up|Overall Study||40
7599554|NCT02554929|18706543|P2|Per Protocol Post-Intervention|Overall Study||36
7599555|NCT02554929|18706544|P1|Per Protocol Post-Intervention|Overall Study||42
7599556|NCT02554929|18706543|P2|Per Protocol Received Intervention|Overall Study||36
7599557|NCT02554929|18706544|P1|Per Protocol Received Intervention|Overall Study||44
7599558|NCT02554929|18706543|P2|STARTED|Overall Study||44
7599559|NCT02554929|18706544|P1|STARTED|Overall Study||46
7599560|NCT02554890|18706562|P2|NOT COMPLETED|Open-label||52
7599561|NCT02554890|18706563|P1|NOT COMPLETED|Open-label||0
7599562|NCT02554890|18706562|P2|COMPLETED|Open-label||835
7599563|NCT02554890|18706563|P1|COMPLETED|Open-label||0
7599564|NCT02554890|18706562|P2|STARTED|Open-label||887
7599565|NCT02554890|18706563|P1|STARTED|Open-label||0
7599566|NCT02554890|18706562|P2|NOT COMPLETED|Double-blind||91
7599567|NCT02554890|18706563|P1|NOT COMPLETED|Double-blind||96
7599568|NCT02554890|18706562|P2|COMPLETED|Double-blind||352
7599569|NCT02554890|18706563|P1|COMPLETED|Double-blind||348
7599570|NCT02554890|18706562|P2|Treated Patients|Double-blind||439
7599571|NCT02554890|18706563|P1|Treated Patients|Double-blind||436
7599572|NCT02554890|18706562|P2|STARTED|Double-blind||443
7599573|NCT02554890|18706563|P1|STARTED|Double-blind||444
7599574|NCT02554877|18706591|P4|NOT COMPLETED|Overall Study||7
7599575|NCT02554877|18706592|P3|NOT COMPLETED|Overall Study||6
7599576|NCT02554877|18706593|P2|NOT COMPLETED|Overall Study||7
7599577|NCT02554877|18706594|P1|NOT COMPLETED|Overall Study||12
7599578|NCT02554877|18706591|P4|COMPLETED|Overall Study||45
7599579|NCT02554877|18706592|P3|COMPLETED|Overall Study||46
7599580|NCT02554877|18706593|P2|COMPLETED|Overall Study||44
7599581|NCT02554877|18706594|P1|COMPLETED|Overall Study||39
7599582|NCT02554877|18706591|P4|STARTED|Overall Study||52
7599583|NCT02554877|18706592|P3|STARTED|Overall Study||52
7599584|NCT02554877|18706593|P2|STARTED|Overall Study||51
7599585|NCT02554877|18706594|P1|STARTED|Overall Study||51
7599586|NCT02554799|18706658|P2|NOT COMPLETED|Overall Study||0
7599587|NCT02554799|18706659|P1|NOT COMPLETED|Overall Study||0
7599588|NCT02554799|18706658|P2|COMPLETED|Overall Study||9
7599589|NCT02554799|18706659|P1|COMPLETED|Overall Study||9
7599590|NCT02554799|18706658|P2|STARTED|Overall Study||9
7599591|NCT02554799|18706659|P1|STARTED|Overall Study||9
7599592|NCT02554786|18706682|P5|NOT COMPLETED|Overall Study||30
7599593|NCT02554786|18706683|P4|NOT COMPLETED|Overall Study||41
7599594|NCT02554786|18706684|P3|NOT COMPLETED|Overall Study||30
7599595|NCT02554786|18706685|P2|NOT COMPLETED|Overall Study||26
7599596|NCT02554786|18706686|P1|NOT COMPLETED|Overall Study||35
7599597|NCT02554786|18706682|P5|COMPLETED|Overall Study||416
7599598|NCT02554786|18706683|P4|COMPLETED|Overall Study||403
7599599|NCT02554786|18706684|P3|COMPLETED|Overall Study||412
7599600|NCT02554786|18706685|P2|COMPLETED|Overall Study||413
7599601|NCT02554786|18706686|P1|COMPLETED|Overall Study||410
7599602|NCT02554786|18706682|P5|STARTED|Overall Study||446
7599603|NCT02554786|18706683|P4|STARTED|Overall Study||444
7599604|NCT02554786|18706684|P3|STARTED|Overall Study||442
7599605|NCT02554786|18706685|P2|STARTED|Overall Study||439
7599606|NCT02554786|18706686|P1|STARTED|Overall Study||445
7599607|NCT02554760|18706828|P2|NOT COMPLETED|Overall Study||0
7599608|NCT02554760|18706829|P1|NOT COMPLETED|Overall Study||0
7599609|NCT02554760|18706828|P2|COMPLETED|Overall Study||10
7599610|NCT02554760|18706829|P1|COMPLETED|Overall Study||9
7599611|NCT02554760|18706828|P2|STARTED|Overall Study||10
7599612|NCT02554760|18706829|P1|STARTED|Overall Study||9
7599613|NCT02554682|18706848|P10|NOT COMPLETED|Overall Study||2
7599614|NCT02554682|18706849|P9|NOT COMPLETED|Overall Study||2
7599615|NCT02554682|18706850|P8|NOT COMPLETED|Overall Study||6
7599616|NCT02554682|18706851|P7|NOT COMPLETED|Overall Study||6
7599617|NCT02554682|18706852|P6|NOT COMPLETED|Overall Study||1
7599618|NCT02554682|18706853|P5|NOT COMPLETED|Overall Study||2
7599619|NCT02554682|18706854|P4|NOT COMPLETED|Overall Study||3
7599620|NCT02554682|18706855|P3|NOT COMPLETED|Overall Study||4
7599621|NCT02554682|18706856|P2|NOT COMPLETED|Overall Study||12
7599622|NCT02554682|18706857|P1|NOT COMPLETED|Overall Study||15
7599623|NCT02554682|18706848|P10|COMPLETED|Overall Study||24
7599624|NCT02554682|18706849|P9|COMPLETED|Overall Study||24
7599625|NCT02554682|18706850|P8|COMPLETED|Overall Study||22
7599626|NCT02554682|18706851|P7|COMPLETED|Overall Study||22
7599627|NCT02554682|18706852|P6|COMPLETED|Overall Study||39
7599628|NCT02554682|18706853|P5|COMPLETED|Overall Study||38
7599629|NCT02554682|18706854|P4|COMPLETED|Overall Study||37
7599630|NCT02554682|18706855|P3|COMPLETED|Overall Study||36
7599631|NCT02554682|18706856|P2|COMPLETED|Overall Study||28
7599632|NCT02554682|18706857|P1|COMPLETED|Overall Study||25
7599633|NCT02554682|18706848|P10|STARTED|Overall Study||26
7599634|NCT02554682|18706849|P9|STARTED|Overall Study||26
7599635|NCT02554682|18706850|P8|STARTED|Overall Study||28
7599636|NCT02554682|18706851|P7|STARTED|Overall Study||28
7599637|NCT02554682|18706852|P6|STARTED|Overall Study||40
7599638|NCT02554682|18706853|P5|STARTED|Overall Study||40
7599639|NCT02554682|18706854|P4|STARTED|Overall Study||40
7599640|NCT02554682|18706855|P3|STARTED|Overall Study||40
7599641|NCT02554682|18706856|P2|STARTED|Overall Study||40
7599642|NCT02554682|18706857|P1|STARTED|Overall Study||40
7599643|NCT02554656|18706906|P1|NOT COMPLETED|Overall Study||3
7599644|NCT02554656|18706906|P1|COMPLETED|Overall Study||86
7599645|NCT02554656|18706906|P1|STARTED|Overall Study||89
7599646|NCT02554435|18706916|P2|NOT COMPLETED|Overall Study||1
7599647|NCT02554435|18706917|P1|NOT COMPLETED|Overall Study||6
7599648|NCT02554435|18706916|P2|COMPLETED|Overall Study||19
7599649|NCT02554435|18706917|P1|COMPLETED|Overall Study||14
7599650|NCT02554435|18706916|P2|STARTED|Overall Study||20
7599651|NCT02554435|18706917|P1|STARTED|Overall Study||20
7599652|NCT02554279|18706951|P2|NOT COMPLETED|Overall Study||18
7599653|NCT02554279|18706952|P1|NOT COMPLETED|Overall Study||32
7599654|NCT02554279|18706951|P2|COMPLETED|Overall Study||291
7599655|NCT02554279|18706952|P1|COMPLETED|Overall Study||279
7599656|NCT02554279|18706951|P2|Completed Fresh Blastocyst Transfer|Overall Study||191
7599657|NCT02554279|18706952|P1|Completed Fresh Blastocyst Transfer|Overall Study||201
7599658|NCT02554279|18706951|P2|Completed Oocyte Retrieval|Overall Study||306
7599659|NCT02554279|18706952|P1|Completed Oocyte Retrieval|Overall Study||292
7599660|NCT02554279|18706951|P2|Received Trigger|Overall Study||307
7599661|NCT02554279|18706952|P1|Received Trigger|Overall Study||293
7599662|NCT02554279|18706951|P2|Completed Day 6 of Stimulation|Overall Study||309
7599663|NCT02554279|18706952|P1|Completed Day 6 of Stimulation|Overall Study||308
7599664|NCT02554279|18706951|P2|Treated|Overall Study||309
7599665|NCT02554279|18706952|P1|Treated|Overall Study||310
7599666|NCT02554279|18706951|P2|STARTED|Overall Study||309
7599667|NCT02554279|18706952|P1|STARTED|Overall Study||311
7599668|NCT02554019|18706987|P3|NOT COMPLETED|Overall Study||2
7599669|NCT02554019|18706988|P2|NOT COMPLETED|Overall Study||0
7599670|NCT02554019|18706989|P1|NOT COMPLETED|Overall Study||2
7599671|NCT02554019|18706987|P3|COMPLETED|Overall Study||10
7599672|NCT02554019|18706988|P2|COMPLETED|Overall Study||12
7599673|NCT02554019|18706989|P1|COMPLETED|Overall Study||10
7599674|NCT02554019|18706987|P3|STARTED|Overall Study||12
7599675|NCT02554019|18706988|P2|STARTED|Overall Study||12
7599676|NCT02554019|18706989|P1|STARTED|Overall Study||12
7599677|NCT02553928|18707011|P2|NOT COMPLETED|Overall Study||3
7599678|NCT02553928|18707012|P1|NOT COMPLETED|Overall Study||2
7599679|NCT02553928|18707011|P2|COMPLETED|Overall Study||29
7599680|NCT02553928|18707012|P1|COMPLETED|Overall Study||28
7599681|NCT02553928|18707011|P2|STARTED|Overall Study||32
7599682|NCT02553928|18707012|P1|STARTED|Overall Study||30
7599683|NCT02553915|18707024|P4|NOT COMPLETED|Overall Study||3
7599684|NCT02553915|18707025|P3|NOT COMPLETED|Overall Study||3
7599685|NCT02553915|18707026|P2|NOT COMPLETED|Overall Study||1
7599686|NCT02553915|18707027|P1|NOT COMPLETED|Overall Study||4
7599687|NCT02553915|18707024|P4|COMPLETED|Overall Study||13
7599688|NCT02553915|18707025|P3|COMPLETED|Overall Study||12
7599689|NCT02553915|18707026|P2|COMPLETED|Overall Study||14
7599690|NCT02553915|18707027|P1|COMPLETED|Overall Study||11
7599691|NCT02553915|18707024|P4|STARTED|Overall Study||16
7599692|NCT02553915|18707025|P3|STARTED|Overall Study||15
7599693|NCT02553915|18707026|P2|STARTED|Overall Study||15
7599694|NCT02553915|18707027|P1|STARTED|Overall Study||15
7599695|NCT02553798|18707057|P1|NOT COMPLETED|Overall Study||338
7599696|NCT02553798|18707057|P1|COMPLETED|Overall Study||226
7599697|NCT02553798|18707057|P1|STARTED|Overall Study||564
7599698|NCT02553772|18707066|P2|NOT COMPLETED|Overall Study||6
7599699|NCT02553772|18707067|P1|NOT COMPLETED|Overall Study||6
7599700|NCT02553772|18707066|P2|COMPLETED|Overall Study||116
7599701|NCT02553772|18707067|P1|COMPLETED|Overall Study||114
7599702|NCT02553772|18707066|P2|STARTED|Overall Study||122
7599703|NCT02553772|18707067|P1|STARTED|Overall Study||120
7599704|NCT02553746|18707083|P2|NOT COMPLETED|Overall Study||2
7599705|NCT02553746|18707084|P1|NOT COMPLETED|Overall Study||3
7599706|NCT02553746|18707083|P2|COMPLETED|Overall Study||64
7599707|NCT02553746|18707084|P1|COMPLETED|Overall Study||77
7599708|NCT02553746|18707083|P2|STARTED|Overall Study||66
7599709|NCT02553746|18707084|P1|STARTED|Overall Study||80
7599710|NCT02553629|18707112|P2|NOT COMPLETED|Overall Study||6
7599711|NCT02553629|18707113|P1|NOT COMPLETED|Overall Study||3
7599712|NCT02553629|18707112|P2|COMPLETED|Overall Study||50
7599713|NCT02553629|18707113|P1|COMPLETED|Overall Study||50
7599714|NCT02553629|18707112|P2|STARTED|Overall Study||56
7599715|NCT02553629|18707113|P1|STARTED|Overall Study||53
7599716|NCT02553538|18707129|P2|NOT COMPLETED|Overall Study||56
7599717|NCT02553538|18707130|P1|NOT COMPLETED|Overall Study||187
7599718|NCT02553538|18707129|P2|COMPLETED|Overall Study||764
7599719|NCT02553538|18707130|P1|COMPLETED|Overall Study||605
7599720|NCT02553538|18707129|P2|STARTED|Overall Study||820
7599721|NCT02553538|18707130|P1|STARTED|Overall Study||792
7599722|NCT02553512|18707142|P1|NOT COMPLETED|Overall Study||23
7599723|NCT02553512|18707142|P1|COMPLETED|Overall Study||144
7599724|NCT02553512|18707142|P1|STARTED|Overall Study||167
7599725|NCT02553499|18707164|P14|NOT COMPLETED|Overall Study||2
7599726|NCT02553499|18707165|P13|NOT COMPLETED|Overall Study||3
7599727|NCT02553499|18707166|P12|NOT COMPLETED|Overall Study||3
7599728|NCT02553499|18707167|P11|NOT COMPLETED|Overall Study||3
7599729|NCT02553499|18707168|P10|NOT COMPLETED|Overall Study||3
7599730|NCT02553499|18707169|P9|NOT COMPLETED|Overall Study||3
7599731|NCT02553499|18707170|P8|NOT COMPLETED|Overall Study||3
7599732|NCT02553499|18707171|P7|NOT COMPLETED|Overall Study||3
7599733|NCT02553499|18707172|P6|NOT COMPLETED|Overall Study||3
7599734|NCT02553499|18707173|P5|NOT COMPLETED|Overall Study||3
7599735|NCT02553499|18707174|P4|NOT COMPLETED|Overall Study||2
7599736|NCT02553499|18707175|P3|NOT COMPLETED|Overall Study||2
7599737|NCT02553499|18707176|P2|NOT COMPLETED|Overall Study||2
7599738|NCT02553499|18707177|P1|NOT COMPLETED|Overall Study||2
7599739|NCT02553499|18707164|P14|COMPLETED|Overall Study||0
7599740|NCT02553499|18707165|P13|COMPLETED|Overall Study||0
7599741|NCT02553499|18707166|P12|COMPLETED|Overall Study||0
7599742|NCT02553499|18707167|P11|COMPLETED|Overall Study||0
7599743|NCT02553499|18707168|P10|COMPLETED|Overall Study||0
7599744|NCT02553499|18707169|P9|COMPLETED|Overall Study||0
7599745|NCT02553499|18707170|P8|COMPLETED|Overall Study||0
7599746|NCT02553499|18707171|P7|COMPLETED|Overall Study||0
7599747|NCT02553499|18707172|P6|COMPLETED|Overall Study||0
7599748|NCT02553499|18707173|P5|COMPLETED|Overall Study||0
7599749|NCT02553499|18707174|P4|COMPLETED|Overall Study||0
7599750|NCT02553499|18707175|P3|COMPLETED|Overall Study||0
7599751|NCT02553499|18707176|P2|COMPLETED|Overall Study||0
7599752|NCT02553499|18707177|P1|COMPLETED|Overall Study||0
7599753|NCT02553499|18707164|P14|STARTED|Overall Study||2
7599754|NCT02553499|18707165|P13|STARTED|Overall Study||3
7599755|NCT02553499|18707166|P12|STARTED|Overall Study||3
7599756|NCT02553499|18707167|P11|STARTED|Overall Study||3
7599757|NCT02553499|18707168|P10|STARTED|Overall Study||3
7599758|NCT02553499|18707169|P9|STARTED|Overall Study||3
7599759|NCT02553499|18707170|P8|STARTED|Overall Study||3
7599760|NCT02553499|18707171|P7|STARTED|Overall Study||3
7599761|NCT02553499|18707172|P6|STARTED|Overall Study||3
7599762|NCT02553499|18707173|P5|STARTED|Overall Study||3
7599763|NCT02553499|18707174|P4|STARTED|Overall Study||2
7599764|NCT02553499|18707175|P3|STARTED|Overall Study||2
7599765|NCT02553499|18707176|P2|STARTED|Overall Study||2
7599766|NCT02553499|18707177|P1|STARTED|Overall Study||2
7599767|NCT02553421|18707279|P2|NOT COMPLETED|Overall Study||1
7599768|NCT02553421|18707280|P1|NOT COMPLETED|Overall Study||29
7599769|NCT02553421|18707279|P2|COMPLETED|Overall Study||57
7599770|NCT02553421|18707280|P1|COMPLETED|Overall Study||156
7599771|NCT02553421|18707279|P2|STARTED|Overall Study||58
7599772|NCT02553421|18707280|P1|STARTED|Overall Study||185
7599773|NCT02553395|18707288|P2|NOT COMPLETED|Second Intervention||0
7599774|NCT02553395|18707289|P1|NOT COMPLETED|Second Intervention||0
7599775|NCT02553395|18707288|P2|COMPLETED|Second Intervention||18
7599776|NCT02553395|18707289|P1|COMPLETED|Second Intervention||12
7599777|NCT02553395|18707288|P2|STARTED|Second Intervention||18
7599778|NCT02553395|18707289|P1|STARTED|Second Intervention||12
7599779|NCT02553395|18707288|P2|NOT COMPLETED|First Intervention||0
7599780|NCT02553395|18707289|P1|NOT COMPLETED|First Intervention||0
7599781|NCT02553395|18707288|P2|COMPLETED|First Intervention||18
7599782|NCT02553395|18707289|P1|COMPLETED|First Intervention||12
7599783|NCT02553395|18707288|P2|STARTED|First Intervention||18
7599784|NCT02553395|18707289|P1|STARTED|First Intervention||12
7599785|NCT02553330|18707335|P3|NOT COMPLETED|Overall Study||37
7599786|NCT02553330|18707336|P2|NOT COMPLETED|Overall Study||39
7599787|NCT02553330|18707337|P1|NOT COMPLETED|Overall Study||5
7599788|NCT02553330|18707335|P3|COMPLETED|Overall Study||2
7599789|NCT02553330|18707336|P2|COMPLETED|Overall Study||0
7599790|NCT02553330|18707337|P1|COMPLETED|Overall Study||7
7599791|NCT02553330|18707335|P3|STARTED|Overall Study||39
7599792|NCT02553330|18707336|P2|STARTED|Overall Study||39
7599793|NCT02553330|18707337|P1|STARTED|Overall Study||12
7599794|NCT02553317|18707361|P2|NOT COMPLETED|Open-label (OL) Treatment Period||4
7599795|NCT02553317|18707362|P1|NOT COMPLETED|Open-label (OL) Treatment Period||0
7599796|NCT02553317|18707361|P2|COMPLETED|Open-label (OL) Treatment Period||22
7599797|NCT02553317|18707362|P1|COMPLETED|Open-label (OL) Treatment Period||2
7599798|NCT02553317|18707361|P2|STARTED|Open-label (OL) Treatment Period|26 patients on placebo had a recurrence of TTP during the DB period and started OL treatment.|26
7599799|NCT02553317|18707362|P1|STARTED|Open-label (OL) Treatment Period|2 patients on caplacizumab had a recurrence of TTP during the DB period and started OL treatment.|2
7599800|NCT02553317|18707361|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||8
7599801|NCT02553317|18707362|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||3
7599802|NCT02553317|18707361|P2|COMPLETED|Double-blind (DB) Treatment Period||65
7599803|NCT02553317|18707362|P1|COMPLETED|Double-blind (DB) Treatment Period||68
7599804|NCT02553317|18707361|P2|STARTED|Double-blind (DB) Treatment Period||73
7599805|NCT02553317|18707362|P1|STARTED|Double-blind (DB) Treatment Period|One patient withdrew consent prior to first dosing and did not start the DB treatment period.|71
7599806|NCT02553317|18707361|P2|NOT COMPLETED|Overall Treatment Period + Follow-up||23
7599807|NCT02553317|18707362|P1|NOT COMPLETED|Overall Treatment Period + Follow-up||14
7599808|NCT02553317|18707361|P2|COMPLETED|Overall Treatment Period + Follow-up||50
7599809|NCT02553317|18707362|P1|COMPLETED|Overall Treatment Period + Follow-up||58
7599810|NCT02553317|18707361|P2|Received Study Drug|Overall Treatment Period + Follow-up||73
7599811|NCT02553317|18707362|P1|Received Study Drug|Overall Treatment Period + Follow-up||71
7599812|NCT02553317|18707361|P2|STARTED|Overall Treatment Period + Follow-up||73
7599813|NCT02553317|18707362|P1|STARTED|Overall Treatment Period + Follow-up||72
7599814|NCT02553135|18707385|P1|NOT COMPLETED|Overall Study||0
7599815|NCT02553135|18707385|P1|COMPLETED|Overall Study||6
7599816|NCT02553135|18707385|P1|STARTED|Overall Study||6
7599817|NCT02552966|18707392|P1|NOT COMPLETED|Overall Study||5
7599818|NCT02552966|18707392|P1|COMPLETED|Overall Study||15
7599819|NCT02552966|18707392|P1|STARTED|Overall Study||20
7599820|NCT02552810|18707401|P2|NOT COMPLETED|Overall Study||0
7599821|NCT02552810|18707402|P1|NOT COMPLETED|Overall Study||0
7599822|NCT02552810|18707401|P2|COMPLETED|Overall Study||15
7599823|NCT02552810|18707402|P1|COMPLETED|Overall Study||15
7599824|NCT02552810|18707401|P2|STARTED|Overall Study||15
7599825|NCT02552810|18707402|P1|STARTED|Overall Study||15
7599826|NCT02552732|18707418|P1|NOT COMPLETED|Overall Study||10
7599827|NCT02552732|18707418|P1|COMPLETED|Overall Study||19
7599828|NCT02552732|18707418|P1|Completed Day 1 and Day 31 Spirometry|Overall Study||12
7599829|NCT02552732|18707418|P1|Completed Week 4|Overall Study||19
7599830|NCT02552732|18707418|P1|Completed Week 3|Overall Study||19
7599831|NCT02552732|18707418|P1|Completed Week 2|Overall Study||20
7599832|NCT02552732|18707418|P1|Completed Week 1|Overall Study||21
7599833|NCT02552732|18707418|P1|Used Device|Overall Study||23
7599834|NCT02552732|18707418|P1|STARTED|Overall Study||29
7599835|NCT02552368|18707445|P1|NOT COMPLETED|Overall Study||13
7599836|NCT02552368|18707445|P1|COMPLETED|Overall Study||10
7599837|NCT02552368|18707445|P1|STARTED|Overall Study||23
7599838|NCT02552355|18707454|P4|NOT COMPLETED|Overall Study||1
7599839|NCT02552355|18707455|P3|NOT COMPLETED|Overall Study||2
7599840|NCT02552355|18707456|P2|NOT COMPLETED|Overall Study||2
7599841|NCT02552355|18707457|P1|NOT COMPLETED|Overall Study||0
7599842|NCT02552355|18707454|P4|COMPLETED|Overall Study||14
7599843|NCT02552355|18707455|P3|COMPLETED|Overall Study||12
7599844|NCT02552355|18707456|P2|COMPLETED|Overall Study||11
7599845|NCT02552355|18707457|P1|COMPLETED|Overall Study||14
7599846|NCT02552355|18707454|P4|STARTED|Overall Study||15
7599847|NCT02552355|18707455|P3|STARTED|Overall Study||14
7599848|NCT02552355|18707456|P2|STARTED|Overall Study||13
7599849|NCT02552355|18707457|P1|STARTED|Overall Study||14
7599850|NCT02552316|18707499|P1|NOT COMPLETED|Overall Study||2
7599851|NCT02552316|18707499|P1|COMPLETED|Overall Study||32
7599852|NCT02552316|18707499|P1|STARTED|Overall Study||34
7599853|NCT02552303|18707551|P4|NOT COMPLETED|Follow-Up||0
7599854|NCT02552303|18707552|P3|NOT COMPLETED|Follow-Up||1
7599855|NCT02552303|18707553|P2|NOT COMPLETED|Follow-Up||2
7599856|NCT02552303|18707554|P1|NOT COMPLETED|Follow-Up||0
7599857|NCT02552303|18707551|P4|COMPLETED|Follow-Up||10
7599858|NCT02552303|18707552|P3|COMPLETED|Follow-Up||6
7599859|NCT02552303|18707553|P2|COMPLETED|Follow-Up||6
7599860|NCT02552303|18707554|P1|COMPLETED|Follow-Up||7
7599861|NCT02552303|18707551|P4|STARTED|Follow-Up||10
7599862|NCT02552303|18707552|P3|STARTED|Follow-Up||7
7599863|NCT02552303|18707553|P2|STARTED|Follow-Up||8
7599864|NCT02552303|18707554|P1|STARTED|Follow-Up||7
7599865|NCT02552303|18707551|P4|NOT COMPLETED|Allocation||1
7599866|NCT02552303|18707552|P3|NOT COMPLETED|Allocation||1
7599867|NCT02552303|18707553|P2|NOT COMPLETED|Allocation||2
7599868|NCT02552303|18707554|P1|NOT COMPLETED|Allocation||3
7599869|NCT02552303|18707551|P4|COMPLETED|Allocation||10
7599870|NCT02552303|18707552|P3|COMPLETED|Allocation||7
7599871|NCT02552303|18707553|P2|COMPLETED|Allocation||8
7599872|NCT02552303|18707554|P1|COMPLETED|Allocation||7
7599873|NCT02552303|18707551|P4|STARTED|Allocation||11
7599874|NCT02552303|18707552|P3|STARTED|Allocation||8
7599875|NCT02552303|18707553|P2|STARTED|Allocation||10
7599876|NCT02552303|18707554|P1|STARTED|Allocation||10
7599877|NCT02552238|18707568|P1|NOT COMPLETED|Overall Study||2
7599878|NCT02552238|18707568|P1|COMPLETED|Overall Study||172
7599879|NCT02552238|18707568|P1|STARTED|Overall Study||174
7599880|NCT02552212|18707581|P2|NOT COMPLETED|Overall Study||17
7599881|NCT02552212|18707582|P1|NOT COMPLETED|Overall Study||15
7599882|NCT02552212|18707581|P2|COMPLETED|Overall Study||142
7599883|NCT02552212|18707582|P1|COMPLETED|Overall Study||143
7599884|NCT02552212|18707581|P2|Received OL-CZP|Overall Study||20
7599885|NCT02552212|18707582|P1|Received OL-CZP|Overall Study||96
7599886|NCT02552212|18707581|P2|STARTED|Overall Study||159
7599887|NCT02552212|18707582|P1|STARTED|Overall Study||158
7599888|NCT02552147|18707656|P2|NOT COMPLETED|Second Intervention (7 Days)||0
7599889|NCT02552147|18707657|P1|NOT COMPLETED|Second Intervention (7 Days)||2
7599890|NCT02552147|18707656|P2|COMPLETED|Second Intervention (7 Days)||4
7599891|NCT02552147|18707657|P1|COMPLETED|Second Intervention (7 Days)||1
7599892|NCT02552147|18707656|P2|STARTED|Second Intervention (7 Days)||4
7599893|NCT02552147|18707657|P1|STARTED|Second Intervention (7 Days)||3
7599894|NCT02552147|18707656|P2|NOT COMPLETED|Washout (7 Days)||0
7599895|NCT02552147|18707657|P1|NOT COMPLETED|Washout (7 Days)||0
7599896|NCT02552147|18707656|P2|COMPLETED|Washout (7 Days)||4
7599897|NCT02552147|18707657|P1|COMPLETED|Washout (7 Days)||3
7599898|NCT02552147|18707656|P2|STARTED|Washout (7 Days)||4
7599899|NCT02552147|18707657|P1|STARTED|Washout (7 Days)||3
7599900|NCT02552147|18707656|P2|NOT COMPLETED|First Intervention (7 Days)||0
7599901|NCT02552147|18707657|P1|NOT COMPLETED|First Intervention (7 Days)||1
7599902|NCT02552147|18707656|P2|COMPLETED|First Intervention (7 Days)||4
7599903|NCT02552147|18707657|P1|COMPLETED|First Intervention (7 Days)||3
7599904|NCT02552147|18707656|P2|STARTED|First Intervention (7 Days)||4
7599905|NCT02552147|18707657|P1|STARTED|First Intervention (7 Days)||4
7599906|NCT02552121|18707691|P8|NOT COMPLETED|Part 2: Cohort Expansion||3
7599907|NCT02552121|18707692|P7|NOT COMPLETED|Part 2: Cohort Expansion||1
7599908|NCT02552121|18707693|P6|NOT COMPLETED|Part 2: Cohort Expansion||4
7599909|NCT02552121|18707694|P5|NOT COMPLETED|Part 2: Cohort Expansion||1
7599910|NCT02552121|18707695|P4|NOT COMPLETED|Part 2: Cohort Expansion||3
7599911|NCT02552121|18707696|P3|NOT COMPLETED|Part 2: Cohort Expansion||11
7599912|NCT02552121|18707697|P2|NOT COMPLETED|Part 2: Cohort Expansion||0
7599913|NCT02552121|18707698|P1|NOT COMPLETED|Part 2: Cohort Expansion||0
7599914|NCT02552121|18707691|P8|COMPLETED|Part 2: Cohort Expansion||0
7599915|NCT02552121|18707692|P7|COMPLETED|Part 2: Cohort Expansion||0
7599916|NCT02552121|18707693|P6|COMPLETED|Part 2: Cohort Expansion||1
7599917|NCT02552121|18707694|P5|COMPLETED|Part 2: Cohort Expansion||0
7599918|NCT02552121|18707695|P4|COMPLETED|Part 2: Cohort Expansion||0
7599919|NCT02552121|18707696|P3|COMPLETED|Part 2: Cohort Expansion||0
7599920|NCT02552121|18707697|P2|COMPLETED|Part 2: Cohort Expansion||0
7599921|NCT02552121|18707698|P1|COMPLETED|Part 2: Cohort Expansion||0
7599922|NCT02552121|18707691|P8|STARTED|Part 2: Cohort Expansion||3
7599923|NCT02552121|18707692|P7|STARTED|Part 2: Cohort Expansion||1
7599924|NCT02552121|18707693|P6|STARTED|Part 2: Cohort Expansion||5
7599925|NCT02552121|18707694|P5|STARTED|Part 2: Cohort Expansion||1
7599926|NCT02552121|18707695|P4|STARTED|Part 2: Cohort Expansion||3
7599927|NCT02552121|18707696|P3|STARTED|Part 2: Cohort Expansion||11
7599928|NCT02552121|18707697|P2|STARTED|Part 2: Cohort Expansion||0
7599929|NCT02552121|18707698|P1|STARTED|Part 2: Cohort Expansion||0
7599930|NCT02552121|18707691|P8|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
7599931|NCT02552121|18707692|P7|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
7599932|NCT02552121|18707693|P6|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
7599933|NCT02552121|18707694|P5|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
7599934|NCT02552121|18707695|P4|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
7599935|NCT02552121|18707696|P3|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
7599936|NCT02552121|18707697|P2|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||6
7599937|NCT02552121|18707698|P1|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
7599938|NCT02552121|18707691|P8|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
7599939|NCT02552121|18707692|P7|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
7599940|NCT02552121|18707693|P6|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
7599941|NCT02552121|18707694|P5|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
7599942|NCT02552121|18707695|P4|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
7599943|NCT02552121|18707696|P3|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
7599944|NCT02552121|18707697|P2|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
7599945|NCT02552121|18707698|P1|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
7599946|NCT02552121|18707691|P8|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
7599947|NCT02552121|18707692|P7|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
7599948|NCT02552121|18707693|P6|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
7599949|NCT02552121|18707694|P5|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
7599950|NCT02552121|18707695|P4|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
7599951|NCT02552121|18707696|P3|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
7599952|NCT02552121|18707697|P2|STARTED|Part 1: Dose Level 2 (Week 17-48)||6
7599953|NCT02552121|18707698|P1|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
7599954|NCT02552121|18707691|P8|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599955|NCT02552121|18707692|P7|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599956|NCT02552121|18707693|P6|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599957|NCT02552121|18707694|P5|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599958|NCT02552121|18707695|P4|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599959|NCT02552121|18707696|P3|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599960|NCT02552121|18707697|P2|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599961|NCT02552121|18707698|P1|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||3
7599962|NCT02552121|18707691|P8|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599963|NCT02552121|18707692|P7|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599964|NCT02552121|18707693|P6|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599965|NCT02552121|18707694|P5|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599966|NCT02552121|18707695|P4|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599967|NCT02552121|18707696|P3|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599968|NCT02552121|18707697|P2|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599969|NCT02552121|18707698|P1|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599970|NCT02552121|18707691|P8|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599971|NCT02552121|18707692|P7|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599972|NCT02552121|18707693|P6|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599973|NCT02552121|18707694|P5|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599974|NCT02552121|18707695|P4|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599975|NCT02552121|18707696|P3|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599976|NCT02552121|18707697|P2|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
7599977|NCT02552121|18707698|P1|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||3
7599978|NCT02551887|18707944|P3|NOT COMPLETED|Overall Study||0
7599979|NCT02551887|18707945|P2|NOT COMPLETED|Overall Study||0
7599980|NCT02551887|18707946|P1|NOT COMPLETED|Overall Study||0
7599981|NCT02551887|18707944|P3|COMPLETED|Overall Study||222
7599982|NCT02551887|18707945|P2|COMPLETED|Overall Study||124
7599983|NCT02551887|18707946|P1|COMPLETED|Overall Study||301
7599984|NCT02551887|18707944|P3|STARTED|Overall Study||222
7599985|NCT02551887|18707945|P2|STARTED|Overall Study||124
7599986|NCT02551887|18707946|P1|STARTED|Overall Study||301
7599987|NCT02551874|18707959|P2|NOT COMPLETED|Overall Study||39
7599988|NCT02551874|18707960|P1|NOT COMPLETED|Overall Study||28
7599989|NCT02551874|18707959|P2|COMPLETED|Overall Study||287
7599990|NCT02551874|18707960|P1|COMPLETED|Overall Study||296
7599991|NCT02551874|18707959|P2|Received Treatment in Long-term Study|Overall Study||284
7599992|NCT02551874|18707960|P1|Received Treatment in Long-term Study|Overall Study||295
7599993|NCT02551874|18707959|P2|Entered Long-term Study|Overall Study||294
7599994|NCT02551874|18707960|P1|Entered Long-term Study|Overall Study||306
7599995|NCT02551874|18707959|P2|Received Treatment in Short-term Study|Overall Study||319
7599996|NCT02551874|18707960|P1|Received Treatment in Short-term Study|Overall Study||324
7599997|NCT02551874|18707959|P2|STARTED|Overall Study||326
7599998|NCT02551874|18707960|P1|STARTED|Overall Study||324
7599999|NCT02551822|18707978|P2|NOT COMPLETED|Overall Study||2
7600000|NCT02551822|18707979|P1|NOT COMPLETED|Overall Study||2
7600001|NCT02551822|18707978|P2|COMPLETED|Overall Study||10
7600002|NCT02551822|18707979|P1|COMPLETED|Overall Study||9
7600003|NCT02551822|18707978|P2|STARTED|Overall Study||12
7600004|NCT02551822|18707979|P1|STARTED|Overall Study||11
7600005|NCT02551809|18707992|P3|NOT COMPLETED|Overall Study||1
7600006|NCT02551809|18707993|P2|NOT COMPLETED|Overall Study||1
7600007|NCT02551809|18707994|P1|NOT COMPLETED|Overall Study||0
7600008|NCT02551809|18707992|P3|COMPLETED|Overall Study||13
7600009|NCT02551809|18707993|P2|COMPLETED|Overall Study||14
7600010|NCT02551809|18707994|P1|COMPLETED|Overall Study||14
7600011|NCT02551809|18707992|P3|STARTED|Overall Study||14
7600012|NCT02551809|18707993|P2|STARTED|Overall Study||15
7600013|NCT02551809|18707994|P1|STARTED|Overall Study||14
7600014|NCT02551770|18708002|P2|NOT COMPLETED|Overall Study||3
7600015|NCT02551770|18708003|P1|NOT COMPLETED|Overall Study||3
7600016|NCT02551770|18708002|P2|COMPLETED|Overall Study||48
7600017|NCT02551770|18708003|P1|COMPLETED|Overall Study||48
7600018|NCT02551770|18708002|P2|STARTED|Overall Study||51
7600019|NCT02551770|18708003|P1|STARTED|Overall Study||51
7600020|NCT02551757|18708022|P2|NOT COMPLETED|Overall Study||3
7600021|NCT02551757|18708023|P1|NOT COMPLETED|Overall Study||7
7600022|NCT02551757|18708022|P2|COMPLETED|Overall Study||17
7600023|NCT02551757|18708023|P1|COMPLETED|Overall Study||13
7600024|NCT02551757|18708022|P2|STARTED|Overall Study||20
7600025|NCT02551757|18708023|P1|STARTED|Overall Study||20
7600026|NCT02551744|18708035|P2|NOT COMPLETED|Overall Study||0
7600027|NCT02551744|18708036|P1|NOT COMPLETED|Overall Study||0
7600028|NCT02551744|18708035|P2|COMPLETED|Overall Study||51
7600029|NCT02551744|18708036|P1|COMPLETED|Overall Study||50
7600030|NCT02551744|18708035|P2|STARTED|Overall Study||51
7600031|NCT02551744|18708036|P1|STARTED|Overall Study||50
7600032|NCT02551731|18708042|P1|NOT COMPLETED|Overall Study||2
7600033|NCT02551731|18708042|P1|COMPLETED|Overall Study||7
7600034|NCT02551731|18708042|P1|STARTED|Overall Study||9
7600035|NCT02551692|18708062|P3|NOT COMPLETED|Overall Study||5
7600036|NCT02551692|18708063|P2|NOT COMPLETED|Overall Study||1
7600037|NCT02551692|18708064|P1|NOT COMPLETED|Overall Study||1
7600038|NCT02551692|18708062|P3|COMPLETED|Overall Study||25
7600039|NCT02551692|18708063|P2|COMPLETED|Overall Study||26
7600040|NCT02551692|18708064|P1|COMPLETED|Overall Study||30
7600041|NCT02551692|18708062|P3|STARTED|Overall Study||30
7600042|NCT02551692|18708063|P2|STARTED|Overall Study||27
7600043|NCT02551692|18708064|P1|STARTED|Overall Study||31
7600044|NCT02551666|18708080|P2|NOT COMPLETED|Overall Study||3
7600045|NCT02551666|18708081|P1|NOT COMPLETED|Overall Study||1
7600046|NCT02551666|18708080|P2|COMPLETED|Overall Study||16
7600047|NCT02551666|18708081|P1|COMPLETED|Overall Study||15
7600048|NCT02551666|18708080|P2|STARTED|Overall Study||19
7600049|NCT02551666|18708081|P1|STARTED|Overall Study||16
7600050|NCT02551653|18708109|P2|NOT COMPLETED|Overall Study||0
7600051|NCT02551653|18708110|P1|NOT COMPLETED|Overall Study||0
7600052|NCT02551653|18708109|P2|COMPLETED|Overall Study||5
7600053|NCT02551653|18708110|P1|COMPLETED|Overall Study||5
7600054|NCT02551653|18708109|P2|STARTED|Overall Study||5
7600055|NCT02551653|18708110|P1|STARTED|Overall Study||5
7600056|NCT02551432|18708118|P1|NOT COMPLETED|Overall Study||0
7600057|NCT02551432|18708118|P1|COMPLETED|Overall Study||26
7600058|NCT02551432|18708118|P1|STARTED|Overall Study||26
7600059|NCT02551224|18708124|P2|NOT COMPLETED|Second Intervention (5 Min After First )||0
7600060|NCT02551224|18708125|P1|NOT COMPLETED|Second Intervention (5 Min After First )||0
7600061|NCT02551224|18708124|P2|COMPLETED|Second Intervention (5 Min After First )||50
7600062|NCT02551224|18708125|P1|COMPLETED|Second Intervention (5 Min After First )||50
7600063|NCT02551224|18708124|P2|STARTED|Second Intervention (5 Min After First )||50
7600064|NCT02551224|18708125|P1|STARTED|Second Intervention (5 Min After First )||50
7600065|NCT02551224|18708124|P2|NOT COMPLETED|First Intervention||0
7600066|NCT02551224|18708125|P1|NOT COMPLETED|First Intervention||0
7600067|NCT02551224|18708124|P2|COMPLETED|First Intervention||50
7600068|NCT02551224|18708125|P1|COMPLETED|First Intervention||50
7600069|NCT02551224|18708124|P2|STARTED|First Intervention||50
7600070|NCT02551224|18708125|P1|STARTED|First Intervention||50
7600071|NCT02551094|18708135|P2|NOT COMPLETED|Overall Study||147
7600072|NCT02551094|18708136|P1|NOT COMPLETED|Overall Study||140
7600073|NCT02551094|18708135|P2|COMPLETED|Overall Study||2232
7600074|NCT02551094|18708136|P1|COMPLETED|Overall Study||2226
7600075|NCT02551094|18708135|P2|STARTED|Overall Study||2379
7600076|NCT02551094|18708136|P1|STARTED|Overall Study||2366
7600077|NCT02551055|18708171|P8|NOT COMPLETED|Overall Study||0
7600078|NCT02551055|18708172|P7|NOT COMPLETED|Overall Study||3
7600079|NCT02551055|18708173|P6|NOT COMPLETED|Overall Study||1
7600080|NCT02551055|18708174|P5|NOT COMPLETED|Overall Study||7
7600081|NCT02551055|18708175|P4|NOT COMPLETED|Overall Study||5
7600082|NCT02551055|18708176|P3|NOT COMPLETED|Overall Study||2
7600083|NCT02551055|18708177|P2|NOT COMPLETED|Overall Study||6
7600084|NCT02551055|18708178|P1|NOT COMPLETED|Overall Study||4
7600085|NCT02551055|18708171|P8|COMPLETED|Overall Study||0
7600086|NCT02551055|18708172|P7|COMPLETED|Overall Study||1
7600087|NCT02551055|18708173|P6|COMPLETED|Overall Study||1
7600088|NCT02551055|18708174|P5|COMPLETED|Overall Study||0
7600089|NCT02551055|18708175|P4|COMPLETED|Overall Study||1
7600090|NCT02551055|18708176|P3|COMPLETED|Overall Study||1
7600091|NCT02551055|18708177|P2|COMPLETED|Overall Study||0
7600092|NCT02551055|18708178|P1|COMPLETED|Overall Study||0
7600093|NCT02551055|18708171|P8|STARTED|Overall Study||0
7600094|NCT02551055|18708172|P7|STARTED|Overall Study||4
7600095|NCT02551055|18708173|P6|STARTED|Overall Study||2
7600096|NCT02551055|18708174|P5|STARTED|Overall Study||7
7600097|NCT02551055|18708175|P4|STARTED|Overall Study||6
7600098|NCT02551055|18708176|P3|STARTED|Overall Study||3
7600099|NCT02551055|18708177|P2|STARTED|Overall Study||6
7600100|NCT02551055|18708178|P1|STARTED|Overall Study||4
7600101|NCT02550873|18708253|P3|NOT COMPLETED|Open Label Extension||111
7600102|NCT02550873|18708254|P2|NOT COMPLETED|Open Label Extension||0
7600103|NCT02550873|18708255|P1|NOT COMPLETED|Open Label Extension||0
7600104|NCT02550873|18708253|P3|COMPLETED|Open Label Extension|Open Label extension is ongoing|0
7600105|NCT02550873|18708254|P2|COMPLETED|Open Label Extension||0
7600106|NCT02550873|18708255|P1|COMPLETED|Open Label Extension||0
7600107|NCT02550873|18708253|P3|STARTED|Open Label Extension||111
7600108|NCT02550873|18708254|P2|STARTED|Open Label Extension||0
7600109|NCT02550873|18708255|P1|STARTED|Open Label Extension||0
7600110|NCT02550873|18708253|P3|NOT COMPLETED|Randomized Double Blind||0
7600111|NCT02550873|18708254|P2|NOT COMPLETED|Randomized Double Blind||2
7600112|NCT02550873|18708255|P1|NOT COMPLETED|Randomized Double Blind||4
7600113|NCT02550873|18708253|P3|COMPLETED|Randomized Double Blind||0
7600114|NCT02550873|18708254|P2|COMPLETED|Randomized Double Blind||37
7600115|NCT02550873|18708255|P1|COMPLETED|Randomized Double Blind||74
7600116|NCT02550873|18708253|P3|Continue to Open Label Extension|Randomized Double Blind||0
7600117|NCT02550873|18708254|P2|Continue to Open Label Extension|Randomized Double Blind||37
7600118|NCT02550873|18708255|P1|Continue to Open Label Extension|Randomized Double Blind||74
7600119|NCT02550873|18708253|P3|Received Treatment|Randomized Double Blind||0
7600120|NCT02550873|18708254|P2|Received Treatment|Randomized Double Blind||39
7600121|NCT02550873|18708255|P1|Received Treatment|Randomized Double Blind||77
7600122|NCT02550873|18708253|P3|STARTED|Randomized Double Blind||0
7600123|NCT02550873|18708254|P2|STARTED|Randomized Double Blind||39
7600124|NCT02550873|18708255|P1|STARTED|Randomized Double Blind||78
7600125|NCT02550795|18708336|P3|NOT COMPLETED|Overall Study||0
7600126|NCT02550795|18708337|P2|NOT COMPLETED|Overall Study||1
7600127|NCT02550795|18708338|P1|NOT COMPLETED|Overall Study||0
7600128|NCT02550795|18708336|P3|COMPLETED|Overall Study||50
7600129|NCT02550795|18708337|P2|COMPLETED|Overall Study||49
7600130|NCT02550795|18708338|P1|COMPLETED|Overall Study||50
7600131|NCT02550795|18708336|P3|STARTED|Overall Study||50
7600132|NCT02550795|18708337|P2|STARTED|Overall Study||50
7600133|NCT02550795|18708338|P1|STARTED|Overall Study||50
7600134|NCT02550652|18708354|P2|NOT COMPLETED|Overall Study||62
7600135|NCT02550652|18708355|P1|NOT COMPLETED|Overall Study||63
7600136|NCT02550652|18708354|P2|COMPLETED|Overall Study||0
7600137|NCT02550652|18708355|P1|COMPLETED|Overall Study||0
7600138|NCT02550652|18708354|P2|STARTED|Overall Study||62
7600139|NCT02550652|18708355|P1|STARTED|Overall Study||63
7600140|NCT02550288|18708402|P5|NOT COMPLETED|Overall Study||3
7600141|NCT02550288|18708403|P4|NOT COMPLETED|Overall Study||3
7600142|NCT02550288|18708404|P3|NOT COMPLETED|Overall Study||1
7600143|NCT02550288|18708405|P2|NOT COMPLETED|Overall Study||3
7600144|NCT02550288|18708406|P1|NOT COMPLETED|Overall Study||2
7600145|NCT02550288|18708402|P5|COMPLETED|Overall Study||66
7600146|NCT02550288|18708403|P4|COMPLETED|Overall Study||65
7600147|NCT02550288|18708404|P3|COMPLETED|Overall Study||68
7600148|NCT02550288|18708405|P2|COMPLETED|Overall Study||65
7600149|NCT02550288|18708406|P1|COMPLETED|Overall Study||33
7600150|NCT02550288|18708402|P5|STARTED|Overall Study||69
7600151|NCT02550288|18708403|P4|STARTED|Overall Study||68
7600152|NCT02550288|18708404|P3|STARTED|Overall Study||69
7600153|NCT02550288|18708405|P2|STARTED|Overall Study||68
7600154|NCT02550288|18708406|P1|STARTED|Overall Study||35
7600155|NCT02550210|18708503|P1|NOT COMPLETED|Overall Study||4
7600156|NCT02550210|18708503|P1|COMPLETED|Overall Study||19
7600157|NCT02550210|18708503|P1|STARTED|Overall Study||23
7600158|NCT02550197|18708512|P2|NOT COMPLETED|Overall Study||0
7600159|NCT02550197|18708513|P1|NOT COMPLETED|Overall Study||0
7600160|NCT02550197|18708512|P2|COMPLETED|Overall Study||100
7600161|NCT02550197|18708513|P1|COMPLETED|Overall Study||200
7600162|NCT02550197|18708512|P2|STARTED|Overall Study||100
7600163|NCT02550197|18708513|P1|STARTED|Overall Study||200
7600164|NCT02550132|18708531|P1|NOT COMPLETED|Overall Study||0
7600165|NCT02550132|18708531|P1|COMPLETED|Overall Study||25
7600166|NCT02550132|18708531|P1|STARTED|Overall Study||25
7600167|NCT02550106|18708562|P1|NOT COMPLETED|Overall Study||12
7600168|NCT02550106|18708562|P1|COMPLETED|Overall Study||124
7600169|NCT02550106|18708562|P1|STARTED|Overall Study||136
7600170|NCT02549859|18708586|P1|NOT COMPLETED|Visit 2||0
7600171|NCT02549859|18708586|P1|COMPLETED|Visit 2||10
7600172|NCT02549859|18708586|P1|STARTED|Visit 2||10
7600173|NCT02549859|18708586|P1|NOT COMPLETED|Long-term 60 Hz DBS||1
7600174|NCT02549859|18708586|P1|COMPLETED|Long-term 60 Hz DBS||10
7600175|NCT02549859|18708586|P1|STARTED|Long-term 60 Hz DBS||11
7600176|NCT02549859|18708586|P1|NOT COMPLETED|Visit 1||0
7600177|NCT02549859|18708586|P1|COMPLETED|Visit 1||11
7600178|NCT02549859|18708586|P1|STARTED|Visit 1||11
7600179|NCT02549755|18708651|P1|NOT COMPLETED|Overall Study||1
7600180|NCT02549755|18708651|P1|COMPLETED|Overall Study||0
7600181|NCT02549755|18708651|P1|STARTED|Overall Study||1
7600182|NCT02549716|18708657|P2|NOT COMPLETED|Overall Study||0
7600183|NCT02549716|18708658|P1|NOT COMPLETED|Overall Study||0
7600184|NCT02549716|18708657|P2|COMPLETED|Overall Study||2
7600185|NCT02549716|18708658|P1|COMPLETED|Overall Study||1
7600186|NCT02549716|18708657|P2|STARTED|Overall Study||2
7600187|NCT02549716|18708658|P1|STARTED|Overall Study||1
7600188|NCT02549573|18708672|P2|NOT COMPLETED|Overall Study||3
7600189|NCT02549573|18708673|P1|NOT COMPLETED|Overall Study||0
7600190|NCT02549573|18708672|P2|COMPLETED|Overall Study||4
7600191|NCT02549573|18708673|P1|COMPLETED|Overall Study||6
7600192|NCT02549573|18708672|P2|STARTED|Overall Study||7
7600193|NCT02549573|18708673|P1|STARTED|Overall Study||6
7600194|NCT02549508|18708717|P2|NOT COMPLETED|Overall Study||17
7600195|NCT02549508|18708718|P1|NOT COMPLETED|Overall Study||14
7600196|NCT02549508|18708717|P2|COMPLETED|Overall Study||21
7600197|NCT02549508|18708718|P1|COMPLETED|Overall Study||33
7600198|NCT02549508|18708717|P2|STARTED|Overall Study||38
7600199|NCT02549508|18708718|P1|STARTED|Overall Study||47
7600200|NCT02549365|18708730|P2|NOT COMPLETED|Overall Study||0
7600201|NCT02549365|18708731|P1|NOT COMPLETED|Overall Study||0
7600202|NCT02549365|18708730|P2|COMPLETED|Overall Study||112
7600203|NCT02549365|18708731|P1|COMPLETED|Overall Study||164
7600204|NCT02549365|18708730|P2|STARTED|Overall Study||112
7600205|NCT02549365|18708731|P1|STARTED|Overall Study||164
7600206|NCT02549352|18708740|P2|NOT COMPLETED|12-month Follow-up||12
7600207|NCT02549352|18708741|P1|NOT COMPLETED|12-month Follow-up||8
7600208|NCT02549352|18708740|P2|COMPLETED|12-month Follow-up||81
7600209|NCT02549352|18708741|P1|COMPLETED|12-month Follow-up||199
7600210|NCT02549352|18708740|P2|STARTED|12-month Follow-up||93
7600211|NCT02549352|18708741|P1|STARTED|12-month Follow-up||207
7600212|NCT02549352|18708740|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||6
7600213|NCT02549352|18708741|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
7600214|NCT02549352|18708740|P2|COMPLETED|3-day Treatment and 8-week Follow-up||96
7600215|NCT02549352|18708741|P1|COMPLETED|3-day Treatment and 8-week Follow-up||207
7600216|NCT02549352|18708740|P2|Treated|3-day Treatment and 8-week Follow-up|1 participant was included in 0.037% in the safety analysis set as they received both IMPs in error|101
7600217|NCT02549352|18708741|P1|Treated|3-day Treatment and 8-week Follow-up||209
7600218|NCT02549352|18708740|P2|STARTED|3-day Treatment and 8-week Follow-up||102
7600219|NCT02549352|18708741|P1|STARTED|3-day Treatment and 8-week Follow-up||209
7600220|NCT02549339|18708757|P2|NOT COMPLETED|12-month Follow-up||11
7600221|NCT02549339|18708758|P1|NOT COMPLETED|12-month Follow-up||9
7600222|NCT02549339|18708757|P2|COMPLETED|12-month Follow-up||87
7600223|NCT02549339|18708758|P1|COMPLETED|12-month Follow-up||192
7600224|NCT02549339|18708757|P2|STARTED|12-month Follow-up||98
7600225|NCT02549339|18708758|P1|STARTED|12-month Follow-up||201
7600226|NCT02549339|18708757|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||5
7600227|NCT02549339|18708758|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
7600228|NCT02549339|18708757|P2|COMPLETED|3-day Treatment and 8-week Follow-up||99
7600229|NCT02549339|18708758|P1|COMPLETED|3-day Treatment and 8-week Follow-up||201
7600230|NCT02549339|18708757|P2|Treated|3-day Treatment and 8-week Follow-up||104
7600231|NCT02549339|18708758|P1|Treated|3-day Treatment and 8-week Follow-up||202
7600232|NCT02549339|18708757|P2|STARTED|3-day Treatment and 8-week Follow-up||104
7600233|NCT02549339|18708758|P1|STARTED|3-day Treatment and 8-week Follow-up||205
7600234|NCT02549287|18708774|P2|NOT COMPLETED|Overall Study||32
7600235|NCT02549287|18708775|P1|NOT COMPLETED|Overall Study||80
7600236|NCT02549287|18708774|P2|COMPLETED|Overall Study||64
7600237|NCT02549287|18708775|P1|COMPLETED|Overall Study||113
7600238|NCT02549287|18708774|P2|STARTED|Overall Study||96
7600239|NCT02549287|18708775|P1|STARTED|Overall Study||193
7600240|NCT02549196|18708809|P4|NOT COMPLETED|Overall Study||1
7600241|NCT02549196|18708810|P3|NOT COMPLETED|Overall Study||1
7600242|NCT02549196|18708811|P2|NOT COMPLETED|Overall Study||0
7600243|NCT02549196|18708812|P1|NOT COMPLETED|Overall Study||1
7600244|NCT02549196|18708809|P4|COMPLETED|Overall Study||12
7600245|NCT02549196|18708810|P3|COMPLETED|Overall Study||5
7600246|NCT02549196|18708811|P2|COMPLETED|Overall Study||1
7600247|NCT02549196|18708812|P1|COMPLETED|Overall Study||7
7600248|NCT02549196|18708809|P4|STARTED|Overall Study||13
7600249|NCT02549196|18708810|P3|STARTED|Overall Study||6
7600250|NCT02549196|18708811|P2|STARTED|Overall Study||1
7600251|NCT02549196|18708812|P1|STARTED|Overall Study||8
7600252|NCT02549040|18708826|P1|NOT COMPLETED|Period 5||0
7600253|NCT02549040|18708826|P1|COMPLETED|Period 5||16
7600254|NCT02549040|18708826|P1|STARTED|Period 5||16
7600255|NCT02549040|18708826|P1|NOT COMPLETED|Period 4||0
7600256|NCT02549040|18708826|P1|COMPLETED|Period 4||16
7600257|NCT02549040|18708826|P1|STARTED|Period 4||16
7600258|NCT02549040|18708826|P1|NOT COMPLETED|Period 3||0
7600259|NCT02549040|18708826|P1|COMPLETED|Period 3||16
7600260|NCT02549040|18708826|P1|STARTED|Period 3||16
7600261|NCT02549040|18708826|P1|NOT COMPLETED|Period 2||0
7600262|NCT02549040|18708826|P1|COMPLETED|Period 2||16
7600263|NCT02549040|18708826|P1|STARTED|Period 2||16
7600264|NCT02549040|18708826|P1|NOT COMPLETED|Period 1||0
7600265|NCT02549040|18708826|P1|COMPLETED|Period 1||16
7600266|NCT02549040|18708826|P1|STARTED|Period 1||16
7600267|NCT02549027|18708868|P6|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
7600268|NCT02549027|18708869|P5|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2
7600269|NCT02549027|18708870|P4|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
7600270|NCT02549027|18708871|P3|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
7600271|NCT02549027|18708872|P2|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
7600272|NCT02549027|18708873|P1|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
7600273|NCT02549027|18708868|P6|COMPLETED|Period 5 - MK-6096 or Placebo||1
7600274|NCT02549027|18708869|P5|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14
7600275|NCT02549027|18708870|P4|COMPLETED|Period 5 - MK-6096 or Placebo||0
7600276|NCT02549027|18708871|P3|COMPLETED|Period 5 - MK-6096 or Placebo||0
7600277|NCT02549027|18708872|P2|COMPLETED|Period 5 - MK-6096 or Placebo||0
7600278|NCT02549027|18708873|P1|COMPLETED|Period 5 - MK-6096 or Placebo||0
7600279|NCT02549027|18708868|P6|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1
7600280|NCT02549027|18708869|P5|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16
7600281|NCT02549027|18708870|P4|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
7600282|NCT02549027|18708871|P3|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
7600283|NCT02549027|18708872|P2|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
7600284|NCT02549027|18708873|P1|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0
7600285|NCT02549027|18708868|P6|NOT COMPLETED|Washout After Period 4||0
7600286|NCT02549027|18708869|P5|NOT COMPLETED|Washout After Period 4||0
7600287|NCT02549027|18708870|P4|NOT COMPLETED|Washout After Period 4||1
7600288|NCT02549027|18708871|P3|NOT COMPLETED|Washout After Period 4||1
7600289|NCT02549027|18708872|P2|NOT COMPLETED|Washout After Period 4||1
7600290|NCT02549027|18708873|P1|NOT COMPLETED|Washout After Period 4||0
7600291|NCT02549027|18708868|P6|COMPLETED|Washout After Period 4||0
7600292|NCT02549027|18708869|P5|COMPLETED|Washout After Period 4||0
7600293|NCT02549027|18708870|P4|COMPLETED|Washout After Period 4||4
7600294|NCT02549027|18708871|P3|COMPLETED|Washout After Period 4||4
7600295|NCT02549027|18708872|P2|COMPLETED|Washout After Period 4||4
7600296|NCT02549027|18708873|P1|COMPLETED|Washout After Period 4||5
7600297|NCT02549027|18708868|P6|STARTED|Washout After Period 4||0
7600298|NCT02549027|18708869|P5|STARTED|Washout After Period 4||0
7600299|NCT02549027|18708870|P4|STARTED|Washout After Period 4||5
7600300|NCT02549027|18708871|P3|STARTED|Washout After Period 4||5
7600301|NCT02549027|18708872|P2|STARTED|Washout After Period 4||5
7600302|NCT02549027|18708873|P1|STARTED|Washout After Period 4||5
7600303|NCT02549027|18708868|P6|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
7600304|NCT02549027|18708869|P5|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
7600305|NCT02549027|18708870|P4|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
7600306|NCT02549027|18708871|P3|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
7600307|NCT02549027|18708872|P2|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
7600308|NCT02549027|18708873|P1|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
7600309|NCT02549027|18708868|P6|COMPLETED|Period 4 - MK-1064 or Placebo||0
7600310|NCT02549027|18708869|P5|COMPLETED|Period 4 - MK-1064 or Placebo||0
7600311|NCT02549027|18708870|P4|COMPLETED|Period 4 - MK-1064 or Placebo||5
7600312|NCT02549027|18708871|P3|COMPLETED|Period 4 - MK-1064 or Placebo||5
7600313|NCT02549027|18708872|P2|COMPLETED|Period 4 - MK-1064 or Placebo||5
7600314|NCT02549027|18708873|P1|COMPLETED|Period 4 - MK-1064 or Placebo||5
7600315|NCT02549027|18708868|P6|STARTED|Period 4 - MK-1064 or Placebo||0
7600316|NCT02549027|18708869|P5|STARTED|Period 4 - MK-1064 or Placebo||0
7600317|NCT02549027|18708870|P4|STARTED|Period 4 - MK-1064 or Placebo||5
7600318|NCT02549027|18708871|P3|STARTED|Period 4 - MK-1064 or Placebo||5
7600319|NCT02549027|18708872|P2|STARTED|Period 4 - MK-1064 or Placebo||5
7600320|NCT02549027|18708873|P1|STARTED|Period 4 - MK-1064 or Placebo||5
7600321|NCT02549027|18708868|P6|NOT COMPLETED|Washout After Period 3||0
7600322|NCT02549027|18708869|P5|NOT COMPLETED|Washout After Period 3||0
7600323|NCT02549027|18708870|P4|NOT COMPLETED|Washout After Period 3||0
7600324|NCT02549027|18708871|P3|NOT COMPLETED|Washout After Period 3||0
7600325|NCT02549027|18708872|P2|NOT COMPLETED|Washout After Period 3||0
7600326|NCT02549027|18708873|P1|NOT COMPLETED|Washout After Period 3||0
7600327|NCT02549027|18708868|P6|COMPLETED|Washout After Period 3||0
7600328|NCT02549027|18708869|P5|COMPLETED|Washout After Period 3||0
7600329|NCT02549027|18708870|P4|COMPLETED|Washout After Period 3||5
7600330|NCT02549027|18708871|P3|COMPLETED|Washout After Period 3||5
7600331|NCT02549027|18708872|P2|COMPLETED|Washout After Period 3||5
7600332|NCT02549027|18708873|P1|COMPLETED|Washout After Period 3||5
7600333|NCT02549027|18708868|P6|STARTED|Washout After Period 3||0
7600334|NCT02549027|18708869|P5|STARTED|Washout After Period 3||0
7600335|NCT02549027|18708870|P4|STARTED|Washout After Period 3||5
7600336|NCT02549027|18708871|P3|STARTED|Washout After Period 3||5
7600337|NCT02549027|18708872|P2|STARTED|Washout After Period 3||5
7600338|NCT02549027|18708873|P1|STARTED|Washout After Period 3||5
7600339|NCT02549027|18708868|P6|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
7600340|NCT02549027|18708869|P5|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
7600341|NCT02549027|18708870|P4|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
7600342|NCT02549027|18708871|P3|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
7600343|NCT02549027|18708872|P2|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
7600344|NCT02549027|18708873|P1|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
7600345|NCT02549027|18708868|P6|COMPLETED|Period 3 - MK-1064 or Placebo||0
7600346|NCT02549027|18708869|P5|COMPLETED|Period 3 - MK-1064 or Placebo||0
7600347|NCT02549027|18708870|P4|COMPLETED|Period 3 - MK-1064 or Placebo||5
7600348|NCT02549027|18708871|P3|COMPLETED|Period 3 - MK-1064 or Placebo||5
7600349|NCT02549027|18708872|P2|COMPLETED|Period 3 - MK-1064 or Placebo||5
7600350|NCT02549027|18708873|P1|COMPLETED|Period 3 - MK-1064 or Placebo||5
7600351|NCT02549027|18708868|P6|STARTED|Period 3 - MK-1064 or Placebo||0
7600352|NCT02549027|18708869|P5|STARTED|Period 3 - MK-1064 or Placebo||0
7600353|NCT02549027|18708870|P4|STARTED|Period 3 - MK-1064 or Placebo||5
7600354|NCT02549027|18708871|P3|STARTED|Period 3 - MK-1064 or Placebo||5
7600355|NCT02549027|18708872|P2|STARTED|Period 3 - MK-1064 or Placebo||5
7600356|NCT02549027|18708873|P1|STARTED|Period 3 - MK-1064 or Placebo||5
7600357|NCT02549027|18708868|P6|NOT COMPLETED|Washout After Period 2||0
7600358|NCT02549027|18708869|P5|NOT COMPLETED|Washout After Period 2||0
7600359|NCT02549027|18708870|P4|NOT COMPLETED|Washout After Period 2||0
7600360|NCT02549027|18708871|P3|NOT COMPLETED|Washout After Period 2||0
7600361|NCT02549027|18708872|P2|NOT COMPLETED|Washout After Period 2||0
7600362|NCT02549027|18708873|P1|NOT COMPLETED|Washout After Period 2||0
7600363|NCT02549027|18708868|P6|COMPLETED|Washout After Period 2||0
7600364|NCT02549027|18708869|P5|COMPLETED|Washout After Period 2||0
7600365|NCT02549027|18708870|P4|COMPLETED|Washout After Period 2||5
7600366|NCT02549027|18708871|P3|COMPLETED|Washout After Period 2||5
7600367|NCT02549027|18708872|P2|COMPLETED|Washout After Period 2||5
7600368|NCT02549027|18708873|P1|COMPLETED|Washout After Period 2||5
7600369|NCT02549027|18708868|P6|STARTED|Washout After Period 2||0
7600370|NCT02549027|18708869|P5|STARTED|Washout After Period 2||0
7600371|NCT02549027|18708870|P4|STARTED|Washout After Period 2||5
7600372|NCT02549027|18708871|P3|STARTED|Washout After Period 2||5
7600373|NCT02549027|18708872|P2|STARTED|Washout After Period 2||5
7600374|NCT02549027|18708873|P1|STARTED|Washout After Period 2||5
7600375|NCT02549027|18708868|P6|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
7600376|NCT02549027|18708869|P5|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
7600377|NCT02549027|18708870|P4|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
7600378|NCT02549027|18708871|P3|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
7600379|NCT02549027|18708872|P2|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
7600380|NCT02549027|18708873|P1|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
7600381|NCT02549027|18708868|P6|COMPLETED|Period 2 - MK-1064 or Placebo||0
7600382|NCT02549027|18708869|P5|COMPLETED|Period 2 - MK-1064 or Placebo||0
7600383|NCT02549027|18708870|P4|COMPLETED|Period 2 - MK-1064 or Placebo||5
7600384|NCT02549027|18708871|P3|COMPLETED|Period 2 - MK-1064 or Placebo||5
7600385|NCT02549027|18708872|P2|COMPLETED|Period 2 - MK-1064 or Placebo||5
7600386|NCT02549027|18708873|P1|COMPLETED|Period 2 - MK-1064 or Placebo||5
7600387|NCT02549027|18708868|P6|STARTED|Period 2 - MK-1064 or Placebo||0
7600388|NCT02549027|18708869|P5|STARTED|Period 2 - MK-1064 or Placebo||0
7600389|NCT02549027|18708870|P4|STARTED|Period 2 - MK-1064 or Placebo||5
7600390|NCT02549027|18708871|P3|STARTED|Period 2 - MK-1064 or Placebo||5
7600391|NCT02549027|18708872|P2|STARTED|Period 2 - MK-1064 or Placebo||5
7600392|NCT02549027|18708873|P1|STARTED|Period 2 - MK-1064 or Placebo||5
7600393|NCT02549027|18708868|P6|NOT COMPLETED|Washout After Period 1||0
7600394|NCT02549027|18708869|P5|NOT COMPLETED|Washout After Period 1||0
7600395|NCT02549027|18708870|P4|NOT COMPLETED|Washout After Period 1||0
7600396|NCT02549027|18708871|P3|NOT COMPLETED|Washout After Period 1||0
7600397|NCT02549027|18708872|P2|NOT COMPLETED|Washout After Period 1||0
7600398|NCT02549027|18708873|P1|NOT COMPLETED|Washout After Period 1||0
7600399|NCT02549027|18708868|P6|COMPLETED|Washout After Period 1||0
7600400|NCT02549027|18708869|P5|COMPLETED|Washout After Period 1||0
7600401|NCT02549027|18708870|P4|COMPLETED|Washout After Period 1||5
7600402|NCT02549027|18708871|P3|COMPLETED|Washout After Period 1||5
7600403|NCT02549027|18708872|P2|COMPLETED|Washout After Period 1||5
7600404|NCT02549027|18708873|P1|COMPLETED|Washout After Period 1||5
7600405|NCT02549027|18708868|P6|STARTED|Washout After Period 1||0
7600406|NCT02549027|18708869|P5|STARTED|Washout After Period 1||0
7600407|NCT02549027|18708870|P4|STARTED|Washout After Period 1||5
7600408|NCT02549027|18708871|P3|STARTED|Washout After Period 1||5
7600409|NCT02549027|18708872|P2|STARTED|Washout After Period 1||5
7600410|NCT02549027|18708873|P1|STARTED|Washout After Period 1||5
7600411|NCT02549027|18708868|P6|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
7600412|NCT02549027|18708869|P5|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
7600413|NCT02549027|18708870|P4|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
7600414|NCT02549027|18708871|P3|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
7600415|NCT02549027|18708872|P2|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
7600416|NCT02549027|18708873|P1|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
7600417|NCT02549027|18708868|P6|COMPLETED|Period 1 - MK-1064 or Placebo||0
7600418|NCT02549027|18708869|P5|COMPLETED|Period 1 - MK-1064 or Placebo||0
7600419|NCT02549027|18708870|P4|COMPLETED|Period 1 - MK-1064 or Placebo||5
7600420|NCT02549027|18708871|P3|COMPLETED|Period 1 - MK-1064 or Placebo||5
7600421|NCT02549027|18708872|P2|COMPLETED|Period 1 - MK-1064 or Placebo||5
7600422|NCT02549027|18708873|P1|COMPLETED|Period 1 - MK-1064 or Placebo||5
7600423|NCT02549027|18708868|P6|STARTED|Period 1 - MK-1064 or Placebo||0
7600424|NCT02549027|18708869|P5|STARTED|Period 1 - MK-1064 or Placebo||0
7600425|NCT02549027|18708870|P4|STARTED|Period 1 - MK-1064 or Placebo||5
7600426|NCT02549027|18708871|P3|STARTED|Period 1 - MK-1064 or Placebo||5
7600427|NCT02549027|18708872|P2|STARTED|Period 1 - MK-1064 or Placebo||5
7600428|NCT02549027|18708873|P1|STARTED|Period 1 - MK-1064 or Placebo||5
7600429|NCT02549014|18708910|P2|NOT COMPLETED|Overall Study||0
7600430|NCT02549014|18708911|P1|NOT COMPLETED|Overall Study||0
7600431|NCT02549014|18708910|P2|COMPLETED|Overall Study||8
7600432|NCT02549014|18708911|P1|COMPLETED|Overall Study||8
7600433|NCT02549014|18708910|P2|STARTED|Overall Study||8
7600434|NCT02549014|18708911|P1|STARTED|Overall Study||8
7600435|NCT02548962|18709003|P2|NOT COMPLETED|Overall Study||0
7600436|NCT02548962|18709004|P1|NOT COMPLETED|Overall Study||1
7600437|NCT02548962|18709003|P2|COMPLETED|Overall Study||3
7600438|NCT02548962|18709004|P1|COMPLETED|Overall Study||7
7600439|NCT02548962|18709003|P2|STARTED|Overall Study||3
7600440|NCT02548962|18709004|P1|STARTED|Overall Study||8
7600441|NCT02548845|18709014|P1|NOT COMPLETED|Overall Study||0
7600442|NCT02548845|18709014|P1|COMPLETED|Overall Study||70
7600443|NCT02548845|18709014|P1|STARTED|Overall Study||70
7600444|NCT02548754|18709028|P2|NOT COMPLETED|Overall Study||4
7600445|NCT02548754|18709029|P1|NOT COMPLETED|Overall Study||2
7600446|NCT02548754|18709028|P2|COMPLETED|Overall Study||23
7600447|NCT02548754|18709029|P1|COMPLETED|Overall Study||24
7600448|NCT02548754|18709028|P2|STARTED|Overall Study||27
7600449|NCT02548754|18709029|P1|STARTED|Overall Study||26
7600450|NCT02548728|18709041|P2|NOT COMPLETED|Overall Study||0
7600451|NCT02548728|18709042|P1|NOT COMPLETED|Overall Study||0
7600452|NCT02548728|18709041|P2|COMPLETED|Overall Study||6
7600453|NCT02548728|18709042|P1|COMPLETED|Overall Study||6
7600454|NCT02548728|18709041|P2|STARTED|Overall Study||6
7600455|NCT02548728|18709042|P1|STARTED|Overall Study||6
7600456|NCT02548650|18709056|P2|NOT COMPLETED|Double Therapy||2
7600457|NCT02548650|18709057|P1|NOT COMPLETED|Double Therapy||1
7600458|NCT02548650|18709056|P2|COMPLETED|Double Therapy||30
7600459|NCT02548650|18709057|P1|COMPLETED|Double Therapy||28
7600460|NCT02548650|18709056|P2|STARTED|Double Therapy||32
7600461|NCT02548650|18709057|P1|STARTED|Double Therapy||29
7600462|NCT02548650|18709056|P2|NOT COMPLETED|Triple Therapy||4
7600463|NCT02548650|18709057|P1|NOT COMPLETED|Triple Therapy||1
7600464|NCT02548650|18709056|P2|COMPLETED|Triple Therapy||32
7600465|NCT02548650|18709057|P1|COMPLETED|Triple Therapy||29
7600466|NCT02548650|18709056|P2|STARTED|Triple Therapy||36
7600467|NCT02548650|18709057|P1|STARTED|Triple Therapy||30
7600468|NCT02548585|18709072|P7|NOT COMPLETED|Overall Study||1
7600469|NCT02548585|18709073|P6|NOT COMPLETED|Overall Study||2
7600470|NCT02548585|18709074|P5|NOT COMPLETED|Overall Study||3
7600471|NCT02548585|18709075|P4|NOT COMPLETED|Overall Study||2
7600472|NCT02548585|18709076|P3|NOT COMPLETED|Overall Study||0
7600473|NCT02548585|18709077|P2|NOT COMPLETED|Overall Study||0
7600474|NCT02548585|18709078|P1|NOT COMPLETED|Overall Study||2
7600475|NCT02548585|18709072|P7|COMPLETED|Overall Study||11
7600476|NCT02548585|18709073|P6|COMPLETED|Overall Study||10
7600477|NCT02548585|18709074|P5|COMPLETED|Overall Study||22
7600478|NCT02548585|18709075|P4|COMPLETED|Overall Study||5
7600479|NCT02548585|18709076|P3|COMPLETED|Overall Study||6
7600480|NCT02548585|18709077|P2|COMPLETED|Overall Study||6
7600481|NCT02548585|18709078|P1|COMPLETED|Overall Study||43
7600482|NCT02548585|18709072|P7|Treated|Overall Study||12
7600483|NCT02548585|18709073|P6|Treated|Overall Study||11
7600484|NCT02548585|18709074|P5|Treated|Overall Study||25
7600485|NCT02548585|18709075|P4|Treated|Overall Study||7
7600486|NCT02548585|18709076|P3|Treated|Overall Study||6
7600487|NCT02548585|18709077|P2|Treated|Overall Study||6
7600488|NCT02548585|18709078|P1|Treated|Overall Study||45
7600489|NCT02548585|18709072|P7|STARTED|Overall Study||12
7600490|NCT02548585|18709073|P6|STARTED|Overall Study||12
7600491|NCT02548585|18709074|P5|STARTED|Overall Study||25
7600492|NCT02548585|18709075|P4|STARTED|Overall Study||7
7600493|NCT02548585|18709076|P3|STARTED|Overall Study||6
7600494|NCT02548585|18709077|P2|STARTED|Overall Study||6
7600495|NCT02548585|18709078|P1|STARTED|Overall Study||45
7600496|NCT02548455|18709296|P1|NOT COMPLETED|Overall Study||240
7600497|NCT02548455|18709296|P1|COMPLETED|Overall Study|Completed 6-Month Follow-up|259
7600498|NCT02548455|18709296|P1|Completed 12-Month Follow-up|Overall Study|Study completed prior to all subjects reaching the 6- and 12-month visits.|61
7600499|NCT02548455|18709296|P1|Completed 6-Month Follow-up|Overall Study||259
7600500|NCT02548455|18709296|P1|Completed Pre-Discharge|Overall Study||484
7600501|NCT02548455|18709296|P1|STARTED|Overall Study|A total of 499 subjects were enrolled at 31 investigational sites.|499
7600502|NCT02548312|18709308|P8|NOT COMPLETED|Overall Study||42
7600503|NCT02548312|18709309|P7|NOT COMPLETED|Overall Study||40
7600504|NCT02548312|18709310|P6|NOT COMPLETED|Overall Study||40
7600505|NCT02548312|18709311|P5|NOT COMPLETED|Overall Study||34
7600506|NCT02548312|18709312|P4|NOT COMPLETED|Overall Study||46
7600507|NCT02548312|18709313|P3|NOT COMPLETED|Overall Study||38
7600508|NCT02548312|18709314|P2|NOT COMPLETED|Overall Study||43
7600509|NCT02548312|18709315|P1|NOT COMPLETED|Overall Study||33
7600510|NCT02548312|18709308|P8|COMPLETED|Overall Study||91
7600511|NCT02548312|18709309|P7|COMPLETED|Overall Study||93
7600512|NCT02548312|18709310|P6|COMPLETED|Overall Study||93
7600513|NCT02548312|18709311|P5|COMPLETED|Overall Study||99
7600514|NCT02548312|18709312|P4|COMPLETED|Overall Study||87
7600515|NCT02548312|18709313|P3|COMPLETED|Overall Study||96
7600516|NCT02548312|18709314|P2|COMPLETED|Overall Study||90
7600517|NCT02548312|18709315|P1|COMPLETED|Overall Study||100
7600518|NCT02548312|18709308|P8|STARTED|Overall Study||133
7600519|NCT02548312|18709309|P7|STARTED|Overall Study||133
7600520|NCT02548312|18709310|P6|STARTED|Overall Study||133
7600521|NCT02548312|18709311|P5|STARTED|Overall Study||133
7600522|NCT02548312|18709312|P4|STARTED|Overall Study||133
7600523|NCT02548312|18709313|P3|STARTED|Overall Study||134
7600524|NCT02548312|18709314|P2|STARTED|Overall Study||133
7600525|NCT02548312|18709315|P1|STARTED|Overall Study||133
7600526|NCT02548156|18709357|P6|NOT COMPLETED|Period 3||0
7600527|NCT02548156|18709358|P5|NOT COMPLETED|Period 3||0
7600528|NCT02548156|18709359|P4|NOT COMPLETED|Period 3||0
7600529|NCT02548156|18709360|P3|NOT COMPLETED|Period 3||0
7600530|NCT02548156|18709361|P2|NOT COMPLETED|Period 3||0
7600531|NCT02548156|18709362|P1|NOT COMPLETED|Period 3||0
7600532|NCT02548156|18709357|P6|COMPLETED|Period 3||5
7600533|NCT02548156|18709358|P5|COMPLETED|Period 3||4
7600534|NCT02548156|18709359|P4|COMPLETED|Period 3||5
7600535|NCT02548156|18709360|P3|COMPLETED|Period 3||4
7600536|NCT02548156|18709361|P2|COMPLETED|Period 3||5
7600537|NCT02548156|18709362|P1|COMPLETED|Period 3||5
7600538|NCT02548156|18709357|P6|STARTED|Period 3||5
7600539|NCT02548156|18709358|P5|STARTED|Period 3||4
7600540|NCT02548156|18709359|P4|STARTED|Period 3||5
7600541|NCT02548156|18709360|P3|STARTED|Period 3||4
7600542|NCT02548156|18709361|P2|STARTED|Period 3||5
7600543|NCT02548156|18709362|P1|STARTED|Period 3||5
7600544|NCT02548156|18709357|P6|NOT COMPLETED|Washout Period 2||0
7600545|NCT02548156|18709358|P5|NOT COMPLETED|Washout Period 2||0
7600546|NCT02548156|18709359|P4|NOT COMPLETED|Washout Period 2||0
7600547|NCT02548156|18709360|P3|NOT COMPLETED|Washout Period 2||0
7600548|NCT02548156|18709361|P2|NOT COMPLETED|Washout Period 2||0
7600549|NCT02548156|18709362|P1|NOT COMPLETED|Washout Period 2||0
7600550|NCT02548156|18709357|P6|COMPLETED|Washout Period 2||5
7600551|NCT02548156|18709358|P5|COMPLETED|Washout Period 2||4
7600552|NCT02548156|18709359|P4|COMPLETED|Washout Period 2||5
7600553|NCT02548156|18709360|P3|COMPLETED|Washout Period 2||4
7600554|NCT02548156|18709361|P2|COMPLETED|Washout Period 2||5
7600555|NCT02548156|18709362|P1|COMPLETED|Washout Period 2||5
7600556|NCT02548156|18709357|P6|STARTED|Washout Period 2||5
7600557|NCT02548156|18709358|P5|STARTED|Washout Period 2||4
7600558|NCT02548156|18709359|P4|STARTED|Washout Period 2||5
7600559|NCT02548156|18709360|P3|STARTED|Washout Period 2||4
7600560|NCT02548156|18709361|P2|STARTED|Washout Period 2||5
7600561|NCT02548156|18709362|P1|STARTED|Washout Period 2||5
7600562|NCT02548156|18709357|P6|NOT COMPLETED|Period 2||0
7600563|NCT02548156|18709358|P5|NOT COMPLETED|Period 2||0
7600564|NCT02548156|18709359|P4|NOT COMPLETED|Period 2||0
7600565|NCT02548156|18709360|P3|NOT COMPLETED|Period 2||0
7600566|NCT02548156|18709361|P2|NOT COMPLETED|Period 2||0
7600567|NCT02548156|18709362|P1|NOT COMPLETED|Period 2||0
7600568|NCT02548156|18709357|P6|COMPLETED|Period 2||5
7600569|NCT02548156|18709358|P5|COMPLETED|Period 2||4
7600570|NCT02548156|18709359|P4|COMPLETED|Period 2||5
7600571|NCT02548156|18709360|P3|COMPLETED|Period 2||4
7600572|NCT02548156|18709361|P2|COMPLETED|Period 2||5
7600573|NCT02548156|18709362|P1|COMPLETED|Period 2||5
7600574|NCT02548156|18709357|P6|STARTED|Period 2||5
7600575|NCT02548156|18709358|P5|STARTED|Period 2||4
7600576|NCT02548156|18709359|P4|STARTED|Period 2||5
7600577|NCT02548156|18709360|P3|STARTED|Period 2||4
7600578|NCT02548156|18709361|P2|STARTED|Period 2||5
7600579|NCT02548156|18709362|P1|STARTED|Period 2||5
7600580|NCT02548156|18709357|P6|NOT COMPLETED|Washout Period 1||0
7600581|NCT02548156|18709358|P5|NOT COMPLETED|Washout Period 1||1
7600582|NCT02548156|18709359|P4|NOT COMPLETED|Washout Period 1||0
7600583|NCT02548156|18709360|P3|NOT COMPLETED|Washout Period 1||0
7600584|NCT02548156|18709361|P2|NOT COMPLETED|Washout Period 1||0
7600585|NCT02548156|18709362|P1|NOT COMPLETED|Washout Period 1||0
7600586|NCT02548156|18709357|P6|COMPLETED|Washout Period 1||5
7600587|NCT02548156|18709358|P5|COMPLETED|Washout Period 1||4
7600588|NCT02548156|18709359|P4|COMPLETED|Washout Period 1||5
7600589|NCT02548156|18709360|P3|COMPLETED|Washout Period 1||4
7600590|NCT02548156|18709361|P2|COMPLETED|Washout Period 1||5
7600591|NCT02548156|18709362|P1|COMPLETED|Washout Period 1||5
7600592|NCT02548156|18709357|P6|STARTED|Washout Period 1||5
7600593|NCT02548156|18709358|P5|STARTED|Washout Period 1||5
7600594|NCT02548156|18709359|P4|STARTED|Washout Period 1||5
7600595|NCT02548156|18709360|P3|STARTED|Washout Period 1||4
7600596|NCT02548156|18709361|P2|STARTED|Washout Period 1||5
7600597|NCT02548156|18709362|P1|STARTED|Washout Period 1||5
7600598|NCT02548156|18709357|P6|NOT COMPLETED|Period 1||0
7600599|NCT02548156|18709358|P5|NOT COMPLETED|Period 1||0
7600600|NCT02548156|18709359|P4|NOT COMPLETED|Period 1||0
7600601|NCT02548156|18709360|P3|NOT COMPLETED|Period 1||0
7600602|NCT02548156|18709361|P2|NOT COMPLETED|Period 1||0
7600603|NCT02548156|18709362|P1|NOT COMPLETED|Period 1||0
7600604|NCT02548156|18709357|P6|COMPLETED|Period 1||5
7600605|NCT02548156|18709358|P5|COMPLETED|Period 1||5
7600606|NCT02548156|18709359|P4|COMPLETED|Period 1||5
7600607|NCT02548156|18709360|P3|COMPLETED|Period 1||4
7600608|NCT02548156|18709361|P2|COMPLETED|Period 1||5
7600609|NCT02548156|18709362|P1|COMPLETED|Period 1||5
7600610|NCT02548156|18709357|P6|STARTED|Period 1||5
7600611|NCT02548156|18709358|P5|STARTED|Period 1||5
7600612|NCT02548156|18709359|P4|STARTED|Period 1||5
7600613|NCT02548156|18709360|P3|STARTED|Period 1||4
7600614|NCT02548156|18709361|P2|STARTED|Period 1||5
7600615|NCT02548156|18709362|P1|STARTED|Period 1||5
7600616|NCT02548143|18709381|P2|NOT COMPLETED|Overall Study||1
7600617|NCT02548143|18709382|P1|NOT COMPLETED|Overall Study||1
7600618|NCT02548143|18709381|P2|COMPLETED|Overall Study||5
7600619|NCT02548143|18709382|P1|COMPLETED|Overall Study||5
7600620|NCT02548143|18709381|P2|STARTED|Overall Study||6
7600621|NCT02548143|18709382|P1|STARTED|Overall Study||6
7600622|NCT02548078|18709394|P2|NOT COMPLETED|Overall Study||6
7600623|NCT02548078|18709395|P1|NOT COMPLETED|Overall Study||5
7600624|NCT02548078|18709394|P2|COMPLETED|Overall Study||294
7600625|NCT02548078|18709395|P1|COMPLETED|Overall Study||295
7600626|NCT02548078|18709394|P2|STARTED|Overall Study||300
7600627|NCT02548078|18709395|P1|STARTED|Overall Study||300
7600628|NCT02547987|18709583|P1|NOT COMPLETED|Overall Study||3
7600629|NCT02547987|18709583|P1|COMPLETED|Overall Study||22
7600630|NCT02547987|18709583|P1|STARTED|Overall Study||25
7600631|NCT02547974|18709591|P4|NOT COMPLETED|Overall Study||0
7600632|NCT02547974|18709592|P3|NOT COMPLETED|Overall Study||0
7600633|NCT02547974|18709593|P2|NOT COMPLETED|Overall Study||0
7600634|NCT02547974|18709594|P1|NOT COMPLETED|Overall Study||1
7600635|NCT02547974|18709591|P4|COMPLETED|Overall Study||44
7600636|NCT02547974|18709592|P3|COMPLETED|Overall Study||30
7600637|NCT02547974|18709593|P2|COMPLETED|Overall Study||31
7600638|NCT02547974|18709594|P1|COMPLETED|Overall Study||14
7600639|NCT02547974|18709591|P4|STARTED|Overall Study||44
7600640|NCT02547974|18709592|P3|STARTED|Overall Study||30
7600641|NCT02547974|18709593|P2|STARTED|Overall Study||31
7600642|NCT02547974|18709594|P1|STARTED|Overall Study||15
7600643|NCT02547935|18709681|P3|NOT COMPLETED|Overall Study||5
7600644|NCT02547935|18709682|P2|NOT COMPLETED|Overall Study||8
7600645|NCT02547935|18709683|P1|NOT COMPLETED|Overall Study||5
7600646|NCT02547935|18709681|P3|COMPLETED|Overall Study||143
7600647|NCT02547935|18709682|P2|COMPLETED|Overall Study||137
7600648|NCT02547935|18709683|P1|COMPLETED|Overall Study||150
7600649|NCT02547935|18709681|P3|Safety Analysis Set|Overall Study||148
7600650|NCT02547935|18709682|P2|Safety Analysis Set|Overall Study||145
7600651|NCT02547935|18709683|P1|Safety Analysis Set|Overall Study||152
7600652|NCT02547935|18709681|P3|Full Analysis Set|Overall Study||148
7600653|NCT02547935|18709682|P2|Full Analysis Set|Overall Study||144
7600654|NCT02547935|18709683|P1|Full Analysis Set|Overall Study||152
7600655|NCT02547935|18709681|P3|Received Treatment|Overall Study||148
7600656|NCT02547935|18709682|P2|Received Treatment|Overall Study||145
7600657|NCT02547935|18709683|P1|Received Treatment|Overall Study||152
7600658|NCT02547935|18709681|P3|STARTED|Overall Study||148
7600659|NCT02547935|18709682|P2|STARTED|Overall Study||145
7600660|NCT02547935|18709683|P1|STARTED|Overall Study||155
7600661|NCT02547779|18709712|P2|NOT COMPLETED|Overall Study||0
7600662|NCT02547779|18709713|P1|NOT COMPLETED|Overall Study||0
7600663|NCT02547779|18709712|P2|COMPLETED|Overall Study||5207
7600664|NCT02547779|18709713|P1|COMPLETED|Overall Study||5214
7600665|NCT02547779|18709712|P2|STARTED|Overall Study||5207
7600666|NCT02547779|18709713|P1|STARTED|Overall Study||5214
7600667|NCT02547766|18709721|P1|NOT COMPLETED|Overall Study||1
7600668|NCT02547766|18709721|P1|COMPLETED|Overall Study||9
7600669|NCT02547766|18709721|P1|STARTED|Overall Study||10
7600670|NCT02547714|18709728|P1|NOT COMPLETED|Overall Study||0
7600671|NCT02547714|18709728|P1|COMPLETED|Overall Study||34
7600672|NCT02547714|18709728|P1|STARTED|Overall Study||34
7600673|NCT02547649|18709741|P3|NOT COMPLETED|Overall Study||4
7600674|NCT02547649|18709742|P2|NOT COMPLETED|Overall Study||5
7600675|NCT02547649|18709743|P1|NOT COMPLETED|Overall Study||3
7600676|NCT02547649|18709741|P3|COMPLETED|Overall Study||224
7600677|NCT02547649|18709742|P2|COMPLETED|Overall Study||226
7600678|NCT02547649|18709743|P1|COMPLETED|Overall Study||228
7600679|NCT02547649|18709741|P3|Vaccinated|Overall Study||227
7600680|NCT02547649|18709742|P2|Vaccinated|Overall Study||231
7600681|NCT02547649|18709743|P1|Vaccinated|Overall Study||231
7600682|NCT02547649|18709741|P3|STARTED|Overall Study||228
7600683|NCT02547649|18709742|P2|STARTED|Overall Study||231
7600684|NCT02547649|18709743|P1|STARTED|Overall Study||231
7600685|NCT02547623|18709777|P2|NOT COMPLETED|Overall Study||3
7600686|NCT02547623|18709778|P1|NOT COMPLETED|Overall Study||4
7600687|NCT02547623|18709777|P2|COMPLETED|Overall Study||52
7600688|NCT02547623|18709778|P1|COMPLETED|Overall Study||122
7600689|NCT02547623|18709777|P2|STARTED|Overall Study||55
7600690|NCT02547623|18709778|P1|STARTED|Overall Study||126
7600691|NCT02547454|18709808|P1|NOT COMPLETED|Overall Study||172
7600692|NCT02547454|18709808|P1|COMPLETED|Overall Study||221
7600693|NCT02547454|18709808|P1|STARTED|Overall Study||393
7600694|NCT02547363|18709838|P2|NOT COMPLETED|12-month Follow-up||5
7600695|NCT02547363|18709839|P1|NOT COMPLETED|12-month Follow-up||10
7600696|NCT02547363|18709838|P2|COMPLETED|12-month Follow-up||81
7600697|NCT02547363|18709839|P1|COMPLETED|12-month Follow-up||194
7600698|NCT02547363|18709838|P2|STARTED|12-month Follow-up||86
7600699|NCT02547363|18709839|P1|STARTED|12-month Follow-up||204
7600700|NCT02547363|18709838|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||11
7600701|NCT02547363|18709839|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
7600702|NCT02547363|18709838|P2|COMPLETED|3-day Treatment and 8-week Follow-up||94
7600703|NCT02547363|18709839|P1|COMPLETED|3-day Treatment and 8-week Follow-up||207
7600704|NCT02547363|18709838|P2|Treated|3-day Treatment and 8-week Follow-up||104
7600705|NCT02547363|18709839|P1|Treated|3-day Treatment and 8-week Follow-up||209
7600706|NCT02547363|18709838|P2|STARTED|3-day Treatment and 8-week Follow-up||105
7600707|NCT02547363|18709839|P1|STARTED|3-day Treatment and 8-week Follow-up||211
7600708|NCT02547233|18709855|P2|NOT COMPLETED|12-month Follow-up||17
7600709|NCT02547233|18709856|P1|NOT COMPLETED|12-month Follow-up||14
7600710|NCT02547233|18709855|P2|COMPLETED|12-month Follow-up||67
7600711|NCT02547233|18709856|P1|COMPLETED|12-month Follow-up||185
7600712|NCT02547233|18709855|P2|STARTED|12-month Follow-up||84
7600713|NCT02547233|18709856|P1|STARTED|12-month Follow-up||199
7600714|NCT02547233|18709855|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||10
7600715|NCT02547233|18709856|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
7600716|NCT02547233|18709855|P2|COMPLETED|3-day Treatment and 8-week Follow-up||92
7600717|NCT02547233|18709856|P1|COMPLETED|3-day Treatment and 8-week Follow-up||203
7600718|NCT02547233|18709855|P2|Treated|3-day Treatment and 8-week Follow-up||100
7600719|NCT02547233|18709856|P1|Treated|3-day Treatment and 8-week Follow-up||205
7600720|NCT02547233|18709855|P2|STARTED|3-day Treatment and 8-week Follow-up||102
7600721|NCT02547233|18709856|P1|STARTED|3-day Treatment and 8-week Follow-up||205
7600722|NCT02547220|18709872|P2|NOT COMPLETED|Overall Study||20
7600723|NCT02547220|18709873|P1|NOT COMPLETED|Overall Study||19
7600724|NCT02547220|18709872|P2|COMPLETED|Overall Study||0
7600725|NCT02547220|18709873|P1|COMPLETED|Overall Study||0
7600726|NCT02547220|18709872|P2|STARTED|Overall Study||20
7600727|NCT02547220|18709873|P1|STARTED|Overall Study||19
7600728|NCT02547129|18709909|P2|NOT COMPLETED|Overall Study||0
7600729|NCT02547129|18709910|P1|NOT COMPLETED|Overall Study||1
7600730|NCT02547129|18709909|P2|COMPLETED|Overall Study||2
7600731|NCT02547129|18709910|P1|COMPLETED|Overall Study||1
7600732|NCT02547129|18709909|P2|STARTED|Overall Study||2
7600733|NCT02547129|18709910|P1|STARTED|Overall Study||2
7600734|NCT02547064|18709924|P2|NOT COMPLETED|Overall Study||2
7600735|NCT02547064|18709925|P1|NOT COMPLETED|Overall Study||3
7600736|NCT02547064|18709924|P2|COMPLETED|Overall Study||79
7600737|NCT02547064|18709925|P1|COMPLETED|Overall Study||78
7600738|NCT02547064|18709924|P2|STARTED|Overall Study||81
7600739|NCT02547064|18709925|P1|STARTED|Overall Study||81
7600740|NCT02547038|18709953|P2|NOT COMPLETED|Overall Study||2
7600741|NCT02547038|18709954|P1|NOT COMPLETED|Overall Study||3
7600742|NCT02547038|18709953|P2|COMPLETED|Overall Study||174
7600743|NCT02547038|18709954|P1|COMPLETED|Overall Study||173
7600744|NCT02547038|18709953|P2|STARTED|Overall Study||176
7600745|NCT02547038|18709954|P1|STARTED|Overall Study||176
7600746|NCT02547012|18709962|P2|NOT COMPLETED|Overall Study||0
7600747|NCT02547012|18709963|P1|NOT COMPLETED|Overall Study||0
7600748|NCT02547012|18709962|P2|COMPLETED|Overall Study||27
7600749|NCT02547012|18709963|P1|COMPLETED|Overall Study||24
7600750|NCT02547012|18709962|P2|STARTED|Overall Study||27
7600751|NCT02547012|18709963|P1|STARTED|Overall Study||24
7600752|NCT02546986|18709971|P2|NOT COMPLETED|Survival Follow-Up Phase||35
7600753|NCT02546986|18709972|P1|NOT COMPLETED|Survival Follow-Up Phase||36
7600754|NCT02546986|18709971|P2|COMPLETED|Survival Follow-Up Phase||0
7600755|NCT02546986|18709972|P1|COMPLETED|Survival Follow-Up Phase||0
7600756|NCT02546986|18709971|P2|STARTED|Survival Follow-Up Phase||35
7600757|NCT02546986|18709972|P1|STARTED|Survival Follow-Up Phase||36
7600758|NCT02546986|18709971|P2|NOT COMPLETED|Treatment Period||49
7600759|NCT02546986|18709972|P1|NOT COMPLETED|Treatment Period||51
7600760|NCT02546986|18709971|P2|COMPLETED|Treatment Period||0
7600761|NCT02546986|18709972|P1|COMPLETED|Treatment Period||0
7600762|NCT02546986|18709971|P2|STARTED|Treatment Period||49
7600763|NCT02546986|18709972|P1|STARTED|Treatment Period||51
7600764|NCT02546856|18709997|P2|NOT COMPLETED|6 Months Evaluation||7
7600765|NCT02546856|18709998|P1|NOT COMPLETED|6 Months Evaluation||8
7600766|NCT02546856|18709997|P2|COMPLETED|6 Months Evaluation||138
7600767|NCT02546856|18709998|P1|COMPLETED|6 Months Evaluation||136
7600768|NCT02546856|18709997|P2|STARTED|6 Months Evaluation||145
7600769|NCT02546856|18709998|P1|STARTED|6 Months Evaluation||144
7600770|NCT02546856|18709997|P2|NOT COMPLETED|4 Months Evaluation||11
7600771|NCT02546856|18709998|P1|NOT COMPLETED|4 Months Evaluation||20
7600772|NCT02546856|18709997|P2|COMPLETED|4 Months Evaluation||145
7600773|NCT02546856|18709998|P1|COMPLETED|4 Months Evaluation||144
7600774|NCT02546856|18709997|P2|STARTED|4 Months Evaluation||156
7600775|NCT02546856|18709998|P1|STARTED|4 Months Evaluation||164
7600776|NCT02546765|18710048|P4|NOT COMPLETED|Overall Study||0
7600777|NCT02546765|18710049|P3|NOT COMPLETED|Overall Study||0
7600778|NCT02546765|18710050|P2|NOT COMPLETED|Overall Study||1
7600779|NCT02546765|18710051|P1|NOT COMPLETED|Overall Study||0
7600780|NCT02546765|18710048|P4|COMPLETED|Overall Study||30
7600781|NCT02546765|18710049|P3|COMPLETED|Overall Study||30
7600782|NCT02546765|18710050|P2|COMPLETED|Overall Study|29 Received study drug; 1 withdrew before surgery and after randomization|29
7600783|NCT02546765|18710051|P1|COMPLETED|Overall Study||31
7600784|NCT02546765|18710048|P4|STARTED|Overall Study||30
7600785|NCT02546765|18710049|P3|STARTED|Overall Study||30
7600786|NCT02546765|18710050|P2|STARTED|Overall Study||30
7600787|NCT02546765|18710051|P1|STARTED|Overall Study||31
7600788|NCT02546609|18710092|P3|NOT COMPLETED|Overall Study||7
7600789|NCT02546609|18710093|P2|NOT COMPLETED|Overall Study||11
7600790|NCT02546609|18710094|P1|NOT COMPLETED|Overall Study||2
7600791|NCT02546609|18710092|P3|COMPLETED|Overall Study||25
7600792|NCT02546609|18710093|P2|COMPLETED|Overall Study||24
7600793|NCT02546609|18710094|P1|COMPLETED|Overall Study||22
7600794|NCT02546609|18710092|P3|STARTED|Overall Study||32
7600795|NCT02546609|18710093|P2|STARTED|Overall Study||35
7600796|NCT02546609|18710094|P1|STARTED|Overall Study||24
7600797|NCT02546570|18710137|P2|NOT COMPLETED|Overall Study||0
7600798|NCT02546570|18710138|P1|NOT COMPLETED|Overall Study||0
7600799|NCT02546570|18710137|P2|COMPLETED|Overall Study||2
7600800|NCT02546570|18710138|P1|COMPLETED|Overall Study||9
7600801|NCT02546570|18710137|P2|Crossover Order: Placebo, Oxytocin|Overall Study||0
7600802|NCT02546570|18710138|P1|Crossover Order: Placebo, Oxytocin|Overall Study||3
7600803|NCT02546570|18710137|P2|Crossover Order: Oxytocin, Placebo|Overall Study||2
7600804|NCT02546570|18710138|P1|Crossover Order: Oxytocin, Placebo|Overall Study||6
7600805|NCT02546570|18710137|P2|STARTED|Overall Study||2
7600806|NCT02546570|18710138|P1|STARTED|Overall Study||9
7600807|NCT02546544|18710174|P1|NOT COMPLETED|Overall Study||16
7600808|NCT02546544|18710174|P1|COMPLETED|Overall Study||0
7600809|NCT02546544|18710174|P1|Received Allocated Intervention|Overall Study||16
7600810|NCT02546544|18710174|P1|STARTED|Overall Study||16
7600811|NCT02546388|18710185|P2|NOT COMPLETED|Overall Study||0
7600812|NCT02546388|18710186|P1|NOT COMPLETED|Overall Study||0
7600813|NCT02546388|18710185|P2|COMPLETED|Overall Study||13
7600814|NCT02546388|18710186|P1|COMPLETED|Overall Study||4
7600815|NCT02546388|18710185|P2|STARTED|Overall Study||13
7600816|NCT02546388|18710186|P1|STARTED|Overall Study||4
7600817|NCT02546375|18710193|P1|NOT COMPLETED|Overall Study||0
7600818|NCT02546375|18710193|P1|COMPLETED|Overall Study||87
7600819|NCT02546375|18710193|P1|STARTED|Overall Study||87
7600820|NCT02546362|18710215|P1|NOT COMPLETED|12-week Treatment Period||9
7600821|NCT02546362|18710215|P1|COMPLETED|12-week Treatment Period||38
7600822|NCT02546362|18710215|P1|STARTED|12-week Treatment Period||47
7600823|NCT02546362|18710215|P1|NOT COMPLETED|4-week Treatment Period||3
7600824|NCT02546362|18710215|P1|COMPLETED|4-week Treatment Period||47
7600825|NCT02546362|18710215|P1|STARTED|4-week Treatment Period||50
7600826|NCT02546323|18710236|P2|NOT COMPLETED|Overall Study||66
7600827|NCT02546323|18710237|P1|NOT COMPLETED|Overall Study||60
7600828|NCT02546323|18710236|P2|COMPLETED|Overall Study||205
7600829|NCT02546323|18710237|P1|COMPLETED|Overall Study||212
7600830|NCT02546323|18710236|P2|Received Treatment|Overall Study||268
7600831|NCT02546323|18710237|P1|Received Treatment|Overall Study||272
7600832|NCT02546323|18710236|P2|STARTED|Overall Study||271
7600833|NCT02546323|18710237|P1|STARTED|Overall Study||272
7600834|NCT02546193|18710257|P4|NOT COMPLETED|Overall Study||0
7600835|NCT02546193|18710258|P3|NOT COMPLETED|Overall Study||2
7600836|NCT02546193|18710259|P2|NOT COMPLETED|Overall Study||6
7600837|NCT02546193|18710260|P1|NOT COMPLETED|Overall Study||6
7600838|NCT02546193|18710257|P4|COMPLETED|Overall Study||0
7600839|NCT02546193|18710258|P3|COMPLETED|Overall Study||0
7600840|NCT02546193|18710259|P2|COMPLETED|Overall Study||4
7600841|NCT02546193|18710260|P1|COMPLETED|Overall Study||4
7600842|NCT02546193|18710257|P4|STARTED|Overall Study||0
7600843|NCT02546193|18710258|P3|STARTED|Overall Study|Enrolled independently (Prospective study). Not counted in Outpatient Foley Catheter Arm.|2
7600844|NCT02546193|18710259|P2|STARTED|Overall Study||10
7600845|NCT02546193|18710260|P1|STARTED|Overall Study||10
7600846|NCT02545933|18710297|P3|NOT COMPLETED|Overall Study||4
7600847|NCT02545933|18710298|P2|NOT COMPLETED|Overall Study||3
7600848|NCT02545933|18710299|P1|NOT COMPLETED|Overall Study||6
7600849|NCT02545933|18710297|P3|COMPLETED|Overall Study||39
7600850|NCT02545933|18710298|P2|COMPLETED|Overall Study||40
7600851|NCT02545933|18710299|P1|COMPLETED|Overall Study||38
7600852|NCT02545933|18710297|P3|STARTED|Overall Study||43
7600853|NCT02545933|18710298|P2|STARTED|Overall Study||43
7600854|NCT02545933|18710299|P1|STARTED|Overall Study||44
7600855|NCT02545868|18710310|P3|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||34
7600856|NCT02545868|18710311|P2|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||35
7600857|NCT02545868|18710312|P1|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||33
7600858|NCT02545868|18710310|P3|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
7600859|NCT02545868|18710311|P2|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
7600860|NCT02545868|18710312|P1|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
7600861|NCT02545868|18710310|P3|STARTED|Optional Ocrelizumab Ext (OOE) Period||34
7600862|NCT02545868|18710311|P2|STARTED|Optional Ocrelizumab Ext (OOE) Period||35
7600863|NCT02545868|18710312|P1|STARTED|Optional Ocrelizumab Ext (OOE) Period||33
7600864|NCT02545868|18710310|P3|NOT COMPLETED|Immunization Study Period (ISP)||0
7600865|NCT02545868|18710311|P2|NOT COMPLETED|Immunization Study Period (ISP)||0
7600866|NCT02545868|18710312|P1|NOT COMPLETED|Immunization Study Period (ISP)||0
7600867|NCT02545868|18710310|P3|COMPLETED|Immunization Study Period (ISP)||34
7600868|NCT02545868|18710311|P2|COMPLETED|Immunization Study Period (ISP)||35
7600869|NCT02545868|18710312|P1|COMPLETED|Immunization Study Period (ISP)||33
7600870|NCT02545868|18710310|P3|STARTED|Immunization Study Period (ISP)||34
7600871|NCT02545868|18710311|P2|STARTED|Immunization Study Period (ISP)||35
7600872|NCT02545868|18710312|P1|STARTED|Immunization Study Period (ISP)||33
7600873|NCT02545608|18710385|P2|NOT COMPLETED|Overall Study||7
7600874|NCT02545608|18710386|P1|NOT COMPLETED|Overall Study||0
7600875|NCT02545608|18710385|P2|COMPLETED|Overall Study||93
7600876|NCT02545608|18710386|P1|COMPLETED|Overall Study||9
7600877|NCT02545608|18710385|P2|STARTED|Overall Study|Split hand study design. Total no. of subjects in Randomised group and No-treatment control is 100.|100
7600878|NCT02545608|18710386|P1|STARTED|Overall Study||9
7600879|NCT02545543|18710395|P2|NOT COMPLETED|Overall Study||34
7600880|NCT02545543|18710396|P1|NOT COMPLETED|Overall Study||81
7600881|NCT02545543|18710395|P2|COMPLETED|Overall Study||535
7600882|NCT02545543|18710396|P1|COMPLETED|Overall Study||1628
7600883|NCT02545543|18710395|P2|STARTED|Overall Study||569
7600884|NCT02545543|18710396|P1|STARTED|Overall Study||1709
7600885|NCT02545504|18710422|P2|NOT COMPLETED|Overall Study||214
7600886|NCT02545504|18710423|P1|NOT COMPLETED|Overall Study||218
7600887|NCT02545504|18710422|P2|COMPLETED|Overall Study||0
7600888|NCT02545504|18710423|P1|COMPLETED|Overall Study||0
7600889|NCT02545504|18710422|P2|STARTED|Overall Study||214
7600890|NCT02545504|18710423|P1|STARTED|Overall Study||218
7600891|NCT02545322|18710437|P1|NOT COMPLETED|Overall Study||3
7600892|NCT02545322|18710437|P1|COMPLETED|Overall Study||15
7600893|NCT02545322|18710437|P1|STARTED|Overall Study||18
7600894|NCT02545270|18710445|P3|NOT COMPLETED|Overall Study||2
7600895|NCT02545270|18710446|P2|NOT COMPLETED|Overall Study||1
7600896|NCT02545270|18710447|P1|NOT COMPLETED|Overall Study||0
7600897|NCT02545270|18710445|P3|COMPLETED|Overall Study||3
7600898|NCT02545270|18710446|P2|COMPLETED|Overall Study||4
7600899|NCT02545270|18710447|P1|COMPLETED|Overall Study||6
7600900|NCT02545270|18710445|P3|STARTED|Overall Study||5
7600901|NCT02545270|18710446|P2|STARTED|Overall Study||5
7600902|NCT02545270|18710447|P1|STARTED|Overall Study||6
7600903|NCT02545101|18710457|P1|NOT COMPLETED|Overall Study||0
7600904|NCT02545101|18710457|P1|COMPLETED|Overall Study||100
7600905|NCT02545101|18710457|P1|STARTED|Overall Study||100
7600906|NCT02545075|18710476|P2|NOT COMPLETED|Treatment||53
7600907|NCT02545075|18710477|P1|NOT COMPLETED|Treatment||122
7600908|NCT02545075|18710476|P2|COMPLETED|Treatment||0
7600909|NCT02545075|18710477|P1|COMPLETED|Treatment||0
7600910|NCT02545075|18710476|P2|STARTED|Treatment||53
7600911|NCT02545075|18710477|P1|STARTED|Treatment||122
7600912|NCT02545075|18710476|P2|NOT COMPLETED|Randomization||7
7600913|NCT02545075|18710477|P1|NOT COMPLETED|Randomization||0
7600914|NCT02545075|18710476|P2|COMPLETED|Randomization||53
7600915|NCT02545075|18710477|P1|COMPLETED|Randomization||122
7600916|NCT02545075|18710476|P2|STARTED|Randomization||60
7600917|NCT02545075|18710477|P1|STARTED|Randomization||122
7600918|NCT02544984|18710499|P2|NOT COMPLETED|Overall Study||2
7600919|NCT02544984|18710500|P1|NOT COMPLETED|Overall Study||2
7600920|NCT02544984|18710499|P2|COMPLETED|Overall Study||28
7600921|NCT02544984|18710500|P1|COMPLETED|Overall Study||28
7600922|NCT02544984|18710499|P2|STARTED|Overall Study||30
7600923|NCT02544984|18710500|P1|STARTED|Overall Study||30
7600924|NCT02544763|18710513|P3|NOT COMPLETED|Overall Study||1
7600925|NCT02544763|18710514|P2|NOT COMPLETED|Overall Study||12
7600926|NCT02544763|18710515|P1|NOT COMPLETED|Overall Study||10
7600927|NCT02544763|18710513|P3|COMPLETED|Overall Study||75
7600928|NCT02544763|18710514|P2|COMPLETED|Overall Study||61
7600929|NCT02544763|18710515|P1|COMPLETED|Overall Study||65
7600930|NCT02544763|18710513|P3|STARTED|Overall Study||76
7600931|NCT02544763|18710514|P2|STARTED|Overall Study||73
7600932|NCT02544763|18710515|P1|STARTED|Overall Study||75
7600933|NCT02544633|18710539|P4|NOT COMPLETED|Survival Follow-up Period||12
7600934|NCT02544633|18710540|P3|NOT COMPLETED|Survival Follow-up Period||7
7600935|NCT02544633|18710541|P2|NOT COMPLETED|Survival Follow-up Period||19
7600936|NCT02544633|18710542|P1|NOT COMPLETED|Survival Follow-up Period||28
7600937|NCT02544633|18710539|P4|COMPLETED|Survival Follow-up Period||0
7600938|NCT02544633|18710540|P3|COMPLETED|Survival Follow-up Period||0
7600939|NCT02544633|18710541|P2|COMPLETED|Survival Follow-up Period||0
7600940|NCT02544633|18710542|P1|COMPLETED|Survival Follow-up Period||0
7600941|NCT02544633|18710539|P4|STARTED|Survival Follow-up Period||12
7600942|NCT02544633|18710540|P3|STARTED|Survival Follow-up Period||7
7600943|NCT02544633|18710541|P2|STARTED|Survival Follow-up Period||19
7600944|NCT02544633|18710542|P1|STARTED|Survival Follow-up Period||28
7600945|NCT02544633|18710539|P4|NOT COMPLETED|Treatment Period||12
7600946|NCT02544633|18710540|P3|NOT COMPLETED|Treatment Period||8
7600947|NCT02544633|18710541|P2|NOT COMPLETED|Treatment Period||20
7600948|NCT02544633|18710542|P1|NOT COMPLETED|Treatment Period||28
7600949|NCT02544633|18710539|P4|COMPLETED|Treatment Period||0
7600950|NCT02544633|18710540|P3|COMPLETED|Treatment Period||0
7600951|NCT02544633|18710541|P2|COMPLETED|Treatment Period||0
7600952|NCT02544633|18710542|P1|COMPLETED|Treatment Period||0
7600953|NCT02544633|18710539|P4|STARTED|Treatment Period||12
7600954|NCT02544633|18710540|P3|STARTED|Treatment Period||8
7600955|NCT02544633|18710541|P2|STARTED|Treatment Period||20
7600956|NCT02544633|18710542|P1|STARTED|Treatment Period||28
7600957|NCT02544607|18710615|P1|NOT COMPLETED|Overall Study||0
7600958|NCT02544607|18710615|P1|COMPLETED|Overall Study||16
7600959|NCT02544607|18710615|P1|STARTED|Overall Study||16
7600960|NCT02544451|18710626|P3|NOT COMPLETED|Overall Study||1
7600961|NCT02544451|18710627|P2|NOT COMPLETED|Overall Study||12
7600962|NCT02544451|18710628|P1|NOT COMPLETED|Overall Study||14
7600963|NCT02544451|18710626|P3|COMPLETED|Overall Study||5
7600964|NCT02544451|18710627|P2|COMPLETED|Overall Study||84
7600965|NCT02544451|18710628|P1|COMPLETED|Overall Study||129
7600966|NCT02544451|18710626|P3|STARTED|Overall Study||6
7600967|NCT02544451|18710627|P2|STARTED|Overall Study||96
7600968|NCT02544451|18710628|P1|STARTED|Overall Study||143
7600969|NCT02544217|18710677|P6|NOT COMPLETED|Overall Study||0
7600970|NCT02544217|18710678|P5|NOT COMPLETED|Overall Study||0
7600971|NCT02544217|18710679|P4|NOT COMPLETED|Overall Study||0
7600972|NCT02544217|18710680|P3|NOT COMPLETED|Overall Study||0
7600973|NCT02544217|18710681|P2|NOT COMPLETED|Overall Study||1
7600974|NCT02544217|18710682|P1|NOT COMPLETED|Overall Study||1
7600975|NCT02544217|18710677|P6|COMPLETED|Overall Study||6
7600976|NCT02544217|18710678|P5|COMPLETED|Overall Study||4
7600977|NCT02544217|18710679|P4|COMPLETED|Overall Study||4
7600978|NCT02544217|18710680|P3|COMPLETED|Overall Study||4
7600979|NCT02544217|18710681|P2|COMPLETED|Overall Study|Two subjects prematurely withdrew from the study for non-medical reasons and were replaced.|6
7600980|NCT02544217|18710682|P1|COMPLETED|Overall Study||6
7600981|NCT02544217|18710677|P6|STARTED|Overall Study||6
7600982|NCT02544217|18710678|P5|STARTED|Overall Study||4
7600983|NCT02544217|18710679|P4|STARTED|Overall Study||4
7600984|NCT02544217|18710680|P3|STARTED|Overall Study||4
7600985|NCT02544217|18710681|P2|STARTED|Overall Study||7
7600986|NCT02544217|18710682|P1|STARTED|Overall Study||7
7600987|NCT02544152|18711477|P2|NOT COMPLETED|Overall Study||7
7600988|NCT02544152|18711478|P1|NOT COMPLETED|Overall Study||1
7600989|NCT02544152|18711477|P2|COMPLETED|Overall Study||30
7600990|NCT02544152|18711478|P1|COMPLETED|Overall Study||33
7600991|NCT02544152|18711477|P2|Safety Analysis Set (SAS)|Overall Study||37
7600992|NCT02544152|18711478|P1|Safety Analysis Set (SAS)|Overall Study||34
7600993|NCT02544152|18711477|P2|Modified Intent to Treat (mITT)|Overall Study||37
7600994|NCT02544152|18711478|P1|Modified Intent to Treat (mITT)|Overall Study||34
7600995|NCT02544152|18711477|P2|STARTED|Overall Study||37
7600996|NCT02544152|18711478|P1|STARTED|Overall Study||34
7600997|NCT02544074|18711521|P21|NOT COMPLETED|Overall Study||0
7600998|NCT02544074|18711522|P20|NOT COMPLETED|Overall Study||0
7600999|NCT02544074|18711523|P19|NOT COMPLETED|Overall Study||0
7601000|NCT02544074|18711524|P18|NOT COMPLETED|Overall Study||0
7601001|NCT02544074|18711525|P17|NOT COMPLETED|Overall Study||0
7601002|NCT02544074|18711526|P16|NOT COMPLETED|Overall Study||0
7601003|NCT02544074|18711527|P15|NOT COMPLETED|Overall Study||0
7601004|NCT02544074|18711528|P14|NOT COMPLETED|Overall Study||0
7601005|NCT02544074|18711529|P13|NOT COMPLETED|Overall Study||0
7601006|NCT02544074|18711530|P12|NOT COMPLETED|Overall Study||0
7601007|NCT02544074|18711531|P11|NOT COMPLETED|Overall Study||0
7601008|NCT02544074|18711532|P10|NOT COMPLETED|Overall Study||1
7601009|NCT02544074|18711533|P9|NOT COMPLETED|Overall Study||0
7601010|NCT02544074|18711534|P8|NOT COMPLETED|Overall Study||0
7601011|NCT02544074|18711535|P7|NOT COMPLETED|Overall Study||0
7601012|NCT02544074|18711536|P6|NOT COMPLETED|Overall Study||1
7601013|NCT02544074|18711537|P5|NOT COMPLETED|Overall Study||0
7601014|NCT02544074|18711538|P4|NOT COMPLETED|Overall Study||0
7601015|NCT02544074|18711539|P3|NOT COMPLETED|Overall Study||0
7601016|NCT02544074|18711540|P2|NOT COMPLETED|Overall Study||1
7601017|NCT02544074|18711541|P1|NOT COMPLETED|Overall Study||0
7601018|NCT02544074|18711521|P21|COMPLETED|Overall Study||3
7601019|NCT02544074|18711522|P20|COMPLETED|Overall Study||3
7601020|NCT02544074|18711523|P19|COMPLETED|Overall Study||4
7601021|NCT02544074|18711524|P18|COMPLETED|Overall Study||3
7601022|NCT02544074|18711525|P17|COMPLETED|Overall Study||6
7601023|NCT02544074|18711526|P16|COMPLETED|Overall Study||8
7601024|NCT02544074|18711527|P15|COMPLETED|Overall Study||5
7601025|NCT02544074|18711528|P14|COMPLETED|Overall Study||5
7601026|NCT02544074|18711529|P13|COMPLETED|Overall Study||4
7601027|NCT02544074|18711530|P12|COMPLETED|Overall Study||3
7601028|NCT02544074|18711531|P11|COMPLETED|Overall Study||2
7601029|NCT02544074|18711532|P10|COMPLETED|Overall Study||1
7601030|NCT02544074|18711533|P9|COMPLETED|Overall Study||6
7601031|NCT02544074|18711534|P8|COMPLETED|Overall Study||4
7601032|NCT02544074|18711535|P7|COMPLETED|Overall Study||2
7601033|NCT02544074|18711536|P6|COMPLETED|Overall Study||0
7601034|NCT02544074|18711537|P5|COMPLETED|Overall Study||4
7601035|NCT02544074|18711538|P4|COMPLETED|Overall Study||1
7601036|NCT02544074|18711539|P3|COMPLETED|Overall Study||1
7601037|NCT02544074|18711540|P2|COMPLETED|Overall Study||0
7601038|NCT02544074|18711541|P1|COMPLETED|Overall Study||1
7601039|NCT02544074|18711521|P21|STARTED|Overall Study||3
7601040|NCT02544074|18711522|P20|STARTED|Overall Study||3
7601041|NCT02544074|18711523|P19|STARTED|Overall Study||4
7601042|NCT02544074|18711524|P18|STARTED|Overall Study||3
7601043|NCT02544074|18711525|P17|STARTED|Overall Study||6
7601044|NCT02544074|18711526|P16|STARTED|Overall Study||8
7601045|NCT02544074|18711527|P15|STARTED|Overall Study||5
7601046|NCT02544074|18711528|P14|STARTED|Overall Study||5
7601047|NCT02544074|18711529|P13|STARTED|Overall Study||4
7601048|NCT02544074|18711530|P12|STARTED|Overall Study||3
7601049|NCT02544074|18711531|P11|STARTED|Overall Study||2
7601050|NCT02544074|18711532|P10|STARTED|Overall Study||2
7601051|NCT02544074|18711533|P9|STARTED|Overall Study||6
7601052|NCT02544074|18711534|P8|STARTED|Overall Study||4
7601053|NCT02544074|18711535|P7|STARTED|Overall Study||2
7601054|NCT02544074|18711536|P6|STARTED|Overall Study||1
7601055|NCT02544074|18711537|P5|STARTED|Overall Study||4
7601056|NCT02544074|18711538|P4|STARTED|Overall Study||1
7601057|NCT02544074|18711539|P3|STARTED|Overall Study||1
7601058|NCT02544074|18711540|P2|STARTED|Overall Study||1
7601059|NCT02544074|18711541|P1|STARTED|Overall Study||1
7601060|NCT02543918|18711577|P2|NOT COMPLETED|Overall Study||4
7601061|NCT02543918|18711578|P1|NOT COMPLETED|Overall Study||3
7601062|NCT02543918|18711577|P2|COMPLETED|Overall Study||39
7601063|NCT02543918|18711578|P1|COMPLETED|Overall Study||38
7601064|NCT02543918|18711577|P2|Received at Least 1 Dose of Study Drug|Overall Study||42
7601065|NCT02543918|18711578|P1|Received at Least 1 Dose of Study Drug|Overall Study||41
7601066|NCT02543918|18711577|P2|STARTED|Overall Study||43
7601067|NCT02543918|18711578|P1|STARTED|Overall Study||41
7601068|NCT02543892|18711592|P8|NOT COMPLETED|Had Immunology Data||0
7601069|NCT02543892|18711593|P7|NOT COMPLETED|Had Immunology Data||1
7601070|NCT02543892|18711594|P6|NOT COMPLETED|Had Immunology Data||0
7601071|NCT02543892|18711595|P5|NOT COMPLETED|Had Immunology Data||0
7601072|NCT02543892|18711596|P4|NOT COMPLETED|Had Immunology Data||0
7601073|NCT02543892|18711597|P3|NOT COMPLETED|Had Immunology Data||0
7601074|NCT02543892|18711598|P2|NOT COMPLETED|Had Immunology Data||0
7601075|NCT02543892|18711599|P1|NOT COMPLETED|Had Immunology Data||0
7601076|NCT02543892|18711592|P8|COMPLETED|Had Immunology Data||49
7601077|NCT02543892|18711593|P7|COMPLETED|Had Immunology Data|Subject received both vaccinations and attended last visit, but withdrew consent afterwards.|49
7601078|NCT02543892|18711594|P6|COMPLETED|Had Immunology Data||49
7601079|NCT02543892|18711595|P5|COMPLETED|Had Immunology Data||50
7601080|NCT02543892|18711596|P4|COMPLETED|Had Immunology Data||12
7601081|NCT02543892|18711597|P3|COMPLETED|Had Immunology Data||12
7601082|NCT02543892|18711598|P2|COMPLETED|Had Immunology Data||11
7601083|NCT02543892|18711599|P1|COMPLETED|Had Immunology Data||11
7601084|NCT02543892|18711592|P8|STARTED|Had Immunology Data||49
7601085|NCT02543892|18711593|P7|STARTED|Had Immunology Data||50
7601086|NCT02543892|18711594|P6|STARTED|Had Immunology Data||49
7601087|NCT02543892|18711595|P5|STARTED|Had Immunology Data||50
7601088|NCT02543892|18711596|P4|STARTED|Had Immunology Data||12
7601089|NCT02543892|18711597|P3|STARTED|Had Immunology Data||12
7601090|NCT02543892|18711598|P2|STARTED|Had Immunology Data||11
7601091|NCT02543892|18711599|P1|STARTED|Had Immunology Data||11
7601092|NCT02543892|18711592|P8|NOT COMPLETED|Received Vaccination 2||1
7601093|NCT02543892|18711593|P7|NOT COMPLETED|Received Vaccination 2||0
7601094|NCT02543892|18711594|P6|NOT COMPLETED|Received Vaccination 2||1
7601095|NCT02543892|18711595|P5|NOT COMPLETED|Received Vaccination 2||0
7601096|NCT02543892|18711596|P4|NOT COMPLETED|Received Vaccination 2||0
7601097|NCT02543892|18711597|P3|NOT COMPLETED|Received Vaccination 2||0
7601098|NCT02543892|18711598|P2|NOT COMPLETED|Received Vaccination 2||1
7601099|NCT02543892|18711599|P1|NOT COMPLETED|Received Vaccination 2||1
7601100|NCT02543892|18711592|P8|COMPLETED|Received Vaccination 2||49
7601101|NCT02543892|18711593|P7|COMPLETED|Received Vaccination 2||50
7601102|NCT02543892|18711594|P6|COMPLETED|Received Vaccination 2||49
7601103|NCT02543892|18711595|P5|COMPLETED|Received Vaccination 2||50
7601104|NCT02543892|18711596|P4|COMPLETED|Received Vaccination 2||12
7601105|NCT02543892|18711597|P3|COMPLETED|Received Vaccination 2||12
7601106|NCT02543892|18711598|P2|COMPLETED|Received Vaccination 2||11
7601107|NCT02543892|18711599|P1|COMPLETED|Received Vaccination 2||11
7601108|NCT02543892|18711592|P8|STARTED|Received Vaccination 2||50
7601109|NCT02543892|18711593|P7|STARTED|Received Vaccination 2||50
7601110|NCT02543892|18711594|P6|STARTED|Received Vaccination 2||50
7601111|NCT02543892|18711595|P5|STARTED|Received Vaccination 2||50
7601112|NCT02543892|18711596|P4|STARTED|Received Vaccination 2||12
7601113|NCT02543892|18711597|P3|STARTED|Received Vaccination 2||12
7601114|NCT02543892|18711598|P2|STARTED|Received Vaccination 2||12
7601115|NCT02543892|18711599|P1|STARTED|Received Vaccination 2||12
7601116|NCT02543892|18711592|P8|NOT COMPLETED|Received Vaccination 1||0
7601117|NCT02543892|18711593|P7|NOT COMPLETED|Received Vaccination 1||0
7601118|NCT02543892|18711594|P6|NOT COMPLETED|Received Vaccination 1||0
7601119|NCT02543892|18711595|P5|NOT COMPLETED|Received Vaccination 1||0
7601120|NCT02543892|18711596|P4|NOT COMPLETED|Received Vaccination 1||0
7601121|NCT02543892|18711597|P3|NOT COMPLETED|Received Vaccination 1||0
7601122|NCT02543892|18711598|P2|NOT COMPLETED|Received Vaccination 1||0
7601123|NCT02543892|18711599|P1|NOT COMPLETED|Received Vaccination 1||0
7601124|NCT02543892|18711592|P8|COMPLETED|Received Vaccination 1||50
7601125|NCT02543892|18711593|P7|COMPLETED|Received Vaccination 1||50
7601126|NCT02543892|18711594|P6|COMPLETED|Received Vaccination 1||50
7601127|NCT02543892|18711595|P5|COMPLETED|Received Vaccination 1||50
7601128|NCT02543892|18711596|P4|COMPLETED|Received Vaccination 1||12
7601129|NCT02543892|18711597|P3|COMPLETED|Received Vaccination 1||12
7601130|NCT02543892|18711598|P2|COMPLETED|Received Vaccination 1||12
7601131|NCT02543892|18711599|P1|COMPLETED|Received Vaccination 1||12
7601132|NCT02543892|18711592|P8|STARTED|Received Vaccination 1||50
7601133|NCT02543892|18711593|P7|STARTED|Received Vaccination 1||50
7601134|NCT02543892|18711594|P6|STARTED|Received Vaccination 1||50
7601135|NCT02543892|18711595|P5|STARTED|Received Vaccination 1||50
7601136|NCT02543892|18711596|P4|STARTED|Received Vaccination 1||12
7601137|NCT02543892|18711597|P3|STARTED|Received Vaccination 1||12
7601138|NCT02543892|18711598|P2|STARTED|Received Vaccination 1||12
7601139|NCT02543892|18711599|P1|STARTED|Received Vaccination 1||12
7601140|NCT02543840|18711647|P2|NOT COMPLETED|Overall Study||0
7601141|NCT02543840|18711648|P1|NOT COMPLETED|Overall Study||0
7601142|NCT02543840|18711647|P2|COMPLETED|Overall Study||62
7601143|NCT02543840|18711648|P1|COMPLETED|Overall Study||1050
7601144|NCT02543840|18711647|P2|12 Month Timepoint (t12)|Overall Study|22 new providers completed at 12 months; 21 completed at both 0 and 12 months. 19 completed only T0.|22
7601145|NCT02543840|18711648|P1|12 Month Timepoint (t12)|Overall Study|91 continued from 0 months (t0), 16 from 6 months (t6), 91 from t0 & t6; 391 added at 12 months.|391
7601146|NCT02543840|18711647|P2|6 Month Timepoint (t6)|Overall Study||0
7601147|NCT02543840|18711648|P1|6 Month Timepoint (t6)|Overall Study|593 participants started at 0 months; 188 repeated and 66 participants added at 6 months timepoint.|66
7601148|NCT02543840|18711647|P2|0 Month Timepoint (t0)|Overall Study||40
7601149|NCT02543840|18711648|P1|0 Month Timepoint (t0)|Overall Study||593
7601150|NCT02543840|18711647|P2|STARTED|Overall Study||62
7601151|NCT02543840|18711648|P1|STARTED|Overall Study|This is a quasi-experimental design, not a RCT. 1050 veterans did 1436 interviews at 3 time points.|1050
7601152|NCT02543801|18711666|P4|NOT COMPLETED|Overall Study||0
7601153|NCT02543801|18711667|P3|NOT COMPLETED|Overall Study||0
7601154|NCT02543801|18711668|P2|NOT COMPLETED|Overall Study||2
7601155|NCT02543801|18711669|P1|NOT COMPLETED|Overall Study||1
7601156|NCT02543801|18711666|P4|COMPLETED|Overall Study||59
7601157|NCT02543801|18711667|P3|COMPLETED|Overall Study||59
7601158|NCT02543801|18711668|P2|COMPLETED|Overall Study||58
7601159|NCT02543801|18711669|P1|COMPLETED|Overall Study||60
7601160|NCT02543801|18711666|P4|STARTED|Overall Study||59
7601161|NCT02543801|18711667|P3|STARTED|Overall Study||59
7601162|NCT02543801|18711668|P2|STARTED|Overall Study||60
7601163|NCT02543801|18711669|P1|STARTED|Overall Study||61
7601164|NCT02543658|18711689|P2|NOT COMPLETED|Overall Study||4
7601165|NCT02543658|18711690|P1|NOT COMPLETED|Overall Study||0
7601166|NCT02543658|18711689|P2|COMPLETED|Overall Study||36
7601167|NCT02543658|18711690|P1|COMPLETED|Overall Study||40
7601168|NCT02543658|18711689|P2|STARTED|Overall Study||40
7601169|NCT02543658|18711690|P1|STARTED|Overall Study||40
7601170|NCT02543554|18711718|P2|NOT COMPLETED|Overall Study||0
7601171|NCT02543554|18711719|P1|NOT COMPLETED|Overall Study||0
7601172|NCT02543554|18711718|P2|COMPLETED|Overall Study||513
7601173|NCT02543554|18711719|P1|COMPLETED|Overall Study||1192
7601174|NCT02543554|18711718|P2|STARTED|Overall Study||513
7601175|NCT02543554|18711719|P1|STARTED|Overall Study||1192
7601176|NCT02543528|18711727|P5|NOT COMPLETED|Extended Wear Period||0
7601177|NCT02543528|18711728|P4|NOT COMPLETED|Extended Wear Period||12
7601178|NCT02543528|18711729|P3|NOT COMPLETED|Extended Wear Period||23
7601179|NCT02543528|18711730|P2|NOT COMPLETED|Extended Wear Period||21
7601180|NCT02543528|18711731|P1|NOT COMPLETED|Extended Wear Period||28
7601181|NCT02543528|18711727|P5|COMPLETED|Extended Wear Period||0
7601182|NCT02543528|18711728|P4|COMPLETED|Extended Wear Period||23
7601183|NCT02543528|18711729|P3|COMPLETED|Extended Wear Period||13
7601184|NCT02543528|18711730|P2|COMPLETED|Extended Wear Period||14
7601185|NCT02543528|18711731|P1|COMPLETED|Extended Wear Period||8
7601186|NCT02543528|18711727|P5|STARTED|Extended Wear Period||0
7601187|NCT02543528|18711728|P4|STARTED|Extended Wear Period||35
7601188|NCT02543528|18711729|P3|STARTED|Extended Wear Period||36
7601189|NCT02543528|18711730|P2|STARTED|Extended Wear Period||35
7601190|NCT02543528|18711731|P1|STARTED|Extended Wear Period||36
7601191|NCT02543528|18711727|P5|NOT COMPLETED|Adaptation Period||26
7601192|NCT02543528|18711728|P4|NOT COMPLETED|Adaptation Period||0
7601193|NCT02543528|18711729|P3|NOT COMPLETED|Adaptation Period||0
7601194|NCT02543528|18711730|P2|NOT COMPLETED|Adaptation Period||0
7601195|NCT02543528|18711731|P1|NOT COMPLETED|Adaptation Period||0
7601196|NCT02543528|18711727|P5|COMPLETED|Adaptation Period||142
7601197|NCT02543528|18711728|P4|COMPLETED|Adaptation Period||0
7601198|NCT02543528|18711729|P3|COMPLETED|Adaptation Period||0
7601199|NCT02543528|18711730|P2|COMPLETED|Adaptation Period||0
7601200|NCT02543528|18711731|P1|COMPLETED|Adaptation Period||0
7601201|NCT02543528|18711727|P5|STARTED|Adaptation Period||168
7601202|NCT02543528|18711728|P4|STARTED|Adaptation Period||0
7601203|NCT02543528|18711729|P3|STARTED|Adaptation Period||0
7601204|NCT02543528|18711730|P2|STARTED|Adaptation Period||0
7601205|NCT02543528|18711731|P1|STARTED|Adaptation Period||0
7601206|NCT02543437|18711750|P1|NOT COMPLETED|Overall Study||0
7601207|NCT02543437|18711750|P1|COMPLETED|Overall Study||117
7601208|NCT02543437|18711750|P1|STARTED|Overall Study||117
7601209|NCT02543398|18711757|P2|NOT COMPLETED|Overall Study||0
7601210|NCT02543398|18711758|P1|NOT COMPLETED|Overall Study||0
7601211|NCT02543398|18711757|P2|COMPLETED|Overall Study||20
7601212|NCT02543398|18711758|P1|COMPLETED|Overall Study||20
7601213|NCT02543398|18711757|P2|STARTED|Overall Study||20
7601214|NCT02543398|18711758|P1|STARTED|Overall Study||20
7601215|NCT02543346|18711764|P4|NOT COMPLETED|Second Treatment Visit||0
7601216|NCT02543346|18711765|P3|NOT COMPLETED|Second Treatment Visit||0
7601217|NCT02543346|18711766|P2|NOT COMPLETED|Second Treatment Visit||0
7601218|NCT02543346|18711767|P1|NOT COMPLETED|Second Treatment Visit||0
7601219|NCT02543346|18711764|P4|COMPLETED|Second Treatment Visit||21
7601220|NCT02543346|18711765|P3|COMPLETED|Second Treatment Visit||22
7601221|NCT02543346|18711766|P2|COMPLETED|Second Treatment Visit||23
7601222|NCT02543346|18711767|P1|COMPLETED|Second Treatment Visit||25
7601223|NCT02543346|18711764|P4|STARTED|Second Treatment Visit||21
7601224|NCT02543346|18711765|P3|STARTED|Second Treatment Visit||22
7601225|NCT02543346|18711766|P2|STARTED|Second Treatment Visit||23
7601226|NCT02543346|18711767|P1|STARTED|Second Treatment Visit||25
7601227|NCT02543346|18711764|P4|NOT COMPLETED|Second Priming Visit||2
7601228|NCT02543346|18711765|P3|NOT COMPLETED|Second Priming Visit||2
7601229|NCT02543346|18711766|P2|NOT COMPLETED|Second Priming Visit||2
7601230|NCT02543346|18711767|P1|NOT COMPLETED|Second Priming Visit||1
7601231|NCT02543346|18711764|P4|COMPLETED|Second Priming Visit||21
7601232|NCT02543346|18711765|P3|COMPLETED|Second Priming Visit||22
7601233|NCT02543346|18711766|P2|COMPLETED|Second Priming Visit||23
7601234|NCT02543346|18711767|P1|COMPLETED|Second Priming Visit||25
7601235|NCT02543346|18711764|P4|STARTED|Second Priming Visit||23
7601236|NCT02543346|18711765|P3|STARTED|Second Priming Visit||24
7601237|NCT02543346|18711766|P2|STARTED|Second Priming Visit||25
7601238|NCT02543346|18711767|P1|STARTED|Second Priming Visit||26
7601239|NCT02543346|18711764|P4|NOT COMPLETED|Washout (at Least 14 Days)||0
7601240|NCT02543346|18711765|P3|NOT COMPLETED|Washout (at Least 14 Days)||0
7601241|NCT02543346|18711766|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
7601242|NCT02543346|18711767|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
7601243|NCT02543346|18711764|P4|COMPLETED|Washout (at Least 14 Days)||23
7601244|NCT02543346|18711765|P3|COMPLETED|Washout (at Least 14 Days)||24
7601245|NCT02543346|18711766|P2|COMPLETED|Washout (at Least 14 Days)||25
7601246|NCT02543346|18711767|P1|COMPLETED|Washout (at Least 14 Days)||26
7601247|NCT02543346|18711764|P4|STARTED|Washout (at Least 14 Days)||23
7601248|NCT02543346|18711765|P3|STARTED|Washout (at Least 14 Days)||24
7601249|NCT02543346|18711766|P2|STARTED|Washout (at Least 14 Days)||25
7601250|NCT02543346|18711767|P1|STARTED|Washout (at Least 14 Days)||26
7601251|NCT02543346|18711764|P4|NOT COMPLETED|First Treatment Visit||0
7601252|NCT02543346|18711765|P3|NOT COMPLETED|First Treatment Visit||0
7601253|NCT02543346|18711766|P2|NOT COMPLETED|First Treatment Visit||0
7601254|NCT02543346|18711767|P1|NOT COMPLETED|First Treatment Visit||0
7601255|NCT02543346|18711764|P4|COMPLETED|First Treatment Visit||23
7601256|NCT02543346|18711765|P3|COMPLETED|First Treatment Visit||24
7601257|NCT02543346|18711766|P2|COMPLETED|First Treatment Visit||25
7601258|NCT02543346|18711767|P1|COMPLETED|First Treatment Visit||26
7601259|NCT02543346|18711764|P4|STARTED|First Treatment Visit||23
7601260|NCT02543346|18711765|P3|STARTED|First Treatment Visit||24
7601261|NCT02543346|18711766|P2|STARTED|First Treatment Visit||25
7601262|NCT02543346|18711767|P1|STARTED|First Treatment Visit||26
7601263|NCT02543346|18711764|P4|NOT COMPLETED|First Priming Visit||0
7601264|NCT02543346|18711765|P3|NOT COMPLETED|First Priming Visit||0
7601265|NCT02543346|18711766|P2|NOT COMPLETED|First Priming Visit||0
7601266|NCT02543346|18711767|P1|NOT COMPLETED|First Priming Visit||0
7601267|NCT02543346|18711764|P4|COMPLETED|First Priming Visit||23
7601268|NCT02543346|18711765|P3|COMPLETED|First Priming Visit||24
7601269|NCT02543346|18711766|P2|COMPLETED|First Priming Visit||25
7601270|NCT02543346|18711767|P1|COMPLETED|First Priming Visit||26
7601271|NCT02543346|18711764|P4|STARTED|First Priming Visit||23
7601272|NCT02543346|18711765|P3|STARTED|First Priming Visit||24
7601273|NCT02543346|18711766|P2|STARTED|First Priming Visit||25
7601274|NCT02543346|18711767|P1|STARTED|First Priming Visit||26
7601275|NCT02543294|18711793|P1|NOT COMPLETED|Overall Study||12
7601276|NCT02543294|18711793|P1|COMPLETED|Overall Study||8
7601277|NCT02543294|18711793|P1|STARTED|Overall Study||20
7601278|NCT02542943|18711801|P3|NOT COMPLETED|Overall Study||0
7601279|NCT02542943|18711802|P2|NOT COMPLETED|Overall Study||1
7601280|NCT02542943|18711803|P1|NOT COMPLETED|Overall Study||1
7601281|NCT02542943|18711801|P3|COMPLETED|Overall Study||81
7601282|NCT02542943|18711802|P2|COMPLETED|Overall Study||79
7601283|NCT02542943|18711803|P1|COMPLETED|Overall Study||78
7601284|NCT02542943|18711801|P3|STARTED|Overall Study||81
7601285|NCT02542943|18711802|P2|STARTED|Overall Study||80
7601286|NCT02542943|18711803|P1|STARTED|Overall Study||79
7601287|NCT02542865|18711830|P2|NOT COMPLETED|Overall Study||0
7601288|NCT02542865|18711831|P1|NOT COMPLETED|Overall Study||17
7601289|NCT02542865|18711830|P2|COMPLETED|Overall Study||462
7601290|NCT02542865|18711831|P1|COMPLETED|Overall Study||445
7601291|NCT02542865|18711830|P2|Treated|Overall Study||462
7601292|NCT02542865|18711831|P1|Treated|Overall Study||460
7601293|NCT02542865|18711830|P2|STARTED|Overall Study||462
7601294|NCT02542865|18711831|P1|STARTED|Overall Study||462
7601295|NCT02542761|18711875|P2|NOT COMPLETED|Second Intervention||0
7601296|NCT02542761|18711876|P1|NOT COMPLETED|Second Intervention||0
7601297|NCT02542761|18711875|P2|COMPLETED|Second Intervention||5
7601298|NCT02542761|18711876|P1|COMPLETED|Second Intervention||5
7601299|NCT02542761|18711875|P2|STARTED|Second Intervention||5
7601300|NCT02542761|18711876|P1|STARTED|Second Intervention||5
7601301|NCT02542761|18711875|P2|NOT COMPLETED|Acclimation Period 2||0
7601302|NCT02542761|18711876|P1|NOT COMPLETED|Acclimation Period 2||0
7601303|NCT02542761|18711875|P2|COMPLETED|Acclimation Period 2||5
7601304|NCT02542761|18711876|P1|COMPLETED|Acclimation Period 2||5
7601305|NCT02542761|18711875|P2|STARTED|Acclimation Period 2||5
7601306|NCT02542761|18711876|P1|STARTED|Acclimation Period 2||5
7601307|NCT02542761|18711875|P2|NOT COMPLETED|First Intervention||0
7601308|NCT02542761|18711876|P1|NOT COMPLETED|First Intervention||0
7601309|NCT02542761|18711875|P2|COMPLETED|First Intervention||5
7601310|NCT02542761|18711876|P1|COMPLETED|First Intervention||5
7601311|NCT02542761|18711875|P2|STARTED|First Intervention||5
7601312|NCT02542761|18711876|P1|STARTED|First Intervention||5
7601313|NCT02542761|18711875|P2|NOT COMPLETED|Acclimation Period 1||0
7601314|NCT02542761|18711876|P1|NOT COMPLETED|Acclimation Period 1||0
7601315|NCT02542761|18711875|P2|COMPLETED|Acclimation Period 1||5
7601316|NCT02542761|18711876|P1|COMPLETED|Acclimation Period 1||5
7601317|NCT02542761|18711875|P2|STARTED|Acclimation Period 1||5
7601318|NCT02542761|18711876|P1|STARTED|Acclimation Period 1||5
7601319|NCT02542631|18711894|P2|NOT COMPLETED|Overall Study||31
7601320|NCT02542631|18711895|P1|NOT COMPLETED|Overall Study||31
7601321|NCT02542631|18711894|P2|COMPLETED|Overall Study||108
7601322|NCT02542631|18711895|P1|COMPLETED|Overall Study||108
7601323|NCT02542631|18711894|P2|STARTED|Overall Study||139
7601324|NCT02542631|18711895|P1|STARTED|Overall Study||139
7601325|NCT02542605|18711917|P3|NOT COMPLETED|Part B: Randomization Phase||1
7601326|NCT02542605|18711918|P2|NOT COMPLETED|Part B: Randomization Phase||0
7601327|NCT02542605|18711919|P1|NOT COMPLETED|Part B: Randomization Phase||0
7601328|NCT02542605|18711917|P3|COMPLETED|Part B: Randomization Phase||7
7601329|NCT02542605|18711918|P2|COMPLETED|Part B: Randomization Phase||9
7601330|NCT02542605|18711919|P1|COMPLETED|Part B: Randomization Phase||0
7601331|NCT02542605|18711917|P3|Received Placebo/Erenumab|Part B: Randomization Phase||7
7601332|NCT02542605|18711918|P2|Received Placebo/Erenumab|Part B: Randomization Phase||9
7601333|NCT02542605|18711919|P1|Received Placebo/Erenumab|Part B: Randomization Phase||0
7601334|NCT02542605|18711917|P3|PACAP-38 naïve Participants|Part B: Randomization Phase||8
7601335|NCT02542605|18711918|P2|PACAP-38 naïve Participants|Part B: Randomization Phase||7
7601336|NCT02542605|18711919|P1|PACAP-38 naïve Participants|Part B: Randomization Phase||0
7601337|NCT02542605|18711917|P3|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
7601338|NCT02542605|18711918|P2|Not PACAP-38 naïve Participants|Part B: Randomization Phase||2
7601339|NCT02542605|18711919|P1|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
7601340|NCT02542605|18711917|P3|STARTED|Part B: Randomization Phase||8
7601341|NCT02542605|18711918|P2|STARTED|Part B: Randomization Phase||9
7601342|NCT02542605|18711919|P1|STARTED|Part B: Randomization Phase||0
7601343|NCT02542605|18711917|P3|NOT COMPLETED|Part B: Challenge Phase||0
7601344|NCT02542605|18711918|P2|NOT COMPLETED|Part B: Challenge Phase||0
7601345|NCT02542605|18711919|P1|NOT COMPLETED|Part B: Challenge Phase||1
7601346|NCT02542605|18711917|P3|COMPLETED|Part B: Challenge Phase||0
7601347|NCT02542605|18711918|P2|COMPLETED|Part B: Challenge Phase||0
7601348|NCT02542605|18711919|P1|COMPLETED|Part B: Challenge Phase||22
7601349|NCT02542605|18711917|P3|Proceeded to Randomization Phase|Part B: Challenge Phase||0
7601350|NCT02542605|18711918|P2|Proceeded to Randomization Phase|Part B: Challenge Phase||0
7601351|NCT02542605|18711919|P1|Proceeded to Randomization Phase|Part B: Challenge Phase||15
7601352|NCT02542605|18711917|P3|Received PACAP-38|Part B: Challenge Phase||0
7601353|NCT02542605|18711918|P2|Received PACAP-38|Part B: Challenge Phase||0
7601354|NCT02542605|18711919|P1|Received PACAP-38|Part B: Challenge Phase||23
7601355|NCT02542605|18711917|P3|STARTED|Part B: Challenge Phase||0
7601356|NCT02542605|18711918|P2|STARTED|Part B: Challenge Phase||0
7601357|NCT02542605|18711919|P1|STARTED|Part B: Challenge Phase||23
7601358|NCT02542605|18711917|P3|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
7601359|NCT02542605|18711918|P2|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
7601360|NCT02542605|18711919|P1|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
7601361|NCT02542605|18711917|P3|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
7601362|NCT02542605|18711918|P2|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
7601363|NCT02542605|18711919|P1|COMPLETED|Part A: PACAP-38 Dose Selection Phase||12
7601364|NCT02542605|18711917|P3|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
7601365|NCT02542605|18711918|P2|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
7601366|NCT02542605|18711919|P1|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||2
7601367|NCT02542605|18711917|P3|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
7601368|NCT02542605|18711918|P2|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
7601369|NCT02542605|18711919|P1|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||12
7601370|NCT02542605|18711917|P3|STARTED|Part A: PACAP-38 Dose Selection Phase||0
7601371|NCT02542605|18711918|P2|STARTED|Part A: PACAP-38 Dose Selection Phase||0
7601372|NCT02542605|18711919|P1|STARTED|Part A: PACAP-38 Dose Selection Phase||12
7601373|NCT02542462|18711970|P4|NOT COMPLETED|Overall Study||1
7601374|NCT02542462|18711971|P3|NOT COMPLETED|Overall Study||0
7601375|NCT02542462|18711972|P2|NOT COMPLETED|Overall Study||0
7601376|NCT02542462|18711973|P1|NOT COMPLETED|Overall Study||0
7601377|NCT02542462|18711970|P4|COMPLETED|Overall Study||25
7601378|NCT02542462|18711971|P3|COMPLETED|Overall Study||25
7601379|NCT02542462|18711972|P2|COMPLETED|Overall Study||25
7601380|NCT02542462|18711973|P1|COMPLETED|Overall Study||25
7601381|NCT02542462|18711970|P4|STARTED|Overall Study||26
7601382|NCT02542462|18711971|P3|STARTED|Overall Study||25
7601383|NCT02542462|18711972|P2|STARTED|Overall Study||25
7601384|NCT02542462|18711973|P1|STARTED|Overall Study||25
7601385|NCT02542410|18711987|P2|NOT COMPLETED|Overall Study||1
7601386|NCT02542410|18711988|P1|NOT COMPLETED|Overall Study||2
7601387|NCT02542410|18711987|P2|COMPLETED|Overall Study||4
7601388|NCT02542410|18711988|P1|COMPLETED|Overall Study||3
7601389|NCT02542410|18711987|P2|STARTED|Overall Study||5
7601390|NCT02542410|18711988|P1|STARTED|Overall Study||5
7601391|NCT02542280|18711998|P2|NOT COMPLETED|Overall Study||8
7601392|NCT02542280|18711999|P1|NOT COMPLETED|Overall Study||12
7601393|NCT02542280|18711998|P2|COMPLETED|Overall Study||167
7601394|NCT02542280|18711999|P1|COMPLETED|Overall Study||162
7601395|NCT02542280|18711998|P2|STARTED|Overall Study||175
7601396|NCT02542280|18711999|P1|STARTED|Overall Study||174
7601397|NCT02542267|18712007|P1|NOT COMPLETED|Overall Study||77
7601398|NCT02542267|18712007|P1|COMPLETED|Overall Study||31
7601399|NCT02542267|18712007|P1|STARTED|Overall Study||108
7601400|NCT02542072|18712015|P2|NOT COMPLETED|Second Intervention (1 Month)||0
7601401|NCT02542072|18712016|P1|NOT COMPLETED|Second Intervention (1 Month)||2
7601402|NCT02542072|18712015|P2|COMPLETED|Second Intervention (1 Month)||43
7601403|NCT02542072|18712016|P1|COMPLETED|Second Intervention (1 Month)||37
7601404|NCT02542072|18712015|P2|STARTED|Second Intervention (1 Month)||43
7601405|NCT02542072|18712016|P1|STARTED|Second Intervention (1 Month)||39
7601406|NCT02542072|18712015|P2|NOT COMPLETED|First Intervention (1 Month)||3
7601407|NCT02542072|18712016|P1|NOT COMPLETED|First Intervention (1 Month)||5
7601408|NCT02542072|18712015|P2|COMPLETED|First Intervention (1 Month)||43
7601409|NCT02542072|18712016|P1|COMPLETED|First Intervention (1 Month)||39
7601410|NCT02542072|18712015|P2|STARTED|First Intervention (1 Month)||46
7601411|NCT02542072|18712016|P1|STARTED|First Intervention (1 Month)||44
7601412|NCT02542046|18712119|P3|NOT COMPLETED|Overall Study||0
7601413|NCT02542046|18712120|P2|NOT COMPLETED|Overall Study||0
7601414|NCT02542046|18712121|P1|NOT COMPLETED|Overall Study||0
7601415|NCT02542046|18712119|P3|COMPLETED|Overall Study||300
7601416|NCT02542046|18712120|P2|COMPLETED|Overall Study||300
7601417|NCT02542046|18712121|P1|COMPLETED|Overall Study||300
7601418|NCT02542046|18712119|P3|STARTED|Overall Study||300
7601419|NCT02542046|18712120|P2|STARTED|Overall Study||300
7601420|NCT02542046|18712121|P1|STARTED|Overall Study||300
7601421|NCT02541942|18712135|P1|NOT COMPLETED|Overall Study||0
7601422|NCT02541942|18712135|P1|COMPLETED|Overall Study||19
7601423|NCT02541942|18712135|P1|STARTED|Overall Study||19
7601424|NCT02541903|18712140|P1|NOT COMPLETED|Overall Study||1
7601425|NCT02541903|18712140|P1|COMPLETED|Overall Study||7
7601426|NCT02541903|18712140|P1|STARTED|Overall Study||8
7601427|NCT02541864|18712149|P2|NOT COMPLETED|Overall Study||0
7601428|NCT02541864|18712150|P1|NOT COMPLETED|Overall Study||0
7601429|NCT02541864|18712149|P2|COMPLETED|Overall Study||166
7601430|NCT02541864|18712150|P1|COMPLETED|Overall Study||164
7601431|NCT02541864|18712149|P2|STARTED|Overall Study||166
7601432|NCT02541864|18712150|P1|STARTED|Overall Study||164
7601433|NCT02541812|18712158|P2|NOT COMPLETED|Overall Study||0
7601434|NCT02541812|18712159|P1|NOT COMPLETED|Overall Study||0
7601435|NCT02541812|18712158|P2|COMPLETED|Overall Study||10
7601436|NCT02541812|18712159|P1|COMPLETED|Overall Study||10
7601437|NCT02541812|18712158|P2|STARTED|Overall Study||10
7601438|NCT02541812|18712159|P1|STARTED|Overall Study||10
7601439|NCT02541669|18712171|P5|NOT COMPLETED|Double-Blinded Treatment Period||1
7601440|NCT02541669|18712172|P4|NOT COMPLETED|Double-Blinded Treatment Period||0
7601441|NCT02541669|18712173|P3|NOT COMPLETED|Double-Blinded Treatment Period||1
7601442|NCT02541669|18712174|P2|NOT COMPLETED|Double-Blinded Treatment Period||0
7601443|NCT02541669|18712175|P1|NOT COMPLETED|Double-Blinded Treatment Period||0
7601444|NCT02541669|18712171|P5|COMPLETED|Double-Blinded Treatment Period||15
7601445|NCT02541669|18712172|P4|COMPLETED|Double-Blinded Treatment Period||16
7601446|NCT02541669|18712173|P3|COMPLETED|Double-Blinded Treatment Period||15
7601447|NCT02541669|18712174|P2|COMPLETED|Double-Blinded Treatment Period||0
7601448|NCT02541669|18712175|P1|COMPLETED|Double-Blinded Treatment Period||0
7601449|NCT02541669|18712171|P5|STARTED|Double-Blinded Treatment Period||16
7601450|NCT02541669|18712172|P4|STARTED|Double-Blinded Treatment Period||16
7601451|NCT02541669|18712173|P3|STARTED|Double-Blinded Treatment Period||16
7601452|NCT02541669|18712174|P2|STARTED|Double-Blinded Treatment Period||0
7601453|NCT02541669|18712175|P1|STARTED|Double-Blinded Treatment Period||0
7601454|NCT02541669|18712171|P5|NOT COMPLETED|Open Label Treatment Period||0
7601455|NCT02541669|18712172|P4|NOT COMPLETED|Open Label Treatment Period||0
7601456|NCT02541669|18712173|P3|NOT COMPLETED|Open Label Treatment Period||0
7601457|NCT02541669|18712174|P2|NOT COMPLETED|Open Label Treatment Period||0
7601458|NCT02541669|18712175|P1|NOT COMPLETED|Open Label Treatment Period||0
7601459|NCT02541669|18712171|P5|COMPLETED|Open Label Treatment Period||0
7601460|NCT02541669|18712172|P4|COMPLETED|Open Label Treatment Period||0
7601461|NCT02541669|18712173|P3|COMPLETED|Open Label Treatment Period||0
7601462|NCT02541669|18712174|P2|COMPLETED|Open Label Treatment Period||8
7601463|NCT02541669|18712175|P1|COMPLETED|Open Label Treatment Period||8
7601464|NCT02541669|18712171|P5|STARTED|Open Label Treatment Period||0
7601465|NCT02541669|18712172|P4|STARTED|Open Label Treatment Period||0
7601466|NCT02541669|18712173|P3|STARTED|Open Label Treatment Period||0
7601467|NCT02541669|18712174|P2|STARTED|Open Label Treatment Period||8
7601468|NCT02541669|18712175|P1|STARTED|Open Label Treatment Period||8
7601469|NCT02541604|18712222|P12|NOT COMPLETED|Overall Study||3
7601470|NCT02541604|18712223|P11|NOT COMPLETED|Overall Study||2
7601471|NCT02541604|18712224|P10|NOT COMPLETED|Overall Study||4
7601472|NCT02541604|18712225|P9|NOT COMPLETED|Overall Study||4
7601473|NCT02541604|18712226|P8|NOT COMPLETED|Overall Study||10
7601474|NCT02541604|18712227|P7|NOT COMPLETED|Overall Study||10
7601475|NCT02541604|18712228|P6|NOT COMPLETED|Overall Study||10
7601476|NCT02541604|18712229|P5|NOT COMPLETED|Overall Study||10
7601477|NCT02541604|18712230|P4|NOT COMPLETED|Overall Study||3
7601478|NCT02541604|18712231|P3|NOT COMPLETED|Overall Study||11
7601479|NCT02541604|18712232|P2|NOT COMPLETED|Overall Study||9
7601480|NCT02541604|18712233|P1|NOT COMPLETED|Overall Study||11
7601481|NCT02541604|18712222|P12|COMPLETED|Overall Study||0
7601482|NCT02541604|18712223|P11|COMPLETED|Overall Study||0
7601483|NCT02541604|18712224|P10|COMPLETED|Overall Study||0
7601484|NCT02541604|18712225|P9|COMPLETED|Overall Study||0
7601485|NCT02541604|18712226|P8|COMPLETED|Overall Study||0
7601486|NCT02541604|18712227|P7|COMPLETED|Overall Study||0
7601487|NCT02541604|18712228|P6|COMPLETED|Overall Study||0
7601488|NCT02541604|18712229|P5|COMPLETED|Overall Study||0
7601489|NCT02541604|18712230|P4|COMPLETED|Overall Study||0
7601490|NCT02541604|18712231|P3|COMPLETED|Overall Study||0
7601491|NCT02541604|18712232|P2|COMPLETED|Overall Study||0
7601492|NCT02541604|18712233|P1|COMPLETED|Overall Study||0
7601493|NCT02541604|18712222|P12|STARTED|Overall Study||3
7601494|NCT02541604|18712223|P11|STARTED|Overall Study||2
7601495|NCT02541604|18712224|P10|STARTED|Overall Study||4
7601496|NCT02541604|18712225|P9|STARTED|Overall Study||4
7601497|NCT02541604|18712226|P8|STARTED|Overall Study||10
7601498|NCT02541604|18712227|P7|STARTED|Overall Study||10
7601499|NCT02541604|18712228|P6|STARTED|Overall Study||10
7601500|NCT02541604|18712229|P5|STARTED|Overall Study||10
7601501|NCT02541604|18712230|P4|STARTED|Overall Study||3
7601502|NCT02541604|18712231|P3|STARTED|Overall Study||11
7601503|NCT02541604|18712232|P2|STARTED|Overall Study||9
7601504|NCT02541604|18712233|P1|STARTED|Overall Study||11
7601505|NCT02541565|18712338|P1|NOT COMPLETED|Overall Study||3
7601506|NCT02541565|18712338|P1|COMPLETED|Overall Study||27
7601507|NCT02541565|18712338|P1|STARTED|Overall Study||30
7601508|NCT02541422|18712342|P2|NOT COMPLETED|Second Intervention||0
7601509|NCT02541422|18712343|P1|NOT COMPLETED|Second Intervention||0
7601510|NCT02541422|18712342|P2|COMPLETED|Second Intervention||26
7601511|NCT02541422|18712343|P1|COMPLETED|Second Intervention||23
7601512|NCT02541422|18712342|P2|STARTED|Second Intervention||26
7601513|NCT02541422|18712343|P1|STARTED|Second Intervention||23
7601514|NCT02541422|18712342|P2|NOT COMPLETED|First Intervention||0
7601515|NCT02541422|18712343|P1|NOT COMPLETED|First Intervention||0
7601516|NCT02541422|18712342|P2|COMPLETED|First Intervention||26
7601517|NCT02541422|18712343|P1|COMPLETED|First Intervention||23
7601518|NCT02541422|18712342|P2|STARTED|First Intervention||26
7601519|NCT02541422|18712343|P1|STARTED|First Intervention||23
7601520|NCT02540850|18712352|P3|NOT COMPLETED|Overall Study||34
7601521|NCT02540850|18712353|P2|NOT COMPLETED|Overall Study||66
7601522|NCT02540850|18712354|P1|NOT COMPLETED|Overall Study||69
7601523|NCT02540850|18712352|P3|COMPLETED|Overall Study||410
7601524|NCT02540850|18712353|P2|COMPLETED|Overall Study||330
7601525|NCT02540850|18712354|P1|COMPLETED|Overall Study||291
7601526|NCT02540850|18712352|P3|STARTED|Overall Study||444
7601527|NCT02540850|18712353|P2|STARTED|Overall Study||396
7601528|NCT02540850|18712354|P1|STARTED|Overall Study||360
7601529|NCT02540772|18712382|P2|NOT COMPLETED|Overall Study||0
7601530|NCT02540772|18712383|P1|NOT COMPLETED|Overall Study||0
7601531|NCT02540772|18712382|P2|COMPLETED|Overall Study||10
7601532|NCT02540772|18712383|P1|COMPLETED|Overall Study||10
7601533|NCT02540772|18712382|P2|STARTED|Overall Study||10
7601534|NCT02540772|18712383|P1|STARTED|Overall Study||10
7601535|NCT02540668|18712395|P2|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||1
7601536|NCT02540668|18712396|P1|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||0
7601537|NCT02540668|18712395|P2|COMPLETED|Period 2 - LY3314814 and Warfarin||14
7601538|NCT02540668|18712396|P1|COMPLETED|Period 2 - LY3314814 and Warfarin||0
7601539|NCT02540668|18712395|P2|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was co-administered with LY3314814 only in Period 2.|15
7601540|NCT02540668|18712396|P1|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was administered alone only in Period 1.|0
7601541|NCT02540668|18712395|P2|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
7601542|NCT02540668|18712396|P1|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
7601543|NCT02540668|18712395|P2|COMPLETED|Period 1 - Warfarin Single Dose||0
7601544|NCT02540668|18712396|P1|COMPLETED|Period 1 - Warfarin Single Dose||15
7601545|NCT02540668|18712395|P2|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||0
7601546|NCT02540668|18712396|P1|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||15
7601547|NCT02540668|18712395|P2|STARTED|Period 1 - Warfarin Single Dose||0
7601548|NCT02540668|18712396|P1|STARTED|Period 1 - Warfarin Single Dose||15
7601549|NCT02540629|18712415|P2|NOT COMPLETED|Overall Study||0
7601550|NCT02540629|18712416|P1|NOT COMPLETED|Overall Study||0
7601551|NCT02540629|18712415|P2|COMPLETED|Overall Study||6469
7601552|NCT02540629|18712416|P1|COMPLETED|Overall Study||6201
7601553|NCT02540629|18712415|P2|STARTED|Overall Study||6469
7601554|NCT02540629|18712416|P1|STARTED|Overall Study||6201
7601555|NCT02540538|18712427|P3|NOT COMPLETED|Overall Study||0
7601556|NCT02540538|18712428|P2|NOT COMPLETED|Overall Study||1
7601557|NCT02540538|18712429|P1|NOT COMPLETED|Overall Study||0
7601558|NCT02540538|18712427|P3|COMPLETED|Overall Study||10
7601559|NCT02540538|18712428|P2|COMPLETED|Overall Study||11
7601560|NCT02540538|18712429|P1|COMPLETED|Overall Study||12
7601561|NCT02540538|18712427|P3|STARTED|Overall Study||10
7601562|NCT02540538|18712428|P2|STARTED|Overall Study||12
7601563|NCT02540538|18712429|P1|STARTED|Overall Study||12
7601564|NCT02540447|18712445|P2|NOT COMPLETED|Overall Study||0
7601565|NCT02540447|18712446|P1|NOT COMPLETED|Overall Study||0
7601566|NCT02540447|18712445|P2|COMPLETED|Overall Study||40
7601567|NCT02540447|18712446|P1|COMPLETED|Overall Study||40
7601568|NCT02540447|18712445|P2|STARTED|Overall Study||40
7601569|NCT02540447|18712446|P1|STARTED|Overall Study||40
7601570|NCT02540434|18712462|P2|NOT COMPLETED|Overall Study||0
7601571|NCT02540434|18712463|P1|NOT COMPLETED|Overall Study||0
7601572|NCT02540434|18712462|P2|COMPLETED|Overall Study||1
7601573|NCT02540434|18712463|P1|COMPLETED|Overall Study||1
7601574|NCT02540434|18712462|P2|STARTED|Overall Study||1
7601575|NCT02540434|18712463|P1|STARTED|Overall Study||1
7601576|NCT02540356|18712497|P2|NOT COMPLETED|Overall Study||0
7601577|NCT02540356|18712498|P1|NOT COMPLETED|Overall Study||1
7601578|NCT02540356|18712497|P2|COMPLETED|Overall Study||0
7601579|NCT02540356|18712498|P1|COMPLETED|Overall Study||0
7601580|NCT02540356|18712497|P2|STARTED|Overall Study||0
7601581|NCT02540356|18712498|P1|STARTED|Overall Study||1
7601582|NCT02540291|18712533|P4|NOT COMPLETED|Overall Study||7
7601583|NCT02540291|18712534|P3|NOT COMPLETED|Overall Study||7
7601584|NCT02540291|18712535|P2|NOT COMPLETED|Overall Study||8
7601585|NCT02540291|18712536|P1|NOT COMPLETED|Overall Study||8
7601586|NCT02540291|18712533|P4|COMPLETED|Overall Study||0
7601587|NCT02540291|18712534|P3|COMPLETED|Overall Study||0
7601588|NCT02540291|18712535|P2|COMPLETED|Overall Study||0
7601589|NCT02540291|18712536|P1|COMPLETED|Overall Study||0
7601590|NCT02540291|18712533|P4|STARTED|Overall Study||7
7601591|NCT02540291|18712534|P3|STARTED|Overall Study||7
7601592|NCT02540291|18712535|P2|STARTED|Overall Study||8
7601593|NCT02540291|18712536|P1|STARTED|Overall Study||8
7601594|NCT02540265|18712571|P3|NOT COMPLETED|Overall Study||1
7601595|NCT02540265|18712572|P2|NOT COMPLETED|Overall Study||0
7601596|NCT02540265|18712573|P1|NOT COMPLETED|Overall Study||0
7601597|NCT02540265|18712571|P3|COMPLETED|Overall Study||18
7601598|NCT02540265|18712572|P2|COMPLETED|Overall Study||20
7601599|NCT02540265|18712573|P1|COMPLETED|Overall Study||20
7601600|NCT02540265|18712571|P3|Treatment Completion|Overall Study||18
7601601|NCT02540265|18712572|P2|Treatment Completion|Overall Study||19
7601602|NCT02540265|18712573|P1|Treatment Completion|Overall Study||20
7601603|NCT02540265|18712571|P3|STARTED|Overall Study||19
7601604|NCT02540265|18712572|P2|STARTED|Overall Study||20
7601605|NCT02540265|18712573|P1|STARTED|Overall Study||20
7601606|NCT02540226|18712595|P2|NOT COMPLETED|Overall Study||1
7601607|NCT02540226|18712596|P1|NOT COMPLETED|Overall Study||2
7601608|NCT02540226|18712595|P2|COMPLETED|Overall Study||32
7601609|NCT02540226|18712596|P1|COMPLETED|Overall Study||31
7601610|NCT02540226|18712595|P2|STARTED|Overall Study||33
7601611|NCT02540226|18712596|P1|STARTED|Overall Study||33
7601612|NCT02540213|18712628|P1|NOT COMPLETED|Overall Study||39
7601613|NCT02540213|18712628|P1|COMPLETED|Overall Study||201
7601614|NCT02540213|18712628|P1|STARTED|Overall Study||240
7601615|NCT02540161|18712653|P4|NOT COMPLETED|Overall Study||0
7601616|NCT02540161|18712654|P3|NOT COMPLETED|Overall Study||0
7601617|NCT02540161|18712655|P2|NOT COMPLETED|Overall Study||0
7601618|NCT02540161|18712656|P1|NOT COMPLETED|Overall Study||0
7601619|NCT02540161|18712653|P4|COMPLETED|Overall Study||7
7601620|NCT02540161|18712654|P3|COMPLETED|Overall Study||5
7601621|NCT02540161|18712655|P2|COMPLETED|Overall Study||7
7601622|NCT02540161|18712656|P1|COMPLETED|Overall Study||20
7601623|NCT02540161|18712653|P4|STARTED|Overall Study||7
7601624|NCT02540161|18712654|P3|STARTED|Overall Study||5
7601625|NCT02540161|18712655|P2|STARTED|Overall Study||7
7601626|NCT02540161|18712656|P1|STARTED|Overall Study||20
7601627|NCT02540083|18712682|P1|NOT COMPLETED|Overall Study||16
7601628|NCT02540083|18712682|P1|COMPLETED|Overall Study||78
7601629|NCT02540083|18712682|P1|STARTED|Overall Study||94
7601630|NCT02539992|18712695|P3|NOT COMPLETED|Overall Study||4
7601631|NCT02539992|18712696|P2|NOT COMPLETED|Overall Study||4
7601632|NCT02539992|18712697|P1|NOT COMPLETED|Overall Study||0
7601633|NCT02539992|18712695|P3|COMPLETED|Overall Study||14
7601634|NCT02539992|18712696|P2|COMPLETED|Overall Study||7
7601635|NCT02539992|18712697|P1|COMPLETED|Overall Study||15
7601636|NCT02539992|18712695|P3|STARTED|Overall Study||18
7601637|NCT02539992|18712696|P2|STARTED|Overall Study||11
7601638|NCT02539992|18712697|P1|STARTED|Overall Study||15
7601639|NCT02539797|18712723|P3|NOT COMPLETED|Overall Study||0
7601640|NCT02539797|18712724|P2|NOT COMPLETED|Overall Study||1
7601641|NCT02539797|18712725|P1|NOT COMPLETED|Overall Study||0
7601642|NCT02539797|18712723|P3|COMPLETED|Overall Study||13
7601643|NCT02539797|18712724|P2|COMPLETED|Overall Study||12
7601644|NCT02539797|18712725|P1|COMPLETED|Overall Study||12
7601645|NCT02539797|18712723|P3|STARTED|Overall Study||13
7601646|NCT02539797|18712724|P2|STARTED|Overall Study||13
7601647|NCT02539797|18712725|P1|STARTED|Overall Study||12
7601648|NCT02539654|18712736|P1|NOT COMPLETED|Overall Study||0
7601649|NCT02539654|18712736|P1|COMPLETED|Overall Study||14
7601650|NCT02539654|18712736|P1|STARTED|Overall Study||14
7601651|NCT02539563|18712748|P2|NOT COMPLETED|Overall Study||14
7601652|NCT02539563|18712749|P1|NOT COMPLETED|Overall Study||6
7601653|NCT02539563|18712748|P2|COMPLETED|Overall Study||42
7601654|NCT02539563|18712749|P1|COMPLETED|Overall Study||39
7601655|NCT02539563|18712748|P2|STARTED|Overall Study||56
7601656|NCT02539563|18712749|P1|STARTED|Overall Study||45
7601657|NCT02539511|18712765|P2|NOT COMPLETED|Overall Study||0
7601658|NCT02539511|18712766|P1|NOT COMPLETED|Overall Study||6
7601659|NCT02539511|18712765|P2|COMPLETED|Overall Study||17
7601660|NCT02539511|18712766|P1|COMPLETED|Overall Study||17
7601661|NCT02539511|18712765|P2|STARTED|Overall Study||17
7601662|NCT02539511|18712766|P1|STARTED|Overall Study||23
7601663|NCT02539368|18712777|P5|NOT COMPLETED|Overall Study||14
7601664|NCT02539368|18712778|P4|NOT COMPLETED|Overall Study||7
7601665|NCT02539368|18712779|P3|NOT COMPLETED|Overall Study||67
7601666|NCT02539368|18712780|P2|NOT COMPLETED|Overall Study||101
7601667|NCT02539368|18712781|P1|NOT COMPLETED|Overall Study||405
7601668|NCT02539368|18712777|P5|COMPLETED|Overall Study||88
7601669|NCT02539368|18712778|P4|COMPLETED|Overall Study||60
7601670|NCT02539368|18712779|P3|COMPLETED|Overall Study||291
7601671|NCT02539368|18712780|P2|COMPLETED|Overall Study||393
7601672|NCT02539368|18712781|P1|COMPLETED|Overall Study||1117
7601673|NCT02539368|18712777|P5|STARTED|Overall Study||102
7601674|NCT02539368|18712778|P4|STARTED|Overall Study||67
7601675|NCT02539368|18712779|P3|STARTED|Overall Study||358
7601676|NCT02539368|18712780|P2|STARTED|Overall Study||494
7601677|NCT02539368|18712781|P1|STARTED|Overall Study||1522
7601678|NCT02539342|18712903|P2|NOT COMPLETED|Overall Study||0
7601679|NCT02539342|18712904|P1|NOT COMPLETED|Overall Study||0
7601680|NCT02539342|18712903|P2|COMPLETED|Overall Study||0
7601681|NCT02539342|18712904|P1|COMPLETED|Overall Study||1
7601682|NCT02539342|18712903|P2|STARTED|Overall Study||0
7601683|NCT02539342|18712904|P1|STARTED|Overall Study||1
7601684|NCT02539225|18712914|P2|NOT COMPLETED|Part B||16
7601685|NCT02539225|18712915|P1|NOT COMPLETED|Part B||4
7601686|NCT02539225|18712914|P2|COMPLETED|Part B||48
7601687|NCT02539225|18712915|P1|COMPLETED|Part B||54
7601688|NCT02539225|18712914|P2|STARTED|Part B||64
7601689|NCT02539225|18712915|P1|STARTED|Part B||58
7601690|NCT02539225|18712914|P2|NOT COMPLETED|Pre Treatment for Part B||2
7601691|NCT02539225|18712915|P1|NOT COMPLETED|Pre Treatment for Part B||5
7601692|NCT02539225|18712914|P2|COMPLETED|Pre Treatment for Part B||64
7601693|NCT02539225|18712915|P1|COMPLETED|Pre Treatment for Part B||58
7601694|NCT02539225|18712914|P2|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|66
7601695|NCT02539225|18712915|P1|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|63
7601696|NCT02539225|18712914|P2|NOT COMPLETED|Part A||16
7601697|NCT02539225|18712915|P1|NOT COMPLETED|Part A||20
7601698|NCT02539225|18712914|P2|COMPLETED|Part A||78
7601699|NCT02539225|18712915|P1|COMPLETED|Part A||77
7601700|NCT02539225|18712914|P2|Received Any Quantity of Study Drug|Part A||93
7601701|NCT02539225|18712915|P1|Received Any Quantity of Study Drug|Part A||96
7601702|NCT02539225|18712914|P2|STARTED|Part A||94
7601703|NCT02539225|18712915|P1|STARTED|Part A||97
7601704|NCT02539134|18712942|P6|NOT COMPLETED|Overall Study||0
7601705|NCT02539134|18712943|P5|NOT COMPLETED|Overall Study||0
7601706|NCT02539134|18712944|P4|NOT COMPLETED|Overall Study||0
7601707|NCT02539134|18712945|P3|NOT COMPLETED|Overall Study||0
7601708|NCT02539134|18712946|P2|NOT COMPLETED|Overall Study||0
7601709|NCT02539134|18712947|P1|NOT COMPLETED|Overall Study||1
7601710|NCT02539134|18712942|P6|COMPLETED|Overall Study||6
7601711|NCT02539134|18712943|P5|COMPLETED|Overall Study||6
7601712|NCT02539134|18712944|P4|COMPLETED|Overall Study||6
7601713|NCT02539134|18712945|P3|COMPLETED|Overall Study||6
7601714|NCT02539134|18712946|P2|COMPLETED|Overall Study||6
7601715|NCT02539134|18712947|P1|COMPLETED|Overall Study||9
7601716|NCT02539134|18712942|P6|STARTED|Overall Study||6
7601717|NCT02539134|18712943|P5|STARTED|Overall Study||6
7601718|NCT02539134|18712944|P4|STARTED|Overall Study||6
7601719|NCT02539134|18712945|P3|STARTED|Overall Study||6
7601720|NCT02539134|18712946|P2|STARTED|Overall Study||6
7601721|NCT02539134|18712947|P1|STARTED|Overall Study||10
7601722|NCT02539108|18713001|P2|NOT COMPLETED|Overall Study||0
7601723|NCT02539108|18713002|P1|NOT COMPLETED|Overall Study||0
7601724|NCT02539108|18713001|P2|COMPLETED|Overall Study||30
7601725|NCT02539108|18713002|P1|COMPLETED|Overall Study||30
7601726|NCT02539108|18713001|P2|STARTED|Overall Study||30
7601727|NCT02539108|18713002|P1|STARTED|Overall Study||30
7601728|NCT02538965|18713016|P1|NOT COMPLETED|Follow-Up Period||17
7601729|NCT02538965|18713016|P1|COMPLETED|Follow-Up Period||0
7601730|NCT02538965|18713016|P1|STARTED|Follow-Up Period||17
7601731|NCT02538965|18713016|P1|NOT COMPLETED|Treatment Period||17
7601732|NCT02538965|18713016|P1|COMPLETED|Treatment Period||0
7601733|NCT02538965|18713016|P1|STARTED|Treatment Period||17
7601734|NCT02538783|18713037|P2|NOT COMPLETED|Overall Study||1
7601735|NCT02538783|18713038|P1|NOT COMPLETED|Overall Study||0
7601736|NCT02538783|18713037|P2|COMPLETED|Overall Study||128
7601737|NCT02538783|18713038|P1|COMPLETED|Overall Study||130
7601738|NCT02538783|18713037|P2|STARTED|Overall Study||129
7601739|NCT02538783|18713038|P1|STARTED|Overall Study||130
7601740|NCT02538679|18713049|P3|NOT COMPLETED|Overall Study||8
7601741|NCT02538679|18713050|P2|NOT COMPLETED|Overall Study||9
7601742|NCT02538679|18713051|P1|NOT COMPLETED|Overall Study||3
7601743|NCT02538679|18713049|P3|COMPLETED|Overall Study||41
7601744|NCT02538679|18713050|P2|COMPLETED|Overall Study||45
7601745|NCT02538679|18713051|P1|COMPLETED|Overall Study||21
7601746|NCT02538679|18713049|P3|STARTED|Overall Study||49
7601747|NCT02538679|18713050|P2|STARTED|Overall Study||54
7601748|NCT02538679|18713051|P1|STARTED|Overall Study||24
7601749|NCT02538666|18713062|P3|NOT COMPLETED|Overall Study||1
7601750|NCT02538666|18713063|P2|NOT COMPLETED|Overall Study||1
7601751|NCT02538666|18713064|P1|NOT COMPLETED|Overall Study||2
7601752|NCT02538666|18713062|P3|COMPLETED|Overall Study||278
7601753|NCT02538666|18713063|P2|COMPLETED|Overall Study||279
7601754|NCT02538666|18713064|P1|COMPLETED|Overall Study||273
7601755|NCT02538666|18713062|P3|STARTED|Overall Study||279
7601756|NCT02538666|18713063|P2|STARTED|Overall Study||280
7601757|NCT02538666|18713064|P1|STARTED|Overall Study||275
7601758|NCT02538614|18713083|P1|NOT COMPLETED|Overall Study||2
7601759|NCT02538614|18713083|P1|COMPLETED|Overall Study||0
7601760|NCT02538614|18713083|P1|STARTED|Overall Study||2
7601761|NCT02538523|18713101|P2|NOT COMPLETED|Overall Study||0
7601762|NCT02538523|18713102|P1|NOT COMPLETED|Overall Study||0
7601763|NCT02538523|18713101|P2|COMPLETED|Overall Study||29
7601764|NCT02538523|18713102|P1|COMPLETED|Overall Study||29
7601765|NCT02538523|18713101|P2|STARTED|Overall Study||29
7601766|NCT02538523|18713102|P1|STARTED|Overall Study||29
7601767|NCT02538510|18713112|P2|NOT COMPLETED|Overall Study||0
7601768|NCT02538510|18713113|P1|NOT COMPLETED|Overall Study||0
7601769|NCT02538510|18713112|P2|COMPLETED|Overall Study||25
7601770|NCT02538510|18713113|P1|COMPLETED|Overall Study||25
7601771|NCT02538510|18713112|P2|STARTED|Overall Study||25
7601772|NCT02538510|18713113|P1|STARTED|Overall Study||25
7601773|NCT02538471|18713123|P1|NOT COMPLETED|Overall Study||2
7601774|NCT02538471|18713123|P1|COMPLETED|Overall Study||1
7601775|NCT02538471|18713123|P1|STARTED|Overall Study||3
7601776|NCT02538419|18713133|P2|NOT COMPLETED|Overall Study||0
7601777|NCT02538419|18713134|P1|NOT COMPLETED|Overall Study||0
7601778|NCT02538419|18713133|P2|COMPLETED|Overall Study||20
7601779|NCT02538419|18713134|P1|COMPLETED|Overall Study||20
7601780|NCT02538419|18713133|P2|STARTED|Overall Study||20
7601781|NCT02538419|18713134|P1|STARTED|Overall Study||20
7601782|NCT02538354|18713152|P2|NOT COMPLETED|Overall Study||0
7601783|NCT02538354|18713153|P1|NOT COMPLETED|Overall Study||0
7601784|NCT02538354|18713152|P2|COMPLETED|Overall Study||30
7601785|NCT02538354|18713153|P1|COMPLETED|Overall Study||40
7601786|NCT02538354|18713152|P2|STARTED|Overall Study||30
7601787|NCT02538354|18713153|P1|STARTED|Overall Study||40
7601788|NCT02538107|18713159|P1|NOT COMPLETED|Overall Study||110
7601789|NCT02538107|18713159|P1|COMPLETED|Overall Study||180
7601790|NCT02538107|18713159|P1|STARTED|Overall Study||290
7601791|NCT02538094|18713179|P2|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
7601792|NCT02538094|18713180|P1|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
7601793|NCT02538094|18713179|P2|COMPLETED|Intervention 2 (5 Days Per Participant)||3
7601794|NCT02538094|18713180|P1|COMPLETED|Intervention 2 (5 Days Per Participant)||2
7601795|NCT02538094|18713179|P2|STARTED|Intervention 2 (5 Days Per Participant)||3
7601796|NCT02538094|18713180|P1|STARTED|Intervention 2 (5 Days Per Participant)||2
7601797|NCT02538094|18713179|P2|NOT COMPLETED|Washout (4 Weeks)||1
7601798|NCT02538094|18713180|P1|NOT COMPLETED|Washout (4 Weeks)||0
7601799|NCT02538094|18713179|P2|COMPLETED|Washout (4 Weeks)||3
7601800|NCT02538094|18713180|P1|COMPLETED|Washout (4 Weeks)||2
7601801|NCT02538094|18713179|P2|STARTED|Washout (4 Weeks)||4
7601802|NCT02538094|18713180|P1|STARTED|Washout (4 Weeks)||2
7601803|NCT02538094|18713179|P2|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||1
7601804|NCT02538094|18713180|P1|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||0
7601805|NCT02538094|18713179|P2|COMPLETED|Intervention 1 (5 Days Per Participant)||4
7601806|NCT02538094|18713180|P1|COMPLETED|Intervention 1 (5 Days Per Participant)||2
7601807|NCT02538094|18713179|P2|STARTED|Intervention 1 (5 Days Per Participant)||5
7601808|NCT02538094|18713180|P1|STARTED|Intervention 1 (5 Days Per Participant)||2
7601809|NCT02538042|18713190|P2|NOT COMPLETED|Overall Study||11
7601810|NCT02538042|18713191|P1|NOT COMPLETED|Overall Study||11
7601811|NCT02538042|18713190|P2|COMPLETED|Overall Study||6
7601812|NCT02538042|18713191|P1|COMPLETED|Overall Study||6
7601813|NCT02538042|18713190|P2|Completed All Post-Quit Visits|Overall Study||12
7601814|NCT02538042|18713191|P1|Completed All Post-Quit Visits|Overall Study||12
7601815|NCT02538042|18713190|P2|Attended Post-Quit Visit|Overall Study||14
7601816|NCT02538042|18713191|P1|Attended Post-Quit Visit|Overall Study||15
7601817|NCT02538042|18713190|P2|Completed All MCE Sessions|Overall Study||15
7601818|NCT02538042|18713191|P1|Completed All MCE Sessions|Overall Study||15
7601819|NCT02538042|18713190|P2|STARTED|Overall Study||17
7601820|NCT02538042|18713191|P1|STARTED|Overall Study||17
7601821|NCT02538029|18713210|P3|NOT COMPLETED|Overall Study||1
7601822|NCT02538029|18713211|P2|NOT COMPLETED|Overall Study||0
7601823|NCT02538029|18713212|P1|NOT COMPLETED|Overall Study||1
7601824|NCT02538029|18713210|P3|COMPLETED|Overall Study||10
7601825|NCT02538029|18713211|P2|COMPLETED|Overall Study||10
7601826|NCT02538029|18713212|P1|COMPLETED|Overall Study||23
7601827|NCT02538029|18713210|P3|STARTED|Overall Study||11
7601828|NCT02538029|18713211|P2|STARTED|Overall Study||10
7601829|NCT02538029|18713212|P1|STARTED|Overall Study||24
7601830|NCT02538016|18713234|P1|NOT COMPLETED|Overall Study||0
7601831|NCT02538016|18713234|P1|COMPLETED|Overall Study||4
7601832|NCT02538016|18713234|P1|STARTED|Overall Study||4
7601833|NCT02537951|18713239|P1|NOT COMPLETED|Overall Study||0
7601834|NCT02537951|18713239|P1|COMPLETED|Overall Study||10
7601835|NCT02537951|18713239|P1|STARTED|Overall Study||10
7601836|NCT02537873|18713249|P2|NOT COMPLETED|Overall Study||4
7601837|NCT02537873|18713250|P1|NOT COMPLETED|Overall Study||8
7601838|NCT02537873|18713249|P2|COMPLETED|Overall Study||4
7601839|NCT02537873|18713250|P1|COMPLETED|Overall Study||9
7601840|NCT02537873|18713249|P2|STARTED|Overall Study||8
7601841|NCT02537873|18713250|P1|STARTED|Overall Study||17
7601842|NCT02537730|18713268|P2|NOT COMPLETED|Second Intervention (7 Days)||0
7601843|NCT02537730|18713269|P1|NOT COMPLETED|Second Intervention (7 Days)||0
7601844|NCT02537730|18713268|P2|COMPLETED|Second Intervention (7 Days)||16
7601845|NCT02537730|18713269|P1|COMPLETED|Second Intervention (7 Days)||17
7601846|NCT02537730|18713268|P2|STARTED|Second Intervention (7 Days)||16
7601847|NCT02537730|18713269|P1|STARTED|Second Intervention (7 Days)||17
7601848|NCT02537730|18713268|P2|NOT COMPLETED|First Intervention (7 Days)||0
7601849|NCT02537730|18713269|P1|NOT COMPLETED|First Intervention (7 Days)||0
7601850|NCT02537730|18713268|P2|COMPLETED|First Intervention (7 Days)||16
7601851|NCT02537730|18713269|P1|COMPLETED|First Intervention (7 Days)||17
7601852|NCT02537730|18713268|P2|STARTED|First Intervention (7 Days)||16
7601853|NCT02537730|18713269|P1|STARTED|First Intervention (7 Days)||17
7601854|NCT02537717|18713281|P1|NOT COMPLETED|Overall Study||0
7601855|NCT02537717|18713281|P1|COMPLETED|Overall Study||17
7601856|NCT02537717|18713281|P1|STARTED|Overall Study||17
7601857|NCT02537574|18713303|P3|NOT COMPLETED|Overall Study||108
7601858|NCT02537574|18713304|P2|NOT COMPLETED|Overall Study||103
7601859|NCT02537574|18713305|P1|NOT COMPLETED|Overall Study||99
7601860|NCT02537574|18713303|P3|COMPLETED|Overall Study||18
7601861|NCT02537574|18713304|P2|COMPLETED|Overall Study||23
7601862|NCT02537574|18713305|P1|COMPLETED|Overall Study||27
7601863|NCT02537574|18713303|P3|STARTED|Overall Study||126
7601864|NCT02537574|18713304|P2|STARTED|Overall Study||126
7601865|NCT02537574|18713305|P1|STARTED|Overall Study||126
7601866|NCT02537522|18713331|P4|NOT COMPLETED|Phase II - Period 2 Bilateral||0
7601867|NCT02537522|18713332|P3|NOT COMPLETED|Phase II - Period 2 Bilateral||0
7601868|NCT02537522|18713333|P2|NOT COMPLETED|Phase II - Period 2 Bilateral||0
7601869|NCT02537522|18713334|P1|NOT COMPLETED|Phase II - Period 2 Bilateral||0
7601870|NCT02537522|18713331|P4|COMPLETED|Phase II - Period 2 Bilateral||22
7601871|NCT02537522|18713332|P3|COMPLETED|Phase II - Period 2 Bilateral||23
7601872|NCT02537522|18713333|P2|COMPLETED|Phase II - Period 2 Bilateral||0
7601873|NCT02537522|18713334|P1|COMPLETED|Phase II - Period 2 Bilateral||0
7601874|NCT02537522|18713331|P4|STARTED|Phase II - Period 2 Bilateral||22
7601875|NCT02537522|18713332|P3|STARTED|Phase II - Period 2 Bilateral||23
7601876|NCT02537522|18713333|P2|STARTED|Phase II - Period 2 Bilateral||0
7601877|NCT02537522|18713334|P1|STARTED|Phase II - Period 2 Bilateral||0
7601878|NCT02537522|18713331|P4|NOT COMPLETED|Phase II - Period 1 Bilateral||1
7601879|NCT02537522|18713332|P3|NOT COMPLETED|Phase II - Period 1 Bilateral||0
7601880|NCT02537522|18713333|P2|NOT COMPLETED|Phase II - Period 1 Bilateral||0
7601881|NCT02537522|18713334|P1|NOT COMPLETED|Phase II - Period 1 Bilateral||0
7601882|NCT02537522|18713331|P4|COMPLETED|Phase II - Period 1 Bilateral||22
7601883|NCT02537522|18713332|P3|COMPLETED|Phase II - Period 1 Bilateral||23
7601884|NCT02537522|18713333|P2|COMPLETED|Phase II - Period 1 Bilateral||0
7601885|NCT02537522|18713334|P1|COMPLETED|Phase II - Period 1 Bilateral||0
7601886|NCT02537522|18713331|P4|STARTED|Phase II - Period 1 Bilateral||23
7601887|NCT02537522|18713332|P3|STARTED|Phase II - Period 1 Bilateral||23
7601888|NCT02537522|18713333|P2|STARTED|Phase II - Period 1 Bilateral||0
7601889|NCT02537522|18713334|P1|STARTED|Phase II - Period 1 Bilateral||0
7601890|NCT02537522|18713331|P4|NOT COMPLETED|Phase I - Contralateral||0
7601891|NCT02537522|18713332|P3|NOT COMPLETED|Phase I - Contralateral||0
7601892|NCT02537522|18713333|P2|NOT COMPLETED|Phase I - Contralateral||10
7601893|NCT02537522|18713334|P1|NOT COMPLETED|Phase I - Contralateral||15
7601894|NCT02537522|18713331|P4|COMPLETED|Phase I - Contralateral||0
7601895|NCT02537522|18713332|P3|COMPLETED|Phase I - Contralateral||0
7601896|NCT02537522|18713333|P2|COMPLETED|Phase I - Contralateral||27
7601897|NCT02537522|18713334|P1|COMPLETED|Phase I - Contralateral||19
7601898|NCT02537522|18713331|P4|STARTED|Phase I - Contralateral||0
7601899|NCT02537522|18713332|P3|STARTED|Phase I - Contralateral||0
7601900|NCT02537522|18713333|P2|STARTED|Phase I - Contralateral||37
7601901|NCT02537522|18713334|P1|STARTED|Phase I - Contralateral||34
7601902|NCT02537444|18713344|P2|NOT COMPLETED|Overall Study||39
7601903|NCT02537444|18713345|P1|NOT COMPLETED|Overall Study||39
7601904|NCT02537444|18713344|P2|COMPLETED|Overall Study||0
7601905|NCT02537444|18713345|P1|COMPLETED|Overall Study||0
7601906|NCT02537444|18713344|P2|Discontinued Study|Overall Study||39
7601907|NCT02537444|18713345|P1|Discontinued Study|Overall Study||39
7601908|NCT02537444|18713344|P2|Received Study Medication|Overall Study||39
7601909|NCT02537444|18713345|P1|Received Study Medication|Overall Study||38
7601910|NCT02537444|18713344|P2|Enrolled|Overall Study||39
7601911|NCT02537444|18713345|P1|Enrolled|Overall Study||39
7601912|NCT02537444|18713344|P2|STARTED|Overall Study||39
7601913|NCT02537444|18713345|P1|STARTED|Overall Study||39
7601914|NCT02537431|18713351|P1|NOT COMPLETED|Treatment Extension Period II||0
7601915|NCT02537431|18713351|P1|COMPLETED|Treatment Extension Period II||8
7601916|NCT02537431|18713351|P1|STARTED|Treatment Extension Period II|5 participants completing Treatment Extension Period I did not enter Treatment Extension Period II|8
7601917|NCT02537431|18713351|P1|NOT COMPLETED|Treatment Extension Period I||0
7601918|NCT02537431|18713351|P1|COMPLETED|Treatment Extension Period I||13
7601919|NCT02537431|18713351|P1|STARTED|Treatment Extension Period I||13
7601920|NCT02537431|18713351|P1|NOT COMPLETED|Open-Label Period (Week 0 to Week 48)||1
7601921|NCT02537431|18713351|P1|COMPLETED|Open-Label Period (Week 0 to Week 48)|Completed Open-Label Period (Week 0 - Week 48)|13
7601922|NCT02537431|18713351|P1|STARTED|Open-Label Period (Week 0 to Week 48)|Screened and received at least 1 dose of study drug.|14
7601923|NCT02537015|18713380|P1|NOT COMPLETED|Overall Study||6
7601924|NCT02537015|18713380|P1|COMPLETED|Overall Study||75
7601925|NCT02537015|18713380|P1|STARTED|Overall Study||81
7601926|NCT02536976|18713386|P2|NOT COMPLETED|Overall Study||1
7601927|NCT02536976|18713387|P1|NOT COMPLETED|Overall Study||0
7601928|NCT02536976|18713386|P2|COMPLETED|Overall Study||1
7601929|NCT02536976|18713387|P1|COMPLETED|Overall Study||3
7601930|NCT02536976|18713386|P2|Washout|Overall Study||1
7601931|NCT02536976|18713387|P1|Washout|Overall Study||3
7601932|NCT02536976|18713386|P2|Dose Escalation and Maintenance|Overall Study|10 weeks double blind placebo matching mirabegron|1
7601933|NCT02536976|18713387|P1|Dose Escalation and Maintenance|Overall Study|10 weeks double blind mirabegron|3
7601934|NCT02536976|18713386|P2|Randomization|Overall Study|2 weeks double blind placebo matching mirabegron|1
7601935|NCT02536976|18713387|P1|Randomization|Overall Study|2 weeks double blind mirabegron|3
7601936|NCT02536976|18713386|P2|STARTED|Overall Study|2 weeks single blind placebo run-in. 1 participant terminated due to unrelated failing health|2
7601937|NCT02536976|18713387|P1|STARTED|Overall Study|2 weeks single blind placebo run-in|3
7601938|NCT02536963|18713397|P1|NOT COMPLETED|Overall Study||18
7601939|NCT02536963|18713397|P1|COMPLETED|Overall Study||300
7601940|NCT02536963|18713397|P1|STARTED|Overall Study||318
7601941|NCT02536833|18713405|P4|NOT COMPLETED|Overall Study||19
7601942|NCT02536833|18713406|P3|NOT COMPLETED|Overall Study||15
7601943|NCT02536833|18713407|P2|NOT COMPLETED|Overall Study||10
7601944|NCT02536833|18713408|P1|NOT COMPLETED|Overall Study||9
7601945|NCT02536833|18713405|P4|COMPLETED|Overall Study||97
7601946|NCT02536833|18713406|P3|COMPLETED|Overall Study||95
7601947|NCT02536833|18713407|P2|COMPLETED|Overall Study||107
7601948|NCT02536833|18713408|P1|COMPLETED|Overall Study||103
7601949|NCT02536833|18713405|P4|STARTED|Overall Study||116
7601950|NCT02536833|18713406|P3|STARTED|Overall Study||110
7601951|NCT02536833|18713407|P2|STARTED|Overall Study||117
7601952|NCT02536833|18713408|P1|STARTED|Overall Study||112
7601953|NCT02536781|18713469|P2|NOT COMPLETED|Overall Study||0
7601954|NCT02536781|18713470|P1|NOT COMPLETED|Overall Study||2
7601955|NCT02536781|18713469|P2|COMPLETED|Overall Study||34
7601956|NCT02536781|18713470|P1|COMPLETED|Overall Study||34
7601957|NCT02536781|18713469|P2|STARTED|Overall Study||34
7601958|NCT02536781|18713470|P1|STARTED|Overall Study||36
7601959|NCT02536664|18713480|P2|NOT COMPLETED|Overall Study||80
7601960|NCT02536664|18713481|P1|NOT COMPLETED|Overall Study||107
7601961|NCT02536664|18713480|P2|COMPLETED|Overall Study||97
7601962|NCT02536664|18713481|P1|COMPLETED|Overall Study||205
7601963|NCT02536664|18713480|P2|STARTED|Overall Study||177
7601964|NCT02536664|18713481|P1|STARTED|Overall Study||312
7601965|NCT02536378|18713501|P2|NOT COMPLETED|Overall Study||7
7601966|NCT02536378|18713502|P1|NOT COMPLETED|Overall Study||7
7601967|NCT02536378|18713501|P2|COMPLETED|Overall Study||53
7601968|NCT02536378|18713502|P1|COMPLETED|Overall Study||625
7601969|NCT02536378|18713501|P2|STARTED|Overall Study||60
7601970|NCT02536378|18713502|P1|STARTED|Overall Study||632
7601971|NCT02536339|18713516|P1|NOT COMPLETED|Overall Study||31
7601972|NCT02536339|18713516|P1|COMPLETED|Overall Study||9
7601973|NCT02536339|18713516|P1|Received at Least One Dose of Study Drug|Overall Study||39
7601974|NCT02536339|18713516|P1|STARTED|Overall Study||40
7601975|NCT02536313|18713542|P2|NOT COMPLETED|Overall Study||1
7601976|NCT02536313|18713543|P1|NOT COMPLETED|Overall Study||0
7601977|NCT02536313|18713542|P2|COMPLETED|Overall Study||24
7601978|NCT02536313|18713543|P1|COMPLETED|Overall Study||24
7601979|NCT02536313|18713542|P2|STARTED|Overall Study||25
7601980|NCT02536313|18713543|P1|STARTED|Overall Study||24
7601981|NCT02536248|18713561|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
7601982|NCT02536248|18713562|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
7601983|NCT02536248|18713561|P2|COMPLETED|Second Intervention (6 Weeks)||10
7601984|NCT02536248|18713562|P1|COMPLETED|Second Intervention (6 Weeks)||10
7601985|NCT02536248|18713561|P2|STARTED|Second Intervention (6 Weeks)||10
7601986|NCT02536248|18713562|P1|STARTED|Second Intervention (6 Weeks)||10
7601987|NCT02536248|18713561|P2|NOT COMPLETED|Wash-out (14 Days)||0
7601988|NCT02536248|18713562|P1|NOT COMPLETED|Wash-out (14 Days)||0
7601989|NCT02536248|18713561|P2|COMPLETED|Wash-out (14 Days)||10
7601990|NCT02536248|18713562|P1|COMPLETED|Wash-out (14 Days)||10
7601991|NCT02536248|18713561|P2|STARTED|Wash-out (14 Days)||10
7601992|NCT02536248|18713562|P1|STARTED|Wash-out (14 Days)||10
7601993|NCT02536248|18713561|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
7601994|NCT02536248|18713562|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
7601995|NCT02536248|18713561|P2|COMPLETED|First Intervention (6 Weeks)||10
7601996|NCT02536248|18713562|P1|COMPLETED|First Intervention (6 Weeks)||10
7601997|NCT02536248|18713561|P2|STARTED|First Intervention (6 Weeks)||10
7601998|NCT02536248|18713562|P1|STARTED|First Intervention (6 Weeks)||10
7601999|NCT02536105|18713574|P1|NOT COMPLETED|Methylphenidate HCl ER Suspension||2
7602000|NCT02536105|18713574|P1|COMPLETED|Methylphenidate HCl ER Suspension||72
7602001|NCT02536105|18713574|P1|Completion of MPH HCl ER Susp Phase|Methylphenidate HCl ER Suspension||74
7602002|NCT02536105|18713574|P1|STARTED|Methylphenidate HCl ER Suspension||74
7602003|NCT02536105|18713574|P1|NOT COMPLETED|Methylphenidate HCl ER Tablet 2||1
7602004|NCT02536105|18713574|P1|COMPLETED|Methylphenidate HCl ER Tablet 2||72
7602005|NCT02536105|18713574|P1|Completion of MPH HCl ER Tablet 2 Phase|Methylphenidate HCl ER Tablet 2||73
7602006|NCT02536105|18713574|P1|STARTED|Methylphenidate HCl ER Tablet 2||73
7602007|NCT02536105|18713574|P1|NOT COMPLETED|Methylphenidate HCl ER Tablet 1||0
7602008|NCT02536105|18713574|P1|COMPLETED|Methylphenidate HCl ER Tablet 1||72
7602009|NCT02536105|18713574|P1|Completion of MPH HCl ER Tab 1 Day|Methylphenidate HCl ER Tablet 1||72
7602010|NCT02536105|18713574|P1|STARTED|Methylphenidate HCl ER Tablet 1||72
7602011|NCT02536105|18713574|P1|NOT COMPLETED|Placebo||2
7602012|NCT02536105|18713574|P1|COMPLETED|Placebo||72
7602013|NCT02536105|18713574|P1|Completion of Placebo Day|Placebo||74
7602014|NCT02536105|18713574|P1|STARTED|Placebo||74
7602015|NCT02536105|18713574|P1|NOT COMPLETED|Concerta Open Label||8
7602016|NCT02536105|18713574|P1|COMPLETED|Concerta Open Label||72
7602017|NCT02536105|18713574|P1|Completion of Phase|Concerta Open Label||76
7602018|NCT02536105|18713574|P1|STARTED|Concerta Open Label||80
7602019|NCT02536040|18713598|P2|NOT COMPLETED|Overall Study||1
7602020|NCT02536040|18713599|P1|NOT COMPLETED|Overall Study||1
7602021|NCT02536040|18713598|P2|COMPLETED|Overall Study||35
7602022|NCT02536040|18713599|P1|COMPLETED|Overall Study||29
7602023|NCT02536040|18713598|P2|STARTED|Overall Study||36
7602024|NCT02536040|18713599|P1|STARTED|Overall Study||30
7602025|NCT02535806|18713605|P1|NOT COMPLETED|Overall Study||0
7602026|NCT02535806|18713605|P1|COMPLETED|Overall Study||2
7602027|NCT02535806|18713605|P1|STARTED|Overall Study||2
7602028|NCT02535741|18713612|P1|NOT COMPLETED|Overall Study||32
7602029|NCT02535741|18713612|P1|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136
7602030|NCT02535741|18713612|P1|STARTED|Overall Study||168
7602031|NCT02535715|18713620|P3|NOT COMPLETED|Overall Study||1
7602032|NCT02535715|18713621|P2|NOT COMPLETED|Overall Study||0
7602033|NCT02535715|18713622|P1|NOT COMPLETED|Overall Study||0
7602034|NCT02535715|18713620|P3|COMPLETED|Overall Study||2
7602035|NCT02535715|18713621|P2|COMPLETED|Overall Study||4
7602036|NCT02535715|18713622|P1|COMPLETED|Overall Study||4
7602037|NCT02535715|18713620|P3|STARTED|Overall Study||3
7602038|NCT02535715|18713621|P2|STARTED|Overall Study||4
7602039|NCT02535715|18713622|P1|STARTED|Overall Study||4
7602040|NCT02535611|18713644|P2|NOT COMPLETED|Overall Study||0
7602041|NCT02535611|18713645|P1|NOT COMPLETED|Overall Study||0
7602042|NCT02535611|18713644|P2|COMPLETED|Overall Study||20
7602043|NCT02535611|18713645|P1|COMPLETED|Overall Study||27
7602044|NCT02535611|18713644|P2|STARTED|Overall Study||20
7602045|NCT02535611|18713645|P1|STARTED|Overall Study||27
7602046|NCT02535481|18713659|P2|NOT COMPLETED|Overall Study||0
7602047|NCT02535481|18713660|P1|NOT COMPLETED|Overall Study||0
7602048|NCT02535481|18713659|P2|COMPLETED|Overall Study||22
7602049|NCT02535481|18713660|P1|COMPLETED|Overall Study||22
7602050|NCT02535481|18713659|P2|STARTED|Overall Study||22
7602051|NCT02535481|18713660|P1|STARTED|Overall Study||22
7602052|NCT02535416|18713685|P9|NOT COMPLETED|Overall Study||0
7602053|NCT02535416|18713686|P8|NOT COMPLETED|Overall Study||0
7602054|NCT02535416|18713687|P7|NOT COMPLETED|Overall Study||0
7602055|NCT02535416|18713688|P6|NOT COMPLETED|Overall Study||0
7602056|NCT02535416|18713689|P5|NOT COMPLETED|Overall Study||0
7602057|NCT02535416|18713690|P4|NOT COMPLETED|Overall Study||0
7602058|NCT02535416|18713691|P3|NOT COMPLETED|Overall Study||0
7602059|NCT02535416|18713692|P2|NOT COMPLETED|Overall Study||0
7602060|NCT02535416|18713693|P1|NOT COMPLETED|Overall Study||1
7602061|NCT02535416|18713685|P9|COMPLETED|Overall Study||6
7602062|NCT02535416|18713686|P8|COMPLETED|Overall Study||6
7602063|NCT02535416|18713687|P7|COMPLETED|Overall Study||6
7602064|NCT02535416|18713688|P6|COMPLETED|Overall Study||4
7602065|NCT02535416|18713689|P5|COMPLETED|Overall Study||4
7602066|NCT02535416|18713690|P4|COMPLETED|Overall Study||4
7602067|NCT02535416|18713691|P3|COMPLETED|Overall Study||4
7602068|NCT02535416|18713692|P2|COMPLETED|Overall Study||2
7602069|NCT02535416|18713693|P1|COMPLETED|Overall Study||3
7602070|NCT02535416|18713685|P9|STARTED|Overall Study||6
7602071|NCT02535416|18713686|P8|STARTED|Overall Study||6
7602072|NCT02535416|18713687|P7|STARTED|Overall Study||6
7602073|NCT02535416|18713688|P6|STARTED|Overall Study||4
7602074|NCT02535416|18713689|P5|STARTED|Overall Study||4
7602075|NCT02535416|18713690|P4|STARTED|Overall Study||4
7602076|NCT02535416|18713691|P3|STARTED|Overall Study||4
7602077|NCT02535416|18713692|P2|STARTED|Overall Study||2
7602078|NCT02535416|18713693|P1|STARTED|Overall Study||4
7602079|NCT02535364|18713745|P1|NOT COMPLETED|12-Month Follow-up Period||35
7602080|NCT02535364|18713745|P1|COMPLETED|12-Month Follow-up Period||3
7602081|NCT02535364|18713745|P1|STARTED|12-Month Follow-up Period||38
7602082|NCT02535364|18713745|P1|NOT COMPLETED|Study Treatment||2
7602083|NCT02535364|18713745|P1|COMPLETED|Study Treatment||38
7602084|NCT02535364|18713745|P1|STARTED|Study Treatment||40
7602085|NCT02535364|18713745|P1|NOT COMPLETED|Part B Screening||17
7602086|NCT02535364|18713745|P1|COMPLETED|Part B Screening||40
7602087|NCT02535364|18713745|P1|STARTED|Part B Screening||57
7602088|NCT02535364|18713745|P1|NOT COMPLETED|Part A Screening Through Leukapheresis||25
7602089|NCT02535364|18713745|P1|COMPLETED|Part A Screening Through Leukapheresis||57
7602090|NCT02535364|18713745|P1|STARTED|Part A Screening Through Leukapheresis||82
7602091|NCT02535065|18713770|P1|NOT COMPLETED|Overall Study||62
7602092|NCT02535065|18713770|P1|COMPLETED|Overall Study||0
7602093|NCT02535065|18713770|P1|12-Month Follow-up|Overall Study||61
7602094|NCT02535065|18713770|P1|1-Month Follow-up|Overall Study||62
7602095|NCT02535065|18713770|P1|STARTED|Overall Study||62
7602096|NCT02535026|18713775|P1|NOT COMPLETED|Overall Study||0
7602097|NCT02535026|18713775|P1|COMPLETED|Overall Study||580
7602098|NCT02535026|18713775|P1|STARTED|Overall Study||580
7602099|NCT02535000|18713829|P2|NOT COMPLETED|Overall Study||2
7602100|NCT02535000|18713830|P1|NOT COMPLETED|Overall Study||1
7602101|NCT02535000|18713829|P2|COMPLETED|Overall Study||28
7602102|NCT02535000|18713830|P1|COMPLETED|Overall Study||29
7602103|NCT02535000|18713829|P2|STARTED|Overall Study||30
7602104|NCT02535000|18713830|P1|STARTED|Overall Study||30
7602105|NCT02534935|18713841|P3|NOT COMPLETED|Overall Study||5
7602106|NCT02534935|18713842|P2|NOT COMPLETED|Overall Study||10
7602107|NCT02534935|18713843|P1|NOT COMPLETED|Overall Study||0
7602108|NCT02534935|18713841|P3|COMPLETED|Overall Study||127
7602109|NCT02534935|18713842|P2|COMPLETED|Overall Study||210
7602110|NCT02534935|18713843|P1|COMPLETED|Overall Study||44
7602111|NCT02534935|18713841|P3|STARTED|Overall Study||132
7602112|NCT02534935|18713842|P2|STARTED|Overall Study||220
7602113|NCT02534935|18713843|P1|STARTED|Overall Study||44
7602114|NCT02534896|18714004|P3|NOT COMPLETED|Overall Study||1
7602115|NCT02534896|18714005|P2|NOT COMPLETED|Overall Study||1
7602116|NCT02534896|18714006|P1|NOT COMPLETED|Overall Study||4
7602117|NCT02534896|18714004|P3|COMPLETED|Overall Study||48
7602118|NCT02534896|18714005|P2|COMPLETED|Overall Study||51
7602119|NCT02534896|18714006|P1|COMPLETED|Overall Study||45
7602120|NCT02534896|18714004|P3|STARTED|Overall Study||49
7602121|NCT02534896|18714005|P2|STARTED|Overall Study||52
7602122|NCT02534896|18714006|P1|STARTED|Overall Study||49
7602123|NCT02534883|18714025|P2|NOT COMPLETED|Overall Study||3
7602124|NCT02534883|18714026|P1|NOT COMPLETED|Overall Study||8
7602125|NCT02534883|18714025|P2|COMPLETED|Overall Study||0
7602126|NCT02534883|18714026|P1|COMPLETED|Overall Study||0
7602127|NCT02534883|18714025|P2|STARTED|Overall Study||3
7602128|NCT02534883|18714026|P1|STARTED|Overall Study||8
7602129|NCT02534493|18714042|P1|NOT COMPLETED|Overall Study||2
7602130|NCT02534493|18714042|P1|COMPLETED|Overall Study||11
7602131|NCT02534493|18714042|P1|STARTED|Overall Study||13
7602132|NCT02534350|18714053|P2|NOT COMPLETED|Overall Study||0
7602133|NCT02534350|18714054|P1|NOT COMPLETED|Overall Study||4
7602134|NCT02534350|18714053|P2|COMPLETED|Overall Study||20
7602135|NCT02534350|18714054|P1|COMPLETED|Overall Study||37
7602136|NCT02534350|18714053|P2|STARTED|Overall Study||20
7602137|NCT02534350|18714054|P1|STARTED|Overall Study||41
7602138|NCT02534324|18714068|P2|NOT COMPLETED|Overall Study||8
7602139|NCT02534324|18714069|P1|NOT COMPLETED|Overall Study||25
7602140|NCT02534324|18714068|P2|COMPLETED|Overall Study||40
7602141|NCT02534324|18714069|P1|COMPLETED|Overall Study||73
7602142|NCT02534324|18714068|P2|STARTED|Overall Study||48
7602143|NCT02534324|18714069|P1|STARTED|Overall Study||98
7602144|NCT02534285|18714081|P2|NOT COMPLETED|Overall Study||0
7602145|NCT02534285|18714082|P1|NOT COMPLETED|Overall Study||0
7602146|NCT02534285|18714081|P2|COMPLETED|Overall Study||50
7602147|NCT02534285|18714082|P1|COMPLETED|Overall Study||50
7602148|NCT02534285|18714081|P2|STARTED|Overall Study||50
7602149|NCT02534285|18714082|P1|STARTED|Overall Study||50
7602150|NCT02534129|18714088|P2|NOT COMPLETED|Overall Study||0
7602151|NCT02534129|18714089|P1|NOT COMPLETED|Overall Study||0
7602152|NCT02534129|18714088|P2|COMPLETED|Overall Study||13
7602153|NCT02534129|18714089|P1|COMPLETED|Overall Study||13
7602154|NCT02534129|18714088|P2|STARTED|Overall Study||13
7602155|NCT02534129|18714089|P1|STARTED|Overall Study||13
7602156|NCT02534038|18714097|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
7602157|NCT02534038|18714098|P1|NOT COMPLETED|Period 2 (6 Weeks)||0
7602158|NCT02534038|18714097|P2|COMPLETED|Period 2 (6 Weeks)||0
7602159|NCT02534038|18714098|P1|COMPLETED|Period 2 (6 Weeks)||1
7602160|NCT02534038|18714097|P2|STARTED|Period 2 (6 Weeks)||0
7602161|NCT02534038|18714098|P1|STARTED|Period 2 (6 Weeks)||1
7602162|NCT02534038|18714097|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
7602163|NCT02534038|18714098|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
7602164|NCT02534038|18714097|P2|COMPLETED|Period 1 (6 Weeks)||0
7602165|NCT02534038|18714098|P1|COMPLETED|Period 1 (6 Weeks)||1
7602166|NCT02534038|18714097|P2|STARTED|Period 1 (6 Weeks)||0
7602167|NCT02534038|18714098|P1|STARTED|Period 1 (6 Weeks)||1
7602168|NCT02533999|18714134|P2|NOT COMPLETED|Overall Study||7
7602169|NCT02533999|18714135|P1|NOT COMPLETED|Overall Study||6
7602170|NCT02533999|18714134|P2|COMPLETED|Overall Study||30
7602171|NCT02533999|18714135|P1|COMPLETED|Overall Study||32
7602172|NCT02533999|18714134|P2|STARTED|Overall Study||37
7602173|NCT02533999|18714135|P1|STARTED|Overall Study||38
7602174|NCT02533921|18714155|P2|NOT COMPLETED|Overall Study||11
7602175|NCT02533921|18714156|P1|NOT COMPLETED|Overall Study||16
7602176|NCT02533921|18714155|P2|COMPLETED|Overall Study||95
7602177|NCT02533921|18714156|P1|COMPLETED|Overall Study||88
7602178|NCT02533921|18714155|P2|STARTED|Overall Study||106
7602179|NCT02533921|18714156|P1|STARTED|Overall Study||104
7602180|NCT02533726|18714174|P2|NOT COMPLETED|Treatment||0
7602181|NCT02533726|18714175|P1|NOT COMPLETED|Treatment||0
7602182|NCT02533726|18714174|P2|COMPLETED|Treatment||603
7602183|NCT02533726|18714175|P1|COMPLETED|Treatment||709
7602184|NCT02533726|18714174|P2|Per Protocol Population|Treatment||555
7602185|NCT02533726|18714175|P1|Per Protocol Population|Treatment||671
7602186|NCT02533726|18714174|P2|STARTED|Treatment|4 participants allocated to Optimal Turning actually received Standard Care|603
7602187|NCT02533726|18714175|P1|STARTED|Treatment|54 participants allocated to Standard Care actually received Optimal Turning|709
7602188|NCT02533726|18714174|P2|NOT COMPLETED|Initial Allocation||0
7602189|NCT02533726|18714175|P1|NOT COMPLETED|Initial Allocation||0
7602190|NCT02533726|18714174|P2|COMPLETED|Initial Allocation||653
7602191|NCT02533726|18714175|P1|COMPLETED|Initial Allocation||659
7602192|NCT02533726|18714174|P2|STARTED|Initial Allocation||653
7602193|NCT02533726|18714175|P1|STARTED|Initial Allocation||659
7602194|NCT02533570|18714186|P3|NOT COMPLETED|Overall Study||1
7602195|NCT02533570|18714187|P2|NOT COMPLETED|Overall Study||1
7602196|NCT02533570|18714188|P1|NOT COMPLETED|Overall Study||0
7602197|NCT02533570|18714186|P3|COMPLETED|Overall Study||7
7602198|NCT02533570|18714187|P2|COMPLETED|Overall Study||7
7602199|NCT02533570|18714188|P1|COMPLETED|Overall Study||4
7602200|NCT02533570|18714186|P3|STARTED|Overall Study||8
7602201|NCT02533570|18714187|P2|STARTED|Overall Study||8
7602202|NCT02533570|18714188|P1|STARTED|Overall Study||4
7602203|NCT02533531|18714199|P1|NOT COMPLETED|Overall Study||1
7602204|NCT02533531|18714199|P1|COMPLETED|Overall Study||0
7602205|NCT02533531|18714199|P1|STARTED|Overall Study||1
7602206|NCT02533505|18714204|P2|NOT COMPLETED|Overall Study||1
7602207|NCT02533505|18714205|P1|NOT COMPLETED|Overall Study||3
7602208|NCT02533505|18714204|P2|COMPLETED|Overall Study||24
7602209|NCT02533505|18714205|P1|COMPLETED|Overall Study||23
7602210|NCT02533505|18714204|P2|STARTED|Overall Study||25
7602211|NCT02533505|18714205|P1|STARTED|Overall Study||26
7602212|NCT02533466|18714237|P2|NOT COMPLETED|Overall Study||0
7602213|NCT02533466|18714238|P1|NOT COMPLETED|Overall Study||0
7602214|NCT02533466|18714237|P2|COMPLETED|Overall Study||14
7602215|NCT02533466|18714238|P1|COMPLETED|Overall Study||16
7602216|NCT02533466|18714237|P2|STARTED|Overall Study||14
7602217|NCT02533466|18714238|P1|STARTED|Overall Study||16
7602218|NCT02533453|18714262|P1|NOT COMPLETED|Overall Study||9
7602219|NCT02533453|18714262|P1|COMPLETED|Overall Study||101
7602220|NCT02533453|18714262|P1|STARTED|Overall Study||110
7602221|NCT02533427|18714271|P1|NOT COMPLETED|Overall Study||0
7602222|NCT02533427|18714271|P1|COMPLETED|Overall Study||15
7602223|NCT02533427|18714271|P1|STARTED|Overall Study||15
7602224|NCT02533401|18714321|P1|NOT COMPLETED|Overall Study||11
7602225|NCT02533401|18714321|P1|COMPLETED|Overall Study||23
7602226|NCT02533401|18714321|P1|STARTED|Overall Study||34
7602227|NCT02533375|18714329|P1|NOT COMPLETED|Overall Study||5
7602228|NCT02533375|18714329|P1|COMPLETED|Overall Study||5
7602229|NCT02533375|18714329|P1|STARTED|Overall Study||10
7602230|NCT02533258|18714361|P1|NOT COMPLETED|Overall Study||8
7602231|NCT02533258|18714361|P1|COMPLETED|Overall Study||5
7602232|NCT02533258|18714361|P1|STARTED|Overall Study||13
7602233|NCT02533167|18714373|P1|NOT COMPLETED|Overall Study||15
7602234|NCT02533167|18714373|P1|COMPLETED|Overall Study||55
7602235|NCT02533167|18714373|P1|STARTED|Overall Study||70
7602236|NCT02533089|18714384|P2|NOT COMPLETED|Overall Study||114
7602237|NCT02533089|18714385|P1|NOT COMPLETED|Overall Study||241
7602238|NCT02533089|18714384|P2|COMPLETED|Overall Study|6 HC accrued no eligible patients 8 HC no patients with outcome data 114 cases missing outcome|434
7602239|NCT02533089|18714385|P1|COMPLETED|Overall Study|4 HC accrued no eligable patients 11 HC no patients with outcome data 241 cases missing outcome|364
7602240|NCT02533089|18714384|P2|STARTED|Overall Study||548
7602241|NCT02533089|18714385|P1|STARTED|Overall Study||605
7602242|NCT02533063|18714397|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||0
7602243|NCT02533063|18714398|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||0
7602244|NCT02533063|18714397|P2|COMPLETED|Intervention 2 (8 Weeks)||11
7602245|NCT02533063|18714398|P1|COMPLETED|Intervention 2 (8 Weeks)||14
7602246|NCT02533063|18714397|P2|STARTED|Intervention 2 (8 Weeks)||11
7602247|NCT02533063|18714398|P1|STARTED|Intervention 2 (8 Weeks)||14
7602248|NCT02533063|18714397|P2|NOT COMPLETED|Washout (4 Weeks)||0
7602249|NCT02533063|18714398|P1|NOT COMPLETED|Washout (4 Weeks)||0
7602250|NCT02533063|18714397|P2|COMPLETED|Washout (4 Weeks)||11
7602251|NCT02533063|18714398|P1|COMPLETED|Washout (4 Weeks)||14
7602252|NCT02533063|18714397|P2|STARTED|Washout (4 Weeks)||11
7602253|NCT02533063|18714398|P1|STARTED|Washout (4 Weeks)||14
7602254|NCT02533063|18714397|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||5
7602255|NCT02533063|18714398|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||2
7602256|NCT02533063|18714397|P2|COMPLETED|Intervention 1 (8 Weeks)||11
7602257|NCT02533063|18714398|P1|COMPLETED|Intervention 1 (8 Weeks)||14
7602258|NCT02533063|18714397|P2|STARTED|Intervention 1 (8 Weeks)||16
7602259|NCT02533063|18714398|P1|STARTED|Intervention 1 (8 Weeks)||16
7602260|NCT02532998|18714420|P1|NOT COMPLETED|Overall Study||0
7602261|NCT02532998|18714420|P1|COMPLETED|Overall Study||23
7602262|NCT02532998|18714420|P1|STARTED|Overall Study||23
7602263|NCT02532972|18714502|P1|NOT COMPLETED|Overall Study||1
7602264|NCT02532972|18714502|P1|COMPLETED|Overall Study||10
7602265|NCT02532972|18714502|P1|STARTED|Overall Study||11
7602266|NCT02532933|18714510|P2|NOT COMPLETED|Overall Study||6
7602267|NCT02532933|18714511|P1|NOT COMPLETED|Overall Study||6
7602268|NCT02532933|18714510|P2|COMPLETED|Overall Study||16
7602269|NCT02532933|18714511|P1|COMPLETED|Overall Study||16
7602270|NCT02532933|18714510|P2|STARTED|Overall Study||22
7602271|NCT02532933|18714511|P1|STARTED|Overall Study||22
7602272|NCT02532855|18714519|P2|NOT COMPLETED|Overall Study||11
7602273|NCT02532855|18714520|P1|NOT COMPLETED|Overall Study||8
7602274|NCT02532855|18714519|P2|COMPLETED|Overall Study||296
7602275|NCT02532855|18714520|P1|COMPLETED|Overall Study||299
7602276|NCT02532855|18714519|P2|Treated|Overall Study|One participant had a protocol violation, was randomized but did not take study medication.|306
7602277|NCT02532855|18714520|P1|Treated|Overall Study||307
7602278|NCT02532855|18714519|P2|STARTED|Overall Study||307
7602279|NCT02532855|18714520|P1|STARTED|Overall Study||307
7602280|NCT02532764|18714554|P10|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
7602281|NCT02532764|18714555|P9|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
7602282|NCT02532764|18714556|P8|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
7602283|NCT02532764|18714557|P7|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
7602284|NCT02532764|18714558|P6|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
7602285|NCT02532764|18714559|P5|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
7602286|NCT02532764|18714560|P4|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
7602287|NCT02532764|18714561|P3|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
7602288|NCT02532764|18714562|P2|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
7602289|NCT02532764|18714563|P1|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
7602290|NCT02532764|18714554|P10|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||8
7602291|NCT02532764|18714555|P9|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||5
7602292|NCT02532764|18714556|P8|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
7602293|NCT02532764|18714557|P7|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
7602294|NCT02532764|18714558|P6|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
7602295|NCT02532764|18714559|P5|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
7602296|NCT02532764|18714560|P4|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
7602297|NCT02532764|18714561|P3|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
7602298|NCT02532764|18714562|P2|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
7602299|NCT02532764|18714563|P1|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
7602300|NCT02532764|18714554|P10|STARTED|Multiple Ascending Dose (MAD) Cohorst||9
7602301|NCT02532764|18714555|P9|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
7602302|NCT02532764|18714556|P8|STARTED|Multiple Ascending Dose (MAD) Cohorst||7
7602303|NCT02532764|18714557|P7|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
7602304|NCT02532764|18714558|P6|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
7602305|NCT02532764|18714559|P5|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
7602306|NCT02532764|18714560|P4|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
7602307|NCT02532764|18714561|P3|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
7602308|NCT02532764|18714562|P2|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
7602309|NCT02532764|18714563|P1|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
7602310|NCT02532764|18714554|P10|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
7602311|NCT02532764|18714555|P9|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
7602312|NCT02532764|18714556|P8|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
7602313|NCT02532764|18714557|P7|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
7602314|NCT02532764|18714558|P6|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
7602315|NCT02532764|18714559|P5|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
7602316|NCT02532764|18714560|P4|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
7602317|NCT02532764|18714561|P3|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
7602318|NCT02532764|18714562|P2|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
7602319|NCT02532764|18714563|P1|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
7602320|NCT02532764|18714554|P10|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
7602321|NCT02532764|18714555|P9|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
7602322|NCT02532764|18714556|P8|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
7602323|NCT02532764|18714557|P7|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
7602324|NCT02532764|18714558|P6|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
7602325|NCT02532764|18714559|P5|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
7602326|NCT02532764|18714560|P4|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
7602327|NCT02532764|18714561|P3|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
7602328|NCT02532764|18714562|P2|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
7602329|NCT02532764|18714563|P1|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
7602330|NCT02532764|18714554|P10|STARTED|Single Ascending Dose (SAD) Cohorts||0
7602331|NCT02532764|18714555|P9|STARTED|Single Ascending Dose (SAD) Cohorts||0
7602332|NCT02532764|18714556|P8|STARTED|Single Ascending Dose (SAD) Cohorts||0
7602333|NCT02532764|18714557|P7|STARTED|Single Ascending Dose (SAD) Cohorts||0
7602334|NCT02532764|18714558|P6|STARTED|Single Ascending Dose (SAD) Cohorts||0
7602335|NCT02532764|18714559|P5|STARTED|Single Ascending Dose (SAD) Cohorts||9
7602336|NCT02532764|18714560|P4|STARTED|Single Ascending Dose (SAD) Cohorts||6
7602337|NCT02532764|18714561|P3|STARTED|Single Ascending Dose (SAD) Cohorts||9
7602338|NCT02532764|18714562|P2|STARTED|Single Ascending Dose (SAD) Cohorts||6
7602339|NCT02532764|18714563|P1|STARTED|Single Ascending Dose (SAD) Cohorts||6
7602340|NCT02532647|18714714|P3|NOT COMPLETED|Overall Study||1
7602341|NCT02532647|18714715|P2|NOT COMPLETED|Overall Study||0
7602342|NCT02532647|18714716|P1|NOT COMPLETED|Overall Study||1
7602343|NCT02532647|18714714|P3|COMPLETED|Overall Study||30
7602344|NCT02532647|18714715|P2|COMPLETED|Overall Study||16
7602345|NCT02532647|18714716|P1|COMPLETED|Overall Study||31
7602346|NCT02532647|18714714|P3|Safety Population|Overall Study||30
7602347|NCT02532647|18714715|P2|Safety Population|Overall Study||16
7602348|NCT02532647|18714716|P1|Safety Population|Overall Study||31
7602349|NCT02532647|18714714|P3|STARTED|Overall Study||31
7602350|NCT02532647|18714715|P2|STARTED|Overall Study||16
7602351|NCT02532647|18714716|P1|STARTED|Overall Study||32
7602352|NCT02532556|18714730|P1|NOT COMPLETED|Overall Study||0
7602353|NCT02532556|18714730|P1|COMPLETED|Overall Study||12
7602354|NCT02532556|18714730|P1|STARTED|Overall Study||12
7602355|NCT02532543|18714758|P4|NOT COMPLETED|Overall Study||0
7602356|NCT02532543|18714759|P3|NOT COMPLETED|Overall Study||1
7602357|NCT02532543|18714760|P2|NOT COMPLETED|Overall Study||0
7602358|NCT02532543|18714761|P1|NOT COMPLETED|Overall Study||0
7602359|NCT02532543|18714758|P4|COMPLETED|Overall Study||4
7602360|NCT02532543|18714759|P3|COMPLETED|Overall Study||4
7602361|NCT02532543|18714760|P2|COMPLETED|Overall Study||4
7602362|NCT02532543|18714761|P1|COMPLETED|Overall Study||3
7602363|NCT02532543|18714758|P4|STARTED|Overall Study||4
7602364|NCT02532543|18714759|P3|STARTED|Overall Study||5
7602365|NCT02532543|18714760|P2|STARTED|Overall Study||4
7602366|NCT02532543|18714761|P1|STARTED|Overall Study||3
7602367|NCT02532517|18714795|P1|NOT COMPLETED|Overall Study||17
7602368|NCT02532517|18714795|P1|COMPLETED|Overall Study||28
7602369|NCT02532517|18714795|P1|mITT Analysis Set|Overall Study||44
7602370|NCT02532517|18714795|P1|STARTED|Overall Study||45
7602371|NCT02532465|18714815|P2|NOT COMPLETED|Overall Study||1
7602372|NCT02532465|18714816|P1|NOT COMPLETED|Overall Study||1
7602373|NCT02532465|18714815|P2|COMPLETED|Overall Study||24
7602374|NCT02532465|18714816|P1|COMPLETED|Overall Study||24
7602375|NCT02532465|18714815|P2|STARTED|Overall Study||25
7602376|NCT02532465|18714816|P1|STARTED|Overall Study||25
7602377|NCT02532374|18714826|P1|NOT COMPLETED|Overall Study||2
7602378|NCT02532374|18714826|P1|COMPLETED|Overall Study||14
7602379|NCT02532374|18714826|P1|P3L150 μg/Puff (Visit 6)|Overall Study||14
7602380|NCT02532374|18714826|P1|P3L 80 μg/Puff (Visit 5)|Overall Study||14
7602381|NCT02532374|18714826|P1|P3L 50 μg/Puff (Visit 4)|Overall Study||15
7602382|NCT02532374|18714826|P1|Nicorette Inhalator (Visit 3)|Overall Study||15
7602383|NCT02532374|18714826|P1|STARTED|Overall Study||16
7602384|NCT02532283|18714852|P2|NOT COMPLETED|Overall Study||5
7602385|NCT02532283|18714853|P1|NOT COMPLETED|Overall Study||9
7602386|NCT02532283|18714852|P2|COMPLETED|Overall Study||30
7602387|NCT02532283|18714853|P1|COMPLETED|Overall Study||55
7602388|NCT02532283|18714852|P2|Full Analysis Set|Overall Study||32
7602389|NCT02532283|18714853|P1|Full Analysis Set|Overall Study||63
7602390|NCT02532283|18714852|P2|STARTED|Overall Study||35
7602391|NCT02532283|18714853|P1|STARTED|Overall Study||64
7602392|NCT02532179|18714895|P1|NOT COMPLETED|Overall Study||3
7602393|NCT02532179|18714895|P1|COMPLETED|Overall Study||9
7602394|NCT02532179|18714895|P1|STARTED|Overall Study||12
7602395|NCT02532036|18714904|P2|NOT COMPLETED|Overall Study||0
7602396|NCT02532036|18714905|P1|NOT COMPLETED|Overall Study||0
7602397|NCT02532036|18714904|P2|COMPLETED|Overall Study||0
7602398|NCT02532036|18714905|P1|COMPLETED|Overall Study||2
7602399|NCT02532036|18714904|P2|STARTED|Overall Study||0
7602400|NCT02532036|18714905|P1|STARTED|Overall Study||2
7602401|NCT02532010|18714911|P2|NOT COMPLETED|Overall Study||4
7602402|NCT02532010|18714912|P1|NOT COMPLETED|Overall Study||9
7602403|NCT02532010|18714911|P2|COMPLETED|Overall Study||0
7602404|NCT02532010|18714912|P1|COMPLETED|Overall Study||0
7602405|NCT02532010|18714911|P2|STARTED|Overall Study||4
7602406|NCT02532010|18714912|P1|STARTED|Overall Study||9
7602407|NCT02531971|18714932|P2|NOT COMPLETED|Overall Study||0
7602408|NCT02531971|18714933|P1|NOT COMPLETED|Overall Study||0
7602409|NCT02531971|18714932|P2|COMPLETED|Overall Study||13
7602410|NCT02531971|18714933|P1|COMPLETED|Overall Study||11
7602411|NCT02531971|18714932|P2|STARTED|Overall Study||13
7602412|NCT02531971|18714933|P1|STARTED|Overall Study||11
7602413|NCT02531867|18714940|P1|NOT COMPLETED|Overall Study||0
7602414|NCT02531867|18714940|P1|COMPLETED|Overall Study||13
7602415|NCT02531867|18714940|P1|STARTED|Overall Study||13
7602416|NCT02531802|18714965|P21|NOT COMPLETED|Received Vaccination 2||1
7602417|NCT02531802|18714966|P20|NOT COMPLETED|Received Vaccination 2||1
7602418|NCT02531802|18714967|P19|NOT COMPLETED|Received Vaccination 2||3
7602419|NCT02531802|18714968|P18|NOT COMPLETED|Received Vaccination 2||4
7602420|NCT02531802|18714969|P17|NOT COMPLETED|Received Vaccination 2||0
7602421|NCT02531802|18714970|P16|NOT COMPLETED|Received Vaccination 2||0
7602422|NCT02531802|18714971|P15|NOT COMPLETED|Received Vaccination 2||1
7602423|NCT02531802|18714972|P14|NOT COMPLETED|Received Vaccination 2||2
7602424|NCT02531802|18714973|P13|NOT COMPLETED|Received Vaccination 2||2
7602425|NCT02531802|18714974|P12|NOT COMPLETED|Received Vaccination 2||0
7602426|NCT02531802|18714975|P11|NOT COMPLETED|Received Vaccination 2||2
7602427|NCT02531802|18714976|P10|NOT COMPLETED|Received Vaccination 2||3
7602428|NCT02531802|18714977|P9|NOT COMPLETED|Received Vaccination 2||0
7602429|NCT02531802|18714978|P8|NOT COMPLETED|Received Vaccination 2||0
7602430|NCT02531802|18714979|P7|NOT COMPLETED|Received Vaccination 2||0
7602431|NCT02531802|18714980|P6|NOT COMPLETED|Received Vaccination 2||3
7602432|NCT02531802|18714981|P5|NOT COMPLETED|Received Vaccination 2||0
7602433|NCT02531802|18714982|P4|NOT COMPLETED|Received Vaccination 2||0
7602434|NCT02531802|18714983|P3|NOT COMPLETED|Received Vaccination 2||1
7602435|NCT02531802|18714984|P2|NOT COMPLETED|Received Vaccination 2||0
7602436|NCT02531802|18714985|P1|NOT COMPLETED|Received Vaccination 2||0
7602437|NCT02531802|18714965|P21|COMPLETED|Received Vaccination 2||49
7602438|NCT02531802|18714966|P20|COMPLETED|Received Vaccination 2||29
7602439|NCT02531802|18714967|P19|COMPLETED|Received Vaccination 2||27
7602440|NCT02531802|18714968|P18|COMPLETED|Received Vaccination 2||26
7602441|NCT02531802|18714969|P17|COMPLETED|Received Vaccination 2||30
7602442|NCT02531802|18714970|P16|COMPLETED|Received Vaccination 2||30
7602443|NCT02531802|18714971|P15|COMPLETED|Received Vaccination 2||39
7602444|NCT02531802|18714972|P14|COMPLETED|Received Vaccination 2||13
7602445|NCT02531802|18714973|P13|COMPLETED|Received Vaccination 2||13
7602446|NCT02531802|18714974|P12|COMPLETED|Received Vaccination 2||15
7602447|NCT02531802|18714975|P11|COMPLETED|Received Vaccination 2||13
7602448|NCT02531802|18714976|P10|COMPLETED|Received Vaccination 2||49
7602449|NCT02531802|18714977|P9|COMPLETED|Received Vaccination 2||15
7602450|NCT02531802|18714978|P8|COMPLETED|Received Vaccination 2||15
7602451|NCT02531802|18714979|P7|COMPLETED|Received Vaccination 2||15
7602452|NCT02531802|18714980|P6|COMPLETED|Received Vaccination 2||0
7602453|NCT02531802|18714981|P5|COMPLETED|Received Vaccination 2||15
7602454|NCT02531802|18714982|P4|COMPLETED|Received Vaccination 2||15
7602455|NCT02531802|18714983|P3|COMPLETED|Received Vaccination 2||14
7602456|NCT02531802|18714984|P2|COMPLETED|Received Vaccination 2||15
7602457|NCT02531802|18714985|P1|COMPLETED|Received Vaccination 2||15
7602458|NCT02531802|18714965|P21|STARTED|Received Vaccination 2||50
7602459|NCT02531802|18714966|P20|STARTED|Received Vaccination 2||30
7602460|NCT02531802|18714967|P19|STARTED|Received Vaccination 2||30
7602461|NCT02531802|18714968|P18|STARTED|Received Vaccination 2||30
7602462|NCT02531802|18714969|P17|STARTED|Received Vaccination 2||30
7602463|NCT02531802|18714970|P16|STARTED|Received Vaccination 2||30
7602464|NCT02531802|18714971|P15|STARTED|Received Vaccination 2||40
7602465|NCT02531802|18714972|P14|STARTED|Received Vaccination 2||15
7602466|NCT02531802|18714973|P13|STARTED|Received Vaccination 2||15
7602467|NCT02531802|18714974|P12|STARTED|Received Vaccination 2||15
7602468|NCT02531802|18714975|P11|STARTED|Received Vaccination 2||15
7602469|NCT02531802|18714976|P10|STARTED|Received Vaccination 2||52
7602470|NCT02531802|18714977|P9|STARTED|Received Vaccination 2||15
7602471|NCT02531802|18714978|P8|STARTED|Received Vaccination 2||15
7602472|NCT02531802|18714979|P7|STARTED|Received Vaccination 2||15
7602473|NCT02531802|18714980|P6|STARTED|Received Vaccination 2||3
7602474|NCT02531802|18714981|P5|STARTED|Received Vaccination 2||15
7602475|NCT02531802|18714982|P4|STARTED|Received Vaccination 2||15
7602476|NCT02531802|18714983|P3|STARTED|Received Vaccination 2||15
7602477|NCT02531802|18714984|P2|STARTED|Received Vaccination 2||15
7602478|NCT02531802|18714985|P1|STARTED|Received Vaccination 2||15
7602479|NCT02531802|18714965|P21|NOT COMPLETED|Received Vaccination 1||0
7602480|NCT02531802|18714966|P20|NOT COMPLETED|Received Vaccination 1||0
7602481|NCT02531802|18714967|P19|NOT COMPLETED|Received Vaccination 1||0
7602482|NCT02531802|18714968|P18|NOT COMPLETED|Received Vaccination 1||0
7602483|NCT02531802|18714969|P17|NOT COMPLETED|Received Vaccination 1||0
7602484|NCT02531802|18714970|P16|NOT COMPLETED|Received Vaccination 1||0
7602485|NCT02531802|18714971|P15|NOT COMPLETED|Received Vaccination 1||0
7602486|NCT02531802|18714972|P14|NOT COMPLETED|Received Vaccination 1||0
7602487|NCT02531802|18714973|P13|NOT COMPLETED|Received Vaccination 1||0
7602488|NCT02531802|18714974|P12|NOT COMPLETED|Received Vaccination 1||0
7602489|NCT02531802|18714975|P11|NOT COMPLETED|Received Vaccination 1||0
7602490|NCT02531802|18714976|P10|NOT COMPLETED|Received Vaccination 1||0
7602491|NCT02531802|18714977|P9|NOT COMPLETED|Received Vaccination 1||0
7602492|NCT02531802|18714978|P8|NOT COMPLETED|Received Vaccination 1||0
7602493|NCT02531802|18714979|P7|NOT COMPLETED|Received Vaccination 1||0
7602494|NCT02531802|18714980|P6|NOT COMPLETED|Received Vaccination 1||0
7602495|NCT02531802|18714981|P5|NOT COMPLETED|Received Vaccination 1||0
7602496|NCT02531802|18714982|P4|NOT COMPLETED|Received Vaccination 1||0
7602497|NCT02531802|18714983|P3|NOT COMPLETED|Received Vaccination 1||0
7602498|NCT02531802|18714984|P2|NOT COMPLETED|Received Vaccination 1||0
7602499|NCT02531802|18714985|P1|NOT COMPLETED|Received Vaccination 1||0
7602500|NCT02531802|18714965|P21|COMPLETED|Received Vaccination 1||50
7602501|NCT02531802|18714966|P20|COMPLETED|Received Vaccination 1||30
7602502|NCT02531802|18714967|P19|COMPLETED|Received Vaccination 1||30
7602503|NCT02531802|18714968|P18|COMPLETED|Received Vaccination 1||30
7602504|NCT02531802|18714969|P17|COMPLETED|Received Vaccination 1||30
7602505|NCT02531802|18714970|P16|COMPLETED|Received Vaccination 1||30
7602506|NCT02531802|18714971|P15|COMPLETED|Received Vaccination 1||40
7602507|NCT02531802|18714972|P14|COMPLETED|Received Vaccination 1||15
7602508|NCT02531802|18714973|P13|COMPLETED|Received Vaccination 1||15
7602509|NCT02531802|18714974|P12|COMPLETED|Received Vaccination 1||15
7602510|NCT02531802|18714975|P11|COMPLETED|Received Vaccination 1||15
7602511|NCT02531802|18714976|P10|COMPLETED|Received Vaccination 1||52
7602512|NCT02531802|18714977|P9|COMPLETED|Received Vaccination 1||15
7602513|NCT02531802|18714978|P8|COMPLETED|Received Vaccination 1||15
7602514|NCT02531802|18714979|P7|COMPLETED|Received Vaccination 1||15
7602515|NCT02531802|18714980|P6|COMPLETED|Received Vaccination 1||3
7602516|NCT02531802|18714981|P5|COMPLETED|Received Vaccination 1||15
7602517|NCT02531802|18714982|P4|COMPLETED|Received Vaccination 1||15
7602518|NCT02531802|18714983|P3|COMPLETED|Received Vaccination 1||15
7602519|NCT02531802|18714984|P2|COMPLETED|Received Vaccination 1||15
7602520|NCT02531802|18714985|P1|COMPLETED|Received Vaccination 1||15
7602521|NCT02531802|18714965|P21|STARTED|Received Vaccination 1||50
7602522|NCT02531802|18714966|P20|STARTED|Received Vaccination 1||30
7602523|NCT02531802|18714967|P19|STARTED|Received Vaccination 1||30
7602524|NCT02531802|18714968|P18|STARTED|Received Vaccination 1||30
7602525|NCT02531802|18714969|P17|STARTED|Received Vaccination 1||30
7602526|NCT02531802|18714970|P16|STARTED|Received Vaccination 1||30
7602527|NCT02531802|18714971|P15|STARTED|Received Vaccination 1||40
7602528|NCT02531802|18714972|P14|STARTED|Received Vaccination 1||15
7602529|NCT02531802|18714973|P13|STARTED|Received Vaccination 1||15
7602530|NCT02531802|18714974|P12|STARTED|Received Vaccination 1||15
7602531|NCT02531802|18714975|P11|STARTED|Received Vaccination 1||15
7602532|NCT02531802|18714976|P10|STARTED|Received Vaccination 1||52
7602533|NCT02531802|18714977|P9|STARTED|Received Vaccination 1||15
7602534|NCT02531802|18714978|P8|STARTED|Received Vaccination 1||15
7602535|NCT02531802|18714979|P7|STARTED|Received Vaccination 1||15
7602536|NCT02531802|18714980|P6|STARTED|Received Vaccination 1||3
7602537|NCT02531802|18714981|P5|STARTED|Received Vaccination 1||15
7602538|NCT02531802|18714982|P4|STARTED|Received Vaccination 1||15
7602539|NCT02531802|18714983|P3|STARTED|Received Vaccination 1||15
7602540|NCT02531802|18714984|P2|STARTED|Received Vaccination 1||15
7602541|NCT02531802|18714985|P1|STARTED|Received Vaccination 1||15
7602542|NCT02531698|18715417|P2|NOT COMPLETED|Overall Study||2
7602543|NCT02531698|18715418|P1|NOT COMPLETED|Overall Study||11
7602544|NCT02531698|18715417|P2|COMPLETED|Overall Study||104
7602545|NCT02531698|18715418|P1|COMPLETED|Overall Study||283
7602546|NCT02531698|18715417|P2|STARTED|Overall Study||106
7602547|NCT02531698|18715418|P1|STARTED|Overall Study||294
7602548|NCT02531646|18715665|P3|NOT COMPLETED|Overall Study||0
7602549|NCT02531646|18715666|P2|NOT COMPLETED|Overall Study||1
7602550|NCT02531646|18715667|P1|NOT COMPLETED|Overall Study||5
7602551|NCT02531646|18715665|P3|COMPLETED|Overall Study||11
7602552|NCT02531646|18715666|P2|COMPLETED|Overall Study||17
7602553|NCT02531646|18715667|P1|COMPLETED|Overall Study||32
7602554|NCT02531646|18715665|P3|STARTED|Overall Study||11
7602555|NCT02531646|18715666|P2|STARTED|Overall Study||18
7602556|NCT02531646|18715667|P1|STARTED|Overall Study||37
7602557|NCT02531633|18715686|P10|NOT COMPLETED|Part B (104 Weeks)||4
7602558|NCT02531633|18715687|P9|NOT COMPLETED|Part B (104 Weeks)||5
7602559|NCT02531633|18715688|P8|NOT COMPLETED|Part B (104 Weeks)||4
7602560|NCT02531633|18715689|P7|NOT COMPLETED|Part B (104 Weeks)||5
7602561|NCT02531633|18715690|P6|NOT COMPLETED|Part B (104 Weeks)||8
7602562|NCT02531633|18715691|P5|NOT COMPLETED|Part B (104 Weeks)||0
7602563|NCT02531633|18715692|P4|NOT COMPLETED|Part B (104 Weeks)||0
7602564|NCT02531633|18715693|P3|NOT COMPLETED|Part B (104 Weeks)||0
7602565|NCT02531633|18715694|P2|NOT COMPLETED|Part B (104 Weeks)||0
7602566|NCT02531633|18715695|P1|NOT COMPLETED|Part B (104 Weeks)||0
7602567|NCT02531633|18715686|P10|COMPLETED|Part B (104 Weeks)||0
7602568|NCT02531633|18715687|P9|COMPLETED|Part B (104 Weeks)||0
7602569|NCT02531633|18715688|P8|COMPLETED|Part B (104 Weeks)||0
7602570|NCT02531633|18715689|P7|COMPLETED|Part B (104 Weeks)||0
7602571|NCT02531633|18715690|P6|COMPLETED|Part B (104 Weeks)||0
7602572|NCT02531633|18715691|P5|COMPLETED|Part B (104 Weeks)||0
7602573|NCT02531633|18715692|P4|COMPLETED|Part B (104 Weeks)||0
7602574|NCT02531633|18715693|P3|COMPLETED|Part B (104 Weeks)||0
7602575|NCT02531633|18715694|P2|COMPLETED|Part B (104 Weeks)||0
7602576|NCT02531633|18715695|P1|COMPLETED|Part B (104 Weeks)||0
7602577|NCT02531633|18715686|P10|STARTED|Part B (104 Weeks)||4
7602578|NCT02531633|18715687|P9|STARTED|Part B (104 Weeks)||5
7602579|NCT02531633|18715688|P8|STARTED|Part B (104 Weeks)||4
7602580|NCT02531633|18715689|P7|STARTED|Part B (104 Weeks)||5
7602581|NCT02531633|18715690|P6|STARTED|Part B (104 Weeks)||8
7602582|NCT02531633|18715691|P5|STARTED|Part B (104 Weeks)||0
7602583|NCT02531633|18715692|P4|STARTED|Part B (104 Weeks)||0
7602584|NCT02531633|18715693|P3|STARTED|Part B (104 Weeks)||0
7602585|NCT02531633|18715694|P2|STARTED|Part B (104 Weeks)||0
7602586|NCT02531633|18715695|P1|STARTED|Part B (104 Weeks)||0
7602587|NCT02531633|18715686|P10|NOT COMPLETED|Part A (52 Weeks)||0
7602588|NCT02531633|18715687|P9|NOT COMPLETED|Part A (52 Weeks)||0
7602589|NCT02531633|18715688|P8|NOT COMPLETED|Part A (52 Weeks)||0
7602590|NCT02531633|18715689|P7|NOT COMPLETED|Part A (52 Weeks)||0
7602591|NCT02531633|18715690|P6|NOT COMPLETED|Part A (52 Weeks)||0
7602592|NCT02531633|18715691|P5|NOT COMPLETED|Part A (52 Weeks)||23
7602593|NCT02531633|18715692|P4|NOT COMPLETED|Part A (52 Weeks)||22
7602594|NCT02531633|18715693|P3|NOT COMPLETED|Part A (52 Weeks)||22
7602595|NCT02531633|18715694|P2|NOT COMPLETED|Part A (52 Weeks)||34
7602596|NCT02531633|18715695|P1|NOT COMPLETED|Part A (52 Weeks)||34
7602597|NCT02531633|18715686|P10|COMPLETED|Part A (52 Weeks)||0
7602598|NCT02531633|18715687|P9|COMPLETED|Part A (52 Weeks)||0
7602599|NCT02531633|18715688|P8|COMPLETED|Part A (52 Weeks)||0
7602600|NCT02531633|18715689|P7|COMPLETED|Part A (52 Weeks)||0
7602601|NCT02531633|18715690|P6|COMPLETED|Part A (52 Weeks)||0
7602602|NCT02531633|18715691|P5|COMPLETED|Part A (52 Weeks)||4
7602603|NCT02531633|18715692|P4|COMPLETED|Part A (52 Weeks)||5
7602604|NCT02531633|18715693|P3|COMPLETED|Part A (52 Weeks)||4
7602605|NCT02531633|18715694|P2|COMPLETED|Part A (52 Weeks)||5
7602606|NCT02531633|18715695|P1|COMPLETED|Part A (52 Weeks)||8
7602607|NCT02531633|18715686|P10|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
7602608|NCT02531633|18715687|P9|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
7602609|NCT02531633|18715688|P8|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
7602610|NCT02531633|18715689|P7|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
7602611|NCT02531633|18715690|P6|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
7602612|NCT02531633|18715691|P5|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
7602613|NCT02531633|18715692|P4|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
7602614|NCT02531633|18715693|P3|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
7602615|NCT02531633|18715694|P2|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
7602616|NCT02531633|18715695|P1|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
7602617|NCT02531633|18715686|P10|STARTED|Part A (52 Weeks)||0
7602618|NCT02531633|18715687|P9|STARTED|Part A (52 Weeks)||0
7602619|NCT02531633|18715688|P8|STARTED|Part A (52 Weeks)||0
7602620|NCT02531633|18715689|P7|STARTED|Part A (52 Weeks)||0
7602621|NCT02531633|18715690|P6|STARTED|Part A (52 Weeks)||0
7602622|NCT02531633|18715691|P5|STARTED|Part A (52 Weeks)||27
7602623|NCT02531633|18715692|P4|STARTED|Part A (52 Weeks)||27
7602624|NCT02531633|18715693|P3|STARTED|Part A (52 Weeks)||26
7602625|NCT02531633|18715694|P2|STARTED|Part A (52 Weeks)||39
7602626|NCT02531633|18715695|P1|STARTED|Part A (52 Weeks)||42
7602627|NCT02531438|18716174|P2|NOT COMPLETED|Overall Study||26
7602628|NCT02531438|18716175|P1|NOT COMPLETED|Overall Study||30
7602629|NCT02531438|18716174|P2|COMPLETED|Overall Study||362
7602630|NCT02531438|18716175|P1|COMPLETED|Overall Study||356
7602631|NCT02531438|18716174|P2|STARTED|Overall Study||388
7602632|NCT02531438|18716175|P1|STARTED|Overall Study||386
7602633|NCT02531373|18716194|P9|NOT COMPLETED|Overall Study||9
7602634|NCT02531373|18716195|P8|NOT COMPLETED|Overall Study||9
7602635|NCT02531373|18716196|P7|NOT COMPLETED|Overall Study||11
7602636|NCT02531373|18716197|P6|NOT COMPLETED|Overall Study||9
7602637|NCT02531373|18716198|P5|NOT COMPLETED|Overall Study||8
7602638|NCT02531373|18716199|P4|NOT COMPLETED|Overall Study||0
7602639|NCT02531373|18716200|P3|NOT COMPLETED|Overall Study||0
7602640|NCT02531373|18716201|P2|NOT COMPLETED|Overall Study||0
7602641|NCT02531373|18716202|P1|NOT COMPLETED|Overall Study||0
7602642|NCT02531373|18716194|P9|COMPLETED|Overall Study||43
7602643|NCT02531373|18716195|P8|COMPLETED|Overall Study||43
7602644|NCT02531373|18716196|P7|COMPLETED|Overall Study||41
7602645|NCT02531373|18716197|P6|COMPLETED|Overall Study||42
7602646|NCT02531373|18716198|P5|COMPLETED|Overall Study||43
7602647|NCT02531373|18716199|P4|COMPLETED|Overall Study||20
7602648|NCT02531373|18716200|P3|COMPLETED|Overall Study||20
7602649|NCT02531373|18716201|P2|COMPLETED|Overall Study||20
7602650|NCT02531373|18716202|P1|COMPLETED|Overall Study||20
7602651|NCT02531373|18716194|P9|Vaccination 4|Overall Study||43
7602652|NCT02531373|18716195|P8|Vaccination 4|Overall Study||43
7602653|NCT02531373|18716196|P7|Vaccination 4|Overall Study||43
7602654|NCT02531373|18716197|P6|Vaccination 4|Overall Study||43
7602655|NCT02531373|18716198|P5|Vaccination 4|Overall Study||44
7602656|NCT02531373|18716199|P4|Vaccination 4|Overall Study||0
7602657|NCT02531373|18716200|P3|Vaccination 4|Overall Study||0
7602658|NCT02531373|18716201|P2|Vaccination 4|Overall Study||0
7602659|NCT02531373|18716202|P1|Vaccination 4|Overall Study||0
7602660|NCT02531373|18716194|P9|Vaccination 3|Overall Study||49
7602661|NCT02531373|18716195|P8|Vaccination 3|Overall Study||51
7602662|NCT02531373|18716196|P7|Vaccination 3|Overall Study||49
7602663|NCT02531373|18716197|P6|Vaccination 3|Overall Study||47
7602664|NCT02531373|18716198|P5|Vaccination 3|Overall Study||48
7602665|NCT02531373|18716199|P4|Vaccination 3|Overall Study||0
7602666|NCT02531373|18716200|P3|Vaccination 3|Overall Study||0
7602667|NCT02531373|18716201|P2|Vaccination 3|Overall Study||0
7602668|NCT02531373|18716202|P1|Vaccination 3|Overall Study||0
7602669|NCT02531373|18716194|P9|Vaccination 2|Overall Study||51
7602670|NCT02531373|18716195|P8|Vaccination 2|Overall Study||51
7602671|NCT02531373|18716196|P7|Vaccination 2|Overall Study||50
7602672|NCT02531373|18716197|P6|Vaccination 2|Overall Study||48
7602673|NCT02531373|18716198|P5|Vaccination 2|Overall Study||49
7602674|NCT02531373|18716199|P4|Vaccination 2|Overall Study||0
7602675|NCT02531373|18716200|P3|Vaccination 2|Overall Study||0
7602676|NCT02531373|18716201|P2|Vaccination 2|Overall Study||0
7602677|NCT02531373|18716202|P1|Vaccination 2|Overall Study||0
7602678|NCT02531373|18716194|P9|Vaccination 1|Overall Study||52
7602679|NCT02531373|18716195|P8|Vaccination 1|Overall Study||52
7602680|NCT02531373|18716196|P7|Vaccination 1|Overall Study||52
7602681|NCT02531373|18716197|P6|Vaccination 1|Overall Study||50
7602682|NCT02531373|18716198|P5|Vaccination 1|Overall Study||50
7602683|NCT02531373|18716199|P4|Vaccination 1|Overall Study||20
7602684|NCT02531373|18716200|P3|Vaccination 1|Overall Study||20
7602685|NCT02531373|18716201|P2|Vaccination 1|Overall Study||20
7602686|NCT02531373|18716202|P1|Vaccination 1|Overall Study||20
7602687|NCT02531373|18716194|P9|STARTED|Overall Study||52
7602688|NCT02531373|18716195|P8|STARTED|Overall Study||52
7602689|NCT02531373|18716196|P7|STARTED|Overall Study||52
7602690|NCT02531373|18716197|P6|STARTED|Overall Study||51
7602691|NCT02531373|18716198|P5|STARTED|Overall Study||51
7602692|NCT02531373|18716199|P4|STARTED|Overall Study||20
7602693|NCT02531373|18716200|P3|STARTED|Overall Study||20
7602694|NCT02531373|18716201|P2|STARTED|Overall Study||20
7602695|NCT02531373|18716202|P1|STARTED|Overall Study||20
7602696|NCT02531321|18716261|P2|NOT COMPLETED|Overall Study||0
7602697|NCT02531321|18716262|P1|NOT COMPLETED|Overall Study||2
7602698|NCT02531321|18716261|P2|COMPLETED|Overall Study||10
7602699|NCT02531321|18716262|P1|COMPLETED|Overall Study||5
7602700|NCT02531321|18716261|P2|STARTED|Overall Study||10
7602701|NCT02531321|18716262|P1|STARTED|Overall Study||7
7602702|NCT02531308|18716270|P1|NOT COMPLETED|Overall Study||3
7602703|NCT02531308|18716270|P1|COMPLETED|Overall Study||2
7602704|NCT02531308|18716270|P1|STARTED|Overall Study||5
7602705|NCT02531113|18716274|P1|NOT COMPLETED|Extension Period: Week 12 up to Week 160||38
7602706|NCT02531113|18716274|P1|COMPLETED|Extension Period: Week 12 up to Week 160||14
7602707|NCT02531113|18716274|P1|STARTED|Extension Period: Week 12 up to Week 160|6 participants completed induction; did not advance to extension due to lack efficacy.|52
7602708|NCT02531113|18716274|P1|NOT COMPLETED|Induction Period: Week 0 to 12||11
7602709|NCT02531113|18716274|P1|COMPLETED|Induction Period: Week 0 to 12||58
7602710|NCT02531113|18716274|P1|STARTED|Induction Period: Week 0 to 12||69
7602711|NCT02531035|18716306|P2|NOT COMPLETED|Overall Study||95
7602712|NCT02531035|18716307|P1|NOT COMPLETED|Overall Study||81
7602713|NCT02531035|18716306|P2|COMPLETED|Overall Study||605
7602714|NCT02531035|18716307|P1|COMPLETED|Overall Study||624
7602715|NCT02531035|18716306|P2|Treated|Overall Study||699
7602716|NCT02531035|18716307|P1|Treated|Overall Study||703
7602717|NCT02531035|18716306|P2|STARTED|Overall Study||700
7602718|NCT02531035|18716307|P1|STARTED|Overall Study||705
7602719|NCT02531022|18716323|P2|NOT COMPLETED|Overall Study||2
7602720|NCT02531022|18716324|P1|NOT COMPLETED|Overall Study||0
7602721|NCT02531022|18716323|P2|COMPLETED|Overall Study||48
7602722|NCT02531022|18716324|P1|COMPLETED|Overall Study||55
7602723|NCT02531022|18716323|P2|STARTED|Overall Study||50
7602724|NCT02531022|18716324|P1|STARTED|Overall Study||55
7602725|NCT02530970|18716332|P1|NOT COMPLETED|Overall Study||134
7602726|NCT02530970|18716332|P1|COMPLETED|Overall Study||891
7602727|NCT02530970|18716332|P1|STARTED|Overall Study||1025
7602728|NCT02530671|18716339|P2|NOT COMPLETED|Overall Study||0
7602729|NCT02530671|18716340|P1|NOT COMPLETED|Overall Study||3
7602730|NCT02530671|18716339|P2|COMPLETED|Overall Study||55
7602731|NCT02530671|18716340|P1|COMPLETED|Overall Study||52
7602732|NCT02530671|18716339|P2|STARTED|Overall Study||55
7602733|NCT02530671|18716340|P1|STARTED|Overall Study||55
7602734|NCT02530619|18716356|P1|NOT COMPLETED|Follow-up Period (6 Months)||11
7602735|NCT02530619|18716356|P1|COMPLETED|Follow-up Period (6 Months)||10
7602736|NCT02530619|18716356|P1|STARTED|Follow-up Period (6 Months)|Patients who received at least one dose of study drug go into follow-up.|21
7602737|NCT02530619|18716356|P1|NOT COMPLETED|Continued Treatment Cycle 7+||0
7602738|NCT02530619|18716356|P1|COMPLETED|Continued Treatment Cycle 7+||14
7602739|NCT02530619|18716356|P1|STARTED|Continued Treatment Cycle 7+||14
7602740|NCT02530619|18716356|P1|NOT COMPLETED|Continued Treatment Cycles 2 Through 6||10
7602741|NCT02530619|18716356|P1|COMPLETED|Continued Treatment Cycles 2 Through 6||14
7602742|NCT02530619|18716356|P1|STARTED|Continued Treatment Cycles 2 Through 6||24
7602743|NCT02530619|18716356|P1|NOT COMPLETED|Completed 1st Cycle of Treatment||0
7602744|NCT02530619|18716356|P1|COMPLETED|Completed 1st Cycle of Treatment||24
7602745|NCT02530619|18716356|P1|STARTED|Completed 1st Cycle of Treatment||24
7602746|NCT02530619|18716356|P1|NOT COMPLETED|Registered for Study||2
7602747|NCT02530619|18716356|P1|COMPLETED|Registered for Study||24
7602748|NCT02530619|18716356|P1|Received 1st Dose of Alisertib|Registered for Study||24
7602749|NCT02530619|18716356|P1|Registered|Registered for Study||26
7602750|NCT02530619|18716356|P1|STARTED|Registered for Study||26
7602751|NCT02530554|18716360|P4|NOT COMPLETED|Overall Study||0
7602752|NCT02530554|18716361|P3|NOT COMPLETED|Overall Study||0
7602753|NCT02530554|18716362|P2|NOT COMPLETED|Overall Study||0
7602754|NCT02530554|18716363|P1|NOT COMPLETED|Overall Study||0
7602755|NCT02530554|18716360|P4|COMPLETED|Overall Study||14
7602756|NCT02530554|18716361|P3|COMPLETED|Overall Study||12
7602757|NCT02530554|18716362|P2|COMPLETED|Overall Study||14
7602758|NCT02530554|18716363|P1|COMPLETED|Overall Study||12
7602759|NCT02530554|18716360|P4|STARTED|Overall Study||14
7602760|NCT02530554|18716361|P3|STARTED|Overall Study||12
7602761|NCT02530554|18716362|P2|STARTED|Overall Study||14
7602762|NCT02530554|18716363|P1|STARTED|Overall Study||12
7602763|NCT02530515|18716373|P3|NOT COMPLETED|Overall Study||0
7602764|NCT02530515|18716374|P2|NOT COMPLETED|Overall Study||0
7602765|NCT02530515|18716375|P1|NOT COMPLETED|Overall Study||0
7602766|NCT02530515|18716373|P3|COMPLETED|Overall Study||8
7602767|NCT02530515|18716374|P2|COMPLETED|Overall Study||0
7602768|NCT02530515|18716375|P1|COMPLETED|Overall Study||0
7602769|NCT02530515|18716373|P3|STARTED|Overall Study||8
7602770|NCT02530515|18716374|P2|STARTED|Overall Study||0
7602771|NCT02530515|18716375|P1|STARTED|Overall Study||0
7602772|NCT02530476|18716396|P4|NOT COMPLETED|Overall Study||0
7602773|NCT02530476|18716397|P3|NOT COMPLETED|Overall Study||0
7602774|NCT02530476|18716398|P2|NOT COMPLETED|Overall Study||0
7602775|NCT02530476|18716399|P1|NOT COMPLETED|Overall Study||0
7602776|NCT02530476|18716396|P4|COMPLETED|Overall Study||3
7602777|NCT02530476|18716397|P3|COMPLETED|Overall Study||7
7602778|NCT02530476|18716398|P2|COMPLETED|Overall Study||3
7602779|NCT02530476|18716399|P1|COMPLETED|Overall Study||4
7602780|NCT02530476|18716396|P4|STARTED|Overall Study||3
7602781|NCT02530476|18716397|P3|STARTED|Overall Study||7
7602782|NCT02530476|18716398|P2|STARTED|Overall Study||3
7602783|NCT02530476|18716399|P1|STARTED|Overall Study||4
7602784|NCT02530450|18716423|P2|NOT COMPLETED|Overall Study||5
7602785|NCT02530450|18716424|P1|NOT COMPLETED|Overall Study||6
7602786|NCT02530450|18716423|P2|COMPLETED|Overall Study||9
7602787|NCT02530450|18716424|P1|COMPLETED|Overall Study||10
7602788|NCT02530450|18716423|P2|STARTED|Overall Study||14
7602789|NCT02530450|18716424|P1|STARTED|Overall Study||16
7602790|NCT02530385|18716432|P2|NOT COMPLETED|Overall Study||1
7602791|NCT02530385|18716433|P1|NOT COMPLETED|Overall Study||0
7602792|NCT02530385|18716432|P2|COMPLETED|Overall Study||11
7602793|NCT02530385|18716433|P1|COMPLETED|Overall Study||12
7602794|NCT02530385|18716432|P2|STARTED|Overall Study||12
7602795|NCT02530385|18716433|P1|STARTED|Overall Study||12
7602796|NCT02530294|18716449|P2|NOT COMPLETED|Overall Study||6
7602797|NCT02530294|18716450|P1|NOT COMPLETED|Overall Study||16
7602798|NCT02530294|18716449|P2|COMPLETED|Overall Study||113
7602799|NCT02530294|18716450|P1|COMPLETED|Overall Study||218
7602800|NCT02530294|18716449|P2|STARTED|Overall Study||119
7602801|NCT02530294|18716450|P1|STARTED|Overall Study||234
7602802|NCT02530281|18716466|P2|NOT COMPLETED|Overall Study||3
7602803|NCT02530281|18716467|P1|NOT COMPLETED|Overall Study||21
7602804|NCT02530281|18716466|P2|COMPLETED|Overall Study||112
7602805|NCT02530281|18716467|P1|COMPLETED|Overall Study||208
7602806|NCT02530281|18716466|P2|STARTED|Overall Study||115
7602807|NCT02530281|18716467|P1|STARTED|Overall Study||229
7602808|NCT02530242|18716485|P2|NOT COMPLETED|Overall Study||1
7602809|NCT02530242|18716486|P1|NOT COMPLETED|Overall Study||0
7602810|NCT02530242|18716485|P2|COMPLETED|Overall Study||15
7602811|NCT02530242|18716486|P1|COMPLETED|Overall Study||16
7602812|NCT02530242|18716485|P2|STARTED|Overall Study||16
7602813|NCT02530242|18716486|P1|STARTED|Overall Study||16
7602814|NCT02530151|18716494|P2|NOT COMPLETED|Overall Study||16
7602815|NCT02530151|18716495|P1|NOT COMPLETED|Overall Study||21
7602816|NCT02530151|18716494|P2|COMPLETED|Overall Study||17
7602817|NCT02530151|18716495|P1|COMPLETED|Overall Study||16
7602818|NCT02530151|18716494|P2|STARTED|Overall Study||33
7602819|NCT02530151|18716495|P1|STARTED|Overall Study||37
7602820|NCT02530125|18716505|P1|NOT COMPLETED|Followed for Survival for 2 Years||3
7602821|NCT02530125|18716505|P1|COMPLETED|Followed for Survival for 2 Years||0
7602822|NCT02530125|18716505|P1|STARTED|Followed for Survival for 2 Years||3
7602823|NCT02530125|18716505|P1|NOT COMPLETED|Completed Treatment||1
7602824|NCT02530125|18716505|P1|COMPLETED|Completed Treatment||3
7602825|NCT02530125|18716505|P1|STARTED|Completed Treatment||4
7602826|NCT02529995|18716519|P2|NOT COMPLETED|Part B||12
7602827|NCT02529995|18716520|P1|NOT COMPLETED|Part B||6
7602828|NCT02529995|18716519|P2|COMPLETED|Part B||4
7602829|NCT02529995|18716520|P1|COMPLETED|Part B||9
7602830|NCT02529995|18716519|P2|STARTED|Part B||16
7602831|NCT02529995|18716520|P1|STARTED|Part B||15
7602832|NCT02529995|18716519|P2|NOT COMPLETED|Part A||16
7602833|NCT02529995|18716520|P1|NOT COMPLETED|Part A||15
7602834|NCT02529995|18716519|P2|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
7602835|NCT02529995|18716520|P1|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
7602836|NCT02529995|18716519|P2|STARTED|Part A||16
7602837|NCT02529995|18716520|P1|STARTED|Part A||15
7602838|NCT02529553|18716563|P9|NOT COMPLETED|Overall Study||3
7602839|NCT02529553|18716564|P8|NOT COMPLETED|Overall Study||6
7602840|NCT02529553|18716565|P7|NOT COMPLETED|Overall Study||3
7602841|NCT02529553|18716566|P6|NOT COMPLETED|Overall Study||4
7602842|NCT02529553|18716567|P5|NOT COMPLETED|Overall Study||3
7602843|NCT02529553|18716568|P4|NOT COMPLETED|Overall Study||3
7602844|NCT02529553|18716569|P3|NOT COMPLETED|Overall Study||1
7602845|NCT02529553|18716570|P2|NOT COMPLETED|Overall Study||1
7602846|NCT02529553|18716571|P1|NOT COMPLETED|Overall Study||1
7602847|NCT02529553|18716563|P9|COMPLETED|Overall Study||0
7602848|NCT02529553|18716564|P8|COMPLETED|Overall Study||0
7602849|NCT02529553|18716565|P7|COMPLETED|Overall Study||0
7602850|NCT02529553|18716566|P6|COMPLETED|Overall Study||0
7602851|NCT02529553|18716567|P5|COMPLETED|Overall Study||0
7602852|NCT02529553|18716568|P4|COMPLETED|Overall Study||0
7602853|NCT02529553|18716569|P3|COMPLETED|Overall Study||0
7602854|NCT02529553|18716570|P2|COMPLETED|Overall Study||0
7602855|NCT02529553|18716571|P1|COMPLETED|Overall Study||0
7602856|NCT02529553|18716563|P9|STARTED|Overall Study||3
7602857|NCT02529553|18716564|P8|STARTED|Overall Study||6
7602858|NCT02529553|18716565|P7|STARTED|Overall Study||3
7602859|NCT02529553|18716566|P6|STARTED|Overall Study||4
7602860|NCT02529553|18716567|P5|STARTED|Overall Study||3
7602861|NCT02529553|18716568|P4|STARTED|Overall Study||3
7602862|NCT02529553|18716569|P3|STARTED|Overall Study||1
7602863|NCT02529553|18716570|P2|STARTED|Overall Study||1
7602864|NCT02529553|18716571|P1|STARTED|Overall Study||1
7602865|NCT02529488|18716610|P1|NOT COMPLETED|Overall Study||4
7602866|NCT02529488|18716610|P1|COMPLETED|Overall Study||145
7602867|NCT02529488|18716610|P1|STARTED|Overall Study||149
7602868|NCT02529137|18716618|P1|NOT COMPLETED|Overall Study||8
7602869|NCT02529137|18716618|P1|COMPLETED|Overall Study||1992
7602870|NCT02529137|18716618|P1|STARTED|Overall Study||2000
7602871|NCT02529072|18716625|P2|NOT COMPLETED|Overall Study||0
7602872|NCT02529072|18716626|P1|NOT COMPLETED|Overall Study||0
7602873|NCT02529072|18716625|P2|COMPLETED|Overall Study||3
7602874|NCT02529072|18716626|P1|COMPLETED|Overall Study||3
7602875|NCT02529072|18716625|P2|STARTED|Overall Study||3
7602876|NCT02529072|18716626|P1|STARTED|Overall Study||3
7602877|NCT02528786|18716636|P1|NOT COMPLETED|Overall Study||0
7602878|NCT02528786|18716636|P1|COMPLETED|Overall Study||8
7602879|NCT02528786|18716636|P1|STARTED|Overall Study||8
7602880|NCT02528721|18716642|P2|NOT COMPLETED|Overall Study||3
7602881|NCT02528721|18716643|P1|NOT COMPLETED|Overall Study||7
7602882|NCT02528721|18716642|P2|COMPLETED|Overall Study||76
7602883|NCT02528721|18716643|P1|COMPLETED|Overall Study||196
7602884|NCT02528721|18716642|P2|STARTED|Overall Study||79
7602885|NCT02528721|18716643|P1|STARTED|Overall Study||203
7602886|NCT02528643|18716655|P2|NOT COMPLETED|Overall Study||85
7602887|NCT02528643|18716656|P1|NOT COMPLETED|Overall Study||39
7602888|NCT02528643|18716655|P2|COMPLETED|Overall Study||25
7602889|NCT02528643|18716656|P1|COMPLETED|Overall Study||16
7602890|NCT02528643|18716655|P2|Treated|Overall Study||107
7602891|NCT02528643|18716656|P1|Treated|Overall Study||55
7602892|NCT02528643|18716655|P2|STARTED|Overall Study||110
7602893|NCT02528643|18716656|P1|STARTED|Overall Study||55
7602894|NCT02528500|18716669|P1|NOT COMPLETED|Overall Study||0
7602895|NCT02528500|18716669|P1|COMPLETED|Overall Study||10
7602896|NCT02528500|18716669|P1|STARTED|Overall Study||10
7602897|NCT02528409|18716675|P2|NOT COMPLETED|Overall Study||16
7602898|NCT02528409|18716676|P1|NOT COMPLETED|Overall Study||22
7602899|NCT02528409|18716675|P2|COMPLETED|Overall Study||24
7602900|NCT02528409|18716676|P1|COMPLETED|Overall Study||18
7602901|NCT02528409|18716675|P2|STARTED|Overall Study||40
7602902|NCT02528409|18716676|P1|STARTED|Overall Study||40
7602903|NCT02528331|18716698|P1|NOT COMPLETED|Overall Study||2
7602904|NCT02528331|18716698|P1|COMPLETED|Overall Study||0
7602905|NCT02528331|18716698|P1|STARTED|Overall Study||2
7602906|NCT02528318|18716710|P5|NOT COMPLETED|Overall Study||0
7602907|NCT02528318|18716711|P4|NOT COMPLETED|Overall Study||0
7602908|NCT02528318|18716712|P3|NOT COMPLETED|Overall Study||0
7602909|NCT02528318|18716713|P2|NOT COMPLETED|Overall Study||0
7602910|NCT02528318|18716714|P1|NOT COMPLETED|Overall Study||0
7602911|NCT02528318|18716710|P5|COMPLETED|Overall Study||24
7602912|NCT02528318|18716711|P4|COMPLETED|Overall Study||0
7602913|NCT02528318|18716712|P3|COMPLETED|Overall Study||8
7602914|NCT02528318|18716713|P2|COMPLETED|Overall Study||8
7602915|NCT02528318|18716714|P1|COMPLETED|Overall Study||8
7602916|NCT02528318|18716710|P5|STARTED|Overall Study||24
7602917|NCT02528318|18716711|P4|STARTED|Overall Study|Study was terminated prior to initiation of this intervention|0
7602918|NCT02528318|18716712|P3|STARTED|Overall Study||8
7602919|NCT02528318|18716713|P2|STARTED|Overall Study||8
7602920|NCT02528318|18716714|P1|STARTED|Overall Study||8
7602921|NCT02528305|18716766|P1|NOT COMPLETED|Overall Study||3
7602922|NCT02528305|18716766|P1|COMPLETED|Overall Study||9
7602923|NCT02528305|18716766|P1|End of Intervention Period Assessment|Overall Study||9
7602924|NCT02528305|18716766|P1|End of Control Period Assessment|Overall Study||11
7602925|NCT02528305|18716766|P1|STARTED|Overall Study||12
7602926|NCT02528253|18716813|P5|NOT COMPLETED|Overall Study||223
7602927|NCT02528253|18716814|P4|NOT COMPLETED|Overall Study||136
7602928|NCT02528253|18716815|P3|NOT COMPLETED|Overall Study||140
7602929|NCT02528253|18716816|P2|NOT COMPLETED|Overall Study||70
7602930|NCT02528253|18716817|P1|NOT COMPLETED|Overall Study||75
7602931|NCT02528253|18716813|P5|COMPLETED|Overall Study||379
7602932|NCT02528253|18716814|P4|COMPLETED|Overall Study||271
7602933|NCT02528253|18716815|P3|COMPLETED|Overall Study||267
7602934|NCT02528253|18716816|P2|COMPLETED|Overall Study||134
7602935|NCT02528253|18716817|P1|COMPLETED|Overall Study||130
7602936|NCT02528253|18716813|P5|Treated at Week 16|Overall Study||307
7602937|NCT02528253|18716814|P4|Treated at Week 16|Overall Study||242
7602938|NCT02528253|18716815|P3|Treated at Week 16|Overall Study||236
7602939|NCT02528253|18716816|P2|Treated at Week 16|Overall Study||95
7602940|NCT02528253|18716817|P1|Treated at Week 16|Overall Study||99
7602941|NCT02528253|18716813|P5|Intent to Treat Population|Overall Study|3 participants randomized to placebo arm received tramadol during the course of study|605
7602942|NCT02528253|18716814|P4|Intent to Treat Population|Overall Study||407
7602943|NCT02528253|18716815|P3|Intent to Treat Population|Overall Study||407
7602944|NCT02528253|18716816|P2|Intent to Treat Population|Overall Study||204
7602945|NCT02528253|18716817|P1|Intent to Treat Population|Overall Study||202
7602946|NCT02528253|18716813|P5|STARTED|Overall Study||602
7602947|NCT02528253|18716814|P4|STARTED|Overall Study||407
7602948|NCT02528253|18716815|P3|STARTED|Overall Study||407
7602949|NCT02528253|18716816|P2|STARTED|Overall Study||204
7602950|NCT02528253|18716817|P1|STARTED|Overall Study||205
7602951|NCT02528214|18717110|P2|NOT COMPLETED|Overall Study||3
7602952|NCT02528214|18717111|P1|NOT COMPLETED|Overall Study||0
7602953|NCT02528214|18717110|P2|COMPLETED|Overall Study||100
7602954|NCT02528214|18717111|P1|COMPLETED|Overall Study||107
7602955|NCT02528214|18717110|P2|Treated|Overall Study||103
7602956|NCT02528214|18717111|P1|Treated|Overall Study||107
7602957|NCT02528214|18717110|P2|STARTED|Overall Study||103
7602958|NCT02528214|18717111|P1|STARTED|Overall Study||107
7602959|NCT02528188|18717146|P3|NOT COMPLETED|Overall Study||251
7602960|NCT02528188|18717147|P2|NOT COMPLETED|Overall Study||276
7602961|NCT02528188|18717148|P1|NOT COMPLETED|Overall Study||267
7602962|NCT02528188|18717146|P3|COMPLETED|Overall Study||757
7602963|NCT02528188|18717147|P2|COMPLETED|Overall Study||729
7602964|NCT02528188|18717148|P1|COMPLETED|Overall Study||741
7602965|NCT02528188|18717146|P3|Treated|Overall Study||996
7602966|NCT02528188|18717147|P2|Treated|Overall Study||998
7602967|NCT02528188|18717148|P1|Treated|Overall Study||1002
7602968|NCT02528188|18717146|P3|STARTED|Overall Study||1008
7602969|NCT02528188|18717147|P2|STARTED|Overall Study||1005
7602970|NCT02528188|18717148|P1|STARTED|Overall Study||1008
7602971|NCT02528097|18717400|P2|NOT COMPLETED|Overall Study||0
7602972|NCT02528097|18717401|P1|NOT COMPLETED|Overall Study||0
7602973|NCT02528097|18717400|P2|COMPLETED|Overall Study||1
7602974|NCT02528097|18717401|P1|COMPLETED|Overall Study||1
7602975|NCT02528097|18717400|P2|STARTED|Overall Study||1
7602976|NCT02528097|18717401|P1|STARTED|Overall Study||1
7602977|NCT02527694|18717411|P2|NOT COMPLETED|Overall Study||8
7602978|NCT02527694|18717412|P1|NOT COMPLETED|Overall Study||10
7602979|NCT02527694|18717411|P2|COMPLETED|Overall Study||21
7602980|NCT02527694|18717412|P1|COMPLETED|Overall Study||10
7602981|NCT02527694|18717411|P2|STARTED|Overall Study||29
7602982|NCT02527694|18717412|P1|STARTED|Overall Study||20
7602983|NCT02527434|18717423|P3|NOT COMPLETED|Overall Study||20
7602984|NCT02527434|18717424|P2|NOT COMPLETED|Overall Study||11
7602985|NCT02527434|18717425|P1|NOT COMPLETED|Overall Study||28
7602986|NCT02527434|18717423|P3|COMPLETED|Overall Study||0
7602987|NCT02527434|18717424|P2|COMPLETED|Overall Study||1
7602988|NCT02527434|18717425|P1|COMPLETED|Overall Study||4
7602989|NCT02527434|18717423|P3|Started Retreatment Phase (MEDI)|Overall Study||1
7602990|NCT02527434|18717424|P2|Started Retreatment Phase (MEDI)|Overall Study||0
7602991|NCT02527434|18717425|P1|Started Retreatment Phase (MEDI)|Overall Study||4
7602992|NCT02527434|18717423|P3|Started Retreatment Phase (COMBO)|Overall Study||4
7602993|NCT02527434|18717424|P2|Started Retreatment Phase (COMBO)|Overall Study||5
7602994|NCT02527434|18717425|P1|Started Retreatment Phase (COMBO)|Overall Study||7
7602995|NCT02527434|18717423|P3|STARTED|Overall Study||20
7602996|NCT02527434|18717424|P2|STARTED|Overall Study||12
7602997|NCT02527434|18717425|P1|STARTED|Overall Study||32
7602998|NCT02527161|18717483|P1|NOT COMPLETED|Overall Study||132
7602999|NCT02527161|18717483|P1|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 5 year outcome interval.|73
7603000|NCT02527161|18717483|P1|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|205
7603001|NCT02527148|18717502|P2|NOT COMPLETED|Overall Study||0
7603002|NCT02527148|18717503|P1|NOT COMPLETED|Overall Study||1
7603003|NCT02527148|18717502|P2|COMPLETED|Overall Study||50
7603004|NCT02527148|18717503|P1|COMPLETED|Overall Study||49
7603005|NCT02527148|18717502|P2|STARTED|Overall Study||50
7603006|NCT02527148|18717503|P1|STARTED|Overall Study||50
7603007|NCT02526693|18717533|P2|NOT COMPLETED|Overall Study||1
7603008|NCT02526693|18717534|P1|NOT COMPLETED|Overall Study||3
7603009|NCT02526693|18717533|P2|COMPLETED|Overall Study||50
7603010|NCT02526693|18717534|P1|COMPLETED|Overall Study||50
7603011|NCT02526693|18717533|P2|STARTED|Overall Study||51
7603012|NCT02526693|18717534|P1|STARTED|Overall Study||53
7603013|NCT02526680|18717544|P1|NOT COMPLETED|Overall Study||0
7603014|NCT02526680|18717544|P1|COMPLETED|Overall Study||27
7603015|NCT02526680|18717544|P1|STARTED|Overall Study||27
7603016|NCT02526667|18717551|P3|NOT COMPLETED|Groin||0
7603017|NCT02526667|18717552|P2|NOT COMPLETED|Groin||0
7603018|NCT02526667|18717553|P1|NOT COMPLETED|Groin||0
7603019|NCT02526667|18717551|P3|COMPLETED|Groin||294
7603020|NCT02526667|18717552|P2|COMPLETED|Groin||56
7603021|NCT02526667|18717553|P1|COMPLETED|Groin||290
7603022|NCT02526667|18717551|P3|STARTED|Groin||294
7603023|NCT02526667|18717552|P2|STARTED|Groin||56
7603024|NCT02526667|18717553|P1|STARTED|Groin||290
7603025|NCT02526667|18717551|P3|NOT COMPLETED|Abdomen||0
7603026|NCT02526667|18717552|P2|NOT COMPLETED|Abdomen||0
7603027|NCT02526667|18717553|P1|NOT COMPLETED|Abdomen||0
7603028|NCT02526667|18717551|P3|COMPLETED|Abdomen||281
7603029|NCT02526667|18717552|P2|COMPLETED|Abdomen||56
7603030|NCT02526667|18717553|P1|COMPLETED|Abdomen||284
7603031|NCT02526667|18717551|P3|STARTED|Abdomen||281
7603032|NCT02526667|18717552|P2|STARTED|Abdomen||56
7603033|NCT02526667|18717553|P1|STARTED|Abdomen||284
7603034|NCT02526654|18717569|P2|NOT COMPLETED|Overall Study||0
7603035|NCT02526654|18717570|P1|NOT COMPLETED|Overall Study||0
7603036|NCT02526654|18717569|P2|COMPLETED|Overall Study||36
7603037|NCT02526654|18717570|P1|COMPLETED|Overall Study||79
7603038|NCT02526654|18717569|P2|STARTED|Overall Study||36
7603039|NCT02526654|18717570|P1|STARTED|Overall Study||79
7603040|NCT02526550|18717579|P1|NOT COMPLETED|Overall Study||1
7603041|NCT02526550|18717579|P1|COMPLETED|Overall Study||49
7603042|NCT02526550|18717579|P1|STARTED|Overall Study||50
7603043|NCT02526524|18717591|P6|NOT COMPLETED|Overall Study||21
7603044|NCT02526524|18717592|P5|NOT COMPLETED|Overall Study||24
7603045|NCT02526524|18717593|P4|NOT COMPLETED|Overall Study||7
7603046|NCT02526524|18717594|P3|NOT COMPLETED|Overall Study||26
7603047|NCT02526524|18717595|P2|NOT COMPLETED|Overall Study||9
7603048|NCT02526524|18717596|P1|NOT COMPLETED|Overall Study||12
7603049|NCT02526524|18717591|P6|COMPLETED|Overall Study||73
7603050|NCT02526524|18717592|P5|COMPLETED|Overall Study||72
7603051|NCT02526524|18717593|P4|COMPLETED|Overall Study||89
7603052|NCT02526524|18717594|P3|COMPLETED|Overall Study||70
7603053|NCT02526524|18717595|P2|COMPLETED|Overall Study||86
7603054|NCT02526524|18717596|P1|COMPLETED|Overall Study||82
7603055|NCT02526524|18717591|P6|STARTED|Overall Study||94
7603056|NCT02526524|18717592|P5|STARTED|Overall Study||96
7603057|NCT02526524|18717593|P4|STARTED|Overall Study||96
7603058|NCT02526524|18717594|P3|STARTED|Overall Study||96
7603059|NCT02526524|18717595|P2|STARTED|Overall Study||95
7603060|NCT02526524|18717596|P1|STARTED|Overall Study||94
7603061|NCT02526290|18717610|P1|NOT COMPLETED|Overall Study||8
7603062|NCT02526290|18717610|P1|COMPLETED|Overall Study||89
7603063|NCT02526290|18717610|P1|STARTED|Overall Study||97
7603064|NCT02526277|18717621|P4|NOT COMPLETED|Overall Study||0
7603065|NCT02526277|18717622|P3|NOT COMPLETED|Overall Study||0
7603066|NCT02526277|18717623|P2|NOT COMPLETED|Overall Study||0
7603067|NCT02526277|18717624|P1|NOT COMPLETED|Overall Study||0
7603068|NCT02526277|18717621|P4|COMPLETED|Overall Study||7
7603069|NCT02526277|18717622|P3|COMPLETED|Overall Study||7
7603070|NCT02526277|18717623|P2|COMPLETED|Overall Study||6
7603071|NCT02526277|18717624|P1|COMPLETED|Overall Study||8
7603072|NCT02526277|18717621|P4|STARTED|Overall Study||7
7603073|NCT02526277|18717622|P3|STARTED|Overall Study||7
7603074|NCT02526277|18717623|P2|STARTED|Overall Study||6
7603075|NCT02526277|18717624|P1|STARTED|Overall Study||8
7603076|NCT02526212|18717644|P2|NOT COMPLETED|Overall Study||1
7603077|NCT02526212|18717645|P1|NOT COMPLETED|Overall Study||2
7603078|NCT02526212|18717644|P2|COMPLETED|Overall Study||7
7603079|NCT02526212|18717645|P1|COMPLETED|Overall Study||8
7603080|NCT02526212|18717644|P2|STARTED|Overall Study||8
7603081|NCT02526212|18717645|P1|STARTED|Overall Study||10
7603082|NCT02525874|18717659|P1|NOT COMPLETED|Overall Study||60
7603083|NCT02525874|18717659|P1|COMPLETED|Overall Study||158
7603084|NCT02525874|18717659|P1|STARTED|Overall Study||218
7603085|NCT02525744|18717672|P4|NOT COMPLETED|Period 5||0
7603086|NCT02525744|18717673|P3|NOT COMPLETED|Period 5||0
7603087|NCT02525744|18717674|P2|NOT COMPLETED|Period 5||0
7603088|NCT02525744|18717675|P1|NOT COMPLETED|Period 5||1
7603089|NCT02525744|18717672|P4|COMPLETED|Period 5||6
7603090|NCT02525744|18717673|P3|COMPLETED|Period 5||5
7603091|NCT02525744|18717674|P2|COMPLETED|Period 5||5
7603092|NCT02525744|18717675|P1|COMPLETED|Period 5||4
7603093|NCT02525744|18717672|P4|Received at Least 1 Dose of Study Drug|Period 5||6
7603094|NCT02525744|18717673|P3|Received at Least 1 Dose of Study Drug|Period 5||5
7603095|NCT02525744|18717674|P2|Received at Least 1 Dose of Study Drug|Period 5||5
7603096|NCT02525744|18717675|P1|Received at Least 1 Dose of Study Drug|Period 5||4
7603097|NCT02525744|18717672|P4|STARTED|Period 5||6
7603098|NCT02525744|18717673|P3|STARTED|Period 5||5
7603099|NCT02525744|18717674|P2|STARTED|Period 5||5
7603100|NCT02525744|18717675|P1|STARTED|Period 5||5
7603101|NCT02525744|18717672|P4|NOT COMPLETED|Period 4||0
7603102|NCT02525744|18717673|P3|NOT COMPLETED|Period 4||0
7603103|NCT02525744|18717674|P2|NOT COMPLETED|Period 4||0
7603104|NCT02525744|18717675|P1|NOT COMPLETED|Period 4||1
7603105|NCT02525744|18717672|P4|COMPLETED|Period 4||6
7603106|NCT02525744|18717673|P3|COMPLETED|Period 4||5
7603107|NCT02525744|18717674|P2|COMPLETED|Period 4||5
7603108|NCT02525744|18717675|P1|COMPLETED|Period 4||5
7603109|NCT02525744|18717672|P4|Received at Least 1 Dose of Study Drug|Period 4||6
7603110|NCT02525744|18717673|P3|Received at Least 1 Dose of Study Drug|Period 4||5
7603111|NCT02525744|18717674|P2|Received at Least 1 Dose of Study Drug|Period 4||5
7603112|NCT02525744|18717675|P1|Received at Least 1 Dose of Study Drug|Period 4||6
7603113|NCT02525744|18717672|P4|STARTED|Period 4||6
7603114|NCT02525744|18717673|P3|STARTED|Period 4||5
7603115|NCT02525744|18717674|P2|STARTED|Period 4||5
7603116|NCT02525744|18717675|P1|STARTED|Period 4||6
7603117|NCT02525744|18717672|P4|NOT COMPLETED|Period 3||0
7603118|NCT02525744|18717673|P3|NOT COMPLETED|Period 3||0
7603119|NCT02525744|18717674|P2|NOT COMPLETED|Period 3||1
7603120|NCT02525744|18717675|P1|NOT COMPLETED|Period 3||0
7603121|NCT02525744|18717672|P4|COMPLETED|Period 3||6
7603122|NCT02525744|18717673|P3|COMPLETED|Period 3||5
7603123|NCT02525744|18717674|P2|COMPLETED|Period 3||5
7603124|NCT02525744|18717675|P1|COMPLETED|Period 3||6
7603125|NCT02525744|18717672|P4|Received at Least 1 Dose of Study Drug|Period 3||6
7603126|NCT02525744|18717673|P3|Received at Least 1 Dose of Study Drug|Period 3||5
7603127|NCT02525744|18717674|P2|Received at Least 1 Dose of Study Drug|Period 3||6
7603128|NCT02525744|18717675|P1|Received at Least 1 Dose of Study Drug|Period 3||6
7603129|NCT02525744|18717672|P4|STARTED|Period 3||6
7603130|NCT02525744|18717673|P3|STARTED|Period 3||5
7603131|NCT02525744|18717674|P2|STARTED|Period 3||6
7603132|NCT02525744|18717675|P1|STARTED|Period 3||6
7603133|NCT02525744|18717672|P4|NOT COMPLETED|Period 2||0
7603134|NCT02525744|18717673|P3|NOT COMPLETED|Period 2||0
7603135|NCT02525744|18717674|P2|NOT COMPLETED|Period 2||0
7603136|NCT02525744|18717675|P1|NOT COMPLETED|Period 2||0
7603137|NCT02525744|18717672|P4|COMPLETED|Period 2||6
7603138|NCT02525744|18717673|P3|COMPLETED|Period 2||5
7603139|NCT02525744|18717674|P2|COMPLETED|Period 2||6
7603140|NCT02525744|18717675|P1|COMPLETED|Period 2||6
7603141|NCT02525744|18717672|P4|Received at Least 1 Dose of Study Drug|Period 2||6
7603142|NCT02525744|18717673|P3|Received at Least 1 Dose of Study Drug|Period 2||5
7603143|NCT02525744|18717674|P2|Received at Least 1 Dose of Study Drug|Period 2||6
7603144|NCT02525744|18717675|P1|Received at Least 1 Dose of Study Drug|Period 2||6
7603145|NCT02525744|18717672|P4|STARTED|Period 2||6
7603146|NCT02525744|18717673|P3|STARTED|Period 2||5
7603147|NCT02525744|18717674|P2|STARTED|Period 2||6
7603148|NCT02525744|18717675|P1|STARTED|Period 2||6
7603149|NCT02525744|18717672|P4|NOT COMPLETED|Period 1||0
7603150|NCT02525744|18717673|P3|NOT COMPLETED|Period 1||1
7603151|NCT02525744|18717674|P2|NOT COMPLETED|Period 1||0
7603152|NCT02525744|18717675|P1|NOT COMPLETED|Period 1||0
7603153|NCT02525744|18717672|P4|COMPLETED|Period 1||6
7603154|NCT02525744|18717673|P3|COMPLETED|Period 1||5
7603155|NCT02525744|18717674|P2|COMPLETED|Period 1||6
7603156|NCT02525744|18717675|P1|COMPLETED|Period 1||6
7603157|NCT02525744|18717672|P4|Received at Least 1 Dose of Study Drug|Period 1||6
7603158|NCT02525744|18717673|P3|Received at Least 1 Dose of Study Drug|Period 1||5
7603159|NCT02525744|18717674|P2|Received at Least 1 Dose of Study Drug|Period 1||6
7603160|NCT02525744|18717675|P1|Received at Least 1 Dose of Study Drug|Period 1||6
7603161|NCT02525744|18717672|P4|STARTED|Period 1||6
7603162|NCT02525744|18717673|P3|STARTED|Period 1||6
7603163|NCT02525744|18717674|P2|STARTED|Period 1||6
7603164|NCT02525744|18717675|P1|STARTED|Period 1||6
7603165|NCT02525718|18717691|P2|NOT COMPLETED|Overall Study||1
7603166|NCT02525718|18717692|P1|NOT COMPLETED|Overall Study||1
7603167|NCT02525718|18717691|P2|COMPLETED|Overall Study||23
7603168|NCT02525718|18717692|P1|COMPLETED|Overall Study||22
7603169|NCT02525718|18717691|P2|STARTED|Overall Study||24
7603170|NCT02525718|18717692|P1|STARTED|Overall Study||23
7603171|NCT02525653|18717704|P1|NOT COMPLETED|Overall Study||0
7603172|NCT02525653|18717704|P1|COMPLETED|Overall Study||40
7603173|NCT02525653|18717704|P1|STARTED|Overall Study||40
7603174|NCT02525627|18717711|P2|NOT COMPLETED|Overall Study||13
7603175|NCT02525627|18717712|P1|NOT COMPLETED|Overall Study||14
7603176|NCT02525627|18717711|P2|COMPLETED|Overall Study||5
7603177|NCT02525627|18717712|P1|COMPLETED|Overall Study||2
7603178|NCT02525627|18717711|P2|STARTED|Overall Study||18
7603179|NCT02525627|18717712|P1|STARTED|Overall Study||16
7603180|NCT02525588|18717724|P2|NOT COMPLETED|Overall Study||3
7603181|NCT02525588|18717725|P1|NOT COMPLETED|Overall Study||6
7603182|NCT02525588|18717724|P2|COMPLETED|Overall Study||45
7603183|NCT02525588|18717725|P1|COMPLETED|Overall Study||42
7603184|NCT02525588|18717724|P2|STARTED|Overall Study||48
7603185|NCT02525588|18717725|P1|STARTED|Overall Study||48
7603186|NCT02525575|18717741|P1|NOT COMPLETED|Overall Study||15
7603187|NCT02525575|18717741|P1|COMPLETED|Overall Study||22
7603188|NCT02525575|18717741|P1|STARTED|Overall Study||37
7603189|NCT02525536|18717751|P3|NOT COMPLETED|Overall Study||0
7603190|NCT02525536|18717752|P2|NOT COMPLETED|Overall Study||0
7603191|NCT02525536|18717753|P1|NOT COMPLETED|Overall Study||0
7603192|NCT02525536|18717751|P3|COMPLETED|Overall Study||6
7603193|NCT02525536|18717752|P2|COMPLETED|Overall Study||6
7603194|NCT02525536|18717753|P1|COMPLETED|Overall Study||6
7603195|NCT02525536|18717751|P3|STARTED|Overall Study||6
7603196|NCT02525536|18717752|P2|STARTED|Overall Study||6
7603197|NCT02525536|18717753|P1|STARTED|Overall Study||6
7603198|NCT02525523|18717826|P2|NOT COMPLETED|Overall Study||25
7603199|NCT02525523|18717827|P1|NOT COMPLETED|Overall Study||23
7603200|NCT02525523|18717826|P2|COMPLETED|Overall Study||44
7603201|NCT02525523|18717827|P1|COMPLETED|Overall Study||46
7603202|NCT02525523|18717826|P2|STARTED|Overall Study||69
7603203|NCT02525523|18717827|P1|STARTED|Overall Study||69
7603204|NCT02525094|18717837|P2|NOT COMPLETED|Overall Study||8
7603205|NCT02525094|18717838|P1|NOT COMPLETED|Overall Study||8
7603206|NCT02525094|18717837|P2|COMPLETED|Overall Study||48
7603207|NCT02525094|18717838|P1|COMPLETED|Overall Study||49
7603208|NCT02525094|18717837|P2|Treated|Overall Study||55
7603209|NCT02525094|18717838|P1|Treated|Overall Study||56
7603210|NCT02525094|18717837|P2|STARTED|Overall Study||56
7603211|NCT02525094|18717838|P1|STARTED|Overall Study||57
7603212|NCT02525055|18717871|P6|NOT COMPLETED|Overall Study||0
7603213|NCT02525055|18717872|P5|NOT COMPLETED|Overall Study||0
7603214|NCT02525055|18717873|P4|NOT COMPLETED|Overall Study||0
7603215|NCT02525055|18717874|P3|NOT COMPLETED|Overall Study||0
7603216|NCT02525055|18717875|P2|NOT COMPLETED|Overall Study||0
7603217|NCT02525055|18717876|P1|NOT COMPLETED|Overall Study||0
7603218|NCT02525055|18717871|P6|COMPLETED|Overall Study||16
7603219|NCT02525055|18717872|P5|COMPLETED|Overall Study||6
7603220|NCT02525055|18717873|P4|COMPLETED|Overall Study||6
7603221|NCT02525055|18717874|P3|COMPLETED|Overall Study||6
7603222|NCT02525055|18717875|P2|COMPLETED|Overall Study||6
7603223|NCT02525055|18717876|P1|COMPLETED|Overall Study||6
7603224|NCT02525055|18717871|P6|STARTED|Overall Study||16
7603225|NCT02525055|18717872|P5|STARTED|Overall Study||6
7603226|NCT02525055|18717873|P4|STARTED|Overall Study||6
7603227|NCT02525055|18717874|P3|STARTED|Overall Study||6
7603228|NCT02525055|18717875|P2|STARTED|Overall Study||6
7603229|NCT02525055|18717876|P1|STARTED|Overall Study||6
7603230|NCT02524977|18717892|P2|NOT COMPLETED|Overall Study||45
7603231|NCT02524977|18717893|P1|NOT COMPLETED|Overall Study||46
7603232|NCT02524977|18717892|P2|COMPLETED|Overall Study||801
7603233|NCT02524977|18717893|P1|COMPLETED|Overall Study||692
7603234|NCT02524977|18717892|P2|STARTED|Overall Study||846
7603235|NCT02524977|18717893|P1|STARTED|Overall Study||738
7603236|NCT02524847|18717901|P1|NOT COMPLETED|Overall Study||14
7603237|NCT02524847|18717901|P1|COMPLETED|Overall Study||15
7603238|NCT02524847|18717901|P1|Started Second Line Treatment|Overall Study||5
7603239|NCT02524847|18717901|P1|Completed Treatment Up to Week 12|Overall Study||14
7603240|NCT02524847|18717901|P1|STARTED|Overall Study||29
7603241|NCT02524665|18717913|P1|NOT COMPLETED|Overall Study||1
7603242|NCT02524665|18717913|P1|COMPLETED|Overall Study||19
7603243|NCT02524665|18717913|P1|STARTED|Overall Study||20
7603244|NCT02524561|18717931|P3|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
7603245|NCT02524561|18717932|P2|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
7603246|NCT02524561|18717933|P1|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
7603247|NCT02524561|18717931|P3|COMPLETED|Final: Year 3 or 4 Post-randomization||187
7603248|NCT02524561|18717932|P2|COMPLETED|Final: Year 3 or 4 Post-randomization||162
7603249|NCT02524561|18717933|P1|COMPLETED|Final: Year 3 or 4 Post-randomization||168
7603250|NCT02524561|18717931|P3|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151
7603251|NCT02524561|18717932|P2|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139
7603252|NCT02524561|18717933|P1|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143
7603253|NCT02524561|18717931|P3|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|187
7603254|NCT02524561|18717932|P2|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|162
7603255|NCT02524561|18717933|P1|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|168
7603256|NCT02524561|18717931|P3|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
7603257|NCT02524561|18717932|P2|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
7603258|NCT02524561|18717933|P1|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
7603259|NCT02524561|18717931|P3|COMPLETED|Year 1: Post Randomization Mammograms||187
7603260|NCT02524561|18717932|P2|COMPLETED|Year 1: Post Randomization Mammograms||162
7603261|NCT02524561|18717933|P1|COMPLETED|Year 1: Post Randomization Mammograms||168
7603262|NCT02524561|18717931|P3|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|148
7603263|NCT02524561|18717932|P2|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|123
7603264|NCT02524561|18717933|P1|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post-randomization mammogram|136
7603265|NCT02524561|18717931|P3|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|187
7603266|NCT02524561|18717932|P2|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|162
7603267|NCT02524561|18717933|P1|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|168
7603268|NCT02524561|18717931|P3|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
7603269|NCT02524561|18717932|P2|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
7603270|NCT02524561|18717933|P1|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
7603271|NCT02524561|18717931|P3|COMPLETED|Baseline: Pre-randomization Mammogram||187
7603272|NCT02524561|18717932|P2|COMPLETED|Baseline: Pre-randomization Mammogram||162
7603273|NCT02524561|18717933|P1|COMPLETED|Baseline: Pre-randomization Mammogram||168
7603274|NCT02524561|18717931|P3|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151
7603275|NCT02524561|18717932|P2|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133
7603276|NCT02524561|18717933|P1|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137
7603277|NCT02524561|18717931|P3|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS.|187
7603278|NCT02524561|18717932|P2|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|162
7603279|NCT02524561|18717933|P1|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|168
7603280|NCT02524418|18717950|P1|NOT COMPLETED|Overall Study||13
7603281|NCT02524418|18717950|P1|COMPLETED|Overall Study||75
7603282|NCT02524418|18717950|P1|STARTED|Overall Study||88
7603283|NCT02524288|18717964|P1|NOT COMPLETED|Overall Study||1941
7603284|NCT02524288|18717964|P1|COMPLETED|Overall Study||0
7603285|NCT02524288|18717964|P1|Treated|Overall Study||1936
7603286|NCT02524288|18717964|P1|STARTED|Overall Study||1941
7603287|NCT02524158|18717974|P2|NOT COMPLETED|6-month Assessment||21
7603288|NCT02524158|18717975|P1|NOT COMPLETED|6-month Assessment||22
7603289|NCT02524158|18717974|P2|COMPLETED|6-month Assessment||55
7603290|NCT02524158|18717975|P1|COMPLETED|6-month Assessment||54
7603291|NCT02524158|18717974|P2|STARTED|6-month Assessment||76
7603292|NCT02524158|18717975|P1|STARTED|6-month Assessment||76
7603293|NCT02524158|18717974|P2|NOT COMPLETED|12-weeks Assessment||13
7603294|NCT02524158|18717975|P1|NOT COMPLETED|12-weeks Assessment||19
7603295|NCT02524158|18717974|P2|COMPLETED|12-weeks Assessment||63
7603296|NCT02524158|18717975|P1|COMPLETED|12-weeks Assessment||57
7603297|NCT02524158|18717974|P2|STARTED|12-weeks Assessment||76
7603298|NCT02524158|18717975|P1|STARTED|12-weeks Assessment||76
7603299|NCT02524145|18718017|P3|NOT COMPLETED|Overall Study||3
7603300|NCT02524145|18718018|P2|NOT COMPLETED|Overall Study||2
7603301|NCT02524145|18718019|P1|NOT COMPLETED|Overall Study||2
7603302|NCT02524145|18718017|P3|COMPLETED|Overall Study||7
7603303|NCT02524145|18718018|P2|COMPLETED|Overall Study||13
7603304|NCT02524145|18718019|P1|COMPLETED|Overall Study||13
7603305|NCT02524145|18718017|P3|STARTED|Overall Study||10
7603306|NCT02524145|18718018|P2|STARTED|Overall Study||15
7603307|NCT02524145|18718019|P1|STARTED|Overall Study||15
7603308|NCT02524106|18718031|P2|NOT COMPLETED|Overall Study||0
7603309|NCT02524106|18718032|P1|NOT COMPLETED|Overall Study||0
7603310|NCT02524106|18718031|P2|COMPLETED|Overall Study||5
7603311|NCT02524106|18718032|P1|COMPLETED|Overall Study||6
7603312|NCT02524106|18718031|P2|STARTED|Overall Study||5
7603313|NCT02524106|18718032|P1|STARTED|Overall Study||6
7603314|NCT02524054|18718042|P3|NOT COMPLETED|Overall Study||0
7603315|NCT02524054|18718043|P2|NOT COMPLETED|Overall Study||0
7603316|NCT02524054|18718044|P1|NOT COMPLETED|Overall Study||0
7603317|NCT02524054|18718042|P3|COMPLETED|Overall Study||8
7603318|NCT02524054|18718043|P2|COMPLETED|Overall Study||9
7603319|NCT02524054|18718044|P1|COMPLETED|Overall Study||7
7603320|NCT02524054|18718042|P3|STARTED|Overall Study||8
7603321|NCT02524054|18718043|P2|STARTED|Overall Study||9
7603322|NCT02524054|18718044|P1|STARTED|Overall Study||7
7603323|NCT02523924|18718055|P1|NOT COMPLETED|Overall Study||0
7603324|NCT02523924|18718055|P1|COMPLETED|Overall Study||31
7603325|NCT02523924|18718055|P1|STARTED|Overall Study||31
7603326|NCT02523690|18718065|P2|NOT COMPLETED|Overall Study||0
7603327|NCT02523690|18718066|P1|NOT COMPLETED|Overall Study||0
7603328|NCT02523690|18718065|P2|COMPLETED|Overall Study||2
7603329|NCT02523690|18718066|P1|COMPLETED|Overall Study||3
7603330|NCT02523690|18718065|P2|STARTED|Overall Study||2
7603331|NCT02523690|18718066|P1|STARTED|Overall Study||3
7603332|NCT02523586|18718082|P1|NOT COMPLETED|Overall Study||4
7603333|NCT02523586|18718082|P1|COMPLETED|Overall Study||10
7603334|NCT02523586|18718082|P1|STARTED|Overall Study||14
7603335|NCT02523235|18718095|P2|NOT COMPLETED|Overall Study||0
7603336|NCT02523235|18718096|P1|NOT COMPLETED|Overall Study||0
7603337|NCT02523235|18718095|P2|COMPLETED|Overall Study||58
7603338|NCT02523235|18718096|P1|COMPLETED|Overall Study||56
7603339|NCT02523235|18718095|P2|STARTED|Overall Study||58
7603340|NCT02523235|18718096|P1|STARTED|Overall Study||56
7603341|NCT02522884|18718116|P1|NOT COMPLETED|Overall Study||18
7603342|NCT02522884|18718116|P1|COMPLETED|Overall Study|Completed 12-month follow-up.|195
7603343|NCT02522884|18718116|P1|STARTED|Overall Study|Intent to Treat (ITT) population.|213
7603344|NCT02522845|18718123|P2|NOT COMPLETED|Overall Study||35
7603345|NCT02522845|18718124|P1|NOT COMPLETED|Overall Study||37
7603346|NCT02522845|18718123|P2|COMPLETED|Overall Study||69
7603347|NCT02522845|18718124|P1|COMPLETED|Overall Study||63
7603348|NCT02522845|18718123|P2|STARTED|Overall Study||104
7603349|NCT02522845|18718124|P1|STARTED|Overall Study||100
7603350|NCT02522728|18718148|P2|NOT COMPLETED|Overall Study||11
7603351|NCT02522728|18718149|P1|NOT COMPLETED|Overall Study||12
7603352|NCT02522728|18718148|P2|COMPLETED|Overall Study||19
7603353|NCT02522728|18718149|P1|COMPLETED|Overall Study||16
7603354|NCT02522728|18718148|P2|STARTED|Overall Study||30
7603355|NCT02522728|18718149|P1|STARTED|Overall Study||28
7603356|NCT02522715|18718165|P2|NOT COMPLETED|Overall Study||0
7603357|NCT02522715|18718166|P1|NOT COMPLETED|Overall Study||0
7603358|NCT02522715|18718165|P2|COMPLETED|Overall Study||33
7603359|NCT02522715|18718166|P1|COMPLETED|Overall Study||3
7603360|NCT02522715|18718165|P2|STARTED|Overall Study|+1 early withdrawal|33
7603361|NCT02522715|18718166|P1|STARTED|Overall Study||3
7603362|NCT02522624|18718176|P2|NOT COMPLETED|Overall Study||0
7603363|NCT02522624|18718177|P1|NOT COMPLETED|Overall Study||1
7603364|NCT02522624|18718176|P2|COMPLETED|Overall Study||163
7603365|NCT02522624|18718177|P1|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164
7603366|NCT02522624|18718176|P2|STARTED|Overall Study||163
7603367|NCT02522624|18718177|P1|STARTED|Overall Study||165
7603368|NCT02522481|18718193|P1|NOT COMPLETED|Overall Study||2
7603369|NCT02522481|18718193|P1|COMPLETED|Overall Study||173
7603370|NCT02522481|18718193|P1|STARTED|Overall Study||175
7603371|NCT02522442|18718206|P2|NOT COMPLETED|Overall Study||0
7603372|NCT02522442|18718207|P1|NOT COMPLETED|Overall Study||0
7603373|NCT02522442|18718206|P2|COMPLETED|Overall Study||22
7603374|NCT02522442|18718207|P1|COMPLETED|Overall Study||26
7603375|NCT02522442|18718206|P2|STARTED|Overall Study||22
7603376|NCT02522442|18718207|P1|STARTED|Overall Study||26
7603377|NCT02522403|18718223|P2|NOT COMPLETED|Overall Study||6
7603378|NCT02522403|18718224|P1|NOT COMPLETED|Overall Study||4
7603379|NCT02522403|18718223|P2|COMPLETED|Overall Study||13
7603380|NCT02522403|18718224|P1|COMPLETED|Overall Study||13
7603381|NCT02522403|18718223|P2|STARTED|Overall Study||19
7603382|NCT02522403|18718224|P1|STARTED|Overall Study||17
7603383|NCT02522377|18718236|P2|NOT COMPLETED|Overall Study||0
7603384|NCT02522377|18718237|P1|NOT COMPLETED|Overall Study||4
7603385|NCT02522377|18718236|P2|COMPLETED|Overall Study||5
7603386|NCT02522377|18718237|P1|COMPLETED|Overall Study||3
7603387|NCT02522377|18718236|P2|STARTED|Overall Study||5
7603388|NCT02522377|18718237|P1|STARTED|Overall Study||7
7603389|NCT02522325|18718253|P2|NOT COMPLETED|Overall Study||1
7603390|NCT02522325|18718254|P1|NOT COMPLETED|Overall Study||0
7603391|NCT02522325|18718253|P2|COMPLETED|Overall Study||14
7603392|NCT02522325|18718254|P1|COMPLETED|Overall Study||15
7603393|NCT02522325|18718253|P2|STARTED|Overall Study||15
7603394|NCT02522325|18718254|P1|STARTED|Overall Study||15
7603395|NCT02522299|18718262|P2|NOT COMPLETED|Overall Study||1
7603396|NCT02522299|18718263|P1|NOT COMPLETED|Overall Study||4
7603397|NCT02522299|18718262|P2|COMPLETED|Overall Study||21
7603398|NCT02522299|18718263|P1|COMPLETED|Overall Study||18
7603399|NCT02522299|18718262|P2|STARTED|Overall Study||22
7603400|NCT02522299|18718263|P1|STARTED|Overall Study||22
7603401|NCT02522286|18718346|P4|NOT COMPLETED|Overall Study||3
7603402|NCT02522286|18718347|P3|NOT COMPLETED|Overall Study||0
7603403|NCT02522286|18718348|P2|NOT COMPLETED|Overall Study||0
7603404|NCT02522286|18718349|P1|NOT COMPLETED|Overall Study||3
7603405|NCT02522286|18718346|P4|COMPLETED|Overall Study||75
7603406|NCT02522286|18718347|P3|COMPLETED|Overall Study||75
7603407|NCT02522286|18718348|P2|COMPLETED|Overall Study||75
7603408|NCT02522286|18718349|P1|COMPLETED|Overall Study||75
7603409|NCT02522286|18718346|P4|STARTED|Overall Study||78
7603410|NCT02522286|18718347|P3|STARTED|Overall Study||75
7603411|NCT02522286|18718348|P2|STARTED|Overall Study||75
7603412|NCT02522286|18718349|P1|STARTED|Overall Study||78
7603413|NCT02521974|18718377|P2|NOT COMPLETED|Overall Study||4
7603414|NCT02521974|18718378|P1|NOT COMPLETED|Overall Study||3
7603415|NCT02521974|18718377|P2|COMPLETED|Overall Study||110
7603416|NCT02521974|18718378|P1|COMPLETED|Overall Study||47
7603417|NCT02521974|18718377|P2|STARTED|Overall Study||114
7603418|NCT02521974|18718378|P1|STARTED|Overall Study||50
7603419|NCT02521948|18718385|P1|NOT COMPLETED|Overall Study||13
7603420|NCT02521948|18718385|P1|COMPLETED|Overall Study||37
7603421|NCT02521948|18718385|P1|STARTED|Overall Study||50
7603422|NCT02521792|18718394|P1|NOT COMPLETED|Overall Study||6
7603423|NCT02521792|18718394|P1|COMPLETED|Overall Study||0
7603424|NCT02521792|18718394|P1|Received Treatment|Overall Study||4
7603425|NCT02521792|18718394|P1|STARTED|Overall Study||6
7603426|NCT02521766|18718409|P2|NOT COMPLETED|Overall Study||3
7603427|NCT02521766|18718410|P1|NOT COMPLETED|Overall Study||5
7603428|NCT02521766|18718409|P2|COMPLETED|Overall Study||62
7603429|NCT02521766|18718410|P1|COMPLETED|Overall Study||44
7603430|NCT02521766|18718409|P2|Per Protocol|Overall Study||65
7603431|NCT02521766|18718410|P1|Per Protocol|Overall Study||47
7603432|NCT02521766|18718409|P2|STARTED|Overall Study||65
7603433|NCT02521766|18718410|P1|STARTED|Overall Study||49
7603434|NCT02521376|18718444|P4|NOT COMPLETED|Overall Study||0
7603435|NCT02521376|18718445|P3|NOT COMPLETED|Overall Study||0
7603436|NCT02521376|18718446|P2|NOT COMPLETED|Overall Study||0
7603437|NCT02521376|18718447|P1|NOT COMPLETED|Overall Study||1
7603438|NCT02521376|18718444|P4|COMPLETED|Overall Study||20
7603439|NCT02521376|18718445|P3|COMPLETED|Overall Study||10
7603440|NCT02521376|18718446|P2|COMPLETED|Overall Study||18
7603441|NCT02521376|18718447|P1|COMPLETED|Overall Study||7
7603442|NCT02521376|18718444|P4|STARTED|Overall Study||20
7603443|NCT02521376|18718445|P3|STARTED|Overall Study||10
7603444|NCT02521376|18718446|P2|STARTED|Overall Study||18
7603445|NCT02521376|18718447|P1|STARTED|Overall Study||8
7603446|NCT02521259|18718479|P2|NOT COMPLETED|Overall Study||5
7603447|NCT02521259|18718480|P1|NOT COMPLETED|Overall Study||1
7603448|NCT02521259|18718479|P2|COMPLETED|Overall Study||28
7603449|NCT02521259|18718480|P1|COMPLETED|Overall Study||34
7603450|NCT02521259|18718479|P2|STARTED|Overall Study||33
7603451|NCT02521259|18718480|P1|STARTED|Overall Study||35
7603452|NCT02521181|18718489|P3|NOT COMPLETED|Overall Study||0
7603453|NCT02521181|18718490|P2|NOT COMPLETED|Overall Study||0
7603454|NCT02521181|18718491|P1|NOT COMPLETED|Overall Study||0
7603455|NCT02521181|18718489|P3|COMPLETED|Overall Study|All patients included in primary analysis|52
7603456|NCT02521181|18718490|P2|COMPLETED|Overall Study|All patients included in primary analysis|90
7603457|NCT02521181|18718491|P1|COMPLETED|Overall Study|All patients included in primary analysis|52
7603458|NCT02521181|18718489|P3|STARTED|Overall Study||52
7603459|NCT02521181|18718490|P2|STARTED|Overall Study||90
7603460|NCT02521181|18718491|P1|STARTED|Overall Study||52
7603461|NCT02520726|18718501|P2|NOT COMPLETED|Overall Study||2
7603462|NCT02520726|18718502|P1|NOT COMPLETED|Overall Study||3
7603463|NCT02520726|18718501|P2|COMPLETED|Overall Study||0
7603464|NCT02520726|18718502|P1|COMPLETED|Overall Study||0
7603465|NCT02520726|18718501|P2|STARTED|Overall Study||2
7603466|NCT02520726|18718502|P1|STARTED|Overall Study||3
7603467|NCT02520531|18718512|P2|NOT COMPLETED|Overall Study||6
7603468|NCT02520531|18718513|P1|NOT COMPLETED|Overall Study||6
7603469|NCT02520531|18718512|P2|COMPLETED|Overall Study||36
7603470|NCT02520531|18718513|P1|COMPLETED|Overall Study||36
7603471|NCT02520531|18718512|P2|STARTED|Overall Study||42
7603472|NCT02520531|18718513|P1|STARTED|Overall Study||42
7603473|NCT02520518|18718531|P4|NOT COMPLETED|Overall Study||1
7603474|NCT02520518|18718532|P3|NOT COMPLETED|Overall Study||2
7603475|NCT02520518|18718533|P2|NOT COMPLETED|Overall Study||0
7603476|NCT02520518|18718534|P1|NOT COMPLETED|Overall Study||0
7603477|NCT02520518|18718531|P4|COMPLETED|Overall Study||1
7603478|NCT02520518|18718532|P3|COMPLETED|Overall Study||1
7603479|NCT02520518|18718533|P2|COMPLETED|Overall Study||1
7603480|NCT02520518|18718534|P1|COMPLETED|Overall Study||3
7603481|NCT02520518|18718531|P4|STARTED|Overall Study||2
7603482|NCT02520518|18718532|P3|STARTED|Overall Study||3
7603483|NCT02520518|18718533|P2|STARTED|Overall Study||1
7603484|NCT02520518|18718534|P1|STARTED|Overall Study||3
7603485|NCT02520414|18718592|P1|NOT COMPLETED|Overall Study||0
7603486|NCT02520414|18718592|P1|COMPLETED|Overall Study||10
7603487|NCT02520414|18718592|P1|STARTED|Overall Study||10
7603488|NCT02520388|18718598|P2|NOT COMPLETED|Overall Study||16
7603489|NCT02520388|18718599|P1|NOT COMPLETED|Overall Study||9
7603490|NCT02520388|18718598|P2|COMPLETED|Overall Study||65
7603491|NCT02520388|18718599|P1|COMPLETED|Overall Study||73
7603492|NCT02520388|18718598|P2|Treated|Overall Study||80
7603493|NCT02520388|18718599|P1|Treated|Overall Study||81
7603494|NCT02520388|18718598|P2|STARTED|Overall Study||81
7603495|NCT02520388|18718599|P1|STARTED|Overall Study||82
7603496|NCT02520310|18718607|P1|NOT COMPLETED|AT 3 Year Clinical Follow-up||4
7603497|NCT02520310|18718607|P1|COMPLETED|AT 3 Year Clinical Follow-up||24
7603498|NCT02520310|18718607|P1|STARTED|AT 3 Year Clinical Follow-up||28
7603499|NCT02520310|18718607|P1|NOT COMPLETED|At 2 Year Clinical Follow-up||0
7603500|NCT02520310|18718607|P1|COMPLETED|At 2 Year Clinical Follow-up||28
7603501|NCT02520310|18718607|P1|STARTED|At 2 Year Clinical Follow-up||28
7603502|NCT02520310|18718607|P1|NOT COMPLETED|At 1 Year Clinical Follow-up||1
7603503|NCT02520310|18718607|P1|COMPLETED|At 1 Year Clinical Follow-up||28
7603504|NCT02520310|18718607|P1|STARTED|At 1 Year Clinical Follow-up||29
7603505|NCT02520310|18718607|P1|NOT COMPLETED|At 6 Months Clinical Follow-up||1
7603506|NCT02520310|18718607|P1|COMPLETED|At 6 Months Clinical Follow-up||29
7603507|NCT02520310|18718607|P1|STARTED|At 6 Months Clinical Follow-up||30
7603508|NCT02520310|18718607|P1|NOT COMPLETED|At 30 Days Clinical Follow-up||0
7603509|NCT02520310|18718607|P1|COMPLETED|At 30 Days Clinical Follow-up||30
7603510|NCT02520310|18718607|P1|STARTED|At 30 Days Clinical Follow-up||30
7603511|NCT02520297|18718778|P1|NOT COMPLETED|Overall Study||0
7603512|NCT02520297|18718778|P1|COMPLETED|Overall Study||1
7603513|NCT02520297|18718778|P1|STARTED|Overall Study||1
7603514|NCT02520284|18718788|P3|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||34
7603515|NCT02520284|18718789|P2|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||35
7603516|NCT02520284|18718790|P1|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||32
7603517|NCT02520284|18718788|P3|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
7603518|NCT02520284|18718789|P2|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
7603519|NCT02520284|18718790|P1|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
7603520|NCT02520284|18718788|P3|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|34
7603521|NCT02520284|18718789|P2|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|35
7603522|NCT02520284|18718790|P1|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|32
7603523|NCT02520284|18718788|P3|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||18
7603524|NCT02520284|18718789|P2|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||16
7603525|NCT02520284|18718790|P1|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||20
7603526|NCT02520284|18718788|P3|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
7603527|NCT02520284|18718789|P2|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
7603528|NCT02520284|18718790|P1|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
7603529|NCT02520284|18718788|P3|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|18
7603530|NCT02520284|18718789|P2|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|16
7603531|NCT02520284|18718790|P1|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|20
7603532|NCT02520284|18718788|P3|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
7603533|NCT02520284|18718789|P2|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||4
7603534|NCT02520284|18718790|P1|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
7603535|NCT02520284|18718788|P3|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|53
7603536|NCT02520284|18718789|P2|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|52
7603537|NCT02520284|18718790|P1|COMPLETED|Blinded Induction Phase: Up to Week 8||52
7603538|NCT02520284|18718788|P3|STARTED|Blinded Induction Phase: Up to Week 8||55
7603539|NCT02520284|18718789|P2|STARTED|Blinded Induction Phase: Up to Week 8||56
7603540|NCT02520284|18718790|P1|STARTED|Blinded Induction Phase: Up to Week 8||54
7603541|NCT02520089|18718824|P2|NOT COMPLETED|Overall Study||4
7603542|NCT02520089|18718825|P1|NOT COMPLETED|Overall Study||3
7603543|NCT02520089|18718824|P2|COMPLETED|Overall Study||7
7603544|NCT02520089|18718825|P1|COMPLETED|Overall Study||9
7603545|NCT02520089|18718824|P2|STARTED|Overall Study||11
7603546|NCT02520089|18718825|P1|STARTED|Overall Study||12
7603547|NCT02519855|18718835|P2|NOT COMPLETED|Overall Study||4
7603548|NCT02519855|18718836|P1|NOT COMPLETED|Overall Study||3
7603549|NCT02519855|18718835|P2|COMPLETED|Overall Study||437
7603550|NCT02519855|18718836|P1|COMPLETED|Overall Study||438
7603551|NCT02519855|18718835|P2|Vaccinated at Week 4|Overall Study||424
7603552|NCT02519855|18718836|P1|Vaccinated at Week 4|Overall Study||432
7603553|NCT02519855|18718835|P2|Vaccinated on Day 1|Overall Study||441
7603554|NCT02519855|18718836|P1|Vaccinated on Day 1|Overall Study||440
7603555|NCT02519855|18718835|P2|STARTED|Overall Study|Participants are included as treated|441
7603643|NCT02519023|18719107|P1|COMPLETED|Overall Study||31
7603556|NCT02519855|18718836|P1|STARTED|Overall Study|Participants are included as treated|441
7603557|NCT02519842|18718854|P3|NOT COMPLETED|Optional Extension: Cycles 2-6||29
7603558|NCT02519842|18718855|P2|NOT COMPLETED|Optional Extension: Cycles 2-6||0
7603559|NCT02519842|18718856|P1|NOT COMPLETED|Optional Extension: Cycles 2-6||0
7603560|NCT02519842|18718854|P3|COMPLETED|Optional Extension: Cycles 2-6||26
7603561|NCT02519842|18718855|P2|COMPLETED|Optional Extension: Cycles 2-6||0
7603562|NCT02519842|18718856|P1|COMPLETED|Optional Extension: Cycles 2-6||0
7603563|NCT02519842|18718854|P3|Treated|Optional Extension: Cycles 2-6||55
7603564|NCT02519842|18718855|P2|Treated|Optional Extension: Cycles 2-6||0
7603565|NCT02519842|18718856|P1|Treated|Optional Extension: Cycles 2-6||0
7603566|NCT02519842|18718854|P3|STARTED|Optional Extension: Cycles 2-6|Enrollment in Cycles 2-6 was optional.|55
7603567|NCT02519842|18718855|P2|STARTED|Optional Extension: Cycles 2-6|28 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
7603568|NCT02519842|18718856|P1|STARTED|Optional Extension: Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
7603569|NCT02519842|18718854|P3|NOT COMPLETED|Base Study: Cycle 1||0
7603570|NCT02519842|18718855|P2|NOT COMPLETED|Base Study: Cycle 1||3
7603571|NCT02519842|18718856|P1|NOT COMPLETED|Base Study: Cycle 1||2
7603572|NCT02519842|18718854|P3|COMPLETED|Base Study: Cycle 1||0
7603573|NCT02519842|18718855|P2|COMPLETED|Base Study: Cycle 1||34
7603574|NCT02519842|18718856|P1|COMPLETED|Base Study: Cycle 1||36
7603575|NCT02519842|18718854|P3|Treated|Base Study: Cycle 1||0
7603576|NCT02519842|18718855|P2|Treated|Base Study: Cycle 1||34
7603577|NCT02519842|18718856|P1|Treated|Base Study: Cycle 1||37
7603578|NCT02519842|18718854|P3|STARTED|Base Study: Cycle 1||0
7603579|NCT02519842|18718855|P2|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|37
7603580|NCT02519842|18718856|P1|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|38
7603581|NCT02519712|18718875|P1|NOT COMPLETED|Overall Study||4
7603582|NCT02519712|18718875|P1|COMPLETED|Overall Study||0
7603583|NCT02519712|18718875|P1|STARTED|Overall Study||4
7603584|NCT02519621|18718882|P3|NOT COMPLETED|Overall Study||0
7603585|NCT02519621|18718883|P2|NOT COMPLETED|Overall Study||0
7603586|NCT02519621|18718884|P1|NOT COMPLETED|Overall Study||0
7603587|NCT02519621|18718882|P3|COMPLETED|Overall Study||30
7603588|NCT02519621|18718883|P2|COMPLETED|Overall Study||30
7603589|NCT02519621|18718884|P1|COMPLETED|Overall Study||30
7603590|NCT02519621|18718882|P3|STARTED|Overall Study||30
7603591|NCT02519621|18718883|P2|STARTED|Overall Study||30
7603592|NCT02519621|18718884|P1|STARTED|Overall Study||30
7603593|NCT02519595|18718904|P3|NOT COMPLETED|Overall Study||16
7603594|NCT02519595|18718905|P2|NOT COMPLETED|Overall Study||22
7603595|NCT02519595|18718906|P1|NOT COMPLETED|Overall Study||8
7603596|NCT02519595|18718904|P3|COMPLETED|Overall Study||40
7603597|NCT02519595|18718905|P2|COMPLETED|Overall Study||35
7603598|NCT02519595|18718906|P1|COMPLETED|Overall Study||50
7603599|NCT02519595|18718904|P3|STARTED|Overall Study||56
7603600|NCT02519595|18718905|P2|STARTED|Overall Study||57
7603601|NCT02519595|18718906|P1|STARTED|Overall Study||58
7603602|NCT02519504|18718931|P2|NOT COMPLETED|Overall Study||103
7603603|NCT02519504|18718932|P1|NOT COMPLETED|Overall Study||113
7603604|NCT02519504|18718931|P2|COMPLETED|Overall Study||144
7603605|NCT02519504|18718932|P1|COMPLETED|Overall Study||206
7603606|NCT02519504|18718931|P2|Attended Direct Testing|Overall Study||149
7603607|NCT02519504|18718932|P1|Attended Direct Testing|Overall Study||212
7603608|NCT02519504|18718931|P2|STARTED|Overall Study||247
7603609|NCT02519504|18718932|P1|STARTED|Overall Study||319
7603610|NCT02519387|18718992|P1|NOT COMPLETED|Overall Study||22
7603611|NCT02519387|18718992|P1|COMPLETED|Overall Study||56
7603612|NCT02519387|18718992|P1|STARTED|Overall Study||78
7603613|NCT02519244|18719000|P1|NOT COMPLETED|Overall Study||0
7603614|NCT02519244|18719000|P1|COMPLETED|Overall Study||10
7603615|NCT02519244|18719000|P1|STARTED|Overall Study||10
7603616|NCT02519231|18719031|P2|NOT COMPLETED|Overall Study||6
7603617|NCT02519231|18719032|P1|NOT COMPLETED|Overall Study||2
7603618|NCT02519231|18719031|P2|COMPLETED|Overall Study|Six participants never turned in their bleeding diaries.|8
7603619|NCT02519231|18719032|P1|COMPLETED|Overall Study|One was lost to follow up and never took the treatment. another never turned in bleeding diary.|12
7603620|NCT02519231|18719031|P2|STARTED|Overall Study||14
7603621|NCT02519231|18719032|P1|STARTED|Overall Study||14
7603622|NCT02519036|18719046|P6|NOT COMPLETED|Overall Study||0
7603623|NCT02519036|18719047|P5|NOT COMPLETED|Overall Study||0
7603624|NCT02519036|18719048|P4|NOT COMPLETED|Overall Study||0
7603625|NCT02519036|18719049|P3|NOT COMPLETED|Overall Study||0
7603626|NCT02519036|18719050|P2|NOT COMPLETED|Overall Study||0
7603627|NCT02519036|18719051|P1|NOT COMPLETED|Overall Study||0
7603628|NCT02519036|18719046|P6|COMPLETED|Overall Study||10
7603629|NCT02519036|18719047|P5|COMPLETED|Overall Study||9
7603630|NCT02519036|18719048|P4|COMPLETED|Overall Study||6
7603631|NCT02519036|18719049|P3|COMPLETED|Overall Study||6
7603632|NCT02519036|18719050|P2|COMPLETED|Overall Study||3
7603633|NCT02519036|18719051|P1|COMPLETED|Overall Study||12
7603634|NCT02519036|18719046|P6|STARTED|Overall Study||10
7603635|NCT02519036|18719047|P5|STARTED|Overall Study||9
7603636|NCT02519036|18719048|P4|STARTED|Overall Study||6
7603637|NCT02519036|18719049|P3|STARTED|Overall Study||6
7603638|NCT02519036|18719050|P2|STARTED|Overall Study||3
7603639|NCT02519036|18719051|P1|STARTED|Overall Study||12
7603640|NCT02519023|18719106|P2|NOT COMPLETED|Overall Study||7
7603641|NCT02519023|18719107|P1|NOT COMPLETED|Overall Study||18
7603642|NCT02519023|18719106|P2|COMPLETED|Overall Study||31
7603644|NCT02519023|18719106|P2|STARTED|Overall Study||38
7603645|NCT02519023|18719107|P1|STARTED|Overall Study||49
7603646|NCT02518997|18719139|P1|NOT COMPLETED|Overall Study||0
7603647|NCT02518997|18719139|P1|COMPLETED|Overall Study||18
7603648|NCT02518997|18719139|P1|STARTED|Overall Study||18
7603649|NCT02518971|18719148|P2|NOT COMPLETED|Overall Study||20
7603650|NCT02518971|18719149|P1|NOT COMPLETED|Overall Study||23
7603651|NCT02518971|18719148|P2|COMPLETED|Overall Study||67
7603652|NCT02518971|18719149|P1|COMPLETED|Overall Study||64
7603653|NCT02518971|18719148|P2|STARTED|Overall Study||87
7603654|NCT02518971|18719149|P1|STARTED|Overall Study||87
7603655|NCT02518919|18719169|P3|NOT COMPLETED|Overall Study||2
7603656|NCT02518919|18719170|P2|NOT COMPLETED|Overall Study||1
7603657|NCT02518919|18719171|P1|NOT COMPLETED|Overall Study||1
7603658|NCT02518919|18719169|P3|COMPLETED|Overall Study||19
7603659|NCT02518919|18719170|P2|COMPLETED|Overall Study||20
7603660|NCT02518919|18719171|P1|COMPLETED|Overall Study||20
7603661|NCT02518919|18719169|P3|STARTED|Overall Study||21
7603662|NCT02518919|18719170|P2|STARTED|Overall Study||21
7603663|NCT02518919|18719171|P1|STARTED|Overall Study||21
7603664|NCT02518750|18719191|P1|NOT COMPLETED|Overall Study||2
7603665|NCT02518750|18719191|P1|COMPLETED|Overall Study||1
7603666|NCT02518750|18719191|P1|STARTED|Overall Study||3
7603667|NCT02518685|18719201|P2|NOT COMPLETED|Overall Study||10
7603668|NCT02518685|18719202|P1|NOT COMPLETED|Overall Study||49
7603669|NCT02518685|18719201|P2|COMPLETED|Overall Study||79
7603670|NCT02518685|18719202|P1|COMPLETED|Overall Study|Randomized Completers (139) plus Open-Label Completers (25)|164
7603671|NCT02518685|18719201|P2|Per Protocol Analysis|Overall Study||89
7603672|NCT02518685|18719202|P1|Per Protocol Analysis|Overall Study|Three TPS-treated subjects were inadvertently unblinded, excluding them from efficacy analyses.|168
7603673|NCT02518685|18719201|P2|Enrolled|Overall Study||89
7603674|NCT02518685|18719202|P1|Enrolled|Overall Study|Includes 171 Successful device deployments, 10 unsuccessful delivery attempts and 32 Open-Label|213
7603675|NCT02518685|18719201|P2|Randomized Cohort|Overall Study||89
7603676|NCT02518685|18719202|P1|Randomized Cohort|Overall Study||181
7603677|NCT02518685|18719201|P2|Safety Cohort|Overall Study||89
7603678|NCT02518685|18719202|P1|Safety Cohort|Overall Study|Randomized to and successfully received TPS (171) + Open-Label TPS-treated Subjects (32)|203
7603679|NCT02518685|18719201|P2|STARTED|Overall Study||89
7603680|NCT02518685|18719202|P1|STARTED|Overall Study||213
7603681|NCT02518620|18719211|P2|NOT COMPLETED|Overall Study||26
7603682|NCT02518620|18719212|P1|NOT COMPLETED|Overall Study||52
7603683|NCT02518620|18719211|P2|COMPLETED|Overall Study||123
7603684|NCT02518620|18719212|P1|COMPLETED|Overall Study||205
7603685|NCT02518620|18719211|P2|STARTED|Overall Study||149
7603686|NCT02518620|18719212|P1|STARTED|Overall Study||257
7603687|NCT02518490|18719235|P2|NOT COMPLETED|Overall Study||1
7603688|NCT02518490|18719236|P1|NOT COMPLETED|Overall Study||1
7603689|NCT02518490|18719235|P2|COMPLETED|Overall Study||17
7603690|NCT02518490|18719236|P1|COMPLETED|Overall Study||17
7603691|NCT02518490|18719235|P2|STARTED|Overall Study||18
7603692|NCT02518490|18719236|P1|STARTED|Overall Study||18
7603693|NCT02518464|18719254|P1|NOT COMPLETED|Overall Study||2
7603694|NCT02518464|18719254|P1|COMPLETED|Overall Study||38
7603695|NCT02518464|18719254|P1|STARTED|Overall Study||40
7603696|NCT02518139|18719261|P3|NOT COMPLETED|Overall Study||94
7603697|NCT02518139|18719262|P2|NOT COMPLETED|Overall Study||144
7603698|NCT02518139|18719263|P1|NOT COMPLETED|Overall Study||145
7603699|NCT02518139|18719261|P3|COMPLETED|Overall Study||262
7603700|NCT02518139|18719262|P2|COMPLETED|Overall Study||191
7603701|NCT02518139|18719263|P1|COMPLETED|Overall Study||219
7603702|NCT02518139|18719261|P3|STARTED|Overall Study||356
7603703|NCT02518139|18719262|P2|STARTED|Overall Study||335
7603704|NCT02518139|18719263|P1|STARTED|Overall Study||364
7603705|NCT02518113|18719275|P4|NOT COMPLETED|Overall Study||0
7603706|NCT02518113|18719276|P3|NOT COMPLETED|Overall Study||4
7603707|NCT02518113|18719277|P2|NOT COMPLETED|Overall Study||5
7603708|NCT02518113|18719278|P1|NOT COMPLETED|Overall Study||3
7603709|NCT02518113|18719275|P4|COMPLETED|Overall Study||3
7603710|NCT02518113|18719276|P3|COMPLETED|Overall Study||11
7603711|NCT02518113|18719277|P2|COMPLETED|Overall Study||7
7603712|NCT02518113|18719278|P1|COMPLETED|Overall Study||3
7603713|NCT02518113|18719275|P4|STARTED|Overall Study||3
7603714|NCT02518113|18719276|P3|STARTED|Overall Study||15
7603715|NCT02518113|18719277|P2|STARTED|Overall Study||12
7603716|NCT02518113|18719278|P1|STARTED|Overall Study||6
7603717|NCT02518048|18719319|P1|NOT COMPLETED|Overall Study||1
7603718|NCT02518048|18719319|P1|COMPLETED|Overall Study||34
7603719|NCT02518048|18719319|P1|STARTED|Overall Study||35
7603720|NCT02517996|18719332|P2|NOT COMPLETED|Overall Study||0
7603721|NCT02517996|18719333|P1|NOT COMPLETED|Overall Study||0
7603722|NCT02517996|18719332|P2|COMPLETED|Overall Study||9
7603723|NCT02517996|18719333|P1|COMPLETED|Overall Study||8
7603724|NCT02517996|18719332|P2|STARTED|Overall Study||9
7603725|NCT02517996|18719333|P1|STARTED|Overall Study||8
7603726|NCT02517905|18719347|P2|NOT COMPLETED|Overall Study||2
7603727|NCT02517905|18719348|P1|NOT COMPLETED|Overall Study||10
7603728|NCT02517905|18719347|P2|COMPLETED|Overall Study||57
7603729|NCT02517905|18719348|P1|COMPLETED|Overall Study||97
7603730|NCT02517905|18719347|P2|STARTED|Overall Study||59
7603731|NCT02517905|18719348|P1|STARTED|Overall Study||107
7603732|NCT02517866|18719364|P3|NOT COMPLETED|Overall Study||0
7603733|NCT02517866|18719365|P2|NOT COMPLETED|Overall Study||6
7603734|NCT02517866|18719366|P1|NOT COMPLETED|Overall Study||20
7603735|NCT02517866|18719364|P3|COMPLETED|Overall Study||1
7603736|NCT02517866|18719365|P2|COMPLETED|Overall Study||84
7603737|NCT02517866|18719366|P1|COMPLETED|Overall Study||269
7603738|NCT02517866|18719364|P3|STARTED|Overall Study||1
7603739|NCT02517866|18719365|P2|STARTED|Overall Study||90
7603740|NCT02517866|18719366|P1|STARTED|Overall Study||289
7603741|NCT02517658|18719411|P3|NOT COMPLETED|Overall Study||0
7603742|NCT02517658|18719412|P2|NOT COMPLETED|Overall Study||0
7603743|NCT02517658|18719413|P1|NOT COMPLETED|Overall Study||0
7603744|NCT02517658|18719411|P3|COMPLETED|Overall Study||33
7603745|NCT02517658|18719412|P2|COMPLETED|Overall Study||33
7603746|NCT02517658|18719413|P1|COMPLETED|Overall Study||33
7603747|NCT02517658|18719411|P3|STARTED|Overall Study||33
7603748|NCT02517658|18719412|P2|STARTED|Overall Study||33
7603749|NCT02517658|18719413|P1|STARTED|Overall Study||33
7603750|NCT02517580|18719421|P1|NOT COMPLETED|Overall Study||4
7603751|NCT02517580|18719421|P1|COMPLETED|Overall Study||56
7603752|NCT02517580|18719421|P1|STARTED|Overall Study||60
7603753|NCT02517567|18719425|P4|NOT COMPLETED|Fourth Exposure (8 Hours)||0
7603754|NCT02517567|18719426|P3|NOT COMPLETED|Fourth Exposure (8 Hours)||0
7603755|NCT02517567|18719427|P2|NOT COMPLETED|Fourth Exposure (8 Hours)||0
7603756|NCT02517567|18719428|P1|NOT COMPLETED|Fourth Exposure (8 Hours)||0
7603757|NCT02517567|18719425|P4|COMPLETED|Fourth Exposure (8 Hours)||8
7603758|NCT02517567|18719426|P3|COMPLETED|Fourth Exposure (8 Hours)||6
7603759|NCT02517567|18719427|P2|COMPLETED|Fourth Exposure (8 Hours)||8
7603760|NCT02517567|18719428|P1|COMPLETED|Fourth Exposure (8 Hours)||6
7603761|NCT02517567|18719425|P4|STARTED|Fourth Exposure (8 Hours)||8
7603762|NCT02517567|18719426|P3|STARTED|Fourth Exposure (8 Hours)|One subject discontinued between Period 3 and Period 4 (withdrawal by subject)|6
7603763|NCT02517567|18719427|P2|STARTED|Fourth Exposure (8 Hours)||8
7603764|NCT02517567|18719428|P1|STARTED|Fourth Exposure (8 Hours)||6
7603765|NCT02517567|18719425|P4|NOT COMPLETED|Third Exposure (8 Hours)||0
7603766|NCT02517567|18719426|P3|NOT COMPLETED|Third Exposure (8 Hours)||0
7603767|NCT02517567|18719427|P2|NOT COMPLETED|Third Exposure (8 Hours)||0
7603768|NCT02517567|18719428|P1|NOT COMPLETED|Third Exposure (8 Hours)||0
7603769|NCT02517567|18719425|P4|COMPLETED|Third Exposure (8 Hours)||8
7603770|NCT02517567|18719426|P3|COMPLETED|Third Exposure (8 Hours)||7
7603771|NCT02517567|18719427|P2|COMPLETED|Third Exposure (8 Hours)||8
7603772|NCT02517567|18719428|P1|COMPLETED|Third Exposure (8 Hours)||6
7603773|NCT02517567|18719425|P4|STARTED|Third Exposure (8 Hours)||8
7603774|NCT02517567|18719426|P3|STARTED|Third Exposure (8 Hours)||7
7603775|NCT02517567|18719427|P2|STARTED|Third Exposure (8 Hours)||8
7603776|NCT02517567|18719428|P1|STARTED|Third Exposure (8 Hours)||6
7603777|NCT02517567|18719425|P4|NOT COMPLETED|Second Exposure (8 Hours)||0
7603778|NCT02517567|18719426|P3|NOT COMPLETED|Second Exposure (8 Hours)||0
7603779|NCT02517567|18719427|P2|NOT COMPLETED|Second Exposure (8 Hours)||0
7603780|NCT02517567|18719428|P1|NOT COMPLETED|Second Exposure (8 Hours)||0
7603781|NCT02517567|18719425|P4|COMPLETED|Second Exposure (8 Hours)||8
7603782|NCT02517567|18719426|P3|COMPLETED|Second Exposure (8 Hours)||7
7603783|NCT02517567|18719427|P2|COMPLETED|Second Exposure (8 Hours)||8
7603784|NCT02517567|18719428|P1|COMPLETED|Second Exposure (8 Hours)||6
7603785|NCT02517567|18719425|P4|STARTED|Second Exposure (8 Hours)||8
7603786|NCT02517567|18719426|P3|STARTED|Second Exposure (8 Hours)||7
7603787|NCT02517567|18719427|P2|STARTED|Second Exposure (8 Hours)||8
7603788|NCT02517567|18719428|P1|STARTED|Second Exposure (8 Hours)||6
7603789|NCT02517567|18719425|P4|NOT COMPLETED|First Exposure (8 Hours)||0
7603790|NCT02517567|18719426|P3|NOT COMPLETED|First Exposure (8 Hours)||0
7603791|NCT02517567|18719427|P2|NOT COMPLETED|First Exposure (8 Hours)||0
7603792|NCT02517567|18719428|P1|NOT COMPLETED|First Exposure (8 Hours)||0
7603793|NCT02517567|18719425|P4|COMPLETED|First Exposure (8 Hours)||8
7603794|NCT02517567|18719426|P3|COMPLETED|First Exposure (8 Hours)||7
7603795|NCT02517567|18719427|P2|COMPLETED|First Exposure (8 Hours)||8
7603796|NCT02517567|18719428|P1|COMPLETED|First Exposure (8 Hours)||6
7603797|NCT02517567|18719425|P4|STARTED|First Exposure (8 Hours)||8
7603798|NCT02517567|18719426|P3|STARTED|First Exposure (8 Hours)||7
7603799|NCT02517567|18719427|P2|STARTED|First Exposure (8 Hours)||8
7603800|NCT02517567|18719428|P1|STARTED|First Exposure (8 Hours)||6
7603801|NCT02517541|18719437|P1|NOT COMPLETED|Test Period (SenSura Mio Convex Soft)||12
7603802|NCT02517541|18719437|P1|COMPLETED|Test Period (SenSura Mio Convex Soft)||61
7603803|NCT02517541|18719437|P1|STARTED|Test Period (SenSura Mio Convex Soft)||73
7603804|NCT02517541|18719437|P1|NOT COMPLETED|Baseline Period (Own Product)||1
7603805|NCT02517541|18719437|P1|COMPLETED|Baseline Period (Own Product)||73
7603806|NCT02517541|18719437|P1|STARTED|Baseline Period (Own Product)||74
7603807|NCT02517528|18719443|P1|NOT COMPLETED|Overall Study||1
7603808|NCT02517528|18719443|P1|COMPLETED|Overall Study||103
7603809|NCT02517528|18719443|P1|STARTED|Overall Study||104
7603810|NCT02517515|18719453|P2|NOT COMPLETED|Overall Study||2
7603811|NCT02517515|18719454|P1|NOT COMPLETED|Overall Study||2
7603812|NCT02517515|18719453|P2|COMPLETED|Overall Study||323
7603813|NCT02517515|18719454|P1|COMPLETED|Overall Study||323
7603814|NCT02517515|18719453|P2|STARTED|Overall Study||325
7603815|NCT02517515|18719454|P1|STARTED|Overall Study||325
7603816|NCT02517463|18719471|P2|NOT COMPLETED|Overall Study||2
7603817|NCT02517463|18719472|P1|NOT COMPLETED|Overall Study||5
7603818|NCT02517463|18719471|P2|COMPLETED|Overall Study||329
7603819|NCT02517463|18719472|P1|COMPLETED|Overall Study||364
7603820|NCT02517463|18719471|P2|STARTED|Overall Study||331
7603821|NCT02517463|18719472|P1|STARTED|Overall Study||369
7603822|NCT02517268|18719484|P2|NOT COMPLETED|Overall Study||0
7603823|NCT02517268|18719485|P1|NOT COMPLETED|Overall Study||1
7603824|NCT02517268|18719484|P2|COMPLETED|Overall Study||37
7603825|NCT02517268|18719485|P1|COMPLETED|Overall Study||39
7603826|NCT02517268|18719484|P2|STARTED|Overall Study||37
7603827|NCT02517268|18719485|P1|STARTED|Overall Study||40
7603828|NCT02517047|18719499|P1|NOT COMPLETED|Overall Study||2
7603829|NCT02517047|18719499|P1|COMPLETED|Overall Study||24
7603830|NCT02517047|18719499|P1|STARTED|Overall Study||26
7603831|NCT02517021|18719508|P2|NOT COMPLETED|Overall Study||85
7603832|NCT02517021|18719509|P1|NOT COMPLETED|Overall Study||83
7603833|NCT02517021|18719508|P2|COMPLETED|Overall Study||117
7603834|NCT02517021|18719509|P1|COMPLETED|Overall Study||120
7603835|NCT02517021|18719508|P2|STARTED|Overall Study||202
7603836|NCT02517021|18719509|P1|STARTED|Overall Study||203
7603837|NCT02516982|18719537|P4|NOT COMPLETED|Overall Study||50
7603838|NCT02516982|18719538|P3|NOT COMPLETED|Overall Study||48
7603839|NCT02516982|18719539|P2|NOT COMPLETED|Overall Study||35
7603840|NCT02516982|18719540|P1|NOT COMPLETED|Overall Study||32
7603841|NCT02516982|18719537|P4|COMPLETED|Overall Study||125
7603842|NCT02516982|18719538|P3|COMPLETED|Overall Study||126
7603843|NCT02516982|18719539|P2|COMPLETED|Overall Study||257
7603844|NCT02516982|18719540|P1|COMPLETED|Overall Study||273
7603845|NCT02516982|18719537|P4|STARTED|Overall Study||175
7603846|NCT02516982|18719538|P3|STARTED|Overall Study||174
7603847|NCT02516982|18719539|P2|STARTED|Overall Study||292
7603848|NCT02516982|18719540|P1|STARTED|Overall Study||305
7603849|NCT02516605|18719567|P5|NOT COMPLETED|Overall Study||1
7603850|NCT02516605|18719568|P4|NOT COMPLETED|Overall Study||1
7603851|NCT02516605|18719569|P3|NOT COMPLETED|Overall Study||0
7603852|NCT02516605|18719570|P2|NOT COMPLETED|Overall Study||0
7603853|NCT02516605|18719571|P1|NOT COMPLETED|Overall Study||0
7603854|NCT02516605|18719567|P5|COMPLETED|Overall Study||20
7603855|NCT02516605|18719568|P4|COMPLETED|Overall Study||7
7603856|NCT02516605|18719569|P3|COMPLETED|Overall Study||12
7603857|NCT02516605|18719570|P2|COMPLETED|Overall Study||9
7603858|NCT02516605|18719571|P1|COMPLETED|Overall Study||11
7603859|NCT02516605|18719567|P5|STARTED|Overall Study||21
7603860|NCT02516605|18719568|P4|STARTED|Overall Study||8
7603861|NCT02516605|18719569|P3|STARTED|Overall Study||12
7603862|NCT02516605|18719570|P2|STARTED|Overall Study||9
7603863|NCT02516605|18719571|P1|STARTED|Overall Study||11
7603864|NCT02516592|18719642|P2|NOT COMPLETED|Overall Study||13
7603865|NCT02516592|18719643|P1|NOT COMPLETED|Overall Study||16
7603866|NCT02516592|18719642|P2|COMPLETED|Overall Study||238
7603867|NCT02516592|18719643|P1|COMPLETED|Overall Study||235
7603868|NCT02516592|18719642|P2|Full Analysis Set|Overall Study||250
7603869|NCT02516592|18719643|P1|Full Analysis Set|Overall Study||248
7603870|NCT02516592|18719642|P2|STARTED|Overall Study||251
7603871|NCT02516592|18719643|P1|STARTED|Overall Study||251
7603872|NCT02516579|18719657|P1|NOT COMPLETED|Overall Study||0
7603873|NCT02516579|18719657|P1|COMPLETED|Overall Study||1906
7603874|NCT02516579|18719657|P1|STARTED|Overall Study||1906
7603875|NCT02516410|18719665|P2|NOT COMPLETED|Overall Study||2
7603876|NCT02516410|18719666|P1|NOT COMPLETED|Overall Study||0
7603877|NCT02516410|18719665|P2|COMPLETED|Overall Study||81
7603878|NCT02516410|18719666|P1|COMPLETED|Overall Study||85
7603879|NCT02516410|18719665|P2|STARTED|Overall Study||83
7603880|NCT02516410|18719666|P1|STARTED|Overall Study||85
7603881|NCT02516306|18719695|P2|NOT COMPLETED|Period 2: Day 8 - 91||2
7603882|NCT02516306|18719696|P1|NOT COMPLETED|Period 2: Day 8 - 91||1
7603883|NCT02516306|18719695|P2|COMPLETED|Period 2: Day 8 - 91||23
7603884|NCT02516306|18719696|P1|COMPLETED|Period 2: Day 8 - 91||49
7603885|NCT02516306|18719695|P2|STARTED|Period 2: Day 8 - 91||25
7603886|NCT02516306|18719696|P1|STARTED|Period 2: Day 8 - 91||50
7603887|NCT02516306|18719695|P2|NOT COMPLETED|Period 1: Day 1 - 7||0
7603888|NCT02516306|18719696|P1|NOT COMPLETED|Period 1: Day 1 - 7||0
7603889|NCT02516306|18719695|P2|COMPLETED|Period 1: Day 1 - 7||25
7603890|NCT02516306|18719696|P1|COMPLETED|Period 1: Day 1 - 7||50
7603891|NCT02516306|18719695|P2|STARTED|Period 1: Day 1 - 7||25
7603892|NCT02516306|18719696|P1|STARTED|Period 1: Day 1 - 7||50
7603893|NCT02516228|18719702|P1|NOT COMPLETED|Overall Study||3
7603894|NCT02516228|18719702|P1|COMPLETED|Overall Study||3
7603895|NCT02516228|18719702|P1|STARTED|Overall Study||6
7603896|NCT02516202|18719713|P3|NOT COMPLETED|Overall Study||3
7603897|NCT02516202|18719714|P2|NOT COMPLETED|Overall Study||1
7603898|NCT02516202|18719715|P1|NOT COMPLETED|Overall Study||2
7603899|NCT02516202|18719713|P3|COMPLETED|Overall Study||97
7603900|NCT02516202|18719714|P2|COMPLETED|Overall Study||99
7603901|NCT02516202|18719715|P1|COMPLETED|Overall Study||100
7603902|NCT02516202|18719713|P3|STARTED|Overall Study||100
7603903|NCT02516202|18719714|P2|STARTED|Overall Study||100
7603904|NCT02516202|18719715|P1|STARTED|Overall Study||102
7603905|NCT02516163|18719741|P1|NOT COMPLETED|Overall Study||28
7603906|NCT02516163|18719741|P1|COMPLETED|Overall Study||24
7603907|NCT02516163|18719741|P1|STARTED|Overall Study||52
7603908|NCT02516150|18719745|P1|NOT COMPLETED|Overall Study||0
7603909|NCT02516150|18719745|P1|COMPLETED|Overall Study||15
7603910|NCT02516150|18719745|P1|STARTED|Overall Study||15
7603911|NCT02516098|18719755|P2|NOT COMPLETED|Washout After Period 2||0
7603912|NCT02516098|18719756|P1|NOT COMPLETED|Washout After Period 2||0
7603913|NCT02516098|18719755|P2|COMPLETED|Washout After Period 2||26
7603914|NCT02516098|18719756|P1|COMPLETED|Washout After Period 2||27
7603915|NCT02516098|18719755|P2|STARTED|Washout After Period 2||26
7603916|NCT02516098|18719756|P1|STARTED|Washout After Period 2||27
7603917|NCT02516098|18719755|P2|NOT COMPLETED|Period 2||1
7603918|NCT02516098|18719756|P1|NOT COMPLETED|Period 2||0
7603919|NCT02516098|18719755|P2|COMPLETED|Period 2||26
7603920|NCT02516098|18719756|P1|COMPLETED|Period 2||27
7603921|NCT02516098|18719755|P2|STARTED|Period 2||27
7603922|NCT02516098|18719756|P1|STARTED|Period 2||27
7603923|NCT02516098|18719755|P2|NOT COMPLETED|Washout After Period 1||1
7603924|NCT02516098|18719756|P1|NOT COMPLETED|Washout After Period 1||0
7603925|NCT02516098|18719755|P2|COMPLETED|Washout After Period 1||27
7603926|NCT02516098|18719756|P1|COMPLETED|Washout After Period 1||27
7603927|NCT02516098|18719755|P2|STARTED|Washout After Period 1||28
7603928|NCT02516098|18719756|P1|STARTED|Washout After Period 1||27
7603929|NCT02516098|18719755|P2|NOT COMPLETED|Period 1||0
7603930|NCT02516098|18719756|P1|NOT COMPLETED|Period 1||1
7603931|NCT02516098|18719755|P2|COMPLETED|Period 1||28
7603932|NCT02516098|18719756|P1|COMPLETED|Period 1||27
7603933|NCT02516098|18719755|P2|STARTED|Period 1||28
7603934|NCT02516098|18719756|P1|STARTED|Period 1||28
7603935|NCT02516046|18719768|P1|NOT COMPLETED|Overall Study||92
7603936|NCT02516046|18719768|P1|COMPLETED|Overall Study|Completed = included in autopsy cohort|64
7603937|NCT02516046|18719768|P1|Valid Autopsy Results and PET Scan|Overall Study|includes 3 front-runners|67
7603938|NCT02516046|18719768|P1|Died While on Study|Overall Study||73
7603939|NCT02516046|18719768|P1|STARTED|Overall Study|Total number of subjects scanned|156
7603940|NCT02515994|18719784|P2|NOT COMPLETED|Overall Study||7
7603941|NCT02515994|18719785|P1|NOT COMPLETED|Overall Study||10
7603942|NCT02515994|18719784|P2|COMPLETED|Overall Study||105
7603943|NCT02515994|18719785|P1|COMPLETED|Overall Study||99
7603944|NCT02515994|18719784|P2|STARTED|Overall Study||112
7603945|NCT02515994|18719785|P1|STARTED|Overall Study||109
7603946|NCT02515942|18719800|P3|NOT COMPLETED|Overall Study||4
7603947|NCT02515942|18719801|P2|NOT COMPLETED|Overall Study||3
7603948|NCT02515942|18719802|P1|NOT COMPLETED|Overall Study||7
7603949|NCT02515942|18719800|P3|COMPLETED|Overall Study||35
7603950|NCT02515942|18719801|P2|COMPLETED|Overall Study||36
7603951|NCT02515942|18719802|P1|COMPLETED|Overall Study||29
7603952|NCT02515942|18719800|P3|Completed Day 337|Overall Study||35
7603953|NCT02515942|18719801|P2|Completed Day 337|Overall Study||36
7603954|NCT02515942|18719802|P1|Completed Day 337|Overall Study||30
7603955|NCT02515942|18719800|P3|Completed Day 253|Overall Study||36
7603956|NCT02515942|18719801|P2|Completed Day 253|Overall Study||37
7603957|NCT02515942|18719802|P1|Completed Day 253|Overall Study|One subject missed Day 253 visit|29
7603958|NCT02515942|18719800|P3|Completed Day 169|Overall Study||37
7603959|NCT02515942|18719801|P2|Completed Day 169|Overall Study||37
7603960|NCT02515942|18719802|P1|Completed Day 169|Overall Study||32
7603961|NCT02515942|18719800|P3|Completed Day 85|Overall Study||37
7603962|NCT02515942|18719801|P2|Completed Day 85|Overall Study||38
7603963|NCT02515942|18719802|P1|Completed Day 85|Overall Study||35
7603964|NCT02515942|18719800|P3|Pharmacokinetics (PK) Analysis Set|Overall Study||0
7603965|NCT02515942|18719801|P2|Pharmacokinetics (PK) Analysis Set|Overall Study||39
7603966|NCT02515942|18719802|P1|Pharmacokinetics (PK) Analysis Set|Overall Study||36
7603967|NCT02515942|18719800|P3|Per Protocol Analysis Set (PPS)|Overall Study||34
7603968|NCT02515942|18719801|P2|Per Protocol Analysis Set (PPS)|Overall Study||35
7603969|NCT02515942|18719802|P1|Per Protocol Analysis Set (PPS)|Overall Study||30
7603970|NCT02515942|18719800|P3|Full Analysis Set (FAS)|Overall Study||38
7603971|NCT02515942|18719801|P2|Full Analysis Set (FAS)|Overall Study||37
7603972|NCT02515942|18719802|P1|Full Analysis Set (FAS)|Overall Study||35
7603973|NCT02515942|18719800|P3|Safety Analysis Set|Overall Study||39
7603974|NCT02515942|18719801|P2|Safety Analysis Set|Overall Study||39
7603975|NCT02515942|18719802|P1|Safety Analysis Set|Overall Study||36
7603976|NCT02515942|18719800|P3|STARTED|Overall Study||39
7603977|NCT02515942|18719801|P2|STARTED|Overall Study||39
7603978|NCT02515942|18719802|P1|STARTED|Overall Study||36
7603979|NCT02515890|18719854|P5|NOT COMPLETED|Overall Study||0
7603980|NCT02515890|18719855|P4|NOT COMPLETED|Overall Study||0
7603981|NCT02515890|18719856|P3|NOT COMPLETED|Overall Study||0
7603982|NCT02515890|18719857|P2|NOT COMPLETED|Overall Study||0
7603983|NCT02515890|18719858|P1|NOT COMPLETED|Overall Study||0
7603984|NCT02515890|18719854|P5|COMPLETED|Overall Study||8
7603985|NCT02515890|18719855|P4|COMPLETED|Overall Study||8
7603986|NCT02515890|18719856|P3|COMPLETED|Overall Study||5
7603987|NCT02515890|18719857|P2|COMPLETED|Overall Study||4
7603988|NCT02515890|18719858|P1|COMPLETED|Overall Study||7
7603989|NCT02515890|18719854|P5|STARTED|Overall Study||8
7603990|NCT02515890|18719855|P4|STARTED|Overall Study||8
7603991|NCT02515890|18719856|P3|STARTED|Overall Study||5
7603992|NCT02515890|18719857|P2|STARTED|Overall Study||4
7603993|NCT02515890|18719858|P1|STARTED|Overall Study||7
7603994|NCT02515851|18719871|P2|NOT COMPLETED|Overall Study||0
7603995|NCT02515851|18719872|P1|NOT COMPLETED|Overall Study||0
7603996|NCT02515851|18719871|P2|COMPLETED|Overall Study||15
7603997|NCT02515851|18719872|P1|COMPLETED|Overall Study||15
7603998|NCT02515851|18719871|P2|STARTED|Overall Study||15
7603999|NCT02515851|18719872|P1|STARTED|Overall Study||15
7604000|NCT02515669|18719888|P4|NOT COMPLETED|228 Week Open-Label Phase||26
7604001|NCT02515669|18719889|P3|NOT COMPLETED|228 Week Open-Label Phase||8
7604002|NCT02515669|18719890|P2|NOT COMPLETED|228 Week Open-Label Phase||9
7604003|NCT02515669|18719891|P1|NOT COMPLETED|228 Week Open-Label Phase||0
7604004|NCT02515669|18719888|P4|COMPLETED|228 Week Open-Label Phase||0
7604005|NCT02515669|18719889|P3|COMPLETED|228 Week Open-Label Phase||0
7604006|NCT02515669|18719890|P2|COMPLETED|228 Week Open-Label Phase||0
7604007|NCT02515669|18719891|P1|COMPLETED|228 Week Open-Label Phase||0
7604181|NCT02514083|18720266|P1|STARTED|Overall Study||29
7604008|NCT02515669|18719888|P4|STARTED|228 Week Open-Label Phase|7 DB placebo participants switched to the Panel 3/Expansion RO cohort for the open-label phase.|26
7604009|NCT02515669|18719889|P3|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 2 RO cohort for the open-label phase.|8
7604010|NCT02515669|18719890|P2|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 1 RO cohort for the open-label phase.|9
7604011|NCT02515669|18719891|P1|STARTED|228 Week Open-Label Phase|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
7604012|NCT02515669|18719888|P4|NOT COMPLETED|24 Week Double-Blind Phase||0
7604013|NCT02515669|18719889|P3|NOT COMPLETED|24 Week Double-Blind Phase||0
7604014|NCT02515669|18719890|P2|NOT COMPLETED|24 Week Double-Blind Phase||0
7604015|NCT02515669|18719891|P1|NOT COMPLETED|24 Week Double-Blind Phase||0
7604016|NCT02515669|18719888|P4|COMPLETED|24 Week Double-Blind Phase||19
7604017|NCT02515669|18719889|P3|COMPLETED|24 Week Double-Blind Phase||6
7604018|NCT02515669|18719890|P2|COMPLETED|24 Week Double-Blind Phase||7
7604019|NCT02515669|18719891|P1|COMPLETED|24 Week Double-Blind Phase||11
7604020|NCT02515669|18719888|P4|STARTED|24 Week Double-Blind Phase||19
7604021|NCT02515669|18719889|P3|STARTED|24 Week Double-Blind Phase||6
7604022|NCT02515669|18719890|P2|STARTED|24 Week Double-Blind Phase||7
7604023|NCT02515669|18719891|P1|STARTED|24 Week Double-Blind Phase||11
7604024|NCT02515656|18719969|P2|NOT COMPLETED|Overall Study||71
7604025|NCT02515656|18719970|P1|NOT COMPLETED|Overall Study||56
7604026|NCT02515656|18719969|P2|COMPLETED|Overall Study||261
7604027|NCT02515656|18719970|P1|COMPLETED|Overall Study||270
7604028|NCT02515656|18719969|P2|Safety Population|Overall Study||328
7604029|NCT02515656|18719970|P1|Safety Population|Overall Study||325
7604030|NCT02515656|18719969|P2|Per Protocol Set (PPS)|Overall Study||275
7604031|NCT02515656|18719970|P1|Per Protocol Set (PPS)|Overall Study||277
7604032|NCT02515656|18719969|P2|Full Analysis Set (FAS)|Overall Study||309
7604033|NCT02515656|18719970|P1|Full Analysis Set (FAS)|Overall Study||302
7604034|NCT02515656|18719969|P2|STARTED|Overall Study||332
7604035|NCT02515656|18719970|P1|STARTED|Overall Study||326
7604036|NCT02515331|18719989|P3|NOT COMPLETED|Overall Study||4
7604037|NCT02515331|18719990|P2|NOT COMPLETED|Overall Study||0
7604038|NCT02515331|18719991|P1|NOT COMPLETED|Overall Study||2
7604039|NCT02515331|18719989|P3|COMPLETED|Overall Study||28
7604040|NCT02515331|18719990|P2|COMPLETED|Overall Study||15
7604041|NCT02515331|18719991|P1|COMPLETED|Overall Study||15
7604042|NCT02515331|18719989|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
7604043|NCT02515331|18719990|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||15
7604044|NCT02515331|18719991|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||17
7604045|NCT02515331|18719989|P3|Primary Pharmacodynamic Analysis Set|Overall Study||29
7604046|NCT02515331|18719990|P2|Primary Pharmacodynamic Analysis Set|Overall Study||14
7604047|NCT02515331|18719991|P1|Primary Pharmacodynamic Analysis Set|Overall Study||15
7604048|NCT02515331|18719989|P3|STARTED|Overall Study||32
7604049|NCT02515331|18719990|P2|STARTED|Overall Study||15
7604050|NCT02515331|18719991|P1|STARTED|Overall Study||17
7604051|NCT02515305|18720015|P3|NOT COMPLETED|Overall Study||14
7604052|NCT02515305|18720016|P2|NOT COMPLETED|Overall Study||35
7604053|NCT02515305|18720017|P1|NOT COMPLETED|Overall Study||29
7604054|NCT02515305|18720015|P3|COMPLETED|Overall Study||113
7604055|NCT02515305|18720016|P2|COMPLETED|Overall Study||343
7604056|NCT02515305|18720017|P1|COMPLETED|Overall Study||356
7604057|NCT02515305|18720015|P3|STARTED|Overall Study||127
7604058|NCT02515305|18720016|P2|STARTED|Overall Study||378
7604059|NCT02515305|18720017|P1|STARTED|Overall Study||385
7604060|NCT02515279|18720028|P1|NOT COMPLETED|Overall Study||104
7604061|NCT02515279|18720028|P1|COMPLETED|Overall Study||359
7604062|NCT02515279|18720028|P1|STARTED|Overall Study||463
7604063|NCT02515253|18720036|P2|NOT COMPLETED|Overall Study||8
7604064|NCT02515253|18720037|P1|NOT COMPLETED|Overall Study||7
7604065|NCT02515253|18720036|P2|COMPLETED|Overall Study||8
7604066|NCT02515253|18720037|P1|COMPLETED|Overall Study||10
7604067|NCT02515253|18720036|P2|STARTED|Overall Study||16
7604068|NCT02515253|18720037|P1|STARTED|Overall Study||17
7604069|NCT02515097|18720047|P2|NOT COMPLETED|Overall Study||6
7604070|NCT02515097|18720048|P1|NOT COMPLETED|Overall Study||7
7604071|NCT02515097|18720047|P2|COMPLETED|Overall Study||65
7604072|NCT02515097|18720048|P1|COMPLETED|Overall Study||135
7604073|NCT02515097|18720047|P2|Safety Population|Overall Study||70
7604074|NCT02515097|18720048|P1|Safety Population|Overall Study||142
7604075|NCT02515097|18720047|P2|Intent-to-Treat (ITT) Population|Overall Study||71
7604076|NCT02515097|18720048|P1|Intent-to-Treat (ITT) Population|Overall Study||142
7604077|NCT02515097|18720047|P2|STARTED|Overall Study||71
7604078|NCT02515097|18720048|P1|STARTED|Overall Study||142
7604079|NCT02515058|18720058|P2|NOT COMPLETED|Overall Study||2
7604080|NCT02515058|18720059|P1|NOT COMPLETED|Overall Study||3
7604081|NCT02515058|18720058|P2|COMPLETED|Overall Study||20
7604082|NCT02515058|18720059|P1|COMPLETED|Overall Study||18
7604083|NCT02515058|18720058|P2|STARTED|Overall Study||22
7604084|NCT02515058|18720059|P1|STARTED|Overall Study||21
7604085|NCT02515045|18720069|P3|NOT COMPLETED|Overall Study||4
7604086|NCT02515045|18720070|P2|NOT COMPLETED|Overall Study||4
7604087|NCT02515045|18720071|P1|NOT COMPLETED|Overall Study||0
7604088|NCT02515045|18720069|P3|COMPLETED|Overall Study||55
7604089|NCT02515045|18720070|P2|COMPLETED|Overall Study||26
7604090|NCT02515045|18720071|P1|COMPLETED|Overall Study||29
7604091|NCT02515045|18720069|P3|STARTED|Overall Study||59
7604092|NCT02515045|18720070|P2|STARTED|Overall Study||30
7604093|NCT02515045|18720071|P1|STARTED|Overall Study||29
7604094|NCT02514889|18720087|P2|NOT COMPLETED|Follow-up Assessment Participation||12
7604095|NCT02514889|18720088|P1|NOT COMPLETED|Follow-up Assessment Participation||10
7604096|NCT02514889|18720087|P2|COMPLETED|Follow-up Assessment Participation||86
7604097|NCT02514889|18720088|P1|COMPLETED|Follow-up Assessment Participation||92
7604098|NCT02514889|18720087|P2|STARTED|Follow-up Assessment Participation||98
7604099|NCT02514889|18720088|P1|STARTED|Follow-up Assessment Participation||102
7604100|NCT02514889|18720087|P2|NOT COMPLETED|Intervention Participation||8
7604101|NCT02514889|18720088|P1|NOT COMPLETED|Intervention Participation||9
7604102|NCT02514889|18720087|P2|COMPLETED|Intervention Participation||98
7604103|NCT02514889|18720088|P1|COMPLETED|Intervention Participation||102
7604104|NCT02514889|18720087|P2|STARTED|Intervention Participation||106
7604105|NCT02514889|18720088|P1|STARTED|Intervention Participation||111
7604106|NCT02514889|18720087|P2|NOT COMPLETED|Randomization/Allocation to Condition||24
7604107|NCT02514889|18720088|P1|NOT COMPLETED|Randomization/Allocation to Condition||20
7604108|NCT02514889|18720087|P2|COMPLETED|Randomization/Allocation to Condition||106
7604109|NCT02514889|18720088|P1|COMPLETED|Randomization/Allocation to Condition||111
7604110|NCT02514889|18720087|P2|STARTED|Randomization/Allocation to Condition||130
7604111|NCT02514889|18720088|P1|STARTED|Randomization/Allocation to Condition||131
7604112|NCT02514824|18720108|P4|NOT COMPLETED|Overall Study||0
7604113|NCT02514824|18720109|P3|NOT COMPLETED|Overall Study||0
7604114|NCT02514824|18720110|P2|NOT COMPLETED|Overall Study||1
7604115|NCT02514824|18720111|P1|NOT COMPLETED|Overall Study||1
7604116|NCT02514824|18720108|P4|COMPLETED|Overall Study||0
7604117|NCT02514824|18720109|P3|COMPLETED|Overall Study||0
7604118|NCT02514824|18720110|P2|COMPLETED|Overall Study||4
7604119|NCT02514824|18720111|P1|COMPLETED|Overall Study||3
7604120|NCT02514824|18720108|P4|Evaluable for Dose-limiting Toxicity|Overall Study||0
7604121|NCT02514824|18720109|P3|Evaluable for Dose-limiting Toxicity|Overall Study||0
7604122|NCT02514824|18720110|P2|Evaluable for Dose-limiting Toxicity|Overall Study||5
7604123|NCT02514824|18720111|P1|Evaluable for Dose-limiting Toxicity|Overall Study||3
7604124|NCT02514824|18720108|P4|STARTED|Overall Study||0
7604125|NCT02514824|18720109|P3|STARTED|Overall Study||0
7604126|NCT02514824|18720110|P2|STARTED|Overall Study||5
7604127|NCT02514824|18720111|P1|STARTED|Overall Study||4
7604128|NCT02514772|18720122|P2|NOT COMPLETED|Overall Study||2
7604129|NCT02514772|18720123|P1|NOT COMPLETED|Overall Study||3
7604130|NCT02514772|18720122|P2|COMPLETED|Overall Study||52
7604131|NCT02514772|18720123|P1|COMPLETED|Overall Study||50
7604132|NCT02514772|18720122|P2|STARTED|Overall Study||54
7604133|NCT02514772|18720123|P1|STARTED|Overall Study||53
7604134|NCT02514746|18720137|P2|NOT COMPLETED|Overall Study||15
7604135|NCT02514746|18720138|P1|NOT COMPLETED|Overall Study||22
7604136|NCT02514746|18720137|P2|COMPLETED|Overall Study||109
7604137|NCT02514746|18720138|P1|COMPLETED|Overall Study||415
7604138|NCT02514746|18720137|P2|Received CD-JEV Booster Vaccine|Overall Study||109
7604139|NCT02514746|18720138|P1|Received CD-JEV Booster Vaccine|Overall Study||424
7604140|NCT02514746|18720137|P2|Valid Serology 4 Years Post Primary Dose|Overall Study||109
7604141|NCT02514746|18720138|P1|Valid Serology 4 Years Post Primary Dose|Overall Study||424
7604142|NCT02514746|18720137|P2|Valid Serology 3 Years Post Primary Dose|Overall Study||123
7604143|NCT02514746|18720138|P1|Valid Serology 3 Years Post Primary Dose|Overall Study||437
7604144|NCT02514746|18720137|P2|STARTED|Overall Study||124
7604145|NCT02514746|18720138|P1|STARTED|Overall Study||437
7604146|NCT02514577|18720175|P2|NOT COMPLETED|Overall Study||13
7604147|NCT02514577|18720176|P1|NOT COMPLETED|Overall Study||14
7604148|NCT02514577|18720175|P2|COMPLETED|Overall Study||61
7604149|NCT02514577|18720176|P1|COMPLETED|Overall Study||129
7604150|NCT02514577|18720175|P2|Safety Population|Overall Study||72
7604151|NCT02514577|18720176|P1|Safety Population|Overall Study||142
7604152|NCT02514577|18720175|P2|Intent-to-Treat (ITT) Population|Overall Study||74
7604153|NCT02514577|18720176|P1|Intent-to-Treat (ITT) Population|Overall Study||143
7604154|NCT02514577|18720175|P2|STARTED|Overall Study||74
7604155|NCT02514577|18720176|P1|STARTED|Overall Study||143
7604156|NCT02514551|18720186|P2|NOT COMPLETED|Overall Study||3
7604157|NCT02514551|18720187|P1|NOT COMPLETED|Overall Study||0
7604158|NCT02514551|18720186|P2|COMPLETED|Overall Study||119
7604159|NCT02514551|18720187|P1|COMPLETED|Overall Study||123
7604160|NCT02514551|18720186|P2|Received at Least One Dose of Study Drug|Overall Study||120
7604161|NCT02514551|18720187|P1|Received at Least One Dose of Study Drug|Overall Study||123
7604162|NCT02514551|18720186|P2|STARTED|Overall Study||122
7604163|NCT02514551|18720187|P1|STARTED|Overall Study||123
7604164|NCT02514473|18720204|P2|NOT COMPLETED|Overall Study||5
7604165|NCT02514473|18720205|P1|NOT COMPLETED|Overall Study||3
7604166|NCT02514473|18720204|P2|COMPLETED|Overall Study||98
7604167|NCT02514473|18720205|P1|COMPLETED|Overall Study||98
7604168|NCT02514473|18720204|P2|STARTED|Overall Study||103
7604169|NCT02514473|18720205|P1|STARTED|Overall Study||101
7604170|NCT02514174|18720246|P1|NOT COMPLETED|Overall Study||25
7604171|NCT02514174|18720246|P1|COMPLETED|Overall Study||0
7604172|NCT02514174|18720246|P1|STARTED|Overall Study||25
7604173|NCT02514122|18720257|P2|NOT COMPLETED|Overall Study||0
7604174|NCT02514122|18720258|P1|NOT COMPLETED|Overall Study||2
7604175|NCT02514122|18720257|P2|COMPLETED|Overall Study||29
7604176|NCT02514122|18720258|P1|COMPLETED|Overall Study|one participant dropped out for religious reasons; one for needle phobia|30
7604177|NCT02514122|18720257|P2|STARTED|Overall Study||29
7604178|NCT02514122|18720258|P1|STARTED|Overall Study||32
7604179|NCT02514083|18720266|P1|NOT COMPLETED|Overall Study||1
7604180|NCT02514083|18720266|P1|COMPLETED|Overall Study||28
7604182|NCT02514070|18720273|P2|NOT COMPLETED|Week 14 to Week 20||2
7604183|NCT02514070|18720274|P1|NOT COMPLETED|Week 14 to Week 20||1
7604184|NCT02514070|18720273|P2|COMPLETED|Week 14 to Week 20||14
7604185|NCT02514070|18720274|P1|COMPLETED|Week 14 to Week 20||16
7604186|NCT02514070|18720273|P2|STARTED|Week 14 to Week 20||16
7604187|NCT02514070|18720274|P1|STARTED|Week 14 to Week 20||17
7604188|NCT02514070|18720273|P2|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0
7604189|NCT02514070|18720274|P1|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0
7604190|NCT02514070|18720273|P2|COMPLETED|Week 6 to Week 14 - Washout Period||16
7604191|NCT02514070|18720274|P1|COMPLETED|Week 6 to Week 14 - Washout Period||17
7604192|NCT02514070|18720273|P2|STARTED|Week 6 to Week 14 - Washout Period||16
7604193|NCT02514070|18720274|P1|STARTED|Week 6 to Week 14 - Washout Period||17
7604194|NCT02514070|18720273|P2|NOT COMPLETED|Weeks 0 to Week 6||4
7604195|NCT02514070|18720274|P1|NOT COMPLETED|Weeks 0 to Week 6||2
7604196|NCT02514070|18720273|P2|COMPLETED|Weeks 0 to Week 6||16
7604197|NCT02514070|18720274|P1|COMPLETED|Weeks 0 to Week 6||17
7604198|NCT02514070|18720273|P2|STARTED|Weeks 0 to Week 6||20
7604199|NCT02514070|18720274|P1|STARTED|Weeks 0 to Week 6||19
7604200|NCT02514044|18720285|P1|NOT COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||0
7604201|NCT02514044|18720285|P1|COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||10
7604202|NCT02514044|18720285|P1|STARTED|Placebo+tDCS+Speech Therapy (1 Day)||10
7604203|NCT02514044|18720285|P1|NOT COMPLETED|Washout (1 Week)||0
7604204|NCT02514044|18720285|P1|COMPLETED|Washout (1 Week)||10
7604205|NCT02514044|18720285|P1|STARTED|Washout (1 Week)||10
7604206|NCT02514044|18720285|P1|NOT COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||0
7604207|NCT02514044|18720285|P1|COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
7604208|NCT02514044|18720285|P1|STARTED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
7604209|NCT02513940|18720299|P6|NOT COMPLETED|Overall Study||0
7604210|NCT02513940|18720300|P5|NOT COMPLETED|Overall Study||0
7604211|NCT02513940|18720301|P4|NOT COMPLETED|Overall Study||0
7604212|NCT02513940|18720302|P3|NOT COMPLETED|Overall Study||0
7604213|NCT02513940|18720303|P2|NOT COMPLETED|Overall Study||0
7604214|NCT02513940|18720304|P1|NOT COMPLETED|Overall Study||0
7604215|NCT02513940|18720299|P6|COMPLETED|Overall Study||3
7604216|NCT02513940|18720300|P5|COMPLETED|Overall Study||2
7604217|NCT02513940|18720301|P4|COMPLETED|Overall Study||2
7604218|NCT02513940|18720302|P3|COMPLETED|Overall Study||2
7604219|NCT02513940|18720303|P2|COMPLETED|Overall Study||3
7604220|NCT02513940|18720304|P1|COMPLETED|Overall Study||2
7604221|NCT02513940|18720299|P6|STARTED|Overall Study||3
7604222|NCT02513940|18720300|P5|STARTED|Overall Study||2
7604223|NCT02513940|18720301|P4|STARTED|Overall Study||2
7604224|NCT02513940|18720302|P3|STARTED|Overall Study||2
7604225|NCT02513940|18720303|P2|STARTED|Overall Study||3
7604226|NCT02513940|18720304|P1|STARTED|Overall Study|This was a crossover study, with a total n=14. All 14 subjects completed each phase of the study|2
7604227|NCT02513823|18720324|P1|NOT COMPLETED|Overall Study||5
7604228|NCT02513823|18720324|P1|COMPLETED|Overall Study||22
7604229|NCT02513823|18720324|P1|STARTED|Overall Study||27
7604230|NCT02513771|18720331|P2|NOT COMPLETED|Overall Study||1
7604231|NCT02513771|18720332|P1|NOT COMPLETED|Overall Study||2
7604232|NCT02513771|18720331|P2|COMPLETED|Overall Study||44
7604233|NCT02513771|18720332|P1|COMPLETED|Overall Study||43
7604234|NCT02513771|18720331|P2|STARTED|Overall Study||45
7604235|NCT02513771|18720332|P1|STARTED|Overall Study||45
7604236|NCT02513745|18720370|P2|NOT COMPLETED|Overall Study||3
7604237|NCT02513745|18720371|P1|NOT COMPLETED|Overall Study||3
7604238|NCT02513745|18720370|P2|COMPLETED|Overall Study||39
7604239|NCT02513745|18720371|P1|COMPLETED|Overall Study||39
7604240|NCT02513745|18720370|P2|STARTED|Overall Study||42
7604241|NCT02513745|18720371|P1|STARTED|Overall Study||42
7604242|NCT02513732|18720381|P1|NOT COMPLETED|Overall Study||0
7604243|NCT02513732|18720381|P1|COMPLETED|Overall Study||100
7604244|NCT02513732|18720381|P1|STARTED|Overall Study||100
7604245|NCT02513719|18720511|P1|NOT COMPLETED|At 5 Years Clinical Follow-up||19
7604246|NCT02513719|18720511|P1|COMPLETED|At 5 Years Clinical Follow-up||254
7604247|NCT02513719|18720511|P1|STARTED|At 5 Years Clinical Follow-up||273
7604248|NCT02513719|18720511|P1|NOT COMPLETED|At 4 Years Clinical Follow-up||16
7604249|NCT02513719|18720511|P1|COMPLETED|At 4 Years Clinical Follow-up||273
7604250|NCT02513719|18720511|P1|STARTED|At 4 Years Clinical Follow-up||289
7604251|NCT02513719|18720511|P1|NOT COMPLETED|At 3 Years Clinical Follow-up||11
7604252|NCT02513719|18720511|P1|COMPLETED|At 3 Years Clinical Follow-up||289
7604253|NCT02513719|18720511|P1|STARTED|At 3 Years Clinical Follow-up||300
7604254|NCT02513719|18720511|P1|NOT COMPLETED|At 2 Years Clinical Follow-up||5
7604255|NCT02513719|18720511|P1|COMPLETED|At 2 Years Clinical Follow-up||300
7604256|NCT02513719|18720511|P1|STARTED|At 2 Years Clinical Follow-up||305
7604257|NCT02513719|18720511|P1|NOT COMPLETED|At 1 Year Clinical Follow-up||7
7604258|NCT02513719|18720511|P1|COMPLETED|At 1 Year Clinical Follow-up||305
7604259|NCT02513719|18720511|P1|STARTED|At 1 Year Clinical Follow-up||312
7604260|NCT02513719|18720511|P1|NOT COMPLETED|At 8 Months Clinical Follow-up||0
7604261|NCT02513719|18720511|P1|COMPLETED|At 8 Months Clinical Follow-up||312
7604262|NCT02513719|18720511|P1|STARTED|At 8 Months Clinical Follow-up||312
7604263|NCT02513641|18720611|P1|NOT COMPLETED|Overall Study||0
7604264|NCT02513641|18720611|P1|COMPLETED|Overall Study||8
7604265|NCT02513641|18720611|P1|STARTED|Overall Study||8
7604266|NCT02513550|18720625|P6|NOT COMPLETED|Post-Treatment Follow-up Period||0
7604267|NCT02513550|18720626|P5|NOT COMPLETED|Post-Treatment Follow-up Period||0
7604268|NCT02513550|18720627|P4|NOT COMPLETED|Post-Treatment Follow-up Period||0
7604269|NCT02513550|18720628|P3|NOT COMPLETED|Post-Treatment Follow-up Period||63
7604270|NCT02513550|18720629|P2|NOT COMPLETED|Post-Treatment Follow-up Period||39
7604271|NCT02513550|18720630|P1|NOT COMPLETED|Post-Treatment Follow-up Period||31
7604272|NCT02513550|18720625|P6|COMPLETED|Post-Treatment Follow-up Period||15
7604273|NCT02513550|18720626|P5|COMPLETED|Post-Treatment Follow-up Period||4
7604274|NCT02513550|18720627|P4|COMPLETED|Post-Treatment Follow-up Period||9
7604275|NCT02513550|18720628|P3|COMPLETED|Post-Treatment Follow-up Period||496
7604276|NCT02513550|18720629|P2|COMPLETED|Post-Treatment Follow-up Period||244
7604277|NCT02513550|18720630|P1|COMPLETED|Post-Treatment Follow-up Period||254
7604278|NCT02513550|18720625|P6|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|15
7604279|NCT02513550|18720626|P5|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|4
7604280|NCT02513550|18720627|P4|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|9
7604281|NCT02513550|18720628|P3|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|559
7604282|NCT02513550|18720629|P2|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|283
7604283|NCT02513550|18720630|P1|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|285
7604284|NCT02513550|18720625|P6|NOT COMPLETED|Double Blind Treatment Period||1
7604285|NCT02513550|18720626|P5|NOT COMPLETED|Double Blind Treatment Period||1
7604286|NCT02513550|18720627|P4|NOT COMPLETED|Double Blind Treatment Period||0
7604287|NCT02513550|18720628|P3|NOT COMPLETED|Double Blind Treatment Period||74
7604288|NCT02513550|18720629|P2|NOT COMPLETED|Double Blind Treatment Period||38
7604289|NCT02513550|18720630|P1|NOT COMPLETED|Double Blind Treatment Period||36
7604290|NCT02513550|18720625|P6|COMPLETED|Double Blind Treatment Period||15
7604291|NCT02513550|18720626|P5|COMPLETED|Double Blind Treatment Period||4
7604292|NCT02513550|18720627|P4|COMPLETED|Double Blind Treatment Period||9
7604293|NCT02513550|18720628|P3|COMPLETED|Double Blind Treatment Period||537
7604294|NCT02513550|18720629|P2|COMPLETED|Double Blind Treatment Period||268
7604295|NCT02513550|18720630|P1|COMPLETED|Double Blind Treatment Period||274
7604296|NCT02513550|18720625|P6|Received at Least One Dose of Study Drug|Double Blind Treatment Period||16
7604297|NCT02513550|18720626|P5|Received at Least One Dose of Study Drug|Double Blind Treatment Period||5
7604298|NCT02513550|18720627|P4|Received at Least One Dose of Study Drug|Double Blind Treatment Period||9
7604299|NCT02513550|18720628|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Period||609
7604300|NCT02513550|18720629|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Period||306
7604301|NCT02513550|18720630|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Period||310
7604302|NCT02513550|18720625|P6|STARTED|Double Blind Treatment Period||16
7604303|NCT02513550|18720626|P5|STARTED|Double Blind Treatment Period||5
7604304|NCT02513550|18720627|P4|STARTED|Double Blind Treatment Period||9
7604305|NCT02513550|18720628|P3|STARTED|Double Blind Treatment Period||611
7604306|NCT02513550|18720629|P2|STARTED|Double Blind Treatment Period||306
7604307|NCT02513550|18720630|P1|STARTED|Double Blind Treatment Period||310
7604308|NCT02513498|18720702|P1|NOT COMPLETED|Overall Study||24
7604309|NCT02513498|18720702|P1|COMPLETED|Overall Study||26
7604310|NCT02513498|18720702|P1|STARTED|Overall Study||50
7604311|NCT02513472|18720724|P2|NOT COMPLETED|Overall Study||93
7604312|NCT02513472|18720725|P1|NOT COMPLETED|Overall Study||65
7604313|NCT02513472|18720724|P2|COMPLETED|Overall Study|Treatment ongoing at data cutoff.|8
7604314|NCT02513472|18720725|P1|COMPLETED|Overall Study|Treatment ongoing at data cutoff.|1
7604315|NCT02513472|18720724|P2|Phase 2|Overall Study||97
7604316|NCT02513472|18720725|P1|Phase 2|Overall Study||63
7604317|NCT02513472|18720724|P2|Phase 1b Safety run-in|Overall Study||4
7604318|NCT02513472|18720725|P1|Phase 1b Safety run-in|Overall Study||3
7604319|NCT02513472|18720724|P2|STARTED|Overall Study||101
7604320|NCT02513472|18720725|P1|STARTED|Overall Study||66
7604321|NCT02513459|18720760|P1|NOT COMPLETED|Overall Study||21
7604322|NCT02513459|18720760|P1|COMPLETED|Overall Study||44
7604323|NCT02513459|18720760|P1|STARTED|Overall Study||65
7604324|NCT02513446|18720801|P2|NOT COMPLETED|Period 2||0
7604325|NCT02513446|18720802|P1|NOT COMPLETED|Period 2||0
7604326|NCT02513446|18720801|P2|COMPLETED|Period 2||8
7604327|NCT02513446|18720802|P1|COMPLETED|Period 2||8
7604328|NCT02513446|18720801|P2|STARTED|Period 2||8
7604329|NCT02513446|18720802|P1|STARTED|Period 2||8
7604330|NCT02513446|18720801|P2|NOT COMPLETED|Washout Period of 10 Days||0
7604331|NCT02513446|18720802|P1|NOT COMPLETED|Washout Period of 10 Days||0
7604332|NCT02513446|18720801|P2|COMPLETED|Washout Period of 10 Days||8
7604333|NCT02513446|18720802|P1|COMPLETED|Washout Period of 10 Days||8
7604334|NCT02513446|18720801|P2|STARTED|Washout Period of 10 Days||8
7604335|NCT02513446|18720802|P1|STARTED|Washout Period of 10 Days||8
7604336|NCT02513446|18720801|P2|NOT COMPLETED|Period 1||0
7604337|NCT02513446|18720802|P1|NOT COMPLETED|Period 1||0
7604338|NCT02513446|18720801|P2|COMPLETED|Period 1||8
7604339|NCT02513446|18720802|P1|COMPLETED|Period 1||8
7604340|NCT02513446|18720801|P2|STARTED|Period 1||8
7604341|NCT02513446|18720802|P1|STARTED|Period 1||8
7604342|NCT02513212|18720815|P2|NOT COMPLETED|Overall Study||0
7604343|NCT02513212|18720816|P1|NOT COMPLETED|Overall Study||1
7604344|NCT02513212|18720815|P2|COMPLETED|Overall Study||12
7604345|NCT02513212|18720816|P1|COMPLETED|Overall Study||11
7604346|NCT02513212|18720815|P2|STARTED|Overall Study||12
7604347|NCT02513212|18720816|P1|STARTED|Overall Study||12
7604348|NCT02513160|18720828|P4|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||2
7604349|NCT02513160|18720829|P3|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||1
7604350|NCT02513160|18720830|P2|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||4
7604351|NCT02513160|18720831|P1|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||6
7604352|NCT02513160|18720828|P4|COMPLETED|Treatment Period (Day 0 to Week 6)||103
7604353|NCT02513160|18720829|P3|COMPLETED|Treatment Period (Day 0 to Week 6)||104
7604354|NCT02513160|18720830|P2|COMPLETED|Treatment Period (Day 0 to Week 6)||104
7604355|NCT02513160|18720831|P1|COMPLETED|Treatment Period (Day 0 to Week 6)||101
7604356|NCT02513160|18720828|P4|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
7604357|NCT02513160|18720829|P3|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
7604358|NCT02513160|18720830|P2|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|108
7604359|NCT02513160|18720831|P1|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|107
7604360|NCT02513160|18720828|P4|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
7604361|NCT02513160|18720829|P3|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
7604362|NCT02513160|18720830|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
7604363|NCT02513160|18720831|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||288
7604364|NCT02513160|18720828|P4|COMPLETED|Run-In Period (Days -14 to Day -1)||0
7604365|NCT02513160|18720829|P3|COMPLETED|Run-In Period (Days -14 to Day -1)||0
7604366|NCT02513160|18720830|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||0
7604367|NCT02513160|18720831|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||425
7604368|NCT02513160|18720828|P4|STARTED|Run-In Period (Days -14 to Day -1)||0
7604369|NCT02513160|18720829|P3|STARTED|Run-In Period (Days -14 to Day -1)||0
7604370|NCT02513160|18720830|P2|STARTED|Run-In Period (Days -14 to Day -1)||0
7604371|NCT02513160|18720831|P1|STARTED|Run-In Period (Days -14 to Day -1)|Enrolled|713
7604372|NCT02513121|18720868|P2|NOT COMPLETED|Overall Study||0
7604373|NCT02513121|18720869|P1|NOT COMPLETED|Overall Study||0
7604374|NCT02513121|18720868|P2|COMPLETED|Overall Study||20
7604375|NCT02513121|18720869|P1|COMPLETED|Overall Study||20
7604376|NCT02513121|18720868|P2|STARTED|Overall Study||20
7604377|NCT02513121|18720869|P1|STARTED|Overall Study||20
7604378|NCT02513095|18720889|P2|NOT COMPLETED|Overall Study||16
7604379|NCT02513095|18720890|P1|NOT COMPLETED|Overall Study||14
7604380|NCT02513095|18720889|P2|COMPLETED|Overall Study||1
7604381|NCT02513095|18720890|P1|COMPLETED|Overall Study||3
7604382|NCT02513095|18720889|P2|STARTED|Overall Study||17
7604383|NCT02513095|18720890|P1|STARTED|Overall Study||17
7604384|NCT02512900|18720898|P2|NOT COMPLETED|Overall Study||0
7604385|NCT02512900|18720899|P1|NOT COMPLETED|Overall Study||0
7604386|NCT02512900|18720898|P2|COMPLETED|Overall Study||10
7604387|NCT02512900|18720899|P1|COMPLETED|Overall Study||11
7604388|NCT02512900|18720898|P2|STARTED|Overall Study||10
7604389|NCT02512900|18720899|P1|STARTED|Overall Study||11
7604390|NCT02512874|18720930|P1|NOT COMPLETED|Overall Study||2
7604391|NCT02512874|18720930|P1|COMPLETED|Overall Study||63
7604392|NCT02512874|18720930|P1|STARTED|Overall Study||65
7604393|NCT02512861|18720941|P2|NOT COMPLETED|Overall Study||9
7604394|NCT02512861|18720942|P1|NOT COMPLETED|Overall Study||6
7604395|NCT02512861|18720941|P2|COMPLETED|Overall Study||40
7604396|NCT02512861|18720942|P1|COMPLETED|Overall Study||38
7604397|NCT02512861|18720941|P2|STARTED|Overall Study||49
7604398|NCT02512861|18720942|P1|STARTED|Overall Study||44
7604399|NCT02512809|18720963|P1|NOT COMPLETED|Overall Study||0
7604400|NCT02512809|18720963|P1|COMPLETED|Overall Study||25
7604401|NCT02512809|18720963|P1|STARTED|Overall Study||25
7604402|NCT02512783|18720969|P2|NOT COMPLETED|Overall Study||0
7604403|NCT02512783|18720970|P1|NOT COMPLETED|Overall Study||0
7604404|NCT02512783|18720969|P2|COMPLETED|Overall Study||75
7604405|NCT02512783|18720970|P1|COMPLETED|Overall Study||96
7604406|NCT02512783|18720969|P2|STARTED|Overall Study||75
7604407|NCT02512783|18720970|P1|STARTED|Overall Study||96
7604408|NCT02512679|18720978|P2|NOT COMPLETED|Overall Study||0
7604409|NCT02512679|18720979|P1|NOT COMPLETED|Overall Study||0
7604410|NCT02512679|18720978|P2|COMPLETED|Overall Study||0
7604411|NCT02512679|18720979|P1|COMPLETED|Overall Study||20
7604412|NCT02512679|18720978|P2|STARTED|Overall Study||0
7604413|NCT02512679|18720979|P1|STARTED|Overall Study||20
7604414|NCT02512575|18720997|P10|NOT COMPLETED|Overall Study||0
7604415|NCT02512575|18720998|P9|NOT COMPLETED|Overall Study||0
7604416|NCT02512575|18720999|P8|NOT COMPLETED|Overall Study||0
7604417|NCT02512575|18721000|P7|NOT COMPLETED|Overall Study||0
7604418|NCT02512575|18721001|P6|NOT COMPLETED|Overall Study||0
7604419|NCT02512575|18721002|P5|NOT COMPLETED|Overall Study||0
7604420|NCT02512575|18721003|P4|NOT COMPLETED|Overall Study||0
7604421|NCT02512575|18721004|P3|NOT COMPLETED|Overall Study||0
7604422|NCT02512575|18721005|P2|NOT COMPLETED|Overall Study||0
7604423|NCT02512575|18721006|P1|NOT COMPLETED|Overall Study||0
7604424|NCT02512575|18720997|P10|COMPLETED|Overall Study||18
7604425|NCT02512575|18720998|P9|COMPLETED|Overall Study||6
7604426|NCT02512575|18720999|P8|COMPLETED|Overall Study||6
7604427|NCT02512575|18721000|P7|COMPLETED|Overall Study||6
7604428|NCT02512575|18721001|P6|COMPLETED|Overall Study||6
7604429|NCT02512575|18721002|P5|COMPLETED|Overall Study||6
7604430|NCT02512575|18721003|P4|COMPLETED|Overall Study||6
7604431|NCT02512575|18721004|P3|COMPLETED|Overall Study||6
7604432|NCT02512575|18721005|P2|COMPLETED|Overall Study||6
7604433|NCT02512575|18721006|P1|COMPLETED|Overall Study||6
7604434|NCT02512575|18720997|P10|STARTED|Overall Study||18
7604435|NCT02512575|18720998|P9|STARTED|Overall Study||6
7604436|NCT02512575|18720999|P8|STARTED|Overall Study||6
7604437|NCT02512575|18721000|P7|STARTED|Overall Study||6
7604438|NCT02512575|18721001|P6|STARTED|Overall Study||6
7604439|NCT02512575|18721002|P5|STARTED|Overall Study||6
7604440|NCT02512575|18721003|P4|STARTED|Overall Study||6
7604441|NCT02512575|18721004|P3|STARTED|Overall Study||6
7604442|NCT02512575|18721005|P2|STARTED|Overall Study||6
7604443|NCT02512575|18721006|P1|STARTED|Overall Study||6
7604444|NCT02512510|18721101|P3|NOT COMPLETED|Overall Study||52
7604445|NCT02512510|18721102|P2|NOT COMPLETED|Overall Study||35
7604446|NCT02512510|18721103|P1|NOT COMPLETED|Overall Study||42
7604447|NCT02512510|18721101|P3|COMPLETED|Overall Study||157
7604448|NCT02512510|18721102|P2|COMPLETED|Overall Study||162
7604449|NCT02512510|18721103|P1|COMPLETED|Overall Study||163
7604450|NCT02512510|18721101|P3|STARTED|Overall Study||209
7604451|NCT02512510|18721102|P2|STARTED|Overall Study||197
7604452|NCT02512510|18721103|P1|STARTED|Overall Study||205
7604453|NCT02512419|18721128|P2|NOT COMPLETED|Overall Study||0
7604454|NCT02512419|18721129|P1|NOT COMPLETED|Overall Study||2
7604455|NCT02512419|18721128|P2|COMPLETED|Overall Study||24
7604456|NCT02512419|18721129|P1|COMPLETED|Overall Study|2 participants became ineligible after enrolling therefore were not included in analysis.|22
7604457|NCT02512419|18721128|P2|STARTED|Overall Study||24
7604458|NCT02512419|18721129|P1|STARTED|Overall Study||24
7604459|NCT02512393|18721139|P2|NOT COMPLETED|Overall Study||0
7604460|NCT02512393|18721140|P1|NOT COMPLETED|Overall Study||1
7604461|NCT02512393|18721139|P2|COMPLETED|Overall Study||20
7604462|NCT02512393|18721140|P1|COMPLETED|Overall Study||20
7604463|NCT02512393|18721139|P2|STARTED|Overall Study||20
7604464|NCT02512393|18721140|P1|STARTED|Overall Study||21
7604465|NCT02512302|18721220|P10|NOT COMPLETED|Period 5||0
7604466|NCT02512302|18721221|P9|NOT COMPLETED|Period 5||0
7604467|NCT02512302|18721222|P8|NOT COMPLETED|Period 5||0
7604468|NCT02512302|18721223|P7|NOT COMPLETED|Period 5||0
7604469|NCT02512302|18721224|P6|NOT COMPLETED|Period 5||0
7604470|NCT02512302|18721225|P5|NOT COMPLETED|Period 5||0
7604471|NCT02512302|18721226|P4|NOT COMPLETED|Period 5||0
7604472|NCT02512302|18721227|P3|NOT COMPLETED|Period 5||0
7604473|NCT02512302|18721228|P2|NOT COMPLETED|Period 5||0
7604474|NCT02512302|18721229|P1|NOT COMPLETED|Period 5||0
7604475|NCT02512302|18721220|P10|COMPLETED|Period 5||2
7604476|NCT02512302|18721221|P9|COMPLETED|Period 5||3
7604477|NCT02512302|18721222|P8|COMPLETED|Period 5||3
7604478|NCT02512302|18721223|P7|COMPLETED|Period 5||1
7604479|NCT02512302|18721224|P6|COMPLETED|Period 5||3
7604480|NCT02512302|18721225|P5|COMPLETED|Period 5||3
7604481|NCT02512302|18721226|P4|COMPLETED|Period 5||3
7604482|NCT02512302|18721227|P3|COMPLETED|Period 5||3
7604483|NCT02512302|18721228|P2|COMPLETED|Period 5||2
7604484|NCT02512302|18721229|P1|COMPLETED|Period 5||3
7604485|NCT02512302|18721220|P10|STARTED|Period 5||2
7604486|NCT02512302|18721221|P9|STARTED|Period 5||3
7604487|NCT02512302|18721222|P8|STARTED|Period 5||3
7604488|NCT02512302|18721223|P7|STARTED|Period 5||1
7604489|NCT02512302|18721224|P6|STARTED|Period 5||3
7604490|NCT02512302|18721225|P5|STARTED|Period 5||3
7604491|NCT02512302|18721226|P4|STARTED|Period 5||3
7604492|NCT02512302|18721227|P3|STARTED|Period 5||3
7604493|NCT02512302|18721228|P2|STARTED|Period 5||2
7604494|NCT02512302|18721229|P1|STARTED|Period 5||3
7604495|NCT02512302|18721220|P10|NOT COMPLETED|Period 4||0
7604496|NCT02512302|18721221|P9|NOT COMPLETED|Period 4||0
7604497|NCT02512302|18721222|P8|NOT COMPLETED|Period 4||0
7604498|NCT02512302|18721223|P7|NOT COMPLETED|Period 4||1
7604499|NCT02512302|18721224|P6|NOT COMPLETED|Period 4||0
7604500|NCT02512302|18721225|P5|NOT COMPLETED|Period 4||0
7604501|NCT02512302|18721226|P4|NOT COMPLETED|Period 4||0
7604502|NCT02512302|18721227|P3|NOT COMPLETED|Period 4||0
7604503|NCT02512302|18721228|P2|NOT COMPLETED|Period 4||0
7604504|NCT02512302|18721229|P1|NOT COMPLETED|Period 4||0
7604505|NCT02512302|18721220|P10|COMPLETED|Period 4||2
7604506|NCT02512302|18721221|P9|COMPLETED|Period 4||3
7604507|NCT02512302|18721222|P8|COMPLETED|Period 4||3
7604508|NCT02512302|18721223|P7|COMPLETED|Period 4||1
7604509|NCT02512302|18721224|P6|COMPLETED|Period 4||3
7604510|NCT02512302|18721225|P5|COMPLETED|Period 4||3
7604511|NCT02512302|18721226|P4|COMPLETED|Period 4||3
7604512|NCT02512302|18721227|P3|COMPLETED|Period 4||3
7604513|NCT02512302|18721228|P2|COMPLETED|Period 4||2
7604514|NCT02512302|18721229|P1|COMPLETED|Period 4||3
7604515|NCT02512302|18721220|P10|STARTED|Period 4||2
7604516|NCT02512302|18721221|P9|STARTED|Period 4||3
7604517|NCT02512302|18721222|P8|STARTED|Period 4||3
7604518|NCT02512302|18721223|P7|STARTED|Period 4||2
7604519|NCT02512302|18721224|P6|STARTED|Period 4||3
7604520|NCT02512302|18721225|P5|STARTED|Period 4||3
7604521|NCT02512302|18721226|P4|STARTED|Period 4||3
7604522|NCT02512302|18721227|P3|STARTED|Period 4||3
7604523|NCT02512302|18721228|P2|STARTED|Period 4||2
7604524|NCT02512302|18721229|P1|STARTED|Period 4||3
7604525|NCT02512302|18721220|P10|NOT COMPLETED|Period 3||0
7604526|NCT02512302|18721221|P9|NOT COMPLETED|Period 3||0
7604527|NCT02512302|18721222|P8|NOT COMPLETED|Period 3||0
7604528|NCT02512302|18721223|P7|NOT COMPLETED|Period 3||0
7604529|NCT02512302|18721224|P6|NOT COMPLETED|Period 3||0
7604530|NCT02512302|18721225|P5|NOT COMPLETED|Period 3||0
7604531|NCT02512302|18721226|P4|NOT COMPLETED|Period 3||0
7604532|NCT02512302|18721227|P3|NOT COMPLETED|Period 3||1
7604533|NCT02512302|18721228|P2|NOT COMPLETED|Period 3||0
7604534|NCT02512302|18721229|P1|NOT COMPLETED|Period 3||0
7604535|NCT02512302|18721220|P10|COMPLETED|Period 3||2
7604536|NCT02512302|18721221|P9|COMPLETED|Period 3||3
7604537|NCT02512302|18721222|P8|COMPLETED|Period 3||3
7604538|NCT02512302|18721223|P7|COMPLETED|Period 3||2
7604539|NCT02512302|18721224|P6|COMPLETED|Period 3||3
7604540|NCT02512302|18721225|P5|COMPLETED|Period 3||3
7604541|NCT02512302|18721226|P4|COMPLETED|Period 3||3
7604542|NCT02512302|18721227|P3|COMPLETED|Period 3||3
7604543|NCT02512302|18721228|P2|COMPLETED|Period 3||2
7604544|NCT02512302|18721229|P1|COMPLETED|Period 3||3
7604545|NCT02512302|18721220|P10|STARTED|Period 3||2
7604546|NCT02512302|18721221|P9|STARTED|Period 3||3
7604547|NCT02512302|18721222|P8|STARTED|Period 3||3
7604548|NCT02512302|18721223|P7|STARTED|Period 3||2
7604549|NCT02512302|18721224|P6|STARTED|Period 3||3
7604550|NCT02512302|18721225|P5|STARTED|Period 3||3
7604551|NCT02512302|18721226|P4|STARTED|Period 3||3
7604552|NCT02512302|18721227|P3|STARTED|Period 3||4
7604553|NCT02512302|18721228|P2|STARTED|Period 3||2
7604554|NCT02512302|18721229|P1|STARTED|Period 3||3
7604555|NCT02512302|18721220|P10|NOT COMPLETED|Period 2||1
7604556|NCT02512302|18721221|P9|NOT COMPLETED|Period 2||0
7604557|NCT02512302|18721222|P8|NOT COMPLETED|Period 2||0
7604558|NCT02512302|18721223|P7|NOT COMPLETED|Period 2||0
7604559|NCT02512302|18721224|P6|NOT COMPLETED|Period 2||0
7604560|NCT02512302|18721225|P5|NOT COMPLETED|Period 2||0
7604561|NCT02512302|18721226|P4|NOT COMPLETED|Period 2||0
7604562|NCT02512302|18721227|P3|NOT COMPLETED|Period 2||0
7604563|NCT02512302|18721228|P2|NOT COMPLETED|Period 2||0
7604564|NCT02512302|18721229|P1|NOT COMPLETED|Period 2||0
7604565|NCT02512302|18721220|P10|COMPLETED|Period 2||2
7604566|NCT02512302|18721221|P9|COMPLETED|Period 2||3
7604567|NCT02512302|18721222|P8|COMPLETED|Period 2||3
7604568|NCT02512302|18721223|P7|COMPLETED|Period 2||2
7604569|NCT02512302|18721224|P6|COMPLETED|Period 2||3
7604570|NCT02512302|18721225|P5|COMPLETED|Period 2||3
7604571|NCT02512302|18721226|P4|COMPLETED|Period 2||3
7604572|NCT02512302|18721227|P3|COMPLETED|Period 2||4
7604573|NCT02512302|18721228|P2|COMPLETED|Period 2||2
7604574|NCT02512302|18721229|P1|COMPLETED|Period 2||3
7604575|NCT02512302|18721220|P10|STARTED|Period 2||3
7604576|NCT02512302|18721221|P9|STARTED|Period 2||3
7604577|NCT02512302|18721222|P8|STARTED|Period 2||3
7604578|NCT02512302|18721223|P7|STARTED|Period 2||2
7604579|NCT02512302|18721224|P6|STARTED|Period 2||3
7604580|NCT02512302|18721225|P5|STARTED|Period 2||3
7604581|NCT02512302|18721226|P4|STARTED|Period 2||3
7604582|NCT02512302|18721227|P3|STARTED|Period 2||4
7604583|NCT02512302|18721228|P2|STARTED|Period 2||2
7604584|NCT02512302|18721229|P1|STARTED|Period 2||3
7604585|NCT02512302|18721220|P10|NOT COMPLETED|Period 1||0
7604586|NCT02512302|18721221|P9|NOT COMPLETED|Period 1||0
7604587|NCT02512302|18721222|P8|NOT COMPLETED|Period 1||0
7604588|NCT02512302|18721223|P7|NOT COMPLETED|Period 1||0
7604589|NCT02512302|18721224|P6|NOT COMPLETED|Period 1||0
7604590|NCT02512302|18721225|P5|NOT COMPLETED|Period 1||0
7604591|NCT02512302|18721226|P4|NOT COMPLETED|Period 1||0
7604592|NCT02512302|18721227|P3|NOT COMPLETED|Period 1||0
7604593|NCT02512302|18721228|P2|NOT COMPLETED|Period 1||1
7604594|NCT02512302|18721229|P1|NOT COMPLETED|Period 1||0
7604595|NCT02512302|18721220|P10|COMPLETED|Period 1||3
7604596|NCT02512302|18721221|P9|COMPLETED|Period 1||3
7604597|NCT02512302|18721222|P8|COMPLETED|Period 1||3
7604598|NCT02512302|18721223|P7|COMPLETED|Period 1||2
7604599|NCT02512302|18721224|P6|COMPLETED|Period 1||3
7604600|NCT02512302|18721225|P5|COMPLETED|Period 1||3
7604601|NCT02512302|18721226|P4|COMPLETED|Period 1||3
7604602|NCT02512302|18721227|P3|COMPLETED|Period 1||4
7604603|NCT02512302|18721228|P2|COMPLETED|Period 1||2
7604604|NCT02512302|18721229|P1|COMPLETED|Period 1||3
7604605|NCT02512302|18721220|P10|STARTED|Period 1||3
7604606|NCT02512302|18721221|P9|STARTED|Period 1||3
7604607|NCT02512302|18721222|P8|STARTED|Period 1||3
7604608|NCT02512302|18721223|P7|STARTED|Period 1||2
7604609|NCT02512302|18721224|P6|STARTED|Period 1||3
7604610|NCT02512302|18721225|P5|STARTED|Period 1||3
7604611|NCT02512302|18721226|P4|STARTED|Period 1||3
7604612|NCT02512302|18721227|P3|STARTED|Period 1||4
7604613|NCT02512302|18721228|P2|STARTED|Period 1||3
7604614|NCT02512302|18721229|P1|STARTED|Period 1||3
7604615|NCT02512276|18721303|P2|NOT COMPLETED|Overall Study||11
7604616|NCT02512276|18721304|P1|NOT COMPLETED|Overall Study||8
7604617|NCT02512276|18721303|P2|COMPLETED|Overall Study||2029
7604618|NCT02512276|18721304|P1|COMPLETED|Overall Study||2030
7604619|NCT02512276|18721303|P2|STARTED|Overall Study||2040
7604620|NCT02512276|18721304|P1|STARTED|Overall Study||2038
7604621|NCT02512224|18721322|P2|NOT COMPLETED|Overall Study||0
7604622|NCT02512224|18721323|P1|NOT COMPLETED|Overall Study||0
7604623|NCT02512224|18721322|P2|COMPLETED|Overall Study||2912
7604624|NCT02512224|18721323|P1|COMPLETED|Overall Study||2912
7604625|NCT02512224|18721322|P2|STARTED|Overall Study||2912
7604626|NCT02512224|18721323|P1|STARTED|Overall Study||2912
7604627|NCT02512094|18721339|P1|NOT COMPLETED|Overall Study||0
7604628|NCT02512094|18721339|P1|COMPLETED|Overall Study||53
7604629|NCT02512094|18721339|P1|STARTED|Overall Study||53
7604630|NCT02512068|18721345|P2|NOT COMPLETED|Overall Study||13
7604631|NCT02512068|18721346|P1|NOT COMPLETED|Overall Study||12
7604632|NCT02512068|18721345|P2|COMPLETED|Overall Study||39
7604633|NCT02512068|18721346|P1|COMPLETED|Overall Study||43
7604634|NCT02512068|18721345|P2|STARTED|Overall Study||52
7604635|NCT02512068|18721346|P1|STARTED|Overall Study||55
7604636|NCT02512042|18721372|P2|NOT COMPLETED|Overall Study||25
7604637|NCT02512042|18721373|P1|NOT COMPLETED|Overall Study||23
7604638|NCT02512042|18721372|P2|COMPLETED|Overall Study||453
7604639|NCT02512042|18721373|P1|COMPLETED|Overall Study||472
7604640|NCT02512042|18721372|P2|STARTED|Overall Study||478
7604641|NCT02512042|18721373|P1|STARTED|Overall Study||495
7604642|NCT02511782|18721382|P3|NOT COMPLETED|Overall Study||0
7604643|NCT02511782|18721383|P2|NOT COMPLETED|Overall Study||0
7604644|NCT02511782|18721384|P1|NOT COMPLETED|Overall Study||1
7604645|NCT02511782|18721382|P3|COMPLETED|Overall Study||10
7604646|NCT02511782|18721383|P2|COMPLETED|Overall Study||2
7604647|NCT02511782|18721384|P1|COMPLETED|Overall Study||50
7604648|NCT02511782|18721382|P3|STARTED|Overall Study||10
7604649|NCT02511782|18721383|P2|STARTED|Overall Study||2
7604650|NCT02511782|18721384|P1|STARTED|Overall Study||51
7604651|NCT02511730|18721394|P2|NOT COMPLETED|Session Reading Session||0
7604652|NCT02511730|18721395|P1|NOT COMPLETED|Session Reading Session||0
7604653|NCT02511730|18721394|P2|COMPLETED|Session Reading Session||50
7604654|NCT02511730|18721395|P1|COMPLETED|Session Reading Session||50
7604655|NCT02511730|18721394|P2|STARTED|Session Reading Session||50
7604656|NCT02511730|18721395|P1|STARTED|Session Reading Session||50
7604657|NCT02511730|18721394|P2|NOT COMPLETED|4 Week Memory Washout Period||0
7604658|NCT02511730|18721395|P1|NOT COMPLETED|4 Week Memory Washout Period||0
7604659|NCT02511730|18721394|P2|COMPLETED|4 Week Memory Washout Period||50
7604660|NCT02511730|18721395|P1|COMPLETED|4 Week Memory Washout Period||50
7604661|NCT02511730|18721394|P2|STARTED|4 Week Memory Washout Period||50
7604662|NCT02511730|18721395|P1|STARTED|4 Week Memory Washout Period||50
7604663|NCT02511730|18721394|P2|NOT COMPLETED|First Reading Session||0
7604664|NCT02511730|18721395|P1|NOT COMPLETED|First Reading Session||0
7604665|NCT02511730|18721394|P2|COMPLETED|First Reading Session||50
7604666|NCT02511730|18721395|P1|COMPLETED|First Reading Session||50
7604667|NCT02511730|18721394|P2|STARTED|First Reading Session||50
7604668|NCT02511730|18721395|P1|STARTED|First Reading Session||50
7604669|NCT02511717|18721403|P2|NOT COMPLETED|Overall Study||0
7604670|NCT02511717|18721404|P1|NOT COMPLETED|Overall Study||2
7604671|NCT02511717|18721403|P2|COMPLETED|Overall Study||10
7604672|NCT02511717|18721404|P1|COMPLETED|Overall Study||8
7604673|NCT02511717|18721403|P2|STARTED|Overall Study||10
7604674|NCT02511717|18721404|P1|STARTED|Overall Study||10
7604675|NCT02511678|18721410|P1|NOT COMPLETED|Overall Study||36
7604676|NCT02511678|18721410|P1|COMPLETED|Overall Study||37
7604677|NCT02511678|18721410|P1|Safety Population|Overall Study|Participants for whom received the complete study cryoablation procedure.|65
7604678|NCT02511678|18721410|P1|Participants Discontinued Pre-Treatment|Overall Study||7
7604679|NCT02511678|18721410|P1|Intent-to-Treat (ITT) Population|Overall Study|Participants for whom cryoablation via Galil Medical cryoablation system was attempted or performed.|66
7604680|NCT02511678|18721410|P1|STARTED|Overall Study||73
7604681|NCT02511587|18721425|P2|NOT COMPLETED|Overall Study||0
7604682|NCT02511587|18721426|P1|NOT COMPLETED|Overall Study||0
7604683|NCT02511587|18721425|P2|COMPLETED|Overall Study||58
7604684|NCT02511587|18721426|P1|COMPLETED|Overall Study||58
7604685|NCT02511587|18721425|P2|STARTED|Overall Study||58
7604686|NCT02511587|18721426|P1|STARTED|Overall Study||58
7604687|NCT02511561|18721439|P3|NOT COMPLETED|Overall Study||0
7604688|NCT02511561|18721440|P2|NOT COMPLETED|Overall Study||0
7604689|NCT02511561|18721441|P1|NOT COMPLETED|Overall Study||0
7604690|NCT02511561|18721439|P3|COMPLETED|Overall Study||25
7604691|NCT02511561|18721440|P2|COMPLETED|Overall Study||25
7604692|NCT02511561|18721441|P1|COMPLETED|Overall Study||25
7604693|NCT02511561|18721439|P3|STARTED|Overall Study||25
7604694|NCT02511561|18721440|P2|STARTED|Overall Study||25
7604695|NCT02511561|18721441|P1|STARTED|Overall Study||25
7604696|NCT02511535|18721467|P3|NOT COMPLETED|Overall Study||0
7604697|NCT02511535|18721468|P2|NOT COMPLETED|Overall Study||0
7604698|NCT02511535|18721469|P1|NOT COMPLETED|Overall Study||0
7604699|NCT02511535|18721467|P3|COMPLETED|Overall Study||49
7604700|NCT02511535|18721468|P2|COMPLETED|Overall Study||21
7604701|NCT02511535|18721469|P1|COMPLETED|Overall Study||49
7604702|NCT02511535|18721467|P3|STARTED|Overall Study||49
7604703|NCT02511535|18721468|P2|STARTED|Overall Study||21
7604704|NCT02511535|18721469|P1|STARTED|Overall Study||49
7604705|NCT02511431|18721492|P6|NOT COMPLETED|Post-treatment Follow-up||0
7604706|NCT02511431|18721493|P5|NOT COMPLETED|Post-treatment Follow-up||0
7604707|NCT02511431|18721494|P4|NOT COMPLETED|Post-treatment Follow-up||0
7604708|NCT02511431|18721495|P3|NOT COMPLETED|Post-treatment Follow-up||0
7604709|NCT02511431|18721496|P2|NOT COMPLETED|Post-treatment Follow-up||0
7604710|NCT02511431|18721497|P1|NOT COMPLETED|Post-treatment Follow-up||0
7604711|NCT02511431|18721492|P6|COMPLETED|Post-treatment Follow-up||2
7604712|NCT02511431|18721493|P5|COMPLETED|Post-treatment Follow-up||3
7604713|NCT02511431|18721494|P4|COMPLETED|Post-treatment Follow-up||3
7604714|NCT02511431|18721495|P3|COMPLETED|Post-treatment Follow-up||3
7604715|NCT02511431|18721496|P2|COMPLETED|Post-treatment Follow-up||4
7604716|NCT02511431|18721497|P1|COMPLETED|Post-treatment Follow-up||4
7604717|NCT02511431|18721492|P6|STARTED|Post-treatment Follow-up||2
7604718|NCT02511431|18721493|P5|STARTED|Post-treatment Follow-up||3
7604719|NCT02511431|18721494|P4|STARTED|Post-treatment Follow-up||3
7604720|NCT02511431|18721495|P3|STARTED|Post-treatment Follow-up||3
7604721|NCT02511431|18721496|P2|STARTED|Post-treatment Follow-up||4
7604722|NCT02511431|18721497|P1|STARTED|Post-treatment Follow-up||4
7604723|NCT02511431|18721492|P6|NOT COMPLETED|Treatment||1
7604724|NCT02511431|18721493|P5|NOT COMPLETED|Treatment||0
7604725|NCT02511431|18721494|P4|NOT COMPLETED|Treatment||0
7604726|NCT02511431|18721495|P3|NOT COMPLETED|Treatment||1
7604727|NCT02511431|18721496|P2|NOT COMPLETED|Treatment||0
7604728|NCT02511431|18721497|P1|NOT COMPLETED|Treatment||0
7604729|NCT02511431|18721492|P6|COMPLETED|Treatment||2
7604730|NCT02511431|18721493|P5|COMPLETED|Treatment||3
7604731|NCT02511431|18721494|P4|COMPLETED|Treatment||3
7604732|NCT02511431|18721495|P3|COMPLETED|Treatment||3
7604733|NCT02511431|18721496|P2|COMPLETED|Treatment||4
7604734|NCT02511431|18721497|P1|COMPLETED|Treatment||4
7604735|NCT02511431|18721492|P6|STARTED|Treatment||3
7604736|NCT02511431|18721493|P5|STARTED|Treatment||3
7604737|NCT02511431|18721494|P4|STARTED|Treatment||3
7604738|NCT02511431|18721495|P3|STARTED|Treatment||4
7604739|NCT02511431|18721496|P2|STARTED|Treatment||4
7604740|NCT02511431|18721497|P1|STARTED|Treatment||4
7604741|NCT02511379|18721518|P1|NOT COMPLETED|Overall Study||0
7604742|NCT02511379|18721518|P1|COMPLETED|Overall Study||14
7604743|NCT02511379|18721518|P1|STARTED|Overall Study||14
7604744|NCT02511184|18721524|P2|NOT COMPLETED|Overall Study||7
7604745|NCT02511184|18721525|P1|NOT COMPLETED|Overall Study||2
7604746|NCT02511184|18721524|P2|COMPLETED|Overall Study||0
7604747|NCT02511184|18721525|P1|COMPLETED|Overall Study||0
7604748|NCT02511184|18721524|P2|STARTED|Overall Study||7
7604749|NCT02511184|18721525|P1|STARTED|Overall Study||2
7604750|NCT02510820|18721575|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
7604751|NCT02510820|18721576|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
7604752|NCT02510820|18721575|P2|COMPLETED|Second Intervention (4 Weeks)||26
7604753|NCT02510820|18721576|P1|COMPLETED|Second Intervention (4 Weeks)||20
7604754|NCT02510820|18721575|P2|STARTED|Second Intervention (4 Weeks)||26
7604755|NCT02510820|18721576|P1|STARTED|Second Intervention (4 Weeks)||21
7604756|NCT02510820|18721575|P2|NOT COMPLETED|Washout (1 Week)||0
7604757|NCT02510820|18721576|P1|NOT COMPLETED|Washout (1 Week)||0
7604758|NCT02510820|18721575|P2|COMPLETED|Washout (1 Week)||26
7604759|NCT02510820|18721576|P1|COMPLETED|Washout (1 Week)||21
7604760|NCT02510820|18721575|P2|STARTED|Washout (1 Week)||26
7604761|NCT02510820|18721576|P1|STARTED|Washout (1 Week)||21
7604762|NCT02510820|18721575|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
7604763|NCT02510820|18721576|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
7604764|NCT02510820|18721575|P2|COMPLETED|First Intervention (4 Weeks)||26
7604765|NCT02510820|18721576|P1|COMPLETED|First Intervention (4 Weeks)||21
7604766|NCT02510820|18721575|P2|STARTED|First Intervention (4 Weeks)||27
7604767|NCT02510820|18721576|P1|STARTED|First Intervention (4 Weeks)||21
7604768|NCT02510664|18721617|P3|NOT COMPLETED|Overall Study||0
7604769|NCT02510664|18721618|P2|NOT COMPLETED|Overall Study||20
7604770|NCT02510664|18721619|P1|NOT COMPLETED|Overall Study||20
7604771|NCT02510664|18721617|P3|COMPLETED|Overall Study||4
7604772|NCT02510664|18721618|P2|COMPLETED|Overall Study||64
7604773|NCT02510664|18721619|P1|COMPLETED|Overall Study||64
7604774|NCT02510664|18721617|P3|STARTED|Overall Study||4
7604775|NCT02510664|18721618|P2|STARTED|Overall Study||84
7604776|NCT02510664|18721619|P1|STARTED|Overall Study||84
7604777|NCT02510144|18721650|P2|NOT COMPLETED|Overall Study||0
7604778|NCT02510144|18721651|P1|NOT COMPLETED|Overall Study||0
7604779|NCT02510144|18721650|P2|COMPLETED|Overall Study||41
7604780|NCT02510144|18721651|P1|COMPLETED|Overall Study||39
7604781|NCT02510144|18721650|P2|STARTED|Overall Study||41
7604782|NCT02510144|18721651|P1|STARTED|Overall Study||39
7604783|NCT02510014|18721661|P2|NOT COMPLETED|Treatment Period||57
7604784|NCT02510014|18721662|P1|NOT COMPLETED|Treatment Period||206
7604785|NCT02510014|18721661|P2|COMPLETED|Treatment Period||200
7604786|NCT02510014|18721662|P1|COMPLETED|Treatment Period||206
7604787|NCT02510014|18721661|P2|STARTED|Treatment Period||257
7604788|NCT02510014|18721662|P1|STARTED|Treatment Period||412
7604789|NCT02510014|18721661|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||10
7604790|NCT02510014|18721662|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||96
7604791|NCT02510014|18721661|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||257
7604792|NCT02510014|18721662|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||412
7604793|NCT02510014|18721661|P2|STARTED|Run-In Period (Days -14 to Day -1)||267
7604794|NCT02510014|18721662|P1|STARTED|Run-In Period (Days -14 to Day -1)||508
7604795|NCT02509936|18721684|P2|NOT COMPLETED|Overall Study||16
7604796|NCT02509936|18721685|P1|NOT COMPLETED|Overall Study||12
7604797|NCT02509936|18721684|P2|COMPLETED|Overall Study||145
7604798|NCT02509936|18721685|P1|COMPLETED|Overall Study||151
7604799|NCT02509936|18721684|P2|STARTED|Overall Study||161
7604800|NCT02509936|18721685|P1|STARTED|Overall Study||163
7604801|NCT02509767|18721711|P2|NOT COMPLETED|Overall Study||41
7604802|NCT02509767|18721712|P1|NOT COMPLETED|Overall Study||44
7604803|NCT02509767|18721711|P2|COMPLETED|Overall Study||159
7604804|NCT02509767|18721712|P1|COMPLETED|Overall Study||157
7604805|NCT02509767|18721711|P2|STARTED|Overall Study||200
7604806|NCT02509767|18721712|P1|STARTED|Overall Study||201
7604807|NCT02509585|18721723|P1|NOT COMPLETED|Overall Study||0
7604808|NCT02509585|18721723|P1|COMPLETED|Overall Study||18
7604809|NCT02509585|18721723|P1|STARTED|Overall Study||18
7604810|NCT02509481|18721738|P2|NOT COMPLETED|Overall Study||0
7604811|NCT02509481|18721739|P1|NOT COMPLETED|Overall Study||0
7604812|NCT02509481|18721738|P2|COMPLETED|Overall Study||1447
7604813|NCT02509481|18721739|P1|COMPLETED|Overall Study||1265
7604814|NCT02509481|18721738|P2|STARTED|Overall Study||1447
7604815|NCT02509481|18721739|P1|STARTED|Overall Study||1265
7604816|NCT02509156|18721757|P2|NOT COMPLETED|Randomized Phase||1
7604817|NCT02509156|18721758|P1|NOT COMPLETED|Randomized Phase||2
7604818|NCT02509156|18721757|P2|COMPLETED|Randomized Phase||16
7604819|NCT02509156|18721758|P1|COMPLETED|Randomized Phase||12
7604820|NCT02509156|18721757|P2|STARTED|Randomized Phase||17
7604821|NCT02509156|18721758|P1|STARTED|Randomized Phase|Includes randomized participants only|14
7604822|NCT02509156|18721757|P2|NOT COMPLETED|Open-Label Lead-In Phase||0
7604823|NCT02509156|18721758|P1|NOT COMPLETED|Open-Label Lead-In Phase||0
7604824|NCT02509156|18721757|P2|COMPLETED|Open-Label Lead-In Phase||0
7604825|NCT02509156|18721758|P1|COMPLETED|Open-Label Lead-In Phase||6
7604826|NCT02509156|18721757|P2|STARTED|Open-Label Lead-In Phase||0
7604827|NCT02509156|18721758|P1|STARTED|Open-Label Lead-In Phase||6
7604828|NCT02509117|18721828|P10|NOT COMPLETED|Period 4 -Part A: 4 Days||0
7604829|NCT02509117|18721829|P9|NOT COMPLETED|Period 4 -Part A: 4 Days||0
7604830|NCT02509117|18721830|P8|NOT COMPLETED|Period 4 -Part A: 4 Days||0
7604831|NCT02509117|18721831|P7|NOT COMPLETED|Period 4 -Part A: 4 Days||0
7604832|NCT02509117|18721832|P6|NOT COMPLETED|Period 4 -Part A: 4 Days||0
7604833|NCT02509117|18721833|P5|NOT COMPLETED|Period 4 -Part A: 4 Days||0
7604834|NCT02509117|18721834|P4|NOT COMPLETED|Period 4 -Part A: 4 Days||0
7604835|NCT02509117|18721835|P3|NOT COMPLETED|Period 4 -Part A: 4 Days||0
7604836|NCT02509117|18721836|P2|NOT COMPLETED|Period 4 -Part A: 4 Days||0
7604837|NCT02509117|18721837|P1|NOT COMPLETED|Period 4 -Part A: 4 Days||0
7604838|NCT02509117|18721828|P10|COMPLETED|Period 4 -Part A: 4 Days||0
7604839|NCT02509117|18721829|P9|COMPLETED|Period 4 -Part A: 4 Days||0
7604840|NCT02509117|18721830|P8|COMPLETED|Period 4 -Part A: 4 Days||0
7604841|NCT02509117|18721831|P7|COMPLETED|Period 4 -Part A: 4 Days||0
7604842|NCT02509117|18721832|P6|COMPLETED|Period 4 -Part A: 4 Days||0
7604843|NCT02509117|18721833|P5|COMPLETED|Period 4 -Part A: 4 Days||0
7604844|NCT02509117|18721834|P4|COMPLETED|Period 4 -Part A: 4 Days||2
7604845|NCT02509117|18721835|P3|COMPLETED|Period 4 -Part A: 4 Days||2
7604846|NCT02509117|18721836|P2|COMPLETED|Period 4 -Part A: 4 Days||2
7604847|NCT02509117|18721837|P1|COMPLETED|Period 4 -Part A: 4 Days||2
7604848|NCT02509117|18721828|P10|STARTED|Period 4 -Part A: 4 Days||0
7604849|NCT02509117|18721829|P9|STARTED|Period 4 -Part A: 4 Days||0
7604850|NCT02509117|18721830|P8|STARTED|Period 4 -Part A: 4 Days||0
7604851|NCT02509117|18721831|P7|STARTED|Period 4 -Part A: 4 Days||0
7604852|NCT02509117|18721832|P6|STARTED|Period 4 -Part A: 4 Days||0
7604853|NCT02509117|18721833|P5|STARTED|Period 4 -Part A: 4 Days||0
7604854|NCT02509117|18721834|P4|STARTED|Period 4 -Part A: 4 Days||2
7604855|NCT02509117|18721835|P3|STARTED|Period 4 -Part A: 4 Days||2
7604856|NCT02509117|18721836|P2|STARTED|Period 4 -Part A: 4 Days||2
7604857|NCT02509117|18721837|P1|STARTED|Period 4 -Part A: 4 Days||2
7604858|NCT02509117|18721828|P10|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
7604859|NCT02509117|18721829|P9|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
7604860|NCT02509117|18721830|P8|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
7604861|NCT02509117|18721831|P7|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
7604862|NCT02509117|18721832|P6|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
7604863|NCT02509117|18721833|P5|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
7604864|NCT02509117|18721834|P4|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
7604865|NCT02509117|18721835|P3|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
7604866|NCT02509117|18721836|P2|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
7604867|NCT02509117|18721837|P1|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
7604868|NCT02509117|18721828|P10|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
7604869|NCT02509117|18721829|P9|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
7604870|NCT02509117|18721830|P8|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
7604871|NCT02509117|18721831|P7|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
7604872|NCT02509117|18721832|P6|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
7604873|NCT02509117|18721833|P5|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
7604874|NCT02509117|18721834|P4|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
7604875|NCT02509117|18721835|P3|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
7604876|NCT02509117|18721836|P2|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
7604877|NCT02509117|18721837|P1|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
7604878|NCT02509117|18721828|P10|STARTED|Washout Period 3 (Part A: 7 Days)||0
7604879|NCT02509117|18721829|P9|STARTED|Washout Period 3 (Part A: 7 Days)||0
7604880|NCT02509117|18721830|P8|STARTED|Washout Period 3 (Part A: 7 Days)||0
7604881|NCT02509117|18721831|P7|STARTED|Washout Period 3 (Part A: 7 Days)||0
7604882|NCT02509117|18721832|P6|STARTED|Washout Period 3 (Part A: 7 Days)||0
7604883|NCT02509117|18721833|P5|STARTED|Washout Period 3 (Part A: 7 Days)||0
7604884|NCT02509117|18721834|P4|STARTED|Washout Period 3 (Part A: 7 Days)||2
7604885|NCT02509117|18721835|P3|STARTED|Washout Period 3 (Part A: 7 Days)||2
7604886|NCT02509117|18721836|P2|STARTED|Washout Period 3 (Part A: 7 Days)||2
7604887|NCT02509117|18721837|P1|STARTED|Washout Period 3 (Part A: 7 Days)||2
7604888|NCT02509117|18721828|P10|NOT COMPLETED|Period 3 -Part A: 4 Days||0
7604889|NCT02509117|18721829|P9|NOT COMPLETED|Period 3 -Part A: 4 Days||0
7604890|NCT02509117|18721830|P8|NOT COMPLETED|Period 3 -Part A: 4 Days||0
7604891|NCT02509117|18721831|P7|NOT COMPLETED|Period 3 -Part A: 4 Days||0
7604892|NCT02509117|18721832|P6|NOT COMPLETED|Period 3 -Part A: 4 Days||0
7604893|NCT02509117|18721833|P5|NOT COMPLETED|Period 3 -Part A: 4 Days||0
7604894|NCT02509117|18721834|P4|NOT COMPLETED|Period 3 -Part A: 4 Days||0
7604895|NCT02509117|18721835|P3|NOT COMPLETED|Period 3 -Part A: 4 Days||0
7604896|NCT02509117|18721836|P2|NOT COMPLETED|Period 3 -Part A: 4 Days||0
7604897|NCT02509117|18721837|P1|NOT COMPLETED|Period 3 -Part A: 4 Days||0
7604898|NCT02509117|18721828|P10|COMPLETED|Period 3 -Part A: 4 Days||0
7604899|NCT02509117|18721829|P9|COMPLETED|Period 3 -Part A: 4 Days||0
7604900|NCT02509117|18721830|P8|COMPLETED|Period 3 -Part A: 4 Days||0
7604901|NCT02509117|18721831|P7|COMPLETED|Period 3 -Part A: 4 Days||0
7604902|NCT02509117|18721832|P6|COMPLETED|Period 3 -Part A: 4 Days||0
7604903|NCT02509117|18721833|P5|COMPLETED|Period 3 -Part A: 4 Days||0
7604904|NCT02509117|18721834|P4|COMPLETED|Period 3 -Part A: 4 Days||2
7604905|NCT02509117|18721835|P3|COMPLETED|Period 3 -Part A: 4 Days||2
7604906|NCT02509117|18721836|P2|COMPLETED|Period 3 -Part A: 4 Days||2
7604907|NCT02509117|18721837|P1|COMPLETED|Period 3 -Part A: 4 Days||2
7604908|NCT02509117|18721828|P10|STARTED|Period 3 -Part A: 4 Days||0
7604909|NCT02509117|18721829|P9|STARTED|Period 3 -Part A: 4 Days||0
7604910|NCT02509117|18721830|P8|STARTED|Period 3 -Part A: 4 Days||0
7604911|NCT02509117|18721831|P7|STARTED|Period 3 -Part A: 4 Days||0
7604912|NCT02509117|18721832|P6|STARTED|Period 3 -Part A: 4 Days||0
7604913|NCT02509117|18721833|P5|STARTED|Period 3 -Part A: 4 Days||0
7604914|NCT02509117|18721834|P4|STARTED|Period 3 -Part A: 4 Days||2
7604915|NCT02509117|18721835|P3|STARTED|Period 3 -Part A: 4 Days||2
7604916|NCT02509117|18721836|P2|STARTED|Period 3 -Part A: 4 Days||2
7604917|NCT02509117|18721837|P1|STARTED|Period 3 -Part A: 4 Days||2
7604918|NCT02509117|18721828|P10|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
7604919|NCT02509117|18721829|P9|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
7604920|NCT02509117|18721830|P8|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
7604921|NCT02509117|18721831|P7|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
7604922|NCT02509117|18721832|P6|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
7604923|NCT02509117|18721833|P5|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
7604924|NCT02509117|18721834|P4|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
7604925|NCT02509117|18721835|P3|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
7604926|NCT02509117|18721836|P2|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
7604927|NCT02509117|18721837|P1|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
7604928|NCT02509117|18721828|P10|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
7604929|NCT02509117|18721829|P9|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
7604930|NCT02509117|18721830|P8|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
7604931|NCT02509117|18721831|P7|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
7604932|NCT02509117|18721832|P6|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
7604933|NCT02509117|18721833|P5|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
7604934|NCT02509117|18721834|P4|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
7604935|NCT02509117|18721835|P3|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
7604936|NCT02509117|18721836|P2|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
7604937|NCT02509117|18721837|P1|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
7604938|NCT02509117|18721828|P10|STARTED|Washout Period 2 (Part A: 7 Days)||0
7604939|NCT02509117|18721829|P9|STARTED|Washout Period 2 (Part A: 7 Days)||0
7604940|NCT02509117|18721830|P8|STARTED|Washout Period 2 (Part A: 7 Days)||0
7604941|NCT02509117|18721831|P7|STARTED|Washout Period 2 (Part A: 7 Days)||0
7604942|NCT02509117|18721832|P6|STARTED|Washout Period 2 (Part A: 7 Days)||0
7604943|NCT02509117|18721833|P5|STARTED|Washout Period 2 (Part A: 7 Days)||0
7604944|NCT02509117|18721834|P4|STARTED|Washout Period 2 (Part A: 7 Days)||2
7604945|NCT02509117|18721835|P3|STARTED|Washout Period 2 (Part A: 7 Days)||2
7604946|NCT02509117|18721836|P2|STARTED|Washout Period 2 (Part A: 7 Days)||2
7604947|NCT02509117|18721837|P1|STARTED|Washout Period 2 (Part A: 7 Days)||2
7604948|NCT02509117|18721828|P10|NOT COMPLETED|Period 2 -Part A: 4 Days||0
7604949|NCT02509117|18721829|P9|NOT COMPLETED|Period 2 -Part A: 4 Days||0
7604950|NCT02509117|18721830|P8|NOT COMPLETED|Period 2 -Part A: 4 Days||0
7604951|NCT02509117|18721831|P7|NOT COMPLETED|Period 2 -Part A: 4 Days||0
7604952|NCT02509117|18721832|P6|NOT COMPLETED|Period 2 -Part A: 4 Days||0
7604953|NCT02509117|18721833|P5|NOT COMPLETED|Period 2 -Part A: 4 Days||0
7604954|NCT02509117|18721834|P4|NOT COMPLETED|Period 2 -Part A: 4 Days||0
7604955|NCT02509117|18721835|P3|NOT COMPLETED|Period 2 -Part A: 4 Days||0
7604956|NCT02509117|18721836|P2|NOT COMPLETED|Period 2 -Part A: 4 Days||0
7604957|NCT02509117|18721837|P1|NOT COMPLETED|Period 2 -Part A: 4 Days||0
7604958|NCT02509117|18721828|P10|COMPLETED|Period 2 -Part A: 4 Days||0
7604959|NCT02509117|18721829|P9|COMPLETED|Period 2 -Part A: 4 Days||0
7604960|NCT02509117|18721830|P8|COMPLETED|Period 2 -Part A: 4 Days||0
7604961|NCT02509117|18721831|P7|COMPLETED|Period 2 -Part A: 4 Days||0
7604962|NCT02509117|18721832|P6|COMPLETED|Period 2 -Part A: 4 Days||0
7604963|NCT02509117|18721833|P5|COMPLETED|Period 2 -Part A: 4 Days||0
7604964|NCT02509117|18721834|P4|COMPLETED|Period 2 -Part A: 4 Days||2
7604965|NCT02509117|18721835|P3|COMPLETED|Period 2 -Part A: 4 Days||2
7604966|NCT02509117|18721836|P2|COMPLETED|Period 2 -Part A: 4 Days||2
7604967|NCT02509117|18721837|P1|COMPLETED|Period 2 -Part A: 4 Days||2
7604968|NCT02509117|18721828|P10|Treated|Period 2 -Part A: 4 Days||0
7604969|NCT02509117|18721829|P9|Treated|Period 2 -Part A: 4 Days||0
7604970|NCT02509117|18721830|P8|Treated|Period 2 -Part A: 4 Days||0
7604971|NCT02509117|18721831|P7|Treated|Period 2 -Part A: 4 Days||0
7604972|NCT02509117|18721832|P6|Treated|Period 2 -Part A: 4 Days||0
7604973|NCT02509117|18721833|P5|Treated|Period 2 -Part A: 4 Days||0
7604974|NCT02509117|18721834|P4|Treated|Period 2 -Part A: 4 Days||2
7604975|NCT02509117|18721835|P3|Treated|Period 2 -Part A: 4 Days||2
7604976|NCT02509117|18721836|P2|Treated|Period 2 -Part A: 4 Days||2
7604977|NCT02509117|18721837|P1|Treated|Period 2 -Part A: 4 Days||2
7604978|NCT02509117|18721828|P10|STARTED|Period 2 -Part A: 4 Days||0
7604979|NCT02509117|18721829|P9|STARTED|Period 2 -Part A: 4 Days||0
7604980|NCT02509117|18721830|P8|STARTED|Period 2 -Part A: 4 Days||0
7604981|NCT02509117|18721831|P7|STARTED|Period 2 -Part A: 4 Days||0
7604982|NCT02509117|18721832|P6|STARTED|Period 2 -Part A: 4 Days||0
7604983|NCT02509117|18721833|P5|STARTED|Period 2 -Part A: 4 Days||0
7604984|NCT02509117|18721834|P4|STARTED|Period 2 -Part A: 4 Days||2
7604985|NCT02509117|18721835|P3|STARTED|Period 2 -Part A: 4 Days||2
7604986|NCT02509117|18721836|P2|STARTED|Period 2 -Part A: 4 Days|1 participant was added in intervention period 2|2
7604987|NCT02509117|18721837|P1|STARTED|Period 2 -Part A: 4 Days||2
7604988|NCT02509117|18721828|P10|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
7604989|NCT02509117|18721829|P9|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
7604990|NCT02509117|18721830|P8|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
7604991|NCT02509117|18721831|P7|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
7604992|NCT02509117|18721832|P6|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
7604993|NCT02509117|18721833|P5|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
7604994|NCT02509117|18721834|P4|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
7604995|NCT02509117|18721835|P3|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
7604996|NCT02509117|18721836|P2|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
7604997|NCT02509117|18721837|P1|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
7604998|NCT02509117|18721828|P10|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
7604999|NCT02509117|18721829|P9|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
7605000|NCT02509117|18721830|P8|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
7605001|NCT02509117|18721831|P7|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
7605002|NCT02509117|18721832|P6|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
7605003|NCT02509117|18721833|P5|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
7605004|NCT02509117|18721834|P4|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
7605005|NCT02509117|18721835|P3|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
7605006|NCT02509117|18721836|P2|COMPLETED|Washout Period 1 (Part A: 7 Days)||1
7605007|NCT02509117|18721837|P1|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
7605008|NCT02509117|18721828|P10|STARTED|Washout Period 1 (Part A: 7 Days)||0
7605009|NCT02509117|18721829|P9|STARTED|Washout Period 1 (Part A: 7 Days)||0
7605010|NCT02509117|18721830|P8|STARTED|Washout Period 1 (Part A: 7 Days)||0
7605011|NCT02509117|18721831|P7|STARTED|Washout Period 1 (Part A: 7 Days)||0
7605012|NCT02509117|18721832|P6|STARTED|Washout Period 1 (Part A: 7 Days)||0
7605013|NCT02509117|18721833|P5|STARTED|Washout Period 1 (Part A: 7 Days)||0
7605014|NCT02509117|18721834|P4|STARTED|Washout Period 1 (Part A: 7 Days)||2
7605015|NCT02509117|18721835|P3|STARTED|Washout Period 1 (Part A: 7 Days)||2
7605016|NCT02509117|18721836|P2|STARTED|Washout Period 1 (Part A: 7 Days)||1
7605017|NCT02509117|18721837|P1|STARTED|Washout Period 1 (Part A: 7 Days)||2
7605018|NCT02509117|18721828|P10|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
7605019|NCT02509117|18721829|P9|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
7605020|NCT02509117|18721830|P8|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
7605021|NCT02509117|18721831|P7|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
7605022|NCT02509117|18721832|P6|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
7605023|NCT02509117|18721833|P5|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
7605024|NCT02509117|18721834|P4|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
7605025|NCT02509117|18721835|P3|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
7605026|NCT02509117|18721836|P2|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
7605027|NCT02509117|18721837|P1|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
7605028|NCT02509117|18721828|P10|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
7605029|NCT02509117|18721829|P9|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||4
7605030|NCT02509117|18721830|P8|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
7605031|NCT02509117|18721831|P7|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
7605032|NCT02509117|18721832|P6|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
7605033|NCT02509117|18721833|P5|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
7605034|NCT02509117|18721834|P4|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
7605035|NCT02509117|18721835|P3|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
7605036|NCT02509117|18721836|P2|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
7605037|NCT02509117|18721837|P1|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
7605038|NCT02509117|18721828|P10|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||10
7605039|NCT02509117|18721829|P9|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||4
7605040|NCT02509117|18721830|P8|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
7605041|NCT02509117|18721831|P7|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
7605042|NCT02509117|18721832|P6|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
7605043|NCT02509117|18721833|P5|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
7605044|NCT02509117|18721834|P4|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
7605045|NCT02509117|18721835|P3|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
7605046|NCT02509117|18721836|P2|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||1
7605047|NCT02509117|18721837|P1|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
7605048|NCT02509117|18721828|P10|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||10
7605049|NCT02509117|18721829|P9|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||4
7605050|NCT02509117|18721830|P8|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
7605051|NCT02509117|18721831|P7|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
7605052|NCT02509117|18721832|P6|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
7605053|NCT02509117|18721833|P5|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
7605054|NCT02509117|18721834|P4|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
7605055|NCT02509117|18721835|P3|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
7605056|NCT02509117|18721836|P2|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
7605057|NCT02509117|18721837|P1|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
7605058|NCT02509078|18722048|P2|NOT COMPLETED|Overall Study||1
7605059|NCT02509078|18722049|P1|NOT COMPLETED|Overall Study||1
7605060|NCT02509078|18722048|P2|COMPLETED|Overall Study||505
7605061|NCT02509078|18722049|P1|COMPLETED|Overall Study||501
7605062|NCT02509078|18722048|P2|STARTED|Overall Study||506
7605063|NCT02509078|18722049|P1|STARTED|Overall Study||502
7605064|NCT02509065|18722085|P23|NOT COMPLETED|Overall Study||0
7605065|NCT02509065|18722086|P22|NOT COMPLETED|Overall Study||0
7605066|NCT02509065|18722087|P21|NOT COMPLETED|Overall Study||0
7605067|NCT02509065|18722088|P20|NOT COMPLETED|Overall Study||0
7605068|NCT02509065|18722089|P19|NOT COMPLETED|Overall Study||0
7605069|NCT02509065|18722090|P18|NOT COMPLETED|Overall Study||0
7605070|NCT02509065|18722091|P17|NOT COMPLETED|Overall Study||0
7605071|NCT02509065|18722092|P16|NOT COMPLETED|Overall Study||0
7605072|NCT02509065|18722093|P15|NOT COMPLETED|Overall Study||0
7605073|NCT02509065|18722094|P14|NOT COMPLETED|Overall Study||0
7605074|NCT02509065|18722095|P13|NOT COMPLETED|Overall Study||0
7605075|NCT02509065|18722096|P12|NOT COMPLETED|Overall Study||0
7605076|NCT02509065|18722097|P11|NOT COMPLETED|Overall Study||0
7605077|NCT02509065|18722098|P10|NOT COMPLETED|Overall Study||0
7605078|NCT02509065|18722099|P9|NOT COMPLETED|Overall Study||0
7605079|NCT02509065|18722100|P8|NOT COMPLETED|Overall Study||0
7605080|NCT02509065|18722101|P7|NOT COMPLETED|Overall Study||0
7605081|NCT02509065|18722102|P6|NOT COMPLETED|Overall Study||0
7605082|NCT02509065|18722103|P5|NOT COMPLETED|Overall Study||0
7605083|NCT02509065|18722104|P4|NOT COMPLETED|Overall Study||0
7605084|NCT02509065|18722105|P3|NOT COMPLETED|Overall Study||0
7605085|NCT02509065|18722106|P2|NOT COMPLETED|Overall Study||0
7605086|NCT02509065|18722107|P1|NOT COMPLETED|Overall Study||0
7605087|NCT02509065|18722085|P23|COMPLETED|Overall Study||1
7605088|NCT02509065|18722086|P22|COMPLETED|Overall Study||1
7605089|NCT02509065|18722087|P21|COMPLETED|Overall Study||1
7605090|NCT02509065|18722088|P20|COMPLETED|Overall Study||1
7605091|NCT02509065|18722089|P19|COMPLETED|Overall Study||1
7605092|NCT02509065|18722090|P18|COMPLETED|Overall Study||1
7605093|NCT02509065|18722091|P17|COMPLETED|Overall Study||1
7605094|NCT02509065|18722092|P16|COMPLETED|Overall Study||1
7605095|NCT02509065|18722093|P15|COMPLETED|Overall Study||1
7605096|NCT02509065|18722094|P14|COMPLETED|Overall Study||1
7605097|NCT02509065|18722095|P13|COMPLETED|Overall Study||1
7605098|NCT02509065|18722096|P12|COMPLETED|Overall Study||1
7605099|NCT02509065|18722097|P11|COMPLETED|Overall Study||1
7605100|NCT02509065|18722098|P10|COMPLETED|Overall Study||1
7605101|NCT02509065|18722099|P9|COMPLETED|Overall Study||1
7605102|NCT02509065|18722100|P8|COMPLETED|Overall Study||1
7605103|NCT02509065|18722101|P7|COMPLETED|Overall Study||1
7605104|NCT02509065|18722102|P6|COMPLETED|Overall Study||1
7605105|NCT02509065|18722103|P5|COMPLETED|Overall Study||1
7605106|NCT02509065|18722104|P4|COMPLETED|Overall Study||1
7605107|NCT02509065|18722105|P3|COMPLETED|Overall Study||2
7605108|NCT02509065|18722106|P2|COMPLETED|Overall Study||1
7605109|NCT02509065|18722107|P1|COMPLETED|Overall Study||1
7605110|NCT02509065|18722085|P23|STARTED|Overall Study||1
7605111|NCT02509065|18722086|P22|STARTED|Overall Study||1
7605112|NCT02509065|18722087|P21|STARTED|Overall Study||1
7605113|NCT02509065|18722088|P20|STARTED|Overall Study||1
7605114|NCT02509065|18722089|P19|STARTED|Overall Study||1
7605115|NCT02509065|18722090|P18|STARTED|Overall Study||1
7605116|NCT02509065|18722091|P17|STARTED|Overall Study||1
7605117|NCT02509065|18722092|P16|STARTED|Overall Study||1
7605118|NCT02509065|18722093|P15|STARTED|Overall Study||1
7605119|NCT02509065|18722094|P14|STARTED|Overall Study||1
7605120|NCT02509065|18722095|P13|STARTED|Overall Study||1
7605121|NCT02509065|18722096|P12|STARTED|Overall Study||1
7605122|NCT02509065|18722097|P11|STARTED|Overall Study||1
7605123|NCT02509065|18722098|P10|STARTED|Overall Study||1
7605124|NCT02509065|18722099|P9|STARTED|Overall Study||1
7605125|NCT02509065|18722100|P8|STARTED|Overall Study||1
7605126|NCT02509065|18722101|P7|STARTED|Overall Study||1
7605127|NCT02509065|18722102|P6|STARTED|Overall Study||1
7605128|NCT02509065|18722103|P5|STARTED|Overall Study||1
7605129|NCT02509065|18722104|P4|STARTED|Overall Study||1
7605130|NCT02509065|18722105|P3|STARTED|Overall Study||2
7605131|NCT02509065|18722106|P2|STARTED|Overall Study||1
7605132|NCT02509065|18722107|P1|STARTED|Overall Study||1
7605133|NCT02509026|18722192|P1|NOT COMPLETED|Retreatment Period (12 Weeks)||4
7605134|NCT02509026|18722192|P1|COMPLETED|Retreatment Period (12 Weeks)||84
7605135|NCT02509026|18722192|P1|Treated|Retreatment Period (12 Weeks)||87
7605136|NCT02509026|18722192|P1|STARTED|Retreatment Period (12 Weeks)|Participants who completed Period 2 and achieved ASDAS-ESR>=2.1 were eligible to enter into Period 3|88
7605137|NCT02509026|18722192|P1|NOT COMPLETED|Withdrawal Period (40 Weeks)||7
7605138|NCT02509026|18722192|P1|COMPLETED|Withdrawal Period (40 Weeks)||112
7605139|NCT02509026|18722192|P1|STARTED|Withdrawal Period (40 Weeks)|Participants who completed Period 1 and achieved ASDAS-CRP<1.3 were eligible to enter into Period 2|119
7605140|NCT02509026|18722192|P1|NOT COMPLETED|Induction Period (24 Weeks)||22
7605141|NCT02509026|18722192|P1|COMPLETED|Induction Period (24 Weeks)||188
7605142|NCT02509026|18722192|P1|Treated|Induction Period (24 Weeks)||209
7605143|NCT02509026|18722192|P1|STARTED|Induction Period (24 Weeks)||210
7605144|NCT02508935|18722389|P1|NOT COMPLETED|Overall Study||23
7605145|NCT02508935|18722389|P1|COMPLETED|Overall Study||0
7605146|NCT02508935|18722389|P1|STARTED|Overall Study||23
7605147|NCT02508701|18722405|P4|NOT COMPLETED|Overall Study||3
7605148|NCT02508701|18722406|P3|NOT COMPLETED|Overall Study||5
7605149|NCT02508701|18722407|P2|NOT COMPLETED|Overall Study||5
7605150|NCT02508701|18722408|P1|NOT COMPLETED|Overall Study||9
7605151|NCT02508701|18722405|P4|COMPLETED|Overall Study||1
7605152|NCT02508701|18722406|P3|COMPLETED|Overall Study||0
7605153|NCT02508701|18722407|P2|COMPLETED|Overall Study||1
7605154|NCT02508701|18722408|P1|COMPLETED|Overall Study||0
7605155|NCT02508701|18722405|P4|STARTED|Overall Study||4
7605156|NCT02508701|18722406|P3|STARTED|Overall Study||5
7605157|NCT02508701|18722407|P2|STARTED|Overall Study||6
7605158|NCT02508701|18722408|P1|STARTED|Overall Study||9
7605159|NCT02508480|18722432|P2|NOT COMPLETED|Overall Study||4
7605160|NCT02508480|18722433|P1|NOT COMPLETED|Overall Study||5
7605161|NCT02508480|18722432|P2|COMPLETED|Overall Study||93
7605162|NCT02508480|18722433|P1|COMPLETED|Overall Study||90
7605163|NCT02508480|18722432|P2|Six-Month Follow-Up|Overall Study||86
7605164|NCT02508480|18722433|P1|Six-Month Follow-Up|Overall Study||84
7605165|NCT02508480|18722432|P2|Three Month Follow-up|Overall Study||86
7605166|NCT02508480|18722433|P1|Three Month Follow-up|Overall Study||84
7605167|NCT02508480|18722432|P2|Post-Treatment Assessment|Overall Study||89
7605168|NCT02508480|18722433|P1|Post-Treatment Assessment|Overall Study||87
7605169|NCT02508480|18722432|P2|STARTED|Overall Study||97
7605170|NCT02508480|18722433|P1|STARTED|Overall Study||95
7605171|NCT02508428|18722457|P2|NOT COMPLETED|Overall Study||67
7605172|NCT02508428|18722458|P1|NOT COMPLETED|Overall Study||52
7605173|NCT02508428|18722457|P2|COMPLETED|Overall Study||44
7605174|NCT02508428|18722458|P1|COMPLETED|Overall Study||62
7605175|NCT02508428|18722457|P2|STARTED|Overall Study||111
7605176|NCT02508428|18722458|P1|STARTED|Overall Study||114
7605177|NCT02508259|18722474|P2|NOT COMPLETED|Overall Study||0
7605178|NCT02508259|18722475|P1|NOT COMPLETED|Overall Study||0
7605179|NCT02508259|18722474|P2|COMPLETED|Overall Study||5
7605180|NCT02508259|18722475|P1|COMPLETED|Overall Study||5
7605181|NCT02508259|18722474|P2|STARTED|Overall Study||5
7605182|NCT02508259|18722475|P1|STARTED|Overall Study||5
7605183|NCT02508207|18722493|P2|NOT COMPLETED|Overall Study||0
7605184|NCT02508207|18722494|P1|NOT COMPLETED|Overall Study||0
7605185|NCT02508207|18722493|P2|COMPLETED|Overall Study||27
7605186|NCT02508207|18722494|P1|COMPLETED|Overall Study||7
7605187|NCT02508207|18722493|P2|STARTED|Overall Study||27
7605188|NCT02508207|18722494|P1|STARTED|Overall Study||7
7605189|NCT02508194|18722510|P2|NOT COMPLETED|Overall Study||44
7605190|NCT02508194|18722511|P1|NOT COMPLETED|Overall Study||52
7605191|NCT02508194|18722510|P2|COMPLETED|Overall Study||907
7605192|NCT02508194|18722511|P1|COMPLETED|Overall Study||897
7605193|NCT02508194|18722510|P2|STARTED|Overall Study||951
7605194|NCT02508194|18722511|P1|STARTED|Overall Study||949
7605195|NCT02508116|18722551|P2|NOT COMPLETED|Overall Study||7
7605196|NCT02508116|18722552|P1|NOT COMPLETED|Overall Study||8
7605197|NCT02508116|18722551|P2|COMPLETED|Overall Study||250
7605198|NCT02508116|18722552|P1|COMPLETED|Overall Study||244
7605199|NCT02508116|18722551|P2|Received Intervention as Randomized|Overall Study||255
7605200|NCT02508116|18722552|P1|Received Intervention as Randomized|Overall Study||249
7605201|NCT02508116|18722551|P2|STARTED|Overall Study||257
7605202|NCT02508116|18722552|P1|STARTED|Overall Study||252
7605203|NCT02508103|18722566|P2|NOT COMPLETED|Overall Study||0
7605204|NCT02508103|18722567|P1|NOT COMPLETED|Overall Study||0
7605205|NCT02508103|18722566|P2|COMPLETED|Overall Study||5
7605206|NCT02508103|18722567|P1|COMPLETED|Overall Study||5
7605207|NCT02508103|18722566|P2|STARTED|Overall Study||5
7605208|NCT02508103|18722567|P1|STARTED|Overall Study||5
7605209|NCT02508077|18722575|P1|NOT COMPLETED|Overall Study||0
7605210|NCT02508077|18722575|P1|COMPLETED|Overall Study||1
7605211|NCT02508077|18722575|P1|STARTED|Overall Study||1
7605212|NCT02507973|18722579|P1|NOT COMPLETED|Overall Study||1
7605213|NCT02507973|18722579|P1|COMPLETED|Overall Study||7
7605214|NCT02507973|18722579|P1|STARTED|Overall Study||8
7605215|NCT02507752|18722585|P1|NOT COMPLETED|Overall Study||17
7605216|NCT02507752|18722585|P1|COMPLETED|Overall Study||55
7605217|NCT02507752|18722585|P1|STARTED|Overall Study||72
7605218|NCT02507388|18722605|P2|NOT COMPLETED|Overall Study||0
7605219|NCT02507388|18722606|P1|NOT COMPLETED|Overall Study||0
7605220|NCT02507388|18722605|P2|COMPLETED|Overall Study||25
7605221|NCT02507388|18722606|P1|COMPLETED|Overall Study||25
7605222|NCT02507388|18722605|P2|STARTED|Overall Study||25
7605223|NCT02507388|18722606|P1|STARTED|Overall Study||25
7605224|NCT02507375|18722629|P2|NOT COMPLETED|Overall Study||8
7605225|NCT02507375|18722630|P1|NOT COMPLETED|Overall Study||4
7605226|NCT02507375|18722629|P2|COMPLETED|Overall Study||1
7605227|NCT02507375|18722630|P1|COMPLETED|Overall Study||2
7605228|NCT02507375|18722629|P2|Extension Period|Overall Study||1
7605229|NCT02507375|18722630|P1|Extension Period|Overall Study||2
7605230|NCT02507375|18722629|P2|Cycle 6|Overall Study||1
7605231|NCT02507375|18722630|P1|Cycle 6|Overall Study||3
7605232|NCT02507375|18722629|P2|Cycle 5|Overall Study||1
7605233|NCT02507375|18722630|P1|Cycle 5|Overall Study||3
7605234|NCT02507375|18722629|P2|Cycle 4|Overall Study||2
7605235|NCT02507375|18722630|P1|Cycle 4|Overall Study||4
7605236|NCT02507375|18722629|P2|Cycle 3|Overall Study||5
7605237|NCT02507375|18722630|P1|Cycle 3|Overall Study||4
7605238|NCT02507375|18722629|P2|Cycle 2|Overall Study||5
7605239|NCT02507375|18722630|P1|Cycle 2|Overall Study||5
7605240|NCT02507375|18722629|P2|Received Pertuzumab|Overall Study||6
7605241|NCT02507375|18722630|P1|Received Pertuzumab|Overall Study||6
7605242|NCT02507375|18722629|P2|Cycle 1|Overall Study||9
7605243|NCT02507375|18722630|P1|Cycle 1|Overall Study||6
7605244|NCT02507375|18722629|P2|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9
7605245|NCT02507375|18722630|P1|STARTED|Overall Study||6
7605246|NCT02507349|18722649|P2|NOT COMPLETED|Overall Study||161
7605247|NCT02507349|18722650|P1|NOT COMPLETED|Overall Study||187
7605248|NCT02507349|18722649|P2|COMPLETED|Overall Study||1050
7605249|NCT02507349|18722650|P1|COMPLETED|Overall Study||1045
7605250|NCT02507349|18722649|P2|STARTED|Overall Study||1211
7605251|NCT02507349|18722650|P1|STARTED|Overall Study||1232
7605252|NCT02507219|18722674|P6|NOT COMPLETED|Overall Study||0
7605253|NCT02507219|18722675|P5|NOT COMPLETED|Overall Study||1
7605254|NCT02507219|18722676|P4|NOT COMPLETED|Overall Study||0
7605255|NCT02507219|18722677|P3|NOT COMPLETED|Overall Study||0
7605256|NCT02507219|18722678|P2|NOT COMPLETED|Overall Study||0
7605257|NCT02507219|18722679|P1|NOT COMPLETED|Overall Study||1
7605258|NCT02507219|18722674|P6|COMPLETED|Overall Study||3
7605259|NCT02507219|18722675|P5|COMPLETED|Overall Study||3
7605260|NCT02507219|18722676|P4|COMPLETED|Overall Study||3
7605261|NCT02507219|18722677|P3|COMPLETED|Overall Study||3
7605262|NCT02507219|18722678|P2|COMPLETED|Overall Study||4
7605263|NCT02507219|18722679|P1|COMPLETED|Overall Study||4
7605264|NCT02507219|18722674|P6|STARTED|Overall Study||3
7605265|NCT02507219|18722675|P5|STARTED|Overall Study||4
7605266|NCT02507219|18722676|P4|STARTED|Overall Study||3
7605267|NCT02507219|18722677|P3|STARTED|Overall Study||3
7605268|NCT02507219|18722678|P2|STARTED|Overall Study||4
7605269|NCT02507219|18722679|P1|STARTED|Overall Study||5
7605270|NCT02507011|18722687|P2|NOT COMPLETED|Second Intervention||0
7605271|NCT02507011|18722688|P1|NOT COMPLETED|Second Intervention||0
7605272|NCT02507011|18722687|P2|COMPLETED|Second Intervention||1
7605273|NCT02507011|18722688|P1|COMPLETED|Second Intervention||1
7605274|NCT02507011|18722687|P2|STARTED|Second Intervention||1
7605275|NCT02507011|18722688|P1|STARTED|Second Intervention||1
7605276|NCT02507011|18722687|P2|NOT COMPLETED|First Intervention||0
7605277|NCT02507011|18722688|P1|NOT COMPLETED|First Intervention||0
7605278|NCT02507011|18722687|P2|COMPLETED|First Intervention||1
7605279|NCT02507011|18722688|P1|COMPLETED|First Intervention||1
7605280|NCT02507011|18722687|P2|STARTED|First Intervention||1
7605281|NCT02507011|18722688|P1|STARTED|First Intervention||1
7605282|NCT02506985|18722696|P2|NOT COMPLETED|Overall Study||0
7605283|NCT02506985|18722697|P1|NOT COMPLETED|Overall Study||0
7605284|NCT02506985|18722696|P2|COMPLETED|Overall Study||6
7605285|NCT02506985|18722697|P1|COMPLETED|Overall Study||4
7605286|NCT02506985|18722696|P2|STARTED|Overall Study||6
7605287|NCT02506985|18722697|P1|STARTED|Overall Study||4
7605288|NCT02506881|18722715|P4|NOT COMPLETED|Second Intervention (Day 1)||0
7605289|NCT02506881|18722716|P3|NOT COMPLETED|Second Intervention (Day 1)||0
7605290|NCT02506881|18722717|P2|NOT COMPLETED|Second Intervention (Day 1)||0
7605291|NCT02506881|18722718|P1|NOT COMPLETED|Second Intervention (Day 1)||0
7605292|NCT02506881|18722715|P4|COMPLETED|Second Intervention (Day 1)||12
7605293|NCT02506881|18722716|P3|COMPLETED|Second Intervention (Day 1)||12
7605294|NCT02506881|18722717|P2|COMPLETED|Second Intervention (Day 1)||12
7605295|NCT02506881|18722718|P1|COMPLETED|Second Intervention (Day 1)||12
7605296|NCT02506881|18722715|P4|STARTED|Second Intervention (Day 1)||12
7605297|NCT02506881|18722716|P3|STARTED|Second Intervention (Day 1)||12
7605298|NCT02506881|18722717|P2|STARTED|Second Intervention (Day 1)||12
7605299|NCT02506881|18722718|P1|STARTED|Second Intervention (Day 1)||12
7605300|NCT02506881|18722715|P4|NOT COMPLETED|Washout (at Least 25 Days)||0
7605301|NCT02506881|18722716|P3|NOT COMPLETED|Washout (at Least 25 Days)||0
7605302|NCT02506881|18722717|P2|NOT COMPLETED|Washout (at Least 25 Days)||0
7605303|NCT02506881|18722718|P1|NOT COMPLETED|Washout (at Least 25 Days)||0
7605304|NCT02506881|18722715|P4|COMPLETED|Washout (at Least 25 Days)||12
7605305|NCT02506881|18722716|P3|COMPLETED|Washout (at Least 25 Days)||12
7605306|NCT02506881|18722717|P2|COMPLETED|Washout (at Least 25 Days)||12
7605307|NCT02506881|18722718|P1|COMPLETED|Washout (at Least 25 Days)||12
7605308|NCT02506881|18722715|P4|STARTED|Washout (at Least 25 Days)||12
7605309|NCT02506881|18722716|P3|STARTED|Washout (at Least 25 Days)||12
7605310|NCT02506881|18722717|P2|STARTED|Washout (at Least 25 Days)||12
7605311|NCT02506881|18722718|P1|STARTED|Washout (at Least 25 Days)||12
7605312|NCT02506881|18722715|P4|NOT COMPLETED|First Intervention (Day 1)||12
7605313|NCT02506881|18722716|P3|NOT COMPLETED|First Intervention (Day 1)||13
7605314|NCT02506881|18722717|P2|NOT COMPLETED|First Intervention (Day 1)||0
7605315|NCT02506881|18722718|P1|NOT COMPLETED|First Intervention (Day 1)||1
7605316|NCT02506881|18722715|P4|COMPLETED|First Intervention (Day 1)||12
7605317|NCT02506881|18722716|P3|COMPLETED|First Intervention (Day 1)||12
7605318|NCT02506881|18722717|P2|COMPLETED|First Intervention (Day 1)||12
7605319|NCT02506881|18722718|P1|COMPLETED|First Intervention (Day 1)||12
7605320|NCT02506881|18722715|P4|STARTED|First Intervention (Day 1)||24
7605321|NCT02506881|18722716|P3|STARTED|First Intervention (Day 1)||25
7605322|NCT02506881|18722717|P2|STARTED|First Intervention (Day 1)||12
7605323|NCT02506881|18722718|P1|STARTED|First Intervention (Day 1)||13
7605324|NCT02506868|18722754|P2|NOT COMPLETED|Additional Period of Study (Until 52W)||5
7605325|NCT02506868|18722755|P1|NOT COMPLETED|Additional Period of Study (Until 52W)||3
7605326|NCT02506868|18722754|P2|COMPLETED|Additional Period of Study (Until 52W)||85
7605327|NCT02506868|18722755|P1|COMPLETED|Additional Period of Study (Until 52W)||83
7605328|NCT02506868|18722754|P2|STARTED|Additional Period of Study (Until 52W)||90
7605329|NCT02506868|18722755|P1|STARTED|Additional Period of Study (Until 52W)||86
7605330|NCT02506868|18722754|P2|NOT COMPLETED|Main Period of Study (24 Weeks)||8
7605331|NCT02506868|18722755|P1|NOT COMPLETED|Main Period of Study (24 Weeks)||12
7605332|NCT02506868|18722754|P2|COMPLETED|Main Period of Study (24 Weeks)||90
7605333|NCT02506868|18722755|P1|COMPLETED|Main Period of Study (24 Weeks)||86
7605334|NCT02506868|18722754|P2|Per Protocol Population|Main Period of Study (24 Weeks)||90
7605335|NCT02506868|18722755|P1|Per Protocol Population|Main Period of Study (24 Weeks)||86
7605336|NCT02506868|18722754|P2|mITT Population|Main Period of Study (24 Weeks)|One patient from Aranesp group was excluded prior to the first administration|97
7605337|NCT02506868|18722755|P1|mITT Population|Main Period of Study (24 Weeks)||98
7605338|NCT02506868|18722754|P2|STARTED|Main Period of Study (24 Weeks)||98
7605339|NCT02506868|18722755|P1|STARTED|Main Period of Study (24 Weeks)||98
7605340|NCT02506816|18722791|P1|NOT COMPLETED|Overall Study||3
7605341|NCT02506816|18722791|P1|COMPLETED|Overall Study||33
7605342|NCT02506816|18722791|P1|Samples Availability|Overall Study|31 of 36 patients had valid samples for analysis of biomarkers (primary and secondary analysis)|31
7605343|NCT02506816|18722791|P1|STARTED|Overall Study||36
7605344|NCT02506673|18722800|P2|NOT COMPLETED|Overall Study||0
7605345|NCT02506673|18722801|P1|NOT COMPLETED|Overall Study||0
7605346|NCT02506673|18722800|P2|COMPLETED|Overall Study||13
7605347|NCT02506673|18722801|P1|COMPLETED|Overall Study||13
7605348|NCT02506673|18722800|P2|STARTED|Overall Study||13
7605349|NCT02506673|18722801|P1|STARTED|Overall Study||13
7605350|NCT02506660|18722833|P2|NOT COMPLETED|Overall Study||1
7605351|NCT02506660|18722834|P1|NOT COMPLETED|Overall Study||2
7605352|NCT02506660|18722833|P2|COMPLETED|Overall Study||63
7605353|NCT02506660|18722834|P1|COMPLETED|Overall Study||62
7605354|NCT02506660|18722833|P2|STARTED|Overall Study||64
7605355|NCT02506660|18722834|P1|STARTED|Overall Study||64
7605356|NCT02506634|18722860|P1|NOT COMPLETED|Overall Study||17
7605357|NCT02506634|18722860|P1|COMPLETED|Overall Study||357
7605358|NCT02506634|18722860|P1|Participants Who Finished GERDQ|Overall Study||342
7605359|NCT02506634|18722860|P1|Participants Who Received PPI Treatment|Overall Study||357
7605360|NCT02506634|18722860|P1|Participants Who Were Diagnosed as GERD|Overall Study||154
7605361|NCT02506634|18722860|P1|STARTED|Overall Study||374
7605362|NCT02506309|18722900|P2|NOT COMPLETED|Overall Study||20
7605363|NCT02506309|18722901|P1|NOT COMPLETED|Overall Study||18
7605364|NCT02506309|18722900|P2|COMPLETED|Overall Study||64
7605365|NCT02506309|18722901|P1|COMPLETED|Overall Study||66
7605366|NCT02506309|18722900|P2|STARTED|Overall Study||84
7605367|NCT02506309|18722901|P1|STARTED|Overall Study||84
7605368|NCT02506257|18722917|P4|NOT COMPLETED|Overall Study||0
7605369|NCT02506257|18722918|P3|NOT COMPLETED|Overall Study||4
7605370|NCT02506257|18722919|P2|NOT COMPLETED|Overall Study||2
7605371|NCT02506257|18722920|P1|NOT COMPLETED|Overall Study||0
7605372|NCT02506257|18722917|P4|COMPLETED|Overall Study||9
7605373|NCT02506257|18722918|P3|COMPLETED|Overall Study||23
7605374|NCT02506257|18722919|P2|COMPLETED|Overall Study||26
7605375|NCT02506257|18722920|P1|COMPLETED|Overall Study||26
7605376|NCT02506257|18722917|P4|STARTED|Overall Study||9
7605377|NCT02506257|18722918|P3|STARTED|Overall Study||27
7605378|NCT02506257|18722919|P2|STARTED|Overall Study||28
7605379|NCT02506257|18722920|P1|STARTED|Overall Study||26
7605380|NCT02506101|18722952|P2|NOT COMPLETED|Overall Study||0
7605381|NCT02506101|18722953|P1|NOT COMPLETED|Overall Study||2
7605382|NCT02506101|18722952|P2|COMPLETED|Overall Study||0
7605383|NCT02506101|18722953|P1|COMPLETED|Overall Study||0
7605384|NCT02506101|18722952|P2|STARTED|Overall Study||0
7605385|NCT02506101|18722953|P1|STARTED|Overall Study||2
7605386|NCT02506036|18722969|P2|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
7605387|NCT02506036|18722970|P1|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
7605388|NCT02506036|18722969|P2|COMPLETED|Second Intervention (4-6 Weeks)||1
7605389|NCT02506036|18722970|P1|COMPLETED|Second Intervention (4-6 Weeks)||2
7605390|NCT02506036|18722969|P2|STARTED|Second Intervention (4-6 Weeks)||1
7605391|NCT02506036|18722970|P1|STARTED|Second Intervention (4-6 Weeks)||2
7605392|NCT02506036|18722969|P2|NOT COMPLETED|Washout (1-2 Weeks)||0
7605393|NCT02506036|18722970|P1|NOT COMPLETED|Washout (1-2 Weeks)||0
7605394|NCT02506036|18722969|P2|COMPLETED|Washout (1-2 Weeks)||1
7605395|NCT02506036|18722970|P1|COMPLETED|Washout (1-2 Weeks)||2
7605396|NCT02506036|18722969|P2|STARTED|Washout (1-2 Weeks)||1
7605397|NCT02506036|18722970|P1|STARTED|Washout (1-2 Weeks)||2
7605398|NCT02506036|18722969|P2|NOT COMPLETED|First Intervention (4-6 Weeks)||2
7605399|NCT02506036|18722970|P1|NOT COMPLETED|First Intervention (4-6 Weeks)||1
7605400|NCT02506036|18722969|P2|COMPLETED|First Intervention (4-6 Weeks)||1
7605401|NCT02506036|18722970|P1|COMPLETED|First Intervention (4-6 Weeks)||2
7605402|NCT02506036|18722969|P2|STARTED|First Intervention (4-6 Weeks)||3
7605403|NCT02506036|18722970|P1|STARTED|First Intervention (4-6 Weeks)||3
7605404|NCT02505945|18722978|P2|NOT COMPLETED|Overall Study||4
7605405|NCT02505945|18722979|P1|NOT COMPLETED|Overall Study||22
7605406|NCT02505945|18722978|P2|COMPLETED|Overall Study||46
7605407|NCT02505945|18722979|P1|COMPLETED|Overall Study||80
7605408|NCT02505945|18722978|P2|STARTED|Overall Study||50
7605409|NCT02505945|18722979|P1|STARTED|Overall Study||102
7605410|NCT02505919|18722989|P2|NOT COMPLETED|36 Months Follow-Up||5
7605411|NCT02505919|18722990|P1|NOT COMPLETED|36 Months Follow-Up||15
7605412|NCT02505919|18722989|P2|COMPLETED|36 Months Follow-Up||55
7605413|NCT02505919|18722990|P1|COMPLETED|36 Months Follow-Up||97
7605414|NCT02505919|18722989|P2|STARTED|36 Months Follow-Up||60
7605415|NCT02505919|18722990|P1|STARTED|36 Months Follow-Up||112
7605416|NCT02505919|18722989|P2|NOT COMPLETED|24 Months Follow-Up||1
7605417|NCT02505919|18722990|P1|NOT COMPLETED|24 Months Follow-Up||3
7605418|NCT02505919|18722989|P2|COMPLETED|24 Months Follow-Up||60
7605419|NCT02505919|18722990|P1|COMPLETED|24 Months Follow-Up||112
7605420|NCT02505919|18722989|P2|STARTED|24 Months Follow-Up||61
7605421|NCT02505919|18722990|P1|STARTED|24 Months Follow-Up||115
7605422|NCT02505919|18722989|P2|NOT COMPLETED|12 Months Follow-Up||2
7605423|NCT02505919|18722990|P1|NOT COMPLETED|12 Months Follow-Up||1
7605424|NCT02505919|18722989|P2|COMPLETED|12 Months Follow-Up||61
7605425|NCT02505919|18722990|P1|COMPLETED|12 Months Follow-Up||115
7605426|NCT02505919|18722989|P2|STARTED|12 Months Follow-Up||63
7605427|NCT02505919|18722990|P1|STARTED|12 Months Follow-Up||116
7605428|NCT02505919|18722989|P2|NOT COMPLETED|6 Months Follow-Up||2
7605429|NCT02505919|18722990|P1|NOT COMPLETED|6 Months Follow-Up||0
7605430|NCT02505919|18722989|P2|COMPLETED|6 Months Follow-Up||63
7605431|NCT02505919|18722990|P1|COMPLETED|6 Months Follow-Up||116
7605432|NCT02505919|18722989|P2|STARTED|6 Months Follow-Up||65
7605433|NCT02505919|18722990|P1|STARTED|6 Months Follow-Up||116
7605434|NCT02505919|18722989|P2|NOT COMPLETED|3 Months Follow-Up||0
7605435|NCT02505919|18722990|P1|NOT COMPLETED|3 Months Follow-Up||0
7605436|NCT02505919|18722989|P2|COMPLETED|3 Months Follow-Up||65
7605437|NCT02505919|18722990|P1|COMPLETED|3 Months Follow-Up||116
7605438|NCT02505919|18722989|P2|STARTED|3 Months Follow-Up||65
7605439|NCT02505919|18722990|P1|STARTED|3 Months Follow-Up||116
7605440|NCT02505919|18722989|P2|NOT COMPLETED|1 Month Follow-Up||0
7605441|NCT02505919|18722990|P1|NOT COMPLETED|1 Month Follow-Up||0
7605442|NCT02505919|18722989|P2|COMPLETED|1 Month Follow-Up||65
7605443|NCT02505919|18722990|P1|COMPLETED|1 Month Follow-Up||116
7605444|NCT02505919|18722989|P2|STARTED|1 Month Follow-Up||65
7605445|NCT02505919|18722990|P1|STARTED|1 Month Follow-Up||116
7605446|NCT02505919|18722989|P2|NOT COMPLETED|1 Week Follow-Up||0
7605447|NCT02505919|18722990|P1|NOT COMPLETED|1 Week Follow-Up||0
7605448|NCT02505919|18722989|P2|COMPLETED|1 Week Follow-Up||65
7605449|NCT02505919|18722990|P1|COMPLETED|1 Week Follow-Up||116
7605450|NCT02505919|18722989|P2|STARTED|1 Week Follow-Up||65
7605451|NCT02505919|18722990|P1|STARTED|1 Week Follow-Up||116
7605452|NCT02505919|18722989|P2|NOT COMPLETED|Treatment||2
7605453|NCT02505919|18722990|P1|NOT COMPLETED|Treatment||1
7605454|NCT02505919|18722989|P2|COMPLETED|Treatment||65
7605455|NCT02505919|18722990|P1|COMPLETED|Treatment||116
7605456|NCT02505919|18722989|P2|STARTED|Treatment||67
7605457|NCT02505919|18722990|P1|STARTED|Treatment||117
7605458|NCT02505867|18723000|P2|NOT COMPLETED|Overall Study||6
7605459|NCT02505867|18723001|P1|NOT COMPLETED|Overall Study||6
7605460|NCT02505867|18723000|P2|COMPLETED|Overall Study||0
7605461|NCT02505867|18723001|P1|COMPLETED|Overall Study||0
7605462|NCT02505867|18723000|P2|STARTED|Overall Study||6
7605463|NCT02505867|18723001|P1|STARTED|Overall Study||6
7605464|NCT02505542|18723007|P4|NOT COMPLETED|Part B: Double-Blind Period||7
7605465|NCT02505542|18723008|P3|NOT COMPLETED|Part B: Double-Blind Period||9
7605466|NCT02505542|18723009|P2|NOT COMPLETED|Part B: Double-Blind Period||12
7605467|NCT02505542|18723010|P1|NOT COMPLETED|Part B: Double-Blind Period||0
7605468|NCT02505542|18723007|P4|COMPLETED|Part B: Double-Blind Period||98
7605469|NCT02505542|18723008|P3|COMPLETED|Part B: Double-Blind Period||95
7605470|NCT02505542|18723009|P2|COMPLETED|Part B: Double-Blind Period||92
7605471|NCT02505542|18723010|P1|COMPLETED|Part B: Double-Blind Period||0
7605472|NCT02505542|18723007|P4|Started Escape Period|Part B: Double-Blind Period||15
7605473|NCT02505542|18723008|P3|Started Escape Period|Part B: Double-Blind Period||7
7605474|NCT02505542|18723009|P2|Started Escape Period|Part B: Double-Blind Period||73
7605475|NCT02505542|18723010|P1|Started Escape Period|Part B: Double-Blind Period||0
7605476|NCT02505542|18723007|P4|STARTED|Part B: Double-Blind Period||105
7605477|NCT02505542|18723008|P3|STARTED|Part B: Double-Blind Period||104
7605478|NCT02505542|18723009|P2|STARTED|Part B: Double-Blind Period||104
7605479|NCT02505542|18723010|P1|STARTED|Part B: Double-Blind Period||0
7605480|NCT02505542|18723007|P4|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
7605481|NCT02505542|18723008|P3|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
7605482|NCT02505542|18723009|P2|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
7605483|NCT02505542|18723010|P1|NOT COMPLETED|Completed Part A, Did Not Enter Part B||346
7605484|NCT02505542|18723007|P4|COMPLETED|Completed Part A, Did Not Enter Part B||0
7605485|NCT02505542|18723008|P3|COMPLETED|Completed Part A, Did Not Enter Part B||0
7605486|NCT02505542|18723009|P2|COMPLETED|Completed Part A, Did Not Enter Part B||0
7605487|NCT02505542|18723010|P1|COMPLETED|Completed Part A, Did Not Enter Part B||313
7605488|NCT02505542|18723007|P4|STARTED|Completed Part A, Did Not Enter Part B||0
7605489|NCT02505542|18723008|P3|STARTED|Completed Part A, Did Not Enter Part B||0
7605490|NCT02505542|18723009|P2|STARTED|Completed Part A, Did Not Enter Part B||0
7605491|NCT02505542|18723010|P1|STARTED|Completed Part A, Did Not Enter Part B||659
7605492|NCT02505542|18723007|P4|NOT COMPLETED|Part A: Open-Label Period||0
7605493|NCT02505542|18723008|P3|NOT COMPLETED|Part A: Open-Label Period||0
7605494|NCT02505542|18723009|P2|NOT COMPLETED|Part A: Open-Label Period||0
7605495|NCT02505542|18723010|P1|NOT COMPLETED|Part A: Open-Label Period||77
7605496|NCT02505542|18723007|P4|COMPLETED|Part A: Open-Label Period||0
7605497|NCT02505542|18723008|P3|COMPLETED|Part A: Open-Label Period||0
7605498|NCT02505542|18723009|P2|COMPLETED|Part A: Open-Label Period||0
7605499|NCT02505542|18723010|P1|COMPLETED|Part A: Open-Label Period||659
7605500|NCT02505542|18723007|P4|STARTED|Part A: Open-Label Period||0
7605501|NCT02505542|18723008|P3|STARTED|Part A: Open-Label Period||0
7605502|NCT02505542|18723009|P2|STARTED|Part A: Open-Label Period||0
7605503|NCT02505542|18723010|P1|STARTED|Part A: Open-Label Period||736
7605504|NCT02505334|18723118|P2|NOT COMPLETED|Extension Treatment Period||0
7605505|NCT02505334|18723119|P1|NOT COMPLETED|Extension Treatment Period||18
7605506|NCT02505334|18723118|P2|COMPLETED|Extension Treatment Period||0
7605507|NCT02505334|18723119|P1|COMPLETED|Extension Treatment Period||194
7605508|NCT02505334|18723118|P2|STARTED|Extension Treatment Period|This treatment arm is not considered for this period as the subjects were treated for 26 weeks|0
7605509|NCT02505334|18723119|P1|STARTED|Extension Treatment Period|6 subjects withdrew from the trial after the main period and prior to entering the extension period|212
7605510|NCT02505334|18723118|P2|NOT COMPLETED|Main Treatment Period||39
7605511|NCT02505334|18723119|P1|NOT COMPLETED|Main Treatment Period||15
7605512|NCT02505334|18723118|P2|COMPLETED|Main Treatment Period||194
7605513|NCT02505334|18723119|P1|COMPLETED|Main Treatment Period||218
7605514|NCT02505334|18723118|P2|STARTED|Main Treatment Period||233
7605515|NCT02505334|18723119|P1|STARTED|Main Treatment Period||233
7605516|NCT02505269|18723244|P1|NOT COMPLETED|Overall Study||0
7605517|NCT02505269|18723244|P1|COMPLETED|Overall Study||34
7605518|NCT02505269|18723244|P1|STARTED|Overall Study||34
7605519|NCT02505217|18723252|P2|NOT COMPLETED|Overall Study||2
7605520|NCT02505217|18723253|P1|NOT COMPLETED|Overall Study||1
7605521|NCT02505217|18723252|P2|COMPLETED|Overall Study||93
7605522|NCT02505217|18723253|P1|COMPLETED|Overall Study||104
7605523|NCT02505217|18723252|P2|STARTED|Overall Study||95
7605524|NCT02505217|18723253|P1|STARTED|Overall Study||105
7605525|NCT02504931|18723263|P2|NOT COMPLETED|Overall Study||10
7605526|NCT02504931|18723264|P1|NOT COMPLETED|Overall Study||12
7605527|NCT02504931|18723263|P2|COMPLETED|Overall Study||13
7605528|NCT02504931|18723264|P1|COMPLETED|Overall Study||14
7605529|NCT02504931|18723263|P2|STARTED|Overall Study||23
7605530|NCT02504931|18723264|P1|STARTED|Overall Study||26
7605531|NCT02504892|18723272|P1|NOT COMPLETED|Overall Study||2
7605532|NCT02504892|18723272|P1|COMPLETED|Overall Study||1
7605533|NCT02504892|18723272|P1|STARTED|Overall Study||3
7605534|NCT02504827|18723279|P1|NOT COMPLETED|Overall Study||1
7605535|NCT02504827|18723279|P1|COMPLETED|Overall Study||11
7605536|NCT02504827|18723279|P1|STARTED|Overall Study||12
7605537|NCT02504775|18723284|P2|NOT COMPLETED|Period 2||0
7605538|NCT02504775|18723285|P1|NOT COMPLETED|Period 2||0
7605539|NCT02504775|18723284|P2|COMPLETED|Period 2||14
7605540|NCT02504775|18723285|P1|COMPLETED|Period 2||14
7605541|NCT02504775|18723284|P2|STARTED|Period 2||14
7605542|NCT02504775|18723285|P1|STARTED|Period 2||14
7605543|NCT02504775|18723284|P2|NOT COMPLETED|Washout||0
7605544|NCT02504775|18723285|P1|NOT COMPLETED|Washout||0
7605545|NCT02504775|18723284|P2|COMPLETED|Washout||14
7605546|NCT02504775|18723285|P1|COMPLETED|Washout||14
7605547|NCT02504775|18723284|P2|STARTED|Washout||14
7605548|NCT02504775|18723285|P1|STARTED|Washout||14
7605549|NCT02504775|18723284|P2|NOT COMPLETED|Period 1||0
7605550|NCT02504775|18723285|P1|NOT COMPLETED|Period 1||0
7605551|NCT02504775|18723284|P2|COMPLETED|Period 1||14
7605552|NCT02504775|18723285|P1|COMPLETED|Period 1||14
7605553|NCT02504775|18723284|P2|STARTED|Period 1||14
7605554|NCT02504775|18723285|P1|STARTED|Period 1||14
7605555|NCT02504723|18723299|P2|NOT COMPLETED|Overall Study||0
7605556|NCT02504723|18723300|P1|NOT COMPLETED|Overall Study||0
7605557|NCT02504723|18723299|P2|COMPLETED|Overall Study||61
7605558|NCT02504723|18723300|P1|COMPLETED|Overall Study||60
7605559|NCT02504723|18723299|P2|STARTED|Overall Study||61
7605560|NCT02504723|18723300|P1|STARTED|Overall Study||60
7605561|NCT02504671|18723318|P6|NOT COMPLETED|Overall Study||14
7605562|NCT02504671|18723319|P5|NOT COMPLETED|Overall Study||12
7605563|NCT02504671|18723320|P4|NOT COMPLETED|Overall Study||10
7605564|NCT02504671|18723321|P3|NOT COMPLETED|Overall Study||10
7605565|NCT02504671|18723322|P2|NOT COMPLETED|Overall Study||14
7605566|NCT02504671|18723323|P1|NOT COMPLETED|Overall Study||12
7605567|NCT02504671|18723318|P6|COMPLETED|Overall Study||23
7605568|NCT02504671|18723319|P5|COMPLETED|Overall Study||25
7605569|NCT02504671|18723320|P4|COMPLETED|Overall Study||27
7605570|NCT02504671|18723321|P3|COMPLETED|Overall Study||27
7605571|NCT02504671|18723322|P2|COMPLETED|Overall Study||23
7605572|NCT02504671|18723323|P1|COMPLETED|Overall Study||25
7605573|NCT02504671|18723318|P6|STARTED|Overall Study||37
7605574|NCT02504671|18723319|P5|STARTED|Overall Study||37
7605575|NCT02504671|18723320|P4|STARTED|Overall Study||37
7605576|NCT02504671|18723321|P3|STARTED|Overall Study||37
7605577|NCT02504671|18723322|P2|STARTED|Overall Study||37
7605578|NCT02504671|18723323|P1|STARTED|Overall Study||37
7605579|NCT02504645|18723465|P2|NOT COMPLETED|Overall Study||25
7605580|NCT02504645|18723466|P1|NOT COMPLETED|Overall Study||24
7605581|NCT02504645|18723465|P2|COMPLETED|Overall Study||76
7605582|NCT02504645|18723466|P1|COMPLETED|Overall Study||77
7605583|NCT02504645|18723465|P2|STARTED|Overall Study||101
7605584|NCT02504645|18723466|P1|STARTED|Overall Study||101
7605585|NCT02504619|18723474|P1|NOT COMPLETED|Overall Study||0
7605586|NCT02504619|18723474|P1|COMPLETED|Overall Study||1
7605587|NCT02504619|18723474|P1|STARTED|Overall Study||1
7605588|NCT02504554|18723482|P2|NOT COMPLETED|Overall Study||0
7605589|NCT02504554|18723483|P1|NOT COMPLETED|Overall Study||0
7605590|NCT02504554|18723482|P2|COMPLETED|Overall Study||6
7605591|NCT02504554|18723483|P1|COMPLETED|Overall Study||12
7605592|NCT02504554|18723482|P2|STARTED|Overall Study||6
7605593|NCT02504554|18723483|P1|STARTED|Overall Study|1 participant was switched from the oral group to the rectal group due to nausea/vomiting.|12
7605594|NCT02504541|18723495|P1|NOT COMPLETED|Overall Study||20
7605595|NCT02504541|18723495|P1|COMPLETED|Overall Study||113
7605596|NCT02504541|18723495|P1|STARTED|Overall Study||133
7605597|NCT02504502|18723501|P2|NOT COMPLETED|Crossover to Enhanced Report||0
7605598|NCT02504502|18723502|P1|NOT COMPLETED|Crossover to Enhanced Report||5
7605599|NCT02504502|18723501|P2|COMPLETED|Crossover to Enhanced Report|the enhanced report arm was completed in first period and does not carry forward to period 2|0
7605600|NCT02504502|18723502|P1|COMPLETED|Crossover to Enhanced Report||15
7605692|NCT02503865|18723616|P3|COMPLETED|Overall Study||64
7605601|NCT02504502|18723501|P2|STARTED|Crossover to Enhanced Report|The enhanced report arm was completed in first period and does not carry forward to period 2.|0
7605602|NCT02504502|18723502|P1|STARTED|Crossover to Enhanced Report||20
7605603|NCT02504502|18723501|P2|NOT COMPLETED|Routine Care vs. Enhanced Report||7
7605604|NCT02504502|18723502|P1|NOT COMPLETED|Routine Care vs. Enhanced Report||4
7605605|NCT02504502|18723501|P2|COMPLETED|Routine Care vs. Enhanced Report||21
7605606|NCT02504502|18723502|P1|COMPLETED|Routine Care vs. Enhanced Report||20
7605607|NCT02504502|18723501|P2|STARTED|Routine Care vs. Enhanced Report||28
7605608|NCT02504502|18723502|P1|STARTED|Routine Care vs. Enhanced Report||24
7605609|NCT02504424|18723508|P1|NOT COMPLETED|Overall Study||2
7605610|NCT02504424|18723508|P1|COMPLETED|Overall Study||48
7605611|NCT02504424|18723508|P1|STARTED|Overall Study||50
7605612|NCT02504320|18723517|P4|NOT COMPLETED|Treatment Period 4||0
7605613|NCT02504320|18723518|P3|NOT COMPLETED|Treatment Period 4||0
7605614|NCT02504320|18723519|P2|NOT COMPLETED|Treatment Period 4||0
7605615|NCT02504320|18723520|P1|NOT COMPLETED|Treatment Period 4||0
7605616|NCT02504320|18723517|P4|COMPLETED|Treatment Period 4||19
7605617|NCT02504320|18723518|P3|COMPLETED|Treatment Period 4||18
7605618|NCT02504320|18723519|P2|COMPLETED|Treatment Period 4||18
7605619|NCT02504320|18723520|P1|COMPLETED|Treatment Period 4||19
7605620|NCT02504320|18723517|P4|STARTED|Treatment Period 4||19
7605621|NCT02504320|18723518|P3|STARTED|Treatment Period 4||18
7605622|NCT02504320|18723519|P2|STARTED|Treatment Period 4||18
7605623|NCT02504320|18723520|P1|STARTED|Treatment Period 4||19
7605624|NCT02504320|18723517|P4|NOT COMPLETED|Treatment Period 3||1
7605625|NCT02504320|18723518|P3|NOT COMPLETED|Treatment Period 3||1
7605626|NCT02504320|18723519|P2|NOT COMPLETED|Treatment Period 3||0
7605627|NCT02504320|18723520|P1|NOT COMPLETED|Treatment Period 3||0
7605628|NCT02504320|18723517|P4|COMPLETED|Treatment Period 3||19
7605629|NCT02504320|18723518|P3|COMPLETED|Treatment Period 3||18
7605630|NCT02504320|18723519|P2|COMPLETED|Treatment Period 3||18
7605631|NCT02504320|18723520|P1|COMPLETED|Treatment Period 3||19
7605632|NCT02504320|18723517|P4|STARTED|Treatment Period 3||20
7605633|NCT02504320|18723518|P3|STARTED|Treatment Period 3||19
7605634|NCT02504320|18723519|P2|STARTED|Treatment Period 3||18
7605635|NCT02504320|18723520|P1|STARTED|Treatment Period 3||19
7605636|NCT02504320|18723517|P4|NOT COMPLETED|Treatment Period 2||0
7605637|NCT02504320|18723518|P3|NOT COMPLETED|Treatment Period 2||0
7605638|NCT02504320|18723519|P2|NOT COMPLETED|Treatment Period 2||1
7605639|NCT02504320|18723520|P1|NOT COMPLETED|Treatment Period 2||0
7605640|NCT02504320|18723517|P4|COMPLETED|Treatment Period 2||20
7605641|NCT02504320|18723518|P3|COMPLETED|Treatment Period 2||19
7605642|NCT02504320|18723519|P2|COMPLETED|Treatment Period 2||18
7605643|NCT02504320|18723520|P1|COMPLETED|Treatment Period 2||19
7605644|NCT02504320|18723517|P4|STARTED|Treatment Period 2||20
7605645|NCT02504320|18723518|P3|STARTED|Treatment Period 2||19
7605646|NCT02504320|18723519|P2|STARTED|Treatment Period 2||19
7605647|NCT02504320|18723520|P1|STARTED|Treatment Period 2||19
7605648|NCT02504320|18723517|P4|NOT COMPLETED|Treatment Period 1||0
7605649|NCT02504320|18723518|P3|NOT COMPLETED|Treatment Period 1||1
7605650|NCT02504320|18723519|P2|NOT COMPLETED|Treatment Period 1||0
7605651|NCT02504320|18723520|P1|NOT COMPLETED|Treatment Period 1||0
7605652|NCT02504320|18723517|P4|COMPLETED|Treatment Period 1||20
7605653|NCT02504320|18723518|P3|COMPLETED|Treatment Period 1||19
7605654|NCT02504320|18723519|P2|COMPLETED|Treatment Period 1||19
7605655|NCT02504320|18723520|P1|COMPLETED|Treatment Period 1||19
7605656|NCT02504320|18723517|P4|STARTED|Treatment Period 1||20
7605657|NCT02504320|18723518|P3|STARTED|Treatment Period 1||20
7605658|NCT02504320|18723519|P2|STARTED|Treatment Period 1||19
7605659|NCT02504320|18723520|P1|STARTED|Treatment Period 1||19
7605660|NCT02504294|18723540|P2|NOT COMPLETED|Overall Study||48
7605661|NCT02504294|18723541|P1|NOT COMPLETED|Overall Study||56
7605662|NCT02504294|18723540|P2|COMPLETED|Overall Study||158
7605663|NCT02504294|18723541|P1|COMPLETED|Overall Study||156
7605664|NCT02504294|18723540|P2|STARTED|Overall Study||206
7605665|NCT02504294|18723541|P1|STARTED|Overall Study||212
7605666|NCT02504268|18723551|P2|NOT COMPLETED|Overall Study||68
7605667|NCT02504268|18723552|P1|NOT COMPLETED|Overall Study||63
7605668|NCT02504268|18723551|P2|COMPLETED|Overall Study||233
7605669|NCT02504268|18723552|P1|COMPLETED|Overall Study||388
7605670|NCT02504268|18723551|P2|STARTED|Overall Study||301
7605671|NCT02504268|18723552|P1|STARTED|Overall Study||451
7605672|NCT02504216|18723568|P2|NOT COMPLETED|Overall Study||15
7605673|NCT02504216|18723569|P1|NOT COMPLETED|Overall Study||11
7605674|NCT02504216|18723568|P2|COMPLETED|Overall Study||3263
7605675|NCT02504216|18723569|P1|COMPLETED|Overall Study||3275
7605676|NCT02504216|18723568|P2|Received Treatment|Overall Study||3248
7605677|NCT02504216|18723569|P1|Received Treatment|Overall Study||3256
7605678|NCT02504216|18723568|P2|STARTED|Overall Study||3278
7605679|NCT02504216|18723569|P1|STARTED|Overall Study||3286
7605680|NCT02504099|18723595|P1|NOT COMPLETED|Overall Study||0
7605681|NCT02504099|18723595|P1|COMPLETED|Overall Study||3
7605682|NCT02504099|18723595|P1|STARTED|Overall Study||3
7605683|NCT02504073|18723603|P1|NOT COMPLETED|Overall Study||0
7605684|NCT02504073|18723603|P1|COMPLETED|Overall Study||54
7605685|NCT02504073|18723603|P1|STARTED|Overall Study||54
7605686|NCT02503982|18723609|P1|NOT COMPLETED|Overall Study||0
7605687|NCT02503982|18723609|P1|COMPLETED|Overall Study||13
7605688|NCT02503982|18723609|P1|STARTED|Overall Study||13
7605689|NCT02503865|18723616|P3|NOT COMPLETED|Overall Study||2
7605690|NCT02503865|18723617|P2|NOT COMPLETED|Overall Study||47
7605691|NCT02503865|18723618|P1|NOT COMPLETED|Overall Study||5
7605693|NCT02503865|18723617|P2|COMPLETED|Overall Study||222
7605694|NCT02503865|18723618|P1|COMPLETED|Overall Study||65
7605695|NCT02503865|18723616|P3|STARTED|Overall Study||66
7605696|NCT02503865|18723617|P2|STARTED|Overall Study||269
7605697|NCT02503865|18723618|P1|STARTED|Overall Study||70
7605698|NCT02503852|18723642|P4|NOT COMPLETED|Overall Study||1
7605699|NCT02503852|18723643|P3|NOT COMPLETED|Overall Study||3
7605700|NCT02503852|18723644|P2|NOT COMPLETED|Overall Study||3
7605701|NCT02503852|18723645|P1|NOT COMPLETED|Overall Study||4
7605702|NCT02503852|18723642|P4|COMPLETED|Overall Study||8
7605703|NCT02503852|18723643|P3|COMPLETED|Overall Study||21
7605704|NCT02503852|18723644|P2|COMPLETED|Overall Study||19
7605705|NCT02503852|18723645|P1|COMPLETED|Overall Study||12
7605706|NCT02503852|18723642|P4|STARTED|Overall Study||9
7605707|NCT02503852|18723643|P3|STARTED|Overall Study||24
7605708|NCT02503852|18723644|P2|STARTED|Overall Study||22
7605709|NCT02503852|18723645|P1|STARTED|Overall Study||16
7605710|NCT02503787|18723663|P1|NOT COMPLETED|Implant to 3 Month Endpoint||3
7605711|NCT02503787|18723663|P1|COMPLETED|Implant to 3 Month Endpoint||29
7605712|NCT02503787|18723663|P1|STARTED|Implant to 3 Month Endpoint||32
7605713|NCT02503787|18723663|P1|NOT COMPLETED|Successful Trial (≥50% Pain Relief)||5
7605714|NCT02503787|18723663|P1|COMPLETED|Successful Trial (≥50% Pain Relief)||32
7605715|NCT02503787|18723663|P1|STARTED|Successful Trial (≥50% Pain Relief)||37
7605716|NCT02503787|18723663|P1|NOT COMPLETED|Device Trial (HD Programming Trial)||7
7605717|NCT02503787|18723663|P1|COMPLETED|Device Trial (HD Programming Trial)||37
7605718|NCT02503787|18723663|P1|STARTED|Device Trial (HD Programming Trial)||44
7605719|NCT02503787|18723663|P1|NOT COMPLETED|Enrollment||20
7605720|NCT02503787|18723663|P1|COMPLETED|Enrollment||44
7605721|NCT02503787|18723663|P1|STARTED|Enrollment||64
7605722|NCT02503735|18723670|P1|NOT COMPLETED|Overall Study||0
7605723|NCT02503735|18723670|P1|COMPLETED|Overall Study||10
7605724|NCT02503735|18723670|P1|SVR 12 (12week Post Treatment RNA Neg)|Overall Study||8
7605725|NCT02503735|18723670|P1|STARTED|Overall Study||10
7605726|NCT02503540|18723680|P1|NOT COMPLETED|Overall Study||3
7605727|NCT02503540|18723680|P1|COMPLETED|Overall Study||28
7605728|NCT02503540|18723680|P1|STARTED|Overall Study||31
7605729|NCT02503501|18723701|P2|NOT COMPLETED|Overall Study||3
7605730|NCT02503501|18723702|P1|NOT COMPLETED|Overall Study||1
7605731|NCT02503501|18723701|P2|COMPLETED|Overall Study||13
7605732|NCT02503501|18723702|P1|COMPLETED|Overall Study||18
7605733|NCT02503501|18723701|P2|STARTED|Overall Study||16
7605734|NCT02503501|18723702|P1|STARTED|Overall Study||19
7605735|NCT02503410|18723714|P2|NOT COMPLETED|Overall Study||0
7605736|NCT02503410|18723715|P1|NOT COMPLETED|Overall Study||0
7605737|NCT02503410|18723714|P2|COMPLETED|Overall Study||3
7605738|NCT02503410|18723715|P1|COMPLETED|Overall Study||4
7605739|NCT02503410|18723714|P2|STARTED|Overall Study||3
7605740|NCT02503410|18723715|P1|STARTED|Overall Study||4
7605741|NCT02503332|18723738|P4|NOT COMPLETED|Overall Study||4
7605742|NCT02503332|18723739|P3|NOT COMPLETED|Overall Study||8
7605743|NCT02503332|18723740|P2|NOT COMPLETED|Overall Study||19
7605744|NCT02503332|18723741|P1|NOT COMPLETED|Overall Study||34
7605745|NCT02503332|18723738|P4|COMPLETED|Overall Study||36
7605746|NCT02503332|18723739|P3|COMPLETED|Overall Study||33
7605747|NCT02503332|18723740|P2|COMPLETED|Overall Study||60
7605748|NCT02503332|18723741|P1|COMPLETED|Overall Study||52
7605749|NCT02503332|18723738|P4|STARTED|Overall Study||40
7605750|NCT02503332|18723739|P3|STARTED|Overall Study||41
7605751|NCT02503332|18723740|P2|STARTED|Overall Study||79
7605752|NCT02503332|18723741|P1|STARTED|Overall Study||86
7605753|NCT02503254|18723778|P2|NOT COMPLETED|Overall Study||0
7605754|NCT02503254|18723779|P1|NOT COMPLETED|Overall Study||0
7605755|NCT02503254|18723778|P2|COMPLETED|Overall Study||39
7605756|NCT02503254|18723779|P1|COMPLETED|Overall Study||41
7605757|NCT02503254|18723778|P2|STARTED|Overall Study||39
7605758|NCT02503254|18723779|P1|STARTED|Overall Study||41
7605759|NCT02503215|18723792|P1|NOT COMPLETED|Overall Study||3
7605760|NCT02503215|18723792|P1|COMPLETED|Overall Study||14
7605761|NCT02503215|18723792|P1|STARTED|Overall Study||17
7605762|NCT02503202|18723803|P5|NOT COMPLETED|Extension: Month 6 to 24||1
7605763|NCT02503202|18723804|P4|NOT COMPLETED|Extension: Month 6 to 24||18
7605764|NCT02503202|18723805|P3|NOT COMPLETED|Extension: Month 6 to 24||9
7605765|NCT02503202|18723806|P2|NOT COMPLETED|Extension: Month 6 to 24||16
7605766|NCT02503202|18723807|P1|NOT COMPLETED|Extension: Month 6 to 24||11
7605767|NCT02503202|18723803|P5|COMPLETED|Extension: Month 6 to 24||67
7605768|NCT02503202|18723804|P4|COMPLETED|Extension: Month 6 to 24||119
7605769|NCT02503202|18723805|P3|COMPLETED|Extension: Month 6 to 24||103
7605770|NCT02503202|18723806|P2|COMPLETED|Extension: Month 6 to 24||114
7605771|NCT02503202|18723807|P1|COMPLETED|Extension: Month 6 to 24||108
7605772|NCT02503202|18723803|P5|STARTED|Extension: Month 6 to 24||68
7605773|NCT02503202|18723804|P4|STARTED|Extension: Month 6 to 24||137
7605774|NCT02503202|18723805|P3|STARTED|Extension: Month 6 to 24||112
7605775|NCT02503202|18723806|P2|STARTED|Extension: Month 6 to 24||130
7605776|NCT02503202|18723807|P1|STARTED|Extension: Month 6 to 24||119
7605777|NCT02503202|18723803|P5|NOT COMPLETED|Base Study: Up to Month 6||3
7605778|NCT02503202|18723804|P4|NOT COMPLETED|Base Study: Up to Month 6||11
7605779|NCT02503202|18723805|P3|NOT COMPLETED|Base Study: Up to Month 6||15
7605780|NCT02503202|18723806|P2|NOT COMPLETED|Base Study: Up to Month 6||12
7605781|NCT02503202|18723807|P1|NOT COMPLETED|Base Study: Up to Month 6||18
7605782|NCT02503202|18723803|P5|COMPLETED|Base Study: Up to Month 6||130
7605783|NCT02503202|18723804|P4|COMPLETED|Base Study: Up to Month 6||255
7605784|NCT02503202|18723805|P3|COMPLETED|Base Study: Up to Month 6||252
7605785|NCT02503202|18723806|P2|COMPLETED|Base Study: Up to Month 6||253
7605786|NCT02503202|18723807|P1|COMPLETED|Base Study: Up to Month 6||248
7605787|NCT02503202|18723803|P5|Vaccinated|Base Study: Up to Month 6||133
7605788|NCT02503202|18723804|P4|Vaccinated|Base Study: Up to Month 6||264
7605789|NCT02503202|18723805|P3|Vaccinated|Base Study: Up to Month 6||266
7605790|NCT02503202|18723806|P2|Vaccinated|Base Study: Up to Month 6||265
7605791|NCT02503202|18723807|P1|Vaccinated|Base Study: Up to Month 6||266
7605792|NCT02503202|18723803|P5|STARTED|Base Study: Up to Month 6||133
7605793|NCT02503202|18723804|P4|STARTED|Base Study: Up to Month 6||266
7605794|NCT02503202|18723805|P3|STARTED|Base Study: Up to Month 6||267
7605795|NCT02503202|18723806|P2|STARTED|Base Study: Up to Month 6||265
7605796|NCT02503202|18723807|P1|STARTED|Base Study: Up to Month 6||266
7605797|NCT02503085|18723849|P4|NOT COMPLETED|Period 4||0
7605798|NCT02503085|18723850|P3|NOT COMPLETED|Period 4||0
7605799|NCT02503085|18723851|P2|NOT COMPLETED|Period 4||0
7605800|NCT02503085|18723852|P1|NOT COMPLETED|Period 4||0
7605801|NCT02503085|18723849|P4|COMPLETED|Period 4||7
7605802|NCT02503085|18723850|P3|COMPLETED|Period 4||6
7605803|NCT02503085|18723851|P2|COMPLETED|Period 4||7
7605804|NCT02503085|18723852|P1|COMPLETED|Period 4||6
7605805|NCT02503085|18723849|P4|STARTED|Period 4||7
7605806|NCT02503085|18723850|P3|STARTED|Period 4||6
7605807|NCT02503085|18723851|P2|STARTED|Period 4||7
7605808|NCT02503085|18723852|P1|STARTED|Period 4||6
7605809|NCT02503085|18723849|P4|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
7605810|NCT02503085|18723850|P3|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
7605811|NCT02503085|18723851|P2|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
7605812|NCT02503085|18723852|P1|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
7605813|NCT02503085|18723849|P4|COMPLETED|Period 3: Washout (3 to 7 Days)||7
7605814|NCT02503085|18723850|P3|COMPLETED|Period 3: Washout (3 to 7 Days)||6
7605815|NCT02503085|18723851|P2|COMPLETED|Period 3: Washout (3 to 7 Days)||7
7605816|NCT02503085|18723852|P1|COMPLETED|Period 3: Washout (3 to 7 Days)||6
7605817|NCT02503085|18723849|P4|STARTED|Period 3: Washout (3 to 7 Days)||7
7605818|NCT02503085|18723850|P3|STARTED|Period 3: Washout (3 to 7 Days)||6
7605819|NCT02503085|18723851|P2|STARTED|Period 3: Washout (3 to 7 Days)||7
7605820|NCT02503085|18723852|P1|STARTED|Period 3: Washout (3 to 7 Days)||6
7605821|NCT02503085|18723849|P4|NOT COMPLETED|Period 3||0
7605822|NCT02503085|18723850|P3|NOT COMPLETED|Period 3||0
7605823|NCT02503085|18723851|P2|NOT COMPLETED|Period 3||0
7605824|NCT02503085|18723852|P1|NOT COMPLETED|Period 3||0
7605825|NCT02503085|18723849|P4|COMPLETED|Period 3||7
7605826|NCT02503085|18723850|P3|COMPLETED|Period 3||6
7605827|NCT02503085|18723851|P2|COMPLETED|Period 3||7
7605828|NCT02503085|18723852|P1|COMPLETED|Period 3||6
7605829|NCT02503085|18723849|P4|STARTED|Period 3||7
7605830|NCT02503085|18723850|P3|STARTED|Period 3||6
7605831|NCT02503085|18723851|P2|STARTED|Period 3||7
7605832|NCT02503085|18723852|P1|STARTED|Period 3||6
7605833|NCT02503085|18723849|P4|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
7605834|NCT02503085|18723850|P3|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
7605835|NCT02503085|18723851|P2|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
7605836|NCT02503085|18723852|P1|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
7605837|NCT02503085|18723849|P4|COMPLETED|Period 2: Washout (3 to 7 Days)||7
7605838|NCT02503085|18723850|P3|COMPLETED|Period 2: Washout (3 to 7 Days)||6
7605839|NCT02503085|18723851|P2|COMPLETED|Period 2: Washout (3 to 7 Days)||7
7605840|NCT02503085|18723852|P1|COMPLETED|Period 2: Washout (3 to 7 Days)||6
7605841|NCT02503085|18723849|P4|STARTED|Period 2: Washout (3 to 7 Days)||7
7605842|NCT02503085|18723850|P3|STARTED|Period 2: Washout (3 to 7 Days)||7
7605843|NCT02503085|18723851|P2|STARTED|Period 2: Washout (3 to 7 Days)||7
7605844|NCT02503085|18723852|P1|STARTED|Period 2: Washout (3 to 7 Days)||7
7605845|NCT02503085|18723849|P4|NOT COMPLETED|Period 2||0
7605846|NCT02503085|18723850|P3|NOT COMPLETED|Period 2||0
7605847|NCT02503085|18723851|P2|NOT COMPLETED|Period 2||0
7605848|NCT02503085|18723852|P1|NOT COMPLETED|Period 2||0
7605849|NCT02503085|18723849|P4|COMPLETED|Period 2||7
7605850|NCT02503085|18723850|P3|COMPLETED|Period 2||7
7605851|NCT02503085|18723851|P2|COMPLETED|Period 2||7
7605852|NCT02503085|18723852|P1|COMPLETED|Period 2||7
7605853|NCT02503085|18723849|P4|STARTED|Period 2||7
7605854|NCT02503085|18723850|P3|STARTED|Period 2||7
7605855|NCT02503085|18723851|P2|STARTED|Period 2||7
7605856|NCT02503085|18723852|P1|STARTED|Period 2||7
7605857|NCT02503085|18723849|P4|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
7605858|NCT02503085|18723850|P3|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
7605859|NCT02503085|18723851|P2|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
7605860|NCT02503085|18723852|P1|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
7605861|NCT02503085|18723849|P4|COMPLETED|Period 1: Washout (3 to 7 Days)||7
7605862|NCT02503085|18723850|P3|COMPLETED|Period 1: Washout (3 to 7 Days)||7
7605863|NCT02503085|18723851|P2|COMPLETED|Period 1: Washout (3 to 7 Days)||7
7605864|NCT02503085|18723852|P1|COMPLETED|Period 1: Washout (3 to 7 Days)||7
7605865|NCT02503085|18723849|P4|STARTED|Period 1: Washout (3 to 7 Days)||7
7605866|NCT02503085|18723850|P3|STARTED|Period 1: Washout (3 to 7 Days)||7
7605867|NCT02503085|18723851|P2|STARTED|Period 1: Washout (3 to 7 Days)||7
7605868|NCT02503085|18723852|P1|STARTED|Period 1: Washout (3 to 7 Days)||7
7605869|NCT02503085|18723849|P4|NOT COMPLETED|Period 1||0
7605870|NCT02503085|18723850|P3|NOT COMPLETED|Period 1||0
7605871|NCT02503085|18723851|P2|NOT COMPLETED|Period 1||0
7605872|NCT02503085|18723852|P1|NOT COMPLETED|Period 1||0
7605873|NCT02503085|18723849|P4|COMPLETED|Period 1||7
7605874|NCT02503085|18723850|P3|COMPLETED|Period 1||7
7605875|NCT02503085|18723851|P2|COMPLETED|Period 1||7
7605876|NCT02503085|18723852|P1|COMPLETED|Period 1||7
7605877|NCT02503085|18723849|P4|STARTED|Period 1||7
7605878|NCT02503085|18723850|P3|STARTED|Period 1||7
7605879|NCT02503085|18723851|P2|STARTED|Period 1||7
7605880|NCT02503085|18723852|P1|STARTED|Period 1||7
7605881|NCT02502864|18723891|P1|NOT COMPLETED|Overall Study||1
7605882|NCT02502864|18723891|P1|COMPLETED|Overall Study||8
7605883|NCT02502864|18723891|P1|STARTED|Overall Study||9
7605884|NCT02502734|18723900|P2|NOT COMPLETED|Double-blind Treatment Period 2||0
7605885|NCT02502734|18723901|P1|NOT COMPLETED|Double-blind Treatment Period 2||0
7605886|NCT02502734|18723900|P2|COMPLETED|Double-blind Treatment Period 2||30
7605887|NCT02502734|18723901|P1|COMPLETED|Double-blind Treatment Period 2||28
7605888|NCT02502734|18723900|P2|STARTED|Double-blind Treatment Period 2||30
7605889|NCT02502734|18723901|P1|STARTED|Double-blind Treatment Period 2||28
7605890|NCT02502734|18723900|P2|NOT COMPLETED|Washout Period||0
7605891|NCT02502734|18723901|P1|NOT COMPLETED|Washout Period||1
7605892|NCT02502734|18723900|P2|COMPLETED|Washout Period||30
7605893|NCT02502734|18723901|P1|COMPLETED|Washout Period||28
7605894|NCT02502734|18723900|P2|STARTED|Washout Period||30
7605895|NCT02502734|18723901|P1|STARTED|Washout Period||29
7605896|NCT02502734|18723900|P2|NOT COMPLETED|Double-blind Treatment Period 1||0
7605897|NCT02502734|18723901|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
7605898|NCT02502734|18723900|P2|COMPLETED|Double-blind Treatment Period 1||30
7605899|NCT02502734|18723901|P1|COMPLETED|Double-blind Treatment Period 1||29
7605900|NCT02502734|18723900|P2|STARTED|Double-blind Treatment Period 1||30
7605901|NCT02502734|18723901|P1|STARTED|Double-blind Treatment Period 1||30
7605902|NCT02502526|18723912|P3|NOT COMPLETED|Overall Study||6
7605903|NCT02502526|18723913|P2|NOT COMPLETED|Overall Study||4
7605904|NCT02502526|18723914|P1|NOT COMPLETED|Overall Study||6
7605905|NCT02502526|18723912|P3|COMPLETED|Overall Study||55
7605906|NCT02502526|18723913|P2|COMPLETED|Overall Study||55
7605907|NCT02502526|18723914|P1|COMPLETED|Overall Study||56
7605908|NCT02502526|18723912|P3|Intent-to-Treat (ITT)|Overall Study||59
7605909|NCT02502526|18723913|P2|Intent-to-Treat (ITT)|Overall Study||57
7605910|NCT02502526|18723914|P1|Intent-to-Treat (ITT)|Overall Study||57
7605911|NCT02502526|18723912|P3|STARTED|Overall Study||61
7605912|NCT02502526|18723913|P2|STARTED|Overall Study||59
7605913|NCT02502526|18723914|P1|STARTED|Overall Study||62
7605914|NCT02502487|18723930|P3|NOT COMPLETED|Overall Study||0
7605915|NCT02502487|18723931|P2|NOT COMPLETED|Overall Study||0
7605916|NCT02502487|18723932|P1|NOT COMPLETED|Overall Study||0
7605917|NCT02502487|18723930|P3|COMPLETED|Overall Study||86
7605918|NCT02502487|18723931|P2|COMPLETED|Overall Study||86
7605919|NCT02502487|18723932|P1|COMPLETED|Overall Study||86
7605920|NCT02502487|18723930|P3|STARTED|Overall Study||86
7605921|NCT02502487|18723931|P2|STARTED|Overall Study||86
7605922|NCT02502487|18723932|P1|STARTED|Overall Study||86
7605923|NCT02502461|18724002|P2|NOT COMPLETED|Overall Study||0
7605924|NCT02502461|18724003|P1|NOT COMPLETED|Overall Study||0
7605925|NCT02502461|18724002|P2|COMPLETED|Overall Study||44
7605926|NCT02502461|18724003|P1|COMPLETED|Overall Study||46
7605927|NCT02502461|18724002|P2|STARTED|Overall Study||44
7605928|NCT02502461|18724003|P1|STARTED|Overall Study||46
7605929|NCT02502149|18724011|P5|NOT COMPLETED|Treatment Period||0
7605930|NCT02502149|18724012|P4|NOT COMPLETED|Treatment Period||0
7605931|NCT02502149|18724013|P3|NOT COMPLETED|Treatment Period||0
7605932|NCT02502149|18724014|P2|NOT COMPLETED|Treatment Period||0
7605933|NCT02502149|18724015|P1|NOT COMPLETED|Treatment Period||0
7605934|NCT02502149|18724011|P5|COMPLETED|Treatment Period||12
7605935|NCT02502149|18724012|P4|COMPLETED|Treatment Period||11
7605936|NCT02502149|18724013|P3|COMPLETED|Treatment Period||0
7605937|NCT02502149|18724014|P2|COMPLETED|Treatment Period||0
7605938|NCT02502149|18724015|P1|COMPLETED|Treatment Period||0
7605939|NCT02502149|18724011|P5|STARTED|Treatment Period||12
7605940|NCT02502149|18724012|P4|STARTED|Treatment Period||11
7605941|NCT02502149|18724013|P3|STARTED|Treatment Period||0
7605942|NCT02502149|18724014|P2|STARTED|Treatment Period||0
7605943|NCT02502149|18724015|P1|STARTED|Treatment Period||0
7605944|NCT02502149|18724011|P5|NOT COMPLETED|PK2 Assessment Period||0
7605945|NCT02502149|18724012|P4|NOT COMPLETED|PK2 Assessment Period||0
7605946|NCT02502149|18724013|P3|NOT COMPLETED|PK2 Assessment Period||0
7605947|NCT02502149|18724014|P2|NOT COMPLETED|PK2 Assessment Period||0
7605948|NCT02502149|18724015|P1|NOT COMPLETED|PK2 Assessment Period||0
7605949|NCT02502149|18724011|P5|COMPLETED|PK2 Assessment Period||0
7605950|NCT02502149|18724012|P4|COMPLETED|PK2 Assessment Period||0
7605951|NCT02502149|18724013|P3|COMPLETED|PK2 Assessment Period||12
7605952|NCT02502149|18724014|P2|COMPLETED|PK2 Assessment Period||11
7605953|NCT02502149|18724015|P1|COMPLETED|PK2 Assessment Period||0
7605954|NCT02502149|18724011|P5|STARTED|PK2 Assessment Period||0
7605955|NCT02502149|18724012|P4|STARTED|PK2 Assessment Period||0
7605956|NCT02502149|18724013|P3|STARTED|PK2 Assessment Period||12
7605957|NCT02502149|18724014|P2|STARTED|PK2 Assessment Period||11
7605958|NCT02502149|18724015|P1|STARTED|PK2 Assessment Period||0
7605959|NCT02502149|18724011|P5|NOT COMPLETED|Intermediate||0
7605960|NCT02502149|18724012|P4|NOT COMPLETED|Intermediate||0
7605961|NCT02502149|18724013|P3|NOT COMPLETED|Intermediate||0
7605962|NCT02502149|18724014|P2|NOT COMPLETED|Intermediate||0
7605963|NCT02502149|18724015|P1|NOT COMPLETED|Intermediate||1
7605964|NCT02502149|18724011|P5|COMPLETED|Intermediate||0
7605965|NCT02502149|18724012|P4|COMPLETED|Intermediate||0
7605966|NCT02502149|18724013|P3|COMPLETED|Intermediate||0
7605967|NCT02502149|18724014|P2|COMPLETED|Intermediate||0
7605968|NCT02502149|18724015|P1|COMPLETED|Intermediate||23
7605969|NCT02502149|18724011|P5|STARTED|Intermediate||0
7605970|NCT02502149|18724012|P4|STARTED|Intermediate||0
7605971|NCT02502149|18724013|P3|STARTED|Intermediate||0
7605972|NCT02502149|18724014|P2|STARTED|Intermediate||0
7605973|NCT02502149|18724015|P1|STARTED|Intermediate||24
7605974|NCT02502149|18724011|P5|NOT COMPLETED|PK1 Assessment Period||0
7605975|NCT02502149|18724012|P4|NOT COMPLETED|PK1 Assessment Period||0
7605976|NCT02502149|18724013|P3|NOT COMPLETED|PK1 Assessment Period||0
7605977|NCT02502149|18724014|P2|NOT COMPLETED|PK1 Assessment Period||0
7605978|NCT02502149|18724015|P1|NOT COMPLETED|PK1 Assessment Period||0
7605979|NCT02502149|18724011|P5|COMPLETED|PK1 Assessment Period||0
7605980|NCT02502149|18724012|P4|COMPLETED|PK1 Assessment Period||0
7605981|NCT02502149|18724013|P3|COMPLETED|PK1 Assessment Period||0
7605982|NCT02502149|18724014|P2|COMPLETED|PK1 Assessment Period||0
7605983|NCT02502149|18724015|P1|COMPLETED|PK1 Assessment Period||24
7605984|NCT02502149|18724011|P5|STARTED|PK1 Assessment Period||0
7605985|NCT02502149|18724012|P4|STARTED|PK1 Assessment Period||0
7605986|NCT02502149|18724013|P3|STARTED|PK1 Assessment Period||0
7605987|NCT02502149|18724014|P2|STARTED|PK1 Assessment Period||0
7605988|NCT02502149|18724015|P1|STARTED|PK1 Assessment Period||24
7605989|NCT02502071|18724134|P1|NOT COMPLETED|Overall Study||0
7605990|NCT02502071|18724134|P1|COMPLETED|Overall Study||45
7605991|NCT02502071|18724134|P1|STARTED|Overall Study||45
7605992|NCT02502019|18724139|P1|NOT COMPLETED|Overall Study||0
7605993|NCT02502019|18724139|P1|COMPLETED|Overall Study||27
7605994|NCT02502019|18724139|P1|STARTED|Overall Study||27
7605995|NCT02501928|18724150|P6|NOT COMPLETED|Overall Study||0
7605996|NCT02501928|18724151|P5|NOT COMPLETED|Overall Study||1
7605997|NCT02501928|18724152|P4|NOT COMPLETED|Overall Study||0
7605998|NCT02501928|18724153|P3|NOT COMPLETED|Overall Study||0
7605999|NCT02501928|18724154|P2|NOT COMPLETED|Overall Study||0
7606000|NCT02501928|18724155|P1|NOT COMPLETED|Overall Study||0
7606001|NCT02501928|18724150|P6|COMPLETED|Overall Study||3
7606002|NCT02501928|18724151|P5|COMPLETED|Overall Study||6
7606003|NCT02501928|18724152|P4|COMPLETED|Overall Study||0
7606004|NCT02501928|18724153|P3|COMPLETED|Overall Study||0
7606005|NCT02501928|18724154|P2|COMPLETED|Overall Study||2
7606006|NCT02501928|18724155|P1|COMPLETED|Overall Study||0
7606007|NCT02501928|18724150|P6|STARTED|Overall Study||3
7606008|NCT02501928|18724151|P5|STARTED|Overall Study||7
7606009|NCT02501928|18724152|P4|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
7606010|NCT02501928|18724153|P3|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
7606011|NCT02501928|18724154|P2|STARTED|Overall Study||2
7606012|NCT02501928|18724155|P1|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
7606013|NCT02501759|18724373|P1|NOT COMPLETED|Overall Study||1
7606014|NCT02501759|18724373|P1|COMPLETED|Overall Study||1
7606015|NCT02501759|18724373|P1|STARTED|Overall Study||2
7606016|NCT02501629|18724381|P2|NOT COMPLETED|Overall Study||7
7606017|NCT02501629|18724382|P1|NOT COMPLETED|Overall Study||5
7606018|NCT02501629|18724381|P2|COMPLETED|Overall Study||81
7606019|NCT02501629|18724382|P1|COMPLETED|Overall Study||84
7606020|NCT02501629|18724381|P2|STARTED|Overall Study||88
7606021|NCT02501629|18724382|P1|STARTED|Overall Study||89
7606022|NCT02501590|18724406|P2|NOT COMPLETED|Overall Study||0
7606023|NCT02501590|18724407|P1|NOT COMPLETED|Overall Study||0
7606024|NCT02501590|18724406|P2|COMPLETED|Overall Study||35
7606025|NCT02501590|18724407|P1|COMPLETED|Overall Study||13
7606026|NCT02501590|18724406|P2|STARTED|Overall Study||35
7606027|NCT02501590|18724407|P1|STARTED|Overall Study||13
7606028|NCT02501538|18724413|P1|NOT COMPLETED|Overall Study||3
7606029|NCT02501538|18724413|P1|COMPLETED|Overall Study||20
7606030|NCT02501538|18724413|P1|STARTED|Overall Study||23
7606031|NCT02501473|18724428|P8|NOT COMPLETED|Overall Study||0
7606032|NCT02501473|18724429|P7|NOT COMPLETED|Overall Study||1
7606033|NCT02501473|18724430|P6|NOT COMPLETED|Overall Study||14
7606034|NCT02501473|18724431|P5|NOT COMPLETED|Overall Study||4
7606035|NCT02501473|18724432|P4|NOT COMPLETED|Overall Study||14
7606036|NCT02501473|18724433|P3|NOT COMPLETED|Overall Study||13
7606037|NCT02501473|18724434|P2|NOT COMPLETED|Overall Study||3
7606038|NCT02501473|18724435|P1|NOT COMPLETED|Overall Study||3
7606039|NCT02501473|18724428|P8|COMPLETED|Overall Study||0
7606040|NCT02501473|18724429|P7|COMPLETED|Overall Study||0
7606041|NCT02501473|18724430|P6|COMPLETED|Overall Study||0
7606042|NCT02501473|18724431|P5|COMPLETED|Overall Study||0
7606043|NCT02501473|18724432|P4|COMPLETED|Overall Study||0
7606044|NCT02501473|18724433|P3|COMPLETED|Overall Study||0
7606045|NCT02501473|18724434|P2|COMPLETED|Overall Study||0
7606046|NCT02501473|18724435|P1|COMPLETED|Overall Study||0
7606047|NCT02501473|18724428|P8|Treated|Overall Study||0
7606048|NCT02501473|18724429|P7|Treated|Overall Study||1
7606049|NCT02501473|18724430|P6|Treated|Overall Study||14
7606050|NCT02501473|18724431|P5|Treated|Overall Study||4
7606051|NCT02501473|18724432|P4|Treated|Overall Study||13
7606052|NCT02501473|18724433|P3|Treated|Overall Study||13
7606053|NCT02501473|18724434|P2|Treated|Overall Study||3
7606054|NCT02501473|18724435|P1|Treated|Overall Study||3
7606055|NCT02501473|18724428|P8|STARTED|Overall Study||0
7606056|NCT02501473|18724429|P7|STARTED|Overall Study||1
7606057|NCT02501473|18724430|P6|STARTED|Overall Study||14
7606058|NCT02501473|18724431|P5|STARTED|Overall Study||4
7606059|NCT02501473|18724432|P4|STARTED|Overall Study||14
7606060|NCT02501473|18724433|P3|STARTED|Overall Study||13
7606061|NCT02501473|18724434|P2|STARTED|Overall Study||3
7606062|NCT02501473|18724435|P1|STARTED|Overall Study||3
7606063|NCT02501161|18724530|P2|NOT COMPLETED|Overall Study||25
7606064|NCT02501161|18724531|P1|NOT COMPLETED|Overall Study||22
7606065|NCT02501161|18724530|P2|COMPLETED|Overall Study||481
7606066|NCT02501161|18724531|P1|COMPLETED|Overall Study||484
7606067|NCT02501161|18724530|P2|Exposed|Overall Study||504
7606068|NCT02501161|18724531|P1|Exposed|Overall Study||506
7606069|NCT02501161|18724530|P2|STARTED|Overall Study||506
7606070|NCT02501161|18724531|P1|STARTED|Overall Study||506
7606071|NCT02501135|18724643|P1|NOT COMPLETED|Overall Study||0
7606072|NCT02501135|18724643|P1|COMPLETED|Overall Study||281
7606073|NCT02501135|18724643|P1|STARTED|Overall Study||281
7606074|NCT02500979|18724655|P2|NOT COMPLETED|Period 2||0
7606075|NCT02500979|18724656|P1|NOT COMPLETED|Period 2||1
7606076|NCT02500979|18724655|P2|COMPLETED|Period 2||16
7606077|NCT02500979|18724656|P1|COMPLETED|Period 2||11
7606078|NCT02500979|18724655|P2|STARTED|Period 2||16
7606079|NCT02500979|18724656|P1|STARTED|Period 2||12
7606080|NCT02500979|18724655|P2|NOT COMPLETED|Period 1||1
7606081|NCT02500979|18724656|P1|NOT COMPLETED|Period 1||4
7606082|NCT02500979|18724655|P2|COMPLETED|Period 1||16
7606083|NCT02500979|18724656|P1|COMPLETED|Period 1||12
7606084|NCT02500979|18724655|P2|STARTED|Period 1||17
7606085|NCT02500979|18724656|P1|STARTED|Period 1||16
7606086|NCT02500901|18724690|P1|NOT COMPLETED|Overall Study||2
7606087|NCT02500901|18724690|P1|COMPLETED|Overall Study||0
7606088|NCT02500901|18724690|P1|STARTED|Overall Study||2
7606089|NCT02500836|18724699|P3|NOT COMPLETED|Overall Study||1
7606090|NCT02500836|18724700|P2|NOT COMPLETED|Overall Study||5
7606091|NCT02500836|18724701|P1|NOT COMPLETED|Overall Study||3
7606092|NCT02500836|18724699|P3|COMPLETED|Overall Study||127
7606093|NCT02500836|18724700|P2|COMPLETED|Overall Study||254
7606094|NCT02500836|18724701|P1|COMPLETED|Overall Study||256
7606095|NCT02500836|18724699|P3|STARTED|Overall Study||128
7606096|NCT02500836|18724700|P2|STARTED|Overall Study||259
7606097|NCT02500836|18724701|P1|STARTED|Overall Study||259
7606098|NCT02500797|18724718|P8|NOT COMPLETED|Overall Study||0
7606099|NCT02500797|18724719|P7|NOT COMPLETED|Overall Study||0
7606100|NCT02500797|18724720|P6|NOT COMPLETED|Overall Study||1
7606101|NCT02500797|18724721|P5|NOT COMPLETED|Overall Study||1
7606102|NCT02500797|18724722|P4|NOT COMPLETED|Overall Study||0
7606103|NCT02500797|18724723|P3|NOT COMPLETED|Overall Study||0
7606104|NCT02500797|18724724|P2|NOT COMPLETED|Overall Study||0
7606105|NCT02500797|18724725|P1|NOT COMPLETED|Overall Study||1
7606106|NCT02500797|18724718|P8|COMPLETED|Overall Study||11
7606107|NCT02500797|18724719|P7|COMPLETED|Overall Study||10
7606108|NCT02500797|18724720|P6|COMPLETED|Overall Study||14
7606109|NCT02500797|18724721|P5|COMPLETED|Overall Study||13
7606110|NCT02500797|18724722|P4|COMPLETED|Overall Study||14
7606111|NCT02500797|18724723|P3|COMPLETED|Overall Study||15
7606112|NCT02500797|18724724|P2|COMPLETED|Overall Study||42
7606113|NCT02500797|18724725|P1|COMPLETED|Overall Study||42
7606114|NCT02500797|18724718|P8|Arm I Crossover|Overall Study||0
7606115|NCT02500797|18724719|P7|Arm I Crossover|Overall Study||2
7606116|NCT02500797|18724720|P6|Arm I Crossover|Overall Study||0
7606117|NCT02500797|18724721|P5|Arm I Crossover|Overall Study||1
7606118|NCT02500797|18724722|P4|Arm I Crossover|Overall Study||0
7606119|NCT02500797|18724723|P3|Arm I Crossover|Overall Study||6
7606120|NCT02500797|18724724|P2|Arm I Crossover|Overall Study||0
7606121|NCT02500797|18724725|P1|Arm I Crossover|Overall Study||4
7606122|NCT02500797|18724718|P8|STARTED|Overall Study||11
7606123|NCT02500797|18724719|P7|STARTED|Overall Study||10
7606124|NCT02500797|18724720|P6|STARTED|Overall Study||15
7606125|NCT02500797|18724721|P5|STARTED|Overall Study||14
7606126|NCT02500797|18724722|P4|STARTED|Overall Study||14
7606127|NCT02500797|18724723|P3|STARTED|Overall Study||15
7606128|NCT02500797|18724724|P2|STARTED|Overall Study||42
7606129|NCT02500797|18724725|P1|STARTED|Overall Study||43
7606130|NCT02500758|18724785|P2|NOT COMPLETED|Second Intervention (2 Minutes)||2
7606131|NCT02500758|18724786|P1|NOT COMPLETED|Second Intervention (2 Minutes)||3
7606132|NCT02500758|18724785|P2|COMPLETED|Second Intervention (2 Minutes)||10
7606133|NCT02500758|18724786|P1|COMPLETED|Second Intervention (2 Minutes)||10
7606134|NCT02500758|18724785|P2|STARTED|Second Intervention (2 Minutes)||12
7606135|NCT02500758|18724786|P1|STARTED|Second Intervention (2 Minutes)||13
7606136|NCT02500758|18724785|P2|NOT COMPLETED|Washout (1 Week)||2
7606137|NCT02500758|18724786|P1|NOT COMPLETED|Washout (1 Week)||2
7606138|NCT02500758|18724785|P2|COMPLETED|Washout (1 Week)||12
7606139|NCT02500758|18724786|P1|COMPLETED|Washout (1 Week)||13
7606140|NCT02500758|18724785|P2|STARTED|Washout (1 Week)||14
7606141|NCT02500758|18724786|P1|STARTED|Washout (1 Week)||15
7606142|NCT02500758|18724785|P2|NOT COMPLETED|First Intervention (2 Minutes)||1
7606143|NCT02500758|18724786|P1|NOT COMPLETED|First Intervention (2 Minutes)||0
7606144|NCT02500758|18724785|P2|COMPLETED|First Intervention (2 Minutes)||14
7606145|NCT02500758|18724786|P1|COMPLETED|First Intervention (2 Minutes)||15
7606146|NCT02500758|18724785|P2|STARTED|First Intervention (2 Minutes)||15
7606147|NCT02500758|18724786|P1|STARTED|First Intervention (2 Minutes)||15
7606148|NCT02500732|18724796|P2|NOT COMPLETED|Overall Study||1
7606149|NCT02500732|18724797|P1|NOT COMPLETED|Overall Study||0
7606150|NCT02500732|18724796|P2|COMPLETED|Overall Study|Not true event in 1 participant (pseudosyncope)|29
7606151|NCT02500732|18724797|P1|COMPLETED|Overall Study||27
7606152|NCT02500732|18724796|P2|STARTED|Overall Study||30
7606153|NCT02500732|18724797|P1|STARTED|Overall Study||27
7606154|NCT02500706|18724814|P3|NOT COMPLETED|Overall Study||7
7606155|NCT02500706|18724815|P2|NOT COMPLETED|Overall Study||7
7606156|NCT02500706|18724816|P1|NOT COMPLETED|Overall Study||4
7606157|NCT02500706|18724814|P3|COMPLETED|Overall Study||335
7606158|NCT02500706|18724815|P2|COMPLETED|Overall Study||334
7606159|NCT02500706|18724816|P1|COMPLETED|Overall Study||338
7606160|NCT02500706|18724814|P3|Exposed|Overall Study||342
7606161|NCT02500706|18724815|P2|Exposed|Overall Study||341
7606162|NCT02500706|18724816|P1|Exposed|Overall Study||342
7606163|NCT02500706|18724814|P3|STARTED|Overall Study||342
7606164|NCT02500706|18724815|P2|STARTED|Overall Study||341
7606165|NCT02500706|18724816|P1|STARTED|Overall Study||342
7606166|NCT02500641|18724970|P2|NOT COMPLETED|Overall Study||12
7606167|NCT02500641|18724971|P1|NOT COMPLETED|Overall Study||10
7606168|NCT02500641|18724970|P2|COMPLETED|Overall Study||86
7606169|NCT02500641|18724971|P1|COMPLETED|Overall Study||88
7606170|NCT02500641|18724970|P2|STARTED|Overall Study||98
7606171|NCT02500641|18724971|P1|STARTED|Overall Study||98
7606172|NCT02500628|18724979|P2|NOT COMPLETED|Overall Study||0
7606173|NCT02500628|18724980|P1|NOT COMPLETED|Overall Study||0
7606174|NCT02500628|18724979|P2|COMPLETED|Overall Study||23
7606175|NCT02500628|18724980|P1|COMPLETED|Overall Study||38
7606176|NCT02500628|18724979|P2|STARTED|Overall Study||23
7606177|NCT02500628|18724980|P1|STARTED|Overall Study||38
7606178|NCT02500537|18724992|P2|NOT COMPLETED|Overall Study||1
7606179|NCT02500537|18724993|P1|NOT COMPLETED|Overall Study||3
7606180|NCT02500537|18724992|P2|COMPLETED|Overall Study||39
7606181|NCT02500537|18724993|P1|COMPLETED|Overall Study||57
7606182|NCT02500537|18724992|P2|STARTED|Overall Study||40
7606183|NCT02500537|18724993|P1|STARTED|Overall Study||60
7606184|NCT02500368|18725011|P2|NOT COMPLETED|Second Intervention (1 Week)||0
7606185|NCT02500368|18725012|P1|NOT COMPLETED|Second Intervention (1 Week)||0
7606186|NCT02500368|18725011|P2|COMPLETED|Second Intervention (1 Week)||20
7606187|NCT02500368|18725012|P1|COMPLETED|Second Intervention (1 Week)||20
7606188|NCT02500368|18725011|P2|STARTED|Second Intervention (1 Week)||20
7606189|NCT02500368|18725012|P1|STARTED|Second Intervention (1 Week)||20
7606190|NCT02500368|18725011|P2|NOT COMPLETED|First Intervention (1 Week)||0
7606191|NCT02500368|18725012|P1|NOT COMPLETED|First Intervention (1 Week)||0
7606192|NCT02500368|18725011|P2|COMPLETED|First Intervention (1 Week)||20
7606193|NCT02500368|18725012|P1|COMPLETED|First Intervention (1 Week)||20
7606194|NCT02500368|18725011|P2|STARTED|First Intervention (1 Week)||20
7606195|NCT02500368|18725012|P1|STARTED|First Intervention (1 Week)||20
7606196|NCT02500056|18725062|P2|NOT COMPLETED|Overall Study||8
7606197|NCT02500056|18725063|P1|NOT COMPLETED|Overall Study||7
7606198|NCT02500056|18725062|P2|COMPLETED|Overall Study||65
7606199|NCT02500056|18725063|P1|COMPLETED|Overall Study||63
7606200|NCT02500056|18725062|P2|STARTED|Overall Study||73
7606201|NCT02500056|18725063|P1|STARTED|Overall Study||70
7606202|NCT02499952|18725073|P1|NOT COMPLETED|Overall Study||10
7606203|NCT02499952|18725073|P1|COMPLETED|Overall Study||2
7606204|NCT02499952|18725073|P1|STARTED|Overall Study||12
7606205|NCT02499900|18725082|P2|NOT COMPLETED|Extension Study Period||20
7606206|NCT02499900|18725083|P1|NOT COMPLETED|Extension Study Period||12
7606207|NCT02499900|18725082|P2|COMPLETED|Extension Study Period||377
7606208|NCT02499900|18725083|P1|COMPLETED|Extension Study Period||380
7606209|NCT02499900|18725082|P2|Safety Analysis Set|Extension Study Period|One participant was not treated in the Extension Study Period|396
7606210|NCT02499900|18725083|P1|Safety Analysis Set|Extension Study Period||392
7606211|NCT02499900|18725082|P2|STARTED|Extension Study Period||397
7606212|NCT02499900|18725083|P1|STARTED|Extension Study Period||392
7606213|NCT02499900|18725082|P2|NOT COMPLETED|Completed Core, Continued Into Extension||2
7606214|NCT02499900|18725083|P1|NOT COMPLETED|Completed Core, Continued Into Extension||3
7606215|NCT02499900|18725082|P2|COMPLETED|Completed Core, Continued Into Extension||397
7606216|NCT02499900|18725083|P1|COMPLETED|Completed Core, Continued Into Extension||392
7606217|NCT02499900|18725082|P2|STARTED|Completed Core, Continued Into Extension||399
7606218|NCT02499900|18725083|P1|STARTED|Completed Core, Continued Into Extension||395
7606219|NCT02499900|18725082|P2|NOT COMPLETED|Core Study Period||32
7606220|NCT02499900|18725083|P1|NOT COMPLETED|Core Study Period||35
7606221|NCT02499900|18725082|P2|COMPLETED|Core Study Period||399
7606222|NCT02499900|18725083|P1|COMPLETED|Core Study Period||395
7606223|NCT02499900|18725082|P2|Safety Analysis Set|Core Study Period||430
7606224|NCT02499900|18725083|P1|Safety Analysis Set|Core Study Period||427
7606225|NCT02499900|18725082|P2|STARTED|Core Study Period||431
7606226|NCT02499900|18725083|P1|STARTED|Core Study Period||430
7606227|NCT02499887|18725105|P2|NOT COMPLETED|Overall Study||0
7606228|NCT02499887|18725106|P1|NOT COMPLETED|Overall Study||0
7606229|NCT02499887|18725105|P2|COMPLETED|Overall Study||3
7606230|NCT02499887|18725106|P1|COMPLETED|Overall Study||3
7606231|NCT02499887|18725105|P2|STARTED|Overall Study||3
7606232|NCT02499887|18725106|P1|STARTED|Overall Study||3
7606233|NCT02499783|18725114|P3|NOT COMPLETED|Open Label Period: Weeks 8 to 26||29
7606234|NCT02499783|18725115|P2|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
7606235|NCT02499783|18725116|P1|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
7606236|NCT02499783|18725114|P3|COMPLETED|Open Label Period: Weeks 8 to 26||159
7606237|NCT02499783|18725115|P2|COMPLETED|Open Label Period: Weeks 8 to 26||0
7606238|NCT02499783|18725116|P1|COMPLETED|Open Label Period: Weeks 8 to 26||0
7606239|NCT02499783|18725114|P3|STARTED|Open Label Period: Weeks 8 to 26||188
7606240|NCT02499783|18725115|P2|STARTED|Open Label Period: Weeks 8 to 26||0
7606241|NCT02499783|18725116|P1|STARTED|Open Label Period: Weeks 8 to 26||0
7606242|NCT02499783|18725114|P3|NOT COMPLETED|DB Period: Weeks 0-8||0
7606243|NCT02499783|18725115|P2|NOT COMPLETED|DB Period: Weeks 0-8||7
7606244|NCT02499783|18725116|P1|NOT COMPLETED|DB Period: Weeks 0-8||10
7606245|NCT02499783|18725114|P3|COMPLETED|DB Period: Weeks 0-8||0
7606246|NCT02499783|18725115|P2|COMPLETED|DB Period: Weeks 0-8||96
7606247|NCT02499783|18725116|P1|COMPLETED|DB Period: Weeks 0-8||92
7606248|NCT02499783|18725114|P3|STARTED|DB Period: Weeks 0-8||0
7606249|NCT02499783|18725115|P2|STARTED|DB Period: Weeks 0-8||103
7606250|NCT02499783|18725116|P1|STARTED|DB Period: Weeks 0-8||102
7606251|NCT02499783|18725114|P3|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
7606252|NCT02499783|18725115|P2|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||5
7606253|NCT02499783|18725116|P1|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||4
7606254|NCT02499783|18725114|P3|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
7606255|NCT02499783|18725115|P2|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
7606256|NCT02499783|18725116|P1|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
7606257|NCT02499783|18725114|P3|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||0
7606258|NCT02499783|18725115|P2|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||103
7606259|NCT02499783|18725116|P1|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||102
7606260|NCT02499770|18725165|P2|NOT COMPLETED|Overall Study||77
7606261|NCT02499770|18725166|P1|NOT COMPLETED|Overall Study||19
7606262|NCT02499770|18725165|P2|COMPLETED|Overall Study||0
7606263|NCT02499770|18725166|P1|COMPLETED|Overall Study||0
7606264|NCT02499770|18725165|P2|STARTED|Overall Study||77
7606265|NCT02499770|18725166|P1|STARTED|Overall Study||19
7606266|NCT02499692|18725275|P1|NOT COMPLETED|Overall Study||0
7606267|NCT02499692|18725275|P1|COMPLETED|Overall Study||103
7606268|NCT02499692|18725275|P1|STARTED|Overall Study||103
7606269|NCT02499575|18725286|P2|NOT COMPLETED|Overall Study||1
7606270|NCT02499575|18725287|P1|NOT COMPLETED|Overall Study||0
7606271|NCT02499575|18725286|P2|COMPLETED|Overall Study||0
7606272|NCT02499575|18725287|P1|COMPLETED|Overall Study||1
7606273|NCT02499575|18725286|P2|STARTED|Overall Study||1
7606274|NCT02499575|18725287|P1|STARTED|Overall Study||1
7606275|NCT02499406|18725297|P1|NOT COMPLETED|Overall Study||4
7606276|NCT02499406|18725297|P1|COMPLETED|Overall Study||13
7606277|NCT02499406|18725297|P1|STARTED|Overall Study||17
7606278|NCT02499380|18725313|P1|NOT COMPLETED|Overall Study||3
7606279|NCT02499380|18725313|P1|COMPLETED|Overall Study||17
7606280|NCT02499380|18725313|P1|STARTED|Overall Study||20
7606281|NCT02499263|18725318|P1|NOT COMPLETED|Overall Study||62
7606282|NCT02499263|18725318|P1|COMPLETED|Overall Study||84
7606283|NCT02499263|18725318|P1|STARTED|Overall Study||146
7606284|NCT02499172|18725355|P4|NOT COMPLETED|Overall Study||436
7606285|NCT02499172|18725356|P3|NOT COMPLETED|Overall Study||523
7606286|NCT02499172|18725357|P2|NOT COMPLETED|Overall Study||64
7606287|NCT02499172|18725358|P1|NOT COMPLETED|Overall Study||65
7606288|NCT02499172|18725355|P4|COMPLETED|Overall Study||0
7606289|NCT02499172|18725356|P3|COMPLETED|Overall Study||0
7606290|NCT02499172|18725357|P2|COMPLETED|Overall Study||835
7606291|NCT02499172|18725358|P1|COMPLETED|Overall Study||835
7606292|NCT02499172|18725355|P4|STARTED|Overall Study||436
7606293|NCT02499172|18725356|P3|STARTED|Overall Study||523
7606294|NCT02499172|18725357|P2|STARTED|Overall Study||899
7606295|NCT02499172|18725358|P1|STARTED|Overall Study||900
7606296|NCT02499159|18725370|P2|NOT COMPLETED|30-Day Follow-Up Phone Call||2
7606297|NCT02499159|18725371|P1|NOT COMPLETED|30-Day Follow-Up Phone Call||7
7606298|NCT02499159|18725370|P2|COMPLETED|30-Day Follow-Up Phone Call||47
7606299|NCT02499159|18725371|P1|COMPLETED|30-Day Follow-Up Phone Call||42
7606300|NCT02499159|18725370|P2|STARTED|30-Day Follow-Up Phone Call||49
7606301|NCT02499159|18725371|P1|STARTED|30-Day Follow-Up Phone Call||49
7606302|NCT02499159|18725370|P2|NOT COMPLETED|Randomization||1
7606303|NCT02499159|18725371|P1|NOT COMPLETED|Randomization||1
7606304|NCT02499159|18725370|P2|COMPLETED|Randomization||49
7606305|NCT02499159|18725371|P1|COMPLETED|Randomization||49
7606306|NCT02499159|18725370|P2|STARTED|Randomization||50
7606307|NCT02499159|18725371|P1|STARTED|Randomization||50
7606308|NCT02499146|18725395|P1|NOT COMPLETED|Overall Study||26
7606309|NCT02499146|18725395|P1|COMPLETED|Overall Study||0
7606310|NCT02499146|18725395|P1|STARTED|Overall Study||26
7606311|NCT02499120|18725435|P2|NOT COMPLETED|Overall Study||60
7606312|NCT02499120|18725436|P1|NOT COMPLETED|Overall Study||65
7606313|NCT02499120|18725435|P2|COMPLETED|Overall Study||0
7606314|NCT02499120|18725436|P1|COMPLETED|Overall Study||0
7606315|NCT02499120|18725435|P2|Received Treatment|Overall Study||60
7606316|NCT02499120|18725436|P1|Received Treatment|Overall Study||64
7606317|NCT02499120|18725435|P2|STARTED|Overall Study||60
7606318|NCT02499120|18725436|P1|STARTED|Overall Study||65
7606319|NCT02499029|18725467|P2|NOT COMPLETED|Overall Study||3
7606320|NCT02499029|18725468|P1|NOT COMPLETED|Overall Study||5
7606321|NCT02499029|18725467|P2|COMPLETED|Overall Study||14
7606322|NCT02499029|18725468|P1|COMPLETED|Overall Study||13
7606323|NCT02499029|18725467|P2|STARTED|Overall Study||17
7606324|NCT02499029|18725468|P1|STARTED|Overall Study||18
7606325|NCT02498834|18725482|P2|NOT COMPLETED|Overall Study||10
7606326|NCT02498834|18725483|P1|NOT COMPLETED|Overall Study||10
7606327|NCT02498834|18725482|P2|COMPLETED|Overall Study||164
7606328|NCT02498834|18725483|P1|COMPLETED|Overall Study||175
7606329|NCT02498834|18725482|P2|STARTED|Overall Study||174
7606330|NCT02498834|18725483|P1|STARTED|Overall Study||185
7606331|NCT02498821|18725495|P2|NOT COMPLETED|Overall Study||5
7606332|NCT02498821|18725496|P1|NOT COMPLETED|Overall Study||3
7606333|NCT02498821|18725495|P2|COMPLETED|Overall Study||60
7606334|NCT02498821|18725496|P1|COMPLETED|Overall Study||60
7606335|NCT02498821|18725495|P2|STARTED|Overall Study||65
7606336|NCT02498821|18725496|P1|STARTED|Overall Study||63
7606337|NCT02498769|18725525|P2|NOT COMPLETED|Overall Study||0
7606338|NCT02498769|18725526|P1|NOT COMPLETED|Overall Study||0
7606339|NCT02498769|18725525|P2|COMPLETED|Overall Study||67
7606340|NCT02498769|18725526|P1|COMPLETED|Overall Study||63
7606341|NCT02498769|18725525|P2|STARTED|Overall Study||67
7606342|NCT02498769|18725526|P1|STARTED|Overall Study||63
7606343|NCT02498678|18725540|P2|NOT COMPLETED|Overall Study||2
7606344|NCT02498678|18725541|P1|NOT COMPLETED|Overall Study||0
7606345|NCT02498678|18725540|P2|COMPLETED|Overall Study||23
7606346|NCT02498678|18725541|P1|COMPLETED|Overall Study||25
7606347|NCT02498678|18725540|P2|STARTED|Overall Study||25
7606348|NCT02498678|18725541|P1|STARTED|Overall Study||25
7606349|NCT02498652|18725557|P2|NOT COMPLETED|Overall Study||1
7606350|NCT02498652|18725558|P1|NOT COMPLETED|Overall Study||0
7606351|NCT02498652|18725557|P2|COMPLETED|Overall Study|One subject was withdrawn due to noncompliance/protocol violation|20
7606352|NCT02498652|18725558|P1|COMPLETED|Overall Study||20
7606353|NCT02498652|18725557|P2|STARTED|Overall Study||21
7606354|NCT02498652|18725558|P1|STARTED|Overall Study||20
7606355|NCT02498600|18725659|P2|NOT COMPLETED|Overall Study||0
7606356|NCT02498600|18725660|P1|NOT COMPLETED|Overall Study||0
7606357|NCT02498600|18725659|P2|COMPLETED|Overall Study||51
7606358|NCT02498600|18725660|P1|COMPLETED|Overall Study||49
7606359|NCT02498600|18725659|P2|STARTED|Overall Study||51
7606360|NCT02498600|18725660|P1|STARTED|Overall Study||49
7606361|NCT02498522|18725674|P2|NOT COMPLETED|Overall Study||2
7606362|NCT02498522|18725675|P1|NOT COMPLETED|Overall Study||2
7606363|NCT02498522|18725674|P2|COMPLETED|Overall Study||83
7606364|NCT02498522|18725675|P1|COMPLETED|Overall Study||83
7606365|NCT02498522|18725674|P2|STARTED|Overall Study||85
7606366|NCT02498522|18725675|P1|STARTED|Overall Study||85
7606367|NCT02498483|18725683|P2|NOT COMPLETED|Overall Study||0
7606368|NCT02498483|18725684|P1|NOT COMPLETED|Overall Study||0
7606369|NCT02498483|18725683|P2|COMPLETED|Overall Study||5
7606370|NCT02498483|18725684|P1|COMPLETED|Overall Study||6
7606371|NCT02498483|18725683|P2|STARTED|Overall Study||5
7606372|NCT02498483|18725684|P1|STARTED|Overall Study||6
7606373|NCT02498418|18725701|P3|NOT COMPLETED|Overall Study||6
7606374|NCT02498418|18725702|P2|NOT COMPLETED|Overall Study||2
7606375|NCT02498418|18725703|P1|NOT COMPLETED|Overall Study||2
7606376|NCT02498418|18725701|P3|COMPLETED|Overall Study||238
7606377|NCT02498418|18725702|P2|COMPLETED|Overall Study||246
7606378|NCT02498418|18725703|P1|COMPLETED|Overall Study||245
7606379|NCT02498418|18725701|P3|Per-protocol Analysis Set|Overall Study||176
7606380|NCT02498418|18725702|P2|Per-protocol Analysis Set|Overall Study||181
7606381|NCT02498418|18725703|P1|Per-protocol Analysis Set|Overall Study||182
7606382|NCT02498418|18725701|P3|Modified Intent-to-treat Population|Overall Study||180
7606383|NCT02498418|18725702|P2|Modified Intent-to-treat Population|Overall Study||186
7606384|NCT02498418|18725703|P1|Modified Intent-to-treat Population|Overall Study||183
7606385|NCT02498418|18725701|P3|Safety Population|Overall Study||244
7606386|NCT02498418|18725702|P2|Safety Population|Overall Study||247
7606387|NCT02498418|18725703|P1|Safety Population|Overall Study||246
7606388|NCT02498418|18725701|P3|STARTED|Overall Study||244
7606389|NCT02498418|18725702|P2|STARTED|Overall Study||248
7606390|NCT02498418|18725703|P1|STARTED|Overall Study||247
7606391|NCT02498236|18725727|P8|NOT COMPLETED|Overall Study||1
7606392|NCT02498236|18725728|P7|NOT COMPLETED|Overall Study||1
7606393|NCT02498236|18725729|P6|NOT COMPLETED|Overall Study||0
7606394|NCT02498236|18725730|P5|NOT COMPLETED|Overall Study||1
7606395|NCT02498236|18725731|P4|NOT COMPLETED|Overall Study||0
7606396|NCT02498236|18725732|P3|NOT COMPLETED|Overall Study||0
7606397|NCT02498236|18725733|P2|NOT COMPLETED|Overall Study||0
7606398|NCT02498236|18725734|P1|NOT COMPLETED|Overall Study||1
7606399|NCT02498236|18725727|P8|COMPLETED|Overall Study||6
7606400|NCT02498236|18725728|P7|COMPLETED|Overall Study||6
7606401|NCT02498236|18725729|P6|COMPLETED|Overall Study||6
7606402|NCT02498236|18725730|P5|COMPLETED|Overall Study||6
7606403|NCT02498236|18725731|P4|COMPLETED|Overall Study||6
7606404|NCT02498236|18725732|P3|COMPLETED|Overall Study||6
7606405|NCT02498236|18725733|P2|COMPLETED|Overall Study||6
7606406|NCT02498236|18725734|P1|COMPLETED|Overall Study||5
7606407|NCT02498236|18725727|P8|Randomized|Overall Study||7
7606408|NCT02498236|18725728|P7|Randomized|Overall Study||7
7606409|NCT02498236|18725729|P6|Randomized|Overall Study||6
7606410|NCT02498236|18725730|P5|Randomized|Overall Study||7
7606411|NCT02498236|18725731|P4|Randomized|Overall Study||6
7606412|NCT02498236|18725732|P3|Randomized|Overall Study||6
7606413|NCT02498236|18725733|P2|Randomized|Overall Study||6
7606414|NCT02498236|18725734|P1|Randomized|Overall Study||6
7606415|NCT02498236|18725727|P8|STARTED|Overall Study||7
7606416|NCT02498236|18725728|P7|STARTED|Overall Study||7
7606417|NCT02498236|18725729|P6|STARTED|Overall Study||6
7606418|NCT02498236|18725730|P5|STARTED|Overall Study||7
7606419|NCT02498236|18725731|P4|STARTED|Overall Study||6
7606420|NCT02498236|18725732|P3|STARTED|Overall Study||6
7606421|NCT02498236|18725733|P2|STARTED|Overall Study||6
7606422|NCT02498236|18725734|P1|STARTED|Overall Study||6
7606423|NCT02498067|18725763|P1|NOT COMPLETED|Overall Study||33
7606424|NCT02498067|18725763|P1|COMPLETED|Overall Study||71
7606425|NCT02498067|18725763|P1|STARTED|Overall Study||104
7606426|NCT02497976|18725784|P2|NOT COMPLETED|Overall Study||1
7606427|NCT02497976|18725785|P1|NOT COMPLETED|Overall Study||2
7606428|NCT02497976|18725784|P2|COMPLETED|Overall Study||13
7606429|NCT02497976|18725785|P1|COMPLETED|Overall Study||26
7606430|NCT02497976|18725784|P2|STARTED|Overall Study||14
7606431|NCT02497976|18725785|P1|STARTED|Overall Study||28
7606432|NCT02497937|18725801|P2|NOT COMPLETED|Period 2 (Up to 7 Days)||0
7606433|NCT02497937|18725802|P1|NOT COMPLETED|Period 2 (Up to 7 Days)||0
7606434|NCT02497937|18725801|P2|COMPLETED|Period 2 (Up to 7 Days)||5
7606435|NCT02497937|18725802|P1|COMPLETED|Period 2 (Up to 7 Days)||6
7606436|NCT02497937|18725801|P2|STARTED|Period 2 (Up to 7 Days)||5
7606437|NCT02497937|18725802|P1|STARTED|Period 2 (Up to 7 Days)||6
7606438|NCT02497937|18725801|P2|NOT COMPLETED|Washout Period (Up to 14 Days)||0
7606439|NCT02497937|18725802|P1|NOT COMPLETED|Washout Period (Up to 14 Days)||0
7606440|NCT02497937|18725801|P2|COMPLETED|Washout Period (Up to 14 Days)||5
7606441|NCT02497937|18725802|P1|COMPLETED|Washout Period (Up to 14 Days)||6
7606442|NCT02497937|18725801|P2|STARTED|Washout Period (Up to 14 Days)||5
7606443|NCT02497937|18725802|P1|STARTED|Washout Period (Up to 14 Days)||6
7606444|NCT02497937|18725801|P2|NOT COMPLETED|Period 1 (Up to 7 Days)||0
7606445|NCT02497937|18725802|P1|NOT COMPLETED|Period 1 (Up to 7 Days)||0
7606446|NCT02497937|18725801|P2|COMPLETED|Period 1 (Up to 7 Days)||5
7606447|NCT02497937|18725802|P1|COMPLETED|Period 1 (Up to 7 Days)||6
7606448|NCT02497937|18725801|P2|STARTED|Period 1 (Up to 7 Days)||5
7606449|NCT02497937|18725802|P1|STARTED|Period 1 (Up to 7 Days)||6
7606450|NCT02497781|18725880|P2|NOT COMPLETED|Overall Study||3
7606451|NCT02497781|18725881|P1|NOT COMPLETED|Overall Study||4
7606452|NCT02497781|18725880|P2|COMPLETED|Overall Study||26
7606453|NCT02497781|18725881|P1|COMPLETED|Overall Study||64
7606454|NCT02497781|18725880|P2|Treated|Overall Study||28
7606455|NCT02497781|18725881|P1|Treated|Overall Study||67
7606456|NCT02497781|18725880|P2|STARTED|Overall Study||29
7606457|NCT02497781|18725881|P1|STARTED|Overall Study||68
7606458|NCT02497755|18725944|P2|NOT COMPLETED|Overall Study||0
7606459|NCT02497755|18725945|P1|NOT COMPLETED|Overall Study||1
7606460|NCT02497755|18725944|P2|COMPLETED|Overall Study||1
7606461|NCT02497755|18725945|P1|COMPLETED|Overall Study||17
7606462|NCT02497755|18725944|P2|STARTED|Overall Study||1
7606463|NCT02497755|18725945|P1|STARTED|Overall Study||18
7606464|NCT02497612|18725962|P4|NOT COMPLETED|Overall Study||47
7606465|NCT02497612|18725963|P3|NOT COMPLETED|Overall Study||49
7606466|NCT02497612|18725964|P2|NOT COMPLETED|Overall Study||57
7606467|NCT02497612|18725965|P1|NOT COMPLETED|Overall Study||66
7606468|NCT02497612|18725962|P4|COMPLETED|Overall Study||46
7606469|NCT02497612|18725963|P3|COMPLETED|Overall Study||48
7606470|NCT02497612|18725964|P2|COMPLETED|Overall Study||37
7606471|NCT02497612|18725965|P1|COMPLETED|Overall Study||27
7606472|NCT02497612|18725962|P4|Cohort 4: >6 Months to <=2 Years|Overall Study||7
7606473|NCT02497612|18725963|P3|Cohort 4: >6 Months to <=2 Years|Overall Study||6
7606474|NCT02497612|18725964|P2|Cohort 4: >6 Months to <=2 Years|Overall Study||8
7606475|NCT02497612|18725965|P1|Cohort 4: >6 Months to <=2 Years|Overall Study||7
7606476|NCT02497612|18725962|P4|Cohort 3: >2 Years to <=5 Years|Overall Study||65
7606477|NCT02497612|18725963|P3|Cohort 3: >2 Years to <=5 Years|Overall Study||67
7606478|NCT02497612|18725964|P2|Cohort 3: >2 Years to <=5 Years|Overall Study||66
7606479|NCT02497612|18725965|P1|Cohort 3: >2 Years to <=5 Years|Overall Study||66
7606480|NCT02497612|18725962|P4|Cohort 2: >5 Years to <=14 Years|Overall Study||5
7606481|NCT02497612|18725963|P3|Cohort 2: >5 Years to <=14 Years|Overall Study||6
7606482|NCT02497612|18725964|P2|Cohort 2: >5 Years to <=14 Years|Overall Study||5
7606483|NCT02497612|18725965|P1|Cohort 2: >5 Years to <=14 Years|Overall Study||6
7606484|NCT02497612|18725962|P4|Cohort 1: >14 Years to <70 Years|Overall Study||16
7606485|NCT02497612|18725963|P3|Cohort 1: >14 Years to <70 Years|Overall Study||18
7606486|NCT02497612|18725964|P2|Cohort 1: >14 Years to <70 Years|Overall Study||15
7606487|NCT02497612|18725965|P1|Cohort 1: >14 Years to <70 Years|Overall Study||14
7606488|NCT02497612|18725962|P4|Treated|Overall Study||91
7606489|NCT02497612|18725963|P3|Treated|Overall Study||96
7606490|NCT02497612|18725964|P2|Treated|Overall Study||94
7606491|NCT02497612|18725965|P1|Treated|Overall Study||92
7606492|NCT02497612|18725962|P4|STARTED|Overall Study||93
7606493|NCT02497612|18725963|P3|STARTED|Overall Study||97
7606494|NCT02497612|18725964|P2|STARTED|Overall Study||94
7606495|NCT02497612|18725965|P1|STARTED|Overall Study||93
7606496|NCT02497469|18726093|P2|NOT COMPLETED|Overall Study||115
7606497|NCT02497469|18726094|P1|NOT COMPLETED|Overall Study||169
7606498|NCT02497469|18726093|P2|COMPLETED|Overall Study||270
7606499|NCT02497469|18726094|P1|COMPLETED|Overall Study||217
7606500|NCT02497469|18726093|P2|Safety Analysis Set|Overall Study||383
7606501|NCT02497469|18726094|P1|Safety Analysis Set|Overall Study||386
7606502|NCT02497469|18726093|P2|STARTED|Overall Study||385
7606503|NCT02497469|18726094|P1|STARTED|Overall Study||386
7606504|NCT02497391|18726104|P6|NOT COMPLETED|Period 3 (14 Days)||0
7606505|NCT02497391|18726105|P5|NOT COMPLETED|Period 3 (14 Days)||1
7606506|NCT02497391|18726106|P4|NOT COMPLETED|Period 3 (14 Days)||0
7606507|NCT02497391|18726107|P3|NOT COMPLETED|Period 3 (14 Days)||1
7606508|NCT02497391|18726108|P2|NOT COMPLETED|Period 3 (14 Days)||1
7606509|NCT02497391|18726109|P1|NOT COMPLETED|Period 3 (14 Days)||0
7606510|NCT02497391|18726104|P6|COMPLETED|Period 3 (14 Days)||13
7606511|NCT02497391|18726105|P5|COMPLETED|Period 3 (14 Days)||13
7606512|NCT02497391|18726106|P4|COMPLETED|Period 3 (14 Days)||13
7606513|NCT02497391|18726107|P3|COMPLETED|Period 3 (14 Days)||12
7606514|NCT02497391|18726108|P2|COMPLETED|Period 3 (14 Days)||13
7606515|NCT02497391|18726109|P1|COMPLETED|Period 3 (14 Days)||12
7606516|NCT02497391|18726104|P6|STARTED|Period 3 (14 Days)||13
7606517|NCT02497391|18726105|P5|STARTED|Period 3 (14 Days)||14
7606518|NCT02497391|18726106|P4|STARTED|Period 3 (14 Days)||13
7606519|NCT02497391|18726107|P3|STARTED|Period 3 (14 Days)||13
7606520|NCT02497391|18726108|P2|STARTED|Period 3 (14 Days)||14
7606521|NCT02497391|18726109|P1|STARTED|Period 3 (14 Days)||12
7606522|NCT02497391|18726104|P6|NOT COMPLETED|Period 2 (14 Days)||3
7606523|NCT02497391|18726105|P5|NOT COMPLETED|Period 2 (14 Days)||2
7606524|NCT02497391|18726106|P4|NOT COMPLETED|Period 2 (14 Days)||3
7606525|NCT02497391|18726107|P3|NOT COMPLETED|Period 2 (14 Days)||3
7606526|NCT02497391|18726108|P2|NOT COMPLETED|Period 2 (14 Days)||1
7606527|NCT02497391|18726109|P1|NOT COMPLETED|Period 2 (14 Days)||4
7606528|NCT02497391|18726104|P6|COMPLETED|Period 2 (14 Days)||13
7606529|NCT02497391|18726105|P5|COMPLETED|Period 2 (14 Days)||14
7606530|NCT02497391|18726106|P4|COMPLETED|Period 2 (14 Days)||13
7606531|NCT02497391|18726107|P3|COMPLETED|Period 2 (14 Days)||13
7606532|NCT02497391|18726108|P2|COMPLETED|Period 2 (14 Days)||14
7606533|NCT02497391|18726109|P1|COMPLETED|Period 2 (14 Days)||12
7606534|NCT02497391|18726104|P6|STARTED|Period 2 (14 Days)||16
7606535|NCT02497391|18726105|P5|STARTED|Period 2 (14 Days)||16
7606536|NCT02497391|18726106|P4|STARTED|Period 2 (14 Days)||16
7606537|NCT02497391|18726107|P3|STARTED|Period 2 (14 Days)||16
7606538|NCT02497391|18726108|P2|STARTED|Period 2 (14 Days)||15
7606539|NCT02497391|18726109|P1|STARTED|Period 2 (14 Days)||16
7606540|NCT02497391|18726104|P6|NOT COMPLETED|Period 1 (14 Days)||0
7606541|NCT02497391|18726105|P5|NOT COMPLETED|Period 1 (14 Days)||0
7606542|NCT02497391|18726106|P4|NOT COMPLETED|Period 1 (14 Days)||0
7606543|NCT02497391|18726107|P3|NOT COMPLETED|Period 1 (14 Days)||0
7606544|NCT02497391|18726108|P2|NOT COMPLETED|Period 1 (14 Days)||0
7606545|NCT02497391|18726109|P1|NOT COMPLETED|Period 1 (14 Days)||0
7606546|NCT02497391|18726104|P6|COMPLETED|Period 1 (14 Days)||16
7606547|NCT02497391|18726105|P5|COMPLETED|Period 1 (14 Days)||16
7606548|NCT02497391|18726106|P4|COMPLETED|Period 1 (14 Days)||16
7606549|NCT02497391|18726107|P3|COMPLETED|Period 1 (14 Days)||16
7606550|NCT02497391|18726108|P2|COMPLETED|Period 1 (14 Days)||15
7606551|NCT02497391|18726109|P1|COMPLETED|Period 1 (14 Days)||16
7606552|NCT02497391|18726104|P6|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
7606553|NCT02497391|18726105|P5|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
7606554|NCT02497391|18726106|P4|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
7606555|NCT02497391|18726107|P3|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
7606556|NCT02497391|18726108|P2|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||15
7606557|NCT02497391|18726109|P1|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
7606558|NCT02497391|18726104|P6|STARTED|Period 1 (14 Days)||16
7606559|NCT02497391|18726105|P5|STARTED|Period 1 (14 Days)||16
7606560|NCT02497391|18726106|P4|STARTED|Period 1 (14 Days)||16
7606561|NCT02497391|18726107|P3|STARTED|Period 1 (14 Days)||16
7606562|NCT02497391|18726108|P2|STARTED|Period 1 (14 Days)||15
7606563|NCT02497391|18726109|P1|STARTED|Period 1 (14 Days)||16
7606564|NCT02497287|18726120|P1|NOT COMPLETED|Follow-up Phase (4 Week)||31
7606565|NCT02497287|18726120|P1|COMPLETED|Follow-up Phase (4 Week)||326
7606566|NCT02497287|18726120|P1|STARTED|Follow-up Phase (4 Week)|Included non-responders (IND phase) or discontinued treatment phase or completed OP/MA phase.|357
7606567|NCT02497287|18726120|P1|NOT COMPLETED|Optimization/Maintenance (48 Weeks)||453
7606568|NCT02497287|18726120|P1|COMPLETED|Optimization/Maintenance (48 Weeks)||150
7606569|NCT02497287|18726120|P1|STARTED|Optimization/Maintenance (48 Weeks)|Included who completed IND phase (580) + responders from TRD3005 (23).|603
7606570|NCT02497287|18726120|P1|NOT COMPLETED|Induction Phase (4 Weeks)||199
7606571|NCT02497287|18726120|P1|COMPLETED|Induction Phase (4 Weeks)||580
7606572|NCT02497287|18726120|P1|STARTED|Induction Phase (4 Weeks)|Included DE participants (691) and non-responders from TRD3005 (88).|779
7606573|NCT02497235|18726164|P5|NOT COMPLETED|Overall Study||0
7606574|NCT02497235|18726165|P4|NOT COMPLETED|Overall Study||0
7606575|NCT02497235|18726166|P3|NOT COMPLETED|Overall Study||0
7606576|NCT02497235|18726167|P2|NOT COMPLETED|Overall Study||0
7606577|NCT02497235|18726168|P1|NOT COMPLETED|Overall Study||0
7606578|NCT02497235|18726164|P5|COMPLETED|Overall Study||3
7606579|NCT02497235|18726165|P4|COMPLETED|Overall Study||2
7606580|NCT02497235|18726166|P3|COMPLETED|Overall Study||2
7606581|NCT02497235|18726167|P2|COMPLETED|Overall Study||2
7606582|NCT02497235|18726168|P1|COMPLETED|Overall Study||2
7606583|NCT02497235|18726164|P5|STARTED|Overall Study||3
7606584|NCT02497235|18726165|P4|STARTED|Overall Study||2
7606585|NCT02497235|18726166|P3|STARTED|Overall Study||2
7606586|NCT02497235|18726167|P2|STARTED|Overall Study||2
7606587|NCT02497235|18726168|P1|STARTED|Overall Study||2
7606588|NCT02497040|18726201|P3|NOT COMPLETED|Overall Study||0
7606589|NCT02497040|18726202|P2|NOT COMPLETED|Overall Study||0
7606590|NCT02497040|18726203|P1|NOT COMPLETED|Overall Study||0
7606591|NCT02497040|18726201|P3|COMPLETED|Overall Study||30
7606592|NCT02497040|18726202|P2|COMPLETED|Overall Study||30
7606593|NCT02497040|18726203|P1|COMPLETED|Overall Study||30
7606594|NCT02497040|18726201|P3|STARTED|Overall Study||30
7606595|NCT02497040|18726202|P2|STARTED|Overall Study||30
7606596|NCT02497040|18726203|P1|STARTED|Overall Study||30
7606597|NCT02497001|18726215|P4|NOT COMPLETED|Overall Study||41
7606598|NCT02497001|18726216|P3|NOT COMPLETED|Overall Study||50
7606599|NCT02497001|18726217|P2|NOT COMPLETED|Overall Study||103
7606600|NCT02497001|18726218|P1|NOT COMPLETED|Overall Study||74
7606601|NCT02497001|18726215|P4|COMPLETED|Overall Study||278
7606602|NCT02497001|18726216|P3|COMPLETED|Overall Study||266
7606603|NCT02497001|18726217|P2|COMPLETED|Overall Study||524
7606604|NCT02497001|18726218|P1|COMPLETED|Overall Study||566
7606605|NCT02497001|18726215|P4|STARTED|Overall Study||319
7606606|NCT02497001|18726216|P3|STARTED|Overall Study||316
7606607|NCT02497001|18726217|P2|STARTED|Overall Study||627
7606608|NCT02497001|18726218|P1|STARTED|Overall Study||640
7606609|NCT02496884|18726279|P4|NOT COMPLETED|Overall Study||0
7606610|NCT02496884|18726280|P3|NOT COMPLETED|Overall Study||0
7606611|NCT02496884|18726281|P2|NOT COMPLETED|Overall Study||3
7606612|NCT02496884|18726282|P1|NOT COMPLETED|Overall Study||2
7606613|NCT02496884|18726279|P4|COMPLETED|Overall Study||4
7606614|NCT02496884|18726280|P3|COMPLETED|Overall Study||1
7606615|NCT02496884|18726281|P2|COMPLETED|Overall Study||31
7606616|NCT02496884|18726282|P1|COMPLETED|Overall Study||15
7606617|NCT02496884|18726279|P4|Completed Treatment Per Protocol|Overall Study||3
7606618|NCT02496884|18726280|P3|Completed Treatment Per Protocol|Overall Study||1
7606619|NCT02496884|18726281|P2|Completed Treatment Per Protocol|Overall Study||27
7606620|NCT02496884|18726282|P1|Completed Treatment Per Protocol|Overall Study||16
7606621|NCT02496884|18726279|P4|Pharmacokinetic (PK) Analysis Set|Overall Study||4
7606622|NCT02496884|18726280|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
7606623|NCT02496884|18726281|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||33
7606624|NCT02496884|18726282|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||0
7606625|NCT02496884|18726279|P4|Modified Intent to Treat Set (mITT)|Overall Study||4
7606626|NCT02496884|18726280|P3|Modified Intent to Treat Set (mITT)|Overall Study||1
7606627|NCT02496884|18726281|P2|Modified Intent to Treat Set (mITT)|Overall Study||34
7606628|NCT02496884|18726282|P1|Modified Intent to Treat Set (mITT)|Overall Study||17
7606629|NCT02496884|18726279|P4|Safety Analysis Set|Overall Study||4
7606630|NCT02496884|18726280|P3|Safety Analysis Set|Overall Study||1
7606631|NCT02496884|18726281|P2|Safety Analysis Set|Overall Study||34
7606632|NCT02496884|18726282|P1|Safety Analysis Set|Overall Study||17
7606633|NCT02496884|18726279|P4|STARTED|Overall Study||4
7606634|NCT02496884|18726280|P3|STARTED|Overall Study||1
7606635|NCT02496884|18726281|P2|STARTED|Overall Study||34
7606636|NCT02496884|18726282|P1|STARTED|Overall Study||17
7606637|NCT02496767|18726308|P8|NOT COMPLETED|Double-blind, Withdrawal Phase||5
7606638|NCT02496767|18726309|P7|NOT COMPLETED|Double-blind, Withdrawal Phase||4
7606639|NCT02496767|18726310|P6|NOT COMPLETED|Double-blind, Withdrawal Phase||6
7606640|NCT02496767|18726311|P5|NOT COMPLETED|Double-blind, Withdrawal Phase||0
7606641|NCT02496767|18726312|P4|NOT COMPLETED|Double-blind, Withdrawal Phase||0
7606642|NCT02496767|18726313|P3|NOT COMPLETED|Double-blind, Withdrawal Phase||0
7606643|NCT02496767|18726314|P2|NOT COMPLETED|Double-blind, Withdrawal Phase||0
7606644|NCT02496767|18726315|P1|NOT COMPLETED|Double-blind, Withdrawal Phase||0
7606645|NCT02496767|18726308|P8|COMPLETED|Double-blind, Withdrawal Phase||96
7606646|NCT02496767|18726309|P7|COMPLETED|Double-blind, Withdrawal Phase||99
7606647|NCT02496767|18726310|P6|COMPLETED|Double-blind, Withdrawal Phase||126
7606648|NCT02496767|18726311|P5|COMPLETED|Double-blind, Withdrawal Phase||0
7606649|NCT02496767|18726312|P4|COMPLETED|Double-blind, Withdrawal Phase||0
7606650|NCT02496767|18726313|P3|COMPLETED|Double-blind, Withdrawal Phase||0
7606651|NCT02496767|18726314|P2|COMPLETED|Double-blind, Withdrawal Phase||0
7606652|NCT02496767|18726315|P1|COMPLETED|Double-blind, Withdrawal Phase||0
7606653|NCT02496767|18726308|P8|STARTED|Double-blind, Withdrawal Phase||101
7606654|NCT02496767|18726309|P7|STARTED|Double-blind, Withdrawal Phase||103
7606655|NCT02496767|18726310|P6|STARTED|Double-blind, Withdrawal Phase||132
7606656|NCT02496767|18726311|P5|STARTED|Double-blind, Withdrawal Phase||0
7606657|NCT02496767|18726312|P4|STARTED|Double-blind, Withdrawal Phase||0
7606658|NCT02496767|18726313|P3|STARTED|Double-blind, Withdrawal Phase||0
7606659|NCT02496767|18726314|P2|STARTED|Double-blind, Withdrawal Phase||0
7606660|NCT02496767|18726315|P1|STARTED|Double-blind, Withdrawal Phase||0
7606661|NCT02496767|18726308|P8|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
7606662|NCT02496767|18726309|P7|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
7606663|NCT02496767|18726310|P6|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
7606664|NCT02496767|18726311|P5|NOT COMPLETED|Double-blind, Placebo-controlled Phase||66
7606665|NCT02496767|18726312|P4|NOT COMPLETED|Double-blind, Placebo-controlled Phase||61
7606666|NCT02496767|18726313|P3|NOT COMPLETED|Double-blind, Placebo-controlled Phase||46
7606667|NCT02496767|18726314|P2|NOT COMPLETED|Double-blind, Placebo-controlled Phase||56
7606668|NCT02496767|18726315|P1|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
7606669|NCT02496767|18726308|P8|COMPLETED|Double-blind, Placebo-controlled Phase||0
7606670|NCT02496767|18726309|P7|COMPLETED|Double-blind, Placebo-controlled Phase||0
7606671|NCT02496767|18726310|P6|COMPLETED|Double-blind, Placebo-controlled Phase||0
7606672|NCT02496767|18726311|P5|COMPLETED|Double-blind, Placebo-controlled Phase||59
7606673|NCT02496767|18726312|P4|COMPLETED|Double-blind, Placebo-controlled Phase||65
7606674|NCT02496767|18726313|P3|COMPLETED|Double-blind, Placebo-controlled Phase||80
7606675|NCT02496767|18726314|P2|COMPLETED|Double-blind, Placebo-controlled Phase||132
7606676|NCT02496767|18726315|P1|COMPLETED|Double-blind, Placebo-controlled Phase||0
7606677|NCT02496767|18726308|P8|STARTED|Double-blind, Placebo-controlled Phase||0
7606678|NCT02496767|18726309|P7|STARTED|Double-blind, Placebo-controlled Phase||0
7606679|NCT02496767|18726310|P6|STARTED|Double-blind, Placebo-controlled Phase||0
7606680|NCT02496767|18726311|P5|STARTED|Double-blind, Placebo-controlled Phase||125
7606681|NCT02496767|18726312|P4|STARTED|Double-blind, Placebo-controlled Phase||126
7606682|NCT02496767|18726313|P3|STARTED|Double-blind, Placebo-controlled Phase||126
7606683|NCT02496767|18726314|P2|STARTED|Double-blind, Placebo-controlled Phase||188
7606684|NCT02496767|18726315|P1|STARTED|Double-blind, Placebo-controlled Phase||0
7606685|NCT02496767|18726308|P8|NOT COMPLETED|Open-label Lead-in Phase||0
7606686|NCT02496767|18726309|P7|NOT COMPLETED|Open-label Lead-in Phase||0
7606687|NCT02496767|18726310|P6|NOT COMPLETED|Open-label Lead-in Phase||0
7606688|NCT02496767|18726311|P5|NOT COMPLETED|Open-label Lead-in Phase||0
7606689|NCT02496767|18726312|P4|NOT COMPLETED|Open-label Lead-in Phase||0
7606690|NCT02496767|18726313|P3|NOT COMPLETED|Open-label Lead-in Phase||0
7606691|NCT02496767|18726314|P2|NOT COMPLETED|Open-label Lead-in Phase||0
7606692|NCT02496767|18726315|P1|NOT COMPLETED|Open-label Lead-in Phase||179
7606693|NCT02496767|18726308|P8|COMPLETED|Open-label Lead-in Phase||0
7606694|NCT02496767|18726309|P7|COMPLETED|Open-label Lead-in Phase||0
7606695|NCT02496767|18726310|P6|COMPLETED|Open-label Lead-in Phase||0
7606696|NCT02496767|18726311|P5|COMPLETED|Open-label Lead-in Phase||0
7606697|NCT02496767|18726312|P4|COMPLETED|Open-label Lead-in Phase||0
7606698|NCT02496767|18726313|P3|COMPLETED|Open-label Lead-in Phase||0
7606699|NCT02496767|18726314|P2|COMPLETED|Open-label Lead-in Phase||0
7606700|NCT02496767|18726315|P1|COMPLETED|Open-label Lead-in Phase||565
7606701|NCT02496767|18726308|P8|STARTED|Open-label Lead-in Phase||0
7606702|NCT02496767|18726309|P7|STARTED|Open-label Lead-in Phase||0
7606703|NCT02496767|18726310|P6|STARTED|Open-label Lead-in Phase||0
7606704|NCT02496767|18726311|P5|STARTED|Open-label Lead-in Phase||0
7606705|NCT02496767|18726312|P4|STARTED|Open-label Lead-in Phase||0
7606706|NCT02496767|18726313|P3|STARTED|Open-label Lead-in Phase||0
7606707|NCT02496767|18726314|P2|STARTED|Open-label Lead-in Phase||0
7606708|NCT02496767|18726315|P1|STARTED|Open-label Lead-in Phase||744
7606709|NCT02496702|18726355|P2|NOT COMPLETED|Overall Study||8
7606710|NCT02496702|18726356|P1|NOT COMPLETED|Overall Study||8
7606711|NCT02496702|18726355|P2|COMPLETED|Overall Study||22
7606712|NCT02496702|18726356|P1|COMPLETED|Overall Study||22
7606713|NCT02496702|18726355|P2|Did Not Receive Allocated Intervention|Overall Study||0
7606714|NCT02496702|18726356|P1|Did Not Receive Allocated Intervention|Overall Study||9
7606715|NCT02496702|18726355|P2|Received Allocated Intervention|Overall Study||0
7606716|NCT02496702|18726356|P1|Received Allocated Intervention|Overall Study||21
7606717|NCT02496702|18726355|P2|STARTED|Overall Study||30
7606718|NCT02496702|18726356|P1|STARTED|Overall Study||30
7606719|NCT02496533|18726378|P2|NOT COMPLETED|Overall Study||6
7606720|NCT02496533|18726379|P1|NOT COMPLETED|Overall Study||3
7606721|NCT02496533|18726378|P2|COMPLETED|Overall Study||106
7606722|NCT02496533|18726379|P1|COMPLETED|Overall Study||102
7606723|NCT02496533|18726378|P2|STARTED|Overall Study||112
7606724|NCT02496533|18726379|P1|STARTED|Overall Study||105
7606725|NCT02496221|18726391|P2|NOT COMPLETED|Treatment Period 2 - 4 Days||1
7606726|NCT02496221|18726392|P1|NOT COMPLETED|Treatment Period 2 - 4 Days||2
7606727|NCT02496221|18726391|P2|COMPLETED|Treatment Period 2 - 4 Days||9
7606728|NCT02496221|18726392|P1|COMPLETED|Treatment Period 2 - 4 Days||8
7606729|NCT02496221|18726391|P2|STARTED|Treatment Period 2 - 4 Days||10
7606730|NCT02496221|18726392|P1|STARTED|Treatment Period 2 - 4 Days||10
7606731|NCT02496221|18726391|P2|NOT COMPLETED|Treatment Period 1 - 4 Days||0
7606732|NCT02496221|18726392|P1|NOT COMPLETED|Treatment Period 1 - 4 Days||0
7606733|NCT02496221|18726391|P2|COMPLETED|Treatment Period 1 - 4 Days||10
7606734|NCT02496221|18726392|P1|COMPLETED|Treatment Period 1 - 4 Days||10
7606735|NCT02496221|18726391|P2|STARTED|Treatment Period 1 - 4 Days||10
7606736|NCT02496221|18726392|P1|STARTED|Treatment Period 1 - 4 Days||10
7606737|NCT02496091|18726426|P1|NOT COMPLETED|Overall Study||2
7606738|NCT02496091|18726426|P1|COMPLETED|Overall Study||142
7606739|NCT02496091|18726426|P1|STARTED|Overall Study||144
7606740|NCT02496039|18726435|P1|NOT COMPLETED|Overall Study||4
7606741|NCT02496039|18726435|P1|COMPLETED|Overall Study||1
7606742|NCT02496039|18726435|P1|STARTED|Overall Study||5
7606743|NCT02496000|18726450|P3|NOT COMPLETED|Overall Study||2
7606744|NCT02496000|18726451|P2|NOT COMPLETED|Overall Study||5
7606745|NCT02496000|18726452|P1|NOT COMPLETED|Overall Study||2
7606746|NCT02496000|18726450|P3|COMPLETED|Overall Study||61
7606747|NCT02496000|18726451|P2|COMPLETED|Overall Study||56
7606748|NCT02496000|18726452|P1|COMPLETED|Overall Study||62
7606749|NCT02496000|18726450|P3|STARTED|Overall Study||63
7606750|NCT02496000|18726451|P2|STARTED|Overall Study||61
7606751|NCT02496000|18726452|P1|STARTED|Overall Study||64
7606752|NCT02495948|18726473|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
7606753|NCT02495948|18726474|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
7606754|NCT02495948|18726473|P2|COMPLETED|Period 2, Second 30 Days of Wear||82
7606755|NCT02495948|18726474|P1|COMPLETED|Period 2, Second 30 Days of Wear||82
7606756|NCT02495948|18726473|P2|STARTED|Period 2, Second 30 Days of Wear||83
7606757|NCT02495948|18726474|P1|STARTED|Period 2, Second 30 Days of Wear||83
7606758|NCT02495948|18726473|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
7606759|NCT02495948|18726474|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
7606760|NCT02495948|18726473|P2|COMPLETED|Period 1, First 30 Days of Wear||83
7606761|NCT02495948|18726474|P1|COMPLETED|Period 1, First 30 Days of Wear||83
7606762|NCT02495948|18726473|P2|STARTED|Period 1, First 30 Days of Wear||84
7606763|NCT02495948|18726474|P1|STARTED|Period 1, First 30 Days of Wear||83
7606764|NCT02495883|18726483|P2|NOT COMPLETED|Overall Study||0
7606765|NCT02495883|18726484|P1|NOT COMPLETED|Overall Study||1
7606766|NCT02495883|18726483|P2|COMPLETED|Overall Study||24
7606767|NCT02495883|18726484|P1|COMPLETED|Overall Study||31
7606768|NCT02495883|18726483|P2|STARTED|Overall Study||24
7606769|NCT02495883|18726484|P1|STARTED|Overall Study||32
7606770|NCT02495857|18726492|P3|NOT COMPLETED|Overall Study||18
7606771|NCT02495857|18726493|P2|NOT COMPLETED|Overall Study||16
7606772|NCT02495857|18726494|P1|NOT COMPLETED|Overall Study||22
7606773|NCT02495857|18726492|P3|COMPLETED|Overall Study||181
7606774|NCT02495857|18726493|P2|COMPLETED|Overall Study||184
7606775|NCT02495857|18726494|P1|COMPLETED|Overall Study||178
7606776|NCT02495857|18726492|P3|STARTED|Overall Study||199
7606777|NCT02495857|18726493|P2|STARTED|Overall Study||200
7606778|NCT02495857|18726494|P1|STARTED|Overall Study||200
7606779|NCT02495844|18726510|P2|NOT COMPLETED|Overall Study||4
7606780|NCT02495844|18726511|P1|NOT COMPLETED|Overall Study||1
7606781|NCT02495844|18726510|P2|COMPLETED|Overall Study||24
7606782|NCT02495844|18726511|P1|COMPLETED|Overall Study||26
7606783|NCT02495844|18726510|P2|STARTED|Overall Study||28
7606784|NCT02495844|18726511|P1|STARTED|Overall Study||27
7606785|NCT02495831|18726541|P2|NOT COMPLETED|Second Intervention||0
7606786|NCT02495831|18726542|P1|NOT COMPLETED|Second Intervention||0
7606787|NCT02495831|18726541|P2|COMPLETED|Second Intervention||10
7606788|NCT02495831|18726542|P1|COMPLETED|Second Intervention||12
7606789|NCT02495831|18726541|P2|STARTED|Second Intervention||10
7606790|NCT02495831|18726542|P1|STARTED|Second Intervention|One participant withdrew at the end of period 1|12
7606791|NCT02495831|18726541|P2|NOT COMPLETED|First Intervention||0
7606792|NCT02495831|18726542|P1|NOT COMPLETED|First Intervention||0
7606793|NCT02495831|18726541|P2|COMPLETED|First Intervention||10
7606794|NCT02495831|18726542|P1|COMPLETED|First Intervention||13
7606795|NCT02495831|18726541|P2|STARTED|First Intervention||10
7606796|NCT02495831|18726542|P1|STARTED|First Intervention||13
7606797|NCT02495779|18726556|P1|NOT COMPLETED|Overall Study||6
7606798|NCT02495779|18726556|P1|COMPLETED|Overall Study||48
7606799|NCT02495779|18726556|P1|STARTED|Overall Study||54
7606800|NCT02495623|18726563|P3|NOT COMPLETED|Overall Study||8
7606801|NCT02495623|18726564|P2|NOT COMPLETED|Overall Study||9
7606802|NCT02495623|18726565|P1|NOT COMPLETED|Overall Study||5
7606803|NCT02495623|18726563|P3|COMPLETED|Overall Study||20
7606804|NCT02495623|18726564|P2|COMPLETED|Overall Study||17
7606805|NCT02495623|18726565|P1|COMPLETED|Overall Study||20
7606806|NCT02495623|18726563|P3|Dosed|Overall Study||22
7606807|NCT02495623|18726564|P2|Dosed|Overall Study||19
7606808|NCT02495623|18726565|P1|Dosed|Overall Study||22
7606809|NCT02495623|18726563|P3|STARTED|Overall Study||28
7606810|NCT02495623|18726564|P2|STARTED|Overall Study||26
7606811|NCT02495623|18726565|P1|STARTED|Overall Study||25
7606812|NCT02495467|18726575|P2|NOT COMPLETED|Second Intervention (4 Weeks)||3
7606813|NCT02495467|18726576|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
7606814|NCT02495467|18726575|P2|COMPLETED|Second Intervention (4 Weeks)||113
7606815|NCT02495467|18726576|P1|COMPLETED|Second Intervention (4 Weeks)||112
7606816|NCT02495467|18726575|P2|STARTED|Second Intervention (4 Weeks)||116
7606817|NCT02495467|18726576|P1|STARTED|Second Intervention (4 Weeks)||112
7606818|NCT02495467|18726575|P2|NOT COMPLETED|Washout (1 Week)||2
7606819|NCT02495467|18726576|P1|NOT COMPLETED|Washout (1 Week)||2
7606820|NCT02495467|18726575|P2|COMPLETED|Washout (1 Week)||116
7606821|NCT02495467|18726576|P1|COMPLETED|Washout (1 Week)||112
7606822|NCT02495467|18726575|P2|STARTED|Washout (1 Week)||118
7606823|NCT02495467|18726576|P1|STARTED|Washout (1 Week)||114
7606824|NCT02495467|18726575|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
7606825|NCT02495467|18726576|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
7606826|NCT02495467|18726575|P2|COMPLETED|First Intervention (4 Weeks)|One subject completed visits in treatment Period 1 but never used treatment|118
7606827|NCT02495467|18726576|P1|COMPLETED|First Intervention (4 Weeks)||114
7606828|NCT02495467|18726575|P2|STARTED|First Intervention (4 Weeks)||118
7606829|NCT02495467|18726576|P1|STARTED|First Intervention (4 Weeks)||114
7606830|NCT02495454|18726604|P1|NOT COMPLETED|Overall Study||1
7606831|NCT02495454|18726604|P1|COMPLETED|Overall Study|One case excluded for violation of inclusion criteria (transformed lymphoma)|33
7606832|NCT02495454|18726604|P1|STARTED|Overall Study||34
7606833|NCT02495389|18726613|P1|NOT COMPLETED|Overall Study||40
7606834|NCT02495389|18726613|P1|COMPLETED|Overall Study||44
7606835|NCT02495389|18726613|P1|STARTED|Overall Study||84
7606836|NCT02495259|18726624|P3|NOT COMPLETED|Overall Study||0
7606837|NCT02495259|18726625|P2|NOT COMPLETED|Overall Study||1
7606838|NCT02495259|18726626|P1|NOT COMPLETED|Overall Study||0
7606839|NCT02495259|18726624|P3|COMPLETED|Overall Study||8
7606840|NCT02495259|18726625|P2|COMPLETED|Overall Study||3
7606841|NCT02495259|18726626|P1|COMPLETED|Overall Study||7
7606842|NCT02495259|18726624|P3|STARTED|Overall Study||8
7606843|NCT02495259|18726625|P2|STARTED|Overall Study||4
7606844|NCT02495259|18726626|P1|STARTED|Overall Study||7
7606845|NCT02495233|18726651|P2|NOT COMPLETED|Overall Study||1
7606846|NCT02495233|18726652|P1|NOT COMPLETED|Overall Study||0
7606847|NCT02495233|18726651|P2|COMPLETED|Overall Study||6
7606848|NCT02495233|18726652|P1|COMPLETED|Overall Study||3
7606849|NCT02495233|18726651|P2|STARTED|Overall Study||7
7606850|NCT02495233|18726652|P1|STARTED|Overall Study||3
7606851|NCT02495168|18726681|P3|NOT COMPLETED|Overall Study||17
7606852|NCT02495168|18726682|P2|NOT COMPLETED|Overall Study||54
7606853|NCT02495168|18726683|P1|NOT COMPLETED|Overall Study||38
7606854|NCT02495168|18726681|P3|COMPLETED|Overall Study||110
7606855|NCT02495168|18726682|P2|COMPLETED|Overall Study||462
7606856|NCT02495168|18726683|P1|COMPLETED|Overall Study||466
7606857|NCT02495168|18726681|P3|Day 42 (D42PPS) Population|Overall Study||88
7606858|NCT02495168|18726682|P2|Day 42 (D42PPS) Population|Overall Study||383
7606859|NCT02495168|18726683|P1|Day 42 (D42PPS) Population|Overall Study||382
7606860|NCT02495168|18726681|P3|Day1 Per-protocol Set (D1PPS) Population|Overall Study||99
7606861|NCT02495168|18726682|P2|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
7606862|NCT02495168|18726683|P1|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
7606863|NCT02495168|18726681|P3|Modified Intent-to-Treat Population|Overall Study||111
7606864|NCT02495168|18726682|P2|Modified Intent-to-Treat Population|Overall Study||478
7606865|NCT02495168|18726683|P1|Modified Intent-to-Treat Population|Overall Study||468
7606866|NCT02495168|18726681|P3|Safety Population|Overall Study||126
7606867|NCT02495168|18726682|P2|Safety Population|Overall Study||514
7606868|NCT02495168|18726683|P1|Safety Population|Overall Study||501
7606869|NCT02495168|18726681|P3|STARTED|Overall Study||127
7606870|NCT02495168|18726682|P2|STARTED|Overall Study||516
7606871|NCT02495168|18726683|P1|STARTED|Overall Study||504
7606872|NCT02495038|18726703|P3|NOT COMPLETED|Overall Study||0
7606873|NCT02495038|18726704|P2|NOT COMPLETED|Overall Study||0
7606874|NCT02495038|18726705|P1|NOT COMPLETED|Overall Study||0
7606875|NCT02495038|18726703|P3|COMPLETED|Overall Study||27
7606876|NCT02495038|18726704|P2|COMPLETED|Overall Study||27
7606877|NCT02495038|18726705|P1|COMPLETED|Overall Study||27
7606878|NCT02495038|18726703|P3|STARTED|Overall Study||27
7606879|NCT02495038|18726704|P2|STARTED|Overall Study||27
7606880|NCT02495038|18726705|P1|STARTED|Overall Study||27
7606881|NCT02495025|18726742|P2|NOT COMPLETED|Overall Study||14
7606882|NCT02495025|18726743|P1|NOT COMPLETED|Overall Study||26
7606883|NCT02495025|18726742|P2|COMPLETED|Overall Study||61
7606884|NCT02495025|18726743|P1|COMPLETED|Overall Study||51
7606885|NCT02495025|18726742|P2|STARTED|Overall Study||75
7606886|NCT02495025|18726743|P1|STARTED|Overall Study||77
7606887|NCT02494817|18726757|P2|NOT COMPLETED|Overall Study||49
7606888|NCT02494817|18726758|P1|NOT COMPLETED|Overall Study||55
7606889|NCT02494817|18726757|P2|COMPLETED|Overall Study|41 couples and 5 partnered men completed all 3 assessments (baseline, 3- and 6-month)|87
7606890|NCT02494817|18726758|P1|COMPLETED|Overall Study|49 couples and 9 partnered men completed all 3 assessments (baseline, 3- and 6-month)|107
7606891|NCT02494817|18726757|P2|6 Month Assessment|Overall Study|represents 45 couples and 8 partnered men|98
7606892|NCT02494817|18726758|P1|6 Month Assessment|Overall Study|represents 52 couples and 11 partnered men|115
7606893|NCT02494817|18726757|P2|3 Month Assessment|Overall Study|represents 44 couples and 4 partnered men|92
7606894|NCT02494817|18726758|P1|3 Month Assessment|Overall Study|represents 59 couples and 7 partnered men|125
7606895|NCT02494817|18726757|P2|STARTED|Overall Study|representing 68 couples|136
7606896|NCT02494817|18726758|P1|STARTED|Overall Study|representing 81 couples|162
7606897|NCT02494713|18726778|P1|NOT COMPLETED|Overall Study||0
7606898|NCT02494713|18726778|P1|COMPLETED|Overall Study||4
7606899|NCT02494713|18726778|P1|STARTED|Overall Study||4
7606900|NCT02494596|18726795|P3|NOT COMPLETED|Overall Study||1
7606901|NCT02494596|18726796|P2|NOT COMPLETED|Overall Study||5
7606902|NCT02494596|18726797|P1|NOT COMPLETED|Overall Study||3
7606903|NCT02494596|18726795|P3|COMPLETED|Overall Study||6
7606904|NCT02494596|18726796|P2|COMPLETED|Overall Study||2
7606905|NCT02494596|18726797|P1|COMPLETED|Overall Study||2
7606906|NCT02494596|18726795|P3|STARTED|Overall Study||7
7606907|NCT02494596|18726796|P2|STARTED|Overall Study||7
7606908|NCT02494596|18726797|P1|STARTED|Overall Study||5
7606909|NCT02494583|18726825|P3|NOT COMPLETED|Overall Study||250
7606910|NCT02494583|18726826|P2|NOT COMPLETED|Overall Study||257
7606911|NCT02494583|18726827|P1|NOT COMPLETED|Overall Study||256
7606912|NCT02494583|18726825|P3|COMPLETED|Overall Study||0
7606913|NCT02494583|18726826|P2|COMPLETED|Overall Study||0
7606914|NCT02494583|18726827|P1|COMPLETED|Overall Study||0
7606915|NCT02494583|18726825|P3|Treated|Overall Study||244
7606916|NCT02494583|18726826|P2|Treated|Overall Study||250
7606917|NCT02494583|18726827|P1|Treated|Overall Study|1 participant randomized to the pembro combo arm received pembrolizumab monotherapy by mistake.|254
7606918|NCT02494583|18726825|P3|STARTED|Overall Study||250
7606919|NCT02494583|18726826|P2|STARTED|Overall Study||257
7606920|NCT02494583|18726827|P1|STARTED|Overall Study||256
7606921|NCT02494518|18726883|P3|NOT COMPLETED|Overall Study||3
7606922|NCT02494518|18726884|P2|NOT COMPLETED|Overall Study||2
7606923|NCT02494518|18726885|P1|NOT COMPLETED|Overall Study||1
7606924|NCT02494518|18726883|P3|COMPLETED|Overall Study||8
7606925|NCT02494518|18726884|P2|COMPLETED|Overall Study||10
7606926|NCT02494518|18726885|P1|COMPLETED|Overall Study||10
7606927|NCT02494518|18726883|P3|STARTED|Overall Study||11
7606928|NCT02494518|18726884|P2|STARTED|Overall Study||12
7606929|NCT02494518|18726885|P1|STARTED|Overall Study||11
7606930|NCT02494440|18726917|P1|NOT COMPLETED|Overall Study||0
7606931|NCT02494440|18726917|P1|COMPLETED|Overall Study||90
7606932|NCT02494440|18726917|P1|STARTED|Overall Study||90
7606933|NCT02494401|18726925|P2|NOT COMPLETED|Overall Study||27
7606934|NCT02494401|18726926|P1|NOT COMPLETED|Overall Study||25
7606935|NCT02494401|18726925|P2|COMPLETED|Overall Study||106
7606936|NCT02494401|18726926|P1|COMPLETED|Overall Study||109
7606937|NCT02494401|18726925|P2|6 Month Follow up|Overall Study||106
7606938|NCT02494401|18726926|P1|6 Month Follow up|Overall Study||109
7606939|NCT02494401|18726925|P2|Week 16|Overall Study||124
7606940|NCT02494401|18726926|P1|Week 16|Overall Study||123
7606941|NCT02494401|18726925|P2|STARTED|Overall Study||133
7606942|NCT02494401|18726926|P1|STARTED|Overall Study||134
7606943|NCT02494336|18726966|P2|NOT COMPLETED|Overall Study||0
7606944|NCT02494336|18726967|P1|NOT COMPLETED|Overall Study||0
7606945|NCT02494336|18726966|P2|COMPLETED|Overall Study||24
7606946|NCT02494336|18726967|P1|COMPLETED|Overall Study||24
7606947|NCT02494336|18726966|P2|STARTED|Overall Study||24
7606948|NCT02494336|18726967|P1|STARTED|Overall Study||24
7606949|NCT02494323|18726973|P1|NOT COMPLETED|Overall Study||0
7606950|NCT02494323|18726973|P1|COMPLETED|Overall Study||70
7606951|NCT02494323|18726973|P1|STARTED|Overall Study||70
7606952|NCT02494206|18726978|P1|NOT COMPLETED|Overall Study||2
7606953|NCT02494206|18726978|P1|COMPLETED|Overall Study||7
7606954|NCT02494206|18726978|P1|STARTED|Overall Study||9
7606955|NCT02494180|18726984|P2|NOT COMPLETED|Overall Study||0
7606956|NCT02494180|18726985|P1|NOT COMPLETED|Overall Study||0
7606957|NCT02494180|18726984|P2|COMPLETED|Overall Study||85
7606958|NCT02494180|18726985|P1|COMPLETED|Overall Study||85
7606959|NCT02494180|18726984|P2|STARTED|Overall Study||85
7606960|NCT02494180|18726985|P1|STARTED|Overall Study||85
7606961|NCT02494102|18727007|P2|NOT COMPLETED|Overall Study||0
7606962|NCT02494102|18727008|P1|NOT COMPLETED|Overall Study||0
7606963|NCT02494102|18727007|P2|COMPLETED|Overall Study||47
7606964|NCT02494102|18727008|P1|COMPLETED|Overall Study||42
7606965|NCT02494102|18727007|P2|STARTED|Overall Study||47
7606966|NCT02494102|18727008|P1|STARTED|Overall Study||42
7606967|NCT02494076|18727018|P2|NOT COMPLETED|Overall Study||0
7606968|NCT02494076|18727019|P1|NOT COMPLETED|Overall Study||0
7606969|NCT02494076|18727018|P2|COMPLETED|Overall Study||26
7606970|NCT02494076|18727019|P1|COMPLETED|Overall Study||26
7606971|NCT02494076|18727018|P2|STARTED|Overall Study||26
7606972|NCT02494076|18727019|P1|STARTED|Overall Study||26
7606973|NCT02493946|18727032|P3|NOT COMPLETED|Open Label Period||86
7606974|NCT02493946|18727033|P2|NOT COMPLETED|Open Label Period||0
7606975|NCT02493946|18727034|P1|NOT COMPLETED|Open Label Period||0
7606976|NCT02493946|18727032|P3|COMPLETED|Open Label Period||509
7606977|NCT02493946|18727033|P2|COMPLETED|Open Label Period||0
7606978|NCT02493946|18727034|P1|COMPLETED|Open Label Period||0
7606979|NCT02493946|18727032|P3|STARTED|Open Label Period|The previous period relates to DB period only, this period relates to OL treatment only.|595
7606980|NCT02493946|18727033|P2|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
7606981|NCT02493946|18727034|P1|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
7606982|NCT02493946|18727032|P3|NOT COMPLETED|DB Period||0
7606983|NCT02493946|18727033|P2|NOT COMPLETED|DB Period||5
7606984|NCT02493946|18727034|P1|NOT COMPLETED|DB Period||8
7606985|NCT02493946|18727032|P3|COMPLETED|DB Period||0
7606986|NCT02493946|18727033|P2|COMPLETED|DB Period||59
7606987|NCT02493946|18727034|P1|COMPLETED|DB Period||118
7606988|NCT02493946|18727032|P3|STARTED|DB Period||0
7606989|NCT02493946|18727033|P2|STARTED|DB Period||64
7606990|NCT02493946|18727034|P1|STARTED|DB Period||126
7606991|NCT02493868|18727067|P2|NOT COMPLETED|Follow-up Phase||2
7606992|NCT02493868|18727068|P1|NOT COMPLETED|Follow-up Phase||11
7606993|NCT02493868|18727067|P2|COMPLETED|Follow-up Phase||62
7606994|NCT02493868|18727068|P1|COMPLETED|Follow-up Phase||470
7606995|NCT02493868|18727067|P2|STARTED|Follow-up Phase||64
7606996|NCT02493868|18727068|P1|STARTED|Follow-up Phase||481
7606997|NCT02493868|18727067|P2|NOT COMPLETED|Maintenance Phase: DE+TE Participants||22
7606998|NCT02493868|18727068|P1|NOT COMPLETED|Maintenance Phase: DE+TE Participants||13
7606999|NCT02493868|18727067|P2|COMPLETED|Maintenance Phase: DE+TE Participants||177
7607000|NCT02493868|18727068|P1|COMPLETED|Maintenance Phase: DE+TE Participants||139
7607001|NCT02493868|18727067|P2|Stable Responders|Maintenance Phase: DE+TE Participants||59
7607002|NCT02493868|18727068|P1|Stable Responders|Maintenance Phase: DE+TE Participants||62
7607003|NCT02493868|18727067|P2|Stable Remitters|Maintenance Phase: DE+TE Participants||86
7607004|NCT02493868|18727068|P1|Stable Remitters|Maintenance Phase: DE+TE Participants||90
7607005|NCT02493868|18727067|P2|STARTED|Maintenance Phase: DE+TE Participants|145 participants randomized from intranasal esketamine arm after OP phase+54 continued from OP phase|199
7607006|NCT02493868|18727068|P1|STARTED|Maintenance Phase: DE+TE Participants|152 participants randomized from intranasal esketamine arm after OP phase: DE (90) + TE (62)|152
7607007|NCT02493868|18727067|P2|NOT COMPLETED|Optimization Phase: DE+TE Participants||32
7607008|NCT02493868|18727068|P1|NOT COMPLETED|Optimization Phase: DE+TE Participants||158
7607009|NCT02493868|18727067|P2|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria continued to MA phase.|54
7607010|NCT02493868|18727068|P1|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria randomized to MA phase|297
7607011|NCT02493868|18727067|P2|STARTED|Optimization Phase: DE+TE Participants|Placebo treated transferred-entry participant.|86
7607012|NCT02493868|18727068|P1|STARTED|Optimization Phase: DE+TE Participants|Total participants: direct-entry (273) + esketamine-treated transferred-entry participants (182).|455
7607013|NCT02493868|18727067|P2|NOT COMPLETED|Induction Phase: DE Participants||0
7607014|NCT02493868|18727068|P1|NOT COMPLETED|Induction Phase: DE Participants||164
7607015|NCT02493868|18727067|P2|COMPLETED|Induction Phase: DE Participants||0
7607016|NCT02493868|18727068|P1|COMPLETED|Induction Phase: DE Participants|Participants who completed and met predefined response criteria continued to OP phase.|273
7607017|NCT02493868|18727067|P2|STARTED|Induction Phase: DE Participants||0
7607018|NCT02493868|18727068|P1|STARTED|Induction Phase: DE Participants||437
7607019|NCT02493855|18727117|P3|NOT COMPLETED|Overall Study||0
7607020|NCT02493855|18727118|P2|NOT COMPLETED|Overall Study||1
7607021|NCT02493855|18727119|P1|NOT COMPLETED|Overall Study||2
7607022|NCT02493855|18727117|P3|COMPLETED|Overall Study||6
7607023|NCT02493855|18727118|P2|COMPLETED|Overall Study||18
7607024|NCT02493855|18727119|P1|COMPLETED|Overall Study||19
7607025|NCT02493855|18727117|P3|STARTED|Overall Study||6
7607026|NCT02493855|18727118|P2|STARTED|Overall Study||19
7607027|NCT02493855|18727119|P1|STARTED|Overall Study||21
7607028|NCT02493777|18727129|P2|NOT COMPLETED|Overall Study||1
7607029|NCT02493777|18727130|P1|NOT COMPLETED|Overall Study||0
7607030|NCT02493777|18727129|P2|COMPLETED|Overall Study||53
7607031|NCT02493777|18727130|P1|COMPLETED|Overall Study||65
7607032|NCT02493777|18727129|P2|STARTED|Overall Study||54
7607033|NCT02493777|18727130|P1|STARTED|Overall Study||65
7607034|NCT02493764|18727140|P2|NOT COMPLETED|Overall Study||82
7607035|NCT02493764|18727141|P1|NOT COMPLETED|Overall Study||83
7607036|NCT02493764|18727140|P2|COMPLETED|Overall Study||187
7607037|NCT02493764|18727141|P1|COMPLETED|Overall Study||185
7607038|NCT02493764|18727140|P2|STARTED|Overall Study||269
7607039|NCT02493764|18727141|P1|STARTED|Overall Study||268
7607040|NCT02493751|18727191|P2|NOT COMPLETED|Overall Study||29
7607041|NCT02493751|18727192|P1|NOT COMPLETED|Overall Study||13
7607042|NCT02493751|18727191|P2|COMPLETED|Overall Study|Participants who died were considered as completed.|10
7607043|NCT02493751|18727192|P1|COMPLETED|Overall Study|Participants who died were considered as completed.|3
7607044|NCT02493751|18727191|P2|STARTED|Overall Study||39
7607045|NCT02493751|18727192|P1|STARTED|Overall Study||16
7607046|NCT02493712|18727200|P3|NOT COMPLETED|Overall Study||6
7607047|NCT02493712|18727201|P2|NOT COMPLETED|Overall Study||6
7607048|NCT02493712|18727202|P1|NOT COMPLETED|Overall Study||2
7607049|NCT02493712|18727200|P3|COMPLETED|Overall Study||11
7607050|NCT02493712|18727201|P2|COMPLETED|Overall Study||12
7607051|NCT02493712|18727202|P1|COMPLETED|Overall Study||14
7607052|NCT02493712|18727200|P3|STARTED|Overall Study||17
7607053|NCT02493712|18727201|P2|STARTED|Overall Study||18
7607054|NCT02493712|18727202|P1|STARTED|Overall Study||16
7607055|NCT02493621|18727215|P2|NOT COMPLETED|Overall Study||0
7607056|NCT02493621|18727216|P1|NOT COMPLETED|Overall Study||0
7607057|NCT02493621|18727215|P2|COMPLETED|Overall Study||58
7607058|NCT02493621|18727216|P1|COMPLETED|Overall Study||58
7607059|NCT02493621|18727215|P2|STARTED|Overall Study||58
7607060|NCT02493621|18727216|P1|STARTED|Overall Study||58
7607061|NCT02493608|18727226|P2|NOT COMPLETED|Overall Study||0
7607062|NCT02493608|18727227|P1|NOT COMPLETED|Overall Study||0
7607063|NCT02493608|18727226|P2|COMPLETED|Overall Study||48
7607064|NCT02493608|18727227|P1|COMPLETED|Overall Study||48
7607065|NCT02493608|18727226|P2|STARTED|Overall Study||48
7607066|NCT02493608|18727227|P1|STARTED|Overall Study||48
7607067|NCT02493517|18727239|P2|NOT COMPLETED|Overall Study||7
7607068|NCT02493517|18727240|P1|NOT COMPLETED|Overall Study||2
7607069|NCT02493517|18727239|P2|COMPLETED|Overall Study||57
7607070|NCT02493517|18727240|P1|COMPLETED|Overall Study||62
7607071|NCT02493517|18727239|P2|STARTED|Overall Study||64
7607072|NCT02493517|18727240|P1|STARTED|Overall Study||64
7607073|NCT02493452|18727265|P3|NOT COMPLETED|Overall Study||54
7607074|NCT02493452|18727266|P2|NOT COMPLETED|Overall Study||49
7607075|NCT02493452|18727267|P1|NOT COMPLETED|Overall Study||50
7607076|NCT02493452|18727265|P3|COMPLETED|Overall Study||325
7607077|NCT02493452|18727266|P2|COMPLETED|Overall Study||328
7607078|NCT02493452|18727267|P1|COMPLETED|Overall Study||329
7607079|NCT02493452|18727265|P3|STARTED|Overall Study||379
7607080|NCT02493452|18727266|P2|STARTED|Overall Study||377
7607081|NCT02493452|18727267|P1|STARTED|Overall Study||379
7607082|NCT02493361|18727299|P1|NOT COMPLETED|Overall Study||14
7607083|NCT02493361|18727299|P1|COMPLETED|Overall Study||10
7607084|NCT02493361|18727299|P1|STARTED|Overall Study||24
7607085|NCT02493257|18727305|P2|NOT COMPLETED|Overall Study||1
7607086|NCT02493257|18727306|P1|NOT COMPLETED|Overall Study||1
7607087|NCT02493257|18727305|P2|COMPLETED|Overall Study||10
7607088|NCT02493257|18727306|P1|COMPLETED|Overall Study||10
7607089|NCT02493257|18727305|P2|12 Week Follow up|Overall Study||10
7607090|NCT02493257|18727306|P1|12 Week Follow up|Overall Study||10
7607091|NCT02493257|18727305|P2|4 Week Follow up|Overall Study||11
7607092|NCT02493257|18727306|P1|4 Week Follow up|Overall Study||11
7607093|NCT02493257|18727305|P2|STARTED|Overall Study||11
7607094|NCT02493257|18727306|P1|STARTED|Overall Study||11
7607095|NCT02493127|18727320|P2|NOT COMPLETED|Overall Study||1
7607096|NCT02493127|18727321|P1|NOT COMPLETED|Overall Study||1
7607097|NCT02493127|18727320|P2|COMPLETED|Overall Study||60
7607098|NCT02493127|18727321|P1|COMPLETED|Overall Study||60
7607099|NCT02493127|18727320|P2|STARTED|Overall Study||61
7607100|NCT02493127|18727321|P1|STARTED|Overall Study||61
7607101|NCT02493088|18727333|P1|NOT COMPLETED|Overall Study||0
7607102|NCT02493088|18727333|P1|COMPLETED|Overall Study||11
7607103|NCT02493088|18727333|P1|STARTED|Overall Study||11
7607104|NCT02493062|18727339|P1|NOT COMPLETED|Overall Study||12
7607105|NCT02493062|18727339|P1|COMPLETED|Overall Study||23
7607106|NCT02493062|18727339|P1|STARTED|Overall Study||35
7607107|NCT02493036|18727350|P3|NOT COMPLETED|Overall Study||2
7607108|NCT02493036|18727351|P2|NOT COMPLETED|Overall Study||2
7607109|NCT02493036|18727352|P1|NOT COMPLETED|Overall Study||1
7607110|NCT02493036|18727350|P3|COMPLETED|Overall Study||15
7607111|NCT02493036|18727351|P2|COMPLETED|Overall Study||18
7607112|NCT02493036|18727352|P1|COMPLETED|Overall Study||16
7607113|NCT02493036|18727350|P3|STARTED|Overall Study||17
7607114|NCT02493036|18727351|P2|STARTED|Overall Study||20
7607115|NCT02493036|18727352|P1|STARTED|Overall Study||17
7607116|NCT02492997|18727362|P2|NOT COMPLETED|Overall Study||1
7607117|NCT02492997|18727363|P1|NOT COMPLETED|Overall Study||2
7607118|NCT02492997|18727362|P2|COMPLETED|Overall Study||20
7607119|NCT02492997|18727363|P1|COMPLETED|Overall Study||19
7607120|NCT02492997|18727362|P2|STARTED|Overall Study||21
7607121|NCT02492997|18727363|P1|STARTED|Overall Study||21
7607122|NCT02492984|18727373|P2|NOT COMPLETED|Overall Study||0
7607123|NCT02492984|18727374|P1|NOT COMPLETED|Overall Study||3
7607124|NCT02492984|18727373|P2|COMPLETED|Overall Study||14
7607125|NCT02492984|18727374|P1|COMPLETED|Overall Study||70
7607126|NCT02492984|18727373|P2|STARTED|Overall Study||14
7607127|NCT02492984|18727374|P1|STARTED|Overall Study||73
7607128|NCT02492958|18727398|P4|NOT COMPLETED|Overall Study||0
7607129|NCT02492958|18727399|P3|NOT COMPLETED|Overall Study||2
7607130|NCT02492958|18727400|P2|NOT COMPLETED|Overall Study||0
7607131|NCT02492958|18727401|P1|NOT COMPLETED|Overall Study||1
7607132|NCT02492958|18727398|P4|COMPLETED|Overall Study||34
7607133|NCT02492958|18727399|P3|COMPLETED|Overall Study||32
7607134|NCT02492958|18727400|P2|COMPLETED|Overall Study||34
7607135|NCT02492958|18727401|P1|COMPLETED|Overall Study||33
7607136|NCT02492958|18727398|P4|STARTED|Overall Study||34
7607137|NCT02492958|18727399|P3|STARTED|Overall Study||34
7607138|NCT02492958|18727400|P2|STARTED|Overall Study||34
7607139|NCT02492958|18727401|P1|STARTED|Overall Study||34
7607140|NCT02492880|18727487|P1|NOT COMPLETED|Overall Study||2
7607141|NCT02492880|18727487|P1|COMPLETED|Overall Study||13
7607142|NCT02492880|18727487|P1|STARTED|Overall Study||15
7607143|NCT02492841|18727494|P3|NOT COMPLETED|Overall Study||35
7607144|NCT02492841|18727495|P2|NOT COMPLETED|Overall Study||31
7607145|NCT02492841|18727496|P1|NOT COMPLETED|Overall Study||34
7607146|NCT02492841|18727494|P3|COMPLETED|Overall Study||25
7607147|NCT02492841|18727495|P2|COMPLETED|Overall Study||22
7607148|NCT02492841|18727496|P1|COMPLETED|Overall Study||22
7607149|NCT02492841|18727494|P3|STARTED|Overall Study||60
7607150|NCT02492841|18727495|P2|STARTED|Overall Study||53
7607151|NCT02492841|18727496|P1|STARTED|Overall Study||56
7607152|NCT02492802|18727507|P1|NOT COMPLETED|Overall Study||0
7607153|NCT02492802|18727507|P1|COMPLETED|Overall Study||64
7607154|NCT02492802|18727507|P1|STARTED|Overall Study||64
7607155|NCT02492763|18727515|P4|NOT COMPLETED|Overall Study||13
7607156|NCT02492763|18727516|P3|NOT COMPLETED|Overall Study||10
7607157|NCT02492763|18727517|P2|NOT COMPLETED|Overall Study||15
7607158|NCT02492763|18727518|P1|NOT COMPLETED|Overall Study||16
7607159|NCT02492763|18727515|P4|COMPLETED|Overall Study||30
7607160|NCT02492763|18727516|P3|COMPLETED|Overall Study||33
7607161|NCT02492763|18727517|P2|COMPLETED|Overall Study||29
7607162|NCT02492763|18727518|P1|COMPLETED|Overall Study||30
7607163|NCT02492763|18727515|P4|Treated|Overall Study||42
7607164|NCT02492763|18727516|P3|Treated|Overall Study||43
7607165|NCT02492763|18727517|P2|Treated|Overall Study||44
7607166|NCT02492763|18727518|P1|Treated|Overall Study||46
7607167|NCT02492763|18727515|P4|STARTED|Overall Study||43
7607168|NCT02492763|18727516|P3|STARTED|Overall Study||43
7607169|NCT02492763|18727517|P2|STARTED|Overall Study||44
7607170|NCT02492763|18727518|P1|STARTED|Overall Study||46
7607171|NCT02492750|18727575|P3|NOT COMPLETED|Overall Study||0
7607172|NCT02492750|18727576|P2|NOT COMPLETED|Overall Study||0
7607173|NCT02492750|18727577|P1|NOT COMPLETED|Overall Study||0
7607174|NCT02492750|18727575|P3|COMPLETED|Overall Study||6
7607175|NCT02492750|18727576|P2|COMPLETED|Overall Study||4
7607176|NCT02492750|18727577|P1|COMPLETED|Overall Study||4
7607177|NCT02492750|18727575|P3|STARTED|Overall Study||6
7607178|NCT02492750|18727576|P2|STARTED|Overall Study||4
7607179|NCT02492750|18727577|P1|STARTED|Overall Study||4
7607180|NCT02492451|18727594|P3|NOT COMPLETED|Overall Study||0
7607181|NCT02492451|18727595|P2|NOT COMPLETED|Overall Study||0
7607182|NCT02492451|18727596|P1|NOT COMPLETED|Overall Study||0
7607183|NCT02492451|18727594|P3|COMPLETED|Overall Study||39
7607184|NCT02492451|18727595|P2|COMPLETED|Overall Study||39
7607185|NCT02492451|18727596|P1|COMPLETED|Overall Study||40
7607186|NCT02492451|18727594|P3|STARTED|Overall Study||39
7607187|NCT02492451|18727595|P2|STARTED|Overall Study||39
7607188|NCT02492451|18727596|P1|STARTED|Overall Study||40
7607189|NCT02492295|18727604|P1|NOT COMPLETED|Overall Study||0
7607190|NCT02492295|18727604|P1|COMPLETED|Overall Study||0
7607191|NCT02492295|18727604|P1|STARTED|Overall Study||0
7607192|NCT02492165|18727623|P4|NOT COMPLETED|Overall Study||0
7607193|NCT02492165|18727624|P3|NOT COMPLETED|Overall Study||0
7607194|NCT02492165|18727625|P2|NOT COMPLETED|Overall Study||1
7607195|NCT02492165|18727626|P1|NOT COMPLETED|Overall Study||0
7607196|NCT02492165|18727623|P4|COMPLETED|Overall Study||30
7607197|NCT02492165|18727624|P3|COMPLETED|Overall Study||60
7607198|NCT02492165|18727625|P2|COMPLETED|Overall Study||59
7607199|NCT02492165|18727626|P1|COMPLETED|Overall Study||100
7607200|NCT02492165|18727623|P4|STARTED|Overall Study||30
7607201|NCT02492165|18727624|P3|STARTED|Overall Study||60
7607202|NCT02492165|18727625|P2|STARTED|Overall Study||60
7607203|NCT02492165|18727626|P1|STARTED|Overall Study||100
7607204|NCT02492100|18727648|P1|NOT COMPLETED|Overall Study||1
7607205|NCT02492100|18727648|P1|COMPLETED|Overall Study||46
7607206|NCT02492100|18727648|P1|STARTED|Overall Study||47
7607207|NCT02491944|18727655|P1|NOT COMPLETED|Overall Study||0
7607208|NCT02491944|18727655|P1|COMPLETED|Overall Study||10
7607209|NCT02491944|18727655|P1|STARTED|Overall Study||10
7607210|NCT02491892|18727677|P2|NOT COMPLETED|Overall Study||38
7607211|NCT02491892|18727678|P1|NOT COMPLETED|Overall Study||41
7607212|NCT02491892|18727677|P2|COMPLETED|Overall Study||0
7607213|NCT02491892|18727678|P1|COMPLETED|Overall Study||0
7607214|NCT02491892|18727677|P2|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37
7607215|NCT02491892|18727678|P1|Treated|Overall Study||41
7607216|NCT02491892|18727677|P2|STARTED|Overall Study||38
7607217|NCT02491892|18727678|P1|STARTED|Overall Study||41
7607218|NCT02491788|18727724|P2|NOT COMPLETED|Overall Study||0
7607219|NCT02491788|18727725|P1|NOT COMPLETED|Overall Study||0
7607220|NCT02491788|18727724|P2|COMPLETED|Overall Study||11
7607221|NCT02491788|18727725|P1|COMPLETED|Overall Study||8
7607222|NCT02491788|18727724|P2|STARTED|Overall Study||11
7607223|NCT02491788|18727725|P1|STARTED|Overall Study||8
7607224|NCT02491684|18727733|P2|NOT COMPLETED|Treatment Phase||3
7607225|NCT02491684|18727734|P1|NOT COMPLETED|Treatment Phase||3
7607226|NCT02491684|18727733|P2|COMPLETED|Treatment Phase||57
7607227|NCT02491684|18727734|P1|COMPLETED|Treatment Phase||58
7607228|NCT02491684|18727733|P2|STARTED|Treatment Phase||60
7607229|NCT02491684|18727734|P1|STARTED|Treatment Phase||61
7607230|NCT02491684|18727733|P2|NOT COMPLETED|Pre-treatment Phase||0
7607231|NCT02491684|18727734|P1|NOT COMPLETED|Pre-treatment Phase||0
7607232|NCT02491684|18727733|P2|COMPLETED|Pre-treatment Phase||60
7607233|NCT02491684|18727734|P1|COMPLETED|Pre-treatment Phase||61
7607234|NCT02491684|18727733|P2|STARTED|Pre-treatment Phase||60
7607235|NCT02491684|18727734|P1|STARTED|Pre-treatment Phase||61
7607236|NCT02491463|18727772|P4|NOT COMPLETED|Overall Study||1
7607237|NCT02491463|18727773|P3|NOT COMPLETED|Overall Study||4
7607238|NCT02491463|18727774|P2|NOT COMPLETED|Overall Study||10
7607239|NCT02491463|18727775|P1|NOT COMPLETED|Overall Study||2
7607240|NCT02491463|18727772|P4|COMPLETED|Overall Study||14
7607241|NCT02491463|18727773|P3|COMPLETED|Overall Study||15
7607242|NCT02491463|18727774|P2|COMPLETED|Overall Study||21
7607243|NCT02491463|18727775|P1|COMPLETED|Overall Study||5
7607244|NCT02491463|18727772|P4|STARTED|Overall Study||15
7607245|NCT02491463|18727773|P3|STARTED|Overall Study||19
7607246|NCT02491463|18727774|P2|STARTED|Overall Study||31
7607247|NCT02491463|18727775|P1|STARTED|Overall Study||7
7607248|NCT02491437|18727863|P2|NOT COMPLETED|Overall Study||357
7607249|NCT02491437|18727864|P1|NOT COMPLETED|Overall Study||352
7607250|NCT02491437|18727863|P2|COMPLETED|Overall Study||157
7607251|NCT02491437|18727864|P1|COMPLETED|Overall Study||168
7607252|NCT02491437|18727863|P2|Full Analysis Sample|Overall Study||489
7607253|NCT02491437|18727864|P1|Full Analysis Sample|Overall Study||494
7607254|NCT02491437|18727863|P2|Safety Sample|Overall Study||512
7607255|NCT02491437|18727864|P1|Safety Sample|Overall Study||518
7607256|NCT02491437|18727863|P2|STARTED|Overall Study||514
7607257|NCT02491437|18727864|P1|STARTED|Overall Study||520
7607258|NCT02491411|18727878|P1|NOT COMPLETED|Overall Study||4
7607259|NCT02491411|18727878|P1|COMPLETED|Overall Study||0
7607260|NCT02491411|18727878|P1|STARTED|Overall Study||4
7607261|NCT02491359|18727888|P1|NOT COMPLETED|Overall Study||16
7607262|NCT02491359|18727888|P1|COMPLETED|Overall Study||4
7607263|NCT02491359|18727888|P1|STARTED|Overall Study||20
7607264|NCT02491073|18727909|P2|NOT COMPLETED|Overall Study||0
7607265|NCT02491073|18727910|P1|NOT COMPLETED|Overall Study||1
7607266|NCT02491073|18727909|P2|COMPLETED|Overall Study||34
7607267|NCT02491073|18727910|P1|COMPLETED|Overall Study||36
7607268|NCT02491073|18727909|P2|STARTED|Overall Study||34
7607269|NCT02491073|18727910|P1|STARTED|Overall Study||37
7607270|NCT02490670|18727938|P2|NOT COMPLETED|Period 2 (19 Days)||0
7607271|NCT02490670|18727939|P1|NOT COMPLETED|Period 2 (19 Days)||0
7607272|NCT02490670|18727938|P2|COMPLETED|Period 2 (19 Days)||14
7607273|NCT02490670|18727939|P1|COMPLETED|Period 2 (19 Days)||14
7607274|NCT02490670|18727938|P2|STARTED|Period 2 (19 Days)||14
7607275|NCT02490670|18727939|P1|STARTED|Period 2 (19 Days)||14
7607276|NCT02490670|18727938|P2|NOT COMPLETED|Washout Period (7 Days)||0
7607277|NCT02490670|18727939|P1|NOT COMPLETED|Washout Period (7 Days)||0
7607278|NCT02490670|18727938|P2|COMPLETED|Washout Period (7 Days)||14
7607279|NCT02490670|18727939|P1|COMPLETED|Washout Period (7 Days)||14
7607280|NCT02490670|18727938|P2|STARTED|Washout Period (7 Days)||14
7607281|NCT02490670|18727939|P1|STARTED|Washout Period (7 Days)||14
7607282|NCT02490670|18727938|P2|NOT COMPLETED|Period 1 (19 Days)||0
7607283|NCT02490670|18727939|P1|NOT COMPLETED|Period 1 (19 Days)||0
7607284|NCT02490670|18727938|P2|COMPLETED|Period 1 (19 Days)||14
7607285|NCT02490670|18727939|P1|COMPLETED|Period 1 (19 Days)||14
7607286|NCT02490670|18727938|P2|STARTED|Period 1 (19 Days)||14
7607287|NCT02490670|18727939|P1|STARTED|Period 1 (19 Days)||14
7607288|NCT02490631|18727949|P2|NOT COMPLETED|Overall Study||0
7607289|NCT02490631|18727950|P1|NOT COMPLETED|Overall Study||0
7607290|NCT02490631|18727949|P2|COMPLETED|Overall Study||75
7607291|NCT02490631|18727950|P1|COMPLETED|Overall Study||76
7607292|NCT02490631|18727949|P2|STARTED|Overall Study||75
7607293|NCT02490631|18727950|P1|STARTED|Overall Study||76
7607294|NCT02490475|18727962|P4|NOT COMPLETED|Period 2: Extension Phase||1
7607295|NCT02490475|18727963|P3|NOT COMPLETED|Period 2: Extension Phase||3
7607296|NCT02490475|18727964|P2|NOT COMPLETED|Period 2: Extension Phase||0
7607297|NCT02490475|18727965|P1|NOT COMPLETED|Period 2: Extension Phase||1
7607298|NCT02490475|18727962|P4|COMPLETED|Period 2: Extension Phase||0
7607299|NCT02490475|18727963|P3|COMPLETED|Period 2: Extension Phase||0
7607300|NCT02490475|18727964|P2|COMPLETED|Period 2: Extension Phase||0
7607301|NCT02490475|18727965|P1|COMPLETED|Period 2: Extension Phase||0
7607302|NCT02490475|18727962|P4|STARTED|Period 2: Extension Phase||1
7607303|NCT02490475|18727963|P3|STARTED|Period 2: Extension Phase||3
7607304|NCT02490475|18727964|P2|STARTED|Period 2: Extension Phase||0
7607305|NCT02490475|18727965|P1|STARTED|Period 2: Extension Phase||1
7607306|NCT02490475|18727962|P4|NOT COMPLETED|Period 1: First 6 Cycles||5
7607307|NCT02490475|18727963|P3|NOT COMPLETED|Period 1: First 6 Cycles||6
7607308|NCT02490475|18727964|P2|NOT COMPLETED|Period 1: First 6 Cycles||2
7607309|NCT02490475|18727965|P1|NOT COMPLETED|Period 1: First 6 Cycles||6
7607310|NCT02490475|18727962|P4|COMPLETED|Period 1: First 6 Cycles||0
7607311|NCT02490475|18727963|P3|COMPLETED|Period 1: First 6 Cycles||0
7607312|NCT02490475|18727964|P2|COMPLETED|Period 1: First 6 Cycles||0
7607313|NCT02490475|18727965|P1|COMPLETED|Period 1: First 6 Cycles||0
7607314|NCT02490475|18727962|P4|STARTED|Period 1: First 6 Cycles||5
7607315|NCT02490475|18727963|P3|STARTED|Period 1: First 6 Cycles||6
7607316|NCT02490475|18727964|P2|STARTED|Period 1: First 6 Cycles||2
7607317|NCT02490475|18727965|P1|STARTED|Period 1: First 6 Cycles||6
7607318|NCT02490371|18728043|P2|NOT COMPLETED|Overall Study||1
7607319|NCT02490371|18728044|P1|NOT COMPLETED|Overall Study||1
7607320|NCT02490371|18728043|P2|COMPLETED|Overall Study||11
7607321|NCT02490371|18728044|P1|COMPLETED|Overall Study||11
7607322|NCT02490371|18728043|P2|STARTED|Overall Study||12
7607323|NCT02490371|18728044|P1|STARTED|Overall Study||12
7607324|NCT02490293|18728062|P2|NOT COMPLETED|Overall Study||3
7607325|NCT02490293|18728063|P1|NOT COMPLETED|Overall Study||2
7607326|NCT02490293|18728062|P2|COMPLETED|Overall Study||99
7607327|NCT02490293|18728063|P1|COMPLETED|Overall Study||94
7607328|NCT02490293|18728062|P2|STARTED|Overall Study||102
7607329|NCT02490293|18728063|P1|STARTED|Overall Study||96
7607330|NCT02489981|18728071|P1|NOT COMPLETED|Overall Study||127
7607331|NCT02489981|18728071|P1|COMPLETED|Overall Study||213
7607332|NCT02489981|18728071|P1|STARTED|Overall Study||340
7607333|NCT02489968|18728078|P6|NOT COMPLETED|Double-blind Treatment Period||8
7607334|NCT02489968|18728079|P5|NOT COMPLETED|Double-blind Treatment Period||6
7607335|NCT02489968|18728080|P4|NOT COMPLETED|Double-blind Treatment Period||8
7607336|NCT02489968|18728081|P3|NOT COMPLETED|Double-blind Treatment Period||2
7607337|NCT02489968|18728082|P2|NOT COMPLETED|Double-blind Treatment Period||0
7607338|NCT02489968|18728083|P1|NOT COMPLETED|Double-blind Treatment Period||0
7607339|NCT02489968|18728078|P6|COMPLETED|Double-blind Treatment Period||108
7607340|NCT02489968|18728079|P5|COMPLETED|Double-blind Treatment Period||110
7607341|NCT02489968|18728080|P4|COMPLETED|Double-blind Treatment Period||100
7607342|NCT02489968|18728081|P3|COMPLETED|Double-blind Treatment Period||105
7607343|NCT02489968|18728082|P2|COMPLETED|Double-blind Treatment Period||0
7607344|NCT02489968|18728083|P1|COMPLETED|Double-blind Treatment Period||0
7607345|NCT02489968|18728078|P6|STARTED|Double-blind Treatment Period||116
7607346|NCT02489968|18728079|P5|STARTED|Double-blind Treatment Period||116
7607347|NCT02489968|18728080|P4|STARTED|Double-blind Treatment Period||108
7607348|NCT02489968|18728081|P3|STARTED|Double-blind Treatment Period||107
7607349|NCT02489968|18728082|P2|STARTED|Double-blind Treatment Period||0
7607350|NCT02489968|18728083|P1|STARTED|Double-blind Treatment Period||0
7607351|NCT02489968|18728078|P6|NOT COMPLETED|Open-label Treatment Period||0
7607352|NCT02489968|18728079|P5|NOT COMPLETED|Open-label Treatment Period||0
7607353|NCT02489968|18728080|P4|NOT COMPLETED|Open-label Treatment Period||0
7607354|NCT02489968|18728081|P3|NOT COMPLETED|Open-label Treatment Period||0
7607355|NCT02489968|18728082|P2|NOT COMPLETED|Open-label Treatment Period||208
7607356|NCT02489968|18728083|P1|NOT COMPLETED|Open-label Treatment Period||224
7607357|NCT02489968|18728078|P6|COMPLETED|Open-label Treatment Period||0
7607358|NCT02489968|18728079|P5|COMPLETED|Open-label Treatment Period||0
7607359|NCT02489968|18728080|P4|COMPLETED|Open-label Treatment Period||0
7607360|NCT02489968|18728081|P3|COMPLETED|Open-label Treatment Period||0
7607361|NCT02489968|18728082|P2|COMPLETED|Open-label Treatment Period||232
7607362|NCT02489968|18728083|P1|COMPLETED|Open-label Treatment Period||215
7607363|NCT02489968|18728078|P6|STARTED|Open-label Treatment Period||0
7607364|NCT02489968|18728079|P5|STARTED|Open-label Treatment Period||0
7607365|NCT02489968|18728080|P4|STARTED|Open-label Treatment Period||0
7607366|NCT02489968|18728081|P3|STARTED|Open-label Treatment Period||0
7607367|NCT02489968|18728082|P2|STARTED|Open-label Treatment Period|1 subject did not receive treatment and hence excluded. Started represents treated numbers.|440
7607368|NCT02489968|18728083|P1|STARTED|Open-label Treatment Period||439
7607369|NCT02489799|18728097|P2|NOT COMPLETED|Overall Study||9
7607370|NCT02489799|18728098|P1|NOT COMPLETED|Overall Study||9
7607371|NCT02489799|18728097|P2|COMPLETED|Overall Study||38
7607372|NCT02489799|18728098|P1|COMPLETED|Overall Study||36
7607373|NCT02489799|18728097|P2|Postsurgical One Week Visit (V3)|Overall Study||39
7607374|NCT02489799|18728098|P1|Postsurgical One Week Visit (V3)|Overall Study||40
7607375|NCT02489799|18728097|P2|Presurgical Consent Visit (V2)|Overall Study||39
7607376|NCT02489799|18728098|P1|Presurgical Consent Visit (V2)|Overall Study||40
7607377|NCT02489799|18728097|P2|STARTED|Overall Study||47
7607378|NCT02489799|18728098|P1|STARTED|Overall Study||45
7607379|NCT02489773|18728124|P2|NOT COMPLETED|Overall Study||2
7607380|NCT02489773|18728125|P1|NOT COMPLETED|Overall Study||7
7607381|NCT02489773|18728124|P2|COMPLETED|Overall Study||50
7607382|NCT02489773|18728125|P1|COMPLETED|Overall Study||91
7607383|NCT02489773|18728124|P2|STARTED|Overall Study||52
7607384|NCT02489773|18728125|P1|STARTED|Overall Study||98
7607385|NCT02489500|18728135|P2|NOT COMPLETED|Overall Study||1
7607386|NCT02489500|18728136|P1|NOT COMPLETED|Overall Study||1
7607387|NCT02489500|18728135|P2|COMPLETED|Overall Study||0
7607388|NCT02489500|18728136|P1|COMPLETED|Overall Study||1
7607389|NCT02489500|18728135|P2|STARTED|Overall Study||1
7607390|NCT02489500|18728136|P1|STARTED|Overall Study||2
7607391|NCT02489357|18728148|P1|NOT COMPLETED|Overall Study||0
7607392|NCT02489357|18728148|P1|COMPLETED|Overall Study||12
7607393|NCT02489357|18728148|P1|STARTED|Overall Study||12
7607394|NCT02489344|18728154|P1|NOT COMPLETED|LTS14116 (Extension Study): 31 Months||3
7607395|NCT02489344|18728154|P1|COMPLETED|LTS14116 (Extension Study): 31 Months||5
7607396|NCT02489344|18728154|P1|STARTED|LTS14116 (Extension Study): 31 Months||8
7607397|NCT02489344|18728154|P1|NOT COMPLETED|ACT13739 (Initial Study): 26 Weeks||2
7607398|NCT02489344|18728154|P1|COMPLETED|ACT13739 (Initial Study): 26 Weeks||9
7607399|NCT02489344|18728154|P1|STARTED|ACT13739 (Initial Study): 26 Weeks||11
7607400|NCT02489279|18728196|P2|NOT COMPLETED|Overall Study||10
7607401|NCT02489279|18728197|P1|NOT COMPLETED|Overall Study||12
7607402|NCT02489279|18728196|P2|COMPLETED|Overall Study||31
7607403|NCT02489279|18728197|P1|COMPLETED|Overall Study||32
7607404|NCT02489279|18728196|P2|STARTED|Overall Study||41
7607405|NCT02489279|18728197|P1|STARTED|Overall Study||44
7607406|NCT02489227|18728212|P3|NOT COMPLETED|Overall Study||19
7607407|NCT02489227|18728213|P2|NOT COMPLETED|Overall Study||34
7607408|NCT02489227|18728214|P1|NOT COMPLETED|Overall Study||54
7607409|NCT02489227|18728212|P3|COMPLETED|Overall Study||117
7607410|NCT02489227|18728213|P2|COMPLETED|Overall Study||101
7607411|NCT02489227|18728214|P1|COMPLETED|Overall Study||220
7607412|NCT02489227|18728212|P3|STARTED|Overall Study||136
7607413|NCT02489227|18728213|P2|STARTED|Overall Study||135
7607414|NCT02489227|18728214|P1|STARTED|Overall Study||274
7607415|NCT02489110|18728226|P2|NOT COMPLETED|Overall Study||25
7607416|NCT02489110|18728227|P1|NOT COMPLETED|Overall Study||27
7607417|NCT02489110|18728226|P2|COMPLETED|Overall Study||50
7607418|NCT02489110|18728227|P1|COMPLETED|Overall Study||48
7607419|NCT02489110|18728226|P2|STARTED|Overall Study||75
7607420|NCT02489110|18728227|P1|STARTED|Overall Study||75
7607421|NCT02488980|18728238|P3|NOT COMPLETED|Overall Study||2
7607422|NCT02488980|18728239|P2|NOT COMPLETED|Overall Study||2
7607423|NCT02488980|18728240|P1|NOT COMPLETED|Overall Study||2
7607424|NCT02488980|18728238|P3|COMPLETED|Overall Study||99
7607425|NCT02488980|18728239|P2|COMPLETED|Overall Study||99
7607426|NCT02488980|18728240|P1|COMPLETED|Overall Study||102
7607427|NCT02488980|18728238|P3|STARTED|Overall Study||101
7607428|NCT02488980|18728239|P2|STARTED|Overall Study||101
7607429|NCT02488980|18728240|P1|STARTED|Overall Study||104
7607430|NCT02488915|18728257|P1|NOT COMPLETED|Overall Study||26
7607431|NCT02488915|18728257|P1|COMPLETED|Overall Study||202
7607432|NCT02488915|18728257|P1|STARTED|Overall Study||228
7607433|NCT02488824|18728275|P2|NOT COMPLETED|Overall Study||1
7607434|NCT02488824|18728276|P1|NOT COMPLETED|Overall Study||1
7607435|NCT02488824|18728275|P2|COMPLETED|Overall Study||19
7607436|NCT02488824|18728276|P1|COMPLETED|Overall Study||20
7607437|NCT02488824|18728275|P2|STARTED|Overall Study||20
7607438|NCT02488824|18728276|P1|STARTED|Overall Study||21
7607439|NCT02488681|18728290|P1|NOT COMPLETED|Overall Study||7
7607440|NCT02488681|18728290|P1|COMPLETED|Overall Study|Patients successfully implanted with Micra|269
7607441|NCT02488681|18728290|P1|STARTED|Overall Study|Patients with Micra implant attempt|276
7607442|NCT02488330|18728294|P1|NOT COMPLETED|Overall Study||12
7607443|NCT02488330|18728294|P1|COMPLETED|Overall Study||0
7607444|NCT02488330|18728294|P1|STARTED|Overall Study||12
7607445|NCT02488317|18728300|P2|NOT COMPLETED|Overall Study||47
7607446|NCT02488317|18728301|P1|NOT COMPLETED|Overall Study||54
7607447|NCT02488317|18728300|P2|COMPLETED|Overall Study||70
7607448|NCT02488317|18728301|P1|COMPLETED|Overall Study||63
7607449|NCT02488317|18728300|P2|STARTED|Overall Study||117
7607450|NCT02488317|18728301|P1|STARTED|Overall Study||117
7607451|NCT02488239|18728315|P1|NOT COMPLETED|Overall Study||10
7607452|NCT02488239|18728315|P1|COMPLETED|Overall Study||54
7607453|NCT02488239|18728315|P1|STARTED|Overall Study||64
7607454|NCT02488070|18728320|P1|NOT COMPLETED|Overall Study||0
7607455|NCT02488070|18728320|P1|COMPLETED|Overall Study||10
7607456|NCT02488070|18728320|P1|STARTED|Overall Study||10
7607457|NCT02488018|18728328|P1|NOT COMPLETED|Overall Study||0
7607458|NCT02488018|18728328|P1|COMPLETED|Overall Study||10
7607459|NCT02488018|18728328|P1|STARTED|Overall Study||10
7607460|NCT02488005|18728332|P1|NOT COMPLETED|Overall Study||2
7607461|NCT02488005|18728332|P1|COMPLETED|Overall Study||13
7607462|NCT02488005|18728332|P1|STARTED|Overall Study||15
7607463|NCT02487979|18728342|P1|NOT COMPLETED|Overall Study||21
7607464|NCT02487979|18728342|P1|COMPLETED|Overall Study||1
7607465|NCT02487979|18728342|P1|STARTED|Overall Study||22
7607466|NCT02487810|18728354|P2|NOT COMPLETED|Overall Study||0
7607467|NCT02487810|18728355|P1|NOT COMPLETED|Overall Study||1
7607468|NCT02487810|18728354|P2|COMPLETED|Overall Study||102
7607469|NCT02487810|18728355|P1|COMPLETED|Overall Study||97
7607470|NCT02487810|18728354|P2|STARTED|Overall Study||102
7607471|NCT02487810|18728355|P1|STARTED|Overall Study||98
7607472|NCT02487771|18728387|P2|NOT COMPLETED|Overall Study||14
7607473|NCT02487771|18728388|P1|NOT COMPLETED|Overall Study||10
7607474|NCT02487771|18728387|P2|COMPLETED|Overall Study||85
7607475|NCT02487771|18728388|P1|COMPLETED|Overall Study||81
7607476|NCT02487771|18728387|P2|STARTED|Overall Study||99
7607477|NCT02487771|18728388|P1|STARTED|Overall Study||91
7607478|NCT02487563|18728541|P3|NOT COMPLETED|Overall Study||1
7607479|NCT02487563|18728542|P2|NOT COMPLETED|Overall Study||3
7607480|NCT02487563|18728543|P1|NOT COMPLETED|Overall Study||2
7607481|NCT02487563|18728541|P3|COMPLETED|Overall Study||31
7607482|NCT02487563|18728542|P2|COMPLETED|Overall Study||30
7607483|NCT02487563|18728543|P1|COMPLETED|Overall Study||30
7607484|NCT02487563|18728541|P3|STARTED|Overall Study||32
7607485|NCT02487563|18728542|P2|STARTED|Overall Study||33
7607486|NCT02487563|18728543|P1|STARTED|Overall Study||32
7607487|NCT02487498|18728554|P2|NOT COMPLETED|Period: Period 2||5
7607488|NCT02487498|18728555|P1|NOT COMPLETED|Period: Period 2||6
7607489|NCT02487498|18728554|P2|COMPLETED|Period: Period 2||154
7607490|NCT02487498|18728555|P1|COMPLETED|Period: Period 2||164
7607491|NCT02487498|18728554|P2|STARTED|Period: Period 2||159
7607492|NCT02487498|18728555|P1|STARTED|Period: Period 2||170
7607493|NCT02487498|18728554|P2|NOT COMPLETED|Period: Washout||7
7607494|NCT02487498|18728555|P1|NOT COMPLETED|Period: Washout||2
7607495|NCT02487498|18728554|P2|COMPLETED|Period: Washout||159
7607496|NCT02487498|18728555|P1|COMPLETED|Period: Washout||170
7607497|NCT02487498|18728554|P2|STARTED|Period: Washout||166
7607498|NCT02487498|18728555|P1|STARTED|Period: Washout||172
7607499|NCT02487498|18728554|P2|NOT COMPLETED|Period: Period 1||11
7607500|NCT02487498|18728555|P1|NOT COMPLETED|Period: Period 1||6
7607501|NCT02487498|18728554|P2|COMPLETED|Period: Period 1||166
7607502|NCT02487498|18728555|P1|COMPLETED|Period: Period 1||172
7607503|NCT02487498|18728554|P2|STARTED|Period: Period 1||177
7607504|NCT02487498|18728555|P1|STARTED|Period: Period 1||178
7607505|NCT02487485|18728580|P2|NOT COMPLETED|Overall Study||3
7607506|NCT02487485|18728581|P1|NOT COMPLETED|Overall Study||3
7607507|NCT02487485|18728580|P2|COMPLETED|Overall Study||8
7607508|NCT02487485|18728581|P1|COMPLETED|Overall Study||9
7607509|NCT02487485|18728580|P2|STARTED|Overall Study||11
7607510|NCT02487485|18728581|P1|STARTED|Overall Study||12
7607511|NCT02487472|18728599|P1|NOT COMPLETED|Overall Study||11
7607512|NCT02487472|18728599|P1|COMPLETED|Overall Study||90
7607513|NCT02487472|18728599|P1|STARTED|Overall Study||101
7607514|NCT02487446|18728615|P2|NOT COMPLETED|Period 2||5
7607515|NCT02487446|18728616|P1|NOT COMPLETED|Period 2||8
7607516|NCT02487446|18728615|P2|COMPLETED|Period 2||158
7607517|NCT02487446|18728616|P1|COMPLETED|Period 2||154
7607518|NCT02487446|18728615|P2|STARTED|Period 2||163
7607519|NCT02487446|18728616|P1|STARTED|Period 2||162
7607520|NCT02487446|18728615|P2|NOT COMPLETED|Washout||8
7607521|NCT02487446|18728616|P1|NOT COMPLETED|Washout||3
7607522|NCT02487446|18728615|P2|COMPLETED|Washout||163
7607523|NCT02487446|18728616|P1|COMPLETED|Washout||162
7607524|NCT02487446|18728615|P2|STARTED|Washout||171
7607525|NCT02487446|18728616|P1|STARTED|Washout||165
7607526|NCT02487446|18728615|P2|NOT COMPLETED|Period 1||8
7607527|NCT02487446|18728616|P1|NOT COMPLETED|Period 1||13
7607528|NCT02487446|18728615|P2|COMPLETED|Period 1||171
7607529|NCT02487446|18728616|P1|COMPLETED|Period 1||165
7607530|NCT02487446|18728615|P2|STARTED|Period 1||179
7607531|NCT02487446|18728616|P1|STARTED|Period 1||178
7607532|NCT02487303|18728642|P3|NOT COMPLETED|Overall Study||1
7607533|NCT02487303|18728643|P2|NOT COMPLETED|Overall Study||4
7607534|NCT02487303|18728644|P1|NOT COMPLETED|Overall Study||2
7607535|NCT02487303|18728642|P3|COMPLETED|Overall Study||47
7607536|NCT02487303|18728643|P2|COMPLETED|Overall Study||47
7607537|NCT02487303|18728644|P1|COMPLETED|Overall Study||47
7607538|NCT02487303|18728642|P3|STARTED|Overall Study||48
7607539|NCT02487303|18728643|P2|STARTED|Overall Study||51
7607540|NCT02487303|18728644|P1|STARTED|Overall Study||49
7607541|NCT02487277|18728663|P2|NOT COMPLETED|Overall Study||0
7607542|NCT02487277|18728664|P1|NOT COMPLETED|Overall Study||0
7607543|NCT02487277|18728663|P2|COMPLETED|Overall Study||0
7607544|NCT02487277|18728664|P1|COMPLETED|Overall Study||3
7607545|NCT02487277|18728663|P2|STARTED|Overall Study||0
7607546|NCT02487277|18728664|P1|STARTED|Overall Study||3
7607547|NCT02487225|18728681|P2|NOT COMPLETED|Overall Study||30
7607548|NCT02487225|18728682|P1|NOT COMPLETED|Overall Study||27
7607549|NCT02487225|18728681|P2|COMPLETED|Overall Study||8
7607550|NCT02487225|18728682|P1|COMPLETED|Overall Study||18
7607551|NCT02487225|18728681|P2|STARTED|Overall Study||38
7607552|NCT02487225|18728682|P1|STARTED|Overall Study||45
7607553|NCT02487199|18728696|P2|NOT COMPLETED|Overall Study||1
7607554|NCT02487199|18728697|P1|NOT COMPLETED|Overall Study||0
7607555|NCT02487199|18728696|P2|COMPLETED|Overall Study||4
7607556|NCT02487199|18728697|P1|COMPLETED|Overall Study||13
7607557|NCT02487199|18728696|P2|STARTED|Overall Study||5
7607558|NCT02487199|18728697|P1|STARTED|Overall Study||13
7607559|NCT02487056|18728709|P1|NOT COMPLETED|Overall Study||16
7607560|NCT02487056|18728709|P1|COMPLETED|Overall Study||1606
7607561|NCT02487056|18728709|P1|STARTED|Overall Study||1622
7607562|NCT02487030|18728722|P7|NOT COMPLETED|Overall Study||0
7607563|NCT02487030|18728723|P6|NOT COMPLETED|Overall Study||1
7607564|NCT02487030|18728724|P5|NOT COMPLETED|Overall Study||2
7607565|NCT02487030|18728725|P4|NOT COMPLETED|Overall Study||2
7607566|NCT02487030|18728726|P3|NOT COMPLETED|Overall Study||2
7607567|NCT02487030|18728727|P2|NOT COMPLETED|Overall Study||4
7607568|NCT02487030|18728728|P1|NOT COMPLETED|Overall Study||2
7607569|NCT02487030|18728722|P7|COMPLETED|Overall Study||11
7607570|NCT02487030|18728723|P6|COMPLETED|Overall Study||37
7607571|NCT02487030|18728724|P5|COMPLETED|Overall Study||34
7607572|NCT02487030|18728725|P4|COMPLETED|Overall Study||40
7607573|NCT02487030|18728726|P3|COMPLETED|Overall Study||41
7607574|NCT02487030|18728727|P2|COMPLETED|Overall Study||38
7607575|NCT02487030|18728728|P1|COMPLETED|Overall Study||41
7607576|NCT02487030|18728722|P7|STARTED|Overall Study||11
7607577|NCT02487030|18728723|P6|STARTED|Overall Study||38
7607578|NCT02487030|18728724|P5|STARTED|Overall Study||36
7607579|NCT02487030|18728725|P4|STARTED|Overall Study||42
7607580|NCT02487030|18728726|P3|STARTED|Overall Study||43
7607581|NCT02487030|18728727|P2|STARTED|Overall Study||42
7607582|NCT02487030|18728728|P1|STARTED|Overall Study||43
7607583|NCT02486952|18728759|P1|NOT COMPLETED|Overall Study||50
7607584|NCT02486952|18728759|P1|COMPLETED|Overall Study||104
7607585|NCT02486952|18728759|P1|Started Induction Therapy|Overall Study||151
7607586|NCT02486952|18728759|P1|STARTED|Overall Study||154
7607587|NCT02486939|18728766|P2|NOT COMPLETED|Overall Study||2
7607588|NCT02486939|18728767|P1|NOT COMPLETED|Overall Study||1
7607589|NCT02486939|18728766|P2|COMPLETED|Overall Study||132
7607590|NCT02486939|18728767|P1|COMPLETED|Overall Study||224
7607591|NCT02486939|18728766|P2|STARTED|Overall Study||134
7607592|NCT02486939|18728767|P1|STARTED|Overall Study||225
7607593|NCT02486796|18728777|P2|NOT COMPLETED|Overall Study||1
7607594|NCT02486796|18728778|P1|NOT COMPLETED|Overall Study||2
7607595|NCT02486796|18728777|P2|COMPLETED|Overall Study||1
7607596|NCT02486796|18728778|P1|COMPLETED|Overall Study||1
7607597|NCT02486796|18728777|P2|STARTED|Overall Study||2
7607598|NCT02486796|18728778|P1|STARTED|Overall Study||3
7607599|NCT02486757|18728790|P1|NOT COMPLETED|Overall Study||1
7607600|NCT02486757|18728790|P1|COMPLETED|Overall Study||5
7607601|NCT02486757|18728790|P1|STARTED|Overall Study||6
7607602|NCT02486692|18728796|P2|NOT COMPLETED|Overall Study||7
7607603|NCT02486692|18728797|P1|NOT COMPLETED|Overall Study||4
7607604|NCT02486692|18728796|P2|COMPLETED|Overall Study||23
7607605|NCT02486692|18728797|P1|COMPLETED|Overall Study||26
7607606|NCT02486692|18728796|P2|STARTED|Overall Study||30
7607607|NCT02486692|18728797|P1|STARTED|Overall Study||30
7607608|NCT02486653|18728809|P2|NOT COMPLETED|Overall Study||4
7607609|NCT02486653|18728810|P1|NOT COMPLETED|Overall Study||6
7607610|NCT02486653|18728809|P2|COMPLETED|Overall Study||71
7607611|NCT02486653|18728810|P1|COMPLETED|Overall Study||70
7607612|NCT02486653|18728809|P2|STARTED|Overall Study||75
7607613|NCT02486653|18728810|P1|STARTED|Overall Study||76
7607614|NCT02486627|18728834|P2|NOT COMPLETED|Overall Study||9
7607615|NCT02486627|18728835|P1|NOT COMPLETED|Overall Study||7
7607616|NCT02486627|18728834|P2|COMPLETED|Overall Study||294
7607617|NCT02486627|18728835|P1|COMPLETED|Overall Study||299
7607618|NCT02486627|18728834|P2|STARTED|Overall Study||303
7607619|NCT02486627|18728835|P1|STARTED|Overall Study||306
7607620|NCT02486588|18728858|P6|NOT COMPLETED|Overall Study||746
7607621|NCT02486588|18728859|P5|NOT COMPLETED|Overall Study||746
7607622|NCT02486588|18728860|P4|NOT COMPLETED|Overall Study||738
7607623|NCT02486588|18728861|P3|NOT COMPLETED|Overall Study||755
7607624|NCT02486588|18728862|P2|NOT COMPLETED|Overall Study||750
7607625|NCT02486588|18728863|P1|NOT COMPLETED|Overall Study||738
7607626|NCT02486588|18728858|P6|COMPLETED|Overall Study||459
7607627|NCT02486588|18728859|P5|COMPLETED|Overall Study||497
7607628|NCT02486588|18728860|P4|COMPLETED|Overall Study||468
7607629|NCT02486588|18728861|P3|COMPLETED|Overall Study||465
7607630|NCT02486588|18728862|P2|COMPLETED|Overall Study||502
7607631|NCT02486588|18728863|P1|COMPLETED|Overall Study||450
7607632|NCT02486588|18728858|P6|STARTED|Overall Study||1205
7607633|NCT02486588|18728859|P5|STARTED|Overall Study||1243
7607634|NCT02486588|18728860|P4|STARTED|Overall Study||1206
7607635|NCT02486588|18728861|P3|STARTED|Overall Study||1220
7607636|NCT02486588|18728862|P2|STARTED|Overall Study||1252
7607637|NCT02486588|18728863|P1|STARTED|Overall Study||1188
7607638|NCT02486328|18728921|P2|NOT COMPLETED|Overall Study||1
7607639|NCT02486328|18728922|P1|NOT COMPLETED|Overall Study||2
7607640|NCT02486328|18728921|P2|COMPLETED|Overall Study||50
7607641|NCT02486328|18728922|P1|COMPLETED|Overall Study||50
7607642|NCT02486328|18728921|P2|STARTED|Overall Study||51
7607643|NCT02486328|18728922|P1|STARTED|Overall Study||52
7607644|NCT02486302|18728938|P1|NOT COMPLETED|Overall Study||676
7607645|NCT02486302|18728938|P1|COMPLETED|Overall Study||858
7607646|NCT02486302|18728938|P1|Treated|Overall Study||1523
7607647|NCT02486302|18728938|P1|STARTED|Overall Study||1534
7607648|NCT02486263|18728995|P2|NOT COMPLETED|Overall Study||1
7607649|NCT02486263|18728996|P1|NOT COMPLETED|Overall Study||3
7607650|NCT02486263|18728995|P2|COMPLETED|Overall Study||35
7607651|NCT02486263|18728996|P1|COMPLETED|Overall Study||37
7607652|NCT02486263|18728995|P2|STARTED|Overall Study||36
7607653|NCT02486263|18728996|P1|STARTED|Overall Study||40
7607654|NCT02486211|18729012|P2|NOT COMPLETED|Overall Study||0
7607655|NCT02486211|18729013|P1|NOT COMPLETED|Overall Study||1
7607656|NCT02486211|18729012|P2|COMPLETED|Overall Study||7
7607657|NCT02486211|18729013|P1|COMPLETED|Overall Study||6
7607658|NCT02486211|18729012|P2|STARTED|Overall Study||7
7607659|NCT02486211|18729013|P1|STARTED|Overall Study||7
7607660|NCT02486016|18729027|P1|NOT COMPLETED|Overall Study||0
7607661|NCT02486016|18729027|P1|COMPLETED|Overall Study||10
7607662|NCT02486016|18729027|P1|STARTED|Overall Study|Same 10 volunteers completed Apotex, Duragesic and Mylan arms of the study; crossover study.|10
7607663|NCT02485925|18729035|P1|NOT COMPLETED|Overall Study||15
7607664|NCT02485925|18729035|P1|COMPLETED|Overall Study||185
7607665|NCT02485925|18729035|P1|Per-Protocol Population|Overall Study||166
7607666|NCT02485925|18729035|P1|Intent to Treat (ITT) Population|Overall Study||193
7607667|NCT02485925|18729035|P1|Safety Population|Overall Study||200
7607668|NCT02485925|18729035|P1|STARTED|Overall Study||200
7607669|NCT02485912|18729045|P2|NOT COMPLETED|Overall Study||0
7607670|NCT02485912|18729046|P1|NOT COMPLETED|Overall Study||0
7607671|NCT02485912|18729045|P2|COMPLETED|Overall Study||20
7607672|NCT02485912|18729046|P1|COMPLETED|Overall Study||20
7607673|NCT02485912|18729045|P2|STARTED|Overall Study||20
7607674|NCT02485912|18729046|P1|STARTED|Overall Study||20
7607675|NCT02485834|18729054|P2|NOT COMPLETED|Overall Study||0
7607676|NCT02485834|18729055|P1|NOT COMPLETED|Overall Study||0
7607677|NCT02485834|18729054|P2|COMPLETED|Overall Study||2
7607678|NCT02485834|18729055|P1|COMPLETED|Overall Study||3
7607679|NCT02485834|18729054|P2|STARTED|Overall Study||2
7607680|NCT02485834|18729055|P1|STARTED|Overall Study||3
7607681|NCT02485717|18729067|P3|NOT COMPLETED|Overall Study||1
7607682|NCT02485717|18729068|P2|NOT COMPLETED|Overall Study||2
7607683|NCT02485717|18729069|P1|NOT COMPLETED|Overall Study||6
7607684|NCT02485717|18729067|P3|COMPLETED|Overall Study||19
7607685|NCT02485717|18729068|P2|COMPLETED|Overall Study||127
7607686|NCT02485717|18729069|P1|COMPLETED|Overall Study||136
7607687|NCT02485717|18729067|P3|STARTED|Overall Study||20
7607688|NCT02485717|18729068|P2|STARTED|Overall Study||129
7607689|NCT02485717|18729069|P1|STARTED|Overall Study||142
7607690|NCT02485704|18729084|P2|NOT COMPLETED|Overall Study||8
7607691|NCT02485704|18729085|P1|NOT COMPLETED|Overall Study||5
7607692|NCT02485704|18729084|P2|COMPLETED|Overall Study||118
7607693|NCT02485704|18729085|P1|COMPLETED|Overall Study||149
7607694|NCT02485704|18729084|P2|STARTED|Overall Study||126
7607695|NCT02485704|18729085|P1|STARTED|Overall Study||154
7607696|NCT02485561|18729094|P3|NOT COMPLETED|Overall Study||23
7607697|NCT02485561|18729095|P2|NOT COMPLETED|Overall Study||39
7607698|NCT02485561|18729096|P1|NOT COMPLETED|Overall Study||28
7607699|NCT02485561|18729094|P3|COMPLETED|Overall Study||136
7607700|NCT02485561|18729095|P2|COMPLETED|Overall Study||118
7607701|NCT02485561|18729096|P1|COMPLETED|Overall Study||133
7607702|NCT02485561|18729094|P3|Completed 1 mo Survey|Overall Study||144
7607703|NCT02485561|18729095|P2|Completed 1 mo Survey|Overall Study||138
7607704|NCT02485561|18729096|P1|Completed 1 mo Survey|Overall Study||145
7607705|NCT02485561|18729094|P3|STARTED|Overall Study||159
7607706|NCT02485561|18729095|P2|STARTED|Overall Study||157
7607707|NCT02485561|18729096|P1|STARTED|Overall Study||161
7607708|NCT02485483|18729133|P2|NOT COMPLETED|Overall Study||0
7607709|NCT02485483|18729134|P1|NOT COMPLETED|Overall Study||54
7607710|NCT02485483|18729133|P2|COMPLETED|Overall Study||1015
7607711|NCT02485483|18729134|P1|COMPLETED|Overall Study||223
7607712|NCT02485483|18729133|P2|STARTED|Overall Study||1015
7607713|NCT02485483|18729134|P1|STARTED|Overall Study||277
7607714|NCT02485353|18729149|P1|NOT COMPLETED|Overall Study||2
7607715|NCT02485353|18729149|P1|COMPLETED|Overall Study||0
7607716|NCT02485353|18729149|P1|STARTED|Overall Study||2
7607717|NCT02485301|18729156|P2|NOT COMPLETED|Overall Study||49
7607718|NCT02485301|18729157|P1|NOT COMPLETED|Overall Study||38
7607719|NCT02485301|18729156|P2|COMPLETED|Overall Study||1455
7607720|NCT02485301|18729157|P1|COMPLETED|Overall Study||1471
7607721|NCT02485301|18729156|P2|STARTED|Overall Study||1504
7607722|NCT02485301|18729157|P1|STARTED|Overall Study||1509
7607723|NCT02485158|18729207|P1|NOT COMPLETED|Overall Study||4
7607724|NCT02485158|18729207|P1|COMPLETED|Overall Study||24
7607725|NCT02485158|18729207|P1|STARTED|Overall Study||28
7607726|NCT02484911|18729296|P2|NOT COMPLETED|Overall Study||2
7607727|NCT02484911|18729297|P1|NOT COMPLETED|Overall Study||4
7607728|NCT02484911|18729296|P2|COMPLETED|Overall Study||58
7607729|NCT02484911|18729297|P1|COMPLETED|Overall Study||56
7607730|NCT02484911|18729296|P2|STARTED|Overall Study||60
7607731|NCT02484911|18729297|P1|STARTED|Overall Study||60
7607732|NCT02484898|18729325|P1|NOT COMPLETED|Overall Study||18
7607733|NCT02484898|18729325|P1|COMPLETED|Overall Study||182
7607734|NCT02484898|18729325|P1|STARTED|Overall Study||200
7607735|NCT02484859|18729331|P2|NOT COMPLETED|Overall Study||0
7607736|NCT02484859|18729332|P1|NOT COMPLETED|Overall Study||0
7607737|NCT02484859|18729331|P2|COMPLETED|Overall Study||44
7607738|NCT02484859|18729332|P1|COMPLETED|Overall Study||44
7607739|NCT02484859|18729331|P2|STARTED|Overall Study||44
7607740|NCT02484859|18729332|P1|STARTED|Overall Study||44
7607741|NCT02484807|18729352|P6|NOT COMPLETED|Overall Study||0
7607742|NCT02484807|18729353|P5|NOT COMPLETED|Overall Study||0
7607743|NCT02484807|18729354|P4|NOT COMPLETED|Overall Study||0
7607744|NCT02484807|18729355|P3|NOT COMPLETED|Overall Study||0
7607745|NCT02484807|18729356|P2|NOT COMPLETED|Overall Study||0
7607746|NCT02484807|18729357|P1|NOT COMPLETED|Overall Study||0
7607747|NCT02484807|18729352|P6|COMPLETED|Overall Study||6
7607748|NCT02484807|18729353|P5|COMPLETED|Overall Study||33
7607749|NCT02484807|18729354|P4|COMPLETED|Overall Study||21
7607750|NCT02484807|18729355|P3|COMPLETED|Overall Study||19
7607751|NCT02484807|18729356|P2|COMPLETED|Overall Study||7
7607752|NCT02484807|18729357|P1|COMPLETED|Overall Study||39
7607753|NCT02484807|18729352|P6|STARTED|Overall Study||6
7607754|NCT02484807|18729353|P5|STARTED|Overall Study||33
7607755|NCT02484807|18729354|P4|STARTED|Overall Study||21
7607756|NCT02484807|18729355|P3|STARTED|Overall Study||19
7607757|NCT02484807|18729356|P2|STARTED|Overall Study||7
7607758|NCT02484807|18729357|P1|STARTED|Overall Study||39
7607759|NCT02484729|18729387|P10|NOT COMPLETED|Overall Study||1
7607760|NCT02484729|18729388|P9|NOT COMPLETED|Overall Study||0
7607761|NCT02484729|18729389|P8|NOT COMPLETED|Overall Study||0
7607762|NCT02484729|18729390|P7|NOT COMPLETED|Overall Study||0
7607763|NCT02484729|18729391|P6|NOT COMPLETED|Overall Study||0
7607764|NCT02484729|18729392|P5|NOT COMPLETED|Overall Study||0
7607765|NCT02484729|18729393|P4|NOT COMPLETED|Overall Study||0
7607766|NCT02484729|18729394|P3|NOT COMPLETED|Overall Study||0
7607767|NCT02484729|18729395|P2|NOT COMPLETED|Overall Study||0
7607768|NCT02484729|18729396|P1|NOT COMPLETED|Overall Study||0
7607769|NCT02484729|18729387|P10|COMPLETED|Overall Study||7
7607770|NCT02484729|18729388|P9|COMPLETED|Overall Study||6
7607771|NCT02484729|18729389|P8|COMPLETED|Overall Study||6
7607772|NCT02484729|18729390|P7|COMPLETED|Overall Study||5
7607773|NCT02484729|18729391|P6|COMPLETED|Overall Study||6
7607774|NCT02484729|18729392|P5|COMPLETED|Overall Study||5
7607775|NCT02484729|18729393|P4|COMPLETED|Overall Study||6
7607776|NCT02484729|18729394|P3|COMPLETED|Overall Study||6
7607777|NCT02484729|18729395|P2|COMPLETED|Overall Study||6
7607778|NCT02484729|18729396|P1|COMPLETED|Overall Study||16
7607779|NCT02484729|18729387|P10|STARTED|Overall Study||8
7607780|NCT02484729|18729388|P9|STARTED|Overall Study||6
7607781|NCT02484729|18729389|P8|STARTED|Overall Study||6
7607782|NCT02484729|18729390|P7|STARTED|Overall Study||5
7607783|NCT02484729|18729391|P6|STARTED|Overall Study||6
7607784|NCT02484729|18729392|P5|STARTED|Overall Study||5
7607785|NCT02484729|18729393|P4|STARTED|Overall Study||6
7607786|NCT02484729|18729394|P3|STARTED|Overall Study||6
7607787|NCT02484729|18729395|P2|STARTED|Overall Study||6
7607788|NCT02484729|18729396|P1|STARTED|Overall Study||16
7607789|NCT02484690|18729597|P5|NOT COMPLETED|Overall Study||6
7607790|NCT02484690|18729598|P4|NOT COMPLETED|Overall Study||2
7607791|NCT02484690|18729599|P3|NOT COMPLETED|Overall Study||3
7607792|NCT02484690|18729600|P2|NOT COMPLETED|Overall Study||6
7607793|NCT02484690|18729601|P1|NOT COMPLETED|Overall Study||4
7607794|NCT02484690|18729597|P5|COMPLETED|Overall Study||58
7607795|NCT02484690|18729598|P4|COMPLETED|Overall Study||44
7607796|NCT02484690|18729599|P3|COMPLETED|Overall Study||36
7607797|NCT02484690|18729600|P2|COMPLETED|Overall Study||40
7607798|NCT02484690|18729601|P1|COMPLETED|Overall Study||64
7607799|NCT02484690|18729597|P5|Received at Least One Dose of Study Drug|Overall Study||64
7607800|NCT02484690|18729598|P4|Received at Least One Dose of Study Drug|Overall Study||46
7607801|NCT02484690|18729599|P3|Received at Least One Dose of Study Drug|Overall Study||39
7607802|NCT02484690|18729600|P2|Received at Least One Dose of Study Drug|Overall Study||46
7607803|NCT02484690|18729601|P1|Received at Least One Dose of Study Drug|Overall Study||67
7607804|NCT02484690|18729597|P5|STARTED|Overall Study||64
7607805|NCT02484690|18729598|P4|STARTED|Overall Study||46
7607806|NCT02484690|18729599|P3|STARTED|Overall Study||39
7607807|NCT02484690|18729600|P2|STARTED|Overall Study||46
7607808|NCT02484690|18729601|P1|STARTED|Overall Study||68
7607809|NCT02484651|18729745|P2|NOT COMPLETED|Overall Study||4
7607810|NCT02484651|18729746|P1|NOT COMPLETED|Overall Study||3
7607811|NCT02484651|18729745|P2|COMPLETED|Overall Study||31
7607812|NCT02484651|18729746|P1|COMPLETED|Overall Study||32
7607813|NCT02484651|18729745|P2|Data Analysis|Overall Study||31
7607814|NCT02484651|18729746|P1|Data Analysis|Overall Study||32
7607815|NCT02484651|18729745|P2|End of Clinical Study|Overall Study||35
7607816|NCT02484651|18729746|P1|End of Clinical Study|Overall Study||35
7607817|NCT02484651|18729745|P2|STARTED|Overall Study|35 patients were randomized|35
7607818|NCT02484651|18729746|P1|STARTED|Overall Study|35 patients were randomized|35
7607819|NCT02484222|18729758|P1|NOT COMPLETED|Overall Study||3
7607820|NCT02484222|18729758|P1|COMPLETED|Overall Study||77
7607821|NCT02484222|18729758|P1|STARTED|Overall Study||80
7607822|NCT02484092|18729765|P1|NOT COMPLETED|Overall Study||0
7607823|NCT02484092|18729765|P1|COMPLETED|Overall Study||15
7607824|NCT02484092|18729765|P1|STARTED|Overall Study||15
7607825|NCT02483975|18729780|P2|NOT COMPLETED|Overall Study||2
7607826|NCT02483975|18729781|P1|NOT COMPLETED|Overall Study||2
7607827|NCT02483975|18729780|P2|COMPLETED|Overall Study|Subject reported as not completed due to AE was discontinued due to exacerbation, was not an AE/SAE|53
7607828|NCT02483975|18729781|P1|COMPLETED|Overall Study||54
7607829|NCT02483975|18729780|P2|STARTED|Overall Study||55
7607830|NCT02483975|18729781|P1|STARTED|Overall Study||56
7607831|NCT02483676|18729797|P2|NOT COMPLETED|Overall Study||5
7607832|NCT02483676|18729798|P1|NOT COMPLETED|Overall Study||6
7607833|NCT02483676|18729797|P2|COMPLETED|Overall Study||17
7607834|NCT02483676|18729798|P1|COMPLETED|Overall Study||17
7607835|NCT02483676|18729797|P2|STARTED|Overall Study||22
7607836|NCT02483676|18729798|P1|STARTED|Overall Study||23
7607837|NCT02483611|18729819|P3|NOT COMPLETED|Overall Study||1
7607838|NCT02483611|18729820|P2|NOT COMPLETED|Overall Study||0
7607839|NCT02483611|18729821|P1|NOT COMPLETED|Overall Study||0
7607840|NCT02483611|18729819|P3|COMPLETED|Overall Study|One patient required decurarization|15
7607841|NCT02483611|18729820|P2|COMPLETED|Overall Study||16
7607842|NCT02483611|18729821|P1|COMPLETED|Overall Study||16
7607843|NCT02483611|18729819|P3|STARTED|Overall Study||16
7607844|NCT02483611|18729820|P2|STARTED|Overall Study||16
7607845|NCT02483611|18729821|P1|STARTED|Overall Study||16
7607846|NCT02483585|18729918|P2|NOT COMPLETED|Open-label Treatment Phase||25
7607847|NCT02483585|18729919|P1|NOT COMPLETED|Open-label Treatment Phase||27
7607848|NCT02483585|18729918|P2|COMPLETED|Open-label Treatment Phase||243
7607849|NCT02483585|18729919|P1|COMPLETED|Open-label Treatment Phase||243
7607850|NCT02483585|18729918|P2|STARTED|Open-label Treatment Phase|Three participants who completed the double-blind phase did not enter the open-label treatment phase|268
7607851|NCT02483585|18729919|P1|STARTED|Open-label Treatment Phase|Five participants who completed the double-blind phase did not enter the open-label treatment phase|270
7607852|NCT02483585|18729918|P2|NOT COMPLETED|Double-blind Treatment Phase||15
7607853|NCT02483585|18729919|P1|NOT COMPLETED|Double-blind Treatment Phase||16
7607854|NCT02483585|18729918|P2|COMPLETED|Double-blind Treatment Phase||271
7607855|NCT02483585|18729919|P1|COMPLETED|Double-blind Treatment Phase||275
7607856|NCT02483585|18729918|P2|Received Treatment|Double-blind Treatment Phase||283
7607857|NCT02483585|18729919|P1|Received Treatment|Double-blind Treatment Phase||289
7607858|NCT02483585|18729918|P2|STARTED|Double-blind Treatment Phase||286
7607859|NCT02483585|18729919|P1|STARTED|Double-blind Treatment Phase||291
7607860|NCT02483572|18729941|P2|NOT COMPLETED|Overall Study||1
7607861|NCT02483572|18729942|P1|NOT COMPLETED|Overall Study||2
7607862|NCT02483572|18729941|P2|COMPLETED|Overall Study||1
7607863|NCT02483572|18729942|P1|COMPLETED|Overall Study||0
7607864|NCT02483572|18729941|P2|STARTED|Overall Study||2
7607865|NCT02483572|18729942|P1|STARTED|Overall Study||2
7607866|NCT02483533|18729956|P2|NOT COMPLETED|Overall Study||50
7607867|NCT02483533|18729957|P1|NOT COMPLETED|Overall Study||50
7607868|NCT02483533|18729956|P2|COMPLETED|Overall Study||0
7607869|NCT02483533|18729957|P1|COMPLETED|Overall Study||0
7607870|NCT02483533|18729956|P2|STARTED|Overall Study||50
7607871|NCT02483533|18729957|P1|STARTED|Overall Study||50
7607872|NCT02483520|18729967|P2|NOT COMPLETED|Overall Study||24
7607873|NCT02483520|18729968|P1|NOT COMPLETED|Overall Study||11
7607874|NCT02483520|18729967|P2|COMPLETED|Overall Study||73
7607875|NCT02483520|18729968|P1|COMPLETED|Overall Study||81
7607876|NCT02483520|18729967|P2|Persons With Dementia|Overall Study||41
7607877|NCT02483520|18729968|P1|Persons With Dementia|Overall Study||42
7607878|NCT02483520|18729967|P2|Caregivers|Overall Study||56
7607879|NCT02483520|18729968|P1|Caregivers|Overall Study||50
7607880|NCT02483520|18729967|P2|STARTED|Overall Study||97
7607881|NCT02483520|18729968|P1|STARTED|Overall Study||92
7607882|NCT02483416|18730008|P2|NOT COMPLETED|Overall Study||1
7607883|NCT02483416|18730009|P1|NOT COMPLETED|Overall Study||3
7607884|NCT02483416|18730008|P2|COMPLETED|Overall Study||6
7607885|NCT02483416|18730009|P1|COMPLETED|Overall Study||18
7607886|NCT02483416|18730008|P2|STARTED|Overall Study||7
7607887|NCT02483416|18730009|P1|STARTED|Overall Study||21
7607888|NCT02483000|18730064|P1|NOT COMPLETED|Overall Study||0
7607889|NCT02483000|18730064|P1|COMPLETED|Overall Study||3
7607890|NCT02483000|18730064|P1|STARTED|Overall Study||3
7607891|NCT02482935|18730073|P2|NOT COMPLETED|Period 2||0
7607892|NCT02482935|18730074|P1|NOT COMPLETED|Period 2||0
7607893|NCT02482935|18730073|P2|COMPLETED|Period 2||15
7607894|NCT02482935|18730074|P1|COMPLETED|Period 2||14
7607895|NCT02482935|18730073|P2|Follow-up|Period 2||15
7607896|NCT02482935|18730074|P1|Follow-up|Period 2||14
7607897|NCT02482935|18730073|P2|Received Abemaciclib|Period 2||15
7607898|NCT02482935|18730074|P1|Received Abemaciclib|Period 2||14
7607899|NCT02482935|18730073|P2|STARTED|Period 2||15
7607900|NCT02482935|18730074|P1|STARTED|Period 2||14
7607901|NCT02482935|18730073|P2|NOT COMPLETED|Period 1||0
7607902|NCT02482935|18730074|P1|NOT COMPLETED|Period 1||1
7607903|NCT02482935|18730073|P2|COMPLETED|Period 1||15
7607904|NCT02482935|18730074|P1|COMPLETED|Period 1||14
7607905|NCT02482935|18730073|P2|Washout|Period 1||15
7607906|NCT02482935|18730074|P1|Washout|Period 1||15
7607907|NCT02482935|18730073|P2|Received Abemaciclib|Period 1||15
7607908|NCT02482935|18730074|P1|Received Abemaciclib|Period 1||15
7607909|NCT02482935|18730073|P2|STARTED|Period 1||15
7607910|NCT02482935|18730074|P1|STARTED|Period 1||15
7607911|NCT02482870|18730084|P2|NOT COMPLETED|Period 2 - Rest of the Study||0
7607912|NCT02482870|18730085|P1|NOT COMPLETED|Period 2 - Rest of the Study||0
7607913|NCT02482870|18730084|P2|COMPLETED|Period 2 - Rest of the Study||202
7607914|NCT02482870|18730085|P1|COMPLETED|Period 2 - Rest of the Study||186
7607915|NCT02482870|18730084|P2|STARTED|Period 2 - Rest of the Study||202
7607916|NCT02482870|18730085|P1|STARTED|Period 2 - Rest of the Study||186
7607917|NCT02482870|18730084|P2|NOT COMPLETED|Period 1 - First 60 Patients||0
7607918|NCT02482870|18730085|P1|NOT COMPLETED|Period 1 - First 60 Patients||0
7607919|NCT02482870|18730084|P2|COMPLETED|Period 1 - First 60 Patients||30
7607920|NCT02482870|18730085|P1|COMPLETED|Period 1 - First 60 Patients||30
7607921|NCT02482870|18730084|P2|STARTED|Period 1 - First 60 Patients||30
7607922|NCT02482870|18730085|P1|STARTED|Period 1 - First 60 Patients||30
7607923|NCT02482805|18730102|P3|NOT COMPLETED|Overall Study||0
7607924|NCT02482805|18730103|P2|NOT COMPLETED|Overall Study||4
7607925|NCT02482805|18730104|P1|NOT COMPLETED|Overall Study||4
7607926|NCT02482805|18730102|P3|COMPLETED|Overall Study||20
7607927|NCT02482805|18730103|P2|COMPLETED|Overall Study||23
7607928|NCT02482805|18730104|P1|COMPLETED|Overall Study||22
7607929|NCT02482805|18730102|P3|STARTED|Overall Study||20
7607930|NCT02482805|18730103|P2|STARTED|Overall Study||27
7607931|NCT02482805|18730104|P1|STARTED|Overall Study||26
7607932|NCT02482675|18730118|P23|NOT COMPLETED|Overall Study||0
7607933|NCT02482675|18730119|P22|NOT COMPLETED|Overall Study||0
7607934|NCT02482675|18730120|P21|NOT COMPLETED|Overall Study||0
7607935|NCT02482675|18730121|P20|NOT COMPLETED|Overall Study||0
7607936|NCT02482675|18730122|P19|NOT COMPLETED|Overall Study||0
7607937|NCT02482675|18730123|P18|NOT COMPLETED|Overall Study||0
7607938|NCT02482675|18730124|P17|NOT COMPLETED|Overall Study||0
7607939|NCT02482675|18730125|P16|NOT COMPLETED|Overall Study||0
7607940|NCT02482675|18730126|P15|NOT COMPLETED|Overall Study||0
7607941|NCT02482675|18730127|P14|NOT COMPLETED|Overall Study||0
7607942|NCT02482675|18730128|P13|NOT COMPLETED|Overall Study||0
7607943|NCT02482675|18730129|P12|NOT COMPLETED|Overall Study||0
7607944|NCT02482675|18730130|P11|NOT COMPLETED|Overall Study||0
7607945|NCT02482675|18730131|P10|NOT COMPLETED|Overall Study||0
7607946|NCT02482675|18730132|P9|NOT COMPLETED|Overall Study||0
7607947|NCT02482675|18730133|P8|NOT COMPLETED|Overall Study||0
7607948|NCT02482675|18730134|P7|NOT COMPLETED|Overall Study||0
7607949|NCT02482675|18730135|P6|NOT COMPLETED|Overall Study||0
7607950|NCT02482675|18730136|P5|NOT COMPLETED|Overall Study||0
7607951|NCT02482675|18730137|P4|NOT COMPLETED|Overall Study||0
7607952|NCT02482675|18730138|P3|NOT COMPLETED|Overall Study||0
7607953|NCT02482675|18730139|P2|NOT COMPLETED|Overall Study||0
7607954|NCT02482675|18730140|P1|NOT COMPLETED|Overall Study||0
7607955|NCT02482675|18730118|P23|COMPLETED|Overall Study||1
7607956|NCT02482675|18730119|P22|COMPLETED|Overall Study||1
7607957|NCT02482675|18730120|P21|COMPLETED|Overall Study||1
7607958|NCT02482675|18730121|P20|COMPLETED|Overall Study||1
7607959|NCT02482675|18730122|P19|COMPLETED|Overall Study||1
7607960|NCT02482675|18730123|P18|COMPLETED|Overall Study||1
7607961|NCT02482675|18730124|P17|COMPLETED|Overall Study||1
7607962|NCT02482675|18730125|P16|COMPLETED|Overall Study||1
7607963|NCT02482675|18730126|P15|COMPLETED|Overall Study||1
7607964|NCT02482675|18730127|P14|COMPLETED|Overall Study||1
7607965|NCT02482675|18730128|P13|COMPLETED|Overall Study||1
7607966|NCT02482675|18730129|P12|COMPLETED|Overall Study||1
7607967|NCT02482675|18730130|P11|COMPLETED|Overall Study||1
7607968|NCT02482675|18730131|P10|COMPLETED|Overall Study||1
7607969|NCT02482675|18730132|P9|COMPLETED|Overall Study||1
7607970|NCT02482675|18730133|P8|COMPLETED|Overall Study||1
7607971|NCT02482675|18730134|P7|COMPLETED|Overall Study||1
7607972|NCT02482675|18730135|P6|COMPLETED|Overall Study||1
7607973|NCT02482675|18730136|P5|COMPLETED|Overall Study||1
7607974|NCT02482675|18730137|P4|COMPLETED|Overall Study||1
7607975|NCT02482675|18730138|P3|COMPLETED|Overall Study||1
7607976|NCT02482675|18730139|P2|COMPLETED|Overall Study||1
7607977|NCT02482675|18730140|P1|COMPLETED|Overall Study||1
7607978|NCT02482675|18730118|P23|STARTED|Overall Study||1
7607979|NCT02482675|18730119|P22|STARTED|Overall Study||1
7607980|NCT02482675|18730120|P21|STARTED|Overall Study||1
7607981|NCT02482675|18730121|P20|STARTED|Overall Study||1
7607982|NCT02482675|18730122|P19|STARTED|Overall Study||1
7607983|NCT02482675|18730123|P18|STARTED|Overall Study||1
7607984|NCT02482675|18730124|P17|STARTED|Overall Study||1
7607985|NCT02482675|18730125|P16|STARTED|Overall Study||1
7607986|NCT02482675|18730126|P15|STARTED|Overall Study||1
7607987|NCT02482675|18730127|P14|STARTED|Overall Study||1
7607988|NCT02482675|18730128|P13|STARTED|Overall Study||1
7607989|NCT02482675|18730129|P12|STARTED|Overall Study||1
7607990|NCT02482675|18730130|P11|STARTED|Overall Study||1
7607991|NCT02482675|18730131|P10|STARTED|Overall Study||1
7607992|NCT02482675|18730132|P9|STARTED|Overall Study||1
7607993|NCT02482675|18730133|P8|STARTED|Overall Study||1
7607994|NCT02482675|18730134|P7|STARTED|Overall Study||1
7607995|NCT02482675|18730135|P6|STARTED|Overall Study||1
7607996|NCT02482675|18730136|P5|STARTED|Overall Study||1
7607997|NCT02482675|18730137|P4|STARTED|Overall Study||1
7607998|NCT02482675|18730138|P3|STARTED|Overall Study||1
7607999|NCT02482675|18730139|P2|STARTED|Overall Study||1
7608000|NCT02482675|18730140|P1|STARTED|Overall Study||1
7608001|NCT02482610|18730198|P6|NOT COMPLETED|Overall Study||0
7608002|NCT02482610|18730199|P5|NOT COMPLETED|Overall Study||0
7608003|NCT02482610|18730200|P4|NOT COMPLETED|Overall Study||0
7608004|NCT02482610|18730201|P3|NOT COMPLETED|Overall Study||0
7608005|NCT02482610|18730202|P2|NOT COMPLETED|Overall Study||0
7608006|NCT02482610|18730203|P1|NOT COMPLETED|Overall Study||0
7608007|NCT02482610|18730198|P6|COMPLETED|Overall Study||5
7608008|NCT02482610|18730199|P5|COMPLETED|Overall Study||3
7608009|NCT02482610|18730200|P4|COMPLETED|Overall Study||3
7608010|NCT02482610|18730201|P3|COMPLETED|Overall Study||2
7608011|NCT02482610|18730202|P2|COMPLETED|Overall Study||5
7608012|NCT02482610|18730203|P1|COMPLETED|Overall Study||4
7608013|NCT02482610|18730198|P6|STARTED|Overall Study||5
7608014|NCT02482610|18730199|P5|STARTED|Overall Study||3
7608015|NCT02482610|18730200|P4|STARTED|Overall Study||3
7608016|NCT02482610|18730201|P3|STARTED|Overall Study||2
7608017|NCT02482610|18730202|P2|STARTED|Overall Study||5
7608018|NCT02482610|18730203|P1|STARTED|Overall Study||4
7608019|NCT02482571|18730223|P1|NOT COMPLETED|Overall Study||8
7608020|NCT02482571|18730223|P1|COMPLETED|Overall Study||17
7608021|NCT02482571|18730223|P1|STARTED|Overall Study||25
7608022|NCT02482428|18730235|P5|NOT COMPLETED|Overall Study||7
7608023|NCT02482428|18730236|P4|NOT COMPLETED|Overall Study||2
7608024|NCT02482428|18730237|P3|NOT COMPLETED|Overall Study||1
7608025|NCT02482428|18730238|P2|NOT COMPLETED|Overall Study||12
7608026|NCT02482428|18730239|P1|NOT COMPLETED|Overall Study||9
7608027|NCT02482428|18730235|P5|COMPLETED|Overall Study||15
7608028|NCT02482428|18730236|P4|COMPLETED|Overall Study||8
7608029|NCT02482428|18730237|P3|COMPLETED|Overall Study||9
7608030|NCT02482428|18730238|P2|COMPLETED|Overall Study||10
7608031|NCT02482428|18730239|P1|COMPLETED|Overall Study||15
7608032|NCT02482428|18730235|P5|STARTED|Overall Study||22
7608033|NCT02482428|18730236|P4|STARTED|Overall Study||10
7608034|NCT02482428|18730237|P3|STARTED|Overall Study||10
7608035|NCT02482428|18730238|P2|STARTED|Overall Study||22
7608036|NCT02482428|18730239|P1|STARTED|Overall Study||24
7608037|NCT02482298|18730262|P3|NOT COMPLETED|Overall Study||3
7608038|NCT02482298|18730263|P2|NOT COMPLETED|Overall Study||3
7608039|NCT02482298|18730264|P1|NOT COMPLETED|Overall Study||2
7608040|NCT02482298|18730262|P3|COMPLETED|Overall Study||27
7608041|NCT02482298|18730263|P2|COMPLETED|Overall Study||24
7608042|NCT02482298|18730264|P1|COMPLETED|Overall Study||28
7608043|NCT02482298|18730262|P3|STARTED|Overall Study||30
7608044|NCT02482298|18730263|P2|STARTED|Overall Study||27
7608045|NCT02482298|18730264|P1|STARTED|Overall Study||30
7608046|NCT02482233|18730286|P2|NOT COMPLETED|Overall Study||1
7608047|NCT02482233|18730287|P1|NOT COMPLETED|Overall Study||1
7608048|NCT02482233|18730286|P2|COMPLETED|Overall Study||19
7608049|NCT02482233|18730287|P1|COMPLETED|Overall Study||9
7608050|NCT02482233|18730286|P2|STARTED|Overall Study||20
7608051|NCT02482233|18730287|P1|STARTED|Overall Study||10
7608052|NCT02482129|18730323|P2|NOT COMPLETED|Overall Study||2
7608053|NCT02482129|18730324|P1|NOT COMPLETED|Overall Study||6
7608054|NCT02482129|18730323|P2|COMPLETED|Overall Study||9
7608055|NCT02482129|18730324|P1|COMPLETED|Overall Study||26
7608056|NCT02482129|18730323|P2|Treated, as Randomized|Overall Study||9
7608057|NCT02482129|18730324|P1|Treated, as Randomized|Overall Study||30
7608058|NCT02482129|18730323|P2|STARTED|Overall Study||11
7608059|NCT02482129|18730324|P1|STARTED|Overall Study||32
7608060|NCT02482025|18730353|P2|NOT COMPLETED|Overall Study||0
7608061|NCT02482025|18730354|P1|NOT COMPLETED|Overall Study||0
7608062|NCT02482025|18730353|P2|COMPLETED|Overall Study||118
7608063|NCT02482025|18730354|P1|COMPLETED|Overall Study||122
7608064|NCT02482025|18730353|P2|STARTED|Overall Study||118
7608065|NCT02482025|18730354|P1|STARTED|Overall Study||122
7608066|NCT02481947|18730364|P2|NOT COMPLETED|Overall Study||36
7608067|NCT02481947|18730365|P1|NOT COMPLETED|Overall Study||46
7608068|NCT02481947|18730364|P2|COMPLETED|Overall Study||193
7608069|NCT02481947|18730365|P1|COMPLETED|Overall Study||184
7608070|NCT02481947|18730364|P2|STARTED|Overall Study||229
7608071|NCT02481947|18730365|P1|STARTED|Overall Study||230
7608072|NCT02481934|18730371|P1|NOT COMPLETED|Overall Study||2
7608073|NCT02481934|18730371|P1|COMPLETED|Overall Study||3
7608074|NCT02481934|18730371|P1|STARTED|Overall Study||5
7608075|NCT02481830|18730378|P2|NOT COMPLETED|Overall Study||20
7608076|NCT02481830|18730379|P1|NOT COMPLETED|Overall Study||2
7608077|NCT02481830|18730378|P2|COMPLETED|Overall Study||265
7608078|NCT02481830|18730379|P1|COMPLETED|Overall Study||282
7608079|NCT02481830|18730378|P2|STARTED|Overall Study||285
7608080|NCT02481830|18730379|P1|STARTED|Overall Study||284
7608081|NCT02481596|18730392|P3|NOT COMPLETED|Overall Study||8
7608082|NCT02481596|18730393|P2|NOT COMPLETED|Overall Study||1
7608083|NCT02481596|18730394|P1|NOT COMPLETED|Overall Study||3
7608084|NCT02481596|18730392|P3|COMPLETED|Overall Study||245
7608085|NCT02481596|18730393|P2|COMPLETED|Overall Study||126
7608086|NCT02481596|18730394|P1|COMPLETED|Overall Study||123
7608087|NCT02481596|18730392|P3|STARTED|Overall Study||253
7608088|NCT02481596|18730393|P2|STARTED|Overall Study||127
7608089|NCT02481596|18730394|P1|STARTED|Overall Study||126
7608090|NCT02481557|18730419|P2|NOT COMPLETED|Overall Study||0
7608091|NCT02481557|18730420|P1|NOT COMPLETED|Overall Study||0
7608092|NCT02481557|18730419|P2|COMPLETED|Overall Study||19
7608093|NCT02481557|18730420|P1|COMPLETED|Overall Study||17
7608094|NCT02481557|18730419|P2|STARTED|Overall Study||19
7608095|NCT02481557|18730420|P1|STARTED|Overall Study||17
7608096|NCT02481440|18730428|P1|NOT COMPLETED|Overall Study||61
7608097|NCT02481440|18730428|P1|COMPLETED|Overall Study||41
7608098|NCT02481440|18730428|P1|STARTED|Overall Study||102
7608099|NCT02481375|18730445|P4|NOT COMPLETED|Overall Study||14
7608100|NCT02481375|18730446|P3|NOT COMPLETED|Overall Study||10
7608101|NCT02481375|18730447|P2|NOT COMPLETED|Overall Study||11
7608102|NCT02481375|18730448|P1|NOT COMPLETED|Overall Study||14
7608103|NCT02481375|18730445|P4|COMPLETED|Overall Study||186
7608104|NCT02481375|18730446|P3|COMPLETED|Overall Study||191
7608105|NCT02481375|18730447|P2|COMPLETED|Overall Study||191
7608106|NCT02481375|18730448|P1|COMPLETED|Overall Study||192
7608107|NCT02481375|18730445|P4|STARTED|Overall Study||200
7608108|NCT02481375|18730446|P3|STARTED|Overall Study||201
7608109|NCT02481375|18730447|P2|STARTED|Overall Study||202
7608110|NCT02481375|18730448|P1|STARTED|Overall Study||206
7608111|NCT02481297|18730460|P2|NOT COMPLETED|Overall Study||0
7608112|NCT02481297|18730461|P1|NOT COMPLETED|Overall Study||0
7608113|NCT02481297|18730460|P2|COMPLETED|Overall Study||6
7608114|NCT02481297|18730461|P1|COMPLETED|Overall Study||1
7608115|NCT02481297|18730460|P2|STARTED|Overall Study||6
7608116|NCT02481297|18730461|P1|STARTED|Overall Study||1
7608117|NCT02481258|18730473|P2|NOT COMPLETED|Overall Study||0
7608118|NCT02481258|18730474|P1|NOT COMPLETED|Overall Study||0
7608119|NCT02481258|18730473|P2|COMPLETED|Overall Study||11
7608120|NCT02481258|18730474|P1|COMPLETED|Overall Study||12
7608121|NCT02481258|18730473|P2|STARTED|Overall Study||11
7608122|NCT02481258|18730474|P1|STARTED|Overall Study||12
7608123|NCT02481219|18730482|P2|NOT COMPLETED|Overall Study||1
7608124|NCT02481219|18730483|P1|NOT COMPLETED|Overall Study||2
7608125|NCT02481219|18730482|P2|COMPLETED|Overall Study||61
7608126|NCT02481219|18730483|P1|COMPLETED|Overall Study||58
7608127|NCT02481219|18730482|P2|STARTED|Overall Study||62
7608128|NCT02481219|18730483|P1|STARTED|Overall Study||60
7608129|NCT02481141|18730501|P2|NOT COMPLETED|Overall Study||5
7608130|NCT02481141|18730502|P1|NOT COMPLETED|Overall Study||9
7608131|NCT02481141|18730501|P2|COMPLETED|Overall Study||13
7608132|NCT02481141|18730502|P1|COMPLETED|Overall Study||26
7608133|NCT02481141|18730501|P2|STARTED|Overall Study||18
7608134|NCT02481141|18730502|P1|STARTED|Overall Study||35
7608135|NCT02481050|18730554|P1|NOT COMPLETED|Overall Study||58
7608136|NCT02481050|18730554|P1|COMPLETED|Overall Study||0
7608137|NCT02481050|18730554|P1|STARTED|Overall Study||58
7608138|NCT02480998|18730565|P2|NOT COMPLETED|Overall Study||0
7608139|NCT02480998|18730566|P1|NOT COMPLETED|Overall Study||0
7608140|NCT02480998|18730565|P2|COMPLETED|Overall Study||28
7608141|NCT02480998|18730566|P1|COMPLETED|Overall Study||56
7608142|NCT02480998|18730565|P2|STARTED|Overall Study||28
7608143|NCT02480998|18730566|P1|STARTED|Overall Study||56
7608144|NCT02480920|18730578|P1|NOT COMPLETED|Overall Study||0
7608145|NCT02480920|18730578|P1|COMPLETED|Overall Study||2738
7608146|NCT02480920|18730578|P1|STARTED|Overall Study||2738
7608147|NCT02480764|18730585|P3|NOT COMPLETED|Overall Study||21
7608148|NCT02480764|18730586|P2|NOT COMPLETED|Overall Study||20
7608149|NCT02480764|18730587|P1|NOT COMPLETED|Overall Study||10
7608150|NCT02480764|18730585|P3|COMPLETED|Overall Study||183
7608151|NCT02480764|18730586|P2|COMPLETED|Overall Study||189
7608152|NCT02480764|18730587|P1|COMPLETED|Overall Study||189
7608153|NCT02480764|18730585|P3|STARTED|Overall Study||204
7608154|NCT02480764|18730586|P2|STARTED|Overall Study||209
7608155|NCT02480764|18730587|P1|STARTED|Overall Study||199
7608156|NCT02480712|18730613|P1|NOT COMPLETED|Overall Study||11
7608157|NCT02480712|18730613|P1|COMPLETED|Overall Study||96
7608158|NCT02480712|18730613|P1|STARTED|Overall Study||107
7608159|NCT02480621|18730632|P2|NOT COMPLETED|Follow Up||2
7608160|NCT02480621|18730633|P1|NOT COMPLETED|Follow Up||4
7608161|NCT02480621|18730632|P2|COMPLETED|Follow Up||37
7608162|NCT02480621|18730633|P1|COMPLETED|Follow Up||39
7608163|NCT02480621|18730632|P2|STARTED|Follow Up||39
7608164|NCT02480621|18730633|P1|STARTED|Follow Up||43
7608165|NCT02480621|18730632|P2|NOT COMPLETED|Randomization||1
7608166|NCT02480621|18730633|P1|NOT COMPLETED|Randomization||1
7608167|NCT02480621|18730632|P2|COMPLETED|Randomization||39
7608168|NCT02480621|18730633|P1|COMPLETED|Randomization||43
7608169|NCT02480621|18730632|P2|STARTED|Randomization||40
7608170|NCT02480621|18730633|P1|STARTED|Randomization||44
7608171|NCT02480582|18730639|P6|NOT COMPLETED|Overall Study||0
7608172|NCT02480582|18730640|P5|NOT COMPLETED|Overall Study||0
7608173|NCT02480582|18730641|P4|NOT COMPLETED|Overall Study||0
7608174|NCT02480582|18730642|P3|NOT COMPLETED|Overall Study||0
7608175|NCT02480582|18730643|P2|NOT COMPLETED|Overall Study||0
7608176|NCT02480582|18730644|P1|NOT COMPLETED|Overall Study||0
7608177|NCT02480582|18730639|P6|COMPLETED|Overall Study||7
7608178|NCT02480582|18730640|P5|COMPLETED|Overall Study||7
7608179|NCT02480582|18730641|P4|COMPLETED|Overall Study||7
7608180|NCT02480582|18730642|P3|COMPLETED|Overall Study||7
7608181|NCT02480582|18730643|P2|COMPLETED|Overall Study||7
7608182|NCT02480582|18730644|P1|COMPLETED|Overall Study||7
7608183|NCT02480582|18730639|P6|STARTED|Overall Study||7
7608184|NCT02480582|18730640|P5|STARTED|Overall Study||7
7608185|NCT02480582|18730641|P4|STARTED|Overall Study||7
7608186|NCT02480582|18730642|P3|STARTED|Overall Study||7
7608187|NCT02480582|18730643|P2|STARTED|Overall Study||7
7608188|NCT02480582|18730644|P1|STARTED|Overall Study||7
7608189|NCT02480439|18730667|P3|NOT COMPLETED|Treatment Period 3||0
7608190|NCT02480439|18730668|P2|NOT COMPLETED|Treatment Period 3||0
7608191|NCT02480439|18730669|P1|NOT COMPLETED|Treatment Period 3||0
7608192|NCT02480439|18730667|P3|COMPLETED|Treatment Period 3||7
7608193|NCT02480439|18730668|P2|COMPLETED|Treatment Period 3||7
7608194|NCT02480439|18730669|P1|COMPLETED|Treatment Period 3||8
7608195|NCT02480439|18730667|P3|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7
7608196|NCT02480439|18730668|P2|STARTED|Treatment Period 3||7
7608197|NCT02480439|18730669|P1|STARTED|Treatment Period 3||8
7608198|NCT02480439|18730667|P3|NOT COMPLETED|Treatment Period 2||0
7608199|NCT02480439|18730668|P2|NOT COMPLETED|Treatment Period 2||0
7608200|NCT02480439|18730669|P1|NOT COMPLETED|Treatment Period 2||0
7608201|NCT02480439|18730667|P3|COMPLETED|Treatment Period 2||8
7608202|NCT02480439|18730668|P2|COMPLETED|Treatment Period 2||7
7608203|NCT02480439|18730669|P1|COMPLETED|Treatment Period 2||8
7608204|NCT02480439|18730667|P3|STARTED|Treatment Period 2||8
7608205|NCT02480439|18730668|P2|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7
7608206|NCT02480439|18730669|P1|STARTED|Treatment Period 2||8
7608207|NCT02480439|18730667|P3|NOT COMPLETED|Treatment Period 1||0
7608208|NCT02480439|18730668|P2|NOT COMPLETED|Treatment Period 1||0
7608209|NCT02480439|18730669|P1|NOT COMPLETED|Treatment Period 1||0
7608210|NCT02480439|18730667|P3|COMPLETED|Treatment Period 1||8
7608211|NCT02480439|18730668|P2|COMPLETED|Treatment Period 1||8
7608212|NCT02480439|18730669|P1|COMPLETED|Treatment Period 1||8
7608213|NCT02480439|18730667|P3|STARTED|Treatment Period 1||8
7608214|NCT02480439|18730668|P2|STARTED|Treatment Period 1||8
7608215|NCT02480439|18730669|P1|STARTED|Treatment Period 1||8
7608216|NCT02480166|18730695|P3|NOT COMPLETED|Overall Study||0
7608217|NCT02480166|18730696|P2|NOT COMPLETED|Overall Study||0
7608218|NCT02480166|18730697|P1|NOT COMPLETED|Overall Study||0
7608219|NCT02480166|18730695|P3|COMPLETED|Overall Study||4
7608220|NCT02480166|18730696|P2|COMPLETED|Overall Study||36
7608221|NCT02480166|18730697|P1|COMPLETED|Overall Study||20
7608222|NCT02480166|18730695|P3|STARTED|Overall Study||4
7608223|NCT02480166|18730696|P2|STARTED|Overall Study||36
7608224|NCT02480166|18730697|P1|STARTED|Overall Study||20
7608225|NCT02480153|18730710|P3|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||4
7608226|NCT02480153|18730711|P2|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||3
7608227|NCT02480153|18730712|P1|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||7
7608228|NCT02480153|18730710|P3|COMPLETED|Period 3: Week 52 Dosing to Week 78||123
7608229|NCT02480153|18730711|P2|COMPLETED|Period 3: Week 52 Dosing to Week 78||118
7608230|NCT02480153|18730712|P1|COMPLETED|Period 3: Week 52 Dosing to Week 78||252
7608231|NCT02480153|18730710|P3|Received Treatment|Period 3: Week 52 Dosing to Week 78||127
7608232|NCT02480153|18730711|P2|Received Treatment|Period 3: Week 52 Dosing to Week 78||120
7608233|NCT02480153|18730712|P1|Received Treatment|Period 3: Week 52 Dosing to Week 78||258
7608234|NCT02480153|18730710|P3|STARTED|Period 3: Week 52 Dosing to Week 78||127
7608235|NCT02480153|18730711|P2|STARTED|Period 3: Week 52 Dosing to Week 78||121
7608236|NCT02480153|18730712|P1|STARTED|Period 3: Week 52 Dosing to Week 78||259
7608237|NCT02480153|18730710|P3|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||7
7608238|NCT02480153|18730711|P2|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||13
7608239|NCT02480153|18730712|P1|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||20
7608240|NCT02480153|18730710|P3|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||127
7608241|NCT02480153|18730711|P2|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||122
7608242|NCT02480153|18730712|P1|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||263
7608243|NCT02480153|18730710|P3|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||133
7608244|NCT02480153|18730711|P2|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||135
7608245|NCT02480153|18730712|P1|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||283
7608246|NCT02480153|18730710|P3|STARTED|Period 2: Week 26 to Week 52 Pre-dose||134
7608247|NCT02480153|18730711|P2|STARTED|Period 2: Week 26 to Week 52 Pre-dose||135
7608248|NCT02480153|18730712|P1|STARTED|Period 2: Week 26 to Week 52 Pre-dose||283
7608249|NCT02480153|18730710|P3|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
7608250|NCT02480153|18730711|P2|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||16
7608251|NCT02480153|18730712|P1|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||4
7608252|NCT02480153|18730710|P3|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
7608253|NCT02480153|18730711|P2|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||284
7608254|NCT02480153|18730712|P1|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||293
7608255|NCT02480153|18730710|P3|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||0
7608256|NCT02480153|18730711|P2|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||299
7608257|NCT02480153|18730712|P1|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||297
7608258|NCT02480153|18730710|P3|STARTED|Period 1: First Dose to Week 26 Pre-dose||0
7608259|NCT02480153|18730711|P2|STARTED|Period 1: First Dose to Week 26 Pre-dose||300
7608260|NCT02480153|18730712|P1|STARTED|Period 1: First Dose to Week 26 Pre-dose||297
7608261|NCT02480114|18730889|P2|NOT COMPLETED|Overall Study||8
7608262|NCT02480114|18730890|P1|NOT COMPLETED|Overall Study||9
7608263|NCT02480114|18730889|P2|COMPLETED|Overall Study||30
7608264|NCT02480114|18730890|P1|COMPLETED|Overall Study||32
7608265|NCT02480114|18730889|P2|STARTED|Overall Study||38
7608266|NCT02480114|18730890|P1|STARTED|Overall Study||41
7608267|NCT02480010|18730902|P2|NOT COMPLETED|Overall Study||33
7608268|NCT02480010|18730903|P1|NOT COMPLETED|Overall Study||35
7608269|NCT02480010|18730902|P2|COMPLETED|Overall Study||0
7608270|NCT02480010|18730903|P1|COMPLETED|Overall Study||0
7608271|NCT02480010|18730902|P2|STARTED|Overall Study||33
7608272|NCT02480010|18730903|P1|STARTED|Overall Study||35
7608273|NCT02479880|18730949|P2|NOT COMPLETED|Overall Study||13
7608274|NCT02479880|18730950|P1|NOT COMPLETED|Overall Study||13
7608275|NCT02479880|18730949|P2|COMPLETED|Overall Study||2
7608276|NCT02479880|18730950|P1|COMPLETED|Overall Study||2
7608277|NCT02479880|18730949|P2|STARTED|Overall Study||15
7608278|NCT02479880|18730950|P1|STARTED|Overall Study||15
7608279|NCT02479802|18730956|P1|NOT COMPLETED|Overall Study||2
7608280|NCT02479802|18730956|P1|COMPLETED|Overall Study||11
7608281|NCT02479802|18730956|P1|STARTED|Overall Study||13
7608282|NCT02479763|18730967|P2|NOT COMPLETED|Overall Study||3
7608283|NCT02479763|18730968|P1|NOT COMPLETED|Overall Study||3
7608284|NCT02479763|18730967|P2|COMPLETED|Overall Study||50
7608285|NCT02479763|18730968|P1|COMPLETED|Overall Study||50
7608286|NCT02479763|18730967|P2|STARTED|Overall Study||53
7608287|NCT02479763|18730968|P1|STARTED|Overall Study||53
7608288|NCT02479412|18730983|P9|NOT COMPLETED|Overall Study||1
7608289|NCT02479412|18730984|P8|NOT COMPLETED|Overall Study||1
7608290|NCT02479412|18730985|P7|NOT COMPLETED|Overall Study||0
7608291|NCT02479412|18730986|P6|NOT COMPLETED|Overall Study||0
7608292|NCT02479412|18730987|P5|NOT COMPLETED|Overall Study||1
7608293|NCT02479412|18730988|P4|NOT COMPLETED|Overall Study||1
7608294|NCT02479412|18730989|P3|NOT COMPLETED|Overall Study||2
7608295|NCT02479412|18730990|P2|NOT COMPLETED|Overall Study||0
7608296|NCT02479412|18730991|P1|NOT COMPLETED|Overall Study||0
7608297|NCT02479412|18730983|P9|COMPLETED|Overall Study||6
7608298|NCT02479412|18730984|P8|COMPLETED|Overall Study||4
7608299|NCT02479412|18730985|P7|COMPLETED|Overall Study||6
7608300|NCT02479412|18730986|P6|COMPLETED|Overall Study||5
7608301|NCT02479412|18730987|P5|COMPLETED|Overall Study||5
7608302|NCT02479412|18730988|P4|COMPLETED|Overall Study||6
7608303|NCT02479412|18730989|P3|COMPLETED|Overall Study||4
7608304|NCT02479412|18730990|P2|COMPLETED|Overall Study||6
7608305|NCT02479412|18730991|P1|COMPLETED|Overall Study||6
7608306|NCT02479412|18730983|P9|STARTED|Overall Study||7
7608307|NCT02479412|18730984|P8|STARTED|Overall Study||5
7608308|NCT02479412|18730985|P7|STARTED|Overall Study||6
7608309|NCT02479412|18730986|P6|STARTED|Overall Study||5
7608310|NCT02479412|18730987|P5|STARTED|Overall Study||6
7608311|NCT02479412|18730988|P4|STARTED|Overall Study||7
7608312|NCT02479412|18730989|P3|STARTED|Overall Study||6
7608313|NCT02479412|18730990|P2|STARTED|Overall Study||6
7608314|NCT02479412|18730991|P1|STARTED|Overall Study||6
7608315|NCT02479139|18731068|P6|NOT COMPLETED|Overall Study||6
7608316|NCT02479139|18731069|P5|NOT COMPLETED|Overall Study||5
7608317|NCT02479139|18731070|P4|NOT COMPLETED|Overall Study||7
7608318|NCT02479139|18731071|P3|NOT COMPLETED|Overall Study||7
7608319|NCT02479139|18731072|P2|NOT COMPLETED|Overall Study||10
7608320|NCT02479139|18731073|P1|NOT COMPLETED|Overall Study||8
7608321|NCT02479139|18731068|P6|COMPLETED|Overall Study||19
7608322|NCT02479139|18731069|P5|COMPLETED|Overall Study||17
7608323|NCT02479139|18731070|P4|COMPLETED|Overall Study||14
7608324|NCT02479139|18731071|P3|COMPLETED|Overall Study||21
7608325|NCT02479139|18731072|P2|COMPLETED|Overall Study||12
7608326|NCT02479139|18731073|P1|COMPLETED|Overall Study||19
7608327|NCT02479139|18731068|P6|STARTED|Overall Study||25
7608328|NCT02479139|18731069|P5|STARTED|Overall Study||22
7608329|NCT02479139|18731070|P4|STARTED|Overall Study||21
7608330|NCT02479139|18731071|P3|STARTED|Overall Study||28
7608331|NCT02479139|18731072|P2|STARTED|Overall Study||22
7608332|NCT02479139|18731073|P1|STARTED|Overall Study||27
7608333|NCT02478671|18731099|P1|NOT COMPLETED|Overall Study||0
7608334|NCT02478671|18731099|P1|COMPLETED|Overall Study||4
7608335|NCT02478671|18731099|P1|STARTED|Overall Study||4
7608336|NCT02478632|18731106|P2|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||4
7608337|NCT02478632|18731107|P1|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||7
7608338|NCT02478632|18731106|P2|COMPLETED|Late Switch Phase (Week 52 to Week 148)||40
7608339|NCT02478632|18731107|P1|COMPLETED|Late Switch Phase (Week 52 to Week 148)||42
7608340|NCT02478632|18731106|P2|STARTED|Late Switch Phase (Week 52 to Week 148)||44
7608341|NCT02478632|18731107|P1|STARTED|Late Switch Phase (Week 52 to Week 148)||49
7608342|NCT02478632|18731106|P2|NOT COMPLETED|Early Switch Phase (Up to Week 52)||5
7608343|NCT02478632|18731107|P1|NOT COMPLETED|Early Switch Phase (Up to Week 52)||4
7608344|NCT02478632|18731106|P2|COMPLETED|Early Switch Phase (Up to Week 52)||44
7608345|NCT02478632|18731107|P1|COMPLETED|Early Switch Phase (Up to Week 52)||49
7608346|NCT02478632|18731106|P2|STARTED|Early Switch Phase (Up to Week 52)||49
7608347|NCT02478632|18731107|P1|STARTED|Early Switch Phase (Up to Week 52)||53
7608348|NCT02478580|18731133|P2|NOT COMPLETED|Overall Study||0
7608349|NCT02478580|18731134|P1|NOT COMPLETED|Overall Study||0
7608350|NCT02478580|18731133|P2|COMPLETED|Overall Study||33
7608351|NCT02478580|18731134|P1|COMPLETED|Overall Study||34
7608352|NCT02478580|18731133|P2|STARTED|Overall Study||33
7608353|NCT02478580|18731134|P1|STARTED|Overall Study||34
7608354|NCT02478463|18731142|P1|NOT COMPLETED|Treatment Period 2 (Up to 52 Weeks)||1
7608355|NCT02478463|18731142|P1|COMPLETED|Treatment Period 2 (Up to 52 Weeks)||16
7608356|NCT02478463|18731142|P1|STARTED|Treatment Period 2 (Up to 52 Weeks)||17
7608357|NCT02478463|18731142|P1|NOT COMPLETED|Washout Period (Up to 42 Days)||1
7608358|NCT02478463|18731142|P1|COMPLETED|Washout Period (Up to 42 Days)||17
7608359|NCT02478463|18731142|P1|STARTED|Washout Period (Up to 42 Days)||18
7608360|NCT02478463|18731142|P1|NOT COMPLETED|Treatment Period 1 (Up to Day 29)||1
7608361|NCT02478463|18731142|P1|COMPLETED|Treatment Period 1 (Up to Day 29)||18
7608362|NCT02478463|18731142|P1|STARTED|Treatment Period 1 (Up to Day 29)||19
7608363|NCT02478398|18731259|P2|NOT COMPLETED|Overall Study||21
7608364|NCT02478398|18731260|P1|NOT COMPLETED|Overall Study||52
7608365|NCT02478398|18731259|P2|COMPLETED|Overall Study||491
7608366|NCT02478398|18731260|P1|COMPLETED|Overall Study||461
7608367|NCT02478398|18731259|P2|Treated|Overall Study||510
7608368|NCT02478398|18731260|P1|Treated|Overall Study||512
7608369|NCT02478398|18731259|P2|STARTED|Overall Study||512
7608370|NCT02478398|18731260|P1|STARTED|Overall Study||513
7608371|NCT02478372|18731280|P2|NOT COMPLETED|Overall Study||14
7608372|NCT02478372|18731281|P1|NOT COMPLETED|Overall Study||13
7608373|NCT02478372|18731280|P2|COMPLETED|Overall Study||107
7608374|NCT02478372|18731281|P1|COMPLETED|Overall Study||108
7608375|NCT02478372|18731280|P2|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107
7608376|NCT02478372|18731281|P1|Reviewed at One Year|Overall Study|Routine follow up at one year|108
7608377|NCT02478372|18731280|P2|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113
7608378|NCT02478372|18731281|P1|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108
7608379|NCT02478372|18731280|P2|Recieved Allocation Intervention|Overall Study||113
7608380|NCT02478372|18731281|P1|Recieved Allocation Intervention|Overall Study||109
7608381|NCT02478372|18731280|P2|STARTED|Overall Study||121
7608382|NCT02478372|18731281|P1|STARTED|Overall Study||121
7608383|NCT02478359|18731305|P2|NOT COMPLETED|Overall Study||65
7608384|NCT02478359|18731306|P1|NOT COMPLETED|Overall Study||106
7608385|NCT02478359|18731305|P2|COMPLETED|Overall Study||1293
7608386|NCT02478359|18731306|P1|COMPLETED|Overall Study||1243
7608387|NCT02478359|18731305|P2|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 65|1293
7608388|NCT02478359|18731306|P1|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 106|1243
7608389|NCT02478359|18731305|P2|STARTED|Overall Study||1358
7608390|NCT02478359|18731306|P1|STARTED|Overall Study||1349
7608391|NCT02478164|18731378|P1|NOT COMPLETED|Overall Study||15
7608392|NCT02478164|18731378|P1|COMPLETED|Overall Study||0
7608393|NCT02478164|18731378|P1|STARTED|Overall Study|17 participants enrolled. 15 of 17 received ponatinib as 2 participants withdrew prior to ponatinib.|15
7608394|NCT02477709|18731385|P1|NOT COMPLETED|Overall Study||0
7608395|NCT02477709|18731385|P1|COMPLETED|Overall Study||6
7608396|NCT02477709|18731385|P1|STARTED|Overall Study||6
7608397|NCT02477670|18731391|P7|NOT COMPLETED|Stage 2||0
7608398|NCT02477670|18731392|P6|NOT COMPLETED|Stage 2||0
7608399|NCT02477670|18731393|P5|NOT COMPLETED|Stage 2||0
7608400|NCT02477670|18731394|P4|NOT COMPLETED|Stage 2||1
7608401|NCT02477670|18731395|P3|NOT COMPLETED|Stage 2||2
7608402|NCT02477670|18731396|P2|NOT COMPLETED|Stage 2||0
7608403|NCT02477670|18731397|P1|NOT COMPLETED|Stage 2||0
7608404|NCT02477670|18731391|P7|COMPLETED|Stage 2||42
7608405|NCT02477670|18731392|P6|COMPLETED|Stage 2||1
7608406|NCT02477670|18731393|P5|COMPLETED|Stage 2||2
7608407|NCT02477670|18731394|P4|COMPLETED|Stage 2||32
7608408|NCT02477670|18731395|P3|COMPLETED|Stage 2||28
7608409|NCT02477670|18731396|P2|COMPLETED|Stage 2||0
7608410|NCT02477670|18731397|P1|COMPLETED|Stage 2||0
7608411|NCT02477670|18731391|P7|STARTED|Stage 2||42
7608412|NCT02477670|18731392|P6|STARTED|Stage 2||1
7608413|NCT02477670|18731393|P5|STARTED|Stage 2||2
7608414|NCT02477670|18731394|P4|STARTED|Stage 2||33
7608415|NCT02477670|18731395|P3|STARTED|Stage 2||30
7608416|NCT02477670|18731396|P2|STARTED|Stage 2||0
7608417|NCT02477670|18731397|P1|STARTED|Stage 2||0
7608418|NCT02477670|18731391|P7|NOT COMPLETED|Stage 1||0
7608419|NCT02477670|18731392|P6|NOT COMPLETED|Stage 1||0
7608420|NCT02477670|18731393|P5|NOT COMPLETED|Stage 1||0
7608421|NCT02477670|18731394|P4|NOT COMPLETED|Stage 1||0
7608422|NCT02477670|18731395|P3|NOT COMPLETED|Stage 1||0
7608423|NCT02477670|18731396|P2|NOT COMPLETED|Stage 1||13
7608424|NCT02477670|18731397|P1|NOT COMPLETED|Stage 1||4
7608425|NCT02477670|18731391|P7|COMPLETED|Stage 1||0
7608426|NCT02477670|18731392|P6|COMPLETED|Stage 1||0
7608427|NCT02477670|18731393|P5|COMPLETED|Stage 1||0
7608428|NCT02477670|18731394|P4|COMPLETED|Stage 1||0
7608429|NCT02477670|18731395|P3|COMPLETED|Stage 1||0
7608430|NCT02477670|18731396|P2|COMPLETED|Stage 1||67
7608431|NCT02477670|18731397|P1|COMPLETED|Stage 1||43
7608432|NCT02477670|18731391|P7|STARTED|Stage 1||0
7608433|NCT02477670|18731392|P6|STARTED|Stage 1||0
7608434|NCT02477670|18731393|P5|STARTED|Stage 1||0
7608435|NCT02477670|18731394|P4|STARTED|Stage 1||0
7608436|NCT02477670|18731395|P3|STARTED|Stage 1||0
7608437|NCT02477670|18731396|P2|STARTED|Stage 1||80
7608438|NCT02477670|18731397|P1|STARTED|Stage 1||47
7608439|NCT02477618|18731613|P2|NOT COMPLETED|Overall Study||14
7608440|NCT02477618|18731614|P1|NOT COMPLETED|Overall Study||15
7608441|NCT02477618|18731613|P2|COMPLETED|Overall Study||53
7608442|NCT02477618|18731614|P1|COMPLETED|Overall Study||50
7608443|NCT02477618|18731613|P2|Intent-to-Treat Analysis Set|Overall Study||66
7608444|NCT02477618|18731614|P1|Intent-to-Treat Analysis Set|Overall Study||66
7608445|NCT02477618|18731613|P2|STARTED|Overall Study||67
7608446|NCT02477618|18731614|P1|STARTED|Overall Study||65
7608447|NCT02477605|18731638|P2|NOT COMPLETED|Overall Study||4
7608448|NCT02477605|18731639|P1|NOT COMPLETED|Overall Study||1
7608449|NCT02477605|18731638|P2|COMPLETED|Overall Study||64
7608450|NCT02477605|18731639|P1|COMPLETED|Overall Study||67
7608451|NCT02477605|18731638|P2|Randomized and Treated|Overall Study||68
7608452|NCT02477605|18731639|P1|Randomized and Treated|Overall Study||67
7608453|NCT02477605|18731638|P2|STARTED|Overall Study||68
7608454|NCT02477605|18731639|P1|STARTED|Overall Study||68
7608455|NCT02477553|18731655|P2|NOT COMPLETED|Overall Study||20
7608456|NCT02477553|18731656|P1|NOT COMPLETED|Overall Study||20
7608457|NCT02477553|18731655|P2|COMPLETED|Overall Study||344
7608458|NCT02477553|18731656|P1|COMPLETED|Overall Study||344
7608459|NCT02477553|18731655|P2|STARTED|Overall Study||364
7608460|NCT02477553|18731656|P1|STARTED|Overall Study||364
7608461|NCT02477527|18731676|P1|NOT COMPLETED|Overall Study||6
7608462|NCT02477527|18731676|P1|COMPLETED|Overall Study||21
7608463|NCT02477527|18731676|P1|STARTED|Overall Study||27
7608464|NCT02477423|18731686|P2|NOT COMPLETED|Overall Study||4
7608465|NCT02477423|18731687|P1|NOT COMPLETED|Overall Study||1
7608466|NCT02477423|18731686|P2|COMPLETED|Overall Study||11
7608467|NCT02477423|18731687|P1|COMPLETED|Overall Study||11
7608468|NCT02477423|18731686|P2|STARTED|Overall Study||15
7608469|NCT02477423|18731687|P1|STARTED|Overall Study||12
7608470|NCT02477332|18731711|P6|NOT COMPLETED|Overall Study||5
7608471|NCT02477332|18731712|P5|NOT COMPLETED|Overall Study||4
7608472|NCT02477332|18731713|P4|NOT COMPLETED|Overall Study||13
7608473|NCT02477332|18731714|P3|NOT COMPLETED|Overall Study||12
7608474|NCT02477332|18731715|P2|NOT COMPLETED|Overall Study||7
7608475|NCT02477332|18731716|P1|NOT COMPLETED|Overall Study||3
7608476|NCT02477332|18731711|P6|COMPLETED|Overall Study||37
7608477|NCT02477332|18731712|P5|COMPLETED|Overall Study||39
7608478|NCT02477332|18731713|P4|COMPLETED|Overall Study||72
7608479|NCT02477332|18731714|P3|COMPLETED|Overall Study||73
7608480|NCT02477332|18731715|P2|COMPLETED|Overall Study||77
7608481|NCT02477332|18731716|P1|COMPLETED|Overall Study||40
7608482|NCT02477332|18731711|P6|STARTED|Overall Study||42
7608483|NCT02477332|18731712|P5|STARTED|Overall Study||43
7608484|NCT02477332|18731713|P4|STARTED|Overall Study||85
7608485|NCT02477332|18731714|P3|STARTED|Overall Study||85
7608486|NCT02477332|18731715|P2|STARTED|Overall Study||84
7608487|NCT02477332|18731716|P1|STARTED|Overall Study||43
7608488|NCT02477319|18731794|P4|NOT COMPLETED|Overall Study||22
7608489|NCT02477319|18731795|P3|NOT COMPLETED|Overall Study||15
7608490|NCT02477319|18731796|P2|NOT COMPLETED|Overall Study||3
7608491|NCT02477319|18731797|P1|NOT COMPLETED|Overall Study||0
7608492|NCT02477319|18731794|P4|COMPLETED|Overall Study||171
7608493|NCT02477319|18731795|P3|COMPLETED|Overall Study||149
7608494|NCT02477319|18731796|P2|COMPLETED|Overall Study||37
7608495|NCT02477319|18731797|P1|COMPLETED|Overall Study||55
7608496|NCT02477319|18731794|P4|STARTED|Overall Study||193
7608497|NCT02477319|18731795|P3|STARTED|Overall Study||164
7608498|NCT02477319|18731796|P2|STARTED|Overall Study||40
7608499|NCT02477319|18731797|P1|STARTED|Overall Study||55
7608500|NCT02477215|18731808|P3|NOT COMPLETED|Fixed Dose Phase||0
7608501|NCT02477215|18731809|P2|NOT COMPLETED|Fixed Dose Phase||7
7608502|NCT02477215|18731810|P1|NOT COMPLETED|Fixed Dose Phase||0
7608503|NCT02477215|18731808|P3|COMPLETED|Fixed Dose Phase||0
7608504|NCT02477215|18731809|P2|COMPLETED|Fixed Dose Phase||13
7608505|NCT02477215|18731810|P1|COMPLETED|Fixed Dose Phase||0
7608506|NCT02477215|18731808|P3|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
7608507|NCT02477215|18731809|P2|STARTED|Fixed Dose Phase|Subjects in Period 1 did not continue into Period 2. This is a new subject population.|20
7608508|NCT02477215|18731810|P1|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
7608509|NCT02477215|18731808|P3|NOT COMPLETED|Dose Escalation Phase||0
7608510|NCT02477215|18731809|P2|NOT COMPLETED|Dose Escalation Phase||2
7608511|NCT02477215|18731810|P1|NOT COMPLETED|Dose Escalation Phase||1
7608512|NCT02477215|18731808|P3|COMPLETED|Dose Escalation Phase||6
7608513|NCT02477215|18731809|P2|COMPLETED|Dose Escalation Phase||6
7608514|NCT02477215|18731810|P1|COMPLETED|Dose Escalation Phase||3
7608515|NCT02477215|18731808|P3|STARTED|Dose Escalation Phase||6
7608516|NCT02477215|18731809|P2|STARTED|Dose Escalation Phase||8
7608517|NCT02477215|18731810|P1|STARTED|Dose Escalation Phase||4
7608518|NCT02477020|18731826|P2|NOT COMPLETED|Overall Study||28
7608519|NCT02477020|18731827|P1|NOT COMPLETED|Overall Study||30
7608520|NCT02477020|18731826|P2|COMPLETED|Overall Study|Completed = participants who completed study treatment.|55
7608521|NCT02477020|18731827|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|51
7608522|NCT02477020|18731826|P2|STARTED|Overall Study||83
7608523|NCT02477020|18731827|P1|STARTED|Overall Study||81
7608524|NCT02476994|18731857|P2|NOT COMPLETED|Overall Study||0
7608525|NCT02476994|18731858|P1|NOT COMPLETED|Overall Study||1
7608526|NCT02476994|18731857|P2|COMPLETED|Overall Study||0
7608527|NCT02476994|18731858|P1|COMPLETED|Overall Study||0
7608528|NCT02476994|18731857|P2|STARTED|Overall Study||0
7608529|NCT02476994|18731858|P1|STARTED|Overall Study||1
7608530|NCT02476916|18731886|P2|NOT COMPLETED|Extension Period||18
7608531|NCT02476916|18731887|P1|NOT COMPLETED|Extension Period||18
7608532|NCT02476916|18731886|P2|COMPLETED|Extension Period||0
7608533|NCT02476916|18731887|P1|COMPLETED|Extension Period||0
7608534|NCT02476916|18731886|P2|STARTED|Extension Period||18
7608535|NCT02476916|18731887|P1|STARTED|Extension Period||18
7608536|NCT02476916|18731886|P2|NOT COMPLETED|Core Period||3
7608537|NCT02476916|18731887|P1|NOT COMPLETED|Core Period||6
7608538|NCT02476916|18731886|P2|COMPLETED|Core Period||22
7608539|NCT02476916|18731887|P1|COMPLETED|Core Period||21
7608540|NCT02476916|18731886|P2|STARTED|Core Period||25
7608541|NCT02476916|18731887|P1|STARTED|Core Period||27
7608542|NCT02476890|18731933|P4|NOT COMPLETED|Overall Study||0
7608543|NCT02476890|18731934|P3|NOT COMPLETED|Overall Study||0
7608544|NCT02476890|18731935|P2|NOT COMPLETED|Overall Study||0
7608545|NCT02476890|18731936|P1|NOT COMPLETED|Overall Study||0
7608546|NCT02476890|18731933|P4|COMPLETED|Overall Study||12
7608547|NCT02476890|18731934|P3|COMPLETED|Overall Study||12
7608548|NCT02476890|18731935|P2|COMPLETED|Overall Study||6
7608549|NCT02476890|18731936|P1|COMPLETED|Overall Study||6
7608550|NCT02476890|18731933|P4|Washout|Overall Study||12
7608551|NCT02476890|18731934|P3|Washout|Overall Study||12
7608552|NCT02476890|18731935|P2|Washout|Overall Study||6
7608553|NCT02476890|18731936|P1|Washout|Overall Study||6
7608554|NCT02476890|18731933|P4|STARTED|Overall Study|Crossover study|12
7608555|NCT02476890|18731934|P3|STARTED|Overall Study|Crossover study|12
7608556|NCT02476890|18731935|P2|STARTED|Overall Study|Crossover study|6
7608557|NCT02476890|18731936|P1|STARTED|Overall Study|Crossover study|6
7608558|NCT02476617|18731972|P1|NOT COMPLETED|Overall Study||2
7608559|NCT02476617|18731972|P1|COMPLETED|Overall Study||23
7608560|NCT02476617|18731972|P1|STARTED|Overall Study||25
7608561|NCT02476578|18731978|P2|NOT COMPLETED|Overall Study||56
7608562|NCT02476578|18731979|P1|NOT COMPLETED|Overall Study||41
7608563|NCT02476578|18731978|P2|COMPLETED|Overall Study||4218
7608564|NCT02476578|18731979|P1|COMPLETED|Overall Study||4269
7608565|NCT02476578|18731978|P2|Left Before End of Trial|Overall Study||13
7608566|NCT02476578|18731979|P1|Left Before End of Trial|Overall Study||6
7608567|NCT02476578|18731978|P2|Died Before Email Was Sent|Overall Study||43
7608568|NCT02476578|18731979|P1|Died Before Email Was Sent|Overall Study||35
7608569|NCT02476578|18731978|P2|STARTED|Overall Study||4274
7608570|NCT02476578|18731979|P1|STARTED|Overall Study||4310
7608571|NCT02476565|18731993|P2|NOT COMPLETED|Overall Study||0
7608572|NCT02476565|18731994|P1|NOT COMPLETED|Overall Study||0
7608573|NCT02476565|18731993|P2|COMPLETED|Overall Study||19
7608574|NCT02476565|18731994|P1|COMPLETED|Overall Study||20
7608575|NCT02476565|18731993|P2|STARTED|Overall Study||19
7608576|NCT02476565|18731994|P1|STARTED|Overall Study||20
7608577|NCT02476448|18732018|P4|NOT COMPLETED|Overall Study||0
7608578|NCT02476448|18732019|P3|NOT COMPLETED|Overall Study||0
7608579|NCT02476448|18732020|P2|NOT COMPLETED|Overall Study||0
7608580|NCT02476448|18732021|P1|NOT COMPLETED|Overall Study||0
7608581|NCT02476448|18732018|P4|COMPLETED|Overall Study||44
7608582|NCT02476448|18732019|P3|COMPLETED|Overall Study||44
7608583|NCT02476448|18732020|P2|COMPLETED|Overall Study||44
7608584|NCT02476448|18732021|P1|COMPLETED|Overall Study||44
7608585|NCT02476448|18732018|P4|STARTED|Overall Study||44
7608586|NCT02476448|18732019|P3|STARTED|Overall Study||44
7608587|NCT02476448|18732020|P2|STARTED|Overall Study||44
7608588|NCT02476448|18732021|P1|STARTED|Overall Study|one given phenazopyridine pre-op and was analyzed in her randomization group per intention to treat|44
7608589|NCT02476422|18732041|P2|NOT COMPLETED|Overall Study||1
7608590|NCT02476422|18732042|P1|NOT COMPLETED|Overall Study||0
7608591|NCT02476422|18732041|P2|COMPLETED|Overall Study||161
7608592|NCT02476422|18732042|P1|COMPLETED|Overall Study||166
7608593|NCT02476422|18732041|P2|STARTED|Overall Study||162
7608594|NCT02476422|18732042|P1|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166
7608595|NCT02476357|18732074|P2|NOT COMPLETED|Overall Study||0
7608596|NCT02476357|18732075|P1|NOT COMPLETED|Overall Study||0
7608597|NCT02476357|18732074|P2|COMPLETED|Overall Study||40
7608598|NCT02476357|18732075|P1|COMPLETED|Overall Study||40
7608599|NCT02476357|18732074|P2|STARTED|Overall Study||40
7608600|NCT02476357|18732075|P1|STARTED|Overall Study||40
7608601|NCT02476201|18732083|P1|NOT COMPLETED|Overall Study||26
7608602|NCT02476201|18732083|P1|COMPLETED|Overall Study||79
7608603|NCT02476201|18732083|P1|6 Months Visit|Overall Study||82
7608604|NCT02476201|18732083|P1|Sucessful Implants|Overall Study||102
7608605|NCT02476201|18732083|P1|Implant Attempts|Overall Study||103
7608606|NCT02476201|18732083|P1|STARTED|Overall Study||105
7608607|NCT02476175|18732091|P1|NOT COMPLETED|Overall Study||2
7608608|NCT02476175|18732091|P1|COMPLETED|Overall Study||33
7608609|NCT02476175|18732091|P1|STARTED|Overall Study||35
7608610|NCT02476032|18732102|P3|NOT COMPLETED|Overall Study||1
7608611|NCT02476032|18732103|P2|NOT COMPLETED|Overall Study||1
7608612|NCT02476032|18732104|P1|NOT COMPLETED|Overall Study||0
7608613|NCT02476032|18732102|P3|COMPLETED|Overall Study||19
7608614|NCT02476032|18732103|P2|COMPLETED|Overall Study||19
7608615|NCT02476032|18732104|P1|COMPLETED|Overall Study||20
7608616|NCT02476032|18732102|P3|STARTED|Overall Study||20
7608617|NCT02476032|18732103|P2|STARTED|Overall Study||20
7608618|NCT02476032|18732104|P1|STARTED|Overall Study||20
7608619|NCT02476006|18732115|P1|NOT COMPLETED|Overall Study||120
7608620|NCT02476006|18732115|P1|COMPLETED|Overall Study||878
7608621|NCT02476006|18732115|P1|Treated|Overall Study||994
7608622|NCT02476006|18732115|P1|STARTED|Overall Study||998
7608623|NCT02475980|18732129|P1|NOT COMPLETED|Overall Study||5
7608624|NCT02475980|18732129|P1|COMPLETED|Overall Study||8
7608625|NCT02475980|18732129|P1|STARTED|Overall Study||13
7608626|NCT02475837|18732140|P2|NOT COMPLETED|Overall Study||0
7608627|NCT02475837|18732141|P1|NOT COMPLETED|Overall Study||0
7608628|NCT02475837|18732140|P2|COMPLETED|Overall Study||7
7608629|NCT02475837|18732141|P1|COMPLETED|Overall Study||6
7608630|NCT02475837|18732140|P2|STARTED|Overall Study||7
7608631|NCT02475837|18732141|P1|STARTED|Overall Study||6
7608632|NCT02475733|18732155|P2|NOT COMPLETED|Overall Study||0
7608633|NCT02475733|18732156|P1|NOT COMPLETED|Overall Study||2
7608634|NCT02475733|18732155|P2|COMPLETED|Overall Study||22
7608635|NCT02475733|18732156|P1|COMPLETED|Overall Study||59
7608636|NCT02475733|18732155|P2|STARTED|Overall Study||22
7608637|NCT02475733|18732156|P1|STARTED|Overall Study||61
7608638|NCT02475655|18732213|P2|NOT COMPLETED|Overall Study||1
7608639|NCT02475655|18732214|P1|NOT COMPLETED|Overall Study||0
7608640|NCT02475655|18732213|P2|COMPLETED|Overall Study||19
7608641|NCT02475655|18732214|P1|COMPLETED|Overall Study||40
7608642|NCT02475655|18732213|P2|STARTED|Overall Study||20
7608643|NCT02475655|18732214|P1|STARTED|Overall Study||40
7608644|NCT02475629|18732366|P1|NOT COMPLETED|Overall Study||9
7608645|NCT02475629|18732366|P1|COMPLETED|Overall Study||31
7608646|NCT02475629|18732366|P1|STARTED|Overall Study||40
7608647|NCT02475564|18732389|P2|NOT COMPLETED|Overall Study||1
7608648|NCT02475564|18732390|P1|NOT COMPLETED|Overall Study||4
7608649|NCT02475564|18732389|P2|COMPLETED|Overall Study||21
7608650|NCT02475564|18732390|P1|COMPLETED|Overall Study||18
7608651|NCT02475564|18732389|P2|STARTED|Overall Study||22
7608652|NCT02475564|18732390|P1|STARTED|Overall Study||22
7608653|NCT02475395|18732402|P2|NOT COMPLETED|Overall Study||3
7608654|NCT02475395|18732403|P1|NOT COMPLETED|Overall Study||30
7608655|NCT02475395|18732402|P2|COMPLETED|Overall Study||11
7608656|NCT02475395|18732403|P1|COMPLETED|Overall Study||228
7608657|NCT02475395|18732402|P2|STARTED|Overall Study||14
7608658|NCT02475395|18732403|P1|STARTED|Overall Study||258
7608659|NCT02475278|18732413|P1|NOT COMPLETED|Overall Study||2
7608660|NCT02475278|18732413|P1|COMPLETED|Overall Study||48
7608661|NCT02475278|18732413|P1|STARTED|Overall Study||50
7608662|NCT02475265|18732424|P1|NOT COMPLETED|Overall Study||3
7608663|NCT02475265|18732424|P1|COMPLETED|Overall Study||8
7608664|NCT02475265|18732424|P1|STARTED|Overall Study||11
7608665|NCT02475070|18732430|P2|NOT COMPLETED|Overall Study||0
7608666|NCT02475070|18732431|P1|NOT COMPLETED|Overall Study||0
7608667|NCT02475070|18732430|P2|COMPLETED|Overall Study||11
7608668|NCT02475070|18732431|P1|COMPLETED|Overall Study||17
7608669|NCT02475070|18732430|P2|STARTED|Overall Study||11
7608670|NCT02475070|18732431|P1|STARTED|Overall Study||17
7608671|NCT02475031|18732441|P2|NOT COMPLETED|Overall Study||0
7608672|NCT02475031|18732442|P1|NOT COMPLETED|Overall Study||0
7608673|NCT02475031|18732441|P2|COMPLETED|Overall Study||35
7608674|NCT02475031|18732442|P1|COMPLETED|Overall Study||35
7608675|NCT02475031|18732441|P2|STARTED|Overall Study||35
7608676|NCT02475031|18732442|P1|STARTED|Overall Study||35
7608677|NCT02474901|18732458|P2|NOT COMPLETED|Overall Study||0
7608678|NCT02474901|18732459|P1|NOT COMPLETED|Overall Study||1
7608679|NCT02474901|18732458|P2|COMPLETED|Overall Study||56
7608680|NCT02474901|18732459|P1|COMPLETED|Overall Study||44
7608681|NCT02474901|18732458|P2|STARTED|Overall Study||56
7608682|NCT02474901|18732459|P1|STARTED|Overall Study||45
7608683|NCT02474589|18732475|P2|NOT COMPLETED|Overall Study||5
7608684|NCT02474589|18732476|P1|NOT COMPLETED|Overall Study||25
7608685|NCT02474589|18732475|P2|COMPLETED|Overall Study||85
7608686|NCT02474589|18732476|P1|COMPLETED|Overall Study||334
7608687|NCT02474589|18732475|P2|STARTED|Overall Study||90
7608688|NCT02474589|18732476|P1|STARTED|Overall Study||359
7608689|NCT02474498|18732485|P3|NOT COMPLETED|Overall Study||0
7608690|NCT02474498|18732486|P2|NOT COMPLETED|Overall Study||0
7608691|NCT02474498|18732487|P1|NOT COMPLETED|Overall Study||0
7608692|NCT02474498|18732485|P3|COMPLETED|Overall Study||14
7608693|NCT02474498|18732486|P2|COMPLETED|Overall Study||14
7608694|NCT02474498|18732487|P1|COMPLETED|Overall Study||13
7608695|NCT02474498|18732485|P3|STARTED|Overall Study||14
7608696|NCT02474498|18732486|P2|STARTED|Overall Study||14
7608697|NCT02474498|18732487|P1|STARTED|Overall Study||13
7608698|NCT02474407|18732504|P2|NOT COMPLETED|Second Intervention (14 Days)||0
7608699|NCT02474407|18732505|P1|NOT COMPLETED|Second Intervention (14 Days)||0
7608700|NCT02474407|18732504|P2|COMPLETED|Second Intervention (14 Days)||39
7608701|NCT02474407|18732505|P1|COMPLETED|Second Intervention (14 Days)||39
7608702|NCT02474407|18732504|P2|STARTED|Second Intervention (14 Days)||39
7608703|NCT02474407|18732505|P1|STARTED|Second Intervention (14 Days)||39
7608704|NCT02474407|18732504|P2|NOT COMPLETED|Washout (14 Days)||0
7608705|NCT02474407|18732505|P1|NOT COMPLETED|Washout (14 Days)||0
7608706|NCT02474407|18732504|P2|COMPLETED|Washout (14 Days)||39
7608707|NCT02474407|18732505|P1|COMPLETED|Washout (14 Days)||39
7608708|NCT02474407|18732504|P2|STARTED|Washout (14 Days)||39
7608709|NCT02474407|18732505|P1|STARTED|Washout (14 Days)||39
7608710|NCT02474407|18732504|P2|NOT COMPLETED|First Intervention (14 Days)||0
7608711|NCT02474407|18732505|P1|NOT COMPLETED|First Intervention (14 Days)||0
7608712|NCT02474407|18732504|P2|COMPLETED|First Intervention (14 Days)||39
7608713|NCT02474407|18732505|P1|COMPLETED|First Intervention (14 Days)||39
7608714|NCT02474407|18732504|P2|STARTED|First Intervention (14 Days)||39
7608715|NCT02474407|18732505|P1|STARTED|First Intervention (14 Days)||39
7608716|NCT02474082|18732535|P2|NOT COMPLETED|Overall Study||54
7608717|NCT02474082|18732536|P1|NOT COMPLETED|Overall Study||6
7608718|NCT02474082|18732535|P2|COMPLETED|Overall Study||43
7608719|NCT02474082|18732536|P1|COMPLETED|Overall Study||99
7608720|NCT02474082|18732535|P2|Full Analysis Set (FAS)|Overall Study||95
7608721|NCT02474082|18732536|P1|Full Analysis Set (FAS)|Overall Study||105
7608722|NCT02474082|18732535|P2|STARTED|Overall Study||97
7608723|NCT02474082|18732536|P1|STARTED|Overall Study||105
7608724|NCT02474069|18732570|P3|NOT COMPLETED|Comparative Dosing Phase (CDP)||6
7608725|NCT02474069|18732571|P2|NOT COMPLETED|Comparative Dosing Phase (CDP)||9
7608726|NCT02474069|18732572|P1|NOT COMPLETED|Comparative Dosing Phase (CDP)||0
7608727|NCT02474069|18732570|P3|COMPLETED|Comparative Dosing Phase (CDP)||157
7608728|NCT02474069|18732571|P2|COMPLETED|Comparative Dosing Phase (CDP)||153
7608729|NCT02474069|18732572|P1|COMPLETED|Comparative Dosing Phase (CDP)||0
7608730|NCT02474069|18732570|P3|STARTED|Comparative Dosing Phase (CDP)||163
7608731|NCT02474069|18732571|P2|STARTED|Comparative Dosing Phase (CDP)||162
7608732|NCT02474069|18732572|P1|STARTED|Comparative Dosing Phase (CDP)||0
7608733|NCT02474069|18732570|P3|NOT COMPLETED|Selection Phase (SP)||0
7608734|NCT02474069|18732571|P2|NOT COMPLETED|Selection Phase (SP)||0
7608735|NCT02474069|18732572|P1|NOT COMPLETED|Selection Phase (SP)||23
7608736|NCT02474069|18732570|P3|COMPLETED|Selection Phase (SP)||0
7608737|NCT02474069|18732571|P2|COMPLETED|Selection Phase (SP)||0
7608738|NCT02474069|18732572|P1|COMPLETED|Selection Phase (SP)||749
7608739|NCT02474069|18732570|P3|STARTED|Selection Phase (SP)||0
7608740|NCT02474069|18732571|P2|STARTED|Selection Phase (SP)||0
7608741|NCT02474069|18732572|P1|STARTED|Selection Phase (SP)||772
7608742|NCT02473991|18732597|P1|NOT COMPLETED|Overall Study||0
7608743|NCT02473991|18732597|P1|COMPLETED|Overall Study||395
7608744|NCT02473991|18732597|P1|STARTED|Overall Study||395
7608745|NCT02473965|18732605|P2|NOT COMPLETED|Overall Study||10
7608746|NCT02473965|18732606|P1|NOT COMPLETED|Overall Study||12
7608747|NCT02473965|18732605|P2|COMPLETED|Overall Study||20
7608748|NCT02473965|18732606|P1|COMPLETED|Overall Study||18
7608749|NCT02473965|18732605|P2|STARTED|Overall Study||30
7608750|NCT02473965|18732606|P1|STARTED|Overall Study||30
7608751|NCT02473952|18732618|P2|NOT COMPLETED|Overall Study||8
7608752|NCT02473952|18732619|P1|NOT COMPLETED|Overall Study||2
7608753|NCT02473952|18732618|P2|COMPLETED|Overall Study||24
7608754|NCT02473952|18732619|P1|COMPLETED|Overall Study||28
7608755|NCT02473952|18732618|P2|STARTED|Overall Study||32
7608756|NCT02473952|18732619|P1|STARTED|Overall Study||30
7608757|NCT02473913|18732627|P2|NOT COMPLETED|Overall Study||3
7608758|NCT02473913|18732628|P1|NOT COMPLETED|Overall Study||3
7608759|NCT02473913|18732627|P2|COMPLETED|Overall Study||8
7608760|NCT02473913|18732628|P1|COMPLETED|Overall Study||8
7608761|NCT02473913|18732627|P2|STARTED|Overall Study||11
7608762|NCT02473913|18732628|P1|STARTED|Overall Study||11
7608763|NCT02473783|18732648|P2|NOT COMPLETED|Overall Study||0
7608764|NCT02473783|18732649|P1|NOT COMPLETED|Overall Study||0
7608765|NCT02473783|18732648|P2|COMPLETED|Overall Study||17
7608766|NCT02473783|18732649|P1|COMPLETED|Overall Study||20
7608767|NCT02473783|18732648|P2|STARTED|Overall Study||17
7608768|NCT02473783|18732649|P1|STARTED|Overall Study||20
7608769|NCT02473718|18732659|P2|NOT COMPLETED|Overall Study||0
7608770|NCT02473718|18732660|P1|NOT COMPLETED|Overall Study||0
7608771|NCT02473718|18732659|P2|COMPLETED|Overall Study||41
7608772|NCT02473718|18732660|P1|COMPLETED|Overall Study||41
7608773|NCT02473718|18732659|P2|STARTED|Overall Study||41
7608774|NCT02473718|18732660|P1|STARTED|Overall Study||41
7608775|NCT02473640|18732680|P1|NOT COMPLETED|Treatment Period 2||0
7608776|NCT02473640|18732680|P1|COMPLETED|Treatment Period 2||14
7608777|NCT02473640|18732680|P1|STARTED|Treatment Period 2||14
7608778|NCT02473640|18732680|P1|NOT COMPLETED|Run-in Phase||0
7608779|NCT02473640|18732680|P1|COMPLETED|Run-in Phase||14
7608780|NCT02473640|18732680|P1|STARTED|Run-in Phase||14
7608781|NCT02473640|18732680|P1|NOT COMPLETED|Treatment Period 1||1
7608782|NCT02473640|18732680|P1|COMPLETED|Treatment Period 1||14
7608783|NCT02473640|18732680|P1|STARTED|Treatment Period 1||15
7608784|NCT02473523|18732689|P1|NOT COMPLETED|Overall Study||2
7608785|NCT02473523|18732689|P1|COMPLETED|Overall Study||0
7608786|NCT02473523|18732689|P1|STARTED|Overall Study||2
7608787|NCT02473510|18732710|P2|NOT COMPLETED|Overall Study||2
7608788|NCT02473510|18732711|P1|NOT COMPLETED|Overall Study||1
7608789|NCT02473510|18732710|P2|COMPLETED|Overall Study||238
7608790|NCT02473510|18732711|P1|COMPLETED|Overall Study||59
7608791|NCT02473510|18732710|P2|STARTED|Overall Study||240
7608792|NCT02473510|18732711|P1|STARTED|Overall Study||60
7608793|NCT02473471|18732725|P1|NOT COMPLETED|Overall Study||3
7608794|NCT02473471|18732725|P1|COMPLETED|Overall Study||32
7608795|NCT02473471|18732725|P1|Randomized Not Treated|Overall Study||2
7608796|NCT02473471|18732725|P1|Received Allocated Intervention|Overall Study||33
7608797|NCT02473471|18732725|P1|STARTED|Overall Study||35
7608798|NCT02473445|18732756|P1|NOT COMPLETED|Overall Study||22
7608799|NCT02473445|18732756|P1|COMPLETED|Overall Study||0
7608800|NCT02473445|18732756|P1|STARTED|Overall Study||22
7608801|NCT02473367|18732762|P1|NOT COMPLETED|Period 4||1
7608802|NCT02473367|18732762|P1|COMPLETED|Period 4||18
7608803|NCT02473367|18732762|P1|STARTED|Period 4||19
7608804|NCT02473367|18732762|P1|NOT COMPLETED|Wait 3||0
7608805|NCT02473367|18732762|P1|COMPLETED|Wait 3||19
7608806|NCT02473367|18732762|P1|STARTED|Wait 3||19
7608807|NCT02473367|18732762|P1|NOT COMPLETED|Period 3||0
7608808|NCT02473367|18732762|P1|COMPLETED|Period 3||19
7608809|NCT02473367|18732762|P1|STARTED|Period 3||19
7608810|NCT02473367|18732762|P1|NOT COMPLETED|Wait 2||0
7608811|NCT02473367|18732762|P1|COMPLETED|Wait 2||19
7608812|NCT02473367|18732762|P1|STARTED|Wait 2||19
7608813|NCT02473367|18732762|P1|NOT COMPLETED|Period 2||0
7608814|NCT02473367|18732762|P1|COMPLETED|Period 2||19
7608815|NCT02473367|18732762|P1|STARTED|Period 2||19
7608816|NCT02473367|18732762|P1|NOT COMPLETED|Wait 1||1
7608817|NCT02473367|18732762|P1|COMPLETED|Wait 1||19
7608818|NCT02473367|18732762|P1|STARTED|Wait 1||20
7608819|NCT02473367|18732762|P1|NOT COMPLETED|Period 1||0
7608820|NCT02473367|18732762|P1|COMPLETED|Period 1||20
7608821|NCT02473367|18732762|P1|STARTED|Period 1||20
7608822|NCT02473289|18732782|P2|NOT COMPLETED|Overall Study||13
7608823|NCT02473289|18732783|P1|NOT COMPLETED|Overall Study||11
7608824|NCT02473289|18732782|P2|COMPLETED|Overall Study||81
7608825|NCT02473289|18732783|P1|COMPLETED|Overall Study||88
7608826|NCT02473289|18732782|P2|STARTED|Overall Study||94
7608827|NCT02473289|18732783|P1|STARTED|Overall Study||99
7608828|NCT02472977|18732808|P3|NOT COMPLETED|Overall Study||8
7608829|NCT02472977|18732809|P2|NOT COMPLETED|Overall Study||27
7608830|NCT02472977|18732810|P1|NOT COMPLETED|Overall Study||6
7608831|NCT02472977|18732808|P3|COMPLETED|Overall Study||0
7608832|NCT02472977|18732809|P2|COMPLETED|Overall Study||0
7608833|NCT02472977|18732810|P1|COMPLETED|Overall Study||0
7608834|NCT02472977|18732808|P3|STARTED|Overall Study||8
7608835|NCT02472977|18732809|P2|STARTED|Overall Study||27
7608836|NCT02472977|18732810|P1|STARTED|Overall Study||6
7608837|NCT02472964|18732835|P2|NOT COMPLETED|Part 2 (Week 24-week 48)||63
7608838|NCT02472964|18732836|P1|NOT COMPLETED|Part 2 (Week 24-week 48)||65
7608839|NCT02472964|18732835|P2|COMPLETED|Part 2 (Week 24-week 48)||116
7608840|NCT02472964|18732836|P1|COMPLETED|Part 2 (Week 24-week 48)||98
7608841|NCT02472964|18732835|P2|STARTED|Part 2 (Week 24-week 48)||179
7608842|NCT02472964|18732836|P1|STARTED|Part 2 (Week 24-week 48)||163
7608843|NCT02472964|18732835|P2|NOT COMPLETED|Part 1 (up to Week 24)||62
7608844|NCT02472964|18732836|P1|NOT COMPLETED|Part 1 (up to Week 24)||75
7608845|NCT02472964|18732835|P2|COMPLETED|Part 1 (up to Week 24)||185
7608846|NCT02472964|18732836|P1|COMPLETED|Part 1 (up to Week 24)||171
7608847|NCT02472964|18732835|P2|STARTED|Part 1 (up to Week 24)||247
7608848|NCT02472964|18732836|P1|STARTED|Part 1 (up to Week 24)||246
7608849|NCT02472886|18732845|P3|NOT COMPLETED|Overall Study||1
7608850|NCT02472886|18732846|P2|NOT COMPLETED|Overall Study||2
7608851|NCT02472886|18732847|P1|NOT COMPLETED|Overall Study||0
7608852|NCT02472886|18732845|P3|COMPLETED|Overall Study||26
7608853|NCT02472886|18732846|P2|COMPLETED|Overall Study||57
7608854|NCT02472886|18732847|P1|COMPLETED|Overall Study||67
7608855|NCT02472886|18732845|P3|STARTED|Overall Study||27
7608856|NCT02472886|18732846|P2|STARTED|Overall Study||59
7608857|NCT02472886|18732847|P1|STARTED|Overall Study||67
7608858|NCT02472847|18732875|P2|NOT COMPLETED|Overall Study||5
7608859|NCT02472847|18732876|P1|NOT COMPLETED|Overall Study||1
7608860|NCT02472847|18732875|P2|COMPLETED|Overall Study||21
7608861|NCT02472847|18732876|P1|COMPLETED|Overall Study||23
7608862|NCT02472847|18732875|P2|STARTED|Overall Study||26
7608863|NCT02472847|18732876|P1|STARTED|Overall Study||24
7608864|NCT02472795|18732887|P5|NOT COMPLETED|Overall Study||3
7608865|NCT02472795|18732888|P4|NOT COMPLETED|Overall Study||0
7608866|NCT02472795|18732889|P3|NOT COMPLETED|Overall Study||0
7608867|NCT02472795|18732890|P2|NOT COMPLETED|Overall Study||1
7608868|NCT02472795|18732891|P1|NOT COMPLETED|Overall Study||0
7608869|NCT02472795|18732887|P5|COMPLETED|Overall Study||14
7608870|NCT02472795|18732888|P4|COMPLETED|Overall Study||13
7608871|NCT02472795|18732889|P3|COMPLETED|Overall Study||13
7608872|NCT02472795|18732890|P2|COMPLETED|Overall Study||11
7608873|NCT02472795|18732891|P1|COMPLETED|Overall Study||12
7608874|NCT02472795|18732887|P5|Modified Pharmacodynamic Analysis Set|Overall Study||16
7608875|NCT02472795|18732888|P4|Modified Pharmacodynamic Analysis Set|Overall Study||9
7608876|NCT02472795|18732889|P3|Modified Pharmacodynamic Analysis Set|Overall Study||13
7608877|NCT02472795|18732890|P2|Modified Pharmacodynamic Analysis Set|Overall Study||10
7608878|NCT02472795|18732891|P1|Modified Pharmacodynamic Analysis Set|Overall Study||12
7608879|NCT02472795|18732887|P5|Pharmacodynamic Set|Overall Study||16
7608880|NCT02472795|18732888|P4|Pharmacodynamic Set|Overall Study||13
7608881|NCT02472795|18732889|P3|Pharmacodynamic Set|Overall Study||13
7608882|NCT02472795|18732890|P2|Pharmacodynamic Set|Overall Study||10
7608883|NCT02472795|18732891|P1|Pharmacodynamic Set|Overall Study||12
7608884|NCT02472795|18732887|P5|STARTED|Overall Study||17
7608885|NCT02472795|18732888|P4|STARTED|Overall Study||13
7608886|NCT02472795|18732889|P3|STARTED|Overall Study||13
7608887|NCT02472795|18732890|P2|STARTED|Overall Study||12
7608888|NCT02472795|18732891|P1|STARTED|Overall Study||12
7608889|NCT02472756|18732923|P1|NOT COMPLETED|Maintenance (Approximately 2 Years)||10
7608890|NCT02472756|18732923|P1|COMPLETED|Maintenance (Approximately 2 Years)||10
7608891|NCT02472756|18732923|P1|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20
7608892|NCT02472756|18732923|P1|NOT COMPLETED|Induction (Approximately 6 Months)||2
7608893|NCT02472756|18732923|P1|COMPLETED|Induction (Approximately 6 Months)||39
7608894|NCT02472756|18732923|P1|Treated|Induction (Approximately 6 Months)||40
7608895|NCT02472756|18732923|P1|STARTED|Induction (Approximately 6 Months)||41
7608896|NCT02472730|18732931|P2|NOT COMPLETED|Overall Study||7
7608897|NCT02472730|18732932|P1|NOT COMPLETED|Overall Study||9
7608898|NCT02472730|18732931|P2|COMPLETED|Overall Study||102
7608899|NCT02472730|18732932|P1|COMPLETED|Overall Study||101
7608900|NCT02472730|18732931|P2|STARTED|Overall Study||109
7608901|NCT02472730|18732932|P1|STARTED|Overall Study||110
7608902|NCT02472652|18732944|P1|NOT COMPLETED|Overall Study||1
7608903|NCT02472652|18732944|P1|COMPLETED|Overall Study||1
7608904|NCT02472652|18732944|P1|STARTED|Overall Study||2
7608905|NCT02472639|18732951|P2|NOT COMPLETED|Overall Study||3
7608906|NCT02472639|18732952|P1|NOT COMPLETED|Overall Study||4
7608907|NCT02472639|18732951|P2|COMPLETED|Overall Study||0
7608908|NCT02472639|18732952|P1|COMPLETED|Overall Study||0
7608909|NCT02472639|18732951|P2|STARTED|Overall Study||3
7608910|NCT02472639|18732952|P1|STARTED|Overall Study||4
7608911|NCT02472522|18732968|P2|NOT COMPLETED|Overall Study||0
7608912|NCT02472522|18732969|P1|NOT COMPLETED|Overall Study||0
7608913|NCT02472522|18732968|P2|COMPLETED|Overall Study||50
7608914|NCT02472522|18732969|P1|COMPLETED|Overall Study||50
7608915|NCT02472522|18732968|P2|STARTED|Overall Study||50
7608916|NCT02472522|18732969|P1|STARTED|Overall Study||50
7608917|NCT02472457|18733001|P2|NOT COMPLETED|Overall Study||1
7608918|NCT02472457|18733002|P1|NOT COMPLETED|Overall Study||0
7608919|NCT02472457|18733001|P2|COMPLETED|Overall Study||10
7608920|NCT02472457|18733002|P1|COMPLETED|Overall Study||8
7608921|NCT02472457|18733001|P2|STARTED|Overall Study||11
7608922|NCT02472457|18733002|P1|STARTED|Overall Study|1 subject followed the Specific Carbohydrate Diet|8
7608923|NCT02472405|18733008|P1|NOT COMPLETED|Overall Study||10
7608924|NCT02472405|18733008|P1|COMPLETED|Overall Study||8
7608925|NCT02472405|18733008|P1|STARTED|Overall Study||18
7608926|NCT02472366|18733016|P2|NOT COMPLETED|Overall Study||0
7608927|NCT02472366|18733017|P1|NOT COMPLETED|Overall Study||1
7608928|NCT02472366|18733016|P2|COMPLETED|Overall Study||10
7608929|NCT02472366|18733017|P1|COMPLETED|Overall Study||5
7608930|NCT02472366|18733016|P2|STARTED|Overall Study||10
7608931|NCT02472366|18733017|P1|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6
7608932|NCT02472353|18733033|P2|NOT COMPLETED|Overall Study||6
7608933|NCT02472353|18733034|P1|NOT COMPLETED|Overall Study||4
7608934|NCT02472353|18733033|P2|COMPLETED|Overall Study||10
7608935|NCT02472353|18733034|P1|COMPLETED|Overall Study||10
7608936|NCT02472353|18733033|P2|STARTED|Overall Study||16
7608937|NCT02472353|18733034|P1|STARTED|Overall Study||14
7608938|NCT02472314|18733042|P2|NOT COMPLETED|Overall Study||0
7608939|NCT02472314|18733043|P1|NOT COMPLETED|Overall Study||0
7608940|NCT02472314|18733042|P2|COMPLETED|Overall Study||36
7608941|NCT02472314|18733043|P1|COMPLETED|Overall Study||34
7608942|NCT02472314|18733042|P2|STARTED|Overall Study||36
7608943|NCT02472314|18733043|P1|STARTED|Overall Study||34
7608944|NCT02472262|18733058|P3|NOT COMPLETED|Overall Study||25
7608945|NCT02472262|18733059|P2|NOT COMPLETED|Overall Study||21
7608946|NCT02472262|18733060|P1|NOT COMPLETED|Overall Study||18
7608947|NCT02472262|18733058|P3|COMPLETED|Overall Study||93
7608948|NCT02472262|18733059|P2|COMPLETED|Overall Study||99
7608949|NCT02472262|18733060|P1|COMPLETED|Overall Study||99
7608950|NCT02472262|18733058|P3|STARTED|Overall Study||118
7608951|NCT02472262|18733059|P2|STARTED|Overall Study||120
7608952|NCT02472262|18733060|P1|STARTED|Overall Study||117
7608953|NCT02472145|18733071|P3|NOT COMPLETED|Overall Study||157
7608954|NCT02472145|18733072|P2|NOT COMPLETED|Overall Study||159
7608955|NCT02472145|18733073|P1|NOT COMPLETED|Overall Study||10
7608956|NCT02472145|18733071|P3|COMPLETED|Overall Study||0
7608957|NCT02472145|18733072|P2|COMPLETED|Overall Study||0
7608958|NCT02472145|18733073|P1|COMPLETED|Overall Study||0
7608959|NCT02472145|18733071|P3|Safety|Overall Study|1 participant who was not treated and 9 participants who received only decitabine were excluded.|147
7608960|NCT02472145|18733072|P2|Safety|Overall Study|9 participants who received decitabine,not JNJ-56022473 included,3 untreated participant excluded.|165
7608961|NCT02472145|18733073|P1|Safety|Overall Study||10
7608962|NCT02472145|18733071|P3|Treated|Overall Study||156
7608963|NCT02472145|18733072|P2|Treated|Overall Study||156
7608964|NCT02472145|18733073|P1|Treated|Overall Study||10
7608965|NCT02472145|18733071|P3|STARTED|Overall Study||157
7608966|NCT02472145|18733072|P2|STARTED|Overall Study||159
7608967|NCT02472145|18733073|P1|STARTED|Overall Study||10
7608968|NCT02471755|18733094|P2|NOT COMPLETED|Overall Study||1
7608969|NCT02471755|18733095|P1|NOT COMPLETED|Overall Study||1
7608970|NCT02471755|18733094|P2|COMPLETED|Overall Study||44
7608971|NCT02471755|18733095|P1|COMPLETED|Overall Study||44
7608972|NCT02471755|18733094|P2|STARTED|Overall Study||45
7608973|NCT02471755|18733095|P1|STARTED|Overall Study||45
7608974|NCT02471651|18733113|P2|NOT COMPLETED|Overall Study||5
7608975|NCT02471651|18733114|P1|NOT COMPLETED|Overall Study||5
7608976|NCT02471651|18733113|P2|COMPLETED|Overall Study||15
7608977|NCT02471651|18733114|P1|COMPLETED|Overall Study||15
7608978|NCT02471651|18733113|P2|STARTED|Overall Study||20
7608979|NCT02471651|18733114|P1|STARTED|Overall Study||20
7608980|NCT02471612|18733124|P1|NOT COMPLETED|Overall Study||2
7608981|NCT02471612|18733124|P1|COMPLETED|Overall Study||157
7608982|NCT02471612|18733124|P1|STARTED|Overall Study||159
7608983|NCT02471521|18733143|P2|NOT COMPLETED|Overall Study||8
7608984|NCT02471521|18733144|P1|NOT COMPLETED|Overall Study||0
7608985|NCT02471521|18733143|P2|COMPLETED|Overall Study||52
7608986|NCT02471521|18733144|P1|COMPLETED|Overall Study||60
7608987|NCT02471521|18733143|P2|STARTED|Overall Study||60
7608988|NCT02471521|18733144|P1|STARTED|Overall Study||60
7608989|NCT02471404|18733155|P3|NOT COMPLETED|Overall Study||25
7608990|NCT02471404|18733156|P2|NOT COMPLETED|Overall Study||14
7608991|NCT02471404|18733157|P1|NOT COMPLETED|Overall Study||33
7608992|NCT02471404|18733155|P3|COMPLETED|Overall Study||288
7608993|NCT02471404|18733156|P2|COMPLETED|Overall Study||298
7608994|NCT02471404|18733157|P1|COMPLETED|Overall Study||281
7608995|NCT02471404|18733155|P3|STARTED|Overall Study||313
7608996|NCT02471404|18733156|P2|STARTED|Overall Study||312
7608997|NCT02471404|18733157|P1|STARTED|Overall Study||314
7608998|NCT02471326|18733180|P1|NOT COMPLETED|Overall Study||1
7608999|NCT02471326|18733180|P1|COMPLETED|Overall Study||9
7609000|NCT02471326|18733180|P1|STARTED|Overall Study||10
7609001|NCT02471313|18733185|P1|NOT COMPLETED|Overall Study||0
7609002|NCT02471313|18733185|P1|COMPLETED|Overall Study||3
7609003|NCT02471313|18733185|P1|STARTED|Overall Study||3
7609004|NCT02471183|18733189|P1|NOT COMPLETED|Extended Treatment Period||1
7609005|NCT02471183|18733189|P1|COMPLETED|Extended Treatment Period||31
7609006|NCT02471183|18733189|P1|STARTED|Extended Treatment Period||32
7609007|NCT02471183|18733189|P1|NOT COMPLETED|Main Treatment Period||2
7609008|NCT02471183|18733189|P1|COMPLETED|Main Treatment Period||32
7609009|NCT02471183|18733189|P1|STARTED|Main Treatment Period||34
7609010|NCT02471014|18733206|P2|NOT COMPLETED|Overall Study||2
7609011|NCT02471014|18733207|P1|NOT COMPLETED|Overall Study||2
7609012|NCT02471014|18733206|P2|COMPLETED|Overall Study||23
7609013|NCT02471014|18733207|P1|COMPLETED|Overall Study||23
7609014|NCT02471014|18733206|P2|STARTED|Overall Study||25
7609015|NCT02471014|18733207|P1|STARTED|Overall Study||25
7609016|NCT02470949|18733213|P2|NOT COMPLETED|Second Intervention||0
7609017|NCT02470949|18733214|P1|NOT COMPLETED|Second Intervention||0
7609018|NCT02470949|18733213|P2|COMPLETED|Second Intervention||2
7609019|NCT02470949|18733214|P1|COMPLETED|Second Intervention||4
7609020|NCT02470949|18733213|P2|STARTED|Second Intervention||2
7609021|NCT02470949|18733214|P1|STARTED|Second Intervention||4
7609022|NCT02470949|18733213|P2|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
7609023|NCT02470949|18733214|P1|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
7609024|NCT02470949|18733213|P2|COMPLETED|Washout Period for a Minimum of 4 Weeks||5
7609025|NCT02470949|18733214|P1|COMPLETED|Washout Period for a Minimum of 4 Weeks||4
7609026|NCT02470949|18733213|P2|STARTED|Washout Period for a Minimum of 4 Weeks||5
7609027|NCT02470949|18733214|P1|STARTED|Washout Period for a Minimum of 4 Weeks||4
7609028|NCT02470949|18733213|P2|NOT COMPLETED|First Intervention||0
7609029|NCT02470949|18733214|P1|NOT COMPLETED|First Intervention||0
7609030|NCT02470949|18733213|P2|COMPLETED|First Intervention||5
7609031|NCT02470949|18733214|P1|COMPLETED|First Intervention||4
7609032|NCT02470949|18733213|P2|STARTED|First Intervention||5
7609033|NCT02470949|18733214|P1|STARTED|First Intervention||4
7609034|NCT02470910|18733224|P1|NOT COMPLETED|Overall Study||0
7609035|NCT02470910|18733224|P1|COMPLETED|Overall Study||15
7609036|NCT02470910|18733224|P1|STARTED|Overall Study||15
7609037|NCT02470806|18733233|P2|NOT COMPLETED|Overall Study||42
7609038|NCT02470806|18733234|P1|NOT COMPLETED|Overall Study||18
7609039|NCT02470806|18733233|P2|COMPLETED|Overall Study||42
7609040|NCT02470806|18733234|P1|COMPLETED|Overall Study||62
7609041|NCT02470806|18733233|P2|STARTED|Overall Study|The Safety analysis included 164, ITT was 161, and Per Protocol was 115 subjects (total both arms).|84
7609042|NCT02470806|18733234|P1|STARTED|Overall Study||80
7609043|NCT02470754|18733248|P2|NOT COMPLETED|Overall Study||0
7609044|NCT02470754|18733249|P1|NOT COMPLETED|Overall Study||2
7609045|NCT02470754|18733248|P2|COMPLETED|Overall Study||19
7609046|NCT02470754|18733249|P1|COMPLETED|Overall Study||17
7609047|NCT02470754|18733248|P2|STARTED|Overall Study||19
7609048|NCT02470754|18733249|P1|STARTED|Overall Study||19
7609049|NCT02470741|18733277|P2|NOT COMPLETED|Overall Study||2
7609050|NCT02470741|18733278|P1|NOT COMPLETED|Overall Study||3
7609051|NCT02470741|18733277|P2|COMPLETED|Overall Study||4
7609052|NCT02470741|18733278|P1|COMPLETED|Overall Study||3
7609053|NCT02470741|18733277|P2|STARTED|Overall Study||6
7609054|NCT02470741|18733278|P1|STARTED|Overall Study||6
7609055|NCT02470585|18733287|P3|NOT COMPLETED|Overall Study||125
7609056|NCT02470585|18733288|P2|NOT COMPLETED|Overall Study||117
7609057|NCT02470585|18733289|P1|NOT COMPLETED|Overall Study||107
7609058|NCT02470585|18733287|P3|COMPLETED|Overall Study||257
7609059|NCT02470585|18733288|P2|COMPLETED|Overall Study||266
7609060|NCT02470585|18733289|P1|COMPLETED|Overall Study||268
7609061|NCT02470585|18733287|P3|Received Study Drug|Overall Study||377
7609062|NCT02470585|18733288|P2|Received Study Drug|Overall Study||376
7609063|NCT02470585|18733289|P1|Received Study Drug|Overall Study||371
7609064|NCT02470585|18733287|P3|STARTED|Overall Study||382
7609065|NCT02470585|18733288|P2|STARTED|Overall Study||383
7609066|NCT02470585|18733289|P1|STARTED|Overall Study||375
7609067|NCT02470494|18733312|P1|NOT COMPLETED|Overall Study||5
7609068|NCT02470494|18733312|P1|COMPLETED|Overall Study||41
7609069|NCT02470494|18733312|P1|STARTED|Overall Study||46
7609070|NCT02470429|18733322|P2|NOT COMPLETED|Overall Study||0
7609071|NCT02470429|18733323|P1|NOT COMPLETED|Overall Study||2
7609072|NCT02470429|18733322|P2|COMPLETED|Overall Study||49
7609073|NCT02470429|18733323|P1|COMPLETED|Overall Study||48
7609074|NCT02470429|18733322|P2|STARTED|Overall Study||49
7609075|NCT02470429|18733323|P1|STARTED|Overall Study||50
7609076|NCT02470403|18733341|P5|NOT COMPLETED|Overall Study||0
7609077|NCT02470403|18733342|P4|NOT COMPLETED|Overall Study||4
7609078|NCT02470403|18733343|P3|NOT COMPLETED|Overall Study||0
7609079|NCT02470403|18733344|P2|NOT COMPLETED|Overall Study||1
7609080|NCT02470403|18733345|P1|NOT COMPLETED|Overall Study||2
7609081|NCT02470403|18733341|P5|COMPLETED|Overall Study||10
7609082|NCT02470403|18733342|P4|COMPLETED|Overall Study||39
7609083|NCT02470403|18733343|P3|COMPLETED|Overall Study||40
7609084|NCT02470403|18733344|P2|COMPLETED|Overall Study||43
7609085|NCT02470403|18733345|P1|COMPLETED|Overall Study||42
7609086|NCT02470403|18733341|P5|Normoglycemic|Overall Study||5
7609087|NCT02470403|18733342|P4|Normoglycemic|Overall Study||23
7609088|NCT02470403|18733343|P3|Normoglycemic|Overall Study||20
7609089|NCT02470403|18733344|P2|Normoglycemic|Overall Study||20
7609090|NCT02470403|18733345|P1|Normoglycemic|Overall Study||20
7609091|NCT02470403|18733341|P5|Dysglycemic|Overall Study||5
7609092|NCT02470403|18733342|P4|Dysglycemic|Overall Study||20
7609093|NCT02470403|18733343|P3|Dysglycemic|Overall Study||20
7609094|NCT02470403|18733344|P2|Dysglycemic|Overall Study||24
7609095|NCT02470403|18733345|P1|Dysglycemic|Overall Study||24
7609096|NCT02470403|18733341|P5|STARTED|Overall Study||10
7609097|NCT02470403|18733342|P4|STARTED|Overall Study||43
7609098|NCT02470403|18733343|P3|STARTED|Overall Study||40
7609099|NCT02470403|18733344|P2|STARTED|Overall Study||44
7609100|NCT02470403|18733345|P1|STARTED|Overall Study||44
7609101|NCT02470390|18733385|P2|NOT COMPLETED|Overall Study||1
7609102|NCT02470390|18733386|P1|NOT COMPLETED|Overall Study||0
7609103|NCT02470390|18733385|P2|COMPLETED|Overall Study||6
7609104|NCT02470390|18733386|P1|COMPLETED|Overall Study||6
7609105|NCT02470390|18733385|P2|STARTED|Overall Study||7
7609106|NCT02470390|18733386|P1|STARTED|Overall Study||6
7609107|NCT02470312|18733414|P2|NOT COMPLETED|Overall Study||12
7609108|NCT02470312|18733415|P1|NOT COMPLETED|Overall Study||5
7609109|NCT02470312|18733414|P2|COMPLETED|Overall Study||419
7609110|NCT02470312|18733415|P1|COMPLETED|Overall Study||142
7609111|NCT02470312|18733414|P2|STARTED|Overall Study||431
7609112|NCT02470312|18733415|P1|STARTED|Overall Study||147
7609113|NCT02469961|18733425|P2|NOT COMPLETED|Overall Study||1
7609114|NCT02469961|18733426|P1|NOT COMPLETED|Overall Study||4
7609115|NCT02469961|18733425|P2|COMPLETED|Overall Study||24
7609116|NCT02469961|18733426|P1|COMPLETED|Overall Study||21
7609117|NCT02469961|18733425|P2|STARTED|Overall Study||25
7609118|NCT02469961|18733426|P1|STARTED|Overall Study||25
7609119|NCT02469896|18733440|P2|NOT COMPLETED|Overall Study||0
7609120|NCT02469896|18733441|P1|NOT COMPLETED|Overall Study||2
7609121|NCT02469896|18733440|P2|COMPLETED|Overall Study||14
7609122|NCT02469896|18733441|P1|COMPLETED|Overall Study||6
7609123|NCT02469896|18733440|P2|STARTED|Overall Study||14
7609124|NCT02469896|18733441|P1|STARTED|Overall Study||8
7609125|NCT02469870|18733467|P2|NOT COMPLETED|Overall Study||7
7609126|NCT02469870|18733468|P1|NOT COMPLETED|Overall Study||4
7609127|NCT02469870|18733467|P2|COMPLETED|Overall Study||72
7609128|NCT02469870|18733468|P1|COMPLETED|Overall Study||73
7609129|NCT02469870|18733467|P2|STARTED|Overall Study||79
7609130|NCT02469870|18733468|P1|STARTED|Overall Study||77
7609131|NCT02469714|18733486|P2|NOT COMPLETED|Overall Study||5
7609132|NCT02469714|18733487|P1|NOT COMPLETED|Overall Study||8
7609133|NCT02469714|18733486|P2|COMPLETED|Overall Study||50
7609134|NCT02469714|18733487|P1|COMPLETED|Overall Study||47
7609135|NCT02469714|18733486|P2|8 Month Follow-Up|Overall Study||50
7609136|NCT02469714|18733487|P1|8 Month Follow-Up|Overall Study||49
7609137|NCT02469714|18733486|P2|4 Month Follow-Up|Overall Study||51
7609138|NCT02469714|18733487|P1|4 Month Follow-Up|Overall Study||50
7609139|NCT02469714|18733486|P2|STARTED|Overall Study||55
7609140|NCT02469714|18733487|P1|STARTED|Overall Study||55
7609141|NCT02469701|18733507|P1|NOT COMPLETED|Overall Study||0
7609142|NCT02469701|18733507|P1|COMPLETED|Overall Study||10
7609143|NCT02469701|18733507|P1|STARTED|Overall Study||10
7609144|NCT02469623|18733511|P1|NOT COMPLETED|Overall Study||13
7609145|NCT02469623|18733511|P1|COMPLETED|Overall Study||72
7609146|NCT02469623|18733511|P1|STARTED|Overall Study||85
7609147|NCT02469610|18733518|P2|NOT COMPLETED|Overall Study||1
7609148|NCT02469610|18733519|P1|NOT COMPLETED|Overall Study||4
7609149|NCT02469610|18733518|P2|COMPLETED|Overall Study||30
7609150|NCT02469610|18733519|P1|COMPLETED|Overall Study||30
7609151|NCT02469610|18733518|P2|STARTED|Overall Study||31
7609152|NCT02469610|18733519|P1|STARTED|Overall Study||34
7609153|NCT02469597|18733529|P2|NOT COMPLETED|Overall Study||0
7609154|NCT02469597|18733530|P1|NOT COMPLETED|Overall Study||0
7609155|NCT02469597|18733529|P2|COMPLETED|Overall Study||24
7609156|NCT02469597|18733530|P1|COMPLETED|Overall Study||22
7609157|NCT02469597|18733529|P2|STARTED|Overall Study||24
7609158|NCT02469597|18733530|P1|STARTED|Overall Study||22
7609159|NCT02469415|18733546|P1|NOT COMPLETED|Overall Study||3
7609160|NCT02469415|18733546|P1|COMPLETED|Overall Study||0
7609161|NCT02469415|18733546|P1|STARTED|Overall Study||3
7609162|NCT02469298|18733554|P4|NOT COMPLETED|Overall Study||2
7609163|NCT02469298|18733555|P3|NOT COMPLETED|Overall Study||2
7609164|NCT02469298|18733556|P2|NOT COMPLETED|Overall Study||1
7609165|NCT02469298|18733557|P1|NOT COMPLETED|Overall Study||1
7609166|NCT02469298|18733554|P4|COMPLETED|Overall Study||5
7609167|NCT02469298|18733555|P3|COMPLETED|Overall Study||14
7609168|NCT02469298|18733556|P2|COMPLETED|Overall Study||6
7609169|NCT02469298|18733557|P1|COMPLETED|Overall Study||14
7609170|NCT02469298|18733554|P4|STARTED|Overall Study||7
7609171|NCT02469298|18733555|P3|STARTED|Overall Study||16
7609172|NCT02469298|18733556|P2|STARTED|Overall Study||7
7609173|NCT02469298|18733557|P1|STARTED|Overall Study||15
7609174|NCT02469246|18733697|P2|NOT COMPLETED|Open-Label Extension (OLE)||0
7609175|NCT02469246|18733698|P1|NOT COMPLETED|Open-Label Extension (OLE)||0
7609176|NCT02469246|18733697|P2|COMPLETED|Open-Label Extension (OLE)||5
7609177|NCT02469246|18733698|P1|COMPLETED|Open-Label Extension (OLE)||6
7609178|NCT02469246|18733697|P2|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|5
7609179|NCT02469246|18733698|P1|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|6
7609180|NCT02469246|18733697|P2|NOT COMPLETED|Double-Blind Phase||56
7609181|NCT02469246|18733698|P1|NOT COMPLETED|Double-Blind Phase||67
7609182|NCT02469246|18733697|P2|COMPLETED|Double-Blind Phase||226
7609183|NCT02469246|18733698|P1|COMPLETED|Double-Blind Phase||218
7609184|NCT02469246|18733697|P2|STARTED|Double-Blind Phase||282
7609185|NCT02469246|18733698|P1|STARTED|Double-Blind Phase||285
7609186|NCT02469168|18733730|P2|NOT COMPLETED|Overall Study||0
7609187|NCT02469168|18733731|P1|NOT COMPLETED|Overall Study||1
7609188|NCT02469168|18733730|P2|COMPLETED|Overall Study||0
7609189|NCT02469168|18733731|P1|COMPLETED|Overall Study||0
7609190|NCT02469168|18733730|P2|STARTED|Overall Study||0
7609191|NCT02469168|18733731|P1|STARTED|Overall Study||1
7609192|NCT02469116|18733739|P1|NOT COMPLETED|Overall Study||0
7609193|NCT02469116|18733739|P1|COMPLETED|Overall Study||18
7609194|NCT02469116|18733739|P1|STARTED|Overall Study||18
7609195|NCT02469090|18733751|P3|NOT COMPLETED|Period 2: Maintenance Treatment Phase||20
7609196|NCT02469090|18733752|P2|NOT COMPLETED|Period 2: Maintenance Treatment Phase||9
7609197|NCT02469090|18733753|P1|NOT COMPLETED|Period 2: Maintenance Treatment Phase||0
7609198|NCT02469090|18733751|P3|COMPLETED|Period 2: Maintenance Treatment Phase||34
7609199|NCT02469090|18733752|P2|COMPLETED|Period 2: Maintenance Treatment Phase||46
7609200|NCT02469090|18733753|P1|COMPLETED|Period 2: Maintenance Treatment Phase||0
7609201|NCT02469090|18733751|P3|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to APL-130277 Maintenance Phase|54
7609202|NCT02469090|18733752|P2|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to Placebo in the Maintenance Phase|55
7609203|NCT02469090|18733753|P1|STARTED|Period 2: Maintenance Treatment Phase|Subjects who completed the Titration Phase were eligible to proceed to Maintenance Treatment Phase|0
7609204|NCT02469090|18733751|P3|NOT COMPLETED|Period 1: Dose Titration Phase||0
7609205|NCT02469090|18733752|P2|NOT COMPLETED|Period 1: Dose Titration Phase||0
7609206|NCT02469090|18733753|P1|NOT COMPLETED|Period 1: Dose Titration Phase||32
7609207|NCT02469090|18733751|P3|COMPLETED|Period 1: Dose Titration Phase||0
7609208|NCT02469090|18733752|P2|COMPLETED|Period 1: Dose Titration Phase||0
7609209|NCT02469090|18733753|P1|COMPLETED|Period 1: Dose Titration Phase||109
7609210|NCT02469090|18733751|P3|STARTED|Period 1: Dose Titration Phase||0
7609211|NCT02469090|18733752|P2|STARTED|Period 1: Dose Titration Phase||0
7609212|NCT02469090|18733753|P1|STARTED|Period 1: Dose Titration Phase||141
7609213|NCT02469077|18733780|P2|NOT COMPLETED|Post Intervention /Followup||1
7609214|NCT02469077|18733781|P1|NOT COMPLETED|Post Intervention /Followup||2
7609215|NCT02469077|18733780|P2|COMPLETED|Post Intervention /Followup||44
7609216|NCT02469077|18733781|P1|COMPLETED|Post Intervention /Followup||38
7609217|NCT02469077|18733780|P2|Post Intervention Naloxone|Post Intervention /Followup||44
7609218|NCT02469077|18733781|P1|Post Intervention Naloxone|Post Intervention /Followup||39
7609219|NCT02469077|18733780|P2|Post Intervention Morphine|Post Intervention /Followup||45
7609220|NCT02469077|18733781|P1|Post Intervention Morphine|Post Intervention /Followup||40
7609221|NCT02469077|18733780|P2|Post Intervention Placebo|Post Intervention /Followup||45
7609222|NCT02469077|18733781|P1|Post Intervention Placebo|Post Intervention /Followup||39
7609223|NCT02469077|18733780|P2|STARTED|Post Intervention /Followup||45
7609224|NCT02469077|18733781|P1|STARTED|Post Intervention /Followup||40
7609225|NCT02469077|18733780|P2|NOT COMPLETED|Post Randomization/Intervention Period||4
7609226|NCT02469077|18733781|P1|NOT COMPLETED|Post Randomization/Intervention Period||4
7609227|NCT02469077|18733780|P2|COMPLETED|Post Randomization/Intervention Period||45
7609228|NCT02469077|18733781|P1|COMPLETED|Post Randomization/Intervention Period||40
7609229|NCT02469077|18733780|P2|STARTED|Post Randomization/Intervention Period||49
7609230|NCT02469077|18733781|P1|STARTED|Post Randomization/Intervention Period||44
7609231|NCT02469077|18733780|P2|NOT COMPLETED|Pre Randomization - Pre Intervention||0
7609232|NCT02469077|18733781|P1|NOT COMPLETED|Pre Randomization - Pre Intervention||0
7609233|NCT02469077|18733780|P2|COMPLETED|Pre Randomization - Pre Intervention||49
7609234|NCT02469077|18733781|P1|COMPLETED|Pre Randomization - Pre Intervention||44
7609235|NCT02469077|18733780|P2|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||49
7609236|NCT02469077|18733781|P1|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||44
7609237|NCT02469077|18733780|P2|Pre Intervention Morpine|Pre Randomization - Pre Intervention||49
7609238|NCT02469077|18733781|P1|Pre Intervention Morpine|Pre Randomization - Pre Intervention||44
7609239|NCT02469077|18733780|P2|Pre Intervention Placebo|Pre Randomization - Pre Intervention||49
7609240|NCT02469077|18733781|P1|Pre Intervention Placebo|Pre Randomization - Pre Intervention||44
7609241|NCT02469077|18733780|P2|STARTED|Pre Randomization - Pre Intervention||49
7609242|NCT02469077|18733781|P1|STARTED|Pre Randomization - Pre Intervention||44
7609243|NCT02469064|18733813|P2|NOT COMPLETED|Overall Study||3
7609244|NCT02469064|18733814|P1|NOT COMPLETED|Overall Study||1
7609245|NCT02469064|18733813|P2|COMPLETED|Overall Study||59
7609246|NCT02469064|18733814|P1|COMPLETED|Overall Study||63
7609247|NCT02469064|18733813|P2|STARTED|Overall Study||62
7609248|NCT02469064|18733814|P1|STARTED|Overall Study||64
7609249|NCT02469038|18733824|P2|NOT COMPLETED|Overall Study||5
7609250|NCT02469038|18733825|P1|NOT COMPLETED|Overall Study||4
7609251|NCT02469038|18733824|P2|COMPLETED|Overall Study||19
7609252|NCT02469038|18733825|P1|COMPLETED|Overall Study||22
7609253|NCT02469038|18733824|P2|STARTED|Overall Study||24
7609254|NCT02469038|18733825|P1|STARTED|Overall Study||26
7609255|NCT02468934|18733843|P1|NOT COMPLETED|Overall Study||7
7609256|NCT02468934|18733843|P1|COMPLETED|Overall Study||20
7609257|NCT02468934|18733843|P1|Underwent Total Knee Arthroplasty|Overall Study||20
7609258|NCT02468934|18733843|P1|Enrolled/Received Leads|Overall Study||24
7609259|NCT02468934|18733843|P1|STARTED|Overall Study||27
7609260|NCT02468830|18733862|P1|NOT COMPLETED|Overall Study||3
7609261|NCT02468830|18733862|P1|COMPLETED|Overall Study||55
7609262|NCT02468830|18733862|P1|STARTED|Overall Study||58
7609263|NCT02468700|18733872|P2|NOT COMPLETED|Overall Study||2
7609264|NCT02468700|18733873|P1|NOT COMPLETED|Overall Study||2
7609265|NCT02468700|18733872|P2|COMPLETED|Overall Study||19
7609266|NCT02468700|18733873|P1|COMPLETED|Overall Study||20
7609267|NCT02468700|18733872|P2|STARTED|Overall Study||21
7609268|NCT02468700|18733873|P1|STARTED|Overall Study||22
7609269|NCT02468674|18733894|P9|NOT COMPLETED|Overall Study||3
7609270|NCT02468674|18733895|P8|NOT COMPLETED|Overall Study||4
7609271|NCT02468674|18733896|P7|NOT COMPLETED|Overall Study||1
7609272|NCT02468674|18733897|P6|NOT COMPLETED|Overall Study||1
7609273|NCT02468674|18733898|P5|NOT COMPLETED|Overall Study||1
7609274|NCT02468674|18733899|P4|NOT COMPLETED|Overall Study||1
7609275|NCT02468674|18733900|P3|NOT COMPLETED|Overall Study||0
7609276|NCT02468674|18733901|P2|NOT COMPLETED|Overall Study||0
7609277|NCT02468674|18733902|P1|NOT COMPLETED|Overall Study||1
7609278|NCT02468674|18733894|P9|COMPLETED|Overall Study||40
7609279|NCT02468674|18733895|P8|COMPLETED|Overall Study||65
7609280|NCT02468674|18733896|P7|COMPLETED|Overall Study||14
7609281|NCT02468674|18733897|P6|COMPLETED|Overall Study||6
7609282|NCT02468674|18733898|P5|COMPLETED|Overall Study||6
7609283|NCT02468674|18733899|P4|COMPLETED|Overall Study||3
7609284|NCT02468674|18733900|P3|COMPLETED|Overall Study||5
7609285|NCT02468674|18733901|P2|COMPLETED|Overall Study||5
7609286|NCT02468674|18733902|P1|COMPLETED|Overall Study||4
7609287|NCT02468674|18733894|P9|STARTED|Overall Study||43
7609288|NCT02468674|18733895|P8|STARTED|Overall Study||69
7609289|NCT02468674|18733896|P7|STARTED|Overall Study||15
7609290|NCT02468674|18733897|P6|STARTED|Overall Study||7
7609291|NCT02468674|18733898|P5|STARTED|Overall Study||7
7609292|NCT02468674|18733899|P4|STARTED|Overall Study||4
7609293|NCT02468674|18733900|P3|STARTED|Overall Study||5
7609294|NCT02468674|18733901|P2|STARTED|Overall Study||5
7609295|NCT02468674|18733902|P1|STARTED|Overall Study||5
7609296|NCT02468648|18733958|P1|NOT COMPLETED|Overall Study||1
7609297|NCT02468648|18733958|P1|COMPLETED|Overall Study||71
7609298|NCT02468648|18733958|P1|STARTED|Overall Study||72
7609299|NCT02468583|18733967|P2|NOT COMPLETED|Overall Study||0
7609300|NCT02468583|18733968|P1|NOT COMPLETED|Overall Study||0
7609301|NCT02468583|18733967|P2|COMPLETED|Overall Study||3
7609302|NCT02468583|18733968|P1|COMPLETED|Overall Study||3
7609303|NCT02468583|18733967|P2|STARTED|Overall Study||3
7609304|NCT02468583|18733968|P1|STARTED|Overall Study||3
7609305|NCT02468570|18734006|P2|NOT COMPLETED|Overall Study||0
7609306|NCT02468570|18734007|P1|NOT COMPLETED|Overall Study||0
7609307|NCT02468570|18734006|P2|COMPLETED|Overall Study||3
7609308|NCT02468570|18734007|P1|COMPLETED|Overall Study||6
7609309|NCT02468570|18734006|P2|STARTED|Overall Study||3
7609310|NCT02468570|18734007|P1|STARTED|Overall Study||6
7609311|NCT02468414|18734025|P2|NOT COMPLETED|Overall Study||0
7609312|NCT02468414|18734026|P1|NOT COMPLETED|Overall Study||3
7609313|NCT02468414|18734025|P2|COMPLETED|Overall Study||0
7609314|NCT02468414|18734026|P1|COMPLETED|Overall Study||0
7609315|NCT02468414|18734025|P2|Safety Follow-up|Overall Study||0
7609316|NCT02468414|18734026|P1|Safety Follow-up|Overall Study||0
7609317|NCT02468414|18734025|P2|Implantation|Overall Study||0
7609318|NCT02468414|18734026|P1|Implantation|Overall Study||1
7609319|NCT02468414|18734025|P2|Harvesting|Overall Study||0
7609320|NCT02468414|18734026|P1|Harvesting|Overall Study||1
7609321|NCT02468414|18734025|P2|Successfully Screened|Overall Study||0
7609322|NCT02468414|18734026|P1|Successfully Screened|Overall Study||2
7609323|NCT02468414|18734025|P2|STARTED|Overall Study||0
7609324|NCT02468414|18734026|P1|STARTED|Overall Study||3
7609325|NCT02468193|18734032|P1|NOT COMPLETED|Overall Study||6
7609326|NCT02468193|18734032|P1|COMPLETED|Overall Study||3
7609327|NCT02468193|18734032|P1|Discontinued Study in Optional Ext. Per.|Overall Study||2
7609328|NCT02468193|18734032|P1|Completed Optional Extension Period|Overall Study||0
7609329|NCT02468193|18734032|P1|Compl. Wk-48, Entered Opt. Ext. Period|Overall Study||2
7609330|NCT02468193|18734032|P1|Compl. Wk-48, Didn't Enter Opt. Ext. Per|Overall Study||0
7609331|NCT02468193|18734032|P1|Discontinued at or Prior to Week48|Overall Study||2
7609332|NCT02468193|18734032|P1|Completed Week-48 (Study Period II)|Overall Study||2
7609333|NCT02468193|18734032|P1|Completed Week-12, Entered Study Per. II|Overall Study||4
7609334|NCT02468193|18734032|P1|Completed Week-12, Did Not Enter Per. II|Overall Study||3
7609335|NCT02468193|18734032|P1|Discontinued at or Prior to Week-12|Overall Study||2
7609336|NCT02468193|18734032|P1|Completed Week-12 (Study Period I)|Overall Study||7
7609337|NCT02468193|18734032|P1|STARTED|Overall Study||9
7609338|NCT02468154|18734126|P2|NOT COMPLETED|Overall Study||0
7609339|NCT02468154|18734127|P1|NOT COMPLETED|Overall Study||0
7609340|NCT02468154|18734126|P2|COMPLETED|Overall Study||28
7609341|NCT02468154|18734127|P1|COMPLETED|Overall Study||29
7609342|NCT02468154|18734126|P2|STARTED|Overall Study||28
7609343|NCT02468154|18734127|P1|STARTED|Overall Study||29
7609344|NCT02467842|18734142|P3|NOT COMPLETED|Overall Study||0
7609345|NCT02467842|18734143|P2|NOT COMPLETED|Overall Study||0
7609346|NCT02467842|18734144|P1|NOT COMPLETED|Overall Study||0
7609347|NCT02467842|18734142|P3|COMPLETED|Overall Study||378
7609348|NCT02467842|18734143|P2|COMPLETED|Overall Study||373
7609349|NCT02467842|18734144|P1|COMPLETED|Overall Study||752
7609350|NCT02467842|18734142|P3|STARTED|Overall Study||378
7609351|NCT02467842|18734143|P2|STARTED|Overall Study||373
7609352|NCT02467842|18734144|P1|STARTED|Overall Study||752
7609353|NCT02467777|18734169|P2|NOT COMPLETED|Overall Study||0
7609354|NCT02467777|18734170|P1|NOT COMPLETED|Overall Study||0
7609355|NCT02467777|18734169|P2|COMPLETED|Overall Study||27
7609356|NCT02467777|18734170|P1|COMPLETED|Overall Study||23
7609357|NCT02467777|18734169|P2|STARTED|Overall Study||27
7609358|NCT02467777|18734170|P1|STARTED|Overall Study||23
7609359|NCT02467621|18734178|P2|NOT COMPLETED|Overall Study||6
7609360|NCT02467621|18734179|P1|NOT COMPLETED|Overall Study||1
7609361|NCT02467621|18734178|P2|COMPLETED|Overall Study||1647
7609362|NCT02467621|18734179|P1|COMPLETED|Overall Study||1644
7609363|NCT02467621|18734178|P2|STARTED|Overall Study||1653
7609364|NCT02467621|18734179|P1|STARTED|Overall Study||1645
7609365|NCT02467504|18734199|P2|NOT COMPLETED|Overall Study||1
7609366|NCT02467504|18734200|P1|NOT COMPLETED|Overall Study||6
7609367|NCT02467504|18734199|P2|COMPLETED|Overall Study||23
7609368|NCT02467504|18734200|P1|COMPLETED|Overall Study||17
7609369|NCT02467504|18734199|P2|STARTED|Overall Study||24
7609370|NCT02467504|18734200|P1|STARTED|Overall Study||23
7609371|NCT02467491|18734244|P1|NOT COMPLETED|Overall Study||0
7609372|NCT02467491|18734244|P1|COMPLETED|Overall Study||12
7609373|NCT02467491|18734244|P1|STARTED|Overall Study||12
7609374|NCT02467465|18734255|P2|NOT COMPLETED|Overall Study||0
7609375|NCT02467465|18734256|P1|NOT COMPLETED|Overall Study||0
7609376|NCT02467465|18734255|P2|COMPLETED|Overall Study||15
7609377|NCT02467465|18734256|P1|COMPLETED|Overall Study||15
7609378|NCT02467465|18734255|P2|STARTED|Overall Study||15
7609379|NCT02467465|18734256|P1|STARTED|Overall Study||15
7609380|NCT02467387|18734300|P2|NOT COMPLETED|Second Intervention||0
7609381|NCT02467387|18734301|P1|NOT COMPLETED|Second Intervention||3
7609382|NCT02467387|18734300|P2|COMPLETED|Second Intervention||12
7609383|NCT02467387|18734301|P1|COMPLETED|Second Intervention||7
7609384|NCT02467387|18734300|P2|STARTED|Second Intervention||12
7609385|NCT02467387|18734301|P1|STARTED|Second Intervention||10
7609386|NCT02467387|18734300|P2|NOT COMPLETED|First Intervention||0
7609387|NCT02467387|18734301|P1|NOT COMPLETED|First Intervention||1
7609388|NCT02467387|18734300|P2|COMPLETED|First Intervention||12
7609389|NCT02467387|18734301|P1|COMPLETED|First Intervention||10
7609390|NCT02467387|18734300|P2|Received Treatment as Randomized|First Intervention||12
7609391|NCT02467387|18734301|P1|Received Treatment as Randomized|First Intervention||10
7609392|NCT02467387|18734300|P2|STARTED|First Intervention||12
7609393|NCT02467387|18734301|P1|STARTED|First Intervention||11
7609394|NCT02467179|18734311|P2|NOT COMPLETED|Overall Study||0
7609395|NCT02467179|18734312|P1|NOT COMPLETED|Overall Study||0
7609396|NCT02467179|18734311|P2|COMPLETED|Overall Study||25
7609397|NCT02467179|18734312|P1|COMPLETED|Overall Study||25
7609398|NCT02467179|18734311|P2|STARTED|Overall Study||25
7609399|NCT02467179|18734312|P1|STARTED|Overall Study||25
7609400|NCT02467075|18734322|P2|NOT COMPLETED|30 Day Follow-up||0
7609401|NCT02467075|18734323|P1|NOT COMPLETED|30 Day Follow-up||0
7609402|NCT02467075|18734322|P2|COMPLETED|30 Day Follow-up||1
7609403|NCT02467075|18734323|P1|COMPLETED|30 Day Follow-up||0
7609404|NCT02467075|18734322|P2|STARTED|30 Day Follow-up||1
7609405|NCT02467075|18734323|P1|STARTED|30 Day Follow-up||0
7609406|NCT02467075|18734322|P2|NOT COMPLETED|72 Hour Follow-up||0
7609407|NCT02467075|18734323|P1|NOT COMPLETED|72 Hour Follow-up||0
7609408|NCT02467075|18734322|P2|COMPLETED|72 Hour Follow-up||1
7609409|NCT02467075|18734323|P1|COMPLETED|72 Hour Follow-up||0
7609410|NCT02467075|18734322|P2|STARTED|72 Hour Follow-up||1
7609411|NCT02467075|18734323|P1|STARTED|72 Hour Follow-up||0
7609412|NCT02467075|18734322|P2|NOT COMPLETED|48 Hour Follow-up||0
7609413|NCT02467075|18734323|P1|NOT COMPLETED|48 Hour Follow-up||0
7609414|NCT02467075|18734322|P2|COMPLETED|48 Hour Follow-up||1
7609415|NCT02467075|18734323|P1|COMPLETED|48 Hour Follow-up||0
7609416|NCT02467075|18734322|P2|STARTED|48 Hour Follow-up||1
7609417|NCT02467075|18734323|P1|STARTED|48 Hour Follow-up||0
7609418|NCT02467075|18734322|P2|NOT COMPLETED|Initial CT Scan||0
7609419|NCT02467075|18734323|P1|NOT COMPLETED|Initial CT Scan||0
7609420|NCT02467075|18734322|P2|COMPLETED|Initial CT Scan||1
7609421|NCT02467075|18734323|P1|COMPLETED|Initial CT Scan||0
7609422|NCT02467075|18734322|P2|STARTED|Initial CT Scan||1
7609423|NCT02467075|18734323|P1|STARTED|Initial CT Scan||0
7609424|NCT02466958|18734341|P2|NOT COMPLETED|Overall Study||3
7609425|NCT02466958|18734342|P1|NOT COMPLETED|Overall Study||10
7609426|NCT02466958|18734341|P2|COMPLETED|Overall Study||9
7609427|NCT02466958|18734342|P1|COMPLETED|Overall Study||7
7609428|NCT02466958|18734341|P2|STARTED|Overall Study||12
7609429|NCT02466958|18734342|P1|STARTED|Overall Study||17
7609430|NCT02466659|18734354|P2|NOT COMPLETED|Overall Study||2
7609431|NCT02466659|18734355|P1|NOT COMPLETED|Overall Study||5
7609432|NCT02466659|18734354|P2|COMPLETED|Overall Study||1
7609433|NCT02466659|18734355|P1|COMPLETED|Overall Study||0
7609434|NCT02466659|18734354|P2|STARTED|Overall Study||3
7609435|NCT02466659|18734355|P1|STARTED|Overall Study||5
7609436|NCT02466646|18734366|P3|NOT COMPLETED|Overall Study||0
7609437|NCT02466646|18734367|P2|NOT COMPLETED|Overall Study||0
7609438|NCT02466646|18734368|P1|NOT COMPLETED|Overall Study||0
7609439|NCT02466646|18734366|P3|COMPLETED|Overall Study||14
7609440|NCT02466646|18734367|P2|COMPLETED|Overall Study||14
7609441|NCT02466646|18734368|P1|COMPLETED|Overall Study||14
7609442|NCT02466646|18734366|P3|STARTED|Overall Study||14
7609443|NCT02466646|18734367|P2|STARTED|Overall Study||14
7609444|NCT02466646|18734368|P1|STARTED|Overall Study||14
7609445|NCT02466555|18734409|P1|NOT COMPLETED|Overall Study||2
7609446|NCT02466555|18734409|P1|COMPLETED|Overall Study||28
7609447|NCT02466555|18734409|P1|STARTED|Overall Study||30
7609448|NCT02466516|18734421|P5|NOT COMPLETED|Overall Study||0
7609449|NCT02466516|18734422|P4|NOT COMPLETED|Overall Study||0
7609450|NCT02466516|18734423|P3|NOT COMPLETED|Overall Study||1
7609451|NCT02466516|18734424|P2|NOT COMPLETED|Overall Study||1
7609452|NCT02466516|18734425|P1|NOT COMPLETED|Overall Study||4
7609453|NCT02466516|18734421|P5|COMPLETED|Overall Study||10
7609454|NCT02466516|18734422|P4|COMPLETED|Overall Study||10
7609455|NCT02466516|18734423|P3|COMPLETED|Overall Study||9
7609456|NCT02466516|18734424|P2|COMPLETED|Overall Study||21
7609457|NCT02466516|18734425|P1|COMPLETED|Overall Study||16
7609458|NCT02466516|18734421|P5|STARTED|Overall Study||10
7609459|NCT02466516|18734422|P4|STARTED|Overall Study||10
7609460|NCT02466516|18734423|P3|STARTED|Overall Study||10
7609461|NCT02466516|18734424|P2|STARTED|Overall Study||22
7609462|NCT02466516|18734425|P1|STARTED|Overall Study||20
7609463|NCT02466425|18734444|P2|NOT COMPLETED|Overall Study||16
7609464|NCT02466425|18734445|P1|NOT COMPLETED|Overall Study||14
7609465|NCT02466425|18734444|P2|COMPLETED|Overall Study||116
7609466|NCT02466425|18734445|P1|COMPLETED|Overall Study||118
7609467|NCT02466425|18734444|P2|Treated|Overall Study||132
7609468|NCT02466425|18734445|P1|Treated|Overall Study||131
7609469|NCT02466425|18734444|P2|STARTED|Overall Study||132
7609470|NCT02466425|18734445|P1|STARTED|Overall Study||132
7609471|NCT02466412|18734455|P2|NOT COMPLETED|Second Intervention (Day 3)||0
7609472|NCT02466412|18734456|P1|NOT COMPLETED|Second Intervention (Day 3)||0
7609473|NCT02466412|18734455|P2|COMPLETED|Second Intervention (Day 3)||24
7609474|NCT02466412|18734456|P1|COMPLETED|Second Intervention (Day 3)||24
7609475|NCT02466412|18734455|P2|STARTED|Second Intervention (Day 3)||24
7609476|NCT02466412|18734456|P1|STARTED|Second Intervention (Day 3)||24
7609477|NCT02466412|18734455|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
7609478|NCT02466412|18734456|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
7609479|NCT02466412|18734455|P2|COMPLETED|Washout Period of 1 Day (Day 2)||24
7609480|NCT02466412|18734456|P1|COMPLETED|Washout Period of 1 Day (Day 2)||24
7609481|NCT02466412|18734455|P2|STARTED|Washout Period of 1 Day (Day 2)||24
7609482|NCT02466412|18734456|P1|STARTED|Washout Period of 1 Day (Day 2)||24
7609483|NCT02466412|18734455|P2|NOT COMPLETED|First Intervention (Day 1)||0
7609484|NCT02466412|18734456|P1|NOT COMPLETED|First Intervention (Day 1)||0
7609485|NCT02466412|18734455|P2|COMPLETED|First Intervention (Day 1)||24
7609486|NCT02466412|18734456|P1|COMPLETED|First Intervention (Day 1)||24
7609487|NCT02466412|18734455|P2|STARTED|First Intervention (Day 1)||24
7609488|NCT02466412|18734456|P1|STARTED|First Intervention (Day 1)||24
7609489|NCT02466412|18734455|P2|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
7609490|NCT02466412|18734456|P1|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
7609491|NCT02466412|18734455|P2|COMPLETED|Washout Period of 1 Day (Day -1)||24
7609492|NCT02466412|18734456|P1|COMPLETED|Washout Period of 1 Day (Day -1)||24
7609493|NCT02466412|18734455|P2|STARTED|Washout Period of 1 Day (Day -1)||24
7609494|NCT02466412|18734456|P1|STARTED|Washout Period of 1 Day (Day -1)||24
7609495|NCT02466399|18734467|P2|NOT COMPLETED|Overall Study||0
7609496|NCT02466399|18734468|P1|NOT COMPLETED|Overall Study||2
7609497|NCT02466399|18734467|P2|COMPLETED|Overall Study||27
7609498|NCT02466399|18734468|P1|COMPLETED|Overall Study||51
7609499|NCT02466399|18734467|P2|STARTED|Overall Study||27
7609500|NCT02466399|18734468|P1|STARTED|Overall Study||53
7609501|NCT02466230|18734474|P1|NOT COMPLETED|Overall Study||0
7609502|NCT02466230|18734474|P1|COMPLETED|Overall Study||28
7609503|NCT02466230|18734474|P1|STARTED|Overall Study||28
7609504|NCT02466087|18734479|P2|NOT COMPLETED|Second Intervention: Weeks 7-12||0
7609505|NCT02466087|18734480|P1|NOT COMPLETED|Second Intervention: Weeks 7-12||0
7609506|NCT02466087|18734479|P2|COMPLETED|Second Intervention: Weeks 7-12||57
7609507|NCT02466087|18734480|P1|COMPLETED|Second Intervention: Weeks 7-12||55
7609508|NCT02466087|18734479|P2|STARTED|Second Intervention: Weeks 7-12||57
7609509|NCT02466087|18734480|P1|STARTED|Second Intervention: Weeks 7-12||55
7609510|NCT02466087|18734479|P2|NOT COMPLETED|First Intervention: Weeks 1-6||7
7609511|NCT02466087|18734480|P1|NOT COMPLETED|First Intervention: Weeks 1-6||7
7609512|NCT02466087|18734479|P2|COMPLETED|First Intervention: Weeks 1-6||57
7609513|NCT02466087|18734480|P1|COMPLETED|First Intervention: Weeks 1-6||55
7609514|NCT02466087|18734479|P2|STARTED|First Intervention: Weeks 1-6||64
7609515|NCT02466087|18734480|P1|STARTED|First Intervention: Weeks 1-6||62
7609516|NCT02465931|18734492|P2|NOT COMPLETED|Overall Study||11
7609517|NCT02465931|18734493|P1|NOT COMPLETED|Overall Study||11
7609518|NCT02465931|18734492|P2|COMPLETED|Overall Study||45
7609519|NCT02465931|18734493|P1|COMPLETED|Overall Study||44
7609520|NCT02465931|18734492|P2|STARTED|Overall Study||56
7609521|NCT02465931|18734493|P1|STARTED|Overall Study||55
7609522|NCT02465866|18734499|P4|NOT COMPLETED|Period 4: Washout (14 Days)||0
7609523|NCT02465866|18734500|P3|NOT COMPLETED|Period 4: Washout (14 Days)||0
7609524|NCT02465866|18734501|P2|NOT COMPLETED|Period 4: Washout (14 Days)||0
7609525|NCT02465866|18734502|P1|NOT COMPLETED|Period 4: Washout (14 Days)||0
7609526|NCT02465866|18734499|P4|COMPLETED|Period 4: Washout (14 Days)||5
7609527|NCT02465866|18734500|P3|COMPLETED|Period 4: Washout (14 Days)||5
7609528|NCT02465866|18734501|P2|COMPLETED|Period 4: Washout (14 Days)||4
7609529|NCT02465866|18734502|P1|COMPLETED|Period 4: Washout (14 Days)||5
7609530|NCT02465866|18734499|P4|STARTED|Period 4: Washout (14 Days)||5
7609531|NCT02465866|18734500|P3|STARTED|Period 4: Washout (14 Days)||5
7609532|NCT02465866|18734501|P2|STARTED|Period 4: Washout (14 Days)||4
7609533|NCT02465866|18734502|P1|STARTED|Period 4: Washout (14 Days)||5
7609534|NCT02465866|18734499|P4|NOT COMPLETED|Period 4||0
7609535|NCT02465866|18734500|P3|NOT COMPLETED|Period 4||0
7609536|NCT02465866|18734501|P2|NOT COMPLETED|Period 4||0
7609537|NCT02465866|18734502|P1|NOT COMPLETED|Period 4||0
7609538|NCT02465866|18734499|P4|COMPLETED|Period 4||5
7609539|NCT02465866|18734500|P3|COMPLETED|Period 4||5
7609540|NCT02465866|18734501|P2|COMPLETED|Period 4||4
7609541|NCT02465866|18734502|P1|COMPLETED|Period 4||5
7609542|NCT02465866|18734499|P4|STARTED|Period 4||5
7609543|NCT02465866|18734500|P3|STARTED|Period 4||5
7609544|NCT02465866|18734501|P2|STARTED|Period 4||4
7609545|NCT02465866|18734502|P1|STARTED|Period 4||5
7609546|NCT02465866|18734499|P4|NOT COMPLETED|Period 3: Washout (14 Days)||0
7609547|NCT02465866|18734500|P3|NOT COMPLETED|Period 3: Washout (14 Days)||0
7609548|NCT02465866|18734501|P2|NOT COMPLETED|Period 3: Washout (14 Days)||0
7609549|NCT02465866|18734502|P1|NOT COMPLETED|Period 3: Washout (14 Days)||0
7609550|NCT02465866|18734499|P4|COMPLETED|Period 3: Washout (14 Days)||5
7609551|NCT02465866|18734500|P3|COMPLETED|Period 3: Washout (14 Days)||5
7609552|NCT02465866|18734501|P2|COMPLETED|Period 3: Washout (14 Days)||4
7609553|NCT02465866|18734502|P1|COMPLETED|Period 3: Washout (14 Days)||5
7609554|NCT02465866|18734499|P4|STARTED|Period 3: Washout (14 Days)||5
7609555|NCT02465866|18734500|P3|STARTED|Period 3: Washout (14 Days)||5
7609556|NCT02465866|18734501|P2|STARTED|Period 3: Washout (14 Days)||4
7609557|NCT02465866|18734502|P1|STARTED|Period 3: Washout (14 Days)||5
7609558|NCT02465866|18734499|P4|NOT COMPLETED|Period 3||0
7609559|NCT02465866|18734500|P3|NOT COMPLETED|Period 3||0
7609560|NCT02465866|18734501|P2|NOT COMPLETED|Period 3||1
7609561|NCT02465866|18734502|P1|NOT COMPLETED|Period 3||0
7609562|NCT02465866|18734499|P4|COMPLETED|Period 3||5
7609563|NCT02465866|18734500|P3|COMPLETED|Period 3||5
7609564|NCT02465866|18734501|P2|COMPLETED|Period 3||4
7609565|NCT02465866|18734502|P1|COMPLETED|Period 3||5
7609566|NCT02465866|18734499|P4|STARTED|Period 3||5
7609567|NCT02465866|18734500|P3|STARTED|Period 3||5
7609568|NCT02465866|18734501|P2|STARTED|Period 3||5
7609569|NCT02465866|18734502|P1|STARTED|Period 3||5
7609570|NCT02465866|18734499|P4|NOT COMPLETED|Period 2: Washout (14 Days)||0
7609571|NCT02465866|18734500|P3|NOT COMPLETED|Period 2: Washout (14 Days)||0
7609572|NCT02465866|18734501|P2|NOT COMPLETED|Period 2: Washout (14 Days)||0
7609573|NCT02465866|18734502|P1|NOT COMPLETED|Period 2: Washout (14 Days)||0
7609574|NCT02465866|18734499|P4|COMPLETED|Period 2: Washout (14 Days)||5
7609575|NCT02465866|18734500|P3|COMPLETED|Period 2: Washout (14 Days)||5
7609576|NCT02465866|18734501|P2|COMPLETED|Period 2: Washout (14 Days)||5
7609577|NCT02465866|18734502|P1|COMPLETED|Period 2: Washout (14 Days)||5
7609578|NCT02465866|18734499|P4|STARTED|Period 2: Washout (14 Days)||5
7609579|NCT02465866|18734500|P3|STARTED|Period 2: Washout (14 Days)||5
7609580|NCT02465866|18734501|P2|STARTED|Period 2: Washout (14 Days)||5
7609581|NCT02465866|18734502|P1|STARTED|Period 2: Washout (14 Days)||5
7609582|NCT02465866|18734499|P4|NOT COMPLETED|Period 2||0
7609583|NCT02465866|18734500|P3|NOT COMPLETED|Period 2||0
7609584|NCT02465866|18734501|P2|NOT COMPLETED|Period 2||0
7609585|NCT02465866|18734502|P1|NOT COMPLETED|Period 2||0
7609586|NCT02465866|18734499|P4|COMPLETED|Period 2||5
7609587|NCT02465866|18734500|P3|COMPLETED|Period 2||5
7609588|NCT02465866|18734501|P2|COMPLETED|Period 2||5
7609589|NCT02465866|18734502|P1|COMPLETED|Period 2||5
7609590|NCT02465866|18734499|P4|STARTED|Period 2||5
7609591|NCT02465866|18734500|P3|STARTED|Period 2||5
7609592|NCT02465866|18734501|P2|STARTED|Period 2||5
7609593|NCT02465866|18734502|P1|STARTED|Period 2||5
7609594|NCT02465866|18734499|P4|NOT COMPLETED|Period 1: Washout (14 Days)||0
7609595|NCT02465866|18734500|P3|NOT COMPLETED|Period 1: Washout (14 Days)||0
7609596|NCT02465866|18734501|P2|NOT COMPLETED|Period 1: Washout (14 Days)||0
7609597|NCT02465866|18734502|P1|NOT COMPLETED|Period 1: Washout (14 Days)||0
7609598|NCT02465866|18734499|P4|COMPLETED|Period 1: Washout (14 Days)||5
7609599|NCT02465866|18734500|P3|COMPLETED|Period 1: Washout (14 Days)||5
7609600|NCT02465866|18734501|P2|COMPLETED|Period 1: Washout (14 Days)||5
7609601|NCT02465866|18734502|P1|COMPLETED|Period 1: Washout (14 Days)||5
7609602|NCT02465866|18734499|P4|STARTED|Period 1: Washout (14 Days)||5
7609603|NCT02465866|18734500|P3|STARTED|Period 1: Washout (14 Days)||5
7609604|NCT02465866|18734501|P2|STARTED|Period 1: Washout (14 Days)||5
7609605|NCT02465866|18734502|P1|STARTED|Period 1: Washout (14 Days)||5
7609606|NCT02465866|18734499|P4|NOT COMPLETED|Period 1||0
7609607|NCT02465866|18734500|P3|NOT COMPLETED|Period 1||0
7609608|NCT02465866|18734501|P2|NOT COMPLETED|Period 1||0
7609609|NCT02465866|18734502|P1|NOT COMPLETED|Period 1||0
7609610|NCT02465866|18734499|P4|COMPLETED|Period 1||5
7609611|NCT02465866|18734500|P3|COMPLETED|Period 1||5
7609612|NCT02465866|18734501|P2|COMPLETED|Period 1||5
7609613|NCT02465866|18734502|P1|COMPLETED|Period 1||5
7609614|NCT02465866|18734499|P4|STARTED|Period 1||5
7609615|NCT02465866|18734500|P3|STARTED|Period 1||5
7609616|NCT02465866|18734501|P2|STARTED|Period 1||5
7609617|NCT02465866|18734502|P1|STARTED|Period 1||5
7609618|NCT02465632|18734575|P3|NOT COMPLETED|Overall Study||17
7609619|NCT02465632|18734576|P2|NOT COMPLETED|Overall Study||23
7609620|NCT02465632|18734577|P1|NOT COMPLETED|Overall Study||31
7609621|NCT02465632|18734575|P3|COMPLETED|Overall Study||203
7609622|NCT02465632|18734576|P2|COMPLETED|Overall Study||417
7609623|NCT02465632|18734577|P1|COMPLETED|Overall Study||409
7609624|NCT02465632|18734575|P3|STARTED|Overall Study||220
7609625|NCT02465632|18734576|P2|STARTED|Overall Study||440
7609626|NCT02465632|18734577|P1|STARTED|Overall Study||440
7609627|NCT02465528|18734592|P4|NOT COMPLETED|Overall Study||5
7609628|NCT02465528|18734593|P3|NOT COMPLETED|Overall Study||12
7609629|NCT02465528|18734594|P2|NOT COMPLETED|Overall Study||4
7609630|NCT02465528|18734595|P1|NOT COMPLETED|Overall Study||1
7609631|NCT02465528|18734592|P4|COMPLETED|Overall Study||0
7609632|NCT02465528|18734593|P3|COMPLETED|Overall Study||0
7609633|NCT02465528|18734594|P2|COMPLETED|Overall Study||0
7609634|NCT02465528|18734595|P1|COMPLETED|Overall Study||0
7609635|NCT02465528|18734592|P4|STARTED|Overall Study||5
7609636|NCT02465528|18734593|P3|STARTED|Overall Study||12
7609637|NCT02465528|18734594|P2|STARTED|Overall Study||4
7609638|NCT02465528|18734595|P1|STARTED|Overall Study||1
7609639|NCT02465515|18734628|P2|NOT COMPLETED|Overall Study||111
7609640|NCT02465515|18734629|P1|NOT COMPLETED|Overall Study||154
7609641|NCT02465515|18734628|P2|COMPLETED|Overall Study||4620
7609642|NCT02465515|18734629|P1|COMPLETED|Overall Study||4578
7609643|NCT02465515|18734628|P2|STARTED|Overall Study||4731
7609644|NCT02465515|18734629|P1|STARTED|Overall Study||4732
7609645|NCT02465489|18734675|P1|NOT COMPLETED|Overall Study||5
7609646|NCT02465489|18734675|P1|COMPLETED|Overall Study||15
7609647|NCT02465489|18734675|P1|STARTED|Overall Study||20
7609648|NCT02465463|18734704|P2|NOT COMPLETED|Overall Study||1
7609649|NCT02465463|18734705|P1|NOT COMPLETED|Overall Study||4
7609650|NCT02465463|18734704|P2|COMPLETED|Overall Study||4
7609651|NCT02465463|18734705|P1|COMPLETED|Overall Study||4
7609652|NCT02465463|18734704|P2|STARTED|Overall Study||5
7609653|NCT02465463|18734705|P1|STARTED|Overall Study||8
7609654|NCT02465450|18734724|P6|NOT COMPLETED|Treatment Period 2||0
7609655|NCT02465450|18734725|P5|NOT COMPLETED|Treatment Period 2||4
7609656|NCT02465450|18734726|P4|NOT COMPLETED|Treatment Period 2||3
7609657|NCT02465450|18734727|P3|NOT COMPLETED|Treatment Period 2||0
7609658|NCT02465450|18734728|P2|NOT COMPLETED|Treatment Period 2||0
7609659|NCT02465450|18734729|P1|NOT COMPLETED|Treatment Period 2||0
7609660|NCT02465450|18734724|P6|COMPLETED|Treatment Period 2||23
7609661|NCT02465450|18734725|P5|COMPLETED|Treatment Period 2||24
7609662|NCT02465450|18734726|P4|COMPLETED|Treatment Period 2||27
7609663|NCT02465450|18734727|P3|COMPLETED|Treatment Period 2||0
7609664|NCT02465450|18734728|P2|COMPLETED|Treatment Period 2||0
7609665|NCT02465450|18734729|P1|COMPLETED|Treatment Period 2||0
7609666|NCT02465450|18734724|P6|STARTED|Treatment Period 2||23
7609667|NCT02465450|18734725|P5|STARTED|Treatment Period 2||28
7609668|NCT02465450|18734726|P4|STARTED|Treatment Period 2||30
7609669|NCT02465450|18734727|P3|STARTED|Treatment Period 2||0
7609670|NCT02465450|18734728|P2|STARTED|Treatment Period 2||0
7609671|NCT02465450|18734729|P1|STARTED|Treatment Period 2||0
7609672|NCT02465450|18734724|P6|NOT COMPLETED|Treatment Period 1||0
7609673|NCT02465450|18734725|P5|NOT COMPLETED|Treatment Period 1||0
7609674|NCT02465450|18734726|P4|NOT COMPLETED|Treatment Period 1||0
7609675|NCT02465450|18734727|P3|NOT COMPLETED|Treatment Period 1||1
7609676|NCT02465450|18734728|P2|NOT COMPLETED|Treatment Period 1||1
7609677|NCT02465450|18734729|P1|NOT COMPLETED|Treatment Period 1||2
7609678|NCT02465450|18734724|P6|COMPLETED|Treatment Period 1||0
7609679|NCT02465450|18734725|P5|COMPLETED|Treatment Period 1||0
7609680|NCT02465450|18734726|P4|COMPLETED|Treatment Period 1||0
7609681|NCT02465450|18734727|P3|COMPLETED|Treatment Period 1||34
7609682|NCT02465450|18734728|P2|COMPLETED|Treatment Period 1||23
7609683|NCT02465450|18734729|P1|COMPLETED|Treatment Period 1||24
7609684|NCT02465450|18734724|P6|STARTED|Treatment Period 1||0
7609685|NCT02465450|18734725|P5|STARTED|Treatment Period 1||0
7609686|NCT02465450|18734726|P4|STARTED|Treatment Period 1||0
7609687|NCT02465450|18734727|P3|STARTED|Treatment Period 1||35
7609688|NCT02465450|18734728|P2|STARTED|Treatment Period 1||24
7609689|NCT02465450|18734729|P1|STARTED|Treatment Period 1||26
7609690|NCT02465437|18734753|P4|NOT COMPLETED|Overall Study||1
7609691|NCT02465437|18734754|P3|NOT COMPLETED|Overall Study||1
7609692|NCT02465437|18734755|P2|NOT COMPLETED|Overall Study||1
7609693|NCT02465437|18734756|P1|NOT COMPLETED|Overall Study||1
7609694|NCT02465437|18734753|P4|COMPLETED|Overall Study||14
7609695|NCT02465437|18734754|P3|COMPLETED|Overall Study||8
7609696|NCT02465437|18734755|P2|COMPLETED|Overall Study||8
7609697|NCT02465437|18734756|P1|COMPLETED|Overall Study||8
7609698|NCT02465437|18734753|P4|STARTED|Overall Study||15
7609699|NCT02465437|18734754|P3|STARTED|Overall Study||9
7609700|NCT02465437|18734755|P2|STARTED|Overall Study||9
7609701|NCT02465437|18734756|P1|STARTED|Overall Study||9
7609702|NCT02465372|18734776|P2|NOT COMPLETED|Overall Study||97
7609703|NCT02465372|18734777|P1|NOT COMPLETED|Overall Study||122
7609704|NCT02465372|18734776|P2|COMPLETED|Overall Study||153
7609705|NCT02465372|18734777|P1|COMPLETED|Overall Study||227
7609706|NCT02465372|18734776|P2|STARTED|Overall Study||250
7609707|NCT02465372|18734777|P1|STARTED|Overall Study||349
7609708|NCT02465216|18734792|P5|NOT COMPLETED|Overall Study||3
7609709|NCT02465216|18734793|P4|NOT COMPLETED|Overall Study||2
7609710|NCT02465216|18734794|P3|NOT COMPLETED|Overall Study||1
7609711|NCT02465216|18734795|P2|NOT COMPLETED|Overall Study||0
7609712|NCT02465216|18734796|P1|NOT COMPLETED|Overall Study||3
7609713|NCT02465216|18734792|P5|COMPLETED|Overall Study||9
7609714|NCT02465216|18734793|P4|COMPLETED|Overall Study||12
7609715|NCT02465216|18734794|P3|COMPLETED|Overall Study||13
7609716|NCT02465216|18734795|P2|COMPLETED|Overall Study||5
7609717|NCT02465216|18734796|P1|COMPLETED|Overall Study||12
7609718|NCT02465216|18734792|P5|STARTED|Overall Study||12
7609719|NCT02465216|18734793|P4|STARTED|Overall Study||14
7609720|NCT02465216|18734794|P3|STARTED|Overall Study||14
7609721|NCT02465216|18734795|P2|STARTED|Overall Study||5
7609722|NCT02465216|18734796|P1|STARTED|Overall Study||15
7609723|NCT02465203|18734816|P3|NOT COMPLETED|Overall Study||13
7609724|NCT02465203|18734817|P2|NOT COMPLETED|Overall Study||36
7609725|NCT02465203|18734818|P1|NOT COMPLETED|Overall Study||56
7609726|NCT02465203|18734816|P3|COMPLETED|Overall Study||0
7609727|NCT02465203|18734817|P2|COMPLETED|Overall Study||0
7609728|NCT02465203|18734818|P1|COMPLETED|Overall Study||0
7609729|NCT02465203|18734816|P3|STARTED|Overall Study||13
7609730|NCT02465203|18734817|P2|STARTED|Overall Study||36
7609731|NCT02465203|18734818|P1|STARTED|Overall Study||56
7609732|NCT02465099|18734831|P2|NOT COMPLETED|Overall Study||0
7609733|NCT02465099|18734832|P1|NOT COMPLETED|Overall Study||0
7609734|NCT02465099|18734831|P2|COMPLETED|Overall Study||19
7609735|NCT02465099|18734832|P1|COMPLETED|Overall Study||45
7609736|NCT02465099|18734831|P2|STARTED|Overall Study||19
7609737|NCT02465099|18734832|P1|STARTED|Overall Study||45
7609738|NCT02465073|18734841|P3|NOT COMPLETED|Overall Study||1
7609739|NCT02465073|18734842|P2|NOT COMPLETED|Overall Study||1
7609740|NCT02465073|18734843|P1|NOT COMPLETED|Overall Study||2
7609741|NCT02465073|18734841|P3|COMPLETED|Overall Study||15
7609742|NCT02465073|18734842|P2|COMPLETED|Overall Study||15
7609743|NCT02465073|18734843|P1|COMPLETED|Overall Study||15
7609744|NCT02465073|18734841|P3|STARTED|Overall Study||16
7609745|NCT02465073|18734842|P2|STARTED|Overall Study||16
7609746|NCT02465073|18734843|P1|STARTED|Overall Study||17
7609747|NCT02464917|18734853|P2|NOT COMPLETED|Overall Study||0
7609748|NCT02464917|18734854|P1|NOT COMPLETED|Overall Study||0
7609749|NCT02464917|18734853|P2|COMPLETED|Overall Study||35
7609750|NCT02464917|18734854|P1|COMPLETED|Overall Study||35
7609751|NCT02464917|18734853|P2|STARTED|Overall Study||35
7609752|NCT02464917|18734854|P1|STARTED|Overall Study||35
7609753|NCT02464540|18734880|P2|NOT COMPLETED|Overall Study||0
7609754|NCT02464540|18734881|P1|NOT COMPLETED|Overall Study||0
7609755|NCT02464540|18734880|P2|COMPLETED|Overall Study||11
7609756|NCT02464540|18734881|P1|COMPLETED|Overall Study||11
7609757|NCT02464540|18734880|P2|STARTED|Overall Study||11
7609758|NCT02464540|18734881|P1|STARTED|Overall Study||11
7609759|NCT02464176|18734890|P3|NOT COMPLETED|Overall Study||0
7609760|NCT02464176|18734891|P2|NOT COMPLETED|Overall Study||0
7609761|NCT02464176|18734892|P1|NOT COMPLETED|Overall Study||0
7609762|NCT02464176|18734890|P3|COMPLETED|Overall Study||15
7609763|NCT02464176|18734891|P2|COMPLETED|Overall Study||50
7609764|NCT02464176|18734892|P1|COMPLETED|Overall Study||50
7609765|NCT02464176|18734890|P3|STARTED|Overall Study||15
7609766|NCT02464176|18734891|P2|STARTED|Overall Study||50
7609767|NCT02464176|18734892|P1|STARTED|Overall Study||50
7609768|NCT02464163|18734913|P4|NOT COMPLETED|Overall Study||5
7609769|NCT02464163|18734914|P3|NOT COMPLETED|Overall Study||5
7609770|NCT02464163|18734915|P2|NOT COMPLETED|Overall Study||8
7609771|NCT02464163|18734916|P1|NOT COMPLETED|Overall Study||3
7609772|NCT02464163|18734913|P4|COMPLETED|Overall Study||96
7609773|NCT02464163|18734914|P3|COMPLETED|Overall Study||97
7609774|NCT02464163|18734915|P2|COMPLETED|Overall Study||94
7609775|NCT02464163|18734916|P1|COMPLETED|Overall Study||99
7609776|NCT02464163|18734913|P4|STARTED|Overall Study||101
7609777|NCT02464163|18734914|P3|STARTED|Overall Study||102
7609778|NCT02464163|18734915|P2|STARTED|Overall Study||102
7609779|NCT02464163|18734916|P1|STARTED|Overall Study||102
7609780|NCT02464059|18734938|P1|NOT COMPLETED|Overall Study||6
7609781|NCT02464059|18734938|P1|COMPLETED|Overall Study||17
7609782|NCT02464059|18734938|P1|STARTED|Overall Study||23
7609783|NCT02464033|18734944|P1|NOT COMPLETED|Overall Study||0
7609784|NCT02464033|18734944|P1|COMPLETED|Overall Study||20
7609785|NCT02464033|18734944|P1|STARTED|Overall Study||20
7609786|NCT02463981|18734975|P2|NOT COMPLETED|Overall Study||2
7609787|NCT02463981|18734976|P1|NOT COMPLETED|Overall Study||3
7609788|NCT02463981|18734975|P2|COMPLETED|Overall Study||14
7609789|NCT02463981|18734976|P1|COMPLETED|Overall Study||18
7609790|NCT02463981|18734975|P2|STARTED|Overall Study||16
7609791|NCT02463981|18734976|P1|STARTED|Overall Study||21
7609792|NCT02463487|18734986|P2|NOT COMPLETED|Overall Study||10
7609793|NCT02463487|18734987|P1|NOT COMPLETED|Overall Study||10
7609794|NCT02463487|18734986|P2|COMPLETED|Overall Study||65
7609795|NCT02463487|18734987|P1|COMPLETED|Overall Study||65
7609796|NCT02463487|18734986|P2|STARTED|Overall Study||75
7609797|NCT02463487|18734987|P1|STARTED|Overall Study||75
7609798|NCT02463409|18734997|P1|NOT COMPLETED|Overall Study||2
7609799|NCT02463409|18734997|P1|COMPLETED|Overall Study||4
7609800|NCT02463409|18734997|P1|STARTED|Overall Study||6
7609801|NCT02463331|18735005|P2|NOT COMPLETED|Overall Study||6
7609802|NCT02463331|18735006|P1|NOT COMPLETED|Overall Study||16
7609803|NCT02463331|18735005|P2|COMPLETED|Overall Study||25
7609804|NCT02463331|18735006|P1|COMPLETED|Overall Study||10
7609805|NCT02463331|18735005|P2|STARTED|Overall Study||31
7609806|NCT02463331|18735006|P1|STARTED|Overall Study||26
7609807|NCT02463227|18735014|P1|NOT COMPLETED|Overall Study||0
7609808|NCT02463227|18735014|P1|COMPLETED|Overall Study||14
7609809|NCT02463227|18735014|P1|STARTED|Overall Study||14
7609810|NCT02463097|18735022|P1|NOT COMPLETED|Overall Study||1
7609811|NCT02463097|18735022|P1|COMPLETED|Overall Study||123
7609812|NCT02463097|18735022|P1|STARTED|Overall Study||124
7609813|NCT02463071|18735031|P3|NOT COMPLETED|Overall Study||6
7609814|NCT02463071|18735032|P2|NOT COMPLETED|Overall Study||16
7609815|NCT02463071|18735033|P1|NOT COMPLETED|Overall Study||12
7609816|NCT02463071|18735031|P3|COMPLETED|Overall Study||71
7609817|NCT02463071|18735032|P2|COMPLETED|Overall Study||138
7609818|NCT02463071|18735033|P1|COMPLETED|Overall Study||140
7609819|NCT02463071|18735031|P3|STARTED|Overall Study||77
7609820|NCT02463071|18735032|P2|STARTED|Overall Study||154
7609821|NCT02463071|18735033|P1|STARTED|Overall Study||152
7609822|NCT02463032|18735061|P2|NOT COMPLETED|Overall Study||64
7609823|NCT02463032|18735062|P1|NOT COMPLETED|Overall Study||71
7609824|NCT02463032|18735061|P2|COMPLETED|Overall Study||0
7609825|NCT02463032|18735062|P1|COMPLETED|Overall Study||1
7609826|NCT02463032|18735061|P2|STARTED|Overall Study||64
7609827|NCT02463032|18735062|P1|STARTED|Overall Study||72
7609828|NCT02462967|18735083|P3|NOT COMPLETED|Overall Study||3
7609829|NCT02462967|18735084|P2|NOT COMPLETED|Overall Study||6
7609830|NCT02462967|18735085|P1|NOT COMPLETED|Overall Study||2
7609831|NCT02462967|18735083|P3|COMPLETED|Overall Study||51
7609832|NCT02462967|18735084|P2|COMPLETED|Overall Study||48
7609833|NCT02462967|18735085|P1|COMPLETED|Overall Study||52
7609834|NCT02462967|18735083|P3|STARTED|Overall Study||54
7609835|NCT02462967|18735084|P2|STARTED|Overall Study||54
7609836|NCT02462967|18735085|P1|STARTED|Overall Study||54
7609837|NCT02462928|18735114|P3|NOT COMPLETED|Overall Study||57
7609838|NCT02462928|18735115|P2|NOT COMPLETED|Overall Study||92
7609839|NCT02462928|18735116|P1|NOT COMPLETED|Overall Study||90
7609840|NCT02462928|18735114|P3|COMPLETED|Overall Study||255
7609841|NCT02462928|18735115|P2|COMPLETED|Overall Study||221
7609842|NCT02462928|18735116|P1|COMPLETED|Overall Study||224
7609843|NCT02462928|18735114|P3|STARTED|Overall Study||312
7609844|NCT02462928|18735115|P2|STARTED|Overall Study||313
7609845|NCT02462928|18735116|P1|STARTED|Overall Study||314
7609846|NCT02462876|18735136|P1|NOT COMPLETED|Overall Study||33
7609847|NCT02462876|18735136|P1|COMPLETED|Overall Study||27
7609848|NCT02462876|18735136|P1|STARTED|Overall Study||60
7609849|NCT02462759|18735146|P3|NOT COMPLETED|Part 2: Open-Label Phase||0
7609850|NCT02462759|18735147|P2|NOT COMPLETED|Part 2: Open-Label Phase||0
7609851|NCT02462759|18735148|P1|NOT COMPLETED|Part 2: Open-Label Phase||0
7609852|NCT02462759|18735146|P3|COMPLETED|Part 2: Open-Label Phase||20
7609853|NCT02462759|18735147|P2|COMPLETED|Part 2: Open-Label Phase||0
7609854|NCT02462759|18735148|P1|COMPLETED|Part 2: Open-Label Phase||0
7609855|NCT02462759|18735146|P3|STARTED|Part 2: Open-Label Phase||20
7609856|NCT02462759|18735147|P2|STARTED|Part 2: Open-Label Phase||0
7609857|NCT02462759|18735148|P1|STARTED|Part 2: Open-Label Phase||0
7609858|NCT02462759|18735146|P3|NOT COMPLETED|Part 1: Double Blind||0
7609859|NCT02462759|18735147|P2|NOT COMPLETED|Part 1: Double Blind||0
7609860|NCT02462759|18735148|P1|NOT COMPLETED|Part 1: Double Blind||1
7609861|NCT02462759|18735146|P3|COMPLETED|Part 1: Double Blind||0
7609862|NCT02462759|18735147|P2|COMPLETED|Part 1: Double Blind||14
7609863|NCT02462759|18735148|P1|COMPLETED|Part 1: Double Blind||6
7609864|NCT02462759|18735146|P3|STARTED|Part 1: Double Blind||0
7609865|NCT02462759|18735147|P2|STARTED|Part 1: Double Blind||14
7609866|NCT02462759|18735148|P1|STARTED|Part 1: Double Blind||7
7609867|NCT02462720|18735196|P2|NOT COMPLETED|Part 2||1
7609868|NCT02462720|18735197|P1|NOT COMPLETED|Part 2||1
7609869|NCT02462720|18735196|P2|COMPLETED|Part 2||16
7609870|NCT02462720|18735197|P1|COMPLETED|Part 2||17
7609871|NCT02462720|18735196|P2|STARTED|Part 2||17
7609872|NCT02462720|18735197|P1|STARTED|Part 2||18
7609873|NCT02462720|18735196|P2|NOT COMPLETED|Part 1||0
7609874|NCT02462720|18735197|P1|NOT COMPLETED|Part 1||0
7609875|NCT02462720|18735196|P2|COMPLETED|Part 1||17
7609876|NCT02462720|18735197|P1|COMPLETED|Part 1||18
7609877|NCT02462720|18735196|P2|STARTED|Part 1||17
7609878|NCT02462720|18735197|P1|STARTED|Part 1||18
7609879|NCT02462486|18735210|P3|NOT COMPLETED|Overall Study||52
7609880|NCT02462486|18735211|P2|NOT COMPLETED|Overall Study||92
7609881|NCT02462486|18735212|P1|NOT COMPLETED|Overall Study||94
7609882|NCT02462486|18735210|P3|COMPLETED|Overall Study||266
7609883|NCT02462486|18735211|P2|COMPLETED|Overall Study||223
7609884|NCT02462486|18735212|P1|COMPLETED|Overall Study||222
7609885|NCT02462486|18735210|P3|STARTED|Overall Study||318
7609886|NCT02462486|18735211|P2|STARTED|Overall Study||315
7609887|NCT02462486|18735212|P1|STARTED|Overall Study||316
7609888|NCT02462473|18735232|P1|NOT COMPLETED|Overall Study||4
7609889|NCT02462473|18735232|P1|COMPLETED|Overall Study||5
7609890|NCT02462473|18735232|P1|STARTED|Overall Study||9
7609891|NCT02462382|18735245|P2|NOT COMPLETED|Overall Study||0
7609892|NCT02462382|18735246|P1|NOT COMPLETED|Overall Study||0
7609893|NCT02462382|18735245|P2|COMPLETED|Overall Study||27
7609894|NCT02462382|18735246|P1|COMPLETED|Overall Study||24
7609895|NCT02462382|18735245|P2|STARTED|Overall Study||27
7609896|NCT02462382|18735246|P1|STARTED|Overall Study||24
7609897|NCT02462291|18735260|P2|NOT COMPLETED|Overall Study||6
7609898|NCT02462291|18735261|P1|NOT COMPLETED|Overall Study||5
7609899|NCT02462291|18735260|P2|COMPLETED|Overall Study||75
7609900|NCT02462291|18735261|P1|COMPLETED|Overall Study||77
7609901|NCT02462291|18735260|P2|STARTED|Overall Study||81
7609902|NCT02462291|18735261|P1|STARTED|Overall Study||82
7609903|NCT02462148|18735302|P3|NOT COMPLETED|Overall Study||0
7609904|NCT02462148|18735303|P2|NOT COMPLETED|Overall Study||0
7609905|NCT02462148|18735304|P1|NOT COMPLETED|Overall Study||1
7609906|NCT02462148|18735302|P3|COMPLETED|Overall Study||12
7609907|NCT02462148|18735303|P2|COMPLETED|Overall Study||36
7609908|NCT02462148|18735304|P1|COMPLETED|Overall Study||36
7609909|NCT02462148|18735302|P3|STARTED|Overall Study||12
7609910|NCT02462148|18735303|P2|STARTED|Overall Study||36
7609911|NCT02462148|18735304|P1|STARTED|Overall Study||37
7609912|NCT02462122|18735329|P2|NOT COMPLETED|Overall Study||13
7609913|NCT02462122|18735330|P1|NOT COMPLETED|Overall Study||21
7609914|NCT02462122|18735329|P2|COMPLETED|Overall Study||61
7609915|NCT02462122|18735330|P1|COMPLETED|Overall Study||120
7609916|NCT02462122|18735329|P2|STARTED|Overall Study||74
7609917|NCT02462122|18735330|P1|STARTED|Overall Study||141
7609918|NCT02462083|18735338|P1|NOT COMPLETED|Overall Study||419
7609919|NCT02462083|18735338|P1|COMPLETED|Overall Study||136
7609920|NCT02462083|18735338|P1|Safety Population|Overall Study||550
7609921|NCT02462083|18735338|P1|STARTED|Overall Study||555
7609922|NCT02462070|18735344|P2|NOT COMPLETED|Overall Study||11
7609923|NCT02462070|18735345|P1|NOT COMPLETED|Overall Study||23
7609924|NCT02462070|18735344|P2|COMPLETED|Overall Study||57
7609925|NCT02462070|18735345|P1|COMPLETED|Overall Study||112
7609926|NCT02462070|18735344|P2|STARTED|Overall Study||68
7609927|NCT02462070|18735345|P1|STARTED|Overall Study||135
7609928|NCT02462057|18735358|P5|NOT COMPLETED|Overall Study||50
7609929|NCT02462057|18735359|P4|NOT COMPLETED|Overall Study||51
7609930|NCT02462057|18735360|P3|NOT COMPLETED|Overall Study||46
7609931|NCT02462057|18735361|P2|NOT COMPLETED|Overall Study||40
7609932|NCT02462057|18735362|P1|NOT COMPLETED|Overall Study||54
7609933|NCT02462057|18735358|P5|COMPLETED|Overall Study||708
7609934|NCT02462057|18735359|P4|COMPLETED|Overall Study||701
7609935|NCT02462057|18735360|P3|COMPLETED|Overall Study||766
7609936|NCT02462057|18735361|P2|COMPLETED|Overall Study||753
7609937|NCT02462057|18735362|P1|COMPLETED|Overall Study||737
7609938|NCT02462057|18735358|P5|STARTED|Overall Study||758
7609939|NCT02462057|18735359|P4|STARTED|Overall Study||752
7609940|NCT02462057|18735360|P3|STARTED|Overall Study||812
7609941|NCT02462057|18735361|P2|STARTED|Overall Study||793
7609942|NCT02462057|18735362|P1|STARTED|Overall Study||791
7609943|NCT02461992|18735374|P1|NOT COMPLETED|Overall Study||0
7609944|NCT02461992|18735374|P1|COMPLETED|Overall Study||13
7609945|NCT02461992|18735374|P1|STARTED|Overall Study||13
7609946|NCT02461966|18735394|P3|NOT COMPLETED|Overall Study||0
7609947|NCT02461966|18735395|P2|NOT COMPLETED|Overall Study||0
7609948|NCT02461966|18735396|P1|NOT COMPLETED|Overall Study||0
7609949|NCT02461966|18735394|P3|COMPLETED|Overall Study||60
7609950|NCT02461966|18735395|P2|COMPLETED|Overall Study||80
7609951|NCT02461966|18735396|P1|COMPLETED|Overall Study||160
7609952|NCT02461966|18735394|P3|STARTED|Overall Study||60
7609953|NCT02461966|18735395|P2|STARTED|Overall Study||80
7609954|NCT02461966|18735396|P1|STARTED|Overall Study||160
7609955|NCT02461771|18735407|P3|NOT COMPLETED|Overall Study||0
7609956|NCT02461771|18735408|P2|NOT COMPLETED|Overall Study||0
7609957|NCT02461771|18735409|P1|NOT COMPLETED|Overall Study||0
7609958|NCT02461771|18735407|P3|COMPLETED|Overall Study||7
7609959|NCT02461771|18735408|P2|COMPLETED|Overall Study||3
7609960|NCT02461771|18735409|P1|COMPLETED|Overall Study||3
7609961|NCT02461771|18735407|P3|STARTED|Overall Study||7
7609962|NCT02461771|18735408|P2|STARTED|Overall Study||3
7609963|NCT02461771|18735409|P1|STARTED|Overall Study||3
7609964|NCT02461758|18735448|P4|NOT COMPLETED|Overall Study||0
7609965|NCT02461758|18735449|P3|NOT COMPLETED|Overall Study||1
7609966|NCT02461758|18735450|P2|NOT COMPLETED|Overall Study||1
7609967|NCT02461758|18735451|P1|NOT COMPLETED|Overall Study||0
7609968|NCT02461758|18735448|P4|COMPLETED|Overall Study||15
7609969|NCT02461758|18735449|P3|COMPLETED|Overall Study||25
7609970|NCT02461758|18735450|P2|COMPLETED|Overall Study||19
7609971|NCT02461758|18735451|P1|COMPLETED|Overall Study||20
7609972|NCT02461758|18735448|P4|STARTED|Overall Study||15
7609973|NCT02461758|18735449|P3|STARTED|Overall Study||26
7609974|NCT02461758|18735450|P2|STARTED|Overall Study||20
7609975|NCT02461758|18735451|P1|STARTED|Overall Study||20
7609976|NCT02461693|18735477|P2|NOT COMPLETED|Overall Study||0
7609977|NCT02461693|18735478|P1|NOT COMPLETED|Overall Study||0
7609978|NCT02461693|18735477|P2|COMPLETED|Overall Study||102
7609979|NCT02461693|18735478|P1|COMPLETED|Overall Study||103
7609980|NCT02461693|18735477|P2|STARTED|Overall Study||102
7609981|NCT02461693|18735478|P1|STARTED|Overall Study||103
7609982|NCT02461628|18735492|P2|NOT COMPLETED|Overall Study||7
7609983|NCT02461628|18735493|P1|NOT COMPLETED|Overall Study||4
7609984|NCT02461628|18735492|P2|COMPLETED|Overall Study||3625
7609985|NCT02461628|18735493|P1|COMPLETED|Overall Study||3729
7609986|NCT02461628|18735492|P2|18 Month Survey|Overall Study||905
7609987|NCT02461628|18735493|P1|18 Month Survey|Overall Study||995
7609988|NCT02461628|18735492|P2|12 Month Survey|Overall Study||914
7609989|NCT02461628|18735493|P1|12 Month Survey|Overall Study||882
7609990|NCT02461628|18735492|P2|6 Month Survey|Overall Study||832
7609991|NCT02461628|18735493|P1|6 Month Survey|Overall Study||814
7609992|NCT02461628|18735492|P2|Baseline Survey|Overall Study||974
7609993|NCT02461628|18735493|P1|Baseline Survey|Overall Study||1038
7609994|NCT02461628|18735492|P2|STARTED|Overall Study||3632
7609995|NCT02461628|18735493|P1|STARTED|Overall Study||3733
7609996|NCT02461589|18735517|P10|NOT COMPLETED|Overall Study||5
7609997|NCT02461589|18735518|P9|NOT COMPLETED|Overall Study||6
7609998|NCT02461589|18735519|P8|NOT COMPLETED|Overall Study||5
7609999|NCT02461589|18735520|P7|NOT COMPLETED|Overall Study||6
7610000|NCT02461589|18735521|P6|NOT COMPLETED|Overall Study||3
7610001|NCT02461589|18735522|P5|NOT COMPLETED|Overall Study||2
7610002|NCT02461589|18735523|P4|NOT COMPLETED|Overall Study||5
7610003|NCT02461589|18735524|P3|NOT COMPLETED|Overall Study||5
7610004|NCT02461589|18735525|P2|NOT COMPLETED|Overall Study||2
7610005|NCT02461589|18735526|P1|NOT COMPLETED|Overall Study||6
7610006|NCT02461589|18735517|P10|COMPLETED|Overall Study||60
7610007|NCT02461589|18735518|P9|COMPLETED|Overall Study||123
7610008|NCT02461589|18735519|P8|COMPLETED|Overall Study||60
7610009|NCT02461589|18735520|P7|COMPLETED|Overall Study||58
7610010|NCT02461589|18735521|P6|COMPLETED|Overall Study||61
7610011|NCT02461589|18735522|P5|COMPLETED|Overall Study||62
7610012|NCT02461589|18735523|P4|COMPLETED|Overall Study||58
7610013|NCT02461589|18735524|P3|COMPLETED|Overall Study||60
7610014|NCT02461589|18735525|P2|COMPLETED|Overall Study||61
7610015|NCT02461589|18735526|P1|COMPLETED|Overall Study||58
7610016|NCT02461589|18735517|P10|Exposed|Overall Study||64
7610017|NCT02461589|18735518|P9|Exposed|Overall Study||129
7610018|NCT02461589|18735519|P8|Exposed|Overall Study||65
7610019|NCT02461589|18735520|P7|Exposed|Overall Study||64
7610020|NCT02461589|18735521|P6|Exposed|Overall Study||64
7610021|NCT02461589|18735522|P5|Exposed|Overall Study||64
7610022|NCT02461589|18735523|P4|Exposed|Overall Study||63
7610023|NCT02461589|18735524|P3|Exposed|Overall Study||65
7610024|NCT02461589|18735525|P2|Exposed|Overall Study||63
7610025|NCT02461589|18735526|P1|Exposed|Overall Study||64
7610026|NCT02461589|18735517|P10|STARTED|Overall Study||65
7610027|NCT02461589|18735518|P9|STARTED|Overall Study||129
7610028|NCT02461589|18735519|P8|STARTED|Overall Study||65
7610029|NCT02461589|18735520|P7|STARTED|Overall Study||64
7610030|NCT02461589|18735521|P6|STARTED|Overall Study||64
7610031|NCT02461589|18735522|P5|STARTED|Overall Study||64
7610032|NCT02461589|18735523|P4|STARTED|Overall Study||63
7610033|NCT02461589|18735524|P3|STARTED|Overall Study||65
7610034|NCT02461589|18735525|P2|STARTED|Overall Study||63
7610035|NCT02461589|18735526|P1|STARTED|Overall Study||64
7610036|NCT02461563|18735582|P4|NOT COMPLETED|Overall Study||0
7610037|NCT02461563|18735583|P3|NOT COMPLETED|Overall Study||0
7610038|NCT02461563|18735584|P2|NOT COMPLETED|Overall Study||0
7610039|NCT02461563|18735585|P1|NOT COMPLETED|Overall Study||0
7610040|NCT02461563|18735582|P4|COMPLETED|Overall Study||3
7610041|NCT02461563|18735583|P3|COMPLETED|Overall Study||3
7610042|NCT02461563|18735584|P2|COMPLETED|Overall Study||3
7610043|NCT02461563|18735585|P1|COMPLETED|Overall Study||3
7610044|NCT02461563|18735582|P4|STARTED|Overall Study||3
7610045|NCT02461563|18735583|P3|STARTED|Overall Study||3
7610046|NCT02461563|18735584|P2|STARTED|Overall Study||3
7610047|NCT02461563|18735585|P1|STARTED|Overall Study||3
7610048|NCT02461550|18735619|P1|NOT COMPLETED|Overall Study||0
7610049|NCT02461550|18735619|P1|COMPLETED|Overall Study||2
7610050|NCT02461550|18735619|P1|STARTED|Overall Study||2
7610051|NCT02461433|18735625|P2|NOT COMPLETED|Overall Study||0
7610052|NCT02461433|18735626|P1|NOT COMPLETED|Overall Study||0
7610053|NCT02461433|18735625|P2|COMPLETED|Overall Study||1
7610054|NCT02461433|18735626|P1|COMPLETED|Overall Study||1
7610055|NCT02461433|18735625|P2|STARTED|Overall Study||1
7610056|NCT02461433|18735626|P1|STARTED|Overall Study||1
7610057|NCT02461355|18735652|P1|NOT COMPLETED|Overall Study||0
7610058|NCT02461355|18735652|P1|COMPLETED|Overall Study||2
7610059|NCT02461355|18735652|P1|STARTED|Overall Study||2
7610060|NCT02461290|18735659|P1|NOT COMPLETED|Overall Study||10
7610061|NCT02461290|18735659|P1|COMPLETED|Overall Study||89
7610062|NCT02461290|18735659|P1|STARTED|Overall Study||99
7610063|NCT02461160|18735679|P13|NOT COMPLETED|Overall Study||0
7610064|NCT02461160|18735680|P12|NOT COMPLETED|Overall Study||0
7610065|NCT02461160|18735681|P11|NOT COMPLETED|Overall Study||0
7610066|NCT02461160|18735682|P10|NOT COMPLETED|Overall Study||0
7610067|NCT02461160|18735683|P9|NOT COMPLETED|Overall Study||0
7610068|NCT02461160|18735684|P8|NOT COMPLETED|Overall Study||1
7610069|NCT02461160|18735685|P7|NOT COMPLETED|Overall Study||0
7610070|NCT02461160|18735686|P6|NOT COMPLETED|Overall Study||0
7610071|NCT02461160|18735687|P5|NOT COMPLETED|Overall Study||0
7610072|NCT02461160|18735688|P4|NOT COMPLETED|Overall Study||0
7610073|NCT02461160|18735689|P3|NOT COMPLETED|Overall Study||0
7610074|NCT02461160|18735690|P2|NOT COMPLETED|Overall Study||0
7610075|NCT02461160|18735691|P1|NOT COMPLETED|Overall Study||0
7610076|NCT02461160|18735679|P13|COMPLETED|Overall Study||8
7610077|NCT02461160|18735680|P12|COMPLETED|Overall Study||4
7610078|NCT02461160|18735681|P11|COMPLETED|Overall Study||4
7610079|NCT02461160|18735682|P10|COMPLETED|Overall Study||4
7610080|NCT02461160|18735683|P9|COMPLETED|Overall Study||12
7610081|NCT02461160|18735684|P8|COMPLETED|Overall Study||5
7610082|NCT02461160|18735685|P7|COMPLETED|Overall Study||6
7610083|NCT02461160|18735686|P6|COMPLETED|Overall Study||6
7610084|NCT02461160|18735687|P5|COMPLETED|Overall Study||6
7610085|NCT02461160|18735688|P4|COMPLETED|Overall Study||12
7610086|NCT02461160|18735689|P3|COMPLETED|Overall Study||6
7610087|NCT02461160|18735690|P2|COMPLETED|Overall Study||6
7610088|NCT02461160|18735691|P1|COMPLETED|Overall Study||8
7610089|NCT02461160|18735679|P13|STARTED|Overall Study||8
7610090|NCT02461160|18735680|P12|STARTED|Overall Study||4
7610091|NCT02461160|18735681|P11|STARTED|Overall Study||4
7610092|NCT02461160|18735682|P10|STARTED|Overall Study||4
7610093|NCT02461160|18735683|P9|STARTED|Overall Study||12
7610094|NCT02461160|18735684|P8|STARTED|Overall Study||6
7610095|NCT02461160|18735685|P7|STARTED|Overall Study||6
7610096|NCT02461160|18735686|P6|STARTED|Overall Study||6
7610097|NCT02461160|18735687|P5|STARTED|Overall Study||6
7610098|NCT02461160|18735688|P4|STARTED|Overall Study||12
7610099|NCT02461160|18735689|P3|STARTED|Overall Study||6
7610100|NCT02461160|18735690|P2|STARTED|Overall Study||6
7610101|NCT02461160|18735691|P1|STARTED|Overall Study||8
7610102|NCT02461134|18735902|P1|NOT COMPLETED|Overall Study||1
7610103|NCT02461134|18735902|P1|COMPLETED|Overall Study||0
7610104|NCT02461134|18735902|P1|STARTED|Overall Study||1
7610105|NCT02460991|18735910|P2|NOT COMPLETED|Overall Study||2
7610106|NCT02460991|18735911|P1|NOT COMPLETED|Overall Study||0
7610107|NCT02460991|18735910|P2|COMPLETED|Overall Study||0
7610108|NCT02460991|18735911|P1|COMPLETED|Overall Study||0
7610109|NCT02460991|18735910|P2|STARTED|Overall Study||2
7610110|NCT02460991|18735911|P1|STARTED|Overall Study||0
7610111|NCT02460978|18735928|P3|NOT COMPLETED|Overall Study||33
7610112|NCT02460978|18735929|P2|NOT COMPLETED|Overall Study||25
7610113|NCT02460978|18735930|P1|NOT COMPLETED|Overall Study||27
7610114|NCT02460978|18735928|P3|COMPLETED|Overall Study||239
7610115|NCT02460978|18735929|P2|COMPLETED|Overall Study||245
7610116|NCT02460978|18735930|P1|COMPLETED|Overall Study||244
7610117|NCT02460978|18735928|P3|STARTED|Overall Study||272
7610118|NCT02460978|18735929|P2|STARTED|Overall Study||270
7610119|NCT02460978|18735930|P1|STARTED|Overall Study||271
7610120|NCT02460822|18735956|P1|NOT COMPLETED|Overall Study||1
7610121|NCT02460822|18735956|P1|COMPLETED|Overall Study||15
7610122|NCT02460822|18735956|P1|STARTED|Overall Study||16
7610123|NCT02460679|18735965|P1|NOT COMPLETED|Overall Study||5
7610124|NCT02460679|18735965|P1|COMPLETED|Overall Study||14
7610125|NCT02460679|18735965|P1|Received at Least 1 Dose of Study Drug|Overall Study||19
7610126|NCT02460679|18735965|P1|STARTED|Overall Study||19
7610127|NCT02460575|18735990|P2|NOT COMPLETED|Overall Study||0
7610128|NCT02460575|18735991|P1|NOT COMPLETED|Overall Study||1
7610129|NCT02460575|18735990|P2|COMPLETED|Overall Study||20
7610130|NCT02460575|18735991|P1|COMPLETED|Overall Study||39
7610131|NCT02460575|18735990|P2|STARTED|Overall Study||20
7610132|NCT02460575|18735991|P1|STARTED|Overall Study||40
7610133|NCT02460562|18736001|P2|NOT COMPLETED|Overall Study||16
7610134|NCT02460562|18736002|P1|NOT COMPLETED|Overall Study||15
7610135|NCT02460562|18736001|P2|COMPLETED|Overall Study||60
7610136|NCT02460562|18736002|P1|COMPLETED|Overall Study||59
7610137|NCT02460562|18736001|P2|STARTED|Overall Study||76
7610138|NCT02460562|18736002|P1|STARTED|Overall Study||74
7610139|NCT02460458|18736010|P1|NOT COMPLETED|Second Prospective Phase||152
7610140|NCT02460458|18736010|P1|COMPLETED|Second Prospective Phase|Information not available yet, anticipated date is december 2022|0
7610141|NCT02460458|18736010|P1|STARTED|Second Prospective Phase||152
7610142|NCT02460458|18736010|P1|NOT COMPLETED|Confirmation of Clinical Phase Data||9
7610143|NCT02460458|18736010|P1|COMPLETED|Confirmation of Clinical Phase Data||152
7610144|NCT02460458|18736010|P1|STARTED|Confirmation of Clinical Phase Data||161
7610145|NCT02460458|18736010|P1|NOT COMPLETED|First Prospective Phase||16
7610146|NCT02460458|18736010|P1|COMPLETED|First Prospective Phase||161
7610147|NCT02460458|18736010|P1|STARTED|First Prospective Phase||177
7610148|NCT02460458|18736010|P1|NOT COMPLETED|Confirmatory Phase||88
7610149|NCT02460458|18736010|P1|COMPLETED|Confirmatory Phase||177
7610150|NCT02460458|18736010|P1|STARTED|Confirmatory Phase||265
7610151|NCT02460458|18736010|P1|NOT COMPLETED|Retrospective Phase||0
7610152|NCT02460458|18736010|P1|COMPLETED|Retrospective Phase||265
7610153|NCT02460458|18736010|P1|STARTED|Retrospective Phase||265
7610154|NCT02460380|18736026|P2|NOT COMPLETED|Overall Study||5
7610155|NCT02460380|18736027|P1|NOT COMPLETED|Overall Study||10
7610156|NCT02460380|18736026|P2|COMPLETED|Overall Study||18
7610157|NCT02460380|18736027|P1|COMPLETED|Overall Study||35
7610158|NCT02460380|18736026|P2|STARTED|Overall Study||23
7610159|NCT02460380|18736027|P1|STARTED|Overall Study||45
7610160|NCT02460263|18736047|P1|NOT COMPLETED|In-Home Period||0
7610161|NCT02460263|18736047|P1|COMPLETED|In-Home Period||28
7610162|NCT02460263|18736047|P1|STARTED|In-Home Period||28
7610163|NCT02460263|18736047|P1|NOT COMPLETED|Transition Period||2
7610164|NCT02460263|18736047|P1|COMPLETED|Transition Period||28
7610165|NCT02460263|18736047|P1|STARTED|Transition Period||30
7610166|NCT02460263|18736047|P1|NOT COMPLETED|In-Center Period||0
7610167|NCT02460263|18736047|P1|COMPLETED|In-Center Period||30
7610168|NCT02460263|18736047|P1|STARTED|In-Center Period||30
7610169|NCT02460198|18736060|P2|NOT COMPLETED|Overall Study||63
7610170|NCT02460198|18736061|P1|NOT COMPLETED|Overall Study||61
7610171|NCT02460198|18736060|P2|COMPLETED|Overall Study||0
7610172|NCT02460198|18736061|P1|COMPLETED|Overall Study||0
7610173|NCT02460198|18736060|P2|STARTED|Overall Study||63
7610174|NCT02460198|18736061|P1|STARTED|Overall Study||61
7610175|NCT02460172|18736079|P1|NOT COMPLETED|Overall Study||0
7610176|NCT02460172|18736079|P1|COMPLETED|Overall Study||25
7610177|NCT02460172|18736079|P1|STARTED|Overall Study||25
7610178|NCT02460159|18736095|P2|NOT COMPLETED|Overall Study||1
7610179|NCT02460159|18736096|P1|NOT COMPLETED|Overall Study||6
7610180|NCT02460159|18736095|P2|COMPLETED|Overall Study||17
7610181|NCT02460159|18736096|P1|COMPLETED|Overall Study||111
7610182|NCT02460159|18736095|P2|STARTED|Overall Study||18
7610183|NCT02460159|18736096|P1|STARTED|Overall Study||117
7610184|NCT02459951|18736124|P1|NOT COMPLETED|Overall Study||1
7610185|NCT02459951|18736124|P1|COMPLETED|Overall Study||9
7610186|NCT02459951|18736124|P1|STARTED|Overall Study||10
7610187|NCT02459899|18736135|P4|NOT COMPLETED|Overall Study||2
7610188|NCT02459899|18736136|P3|NOT COMPLETED|Overall Study||0
7610189|NCT02459899|18736137|P2|NOT COMPLETED|Overall Study||6
7610190|NCT02459899|18736138|P1|NOT COMPLETED|Overall Study||3
7610191|NCT02459899|18736135|P4|COMPLETED|Overall Study||33
7610192|NCT02459899|18736136|P3|COMPLETED|Overall Study||35
7610193|NCT02459899|18736137|P2|COMPLETED|Overall Study||29
7610194|NCT02459899|18736138|P1|COMPLETED|Overall Study||33
7610195|NCT02459899|18736135|P4|STARTED|Overall Study||35
7610196|NCT02459899|18736136|P3|STARTED|Overall Study||35
7610197|NCT02459899|18736137|P2|STARTED|Overall Study||35
7610198|NCT02459899|18736138|P1|STARTED|Overall Study||36
7610199|NCT02459665|18736172|P4|NOT COMPLETED|Overall Study||2
7610200|NCT02459665|18736173|P3|NOT COMPLETED|Overall Study||1
7610201|NCT02459665|18736174|P2|NOT COMPLETED|Overall Study||1
7610202|NCT02459665|18736175|P1|NOT COMPLETED|Overall Study||0
7610203|NCT02459665|18736172|P4|COMPLETED|Overall Study||15
7610204|NCT02459665|18736173|P3|COMPLETED|Overall Study||16
7610205|NCT02459665|18736174|P2|COMPLETED|Overall Study||16
7610206|NCT02459665|18736175|P1|COMPLETED|Overall Study||17
7610207|NCT02459665|18736172|P4|Month 6 Visit|Overall Study||15
7610208|NCT02459665|18736173|P3|Month 6 Visit|Overall Study||16
7610209|NCT02459665|18736174|P2|Month 6 Visit|Overall Study||16
7610210|NCT02459665|18736175|P1|Month 6 Visit|Overall Study||17
7610211|NCT02459665|18736172|P4|Month 2 Visit|Overall Study||16
7610212|NCT02459665|18736173|P3|Month 2 Visit|Overall Study||17
7610213|NCT02459665|18736174|P2|Month 2 Visit|Overall Study||16
7610214|NCT02459665|18736175|P1|Month 2 Visit|Overall Study||17
7610215|NCT02459665|18736172|P4|Month 1 Visit|Overall Study||16
7610216|NCT02459665|18736173|P3|Month 1 Visit|Overall Study||17
7610217|NCT02459665|18736174|P2|Month 1 Visit|Overall Study||17
7610218|NCT02459665|18736175|P1|Month 1 Visit|Overall Study||17
7610219|NCT02459665|18736172|P4|Day 7 Visit|Overall Study||16
7610220|NCT02459665|18736173|P3|Day 7 Visit|Overall Study||17
7610221|NCT02459665|18736174|P2|Day 7 Visit|Overall Study||17
7610222|NCT02459665|18736175|P1|Day 7 Visit|Overall Study||17
7610223|NCT02459665|18736172|P4|STARTED|Overall Study||17
7610224|NCT02459665|18736173|P3|STARTED|Overall Study||17
7610225|NCT02459665|18736174|P2|STARTED|Overall Study||17
7610226|NCT02459665|18736175|P1|STARTED|Overall Study||17
7610227|NCT02459418|18736206|P2|NOT COMPLETED|Overall Study||6
7610228|NCT02459418|18736207|P1|NOT COMPLETED|Overall Study||8
7610229|NCT02459418|18736206|P2|COMPLETED|Overall Study||15
7610230|NCT02459418|18736207|P1|COMPLETED|Overall Study||13
7610231|NCT02459418|18736206|P2|Received Second Treatment|Overall Study||15
7610232|NCT02459418|18736207|P1|Received Second Treatment|Overall Study||13
7610233|NCT02459418|18736206|P2|Received First Treatment|Overall Study||21
7610234|NCT02459418|18736207|P1|Received First Treatment|Overall Study||21
7610235|NCT02459418|18736206|P2|STARTED|Overall Study||21
7610236|NCT02459418|18736207|P1|STARTED|Overall Study||21
7610237|NCT02459275|18736229|P2|NOT COMPLETED|Overall Study||0
7610238|NCT02459275|18736230|P1|NOT COMPLETED|Overall Study||0
7610239|NCT02459275|18736229|P2|COMPLETED|Overall Study||17
7610240|NCT02459275|18736230|P1|COMPLETED|Overall Study||19
7610241|NCT02459275|18736229|P2|STARTED|Overall Study||17
7610242|NCT02459275|18736230|P1|STARTED|Overall Study||19
7610243|NCT02459197|18736248|P2|NOT COMPLETED|Overall Study||1
7610244|NCT02459197|18736249|P1|NOT COMPLETED|Overall Study||0
7610245|NCT02459197|18736248|P2|COMPLETED|Overall Study||55
7610246|NCT02459197|18736249|P1|COMPLETED|Overall Study||58
7610247|NCT02459197|18736248|P2|STARTED|Overall Study||56
7610248|NCT02459197|18736249|P1|STARTED|Overall Study||58
7610249|NCT02459119|18736263|P1|NOT COMPLETED|Overall Study||0
7610250|NCT02459119|18736263|P1|COMPLETED|Overall Study||17
7610251|NCT02459119|18736263|P1|STARTED|Overall Study||17
7610252|NCT02459093|18736273|P2|NOT COMPLETED|Overall Study||18
7610253|NCT02459093|18736274|P1|NOT COMPLETED|Overall Study||12
7610254|NCT02459093|18736273|P2|COMPLETED|Overall Study||257
7610255|NCT02459093|18736274|P1|COMPLETED|Overall Study||263
7610256|NCT02459093|18736273|P2|STARTED|Overall Study||275
7610257|NCT02459093|18736274|P1|STARTED|Overall Study||275
7610258|NCT02459080|18736285|P3|NOT COMPLETED|Overall Study||58
7610259|NCT02459080|18736286|P2|NOT COMPLETED|Overall Study||40
7610260|NCT02459080|18736287|P1|NOT COMPLETED|Overall Study||44
7610261|NCT02459080|18736285|P3|COMPLETED|Overall Study||151
7610262|NCT02459080|18736286|P2|COMPLETED|Overall Study||158
7610263|NCT02459080|18736287|P1|COMPLETED|Overall Study||168
7610264|NCT02459080|18736285|P3|STARTED|Overall Study||209
7610265|NCT02459080|18736286|P2|STARTED|Overall Study||198
7610266|NCT02459080|18736287|P1|STARTED|Overall Study||212
7610267|NCT02458768|18736312|P2|NOT COMPLETED|Overall Study||5
7610268|NCT02458768|18736313|P1|NOT COMPLETED|Overall Study||7
7610269|NCT02458768|18736312|P2|COMPLETED|Overall Study||50
7610270|NCT02458768|18736313|P1|COMPLETED|Overall Study||50
7610271|NCT02458768|18736312|P2|STARTED|Overall Study||55
7610272|NCT02458768|18736313|P1|STARTED|Overall Study||57
7610273|NCT02458690|18736321|P2|NOT COMPLETED|Overall Study||9
7610274|NCT02458690|18736322|P1|NOT COMPLETED|Overall Study||8
7610275|NCT02458690|18736321|P2|COMPLETED|Overall Study||100
7610276|NCT02458690|18736322|P1|COMPLETED|Overall Study||99
7610277|NCT02458690|18736321|P2|STARTED|Overall Study||109
7610278|NCT02458690|18736322|P1|STARTED|Overall Study||107
7610279|NCT02458469|18736328|P6|NOT COMPLETED|Third Intervention (2 Weeks)||0
7610280|NCT02458469|18736329|P5|NOT COMPLETED|Third Intervention (2 Weeks)||0
7610281|NCT02458469|18736330|P4|NOT COMPLETED|Third Intervention (2 Weeks)||0
7610282|NCT02458469|18736331|P3|NOT COMPLETED|Third Intervention (2 Weeks)||0
7610283|NCT02458469|18736332|P2|NOT COMPLETED|Third Intervention (2 Weeks)||0
7610284|NCT02458469|18736333|P1|NOT COMPLETED|Third Intervention (2 Weeks)||0
7610285|NCT02458469|18736328|P6|COMPLETED|Third Intervention (2 Weeks)||1
7610286|NCT02458469|18736329|P5|COMPLETED|Third Intervention (2 Weeks)||1
7610287|NCT02458469|18736330|P4|COMPLETED|Third Intervention (2 Weeks)||0
7610288|NCT02458469|18736331|P3|COMPLETED|Third Intervention (2 Weeks)||2
7610289|NCT02458469|18736332|P2|COMPLETED|Third Intervention (2 Weeks)||2
7610290|NCT02458469|18736333|P1|COMPLETED|Third Intervention (2 Weeks)||2
7610291|NCT02458469|18736328|P6|STARTED|Third Intervention (2 Weeks)||1
7610292|NCT02458469|18736329|P5|STARTED|Third Intervention (2 Weeks)||1
7610293|NCT02458469|18736330|P4|STARTED|Third Intervention (2 Weeks)||0
7610294|NCT02458469|18736331|P3|STARTED|Third Intervention (2 Weeks)||2
7610295|NCT02458469|18736332|P2|STARTED|Third Intervention (2 Weeks)||2
7610296|NCT02458469|18736333|P1|STARTED|Third Intervention (2 Weeks)||2
7610297|NCT02458469|18736328|P6|NOT COMPLETED|Second Washout (2 Weeks)||0
7610298|NCT02458469|18736329|P5|NOT COMPLETED|Second Washout (2 Weeks)||0
7610299|NCT02458469|18736330|P4|NOT COMPLETED|Second Washout (2 Weeks)||0
7610300|NCT02458469|18736331|P3|NOT COMPLETED|Second Washout (2 Weeks)||0
7610301|NCT02458469|18736332|P2|NOT COMPLETED|Second Washout (2 Weeks)||0
7610302|NCT02458469|18736333|P1|NOT COMPLETED|Second Washout (2 Weeks)||0
7610303|NCT02458469|18736328|P6|COMPLETED|Second Washout (2 Weeks)||1
7610304|NCT02458469|18736329|P5|COMPLETED|Second Washout (2 Weeks)||1
7610305|NCT02458469|18736330|P4|COMPLETED|Second Washout (2 Weeks)||0
7610306|NCT02458469|18736331|P3|COMPLETED|Second Washout (2 Weeks)||2
7610307|NCT02458469|18736332|P2|COMPLETED|Second Washout (2 Weeks)||2
7610308|NCT02458469|18736333|P1|COMPLETED|Second Washout (2 Weeks)||2
7610309|NCT02458469|18736328|P6|STARTED|Second Washout (2 Weeks)||1
7610310|NCT02458469|18736329|P5|STARTED|Second Washout (2 Weeks)||1
7610311|NCT02458469|18736330|P4|STARTED|Second Washout (2 Weeks)||0
7610312|NCT02458469|18736331|P3|STARTED|Second Washout (2 Weeks)||2
7610313|NCT02458469|18736332|P2|STARTED|Second Washout (2 Weeks)||2
7610314|NCT02458469|18736333|P1|STARTED|Second Washout (2 Weeks)||2
7610315|NCT02458469|18736328|P6|NOT COMPLETED|Second Intervention (2 Weeks)||1
7610316|NCT02458469|18736329|P5|NOT COMPLETED|Second Intervention (2 Weeks)||0
7610317|NCT02458469|18736330|P4|NOT COMPLETED|Second Intervention (2 Weeks)||0
7610318|NCT02458469|18736331|P3|NOT COMPLETED|Second Intervention (2 Weeks)||0
7610319|NCT02458469|18736332|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
7610320|NCT02458469|18736333|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
7610321|NCT02458469|18736328|P6|COMPLETED|Second Intervention (2 Weeks)||1
7610322|NCT02458469|18736329|P5|COMPLETED|Second Intervention (2 Weeks)||1
7610323|NCT02458469|18736330|P4|COMPLETED|Second Intervention (2 Weeks)||0
7610324|NCT02458469|18736331|P3|COMPLETED|Second Intervention (2 Weeks)||2
7610325|NCT02458469|18736332|P2|COMPLETED|Second Intervention (2 Weeks)||2
7610326|NCT02458469|18736333|P1|COMPLETED|Second Intervention (2 Weeks)||2
7610327|NCT02458469|18736328|P6|STARTED|Second Intervention (2 Weeks)||2
7610328|NCT02458469|18736329|P5|STARTED|Second Intervention (2 Weeks)||1
7610329|NCT02458469|18736330|P4|STARTED|Second Intervention (2 Weeks)||0
7610330|NCT02458469|18736331|P3|STARTED|Second Intervention (2 Weeks)||2
7610331|NCT02458469|18736332|P2|STARTED|Second Intervention (2 Weeks)||2
7610332|NCT02458469|18736333|P1|STARTED|Second Intervention (2 Weeks)||2
7610333|NCT02458469|18736328|P6|NOT COMPLETED|First Washout (2 Weeks)||0
7610334|NCT02458469|18736329|P5|NOT COMPLETED|First Washout (2 Weeks)||0
7610335|NCT02458469|18736330|P4|NOT COMPLETED|First Washout (2 Weeks)||0
7610336|NCT02458469|18736331|P3|NOT COMPLETED|First Washout (2 Weeks)||0
7610337|NCT02458469|18736332|P2|NOT COMPLETED|First Washout (2 Weeks)||0
7610338|NCT02458469|18736333|P1|NOT COMPLETED|First Washout (2 Weeks)||0
7610339|NCT02458469|18736328|P6|COMPLETED|First Washout (2 Weeks)||2
7610340|NCT02458469|18736329|P5|COMPLETED|First Washout (2 Weeks)||1
7610341|NCT02458469|18736330|P4|COMPLETED|First Washout (2 Weeks)||0
7610342|NCT02458469|18736331|P3|COMPLETED|First Washout (2 Weeks)||2
7610343|NCT02458469|18736332|P2|COMPLETED|First Washout (2 Weeks)||2
7610344|NCT02458469|18736333|P1|COMPLETED|First Washout (2 Weeks)||2
7610345|NCT02458469|18736328|P6|STARTED|First Washout (2 Weeks)||2
7610346|NCT02458469|18736329|P5|STARTED|First Washout (2 Weeks)||1
7610347|NCT02458469|18736330|P4|STARTED|First Washout (2 Weeks)||0
7610348|NCT02458469|18736331|P3|STARTED|First Washout (2 Weeks)||2
7610349|NCT02458469|18736332|P2|STARTED|First Washout (2 Weeks)||2
7610350|NCT02458469|18736333|P1|STARTED|First Washout (2 Weeks)||2
7610351|NCT02458469|18736328|P6|NOT COMPLETED|First Intervention (2 Weeks)||0
7610352|NCT02458469|18736329|P5|NOT COMPLETED|First Intervention (2 Weeks)||0
7610353|NCT02458469|18736330|P4|NOT COMPLETED|First Intervention (2 Weeks)||0
7610354|NCT02458469|18736331|P3|NOT COMPLETED|First Intervention (2 Weeks)||1
7610355|NCT02458469|18736332|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
7610356|NCT02458469|18736333|P1|NOT COMPLETED|First Intervention (2 Weeks)||1
7610357|NCT02458469|18736328|P6|COMPLETED|First Intervention (2 Weeks)||2
7610358|NCT02458469|18736329|P5|COMPLETED|First Intervention (2 Weeks)||1
7610359|NCT02458469|18736330|P4|COMPLETED|First Intervention (2 Weeks)||0
7610360|NCT02458469|18736331|P3|COMPLETED|First Intervention (2 Weeks)||2
7610361|NCT02458469|18736332|P2|COMPLETED|First Intervention (2 Weeks)||2
7610362|NCT02458469|18736333|P1|COMPLETED|First Intervention (2 Weeks)||2
7610363|NCT02458469|18736328|P6|STARTED|First Intervention (2 Weeks)||2
7610364|NCT02458469|18736329|P5|STARTED|First Intervention (2 Weeks)||1
7610365|NCT02458469|18736330|P4|STARTED|First Intervention (2 Weeks)||0
7610366|NCT02458469|18736331|P3|STARTED|First Intervention (2 Weeks)||3
7610367|NCT02458469|18736332|P2|STARTED|First Intervention (2 Weeks)||2
7610368|NCT02458469|18736333|P1|STARTED|First Intervention (2 Weeks)||3
7610369|NCT02458365|18736346|P2|NOT COMPLETED|Overall Study||294
7610370|NCT02458365|18736347|P1|NOT COMPLETED|Overall Study||277
7610371|NCT02458365|18736346|P2|COMPLETED|Overall Study||1607
7610372|NCT02458365|18736347|P1|COMPLETED|Overall Study||1723
7610373|NCT02458365|18736346|P2|STARTED|Overall Study||1901
7610374|NCT02458365|18736347|P1|STARTED|Overall Study||2000
7610375|NCT02458352|18736367|P1|NOT COMPLETED|Overall Study||0
7610376|NCT02458352|18736367|P1|COMPLETED|Overall Study||105
7610377|NCT02458352|18736367|P1|STARTED|Overall Study||105
7610378|NCT02458287|18736379|P4|NOT COMPLETED|Overall Study||3
7610379|NCT02458287|18736380|P3|NOT COMPLETED|Overall Study||3
7610380|NCT02458287|18736381|P2|NOT COMPLETED|Overall Study||4
7610381|NCT02458287|18736382|P1|NOT COMPLETED|Overall Study||0
7610382|NCT02458287|18736379|P4|COMPLETED|Overall Study||97
7610383|NCT02458287|18736380|P3|COMPLETED|Overall Study||46
7610384|NCT02458287|18736381|P2|COMPLETED|Overall Study||96
7610385|NCT02458287|18736382|P1|COMPLETED|Overall Study||50
7610386|NCT02458287|18736379|P4|STARTED|Overall Study||100
7610387|NCT02458287|18736380|P3|STARTED|Overall Study||49
7610388|NCT02458287|18736381|P2|STARTED|Overall Study||100
7610389|NCT02458287|18736382|P1|STARTED|Overall Study||50
7610390|NCT02458235|18736427|P1|NOT COMPLETED|Overall Study||0
7610391|NCT02458235|18736427|P1|COMPLETED|Overall Study||17
7610392|NCT02458235|18736427|P1|STARTED|Overall Study||17
7610393|NCT02458092|18736440|P2|NOT COMPLETED|Overall Study||0
7610394|NCT02458092|18736441|P1|NOT COMPLETED|Overall Study||1
7610395|NCT02458092|18736440|P2|COMPLETED|Overall Study||10
7610396|NCT02458092|18736441|P1|COMPLETED|Overall Study||19
7610397|NCT02458092|18736440|P2|STARTED|Overall Study||10
7610398|NCT02458092|18736441|P1|STARTED|Overall Study||20
7610399|NCT02457910|18736459|P6|NOT COMPLETED|Overall Study||11
7610400|NCT02457910|18736460|P5|NOT COMPLETED|Overall Study||5
7610401|NCT02457910|18736461|P4|NOT COMPLETED|Overall Study||2
7610402|NCT02457910|18736462|P3|NOT COMPLETED|Overall Study||3
7610403|NCT02457910|18736463|P2|NOT COMPLETED|Overall Study||5
7610404|NCT02457910|18736464|P1|NOT COMPLETED|Overall Study||3
7610405|NCT02457910|18736459|P6|COMPLETED|Overall Study||1
7610406|NCT02457910|18736460|P5|COMPLETED|Overall Study||0
7610407|NCT02457910|18736461|P4|COMPLETED|Overall Study||0
7610408|NCT02457910|18736462|P3|COMPLETED|Overall Study||0
7610409|NCT02457910|18736463|P2|COMPLETED|Overall Study||0
7610410|NCT02457910|18736464|P1|COMPLETED|Overall Study||0
7610411|NCT02457910|18736459|P6|STARTED|Overall Study||12
7610412|NCT02457910|18736460|P5|STARTED|Overall Study|3 participants crossed over to enzalutamide and taselisib|5
7610413|NCT02457910|18736461|P4|STARTED|Overall Study||2
7610414|NCT02457910|18736462|P3|STARTED|Overall Study||3
7610415|NCT02457910|18736463|P2|STARTED|Overall Study|In dose escalation, two patients receiving the 4 mg dose of taselisib were removed for toxicities|5
7610416|NCT02457910|18736464|P1|STARTED|Overall Study||3
7610417|NCT02457897|18736481|P1|NOT COMPLETED|Part 2 Long-term (6 Month) Study||0
7610418|NCT02457897|18736481|P1|COMPLETED|Part 2 Long-term (6 Month) Study||5
7610419|NCT02457897|18736481|P1|STARTED|Part 2 Long-term (6 Month) Study|Two patients were not eligible for Part 2 study because their HbA1c was less than 7.|5
7610420|NCT02457897|18736481|P1|NOT COMPLETED|Part 1 Short-term (2 Weeks) Study||0
7610421|NCT02457897|18736481|P1|COMPLETED|Part 1 Short-term (2 Weeks) Study||7
7610422|NCT02457897|18736481|P1|STARTED|Part 1 Short-term (2 Weeks) Study||7
7610423|NCT02457819|18736488|P1|NOT COMPLETED|Overall Study||99
7610424|NCT02457819|18736488|P1|COMPLETED|Overall Study||138
7610425|NCT02457819|18736488|P1|Safety Population|Overall Study||236
7610426|NCT02457819|18736488|P1|STARTED|Overall Study||237
7610427|NCT02457793|18736500|P6|NOT COMPLETED|Overall Study||6
7610428|NCT02457793|18736501|P5|NOT COMPLETED|Overall Study||4
7610429|NCT02457793|18736502|P4|NOT COMPLETED|Overall Study||5
7610430|NCT02457793|18736503|P3|NOT COMPLETED|Overall Study||3
7610431|NCT02457793|18736504|P2|NOT COMPLETED|Overall Study||4
7610432|NCT02457793|18736505|P1|NOT COMPLETED|Overall Study||1
7610433|NCT02457793|18736500|P6|COMPLETED|Overall Study||0
7610434|NCT02457793|18736501|P5|COMPLETED|Overall Study||0
7610435|NCT02457793|18736502|P4|COMPLETED|Overall Study||0
7610436|NCT02457793|18736503|P3|COMPLETED|Overall Study||0
7610437|NCT02457793|18736504|P2|COMPLETED|Overall Study||1
7610438|NCT02457793|18736505|P1|COMPLETED|Overall Study||0
7610439|NCT02457793|18736500|P6|STARTED|Overall Study||6
7610440|NCT02457793|18736501|P5|STARTED|Overall Study||4
7610441|NCT02457793|18736502|P4|STARTED|Overall Study||5
7610442|NCT02457793|18736503|P3|STARTED|Overall Study||3
7610443|NCT02457793|18736504|P2|STARTED|Overall Study||5
7610444|NCT02457793|18736505|P1|STARTED|Overall Study||1
7610445|NCT02457728|18736645|P1|NOT COMPLETED|Overall Study||0
7610446|NCT02457728|18736645|P1|COMPLETED|Overall Study||34
7610447|NCT02457728|18736645|P1|STARTED|Overall Study||34
7610448|NCT02457637|18736649|P1|NOT COMPLETED|Clinic or Telephone Follow-up||71
7610449|NCT02457637|18736649|P1|COMPLETED|Clinic or Telephone Follow-up||2529
7610450|NCT02457637|18736649|P1|One-year Death|Clinic or Telephone Follow-up||475
7610451|NCT02457637|18736649|P1|One-year Liver Transplantation|Clinic or Telephone Follow-up||182
7610452|NCT02457637|18736649|P1|STARTED|Clinic or Telephone Follow-up||2600
7610453|NCT02457637|18736649|P1|NOT COMPLETED|28-Days Hospitalization and Observation||0
7610454|NCT02457637|18736649|P1|COMPLETED|28-Days Hospitalization and Observation|Death and receiving Liver transplantation are two end points of our observation.|2600
7610455|NCT02457637|18736649|P1|Death|28-Days Hospitalization and Observation||74
7610456|NCT02457637|18736649|P1|Liver Transplantation|28-Days Hospitalization and Observation||124
7610457|NCT02457637|18736649|P1|STARTED|28-Days Hospitalization and Observation||2600
7610458|NCT02457637|18736649|P1|NOT COMPLETED|Recruitment||0
7610459|NCT02457637|18736649|P1|COMPLETED|Recruitment|2361 patients were excluded according to our exclusion criteria,2600 patients remained.|2600
7610460|NCT02457637|18736649|P1|STARTED|Recruitment|2600 is the number of inpatients who met our eligibility.|2600
7610461|NCT02457611|18736657|P1|NOT COMPLETED|Overall Study||3
7610462|NCT02457611|18736657|P1|COMPLETED|Overall Study||23
7610463|NCT02457611|18736657|P1|STARTED|Overall Study||26
7610464|NCT02457546|18736671|P2|NOT COMPLETED|Overall Study||4
7610465|NCT02457546|18736672|P1|NOT COMPLETED|Overall Study||9
7610466|NCT02457546|18736671|P2|COMPLETED|Overall Study||116
7610467|NCT02457546|18736672|P1|COMPLETED|Overall Study||105
7610468|NCT02457546|18736671|P2|STARTED|Overall Study||120
7610469|NCT02457546|18736672|P1|STARTED|Overall Study||114
7610470|NCT02457325|18736682|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7610471|NCT02457325|18736683|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7610472|NCT02457325|18736682|P2|COMPLETED|Second Intervention (1 Day)||23
7610473|NCT02457325|18736683|P1|COMPLETED|Second Intervention (1 Day)||23
7610474|NCT02457325|18736682|P2|STARTED|Second Intervention (1 Day)||23
7610475|NCT02457325|18736683|P1|STARTED|Second Intervention (1 Day)||23
7610476|NCT02457325|18736682|P2|NOT COMPLETED|Washout (1-2 Months)||0
7610477|NCT02457325|18736683|P1|NOT COMPLETED|Washout (1-2 Months)||0
7610478|NCT02457325|18736682|P2|COMPLETED|Washout (1-2 Months)||23
7610479|NCT02457325|18736683|P1|COMPLETED|Washout (1-2 Months)||23
7610480|NCT02457325|18736682|P2|STARTED|Washout (1-2 Months)||23
7610481|NCT02457325|18736683|P1|STARTED|Washout (1-2 Months)||23
7610482|NCT02457325|18736682|P2|NOT COMPLETED|First Intervention (1 Day)||2
7610483|NCT02457325|18736683|P1|NOT COMPLETED|First Intervention (1 Day)||2
7610484|NCT02457325|18736682|P2|COMPLETED|First Intervention (1 Day)||23
7610485|NCT02457325|18736683|P1|COMPLETED|First Intervention (1 Day)||23
7610486|NCT02457325|18736682|P2|STARTED|First Intervention (1 Day)||25
7610487|NCT02457325|18736683|P1|STARTED|First Intervention (1 Day)||25
7610488|NCT02457260|18736712|P3|NOT COMPLETED|Overall Study||1
7610489|NCT02457260|18736713|P2|NOT COMPLETED|Overall Study||3
7610490|NCT02457260|18736714|P1|NOT COMPLETED|Overall Study||2
7610491|NCT02457260|18736712|P3|COMPLETED|Overall Study||1
7610492|NCT02457260|18736713|P2|COMPLETED|Overall Study||4
7610493|NCT02457260|18736714|P1|COMPLETED|Overall Study||10
7610494|NCT02457260|18736712|P3|STARTED|Overall Study||2
7610495|NCT02457260|18736713|P2|STARTED|Overall Study||7
7610496|NCT02457260|18736714|P1|STARTED|Overall Study||12
7610497|NCT02457247|18736756|P4|NOT COMPLETED|Period 2||0
7610498|NCT02457247|18736757|P3|NOT COMPLETED|Period 2||0
7610499|NCT02457247|18736758|P2|NOT COMPLETED|Period 2||3
7610500|NCT02457247|18736759|P1|NOT COMPLETED|Period 2||2
7610501|NCT02457247|18736756|P4|COMPLETED|Period 2||70
7610502|NCT02457247|18736757|P3|COMPLETED|Period 2||68
7610503|NCT02457247|18736758|P2|COMPLETED|Period 2||65
7610504|NCT02457247|18736759|P1|COMPLETED|Period 2||64
7610505|NCT02457247|18736756|P4|STARTED|Period 2||70
7610506|NCT02457247|18736757|P3|STARTED|Period 2||68
7610507|NCT02457247|18736758|P2|STARTED|Period 2||68
7610508|NCT02457247|18736759|P1|STARTED|Period 2||66
7610509|NCT02457247|18736756|P4|NOT COMPLETED|Period 1||0
7610510|NCT02457247|18736757|P3|NOT COMPLETED|Period 1||0
7610511|NCT02457247|18736758|P2|NOT COMPLETED|Period 1||2
7610512|NCT02457247|18736759|P1|NOT COMPLETED|Period 1||2
7610513|NCT02457247|18736756|P4|COMPLETED|Period 1||70
7610514|NCT02457247|18736757|P3|COMPLETED|Period 1||68
7610515|NCT02457247|18736758|P2|COMPLETED|Period 1||68
7610516|NCT02457247|18736759|P1|COMPLETED|Period 1||66
7610517|NCT02457247|18736756|P4|STARTED|Period 1||70
7610518|NCT02457247|18736757|P3|STARTED|Period 1||68
7610519|NCT02457247|18736758|P2|STARTED|Period 1||70
7610520|NCT02457247|18736759|P1|STARTED|Period 1||68
7610521|NCT02457195|18736779|P1|NOT COMPLETED|Overall Study||9
7610522|NCT02457195|18736779|P1|COMPLETED|Overall Study||41
7610523|NCT02457195|18736779|P1|STARTED|Overall Study||50
7610524|NCT02457182|18736785|P2|NOT COMPLETED|Overall Study||0
7610525|NCT02457182|18736786|P1|NOT COMPLETED|Overall Study||1
7610526|NCT02457182|18736785|P2|COMPLETED|Overall Study||11
7610527|NCT02457182|18736786|P1|COMPLETED|Overall Study||8
7610528|NCT02457182|18736785|P2|STARTED|Overall Study||11
7610529|NCT02457182|18736786|P1|STARTED|Overall Study||9
7610530|NCT02457065|18736804|P2|NOT COMPLETED|Overall Study||11
7610531|NCT02457065|18736805|P1|NOT COMPLETED|Overall Study||9
7610532|NCT02457065|18736804|P2|COMPLETED|Overall Study||16
7610533|NCT02457065|18736805|P1|COMPLETED|Overall Study||18
7610534|NCT02457065|18736804|P2|STARTED|Overall Study||27
7610535|NCT02457065|18736805|P1|STARTED|Overall Study||27
7610536|NCT02456896|18736815|P2|NOT COMPLETED|Overall Study||4
7610537|NCT02456896|18736816|P1|NOT COMPLETED|Overall Study||6
7610538|NCT02456896|18736815|P2|COMPLETED|Overall Study||21
7610539|NCT02456896|18736816|P1|COMPLETED|Overall Study||19
7610540|NCT02456896|18736815|P2|STARTED|Overall Study||25
7610541|NCT02456896|18736816|P1|STARTED|Overall Study||25
7610542|NCT02456740|18736827|P9|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||18
7610543|NCT02456740|18736828|P8|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
7610544|NCT02456740|18736829|P7|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||9
7610545|NCT02456740|18736830|P6|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||13
7610546|NCT02456740|18736831|P5|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||17
7610547|NCT02456740|18736832|P4|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||14
7610548|NCT02456740|18736833|P3|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
7610549|NCT02456740|18736834|P2|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
7610550|NCT02456740|18736835|P1|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
7610551|NCT02456740|18736827|P9|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||126
7610552|NCT02456740|18736828|P8|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||128
7610553|NCT02456740|18736829|P7|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||131
7610554|NCT02456740|18736830|P6|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||130
7610555|NCT02456740|18736831|P5|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||123
7610556|NCT02456740|18736832|P4|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||124
7610557|NCT02456740|18736833|P3|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
7610558|NCT02456740|18736834|P2|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
7610559|NCT02456740|18736835|P1|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
7610560|NCT02456740|18736827|P9|STARTED|Active Treatment Phase (Weeks 24 - 52)||144
7610561|NCT02456740|18736828|P8|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
7610562|NCT02456740|18736829|P7|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
7610563|NCT02456740|18736830|P6|STARTED|Active Treatment Phase (Weeks 24 - 52)||143
7610564|NCT02456740|18736831|P5|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
7610565|NCT02456740|18736832|P4|STARTED|Active Treatment Phase (Weeks 24 - 52)||138
7610566|NCT02456740|18736833|P3|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
7610567|NCT02456740|18736834|P2|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
7610568|NCT02456740|18736835|P1|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
7610569|NCT02456740|18736827|P9|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
7610570|NCT02456740|18736828|P8|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
7610571|NCT02456740|18736829|P7|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
7610572|NCT02456740|18736830|P6|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
7610573|NCT02456740|18736831|P5|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
7610574|NCT02456740|18736832|P4|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
7610575|NCT02456740|18736833|P3|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||27
7610576|NCT02456740|18736834|P2|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||33
7610577|NCT02456740|18736835|P1|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||37
7610578|NCT02456740|18736827|P9|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
7610579|NCT02456740|18736828|P8|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
7610580|NCT02456740|18736829|P7|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
7610581|NCT02456740|18736830|P6|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
7610582|NCT02456740|18736831|P5|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
7610583|NCT02456740|18736832|P4|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
7610584|NCT02456740|18736833|P3|COMPLETED|Double-blind Treatment Phase (24 Weeks)||292
7610585|NCT02456740|18736834|P2|COMPLETED|Double-blind Treatment Phase (24 Weeks)||284
7610586|NCT02456740|18736835|P1|COMPLETED|Double-blind Treatment Phase (24 Weeks)||282
7610587|NCT02456740|18736827|P9|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
7610588|NCT02456740|18736828|P8|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
7610589|NCT02456740|18736829|P7|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
7610590|NCT02456740|18736830|P6|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
7610591|NCT02456740|18736831|P5|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
7610592|NCT02456740|18736832|P4|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
7610593|NCT02456740|18736833|P3|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
7610594|NCT02456740|18736834|P2|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||314
7610595|NCT02456740|18736835|P1|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
7610596|NCT02456740|18736827|P9|STARTED|Double-blind Treatment Phase (24 Weeks)||0
7610597|NCT02456740|18736828|P8|STARTED|Double-blind Treatment Phase (24 Weeks)||0
7610598|NCT02456740|18736829|P7|STARTED|Double-blind Treatment Phase (24 Weeks)||0
7610599|NCT02456740|18736830|P6|STARTED|Double-blind Treatment Phase (24 Weeks)||0
7610600|NCT02456740|18736831|P5|STARTED|Double-blind Treatment Phase (24 Weeks)||0
7610601|NCT02456740|18736832|P4|STARTED|Double-blind Treatment Phase (24 Weeks)||0
7610602|NCT02456740|18736833|P3|STARTED|Double-blind Treatment Phase (24 Weeks)||319
7610603|NCT02456740|18736834|P2|STARTED|Double-blind Treatment Phase (24 Weeks)||317
7610604|NCT02456740|18736835|P1|STARTED|Double-blind Treatment Phase (24 Weeks)||319
7610605|NCT02456727|18736859|P2|NOT COMPLETED|Overall Study||106
7610606|NCT02456727|18736860|P1|NOT COMPLETED|Overall Study||109
7610607|NCT02456727|18736859|P2|COMPLETED|Overall Study||284
7610608|NCT02456727|18736860|P1|COMPLETED|Overall Study||280
7610609|NCT02456727|18736859|P2|24 Week|Overall Study||284
7610610|NCT02456727|18736860|P1|24 Week|Overall Study||280
7610611|NCT02456727|18736859|P2|12 Week|Overall Study||310
7610612|NCT02456727|18736860|P1|12 Week|Overall Study||295
7610613|NCT02456727|18736859|P2|6 Week|Overall Study||320
7610614|NCT02456727|18736860|P1|6 Week|Overall Study||298
7610615|NCT02456727|18736859|P2|Initiated Treatment|Overall Study||360
7610616|NCT02456727|18736860|P1|Initiated Treatment|Overall Study||346
7610617|NCT02456727|18736859|P2|STARTED|Overall Study||390
7610618|NCT02456727|18736860|P1|STARTED|Overall Study||389
7610619|NCT02456662|18736942|P2|NOT COMPLETED|Overall Study||1
7610620|NCT02456662|18736943|P1|NOT COMPLETED|Overall Study||2
7610621|NCT02456662|18736942|P2|COMPLETED|Overall Study||159
7610622|NCT02456662|18736943|P1|COMPLETED|Overall Study||157
7610623|NCT02456662|18736942|P2|STARTED|Overall Study||160
7610624|NCT02456662|18736943|P1|STARTED|Overall Study||159
7610625|NCT02456636|18736952|P3|NOT COMPLETED|Overall Study||75
7610626|NCT02456636|18736953|P2|NOT COMPLETED|Overall Study||69
7610627|NCT02456636|18736954|P1|NOT COMPLETED|Overall Study||68
7610628|NCT02456636|18736952|P3|COMPLETED|Overall Study||400
7610629|NCT02456636|18736953|P2|COMPLETED|Overall Study||410
7610630|NCT02456636|18736954|P1|COMPLETED|Overall Study||410
7610631|NCT02456636|18736952|P3|18 Month|Overall Study||461
7610632|NCT02456636|18736953|P2|18 Month|Overall Study||463
7610633|NCT02456636|18736954|P1|18 Month|Overall Study||467
7610634|NCT02456636|18736952|P3|6 Month|Overall Study||468
7610635|NCT02456636|18736953|P2|6 Month|Overall Study||474
7610636|NCT02456636|18736954|P1|6 Month|Overall Study||474
7610637|NCT02456636|18736952|P3|STARTED|Overall Study||475
7610638|NCT02456636|18736953|P2|STARTED|Overall Study||479
7610639|NCT02456636|18736954|P1|STARTED|Overall Study||478
7610640|NCT02456103|18737004|P1|NOT COMPLETED|Overall Study||246
7610641|NCT02456103|18737004|P1|COMPLETED|Overall Study||0
7610642|NCT02456103|18737004|P1|Intent-to-treat (ITT) Population|Overall Study||244
7610643|NCT02456103|18737004|P1|As-Treated Population|Overall Study||245
7610644|NCT02456103|18737004|P1|STARTED|Overall Study||246
7610645|NCT02455518|18737017|P4|NOT COMPLETED|Overall Study||3
7610646|NCT02455518|18737018|P3|NOT COMPLETED|Overall Study||1
7610647|NCT02455518|18737019|P2|NOT COMPLETED|Overall Study||1
7610648|NCT02455518|18737020|P1|NOT COMPLETED|Overall Study||0
7610649|NCT02455518|18737017|P4|COMPLETED|Overall Study||101
7610650|NCT02455518|18737018|P3|COMPLETED|Overall Study||103
7610651|NCT02455518|18737019|P2|COMPLETED|Overall Study||103
7610652|NCT02455518|18737020|P1|COMPLETED|Overall Study||104
7610653|NCT02455518|18737017|P4|STARTED|Overall Study||104
7610654|NCT02455518|18737018|P3|STARTED|Overall Study||104
7610655|NCT02455518|18737019|P2|STARTED|Overall Study||104
7610656|NCT02455518|18737020|P1|STARTED|Overall Study||104
7610657|NCT02455453|18737034|P1|NOT COMPLETED|Overall Study||0
7610658|NCT02455453|18737034|P1|COMPLETED|Overall Study||47
7610659|NCT02455453|18737034|P1|STARTED|Overall Study||47
7610660|NCT02455388|18737042|P3|NOT COMPLETED|Overall Study||11
7610661|NCT02455388|18737043|P2|NOT COMPLETED|Overall Study||0
7610662|NCT02455388|18737044|P1|NOT COMPLETED|Overall Study||1
7610663|NCT02455388|18737042|P3|COMPLETED|Overall Study||326
7610664|NCT02455388|18737043|P2|COMPLETED|Overall Study||15
7610665|NCT02455388|18737044|P1|COMPLETED|Overall Study||17
7610666|NCT02455388|18737042|P3|STARTED|Overall Study||337
7610667|NCT02455388|18737043|P2|STARTED|Overall Study||15
7610668|NCT02455388|18737044|P1|STARTED|Overall Study||18
7610669|NCT02455336|18737055|P2|NOT COMPLETED|Overall Study||2
7610670|NCT02455336|18737056|P1|NOT COMPLETED|Overall Study||5
7610671|NCT02455336|18737055|P2|COMPLETED|Overall Study||6
7610672|NCT02455336|18737056|P1|COMPLETED|Overall Study||10
7610673|NCT02455336|18737055|P2|STARTED|Overall Study||8
7610674|NCT02455336|18737056|P1|STARTED|Overall Study||15
7610675|NCT02455076|18737071|P5|NOT COMPLETED|Outpatient||12
7610676|NCT02455076|18737072|P4|NOT COMPLETED|Outpatient||6
7610677|NCT02455076|18737073|P3|NOT COMPLETED|Outpatient||0
7610678|NCT02455076|18737074|P2|NOT COMPLETED|Outpatient||0
7610679|NCT02455076|18737075|P1|NOT COMPLETED|Outpatient||0
7610680|NCT02455076|18737071|P5|COMPLETED|Outpatient||43
7610681|NCT02455076|18737072|P4|COMPLETED|Outpatient||42
7610682|NCT02455076|18737073|P3|COMPLETED|Outpatient||0
7610683|NCT02455076|18737074|P2|COMPLETED|Outpatient||0
7610684|NCT02455076|18737075|P1|COMPLETED|Outpatient||0
7610685|NCT02455076|18737071|P5|STARTED|Outpatient||55
7610686|NCT02455076|18737072|P4|STARTED|Outpatient||48
7610687|NCT02455076|18737073|P3|STARTED|Outpatient||0
7610688|NCT02455076|18737074|P2|STARTED|Outpatient||0
7610689|NCT02455076|18737075|P1|STARTED|Outpatient||0
7610690|NCT02455076|18737071|P5|NOT COMPLETED|Inpatient||0
7610691|NCT02455076|18737072|P4|NOT COMPLETED|Inpatient||0
7610692|NCT02455076|18737073|P3|NOT COMPLETED|Inpatient||0
7610693|NCT02455076|18737074|P2|NOT COMPLETED|Inpatient||1
7610694|NCT02455076|18737075|P1|NOT COMPLETED|Inpatient||4
7610695|NCT02455076|18737071|P5|COMPLETED|Inpatient||0
7610696|NCT02455076|18737072|P4|COMPLETED|Inpatient||0
7610697|NCT02455076|18737073|P3|COMPLETED|Inpatient||52
7610698|NCT02455076|18737074|P2|COMPLETED|Inpatient||50
7610699|NCT02455076|18737075|P1|COMPLETED|Inpatient||43
7610700|NCT02455076|18737071|P5|STARTED|Inpatient||0
7610701|NCT02455076|18737072|P4|STARTED|Inpatient||0
7610702|NCT02455076|18737073|P3|STARTED|Inpatient||52
7610703|NCT02455076|18737074|P2|STARTED|Inpatient||51
7610704|NCT02455076|18737075|P1|STARTED|Inpatient||47
7610705|NCT02455050|18737161|P4|NOT COMPLETED|Treatment Period 2||1
7610706|NCT02455050|18737162|P3|NOT COMPLETED|Treatment Period 2||2
7610707|NCT02455050|18737163|P2|NOT COMPLETED|Treatment Period 2||0
7610708|NCT02455050|18737164|P1|NOT COMPLETED|Treatment Period 2||1
7610709|NCT02455050|18737161|P4|COMPLETED|Treatment Period 2||17
7610710|NCT02455050|18737162|P3|COMPLETED|Treatment Period 2||17
7610711|NCT02455050|18737163|P2|COMPLETED|Treatment Period 2||18
7610712|NCT02455050|18737164|P1|COMPLETED|Treatment Period 2||18
7610713|NCT02455050|18737161|P4|STARTED|Treatment Period 2||18
7610714|NCT02455050|18737162|P3|STARTED|Treatment Period 2||19
7610715|NCT02455050|18737163|P2|STARTED|Treatment Period 2||18
7610716|NCT02455050|18737164|P1|STARTED|Treatment Period 2||19
7610717|NCT02455050|18737161|P4|NOT COMPLETED|Treatment Period 1||2
7610718|NCT02455050|18737162|P3|NOT COMPLETED|Treatment Period 1||1
7610719|NCT02455050|18737163|P2|NOT COMPLETED|Treatment Period 1||1
7610720|NCT02455050|18737164|P1|NOT COMPLETED|Treatment Period 1||1
7610721|NCT02455050|18737161|P4|COMPLETED|Treatment Period 1||18
7610722|NCT02455050|18737162|P3|COMPLETED|Treatment Period 1||19
7610723|NCT02455050|18737163|P2|COMPLETED|Treatment Period 1||18
7610724|NCT02455050|18737164|P1|COMPLETED|Treatment Period 1||19
7610725|NCT02455050|18737161|P4|STARTED|Treatment Period 1||20
7610726|NCT02455050|18737162|P3|STARTED|Treatment Period 1||20
7610727|NCT02455050|18737163|P2|STARTED|Treatment Period 1||19
7610728|NCT02455050|18737164|P1|STARTED|Treatment Period 1||20
7610729|NCT02454959|18737228|P1|NOT COMPLETED|Overall Study||9
7610730|NCT02454959|18737228|P1|COMPLETED|Overall Study||70
7610731|NCT02454959|18737228|P1|GFF MDI (PT003) Without Aerochamber|Overall Study||77
7610732|NCT02454959|18737228|P1|GFF MDI (PT003) With Aerochamber|Overall Study||73
7610733|NCT02454959|18737228|P1|STARTED|Overall Study||79
7610734|NCT02454933|18737248|P2|NOT COMPLETED|Overall Study||8
7610735|NCT02454933|18737249|P1|NOT COMPLETED|Overall Study||8
7610736|NCT02454933|18737248|P2|COMPLETED|Overall Study||4
7610737|NCT02454933|18737249|P1|COMPLETED|Overall Study||9
7610738|NCT02454933|18737248|P2|Treatment Group Randomised to|Overall Study||14
7610739|NCT02454933|18737249|P1|Treatment Group Randomised to|Overall Study||15
7610740|NCT02454933|18737248|P2|STARTED|Overall Study|2 subjects switched to osimertinib monotherapy Cycle 1 Day 1|12
7610741|NCT02454933|18737249|P1|STARTED|Overall Study||17
7610742|NCT02454608|18737257|P3|NOT COMPLETED|Open Label Period||19
7610743|NCT02454608|18737258|P2|NOT COMPLETED|Open Label Period||0
7610744|NCT02454608|18737259|P1|NOT COMPLETED|Open Label Period||0
7610745|NCT02454608|18737257|P3|COMPLETED|Open Label Period||10
7610746|NCT02454608|18737258|P2|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
7610747|NCT02454608|18737259|P1|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
7610748|NCT02454608|18737257|P3|STARTED|Open Label Period||29
7610749|NCT02454608|18737258|P2|STARTED|Open Label Period|This arm is not part of this period of the study|0
7610750|NCT02454608|18737259|P1|STARTED|Open Label Period|This arm is not part of this period of the study|0
7610751|NCT02454608|18737257|P3|NOT COMPLETED|Double-Blind Period||0
7610752|NCT02454608|18737258|P2|NOT COMPLETED|Double-Blind Period||2
7610753|NCT02454608|18737259|P1|NOT COMPLETED|Double-Blind Period||0
7610754|NCT02454608|18737257|P3|COMPLETED|Double-Blind Period|This arm is not part of this period of the study|0
7610755|NCT02454608|18737258|P2|COMPLETED|Double-Blind Period||12
7610756|NCT02454608|18737259|P1|COMPLETED|Double-Blind Period||15
7610757|NCT02454608|18737257|P3|STARTED|Double-Blind Period|This arm is not part of this period of the study|0
7610758|NCT02454608|18737258|P2|STARTED|Double-Blind Period||14
7610759|NCT02454608|18737259|P1|STARTED|Double-Blind Period||15
7610760|NCT02454530|18737282|P2|NOT COMPLETED|Overall Study||127
7610761|NCT02454530|18737283|P1|NOT COMPLETED|Overall Study||70
7610762|NCT02454530|18737282|P2|COMPLETED|Overall Study||481
7610763|NCT02454530|18737283|P1|COMPLETED|Overall Study||482
7610764|NCT02454530|18737282|P2|STARTED|Overall Study||608
7610765|NCT02454530|18737283|P1|STARTED|Overall Study||552
7610766|NCT02454478|18737320|P1|NOT COMPLETED|Overall Study||1
7610767|NCT02454478|18737320|P1|COMPLETED|Overall Study||6
7610768|NCT02454478|18737320|P1|STARTED|Overall Study||7
7610769|NCT02454296|18737336|P2|NOT COMPLETED|Overall Study||0
7610770|NCT02454296|18737337|P1|NOT COMPLETED|Overall Study||0
7610771|NCT02454296|18737336|P2|COMPLETED|Overall Study||21
7610772|NCT02454296|18737337|P1|COMPLETED|Overall Study||20
7610773|NCT02454296|18737336|P2|STARTED|Overall Study||21
7610774|NCT02454296|18737337|P1|STARTED|Overall Study||20
7610775|NCT02454283|18737349|P2|NOT COMPLETED|Overall Study||0
7610776|NCT02454283|18737350|P1|NOT COMPLETED|Overall Study||0
7610777|NCT02454283|18737349|P2|COMPLETED|Overall Study||15
7610778|NCT02454283|18737350|P1|COMPLETED|Overall Study||26
7610779|NCT02454283|18737349|P2|STARTED|Overall Study||15
7610780|NCT02454283|18737350|P1|STARTED|Overall Study||26
7610781|NCT02454179|18737360|P2|NOT COMPLETED|Overall Study||39
7610782|NCT02454179|18737361|P1|NOT COMPLETED|Overall Study||39
7610783|NCT02454179|18737360|P2|COMPLETED|Overall Study||0
7610784|NCT02454179|18737361|P1|COMPLETED|Overall Study||0
7610785|NCT02454179|18737360|P2|Discontinue Study|Overall Study||39
7610786|NCT02454179|18737361|P1|Discontinue Study|Overall Study||39
7610787|NCT02454179|18737360|P2|Received Study Medication|Overall Study||37
7610788|NCT02454179|18737361|P1|Received Study Medication|Overall Study||39
7610789|NCT02454179|18737360|P2|Enrolled|Overall Study||39
7610790|NCT02454179|18737361|P1|Enrolled|Overall Study||39
7610791|NCT02454179|18737360|P2|STARTED|Overall Study||39
7610792|NCT02454179|18737361|P1|STARTED|Overall Study||39
7610793|NCT02454127|18737371|P4|NOT COMPLETED|Overall Study||20
7610794|NCT02454127|18737372|P3|NOT COMPLETED|Overall Study||14
7610795|NCT02454127|18737373|P2|NOT COMPLETED|Overall Study||14
7610796|NCT02454127|18737374|P1|NOT COMPLETED|Overall Study||19
7610797|NCT02454127|18737371|P4|COMPLETED|Overall Study||20
7610798|NCT02454127|18737372|P3|COMPLETED|Overall Study||26
7610799|NCT02454127|18737373|P2|COMPLETED|Overall Study||26
7610800|NCT02454127|18737374|P1|COMPLETED|Overall Study||21
7610801|NCT02454127|18737371|P4|STARTED|Overall Study||40
7610802|NCT02454127|18737372|P3|STARTED|Overall Study||40
7610803|NCT02454127|18737373|P2|STARTED|Overall Study||40
7610804|NCT02454127|18737374|P1|STARTED|Overall Study||40
7610805|NCT02454101|18737414|P2|NOT COMPLETED|Overall Study||7
7610806|NCT02454101|18737415|P1|NOT COMPLETED|Overall Study||5
7610807|NCT02454101|18737414|P2|COMPLETED|Overall Study||143
7610808|NCT02454101|18737415|P1|COMPLETED|Overall Study||145
7610809|NCT02454101|18737414|P2|STARTED|Overall Study||150
7610810|NCT02454101|18737415|P1|STARTED|Overall Study||150
7610811|NCT02453841|18737437|P1|NOT COMPLETED|Overall Study||3
7610812|NCT02453841|18737437|P1|COMPLETED|Overall Study||27
7610813|NCT02453841|18737437|P1|STARTED|Overall Study||30
7610814|NCT02453750|18737444|P1|NOT COMPLETED|Overall Study||0
7610815|NCT02453750|18737444|P1|COMPLETED|Overall Study||21
7610816|NCT02453750|18737444|P1|STARTED|Overall Study||21
7610817|NCT02453711|18737460|P9|NOT COMPLETED|Overall Study||13
7610818|NCT02453711|18737461|P8|NOT COMPLETED|Overall Study||7
7610819|NCT02453711|18737462|P7|NOT COMPLETED|Overall Study||3
7610820|NCT02453711|18737463|P6|NOT COMPLETED|Overall Study||6
7610821|NCT02453711|18737464|P5|NOT COMPLETED|Overall Study||2
7610822|NCT02453711|18737465|P4|NOT COMPLETED|Overall Study||7
7610823|NCT02453711|18737466|P3|NOT COMPLETED|Overall Study||9
7610824|NCT02453711|18737467|P2|NOT COMPLETED|Overall Study||7
7610825|NCT02453711|18737468|P1|NOT COMPLETED|Overall Study||11
7610826|NCT02453711|18737460|P9|COMPLETED|Overall Study||123
7610827|NCT02453711|18737461|P8|COMPLETED|Overall Study||96
7610828|NCT02453711|18737462|P7|COMPLETED|Overall Study||100
7610829|NCT02453711|18737463|P6|COMPLETED|Overall Study||96
7610830|NCT02453711|18737464|P5|COMPLETED|Overall Study||100
7610831|NCT02453711|18737465|P4|COMPLETED|Overall Study||96
7610832|NCT02453711|18737466|P3|COMPLETED|Overall Study||94
7610833|NCT02453711|18737467|P2|COMPLETED|Overall Study||95
7610834|NCT02453711|18737468|P1|COMPLETED|Overall Study||92
7610835|NCT02453711|18737460|P9|Safety Analysis Set|Overall Study||136
7610836|NCT02453711|18737461|P8|Safety Analysis Set|Overall Study||103
7610837|NCT02453711|18737462|P7|Safety Analysis Set|Overall Study||103
7610838|NCT02453711|18737463|P6|Safety Analysis Set|Overall Study||102
7610839|NCT02453711|18737464|P5|Safety Analysis Set|Overall Study||102
7610840|NCT02453711|18737465|P4|Safety Analysis Set|Overall Study||103
7610841|NCT02453711|18737466|P3|Safety Analysis Set|Overall Study||103
7610842|NCT02453711|18737467|P2|Safety Analysis Set|Overall Study||102
7610843|NCT02453711|18737468|P1|Safety Analysis Set|Overall Study||103
7610844|NCT02453711|18737460|P9|Full Analysis Set|Overall Study||136
7610845|NCT02453711|18737461|P8|Full Analysis Set|Overall Study||103
7610846|NCT02453711|18737462|P7|Full Analysis Set|Overall Study||103
7610847|NCT02453711|18737463|P6|Full Analysis Set|Overall Study||102
7610848|NCT02453711|18737464|P5|Full Analysis Set|Overall Study||102
7610849|NCT02453711|18737465|P4|Full Analysis Set|Overall Study||103
7610850|NCT02453711|18737466|P3|Full Analysis Set|Overall Study||103
7610851|NCT02453711|18737467|P2|Full Analysis Set|Overall Study||102
7610852|NCT02453711|18737468|P1|Full Analysis Set|Overall Study||103
7610853|NCT02453711|18737460|P9|STARTED|Overall Study||136
7610854|NCT02453711|18737461|P8|STARTED|Overall Study||103
7610855|NCT02453711|18737462|P7|STARTED|Overall Study||103
7610856|NCT02453711|18737463|P6|STARTED|Overall Study||102
7610857|NCT02453711|18737464|P5|STARTED|Overall Study||102
7610858|NCT02453711|18737465|P4|STARTED|Overall Study||103
7610859|NCT02453711|18737466|P3|STARTED|Overall Study||103
7610860|NCT02453711|18737467|P2|STARTED|Overall Study||102
7610861|NCT02453711|18737468|P1|STARTED|Overall Study||103
7610862|NCT02453685|18737812|P2|NOT COMPLETED|Overall Study||12
7610863|NCT02453685|18737813|P1|NOT COMPLETED|Overall Study||19
7610864|NCT02453685|18737812|P2|COMPLETED|Overall Study||155
7610865|NCT02453685|18737813|P1|COMPLETED|Overall Study||149
7610866|NCT02453685|18737812|P2|Exposed|Overall Study||166
7610867|NCT02453685|18737813|P1|Exposed|Overall Study||166
7610868|NCT02453685|18737812|P2|STARTED|Overall Study||167
7610869|NCT02453685|18737813|P1|STARTED|Overall Study||168
7610870|NCT02453672|18737828|P3|NOT COMPLETED|Overall Study||1
7610871|NCT02453672|18737829|P2|NOT COMPLETED|Overall Study||2
7610872|NCT02453672|18737830|P1|NOT COMPLETED|Overall Study||3
7610873|NCT02453672|18737828|P3|COMPLETED|Overall Study||38
7610874|NCT02453672|18737829|P2|COMPLETED|Overall Study||38
7610875|NCT02453672|18737830|P1|COMPLETED|Overall Study||37
7610876|NCT02453672|18737828|P3|STARTED|Overall Study||39
7610877|NCT02453672|18737829|P2|STARTED|Overall Study||40
7610878|NCT02453672|18737830|P1|STARTED|Overall Study||40
7610879|NCT02453581|18737847|P3|NOT COMPLETED|Overall Study||0
7610880|NCT02453581|18737848|P2|NOT COMPLETED|Overall Study||0
7610881|NCT02453581|18737849|P1|NOT COMPLETED|Overall Study||0
7610882|NCT02453581|18737847|P3|COMPLETED|Overall Study||8
7610883|NCT02453581|18737848|P2|COMPLETED|Overall Study||8
7610884|NCT02453581|18737849|P1|COMPLETED|Overall Study||8
7610885|NCT02453581|18737847|P3|STARTED|Overall Study||8
7610886|NCT02453581|18737848|P2|STARTED|Overall Study||8
7610887|NCT02453581|18737849|P1|STARTED|Overall Study||8
7610888|NCT02453555|18737871|P6|NOT COMPLETED|Extension Period||1
7610889|NCT02453555|18737872|P5|NOT COMPLETED|Extension Period||1
7610890|NCT02453555|18737873|P4|NOT COMPLETED|Extension Period||2
7610891|NCT02453555|18737874|P3|NOT COMPLETED|Extension Period||3
7610892|NCT02453555|18737875|P2|NOT COMPLETED|Extension Period||0
7610893|NCT02453555|18737876|P1|NOT COMPLETED|Extension Period||0
7610894|NCT02453555|18737871|P6|COMPLETED|Extension Period||5
7610895|NCT02453555|18737872|P5|COMPLETED|Extension Period||79
7610896|NCT02453555|18737873|P4|COMPLETED|Extension Period||49
7610897|NCT02453555|18737874|P3|COMPLETED|Extension Period||123
7610898|NCT02453555|18737875|P2|COMPLETED|Extension Period||0
7610899|NCT02453555|18737876|P1|COMPLETED|Extension Period||0
7610900|NCT02453555|18737871|P6|STARTED|Extension Period||6
7610901|NCT02453555|18737872|P5|STARTED|Extension Period||80
7610902|NCT02453555|18737873|P4|STARTED|Extension Period||51
7610903|NCT02453555|18737874|P3|STARTED|Extension Period||126
7610904|NCT02453555|18737875|P2|STARTED|Extension Period|This reporting group is not applicable in this period.|0
7610905|NCT02453555|18737876|P1|STARTED|Extension Period|This reporting group is not applicable in this period.|0
7610906|NCT02453555|18737871|P6|NOT COMPLETED|24-week Double-blind Treatment Period||0
7610907|NCT02453555|18737872|P5|NOT COMPLETED|24-week Double-blind Treatment Period||0
7610908|NCT02453555|18737873|P4|NOT COMPLETED|24-week Double-blind Treatment Period||0
7610909|NCT02453555|18737874|P3|NOT COMPLETED|24-week Double-blind Treatment Period||0
7610910|NCT02453555|18737875|P2|NOT COMPLETED|24-week Double-blind Treatment Period||7
7610911|NCT02453555|18737876|P1|NOT COMPLETED|24-week Double-blind Treatment Period||5
7610912|NCT02453555|18737871|P6|COMPLETED|24-week Double-blind Treatment Period||0
7610913|NCT02453555|18737872|P5|COMPLETED|24-week Double-blind Treatment Period||0
7610914|NCT02453555|18737873|P4|COMPLETED|24-week Double-blind Treatment Period||0
7610915|NCT02453555|18737874|P3|COMPLETED|24-week Double-blind Treatment Period||0
7610916|NCT02453555|18737875|P2|COMPLETED|24-week Double-blind Treatment Period||86
7610917|NCT02453555|18737876|P1|COMPLETED|24-week Double-blind Treatment Period||177
7610918|NCT02453555|18737871|P6|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
7610919|NCT02453555|18737872|P5|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
7610920|NCT02453555|18737873|P4|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
7610921|NCT02453555|18737874|P3|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
7610922|NCT02453555|18737875|P2|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|93
7610923|NCT02453555|18737876|P1|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|182
7610924|NCT02453386|18737892|P3|NOT COMPLETED|Overall Study||41
7610925|NCT02453386|18737893|P2|NOT COMPLETED|Overall Study||49
7610926|NCT02453386|18737894|P1|NOT COMPLETED|Overall Study||49
7610927|NCT02453386|18737892|P3|COMPLETED|Overall Study||108
7610928|NCT02453386|18737893|P2|COMPLETED|Overall Study||100
7610929|NCT02453386|18737894|P1|COMPLETED|Overall Study||102
7610930|NCT02453386|18737892|P3|STARTED|Overall Study||149
7610931|NCT02453386|18737893|P2|STARTED|Overall Study||149
7610932|NCT02453386|18737894|P1|STARTED|Overall Study||151
7610933|NCT02453360|18737920|P3|NOT COMPLETED|Overall Study||0
7610934|NCT02453360|18737921|P2|NOT COMPLETED|Overall Study||0
7610935|NCT02453360|18737922|P1|NOT COMPLETED|Overall Study||0
7610936|NCT02453360|18737920|P3|COMPLETED|Overall Study||20
7610937|NCT02453360|18737921|P2|COMPLETED|Overall Study||20
7610938|NCT02453360|18737922|P1|COMPLETED|Overall Study||20
7610939|NCT02453360|18737920|P3|STARTED|Overall Study||20
7610940|NCT02453360|18737921|P2|STARTED|Overall Study||20
7610941|NCT02453360|18737922|P1|STARTED|Overall Study||20
7610942|NCT02453347|18737942|P1|NOT COMPLETED|Overall Study||0
7610943|NCT02453347|18737942|P1|COMPLETED|Overall Study||6
7610944|NCT02453347|18737942|P1|STARTED|Overall Study||6
7610945|NCT02453321|18737958|P3|NOT COMPLETED|Overall Study||2
7610946|NCT02453321|18737959|P2|NOT COMPLETED|Overall Study||2
7610947|NCT02453321|18737960|P1|NOT COMPLETED|Overall Study||1
7610948|NCT02453321|18737958|P3|COMPLETED|Overall Study||19
7610949|NCT02453321|18737959|P2|COMPLETED|Overall Study||19
7610950|NCT02453321|18737960|P1|COMPLETED|Overall Study||19
7610951|NCT02453321|18737958|P3|STARTED|Overall Study||21
7610952|NCT02453321|18737959|P2|STARTED|Overall Study||21
7610953|NCT02453321|18737960|P1|STARTED|Overall Study||20
7610954|NCT02453282|18737980|P3|NOT COMPLETED|Overall Study||372
7610955|NCT02453282|18737981|P2|NOT COMPLETED|Overall Study||372
7610956|NCT02453282|18737982|P1|NOT COMPLETED|Overall Study||374
7610957|NCT02453282|18737980|P3|COMPLETED|Overall Study||0
7610958|NCT02453282|18737981|P2|COMPLETED|Overall Study||0
7610959|NCT02453282|18737982|P1|COMPLETED|Overall Study||0
7610960|NCT02453282|18737980|P3|Received Treatment|Overall Study||352
7610961|NCT02453282|18737981|P2|Received Treatment|Overall Study||371
7610962|NCT02453282|18737982|P1|Received Treatment|Overall Study||369
7610963|NCT02453282|18737980|P3|STARTED|Overall Study||372
7610964|NCT02453282|18737981|P2|STARTED|Overall Study||372
7610965|NCT02453282|18737982|P1|STARTED|Overall Study||374
7610966|NCT02453256|18738063|P2|NOT COMPLETED|Open Label Period||7
7610967|NCT02453256|18738064|P1|NOT COMPLETED|Open Label Period||7
7610968|NCT02453256|18738063|P2|COMPLETED|Open Label Period||85
7610969|NCT02453256|18738064|P1|COMPLETED|Open Label Period||82
7610970|NCT02453256|18738063|P2|STARTED|Open Label Period||92
7610971|NCT02453256|18738064|P1|STARTED|Open Label Period||89
7610972|NCT02453256|18738063|P2|NOT COMPLETED|Double Blind Period||9
7610973|NCT02453256|18738064|P1|NOT COMPLETED|Double Blind Period||13
7610974|NCT02453256|18738063|P2|COMPLETED|Double Blind Period||95
7610975|NCT02453256|18738064|P1|COMPLETED|Double Blind Period||93
7610976|NCT02453256|18738063|P2|STARTED|Double Blind Period||104
7610977|NCT02453256|18738064|P1|STARTED|Double Blind Period||106
7610978|NCT02453191|18738184|P1|NOT COMPLETED|Overall Study||1
7610979|NCT02453191|18738184|P1|COMPLETED|Overall Study||29
7610980|NCT02453191|18738184|P1|STARTED|Overall Study||30
7610981|NCT02453113|18738192|P1|NOT COMPLETED|Overall Study||0
7610982|NCT02453113|18738192|P1|COMPLETED|Overall Study||10
7610983|NCT02453113|18738192|P1|STARTED|Overall Study||10
7610984|NCT02453048|18738201|P5|NOT COMPLETED|Overall Study||6
7610985|NCT02453048|18738202|P4|NOT COMPLETED|Overall Study||0
7610986|NCT02453048|18738203|P3|NOT COMPLETED|Overall Study||2
7610987|NCT02453048|18738204|P2|NOT COMPLETED|Overall Study||1
7610988|NCT02453048|18738205|P1|NOT COMPLETED|Overall Study||0
7610989|NCT02453048|18738201|P5|COMPLETED|Overall Study||0
7610990|NCT02453048|18738202|P4|COMPLETED|Overall Study||12
7610991|NCT02453048|18738203|P3|COMPLETED|Overall Study||10
7610992|NCT02453048|18738204|P2|COMPLETED|Overall Study||11
7610993|NCT02453048|18738205|P1|COMPLETED|Overall Study||12
7610994|NCT02453048|18738201|P5|6-month Follow-up|Overall Study||6
7610995|NCT02453048|18738202|P4|6-month Follow-up|Overall Study||12
7610996|NCT02453048|18738203|P3|6-month Follow-up|Overall Study||12
7610997|NCT02453048|18738204|P2|6-month Follow-up|Overall Study||12
7610998|NCT02453048|18738205|P1|6-month Follow-up|Overall Study||12
7610999|NCT02453048|18738201|P5|STARTED|Overall Study||6
7611000|NCT02453048|18738202|P4|STARTED|Overall Study||12
7611001|NCT02453048|18738203|P3|STARTED|Overall Study||12
7611002|NCT02453048|18738204|P2|STARTED|Overall Study||12
7611003|NCT02453048|18738205|P1|STARTED|Overall Study||12
7611004|NCT02452944|18738229|P2|NOT COMPLETED|Overall Study||0
7611005|NCT02452944|18738230|P1|NOT COMPLETED|Overall Study||0
7611006|NCT02452944|18738229|P2|COMPLETED|Overall Study||31
7611007|NCT02452944|18738230|P1|COMPLETED|Overall Study||31
7611008|NCT02452944|18738229|P2|STARTED|Overall Study||31
7611009|NCT02452944|18738230|P1|STARTED|Overall Study||31
7611010|NCT02452931|18738238|P1|NOT COMPLETED|Overall Study||4
7611011|NCT02452931|18738238|P1|COMPLETED|Overall Study||60
7611012|NCT02452931|18738238|P1|STARTED|Overall Study||64
7611013|NCT02452892|18738265|P4|NOT COMPLETED|Follow-up||1
7611014|NCT02452892|18738266|P3|NOT COMPLETED|Follow-up||0
7611015|NCT02452892|18738267|P2|NOT COMPLETED|Follow-up||0
7611016|NCT02452892|18738268|P1|NOT COMPLETED|Follow-up||1
7611017|NCT02452892|18738265|P4|COMPLETED|Follow-up||38
7611018|NCT02452892|18738266|P3|COMPLETED|Follow-up||7
7611019|NCT02452892|18738267|P2|COMPLETED|Follow-up||7
7611020|NCT02452892|18738268|P1|COMPLETED|Follow-up||62
7611021|NCT02452892|18738265|P4|STARTED|Follow-up||39
7611022|NCT02452892|18738266|P3|STARTED|Follow-up||7
7611023|NCT02452892|18738267|P2|STARTED|Follow-up||7
7611024|NCT02452892|18738268|P1|STARTED|Follow-up||63
7611025|NCT02452892|18738265|P4|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
7611026|NCT02452892|18738266|P3|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
7611027|NCT02452892|18738267|P2|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
7611028|NCT02452892|18738268|P1|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
7611029|NCT02452892|18738265|P4|COMPLETED|Week 2 Stratification & Re-Randomization||39
7611030|NCT02452892|18738266|P3|COMPLETED|Week 2 Stratification & Re-Randomization||7
7611031|NCT02452892|18738267|P2|COMPLETED|Week 2 Stratification & Re-Randomization||7
7611032|NCT02452892|18738268|P1|COMPLETED|Week 2 Stratification & Re-Randomization||63
7611033|NCT02452892|18738265|P4|Responders|Week 2 Stratification & Re-Randomization||0
7611034|NCT02452892|18738266|P3|Responders|Week 2 Stratification & Re-Randomization||7
7611035|NCT02452892|18738267|P2|Responders|Week 2 Stratification & Re-Randomization||7
7611036|NCT02452892|18738268|P1|Responders|Week 2 Stratification & Re-Randomization||27
7611037|NCT02452892|18738265|P4|Non-reponders|Week 2 Stratification & Re-Randomization||41
7611038|NCT02452892|18738266|P3|Non-reponders|Week 2 Stratification & Re-Randomization||0
7611039|NCT02452892|18738267|P2|Non-reponders|Week 2 Stratification & Re-Randomization||0
7611040|NCT02452892|18738268|P1|Non-reponders|Week 2 Stratification & Re-Randomization||38
7611041|NCT02452892|18738265|P4|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (13), LFMS 20min (14), and LFMS 60 min (14).|41
7611042|NCT02452892|18738266|P3|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0),LFMS 20min (0), LFMS 60min (7)|7
7611043|NCT02452892|18738267|P2|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0), LFMS 20min (7), and LFMS 60min(0).|7
7611044|NCT02452892|18738268|P1|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that started LFMS sham (27), LFMS 20min (19), and LFMS 60min (19)|65
7611045|NCT02452892|18738265|P4|NOT COMPLETED|Week 1 Initial Randommization||0
7611046|NCT02452892|18738266|P3|NOT COMPLETED|Week 1 Initial Randommization||1
7611047|NCT02452892|18738267|P2|NOT COMPLETED|Week 1 Initial Randommization||0
7611048|NCT02452892|18738268|P1|NOT COMPLETED|Week 1 Initial Randommization||1
7611049|NCT02452892|18738265|P4|COMPLETED|Week 1 Initial Randommization||0
7611050|NCT02452892|18738266|P3|COMPLETED|Week 1 Initial Randommization||40
7611051|NCT02452892|18738267|P2|COMPLETED|Week 1 Initial Randommization||40
7611052|NCT02452892|18738268|P1|COMPLETED|Week 1 Initial Randommization||40
7611053|NCT02452892|18738265|P4|STARTED|Week 1 Initial Randommization||0
7611054|NCT02452892|18738266|P3|STARTED|Week 1 Initial Randommization||41
7611055|NCT02452892|18738267|P2|STARTED|Week 1 Initial Randommization||40
7611056|NCT02452892|18738268|P1|STARTED|Week 1 Initial Randommization||41
7611057|NCT02452554|18738303|P6|NOT COMPLETED|Overall Study||9
7611058|NCT02452554|18738304|P5|NOT COMPLETED|Overall Study||5
7611059|NCT02452554|18738305|P4|NOT COMPLETED|Overall Study||1
7611060|NCT02452554|18738306|P3|NOT COMPLETED|Overall Study||11
7611061|NCT02452554|18738307|P2|NOT COMPLETED|Overall Study||17
7611062|NCT02452554|18738308|P1|NOT COMPLETED|Overall Study||17
7611063|NCT02452554|18738303|P6|COMPLETED|Overall Study||1
7611064|NCT02452554|18738304|P5|COMPLETED|Overall Study||0
7611065|NCT02452554|18738305|P4|COMPLETED|Overall Study||0
7611066|NCT02452554|18738306|P3|COMPLETED|Overall Study||1
7611067|NCT02452554|18738307|P2|COMPLETED|Overall Study||0
7611068|NCT02452554|18738308|P1|COMPLETED|Overall Study||0
7611069|NCT02452554|18738303|P6|STARTED|Overall Study||10
7611070|NCT02452554|18738304|P5|STARTED|Overall Study||5
7611071|NCT02452554|18738305|P4|STARTED|Overall Study||1
7611072|NCT02452554|18738306|P3|STARTED|Overall Study||12
7611073|NCT02452554|18738307|P2|STARTED|Overall Study||17
7611074|NCT02452554|18738308|P1|STARTED|Overall Study||17
7611075|NCT02452528|18738325|P2|NOT COMPLETED|Overall Study||1
7611076|NCT02452528|18738326|P1|NOT COMPLETED|Overall Study||1
7611077|NCT02452528|18738325|P2|COMPLETED|Overall Study||1
7611078|NCT02452528|18738326|P1|COMPLETED|Overall Study||1
7611079|NCT02452528|18738325|P2|STARTED|Overall Study||2
7611080|NCT02452528|18738326|P1|STARTED|Overall Study||2
7611081|NCT02452463|18738361|P3|NOT COMPLETED|Overall Study||0
7611082|NCT02452463|18738362|P2|NOT COMPLETED|Overall Study||2
7611083|NCT02452463|18738363|P1|NOT COMPLETED|Overall Study||2
7611084|NCT02452463|18738361|P3|COMPLETED|Overall Study||0
7611085|NCT02452463|18738362|P2|COMPLETED|Overall Study||1
7611086|NCT02452463|18738363|P1|COMPLETED|Overall Study||3
7611087|NCT02452463|18738361|P3|STARTED|Overall Study|"No participants were enrolled in the Arm III (Nintedanib, Durvalumab) Arm."|0
7611088|NCT02452463|18738362|P2|STARTED|Overall Study||3
7611089|NCT02452463|18738363|P1|STARTED|Overall Study||5
7611090|NCT02452424|18738406|P11|NOT COMPLETED|Overall Study||2
7611091|NCT02452424|18738407|P10|NOT COMPLETED|Overall Study||2
7611092|NCT02452424|18738408|P9|NOT COMPLETED|Overall Study||6
7611093|NCT02452424|18738409|P8|NOT COMPLETED|Overall Study||4
7611094|NCT02452424|18738410|P7|NOT COMPLETED|Overall Study||10
7611095|NCT02452424|18738411|P6|NOT COMPLETED|Overall Study||1
7611096|NCT02452424|18738412|P5|NOT COMPLETED|Overall Study||2
7611097|NCT02452424|18738413|P4|NOT COMPLETED|Overall Study||8
7611098|NCT02452424|18738414|P3|NOT COMPLETED|Overall Study||7
7611099|NCT02452424|18738415|P2|NOT COMPLETED|Overall Study||3
7611100|NCT02452424|18738416|P1|NOT COMPLETED|Overall Study||2
7611101|NCT02452424|18738406|P11|COMPLETED|Overall Study||4
7611102|NCT02452424|18738407|P10|COMPLETED|Overall Study||1
7611103|NCT02452424|18738408|P9|COMPLETED|Overall Study||9
7611104|NCT02452424|18738409|P8|COMPLETED|Overall Study||4
7611105|NCT02452424|18738410|P7|COMPLETED|Overall Study||3
7611106|NCT02452424|18738411|P6|COMPLETED|Overall Study||5
7611107|NCT02452424|18738412|P5|COMPLETED|Overall Study||2
7611108|NCT02452424|18738413|P4|COMPLETED|Overall Study||1
7611109|NCT02452424|18738414|P3|COMPLETED|Overall Study||0
7611110|NCT02452424|18738415|P2|COMPLETED|Overall Study||0
7611111|NCT02452424|18738416|P1|COMPLETED|Overall Study||2
7611112|NCT02452424|18738406|P11|STARTED|Overall Study||6
7611113|NCT02452424|18738407|P10|STARTED|Overall Study||3
7611114|NCT02452424|18738408|P9|STARTED|Overall Study||15
7611115|NCT02452424|18738409|P8|STARTED|Overall Study||8
7611116|NCT02452424|18738410|P7|STARTED|Overall Study||13
7611117|NCT02452424|18738411|P6|STARTED|Overall Study||6
7611118|NCT02452424|18738412|P5|STARTED|Overall Study||4
7611119|NCT02452424|18738413|P4|STARTED|Overall Study||9
7611120|NCT02452424|18738414|P3|STARTED|Overall Study||7
7611121|NCT02452424|18738415|P2|STARTED|Overall Study||3
7611122|NCT02452424|18738416|P1|STARTED|Overall Study||4
7611123|NCT02452398|18738451|P1|NOT COMPLETED|Overall Study||41
7611124|NCT02452398|18738451|P1|COMPLETED|Overall Study|Study was halted prematurely. No results analysis completed.|38
7611125|NCT02452398|18738451|P1|STARTED|Overall Study|Study was halted prematurely. No results analysis completed.|79
7611126|NCT02452359|18738455|P1|NOT COMPLETED|Overall Study||21
7611127|NCT02452359|18738455|P1|COMPLETED|Overall Study||33
7611128|NCT02452359|18738455|P1|STARTED|Overall Study||54
7611129|NCT02452346|18738459|P1|NOT COMPLETED|Overall Study||9
7611130|NCT02452346|18738459|P1|COMPLETED|Overall Study||3
7611131|NCT02452346|18738459|P1|STARTED|Overall Study||12
7611132|NCT02452320|18738467|P2|NOT COMPLETED|Overall Study||1
7611133|NCT02452320|18738468|P1|NOT COMPLETED|Overall Study||0
7611134|NCT02452320|18738467|P2|COMPLETED|Overall Study||63
7611135|NCT02452320|18738468|P1|COMPLETED|Overall Study||64
7611136|NCT02452320|18738467|P2|STARTED|Overall Study||64
7611137|NCT02452320|18738468|P1|STARTED|Overall Study||64
7611138|NCT02452190|18738480|P2|NOT COMPLETED|Overall Study||24
7611139|NCT02452190|18738481|P1|NOT COMPLETED|Overall Study||35
7611140|NCT02452190|18738480|P2|COMPLETED|Overall Study||212
7611141|NCT02452190|18738481|P1|COMPLETED|Overall Study||197
7611142|NCT02452190|18738480|P2|Safety Population|Overall Study||237
7611143|NCT02452190|18738481|P1|Safety Population|Overall Study||231
7611144|NCT02452190|18738480|P2|Intent to Treat (ITT) Population|Overall Study||234
7611145|NCT02452190|18738481|P1|Intent to Treat (ITT) Population|Overall Study||230
7611146|NCT02452190|18738480|P2|STARTED|Overall Study||236
7611147|NCT02452190|18738481|P1|STARTED|Overall Study||232
7611148|NCT02452060|18738507|P2|NOT COMPLETED|Overall Study||0
7611149|NCT02452060|18738508|P1|NOT COMPLETED|Overall Study||0
7611150|NCT02452060|18738507|P2|COMPLETED|Overall Study||44
7611151|NCT02452060|18738508|P1|COMPLETED|Overall Study||46
7611152|NCT02452060|18738507|P2|STARTED|Overall Study||44
7611153|NCT02452060|18738508|P1|STARTED|Overall Study||46
7611154|NCT02452047|18738519|P3|NOT COMPLETED|Overall Study||2
7611155|NCT02452047|18738520|P2|NOT COMPLETED|Overall Study||5
7611156|NCT02452047|18738521|P1|NOT COMPLETED|Overall Study||4
7611157|NCT02452047|18738519|P3|COMPLETED|Overall Study||1
7611158|NCT02452047|18738520|P2|COMPLETED|Overall Study||11
7611159|NCT02452047|18738521|P1|COMPLETED|Overall Study||27
7611160|NCT02452047|18738519|P3|STARTED|Overall Study||3
7611161|NCT02452047|18738520|P2|STARTED|Overall Study||16
7611162|NCT02452047|18738521|P1|STARTED|Overall Study||31
7611163|NCT02452034|18738586|P6|NOT COMPLETED|Overall Study||3
7611164|NCT02452034|18738587|P5|NOT COMPLETED|Overall Study||1
7611165|NCT02452034|18738588|P4|NOT COMPLETED|Overall Study||1
7611166|NCT02452034|18738589|P3|NOT COMPLETED|Overall Study||1
7611167|NCT02452034|18738590|P2|NOT COMPLETED|Overall Study||1
7611168|NCT02452034|18738591|P1|NOT COMPLETED|Overall Study||2
7611169|NCT02452034|18738586|P6|COMPLETED|Overall Study||26
7611170|NCT02452034|18738587|P5|COMPLETED|Overall Study||19
7611171|NCT02452034|18738588|P4|COMPLETED|Overall Study||16
7611172|NCT02452034|18738589|P3|COMPLETED|Overall Study||14
7611173|NCT02452034|18738590|P2|COMPLETED|Overall Study||20
7611174|NCT02452034|18738591|P1|COMPLETED|Overall Study||14
7611175|NCT02452034|18738586|P6|Treated|Overall Study||29
7611176|NCT02452034|18738587|P5|Treated|Overall Study||20
7611177|NCT02452034|18738588|P4|Treated|Overall Study||16
7611178|NCT02452034|18738589|P3|Treated|Overall Study||15
7611179|NCT02452034|18738590|P2|Treated|Overall Study||21
7611180|NCT02452034|18738591|P1|Treated|Overall Study||14
7611181|NCT02452034|18738586|P6|STARTED|Overall Study||29
7611182|NCT02452034|18738587|P5|STARTED|Overall Study||20
7611183|NCT02452034|18738588|P4|STARTED|Overall Study||17
7611184|NCT02452034|18738589|P3|STARTED|Overall Study||15
7611185|NCT02452034|18738590|P2|STARTED|Overall Study||21
7611186|NCT02452034|18738591|P1|STARTED|Overall Study||16
7611187|NCT02451995|18738655|P2|NOT COMPLETED|Overall Study||0
7611188|NCT02451995|18738656|P1|NOT COMPLETED|Overall Study||0
7611189|NCT02451995|18738655|P2|COMPLETED|Overall Study||41
7611190|NCT02451995|18738656|P1|COMPLETED|Overall Study||42
7611191|NCT02451995|18738655|P2|STARTED|Overall Study||41
7611192|NCT02451995|18738656|P1|STARTED|Overall Study||42
7611193|NCT02451943|18738664|P2|NOT COMPLETED|Overall Study||24
7611194|NCT02451943|18738665|P1|NOT COMPLETED|Overall Study||20
7611195|NCT02451943|18738664|P2|COMPLETED|Overall Study||227
7611196|NCT02451943|18738665|P1|COMPLETED|Overall Study||238
7611197|NCT02451943|18738664|P2|Leiomyosarcoma (LMS) Population|Overall Study||115
7611198|NCT02451943|18738665|P1|Leiomyosarcoma (LMS) Population|Overall Study||119
7611199|NCT02451943|18738664|P2|Received at Least One Dose of Study Drug|Overall Study||249
7611200|NCT02451943|18738665|P1|Received at Least One Dose of Study Drug|Overall Study||257
7611201|NCT02451943|18738664|P2|STARTED|Overall Study||251
7611202|NCT02451943|18738665|P1|STARTED|Overall Study||258
7611203|NCT02451930|18738694|P2|NOT COMPLETED|Overall Study||30
7611204|NCT02451930|18738695|P1|NOT COMPLETED|Overall Study||2
7611205|NCT02451930|18738694|P2|COMPLETED|Overall Study||38
7611206|NCT02451930|18738695|P1|COMPLETED|Overall Study||1
7611207|NCT02451930|18738694|P2|Part C Participants|Overall Study||7
7611208|NCT02451930|18738695|P1|Part C Participants|Overall Study||0
7611209|NCT02451930|18738694|P2|Part B Participants|Overall Study||55
7611210|NCT02451930|18738695|P1|Part B Participants|Overall Study||0
7611211|NCT02451930|18738694|P2|Part A Cohort 2 Participants|Overall Study||6
7611212|NCT02451930|18738695|P1|Part A Cohort 2 Participants|Overall Study||0
7611213|NCT02451930|18738694|P2|Received at Least One Dose of Study Drug|Overall Study||68
7611214|NCT02451930|18738695|P1|Received at Least One Dose of Study Drug|Overall Study||3
7611215|NCT02451930|18738694|P2|STARTED|Overall Study||68
7611216|NCT02451930|18738695|P1|STARTED|Overall Study||3
7611217|NCT02451917|18738718|P2|NOT COMPLETED|Second Intervention (24 Weeks)||0
7611218|NCT02451917|18738719|P1|NOT COMPLETED|Second Intervention (24 Weeks)||0
7611219|NCT02451917|18738718|P2|COMPLETED|Second Intervention (24 Weeks)||15
7611220|NCT02451917|18738719|P1|COMPLETED|Second Intervention (24 Weeks)||14
7611221|NCT02451917|18738718|P2|STARTED|Second Intervention (24 Weeks)||15
7611222|NCT02451917|18738719|P1|STARTED|Second Intervention (24 Weeks)||14
7611223|NCT02451917|18738718|P2|NOT COMPLETED|First Intervention (24 Weeks)||3
7611224|NCT02451917|18738719|P1|NOT COMPLETED|First Intervention (24 Weeks)||2
7611225|NCT02451917|18738718|P2|COMPLETED|First Intervention (24 Weeks)||15
7611226|NCT02451917|18738719|P1|COMPLETED|First Intervention (24 Weeks)||14
7611227|NCT02451917|18738718|P2|STARTED|First Intervention (24 Weeks)||18
7611228|NCT02451917|18738719|P1|STARTED|First Intervention (24 Weeks)||16
7611229|NCT02451839|18738737|P3|NOT COMPLETED|Overall Study||7
7611230|NCT02451839|18738738|P2|NOT COMPLETED|Overall Study||19
7611231|NCT02451839|18738739|P1|NOT COMPLETED|Overall Study||28
7611232|NCT02451839|18738737|P3|COMPLETED|Overall Study||30
7611233|NCT02451839|18738738|P2|COMPLETED|Overall Study||40
7611234|NCT02451839|18738739|P1|COMPLETED|Overall Study||44
7611235|NCT02451839|18738737|P3|Baseline WHODAS Data Recorded|Overall Study||37
7611236|NCT02451839|18738738|P2|Baseline WHODAS Data Recorded|Overall Study||57
7611237|NCT02451839|18738739|P1|Baseline WHODAS Data Recorded|Overall Study||70
7611238|NCT02451839|18738737|P3|STARTED|Overall Study||37
7611239|NCT02451839|18738738|P2|STARTED|Overall Study||59
7611240|NCT02451839|18738739|P1|STARTED|Overall Study||72
7611241|NCT02451670|18738761|P2|NOT COMPLETED|Overall Study||696
7611242|NCT02451670|18738762|P1|NOT COMPLETED|Overall Study||714
7611243|NCT02451670|18738761|P2|COMPLETED|Overall Study||4387
7611244|NCT02451670|18738762|P1|COMPLETED|Overall Study||4550
7611245|NCT02451670|18738761|P2|STARTED|Overall Study||5083
7611246|NCT02451670|18738762|P1|STARTED|Overall Study||5264
7611247|NCT02451514|18738771|P3|NOT COMPLETED|Overall Study||0
7611248|NCT02451514|18738772|P2|NOT COMPLETED|Overall Study||0
7611249|NCT02451514|18738773|P1|NOT COMPLETED|Overall Study||0
7611250|NCT02451514|18738771|P3|COMPLETED|Overall Study||50
7611251|NCT02451514|18738772|P2|COMPLETED|Overall Study||46
7611252|NCT02451514|18738773|P1|COMPLETED|Overall Study||33
7611253|NCT02451514|18738771|P3|STARTED|Overall Study||50
7611254|NCT02451514|18738772|P2|STARTED|Overall Study||46
7611255|NCT02451514|18738773|P1|STARTED|Overall Study||33
7611256|NCT02451488|18738861|P2|NOT COMPLETED|Overall Study||0
7611257|NCT02451488|18738862|P1|NOT COMPLETED|Overall Study||0
7611258|NCT02451488|18738861|P2|COMPLETED|Overall Study||4
7611259|NCT02451488|18738862|P1|COMPLETED|Overall Study||4
7611260|NCT02451488|18738861|P2|STARTED|Overall Study||4
7611261|NCT02451488|18738862|P1|STARTED|Overall Study||4
7611262|NCT02451358|18738872|P4|NOT COMPLETED|Overall Study||0
7611263|NCT02451358|18738873|P3|NOT COMPLETED|Overall Study||1
7611264|NCT02451358|18738874|P2|NOT COMPLETED|Overall Study||2
7611265|NCT02451358|18738875|P1|NOT COMPLETED|Overall Study||1
7611266|NCT02451358|18738872|P4|COMPLETED|Overall Study||100
7611267|NCT02451358|18738873|P3|COMPLETED|Overall Study||99
7611268|NCT02451358|18738874|P2|COMPLETED|Overall Study||98
7611269|NCT02451358|18738875|P1|COMPLETED|Overall Study||99
7611270|NCT02451358|18738872|P4|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
7611271|NCT02451358|18738873|P3|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
7611272|NCT02451358|18738874|P2|Vaccinated at Day 28|Overall Study||98
7611273|NCT02451358|18738875|P1|Vaccinated at Day 28|Overall Study||99
7611274|NCT02451358|18738872|P4|Vaccinated at Day 0|Overall Study||100
7611275|NCT02451358|18738873|P3|Vaccinated at Day 0|Overall Study||100
7611276|NCT02451358|18738874|P2|Vaccinated at Day 0|Overall Study||100
7611277|NCT02451358|18738875|P1|Vaccinated at Day 0|Overall Study||100
7611278|NCT02451358|18738872|P4|STARTED|Overall Study||100
7611279|NCT02451358|18738873|P3|STARTED|Overall Study||100
7611280|NCT02451358|18738874|P2|STARTED|Overall Study||100
7611281|NCT02451358|18738875|P1|STARTED|Overall Study||100
7611282|NCT02451202|18738899|P2|NOT COMPLETED|Overall Study||3
7611283|NCT02451202|18738900|P1|NOT COMPLETED|Overall Study||2
7611284|NCT02451202|18738899|P2|COMPLETED|Overall Study||48
7611285|NCT02451202|18738900|P1|COMPLETED|Overall Study||49
7611286|NCT02451202|18738899|P2|STARTED|Overall Study||51
7611287|NCT02451202|18738900|P1|STARTED|Overall Study||51
7611288|NCT02451150|18738910|P2|NOT COMPLETED|Overall Study||0
7611289|NCT02451150|18738911|P1|NOT COMPLETED|Overall Study||0
7611290|NCT02451150|18738910|P2|COMPLETED|Overall Study||3
7611291|NCT02451150|18738911|P1|COMPLETED|Overall Study||3
7611292|NCT02451150|18738910|P2|STARTED|Overall Study||3
7611293|NCT02451150|18738911|P1|STARTED|Overall Study||3
7611294|NCT02451137|18738963|P2|NOT COMPLETED|Overall Study||298
7611295|NCT02451137|18738964|P1|NOT COMPLETED|Overall Study||246
7611296|NCT02451137|18738963|P2|COMPLETED|Overall Study||1355
7611297|NCT02451137|18738964|P1|COMPLETED|Overall Study||1405
7611298|NCT02451137|18738963|P2|Safety Population|Overall Study|9 participants received Toujeo instead of Standard of Care.|1621
7611299|NCT02451137|18738964|P1|Safety Population|Overall Study|4 participants received Standard of Care instead of Toujeo.|1637
7611300|NCT02451137|18738963|P2|Treated|Overall Study||1626
7611301|NCT02451137|18738964|P1|Treated|Overall Study||1632
7611302|NCT02451137|18738963|P2|STARTED|Overall Study||1653
7611303|NCT02451137|18738964|P1|STARTED|Overall Study||1651
7611304|NCT02451124|18738994|P1|NOT COMPLETED|Overall Study||1
7611305|NCT02451124|18738994|P1|COMPLETED|Overall Study||155
7611306|NCT02451124|18738994|P1|STARTED|Overall Study||156
7611307|NCT02451007|18739005|P1|NOT COMPLETED|Overall Study||7
7611308|NCT02451007|18739005|P1|COMPLETED|Overall Study||32
7611309|NCT02451007|18739005|P1|STARTED|Overall Study||39
7611310|NCT02450903|18739012|P1|NOT COMPLETED|Overall Study||20
7611311|NCT02450903|18739012|P1|COMPLETED|Overall Study||0
7611312|NCT02450903|18739012|P1|Entered Survival Follow-up Phase|Overall Study||15
7611313|NCT02450903|18739012|P1|Entered Post-treatment Effic. f/u Phase|Overall Study||4
7611314|NCT02450903|18739012|P1|STARTED|Overall Study||20
7611315|NCT02450799|18739026|P3|NOT COMPLETED|Overall Study||0
7611316|NCT02450799|18739027|P2|NOT COMPLETED|Overall Study||0
7611317|NCT02450799|18739028|P1|NOT COMPLETED|Overall Study||0
7611318|NCT02450799|18739026|P3|COMPLETED|Overall Study||30
7611319|NCT02450799|18739027|P2|COMPLETED|Overall Study||37
7611320|NCT02450799|18739028|P1|COMPLETED|Overall Study||31
7611321|NCT02450799|18739026|P3|STARTED|Overall Study||30
7611322|NCT02450799|18739027|P2|STARTED|Overall Study||37
7611323|NCT02450799|18739028|P1|STARTED|Overall Study||31
7611324|NCT02450747|18739039|P1|NOT COMPLETED|Overall Study||0
7611325|NCT02450747|18739039|P1|COMPLETED|Overall Study||39
7611326|NCT02450747|18739039|P1|STARTED|Overall Study||39
7611327|NCT02450591|18739048|P1|NOT COMPLETED|Overall Study||0
7611328|NCT02450591|18739048|P1|COMPLETED|Overall Study||4
7611329|NCT02450591|18739048|P1|STARTED|Overall Study||4
7611330|NCT02450578|18739056|P4|NOT COMPLETED|Overall Study||0
7611331|NCT02450578|18739057|P3|NOT COMPLETED|Overall Study||0
7611332|NCT02450578|18739058|P2|NOT COMPLETED|Overall Study||0
7611333|NCT02450578|18739059|P1|NOT COMPLETED|Overall Study||1
7611334|NCT02450578|18739056|P4|COMPLETED|Overall Study||4
7611335|NCT02450578|18739057|P3|COMPLETED|Overall Study||6
7611336|NCT02450578|18739058|P2|COMPLETED|Overall Study||6
7611337|NCT02450578|18739059|P1|COMPLETED|Overall Study||5
7611338|NCT02450578|18739056|P4|STARTED|Overall Study||4
7611339|NCT02450578|18739057|P3|STARTED|Overall Study||6
7611340|NCT02450578|18739058|P2|STARTED|Overall Study||6
7611341|NCT02450578|18739059|P1|STARTED|Overall Study||6
7611342|NCT02450552|18739106|P3|NOT COMPLETED|Overall Study||5
7611343|NCT02450552|18739107|P2|NOT COMPLETED|Overall Study||0
7611344|NCT02450552|18739108|P1|NOT COMPLETED|Overall Study||5
7611345|NCT02450552|18739106|P3|COMPLETED|Overall Study||18
7611346|NCT02450552|18739107|P2|COMPLETED|Overall Study||23
7611347|NCT02450552|18739108|P1|COMPLETED|Overall Study||14
7611348|NCT02450552|18739106|P3|STARTED|Overall Study||23
7611349|NCT02450552|18739107|P2|STARTED|Overall Study||23
7611350|NCT02450552|18739108|P1|STARTED|Overall Study||19
7611351|NCT02450539|18739151|P2|NOT COMPLETED|Overall Study||33
7611352|NCT02450539|18739152|P1|NOT COMPLETED|Overall Study||50
7611353|NCT02450539|18739151|P2|COMPLETED|Overall Study||20
7611354|NCT02450539|18739152|P1|COMPLETED|Overall Study||56
7611355|NCT02450539|18739151|P2|Death|Overall Study||20
7611356|NCT02450539|18739152|P1|Death|Overall Study||56
7611357|NCT02450539|18739151|P2|Received at Least One Dose of Study Drug|Overall Study||52
7611358|NCT02450539|18739152|P1|Received at Least One Dose of Study Drug|Overall Study||106
7611359|NCT02450539|18739151|P2|STARTED|Overall Study||53
7611360|NCT02450539|18739152|P1|STARTED|Overall Study||106
7611361|NCT02450526|18739176|P5|NOT COMPLETED|OL Period (Cycles 2-5)||41
7611362|NCT02450526|18739177|P4|NOT COMPLETED|OL Period (Cycles 2-5)||0
7611363|NCT02450526|18739178|P3|NOT COMPLETED|OL Period (Cycles 2-5)||0
7611364|NCT02450526|18739179|P2|NOT COMPLETED|OL Period (Cycles 2-5)||0
7611365|NCT02450526|18739180|P1|NOT COMPLETED|OL Period (Cycles 2-5)||0
7611366|NCT02450526|18739176|P5|COMPLETED|OL Period (Cycles 2-5)||424
7611367|NCT02450526|18739177|P4|COMPLETED|OL Period (Cycles 2-5)||0
7611368|NCT02450526|18739178|P3|COMPLETED|OL Period (Cycles 2-5)||0
7611369|NCT02450526|18739179|P2|COMPLETED|OL Period (Cycles 2-5)||0
7611370|NCT02450526|18739180|P1|COMPLETED|OL Period (Cycles 2-5)||0
7611371|NCT02450526|18739176|P5|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
7611372|NCT02450526|18739177|P4|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
7611373|NCT02450526|18739178|P3|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
7611374|NCT02450526|18739179|P2|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
7611375|NCT02450526|18739180|P1|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
7611376|NCT02450526|18739176|P5|Discontinued During Cycle 4|OL Period (Cycles 2-5)||2
7611377|NCT02450526|18739177|P4|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
7611378|NCT02450526|18739178|P3|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
7611379|NCT02450526|18739179|P2|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
7611380|NCT02450526|18739180|P1|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
7611381|NCT02450526|18739176|P5|Discontinued During Cycle 3|OL Period (Cycles 2-5)||11
7611382|NCT02450526|18739177|P4|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
7611383|NCT02450526|18739178|P3|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
7611384|NCT02450526|18739179|P2|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
7611385|NCT02450526|18739180|P1|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
7611386|NCT02450526|18739176|P5|Discontinued During Cycle 2|OL Period (Cycles 2-5)||28
7611387|NCT02450526|18739177|P4|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
7611388|NCT02450526|18739178|P3|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
7611389|NCT02450526|18739179|P2|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
7611390|NCT02450526|18739180|P1|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
7611391|NCT02450526|18739176|P5|Safety Population|OL Period (Cycles 2-5)||465
7611392|NCT02450526|18739177|P4|Safety Population|OL Period (Cycles 2-5)||0
7611393|NCT02450526|18739178|P3|Safety Population|OL Period (Cycles 2-5)||0
7611394|NCT02450526|18739179|P2|Safety Population|OL Period (Cycles 2-5)||0
7611395|NCT02450526|18739180|P1|Safety Population|OL Period (Cycles 2-5)||0
7611396|NCT02450526|18739176|P5|STARTED|OL Period (Cycles 2-5)|Nine subjects completed the DB Period but were not eligible for retreatment in the OL Period.|465
7611397|NCT02450526|18739177|P4|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
7611398|NCT02450526|18739178|P3|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
7611399|NCT02450526|18739179|P2|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
7611400|NCT02450526|18739180|P1|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
7611401|NCT02450526|18739176|P5|NOT COMPLETED|DB Period (Cycle 1)||0
7611402|NCT02450526|18739177|P4|NOT COMPLETED|DB Period (Cycle 1)||2
7611403|NCT02450526|18739178|P3|NOT COMPLETED|DB Period (Cycle 1)||10
7611404|NCT02450526|18739179|P2|NOT COMPLETED|DB Period (Cycle 1)||3
7611405|NCT02450526|18739180|P1|NOT COMPLETED|DB Period (Cycle 1)||31
7611406|NCT02450526|18739176|P5|COMPLETED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
7611407|NCT02450526|18739177|P4|COMPLETED|DB Period (Cycle 1)||20
7611408|NCT02450526|18739178|P3|COMPLETED|DB Period (Cycle 1)||97
7611409|NCT02450526|18739179|P2|COMPLETED|DB Period (Cycle 1)||63
7611410|NCT02450526|18739180|P1|COMPLETED|DB Period (Cycle 1)||294
7611411|NCT02450526|18739176|P5|Safety Population|DB Period (Cycle 1)||0
7611412|NCT02450526|18739177|P4|Safety Population|DB Period (Cycle 1)||21
7611413|NCT02450526|18739178|P3|Safety Population|DB Period (Cycle 1)||107
7611414|NCT02450526|18739179|P2|Safety Population|DB Period (Cycle 1)||66
7611415|NCT02450526|18739180|P1|Safety Population|DB Period (Cycle 1)||326
7611416|NCT02450526|18739176|P5|STARTED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
7611417|NCT02450526|18739177|P4|STARTED|DB Period (Cycle 1)||22
7611418|NCT02450526|18739178|P3|STARTED|DB Period (Cycle 1)||107
7611419|NCT02450526|18739179|P2|STARTED|DB Period (Cycle 1)||66
7611420|NCT02450526|18739180|P1|STARTED|DB Period (Cycle 1)||325
7611421|NCT02450487|18739265|P1|NOT COMPLETED|Overall Study||3
7611422|NCT02450487|18739265|P1|COMPLETED|Overall Study||102
7611423|NCT02450487|18739265|P1|STARTED|Overall Study||105
7611424|NCT02450383|18739272|P2|NOT COMPLETED|Overall Study||0
7611425|NCT02450383|18739273|P1|NOT COMPLETED|Overall Study||0
7611426|NCT02450383|18739272|P2|COMPLETED|Overall Study||10
7611427|NCT02450383|18739273|P1|COMPLETED|Overall Study||10
7611428|NCT02450383|18739272|P2|STARTED|Overall Study||10
7611429|NCT02450383|18739273|P1|STARTED|Overall Study||10
7611430|NCT02450331|18739287|P2|NOT COMPLETED|Overall Study||406
7611431|NCT02450331|18739288|P1|NOT COMPLETED|Overall Study||403
7611432|NCT02450331|18739287|P2|COMPLETED|Overall Study||0
7611433|NCT02450331|18739288|P1|COMPLETED|Overall Study||0
7611434|NCT02450331|18739287|P2|STARTED|Overall Study||406
7611435|NCT02450331|18739288|P1|STARTED|Overall Study||403
7611436|NCT02449915|18739311|P2|NOT COMPLETED|Overall Study||4
7611437|NCT02449915|18739312|P1|NOT COMPLETED|Overall Study||2
7611438|NCT02449915|18739311|P2|COMPLETED|Overall Study||31
7611439|NCT02449915|18739312|P1|COMPLETED|Overall Study||33
7611440|NCT02449915|18739311|P2|STARTED|Overall Study||35
7611441|NCT02449915|18739312|P1|STARTED|Overall Study||35
7611442|NCT02449902|18739320|P2|NOT COMPLETED|Overall Study||2
7611443|NCT02449902|18739321|P1|NOT COMPLETED|Overall Study||0
7611444|NCT02449902|18739320|P2|COMPLETED|Overall Study||24
7611445|NCT02449902|18739321|P1|COMPLETED|Overall Study||24
7611446|NCT02449902|18739320|P2|STARTED|Overall Study||26
7611447|NCT02449902|18739321|P1|STARTED|Overall Study||24
7611448|NCT02449889|18739348|P3|NOT COMPLETED|Overall Study||1
7611449|NCT02449889|18739349|P2|NOT COMPLETED|Overall Study||6
7611450|NCT02449889|18739350|P1|NOT COMPLETED|Overall Study||1
7611451|NCT02449889|18739348|P3|COMPLETED|Overall Study||59
7611452|NCT02449889|18739349|P2|COMPLETED|Overall Study||52
7611453|NCT02449889|18739350|P1|COMPLETED|Overall Study||57
7611454|NCT02449889|18739348|P3|STARTED|Overall Study||60
7611455|NCT02449889|18739349|P2|STARTED|Overall Study||58
7611456|NCT02449889|18739350|P1|STARTED|Overall Study||58
7611457|NCT02449798|18739376|P1|NOT COMPLETED|Overall Study||0
7611458|NCT02449798|18739376|P1|COMPLETED|Overall Study||120
7611459|NCT02449798|18739376|P1|STARTED|Overall Study||120
7611460|NCT02449473|18739390|P2|NOT COMPLETED|Overall Study||0
7611461|NCT02449473|18739391|P1|NOT COMPLETED|Overall Study||0
7611462|NCT02449473|18739390|P2|COMPLETED|Overall Study||40
7611463|NCT02449473|18739391|P1|COMPLETED|Overall Study||39
7611464|NCT02449473|18739390|P2|STARTED|Overall Study||40
7611465|NCT02449473|18739391|P1|STARTED|Overall Study||39
7611466|NCT02449434|18739407|P2|NOT COMPLETED|Overall Study||0
7611467|NCT02449434|18739408|P1|NOT COMPLETED|Overall Study||0
7611468|NCT02449434|18739407|P2|COMPLETED|Overall Study||300
7611469|NCT02449434|18739408|P1|COMPLETED|Overall Study||300
7611470|NCT02449434|18739407|P2|STARTED|Overall Study||300
7611471|NCT02449434|18739408|P1|STARTED|Overall Study||300
7611472|NCT02449356|18739416|P2|NOT COMPLETED|Overall Study||0
7611473|NCT02449356|18739417|P1|NOT COMPLETED|Overall Study||0
7611474|NCT02449356|18739416|P2|COMPLETED|Overall Study||30
7611475|NCT02449356|18739417|P1|COMPLETED|Overall Study||30
7611476|NCT02449356|18739416|P2|STARTED|Overall Study||30
7611477|NCT02449356|18739417|P1|STARTED|Overall Study||30
7611478|NCT02449291|18739436|P3|NOT COMPLETED|Overall Study||1
7611479|NCT02449291|18739437|P2|NOT COMPLETED|Overall Study||2
7611480|NCT02449291|18739438|P1|NOT COMPLETED|Overall Study||5
7611481|NCT02449291|18739436|P3|COMPLETED|Overall Study||180
7611482|NCT02449291|18739437|P2|COMPLETED|Overall Study||186
7611483|NCT02449291|18739438|P1|COMPLETED|Overall Study||186
7611484|NCT02449291|18739436|P3|STARTED|Overall Study||181
7611485|NCT02449291|18739437|P2|STARTED|Overall Study||188
7611486|NCT02449291|18739438|P1|STARTED|Overall Study||191
7611487|NCT02449174|18739475|P2|NOT COMPLETED|Overall Study||0
7611488|NCT02449174|18739476|P1|NOT COMPLETED|Overall Study||0
7611489|NCT02449174|18739475|P2|COMPLETED|Overall Study||32
7611490|NCT02449174|18739476|P1|COMPLETED|Overall Study||36
7611491|NCT02449174|18739475|P2|STARTED|Overall Study||32
7611492|NCT02449174|18739476|P1|STARTED|Overall Study||36
7611493|NCT02449044|18739484|P1|NOT COMPLETED|Overall Study||64
7611494|NCT02449044|18739484|P1|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47
7611495|NCT02449044|18739484|P1|STARTED|Overall Study||111
7611496|NCT02449018|18739505|P2|NOT COMPLETED|Overall Study||2
7611497|NCT02449018|18739506|P1|NOT COMPLETED|Overall Study||12
7611498|NCT02449018|18739505|P2|COMPLETED|Overall Study||26
7611499|NCT02449018|18739506|P1|COMPLETED|Overall Study||52
7611500|NCT02449018|18739505|P2|STARTED|Overall Study||28
7611501|NCT02449018|18739506|P1|STARTED|Overall Study||64
7611502|NCT02448914|18739533|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7611503|NCT02448914|18739534|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7611504|NCT02448914|18739533|P2|COMPLETED|Second Intervention (1 Day)||5
7611505|NCT02448914|18739534|P1|COMPLETED|Second Intervention (1 Day)||6
7611506|NCT02448914|18739533|P2|STARTED|Second Intervention (1 Day)||5
7611507|NCT02448914|18739534|P1|STARTED|Second Intervention (1 Day)||6
7611508|NCT02448914|18739533|P2|NOT COMPLETED|First Intervention (1 Day)||0
7611509|NCT02448914|18739534|P1|NOT COMPLETED|First Intervention (1 Day)||0
7611510|NCT02448914|18739533|P2|COMPLETED|First Intervention (1 Day)||5
7611511|NCT02448914|18739534|P1|COMPLETED|First Intervention (1 Day)||6
7611512|NCT02448914|18739533|P2|STARTED|First Intervention (1 Day)||5
7611513|NCT02448914|18739534|P1|STARTED|First Intervention (1 Day)||6
7611514|NCT02448875|18739553|P3|NOT COMPLETED|Overall Study||1
7611515|NCT02448875|18739554|P2|NOT COMPLETED|Overall Study||1
7611516|NCT02448875|18739555|P1|NOT COMPLETED|Overall Study||7
7611517|NCT02448875|18739553|P3|COMPLETED|Overall Study||60
7611518|NCT02448875|18739554|P2|COMPLETED|Overall Study||20
7611519|NCT02448875|18739555|P1|COMPLETED|Overall Study||53
7611520|NCT02448875|18739553|P3|Safety Analysis Set|Overall Study||61
7611521|NCT02448875|18739554|P2|Safety Analysis Set|Overall Study||21
7611522|NCT02448875|18739555|P1|Safety Analysis Set|Overall Study||60
7611523|NCT02448875|18739553|P3|Full Analysis Set|Overall Study||61
7611524|NCT02448875|18739554|P2|Full Analysis Set|Overall Study||21
7611525|NCT02448875|18739555|P1|Full Analysis Set|Overall Study||60
7611526|NCT02448875|18739553|P3|Completed Dose Selection Phase|Overall Study||20
7611527|NCT02448875|18739554|P2|Completed Dose Selection Phase|Overall Study||21
7611528|NCT02448875|18739555|P1|Completed Dose Selection Phase|Overall Study||20
7611529|NCT02448875|18739553|P3|STARTED|Overall Study||61
7611530|NCT02448875|18739554|P2|STARTED|Overall Study||21
7611531|NCT02448875|18739555|P1|STARTED|Overall Study||60
7611532|NCT02448862|18739580|P2|NOT COMPLETED|Overall Study||0
7611533|NCT02448862|18739581|P1|NOT COMPLETED|Overall Study||0
7611534|NCT02448862|18739580|P2|COMPLETED|Overall Study||6050
7611535|NCT02448862|18739581|P1|COMPLETED|Overall Study||4525
7611536|NCT02448862|18739580|P2|STARTED|Overall Study||6050
7611537|NCT02448862|18739581|P1|STARTED|Overall Study||4525
7611538|NCT02448810|18739603|P8|NOT COMPLETED|Overall Study||8
7611539|NCT02448810|18739604|P7|NOT COMPLETED|Overall Study||18
7611540|NCT02448810|18739605|P6|NOT COMPLETED|Overall Study||16
7611541|NCT02448810|18739606|P5|NOT COMPLETED|Overall Study||31
7611542|NCT02448810|18739607|P4|NOT COMPLETED|Overall Study||3
7611543|NCT02448810|18739608|P3|NOT COMPLETED|Overall Study||3
7611544|NCT02448810|18739609|P2|NOT COMPLETED|Overall Study||3
7611545|NCT02448810|18739610|P1|NOT COMPLETED|Overall Study||3
7611546|NCT02448810|18739603|P8|COMPLETED|Overall Study||0
7611547|NCT02448810|18739604|P7|COMPLETED|Overall Study||0
7611548|NCT02448810|18739605|P6|COMPLETED|Overall Study||0
7611549|NCT02448810|18739606|P5|COMPLETED|Overall Study||0
7611550|NCT02448810|18739607|P4|COMPLETED|Overall Study||0
7611551|NCT02448810|18739608|P3|COMPLETED|Overall Study||0
7611552|NCT02448810|18739609|P2|COMPLETED|Overall Study||0
7611553|NCT02448810|18739610|P1|COMPLETED|Overall Study||0
7611554|NCT02448810|18739603|P8|Treated|Overall Study||7
7611555|NCT02448810|18739604|P7|Treated|Overall Study||18
7611556|NCT02448810|18739605|P6|Treated|Overall Study||13
7611557|NCT02448810|18739606|P5|Treated|Overall Study||29
7611558|NCT02448810|18739607|P4|Treated|Overall Study||3
7611559|NCT02448810|18739608|P3|Treated|Overall Study||3
7611560|NCT02448810|18739609|P2|Treated|Overall Study||3
7611561|NCT02448810|18739610|P1|Treated|Overall Study||3
7611562|NCT02448810|18739603|P8|STARTED|Overall Study||8
7611563|NCT02448810|18739604|P7|STARTED|Overall Study||18
7611564|NCT02448810|18739605|P6|STARTED|Overall Study||16
7611565|NCT02448810|18739606|P5|STARTED|Overall Study||31
7611566|NCT02448810|18739607|P4|STARTED|Overall Study||3
7611567|NCT02448810|18739608|P3|STARTED|Overall Study||3
7611568|NCT02448810|18739609|P2|STARTED|Overall Study||3
7611569|NCT02448810|18739610|P1|STARTED|Overall Study||3
7611570|NCT02448719|18739687|P11|NOT COMPLETED|Overall Study||0
7611571|NCT02448719|18739688|P10|NOT COMPLETED|Overall Study||0
7611572|NCT02448719|18739689|P9|NOT COMPLETED|Overall Study||0
7611573|NCT02448719|18739690|P8|NOT COMPLETED|Overall Study||0
7611574|NCT02448719|18739691|P7|NOT COMPLETED|Overall Study||0
7611575|NCT02448719|18739692|P6|NOT COMPLETED|Overall Study||0
7611576|NCT02448719|18739693|P5|NOT COMPLETED|Overall Study||1
7611577|NCT02448719|18739694|P4|NOT COMPLETED|Overall Study||0
7611578|NCT02448719|18739695|P3|NOT COMPLETED|Overall Study||0
7611579|NCT02448719|18739696|P2|NOT COMPLETED|Overall Study||0
7611580|NCT02448719|18739697|P1|NOT COMPLETED|Overall Study||0
7611581|NCT02448719|18739687|P11|COMPLETED|Overall Study||6
7611582|NCT02448719|18739688|P10|COMPLETED|Overall Study||6
7611583|NCT02448719|18739689|P9|COMPLETED|Overall Study||6
7611584|NCT02448719|18739690|P8|COMPLETED|Overall Study||6
7611585|NCT02448719|18739691|P7|COMPLETED|Overall Study||6
7611586|NCT02448719|18739692|P6|COMPLETED|Overall Study||6
7611587|NCT02448719|18739693|P5|COMPLETED|Overall Study||5
7611588|NCT02448719|18739694|P4|COMPLETED|Overall Study||6
7611589|NCT02448719|18739695|P3|COMPLETED|Overall Study||6
7611590|NCT02448719|18739696|P2|COMPLETED|Overall Study||6
7611591|NCT02448719|18739697|P1|COMPLETED|Overall Study||12
7611592|NCT02448719|18739687|P11|STARTED|Overall Study||6
7611593|NCT02448719|18739688|P10|STARTED|Overall Study||6
7611594|NCT02448719|18739689|P9|STARTED|Overall Study||6
7611595|NCT02448719|18739690|P8|STARTED|Overall Study||6
7611596|NCT02448719|18739691|P7|STARTED|Overall Study||6
7611597|NCT02448719|18739692|P6|STARTED|Overall Study||6
7611598|NCT02448719|18739693|P5|STARTED|Overall Study||6
7611599|NCT02448719|18739694|P4|STARTED|Overall Study||6
7611600|NCT02448719|18739695|P3|STARTED|Overall Study||6
7611601|NCT02448719|18739696|P2|STARTED|Overall Study||6
7611602|NCT02448719|18739697|P1|STARTED|Overall Study||12
7611603|NCT02448706|18739921|P2|NOT COMPLETED|Overall Study||4
7611604|NCT02448706|18739922|P1|NOT COMPLETED|Overall Study||5
7611605|NCT02448706|18739921|P2|COMPLETED|Overall Study||20
7611606|NCT02448706|18739922|P1|COMPLETED|Overall Study||20
7611607|NCT02448706|18739921|P2|Completed Baseline Testing|Overall Study||23
7611608|NCT02448706|18739922|P1|Completed Baseline Testing|Overall Study||24
7611609|NCT02448706|18739921|P2|Withdrew for Personal Reasons|Overall Study||1
7611610|NCT02448706|18739922|P1|Withdrew for Personal Reasons|Overall Study||1
7611611|NCT02448706|18739921|P2|STARTED|Overall Study||24
7611612|NCT02448706|18739922|P1|STARTED|Overall Study||25
7611613|NCT02448680|18739936|P2|NOT COMPLETED|Overall Study||3
7611614|NCT02448680|18739937|P1|NOT COMPLETED|Overall Study||1
7611615|NCT02448680|18739936|P2|COMPLETED|Overall Study||10
7611616|NCT02448680|18739937|P1|COMPLETED|Overall Study||11
7611617|NCT02448680|18739936|P2|STARTED|Overall Study||13
7611618|NCT02448680|18739937|P1|STARTED|Overall Study||12
7611619|NCT02448654|18739957|P2|NOT COMPLETED|Overall Study||4
7611620|NCT02448654|18739958|P1|NOT COMPLETED|Overall Study||3
7611621|NCT02448654|18739957|P2|COMPLETED|Overall Study||13
7611622|NCT02448654|18739958|P1|COMPLETED|Overall Study||16
7611623|NCT02448654|18739957|P2|Started Pills (Tolcapone or Placebo)|Overall Study||15
7611624|NCT02448654|18739958|P1|Started Pills (Tolcapone or Placebo)|Overall Study||17
7611625|NCT02448654|18739957|P2|STARTED|Overall Study||17
7611626|NCT02448654|18739958|P1|STARTED|Overall Study||19
7611627|NCT02448641|18739971|P3|NOT COMPLETED|Overall Study||4
7611628|NCT02448641|18739972|P2|NOT COMPLETED|Overall Study||5
7611629|NCT02448641|18739973|P1|NOT COMPLETED|Overall Study||1
7611630|NCT02448641|18739971|P3|COMPLETED|Overall Study||48
7611631|NCT02448641|18739972|P2|COMPLETED|Overall Study||51
7611632|NCT02448641|18739973|P1|COMPLETED|Overall Study||54
7611633|NCT02448641|18739971|P3|STARTED|Overall Study||52
7611634|NCT02448641|18739972|P2|STARTED|Overall Study||56
7611635|NCT02448641|18739973|P1|STARTED|Overall Study||55
7611636|NCT02448563|18740006|P2|NOT COMPLETED|Overall Study||11
7611637|NCT02448563|18740007|P1|NOT COMPLETED|Overall Study||16
7611638|NCT02448563|18740006|P2|COMPLETED|Overall Study||19
7611639|NCT02448563|18740007|P1|COMPLETED|Overall Study||16
7611640|NCT02448563|18740006|P2|STARTED|Overall Study|Randomized after completing Visit 2|30
7611641|NCT02448563|18740007|P1|STARTED|Overall Study|Randomized after completing Visit 2|32
7611642|NCT02448537|18740029|P3|NOT COMPLETED|Overall Study||1
7611643|NCT02448537|18740030|P2|NOT COMPLETED|Overall Study||1
7611644|NCT02448537|18740031|P1|NOT COMPLETED|Overall Study||1
7611645|NCT02448537|18740029|P3|COMPLETED|Overall Study||11
7611646|NCT02448537|18740030|P2|COMPLETED|Overall Study||9
7611647|NCT02448537|18740031|P1|COMPLETED|Overall Study||19
7611648|NCT02448537|18740029|P3|STARTED|Overall Study||12
7611649|NCT02448537|18740030|P2|STARTED|Overall Study||10
7611650|NCT02448537|18740031|P1|STARTED|Overall Study||20
7611651|NCT02448368|18740047|P13|NOT COMPLETED|Overall Study||0
7611652|NCT02448368|18740048|P12|NOT COMPLETED|Overall Study||0
7611653|NCT02448368|18740049|P11|NOT COMPLETED|Overall Study||0
7611654|NCT02448368|18740050|P10|NOT COMPLETED|Overall Study||0
7611655|NCT02448368|18740051|P9|NOT COMPLETED|Overall Study||0
7611656|NCT02448368|18740052|P8|NOT COMPLETED|Overall Study||0
7611657|NCT02448368|18740053|P7|NOT COMPLETED|Overall Study||0
7611658|NCT02448368|18740054|P6|NOT COMPLETED|Overall Study||0
7611659|NCT02448368|18740055|P5|NOT COMPLETED|Overall Study||0
7611660|NCT02448368|18740056|P4|NOT COMPLETED|Overall Study||0
7611661|NCT02448368|18740057|P3|NOT COMPLETED|Overall Study||0
7611662|NCT02448368|18740058|P2|NOT COMPLETED|Overall Study||0
7611663|NCT02448368|18740059|P1|NOT COMPLETED|Overall Study||0
7611664|NCT02448368|18740047|P13|COMPLETED|Overall Study||5
7611665|NCT02448368|18740048|P12|COMPLETED|Overall Study||5
7611666|NCT02448368|18740049|P11|COMPLETED|Overall Study||5
7611667|NCT02448368|18740050|P10|COMPLETED|Overall Study||2
7611668|NCT02448368|18740051|P9|COMPLETED|Overall Study||2
7611669|NCT02448368|18740052|P8|COMPLETED|Overall Study||2
7611670|NCT02448368|18740053|P7|COMPLETED|Overall Study||2
7611671|NCT02448368|18740054|P6|COMPLETED|Overall Study||2
7611672|NCT02448368|18740055|P5|COMPLETED|Overall Study||2
7611673|NCT02448368|18740056|P4|COMPLETED|Overall Study||2
7611674|NCT02448368|18740057|P3|COMPLETED|Overall Study||2
7611675|NCT02448368|18740058|P2|COMPLETED|Overall Study||2
7611676|NCT02448368|18740059|P1|COMPLETED|Overall Study||2
7611677|NCT02448368|18740047|P13|STARTED|Overall Study||5
7611678|NCT02448368|18740048|P12|STARTED|Overall Study||5
7611679|NCT02448368|18740049|P11|STARTED|Overall Study||5
7611680|NCT02448368|18740050|P10|STARTED|Overall Study||2
7611681|NCT02448368|18740051|P9|STARTED|Overall Study||2
7611682|NCT02448368|18740052|P8|STARTED|Overall Study||2
7611683|NCT02448368|18740053|P7|STARTED|Overall Study||2
7611684|NCT02448368|18740054|P6|STARTED|Overall Study||2
7611685|NCT02448368|18740055|P5|STARTED|Overall Study||2
7611686|NCT02448368|18740056|P4|STARTED|Overall Study||2
7611687|NCT02448368|18740057|P3|STARTED|Overall Study||2
7611688|NCT02448368|18740058|P2|STARTED|Overall Study||2
7611689|NCT02448368|18740059|P1|STARTED|Overall Study||2
7611690|NCT02448303|18740136|P2|NOT COMPLETED|Overall Study||36
7611691|NCT02448303|18740137|P1|NOT COMPLETED|Overall Study||38
7611692|NCT02448303|18740136|P2|COMPLETED|Overall Study||0
7611693|NCT02448303|18740137|P1|COMPLETED|Overall Study||0
7611694|NCT02448303|18740136|P2|Discontinued Study|Overall Study||36
7611695|NCT02448303|18740137|P1|Discontinued Study|Overall Study||38
7611696|NCT02448303|18740136|P2|Received Study Medication|Overall Study||35
7611697|NCT02448303|18740137|P1|Received Study Medication|Overall Study||33
7611698|NCT02448303|18740136|P2|Enrolled|Overall Study||36
7611699|NCT02448303|18740137|P1|Enrolled|Overall Study||38
7611700|NCT02448303|18740136|P2|STARTED|Overall Study||36
7611701|NCT02448303|18740137|P1|STARTED|Overall Study||38
7611702|NCT02448043|18740145|P2|NOT COMPLETED|Overall Study||4
7611703|NCT02448043|18740146|P1|NOT COMPLETED|Overall Study||3
7611704|NCT02448043|18740145|P2|COMPLETED|Overall Study||18
7611705|NCT02448043|18740146|P1|COMPLETED|Overall Study||20
7611706|NCT02448043|18740145|P2|STARTED|Overall Study||22
7611707|NCT02448043|18740146|P1|STARTED|Overall Study||23
7611708|NCT02447952|18740164|P1|NOT COMPLETED|Overall Study||7
7611709|NCT02447952|18740164|P1|COMPLETED|Overall Study||18
7611710|NCT02447952|18740164|P1|STARTED|Overall Study||25
7611711|NCT02447926|18740216|P1|NOT COMPLETED|Overall Study||0
7611712|NCT02447926|18740216|P1|COMPLETED|Overall Study||1
7611713|NCT02447926|18740216|P1|STARTED|Overall Study||1
7611714|NCT02447887|18740221|P1|NOT COMPLETED|Overall Study||3
7611715|NCT02447887|18740221|P1|COMPLETED|Overall Study||0
7611716|NCT02447887|18740221|P1|STARTED|Overall Study||3
7611717|NCT02447848|18740234|P1|NOT COMPLETED|Overall Study||11
7611718|NCT02447848|18740234|P1|COMPLETED|Overall Study||65
7611719|NCT02447848|18740234|P1|STARTED|Overall Study||76
7611720|NCT02447575|18740240|P1|NOT COMPLETED|Overall Study||0
7611721|NCT02447575|18740240|P1|COMPLETED|Overall Study||23
7611722|NCT02447575|18740240|P1|STARTED|Overall Study|23 subjects were enrolled in the study: http://dx.doi.org/10.1016/j.chest.2016.08.017|23
7611723|NCT02447497|18740248|P4|NOT COMPLETED|Overall Study||2
7611724|NCT02447497|18740249|P3|NOT COMPLETED|Overall Study||2
7611725|NCT02447497|18740250|P2|NOT COMPLETED|Overall Study||6
7611726|NCT02447497|18740251|P1|NOT COMPLETED|Overall Study||6
7611727|NCT02447497|18740248|P4|COMPLETED|Overall Study||21
7611728|NCT02447497|18740249|P3|COMPLETED|Overall Study||21
7611729|NCT02447497|18740250|P2|COMPLETED|Overall Study||19
7611730|NCT02447497|18740251|P1|COMPLETED|Overall Study||19
7611731|NCT02447497|18740248|P4|STARTED|Overall Study||23
7611732|NCT02447497|18740249|P3|STARTED|Overall Study||23
7611733|NCT02447497|18740250|P2|STARTED|Overall Study||25
7611734|NCT02447497|18740251|P1|STARTED|Overall Study||25
7611735|NCT02447458|18740275|P6|NOT COMPLETED|Overall Study||0
7611736|NCT02447458|18740276|P5|NOT COMPLETED|Overall Study||0
7611737|NCT02447458|18740277|P4|NOT COMPLETED|Overall Study||0
7611738|NCT02447458|18740278|P3|NOT COMPLETED|Overall Study||1
7611739|NCT02447458|18740279|P2|NOT COMPLETED|Overall Study||0
7611740|NCT02447458|18740280|P1|NOT COMPLETED|Overall Study||0
7611741|NCT02447458|18740275|P6|COMPLETED|Overall Study||10
7611742|NCT02447458|18740276|P5|COMPLETED|Overall Study||6
7611743|NCT02447458|18740277|P4|COMPLETED|Overall Study||6
7611744|NCT02447458|18740278|P3|COMPLETED|Overall Study||5
7611745|NCT02447458|18740279|P2|COMPLETED|Overall Study||6
7611746|NCT02447458|18740280|P1|COMPLETED|Overall Study||5
7611747|NCT02447458|18740275|P6|STARTED|Overall Study||10
7611748|NCT02447458|18740276|P5|STARTED|Overall Study||6
7611749|NCT02447458|18740277|P4|STARTED|Overall Study||6
7611750|NCT02447458|18740278|P3|STARTED|Overall Study||6
7611751|NCT02447458|18740279|P2|STARTED|Overall Study||6
7611752|NCT02447458|18740280|P1|STARTED|Overall Study||5
7611753|NCT02447432|18740378|P2|NOT COMPLETED|Epoch 002||0
7611754|NCT02447432|18740379|P1|NOT COMPLETED|Epoch 002||0
7611755|NCT02447432|18740378|P2|COMPLETED|Epoch 002||145
7611756|NCT02447432|18740379|P1|COMPLETED|Epoch 002||152
7611757|NCT02447432|18740378|P2|STARTED|Epoch 002||145
7611758|NCT02447432|18740379|P1|STARTED|Epoch 002||152
7611759|NCT02447432|18740378|P2|NOT COMPLETED|Epoch 001||13
7611760|NCT02447432|18740379|P1|NOT COMPLETED|Epoch 001||5
7611761|NCT02447432|18740378|P2|COMPLETED|Epoch 001||147
7611762|NCT02447432|18740379|P1|COMPLETED|Epoch 001||155
7611763|NCT02447432|18740378|P2|STARTED|Epoch 001||160
7611764|NCT02447432|18740379|P1|STARTED|Epoch 001||160
7611765|NCT02447328|18740411|P1|NOT COMPLETED|Overall Study||1
7611766|NCT02447328|18740411|P1|COMPLETED|Overall Study||82
7611767|NCT02447328|18740411|P1|STARTED|Overall Study|Enrolment 85 Screening Failure 2 starting study drug 83|83
7611768|NCT02447250|18740415|P1|NOT COMPLETED|Third Dose (360 mcg Albuterol)||5
7611769|NCT02447250|18740415|P1|COMPLETED|Third Dose (360 mcg Albuterol)||8
7611770|NCT02447250|18740415|P1|STARTED|Third Dose (360 mcg Albuterol)||13
7611771|NCT02447250|18740415|P1|NOT COMPLETED|Second Dose (270 mcg Albuterol)||1
7611772|NCT02447250|18740415|P1|COMPLETED|Second Dose (270 mcg Albuterol)||13
7611773|NCT02447250|18740415|P1|STARTED|Second Dose (270 mcg Albuterol)||14
7611774|NCT02447250|18740415|P1|NOT COMPLETED|First Dose (180 mcg Albuterol)||0
7611775|NCT02447250|18740415|P1|COMPLETED|First Dose (180 mcg Albuterol)||14
7611776|NCT02447250|18740415|P1|STARTED|First Dose (180 mcg Albuterol)||14
7611777|NCT02447133|18740426|P1|NOT COMPLETED|Overall Study||0
7611778|NCT02447133|18740426|P1|COMPLETED|Overall Study||12
7611779|NCT02447133|18740426|P1|STARTED|Overall Study||12
7611780|NCT02447081|18740432|P1|NOT COMPLETED|Overall Study||224
7611781|NCT02447081|18740432|P1|COMPLETED|Overall Study||864
7611782|NCT02447081|18740432|P1|STARTED|Overall Study||1088
7611783|NCT02447029|18740448|P2|NOT COMPLETED|Overall Study||2
7611784|NCT02447029|18740449|P1|NOT COMPLETED|Overall Study||3
7611785|NCT02447029|18740448|P2|COMPLETED|Overall Study||68
7611786|NCT02447029|18740449|P1|COMPLETED|Overall Study||69
7611787|NCT02447029|18740448|P2|Treated|Overall Study||68
7611788|NCT02447029|18740449|P1|Treated|Overall Study||69
7611789|NCT02447029|18740448|P2|STARTED|Overall Study||70
7611790|NCT02447029|18740449|P1|STARTED|Overall Study||72
7611791|NCT02447003|18740469|P2|NOT COMPLETED|Overall Study||84
7611792|NCT02447003|18740470|P1|NOT COMPLETED|Overall Study||170
7611793|NCT02447003|18740469|P2|COMPLETED|Overall Study||0
7611794|NCT02447003|18740470|P1|COMPLETED|Overall Study||0
7611795|NCT02447003|18740469|P2|STARTED|Overall Study||84
7611796|NCT02447003|18740470|P1|STARTED|Overall Study||170
7611797|NCT02446990|18740506|P2|NOT COMPLETED|Overall Study||658
7611798|NCT02446990|18740507|P1|NOT COMPLETED|Overall Study||720
7611799|NCT02446990|18740506|P2|COMPLETED|Overall Study||8894
7611800|NCT02446990|18740507|P1|COMPLETED|Overall Study||8830
7611801|NCT02446990|18740506|P2|STARTED|Overall Study||9552
7611802|NCT02446990|18740507|P1|STARTED|Overall Study||9550
7611803|NCT02446912|18740542|P3|NOT COMPLETED|Overall Study||35
7611804|NCT02446912|18740543|P2|NOT COMPLETED|Overall Study||35
7611805|NCT02446912|18740544|P1|NOT COMPLETED|Overall Study||18
7611806|NCT02446912|18740542|P3|COMPLETED|Overall Study||149
7611807|NCT02446912|18740543|P2|COMPLETED|Overall Study||145
7611808|NCT02446912|18740544|P1|COMPLETED|Overall Study||75
7611809|NCT02446912|18740542|P3|Participants Who Completed Week 52|Overall Study||157
7611810|NCT02446912|18740543|P2|Participants Who Completed Week 52|Overall Study||153
7611811|NCT02446912|18740544|P1|Participants Who Completed Week 52|Overall Study||80
7611812|NCT02446912|18740542|P3|STARTED|Overall Study||184
7611813|NCT02446912|18740543|P2|STARTED|Overall Study||180
7611814|NCT02446912|18740544|P1|STARTED|Overall Study||93
7611815|NCT02446899|18740617|P2|NOT COMPLETED|Overall Study||48
7611816|NCT02446899|18740618|P1|NOT COMPLETED|Overall Study||25
7611817|NCT02446899|18740617|P2|COMPLETED|Overall Study||136
7611818|NCT02446899|18740618|P1|COMPLETED|Overall Study||156
7611819|NCT02446899|18740617|P2|Received Study Drug|Overall Study||182
7611820|NCT02446899|18740618|P1|Received Study Drug|Overall Study||180
7611821|NCT02446899|18740617|P2|STARTED|Overall Study||184
7611822|NCT02446899|18740618|P1|STARTED|Overall Study||181
7611823|NCT02446847|18740644|P2|NOT COMPLETED|Overall Study||2
7611824|NCT02446847|18740645|P1|NOT COMPLETED|Overall Study||0
7611825|NCT02446847|18740644|P2|COMPLETED|Overall Study||6
7611826|NCT02446847|18740645|P1|COMPLETED|Overall Study||8
7611827|NCT02446847|18740644|P2|STARTED|Overall Study||8
7611828|NCT02446847|18740645|P1|STARTED|Overall Study||8
7611829|NCT02446769|18740655|P3|NOT COMPLETED|Study Period||0
7611830|NCT02446769|18740656|P2|NOT COMPLETED|Study Period||2
7611831|NCT02446769|18740657|P1|NOT COMPLETED|Study Period||0
7611832|NCT02446769|18740655|P3|COMPLETED|Study Period||3
7611833|NCT02446769|18740656|P2|COMPLETED|Study Period||2
7611834|NCT02446769|18740657|P1|COMPLETED|Study Period||0
7611835|NCT02446769|18740655|P3|STARTED|Study Period||3
7611836|NCT02446769|18740656|P2|STARTED|Study Period||4
7611837|NCT02446769|18740657|P1|STARTED|Study Period||0
7611838|NCT02446769|18740655|P3|NOT COMPLETED|Screening Period||0
7611839|NCT02446769|18740656|P2|NOT COMPLETED|Screening Period||0
7611840|NCT02446769|18740657|P1|NOT COMPLETED|Screening Period||11
7611841|NCT02446769|18740655|P3|COMPLETED|Screening Period||0
7611842|NCT02446769|18740656|P2|COMPLETED|Screening Period||0
7611843|NCT02446769|18740657|P1|COMPLETED|Screening Period||7
7611844|NCT02446769|18740655|P3|STARTED|Screening Period||0
7611845|NCT02446769|18740656|P2|STARTED|Screening Period||0
7611846|NCT02446769|18740657|P1|STARTED|Screening Period||18
7611847|NCT02446743|18740680|P2|NOT COMPLETED|Overall Study||5
7611848|NCT02446743|18740681|P1|NOT COMPLETED|Overall Study||5
7611849|NCT02446743|18740680|P2|COMPLETED|Overall Study||250
7611850|NCT02446743|18740681|P1|COMPLETED|Overall Study||271
7611851|NCT02446743|18740680|P2|STARTED|Overall Study||255
7611852|NCT02446743|18740681|P1|STARTED|Overall Study||276
7611853|NCT02446717|18740836|P5|NOT COMPLETED|Overall Study||1
7611854|NCT02446717|18740837|P4|NOT COMPLETED|Overall Study||1
7611855|NCT02446717|18740838|P3|NOT COMPLETED|Overall Study||2
7611856|NCT02446717|18740839|P2|NOT COMPLETED|Overall Study||1
7611857|NCT02446717|18740840|P1|NOT COMPLETED|Overall Study||0
7611858|NCT02446717|18740836|P5|COMPLETED|Overall Study||46
7611859|NCT02446717|18740837|P4|COMPLETED|Overall Study||43
7611860|NCT02446717|18740838|P3|COMPLETED|Overall Study||20
7611861|NCT02446717|18740839|P2|COMPLETED|Overall Study||21
7611862|NCT02446717|18740840|P1|COMPLETED|Overall Study||6
7611863|NCT02446717|18740836|P5|STARTED|Overall Study||47
7611864|NCT02446717|18740837|P4|STARTED|Overall Study||44
7611865|NCT02446717|18740838|P3|STARTED|Overall Study||22
7611866|NCT02446717|18740839|P2|STARTED|Overall Study||22
7611867|NCT02446717|18740840|P1|STARTED|Overall Study||6
7611868|NCT02446691|18740867|P1|NOT COMPLETED|Overall Study||11
7611869|NCT02446691|18740867|P1|COMPLETED|Overall Study||117
7611870|NCT02446691|18740867|P1|STARTED|Overall Study||128
7611871|NCT02446613|18740887|P2|NOT COMPLETED|Overall Study||0
7611872|NCT02446613|18740888|P1|NOT COMPLETED|Overall Study||0
7611873|NCT02446613|18740887|P2|COMPLETED|Overall Study||10
7611874|NCT02446613|18740888|P1|COMPLETED|Overall Study||6
7611875|NCT02446613|18740887|P2|STARTED|Overall Study||10
7611876|NCT02446613|18740888|P1|STARTED|Overall Study||6
7611877|NCT02446496|18740910|P1|NOT COMPLETED|Overall Study||0
7611878|NCT02446496|18740910|P1|COMPLETED|Overall Study||24
7611879|NCT02446496|18740910|P1|STARTED|Overall Study||24
7611880|NCT02446483|18740922|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
7611881|NCT02446483|18740923|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
7611882|NCT02446483|18740922|P2|COMPLETED|Period 3: Intervention Period 2||30
7611883|NCT02446483|18740923|P1|COMPLETED|Period 3: Intervention Period 2||30
7611884|NCT02446483|18740922|P2|STARTED|Period 3: Intervention Period 2||30
7611885|NCT02446483|18740923|P1|STARTED|Period 3: Intervention Period 2||30
7611886|NCT02446483|18740922|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
7611887|NCT02446483|18740923|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
7611888|NCT02446483|18740922|P2|COMPLETED|Period 2: Washout Period (7 Days)||30
7611889|NCT02446483|18740923|P1|COMPLETED|Period 2: Washout Period (7 Days)||30
7611890|NCT02446483|18740922|P2|STARTED|Period 2: Washout Period (7 Days)||30
7611891|NCT02446483|18740923|P1|STARTED|Period 2: Washout Period (7 Days)||30
7611892|NCT02446483|18740922|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
7611893|NCT02446483|18740923|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
7611894|NCT02446483|18740922|P2|COMPLETED|Period 1: Intervention Period 1||30
7611895|NCT02446483|18740923|P1|COMPLETED|Period 1: Intervention Period 1||30
7611896|NCT02446483|18740922|P2|STARTED|Period 1: Intervention Period 1||30
7611897|NCT02446483|18740923|P1|STARTED|Period 1: Intervention Period 1||30
7611898|NCT02446418|18740937|P2|NOT COMPLETED|Overall Study||16
7611899|NCT02446418|18740938|P1|NOT COMPLETED|Overall Study||18
7611900|NCT02446418|18740937|P2|COMPLETED|Overall Study||194
7611901|NCT02446418|18740938|P1|COMPLETED|Overall Study||192
7611902|NCT02446418|18740937|P2|STARTED|Overall Study||210
7611903|NCT02446418|18740938|P1|STARTED|Overall Study||210
7611904|NCT02446314|18740952|P4|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
7611905|NCT02446314|18740953|P3|NOT COMPLETED|Thirteen to Twenty Four Weeks||2
7611906|NCT02446314|18740954|P2|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
7611907|NCT02446314|18740955|P1|NOT COMPLETED|Thirteen to Twenty Four Weeks||0
7611908|NCT02446314|18740952|P4|COMPLETED|Thirteen to Twenty Four Weeks||28
7611909|NCT02446314|18740953|P3|COMPLETED|Thirteen to Twenty Four Weeks||29
7611910|NCT02446314|18740954|P2|COMPLETED|Thirteen to Twenty Four Weeks||28
7611911|NCT02446314|18740955|P1|COMPLETED|Thirteen to Twenty Four Weeks||27
7611912|NCT02446314|18740952|P4|STARTED|Thirteen to Twenty Four Weeks||29
7611913|NCT02446314|18740953|P3|STARTED|Thirteen to Twenty Four Weeks||31
7611914|NCT02446314|18740954|P2|STARTED|Thirteen to Twenty Four Weeks||29
7611915|NCT02446314|18740955|P1|STARTED|Thirteen to Twenty Four Weeks||27
7611916|NCT02446314|18740952|P4|NOT COMPLETED|Zero to Twelve Weeks.||2
7611917|NCT02446314|18740953|P3|NOT COMPLETED|Zero to Twelve Weeks.||0
7611918|NCT02446314|18740954|P2|NOT COMPLETED|Zero to Twelve Weeks.||1
7611919|NCT02446314|18740955|P1|NOT COMPLETED|Zero to Twelve Weeks.||3
7611920|NCT02446314|18740952|P4|COMPLETED|Zero to Twelve Weeks.||29
7611921|NCT02446314|18740953|P3|COMPLETED|Zero to Twelve Weeks.||31
7611922|NCT02446314|18740954|P2|COMPLETED|Zero to Twelve Weeks.||29
7611923|NCT02446314|18740955|P1|COMPLETED|Zero to Twelve Weeks.||27
7611924|NCT02446314|18740952|P4|STARTED|Zero to Twelve Weeks.||31
7611925|NCT02446314|18740953|P3|STARTED|Zero to Twelve Weeks.||31
7611926|NCT02446314|18740954|P2|STARTED|Zero to Twelve Weeks.||30
7611927|NCT02446314|18740955|P1|STARTED|Zero to Twelve Weeks.||30
7611928|NCT02446223|18741001|P1|NOT COMPLETED|Overall Study||1
7611929|NCT02446223|18741001|P1|COMPLETED|Overall Study||20
7611930|NCT02446223|18741001|P1|STARTED|Overall Study||21
7611931|NCT02446171|18741009|P4|NOT COMPLETED|Overall Study||0
7611932|NCT02446171|18741010|P3|NOT COMPLETED|Overall Study||2
7611933|NCT02446171|18741011|P2|NOT COMPLETED|Overall Study||0
7611934|NCT02446171|18741012|P1|NOT COMPLETED|Overall Study||0
7611935|NCT02446171|18741009|P4|COMPLETED|Overall Study||11
7611936|NCT02446171|18741010|P3|COMPLETED|Overall Study||9
7611937|NCT02446171|18741011|P2|COMPLETED|Overall Study||11
7611938|NCT02446171|18741012|P1|COMPLETED|Overall Study||11
7611939|NCT02446171|18741009|P4|STARTED|Overall Study||11
7611940|NCT02446171|18741010|P3|STARTED|Overall Study||11
7611941|NCT02446171|18741011|P2|STARTED|Overall Study||11
7611942|NCT02446171|18741012|P1|STARTED|Overall Study||11
7611943|NCT02446015|18741083|P2|NOT COMPLETED|Overall Study||1
7611944|NCT02446015|18741084|P1|NOT COMPLETED|Overall Study||1
7611945|NCT02446015|18741083|P2|COMPLETED|Overall Study||62
7611946|NCT02446015|18741084|P1|COMPLETED|Overall Study||33
7611947|NCT02446015|18741083|P2|STARTED|Overall Study||63
7611948|NCT02446015|18741084|P1|STARTED|Overall Study||34
7611949|NCT02445963|18741099|P4|NOT COMPLETED|Overall Study||0
7611950|NCT02445963|18741100|P3|NOT COMPLETED|Overall Study||1
7611951|NCT02445963|18741101|P2|NOT COMPLETED|Overall Study||0
7611952|NCT02445963|18741102|P1|NOT COMPLETED|Overall Study||2
7611953|NCT02445963|18741099|P4|COMPLETED|Overall Study||10
7611954|NCT02445963|18741100|P3|COMPLETED|Overall Study||9
7611955|NCT02445963|18741101|P2|COMPLETED|Overall Study||9
7611956|NCT02445963|18741102|P1|COMPLETED|Overall Study||7
7611957|NCT02445963|18741099|P4|STARTED|Overall Study||10
7611958|NCT02445963|18741100|P3|STARTED|Overall Study||10
7611959|NCT02445963|18741101|P2|STARTED|Overall Study||9
7611960|NCT02445963|18741102|P1|STARTED|Overall Study||9
7611961|NCT02445911|18741128|P4|NOT COMPLETED|Overall Study||0
7611962|NCT02445911|18741129|P3|NOT COMPLETED|Overall Study||0
7611963|NCT02445911|18741130|P2|NOT COMPLETED|Overall Study||0
7611964|NCT02445911|18741131|P1|NOT COMPLETED|Overall Study||0
7611965|NCT02445911|18741128|P4|COMPLETED|Overall Study||20
7611966|NCT02445911|18741129|P3|COMPLETED|Overall Study||21
7611967|NCT02445911|18741130|P2|COMPLETED|Overall Study||20
7611968|NCT02445911|18741131|P1|COMPLETED|Overall Study||20
7611969|NCT02445911|18741128|P4|STARTED|Overall Study||20
7611970|NCT02445911|18741129|P3|STARTED|Overall Study||21
7611971|NCT02445911|18741130|P2|STARTED|Overall Study||20
7611972|NCT02445911|18741131|P1|STARTED|Overall Study||20
7611973|NCT02445859|18741203|P2|NOT COMPLETED|Overall Study||3
7611974|NCT02445859|18741204|P1|NOT COMPLETED|Overall Study||2
7611975|NCT02445859|18741203|P2|COMPLETED|Overall Study||42
7611976|NCT02445859|18741204|P1|COMPLETED|Overall Study||43
7611977|NCT02445859|18741203|P2|STARTED|Overall Study||45
7611978|NCT02445859|18741204|P1|STARTED|Overall Study||45
7611979|NCT02445807|18741212|P2|NOT COMPLETED|Overall Study||0
7611980|NCT02445807|18741213|P1|NOT COMPLETED|Overall Study||0
7611981|NCT02445807|18741212|P2|COMPLETED|Overall Study||89
7611982|NCT02445807|18741213|P1|COMPLETED|Overall Study||176
7611983|NCT02445807|18741212|P2|STARTED|Overall Study||89
7611984|NCT02445807|18741213|P1|STARTED|Overall Study||176
7611985|NCT02445794|18741227|P4|NOT COMPLETED|Overall Study||0
7611986|NCT02445794|18741228|P3|NOT COMPLETED|Overall Study||2
7611987|NCT02445794|18741229|P2|NOT COMPLETED|Overall Study||0
7611988|NCT02445794|18741230|P1|NOT COMPLETED|Overall Study||0
7611989|NCT02445794|18741227|P4|COMPLETED|Overall Study||3
7611990|NCT02445794|18741228|P3|COMPLETED|Overall Study||5
7611991|NCT02445794|18741229|P2|COMPLETED|Overall Study||3
7611992|NCT02445794|18741230|P1|COMPLETED|Overall Study||6
7611993|NCT02445794|18741227|P4|STARTED|Overall Study||3
7611994|NCT02445794|18741228|P3|STARTED|Overall Study||7
7611995|NCT02445794|18741229|P2|STARTED|Overall Study||3
7611996|NCT02445794|18741230|P1|STARTED|Overall Study||6
7611997|NCT02445755|18741260|P1|NOT COMPLETED|Overall Study||13
7611998|NCT02445755|18741260|P1|COMPLETED|Overall Study||100
7611999|NCT02445755|18741260|P1|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113
7612000|NCT02445625|18741267|P1|NOT COMPLETED|Overall Study||0
7612001|NCT02445625|18741267|P1|COMPLETED|Overall Study||15
7612002|NCT02445625|18741267|P1|STARTED|Overall Study||15
7612003|NCT02445586|18741274|P1|NOT COMPLETED|Overall Study||39
7612004|NCT02445586|18741274|P1|COMPLETED|Overall Study||13
7612005|NCT02445586|18741274|P1|Received at Least One Dose of Study Drug|Overall Study||52
7612006|NCT02445586|18741274|P1|STARTED|Overall Study||52
7612007|NCT02445573|18741314|P2|NOT COMPLETED|Overall Study||2
7612008|NCT02445573|18741315|P1|NOT COMPLETED|Overall Study||1
7612009|NCT02445573|18741314|P2|COMPLETED|Overall Study||38
7612010|NCT02445573|18741315|P1|COMPLETED|Overall Study||39
7612011|NCT02445573|18741314|P2|STARTED|Overall Study||40
7612012|NCT02445573|18741315|P1|STARTED|Overall Study||40
7612013|NCT02445326|18741331|P2|NOT COMPLETED|Overall Study||1
7612014|NCT02445326|18741332|P1|NOT COMPLETED|Overall Study||2
7612015|NCT02445326|18741331|P2|COMPLETED|Overall Study||37
7612016|NCT02445326|18741332|P1|COMPLETED|Overall Study||33
7612017|NCT02445326|18741331|P2|STARTED|Overall Study||38
7612018|NCT02445326|18741332|P1|STARTED|Overall Study||35
7612019|NCT02445287|18741350|P2|NOT COMPLETED|Overall Study||0
7612020|NCT02445287|18741351|P1|NOT COMPLETED|Overall Study||0
7612021|NCT02445287|18741350|P2|COMPLETED|Overall Study||13
7612022|NCT02445287|18741351|P1|COMPLETED|Overall Study||35
7612023|NCT02445287|18741350|P2|STARTED|Overall Study||13
7612024|NCT02445287|18741351|P1|STARTED|Overall Study||35
7612025|NCT02445196|18741366|P2|NOT COMPLETED|Overall Study||6
7612026|NCT02445196|18741367|P1|NOT COMPLETED|Overall Study||11
7612027|NCT02445196|18741366|P2|COMPLETED|Overall Study||52
7612028|NCT02445196|18741367|P1|COMPLETED|Overall Study||51
7612029|NCT02445196|18741366|P2|STARTED|Overall Study||58
7612030|NCT02445196|18741367|P1|STARTED|Overall Study||62
7612031|NCT02445027|18741380|P1|NOT COMPLETED|Overall Study||15
7612032|NCT02445027|18741380|P1|COMPLETED|Overall Study||45
7612033|NCT02445027|18741380|P1|STARTED|Overall Study||60
7612034|NCT02445014|18741384|P1|NOT COMPLETED|Overall Study||0
7612035|NCT02445014|18741384|P1|COMPLETED|Overall Study||3
7612036|NCT02445014|18741384|P1|STARTED|Overall Study||3
7612037|NCT02444988|18741390|P2|NOT COMPLETED|Overall Study||0
7612038|NCT02444988|18741391|P1|NOT COMPLETED|Overall Study||0
7612039|NCT02444988|18741390|P2|COMPLETED|Overall Study||2735
7612040|NCT02444988|18741391|P1|COMPLETED|Overall Study||2646
7612041|NCT02444988|18741390|P2|STARTED|Overall Study||2735
7612042|NCT02444988|18741391|P1|STARTED|Overall Study||2646
7612043|NCT02444936|18741401|P2|NOT COMPLETED|Overall Study||0
7612044|NCT02444936|18741402|P1|NOT COMPLETED|Overall Study||0
7612045|NCT02444936|18741401|P2|COMPLETED|Overall Study||12
7612046|NCT02444936|18741402|P1|COMPLETED|Overall Study||10
7612047|NCT02444936|18741401|P2|STARTED|Overall Study||12
7612048|NCT02444936|18741402|P1|STARTED|Overall Study||10
7612049|NCT02444793|18741412|P4|NOT COMPLETED|Overall Study||3
7612050|NCT02444793|18741413|P3|NOT COMPLETED|Overall Study||4
7612051|NCT02444793|18741414|P2|NOT COMPLETED|Overall Study||6
7612052|NCT02444793|18741415|P1|NOT COMPLETED|Overall Study||11
7612053|NCT02444793|18741412|P4|COMPLETED|Overall Study||0
7612054|NCT02444793|18741413|P3|COMPLETED|Overall Study||0
7612055|NCT02444793|18741414|P2|COMPLETED|Overall Study||0
7612056|NCT02444793|18741415|P1|COMPLETED|Overall Study||0
7612057|NCT02444793|18741412|P4|STARTED|Overall Study||3
7612058|NCT02444793|18741413|P3|STARTED|Overall Study||4
7612059|NCT02444793|18741414|P2|STARTED|Overall Study||6
7612060|NCT02444793|18741415|P1|STARTED|Overall Study||11
7612061|NCT02444715|18741542|P2|NOT COMPLETED|Overall Study||16
7612062|NCT02444715|18741543|P1|NOT COMPLETED|Overall Study||10
7612063|NCT02444715|18741542|P2|COMPLETED|Overall Study||32
7612064|NCT02444715|18741543|P1|COMPLETED|Overall Study||36
7612065|NCT02444715|18741542|P2|STARTED|Overall Study||48
7612066|NCT02444715|18741543|P1|STARTED|Overall Study||46
7612067|NCT02444533|18741574|P2|NOT COMPLETED|Overall Study||4
7612068|NCT02444533|18741575|P1|NOT COMPLETED|Overall Study||2
7612069|NCT02444533|18741574|P2|COMPLETED|Overall Study||18
7612070|NCT02444533|18741575|P1|COMPLETED|Overall Study||15
7612071|NCT02444533|18741574|P2|STARTED|Overall Study||22
7612072|NCT02444533|18741575|P1|STARTED|Overall Study||17
7612073|NCT02444234|18741589|P2|NOT COMPLETED|Second Intervention (3 Days)||0
7612074|NCT02444234|18741590|P1|NOT COMPLETED|Second Intervention (3 Days)||0
7612075|NCT02444234|18741589|P2|COMPLETED|Second Intervention (3 Days)||5
7612076|NCT02444234|18741590|P1|COMPLETED|Second Intervention (3 Days)||6
7612077|NCT02444234|18741589|P2|STARTED|Second Intervention (3 Days)||5
7612078|NCT02444234|18741590|P1|STARTED|Second Intervention (3 Days)||6
7612079|NCT02444234|18741589|P2|NOT COMPLETED|Washout (2 Day Minimum)||0
7612080|NCT02444234|18741590|P1|NOT COMPLETED|Washout (2 Day Minimum)||0
7612081|NCT02444234|18741589|P2|COMPLETED|Washout (2 Day Minimum)||5
7612082|NCT02444234|18741590|P1|COMPLETED|Washout (2 Day Minimum)||6
7612083|NCT02444234|18741589|P2|STARTED|Washout (2 Day Minimum)||5
7612084|NCT02444234|18741590|P1|STARTED|Washout (2 Day Minimum)||6
7612085|NCT02444234|18741589|P2|NOT COMPLETED|First Intervention (3 Days)||0
7612086|NCT02444234|18741590|P1|NOT COMPLETED|First Intervention (3 Days)||0
7612087|NCT02444234|18741589|P2|COMPLETED|First Intervention (3 Days)||5
7612088|NCT02444234|18741590|P1|COMPLETED|First Intervention (3 Days)||6
7612089|NCT02444234|18741589|P2|STARTED|First Intervention (3 Days)||5
7612090|NCT02444234|18741590|P1|STARTED|First Intervention (3 Days)||6
7612091|NCT02444182|18741608|P2|NOT COMPLETED|Overall Study||5
7612092|NCT02444182|18741609|P1|NOT COMPLETED|Overall Study||2
7612093|NCT02444182|18741608|P2|COMPLETED|Overall Study||49
7612094|NCT02444182|18741609|P1|COMPLETED|Overall Study||52
7612095|NCT02444182|18741608|P2|STARTED|Overall Study||54
7612096|NCT02444182|18741609|P1|STARTED|Overall Study||54
7612097|NCT02444143|18741619|P2|NOT COMPLETED|Overall Study||1
7612098|NCT02444143|18741620|P1|NOT COMPLETED|Overall Study||0
7612099|NCT02444143|18741619|P2|COMPLETED|Overall Study|1 patient withdrawal|9
7612100|NCT02444143|18741620|P1|COMPLETED|Overall Study||10
7612101|NCT02444143|18741619|P2|STARTED|Overall Study||10
7612102|NCT02444143|18741620|P1|STARTED|Overall Study||10
7612103|NCT02443883|18741632|P4|NOT COMPLETED|Overall Study||5
7612104|NCT02443883|18741633|P3|NOT COMPLETED|Overall Study||1
7612105|NCT02443883|18741634|P2|NOT COMPLETED|Overall Study||4
7612106|NCT02443883|18741635|P1|NOT COMPLETED|Overall Study||6
7612107|NCT02443883|18741632|P4|COMPLETED|Overall Study||36
7612108|NCT02443883|18741633|P3|COMPLETED|Overall Study||40
7612109|NCT02443883|18741634|P2|COMPLETED|Overall Study||38
7612110|NCT02443883|18741635|P1|COMPLETED|Overall Study||34
7612111|NCT02443883|18741632|P4|Received at Least One Dose of Study Drug|Overall Study||40
7612112|NCT02443883|18741633|P3|Received at Least One Dose of Study Drug|Overall Study||41
7612113|NCT02443883|18741634|P2|Received at Least One Dose of Study Drug|Overall Study||42
7612114|NCT02443883|18741635|P1|Received at Least One Dose of Study Drug|Overall Study||38
7612115|NCT02443883|18741632|P4|STARTED|Overall Study||41
7612116|NCT02443883|18741633|P3|STARTED|Overall Study||41
7612117|NCT02443883|18741634|P2|STARTED|Overall Study||42
7612118|NCT02443883|18741635|P1|STARTED|Overall Study||40
7612119|NCT02443805|18741655|P2|NOT COMPLETED|Overall Study||127
7612120|NCT02443805|18741656|P1|NOT COMPLETED|Overall Study||213
7612121|NCT02443805|18741655|P2|COMPLETED|Overall Study||678
7612122|NCT02443805|18741656|P1|COMPLETED|Overall Study||589
7612123|NCT02443805|18741655|P2|STARTED|Overall Study||805
7612124|NCT02443805|18741656|P1|STARTED|Overall Study||802
7612125|NCT02443792|18741668|P2|NOT COMPLETED|Overall Study||2
7612126|NCT02443792|18741669|P1|NOT COMPLETED|Overall Study||7
7612127|NCT02443792|18741668|P2|COMPLETED|Overall Study||23
7612128|NCT02443792|18741669|P1|COMPLETED|Overall Study||43
7612129|NCT02443792|18741668|P2|STARTED|Overall Study||25
7612130|NCT02443792|18741669|P1|STARTED|Overall Study||50
7612131|NCT02443740|18741687|P11|NOT COMPLETED|Intervention Period 4 (3 Days)||0
7612132|NCT02443740|18741688|P10|NOT COMPLETED|Intervention Period 4 (3 Days)||0
7612133|NCT02443740|18741689|P9|NOT COMPLETED|Intervention Period 4 (3 Days)||0
7612134|NCT02443740|18741690|P8|NOT COMPLETED|Intervention Period 4 (3 Days)||0
7612135|NCT02443740|18741691|P7|NOT COMPLETED|Intervention Period 4 (3 Days)||0
7612136|NCT02443740|18741692|P6|NOT COMPLETED|Intervention Period 4 (3 Days)||0
7612137|NCT02443740|18741693|P5|NOT COMPLETED|Intervention Period 4 (3 Days)||0
7612138|NCT02443740|18741694|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
7612139|NCT02443740|18741695|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
7612140|NCT02443740|18741696|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
7612141|NCT02443740|18741697|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||0
7612142|NCT02443740|18741687|P11|COMPLETED|Intervention Period 4 (3 Days)||0
7612143|NCT02443740|18741688|P10|COMPLETED|Intervention Period 4 (3 Days)||0
7612144|NCT02443740|18741689|P9|COMPLETED|Intervention Period 4 (3 Days)||0
7612145|NCT02443740|18741690|P8|COMPLETED|Intervention Period 4 (3 Days)||2
7612146|NCT02443740|18741691|P7|COMPLETED|Intervention Period 4 (3 Days)||2
7612147|NCT02443740|18741692|P6|COMPLETED|Intervention Period 4 (3 Days)||2
7612148|NCT02443740|18741693|P5|COMPLETED|Intervention Period 4 (3 Days)||2
7612149|NCT02443740|18741694|P4|COMPLETED|Intervention Period 4 (3 Days)||3
7612150|NCT02443740|18741695|P3|COMPLETED|Intervention Period 4 (3 Days)||2
7612151|NCT02443740|18741696|P2|COMPLETED|Intervention Period 4 (3 Days)||2
7612152|NCT02443740|18741697|P1|COMPLETED|Intervention Period 4 (3 Days)||1
7612153|NCT02443740|18741687|P11|STARTED|Intervention Period 4 (3 Days)||0
7612154|NCT02443740|18741688|P10|STARTED|Intervention Period 4 (3 Days)||0
7612155|NCT02443740|18741689|P9|STARTED|Intervention Period 4 (3 Days)||0
7612156|NCT02443740|18741690|P8|STARTED|Intervention Period 4 (3 Days)||2
7612157|NCT02443740|18741691|P7|STARTED|Intervention Period 4 (3 Days)||2
7612158|NCT02443740|18741692|P6|STARTED|Intervention Period 4 (3 Days)||2
7612159|NCT02443740|18741693|P5|STARTED|Intervention Period 4 (3 Days)||2
7612160|NCT02443740|18741694|P4|STARTED|Intervention Period 4 (3 Days)||3
7612161|NCT02443740|18741695|P3|STARTED|Intervention Period 4 (3 Days)||2
7612162|NCT02443740|18741696|P2|STARTED|Intervention Period 4 (3 Days)||2
7612163|NCT02443740|18741697|P1|STARTED|Intervention Period 4 (3 Days)||1
7612164|NCT02443740|18741687|P11|NOT COMPLETED|Washout Period 3 (7 Days)||0
7612165|NCT02443740|18741688|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
7612166|NCT02443740|18741689|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
7612167|NCT02443740|18741690|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
7612168|NCT02443740|18741691|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
7612169|NCT02443740|18741692|P6|NOT COMPLETED|Washout Period 3 (7 Days)||0
7612170|NCT02443740|18741693|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
7612171|NCT02443740|18741694|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
7612172|NCT02443740|18741695|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
7612173|NCT02443740|18741696|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
7612174|NCT02443740|18741697|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
7612175|NCT02443740|18741687|P11|COMPLETED|Washout Period 3 (7 Days)||0
7612176|NCT02443740|18741688|P10|COMPLETED|Washout Period 3 (7 Days)||0
7612177|NCT02443740|18741689|P9|COMPLETED|Washout Period 3 (7 Days)||0
7612178|NCT02443740|18741690|P8|COMPLETED|Washout Period 3 (7 Days)||2
7612179|NCT02443740|18741691|P7|COMPLETED|Washout Period 3 (7 Days)||2
7612180|NCT02443740|18741692|P6|COMPLETED|Washout Period 3 (7 Days)||2
7612181|NCT02443740|18741693|P5|COMPLETED|Washout Period 3 (7 Days)||2
7612182|NCT02443740|18741694|P4|COMPLETED|Washout Period 3 (7 Days)||3
7612183|NCT02443740|18741695|P3|COMPLETED|Washout Period 3 (7 Days)||2
7612184|NCT02443740|18741696|P2|COMPLETED|Washout Period 3 (7 Days)||2
7612185|NCT02443740|18741697|P1|COMPLETED|Washout Period 3 (7 Days)||1
7612186|NCT02443740|18741687|P11|STARTED|Washout Period 3 (7 Days)||0
7612187|NCT02443740|18741688|P10|STARTED|Washout Period 3 (7 Days)||0
7612188|NCT02443740|18741689|P9|STARTED|Washout Period 3 (7 Days)||0
7612189|NCT02443740|18741690|P8|STARTED|Washout Period 3 (7 Days)||2
7612190|NCT02443740|18741691|P7|STARTED|Washout Period 3 (7 Days)||2
7612191|NCT02443740|18741692|P6|STARTED|Washout Period 3 (7 Days)||2
7612192|NCT02443740|18741693|P5|STARTED|Washout Period 3 (7 Days)||2
7612193|NCT02443740|18741694|P4|STARTED|Washout Period 3 (7 Days)||3
7612194|NCT02443740|18741695|P3|STARTED|Washout Period 3 (7 Days)||2
7612195|NCT02443740|18741696|P2|STARTED|Washout Period 3 (7 Days)||2
7612196|NCT02443740|18741697|P1|STARTED|Washout Period 3 (7 Days)||1
7612197|NCT02443740|18741687|P11|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7612198|NCT02443740|18741688|P10|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7612199|NCT02443740|18741689|P9|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7612200|NCT02443740|18741690|P8|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7612201|NCT02443740|18741691|P7|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7612202|NCT02443740|18741692|P6|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7612203|NCT02443740|18741693|P5|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7612204|NCT02443740|18741694|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7612205|NCT02443740|18741695|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7612206|NCT02443740|18741696|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7612207|NCT02443740|18741697|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7612208|NCT02443740|18741687|P11|COMPLETED|Intervention Period 3 (3 Days)||0
7612209|NCT02443740|18741688|P10|COMPLETED|Intervention Period 3 (3 Days)||0
7612210|NCT02443740|18741689|P9|COMPLETED|Intervention Period 3 (3 Days)||0
7612211|NCT02443740|18741690|P8|COMPLETED|Intervention Period 3 (3 Days)||2
7612212|NCT02443740|18741691|P7|COMPLETED|Intervention Period 3 (3 Days)||2
7612213|NCT02443740|18741692|P6|COMPLETED|Intervention Period 3 (3 Days)||2
7612214|NCT02443740|18741693|P5|COMPLETED|Intervention Period 3 (3 Days)||2
7612215|NCT02443740|18741694|P4|COMPLETED|Intervention Period 3 (3 Days)||3
7612216|NCT02443740|18741695|P3|COMPLETED|Intervention Period 3 (3 Days)||2
7612217|NCT02443740|18741696|P2|COMPLETED|Intervention Period 3 (3 Days)||2
7612218|NCT02443740|18741697|P1|COMPLETED|Intervention Period 3 (3 Days)||1
7612219|NCT02443740|18741687|P11|STARTED|Intervention Period 3 (3 Days)||0
7612220|NCT02443740|18741688|P10|STARTED|Intervention Period 3 (3 Days)||0
7612221|NCT02443740|18741689|P9|STARTED|Intervention Period 3 (3 Days)||0
7612222|NCT02443740|18741690|P8|STARTED|Intervention Period 3 (3 Days)||2
7612223|NCT02443740|18741691|P7|STARTED|Intervention Period 3 (3 Days)||2
7612224|NCT02443740|18741692|P6|STARTED|Intervention Period 3 (3 Days)||2
7612225|NCT02443740|18741693|P5|STARTED|Intervention Period 3 (3 Days)||2
7612226|NCT02443740|18741694|P4|STARTED|Intervention Period 3 (3 Days)||3
7612227|NCT02443740|18741695|P3|STARTED|Intervention Period 3 (3 Days)||2
7612228|NCT02443740|18741696|P2|STARTED|Intervention Period 3 (3 Days)||2
7612229|NCT02443740|18741697|P1|STARTED|Intervention Period 3 (3 Days)||1
7612230|NCT02443740|18741687|P11|NOT COMPLETED|Washout Period 2 (7 Days)||0
7612231|NCT02443740|18741688|P10|NOT COMPLETED|Washout Period 2 (7 Days)||0
7612232|NCT02443740|18741689|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
7612233|NCT02443740|18741690|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
7612234|NCT02443740|18741691|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
7612235|NCT02443740|18741692|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
7612236|NCT02443740|18741693|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
7612237|NCT02443740|18741694|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
7612238|NCT02443740|18741695|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
7612239|NCT02443740|18741696|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
7612240|NCT02443740|18741697|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
7612241|NCT02443740|18741687|P11|COMPLETED|Washout Period 2 (7 Days)||0
7612242|NCT02443740|18741688|P10|COMPLETED|Washout Period 2 (7 Days)||0
7612243|NCT02443740|18741689|P9|COMPLETED|Washout Period 2 (7 Days)||0
7612244|NCT02443740|18741690|P8|COMPLETED|Washout Period 2 (7 Days)||2
7612245|NCT02443740|18741691|P7|COMPLETED|Washout Period 2 (7 Days)||2
7612246|NCT02443740|18741692|P6|COMPLETED|Washout Period 2 (7 Days)||2
7612247|NCT02443740|18741693|P5|COMPLETED|Washout Period 2 (7 Days)||2
7612248|NCT02443740|18741694|P4|COMPLETED|Washout Period 2 (7 Days)||3
7612249|NCT02443740|18741695|P3|COMPLETED|Washout Period 2 (7 Days)||2
7612250|NCT02443740|18741696|P2|COMPLETED|Washout Period 2 (7 Days)||2
7612251|NCT02443740|18741697|P1|COMPLETED|Washout Period 2 (7 Days)||1
7612252|NCT02443740|18741687|P11|STARTED|Washout Period 2 (7 Days)||0
7612253|NCT02443740|18741688|P10|STARTED|Washout Period 2 (7 Days)||0
7612254|NCT02443740|18741689|P9|STARTED|Washout Period 2 (7 Days)||0
7612255|NCT02443740|18741690|P8|STARTED|Washout Period 2 (7 Days)||2
7612256|NCT02443740|18741691|P7|STARTED|Washout Period 2 (7 Days)||2
7612257|NCT02443740|18741692|P6|STARTED|Washout Period 2 (7 Days)||2
7612258|NCT02443740|18741693|P5|STARTED|Washout Period 2 (7 Days)||2
7612259|NCT02443740|18741694|P4|STARTED|Washout Period 2 (7 Days)||3
7612260|NCT02443740|18741695|P3|STARTED|Washout Period 2 (7 Days)||2
7612261|NCT02443740|18741696|P2|STARTED|Washout Period 2 (7 Days)||2
7612262|NCT02443740|18741697|P1|STARTED|Washout Period 2 (7 Days)||1
7612263|NCT02443740|18741687|P11|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7612264|NCT02443740|18741688|P10|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7612265|NCT02443740|18741689|P9|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7612266|NCT02443740|18741690|P8|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7612267|NCT02443740|18741691|P7|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7612268|NCT02443740|18741692|P6|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7612269|NCT02443740|18741693|P5|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7612270|NCT02443740|18741694|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7612271|NCT02443740|18741695|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7612272|NCT02443740|18741696|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7612273|NCT02443740|18741697|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7612274|NCT02443740|18741687|P11|COMPLETED|Intervention Period 2 (3 Days)||3
7612275|NCT02443740|18741688|P10|COMPLETED|Intervention Period 2 (3 Days)||3
7612276|NCT02443740|18741689|P9|COMPLETED|Intervention Period 2 (3 Days)||0
7612277|NCT02443740|18741690|P8|COMPLETED|Intervention Period 2 (3 Days)||2
7612278|NCT02443740|18741691|P7|COMPLETED|Intervention Period 2 (3 Days)||2
7612279|NCT02443740|18741692|P6|COMPLETED|Intervention Period 2 (3 Days)||2
7612280|NCT02443740|18741693|P5|COMPLETED|Intervention Period 2 (3 Days)||2
7612281|NCT02443740|18741694|P4|COMPLETED|Intervention Period 2 (3 Days)||3
7612282|NCT02443740|18741695|P3|COMPLETED|Intervention Period 2 (3 Days)||2
7612283|NCT02443740|18741696|P2|COMPLETED|Intervention Period 2 (3 Days)||2
7612284|NCT02443740|18741697|P1|COMPLETED|Intervention Period 2 (3 Days)||1
7612285|NCT02443740|18741687|P11|STARTED|Intervention Period 2 (3 Days)||3
7612286|NCT02443740|18741688|P10|STARTED|Intervention Period 2 (3 Days)||3
7612287|NCT02443740|18741689|P9|STARTED|Intervention Period 2 (3 Days)||0
7612288|NCT02443740|18741690|P8|STARTED|Intervention Period 2 (3 Days)||2
7612289|NCT02443740|18741691|P7|STARTED|Intervention Period 2 (3 Days)||2
7612290|NCT02443740|18741692|P6|STARTED|Intervention Period 2 (3 Days)||2
7612291|NCT02443740|18741693|P5|STARTED|Intervention Period 2 (3 Days)||2
7612292|NCT02443740|18741694|P4|STARTED|Intervention Period 2 (3 Days)||3
7612293|NCT02443740|18741695|P3|STARTED|Intervention Period 2 (3 Days)||2
7612294|NCT02443740|18741696|P2|STARTED|Intervention Period 2 (3 Days)||2
7612295|NCT02443740|18741697|P1|STARTED|Intervention Period 2 (3 Days)||1
7612296|NCT02443740|18741687|P11|NOT COMPLETED|Washout Period 1 (7 Days)||0
7612297|NCT02443740|18741688|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
7612298|NCT02443740|18741689|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
7612299|NCT02443740|18741690|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
7612300|NCT02443740|18741691|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
7612301|NCT02443740|18741692|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
7612302|NCT02443740|18741693|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
7612303|NCT02443740|18741694|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
7612304|NCT02443740|18741695|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
7612305|NCT02443740|18741696|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
7612306|NCT02443740|18741697|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
7612307|NCT02443740|18741687|P11|COMPLETED|Washout Period 1 (7 Days)||3
7612308|NCT02443740|18741688|P10|COMPLETED|Washout Period 1 (7 Days)||3
7612309|NCT02443740|18741689|P9|COMPLETED|Washout Period 1 (7 Days)||0
7612310|NCT02443740|18741690|P8|COMPLETED|Washout Period 1 (7 Days)||2
7612311|NCT02443740|18741691|P7|COMPLETED|Washout Period 1 (7 Days)||2
7612312|NCT02443740|18741692|P6|COMPLETED|Washout Period 1 (7 Days)||2
7612313|NCT02443740|18741693|P5|COMPLETED|Washout Period 1 (7 Days)||2
7612314|NCT02443740|18741694|P4|COMPLETED|Washout Period 1 (7 Days)||3
7612315|NCT02443740|18741695|P3|COMPLETED|Washout Period 1 (7 Days)||2
7612316|NCT02443740|18741696|P2|COMPLETED|Washout Period 1 (7 Days)||2
7612317|NCT02443740|18741697|P1|COMPLETED|Washout Period 1 (7 Days)||1
7612318|NCT02443740|18741687|P11|STARTED|Washout Period 1 (7 Days)||3
7612319|NCT02443740|18741688|P10|STARTED|Washout Period 1 (7 Days)||3
7612320|NCT02443740|18741689|P9|STARTED|Washout Period 1 (7 Days)||0
7612321|NCT02443740|18741690|P8|STARTED|Washout Period 1 (7 Days)||2
7612322|NCT02443740|18741691|P7|STARTED|Washout Period 1 (7 Days)||2
7612323|NCT02443740|18741692|P6|STARTED|Washout Period 1 (7 Days)||2
7612324|NCT02443740|18741693|P5|STARTED|Washout Period 1 (7 Days)||2
7612325|NCT02443740|18741694|P4|STARTED|Washout Period 1 (7 Days)||3
7612326|NCT02443740|18741695|P3|STARTED|Washout Period 1 (7 Days)||2
7612327|NCT02443740|18741696|P2|STARTED|Washout Period 1 (7 Days)||2
7612328|NCT02443740|18741697|P1|STARTED|Washout Period 1 (7 Days)||1
7612329|NCT02443740|18741687|P11|NOT COMPLETED|Intervention Period 1 (3 Days)||0
7612330|NCT02443740|18741688|P10|NOT COMPLETED|Intervention Period 1 (3 Days)||0
7612331|NCT02443740|18741689|P9|NOT COMPLETED|Intervention Period 1 (3 Days)||0
7612332|NCT02443740|18741690|P8|NOT COMPLETED|Intervention Period 1 (3 Days)||0
7612333|NCT02443740|18741691|P7|NOT COMPLETED|Intervention Period 1 (3 Days)||1
7612334|NCT02443740|18741692|P6|NOT COMPLETED|Intervention Period 1 (3 Days)||2
7612335|NCT02443740|18741693|P5|NOT COMPLETED|Intervention Period 1 (3 Days)||0
7612336|NCT02443740|18741694|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
7612337|NCT02443740|18741695|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
7612338|NCT02443740|18741696|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
7612339|NCT02443740|18741697|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||1
7612340|NCT02443740|18741687|P11|COMPLETED|Intervention Period 1 (3 Days)||3
7612341|NCT02443740|18741688|P10|COMPLETED|Intervention Period 1 (3 Days)||3
7612342|NCT02443740|18741689|P9|COMPLETED|Intervention Period 1 (3 Days)||6
7612343|NCT02443740|18741690|P8|COMPLETED|Intervention Period 1 (3 Days)||2
7612344|NCT02443740|18741691|P7|COMPLETED|Intervention Period 1 (3 Days)||2
7612345|NCT02443740|18741692|P6|COMPLETED|Intervention Period 1 (3 Days)||2
7612346|NCT02443740|18741693|P5|COMPLETED|Intervention Period 1 (3 Days)||2
7612347|NCT02443740|18741694|P4|COMPLETED|Intervention Period 1 (3 Days)||3
7612348|NCT02443740|18741695|P3|COMPLETED|Intervention Period 1 (3 Days)||2
7612349|NCT02443740|18741696|P2|COMPLETED|Intervention Period 1 (3 Days)||2
7612350|NCT02443740|18741697|P1|COMPLETED|Intervention Period 1 (3 Days)||1
7612351|NCT02443740|18741687|P11|STARTED|Intervention Period 1 (3 Days)||3
7612352|NCT02443740|18741688|P10|STARTED|Intervention Period 1 (3 Days)||3
7612353|NCT02443740|18741689|P9|STARTED|Intervention Period 1 (3 Days)||6
7612354|NCT02443740|18741690|P8|STARTED|Intervention Period 1 (3 Days)||2
7612355|NCT02443740|18741691|P7|STARTED|Intervention Period 1 (3 Days)||3
7612356|NCT02443740|18741692|P6|STARTED|Intervention Period 1 (3 Days)||4
7612357|NCT02443740|18741693|P5|STARTED|Intervention Period 1 (3 Days)||2
7612358|NCT02443740|18741694|P4|STARTED|Intervention Period 1 (3 Days)||3
7612359|NCT02443740|18741695|P3|STARTED|Intervention Period 1 (3 Days)||2
7612360|NCT02443740|18741696|P2|STARTED|Intervention Period 1 (3 Days)||2
7612361|NCT02443740|18741697|P1|STARTED|Intervention Period 1 (3 Days)||2
7612362|NCT02443688|18741879|P3|NOT COMPLETED|Overall Study||12
7612363|NCT02443688|18741880|P2|NOT COMPLETED|Overall Study||9
7612364|NCT02443688|18741881|P1|NOT COMPLETED|Overall Study||12
7612365|NCT02443688|18741879|P3|COMPLETED|Overall Study||55
7612366|NCT02443688|18741880|P2|COMPLETED|Overall Study||58
7612367|NCT02443688|18741881|P1|COMPLETED|Overall Study||54
7612368|NCT02443688|18741879|P3|STARTED|Overall Study||67
7612369|NCT02443688|18741880|P2|STARTED|Overall Study||67
7612370|NCT02443688|18741881|P1|STARTED|Overall Study||66
7612371|NCT02443571|18741946|P3|NOT COMPLETED|Overall Study||0
7612372|NCT02443571|18741947|P2|NOT COMPLETED|Overall Study||0
7612373|NCT02443571|18741948|P1|NOT COMPLETED|Overall Study||0
7612374|NCT02443571|18741946|P3|COMPLETED|Overall Study||23
7612375|NCT02443571|18741947|P2|COMPLETED|Overall Study||95
7612376|NCT02443571|18741948|P1|COMPLETED|Overall Study||596
7612377|NCT02443571|18741946|P3|STARTED|Overall Study||23
7612378|NCT02443571|18741947|P2|STARTED|Overall Study||95
7612379|NCT02443571|18741948|P1|STARTED|Overall Study||596
7612380|NCT02443519|18741960|P2|NOT COMPLETED|Overall Study||3
7612381|NCT02443519|18741961|P1|NOT COMPLETED|Overall Study||2
7612382|NCT02443519|18741960|P2|COMPLETED|Overall Study||26
7612383|NCT02443519|18741961|P1|COMPLETED|Overall Study||29
7612384|NCT02443519|18741960|P2|STARTED|Overall Study||29
7612385|NCT02443519|18741961|P1|STARTED|Overall Study||31
7612386|NCT02443402|18741991|P2|NOT COMPLETED|Overall Study||3
7612387|NCT02443402|18741992|P1|NOT COMPLETED|Overall Study||4
7612388|NCT02443402|18741991|P2|COMPLETED|Overall Study||28
7612389|NCT02443402|18741992|P1|COMPLETED|Overall Study||32
7612390|NCT02443402|18741991|P2|STARTED|Overall Study||31
7612391|NCT02443402|18741992|P1|STARTED|Overall Study||36
7612392|NCT02443337|18742054|P2|NOT COMPLETED|Overall Study||2
7612393|NCT02443337|18742055|P1|NOT COMPLETED|Overall Study||5
7612394|NCT02443337|18742054|P2|COMPLETED|Overall Study||14
7612395|NCT02443337|18742055|P1|COMPLETED|Overall Study||10
7612396|NCT02443337|18742054|P2|Received at Least One Dose of Study Drug|Overall Study||16
7612397|NCT02443337|18742055|P1|Received at Least One Dose of Study Drug|Overall Study||15
7612398|NCT02443337|18742054|P2|STARTED|Overall Study||16
7612399|NCT02443337|18742055|P1|STARTED|Overall Study||15
7612400|NCT02443298|18742073|P2|NOT COMPLETED|Overall Study||5
7612401|NCT02443298|18742074|P1|NOT COMPLETED|Overall Study||4
7612402|NCT02443298|18742073|P2|COMPLETED|Overall Study||104
7612403|NCT02443298|18742074|P1|COMPLETED|Overall Study||101
7612404|NCT02443298|18742073|P2|STARTED|Overall Study||109
7612405|NCT02443298|18742074|P1|STARTED|Overall Study||105
7612406|NCT02443103|18742094|P1|NOT COMPLETED|Overall Study||3
7612407|NCT02443103|18742094|P1|COMPLETED|Overall Study||1
7612408|NCT02443103|18742094|P1|STARTED|Overall Study||4
7612409|NCT02442856|18742099|P1|NOT COMPLETED|Overall Study||0
7612410|NCT02442856|18742099|P1|COMPLETED|Overall Study||21
7612411|NCT02442856|18742099|P1|STARTED|Overall Study||21
7612412|NCT02442830|18742107|P2|NOT COMPLETED|Overall Study||1
7612413|NCT02442830|18742108|P1|NOT COMPLETED|Overall Study||0
7612414|NCT02442830|18742107|P2|COMPLETED|Overall Study||44
7612415|NCT02442830|18742108|P1|COMPLETED|Overall Study||42
7612416|NCT02442830|18742107|P2|STARTED|Overall Study||45
7612417|NCT02442830|18742108|P1|STARTED|Overall Study||42
7612418|NCT02442804|18742118|P2|NOT COMPLETED|Overall Study||1
7612419|NCT02442804|18742119|P1|NOT COMPLETED|Overall Study||1
7612420|NCT02442804|18742118|P2|COMPLETED|Overall Study||7
7612421|NCT02442804|18742119|P1|COMPLETED|Overall Study||7
7612422|NCT02442804|18742118|P2|STARTED|Overall Study||8
7612423|NCT02442804|18742119|P1|STARTED|Overall Study||8
7612424|NCT02442700|18742149|P2|NOT COMPLETED|Later 12 Weeks||0
7612425|NCT02442700|18742150|P1|NOT COMPLETED|Later 12 Weeks||0
7612426|NCT02442700|18742149|P2|COMPLETED|Later 12 Weeks||12
7612427|NCT02442700|18742150|P1|COMPLETED|Later 12 Weeks||12
7612428|NCT02442700|18742149|P2|STARTED|Later 12 Weeks||12
7612429|NCT02442700|18742150|P1|STARTED|Later 12 Weeks||12
7612430|NCT02442700|18742149|P2|NOT COMPLETED|First 12 Weeks||0
7612431|NCT02442700|18742150|P1|NOT COMPLETED|First 12 Weeks||0
7612432|NCT02442700|18742149|P2|COMPLETED|First 12 Weeks||12
7612433|NCT02442700|18742150|P1|COMPLETED|First 12 Weeks||12
7612434|NCT02442700|18742149|P2|STARTED|First 12 Weeks||12
7612435|NCT02442700|18742150|P1|STARTED|First 12 Weeks||12
7612436|NCT02442687|18742161|P3|NOT COMPLETED|Overall Study||3
7612437|NCT02442687|18742162|P2|NOT COMPLETED|Overall Study||11
7612438|NCT02442687|18742163|P1|NOT COMPLETED|Overall Study||8
7612439|NCT02442687|18742161|P3|COMPLETED|Overall Study||19
7612440|NCT02442687|18742162|P2|COMPLETED|Overall Study||11
7612441|NCT02442687|18742163|P1|COMPLETED|Overall Study||13
7612442|NCT02442687|18742161|P3|STARTED|Overall Study||22
7612443|NCT02442687|18742162|P2|STARTED|Overall Study||22
7612444|NCT02442687|18742163|P1|STARTED|Overall Study||21
7612445|NCT02442622|18742226|P2|NOT COMPLETED|Overall Study||1
7612446|NCT02442622|18742227|P1|NOT COMPLETED|Overall Study||3
7612447|NCT02442622|18742226|P2|COMPLETED|Overall Study||16
7612448|NCT02442622|18742227|P1|COMPLETED|Overall Study||12
7612449|NCT02442622|18742226|P2|STARTED|Overall Study||17
7612450|NCT02442622|18742227|P1|STARTED|Overall Study||15
7612451|NCT02442349|18742237|P1|NOT COMPLETED|Overall Study||171
7612452|NCT02442349|18742237|P1|COMPLETED|Overall Study||0
7612453|NCT02442349|18742237|P1|STARTED|Overall Study||171
7612454|NCT02442310|18742242|P1|NOT COMPLETED|Overall Study||3
7612455|NCT02442310|18742242|P1|COMPLETED|Overall Study||17
7612456|NCT02442310|18742242|P1|STARTED|Overall Study||20
7612457|NCT02442284|18742264|P1|NOT COMPLETED|Overall Study||7
7612458|NCT02442284|18742264|P1|COMPLETED|Overall Study||92
7612459|NCT02442284|18742264|P1|STARTED|Overall Study||99
7612460|NCT02442271|18742271|P1|NOT COMPLETED|Overall Study||4
7612461|NCT02442271|18742271|P1|COMPLETED|Overall Study||218
7612462|NCT02442271|18742271|P1|STARTED|Overall Study||222
7612463|NCT02442206|18742297|P2|NOT COMPLETED|Period 2||0
7612464|NCT02442206|18742298|P1|NOT COMPLETED|Period 2||1
7612465|NCT02442206|18742297|P2|COMPLETED|Period 2||29
7612466|NCT02442206|18742298|P1|COMPLETED|Period 2||28
7612467|NCT02442206|18742297|P2|STARTED|Period 2||29
7612468|NCT02442206|18742298|P1|STARTED|Period 2||29
7612469|NCT02442206|18742297|P2|NOT COMPLETED|Period 1||3
7612470|NCT02442206|18742298|P1|NOT COMPLETED|Period 1||1
7612471|NCT02442206|18742297|P2|COMPLETED|Period 1||29
7612472|NCT02442206|18742298|P1|COMPLETED|Period 1||29
7612473|NCT02442206|18742297|P2|STARTED|Period 1||32
7612474|NCT02442206|18742298|P1|STARTED|Period 1||30
7612475|NCT02441946|18742330|P3|NOT COMPLETED|Extension Period (8 Weeks)||0
7612476|NCT02441946|18742331|P2|NOT COMPLETED|Extension Period (8 Weeks)||0
7612477|NCT02441946|18742332|P1|NOT COMPLETED|Extension Period (8 Weeks)||2
7612478|NCT02441946|18742330|P3|COMPLETED|Extension Period (8 Weeks)||0
7612479|NCT02441946|18742331|P2|COMPLETED|Extension Period (8 Weeks)||0
7612480|NCT02441946|18742332|P1|COMPLETED|Extension Period (8 Weeks)||40
7612481|NCT02441946|18742330|P3|STARTED|Extension Period (8 Weeks)||0
7612482|NCT02441946|18742331|P2|STARTED|Extension Period (8 Weeks)||0
7612483|NCT02441946|18742332|P1|STARTED|Extension Period (8 Weeks)|All participants who did not discontinue continued to the extension period.|42
7612484|NCT02441946|18742330|P3|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
7612485|NCT02441946|18742331|P2|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
7612486|NCT02441946|18742332|P1|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||27
7612487|NCT02441946|18742330|P3|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
7612488|NCT02441946|18742331|P2|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
7612489|NCT02441946|18742332|P1|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||190
7612490|NCT02441946|18742330|P3|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
7612491|NCT02441946|18742331|P2|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
7612492|NCT02441946|18742332|P1|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||5
7612493|NCT02441946|18742330|P3|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
7612494|NCT02441946|18742331|P2|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
7612495|NCT02441946|18742332|P1|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||217
7612496|NCT02441946|18742330|P3|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
7612497|NCT02441946|18742331|P2|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
7612498|NCT02441946|18742332|P1|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned to abemaciclib + anastrozole post cycle 1.|217
7612499|NCT02441946|18742330|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
7612500|NCT02441946|18742331|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
7612501|NCT02441946|18742332|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||2
7612502|NCT02441946|18742330|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||74
7612503|NCT02441946|18742331|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||71
7612504|NCT02441946|18742332|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||72
7612505|NCT02441946|18742330|P3|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
7612506|NCT02441946|18742331|P2|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)|1 participant did not receive drug due to an error in randomization.|75
7612507|NCT02441946|18742332|P1|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
7612508|NCT02441946|18742330|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||74
7612509|NCT02441946|18742331|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||76
7612510|NCT02441946|18742332|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||74
7612511|NCT02441517|18742353|P1|NOT COMPLETED|Overall Study||4
7612512|NCT02441517|18742353|P1|COMPLETED|Overall Study||0
7612513|NCT02441517|18742353|P1|Received Treatment|Overall Study||4
7612514|NCT02441517|18742353|P1|STARTED|Overall Study||4
7612515|NCT02441309|18742366|P3|NOT COMPLETED|Overall Study||3
7612516|NCT02441309|18742367|P2|NOT COMPLETED|Overall Study||2
7612517|NCT02441309|18742368|P1|NOT COMPLETED|Overall Study||3
7612518|NCT02441309|18742366|P3|COMPLETED|Overall Study||0
7612519|NCT02441309|18742367|P2|COMPLETED|Overall Study||0
7612520|NCT02441309|18742368|P1|COMPLETED|Overall Study||0
7612521|NCT02441309|18742366|P3|Received Allocated Intervention|Overall Study||3
7612522|NCT02441309|18742367|P2|Received Allocated Intervention|Overall Study||2
7612523|NCT02441309|18742368|P1|Received Allocated Intervention|Overall Study||1
7612524|NCT02441309|18742366|P3|STARTED|Overall Study||3
7612525|NCT02441309|18742367|P2|STARTED|Overall Study||2
7612526|NCT02441309|18742368|P1|STARTED|Overall Study||3
7612527|NCT02441283|18742397|P1|NOT COMPLETED|Overall Study||90
7612528|NCT02441283|18742397|P1|COMPLETED|Overall Study||287
7612529|NCT02441283|18742397|P1|STARTED|Overall Study||377
7612530|NCT02441218|18742410|P2|NOT COMPLETED|Overall Study||612
7612531|NCT02441218|18742411|P1|NOT COMPLETED|Overall Study||578
7612532|NCT02441218|18742410|P2|COMPLETED|Overall Study||2652
7612533|NCT02441218|18742411|P1|COMPLETED|Overall Study||2663
7612534|NCT02441218|18742410|P2|STARTED|Overall Study||3264
7612535|NCT02441218|18742411|P1|STARTED|Overall Study||3241
7612536|NCT02441179|18742437|P2|NOT COMPLETED|Overall Study||1
7612537|NCT02441179|18742438|P1|NOT COMPLETED|Overall Study||1
7612538|NCT02441179|18742437|P2|COMPLETED|Overall Study||16
7612539|NCT02441179|18742438|P1|COMPLETED|Overall Study||17
7612540|NCT02441179|18742437|P2|STARTED|Overall Study||17
7612541|NCT02441179|18742438|P1|STARTED|Overall Study||18
7612542|NCT02441114|18742456|P1|NOT COMPLETED|Period3||0
7612543|NCT02441114|18742456|P1|COMPLETED|Period3||6
7612544|NCT02441114|18742456|P1|STARTED|Period3||6
7612545|NCT02441114|18742456|P1|NOT COMPLETED|Washout2||4
7612546|NCT02441114|18742456|P1|COMPLETED|Washout2||6
7612547|NCT02441114|18742456|P1|STARTED|Washout2||10
7612548|NCT02441114|18742456|P1|NOT COMPLETED|Period2||0
7612549|NCT02441114|18742456|P1|COMPLETED|Period2||10
7612550|NCT02441114|18742456|P1|STARTED|Period2||10
7612551|NCT02441114|18742456|P1|NOT COMPLETED|Washout1||0
7612552|NCT02441114|18742456|P1|COMPLETED|Washout1||10
7612553|NCT02441114|18742456|P1|STARTED|Washout1||10
7612554|NCT02441114|18742456|P1|NOT COMPLETED|Period1||0
7612555|NCT02441114|18742456|P1|COMPLETED|Period1||10
7612556|NCT02441114|18742456|P1|STARTED|Period1||10
7612557|NCT02441062|18742462|P1|NOT COMPLETED|Overall Study||0
7612558|NCT02441062|18742462|P1|COMPLETED|Overall Study||122
7612559|NCT02441062|18742462|P1|STARTED|Overall Study||122
7612560|NCT02441036|18742471|P5|NOT COMPLETED|Overall Study||0
7612561|NCT02441036|18742472|P4|NOT COMPLETED|Overall Study||1
7612562|NCT02441036|18742473|P3|NOT COMPLETED|Overall Study||0
7612563|NCT02441036|18742474|P2|NOT COMPLETED|Overall Study||1
7612564|NCT02441036|18742475|P1|NOT COMPLETED|Overall Study||0
7612565|NCT02441036|18742471|P5|COMPLETED|Overall Study||1
7612566|NCT02441036|18742472|P4|COMPLETED|Overall Study||3
7612567|NCT02441036|18742473|P3|COMPLETED|Overall Study||3
7612568|NCT02441036|18742474|P2|COMPLETED|Overall Study||4
7612569|NCT02441036|18742475|P1|COMPLETED|Overall Study||3
7612570|NCT02441036|18742471|P5|Tissue Resected|Overall Study||1
7612571|NCT02441036|18742472|P4|Tissue Resected|Overall Study||3
7612572|NCT02441036|18742473|P3|Tissue Resected|Overall Study||3
7612573|NCT02441036|18742474|P2|Tissue Resected|Overall Study||4
7612574|NCT02441036|18742475|P1|Tissue Resected|Overall Study||3
7612575|NCT02441036|18742471|P5|Treated|Overall Study||1
7612576|NCT02441036|18742472|P4|Treated|Overall Study||4
7612577|NCT02441036|18742473|P3|Treated|Overall Study||3
7612578|NCT02441036|18742474|P2|Treated|Overall Study||5
7612579|NCT02441036|18742475|P1|Treated|Overall Study||3
7612580|NCT02441036|18742471|P5|STARTED|Overall Study||1
7612581|NCT02441036|18742472|P4|STARTED|Overall Study||4
7612582|NCT02441036|18742473|P3|STARTED|Overall Study||3
7612583|NCT02441036|18742474|P2|STARTED|Overall Study||5
7612584|NCT02441036|18742475|P1|STARTED|Overall Study||3
7612585|NCT02440789|18742502|P1|NOT COMPLETED|Overall Study||4
7612586|NCT02440789|18742502|P1|COMPLETED|Overall Study||28
7612587|NCT02440789|18742502|P1|Completed 20 Weeks of Sirolimus|Overall Study||16
7612588|NCT02440789|18742502|P1|Initiated Sirolimus|Overall Study||30
7612589|NCT02440789|18742502|P1|STARTED|Overall Study||32
7612590|NCT02440659|18742553|P2|NOT COMPLETED|Overall Study||335
7612591|NCT02440659|18742554|P1|NOT COMPLETED|Overall Study||651
7612592|NCT02440659|18742553|P2|COMPLETED|Overall Study||614
7612593|NCT02440659|18742554|P1|COMPLETED|Overall Study||1346
7612594|NCT02440659|18742553|P2|STARTED|Overall Study||949
7612595|NCT02440659|18742554|P1|STARTED|Overall Study||1997
7612596|NCT02440633|18742560|P1|NOT COMPLETED|Overall Study||0
7612597|NCT02440633|18742560|P1|COMPLETED|Overall Study||8
7612598|NCT02440633|18742560|P1|STARTED|Overall Study||8
7612599|NCT02440594|18742577|P8|NOT COMPLETED|Overall Study||56
7612600|NCT02440594|18742578|P7|NOT COMPLETED|Overall Study||37
7612601|NCT02440594|18742579|P6|NOT COMPLETED|Overall Study||7
7612602|NCT02440594|18742580|P5|NOT COMPLETED|Overall Study||9
7612603|NCT02440594|18742581|P4|NOT COMPLETED|Overall Study||89
7612604|NCT02440594|18742582|P3|NOT COMPLETED|Overall Study||117
7612605|NCT02440594|18742583|P2|NOT COMPLETED|Overall Study||108
7612606|NCT02440594|18742584|P1|NOT COMPLETED|Overall Study||132
7612607|NCT02440594|18742577|P8|COMPLETED|Overall Study||234
7612608|NCT02440594|18742578|P7|COMPLETED|Overall Study||113
7612609|NCT02440594|18742579|P6|COMPLETED|Overall Study||47
7612610|NCT02440594|18742580|P5|COMPLETED|Overall Study||46
7612611|NCT02440594|18742581|P4|COMPLETED|Overall Study||340
7612612|NCT02440594|18742582|P3|COMPLETED|Overall Study||319
7612613|NCT02440594|18742583|P2|COMPLETED|Overall Study||401
7612614|NCT02440594|18742584|P1|COMPLETED|Overall Study||377
7612615|NCT02440594|18742577|P8|STARTED|Overall Study||290
7612616|NCT02440594|18742578|P7|STARTED|Overall Study||150
7612617|NCT02440594|18742579|P6|STARTED|Overall Study||54
7612618|NCT02440594|18742580|P5|STARTED|Overall Study||55
7612619|NCT02440594|18742581|P4|STARTED|Overall Study||429
7612620|NCT02440594|18742582|P3|STARTED|Overall Study||436
7612621|NCT02440594|18742583|P2|STARTED|Overall Study||509
7612622|NCT02440594|18742584|P1|STARTED|Overall Study||509
7612623|NCT02440451|18742616|P1|NOT COMPLETED|Overall Study||0
7612624|NCT02440451|18742616|P1|COMPLETED|Overall Study||15
7612625|NCT02440451|18742616|P1|STARTED|Overall Study||15
7612626|NCT02440334|18742622|P1|NOT COMPLETED|Overall Study||0
7612627|NCT02440334|18742622|P1|COMPLETED|Overall Study||53
7612628|NCT02440334|18742622|P1|STARTED|Overall Study||53
7612629|NCT02440308|18742626|P1|NOT COMPLETED|Overall Study||0
7612630|NCT02440308|18742626|P1|COMPLETED|Overall Study||10
7612631|NCT02440308|18742626|P1|STARTED|Overall Study||10
7612632|NCT02440204|18742634|P3|NOT COMPLETED|Overall Study||0
7612633|NCT02440204|18742635|P2|NOT COMPLETED|Overall Study||0
7612634|NCT02440204|18742636|P1|NOT COMPLETED|Overall Study||0
7612635|NCT02440204|18742634|P3|COMPLETED|Overall Study||22
7612636|NCT02440204|18742635|P2|COMPLETED|Overall Study||24
7612637|NCT02440204|18742636|P1|COMPLETED|Overall Study||22
7612638|NCT02440204|18742634|P3|STARTED|Overall Study||22
7612639|NCT02440204|18742635|P2|STARTED|Overall Study||24
7612640|NCT02440204|18742636|P1|STARTED|Overall Study||22
7612641|NCT02440022|18742649|P2|NOT COMPLETED|Overall Study||13
7612642|NCT02440022|18742650|P1|NOT COMPLETED|Overall Study||27
7612643|NCT02440022|18742649|P2|COMPLETED|Overall Study||131
7612644|NCT02440022|18742650|P1|COMPLETED|Overall Study||114
7612645|NCT02440022|18742649|P2|STARTED|Overall Study||144
7612646|NCT02440022|18742650|P1|STARTED|Overall Study||141
7612647|NCT02439879|18742676|P2|NOT COMPLETED|Overall Study||0
7612648|NCT02439879|18742677|P1|NOT COMPLETED|Overall Study||0
7612649|NCT02439879|18742676|P2|COMPLETED|Overall Study||17
7612650|NCT02439879|18742677|P1|COMPLETED|Overall Study||16
7612651|NCT02439879|18742676|P2|STARTED|Overall Study||17
7612652|NCT02439879|18742677|P1|STARTED|Overall Study||16
7612653|NCT02439814|18742685|P2|NOT COMPLETED|Overall Study||0
7612654|NCT02439814|18742686|P1|NOT COMPLETED|Overall Study||0
7612655|NCT02439814|18742685|P2|COMPLETED|Overall Study||10
7612656|NCT02439814|18742686|P1|COMPLETED|Overall Study||11
7612657|NCT02439814|18742685|P2|STARTED|Overall Study||10
7612658|NCT02439814|18742686|P1|STARTED|Overall Study||11
7612659|NCT02439710|18742692|P1|NOT COMPLETED|Overall Study||0
7612660|NCT02439710|18742692|P1|COMPLETED|Overall Study||656
7612661|NCT02439710|18742692|P1|STARTED|Overall Study||656
7612662|NCT02439320|18742701|P3|NOT COMPLETED|Overall Study||99
7612663|NCT02439320|18742702|P2|NOT COMPLETED|Overall Study||114
7612664|NCT02439320|18742703|P1|NOT COMPLETED|Overall Study||96
7612665|NCT02439320|18742701|P3|COMPLETED|Overall Study||643
7612666|NCT02439320|18742702|P2|COMPLETED|Overall Study||631
7612667|NCT02439320|18742703|P1|COMPLETED|Overall Study||648
7612668|NCT02439320|18742701|P3|2nd Dose (After 2 Hour Assessment)|Overall Study||401
7612669|NCT02439320|18742702|P2|2nd Dose (After 2 Hour Assessment)|Overall Study||238
7612670|NCT02439320|18742703|P1|2nd Dose (After 2 Hour Assessment)|Overall Study||289
7612671|NCT02439320|18742701|P3|1st Dose (by 4 Hours Migraine Onset)|Overall Study||617
7612672|NCT02439320|18742702|P2|1st Dose (by 4 Hours Migraine Onset)|Overall Study||609
7612673|NCT02439320|18742703|P1|1st Dose (by 4 Hours Migraine Onset)|Overall Study||630
7612674|NCT02439320|18742701|P3|Confirmed Eligibility|Overall Study||705
7612675|NCT02439320|18742702|P2|Confirmed Eligibility|Overall Study||695
7612676|NCT02439320|18742703|P1|Confirmed Eligibility|Overall Study||710
7612677|NCT02439320|18742701|P3|STARTED|Overall Study||742
7612678|NCT02439320|18742702|P2|STARTED|Overall Study||745
7612679|NCT02439320|18742703|P1|STARTED|Overall Study||744
7612680|NCT02439281|18742748|P2|NOT COMPLETED|Overall Study||0
7612681|NCT02439281|18742749|P1|NOT COMPLETED|Overall Study||0
7612682|NCT02439281|18742748|P2|COMPLETED|Overall Study||26
7612683|NCT02439281|18742749|P1|COMPLETED|Overall Study||24
7612684|NCT02439281|18742748|P2|STARTED|Overall Study||26
7612685|NCT02439281|18742749|P1|STARTED|Overall Study||24
7612686|NCT02439164|18742769|P2|NOT COMPLETED|Overall Study||0
7612687|NCT02439164|18742770|P1|NOT COMPLETED|Overall Study||0
7612688|NCT02439164|18742769|P2|COMPLETED|Overall Study||18
7612689|NCT02439164|18742770|P1|COMPLETED|Overall Study||18
7612690|NCT02439164|18742769|P2|STARTED|Overall Study||18
7612691|NCT02439164|18742770|P1|STARTED|Overall Study||18
7612692|NCT02439138|18742783|P1|NOT COMPLETED|Overall Study||3
7612693|NCT02439138|18742783|P1|COMPLETED|Overall Study||2
7612694|NCT02439138|18742783|P1|STARTED|Overall Study||5
7612695|NCT02438826|18742796|P4|NOT COMPLETED|Post-Treatment Phase||0
7612696|NCT02438826|18742797|P3|NOT COMPLETED|Post-Treatment Phase||0
7612697|NCT02438826|18742798|P2|NOT COMPLETED|Post-Treatment Phase||1
7612698|NCT02438826|18742799|P1|NOT COMPLETED|Post-Treatment Phase||9
7612699|NCT02438826|18742796|P4|COMPLETED|Post-Treatment Phase||4
7612700|NCT02438826|18742797|P3|COMPLETED|Post-Treatment Phase||2
7612701|NCT02438826|18742798|P2|COMPLETED|Post-Treatment Phase||92
7612702|NCT02438826|18742799|P1|COMPLETED|Post-Treatment Phase||84
7612703|NCT02438826|18742796|P4|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|4
7612704|NCT02438826|18742797|P3|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|2
7612705|NCT02438826|18742798|P2|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
7612706|NCT02438826|18742799|P1|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
7612707|NCT02438826|18742796|P4|NOT COMPLETED|Open-Label Treatment Phase||0
7612708|NCT02438826|18742797|P3|NOT COMPLETED|Open-Label Treatment Phase||0
7612709|NCT02438826|18742798|P2|NOT COMPLETED|Open-Label Treatment Phase||33
7612710|NCT02438826|18742799|P1|NOT COMPLETED|Open-Label Treatment Phase||44
7612711|NCT02438826|18742796|P4|COMPLETED|Open-Label Treatment Phase||0
7612712|NCT02438826|18742797|P3|COMPLETED|Open-Label Treatment Phase||0
7612713|NCT02438826|18742798|P2|COMPLETED|Open-Label Treatment Phase||80
7612714|NCT02438826|18742799|P1|COMPLETED|Open-Label Treatment Phase||72
7612715|NCT02438826|18742796|P4|STARTED|Open-Label Treatment Phase||0
7612716|NCT02438826|18742797|P3|STARTED|Open-Label Treatment Phase||0
7612717|NCT02438826|18742798|P2|STARTED|Open-Label Treatment Phase||113
7612718|NCT02438826|18742799|P1|STARTED|Open-Label Treatment Phase|This period is optional phase, one participant chose not to enter the open-label phase.|116
7612719|NCT02438826|18742796|P4|NOT COMPLETED|Double-Blind Treatment Phase||0
7612720|NCT02438826|18742797|P3|NOT COMPLETED|Double-Blind Treatment Phase||0
7612721|NCT02438826|18742798|P2|NOT COMPLETED|Double-Blind Treatment Phase||4
7612722|NCT02438826|18742799|P1|NOT COMPLETED|Double-Blind Treatment Phase||6
7612723|NCT02438826|18742796|P4|COMPLETED|Double-Blind Treatment Phase||0
7612724|NCT02438826|18742797|P3|COMPLETED|Double-Blind Treatment Phase||0
7612725|NCT02438826|18742798|P2|COMPLETED|Double-Blind Treatment Phase||113
7612726|NCT02438826|18742799|P1|COMPLETED|Double-Blind Treatment Phase||117
7612727|NCT02438826|18742796|P4|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
7612728|NCT02438826|18742797|P3|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
7612729|NCT02438826|18742798|P2|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||117
7612730|NCT02438826|18742799|P1|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||120
7612731|NCT02438826|18742796|P4|STARTED|Double-Blind Treatment Phase||0
7612732|NCT02438826|18742797|P3|STARTED|Double-Blind Treatment Phase||0
7612733|NCT02438826|18742798|P2|STARTED|Double-Blind Treatment Phase||117
7612734|NCT02438826|18742799|P1|STARTED|Double-Blind Treatment Phase||123
7612735|NCT02438813|18742833|P1|NOT COMPLETED|Overall Study||525
7612736|NCT02438813|18742833|P1|COMPLETED|Overall Study||504
7612737|NCT02438813|18742833|P1|Did Not ReceiveTreatment for SMF|Overall Study||353
7612738|NCT02438813|18742833|P1|Received Treatment for SMF|Overall Study||676
7612739|NCT02438813|18742833|P1|STARTED|Overall Study||1029
7612740|NCT02438787|18742885|P3|NOT COMPLETED|Overall Study||83
7612741|NCT02438787|18742886|P2|NOT COMPLETED|Overall Study||83
7612742|NCT02438787|18742887|P1|NOT COMPLETED|Overall Study||81
7612743|NCT02438787|18742885|P3|COMPLETED|Overall Study||22
7612744|NCT02438787|18742886|P2|COMPLETED|Overall Study||23
7612745|NCT02438787|18742887|P1|COMPLETED|Overall Study||23
7612746|NCT02438787|18742885|P3|Cross Over at Week 24|Overall Study||0
7612747|NCT02438787|18742886|P2|Cross Over at Week 24|Overall Study||0
7612748|NCT02438787|18742887|P1|Cross Over at Week 24|Overall Study|Out of 43: crossed over to Ustekinumab 45 mg (n=21) and Ustekinumab 90 mg (n=22)|43
7612749|NCT02438787|18742885|P3|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|20
7612750|NCT02438787|18742886|P2|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
7612751|NCT02438787|18742887|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
7612752|NCT02438787|18742885|P3|STARTED|Overall Study||105
7612753|NCT02438787|18742886|P2|STARTED|Overall Study||106
7612754|NCT02438787|18742887|P1|STARTED|Overall Study||104
7612755|NCT02438540|18742932|P2|NOT COMPLETED|Overall Study||0
7612756|NCT02438540|18742933|P1|NOT COMPLETED|Overall Study||0
7612757|NCT02438540|18742932|P2|COMPLETED|Overall Study||20
7612758|NCT02438540|18742933|P1|COMPLETED|Overall Study||19
7612759|NCT02438540|18742932|P2|STARTED|Overall Study||20
7612760|NCT02438540|18742933|P1|STARTED|Overall Study||19
7612761|NCT02438475|18742975|P2|NOT COMPLETED|Overall Study||0
7612762|NCT02438475|18742976|P1|NOT COMPLETED|Overall Study||2
7612763|NCT02438475|18742975|P2|COMPLETED|Overall Study||104
7612764|NCT02438475|18742976|P1|COMPLETED|Overall Study||102
7612765|NCT02438475|18742975|P2|STARTED|Overall Study||104
7612766|NCT02438475|18742976|P1|STARTED|Overall Study||104
7612767|NCT02438423|18742990|P4|NOT COMPLETED|Overall Study||0
7612768|NCT02438423|18742991|P3|NOT COMPLETED|Overall Study||0
7612769|NCT02438423|18742992|P2|NOT COMPLETED|Overall Study||0
7612770|NCT02438423|18742993|P1|NOT COMPLETED|Overall Study||0
7612771|NCT02438423|18742990|P4|COMPLETED|Overall Study||25
7612772|NCT02438423|18742991|P3|COMPLETED|Overall Study||25
7612773|NCT02438423|18742992|P2|COMPLETED|Overall Study||25
7612774|NCT02438423|18742993|P1|COMPLETED|Overall Study||25
7612775|NCT02438423|18742990|P4|STARTED|Overall Study||25
7612776|NCT02438423|18742991|P3|STARTED|Overall Study||25
7612777|NCT02438423|18742992|P2|STARTED|Overall Study||25
7612778|NCT02438423|18742993|P1|STARTED|Overall Study||25
7612779|NCT02438384|18743020|P3|NOT COMPLETED|Overall Study||4
7612780|NCT02438384|18743021|P2|NOT COMPLETED|Overall Study||6
7612781|NCT02438384|18743022|P1|NOT COMPLETED|Overall Study||8
7612782|NCT02438384|18743020|P3|COMPLETED|Overall Study||21
7612783|NCT02438384|18743021|P2|COMPLETED|Overall Study||19
7612784|NCT02438384|18743022|P1|COMPLETED|Overall Study||17
7612785|NCT02438384|18743020|P3|STARTED|Overall Study||25
7612786|NCT02438384|18743021|P2|STARTED|Overall Study||25
7612787|NCT02438384|18743022|P1|STARTED|Overall Study||25
7612788|NCT02438280|18743041|P2|NOT COMPLETED|Overall Study||0
7612789|NCT02438280|18743042|P1|NOT COMPLETED|Overall Study||1
7612790|NCT02438280|18743041|P2|COMPLETED|Overall Study||13
7612791|NCT02438280|18743042|P1|COMPLETED|Overall Study||13
7612792|NCT02438280|18743041|P2|STARTED|Overall Study||13
7612793|NCT02438280|18743042|P1|STARTED|Overall Study||14
7612794|NCT02438137|18743052|P2|NOT COMPLETED|Overall Study||6
7612795|NCT02438137|18743053|P1|NOT COMPLETED|Overall Study||8
7612796|NCT02438137|18743052|P2|COMPLETED|Overall Study||15
7612797|NCT02438137|18743053|P1|COMPLETED|Overall Study||36
7612798|NCT02438137|18743052|P2|STARTED|Overall Study||21
7612799|NCT02438137|18743053|P1|STARTED|Overall Study||44
7612800|NCT02437903|18743061|P1|NOT COMPLETED|Overall Study||5
7612801|NCT02437903|18743061|P1|COMPLETED|Overall Study||25
7612802|NCT02437903|18743061|P1|STARTED|Overall Study||30
7612803|NCT02437890|18743074|P5|NOT COMPLETED|Overall Study||16
7612804|NCT02437890|18743075|P4|NOT COMPLETED|Overall Study||22
7612805|NCT02437890|18743076|P3|NOT COMPLETED|Overall Study||15
7612806|NCT02437890|18743077|P2|NOT COMPLETED|Overall Study||16
7612807|NCT02437890|18743078|P1|NOT COMPLETED|Overall Study||8
7612808|NCT02437890|18743074|P5|COMPLETED|Overall Study||46
7612809|NCT02437890|18743075|P4|COMPLETED|Overall Study||40
7612810|NCT02437890|18743076|P3|COMPLETED|Overall Study||47
7612811|NCT02437890|18743077|P2|COMPLETED|Overall Study||48
7612812|NCT02437890|18743078|P1|COMPLETED|Overall Study||54
7612813|NCT02437890|18743074|P5|STARTED|Overall Study||62
7612814|NCT02437890|18743075|P4|STARTED|Overall Study||62
7612815|NCT02437890|18743076|P3|STARTED|Overall Study||62
7612816|NCT02437890|18743077|P2|STARTED|Overall Study||64
7612817|NCT02437890|18743078|P1|STARTED|Overall Study||62
7612818|NCT02437864|18743291|P2|NOT COMPLETED|Overall Study||0
7612819|NCT02437864|18743292|P1|NOT COMPLETED|Overall Study||4
7612820|NCT02437864|18743291|P2|COMPLETED|Overall Study||160
7612821|NCT02437864|18743292|P1|COMPLETED|Overall Study||196
7612822|NCT02437864|18743291|P2|STARTED|Overall Study||160
7612823|NCT02437864|18743292|P1|STARTED|Overall Study||200
7612824|NCT02437669|18743306|P1|NOT COMPLETED|Overall Study||0
7612825|NCT02437669|18743306|P1|COMPLETED|Overall Study||35
7612826|NCT02437669|18743306|P1|STARTED|Overall Study||35
7612827|NCT02437513|18743313|P1|NOT COMPLETED|Overall Study||2
7612828|NCT02437513|18743313|P1|COMPLETED|Overall Study||0
7612829|NCT02437513|18743313|P1|STARTED|Overall Study||2
7612830|NCT02437487|18743323|P2|NOT COMPLETED|Overall Study||14
7612831|NCT02437487|18743324|P1|NOT COMPLETED|Overall Study||27
7612832|NCT02437487|18743323|P2|COMPLETED|Overall Study||16
7612833|NCT02437487|18743324|P1|COMPLETED|Overall Study||32
7612834|NCT02437487|18743323|P2|Intention-to-Treat Population|Overall Study||30
7612835|NCT02437487|18743324|P1|Intention-to-Treat Population|Overall Study||59
7612836|NCT02437487|18743323|P2|Actual Treatment Received|Overall Study||29
7612837|NCT02437487|18743324|P1|Actual Treatment Received|Overall Study||60
7612838|NCT02437487|18743323|P2|STARTED|Overall Study||30
7612839|NCT02437487|18743324|P1|STARTED|Overall Study||59
7612840|NCT02437409|18743338|P1|NOT COMPLETED|Overall Study||15
7612841|NCT02437409|18743338|P1|COMPLETED|Overall Study|In total 100 patients fulfilled the in-and exclusion criteria,15 patients were excluded/discontinued|100
7612842|NCT02437409|18743338|P1|STARTED|Overall Study|Eventually 100 evaluable patients, attrition rate of 15%|115
7612843|NCT02437383|18743349|P2|NOT COMPLETED|Overall Study||13
7612844|NCT02437383|18743350|P1|NOT COMPLETED|Overall Study||13
7612845|NCT02437383|18743349|P2|COMPLETED|Overall Study||87
7612846|NCT02437383|18743350|P1|COMPLETED|Overall Study||87
7612847|NCT02437383|18743349|P2|STARTED|Overall Study||100
7612848|NCT02437383|18743350|P1|STARTED|Overall Study||100
7612849|NCT02437344|18743424|P1|NOT COMPLETED|Overall Study||1
7612850|NCT02437344|18743424|P1|COMPLETED|Overall Study||15
7612851|NCT02437344|18743424|P1|STARTED|Overall Study||16
7612852|NCT02437318|18743431|P2|NOT COMPLETED|Overall Study||242
7612853|NCT02437318|18743432|P1|NOT COMPLETED|Overall Study||229
7612854|NCT02437318|18743431|P2|COMPLETED|Overall Study||46
7612855|NCT02437318|18743432|P1|COMPLETED|Overall Study||55
7612856|NCT02437318|18743431|P2|Untreated (Protocol Deviation)|Overall Study||1
7612857|NCT02437318|18743432|P1|Untreated (Protocol Deviation)|Overall Study||0
7612858|NCT02437318|18743431|P2|End of Treatment (Didn't Complete)|Overall Study||241
7612859|NCT02437318|18743432|P1|End of Treatment (Didn't Complete)|Overall Study||229
7612860|NCT02437318|18743431|P2|STARTED|Overall Study||288
7612861|NCT02437318|18743432|P1|STARTED|Overall Study||284
7612862|NCT02437305|18743440|P2|NOT COMPLETED|Overall Study||12
7612863|NCT02437305|18743441|P1|NOT COMPLETED|Overall Study||18
7612864|NCT02437305|18743440|P2|COMPLETED|Overall Study||38
7612865|NCT02437305|18743441|P1|COMPLETED|Overall Study||32
7612866|NCT02437305|18743440|P2|STARTED|Overall Study||50
7612867|NCT02437305|18743441|P1|STARTED|Overall Study||50
7612868|NCT02437253|18743451|P2|NOT COMPLETED|Overall Study||0
7612869|NCT02437253|18743452|P1|NOT COMPLETED|Overall Study||0
7612870|NCT02437253|18743451|P2|COMPLETED|Overall Study||1
7612871|NCT02437253|18743452|P1|COMPLETED|Overall Study||1
7612872|NCT02437253|18743451|P2|STARTED|Overall Study||1
7612873|NCT02437253|18743452|P1|STARTED|Overall Study||1
7612874|NCT02437188|18743468|P2|NOT COMPLETED|Overall Study||9
7612875|NCT02437188|18743469|P1|NOT COMPLETED|Overall Study||4
7612876|NCT02437188|18743468|P2|COMPLETED|Overall Study||35
7612877|NCT02437188|18743469|P1|COMPLETED|Overall Study||40
7612878|NCT02437188|18743468|P2|STARTED|Overall Study||44
7612879|NCT02437188|18743469|P1|STARTED|Overall Study||44
7612880|NCT02437162|18743486|P3|NOT COMPLETED|Overall Study||109
7612881|NCT02437162|18743487|P2|NOT COMPLETED|Overall Study||108
7612882|NCT02437162|18743488|P1|NOT COMPLETED|Overall Study||107
7612883|NCT02437162|18743486|P3|COMPLETED|Overall Study||6
7612884|NCT02437162|18743487|P2|COMPLETED|Overall Study||8
7612885|NCT02437162|18743488|P1|COMPLETED|Overall Study||9
7612886|NCT02437162|18743486|P3|Cross Over at Week 24|Overall Study||0
7612887|NCT02437162|18743487|P2|Cross Over at Week 24|Overall Study||0
7612888|NCT02437162|18743488|P1|Cross Over at Week 24|Overall Study|Out of 87: crossed over to Ustekinumab 45 mg (n=44) and Ustekinumab 90 mg (n=43)|87
7612889|NCT02437162|18743486|P3|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|14
7612890|NCT02437162|18743487|P2|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
7612891|NCT02437162|18743488|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|26
7612892|NCT02437162|18743486|P3|Treated|Overall Study||114
7612893|NCT02437162|18743487|P2|Treated|Overall Study||116
7612894|NCT02437162|18743488|P1|Treated|Overall Study||116
7612895|NCT02437162|18743486|P3|STARTED|Overall Study||115
7612896|NCT02437162|18743487|P2|STARTED|Overall Study||116
7612897|NCT02437162|18743488|P1|STARTED|Overall Study||116
7612898|NCT02436915|18743608|P2|NOT COMPLETED|Overall Study||1
7612899|NCT02436915|18743609|P1|NOT COMPLETED|Overall Study||0
7612900|NCT02436915|18743608|P2|COMPLETED|Overall Study||9
7612901|NCT02436915|18743609|P1|COMPLETED|Overall Study||9
7612902|NCT02436915|18743608|P2|STARTED|Overall Study||10
7612903|NCT02436915|18743609|P1|STARTED|Overall Study||9
7612904|NCT02436889|18743631|P2|NOT COMPLETED|Overall Study||1
7612905|NCT02436889|18743632|P1|NOT COMPLETED|Overall Study||1
7612906|NCT02436889|18743631|P2|COMPLETED|Overall Study||10
7612907|NCT02436889|18743632|P1|COMPLETED|Overall Study||11
7612908|NCT02436889|18743631|P2|STARTED|Overall Study||11
7612909|NCT02436889|18743632|P1|STARTED|Overall Study||12
7612910|NCT02436811|18743651|P3|NOT COMPLETED|Overall Study||7
7612911|NCT02436811|18743652|P2|NOT COMPLETED|Overall Study||9
7612912|NCT02436811|18743653|P1|NOT COMPLETED|Overall Study||2
7612913|NCT02436811|18743651|P3|COMPLETED|Overall Study||53
7612914|NCT02436811|18743652|P2|COMPLETED|Overall Study||51
7612915|NCT02436811|18743653|P1|COMPLETED|Overall Study||58
7612916|NCT02436811|18743651|P3|STARTED|Overall Study||60
7612917|NCT02436811|18743652|P2|STARTED|Overall Study||60
7612918|NCT02436811|18743653|P1|STARTED|Overall Study||60
7612919|NCT02436759|18743663|P2|NOT COMPLETED|Overall Study||1
7612920|NCT02436759|18743664|P1|NOT COMPLETED|Overall Study||4
7612921|NCT02436759|18743663|P2|COMPLETED|Overall Study||45
7612922|NCT02436759|18743664|P1|COMPLETED|Overall Study||90
7612923|NCT02436759|18743663|P2|Subjects Treated|Overall Study||46
7612924|NCT02436759|18743664|P1|Subjects Treated|Overall Study||94
7612925|NCT02436759|18743663|P2|Subjects Randomized|Overall Study||46
7612926|NCT02436759|18743664|P1|Subjects Randomized|Overall Study||94
7612927|NCT02436759|18743663|P2|STARTED|Overall Study||46
7612928|NCT02436759|18743664|P1|STARTED|Overall Study||94
7612929|NCT02436681|18743672|P1|NOT COMPLETED|Overall Study||14
7612930|NCT02436681|18743672|P1|COMPLETED|Overall Study||27
7612931|NCT02436681|18743672|P1|STARTED|Overall Study||41
7612932|NCT02436668|18743685|P2|NOT COMPLETED|Overall Study||4
7612933|NCT02436668|18743686|P1|NOT COMPLETED|Overall Study||1
7612934|NCT02436668|18743685|P2|COMPLETED|Overall Study||207
7612935|NCT02436668|18743686|P1|COMPLETED|Overall Study||212
7612936|NCT02436668|18743685|P2|STARTED|Overall Study||211
7612937|NCT02436668|18743686|P1|STARTED|Overall Study||213
7612938|NCT02436577|18743712|P6|NOT COMPLETED|Overall Study||0
7612939|NCT02436577|18743713|P5|NOT COMPLETED|Overall Study||0
7612940|NCT02436577|18743714|P4|NOT COMPLETED|Overall Study||0
7612941|NCT02436577|18743715|P3|NOT COMPLETED|Overall Study||0
7612942|NCT02436577|18743716|P2|NOT COMPLETED|Overall Study||1
7612943|NCT02436577|18743717|P1|NOT COMPLETED|Overall Study||0
7612944|NCT02436577|18743712|P6|COMPLETED|Overall Study||7
7612945|NCT02436577|18743713|P5|COMPLETED|Overall Study||7
7612946|NCT02436577|18743714|P4|COMPLETED|Overall Study||7
7612947|NCT02436577|18743715|P3|COMPLETED|Overall Study||7
7612948|NCT02436577|18743716|P2|COMPLETED|Overall Study||6
7612949|NCT02436577|18743717|P1|COMPLETED|Overall Study||7
7612950|NCT02436577|18743712|P6|STARTED|Overall Study||7
7612951|NCT02436577|18743713|P5|STARTED|Overall Study||7
7612952|NCT02436577|18743714|P4|STARTED|Overall Study||7
7612953|NCT02436577|18743715|P3|STARTED|Overall Study||7
7612954|NCT02436577|18743716|P2|STARTED|Overall Study||7
7612955|NCT02436577|18743717|P1|STARTED|Overall Study||7
7612956|NCT02436356|18743773|P3|NOT COMPLETED|Overall Study||2
7612957|NCT02436356|18743774|P2|NOT COMPLETED|Overall Study||1
7612958|NCT02436356|18743775|P1|NOT COMPLETED|Overall Study||5
7612959|NCT02436356|18743773|P3|COMPLETED|Overall Study||2
7612960|NCT02436356|18743774|P2|COMPLETED|Overall Study||10
7612961|NCT02436356|18743775|P1|COMPLETED|Overall Study||28
7612962|NCT02436356|18743773|P3|Low Energy Fracture|Overall Study||0
7612963|NCT02436356|18743774|P2|Low Energy Fracture|Overall Study||0
7612964|NCT02436356|18743775|P1|Low Energy Fracture|Overall Study||19
7612965|NCT02436356|18743773|P3|High Energy Fracture|Overall Study||4
7612966|NCT02436356|18743774|P2|High Energy Fracture|Overall Study||0
7612967|NCT02436356|18743775|P1|High Energy Fracture|Overall Study||14
7612968|NCT02436356|18743773|P3|STARTED|Overall Study||4
7612969|NCT02436356|18743774|P2|STARTED|Overall Study||11
7612970|NCT02436356|18743775|P1|STARTED|Overall Study||33
7612971|NCT02436330|18743806|P2|NOT COMPLETED|Cohort 6||1
7612972|NCT02436330|18743807|P1|NOT COMPLETED|Cohort 6||3
7612973|NCT02436330|18743806|P2|COMPLETED|Cohort 6||4
7612974|NCT02436330|18743807|P1|COMPLETED|Cohort 6||1
7612975|NCT02436330|18743806|P2|STARTED|Cohort 6||5
7612976|NCT02436330|18743807|P1|STARTED|Cohort 6||4
7612977|NCT02436330|18743806|P2|NOT COMPLETED|Cohort 5||4
7612978|NCT02436330|18743807|P1|NOT COMPLETED|Cohort 5||6
7612979|NCT02436330|18743806|P2|COMPLETED|Cohort 5||1
7612980|NCT02436330|18743807|P1|COMPLETED|Cohort 5||4
7612981|NCT02436330|18743806|P2|STARTED|Cohort 5||5
7612982|NCT02436330|18743807|P1|STARTED|Cohort 5||10
7612983|NCT02436330|18743806|P2|NOT COMPLETED|Cohort 4||0
7612984|NCT02436330|18743807|P1|NOT COMPLETED|Cohort 4||2
7612985|NCT02436330|18743806|P2|COMPLETED|Cohort 4||0
7612986|NCT02436330|18743807|P1|COMPLETED|Cohort 4||4
7612987|NCT02436330|18743806|P2|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
7612988|NCT02436330|18743807|P1|STARTED|Cohort 4||6
7612989|NCT02436330|18743806|P2|NOT COMPLETED|Cohort 3||0
7612990|NCT02436330|18743807|P1|NOT COMPLETED|Cohort 3||5
7612991|NCT02436330|18743806|P2|COMPLETED|Cohort 3||0
7612992|NCT02436330|18743807|P1|COMPLETED|Cohort 3||7
7612993|NCT02436330|18743806|P2|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
7612994|NCT02436330|18743807|P1|STARTED|Cohort 3||12
7612995|NCT02436330|18743806|P2|NOT COMPLETED|Cohort 2||3
7612996|NCT02436330|18743807|P1|NOT COMPLETED|Cohort 2||4
7612997|NCT02436330|18743806|P2|COMPLETED|Cohort 2||7
7612998|NCT02436330|18743807|P1|COMPLETED|Cohort 2||10
7612999|NCT02436330|18743806|P2|STARTED|Cohort 2||10
7613000|NCT02436330|18743807|P1|STARTED|Cohort 2||14
7613001|NCT02436330|18743806|P2|NOT COMPLETED|Cohort 1||3
7613002|NCT02436330|18743807|P1|NOT COMPLETED|Cohort 1||5
7613003|NCT02436330|18743806|P2|COMPLETED|Cohort 1||1
7613004|NCT02436330|18743807|P1|COMPLETED|Cohort 1||9
7613005|NCT02436330|18743806|P2|STARTED|Cohort 1||4
7613006|NCT02436330|18743807|P1|STARTED|Cohort 1||14
7613007|NCT02436304|18743852|P3|NOT COMPLETED|Overall Study||1
7613008|NCT02436304|18743853|P2|NOT COMPLETED|Overall Study||2
7613009|NCT02436304|18743854|P1|NOT COMPLETED|Overall Study||0
7613010|NCT02436304|18743852|P3|COMPLETED|Overall Study||100
7613011|NCT02436304|18743853|P2|COMPLETED|Overall Study||100
7613012|NCT02436304|18743854|P1|COMPLETED|Overall Study||153
7613013|NCT02436304|18743852|P3|STARTED|Overall Study||101
7613014|NCT02436304|18743853|P2|STARTED|Overall Study||102
7613015|NCT02436304|18743854|P1|STARTED|Overall Study||153
7613016|NCT02436239|18743873|P4|NOT COMPLETED|Down-Taper Period||2
7613017|NCT02436239|18743874|P3|NOT COMPLETED|Down-Taper Period||1
7613018|NCT02436239|18743875|P2|NOT COMPLETED|Down-Taper Period||4
7613019|NCT02436239|18743876|P1|NOT COMPLETED|Down-Taper Period||4
7613020|NCT02436239|18743873|P4|COMPLETED|Down-Taper Period||4
7613021|NCT02436239|18743874|P3|COMPLETED|Down-Taper Period||43
7613022|NCT02436239|18743875|P2|COMPLETED|Down-Taper Period||99
7613023|NCT02436239|18743876|P1|COMPLETED|Down-Taper Period||86
7613024|NCT02436239|18743873|P4|STARTED|Down-Taper Period|One participant who completed the open-label treatment period did not enter the down-taper period.|6
7613025|NCT02436239|18743874|P3|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|44
7613026|NCT02436239|18743875|P2|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|103
7613027|NCT02436239|18743876|P1|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|90
7613028|NCT02436239|18743873|P4|NOT COMPLETED|Open-Lable Treatment Period||5
7613029|NCT02436239|18743874|P3|NOT COMPLETED|Open-Lable Treatment Period||27
7613030|NCT02436239|18743875|P2|NOT COMPLETED|Open-Lable Treatment Period||34
7613031|NCT02436239|18743876|P1|NOT COMPLETED|Open-Lable Treatment Period||33
7613032|NCT02436239|18743873|P4|COMPLETED|Open-Lable Treatment Period||7
7613033|NCT02436239|18743874|P3|COMPLETED|Open-Lable Treatment Period||38
7613034|NCT02436239|18743875|P2|COMPLETED|Open-Lable Treatment Period||97
7613035|NCT02436239|18743876|P1|COMPLETED|Open-Lable Treatment Period||89
7613036|NCT02436239|18743873|P4|STARTED|Open-Lable Treatment Period||12
7613037|NCT02436239|18743874|P3|STARTED|Open-Lable Treatment Period||65
7613038|NCT02436239|18743875|P2|STARTED|Open-Lable Treatment Period||131
7613039|NCT02436239|18743876|P1|STARTED|Open-Lable Treatment Period||122
7613040|NCT02436200|18743898|P1|NOT COMPLETED|Overall Study||1
7613041|NCT02436200|18743898|P1|COMPLETED|Overall Study||20
7613042|NCT02436200|18743898|P1|STARTED|Overall Study||21
7613043|NCT02436135|18743905|P2|NOT COMPLETED|Overall Study||4
7613044|NCT02436135|18743906|P1|NOT COMPLETED|Overall Study||6
7613045|NCT02436135|18743905|P2|COMPLETED|Overall Study||0
7613046|NCT02436135|18743906|P1|COMPLETED|Overall Study||0
7613047|NCT02436135|18743905|P2|STARTED|Overall Study||4
7613048|NCT02436135|18743906|P1|STARTED|Overall Study||6
7613049|NCT02436031|18743930|P2|NOT COMPLETED|Second Study Night||0
7613050|NCT02436031|18743931|P1|NOT COMPLETED|Second Study Night||0
7613051|NCT02436031|18743930|P2|COMPLETED|Second Study Night||8
7613052|NCT02436031|18743931|P1|COMPLETED|Second Study Night||7
7613053|NCT02436031|18743930|P2|STARTED|Second Study Night||8
7613054|NCT02436031|18743931|P1|STARTED|Second Study Night|1 participant did not tolerate the study setup so did not participate in the second study night|7
7613055|NCT02436031|18743930|P2|NOT COMPLETED|First Study Night||0
7613056|NCT02436031|18743931|P1|NOT COMPLETED|First Study Night||0
7613057|NCT02436031|18743930|P2|COMPLETED|First Study Night||8
7613058|NCT02436031|18743931|P1|COMPLETED|First Study Night||8
7613059|NCT02436031|18743930|P2|STARTED|First Study Night||8
7613060|NCT02436031|18743931|P1|STARTED|First Study Night||8
7613061|NCT02436005|18743941|P2|NOT COMPLETED|Second Intervention||1
7613062|NCT02436005|18743942|P1|NOT COMPLETED|Second Intervention||0
7613063|NCT02436005|18743941|P2|COMPLETED|Second Intervention||12
7613064|NCT02436005|18743942|P1|COMPLETED|Second Intervention||12
7613065|NCT02436005|18743941|P2|STARTED|Second Intervention||13
7613066|NCT02436005|18743942|P1|STARTED|Second Intervention||12
7613067|NCT02436005|18743941|P2|NOT COMPLETED|First Intervention||0
7613068|NCT02436005|18743942|P1|NOT COMPLETED|First Intervention||0
7613069|NCT02436005|18743941|P2|COMPLETED|First Intervention||13
7613070|NCT02436005|18743942|P1|COMPLETED|First Intervention||12
7613071|NCT02436005|18743941|P2|STARTED|First Intervention||13
7613072|NCT02436005|18743942|P1|STARTED|First Intervention||12
7613073|NCT02435966|18744007|P3|NOT COMPLETED|Overall Study||0
7613074|NCT02435966|18744008|P2|NOT COMPLETED|Overall Study||1
7613075|NCT02435966|18744009|P1|NOT COMPLETED|Overall Study||0
7613076|NCT02435966|18744007|P3|COMPLETED|Overall Study||30
7613077|NCT02435966|18744008|P2|COMPLETED|Overall Study||53
7613078|NCT02435966|18744009|P1|COMPLETED|Overall Study||47
7613079|NCT02435966|18744007|P3|Follow-up|Overall Study||30
7613080|NCT02435966|18744008|P2|Follow-up|Overall Study||53
7613081|NCT02435966|18744009|P1|Follow-up|Overall Study||47
7613082|NCT02435966|18744007|P3|Second Intervention|Overall Study||30
7613083|NCT02435966|18744008|P2|Second Intervention|Overall Study||53
7613084|NCT02435966|18744009|P1|Second Intervention|Overall Study||47
7613085|NCT02435966|18744007|P3|First Intervention|Overall Study||30
7613086|NCT02435966|18744008|P2|First Intervention|Overall Study||54
7613087|NCT02435966|18744009|P1|First Intervention|Overall Study||47
7613088|NCT02435966|18744007|P3|STARTED|Overall Study||30
7613089|NCT02435966|18744008|P2|STARTED|Overall Study||54
7613090|NCT02435966|18744009|P1|STARTED|Overall Study||47
7613091|NCT02435914|18744021|P4|NOT COMPLETED|Overall Study||0
7613092|NCT02435914|18744022|P3|NOT COMPLETED|Overall Study||1
7613093|NCT02435914|18744023|P2|NOT COMPLETED|Overall Study||1
7613094|NCT02435914|18744024|P1|NOT COMPLETED|Overall Study||1
7613095|NCT02435914|18744021|P4|COMPLETED|Overall Study||59
7613096|NCT02435914|18744022|P3|COMPLETED|Overall Study||59
7613097|NCT02435914|18744023|P2|COMPLETED|Overall Study||58
7613098|NCT02435914|18744024|P1|COMPLETED|Overall Study||57
7613099|NCT02435914|18744021|P4|STARTED|Overall Study||59
7613100|NCT02435914|18744022|P3|STARTED|Overall Study||60
7613101|NCT02435914|18744023|P2|STARTED|Overall Study||59
7613102|NCT02435914|18744024|P1|STARTED|Overall Study||58
7613103|NCT02435901|18744046|P1|NOT COMPLETED|Overall Study||0
7613104|NCT02435901|18744046|P1|COMPLETED|Overall Study||29
7613105|NCT02435901|18744046|P1|STARTED|Overall Study||29
7613106|NCT02435836|18744052|P1|NOT COMPLETED|Overall Study||631
7613107|NCT02435836|18744052|P1|COMPLETED|Overall Study||0
7613108|NCT02435836|18744052|P1|STARTED|Overall Study||631
7613109|NCT02435706|18744070|P2|NOT COMPLETED|Overall Study||1
7613110|NCT02435706|18744071|P1|NOT COMPLETED|Overall Study||2
7613111|NCT02435706|18744070|P2|COMPLETED|Overall Study||20
7613112|NCT02435706|18744071|P1|COMPLETED|Overall Study||16
7613113|NCT02435706|18744070|P2|STARTED|Overall Study||21
7613114|NCT02435706|18744071|P1|STARTED|Overall Study||18
7613115|NCT02435524|18744085|P2|NOT COMPLETED|Endline Survey||0
7613116|NCT02435524|18744086|P1|NOT COMPLETED|Endline Survey||0
7613117|NCT02435524|18744085|P2|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1161
7613118|NCT02435524|18744086|P1|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1092
7613119|NCT02435524|18744085|P2|STARTED|Endline Survey||1161
7613120|NCT02435524|18744086|P1|STARTED|Endline Survey||1092
7613121|NCT02435524|18744085|P2|NOT COMPLETED|Baseline Survey||0
7613122|NCT02435524|18744086|P1|NOT COMPLETED|Baseline Survey||0
7613123|NCT02435524|18744085|P2|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1177
7613124|NCT02435524|18744086|P1|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1111
7613125|NCT02435524|18744085|P2|STARTED|Baseline Survey||1177
7613126|NCT02435524|18744086|P1|STARTED|Baseline Survey||1111
7613127|NCT02435511|18744094|P2|NOT COMPLETED|Overall Study||35
7613128|NCT02435511|18744095|P1|NOT COMPLETED|Overall Study||44
7613129|NCT02435511|18744094|P2|COMPLETED|Overall Study|Defined as completing the 3 month follow-up; not necessarily all time points|174
7613130|NCT02435511|18744095|P1|COMPLETED|Overall Study|Defined as completing the 3 month follow-up, not necessarily all time points|158
7613131|NCT02435511|18744094|P2|STARTED|Overall Study|Defined as enrolled and completed baseline|209
7613132|NCT02435511|18744095|P1|STARTED|Overall Study|Defined as enrolled and completed baseline|202
7613133|NCT02435433|18744111|P5|NOT COMPLETED|Overall Study||0
7613134|NCT02435433|18744112|P4|NOT COMPLETED|Overall Study||0
7613135|NCT02435433|18744113|P3|NOT COMPLETED|Overall Study||0
7613136|NCT02435433|18744114|P2|NOT COMPLETED|Overall Study||5
7613137|NCT02435433|18744115|P1|NOT COMPLETED|Overall Study||15
7613138|NCT02435433|18744111|P5|COMPLETED|Overall Study||0
7613139|NCT02435433|18744112|P4|COMPLETED|Overall Study||0
7613140|NCT02435433|18744113|P3|COMPLETED|Overall Study||0
7613141|NCT02435433|18744114|P2|COMPLETED|Overall Study||90
7613142|NCT02435433|18744115|P1|COMPLETED|Overall Study||182
7613143|NCT02435433|18744111|P5|Participants Who Received Study Drug|Overall Study||0
7613144|NCT02435433|18744112|P4|Participants Who Received Study Drug|Overall Study||0
7613145|NCT02435433|18744113|P3|Participants Who Received Study Drug|Overall Study||0
7613146|NCT02435433|18744114|P2|Participants Who Received Study Drug|Overall Study||95
7613147|NCT02435433|18744115|P1|Participants Who Received Study Drug|Overall Study||197
7613148|NCT02435433|18744111|P5|STARTED|Overall Study||0
7613149|NCT02435433|18744112|P4|STARTED|Overall Study||0
7613150|NCT02435433|18744113|P3|STARTED|Overall Study||0
7613151|NCT02435433|18744114|P2|STARTED|Overall Study||95
7613152|NCT02435433|18744115|P1|STARTED|Overall Study||197
7613153|NCT02435277|18744141|P4|NOT COMPLETED|Overall Study||0
7613154|NCT02435277|18744142|P3|NOT COMPLETED|Overall Study||0
7613155|NCT02435277|18744143|P2|NOT COMPLETED|Overall Study||1
7613156|NCT02435277|18744144|P1|NOT COMPLETED|Overall Study||2
7613157|NCT02435277|18744141|P4|COMPLETED|Overall Study||11
7613158|NCT02435277|18744142|P3|COMPLETED|Overall Study||11
7613159|NCT02435277|18744143|P2|COMPLETED|Overall Study||15
7613160|NCT02435277|18744144|P1|COMPLETED|Overall Study||10
7613161|NCT02435277|18744141|P4|STARTED|Overall Study||11
7613162|NCT02435277|18744142|P3|STARTED|Overall Study||11
7613163|NCT02435277|18744143|P2|STARTED|Overall Study||16
7613164|NCT02435277|18744144|P1|STARTED|Overall Study||12
7613165|NCT02435147|18744158|P1|NOT COMPLETED|Overall Study||11
7613166|NCT02435147|18744158|P1|COMPLETED|Overall Study||75
7613167|NCT02435147|18744158|P1|STARTED|Overall Study||86
7613168|NCT02435069|18744163|P5|NOT COMPLETED|Effectiveness - Second Intervention||1
7613169|NCT02435069|18744164|P4|NOT COMPLETED|Effectiveness - Second Intervention||0
7613170|NCT02435069|18744165|P3|NOT COMPLETED|Effectiveness - Second Intervention||0
7613171|NCT02435069|18744166|P2|NOT COMPLETED|Effectiveness - Second Intervention||0
7613172|NCT02435069|18744167|P1|NOT COMPLETED|Effectiveness - Second Intervention||0
7613173|NCT02435069|18744163|P5|COMPLETED|Effectiveness - Second Intervention||0
7613174|NCT02435069|18744164|P4|COMPLETED|Effectiveness - Second Intervention||1
7613175|NCT02435069|18744165|P3|COMPLETED|Effectiveness - Second Intervention||0
7613176|NCT02435069|18744166|P2|COMPLETED|Effectiveness - Second Intervention||0
7613177|NCT02435069|18744167|P1|COMPLETED|Effectiveness - Second Intervention||0
7613178|NCT02435069|18744163|P5|STARTED|Effectiveness - Second Intervention||1
7613179|NCT02435069|18744164|P4|STARTED|Effectiveness - Second Intervention||1
7613180|NCT02435069|18744165|P3|STARTED|Effectiveness - Second Intervention||0
7613181|NCT02435069|18744166|P2|STARTED|Effectiveness - Second Intervention||0
7613182|NCT02435069|18744167|P1|STARTED|Effectiveness - Second Intervention||0
7613183|NCT02435069|18744163|P5|NOT COMPLETED|Dose Response - First Intervention||0
7613184|NCT02435069|18744164|P4|NOT COMPLETED|Dose Response - First Intervention||0
7613185|NCT02435069|18744165|P3|NOT COMPLETED|Dose Response - First Intervention||1
7613186|NCT02435069|18744166|P2|NOT COMPLETED|Dose Response - First Intervention||1
7613187|NCT02435069|18744167|P1|NOT COMPLETED|Dose Response - First Intervention||0
7613188|NCT02435069|18744163|P5|COMPLETED|Dose Response - First Intervention||0
7613189|NCT02435069|18744164|P4|COMPLETED|Dose Response - First Intervention||0
7613190|NCT02435069|18744165|P3|COMPLETED|Dose Response - First Intervention||1
7613191|NCT02435069|18744166|P2|COMPLETED|Dose Response - First Intervention||2
7613192|NCT02435069|18744167|P1|COMPLETED|Dose Response - First Intervention||0
7613193|NCT02435069|18744163|P5|STARTED|Dose Response - First Intervention||0
7613194|NCT02435069|18744164|P4|STARTED|Dose Response - First Intervention||0
7613195|NCT02435069|18744165|P3|STARTED|Dose Response - First Intervention||2
7613196|NCT02435069|18744166|P2|STARTED|Dose Response - First Intervention||3
7613197|NCT02435069|18744167|P1|STARTED|Dose Response - First Intervention||0
7613198|NCT02435069|18744163|P5|NOT COMPLETED|Preoperative Baseline Phase||0
7613199|NCT02435069|18744164|P4|NOT COMPLETED|Preoperative Baseline Phase||0
7613200|NCT02435069|18744165|P3|NOT COMPLETED|Preoperative Baseline Phase||0
7613201|NCT02435069|18744166|P2|NOT COMPLETED|Preoperative Baseline Phase||0
7613202|NCT02435069|18744167|P1|NOT COMPLETED|Preoperative Baseline Phase||0
7613203|NCT02435069|18744163|P5|COMPLETED|Preoperative Baseline Phase||0
7613204|NCT02435069|18744164|P4|COMPLETED|Preoperative Baseline Phase||0
7613205|NCT02435069|18744165|P3|COMPLETED|Preoperative Baseline Phase||0
7613206|NCT02435069|18744166|P2|COMPLETED|Preoperative Baseline Phase||0
7613207|NCT02435069|18744167|P1|COMPLETED|Preoperative Baseline Phase||5
7613208|NCT02435069|18744163|P5|STARTED|Preoperative Baseline Phase||0
7613209|NCT02435069|18744164|P4|STARTED|Preoperative Baseline Phase||0
7613210|NCT02435069|18744165|P3|STARTED|Preoperative Baseline Phase||0
7613211|NCT02435069|18744166|P2|STARTED|Preoperative Baseline Phase||0
7613212|NCT02435069|18744167|P1|STARTED|Preoperative Baseline Phase||5
7613213|NCT02434939|18744189|P2|NOT COMPLETED|Overall Study||49
7613214|NCT02434939|18744190|P1|NOT COMPLETED|Overall Study||37
7613215|NCT02434939|18744189|P2|COMPLETED|Overall Study||71
7613216|NCT02434939|18744190|P1|COMPLETED|Overall Study||83
7613217|NCT02434939|18744189|P2|STARTED|Overall Study||120
7613218|NCT02434939|18744190|P1|STARTED|Overall Study||120
7613219|NCT02434770|18744205|P3|NOT COMPLETED|Week 18 to Week||6
7613220|NCT02434770|18744206|P2|NOT COMPLETED|Week 18 to Week||8
7613221|NCT02434770|18744207|P1|NOT COMPLETED|Week 18 to Week||8
7613222|NCT02434770|18744205|P3|COMPLETED|Week 18 to Week||227
7613223|NCT02434770|18744206|P2|COMPLETED|Week 18 to Week||220
7613224|NCT02434770|18744207|P1|COMPLETED|Week 18 to Week||227
7613225|NCT02434770|18744205|P3|STARTED|Week 18 to Week||233
7613226|NCT02434770|18744206|P2|STARTED|Week 18 to Week||228
7613227|NCT02434770|18744207|P1|STARTED|Week 18 to Week||235
7613228|NCT02434770|18744205|P3|NOT COMPLETED|Week 1 to Week 18||17
7613229|NCT02434770|18744206|P2|NOT COMPLETED|Week 1 to Week 18||22
7613230|NCT02434770|18744207|P1|NOT COMPLETED|Week 1 to Week 18||15
7613231|NCT02434770|18744205|P3|COMPLETED|Week 1 to Week 18||233
7613232|NCT02434770|18744206|P2|COMPLETED|Week 1 to Week 18||228
7613233|NCT02434770|18744207|P1|COMPLETED|Week 1 to Week 18||235
7613234|NCT02434770|18744205|P3|Received at Least One Vaccination|Week 1 to Week 18||250
7613235|NCT02434770|18744206|P2|Received at Least One Vaccination|Week 1 to Week 18||250
7613236|NCT02434770|18744207|P1|Received at Least One Vaccination|Week 1 to Week 18||249
7613237|NCT02434770|18744205|P3|STARTED|Week 1 to Week 18||250
7613238|NCT02434770|18744206|P2|STARTED|Week 1 to Week 18||250
7613239|NCT02434770|18744207|P1|STARTED|Week 1 to Week 18||250
7613240|NCT02434523|18744244|P2|NOT COMPLETED|Overall Study||6
7613241|NCT02434523|18744245|P1|NOT COMPLETED|Overall Study||5
7613242|NCT02434523|18744244|P2|COMPLETED|Overall Study||9
7613243|NCT02434523|18744245|P1|COMPLETED|Overall Study||10
7613244|NCT02434523|18744244|P2|STARTED|Overall Study||15
7613245|NCT02434523|18744245|P1|STARTED|Overall Study||15
7613246|NCT02434497|18744257|P1|NOT COMPLETED|Overall Study||5
7613247|NCT02434497|18744257|P1|COMPLETED|Overall Study||4
7613248|NCT02434497|18744257|P1|STARTED|Overall Study||9
7613249|NCT02434471|18744357|P1|NOT COMPLETED|Overall Study||9
7613250|NCT02434471|18744357|P1|COMPLETED|Overall Study||25
7613251|NCT02434471|18744357|P1|STARTED|Overall Study||34
7613252|NCT02434328|18744366|P2|NOT COMPLETED|Overall Study||42
7613253|NCT02434328|18744367|P1|NOT COMPLETED|Overall Study||30
7613254|NCT02434328|18744366|P2|COMPLETED|Overall Study||329
7613255|NCT02434328|18744367|P1|COMPLETED|Overall Study||342
7613256|NCT02434328|18744366|P2|Randomized and Treated|Overall Study||369
7613257|NCT02434328|18744367|P1|Randomized and Treated|Overall Study||370
7613258|NCT02434328|18744366|P2|STARTED|Overall Study||371
7613259|NCT02434328|18744367|P1|STARTED|Overall Study||372
7613260|NCT02434146|18744430|P1|NOT COMPLETED|Overall Study||0
7613261|NCT02434146|18744430|P1|COMPLETED|Overall Study||3
7613262|NCT02434146|18744430|P1|STARTED|Overall Study||3
7613263|NCT02433834|18744442|P1|NOT COMPLETED|Overall Study||37
7613264|NCT02433834|18744442|P1|COMPLETED|Overall Study|Subject PT001101-040014 did not complete Period 4 but completed the study. CSR states 210 completed.|211
7613265|NCT02433834|18744442|P1|SAL 50 µg|Overall Study||167
7613266|NCT02433834|18744442|P1|Placebo MDI|Overall Study||174
7613267|NCT02433834|18744442|P1|GP MDI 1.9 µg|Overall Study||107
7613268|NCT02433834|18744442|P1|GP MDI 3.6 µg|Overall Study||118
7613269|NCT02433834|18744442|P1|GP MDI 7.2 µg|Overall Study||228
7613270|NCT02433834|18744442|P1|GP MDI 14.4 µg|Overall Study||230
7613271|NCT02433834|18744442|P1|GP MDI 28.8 µg|Overall Study||112
7613272|NCT02433834|18744442|P1|STARTED|Overall Study||248
7613273|NCT02433678|18744502|P2|NOT COMPLETED|Overall Study||2
7613274|NCT02433678|18744503|P1|NOT COMPLETED|Overall Study||1
7613275|NCT02433678|18744502|P2|COMPLETED|Overall Study||24
7613276|NCT02433678|18744503|P1|COMPLETED|Overall Study||25
7613277|NCT02433678|18744502|P2|STARTED|Overall Study||26
7613278|NCT02433678|18744503|P1|STARTED|Overall Study||26
7613279|NCT02433665|18744537|P2|NOT COMPLETED|Overall Study||0
7613280|NCT02433665|18744538|P1|NOT COMPLETED|Overall Study||0
7613281|NCT02433665|18744537|P2|COMPLETED|Overall Study||79
7613282|NCT02433665|18744538|P1|COMPLETED|Overall Study||77
7613283|NCT02433665|18744537|P2|STARTED|Overall Study||79
7613284|NCT02433665|18744538|P1|STARTED|Overall Study||77
7613285|NCT02433613|18744544|P1|NOT COMPLETED|Overall Study||17
7613286|NCT02433613|18744544|P1|COMPLETED|Overall Study||1054
7613287|NCT02433613|18744544|P1|STARTED|Overall Study||1071
7613288|NCT02433496|18744564|P3|NOT COMPLETED|Overall Study||0
7613289|NCT02433496|18744565|P2|NOT COMPLETED|Overall Study||0
7613290|NCT02433496|18744566|P1|NOT COMPLETED|Overall Study||0
7613291|NCT02433496|18744564|P3|COMPLETED|Overall Study|This includes patients (9813) and providers (20).|9833
7613292|NCT02433496|18744565|P2|COMPLETED|Overall Study|This includes patients (13296) and providers (13).|13309
7613293|NCT02433496|18744566|P1|COMPLETED|Overall Study|This includes patients (29956) and providers (34).|29990
7613294|NCT02433496|18744564|P3|STARTED|Overall Study|This includes patients (9813) and providers (20).|9833
7613295|NCT02433496|18744565|P2|STARTED|Overall Study|This includes patients (13296) and providers (13).|13309
7613296|NCT02433496|18744566|P1|STARTED|Overall Study|This includes patients (29956) and providers (34).|29990
7613297|NCT02433483|18744596|P1|NOT COMPLETED|Overall Study||2
7613298|NCT02433483|18744596|P1|COMPLETED|Overall Study||0
7613299|NCT02433483|18744596|P1|STARTED|Overall Study||2
7613300|NCT02433366|18744610|P2|NOT COMPLETED|Overall Study||0
7613301|NCT02433366|18744611|P1|NOT COMPLETED|Overall Study||0
7613302|NCT02433366|18744610|P2|COMPLETED|Overall Study||802
7613303|NCT02433366|18744611|P1|COMPLETED|Overall Study||411
7613304|NCT02433366|18744610|P2|STARTED|Overall Study||802
7613305|NCT02433366|18744611|P1|STARTED|Overall Study||411
7613306|NCT02433340|18744623|P4|NOT COMPLETED|Overall Study||2
7613307|NCT02433340|18744624|P3|NOT COMPLETED|Overall Study||2
7613308|NCT02433340|18744625|P2|NOT COMPLETED|Overall Study||2
7613309|NCT02433340|18744626|P1|NOT COMPLETED|Overall Study||2
7613310|NCT02433340|18744623|P4|COMPLETED|Overall Study||38
7613311|NCT02433340|18744624|P3|COMPLETED|Overall Study||37
7613312|NCT02433340|18744625|P2|COMPLETED|Overall Study||35
7613313|NCT02433340|18744626|P1|COMPLETED|Overall Study||40
7613314|NCT02433340|18744623|P4|STARTED|Overall Study||40
7613315|NCT02433340|18744624|P3|STARTED|Overall Study||39
7613316|NCT02433340|18744625|P2|STARTED|Overall Study||37
7613317|NCT02433340|18744626|P1|STARTED|Overall Study||42
7613318|NCT02433288|18745520|P2|NOT COMPLETED|Overall Study||126
7613319|NCT02433288|18745521|P1|NOT COMPLETED|Overall Study||123
7613320|NCT02433288|18745520|P2|COMPLETED|Overall Study||316
7613321|NCT02433288|18745521|P1|COMPLETED|Overall Study||320
7613322|NCT02433288|18745520|P2|STARTED|Overall Study||442
7613323|NCT02433288|18745521|P1|STARTED|Overall Study||443
7613324|NCT02433080|18745537|P2|NOT COMPLETED|Overall Study||4
7613325|NCT02433080|18745538|P1|NOT COMPLETED|Overall Study||1
7613326|NCT02433080|18745537|P2|COMPLETED|Overall Study||24
7613327|NCT02433080|18745538|P1|COMPLETED|Overall Study||25
7613328|NCT02433080|18745537|P2|8 Weeks|Overall Study||24
7613329|NCT02433080|18745538|P1|8 Weeks|Overall Study||25
7613330|NCT02433080|18745537|P2|STARTED|Overall Study||28
7613331|NCT02433080|18745538|P1|STARTED|Overall Study||26
7613332|NCT02432742|18745564|P1|NOT COMPLETED|Overall Study||5
7613333|NCT02432742|18745564|P1|COMPLETED|Overall Study||95
7613334|NCT02432742|18745564|P1|STARTED|Overall Study||100
7613335|NCT02432729|18745569|P1|NOT COMPLETED|Month 12 Visit||196
7613336|NCT02432729|18745569|P1|COMPLETED|Month 12 Visit||436
7613337|NCT02432729|18745569|P1|STARTED|Month 12 Visit||632
7613338|NCT02432729|18745569|P1|NOT COMPLETED|Month 6 Visit||86
7613339|NCT02432729|18745569|P1|COMPLETED|Month 6 Visit||632
7613340|NCT02432729|18745569|P1|STARTED|Month 6 Visit||718
7613341|NCT02432729|18745569|P1|NOT COMPLETED|Month 3 Visit||2
7613342|NCT02432729|18745569|P1|COMPLETED|Month 3 Visit||718
7613343|NCT02432729|18745569|P1|STARTED|Month 3 Visit||720
7613344|NCT02432716|18745597|P2|NOT COMPLETED|Overall Study||0
7613345|NCT02432716|18745598|P1|NOT COMPLETED|Overall Study||0
7613346|NCT02432716|18745597|P2|COMPLETED|Overall Study||6
7613347|NCT02432716|18745598|P1|COMPLETED|Overall Study||6
7613348|NCT02432716|18745597|P2|STARTED|Overall Study||6
7613349|NCT02432716|18745598|P1|STARTED|Overall Study||6
7613350|NCT02432456|18745614|P2|NOT COMPLETED|Overall Study||0
7613351|NCT02432456|18745615|P1|NOT COMPLETED|Overall Study||0
7613352|NCT02432456|18745614|P2|COMPLETED|Overall Study||75
7613353|NCT02432456|18745615|P1|COMPLETED|Overall Study||75
7613354|NCT02432456|18745614|P2|STARTED|Overall Study||75
7613355|NCT02432456|18745615|P1|STARTED|Overall Study||75
7613356|NCT02432300|18745637|P1|NOT COMPLETED|Overall Study||4
7613357|NCT02432300|18745637|P1|COMPLETED|Overall Study||13
7613358|NCT02432300|18745637|P1|STARTED|Overall Study||17
7613359|NCT02432287|18745646|P2|NOT COMPLETED|Second Intervention||0
7613360|NCT02432287|18745647|P1|NOT COMPLETED|Second Intervention||0
7613361|NCT02432287|18745646|P2|COMPLETED|Second Intervention||7
7613362|NCT02432287|18745647|P1|COMPLETED|Second Intervention||7
7613363|NCT02432287|18745646|P2|STARTED|Second Intervention||7
7613364|NCT02432287|18745647|P1|STARTED|Second Intervention||7
7613365|NCT02432287|18745646|P2|NOT COMPLETED|Washout Period||0
7613366|NCT02432287|18745647|P1|NOT COMPLETED|Washout Period||0
7613367|NCT02432287|18745646|P2|COMPLETED|Washout Period||7
7613368|NCT02432287|18745647|P1|COMPLETED|Washout Period||7
7613369|NCT02432287|18745646|P2|STARTED|Washout Period||7
7613370|NCT02432287|18745647|P1|STARTED|Washout Period||7
7613371|NCT02432287|18745646|P2|NOT COMPLETED|First Intervention||1
7613372|NCT02432287|18745647|P1|NOT COMPLETED|First Intervention||0
7613373|NCT02432287|18745646|P2|COMPLETED|First Intervention||7
7613374|NCT02432287|18745647|P1|COMPLETED|First Intervention||8
7613375|NCT02432287|18745646|P2|STARTED|First Intervention||8
7613376|NCT02432287|18745647|P1|STARTED|First Intervention||8
7613377|NCT02432274|18745663|P8|NOT COMPLETED|Overall Study||20
7613378|NCT02432274|18745664|P7|NOT COMPLETED|Overall Study||15
7613379|NCT02432274|18745665|P6|NOT COMPLETED|Overall Study||7
7613380|NCT02432274|18745666|P5|NOT COMPLETED|Overall Study||31
7613381|NCT02432274|18745667|P4|NOT COMPLETED|Overall Study||1
7613382|NCT02432274|18745668|P3|NOT COMPLETED|Overall Study||11
7613383|NCT02432274|18745669|P2|NOT COMPLETED|Overall Study||9
7613384|NCT02432274|18745670|P1|NOT COMPLETED|Overall Study||3
7613385|NCT02432274|18745663|P8|COMPLETED|Overall Study||0
7613386|NCT02432274|18745664|P7|COMPLETED|Overall Study||0
7613387|NCT02432274|18745665|P6|COMPLETED|Overall Study||0
7613388|NCT02432274|18745666|P5|COMPLETED|Overall Study||0
7613389|NCT02432274|18745667|P4|COMPLETED|Overall Study||0
7613390|NCT02432274|18745668|P3|COMPLETED|Overall Study||0
7613391|NCT02432274|18745669|P2|COMPLETED|Overall Study||0
7613392|NCT02432274|18745670|P1|COMPLETED|Overall Study||0
7613393|NCT02432274|18745663|P8|Treated (Safety Population)|Overall Study||20
7613394|NCT02432274|18745664|P7|Treated (Safety Population)|Overall Study||11
7613395|NCT02432274|18745665|P6|Treated (Safety Population)|Overall Study|4 participants assigned to lenvatinib14mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|11
7613396|NCT02432274|18745666|P5|Treated (Safety Population)|Overall Study||31
7613397|NCT02432274|18745667|P4|Treated (Safety Population)|Overall Study||1
7613398|NCT02432274|18745668|P3|Treated (Safety Population)|Overall Study||7
7613399|NCT02432274|18745669|P2|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 14mg/m^2 (dose capped at 24 mg/day).|11
7613400|NCT02432274|18745670|P1|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|5
7613401|NCT02432274|18745663|P8|Underwent Run-in Period|Overall Study||0
7613402|NCT02432274|18745664|P7|Underwent Run-in Period|Overall Study||0
7613403|NCT02432274|18745665|P6|Underwent Run-in Period|Overall Study||0
7613404|NCT02432274|18745666|P5|Underwent Run-in Period|Overall Study||0
7613405|NCT02432274|18745667|P4|Underwent Run-in Period|Overall Study||0
7613406|NCT02432274|18745668|P3|Underwent Run-in Period|Overall Study||0
7613407|NCT02432274|18745669|P2|Underwent Run-in Period|Overall Study||1
7613408|NCT02432274|18745670|P1|Underwent Run-in Period|Overall Study||1
7613409|NCT02432274|18745663|P8|STARTED|Overall Study||20
7613410|NCT02432274|18745664|P7|STARTED|Overall Study||15
7613411|NCT02432274|18745665|P6|STARTED|Overall Study||7
7613412|NCT02432274|18745666|P5|STARTED|Overall Study||31
7613413|NCT02432274|18745667|P4|STARTED|Overall Study||1
7613414|NCT02432274|18745668|P3|STARTED|Overall Study||11
7613415|NCT02432274|18745669|P2|STARTED|Overall Study||9
7613416|NCT02432274|18745670|P1|STARTED|Overall Study||3
7613417|NCT02432196|18745783|P1|NOT COMPLETED|Overall Study||26
7613418|NCT02432196|18745783|P1|COMPLETED|Overall Study||0
7613419|NCT02432196|18745783|P1|Implanted With Device|Overall Study||25
7613420|NCT02432196|18745783|P1|STARTED|Overall Study||26
7613421|NCT02432144|18745791|P1|NOT COMPLETED|Overall Study||1
7613422|NCT02432144|18745791|P1|COMPLETED|Overall Study||11
7613423|NCT02432144|18745791|P1|STARTED|Overall Study||12
7613424|NCT02432105|18745799|P3|NOT COMPLETED|Overall Study||3
7613425|NCT02432105|18745800|P2|NOT COMPLETED|Overall Study||2
7613426|NCT02432105|18745801|P1|NOT COMPLETED|Overall Study||2
7613427|NCT02432105|18745799|P3|COMPLETED|Overall Study||108
7613428|NCT02432105|18745800|P2|COMPLETED|Overall Study||108
7613429|NCT02432105|18745801|P1|COMPLETED|Overall Study||162
7613430|NCT02432105|18745799|P3|STARTED|Overall Study||111
7613431|NCT02432105|18745800|P2|STARTED|Overall Study||110
7613432|NCT02432105|18745801|P1|STARTED|Overall Study||164
7613433|NCT02432040|18745818|P2|NOT COMPLETED|Overall Study||6
7613434|NCT02432040|18745819|P1|NOT COMPLETED|Overall Study||8
7613435|NCT02432040|18745818|P2|COMPLETED|Overall Study||8
7613436|NCT02432040|18745819|P1|COMPLETED|Overall Study||6
7613437|NCT02432040|18745818|P2|STARTED|Overall Study||14
7613438|NCT02432040|18745819|P1|STARTED|Overall Study||14
7613439|NCT02431806|18745843|P4|NOT COMPLETED|Double-blind Down-taper Period||0
7613440|NCT02431806|18745844|P3|NOT COMPLETED|Double-blind Down-taper Period||0
7613441|NCT02431806|18745845|P2|NOT COMPLETED|Double-blind Down-taper Period||0
7613442|NCT02431806|18745846|P1|NOT COMPLETED|Double-blind Down-taper Period||0
7613443|NCT02431806|18745843|P4|COMPLETED|Double-blind Down-taper Period||107
7613444|NCT02431806|18745844|P3|COMPLETED|Double-blind Down-taper Period||104
7613445|NCT02431806|18745845|P2|COMPLETED|Double-blind Down-taper Period||109
7613446|NCT02431806|18745846|P1|COMPLETED|Double-blind Down-taper Period||111
7613447|NCT02431806|18745843|P4|STARTED|Double-blind Down-taper Period||107
7613448|NCT02431806|18745844|P3|STARTED|Double-blind Down-taper Period||104
7613449|NCT02431806|18745845|P2|STARTED|Double-blind Down-taper Period||109
7613450|NCT02431806|18745846|P1|STARTED|Double-blind Down-taper Period||111
7613451|NCT02431806|18745843|P4|NOT COMPLETED|Double-blind Treatment Period||26
7613452|NCT02431806|18745844|P3|NOT COMPLETED|Double-blind Treatment Period||32
7613453|NCT02431806|18745845|P2|NOT COMPLETED|Double-blind Treatment Period||21
7613454|NCT02431806|18745846|P1|NOT COMPLETED|Double-blind Treatment Period||25
7613455|NCT02431806|18745843|P4|COMPLETED|Double-blind Treatment Period||109
7613456|NCT02431806|18745844|P3|COMPLETED|Double-blind Treatment Period||107
7613457|NCT02431806|18745845|P2|COMPLETED|Double-blind Treatment Period||115
7613458|NCT02431806|18745846|P1|COMPLETED|Double-blind Treatment Period||117
7613459|NCT02431806|18745843|P4|Safety Population|Double-blind Treatment Period||134
7613460|NCT02431806|18745844|P3|Safety Population|Double-blind Treatment Period||138
7613461|NCT02431806|18745845|P2|Safety Population|Double-blind Treatment Period||134
7613462|NCT02431806|18745846|P1|Safety Population|Double-blind Treatment Period||141
7613463|NCT02431806|18745843|P4|STARTED|Double-blind Treatment Period||135
7613464|NCT02431806|18745844|P3|STARTED|Double-blind Treatment Period||139
7613465|NCT02431806|18745845|P2|STARTED|Double-blind Treatment Period||136
7613466|NCT02431806|18745846|P1|STARTED|Double-blind Treatment Period||142
7613467|NCT02431793|18745863|P3|NOT COMPLETED|Overall Study||117
7613468|NCT02431793|18745864|P2|NOT COMPLETED|Overall Study||134
7613469|NCT02431793|18745865|P1|NOT COMPLETED|Overall Study||119
7613470|NCT02431793|18745863|P3|COMPLETED|Overall Study||90
7613471|NCT02431793|18745864|P2|COMPLETED|Overall Study||109
7613472|NCT02431793|18745865|P1|COMPLETED|Overall Study||83
7613473|NCT02431793|18745863|P3|Completed T3 (30 Days Post Enrollment)|Overall Study||93
7613474|NCT02431793|18745864|P2|Completed T3 (30 Days Post Enrollment)|Overall Study||113
7613475|NCT02431793|18745865|P1|Completed T3 (30 Days Post Enrollment)|Overall Study||85
7613476|NCT02431793|18745863|P3|Completed T2 (7-14 Days Post Enrollment)|Overall Study||107
7613477|NCT02431793|18745864|P2|Completed T2 (7-14 Days Post Enrollment)|Overall Study||141
7613478|NCT02431793|18745865|P1|Completed T2 (7-14 Days Post Enrollment)|Overall Study||95
7613479|NCT02431793|18745863|P3|Completed T1 (3-5 Days Post Enrollment)|Overall Study||143
7613480|NCT02431793|18745864|P2|Completed T1 (3-5 Days Post Enrollment)|Overall Study||180
7613481|NCT02431793|18745865|P1|Completed T1 (3-5 Days Post Enrollment)|Overall Study||136
7613482|NCT02431793|18745863|P3|STARTED|Overall Study||207
7613483|NCT02431793|18745864|P2|STARTED|Overall Study||243
7613484|NCT02431793|18745865|P1|STARTED|Overall Study||202
7613485|NCT02431754|18745887|P2|NOT COMPLETED|Period 2 (8 Weeks)||4
7613486|NCT02431754|18745888|P1|NOT COMPLETED|Period 2 (8 Weeks)||1
7613487|NCT02431754|18745887|P2|COMPLETED|Period 2 (8 Weeks)||78
7613488|NCT02431754|18745888|P1|COMPLETED|Period 2 (8 Weeks)||74
7613489|NCT02431754|18745887|P2|STARTED|Period 2 (8 Weeks)||82
7613490|NCT02431754|18745888|P1|STARTED|Period 2 (8 Weeks)||75
7613491|NCT02431754|18745887|P2|NOT COMPLETED|Wash-out Period (4 Weeks)||0
7613492|NCT02431754|18745888|P1|NOT COMPLETED|Wash-out Period (4 Weeks)||4
7613493|NCT02431754|18745887|P2|COMPLETED|Wash-out Period (4 Weeks)||82
7613494|NCT02431754|18745888|P1|COMPLETED|Wash-out Period (4 Weeks)||75
7613495|NCT02431754|18745887|P2|STARTED|Wash-out Period (4 Weeks)||82
7613496|NCT02431754|18745888|P1|STARTED|Wash-out Period (4 Weeks)||79
7613497|NCT02431754|18745887|P2|NOT COMPLETED|Period 1 (8 Weeks)||4
7613498|NCT02431754|18745888|P1|NOT COMPLETED|Period 1 (8 Weeks)||6
7613499|NCT02431754|18745887|P2|COMPLETED|Period 1 (8 Weeks)||82
7613500|NCT02431754|18745888|P1|COMPLETED|Period 1 (8 Weeks)||79
7613501|NCT02431754|18745887|P2|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86
7613502|NCT02431754|18745888|P1|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85
7613503|NCT02431754|18745887|P2|STARTED|Period 1 (8 Weeks)||86
7613504|NCT02431754|18745888|P1|STARTED|Period 1 (8 Weeks)||85
7613505|NCT02431741|18745906|P1|NOT COMPLETED|Overall Study||0
7613506|NCT02431741|18745906|P1|COMPLETED|Overall Study||14
7613507|NCT02431741|18745906|P1|STARTED|Overall Study||14
7613508|NCT02431676|18745913|P3|NOT COMPLETED|Overall Study||2
7613509|NCT02431676|18745914|P2|NOT COMPLETED|Overall Study||1
7613510|NCT02431676|18745915|P1|NOT COMPLETED|Overall Study||0
7613511|NCT02431676|18745913|P3|COMPLETED|Overall Study||40
7613512|NCT02431676|18745914|P2|COMPLETED|Overall Study||38
7613513|NCT02431676|18745915|P1|COMPLETED|Overall Study||40
7613514|NCT02431676|18745913|P3|STARTED|Overall Study||42
7613515|NCT02431676|18745914|P2|STARTED|Overall Study||39
7613516|NCT02431676|18745915|P1|STARTED|Overall Study||40
7613517|NCT02431650|18745931|P2|NOT COMPLETED|Overall Study||0
7613518|NCT02431650|18745932|P1|NOT COMPLETED|Overall Study||0
7613519|NCT02431650|18745931|P2|COMPLETED|Overall Study||6
7613520|NCT02431650|18745932|P1|COMPLETED|Overall Study||5
7613521|NCT02431650|18745931|P2|STARTED|Overall Study||6
7613522|NCT02431650|18745932|P1|STARTED|Overall Study||5
7613523|NCT02431637|18745940|P1|NOT COMPLETED|Overall Study||0
7613524|NCT02431637|18745940|P1|COMPLETED|Overall Study||6
7613525|NCT02431637|18745940|P1|STARTED|Overall Study||6
7613526|NCT02431598|18745945|P6|NOT COMPLETED|Overall Study||0
7613527|NCT02431598|18745946|P5|NOT COMPLETED|Overall Study||0
7613528|NCT02431598|18745947|P4|NOT COMPLETED|Overall Study||0
7613529|NCT02431598|18745948|P3|NOT COMPLETED|Overall Study||0
7613530|NCT02431598|18745949|P2|NOT COMPLETED|Overall Study||0
7613531|NCT02431598|18745950|P1|NOT COMPLETED|Overall Study||0
7613532|NCT02431598|18745945|P6|COMPLETED|Overall Study||6
7613533|NCT02431598|18745946|P5|COMPLETED|Overall Study||7
7613534|NCT02431598|18745947|P4|COMPLETED|Overall Study||7
7613535|NCT02431598|18745948|P3|COMPLETED|Overall Study||9
7613536|NCT02431598|18745949|P2|COMPLETED|Overall Study||9
7613537|NCT02431598|18745950|P1|COMPLETED|Overall Study||6
7613538|NCT02431598|18745945|P6|STARTED|Overall Study||6
7613539|NCT02431598|18745946|P5|STARTED|Overall Study||7
7613540|NCT02431598|18745947|P4|STARTED|Overall Study||7
7613541|NCT02431598|18745948|P3|STARTED|Overall Study||9
7613542|NCT02431598|18745949|P2|STARTED|Overall Study||9
7613543|NCT02431598|18745950|P1|STARTED|Overall Study||6
7613544|NCT02431572|18745977|P3|NOT COMPLETED|Overall Study||0
7613545|NCT02431572|18745978|P2|NOT COMPLETED|Overall Study||0
7613546|NCT02431572|18745979|P1|NOT COMPLETED|Overall Study||1
7613547|NCT02431572|18745977|P3|COMPLETED|Overall Study||9
7613548|NCT02431572|18745978|P2|COMPLETED|Overall Study||1
7613549|NCT02431572|18745979|P1|COMPLETED|Overall Study||0
7613550|NCT02431572|18745977|P3|STARTED|Overall Study||9
7613551|NCT02431572|18745978|P2|STARTED|Overall Study||1
7613552|NCT02431572|18745979|P1|STARTED|Overall Study||1
7613553|NCT02431559|18745991|P4|NOT COMPLETED|Overall Study||31
7613554|NCT02431559|18745992|P3|NOT COMPLETED|Overall Study||4
7613555|NCT02431559|18745993|P2|NOT COMPLETED|Overall Study||3
7613556|NCT02431559|18745994|P1|NOT COMPLETED|Overall Study||2
7613557|NCT02431559|18745991|P4|COMPLETED|Overall Study||9
7613558|NCT02431559|18745992|P3|COMPLETED|Overall Study||2
7613559|NCT02431559|18745993|P2|COMPLETED|Overall Study||1
7613560|NCT02431559|18745994|P1|COMPLETED|Overall Study||1
7613561|NCT02431559|18745991|P4|STARTED|Overall Study||40
7613562|NCT02431559|18745992|P3|STARTED|Overall Study||6
7613563|NCT02431559|18745993|P2|STARTED|Overall Study||4
7613564|NCT02431559|18745994|P1|STARTED|Overall Study||3
7613565|NCT02431533|18746018|P2|NOT COMPLETED|Overall Study||3
7613566|NCT02431533|18746019|P1|NOT COMPLETED|Overall Study||2
7613567|NCT02431533|18746018|P2|COMPLETED|Overall Study||22
7613568|NCT02431533|18746019|P1|COMPLETED|Overall Study||23
7613569|NCT02431533|18746018|P2|STARTED|Overall Study||25
7613570|NCT02431533|18746019|P1|STARTED|Overall Study||25
7613571|NCT02431494|18746054|P3|NOT COMPLETED|Overall Study||0
7613572|NCT02431494|18746055|P2|NOT COMPLETED|Overall Study||0
7613573|NCT02431494|18746056|P1|NOT COMPLETED|Overall Study||0
7613574|NCT02431494|18746054|P3|COMPLETED|Overall Study||0
7613575|NCT02431494|18746055|P2|COMPLETED|Overall Study||0
7613576|NCT02431494|18746056|P1|COMPLETED|Overall Study||0
7613577|NCT02431494|18746054|P3|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
7613578|NCT02431494|18746055|P2|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
7613579|NCT02431494|18746056|P1|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
7613580|NCT02431468|18746085|P3|NOT COMPLETED|Overall Study||9
7613581|NCT02431468|18746086|P2|NOT COMPLETED|Overall Study||18
7613582|NCT02431468|18746087|P1|NOT COMPLETED|Overall Study||8
7613583|NCT02431468|18746085|P3|COMPLETED|Overall Study||39
7613584|NCT02431468|18746086|P2|COMPLETED|Overall Study||29
7613585|NCT02431468|18746087|P1|COMPLETED|Overall Study||38
7613586|NCT02431468|18746085|P3|STARTED|Overall Study||48
7613587|NCT02431468|18746086|P2|STARTED|Overall Study||47
7613588|NCT02431468|18746087|P1|STARTED|Overall Study||46
7613589|NCT02431455|18746109|P2|NOT COMPLETED|Overall Study||0
7613590|NCT02431455|18746110|P1|NOT COMPLETED|Overall Study||0
7613591|NCT02431455|18746109|P2|COMPLETED|Overall Study||112
7613592|NCT02431455|18746110|P1|COMPLETED|Overall Study||112
7613593|NCT02431455|18746109|P2|STARTED|Overall Study||112
7613594|NCT02431455|18746110|P1|STARTED|Overall Study||112
7613595|NCT02431299|18746124|P2|NOT COMPLETED|Overall Study||1
7613596|NCT02431299|18746125|P1|NOT COMPLETED|Overall Study||53
7613597|NCT02431299|18746124|P2|COMPLETED|Overall Study||62
7613598|NCT02431299|18746125|P1|COMPLETED|Overall Study||183
7613599|NCT02431299|18746124|P2|STARTED|Overall Study||63
7613600|NCT02431299|18746125|P1|STARTED|Overall Study||236
7613601|NCT02431273|18746138|P1|NOT COMPLETED|TDF-FTC-MVC (Triple IVR)||0
7613602|NCT02431273|18746138|P1|COMPLETED|TDF-FTC-MVC (Triple IVR)||6
7613603|NCT02431273|18746138|P1|STARTED|TDF-FTC-MVC (Triple IVR)||6
7613604|NCT02431273|18746138|P1|NOT COMPLETED|TDF-FTC (Dual IVR)||0
7613605|NCT02431273|18746138|P1|COMPLETED|TDF-FTC (Dual IVR)||6
7613606|NCT02431273|18746138|P1|STARTED|TDF-FTC (Dual IVR)||6
7613607|NCT02431273|18746138|P1|NOT COMPLETED|TDF (Single IVR)||0
7613608|NCT02431273|18746138|P1|COMPLETED|TDF (Single IVR)||6
7613609|NCT02431273|18746138|P1|STARTED|TDF (Single IVR)||6
7613610|NCT02431260|18746178|P14|NOT COMPLETED|Overall Study||1
7613611|NCT02431260|18746179|P13|NOT COMPLETED|Overall Study||10
7613612|NCT02431260|18746180|P12|NOT COMPLETED|Overall Study||4
7613613|NCT02431260|18746181|P11|NOT COMPLETED|Overall Study||4
7613614|NCT02431260|18746182|P10|NOT COMPLETED|Overall Study||8
7613615|NCT02431260|18746183|P9|NOT COMPLETED|Overall Study||8
7613616|NCT02431260|18746184|P8|NOT COMPLETED|Overall Study||3
7613617|NCT02431260|18746185|P7|NOT COMPLETED|Overall Study||4
7613618|NCT02431260|18746186|P6|NOT COMPLETED|Overall Study||4
7613619|NCT02431260|18746187|P5|NOT COMPLETED|Overall Study||3
7613620|NCT02431260|18746188|P4|NOT COMPLETED|Overall Study||5
7613621|NCT02431260|18746189|P3|NOT COMPLETED|Overall Study||6
7613622|NCT02431260|18746190|P2|NOT COMPLETED|Overall Study||5
7613623|NCT02431260|18746191|P1|NOT COMPLETED|Overall Study||4
7613624|NCT02431260|18746178|P14|COMPLETED|Overall Study||0
7613625|NCT02431260|18746179|P13|COMPLETED|Overall Study||0
7613626|NCT02431260|18746180|P12|COMPLETED|Overall Study||0
7613627|NCT02431260|18746181|P11|COMPLETED|Overall Study||0
7613628|NCT02431260|18746182|P10|COMPLETED|Overall Study||0
7613629|NCT02431260|18746183|P9|COMPLETED|Overall Study||0
7613630|NCT02431260|18746184|P8|COMPLETED|Overall Study||0
7613631|NCT02431260|18746185|P7|COMPLETED|Overall Study||0
7613632|NCT02431260|18746186|P6|COMPLETED|Overall Study||0
7613633|NCT02431260|18746187|P5|COMPLETED|Overall Study||0
7613634|NCT02431260|18746188|P4|COMPLETED|Overall Study||0
7613635|NCT02431260|18746189|P3|COMPLETED|Overall Study||0
7613636|NCT02431260|18746190|P2|COMPLETED|Overall Study||0
7613637|NCT02431260|18746191|P1|COMPLETED|Overall Study||0
7613638|NCT02431260|18746178|P14|STARTED|Overall Study||1
7613639|NCT02431260|18746179|P13|STARTED|Overall Study||10
7613640|NCT02431260|18746180|P12|STARTED|Overall Study||4
7613641|NCT02431260|18746181|P11|STARTED|Overall Study||4
7613642|NCT02431260|18746182|P10|STARTED|Overall Study||8
7613643|NCT02431260|18746183|P9|STARTED|Overall Study||8
7613644|NCT02431260|18746184|P8|STARTED|Overall Study||3
7613645|NCT02431260|18746185|P7|STARTED|Overall Study||4
7613646|NCT02431260|18746186|P6|STARTED|Overall Study||4
7613647|NCT02431260|18746187|P5|STARTED|Overall Study||3
7613648|NCT02431260|18746188|P4|STARTED|Overall Study||5
7613649|NCT02431260|18746189|P3|STARTED|Overall Study||6
7613650|NCT02431260|18746190|P2|STARTED|Overall Study||5
7613651|NCT02431260|18746191|P1|STARTED|Overall Study||4
7613652|NCT02431247|18746284|P2|NOT COMPLETED|Overall Study||363
7613653|NCT02431247|18746285|P1|NOT COMPLETED|Overall Study||362
7613654|NCT02431247|18746284|P2|COMPLETED|Overall Study||0
7613655|NCT02431247|18746285|P1|COMPLETED|Overall Study||0
7613656|NCT02431247|18746284|P2|STARTED|Overall Study||363
7613657|NCT02431247|18746285|P1|STARTED|Overall Study||362
7613658|NCT02431052|18746344|P5|NOT COMPLETED|Overall Study||15
7613659|NCT02431052|18746345|P4|NOT COMPLETED|Overall Study||16
7613660|NCT02431052|18746346|P3|NOT COMPLETED|Overall Study||12
7613661|NCT02431052|18746347|P2|NOT COMPLETED|Overall Study||4
7613662|NCT02431052|18746348|P1|NOT COMPLETED|Overall Study||11
7613663|NCT02431052|18746344|P5|COMPLETED|Overall Study||86
7613664|NCT02431052|18746345|P4|COMPLETED|Overall Study||94
7613665|NCT02431052|18746346|P3|COMPLETED|Overall Study||94
7613666|NCT02431052|18746347|P2|COMPLETED|Overall Study||46
7613667|NCT02431052|18746348|P1|COMPLETED|Overall Study||42
7613668|NCT02431052|18746344|P5|STARTED|Overall Study||101
7613669|NCT02431052|18746345|P4|STARTED|Overall Study||110
7613670|NCT02431052|18746346|P3|STARTED|Overall Study||106
7613671|NCT02431052|18746347|P2|STARTED|Overall Study||50
7613672|NCT02431052|18746348|P1|STARTED|Overall Study||53
7613673|NCT02430870|18746378|P8|NOT COMPLETED|Part 2||1
7613674|NCT02430870|18746379|P7|NOT COMPLETED|Part 2||1
7613675|NCT02430870|18746380|P6|NOT COMPLETED|Part 2||0
7613676|NCT02430870|18746381|P5|NOT COMPLETED|Part 2||0
7613677|NCT02430870|18746382|P4|NOT COMPLETED|Part 2||0
7613678|NCT02430870|18746383|P3|NOT COMPLETED|Part 2||0
7613679|NCT02430870|18746384|P2|NOT COMPLETED|Part 2||0
7613680|NCT02430870|18746385|P1|NOT COMPLETED|Part 2||0
7613681|NCT02430870|18746378|P8|COMPLETED|Part 2||7
7613682|NCT02430870|18746379|P7|COMPLETED|Part 2||5
7613683|NCT02430870|18746380|P6|COMPLETED|Part 2||6
7613684|NCT02430870|18746381|P5|COMPLETED|Part 2||6
7613685|NCT02430870|18746382|P4|COMPLETED|Part 2||6
7613686|NCT02430870|18746383|P3|COMPLETED|Part 2||0
7613687|NCT02430870|18746384|P2|COMPLETED|Part 2||0
7613688|NCT02430870|18746385|P1|COMPLETED|Part 2||0
7613689|NCT02430870|18746378|P8|STARTED|Part 2||8
7613690|NCT02430870|18746379|P7|STARTED|Part 2||6
7613691|NCT02430870|18746380|P6|STARTED|Part 2||6
7613692|NCT02430870|18746381|P5|STARTED|Part 2||6
7613693|NCT02430870|18746382|P4|STARTED|Part 2||6
7613694|NCT02430870|18746383|P3|STARTED|Part 2||0
7613695|NCT02430870|18746384|P2|STARTED|Part 2||0
7613696|NCT02430870|18746385|P1|STARTED|Part 2||0
7613697|NCT02430870|18746378|P8|NOT COMPLETED|Part 1||0
7613698|NCT02430870|18746379|P7|NOT COMPLETED|Part 1||0
7613699|NCT02430870|18746380|P6|NOT COMPLETED|Part 1||0
7613700|NCT02430870|18746381|P5|NOT COMPLETED|Part 1||0
7613701|NCT02430870|18746382|P4|NOT COMPLETED|Part 1||0
7613702|NCT02430870|18746383|P3|NOT COMPLETED|Part 1||0
7613703|NCT02430870|18746384|P2|NOT COMPLETED|Part 1||0
7613704|NCT02430870|18746385|P1|NOT COMPLETED|Part 1||0
7613705|NCT02430870|18746378|P8|COMPLETED|Part 1||0
7613706|NCT02430870|18746379|P7|COMPLETED|Part 1||0
7613707|NCT02430870|18746380|P6|COMPLETED|Part 1||0
7613708|NCT02430870|18746381|P5|COMPLETED|Part 1||0
7613709|NCT02430870|18746382|P4|COMPLETED|Part 1||0
7613710|NCT02430870|18746383|P3|COMPLETED|Part 1||4
7613711|NCT02430870|18746384|P2|COMPLETED|Part 1||6
7613712|NCT02430870|18746385|P1|COMPLETED|Part 1||6
7613713|NCT02430870|18746378|P8|STARTED|Part 1||0
7613714|NCT02430870|18746379|P7|STARTED|Part 1||0
7613715|NCT02430870|18746380|P6|STARTED|Part 1||0
7613716|NCT02430870|18746381|P5|STARTED|Part 1||0
7613717|NCT02430870|18746382|P4|STARTED|Part 1||0
7613718|NCT02430870|18746383|P3|STARTED|Part 1||4
7613719|NCT02430870|18746384|P2|STARTED|Part 1||6
7613720|NCT02430870|18746385|P1|STARTED|Part 1||6
7613721|NCT02430818|18746459|P2|NOT COMPLETED|Overall Study||0
7613722|NCT02430818|18746460|P1|NOT COMPLETED|Overall Study||0
7613723|NCT02430818|18746459|P2|COMPLETED|Overall Study||6
7613724|NCT02430818|18746460|P1|COMPLETED|Overall Study||7
7613725|NCT02430818|18746459|P2|STARTED|Overall Study||6
7613726|NCT02430818|18746460|P1|STARTED|Overall Study||7
7613727|NCT02430532|18746472|P2|NOT COMPLETED|Overall Study||28
7613728|NCT02430532|18746473|P1|NOT COMPLETED|Overall Study||30
7613729|NCT02430532|18746472|P2|COMPLETED|Overall Study||0
7613730|NCT02430532|18746473|P1|COMPLETED|Overall Study||0
7613731|NCT02430532|18746472|P2|STARTED|Overall Study||28
7613732|NCT02430532|18746473|P1|STARTED|Overall Study||30
7613733|NCT02430480|18746487|P1|NOT COMPLETED|Overall Study||3
7613734|NCT02430480|18746487|P1|COMPLETED|Overall Study||36
7613735|NCT02430480|18746487|P1|STARTED|Overall Study||39
7613736|NCT02430389|18746505|P2|NOT COMPLETED|Overall Study||0
7613737|NCT02430389|18746506|P1|NOT COMPLETED|Overall Study||0
7613738|NCT02430389|18746505|P2|COMPLETED|Overall Study||10
7613739|NCT02430389|18746506|P1|COMPLETED|Overall Study||10
7613740|NCT02430389|18746505|P2|STARTED|Overall Study||10
7613741|NCT02430389|18746506|P1|STARTED|Overall Study||10
7613742|NCT02430337|18746516|P2|NOT COMPLETED|Overall Study||0
7613743|NCT02430337|18746517|P1|NOT COMPLETED|Overall Study||0
7613744|NCT02430337|18746516|P2|COMPLETED|Overall Study||20
7613745|NCT02430337|18746517|P1|COMPLETED|Overall Study||11
7613746|NCT02430337|18746516|P2|STARTED|Overall Study||20
7613747|NCT02430337|18746517|P1|STARTED|Overall Study||11
7613748|NCT02430311|18746530|P2|NOT COMPLETED|Part B||8
7613749|NCT02430311|18746531|P1|NOT COMPLETED|Part B||10
7613750|NCT02430311|18746530|P2|COMPLETED|Part B||7
7613751|NCT02430311|18746531|P1|COMPLETED|Part B||9
7613752|NCT02430311|18746530|P2|Received Paclitaxel|Part B||14
7613753|NCT02430311|18746531|P1|Received Paclitaxel|Part B|Cohort 1 patients are planned to receive olaparib monotherapy|0
7613754|NCT02430311|18746530|P2|Received Olaparib|Part B||15
7613755|NCT02430311|18746531|P1|Received Olaparib|Part B||19
7613756|NCT02430311|18746530|P2|STARTED|Part B||15
7613757|NCT02430311|18746531|P1|STARTED|Part B||19
7613758|NCT02430311|18746530|P2|NOT COMPLETED|Part A||1
7613759|NCT02430311|18746531|P1|NOT COMPLETED|Part A||1
7613760|NCT02430311|18746530|P2|COMPLETED|Part A||15
7613761|NCT02430311|18746531|P1|COMPLETED|Part A||19
7613762|NCT02430311|18746530|P2|Received Paclitaxel|Part A||16
7613763|NCT02430311|18746531|P1|Received Paclitaxel|Part A|Cohort 1 patients are planned to receive olaparib monotherapy|0
7613764|NCT02430311|18746530|P2|Received Olaparib|Part A||16
7613765|NCT02430311|18746531|P1|Received Olaparib|Part A||20
7613766|NCT02430311|18746530|P2|STARTED|Part A||16
7613767|NCT02430311|18746531|P1|STARTED|Part A||20
7613768|NCT02430090|18746567|P3|NOT COMPLETED|Overall Study||0
7613769|NCT02430090|18746568|P2|NOT COMPLETED|Overall Study||0
7613770|NCT02430090|18746569|P1|NOT COMPLETED|Overall Study||0
7613771|NCT02430090|18746567|P3|COMPLETED|Overall Study||15
7613772|NCT02430090|18746568|P2|COMPLETED|Overall Study||15
7613773|NCT02430090|18746569|P1|COMPLETED|Overall Study||15
7613774|NCT02430090|18746567|P3|STARTED|Overall Study||15
7613775|NCT02430090|18746568|P2|STARTED|Overall Study||15
7613776|NCT02430090|18746569|P1|STARTED|Overall Study||15
7613777|NCT02429869|18746577|P1|NOT COMPLETED|Overall Study||0
7613778|NCT02429869|18746577|P1|COMPLETED|Overall Study||10
7613779|NCT02429869|18746577|P1|STARTED|Overall Study||10
7613780|NCT02429856|18746585|P2|NOT COMPLETED|Overall Study||19
7613781|NCT02429856|18746586|P1|NOT COMPLETED|Overall Study||19
7613782|NCT02429856|18746585|P2|COMPLETED|Overall Study||32
7613783|NCT02429856|18746586|P1|COMPLETED|Overall Study||30
7613784|NCT02429856|18746585|P2|STARTED|Overall Study||51
7613785|NCT02429856|18746586|P1|STARTED|Overall Study||49
7613786|NCT02429791|18746604|P2|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||28
7613787|NCT02429791|18746605|P1|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||25
7613788|NCT02429791|18746604|P2|COMPLETED|Late Switch Phase (Week 52 to Week 148)||210
7613789|NCT02429791|18746605|P1|COMPLETED|Late Switch Phase (Week 52 to Week 148)||214
7613790|NCT02429791|18746604|P2|STARTED|Late Switch Phase (Week 52 to Week 148)||238
7613791|NCT02429791|18746605|P1|STARTED|Late Switch Phase (Week 52 to Week 148)||239
7613792|NCT02429791|18746604|P2|NOT COMPLETED|Early Switch Phase (Up to Week 52)||18
7613793|NCT02429791|18746605|P1|NOT COMPLETED|Early Switch Phase (Up to Week 52)||13
7613794|NCT02429791|18746604|P2|COMPLETED|Early Switch Phase (Up to Week 52)||238
7613795|NCT02429791|18746605|P1|COMPLETED|Early Switch Phase (Up to Week 52)||239
7613796|NCT02429791|18746604|P2|STARTED|Early Switch Phase (Up to Week 52)||256
7613797|NCT02429791|18746605|P1|STARTED|Early Switch Phase (Up to Week 52)||252
7613798|NCT02429778|18746693|P2|NOT COMPLETED|Overall Study||0
7613799|NCT02429778|18746694|P1|NOT COMPLETED|Overall Study||7
7613800|NCT02429778|18746693|P2|COMPLETED|Overall Study||20
7613801|NCT02429778|18746694|P1|COMPLETED|Overall Study||13
7613802|NCT02429778|18746693|P2|STARTED|Overall Study||20
7613803|NCT02429778|18746694|P1|STARTED|Overall Study||20
7613804|NCT02429583|18746708|P2|NOT COMPLETED|Overall Study||20
7613805|NCT02429583|18746709|P1|NOT COMPLETED|Overall Study||0
7613806|NCT02429583|18746708|P2|COMPLETED|Overall Study||3
7613807|NCT02429583|18746709|P1|COMPLETED|Overall Study||1
7613808|NCT02429583|18746708|P2|STARTED|Overall Study||23
7613809|NCT02429583|18746709|P1|STARTED|Overall Study||1
7613810|NCT02429427|18746725|P2|NOT COMPLETED|Overall Study||179
7613811|NCT02429427|18746726|P1|NOT COMPLETED|Overall Study||371
7613812|NCT02429427|18746725|P2|COMPLETED|Overall Study||697
7613813|NCT02429427|18746726|P1|COMPLETED|Overall Study||1392
7613814|NCT02429427|18746725|P2|STARTED|Overall Study||876
7613815|NCT02429427|18746726|P1|STARTED|Overall Study||1763
7613816|NCT02429310|18746740|P2|NOT COMPLETED|Overall Study||3
7613817|NCT02429310|18746741|P1|NOT COMPLETED|Overall Study||2
7613818|NCT02429310|18746740|P2|COMPLETED|Overall Study||17
7613819|NCT02429310|18746741|P1|COMPLETED|Overall Study||20
7613820|NCT02429310|18746740|P2|STARTED|Overall Study||20
7613821|NCT02429310|18746741|P1|STARTED|Overall Study||22
7613822|NCT02429258|18746751|P2|NOT COMPLETED|Overall Study||1
7613823|NCT02429258|18746752|P1|NOT COMPLETED|Overall Study||2
7613824|NCT02429258|18746751|P2|COMPLETED|Overall Study||49
7613825|NCT02429258|18746752|P1|COMPLETED|Overall Study||48
7613826|NCT02429258|18746751|P2|STARTED|Overall Study||50
7613827|NCT02429258|18746752|P1|STARTED|Overall Study||50
7613828|NCT02429115|18746784|P6|NOT COMPLETED|Overall Study||1
7613829|NCT02429115|18746785|P5|NOT COMPLETED|Overall Study||7
7613830|NCT02429115|18746786|P4|NOT COMPLETED|Overall Study||8
7613831|NCT02429115|18746787|P3|NOT COMPLETED|Overall Study||16
7613832|NCT02429115|18746788|P2|NOT COMPLETED|Overall Study||10
7613833|NCT02429115|18746789|P1|NOT COMPLETED|Overall Study||12
7613834|NCT02429115|18746784|P6|COMPLETED|Overall Study||27
7613835|NCT02429115|18746785|P5|COMPLETED|Overall Study||22
7613836|NCT02429115|18746786|P4|COMPLETED|Overall Study||21
7613837|NCT02429115|18746787|P3|COMPLETED|Overall Study||35
7613838|NCT02429115|18746788|P2|COMPLETED|Overall Study||42
7613839|NCT02429115|18746789|P1|COMPLETED|Overall Study||40
7613840|NCT02429115|18746784|P6|STARTED|Overall Study||28
7613841|NCT02429115|18746785|P5|STARTED|Overall Study||29
7613842|NCT02429115|18746786|P4|STARTED|Overall Study||29
7613843|NCT02429115|18746787|P3|STARTED|Overall Study||51
7613844|NCT02429115|18746788|P2|STARTED|Overall Study||52
7613845|NCT02429115|18746789|P1|STARTED|Overall Study||52
7613846|NCT02428855|18746806|P1|NOT COMPLETED|Overall Study||2
7613847|NCT02428855|18746806|P1|COMPLETED|Overall Study||6
7613848|NCT02428855|18746806|P1|STARTED|Overall Study||8
7613849|NCT02428699|18746813|P2|NOT COMPLETED|Period 2||0
7613850|NCT02428699|18746814|P1|NOT COMPLETED|Period 2||0
7613851|NCT02428699|18746813|P2|COMPLETED|Period 2||23
7613852|NCT02428699|18746814|P1|COMPLETED|Period 2||24
7613853|NCT02428699|18746813|P2|STARTED|Period 2||23
7613854|NCT02428699|18746814|P1|STARTED|Period 2||24
7613855|NCT02428699|18746813|P2|NOT COMPLETED|Washout Period 1||2
7613856|NCT02428699|18746814|P1|NOT COMPLETED|Washout Period 1||1
7613857|NCT02428699|18746813|P2|COMPLETED|Washout Period 1||23
7613858|NCT02428699|18746814|P1|COMPLETED|Washout Period 1||24
7613859|NCT02428699|18746813|P2|STARTED|Washout Period 1||25
7613860|NCT02428699|18746814|P1|STARTED|Washout Period 1||25
7613861|NCT02428699|18746813|P2|NOT COMPLETED|Period 1||0
7613862|NCT02428699|18746814|P1|NOT COMPLETED|Period 1||0
7613863|NCT02428699|18746813|P2|COMPLETED|Period 1||25
7613864|NCT02428699|18746814|P1|COMPLETED|Period 1||25
7613865|NCT02428699|18746813|P2|STARTED|Period 1||25
7613866|NCT02428699|18746814|P1|STARTED|Period 1||25
7613867|NCT02428608|18746842|P1|NOT COMPLETED|Overall Study||83
7613868|NCT02428608|18746842|P1|COMPLETED|Overall Study||487
7613869|NCT02428608|18746842|P1|STARTED|Overall Study||570
7613870|NCT02428595|18746847|P1|NOT COMPLETED|Treatment||19
7613871|NCT02428595|18746847|P1|COMPLETED|Treatment||54
7613872|NCT02428595|18746847|P1|STARTED|Treatment||73
7613873|NCT02428595|18746847|P1|NOT COMPLETED|Fitting||64
7613874|NCT02428595|18746847|P1|COMPLETED|Fitting||73
7613875|NCT02428595|18746847|P1|STARTED|Fitting||137
7613876|NCT02428478|18746863|P2|NOT COMPLETED|Second Study Night||0
7613877|NCT02428478|18746864|P1|NOT COMPLETED|Second Study Night||0
7613878|NCT02428478|18746863|P2|COMPLETED|Second Study Night||6
7613879|NCT02428478|18746864|P1|COMPLETED|Second Study Night||8
7613880|NCT02428478|18746863|P2|STARTED|Second Study Night|2 participants did not return for the second study night|6
7613881|NCT02428478|18746864|P1|STARTED|Second Study Night|1 participant did not return for the second study night|8
7613882|NCT02428478|18746863|P2|NOT COMPLETED|First Study Night||0
7613883|NCT02428478|18746864|P1|NOT COMPLETED|First Study Night||0
7613884|NCT02428478|18746863|P2|COMPLETED|First Study Night||8
7613885|NCT02428478|18746864|P1|COMPLETED|First Study Night||9
7613886|NCT02428478|18746863|P2|STARTED|First Study Night||8
7613887|NCT02428478|18746864|P1|STARTED|First Study Night||9
7613888|NCT02428413|18746874|P2|NOT COMPLETED|Overall Study||9
7613889|NCT02428413|18746875|P1|NOT COMPLETED|Overall Study||8
7613890|NCT02428413|18746874|P2|COMPLETED|Overall Study||52
7613891|NCT02428413|18746875|P1|COMPLETED|Overall Study||56
7613892|NCT02428413|18746874|P2|STARTED|Overall Study||61
7613893|NCT02428413|18746875|P1|STARTED|Overall Study||64
7613894|NCT02428309|18746887|P1|NOT COMPLETED|Overall Study||0
7613895|NCT02428309|18746887|P1|COMPLETED|Overall Study|The enrolled participant completed treatment and was followed through week 152, per protocol.|1
7613896|NCT02428309|18746887|P1|STARTED|Overall Study||1
7613897|NCT02428296|18746910|P1|NOT COMPLETED|Overall Study||9
7613898|NCT02428296|18746910|P1|COMPLETED|Overall Study|Number of participants who completed the full course of treatment.|30
7613899|NCT02428296|18746910|P1|Treated|Overall Study||39
7613900|NCT02428296|18746910|P1|STARTED|Overall Study||39
7613901|NCT02428231|18746922|P2|NOT COMPLETED|Overall Study||17
7613902|NCT02428231|18746923|P1|NOT COMPLETED|Overall Study||13
7613903|NCT02428231|18746922|P2|COMPLETED|Overall Study||15
7613904|NCT02428231|18746923|P1|COMPLETED|Overall Study||17
7613905|NCT02428231|18746922|P2|STARTED|Overall Study||32
7613906|NCT02428231|18746923|P1|STARTED|Overall Study||30
7613907|NCT02428192|18746939|P2|NOT COMPLETED|Overall Study||1
7613908|NCT02428192|18746940|P1|NOT COMPLETED|Overall Study||12
7613909|NCT02428192|18746939|P2|COMPLETED|Overall Study||7
7613910|NCT02428192|18746940|P1|COMPLETED|Overall Study||0
7613911|NCT02428192|18746939|P2|STARTED|Overall Study||8
7613912|NCT02428192|18746940|P1|STARTED|Overall Study||12
7613913|NCT02427984|18746955|P3|NOT COMPLETED|Overall Study||18
7613914|NCT02427984|18746956|P2|NOT COMPLETED|Overall Study||5
7613915|NCT02427984|18746957|P1|NOT COMPLETED|Overall Study||13
7613916|NCT02427984|18746955|P3|COMPLETED|Overall Study||32
7613917|NCT02427984|18746956|P2|COMPLETED|Overall Study||40
7613918|NCT02427984|18746957|P1|COMPLETED|Overall Study||40
7613919|NCT02427984|18746955|P3|STARTED|Overall Study||50
7613920|NCT02427984|18746956|P2|STARTED|Overall Study||45
7613921|NCT02427984|18746957|P1|STARTED|Overall Study||53
7613922|NCT02427958|18746971|P1|NOT COMPLETED|Overall Study||24
7613923|NCT02427958|18746971|P1|COMPLETED|Overall Study||283
7613924|NCT02427958|18746971|P1|STARTED|Overall Study||307
7613925|NCT02427750|18746978|P2|NOT COMPLETED|Overall Study||0
7613926|NCT02427750|18746979|P1|NOT COMPLETED|Overall Study||0
7613927|NCT02427750|18746978|P2|COMPLETED|Overall Study||63
7613928|NCT02427750|18746979|P1|COMPLETED|Overall Study||63
7613929|NCT02427750|18746978|P2|STARTED|Overall Study||63
7613930|NCT02427750|18746979|P1|STARTED|Overall Study||63
7613931|NCT02427737|18747004|P2|NOT COMPLETED|Duke Pre- and Post-Training Groups||395
7613932|NCT02427737|18747005|P1|NOT COMPLETED|Duke Pre- and Post-Training Groups||779
7613933|NCT02427737|18747004|P2|COMPLETED|Duke Pre- and Post-Training Groups||4051
7613934|NCT02427737|18747005|P1|COMPLETED|Duke Pre- and Post-Training Groups||8879
7613935|NCT02427737|18747004|P2|STARTED|Duke Pre- and Post-Training Groups|Note Control=Baseline|4446
7613936|NCT02427737|18747005|P1|STARTED|Duke Pre- and Post-Training Groups|Note this is a pre-training to post-training comparison.|9658
7613937|NCT02427737|18747004|P2|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||215
7613938|NCT02427737|18747005|P1|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||220
7613939|NCT02427737|18747004|P2|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||2716
7613940|NCT02427737|18747005|P1|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||3928
7613941|NCT02427737|18747004|P2|STARTED|OSU Q3FY16 (Third Post Training Quarter)||2931
7613942|NCT02427737|18747005|P1|STARTED|OSU Q3FY16 (Third Post Training Quarter)||4148
7613943|NCT02427737|18747004|P2|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||213
7613944|NCT02427737|18747005|P1|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||214
7613945|NCT02427737|18747004|P2|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||2857
7613946|NCT02427737|18747005|P1|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||3907
7613947|NCT02427737|18747004|P2|STARTED|OSU Q2FY16(Second Post Training Quarter)||3070
7613948|NCT02427737|18747005|P1|STARTED|OSU Q2FY16(Second Post Training Quarter)||4121
7613949|NCT02427737|18747004|P2|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||214
7613950|NCT02427737|18747005|P1|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||215
7613951|NCT02427737|18747004|P2|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3032
7613952|NCT02427737|18747005|P1|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3815
7613953|NCT02427737|18747004|P2|STARTED|OSU Q1FY16 (First Post-Training Quarter)||3246
7613954|NCT02427737|18747005|P1|STARTED|OSU Q1FY16 (First Post-Training Quarter)||4030
7613955|NCT02427737|18747004|P2|NOT COMPLETED|OSU Baseline Q4FY15||216
7613956|NCT02427737|18747005|P1|NOT COMPLETED|OSU Baseline Q4FY15||218
7613957|NCT02427737|18747004|P2|COMPLETED|OSU Baseline Q4FY15||3230
7613958|NCT02427737|18747005|P1|COMPLETED|OSU Baseline Q4FY15||3940
7613959|NCT02427737|18747004|P2|STARTED|OSU Baseline Q4FY15||3446
7613960|NCT02427737|18747005|P1|STARTED|OSU Baseline Q4FY15||4158
7613961|NCT02427672|18747053|P2|NOT COMPLETED|Overall Study||2
7613962|NCT02427672|18747054|P1|NOT COMPLETED|Overall Study||1
7613963|NCT02427672|18747053|P2|COMPLETED|Overall Study||42
7613964|NCT02427672|18747054|P1|COMPLETED|Overall Study||39
7613965|NCT02427672|18747053|P2|STARTED|Overall Study||44
7613966|NCT02427672|18747054|P1|STARTED|Overall Study||40
7613967|NCT02427646|18747064|P2|NOT COMPLETED|Overall Study||14
7613968|NCT02427646|18747065|P1|NOT COMPLETED|Overall Study||8
7613969|NCT02427646|18747064|P2|COMPLETED|Overall Study||14
7613970|NCT02427646|18747065|P1|COMPLETED|Overall Study||16
7613971|NCT02427646|18747064|P2|STARTED|Overall Study||28
7613972|NCT02427646|18747065|P1|STARTED|Overall Study||24
7613973|NCT02427607|18747073|P1|NOT COMPLETED|Overall Study||1
7613974|NCT02427607|18747073|P1|COMPLETED|Overall Study||6
7613975|NCT02427607|18747073|P1|STARTED|Overall Study||7
7613976|NCT02427477|18747079|P2|NOT COMPLETED|Period 3||0
7613977|NCT02427477|18747080|P1|NOT COMPLETED|Period 3||0
7613978|NCT02427477|18747079|P2|COMPLETED|Period 3||60
7613979|NCT02427477|18747080|P1|COMPLETED|Period 3||59
7613980|NCT02427477|18747079|P2|STARTED|Period 3||60
7613981|NCT02427477|18747080|P1|STARTED|Period 3||59
7613982|NCT02427477|18747079|P2|NOT COMPLETED|Period 2||0
7613983|NCT02427477|18747080|P1|NOT COMPLETED|Period 2||0
7613984|NCT02427477|18747079|P2|COMPLETED|Period 2||60
7613985|NCT02427477|18747080|P1|COMPLETED|Period 2||59
7613986|NCT02427477|18747079|P2|STARTED|Period 2||60
7613987|NCT02427477|18747080|P1|STARTED|Period 2||59
7613988|NCT02427477|18747079|P2|NOT COMPLETED|Period 1||0
7613989|NCT02427477|18747080|P1|NOT COMPLETED|Period 1||1
7613990|NCT02427477|18747079|P2|COMPLETED|Period 1||60
7613991|NCT02427477|18747080|P1|COMPLETED|Period 1||59
7613992|NCT02427477|18747079|P2|STARTED|Period 1||60
7613993|NCT02427477|18747080|P1|STARTED|Period 1||60
7613994|NCT02427399|18747093|P5|NOT COMPLETED|Overall Study||15
7613995|NCT02427399|18747094|P4|NOT COMPLETED|Overall Study||18
7613996|NCT02427399|18747095|P3|NOT COMPLETED|Overall Study||12
7613997|NCT02427399|18747096|P2|NOT COMPLETED|Overall Study||16
7613998|NCT02427399|18747097|P1|NOT COMPLETED|Overall Study||14
7613999|NCT02427399|18747093|P5|COMPLETED|Overall Study||205
7614000|NCT02427399|18747094|P4|COMPLETED|Overall Study||202
7614001|NCT02427399|18747095|P3|COMPLETED|Overall Study||208
7614002|NCT02427399|18747096|P2|COMPLETED|Overall Study||204
7614003|NCT02427399|18747097|P1|COMPLETED|Overall Study||206
7614004|NCT02427399|18747093|P5|STARTED|Overall Study||220
7614005|NCT02427399|18747094|P4|STARTED|Overall Study||220
7614006|NCT02427399|18747095|P3|STARTED|Overall Study||220
7614007|NCT02427399|18747096|P2|STARTED|Overall Study||220
7614008|NCT02427399|18747097|P1|STARTED|Overall Study||220
7614009|NCT02427100|18747121|P2|NOT COMPLETED|Overall Study||2
7614010|NCT02427100|18747122|P1|NOT COMPLETED|Overall Study||0
7614011|NCT02427100|18747121|P2|COMPLETED|Overall Study||15
7614012|NCT02427100|18747122|P1|COMPLETED|Overall Study||15
7614013|NCT02427100|18747121|P2|STARTED|Overall Study||17
7614014|NCT02427100|18747122|P1|STARTED|Overall Study||15
7614015|NCT02426918|18747133|P3|NOT COMPLETED|Overall Study||14
7614016|NCT02426918|18747134|P2|NOT COMPLETED|Overall Study||19
7614017|NCT02426918|18747135|P1|NOT COMPLETED|Overall Study||17
7614018|NCT02426918|18747133|P3|COMPLETED|Overall Study||97
7614019|NCT02426918|18747134|P2|COMPLETED|Overall Study||90
7614020|NCT02426918|18747135|P1|COMPLETED|Overall Study||93
7614021|NCT02426918|18747133|P3|Safety Population|Overall Study||107
7614022|NCT02426918|18747134|P2|Safety Population|Overall Study||107
7614023|NCT02426918|18747135|P1|Safety Population|Overall Study||110
7614024|NCT02426918|18747133|P3|STARTED|Overall Study||111
7614025|NCT02426918|18747134|P2|STARTED|Overall Study||109
7614026|NCT02426918|18747135|P1|STARTED|Overall Study||110
7614027|NCT02426749|18747157|P2|NOT COMPLETED|Overall Study||1
7614028|NCT02426749|18747158|P1|NOT COMPLETED|Overall Study||3
7614029|NCT02426749|18747157|P2|COMPLETED|Overall Study||9
7614030|NCT02426749|18747158|P1|COMPLETED|Overall Study||9
7614031|NCT02426749|18747157|P2|STARTED|Overall Study||10
7614032|NCT02426749|18747158|P1|STARTED|Overall Study||12
7614033|NCT02426658|18747170|P1|NOT COMPLETED|Overall Study||3
7614034|NCT02426658|18747170|P1|COMPLETED|Overall Study||13
7614035|NCT02426658|18747170|P1|STARTED|Overall Study||16
7614036|NCT02426580|18747177|P2|NOT COMPLETED|Overall Study||16
7614037|NCT02426580|18747178|P1|NOT COMPLETED|Overall Study||11
7614038|NCT02426580|18747177|P2|COMPLETED|Overall Study|the last patient in this group enrolled in April 2017|54
7614039|NCT02426580|18747178|P1|COMPLETED|Overall Study|the last patient enrolled in this group in April 2017|59
7614040|NCT02426580|18747177|P2|STARTED|Overall Study|January 2014|70
7614041|NCT02426580|18747178|P1|STARTED|Overall Study|April 2015|70
7614042|NCT02426541|18747186|P2|NOT COMPLETED|Overall Study||0
7614043|NCT02426541|18747187|P1|NOT COMPLETED|Overall Study||1
7614044|NCT02426541|18747186|P2|COMPLETED|Overall Study||16
7614045|NCT02426541|18747187|P1|COMPLETED|Overall Study||15
7614046|NCT02426541|18747186|P2|STARTED|Overall Study||16
7614047|NCT02426541|18747187|P1|STARTED|Overall Study||16
7614048|NCT02426138|18747199|P2|NOT COMPLETED|Intent to Treat Population Milestone||0
7614049|NCT02426138|18747200|P1|NOT COMPLETED|Intent to Treat Population Milestone||0
7614050|NCT02426138|18747199|P2|COMPLETED|Intent to Treat Population Milestone||22
7614051|NCT02426138|18747200|P1|COMPLETED|Intent to Treat Population Milestone||20
7614052|NCT02426138|18747199|P2|STARTED|Intent to Treat Population Milestone||22
7614053|NCT02426138|18747200|P1|STARTED|Intent to Treat Population Milestone||20
7614054|NCT02426138|18747199|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
7614055|NCT02426138|18747200|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
7614056|NCT02426138|18747199|P2|COMPLETED|Second Intervention (12 Weeks)||22
7614057|NCT02426138|18747200|P1|COMPLETED|Second Intervention (12 Weeks)||20
7614058|NCT02426138|18747199|P2|STARTED|Second Intervention (12 Weeks)||22
7614059|NCT02426138|18747200|P1|STARTED|Second Intervention (12 Weeks)||20
7614060|NCT02426138|18747199|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
7614061|NCT02426138|18747200|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
7614062|NCT02426138|18747199|P2|COMPLETED|First Intervention (12 Weeks)||22
7614063|NCT02426138|18747200|P1|COMPLETED|First Intervention (12 Weeks)||20
7614064|NCT02426138|18747199|P2|STARTED|First Intervention (12 Weeks)||23
7614065|NCT02426138|18747200|P1|STARTED|First Intervention (12 Weeks)||21
7614066|NCT02426125|18747240|P2|NOT COMPLETED|Overall Study||26
7614067|NCT02426125|18747241|P1|NOT COMPLETED|Overall Study||29
7614068|NCT02426125|18747240|P2|COMPLETED|Overall Study||241
7614069|NCT02426125|18747241|P1|COMPLETED|Overall Study||234
7614070|NCT02426125|18747240|P2|First Randomized Participants|Overall Study||221
7614071|NCT02426125|18747241|P1|First Randomized Participants|Overall Study||216
7614072|NCT02426125|18747240|P2|Received at Least One Dose of Study Drug|Overall Study||265
7614073|NCT02426125|18747241|P1|Received at Least One Dose of Study Drug|Overall Study||258
7614074|NCT02426125|18747240|P2|STARTED|Overall Study||267
7614075|NCT02426125|18747241|P1|STARTED|Overall Study||263
7614076|NCT02425956|18747265|P1|NOT COMPLETED|Overall Study||0
7614077|NCT02425956|18747265|P1|COMPLETED|Overall Study||21
7614078|NCT02425956|18747265|P1|STARTED|Overall Study||21
7614079|NCT02425826|18747272|P3|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
7614080|NCT02425826|18747273|P2|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
7614081|NCT02425826|18747274|P1|NOT COMPLETED|Post-Treatment Observational Follow-Up||1
7614082|NCT02425826|18747272|P3|COMPLETED|Post-Treatment Observational Follow-Up||49
7614083|NCT02425826|18747273|P2|COMPLETED|Post-Treatment Observational Follow-Up||0
7614084|NCT02425826|18747274|P1|COMPLETED|Post-Treatment Observational Follow-Up||80
7614085|NCT02425826|18747272|P3|STARTED|Post-Treatment Observational Follow-Up||49
7614086|NCT02425826|18747273|P2|STARTED|Post-Treatment Observational Follow-Up||0
7614087|NCT02425826|18747274|P1|STARTED|Post-Treatment Observational Follow-Up||81
7614088|NCT02425826|18747272|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||14
7614089|NCT02425826|18747273|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
7614090|NCT02425826|18747274|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||35
7614091|NCT02425826|18747272|P3|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||50
7614092|NCT02425826|18747273|P2|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
7614093|NCT02425826|18747274|P1|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||86
7614094|NCT02425826|18747272|P3|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||64
7614095|NCT02425826|18747273|P2|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||0
7614096|NCT02425826|18747274|P1|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||121
7614097|NCT02425826|18747272|P3|STARTED|Apremilast Extension Phase (Weeks 16-52)||64
7614098|NCT02425826|18747273|P2|STARTED|Apremilast Extension Phase (Weeks 16-52)||0
7614099|NCT02425826|18747274|P1|STARTED|Apremilast Extension Phase (Weeks 16-52)||121
7614100|NCT02425826|18747272|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
7614101|NCT02425826|18747273|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||9
7614102|NCT02425826|18747274|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||27
7614103|NCT02425826|18747272|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
7614104|NCT02425826|18747273|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|64
7614105|NCT02425826|18747274|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|121
7614106|NCT02425826|18747272|P3|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)||0
7614107|NCT02425826|18747273|P2|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|73
7614108|NCT02425826|18747274|P1|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|147
7614109|NCT02425826|18747272|P3|STARTED|Placebo-controlled Phase (Week 0 - 16)||0
7614110|NCT02425826|18747273|P2|STARTED|Placebo-controlled Phase (Week 0 - 16)||73
7614111|NCT02425826|18747274|P1|STARTED|Placebo-controlled Phase (Week 0 - 16)||148
7614112|NCT02425449|18747312|P5|NOT COMPLETED|Overall Study||0
7614113|NCT02425449|18747313|P4|NOT COMPLETED|Overall Study||0
7614114|NCT02425449|18747314|P3|NOT COMPLETED|Overall Study||0
7614115|NCT02425449|18747315|P2|NOT COMPLETED|Overall Study||0
7614116|NCT02425449|18747316|P1|NOT COMPLETED|Overall Study||0
7614117|NCT02425449|18747312|P5|COMPLETED|Overall Study||5
7614118|NCT02425449|18747313|P4|COMPLETED|Overall Study||5
7614119|NCT02425449|18747314|P3|COMPLETED|Overall Study||5
7614120|NCT02425449|18747315|P2|COMPLETED|Overall Study||4
7614121|NCT02425449|18747316|P1|COMPLETED|Overall Study||0
7614122|NCT02425449|18747312|P5|STARTED|Overall Study||5
7614123|NCT02425449|18747313|P4|STARTED|Overall Study||5
7614124|NCT02425449|18747314|P3|STARTED|Overall Study||5
7614125|NCT02425449|18747315|P2|STARTED|Overall Study||4
7614126|NCT02425449|18747316|P1|STARTED|Overall Study||0
7614127|NCT02425111|18747328|P1|NOT COMPLETED|Part B: Treatment Extension Period||10
7614128|NCT02425111|18747328|P1|COMPLETED|Part B: Treatment Extension Period||46
7614129|NCT02425111|18747328|P1|STARTED|Part B: Treatment Extension Period||56
7614130|NCT02425111|18747328|P1|NOT COMPLETED|Part A: Treatment Period||23
7614131|NCT02425111|18747328|P1|COMPLETED|Part A: Treatment Period||78
7614132|NCT02425111|18747328|P1|STARTED|Part A: Treatment Period||101
7614133|NCT02425098|18747349|P2|NOT COMPLETED|Overall Study||16
7614134|NCT02425098|18747350|P1|NOT COMPLETED|Overall Study||13
7614135|NCT02425098|18747349|P2|COMPLETED|Overall Study||159
7614136|NCT02425098|18747350|P1|COMPLETED|Overall Study||163
7614137|NCT02425098|18747349|P2|STARTED|Overall Study||175
7614138|NCT02425098|18747350|P1|STARTED|Overall Study||176
7614139|NCT02424799|18747398|P6|NOT COMPLETED|Part C (Up to Day 23)||0
7614140|NCT02424799|18747399|P5|NOT COMPLETED|Part C (Up to Day 23)||0
7614141|NCT02424799|18747400|P4|NOT COMPLETED|Part C (Up to Day 23)||0
7614142|NCT02424799|18747401|P3|NOT COMPLETED|Part C (Up to Day 23)||0
7614143|NCT02424799|18747402|P2|NOT COMPLETED|Part C (Up to Day 23)||0
7614144|NCT02424799|18747403|P1|NOT COMPLETED|Part C (Up to Day 23)||0
7614145|NCT02424799|18747398|P6|COMPLETED|Part C (Up to Day 23)||4
7614146|NCT02424799|18747399|P5|COMPLETED|Part C (Up to Day 23)||1
7614147|NCT02424799|18747400|P4|COMPLETED|Part C (Up to Day 23)||0
7614148|NCT02424799|18747401|P3|COMPLETED|Part C (Up to Day 23)||0
7614149|NCT02424799|18747402|P2|COMPLETED|Part C (Up to Day 23)||0
7614150|NCT02424799|18747403|P1|COMPLETED|Part C (Up to Day 23)||0
7614151|NCT02424799|18747398|P6|STARTED|Part C (Up to Day 23)||4
7614152|NCT02424799|18747399|P5|STARTED|Part C (Up to Day 23)||1
7614153|NCT02424799|18747400|P4|STARTED|Part C (Up to Day 23)||0
7614154|NCT02424799|18747401|P3|STARTED|Part C (Up to Day 23)||0
7614155|NCT02424799|18747402|P2|STARTED|Part C (Up to Day 23)||0
7614156|NCT02424799|18747403|P1|STARTED|Part C (Up to Day 23)||0
7614157|NCT02424799|18747398|P6|NOT COMPLETED|Part B (Up to Day 19)||0
7614158|NCT02424799|18747399|P5|NOT COMPLETED|Part B (Up to Day 19)||0
7614159|NCT02424799|18747400|P4|NOT COMPLETED|Part B (Up to Day 19)||0
7614160|NCT02424799|18747401|P3|NOT COMPLETED|Part B (Up to Day 19)||0
7614161|NCT02424799|18747402|P2|NOT COMPLETED|Part B (Up to Day 19)||0
7614162|NCT02424799|18747403|P1|NOT COMPLETED|Part B (Up to Day 19)||0
7614163|NCT02424799|18747398|P6|COMPLETED|Part B (Up to Day 19)||0
7614164|NCT02424799|18747399|P5|COMPLETED|Part B (Up to Day 19)||0
7614165|NCT02424799|18747400|P4|COMPLETED|Part B (Up to Day 19)||9
7614166|NCT02424799|18747401|P3|COMPLETED|Part B (Up to Day 19)||3
7614167|NCT02424799|18747402|P2|COMPLETED|Part B (Up to Day 19)||0
7614168|NCT02424799|18747403|P1|COMPLETED|Part B (Up to Day 19)||0
7614169|NCT02424799|18747398|P6|STARTED|Part B (Up to Day 19)||0
7614170|NCT02424799|18747399|P5|STARTED|Part B (Up to Day 19)||0
7614171|NCT02424799|18747400|P4|STARTED|Part B (Up to Day 19)||9
7614172|NCT02424799|18747401|P3|STARTED|Part B (Up to Day 19)||3
7614173|NCT02424799|18747402|P2|STARTED|Part B (Up to Day 19)||0
7614174|NCT02424799|18747403|P1|STARTED|Part B (Up to Day 19)||0
7614175|NCT02424799|18747398|P6|NOT COMPLETED|Part A (Up to Day 11)||0
7614176|NCT02424799|18747399|P5|NOT COMPLETED|Part A (Up to Day 11)||0
7614177|NCT02424799|18747400|P4|NOT COMPLETED|Part A (Up to Day 11)||0
7614178|NCT02424799|18747401|P3|NOT COMPLETED|Part A (Up to Day 11)||0
7614179|NCT02424799|18747402|P2|NOT COMPLETED|Part A (Up to Day 11)||0
7614180|NCT02424799|18747403|P1|NOT COMPLETED|Part A (Up to Day 11)||0
7614181|NCT02424799|18747398|P6|COMPLETED|Part A (Up to Day 11)||0
7614182|NCT02424799|18747399|P5|COMPLETED|Part A (Up to Day 11)||0
7614183|NCT02424799|18747400|P4|COMPLETED|Part A (Up to Day 11)||0
7614184|NCT02424799|18747401|P3|COMPLETED|Part A (Up to Day 11)||0
7614185|NCT02424799|18747402|P2|COMPLETED|Part A (Up to Day 11)||8
7614186|NCT02424799|18747403|P1|COMPLETED|Part A (Up to Day 11)||9
7614187|NCT02424799|18747398|P6|STARTED|Part A (Up to Day 11)||0
7614188|NCT02424799|18747399|P5|STARTED|Part A (Up to Day 11)||0
7614189|NCT02424799|18747400|P4|STARTED|Part A (Up to Day 11)||0
7614190|NCT02424799|18747401|P3|STARTED|Part A (Up to Day 11)||0
7614191|NCT02424799|18747402|P2|STARTED|Part A (Up to Day 11)||8
7614192|NCT02424799|18747403|P1|STARTED|Part A (Up to Day 11)||9
7614193|NCT02424734|18747502|P3|NOT COMPLETED|Overall Study||0
7614194|NCT02424734|18747503|P2|NOT COMPLETED|Overall Study||2
7614195|NCT02424734|18747504|P1|NOT COMPLETED|Overall Study||2
7614196|NCT02424734|18747502|P3|COMPLETED|Overall Study||2
7614197|NCT02424734|18747503|P2|COMPLETED|Overall Study||3
7614198|NCT02424734|18747504|P1|COMPLETED|Overall Study||2
7614199|NCT02424734|18747502|P3|Treated|Overall Study||2
7614200|NCT02424734|18747503|P2|Treated|Overall Study||5
7614201|NCT02424734|18747504|P1|Treated|Overall Study||4
7614202|NCT02424734|18747502|P3|STARTED|Overall Study||2
7614203|NCT02424734|18747503|P2|STARTED|Overall Study||5
7614204|NCT02424734|18747504|P1|STARTED|Overall Study||4
7614205|NCT02424630|18747523|P2|NOT COMPLETED|Overall Study||3
7614206|NCT02424630|18747524|P1|NOT COMPLETED|Overall Study||1
7614207|NCT02424630|18747523|P2|COMPLETED|Overall Study||24
7614208|NCT02424630|18747524|P1|COMPLETED|Overall Study||24
7614209|NCT02424630|18747523|P2|STARTED|Overall Study||27
7614210|NCT02424630|18747524|P1|STARTED|Overall Study||25
7614211|NCT02424591|18747534|P2|NOT COMPLETED|Overall Study||3
7614212|NCT02424591|18747535|P1|NOT COMPLETED|Overall Study||2
7614213|NCT02424591|18747534|P2|COMPLETED|Overall Study||20
7614214|NCT02424591|18747535|P1|COMPLETED|Overall Study||20
7614215|NCT02424591|18747534|P2|STARTED|Overall Study||23
7614216|NCT02424591|18747535|P1|STARTED|Overall Study||22
7614217|NCT02424578|18747547|P2|NOT COMPLETED|Overall Study||1
7614218|NCT02424578|18747548|P1|NOT COMPLETED|Overall Study||0
7614219|NCT02424578|18747547|P2|COMPLETED|Overall Study||14
7614220|NCT02424578|18747548|P1|COMPLETED|Overall Study||15
7614221|NCT02424578|18747547|P2|STARTED|Overall Study||15
7614222|NCT02424578|18747548|P1|STARTED|Overall Study||15
7614223|NCT02424565|18747554|P2|NOT COMPLETED|Period 2 (D3)||0
7614224|NCT02424565|18747555|P1|NOT COMPLETED|Period 2 (D3)||0
7614225|NCT02424565|18747554|P2|COMPLETED|Period 2 (D3)||6
7614226|NCT02424565|18747555|P1|COMPLETED|Period 2 (D3)||8
7614227|NCT02424565|18747554|P2|STARTED|Period 2 (D3)||6
7614228|NCT02424565|18747555|P1|STARTED|Period 2 (D3)||8
7614229|NCT02424565|18747554|P2|NOT COMPLETED|Washout Period||0
7614230|NCT02424565|18747555|P1|NOT COMPLETED|Washout Period||0
7614231|NCT02424565|18747554|P2|COMPLETED|Washout Period||6
7614232|NCT02424565|18747555|P1|COMPLETED|Washout Period||8
7614233|NCT02424565|18747554|P2|STARTED|Washout Period||6
7614234|NCT02424565|18747555|P1|STARTED|Washout Period||8
7614235|NCT02424565|18747554|P2|NOT COMPLETED|Period 1 (D0)||1
7614236|NCT02424565|18747555|P1|NOT COMPLETED|Period 1 (D0)||0
7614237|NCT02424565|18747554|P2|COMPLETED|Period 1 (D0)||6
7614238|NCT02424565|18747555|P1|COMPLETED|Period 1 (D0)||8
7614239|NCT02424565|18747554|P2|STARTED|Period 1 (D0)||7
7614240|NCT02424565|18747555|P1|STARTED|Period 1 (D0)||8
7614241|NCT02424539|18747564|P3|NOT COMPLETED|Overall Study||8
7614242|NCT02424539|18747565|P2|NOT COMPLETED|Overall Study||8
7614243|NCT02424539|18747566|P1|NOT COMPLETED|Overall Study||14
7614244|NCT02424539|18747564|P3|COMPLETED|Overall Study||111
7614245|NCT02424539|18747565|P2|COMPLETED|Overall Study||111
7614246|NCT02424539|18747566|P1|COMPLETED|Overall Study||106
7614247|NCT02424539|18747564|P3|STARTED|Overall Study||119
7614248|NCT02424539|18747565|P2|STARTED|Overall Study||119
7614249|NCT02424539|18747566|P1|STARTED|Overall Study||120
7614250|NCT02424526|18747630|P2|NOT COMPLETED|Overall Study||0
7614251|NCT02424526|18747631|P1|NOT COMPLETED|Overall Study||0
7614252|NCT02424526|18747630|P2|COMPLETED|Overall Study||10
7614253|NCT02424526|18747631|P1|COMPLETED|Overall Study||9
7614254|NCT02424526|18747630|P2|STARTED|Overall Study||10
7614255|NCT02424526|18747631|P1|STARTED|Overall Study||9
7614256|NCT02424383|18747649|P1|NOT COMPLETED|Overall Study||376
7614257|NCT02424383|18747649|P1|COMPLETED|Overall Study||629
7614258|NCT02424383|18747649|P1|Per-Protocol Population|Overall Study||966
7614259|NCT02424383|18747649|P1|STARTED|Overall Study||1005
7614260|NCT02424357|18747662|P2|NOT COMPLETED|Overall Study||0
7614261|NCT02424357|18747663|P1|NOT COMPLETED|Overall Study||0
7614262|NCT02424357|18747662|P2|COMPLETED|Overall Study||30
7614263|NCT02424357|18747663|P1|COMPLETED|Overall Study||35
7614264|NCT02424357|18747662|P2|STARTED|Overall Study||30
7614265|NCT02424357|18747663|P1|STARTED|Overall Study||35
7614266|NCT02424344|18747673|P2|NOT COMPLETED|Overall Study||10
7614267|NCT02424344|18747674|P1|NOT COMPLETED|Overall Study||7
7614268|NCT02424344|18747673|P2|COMPLETED|Overall Study||123
7614269|NCT02424344|18747674|P1|COMPLETED|Overall Study||127
7614270|NCT02424344|18747673|P2|STARTED|Overall Study||133
7614271|NCT02424344|18747674|P1|STARTED|Overall Study||134
7614272|NCT02424175|18747684|P1|NOT COMPLETED|Overall Study||0
7614273|NCT02424175|18747684|P1|COMPLETED|Overall Study||10
7614274|NCT02424175|18747684|P1|STARTED|Overall Study||10
7614275|NCT02424149|18747692|P2|NOT COMPLETED|Overall Study||1
7614276|NCT02424149|18747693|P1|NOT COMPLETED|Overall Study||2
7614277|NCT02424149|18747692|P2|COMPLETED|Overall Study||52
7614278|NCT02424149|18747693|P1|COMPLETED|Overall Study||52
7614279|NCT02424149|18747692|P2|STARTED|Overall Study||53
7614280|NCT02424149|18747693|P1|STARTED|Overall Study||54
7614281|NCT02424097|18747709|P2|NOT COMPLETED|Overall Study||2
7614282|NCT02424097|18747710|P1|NOT COMPLETED|Overall Study||1
7614283|NCT02424097|18747709|P2|COMPLETED|Overall Study||18
7614284|NCT02424097|18747710|P1|COMPLETED|Overall Study||19
7614285|NCT02424097|18747709|P2|STARTED|Overall Study||20
7614286|NCT02424097|18747710|P1|STARTED|Overall Study||20
7614287|NCT02423993|18747722|P4|NOT COMPLETED|Overall Study||0
7614288|NCT02423993|18747723|P3|NOT COMPLETED|Overall Study||0
7614289|NCT02423993|18747724|P2|NOT COMPLETED|Overall Study||0
7614290|NCT02423993|18747725|P1|NOT COMPLETED|Overall Study||0
7614291|NCT02423993|18747722|P4|COMPLETED|Overall Study||19
7614292|NCT02423993|18747723|P3|COMPLETED|Overall Study||23
7614293|NCT02423993|18747724|P2|COMPLETED|Overall Study||16
7614294|NCT02423993|18747725|P1|COMPLETED|Overall Study||19
7614295|NCT02423993|18747722|P4|STARTED|Overall Study||19
7614296|NCT02423993|18747723|P3|STARTED|Overall Study||23
7614297|NCT02423993|18747724|P2|STARTED|Overall Study||16
7614298|NCT02423993|18747725|P1|STARTED|Overall Study||19
7614299|NCT02423980|18747755|P1|NOT COMPLETED|Overall Study||0
7614300|NCT02423980|18747755|P1|COMPLETED|Overall Study||7
7614301|NCT02423980|18747755|P1|STARTED|Overall Study||7
7614302|NCT02423798|18747765|P1|NOT COMPLETED|Overall Study||3
7614303|NCT02423798|18747765|P1|COMPLETED|Overall Study||21
7614304|NCT02423798|18747765|P1|STARTED|Overall Study||24
7614305|NCT02423577|18747773|P2|NOT COMPLETED|Overall Study||0
7614306|NCT02423577|18747774|P1|NOT COMPLETED|Overall Study||0
7614307|NCT02423577|18747773|P2|COMPLETED|Overall Study||26
7614308|NCT02423577|18747774|P1|COMPLETED|Overall Study||53
7614309|NCT02423577|18747773|P2|STARTED|Overall Study||26
7614310|NCT02423577|18747774|P1|STARTED|Overall Study||53
7614311|NCT02423447|18747780|P2|NOT COMPLETED|Overall Study||0
7614312|NCT02423447|18747781|P1|NOT COMPLETED|Overall Study||0
7614313|NCT02423447|18747780|P2|COMPLETED|Overall Study||12
7614314|NCT02423447|18747781|P1|COMPLETED|Overall Study||13
7614315|NCT02423447|18747780|P2|STARTED|Overall Study||12
7614316|NCT02423447|18747781|P1|STARTED|Overall Study||13
7614317|NCT02423408|18747797|P2|NOT COMPLETED|Overall Study||2
7614318|NCT02423408|18747798|P1|NOT COMPLETED|Overall Study||1
7614319|NCT02423408|18747797|P2|COMPLETED|Overall Study||80
7614320|NCT02423408|18747798|P1|COMPLETED|Overall Study||82
7614321|NCT02423408|18747797|P2|STARTED|Overall Study||82
7614322|NCT02423408|18747798|P1|STARTED|Overall Study||83
7614323|NCT02423317|18747812|P2|NOT COMPLETED|Overall Study||0
7614324|NCT02423317|18747813|P1|NOT COMPLETED|Overall Study||0
7614325|NCT02423317|18747812|P2|COMPLETED|Overall Study||30
7614326|NCT02423317|18747813|P1|COMPLETED|Overall Study||30
7614327|NCT02423317|18747812|P2|STARTED|Overall Study||30
7614328|NCT02423317|18747813|P1|STARTED|Overall Study||30
7614329|NCT02423291|18747831|P1|NOT COMPLETED|Overall Study||15
7614330|NCT02423291|18747831|P1|COMPLETED|Overall Study|Patients that have completed therapy|0
7614331|NCT02423291|18747831|P1|STARTED|Overall Study|Patients enrolled|15
7614332|NCT02423200|18747837|P2|NOT COMPLETED|Overall Study||0
7614333|NCT02423200|18747838|P1|NOT COMPLETED|Overall Study||1
7614334|NCT02423200|18747837|P2|COMPLETED|Overall Study||1
7614335|NCT02423200|18747838|P1|COMPLETED|Overall Study||7
7614336|NCT02423200|18747837|P2|STARTED|Overall Study||1
7614337|NCT02423200|18747838|P1|STARTED|Overall Study||8
7614338|NCT02423122|18747848|P2|NOT COMPLETED|Overall Study||0
7614339|NCT02423122|18747849|P1|NOT COMPLETED|Overall Study||0
7614340|NCT02423122|18747848|P2|COMPLETED|Overall Study||7
7614341|NCT02423122|18747849|P1|COMPLETED|Overall Study||9
7614342|NCT02423122|18747848|P2|STARTED|Overall Study||7
7614343|NCT02423122|18747849|P1|STARTED|Overall Study||9
7614344|NCT02423109|18747861|P2|NOT COMPLETED|Lens 2||0
7614345|NCT02423109|18747862|P1|NOT COMPLETED|Lens 2||0
7614346|NCT02423109|18747861|P2|COMPLETED|Lens 2||14
7614347|NCT02423109|18747862|P1|COMPLETED|Lens 2||18
7614348|NCT02423109|18747861|P2|STARTED|Lens 2||14
7614349|NCT02423109|18747862|P1|STARTED|Lens 2||18
7614350|NCT02423109|18747861|P2|NOT COMPLETED|Lens 1||0
7614351|NCT02423109|18747862|P1|NOT COMPLETED|Lens 1||1
7614352|NCT02423109|18747861|P2|COMPLETED|Lens 1||14
7614353|NCT02423109|18747862|P1|COMPLETED|Lens 1||18
7614354|NCT02423109|18747861|P2|STARTED|Lens 1||14
7614355|NCT02423109|18747862|P1|STARTED|Lens 1||19
7614356|NCT02422940|18747872|P2|NOT COMPLETED|Overall Study||121
7614357|NCT02422940|18747873|P1|NOT COMPLETED|Overall Study||121
7614358|NCT02422940|18747872|P2|COMPLETED|Overall Study||21
7614359|NCT02422940|18747873|P1|COMPLETED|Overall Study||31
7614360|NCT02422940|18747872|P2|STARTED|Overall Study||142
7614361|NCT02422940|18747873|P1|STARTED|Overall Study||152
7614362|NCT02422797|18747895|P2|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||18
7614363|NCT02422797|18747896|P1|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||23
7614364|NCT02422797|18747895|P2|COMPLETED|Late Switch Phase (Week 52 to Week 148)||221
7614365|NCT02422797|18747896|P1|COMPLETED|Late Switch Phase (Week 52 to Week 148)||222
7614366|NCT02422797|18747895|P2|STARTED|Late Switch Phase (Week 52 to Week 148)||239
7614367|NCT02422797|18747896|P1|STARTED|Late Switch Phase (Week 52 to Week 148)||245
7614368|NCT02422797|18747895|P2|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
7614369|NCT02422797|18747896|P1|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
7614370|NCT02422797|18747895|P2|COMPLETED|Early Switch Phase (Up to Week 52)||239
7614371|NCT02422797|18747896|P1|COMPLETED|Early Switch Phase (Up to Week 52)||245
7614372|NCT02422797|18747895|P2|STARTED|Early Switch Phase (Up to Week 52)||255
7614373|NCT02422797|18747896|P1|STARTED|Early Switch Phase (Up to Week 52)||261
7614374|NCT02422615|18747984|P2|NOT COMPLETED|Overall Study||166
7614375|NCT02422615|18747985|P1|NOT COMPLETED|Overall Study||280
7614376|NCT02422615|18747984|P2|COMPLETED|Overall Study||76
7614377|NCT02422615|18747985|P1|COMPLETED|Overall Study||204
7614378|NCT02422615|18747984|P2|Untreated|Overall Study||1
7614379|NCT02422615|18747985|P1|Untreated|Overall Study||1
7614380|NCT02422615|18747984|P2|STARTED|Overall Study||242
7614381|NCT02422615|18747985|P1|STARTED|Overall Study||484
7614382|NCT02422446|18747993|P2|NOT COMPLETED|Overall Study||0
7614383|NCT02422446|18747994|P1|NOT COMPLETED|Overall Study||0
7614384|NCT02422446|18747993|P2|COMPLETED|Overall Study||1
7614385|NCT02422446|18747994|P1|COMPLETED|Overall Study||1
7614386|NCT02422446|18747993|P2|STARTED|Overall Study||1
7614387|NCT02422446|18747994|P1|STARTED|Overall Study||1
7614388|NCT02422303|18748002|P2|NOT COMPLETED|Overall Study||1
7614389|NCT02422303|18748003|P1|NOT COMPLETED|Overall Study||1
7614390|NCT02422303|18748002|P2|COMPLETED|Overall Study||5
7614391|NCT02422303|18748003|P1|COMPLETED|Overall Study||5
7614392|NCT02422303|18748002|P2|STARTED|Overall Study||6
7614393|NCT02422303|18748003|P1|STARTED|Overall Study||6
7614394|NCT02422290|18748009|P1|NOT COMPLETED|Overall Study||0
7614395|NCT02422290|18748009|P1|COMPLETED|Overall Study||5
7614396|NCT02422290|18748009|P1|STARTED|Overall Study||5
7614397|NCT02422264|18748018|P2|NOT COMPLETED|Overall Study||4
7614398|NCT02422264|18748019|P1|NOT COMPLETED|Overall Study||5
7614399|NCT02422264|18748018|P2|COMPLETED|Overall Study||301
7614400|NCT02422264|18748019|P1|COMPLETED|Overall Study||291
7614401|NCT02422264|18748018|P2|STARTED|Overall Study||305
7614402|NCT02422264|18748019|P1|STARTED|Overall Study||296
7614403|NCT02422186|18748065|P2|NOT COMPLETED|Follow-up Phase (2 Weeks)||0
7614404|NCT02422186|18748066|P1|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
7614405|NCT02422186|18748065|P2|COMPLETED|Follow-up Phase (2 Weeks)||3
7614406|NCT02422186|18748066|P1|COMPLETED|Follow-up Phase (2 Weeks)||8
7614407|NCT02422186|18748065|P2|STARTED|Follow-up Phase (2 Weeks)||3
7614408|NCT02422186|18748066|P1|STARTED|Follow-up Phase (2 Weeks)||12
7614409|NCT02422186|18748065|P2|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
7614410|NCT02422186|18748066|P1|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||10
7614411|NCT02422186|18748065|P2|COMPLETED|Double-blind Induction Phase (4 Weeks)||60
7614412|NCT02422186|18748066|P1|COMPLETED|Double-blind Induction Phase (4 Weeks)||62
7614413|NCT02422186|18748065|P2|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||65
7614414|NCT02422186|18748066|P1|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||72
7614415|NCT02422186|18748065|P2|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||65
7614416|NCT02422186|18748066|P1|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||72
7614417|NCT02422186|18748065|P2|STARTED|Double-blind Induction Phase (4 Weeks)||66
7614418|NCT02422186|18748066|P1|STARTED|Double-blind Induction Phase (4 Weeks)||72
7614419|NCT02421952|18748088|P1|NOT COMPLETED|Overall Study||109
7614420|NCT02421952|18748088|P1|COMPLETED|Overall Study||99
7614421|NCT02421952|18748088|P1|Included in PACU Analysis|Overall Study||192
7614422|NCT02421952|18748088|P1|Excluded From PACU and Post-Analysis|Overall Study||16
7614423|NCT02421952|18748088|P1|STARTED|Overall Study||208
7614424|NCT02421939|18748097|P2|NOT COMPLETED|Overall Study||124
7614425|NCT02421939|18748098|P1|NOT COMPLETED|Overall Study||209
7614426|NCT02421939|18748097|P2|COMPLETED|Overall Study||0
7614427|NCT02421939|18748098|P1|COMPLETED|Overall Study||38
7614428|NCT02421939|18748097|P2|Treated|Overall Study||109
7614429|NCT02421939|18748098|P1|Treated|Overall Study||246
7614430|NCT02421939|18748097|P2|STARTED|Overall Study||124
7614431|NCT02421939|18748098|P1|STARTED|Overall Study||247
7614432|NCT02421887|18748126|P2|NOT COMPLETED|Overall Study||9
7614433|NCT02421887|18748127|P1|NOT COMPLETED|Overall Study||17
7614434|NCT02421887|18748126|P2|COMPLETED|Overall Study||77
7614435|NCT02421887|18748127|P1|COMPLETED|Overall Study||68
7614436|NCT02421887|18748126|P2|STARTED|Overall Study||86
7614437|NCT02421887|18748127|P1|STARTED|Overall Study||85
7614438|NCT02421666|18748153|P2|NOT COMPLETED|12-month Follow-up||16
7614439|NCT02421666|18748154|P1|NOT COMPLETED|12-month Follow-up||11
7614440|NCT02421666|18748153|P2|COMPLETED|12-month Follow-up||231
7614441|NCT02421666|18748154|P1|COMPLETED|12-month Follow-up||248
7614442|NCT02421666|18748153|P2|STARTED|12-month Follow-up||247
7614443|NCT02421666|18748154|P1|STARTED|12-month Follow-up||259
7614444|NCT02421666|18748153|P2|NOT COMPLETED|6-month Follow-up||13
7614445|NCT02421666|18748154|P1|NOT COMPLETED|6-month Follow-up||13
7614446|NCT02421666|18748153|P2|COMPLETED|6-month Follow-up||247
7614447|NCT02421666|18748154|P1|COMPLETED|6-month Follow-up||259
7614448|NCT02421666|18748153|P2|STARTED|6-month Follow-up||260
7614449|NCT02421666|18748154|P1|STARTED|6-month Follow-up||272
7614450|NCT02421666|18748153|P2|NOT COMPLETED|Overall Study Baseline||0
7614451|NCT02421666|18748154|P1|NOT COMPLETED|Overall Study Baseline||0
7614452|NCT02421666|18748153|P2|COMPLETED|Overall Study Baseline||260
7614453|NCT02421666|18748154|P1|COMPLETED|Overall Study Baseline||272
7614454|NCT02421666|18748153|P2|STARTED|Overall Study Baseline||260
7614455|NCT02421666|18748154|P1|STARTED|Overall Study Baseline||272
7614456|NCT02421588|18748162|P2|NOT COMPLETED|Overall Study||221
7614457|NCT02421588|18748163|P1|NOT COMPLETED|Overall Study||221
7614458|NCT02421588|18748162|P2|COMPLETED|Overall Study||0
7614459|NCT02421588|18748163|P1|COMPLETED|Overall Study||0
7614460|NCT02421588|18748162|P2|STARTED|Overall Study||221
7614461|NCT02421588|18748163|P1|STARTED|Overall Study||221
7614462|NCT02421510|18748186|P3|NOT COMPLETED|Overall Study||36
7614463|NCT02421510|18748187|P2|NOT COMPLETED|Overall Study||35
7614464|NCT02421510|18748188|P1|NOT COMPLETED|Overall Study||33
7614465|NCT02421510|18748186|P3|COMPLETED|Overall Study||227
7614466|NCT02421510|18748187|P2|COMPLETED|Overall Study||226
7614467|NCT02421510|18748188|P1|COMPLETED|Overall Study||225
7614468|NCT02421510|18748186|P3|Completed the 24 Week Treatment Period|Overall Study||240
7614469|NCT02421510|18748187|P2|Completed the 24 Week Treatment Period|Overall Study||239
7614470|NCT02421510|18748188|P1|Completed the 24 Week Treatment Period|Overall Study||236
7614471|NCT02421510|18748186|P3|STARTED|Overall Study||263
7614472|NCT02421510|18748187|P2|STARTED|Overall Study||261
7614473|NCT02421510|18748188|P1|STARTED|Overall Study||258
7614474|NCT02421419|18748220|P3|NOT COMPLETED|Overall Study||1
7614475|NCT02421419|18748221|P2|NOT COMPLETED|Overall Study||0
7614476|NCT02421419|18748222|P1|NOT COMPLETED|Overall Study||0
7614477|NCT02421419|18748220|P3|COMPLETED|Overall Study||8
7614478|NCT02421419|18748221|P2|COMPLETED|Overall Study||11
7614479|NCT02421419|18748222|P1|COMPLETED|Overall Study||6
7614480|NCT02421419|18748220|P3|STARTED|Overall Study||9
7614481|NCT02421419|18748221|P2|STARTED|Overall Study||11
7614482|NCT02421419|18748222|P1|STARTED|Overall Study||6
7614483|NCT02421354|18748239|P1|NOT COMPLETED|Overall Study||0
7614484|NCT02421354|18748239|P1|COMPLETED|Overall Study||8
7614485|NCT02421354|18748239|P1|STARTED|Overall Study||8
7614486|NCT02421224|18748252|P9|NOT COMPLETED|Overall Study||1
7614487|NCT02421224|18748253|P8|NOT COMPLETED|Overall Study||2
7614488|NCT02421224|18748254|P7|NOT COMPLETED|Overall Study||0
7614489|NCT02421224|18748255|P6|NOT COMPLETED|Overall Study||2
7614490|NCT02421224|18748256|P5|NOT COMPLETED|Overall Study||4
7614491|NCT02421224|18748257|P4|NOT COMPLETED|Overall Study||3
7614492|NCT02421224|18748258|P3|NOT COMPLETED|Overall Study||1
7614493|NCT02421224|18748259|P2|NOT COMPLETED|Overall Study||3
7614494|NCT02421224|18748260|P1|NOT COMPLETED|Overall Study||2
7614495|NCT02421224|18748252|P9|COMPLETED|Overall Study||495
7614496|NCT02421224|18748253|P8|COMPLETED|Overall Study||362
7614497|NCT02421224|18748254|P7|COMPLETED|Overall Study||489
7614498|NCT02421224|18748255|P6|COMPLETED|Overall Study||513
7614499|NCT02421224|18748256|P5|COMPLETED|Overall Study||491
7614500|NCT02421224|18748257|P4|COMPLETED|Overall Study||479
7614501|NCT02421224|18748258|P3|COMPLETED|Overall Study||507
7614502|NCT02421224|18748259|P2|COMPLETED|Overall Study||394
7614503|NCT02421224|18748260|P1|COMPLETED|Overall Study||442
7614504|NCT02421224|18748252|P9|STARTED|Overall Study||496
7614505|NCT02421224|18748253|P8|STARTED|Overall Study||364
7614506|NCT02421224|18748254|P7|STARTED|Overall Study||489
7614507|NCT02421224|18748255|P6|STARTED|Overall Study||515
7614508|NCT02421224|18748256|P5|STARTED|Overall Study||495
7614509|NCT02421224|18748257|P4|STARTED|Overall Study||482
7614510|NCT02421224|18748258|P3|STARTED|Overall Study||508
7614511|NCT02421224|18748259|P2|STARTED|Overall Study||397
7614512|NCT02421224|18748260|P1|STARTED|Overall Study||444
7614513|NCT02421211|18748309|P2|NOT COMPLETED|Overall Study||0
7614514|NCT02421211|18748310|P1|NOT COMPLETED|Overall Study||0
7614515|NCT02421211|18748309|P2|COMPLETED|Overall Study||20
7614516|NCT02421211|18748310|P1|COMPLETED|Overall Study||20
7614517|NCT02421211|18748309|P2|STARTED|Overall Study||20
7614518|NCT02421211|18748310|P1|STARTED|Overall Study||20
7614519|NCT02421172|18748356|P5|NOT COMPLETED|Period 2||1
7614520|NCT02421172|18748357|P4|NOT COMPLETED|Period 2||3
7614521|NCT02421172|18748358|P3|NOT COMPLETED|Period 2||7
7614522|NCT02421172|18748359|P2|NOT COMPLETED|Period 2||0
7614523|NCT02421172|18748360|P1|NOT COMPLETED|Period 2||0
7614524|NCT02421172|18748356|P5|COMPLETED|Period 2||14
7614525|NCT02421172|18748357|P4|COMPLETED|Period 2||13
7614526|NCT02421172|18748358|P3|COMPLETED|Period 2||22
7614527|NCT02421172|18748359|P2|COMPLETED|Period 2||0
7614528|NCT02421172|18748360|P1|COMPLETED|Period 2||0
7614529|NCT02421172|18748356|P5|STARTED|Period 2||15
7614530|NCT02421172|18748357|P4|STARTED|Period 2||16
7614531|NCT02421172|18748358|P3|STARTED|Period 2||29
7614532|NCT02421172|18748359|P2|STARTED|Period 2||0
7614533|NCT02421172|18748360|P1|STARTED|Period 2||0
7614534|NCT02421172|18748356|P5|NOT COMPLETED|Period 1||0
7614535|NCT02421172|18748357|P4|NOT COMPLETED|Period 1||0
7614536|NCT02421172|18748358|P3|NOT COMPLETED|Period 1||0
7614537|NCT02421172|18748359|P2|NOT COMPLETED|Period 1||2
7614538|NCT02421172|18748360|P1|NOT COMPLETED|Period 1||4
7614539|NCT02421172|18748356|P5|COMPLETED|Period 1||0
7614540|NCT02421172|18748357|P4|COMPLETED|Period 1||0
7614541|NCT02421172|18748358|P3|COMPLETED|Period 1||0
7614542|NCT02421172|18748359|P2|COMPLETED|Period 1||31
7614543|NCT02421172|18748360|P1|COMPLETED|Period 1||29
7614544|NCT02421172|18748356|P5|PK Analysis Set Period 1|Period 1||0
7614545|NCT02421172|18748357|P4|PK Analysis Set Period 1|Period 1||0
7614546|NCT02421172|18748358|P3|PK Analysis Set Period 1|Period 1||0
7614547|NCT02421172|18748359|P2|PK Analysis Set Period 1|Period 1||0
7614548|NCT02421172|18748360|P1|PK Analysis Set Period 1|Period 1||33
7614549|NCT02421172|18748356|P5|PD Analysis Set Period 1|Period 1||0
7614550|NCT02421172|18748357|P4|PD Analysis Set Period 1|Period 1||0
7614551|NCT02421172|18748358|P3|PD Analysis Set Period 1|Period 1||0
7614552|NCT02421172|18748359|P2|PD Analysis Set Period 1|Period 1||33
7614553|NCT02421172|18748360|P1|PD Analysis Set Period 1|Period 1||31
7614554|NCT02421172|18748356|P5|STARTED|Period 1||0
7614555|NCT02421172|18748357|P4|STARTED|Period 1||0
7614556|NCT02421172|18748358|P3|STARTED|Period 1||0
7614557|NCT02421172|18748359|P2|STARTED|Period 1||33
7614558|NCT02421172|18748360|P1|STARTED|Period 1||33
7614559|NCT02421146|18748387|P4|NOT COMPLETED|Overall Study||0
7614560|NCT02421146|18748388|P3|NOT COMPLETED|Overall Study||0
7614561|NCT02421146|18748389|P2|NOT COMPLETED|Overall Study||0
7614562|NCT02421146|18748390|P1|NOT COMPLETED|Overall Study||0
7614563|NCT02421146|18748387|P4|COMPLETED|Overall Study||3
7614564|NCT02421146|18748388|P3|COMPLETED|Overall Study||3
7614565|NCT02421146|18748389|P2|COMPLETED|Overall Study||4
7614566|NCT02421146|18748390|P1|COMPLETED|Overall Study||2
7614567|NCT02421146|18748387|P4|STARTED|Overall Study||3
7614568|NCT02421146|18748388|P3|STARTED|Overall Study||3
7614569|NCT02421146|18748389|P2|STARTED|Overall Study||4
7614570|NCT02421146|18748390|P1|STARTED|Overall Study||2
7614571|NCT02421120|18748404|P1|NOT COMPLETED|Overall Study||1
7614572|NCT02421120|18748404|P1|COMPLETED|Overall Study||20
7614573|NCT02421120|18748404|P1|STARTED|Overall Study||21
7614574|NCT02421094|18748414|P2|NOT COMPLETED|Overall Study||0
7614575|NCT02421094|18748415|P1|NOT COMPLETED|Overall Study||0
7614576|NCT02421094|18748414|P2|COMPLETED|Overall Study||15
7614577|NCT02421094|18748415|P1|COMPLETED|Overall Study||15
7614578|NCT02421094|18748414|P2|STARTED|Overall Study||15
7614579|NCT02421094|18748415|P1|STARTED|Overall Study||15
7614580|NCT02421055|18748427|P3|NOT COMPLETED|Overall Study||0
7614581|NCT02421055|18748428|P2|NOT COMPLETED|Overall Study||0
7614582|NCT02421055|18748429|P1|NOT COMPLETED|Overall Study||34
7614583|NCT02421055|18748427|P3|COMPLETED|Overall Study||74
7614584|NCT02421055|18748428|P2|COMPLETED|Overall Study||50
7614585|NCT02421055|18748429|P1|COMPLETED|Overall Study||0
7614586|NCT02421055|18748427|P3|Post-operative Complete Sample Set|Overall Study||14
7614587|NCT02421055|18748428|P2|Post-operative Complete Sample Set|Overall Study||13
7614588|NCT02421055|18748429|P1|Post-operative Complete Sample Set|Overall Study||0
7614589|NCT02421055|18748427|P3|Post-operative Serum Sample (Minimum)|Overall Study||26
7614590|NCT02421055|18748428|P2|Post-operative Serum Sample (Minimum)|Overall Study||23
7614591|NCT02421055|18748429|P1|Post-operative Serum Sample (Minimum)|Overall Study||0
7614592|NCT02421055|18748427|P3|Pre-operative Complete Sample Set|Overall Study||36
7614593|NCT02421055|18748428|P2|Pre-operative Complete Sample Set|Overall Study||22
7614594|NCT02421055|18748429|P1|Pre-operative Complete Sample Set|Overall Study||23
7614595|NCT02421055|18748427|P3|Pre-operative Serum Sample (Minimum)|Overall Study||74
7614596|NCT02421055|18748428|P2|Pre-operative Serum Sample (Minimum)|Overall Study||50
7614597|NCT02421055|18748429|P1|Pre-operative Serum Sample (Minimum)|Overall Study||34
7614598|NCT02421055|18748427|P3|STARTED|Overall Study||74
7614599|NCT02421055|18748428|P2|STARTED|Overall Study||50
7614600|NCT02421055|18748429|P1|STARTED|Overall Study||34
7614601|NCT02420951|18748456|P2|NOT COMPLETED|Overall Study||0
7614602|NCT02420951|18748457|P1|NOT COMPLETED|Overall Study||0
7614603|NCT02420951|18748456|P2|COMPLETED|Overall Study||25
7614604|NCT02420951|18748457|P1|COMPLETED|Overall Study||25
7614605|NCT02420951|18748456|P2|STARTED|Overall Study||25
7614606|NCT02420951|18748457|P1|STARTED|Overall Study||25
7614607|NCT02420873|18748476|P3|NOT COMPLETED|Overall Study||0
7614608|NCT02420873|18748477|P2|NOT COMPLETED|Overall Study||0
7614609|NCT02420873|18748478|P1|NOT COMPLETED|Overall Study||0
7614610|NCT02420873|18748476|P3|COMPLETED|Overall Study||0
7614611|NCT02420873|18748477|P2|COMPLETED|Overall Study||0
7614612|NCT02420873|18748478|P1|COMPLETED|Overall Study||9
7614613|NCT02420873|18748476|P3|STARTED|Overall Study||0
7614614|NCT02420873|18748477|P2|STARTED|Overall Study||0
7614615|NCT02420873|18748478|P1|STARTED|Overall Study||9
7614616|NCT02420821|18748488|P2|NOT COMPLETED|Overall Study||137
7614617|NCT02420821|18748489|P1|NOT COMPLETED|Overall Study||168
7614618|NCT02420821|18748488|P2|COMPLETED|Overall Study||317
7614619|NCT02420821|18748489|P1|COMPLETED|Overall Study||293
7614620|NCT02420821|18748488|P2|STARTED|Overall Study||454
7614621|NCT02420821|18748489|P1|STARTED|Overall Study||461
7614622|NCT02420691|18748557|P1|NOT COMPLETED|Overall Study||6
7614623|NCT02420691|18748557|P1|COMPLETED|Overall Study||14
7614624|NCT02420691|18748557|P1|STARTED|Overall Study||20
7614625|NCT02420379|18748567|P2|NOT COMPLETED|Overall Study||4
7614626|NCT02420379|18748568|P1|NOT COMPLETED|Overall Study||1
7614627|NCT02420379|18748567|P2|COMPLETED|Overall Study||3
7614628|NCT02420379|18748568|P1|COMPLETED|Overall Study||25
7614629|NCT02420379|18748567|P2|STARTED|Overall Study||7
7614630|NCT02420379|18748568|P1|STARTED|Overall Study||26
7614631|NCT02420353|18748586|P2|NOT COMPLETED|Overall Study||1
7614632|NCT02420353|18748587|P1|NOT COMPLETED|Overall Study||0
7614633|NCT02420353|18748586|P2|COMPLETED|Overall Study||9
7614634|NCT02420353|18748587|P1|COMPLETED|Overall Study||10
7614635|NCT02420353|18748586|P2|Allocation to Intervention|Overall Study||10
7614636|NCT02420353|18748587|P1|Allocation to Intervention|Overall Study||10
7614637|NCT02420353|18748586|P2|STARTED|Overall Study||10
7614638|NCT02420353|18748587|P1|STARTED|Overall Study||10
7614639|NCT02420327|18748679|P1|NOT COMPLETED|Overall Study||16
7614640|NCT02420327|18748679|P1|COMPLETED|Overall Study||27
7614641|NCT02420327|18748679|P1|STARTED|Overall Study||43
7614642|NCT02420262|18748715|P2|NOT COMPLETED|Overall Study||5
7614643|NCT02420262|18748716|P1|NOT COMPLETED|Overall Study||2
7614644|NCT02420262|18748715|P2|COMPLETED|Overall Study||249
7614645|NCT02420262|18748716|P1|COMPLETED|Overall Study||250
7614646|NCT02420262|18748715|P2|Exposed|Overall Study|One subject withdrew consent before exposure to trial product due to personal reasons.|253
7614647|NCT02420262|18748716|P1|Exposed|Overall Study||252
7614648|NCT02420262|18748715|P2|STARTED|Overall Study||254
7614649|NCT02420262|18748716|P1|STARTED|Overall Study||252
7614650|NCT02420210|18748730|P1|NOT COMPLETED|Overall Study||0
7614651|NCT02420210|18748730|P1|COMPLETED|Overall Study||2
7614652|NCT02420210|18748730|P1|STARTED|Overall Study||2
7614653|NCT02420093|18748742|P2|NOT COMPLETED|Overall Study||1
7614654|NCT02420093|18748743|P1|NOT COMPLETED|Overall Study||1
7614655|NCT02420093|18748742|P2|COMPLETED|Overall Study||7
7614656|NCT02420093|18748743|P1|COMPLETED|Overall Study||8
7614657|NCT02420093|18748742|P2|STARTED|Overall Study||8
7614658|NCT02420093|18748743|P1|STARTED|Overall Study||9
7614659|NCT02420041|18748759|P2|NOT COMPLETED|Overall Study||0
7614660|NCT02420041|18748760|P1|NOT COMPLETED|Overall Study||0
7614661|NCT02420041|18748759|P2|COMPLETED|Overall Study||14
7614662|NCT02420041|18748760|P1|COMPLETED|Overall Study||14
7614663|NCT02420041|18748759|P2|STARTED|Overall Study||14
7614664|NCT02420041|18748760|P1|STARTED|Overall Study||14
7614665|NCT02420015|18748786|P2|NOT COMPLETED|Overall Study||0
7614666|NCT02420015|18748787|P1|NOT COMPLETED|Overall Study||0
7614667|NCT02420015|18748786|P2|COMPLETED|Overall Study||13
7614668|NCT02420015|18748787|P1|COMPLETED|Overall Study||21
7614669|NCT02420015|18748786|P2|STARTED|Overall Study||13
7614670|NCT02420015|18748787|P1|STARTED|Overall Study||21
7614671|NCT02419937|18748805|P2|NOT COMPLETED|Overall Study||0
7614672|NCT02419937|18748806|P1|NOT COMPLETED|Overall Study||1
7614673|NCT02419937|18748805|P2|COMPLETED|Overall Study||16
7614674|NCT02419937|18748806|P1|COMPLETED|Overall Study||11
7614675|NCT02419937|18748805|P2|STARTED|Overall Study||16
7614676|NCT02419937|18748806|P1|STARTED|Overall Study||12
7614677|NCT02419924|18748812|P1|NOT COMPLETED|Overall Study||0
7614678|NCT02419924|18748812|P1|COMPLETED|Overall Study||12
7614679|NCT02419924|18748812|P1|STARTED|Overall Study||12
7614680|NCT02419807|18748819|P1|NOT COMPLETED|Overall Study||10
7614681|NCT02419807|18748819|P1|COMPLETED|Overall Study||92
7614682|NCT02419807|18748819|P1|STARTED|Overall Study||102
7614683|NCT02419755|18748825|P2|NOT COMPLETED|Overall Study||4
7614684|NCT02419755|18748826|P1|NOT COMPLETED|Overall Study||3
7614685|NCT02419755|18748825|P2|COMPLETED|Overall Study||2
7614686|NCT02419755|18748826|P1|COMPLETED|Overall Study||3
7614687|NCT02419755|18748825|P2|STARTED|Overall Study||6
7614688|NCT02419755|18748826|P1|STARTED|Overall Study||6
7614689|NCT02419690|18748852|P2|NOT COMPLETED|Overall Study||0
7614690|NCT02419690|18748853|P1|NOT COMPLETED|Overall Study||0
7614691|NCT02419690|18748852|P2|COMPLETED|Overall Study||122
7614692|NCT02419690|18748853|P1|COMPLETED|Overall Study||122
7614693|NCT02419690|18748852|P2|STARTED|Overall Study||122
7614694|NCT02419690|18748853|P1|STARTED|Overall Study||122
7614695|NCT02419612|18748867|P2|NOT COMPLETED|Long-term Treatment Period||22
7614696|NCT02419612|18748868|P1|NOT COMPLETED|Long-term Treatment Period||22
7614697|NCT02419612|18748867|P2|COMPLETED|Long-term Treatment Period||164
7614698|NCT02419612|18748868|P1|COMPLETED|Long-term Treatment Period||174
7614699|NCT02419612|18748867|P2|Received Treatment|Long-term Treatment Period||183
7614700|NCT02419612|18748868|P1|Received Treatment|Long-term Treatment Period||196
7614701|NCT02419612|18748867|P2|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|186
7614702|NCT02419612|18748868|P1|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|196
7614703|NCT02419612|18748867|P2|NOT COMPLETED|Short-term Treatment Period||23
7614704|NCT02419612|18748868|P1|NOT COMPLETED|Short-term Treatment Period||17
7614705|NCT02419612|18748867|P2|COMPLETED|Short-term Treatment Period||194
7614706|NCT02419612|18748868|P1|COMPLETED|Short-term Treatment Period||210
7614707|NCT02419612|18748867|P2|Recevied Treatment|Short-term Treatment Period||216
7614708|NCT02419612|18748868|P1|Recevied Treatment|Short-term Treatment Period||227
7614709|NCT02419612|18748867|P2|STARTED|Short-term Treatment Period||217
7614710|NCT02419612|18748868|P1|STARTED|Short-term Treatment Period||227
7614711|NCT02419573|18748890|P2|NOT COMPLETED|Overall Study||0
7614712|NCT02419573|18748891|P1|NOT COMPLETED|Overall Study||4
7614713|NCT02419573|18748890|P2|COMPLETED|Overall Study||1505
7614714|NCT02419573|18748891|P1|COMPLETED|Overall Study||1495
7614715|NCT02419573|18748890|P2|STARTED|Overall Study||1505
7614716|NCT02419573|18748891|P1|STARTED|Overall Study||1499
7614717|NCT02419547|18748903|P1|NOT COMPLETED|Overall Study||0
7614718|NCT02419547|18748903|P1|COMPLETED|Overall Study||11
7614719|NCT02419547|18748903|P1|STARTED|Overall Study||11
7614720|NCT02419521|18748907|P1|NOT COMPLETED|Overall Study||1
7614721|NCT02419521|18748907|P1|COMPLETED|Overall Study||74
7614722|NCT02419521|18748907|P1|STARTED|Overall Study||75
7614723|NCT02419508|18748921|P2|NOT COMPLETED|Overall Study||4
7614724|NCT02419508|18748922|P1|NOT COMPLETED|Overall Study||10
7614725|NCT02419508|18748921|P2|COMPLETED|Overall Study||88
7614726|NCT02419508|18748922|P1|COMPLETED|Overall Study||86
7614727|NCT02419508|18748921|P2|Safety Analysis Set|Overall Study||92
7614728|NCT02419508|18748922|P1|Safety Analysis Set|Overall Study||95
7614729|NCT02419508|18748921|P2|Full Analysis Set|Overall Study||92
7614730|NCT02419508|18748922|P1|Full Analysis Set|Overall Study||95
7614731|NCT02419508|18748921|P2|STARTED|Overall Study||92
7614732|NCT02419508|18748922|P1|STARTED|Overall Study||96
7614733|NCT02419469|18748940|P1|NOT COMPLETED|Overall Study||1
7614734|NCT02419469|18748940|P1|COMPLETED|Overall Study||0
7614735|NCT02419469|18748940|P1|STARTED|Overall Study||1
7614736|NCT02419313|18748944|P2|NOT COMPLETED|Second Intervention||0
7614737|NCT02419313|18748945|P1|NOT COMPLETED|Second Intervention||1
7614738|NCT02419313|18748944|P2|COMPLETED|Second Intervention||15
7614739|NCT02419313|18748945|P1|COMPLETED|Second Intervention||15
7614740|NCT02419313|18748944|P2|STARTED|Second Intervention||15
7614741|NCT02419313|18748945|P1|STARTED|Second Intervention||16
7614742|NCT02419313|18748944|P2|NOT COMPLETED|First Intervention||0
7614743|NCT02419313|18748945|P1|NOT COMPLETED|First Intervention||2
7614744|NCT02419313|18748944|P2|COMPLETED|First Intervention||15
7614745|NCT02419313|18748945|P1|COMPLETED|First Intervention||16
7614746|NCT02419313|18748944|P2|STARTED|First Intervention||15
7614747|NCT02419313|18748945|P1|STARTED|First Intervention||18
7614748|NCT02419001|18748957|P2|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
7614749|NCT02419001|18748958|P1|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
7614750|NCT02419001|18748957|P2|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
7614751|NCT02419001|18748958|P1|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
7614752|NCT02419001|18748957|P2|STARTED|Period 2- Ceftriaxone With SYN-004||5
7614753|NCT02419001|18748958|P1|STARTED|Period 2- Ceftriaxone With SYN-004||5
7614754|NCT02419001|18748957|P2|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0
7614755|NCT02419001|18748958|P1|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1
7614756|NCT02419001|18748957|P2|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
7614757|NCT02419001|18748958|P1|COMPLETED|Period 1- Ceftriaxone Without SYN-004|The Adverse Event (AE) was with ceftriaxone, not with Investigational Product (IP)|5
7614758|NCT02419001|18748957|P2|STARTED|Period 1- Ceftriaxone Without SYN-004||5
7614759|NCT02419001|18748958|P1|STARTED|Period 1- Ceftriaxone Without SYN-004||6
7614760|NCT02418910|18748968|P1|NOT COMPLETED|Overall Study||7
7614761|NCT02418910|18748968|P1|COMPLETED|Overall Study||43
7614762|NCT02418910|18748968|P1|STARTED|Overall Study||50
7614763|NCT02418819|18748976|P4|NOT COMPLETED|Overall Study||1
7614764|NCT02418819|18748977|P3|NOT COMPLETED|Overall Study||4
7614765|NCT02418819|18748978|P2|NOT COMPLETED|Overall Study||0
7614766|NCT02418819|18748979|P1|NOT COMPLETED|Overall Study||1
7614767|NCT02418819|18748976|P4|COMPLETED|Overall Study||28
7614768|NCT02418819|18748977|P3|COMPLETED|Overall Study||29
7614769|NCT02418819|18748978|P2|COMPLETED|Overall Study||16
7614770|NCT02418819|18748979|P1|COMPLETED|Overall Study||21
7614771|NCT02418819|18748976|P4|STARTED|Overall Study||29
7614772|NCT02418819|18748977|P3|STARTED|Overall Study||33
7614773|NCT02418819|18748978|P2|STARTED|Overall Study||16
7614774|NCT02418819|18748979|P1|STARTED|Overall Study||22
7614775|NCT02418754|18749022|P5|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
7614776|NCT02418754|18749023|P4|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
7614777|NCT02418754|18749024|P3|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||37
7614778|NCT02418754|18749025|P2|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||42
7614779|NCT02418754|18749026|P1|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||33
7614780|NCT02418754|18749022|P5|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
7614781|NCT02418754|18749023|P4|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
7614782|NCT02418754|18749024|P3|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||71
7614783|NCT02418754|18749025|P2|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||64
7614784|NCT02418754|18749026|P1|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||70
7614785|NCT02418754|18749022|P5|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
7614786|NCT02418754|18749023|P4|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
7614787|NCT02418754|18749024|P3|STARTED|Period 2 (Day 1 to Week 52/End of Study)||108
7614788|NCT02418754|18749025|P2|STARTED|Period 2 (Day 1 to Week 52/End of Study)||106
7614789|NCT02418754|18749026|P1|STARTED|Period 2 (Day 1 to Week 52/End of Study)||103
7614790|NCT02418754|18749022|P5|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
7614791|NCT02418754|18749023|P4|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
7614792|NCT02418754|18749024|P3|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
7614793|NCT02418754|18749025|P2|NOT COMPLETED|Period 1 (Day 1 to Week 12)||4
7614794|NCT02418754|18749026|P1|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
7614795|NCT02418754|18749022|P5|COMPLETED|Period 1 (Day 1 to Week 12)||0
7614796|NCT02418754|18749023|P4|COMPLETED|Period 1 (Day 1 to Week 12)||0
7614797|NCT02418754|18749024|P3|COMPLETED|Period 1 (Day 1 to Week 12)||200
7614798|NCT02418754|18749025|P2|COMPLETED|Period 1 (Day 1 to Week 12)||196
7614799|NCT02418754|18749026|P1|COMPLETED|Period 1 (Day 1 to Week 12)||101
7614800|NCT02418754|18749022|P5|STARTED|Period 1 (Day 1 to Week 12)||0
7614801|NCT02418754|18749023|P4|STARTED|Period 1 (Day 1 to Week 12)||0
7614802|NCT02418754|18749024|P3|STARTED|Period 1 (Day 1 to Week 12)||202
7614803|NCT02418754|18749025|P2|STARTED|Period 1 (Day 1 to Week 12)||200
7614804|NCT02418754|18749026|P1|STARTED|Period 1 (Day 1 to Week 12)||103
7614805|NCT02418676|18749060|P3|NOT COMPLETED|Overall Study||0
7614806|NCT02418676|18749061|P2|NOT COMPLETED|Overall Study||0
7614807|NCT02418676|18749062|P1|NOT COMPLETED|Overall Study||0
7614808|NCT02418676|18749060|P3|COMPLETED|Overall Study||5
7614809|NCT02418676|18749061|P2|COMPLETED|Overall Study||5
7614810|NCT02418676|18749062|P1|COMPLETED|Overall Study||5
7614811|NCT02418676|18749060|P3|STARTED|Overall Study||5
7614812|NCT02418676|18749061|P2|STARTED|Overall Study||5
7614813|NCT02418676|18749062|P1|STARTED|Overall Study||5
7614814|NCT02418585|18749075|P2|NOT COMPLETED|Follow-up Phase (24 Weeks)||25
7614815|NCT02418585|18749076|P1|NOT COMPLETED|Follow-up Phase (24 Weeks)||18
7614816|NCT02418585|18749075|P2|COMPLETED|Follow-up Phase (24 Weeks)||27
7614817|NCT02418585|18749076|P1|COMPLETED|Follow-up Phase (24 Weeks)||16
7614818|NCT02418585|18749075|P2|STARTED|Follow-up Phase (24 Weeks)||52
7614819|NCT02418585|18749076|P1|STARTED|Follow-up Phase (24 Weeks)||34
7614820|NCT02418585|18749075|P2|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||12
7614821|NCT02418585|18749076|P1|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||18
7614822|NCT02418585|18749075|P2|COMPLETED|Double Blind (DB) Phase (4 Weeks)||99
7614823|NCT02418585|18749076|P1|COMPLETED|Double Blind (DB) Phase (4 Weeks)||98
7614824|NCT02418585|18749075|P2|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
7614825|NCT02418585|18749076|P1|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||114
7614826|NCT02418585|18749075|P2|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
7614827|NCT02418585|18749076|P1|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||115
7614828|NCT02418585|18749075|P2|STARTED|Double Blind (DB) Phase (4 Weeks)||111
7614829|NCT02418585|18749076|P1|STARTED|Double Blind (DB) Phase (4 Weeks)||116
7614830|NCT02418546|18749117|P3|NOT COMPLETED|Overall Study||3
7614831|NCT02418546|18749118|P2|NOT COMPLETED|Overall Study||6
7614832|NCT02418546|18749119|P1|NOT COMPLETED|Overall Study||7
7614833|NCT02418546|18749117|P3|COMPLETED|Overall Study||23
7614834|NCT02418546|18749118|P2|COMPLETED|Overall Study||20
7614835|NCT02418546|18749119|P1|COMPLETED|Overall Study||19
7614836|NCT02418546|18749117|P3|STARTED|Overall Study||26
7614837|NCT02418546|18749118|P2|STARTED|Overall Study||26
7614838|NCT02418546|18749119|P1|STARTED|Overall Study||26
7614839|NCT02418468|18749132|P2|NOT COMPLETED|Overall Study||1
7614840|NCT02418468|18749133|P1|NOT COMPLETED|Overall Study||2
7614841|NCT02418468|18749132|P2|COMPLETED|Overall Study||10
7614842|NCT02418468|18749133|P1|COMPLETED|Overall Study||11
7614843|NCT02418468|18749132|P2|STARTED|Overall Study||11
7614844|NCT02418468|18749133|P1|STARTED|Overall Study||13
7614845|NCT02418455|18749139|P1|NOT COMPLETED|Continuation Period||7
7614846|NCT02418455|18749139|P1|COMPLETED|Continuation Period||0
7614847|NCT02418455|18749139|P1|STARTED|Continuation Period||7
7614848|NCT02418455|18749139|P1|NOT COMPLETED|48-Week Treatment Period||1
7614849|NCT02418455|18749139|P1|COMPLETED|48-Week Treatment Period||7
7614850|NCT02418455|18749139|P1|Emergency IND (eIND)|48-Week Treatment Period||1
7614851|NCT02418455|18749139|P1|STARTED|48-Week Treatment Period||8
7614852|NCT02418312|18749162|P2|NOT COMPLETED|Overall Study||0
7614853|NCT02418312|18749163|P1|NOT COMPLETED|Overall Study||0
7614854|NCT02418312|18749162|P2|COMPLETED|Overall Study||114
7614855|NCT02418312|18749163|P1|COMPLETED|Overall Study||114
7614856|NCT02418312|18749162|P2|STARTED|Overall Study||114
7614857|NCT02418312|18749163|P1|STARTED|Overall Study||114
7614858|NCT02418234|18749169|P1|NOT COMPLETED|Overall Study||0
7614859|NCT02418234|18749169|P1|COMPLETED|Overall Study||314
7614860|NCT02418234|18749169|P1|STARTED|Overall Study||314
7614861|NCT02418182|18749182|P2|NOT COMPLETED|Overall Study||17
7614862|NCT02418182|18749183|P1|NOT COMPLETED|Overall Study||18
7614863|NCT02418182|18749182|P2|COMPLETED|Overall Study||33
7614864|NCT02418182|18749183|P1|COMPLETED|Overall Study||31
7614865|NCT02418182|18749182|P2|STARTED|Overall Study||50
7614866|NCT02418182|18749183|P1|STARTED|Overall Study||49
7614867|NCT02418156|18749195|P1|NOT COMPLETED|Overall Study||17
7614868|NCT02418156|18749195|P1|COMPLETED|Overall Study||21
7614869|NCT02418156|18749195|P1|STARTED|Overall Study||38
7614870|NCT02418026|18749201|P2|NOT COMPLETED|Overall Study||0
7614871|NCT02418026|18749202|P1|NOT COMPLETED|Overall Study||0
7614872|NCT02418026|18749201|P2|COMPLETED|Overall Study||35
7614873|NCT02418026|18749202|P1|COMPLETED|Overall Study||44
7614874|NCT02418026|18749201|P2|STARTED|Overall Study||35
7614875|NCT02418026|18749202|P1|STARTED|Overall Study||44
7614876|NCT02418000|18749237|P5|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||4
7614877|NCT02418000|18749238|P4|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
7614878|NCT02418000|18749239|P3|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
7614879|NCT02418000|18749240|P2|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
7614880|NCT02418000|18749241|P1|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
7614881|NCT02418000|18749237|P5|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
7614882|NCT02418000|18749238|P4|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
7614883|NCT02418000|18749239|P3|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
7614884|NCT02418000|18749240|P2|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
7614885|NCT02418000|18749241|P1|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
7614886|NCT02418000|18749237|P5|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||4
7614887|NCT02418000|18749238|P4|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
7614888|NCT02418000|18749239|P3|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
7614889|NCT02418000|18749240|P2|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
7614890|NCT02418000|18749241|P1|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
7614891|NCT02418000|18749237|P5|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
7614892|NCT02418000|18749238|P4|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||3
7614893|NCT02418000|18749239|P3|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
7614894|NCT02418000|18749240|P2|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
7614895|NCT02418000|18749241|P1|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
7614896|NCT02418000|18749237|P5|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
7614897|NCT02418000|18749238|P4|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
7614898|NCT02418000|18749239|P3|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
7614899|NCT02418000|18749240|P2|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
7614900|NCT02418000|18749241|P1|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
7614901|NCT02418000|18749237|P5|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
7614902|NCT02418000|18749238|P4|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||3
7614903|NCT02418000|18749239|P3|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
7614904|NCT02418000|18749240|P2|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
7614905|NCT02418000|18749241|P1|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
7614906|NCT02418000|18749237|P5|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
7614907|NCT02418000|18749238|P4|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
7614908|NCT02418000|18749239|P3|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||3
7614909|NCT02418000|18749240|P2|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
7614910|NCT02418000|18749241|P1|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
7614911|NCT02418000|18749237|P5|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
7614912|NCT02418000|18749238|P4|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
7614913|NCT02418000|18749239|P3|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
7614914|NCT02418000|18749240|P2|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
7614915|NCT02418000|18749241|P1|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
7614916|NCT02418000|18749237|P5|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
7614917|NCT02418000|18749238|P4|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
7614918|NCT02418000|18749239|P3|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||3
7614919|NCT02418000|18749240|P2|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
7614920|NCT02418000|18749241|P1|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
7614921|NCT02418000|18749237|P5|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
7614922|NCT02418000|18749238|P4|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
7614923|NCT02418000|18749239|P3|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
7614924|NCT02418000|18749240|P2|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||10
7614925|NCT02418000|18749241|P1|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
7614926|NCT02418000|18749237|P5|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
7614927|NCT02418000|18749238|P4|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
7614928|NCT02418000|18749239|P3|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
7614929|NCT02418000|18749240|P2|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
7614930|NCT02418000|18749241|P1|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
7614931|NCT02418000|18749237|P5|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
7614932|NCT02418000|18749238|P4|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
7614933|NCT02418000|18749239|P3|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
7614934|NCT02418000|18749240|P2|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||10
7614935|NCT02418000|18749241|P1|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
7614936|NCT02418000|18749237|P5|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
7614937|NCT02418000|18749238|P4|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
7614938|NCT02418000|18749239|P3|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
7614939|NCT02418000|18749240|P2|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
7614940|NCT02418000|18749241|P1|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||7
7614941|NCT02418000|18749237|P5|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
7614942|NCT02418000|18749238|P4|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
7614943|NCT02418000|18749239|P3|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
7614944|NCT02418000|18749240|P2|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
7614945|NCT02418000|18749241|P1|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
7614946|NCT02418000|18749237|P5|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
7614947|NCT02418000|18749238|P4|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
7614948|NCT02418000|18749239|P3|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
7614949|NCT02418000|18749240|P2|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
7614950|NCT02418000|18749241|P1|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||7
7614951|NCT02417961|18749359|P1|NOT COMPLETED|Overall Study||4
7614952|NCT02417961|18749359|P1|COMPLETED|Overall Study||112
7614953|NCT02417961|18749359|P1|STARTED|Overall Study||116
7614954|NCT02417935|18749371|P2|NOT COMPLETED|Tapering Period||0
7614955|NCT02417935|18749372|P1|NOT COMPLETED|Tapering Period||0
7614956|NCT02417935|18749371|P2|COMPLETED|Tapering Period||142
7614957|NCT02417935|18749372|P1|COMPLETED|Tapering Period||134
7614958|NCT02417935|18749371|P2|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|142
7614959|NCT02417935|18749372|P1|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|134
7614960|NCT02417935|18749371|P2|NOT COMPLETED|Treatment Period||16
7614961|NCT02417935|18749372|P1|NOT COMPLETED|Treatment Period||21
7614962|NCT02417935|18749371|P2|COMPLETED|Treatment Period||137
7614963|NCT02417935|18749372|P1|COMPLETED|Treatment Period||130
7614964|NCT02417935|18749371|P2|Received at Least One Dose of Study Drug|Treatment Period||152
7614965|NCT02417935|18749372|P1|Received at Least One Dose of Study Drug|Treatment Period||151
7614966|NCT02417935|18749371|P2|STARTED|Treatment Period||153
7614967|NCT02417935|18749372|P1|STARTED|Treatment Period||151
7614968|NCT02417844|18749396|P2|NOT COMPLETED|Overall Study||0
7614969|NCT02417844|18749397|P1|NOT COMPLETED|Overall Study||0
7614970|NCT02417844|18749396|P2|COMPLETED|Overall Study||17
7614971|NCT02417844|18749397|P1|COMPLETED|Overall Study||17
7614972|NCT02417844|18749396|P2|STARTED|Overall Study||17
7614973|NCT02417844|18749397|P1|STARTED|Overall Study||17
7614974|NCT02417831|18749413|P2|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
7614975|NCT02417831|18749414|P1|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
7614976|NCT02417831|18749413|P2|COMPLETED|Period 2: Treatment Period 2 + Washout||17
7614977|NCT02417831|18749414|P1|COMPLETED|Period 2: Treatment Period 2 + Washout||17
7614978|NCT02417831|18749413|P2|STARTED|Period 2: Treatment Period 2 + Washout||17
7614979|NCT02417831|18749414|P1|STARTED|Period 2: Treatment Period 2 + Washout||17
7614980|NCT02417831|18749413|P2|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
7614981|NCT02417831|18749414|P1|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
7614982|NCT02417831|18749413|P2|COMPLETED|Period 1: Treatment Period 1 + Washout||17
7614983|NCT02417831|18749414|P1|COMPLETED|Period 1: Treatment Period 1 + Washout||17
7614984|NCT02417831|18749413|P2|STARTED|Period 1: Treatment Period 1 + Washout||17
7614985|NCT02417831|18749414|P1|STARTED|Period 1: Treatment Period 1 + Washout||17
7614986|NCT02417753|18749430|P1|NOT COMPLETED|Overall Study||1
7614987|NCT02417753|18749430|P1|COMPLETED|Overall Study||0
7614988|NCT02417753|18749430|P1|STARTED|Overall Study||1
7614989|NCT02417532|18749440|P1|NOT COMPLETED|Overall Study||0
7614990|NCT02417532|18749440|P1|COMPLETED|Overall Study||56
7614991|NCT02417532|18749440|P1|STARTED|Overall Study||56
7614992|NCT02417441|18749450|P2|NOT COMPLETED|Overall Study||19
7614993|NCT02417441|18749451|P1|NOT COMPLETED|Overall Study||52
7614994|NCT02417441|18749450|P2|COMPLETED|Overall Study||306
7614995|NCT02417441|18749451|P1|COMPLETED|Overall Study||593
7614996|NCT02417441|18749450|P2|STARTED|Overall Study||325
7614997|NCT02417441|18749451|P1|STARTED|Overall Study||645
7614998|NCT02417376|18749472|P2|NOT COMPLETED|Overall Study||10
7614999|NCT02417376|18749473|P1|NOT COMPLETED|Overall Study||5
7615000|NCT02417376|18749472|P2|COMPLETED|Overall Study||25
7615001|NCT02417376|18749473|P1|COMPLETED|Overall Study||30
7615002|NCT02417376|18749472|P2|STARTED|Overall Study||35
7615003|NCT02417376|18749473|P1|STARTED|Overall Study||35
7615004|NCT02417246|18749519|P2|NOT COMPLETED|Phase 4 2nd Generic Administered||0
7615005|NCT02417246|18749520|P1|NOT COMPLETED|Phase 4 2nd Generic Administered||0
7615006|NCT02417246|18749519|P2|COMPLETED|Phase 4 2nd Generic Administered||20
7615007|NCT02417246|18749520|P1|COMPLETED|Phase 4 2nd Generic Administered||18
7615008|NCT02417246|18749519|P2|STARTED|Phase 4 2nd Generic Administered||20
7615009|NCT02417246|18749520|P1|STARTED|Phase 4 2nd Generic Administered||18
7615010|NCT02417246|18749519|P2|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||0
7615011|NCT02417246|18749520|P1|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||1
7615012|NCT02417246|18749519|P2|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||20
7615013|NCT02417246|18749520|P1|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||18
7615014|NCT02417246|18749519|P2|STARTED|Phase 3 Brand Name Metoprolol ER #2||20
7615015|NCT02417246|18749520|P1|STARTED|Phase 3 Brand Name Metoprolol ER #2||19
7615016|NCT02417246|18749519|P2|NOT COMPLETED|Phase 2 1st Generic Administered||0
7615017|NCT02417246|18749520|P1|NOT COMPLETED|Phase 2 1st Generic Administered||1
7615018|NCT02417246|18749519|P2|COMPLETED|Phase 2 1st Generic Administered||20
7615019|NCT02417246|18749520|P1|COMPLETED|Phase 2 1st Generic Administered||19
7615020|NCT02417246|18749519|P2|STARTED|Phase 2 1st Generic Administered||20
7615021|NCT02417246|18749520|P1|STARTED|Phase 2 1st Generic Administered||20
7615022|NCT02417246|18749519|P2|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
7615023|NCT02417246|18749520|P1|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
7615024|NCT02417246|18749519|P2|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
7615025|NCT02417246|18749520|P1|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
7615026|NCT02417246|18749519|P2|STARTED|Phase 1 Brand Name Metoprolol ER||24
7615027|NCT02417246|18749520|P1|STARTED|Phase 1 Brand Name Metoprolol ER||24
7615028|NCT02417233|18749543|P3|NOT COMPLETED|Overall Study||59
7615029|NCT02417233|18749544|P2|NOT COMPLETED|Overall Study||51
7615030|NCT02417233|18749545|P1|NOT COMPLETED|Overall Study||36
7615031|NCT02417233|18749543|P3|COMPLETED|Overall Study||239
7615032|NCT02417233|18749544|P2|COMPLETED|Overall Study||238
7615033|NCT02417233|18749545|P1|COMPLETED|Overall Study||133
7615034|NCT02417233|18749543|P3|STARTED|Overall Study||298
7615035|NCT02417233|18749544|P2|STARTED|Overall Study||289
7615036|NCT02417233|18749545|P1|STARTED|Overall Study||169
7615037|NCT02417129|18749568|P2|NOT COMPLETED|Overall Study||0
7615038|NCT02417129|18749569|P1|NOT COMPLETED|Overall Study||0
7615039|NCT02417129|18749568|P2|COMPLETED|Overall Study||0
7615040|NCT02417129|18749569|P1|COMPLETED|Overall Study||2
7615041|NCT02417129|18749568|P2|STARTED|Overall Study||0
7615042|NCT02417129|18749569|P1|STARTED|Overall Study||2
7615043|NCT02417064|18749582|P3|NOT COMPLETED|Follow-up Phase (24 Weeks)||51
7615044|NCT02417064|18749583|P2|NOT COMPLETED|Follow-up Phase (24 Weeks)||42
7615045|NCT02417064|18749584|P1|NOT COMPLETED|Follow-up Phase (24 Weeks)||39
7615046|NCT02417064|18749582|P3|COMPLETED|Follow-up Phase (24 Weeks)||18
7615047|NCT02417064|18749583|P2|COMPLETED|Follow-up Phase (24 Weeks)||10
7615048|NCT02417064|18749584|P1|COMPLETED|Follow-up Phase (24 Weeks)||8
7615049|NCT02417064|18749582|P3|STARTED|Follow-up Phase (24 Weeks)||69
7615050|NCT02417064|18749583|P2|STARTED|Follow-up Phase (24 Weeks)||52
7615051|NCT02417064|18749584|P1|STARTED|Follow-up Phase (24 Weeks)||47
7615052|NCT02417064|18749582|P3|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
7615053|NCT02417064|18749583|P2|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||19
7615054|NCT02417064|18749584|P1|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
7615055|NCT02417064|18749582|P3|COMPLETED|Double-blind Induction Phase (4 Weeks)||107
7615056|NCT02417064|18749583|P2|COMPLETED|Double-blind Induction Phase (4 Weeks)||97
7615057|NCT02417064|18749584|P1|COMPLETED|Double-blind Induction Phase (4 Weeks)||111
7615058|NCT02417064|18749582|P3|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||113
7615059|NCT02417064|18749583|P2|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||116
7615060|NCT02417064|18749584|P1|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||115
7615061|NCT02417064|18749582|P3|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||113
7615062|NCT02417064|18749583|P2|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||114
7615063|NCT02417064|18749584|P1|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||115
7615064|NCT02417064|18749582|P3|STARTED|Double-blind Induction Phase (4 Weeks)||113
7615065|NCT02417064|18749583|P2|STARTED|Double-blind Induction Phase (4 Weeks)||116
7615066|NCT02417064|18749584|P1|STARTED|Double-blind Induction Phase (4 Weeks)||117
7615067|NCT02416973|18749643|P3|NOT COMPLETED|Overall Study||1
7615068|NCT02416973|18749644|P2|NOT COMPLETED|Overall Study||3
7615069|NCT02416973|18749645|P1|NOT COMPLETED|Overall Study||1
7615070|NCT02416973|18749643|P3|COMPLETED|Overall Study||13
7615071|NCT02416973|18749644|P2|COMPLETED|Overall Study||10
7615072|NCT02416973|18749645|P1|COMPLETED|Overall Study||13
7615073|NCT02416973|18749643|P3|STARTED|Overall Study||14
7615074|NCT02416973|18749644|P2|STARTED|Overall Study||13
7615075|NCT02416973|18749645|P1|STARTED|Overall Study||14
7615076|NCT02416934|18749655|P2|NOT COMPLETED|Overall Study||7
7615077|NCT02416934|18749656|P1|NOT COMPLETED|Overall Study||3
7615078|NCT02416934|18749655|P2|COMPLETED|Overall Study||31
7615079|NCT02416934|18749656|P1|COMPLETED|Overall Study||33
7615080|NCT02416934|18749655|P2|Last Participant Completed 1 yr|Overall Study||31
7615081|NCT02416934|18749656|P1|Last Participant Completed 1 yr|Overall Study||33
7615082|NCT02416934|18749655|P2|Double Blind (0-52 Weeks)|Overall Study||38
7615083|NCT02416934|18749656|P1|Double Blind (0-52 Weeks)|Overall Study||36
7615084|NCT02416934|18749655|P2|STARTED|Overall Study||38
7615085|NCT02416934|18749656|P1|STARTED|Overall Study||36
7615086|NCT02416908|18749671|P4|NOT COMPLETED|Maintenance Phase||0
7615087|NCT02416908|18749672|P3|NOT COMPLETED|Maintenance Phase||0
7615088|NCT02416908|18749673|P2|NOT COMPLETED|Maintenance Phase||0
7615089|NCT02416908|18749674|P1|NOT COMPLETED|Maintenance Phase||0
7615090|NCT02416908|18749671|P4|COMPLETED|Maintenance Phase||2
7615091|NCT02416908|18749672|P3|COMPLETED|Maintenance Phase||0
7615092|NCT02416908|18749673|P2|COMPLETED|Maintenance Phase||0
7615093|NCT02416908|18749674|P1|COMPLETED|Maintenance Phase||0
7615094|NCT02416908|18749671|P4|STARTED|Maintenance Phase||2
7615095|NCT02416908|18749672|P3|STARTED|Maintenance Phase||0
7615096|NCT02416908|18749673|P2|STARTED|Maintenance Phase||0
7615097|NCT02416908|18749674|P1|STARTED|Maintenance Phase||0
7615098|NCT02416908|18749671|P4|NOT COMPLETED|Dose Escalation Phase||0
7615099|NCT02416908|18749672|P3|NOT COMPLETED|Dose Escalation Phase||4
7615100|NCT02416908|18749673|P2|NOT COMPLETED|Dose Escalation Phase||0
7615101|NCT02416908|18749674|P1|NOT COMPLETED|Dose Escalation Phase||0
7615102|NCT02416908|18749671|P4|COMPLETED|Dose Escalation Phase||0
7615103|NCT02416908|18749672|P3|COMPLETED|Dose Escalation Phase||30
7615104|NCT02416908|18749673|P2|COMPLETED|Dose Escalation Phase||0
7615105|NCT02416908|18749674|P1|COMPLETED|Dose Escalation Phase||6
7615106|NCT02416908|18749671|P4|STARTED|Dose Escalation Phase||0
7615107|NCT02416908|18749672|P3|STARTED|Dose Escalation Phase||34
7615108|NCT02416908|18749673|P2|STARTED|Dose Escalation Phase||0
7615109|NCT02416908|18749674|P1|STARTED|Dose Escalation Phase||6
7615110|NCT02416791|18749692|P3|NOT COMPLETED|6 Months||1
7615111|NCT02416791|18749693|P2|NOT COMPLETED|6 Months||0
7615112|NCT02416791|18749694|P1|NOT COMPLETED|6 Months||0
7615113|NCT02416791|18749692|P3|COMPLETED|6 Months||2
7615114|NCT02416791|18749693|P2|COMPLETED|6 Months||3
7615115|NCT02416791|18749694|P1|COMPLETED|6 Months||3
7615116|NCT02416791|18749692|P3|STARTED|6 Months||3
7615117|NCT02416791|18749693|P2|STARTED|6 Months||3
7615118|NCT02416791|18749694|P1|STARTED|6 Months||3
7615119|NCT02416791|18749692|P3|NOT COMPLETED|6 Weeks||0
7615120|NCT02416791|18749693|P2|NOT COMPLETED|6 Weeks||0
7615121|NCT02416791|18749694|P1|NOT COMPLETED|6 Weeks||0
7615122|NCT02416791|18749692|P3|COMPLETED|6 Weeks||3
7615123|NCT02416791|18749693|P2|COMPLETED|6 Weeks||3
7615124|NCT02416791|18749694|P1|COMPLETED|6 Weeks||3
7615125|NCT02416791|18749692|P3|STARTED|6 Weeks||3
7615126|NCT02416791|18749693|P2|STARTED|6 Weeks||3
7615127|NCT02416791|18749694|P1|STARTED|6 Weeks||3
7615128|NCT02416713|18749736|P4|NOT COMPLETED|Overall Study||0
7615129|NCT02416713|18749737|P3|NOT COMPLETED|Overall Study||0
7615130|NCT02416713|18749738|P2|NOT COMPLETED|Overall Study||0
7615131|NCT02416713|18749739|P1|NOT COMPLETED|Overall Study||0
7615132|NCT02416713|18749736|P4|COMPLETED|Overall Study||10
7615133|NCT02416713|18749737|P3|COMPLETED|Overall Study||8
7615134|NCT02416713|18749738|P2|COMPLETED|Overall Study||9
7615135|NCT02416713|18749739|P1|COMPLETED|Overall Study||8
7615136|NCT02416713|18749736|P4|STARTED|Overall Study||10
7615137|NCT02416713|18749737|P3|STARTED|Overall Study||8
7615138|NCT02416713|18749738|P2|STARTED|Overall Study||9
7615139|NCT02416713|18749739|P1|STARTED|Overall Study||8
7615140|NCT02416622|18749752|P3|NOT COMPLETED|Overall Study||13
7615141|NCT02416622|18749753|P2|NOT COMPLETED|Overall Study||8
7615142|NCT02416622|18749754|P1|NOT COMPLETED|Overall Study||6
7615143|NCT02416622|18749752|P3|COMPLETED|Overall Study||0
7615144|NCT02416622|18749753|P2|COMPLETED|Overall Study||0
7615145|NCT02416622|18749754|P1|COMPLETED|Overall Study||0
7615146|NCT02416622|18749752|P3|Started Long-Term Follow-Up|Overall Study||13
7615147|NCT02416622|18749753|P2|Started Long-Term Follow-Up|Overall Study||8
7615148|NCT02416622|18749754|P1|Started Long-Term Follow-Up|Overall Study||6
7615149|NCT02416622|18749752|P3|Completed Month 12|Overall Study||13
7615150|NCT02416622|18749753|P2|Completed Month 12|Overall Study||8
7615151|NCT02416622|18749754|P1|Completed Month 12|Overall Study||6
7615152|NCT02416622|18749752|P3|STARTED|Overall Study||13
7615153|NCT02416622|18749753|P2|STARTED|Overall Study||8
7615154|NCT02416622|18749754|P1|STARTED|Overall Study||6
7615155|NCT02416193|18749773|P2|NOT COMPLETED|Overall Study||0
7615156|NCT02416193|18749774|P1|NOT COMPLETED|Overall Study||0
7615157|NCT02416193|18749773|P2|COMPLETED|Overall Study||15
7615158|NCT02416193|18749774|P1|COMPLETED|Overall Study||15
7615159|NCT02416193|18749773|P2|STARTED|Overall Study||15
7615160|NCT02416193|18749774|P1|STARTED|Overall Study||15
7615161|NCT02416180|18749792|P1|NOT COMPLETED|Overall Study||1
7615162|NCT02416180|18749792|P1|COMPLETED|Overall Study||110
7615163|NCT02416180|18749792|P1|STARTED|Overall Study||111
7615164|NCT02416102|18749802|P3|NOT COMPLETED|Overall Study||0
7615165|NCT02416102|18749803|P2|NOT COMPLETED|Overall Study||8
7615166|NCT02416102|18749804|P1|NOT COMPLETED|Overall Study||9
7615167|NCT02416102|18749802|P3|COMPLETED|Overall Study||0
7615168|NCT02416102|18749803|P2|COMPLETED|Overall Study||7
7615169|NCT02416102|18749804|P1|COMPLETED|Overall Study||7
7615170|NCT02416102|18749802|P3|STARTED|Overall Study||0
7615171|NCT02416102|18749803|P2|STARTED|Overall Study||15
7615172|NCT02416102|18749804|P1|STARTED|Overall Study||16
7615173|NCT02416011|18749821|P3|NOT COMPLETED|Overall Study||53
7615174|NCT02416011|18749822|P2|NOT COMPLETED|Overall Study||53
7615175|NCT02416011|18749823|P1|NOT COMPLETED|Overall Study||14
7615176|NCT02416011|18749821|P3|COMPLETED|Overall Study||1114
7615177|NCT02416011|18749822|P2|COMPLETED|Overall Study||1101
7615178|NCT02416011|18749823|P1|COMPLETED|Overall Study||561
7615179|NCT02416011|18749821|P3|STARTED|Overall Study||1167
7615180|NCT02416011|18749822|P2|STARTED|Overall Study||1154
7615181|NCT02416011|18749823|P1|STARTED|Overall Study||575
7615182|NCT02415998|18749844|P1|NOT COMPLETED|Overall Study||5
7615183|NCT02415998|18749844|P1|COMPLETED|Overall Study||20
7615184|NCT02415998|18749844|P1|STARTED|Overall Study||25
7615185|NCT02415959|18749853|P5|NOT COMPLETED|Overall Study||0
7615186|NCT02415959|18749854|P4|NOT COMPLETED|Overall Study||1
7615187|NCT02415959|18749855|P3|NOT COMPLETED|Overall Study||0
7615188|NCT02415959|18749856|P2|NOT COMPLETED|Overall Study||1
7615189|NCT02415959|18749857|P1|NOT COMPLETED|Overall Study||0
7615190|NCT02415959|18749853|P5|COMPLETED|Overall Study||14
7615191|NCT02415959|18749854|P4|COMPLETED|Overall Study||13
7615192|NCT02415959|18749855|P3|COMPLETED|Overall Study||14
7615193|NCT02415959|18749856|P2|COMPLETED|Overall Study||13
7615194|NCT02415959|18749857|P1|COMPLETED|Overall Study||14
7615195|NCT02415959|18749853|P5|STARTED|Overall Study||14
7615196|NCT02415959|18749854|P4|STARTED|Overall Study||14
7615197|NCT02415959|18749855|P3|STARTED|Overall Study||14
7615198|NCT02415959|18749856|P2|STARTED|Overall Study||14
7615199|NCT02415959|18749857|P1|STARTED|Overall Study||14
7615200|NCT02415855|18749891|P2|NOT COMPLETED|Overall Study||2
7615201|NCT02415855|18749892|P1|NOT COMPLETED|Overall Study||3
7615202|NCT02415855|18749891|P2|COMPLETED|Overall Study||62
7615203|NCT02415855|18749892|P1|COMPLETED|Overall Study||34
7615204|NCT02415855|18749891|P2|STARTED|Overall Study||64
7615205|NCT02415855|18749892|P1|STARTED|Overall Study||37
7615206|NCT02415842|18749919|P13|NOT COMPLETED|Overall Study||0
7615207|NCT02415842|18749920|P12|NOT COMPLETED|Overall Study||0
7615208|NCT02415842|18749921|P11|NOT COMPLETED|Overall Study||0
7615209|NCT02415842|18749922|P10|NOT COMPLETED|Overall Study||0
7615210|NCT02415842|18749923|P9|NOT COMPLETED|Overall Study||0
7615211|NCT02415842|18749924|P8|NOT COMPLETED|Overall Study||0
7615212|NCT02415842|18749925|P7|NOT COMPLETED|Overall Study||0
7615213|NCT02415842|18749926|P6|NOT COMPLETED|Overall Study||0
7615214|NCT02415842|18749927|P5|NOT COMPLETED|Overall Study||0
7615215|NCT02415842|18749928|P4|NOT COMPLETED|Overall Study||0
7615216|NCT02415842|18749929|P3|NOT COMPLETED|Overall Study||0
7615217|NCT02415842|18749930|P2|NOT COMPLETED|Overall Study||0
7615218|NCT02415842|18749931|P1|NOT COMPLETED|Overall Study||0
7615219|NCT02415842|18749919|P13|COMPLETED|Overall Study||20
7615220|NCT02415842|18749920|P12|COMPLETED|Overall Study||33
7615221|NCT02415842|18749921|P11|COMPLETED|Overall Study||49
7615222|NCT02415842|18749922|P10|COMPLETED|Overall Study||53
7615223|NCT02415842|18749923|P9|COMPLETED|Overall Study||29
7615224|NCT02415842|18749924|P8|COMPLETED|Overall Study||26
7615225|NCT02415842|18749925|P7|COMPLETED|Overall Study||30
7615226|NCT02415842|18749926|P6|COMPLETED|Overall Study||30
7615227|NCT02415842|18749927|P5|COMPLETED|Overall Study||30
7615228|NCT02415842|18749928|P4|COMPLETED|Overall Study||27
7615229|NCT02415842|18749929|P3|COMPLETED|Overall Study||29
7615230|NCT02415842|18749930|P2|COMPLETED|Overall Study||29
7615231|NCT02415842|18749931|P1|COMPLETED|Overall Study||29
7615232|NCT02415842|18749919|P13|STARTED|Overall Study||20
7615233|NCT02415842|18749920|P12|STARTED|Overall Study||33
7615234|NCT02415842|18749921|P11|STARTED|Overall Study||49
7615235|NCT02415842|18749922|P10|STARTED|Overall Study||53
7615236|NCT02415842|18749923|P9|STARTED|Overall Study||29
7615237|NCT02415842|18749924|P8|STARTED|Overall Study||26
7615238|NCT02415842|18749925|P7|STARTED|Overall Study||30
7615239|NCT02415842|18749926|P6|STARTED|Overall Study||30
7615240|NCT02415842|18749927|P5|STARTED|Overall Study||30
7615241|NCT02415842|18749928|P4|STARTED|Overall Study||27
7615242|NCT02415842|18749929|P3|STARTED|Overall Study||29
7615243|NCT02415842|18749930|P2|STARTED|Overall Study||29
7615244|NCT02415842|18749931|P1|STARTED|Overall Study||29
7615245|NCT02415608|18750272|P2|NOT COMPLETED|Overall Study||0
7615246|NCT02415608|18750273|P1|NOT COMPLETED|Overall Study||0
7615247|NCT02415608|18750272|P2|COMPLETED|Overall Study||1
7615248|NCT02415608|18750273|P1|COMPLETED|Overall Study||3
7615249|NCT02415608|18750272|P2|STARTED|Overall Study||1
7615250|NCT02415608|18750273|P1|STARTED|Overall Study||3
7615251|NCT02415595|18750303|P4|NOT COMPLETED|Overall Study||53
7615252|NCT02415595|18750304|P3|NOT COMPLETED|Overall Study||51
7615253|NCT02415595|18750305|P2|NOT COMPLETED|Overall Study||52
7615254|NCT02415595|18750306|P1|NOT COMPLETED|Overall Study||50
7615255|NCT02415595|18750303|P4|COMPLETED|Overall Study||0
7615256|NCT02415595|18750304|P3|COMPLETED|Overall Study||0
7615257|NCT02415595|18750305|P2|COMPLETED|Overall Study||0
7615258|NCT02415595|18750306|P1|COMPLETED|Overall Study||0
7615259|NCT02415595|18750303|P4|STARTED|Overall Study||53
7615260|NCT02415595|18750304|P3|STARTED|Overall Study||51
7615261|NCT02415595|18750305|P2|STARTED|Overall Study||52
7615262|NCT02415595|18750306|P1|STARTED|Overall Study||50
7615263|NCT02415439|18750378|P13|NOT COMPLETED|Overall Study||0
7615264|NCT02415439|18750379|P12|NOT COMPLETED|Overall Study||0
7615265|NCT02415439|18750380|P11|NOT COMPLETED|Overall Study||0
7615266|NCT02415439|18750381|P10|NOT COMPLETED|Overall Study||0
7615267|NCT02415439|18750382|P9|NOT COMPLETED|Overall Study||1
7615268|NCT02415439|18750383|P8|NOT COMPLETED|Overall Study||0
7615269|NCT02415439|18750384|P7|NOT COMPLETED|Overall Study||0
7615270|NCT02415439|18750385|P6|NOT COMPLETED|Overall Study||0
7615271|NCT02415439|18750386|P5|NOT COMPLETED|Overall Study||0
7615272|NCT02415439|18750387|P4|NOT COMPLETED|Overall Study||0
7615273|NCT02415439|18750388|P3|NOT COMPLETED|Overall Study||0
7615274|NCT02415439|18750389|P2|NOT COMPLETED|Overall Study||0
7615275|NCT02415439|18750390|P1|NOT COMPLETED|Overall Study||0
7615276|NCT02415439|18750378|P13|COMPLETED|Overall Study||8
7615277|NCT02415439|18750379|P12|COMPLETED|Overall Study||6
7615278|NCT02415439|18750380|P11|COMPLETED|Overall Study||6
7615279|NCT02415439|18750381|P10|COMPLETED|Overall Study||6
7615280|NCT02415439|18750382|P9|COMPLETED|Overall Study||5
7615281|NCT02415439|18750383|P8|COMPLETED|Overall Study||12
7615282|NCT02415439|18750384|P7|COMPLETED|Overall Study||6
7615283|NCT02415439|18750385|P6|COMPLETED|Overall Study||6
7615284|NCT02415439|18750386|P5|COMPLETED|Overall Study||6
7615285|NCT02415439|18750387|P4|COMPLETED|Overall Study||6
7615286|NCT02415439|18750388|P3|COMPLETED|Overall Study||6
7615287|NCT02415439|18750389|P2|COMPLETED|Overall Study||6
7615288|NCT02415439|18750390|P1|COMPLETED|Overall Study||6
7615289|NCT02415439|18750378|P13|STARTED|Overall Study||8
7615290|NCT02415439|18750379|P12|STARTED|Overall Study||6
7615291|NCT02415439|18750380|P11|STARTED|Overall Study||6
7615292|NCT02415439|18750381|P10|STARTED|Overall Study||6
7615293|NCT02415439|18750382|P9|STARTED|Overall Study||6
7615294|NCT02415439|18750383|P8|STARTED|Overall Study||12
7615295|NCT02415439|18750384|P7|STARTED|Overall Study||6
7615296|NCT02415439|18750385|P6|STARTED|Overall Study||6
7615297|NCT02415439|18750386|P5|STARTED|Overall Study||6
7615298|NCT02415439|18750387|P4|STARTED|Overall Study||6
7615299|NCT02415439|18750388|P3|STARTED|Overall Study||6
7615300|NCT02415439|18750389|P2|STARTED|Overall Study||6
7615301|NCT02415439|18750390|P1|STARTED|Overall Study||6
7615302|NCT02415400|18750448|P4|NOT COMPLETED|Overall Study||83
7615303|NCT02415400|18750449|P3|NOT COMPLETED|Overall Study||85
7615304|NCT02415400|18750450|P2|NOT COMPLETED|Overall Study||62
7615305|NCT02415400|18750451|P1|NOT COMPLETED|Overall Study||66
7615306|NCT02415400|18750448|P4|COMPLETED|Overall Study||1071
7615307|NCT02415400|18750449|P3|COMPLETED|Overall Study||1069
7615308|NCT02415400|18750450|P2|COMPLETED|Overall Study||1091
7615309|NCT02415400|18750451|P1|COMPLETED|Overall Study||1087
7615310|NCT02415400|18750448|P4|STARTED|Overall Study||1154
7615311|NCT02415400|18750449|P3|STARTED|Overall Study||1154
7615312|NCT02415400|18750450|P2|STARTED|Overall Study||1153
7615313|NCT02415400|18750451|P1|STARTED|Overall Study||1153
7615314|NCT02415244|18750477|P2|NOT COMPLETED|Overall Study||0
7615315|NCT02415244|18750478|P1|NOT COMPLETED|Overall Study||0
7615316|NCT02415244|18750477|P2|COMPLETED|Overall Study||25
7615317|NCT02415244|18750478|P1|COMPLETED|Overall Study||50
7615318|NCT02415244|18750477|P2|STARTED|Overall Study||25
7615319|NCT02415244|18750478|P1|STARTED|Overall Study||50
7615320|NCT02415166|18750488|P4|NOT COMPLETED|Overall Study||0
7615321|NCT02415166|18750489|P3|NOT COMPLETED|Overall Study||0
7615322|NCT02415166|18750490|P2|NOT COMPLETED|Overall Study||0
7615323|NCT02415166|18750491|P1|NOT COMPLETED|Overall Study||0
7615324|NCT02415166|18750488|P4|COMPLETED|Overall Study||0
7615325|NCT02415166|18750489|P3|COMPLETED|Overall Study||0
7615326|NCT02415166|18750490|P2|COMPLETED|Overall Study||0
7615327|NCT02415166|18750491|P1|COMPLETED|Overall Study||6
7615328|NCT02415166|18750488|P4|STARTED|Overall Study||0
7615329|NCT02415166|18750489|P3|STARTED|Overall Study||0
7615330|NCT02415166|18750490|P2|STARTED|Overall Study||0
7615331|NCT02415166|18750491|P1|STARTED|Overall Study||6
7615332|NCT02415127|18750519|P2|NOT COMPLETED|Overall Study||0
7615333|NCT02415127|18750520|P1|NOT COMPLETED|Overall Study||1
7615334|NCT02415127|18750519|P2|COMPLETED|Overall Study||45
7615335|NCT02415127|18750520|P1|COMPLETED|Overall Study||46
7615336|NCT02415127|18750519|P2|STARTED|Overall Study||45
7615337|NCT02415127|18750520|P1|STARTED|Overall Study||47
7615338|NCT02414958|18750537|P3|NOT COMPLETED|Overall Study||14
7615339|NCT02414958|18750538|P2|NOT COMPLETED|Overall Study||20
7615340|NCT02414958|18750539|P1|NOT COMPLETED|Overall Study||32
7615341|NCT02414958|18750537|P3|COMPLETED|Overall Study||230
7615342|NCT02414958|18750538|P2|COMPLETED|Overall Study||223
7615343|NCT02414958|18750539|P1|COMPLETED|Overall Study||211
7615344|NCT02414958|18750537|P3|STARTED|Overall Study||244
7615345|NCT02414958|18750538|P2|STARTED|Overall Study||243
7615346|NCT02414958|18750539|P1|STARTED|Overall Study||243
7615347|NCT02414854|18750572|P4|NOT COMPLETED|Overall Study||51
7615348|NCT02414854|18750573|P3|NOT COMPLETED|Overall Study||20
7615349|NCT02414854|18750574|P2|NOT COMPLETED|Overall Study||45
7615350|NCT02414854|18750575|P1|NOT COMPLETED|Overall Study||22
7615351|NCT02414854|18750572|P4|COMPLETED|Overall Study||582
7615352|NCT02414854|18750573|P3|COMPLETED|Overall Study||301
7615353|NCT02414854|18750574|P2|COMPLETED|Overall Study||586
7615354|NCT02414854|18750575|P1|COMPLETED|Overall Study||295
7615355|NCT02414854|18750572|P4|Treated|Overall Study|1 got other treatment (dupilumab 200) than assigned + was allocated to that in AE table|632
7615356|NCT02414854|18750573|P3|Treated|Overall Study||321
7615357|NCT02414854|18750574|P2|Treated|Overall Study||629
7615358|NCT02414854|18750575|P1|Treated|Overall Study|2 got other treatment (1 each dupilumab 200+300) than assigned + were allocated to those in AE table|315
7615359|NCT02414854|18750572|P4|STARTED|Overall Study||633
7615360|NCT02414854|18750573|P3|STARTED|Overall Study||321
7615361|NCT02414854|18750574|P2|STARTED|Overall Study||631
7615362|NCT02414854|18750575|P1|STARTED|Overall Study||317
7615363|NCT02414841|18750739|P2|NOT COMPLETED|Overall Study||33
7615364|NCT02414841|18750740|P1|NOT COMPLETED|Overall Study||56
7615365|NCT02414841|18750739|P2|COMPLETED|Overall Study||175
7615366|NCT02414841|18750740|P1|COMPLETED|Overall Study||349
7615367|NCT02414841|18750739|P2|STARTED|Overall Study||208
7615368|NCT02414841|18750740|P1|STARTED|Overall Study||405
7615369|NCT02414828|18750752|P4|NOT COMPLETED|Overall Study||2
7615370|NCT02414828|18750753|P3|NOT COMPLETED|Overall Study||1
7615371|NCT02414828|18750754|P2|NOT COMPLETED|Overall Study||1
7615372|NCT02414828|18750755|P1|NOT COMPLETED|Overall Study||0
7615373|NCT02414828|18750752|P4|COMPLETED|Overall Study||29
7615374|NCT02414828|18750753|P3|COMPLETED|Overall Study||19
7615375|NCT02414828|18750754|P2|COMPLETED|Overall Study||9
7615376|NCT02414828|18750755|P1|COMPLETED|Overall Study||11
7615377|NCT02414828|18750752|P4|STARTED|Overall Study||31
7615378|NCT02414828|18750753|P3|STARTED|Overall Study||20
7615379|NCT02414828|18750754|P2|STARTED|Overall Study||10
7615380|NCT02414828|18750755|P1|STARTED|Overall Study||11
7615381|NCT02414698|18750795|P2|NOT COMPLETED|Overall Study||0
7615382|NCT02414698|18750796|P1|NOT COMPLETED|Overall Study||0
7615383|NCT02414698|18750795|P2|COMPLETED|Overall Study||1
7615384|NCT02414698|18750796|P1|COMPLETED|Overall Study||3
7615385|NCT02414698|18750795|P2|STARTED|Overall Study||1
7615386|NCT02414698|18750796|P1|STARTED|Overall Study||3
7615387|NCT02414633|18750806|P1|NOT COMPLETED|Overall Study||0
7615388|NCT02414633|18750806|P1|COMPLETED|Overall Study||148
7615389|NCT02414633|18750806|P1|STARTED|Overall Study||148
7615390|NCT02414243|18750829|P2|NOT COMPLETED|Overall Study||4
7615391|NCT02414243|18750830|P1|NOT COMPLETED|Overall Study||6
7615392|NCT02414243|18750829|P2|COMPLETED|Overall Study||17
7615393|NCT02414243|18750830|P1|COMPLETED|Overall Study||13
7615394|NCT02414243|18750829|P2|Entered Open Challenge at Home|Overall Study||20
7615395|NCT02414243|18750830|P1|Entered Open Challenge at Home|Overall Study||17
7615396|NCT02414243|18750829|P2|Moved to the Other Group|Overall Study||20
7615397|NCT02414243|18750830|P1|Moved to the Other Group|Overall Study||17
7615398|NCT02414243|18750829|P2|STARTED|Overall Study||21
7615399|NCT02414243|18750830|P1|STARTED|Overall Study||19
7615400|NCT02414204|18750839|P2|NOT COMPLETED|Overall Study||0
7615401|NCT02414204|18750840|P1|NOT COMPLETED|Overall Study||0
7615402|NCT02414204|18750839|P2|COMPLETED|Overall Study||2
7615403|NCT02414204|18750840|P1|COMPLETED|Overall Study||2
7615404|NCT02414204|18750839|P2|STARTED|Overall Study||2
7615405|NCT02414204|18750840|P1|STARTED|Overall Study||2
7615406|NCT02414152|18750848|P1|NOT COMPLETED|Overall Study||2
7615407|NCT02414152|18750848|P1|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0
7615408|NCT02414152|18750848|P1|STARTED|Overall Study||2
7615409|NCT02413996|18750854|P2|NOT COMPLETED|Overall Study||2
7615410|NCT02413996|18750855|P1|NOT COMPLETED|Overall Study||9
7615411|NCT02413996|18750854|P2|COMPLETED|Overall Study||39
7615412|NCT02413996|18750855|P1|COMPLETED|Overall Study||35
7615413|NCT02413996|18750854|P2|STARTED|Overall Study||41
7615414|NCT02413996|18750855|P1|STARTED|Overall Study||44
7615415|NCT02413918|18750877|P1|NOT COMPLETED|Overall Study||25
7615416|NCT02413918|18750877|P1|COMPLETED|Overall Study||16
7615417|NCT02413918|18750877|P1|STARTED|Overall Study||41
7615418|NCT02413879|18750884|P1|NOT COMPLETED|Overall Study||0
7615419|NCT02413879|18750884|P1|COMPLETED|Overall Study||86
7615420|NCT02413879|18750884|P1|STARTED|Overall Study||86
7615421|NCT02413684|18750890|P1|NOT COMPLETED|Overall Study||13
7615422|NCT02413684|18750890|P1|COMPLETED|Overall Study||40
7615423|NCT02413684|18750890|P1|STARTED|Overall Study||53
7615424|NCT02413593|18750900|P1|NOT COMPLETED|Overall Study||4
7615425|NCT02413593|18750900|P1|COMPLETED|Overall Study||107
7615426|NCT02413593|18750900|P1|STARTED|Overall Study||111
7615427|NCT02413580|18750909|P1|NOT COMPLETED|Overall Study||3
7615428|NCT02413580|18750909|P1|COMPLETED|Overall Study||46
7615429|NCT02413580|18750909|P1|STARTED|Overall Study||49
7615430|NCT02413489|18750919|P3|NOT COMPLETED|Overall Study||5
7615431|NCT02413489|18750920|P2|NOT COMPLETED|Overall Study||16
7615432|NCT02413489|18750921|P1|NOT COMPLETED|Overall Study||15
7615433|NCT02413489|18750919|P3|COMPLETED|Overall Study||0
7615434|NCT02413489|18750920|P2|COMPLETED|Overall Study||0
7615435|NCT02413489|18750921|P1|COMPLETED|Overall Study||0
7615436|NCT02413489|18750919|P3|STARTED|Overall Study||5
7615437|NCT02413489|18750920|P2|STARTED|Overall Study||16
7615438|NCT02413489|18750921|P1|STARTED|Overall Study||15
7615439|NCT02413463|18750943|P2|NOT COMPLETED|Overall Study||2
7615440|NCT02413463|18750944|P1|NOT COMPLETED|Overall Study||5
7615441|NCT02413463|18750943|P2|COMPLETED|Overall Study||28
7615442|NCT02413463|18750944|P1|COMPLETED|Overall Study||25
7615443|NCT02413463|18750943|P2|STARTED|Overall Study||30
7615444|NCT02413463|18750944|P1|STARTED|Overall Study||30
7615445|NCT02413398|18750962|P2|NOT COMPLETED|Overall Study||7
7615446|NCT02413398|18750963|P1|NOT COMPLETED|Overall Study||4
7615447|NCT02413398|18750962|P2|COMPLETED|Overall Study||154
7615448|NCT02413398|18750963|P1|COMPLETED|Overall Study||156
7615449|NCT02413398|18750962|P2|STARTED|Overall Study||161
7615450|NCT02413398|18750963|P1|STARTED|Overall Study||160
7615451|NCT02413372|18750978|P3|NOT COMPLETED|Follow-up||2
7615452|NCT02413372|18750979|P2|NOT COMPLETED|Follow-up||1
7615453|NCT02413372|18750980|P1|NOT COMPLETED|Follow-up||2
7615454|NCT02413372|18750978|P3|COMPLETED|Follow-up||23
7615455|NCT02413372|18750979|P2|COMPLETED|Follow-up||20
7615456|NCT02413372|18750980|P1|COMPLETED|Follow-up||20
7615457|NCT02413372|18750978|P3|STARTED|Follow-up||25
7615458|NCT02413372|18750979|P2|STARTED|Follow-up||21
7615459|NCT02413372|18750980|P1|STARTED|Follow-up||22
7615460|NCT02413372|18750978|P3|NOT COMPLETED|Treatment||1
7615461|NCT02413372|18750979|P2|NOT COMPLETED|Treatment||2
7615462|NCT02413372|18750980|P1|NOT COMPLETED|Treatment||1
7615463|NCT02413372|18750978|P3|COMPLETED|Treatment||25
7615464|NCT02413372|18750979|P2|COMPLETED|Treatment||22
7615465|NCT02413372|18750980|P1|COMPLETED|Treatment||24
7615466|NCT02413372|18750978|P3|STARTED|Treatment||26
7615467|NCT02413372|18750979|P2|STARTED|Treatment||24
7615468|NCT02413372|18750980|P1|STARTED|Treatment||25
7615469|NCT02413346|18751029|P2|NOT COMPLETED|Overall Study||70
7615470|NCT02413346|18751030|P1|NOT COMPLETED|Overall Study||59
7615471|NCT02413346|18751029|P2|COMPLETED|Overall Study||177
7615472|NCT02413346|18751030|P1|COMPLETED|Overall Study||177
7615473|NCT02413346|18751029|P2|STARTED|Overall Study||247
7615474|NCT02413346|18751030|P1|STARTED|Overall Study||236
7615475|NCT02413333|18751040|P2|NOT COMPLETED|Period 2||0
7615476|NCT02413333|18751041|P1|NOT COMPLETED|Period 2||1
7615477|NCT02413333|18751040|P2|COMPLETED|Period 2||65
7615478|NCT02413333|18751041|P1|COMPLETED|Period 2||64
7615479|NCT02413333|18751040|P2|STARTED|Period 2||65
7615480|NCT02413333|18751041|P1|STARTED|Period 2||65
7615481|NCT02413333|18751040|P2|NOT COMPLETED|Period 1||1
7615482|NCT02413333|18751041|P1|NOT COMPLETED|Period 1||1
7615483|NCT02413333|18751040|P2|COMPLETED|Period 1||65
7615484|NCT02413333|18751041|P1|COMPLETED|Period 1||65
7615485|NCT02413333|18751040|P2|Randomized and Treated|Period 1||66
7615486|NCT02413333|18751041|P1|Randomized and Treated|Period 1||66
7615487|NCT02413333|18751040|P2|STARTED|Period 1||66
7615488|NCT02413333|18751041|P1|STARTED|Period 1||66
7615489|NCT02413294|18751049|P1|NOT COMPLETED|Overall Study||1
7615490|NCT02413294|18751049|P1|COMPLETED|Overall Study||11
7615491|NCT02413294|18751049|P1|STARTED|Overall Study||12
7615492|NCT02413255|18751084|P17|NOT COMPLETED|Overall Study||0
7615493|NCT02413255|18751085|P16|NOT COMPLETED|Overall Study||0
7615494|NCT02413255|18751086|P15|NOT COMPLETED|Overall Study||1
7615495|NCT02413255|18751087|P14|NOT COMPLETED|Overall Study||0
7615496|NCT02413255|18751088|P13|NOT COMPLETED|Overall Study||0
7615497|NCT02413255|18751089|P12|NOT COMPLETED|Overall Study||0
7615498|NCT02413255|18751090|P11|NOT COMPLETED|Overall Study||0
7615499|NCT02413255|18751091|P10|NOT COMPLETED|Overall Study||0
7615500|NCT02413255|18751092|P9|NOT COMPLETED|Overall Study||0
7615501|NCT02413255|18751093|P8|NOT COMPLETED|Overall Study||0
7615502|NCT02413255|18751094|P7|NOT COMPLETED|Overall Study||0
7615503|NCT02413255|18751095|P6|NOT COMPLETED|Overall Study||0
7615504|NCT02413255|18751096|P5|NOT COMPLETED|Overall Study||0
7615505|NCT02413255|18751097|P4|NOT COMPLETED|Overall Study||0
7615506|NCT02413255|18751098|P3|NOT COMPLETED|Overall Study||0
7615507|NCT02413255|18751099|P2|NOT COMPLETED|Overall Study||0
7615508|NCT02413255|18751100|P1|NOT COMPLETED|Overall Study||0
7615509|NCT02413255|18751084|P17|COMPLETED|Overall Study||6
7615510|NCT02413255|18751085|P16|COMPLETED|Overall Study||6
7615511|NCT02413255|18751086|P15|COMPLETED|Overall Study||5
7615512|NCT02413255|18751087|P14|COMPLETED|Overall Study||6
7615513|NCT02413255|18751088|P13|COMPLETED|Overall Study||6
7615514|NCT02413255|18751089|P12|COMPLETED|Overall Study||6
7615515|NCT02413255|18751090|P11|COMPLETED|Overall Study||12
7615516|NCT02413255|18751091|P10|COMPLETED|Overall Study||6
7615517|NCT02413255|18751092|P9|COMPLETED|Overall Study||6
7615518|NCT02413255|18751093|P8|COMPLETED|Overall Study||6
7615519|NCT02413255|18751094|P7|COMPLETED|Overall Study||6
7615520|NCT02413255|18751095|P6|COMPLETED|Overall Study||6
7615521|NCT02413255|18751096|P5|COMPLETED|Overall Study||6
7615522|NCT02413255|18751097|P4|COMPLETED|Overall Study||6
7615523|NCT02413255|18751098|P3|COMPLETED|Overall Study||6
7615524|NCT02413255|18751099|P2|COMPLETED|Overall Study||6
7615525|NCT02413255|18751100|P1|COMPLETED|Overall Study||18
7615526|NCT02413255|18751084|P17|STARTED|Overall Study||6
7615527|NCT02413255|18751085|P16|STARTED|Overall Study||6
7615528|NCT02413255|18751086|P15|STARTED|Overall Study||6
7615529|NCT02413255|18751087|P14|STARTED|Overall Study||6
7615530|NCT02413255|18751088|P13|STARTED|Overall Study||6
7615531|NCT02413255|18751089|P12|STARTED|Overall Study||6
7615532|NCT02413255|18751090|P11|STARTED|Overall Study||12
7615533|NCT02413255|18751091|P10|STARTED|Overall Study||6
7615534|NCT02413255|18751092|P9|STARTED|Overall Study||6
7615535|NCT02413255|18751093|P8|STARTED|Overall Study||6
7615536|NCT02413255|18751094|P7|STARTED|Overall Study||6
7615537|NCT02413255|18751095|P6|STARTED|Overall Study||6
7615538|NCT02413255|18751096|P5|STARTED|Overall Study||6
7615539|NCT02413255|18751097|P4|STARTED|Overall Study||6
7615540|NCT02413255|18751098|P3|STARTED|Overall Study||6
7615541|NCT02413255|18751099|P2|STARTED|Overall Study||6
7615542|NCT02413255|18751100|P1|STARTED|Overall Study||18
7615543|NCT02413229|18751456|P8|NOT COMPLETED|Overall Study||4
7615544|NCT02413229|18751457|P7|NOT COMPLETED|Overall Study||0
7615545|NCT02413229|18751458|P6|NOT COMPLETED|Overall Study||0
7615546|NCT02413229|18751459|P5|NOT COMPLETED|Overall Study||3
7615547|NCT02413229|18751460|P4|NOT COMPLETED|Overall Study||1
7615548|NCT02413229|18751461|P3|NOT COMPLETED|Overall Study||1
7615549|NCT02413229|18751462|P2|NOT COMPLETED|Overall Study||1
7615550|NCT02413229|18751463|P1|NOT COMPLETED|Overall Study||1
7615551|NCT02413229|18751456|P8|COMPLETED|Overall Study||11
7615552|NCT02413229|18751457|P7|COMPLETED|Overall Study||25
7615553|NCT02413229|18751458|P6|COMPLETED|Overall Study||12
7615554|NCT02413229|18751459|P5|COMPLETED|Overall Study||21
7615555|NCT02413229|18751460|P4|COMPLETED|Overall Study||11
7615556|NCT02413229|18751461|P3|COMPLETED|Overall Study||25
7615557|NCT02413229|18751462|P2|COMPLETED|Overall Study||11
7615558|NCT02413229|18751463|P1|COMPLETED|Overall Study||24
7615559|NCT02413229|18751456|P8|STARTED|Overall Study||15
7615560|NCT02413229|18751457|P7|STARTED|Overall Study||25
7615561|NCT02413229|18751458|P6|STARTED|Overall Study||12
7615562|NCT02413229|18751459|P5|STARTED|Overall Study||24
7615563|NCT02413229|18751460|P4|STARTED|Overall Study||12
7615564|NCT02413229|18751461|P3|STARTED|Overall Study||26
7615565|NCT02413229|18751462|P2|STARTED|Overall Study||12
7615566|NCT02413229|18751463|P1|STARTED|Overall Study||25
7615567|NCT02413203|18751483|P2|NOT COMPLETED|Overall Study||0
7615568|NCT02413203|18751484|P1|NOT COMPLETED|Overall Study||0
7615569|NCT02413203|18751483|P2|COMPLETED|Overall Study||10
7615570|NCT02413203|18751484|P1|COMPLETED|Overall Study||10
7615571|NCT02413203|18751483|P2|STARTED|Overall Study||10
7615572|NCT02413203|18751484|P1|STARTED|Overall Study||10
7615573|NCT02413190|18751504|P1|NOT COMPLETED|Overall Study||0
7615574|NCT02413190|18751504|P1|COMPLETED|Overall Study||94
7615575|NCT02413190|18751504|P1|STARTED|Overall Study||94
7615576|NCT02413151|18751510|P2|NOT COMPLETED|Overall Study||2
7615577|NCT02413151|18751511|P1|NOT COMPLETED|Overall Study||10
7615578|NCT02413151|18751510|P2|COMPLETED|Overall Study||28
7615579|NCT02413151|18751511|P1|COMPLETED|Overall Study||22
7615580|NCT02413151|18751510|P2|STARTED|Overall Study||30
7615581|NCT02413151|18751511|P1|STARTED|Overall Study||32
7615582|NCT02413047|18751539|P1|NOT COMPLETED|Overall Study||0
7615583|NCT02413047|18751539|P1|COMPLETED|Overall Study||3
7615584|NCT02413047|18751539|P1|Participants on Adalimumab|Overall Study||1
7615585|NCT02413047|18751539|P1|Participants on Infliximab|Overall Study||2
7615586|NCT02413047|18751539|P1|STARTED|Overall Study||3
7615587|NCT02413034|18751552|P2|NOT COMPLETED|Overall Study||0
7615588|NCT02413034|18751553|P1|NOT COMPLETED|Overall Study||0
7615589|NCT02413034|18751552|P2|COMPLETED|Overall Study||14
7615590|NCT02413034|18751553|P1|COMPLETED|Overall Study||14
7615591|NCT02413034|18751552|P2|STARTED|Overall Study||14
7615592|NCT02413034|18751553|P1|STARTED|Overall Study||14
7615593|NCT02413008|18751563|P2|NOT COMPLETED|Overall Study||2
7615594|NCT02413008|18751564|P1|NOT COMPLETED|Overall Study||7
7615595|NCT02413008|18751563|P2|COMPLETED|Overall Study||9
7615596|NCT02413008|18751564|P1|COMPLETED|Overall Study||43
7615597|NCT02413008|18751563|P2|STARTED|Overall Study||11
7615598|NCT02413008|18751564|P1|STARTED|Overall Study||50
7615599|NCT02412878|18751602|P2|NOT COMPLETED|Overall Study||13
7615600|NCT02412878|18751603|P1|NOT COMPLETED|Overall Study||21
7615601|NCT02412878|18751602|P2|COMPLETED|Overall Study||227
7615602|NCT02412878|18751603|P1|COMPLETED|Overall Study||217
7615603|NCT02412878|18751602|P2|Received Carfilzomib|Overall Study||238
7615604|NCT02412878|18751603|P1|Received Carfilzomib|Overall Study||235
7615605|NCT02412878|18751602|P2|STARTED|Overall Study||240
7615606|NCT02412878|18751603|P1|STARTED|Overall Study||238
7615607|NCT02412852|18751621|P4|NOT COMPLETED|Overall Study||1
7615608|NCT02412852|18751622|P3|NOT COMPLETED|Overall Study||0
7615609|NCT02412852|18751623|P2|NOT COMPLETED|Overall Study||1
7615610|NCT02412852|18751624|P1|NOT COMPLETED|Overall Study||0
7615611|NCT02412852|18751621|P4|COMPLETED|Overall Study||8
7615612|NCT02412852|18751622|P3|COMPLETED|Overall Study||5
7615613|NCT02412852|18751623|P2|COMPLETED|Overall Study||7
7615614|NCT02412852|18751624|P1|COMPLETED|Overall Study||4
7615615|NCT02412852|18751621|P4|STARTED|Overall Study||9
7615616|NCT02412852|18751622|P3|STARTED|Overall Study||5
7615617|NCT02412852|18751623|P2|STARTED|Overall Study||8
7615618|NCT02412852|18751624|P1|STARTED|Overall Study||4
7615619|NCT02412761|18751650|P6|NOT COMPLETED|Third Intervention (2 Weeks)||0
7615620|NCT02412761|18751651|P5|NOT COMPLETED|Third Intervention (2 Weeks)||0
7615621|NCT02412761|18751652|P4|NOT COMPLETED|Third Intervention (2 Weeks)||0
7615622|NCT02412761|18751653|P3|NOT COMPLETED|Third Intervention (2 Weeks)||0
7615623|NCT02412761|18751654|P2|NOT COMPLETED|Third Intervention (2 Weeks)||0
7615624|NCT02412761|18751655|P1|NOT COMPLETED|Third Intervention (2 Weeks)||0
7615625|NCT02412761|18751650|P6|COMPLETED|Third Intervention (2 Weeks)||6
7615626|NCT02412761|18751651|P5|COMPLETED|Third Intervention (2 Weeks)||4
7615627|NCT02412761|18751652|P4|COMPLETED|Third Intervention (2 Weeks)||8
7615628|NCT02412761|18751653|P3|COMPLETED|Third Intervention (2 Weeks)||4
7615629|NCT02412761|18751654|P2|COMPLETED|Third Intervention (2 Weeks)||5
7615630|NCT02412761|18751655|P1|COMPLETED|Third Intervention (2 Weeks)||5
7615631|NCT02412761|18751650|P6|STARTED|Third Intervention (2 Weeks)||6
7615632|NCT02412761|18751651|P5|STARTED|Third Intervention (2 Weeks)||4
7615633|NCT02412761|18751652|P4|STARTED|Third Intervention (2 Weeks)||8
7615634|NCT02412761|18751653|P3|STARTED|Third Intervention (2 Weeks)||4
7615635|NCT02412761|18751654|P2|STARTED|Third Intervention (2 Weeks)||5
7615636|NCT02412761|18751655|P1|STARTED|Third Intervention (2 Weeks)||5
7615637|NCT02412761|18751650|P6|NOT COMPLETED|Second Intervention (2 Weeks)||0
7615638|NCT02412761|18751651|P5|NOT COMPLETED|Second Intervention (2 Weeks)||0
7615639|NCT02412761|18751652|P4|NOT COMPLETED|Second Intervention (2 Weeks)||0
7615640|NCT02412761|18751653|P3|NOT COMPLETED|Second Intervention (2 Weeks)||0
7615641|NCT02412761|18751654|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
7615642|NCT02412761|18751655|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
7615643|NCT02412761|18751650|P6|COMPLETED|Second Intervention (2 Weeks)||6
7615644|NCT02412761|18751651|P5|COMPLETED|Second Intervention (2 Weeks)||4
7615645|NCT02412761|18751652|P4|COMPLETED|Second Intervention (2 Weeks)||8
7615646|NCT02412761|18751653|P3|COMPLETED|Second Intervention (2 Weeks)||4
7615647|NCT02412761|18751654|P2|COMPLETED|Second Intervention (2 Weeks)||5
7615648|NCT02412761|18751655|P1|COMPLETED|Second Intervention (2 Weeks)||5
7615649|NCT02412761|18751650|P6|STARTED|Second Intervention (2 Weeks)||6
7615650|NCT02412761|18751651|P5|STARTED|Second Intervention (2 Weeks)||4
7615651|NCT02412761|18751652|P4|STARTED|Second Intervention (2 Weeks)||8
7615652|NCT02412761|18751653|P3|STARTED|Second Intervention (2 Weeks)||4
7615653|NCT02412761|18751654|P2|STARTED|Second Intervention (2 Weeks)||5
7615654|NCT02412761|18751655|P1|STARTED|Second Intervention (2 Weeks)||5
7615655|NCT02412761|18751650|P6|NOT COMPLETED|First Intervention (2 Weeks)||1
7615656|NCT02412761|18751651|P5|NOT COMPLETED|First Intervention (2 Weeks)||0
7615657|NCT02412761|18751652|P4|NOT COMPLETED|First Intervention (2 Weeks)||0
7615658|NCT02412761|18751653|P3|NOT COMPLETED|First Intervention (2 Weeks)||1
7615659|NCT02412761|18751654|P2|NOT COMPLETED|First Intervention (2 Weeks)||1
7615660|NCT02412761|18751655|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
7615661|NCT02412761|18751650|P6|COMPLETED|First Intervention (2 Weeks)||6
7615662|NCT02412761|18751651|P5|COMPLETED|First Intervention (2 Weeks)||4
7615663|NCT02412761|18751652|P4|COMPLETED|First Intervention (2 Weeks)||8
7615664|NCT02412761|18751653|P3|COMPLETED|First Intervention (2 Weeks)||4
7615665|NCT02412761|18751654|P2|COMPLETED|First Intervention (2 Weeks)||5
7615666|NCT02412761|18751655|P1|COMPLETED|First Intervention (2 Weeks)||5
7615667|NCT02412761|18751650|P6|STARTED|First Intervention (2 Weeks)||7
7615668|NCT02412761|18751651|P5|STARTED|First Intervention (2 Weeks)||4
7615669|NCT02412761|18751652|P4|STARTED|First Intervention (2 Weeks)||8
7615670|NCT02412761|18751653|P3|STARTED|First Intervention (2 Weeks)||5
7615671|NCT02412761|18751654|P2|STARTED|First Intervention (2 Weeks)||6
7615672|NCT02412761|18751655|P1|STARTED|First Intervention (2 Weeks)||5
7615673|NCT02412722|18751669|P6|NOT COMPLETED|Overall Study||13
7615674|NCT02412722|18751670|P5|NOT COMPLETED|Overall Study||7
7615675|NCT02412722|18751671|P4|NOT COMPLETED|Overall Study||15
7615676|NCT02412722|18751672|P3|NOT COMPLETED|Overall Study||7
7615677|NCT02412722|18751673|P2|NOT COMPLETED|Overall Study||8
7615678|NCT02412722|18751674|P1|NOT COMPLETED|Overall Study||11
7615679|NCT02412722|18751669|P6|COMPLETED|Overall Study||0
7615680|NCT02412722|18751670|P5|COMPLETED|Overall Study||0
7615681|NCT02412722|18751671|P4|COMPLETED|Overall Study||0
7615682|NCT02412722|18751672|P3|COMPLETED|Overall Study||0
7615683|NCT02412722|18751673|P2|COMPLETED|Overall Study||0
7615684|NCT02412722|18751674|P1|COMPLETED|Overall Study||0
7615685|NCT02412722|18751669|P6|Safety Population|Overall Study||13
7615686|NCT02412722|18751670|P5|Safety Population|Overall Study||7
7615687|NCT02412722|18751671|P4|Safety Population|Overall Study||15
7615688|NCT02412722|18751672|P3|Safety Population|Overall Study||7
7615689|NCT02412722|18751673|P2|Safety Population|Overall Study||6
7615690|NCT02412722|18751674|P1|Safety Population|Overall Study||11
7615691|NCT02412722|18751669|P6|STARTED|Overall Study||13
7615692|NCT02412722|18751670|P5|STARTED|Overall Study||7
7615693|NCT02412722|18751671|P4|STARTED|Overall Study||15
7615694|NCT02412722|18751672|P3|STARTED|Overall Study||7
7615695|NCT02412722|18751673|P2|STARTED|Overall Study||8
7615696|NCT02412722|18751674|P1|STARTED|Overall Study||11
7615697|NCT02412657|18751745|P3|NOT COMPLETED|Overall Study||3
7615698|NCT02412657|18751746|P2|NOT COMPLETED|Overall Study||2
7615699|NCT02412657|18751747|P1|NOT COMPLETED|Overall Study||1
7615700|NCT02412657|18751745|P3|COMPLETED|Overall Study||22
7615701|NCT02412657|18751746|P2|COMPLETED|Overall Study||23
7615702|NCT02412657|18751747|P1|COMPLETED|Overall Study||24
7615703|NCT02412657|18751745|P3|STARTED|Overall Study||25
7615704|NCT02412657|18751746|P2|STARTED|Overall Study||25
7615705|NCT02412657|18751747|P1|STARTED|Overall Study||25
7615706|NCT02412644|18751757|P2|NOT COMPLETED|Overall Study||4
7615707|NCT02412644|18751758|P1|NOT COMPLETED|Overall Study||15
7615708|NCT02412644|18751757|P2|COMPLETED|Overall Study||4
7615709|NCT02412644|18751758|P1|COMPLETED|Overall Study||6
7615710|NCT02412644|18751757|P2|STARTED|Overall Study||8
7615711|NCT02412644|18751758|P1|STARTED|Overall Study||21
7615712|NCT02412501|18751770|P1|NOT COMPLETED|Overall Study||0
7615713|NCT02412501|18751770|P1|COMPLETED|Overall Study||101
7615714|NCT02412501|18751770|P1|STARTED|Overall Study||101
7615715|NCT02412488|18751791|P1|NOT COMPLETED|Overall Study||18
7615716|NCT02412488|18751791|P1|COMPLETED|Overall Study||174
7615717|NCT02412488|18751791|P1|Reveal LINQ Implanted|Overall Study||191
7615718|NCT02412488|18751791|P1|STARTED|Overall Study||192
7615719|NCT02412436|18751795|P1|NOT COMPLETED|Overall Study||18
7615720|NCT02412436|18751795|P1|COMPLETED|Overall Study||44
7615721|NCT02412436|18751795|P1|STARTED|Overall Study||62
7615722|NCT02412371|18751815|P6|NOT COMPLETED|Overall Study||5
7615723|NCT02412371|18751816|P5|NOT COMPLETED|Overall Study||12
7615724|NCT02412371|18751817|P4|NOT COMPLETED|Overall Study||8
7615725|NCT02412371|18751818|P3|NOT COMPLETED|Overall Study||7
7615726|NCT02412371|18751819|P2|NOT COMPLETED|Overall Study||9
7615727|NCT02412371|18751820|P1|NOT COMPLETED|Overall Study||7
7615728|NCT02412371|18751815|P6|COMPLETED|Overall Study||0
7615729|NCT02412371|18751816|P5|COMPLETED|Overall Study||0
7615730|NCT02412371|18751817|P4|COMPLETED|Overall Study||0
7615731|NCT02412371|18751818|P3|COMPLETED|Overall Study||0
7615732|NCT02412371|18751819|P2|COMPLETED|Overall Study||0
7615733|NCT02412371|18751820|P1|COMPLETED|Overall Study||0
7615734|NCT02412371|18751815|P6|STARTED|Overall Study||5
7615735|NCT02412371|18751816|P5|STARTED|Overall Study||12
7615736|NCT02412371|18751817|P4|STARTED|Overall Study||8
7615737|NCT02412371|18751818|P3|STARTED|Overall Study||7
7615738|NCT02412371|18751819|P2|STARTED|Overall Study||9
7615739|NCT02412371|18751820|P1|STARTED|Overall Study||7
7615740|NCT02412306|18751848|P5|NOT COMPLETED|Overall Study||2
7615741|NCT02412306|18751849|P4|NOT COMPLETED|Overall Study||0
7615742|NCT02412306|18751850|P3|NOT COMPLETED|Overall Study||16
7615743|NCT02412306|18751851|P2|NOT COMPLETED|Overall Study||8
7615744|NCT02412306|18751852|P1|NOT COMPLETED|Overall Study||5
7615745|NCT02412306|18751848|P5|COMPLETED|Overall Study||15
7615746|NCT02412306|18751849|P4|COMPLETED|Overall Study||14
7615747|NCT02412306|18751850|P3|COMPLETED|Overall Study||5
7615748|NCT02412306|18751851|P2|COMPLETED|Overall Study||1
7615749|NCT02412306|18751852|P1|COMPLETED|Overall Study||0
7615750|NCT02412306|18751848|P5|STARTED|Overall Study||17
7615751|NCT02412306|18751849|P4|STARTED|Overall Study||14
7615752|NCT02412306|18751850|P3|STARTED|Overall Study||21
7615753|NCT02412306|18751851|P2|STARTED|Overall Study||9
7615754|NCT02412306|18751852|P1|STARTED|Overall Study||5
7615755|NCT02412111|18751914|P3|NOT COMPLETED|Active Comparator Period (8 Weeks)||6
7615756|NCT02412111|18751915|P2|NOT COMPLETED|Active Comparator Period (8 Weeks)||1
7615757|NCT02412111|18751916|P1|NOT COMPLETED|Active Comparator Period (8 Weeks)||0
7615758|NCT02412111|18751914|P3|COMPLETED|Active Comparator Period (8 Weeks)||69
7615759|NCT02412111|18751915|P2|COMPLETED|Active Comparator Period (8 Weeks)||75
7615760|NCT02412111|18751916|P1|COMPLETED|Active Comparator Period (8 Weeks)||0
7615761|NCT02412111|18751914|P3|Full Analysis Set|Active Comparator Period (8 Weeks)||74
7615762|NCT02412111|18751915|P2|Full Analysis Set|Active Comparator Period (8 Weeks)||76
7615763|NCT02412111|18751916|P1|Full Analysis Set|Active Comparator Period (8 Weeks)||0
7615764|NCT02412111|18751914|P3|STARTED|Active Comparator Period (8 Weeks)||75
7615765|NCT02412111|18751915|P2|STARTED|Active Comparator Period (8 Weeks)||76
7615766|NCT02412111|18751916|P1|STARTED|Active Comparator Period (8 Weeks)||0
7615767|NCT02412111|18751914|P3|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
7615768|NCT02412111|18751915|P2|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
7615769|NCT02412111|18751916|P1|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||3
7615770|NCT02412111|18751914|P3|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
7615771|NCT02412111|18751915|P2|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
7615772|NCT02412111|18751916|P1|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||153
7615773|NCT02412111|18751914|P3|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
7615774|NCT02412111|18751915|P2|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
7615775|NCT02412111|18751916|P1|STARTED|Ivacaftor Run-in Period (4 Weeks)||156
7615776|NCT02412098|18751938|P3|NOT COMPLETED|Overall Study||0
7615777|NCT02412098|18751939|P2|NOT COMPLETED|Overall Study||0
7615778|NCT02412098|18751940|P1|NOT COMPLETED|Overall Study||0
7615779|NCT02412098|18751938|P3|COMPLETED|Overall Study||21
7615780|NCT02412098|18751939|P2|COMPLETED|Overall Study||14
7615781|NCT02412098|18751940|P1|COMPLETED|Overall Study||14
7615782|NCT02412098|18751938|P3|STARTED|Overall Study||21
7615783|NCT02412098|18751939|P2|STARTED|Overall Study||14
7615784|NCT02412098|18751940|P1|STARTED|Overall Study||14
7615785|NCT02411929|18751967|P1|NOT COMPLETED|Period 2||0
7615786|NCT02411929|18751967|P1|COMPLETED|Period 2||8
7615787|NCT02411929|18751967|P1|STARTED|Period 2||8
7615788|NCT02411929|18751967|P1|NOT COMPLETED|Washout Period||0
7615789|NCT02411929|18751967|P1|COMPLETED|Washout Period||8
7615790|NCT02411929|18751967|P1|STARTED|Washout Period||8
7615791|NCT02411929|18751967|P1|NOT COMPLETED|Period 1||0
7615792|NCT02411929|18751967|P1|COMPLETED|Period 1||8
7615793|NCT02411929|18751967|P1|STARTED|Period 1||8
7615794|NCT02411747|18751999|P2|NOT COMPLETED|Overall Study||4
7615795|NCT02411747|18752000|P1|NOT COMPLETED|Overall Study||3
7615796|NCT02411747|18751999|P2|COMPLETED|Overall Study||12
7615797|NCT02411747|18752000|P1|COMPLETED|Overall Study||13
7615798|NCT02411747|18751999|P2|Simulation Training Completed|Overall Study||16
7615799|NCT02411747|18752000|P1|Simulation Training Completed|Overall Study||16
7615800|NCT02411747|18751999|P2|STARTED|Overall Study||16
7615801|NCT02411747|18752000|P1|STARTED|Overall Study||16
7615802|NCT02411643|18752006|P1|NOT COMPLETED|Overall Study||0
7615803|NCT02411643|18752006|P1|COMPLETED|Overall Study||2
7615804|NCT02411643|18752006|P1|STARTED|Overall Study||2
7615805|NCT02411591|18752016|P3|NOT COMPLETED|Overall Study||3
7615806|NCT02411591|18752017|P2|NOT COMPLETED|Overall Study||10
7615807|NCT02411591|18752018|P1|NOT COMPLETED|Overall Study||0
7615808|NCT02411591|18752016|P3|COMPLETED|Overall Study||3
7615809|NCT02411591|18752017|P2|COMPLETED|Overall Study||47
7615810|NCT02411591|18752018|P1|COMPLETED|Overall Study||3
7615811|NCT02411591|18752016|P3|Death|Overall Study||0
7615812|NCT02411591|18752017|P2|Death|Overall Study||2
7615813|NCT02411591|18752018|P1|Death|Overall Study||0
7615814|NCT02411591|18752016|P3|Progressive Disease|Overall Study||3
7615815|NCT02411591|18752017|P2|Progressive Disease|Overall Study||42
7615816|NCT02411591|18752018|P1|Progressive Disease|Overall Study||3
7615817|NCT02411591|18752016|P3|Expansion Cohort Part B|Overall Study||0
7615818|NCT02411591|18752017|P2|Expansion Cohort Part B|Overall Study||51
7615819|NCT02411591|18752018|P1|Expansion Cohort Part B|Overall Study||0
7615820|NCT02411591|18752016|P3|Part A|Overall Study||6
7615821|NCT02411591|18752017|P2|Part A|Overall Study||6
7615822|NCT02411591|18752018|P1|Part A|Overall Study||3
7615823|NCT02411591|18752016|P3|STARTED|Overall Study||6
7615824|NCT02411591|18752017|P2|STARTED|Overall Study||57
7615825|NCT02411591|18752018|P1|STARTED|Overall Study||3
7615826|NCT02411578|18752050|P2|NOT COMPLETED|Extension Phase||0
7615827|NCT02411578|18752051|P1|NOT COMPLETED|Extension Phase||0
7615828|NCT02411578|18752050|P2|COMPLETED|Extension Phase||9
7615829|NCT02411578|18752051|P1|COMPLETED|Extension Phase||8
7615830|NCT02411578|18752050|P2|STARTED|Extension Phase|2 Crossover Trial participants could not continue due to study syringes expiration|9
7615831|NCT02411578|18752051|P1|STARTED|Extension Phase||8
7615832|NCT02411578|18752050|P2|NOT COMPLETED|Crossover Trial Phase||1
7615833|NCT02411578|18752051|P1|NOT COMPLETED|Crossover Trial Phase||0
7615834|NCT02411578|18752050|P2|COMPLETED|Crossover Trial Phase||11
7615835|NCT02411578|18752051|P1|COMPLETED|Crossover Trial Phase||8
7615836|NCT02411578|18752050|P2|STARTED|Crossover Trial Phase||12
7615837|NCT02411578|18752051|P1|STARTED|Crossover Trial Phase||8
7615838|NCT02411565|18752093|P2|NOT COMPLETED|Overall Study||0
7615839|NCT02411565|18752094|P1|NOT COMPLETED|Overall Study||0
7615840|NCT02411565|18752093|P2|COMPLETED|Overall Study||2
7615841|NCT02411565|18752094|P1|COMPLETED|Overall Study||1
7615842|NCT02411565|18752093|P2|STARTED|Overall Study||2
7615843|NCT02411565|18752094|P1|STARTED|Overall Study||1
7615844|NCT02411539|18752108|P2|NOT COMPLETED|Overall Study||1
7615845|NCT02411539|18752109|P1|NOT COMPLETED|Overall Study||2
7615846|NCT02411539|18752108|P2|COMPLETED|Overall Study||19
7615847|NCT02411539|18752109|P1|COMPLETED|Overall Study||18
7615848|NCT02411539|18752108|P2|STARTED|Overall Study||20
7615849|NCT02411539|18752109|P1|STARTED|Overall Study||20
7615850|NCT02411461|18752187|P3|NOT COMPLETED|Overall Study||0
7615851|NCT02411461|18752188|P2|NOT COMPLETED|Overall Study||0
7615852|NCT02411461|18752189|P1|NOT COMPLETED|Overall Study||0
7615853|NCT02411461|18752187|P3|COMPLETED|Overall Study||15
7615854|NCT02411461|18752188|P2|COMPLETED|Overall Study||8
7615855|NCT02411461|18752189|P1|COMPLETED|Overall Study||16
7615856|NCT02411461|18752187|P3|STARTED|Overall Study||15
7615857|NCT02411461|18752188|P2|STARTED|Overall Study||8
7615858|NCT02411461|18752189|P1|STARTED|Overall Study||16
7615859|NCT02411448|18752200|P3|NOT COMPLETED|Overall Study||52
7615860|NCT02411448|18752201|P2|NOT COMPLETED|Overall Study||83
7615861|NCT02411448|18752202|P1|NOT COMPLETED|Overall Study||4
7615862|NCT02411448|18752200|P3|COMPLETED|Overall Study||173
7615863|NCT02411448|18752201|P2|COMPLETED|Overall Study||141
7615864|NCT02411448|18752202|P1|COMPLETED|Overall Study||10
7615865|NCT02411448|18752200|P3|Received at Least One Dose of Study Drug|Overall Study||225
7615866|NCT02411448|18752201|P2|Received at Least One Dose of Study Drug|Overall Study||221
7615867|NCT02411448|18752202|P1|Received at Least One Dose of Study Drug|Overall Study||14
7615868|NCT02411448|18752200|P3|STARTED|Overall Study||225
7615869|NCT02411448|18752201|P2|STARTED|Overall Study||224
7615870|NCT02411448|18752202|P1|STARTED|Overall Study||14
7615871|NCT02411396|18752231|P1|NOT COMPLETED|Overall Study||41
7615872|NCT02411396|18752231|P1|COMPLETED|Overall Study||442
7615873|NCT02411396|18752231|P1|STARTED|Overall Study||483
7615874|NCT02411292|18752244|P1|NOT COMPLETED|Overall Study||21
7615875|NCT02411292|18752244|P1|COMPLETED|Overall Study||89
7615876|NCT02411292|18752244|P1|STARTED|Overall Study||110
7615877|NCT02411201|18752250|P1|NOT COMPLETED|Overall Study||6
7615878|NCT02411201|18752250|P1|COMPLETED|Overall Study||45
7615879|NCT02411201|18752250|P1|STARTED|Overall Study||51
7615880|NCT02411110|18752263|P2|NOT COMPLETED|Treatment Period 2||4
7615881|NCT02411110|18752264|P1|NOT COMPLETED|Treatment Period 2||1
7615882|NCT02411110|18752263|P2|COMPLETED|Treatment Period 2||44
7615883|NCT02411110|18752264|P1|COMPLETED|Treatment Period 2||49
7615884|NCT02411110|18752263|P2|STARTED|Treatment Period 2|Period 2 was optional.|48
7615885|NCT02411110|18752264|P1|STARTED|Treatment Period 2|Period 2 was optional.|50
7615886|NCT02411110|18752263|P2|NOT COMPLETED|Treatment Period 1||7
7615887|NCT02411110|18752264|P1|NOT COMPLETED|Treatment Period 1||9
7615888|NCT02411110|18752263|P2|COMPLETED|Treatment Period 1||59
7615889|NCT02411110|18752264|P1|COMPLETED|Treatment Period 1||56
7615890|NCT02411110|18752263|P2|STARTED|Treatment Period 1||66
7615891|NCT02411110|18752264|P1|STARTED|Treatment Period 1||65
7615892|NCT02411084|18752274|P2|NOT COMPLETED|Overall Study||13
7615893|NCT02411084|18752275|P1|NOT COMPLETED|Overall Study||13
7615894|NCT02411084|18752274|P2|COMPLETED|Overall Study||5
7615895|NCT02411084|18752275|P1|COMPLETED|Overall Study||5
7615896|NCT02411084|18752274|P2|STARTED|Overall Study||18
7615897|NCT02411084|18752275|P1|STARTED|Overall Study||18
7615898|NCT02410967|18752290|P2|NOT COMPLETED|Follow-up Phase (8 Weeks)||6
7615899|NCT02410967|18752291|P1|NOT COMPLETED|Follow-up Phase (8 Weeks)||4
7615900|NCT02410967|18752290|P2|COMPLETED|Follow-up Phase (8 Weeks)||16
7615901|NCT02410967|18752291|P1|COMPLETED|Follow-up Phase (8 Weeks)||22
7615902|NCT02410967|18752290|P2|STARTED|Follow-up Phase (8 Weeks)||22
7615903|NCT02410967|18752291|P1|STARTED|Follow-up Phase (8 Weeks)||26
7615904|NCT02410967|18752290|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||4
7615905|NCT02410967|18752291|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||1
7615906|NCT02410967|18752290|P2|COMPLETED|Treatment Phase (4 Weeks)||22
7615907|NCT02410967|18752291|P1|COMPLETED|Treatment Phase (4 Weeks)||26
7615908|NCT02410967|18752290|P2|STARTED|Treatment Phase (4 Weeks)||26
7615909|NCT02410967|18752291|P1|STARTED|Treatment Phase (4 Weeks)||27
7615910|NCT02410824|18752307|P2|NOT COMPLETED|Second Intervention (One Week)||0
7615911|NCT02410824|18752308|P1|NOT COMPLETED|Second Intervention (One Week)||0
7615912|NCT02410824|18752307|P2|COMPLETED|Second Intervention (One Week)||22
7615913|NCT02410824|18752308|P1|COMPLETED|Second Intervention (One Week)||22
7615914|NCT02410824|18752307|P2|STARTED|Second Intervention (One Week)||22
7615915|NCT02410824|18752308|P1|STARTED|Second Intervention (One Week)||22
7615916|NCT02410824|18752307|P2|NOT COMPLETED|First Intervention (One Week)||1
7615917|NCT02410824|18752308|P1|NOT COMPLETED|First Intervention (One Week)||0
7615918|NCT02410824|18752307|P2|COMPLETED|First Intervention (One Week)||22
7615919|NCT02410824|18752308|P1|COMPLETED|First Intervention (One Week)||22
7615920|NCT02410824|18752307|P2|STARTED|First Intervention (One Week)||23
7615921|NCT02410824|18752308|P1|STARTED|First Intervention (One Week)||22
7615922|NCT02410811|18752344|P4|NOT COMPLETED|Overall Study||0
7615923|NCT02410811|18752345|P3|NOT COMPLETED|Overall Study||1
7615924|NCT02410811|18752346|P2|NOT COMPLETED|Overall Study||0
7615925|NCT02410811|18752347|P1|NOT COMPLETED|Overall Study||0
7615926|NCT02410811|18752344|P4|COMPLETED|Overall Study||7
7615927|NCT02410811|18752345|P3|COMPLETED|Overall Study||10
7615928|NCT02410811|18752346|P2|COMPLETED|Overall Study||10
7615929|NCT02410811|18752347|P1|COMPLETED|Overall Study||5
7615930|NCT02410811|18752344|P4|STARTED|Overall Study||7
7615931|NCT02410811|18752345|P3|STARTED|Overall Study||11
7615932|NCT02410811|18752346|P2|STARTED|Overall Study||10
7615933|NCT02410811|18752347|P1|STARTED|Overall Study||5
7615934|NCT02410707|18752361|P1|NOT COMPLETED|Overall Study||0
7615935|NCT02410707|18752361|P1|COMPLETED|Overall Study||43
7615936|NCT02410707|18752361|P1|STARTED|Overall Study||43
7615937|NCT02410629|18752374|P2|NOT COMPLETED|Overall Study||3
7615938|NCT02410629|18752375|P1|NOT COMPLETED|Overall Study||3
7615939|NCT02410629|18752374|P2|COMPLETED|Overall Study|6 subjects from the conventional hand exercise group were crossed over to music glove group.|6
7615940|NCT02410629|18752375|P1|COMPLETED|Overall Study|5 subjects from the music glove group were crossed over to conventional hand exercise group.|5
7615941|NCT02410629|18752374|P2|STARTED|Overall Study||9
7615942|NCT02410629|18752375|P1|STARTED|Overall Study||8
7615943|NCT02410577|18752387|P1|NOT COMPLETED|Overall Study||0
7615944|NCT02410577|18752387|P1|COMPLETED|Overall Study||2
7615945|NCT02410577|18752387|P1|STARTED|Overall Study||2
7615946|NCT02410551|18752391|P1|NOT COMPLETED|Overall Study||4
7615947|NCT02410551|18752391|P1|COMPLETED|Overall Study||0
7615948|NCT02410551|18752391|P1|STARTED|Overall Study||4
7615949|NCT02410382|18752398|P2|NOT COMPLETED|Overall Study||0
7615950|NCT02410382|18752399|P1|NOT COMPLETED|Overall Study||0
7615951|NCT02410382|18752398|P2|COMPLETED|Overall Study||0
7615952|NCT02410382|18752399|P1|COMPLETED|Overall Study|Study was terminated by IRB - attempts made to obtain info were unsuccessful.|0
7615953|NCT02410382|18752398|P2|STARTED|Overall Study||0
7615954|NCT02410382|18752399|P1|STARTED|Overall Study||0
7615955|NCT02410343|18752409|P2|NOT COMPLETED|Extension Period (12 Months)||1
7615956|NCT02410343|18752410|P1|NOT COMPLETED|Extension Period (12 Months)||1
7615957|NCT02410343|18752409|P2|COMPLETED|Extension Period (12 Months)||0
7615958|NCT02410343|18752410|P1|COMPLETED|Extension Period (12 Months)||0
7615959|NCT02410343|18752409|P2|STARTED|Extension Period (12 Months)||1
7615960|NCT02410343|18752410|P1|STARTED|Extension Period (12 Months)||1
7615961|NCT02410343|18752409|P2|NOT COMPLETED|Core Period (24 Weeks)||7
7615962|NCT02410343|18752410|P1|NOT COMPLETED|Core Period (24 Weeks)||5
7615963|NCT02410343|18752409|P2|COMPLETED|Core Period (24 Weeks)||1
7615964|NCT02410343|18752410|P1|COMPLETED|Core Period (24 Weeks)||1
7615965|NCT02410343|18752409|P2|STARTED|Core Period (24 Weeks)||8
7615966|NCT02410343|18752410|P1|STARTED|Core Period (24 Weeks)||6
7615967|NCT02410291|18752447|P2|NOT COMPLETED|Overall Study||0
7615968|NCT02410291|18752448|P1|NOT COMPLETED|Overall Study||0
7615969|NCT02410291|18752447|P2|COMPLETED|Overall Study||29
7615970|NCT02410291|18752448|P1|COMPLETED|Overall Study||29
7615971|NCT02410291|18752447|P2|STARTED|Overall Study||29
7615972|NCT02410291|18752448|P1|STARTED|Overall Study||29
7615973|NCT02410278|18752456|P3|NOT COMPLETED|Study Treatment Period||4
7615974|NCT02410278|18752457|P2|NOT COMPLETED|Study Treatment Period||11
7615975|NCT02410278|18752458|P1|NOT COMPLETED|Study Treatment Period||0
7615976|NCT02410278|18752456|P3|COMPLETED|Study Treatment Period||29
7615977|NCT02410278|18752457|P2|COMPLETED|Study Treatment Period||20
7615978|NCT02410278|18752458|P1|COMPLETED|Study Treatment Period||0
7615979|NCT02410278|18752456|P3|Completed Randomized Study Treatment|Study Treatment Period||29
7615980|NCT02410278|18752457|P2|Completed Randomized Study Treatment|Study Treatment Period||20
7615981|NCT02410278|18752458|P1|Completed Randomized Study Treatment|Study Treatment Period||0
7615982|NCT02410278|18752456|P3|Modified Intent-to Treat(mITT)Population|Study Treatment Period||33
7615983|NCT02410278|18752457|P2|Modified Intent-to Treat(mITT)Population|Study Treatment Period||30
7615984|NCT02410278|18752458|P1|Modified Intent-to Treat(mITT)Population|Study Treatment Period||0
7615985|NCT02410278|18752456|P3|STARTED|Study Treatment Period||33
7615986|NCT02410278|18752457|P2|STARTED|Study Treatment Period||31
7615987|NCT02410278|18752458|P1|STARTED|Study Treatment Period||0
7615988|NCT02410278|18752456|P3|NOT COMPLETED|Run-in Period||0
7615989|NCT02410278|18752457|P2|NOT COMPLETED|Run-in Period||0
7615990|NCT02410278|18752458|P1|NOT COMPLETED|Run-in Period||38
7615991|NCT02410278|18752456|P3|COMPLETED|Run-in Period||0
7615992|NCT02410278|18752457|P2|COMPLETED|Run-in Period||0
7615993|NCT02410278|18752458|P1|COMPLETED|Run-in Period||64
7615994|NCT02410278|18752456|P3|Received at Least 1 Dose of DMF|Run-in Period||0
7615995|NCT02410278|18752457|P2|Received at Least 1 Dose of DMF|Run-in Period||0
7615996|NCT02410278|18752458|P1|Received at Least 1 Dose of DMF|Run-in Period||98
7615997|NCT02410278|18752456|P3|STARTED|Run-in Period||0
7615998|NCT02410278|18752457|P2|STARTED|Run-in Period||0
7615999|NCT02410278|18752458|P1|STARTED|Run-in Period||102
7616000|NCT02410252|18752483|P1|NOT COMPLETED|Overall Study||6
7616001|NCT02410252|18752483|P1|COMPLETED|Overall Study||19
7616002|NCT02410252|18752483|P1|STARTED|Overall Study||25
7616003|NCT02410213|18752489|P2|NOT COMPLETED|Overall Study||0
7616004|NCT02410213|18752490|P1|NOT COMPLETED|Overall Study||0
7616005|NCT02410213|18752489|P2|COMPLETED|Overall Study||19
7616006|NCT02410213|18752490|P1|COMPLETED|Overall Study||16
7616007|NCT02410213|18752489|P2|STARTED|Overall Study||19
7616008|NCT02410213|18752490|P1|STARTED|Overall Study||16
7616009|NCT02410200|18752496|P1|NOT COMPLETED|Overall Study||2
7616010|NCT02410200|18752496|P1|COMPLETED|Overall Study||20
7616011|NCT02410200|18752496|P1|STARTED|Overall Study||22
7616012|NCT02410161|18752509|P2|NOT COMPLETED|Overall Study||0
7616013|NCT02410161|18752510|P1|NOT COMPLETED|Overall Study||0
7616014|NCT02410161|18752509|P2|COMPLETED|Overall Study||10
7616015|NCT02410161|18752510|P1|COMPLETED|Overall Study||10
7616016|NCT02410161|18752509|P2|STARTED|Overall Study||10
7616017|NCT02410161|18752510|P1|STARTED|Overall Study||10
7616018|NCT02410018|18752526|P2|NOT COMPLETED|Overall Study||0
7616019|NCT02410018|18752527|P1|NOT COMPLETED|Overall Study||0
7616020|NCT02410018|18752526|P2|COMPLETED|Overall Study||1
7616021|NCT02410018|18752527|P1|COMPLETED|Overall Study||2
7616022|NCT02410018|18752526|P2|STARTED|Overall Study||1
7616023|NCT02410018|18752527|P1|STARTED|Overall Study||2
7616024|NCT02409927|18752547|P1|NOT COMPLETED|Overall Study||0
7616025|NCT02409927|18752547|P1|COMPLETED|Overall Study||10
7616026|NCT02409927|18752547|P1|STARTED|Overall Study||10
7616027|NCT02409914|18752555|P1|NOT COMPLETED|Overall Study||0
7616028|NCT02409914|18752555|P1|COMPLETED|Overall Study||7
7616029|NCT02409914|18752555|P1|STARTED|Overall Study||7
7616030|NCT02409784|18752561|P1|NOT COMPLETED|Overall Study||0
7616031|NCT02409784|18752561|P1|COMPLETED|Overall Study||10
7616032|NCT02409784|18752561|P1|STARTED|Overall Study||10
7616033|NCT02409732|18752566|P1|NOT COMPLETED|Overall Study||6
7616034|NCT02409732|18752566|P1|COMPLETED|Overall Study||14
7616035|NCT02409732|18752566|P1|STARTED|Overall Study|First patient consented on 4/23/15|20
7616036|NCT02409719|18752576|P2|NOT COMPLETED|Overall Study||3
7616037|NCT02409719|18752577|P1|NOT COMPLETED|Overall Study||3
7616038|NCT02409719|18752576|P2|COMPLETED|Overall Study||42
7616039|NCT02409719|18752577|P1|COMPLETED|Overall Study||28
7616040|NCT02409719|18752576|P2|12 Months|Overall Study||42
7616041|NCT02409719|18752577|P1|12 Months|Overall Study||28
7616042|NCT02409719|18752576|P2|6 Months|Overall Study||42
7616043|NCT02409719|18752577|P1|6 Months|Overall Study||28
7616044|NCT02409719|18752576|P2|3 Months|Overall Study||42
7616045|NCT02409719|18752577|P1|3 Months|Overall Study||28
7616046|NCT02409719|18752576|P2|6 Weeks|Overall Study||42
7616047|NCT02409719|18752577|P1|6 Weeks|Overall Study||28
7616048|NCT02409719|18752576|P2|4 Weeks|Overall Study||42
7616049|NCT02409719|18752577|P1|4 Weeks|Overall Study||28
7616050|NCT02409719|18752576|P2|2 Weeks|Overall Study||42
7616051|NCT02409719|18752577|P1|2 Weeks|Overall Study||28
7616052|NCT02409719|18752576|P2|STARTED|Overall Study||45
7616053|NCT02409719|18752577|P1|STARTED|Overall Study||31
7616054|NCT02409667|18752587|P5|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||3
7616055|NCT02409667|18752588|P4|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||8
7616056|NCT02409667|18752589|P3|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||21
7616057|NCT02409667|18752590|P2|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||23
7616058|NCT02409667|18752591|P1|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
7616059|NCT02409667|18752587|P5|COMPLETED|Treatment Period 2, Week 24 to Week 52)||90
7616060|NCT02409667|18752588|P4|COMPLETED|Treatment Period 2, Week 24 to Week 52)||106
7616061|NCT02409667|18752589|P3|COMPLETED|Treatment Period 2, Week 24 to Week 52)||641
7616062|NCT02409667|18752590|P2|COMPLETED|Treatment Period 2, Week 24 to Week 52)||621
7616063|NCT02409667|18752591|P1|COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
7616064|NCT02409667|18752587|P5|STARTED|Treatment Period 2, Week 24 to Week 52)||93
7616065|NCT02409667|18752588|P4|STARTED|Treatment Period 2, Week 24 to Week 52)||114
7616066|NCT02409667|18752589|P3|STARTED|Treatment Period 2, Week 24 to Week 52)||662
7616067|NCT02409667|18752590|P2|STARTED|Treatment Period 2, Week 24 to Week 52)||644
7616068|NCT02409667|18752591|P1|STARTED|Treatment Period 2, Week 24 to Week 52)||0
7616069|NCT02409667|18752587|P5|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
7616070|NCT02409667|18752588|P4|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
7616071|NCT02409667|18752589|P3|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
7616072|NCT02409667|18752590|P2|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
7616073|NCT02409667|18752591|P1|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||121
7616074|NCT02409667|18752587|P5|COMPLETED|Treatment Period 1, Baseline to Week 24||0
7616075|NCT02409667|18752588|P4|COMPLETED|Treatment Period 1, Baseline to Week 24||0
7616076|NCT02409667|18752589|P3|COMPLETED|Treatment Period 1, Baseline to Week 24||0
7616077|NCT02409667|18752590|P2|COMPLETED|Treatment Period 1, Baseline to Week 24||0
7616078|NCT02409667|18752591|P1|COMPLETED|Treatment Period 1, Baseline to Week 24||1526
7616079|NCT02409667|18752587|P5|STARTED|Treatment Period 1, Baseline to Week 24||0
7616080|NCT02409667|18752588|P4|STARTED|Treatment Period 1, Baseline to Week 24||0
7616081|NCT02409667|18752589|P3|STARTED|Treatment Period 1, Baseline to Week 24||0
7616082|NCT02409667|18752590|P2|STARTED|Treatment Period 1, Baseline to Week 24||0
7616083|NCT02409667|18752591|P1|STARTED|Treatment Period 1, Baseline to Week 24||1647
7616084|NCT02409459|18752632|P2|NOT COMPLETED|Overall Study||1
7616085|NCT02409459|18752633|P1|NOT COMPLETED|Overall Study||1
7616086|NCT02409459|18752632|P2|COMPLETED|Overall Study||39
7616087|NCT02409459|18752633|P1|COMPLETED|Overall Study||40
7616088|NCT02409459|18752632|P2|STARTED|Overall Study||40
7616089|NCT02409459|18752633|P1|STARTED|Overall Study||41
7616090|NCT02409355|18752653|P2|NOT COMPLETED|Overall Study||4
7616091|NCT02409355|18752654|P1|NOT COMPLETED|Overall Study||4
7616092|NCT02409355|18752653|P2|COMPLETED|Overall Study||0
7616093|NCT02409355|18752654|P1|COMPLETED|Overall Study||0
7616094|NCT02409355|18752653|P2|STARTED|Overall Study||4
7616095|NCT02409355|18752654|P1|STARTED|Overall Study||4
7616096|NCT02409329|18752663|P3|NOT COMPLETED|Overall Study||9
7616097|NCT02409329|18752664|P2|NOT COMPLETED|Overall Study||6
7616098|NCT02409329|18752665|P1|NOT COMPLETED|Overall Study||5
7616099|NCT02409329|18752663|P3|COMPLETED|Overall Study||244
7616100|NCT02409329|18752664|P2|COMPLETED|Overall Study||120
7616101|NCT02409329|18752665|P1|COMPLETED|Overall Study||122
7616102|NCT02409329|18752663|P3|STARTED|Overall Study||253
7616103|NCT02409329|18752664|P2|STARTED|Overall Study||126
7616104|NCT02409329|18752665|P1|STARTED|Overall Study||127
7616105|NCT02409277|18752688|P3|NOT COMPLETED|Overall Study||0
7616106|NCT02409277|18752689|P2|NOT COMPLETED|Overall Study||17
7616107|NCT02409277|18752690|P1|NOT COMPLETED|Overall Study||100
7616108|NCT02409277|18752688|P3|COMPLETED|Overall Study||599
7616109|NCT02409277|18752689|P2|COMPLETED|Overall Study||43
7616110|NCT02409277|18752690|P1|COMPLETED|Overall Study||167
7616111|NCT02409277|18752688|P3|12 Months Follow-up|Overall Study||599
7616112|NCT02409277|18752689|P2|12 Months Follow-up|Overall Study||43
7616113|NCT02409277|18752690|P1|12 Months Follow-up|Overall Study||167
7616114|NCT02409277|18752688|P3|6 Months Follow-up|Overall Study||599
7616115|NCT02409277|18752689|P2|6 Months Follow-up|Overall Study||42
7616116|NCT02409277|18752690|P1|6 Months Follow-up|Overall Study||182
7616117|NCT02409277|18752688|P3|3 Months Follow-up|Overall Study||599
7616118|NCT02409277|18752689|P2|3 Months Follow-up|Overall Study||40
7616119|NCT02409277|18752690|P1|3 Months Follow-up|Overall Study||178
7616120|NCT02409277|18752688|P3|STARTED|Overall Study||599
7616121|NCT02409277|18752689|P2|STARTED|Overall Study||60
7616122|NCT02409277|18752690|P1|STARTED|Overall Study||267
7616123|NCT02408965|18752730|P2|NOT COMPLETED|Overall Study||0
7616124|NCT02408965|18752731|P1|NOT COMPLETED|Overall Study||0
7616125|NCT02408965|18752730|P2|COMPLETED|Overall Study||144
7616126|NCT02408965|18752731|P1|COMPLETED|Overall Study||140
7616127|NCT02408965|18752730|P2|STARTED|Overall Study||144
7616128|NCT02408965|18752731|P1|STARTED|Overall Study||140
7616129|NCT02408796|18752753|P1|NOT COMPLETED|Overall Study||0
7616130|NCT02408796|18752753|P1|COMPLETED|Overall Study||39
7616131|NCT02408796|18752753|P1|STARTED|Overall Study||39
7616132|NCT02408692|18752762|P3|NOT COMPLETED|Overall Study||0
7616133|NCT02408692|18752763|P2|NOT COMPLETED|Overall Study||0
7616134|NCT02408692|18752764|P1|NOT COMPLETED|Overall Study||0
7616135|NCT02408692|18752762|P3|COMPLETED|Overall Study||5
7616136|NCT02408692|18752763|P2|COMPLETED|Overall Study||5
7616137|NCT02408692|18752764|P1|COMPLETED|Overall Study||5
7616138|NCT02408692|18752762|P3|STARTED|Overall Study||5
7616139|NCT02408692|18752763|P2|STARTED|Overall Study||5
7616140|NCT02408692|18752764|P1|STARTED|Overall Study||5
7616141|NCT02408523|18752777|P2|NOT COMPLETED|Overall Study||18
7616142|NCT02408523|18752778|P1|NOT COMPLETED|Overall Study||11
7616143|NCT02408523|18752777|P2|COMPLETED|Overall Study||103
7616144|NCT02408523|18752778|P1|COMPLETED|Overall Study||110
7616145|NCT02408523|18752777|P2|Enrolled Safety Folllow-up Period|Overall Study||11
7616146|NCT02408523|18752778|P1|Enrolled Safety Folllow-up Period|Overall Study||10
7616147|NCT02408523|18752777|P2|Enrolled Taper Period|Overall Study||9
7616148|NCT02408523|18752778|P1|Enrolled Taper Period|Overall Study||7
7616149|NCT02408523|18752777|P2|Enrolled Transition Period|Overall Study||101
7616150|NCT02408523|18752778|P1|Enrolled Transition Period|Overall Study||108
7616151|NCT02408523|18752777|P2|Completed Treatment Period|Overall Study||103
7616152|NCT02408523|18752778|P1|Completed Treatment Period|Overall Study||110
7616153|NCT02408523|18752777|P2|STARTED|Overall Study||121
7616154|NCT02408523|18752778|P1|STARTED|Overall Study||121
7616155|NCT02408484|18752798|P1|NOT COMPLETED|Overall Study||4
7616156|NCT02408484|18752798|P1|COMPLETED|Overall Study||11
7616157|NCT02408484|18752798|P1|SURG Population|Overall Study||3
7616158|NCT02408484|18752798|P1|BLEED Population|Overall Study||8
7616159|NCT02408484|18752798|P1|firstBLEED Population|Overall Study||8
7616160|NCT02408484|18752798|P1|PK Population|Overall Study||13
7616161|NCT02408484|18752798|P1|FAS Population|Overall Study||14
7616162|NCT02408484|18752798|P1|SAF Population|Overall Study||14
7616163|NCT02408484|18752798|P1|STARTED|Overall Study||15
7616164|NCT02408445|18752832|P2|NOT COMPLETED|Overall Study||0
7616165|NCT02408445|18752833|P1|NOT COMPLETED|Overall Study||0
7616166|NCT02408445|18752832|P2|COMPLETED|Overall Study||10
7616167|NCT02408445|18752833|P1|COMPLETED|Overall Study||10
7616168|NCT02408445|18752832|P2|STARTED|Overall Study||10
7616169|NCT02408445|18752833|P1|STARTED|Overall Study||10
7616170|NCT02408315|18752862|P2|NOT COMPLETED|Overall Study||0
7616171|NCT02408315|18752863|P1|NOT COMPLETED|Overall Study||0
7616172|NCT02408315|18752862|P2|COMPLETED|Overall Study||152
7616173|NCT02408315|18752863|P1|COMPLETED|Overall Study||148
7616174|NCT02408315|18752862|P2|STARTED|Overall Study||152
7616175|NCT02408315|18752863|P1|STARTED|Overall Study||148
7616176|NCT02408263|18752885|P2|NOT COMPLETED|Overall Study||0
7616177|NCT02408263|18752886|P1|NOT COMPLETED|Overall Study||0
7616178|NCT02408263|18752885|P2|COMPLETED|Overall Study||25
7616179|NCT02408263|18752886|P1|COMPLETED|Overall Study||25
7616180|NCT02408263|18752885|P2|STARTED|Overall Study||25
7616181|NCT02408263|18752886|P1|STARTED|Overall Study||25
7616182|NCT02408198|18752894|P2|NOT COMPLETED|Overall Study||0
7616183|NCT02408198|18752895|P1|NOT COMPLETED|Overall Study||3
7616184|NCT02408198|18752894|P2|COMPLETED|Overall Study||5
7616185|NCT02408198|18752895|P1|COMPLETED|Overall Study||10
7616186|NCT02408198|18752894|P2|STARTED|Overall Study||5
7616187|NCT02408198|18752895|P1|STARTED|Overall Study||13
7616188|NCT02408068|18752901|P6|NOT COMPLETED|Treatment 3 (1.5 Days)||0
7616189|NCT02408068|18752902|P5|NOT COMPLETED|Treatment 3 (1.5 Days)||0
7616190|NCT02408068|18752903|P4|NOT COMPLETED|Treatment 3 (1.5 Days)||0
7616191|NCT02408068|18752904|P3|NOT COMPLETED|Treatment 3 (1.5 Days)||1
7616192|NCT02408068|18752905|P2|NOT COMPLETED|Treatment 3 (1.5 Days)||0
7616193|NCT02408068|18752906|P1|NOT COMPLETED|Treatment 3 (1.5 Days)||0
7616194|NCT02408068|18752901|P6|COMPLETED|Treatment 3 (1.5 Days)||3
7616195|NCT02408068|18752902|P5|COMPLETED|Treatment 3 (1.5 Days)||3
7616196|NCT02408068|18752903|P4|COMPLETED|Treatment 3 (1.5 Days)||3
7616197|NCT02408068|18752904|P3|COMPLETED|Treatment 3 (1.5 Days)||2
7616198|NCT02408068|18752905|P2|COMPLETED|Treatment 3 (1.5 Days)||3
7616199|NCT02408068|18752906|P1|COMPLETED|Treatment 3 (1.5 Days)||3
7616200|NCT02408068|18752901|P6|STARTED|Treatment 3 (1.5 Days)||3
7616201|NCT02408068|18752902|P5|STARTED|Treatment 3 (1.5 Days)||3
7616202|NCT02408068|18752903|P4|STARTED|Treatment 3 (1.5 Days)||3
7616203|NCT02408068|18752904|P3|STARTED|Treatment 3 (1.5 Days)||3
7616204|NCT02408068|18752905|P2|STARTED|Treatment 3 (1.5 Days)||3
7616205|NCT02408068|18752906|P1|STARTED|Treatment 3 (1.5 Days)||3
7616206|NCT02408068|18752901|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
7616207|NCT02408068|18752902|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
7616208|NCT02408068|18752903|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
7616209|NCT02408068|18752904|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
7616210|NCT02408068|18752905|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
7616211|NCT02408068|18752906|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
7616212|NCT02408068|18752901|P6|COMPLETED|Washout Period 2 (7 Days)||3
7616213|NCT02408068|18752902|P5|COMPLETED|Washout Period 2 (7 Days)||3
7616214|NCT02408068|18752903|P4|COMPLETED|Washout Period 2 (7 Days)||3
7616215|NCT02408068|18752904|P3|COMPLETED|Washout Period 2 (7 Days)||3
7616216|NCT02408068|18752905|P2|COMPLETED|Washout Period 2 (7 Days)||3
7616217|NCT02408068|18752906|P1|COMPLETED|Washout Period 2 (7 Days)||3
7616218|NCT02408068|18752901|P6|STARTED|Washout Period 2 (7 Days)||3
7616219|NCT02408068|18752902|P5|STARTED|Washout Period 2 (7 Days)||3
7616220|NCT02408068|18752903|P4|STARTED|Washout Period 2 (7 Days)||3
7616221|NCT02408068|18752904|P3|STARTED|Washout Period 2 (7 Days)||3
7616222|NCT02408068|18752905|P2|STARTED|Washout Period 2 (7 Days)||3
7616223|NCT02408068|18752906|P1|STARTED|Washout Period 2 (7 Days)||3
7616224|NCT02408068|18752901|P6|NOT COMPLETED|Treatment 2 (1.5 Days)||0
7616225|NCT02408068|18752902|P5|NOT COMPLETED|Treatment 2 (1.5 Days)||0
7616226|NCT02408068|18752903|P4|NOT COMPLETED|Treatment 2 (1.5 Days)||0
7616227|NCT02408068|18752904|P3|NOT COMPLETED|Treatment 2 (1.5 Days)||0
7616228|NCT02408068|18752905|P2|NOT COMPLETED|Treatment 2 (1.5 Days)||0
7616229|NCT02408068|18752906|P1|NOT COMPLETED|Treatment 2 (1.5 Days)||0
7616230|NCT02408068|18752901|P6|COMPLETED|Treatment 2 (1.5 Days)||3
7616231|NCT02408068|18752902|P5|COMPLETED|Treatment 2 (1.5 Days)||3
7616232|NCT02408068|18752903|P4|COMPLETED|Treatment 2 (1.5 Days)||3
7616233|NCT02408068|18752904|P3|COMPLETED|Treatment 2 (1.5 Days)||3
7616234|NCT02408068|18752905|P2|COMPLETED|Treatment 2 (1.5 Days)||3
7616235|NCT02408068|18752906|P1|COMPLETED|Treatment 2 (1.5 Days)||3
7616236|NCT02408068|18752901|P6|STARTED|Treatment 2 (1.5 Days)||3
7616237|NCT02408068|18752902|P5|STARTED|Treatment 2 (1.5 Days)||3
7616238|NCT02408068|18752903|P4|STARTED|Treatment 2 (1.5 Days)||3
7616239|NCT02408068|18752904|P3|STARTED|Treatment 2 (1.5 Days)||3
7616240|NCT02408068|18752905|P2|STARTED|Treatment 2 (1.5 Days)||3
7616241|NCT02408068|18752906|P1|STARTED|Treatment 2 (1.5 Days)||3
7616242|NCT02408068|18752901|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
7616243|NCT02408068|18752902|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
7616244|NCT02408068|18752903|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
7616245|NCT02408068|18752904|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
7616246|NCT02408068|18752905|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
7616247|NCT02408068|18752906|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
7616248|NCT02408068|18752901|P6|COMPLETED|Washout Period 1 (7 Days)||3
7616249|NCT02408068|18752902|P5|COMPLETED|Washout Period 1 (7 Days)||3
7616250|NCT02408068|18752903|P4|COMPLETED|Washout Period 1 (7 Days)||3
7616251|NCT02408068|18752904|P3|COMPLETED|Washout Period 1 (7 Days)||3
7616252|NCT02408068|18752905|P2|COMPLETED|Washout Period 1 (7 Days)||3
7616253|NCT02408068|18752906|P1|COMPLETED|Washout Period 1 (7 Days)||3
7616254|NCT02408068|18752901|P6|STARTED|Washout Period 1 (7 Days)||3
7616255|NCT02408068|18752902|P5|STARTED|Washout Period 1 (7 Days)||3
7616256|NCT02408068|18752903|P4|STARTED|Washout Period 1 (7 Days)||3
7616257|NCT02408068|18752904|P3|STARTED|Washout Period 1 (7 Days)||3
7616258|NCT02408068|18752905|P2|STARTED|Washout Period 1 (7 Days)||3
7616259|NCT02408068|18752906|P1|STARTED|Washout Period 1 (7 Days)||3
7616260|NCT02408068|18752901|P6|NOT COMPLETED|Treatment 1 (1.5 Days)||0
7616261|NCT02408068|18752902|P5|NOT COMPLETED|Treatment 1 (1.5 Days)||0
7616262|NCT02408068|18752903|P4|NOT COMPLETED|Treatment 1 (1.5 Days)||0
7616263|NCT02408068|18752904|P3|NOT COMPLETED|Treatment 1 (1.5 Days)||0
7616264|NCT02408068|18752905|P2|NOT COMPLETED|Treatment 1 (1.5 Days)||0
7616265|NCT02408068|18752906|P1|NOT COMPLETED|Treatment 1 (1.5 Days)||0
7616266|NCT02408068|18752901|P6|COMPLETED|Treatment 1 (1.5 Days)||3
7616267|NCT02408068|18752902|P5|COMPLETED|Treatment 1 (1.5 Days)||3
7616268|NCT02408068|18752903|P4|COMPLETED|Treatment 1 (1.5 Days)||3
7616269|NCT02408068|18752904|P3|COMPLETED|Treatment 1 (1.5 Days)||3
7616270|NCT02408068|18752905|P2|COMPLETED|Treatment 1 (1.5 Days)||3
7616271|NCT02408068|18752906|P1|COMPLETED|Treatment 1 (1.5 Days)||3
7616272|NCT02408068|18752901|P6|STARTED|Treatment 1 (1.5 Days)||3
7616273|NCT02408068|18752902|P5|STARTED|Treatment 1 (1.5 Days)||3
7616274|NCT02408068|18752903|P4|STARTED|Treatment 1 (1.5 Days)||3
7616275|NCT02408068|18752904|P3|STARTED|Treatment 1 (1.5 Days)||3
7616276|NCT02408068|18752905|P2|STARTED|Treatment 1 (1.5 Days)||3
7616277|NCT02408068|18752906|P1|STARTED|Treatment 1 (1.5 Days)||3
7616278|NCT02407756|18752933|P4|NOT COMPLETED|Overall Study||0
7616279|NCT02407756|18752934|P3|NOT COMPLETED|Overall Study||0
7616280|NCT02407756|18752935|P2|NOT COMPLETED|Overall Study||0
7616281|NCT02407756|18752936|P1|NOT COMPLETED|Overall Study||0
7616282|NCT02407756|18752933|P4|COMPLETED|Overall Study||19
7616283|NCT02407756|18752934|P3|COMPLETED|Overall Study||20
7616284|NCT02407756|18752935|P2|COMPLETED|Overall Study||18
7616285|NCT02407756|18752936|P1|COMPLETED|Overall Study||20
7616286|NCT02407756|18752933|P4|Treated|Overall Study||19
7616287|NCT02407756|18752934|P3|Treated|Overall Study||20
7616288|NCT02407756|18752935|P2|Treated|Overall Study||18
7616289|NCT02407756|18752936|P1|Treated|Overall Study||20
7616290|NCT02407756|18752933|P4|STARTED|Overall Study||19
7616291|NCT02407756|18752934|P3|STARTED|Overall Study||20
7616292|NCT02407756|18752935|P2|STARTED|Overall Study||18
7616293|NCT02407756|18752936|P1|STARTED|Overall Study||20
7616294|NCT02407704|18752978|P4|NOT COMPLETED|Overall Study||3
7616295|NCT02407704|18752979|P3|NOT COMPLETED|Overall Study||1
7616296|NCT02407704|18752980|P2|NOT COMPLETED|Overall Study||0
7616297|NCT02407704|18752981|P1|NOT COMPLETED|Overall Study||0
7616298|NCT02407704|18752978|P4|COMPLETED|Overall Study||2
7616299|NCT02407704|18752979|P3|COMPLETED|Overall Study||4
7616300|NCT02407704|18752980|P2|COMPLETED|Overall Study||3
7616301|NCT02407704|18752981|P1|COMPLETED|Overall Study||2
7616302|NCT02407704|18752978|P4|STARTED|Overall Study||5
7616303|NCT02407704|18752979|P3|STARTED|Overall Study||5
7616304|NCT02407704|18752980|P2|STARTED|Overall Study||3
7616305|NCT02407704|18752981|P1|STARTED|Overall Study||2
7616306|NCT02407457|18753017|P2|NOT COMPLETED|5-year||63
7616307|NCT02407457|18753018|P1|NOT COMPLETED|5-year||71
7616308|NCT02407457|18753017|P2|COMPLETED|5-year||0
7616309|NCT02407457|18753018|P1|COMPLETED|5-year|Due to the time frame of the study - subjects have not passed 5-year.|0
7616310|NCT02407457|18753017|P2|STARTED|5-year||63
7616311|NCT02407457|18753018|P1|STARTED|5-year||71
7616312|NCT02407457|18753017|P2|NOT COMPLETED|4-year||77
7616313|NCT02407457|18753018|P1|NOT COMPLETED|4-year||86
7616314|NCT02407457|18753017|P2|COMPLETED|4-year||63
7616315|NCT02407457|18753018|P1|COMPLETED|4-year||71
7616316|NCT02407457|18753017|P2|STARTED|4-year||140
7616317|NCT02407457|18753018|P1|STARTED|4-year||157
7616318|NCT02407457|18753017|P2|NOT COMPLETED|3-year||42
7616319|NCT02407457|18753018|P1|NOT COMPLETED|3-year||48
7616320|NCT02407457|18753017|P2|COMPLETED|3-year||140
7616321|NCT02407457|18753018|P1|COMPLETED|3-year||157
7616322|NCT02407457|18753017|P2|STARTED|3-year||182
7616323|NCT02407457|18753018|P1|STARTED|3-year||205
7616324|NCT02407457|18753017|P2|NOT COMPLETED|2-year||14
7616325|NCT02407457|18753018|P1|NOT COMPLETED|2-year||15
7616326|NCT02407457|18753017|P2|COMPLETED|2-year||182
7616327|NCT02407457|18753018|P1|COMPLETED|2-year||205
7616328|NCT02407457|18753017|P2|STARTED|2-year||196
7616329|NCT02407457|18753018|P1|STARTED|2-year||220
7616330|NCT02407457|18753017|P2|NOT COMPLETED|1 Year||24
7616331|NCT02407457|18753018|P1|NOT COMPLETED|1 Year||15
7616332|NCT02407457|18753017|P2|COMPLETED|1 Year||196
7616333|NCT02407457|18753018|P1|COMPLETED|1 Year||220
7616334|NCT02407457|18753017|P2|STARTED|1 Year||220
7616335|NCT02407457|18753018|P1|STARTED|1 Year||235
7616336|NCT02407249|18753024|P1|NOT COMPLETED|Overall Study||26
7616337|NCT02407249|18753024|P1|COMPLETED|Overall Study||47
7616338|NCT02407249|18753024|P1|Treated|Overall Study||60
7616339|NCT02407249|18753024|P1|STARTED|Overall Study||73
7616340|NCT02407236|18753040|P8|NOT COMPLETED|Maintenance Study (44 Weeks)||8
7616341|NCT02407236|18753041|P7|NOT COMPLETED|Maintenance Study (44 Weeks)||9
7616342|NCT02407236|18753042|P6|NOT COMPLETED|Maintenance Study (44 Weeks)||8
7616343|NCT02407236|18753043|P5|NOT COMPLETED|Maintenance Study (44 Weeks)||11
7616344|NCT02407236|18753044|P4|NOT COMPLETED|Maintenance Study (44 Weeks)||10
7616345|NCT02407236|18753045|P3|NOT COMPLETED|Maintenance Study (44 Weeks)||0
7616346|NCT02407236|18753046|P2|NOT COMPLETED|Maintenance Study (44 Weeks)||0
7616347|NCT02407236|18753047|P1|NOT COMPLETED|Maintenance Study (44 Weeks)||0
7616348|NCT02407236|18753040|P8|COMPLETED|Maintenance Study (44 Weeks)||149
7616349|NCT02407236|18753041|P7|COMPLETED|Maintenance Study (44 Weeks)||94
7616350|NCT02407236|18753042|P6|COMPLETED|Maintenance Study (44 Weeks)||168
7616351|NCT02407236|18753043|P5|COMPLETED|Maintenance Study (44 Weeks)||161
7616352|NCT02407236|18753044|P4|COMPLETED|Maintenance Study (44 Weeks)||165
7616353|NCT02407236|18753045|P3|COMPLETED|Maintenance Study (44 Weeks)||0
7616354|NCT02407236|18753046|P2|COMPLETED|Maintenance Study (44 Weeks)||0
7616355|NCT02407236|18753047|P1|COMPLETED|Maintenance Study (44 Weeks)||0
7616356|NCT02407236|18753040|P8|STARTED|Maintenance Study (44 Weeks)||157
7616357|NCT02407236|18753041|P7|STARTED|Maintenance Study (44 Weeks)||103
7616358|NCT02407236|18753042|P6|STARTED|Maintenance Study (44 Weeks)||176
7616359|NCT02407236|18753043|P5|STARTED|Maintenance Study (44 Weeks)||172
7616360|NCT02407236|18753044|P4|STARTED|Maintenance Study (44 Weeks)||175
7616361|NCT02407236|18753045|P3|STARTED|Maintenance Study (44 Weeks)||0
7616362|NCT02407236|18753046|P2|STARTED|Maintenance Study (44 Weeks)||0
7616363|NCT02407236|18753047|P1|STARTED|Maintenance Study (44 Weeks)||0
7616364|NCT02407236|18753040|P8|NOT COMPLETED|Induction Study (8 Weeks)||0
7616365|NCT02407236|18753041|P7|NOT COMPLETED|Induction Study (8 Weeks)||0
7616366|NCT02407236|18753042|P6|NOT COMPLETED|Induction Study (8 Weeks)||0
7616367|NCT02407236|18753043|P5|NOT COMPLETED|Induction Study (8 Weeks)||0
7616368|NCT02407236|18753044|P4|NOT COMPLETED|Induction Study (8 Weeks)||0
7616369|NCT02407236|18753045|P3|NOT COMPLETED|Induction Study (8 Weeks)||15
7616370|NCT02407236|18753046|P2|NOT COMPLETED|Induction Study (8 Weeks)||11
7616371|NCT02407236|18753047|P1|NOT COMPLETED|Induction Study (8 Weeks)||23
7616372|NCT02407236|18753040|P8|COMPLETED|Induction Study (8 Weeks)||0
7616373|NCT02407236|18753041|P7|COMPLETED|Induction Study (8 Weeks)||0
7616374|NCT02407236|18753042|P6|COMPLETED|Induction Study (8 Weeks)||0
7616375|NCT02407236|18753043|P5|COMPLETED|Induction Study (8 Weeks)||0
7616376|NCT02407236|18753044|P4|COMPLETED|Induction Study (8 Weeks)||0
7616377|NCT02407236|18753045|P3|COMPLETED|Induction Study (8 Weeks)||307
7616378|NCT02407236|18753046|P2|COMPLETED|Induction Study (8 Weeks)||309
7616379|NCT02407236|18753047|P1|COMPLETED|Induction Study (8 Weeks)||296
7616380|NCT02407236|18753040|P8|Non-responders at Week 8|Induction Study (8 Weeks)||0
7616381|NCT02407236|18753041|P7|Non-responders at Week 8|Induction Study (8 Weeks)||0
7616382|NCT02407236|18753042|P6|Non-responders at Week 8|Induction Study (8 Weeks)||0
7616383|NCT02407236|18753043|P5|Non-responders at Week 8|Induction Study (8 Weeks)||0
7616384|NCT02407236|18753044|P4|Non-responders at Week 8|Induction Study (8 Weeks)||0
7616385|NCT02407236|18753045|P3|Non-responders at Week 8|Induction Study (8 Weeks)||101
7616386|NCT02407236|18753046|P2|Non-responders at Week 8|Induction Study (8 Weeks)||132
7616387|NCT02407236|18753047|P1|Non-responders at Week 8|Induction Study (8 Weeks)||184
7616388|NCT02407236|18753040|P8|Safety Analysis Set|Induction Study (8 Weeks)||0
7616389|NCT02407236|18753041|P7|Safety Analysis Set|Induction Study (8 Weeks)||0
7616390|NCT02407236|18753042|P6|Safety Analysis Set|Induction Study (8 Weeks)||0
7616391|NCT02407236|18753043|P5|Safety Analysis Set|Induction Study (8 Weeks)||0
7616392|NCT02407236|18753044|P4|Safety Analysis Set|Induction Study (8 Weeks)||0
7616393|NCT02407236|18753045|P3|Safety Analysis Set|Induction Study (8 Weeks)||320
7616394|NCT02407236|18753046|P2|Safety Analysis Set|Induction Study (8 Weeks)|1 participant of ustekinumab 130mg never had drug, 2 participants planned to 6 mg/kg but had 130mg.|321
7616395|NCT02407236|18753047|P1|Safety Analysis Set|Induction Study (8 Weeks)||319
7616396|NCT02407236|18753040|P8|Completed Safety Follow-up|Induction Study (8 Weeks)||0
7616397|NCT02407236|18753041|P7|Completed Safety Follow-up|Induction Study (8 Weeks)||0
7616398|NCT02407236|18753042|P6|Completed Safety Follow-up|Induction Study (8 Weeks)||0
7616399|NCT02407236|18753043|P5|Completed Safety Follow-up|Induction Study (8 Weeks)||0
7616400|NCT02407236|18753044|P4|Completed Safety Follow-up|Induction Study (8 Weeks)||0
7616401|NCT02407236|18753045|P3|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 22 from IW- 16.|32
7616402|NCT02407236|18753046|P2|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 37 from IW- 16.|47
7616403|NCT02407236|18753047|P1|Completed Safety Follow-up|Induction Study (8 Weeks)|17 participants from Induction Week (IW)- 8 and 33 participants from IW- 16.|50
7616404|NCT02407236|18753040|P8|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
7616405|NCT02407236|18753041|P7|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
7616406|NCT02407236|18753042|P6|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
7616407|NCT02407236|18753043|P5|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
7616408|NCT02407236|18753044|P4|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
7616409|NCT02407236|18753045|P3|Clinical Response at IS Week 16|Induction Study (8 Weeks)||67
7616410|NCT02407236|18753046|P2|Clinical Response at IS Week 16|Induction Study (8 Weeks)||90
7616411|NCT02407236|18753047|P1|Clinical Response at IS Week 16|Induction Study (8 Weeks)||143
7616412|NCT02407236|18753040|P8|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
7616413|NCT02407236|18753041|P7|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
7616414|NCT02407236|18753042|P6|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
7616415|NCT02407236|18753043|P5|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
7616416|NCT02407236|18753044|P4|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
7616417|NCT02407236|18753045|P3|Clinical Response at IS Week 8|Induction Study (8 Weeks)||208
7616418|NCT02407236|18753046|P2|Clinical Response at IS Week 8|Induction Study (8 Weeks)||172
7616419|NCT02407236|18753047|P1|Clinical Response at IS Week 8|Induction Study (8 Weeks)||103
7616420|NCT02407236|18753040|P8|STARTED|Induction Study (8 Weeks)||0
7616421|NCT02407236|18753041|P7|STARTED|Induction Study (8 Weeks)||0
7616422|NCT02407236|18753042|P6|STARTED|Induction Study (8 Weeks)||0
7616423|NCT02407236|18753043|P5|STARTED|Induction Study (8 Weeks)||0
7616424|NCT02407236|18753044|P4|STARTED|Induction Study (8 Weeks)||0
7616425|NCT02407236|18753045|P3|STARTED|Induction Study (8 Weeks)||322
7616426|NCT02407236|18753046|P2|STARTED|Induction Study (8 Weeks)||320
7616427|NCT02407236|18753047|P1|STARTED|Induction Study (8 Weeks)||319
7616428|NCT02407223|18753287|P3|NOT COMPLETED|Overall Study||122
7616429|NCT02407223|18753288|P2|NOT COMPLETED|Overall Study||118
7616430|NCT02407223|18753289|P1|NOT COMPLETED|Overall Study||116
7616431|NCT02407223|18753287|P3|COMPLETED|Overall Study||0
7616432|NCT02407223|18753288|P2|COMPLETED|Overall Study||0
7616433|NCT02407223|18753289|P1|COMPLETED|Overall Study||0
7616434|NCT02407223|18753287|P3|Qualified Re-randomization at Week 52|Overall Study||2
7616435|NCT02407223|18753288|P2|Qualified Re-randomization at Week 52|Overall Study||3
7616436|NCT02407223|18753289|P1|Qualified Re-randomization at Week 52|Overall Study||0
7616437|NCT02407223|18753287|P3|Cross Over at Week 24|Overall Study||0
7616438|NCT02407223|18753288|P2|Cross Over at Week 24|Overall Study||0
7616439|NCT02407223|18753289|P1|Cross Over at Week 24|Overall Study|Study discontinuation/completion reported under randomization group|60
7616440|NCT02407223|18753287|P3|Early Escape at Week 16|Overall Study||0
7616441|NCT02407223|18753288|P2|Early Escape at Week 16|Overall Study||0
7616442|NCT02407223|18753289|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|22
7616443|NCT02407223|18753287|P3|STARTED|Overall Study||122
7616444|NCT02407223|18753288|P2|STARTED|Overall Study||118
7616445|NCT02407223|18753289|P1|STARTED|Overall Study||116
7616446|NCT02407132|18753334|P2|NOT COMPLETED|12 Months Post-intervention||2
7616447|NCT02407132|18753335|P1|NOT COMPLETED|12 Months Post-intervention||13
7616448|NCT02407132|18753334|P2|COMPLETED|12 Months Post-intervention||90
7616449|NCT02407132|18753335|P1|COMPLETED|12 Months Post-intervention||83
7616450|NCT02407132|18753334|P2|STARTED|12 Months Post-intervention||92
7616451|NCT02407132|18753335|P1|STARTED|12 Months Post-intervention||96
7616452|NCT02407132|18753334|P2|NOT COMPLETED|6 Months Post-intervention||9
7616453|NCT02407132|18753335|P1|NOT COMPLETED|6 Months Post-intervention||11
7616454|NCT02407132|18753334|P2|COMPLETED|6 Months Post-intervention||92
7616455|NCT02407132|18753335|P1|COMPLETED|6 Months Post-intervention||96
7616456|NCT02407132|18753334|P2|STARTED|6 Months Post-intervention||101
7616457|NCT02407132|18753335|P1|STARTED|6 Months Post-intervention||107
7616458|NCT02407132|18753334|P2|NOT COMPLETED|Immediate Post-intervention||10
7616459|NCT02407132|18753335|P1|NOT COMPLETED|Immediate Post-intervention||3
7616460|NCT02407132|18753334|P2|COMPLETED|Immediate Post-intervention||101
7616461|NCT02407132|18753335|P1|COMPLETED|Immediate Post-intervention||107
7616462|NCT02407132|18753334|P2|STARTED|Immediate Post-intervention||111
7616463|NCT02407132|18753335|P1|STARTED|Immediate Post-intervention||110
7616464|NCT02407041|18753359|P1|NOT COMPLETED|Overall Study||0
7616465|NCT02407041|18753359|P1|COMPLETED|Overall Study||5
7616466|NCT02407041|18753359|P1|STARTED|Overall Study||5
7616467|NCT02406937|18753366|P3|NOT COMPLETED|Overall Study||2
7616468|NCT02406937|18753367|P2|NOT COMPLETED|Overall Study||1
7616469|NCT02406937|18753368|P1|NOT COMPLETED|Overall Study||1
7616470|NCT02406937|18753366|P3|COMPLETED|Overall Study||58
7616471|NCT02406937|18753367|P2|COMPLETED|Overall Study||59
7616472|NCT02406937|18753368|P1|COMPLETED|Overall Study||59
7616473|NCT02406937|18753366|P3|STARTED|Overall Study||60
7616474|NCT02406937|18753367|P2|STARTED|Overall Study||60
7616475|NCT02406937|18753368|P1|STARTED|Overall Study||60
7616476|NCT02406885|18753426|P2|NOT COMPLETED|Overall Study||2
7616477|NCT02406885|18753427|P1|NOT COMPLETED|Overall Study||3
7616478|NCT02406885|18753426|P2|COMPLETED|Overall Study||14
7616479|NCT02406885|18753427|P1|COMPLETED|Overall Study||14
7616480|NCT02406885|18753426|P2|STARTED|Overall Study||16
7616481|NCT02406885|18753427|P1|STARTED|Overall Study||17
7616482|NCT02406677|18753441|P2|NOT COMPLETED|Overall Study||598
7616483|NCT02406677|18753442|P1|NOT COMPLETED|Overall Study||301
7616484|NCT02406677|18753441|P2|COMPLETED|Overall Study||3967
7616485|NCT02406677|18753442|P1|COMPLETED|Overall Study||6135
7616486|NCT02406677|18753441|P2|STARTED|Overall Study||4565
7616487|NCT02406677|18753442|P1|STARTED|Overall Study||6436
7616488|NCT02406612|18753456|P2|NOT COMPLETED|Overall Study||4
7616489|NCT02406612|18753457|P1|NOT COMPLETED|Overall Study||4
7616490|NCT02406612|18753456|P2|COMPLETED|Overall Study||17
7616491|NCT02406612|18753457|P1|COMPLETED|Overall Study||22
7616492|NCT02406612|18753456|P2|STARTED|Overall Study||21
7616493|NCT02406612|18753457|P1|STARTED|Overall Study||26
7616494|NCT02406586|18753472|P3|NOT COMPLETED|Overall Study||2
7616495|NCT02406586|18753473|P2|NOT COMPLETED|Overall Study||4
7616496|NCT02406586|18753474|P1|NOT COMPLETED|Overall Study||1
7616497|NCT02406586|18753472|P3|COMPLETED|Overall Study||10
7616498|NCT02406586|18753473|P2|COMPLETED|Overall Study||8
7616499|NCT02406586|18753474|P1|COMPLETED|Overall Study||11
7616500|NCT02406586|18753472|P3|STARTED|Overall Study||12
7616501|NCT02406586|18753473|P2|STARTED|Overall Study||12
7616502|NCT02406586|18753474|P1|STARTED|Overall Study||12
7616503|NCT02406573|18753548|P1|NOT COMPLETED|Overall Study||0
7616504|NCT02406573|18753548|P1|COMPLETED|Overall Study||30
7616505|NCT02406573|18753548|P1|STARTED|Overall Study||30
7616506|NCT02406495|18753554|P1|NOT COMPLETED|Overall Study||0
7616507|NCT02406495|18753554|P1|COMPLETED|Overall Study||40
7616508|NCT02406495|18753554|P1|STARTED|Overall Study||40
7616509|NCT02406443|18753595|P2|NOT COMPLETED|Overall Study||2
7616510|NCT02406443|18753596|P1|NOT COMPLETED|Overall Study||2
7616511|NCT02406443|18753595|P2|COMPLETED|Overall Study||16
7616512|NCT02406443|18753596|P1|COMPLETED|Overall Study||16
7616513|NCT02406443|18753595|P2|STARTED|Overall Study||18
7616514|NCT02406443|18753596|P1|STARTED|Overall Study||18
7616515|NCT02406261|18753616|P2|NOT COMPLETED|Period 2||3
7616516|NCT02406261|18753617|P1|NOT COMPLETED|Period 2||0
7616517|NCT02406261|18753616|P2|COMPLETED|Period 2||29
7616518|NCT02406261|18753617|P1|COMPLETED|Period 2||0
7616519|NCT02406261|18753616|P2|STARTED|Period 2||32
7616520|NCT02406261|18753617|P1|STARTED|Period 2|Cohort A participated in Period 1 only|0
7616521|NCT02406261|18753616|P2|NOT COMPLETED|Period 1||0
7616522|NCT02406261|18753617|P1|NOT COMPLETED|Period 1||3
7616523|NCT02406261|18753616|P2|COMPLETED|Period 1||32
7616524|NCT02406261|18753617|P1|COMPLETED|Period 1||47
7616525|NCT02406261|18753616|P2|Received at Least One Dose of Study Drug|Period 1||32
7616526|NCT02406261|18753617|P1|Received at Least One Dose of Study Drug|Period 1||50
7616527|NCT02406261|18753616|P2|STARTED|Period 1||32
7616528|NCT02406261|18753617|P1|STARTED|Period 1||50
7616529|NCT02406248|18753629|P1|NOT COMPLETED|Overall Study||9
7616530|NCT02406248|18753629|P1|COMPLETED|Overall Study||99
7616531|NCT02406248|18753629|P1|STARTED|Overall Study||108
7616532|NCT02406027|18753640|P7|NOT COMPLETED|Open-label Phase (Period 2)||22
7616533|NCT02406027|18753641|P6|NOT COMPLETED|Open-label Phase (Period 2)||26
7616534|NCT02406027|18753642|P5|NOT COMPLETED|Open-label Phase (Period 2)||14
7616535|NCT02406027|18753643|P4|NOT COMPLETED|Open-label Phase (Period 2)||15
7616536|NCT02406027|18753644|P3|NOT COMPLETED|Open-label Phase (Period 2)||0
7616537|NCT02406027|18753645|P2|NOT COMPLETED|Open-label Phase (Period 2)||0
7616538|NCT02406027|18753646|P1|NOT COMPLETED|Open-label Phase (Period 2)||0
7616539|NCT02406027|18753640|P7|COMPLETED|Open-label Phase (Period 2)||0
7616540|NCT02406027|18753641|P6|COMPLETED|Open-label Phase (Period 2)||0
7616541|NCT02406027|18753642|P5|COMPLETED|Open-label Phase (Period 2)||0
7616542|NCT02406027|18753643|P4|COMPLETED|Open-label Phase (Period 2)||0
7616543|NCT02406027|18753644|P3|COMPLETED|Open-label Phase (Period 2)||0
7616544|NCT02406027|18753645|P2|COMPLETED|Open-label Phase (Period 2)||0
7616545|NCT02406027|18753646|P1|COMPLETED|Open-label Phase (Period 2)||0
7616546|NCT02406027|18753640|P7|STARTED|Open-label Phase (Period 2)||22
7616547|NCT02406027|18753641|P6|STARTED|Open-label Phase (Period 2)||26
7616548|NCT02406027|18753642|P5|STARTED|Open-label Phase (Period 2)||14
7616549|NCT02406027|18753643|P4|STARTED|Open-label Phase (Period 2)||15
7616550|NCT02406027|18753644|P3|STARTED|Open-label Phase (Period 2)||0
7616551|NCT02406027|18753645|P2|STARTED|Open-label Phase (Period 2)||0
7616552|NCT02406027|18753646|P1|STARTED|Open-label Phase (Period 2)||0
7616553|NCT02406027|18753640|P7|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
7616554|NCT02406027|18753641|P6|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
7616555|NCT02406027|18753642|P5|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
7616556|NCT02406027|18753643|P4|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
7616557|NCT02406027|18753644|P3|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||4
7616558|NCT02406027|18753645|P2|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||3
7616639|NCT02405442|18753782|P3|COMPLETED|Open-Label Phase (up to Week 52)||2
7616559|NCT02406027|18753646|P1|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||6
7616560|NCT02406027|18753640|P7|COMPLETED|Double-blind Treatment Phase (Period 1)||0
7616561|NCT02406027|18753641|P6|COMPLETED|Double-blind Treatment Phase (Period 1)||0
7616562|NCT02406027|18753642|P5|COMPLETED|Double-blind Treatment Phase (Period 1)||0
7616563|NCT02406027|18753643|P4|COMPLETED|Double-blind Treatment Phase (Period 1)||0
7616564|NCT02406027|18753644|P3|COMPLETED|Double-blind Treatment Phase (Period 1)||22
7616565|NCT02406027|18753645|P2|COMPLETED|Double-blind Treatment Phase (Period 1)||26
7616566|NCT02406027|18753646|P1|COMPLETED|Double-blind Treatment Phase (Period 1)||29
7616567|NCT02406027|18753640|P7|Prodromal|Double-blind Treatment Phase (Period 1)||0
7616568|NCT02406027|18753641|P6|Prodromal|Double-blind Treatment Phase (Period 1)||0
7616569|NCT02406027|18753642|P5|Prodromal|Double-blind Treatment Phase (Period 1)||0
7616570|NCT02406027|18753643|P4|Prodromal|Double-blind Treatment Phase (Period 1)||0
7616571|NCT02406027|18753644|P3|Prodromal|Double-blind Treatment Phase (Period 1)||20
7616572|NCT02406027|18753645|P2|Prodromal|Double-blind Treatment Phase (Period 1)||21
7616573|NCT02406027|18753646|P1|Prodromal|Double-blind Treatment Phase (Period 1)||29
7616574|NCT02406027|18753640|P7|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
7616575|NCT02406027|18753641|P6|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
7616576|NCT02406027|18753642|P5|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
7616577|NCT02406027|18753643|P4|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
7616578|NCT02406027|18753644|P3|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
7616579|NCT02406027|18753645|P2|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||8
7616580|NCT02406027|18753646|P1|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
7616581|NCT02406027|18753640|P7|STARTED|Double-blind Treatment Phase (Period 1)||0
7616582|NCT02406027|18753641|P6|STARTED|Double-blind Treatment Phase (Period 1)||0
7616583|NCT02406027|18753642|P5|STARTED|Double-blind Treatment Phase (Period 1)||0
7616584|NCT02406027|18753643|P4|STARTED|Double-blind Treatment Phase (Period 1)||0
7616585|NCT02406027|18753644|P3|STARTED|Double-blind Treatment Phase (Period 1)||26
7616586|NCT02406027|18753645|P2|STARTED|Double-blind Treatment Phase (Period 1)||29
7616587|NCT02406027|18753646|P1|STARTED|Double-blind Treatment Phase (Period 1)||35
7616588|NCT02405962|18753676|P2|NOT COMPLETED|Overall Study||5
7616589|NCT02405962|18753677|P1|NOT COMPLETED|Overall Study||1
7616590|NCT02405962|18753676|P2|COMPLETED|Overall Study||79
7616591|NCT02405962|18753677|P1|COMPLETED|Overall Study||83
7616592|NCT02405962|18753676|P2|3 Months After the Intervention|Overall Study||79
7616593|NCT02405962|18753677|P1|3 Months After the Intervention|Overall Study||80
7616594|NCT02405962|18753676|P2|Post-intervention|Overall Study||81
7616595|NCT02405962|18753677|P1|Post-intervention|Overall Study||80
7616596|NCT02405962|18753676|P2|STARTED|Overall Study||84
7616597|NCT02405962|18753677|P1|STARTED|Overall Study||84
7616598|NCT02405780|18753715|P4|NOT COMPLETED|Period II||18
7616599|NCT02405780|18753716|P3|NOT COMPLETED|Period II||12
7616600|NCT02405780|18753717|P2|NOT COMPLETED|Period II||12
7616601|NCT02405780|18753718|P1|NOT COMPLETED|Period II||15
7616602|NCT02405780|18753715|P4|COMPLETED|Period II||172
7616603|NCT02405780|18753716|P3|COMPLETED|Period II||81
7616604|NCT02405780|18753717|P2|COMPLETED|Period II||88
7616605|NCT02405780|18753718|P1|COMPLETED|Period II||174
7616606|NCT02405780|18753715|P4|STARTED|Period II||190
7616607|NCT02405780|18753716|P3|STARTED|Period II||93
7616608|NCT02405780|18753717|P2|STARTED|Period II||100
7616609|NCT02405780|18753718|P1|STARTED|Period II||189
7616610|NCT02405780|18753715|P4|NOT COMPLETED|Period I||23
7616611|NCT02405780|18753716|P3|NOT COMPLETED|Period I||15
7616612|NCT02405780|18753717|P2|NOT COMPLETED|Period I||8
7616613|NCT02405780|18753718|P1|NOT COMPLETED|Period I||27
7616614|NCT02405780|18753715|P4|COMPLETED|Period I||190
7616615|NCT02405780|18753716|P3|COMPLETED|Period I||93
7616616|NCT02405780|18753717|P2|COMPLETED|Period I||100
7616617|NCT02405780|18753718|P1|COMPLETED|Period I||189
7616618|NCT02405780|18753715|P4|STARTED|Period I||213
7616619|NCT02405780|18753716|P3|STARTED|Period I||108
7616620|NCT02405780|18753717|P2|STARTED|Period I||108
7616621|NCT02405780|18753718|P1|STARTED|Period I||216
7616622|NCT02405442|18753781|P4|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
7616623|NCT02405442|18753782|P3|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
7616624|NCT02405442|18753783|P2|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
7616625|NCT02405442|18753784|P1|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||3
7616626|NCT02405442|18753781|P4|COMPLETED|Extended Treatment Phase(up to Week 208)||0
7616627|NCT02405442|18753782|P3|COMPLETED|Extended Treatment Phase(up to Week 208)||0
7616628|NCT02405442|18753783|P2|COMPLETED|Extended Treatment Phase(up to Week 208)||0
7616629|NCT02405442|18753784|P1|COMPLETED|Extended Treatment Phase(up to Week 208)||0
7616630|NCT02405442|18753781|P4|STARTED|Extended Treatment Phase(up to Week 208)||2
7616631|NCT02405442|18753782|P3|STARTED|Extended Treatment Phase(up to Week 208)||2
7616632|NCT02405442|18753783|P2|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|2
7616633|NCT02405442|18753784|P1|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|3
7616634|NCT02405442|18753781|P4|NOT COMPLETED|Open-Label Phase (up to Week 52)||24
7616635|NCT02405442|18753782|P3|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
7616636|NCT02405442|18753783|P2|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
7616637|NCT02405442|18753784|P1|NOT COMPLETED|Open-Label Phase (up to Week 52)||48
7616638|NCT02405442|18753781|P4|COMPLETED|Open-Label Phase (up to Week 52)||2
7616640|NCT02405442|18753783|P2|COMPLETED|Open-Label Phase (up to Week 52)||3
7616641|NCT02405442|18753784|P1|COMPLETED|Open-Label Phase (up to Week 52)||4
7616642|NCT02405442|18753781|P4|STARTED|Open-Label Phase (up to Week 52)|1 participant completed Double-Blind Phase, but did not continue in Open-Label Phase.|26
7616643|NCT02405442|18753782|P3|STARTED|Open-Label Phase (up to Week 52)||47
7616644|NCT02405442|18753783|P2|STARTED|Open-Label Phase (up to Week 52)||48
7616645|NCT02405442|18753784|P1|STARTED|Open-Label Phase (up to Week 52)||52
7616646|NCT02405442|18753781|P4|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
7616647|NCT02405442|18753782|P3|NOT COMPLETED|Double-Blind Phase (up to Week 8)||6
7616648|NCT02405442|18753783|P2|NOT COMPLETED|Double-Blind Phase (up to Week 8)||5
7616649|NCT02405442|18753784|P1|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
7616650|NCT02405442|18753781|P4|COMPLETED|Double-Blind Phase (up to Week 8)||27
7616651|NCT02405442|18753782|P3|COMPLETED|Double-Blind Phase (up to Week 8)||47
7616652|NCT02405442|18753783|P2|COMPLETED|Double-Blind Phase (up to Week 8)||48
7616653|NCT02405442|18753784|P1|COMPLETED|Double-Blind Phase (up to Week 8)||52
7616654|NCT02405442|18753781|P4|STARTED|Double-Blind Phase (up to Week 8)||28
7616655|NCT02405442|18753782|P3|STARTED|Double-Blind Phase (up to Week 8)||53
7616656|NCT02405442|18753783|P2|STARTED|Double-Blind Phase (up to Week 8)||53
7616657|NCT02405442|18753784|P1|STARTED|Double-Blind Phase (up to Week 8)||53
7616658|NCT02405429|18753810|P1|NOT COMPLETED|Overall Study||0
7616659|NCT02405429|18753810|P1|COMPLETED|Overall Study||49
7616660|NCT02405429|18753810|P1|STARTED|Overall Study||49
7616661|NCT02405390|18753820|P2|NOT COMPLETED|Overall Study||0
7616662|NCT02405390|18753821|P1|NOT COMPLETED|Overall Study||0
7616663|NCT02405390|18753820|P2|COMPLETED|Overall Study||46
7616664|NCT02405390|18753821|P1|COMPLETED|Overall Study||46
7616665|NCT02405390|18753820|P2|STARTED|Overall Study||46
7616666|NCT02405390|18753821|P1|STARTED|Overall Study||46
7616667|NCT02405195|18753829|P1|NOT COMPLETED|Overall Study||0
7616668|NCT02405195|18753829|P1|COMPLETED|Overall Study||18
7616669|NCT02405195|18753829|P1|STARTED|Overall Study||18
7616670|NCT02405091|18753838|P3|NOT COMPLETED|Overall Study||2
7616671|NCT02405091|18753839|P2|NOT COMPLETED|Overall Study||33
7616672|NCT02405091|18753840|P1|NOT COMPLETED|Overall Study||29
7616673|NCT02405091|18753838|P3|COMPLETED|Overall Study||9
7616674|NCT02405091|18753839|P2|COMPLETED|Overall Study||74
7616675|NCT02405091|18753840|P1|COMPLETED|Overall Study||20
7616676|NCT02405091|18753838|P3|STARTED|Overall Study||11
7616677|NCT02405091|18753839|P2|STARTED|Overall Study||107
7616678|NCT02405091|18753840|P1|STARTED|Overall Study||49
7616679|NCT02404792|18753863|P2|NOT COMPLETED|Overall Study||8
7616680|NCT02404792|18753864|P1|NOT COMPLETED|Overall Study||5
7616681|NCT02404792|18753863|P2|COMPLETED|Overall Study||29
7616682|NCT02404792|18753864|P1|COMPLETED|Overall Study||27
7616683|NCT02404792|18753863|P2|STARTED|Overall Study||37
7616684|NCT02404792|18753864|P1|STARTED|Overall Study||32
7616685|NCT02404649|18753876|P2|NOT COMPLETED|Overall Study||2
7616686|NCT02404649|18753877|P1|NOT COMPLETED|Overall Study||1
7616687|NCT02404649|18753876|P2|COMPLETED|Overall Study||14
7616688|NCT02404649|18753877|P1|COMPLETED|Overall Study||16
7616689|NCT02404649|18753876|P2|STARTED|Overall Study||16
7616690|NCT02404649|18753877|P1|STARTED|Overall Study||17
7616691|NCT02404610|18753887|P2|NOT COMPLETED|Overall Study||0
7616692|NCT02404610|18753888|P1|NOT COMPLETED|Overall Study||0
7616693|NCT02404610|18753887|P2|COMPLETED|Overall Study||53
7616694|NCT02404610|18753888|P1|COMPLETED|Overall Study||54
7616695|NCT02404610|18753887|P2|STARTED|Overall Study||53
7616696|NCT02404610|18753888|P1|STARTED|Overall Study||54
7616697|NCT02404545|18753896|P2|NOT COMPLETED|Overall Study||6
7616698|NCT02404545|18753897|P1|NOT COMPLETED|Overall Study||6
7616699|NCT02404545|18753896|P2|COMPLETED|Overall Study||0
7616700|NCT02404545|18753897|P1|COMPLETED|Overall Study||0
7616701|NCT02404545|18753896|P2|STARTED|Overall Study||6
7616702|NCT02404545|18753897|P1|STARTED|Overall Study||6
7616703|NCT02404532|18753904|P1|NOT COMPLETED|Overall Study||0
7616704|NCT02404532|18753904|P1|COMPLETED|Overall Study||29
7616705|NCT02404532|18753904|P1|STARTED|Overall Study||29
7616706|NCT02404493|18753916|P2|NOT COMPLETED|Overall Study||1
7616707|NCT02404493|18753917|P1|NOT COMPLETED|Overall Study||1
7616708|NCT02404493|18753916|P2|COMPLETED|Overall Study||5
7616709|NCT02404493|18753917|P1|COMPLETED|Overall Study||16
7616710|NCT02404493|18753916|P2|STARTED|Overall Study||6
7616711|NCT02404493|18753917|P1|STARTED|Overall Study||17
7616712|NCT02404389|18754162|P5|NOT COMPLETED|Overall Study||3
7616713|NCT02404389|18754163|P4|NOT COMPLETED|Overall Study||1
7616714|NCT02404389|18754164|P3|NOT COMPLETED|Overall Study||1
7616715|NCT02404389|18754165|P2|NOT COMPLETED|Overall Study||0
7616716|NCT02404389|18754166|P1|NOT COMPLETED|Overall Study||2
7616717|NCT02404389|18754162|P5|COMPLETED|Overall Study||18
7616718|NCT02404389|18754163|P4|COMPLETED|Overall Study||9
7616719|NCT02404389|18754164|P3|COMPLETED|Overall Study||10
7616720|NCT02404389|18754165|P2|COMPLETED|Overall Study||20
7616721|NCT02404389|18754166|P1|COMPLETED|Overall Study||18
7616722|NCT02404389|18754162|P5|STARTED|Overall Study||21
7616723|NCT02404389|18754163|P4|STARTED|Overall Study||10
7616724|NCT02404389|18754164|P3|STARTED|Overall Study||11
7616725|NCT02404389|18754165|P2|STARTED|Overall Study||20
7616726|NCT02404389|18754166|P1|STARTED|Overall Study||20
7616727|NCT02404350|18754206|P4|NOT COMPLETED|Overall Study||37
7616728|NCT02404350|18754207|P3|NOT COMPLETED|Overall Study||6
7616729|NCT02404350|18754208|P2|NOT COMPLETED|Overall Study||6
7616730|NCT02404350|18754209|P1|NOT COMPLETED|Overall Study||15
7616731|NCT02404350|18754206|P4|COMPLETED|Overall Study||295
7616732|NCT02404350|18754207|P3|COMPLETED|Overall Study||216
7616733|NCT02404350|18754208|P2|COMPLETED|Overall Study||214
7616734|NCT02404350|18754209|P1|COMPLETED|Overall Study||207
7616735|NCT02404350|18754206|P4|STARTED|Overall Study||332
7616736|NCT02404350|18754207|P3|STARTED|Overall Study||222
7616737|NCT02404350|18754208|P2|STARTED|Overall Study||220
7616738|NCT02404350|18754209|P1|STARTED|Overall Study||222
7616739|NCT02404311|18754257|P5|NOT COMPLETED|Part B: Month 30-36||0
7616740|NCT02404311|18754258|P4|NOT COMPLETED|Part B: Month 30-36||0
7616741|NCT02404311|18754259|P3|NOT COMPLETED|Part B: Month 30-36||0
7616742|NCT02404311|18754260|P2|NOT COMPLETED|Part B: Month 30-36||0
7616743|NCT02404311|18754261|P1|NOT COMPLETED|Part B: Month 30-36||0
7616744|NCT02404311|18754257|P5|COMPLETED|Part B: Month 30-36||7
7616745|NCT02404311|18754258|P4|COMPLETED|Part B: Month 30-36||31
7616746|NCT02404311|18754259|P3|COMPLETED|Part B: Month 30-36||32
7616747|NCT02404311|18754260|P2|COMPLETED|Part B: Month 30-36||0
7616748|NCT02404311|18754261|P1|COMPLETED|Part B: Month 30-36||0
7616749|NCT02404311|18754257|P5|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||6
7616750|NCT02404311|18754258|P4|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||30
7616751|NCT02404311|18754259|P3|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||28
7616752|NCT02404311|18754260|P2|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
7616753|NCT02404311|18754261|P1|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
7616754|NCT02404311|18754257|P5|STARTED|Part B: Month 30-36||7
7616755|NCT02404311|18754258|P4|STARTED|Part B: Month 30-36||31
7616756|NCT02404311|18754259|P3|STARTED|Part B: Month 30-36||32
7616757|NCT02404311|18754260|P2|STARTED|Part B: Month 30-36||0
7616758|NCT02404311|18754261|P1|STARTED|Part B: Month 30-36||0
7616759|NCT02404311|18754257|P5|NOT COMPLETED|Part A: Month 0-18||0
7616760|NCT02404311|18754258|P4|NOT COMPLETED|Part A: Month 0-18||0
7616761|NCT02404311|18754259|P3|NOT COMPLETED|Part A: Month 0-18||0
7616762|NCT02404311|18754260|P2|NOT COMPLETED|Part A: Month 0-18||6
7616763|NCT02404311|18754261|P1|NOT COMPLETED|Part A: Month 0-18||26
7616764|NCT02404311|18754257|P5|COMPLETED|Part A: Month 0-18||0
7616765|NCT02404311|18754258|P4|COMPLETED|Part A: Month 0-18||0
7616766|NCT02404311|18754259|P3|COMPLETED|Part A: Month 0-18||0
7616767|NCT02404311|18754260|P2|COMPLETED|Part A: Month 0-18||36
7616768|NCT02404311|18754261|P1|COMPLETED|Part A: Month 0-18||184
7616769|NCT02404311|18754257|P5|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
7616770|NCT02404311|18754258|P4|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
7616771|NCT02404311|18754259|P3|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
7616772|NCT02404311|18754260|P2|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||33
7616773|NCT02404311|18754261|P1|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||186
7616774|NCT02404311|18754257|P5|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
7616775|NCT02404311|18754258|P4|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
7616776|NCT02404311|18754259|P3|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
7616777|NCT02404311|18754260|P2|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||37
7616778|NCT02404311|18754261|P1|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||194
7616779|NCT02404311|18754257|P5|Per Protocol|Part A: Month 0-18||0
7616780|NCT02404311|18754258|P4|Per Protocol|Part A: Month 0-18||0
7616781|NCT02404311|18754259|P3|Per Protocol|Part A: Month 0-18||0
7616782|NCT02404311|18754260|P2|Per Protocol|Part A: Month 0-18||37
7616783|NCT02404311|18754261|P1|Per Protocol|Part A: Month 0-18||185
7616784|NCT02404311|18754257|P5|STARTED|Part A: Month 0-18||0
7616785|NCT02404311|18754258|P4|STARTED|Part A: Month 0-18||0
7616786|NCT02404311|18754259|P3|STARTED|Part A: Month 0-18||0
7616787|NCT02404311|18754260|P2|STARTED|Part A: Month 0-18||42
7616788|NCT02404311|18754261|P1|STARTED|Part A: Month 0-18||210
7616789|NCT02404285|18754365|P2|NOT COMPLETED|Overall Study||2
7616790|NCT02404285|18754366|P1|NOT COMPLETED|Overall Study||2
7616791|NCT02404285|18754365|P2|COMPLETED|Overall Study||33
7616792|NCT02404285|18754366|P1|COMPLETED|Overall Study||31
7616793|NCT02404285|18754365|P2|STARTED|Overall Study||35
7616794|NCT02404285|18754366|P1|STARTED|Overall Study||33
7616795|NCT02404220|18754402|P4|NOT COMPLETED|Overall Study||10
7616796|NCT02404220|18754403|P3|NOT COMPLETED|Overall Study||7
7616797|NCT02404220|18754404|P2|NOT COMPLETED|Overall Study||8
7616798|NCT02404220|18754405|P1|NOT COMPLETED|Overall Study||5
7616799|NCT02404220|18754402|P4|COMPLETED|Overall Study||0
7616800|NCT02404220|18754403|P3|COMPLETED|Overall Study||0
7616801|NCT02404220|18754404|P2|COMPLETED|Overall Study||0
7616802|NCT02404220|18754405|P1|COMPLETED|Overall Study||0
7616803|NCT02404220|18754402|P4|STARTED|Overall Study||10
7616804|NCT02404220|18754403|P3|STARTED|Overall Study||7
7616805|NCT02404220|18754404|P2|STARTED|Overall Study||8
7616806|NCT02404220|18754405|P1|STARTED|Overall Study||5
7616807|NCT02404168|18754431|P1|NOT COMPLETED|Overall Study||0
7616808|NCT02404168|18754431|P1|COMPLETED|Overall Study||4
7616809|NCT02404168|18754431|P1|STARTED|Overall Study||4
7616810|NCT02404103|18754441|P2|NOT COMPLETED|Overall Study||3
7616811|NCT02404103|18754442|P1|NOT COMPLETED|Overall Study||4
7616812|NCT02404103|18754441|P2|COMPLETED|Overall Study||9
7616813|NCT02404103|18754442|P1|COMPLETED|Overall Study||10
7616814|NCT02404103|18754441|P2|STARTED|Overall Study||12
7616815|NCT02404103|18754442|P1|STARTED|Overall Study||14
7616816|NCT02404025|18754462|P1|NOT COMPLETED|Overall Study||4
7616817|NCT02404025|18754462|P1|COMPLETED|Overall Study||6
7616818|NCT02404025|18754462|P1|STARTED|Overall Study||10
7616819|NCT02403999|18754494|P3|NOT COMPLETED|Overall Study||0
7616820|NCT02403999|18754495|P2|NOT COMPLETED|Overall Study||0
7616821|NCT02403999|18754496|P1|NOT COMPLETED|Overall Study||0
7616822|NCT02403999|18754494|P3|COMPLETED|Overall Study||11
7616823|NCT02403999|18754495|P2|COMPLETED|Overall Study||10
7616824|NCT02403999|18754496|P1|COMPLETED|Overall Study||10
7616825|NCT02403999|18754494|P3|STARTED|Overall Study||11
7616826|NCT02403999|18754495|P2|STARTED|Overall Study||10
7616827|NCT02403999|18754496|P1|STARTED|Overall Study||10
7616828|NCT02403986|18754509|P2|NOT COMPLETED|Overall Study||4
7616829|NCT02403986|18754510|P1|NOT COMPLETED|Overall Study||5
7616830|NCT02403986|18754509|P2|COMPLETED|Overall Study||23
7616831|NCT02403986|18754510|P1|COMPLETED|Overall Study||21
7616832|NCT02403986|18754509|P2|STARTED|Overall Study||27
7616833|NCT02403986|18754510|P1|STARTED|Overall Study||26
7616834|NCT02403895|18754518|P1|NOT COMPLETED|Overall Study||0
7616835|NCT02403895|18754518|P1|COMPLETED|Overall Study||11
7616836|NCT02403895|18754518|P1|STARTED|Overall Study||11
7616837|NCT02403830|18754531|P2|NOT COMPLETED|Visit 2||0
7616838|NCT02403830|18754532|P1|NOT COMPLETED|Visit 2||0
7616839|NCT02403830|18754531|P2|COMPLETED|Visit 2||15
7616840|NCT02403830|18754532|P1|COMPLETED|Visit 2||14
7616841|NCT02403830|18754531|P2|STARTED|Visit 2||15
7616842|NCT02403830|18754532|P1|STARTED|Visit 2|One subject completed visit 1 and then withdrew from the study for an adverse event (nausea).|14
7616843|NCT02403830|18754531|P2|NOT COMPLETED|Visit 1||0
7616844|NCT02403830|18754532|P1|NOT COMPLETED|Visit 1||0
7616845|NCT02403830|18754531|P2|COMPLETED|Visit 1||15
7616846|NCT02403830|18754532|P1|COMPLETED|Visit 1||15
7616847|NCT02403830|18754531|P2|STARTED|Visit 1||15
7616848|NCT02403830|18754532|P1|STARTED|Visit 1||15
7616849|NCT02403817|18754544|P2|NOT COMPLETED|Overall Study||0
7616850|NCT02403817|18754545|P1|NOT COMPLETED|Overall Study||5
7616851|NCT02403817|18754544|P2|COMPLETED|Overall Study||2
7616852|NCT02403817|18754545|P1|COMPLETED|Overall Study||23
7616853|NCT02403817|18754544|P2|STARTED|Overall Study||2
7616854|NCT02403817|18754545|P1|STARTED|Overall Study||28
7616855|NCT02403778|18754559|P2|NOT COMPLETED|Overall Study||0
7616856|NCT02403778|18754560|P1|NOT COMPLETED|Overall Study||0
7616857|NCT02403778|18754559|P2|COMPLETED|Overall Study||4
7616858|NCT02403778|18754560|P1|COMPLETED|Overall Study||6
7616859|NCT02403778|18754559|P2|STARTED|Overall Study||4
7616860|NCT02403778|18754560|P1|STARTED|Overall Study||6
7616861|NCT02403674|18754576|P2|NOT COMPLETED|Overall Study||63
7616862|NCT02403674|18754577|P1|NOT COMPLETED|Overall Study||55
7616863|NCT02403674|18754576|P2|COMPLETED|Overall Study||303
7616864|NCT02403674|18754577|P1|COMPLETED|Overall Study||313
7616865|NCT02403674|18754576|P2|Treated|Overall Study||364
7616866|NCT02403674|18754577|P1|Treated|Overall Study||364
7616867|NCT02403674|18754576|P2|STARTED|Overall Study||366
7616868|NCT02403674|18754577|P1|STARTED|Overall Study||368
7616869|NCT02403635|18754616|P1|NOT COMPLETED|Overall Study||9
7616870|NCT02403635|18754616|P1|COMPLETED|Overall Study||18
7616871|NCT02403635|18754616|P1|Received the First Dose|Overall Study||18
7616872|NCT02403635|18754616|P1|Screening (28 Days)|Overall Study||27
7616873|NCT02403635|18754616|P1|STARTED|Overall Study||27
7616874|NCT02403479|18754684|P2|NOT COMPLETED|Overall Study||0
7616875|NCT02403479|18754685|P1|NOT COMPLETED|Overall Study||2
7616876|NCT02403479|18754684|P2|COMPLETED|Overall Study||12
7616877|NCT02403479|18754685|P1|COMPLETED|Overall Study||8
7616878|NCT02403479|18754684|P2|STARTED|Overall Study||12
7616879|NCT02403479|18754685|P1|STARTED|Overall Study||10
7616880|NCT02403271|18754693|P2|NOT COMPLETED|Period 2||124
7616881|NCT02403271|18754694|P1|NOT COMPLETED|Period 2||0
7616882|NCT02403271|18754693|P2|COMPLETED|Period 2||0
7616883|NCT02403271|18754694|P1|COMPLETED|Period 2||0
7616884|NCT02403271|18754693|P2|STARTED|Period 2|Phase 2 includes all subjects who participated in Phase 1b.|124
7616885|NCT02403271|18754694|P1|STARTED|Period 2||0
7616886|NCT02403271|18754693|P2|NOT COMPLETED|Period 1||0
7616887|NCT02403271|18754694|P1|NOT COMPLETED|Period 1||1
7616888|NCT02403271|18754693|P2|COMPLETED|Period 1||0
7616889|NCT02403271|18754694|P1|COMPLETED|Period 1||6
7616890|NCT02403271|18754693|P2|STARTED|Period 1||0
7616891|NCT02403271|18754694|P1|STARTED|Period 1|All Phase 1b participants went on to participate in Phase 2.|7
7616892|NCT02403206|18754708|P2|NOT COMPLETED|Overall Study||10
7616893|NCT02403206|18754709|P1|NOT COMPLETED|Overall Study||11
7616894|NCT02403206|18754708|P2|COMPLETED|Overall Study||186
7616895|NCT02403206|18754709|P1|COMPLETED|Overall Study||183
7616896|NCT02403206|18754708|P2|Randomized and Treated|Overall Study||190
7616897|NCT02403206|18754709|P1|Randomized and Treated|Overall Study||188
7616898|NCT02403206|18754708|P2|Treated Prior to Randomization|Overall Study||1
7616899|NCT02403206|18754709|P1|Treated Prior to Randomization|Overall Study||0
7616900|NCT02403206|18754708|P2|STARTED|Overall Study||196
7616901|NCT02403206|18754709|P1|STARTED|Overall Study||194
7616902|NCT02403180|18754720|P2|NOT COMPLETED|Period 2 (5 Days)||1
7616903|NCT02403180|18754721|P1|NOT COMPLETED|Period 2 (5 Days)||0
7616904|NCT02403180|18754720|P2|COMPLETED|Period 2 (5 Days)||32
7616905|NCT02403180|18754721|P1|COMPLETED|Period 2 (5 Days)||36
7616906|NCT02403180|18754720|P2|STARTED|Period 2 (5 Days)||33
7616907|NCT02403180|18754721|P1|STARTED|Period 2 (5 Days)||36
7616908|NCT02403180|18754720|P2|NOT COMPLETED|Period 1 (5 Days)||0
7616909|NCT02403180|18754721|P1|NOT COMPLETED|Period 1 (5 Days)||0
7616910|NCT02403180|18754720|P2|COMPLETED|Period 1 (5 Days)||33
7616911|NCT02403180|18754721|P1|COMPLETED|Period 1 (5 Days)||36
7616912|NCT02403180|18754720|P2|Randomized|Period 1 (5 Days)||33
7616913|NCT02403180|18754721|P1|Randomized|Period 1 (5 Days)||36
7616914|NCT02403180|18754720|P2|STARTED|Period 1 (5 Days)||33
7616915|NCT02403180|18754721|P1|STARTED|Period 1 (5 Days)||36
7616916|NCT02403180|18754720|P2|NOT COMPLETED|Pre-Treatment Period||1
7616917|NCT02403180|18754721|P1|NOT COMPLETED|Pre-Treatment Period||0
7616918|NCT02403180|18754720|P2|COMPLETED|Pre-Treatment Period||33
7616919|NCT02403180|18754721|P1|COMPLETED|Pre-Treatment Period||36
7616920|NCT02403180|18754720|P2|STARTED|Pre-Treatment Period||34
7616921|NCT02403180|18754721|P1|STARTED|Pre-Treatment Period||36
7616922|NCT02403154|18754733|P4|NOT COMPLETED|Overall Study||1
7616923|NCT02403154|18754734|P3|NOT COMPLETED|Overall Study||1
7616924|NCT02403154|18754735|P2|NOT COMPLETED|Overall Study||0
7616925|NCT02403154|18754736|P1|NOT COMPLETED|Overall Study||2
7616926|NCT02403154|18754733|P4|COMPLETED|Overall Study||0
7616927|NCT02403154|18754734|P3|COMPLETED|Overall Study||0
7616928|NCT02403154|18754735|P2|COMPLETED|Overall Study||0
7616929|NCT02403154|18754736|P1|COMPLETED|Overall Study||0
7616930|NCT02403154|18754733|P4|STARTED|Overall Study||1
7616931|NCT02403154|18754734|P3|STARTED|Overall Study||1
7616932|NCT02403154|18754735|P2|STARTED|Overall Study||0
7616933|NCT02403154|18754736|P1|STARTED|Overall Study||2
7616934|NCT02402933|18754750|P1|NOT COMPLETED|Overall Study||14
7616935|NCT02402933|18754750|P1|COMPLETED|Overall Study||12
7616936|NCT02402933|18754750|P1|Received at Least One Dose of Study Drug|Overall Study||22
7616937|NCT02402933|18754750|P1|STARTED|Overall Study||26
7616938|NCT02402907|18754759|P2|NOT COMPLETED|Overall Study||27
7616939|NCT02402907|18754760|P1|NOT COMPLETED|Overall Study||20
7616940|NCT02402907|18754759|P2|COMPLETED|Overall Study||647
7616941|NCT02402907|18754760|P1|COMPLETED|Overall Study||662
7616942|NCT02402907|18754759|P2|STARTED|Overall Study||674
7616943|NCT02402907|18754760|P1|STARTED|Overall Study||682
7616944|NCT02402881|18754780|P2|NOT COMPLETED|Post-Intervention Study Period||0
7616945|NCT02402881|18754781|P1|NOT COMPLETED|Post-Intervention Study Period||0
7616946|NCT02402881|18754780|P2|COMPLETED|Post-Intervention Study Period||8662
7616947|NCT02402881|18754781|P1|COMPLETED|Post-Intervention Study Period||3111
7616948|NCT02402881|18754780|P2|STARTED|Post-Intervention Study Period||8662
7616949|NCT02402881|18754781|P1|STARTED|Post-Intervention Study Period||3111
7616950|NCT02402881|18754780|P2|NOT COMPLETED|Pre-Intervention Study Period||0
7616951|NCT02402881|18754781|P1|NOT COMPLETED|Pre-Intervention Study Period||0
7616952|NCT02402881|18754780|P2|COMPLETED|Pre-Intervention Study Period||5657
7616953|NCT02402881|18754781|P1|COMPLETED|Pre-Intervention Study Period||2222
7616954|NCT02402881|18754780|P2|STARTED|Pre-Intervention Study Period||5657
7616955|NCT02402881|18754781|P1|STARTED|Pre-Intervention Study Period||2222
7616956|NCT02402764|18754789|P1|NOT COMPLETED|Overall Study||0
7616957|NCT02402764|18754789|P1|COMPLETED|Overall Study||10
7616958|NCT02402764|18754789|P1|STARTED|Overall Study||10
7616959|NCT02402452|18754799|P2|NOT COMPLETED|Overall Study||0
7616960|NCT02402452|18754800|P1|NOT COMPLETED|Overall Study||0
7616961|NCT02402452|18754799|P2|COMPLETED|Overall Study||10
7616962|NCT02402452|18754800|P1|COMPLETED|Overall Study||10
7616963|NCT02402452|18754799|P2|STARTED|Overall Study||10
7616964|NCT02402452|18754800|P1|STARTED|Overall Study||10
7616965|NCT02402322|18754815|P3|NOT COMPLETED|Follow-up||24
7616966|NCT02402322|18754816|P2|NOT COMPLETED|Follow-up||3
7616967|NCT02402322|18754817|P1|NOT COMPLETED|Follow-up||6
7616968|NCT02402322|18754815|P3|COMPLETED|Follow-up||0
7616969|NCT02402322|18754816|P2|COMPLETED|Follow-up||21
7616970|NCT02402322|18754817|P1|COMPLETED|Follow-up||18
7616971|NCT02402322|18754815|P3|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24
7616972|NCT02402322|18754816|P2|STARTED|Follow-up||24
7616973|NCT02402322|18754817|P1|STARTED|Follow-up||24
7616974|NCT02402322|18754815|P3|NOT COMPLETED|Pretreatment||1
7616975|NCT02402322|18754816|P2|NOT COMPLETED|Pretreatment||1
7616976|NCT02402322|18754817|P1|NOT COMPLETED|Pretreatment||3
7616977|NCT02402322|18754815|P3|COMPLETED|Pretreatment||24
7616978|NCT02402322|18754816|P2|COMPLETED|Pretreatment||24
7616979|NCT02402322|18754817|P1|COMPLETED|Pretreatment||24
7616980|NCT02402322|18754815|P3|Posttreatment Measures|Pretreatment||24
7616981|NCT02402322|18754816|P2|Posttreatment Measures|Pretreatment||24
7616982|NCT02402322|18754817|P1|Posttreatment Measures|Pretreatment||24
7616983|NCT02402322|18754815|P3|STARTED|Pretreatment||25
7616984|NCT02402322|18754816|P2|STARTED|Pretreatment||25
7616985|NCT02402322|18754817|P1|STARTED|Pretreatment||27
7616986|NCT02402296|18754851|P2|NOT COMPLETED|Overall Study||0
7616987|NCT02402296|18754852|P1|NOT COMPLETED|Overall Study||0
7616988|NCT02402296|18754851|P2|COMPLETED|Overall Study||15
7616989|NCT02402296|18754852|P1|COMPLETED|Overall Study||15
7616990|NCT02402296|18754851|P2|STARTED|Overall Study||15
7616991|NCT02402296|18754852|P1|STARTED|Overall Study||15
7616992|NCT02402218|18754867|P3|NOT COMPLETED|Overall Study||17
7616993|NCT02402218|18754868|P2|NOT COMPLETED|Overall Study||13
7616994|NCT02402218|18754869|P1|NOT COMPLETED|Overall Study||14
7616995|NCT02402218|18754867|P3|COMPLETED|Overall Study||37
7616996|NCT02402218|18754868|P2|COMPLETED|Overall Study||41
7616997|NCT02402218|18754869|P1|COMPLETED|Overall Study||22
7616998|NCT02402218|18754867|P3|Achieved Sustained Virologic Response|Overall Study||37
7616999|NCT02402218|18754868|P2|Achieved Sustained Virologic Response|Overall Study||41
7617000|NCT02402218|18754869|P1|Achieved Sustained Virologic Response|Overall Study||22
7617001|NCT02402218|18754867|P3|Completed Treatment With LDV/SOF|Overall Study||39
7617002|NCT02402218|18754868|P2|Completed Treatment With LDV/SOF|Overall Study||42
7617003|NCT02402218|18754869|P1|Completed Treatment With LDV/SOF|Overall Study||23
7617004|NCT02402218|18754867|P3|Initiated Treatment With LDV/SOF|Overall Study||41
7617005|NCT02402218|18754868|P2|Initiated Treatment With LDV/SOF|Overall Study||45
7617006|NCT02402218|18754869|P1|Initiated Treatment With LDV/SOF|Overall Study||24
7617007|NCT02402218|18754867|P3|STARTED|Overall Study||54
7617008|NCT02402218|18754868|P2|STARTED|Overall Study||54
7617009|NCT02402218|18754869|P1|STARTED|Overall Study||36
7617010|NCT02402166|18754892|P1|NOT COMPLETED|Overall Study||5
7617011|NCT02402166|18754892|P1|COMPLETED|Overall Study||19
7617012|NCT02402166|18754892|P1|STARTED|Overall Study||24
7617013|NCT02402153|18754913|P1|NOT COMPLETED|Overall Study||0
7617014|NCT02402153|18754913|P1|COMPLETED|Overall Study||18
7617015|NCT02402153|18754913|P1|STARTED|Overall Study||18
7617016|NCT02402127|18754929|P6|NOT COMPLETED|Third Wear Period (1 Day)||0
7617017|NCT02402127|18754930|P5|NOT COMPLETED|Third Wear Period (1 Day)||0
7617018|NCT02402127|18754931|P4|NOT COMPLETED|Third Wear Period (1 Day)||0
7617019|NCT02402127|18754932|P3|NOT COMPLETED|Third Wear Period (1 Day)||0
7617020|NCT02402127|18754933|P2|NOT COMPLETED|Third Wear Period (1 Day)||0
7617021|NCT02402127|18754934|P1|NOT COMPLETED|Third Wear Period (1 Day)||0
7617022|NCT02402127|18754929|P6|COMPLETED|Third Wear Period (1 Day)||4
7617023|NCT02402127|18754930|P5|COMPLETED|Third Wear Period (1 Day)||4
7617024|NCT02402127|18754931|P4|COMPLETED|Third Wear Period (1 Day)||4
7617025|NCT02402127|18754932|P3|COMPLETED|Third Wear Period (1 Day)||4
7617026|NCT02402127|18754933|P2|COMPLETED|Third Wear Period (1 Day)||4
7617027|NCT02402127|18754934|P1|COMPLETED|Third Wear Period (1 Day)||4
7617028|NCT02402127|18754929|P6|STARTED|Third Wear Period (1 Day)||4
7617029|NCT02402127|18754930|P5|STARTED|Third Wear Period (1 Day)||4
7617030|NCT02402127|18754931|P4|STARTED|Third Wear Period (1 Day)||4
7617031|NCT02402127|18754932|P3|STARTED|Third Wear Period (1 Day)||4
7617032|NCT02402127|18754933|P2|STARTED|Third Wear Period (1 Day)||4
7617033|NCT02402127|18754934|P1|STARTED|Third Wear Period (1 Day)||4
7617034|NCT02402127|18754929|P6|NOT COMPLETED|Second Wear Period (1 Day)||0
7617035|NCT02402127|18754930|P5|NOT COMPLETED|Second Wear Period (1 Day)||0
7617036|NCT02402127|18754931|P4|NOT COMPLETED|Second Wear Period (1 Day)||0
7617037|NCT02402127|18754932|P3|NOT COMPLETED|Second Wear Period (1 Day)||0
7617038|NCT02402127|18754933|P2|NOT COMPLETED|Second Wear Period (1 Day)||0
7617039|NCT02402127|18754934|P1|NOT COMPLETED|Second Wear Period (1 Day)||0
7617040|NCT02402127|18754929|P6|COMPLETED|Second Wear Period (1 Day)||4
7617041|NCT02402127|18754930|P5|COMPLETED|Second Wear Period (1 Day)||4
7617042|NCT02402127|18754931|P4|COMPLETED|Second Wear Period (1 Day)||4
7617043|NCT02402127|18754932|P3|COMPLETED|Second Wear Period (1 Day)||4
7617044|NCT02402127|18754933|P2|COMPLETED|Second Wear Period (1 Day)||4
7617045|NCT02402127|18754934|P1|COMPLETED|Second Wear Period (1 Day)||4
7617046|NCT02402127|18754929|P6|STARTED|Second Wear Period (1 Day)||4
7617047|NCT02402127|18754930|P5|STARTED|Second Wear Period (1 Day)||4
7617048|NCT02402127|18754931|P4|STARTED|Second Wear Period (1 Day)||4
7617049|NCT02402127|18754932|P3|STARTED|Second Wear Period (1 Day)||4
7617050|NCT02402127|18754933|P2|STARTED|Second Wear Period (1 Day)||4
7617051|NCT02402127|18754934|P1|STARTED|Second Wear Period (1 Day)||4
7617052|NCT02402127|18754929|P6|NOT COMPLETED|First Wear Period (1 Day)||0
7617053|NCT02402127|18754930|P5|NOT COMPLETED|First Wear Period (1 Day)||0
7617054|NCT02402127|18754931|P4|NOT COMPLETED|First Wear Period (1 Day)||0
7617055|NCT02402127|18754932|P3|NOT COMPLETED|First Wear Period (1 Day)||0
7617056|NCT02402127|18754933|P2|NOT COMPLETED|First Wear Period (1 Day)||0
7617057|NCT02402127|18754934|P1|NOT COMPLETED|First Wear Period (1 Day)||0
7617058|NCT02402127|18754929|P6|COMPLETED|First Wear Period (1 Day)||4
7617059|NCT02402127|18754930|P5|COMPLETED|First Wear Period (1 Day)||4
7617060|NCT02402127|18754931|P4|COMPLETED|First Wear Period (1 Day)||4
7617061|NCT02402127|18754932|P3|COMPLETED|First Wear Period (1 Day)||4
7617062|NCT02402127|18754933|P2|COMPLETED|First Wear Period (1 Day)||4
7617063|NCT02402127|18754934|P1|COMPLETED|First Wear Period (1 Day)||4
7617064|NCT02402127|18754929|P6|Randomized and Treated|First Wear Period (1 Day)||4
7617065|NCT02402127|18754930|P5|Randomized and Treated|First Wear Period (1 Day)||4
7617066|NCT02402127|18754931|P4|Randomized and Treated|First Wear Period (1 Day)||4
7617067|NCT02402127|18754932|P3|Randomized and Treated|First Wear Period (1 Day)||4
7617068|NCT02402127|18754933|P2|Randomized and Treated|First Wear Period (1 Day)||4
7617069|NCT02402127|18754934|P1|Randomized and Treated|First Wear Period (1 Day)||4
7617070|NCT02402127|18754929|P6|STARTED|First Wear Period (1 Day)||4
7617071|NCT02402127|18754930|P5|STARTED|First Wear Period (1 Day)||4
7617072|NCT02402127|18754931|P4|STARTED|First Wear Period (1 Day)||4
7617073|NCT02402127|18754932|P3|STARTED|First Wear Period (1 Day)||4
7617074|NCT02402127|18754933|P2|STARTED|First Wear Period (1 Day)||4
7617075|NCT02402127|18754934|P1|STARTED|First Wear Period (1 Day)||4
7617076|NCT02402062|18754945|P1|NOT COMPLETED|Overall Study||0
7617077|NCT02402062|18754945|P1|COMPLETED|Overall Study||17
7617078|NCT02402062|18754945|P1|STARTED|Overall Study||17
7617079|NCT02402036|18754955|P1|NOT COMPLETED|Overall Study||0
7617080|NCT02402036|18754955|P1|COMPLETED|Overall Study||10
7617081|NCT02402036|18754955|P1|STARTED|Overall Study||10
7617082|NCT02401867|18754959|P1|NOT COMPLETED|Analysis||9
7617083|NCT02401867|18754959|P1|COMPLETED|Analysis|Comparative analysis of vaginal HPV DNA results and cervical HPV DNA results|131
7617084|NCT02401867|18754959|P1|STARTED|Analysis||140
7617085|NCT02401867|18754959|P1|NOT COMPLETED|Specimen Collection||10
7617086|NCT02401867|18754959|P1|COMPLETED|Specimen Collection|Completed both vaginal self-swab and provider-collected cervical swab|140
7617087|NCT02401867|18754959|P1|STARTED|Specimen Collection||150
7617088|NCT02401867|18754959|P1|NOT COMPLETED|Enrolled||0
7617089|NCT02401867|18754959|P1|COMPLETED|Enrolled||150
7617090|NCT02401867|18754959|P1|STARTED|Enrolled||150
7617091|NCT02401672|18754966|P2|NOT COMPLETED|Overall Study||3
7617092|NCT02401672|18754967|P1|NOT COMPLETED|Overall Study||1
7617093|NCT02401672|18754966|P2|COMPLETED|Overall Study||17
7617094|NCT02401672|18754967|P1|COMPLETED|Overall Study||21
7617095|NCT02401672|18754966|P2|STARTED|Overall Study||20
7617096|NCT02401672|18754967|P1|STARTED|Overall Study||22
7617097|NCT02401555|18754982|P3|NOT COMPLETED|Overall Study||0
7617098|NCT02401555|18754983|P2|NOT COMPLETED|Overall Study||0
7617099|NCT02401555|18754984|P1|NOT COMPLETED|Overall Study||0
7617100|NCT02401555|18754982|P3|COMPLETED|Overall Study||120
7617101|NCT02401555|18754983|P2|COMPLETED|Overall Study||212
7617102|NCT02401555|18754984|P1|COMPLETED|Overall Study||87
7617103|NCT02401555|18754982|P3|STARTED|Overall Study||120
7617104|NCT02401555|18754983|P2|STARTED|Overall Study||212
7617105|NCT02401555|18754984|P1|STARTED|Overall Study||87
7617106|NCT02401542|18754995|P3|NOT COMPLETED|Overall Study||0
7617107|NCT02401542|18754996|P2|NOT COMPLETED|Overall Study||0
7617108|NCT02401542|18754997|P1|NOT COMPLETED|Overall Study||1
7617109|NCT02401542|18754995|P3|COMPLETED|Overall Study||0
7617110|NCT02401542|18754996|P2|COMPLETED|Overall Study||30
7617111|NCT02401542|18754997|P1|COMPLETED|Overall Study||40
7617112|NCT02401542|18754995|P3|STARTED|Overall Study||0
7617113|NCT02401542|18754996|P2|STARTED|Overall Study||30
7617114|NCT02401542|18754997|P1|STARTED|Overall Study||41
7617115|NCT02401529|18755009|P2|NOT COMPLETED|Overall Study||7
7617116|NCT02401529|18755010|P1|NOT COMPLETED|Overall Study||9
7617117|NCT02401529|18755009|P2|COMPLETED|Overall Study||50
7617118|NCT02401529|18755010|P1|COMPLETED|Overall Study||50
7617119|NCT02401529|18755009|P2|STARTED|Overall Study||57
7617120|NCT02401529|18755010|P1|STARTED|Overall Study||59
7617121|NCT02401464|18755038|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
7617122|NCT02401464|18755039|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
7617123|NCT02401464|18755040|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
7617124|NCT02401464|18755041|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
7617125|NCT02401464|18755038|P4|COMPLETED|Intervention Period 2 (6 Days)||13
7617126|NCT02401464|18755039|P3|COMPLETED|Intervention Period 2 (6 Days)||13
7617127|NCT02401464|18755040|P2|COMPLETED|Intervention Period 2 (6 Days)||13
7617128|NCT02401464|18755041|P1|COMPLETED|Intervention Period 2 (6 Days)||13
7617129|NCT02401464|18755038|P4|STARTED|Intervention Period 2 (6 Days)||13
7617130|NCT02401464|18755039|P3|STARTED|Intervention Period 2 (6 Days)||13
7617131|NCT02401464|18755040|P2|STARTED|Intervention Period 2 (6 Days)||13
7617132|NCT02401464|18755041|P1|STARTED|Intervention Period 2 (6 Days)||13
7617133|NCT02401464|18755038|P4|NOT COMPLETED|Washout Period (At Least 6 Days)||0
7617134|NCT02401464|18755039|P3|NOT COMPLETED|Washout Period (At Least 6 Days)||0
7617135|NCT02401464|18755040|P2|NOT COMPLETED|Washout Period (At Least 6 Days)||0
7617136|NCT02401464|18755041|P1|NOT COMPLETED|Washout Period (At Least 6 Days)||0
7617137|NCT02401464|18755038|P4|COMPLETED|Washout Period (At Least 6 Days)||13
7617138|NCT02401464|18755039|P3|COMPLETED|Washout Period (At Least 6 Days)||13
7617139|NCT02401464|18755040|P2|COMPLETED|Washout Period (At Least 6 Days)||13
7617140|NCT02401464|18755041|P1|COMPLETED|Washout Period (At Least 6 Days)||13
7617141|NCT02401464|18755038|P4|STARTED|Washout Period (At Least 6 Days)||13
7617142|NCT02401464|18755039|P3|STARTED|Washout Period (At Least 6 Days)||13
7617143|NCT02401464|18755040|P2|STARTED|Washout Period (At Least 6 Days)||13
7617144|NCT02401464|18755041|P1|STARTED|Washout Period (At Least 6 Days)||13
7617145|NCT02401464|18755038|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
7617146|NCT02401464|18755039|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
7617147|NCT02401464|18755040|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
7617148|NCT02401464|18755041|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
7617149|NCT02401464|18755038|P4|COMPLETED|Intervention Period 1 (6 Days)||13
7617150|NCT02401464|18755039|P3|COMPLETED|Intervention Period 1 (6 Days)||13
7617151|NCT02401464|18755040|P2|COMPLETED|Intervention Period 1 (6 Days)||13
7617152|NCT02401464|18755041|P1|COMPLETED|Intervention Period 1 (6 Days)||13
7617153|NCT02401464|18755038|P4|STARTED|Intervention Period 1 (6 Days)||13
7617154|NCT02401464|18755039|P3|STARTED|Intervention Period 1 (6 Days)||13
7617155|NCT02401464|18755040|P2|STARTED|Intervention Period 1 (6 Days)||13
7617156|NCT02401464|18755041|P1|STARTED|Intervention Period 1 (6 Days)||13
7617157|NCT02401412|18755077|P2|NOT COMPLETED|Overall Study||32
7617158|NCT02401412|18755078|P1|NOT COMPLETED|Overall Study||30
7617159|NCT02401412|18755077|P2|COMPLETED|Overall Study||49
7617160|NCT02401412|18755078|P1|COMPLETED|Overall Study||59
7617161|NCT02401412|18755077|P2|Received Study Device|Overall Study||80
7617162|NCT02401412|18755078|P1|Received Study Device|Overall Study||89
7617163|NCT02401412|18755077|P2|STARTED|Overall Study||81
7617164|NCT02401412|18755078|P1|STARTED|Overall Study||89
7617165|NCT02401256|18755086|P1|NOT COMPLETED|Overall Study||17
7617166|NCT02401256|18755086|P1|COMPLETED|Overall Study||53
7617167|NCT02401256|18755086|P1|Analysed|Overall Study|Volunteers that completed at least until Phase 2 inpatient visit (Volunteers with Efavirenz PK data)|61
7617168|NCT02401256|18755086|P1|Finished Phase 3|Overall Study||53
7617169|NCT02401256|18755086|P1|Finished Phase 2|Overall Study||58
7617170|NCT02401256|18755086|P1|Finished Phase 1|Overall Study||64
7617171|NCT02401256|18755086|P1|STARTED|Overall Study||70
7617172|NCT02401230|18755095|P3|NOT COMPLETED|Overall Study||4
7617173|NCT02401230|18755096|P2|NOT COMPLETED|Overall Study||6
7617174|NCT02401230|18755097|P1|NOT COMPLETED|Overall Study||6
7617175|NCT02401230|18755095|P3|COMPLETED|Overall Study||21
7617176|NCT02401230|18755096|P2|COMPLETED|Overall Study||19
7617177|NCT02401230|18755097|P1|COMPLETED|Overall Study||20
7617178|NCT02401230|18755095|P3|STARTED|Overall Study||25
7617179|NCT02401230|18755096|P2|STARTED|Overall Study||25
7617180|NCT02401230|18755097|P1|STARTED|Overall Study||26
7617181|NCT02401048|18755132|P2|NOT COMPLETED|Overall Study||30
7617182|NCT02401048|18755133|P1|NOT COMPLETED|Overall Study||22
7617183|NCT02401048|18755132|P2|COMPLETED|Overall Study||4
7617184|NCT02401048|18755133|P1|COMPLETED|Overall Study||5
7617185|NCT02401048|18755132|P2|STARTED|Overall Study||34
7617186|NCT02401048|18755133|P1|STARTED|Overall Study||27
7617187|NCT02401022|18755165|P2|NOT COMPLETED|Overall Study||20
7617188|NCT02401022|18755166|P1|NOT COMPLETED|Overall Study||15
7617189|NCT02401022|18755165|P2|COMPLETED|Overall Study||90
7617190|NCT02401022|18755166|P1|COMPLETED|Overall Study||89
7617191|NCT02401022|18755165|P2|STARTED|Overall Study||110
7617192|NCT02401022|18755166|P1|STARTED|Overall Study||104
7617193|NCT02400996|18755172|P1|NOT COMPLETED|Overall Study||0
7617194|NCT02400996|18755172|P1|COMPLETED|Overall Study||40
7617195|NCT02400996|18755172|P1|STARTED|Overall Study||40
7617196|NCT02400905|18755176|P1|NOT COMPLETED|Overall Study||271
7617197|NCT02400905|18755176|P1|COMPLETED|Overall Study||0
7617198|NCT02400905|18755176|P1|12-month Follow-up|Overall Study||256
7617199|NCT02400905|18755176|P1|STARTED|Overall Study||271
7617200|NCT02400749|18755186|P2|NOT COMPLETED|Week 17 - 32||3
7617201|NCT02400749|18755187|P1|NOT COMPLETED|Week 17 - 32||5
7617202|NCT02400749|18755186|P2|COMPLETED|Week 17 - 32||41
7617203|NCT02400749|18755187|P1|COMPLETED|Week 17 - 32||34
7617204|NCT02400749|18755186|P2|STARTED|Week 17 - 32||44
7617205|NCT02400749|18755187|P1|STARTED|Week 17 - 32||39
7617206|NCT02400749|18755186|P2|NOT COMPLETED|Week 0 -16||6
7617207|NCT02400749|18755187|P1|NOT COMPLETED|Week 0 -16||11
7617208|NCT02400749|18755186|P2|COMPLETED|Week 0 -16||44
7617209|NCT02400749|18755187|P1|COMPLETED|Week 0 -16||39
7617210|NCT02400749|18755186|P2|STARTED|Week 0 -16||50
7617211|NCT02400749|18755187|P1|STARTED|Week 0 -16||50
7617212|NCT02400710|18755203|P2|NOT COMPLETED|Overall Study||0
7617213|NCT02400710|18755204|P1|NOT COMPLETED|Overall Study||0
7617214|NCT02400710|18755203|P2|COMPLETED|Overall Study||10
7617215|NCT02400710|18755204|P1|COMPLETED|Overall Study||10
7617216|NCT02400710|18755203|P2|STARTED|Overall Study||10
7617217|NCT02400710|18755204|P1|STARTED|Overall Study||10
7617218|NCT02400580|18755214|P2|NOT COMPLETED|Overall Study||1
7617219|NCT02400580|18755215|P1|NOT COMPLETED|Overall Study||2
7617220|NCT02400580|18755214|P2|COMPLETED|Overall Study||91
7617221|NCT02400580|18755215|P1|COMPLETED|Overall Study||89
7617222|NCT02400580|18755214|P2|STARTED|Overall Study||92
7617223|NCT02400580|18755215|P1|STARTED|Overall Study||91
7617224|NCT02400463|18755231|P1|NOT COMPLETED|Overall Study||0
7617225|NCT02400463|18755231|P1|COMPLETED|Overall Study||6
7617226|NCT02400463|18755231|P1|STARTED|Overall Study||6
7617227|NCT02400437|18755237|P1|NOT COMPLETED|Overall Study||0
7617228|NCT02400437|18755237|P1|COMPLETED|Overall Study||26
7617229|NCT02400437|18755237|P1|STARTED|Overall Study||26
7617230|NCT02400346|18755248|P1|NOT COMPLETED|Overall Study||44
7617231|NCT02400346|18755248|P1|COMPLETED|Overall Study||88
7617232|NCT02400346|18755248|P1|STARTED|Overall Study||132
7617233|NCT02400333|18755256|P4|NOT COMPLETED|Overall Study||2
7617234|NCT02400333|18755257|P3|NOT COMPLETED|Overall Study||2
7617235|NCT02400333|18755258|P2|NOT COMPLETED|Overall Study||1
7617236|NCT02400333|18755259|P1|NOT COMPLETED|Overall Study||1
7617237|NCT02400333|18755256|P4|COMPLETED|Overall Study||7
7617238|NCT02400333|18755257|P3|COMPLETED|Overall Study||7
7617239|NCT02400333|18755258|P2|COMPLETED|Overall Study||8
7617240|NCT02400333|18755259|P1|COMPLETED|Overall Study||8
7617241|NCT02400333|18755256|P4|STARTED|Overall Study||9
7617242|NCT02400333|18755257|P3|STARTED|Overall Study||9
7617243|NCT02400333|18755258|P2|STARTED|Overall Study||9
7617244|NCT02400333|18755259|P1|STARTED|Overall Study||9
7617245|NCT02400307|18755319|P2|NOT COMPLETED|Overall Study||0
7617246|NCT02400307|18755320|P1|NOT COMPLETED|Overall Study||1
7617247|NCT02400307|18755319|P2|COMPLETED|Overall Study||8
7617248|NCT02400307|18755320|P1|COMPLETED|Overall Study||10
7617249|NCT02400307|18755319|P2|STARTED|Overall Study||8
7617250|NCT02400307|18755320|P1|STARTED|Overall Study||11
7617251|NCT02400073|18755340|P1|NOT COMPLETED|Overall Study||11
7617252|NCT02400073|18755340|P1|COMPLETED|Overall Study||111
7617253|NCT02400073|18755340|P1|STARTED|Overall Study||122
7617254|NCT02399917|18755348|P3|NOT COMPLETED|Overall Study||0
7617255|NCT02399917|18755349|P2|NOT COMPLETED|Overall Study||0
7617256|NCT02399917|18755350|P1|NOT COMPLETED|Overall Study||0
7617257|NCT02399917|18755348|P3|COMPLETED|Overall Study||24
7617258|NCT02399917|18755349|P2|COMPLETED|Overall Study||6
7617259|NCT02399917|18755350|P1|COMPLETED|Overall Study||6
7617260|NCT02399917|18755348|P3|STARTED|Overall Study||24
7617261|NCT02399917|18755349|P2|STARTED|Overall Study||6
7617262|NCT02399917|18755350|P1|STARTED|Overall Study||6
7617263|NCT02399345|18755368|P1|NOT COMPLETED|Overall Study||0
7617264|NCT02399345|18755368|P1|COMPLETED|Overall Study||10
7617265|NCT02399345|18755368|P1|STARTED|Overall Study||10
7617266|NCT02399254|18755374|P1|NOT COMPLETED|Overall Study||2
7617267|NCT02399254|18755374|P1|COMPLETED|Overall Study||19
7617268|NCT02399254|18755374|P1|STARTED|Overall Study||21
7617269|NCT02399163|18755381|P1|NOT COMPLETED|Overall Study||9
7617270|NCT02399163|18755381|P1|COMPLETED|Overall Study||53
7617271|NCT02399163|18755381|P1|STARTED|Overall Study||62
7617272|NCT02399111|18755409|P4|NOT COMPLETED|Overall Study||0
7617273|NCT02399111|18755410|P3|NOT COMPLETED|Overall Study||0
7617274|NCT02399111|18755411|P2|NOT COMPLETED|Overall Study||0
7617275|NCT02399111|18755412|P1|NOT COMPLETED|Overall Study||0
7617276|NCT02399111|18755409|P4|COMPLETED|Overall Study||0
7617277|NCT02399111|18755410|P3|COMPLETED|Overall Study||4
7617278|NCT02399111|18755411|P2|COMPLETED|Overall Study||1
7617279|NCT02399111|18755412|P1|COMPLETED|Overall Study||4
7617280|NCT02399111|18755409|P4|STARTED|Overall Study||0
7617281|NCT02399111|18755410|P3|STARTED|Overall Study||4
7617282|NCT02399111|18755411|P2|STARTED|Overall Study||1
7617283|NCT02399111|18755412|P1|STARTED|Overall Study||4
7617284|NCT02399085|18755426|P1|NOT COMPLETED|Overall Study||51
7617285|NCT02399085|18755426|P1|COMPLETED|Overall Study|30 patients completed the combination treatment on both study drugs (12 cycles).|30
7617286|NCT02399085|18755426|P1|STARTED|Overall Study||81
7617287|NCT02398409|18755436|P2|NOT COMPLETED|Overall Study||5
7617288|NCT02398409|18755437|P1|NOT COMPLETED|Overall Study||2
7617289|NCT02398409|18755436|P2|COMPLETED|Overall Study||63
7617290|NCT02398409|18755437|P1|COMPLETED|Overall Study||67
7617291|NCT02398409|18755436|P2|STARTED|Overall Study||68
7617292|NCT02398409|18755437|P1|STARTED|Overall Study||69
7617293|NCT02398227|18755451|P2|NOT COMPLETED|Overall Study||18
7617294|NCT02398227|18755452|P1|NOT COMPLETED|Overall Study||27
7617295|NCT02398227|18755451|P2|COMPLETED|Overall Study||71
7617296|NCT02398227|18755452|P1|COMPLETED|Overall Study||56
7617297|NCT02398227|18755451|P2|STARTED|Overall Study||89
7617298|NCT02398227|18755452|P1|STARTED|Overall Study||83
7617299|NCT02398188|18755462|P2|NOT COMPLETED|Overall Study||34
7617300|NCT02398188|18755463|P1|NOT COMPLETED|Overall Study||27
7617301|NCT02398188|18755462|P2|COMPLETED|Overall Study||361
7617302|NCT02398188|18755463|P1|COMPLETED|Overall Study||371
7617303|NCT02398188|18755462|P2|STARTED|Overall Study||395
7617304|NCT02398188|18755463|P1|STARTED|Overall Study||398
7617305|NCT02397954|18755473|P1|NOT COMPLETED|Overall Study||0
7617306|NCT02397954|18755473|P1|COMPLETED|Overall Study||4
7617307|NCT02397954|18755473|P1|STARTED|Overall Study||4
7617308|NCT02397915|18755481|P4|NOT COMPLETED|Period 2||0
7617309|NCT02397915|18755482|P3|NOT COMPLETED|Period 2||0
7617310|NCT02397915|18755483|P2|NOT COMPLETED|Period 2||0
7617311|NCT02397915|18755484|P1|NOT COMPLETED|Period 2||0
7617312|NCT02397915|18755481|P4|COMPLETED|Period 2||149
7617313|NCT02397915|18755482|P3|COMPLETED|Period 2||149
7617314|NCT02397915|18755483|P2|COMPLETED|Period 2||0
7617315|NCT02397915|18755484|P1|COMPLETED|Period 2||0
7617316|NCT02397915|18755481|P4|STARTED|Period 2||149
7617317|NCT02397915|18755482|P3|STARTED|Period 2||149
7617318|NCT02397915|18755483|P2|STARTED|Period 2||0
7617319|NCT02397915|18755484|P1|STARTED|Period 2||0
7617320|NCT02397915|18755481|P4|NOT COMPLETED|Period 1||0
7617321|NCT02397915|18755482|P3|NOT COMPLETED|Period 1||0
7617322|NCT02397915|18755483|P2|NOT COMPLETED|Period 1||1
7617323|NCT02397915|18755484|P1|NOT COMPLETED|Period 1||1
7617324|NCT02397915|18755481|P4|COMPLETED|Period 1||0
7617325|NCT02397915|18755482|P3|COMPLETED|Period 1||0
7617326|NCT02397915|18755483|P2|COMPLETED|Period 1||149
7617327|NCT02397915|18755484|P1|COMPLETED|Period 1||149
7617328|NCT02397915|18755481|P4|STARTED|Period 1||0
7617329|NCT02397915|18755482|P3|STARTED|Period 1||0
7617330|NCT02397915|18755483|P2|STARTED|Period 1||150
7617331|NCT02397915|18755484|P1|STARTED|Period 1||150
7617332|NCT02397837|18755536|P2|NOT COMPLETED|Overall Study||6
7617333|NCT02397837|18755537|P1|NOT COMPLETED|Overall Study||7
7617334|NCT02397837|18755536|P2|COMPLETED|Overall Study||24
7617335|NCT02397837|18755537|P1|COMPLETED|Overall Study||26
7617336|NCT02397837|18755536|P2|STARTED|Overall Study||30
7617337|NCT02397837|18755537|P1|STARTED|Overall Study||33
7617338|NCT02397785|18755563|P2|NOT COMPLETED|Overall Study||9
7617339|NCT02397785|18755564|P1|NOT COMPLETED|Overall Study||2
7617340|NCT02397785|18755563|P2|COMPLETED|Overall Study||25
7617341|NCT02397785|18755564|P1|COMPLETED|Overall Study||22
7617342|NCT02397785|18755563|P2|STARTED|Overall Study||34
7617343|NCT02397785|18755564|P1|STARTED|Overall Study||24
7617344|NCT02397707|18755611|P3|NOT COMPLETED|Overall Study||0
7617345|NCT02397707|18755612|P2|NOT COMPLETED|Overall Study||0
7617346|NCT02397707|18755613|P1|NOT COMPLETED|Overall Study||0
7617347|NCT02397707|18755611|P3|COMPLETED|Overall Study||9
7617348|NCT02397707|18755612|P2|COMPLETED|Overall Study||10
7617349|NCT02397707|18755613|P1|COMPLETED|Overall Study||14
7617350|NCT02397707|18755611|P3|STARTED|Overall Study||9
7617351|NCT02397707|18755612|P2|STARTED|Overall Study||10
7617352|NCT02397707|18755613|P1|STARTED|Overall Study||14
7617353|NCT02397694|18755632|P2|NOT COMPLETED|Open Label Extension Phase||1
7617354|NCT02397694|18755633|P1|NOT COMPLETED|Open Label Extension Phase||8
7617355|NCT02397694|18755632|P2|COMPLETED|Open Label Extension Phase||29
7617356|NCT02397694|18755633|P1|COMPLETED|Open Label Extension Phase||54
7617357|NCT02397694|18755632|P2|STARTED|Open Label Extension Phase||30
7617358|NCT02397694|18755633|P1|STARTED|Open Label Extension Phase||62
7617359|NCT02397694|18755632|P2|NOT COMPLETED|Double-Blinded Phase||3
7617360|NCT02397694|18755633|P1|NOT COMPLETED|Double-Blinded Phase||3
7617361|NCT02397694|18755632|P2|COMPLETED|Double-Blinded Phase||30
7617362|NCT02397694|18755633|P1|COMPLETED|Double-Blinded Phase||62
7617363|NCT02397694|18755632|P2|STARTED|Double-Blinded Phase||33
7617364|NCT02397694|18755633|P1|STARTED|Double-Blinded Phase||65
7617365|NCT02397655|18755671|P1|NOT COMPLETED|Overall Study||1301
7617366|NCT02397655|18755671|P1|COMPLETED|Overall Study||10711
7617367|NCT02397655|18755671|P1|STARTED|Overall Study||12012
7617368|NCT02397564|18755675|P1|NOT COMPLETED|Overall Study||4
7617369|NCT02397564|18755675|P1|COMPLETED|Overall Study||16
7617370|NCT02397564|18755675|P1|STARTED|Overall Study||20
7617371|NCT02397473|18755682|P2|NOT COMPLETED|Post Treatment Follow-up Phase||2
7617372|NCT02397473|18755683|P1|NOT COMPLETED|Post Treatment Follow-up Phase||3
7617373|NCT02397473|18755682|P2|COMPLETED|Post Treatment Follow-up Phase||45
7617374|NCT02397473|18755683|P1|COMPLETED|Post Treatment Follow-up Phase||47
7617375|NCT02397473|18755682|P2|STARTED|Post Treatment Follow-up Phase||47
7617376|NCT02397473|18755683|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued treatment period had an option to enter post treatment phase.|50
7617377|NCT02397473|18755682|P2|NOT COMPLETED|Treatment Phase||7
7617378|NCT02397473|18755683|P1|NOT COMPLETED|Treatment Phase||12
7617379|NCT02397473|18755682|P2|COMPLETED|Treatment Phase||45
7617380|NCT02397473|18755683|P1|COMPLETED|Treatment Phase||45
7617381|NCT02397473|18755682|P2|Received at Least One Dose of Study Drug|Treatment Phase||49
7617382|NCT02397473|18755683|P1|Received at Least One Dose of Study Drug|Treatment Phase||57
7617383|NCT02397473|18755682|P2|STARTED|Treatment Phase||52
7617384|NCT02397473|18755683|P1|STARTED|Treatment Phase||57
7617385|NCT02397447|18755713|P2|NOT COMPLETED|Overall Study||2
7617386|NCT02397447|18755714|P1|NOT COMPLETED|Overall Study||2
7617387|NCT02397447|18755713|P2|COMPLETED|Overall Study||10
7617388|NCT02397447|18755714|P1|COMPLETED|Overall Study||10
7617389|NCT02397447|18755713|P2|STARTED|Overall Study||12
7617390|NCT02397447|18755714|P1|STARTED|Overall Study||12
7617391|NCT02397408|18755760|P1|NOT COMPLETED|Overall Study||6
7617392|NCT02397408|18755760|P1|COMPLETED|Overall Study||12
7617393|NCT02397408|18755760|P1|Completed Surgery Per Protocol|Overall Study||16
7617394|NCT02397408|18755760|P1|STARTED|Overall Study||18
7617395|NCT02397265|18755778|P3|NOT COMPLETED|Third Intervention of Three||0
7617396|NCT02397265|18755779|P2|NOT COMPLETED|Third Intervention of Three||0
7617397|NCT02397265|18755780|P1|NOT COMPLETED|Third Intervention of Three||0
7617398|NCT02397265|18755778|P3|COMPLETED|Third Intervention of Three||2
7617399|NCT02397265|18755779|P2|COMPLETED|Third Intervention of Three||2
7617400|NCT02397265|18755780|P1|COMPLETED|Third Intervention of Three||2
7617401|NCT02397265|18755778|P3|STARTED|Third Intervention of Three||2
7617402|NCT02397265|18755779|P2|STARTED|Third Intervention of Three||2
7617403|NCT02397265|18755780|P1|STARTED|Third Intervention of Three||2
7617404|NCT02397265|18755778|P3|NOT COMPLETED|Second Intervention of Three||0
7617405|NCT02397265|18755779|P2|NOT COMPLETED|Second Intervention of Three||0
7617406|NCT02397265|18755780|P1|NOT COMPLETED|Second Intervention of Three||0
7617407|NCT02397265|18755778|P3|COMPLETED|Second Intervention of Three||2
7617408|NCT02397265|18755779|P2|COMPLETED|Second Intervention of Three||2
7617409|NCT02397265|18755780|P1|COMPLETED|Second Intervention of Three||2
7617410|NCT02397265|18755778|P3|STARTED|Second Intervention of Three||2
7617411|NCT02397265|18755779|P2|STARTED|Second Intervention of Three||2
7617412|NCT02397265|18755780|P1|STARTED|Second Intervention of Three||2
7617413|NCT02397265|18755778|P3|NOT COMPLETED|First Intervention of Three||0
7617414|NCT02397265|18755779|P2|NOT COMPLETED|First Intervention of Three||0
7617415|NCT02397265|18755780|P1|NOT COMPLETED|First Intervention of Three||0
7617416|NCT02397265|18755778|P3|COMPLETED|First Intervention of Three||2
7617417|NCT02397265|18755779|P2|COMPLETED|First Intervention of Three||2
7617418|NCT02397265|18755780|P1|COMPLETED|First Intervention of Three||2
7617419|NCT02397265|18755778|P3|STARTED|First Intervention of Three||2
7617420|NCT02397265|18755779|P2|STARTED|First Intervention of Three||2
7617421|NCT02397265|18755780|P1|STARTED|First Intervention of Three||2
7617422|NCT02397122|18755790|P2|NOT COMPLETED|Overall Study||0
7617423|NCT02397122|18755791|P1|NOT COMPLETED|Overall Study||0
7617424|NCT02397122|18755790|P2|COMPLETED|Overall Study||20
7617425|NCT02397122|18755791|P1|COMPLETED|Overall Study||20
7617426|NCT02397122|18755790|P2|STARTED|Overall Study||20
7617427|NCT02397122|18755791|P1|STARTED|Overall Study||20
7617428|NCT02397096|18755809|P2|NOT COMPLETED|Study Extensions||202
7617429|NCT02397096|18755810|P1|NOT COMPLETED|Study Extensions||399
7617430|NCT02397096|18755809|P2|COMPLETED|Study Extensions|The extension study is ongoing.|0
7617431|NCT02397096|18755810|P1|COMPLETED|Study Extensions|The extension study is ongoing.|0
7617432|NCT02397096|18755809|P2|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|202
7617433|NCT02397096|18755810|P1|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|399
7617434|NCT02397096|18755809|P2|NOT COMPLETED|Week 24 to Week 48||7
7617435|NCT02397096|18755810|P1|NOT COMPLETED|Week 24 to Week 48||20
7617436|NCT02397096|18755809|P2|COMPLETED|Week 24 to Week 48||202
7617437|NCT02397096|18755810|P1|COMPLETED|Week 24 to Week 48||407
7617438|NCT02397096|18755809|P2|STARTED|Week 24 to Week 48||209
7617439|NCT02397096|18755810|P1|STARTED|Week 24 to Week 48||427
7617440|NCT02397096|18755809|P2|NOT COMPLETED|Day 1 to Week 24||14
7617441|NCT02397096|18755810|P1|NOT COMPLETED|Day 1 to Week 24||20
7617442|NCT02397096|18755809|P2|COMPLETED|Day 1 to Week 24||209
7617443|NCT02397096|18755810|P1|COMPLETED|Day 1 to Week 24||427
7617444|NCT02397096|18755809|P2|STARTED|Day 1 to Week 24||223
7617445|NCT02397096|18755810|P1|STARTED|Day 1 to Week 24||447
7617446|NCT02396953|18755843|P3|NOT COMPLETED|Overall Study||3
7617447|NCT02396953|18755844|P2|NOT COMPLETED|Overall Study||3
7617448|NCT02396953|18755845|P1|NOT COMPLETED|Overall Study||4
7617449|NCT02396953|18755843|P3|COMPLETED|Overall Study||7
7617450|NCT02396953|18755844|P2|COMPLETED|Overall Study||6
7617451|NCT02396953|18755845|P1|COMPLETED|Overall Study||5
7617452|NCT02396953|18755843|P3|STARTED|Overall Study||10
7617453|NCT02396953|18755844|P2|STARTED|Overall Study||9
7617454|NCT02396953|18755845|P1|STARTED|Overall Study||9
7617455|NCT02396745|18755895|P1|NOT COMPLETED|Overall Study||0
7617456|NCT02396745|18755895|P1|COMPLETED|Overall Study||1
7617457|NCT02396745|18755895|P1|STARTED|Overall Study||1
7617458|NCT02396732|18755907|P2|NOT COMPLETED|Overall Study||0
7617459|NCT02396732|18755908|P1|NOT COMPLETED|Overall Study||0
7617460|NCT02396732|18755907|P2|COMPLETED|Overall Study||17
7617461|NCT02396732|18755908|P1|COMPLETED|Overall Study||14
7617462|NCT02396732|18755907|P2|STARTED|Overall Study||17
7617463|NCT02396732|18755908|P1|STARTED|Overall Study||14
7617464|NCT02396537|18755920|P2|NOT COMPLETED|Overall Study||1
7617465|NCT02396537|18755921|P1|NOT COMPLETED|Overall Study||0
7617466|NCT02396537|18755920|P2|COMPLETED|Overall Study||36
7617467|NCT02396537|18755921|P1|COMPLETED|Overall Study||40
7617468|NCT02396537|18755920|P2|STARTED|Overall Study||37
7617469|NCT02396537|18755921|P1|STARTED|Overall Study||40
7617470|NCT02396511|18755927|P1|NOT COMPLETED|Overall Study||0
7617471|NCT02396511|18755927|P1|COMPLETED|Overall Study||2
7617472|NCT02396511|18755927|P1|STARTED|Overall Study||2
7617473|NCT02396420|18755933|P1|NOT COMPLETED|Overall Study||1
7617474|NCT02396420|18755933|P1|COMPLETED|Overall Study||1
7617475|NCT02396420|18755933|P1|6 Months Post PAE|Overall Study||2
7617476|NCT02396420|18755933|P1|3 Months Post PAE|Overall Study||2
7617477|NCT02396420|18755933|P1|1 Month Post PAE|Overall Study||2
7617478|NCT02396420|18755933|P1|STARTED|Overall Study||2
7617479|NCT02396381|18755957|P2|NOT COMPLETED|Overall Study||74
7617480|NCT02396381|18755958|P1|NOT COMPLETED|Overall Study||107
7617481|NCT02396381|18755957|P2|COMPLETED|Overall Study||422
7617482|NCT02396381|18755958|P1|COMPLETED|Overall Study||381
7617483|NCT02396381|18755957|P2|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||443
7617484|NCT02396381|18755958|P1|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||414
7617485|NCT02396381|18755957|P2|STARTED|Overall Study||496
7617486|NCT02396381|18755958|P1|STARTED|Overall Study||488
7617487|NCT02396316|18755997|P2|NOT COMPLETED|Overall Study||5
7617488|NCT02396316|18755998|P1|NOT COMPLETED|Overall Study||7
7617489|NCT02396316|18755997|P2|COMPLETED|Overall Study||22
7617490|NCT02396316|18755998|P1|COMPLETED|Overall Study||20
7617491|NCT02396316|18755997|P2|Received Active Injection at Week 9|Overall Study||1
7617492|NCT02396316|18755998|P1|Received Active Injection at Week 9|Overall Study||2
7617493|NCT02396316|18755997|P2|Received Active Injection at Week 5|Overall Study||4
7617494|NCT02396316|18755998|P1|Received Active Injection at Week 5|Overall Study||4
7617495|NCT02396316|18755997|P2|Received AFL Injection at Week 1|Overall Study||22
7617496|NCT02396316|18755998|P1|Received AFL Injection at Week 1|Overall Study||0
7617497|NCT02396316|18755997|P2|Received Sham Injection at Week 1|Overall Study||0
7617498|NCT02396316|18755998|P1|Received Sham Injection at Week 1|Overall Study||10
7617499|NCT02396316|18755997|P2|Treated|Overall Study||27
7617500|NCT02396316|18755998|P1|Treated|Overall Study||27
7617501|NCT02396316|18755997|P2|STARTED|Overall Study||27
7617502|NCT02396316|18755998|P1|STARTED|Overall Study||27
7617503|NCT02396251|18756010|P2|NOT COMPLETED|Overall Study||5
7617504|NCT02396251|18756011|P1|NOT COMPLETED|Overall Study||13
7617505|NCT02396251|18756010|P2|COMPLETED|Overall Study||7
7617506|NCT02396251|18756011|P1|COMPLETED|Overall Study||23
7617507|NCT02396251|18756010|P2|STARTED|Overall Study||12
7617508|NCT02396251|18756011|P1|STARTED|Overall Study||36
7617509|NCT02396212|18756017|P1|NOT COMPLETED|Overall Study||3
7617510|NCT02396212|18756017|P1|COMPLETED|Overall Study||16
7617511|NCT02396212|18756017|P1|STARTED|Overall Study||19
7617512|NCT02396160|18756038|P2|NOT COMPLETED|Overall Study||2
7617513|NCT02396160|18756039|P1|NOT COMPLETED|Overall Study||6
7617514|NCT02396160|18756038|P2|COMPLETED|Overall Study||73
7617515|NCT02396160|18756039|P1|COMPLETED|Overall Study||69
7617516|NCT02396160|18756038|P2|STARTED|Overall Study||75
7617517|NCT02396160|18756039|P1|STARTED|Overall Study||75
7617518|NCT02396147|18756055|P2|NOT COMPLETED|Period 3||0
7617519|NCT02396147|18756056|P1|NOT COMPLETED|Period 3||0
7617520|NCT02396147|18756055|P2|COMPLETED|Period 3||27
7617521|NCT02396147|18756056|P1|COMPLETED|Period 3||27
7617522|NCT02396147|18756055|P2|STARTED|Period 3||27
7617523|NCT02396147|18756056|P1|STARTED|Period 3||27
7617524|NCT02396147|18756055|P2|NOT COMPLETED|Period 2||0
7617525|NCT02396147|18756056|P1|NOT COMPLETED|Period 2||0
7617526|NCT02396147|18756055|P2|COMPLETED|Period 2||27
7617527|NCT02396147|18756056|P1|COMPLETED|Period 2||27
7617528|NCT02396147|18756055|P2|STARTED|Period 2||27
7617529|NCT02396147|18756056|P1|STARTED|Period 2||27
7617530|NCT02396147|18756055|P2|NOT COMPLETED|Period 1||0
7617531|NCT02396147|18756056|P1|NOT COMPLETED|Period 1||0
7617532|NCT02396147|18756055|P2|COMPLETED|Period 1||27
7617533|NCT02396147|18756056|P1|COMPLETED|Period 1||27
7617534|NCT02396147|18756055|P2|STARTED|Period 1||27
7617535|NCT02396147|18756056|P1|STARTED|Period 1||27
7617536|NCT02395978|18756129|P5|NOT COMPLETED|Overall Study||5
7617537|NCT02395978|18756130|P4|NOT COMPLETED|Overall Study||5
7617538|NCT02395978|18756131|P3|NOT COMPLETED|Overall Study||2
7617539|NCT02395978|18756132|P2|NOT COMPLETED|Overall Study||0
7617540|NCT02395978|18756133|P1|NOT COMPLETED|Overall Study||0
7617541|NCT02395978|18756129|P5|COMPLETED|Overall Study||15
7617542|NCT02395978|18756130|P4|COMPLETED|Overall Study||14
7617543|NCT02395978|18756131|P3|COMPLETED|Overall Study||19
7617544|NCT02395978|18756132|P2|COMPLETED|Overall Study||6
7617545|NCT02395978|18756133|P1|COMPLETED|Overall Study||6
7617546|NCT02395978|18756129|P5|STARTED|Overall Study||20
7617547|NCT02395978|18756130|P4|STARTED|Overall Study||19
7617548|NCT02395978|18756131|P3|STARTED|Overall Study||21
7617549|NCT02395978|18756132|P2|STARTED|Overall Study||6
7617550|NCT02395978|18756133|P1|STARTED|Overall Study||6
7617551|NCT02395822|18756170|P1|NOT COMPLETED|Overall Study||2
7617552|NCT02395822|18756170|P1|COMPLETED|Overall Study||15
7617553|NCT02395822|18756170|P1|STARTED|Overall Study||17
7617554|NCT02395692|18756178|P2|NOT COMPLETED|Overall Study||0
7617555|NCT02395692|18756179|P1|NOT COMPLETED|Overall Study||0
7617556|NCT02395692|18756178|P2|COMPLETED|Overall Study||0
7617557|NCT02395692|18756179|P1|COMPLETED|Overall Study||19
7617558|NCT02395692|18756178|P2|STARTED|Overall Study||0
7617559|NCT02395692|18756179|P1|STARTED|Overall Study||19
7617560|NCT02395666|18756191|P2|NOT COMPLETED|Overall Study||1
7617561|NCT02395666|18756192|P1|NOT COMPLETED|Overall Study||6
7617562|NCT02395666|18756191|P2|COMPLETED|Overall Study||38
7617563|NCT02395666|18756192|P1|COMPLETED|Overall Study||95
7617564|NCT02395666|18756191|P2|STARTED|Overall Study||39
7617565|NCT02395666|18756192|P1|STARTED|Overall Study||101
7617566|NCT02395653|18756206|P1|NOT COMPLETED|Overall Study||12
7617567|NCT02395653|18756206|P1|COMPLETED|Overall Study||59
7617568|NCT02395653|18756206|P1|Received at Least 1 Dose of Study Drug|Overall Study||61
7617569|NCT02395653|18756206|P1|STARTED|Overall Study||71
7617570|NCT02395627|18756216|P3|NOT COMPLETED|Overall Study||0
7617571|NCT02395627|18756217|P2|NOT COMPLETED|Overall Study||3
7617572|NCT02395627|18756218|P1|NOT COMPLETED|Overall Study||3
7617573|NCT02395627|18756216|P3|COMPLETED|Overall Study||4
7617574|NCT02395627|18756217|P2|COMPLETED|Overall Study||13
7617575|NCT02395627|18756218|P1|COMPLETED|Overall Study||15
7617576|NCT02395627|18756216|P3|STARTED|Overall Study||4
7617577|NCT02395627|18756217|P2|STARTED|Overall Study||16
7617578|NCT02395627|18756218|P1|STARTED|Overall Study||18
7617579|NCT02395536|18756246|P2|NOT COMPLETED|Overall Study||30
7617580|NCT02395536|18756247|P1|NOT COMPLETED|Overall Study||20
7617581|NCT02395536|18756246|P2|COMPLETED|Overall Study||227
7617582|NCT02395536|18756247|P1|COMPLETED|Overall Study||244
7617583|NCT02395536|18756246|P2|REVEAL LINQ Insertion|Overall Study||231
7617584|NCT02395536|18756247|P1|REVEAL LINQ Insertion|Overall Study||251
7617585|NCT02395536|18756246|P2|STARTED|Overall Study||257
7617586|NCT02395536|18756247|P1|STARTED|Overall Study||264
7617587|NCT02395471|18756255|P2|NOT COMPLETED|Overall Study||3
7617588|NCT02395471|18756256|P1|NOT COMPLETED|Overall Study||7
7617589|NCT02395471|18756255|P2|COMPLETED|Overall Study||59
7617590|NCT02395471|18756256|P1|COMPLETED|Overall Study||122
7617591|NCT02395471|18756255|P2|STARTED|Overall Study||62
7617592|NCT02395471|18756256|P1|STARTED|Overall Study||129
7617593|NCT02395302|18756271|P1|NOT COMPLETED|Overall Study||14
7617594|NCT02395302|18756271|P1|COMPLETED|Overall Study||14
7617595|NCT02395302|18756271|P1|STARTED|Overall Study||28
7617596|NCT02395185|18756275|P1|NOT COMPLETED|Overall Study||0
7617597|NCT02395185|18756275|P1|COMPLETED|Overall Study||33
7617598|NCT02395185|18756275|P1|Sequence 18 (m,w,m,s,w,s)|Overall Study||1
7617599|NCT02395185|18756275|P1|Sequence 17 (w,m,s,w,s,m)|Overall Study||1
7617600|NCT02395185|18756275|P1|Sequence 16 (m,s,w,s,m,w)|Overall Study||1
7617601|NCT02395185|18756275|P1|Sequence 15 (s,w,s,m,w,m)|Overall Study||2
7617602|NCT02395185|18756275|P1|Sequence 14 (w,s,m,w,m,s)|Overall Study||2
7617603|NCT02395185|18756275|P1|Sequence 13 (s,m,w,m,s,w)|Overall Study||2
7617604|NCT02395185|18756275|P1|Sequence 12 (s,w,w,m,m,s)|Overall Study||2
7617605|NCT02395185|18756275|P1|Sequence 11 (w,w,m,m,s,s)|Overall Study||2
7617606|NCT02395185|18756275|P1|Sequence 10 (w,m,m,s,s,w)|Overall Study||2
7617607|NCT02395185|18756275|P1|Sequence 9 (m,m,s,s,w,w)|Overall Study||2
7617608|NCT02395185|18756275|P1|Sequence 8 (m,s,s,w,w,m)|Overall Study||2
7617609|NCT02395185|18756275|P1|Sequence 7 (s,s,w,w,m,m)|Overall Study||2
7617610|NCT02395185|18756275|P1|Sequence 6 (s,m,m,w,w,s)|Overall Study||2
7617611|NCT02395185|18756275|P1|Sequence 5 (m,m,w,w,s,s)|Overall Study||2
7617612|NCT02395185|18756275|P1|Sequence 4 (m,w,w,s,s,m)|Overall Study||2
7617613|NCT02395185|18756275|P1|Sequence 3 (w,w,s,s,m,m)|Overall Study||2
7617614|NCT02395185|18756275|P1|Sequence 2 (w,s,s,m,m,w)|Overall Study||2
7617615|NCT02395185|18756275|P1|Sequence 1 (s,s,m,m,w,w)|Overall Study|one of the participants in this milestone did not have a guardian enrolled due to age.|2
7617616|NCT02395185|18756275|P1|STARTED|Overall Study|32 guardians participated with these infants. one infant did not have a guardian participate.|33
7617617|NCT02395172|18756291|P2|NOT COMPLETED|Overall Study||31
7617618|NCT02395172|18756292|P1|NOT COMPLETED|Overall Study||3
7617619|NCT02395172|18756291|P2|COMPLETED|Overall Study||365
7617620|NCT02395172|18756292|P1|COMPLETED|Overall Study||393
7617621|NCT02395172|18756291|P2|Treated|Overall Study||365
7617622|NCT02395172|18756292|P1|Treated|Overall Study||393
7617623|NCT02395172|18756291|P2|STARTED|Overall Study||396
7617624|NCT02395172|18756292|P1|STARTED|Overall Study||396
7617625|NCT02395133|18756331|P4|NOT COMPLETED|Overall Study||14
7617626|NCT02395133|18756332|P3|NOT COMPLETED|Overall Study||10
7617627|NCT02395133|18756333|P2|NOT COMPLETED|Overall Study||9
7617628|NCT02395133|18756334|P1|NOT COMPLETED|Overall Study||14
7617629|NCT02395133|18756331|P4|COMPLETED|Overall Study||155
7617630|NCT02395133|18756332|P3|COMPLETED|Overall Study||76
7617631|NCT02395133|18756333|P2|COMPLETED|Overall Study||75
7617632|NCT02395133|18756334|P1|COMPLETED|Overall Study||69
7617633|NCT02395133|18756331|P4|STARTED|Overall Study||169
7617634|NCT02395133|18756332|P3|STARTED|Overall Study||86
7617635|NCT02395133|18756333|P2|STARTED|Overall Study||84
7617636|NCT02395133|18756334|P1|STARTED|Overall Study||83
7617637|NCT02395055|18756422|P2|NOT COMPLETED|Overall Study||3
7617638|NCT02395055|18756423|P1|NOT COMPLETED|Overall Study||7
7617639|NCT02395055|18756422|P2|COMPLETED|Overall Study||44
7617640|NCT02395055|18756423|P1|COMPLETED|Overall Study||40
7617641|NCT02395055|18756422|P2|STARTED|Overall Study||47
7617642|NCT02395055|18756423|P1|STARTED|Overall Study||47
7617643|NCT02395042|18756436|P3|NOT COMPLETED|Treatment 2 Period||0
7617644|NCT02395042|18756437|P2|NOT COMPLETED|Treatment 2 Period||1
7617645|NCT02395042|18756438|P1|NOT COMPLETED|Treatment 2 Period||1
7617646|NCT02395042|18756436|P3|COMPLETED|Treatment 2 Period||13
7617647|NCT02395042|18756437|P2|COMPLETED|Treatment 2 Period||23
7617648|NCT02395042|18756438|P1|COMPLETED|Treatment 2 Period||9
7617649|NCT02395042|18756436|P3|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|13
7617650|NCT02395042|18756437|P2|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|24
7617651|NCT02395042|18756438|P1|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|10
7617652|NCT02395042|18756436|P3|NOT COMPLETED|Treatment 1 Period||2
7617653|NCT02395042|18756437|P2|NOT COMPLETED|Treatment 1 Period||6
7617654|NCT02395042|18756438|P1|NOT COMPLETED|Treatment 1 Period||3
7617655|NCT02395042|18756436|P3|COMPLETED|Treatment 1 Period||14
7617656|NCT02395042|18756437|P2|COMPLETED|Treatment 1 Period||25
7617657|NCT02395042|18756438|P1|COMPLETED|Treatment 1 Period||9
7617658|NCT02395042|18756436|P3|STARTED|Treatment 1 Period||16
7617659|NCT02395042|18756437|P2|STARTED|Treatment 1 Period||31
7617660|NCT02395042|18756438|P1|STARTED|Treatment 1 Period||12
7617661|NCT02394951|18756457|P2|NOT COMPLETED|Period II||4
7617662|NCT02394951|18756458|P1|NOT COMPLETED|Period II||0
7617663|NCT02394951|18756457|P2|COMPLETED|Period II||9
7617664|NCT02394951|18756458|P1|COMPLETED|Period II||11
7617665|NCT02394951|18756457|P2|STARTED|Period II||13
7617666|NCT02394951|18756458|P1|STARTED|Period II||11
7617667|NCT02394951|18756457|P2|NOT COMPLETED|Period I||1
7617668|NCT02394951|18756458|P1|NOT COMPLETED|Period I||1
7617669|NCT02394951|18756457|P2|COMPLETED|Period I||13
7617670|NCT02394951|18756458|P1|COMPLETED|Period I||11
7617671|NCT02394951|18756457|P2|STARTED|Period I||14
7617672|NCT02394951|18756458|P1|STARTED|Period I||12
7617673|NCT02394925|18756476|P1|NOT COMPLETED|Overall Study||29
7617674|NCT02394925|18756476|P1|COMPLETED|Overall Study||79
7617675|NCT02394925|18756476|P1|STARTED|Overall Study||108
7617676|NCT02394912|18756480|P1|NOT COMPLETED|Overall Study||0
7617677|NCT02394912|18756480|P1|COMPLETED|Overall Study||21
7617678|NCT02394912|18756480|P1|STARTED|Overall Study||21
7617679|NCT02394808|18756486|P2|NOT COMPLETED|Period 2||0
7617680|NCT02394808|18756487|P1|NOT COMPLETED|Period 2||1
7617681|NCT02394808|18756486|P2|COMPLETED|Period 2||28
7617682|NCT02394808|18756487|P1|COMPLETED|Period 2||24
7617683|NCT02394808|18756486|P2|STARTED|Period 2||28
7617684|NCT02394808|18756487|P1|STARTED|Period 2||25
7617685|NCT02394808|18756486|P2|NOT COMPLETED|Period 1||1
7617686|NCT02394808|18756487|P1|NOT COMPLETED|Period 1||0
7617687|NCT02394808|18756486|P2|COMPLETED|Period 1||28
7617688|NCT02394808|18756487|P1|COMPLETED|Period 1||25
7617689|NCT02394808|18756486|P2|STARTED|Period 1||29
7617690|NCT02394808|18756487|P1|STARTED|Period 1||25
7617691|NCT02394756|18756495|P6|NOT COMPLETED|Period 3||0
7617692|NCT02394756|18756496|P5|NOT COMPLETED|Period 3||0
7617693|NCT02394756|18756497|P4|NOT COMPLETED|Period 3||0
7617694|NCT02394756|18756498|P3|NOT COMPLETED|Period 3||0
7617695|NCT02394756|18756499|P2|NOT COMPLETED|Period 3||0
7617696|NCT02394756|18756500|P1|NOT COMPLETED|Period 3||0
7617697|NCT02394756|18756495|P6|COMPLETED|Period 3||6
7617698|NCT02394756|18756496|P5|COMPLETED|Period 3||6
7617699|NCT02394756|18756497|P4|COMPLETED|Period 3||6
7617700|NCT02394756|18756498|P3|COMPLETED|Period 3||6
7617701|NCT02394756|18756499|P2|COMPLETED|Period 3||6
7617702|NCT02394756|18756500|P1|COMPLETED|Period 3||7
7617703|NCT02394756|18756495|P6|STARTED|Period 3||6
7617704|NCT02394756|18756496|P5|STARTED|Period 3||6
7617705|NCT02394756|18756497|P4|STARTED|Period 3||6
7617706|NCT02394756|18756498|P3|STARTED|Period 3||6
7617707|NCT02394756|18756499|P2|STARTED|Period 3||6
7617708|NCT02394756|18756500|P1|STARTED|Period 3||7
7617709|NCT02394756|18756495|P6|NOT COMPLETED|Period 2||0
7617710|NCT02394756|18756496|P5|NOT COMPLETED|Period 2||1
7617711|NCT02394756|18756497|P4|NOT COMPLETED|Period 2||0
7617712|NCT02394756|18756498|P3|NOT COMPLETED|Period 2||0
7617713|NCT02394756|18756499|P2|NOT COMPLETED|Period 2||0
7617714|NCT02394756|18756500|P1|NOT COMPLETED|Period 2||0
7617715|NCT02394756|18756495|P6|COMPLETED|Period 2||6
7617716|NCT02394756|18756496|P5|COMPLETED|Period 2||6
7617717|NCT02394756|18756497|P4|COMPLETED|Period 2||6
7617718|NCT02394756|18756498|P3|COMPLETED|Period 2||6
7617719|NCT02394756|18756499|P2|COMPLETED|Period 2||6
7617720|NCT02394756|18756500|P1|COMPLETED|Period 2||7
7617721|NCT02394756|18756495|P6|STARTED|Period 2||6
7617722|NCT02394756|18756496|P5|STARTED|Period 2||7
7617723|NCT02394756|18756497|P4|STARTED|Period 2||6
7617724|NCT02394756|18756498|P3|STARTED|Period 2||6
7617725|NCT02394756|18756499|P2|STARTED|Period 2||6
7617726|NCT02394756|18756500|P1|STARTED|Period 2||7
7617727|NCT02394756|18756495|P6|NOT COMPLETED|Period 1||1
7617728|NCT02394756|18756496|P5|NOT COMPLETED|Period 1||0
7617729|NCT02394756|18756497|P4|NOT COMPLETED|Period 1||1
7617730|NCT02394756|18756498|P3|NOT COMPLETED|Period 1||1
7617731|NCT02394756|18756499|P2|NOT COMPLETED|Period 1||1
7617732|NCT02394756|18756500|P1|NOT COMPLETED|Period 1||0
7617733|NCT02394756|18756495|P6|COMPLETED|Period 1||6
7617734|NCT02394756|18756496|P5|COMPLETED|Period 1||7
7617735|NCT02394756|18756497|P4|COMPLETED|Period 1||6
7617736|NCT02394756|18756498|P3|COMPLETED|Period 1||6
7617737|NCT02394756|18756499|P2|COMPLETED|Period 1||6
7617738|NCT02394756|18756500|P1|COMPLETED|Period 1||7
7617739|NCT02394756|18756495|P6|STARTED|Period 1||7
7617740|NCT02394756|18756496|P5|STARTED|Period 1||7
7617741|NCT02394756|18756497|P4|STARTED|Period 1||7
7617742|NCT02394756|18756498|P3|STARTED|Period 1||7
7617743|NCT02394756|18756499|P2|STARTED|Period 1||7
7617744|NCT02394756|18756500|P1|STARTED|Period 1||7
7617745|NCT02394730|18756513|P2|NOT COMPLETED|Overall Study||1
7617746|NCT02394730|18756514|P1|NOT COMPLETED|Overall Study||1
7617747|NCT02394730|18756513|P2|COMPLETED|Overall Study||30
7617748|NCT02394730|18756514|P1|COMPLETED|Overall Study||33
7617749|NCT02394730|18756513|P2|STARTED|Overall Study||31
7617750|NCT02394730|18756514|P1|STARTED|Overall Study||34
7617751|NCT02394665|18756551|P3|NOT COMPLETED|Overall Study||0
7617752|NCT02394665|18756552|P2|NOT COMPLETED|Overall Study||0
7617753|NCT02394665|18756553|P1|NOT COMPLETED|Overall Study||1
7617754|NCT02394665|18756551|P3|COMPLETED|Overall Study||0
7617755|NCT02394665|18756552|P2|COMPLETED|Overall Study||0
7617756|NCT02394665|18756553|P1|COMPLETED|Overall Study||0
7617757|NCT02394665|18756551|P3|STARTED|Overall Study||0
7617758|NCT02394665|18756552|P2|STARTED|Overall Study||0
7617759|NCT02394665|18756553|P1|STARTED|Overall Study||1
7617760|NCT02394600|18756575|P2|NOT COMPLETED|Overall Study||2
7617761|NCT02394600|18756576|P1|NOT COMPLETED|Overall Study||4
7617762|NCT02394600|18756575|P2|COMPLETED|Overall Study||44
7617763|NCT02394600|18756576|P1|COMPLETED|Overall Study||43
7617764|NCT02394600|18756575|P2|STARTED|Overall Study||46
7617765|NCT02394600|18756576|P1|STARTED|Overall Study||47
7617766|NCT02394561|18756586|P2|NOT COMPLETED|Extension Phase||12
7617767|NCT02394561|18756587|P1|NOT COMPLETED|Extension Phase||11
7617768|NCT02394561|18756586|P2|COMPLETED|Extension Phase||207
7617769|NCT02394561|18756587|P1|COMPLETED|Extension Phase||151
7617770|NCT02394561|18756586|P2|STARTED|Extension Phase||219
7617771|NCT02394561|18756587|P1|STARTED|Extension Phase||162
7617772|NCT02394561|18756586|P2|NOT COMPLETED|CORE Phase||19
7617773|NCT02394561|18756587|P1|NOT COMPLETED|CORE Phase||13
7617774|NCT02394561|18756586|P2|COMPLETED|CORE Phase||227
7617775|NCT02394561|18756587|P1|COMPLETED|CORE Phase||172
7617776|NCT02394561|18756586|P2|ITT Set|CORE Phase||246
7617777|NCT02394561|18756587|P1|ITT Set|CORE Phase||184
7617778|NCT02394561|18756586|P2|Safety Set|CORE Phase||246
7617779|NCT02394561|18756587|P1|Safety Set|CORE Phase||185
7617780|NCT02394561|18756586|P2|Full Analysis Set|CORE Phase||246
7617781|NCT02394561|18756587|P1|Full Analysis Set|CORE Phase||185
7617782|NCT02394561|18756586|P2|STARTED|CORE Phase||246
7617783|NCT02394561|18756587|P1|STARTED|CORE Phase||185
7617784|NCT02394548|18756609|P1|NOT COMPLETED|Overall Study||1
7617785|NCT02394548|18756609|P1|COMPLETED|Overall Study||25
7617786|NCT02394548|18756609|P1|STARTED|Overall Study||26
7617787|NCT02394457|18756617|P2|NOT COMPLETED|Overall Study||0
7617788|NCT02394457|18756618|P1|NOT COMPLETED|Overall Study||0
7617789|NCT02394457|18756617|P2|COMPLETED|Overall Study||13
7617790|NCT02394457|18756618|P1|COMPLETED|Overall Study||15
7617791|NCT02394457|18756617|P2|STARTED|Overall Study||13
7617792|NCT02394457|18756618|P1|STARTED|Overall Study||15
7617793|NCT02394340|18756634|P1|NOT COMPLETED|Overall Study||2
7617794|NCT02394340|18756634|P1|COMPLETED|Overall Study||18
7617795|NCT02394340|18756634|P1|Received at Least 1 Dose of Study Drug|Overall Study||20
7617796|NCT02394340|18756634|P1|STARTED|Overall Study||20
7617797|NCT02393950|18756641|P2|NOT COMPLETED|Overall Study||1
7617798|NCT02393950|18756642|P1|NOT COMPLETED|Overall Study||1
7617799|NCT02393950|18756641|P2|COMPLETED|Overall Study||8
7617800|NCT02393950|18756642|P1|COMPLETED|Overall Study||8
7617801|NCT02393950|18756641|P2|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8
7617802|NCT02393950|18756642|P1|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8
7617803|NCT02393950|18756641|P2|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8
7617804|NCT02393950|18756642|P1|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8
7617805|NCT02393950|18756641|P2|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8
7617806|NCT02393950|18756642|P1|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8
7617807|NCT02393950|18756641|P2|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8
7617808|NCT02393950|18756642|P1|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8
7617809|NCT02393950|18756641|P2|STARTED|Overall Study||9
7617810|NCT02393950|18756642|P1|STARTED|Overall Study||9
7617811|NCT02393859|18756709|P2|NOT COMPLETED|Overall Study||54
7617812|NCT02393859|18756710|P1|NOT COMPLETED|Overall Study||54
7617813|NCT02393859|18756709|P2|COMPLETED|Overall Study||0
7617814|NCT02393859|18756710|P1|COMPLETED|Overall Study||0
7617815|NCT02393859|18756709|P2|STARTED|Overall Study||54
7617816|NCT02393859|18756710|P1|STARTED|Overall Study||54
7617817|NCT02393755|18756735|P2|NOT COMPLETED|Overall Study||7
7617818|NCT02393755|18756736|P1|NOT COMPLETED|Overall Study||0
7617819|NCT02393755|18756735|P2|COMPLETED|Overall Study||32
7617820|NCT02393755|18756736|P1|COMPLETED|Overall Study||3
7617821|NCT02393755|18756735|P2|STARTED|Overall Study||39
7617822|NCT02393755|18756736|P1|STARTED|Overall Study||3
7617823|NCT02393677|18756748|P2|NOT COMPLETED|Overall Study||0
7617824|NCT02393677|18756749|P1|NOT COMPLETED|Overall Study||0
7617825|NCT02393677|18756748|P2|COMPLETED|Overall Study||40
7617826|NCT02393677|18756749|P1|COMPLETED|Overall Study||40
7617827|NCT02393677|18756748|P2|STARTED|Overall Study||40
7617828|NCT02393677|18756749|P1|STARTED|Overall Study||40
7617829|NCT02393547|18756755|P1|NOT COMPLETED|Overall Study||6
7617830|NCT02393547|18756755|P1|COMPLETED|Overall Study||14
7617831|NCT02393547|18756755|P1|STARTED|Overall Study||20
7617832|NCT02393417|18756766|P4|NOT COMPLETED|Overall Study||12
7617833|NCT02393417|18756767|P3|NOT COMPLETED|Overall Study||10
7617834|NCT02393417|18756768|P2|NOT COMPLETED|Overall Study||13
7617835|NCT02393417|18756769|P1|NOT COMPLETED|Overall Study||15
7617836|NCT02393417|18756766|P4|COMPLETED|Overall Study||29
7617837|NCT02393417|18756767|P3|COMPLETED|Overall Study||30
7617838|NCT02393417|18756768|P2|COMPLETED|Overall Study||32
7617839|NCT02393417|18756769|P1|COMPLETED|Overall Study||28
7617840|NCT02393417|18756766|P4|Completed Treatment|Overall Study||30
7617841|NCT02393417|18756767|P3|Completed Treatment|Overall Study||32
7617842|NCT02393417|18756768|P2|Completed Treatment|Overall Study||34
7617843|NCT02393417|18756769|P1|Completed Treatment|Overall Study||30
7617844|NCT02393417|18756766|P4|STARTED|Overall Study||41
7617845|NCT02393417|18756767|P3|STARTED|Overall Study||40
7617846|NCT02393417|18756768|P2|STARTED|Overall Study||45
7617847|NCT02393417|18756769|P1|STARTED|Overall Study||43
7617848|NCT02393378|18756827|P2|NOT COMPLETED|Overall Study||0
7617849|NCT02393378|18756828|P1|NOT COMPLETED|Overall Study||0
7617850|NCT02393378|18756827|P2|COMPLETED|Overall Study||4
7617851|NCT02393378|18756828|P1|COMPLETED|Overall Study||3
7617852|NCT02393378|18756827|P2|STARTED|Overall Study||4
7617853|NCT02393378|18756828|P1|STARTED|Overall Study||3
7617854|NCT02393209|18756846|P4|NOT COMPLETED|Overall Study||0
7617855|NCT02393209|18756847|P3|NOT COMPLETED|Overall Study||0
7617856|NCT02393209|18756848|P2|NOT COMPLETED|Overall Study||8
7617857|NCT02393209|18756849|P1|NOT COMPLETED|Overall Study||6
7617858|NCT02393209|18756846|P4|COMPLETED|Overall Study||0
7617859|NCT02393209|18756847|P3|COMPLETED|Overall Study||0
7617860|NCT02393209|18756848|P2|COMPLETED|Overall Study||0
7617861|NCT02393209|18756849|P1|COMPLETED|Overall Study||0
7617862|NCT02393209|18756846|P4|STARTED|Overall Study||0
7617863|NCT02393209|18756847|P3|STARTED|Overall Study||0
7617864|NCT02393209|18756848|P2|STARTED|Overall Study||8
7617865|NCT02393209|18756849|P1|STARTED|Overall Study||6
7617866|NCT02392806|18756907|P2|NOT COMPLETED|Overall Study||0
7617867|NCT02392806|18756908|P1|NOT COMPLETED|Overall Study||0
7617868|NCT02392806|18756907|P2|COMPLETED|Overall Study||21
7617869|NCT02392806|18756908|P1|COMPLETED|Overall Study||22
7617870|NCT02392806|18756907|P2|STARTED|Overall Study||21
7617871|NCT02392806|18756908|P1|STARTED|Overall Study||22
7617872|NCT02392767|18756918|P2|NOT COMPLETED|Overall Study||0
7617873|NCT02392767|18756919|P1|NOT COMPLETED|Overall Study||0
7617874|NCT02392767|18756918|P2|COMPLETED|Overall Study||13
7617875|NCT02392767|18756919|P1|COMPLETED|Overall Study||12
7617876|NCT02392767|18756918|P2|STARTED|Overall Study||13
7617877|NCT02392767|18756919|P1|STARTED|Overall Study||12
7617878|NCT02392624|18756938|P3|NOT COMPLETED|Overall Study||13
7617879|NCT02392624|18756939|P2|NOT COMPLETED|Overall Study||15
7617880|NCT02392624|18756940|P1|NOT COMPLETED|Overall Study||71
7617881|NCT02392624|18756938|P3|COMPLETED|Overall Study||40
7617882|NCT02392624|18756939|P2|COMPLETED|Overall Study||66
7617883|NCT02392624|18756940|P1|COMPLETED|Overall Study||0
7617884|NCT02392624|18756938|P3|STARTED|Overall Study||53
7617885|NCT02392624|18756939|P2|STARTED|Overall Study||81
7617886|NCT02392624|18756940|P1|STARTED|Overall Study||71
7617887|NCT02392611|18756962|P9|NOT COMPLETED|Overall Study||0
7617888|NCT02392611|18756963|P8|NOT COMPLETED|Overall Study||0
7617889|NCT02392611|18756964|P7|NOT COMPLETED|Overall Study||1
7617890|NCT02392611|18756965|P6|NOT COMPLETED|Overall Study||1
7617891|NCT02392611|18756966|P5|NOT COMPLETED|Overall Study||1
7617892|NCT02392611|18756967|P4|NOT COMPLETED|Overall Study||6
7617893|NCT02392611|18756968|P3|NOT COMPLETED|Overall Study||0
7617894|NCT02392611|18756969|P2|NOT COMPLETED|Overall Study||0
7617895|NCT02392611|18756970|P1|NOT COMPLETED|Overall Study||1
7617896|NCT02392611|18756962|P9|COMPLETED|Overall Study||3
7617897|NCT02392611|18756963|P8|COMPLETED|Overall Study||3
7617898|NCT02392611|18756964|P7|COMPLETED|Overall Study||3
7617899|NCT02392611|18756965|P6|COMPLETED|Overall Study||3
7617900|NCT02392611|18756966|P5|COMPLETED|Overall Study||5
7617901|NCT02392611|18756967|P4|COMPLETED|Overall Study||3
7617902|NCT02392611|18756968|P3|COMPLETED|Overall Study||1
7617903|NCT02392611|18756969|P2|COMPLETED|Overall Study||1
7617904|NCT02392611|18756970|P1|COMPLETED|Overall Study||1
7617905|NCT02392611|18756962|P9|STARTED|Overall Study||3
7617906|NCT02392611|18756963|P8|STARTED|Overall Study||3
7617907|NCT02392611|18756964|P7|STARTED|Overall Study||4
7617908|NCT02392611|18756965|P6|STARTED|Overall Study||4
7617909|NCT02392611|18756966|P5|STARTED|Overall Study||6
7617910|NCT02392611|18756967|P4|STARTED|Overall Study||9
7617911|NCT02392611|18756968|P3|STARTED|Overall Study||1
7617912|NCT02392611|18756969|P2|STARTED|Overall Study||1
7617913|NCT02392611|18756970|P1|STARTED|Overall Study||2
7617914|NCT02392559|18757046|P2|NOT COMPLETED|Overall Study||1
7617915|NCT02392559|18757047|P1|NOT COMPLETED|Overall Study||0
7617916|NCT02392559|18757046|P2|COMPLETED|Overall Study||104
7617917|NCT02392559|18757047|P1|COMPLETED|Overall Study||53
7617918|NCT02392559|18757046|P2|Randomized and Dosed|Overall Study||104
7617919|NCT02392559|18757047|P1|Randomized and Dosed|Overall Study||53
7617920|NCT02392559|18757046|P2|STARTED|Overall Study||105
7617921|NCT02392559|18757047|P1|STARTED|Overall Study||53
7617922|NCT02392507|18757078|P1|NOT COMPLETED|Maintenance Regimen||2
7617923|NCT02392507|18757078|P1|COMPLETED|Maintenance Regimen||32
7617924|NCT02392507|18757078|P1|STARTED|Maintenance Regimen|After induction regimen participants with disease response are eligible for maintenance regimen.|34
7617925|NCT02392507|18757078|P1|NOT COMPLETED|Induction Regimen||7
7617926|NCT02392507|18757078|P1|COMPLETED|Induction Regimen||47
7617927|NCT02392507|18757078|P1|Received at Least 1 Dose of Study Drug|Induction Regimen||54
7617928|NCT02392507|18757078|P1|STARTED|Induction Regimen||54
7617929|NCT02392494|18757096|P4|NOT COMPLETED|Overall Study||0
7617930|NCT02392494|18757097|P3|NOT COMPLETED|Overall Study||0
7617931|NCT02392494|18757098|P2|NOT COMPLETED|Overall Study||0
7617932|NCT02392494|18757099|P1|NOT COMPLETED|Overall Study||0
7617933|NCT02392494|18757096|P4|COMPLETED|Overall Study||0
7617934|NCT02392494|18757097|P3|COMPLETED|Overall Study||3
7617935|NCT02392494|18757098|P2|COMPLETED|Overall Study||3
7617936|NCT02392494|18757099|P1|COMPLETED|Overall Study||3
7617937|NCT02392494|18757096|P4|STARTED|Overall Study||0
7617938|NCT02392494|18757097|P3|STARTED|Overall Study||3
7617939|NCT02392494|18757098|P2|STARTED|Overall Study||3
7617940|NCT02392494|18757099|P1|STARTED|Overall Study||3
7617941|NCT02392481|18757117|P4|NOT COMPLETED|Overall Study||2
7617942|NCT02392481|18757118|P3|NOT COMPLETED|Overall Study||2
7617943|NCT02392481|18757119|P2|NOT COMPLETED|Overall Study||0
7617944|NCT02392481|18757120|P1|NOT COMPLETED|Overall Study||0
7617945|NCT02392481|18757117|P4|COMPLETED|Overall Study||25
7617946|NCT02392481|18757118|P3|COMPLETED|Overall Study||18
7617947|NCT02392481|18757119|P2|COMPLETED|Overall Study||12
7617948|NCT02392481|18757120|P1|COMPLETED|Overall Study||10
7617949|NCT02392481|18757117|P4|STARTED|Overall Study||27
7617950|NCT02392481|18757118|P3|STARTED|Overall Study||20
7617951|NCT02392481|18757119|P2|STARTED|Overall Study||12
7617952|NCT02392481|18757120|P1|STARTED|Overall Study||10
7617953|NCT02392403|18757142|P1|NOT COMPLETED|Overall Study||3
7617954|NCT02392403|18757142|P1|COMPLETED|Overall Study||42
7617955|NCT02392403|18757142|P1|STARTED|Overall Study||45
7617956|NCT02392377|18757156|P2|NOT COMPLETED|Overall Study||1
7617957|NCT02392377|18757157|P1|NOT COMPLETED|Overall Study||0
7617958|NCT02392377|18757156|P2|COMPLETED|Overall Study||0
7617959|NCT02392377|18757157|P1|COMPLETED|Overall Study||0
7617960|NCT02392377|18757156|P2|STARTED|Overall Study||1
7617961|NCT02392377|18757157|P1|STARTED|Overall Study||0
7617962|NCT02392351|18757183|P2|NOT COMPLETED|Overall Study||17
7617963|NCT02392351|18757184|P1|NOT COMPLETED|Overall Study||34
7617964|NCT02392351|18757183|P2|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
7617965|NCT02392351|18757184|P1|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
7617966|NCT02392351|18757183|P2|STARTED|Overall Study||17
7617967|NCT02392351|18757184|P1|STARTED|Overall Study||34
7617968|NCT02392286|18757232|P2|NOT COMPLETED|Overall Study||2
7617969|NCT02392286|18757233|P1|NOT COMPLETED|Overall Study||3
7617970|NCT02392286|18757232|P2|COMPLETED|Overall Study||6
7617971|NCT02392286|18757233|P1|COMPLETED|Overall Study||4
7617972|NCT02392286|18757232|P2|STARTED|Overall Study||8
7617973|NCT02392286|18757233|P1|STARTED|Overall Study||7
7617974|NCT02392247|18757249|P1|NOT COMPLETED|Overall Study||2
7617975|NCT02392247|18757249|P1|COMPLETED|Overall Study||50
7617976|NCT02392247|18757249|P1|STARTED|Overall Study||52
7617977|NCT02392234|18757260|P6|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
7617978|NCT02392234|18757261|P5|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
7617979|NCT02392234|18757262|P4|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
7617980|NCT02392234|18757263|P3|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
7617981|NCT02392234|18757264|P2|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
7617982|NCT02392234|18757265|P1|NOT COMPLETED|Treatment Period 2 (8 Weeks)||1
7617983|NCT02392234|18757260|P6|COMPLETED|Treatment Period 2 (8 Weeks)||38
7617984|NCT02392234|18757261|P5|COMPLETED|Treatment Period 2 (8 Weeks)||37
7617985|NCT02392234|18757262|P4|COMPLETED|Treatment Period 2 (8 Weeks)||41
7617986|NCT02392234|18757263|P3|COMPLETED|Treatment Period 2 (8 Weeks)||38
7617987|NCT02392234|18757264|P2|COMPLETED|Treatment Period 2 (8 Weeks)||43
7617988|NCT02392234|18757265|P1|COMPLETED|Treatment Period 2 (8 Weeks)||37
7617989|NCT02392234|18757260|P6|STARTED|Treatment Period 2 (8 Weeks)||38
7617990|NCT02392234|18757261|P5|STARTED|Treatment Period 2 (8 Weeks)||37
7617991|NCT02392234|18757262|P4|STARTED|Treatment Period 2 (8 Weeks)||41
7617992|NCT02392234|18757263|P3|STARTED|Treatment Period 2 (8 Weeks)||38
7617993|NCT02392234|18757264|P2|STARTED|Treatment Period 2 (8 Weeks)||43
7617994|NCT02392234|18757265|P1|STARTED|Treatment Period 2 (8 Weeks)||38
7617995|NCT02392234|18757260|P6|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
7617996|NCT02392234|18757261|P5|NOT COMPLETED|Treatment Period 1 (8 Weeks)||4
7617997|NCT02392234|18757262|P4|NOT COMPLETED|Treatment Period 1 (8 Weeks)||1
7617998|NCT02392234|18757263|P3|NOT COMPLETED|Treatment Period 1 (8 Weeks)||2
7617999|NCT02392234|18757264|P2|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
7618000|NCT02392234|18757265|P1|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
7618001|NCT02392234|18757260|P6|COMPLETED|Treatment Period 1 (8 Weeks)||38
7618002|NCT02392234|18757261|P5|COMPLETED|Treatment Period 1 (8 Weeks)||37
7618003|NCT02392234|18757262|P4|COMPLETED|Treatment Period 1 (8 Weeks)||41
7618004|NCT02392234|18757263|P3|COMPLETED|Treatment Period 1 (8 Weeks)||38
7618005|NCT02392234|18757264|P2|COMPLETED|Treatment Period 1 (8 Weeks)||43
7618006|NCT02392234|18757265|P1|COMPLETED|Treatment Period 1 (8 Weeks)||38
7618007|NCT02392234|18757260|P6|Treated|Treatment Period 1 (8 Weeks)||41
7618008|NCT02392234|18757261|P5|Treated|Treatment Period 1 (8 Weeks)||40
7618009|NCT02392234|18757262|P4|Treated|Treatment Period 1 (8 Weeks)||42
7618010|NCT02392234|18757263|P3|Treated|Treatment Period 1 (8 Weeks)||39
7618011|NCT02392234|18757264|P2|Treated|Treatment Period 1 (8 Weeks)||43
7618012|NCT02392234|18757265|P1|Treated|Treatment Period 1 (8 Weeks)||41
7618013|NCT02392234|18757260|P6|STARTED|Treatment Period 1 (8 Weeks)||41
7618014|NCT02392234|18757261|P5|STARTED|Treatment Period 1 (8 Weeks)||41
7618015|NCT02392234|18757262|P4|STARTED|Treatment Period 1 (8 Weeks)||42
7618016|NCT02392234|18757263|P3|STARTED|Treatment Period 1 (8 Weeks)||40
7618017|NCT02392234|18757264|P2|STARTED|Treatment Period 1 (8 Weeks)||43
7618018|NCT02392234|18757265|P1|STARTED|Treatment Period 1 (8 Weeks)||41
7618019|NCT02392208|18757287|P1|NOT COMPLETED|Telavancin After Hemodialysis||0
7618020|NCT02392208|18757287|P1|COMPLETED|Telavancin After Hemodialysis||8
7618021|NCT02392208|18757287|P1|STARTED|Telavancin After Hemodialysis||8
7618022|NCT02392208|18757287|P1|NOT COMPLETED|Telavancin Before Hemodialysis||0
7618023|NCT02392208|18757287|P1|COMPLETED|Telavancin Before Hemodialysis||8
7618024|NCT02392208|18757287|P1|STARTED|Telavancin Before Hemodialysis||8
7618025|NCT02392195|18757297|P1|NOT COMPLETED|Overall Study||8
7618026|NCT02392195|18757297|P1|COMPLETED|Overall Study||2
7618027|NCT02392195|18757297|P1|STARTED|Overall Study||10
7618028|NCT02392104|18757303|P1|NOT COMPLETED|Overall Study||11
7618029|NCT02392104|18757303|P1|COMPLETED|Overall Study||39
7618030|NCT02392104|18757303|P1|STARTED|Overall Study|one participant enrolled but was removed prior to starting study protocol|50
7618031|NCT02392000|18757314|P1|NOT COMPLETED|Overall Study||27
7618032|NCT02392000|18757314|P1|COMPLETED|Overall Study||11
7618033|NCT02392000|18757314|P1|STARTED|Overall Study||38
7618034|NCT02391987|18757324|P2|NOT COMPLETED|Overall Study||0
7618035|NCT02391987|18757325|P1|NOT COMPLETED|Overall Study||0
7618036|NCT02391987|18757324|P2|COMPLETED|Overall Study||58
7618037|NCT02391987|18757325|P1|COMPLETED|Overall Study||54
7618038|NCT02391987|18757324|P2|STARTED|Overall Study||58
7618039|NCT02391987|18757325|P1|STARTED|Overall Study||54
7618040|NCT02391961|18757337|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
7618041|NCT02391961|18757338|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
7618042|NCT02391961|18757337|P2|COMPLETED|Second Intervention (4 Weeks)||7
7618043|NCT02391961|18757338|P1|COMPLETED|Second Intervention (4 Weeks)||6
7618044|NCT02391961|18757337|P2|STARTED|Second Intervention (4 Weeks)||8
7618045|NCT02391961|18757338|P1|STARTED|Second Intervention (4 Weeks)||7
7618046|NCT02391961|18757337|P2|NOT COMPLETED|Washout (2 Weeks)||1
7618047|NCT02391961|18757338|P1|NOT COMPLETED|Washout (2 Weeks)||1
7618048|NCT02391961|18757337|P2|COMPLETED|Washout (2 Weeks)||8
7618049|NCT02391961|18757338|P1|COMPLETED|Washout (2 Weeks)||7
7618050|NCT02391961|18757337|P2|STARTED|Washout (2 Weeks)||9
7618051|NCT02391961|18757338|P1|STARTED|Washout (2 Weeks)||8
7618052|NCT02391961|18757337|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
7618053|NCT02391961|18757338|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
7618054|NCT02391961|18757337|P2|COMPLETED|First Intervention (4 Weeks)||9
7618055|NCT02391961|18757338|P1|COMPLETED|First Intervention (4 Weeks)||8
7618056|NCT02391961|18757337|P2|STARTED|First Intervention (4 Weeks)||9
7618057|NCT02391961|18757338|P1|STARTED|First Intervention (4 Weeks)||10
7618058|NCT02391948|18757361|P5|NOT COMPLETED|24-month Assessment||10
7618059|NCT02391948|18757362|P4|NOT COMPLETED|24-month Assessment||9
7618060|NCT02391948|18757363|P3|NOT COMPLETED|24-month Assessment||3
7618061|NCT02391948|18757364|P2|NOT COMPLETED|24-month Assessment||10
7618062|NCT02391948|18757365|P1|NOT COMPLETED|24-month Assessment||14
7618063|NCT02391948|18757361|P5|COMPLETED|24-month Assessment||69
7618064|NCT02391948|18757362|P4|COMPLETED|24-month Assessment||75
7618065|NCT02391948|18757363|P3|COMPLETED|24-month Assessment||48
7618066|NCT02391948|18757364|P2|COMPLETED|24-month Assessment||97
7618067|NCT02391948|18757365|P1|COMPLETED|24-month Assessment||135
7618068|NCT02391948|18757361|P5|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 4 of the Not Completed remained active.|79
7618069|NCT02391948|18757362|P4|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 1 of the Not Completed remained active.|84
7618070|NCT02391948|18757363|P3|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 3 of the Not Completed remained active.|51
7618071|NCT02391948|18757364|P2|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 6 of the Not Completed remained active.|107
7618072|NCT02391948|18757365|P1|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 2 of the Not Completed remained active.|149
7618073|NCT02391948|18757361|P5|NOT COMPLETED|18-month Assessment||30
7618074|NCT02391948|18757362|P4|NOT COMPLETED|18-month Assessment||36
7618075|NCT02391948|18757363|P3|NOT COMPLETED|18-month Assessment||26
7618076|NCT02391948|18757364|P2|NOT COMPLETED|18-month Assessment||50
7618077|NCT02391948|18757365|P1|NOT COMPLETED|18-month Assessment||72
7618078|NCT02391948|18757361|P5|COMPLETED|18-month Assessment||75
7618079|NCT02391948|18757362|P4|COMPLETED|18-month Assessment||83
7618080|NCT02391948|18757363|P3|COMPLETED|18-month Assessment||48
7618081|NCT02391948|18757364|P2|COMPLETED|18-month Assessment||101
7618082|NCT02391948|18757365|P1|COMPLETED|18-month Assessment||147
7618083|NCT02391948|18757361|P5|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|105
7618084|NCT02391948|18757362|P4|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 3 of the Not Completed remained active.|119
7618085|NCT02391948|18757363|P3|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 1 of the Not Completed remained active.|74
7618086|NCT02391948|18757364|P2|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 4 of the Not Completed remained active.|151
7618087|NCT02391948|18757365|P1|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|219
7618088|NCT02391948|18757361|P5|NOT COMPLETED|12-month Assessment||6
7618089|NCT02391948|18757362|P4|NOT COMPLETED|12-month Assessment||9
7618090|NCT02391948|18757363|P3|NOT COMPLETED|12-month Assessment||4
7618091|NCT02391948|18757364|P2|NOT COMPLETED|12-month Assessment||9
7618092|NCT02391948|18757365|P1|NOT COMPLETED|12-month Assessment||8
7618093|NCT02391948|18757361|P5|COMPLETED|12-month Assessment||103
7618094|NCT02391948|18757362|P4|COMPLETED|12-month Assessment||116
7618095|NCT02391948|18757363|P3|COMPLETED|12-month Assessment||73
7618096|NCT02391948|18757364|P2|COMPLETED|12-month Assessment||147
7618097|NCT02391948|18757365|P1|COMPLETED|12-month Assessment||217
7618098|NCT02391948|18757361|P5|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 24 of the Not Completed remained active.|109
7618099|NCT02391948|18757362|P4|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 41 of the Not Completed remained active.|125
7618100|NCT02391948|18757363|P3|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 28 of the Not Completed remained active.|77
7618101|NCT02391948|18757364|P2|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 51 of the Not Completed remained active.|156
7618102|NCT02391948|18757365|P1|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 77 of the Not Completed remained active.|225
7618103|NCT02391948|18757361|P5|NOT COMPLETED|6-month Assessment||26
7618104|NCT02391948|18757362|P4|NOT COMPLETED|6-month Assessment||45
7618105|NCT02391948|18757363|P3|NOT COMPLETED|6-month Assessment||31
7618106|NCT02391948|18757364|P2|NOT COMPLETED|6-month Assessment||56
7618107|NCT02391948|18757365|P1|NOT COMPLETED|6-month Assessment||79
7618108|NCT02391948|18757361|P5|COMPLETED|6-month Assessment||85
7618109|NCT02391948|18757362|P4|COMPLETED|6-month Assessment||84
7618110|NCT02391948|18757363|P3|COMPLETED|6-month Assessment||49
7618111|NCT02391948|18757364|P2|COMPLETED|6-month Assessment||105
7618112|NCT02391948|18757365|P1|COMPLETED|6-month Assessment||148
7618113|NCT02391948|18757361|P5|STARTED|6-month Assessment||111
7618114|NCT02391948|18757362|P4|STARTED|6-month Assessment||129
7618115|NCT02391948|18757363|P3|STARTED|6-month Assessment||80
7618116|NCT02391948|18757364|P2|STARTED|6-month Assessment||161
7618117|NCT02391948|18757365|P1|STARTED|6-month Assessment||227
7618118|NCT02391948|18757361|P5|NOT COMPLETED|Baseline||0
7618119|NCT02391948|18757362|P4|NOT COMPLETED|Baseline||0
7618120|NCT02391948|18757363|P3|NOT COMPLETED|Baseline||0
7618121|NCT02391948|18757364|P2|NOT COMPLETED|Baseline||0
7618122|NCT02391948|18757365|P1|NOT COMPLETED|Baseline||0
7618123|NCT02391948|18757361|P5|COMPLETED|Baseline||111
7618124|NCT02391948|18757362|P4|COMPLETED|Baseline||129
7618125|NCT02391948|18757363|P3|COMPLETED|Baseline||80
7618126|NCT02391948|18757364|P2|COMPLETED|Baseline||161
7618127|NCT02391948|18757365|P1|COMPLETED|Baseline||227
7618128|NCT02391948|18757361|P5|STARTED|Baseline||111
7618129|NCT02391948|18757362|P4|STARTED|Baseline||129
7618130|NCT02391948|18757363|P3|STARTED|Baseline||80
7618131|NCT02391948|18757364|P2|STARTED|Baseline||161
7618132|NCT02391948|18757365|P1|STARTED|Baseline||227
7618133|NCT02391714|18757459|P2|NOT COMPLETED|Overall Study||0
7618134|NCT02391714|18757460|P1|NOT COMPLETED|Overall Study||0
7618135|NCT02391714|18757459|P2|COMPLETED|Overall Study||40
7618136|NCT02391714|18757460|P1|COMPLETED|Overall Study||40
7618137|NCT02391714|18757459|P2|STARTED|Overall Study||40
7618138|NCT02391714|18757460|P1|STARTED|Overall Study||40
7618139|NCT02391701|18757472|P2|NOT COMPLETED|Overall Study||38
7618140|NCT02391701|18757473|P1|NOT COMPLETED|Overall Study||21
7618141|NCT02391701|18757472|P2|COMPLETED|Overall Study||315
7618142|NCT02391701|18757473|P1|COMPLETED|Overall Study||346
7618143|NCT02391701|18757472|P2|STARTED|Overall Study||353
7618144|NCT02391701|18757473|P1|STARTED|Overall Study||367
7618145|NCT02391584|18757489|P2|NOT COMPLETED|12 Month (End of Study)||0
7618146|NCT02391584|18757490|P1|NOT COMPLETED|12 Month (End of Study)||2
7618147|NCT02391584|18757489|P2|COMPLETED|12 Month (End of Study)||0
7618148|NCT02391584|18757490|P1|COMPLETED|12 Month (End of Study)||49
7618149|NCT02391584|18757489|P2|STARTED|12 Month (End of Study)||0
7618150|NCT02391584|18757490|P1|STARTED|12 Month (End of Study)||51
7618151|NCT02391584|18757489|P2|NOT COMPLETED|6 Month||0
7618152|NCT02391584|18757490|P1|NOT COMPLETED|6 Month||1
7618153|NCT02391584|18757489|P2|COMPLETED|6 Month||0
7618154|NCT02391584|18757490|P1|COMPLETED|6 Month||51
7618155|NCT02391584|18757489|P2|STARTED|6 Month||0
7618156|NCT02391584|18757490|P1|STARTED|6 Month||52
7618157|NCT02391584|18757489|P2|NOT COMPLETED|3 Month||0
7618158|NCT02391584|18757490|P1|NOT COMPLETED|3 Month||1
7618159|NCT02391584|18757489|P2|COMPLETED|3 Month||0
7618160|NCT02391584|18757490|P1|COMPLETED|3 Month||52
7618161|NCT02391584|18757489|P2|STARTED|3 Month|23 Crossover participants are included in balloon dilation arm for remainder of study visits.|0
7618162|NCT02391584|18757490|P1|STARTED|3 Month|Includes 30 balloon dilation and 23 crossover participants|53
7618163|NCT02391584|18757489|P2|NOT COMPLETED|Primary Endpoint (6-weeks)||2
7618164|NCT02391584|18757490|P1|NOT COMPLETED|Primary Endpoint (6-weeks)||2
7618165|NCT02391584|18757489|P2|COMPLETED|Primary Endpoint (6-weeks)||27
7618166|NCT02391584|18757490|P1|COMPLETED|Primary Endpoint (6-weeks)||29
7618167|NCT02391584|18757489|P2|STARTED|Primary Endpoint (6-weeks)||29
7618168|NCT02391584|18757490|P1|STARTED|Primary Endpoint (6-weeks)||31
7618169|NCT02391545|18757507|P2|NOT COMPLETED|Overall Study||28
7618170|NCT02391545|18757508|P1|NOT COMPLETED|Overall Study||26
7618171|NCT02391545|18757507|P2|COMPLETED|Overall Study||0
7618172|NCT02391545|18757508|P1|COMPLETED|Overall Study||1
7618173|NCT02391545|18757507|P2|STARTED|Overall Study||28
7618174|NCT02391545|18757508|P1|STARTED|Overall Study||27
7618175|NCT02391363|18757528|P2|NOT COMPLETED|Overall Study||8
7618176|NCT02391363|18757529|P1|NOT COMPLETED|Overall Study||11
7618177|NCT02391363|18757528|P2|COMPLETED|Overall Study||56
7618178|NCT02391363|18757529|P1|COMPLETED|Overall Study||59
7618179|NCT02391363|18757528|P2|STARTED|Overall Study||64
7618180|NCT02391363|18757529|P1|STARTED|Overall Study||70
7618181|NCT02391350|18757595|P2|NOT COMPLETED|Overall Study||17
7618182|NCT02391350|18757596|P1|NOT COMPLETED|Overall Study||12
7618183|NCT02391350|18757595|P2|COMPLETED|Overall Study||93
7618184|NCT02391350|18757596|P1|COMPLETED|Overall Study||98
7618185|NCT02391350|18757595|P2|6-month Follow-up|Overall Study||96
7618186|NCT02391350|18757596|P1|6-month Follow-up|Overall Study||100
7618187|NCT02391350|18757595|P2|4-week Follow-up|Overall Study||105
7618188|NCT02391350|18757596|P1|4-week Follow-up|Overall Study||106
7618189|NCT02391350|18757595|P2|STARTED|Overall Study||110
7618190|NCT02391350|18757596|P1|STARTED|Overall Study||110
7618191|NCT02391311|18757614|P2|NOT COMPLETED|Overall Study||2
7618192|NCT02391311|18757615|P1|NOT COMPLETED|Overall Study||3
7618193|NCT02391311|18757614|P2|COMPLETED|Overall Study||19
7618194|NCT02391311|18757615|P1|COMPLETED|Overall Study||18
7618195|NCT02391311|18757614|P2|STARTED|Overall Study||21
7618196|NCT02391311|18757615|P1|STARTED|Overall Study||21
7618197|NCT02391116|18757623|P1|NOT COMPLETED|Survival Follow-up||4
7618198|NCT02391116|18757623|P1|COMPLETED|Survival Follow-up|Reason for completed in this period included death (35) and clinical endpoint reached (7)|42
7618199|NCT02391116|18757623|P1|STARTED|Survival Follow-up|21 participants discontinued from treatment didn't enter due to withdrawal by subject (3) and death|46
7618200|NCT02391116|18757623|P1|NOT COMPLETED|Active Follow-up||3
7618201|NCT02391116|18757623|P1|COMPLETED|Active Follow-up|Reasons for completion in this period included death (2) and PD (4)|6
7618202|NCT02391116|18757623|P1|STARTED|Active Follow-up|This period incorporates safety follow-up with radiological|9
7618203|NCT02391116|18757623|P1|NOT COMPLETED|Safety Follow-up||13
7618204|NCT02391116|18757623|P1|COMPLETED|Safety Follow-up|14 participants were considered completed due to death|43
7618205|NCT02391116|18757623|P1|STARTED|Safety Follow-up|This period excludes 2 deaths on treatment and 9 participants entering active follow-up|56
7618206|NCT02391116|18757623|P1|NOT COMPLETED|Treatment||14
7618207|NCT02391116|18757623|P1|COMPLETED|Treatment|Reasons for completion in this period included death (2), PD (50) and lack of efficacy (1)|53
7618208|NCT02391116|18757623|P1|Included in Per Protocol Set|Treatment||40
7618209|NCT02391116|18757623|P1|STARTED|Treatment||67
7618210|NCT02391038|18757677|P3|NOT COMPLETED|Overall Study||6
7618211|NCT02391038|18757678|P2|NOT COMPLETED|Overall Study||3
7618212|NCT02391038|18757679|P1|NOT COMPLETED|Overall Study||3
7618213|NCT02391038|18757677|P3|COMPLETED|Overall Study||0
7618214|NCT02391038|18757678|P2|COMPLETED|Overall Study||0
7618215|NCT02391038|18757679|P1|COMPLETED|Overall Study||0
7618216|NCT02391038|18757677|P3|STARTED|Overall Study||6
7618217|NCT02391038|18757678|P2|STARTED|Overall Study||3
7618218|NCT02391038|18757679|P1|STARTED|Overall Study||3
7618219|NCT02390791|18757795|P2|NOT COMPLETED|Overall Study||0
7618220|NCT02390791|18757796|P1|NOT COMPLETED|Overall Study||0
7618221|NCT02390791|18757795|P2|COMPLETED|Overall Study||45
7618222|NCT02390791|18757796|P1|COMPLETED|Overall Study||40
7618223|NCT02390791|18757795|P2|STARTED|Overall Study||45
7618224|NCT02390791|18757796|P1|STARTED|Overall Study||40
7618225|NCT02390557|18757823|P3|NOT COMPLETED|Wave 2||23
7618226|NCT02390557|18757824|P2|NOT COMPLETED|Wave 2||41
7618227|NCT02390557|18757825|P1|NOT COMPLETED|Wave 2||72
7618228|NCT02390557|18757823|P3|COMPLETED|Wave 2||112
7618229|NCT02390557|18757824|P2|COMPLETED|Wave 2||115
7618230|NCT02390557|18757825|P1|COMPLETED|Wave 2||88
7618231|NCT02390557|18757823|P3|STARTED|Wave 2||135
7618232|NCT02390557|18757824|P2|STARTED|Wave 2||156
7618233|NCT02390557|18757825|P1|STARTED|Wave 2||160
7618234|NCT02390557|18757823|P3|NOT COMPLETED|Wave 1||0
7618235|NCT02390557|18757824|P2|NOT COMPLETED|Wave 1||0
7618236|NCT02390557|18757825|P1|NOT COMPLETED|Wave 1||0
7618237|NCT02390557|18757823|P3|COMPLETED|Wave 1||135
7618238|NCT02390557|18757824|P2|COMPLETED|Wave 1||156
7618239|NCT02390557|18757825|P1|COMPLETED|Wave 1||160
7618240|NCT02390557|18757823|P3|STARTED|Wave 1||135
7618241|NCT02390557|18757824|P2|STARTED|Wave 1||156
7618242|NCT02390557|18757825|P1|STARTED|Wave 1||160
7618243|NCT02390362|18757835|P2|NOT COMPLETED|Overall Study||1
7618244|NCT02390362|18757836|P1|NOT COMPLETED|Overall Study||0
7618245|NCT02390362|18757835|P2|COMPLETED|Overall Study||1
7618246|NCT02390362|18757836|P1|COMPLETED|Overall Study||1
7618247|NCT02390362|18757835|P2|STARTED|Overall Study||2
7618248|NCT02390362|18757836|P1|STARTED|Overall Study|1 subject enrolled in this arm. completed 2 doses of Rituximab.|1
7618249|NCT02390219|18757844|P1|NOT COMPLETED|Overall Study||13
7618250|NCT02390219|18757844|P1|COMPLETED|Overall Study||33
7618251|NCT02390219|18757844|P1|STARTED|Overall Study||46
7618252|NCT02390167|18757854|P1|NOT COMPLETED|Overall Study||1
7618253|NCT02390167|18757854|P1|COMPLETED|Overall Study||375
7618254|NCT02390167|18757854|P1|Without Diabetes|Overall Study||43
7618255|NCT02390167|18757854|P1|With Diabetes|Overall Study||333
7618256|NCT02390167|18757854|P1|STARTED|Overall Study||376
7618257|NCT02390076|18757876|P3|NOT COMPLETED|Overall Study||4
7618258|NCT02390076|18757877|P2|NOT COMPLETED|Overall Study||1
7618259|NCT02390076|18757878|P1|NOT COMPLETED|Overall Study||2
7618260|NCT02390076|18757876|P3|COMPLETED|Overall Study||11
7618261|NCT02390076|18757877|P2|COMPLETED|Overall Study||17
7618262|NCT02390076|18757878|P1|COMPLETED|Overall Study||16
7618263|NCT02390076|18757876|P3|STARTED|Overall Study||15
7618264|NCT02390076|18757877|P2|STARTED|Overall Study||18
7618265|NCT02390076|18757878|P1|STARTED|Overall Study||18
7618266|NCT02389946|18757891|P2|NOT COMPLETED|Overall Study||15
7618267|NCT02389946|18757892|P1|NOT COMPLETED|Overall Study||24
7618268|NCT02389946|18757891|P2|COMPLETED|Overall Study||435
7618269|NCT02389946|18757892|P1|COMPLETED|Overall Study||860
7618270|NCT02389946|18757891|P2|STARTED|Overall Study||450
7618271|NCT02389946|18757892|P1|STARTED|Overall Study||884
7618272|NCT02389894|18757907|P3|NOT COMPLETED|Overall Study||9
7618273|NCT02389894|18757908|P2|NOT COMPLETED|Overall Study||10
7618274|NCT02389894|18757909|P1|NOT COMPLETED|Overall Study||8
7618275|NCT02389894|18757907|P3|COMPLETED|Overall Study||123
7618276|NCT02389894|18757908|P2|COMPLETED|Overall Study||108
7618277|NCT02389894|18757909|P1|COMPLETED|Overall Study||125
7618278|NCT02389894|18757907|P3|STARTED|Overall Study||132
7618279|NCT02389894|18757908|P2|STARTED|Overall Study||118
7618280|NCT02389894|18757909|P1|STARTED|Overall Study||133
7618281|NCT02389881|18757984|P7|NOT COMPLETED|Overall Study||0
7618282|NCT02389881|18757985|P6|NOT COMPLETED|Overall Study||0
7618283|NCT02389881|18757986|P5|NOT COMPLETED|Overall Study||0
7618284|NCT02389881|18757987|P4|NOT COMPLETED|Overall Study||0
7618285|NCT02389881|18757988|P3|NOT COMPLETED|Overall Study||0
7618286|NCT02389881|18757989|P2|NOT COMPLETED|Overall Study||0
7618287|NCT02389881|18757990|P1|NOT COMPLETED|Overall Study||0
7618288|NCT02389881|18757984|P7|COMPLETED|Overall Study||2
7618289|NCT02389881|18757985|P6|COMPLETED|Overall Study||8
7618290|NCT02389881|18757986|P5|COMPLETED|Overall Study||6
7618291|NCT02389881|18757987|P4|COMPLETED|Overall Study||6
7618292|NCT02389881|18757988|P3|COMPLETED|Overall Study||6
7618293|NCT02389881|18757989|P2|COMPLETED|Overall Study||6
7618294|NCT02389881|18757990|P1|COMPLETED|Overall Study||6
7618295|NCT02389881|18757984|P7|STARTED|Overall Study||2
7618296|NCT02389881|18757985|P6|STARTED|Overall Study||8
7618297|NCT02389881|18757986|P5|STARTED|Overall Study||6
7618298|NCT02389881|18757987|P4|STARTED|Overall Study||6
7618299|NCT02389881|18757988|P3|STARTED|Overall Study||6
7618300|NCT02389881|18757989|P2|STARTED|Overall Study||6
7618301|NCT02389881|18757990|P1|STARTED|Overall Study||6
7618302|NCT02389829|18758041|P2|NOT COMPLETED|Overall Study||1
7618303|NCT02389829|18758042|P1|NOT COMPLETED|Overall Study||0
7618304|NCT02389829|18758041|P2|COMPLETED|Overall Study||62
7618305|NCT02389829|18758042|P1|COMPLETED|Overall Study||64
7618306|NCT02389829|18758041|P2|STARTED|Overall Study||63
7618307|NCT02389829|18758042|P1|STARTED|Overall Study||64
7618308|NCT02389816|18758057|P3|NOT COMPLETED|Overall Study||12
7618309|NCT02389816|18758058|P2|NOT COMPLETED|Overall Study||13
7618310|NCT02389816|18758059|P1|NOT COMPLETED|Overall Study||15
7618311|NCT02389816|18758057|P3|COMPLETED|Overall Study||152
7618312|NCT02389816|18758058|P2|COMPLETED|Overall Study||152
7618313|NCT02389816|18758059|P1|COMPLETED|Overall Study||149
7618314|NCT02389816|18758057|P3|STARTED|Overall Study||164
7618315|NCT02389816|18758058|P2|STARTED|Overall Study||165
7618316|NCT02389816|18758059|P1|STARTED|Overall Study||164
7618317|NCT02389764|18758091|P1|NOT COMPLETED|Overall Study||9
7618318|NCT02389764|18758091|P1|COMPLETED|Overall Study||0
7618319|NCT02389764|18758091|P1|STARTED|Overall Study||9
7618320|NCT02389738|18758096|P1|NOT COMPLETED|Overall Study||1
7618321|NCT02389738|18758096|P1|COMPLETED|Overall Study||5
7618322|NCT02389738|18758096|P1|STARTED|Overall Study||6
7618323|NCT02389725|18758102|P2|NOT COMPLETED|Overall Study||0
7618324|NCT02389725|18758103|P1|NOT COMPLETED|Overall Study||0
7618325|NCT02389725|18758102|P2|COMPLETED|Overall Study||60
7618326|NCT02389725|18758103|P1|COMPLETED|Overall Study||59
7618327|NCT02389725|18758102|P2|STARTED|Overall Study||60
7618328|NCT02389725|18758103|P1|STARTED|Overall Study||59
7618329|NCT02389712|18758117|P2|NOT COMPLETED|Overall Study||0
7618330|NCT02389712|18758118|P1|NOT COMPLETED|Overall Study||0
7618331|NCT02389712|18758117|P2|COMPLETED|Overall Study||1
7618332|NCT02389712|18758118|P1|COMPLETED|Overall Study||1
7618333|NCT02389712|18758117|P2|STARTED|Overall Study||1
7618334|NCT02389712|18758118|P1|STARTED|Overall Study||1
7618335|NCT02389621|18758126|P2|NOT COMPLETED|Posttreatment Period||4
7618336|NCT02389621|18758127|P1|NOT COMPLETED|Posttreatment Period||9
7618337|NCT02389621|18758126|P2|COMPLETED|Posttreatment Period||102
7618338|NCT02389621|18758127|P1|COMPLETED|Posttreatment Period||98
7618339|NCT02389621|18758126|P2|STARTED|Posttreatment Period||106
7618340|NCT02389621|18758127|P1|STARTED|Posttreatment Period||107
7618341|NCT02389621|18758126|P2|NOT COMPLETED|Treatment Period||1
7618342|NCT02389621|18758127|P1|NOT COMPLETED|Treatment Period||1
7618343|NCT02389621|18758126|P2|COMPLETED|Treatment Period||106
7618344|NCT02389621|18758127|P1|COMPLETED|Treatment Period||107
7618345|NCT02389621|18758126|P2|Received Study Drug|Treatment Period||107
7618346|NCT02389621|18758127|P1|Received Study Drug|Treatment Period||107
7618347|NCT02389621|18758126|P2|STARTED|Treatment Period||107
7618348|NCT02389621|18758127|P1|STARTED|Treatment Period||108
7618349|NCT02389452|18758157|P1|NOT COMPLETED|Overall Study||25
7618350|NCT02389452|18758157|P1|COMPLETED|Overall Study||369
7618351|NCT02389452|18758157|P1|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11
7618352|NCT02389452|18758157|P1|STARTED|Overall Study||394
7618353|NCT02389374|18758178|P3|NOT COMPLETED|Overall Study||1
7618354|NCT02389374|18758179|P2|NOT COMPLETED|Overall Study||28
7618355|NCT02389374|18758180|P1|NOT COMPLETED|Overall Study||9
7618356|NCT02389374|18758178|P3|COMPLETED|Overall Study||10
7618357|NCT02389374|18758179|P2|COMPLETED|Overall Study||87
7618358|NCT02389374|18758180|P1|COMPLETED|Overall Study||46
7618359|NCT02389374|18758178|P3|STARTED|Overall Study||11
7618360|NCT02389374|18758179|P2|STARTED|Overall Study||115
7618361|NCT02389374|18758180|P1|STARTED|Overall Study||55
7618362|NCT02389361|18758212|P2|NOT COMPLETED|Overall Study||0
7618363|NCT02389361|18758213|P1|NOT COMPLETED|Overall Study||0
7618364|NCT02389361|18758212|P2|COMPLETED|Overall Study||27
7618365|NCT02389361|18758213|P1|COMPLETED|Overall Study||24
7618366|NCT02389361|18758212|P2|STARTED|Overall Study||27
7618367|NCT02389361|18758213|P1|STARTED|Overall Study||24
7618368|NCT02389101|18758219|P1|NOT COMPLETED|Overall Study||0
7618369|NCT02389101|18758219|P1|COMPLETED|Overall Study||21
7618370|NCT02389101|18758219|P1|STARTED|Overall Study||21
7618371|NCT02389088|18758223|P1|NOT COMPLETED|Phase II - All Study Participants||0
7618372|NCT02389088|18758223|P1|COMPLETED|Phase II - All Study Participants||9
7618373|NCT02389088|18758223|P1|STARTED|Phase II - All Study Participants||9
7618374|NCT02389088|18758223|P1|NOT COMPLETED|Overall Study - Phase I||0
7618375|NCT02389088|18758223|P1|COMPLETED|Overall Study - Phase I||9
7618376|NCT02389088|18758223|P1|STARTED|Overall Study - Phase I||9
7618377|NCT02388997|18758269|P2|NOT COMPLETED|Overall Study||6
7618378|NCT02388997|18758270|P1|NOT COMPLETED|Overall Study||3
7618379|NCT02388997|18758269|P2|COMPLETED|Overall Study||10
7618380|NCT02388997|18758270|P1|COMPLETED|Overall Study||12
7618381|NCT02388997|18758269|P2|STARTED|Overall Study||16
7618382|NCT02388997|18758270|P1|STARTED|Overall Study||15
7618383|NCT02388932|18758288|P1|NOT COMPLETED|Overall Study||1
7618384|NCT02388932|18758288|P1|COMPLETED|Overall Study||2
7618385|NCT02388932|18758288|P1|STARTED|Overall Study||3
7618386|NCT02388880|18758298|P1|NOT COMPLETED|Overall Study||0
7618387|NCT02388880|18758298|P1|COMPLETED|Overall Study||3
7618388|NCT02388880|18758298|P1|STARTED|Overall Study||3
7618389|NCT02388815|18758305|P1|NOT COMPLETED|Overall Study||4
7618390|NCT02388815|18758305|P1|COMPLETED|Overall Study||85
7618391|NCT02388815|18758305|P1|STARTED|Overall Study||89
7618392|NCT02388776|18758309|P1|NOT COMPLETED|Overall Study||2
7618393|NCT02388776|18758309|P1|COMPLETED|Overall Study||0
7618394|NCT02388776|18758309|P1|STARTED|Overall Study||2
7618395|NCT02388763|18758314|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
7618396|NCT02388763|18758315|P1|NOT COMPLETED|Period 2, 10 Days of Wear||0
7618397|NCT02388763|18758314|P2|COMPLETED|Period 2, 10 Days of Wear||30
7618398|NCT02388763|18758315|P1|COMPLETED|Period 2, 10 Days of Wear||30
7618399|NCT02388763|18758314|P2|STARTED|Period 2, 10 Days of Wear||30
7618400|NCT02388763|18758315|P1|STARTED|Period 2, 10 Days of Wear||30
7618401|NCT02388763|18758314|P2|NOT COMPLETED|Period 1, 10 Days of Wear||1
7618402|NCT02388763|18758315|P1|NOT COMPLETED|Period 1, 10 Days of Wear||1
7618403|NCT02388763|18758314|P2|COMPLETED|Period 1, 10 Days of Wear||30
7618404|NCT02388763|18758315|P1|COMPLETED|Period 1, 10 Days of Wear||30
7618405|NCT02388763|18758314|P2|STARTED|Period 1, 10 Days of Wear||31
7618406|NCT02388763|18758315|P1|STARTED|Period 1, 10 Days of Wear||31
7618407|NCT02388763|18758314|P2|NOT COMPLETED|Habitual, 10 Days of Wear||1
7618408|NCT02388763|18758315|P1|NOT COMPLETED|Habitual, 10 Days of Wear||1
7618409|NCT02388763|18758314|P2|COMPLETED|Habitual, 10 Days of Wear||31
7618410|NCT02388763|18758315|P1|COMPLETED|Habitual, 10 Days of Wear||31
7618411|NCT02388763|18758314|P2|STARTED|Habitual, 10 Days of Wear||32
7618412|NCT02388763|18758315|P1|STARTED|Habitual, 10 Days of Wear||32
7618413|NCT02388737|18758329|P3|NOT COMPLETED|Overall Study||62
7618414|NCT02388737|18758330|P2|NOT COMPLETED|Overall Study||60
7618415|NCT02388737|18758331|P1|NOT COMPLETED|Overall Study||54
7618416|NCT02388737|18758329|P3|COMPLETED|Overall Study||180
7618417|NCT02388737|18758330|P2|COMPLETED|Overall Study||166
7618418|NCT02388737|18758331|P1|COMPLETED|Overall Study||181
7618419|NCT02388737|18758329|P3|STARTED|Overall Study||242
7618420|NCT02388737|18758330|P2|STARTED|Overall Study||226
7618421|NCT02388737|18758331|P1|STARTED|Overall Study||235
7618422|NCT02388724|18758365|P2|NOT COMPLETED|Overall Study||13
7618423|NCT02388724|18758366|P1|NOT COMPLETED|Overall Study||12
7618424|NCT02388724|18758365|P2|COMPLETED|Overall Study||224
7618425|NCT02388724|18758366|P1|COMPLETED|Overall Study||232
7618426|NCT02388724|18758365|P2|Safety Set: Randomized But Not Treated|Overall Study||2
7618427|NCT02388724|18758366|P1|Safety Set: Randomized But Not Treated|Overall Study||0
7618428|NCT02388724|18758365|P2|STARTED|Overall Study||237
7618429|NCT02388724|18758366|P1|STARTED|Overall Study||244
7618430|NCT02388568|18758390|P2|NOT COMPLETED|Overall Study||15
7618431|NCT02388568|18758391|P1|NOT COMPLETED|Overall Study||10
7618432|NCT02388568|18758390|P2|COMPLETED|Overall Study||53
7618433|NCT02388568|18758391|P1|COMPLETED|Overall Study||59
7618434|NCT02388568|18758390|P2|STARTED|Overall Study||68
7618435|NCT02388568|18758391|P1|STARTED|Overall Study||69
7618436|NCT02388386|18758407|P1|NOT COMPLETED|Overall Study||0
7618437|NCT02388386|18758407|P1|COMPLETED|Overall Study||10
7618438|NCT02388386|18758407|P1|STARTED|Overall Study||10
7618439|NCT02388347|18758420|P5|NOT COMPLETED|Overall Study||0
7618440|NCT02388347|18758421|P4|NOT COMPLETED|Overall Study||0
7618441|NCT02388347|18758422|P3|NOT COMPLETED|Overall Study||1
7618442|NCT02388347|18758423|P2|NOT COMPLETED|Overall Study||0
7618443|NCT02388347|18758424|P1|NOT COMPLETED|Overall Study||0
7618444|NCT02388347|18758420|P5|COMPLETED|Overall Study||6
7618445|NCT02388347|18758421|P4|COMPLETED|Overall Study||6
7618446|NCT02388347|18758422|P3|COMPLETED|Overall Study||5
7618447|NCT02388347|18758423|P2|COMPLETED|Overall Study||6
7618448|NCT02388347|18758424|P1|COMPLETED|Overall Study||8
7618449|NCT02388347|18758420|P5|STARTED|Overall Study||6
7618450|NCT02388347|18758421|P4|STARTED|Overall Study||6
7618451|NCT02388347|18758422|P3|STARTED|Overall Study||6
7618452|NCT02388347|18758423|P2|STARTED|Overall Study||6
7618453|NCT02388347|18758424|P1|STARTED|Overall Study||8
7618454|NCT02388321|18758491|P2|NOT COMPLETED|Overall Study||0
7618455|NCT02388321|18758492|P1|NOT COMPLETED|Overall Study||0
7618456|NCT02388321|18758491|P2|COMPLETED|Overall Study||11
7618457|NCT02388321|18758492|P1|COMPLETED|Overall Study||11
7618458|NCT02388321|18758491|P2|STARTED|Overall Study||11
7618459|NCT02388321|18758492|P1|STARTED|Overall Study||11
7618460|NCT02388295|18758503|P3|NOT COMPLETED|Treatment Weeks 3 to 12||0
7618461|NCT02388295|18758504|P2|NOT COMPLETED|Treatment Weeks 3 to 12||1
7618462|NCT02388295|18758505|P1|NOT COMPLETED|Treatment Weeks 3 to 12||1
7618463|NCT02388295|18758503|P3|COMPLETED|Treatment Weeks 3 to 12||17
7618464|NCT02388295|18758504|P2|COMPLETED|Treatment Weeks 3 to 12||13
7618465|NCT02388295|18758505|P1|COMPLETED|Treatment Weeks 3 to 12||15
7618466|NCT02388295|18758503|P3|STARTED|Treatment Weeks 3 to 12||17
7618467|NCT02388295|18758504|P2|STARTED|Treatment Weeks 3 to 12||14
7618468|NCT02388295|18758505|P1|STARTED|Treatment Weeks 3 to 12||16
7618469|NCT02388295|18758503|P3|NOT COMPLETED|Dose Escalation Week 2||1
7618470|NCT02388295|18758504|P2|NOT COMPLETED|Dose Escalation Week 2||2
7618471|NCT02388295|18758505|P1|NOT COMPLETED|Dose Escalation Week 2||1
7618472|NCT02388295|18758503|P3|COMPLETED|Dose Escalation Week 2||17
7618473|NCT02388295|18758504|P2|COMPLETED|Dose Escalation Week 2||14
7618474|NCT02388295|18758505|P1|COMPLETED|Dose Escalation Week 2||16
7618475|NCT02388295|18758503|P3|STARTED|Dose Escalation Week 2||18
7618476|NCT02388295|18758504|P2|STARTED|Dose Escalation Week 2||16
7618477|NCT02388295|18758505|P1|STARTED|Dose Escalation Week 2||17
7618478|NCT02388295|18758503|P3|NOT COMPLETED|Dose Escalation Week 1||2
7618479|NCT02388295|18758504|P2|NOT COMPLETED|Dose Escalation Week 1||3
7618480|NCT02388295|18758505|P1|NOT COMPLETED|Dose Escalation Week 1||2
7618481|NCT02388295|18758503|P3|COMPLETED|Dose Escalation Week 1||18
7618482|NCT02388295|18758504|P2|COMPLETED|Dose Escalation Week 1||16
7618483|NCT02388295|18758505|P1|COMPLETED|Dose Escalation Week 1||17
7618484|NCT02388295|18758503|P3|STARTED|Dose Escalation Week 1|Number randomized to treatment|20
7618485|NCT02388295|18758504|P2|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
7618486|NCT02388295|18758505|P1|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
7618487|NCT02388269|18758523|P3|NOT COMPLETED|Overall Study||10
7618488|NCT02388269|18758524|P2|NOT COMPLETED|Overall Study||2
7618489|NCT02388269|18758525|P1|NOT COMPLETED|Overall Study||9
7618490|NCT02388269|18758523|P3|COMPLETED|Overall Study||0
7618491|NCT02388269|18758524|P2|COMPLETED|Overall Study||38
7618492|NCT02388269|18758525|P1|COMPLETED|Overall Study||32
7618493|NCT02388269|18758523|P3|Open Label|Overall Study||0
7618494|NCT02388269|18758524|P2|Open Label|Overall Study||38
7618495|NCT02388269|18758525|P1|Open Label|Overall Study||37
7618496|NCT02388269|18758523|P3|Randomised Period|Overall Study||0
7618497|NCT02388269|18758524|P2|Randomised Period|Overall Study||40
7618498|NCT02388269|18758525|P1|Randomised Period|Overall Study||41
7618499|NCT02388269|18758523|P3|STARTED|Overall Study||10
7618500|NCT02388269|18758524|P2|STARTED|Overall Study||40
7618501|NCT02388269|18758525|P1|STARTED|Overall Study||41
7618502|NCT02388191|18758557|P2|NOT COMPLETED|Overall Study||0
7618503|NCT02388191|18758558|P1|NOT COMPLETED|Overall Study||1
7618504|NCT02388191|18758557|P2|COMPLETED|Overall Study||60
7618505|NCT02388191|18758558|P1|COMPLETED|Overall Study||58
7618506|NCT02388191|18758557|P2|STARTED|Overall Study||60
7618507|NCT02388191|18758558|P1|STARTED|Overall Study||59
7618508|NCT02388165|18758574|P2|NOT COMPLETED|Overall Study||130
7618509|NCT02388165|18758575|P1|NOT COMPLETED|Overall Study||127
7618510|NCT02388165|18758574|P2|COMPLETED|Overall Study||1594
7618511|NCT02388165|18758575|P1|COMPLETED|Overall Study||1599
7618512|NCT02388165|18758574|P2|Vaccinated (Safety Population)|Overall Study||1709
7618513|NCT02388165|18758575|P1|Vaccinated (Safety Population)|Overall Study||1708
7618514|NCT02388165|18758574|P2|STARTED|Overall Study||1724
7618515|NCT02388165|18758575|P1|STARTED|Overall Study||1726
7618516|NCT02388074|18758605|P1|NOT COMPLETED|Overall Study||3
7618517|NCT02388074|18758605|P1|COMPLETED|Overall Study||22
7618518|NCT02388074|18758605|P1|STARTED|Overall Study||25
7618519|NCT02387996|18758609|P1|NOT COMPLETED|Overall Study||204
7618520|NCT02387996|18758609|P1|COMPLETED|Overall Study|Completed equals continuing in the Treatment Period|66
7618521|NCT02387996|18758609|P1|STARTED|Overall Study||270
7618522|NCT02387983|18758620|P1|NOT COMPLETED|Overall Study||7
7618523|NCT02387983|18758620|P1|COMPLETED|Overall Study||58
7618524|NCT02387983|18758620|P1|STARTED|Overall Study||65
7618525|NCT02387970|18758634|P2|NOT COMPLETED|Overall Study||2
7618526|NCT02387970|18758635|P1|NOT COMPLETED|Overall Study||1
7618527|NCT02387970|18758634|P2|COMPLETED|Overall Study||23
7618528|NCT02387970|18758635|P1|COMPLETED|Overall Study||26
7618529|NCT02387970|18758634|P2|STARTED|Overall Study||25
7618530|NCT02387970|18758635|P1|STARTED|Overall Study||27
7618531|NCT02387957|18758656|P3|NOT COMPLETED|Overall Study||20
7618532|NCT02387957|18758657|P2|NOT COMPLETED|Overall Study||21
7618533|NCT02387957|18758658|P1|NOT COMPLETED|Overall Study||21
7618534|NCT02387957|18758656|P3|COMPLETED|Overall Study|The study was discontinued|1
7618535|NCT02387957|18758657|P2|COMPLETED|Overall Study|The study was discontinued|0
7618536|NCT02387957|18758658|P1|COMPLETED|Overall Study|The study was discontinued|0
7618537|NCT02387957|18758656|P3|STARTED|Overall Study||21
7618538|NCT02387957|18758657|P2|STARTED|Overall Study||21
7618539|NCT02387957|18758658|P1|STARTED|Overall Study||21
7618540|NCT02387853|18758669|P1|NOT COMPLETED|Overall Study||3
7618541|NCT02387853|18758669|P1|COMPLETED|Overall Study||103
7618542|NCT02387853|18758669|P1|STARTED|Overall Study||106
7618543|NCT02387814|18758689|P4|NOT COMPLETED|Overall Study||0
7618544|NCT02387814|18758690|P3|NOT COMPLETED|Overall Study||0
7618545|NCT02387814|18758691|P2|NOT COMPLETED|Overall Study||0
7618546|NCT02387814|18758692|P1|NOT COMPLETED|Overall Study||0
7618547|NCT02387814|18758689|P4|COMPLETED|Overall Study||6
7618548|NCT02387814|18758690|P3|COMPLETED|Overall Study||10
7618549|NCT02387814|18758691|P2|COMPLETED|Overall Study||9
7618550|NCT02387814|18758692|P1|COMPLETED|Overall Study||10
7618551|NCT02387814|18758689|P4|Received Abemaciclib|Overall Study||6
7618552|NCT02387814|18758690|P3|Received Abemaciclib|Overall Study||10
7618553|NCT02387814|18758691|P2|Received Abemaciclib|Overall Study||9
7618554|NCT02387814|18758692|P1|Received Abemaciclib|Overall Study||10
7618555|NCT02387814|18758689|P4|STARTED|Overall Study||6
7618556|NCT02387814|18758690|P3|STARTED|Overall Study||10
7618557|NCT02387814|18758691|P2|STARTED|Overall Study||9
7618558|NCT02387814|18758692|P1|STARTED|Overall Study||10
7618559|NCT02387801|18758708|P2|NOT COMPLETED|Post-Treatment Follow-up||0
7618560|NCT02387801|18758709|P1|NOT COMPLETED|Post-Treatment Follow-up||0
7618561|NCT02387801|18758708|P2|COMPLETED|Post-Treatment Follow-up||12
7618562|NCT02387801|18758709|P1|COMPLETED|Post-Treatment Follow-up||0
7618563|NCT02387801|18758708|P2|STARTED|Post-Treatment Follow-up||12
7618564|NCT02387801|18758709|P1|STARTED|Post-Treatment Follow-up||0
7618565|NCT02387801|18758708|P2|NOT COMPLETED|Maintenance Dosing Period||0
7618566|NCT02387801|18758709|P1|NOT COMPLETED|Maintenance Dosing Period||0
7618567|NCT02387801|18758708|P2|COMPLETED|Maintenance Dosing Period||12
7618568|NCT02387801|18758709|P1|COMPLETED|Maintenance Dosing Period||0
7618569|NCT02387801|18758708|P2|STARTED|Maintenance Dosing Period||12
7618570|NCT02387801|18758709|P1|STARTED|Maintenance Dosing Period|All participants from Induction Dosing Period went to ixe Q4W arm during Maintenance Dosing Period.|0
7618571|NCT02387801|18758708|P2|NOT COMPLETED|Induction Dosing Period||0
7618572|NCT02387801|18758709|P1|NOT COMPLETED|Induction Dosing Period||0
7618573|NCT02387801|18758708|P2|COMPLETED|Induction Dosing Period||6
7618574|NCT02387801|18758709|P1|COMPLETED|Induction Dosing Period||6
7618575|NCT02387801|18758708|P2|STARTED|Induction Dosing Period||6
7618576|NCT02387801|18758709|P1|STARTED|Induction Dosing Period||6
7618577|NCT02387762|18758729|P2|NOT COMPLETED|Overall Study||0
7618578|NCT02387762|18758730|P1|NOT COMPLETED|Overall Study||1
7618579|NCT02387762|18758729|P2|COMPLETED|Overall Study||15
7618580|NCT02387762|18758730|P1|COMPLETED|Overall Study||15
7618581|NCT02387762|18758729|P2|STARTED|Overall Study||15
7618582|NCT02387762|18758730|P1|STARTED|Overall Study||16
7618583|NCT02387749|18758736|P1|NOT COMPLETED|Overall Study||0
7618584|NCT02387749|18758736|P1|COMPLETED|Overall Study||10
7618585|NCT02387749|18758736|P1|STARTED|Overall Study||10
7618586|NCT02387710|18758745|P2|NOT COMPLETED|Second Study Night||0
7618587|NCT02387710|18758746|P1|NOT COMPLETED|Second Study Night||0
7618588|NCT02387710|18758745|P2|COMPLETED|Second Study Night||7
7618589|NCT02387710|18758746|P1|COMPLETED|Second Study Night||9
7618590|NCT02387710|18758745|P2|STARTED|Second Study Night|2 patients did not come back for excessive sleep disruption due to the equipment|7
7618591|NCT02387710|18758746|P1|STARTED|Second Study Night||9
7618592|NCT02387710|18758745|P2|NOT COMPLETED|First Study Night||0
7618593|NCT02387710|18758746|P1|NOT COMPLETED|First Study Night||0
7618594|NCT02387710|18758745|P2|COMPLETED|First Study Night||9
7618595|NCT02387710|18758746|P1|COMPLETED|First Study Night||9
7618596|NCT02387710|18758745|P2|STARTED|First Study Night||9
7618597|NCT02387710|18758746|P1|STARTED|First Study Night||9
7618598|NCT02387580|18758762|P6|NOT COMPLETED|Overall Study||0
7618599|NCT02387580|18758763|P5|NOT COMPLETED|Overall Study||0
7618600|NCT02387580|18758764|P4|NOT COMPLETED|Overall Study||1
7618601|NCT02387580|18758765|P3|NOT COMPLETED|Overall Study||0
7618602|NCT02387580|18758766|P2|NOT COMPLETED|Overall Study||0
7618603|NCT02387580|18758767|P1|NOT COMPLETED|Overall Study||0
7618604|NCT02387580|18758762|P6|COMPLETED|Overall Study||8
7618605|NCT02387580|18758763|P5|COMPLETED|Overall Study||8
7618606|NCT02387580|18758764|P4|COMPLETED|Overall Study||7
7618607|NCT02387580|18758765|P3|COMPLETED|Overall Study||8
7618608|NCT02387580|18758766|P2|COMPLETED|Overall Study||8
7618609|NCT02387580|18758767|P1|COMPLETED|Overall Study||8
7618610|NCT02387580|18758762|P6|STARTED|Overall Study||8
7618611|NCT02387580|18758763|P5|STARTED|Overall Study||8
7618612|NCT02387580|18758764|P4|STARTED|Overall Study||8
7618613|NCT02387580|18758765|P3|STARTED|Overall Study||8
7618614|NCT02387580|18758766|P2|STARTED|Overall Study||8
7618615|NCT02387580|18758767|P1|STARTED|Overall Study||8
7618616|NCT02387554|18758803|P4|NOT COMPLETED|Overall Study||2
7618617|NCT02387554|18758804|P3|NOT COMPLETED|Overall Study||2
7618618|NCT02387554|18758805|P2|NOT COMPLETED|Overall Study||0
7618619|NCT02387554|18758806|P1|NOT COMPLETED|Overall Study||3
7618620|NCT02387554|18758803|P4|COMPLETED|Overall Study||6
7618621|NCT02387554|18758804|P3|COMPLETED|Overall Study||6
7618622|NCT02387554|18758805|P2|COMPLETED|Overall Study||7
7618623|NCT02387554|18758806|P1|COMPLETED|Overall Study||7
7618624|NCT02387554|18758803|P4|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
7618625|NCT02387554|18758804|P3|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
7618626|NCT02387554|18758805|P2|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7
7618627|NCT02387554|18758806|P1|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10
7618628|NCT02387502|18758819|P3|NOT COMPLETED|Overall Study||0
7618629|NCT02387502|18758820|P2|NOT COMPLETED|Overall Study||0
7618630|NCT02387502|18758821|P1|NOT COMPLETED|Overall Study||0
7618631|NCT02387502|18758819|P3|COMPLETED|Overall Study||40
7618632|NCT02387502|18758820|P2|COMPLETED|Overall Study||40
7618633|NCT02387502|18758821|P1|COMPLETED|Overall Study||40
7618634|NCT02387502|18758819|P3|STARTED|Overall Study||40
7618635|NCT02387502|18758820|P2|STARTED|Overall Study||40
7618636|NCT02387502|18758821|P1|STARTED|Overall Study||40
7618637|NCT02387476|18758831|P2|NOT COMPLETED|Overall Study||5
7618638|NCT02387476|18758832|P1|NOT COMPLETED|Overall Study||6
7618639|NCT02387476|18758831|P2|COMPLETED|Overall Study||17
7618640|NCT02387476|18758832|P1|COMPLETED|Overall Study||19
7618641|NCT02387476|18758831|P2|STARTED|Overall Study||22
7618642|NCT02387476|18758832|P1|STARTED|Overall Study||25
7618643|NCT02387372|18758860|P2|NOT COMPLETED|Overall Study||0
7618644|NCT02387372|18758861|P1|NOT COMPLETED|Overall Study||1
7618645|NCT02387372|18758860|P2|COMPLETED|Overall Study||10
7618646|NCT02387372|18758861|P1|COMPLETED|Overall Study||26
7618647|NCT02387372|18758860|P2|Treated|Overall Study||10
7618648|NCT02387372|18758861|P1|Treated|Overall Study||26
7618649|NCT02387372|18758860|P2|STARTED|Overall Study||10
7618650|NCT02387372|18758861|P1|STARTED|Overall Study||27
7618651|NCT02387359|18758910|P3|NOT COMPLETED|Overall Study||56
7618652|NCT02387359|18758911|P2|NOT COMPLETED|Overall Study||42
7618653|NCT02387359|18758912|P1|NOT COMPLETED|Overall Study||59
7618654|NCT02387359|18758910|P3|COMPLETED|Overall Study||293
7618655|NCT02387359|18758911|P2|COMPLETED|Overall Study||309
7618656|NCT02387359|18758912|P1|COMPLETED|Overall Study||295
7618657|NCT02387359|18758910|P3|STARTED|Overall Study||349
7618658|NCT02387359|18758911|P2|STARTED|Overall Study||351
7618659|NCT02387359|18758912|P1|STARTED|Overall Study||354
7618660|NCT02387268|18758944|P1|NOT COMPLETED|Overall Study||1
7618661|NCT02387268|18758944|P1|COMPLETED|Overall Study||9
7618662|NCT02387268|18758944|P1|STARTED|Overall Study||10
7618663|NCT02387164|18758951|P2|NOT COMPLETED|Overall Study||2
7618664|NCT02387164|18758952|P1|NOT COMPLETED|Overall Study||3
7618665|NCT02387164|18758951|P2|COMPLETED|Overall Study||11
7618666|NCT02387164|18758952|P1|COMPLETED|Overall Study||10
7618667|NCT02387164|18758951|P2|STARTED|Overall Study||13
7618668|NCT02387164|18758952|P1|STARTED|Overall Study||13
7618669|NCT02387008|18758977|P3|NOT COMPLETED|Overall Study||0
7618670|NCT02387008|18758978|P2|NOT COMPLETED|Overall Study||0
7618671|NCT02387008|18758979|P1|NOT COMPLETED|Overall Study||0
7618672|NCT02387008|18758977|P3|COMPLETED|Overall Study||4
7618673|NCT02387008|18758978|P2|COMPLETED|Overall Study||0
7618674|NCT02387008|18758979|P1|COMPLETED|Overall Study||2
7618675|NCT02387008|18758977|P3|STARTED|Overall Study||4
7618676|NCT02387008|18758978|P2|STARTED|Overall Study||0
7618677|NCT02387008|18758979|P1|STARTED|Overall Study||2
7618678|NCT02386995|18758996|P1|NOT COMPLETED|Overall Study||0
7618679|NCT02386995|18758996|P1|COMPLETED|Overall Study||30
7618680|NCT02386995|18758996|P1|STARTED|Overall Study||30
7618681|NCT02386345|18759001|P1|NOT COMPLETED|Overall Study||102
7618682|NCT02386345|18759001|P1|COMPLETED|Overall Study||197
7618683|NCT02386345|18759001|P1|STARTED|Overall Study||299
7618684|NCT02386189|18759011|P2|NOT COMPLETED|Overall Study||3
7618685|NCT02386189|18759012|P1|NOT COMPLETED|Overall Study||4
7618686|NCT02386189|18759011|P2|COMPLETED|Overall Study||30
7618687|NCT02386189|18759012|P1|COMPLETED|Overall Study||26
7618688|NCT02386189|18759011|P2|STARTED|Overall Study||33
7618689|NCT02386189|18759012|P1|STARTED|Overall Study||30
7618690|NCT02386098|18759035|P5|NOT COMPLETED|Stage 2 (96 Weeks)||0
7618691|NCT02386098|18759036|P4|NOT COMPLETED|Stage 2 (96 Weeks)||0
7618692|NCT02386098|18759037|P3|NOT COMPLETED|Stage 2 (96 Weeks)||0
7618693|NCT02386098|18759038|P2|NOT COMPLETED|Stage 2 (96 Weeks)||0
7618694|NCT02386098|18759039|P1|NOT COMPLETED|Stage 2 (96 Weeks)||0
7618695|NCT02386098|18759035|P5|COMPLETED|Stage 2 (96 Weeks)||0
7618696|NCT02386098|18759036|P4|COMPLETED|Stage 2 (96 Weeks)||0
7618697|NCT02386098|18759037|P3|COMPLETED|Stage 2 (96 Weeks)||0
7618698|NCT02386098|18759038|P2|COMPLETED|Stage 2 (96 Weeks)||0
7618699|NCT02386098|18759039|P1|COMPLETED|Stage 2 (96 Weeks)||0
7618700|NCT02386098|18759035|P5|STARTED|Stage 2 (96 Weeks)||0
7618701|NCT02386098|18759036|P4|STARTED|Stage 2 (96 Weeks)||0
7618702|NCT02386098|18759037|P3|STARTED|Stage 2 (96 Weeks)||0
7618703|NCT02386098|18759038|P2|STARTED|Stage 2 (96 Weeks)||0
7618704|NCT02386098|18759039|P1|STARTED|Stage 2 (96 Weeks)||0
7618705|NCT02386098|18759035|P5|NOT COMPLETED|Stage 1 (96 Weeks)||0
7618706|NCT02386098|18759036|P4|NOT COMPLETED|Stage 1 (96 Weeks)||0
7618707|NCT02386098|18759037|P3|NOT COMPLETED|Stage 1 (96 Weeks)||0
7618708|NCT02386098|18759038|P2|NOT COMPLETED|Stage 1 (96 Weeks)||43
7618709|NCT02386098|18759039|P1|NOT COMPLETED|Stage 1 (96 Weeks)||43
7618710|NCT02386098|18759035|P5|COMPLETED|Stage 1 (96 Weeks)||0
7618711|NCT02386098|18759036|P4|COMPLETED|Stage 1 (96 Weeks)||0
7618712|NCT02386098|18759037|P3|COMPLETED|Stage 1 (96 Weeks)||0
7618713|NCT02386098|18759038|P2|COMPLETED|Stage 1 (96 Weeks)||0
7618714|NCT02386098|18759039|P1|COMPLETED|Stage 1 (96 Weeks)||0
7618715|NCT02386098|18759035|P5|STARTED|Stage 1 (96 Weeks)||0
7618716|NCT02386098|18759036|P4|STARTED|Stage 1 (96 Weeks)||0
7618717|NCT02386098|18759037|P3|STARTED|Stage 1 (96 Weeks)||0
7618718|NCT02386098|18759038|P2|STARTED|Stage 1 (96 Weeks)||43
7618719|NCT02386098|18759039|P1|STARTED|Stage 1 (96 Weeks)||43
7618720|NCT02385799|18759118|P2|NOT COMPLETED|Overall Study||8
7618721|NCT02385799|18759119|P1|NOT COMPLETED|Overall Study||5
7618722|NCT02385799|18759118|P2|COMPLETED|Overall Study||24
7618723|NCT02385799|18759119|P1|COMPLETED|Overall Study||21
7618724|NCT02385799|18759118|P2|Completed End-of-Treatment Visit|Overall Study||26
7618725|NCT02385799|18759119|P1|Completed End-of-Treatment Visit|Overall Study||21
7618726|NCT02385799|18759118|P2|STARTED|Overall Study||32
7618727|NCT02385799|18759119|P1|STARTED|Overall Study||26
7618728|NCT02385721|18759153|P1|NOT COMPLETED|Overall Study||230
7618729|NCT02385721|18759153|P1|COMPLETED|Overall Study||371
7618730|NCT02385721|18759153|P1|STARTED|Overall Study||601
7618731|NCT02385708|18759160|P2|NOT COMPLETED|Overall Study||15
7618732|NCT02385708|18759161|P1|NOT COMPLETED|Overall Study||8
7618733|NCT02385708|18759160|P2|COMPLETED|Overall Study||67
7618734|NCT02385708|18759161|P1|COMPLETED|Overall Study||73
7618735|NCT02385708|18759160|P2|Intervention Started|Overall Study||82
7618736|NCT02385708|18759161|P1|Intervention Started|Overall Study||81
7618737|NCT02385708|18759160|P2|STARTED|Overall Study||82
7618738|NCT02385708|18759161|P1|STARTED|Overall Study||81
7618739|NCT02385669|18759167|P1|NOT COMPLETED|Overall Study||2
7618740|NCT02385669|18759167|P1|COMPLETED|Overall Study||1
7618741|NCT02385669|18759167|P1|STARTED|Overall Study||3
7618742|NCT02385526|18759175|P3|NOT COMPLETED|Overall Study||0
7618743|NCT02385526|18759176|P2|NOT COMPLETED|Overall Study||3
7618744|NCT02385526|18759177|P1|NOT COMPLETED|Overall Study||2
7618745|NCT02385526|18759175|P3|COMPLETED|Overall Study||20
7618746|NCT02385526|18759176|P2|COMPLETED|Overall Study||17
7618747|NCT02385526|18759177|P1|COMPLETED|Overall Study||20
7618748|NCT02385526|18759175|P3|STARTED|Overall Study||20
7618749|NCT02385526|18759176|P2|STARTED|Overall Study||20
7618750|NCT02385526|18759177|P1|STARTED|Overall Study||22
7618751|NCT02385240|18759188|P3|NOT COMPLETED|Overall Study||1
7618752|NCT02385240|18759189|P2|NOT COMPLETED|Overall Study||6
7618753|NCT02385240|18759190|P1|NOT COMPLETED|Overall Study||1
7618754|NCT02385240|18759188|P3|COMPLETED|Overall Study||184
7618755|NCT02385240|18759189|P2|COMPLETED|Overall Study||178
7618756|NCT02385240|18759190|P1|COMPLETED|Overall Study||182
7618757|NCT02385240|18759188|P3|STARTED|Overall Study||185
7618758|NCT02385240|18759189|P2|STARTED|Overall Study||184
7618759|NCT02385240|18759190|P1|STARTED|Overall Study||183
7618760|NCT02385084|18759204|P6|NOT COMPLETED|Period 3||0
7618761|NCT02385084|18759205|P5|NOT COMPLETED|Period 3||0
7618762|NCT02385084|18759206|P4|NOT COMPLETED|Period 3||0
7618763|NCT02385084|18759207|P3|NOT COMPLETED|Period 3||0
7618764|NCT02385084|18759208|P2|NOT COMPLETED|Period 3||0
7618765|NCT02385084|18759209|P1|NOT COMPLETED|Period 3||0
7618766|NCT02385084|18759204|P6|COMPLETED|Period 3||3
7618767|NCT02385084|18759205|P5|COMPLETED|Period 3||2
7618768|NCT02385084|18759206|P4|COMPLETED|Period 3||3
7618769|NCT02385084|18759207|P3|COMPLETED|Period 3||1
7618770|NCT02385084|18759208|P2|COMPLETED|Period 3||3
7618771|NCT02385084|18759209|P1|COMPLETED|Period 3||2
7618772|NCT02385084|18759204|P6|Washout|Period 3||3
7618773|NCT02385084|18759205|P5|Washout|Period 3||2
7618774|NCT02385084|18759206|P4|Washout|Period 3||3
7618775|NCT02385084|18759207|P3|Washout|Period 3||1
7618776|NCT02385084|18759208|P2|Washout|Period 3||3
7618777|NCT02385084|18759209|P1|Washout|Period 3||2
7618778|NCT02385084|18759204|P6|Received LY2409021|Period 3||3
7618779|NCT02385084|18759205|P5|Received LY2409021|Period 3||2
7618780|NCT02385084|18759206|P4|Received LY2409021|Period 3||3
7618781|NCT02385084|18759207|P3|Received LY2409021|Period 3||1
7618782|NCT02385084|18759208|P2|Received LY2409021|Period 3||3
7618783|NCT02385084|18759209|P1|Received LY2409021|Period 3||2
7618784|NCT02385084|18759204|P6|STARTED|Period 3||3
7618785|NCT02385084|18759205|P5|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|2
7618786|NCT02385084|18759206|P4|STARTED|Period 3||3
7618787|NCT02385084|18759207|P3|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|1
7618788|NCT02385084|18759208|P2|STARTED|Period 3||3
7618789|NCT02385084|18759209|P1|STARTED|Period 3||2
7618790|NCT02385084|18759204|P6|NOT COMPLETED|Period 2||0
7618791|NCT02385084|18759205|P5|NOT COMPLETED|Period 2||0
7618792|NCT02385084|18759206|P4|NOT COMPLETED|Period 2||0
7618793|NCT02385084|18759207|P3|NOT COMPLETED|Period 2||1
7618794|NCT02385084|18759208|P2|NOT COMPLETED|Period 2||0
7618795|NCT02385084|18759209|P1|NOT COMPLETED|Period 2||0
7618796|NCT02385084|18759204|P6|COMPLETED|Period 2||3
7618797|NCT02385084|18759205|P5|COMPLETED|Period 2||3
7618798|NCT02385084|18759206|P4|COMPLETED|Period 2||3
7618799|NCT02385084|18759207|P3|COMPLETED|Period 2||2
7618800|NCT02385084|18759208|P2|COMPLETED|Period 2||3
7618801|NCT02385084|18759209|P1|COMPLETED|Period 2||2
7618802|NCT02385084|18759204|P6|Washout|Period 2||3
7618803|NCT02385084|18759205|P5|Washout|Period 2||3
7618804|NCT02385084|18759206|P4|Washout|Period 2||3
7618805|NCT02385084|18759207|P3|Washout|Period 2||3
7618806|NCT02385084|18759208|P2|Washout|Period 2||3
7618807|NCT02385084|18759209|P1|Washout|Period 2||2
7618808|NCT02385084|18759204|P6|Received LY2409021|Period 2||3
7618809|NCT02385084|18759205|P5|Received LY2409021|Period 2||3
7618810|NCT02385084|18759206|P4|Received LY2409021|Period 2||3
7618811|NCT02385084|18759207|P3|Received LY2409021|Period 2||3
7618812|NCT02385084|18759208|P2|Received LY2409021|Period 2||3
7618813|NCT02385084|18759209|P1|Received LY2409021|Period 2||2
7618814|NCT02385084|18759204|P6|STARTED|Period 2||3
7618815|NCT02385084|18759205|P5|STARTED|Period 2||3
7618816|NCT02385084|18759206|P4|STARTED|Period 2||3
7618817|NCT02385084|18759207|P3|STARTED|Period 2||3
7618818|NCT02385084|18759208|P2|STARTED|Period 2||3
7618819|NCT02385084|18759209|P1|STARTED|Period 2|1 participant discontinued after Period 1 - physician decision. Did not enter Period 2.|2
7618820|NCT02385084|18759204|P6|NOT COMPLETED|Period 1||0
7618821|NCT02385084|18759205|P5|NOT COMPLETED|Period 1||0
7618822|NCT02385084|18759206|P4|NOT COMPLETED|Period 1||0
7618823|NCT02385084|18759207|P3|NOT COMPLETED|Period 1||0
7618824|NCT02385084|18759208|P2|NOT COMPLETED|Period 1||0
7618825|NCT02385084|18759209|P1|NOT COMPLETED|Period 1||0
7618826|NCT02385084|18759204|P6|COMPLETED|Period 1||3
7618827|NCT02385084|18759205|P5|COMPLETED|Period 1||3
7618828|NCT02385084|18759206|P4|COMPLETED|Period 1||3
7618829|NCT02385084|18759207|P3|COMPLETED|Period 1||3
7618830|NCT02385084|18759208|P2|COMPLETED|Period 1||3
7618831|NCT02385084|18759209|P1|COMPLETED|Period 1||3
7618832|NCT02385084|18759204|P6|Washout|Period 1||3
7618833|NCT02385084|18759205|P5|Washout|Period 1||3
7618834|NCT02385084|18759206|P4|Washout|Period 1||3
7618835|NCT02385084|18759207|P3|Washout|Period 1||3
7618836|NCT02385084|18759208|P2|Washout|Period 1||3
7618837|NCT02385084|18759209|P1|Washout|Period 1||3
7618838|NCT02385084|18759204|P6|Received LY2409021|Period 1||3
7618839|NCT02385084|18759205|P5|Received LY2409021|Period 1||3
7618840|NCT02385084|18759206|P4|Received LY2409021|Period 1||3
7618841|NCT02385084|18759207|P3|Received LY2409021|Period 1||3
7618842|NCT02385084|18759208|P2|Received LY2409021|Period 1||3
7618843|NCT02385084|18759209|P1|Received LY2409021|Period 1||3
7618844|NCT02385084|18759204|P6|STARTED|Period 1||3
7618845|NCT02385084|18759205|P5|STARTED|Period 1||3
7618846|NCT02385084|18759206|P4|STARTED|Period 1||3
7618847|NCT02385084|18759207|P3|STARTED|Period 1||3
7618848|NCT02385084|18759208|P2|STARTED|Period 1||3
7618849|NCT02385084|18759209|P1|STARTED|Period 1||3
7618850|NCT02384993|18759222|P2|NOT COMPLETED|Overall Study||1
7618851|NCT02384993|18759223|P1|NOT COMPLETED|Overall Study||0
7618852|NCT02384993|18759222|P2|COMPLETED|Overall Study||11
7618853|NCT02384993|18759223|P1|COMPLETED|Overall Study||12
7618854|NCT02384993|18759222|P2|STARTED|Overall Study||12
7618855|NCT02384993|18759223|P1|STARTED|Overall Study||12
7618856|NCT02384941|18759249|P3|NOT COMPLETED|Overall Study||41
7618857|NCT02384941|18759250|P2|NOT COMPLETED|Overall Study||35
7618858|NCT02384941|18759251|P1|NOT COMPLETED|Overall Study||50
7618859|NCT02384941|18759249|P3|COMPLETED|Overall Study||221
7618860|NCT02384941|18759250|P2|COMPLETED|Overall Study||228
7618861|NCT02384941|18759251|P1|COMPLETED|Overall Study||218
7618862|NCT02384941|18759249|P3|STARTED|Overall Study||262
7618863|NCT02384941|18759250|P2|STARTED|Overall Study||263
7618864|NCT02384941|18759251|P1|STARTED|Overall Study||268
7618865|NCT02384538|18759282|P2|NOT COMPLETED|Overall Study||15
7618866|NCT02384538|18759283|P1|NOT COMPLETED|Overall Study||6
7618867|NCT02384538|18759282|P2|COMPLETED|Overall Study||49
7618868|NCT02384538|18759283|P1|COMPLETED|Overall Study||61
7618869|NCT02384538|18759282|P2|STARTED|Overall Study||64
7618870|NCT02384538|18759283|P1|STARTED|Overall Study||67
7618871|NCT02384460|18759303|P2|NOT COMPLETED|Overall Study||7
7618872|NCT02384460|18759304|P1|NOT COMPLETED|Overall Study||7
7618873|NCT02384460|18759303|P2|COMPLETED|Overall Study||80
7618874|NCT02384460|18759304|P1|COMPLETED|Overall Study||75
7618875|NCT02384460|18759303|P2|Received at Least 1 Dose of Study Drug|Overall Study||87
7618876|NCT02384460|18759304|P1|Received at Least 1 Dose of Study Drug|Overall Study||82
7618877|NCT02384460|18759303|P2|STARTED|Overall Study||87
7618878|NCT02384460|18759304|P1|STARTED|Overall Study||82
7618879|NCT02384382|18759322|P1|NOT COMPLETED|Overall Study||23
7618880|NCT02384382|18759322|P1|COMPLETED|Overall Study||0
7618881|NCT02384382|18759322|P1|STARTED|Overall Study||23
7618882|NCT02384200|18759329|P2|NOT COMPLETED|Overall Study||0
7618883|NCT02384200|18759330|P1|NOT COMPLETED|Overall Study||0
7618884|NCT02384200|18759329|P2|COMPLETED|Overall Study||43
7618885|NCT02384200|18759330|P1|COMPLETED|Overall Study||43
7618886|NCT02384200|18759329|P2|STARTED|Overall Study||43
7618887|NCT02384200|18759330|P1|STARTED|Overall Study||43
7618888|NCT02384096|18759356|P2|NOT COMPLETED|Second Intervention (7 Days)||1
7618889|NCT02384096|18759357|P1|NOT COMPLETED|Second Intervention (7 Days)||0
7618890|NCT02384096|18759356|P2|COMPLETED|Second Intervention (7 Days)||6
7618891|NCT02384096|18759357|P1|COMPLETED|Second Intervention (7 Days)||4
7618892|NCT02384096|18759356|P2|STARTED|Second Intervention (7 Days)||7
7618893|NCT02384096|18759357|P1|STARTED|Second Intervention (7 Days)||4
7618894|NCT02384096|18759356|P2|NOT COMPLETED|First Intervention (7 Days)||0
7618895|NCT02384096|18759357|P1|NOT COMPLETED|First Intervention (7 Days)||1
7618896|NCT02384096|18759356|P2|COMPLETED|First Intervention (7 Days)||7
7618897|NCT02384096|18759357|P1|COMPLETED|First Intervention (7 Days)||4
7618898|NCT02384096|18759356|P2|STARTED|First Intervention (7 Days)||7
7618899|NCT02384096|18759357|P1|STARTED|First Intervention (7 Days)||5
7618900|NCT02384070|18759365|P3|NOT COMPLETED|Overall Study||0
7618901|NCT02384070|18759366|P2|NOT COMPLETED|Overall Study||0
7618902|NCT02384070|18759367|P1|NOT COMPLETED|Overall Study||0
7618903|NCT02384070|18759365|P3|COMPLETED|Overall Study||100
7618904|NCT02384070|18759366|P2|COMPLETED|Overall Study||100
7618905|NCT02384070|18759367|P1|COMPLETED|Overall Study||100
7618906|NCT02384070|18759365|P3|STARTED|Overall Study||100
7618907|NCT02384070|18759366|P2|STARTED|Overall Study||100
7618908|NCT02384070|18759367|P1|STARTED|Overall Study||100
7618909|NCT02384044|18759383|P2|NOT COMPLETED|Overall Study||0
7618910|NCT02384044|18759384|P1|NOT COMPLETED|Overall Study||0
7618911|NCT02384044|18759383|P2|COMPLETED|Overall Study||15
7618912|NCT02384044|18759384|P1|COMPLETED|Overall Study||15
7618913|NCT02384044|18759383|P2|STARTED|Overall Study||15
7618914|NCT02384044|18759384|P1|STARTED|Overall Study||15
7618915|NCT02383966|18759394|P2|NOT COMPLETED|Overall Study||7
7618916|NCT02383966|18759395|P1|NOT COMPLETED|Overall Study||26
7618917|NCT02383966|18759394|P2|COMPLETED|Overall Study||72
7618918|NCT02383966|18759395|P1|COMPLETED|Overall Study||138
7618919|NCT02383966|18759394|P2|STARTED|Overall Study||79
7618920|NCT02383966|18759395|P1|STARTED|Overall Study||164
7618921|NCT02383940|18759415|P2|NOT COMPLETED|Overall Study||3
7618922|NCT02383940|18759416|P1|NOT COMPLETED|Overall Study||9
7618923|NCT02383940|18759415|P2|COMPLETED|Overall Study||40
7618924|NCT02383940|18759416|P1|COMPLETED|Overall Study||35
7618925|NCT02383940|18759415|P2|Treated|Overall Study||43
7618926|NCT02383940|18759416|P1|Treated|Overall Study||42
7618927|NCT02383940|18759415|P2|STARTED|Overall Study||43
7618928|NCT02383940|18759416|P1|STARTED|Overall Study||44
7618929|NCT02383862|18759432|P2|NOT COMPLETED|3 Month Follow up||21
7618930|NCT02383862|18759433|P1|NOT COMPLETED|3 Month Follow up||23
7618931|NCT02383862|18759432|P2|COMPLETED|3 Month Follow up||128
7618932|NCT02383862|18759433|P1|COMPLETED|3 Month Follow up||128
7618933|NCT02383862|18759432|P2|STARTED|3 Month Follow up||149
7618934|NCT02383862|18759433|P1|STARTED|3 Month Follow up||151
7618935|NCT02383862|18759432|P2|NOT COMPLETED|Baseline||0
7618936|NCT02383862|18759433|P1|NOT COMPLETED|Baseline||0
7618937|NCT02383862|18759432|P2|COMPLETED|Baseline||149
7618938|NCT02383862|18759433|P1|COMPLETED|Baseline||151
7618939|NCT02383862|18759432|P2|STARTED|Baseline||149
7618940|NCT02383862|18759433|P1|STARTED|Baseline||151
7618941|NCT02383758|18759466|P2|NOT COMPLETED|Overall Study||2
7618942|NCT02383758|18759467|P1|NOT COMPLETED|Overall Study||0
7618943|NCT02383758|18759466|P2|COMPLETED|Overall Study||8
7618944|NCT02383758|18759467|P1|COMPLETED|Overall Study||10
7618945|NCT02383758|18759466|P2|STARTED|Overall Study||10
7618946|NCT02383758|18759467|P1|STARTED|Overall Study||10
7618947|NCT02383719|18759479|P1|NOT COMPLETED|Overall Study||0
7618948|NCT02383719|18759479|P1|COMPLETED|Overall Study||18
7618949|NCT02383719|18759479|P1|STARTED|Overall Study||18
7618950|NCT02383706|18759483|P1|NOT COMPLETED|Overall Study||28
7618951|NCT02383706|18759483|P1|COMPLETED|Overall Study||80
7618952|NCT02383706|18759483|P1|STARTED|Overall Study||108
7618953|NCT02383667|18759489|P1|NOT COMPLETED|Overall Study||0
7618954|NCT02383667|18759489|P1|COMPLETED|Overall Study||20
7618955|NCT02383667|18759489|P1|STARTED|Overall Study||20
7618956|NCT02383589|18759495|P2|NOT COMPLETED|Safety Follow-up (SFU)||5
7618957|NCT02383589|18759496|P1|NOT COMPLETED|Safety Follow-up (SFU)||7
7618958|NCT02383589|18759495|P2|COMPLETED|Safety Follow-up (SFU)||53
7618959|NCT02383589|18759496|P1|COMPLETED|Safety Follow-up (SFU)||59
7618960|NCT02383589|18759495|P2|STARTED|Safety Follow-up (SFU)||58
7618961|NCT02383589|18759496|P1|STARTED|Safety Follow-up (SFU)||66
7618962|NCT02383589|18759495|P2|NOT COMPLETED|Treatment Period||10
7618963|NCT02383589|18759496|P1|NOT COMPLETED|Treatment Period||1
7618964|NCT02383589|18759495|P2|COMPLETED|Treatment Period||58
7618965|NCT02383589|18759496|P1|COMPLETED|Treatment Period||66
7618966|NCT02383589|18759495|P2|STARTED|Treatment Period||68
7618967|NCT02383589|18759496|P1|STARTED|Treatment Period||67
7618968|NCT02383576|18759521|P2|NOT COMPLETED|Overall Study||45
7618969|NCT02383576|18759522|P1|NOT COMPLETED|Overall Study||63
7618970|NCT02383576|18759521|P2|COMPLETED|Overall Study||46
7618971|NCT02383576|18759522|P1|COMPLETED|Overall Study||31
7618972|NCT02383576|18759521|P2|STARTED|Overall Study||91
7618973|NCT02383576|18759522|P1|STARTED|Overall Study||94
7618974|NCT02383472|18759538|P2|NOT COMPLETED|Overall Study||1
7618975|NCT02383472|18759539|P1|NOT COMPLETED|Overall Study||1
7618976|NCT02383472|18759538|P2|COMPLETED|Overall Study||29
7618977|NCT02383472|18759539|P1|COMPLETED|Overall Study||22
7618978|NCT02383472|18759538|P2|STARTED|Overall Study||30
7618979|NCT02383472|18759539|P1|STARTED|Overall Study||23
7618980|NCT02383433|18759553|P1|NOT COMPLETED|Overall Study||2
7618981|NCT02383433|18759553|P1|COMPLETED|Overall Study||0
7618982|NCT02383433|18759553|P1|STARTED|Overall Study||2
7618983|NCT02383420|18759560|P3|NOT COMPLETED|Overall Study||0
7618984|NCT02383420|18759561|P2|NOT COMPLETED|Overall Study||0
7618985|NCT02383420|18759562|P1|NOT COMPLETED|Overall Study||2
7618986|NCT02383420|18759560|P3|COMPLETED|Overall Study||3
7618987|NCT02383420|18759561|P2|COMPLETED|Overall Study||10
7618988|NCT02383420|18759562|P1|COMPLETED|Overall Study||8
7618989|NCT02383420|18759560|P3|STARTED|Overall Study||3
7618990|NCT02383420|18759561|P2|STARTED|Overall Study||10
7618991|NCT02383420|18759562|P1|STARTED|Overall Study||10
7618992|NCT02383355|18759572|P2|NOT COMPLETED|Overall Study||0
7618993|NCT02383355|18759573|P1|NOT COMPLETED|Overall Study||2
7618994|NCT02383355|18759572|P2|COMPLETED|Overall Study||21
7618995|NCT02383355|18759573|P1|COMPLETED|Overall Study||17
7618996|NCT02383355|18759572|P2|STARTED|Overall Study||21
7618997|NCT02383355|18759573|P1|STARTED|Overall Study||19
7618998|NCT02383173|18759589|P2|NOT COMPLETED|Overall Study||2
7618999|NCT02383173|18759590|P1|NOT COMPLETED|Overall Study||0
7619000|NCT02383173|18759589|P2|COMPLETED|Overall Study||44
7619001|NCT02383173|18759590|P1|COMPLETED|Overall Study||88
7619002|NCT02383173|18759589|P2|STARTED|Overall Study||46
7619003|NCT02383173|18759590|P1|STARTED|Overall Study||88
7619004|NCT02383056|18759614|P2|NOT COMPLETED|Overall Study||2
7619005|NCT02383056|18759615|P1|NOT COMPLETED|Overall Study||1
7619006|NCT02383056|18759614|P2|COMPLETED|Overall Study||5
7619007|NCT02383056|18759615|P1|COMPLETED|Overall Study||6
7619008|NCT02383056|18759614|P2|STARTED|Overall Study||7
7619009|NCT02383056|18759615|P1|STARTED|Overall Study||7
7619010|NCT02383043|18759628|P3|NOT COMPLETED|Overall Study||0
7619011|NCT02383043|18759629|P2|NOT COMPLETED|Overall Study||0
7619012|NCT02383043|18759630|P1|NOT COMPLETED|Overall Study||2
7619013|NCT02383043|18759628|P3|COMPLETED|Overall Study||4
7619014|NCT02383043|18759629|P2|COMPLETED|Overall Study||5
7619015|NCT02383043|18759630|P1|COMPLETED|Overall Study||7
7619016|NCT02383043|18759628|P3|STARTED|Overall Study||4
7619017|NCT02383043|18759629|P2|STARTED|Overall Study||5
7619018|NCT02383043|18759630|P1|STARTED|Overall Study||9
7619019|NCT02383017|18759641|P2|NOT COMPLETED|Overall Study||2
7619020|NCT02383017|18759642|P1|NOT COMPLETED|Overall Study||5
7619021|NCT02383017|18759641|P2|COMPLETED|Overall Study||11
7619022|NCT02383017|18759642|P1|COMPLETED|Overall Study||10
7619023|NCT02383017|18759641|P2|STARTED|Overall Study||13
7619024|NCT02383017|18759642|P1|STARTED|Overall Study||15
7619025|NCT02382991|18759666|P2|NOT COMPLETED|Overall Study||3
7619026|NCT02382991|18759667|P1|NOT COMPLETED|Overall Study||2
7619027|NCT02382991|18759666|P2|COMPLETED|Overall Study||15
7619028|NCT02382991|18759667|P1|COMPLETED|Overall Study||15
7619029|NCT02382991|18759666|P2|STARTED|Overall Study||18
7619030|NCT02382991|18759667|P1|STARTED|Overall Study||17
7619031|NCT02382939|18759679|P2|NOT COMPLETED|Overall Study||3
7619032|NCT02382939|18759680|P1|NOT COMPLETED|Overall Study||3
7619033|NCT02382939|18759679|P2|COMPLETED|Overall Study||58
7619034|NCT02382939|18759680|P1|COMPLETED|Overall Study||28
7619035|NCT02382939|18759679|P2|Exposed|Overall Study||61
7619036|NCT02382939|18759680|P1|Exposed|Overall Study||31
7619037|NCT02382939|18759679|P2|STARTED|Overall Study||61
7619038|NCT02382939|18759680|P1|STARTED|Overall Study||31
7619039|NCT02382913|18759701|P10|NOT COMPLETED|Overall Study||0
7619040|NCT02382913|18759702|P9|NOT COMPLETED|Overall Study||0
7619041|NCT02382913|18759703|P8|NOT COMPLETED|Overall Study||0
7619042|NCT02382913|18759704|P7|NOT COMPLETED|Overall Study||0
7619043|NCT02382913|18759705|P6|NOT COMPLETED|Overall Study||0
7619044|NCT02382913|18759706|P5|NOT COMPLETED|Overall Study||0
7619045|NCT02382913|18759707|P4|NOT COMPLETED|Overall Study||0
7619046|NCT02382913|18759708|P3|NOT COMPLETED|Overall Study||0
7619047|NCT02382913|18759709|P2|NOT COMPLETED|Overall Study||0
7619048|NCT02382913|18759710|P1|NOT COMPLETED|Overall Study||0
7619049|NCT02382913|18759701|P10|COMPLETED|Overall Study||33
7619050|NCT02382913|18759702|P9|COMPLETED|Overall Study||30
7619051|NCT02382913|18759703|P8|COMPLETED|Overall Study||30
7619052|NCT02382913|18759704|P7|COMPLETED|Overall Study||37
7619053|NCT02382913|18759705|P6|COMPLETED|Overall Study||30
7619054|NCT02382913|18759706|P5|COMPLETED|Overall Study||33
7619055|NCT02382913|18759707|P4|COMPLETED|Overall Study||27
7619056|NCT02382913|18759708|P3|COMPLETED|Overall Study||32
7619057|NCT02382913|18759709|P2|COMPLETED|Overall Study||36
7619058|NCT02382913|18759710|P1|COMPLETED|Overall Study||27
7619059|NCT02382913|18759701|P10|STARTED|Overall Study||33
7619060|NCT02382913|18759702|P9|STARTED|Overall Study||30
7619061|NCT02382913|18759703|P8|STARTED|Overall Study||30
7619062|NCT02382913|18759704|P7|STARTED|Overall Study||37
7619063|NCT02382913|18759705|P6|STARTED|Overall Study||30
7619064|NCT02382913|18759706|P5|STARTED|Overall Study||33
7619065|NCT02382913|18759707|P4|STARTED|Overall Study||27
7619066|NCT02382913|18759708|P3|STARTED|Overall Study||32
7619067|NCT02382913|18759709|P2|STARTED|Overall Study||36
7619068|NCT02382913|18759710|P1|STARTED|Overall Study||27
7619069|NCT02382848|18759746|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
7619070|NCT02382848|18759747|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
7619071|NCT02382848|18759746|P2|COMPLETED|Second Intervention (3 Weeks)||5
7619072|NCT02382848|18759747|P1|COMPLETED|Second Intervention (3 Weeks)||3
7619073|NCT02382848|18759746|P2|STARTED|Second Intervention (3 Weeks)||5
7619074|NCT02382848|18759747|P1|STARTED|Second Intervention (3 Weeks)||3
7619075|NCT02382848|18759746|P2|NOT COMPLETED|Washout (1 Week)||0
7619076|NCT02382848|18759747|P1|NOT COMPLETED|Washout (1 Week)||0
7619077|NCT02382848|18759746|P2|COMPLETED|Washout (1 Week)||5
7619078|NCT02382848|18759747|P1|COMPLETED|Washout (1 Week)||3
7619079|NCT02382848|18759746|P2|STARTED|Washout (1 Week)||5
7619080|NCT02382848|18759747|P1|STARTED|Washout (1 Week)||3
7619081|NCT02382848|18759746|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
7619082|NCT02382848|18759747|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
7619083|NCT02382848|18759746|P2|COMPLETED|First Intervention (3 Weeks)||5
7619084|NCT02382848|18759747|P1|COMPLETED|First Intervention (3 Weeks)||3
7619085|NCT02382848|18759746|P2|STARTED|First Intervention (3 Weeks)||5
7619086|NCT02382848|18759747|P1|STARTED|First Intervention (3 Weeks)||3
7619087|NCT02382796|18759763|P1|NOT COMPLETED|Overall Study||7
7619088|NCT02382796|18759763|P1|COMPLETED|Overall Study||0
7619089|NCT02382796|18759763|P1|STARTED|Overall Study||7
7619090|NCT02382744|18759770|P2|NOT COMPLETED|Overall Study||0
7619091|NCT02382744|18759771|P1|NOT COMPLETED|Overall Study||0
7619092|NCT02382744|18759770|P2|COMPLETED|Overall Study||40
7619093|NCT02382744|18759771|P1|COMPLETED|Overall Study||40
7619094|NCT02382744|18759770|P2|Analyzed|Overall Study||40
7619095|NCT02382744|18759771|P1|Analyzed|Overall Study||40
7619096|NCT02382744|18759770|P2|Allocated|Overall Study||40
7619097|NCT02382744|18759771|P1|Allocated|Overall Study||40
7619098|NCT02382744|18759770|P2|STARTED|Overall Study||40
7619099|NCT02382744|18759771|P1|STARTED|Overall Study||40
7619100|NCT02382705|18759802|P1|NOT COMPLETED|Overall Study||24
7619101|NCT02382705|18759802|P1|COMPLETED|Overall Study||33
7619102|NCT02382705|18759802|P1|STARTED|Overall Study||57
7619103|NCT02382640|18759813|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
7619104|NCT02382640|18759814|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
7619105|NCT02382640|18759815|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
7619106|NCT02382640|18759816|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||1
7619107|NCT02382640|18759813|P4|COMPLETED|Intervention Period 4 (3 Days)||9
7619108|NCT02382640|18759814|P3|COMPLETED|Intervention Period 4 (3 Days)||9
7619109|NCT02382640|18759815|P2|COMPLETED|Intervention Period 4 (3 Days)||9
7619110|NCT02382640|18759816|P1|COMPLETED|Intervention Period 4 (3 Days)||8
7619111|NCT02382640|18759813|P4|STARTED|Intervention Period 4 (3 Days)||9
7619112|NCT02382640|18759814|P3|STARTED|Intervention Period 4 (3 Days)||9
7619113|NCT02382640|18759815|P2|STARTED|Intervention Period 4 (3 Days)||9
7619114|NCT02382640|18759816|P1|STARTED|Intervention Period 4 (3 Days)||9
7619115|NCT02382640|18759813|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
7619116|NCT02382640|18759814|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
7619117|NCT02382640|18759815|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
7619118|NCT02382640|18759816|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
7619119|NCT02382640|18759813|P4|COMPLETED|Washout Period 3 (7 Days)||9
7619120|NCT02382640|18759814|P3|COMPLETED|Washout Period 3 (7 Days)||9
7619121|NCT02382640|18759815|P2|COMPLETED|Washout Period 3 (7 Days)||9
7619122|NCT02382640|18759816|P1|COMPLETED|Washout Period 3 (7 Days)||9
7619123|NCT02382640|18759813|P4|STARTED|Washout Period 3 (7 Days)||9
7619124|NCT02382640|18759814|P3|STARTED|Washout Period 3 (7 Days)||9
7619125|NCT02382640|18759815|P2|STARTED|Washout Period 3 (7 Days)||9
7619126|NCT02382640|18759816|P1|STARTED|Washout Period 3 (7 Days)||9
7619127|NCT02382640|18759813|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7619128|NCT02382640|18759814|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7619129|NCT02382640|18759815|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7619130|NCT02382640|18759816|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7619131|NCT02382640|18759813|P4|COMPLETED|Intervention Period 3 (3 Days)||9
7619132|NCT02382640|18759814|P3|COMPLETED|Intervention Period 3 (3 Days)||9
7619133|NCT02382640|18759815|P2|COMPLETED|Intervention Period 3 (3 Days)||9
7619134|NCT02382640|18759816|P1|COMPLETED|Intervention Period 3 (3 Days)||9
7619135|NCT02382640|18759813|P4|STARTED|Intervention Period 3 (3 Days)||9
7619136|NCT02382640|18759814|P3|STARTED|Intervention Period 3 (3 Days)||9
7619137|NCT02382640|18759815|P2|STARTED|Intervention Period 3 (3 Days)||9
7619138|NCT02382640|18759816|P1|STARTED|Intervention Period 3 (3 Days)||9
7619139|NCT02382640|18759813|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
7619140|NCT02382640|18759814|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
7619141|NCT02382640|18759815|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
7619142|NCT02382640|18759816|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
7619143|NCT02382640|18759813|P4|COMPLETED|Washout Period 2 (7 Days)||9
7619144|NCT02382640|18759814|P3|COMPLETED|Washout Period 2 (7 Days)||9
7619145|NCT02382640|18759815|P2|COMPLETED|Washout Period 2 (7 Days)||9
7619146|NCT02382640|18759816|P1|COMPLETED|Washout Period 2 (7 Days)||9
7619147|NCT02382640|18759813|P4|STARTED|Washout Period 2 (7 Days)||9
7619148|NCT02382640|18759814|P3|STARTED|Washout Period 2 (7 Days)||9
7619149|NCT02382640|18759815|P2|STARTED|Washout Period 2 (7 Days)||9
7619150|NCT02382640|18759816|P1|STARTED|Washout Period 2 (7 Days)||9
7619151|NCT02382640|18759813|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7619152|NCT02382640|18759814|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7619153|NCT02382640|18759815|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7619154|NCT02382640|18759816|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7619155|NCT02382640|18759813|P4|COMPLETED|Intervention Period 2 (3 Days)||9
7619156|NCT02382640|18759814|P3|COMPLETED|Intervention Period 2 (3 Days)||9
7619157|NCT02382640|18759815|P2|COMPLETED|Intervention Period 2 (3 Days)||9
7619158|NCT02382640|18759816|P1|COMPLETED|Intervention Period 2 (3 Days)||9
7619159|NCT02382640|18759813|P4|STARTED|Intervention Period 2 (3 Days)||9
7619160|NCT02382640|18759814|P3|STARTED|Intervention Period 2 (3 Days)||9
7619161|NCT02382640|18759815|P2|STARTED|Intervention Period 2 (3 Days)||9
7619162|NCT02382640|18759816|P1|STARTED|Intervention Period 2 (3 Days)||9
7619163|NCT02382640|18759813|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
7619164|NCT02382640|18759814|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
7619165|NCT02382640|18759815|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
7619166|NCT02382640|18759816|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
7619167|NCT02382640|18759813|P4|COMPLETED|Washout Period 1 (7 Days)||9
7619168|NCT02382640|18759814|P3|COMPLETED|Washout Period 1 (7 Days)||9
7619169|NCT02382640|18759815|P2|COMPLETED|Washout Period 1 (7 Days)||9
7619170|NCT02382640|18759816|P1|COMPLETED|Washout Period 1 (7 Days)||9
7619171|NCT02382640|18759813|P4|STARTED|Washout Period 1 (7 Days)||9
7619172|NCT02382640|18759814|P3|STARTED|Washout Period 1 (7 Days)||9
7619173|NCT02382640|18759815|P2|STARTED|Washout Period 1 (7 Days)||9
7619174|NCT02382640|18759816|P1|STARTED|Washout Period 1 (7 Days)||9
7619175|NCT02382640|18759813|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
7619176|NCT02382640|18759814|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
7619177|NCT02382640|18759815|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
7619178|NCT02382640|18759816|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
7619179|NCT02382640|18759813|P4|COMPLETED|Intervention Period 1 (3 Days)||9
7619180|NCT02382640|18759814|P3|COMPLETED|Intervention Period 1 (3 Days)||9
7619181|NCT02382640|18759815|P2|COMPLETED|Intervention Period 1 (3 Days)||9
7619182|NCT02382640|18759816|P1|COMPLETED|Intervention Period 1 (3 Days)||9
7619183|NCT02382640|18759813|P4|STARTED|Intervention Period 1 (3 Days)||9
7619184|NCT02382640|18759814|P3|STARTED|Intervention Period 1 (3 Days)||9
7619185|NCT02382640|18759815|P2|STARTED|Intervention Period 1 (3 Days)||9
7619186|NCT02382640|18759816|P1|STARTED|Intervention Period 1 (3 Days)||9
7619187|NCT02382276|18759857|P3|NOT COMPLETED|Overall Study||39
7619188|NCT02382276|18759858|P2|NOT COMPLETED|Overall Study||10
7619189|NCT02382276|18759859|P1|NOT COMPLETED|Overall Study||11
7619190|NCT02382276|18759857|P3|COMPLETED|Overall Study||133
7619191|NCT02382276|18759858|P2|COMPLETED|Overall Study||84
7619192|NCT02382276|18759859|P1|COMPLETED|Overall Study||126
7619193|NCT02382276|18759857|P3|STARTED|Overall Study||172
7619194|NCT02382276|18759858|P2|STARTED|Overall Study||94
7619195|NCT02382276|18759859|P1|STARTED|Overall Study||137
7619196|NCT02382133|18759871|P1|NOT COMPLETED|Overall Study||33
7619197|NCT02382133|18759871|P1|COMPLETED|Overall Study||10
7619198|NCT02382133|18759871|P1|STARTED|Overall Study||43
7619199|NCT02382016|18759878|P2|NOT COMPLETED|OL Extension Period||0
7619200|NCT02382016|18759879|P1|NOT COMPLETED|OL Extension Period||6
7619201|NCT02382016|18759878|P2|COMPLETED|OL Extension Period||0
7619202|NCT02382016|18759879|P1|COMPLETED|OL Extension Period||27
7619203|NCT02382016|18759878|P2|STARTED|OL Extension Period||0
7619204|NCT02382016|18759879|P1|STARTED|OL Extension Period|Participants(French site) who completed DB,OL periods, consented receiving macitentan in OLE period.|33
7619205|NCT02382016|18759878|P2|NOT COMPLETED|Open-label (OL) Treatment Period||0
7619206|NCT02382016|18759879|P1|NOT COMPLETED|Open-label (OL) Treatment Period||9
7619207|NCT02382016|18759878|P2|COMPLETED|Open-label (OL) Treatment Period||0
7619208|NCT02382016|18759879|P1|COMPLETED|Open-label (OL) Treatment Period||71
7619209|NCT02382016|18759878|P2|STARTED|Open-label (OL) Treatment Period||0
7619210|NCT02382016|18759879|P1|STARTED|Open-label (OL) Treatment Period||80
7619211|NCT02382016|18759878|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||1
7619212|NCT02382016|18759879|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||4
7619213|NCT02382016|18759878|P2|COMPLETED|Double-blind (DB) Treatment Period||41
7619214|NCT02382016|18759879|P1|COMPLETED|Double-blind (DB) Treatment Period||39
7619215|NCT02382016|18759878|P2|STARTED|Double-blind (DB) Treatment Period||42
7619216|NCT02382016|18759879|P1|STARTED|Double-blind (DB) Treatment Period||43
7619217|NCT02381795|18759903|P1|NOT COMPLETED|Overall Study||3
7619218|NCT02381795|18759903|P1|COMPLETED|Overall Study||7
7619219|NCT02381795|18759903|P1|STARTED|Overall Study||10
7619220|NCT02381678|18759907|P3|NOT COMPLETED|Overall Study||0
7619221|NCT02381678|18759908|P2|NOT COMPLETED|Overall Study||0
7619222|NCT02381678|18759909|P1|NOT COMPLETED|Overall Study||0
7619223|NCT02381678|18759907|P3|COMPLETED|Overall Study||32
7619224|NCT02381678|18759908|P2|COMPLETED|Overall Study||139
7619225|NCT02381678|18759909|P1|COMPLETED|Overall Study||54
7619226|NCT02381678|18759907|P3|STARTED|Overall Study||32
7619227|NCT02381678|18759908|P2|STARTED|Overall Study||139
7619228|NCT02381678|18759909|P1|STARTED|Overall Study||54
7619229|NCT02381652|18759918|P3|NOT COMPLETED|Overall Study||1
7619230|NCT02381652|18759919|P2|NOT COMPLETED|Overall Study||0
7619231|NCT02381652|18759920|P1|NOT COMPLETED|Overall Study||0
7619232|NCT02381652|18759918|P3|COMPLETED|Overall Study||49
7619233|NCT02381652|18759919|P2|COMPLETED|Overall Study||98
7619234|NCT02381652|18759920|P1|COMPLETED|Overall Study||94
7619235|NCT02381652|18759918|P3|STARTED|Overall Study|Saline injection in 13-01 study; receiving a Cingal injection in 13-02|50
7619236|NCT02381652|18759919|P2|STARTED|Overall Study|Monovisc injection in 13-01 study; receiving a Cingal injection in 13-02|98
7619237|NCT02381652|18759920|P1|STARTED|Overall Study|Cingal injection in 13-01 study; receiving a 2nd Cingal injection in 13-02|94
7619238|NCT02381418|18759927|P1|NOT COMPLETED|Overall Study||0
7619239|NCT02381418|18759927|P1|COMPLETED|Overall Study||120
7619240|NCT02381418|18759927|P1|STARTED|Overall Study||120
7619241|NCT02381392|18759935|P2|NOT COMPLETED|Overall Study||0
7619242|NCT02381392|18759936|P1|NOT COMPLETED|Overall Study||0
7619243|NCT02381392|18759935|P2|COMPLETED|Overall Study||12
7619244|NCT02381392|18759936|P1|COMPLETED|Overall Study||11
7619245|NCT02381392|18759935|P2|STARTED|Overall Study||12
7619246|NCT02381392|18759936|P1|STARTED|Overall Study||11
7619247|NCT02381288|18759954|P4|NOT COMPLETED|Overall Study||0
7619248|NCT02381288|18759955|P3|NOT COMPLETED|Overall Study||0
7619249|NCT02381288|18759956|P2|NOT COMPLETED|Overall Study||0
7619250|NCT02381288|18759957|P1|NOT COMPLETED|Overall Study||0
7619251|NCT02381288|18759954|P4|COMPLETED|Overall Study||5
7619252|NCT02381288|18759955|P3|COMPLETED|Overall Study||5
7619253|NCT02381288|18759956|P2|COMPLETED|Overall Study||2
7619254|NCT02381288|18759957|P1|COMPLETED|Overall Study||5
7619255|NCT02381288|18759954|P4|STARTED|Overall Study||5
7619256|NCT02381288|18759955|P3|STARTED|Overall Study||5
7619257|NCT02381288|18759956|P2|STARTED|Overall Study||2
7619258|NCT02381288|18759957|P1|STARTED|Overall Study||5
7619259|NCT02381015|18759988|P4|NOT COMPLETED|Year 3 Chart Review||51
7619260|NCT02381015|18759989|P3|NOT COMPLETED|Year 3 Chart Review||58
7619261|NCT02381015|18759990|P2|NOT COMPLETED|Year 3 Chart Review||34
7619262|NCT02381015|18759991|P1|NOT COMPLETED|Year 3 Chart Review||47
7619263|NCT02381015|18759988|P4|COMPLETED|Year 3 Chart Review||118
7619264|NCT02381015|18759989|P3|COMPLETED|Year 3 Chart Review||115
7619265|NCT02381015|18759990|P2|COMPLETED|Year 3 Chart Review||134
7619266|NCT02381015|18759991|P1|COMPLETED|Year 3 Chart Review||125
7619267|NCT02381015|18759988|P4|STARTED|Year 3 Chart Review||169
7619268|NCT02381015|18759989|P3|STARTED|Year 3 Chart Review||173
7619269|NCT02381015|18759990|P2|STARTED|Year 3 Chart Review||168
7619270|NCT02381015|18759991|P1|STARTED|Year 3 Chart Review||172
7619271|NCT02381015|18759988|P4|NOT COMPLETED|Visit 3 - 3 Months Followup||0
7619272|NCT02381015|18759989|P3|NOT COMPLETED|Visit 3 - 3 Months Followup||0
7619273|NCT02381015|18759990|P2|NOT COMPLETED|Visit 3 - 3 Months Followup||0
7619274|NCT02381015|18759991|P1|NOT COMPLETED|Visit 3 - 3 Months Followup||0
7619275|NCT02381015|18759988|P4|COMPLETED|Visit 3 - 3 Months Followup||169
7619276|NCT02381015|18759989|P3|COMPLETED|Visit 3 - 3 Months Followup||173
7619277|NCT02381015|18759990|P2|COMPLETED|Visit 3 - 3 Months Followup||168
7619278|NCT02381015|18759991|P1|COMPLETED|Visit 3 - 3 Months Followup||172
7619279|NCT02381015|18759988|P4|STARTED|Visit 3 - 3 Months Followup||169
7619280|NCT02381015|18759989|P3|STARTED|Visit 3 - 3 Months Followup||173
7619281|NCT02381015|18759990|P2|STARTED|Visit 3 - 3 Months Followup||168
7619282|NCT02381015|18759991|P1|STARTED|Visit 3 - 3 Months Followup||172
7619283|NCT02381015|18759988|P4|NOT COMPLETED|Visit 2 - Results DIsclosure||3
7619284|NCT02381015|18759989|P3|NOT COMPLETED|Visit 2 - Results DIsclosure||2
7619285|NCT02381015|18759990|P2|NOT COMPLETED|Visit 2 - Results DIsclosure||5
7619286|NCT02381015|18759991|P1|NOT COMPLETED|Visit 2 - Results DIsclosure||3
7619287|NCT02381015|18759988|P4|COMPLETED|Visit 2 - Results DIsclosure||169
7619288|NCT02381015|18759989|P3|COMPLETED|Visit 2 - Results DIsclosure||173
7619289|NCT02381015|18759990|P2|COMPLETED|Visit 2 - Results DIsclosure||168
7619290|NCT02381015|18759991|P1|COMPLETED|Visit 2 - Results DIsclosure||172
7619291|NCT02381015|18759988|P4|STARTED|Visit 2 - Results DIsclosure||172
7619292|NCT02381015|18759989|P3|STARTED|Visit 2 - Results DIsclosure||175
7619293|NCT02381015|18759990|P2|STARTED|Visit 2 - Results DIsclosure||173
7619294|NCT02381015|18759991|P1|STARTED|Visit 2 - Results DIsclosure||175
7619295|NCT02381015|18759988|P4|NOT COMPLETED|Visit 1 - Enrollment||3
7619296|NCT02381015|18759989|P3|NOT COMPLETED|Visit 1 - Enrollment||0
7619297|NCT02381015|18759990|P2|NOT COMPLETED|Visit 1 - Enrollment||2
7619298|NCT02381015|18759991|P1|NOT COMPLETED|Visit 1 - Enrollment||0
7619299|NCT02381015|18759988|P4|COMPLETED|Visit 1 - Enrollment||172
7619300|NCT02381015|18759989|P3|COMPLETED|Visit 1 - Enrollment||175
7619301|NCT02381015|18759990|P2|COMPLETED|Visit 1 - Enrollment||173
7619302|NCT02381015|18759991|P1|COMPLETED|Visit 1 - Enrollment||175
7619303|NCT02381015|18759988|P4|STARTED|Visit 1 - Enrollment||175
7619304|NCT02381015|18759989|P3|STARTED|Visit 1 - Enrollment||175
7619305|NCT02381015|18759990|P2|STARTED|Visit 1 - Enrollment||175
7619306|NCT02381015|18759991|P1|STARTED|Visit 1 - Enrollment||175
7619307|NCT02380859|18760023|P2|NOT COMPLETED|Overall Study||0
7619308|NCT02380859|18760024|P1|NOT COMPLETED|Overall Study||2
7619309|NCT02380859|18760023|P2|COMPLETED|Overall Study||13
7619310|NCT02380859|18760024|P1|COMPLETED|Overall Study||17
7619311|NCT02380859|18760023|P2|STARTED|Overall Study||13
7619312|NCT02380859|18760024|P1|STARTED|Overall Study||19
7619313|NCT02380742|18760060|P2|NOT COMPLETED|Overall Study||0
7619314|NCT02380742|18760061|P1|NOT COMPLETED|Overall Study||1
7619315|NCT02380742|18760060|P2|COMPLETED|Overall Study||26
7619316|NCT02380742|18760061|P1|COMPLETED|Overall Study||27
7619317|NCT02380742|18760060|P2|STARTED|Overall Study||26
7619318|NCT02380742|18760061|P1|STARTED|Overall Study||28
7619319|NCT02380703|18760075|P2|NOT COMPLETED|Overall Study||36
7619320|NCT02380703|18760076|P1|NOT COMPLETED|Overall Study||36
7619321|NCT02380703|18760075|P2|COMPLETED|Overall Study||78
7619322|NCT02380703|18760076|P1|COMPLETED|Overall Study||78
7619323|NCT02380703|18760075|P2|Month 12|Overall Study||100
7619324|NCT02380703|18760076|P1|Month 12|Overall Study||99
7619325|NCT02380703|18760075|P2|Month 6|Overall Study||107
7619326|NCT02380703|18760076|P1|Month 6|Overall Study||102
7619327|NCT02380703|18760075|P2|Month 3|Overall Study||109
7619328|NCT02380703|18760076|P1|Month 3|Overall Study||104
7619329|NCT02380703|18760075|P2|STARTED|Overall Study||114
7619330|NCT02380703|18760076|P1|STARTED|Overall Study||114
7619331|NCT02380690|18760098|P2|NOT COMPLETED|Overall Study||12
7619332|NCT02380690|18760099|P1|NOT COMPLETED|Overall Study||34
7619333|NCT02380690|18760098|P2|COMPLETED|Overall Study||82
7619334|NCT02380690|18760099|P1|COMPLETED|Overall Study||85
7619335|NCT02380690|18760098|P2|STARTED|Overall Study||94
7619336|NCT02380690|18760099|P1|STARTED|Overall Study||119
7619337|NCT02380677|18760147|P12|NOT COMPLETED|Overall Study||5
7619338|NCT02380677|18760148|P11|NOT COMPLETED|Overall Study||4
7619339|NCT02380677|18760149|P10|NOT COMPLETED|Overall Study||2
7619340|NCT02380677|18760150|P9|NOT COMPLETED|Overall Study||4
7619341|NCT02380677|18760151|P8|NOT COMPLETED|Overall Study||4
7619342|NCT02380677|18760152|P7|NOT COMPLETED|Overall Study||3
7619343|NCT02380677|18760153|P6|NOT COMPLETED|Overall Study||6
7619344|NCT02380677|18760154|P5|NOT COMPLETED|Overall Study||6
7619345|NCT02380677|18760155|P4|NOT COMPLETED|Overall Study||3
7619346|NCT02380677|18760156|P3|NOT COMPLETED|Overall Study||3
7619347|NCT02380677|18760157|P2|NOT COMPLETED|Overall Study||1
7619348|NCT02380677|18760158|P1|NOT COMPLETED|Overall Study||1
7619349|NCT02380677|18760147|P12|COMPLETED|Overall Study||0
7619350|NCT02380677|18760148|P11|COMPLETED|Overall Study||0
7619351|NCT02380677|18760149|P10|COMPLETED|Overall Study||0
7619352|NCT02380677|18760150|P9|COMPLETED|Overall Study||0
7619353|NCT02380677|18760151|P8|COMPLETED|Overall Study||0
7619354|NCT02380677|18760152|P7|COMPLETED|Overall Study||0
7619355|NCT02380677|18760153|P6|COMPLETED|Overall Study||0
7619356|NCT02380677|18760154|P5|COMPLETED|Overall Study||0
7619357|NCT02380677|18760155|P4|COMPLETED|Overall Study||0
7619358|NCT02380677|18760156|P3|COMPLETED|Overall Study||0
7619359|NCT02380677|18760157|P2|COMPLETED|Overall Study||0
7619360|NCT02380677|18760158|P1|COMPLETED|Overall Study||0
7619361|NCT02380677|18760147|P12|STARTED|Overall Study||5
7619362|NCT02380677|18760148|P11|STARTED|Overall Study||4
7619363|NCT02380677|18760149|P10|STARTED|Overall Study||2
7619364|NCT02380677|18760150|P9|STARTED|Overall Study||4
7619365|NCT02380677|18760151|P8|STARTED|Overall Study||4
7619366|NCT02380677|18760152|P7|STARTED|Overall Study||3
7619367|NCT02380677|18760153|P6|STARTED|Overall Study||6
7619368|NCT02380677|18760154|P5|STARTED|Overall Study||6
7619369|NCT02380677|18760155|P4|STARTED|Overall Study||3
7619370|NCT02380677|18760156|P3|STARTED|Overall Study||3
7619371|NCT02380677|18760157|P2|STARTED|Overall Study||1
7619372|NCT02380677|18760158|P1|STARTED|Overall Study||1
7619373|NCT02380287|18760214|P8|NOT COMPLETED|Overall Study||0
7619374|NCT02380287|18760215|P7|NOT COMPLETED|Overall Study||0
7619375|NCT02380287|18760216|P6|NOT COMPLETED|Overall Study||0
7619376|NCT02380287|18760217|P5|NOT COMPLETED|Overall Study||0
7619377|NCT02380287|18760218|P4|NOT COMPLETED|Overall Study||0
7619378|NCT02380287|18760219|P3|NOT COMPLETED|Overall Study||1
7619379|NCT02380287|18760220|P2|NOT COMPLETED|Overall Study||0
7619380|NCT02380287|18760221|P1|NOT COMPLETED|Overall Study||0
7619381|NCT02380287|18760214|P8|COMPLETED|Overall Study||3
7619382|NCT02380287|18760215|P7|COMPLETED|Overall Study||3
7619383|NCT02380287|18760216|P6|COMPLETED|Overall Study||3
7619384|NCT02380287|18760217|P5|COMPLETED|Overall Study||3
7619385|NCT02380287|18760218|P4|COMPLETED|Overall Study||3
7619386|NCT02380287|18760219|P3|COMPLETED|Overall Study||2
7619387|NCT02380287|18760220|P2|COMPLETED|Overall Study||3
7619388|NCT02380287|18760221|P1|COMPLETED|Overall Study||1
7619389|NCT02380287|18760214|P8|STARTED|Overall Study||3
7619390|NCT02380287|18760215|P7|STARTED|Overall Study||3
7619391|NCT02380287|18760216|P6|STARTED|Overall Study||3
7619392|NCT02380287|18760217|P5|STARTED|Overall Study||3
7619393|NCT02380287|18760218|P4|STARTED|Overall Study||3
7619394|NCT02380287|18760219|P3|STARTED|Overall Study||3
7619395|NCT02380287|18760220|P2|STARTED|Overall Study||3
7619396|NCT02380287|18760221|P1|STARTED|Overall Study||1
7619397|NCT02380261|18760232|P1|NOT COMPLETED|Overall Study||0
7619398|NCT02380261|18760232|P1|COMPLETED|Overall Study||35
7619399|NCT02380261|18760232|P1|STARTED|Overall Study||35
7619400|NCT02380248|18760237|P1|NOT COMPLETED|Overall Study||14
7619401|NCT02380248|18760237|P1|COMPLETED|Overall Study||186
7619402|NCT02380248|18760237|P1|STARTED|Overall Study||200
7619403|NCT02380183|18760244|P2|NOT COMPLETED|Overall Study||0
7619404|NCT02380183|18760245|P1|NOT COMPLETED|Overall Study||0
7619405|NCT02380183|18760244|P2|COMPLETED|Overall Study||34
7619406|NCT02380183|18760245|P1|COMPLETED|Overall Study||36
7619407|NCT02380183|18760244|P2|STARTED|Overall Study||34
7619408|NCT02380183|18760245|P1|STARTED|Overall Study||36
7619409|NCT02379923|18760253|P1|NOT COMPLETED|Overall Study||5
7619410|NCT02379923|18760253|P1|COMPLETED|Overall Study||158
7619411|NCT02379923|18760253|P1|STARTED|Overall Study||163
7619412|NCT02379858|18760269|P2|NOT COMPLETED|Overall Study||0
7619413|NCT02379858|18760270|P1|NOT COMPLETED|Overall Study||0
7619414|NCT02379858|18760269|P2|COMPLETED|Overall Study||4
7619415|NCT02379858|18760270|P1|COMPLETED|Overall Study||6
7619416|NCT02379858|18760269|P2|STARTED|Overall Study||4
7619417|NCT02379858|18760270|P1|STARTED|Overall Study||6
7619418|NCT02379728|18760282|P4|NOT COMPLETED|Overall Study||3
7619419|NCT02379728|18760283|P3|NOT COMPLETED|Overall Study||10
7619420|NCT02379728|18760284|P2|NOT COMPLETED|Overall Study||0
7619421|NCT02379728|18760285|P1|NOT COMPLETED|Overall Study||6
7619422|NCT02379728|18760282|P4|COMPLETED|Overall Study||13
7619423|NCT02379728|18760283|P3|COMPLETED|Overall Study||74
7619424|NCT02379728|18760284|P2|COMPLETED|Overall Study||16
7619425|NCT02379728|18760285|P1|COMPLETED|Overall Study||78
7619426|NCT02379728|18760282|P4|STARTED|Overall Study||16
7619427|NCT02379728|18760283|P3|STARTED|Overall Study||84
7619428|NCT02379728|18760284|P2|STARTED|Overall Study||16
7619429|NCT02379728|18760285|P1|STARTED|Overall Study||84
7619430|NCT02379637|18760341|P2|NOT COMPLETED|Overall Study||1
7619431|NCT02379637|18760342|P1|NOT COMPLETED|Overall Study||2
7619432|NCT02379637|18760341|P2|COMPLETED|Overall Study||34
7619433|NCT02379637|18760342|P1|COMPLETED|Overall Study||33
7619434|NCT02379637|18760341|P2|STARTED|Overall Study||35
7619435|NCT02379637|18760342|P1|STARTED|Overall Study||35
7619436|NCT02379585|18760352|P2|NOT COMPLETED|Overall Study||5
7619437|NCT02379585|18760353|P1|NOT COMPLETED|Overall Study||3
7619438|NCT02379585|18760352|P2|COMPLETED|Overall Study||0
7619439|NCT02379585|18760353|P1|COMPLETED|Overall Study||0
7619440|NCT02379585|18760352|P2|STARTED|Overall Study||5
7619441|NCT02379585|18760353|P1|STARTED|Overall Study||3
7619442|NCT02379442|18760375|P1|NOT COMPLETED|Overall Study||0
7619443|NCT02379442|18760375|P1|COMPLETED|Overall Study||1
7619444|NCT02379442|18760375|P1|STARTED|Overall Study||1
7619445|NCT02379390|18760381|P2|NOT COMPLETED|Overall Study||2
7619446|NCT02379390|18760382|P1|NOT COMPLETED|Overall Study||2
7619447|NCT02379390|18760381|P2|COMPLETED|Overall Study||2
7619448|NCT02379390|18760382|P1|COMPLETED|Overall Study||2
7619449|NCT02379390|18760381|P2|STARTED|Overall Study||4
7619450|NCT02379390|18760382|P1|STARTED|Overall Study||4
7619451|NCT02379221|18760410|P1|NOT COMPLETED|Overall Study||1
7619452|NCT02379221|18760410|P1|COMPLETED|Overall Study||48
7619453|NCT02379221|18760410|P1|STARTED|Overall Study||49
7619454|NCT02379195|18760425|P1|NOT COMPLETED|Overall Study||0
7619455|NCT02379195|18760425|P1|COMPLETED|Overall Study||12
7619456|NCT02379195|18760425|P1|STARTED|Overall Study||12
7619457|NCT02379117|18760435|P2|NOT COMPLETED|Overall Study||0
7619458|NCT02379117|18760436|P1|NOT COMPLETED|Overall Study||0
7619459|NCT02379117|18760435|P2|COMPLETED|Overall Study||31
7619460|NCT02379117|18760436|P1|COMPLETED|Overall Study||30
7619461|NCT02379117|18760435|P2|STARTED|Overall Study||31
7619462|NCT02379117|18760436|P1|STARTED|Overall Study||30
7619463|NCT02379091|18760446|P4|NOT COMPLETED|Overall Study||14
7619464|NCT02379091|18760447|P3|NOT COMPLETED|Overall Study||7
7619465|NCT02379091|18760448|P2|NOT COMPLETED|Overall Study||10
7619466|NCT02379091|18760449|P1|NOT COMPLETED|Overall Study||12
7619467|NCT02379091|18760446|P4|COMPLETED|Overall Study||14
7619468|NCT02379091|18760447|P3|COMPLETED|Overall Study||18
7619469|NCT02379091|18760448|P2|COMPLETED|Overall Study||18
7619470|NCT02379091|18760449|P1|COMPLETED|Overall Study||15
7619471|NCT02379091|18760446|P4|Full Analysis Set|Overall Study||28
7619472|NCT02379091|18760447|P3|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|24
7619473|NCT02379091|18760448|P2|Full Analysis Set|Overall Study||28
7619474|NCT02379091|18760449|P1|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|26
7619475|NCT02379091|18760446|P4|STARTED|Overall Study||28
7619476|NCT02379091|18760447|P3|STARTED|Overall Study||25
7619477|NCT02379091|18760448|P2|STARTED|Overall Study||28
7619478|NCT02379091|18760449|P1|STARTED|Overall Study||27
7619479|NCT02379078|18760487|P2|NOT COMPLETED|Overall Study||35
7619480|NCT02379078|18760488|P1|NOT COMPLETED|Overall Study||39
7619481|NCT02379078|18760487|P2|COMPLETED|Overall Study||79
7619482|NCT02379078|18760488|P1|COMPLETED|Overall Study||72
7619483|NCT02379078|18760487|P2|STARTED|Overall Study||114
7619484|NCT02379078|18760488|P1|STARTED|Overall Study||111
7619485|NCT02379052|18760504|P2|NOT COMPLETED|Overall Study||5
7619486|NCT02379052|18760505|P1|NOT COMPLETED|Overall Study||6
7619487|NCT02379052|18760504|P2|COMPLETED|Overall Study||18
7619488|NCT02379052|18760505|P1|COMPLETED|Overall Study||18
7619489|NCT02379052|18760504|P2|STARTED|Overall Study||23
7619490|NCT02379052|18760505|P1|STARTED|Overall Study||24
7619491|NCT02378961|18760547|P4|NOT COMPLETED|Overall Study||1
7619492|NCT02378961|18760548|P3|NOT COMPLETED|Overall Study||1
7619493|NCT02378961|18760549|P2|NOT COMPLETED|Overall Study||2
7619494|NCT02378961|18760550|P1|NOT COMPLETED|Overall Study||4
7619495|NCT02378961|18760547|P4|COMPLETED|Overall Study||28
7619496|NCT02378961|18760548|P3|COMPLETED|Overall Study||35
7619497|NCT02378961|18760549|P2|COMPLETED|Overall Study||28
7619498|NCT02378961|18760550|P1|COMPLETED|Overall Study||29
7619499|NCT02378961|18760547|P4|STARTED|Overall Study||29
7619500|NCT02378961|18760548|P3|STARTED|Overall Study||36
7619501|NCT02378961|18760549|P2|STARTED|Overall Study||30
7619502|NCT02378961|18760550|P1|STARTED|Overall Study||33
7619503|NCT02378935|18760587|P7|NOT COMPLETED|Overall Study||0
7619504|NCT02378935|18760588|P6|NOT COMPLETED|Overall Study||0
7619505|NCT02378935|18760589|P5|NOT COMPLETED|Overall Study||0
7619506|NCT02378935|18760590|P4|NOT COMPLETED|Overall Study||6
7619507|NCT02378935|18760591|P3|NOT COMPLETED|Overall Study||3
7619508|NCT02378935|18760592|P2|NOT COMPLETED|Overall Study||0
7619509|NCT02378935|18760593|P1|NOT COMPLETED|Overall Study||10
7619510|NCT02378935|18760587|P7|COMPLETED|Overall Study||8
7619511|NCT02378935|18760588|P6|COMPLETED|Overall Study||32
7619512|NCT02378935|18760589|P5|COMPLETED|Overall Study||31
7619513|NCT02378935|18760590|P4|COMPLETED|Overall Study||25
7619514|NCT02378935|18760591|P3|COMPLETED|Overall Study||30
7619515|NCT02378935|18760592|P2|COMPLETED|Overall Study||36
7619516|NCT02378935|18760593|P1|COMPLETED|Overall Study||24
7619517|NCT02378935|18760587|P7|STARTED|Overall Study||8
7619518|NCT02378935|18760588|P6|STARTED|Overall Study||32
7619519|NCT02378935|18760589|P5|STARTED|Overall Study||31
7619520|NCT02378935|18760590|P4|STARTED|Overall Study||31
7619521|NCT02378935|18760591|P3|STARTED|Overall Study||33
7619522|NCT02378935|18760592|P2|STARTED|Overall Study||36
7619523|NCT02378935|18760593|P1|STARTED|Overall Study||34
7619524|NCT02378883|18760644|P1|NOT COMPLETED|12 Months Follow-Up||5
7619525|NCT02378883|18760644|P1|COMPLETED|12 Months Follow-Up||41
7619526|NCT02378883|18760644|P1|STARTED|12 Months Follow-Up|Two deaths occurred between 30 day FU and prior to 12 month FU.|46
7619527|NCT02378883|18760644|P1|NOT COMPLETED|30 Day Follow-Up||6
7619528|NCT02378883|18760644|P1|COMPLETED|30 Day Follow-Up||106
7619529|NCT02378883|18760644|P1|STARTED|30 Day Follow-Up||112
7619530|NCT02378883|18760644|P1|NOT COMPLETED|Discharge||0
7619531|NCT02378883|18760644|P1|COMPLETED|Discharge||112
7619532|NCT02378883|18760644|P1|STARTED|Discharge||112
7619533|NCT02378883|18760644|P1|NOT COMPLETED|Enrollment||9
7619534|NCT02378883|18760644|P1|COMPLETED|Enrollment|Attempted with study device - intent to treat population|112
7619535|NCT02378883|18760644|P1|STARTED|Enrollment|Participants consented and assessed for eligibility|121
7619536|NCT02378844|18760657|P3|NOT COMPLETED|Open Label Period||0
7619537|NCT02378844|18760658|P2|NOT COMPLETED|Open Label Period||48
7619538|NCT02378844|18760659|P1|NOT COMPLETED|Open Label Period||43
7619539|NCT02378844|18760657|P3|COMPLETED|Open Label Period||0
7619540|NCT02378844|18760658|P2|COMPLETED|Open Label Period||87
7619541|NCT02378844|18760659|P1|COMPLETED|Open Label Period||99
7619542|NCT02378844|18760657|P3|STARTED|Open Label Period||0
7619543|NCT02378844|18760658|P2|STARTED|Open Label Period||135
7619544|NCT02378844|18760659|P1|STARTED|Open Label Period||142
7619545|NCT02378844|18760657|P3|NOT COMPLETED|Randomized Period (Double Blind)||0
7619546|NCT02378844|18760658|P2|NOT COMPLETED|Randomized Period (Double Blind)||32
7619547|NCT02378844|18760659|P1|NOT COMPLETED|Randomized Period (Double Blind)||23
7619548|NCT02378844|18760657|P3|COMPLETED|Randomized Period (Double Blind)||0
7619549|NCT02378844|18760658|P2|COMPLETED|Randomized Period (Double Blind)||135
7619550|NCT02378844|18760659|P1|COMPLETED|Randomized Period (Double Blind)||142
7619551|NCT02378844|18760657|P3|STARTED|Randomized Period (Double Blind)||0
7619552|NCT02378844|18760658|P2|STARTED|Randomized Period (Double Blind)||167
7619553|NCT02378844|18760659|P1|STARTED|Randomized Period (Double Blind)||165
7619554|NCT02378844|18760657|P3|NOT COMPLETED|Run-in Period||136
7619555|NCT02378844|18760658|P2|NOT COMPLETED|Run-in Period||5
7619556|NCT02378844|18760659|P1|NOT COMPLETED|Run-in Period||4
7619557|NCT02378844|18760657|P3|COMPLETED|Run-in Period||0
7619558|NCT02378844|18760658|P2|COMPLETED|Run-in Period||167
7619559|NCT02378844|18760659|P1|COMPLETED|Run-in Period||165
7619560|NCT02378844|18760657|P3|STARTED|Run-in Period||136
7619561|NCT02378844|18760658|P2|STARTED|Run-in Period||172
7619562|NCT02378844|18760659|P1|STARTED|Run-in Period||169
7619563|NCT02378753|18760689|P2|NOT COMPLETED|Overall Study||695
7619564|NCT02378753|18760690|P1|NOT COMPLETED|Overall Study||218
7619565|NCT02378753|18760689|P2|COMPLETED|Overall Study||3637
7619566|NCT02378753|18760690|P1|COMPLETED|Overall Study||4101
7619567|NCT02378753|18760689|P2|STARTED|Overall Study||4332
7619568|NCT02378753|18760690|P1|STARTED|Overall Study||4319
7619569|NCT02378662|18760710|P2|NOT COMPLETED|Overall Study||0
7619570|NCT02378662|18760711|P1|NOT COMPLETED|Overall Study||2
7619571|NCT02378662|18760710|P2|COMPLETED|Overall Study||0
7619572|NCT02378662|18760711|P1|COMPLETED|Overall Study||0
7619573|NCT02378662|18760710|P2|Implantation|Overall Study||0
7619574|NCT02378662|18760711|P1|Implantation|Overall Study||2
7619575|NCT02378662|18760710|P2|Harvesting|Overall Study||0
7619576|NCT02378662|18760711|P1|Harvesting|Overall Study||2
7619577|NCT02378662|18760710|P2|STARTED|Overall Study||0
7619578|NCT02378662|18760711|P1|STARTED|Overall Study||2
7619579|NCT02378506|18760717|P1|NOT COMPLETED|Overall Study||25
7619580|NCT02378506|18760717|P1|COMPLETED|Overall Study||163
7619581|NCT02378506|18760717|P1|Treated|Overall Study||187
7619582|NCT02378506|18760717|P1|STARTED|Overall Study||188
7619583|NCT02378480|18760736|P2|NOT COMPLETED|Overall Study||32
7619584|NCT02378480|18760737|P1|NOT COMPLETED|Overall Study||28
7619585|NCT02378480|18760736|P2|COMPLETED|Overall Study||294
7619586|NCT02378480|18760737|P1|COMPLETED|Overall Study||301
7619587|NCT02378480|18760736|P2|STARTED|Overall Study||326
7619588|NCT02378480|18760737|P1|STARTED|Overall Study||329
7619589|NCT02378402|18760752|P3|NOT COMPLETED|Overall Study||0
7619590|NCT02378402|18760753|P2|NOT COMPLETED|Overall Study||2
7619591|NCT02378402|18760754|P1|NOT COMPLETED|Overall Study||0
7619592|NCT02378402|18760752|P3|COMPLETED|Overall Study||21
7619593|NCT02378402|18760753|P2|COMPLETED|Overall Study||23
7619594|NCT02378402|18760754|P1|COMPLETED|Overall Study||25
7619595|NCT02378402|18760752|P3|STARTED|Overall Study||21
7619596|NCT02378402|18760753|P2|STARTED|Overall Study||25
7619597|NCT02378402|18760754|P1|STARTED|Overall Study||25
7619598|NCT02378220|18760764|P2|NOT COMPLETED|Overall Study||1
7619599|NCT02378220|18760765|P1|NOT COMPLETED|Overall Study||6
7619600|NCT02378220|18760764|P2|COMPLETED|Overall Study||56
7619601|NCT02378220|18760765|P1|COMPLETED|Overall Study||47
7619602|NCT02378220|18760764|P2|STARTED|Overall Study||57
7619603|NCT02378220|18760765|P1|STARTED|Overall Study||53
7619604|NCT02378207|18760799|P4|NOT COMPLETED|Overall Study||1
7619605|NCT02378207|18760800|P3|NOT COMPLETED|Overall Study||2
7619606|NCT02378207|18760801|P2|NOT COMPLETED|Overall Study||3
7619607|NCT02378207|18760802|P1|NOT COMPLETED|Overall Study||0
7619608|NCT02378207|18760799|P4|COMPLETED|Overall Study||11
7619609|NCT02378207|18760800|P3|COMPLETED|Overall Study||22
7619610|NCT02378207|18760801|P2|COMPLETED|Overall Study||21
7619611|NCT02378207|18760802|P1|COMPLETED|Overall Study||24
7619612|NCT02378207|18760799|P4|STARTED|Overall Study||12
7619613|NCT02378207|18760800|P3|STARTED|Overall Study||24
7619614|NCT02378207|18760801|P2|STARTED|Overall Study||24
7619615|NCT02378207|18760802|P1|STARTED|Overall Study||24
7619616|NCT02378038|18760816|P1|NOT COMPLETED|Overall Study||5
7619617|NCT02378038|18760816|P1|COMPLETED|Overall Study||0
7619618|NCT02378038|18760816|P1|STARTED|Overall Study||5
7619619|NCT02378025|18760828|P2|NOT COMPLETED|Overall Study||21
7619620|NCT02378025|18760829|P1|NOT COMPLETED|Overall Study||13
7619621|NCT02378025|18760828|P2|COMPLETED|Overall Study||15
7619622|NCT02378025|18760829|P1|COMPLETED|Overall Study||26
7619623|NCT02378025|18760828|P2|STARTED|Overall Study||36
7619624|NCT02378025|18760829|P1|STARTED|Overall Study||39
7619625|NCT02377986|18760845|P1|NOT COMPLETED|Overall Study||0
7619626|NCT02377986|18760845|P1|COMPLETED|Overall Study||5
7619627|NCT02377986|18760845|P1|STARTED|Overall Study||5
7619628|NCT02377947|18760850|P1|NOT COMPLETED|Overall Study||0
7619629|NCT02377947|18760850|P1|COMPLETED|Overall Study||50
7619630|NCT02377947|18760850|P1|STARTED|Overall Study||50
7619631|NCT02377921|18760863|P2|NOT COMPLETED|Overall Study||1
7619632|NCT02377921|18760864|P1|NOT COMPLETED|Overall Study||1
7619633|NCT02377921|18760863|P2|COMPLETED|Overall Study||43
7619634|NCT02377921|18760864|P1|COMPLETED|Overall Study||44
7619635|NCT02377921|18760863|P2|STARTED|Overall Study||44
7619636|NCT02377921|18760864|P1|STARTED|Overall Study||45
7619637|NCT02377817|18760888|P2|NOT COMPLETED|Overall Study||0
7619638|NCT02377817|18760889|P1|NOT COMPLETED|Overall Study||3
7619639|NCT02377817|18760888|P2|COMPLETED|Overall Study||10
7619640|NCT02377817|18760889|P1|COMPLETED|Overall Study||10
7619641|NCT02377817|18760888|P2|STARTED|Overall Study||10
7619642|NCT02377817|18760889|P1|STARTED|Overall Study||13
7619643|NCT02377700|18760951|P1|NOT COMPLETED|Overall Study||0
7619644|NCT02377700|18760951|P1|COMPLETED|Overall Study||5
7619645|NCT02377700|18760951|P1|STARTED|Overall Study||5
7619646|NCT02377674|18760957|P1|NOT COMPLETED|Overall Study||0
7619647|NCT02377674|18760957|P1|COMPLETED|Overall Study||5
7619648|NCT02377674|18760957|P1|STARTED|Overall Study||5
7619649|NCT02377466|18760964|P2|NOT COMPLETED|Overall Study||2
7619650|NCT02377466|18760965|P1|NOT COMPLETED|Overall Study||0
7619651|NCT02377466|18760964|P2|COMPLETED|Overall Study||10
7619652|NCT02377466|18760965|P1|COMPLETED|Overall Study||13
7619653|NCT02377466|18760964|P2|Treated|Overall Study||10
7619654|NCT02377466|18760965|P1|Treated|Overall Study||13
7619655|NCT02377466|18760964|P2|STARTED|Overall Study||12
7619656|NCT02377466|18760965|P1|STARTED|Overall Study||13
7619657|NCT02377427|18761083|P5|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
7619658|NCT02377427|18761084|P4|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
7619659|NCT02377427|18761085|P3|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||1
7619660|NCT02377427|18761086|P2|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
7619661|NCT02377427|18761087|P1|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
7619662|NCT02377427|18761083|P5|COMPLETED|Part B (From Week 20 and up to Week 80)||4
7619663|NCT02377427|18761084|P4|COMPLETED|Part B (From Week 20 and up to Week 80)||10
7619664|NCT02377427|18761085|P3|COMPLETED|Part B (From Week 20 and up to Week 80)||15
7619665|NCT02377427|18761086|P2|COMPLETED|Part B (From Week 20 and up to Week 80)||0
7619666|NCT02377427|18761087|P1|COMPLETED|Part B (From Week 20 and up to Week 80)||0
7619667|NCT02377427|18761083|P5|STARTED|Part B (From Week 20 and up to Week 80)||4
7619668|NCT02377427|18761084|P4|STARTED|Part B (From Week 20 and up to Week 80)||10
7619669|NCT02377427|18761085|P3|STARTED|Part B (From Week 20 and up to Week 80)|Two participants of PartA chose not to continue in PartB;4 shifted to PartB Mepolizumab 40/100mg arm|16
7619670|NCT02377427|18761086|P2|STARTED|Part B (From Week 20 and up to Week 80)||0
7619671|NCT02377427|18761087|P1|STARTED|Part B (From Week 20 and up to Week 80)||0
7619672|NCT02377427|18761083|P5|NOT COMPLETED|Part A (Up to Week 20)||0
7619673|NCT02377427|18761084|P4|NOT COMPLETED|Part A (Up to Week 20)||0
7619674|NCT02377427|18761085|P3|NOT COMPLETED|Part A (Up to Week 20)||0
7619675|NCT02377427|18761086|P2|NOT COMPLETED|Part A (Up to Week 20)||0
7619676|NCT02377427|18761087|P1|NOT COMPLETED|Part A (Up to Week 20)||4
7619677|NCT02377427|18761083|P5|COMPLETED|Part A (Up to Week 20)||0
7619678|NCT02377427|18761084|P4|COMPLETED|Part A (Up to Week 20)||0
7619679|NCT02377427|18761085|P3|COMPLETED|Part A (Up to Week 20)||0
7619680|NCT02377427|18761086|P2|COMPLETED|Part A (Up to Week 20)||10
7619681|NCT02377427|18761087|P1|COMPLETED|Part A (Up to Week 20)||22
7619682|NCT02377427|18761083|P5|STARTED|Part A (Up to Week 20)||0
7619683|NCT02377427|18761084|P4|STARTED|Part A (Up to Week 20)||0
7619684|NCT02377427|18761085|P3|STARTED|Part A (Up to Week 20)||0
7619685|NCT02377427|18761086|P2|STARTED|Part A (Up to Week 20)||10
7619686|NCT02377427|18761087|P1|STARTED|Part A (Up to Week 20)||26
7619687|NCT02377362|18761160|P13|NOT COMPLETED|Part B Overall||0
7619688|NCT02377362|18761161|P12|NOT COMPLETED|Part B Overall||1
7619689|NCT02377362|18761162|P11|NOT COMPLETED|Part B Overall||0
7619690|NCT02377362|18761163|P10|NOT COMPLETED|Part B Overall||1
7619691|NCT02377362|18761164|P9|NOT COMPLETED|Part B Overall||0
7619692|NCT02377362|18761165|P8|NOT COMPLETED|Part B Overall||1
7619693|NCT02377362|18761166|P7|NOT COMPLETED|Part B Overall||2
7619694|NCT02377362|18761167|P6|NOT COMPLETED|Part B Overall||0
7619695|NCT02377362|18761168|P5|NOT COMPLETED|Part B Overall||0
7619696|NCT02377362|18761169|P4|NOT COMPLETED|Part B Overall||0
7619697|NCT02377362|18761170|P3|NOT COMPLETED|Part B Overall||0
7619698|NCT02377362|18761171|P2|NOT COMPLETED|Part B Overall||0
7619699|NCT02377362|18761172|P1|NOT COMPLETED|Part B Overall||0
7619700|NCT02377362|18761160|P13|COMPLETED|Part B Overall||12
7619701|NCT02377362|18761161|P12|COMPLETED|Part B Overall||6
7619702|NCT02377362|18761162|P11|COMPLETED|Part B Overall||6
7619703|NCT02377362|18761163|P10|COMPLETED|Part B Overall||6
7619704|NCT02377362|18761164|P9|COMPLETED|Part B Overall||6
7619705|NCT02377362|18761165|P8|COMPLETED|Part B Overall||5
7619706|NCT02377362|18761166|P7|COMPLETED|Part B Overall||4
7619707|NCT02377362|18761167|P6|COMPLETED|Part B Overall||0
7619708|NCT02377362|18761168|P5|COMPLETED|Part B Overall||0
7619709|NCT02377362|18761169|P4|COMPLETED|Part B Overall||0
7619710|NCT02377362|18761170|P3|COMPLETED|Part B Overall||0
7619711|NCT02377362|18761171|P2|COMPLETED|Part B Overall||0
7619712|NCT02377362|18761172|P1|COMPLETED|Part B Overall||0
7619713|NCT02377362|18761160|P13|STARTED|Part B Overall||12
7619714|NCT02377362|18761161|P12|STARTED|Part B Overall||7
7619715|NCT02377362|18761162|P11|STARTED|Part B Overall||6
7619716|NCT02377362|18761163|P10|STARTED|Part B Overall||7
7619717|NCT02377362|18761164|P9|STARTED|Part B Overall||6
7619718|NCT02377362|18761165|P8|STARTED|Part B Overall||6
7619719|NCT02377362|18761166|P7|STARTED|Part B Overall||6
7619720|NCT02377362|18761167|P6|STARTED|Part B Overall||0
7619721|NCT02377362|18761168|P5|STARTED|Part B Overall||0
7619722|NCT02377362|18761169|P4|STARTED|Part B Overall||0
7619723|NCT02377362|18761170|P3|STARTED|Part B Overall||0
7619724|NCT02377362|18761171|P2|STARTED|Part B Overall||0
7619725|NCT02377362|18761172|P1|STARTED|Part B Overall||0
7619726|NCT02377362|18761160|P13|NOT COMPLETED|Part A Third Treatment||0
7619727|NCT02377362|18761161|P12|NOT COMPLETED|Part A Third Treatment||0
7619728|NCT02377362|18761162|P11|NOT COMPLETED|Part A Third Treatment||0
7619729|NCT02377362|18761163|P10|NOT COMPLETED|Part A Third Treatment||0
7619730|NCT02377362|18761164|P9|NOT COMPLETED|Part A Third Treatment||0
7619731|NCT02377362|18761165|P8|NOT COMPLETED|Part A Third Treatment||0
7619732|NCT02377362|18761166|P7|NOT COMPLETED|Part A Third Treatment||0
7619733|NCT02377362|18761167|P6|NOT COMPLETED|Part A Third Treatment||4
7619734|NCT02377362|18761168|P5|NOT COMPLETED|Part A Third Treatment||3
7619735|NCT02377362|18761169|P4|NOT COMPLETED|Part A Third Treatment||4
7619736|NCT02377362|18761170|P3|NOT COMPLETED|Part A Third Treatment||0
7619737|NCT02377362|18761171|P2|NOT COMPLETED|Part A Third Treatment||0
7619738|NCT02377362|18761172|P1|NOT COMPLETED|Part A Third Treatment||0
7619739|NCT02377362|18761160|P13|COMPLETED|Part A Third Treatment||0
7619740|NCT02377362|18761161|P12|COMPLETED|Part A Third Treatment||0
7619741|NCT02377362|18761162|P11|COMPLETED|Part A Third Treatment||0
7619742|NCT02377362|18761163|P10|COMPLETED|Part A Third Treatment||0
7619743|NCT02377362|18761164|P9|COMPLETED|Part A Third Treatment||0
7619744|NCT02377362|18761165|P8|COMPLETED|Part A Third Treatment||0
7619745|NCT02377362|18761166|P7|COMPLETED|Part A Third Treatment||0
7619746|NCT02377362|18761167|P6|COMPLETED|Part A Third Treatment||0
7619747|NCT02377362|18761168|P5|COMPLETED|Part A Third Treatment||0
7619748|NCT02377362|18761169|P4|COMPLETED|Part A Third Treatment||0
7619749|NCT02377362|18761170|P3|COMPLETED|Part A Third Treatment||4
7619750|NCT02377362|18761171|P2|COMPLETED|Part A Third Treatment||4
7619751|NCT02377362|18761172|P1|COMPLETED|Part A Third Treatment||4
7619752|NCT02377362|18761160|P13|STARTED|Part A Third Treatment||0
7619753|NCT02377362|18761161|P12|STARTED|Part A Third Treatment||0
7619754|NCT02377362|18761162|P11|STARTED|Part A Third Treatment||0
7619755|NCT02377362|18761163|P10|STARTED|Part A Third Treatment||0
7619756|NCT02377362|18761164|P9|STARTED|Part A Third Treatment||0
7619757|NCT02377362|18761165|P8|STARTED|Part A Third Treatment||0
7619758|NCT02377362|18761166|P7|STARTED|Part A Third Treatment||0
7619759|NCT02377362|18761167|P6|STARTED|Part A Third Treatment||4
7619760|NCT02377362|18761168|P5|STARTED|Part A Third Treatment||3
7619761|NCT02377362|18761169|P4|STARTED|Part A Third Treatment||4
7619762|NCT02377362|18761170|P3|STARTED|Part A Third Treatment||4
7619763|NCT02377362|18761171|P2|STARTED|Part A Third Treatment||4
7619764|NCT02377362|18761172|P1|STARTED|Part A Third Treatment||4
7619765|NCT02377362|18761160|P13|NOT COMPLETED|Part A Second Treatment||0
7619766|NCT02377362|18761161|P12|NOT COMPLETED|Part A Second Treatment||0
7619767|NCT02377362|18761162|P11|NOT COMPLETED|Part A Second Treatment||0
7619768|NCT02377362|18761163|P10|NOT COMPLETED|Part A Second Treatment||0
7619769|NCT02377362|18761164|P9|NOT COMPLETED|Part A Second Treatment||0
7619770|NCT02377362|18761165|P8|NOT COMPLETED|Part A Second Treatment||0
7619771|NCT02377362|18761166|P7|NOT COMPLETED|Part A Second Treatment||0
7619772|NCT02377362|18761167|P6|NOT COMPLETED|Part A Second Treatment||0
7619773|NCT02377362|18761168|P5|NOT COMPLETED|Part A Second Treatment||1
7619774|NCT02377362|18761169|P4|NOT COMPLETED|Part A Second Treatment||0
7619775|NCT02377362|18761170|P3|NOT COMPLETED|Part A Second Treatment||0
7619776|NCT02377362|18761171|P2|NOT COMPLETED|Part A Second Treatment||0
7619777|NCT02377362|18761172|P1|NOT COMPLETED|Part A Second Treatment||0
7619778|NCT02377362|18761160|P13|COMPLETED|Part A Second Treatment||0
7619779|NCT02377362|18761161|P12|COMPLETED|Part A Second Treatment||0
7619780|NCT02377362|18761162|P11|COMPLETED|Part A Second Treatment||0
7619781|NCT02377362|18761163|P10|COMPLETED|Part A Second Treatment||0
7619782|NCT02377362|18761164|P9|COMPLETED|Part A Second Treatment||0
7619783|NCT02377362|18761165|P8|COMPLETED|Part A Second Treatment||0
7619784|NCT02377362|18761166|P7|COMPLETED|Part A Second Treatment||0
7619785|NCT02377362|18761167|P6|COMPLETED|Part A Second Treatment||4
7619786|NCT02377362|18761168|P5|COMPLETED|Part A Second Treatment||3
7619787|NCT02377362|18761169|P4|COMPLETED|Part A Second Treatment||4
7619788|NCT02377362|18761170|P3|COMPLETED|Part A Second Treatment||4
7619789|NCT02377362|18761171|P2|COMPLETED|Part A Second Treatment||4
7619790|NCT02377362|18761172|P1|COMPLETED|Part A Second Treatment||4
7619791|NCT02377362|18761160|P13|STARTED|Part A Second Treatment||0
7619792|NCT02377362|18761161|P12|STARTED|Part A Second Treatment||0
7619793|NCT02377362|18761162|P11|STARTED|Part A Second Treatment||0
7619794|NCT02377362|18761163|P10|STARTED|Part A Second Treatment||0
7619795|NCT02377362|18761164|P9|STARTED|Part A Second Treatment||0
7619796|NCT02377362|18761165|P8|STARTED|Part A Second Treatment||0
7619797|NCT02377362|18761166|P7|STARTED|Part A Second Treatment||0
7619798|NCT02377362|18761167|P6|STARTED|Part A Second Treatment||4
7619799|NCT02377362|18761168|P5|STARTED|Part A Second Treatment||4
7619800|NCT02377362|18761169|P4|STARTED|Part A Second Treatment||4
7619801|NCT02377362|18761170|P3|STARTED|Part A Second Treatment||4
7619802|NCT02377362|18761171|P2|STARTED|Part A Second Treatment||4
7619803|NCT02377362|18761172|P1|STARTED|Part A Second Treatment||4
7619804|NCT02377362|18761160|P13|NOT COMPLETED|Part A First Treatment||0
7619805|NCT02377362|18761161|P12|NOT COMPLETED|Part A First Treatment||0
7619806|NCT02377362|18761162|P11|NOT COMPLETED|Part A First Treatment||0
7619807|NCT02377362|18761163|P10|NOT COMPLETED|Part A First Treatment||0
7619808|NCT02377362|18761164|P9|NOT COMPLETED|Part A First Treatment||0
7619809|NCT02377362|18761165|P8|NOT COMPLETED|Part A First Treatment||0
7619810|NCT02377362|18761166|P7|NOT COMPLETED|Part A First Treatment||0
7619811|NCT02377362|18761167|P6|NOT COMPLETED|Part A First Treatment||0
7619812|NCT02377362|18761168|P5|NOT COMPLETED|Part A First Treatment||0
7619813|NCT02377362|18761169|P4|NOT COMPLETED|Part A First Treatment||0
7619814|NCT02377362|18761170|P3|NOT COMPLETED|Part A First Treatment||0
7619815|NCT02377362|18761171|P2|NOT COMPLETED|Part A First Treatment||0
7619816|NCT02377362|18761172|P1|NOT COMPLETED|Part A First Treatment||0
7619817|NCT02377362|18761160|P13|COMPLETED|Part A First Treatment||0
7619818|NCT02377362|18761161|P12|COMPLETED|Part A First Treatment||0
7619819|NCT02377362|18761162|P11|COMPLETED|Part A First Treatment||0
7619820|NCT02377362|18761163|P10|COMPLETED|Part A First Treatment||0
7619821|NCT02377362|18761164|P9|COMPLETED|Part A First Treatment||0
7619822|NCT02377362|18761165|P8|COMPLETED|Part A First Treatment||0
7619823|NCT02377362|18761166|P7|COMPLETED|Part A First Treatment||0
7619824|NCT02377362|18761167|P6|COMPLETED|Part A First Treatment||4
7619825|NCT02377362|18761168|P5|COMPLETED|Part A First Treatment||4
7619826|NCT02377362|18761169|P4|COMPLETED|Part A First Treatment||4
7619827|NCT02377362|18761170|P3|COMPLETED|Part A First Treatment||4
7619828|NCT02377362|18761171|P2|COMPLETED|Part A First Treatment||4
7619829|NCT02377362|18761172|P1|COMPLETED|Part A First Treatment||4
7619830|NCT02377362|18761160|P13|STARTED|Part A First Treatment||0
7619831|NCT02377362|18761161|P12|STARTED|Part A First Treatment||0
7619832|NCT02377362|18761162|P11|STARTED|Part A First Treatment||0
7619833|NCT02377362|18761163|P10|STARTED|Part A First Treatment||0
7619834|NCT02377362|18761164|P9|STARTED|Part A First Treatment||0
7619835|NCT02377362|18761165|P8|STARTED|Part A First Treatment||0
7619836|NCT02377362|18761166|P7|STARTED|Part A First Treatment||0
7619837|NCT02377362|18761167|P6|STARTED|Part A First Treatment||4
7619838|NCT02377362|18761168|P5|STARTED|Part A First Treatment||4
7619839|NCT02377362|18761169|P4|STARTED|Part A First Treatment||4
7619840|NCT02377362|18761170|P3|STARTED|Part A First Treatment||4
7619841|NCT02377362|18761171|P2|STARTED|Part A First Treatment||4
7619842|NCT02377362|18761172|P1|STARTED|Part A First Treatment||4
7619843|NCT02377349|18761381|P2|NOT COMPLETED|Overall Study||11
7619844|NCT02377349|18761382|P1|NOT COMPLETED|Overall Study||16
7619845|NCT02377349|18761381|P2|COMPLETED|Overall Study||335
7619846|NCT02377349|18761382|P1|COMPLETED|Overall Study||325
7619847|NCT02377349|18761381|P2|STARTED|Overall Study||346
7619848|NCT02377349|18761382|P1|STARTED|Overall Study||341
7619849|NCT02377063|18761420|P1|NOT COMPLETED|Overall Study||5
7619850|NCT02377063|18761420|P1|COMPLETED|Overall Study||20
7619851|NCT02377063|18761420|P1|STARTED|Overall Study||25
7619852|NCT02376998|18761424|P1|NOT COMPLETED|Overall Study||9
7619853|NCT02376998|18761424|P1|COMPLETED|Overall Study||11
7619854|NCT02376998|18761424|P1|STARTED|Overall Study||20
7619855|NCT02376933|18761428|P1|NOT COMPLETED|Overall Study||2
7619856|NCT02376933|18761428|P1|COMPLETED|Overall Study||8
7619857|NCT02376933|18761428|P1|STARTED|Overall Study||10
7619858|NCT02376790|18761438|P3|NOT COMPLETED|Overall Study||53
7619859|NCT02376790|18761439|P2|NOT COMPLETED|Overall Study||47
7619860|NCT02376790|18761440|P1|NOT COMPLETED|Overall Study||60
7619861|NCT02376790|18761438|P3|COMPLETED|Overall Study||230
7619862|NCT02376790|18761439|P2|COMPLETED|Overall Study||237
7619863|NCT02376790|18761440|P1|COMPLETED|Overall Study||224
7619864|NCT02376790|18761438|P3|Received Treatment|Overall Study||282
7619865|NCT02376790|18761439|P2|Received Treatment|Overall Study||284
7619866|NCT02376790|18761440|P1|Received Treatment|Overall Study||282
7619867|NCT02376790|18761438|P3|STARTED|Overall Study||283
7619868|NCT02376790|18761439|P2|STARTED|Overall Study||284
7619869|NCT02376790|18761440|P1|STARTED|Overall Study||284
7619870|NCT02376530|18761560|P4|NOT COMPLETED|Overall Study||0
7619871|NCT02376530|18761561|P3|NOT COMPLETED|Overall Study||0
7619872|NCT02376530|18761562|P2|NOT COMPLETED|Overall Study||0
7619873|NCT02376530|18761563|P1|NOT COMPLETED|Overall Study||0
7619874|NCT02376530|18761560|P4|COMPLETED|Overall Study||197
7619875|NCT02376530|18761561|P3|COMPLETED|Overall Study||197
7619876|NCT02376530|18761562|P2|COMPLETED|Overall Study||198
7619877|NCT02376530|18761563|P1|COMPLETED|Overall Study||196
7619878|NCT02376530|18761560|P4|STARTED|Overall Study||197
7619879|NCT02376530|18761561|P3|STARTED|Overall Study||197
7619880|NCT02376530|18761562|P2|STARTED|Overall Study||198
7619881|NCT02376530|18761563|P1|STARTED|Overall Study||196
7619882|NCT02376283|18761576|P3|NOT COMPLETED|Overall Study||0
7619883|NCT02376283|18761577|P2|NOT COMPLETED|Overall Study||0
7619884|NCT02376283|18761578|P1|NOT COMPLETED|Overall Study||0
7619885|NCT02376283|18761576|P3|COMPLETED|Overall Study||30
7619886|NCT02376283|18761577|P2|COMPLETED|Overall Study||30
7619887|NCT02376283|18761578|P1|COMPLETED|Overall Study||27
7619888|NCT02376283|18761576|P3|STARTED|Overall Study||30
7619889|NCT02376283|18761577|P2|STARTED|Overall Study||30
7619890|NCT02376283|18761578|P1|STARTED|Overall Study||27
7619891|NCT02376257|18761596|P3|NOT COMPLETED|Overall Study||0
7619892|NCT02376257|18761597|P2|NOT COMPLETED|Overall Study||0
7619893|NCT02376257|18761598|P1|NOT COMPLETED|Overall Study||0
7619894|NCT02376257|18761596|P3|COMPLETED|Overall Study||11
7619895|NCT02376257|18761597|P2|COMPLETED|Overall Study||12
7619896|NCT02376257|18761598|P1|COMPLETED|Overall Study||13
7619897|NCT02376257|18761596|P3|STARTED|Overall Study||11
7619898|NCT02376257|18761597|P2|STARTED|Overall Study||12
7619899|NCT02376257|18761598|P1|STARTED|Overall Study||13
7619900|NCT02376179|18761627|P1|NOT COMPLETED|Overall Study||0
7619901|NCT02376179|18761627|P1|COMPLETED|Overall Study||84
7619902|NCT02376179|18761627|P1|STARTED|Overall Study||84
7619903|NCT02376166|18761631|P1|NOT COMPLETED|Overall Study||3
7619904|NCT02376166|18761631|P1|COMPLETED|Overall Study||12
7619905|NCT02376166|18761631|P1|STARTED|Overall Study||15
7619906|NCT02375971|18761659|P3|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
7619907|NCT02375971|18761660|P2|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
7619908|NCT02375971|18761661|P1|NOT COMPLETED|Follow-Up Phase (up to Day 169)||7
7619909|NCT02375971|18761659|P3|COMPLETED|Follow-Up Phase (up to Day 169)||64
7619910|NCT02375971|18761660|P2|COMPLETED|Follow-Up Phase (up to Day 169)||71
7619911|NCT02375971|18761661|P1|COMPLETED|Follow-Up Phase (up to Day 169)||66
7619912|NCT02375971|18761659|P3|STARTED|Follow-Up Phase (up to Day 169)||69
7619913|NCT02375971|18761660|P2|STARTED|Follow-Up Phase (up to Day 169)||76
7619914|NCT02375971|18761661|P1|STARTED|Follow-Up Phase (up to Day 169)||73
7619915|NCT02375971|18761659|P3|NOT COMPLETED|Treatment (Day 1 - Baseline)||5
7619916|NCT02375971|18761660|P2|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
7619917|NCT02375971|18761661|P1|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
7619918|NCT02375971|18761659|P3|COMPLETED|Treatment (Day 1 - Baseline)||69
7619919|NCT02375971|18761660|P2|COMPLETED|Treatment (Day 1 - Baseline)||76
7619920|NCT02375971|18761661|P1|COMPLETED|Treatment (Day 1 - Baseline)||73
7619921|NCT02375971|18761659|P3|PK Set|Treatment (Day 1 - Baseline)||0
7619922|NCT02375971|18761660|P2|PK Set|Treatment (Day 1 - Baseline)||46
7619923|NCT02375971|18761661|P1|PK Set|Treatment (Day 1 - Baseline)||49
7619924|NCT02375971|18761659|P3|VEGF Set|Treatment (Day 1 - Baseline)||51
7619925|NCT02375971|18761660|P2|VEGF Set|Treatment (Day 1 - Baseline)||26
7619926|NCT02375971|18761661|P1|VEGF Set|Treatment (Day 1 - Baseline)||19
7619927|NCT02375971|18761659|P3|Safety Set|Treatment (Day 1 - Baseline)||69
7619928|NCT02375971|18761660|P2|Safety Set|Treatment (Day 1 - Baseline)||76
7619929|NCT02375971|18761661|P1|Safety Set|Treatment (Day 1 - Baseline)||73
7619930|NCT02375971|18761659|P3|STARTED|Treatment (Day 1 - Baseline)||74
7619931|NCT02375971|18761660|P2|STARTED|Treatment (Day 1 - Baseline)||77
7619932|NCT02375971|18761661|P1|STARTED|Treatment (Day 1 - Baseline)||74
7619933|NCT02375724|18761703|P2|NOT COMPLETED|Overall Study||6
7619934|NCT02375724|18761704|P1|NOT COMPLETED|Overall Study||6
7619935|NCT02375724|18761703|P2|COMPLETED|Overall Study||128
7619936|NCT02375724|18761704|P1|COMPLETED|Overall Study||129
7619937|NCT02375724|18761703|P2|STARTED|Overall Study||134
7619938|NCT02375724|18761704|P1|STARTED|Overall Study||135
7619939|NCT02375698|18761716|P2|NOT COMPLETED|Overall Study||2
7619940|NCT02375698|18761717|P1|NOT COMPLETED|Overall Study||2
7619941|NCT02375698|18761716|P2|COMPLETED|Overall Study||4
7619942|NCT02375698|18761717|P1|COMPLETED|Overall Study||14
7619943|NCT02375698|18761716|P2|STARTED|Overall Study||6
7619944|NCT02375698|18761717|P1|STARTED|Overall Study||16
7619945|NCT02375373|18761725|P1|NOT COMPLETED|Overall Study||11
7619946|NCT02375373|18761725|P1|COMPLETED|Overall Study||1
7619947|NCT02375373|18761725|P1|STARTED|Overall Study||12
7619948|NCT02375347|18761729|P1|NOT COMPLETED|Overall Study||1
7619949|NCT02375347|18761729|P1|COMPLETED|Overall Study||12
7619950|NCT02375347|18761729|P1|STARTED|Overall Study||13
7619951|NCT02374957|18761735|P2|NOT COMPLETED|Overall Study||0
7619952|NCT02374957|18761736|P1|NOT COMPLETED|Overall Study||1
7619953|NCT02374957|18761735|P2|COMPLETED|Overall Study||9
7619954|NCT02374957|18761736|P1|COMPLETED|Overall Study||10
7619955|NCT02374957|18761735|P2|STARTED|Overall Study||9
7619956|NCT02374957|18761736|P1|STARTED|Overall Study||11
7619957|NCT02374671|18761765|P3|NOT COMPLETED|Implantation- Nonrandomized & Randomized||3
7619958|NCT02374671|18761766|P2|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
7619959|NCT02374671|18761767|P1|NOT COMPLETED|Implantation- Nonrandomized & Randomized||25
7619960|NCT02374671|18761765|P3|COMPLETED|Implantation- Nonrandomized & Randomized|(1) unilaterally implanted subject discontinued (1 eye)|23
7619961|NCT02374671|18761766|P2|COMPLETED|Implantation- Nonrandomized & Randomized||27
7619962|NCT02374671|18761767|P1|COMPLETED|Implantation- Nonrandomized & Randomized||281
7619963|NCT02374671|18761765|P3|STARTED|Implantation- Nonrandomized & Randomized|(3) subjects were unilaterally implanted|26
7619964|NCT02374671|18761766|P2|STARTED|Implantation- Nonrandomized & Randomized|(1) subject was unilaterally implanted|28
7619965|NCT02374671|18761767|P1|STARTED|Implantation- Nonrandomized & Randomized|(8) subjects were unilaterally implanted|306
7619966|NCT02374671|18761765|P3|NOT COMPLETED|Observation (Deferred Implantation)||5
7619967|NCT02374671|18761766|P2|NOT COMPLETED|Observation (Deferred Implantation)||0
7619968|NCT02374671|18761767|P1|NOT COMPLETED|Observation (Deferred Implantation)||0
7619969|NCT02374671|18761765|P3|COMPLETED|Observation (Deferred Implantation)||26
7619970|NCT02374671|18761766|P2|COMPLETED|Observation (Deferred Implantation)||0
7619971|NCT02374671|18761767|P1|COMPLETED|Observation (Deferred Implantation)||0
7619972|NCT02374671|18761765|P3|STARTED|Observation (Deferred Implantation)||31
7619973|NCT02374671|18761766|P2|STARTED|Observation (Deferred Implantation)||0
7619974|NCT02374671|18761767|P1|STARTED|Observation (Deferred Implantation)||0
7619975|NCT02374593|18761775|P2|NOT COMPLETED|Overall Study||0
7619976|NCT02374593|18761776|P1|NOT COMPLETED|Overall Study||2
7619977|NCT02374593|18761775|P2|COMPLETED|Overall Study||44
7619978|NCT02374593|18761776|P1|COMPLETED|Overall Study||22
7619979|NCT02374593|18761775|P2|STARTED|Overall Study||44
7619980|NCT02374593|18761776|P1|STARTED|Overall Study||24
7619981|NCT02374463|18761788|P2|NOT COMPLETED|Overall Study||3
7619982|NCT02374463|18761789|P1|NOT COMPLETED|Overall Study||3
7619983|NCT02374463|18761788|P2|COMPLETED|Overall Study||9
7619984|NCT02374463|18761789|P1|COMPLETED|Overall Study||12
7619985|NCT02374463|18761788|P2|STARTED|Overall Study||12
7619986|NCT02374463|18761789|P1|STARTED|Overall Study||15
7619987|NCT02374398|18761809|P4|NOT COMPLETED|Overall Study||0
7619988|NCT02374398|18761810|P3|NOT COMPLETED|Overall Study||3
7619989|NCT02374398|18761811|P2|NOT COMPLETED|Overall Study||1
7619990|NCT02374398|18761812|P1|NOT COMPLETED|Overall Study||2
7619991|NCT02374398|18761809|P4|COMPLETED|Overall Study||32
7619992|NCT02374398|18761810|P3|COMPLETED|Overall Study||29
7619993|NCT02374398|18761811|P2|COMPLETED|Overall Study||31
7619994|NCT02374398|18761812|P1|COMPLETED|Overall Study||29
7619995|NCT02374398|18761809|P4|STARTED|Overall Study||32
7619996|NCT02374398|18761810|P3|STARTED|Overall Study||32
7619997|NCT02374398|18761811|P2|STARTED|Overall Study||32
7619998|NCT02374398|18761812|P1|STARTED|Overall Study||31
7619999|NCT02374346|18761838|P1|NOT COMPLETED|Overall Study||48
7620000|NCT02374346|18761838|P1|COMPLETED|Overall Study||446
7620001|NCT02374346|18761838|P1|STARTED|Overall Study||494
7620002|NCT02374307|18761846|P2|NOT COMPLETED|6-months Follow-up||6
7620003|NCT02374307|18761847|P1|NOT COMPLETED|6-months Follow-up||3
7620004|NCT02374307|18761846|P2|COMPLETED|6-months Follow-up||64
7620005|NCT02374307|18761847|P1|COMPLETED|6-months Follow-up||71
7620006|NCT02374307|18761846|P2|STARTED|6-months Follow-up|1 subject missed the first follow-up, but continued the study and was assessed at 6 months.|70
7620007|NCT02374307|18761847|P1|STARTED|6-months Follow-up|5 subjects missed the first follow-up, but continued the study and were assessed at 6 months.|74
7620008|NCT02374307|18761846|P2|NOT COMPLETED|3-months Follow-up||9
7620009|NCT02374307|18761847|P1|NOT COMPLETED|3-months Follow-up||8
7620010|NCT02374307|18761846|P2|COMPLETED|3-months Follow-up||69
7620011|NCT02374307|18761847|P1|COMPLETED|3-months Follow-up||69
7620012|NCT02374307|18761846|P2|STARTED|3-months Follow-up||78
7620013|NCT02374307|18761847|P1|STARTED|3-months Follow-up||77
7620014|NCT02374255|18761878|P4|NOT COMPLETED|Overall Study||0
7620015|NCT02374255|18761879|P3|NOT COMPLETED|Overall Study||0
7620016|NCT02374255|18761880|P2|NOT COMPLETED|Overall Study||0
7620017|NCT02374255|18761881|P1|NOT COMPLETED|Overall Study||2
7620018|NCT02374255|18761878|P4|COMPLETED|Overall Study||11
7620019|NCT02374255|18761879|P3|COMPLETED|Overall Study||11
7620020|NCT02374255|18761880|P2|COMPLETED|Overall Study||110
7620021|NCT02374255|18761881|P1|COMPLETED|Overall Study||153
7620022|NCT02374255|18761878|P4|STARTED|Overall Study||11
7620023|NCT02374255|18761879|P3|STARTED|Overall Study||11
7620024|NCT02374255|18761880|P2|STARTED|Overall Study||110
7620025|NCT02374255|18761881|P1|STARTED|Overall Study||155
7620026|NCT02374164|18761902|P3|NOT COMPLETED|Treatment Period 3||0
7620027|NCT02374164|18761903|P2|NOT COMPLETED|Treatment Period 3||0
7620028|NCT02374164|18761904|P1|NOT COMPLETED|Treatment Period 3||0
7620029|NCT02374164|18761902|P3|COMPLETED|Treatment Period 3||12
7620030|NCT02374164|18761903|P2|COMPLETED|Treatment Period 3||11
7620031|NCT02374164|18761904|P1|COMPLETED|Treatment Period 3||12
7620032|NCT02374164|18761902|P3|STARTED|Treatment Period 3||12
7620033|NCT02374164|18761903|P2|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11
7620034|NCT02374164|18761904|P1|STARTED|Treatment Period 3||12
7620035|NCT02374164|18761902|P3|NOT COMPLETED|Treatment Period 2||0
7620036|NCT02374164|18761903|P2|NOT COMPLETED|Treatment Period 2||0
7620037|NCT02374164|18761904|P1|NOT COMPLETED|Treatment Period 2||0
7620038|NCT02374164|18761902|P3|COMPLETED|Treatment Period 2||12
7620039|NCT02374164|18761903|P2|COMPLETED|Treatment Period 2||12
7620040|NCT02374164|18761904|P1|COMPLETED|Treatment Period 2||12
7620041|NCT02374164|18761902|P3|STARTED|Treatment Period 2||12
7620042|NCT02374164|18761903|P2|STARTED|Treatment Period 2||12
7620043|NCT02374164|18761904|P1|STARTED|Treatment Period 2||12
7620044|NCT02374164|18761902|P3|NOT COMPLETED|Treatment Period 1||0
7620045|NCT02374164|18761903|P2|NOT COMPLETED|Treatment Period 1||0
7620046|NCT02374164|18761904|P1|NOT COMPLETED|Treatment Period 1||0
7620047|NCT02374164|18761902|P3|COMPLETED|Treatment Period 1||12
7620048|NCT02374164|18761903|P2|COMPLETED|Treatment Period 1||12
7620049|NCT02374164|18761904|P1|COMPLETED|Treatment Period 1||12
7620050|NCT02374164|18761902|P3|STARTED|Treatment Period 1||12
7620051|NCT02374164|18761903|P2|STARTED|Treatment Period 1||12
7620052|NCT02374164|18761904|P1|STARTED|Treatment Period 1||12
7620053|NCT02374138|18761923|P2|NOT COMPLETED|Twelve Month FollowUp||12
7620054|NCT02374138|18761924|P1|NOT COMPLETED|Twelve Month FollowUp||9
7620055|NCT02374138|18761923|P2|COMPLETED|Twelve Month FollowUp||95
7620056|NCT02374138|18761924|P1|COMPLETED|Twelve Month FollowUp||101
7620057|NCT02374138|18761923|P2|STARTED|Twelve Month FollowUp||107
7620058|NCT02374138|18761924|P1|STARTED|Twelve Month FollowUp||110
7620059|NCT02374138|18761923|P2|NOT COMPLETED|Six Month Follow Up||14
7620060|NCT02374138|18761924|P1|NOT COMPLETED|Six Month Follow Up||8
7620061|NCT02374138|18761923|P2|COMPLETED|Six Month Follow Up|6 Month Follow Up|93
7620062|NCT02374138|18761924|P1|COMPLETED|Six Month Follow Up|6 Month Follow Up|102
7620063|NCT02374138|18761923|P2|STARTED|Six Month Follow Up||107
7620064|NCT02374138|18761924|P1|STARTED|Six Month Follow Up||110
7620065|NCT02374099|18761982|P2|NOT COMPLETED|Overall Study||49
7620066|NCT02374099|18761983|P1|NOT COMPLETED|Overall Study||48
7620067|NCT02374099|18761982|P2|COMPLETED|Overall Study||0
7620068|NCT02374099|18761983|P1|COMPLETED|Overall Study||0
7620069|NCT02374099|18761982|P2|Participants Treated|Overall Study|1 participant randomized, but not treated|48
7620070|NCT02374099|18761983|P1|Participants Treated|Overall Study|2 participants randomized, but not treated|46
7620071|NCT02374099|18761982|P2|STARTED|Overall Study||49
7620072|NCT02374099|18761983|P1|STARTED|Overall Study||48
7620073|NCT02374060|18762002|P3|NOT COMPLETED|Overall Study||3
7620074|NCT02374060|18762003|P2|NOT COMPLETED|Overall Study||1
7620075|NCT02374060|18762004|P1|NOT COMPLETED|Overall Study||2
7620076|NCT02374060|18762002|P3|COMPLETED|Overall Study||61
7620077|NCT02374060|18762003|P2|COMPLETED|Overall Study||62
7620078|NCT02374060|18762004|P1|COMPLETED|Overall Study||63
7620079|NCT02374060|18762002|P3|STARTED|Overall Study||64
7620080|NCT02374060|18762003|P2|STARTED|Overall Study||63
7620081|NCT02374060|18762004|P1|STARTED|Overall Study||65
7620082|NCT02373865|18762056|P2|NOT COMPLETED|Overall Study||0
7620083|NCT02373865|18762057|P1|NOT COMPLETED|Overall Study||0
7620084|NCT02373865|18762056|P2|COMPLETED|Overall Study||2
7620085|NCT02373865|18762057|P1|COMPLETED|Overall Study||2
7620086|NCT02373865|18762056|P2|STARTED|Overall Study||2
7620087|NCT02373865|18762057|P1|STARTED|Overall Study||2
7620088|NCT02373852|18762067|P1|NOT COMPLETED|Overall Study||1
7620089|NCT02373852|18762067|P1|COMPLETED|Overall Study||11
7620090|NCT02373852|18762067|P1|STARTED|Overall Study|Includes patients from a previous retrospective study NCT01042444|12
7620091|NCT02373813|18762075|P4|NOT COMPLETED|Double-Blind Treatment Period||4
7620092|NCT02373813|18762076|P3|NOT COMPLETED|Double-Blind Treatment Period||9
7620093|NCT02373813|18762077|P2|NOT COMPLETED|Double-Blind Treatment Period||13
7620094|NCT02373813|18762078|P1|NOT COMPLETED|Double-Blind Treatment Period||0
7620095|NCT02373813|18762075|P4|COMPLETED|Double-Blind Treatment Period||47
7620096|NCT02373813|18762076|P3|COMPLETED|Double-Blind Treatment Period||92
7620097|NCT02373813|18762077|P2|COMPLETED|Double-Blind Treatment Period||88
7620098|NCT02373813|18762078|P1|COMPLETED|Double-Blind Treatment Period||0
7620099|NCT02373813|18762075|P4|Received Rescue Treatment|Double-Blind Treatment Period||15
7620100|NCT02373813|18762076|P3|Received Rescue Treatment|Double-Blind Treatment Period||36
7620101|NCT02373813|18762077|P2|Received Rescue Treatment|Double-Blind Treatment Period||52
7620102|NCT02373813|18762078|P1|Received Rescue Treatment|Double-Blind Treatment Period||0
7620103|NCT02373813|18762075|P4|Received Investigational Product (IP)|Double-Blind Treatment Period||51
7620104|NCT02373813|18762076|P3|Received Investigational Product (IP)|Double-Blind Treatment Period||100
7620105|NCT02373813|18762077|P2|Received Investigational Product (IP)|Double-Blind Treatment Period||101
7620106|NCT02373813|18762078|P1|Received Investigational Product (IP)|Double-Blind Treatment Period||0
7620107|NCT02373813|18762075|P4|STARTED|Double-Blind Treatment Period||51
7620108|NCT02373813|18762076|P3|STARTED|Double-Blind Treatment Period||101
7620109|NCT02373813|18762077|P2|STARTED|Double-Blind Treatment Period||101
7620110|NCT02373813|18762078|P1|STARTED|Double-Blind Treatment Period||0
7620111|NCT02373813|18762075|P4|NOT COMPLETED|Run-In Period||0
7620112|NCT02373813|18762076|P3|NOT COMPLETED|Run-In Period||0
7620113|NCT02373813|18762077|P2|NOT COMPLETED|Run-In Period||0
7620114|NCT02373813|18762078|P1|NOT COMPLETED|Run-In Period||116
7620115|NCT02373813|18762075|P4|COMPLETED|Run-In Period||0
7620116|NCT02373813|18762076|P3|COMPLETED|Run-In Period||0
7620117|NCT02373813|18762077|P2|COMPLETED|Run-In Period||0
7620118|NCT02373813|18762078|P1|COMPLETED|Run-In Period|1 participant who completed the run-in period had no end of study case report form.|255
7620119|NCT02373813|18762075|P4|Treated|Run-In Period||0
7620120|NCT02373813|18762076|P3|Treated|Run-In Period||0
7620121|NCT02373813|18762077|P2|Treated|Run-In Period||0
7620122|NCT02373813|18762078|P1|Treated|Run-In Period||368
7620123|NCT02373813|18762075|P4|STARTED|Run-In Period||0
7620124|NCT02373813|18762076|P3|STARTED|Run-In Period||0
7620125|NCT02373813|18762077|P2|STARTED|Run-In Period||0
7620126|NCT02373813|18762078|P1|STARTED|Run-In Period||371
7620127|NCT02373371|18762133|P2|NOT COMPLETED|Overall Study||0
7620128|NCT02373371|18762134|P1|NOT COMPLETED|Overall Study||0
7620129|NCT02373371|18762133|P2|COMPLETED|Overall Study||13
7620130|NCT02373371|18762134|P1|COMPLETED|Overall Study||13
7620131|NCT02373371|18762133|P2|STARTED|Overall Study||13
7620132|NCT02373371|18762134|P1|STARTED|Overall Study||13
7620133|NCT02373202|18762150|P4|NOT COMPLETED|Overall Study||1
7620134|NCT02373202|18762151|P3|NOT COMPLETED|Overall Study||3
7620135|NCT02373202|18762152|P2|NOT COMPLETED|Overall Study||6
7620136|NCT02373202|18762153|P1|NOT COMPLETED|Overall Study||2
7620137|NCT02373202|18762150|P4|COMPLETED|Overall Study||30
7620138|NCT02373202|18762151|P3|COMPLETED|Overall Study||27
7620139|NCT02373202|18762152|P2|COMPLETED|Overall Study||9
7620140|NCT02373202|18762153|P1|COMPLETED|Overall Study||13
7620141|NCT02373202|18762150|P4|STARTED|Overall Study||31
7620142|NCT02373202|18762151|P3|STARTED|Overall Study||30
7620143|NCT02373202|18762152|P2|STARTED|Overall Study||15
7620144|NCT02373202|18762153|P1|STARTED|Overall Study||15
7620145|NCT02373137|18762205|P2|NOT COMPLETED|Overall Study||1
7620146|NCT02373137|18762206|P1|NOT COMPLETED|Overall Study||1
7620147|NCT02373137|18762205|P2|COMPLETED|Overall Study||18
7620148|NCT02373137|18762206|P1|COMPLETED|Overall Study||18
7620149|NCT02373137|18762205|P2|12-Month Follow-Up|Overall Study||19
7620150|NCT02373137|18762206|P1|12-Month Follow-Up|Overall Study||19
7620151|NCT02373137|18762205|P2|6-Month Follow-Up|Overall Study||18
7620152|NCT02373137|18762206|P1|6-Month Follow-Up|Overall Study||19
7620153|NCT02373137|18762205|P2|3-Month Follow-Up|Overall Study||19
7620154|NCT02373137|18762206|P1|3-Month Follow-Up|Overall Study||19
7620155|NCT02373137|18762205|P2|STARTED|Overall Study||19
7620156|NCT02373137|18762206|P1|STARTED|Overall Study||19
7620157|NCT02373124|18762238|P1|NOT COMPLETED|Overall Study||1
7620158|NCT02373124|18762238|P1|COMPLETED|Overall Study||3
7620159|NCT02373124|18762238|P1|STARTED|Overall Study||4
7620160|NCT02373098|18762244|P2|NOT COMPLETED|Overall Study||0
7620161|NCT02373098|18762245|P1|NOT COMPLETED|Overall Study||12
7620162|NCT02373098|18762244|P2|COMPLETED|Overall Study||60
7620163|NCT02373098|18762245|P1|COMPLETED|Overall Study||54
7620164|NCT02373098|18762244|P2|STARTED|Overall Study||60
7620165|NCT02373098|18762245|P1|STARTED|Overall Study||66
7620166|NCT02372799|18762273|P3|NOT COMPLETED|Down-taper Period||2
7620167|NCT02372799|18762274|P2|NOT COMPLETED|Down-taper Period||2
7620168|NCT02372799|18762275|P1|NOT COMPLETED|Down-taper Period||1
7620169|NCT02372799|18762273|P3|COMPLETED|Down-taper Period||80
7620170|NCT02372799|18762274|P2|COMPLETED|Down-taper Period||157
7620171|NCT02372799|18762275|P1|COMPLETED|Down-taper Period||151
7620172|NCT02372799|18762273|P3|STARTED|Down-taper Period||82
7620173|NCT02372799|18762274|P2|STARTED|Down-taper Period||159
7620174|NCT02372799|18762275|P1|STARTED|Down-taper Period||152
7620175|NCT02372799|18762273|P3|NOT COMPLETED|Treatment Period||15
7620176|NCT02372799|18762274|P2|NOT COMPLETED|Treatment Period||32
7620177|NCT02372799|18762275|P1|NOT COMPLETED|Treatment Period||34
7620178|NCT02372799|18762273|P3|COMPLETED|Treatment Period||82
7620179|NCT02372799|18762274|P2|COMPLETED|Treatment Period||155
7620180|NCT02372799|18762275|P1|COMPLETED|Treatment Period||152
7620181|NCT02372799|18762273|P3|STARTED|Treatment Period||97
7620182|NCT02372799|18762274|P2|STARTED|Treatment Period||187
7620183|NCT02372799|18762275|P1|STARTED|Treatment Period||186
7620184|NCT02372682|18762288|P2|NOT COMPLETED|Overall Study||14
7620185|NCT02372682|18762289|P1|NOT COMPLETED|Overall Study||8
7620186|NCT02372682|18762288|P2|COMPLETED|Overall Study||79
7620187|NCT02372682|18762289|P1|COMPLETED|Overall Study||70
7620188|NCT02372682|18762288|P2|STARTED|Overall Study||93
7620189|NCT02372682|18762289|P1|STARTED|Overall Study||78
7620190|NCT02372396|18762304|P2|NOT COMPLETED|Overall Study||9
7620191|NCT02372396|18762305|P1|NOT COMPLETED|Overall Study||7
7620192|NCT02372396|18762304|P2|COMPLETED|Overall Study||11
7620193|NCT02372396|18762305|P1|COMPLETED|Overall Study||10
7620194|NCT02372396|18762304|P2|Began Intervention|Overall Study||14
7620195|NCT02372396|18762305|P1|Began Intervention|Overall Study||14
7620196|NCT02372396|18762304|P2|STARTED|Overall Study||20
7620197|NCT02372396|18762305|P1|STARTED|Overall Study||17
7620198|NCT02372344|18762311|P3|NOT COMPLETED|Period 3 (Visit 4)||0
7620199|NCT02372344|18762312|P2|NOT COMPLETED|Period 3 (Visit 4)||0
7620200|NCT02372344|18762313|P1|NOT COMPLETED|Period 3 (Visit 4)||0
7620201|NCT02372344|18762311|P3|COMPLETED|Period 3 (Visit 4)||14
7620202|NCT02372344|18762312|P2|COMPLETED|Period 3 (Visit 4)||14
7620203|NCT02372344|18762313|P1|COMPLETED|Period 3 (Visit 4)||14
7620204|NCT02372344|18762311|P3|STARTED|Period 3 (Visit 4)||14
7620205|NCT02372344|18762312|P2|STARTED|Period 3 (Visit 4)||14
7620206|NCT02372344|18762313|P1|STARTED|Period 3 (Visit 4)||14
7620207|NCT02372344|18762311|P3|NOT COMPLETED|Period 2 (Visit 3)||0
7620208|NCT02372344|18762312|P2|NOT COMPLETED|Period 2 (Visit 3)||0
7620209|NCT02372344|18762313|P1|NOT COMPLETED|Period 2 (Visit 3)||0
7620210|NCT02372344|18762311|P3|COMPLETED|Period 2 (Visit 3)||14
7620211|NCT02372344|18762312|P2|COMPLETED|Period 2 (Visit 3)||14
7620212|NCT02372344|18762313|P1|COMPLETED|Period 2 (Visit 3)||14
7620213|NCT02372344|18762311|P3|STARTED|Period 2 (Visit 3)||14
7620214|NCT02372344|18762312|P2|STARTED|Period 2 (Visit 3)||14
7620215|NCT02372344|18762313|P1|STARTED|Period 2 (Visit 3)||14
7620216|NCT02372344|18762311|P3|NOT COMPLETED|Period 1 (Visit 2)||0
7620217|NCT02372344|18762312|P2|NOT COMPLETED|Period 1 (Visit 2)||0
7620218|NCT02372344|18762313|P1|NOT COMPLETED|Period 1 (Visit 2)||0
7620219|NCT02372344|18762311|P3|COMPLETED|Period 1 (Visit 2)||14
7620220|NCT02372344|18762312|P2|COMPLETED|Period 1 (Visit 2)||14
7620221|NCT02372344|18762313|P1|COMPLETED|Period 1 (Visit 2)||14
7620222|NCT02372344|18762311|P3|STARTED|Period 1 (Visit 2)||14
7620223|NCT02372344|18762312|P2|STARTED|Period 1 (Visit 2)||14
7620224|NCT02372344|18762313|P1|STARTED|Period 1 (Visit 2)||14
7620225|NCT02372253|18762329|P2|NOT COMPLETED|Overall Study||0
7620226|NCT02372253|18762330|P1|NOT COMPLETED|Overall Study||2
7620227|NCT02372253|18762329|P2|COMPLETED|Overall Study||13
7620228|NCT02372253|18762330|P1|COMPLETED|Overall Study||11
7620229|NCT02372253|18762329|P2|STARTED|Overall Study||13
7620230|NCT02372253|18762330|P1|STARTED|Overall Study||13
7620231|NCT02372097|18762348|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
7620232|NCT02372097|18762349|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
7620233|NCT02372097|18762348|P2|COMPLETED|Second Intervention Period (8 Days)||12
7620234|NCT02372097|18762349|P1|COMPLETED|Second Intervention Period (8 Days)||12
7620235|NCT02372097|18762348|P2|STARTED|Second Intervention Period (8 Days)||12
7620236|NCT02372097|18762349|P1|STARTED|Second Intervention Period (8 Days)||12
7620237|NCT02372097|18762348|P2|NOT COMPLETED|Wash Out Period (13 Days)||0
7620238|NCT02372097|18762349|P1|NOT COMPLETED|Wash Out Period (13 Days)||0
7620239|NCT02372097|18762348|P2|COMPLETED|Wash Out Period (13 Days)||12
7620240|NCT02372097|18762349|P1|COMPLETED|Wash Out Period (13 Days)||12
7620241|NCT02372097|18762348|P2|STARTED|Wash Out Period (13 Days)||12
7620242|NCT02372097|18762349|P1|STARTED|Wash Out Period (13 Days)||12
7620243|NCT02372097|18762348|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
7620244|NCT02372097|18762349|P1|NOT COMPLETED|First Intervention Period (8 Days)||0
7620245|NCT02372097|18762348|P2|COMPLETED|First Intervention Period (8 Days)||12
7620246|NCT02372097|18762349|P1|COMPLETED|First Intervention Period (8 Days)||12
7620247|NCT02372097|18762348|P2|STARTED|First Intervention Period (8 Days)||12
7620248|NCT02372097|18762349|P1|STARTED|First Intervention Period (8 Days)||12
7620249|NCT02372071|18762375|P1|NOT COMPLETED|Overall Study||18
7620250|NCT02372071|18762375|P1|COMPLETED|Overall Study||93
7620251|NCT02372071|18762375|P1|STARTED|Overall Study||111
7620252|NCT02372058|18762380|P1|NOT COMPLETED|Overall Study||3
7620253|NCT02372058|18762380|P1|COMPLETED|Overall Study||100
7620254|NCT02372058|18762380|P1|STARTED|Overall Study||103
7620255|NCT02371980|18762386|P5|NOT COMPLETED|Double-blind Period||58
7620256|NCT02371980|18762387|P4|NOT COMPLETED|Double-blind Period||49
7620257|NCT02371980|18762388|P3|NOT COMPLETED|Double-blind Period||56
7620258|NCT02371980|18762389|P2|NOT COMPLETED|Double-blind Period||81
7620259|NCT02371980|18762390|P1|NOT COMPLETED|Double-blind Period||0
7620260|NCT02371980|18762386|P5|COMPLETED|Double-blind Period||86
7620261|NCT02371980|18762387|P4|COMPLETED|Double-blind Period||96
7620262|NCT02371980|18762388|P3|COMPLETED|Double-blind Period||84
7620263|NCT02371980|18762389|P2|COMPLETED|Double-blind Period||70
7620264|NCT02371980|18762390|P1|COMPLETED|Double-blind Period||0
7620265|NCT02371980|18762386|P5|STARTED|Double-blind Period||144
7620266|NCT02371980|18762387|P4|STARTED|Double-blind Period||145
7620267|NCT02371980|18762388|P3|STARTED|Double-blind Period||140
7620268|NCT02371980|18762389|P2|STARTED|Double-blind Period||151
7620269|NCT02371980|18762390|P1|STARTED|Double-blind Period||0
7620270|NCT02371980|18762386|P5|NOT COMPLETED|Open-label Period||0
7620271|NCT02371980|18762387|P4|NOT COMPLETED|Open-label Period||0
7620272|NCT02371980|18762388|P3|NOT COMPLETED|Open-label Period||0
7620273|NCT02371980|18762389|P2|NOT COMPLETED|Open-label Period||0
7620274|NCT02371980|18762390|P1|NOT COMPLETED|Open-label Period||526
7620275|NCT02371980|18762386|P5|COMPLETED|Open-label Period||0
7620276|NCT02371980|18762387|P4|COMPLETED|Open-label Period||0
7620277|NCT02371980|18762388|P3|COMPLETED|Open-label Period||0
7620278|NCT02371980|18762389|P2|COMPLETED|Open-label Period||0
7620279|NCT02371980|18762390|P1|COMPLETED|Open-label Period||580
7620280|NCT02371980|18762386|P5|STARTED|Open-label Period||0
7620281|NCT02371980|18762387|P4|STARTED|Open-label Period||0
7620282|NCT02371980|18762388|P3|STARTED|Open-label Period||0
7620283|NCT02371980|18762389|P2|STARTED|Open-label Period||0
7620284|NCT02371980|18762390|P1|STARTED|Open-label Period||1106
7620285|NCT02371876|18762417|P1|NOT COMPLETED|Overall Study||0
7620286|NCT02371876|18762417|P1|COMPLETED|Overall Study||134
7620287|NCT02371876|18762417|P1|STARTED|Overall Study||134
7620288|NCT02371850|18762427|P1|NOT COMPLETED|Overall Study||0
7620289|NCT02371850|18762427|P1|COMPLETED|Overall Study||10
7620290|NCT02371850|18762427|P1|STARTED|Overall Study||10
7620291|NCT02371785|18762432|P1|NOT COMPLETED|Overall Study||0
7620292|NCT02371785|18762432|P1|COMPLETED|Overall Study||20
7620293|NCT02371785|18762432|P1|STARTED|Overall Study||20
7620294|NCT02371759|18762450|P8|NOT COMPLETED|Overall Study||4
7620295|NCT02371759|18762451|P7|NOT COMPLETED|Overall Study||0
7620296|NCT02371759|18762452|P6|NOT COMPLETED|Overall Study||1
7620297|NCT02371759|18762453|P5|NOT COMPLETED|Overall Study||3
7620298|NCT02371759|18762454|P4|NOT COMPLETED|Overall Study||0
7620299|NCT02371759|18762455|P3|NOT COMPLETED|Overall Study||1
7620300|NCT02371759|18762456|P2|NOT COMPLETED|Overall Study||1
7620301|NCT02371759|18762457|P1|NOT COMPLETED|Overall Study||3
7620302|NCT02371759|18762450|P8|COMPLETED|Overall Study||24
7620303|NCT02371759|18762451|P7|COMPLETED|Overall Study||25
7620304|NCT02371759|18762452|P6|COMPLETED|Overall Study||25
7620305|NCT02371759|18762453|P5|COMPLETED|Overall Study||24
7620306|NCT02371759|18762454|P4|COMPLETED|Overall Study||31
7620307|NCT02371759|18762455|P3|COMPLETED|Overall Study||32
7620308|NCT02371759|18762456|P2|COMPLETED|Overall Study||30
7620309|NCT02371759|18762457|P1|COMPLETED|Overall Study||29
7620310|NCT02371759|18762450|P8|STARTED|Overall Study||28
7620311|NCT02371759|18762451|P7|STARTED|Overall Study||25
7620312|NCT02371759|18762452|P6|STARTED|Overall Study||26
7620313|NCT02371759|18762453|P5|STARTED|Overall Study||27
7620314|NCT02371759|18762454|P4|STARTED|Overall Study||31
7620315|NCT02371759|18762455|P3|STARTED|Overall Study||33
7620316|NCT02371759|18762456|P2|STARTED|Overall Study||31
7620317|NCT02371759|18762457|P1|STARTED|Overall Study||32
7620318|NCT02371746|18762674|P7|NOT COMPLETED|Overall Study||1
7620319|NCT02371746|18762675|P6|NOT COMPLETED|Overall Study||0
7620320|NCT02371746|18762676|P5|NOT COMPLETED|Overall Study||0
7620321|NCT02371746|18762677|P4|NOT COMPLETED|Overall Study||0
7620322|NCT02371746|18762678|P3|NOT COMPLETED|Overall Study||0
7620323|NCT02371746|18762679|P2|NOT COMPLETED|Overall Study||0
7620324|NCT02371746|18762680|P1|NOT COMPLETED|Overall Study||0
7620325|NCT02371746|18762674|P7|COMPLETED|Overall Study||8
7620326|NCT02371746|18762675|P6|COMPLETED|Overall Study||6
7620327|NCT02371746|18762676|P5|COMPLETED|Overall Study||5
7620328|NCT02371746|18762677|P4|COMPLETED|Overall Study||2
7620329|NCT02371746|18762678|P3|COMPLETED|Overall Study||2
7620330|NCT02371746|18762679|P2|COMPLETED|Overall Study||10
7620331|NCT02371746|18762680|P1|COMPLETED|Overall Study||7
7620332|NCT02371746|18762674|P7|STARTED|Overall Study||9
7620333|NCT02371746|18762675|P6|STARTED|Overall Study||6
7620334|NCT02371746|18762676|P5|STARTED|Overall Study||5
7620335|NCT02371746|18762677|P4|STARTED|Overall Study||2
7620336|NCT02371746|18762678|P3|STARTED|Overall Study||2
7620337|NCT02371746|18762679|P2|STARTED|Overall Study||10
7620338|NCT02371746|18762680|P1|STARTED|Overall Study||7
7620339|NCT02371668|18762698|P2|NOT COMPLETED|Overall Study||0
7620340|NCT02371668|18762699|P1|NOT COMPLETED|Overall Study||0
7620341|NCT02371668|18762698|P2|COMPLETED|Overall Study||42
7620342|NCT02371668|18762699|P1|COMPLETED|Overall Study||49
7620343|NCT02371668|18762698|P2|STARTED|Overall Study||42
7620344|NCT02371668|18762699|P1|STARTED|Overall Study||49
7620345|NCT02371629|18762723|P2|NOT COMPLETED|Overall Study||25
7620346|NCT02371629|18762724|P1|NOT COMPLETED|Overall Study||26
7620347|NCT02371629|18762723|P2|COMPLETED|Overall Study||363
7620348|NCT02371629|18762724|P1|COMPLETED|Overall Study||362
7620349|NCT02371629|18762723|P2|STARTED|Overall Study||388
7620350|NCT02371629|18762724|P1|STARTED|Overall Study||388
7620351|NCT02371616|18762760|P2|NOT COMPLETED|Overall Study||7
7620352|NCT02371616|18762761|P1|NOT COMPLETED|Overall Study||4
7620353|NCT02371616|18762760|P2|COMPLETED|Overall Study||147
7620354|NCT02371616|18762761|P1|COMPLETED|Overall Study||146
7620355|NCT02371616|18762760|P2|STARTED|Overall Study||154
7620356|NCT02371616|18762761|P1|STARTED|Overall Study||150
7620357|NCT02371395|18762773|P1|NOT COMPLETED|Overall Study||0
7620358|NCT02371395|18762773|P1|COMPLETED|Overall Study||1000
7620359|NCT02371395|18762773|P1|STARTED|Overall Study||1000
7620360|NCT02371369|18762779|P2|NOT COMPLETED|Part 2||4
7620361|NCT02371369|18762780|P1|NOT COMPLETED|Part 2||9
7620362|NCT02371369|18762779|P2|COMPLETED|Part 2||26
7620363|NCT02371369|18762780|P1|COMPLETED|Part 2||39
7620364|NCT02371369|18762779|P2|STARTED|Part 2|N=30; Only participants who were eligible to receive treatment in Part 2.|30
7620365|NCT02371369|18762780|P1|STARTED|Part 2|N=48; Only participants who were eligible to receive treatment in Part 2.|48
7620366|NCT02371369|18762779|P2|NOT COMPLETED|Part 1||11
7620367|NCT02371369|18762780|P1|NOT COMPLETED|Part 1||9
7620368|NCT02371369|18762779|P2|COMPLETED|Part 1||48
7620369|NCT02371369|18762780|P1|COMPLETED|Part 1||52
7620370|NCT02371369|18762779|P2|STARTED|Part 1||59
7620371|NCT02371369|18762780|P1|STARTED|Part 1||61
7620372|NCT02371356|18762833|P5|NOT COMPLETED|Overall Study||0
7620373|NCT02371356|18762834|P4|NOT COMPLETED|Overall Study||0
7620374|NCT02371356|18762835|P3|NOT COMPLETED|Overall Study||0
7620375|NCT02371356|18762836|P2|NOT COMPLETED|Overall Study||0
7620376|NCT02371356|18762837|P1|NOT COMPLETED|Overall Study||0
7620377|NCT02371356|18762833|P5|COMPLETED|Overall Study||72183
7620378|NCT02371356|18762834|P4|COMPLETED|Overall Study||7423
7620379|NCT02371356|18762835|P3|COMPLETED|Overall Study||2804
7620380|NCT02371356|18762836|P2|COMPLETED|Overall Study||7354
7620381|NCT02371356|18762837|P1|COMPLETED|Overall Study||1320
7620382|NCT02371356|18762833|P5|STARTED|Overall Study||72183
7620383|NCT02371356|18762834|P4|STARTED|Overall Study||7423
7620384|NCT02371356|18762835|P3|STARTED|Overall Study||2804
7620385|NCT02371356|18762836|P2|STARTED|Overall Study||7354
7620386|NCT02371356|18762837|P1|STARTED|Overall Study||1320
7620387|NCT02371187|18762856|P2|NOT COMPLETED|Overall Study||4
7620388|NCT02371187|18762857|P1|NOT COMPLETED|Overall Study||3
7620389|NCT02371187|18762856|P2|COMPLETED|Overall Study||15
7620390|NCT02371187|18762857|P1|COMPLETED|Overall Study||15
7620391|NCT02371187|18762856|P2|STARTED|Overall Study||19
7620392|NCT02371187|18762857|P1|STARTED|Overall Study||18
7620393|NCT02370914|18762871|P1|NOT COMPLETED|Overall Study||2
7620394|NCT02370914|18762871|P1|COMPLETED|Overall Study||82
7620395|NCT02370914|18762871|P1|STARTED|Overall Study||84
7620396|NCT02370888|18762879|P1|NOT COMPLETED|Overall Study||8
7620397|NCT02370888|18762879|P1|COMPLETED|Overall Study||1
7620398|NCT02370888|18762879|P1|Proceed to Treatment|Overall Study||3
7620399|NCT02370888|18762879|P1|STARTED|Overall Study||9
7620400|NCT02370784|18762889|P2|NOT COMPLETED|Overall Study||1
7620401|NCT02370784|18762890|P1|NOT COMPLETED|Overall Study||0
7620402|NCT02370784|18762889|P2|COMPLETED|Overall Study||13
7620403|NCT02370784|18762890|P1|COMPLETED|Overall Study||10
7620404|NCT02370784|18762889|P2|STARTED|Overall Study||14
7620405|NCT02370784|18762890|P1|STARTED|Overall Study||10
7620406|NCT02370667|18762905|P3|NOT COMPLETED|Overall Study||0
7620407|NCT02370667|18762906|P2|NOT COMPLETED|Overall Study||1
7620408|NCT02370667|18762907|P1|NOT COMPLETED|Overall Study||0
7620409|NCT02370667|18762905|P3|COMPLETED|Overall Study||10
7620410|NCT02370667|18762906|P2|COMPLETED|Overall Study||10
7620411|NCT02370667|18762907|P1|COMPLETED|Overall Study||10
7620412|NCT02370667|18762905|P3|STARTED|Overall Study||10
7620413|NCT02370667|18762906|P2|STARTED|Overall Study||11
7620414|NCT02370667|18762907|P1|STARTED|Overall Study||10
7620415|NCT02370641|18762971|P2|NOT COMPLETED|Overall Study||2
7620416|NCT02370641|18762972|P1|NOT COMPLETED|Overall Study||4
7620417|NCT02370641|18762971|P2|COMPLETED|Overall Study||6
7620418|NCT02370641|18762972|P1|COMPLETED|Overall Study||14
7620419|NCT02370641|18762971|P2|STARTED|Overall Study||8
7620420|NCT02370641|18762972|P1|STARTED|Overall Study||18
7620421|NCT02370615|18762980|P2|NOT COMPLETED|Overall Study||0
7620422|NCT02370615|18762981|P1|NOT COMPLETED|Overall Study||1
7620423|NCT02370615|18762980|P2|COMPLETED|Overall Study||18
7620424|NCT02370615|18762981|P1|COMPLETED|Overall Study||15
7620425|NCT02370615|18762980|P2|STARTED|Overall Study||18
7620426|NCT02370615|18762981|P1|STARTED|Overall Study||16
7620427|NCT02370602|18763024|P6|NOT COMPLETED|Overall Study||0
7620428|NCT02370602|18763025|P5|NOT COMPLETED|Overall Study||0
7620429|NCT02370602|18763026|P4|NOT COMPLETED|Overall Study||0
7620430|NCT02370602|18763027|P3|NOT COMPLETED|Overall Study||0
7620431|NCT02370602|18763028|P2|NOT COMPLETED|Overall Study||0
7620432|NCT02370602|18763029|P1|NOT COMPLETED|Overall Study||1
7620433|NCT02370602|18763024|P6|COMPLETED|Overall Study||2
7620434|NCT02370602|18763025|P5|COMPLETED|Overall Study||3
7620435|NCT02370602|18763026|P4|COMPLETED|Overall Study||3
7620436|NCT02370602|18763027|P3|COMPLETED|Overall Study||2
7620437|NCT02370602|18763028|P2|COMPLETED|Overall Study||2
7620438|NCT02370602|18763029|P1|COMPLETED|Overall Study||0
7620439|NCT02370602|18763024|P6|STARTED|Overall Study||2
7620440|NCT02370602|18763025|P5|STARTED|Overall Study||3
7620441|NCT02370602|18763026|P4|STARTED|Overall Study||3
7620442|NCT02370602|18763027|P3|STARTED|Overall Study||2
7620443|NCT02370602|18763028|P2|STARTED|Overall Study||2
7620444|NCT02370602|18763029|P1|STARTED|Overall Study||1
7620445|NCT02370537|18763123|P3|NOT COMPLETED|Part B||259
7620446|NCT02370537|18763124|P2|NOT COMPLETED|Part B||3
7620447|NCT02370537|18763125|P1|NOT COMPLETED|Part B||1
7620448|NCT02370537|18763123|P3|COMPLETED|Part B||23
7620449|NCT02370537|18763124|P2|COMPLETED|Part B||12
7620450|NCT02370537|18763125|P1|COMPLETED|Part B||15
7620451|NCT02370537|18763123|P3|Period 2 Sequence BA|Part B||12
7620452|NCT02370537|18763124|P2|Period 2 Sequence BA|Part B||7
7620453|NCT02370537|18763125|P1|Period 2 Sequence BA|Part B||7
7620454|NCT02370537|18763123|P3|Period 2 Sequence AB|Part B||11
7620455|NCT02370537|18763124|P2|Period 2 Sequence AB|Part B||5
7620456|NCT02370537|18763125|P1|Period 2 Sequence AB|Part B||8
7620457|NCT02370537|18763123|P3|Period 1 Sequence BA|Part B||12
7620458|NCT02370537|18763124|P2|Period 1 Sequence BA|Part B||7
7620459|NCT02370537|18763125|P1|Period 1 Sequence BA|Part B||7
7620460|NCT02370537|18763123|P3|Period 1 Sequence AB|Part B||11
7620461|NCT02370537|18763124|P2|Period 1 Sequence AB|Part B||6
7620462|NCT02370537|18763125|P1|Period 1 Sequence AB|Part B||8
7620463|NCT02370537|18763123|P3|Eligible for Randomisation|Part B||23
7620464|NCT02370537|18763124|P2|Eligible for Randomisation|Part B||13
7620465|NCT02370537|18763125|P1|Eligible for Randomisation|Part B||15
7620466|NCT02370537|18763123|P3|STARTED|Part B||282
7620467|NCT02370537|18763124|P2|STARTED|Part B||15
7620468|NCT02370537|18763125|P1|STARTED|Part B||16
7620469|NCT02370537|18763123|P3|NOT COMPLETED|Part A (Open-label Recruitment)||1
7620470|NCT02370537|18763124|P2|NOT COMPLETED|Part A (Open-label Recruitment)||1
7620471|NCT02370537|18763125|P1|NOT COMPLETED|Part A (Open-label Recruitment)||0
7620472|NCT02370537|18763123|P3|COMPLETED|Part A (Open-label Recruitment)||282
7620473|NCT02370537|18763124|P2|COMPLETED|Part A (Open-label Recruitment)||15
7620474|NCT02370537|18763125|P1|COMPLETED|Part A (Open-label Recruitment)||16
7620475|NCT02370537|18763123|P3|STARTED|Part A (Open-label Recruitment)||283
7620476|NCT02370537|18763124|P2|STARTED|Part A (Open-label Recruitment)||16
7620477|NCT02370537|18763125|P1|STARTED|Part A (Open-label Recruitment)||16
7620478|NCT02370498|18763174|P2|NOT COMPLETED|Overall Study||296
7620479|NCT02370498|18763175|P1|NOT COMPLETED|Overall Study||296
7620480|NCT02370498|18763174|P2|COMPLETED|Overall Study||0
7620481|NCT02370498|18763175|P1|COMPLETED|Overall Study||0
7620482|NCT02370498|18763174|P2|PD-L1 Positive Participants|Overall Study||199
7620483|NCT02370498|18763175|P1|PD-L1 Positive Participants|Overall Study||196
7620484|NCT02370498|18763174|P2|Treated|Overall Study||276
7620485|NCT02370498|18763175|P1|Treated|Overall Study||294
7620486|NCT02370498|18763174|P2|STARTED|Overall Study||296
7620487|NCT02370498|18763175|P1|STARTED|Overall Study||296
7620488|NCT02370420|18763229|P2|NOT COMPLETED|Overall Study||12
7620489|NCT02370420|18763230|P1|NOT COMPLETED|Overall Study||14
7620490|NCT02370420|18763229|P2|COMPLETED|Overall Study||15
7620491|NCT02370420|18763230|P1|COMPLETED|Overall Study||15
7620492|NCT02370420|18763229|P2|STARTED|Overall Study||27
7620493|NCT02370420|18763230|P1|STARTED|Overall Study||29
7620494|NCT02370407|18763242|P2|NOT COMPLETED|Overall Study||0
7620495|NCT02370407|18763243|P1|NOT COMPLETED|Overall Study||0
7620496|NCT02370407|18763242|P2|COMPLETED|Overall Study||20
7620497|NCT02370407|18763243|P1|COMPLETED|Overall Study||20
7620498|NCT02370407|18763242|P2|STARTED|Overall Study||20
7620499|NCT02370407|18763243|P1|STARTED|Overall Study||20
7620500|NCT02370394|18763267|P2|NOT COMPLETED|Overall Study||2
7620501|NCT02370394|18763268|P1|NOT COMPLETED|Overall Study||2
7620502|NCT02370394|18763267|P2|COMPLETED|Overall Study||23
7620503|NCT02370394|18763268|P1|COMPLETED|Overall Study||26
7620504|NCT02370394|18763267|P2|STARTED|Overall Study||25
7620505|NCT02370394|18763268|P1|STARTED|Overall Study||28
7620506|NCT02370368|18763284|P2|NOT COMPLETED|Overall Study||6
7620507|NCT02370368|18763285|P1|NOT COMPLETED|Overall Study||6
7620508|NCT02370368|18763284|P2|COMPLETED|Overall Study||7
7620509|NCT02370368|18763285|P1|COMPLETED|Overall Study||8
7620510|NCT02370368|18763284|P2|STARTED|Overall Study||13
7620511|NCT02370368|18763285|P1|STARTED|Overall Study||14
7620512|NCT02370251|18763295|P1|NOT COMPLETED|Overall Study||11
7620513|NCT02370251|18763295|P1|COMPLETED|Overall Study||52
7620514|NCT02370251|18763295|P1|STARTED|Overall Study||63
7620515|NCT02370160|18763301|P3|NOT COMPLETED|Overall Study||1
7620516|NCT02370160|18763302|P2|NOT COMPLETED|Overall Study||4
7620517|NCT02370160|18763303|P1|NOT COMPLETED|Overall Study||3
7620518|NCT02370160|18763301|P3|COMPLETED|Overall Study||2
7620519|NCT02370160|18763302|P2|COMPLETED|Overall Study||2
7620520|NCT02370160|18763303|P1|COMPLETED|Overall Study||6
7620521|NCT02370160|18763301|P3|STARTED|Overall Study||3
7620522|NCT02370160|18763302|P2|STARTED|Overall Study||6
7620523|NCT02370160|18763303|P1|STARTED|Overall Study||9
7620524|NCT02370121|18763327|P2|NOT COMPLETED|Overall Study||1
7620525|NCT02370121|18763328|P1|NOT COMPLETED|Overall Study||1
7620526|NCT02370121|18763327|P2|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
7620527|NCT02370121|18763328|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
7620528|NCT02370121|18763327|P2|STARTED|Overall Study||12
7620529|NCT02370121|18763328|P1|STARTED|Overall Study||12
7620530|NCT02370095|18763368|P2|NOT COMPLETED|Overall Study||1
7620531|NCT02370095|18763369|P1|NOT COMPLETED|Overall Study||0
7620532|NCT02370095|18763368|P2|COMPLETED|Overall Study||3
7620533|NCT02370095|18763369|P1|COMPLETED|Overall Study||10
7620534|NCT02370095|18763368|P2|STARTED|Overall Study||4
7620535|NCT02370095|18763369|P1|STARTED|Overall Study||10
7620536|NCT02370056|18763401|P2|NOT COMPLETED|Overall Study||0
7620537|NCT02370056|18763402|P1|NOT COMPLETED|Overall Study||0
7620538|NCT02370056|18763401|P2|COMPLETED|Overall Study||26
7620539|NCT02370056|18763402|P1|COMPLETED|Overall Study||27
7620540|NCT02370056|18763401|P2|STARTED|Overall Study||26
7620541|NCT02370056|18763402|P1|STARTED|Overall Study||27
7620542|NCT02370043|18763410|P6|NOT COMPLETED|Overall Study||1
7620543|NCT02370043|18763411|P5|NOT COMPLETED|Overall Study||1
7620544|NCT02370043|18763412|P4|NOT COMPLETED|Overall Study||0
7620545|NCT02370043|18763413|P3|NOT COMPLETED|Overall Study||0
7620546|NCT02370043|18763414|P2|NOT COMPLETED|Overall Study||0
7620547|NCT02370043|18763415|P1|NOT COMPLETED|Overall Study||0
7620548|NCT02370043|18763410|P6|COMPLETED|Overall Study||3
7620549|NCT02370043|18763411|P5|COMPLETED|Overall Study||2
7620550|NCT02370043|18763412|P4|COMPLETED|Overall Study||3
7620551|NCT02370043|18763413|P3|COMPLETED|Overall Study||3
7620552|NCT02370043|18763414|P2|COMPLETED|Overall Study||3
7620553|NCT02370043|18763415|P1|COMPLETED|Overall Study||3
7620554|NCT02370043|18763410|P6|STARTED|Overall Study||4
7620555|NCT02370043|18763411|P5|STARTED|Overall Study||3
7620556|NCT02370043|18763412|P4|STARTED|Overall Study||3
7620557|NCT02370043|18763413|P3|STARTED|Overall Study||3
7620558|NCT02370043|18763414|P2|STARTED|Overall Study||3
7620559|NCT02370043|18763415|P1|STARTED|Overall Study||3
7620560|NCT02370004|18763544|P1|NOT COMPLETED|Overall Study||1
7620561|NCT02370004|18763544|P1|COMPLETED|Overall Study||10
7620562|NCT02370004|18763544|P1|STARTED|Overall Study||11
7620563|NCT02369874|18763556|P3|NOT COMPLETED|Overall Study||61
7620564|NCT02369874|18763557|P2|NOT COMPLETED|Overall Study||57
7620565|NCT02369874|18763558|P1|NOT COMPLETED|Overall Study||44
7620566|NCT02369874|18763556|P3|COMPLETED|Overall Study||188
7620567|NCT02369874|18763557|P2|COMPLETED|Overall Study||183
7620568|NCT02369874|18763558|P1|COMPLETED|Overall Study||203
7620569|NCT02369874|18763556|P3|Received Treatment|Overall Study||240
7620570|NCT02369874|18763557|P2|Received Treatment|Overall Study||237
7620571|NCT02369874|18763558|P1|Received Treatment|Overall Study||246
7620572|NCT02369874|18763556|P3|STARTED|Overall Study||249
7620573|NCT02369874|18763557|P2|STARTED|Overall Study||240
7620574|NCT02369874|18763558|P1|STARTED|Overall Study||247
7620575|NCT02369848|18763605|P1|NOT COMPLETED|Overall Study||4
7620576|NCT02369848|18763605|P1|COMPLETED|Overall Study||56
7620577|NCT02369848|18763605|P1|12 Month Primary Endpoint|Overall Study||30
7620578|NCT02369848|18763605|P1|30 Day Primary Safety Endpoint|Overall Study||58
7620579|NCT02369848|18763605|P1|STARTED|Overall Study||60
7620580|NCT02369835|18763621|P2|NOT COMPLETED|Overall Study||13
7620581|NCT02369835|18763622|P1|NOT COMPLETED|Overall Study||11
7620582|NCT02369835|18763621|P2|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|55
7620583|NCT02369835|18763622|P1|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|53
7620584|NCT02369835|18763621|P2|STARTED|Overall Study||68
7620585|NCT02369835|18763622|P1|STARTED|Overall Study||64
7620586|NCT02369796|18763637|P5|NOT COMPLETED|Overall Study||0
7620587|NCT02369796|18763638|P4|NOT COMPLETED|Overall Study||0
7620588|NCT02369796|18763639|P3|NOT COMPLETED|Overall Study||0
7620589|NCT02369796|18763640|P2|NOT COMPLETED|Overall Study||0
7620590|NCT02369796|18763641|P1|NOT COMPLETED|Overall Study||0
7620591|NCT02369796|18763637|P5|COMPLETED|Overall Study||3
7620592|NCT02369796|18763638|P4|COMPLETED|Overall Study||3
7620593|NCT02369796|18763639|P3|COMPLETED|Overall Study||3
7620594|NCT02369796|18763640|P2|COMPLETED|Overall Study||3
7620595|NCT02369796|18763641|P1|COMPLETED|Overall Study||3
7620596|NCT02369796|18763637|P5|STARTED|Overall Study||3
7620597|NCT02369796|18763638|P4|STARTED|Overall Study||3
7620598|NCT02369796|18763639|P3|STARTED|Overall Study||3
7620599|NCT02369796|18763640|P2|STARTED|Overall Study||3
7620600|NCT02369796|18763641|P1|STARTED|Overall Study||3
7620601|NCT02369744|18763682|P2|NOT COMPLETED|Overall Study||0
7620602|NCT02369744|18763683|P1|NOT COMPLETED|Overall Study||0
7620603|NCT02369744|18763682|P2|COMPLETED|Overall Study||0
7620604|NCT02369744|18763683|P1|COMPLETED|Overall Study||0
7620605|NCT02369744|18763682|P2|STARTED|Overall Study||0
7620606|NCT02369744|18763683|P1|STARTED|Overall Study||0
7620607|NCT02369510|18763698|P3|NOT COMPLETED|Overall Study||6
7620608|NCT02369510|18763699|P2|NOT COMPLETED|Overall Study||3
7620609|NCT02369510|18763700|P1|NOT COMPLETED|Overall Study||2
7620610|NCT02369510|18763698|P3|COMPLETED|Overall Study||17
7620611|NCT02369510|18763699|P2|COMPLETED|Overall Study||19
7620612|NCT02369510|18763700|P1|COMPLETED|Overall Study||21
7620613|NCT02369510|18763698|P3|STARTED|Overall Study||23
7620614|NCT02369510|18763699|P2|STARTED|Overall Study||22
7620615|NCT02369510|18763700|P1|STARTED|Overall Study||23
7620616|NCT02369484|18763729|P1|NOT COMPLETED|Overall Study||0
7620617|NCT02369484|18763729|P1|COMPLETED|Overall Study||13
7620618|NCT02369484|18763729|P1|STARTED|Overall Study||13
7620619|NCT02369341|18763739|P2|NOT COMPLETED|Overall Study||0
7620620|NCT02369341|18763740|P1|NOT COMPLETED|Overall Study||1
7620621|NCT02369341|18763739|P2|COMPLETED|Overall Study||57
7620622|NCT02369341|18763740|P1|COMPLETED|Overall Study||62
7620623|NCT02369341|18763739|P2|STARTED|Overall Study||57
7620624|NCT02369341|18763740|P1|STARTED|Overall Study||63
7620625|NCT02369211|18763796|P2|NOT COMPLETED|Overall Study||2
7620626|NCT02369211|18763797|P1|NOT COMPLETED|Overall Study||0
7620627|NCT02369211|18763796|P2|COMPLETED|Overall Study||41
7620628|NCT02369211|18763797|P1|COMPLETED|Overall Study||43
7620629|NCT02369211|18763796|P2|STARTED|Overall Study||43
7620630|NCT02369211|18763797|P1|STARTED|Overall Study||43
7620631|NCT02369172|18763809|P1|NOT COMPLETED|Overall Study||0
7620632|NCT02369172|18763809|P1|COMPLETED|Overall Study||24
7620633|NCT02369172|18763809|P1|STARTED|Overall Study||24
7620634|NCT02369068|18763883|P2|NOT COMPLETED|6 Months||1
7620635|NCT02369068|18763884|P1|NOT COMPLETED|6 Months||0
7620636|NCT02369068|18763883|P2|COMPLETED|6 Months||7
7620637|NCT02369068|18763884|P1|COMPLETED|6 Months||9
7620638|NCT02369068|18763883|P2|STARTED|6 Months||8
7620639|NCT02369068|18763884|P1|STARTED|6 Months||9
7620640|NCT02369068|18763883|P2|NOT COMPLETED|3 Months||2
7620641|NCT02369068|18763884|P1|NOT COMPLETED|3 Months||0
7620642|NCT02369068|18763883|P2|COMPLETED|3 Months||8
7620643|NCT02369068|18763884|P1|COMPLETED|3 Months||9
7620644|NCT02369068|18763883|P2|STARTED|3 Months||10
7620645|NCT02369068|18763884|P1|STARTED|3 Months||9
7620646|NCT02369068|18763883|P2|NOT COMPLETED|1 Month||1
7620647|NCT02369068|18763884|P1|NOT COMPLETED|1 Month||1
7620648|NCT02369068|18763883|P2|COMPLETED|1 Month||10
7620649|NCT02369068|18763884|P1|COMPLETED|1 Month||9
7620650|NCT02369068|18763883|P2|STARTED|1 Month||11
7620651|NCT02369068|18763884|P1|STARTED|1 Month||10
7620652|NCT02368886|18763916|P4|NOT COMPLETED|Overall Study||4
7620653|NCT02368886|18763917|P3|NOT COMPLETED|Overall Study||1
7620654|NCT02368886|18763918|P2|NOT COMPLETED|Overall Study||1
7620655|NCT02368886|18763919|P1|NOT COMPLETED|Overall Study||1
7620656|NCT02368886|18763916|P4|COMPLETED|Overall Study||29
7620657|NCT02368886|18763917|P3|COMPLETED|Overall Study||33
7620658|NCT02368886|18763918|P2|COMPLETED|Overall Study||26
7620659|NCT02368886|18763919|P1|COMPLETED|Overall Study||28
7620660|NCT02368886|18763916|P4|STARTED|Overall Study||33
7620661|NCT02368886|18763917|P3|STARTED|Overall Study||34
7620662|NCT02368886|18763918|P2|STARTED|Overall Study||27
7620663|NCT02368886|18763919|P1|STARTED|Overall Study||29
7620664|NCT02368691|18763937|P1|NOT COMPLETED|Overall Study||32
7620665|NCT02368691|18763937|P1|COMPLETED|Overall Study||0
7620666|NCT02368691|18763937|P1|STARTED|Overall Study|32 subjects were enrolled and received at least one dose of study drug|32
7620667|NCT02368457|18763950|P2|NOT COMPLETED|Overall Study||0
7620668|NCT02368457|18763951|P1|NOT COMPLETED|Overall Study||0
7620669|NCT02368457|18763950|P2|COMPLETED|Overall Study||12
7620670|NCT02368457|18763951|P1|COMPLETED|Overall Study||12
7620671|NCT02368457|18763950|P2|STARTED|Overall Study||12
7620672|NCT02368457|18763951|P1|STARTED|Overall Study||12
7620673|NCT02368431|18763961|P2|NOT COMPLETED|Overall Study||19
7620674|NCT02368431|18763962|P1|NOT COMPLETED|Overall Study||24
7620675|NCT02368431|18763961|P2|COMPLETED|Overall Study||27
7620676|NCT02368431|18763962|P1|COMPLETED|Overall Study||22
7620677|NCT02368431|18763961|P2|STARTED|Overall Study||46
7620678|NCT02368431|18763962|P1|STARTED|Overall Study||46
7620679|NCT02368314|18763982|P2|NOT COMPLETED|Overall Study||3
7620680|NCT02368314|18763983|P1|NOT COMPLETED|Overall Study||3
7620681|NCT02368314|18763982|P2|COMPLETED|Overall Study||57
7620682|NCT02368314|18763983|P1|COMPLETED|Overall Study||61
7620683|NCT02368314|18763982|P2|STARTED|Overall Study||60
7620684|NCT02368314|18763983|P1|STARTED|Overall Study||64
7620685|NCT02368210|18763995|P2|NOT COMPLETED|Overall Study||1
7620686|NCT02368210|18763996|P1|NOT COMPLETED|Overall Study||1
7620687|NCT02368210|18763995|P2|COMPLETED|Overall Study||75
7620688|NCT02368210|18763996|P1|COMPLETED|Overall Study||74
7620689|NCT02368210|18763995|P2|STARTED|Overall Study||76
7620690|NCT02368210|18763996|P1|STARTED|Overall Study||75
7620691|NCT02368093|18764014|P2|NOT COMPLETED|Overall Study||0
7620692|NCT02368093|18764015|P1|NOT COMPLETED|Overall Study||0
7620693|NCT02368093|18764014|P2|COMPLETED|Overall Study||24
7620694|NCT02368093|18764015|P1|COMPLETED|Overall Study||24
7620695|NCT02368093|18764014|P2|STARTED|Overall Study||24
7620696|NCT02368093|18764015|P1|STARTED|Overall Study||24
7620697|NCT02367911|18764023|P2|NOT COMPLETED|Overall Study||4
7620698|NCT02367911|18764024|P1|NOT COMPLETED|Overall Study||5
7620699|NCT02367911|18764023|P2|COMPLETED|Overall Study||69
7620700|NCT02367911|18764024|P1|COMPLETED|Overall Study||66
7620701|NCT02367911|18764023|P2|STARTED|Overall Study||73
7620702|NCT02367911|18764024|P1|STARTED|Overall Study||71
7620703|NCT02367885|18764035|P3|NOT COMPLETED|Overall Study||0
7620704|NCT02367885|18764036|P2|NOT COMPLETED|Overall Study||0
7620705|NCT02367885|18764037|P1|NOT COMPLETED|Overall Study||2
7620706|NCT02367885|18764035|P3|COMPLETED|Overall Study||33
7620707|NCT02367885|18764036|P2|COMPLETED|Overall Study||33
7620708|NCT02367885|18764037|P1|COMPLETED|Overall Study||31
7620709|NCT02367885|18764035|P3|STARTED|Overall Study||33
7620710|NCT02367885|18764036|P2|STARTED|Overall Study||33
7620711|NCT02367885|18764037|P1|STARTED|Overall Study||33
7620712|NCT02367872|18764110|P8|NOT COMPLETED|Overall Study||0
7620713|NCT02367872|18764111|P7|NOT COMPLETED|Overall Study||0
7620714|NCT02367872|18764112|P6|NOT COMPLETED|Overall Study||0
7620715|NCT02367872|18764113|P5|NOT COMPLETED|Overall Study||0
7620716|NCT02367872|18764114|P4|NOT COMPLETED|Overall Study||0
7620717|NCT02367872|18764115|P3|NOT COMPLETED|Overall Study||0
7620718|NCT02367872|18764116|P2|NOT COMPLETED|Overall Study||0
7620719|NCT02367872|18764117|P1|NOT COMPLETED|Overall Study||0
7620720|NCT02367872|18764110|P8|COMPLETED|Overall Study||6
7620721|NCT02367872|18764111|P7|COMPLETED|Overall Study||6
7620722|NCT02367872|18764112|P6|COMPLETED|Overall Study||6
7620723|NCT02367872|18764113|P5|COMPLETED|Overall Study||6
7620724|NCT02367872|18764114|P4|COMPLETED|Overall Study||6
7620725|NCT02367872|18764115|P3|COMPLETED|Overall Study||6
7620726|NCT02367872|18764116|P2|COMPLETED|Overall Study||6
7620727|NCT02367872|18764117|P1|COMPLETED|Overall Study||6
7620728|NCT02367872|18764110|P8|STARTED|Overall Study||6
7620729|NCT02367872|18764111|P7|STARTED|Overall Study||6
7620730|NCT02367872|18764112|P6|STARTED|Overall Study||6
7620731|NCT02367872|18764113|P5|STARTED|Overall Study||6
7620732|NCT02367872|18764114|P4|STARTED|Overall Study||6
7620733|NCT02367872|18764115|P3|STARTED|Overall Study||6
7620734|NCT02367872|18764116|P2|STARTED|Overall Study||6
7620735|NCT02367872|18764117|P1|STARTED|Overall Study||6
7620736|NCT02367859|18764270|P1|NOT COMPLETED|Overall Study||0
7620737|NCT02367859|18764270|P1|COMPLETED|Overall Study||1
7620738|NCT02367859|18764270|P1|STARTED|Overall Study||1
7620739|NCT02367833|18764280|P3|NOT COMPLETED|Overall Study||0
7620740|NCT02367833|18764281|P2|NOT COMPLETED|Overall Study||1
7620741|NCT02367833|18764282|P1|NOT COMPLETED|Overall Study||1
7620742|NCT02367833|18764280|P3|COMPLETED|Overall Study||8
7620743|NCT02367833|18764281|P2|COMPLETED|Overall Study||8
7620744|NCT02367833|18764282|P1|COMPLETED|Overall Study||8
7620745|NCT02367833|18764280|P3|STARTED|Overall Study||8
7620746|NCT02367833|18764281|P2|STARTED|Overall Study||9
7620747|NCT02367833|18764282|P1|STARTED|Overall Study||9
7620748|NCT02367820|18764300|P1|NOT COMPLETED|Overall Study||236
7620749|NCT02367820|18764300|P1|COMPLETED|Overall Study||402
7620750|NCT02367820|18764300|P1|STARTED|Overall Study||638
7620751|NCT02367794|18764321|P3|NOT COMPLETED|Overall Study||249
7620752|NCT02367794|18764322|P2|NOT COMPLETED|Overall Study||240
7620753|NCT02367794|18764323|P1|NOT COMPLETED|Overall Study||258
7620754|NCT02367794|18764321|P3|COMPLETED|Overall Study||89
7620755|NCT02367794|18764322|P2|COMPLETED|Overall Study||103
7620756|NCT02367794|18764323|P1|COMPLETED|Overall Study||82
7620757|NCT02367794|18764321|P3|STARTED|Overall Study||338
7620758|NCT02367794|18764322|P2|STARTED|Overall Study||343
7620759|NCT02367794|18764323|P1|STARTED|Overall Study||340
7620760|NCT02367781|18764336|P2|NOT COMPLETED|Overall Study||240
7620761|NCT02367781|18764337|P1|NOT COMPLETED|Overall Study||483
7620762|NCT02367781|18764336|P2|COMPLETED|Overall Study||0
7620763|NCT02367781|18764337|P1|COMPLETED|Overall Study||0
7620764|NCT02367781|18764336|P2|STARTED|Overall Study||240
7620765|NCT02367781|18764337|P1|STARTED|Overall Study||483
7620766|NCT02367729|18764347|P2|NOT COMPLETED|Overall Study||8
7620767|NCT02367729|18764348|P1|NOT COMPLETED|Overall Study||3
7620768|NCT02367729|18764347|P2|COMPLETED|Overall Study||47
7620769|NCT02367729|18764348|P1|COMPLETED|Overall Study||57
7620770|NCT02367729|18764347|P2|STARTED|Overall Study||55
7620771|NCT02367729|18764348|P1|STARTED|Overall Study||60
7620772|NCT02367716|18764364|P1|NOT COMPLETED|Overall Study||1
7620773|NCT02367716|18764364|P1|COMPLETED|Overall Study||120
7620774|NCT02367716|18764364|P1|STARTED|Overall Study||121
7620775|NCT02367599|18764373|P2|NOT COMPLETED|Overall Study||0
7620776|NCT02367599|18764374|P1|NOT COMPLETED|Overall Study||0
7620777|NCT02367599|18764373|P2|COMPLETED|Overall Study||48
7620778|NCT02367599|18764374|P1|COMPLETED|Overall Study||48
7620779|NCT02367599|18764373|P2|STARTED|Overall Study||48
7620780|NCT02367599|18764374|P1|STARTED|Overall Study||48
7620781|NCT02367521|18764388|P2|NOT COMPLETED|Overall Study||0
7620782|NCT02367521|18764389|P1|NOT COMPLETED|Overall Study||4
7620783|NCT02367521|18764388|P2|COMPLETED|Overall Study||17
7620784|NCT02367521|18764389|P1|COMPLETED|Overall Study||13
7620785|NCT02367521|18764388|P2|STARTED|Overall Study||17
7620786|NCT02367521|18764389|P1|STARTED|Overall Study||17
7620787|NCT02367430|18764441|P1|NOT COMPLETED|Overall Study||3
7620788|NCT02367430|18764441|P1|COMPLETED|Overall Study||11
7620789|NCT02367430|18764441|P1|STARTED|Overall Study||14
7620790|NCT02367391|18764448|P2|NOT COMPLETED|Overall Study||0
7620791|NCT02367391|18764449|P1|NOT COMPLETED|Overall Study||2
7620792|NCT02367391|18764448|P2|COMPLETED|Overall Study||76
7620793|NCT02367391|18764449|P1|COMPLETED|Overall Study||74
7620794|NCT02367391|18764448|P2|STARTED|Overall Study||76
7620795|NCT02367391|18764449|P1|STARTED|Overall Study||76
7620796|NCT02367352|18764467|P3|NOT COMPLETED|Overall Study||0
7620797|NCT02367352|18764468|P2|NOT COMPLETED|Overall Study||0
7620798|NCT02367352|18764469|P1|NOT COMPLETED|Overall Study||9
7620799|NCT02367352|18764467|P3|COMPLETED|Overall Study||0
7620800|NCT02367352|18764468|P2|COMPLETED|Overall Study||0
7620801|NCT02367352|18764469|P1|COMPLETED|Overall Study||0
7620802|NCT02367352|18764467|P3|STARTED|Overall Study||0
7620803|NCT02367352|18764468|P2|STARTED|Overall Study||0
7620804|NCT02367352|18764469|P1|STARTED|Overall Study||9
7620805|NCT02367170|18764508|P2|NOT COMPLETED|Overall Study||0
7620806|NCT02367170|18764509|P1|NOT COMPLETED|Overall Study||0
7620807|NCT02367170|18764508|P2|COMPLETED|Overall Study||0
7620808|NCT02367170|18764509|P1|COMPLETED|Overall Study||1
7620809|NCT02367170|18764508|P2|STARTED|Overall Study||0
7620810|NCT02367170|18764509|P1|STARTED|Overall Study||1
7620811|NCT02367131|18764519|P1|NOT COMPLETED|Overall Study||222
7620812|NCT02367131|18764519|P1|COMPLETED|Overall Study||201
7620813|NCT02367131|18764519|P1|STARTED|Overall Study|Started are the treated patients|423
7620814|NCT02367105|18764527|P2|NOT COMPLETED|Overall Study||8
7620815|NCT02367105|18764528|P1|NOT COMPLETED|Overall Study||5
7620816|NCT02367105|18764527|P2|COMPLETED|Overall Study||34
7620817|NCT02367105|18764528|P1|COMPLETED|Overall Study||36
7620818|NCT02367105|18764527|P2|STARTED|Overall Study||42
7620819|NCT02367105|18764528|P1|STARTED|Overall Study||41
7620820|NCT02367066|18764596|P2|NOT COMPLETED|Overall Study||0
7620821|NCT02367066|18764597|P1|NOT COMPLETED|Overall Study||0
7620822|NCT02367066|18764596|P2|COMPLETED|Overall Study||10
7620823|NCT02367066|18764597|P1|COMPLETED|Overall Study||10
7620824|NCT02367066|18764596|P2|STARTED|Overall Study||10
7620825|NCT02367066|18764597|P1|STARTED|Overall Study||10
7620826|NCT02367014|18764659|P4|NOT COMPLETED|Overall Study||0
7620827|NCT02367014|18764660|P3|NOT COMPLETED|Overall Study||0
7620828|NCT02367014|18764661|P2|NOT COMPLETED|Overall Study||0
7620829|NCT02367014|18764662|P1|NOT COMPLETED|Overall Study||0
7620830|NCT02367014|18764659|P4|COMPLETED|Overall Study||9
7620831|NCT02367014|18764660|P3|COMPLETED|Overall Study||9
7620832|NCT02367014|18764661|P2|COMPLETED|Overall Study||9
7620833|NCT02367014|18764662|P1|COMPLETED|Overall Study||9
7620834|NCT02367014|18764659|P4|STARTED|Overall Study||9
7620835|NCT02367014|18764660|P3|STARTED|Overall Study||9
7620836|NCT02367014|18764661|P2|STARTED|Overall Study||9
7620837|NCT02367014|18764662|P1|STARTED|Overall Study||9
7620838|NCT02366936|18764780|P1|NOT COMPLETED|Overall Study||8
7620839|NCT02366936|18764780|P1|COMPLETED|Overall Study||24
7620840|NCT02366936|18764780|P1|STARTED|Overall Study||32
7620841|NCT02366923|18764785|P1|NOT COMPLETED|Overall Study||6
7620842|NCT02366923|18764785|P1|COMPLETED|Overall Study||22
7620843|NCT02366923|18764785|P1|STARTED|Overall Study||28
7620844|NCT02366910|18764798|P1|NOT COMPLETED|Overall Study||5
7620845|NCT02366910|18764798|P1|COMPLETED|Overall Study||21
7620846|NCT02366910|18764798|P1|STARTED|Overall Study||26
7620847|NCT02366871|18764812|P2|NOT COMPLETED|Overall Study||0
7620848|NCT02366871|18764813|P1|NOT COMPLETED|Overall Study||0
7620849|NCT02366871|18764812|P2|COMPLETED|Overall Study||196
7620850|NCT02366871|18764813|P1|COMPLETED|Overall Study||204
7620851|NCT02366871|18764812|P2|STARTED|Overall Study||196
7620852|NCT02366871|18764813|P1|STARTED|Overall Study||204
7620853|NCT02366845|18764831|P2|NOT COMPLETED|Overall Study||0
7620854|NCT02366845|18764832|P1|NOT COMPLETED|Overall Study||0
7620855|NCT02366845|18764831|P2|COMPLETED|Overall Study||25
7620856|NCT02366845|18764832|P1|COMPLETED|Overall Study||25
7620857|NCT02366845|18764831|P2|STARTED|Overall Study||25
7620858|NCT02366845|18764832|P1|STARTED|Overall Study||25
7620859|NCT02366767|18764846|P2|NOT COMPLETED|Overall Study||0
7620860|NCT02366767|18764847|P1|NOT COMPLETED|Overall Study||1
7620861|NCT02366767|18764846|P2|COMPLETED|Overall Study||10
7620862|NCT02366767|18764847|P1|COMPLETED|Overall Study||10
7620863|NCT02366767|18764846|P2|STARTED|Overall Study||10
7620864|NCT02366767|18764847|P1|STARTED|Overall Study||11
7620865|NCT02366689|18764860|P3|NOT COMPLETED|Overall Study||2
7620866|NCT02366689|18764861|P2|NOT COMPLETED|Overall Study||3
7620867|NCT02366689|18764862|P1|NOT COMPLETED|Overall Study||4
7620868|NCT02366689|18764860|P3|COMPLETED|Overall Study||59
7620869|NCT02366689|18764861|P2|COMPLETED|Overall Study||55
7620870|NCT02366689|18764862|P1|COMPLETED|Overall Study||56
7620871|NCT02366689|18764860|P3|STARTED|Overall Study||61
7620872|NCT02366689|18764861|P2|STARTED|Overall Study||58
7620873|NCT02366689|18764862|P1|STARTED|Overall Study||60
7620874|NCT02366663|18764887|P2|NOT COMPLETED|Overall Study||0
7620875|NCT02366663|18764888|P1|NOT COMPLETED|Overall Study||0
7620876|NCT02366663|18764887|P2|COMPLETED|Overall Study||1
7620877|NCT02366663|18764888|P1|COMPLETED|Overall Study||2
7620878|NCT02366663|18764887|P2|STARTED|Overall Study||1
7620879|NCT02366663|18764888|P1|STARTED|Overall Study||2
7620880|NCT02366637|18764914|P2|NOT COMPLETED|Second Intervention Period||1
7620881|NCT02366637|18764915|P1|NOT COMPLETED|Second Intervention Period||1
7620882|NCT02366637|18764914|P2|COMPLETED|Second Intervention Period||0
7620883|NCT02366637|18764915|P1|COMPLETED|Second Intervention Period||0
7620884|NCT02366637|18764914|P2|STARTED|Second Intervention Period||1
7620885|NCT02366637|18764915|P1|STARTED|Second Intervention Period||1
7620886|NCT02366637|18764914|P2|NOT COMPLETED|Washout Period 28 to 49 Days||0
7620887|NCT02366637|18764915|P1|NOT COMPLETED|Washout Period 28 to 49 Days||0
7620888|NCT02366637|18764914|P2|COMPLETED|Washout Period 28 to 49 Days||1
7620889|NCT02366637|18764915|P1|COMPLETED|Washout Period 28 to 49 Days||1
7620890|NCT02366637|18764914|P2|STARTED|Washout Period 28 to 49 Days||1
7620891|NCT02366637|18764915|P1|STARTED|Washout Period 28 to 49 Days||1
7620892|NCT02366637|18764914|P2|NOT COMPLETED|First Intervention Period||5
7620893|NCT02366637|18764915|P1|NOT COMPLETED|First Intervention Period||6
7620894|NCT02366637|18764914|P2|COMPLETED|First Intervention Period||1
7620895|NCT02366637|18764915|P1|COMPLETED|First Intervention Period||1
7620896|NCT02366637|18764914|P2|STARTED|First Intervention Period||6
7620897|NCT02366637|18764915|P1|STARTED|First Intervention Period||7
7620898|NCT02366468|18764941|P2|NOT COMPLETED|Overall Study||9
7620899|NCT02366468|18764942|P1|NOT COMPLETED|Overall Study||6
7620900|NCT02366468|18764941|P2|COMPLETED|Overall Study||58
7620901|NCT02366468|18764942|P1|COMPLETED|Overall Study||62
7620902|NCT02366468|18764941|P2|Per Protocol Set (PPS)|Overall Study||61
7620903|NCT02366468|18764942|P1|Per Protocol Set (PPS)|Overall Study||62
7620904|NCT02366468|18764941|P2|Full Analysis Set (FAS)|Overall Study||66
7620905|NCT02366468|18764942|P1|Full Analysis Set (FAS)|Overall Study||67
7620906|NCT02366468|18764941|P2|STARTED|Overall Study||67
7620907|NCT02366468|18764942|P1|STARTED|Overall Study||68
7620908|NCT02366338|18764963|P3|NOT COMPLETED|Overall Study||0
7620909|NCT02366338|18764964|P2|NOT COMPLETED|Overall Study||0
7620910|NCT02366338|18764965|P1|NOT COMPLETED|Overall Study||0
7620911|NCT02366338|18764963|P3|COMPLETED|Overall Study||36
7620912|NCT02366338|18764964|P2|COMPLETED|Overall Study||39
7620913|NCT02366338|18764965|P1|COMPLETED|Overall Study||73
7620914|NCT02366338|18764963|P3|STARTED|Overall Study||36
7620915|NCT02366338|18764964|P2|STARTED|Overall Study||39
7620916|NCT02366338|18764965|P1|STARTED|Overall Study||73
7620917|NCT02366195|18764973|P1|NOT COMPLETED|Overall Study||112
7620918|NCT02366195|18764973|P1|COMPLETED|Overall Study||0
7620919|NCT02366195|18764973|P1|Received Study Drug|Overall Study||111
7620920|NCT02366195|18764973|P1|STARTED|Overall Study||112
7620921|NCT02366143|18764994|P3|NOT COMPLETED|Overall Study||400
7620922|NCT02366143|18764995|P2|NOT COMPLETED|Overall Study||402
7620923|NCT02366143|18764996|P1|NOT COMPLETED|Overall Study||400
7620924|NCT02366143|18764994|P3|COMPLETED|Overall Study||0
7620925|NCT02366143|18764995|P2|COMPLETED|Overall Study||0
7620926|NCT02366143|18764996|P1|COMPLETED|Overall Study||0
7620927|NCT02366143|18764994|P3|STARTED|Overall Study||400
7620928|NCT02366143|18764995|P2|STARTED|Overall Study||402
7620929|NCT02366143|18764996|P1|STARTED|Overall Study||400
7620930|NCT02365961|18765061|P2|NOT COMPLETED|Overall Study||0
7620931|NCT02365961|18765062|P1|NOT COMPLETED|Overall Study||0
7620932|NCT02365961|18765061|P2|COMPLETED|Overall Study||43
7620933|NCT02365961|18765062|P1|COMPLETED|Overall Study||41
7620934|NCT02365961|18765061|P2|STARTED|Overall Study||43
7620935|NCT02365961|18765062|P1|STARTED|Overall Study||41
7620936|NCT02365870|18765078|P2|NOT COMPLETED|Overall Study||0
7620937|NCT02365870|18765079|P1|NOT COMPLETED|Overall Study||0
7620938|NCT02365870|18765078|P2|COMPLETED|Overall Study||3
7620939|NCT02365870|18765079|P1|COMPLETED|Overall Study||1
7620940|NCT02365870|18765078|P2|STARTED|Overall Study||3
7620941|NCT02365870|18765079|P1|STARTED|Overall Study||1
7620942|NCT02365714|18765087|P1|NOT COMPLETED|Overall Study||0
7620943|NCT02365714|18765087|P1|COMPLETED|Overall Study||2
7620944|NCT02365714|18765087|P1|STARTED|Overall Study||2
7620945|NCT02365688|18765093|P1|NOT COMPLETED|Overall Study||0
7620946|NCT02365688|18765093|P1|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18
7620947|NCT02365688|18765093|P1|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18
7620948|NCT02365636|18765100|P3|NOT COMPLETED|Overall Study||3
7620949|NCT02365636|18765101|P2|NOT COMPLETED|Overall Study||7
7620950|NCT02365636|18765102|P1|NOT COMPLETED|Overall Study||6
7620951|NCT02365636|18765100|P3|COMPLETED|Overall Study||97
7620952|NCT02365636|18765101|P2|COMPLETED|Overall Study||93
7620953|NCT02365636|18765102|P1|COMPLETED|Overall Study||94
7620954|NCT02365636|18765100|P3|Full Analysis Set|Overall Study||100
7620955|NCT02365636|18765101|P2|Full Analysis Set|Overall Study||98
7620956|NCT02365636|18765102|P1|Full Analysis Set|Overall Study||100
7620957|NCT02365636|18765100|P3|Safety Population|Overall Study||100
7620958|NCT02365636|18765101|P2|Safety Population|Overall Study|2 terminated prior to treatment due to 1) prohibited concomitant medication 2) exclusion criteria|98
7620959|NCT02365636|18765102|P1|Safety Population|Overall Study||100
7620960|NCT02365636|18765100|P3|STARTED|Overall Study||100
7620961|NCT02365636|18765101|P2|STARTED|Overall Study||100
7620962|NCT02365636|18765102|P1|STARTED|Overall Study||100
7620963|NCT02365584|18765148|P2|NOT COMPLETED|Overall Study||14
7620964|NCT02365584|18765149|P1|NOT COMPLETED|Overall Study||12
7620965|NCT02365584|18765148|P2|COMPLETED|Overall Study||8
7620966|NCT02365584|18765149|P1|COMPLETED|Overall Study||9
7620967|NCT02365584|18765148|P2|STARTED|Overall Study||22
7620968|NCT02365584|18765149|P1|STARTED|Overall Study||21
7620969|NCT02365558|18765173|P2|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||1
7620970|NCT02365558|18765174|P1|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||0
7620971|NCT02365558|18765173|P2|COMPLETED|Period 2 (Day 8 Through Day 20)||32
7620972|NCT02365558|18765174|P1|COMPLETED|Period 2 (Day 8 Through Day 20)||0
7620973|NCT02365558|18765173|P2|STARTED|Period 2 (Day 8 Through Day 20)|Participants completed Period 1 and entered Evacetrapib + Omeprazole for Period 2.|33
7620974|NCT02365558|18765174|P1|STARTED|Period 2 (Day 8 Through Day 20)|Participants move to Evacetrapib + Omeprazole for Period 2.|0
7620975|NCT02365558|18765173|P2|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||0
7620976|NCT02365558|18765174|P1|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||1
7620977|NCT02365558|18765173|P2|COMPLETED|Period 1 (Day 1 Through Day 7)||0
7620978|NCT02365558|18765174|P1|COMPLETED|Period 1 (Day 1 Through Day 7)||33
7620979|NCT02365558|18765173|P2|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||0
7620980|NCT02365558|18765174|P1|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||34
7620981|NCT02365558|18765173|P2|STARTED|Period 1 (Day 1 Through Day 7)||0
7620982|NCT02365558|18765174|P1|STARTED|Period 1 (Day 1 Through Day 7)||34
7620983|NCT02365519|18765187|P3|NOT COMPLETED|Randomized and Treated||1
7620984|NCT02365519|18765188|P2|NOT COMPLETED|Randomized and Treated||2
7620985|NCT02365519|18765189|P1|NOT COMPLETED|Randomized and Treated||0
7620986|NCT02365519|18765187|P3|COMPLETED|Randomized and Treated||64
7620987|NCT02365519|18765188|P2|COMPLETED|Randomized and Treated||67
7620988|NCT02365519|18765189|P1|COMPLETED|Randomized and Treated||0
7620989|NCT02365519|18765187|P3|STARTED|Randomized and Treated||65
7620990|NCT02365519|18765188|P2|STARTED|Randomized and Treated||69
7620991|NCT02365519|18765189|P1|STARTED|Randomized and Treated||0
7620992|NCT02365519|18765187|P3|NOT COMPLETED|Vehicle Run-In||0
7620993|NCT02365519|18765188|P2|NOT COMPLETED|Vehicle Run-In||0
7620994|NCT02365519|18765189|P1|NOT COMPLETED|Vehicle Run-In||79
7620995|NCT02365519|18765187|P3|COMPLETED|Vehicle Run-In||0
7620996|NCT02365519|18765188|P2|COMPLETED|Vehicle Run-In||0
7620997|NCT02365519|18765189|P1|COMPLETED|Vehicle Run-In||134
7620998|NCT02365519|18765187|P3|STARTED|Vehicle Run-In||0
7620999|NCT02365519|18765188|P2|STARTED|Vehicle Run-In||0
7621000|NCT02365519|18765189|P1|STARTED|Vehicle Run-In||213
7621001|NCT02365506|18765213|P3|NOT COMPLETED|Overall Study||1
7621002|NCT02365506|18765214|P2|NOT COMPLETED|Overall Study||0
7621003|NCT02365506|18765215|P1|NOT COMPLETED|Overall Study||0
7621004|NCT02365506|18765213|P3|COMPLETED|Overall Study||4
7621005|NCT02365506|18765214|P2|COMPLETED|Overall Study||4
7621006|NCT02365506|18765215|P1|COMPLETED|Overall Study||4
7621007|NCT02365506|18765213|P3|STARTED|Overall Study||5
7621008|NCT02365506|18765214|P2|STARTED|Overall Study||4
7621009|NCT02365506|18765215|P1|STARTED|Overall Study||4
7621010|NCT02365298|18765244|P2|NOT COMPLETED|Period 2||2
7621011|NCT02365298|18765245|P1|NOT COMPLETED|Period 2||2
7621012|NCT02365298|18765244|P2|COMPLETED|Period 2||12
7621013|NCT02365298|18765245|P1|COMPLETED|Period 2||12
7621014|NCT02365298|18765244|P2|STARTED|Period 2||14
7621015|NCT02365298|18765245|P1|STARTED|Period 2||14
7621016|NCT02365298|18765244|P2|NOT COMPLETED|Period 1||0
7621017|NCT02365298|18765245|P1|NOT COMPLETED|Period 1||0
7621018|NCT02365298|18765244|P2|COMPLETED|Period 1||14
7621019|NCT02365298|18765245|P1|COMPLETED|Period 1||14
7621020|NCT02365298|18765244|P2|STARTED|Period 1||14
7621021|NCT02365298|18765245|P1|STARTED|Period 1||14
7621022|NCT02365285|18765265|P4|NOT COMPLETED|Overall Study||2
7621023|NCT02365285|18765266|P3|NOT COMPLETED|Overall Study||1
7621024|NCT02365285|18765267|P2|NOT COMPLETED|Overall Study||1
7621025|NCT02365285|18765268|P1|NOT COMPLETED|Overall Study||0
7621026|NCT02365285|18765265|P4|COMPLETED|Overall Study||1
7621027|NCT02365285|18765266|P3|COMPLETED|Overall Study||6
7621028|NCT02365285|18765267|P2|COMPLETED|Overall Study||5
7621029|NCT02365285|18765268|P1|COMPLETED|Overall Study||7
7621030|NCT02365285|18765265|P4|STARTED|Overall Study||3
7621031|NCT02365285|18765266|P3|STARTED|Overall Study||7
7621032|NCT02365285|18765267|P2|STARTED|Overall Study||6
7621033|NCT02365285|18765268|P1|STARTED|Overall Study||7
7621034|NCT02365233|18765285|P3|NOT COMPLETED|Overall Study||2
7621035|NCT02365233|18765286|P2|NOT COMPLETED|Overall Study||2
7621036|NCT02365233|18765287|P1|NOT COMPLETED|Overall Study||1
7621037|NCT02365233|18765285|P3|COMPLETED|Overall Study||0
7621038|NCT02365233|18765286|P2|COMPLETED|Overall Study||0
7621039|NCT02365233|18765287|P1|COMPLETED|Overall Study||0
7621040|NCT02365233|18765285|P3|STARTED|Overall Study||2
7621041|NCT02365233|18765286|P2|STARTED|Overall Study||2
7621042|NCT02365233|18765287|P1|STARTED|Overall Study||1
7621043|NCT02365207|18765295|P1|NOT COMPLETED|Overall Study||2
7621044|NCT02365207|18765295|P1|COMPLETED|Overall Study||4
7621045|NCT02365207|18765295|P1|STARTED|Overall Study||6
7621046|NCT02364999|18765301|P2|NOT COMPLETED|Overall Study||173
7621047|NCT02364999|18765302|P1|NOT COMPLETED|Overall Study||165
7621048|NCT02364999|18765301|P2|COMPLETED|Overall Study||188
7621049|NCT02364999|18765302|P1|COMPLETED|Overall Study||193
7621050|NCT02364999|18765301|P2|Received Treatment|Overall Study||358
7621051|NCT02364999|18765302|P1|Received Treatment|Overall Study||356
7621052|NCT02364999|18765301|P2|STARTED|Overall Study||361
7621053|NCT02364999|18765302|P1|STARTED|Overall Study||358
7621054|NCT02364947|18765328|P3|NOT COMPLETED|Overall Study||26
7621055|NCT02364947|18765329|P2|NOT COMPLETED|Overall Study||45
7621056|NCT02364947|18765330|P1|NOT COMPLETED|Overall Study||59
7621057|NCT02364947|18765328|P3|COMPLETED|Overall Study||219
7621058|NCT02364947|18765329|P2|COMPLETED|Overall Study||139
7621059|NCT02364947|18765330|P1|COMPLETED|Overall Study||189
7621060|NCT02364947|18765328|P3|STARTED|Overall Study||245
7621061|NCT02364947|18765329|P2|STARTED|Overall Study||184
7621062|NCT02364947|18765330|P1|STARTED|Overall Study||248
7621063|NCT02364778|18765397|P1|NOT COMPLETED|Overall Study||0
7621064|NCT02364778|18765397|P1|COMPLETED|Overall Study||30
7621065|NCT02364778|18765397|P1|STARTED|Overall Study||30
7621066|NCT02364700|18765409|P1|NOT COMPLETED|Overall Study||0
7621067|NCT02364700|18765409|P1|COMPLETED|Overall Study||12
7621068|NCT02364700|18765409|P1|STARTED|Overall Study||12
7621069|NCT02364570|18765418|P16|NOT COMPLETED|Overall Study||0
7621070|NCT02364570|18765419|P15|NOT COMPLETED|Overall Study||0
7621071|NCT02364570|18765420|P14|NOT COMPLETED|Overall Study||0
7621072|NCT02364570|18765421|P13|NOT COMPLETED|Overall Study||0
7621073|NCT02364570|18765422|P12|NOT COMPLETED|Overall Study||0
7621074|NCT02364570|18765423|P11|NOT COMPLETED|Overall Study||0
7621075|NCT02364570|18765424|P10|NOT COMPLETED|Overall Study||0
7621076|NCT02364570|18765425|P9|NOT COMPLETED|Overall Study||0
7621077|NCT02364570|18765426|P8|NOT COMPLETED|Overall Study||0
7621078|NCT02364570|18765427|P7|NOT COMPLETED|Overall Study||0
7621079|NCT02364570|18765428|P6|NOT COMPLETED|Overall Study||0
7621080|NCT02364570|18765429|P5|NOT COMPLETED|Overall Study||0
7621081|NCT02364570|18765430|P4|NOT COMPLETED|Overall Study||0
7621082|NCT02364570|18765431|P3|NOT COMPLETED|Overall Study||0
7621083|NCT02364570|18765432|P2|NOT COMPLETED|Overall Study||0
7621084|NCT02364570|18765433|P1|NOT COMPLETED|Overall Study||0
7621085|NCT02364570|18765418|P16|COMPLETED|Overall Study||1
7621086|NCT02364570|18765419|P15|COMPLETED|Overall Study||1
7621087|NCT02364570|18765420|P14|COMPLETED|Overall Study||2
7621088|NCT02364570|18765421|P13|COMPLETED|Overall Study||1
7621089|NCT02364570|18765422|P12|COMPLETED|Overall Study||1
7621090|NCT02364570|18765423|P11|COMPLETED|Overall Study||1
7621091|NCT02364570|18765424|P10|COMPLETED|Overall Study||1
7621092|NCT02364570|18765425|P9|COMPLETED|Overall Study||2
7621093|NCT02364570|18765426|P8|COMPLETED|Overall Study||1
7621094|NCT02364570|18765427|P7|COMPLETED|Overall Study||2
7621095|NCT02364570|18765428|P6|COMPLETED|Overall Study||1
7621096|NCT02364570|18765429|P5|COMPLETED|Overall Study||1
7621097|NCT02364570|18765430|P4|COMPLETED|Overall Study||1
7621098|NCT02364570|18765431|P3|COMPLETED|Overall Study||2
7621099|NCT02364570|18765432|P2|COMPLETED|Overall Study||1
7621100|NCT02364570|18765433|P1|COMPLETED|Overall Study||1
7621101|NCT02364570|18765418|P16|STARTED|Overall Study||1
7621102|NCT02364570|18765419|P15|STARTED|Overall Study||1
7621103|NCT02364570|18765420|P14|STARTED|Overall Study||2
7621104|NCT02364570|18765421|P13|STARTED|Overall Study||1
7621105|NCT02364570|18765422|P12|STARTED|Overall Study||1
7621106|NCT02364570|18765423|P11|STARTED|Overall Study||1
7621107|NCT02364570|18765424|P10|STARTED|Overall Study||1
7621108|NCT02364570|18765425|P9|STARTED|Overall Study||2
7621109|NCT02364570|18765426|P8|STARTED|Overall Study||1
7621110|NCT02364570|18765427|P7|STARTED|Overall Study||2
7621111|NCT02364570|18765428|P6|STARTED|Overall Study||1
7621112|NCT02364570|18765429|P5|STARTED|Overall Study||1
7621113|NCT02364570|18765430|P4|STARTED|Overall Study||1
7621114|NCT02364570|18765431|P3|STARTED|Overall Study||2
7621115|NCT02364570|18765432|P2|STARTED|Overall Study||1
7621116|NCT02364570|18765433|P1|STARTED|Overall Study||1
7621117|NCT02364388|18765499|P1|NOT COMPLETED|Overall Study||8
7621118|NCT02364388|18765499|P1|COMPLETED|Overall Study||209
7621119|NCT02364388|18765499|P1|Excluded|Overall Study||8
7621120|NCT02364388|18765499|P1|Biopsied|Overall Study||209
7621121|NCT02364388|18765499|P1|STARTED|Overall Study||217
7621122|NCT02364336|18765506|P2|NOT COMPLETED|Overall Study||1
7621123|NCT02364336|18765507|P1|NOT COMPLETED|Overall Study||0
7621124|NCT02364336|18765506|P2|COMPLETED|Overall Study||11
7621125|NCT02364336|18765507|P1|COMPLETED|Overall Study||1
7621126|NCT02364336|18765506|P2|48 Weeks After End of Peginterferon|Overall Study||10
7621127|NCT02364336|18765507|P1|48 Weeks After End of Peginterferon|Overall Study||1
7621128|NCT02364336|18765506|P2|24 Weeks After End of Peginterferon|Overall Study||11
7621129|NCT02364336|18765507|P1|24 Weeks After End of Peginterferon|Overall Study||1
7621130|NCT02364336|18765506|P2|End of Peginterferon Treatment|Overall Study||11
7621131|NCT02364336|18765507|P1|End of Peginterferon Treatment|Overall Study||1
7621132|NCT02364336|18765506|P2|6 Hours Post First Peginterferon Inject|Overall Study||12
7621133|NCT02364336|18765507|P1|6 Hours Post First Peginterferon Inject|Overall Study||1
7621134|NCT02364336|18765506|P2|STARTED|Overall Study||12
7621135|NCT02364336|18765507|P1|STARTED|Overall Study||1
7621136|NCT02364180|18765520|P1|NOT COMPLETED|Overall Study||1
7621137|NCT02364180|18765520|P1|COMPLETED|Overall Study||10
7621138|NCT02364180|18765520|P1|STARTED|Overall Study||11
7621139|NCT02364076|18765524|P1|NOT COMPLETED|Overall Study||5
7621140|NCT02364076|18765524|P1|COMPLETED|Overall Study||40
7621141|NCT02364076|18765524|P1|STARTED|Overall Study||45
7621142|NCT02364037|18765533|P2|NOT COMPLETED|Overall Study||53
7621143|NCT02364037|18765534|P1|NOT COMPLETED|Overall Study||44
7621144|NCT02364037|18765533|P2|COMPLETED|Overall Study||453
7621145|NCT02364037|18765534|P1|COMPLETED|Overall Study||458
7621146|NCT02364037|18765533|P2|STARTED|Overall Study||506
7621147|NCT02364037|18765534|P1|STARTED|Overall Study||502
7621148|NCT02363972|18765548|P1|NOT COMPLETED|Overall Study||26
7621149|NCT02363972|18765548|P1|COMPLETED|Overall Study||77
7621150|NCT02363972|18765548|P1|STARTED|Overall Study||103
7621151|NCT02363959|18765567|P2|NOT COMPLETED|Overall Study||0
7621152|NCT02363959|18765568|P1|NOT COMPLETED|Overall Study||1
7621153|NCT02363959|18765567|P2|COMPLETED|Overall Study||10
7621154|NCT02363959|18765568|P1|COMPLETED|Overall Study||9
7621155|NCT02363959|18765567|P2|STARTED|Overall Study||10
7621156|NCT02363959|18765568|P1|STARTED|Overall Study||10
7621157|NCT02363946|18765597|P13|NOT COMPLETED|Overall Study||0
7621158|NCT02363946|18765598|P12|NOT COMPLETED|Overall Study||0
7621159|NCT02363946|18765599|P11|NOT COMPLETED|Overall Study||0
7621160|NCT02363946|18765600|P10|NOT COMPLETED|Overall Study||0
7621161|NCT02363946|18765601|P9|NOT COMPLETED|Overall Study||0
7621162|NCT02363946|18765602|P8|NOT COMPLETED|Overall Study||1
7621163|NCT02363946|18765603|P7|NOT COMPLETED|Overall Study||0
7621164|NCT02363946|18765604|P6|NOT COMPLETED|Overall Study||0
7621165|NCT02363946|18765605|P5|NOT COMPLETED|Overall Study||0
7621166|NCT02363946|18765606|P4|NOT COMPLETED|Overall Study||0
7621167|NCT02363946|18765607|P3|NOT COMPLETED|Overall Study||0
7621168|NCT02363946|18765608|P2|NOT COMPLETED|Overall Study||0
7621169|NCT02363946|18765609|P1|NOT COMPLETED|Overall Study||0
7621170|NCT02363946|18765597|P13|COMPLETED|Overall Study||4
7621171|NCT02363946|18765598|P12|COMPLETED|Overall Study||3
7621172|NCT02363946|18765599|P11|COMPLETED|Overall Study||4
7621173|NCT02363946|18765600|P10|COMPLETED|Overall Study||18
7621174|NCT02363946|18765601|P9|COMPLETED|Overall Study||4
7621175|NCT02363946|18765602|P8|COMPLETED|Overall Study||3
7621176|NCT02363946|18765603|P7|COMPLETED|Overall Study||4
7621177|NCT02363946|18765604|P6|COMPLETED|Overall Study||4
7621178|NCT02363946|18765605|P5|COMPLETED|Overall Study||4
7621179|NCT02363946|18765606|P4|COMPLETED|Overall Study||4
7621180|NCT02363946|18765607|P3|COMPLETED|Overall Study||4
7621181|NCT02363946|18765608|P2|COMPLETED|Overall Study||4
7621182|NCT02363946|18765609|P1|COMPLETED|Overall Study||4
7621183|NCT02363946|18765597|P13|STARTED|Overall Study||4
7621184|NCT02363946|18765598|P12|STARTED|Overall Study||3
7621185|NCT02363946|18765599|P11|STARTED|Overall Study||4
7621186|NCT02363946|18765600|P10|STARTED|Overall Study||18
7621187|NCT02363946|18765601|P9|STARTED|Overall Study||4
7621188|NCT02363946|18765602|P8|STARTED|Overall Study||4
7621189|NCT02363946|18765603|P7|STARTED|Overall Study||4
7621190|NCT02363946|18765604|P6|STARTED|Overall Study||4
7621191|NCT02363946|18765605|P5|STARTED|Overall Study||4
7621192|NCT02363946|18765606|P4|STARTED|Overall Study||4
7621193|NCT02363946|18765607|P3|STARTED|Overall Study||4
7621194|NCT02363946|18765608|P2|STARTED|Overall Study||4
7621195|NCT02363946|18765609|P1|STARTED|Overall Study||4
7621196|NCT02363933|18765795|P1|NOT COMPLETED|Overall Study||6
7621197|NCT02363933|18765795|P1|COMPLETED|Overall Study||2
7621198|NCT02363933|18765795|P1|STARTED|Overall Study||8
7621199|NCT02363907|18765800|P1|NOT COMPLETED|Overall Study||0
7621200|NCT02363907|18765800|P1|COMPLETED|Overall Study||30
7621201|NCT02363907|18765800|P1|STARTED|Overall Study||30
7621202|NCT02363803|18765806|P2|NOT COMPLETED|Period 2||0
7621203|NCT02363803|18765807|P1|NOT COMPLETED|Period 2||0
7621204|NCT02363803|18765806|P2|COMPLETED|Period 2||16
7621205|NCT02363803|18765807|P1|COMPLETED|Period 2||17
7621206|NCT02363803|18765806|P2|STARTED|Period 2|One participant did not return for Period 2 treatment|16
7621207|NCT02363803|18765807|P1|STARTED|Period 2||17
7621208|NCT02363803|18765806|P2|NOT COMPLETED|Period 1||0
7621209|NCT02363803|18765807|P1|NOT COMPLETED|Period 1||0
7621210|NCT02363803|18765806|P2|COMPLETED|Period 1||17
7621211|NCT02363803|18765807|P1|COMPLETED|Period 1||17
7621212|NCT02363803|18765806|P2|STARTED|Period 1||17
7621213|NCT02363803|18765807|P1|STARTED|Period 1||17
7621214|NCT02363621|18765827|P2|NOT COMPLETED|Overall Study||0
7621215|NCT02363621|18765828|P1|NOT COMPLETED|Overall Study||1
7621216|NCT02363621|18765827|P2|COMPLETED|Overall Study||50
7621217|NCT02363621|18765828|P1|COMPLETED|Overall Study||50
7621218|NCT02363621|18765827|P2|STARTED|Overall Study||50
7621219|NCT02363621|18765828|P1|STARTED|Overall Study||51
7621220|NCT02363478|18765838|P1|NOT COMPLETED|Overall Study||8
7621221|NCT02363478|18765838|P1|COMPLETED|Overall Study||22
7621222|NCT02363478|18765838|P1|STARTED|Overall Study||30
7621223|NCT02363439|18765845|P1|NOT COMPLETED|Overall Study||4
7621224|NCT02363439|18765845|P1|COMPLETED|Overall Study||1
7621225|NCT02363439|18765845|P1|STARTED|Overall Study||5
7621226|NCT02363322|18765851|P2|NOT COMPLETED|Overall Study||0
7621227|NCT02363322|18765852|P1|NOT COMPLETED|Overall Study||1
7621228|NCT02363322|18765851|P2|COMPLETED|Overall Study||36
7621229|NCT02363322|18765852|P1|COMPLETED|Overall Study||35
7621230|NCT02363322|18765851|P2|STARTED|Overall Study||36
7621231|NCT02363322|18765852|P1|STARTED|Overall Study||36
7621232|NCT02363283|18765862|P1|NOT COMPLETED|Overall Study||2
7621233|NCT02363283|18765862|P1|COMPLETED|Overall Study||35
7621234|NCT02363283|18765862|P1|STARTED|Overall Study||37
7621235|NCT02363270|18765872|P2|NOT COMPLETED|Overall Study||0
7621236|NCT02363270|18765873|P1|NOT COMPLETED|Overall Study||0
7621237|NCT02363270|18765872|P2|COMPLETED|Overall Study||24
7621238|NCT02363270|18765873|P1|COMPLETED|Overall Study||24
7621239|NCT02363270|18765872|P2|STARTED|Overall Study||24
7621240|NCT02363270|18765873|P1|STARTED|Overall Study||24
7621241|NCT02362789|18765881|P3|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||12
7621242|NCT02362789|18765882|P2|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||4
7621243|NCT02362789|18765883|P1|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
7621244|NCT02362789|18765881|P3|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||26
7621245|NCT02362789|18765882|P2|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||38
7621246|NCT02362789|18765883|P1|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
7621247|NCT02362789|18765881|P3|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|38
7621248|NCT02362789|18765882|P2|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|42
7621249|NCT02362789|18765883|P1|STARTED|Randomized Withdrawal (Wk 16 to 32)|N/A. Run-in phase completed.|0
7621250|NCT02362789|18765881|P3|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
7621251|NCT02362789|18765882|P2|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
7621252|NCT02362789|18765883|P1|NOT COMPLETED|Run-in Phase (Week 0 to 16)||2
7621253|NCT02362789|18765881|P3|COMPLETED|Run-in Phase (Week 0 to 16)||0
7621254|NCT02362789|18765882|P2|COMPLETED|Run-in Phase (Week 0 to 16)||0
7621255|NCT02362789|18765883|P1|COMPLETED|Run-in Phase (Week 0 to 16)||128
7621256|NCT02362789|18765881|P3|STARTED|Run-in Phase (Week 0 to 16)||0
7621257|NCT02362789|18765882|P2|STARTED|Run-in Phase (Week 0 to 16)||0
7621258|NCT02362789|18765883|P1|STARTED|Run-in Phase (Week 0 to 16)||130
7621259|NCT02362724|18765892|P2|NOT COMPLETED|Overall Study||1
7621260|NCT02362724|18765893|P1|NOT COMPLETED|Overall Study||6
7621261|NCT02362724|18765892|P2|COMPLETED|Overall Study||29
7621262|NCT02362724|18765893|P1|COMPLETED|Overall Study||53
7621263|NCT02362724|18765892|P2|STARTED|Overall Study||30
7621264|NCT02362724|18765893|P1|STARTED|Overall Study||59
7621265|NCT02362672|18765931|P3|NOT COMPLETED|Double-blind Maintenance Phase||59
7621266|NCT02362672|18765932|P2|NOT COMPLETED|Double-blind Maintenance Phase||60
7621267|NCT02362672|18765933|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
7621268|NCT02362672|18765931|P3|COMPLETED|Double-blind Maintenance Phase||242
7621269|NCT02362672|18765932|P2|COMPLETED|Double-blind Maintenance Phase||249
7621270|NCT02362672|18765933|P1|COMPLETED|Double-blind Maintenance Phase||0
7621271|NCT02362672|18765931|P3|STARTED|Double-blind Maintenance Phase||301
7621272|NCT02362672|18765932|P2|STARTED|Double-blind Maintenance Phase||309
7621273|NCT02362672|18765933|P1|STARTED|Double-blind Maintenance Phase||0
7621274|NCT02362672|18765931|P3|NOT COMPLETED|Titration Phase||0
7621275|NCT02362672|18765932|P2|NOT COMPLETED|Titration Phase||0
7621276|NCT02362672|18765933|P1|NOT COMPLETED|Titration Phase||579
7621277|NCT02362672|18765931|P3|COMPLETED|Titration Phase||0
7621278|NCT02362672|18765932|P2|COMPLETED|Titration Phase||0
7621279|NCT02362672|18765933|P1|COMPLETED|Titration Phase||610
7621280|NCT02362672|18765931|P3|STARTED|Titration Phase||0
7621281|NCT02362672|18765932|P2|STARTED|Titration Phase||0
7621282|NCT02362672|18765933|P1|STARTED|Titration Phase||1189
7621283|NCT02362646|18765952|P2|NOT COMPLETED|Overall Study||24
7621284|NCT02362646|18765953|P1|NOT COMPLETED|Overall Study||38
7621285|NCT02362646|18765952|P2|COMPLETED|Overall Study||29
7621286|NCT02362646|18765953|P1|COMPLETED|Overall Study||68
7621287|NCT02362646|18765952|P2|STARTED|Overall Study||53
7621288|NCT02362646|18765953|P1|STARTED|Overall Study||106
7621289|NCT02362594|18765963|P2|NOT COMPLETED|Overall Study||225
7621290|NCT02362594|18765964|P1|NOT COMPLETED|Overall Study||250
7621291|NCT02362594|18765963|P2|COMPLETED|Overall Study||280
7621292|NCT02362594|18765964|P1|COMPLETED|Overall Study||264
7621293|NCT02362594|18765963|P2|Continuing Part 1 Adjuvant Therapy|Overall Study||21
7621294|NCT02362594|18765964|P1|Continuing Part 1 Adjuvant Therapy|Overall Study||41
7621295|NCT02362594|18765963|P2|Treated|Overall Study||502
7621296|NCT02362594|18765964|P1|Treated|Overall Study||509
7621297|NCT02362594|18765963|P2|STARTED|Overall Study||505
7621298|NCT02362594|18765964|P1|STARTED|Overall Study||514
7621299|NCT02362503|18765985|P3|NOT COMPLETED|Open Label Period-Up to Atleast 96 Weeks||99
7621300|NCT02362503|18765986|P2|NOT COMPLETED|Open Label Period-Up to Atleast 96 Weeks||198
7621301|NCT02362503|18765987|P1|NOT COMPLETED|Open Label Period-Up to Atleast 96 Weeks||68
7621302|NCT02362503|18765985|P3|COMPLETED|Open Label Period-Up to Atleast 96 Weeks||0
7621303|NCT02362503|18765986|P2|COMPLETED|Open Label Period-Up to Atleast 96 Weeks||0
7621304|NCT02362503|18765987|P1|COMPLETED|Open Label Period-Up to Atleast 96 Weeks||0
7621305|NCT02362503|18765985|P3|STARTED|Open Label Period-Up to Atleast 96 Weeks||99
7621306|NCT02362503|18765986|P2|STARTED|Open Label Period-Up to Atleast 96 Weeks|Subject withdrawn due to progression of disease died during study due to squamous cell carcinoma.|198
7621307|NCT02362503|18765987|P1|STARTED|Open Label Period-Up to Atleast 96 Weeks||68
7621308|NCT02362503|18765985|P3|NOT COMPLETED|Double-blind Period-Up to 8 Days||0
7621309|NCT02362503|18765986|P2|NOT COMPLETED|Double-blind Period-Up to 8 Days||5
7621310|NCT02362503|18765987|P1|NOT COMPLETED|Double-blind Period-Up to 8 Days||1
7621311|NCT02362503|18765985|P3|COMPLETED|Double-blind Period-Up to 8 Days||0
7621312|NCT02362503|18765986|P2|COMPLETED|Double-blind Period-Up to 8 Days||198
7621313|NCT02362503|18765987|P1|COMPLETED|Double-blind Period-Up to 8 Days||68
7621314|NCT02362503|18765985|P3|STARTED|Double-blind Period-Up to 8 Days||0
7621315|NCT02362503|18765986|P2|STARTED|Double-blind Period-Up to 8 Days||203
7621316|NCT02362503|18765987|P1|STARTED|Double-blind Period-Up to 8 Days||69
7621317|NCT02362425|18766016|P4|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||3
7621318|NCT02362425|18766017|P3|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||1
7621319|NCT02362425|18766018|P2|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
7621320|NCT02362425|18766019|P1|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
7621321|NCT02362425|18766016|P4|COMPLETED|Phase 2 (up to 6 Months, Randomized)||14
7621322|NCT02362425|18766017|P3|COMPLETED|Phase 2 (up to 6 Months, Randomized)||15
7621323|NCT02362425|18766018|P2|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
7621324|NCT02362425|18766019|P1|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
7621325|NCT02362425|18766016|P4|STARTED|Phase 2 (up to 6 Months, Randomized)||17
7621326|NCT02362425|18766017|P3|STARTED|Phase 2 (up to 6 Months, Randomized)||16
7621327|NCT02362425|18766018|P2|STARTED|Phase 2 (up to 6 Months, Randomized)||0
7621328|NCT02362425|18766019|P1|STARTED|Phase 2 (up to 6 Months, Randomized)||0
7621329|NCT02362425|18766016|P4|NOT COMPLETED|Phase 1 (up to 6 Months)||0
7621330|NCT02362425|18766017|P3|NOT COMPLETED|Phase 1 (up to 6 Months)||0
7621331|NCT02362425|18766018|P2|NOT COMPLETED|Phase 1 (up to 6 Months)||0
7621332|NCT02362425|18766019|P1|NOT COMPLETED|Phase 1 (up to 6 Months)||16
7621333|NCT02362425|18766016|P4|COMPLETED|Phase 1 (up to 6 Months)||0
7621334|NCT02362425|18766017|P3|COMPLETED|Phase 1 (up to 6 Months)||0
7621335|NCT02362425|18766018|P2|COMPLETED|Phase 1 (up to 6 Months)||10
7621336|NCT02362425|18766019|P1|COMPLETED|Phase 1 (up to 6 Months)||37
7621337|NCT02362425|18766016|P4|STARTED|Phase 1 (up to 6 Months)||0
7621338|NCT02362425|18766017|P3|STARTED|Phase 1 (up to 6 Months)||0
7621339|NCT02362425|18766018|P2|STARTED|Phase 1 (up to 6 Months)||10
7621340|NCT02362425|18766019|P1|STARTED|Phase 1 (up to 6 Months)||53
7621341|NCT02362412|18766137|P2|NOT COMPLETED|Treatment Period III||1
7621342|NCT02362412|18766138|P1|NOT COMPLETED|Treatment Period III||0
7621343|NCT02362412|18766137|P2|COMPLETED|Treatment Period III||10
7621344|NCT02362412|18766138|P1|COMPLETED|Treatment Period III||9
7621345|NCT02362412|18766137|P2|TREATED|Treatment Period III||11
7621346|NCT02362412|18766138|P1|TREATED|Treatment Period III||9
7621347|NCT02362412|18766137|P2|STARTED|Treatment Period III||11
7621348|NCT02362412|18766138|P1|STARTED|Treatment Period III||9
7621349|NCT02362412|18766137|P2|NOT COMPLETED|Treatment Period II||0
7621350|NCT02362412|18766138|P1|NOT COMPLETED|Treatment Period II||0
7621351|NCT02362412|18766137|P2|COMPLETED|Treatment Period II||11
7621352|NCT02362412|18766138|P1|COMPLETED|Treatment Period II||9
7621353|NCT02362412|18766137|P2|TREATED|Treatment Period II||11
7621354|NCT02362412|18766138|P1|TREATED|Treatment Period II||9
7621355|NCT02362412|18766137|P2|STARTED|Treatment Period II||11
7621356|NCT02362412|18766138|P1|STARTED|Treatment Period II||9
7621357|NCT02362373|18766164|P1|NOT COMPLETED|Overall Study||0
7621358|NCT02362373|18766164|P1|COMPLETED|Overall Study||20
7621359|NCT02362373|18766164|P1|STARTED|Overall Study||20
7621360|NCT02362360|18766172|P2|NOT COMPLETED|Period 2||0
7621361|NCT02362360|18766173|P1|NOT COMPLETED|Period 2||0
7621362|NCT02362360|18766172|P2|COMPLETED|Period 2||25
7621363|NCT02362360|18766173|P1|COMPLETED|Period 2||23
7621364|NCT02362360|18766172|P2|STARTED|Period 2||25
7621365|NCT02362360|18766173|P1|STARTED|Period 2||23
7621366|NCT02362360|18766172|P2|NOT COMPLETED|Period 1||1
7621367|NCT02362360|18766173|P1|NOT COMPLETED|Period 1||3
7621368|NCT02362360|18766172|P2|COMPLETED|Period 1||25
7621369|NCT02362360|18766173|P1|COMPLETED|Period 1||23
7621370|NCT02362360|18766172|P2|STARTED|Period 1||26
7621371|NCT02362360|18766173|P1|STARTED|Period 1||26
7621372|NCT02362321|18766181|P2|NOT COMPLETED|Overall Study||0
7621373|NCT02362321|18766182|P1|NOT COMPLETED|Overall Study||4
7621374|NCT02362321|18766181|P2|COMPLETED|Overall Study||10
7621375|NCT02362321|18766182|P1|COMPLETED|Overall Study||6
7621376|NCT02362321|18766181|P2|STARTED|Overall Study||10
7621377|NCT02362321|18766182|P1|STARTED|Overall Study||10
7621378|NCT02362282|18766190|P2|NOT COMPLETED|Overall Study||0
7621379|NCT02362282|18766191|P1|NOT COMPLETED|Overall Study||1
7621380|NCT02362282|18766190|P2|COMPLETED|Overall Study||7
7621381|NCT02362282|18766191|P1|COMPLETED|Overall Study||4
7621382|NCT02362282|18766190|P2|STARTED|Overall Study||7
7621383|NCT02362282|18766191|P1|STARTED|Overall Study||5
7621384|NCT02362269|18766199|P2|NOT COMPLETED|Overall Study||6
7621385|NCT02362269|18766200|P1|NOT COMPLETED|Overall Study||1
7621386|NCT02362269|18766199|P2|COMPLETED|Overall Study||80
7621387|NCT02362269|18766200|P1|COMPLETED|Overall Study||82
7621388|NCT02362269|18766199|P2|STARTED|Overall Study||86
7621389|NCT02362269|18766200|P1|STARTED|Overall Study||83
7621390|NCT02362191|18766206|P1|NOT COMPLETED|Overall Study||2
7621391|NCT02362191|18766206|P1|COMPLETED|Overall Study||3
7621392|NCT02362191|18766206|P1|STARTED|Overall Study||5
7621393|NCT02362048|18766213|P2|NOT COMPLETED|Overall Study||40
7621394|NCT02362048|18766214|P1|NOT COMPLETED|Overall Study||37
7621395|NCT02362048|18766213|P2|COMPLETED|Overall Study||0
7621396|NCT02362048|18766214|P1|COMPLETED|Overall Study||0
7621397|NCT02362048|18766213|P2|Discontinued Study|Overall Study||40
7621398|NCT02362048|18766214|P1|Discontinued Study|Overall Study||37
7621399|NCT02362048|18766213|P2|Received Study Medication|Overall Study||38
7621400|NCT02362048|18766214|P1|Received Study Medication|Overall Study||35
7621401|NCT02362048|18766213|P2|Enrolled|Overall Study||40
7621402|NCT02362048|18766214|P1|Enrolled|Overall Study||37
7621403|NCT02362048|18766213|P2|STARTED|Overall Study|40 enrolled but only 38 received study medication.|40
7621404|NCT02362048|18766214|P1|STARTED|Overall Study|37 enrolled but only 35 received study medication.|37
7621405|NCT02361762|18766222|P2|NOT COMPLETED|Overall Study||2
7621406|NCT02361762|18766223|P1|NOT COMPLETED|Overall Study||0
7621407|NCT02361762|18766222|P2|COMPLETED|Overall Study||33
7621408|NCT02361762|18766223|P1|COMPLETED|Overall Study||35
7621409|NCT02361762|18766222|P2|STARTED|Overall Study||35
7621410|NCT02361762|18766223|P1|STARTED|Overall Study||35
7621411|NCT02361736|18766253|P2|NOT COMPLETED|Overall Study||1
7621412|NCT02361736|18766254|P1|NOT COMPLETED|Overall Study||1
7621413|NCT02361736|18766253|P2|COMPLETED|Overall Study||59
7621414|NCT02361736|18766254|P1|COMPLETED|Overall Study||59
7621415|NCT02361736|18766253|P2|STARTED|Overall Study||60
7621416|NCT02361736|18766254|P1|STARTED|Overall Study||60
7621417|NCT02361580|18766274|P2|NOT COMPLETED|Overall Study||3
7621418|NCT02361580|18766275|P1|NOT COMPLETED|Overall Study||6
7621419|NCT02361580|18766274|P2|COMPLETED|Overall Study||0
7621420|NCT02361580|18766275|P1|COMPLETED|Overall Study||0
7621421|NCT02361580|18766274|P2|STARTED|Overall Study||3
7621422|NCT02361580|18766275|P1|STARTED|Overall Study||6
7621423|NCT02361476|18766287|P2|NOT COMPLETED|Overall Study||0
7621424|NCT02361476|18766288|P1|NOT COMPLETED|Overall Study||0
7621425|NCT02361476|18766287|P2|COMPLETED|Overall Study||188
7621426|NCT02361476|18766288|P1|COMPLETED|Overall Study||191
7621427|NCT02361476|18766287|P2|STARTED|Overall Study||188
7621428|NCT02361476|18766288|P1|STARTED|Overall Study||191
7621429|NCT02361216|18766304|P2|NOT COMPLETED|12-month Follow-up||27
7621430|NCT02361216|18766305|P1|NOT COMPLETED|12-month Follow-up||52
7621431|NCT02361216|18766304|P2|COMPLETED|12-month Follow-up||130
7621432|NCT02361216|18766305|P1|COMPLETED|12-month Follow-up||489
7621433|NCT02361216|18766304|P2|STARTED|12-month Follow-up|1 of the 158 subjects did not receive treatment and was also excluded from the 12-month follow-up.|157
7621434|NCT02361216|18766305|P1|STARTED|12-month Follow-up||541
7621435|NCT02361216|18766304|P2|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||19
7621436|NCT02361216|18766305|P1|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||11
7621437|NCT02361216|18766304|P2|COMPLETED|3 Day Treatment and 8 Week Follow/up||158
7621438|NCT02361216|18766305|P1|COMPLETED|3 Day Treatment and 8 Week Follow/up||541
7621439|NCT02361216|18766304|P2|STARTED|3 Day Treatment and 8 Week Follow/up||177
7621440|NCT02361216|18766305|P1|STARTED|3 Day Treatment and 8 Week Follow/up||552
7621441|NCT02360995|18766320|P3|NOT COMPLETED|Overall Study||2
7621442|NCT02360995|18766321|P2|NOT COMPLETED|Overall Study||1
7621443|NCT02360995|18766322|P1|NOT COMPLETED|Overall Study||2
7621444|NCT02360995|18766320|P3|COMPLETED|Overall Study||41
7621445|NCT02360995|18766321|P2|COMPLETED|Overall Study||42
7621446|NCT02360995|18766322|P1|COMPLETED|Overall Study||41
7621447|NCT02360995|18766320|P3|STARTED|Overall Study||43
7621448|NCT02360995|18766321|P2|STARTED|Overall Study||43
7621449|NCT02360995|18766322|P1|STARTED|Overall Study||43
7621450|NCT02360774|18766347|P2|NOT COMPLETED|Overall Study||2
7621451|NCT02360774|18766348|P1|NOT COMPLETED|Overall Study||3
7621452|NCT02360774|18766347|P2|COMPLETED|Overall Study||13
7621453|NCT02360774|18766348|P1|COMPLETED|Overall Study||12
7621454|NCT02360774|18766347|P2|STARTED|Overall Study||15
7621455|NCT02360774|18766348|P1|STARTED|Overall Study||15
7621456|NCT02360631|18766362|P2|NOT COMPLETED|Overall Study||26
7621457|NCT02360631|18766363|P1|NOT COMPLETED|Overall Study||33
7621458|NCT02360631|18766362|P2|COMPLETED|Overall Study||174
7621459|NCT02360631|18766363|P1|COMPLETED|Overall Study||267
7621460|NCT02360631|18766362|P2|Week 12|Overall Study||165
7621461|NCT02360631|18766363|P1|Week 12|Overall Study||249
7621462|NCT02360631|18766362|P2|STARTED|Overall Study||200
7621463|NCT02360631|18766363|P1|STARTED|Overall Study||300
7621464|NCT02360488|18766375|P2|NOT COMPLETED|Overall Study||7
7621465|NCT02360488|18766376|P1|NOT COMPLETED|Overall Study||3
7621466|NCT02360488|18766375|P2|COMPLETED|Overall Study||55
7621467|NCT02360488|18766376|P1|COMPLETED|Overall Study||59
7621468|NCT02360488|18766375|P2|STARTED|Overall Study||62
7621469|NCT02360488|18766376|P1|STARTED|Overall Study||62
7621470|NCT02360475|18766386|P4|NOT COMPLETED|Overall Study||5
7621471|NCT02360475|18766387|P3|NOT COMPLETED|Overall Study||8
7621472|NCT02360475|18766388|P2|NOT COMPLETED|Overall Study||13
7621473|NCT02360475|18766389|P1|NOT COMPLETED|Overall Study||4
7621474|NCT02360475|18766386|P4|COMPLETED|Overall Study||120
7621475|NCT02360475|18766387|P3|COMPLETED|Overall Study||117
7621476|NCT02360475|18766388|P2|COMPLETED|Overall Study||111
7621477|NCT02360475|18766389|P1|COMPLETED|Overall Study||122
7621478|NCT02360475|18766386|P4|STARTED|Overall Study||125
7621479|NCT02360475|18766387|P3|STARTED|Overall Study||125
7621480|NCT02360475|18766388|P2|STARTED|Overall Study||124
7621481|NCT02360475|18766389|P1|STARTED|Overall Study||126
7621482|NCT02360397|18766447|P1|NOT COMPLETED|Overall Study||4
7621483|NCT02360397|18766447|P1|COMPLETED|Overall Study||2
7621484|NCT02360397|18766447|P1|STARTED|Overall Study||6
7621485|NCT02360319|18766456|P2|NOT COMPLETED|Overall Study||61
7621486|NCT02360319|18766457|P1|NOT COMPLETED|Overall Study||88
7621487|NCT02360319|18766456|P2|COMPLETED|Overall Study||173
7621488|NCT02360319|18766457|P1|COMPLETED|Overall Study||167
7621489|NCT02360319|18766456|P2|STARTED|Overall Study||234
7621490|NCT02360319|18766457|P1|STARTED|Overall Study||255
7621491|NCT02360293|18766473|P2|NOT COMPLETED|Overall Study||96
7621492|NCT02360293|18766474|P1|NOT COMPLETED|Overall Study||76
7621493|NCT02360293|18766473|P2|COMPLETED|Overall Study||83
7621494|NCT02360293|18766474|P1|COMPLETED|Overall Study||102
7621495|NCT02360293|18766473|P2|12month Physical Activity|Overall Study||59
7621496|NCT02360293|18766474|P1|12month Physical Activity|Overall Study||68
7621497|NCT02360293|18766473|P2|12month f/u Survey|Overall Study||83
7621498|NCT02360293|18766474|P1|12month f/u Survey|Overall Study||102
7621499|NCT02360293|18766473|P2|6month Physical Activity|Overall Study||108
7621500|NCT02360293|18766474|P1|6month Physical Activity|Overall Study||122
7621501|NCT02360293|18766473|P2|6month f/u Survey|Overall Study||105
7621502|NCT02360293|18766474|P1|6month f/u Survey|Overall Study||110
7621503|NCT02360293|18766473|P2|STARTED|Overall Study||179
7621504|NCT02360293|18766474|P1|STARTED|Overall Study||178
7621505|NCT02360280|18766488|P2|NOT COMPLETED|Overall Study||1
7621506|NCT02360280|18766489|P1|NOT COMPLETED|Overall Study||3
7621507|NCT02360280|18766488|P2|COMPLETED|Overall Study||29
7621508|NCT02360280|18766489|P1|COMPLETED|Overall Study||25
7621509|NCT02360280|18766488|P2|STARTED|Overall Study||30
7621510|NCT02360280|18766489|P1|STARTED|Overall Study||28
7621511|NCT02360228|18766504|P3|NOT COMPLETED|Overall Study||1
7621512|NCT02360228|18766505|P2|NOT COMPLETED|Overall Study||1
7621513|NCT02360228|18766506|P1|NOT COMPLETED|Overall Study||1
7621514|NCT02360228|18766504|P3|COMPLETED|Overall Study||7
7621515|NCT02360228|18766505|P2|COMPLETED|Overall Study||7
7621516|NCT02360228|18766506|P1|COMPLETED|Overall Study||8
7621517|NCT02360228|18766504|P3|STARTED|Overall Study||8
7621518|NCT02360228|18766505|P2|STARTED|Overall Study||8
7621519|NCT02360228|18766506|P1|STARTED|Overall Study||9
7621520|NCT02360215|18766534|P2|NOT COMPLETED|Overall Study||0
7621521|NCT02360215|18766535|P1|NOT COMPLETED|Overall Study||0
7621522|NCT02360215|18766534|P2|COMPLETED|Overall Study||261
7621523|NCT02360215|18766535|P1|COMPLETED|Overall Study||257
7621524|NCT02360215|18766534|P2|EQ-5D-5L VAS at 12 Months|Overall Study||48
7621525|NCT02360215|18766535|P1|EQ-5D-5L VAS at 12 Months|Overall Study||57
7621526|NCT02360215|18766534|P2|EQ-5D-5L VAS at 6 Months|Overall Study||69
7621527|NCT02360215|18766535|P1|EQ-5D-5L VAS at 6 Months|Overall Study||76
7621528|NCT02360215|18766534|P2|EQ-5D-5L VAS at 4 Months|Overall Study||193
7621529|NCT02360215|18766535|P1|EQ-5D-5L VAS at 4 Months|Overall Study||104
7621530|NCT02360215|18766534|P2|EQ-5D-5L VAS at 2 Months|Overall Study||123
7621531|NCT02360215|18766535|P1|EQ-5D-5L VAS at 2 Months|Overall Study||139
7621532|NCT02360215|18766534|P2|EQ-5D-5L Index at 12 Months|Overall Study||45
7621533|NCT02360215|18766535|P1|EQ-5D-5L Index at 12 Months|Overall Study||56
7621534|NCT02360215|18766534|P2|EQ-5D-5L Index at 6 Months|Overall Study||70
7621535|NCT02360215|18766535|P1|EQ-5D-5L Index at 6 Months|Overall Study||79
7621536|NCT02360215|18766534|P2|EQ-5D-5L Index at 4 Months|Overall Study||96
7621537|NCT02360215|18766535|P1|EQ-5D-5L Index at 4 Months|Overall Study||110
7621538|NCT02360215|18766534|P2|EQ-5D-5L Index at 2 Months|Overall Study||125
7621539|NCT02360215|18766535|P1|EQ-5D-5L Index at 2 Months|Overall Study||142
7621540|NCT02360215|18766534|P2|Clinical Trial Battery Composite Score|Overall Study||259
7621541|NCT02360215|18766535|P1|Clinical Trial Battery Composite Score|Overall Study||255
7621542|NCT02360215|18766534|P2|Controlled Oral Word Association (COWA)|Overall Study||261
7621543|NCT02360215|18766535|P1|Controlled Oral Word Association (COWA)|Overall Study||257
7621544|NCT02360215|18766534|P2|TMT Part B|Overall Study||257
7621545|NCT02360215|18766535|P1|TMT Part B|Overall Study||250
7621546|NCT02360215|18766534|P2|Trail Making Test (TMT) Part A|Overall Study||260
7621547|NCT02360215|18766535|P1|Trail Making Test (TMT) Part A|Overall Study||256
7621548|NCT02360215|18766534|P2|HVLT-R Recognition|Overall Study||259
7621549|NCT02360215|18766535|P1|HVLT-R Recognition|Overall Study||255
7621550|NCT02360215|18766534|P2|HVLT-R Delayed Recall|Overall Study||259
7621551|NCT02360215|18766535|P1|HVLT-R Delayed Recall|Overall Study||256
7621552|NCT02360215|18766534|P2|HVLT-R Total Recall|Overall Study||259
7621553|NCT02360215|18766535|P1|HVLT-R Total Recall|Overall Study||256
7621554|NCT02360215|18766534|P2|MDASI-BT Neurologic Factor Score|Overall Study||251
7621555|NCT02360215|18766535|P1|MDASI-BT Neurologic Factor Score|Overall Study||249
7621556|NCT02360215|18766534|P2|MDASI-BT Cognitive Factor Score|Overall Study||251
7621557|NCT02360215|18766535|P1|MDASI-BT Cognitive Factor Score|Overall Study||249
7621558|NCT02360215|18766534|P2|MDASI-BT Intererence Score|Overall Study||251
7621559|NCT02360215|18766535|P1|MDASI-BT Intererence Score|Overall Study||248
7621560|NCT02360215|18766534|P2|MDASI-BT Symptom Score|Overall Study||251
7621561|NCT02360215|18766535|P1|MDASI-BT Symptom Score|Overall Study||249
7621562|NCT02360215|18766534|P2|Started Protocol Treatment|Overall Study||223
7621563|NCT02360215|18766535|P1|Started Protocol Treatment|Overall Study||232
7621564|NCT02360215|18766534|P2|All Randomized Participants|Overall Study||261
7621565|NCT02360215|18766535|P1|All Randomized Participants|Overall Study||257
7621566|NCT02360215|18766534|P2|STARTED|Overall Study||261
7621567|NCT02360215|18766535|P1|STARTED|Overall Study||257
7621568|NCT02360124|18766588|P3|NOT COMPLETED|Overall Study||26
7621569|NCT02360124|18766589|P2|NOT COMPLETED|Overall Study||12
7621570|NCT02360124|18766590|P1|NOT COMPLETED|Overall Study||28
7621571|NCT02360124|18766588|P3|COMPLETED|Overall Study||82
7621572|NCT02360124|18766589|P2|COMPLETED|Overall Study||95
7621573|NCT02360124|18766590|P1|COMPLETED|Overall Study||80
7621574|NCT02360124|18766588|P3|STARTED|Overall Study||108
7621575|NCT02360124|18766589|P2|STARTED|Overall Study||107
7621576|NCT02360124|18766590|P1|STARTED|Overall Study||108
7621577|NCT02360111|18766601|P1|NOT COMPLETED|Overall Study||2
7621578|NCT02360111|18766601|P1|COMPLETED|Overall Study||1
7621579|NCT02360111|18766601|P1|STARTED|Overall Study||3
7621580|NCT02360098|18766611|P1|NOT COMPLETED|Overall Study||7
7621581|NCT02360098|18766611|P1|COMPLETED|Overall Study||29
7621582|NCT02360098|18766611|P1|STARTED|Overall Study||36
7621583|NCT02360085|18766616|P1|NOT COMPLETED|Overall Study||16
7621584|NCT02360085|18766616|P1|COMPLETED|Overall Study||49
7621585|NCT02360085|18766616|P1|STARTED|Overall Study||65
7621586|NCT02360059|18766629|P2|NOT COMPLETED|Overall Study||0
7621587|NCT02360059|18766630|P1|NOT COMPLETED|Overall Study||0
7621588|NCT02360059|18766629|P2|COMPLETED|Overall Study||0
7621589|NCT02360059|18766630|P1|COMPLETED|Overall Study||1
7621590|NCT02360059|18766629|P2|STARTED|Overall Study||0
7621591|NCT02360059|18766630|P1|STARTED|Overall Study||1
7621592|NCT02359955|18766638|P2|NOT COMPLETED|Overall Study||0
7621593|NCT02359955|18766639|P1|NOT COMPLETED|Overall Study||0
7621594|NCT02359955|18766638|P2|COMPLETED|Overall Study||10
7621595|NCT02359955|18766639|P1|COMPLETED|Overall Study||10
7621596|NCT02359955|18766638|P2|STARTED|Overall Study||10
7621597|NCT02359955|18766639|P1|STARTED|Overall Study||10
7621598|NCT02359916|18766662|P7|NOT COMPLETED|Overall Study||0
7621599|NCT02359916|18766663|P6|NOT COMPLETED|Overall Study||0
7621600|NCT02359916|18766664|P5|NOT COMPLETED|Overall Study||0
7621601|NCT02359916|18766665|P4|NOT COMPLETED|Overall Study||0
7621602|NCT02359916|18766666|P3|NOT COMPLETED|Overall Study||0
7621603|NCT02359916|18766667|P2|NOT COMPLETED|Overall Study||0
7621604|NCT02359916|18766668|P1|NOT COMPLETED|Overall Study||0
7621605|NCT02359916|18766662|P7|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
7621606|NCT02359916|18766663|P6|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
7621607|NCT02359916|18766664|P5|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
7621608|NCT02359916|18766665|P4|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
7621609|NCT02359916|18766666|P3|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
7621610|NCT02359916|18766667|P2|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
7621611|NCT02359916|18766668|P1|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
7621612|NCT02359916|18766662|P7|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
7621613|NCT02359916|18766663|P6|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
7621614|NCT02359916|18766664|P5|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
7621615|NCT02359916|18766665|P4|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
7621616|NCT02359916|18766666|P3|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
7621617|NCT02359916|18766667|P2|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
7621618|NCT02359916|18766668|P1|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
7621619|NCT02359903|18766690|P2|NOT COMPLETED|Overall Study||2
7621620|NCT02359903|18766691|P1|NOT COMPLETED|Overall Study||0
7621621|NCT02359903|18766690|P2|COMPLETED|Overall Study||43
7621622|NCT02359903|18766691|P1|COMPLETED|Overall Study||45
7621623|NCT02359903|18766690|P2|STARTED|Overall Study||45
7621624|NCT02359903|18766691|P1|STARTED|Overall Study||45
7621625|NCT02359890|18766699|P1|NOT COMPLETED|Overall Study||10
7621626|NCT02359890|18766699|P1|COMPLETED|Overall Study||155
7621627|NCT02359890|18766699|P1|Per-Protocol (PP) Population|Overall Study|Subjects part of mITT population who had undergone RF ablation.|155
7621628|NCT02359890|18766699|P1|mITT Population|Overall Study|Enrolled subjects who met the inclusion/exclusion criteria and had the study catheter inserted|155
7621629|NCT02359890|18766699|P1|Safety Population|Overall Study|Enrolled subjects who had the study catheter inserted|159
7621630|NCT02359890|18766699|P1|STARTED|Overall Study|Patients who enrolled in the study are those who signed informed consent forms.|165
7621631|NCT02359877|18766710|P4|NOT COMPLETED|Overall Study||3
7621632|NCT02359877|18766711|P3|NOT COMPLETED|Overall Study||0
7621633|NCT02359877|18766712|P2|NOT COMPLETED|Overall Study||0
7621634|NCT02359877|18766713|P1|NOT COMPLETED|Overall Study||1
7621635|NCT02359877|18766710|P4|COMPLETED|Overall Study||11
7621636|NCT02359877|18766711|P3|COMPLETED|Overall Study||6
7621637|NCT02359877|18766712|P2|COMPLETED|Overall Study||6
7621638|NCT02359877|18766713|P1|COMPLETED|Overall Study||33
7621639|NCT02359877|18766710|P4|STARTED|Overall Study||14
7621640|NCT02359877|18766711|P3|STARTED|Overall Study||6
7621641|NCT02359877|18766712|P2|STARTED|Overall Study||6
7621642|NCT02359877|18766713|P1|STARTED|Overall Study||34
7621643|NCT02359851|18766763|P1|NOT COMPLETED|Overall Study||2
7621644|NCT02359851|18766763|P1|COMPLETED|Overall Study||3
7621645|NCT02359851|18766763|P1|STARTED|Overall Study||5
7621646|NCT02359552|18766773|P2|NOT COMPLETED|Overall Study||4
7621647|NCT02359552|18766774|P1|NOT COMPLETED|Overall Study||3
7621648|NCT02359552|18766773|P2|COMPLETED|Overall Study||21
7621649|NCT02359552|18766774|P1|COMPLETED|Overall Study||22
7621650|NCT02359552|18766773|P2|STARTED|Overall Study||25
7621651|NCT02359552|18766774|P1|STARTED|Overall Study||25
7621652|NCT02359435|18766796|P2|NOT COMPLETED|Overall Study||4
7621653|NCT02359435|18766797|P1|NOT COMPLETED|Overall Study||4
7621654|NCT02359435|18766796|P2|COMPLETED|Overall Study||216
7621655|NCT02359435|18766797|P1|COMPLETED|Overall Study||216
7621656|NCT02359435|18766796|P2|STARTED|Overall Study||220
7621657|NCT02359435|18766797|P1|STARTED|Overall Study||220
7621658|NCT02359305|18766805|P2|NOT COMPLETED|Overall Study||0
7621659|NCT02359305|18766806|P1|NOT COMPLETED|Overall Study||0
7621660|NCT02359305|18766805|P2|COMPLETED|Overall Study||34
7621661|NCT02359305|18766806|P1|COMPLETED|Overall Study||34
7621662|NCT02359305|18766805|P2|STARTED|Overall Study||34
7621663|NCT02359305|18766806|P1|STARTED|Overall Study||34
7621664|NCT02359110|18766818|P2|NOT COMPLETED|Overall Study||0
7621665|NCT02359110|18766819|P1|NOT COMPLETED|Overall Study||0
7621666|NCT02359110|18766818|P2|COMPLETED|Overall Study||54
7621667|NCT02359110|18766819|P1|COMPLETED|Overall Study||55
7621668|NCT02359110|18766818|P2|STARTED|Overall Study||54
7621669|NCT02359110|18766819|P1|STARTED|Overall Study||55
7621670|NCT02359058|18766832|P3|NOT COMPLETED|Overall Study||0
7621671|NCT02359058|18766833|P2|NOT COMPLETED|Overall Study||0
7621672|NCT02359058|18766834|P1|NOT COMPLETED|Overall Study||0
7621673|NCT02359058|18766832|P3|COMPLETED|Overall Study||6
7621674|NCT02359058|18766833|P2|COMPLETED|Overall Study||6
7621675|NCT02359058|18766834|P1|COMPLETED|Overall Study||6
7621676|NCT02359058|18766832|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
7621677|NCT02359058|18766833|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
7621678|NCT02359058|18766834|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
7621679|NCT02359058|18766832|P3|STARTED|Overall Study||6
7621680|NCT02359058|18766833|P2|STARTED|Overall Study||6
7621681|NCT02359058|18766834|P1|STARTED|Overall Study||6
7621682|NCT02359045|18766857|P2|NOT COMPLETED|Overall Study||3
7621683|NCT02359045|18766858|P1|NOT COMPLETED|Overall Study||4
7621684|NCT02359045|18766857|P2|COMPLETED|Overall Study||39
7621685|NCT02359045|18766858|P1|COMPLETED|Overall Study||36
7621686|NCT02359045|18766857|P2|STARTED|Overall Study||42
7621687|NCT02359045|18766858|P1|STARTED|Overall Study||40
7621688|NCT02359019|18767091|P1|NOT COMPLETED|Overall Study||0
7621689|NCT02359019|18767091|P1|COMPLETED|Overall Study||45
7621690|NCT02359019|18767091|P1|STARTED|Overall Study||45
7621691|NCT02359006|18767099|P2|NOT COMPLETED|Overall Study||3
7621692|NCT02359006|18767100|P1|NOT COMPLETED|Overall Study||4
7621693|NCT02359006|18767099|P2|COMPLETED|Overall Study||10
7621694|NCT02359006|18767100|P1|COMPLETED|Overall Study||10
7621695|NCT02359006|18767099|P2|STARTED|Overall Study||13
7621696|NCT02359006|18767100|P1|STARTED|Overall Study||14
7621697|NCT02358889|18767143|P3|NOT COMPLETED|Overall Study||1
7621698|NCT02358889|18767144|P2|NOT COMPLETED|Overall Study||2
7621699|NCT02358889|18767145|P1|NOT COMPLETED|Overall Study||0
7621700|NCT02358889|18767143|P3|COMPLETED|Overall Study||27
7621701|NCT02358889|18767144|P2|COMPLETED|Overall Study||28
7621702|NCT02358889|18767145|P1|COMPLETED|Overall Study||30
7621703|NCT02358889|18767143|P3|STARTED|Overall Study||28
7621704|NCT02358889|18767144|P2|STARTED|Overall Study||30
7621705|NCT02358889|18767145|P1|STARTED|Overall Study||30
7621706|NCT02358876|18767162|P1|NOT COMPLETED|Overall Study||2
7621707|NCT02358876|18767162|P1|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30
7621708|NCT02358876|18767162|P1|STARTED|Overall Study||32
7621709|NCT02358863|18767166|P1|NOT COMPLETED|Overall Study||3
7621710|NCT02358863|18767166|P1|COMPLETED|Overall Study||10
7621711|NCT02358863|18767166|P1|STARTED|Overall Study||13
7621712|NCT02358668|18767173|P3|NOT COMPLETED|Overall Study||0
7621713|NCT02358668|18767174|P2|NOT COMPLETED|Overall Study||1
7621714|NCT02358668|18767175|P1|NOT COMPLETED|Overall Study||2
7621715|NCT02358668|18767173|P3|COMPLETED|Overall Study||12
7621716|NCT02358668|18767174|P2|COMPLETED|Overall Study||23
7621717|NCT02358668|18767175|P1|COMPLETED|Overall Study||22
7621718|NCT02358668|18767173|P3|STARTED|Overall Study||12
7621719|NCT02358668|18767174|P2|STARTED|Overall Study||24
7621720|NCT02358668|18767175|P1|STARTED|Overall Study||24
7621721|NCT02358603|18767317|P2|NOT COMPLETED|Overall Study||0
7621722|NCT02358603|18767318|P1|NOT COMPLETED|Overall Study||0
7621723|NCT02358603|18767317|P2|COMPLETED|Overall Study||8
7621724|NCT02358603|18767318|P1|COMPLETED|Overall Study||40
7621725|NCT02358603|18767317|P2|STARTED|Overall Study||8
7621726|NCT02358603|18767318|P1|STARTED|Overall Study||40
7621727|NCT02358473|18767324|P1|NOT COMPLETED|Overall Study||13
7621728|NCT02358473|18767324|P1|COMPLETED|Overall Study||0
7621729|NCT02358473|18767324|P1|STARTED|Overall Study||13
7621730|NCT02358369|18767336|P5|NOT COMPLETED|Treatment Period C||7
7621731|NCT02358369|18767337|P4|NOT COMPLETED|Treatment Period C||0
7621732|NCT02358369|18767338|P3|NOT COMPLETED|Treatment Period C||0
7621733|NCT02358369|18767339|P2|NOT COMPLETED|Treatment Period C||0
7621734|NCT02358369|18767340|P1|NOT COMPLETED|Treatment Period C||0
7621735|NCT02358369|18767336|P5|COMPLETED|Treatment Period C||106
7621736|NCT02358369|18767337|P4|COMPLETED|Treatment Period C||0
7621737|NCT02358369|18767338|P3|COMPLETED|Treatment Period C||0
7621738|NCT02358369|18767339|P2|COMPLETED|Treatment Period C||0
7621739|NCT02358369|18767340|P1|COMPLETED|Treatment Period C||0
7621740|NCT02358369|18767336|P5|STARTED|Treatment Period C||113
7621741|NCT02358369|18767337|P4|STARTED|Treatment Period C||0
7621742|NCT02358369|18767338|P3|STARTED|Treatment Period C||0
7621743|NCT02358369|18767339|P2|STARTED|Treatment Period C||0
7621744|NCT02358369|18767340|P1|STARTED|Treatment Period C||0
7621745|NCT02358369|18767336|P5|NOT COMPLETED|Treatment Period A/B||0
7621746|NCT02358369|18767337|P4|NOT COMPLETED|Treatment Period A/B||4
7621747|NCT02358369|18767338|P3|NOT COMPLETED|Treatment Period A/B||2
7621748|NCT02358369|18767339|P2|NOT COMPLETED|Treatment Period A/B||2
7621749|NCT02358369|18767340|P1|NOT COMPLETED|Treatment Period A/B||0
7621750|NCT02358369|18767336|P5|COMPLETED|Treatment Period A/B||0
7621751|NCT02358369|18767337|P4|COMPLETED|Treatment Period A/B||37
7621752|NCT02358369|18767338|P3|COMPLETED|Treatment Period A/B||38
7621753|NCT02358369|18767339|P2|COMPLETED|Treatment Period A/B||38
7621754|NCT02358369|18767340|P1|COMPLETED|Treatment Period A/B||0
7621755|NCT02358369|18767336|P5|STARTED|Treatment Period A/B||0
7621756|NCT02358369|18767337|P4|STARTED|Treatment Period A/B||41
7621757|NCT02358369|18767338|P3|STARTED|Treatment Period A/B||40
7621758|NCT02358369|18767339|P2|STARTED|Treatment Period A/B||40
7621759|NCT02358369|18767340|P1|STARTED|Treatment Period A/B||0
7621760|NCT02358369|18767336|P5|NOT COMPLETED|Pre-Randomization Washout Period||0
7621761|NCT02358369|18767337|P4|NOT COMPLETED|Pre-Randomization Washout Period||0
7621762|NCT02358369|18767338|P3|NOT COMPLETED|Pre-Randomization Washout Period||0
7621763|NCT02358369|18767339|P2|NOT COMPLETED|Pre-Randomization Washout Period||0
7621764|NCT02358369|18767340|P1|NOT COMPLETED|Pre-Randomization Washout Period||35
7621765|NCT02358369|18767336|P5|COMPLETED|Pre-Randomization Washout Period||0
7621766|NCT02358369|18767337|P4|COMPLETED|Pre-Randomization Washout Period||0
7621767|NCT02358369|18767338|P3|COMPLETED|Pre-Randomization Washout Period||0
7621768|NCT02358369|18767339|P2|COMPLETED|Pre-Randomization Washout Period||0
7621769|NCT02358369|18767340|P1|COMPLETED|Pre-Randomization Washout Period||121
7621770|NCT02358369|18767336|P5|STARTED|Pre-Randomization Washout Period||0
7621771|NCT02358369|18767337|P4|STARTED|Pre-Randomization Washout Period||0
7621772|NCT02358369|18767338|P3|STARTED|Pre-Randomization Washout Period||0
7621773|NCT02358369|18767339|P2|STARTED|Pre-Randomization Washout Period||0
7621774|NCT02358369|18767340|P1|STARTED|Pre-Randomization Washout Period||156
7621775|NCT02358343|18767386|P5|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
7621776|NCT02358343|18767387|P4|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
7621777|NCT02358343|18767388|P3|NOT COMPLETED|Comparative Efficacy Trial / Observation||5
7621778|NCT02358343|18767389|P2|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
7621779|NCT02358343|18767390|P1|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
7621780|NCT02358343|18767386|P5|COMPLETED|Comparative Efficacy Trial / Observation||18
7621781|NCT02358343|18767387|P4|COMPLETED|Comparative Efficacy Trial / Observation||58
7621782|NCT02358343|18767388|P3|COMPLETED|Comparative Efficacy Trial / Observation||55
7621783|NCT02358343|18767389|P2|COMPLETED|Comparative Efficacy Trial / Observation||0
7621784|NCT02358343|18767390|P1|COMPLETED|Comparative Efficacy Trial / Observation||0
7621785|NCT02358343|18767386|P5|STARTED|Comparative Efficacy Trial / Observation||20
7621786|NCT02358343|18767387|P4|STARTED|Comparative Efficacy Trial / Observation|47 completed treatment|60
7621787|NCT02358343|18767388|P3|STARTED|Comparative Efficacy Trial / Observation|44 completed treatment|60
7621788|NCT02358343|18767389|P2|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
7621789|NCT02358343|18767390|P1|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
7621790|NCT02358343|18767386|P5|NOT COMPLETED|Screening Intervention||0
7621791|NCT02358343|18767387|P4|NOT COMPLETED|Screening Intervention||0
7621792|NCT02358343|18767388|P3|NOT COMPLETED|Screening Intervention||0
7621793|NCT02358343|18767389|P2|NOT COMPLETED|Screening Intervention||8
7621794|NCT02358343|18767390|P1|NOT COMPLETED|Screening Intervention||6
7621795|NCT02358343|18767386|P5|COMPLETED|Screening Intervention||0
7621796|NCT02358343|18767387|P4|COMPLETED|Screening Intervention||0
7621797|NCT02358343|18767388|P3|COMPLETED|Screening Intervention||0
7621798|NCT02358343|18767389|P2|COMPLETED|Screening Intervention||84
7621799|NCT02358343|18767390|P1|COMPLETED|Screening Intervention||86
7621800|NCT02358343|18767386|P5|STARTED|Screening Intervention||0
7621801|NCT02358343|18767387|P4|STARTED|Screening Intervention||0
7621802|NCT02358343|18767388|P3|STARTED|Screening Intervention||0
7621803|NCT02358343|18767389|P2|STARTED|Screening Intervention|89 completed control visit|92
7621804|NCT02358343|18767390|P1|STARTED|Screening Intervention|90 completed engagement interview|92
7621805|NCT02358135|18767427|P2|NOT COMPLETED|Overall Study||19
7621806|NCT02358135|18767428|P1|NOT COMPLETED|Overall Study||15
7621807|NCT02358135|18767427|P2|COMPLETED|Overall Study||131
7621808|NCT02358135|18767428|P1|COMPLETED|Overall Study||135
7621809|NCT02358135|18767427|P2|Randomized|Overall Study||148
7621810|NCT02358135|18767428|P1|Randomized|Overall Study||148
7621811|NCT02358135|18767427|P2|STARTED|Overall Study||150
7621812|NCT02358135|18767428|P1|STARTED|Overall Study||150
7621813|NCT02358044|18767446|P2|NOT COMPLETED|Overall Study||7
7621814|NCT02358044|18767447|P1|NOT COMPLETED|Overall Study||2
7621815|NCT02358044|18767446|P2|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|121
7621816|NCT02358044|18767447|P1|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|127
7621817|NCT02358044|18767446|P2|Treated|Overall Study||126
7621818|NCT02358044|18767447|P1|Treated|Overall Study||129
7621819|NCT02358044|18767446|P2|STARTED|Overall Study||128
7621820|NCT02358044|18767447|P1|STARTED|Overall Study||129
7621821|NCT02358031|18767466|P3|NOT COMPLETED|Overall Study||300
7621822|NCT02358031|18767467|P2|NOT COMPLETED|Overall Study||281
7621823|NCT02358031|18767468|P1|NOT COMPLETED|Overall Study||301
7621824|NCT02358031|18767466|P3|COMPLETED|Overall Study||0
7621825|NCT02358031|18767467|P2|COMPLETED|Overall Study||0
7621826|NCT02358031|18767468|P1|COMPLETED|Overall Study||0
7621827|NCT02358031|18767466|P3|Pembro Combo v Control Efficacy Analyses|Overall Study||278
7621828|NCT02358031|18767467|P2|Pembro Combo v Control Efficacy Analyses|Overall Study||281
7621829|NCT02358031|18767468|P1|Pembro Combo v Control Efficacy Analyses|Overall Study||0
7621830|NCT02358031|18767466|P3|Pembro Mono v Control Efficacy Analyses|Overall Study||300
7621831|NCT02358031|18767467|P2|Pembro Mono v Control Efficacy Analyses|Overall Study||0
7621832|NCT02358031|18767468|P1|Pembro Mono v Control Efficacy Analyses|Overall Study||301
7621833|NCT02358031|18767466|P3|Treated|Overall Study||287
7621834|NCT02358031|18767467|P2|Treated|Overall Study||276
7621835|NCT02358031|18767468|P1|Treated|Overall Study||300
7621836|NCT02358031|18767466|P3|STARTED|Overall Study||300
7621837|NCT02358031|18767467|P2|STARTED|Overall Study||281
7621838|NCT02358031|18767468|P1|STARTED|Overall Study||301
7621839|NCT02357940|18767595|P2|NOT COMPLETED|Overall Study||2
7621840|NCT02357940|18767596|P1|NOT COMPLETED|Overall Study||0
7621841|NCT02357940|18767595|P2|COMPLETED|Overall Study||30
7621842|NCT02357940|18767596|P1|COMPLETED|Overall Study||9
7621843|NCT02357940|18767595|P2|STARTED|Overall Study||32
7621844|NCT02357940|18767596|P1|STARTED|Overall Study||9
7621845|NCT02357901|18767723|P4|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||66
7621846|NCT02357901|18767724|P3|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||72
7621847|NCT02357901|18767725|P2|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||78
7621848|NCT02357901|18767726|P1|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||0
7621849|NCT02357901|18767723|P4|COMPLETED|Treatment Period (Day 1 to Week 24)||34
7621850|NCT02357901|18767724|P3|COMPLETED|Treatment Period (Day 1 to Week 24)||129
7621851|NCT02357901|18767725|P2|COMPLETED|Treatment Period (Day 1 to Week 24)||125
7621852|NCT02357901|18767726|P1|COMPLETED|Treatment Period (Day 1 to Week 24)||0
7621853|NCT02357901|18767723|P4|Full Analysis Set|Treatment Period (Day 1 to Week 24)||99
7621854|NCT02357901|18767724|P3|Full Analysis Set|Treatment Period (Day 1 to Week 24)||196
7621855|NCT02357901|18767725|P2|Full Analysis Set|Treatment Period (Day 1 to Week 24)||194
7621856|NCT02357901|18767726|P1|Full Analysis Set|Treatment Period (Day 1 to Week 24)||0
7621857|NCT02357901|18767723|P4|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||100
7621858|NCT02357901|18767724|P3|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||201
7621859|NCT02357901|18767725|P2|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||203
7621860|NCT02357901|18767726|P1|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||0
7621861|NCT02357901|18767723|P4|STARTED|Treatment Period (Day 1 to Week 24)||100
7621862|NCT02357901|18767724|P3|STARTED|Treatment Period (Day 1 to Week 24)||201
7621863|NCT02357901|18767725|P2|STARTED|Treatment Period (Day 1 to Week 24)||203
7621864|NCT02357901|18767726|P1|STARTED|Treatment Period (Day 1 to Week 24)||0
7621865|NCT02357901|18767723|P4|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
7621866|NCT02357901|18767724|P3|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
7621867|NCT02357901|18767725|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
7621868|NCT02357901|18767726|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||161
7621869|NCT02357901|18767723|P4|COMPLETED|Run-In Period (Days -14 to Day -1)||0
7621870|NCT02357901|18767724|P3|COMPLETED|Run-In Period (Days -14 to Day -1)||0
7621871|NCT02357901|18767725|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||0
7621872|NCT02357901|18767726|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||504
7621873|NCT02357901|18767723|P4|STARTED|Run-In Period (Days -14 to Day -1)||0
7621874|NCT02357901|18767724|P3|STARTED|Run-In Period (Days -14 to Day -1)||0
7621875|NCT02357901|18767725|P2|STARTED|Run-In Period (Days -14 to Day -1)||0
7621876|NCT02357901|18767726|P1|STARTED|Run-In Period (Days -14 to Day -1)|Received at least one dose of SUBOXONE sublingual film.|665
7621877|NCT02357810|18767776|P1|NOT COMPLETED|Follow-up at Treatment Discontinuation||18
7621878|NCT02357810|18767776|P1|COMPLETED|Follow-up at Treatment Discontinuation||133
7621879|NCT02357810|18767776|P1|STARTED|Follow-up at Treatment Discontinuation|All patients that receive at least one dose of study treatment go into follow up phase of the study.|151
7621880|NCT02357810|18767776|P1|NOT COMPLETED|12 Week Response and Further Treatment||22
7621881|NCT02357810|18767776|P1|COMPLETED|12 Week Response and Further Treatment||73
7621882|NCT02357810|18767776|P1|Went on to be Treated After Response|12 Week Response and Further Treatment||73
7621883|NCT02357810|18767776|P1|Assessed for 12 Week Response|12 Week Response and Further Treatment||95
7621884|NCT02357810|18767776|P1|STARTED|12 Week Response and Further Treatment||95
7621885|NCT02357810|18767776|P1|NOT COMPLETED|Reached 12 Weeks Response||56
7621886|NCT02357810|18767776|P1|COMPLETED|Reached 12 Weeks Response||95
7621887|NCT02357810|18767776|P1|Reached 12 Weeks/3 Cycles|Reached 12 Weeks Response||95
7621888|NCT02357810|18767776|P1|Reached 6 Week Response|Reached 12 Weeks Response||129
7621889|NCT02357810|18767776|P1|Completed 4 Weeks/1 Cycle|Reached 12 Weeks Response||151
7621890|NCT02357810|18767776|P1|STARTED|Reached 12 Weeks Response||151
7621891|NCT02357810|18767776|P1|NOT COMPLETED|Registered and Started Treatment||27
7621892|NCT02357810|18767776|P1|COMPLETED|Registered and Started Treatment||151
7621893|NCT02357810|18767776|P1|Initiated Treatment on Study|Registered and Started Treatment||151
7621894|NCT02357810|18767776|P1|Registered to Study|Registered and Started Treatment||152
7621895|NCT02357810|18767776|P1|Signed Consent|Registered and Started Treatment||178
7621896|NCT02357810|18767776|P1|STARTED|Registered and Started Treatment||178
7621897|NCT02357758|18767791|P3|NOT COMPLETED|Overall Study||7
7621898|NCT02357758|18767792|P2|NOT COMPLETED|Overall Study||0
7621899|NCT02357758|18767793|P1|NOT COMPLETED|Overall Study||16
7621900|NCT02357758|18767791|P3|COMPLETED|Overall Study||5
7621901|NCT02357758|18767792|P2|COMPLETED|Overall Study||20
7621902|NCT02357758|18767793|P1|COMPLETED|Overall Study||9
7621903|NCT02357758|18767791|P3|STARTED|Overall Study||12
7621904|NCT02357758|18767792|P2|STARTED|Overall Study||20
7621905|NCT02357758|18767793|P1|STARTED|Overall Study||25
7621906|NCT02357706|18767801|P2|NOT COMPLETED|Overall Study||0
7621907|NCT02357706|18767802|P1|NOT COMPLETED|Overall Study||0
7621908|NCT02357706|18767801|P2|COMPLETED|Overall Study||10
7621909|NCT02357706|18767802|P1|COMPLETED|Overall Study||10
7621910|NCT02357706|18767801|P2|STARTED|Overall Study||10
7621911|NCT02357706|18767802|P1|STARTED|Overall Study||10
7621912|NCT02357576|18767826|P2|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
7621913|NCT02357576|18767827|P1|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
7621914|NCT02357576|18767826|P2|COMPLETED|Neurodevelopmental Outcome Follow Up||2
7621915|NCT02357576|18767827|P1|COMPLETED|Neurodevelopmental Outcome Follow Up||6
7621916|NCT02357576|18767826|P2|STARTED|Neurodevelopmental Outcome Follow Up||7
7621917|NCT02357576|18767827|P1|STARTED|Neurodevelopmental Outcome Follow Up|1 patient exited the study after treatment completion and before returning for follow up visits.|11
7621918|NCT02357576|18767826|P2|NOT COMPLETED|Treatment Period||2
7621919|NCT02357576|18767827|P1|NOT COMPLETED|Treatment Period||0
7621920|NCT02357576|18767826|P2|COMPLETED|Treatment Period||7
7621921|NCT02357576|18767827|P1|COMPLETED|Treatment Period||12
7621922|NCT02357576|18767826|P2|STARTED|Treatment Period||9
7621923|NCT02357576|18767827|P1|STARTED|Treatment Period||12
7621924|NCT02357485|18767871|P1|NOT COMPLETED|Overall Study||0
7621925|NCT02357485|18767871|P1|COMPLETED|Overall Study||6
7621926|NCT02357485|18767871|P1|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6
7621927|NCT02357459|18767882|P3|NOT COMPLETED|Overall Study||12
7621928|NCT02357459|18767883|P2|NOT COMPLETED|Overall Study||14
7621929|NCT02357459|18767884|P1|NOT COMPLETED|Overall Study||17
7621930|NCT02357459|18767882|P3|COMPLETED|Overall Study||150
7621931|NCT02357459|18767883|P2|COMPLETED|Overall Study||149
7621932|NCT02357459|18767884|P1|COMPLETED|Overall Study||144
7621933|NCT02357459|18767882|P3|STARTED|Overall Study||162
7621934|NCT02357459|18767883|P2|STARTED|Overall Study||163
7621935|NCT02357459|18767884|P1|STARTED|Overall Study||161
7621936|NCT02357420|18767930|P4|NOT COMPLETED|Overall Study||19
7621937|NCT02357420|18767931|P3|NOT COMPLETED|Overall Study||16
7621938|NCT02357420|18767932|P2|NOT COMPLETED|Overall Study||12
7621939|NCT02357420|18767933|P1|NOT COMPLETED|Overall Study||12
7621940|NCT02357420|18767930|P4|COMPLETED|Overall Study||63
7621941|NCT02357420|18767931|P3|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|93
7621942|NCT02357420|18767932|P2|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|86
7621943|NCT02357420|18767933|P1|COMPLETED|Overall Study|3 participants who discontinued prematurely were included in completed as they fulfilled Visit 8.|92
7621944|NCT02357420|18767930|P4|Full Analysis Set (FAS)|Overall Study|1 participant from safety set did not enter FAS.|81
7621945|NCT02357420|18767931|P3|Full Analysis Set (FAS)|Overall Study||109
7621946|NCT02357420|18767932|P2|Full Analysis Set (FAS)|Overall Study||98
7621947|NCT02357420|18767933|P1|Full Analysis Set (FAS)|Overall Study||104
7621948|NCT02357420|18767930|P4|STARTED|Overall Study||82
7621949|NCT02357420|18767931|P3|STARTED|Overall Study||109
7621950|NCT02357420|18767932|P2|STARTED|Overall Study||98
7621951|NCT02357420|18767933|P1|STARTED|Overall Study||104
7621952|NCT02357394|18767953|P2|NOT COMPLETED|Overall Study||0
7621953|NCT02357394|18767954|P1|NOT COMPLETED|Overall Study||0
7621954|NCT02357394|18767953|P2|COMPLETED|Overall Study||3
7621955|NCT02357394|18767954|P1|COMPLETED|Overall Study||4
7621956|NCT02357394|18767953|P2|STARTED|Overall Study||3
7621957|NCT02357394|18767954|P1|STARTED|Overall Study||4
7621958|NCT02357368|18767996|P4|NOT COMPLETED|Overall Study||3
7621959|NCT02357368|18767997|P3|NOT COMPLETED|Overall Study||1
7621960|NCT02357368|18767998|P2|NOT COMPLETED|Overall Study||3
7621961|NCT02357368|18767999|P1|NOT COMPLETED|Overall Study||6
7621962|NCT02357368|18767996|P4|COMPLETED|Overall Study||5
7621963|NCT02357368|18767997|P3|COMPLETED|Overall Study||13
7621964|NCT02357368|18767998|P2|COMPLETED|Overall Study||15
7621965|NCT02357368|18767999|P1|COMPLETED|Overall Study||13
7621966|NCT02357368|18767996|P4|STARTED|Overall Study||8
7621967|NCT02357368|18767997|P3|STARTED|Overall Study||14
7621968|NCT02357368|18767998|P2|STARTED|Overall Study||18
7621969|NCT02357368|18767999|P1|STARTED|Overall Study||19
7621970|NCT02357342|18768023|P2|NOT COMPLETED|Extension Study||0
7621971|NCT02357342|18768024|P1|NOT COMPLETED|Extension Study||0
7621972|NCT02357342|18768023|P2|COMPLETED|Extension Study||9
7621973|NCT02357342|18768024|P1|COMPLETED|Extension Study||4
7621974|NCT02357342|18768023|P2|STARTED|Extension Study||9
7621975|NCT02357342|18768024|P1|STARTED|Extension Study||4
7621976|NCT02357342|18768023|P2|NOT COMPLETED|First 6 Months||0
7621977|NCT02357342|18768024|P1|NOT COMPLETED|First 6 Months||2
7621978|NCT02357342|18768023|P2|COMPLETED|First 6 Months||20
7621979|NCT02357342|18768024|P1|COMPLETED|First 6 Months|2 patients died. Neither deaths were study drug related.|18
7621980|NCT02357342|18768023|P2|STARTED|First 6 Months||20
7621981|NCT02357342|18768024|P1|STARTED|First 6 Months||20
7621982|NCT02357290|18768034|P1|NOT COMPLETED|Overall Study||26
7621983|NCT02357290|18768034|P1|COMPLETED|Overall Study||14
7621984|NCT02357290|18768034|P1|Exposed|Overall Study||26
7621985|NCT02357290|18768034|P1|STARTED|Overall Study||40
7621986|NCT02357264|18768041|P2|NOT COMPLETED|Overall Study||0
7621987|NCT02357264|18768042|P1|NOT COMPLETED|Overall Study||0
7621988|NCT02357264|18768041|P2|COMPLETED|Overall Study||130
7621989|NCT02357264|18768042|P1|COMPLETED|Overall Study||56
7621990|NCT02357264|18768041|P2|STARTED|Overall Study||130
7621991|NCT02357264|18768042|P1|STARTED|Overall Study||56
7621992|NCT02357173|18768051|P3|NOT COMPLETED|Overall Study||6
7621993|NCT02357173|18768052|P2|NOT COMPLETED|Overall Study||6
7621994|NCT02357173|18768053|P1|NOT COMPLETED|Overall Study||6
7621995|NCT02357173|18768051|P3|COMPLETED|Overall Study||16
7621996|NCT02357173|18768052|P2|COMPLETED|Overall Study||15
7621997|NCT02357173|18768053|P1|COMPLETED|Overall Study||19
7621998|NCT02357173|18768051|P3|STARTED|Overall Study||22
7621999|NCT02357173|18768052|P2|STARTED|Overall Study||21
7622000|NCT02357173|18768053|P1|STARTED|Overall Study||25
7622001|NCT02357147|18768072|P2|NOT COMPLETED|Maintenance Treatment Phase||29
7622002|NCT02357147|18768073|P1|NOT COMPLETED|Maintenance Treatment Phase||26
7622003|NCT02357147|18768072|P2|COMPLETED|Maintenance Treatment Phase||0
7622004|NCT02357147|18768073|P1|COMPLETED|Maintenance Treatment Phase||0
7622005|NCT02357147|18768072|P2|Treated|Maintenance Treatment Phase||29
7622006|NCT02357147|18768073|P1|Treated|Maintenance Treatment Phase||25
7622007|NCT02357147|18768072|P2|STARTED|Maintenance Treatment Phase||29
7622008|NCT02357147|18768073|P1|STARTED|Maintenance Treatment Phase||26
7622009|NCT02357147|18768072|P2|NOT COMPLETED|Combination Treatment Phase||27
7622010|NCT02357147|18768073|P1|NOT COMPLETED|Combination Treatment Phase||26
7622011|NCT02357147|18768072|P2|COMPLETED|Combination Treatment Phase||29
7622012|NCT02357147|18768073|P1|COMPLETED|Combination Treatment Phase||26
7622013|NCT02357147|18768072|P2|Treated|Combination Treatment Phase||54
7622014|NCT02357147|18768073|P1|Treated|Combination Treatment Phase||52
7622015|NCT02357147|18768072|P2|STARTED|Combination Treatment Phase||56
7622016|NCT02357147|18768073|P1|STARTED|Combination Treatment Phase||52
7622017|NCT02356900|18768085|P2|NOT COMPLETED|Overall Study||0
7622018|NCT02356900|18768086|P1|NOT COMPLETED|Overall Study||0
7622019|NCT02356900|18768085|P2|COMPLETED|Overall Study||10
7622020|NCT02356900|18768086|P1|COMPLETED|Overall Study||11
7622021|NCT02356900|18768085|P2|STARTED|Overall Study||10
7622022|NCT02356900|18768086|P1|STARTED|Overall Study||11
7622023|NCT02356887|18768104|P1|NOT COMPLETED|Overall Study||2
7622024|NCT02356887|18768104|P1|COMPLETED|Overall Study||10
7622025|NCT02356887|18768104|P1|STARTED|Overall Study||12
7622026|NCT02356783|18768121|P2|NOT COMPLETED|Overall Study||3
7622027|NCT02356783|18768122|P1|NOT COMPLETED|Overall Study||1
7622028|NCT02356783|18768121|P2|COMPLETED|Overall Study||14
7622029|NCT02356783|18768122|P1|COMPLETED|Overall Study||15
7622030|NCT02356783|18768121|P2|STARTED|Overall Study||17
7622031|NCT02356783|18768122|P1|STARTED|Overall Study||16
7622032|NCT02356692|18768130|P2|NOT COMPLETED|Overall Study||0
7622033|NCT02356692|18768131|P1|NOT COMPLETED|Overall Study||0
7622034|NCT02356692|18768130|P2|COMPLETED|Overall Study||60
7622035|NCT02356692|18768131|P1|COMPLETED|Overall Study||60
7622036|NCT02356692|18768130|P2|STARTED|Overall Study||60
7622037|NCT02356692|18768131|P1|STARTED|Overall Study||60
7622038|NCT02356588|18768143|P2|NOT COMPLETED|Overall Study||13
7622039|NCT02356588|18768144|P1|NOT COMPLETED|Overall Study||5
7622040|NCT02356588|18768143|P2|COMPLETED|Overall Study||41
7622041|NCT02356588|18768144|P1|COMPLETED|Overall Study||102
7622042|NCT02356588|18768143|P2|STARTED|Overall Study||54
7622043|NCT02356588|18768144|P1|STARTED|Overall Study||107
7622044|NCT02356575|18768178|P2|NOT COMPLETED|Overall Study||0
7622045|NCT02356575|18768179|P1|NOT COMPLETED|Overall Study||0
7622046|NCT02356575|18768178|P2|COMPLETED|Overall Study||80
7622047|NCT02356575|18768179|P1|COMPLETED|Overall Study||80
7622048|NCT02356575|18768178|P2|STARTED|Overall Study||80
7622049|NCT02356575|18768179|P1|STARTED|Overall Study||80
7622050|NCT02356562|18768261|P2|NOT COMPLETED|Overall Study||1
7622051|NCT02356562|18768262|P1|NOT COMPLETED|Overall Study||2
7622052|NCT02356562|18768261|P2|COMPLETED|Overall Study||6
7622053|NCT02356562|18768262|P1|COMPLETED|Overall Study||20
7622054|NCT02356562|18768261|P2|STARTED|Overall Study||7
7622055|NCT02356562|18768262|P1|STARTED|Overall Study||22
7622056|NCT02356484|18768272|P1|NOT COMPLETED|Overall Study||0
7622057|NCT02356484|18768272|P1|COMPLETED|Overall Study||138
7622058|NCT02356484|18768272|P1|STARTED|Overall Study||138
7622059|NCT02356471|18768276|P1|NOT COMPLETED|Overall Study||6
7622060|NCT02356471|18768276|P1|COMPLETED|Overall Study||28
7622061|NCT02356471|18768276|P1|STARTED|Overall Study||34
7622062|NCT02356211|18768291|P2|NOT COMPLETED|Overall Study||10
7622063|NCT02356211|18768292|P1|NOT COMPLETED|Overall Study||3
7622064|NCT02356211|18768291|P2|COMPLETED|Overall Study||42
7622065|NCT02356211|18768292|P1|COMPLETED|Overall Study||54
7622066|NCT02356211|18768291|P2|STARTED|Overall Study||52
7622067|NCT02356211|18768292|P1|STARTED|Overall Study||57
7622068|NCT02356198|18768300|P2|NOT COMPLETED|Overall Study||7
7622069|NCT02356198|18768301|P1|NOT COMPLETED|Overall Study||2
7622070|NCT02356198|18768300|P2|COMPLETED|Overall Study||98
7622071|NCT02356198|18768301|P1|COMPLETED|Overall Study||102
7622072|NCT02356198|18768300|P2|STARTED|Overall Study||105
7622073|NCT02356198|18768301|P1|STARTED|Overall Study||104
7622074|NCT02356107|18768315|P1|NOT COMPLETED|Overall Study||3
7622075|NCT02356107|18768315|P1|COMPLETED|Overall Study||12
7622076|NCT02356107|18768315|P1|STARTED|Overall Study||15
7622077|NCT02356003|18768319|P1|NOT COMPLETED|Overall Study||0
7622078|NCT02356003|18768319|P1|COMPLETED|Overall Study||10
7622079|NCT02356003|18768319|P1|STARTED|Overall Study||10
7622080|NCT02355977|18768328|P3|NOT COMPLETED|Overall Study||0
7622081|NCT02355977|18768329|P2|NOT COMPLETED|Overall Study||0
7622082|NCT02355977|18768330|P1|NOT COMPLETED|Overall Study||0
7622083|NCT02355977|18768328|P3|COMPLETED|Overall Study||23
7622084|NCT02355977|18768329|P2|COMPLETED|Overall Study||26
7622085|NCT02355977|18768330|P1|COMPLETED|Overall Study||21
7622086|NCT02355977|18768328|P3|STARTED|Overall Study||23
7622087|NCT02355977|18768329|P2|STARTED|Overall Study||26
7622088|NCT02355977|18768330|P1|STARTED|Overall Study||21
7622089|NCT02355886|18768346|P2|NOT COMPLETED|Overall Study||0
7622090|NCT02355886|18768347|P1|NOT COMPLETED|Overall Study||0
7622091|NCT02355886|18768346|P2|COMPLETED|Overall Study||12
7622092|NCT02355886|18768347|P1|COMPLETED|Overall Study||13
7622093|NCT02355886|18768346|P2|STARTED|Overall Study||12
7622094|NCT02355886|18768347|P1|STARTED|Overall Study||13
7622095|NCT02355743|18768357|P1|NOT COMPLETED|Overall Study||2
7622096|NCT02355743|18768357|P1|COMPLETED|Overall Study||6
7622097|NCT02355743|18768357|P1|STARTED|Overall Study||8
7622098|NCT02355691|18768365|P2|NOT COMPLETED|Overall Study||9
7622099|NCT02355691|18768366|P1|NOT COMPLETED|Overall Study||7
7622100|NCT02355691|18768365|P2|COMPLETED|Overall Study||0
7622101|NCT02355691|18768366|P1|COMPLETED|Overall Study||0
7622102|NCT02355691|18768365|P2|2nd Postop Visit|Overall Study||9
7622103|NCT02355691|18768366|P1|2nd Postop Visit|Overall Study||7
7622104|NCT02355691|18768365|P2|1st Postop Visit|Overall Study||9
7622105|NCT02355691|18768366|P1|1st Postop Visit|Overall Study||7
7622106|NCT02355691|18768365|P2|STARTED|Overall Study||9
7622107|NCT02355691|18768366|P1|STARTED|Overall Study||7
7622108|NCT02355665|18768376|P2|NOT COMPLETED|Overall Study||232
7622109|NCT02355665|18768377|P1|NOT COMPLETED|Overall Study||249
7622110|NCT02355665|18768376|P2|COMPLETED|Overall Study||365
7622111|NCT02355665|18768377|P1|COMPLETED|Overall Study||352
7622112|NCT02355665|18768376|P2|STARTED|Overall Study||597
7622113|NCT02355665|18768377|P1|STARTED|Overall Study||601
7622114|NCT02355275|18768809|P1|NOT COMPLETED|Overall Study||8
7622115|NCT02355275|18768809|P1|COMPLETED|Overall Study||14
7622116|NCT02355275|18768809|P1|STARTED|Overall Study||22
7622117|NCT02355158|18768814|P1|NOT COMPLETED|Overall Study||150
7622118|NCT02355158|18768814|P1|COMPLETED|Overall Study||47
7622119|NCT02355158|18768814|P1|STARTED|Overall Study||197
7622120|NCT02355067|18768820|P2|NOT COMPLETED|Overall Study||8
7622121|NCT02355067|18768821|P1|NOT COMPLETED|Overall Study||8
7622122|NCT02355067|18768820|P2|COMPLETED|Overall Study||12
7622123|NCT02355067|18768821|P1|COMPLETED|Overall Study||12
7622124|NCT02355067|18768820|P2|STARTED|Overall Study||20
7622125|NCT02355067|18768821|P1|STARTED|Overall Study||20
7622126|NCT02355028|18768835|P2|NOT COMPLETED|Overall Study||5
7622127|NCT02355028|18768836|P1|NOT COMPLETED|Overall Study||11
7622128|NCT02355028|18768835|P2|COMPLETED|Overall Study||41
7622129|NCT02355028|18768836|P1|COMPLETED|Overall Study||36
7622130|NCT02355028|18768835|P2|Treated|Overall Study||45
7622131|NCT02355028|18768836|P1|Treated|Overall Study||46
7622132|NCT02355028|18768835|P2|STARTED|Overall Study||46
7622133|NCT02355028|18768836|P1|STARTED|Overall Study||47
7622134|NCT02354976|18768872|P3|NOT COMPLETED|Overall Study||3
7622135|NCT02354976|18768873|P2|NOT COMPLETED|Overall Study||1
7622136|NCT02354976|18768874|P1|NOT COMPLETED|Overall Study||2
7622137|NCT02354976|18768872|P3|COMPLETED|Overall Study||23
7622138|NCT02354976|18768873|P2|COMPLETED|Overall Study||26
7622139|NCT02354976|18768874|P1|COMPLETED|Overall Study||23
7622140|NCT02354976|18768872|P3|STARTED|Overall Study||26
7622141|NCT02354976|18768873|P2|STARTED|Overall Study||27
7622142|NCT02354976|18768874|P1|STARTED|Overall Study||25
7622143|NCT02354924|18768885|P2|NOT COMPLETED|Overall Study||0
7622144|NCT02354924|18768886|P1|NOT COMPLETED|Overall Study||0
7622145|NCT02354924|18768885|P2|COMPLETED|Overall Study||20
7622146|NCT02354924|18768886|P1|COMPLETED|Overall Study||40
7622147|NCT02354924|18768885|P2|STARTED|Overall Study||20
7622148|NCT02354924|18768886|P1|STARTED|Overall Study||40
7622149|NCT02354859|18768898|P2|NOT COMPLETED|Overall Study||2
7622150|NCT02354859|18768899|P1|NOT COMPLETED|Overall Study||0
7622151|NCT02354859|18768898|P2|COMPLETED|Overall Study||57
7622152|NCT02354859|18768899|P1|COMPLETED|Overall Study||60
7622153|NCT02354859|18768898|P2|STARTED|Overall Study||59
7622154|NCT02354859|18768899|P1|STARTED|Overall Study||60
7622155|NCT02354833|18768917|P2|NOT COMPLETED|Overall Study||0
7622156|NCT02354833|18768918|P1|NOT COMPLETED|Overall Study||0
7622157|NCT02354833|18768917|P2|COMPLETED|Overall Study||43
7622158|NCT02354833|18768918|P1|COMPLETED|Overall Study||38
7622159|NCT02354833|18768917|P2|STARTED|Overall Study||43
7622160|NCT02354833|18768918|P1|STARTED|Overall Study||38
7622161|NCT02354781|18768930|P1|NOT COMPLETED|Overall Study||0
7622162|NCT02354781|18768930|P1|COMPLETED|Overall Study||3
7622163|NCT02354781|18768930|P1|STARTED|Overall Study||3
7622164|NCT02354690|18768937|P1|NOT COMPLETED|Overall Study||1
7622165|NCT02354690|18768937|P1|COMPLETED|Overall Study||12
7622166|NCT02354690|18768937|P1|STARTED|Overall Study||13
7622167|NCT02354599|18768951|P6|NOT COMPLETED|Overall Study||1
7622168|NCT02354599|18768952|P5|NOT COMPLETED|Overall Study||0
7622169|NCT02354599|18768953|P4|NOT COMPLETED|Overall Study||0
7622170|NCT02354599|18768954|P3|NOT COMPLETED|Overall Study||0
7622171|NCT02354599|18768955|P2|NOT COMPLETED|Overall Study||1
7622172|NCT02354599|18768956|P1|NOT COMPLETED|Overall Study||1
7622173|NCT02354599|18768951|P6|COMPLETED|Overall Study||5
7622174|NCT02354599|18768952|P5|COMPLETED|Overall Study||2
7622175|NCT02354599|18768953|P4|COMPLETED|Overall Study||6
7622176|NCT02354599|18768954|P3|COMPLETED|Overall Study||6
7622177|NCT02354599|18768955|P2|COMPLETED|Overall Study||5
7622178|NCT02354599|18768956|P1|COMPLETED|Overall Study||5
7622179|NCT02354599|18768951|P6|STARTED|Overall Study||6
7622180|NCT02354599|18768952|P5|STARTED|Overall Study||2
7622181|NCT02354599|18768953|P4|STARTED|Overall Study||6
7622182|NCT02354599|18768954|P3|STARTED|Overall Study||6
7622183|NCT02354599|18768955|P2|STARTED|Overall Study||6
7622184|NCT02354599|18768956|P1|STARTED|Overall Study||6
7622185|NCT02354586|18769026|P1|NOT COMPLETED|Overall Study||341
7622186|NCT02354586|18769026|P1|COMPLETED|Overall Study||122
7622187|NCT02354586|18769026|P1|Ongoing in Study|Overall Study||21
7622188|NCT02354586|18769026|P1|STARTED|Overall Study||463
7622189|NCT02354508|18769045|P3|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
7622190|NCT02354508|18769046|P2|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
7622191|NCT02354508|18769047|P1|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||4
7622192|NCT02354508|18769045|P3|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|36
7622193|NCT02354508|18769046|P2|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|20
7622194|NCT02354508|18769047|P1|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|22
7622195|NCT02354508|18769045|P3|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
7622196|NCT02354508|18769046|P2|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
7622197|NCT02354508|18769047|P1|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|4
7622198|NCT02354508|18769045|P3|STARTED|Period 3: Post-treatment Follow up Phase||39
7622199|NCT02354508|18769046|P2|STARTED|Period 3: Post-treatment Follow up Phase||23
7622200|NCT02354508|18769047|P1|STARTED|Period 3: Post-treatment Follow up Phase||26
7622201|NCT02354508|18769045|P3|NOT COMPLETED|Period 2: Extension Phase||3
7622202|NCT02354508|18769046|P2|NOT COMPLETED|Period 2: Extension Phase||4
7622203|NCT02354508|18769047|P1|NOT COMPLETED|Period 2: Extension Phase||6
7622204|NCT02354508|18769045|P3|COMPLETED|Period 2: Extension Phase||36
7622205|NCT02354508|18769046|P2|COMPLETED|Period 2: Extension Phase||19
7622206|NCT02354508|18769047|P1|COMPLETED|Period 2: Extension Phase||20
7622207|NCT02354508|18769045|P3|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|39
7622208|NCT02354508|18769046|P2|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|23
7622209|NCT02354508|18769047|P1|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|26
7622210|NCT02354508|18769045|P3|NOT COMPLETED|Period 1: Core Phase||6
7622211|NCT02354508|18769046|P2|NOT COMPLETED|Period 1: Core Phase||2
7622212|NCT02354508|18769047|P1|NOT COMPLETED|Period 1: Core Phase||2
7622213|NCT02354508|18769045|P3|COMPLETED|Period 1: Core Phase||47
7622214|NCT02354508|18769046|P2|COMPLETED|Period 1: Core Phase||27
7622215|NCT02354508|18769047|P1|COMPLETED|Period 1: Core Phase||39
7622216|NCT02354508|18769045|P3|STARTED|Period 1: Core Phase||53
7622217|NCT02354508|18769046|P2|STARTED|Period 1: Core Phase||29
7622218|NCT02354508|18769047|P1|STARTED|Period 1: Core Phase||41
7622219|NCT02354482|18769125|P1|NOT COMPLETED|Reference||0
7622220|NCT02354482|18769125|P1|COMPLETED|Reference||2042
7622221|NCT02354482|18769125|P1|STARTED|Reference||2042
7622222|NCT02354482|18769125|P1|NOT COMPLETED|Assessment and Teach Back||0
7622223|NCT02354482|18769125|P1|COMPLETED|Assessment and Teach Back||508
7622224|NCT02354482|18769125|P1|STARTED|Assessment and Teach Back||508
7622225|NCT02354482|18769125|P1|NOT COMPLETED|Patient/Family Caregiver Assessment||0
7622226|NCT02354482|18769125|P1|COMPLETED|Patient/Family Caregiver Assessment||3093
7622227|NCT02354482|18769125|P1|STARTED|Patient/Family Caregiver Assessment||3093
7622228|NCT02354482|18769125|P1|NOT COMPLETED|Hospital-Based Trust and Plain Language||0
7622229|NCT02354482|18769125|P1|COMPLETED|Hospital-Based Trust and Plain Language||2090
7622230|NCT02354482|18769125|P1|STARTED|Hospital-Based Trust and Plain Language||2090
7622231|NCT02354482|18769125|P1|NOT COMPLETED|Home-Based Trust and Plain Language||0
7622232|NCT02354482|18769125|P1|COMPLETED|Home-Based Trust and Plain Language||1979
7622233|NCT02354482|18769125|P1|STARTED|Home-Based Trust and Plain Language||1979
7622234|NCT02354482|18769125|P1|NOT COMPLETED|Patient Communication and Care||0
7622235|NCT02354482|18769125|P1|COMPLETED|Patient Communication and Care||2158
7622236|NCT02354482|18769125|P1|STARTED|Patient Communication and Care||2158
7622237|NCT02354443|18769145|P1|NOT COMPLETED|Overall Study||0
7622238|NCT02354443|18769145|P1|COMPLETED|Overall Study||1
7622239|NCT02354443|18769145|P1|STARTED|Overall Study||1
7622240|NCT02354417|18769149|P1|NOT COMPLETED|Overall Study||1
7622241|NCT02354417|18769149|P1|COMPLETED|Overall Study||2
7622242|NCT02354417|18769149|P1|STARTED|Overall Study||3
7622243|NCT02354378|18769155|P2|NOT COMPLETED|Overall Study||4
7622244|NCT02354378|18769156|P1|NOT COMPLETED|Overall Study||34
7622245|NCT02354378|18769155|P2|COMPLETED|Overall Study||16
7622246|NCT02354378|18769156|P1|COMPLETED|Overall Study||30
7622247|NCT02354378|18769155|P2|STARTED|Overall Study||20
7622248|NCT02354378|18769156|P1|STARTED|Overall Study||64
7622249|NCT02354352|18769166|P2|NOT COMPLETED|Overall Study||3
7622250|NCT02354352|18769167|P1|NOT COMPLETED|Overall Study||3
7622251|NCT02354352|18769166|P2|COMPLETED|Overall Study||23
7622252|NCT02354352|18769167|P1|COMPLETED|Overall Study||23
7622253|NCT02354352|18769166|P2|9 Months|Overall Study||23
7622254|NCT02354352|18769167|P1|9 Months|Overall Study||25
7622255|NCT02354352|18769166|P2|6 Months|Overall Study||23
7622256|NCT02354352|18769167|P1|6 Months|Overall Study||25
7622257|NCT02354352|18769166|P2|3 Months|Overall Study||23
7622258|NCT02354352|18769167|P1|3 Months|Overall Study||25
7622259|NCT02354352|18769166|P2|2 Months|Overall Study||22
7622260|NCT02354352|18769167|P1|2 Months|Overall Study||24
7622261|NCT02354352|18769166|P2|1 Month|Overall Study||23
7622262|NCT02354352|18769167|P1|1 Month|Overall Study||24
7622263|NCT02354352|18769166|P2|2 Weeks|Overall Study||25
7622264|NCT02354352|18769167|P1|2 Weeks|Overall Study||26
7622265|NCT02354352|18769166|P2|STARTED|Overall Study||26
7622266|NCT02354352|18769167|P1|STARTED|Overall Study||26
7622267|NCT02354339|18769175|P2|NOT COMPLETED|Overall Study||0
7622268|NCT02354339|18769176|P1|NOT COMPLETED|Overall Study||0
7622269|NCT02354339|18769175|P2|COMPLETED|Overall Study||12
7622270|NCT02354339|18769176|P1|COMPLETED|Overall Study||12
7622271|NCT02354339|18769175|P2|STARTED|Overall Study||12
7622272|NCT02354339|18769176|P1|STARTED|Overall Study||12
7622273|NCT02354235|18769216|P2|NOT COMPLETED|Overall Study||7
7622274|NCT02354235|18769217|P1|NOT COMPLETED|Overall Study||3
7622275|NCT02354235|18769216|P2|COMPLETED|Overall Study||61
7622276|NCT02354235|18769217|P1|COMPLETED|Overall Study||67
7622277|NCT02354235|18769216|P2|STARTED|Overall Study||68
7622278|NCT02354235|18769217|P1|STARTED|Overall Study||70
7622279|NCT02354222|18769233|P2|NOT COMPLETED|Overall Study||11
7622280|NCT02354222|18769234|P1|NOT COMPLETED|Overall Study||4
7622281|NCT02354222|18769233|P2|COMPLETED|Overall Study||66
7622282|NCT02354222|18769234|P1|COMPLETED|Overall Study||73
7622283|NCT02354222|18769233|P2|STARTED|Overall Study||77
7622284|NCT02354222|18769234|P1|STARTED|Overall Study||77
7622285|NCT02354092|18769250|P2|NOT COMPLETED|Overall Study||0
7622286|NCT02354092|18769251|P1|NOT COMPLETED|Overall Study||0
7622287|NCT02354092|18769250|P2|COMPLETED|Overall Study||7
7622288|NCT02354092|18769251|P1|COMPLETED|Overall Study||7
7622289|NCT02354092|18769250|P2|STARTED|Overall Study||7
7622290|NCT02354092|18769251|P1|STARTED|Overall Study||7
7622291|NCT02353871|18769265|P2|NOT COMPLETED|Overall Study||9
7622292|NCT02353871|18769266|P1|NOT COMPLETED|Overall Study||3
7622293|NCT02353871|18769265|P2|COMPLETED|Overall Study||51
7622294|NCT02353871|18769266|P1|COMPLETED|Overall Study||122
7622295|NCT02353871|18769265|P2|STARTED|Overall Study|Randomised. Included a subject who was randomised by mistake (excluded from mITT population).|60
7622296|NCT02353871|18769266|P1|STARTED|Overall Study|Randomised.|125
7622297|NCT02353832|18769286|P1|NOT COMPLETED|Overall Study||0
7622298|NCT02353832|18769286|P1|COMPLETED|Overall Study||44
7622299|NCT02353832|18769286|P1|STARTED|Overall Study||44
7622300|NCT02353806|18769291|P1|NOT COMPLETED|Overall Study||10
7622301|NCT02353806|18769291|P1|COMPLETED|Overall Study||6
7622302|NCT02353806|18769291|P1|STARTED|Overall Study||16
7622303|NCT02353780|18769309|P3|NOT COMPLETED|Overall Study||0
7622304|NCT02353780|18769310|P2|NOT COMPLETED|Overall Study||0
7622305|NCT02353780|18769311|P1|NOT COMPLETED|Overall Study||0
7622306|NCT02353780|18769309|P3|COMPLETED|Overall Study||3
7622307|NCT02353780|18769310|P2|COMPLETED|Overall Study||3
7622308|NCT02353780|18769311|P1|COMPLETED|Overall Study||3
7622309|NCT02353780|18769309|P3|STARTED|Overall Study||3
7622310|NCT02353780|18769310|P2|STARTED|Overall Study||3
7622311|NCT02353780|18769311|P1|STARTED|Overall Study||3
7622312|NCT02353754|18769348|P2|NOT COMPLETED|Overall Study||0
7622313|NCT02353754|18769349|P1|NOT COMPLETED|Overall Study||2
7622314|NCT02353754|18769348|P2|COMPLETED|Overall Study||0
7622315|NCT02353754|18769349|P1|COMPLETED|Overall Study||10
7622316|NCT02353754|18769348|P2|STARTED|Overall Study||0
7622317|NCT02353754|18769349|P1|STARTED|Overall Study||12
7622318|NCT02353572|18769359|P1|NOT COMPLETED|Overall Study||3
7622319|NCT02353572|18769359|P1|COMPLETED|Overall Study||0
7622320|NCT02353572|18769359|P1|STARTED|Overall Study||3
7622321|NCT02353468|18769363|P1|NOT COMPLETED|Overall Study||3
7622322|NCT02353468|18769363|P1|COMPLETED|Overall Study||0
7622323|NCT02353468|18769363|P1|STARTED|Overall Study||3
7622324|NCT02353442|18769369|P2|NOT COMPLETED|Overall Study||4
7622325|NCT02353442|18769370|P1|NOT COMPLETED|Overall Study||3
7622326|NCT02353442|18769369|P2|COMPLETED|Overall Study||27
7622327|NCT02353442|18769370|P1|COMPLETED|Overall Study||25
7622328|NCT02353442|18769369|P2|STARTED|Overall Study||31
7622329|NCT02353442|18769370|P1|STARTED|Overall Study||28
7622330|NCT02353299|18769384|P4|NOT COMPLETED|Fourth Intervention (1 Night)||0
7622331|NCT02353299|18769385|P3|NOT COMPLETED|Fourth Intervention (1 Night)||0
7622332|NCT02353299|18769386|P2|NOT COMPLETED|Fourth Intervention (1 Night)||0
7622333|NCT02353299|18769387|P1|NOT COMPLETED|Fourth Intervention (1 Night)||0
7622334|NCT02353299|18769384|P4|COMPLETED|Fourth Intervention (1 Night)||13
7622335|NCT02353299|18769385|P3|COMPLETED|Fourth Intervention (1 Night)||13
7622336|NCT02353299|18769386|P2|COMPLETED|Fourth Intervention (1 Night)||12
7622337|NCT02353299|18769387|P1|COMPLETED|Fourth Intervention (1 Night)||13
7622338|NCT02353299|18769384|P4|STARTED|Fourth Intervention (1 Night)||13
7622339|NCT02353299|18769385|P3|STARTED|Fourth Intervention (1 Night)||13
7622340|NCT02353299|18769386|P2|STARTED|Fourth Intervention (1 Night)|One patient withdrawn from study prior to start of fourth intervention.|12
7622341|NCT02353299|18769387|P1|STARTED|Fourth Intervention (1 Night)||13
7622342|NCT02353299|18769384|P4|NOT COMPLETED|Third Intervention (1 Night)||0
7622343|NCT02353299|18769385|P3|NOT COMPLETED|Third Intervention (1 Night)||0
7622344|NCT02353299|18769386|P2|NOT COMPLETED|Third Intervention (1 Night)||0
7622345|NCT02353299|18769387|P1|NOT COMPLETED|Third Intervention (1 Night)||0
7622346|NCT02353299|18769384|P4|COMPLETED|Third Intervention (1 Night)||13
7622347|NCT02353299|18769385|P3|COMPLETED|Third Intervention (1 Night)||13
7622348|NCT02353299|18769386|P2|COMPLETED|Third Intervention (1 Night)||13
7622349|NCT02353299|18769387|P1|COMPLETED|Third Intervention (1 Night)||13
7622350|NCT02353299|18769384|P4|STARTED|Third Intervention (1 Night)||13
7622351|NCT02353299|18769385|P3|STARTED|Third Intervention (1 Night)||13
7622352|NCT02353299|18769386|P2|STARTED|Third Intervention (1 Night)||13
7622353|NCT02353299|18769387|P1|STARTED|Third Intervention (1 Night)||13
7622354|NCT02353299|18769384|P4|NOT COMPLETED|Second Intervention (1 Night)||0
7622355|NCT02353299|18769385|P3|NOT COMPLETED|Second Intervention (1 Night)||0
7622356|NCT02353299|18769386|P2|NOT COMPLETED|Second Intervention (1 Night)||0
7622357|NCT02353299|18769387|P1|NOT COMPLETED|Second Intervention (1 Night)||0
7622358|NCT02353299|18769384|P4|COMPLETED|Second Intervention (1 Night)||13
7622359|NCT02353299|18769385|P3|COMPLETED|Second Intervention (1 Night)||13
7622360|NCT02353299|18769386|P2|COMPLETED|Second Intervention (1 Night)||13
7622361|NCT02353299|18769387|P1|COMPLETED|Second Intervention (1 Night)||13
7622362|NCT02353299|18769384|P4|STARTED|Second Intervention (1 Night)||13
7622363|NCT02353299|18769385|P3|STARTED|Second Intervention (1 Night)||13
7622364|NCT02353299|18769386|P2|STARTED|Second Intervention (1 Night)||13
7622365|NCT02353299|18769387|P1|STARTED|Second Intervention (1 Night)||13
7622366|NCT02353299|18769384|P4|NOT COMPLETED|First Intervention (1 Night)||0
7622367|NCT02353299|18769385|P3|NOT COMPLETED|First Intervention (1 Night)||0
7622368|NCT02353299|18769386|P2|NOT COMPLETED|First Intervention (1 Night)||0
7622369|NCT02353299|18769387|P1|NOT COMPLETED|First Intervention (1 Night)||0
7622370|NCT02353299|18769384|P4|COMPLETED|First Intervention (1 Night)||13
7622371|NCT02353299|18769385|P3|COMPLETED|First Intervention (1 Night)||13
7622372|NCT02353299|18769386|P2|COMPLETED|First Intervention (1 Night)||13
7622373|NCT02353299|18769387|P1|COMPLETED|First Intervention (1 Night)||13
7622374|NCT02353299|18769384|P4|STARTED|First Intervention (1 Night)||13
7622375|NCT02353299|18769385|P3|STARTED|First Intervention (1 Night)||13
7622376|NCT02353299|18769386|P2|STARTED|First Intervention (1 Night)||13
7622377|NCT02353299|18769387|P1|STARTED|First Intervention (1 Night)||13
7622378|NCT02353169|18769425|P4|NOT COMPLETED|Overall Study||3
7622379|NCT02353169|18769426|P3|NOT COMPLETED|Overall Study||4
7622380|NCT02353169|18769427|P2|NOT COMPLETED|Overall Study||6
7622381|NCT02353169|18769428|P1|NOT COMPLETED|Overall Study||3
7622382|NCT02353169|18769425|P4|COMPLETED|Overall Study||12
7622383|NCT02353169|18769426|P3|COMPLETED|Overall Study||12
7622384|NCT02353169|18769427|P2|COMPLETED|Overall Study||12
7622385|NCT02353169|18769428|P1|COMPLETED|Overall Study||12
7622386|NCT02353169|18769425|P4|STARTED|Overall Study||15
7622387|NCT02353169|18769426|P3|STARTED|Overall Study||16
7622388|NCT02353169|18769427|P2|STARTED|Overall Study||18
7622389|NCT02353169|18769428|P1|STARTED|Overall Study||15
7622390|NCT02353091|18769448|P2|NOT COMPLETED|Overall Study||0
7622391|NCT02353091|18769449|P1|NOT COMPLETED|Overall Study||0
7622392|NCT02353091|18769448|P2|COMPLETED|Overall Study||13
7622393|NCT02353091|18769449|P1|COMPLETED|Overall Study||13
7622394|NCT02353091|18769448|P2|STARTED|Overall Study||13
7622395|NCT02353091|18769449|P1|STARTED|Overall Study||13
7622396|NCT02352974|18769487|P1|NOT COMPLETED|Extension||0
7622397|NCT02352974|18769487|P1|COMPLETED|Extension||3
7622398|NCT02352974|18769487|P1|STARTED|Extension|Only 3 out of the 12 patients who completed the main study continued in to the extension period.|3
7622399|NCT02352974|18769487|P1|NOT COMPLETED|Main Study||0
7622400|NCT02352974|18769487|P1|COMPLETED|Main Study||12
7622401|NCT02352974|18769487|P1|STARTED|Main Study||12
7622402|NCT02352948|18769520|P6|NOT COMPLETED|Overall Study||49
7622403|NCT02352948|18769521|P5|NOT COMPLETED|Overall Study||88
7622404|NCT02352948|18769522|P4|NOT COMPLETED|Overall Study||99
7622405|NCT02352948|18769523|P3|NOT COMPLETED|Overall Study||129
7622406|NCT02352948|18769524|P2|NOT COMPLETED|Overall Study||59
7622407|NCT02352948|18769525|P1|NOT COMPLETED|Overall Study||49
7622408|NCT02352948|18769520|P6|COMPLETED|Overall Study||11
7622409|NCT02352948|18769521|P5|COMPLETED|Overall Study||29
7622410|NCT02352948|18769522|P4|COMPLETED|Overall Study||19
7622411|NCT02352948|18769523|P3|COMPLETED|Overall Study||45
7622412|NCT02352948|18769524|P2|COMPLETED|Overall Study||5
7622413|NCT02352948|18769525|P1|COMPLETED|Overall Study||13
7622414|NCT02352948|18769520|P6|Completed Study Treatment|Overall Study||4
7622415|NCT02352948|18769521|P5|Completed Study Treatment|Overall Study||23
7622416|NCT02352948|18769522|P4|Completed Study Treatment|Overall Study||0
7622417|NCT02352948|18769523|P3|Completed Study Treatment|Overall Study||36
7622418|NCT02352948|18769524|P2|Completed Study Treatment|Overall Study||0
7622419|NCT02352948|18769525|P1|Completed Study Treatment|Overall Study||15
7622420|NCT02352948|18769520|P6|Received Treatment|Overall Study||60
7622421|NCT02352948|18769521|P5|Received Treatment|Overall Study||117
7622422|NCT02352948|18769522|P4|Received Treatment|Overall Study||110
7622423|NCT02352948|18769523|P3|Received Treatment|Overall Study||173
7622424|NCT02352948|18769524|P2|Received Treatment|Overall Study||63
7622425|NCT02352948|18769525|P1|Received Treatment|Overall Study||62
7622426|NCT02352948|18769520|P6|STARTED|Overall Study||60
7622427|NCT02352948|18769521|P5|STARTED|Overall Study||117
7622428|NCT02352948|18769522|P4|STARTED|Overall Study||118
7622429|NCT02352948|18769523|P3|STARTED|Overall Study||174
7622430|NCT02352948|18769524|P2|STARTED|Overall Study||64
7622431|NCT02352948|18769525|P1|STARTED|Overall Study||62
7622432|NCT02352922|18769583|P2|NOT COMPLETED|Overall Study||4
7622433|NCT02352922|18769584|P1|NOT COMPLETED|Overall Study||4
7622434|NCT02352922|18769583|P2|COMPLETED|Overall Study|Completed POD14 survey|28
7622435|NCT02352922|18769584|P1|COMPLETED|Overall Study|completed POD14 Survey|28
7622436|NCT02352922|18769583|P2|STARTED|Overall Study||32
7622437|NCT02352922|18769584|P1|STARTED|Overall Study||32
7622438|NCT02352844|18769618|P1|NOT COMPLETED|Overall Study||0
7622439|NCT02352844|18769618|P1|COMPLETED|Overall Study||12
7622440|NCT02352844|18769618|P1|STARTED|Overall Study||12
7622441|NCT02352831|18769626|P2|NOT COMPLETED|Overall Study||0
7622442|NCT02352831|18769627|P1|NOT COMPLETED|Overall Study||0
7622443|NCT02352831|18769626|P2|COMPLETED|Overall Study||10
7622444|NCT02352831|18769627|P1|COMPLETED|Overall Study||6
7622445|NCT02352831|18769626|P2|STARTED|Overall Study||10
7622446|NCT02352831|18769627|P1|STARTED|Overall Study||6
7622447|NCT02352779|18769650|P3|NOT COMPLETED|Overall Study||2
7622448|NCT02352779|18769651|P2|NOT COMPLETED|Overall Study||1
7622449|NCT02352779|18769652|P1|NOT COMPLETED|Overall Study||8
7622450|NCT02352779|18769650|P3|COMPLETED|Overall Study||33
7622451|NCT02352779|18769651|P2|COMPLETED|Overall Study||35
7622452|NCT02352779|18769652|P1|COMPLETED|Overall Study||29
7622453|NCT02352779|18769650|P3|STARTED|Overall Study||35
7622454|NCT02352779|18769651|P2|STARTED|Overall Study||36
7622455|NCT02352779|18769652|P1|STARTED|Overall Study||37
7622456|NCT02352493|18769678|P18|NOT COMPLETED|Overall Study||0
7622457|NCT02352493|18769679|P17|NOT COMPLETED|Overall Study||0
7622458|NCT02352493|18769680|P16|NOT COMPLETED|Overall Study||0
7622459|NCT02352493|18769681|P15|NOT COMPLETED|Overall Study||1
7622460|NCT02352493|18769682|P14|NOT COMPLETED|Overall Study||2
7622461|NCT02352493|18769683|P13|NOT COMPLETED|Overall Study||1
7622462|NCT02352493|18769684|P12|NOT COMPLETED|Overall Study||0
7622463|NCT02352493|18769685|P11|NOT COMPLETED|Overall Study||0
7622464|NCT02352493|18769686|P10|NOT COMPLETED|Overall Study||1
7622465|NCT02352493|18769687|P9|NOT COMPLETED|Overall Study||2
7622466|NCT02352493|18769688|P8|NOT COMPLETED|Overall Study||0
7622467|NCT02352493|18769689|P7|NOT COMPLETED|Overall Study||1
7622468|NCT02352493|18769690|P6|NOT COMPLETED|Overall Study||0
7622469|NCT02352493|18769691|P5|NOT COMPLETED|Overall Study||0
7622470|NCT02352493|18769692|P4|NOT COMPLETED|Overall Study||0
7622471|NCT02352493|18769693|P3|NOT COMPLETED|Overall Study||0
7622472|NCT02352493|18769694|P2|NOT COMPLETED|Overall Study||0
7622473|NCT02352493|18769695|P1|NOT COMPLETED|Overall Study||0
7622474|NCT02352493|18769678|P18|COMPLETED|Overall Study||3
7622475|NCT02352493|18769679|P17|COMPLETED|Overall Study||3
7622476|NCT02352493|18769680|P16|COMPLETED|Overall Study||3
7622477|NCT02352493|18769681|P15|COMPLETED|Overall Study||2
7622478|NCT02352493|18769682|P14|COMPLETED|Overall Study||1
7622479|NCT02352493|18769683|P13|COMPLETED|Overall Study||2
7622480|NCT02352493|18769684|P12|COMPLETED|Overall Study||3
7622481|NCT02352493|18769685|P11|COMPLETED|Overall Study||3
7622482|NCT02352493|18769686|P10|COMPLETED|Overall Study||5
7622483|NCT02352493|18769687|P9|COMPLETED|Overall Study||1
7622484|NCT02352493|18769688|P8|COMPLETED|Overall Study||3
7622485|NCT02352493|18769689|P7|COMPLETED|Overall Study||2
7622486|NCT02352493|18769690|P6|COMPLETED|Overall Study||3
7622487|NCT02352493|18769691|P5|COMPLETED|Overall Study||3
7622488|NCT02352493|18769692|P4|COMPLETED|Overall Study||3
7622489|NCT02352493|18769693|P3|COMPLETED|Overall Study||3
7622490|NCT02352493|18769694|P2|COMPLETED|Overall Study||3
7622491|NCT02352493|18769695|P1|COMPLETED|Overall Study||8
7622492|NCT02352493|18769678|P18|STARTED|Overall Study||3
7622493|NCT02352493|18769679|P17|STARTED|Overall Study||3
7622494|NCT02352493|18769680|P16|STARTED|Overall Study||3
7622495|NCT02352493|18769681|P15|STARTED|Overall Study||3
7622496|NCT02352493|18769682|P14|STARTED|Overall Study||3
7622497|NCT02352493|18769683|P13|STARTED|Overall Study||3
7622498|NCT02352493|18769684|P12|STARTED|Overall Study||3
7622499|NCT02352493|18769685|P11|STARTED|Overall Study||3
7622500|NCT02352493|18769686|P10|STARTED|Overall Study||6
7622501|NCT02352493|18769687|P9|STARTED|Overall Study||3
7622502|NCT02352493|18769688|P8|STARTED|Overall Study||3
7622503|NCT02352493|18769689|P7|STARTED|Overall Study||3
7622504|NCT02352493|18769690|P6|STARTED|Overall Study||3
7622505|NCT02352493|18769691|P5|STARTED|Overall Study||3
7622506|NCT02352493|18769692|P4|STARTED|Overall Study||3
7622507|NCT02352493|18769693|P3|STARTED|Overall Study||3
7622508|NCT02352493|18769694|P2|STARTED|Overall Study||3
7622509|NCT02352493|18769695|P1|STARTED|Overall Study||8
7622510|NCT02352363|18769885|P2|NOT COMPLETED|Overall Study||3
7622511|NCT02352363|18769886|P1|NOT COMPLETED|Overall Study||7
7622512|NCT02352363|18769885|P2|COMPLETED|Overall Study||127
7622513|NCT02352363|18769886|P1|COMPLETED|Overall Study||271
7622514|NCT02352363|18769885|P2|STARTED|Overall Study||130
7622515|NCT02352363|18769886|P1|STARTED|Overall Study||278
7622516|NCT02352298|18769898|P1|NOT COMPLETED|Overall Study||0
7622517|NCT02352298|18769898|P1|COMPLETED|Overall Study||52
7622518|NCT02352298|18769898|P1|STARTED|Overall Study||52
7622519|NCT02352103|18769905|P2|NOT COMPLETED|Overall Study||1
7622520|NCT02352103|18769906|P1|NOT COMPLETED|Overall Study||0
7622521|NCT02352103|18769905|P2|COMPLETED|Overall Study||59
7622522|NCT02352103|18769906|P1|COMPLETED|Overall Study||60
7622523|NCT02352103|18769905|P2|STARTED|Overall Study||60
7622524|NCT02352103|18769906|P1|STARTED|Overall Study||60
7622525|NCT02351960|18769928|P2|NOT COMPLETED|Overall Study||12
7622526|NCT02351960|18769929|P1|NOT COMPLETED|Overall Study||11
7622527|NCT02351960|18769928|P2|COMPLETED|Overall Study||76
7622528|NCT02351960|18769929|P1|COMPLETED|Overall Study||197
7622529|NCT02351960|18769928|P2|STARTED|Overall Study||88
7622530|NCT02351960|18769929|P1|STARTED|Overall Study||208
7622531|NCT02351934|18769950|P2|NOT COMPLETED|Follow-Up||10
7622532|NCT02351934|18769951|P1|NOT COMPLETED|Follow-Up||12
7622533|NCT02351934|18769950|P2|COMPLETED|Follow-Up||51
7622534|NCT02351934|18769951|P1|COMPLETED|Follow-Up||44
7622535|NCT02351934|18769950|P2|STARTED|Follow-Up||61
7622536|NCT02351934|18769951|P1|STARTED|Follow-Up||56
7622537|NCT02351934|18769950|P2|NOT COMPLETED|Allocation||0
7622538|NCT02351934|18769951|P1|NOT COMPLETED|Allocation||6
7622539|NCT02351934|18769950|P2|COMPLETED|Allocation||61
7622540|NCT02351934|18769951|P1|COMPLETED|Allocation||56
7622541|NCT02351934|18769950|P2|Received Allocation|Allocation||61
7622542|NCT02351934|18769951|P1|Received Allocation|Allocation||56
7622543|NCT02351934|18769950|P2|STARTED|Allocation||61
7622544|NCT02351934|18769951|P1|STARTED|Allocation||62
7622545|NCT02351817|18769967|P2|NOT COMPLETED|Period 2||2
7622546|NCT02351817|18769968|P1|NOT COMPLETED|Period 2||1
7622547|NCT02351817|18769967|P2|COMPLETED|Period 2||3
7622548|NCT02351817|18769968|P1|COMPLETED|Period 2||4
7622549|NCT02351817|18769967|P2|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
7622550|NCT02351817|18769968|P1|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
7622551|NCT02351817|18769967|P2|NOT COMPLETED|Period 1||3
7622552|NCT02351817|18769968|P1|NOT COMPLETED|Period 1||1
7622553|NCT02351817|18769967|P2|COMPLETED|Period 1||2
7622554|NCT02351817|18769968|P1|COMPLETED|Period 1||4
7622555|NCT02351817|18769967|P2|STARTED|Period 1||5
7622556|NCT02351817|18769968|P1|STARTED|Period 1||5
7622557|NCT02351817|18769967|P2|NOT COMPLETED|Baseline Period||0
7622558|NCT02351817|18769968|P1|NOT COMPLETED|Baseline Period||0
7622559|NCT02351817|18769967|P2|COMPLETED|Baseline Period||5
7622560|NCT02351817|18769968|P1|COMPLETED|Baseline Period||5
7622561|NCT02351817|18769967|P2|STARTED|Baseline Period||5
7622562|NCT02351817|18769968|P1|STARTED|Baseline Period||5
7622563|NCT02351739|18769977|P2|NOT COMPLETED|Overall Study||40
7622564|NCT02351739|18769978|P1|NOT COMPLETED|Overall Study||38
7622565|NCT02351739|18769977|P2|COMPLETED|Overall Study||0
7622566|NCT02351739|18769978|P1|COMPLETED|Overall Study||0
7622567|NCT02351739|18769977|P2|Discontinued Study|Overall Study||40
7622568|NCT02351739|18769978|P1|Discontinued Study|Overall Study||38
7622569|NCT02351739|18769977|P2|Received Study Medication|Overall Study||40
7622570|NCT02351739|18769978|P1|Received Study Medication|Overall Study||35
7622571|NCT02351739|18769977|P2|Enrolled|Overall Study||40
7622572|NCT02351739|18769978|P1|Enrolled|Overall Study||38
7622573|NCT02351739|18769977|P2|STARTED|Overall Study||40
7622574|NCT02351739|18769978|P1|STARTED|Overall Study||38
7622575|NCT02351505|18769984|P1|NOT COMPLETED|Overall Study||0
7622576|NCT02351505|18769984|P1|COMPLETED|Overall Study||1
7622577|NCT02351505|18769984|P1|STARTED|Overall Study||1
7622578|NCT02351271|18769997|P2|NOT COMPLETED|Overall Study||0
7622579|NCT02351271|18769998|P1|NOT COMPLETED|Overall Study||0
7622580|NCT02351271|18769997|P2|COMPLETED|Overall Study||62
7622581|NCT02351271|18769998|P1|COMPLETED|Overall Study||68
7622582|NCT02351271|18769997|P2|STARTED|Overall Study||62
7622583|NCT02351271|18769998|P1|STARTED|Overall Study||68
7622584|NCT02351258|18770010|P2|NOT COMPLETED|Intervention 2 (12 Months)||0
7622585|NCT02351258|18770011|P1|NOT COMPLETED|Intervention 2 (12 Months)||0
7622586|NCT02351258|18770010|P2|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
7622587|NCT02351258|18770011|P1|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
7622588|NCT02351258|18770010|P2|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
7622589|NCT02351258|18770011|P1|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
7622590|NCT02351258|18770010|P2|NOT COMPLETED|Washout (2-3 Months)||0
7622591|NCT02351258|18770011|P1|NOT COMPLETED|Washout (2-3 Months)||0
7622592|NCT02351258|18770010|P2|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
7622593|NCT02351258|18770011|P1|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
7622594|NCT02351258|18770010|P2|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
7622595|NCT02351258|18770011|P1|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
7622596|NCT02351258|18770010|P2|NOT COMPLETED|Intervention 1 (12 Months)||0
7622597|NCT02351258|18770011|P1|NOT COMPLETED|Intervention 1 (12 Months)||0
7622598|NCT02351258|18770010|P2|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
7622599|NCT02351258|18770011|P1|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
7622600|NCT02351258|18770010|P2|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
7622601|NCT02351258|18770011|P1|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
7622602|NCT02351167|18770029|P3|NOT COMPLETED|Overall Study||21
7622603|NCT02351167|18770030|P2|NOT COMPLETED|Overall Study||18
7622604|NCT02351167|18770031|P1|NOT COMPLETED|Overall Study||19
7622605|NCT02351167|18770029|P3|COMPLETED|Overall Study||252
7622606|NCT02351167|18770030|P2|COMPLETED|Overall Study||256
7622607|NCT02351167|18770031|P1|COMPLETED|Overall Study||256
7622608|NCT02351167|18770029|P3|STARTED|Overall Study||273
7622609|NCT02351167|18770030|P2|STARTED|Overall Study||274
7622610|NCT02351167|18770031|P1|STARTED|Overall Study||275
7622611|NCT02351063|18770073|P1|NOT COMPLETED|Overall Study||0
7622612|NCT02351063|18770073|P1|COMPLETED|Overall Study|Study terminated. No study data collected.|1
7622613|NCT02351063|18770073|P1|STARTED|Overall Study||1
7622614|NCT02351037|18770080|P3|NOT COMPLETED|Overall Study||0
7622615|NCT02351037|18770081|P2|NOT COMPLETED|Overall Study||0
7622616|NCT02351037|18770082|P1|NOT COMPLETED|Overall Study||0
7622617|NCT02351037|18770080|P3|COMPLETED|Overall Study||8
7622618|NCT02351037|18770081|P2|COMPLETED|Overall Study||21
7622619|NCT02351037|18770082|P1|COMPLETED|Overall Study||7
7622620|NCT02351037|18770080|P3|STARTED|Overall Study||8
7622621|NCT02351037|18770081|P2|STARTED|Overall Study||21
7622622|NCT02351037|18770082|P1|STARTED|Overall Study||7
7622623|NCT02350998|18770090|P1|NOT COMPLETED|Overall Study||0
7622624|NCT02350998|18770090|P1|COMPLETED|Overall Study||33
7622625|NCT02350998|18770090|P1|STARTED|Overall Study||33
7622626|NCT02350881|18770097|P1|NOT COMPLETED|Overall Study||0
7622627|NCT02350881|18770097|P1|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64
7622628|NCT02350881|18770097|P1|STARTED|Overall Study|64 patients were included (6 bilateral)|64
7622629|NCT02350816|18770129|P4|NOT COMPLETED|Overall Study||0
7622630|NCT02350816|18770130|P3|NOT COMPLETED|Overall Study||0
7622631|NCT02350816|18770131|P2|NOT COMPLETED|Overall Study||0
7622632|NCT02350816|18770132|P1|NOT COMPLETED|Overall Study||0
7622633|NCT02350816|18770129|P4|COMPLETED|Overall Study||2
7622634|NCT02350816|18770130|P3|COMPLETED|Overall Study||2
7622635|NCT02350816|18770131|P2|COMPLETED|Overall Study||6
7622636|NCT02350816|18770132|P1|COMPLETED|Overall Study||7
7622637|NCT02350816|18770129|P4|STARTED|Overall Study||2
7622638|NCT02350816|18770130|P3|STARTED|Overall Study||2
7622639|NCT02350816|18770131|P2|STARTED|Overall Study||6
7622640|NCT02350816|18770132|P1|STARTED|Overall Study||7
7622641|NCT02350777|18770176|P2|NOT COMPLETED|Overall Study||0
7622642|NCT02350777|18770177|P1|NOT COMPLETED|Overall Study||0
7622643|NCT02350777|18770176|P2|COMPLETED|Overall Study||2
7622644|NCT02350777|18770177|P1|COMPLETED|Overall Study||2
7622645|NCT02350777|18770176|P2|STARTED|Overall Study||2
7622646|NCT02350777|18770177|P1|STARTED|Overall Study||2
7622647|NCT02350660|18770185|P2|NOT COMPLETED|Overall Study||0
7622648|NCT02350660|18770186|P1|NOT COMPLETED|Overall Study||0
7622649|NCT02350660|18770185|P2|COMPLETED|Overall Study||17
7622650|NCT02350660|18770186|P1|COMPLETED|Overall Study||7
7622651|NCT02350660|18770185|P2|STARTED|Overall Study||17
7622652|NCT02350660|18770186|P1|STARTED|Overall Study||7
7622653|NCT02350647|18770194|P2|NOT COMPLETED|Overall Study||6
7622654|NCT02350647|18770195|P1|NOT COMPLETED|Overall Study||6
7622655|NCT02350647|18770194|P2|COMPLETED|Overall Study||26
7622656|NCT02350647|18770195|P1|COMPLETED|Overall Study||26
7622657|NCT02350647|18770194|P2|STARTED|Overall Study||32
7622658|NCT02350647|18770195|P1|STARTED|Overall Study||32
7622659|NCT02350569|18770207|P1|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0
7622660|NCT02350569|18770207|P1|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1
7622661|NCT02350569|18770207|P1|STARTED|Retreatment (LDV/SOF 12 Weeks)|1 completed treatment (Main Study), experienced virologic failure, and entered Retreatment Phase|1
7622662|NCT02350569|18770207|P1|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0
7622663|NCT02350569|18770207|P1|COMPLETED|Main Study (LDV/SOF 4 Weeks)|1 participant discontinued treatment, but completed follow-up visits and study.|16
7622664|NCT02350569|18770207|P1|STARTED|Main Study (LDV/SOF 4 Weeks)||16
7622665|NCT02350478|18770219|P2|NOT COMPLETED|Overall Study||1
7622666|NCT02350478|18770220|P1|NOT COMPLETED|Overall Study||5
7622667|NCT02350478|18770219|P2|COMPLETED|Overall Study||23
7622668|NCT02350478|18770220|P1|COMPLETED|Overall Study||20
7622669|NCT02350478|18770219|P2|STARTED|Overall Study||24
7622670|NCT02350478|18770220|P1|STARTED|Overall Study||25
7622671|NCT02350309|18770242|P6|NOT COMPLETED|Treatment Period 4 (2 Days)||1
7622672|NCT02350309|18770243|P5|NOT COMPLETED|Treatment Period 4 (2 Days)||0
7622673|NCT02350309|18770244|P4|NOT COMPLETED|Treatment Period 4 (2 Days)||0
7622674|NCT02350309|18770245|P3|NOT COMPLETED|Treatment Period 4 (2 Days)||0
7622675|NCT02350309|18770246|P2|NOT COMPLETED|Treatment Period 4 (2 Days)||0
7622676|NCT02350309|18770247|P1|NOT COMPLETED|Treatment Period 4 (2 Days)||0
7622677|NCT02350309|18770242|P6|COMPLETED|Treatment Period 4 (2 Days)||11
7622678|NCT02350309|18770243|P5|COMPLETED|Treatment Period 4 (2 Days)||12
7622679|NCT02350309|18770244|P4|COMPLETED|Treatment Period 4 (2 Days)||11
7622680|NCT02350309|18770245|P3|COMPLETED|Treatment Period 4 (2 Days)||10
7622681|NCT02350309|18770246|P2|COMPLETED|Treatment Period 4 (2 Days)||11
7622682|NCT02350309|18770247|P1|COMPLETED|Treatment Period 4 (2 Days)||12
7622683|NCT02350309|18770242|P6|STARTED|Treatment Period 4 (2 Days)||12
7622684|NCT02350309|18770243|P5|STARTED|Treatment Period 4 (2 Days)||12
7622685|NCT02350309|18770244|P4|STARTED|Treatment Period 4 (2 Days)||11
7622686|NCT02350309|18770245|P3|STARTED|Treatment Period 4 (2 Days)||10
7622687|NCT02350309|18770246|P2|STARTED|Treatment Period 4 (2 Days)||11
7622688|NCT02350309|18770247|P1|STARTED|Treatment Period 4 (2 Days)||12
7622689|NCT02350309|18770242|P6|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
7622690|NCT02350309|18770243|P5|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
7622691|NCT02350309|18770244|P4|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
7622692|NCT02350309|18770245|P3|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
7622693|NCT02350309|18770246|P2|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
7622694|NCT02350309|18770247|P1|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
7622695|NCT02350309|18770242|P6|COMPLETED|Washout Period 3 (12-16 Days)||12
7622696|NCT02350309|18770243|P5|COMPLETED|Washout Period 3 (12-16 Days)||12
7622697|NCT02350309|18770244|P4|COMPLETED|Washout Period 3 (12-16 Days)||11
7622698|NCT02350309|18770245|P3|COMPLETED|Washout Period 3 (12-16 Days)||10
7622699|NCT02350309|18770246|P2|COMPLETED|Washout Period 3 (12-16 Days)||11
7622700|NCT02350309|18770247|P1|COMPLETED|Washout Period 3 (12-16 Days)||12
7622701|NCT02350309|18770242|P6|STARTED|Washout Period 3 (12-16 Days)||12
7622702|NCT02350309|18770243|P5|STARTED|Washout Period 3 (12-16 Days)||12
7622703|NCT02350309|18770244|P4|STARTED|Washout Period 3 (12-16 Days)||11
7622704|NCT02350309|18770245|P3|STARTED|Washout Period 3 (12-16 Days)||10
7622705|NCT02350309|18770246|P2|STARTED|Washout Period 3 (12-16 Days)||11
7622706|NCT02350309|18770247|P1|STARTED|Washout Period 3 (12-16 Days)||12
7622707|NCT02350309|18770242|P6|NOT COMPLETED|Treatment Period 3 (2 Days)||0
7622708|NCT02350309|18770243|P5|NOT COMPLETED|Treatment Period 3 (2 Days)||0
7622709|NCT02350309|18770244|P4|NOT COMPLETED|Treatment Period 3 (2 Days)||0
7622710|NCT02350309|18770245|P3|NOT COMPLETED|Treatment Period 3 (2 Days)||0
7622711|NCT02350309|18770246|P2|NOT COMPLETED|Treatment Period 3 (2 Days)||0
7622712|NCT02350309|18770247|P1|NOT COMPLETED|Treatment Period 3 (2 Days)||0
7622713|NCT02350309|18770242|P6|COMPLETED|Treatment Period 3 (2 Days)||12
7622714|NCT02350309|18770243|P5|COMPLETED|Treatment Period 3 (2 Days)||12
7622715|NCT02350309|18770244|P4|COMPLETED|Treatment Period 3 (2 Days)||11
7622716|NCT02350309|18770245|P3|COMPLETED|Treatment Period 3 (2 Days)||10
7622717|NCT02350309|18770246|P2|COMPLETED|Treatment Period 3 (2 Days)||11
7622718|NCT02350309|18770247|P1|COMPLETED|Treatment Period 3 (2 Days)||12
7622719|NCT02350309|18770242|P6|STARTED|Treatment Period 3 (2 Days)||12
7622720|NCT02350309|18770243|P5|STARTED|Treatment Period 3 (2 Days)||12
7622721|NCT02350309|18770244|P4|STARTED|Treatment Period 3 (2 Days)||11
7622722|NCT02350309|18770245|P3|STARTED|Treatment Period 3 (2 Days)||10
7622723|NCT02350309|18770246|P2|STARTED|Treatment Period 3 (2 Days)||11
7622724|NCT02350309|18770247|P1|STARTED|Treatment Period 3 (2 Days)||12
7622725|NCT02350309|18770242|P6|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
7622726|NCT02350309|18770243|P5|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
7622727|NCT02350309|18770244|P4|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
7622728|NCT02350309|18770245|P3|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
7622729|NCT02350309|18770246|P2|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
7622730|NCT02350309|18770247|P1|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
7622731|NCT02350309|18770242|P6|COMPLETED|Washout Period 2 (12-16 Days)||12
7622732|NCT02350309|18770243|P5|COMPLETED|Washout Period 2 (12-16 Days)||12
7622733|NCT02350309|18770244|P4|COMPLETED|Washout Period 2 (12-16 Days)||11
7622734|NCT02350309|18770245|P3|COMPLETED|Washout Period 2 (12-16 Days)||10
7622735|NCT02350309|18770246|P2|COMPLETED|Washout Period 2 (12-16 Days)||11
7622736|NCT02350309|18770247|P1|COMPLETED|Washout Period 2 (12-16 Days)||12
7622737|NCT02350309|18770242|P6|STARTED|Washout Period 2 (12-16 Days)||12
7622738|NCT02350309|18770243|P5|STARTED|Washout Period 2 (12-16 Days)||12
7622739|NCT02350309|18770244|P4|STARTED|Washout Period 2 (12-16 Days)||11
7622740|NCT02350309|18770245|P3|STARTED|Washout Period 2 (12-16 Days)||10
7622741|NCT02350309|18770246|P2|STARTED|Washout Period 2 (12-16 Days)||11
7622742|NCT02350309|18770247|P1|STARTED|Washout Period 2 (12-16 Days)||12
7622743|NCT02350309|18770242|P6|NOT COMPLETED|Treatment Period 2 (2 Days)||0
7622744|NCT02350309|18770243|P5|NOT COMPLETED|Treatment Period 2 (2 Days)||0
7622745|NCT02350309|18770244|P4|NOT COMPLETED|Treatment Period 2 (2 Days)||0
7622746|NCT02350309|18770245|P3|NOT COMPLETED|Treatment Period 2 (2 Days)||0
7622747|NCT02350309|18770246|P2|NOT COMPLETED|Treatment Period 2 (2 Days)||0
7622748|NCT02350309|18770247|P1|NOT COMPLETED|Treatment Period 2 (2 Days)||0
7622749|NCT02350309|18770242|P6|COMPLETED|Treatment Period 2 (2 Days)||12
7622750|NCT02350309|18770243|P5|COMPLETED|Treatment Period 2 (2 Days)||12
7622751|NCT02350309|18770244|P4|COMPLETED|Treatment Period 2 (2 Days)||11
7622752|NCT02350309|18770245|P3|COMPLETED|Treatment Period 2 (2 Days)||10
7622753|NCT02350309|18770246|P2|COMPLETED|Treatment Period 2 (2 Days)||11
7622754|NCT02350309|18770247|P1|COMPLETED|Treatment Period 2 (2 Days)||12
7622755|NCT02350309|18770242|P6|STARTED|Treatment Period 2 (2 Days)||12
7622756|NCT02350309|18770243|P5|STARTED|Treatment Period 2 (2 Days)||12
7622757|NCT02350309|18770244|P4|STARTED|Treatment Period 2 (2 Days)||11
7622758|NCT02350309|18770245|P3|STARTED|Treatment Period 2 (2 Days)||10
7622759|NCT02350309|18770246|P2|STARTED|Treatment Period 2 (2 Days)||11
7622760|NCT02350309|18770247|P1|STARTED|Treatment Period 2 (2 Days)||12
7622761|NCT02350309|18770242|P6|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
7622762|NCT02350309|18770243|P5|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
7622763|NCT02350309|18770244|P4|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
7622764|NCT02350309|18770245|P3|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
7622765|NCT02350309|18770246|P2|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
7622766|NCT02350309|18770247|P1|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
7622767|NCT02350309|18770242|P6|COMPLETED|Washout Period 1 (12-16 Days)||12
7622768|NCT02350309|18770243|P5|COMPLETED|Washout Period 1 (12-16 Days)||12
7622769|NCT02350309|18770244|P4|COMPLETED|Washout Period 1 (12-16 Days)||11
7622770|NCT02350309|18770245|P3|COMPLETED|Washout Period 1 (12-16 Days)||10
7622771|NCT02350309|18770246|P2|COMPLETED|Washout Period 1 (12-16 Days)||11
7622772|NCT02350309|18770247|P1|COMPLETED|Washout Period 1 (12-16 Days)||12
7622773|NCT02350309|18770242|P6|STARTED|Washout Period 1 (12-16 Days)||12
7622774|NCT02350309|18770243|P5|STARTED|Washout Period 1 (12-16 Days)||12
7622775|NCT02350309|18770244|P4|STARTED|Washout Period 1 (12-16 Days)||11
7622776|NCT02350309|18770245|P3|STARTED|Washout Period 1 (12-16 Days)||10
7622777|NCT02350309|18770246|P2|STARTED|Washout Period 1 (12-16 Days)||11
7622778|NCT02350309|18770247|P1|STARTED|Washout Period 1 (12-16 Days)||12
7622779|NCT02350309|18770242|P6|NOT COMPLETED|Treatment Period 1 (2 Days)||0
7622780|NCT02350309|18770243|P5|NOT COMPLETED|Treatment Period 1 (2 Days)||0
7622781|NCT02350309|18770244|P4|NOT COMPLETED|Treatment Period 1 (2 Days)||0
7622782|NCT02350309|18770245|P3|NOT COMPLETED|Treatment Period 1 (2 Days)||1
7622783|NCT02350309|18770246|P2|NOT COMPLETED|Treatment Period 1 (2 Days)||0
7622784|NCT02350309|18770247|P1|NOT COMPLETED|Treatment Period 1 (2 Days)||0
7622785|NCT02350309|18770242|P6|COMPLETED|Treatment Period 1 (2 Days)||12
7622786|NCT02350309|18770243|P5|COMPLETED|Treatment Period 1 (2 Days)||12
7622787|NCT02350309|18770244|P4|COMPLETED|Treatment Period 1 (2 Days)||11
7622788|NCT02350309|18770245|P3|COMPLETED|Treatment Period 1 (2 Days)||10
7622789|NCT02350309|18770246|P2|COMPLETED|Treatment Period 1 (2 Days)||11
7622790|NCT02350309|18770247|P1|COMPLETED|Treatment Period 1 (2 Days)||12
7622791|NCT02350309|18770242|P6|STARTED|Treatment Period 1 (2 Days)||12
7622792|NCT02350309|18770243|P5|STARTED|Treatment Period 1 (2 Days)||12
7622793|NCT02350309|18770244|P4|STARTED|Treatment Period 1 (2 Days)||11
7622794|NCT02350309|18770245|P3|STARTED|Treatment Period 1 (2 Days)||11
7622795|NCT02350309|18770246|P2|STARTED|Treatment Period 1 (2 Days)||11
7622796|NCT02350309|18770247|P1|STARTED|Treatment Period 1 (2 Days)||12
7622797|NCT02350127|18770288|P2|NOT COMPLETED|8-Month Assessment||9
7622798|NCT02350127|18770289|P1|NOT COMPLETED|8-Month Assessment||6
7622799|NCT02350127|18770288|P2|COMPLETED|8-Month Assessment||26
7622800|NCT02350127|18770289|P1|COMPLETED|8-Month Assessment||27
7622801|NCT02350127|18770288|P2|STARTED|8-Month Assessment||35
7622802|NCT02350127|18770289|P1|STARTED|8-Month Assessment||33
7622803|NCT02350127|18770288|P2|NOT COMPLETED|4-Month Assessment||9
7622804|NCT02350127|18770289|P1|NOT COMPLETED|4-Month Assessment||11
7622805|NCT02350127|18770288|P2|COMPLETED|4-Month Assessment||35
7622806|NCT02350127|18770289|P1|COMPLETED|4-Month Assessment||33
7622807|NCT02350127|18770288|P2|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to health issue (n=1)|43
7622808|NCT02350127|18770289|P1|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to time constraints (n=1) and lack of interest (n=1)|42
7622809|NCT02350127|18770288|P2|STARTED|4-Month Assessment||44
7622810|NCT02350127|18770289|P1|STARTED|4-Month Assessment||44
7622811|NCT02349789|18770328|P1|NOT COMPLETED|Overall Study||2
7622812|NCT02349789|18770328|P1|COMPLETED|Overall Study||9
7622813|NCT02349789|18770328|P1|STARTED|Overall Study||11
7622814|NCT02349711|18770339|P2|NOT COMPLETED|Overall Study||2
7622815|NCT02349711|18770340|P1|NOT COMPLETED|Overall Study||3
7622816|NCT02349711|18770339|P2|COMPLETED|Overall Study||84
7622817|NCT02349711|18770340|P1|COMPLETED|Overall Study||84
7622818|NCT02349711|18770339|P2|STARTED|Overall Study||86
7622819|NCT02349711|18770340|P1|STARTED|Overall Study||87
7622820|NCT02349685|18770355|P3|NOT COMPLETED|Overall Study||4
7622821|NCT02349685|18770356|P2|NOT COMPLETED|Overall Study||2
7622822|NCT02349685|18770357|P1|NOT COMPLETED|Overall Study||5
7622823|NCT02349685|18770355|P3|COMPLETED|Overall Study||37
7622824|NCT02349685|18770356|P2|COMPLETED|Overall Study||87
7622825|NCT02349685|18770357|P1|COMPLETED|Overall Study||84
7622826|NCT02349685|18770355|P3|STARTED|Overall Study||41
7622827|NCT02349685|18770356|P2|STARTED|Overall Study||89
7622828|NCT02349685|18770357|P1|STARTED|Overall Study||89
7622829|NCT02349646|18770368|P1|NOT COMPLETED|Overall Study||17
7622830|NCT02349646|18770368|P1|COMPLETED|Overall Study||16
7622831|NCT02349646|18770368|P1|Receive Permanent System|Overall Study||27
7622832|NCT02349646|18770368|P1|Received Trial System|Overall Study||24
7622833|NCT02349646|18770368|P1|STARTED|Overall Study||33
7622834|NCT02349542|18770373|P1|NOT COMPLETED|Overall Study||5
7622835|NCT02349542|18770373|P1|COMPLETED|Overall Study||15
7622836|NCT02349542|18770373|P1|STARTED|Overall Study||20
7622837|NCT02349477|18770380|P2|NOT COMPLETED|Overall Study||18
7622838|NCT02349477|18770381|P1|NOT COMPLETED|Overall Study||13
7622839|NCT02349477|18770380|P2|COMPLETED|Overall Study||28
7622840|NCT02349477|18770381|P1|COMPLETED|Overall Study||31
7622841|NCT02349477|18770380|P2|STARTED|Overall Study||46
7622842|NCT02349477|18770381|P1|STARTED|Overall Study||44
7622843|NCT02349451|18770397|P4|NOT COMPLETED|Overall Study||1
7622844|NCT02349451|18770398|P3|NOT COMPLETED|Overall Study||2
7622845|NCT02349451|18770399|P2|NOT COMPLETED|Overall Study||1
7622846|NCT02349451|18770400|P1|NOT COMPLETED|Overall Study||0
7622847|NCT02349451|18770397|P4|COMPLETED|Overall Study||72
7622848|NCT02349451|18770398|P3|COMPLETED|Overall Study||69
7622849|NCT02349451|18770399|P2|COMPLETED|Overall Study||71
7622850|NCT02349451|18770400|P1|COMPLETED|Overall Study||24
7622851|NCT02349451|18770397|P4|STARTED|Overall Study||73
7622852|NCT02349451|18770398|P3|STARTED|Overall Study||71
7622853|NCT02349451|18770399|P2|STARTED|Overall Study||72
7622854|NCT02349451|18770400|P1|STARTED|Overall Study||24
7622855|NCT02349438|18770436|P2|NOT COMPLETED|Period 2||0
7622856|NCT02349438|18770437|P1|NOT COMPLETED|Period 2||0
7622857|NCT02349438|18770436|P2|COMPLETED|Period 2||10
7622858|NCT02349438|18770437|P1|COMPLETED|Period 2||11
7622859|NCT02349438|18770436|P2|STARTED|Period 2||10
7622860|NCT02349438|18770437|P1|STARTED|Period 2||11
7622861|NCT02349438|18770436|P2|NOT COMPLETED|Period 1||0
7622862|NCT02349438|18770437|P1|NOT COMPLETED|Period 1||0
7622863|NCT02349438|18770436|P2|COMPLETED|Period 1||10
7622864|NCT02349438|18770437|P1|COMPLETED|Period 1||11
7622865|NCT02349438|18770436|P2|STARTED|Period 1||10
7622866|NCT02349438|18770437|P1|STARTED|Period 1||11
7622867|NCT02349425|18770451|P4|NOT COMPLETED|Period 2||0
7622868|NCT02349425|18770452|P3|NOT COMPLETED|Period 2||1
7622869|NCT02349425|18770453|P2|NOT COMPLETED|Period 2||1
7622870|NCT02349425|18770454|P1|NOT COMPLETED|Period 2||0
7622871|NCT02349425|18770451|P4|COMPLETED|Period 2||15
7622872|NCT02349425|18770452|P3|COMPLETED|Period 2||14
7622873|NCT02349425|18770453|P2|COMPLETED|Period 2||12
7622874|NCT02349425|18770454|P1|COMPLETED|Period 2||14
7622875|NCT02349425|18770451|P4|STARTED|Period 2||15
7622876|NCT02349425|18770452|P3|STARTED|Period 2||15
7622877|NCT02349425|18770453|P2|STARTED|Period 2||13
7622878|NCT02349425|18770454|P1|STARTED|Period 2||14
7622879|NCT02349425|18770451|P4|NOT COMPLETED|Period 1||0
7622880|NCT02349425|18770452|P3|NOT COMPLETED|Period 1||0
7622881|NCT02349425|18770453|P2|NOT COMPLETED|Period 1||1
7622882|NCT02349425|18770454|P1|NOT COMPLETED|Period 1||1
7622883|NCT02349425|18770451|P4|COMPLETED|Period 1||15
7622884|NCT02349425|18770452|P3|COMPLETED|Period 1||15
7622885|NCT02349425|18770453|P2|COMPLETED|Period 1||13
7622886|NCT02349425|18770454|P1|COMPLETED|Period 1||14
7622887|NCT02349425|18770451|P4|STARTED|Period 1||15
7622888|NCT02349425|18770452|P3|STARTED|Period 1||15
7622889|NCT02349425|18770453|P2|STARTED|Period 1||14
7622890|NCT02349425|18770454|P1|STARTED|Period 1||15
7622891|NCT02349412|18770628|P2|NOT COMPLETED|Overall Study||7
7622892|NCT02349412|18770629|P1|NOT COMPLETED|Overall Study||7
7622893|NCT02349412|18770628|P2|COMPLETED|Overall Study||196
7622894|NCT02349412|18770629|P1|COMPLETED|Overall Study||195
7622895|NCT02349412|18770628|P2|Completed Week-24 QOL Assessment Measure|Overall Study||80
7622896|NCT02349412|18770629|P1|Completed Week-24 QOL Assessment Measure|Overall Study||68
7622897|NCT02349412|18770628|P2|Completed Week-12 QOL Assessment Measure|Overall Study||101
7622898|NCT02349412|18770629|P1|Completed Week-12 QOL Assessment Measure|Overall Study||92
7622899|NCT02349412|18770628|P2|STARTED|Overall Study||203
7622900|NCT02349412|18770629|P1|STARTED|Overall Study||202
7622901|NCT02349360|18770645|P2|NOT COMPLETED|Overall Study||1
7622902|NCT02349360|18770646|P1|NOT COMPLETED|Overall Study||0
7622903|NCT02349360|18770645|P2|COMPLETED|Overall Study||20
7622904|NCT02349360|18770646|P1|COMPLETED|Overall Study||21
7622905|NCT02349360|18770645|P2|STARTED|Overall Study||21
7622906|NCT02349360|18770646|P1|STARTED|Overall Study||21
7622907|NCT02349295|18770657|P14|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||1
7622908|NCT02349295|18770658|P13|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||8
7622909|NCT02349295|18770659|P12|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||9
7622910|NCT02349295|18770660|P11|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622911|NCT02349295|18770661|P10|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622912|NCT02349295|18770662|P9|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622913|NCT02349295|18770663|P8|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622914|NCT02349295|18770664|P7|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622915|NCT02349295|18770665|P6|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622916|NCT02349295|18770666|P5|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622917|NCT02349295|18770667|P4|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622918|NCT02349295|18770668|P3|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622919|NCT02349295|18770669|P2|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622920|NCT02349295|18770670|P1|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622921|NCT02349295|18770657|P14|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||16
7622922|NCT02349295|18770658|P13|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||137
7622923|NCT02349295|18770659|P12|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||133
7622924|NCT02349295|18770660|P11|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622925|NCT02349295|18770661|P10|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622926|NCT02349295|18770662|P9|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622927|NCT02349295|18770663|P8|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622928|NCT02349295|18770664|P7|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622929|NCT02349295|18770665|P6|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622930|NCT02349295|18770666|P5|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622931|NCT02349295|18770667|P4|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622932|NCT02349295|18770668|P3|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622933|NCT02349295|18770669|P2|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622934|NCT02349295|18770670|P1|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
7622935|NCT02349295|18770657|P14|STARTED|Follow-Up Period (Up to 12-24 Weeks)|PBO participants who entered post-treatment follow-up.|17
7622936|NCT02349295|18770658|P13|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ4W participants who entered post-treatment follow-up.|145
7622937|NCT02349295|18770659|P12|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ2W participants who entered post-treatment follow-up.|142
7622938|NCT02349295|18770660|P11|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
7622939|NCT02349295|18770661|P10|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
7622940|NCT02349295|18770662|P9|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
7622941|NCT02349295|18770663|P8|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
7622942|NCT02349295|18770664|P7|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
7622943|NCT02349295|18770665|P6|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
7622944|NCT02349295|18770666|P5|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
7622945|NCT02349295|18770667|P4|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
7622946|NCT02349295|18770668|P3|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
7622947|NCT02349295|18770669|P2|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
7622948|NCT02349295|18770670|P1|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
7622949|NCT02349295|18770657|P14|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
7622950|NCT02349295|18770658|P13|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
7622951|NCT02349295|18770659|P12|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
7622952|NCT02349295|18770660|P11|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||23
7622953|NCT02349295|18770661|P10|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||26
7622954|NCT02349295|18770662|P9|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||41
7622955|NCT02349295|18770663|P8|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||52
7622956|NCT02349295|18770664|P7|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
7622957|NCT02349295|18770665|P6|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
7622958|NCT02349295|18770666|P5|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
7622959|NCT02349295|18770667|P4|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
7622960|NCT02349295|18770668|P3|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
7622961|NCT02349295|18770669|P2|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
7622962|NCT02349295|18770670|P1|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
7622963|NCT02349295|18770657|P14|COMPLETED|Long-Term Extension Period (Week 24-156)||0
7622964|NCT02349295|18770658|P13|COMPLETED|Long-Term Extension Period (Week 24-156)||0
7622965|NCT02349295|18770659|P12|COMPLETED|Long-Term Extension Period (Week 24-156)||0
7622966|NCT02349295|18770660|P11|COMPLETED|Long-Term Extension Period (Week 24-156)||23
7622967|NCT02349295|18770661|P10|COMPLETED|Long-Term Extension Period (Week 24-156)||20
7622968|NCT02349295|18770662|P9|COMPLETED|Long-Term Extension Period (Week 24-156)||70
7622969|NCT02349295|18770663|P8|COMPLETED|Long-Term Extension Period (Week 24-156)||55
7622970|NCT02349295|18770664|P7|COMPLETED|Long-Term Extension Period (Week 24-156)||0
7622971|NCT02349295|18770665|P6|COMPLETED|Long-Term Extension Period (Week 24-156)||0
7622972|NCT02349295|18770666|P5|COMPLETED|Long-Term Extension Period (Week 24-156)||0
7622973|NCT02349295|18770667|P4|COMPLETED|Long-Term Extension Period (Week 24-156)||0
7622974|NCT02349295|18770668|P3|COMPLETED|Long-Term Extension Period (Week 24-156)||0
7622975|NCT02349295|18770669|P2|COMPLETED|Long-Term Extension Period (Week 24-156)||0
7622976|NCT02349295|18770670|P1|COMPLETED|Long-Term Extension Period (Week 24-156)||0
7622977|NCT02349295|18770657|P14|STARTED|Long-Term Extension Period (Week 24-156)||0
7622978|NCT02349295|18770658|P13|STARTED|Long-Term Extension Period (Week 24-156)||0
7622979|NCT02349295|18770659|P12|STARTED|Long-Term Extension Period (Week 24-156)||0
7622980|NCT02349295|18770660|P11|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ4W participants who entered the long-term extension period.|46
7622981|NCT02349295|18770661|P10|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ2W participants who entered the long-term extension period.|46
7622982|NCT02349295|18770662|P9|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ4W participants who entered the long-term extension period.|111
7622983|NCT02349295|18770663|P8|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ2W participants who entered the long-term extension period.|107
7622984|NCT02349295|18770664|P7|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
7622985|NCT02349295|18770665|P6|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
7622986|NCT02349295|18770666|P5|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
7622987|NCT02349295|18770667|P4|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
7622988|NCT02349295|18770668|P3|STARTED|Long-Term Extension Period (Week 24-156)||0
7622989|NCT02349295|18770669|P2|STARTED|Long-Term Extension Period (Week 24-156)||0
7622990|NCT02349295|18770670|P1|STARTED|Long-Term Extension Period (Week 24-156)||0
7622991|NCT02349295|18770657|P14|NOT COMPLETED|IR (Week 16-24)||0
7622992|NCT02349295|18770658|P13|NOT COMPLETED|IR (Week 16-24)||0
7622993|NCT02349295|18770659|P12|NOT COMPLETED|IR (Week 16-24)||0
7622994|NCT02349295|18770660|P11|NOT COMPLETED|IR (Week 16-24)||0
7622995|NCT02349295|18770661|P10|NOT COMPLETED|IR (Week 16-24)||0
7622996|NCT02349295|18770662|P9|NOT COMPLETED|IR (Week 16-24)||0
7622997|NCT02349295|18770663|P8|NOT COMPLETED|IR (Week 16-24)||0
7622998|NCT02349295|18770664|P7|NOT COMPLETED|IR (Week 16-24)||0
7622999|NCT02349295|18770665|P6|NOT COMPLETED|IR (Week 16-24)||0
7623000|NCT02349295|18770666|P5|NOT COMPLETED|IR (Week 16-24)||0
7623001|NCT02349295|18770667|P4|NOT COMPLETED|IR (Week 16-24)||1
7623002|NCT02349295|18770668|P3|NOT COMPLETED|IR (Week 16-24)||0
7623003|NCT02349295|18770669|P2|NOT COMPLETED|IR (Week 16-24)||0
7623004|NCT02349295|18770670|P1|NOT COMPLETED|IR (Week 16-24)||0
7623005|NCT02349295|18770657|P14|COMPLETED|IR (Week 16-24)||0
7623006|NCT02349295|18770658|P13|COMPLETED|IR (Week 16-24)||0
7623007|NCT02349295|18770659|P12|COMPLETED|IR (Week 16-24)||0
7623008|NCT02349295|18770660|P11|COMPLETED|IR (Week 16-24)||0
7623009|NCT02349295|18770661|P10|COMPLETED|IR (Week 16-24)||0
7623010|NCT02349295|18770662|P9|COMPLETED|IR (Week 16-24)||0
7623011|NCT02349295|18770663|P8|COMPLETED|IR (Week 16-24)||0
7623012|NCT02349295|18770664|P7|COMPLETED|IR (Week 16-24)||16
7623013|NCT02349295|18770665|P6|COMPLETED|IR (Week 16-24)||16
7623014|NCT02349295|18770666|P5|COMPLETED|IR (Week 16-24)||15
7623015|NCT02349295|18770667|P4|COMPLETED|IR (Week 16-24)||16
7623016|NCT02349295|18770668|P3|COMPLETED|IR (Week 16-24)||0
7623017|NCT02349295|18770669|P2|COMPLETED|IR (Week 16-24)||0
7623018|NCT02349295|18770670|P1|COMPLETED|IR (Week 16-24)||0
7623019|NCT02349295|18770657|P14|STARTED|IR (Week 16-24)||0
7623020|NCT02349295|18770658|P13|STARTED|IR (Week 16-24)||0
7623021|NCT02349295|18770659|P12|STARTED|IR (Week 16-24)||0
7623022|NCT02349295|18770660|P11|STARTED|IR (Week 16-24)||0
7623023|NCT02349295|18770661|P10|STARTED|IR (Week 16-24)||0
7623024|NCT02349295|18770662|P9|STARTED|IR (Week 16-24)||0
7623025|NCT02349295|18770663|P8|STARTED|IR (Week 16-24)||0
7623026|NCT02349295|18770664|P7|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q4W.|16
7623027|NCT02349295|18770665|P6|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q2W.|16
7623028|NCT02349295|18770666|P5|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q4W only.|15
7623029|NCT02349295|18770667|P4|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q2W only.|17
7623030|NCT02349295|18770668|P3|STARTED|IR (Week 16-24)|Only IR participants were included.|0
7623031|NCT02349295|18770669|P2|STARTED|IR (Week 16-24)|Only IR participants were included.|0
7623032|NCT02349295|18770670|P1|STARTED|IR (Week 16-24)|Only IR participants were included.|0
7623033|NCT02349295|18770657|P14|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
7623034|NCT02349295|18770658|P13|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
7623035|NCT02349295|18770659|P12|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
7623036|NCT02349295|18770660|P11|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
7623037|NCT02349295|18770661|P10|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
7623038|NCT02349295|18770662|P9|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
7623039|NCT02349295|18770663|P8|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
7623040|NCT02349295|18770664|P7|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
7623041|NCT02349295|18770665|P6|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
7623042|NCT02349295|18770666|P5|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
7623043|NCT02349295|18770667|P4|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
7623044|NCT02349295|18770668|P3|NOT COMPLETED|Double Blind Treatment (Week 0-24)||24
7623045|NCT02349295|18770669|P2|NOT COMPLETED|Double Blind Treatment (Week 0-24)||11
7623046|NCT02349295|18770670|P1|NOT COMPLETED|Double Blind Treatment (Week 0-24)||14
7623047|NCT02349295|18770657|P14|COMPLETED|Double Blind Treatment (Week 0-24)||0
7623048|NCT02349295|18770658|P13|COMPLETED|Double Blind Treatment (Week 0-24)||0
7623049|NCT02349295|18770659|P12|COMPLETED|Double Blind Treatment (Week 0-24)||0
7623050|NCT02349295|18770660|P11|COMPLETED|Double Blind Treatment (Week 0-24)||0
7623051|NCT02349295|18770661|P10|COMPLETED|Double Blind Treatment (Week 0-24)||0
7623052|NCT02349295|18770662|P9|COMPLETED|Double Blind Treatment (Week 0-24)||0
7623053|NCT02349295|18770663|P8|COMPLETED|Double Blind Treatment (Week 0-24)||0
7623054|NCT02349295|18770664|P7|COMPLETED|Double Blind Treatment (Week 0-24)||0
7623055|NCT02349295|18770665|P6|COMPLETED|Double Blind Treatment (Week 0-24)||0
7623056|NCT02349295|18770666|P5|COMPLETED|Double Blind Treatment (Week 0-24)||0
7623057|NCT02349295|18770667|P4|COMPLETED|Double Blind Treatment (Week 0-24)||0
7623058|NCT02349295|18770668|P3|COMPLETED|Double Blind Treatment (Week 0-24)||94
7623059|NCT02349295|18770669|P2|COMPLETED|Double Blind Treatment (Week 0-24)||111
7623060|NCT02349295|18770670|P1|COMPLETED|Double Blind Treatment (Week 0-24)||109
7623061|NCT02349295|18770657|P14|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
7623062|NCT02349295|18770658|P13|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
7623063|NCT02349295|18770659|P12|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
7623064|NCT02349295|18770660|P11|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
7623065|NCT02349295|18770661|P10|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
7623066|NCT02349295|18770662|P9|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
7623067|NCT02349295|18770663|P8|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
7623068|NCT02349295|18770664|P7|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
7623069|NCT02349295|18770665|P6|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
7623070|NCT02349295|18770666|P5|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
7623071|NCT02349295|18770667|P4|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
7623072|NCT02349295|18770668|P3|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||118
7623073|NCT02349295|18770669|P2|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||122
7623074|NCT02349295|18770670|P1|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||123
7623075|NCT02349295|18770657|P14|STARTED|Double Blind Treatment (Week 0-24)||0
7623076|NCT02349295|18770658|P13|STARTED|Double Blind Treatment (Week 0-24)||0
7623077|NCT02349295|18770659|P12|STARTED|Double Blind Treatment (Week 0-24)||0
7623078|NCT02349295|18770660|P11|STARTED|Double Blind Treatment (Week 0-24)||0
7623079|NCT02349295|18770661|P10|STARTED|Double Blind Treatment (Week 0-24)||0
7623080|NCT02349295|18770662|P9|STARTED|Double Blind Treatment (Week 0-24)||0
7623081|NCT02349295|18770663|P8|STARTED|Double Blind Treatment (Week 0-24)||0
7623082|NCT02349295|18770664|P7|STARTED|Double Blind Treatment (Week 0-24)||0
7623083|NCT02349295|18770665|P6|STARTED|Double Blind Treatment (Week 0-24)||0
7623084|NCT02349295|18770666|P5|STARTED|Double Blind Treatment (Week 0-24)||0
7623085|NCT02349295|18770667|P4|STARTED|Double Blind Treatment (Week 0-24)||0
7623086|NCT02349295|18770668|P3|STARTED|Double Blind Treatment (Week 0-24)||118
7623087|NCT02349295|18770669|P2|STARTED|Double Blind Treatment (Week 0-24)||122
7623088|NCT02349295|18770670|P1|STARTED|Double Blind Treatment (Week 0-24)||123
7623089|NCT02349178|18770765|P1|NOT COMPLETED|Overall Study||0
7623090|NCT02349178|18770765|P1|COMPLETED|Overall Study||6
7623091|NCT02349178|18770765|P1|STARTED|Overall Study||6
7623092|NCT02349152|18770771|P2|NOT COMPLETED|Overall Study||4
7623093|NCT02349152|18770772|P1|NOT COMPLETED|Overall Study||6
7623094|NCT02349152|18770771|P2|COMPLETED|Overall Study||52
7623095|NCT02349152|18770772|P1|COMPLETED|Overall Study||54
7623096|NCT02349152|18770771|P2|STARTED|Overall Study||56
7623097|NCT02349152|18770772|P1|STARTED|Overall Study||60
7623098|NCT02349061|18770810|P3|NOT COMPLETED|Study Extension (Week 56 to Week 120)||3
7623099|NCT02349061|18770811|P2|NOT COMPLETED|Study Extension (Week 56 to Week 120)||5
7623100|NCT02349061|18770812|P1|NOT COMPLETED|Study Extension (Week 56 to Week 120)||0
7623101|NCT02349061|18770810|P3|COMPLETED|Study Extension (Week 56 to Week 120)||14
7623102|NCT02349061|18770811|P2|COMPLETED|Study Extension (Week 56 to Week 120)||24
7623103|NCT02349061|18770812|P1|COMPLETED|Study Extension (Week 56 to Week 120)||0
7623104|NCT02349061|18770810|P3|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|17
7623196|NCT02348658|18770929|P1|STARTED|Period 1 (7 Days)||6
7623105|NCT02349061|18770811|P2|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|29
7623106|NCT02349061|18770812|P1|STARTED|Study Extension (Week 56 to Week 120)||0
7623107|NCT02349061|18770810|P3|NOT COMPLETED|Main Study: Week 24 to 56||3
7623108|NCT02349061|18770811|P2|NOT COMPLETED|Main Study: Week 24 to 56||3
7623109|NCT02349061|18770812|P1|NOT COMPLETED|Main Study: Week 24 to 56||0
7623110|NCT02349061|18770810|P3|COMPLETED|Main Study: Week 24 to 56||30
7623111|NCT02349061|18770811|P2|COMPLETED|Main Study: Week 24 to 56||53
7623112|NCT02349061|18770812|P1|COMPLETED|Main Study: Week 24 to 56||0
7623113|NCT02349061|18770810|P3|STARTED|Main Study: Week 24 to 56||33
7623114|NCT02349061|18770811|P2|STARTED|Main Study: Week 24 to 56||56
7623115|NCT02349061|18770812|P1|STARTED|Main Study: Week 24 to 56||0
7623116|NCT02349061|18770810|P3|NOT COMPLETED|Main Study: PCP (Up to Week 24)||0
7623117|NCT02349061|18770811|P2|NOT COMPLETED|Main Study: PCP (Up to Week 24)||4
7623118|NCT02349061|18770812|P1|NOT COMPLETED|Main Study: PCP (Up to Week 24)||9
7623119|NCT02349061|18770810|P3|COMPLETED|Main Study: PCP (Up to Week 24)||0
7623120|NCT02349061|18770811|P2|COMPLETED|Main Study: PCP (Up to Week 24)||56
7623121|NCT02349061|18770812|P1|COMPLETED|Main Study: PCP (Up to Week 24)||33
7623122|NCT02349061|18770810|P3|STARTED|Main Study: PCP (Up to Week 24)||0
7623123|NCT02349061|18770811|P2|STARTED|Main Study: PCP (Up to Week 24)||60
7623124|NCT02349061|18770812|P1|STARTED|Main Study: PCP (Up to Week 24)||42
7623125|NCT02349048|18770832|P2|NOT COMPLETED|Overall Study||0
7623126|NCT02349048|18770833|P1|NOT COMPLETED|Overall Study||5
7623127|NCT02349048|18770832|P2|COMPLETED|Overall Study||9
7623128|NCT02349048|18770833|P1|COMPLETED|Overall Study||54
7623129|NCT02349048|18770832|P2|STARTED|Overall Study||9
7623130|NCT02349048|18770833|P1|STARTED|Overall Study||59
7623131|NCT02348918|18770862|P9|NOT COMPLETED|Overall Study||0
7623132|NCT02348918|18770863|P8|NOT COMPLETED|Overall Study||0
7623133|NCT02348918|18770864|P7|NOT COMPLETED|Overall Study||0
7623134|NCT02348918|18770865|P6|NOT COMPLETED|Overall Study||0
7623135|NCT02348918|18770866|P5|NOT COMPLETED|Overall Study||0
7623136|NCT02348918|18770867|P4|NOT COMPLETED|Overall Study||0
7623137|NCT02348918|18770868|P3|NOT COMPLETED|Overall Study||0
7623138|NCT02348918|18770869|P2|NOT COMPLETED|Overall Study||0
7623139|NCT02348918|18770870|P1|NOT COMPLETED|Overall Study||0
7623140|NCT02348918|18770862|P9|COMPLETED|Overall Study||15
7623141|NCT02348918|18770863|P8|COMPLETED|Overall Study||16
7623142|NCT02348918|18770864|P7|COMPLETED|Overall Study||13
7623143|NCT02348918|18770865|P6|COMPLETED|Overall Study||17
7623144|NCT02348918|18770866|P5|COMPLETED|Overall Study||19
7623145|NCT02348918|18770867|P4|COMPLETED|Overall Study||24
7623146|NCT02348918|18770868|P3|COMPLETED|Overall Study||42
7623147|NCT02348918|18770869|P2|COMPLETED|Overall Study||33
7623148|NCT02348918|18770870|P1|COMPLETED|Overall Study||39
7623149|NCT02348918|18770862|P9|STARTED|Overall Study||15
7623150|NCT02348918|18770863|P8|STARTED|Overall Study||16
7623151|NCT02348918|18770864|P7|STARTED|Overall Study||13
7623152|NCT02348918|18770865|P6|STARTED|Overall Study||17
7623153|NCT02348918|18770866|P5|STARTED|Overall Study||19
7623154|NCT02348918|18770867|P4|STARTED|Overall Study||24
7623155|NCT02348918|18770868|P3|STARTED|Overall Study||42
7623156|NCT02348918|18770869|P2|STARTED|Overall Study||33
7623157|NCT02348918|18770870|P1|STARTED|Overall Study||39
7623158|NCT02348840|18770894|P4|NOT COMPLETED|Overall Study||0
7623159|NCT02348840|18770895|P3|NOT COMPLETED|Overall Study||0
7623160|NCT02348840|18770896|P2|NOT COMPLETED|Overall Study||1
7623161|NCT02348840|18770897|P1|NOT COMPLETED|Overall Study||2
7623162|NCT02348840|18770894|P4|COMPLETED|Overall Study||374
7623163|NCT02348840|18770895|P3|COMPLETED|Overall Study||425
7623164|NCT02348840|18770896|P2|COMPLETED|Overall Study||20
7623165|NCT02348840|18770897|P1|COMPLETED|Overall Study||21
7623166|NCT02348840|18770894|P4|STARTED|Overall Study||374
7623167|NCT02348840|18770895|P3|STARTED|Overall Study||425
7623168|NCT02348840|18770896|P2|STARTED|Overall Study||21
7623169|NCT02348840|18770897|P1|STARTED|Overall Study||23
7623170|NCT02348723|18770911|P2|NOT COMPLETED|Overall Study||26
7623171|NCT02348723|18770912|P1|NOT COMPLETED|Overall Study||28
7623172|NCT02348723|18770911|P2|COMPLETED|Overall Study||312
7623173|NCT02348723|18770912|P1|COMPLETED|Overall Study||310
7623174|NCT02348723|18770911|P2|STARTED|Overall Study||338
7623175|NCT02348723|18770912|P1|STARTED|Overall Study||338
7623176|NCT02348684|18770924|P1|NOT COMPLETED|Overall Study||0
7623177|NCT02348684|18770924|P1|COMPLETED|Overall Study||20
7623178|NCT02348684|18770924|P1|STARTED|Overall Study||20
7623179|NCT02348658|18770928|P2|NOT COMPLETED|Period 2 (7 Days)||0
7623180|NCT02348658|18770929|P1|NOT COMPLETED|Period 2 (7 Days)||0
7623181|NCT02348658|18770928|P2|COMPLETED|Period 2 (7 Days)||6
7623182|NCT02348658|18770929|P1|COMPLETED|Period 2 (7 Days)||6
7623183|NCT02348658|18770928|P2|STARTED|Period 2 (7 Days)||6
7623184|NCT02348658|18770929|P1|STARTED|Period 2 (7 Days)||6
7623185|NCT02348658|18770928|P2|NOT COMPLETED|Washout Period (22 Days)||0
7623186|NCT02348658|18770929|P1|NOT COMPLETED|Washout Period (22 Days)||0
7623187|NCT02348658|18770928|P2|COMPLETED|Washout Period (22 Days)||6
7623188|NCT02348658|18770929|P1|COMPLETED|Washout Period (22 Days)||6
7623189|NCT02348658|18770928|P2|STARTED|Washout Period (22 Days)||6
7623190|NCT02348658|18770929|P1|STARTED|Washout Period (22 Days)||6
7623191|NCT02348658|18770928|P2|NOT COMPLETED|Period 1 (7 Days)||0
7623192|NCT02348658|18770929|P1|NOT COMPLETED|Period 1 (7 Days)||0
7623193|NCT02348658|18770928|P2|COMPLETED|Period 1 (7 Days)||6
7623194|NCT02348658|18770929|P1|COMPLETED|Period 1 (7 Days)||6
7623195|NCT02348658|18770928|P2|STARTED|Period 1 (7 Days)||6
7623197|NCT02348632|18770963|P2|NOT COMPLETED|Randomized Withdrawal Period||1
7623198|NCT02348632|18770964|P1|NOT COMPLETED|Randomized Withdrawal Period||3
7623199|NCT02348632|18770963|P2|COMPLETED|Randomized Withdrawal Period||141
7623200|NCT02348632|18770964|P1|COMPLETED|Randomized Withdrawal Period||137
7623201|NCT02348632|18770963|P2|STARTED|Randomized Withdrawal Period||142
7623202|NCT02348632|18770964|P1|STARTED|Randomized Withdrawal Period||140
7623203|NCT02348632|18770963|P2|NOT COMPLETED|Open-label Period||0
7623204|NCT02348632|18770964|P1|NOT COMPLETED|Open-label Period||185
7623205|NCT02348632|18770963|P2|COMPLETED|Open-label Period||0
7623206|NCT02348632|18770964|P1|COMPLETED|Open-label Period||458
7623207|NCT02348632|18770963|P2|STARTED|Open-label Period||0
7623208|NCT02348632|18770964|P1|STARTED|Open-label Period||643
7623209|NCT02348619|18770974|P2|NOT COMPLETED|Double-Blind Withdrawal Phase||0
7623210|NCT02348619|18770975|P1|NOT COMPLETED|Double-Blind Withdrawal Phase||2
7623211|NCT02348619|18770974|P2|COMPLETED|Double-Blind Withdrawal Phase||62
7623212|NCT02348619|18770975|P1|COMPLETED|Double-Blind Withdrawal Phase||60
7623213|NCT02348619|18770974|P2|STARTED|Double-Blind Withdrawal Phase||62
7623214|NCT02348619|18770975|P1|STARTED|Double-Blind Withdrawal Phase||62
7623215|NCT02348619|18770974|P2|NOT COMPLETED|Stable-Dose Phase||0
7623216|NCT02348619|18770975|P1|NOT COMPLETED|Stable-Dose Phase||33
7623217|NCT02348619|18770974|P2|COMPLETED|Stable-Dose Phase||0
7623218|NCT02348619|18770975|P1|COMPLETED|Stable-Dose Phase||124
7623219|NCT02348619|18770974|P2|STARTED|Stable-Dose Phase||0
7623220|NCT02348619|18770975|P1|STARTED|Stable-Dose Phase||157
7623221|NCT02348619|18770974|P2|NOT COMPLETED|Titration Phase||0
7623222|NCT02348619|18770975|P1|NOT COMPLETED|Titration Phase||17
7623223|NCT02348619|18770974|P2|COMPLETED|Titration Phase||0
7623224|NCT02348619|18770975|P1|COMPLETED|Titration Phase||157
7623225|NCT02348619|18770974|P2|STARTED|Titration Phase||0
7623226|NCT02348619|18770975|P1|STARTED|Titration Phase||174
7623227|NCT02348606|18770994|P5|NOT COMPLETED|Overall Study||18
7623228|NCT02348606|18770995|P4|NOT COMPLETED|Overall Study||24
7623229|NCT02348606|18770996|P3|NOT COMPLETED|Overall Study||11
7623230|NCT02348606|18770997|P2|NOT COMPLETED|Overall Study||8
7623231|NCT02348606|18770998|P1|NOT COMPLETED|Overall Study||9
7623232|NCT02348606|18770994|P5|COMPLETED|Overall Study||101
7623233|NCT02348606|18770995|P4|COMPLETED|Overall Study||94
7623234|NCT02348606|18770996|P3|COMPLETED|Overall Study||106
7623235|NCT02348606|18770997|P2|COMPLETED|Overall Study||54
7623236|NCT02348606|18770998|P1|COMPLETED|Overall Study||49
7623237|NCT02348606|18770994|P5|STARTED|Overall Study||119
7623238|NCT02348606|18770995|P4|STARTED|Overall Study||118
7623239|NCT02348606|18770996|P3|STARTED|Overall Study||117
7623240|NCT02348606|18770997|P2|STARTED|Overall Study||62
7623241|NCT02348606|18770998|P1|STARTED|Overall Study||58
7623242|NCT02348593|18771054|P4|NOT COMPLETED|Overall Study||7
7623243|NCT02348593|18771055|P3|NOT COMPLETED|Overall Study||16
7623244|NCT02348593|18771056|P2|NOT COMPLETED|Overall Study||8
7623245|NCT02348593|18771057|P1|NOT COMPLETED|Overall Study||10
7623246|NCT02348593|18771054|P4|COMPLETED|Overall Study||52
7623247|NCT02348593|18771055|P3|COMPLETED|Overall Study||43
7623248|NCT02348593|18771056|P2|COMPLETED|Overall Study||51
7623249|NCT02348593|18771057|P1|COMPLETED|Overall Study||49
7623250|NCT02348593|18771054|P4|STARTED|Overall Study||59
7623251|NCT02348593|18771055|P3|STARTED|Overall Study||59
7623252|NCT02348593|18771056|P2|STARTED|Overall Study||59
7623253|NCT02348593|18771057|P1|STARTED|Overall Study||59
7623254|NCT02348385|18771101|P2|NOT COMPLETED|Overall Study||0
7623255|NCT02348385|18771102|P1|NOT COMPLETED|Overall Study||0
7623256|NCT02348385|18771101|P2|COMPLETED|Overall Study||25
7623257|NCT02348385|18771102|P1|COMPLETED|Overall Study||24
7623258|NCT02348385|18771101|P2|STARTED|Overall Study||25
7623259|NCT02348385|18771102|P1|STARTED|Overall Study||24
7623260|NCT02348359|18771114|P4|NOT COMPLETED|Overall Study||12
7623261|NCT02348359|18771115|P3|NOT COMPLETED|Overall Study||14
7623262|NCT02348359|18771116|P2|NOT COMPLETED|Overall Study||17
7623263|NCT02348359|18771117|P1|NOT COMPLETED|Overall Study||11
7623264|NCT02348359|18771114|P4|COMPLETED|Overall Study||27
7623265|NCT02348359|18771115|P3|COMPLETED|Overall Study||25
7623266|NCT02348359|18771116|P2|COMPLETED|Overall Study||22
7623267|NCT02348359|18771117|P1|COMPLETED|Overall Study||29
7623268|NCT02348359|18771114|P4|STARTED|Overall Study||39
7623269|NCT02348359|18771115|P3|STARTED|Overall Study||39
7623270|NCT02348359|18771116|P2|STARTED|Overall Study||39
7623271|NCT02348359|18771117|P1|STARTED|Overall Study||40
7623272|NCT02348203|18771129|P2|NOT COMPLETED|Overall Study||10
7623273|NCT02348203|18771130|P1|NOT COMPLETED|Overall Study||10
7623274|NCT02348203|18771129|P2|COMPLETED|Overall Study||22
7623275|NCT02348203|18771130|P1|COMPLETED|Overall Study||21
7623276|NCT02348203|18771129|P2|STARTED|Overall Study||32
7623277|NCT02348203|18771130|P1|STARTED|Overall Study||31
7623278|NCT02348008|18771138|P3|NOT COMPLETED|Overall Study||19
7623279|NCT02348008|18771139|P2|NOT COMPLETED|Overall Study||10
7623280|NCT02348008|18771140|P1|NOT COMPLETED|Overall Study||3
7623281|NCT02348008|18771138|P3|COMPLETED|Overall Study||29
7623282|NCT02348008|18771139|P2|COMPLETED|Overall Study||0
7623283|NCT02348008|18771140|P1|COMPLETED|Overall Study||0
7623284|NCT02348008|18771138|P3|STARTED|Overall Study||48
7623285|NCT02348008|18771139|P2|STARTED|Overall Study||10
7623286|NCT02348008|18771140|P1|STARTED|Overall Study||3
7623287|NCT02347943|18771156|P3|NOT COMPLETED|Overall Study||45
7623288|NCT02347943|18771157|P2|NOT COMPLETED|Overall Study||67
7623289|NCT02347943|18771158|P1|NOT COMPLETED|Overall Study||140
7623290|NCT02347943|18771156|P3|COMPLETED|Overall Study||0
7623291|NCT02347943|18771157|P2|COMPLETED|Overall Study||0
7623292|NCT02347943|18771158|P1|COMPLETED|Overall Study||0
7623293|NCT02347943|18771156|P3|STARTED|Overall Study||45
7623294|NCT02347943|18771157|P2|STARTED|Overall Study||67
7623295|NCT02347943|18771158|P1|STARTED|Overall Study||140
7623296|NCT02347813|18771168|P2|NOT COMPLETED|Second Intervention, 24 Weeks||0
7623297|NCT02347813|18771169|P1|NOT COMPLETED|Second Intervention, 24 Weeks||0
7623298|NCT02347813|18771168|P2|COMPLETED|Second Intervention, 24 Weeks||4
7623299|NCT02347813|18771169|P1|COMPLETED|Second Intervention, 24 Weeks||4
7623300|NCT02347813|18771168|P2|STARTED|Second Intervention, 24 Weeks||4
7623301|NCT02347813|18771169|P1|STARTED|Second Intervention, 24 Weeks||4
7623302|NCT02347813|18771168|P2|NOT COMPLETED|First Intervention, 24 Weeks||2
7623303|NCT02347813|18771169|P1|NOT COMPLETED|First Intervention, 24 Weeks||2
7623304|NCT02347813|18771168|P2|COMPLETED|First Intervention, 24 Weeks||4
7623305|NCT02347813|18771169|P1|COMPLETED|First Intervention, 24 Weeks||4
7623306|NCT02347813|18771168|P2|STARTED|First Intervention, 24 Weeks||6
7623307|NCT02347813|18771169|P1|STARTED|First Intervention, 24 Weeks||6
7623308|NCT02347787|18771179|P2|NOT COMPLETED|9 Month Follow-Up||71
7623309|NCT02347787|18771180|P1|NOT COMPLETED|9 Month Follow-Up||61
7623310|NCT02347787|18771179|P2|COMPLETED|9 Month Follow-Up||233
7623311|NCT02347787|18771180|P1|COMPLETED|9 Month Follow-Up||227
7623312|NCT02347787|18771179|P2|STARTED|9 Month Follow-Up||304
7623313|NCT02347787|18771180|P1|STARTED|9 Month Follow-Up||288
7623314|NCT02347787|18771179|P2|NOT COMPLETED|6 Month Follow-Up||56
7623315|NCT02347787|18771180|P1|NOT COMPLETED|6 Month Follow-Up||66
7623316|NCT02347787|18771179|P2|COMPLETED|6 Month Follow-Up||248
7623317|NCT02347787|18771180|P1|COMPLETED|6 Month Follow-Up||222
7623318|NCT02347787|18771179|P2|STARTED|6 Month Follow-Up||304
7623319|NCT02347787|18771180|P1|STARTED|6 Month Follow-Up||288
7623320|NCT02347774|18771242|P3|NOT COMPLETED|On Study Treatment||36
7623321|NCT02347774|18771243|P2|NOT COMPLETED|On Study Treatment||31
7623322|NCT02347774|18771244|P1|NOT COMPLETED|On Study Treatment||24
7623323|NCT02347774|18771242|P3|COMPLETED|On Study Treatment||177
7623324|NCT02347774|18771243|P2|COMPLETED|On Study Treatment||183
7623325|NCT02347774|18771244|P1|COMPLETED|On Study Treatment||190
7623326|NCT02347774|18771242|P3|STARTED|On Study Treatment|One subject randomized in error to the placebo arm was never dosed .|213
7623327|NCT02347774|18771243|P2|STARTED|On Study Treatment||214
7623328|NCT02347774|18771244|P1|STARTED|On Study Treatment||214
7623329|NCT02347774|18771242|P3|NOT COMPLETED|Study Participation||25
7623330|NCT02347774|18771243|P2|NOT COMPLETED|Study Participation||21
7623331|NCT02347774|18771244|P1|NOT COMPLETED|Study Participation||15
7623332|NCT02347774|18771242|P3|COMPLETED|Study Participation||188
7623333|NCT02347774|18771243|P2|COMPLETED|Study Participation||193
7623334|NCT02347774|18771244|P1|COMPLETED|Study Participation||199
7623335|NCT02347774|18771242|P3|STARTED|Study Participation|One subject randomized in error to the placebo arm was never dosed .|213
7623336|NCT02347774|18771243|P2|STARTED|Study Participation||214
7623337|NCT02347774|18771244|P1|STARTED|Study Participation||214
7623338|NCT02347761|18771300|P3|NOT COMPLETED|On Study Treatment||42
7623339|NCT02347761|18771301|P2|NOT COMPLETED|On Study Treatment||23
7623340|NCT02347761|18771302|P1|NOT COMPLETED|On Study Treatment||27
7623341|NCT02347761|18771300|P3|COMPLETED|On Study Treatment||176
7623342|NCT02347761|18771301|P2|COMPLETED|On Study Treatment||194
7623343|NCT02347761|18771302|P1|COMPLETED|On Study Treatment||191
7623344|NCT02347761|18771300|P3|STARTED|On Study Treatment||218
7623345|NCT02347761|18771301|P2|STARTED|On Study Treatment||217
7623346|NCT02347761|18771302|P1|STARTED|On Study Treatment||218
7623347|NCT02347761|18771300|P3|NOT COMPLETED|All Collected||27
7623348|NCT02347761|18771301|P2|NOT COMPLETED|All Collected||14
7623349|NCT02347761|18771302|P1|NOT COMPLETED|All Collected||17
7623350|NCT02347761|18771300|P3|COMPLETED|All Collected||191
7623351|NCT02347761|18771301|P2|COMPLETED|All Collected||203
7623352|NCT02347761|18771302|P1|COMPLETED|All Collected||201
7623353|NCT02347761|18771300|P3|STARTED|All Collected||218
7623354|NCT02347761|18771301|P2|STARTED|All Collected||217
7623355|NCT02347761|18771302|P1|STARTED|All Collected||218
7623356|NCT02347657|18771363|P2|NOT COMPLETED|Overall Study||15
7623357|NCT02347657|18771364|P1|NOT COMPLETED|Overall Study||18
7623358|NCT02347657|18771363|P2|COMPLETED|Overall Study||236
7623359|NCT02347657|18771364|P1|COMPLETED|Overall Study||241
7623360|NCT02347657|18771363|P2|Treated|Overall Study||251
7623361|NCT02347657|18771364|P1|Treated|Overall Study||258
7623362|NCT02347657|18771363|P2|STARTED|Overall Study||251
7623363|NCT02347657|18771364|P1|STARTED|Overall Study||259
7623364|NCT02347631|18771391|P2|NOT COMPLETED|Second Intervention (2 Months)||4
7623365|NCT02347631|18771392|P1|NOT COMPLETED|Second Intervention (2 Months)||13
7623366|NCT02347631|18771391|P2|COMPLETED|Second Intervention (2 Months)||44
7623367|NCT02347631|18771392|P1|COMPLETED|Second Intervention (2 Months)||39
7623368|NCT02347631|18771391|P2|STARTED|Second Intervention (2 Months)||48
7623369|NCT02347631|18771392|P1|STARTED|Second Intervention (2 Months)||52
7623370|NCT02347631|18771391|P2|NOT COMPLETED|Washout 2 (1 Month)||3
7623371|NCT02347631|18771392|P1|NOT COMPLETED|Washout 2 (1 Month)||2
7623372|NCT02347631|18771391|P2|COMPLETED|Washout 2 (1 Month)||48
7623373|NCT02347631|18771392|P1|COMPLETED|Washout 2 (1 Month)||52
7623374|NCT02347631|18771391|P2|STARTED|Washout 2 (1 Month)||51
7623375|NCT02347631|18771392|P1|STARTED|Washout 2 (1 Month)||54
7623376|NCT02347631|18771391|P2|NOT COMPLETED|First Intervention (2 Months)||6
7623377|NCT02347631|18771392|P1|NOT COMPLETED|First Intervention (2 Months)||7
7623378|NCT02347631|18771391|P2|COMPLETED|First Intervention (2 Months)||51
7623379|NCT02347631|18771392|P1|COMPLETED|First Intervention (2 Months)||54
7623380|NCT02347631|18771391|P2|STARTED|First Intervention (2 Months)||57
7623381|NCT02347631|18771392|P1|STARTED|First Intervention (2 Months)||61
7623382|NCT02347631|18771391|P2|NOT COMPLETED|Washout 1 (1 Month)||0
7623383|NCT02347631|18771392|P1|NOT COMPLETED|Washout 1 (1 Month)||0
7623384|NCT02347631|18771391|P2|COMPLETED|Washout 1 (1 Month)||57
7623385|NCT02347631|18771392|P1|COMPLETED|Washout 1 (1 Month)||61
7623386|NCT02347631|18771391|P2|STARTED|Washout 1 (1 Month)||57
7623387|NCT02347631|18771392|P1|STARTED|Washout 1 (1 Month)||61
7623388|NCT02347605|18771406|P6|NOT COMPLETED|Overall Study||2
7623389|NCT02347605|18771407|P5|NOT COMPLETED|Overall Study||3
7623390|NCT02347605|18771408|P4|NOT COMPLETED|Overall Study||4
7623391|NCT02347605|18771409|P3|NOT COMPLETED|Overall Study||1
7623392|NCT02347605|18771410|P2|NOT COMPLETED|Overall Study||3
7623393|NCT02347605|18771411|P1|NOT COMPLETED|Overall Study||3
7623394|NCT02347605|18771406|P6|COMPLETED|Overall Study||7
7623395|NCT02347605|18771407|P5|COMPLETED|Overall Study||6
7623396|NCT02347605|18771408|P4|COMPLETED|Overall Study||6
7623397|NCT02347605|18771409|P3|COMPLETED|Overall Study||7
7623398|NCT02347605|18771410|P2|COMPLETED|Overall Study||7
7623399|NCT02347605|18771411|P1|COMPLETED|Overall Study||7
7623400|NCT02347605|18771406|P6|Completed Lab 2|Overall Study||8
7623401|NCT02347605|18771407|P5|Completed Lab 2|Overall Study||6
7623402|NCT02347605|18771408|P4|Completed Lab 2|Overall Study||7
7623403|NCT02347605|18771409|P3|Completed Lab 2|Overall Study||7
7623404|NCT02347605|18771410|P2|Completed Lab 2|Overall Study||7
7623405|NCT02347605|18771411|P1|Completed Lab 2|Overall Study||7
7623406|NCT02347605|18771406|P6|Completed Lab 1|Overall Study||9
7623407|NCT02347605|18771407|P5|Completed Lab 1|Overall Study||8
7623408|NCT02347605|18771408|P4|Completed Lab 1|Overall Study||10
7623409|NCT02347605|18771409|P3|Completed Lab 1|Overall Study||8
7623410|NCT02347605|18771410|P2|Completed Lab 1|Overall Study||10
7623411|NCT02347605|18771411|P1|Completed Lab 1|Overall Study||10
7623412|NCT02347605|18771406|P6|STARTED|Overall Study||9
7623413|NCT02347605|18771407|P5|STARTED|Overall Study||9
7623414|NCT02347605|18771408|P4|STARTED|Overall Study||10
7623415|NCT02347605|18771409|P3|STARTED|Overall Study||8
7623416|NCT02347605|18771410|P2|STARTED|Overall Study||10
7623417|NCT02347605|18771411|P1|STARTED|Overall Study||10
7623418|NCT02347488|18771422|P1|NOT COMPLETED|Overall Study||0
7623419|NCT02347488|18771422|P1|COMPLETED|Overall Study||30
7623420|NCT02347488|18771422|P1|STARTED|Overall Study||30
7623421|NCT02347345|18771435|P3|NOT COMPLETED|Overall Study||0
7623422|NCT02347345|18771436|P2|NOT COMPLETED|Overall Study||0
7623423|NCT02347345|18771437|P1|NOT COMPLETED|Overall Study||0
7623424|NCT02347345|18771435|P3|COMPLETED|Overall Study||12
7623425|NCT02347345|18771436|P2|COMPLETED|Overall Study||12
7623426|NCT02347345|18771437|P1|COMPLETED|Overall Study||10
7623427|NCT02347345|18771435|P3|STARTED|Overall Study||12
7623428|NCT02347345|18771436|P2|STARTED|Overall Study||12
7623429|NCT02347345|18771437|P1|STARTED|Overall Study||10
7623430|NCT02347332|18771453|P2|NOT COMPLETED|Overall Study||229
7623431|NCT02347332|18771454|P1|NOT COMPLETED|Overall Study||230
7623432|NCT02347332|18771453|P2|COMPLETED|Overall Study|6 patients: unknown cause(2home), PDsuspect(1home+1hosp), sudden death(1home), hypercapnie(1hosp).|0
7623433|NCT02347332|18771454|P1|COMPLETED|Overall Study|6 patients: suicide(1), unknown cause(5 - 4 at home +1 in city hospital).|0
7623434|NCT02347332|18771453|P2|STARTED|Overall Study||229
7623435|NCT02347332|18771454|P1|STARTED|Overall Study||230
7623436|NCT02347189|18771468|P1|NOT COMPLETED|Overall Study||11
7623437|NCT02347189|18771468|P1|COMPLETED|Overall Study||28
7623438|NCT02347189|18771468|P1|Implanted > 24 Hours|Overall Study||30
7623439|NCT02347189|18771468|P1|Implanted|Overall Study||30
7623440|NCT02347189|18771468|P1|Catheterized|Overall Study||39
7623441|NCT02347189|18771468|P1|STARTED|Overall Study||39
7623442|NCT02347176|18771487|P4|NOT COMPLETED|Overall Study||4
7623443|NCT02347176|18771488|P3|NOT COMPLETED|Overall Study||8
7623444|NCT02347176|18771489|P2|NOT COMPLETED|Overall Study||10
7623445|NCT02347176|18771490|P1|NOT COMPLETED|Overall Study||12
7623446|NCT02347176|18771487|P4|COMPLETED|Overall Study||48
7623447|NCT02347176|18771488|P3|COMPLETED|Overall Study||43
7623448|NCT02347176|18771489|P2|COMPLETED|Overall Study||40
7623449|NCT02347176|18771490|P1|COMPLETED|Overall Study||39
7623450|NCT02347176|18771487|P4|STARTED|Overall Study||52
7623451|NCT02347176|18771488|P3|STARTED|Overall Study||51
7623452|NCT02347176|18771489|P2|STARTED|Overall Study||50
7623453|NCT02347176|18771490|P1|STARTED|Overall Study||51
7623454|NCT02347124|18771538|P2|NOT COMPLETED|Overall Study||99
7623455|NCT02347124|18771539|P1|NOT COMPLETED|Overall Study||93
7623456|NCT02347124|18771538|P2|COMPLETED|Overall Study||259
7623457|NCT02347124|18771539|P1|COMPLETED|Overall Study||267
7623458|NCT02347124|18771538|P2|2 Month Follow-up|Overall Study||275
7623459|NCT02347124|18771539|P1|2 Month Follow-up|Overall Study||298
7623460|NCT02347124|18771538|P2|STARTED|Overall Study||358
7623461|NCT02347124|18771539|P1|STARTED|Overall Study||360
7623462|NCT02347098|18771575|P2|NOT COMPLETED|Overall Study||8
7623463|NCT02347098|18771576|P1|NOT COMPLETED|Overall Study||7
7623464|NCT02347098|18771575|P2|COMPLETED|Overall Study||58
7623465|NCT02347098|18771576|P1|COMPLETED|Overall Study||56
7623466|NCT02347098|18771575|P2|STARTED|Overall Study||66
7623467|NCT02347098|18771576|P1|STARTED|Overall Study||63
7623468|NCT02347085|18771588|P1|NOT COMPLETED|Overall Study||10
7623469|NCT02347085|18771588|P1|COMPLETED|Overall Study||33
7623470|NCT02347085|18771588|P1|Placebo MDI|Overall Study||40
7623471|NCT02347085|18771588|P1|GFF MDI 14.4/9.6 µg|Overall Study||40
7623472|NCT02347085|18771588|P1|STARTED|Overall Study||43
7623473|NCT02347072|18771610|P1|NOT COMPLETED|Overall Study||18
7623474|NCT02347072|18771610|P1|COMPLETED|Overall Study||62
7623475|NCT02347072|18771610|P1|Spiriva Respimat 5 µg|Overall Study||73
7623476|NCT02347072|18771610|P1|Placebo MDI|Overall Study||72
7623477|NCT02347072|18771610|P1|GFF MDI 14.4/9.6 µg|Overall Study||75
7623478|NCT02347072|18771610|P1|STARTED|Overall Study||80
7623479|NCT02346877|18771644|P2|NOT COMPLETED|Overall Study||0
7623480|NCT02346877|18771645|P1|NOT COMPLETED|Overall Study||19
7623481|NCT02346877|18771644|P2|COMPLETED|Overall Study||0
7623482|NCT02346877|18771645|P1|COMPLETED|Overall Study||0
7623483|NCT02346877|18771644|P2|STARTED|Overall Study||0
7623484|NCT02346877|18771645|P1|STARTED|Overall Study||19
7623485|NCT02346721|18771655|P1|NOT COMPLETED|Overall Study||4
7623486|NCT02346721|18771655|P1|COMPLETED|Overall Study||107
7623487|NCT02346721|18771655|P1|STARTED|Overall Study||111
7623488|NCT02346708|18771666|P2|NOT COMPLETED|Overall Study||1
7623489|NCT02346708|18771667|P1|NOT COMPLETED|Overall Study||2
7623490|NCT02346708|18771666|P2|COMPLETED|Overall Study||24
7623491|NCT02346708|18771667|P1|COMPLETED|Overall Study||22
7623492|NCT02346708|18771666|P2|STARTED|Overall Study||25
7623493|NCT02346708|18771667|P1|STARTED|Overall Study||24
7623494|NCT02346643|18771675|P1|NOT COMPLETED|Overall Study||35
7623495|NCT02346643|18771675|P1|COMPLETED|Overall Study||6
7623496|NCT02346643|18771675|P1|Received Permanent System|Overall Study||31
7623497|NCT02346643|18771675|P1|Received Trial System|Overall Study||29
7623498|NCT02346643|18771675|P1|STARTED|Overall Study||41
7623499|NCT02346461|18771682|P2|NOT COMPLETED|Overall Study||0
7623500|NCT02346461|18771683|P1|NOT COMPLETED|Overall Study||0
7623501|NCT02346461|18771682|P2|COMPLETED|Overall Study||6
7623502|NCT02346461|18771683|P1|COMPLETED|Overall Study||6
7623503|NCT02346461|18771682|P2|STARTED|Overall Study||6
7623504|NCT02346461|18771683|P1|STARTED|Overall Study||6
7623505|NCT02346370|18771705|P3|NOT COMPLETED|Overall Study||4
7623506|NCT02346370|18771706|P2|NOT COMPLETED|Overall Study||4
7623507|NCT02346370|18771707|P1|NOT COMPLETED|Overall Study||8
7623508|NCT02346370|18771705|P3|COMPLETED|Overall Study||0
7623509|NCT02346370|18771706|P2|COMPLETED|Overall Study||0
7623510|NCT02346370|18771707|P1|COMPLETED|Overall Study||0
7623511|NCT02346370|18771705|P3|STARTED|Overall Study||4
7623512|NCT02346370|18771706|P2|STARTED|Overall Study||4
7623513|NCT02346370|18771707|P1|STARTED|Overall Study||8
7623514|NCT02346240|18771756|P24|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||8
7623515|NCT02346240|18771757|P23|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
7623516|NCT02346240|18771758|P22|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||31
7623517|NCT02346240|18771759|P21|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
7623518|NCT02346240|18771760|P20|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
7623519|NCT02346240|18771761|P19|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||17
7623520|NCT02346240|18771762|P18|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
7623521|NCT02346240|18771763|P17|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623522|NCT02346240|18771764|P16|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623523|NCT02346240|18771765|P15|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623524|NCT02346240|18771766|P14|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623525|NCT02346240|18771767|P13|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623526|NCT02346240|18771768|P12|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623527|NCT02346240|18771769|P11|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623528|NCT02346240|18771770|P10|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623529|NCT02346240|18771771|P9|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623530|NCT02346240|18771772|P8|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623531|NCT02346240|18771773|P7|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623532|NCT02346240|18771774|P6|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623533|NCT02346240|18771775|P5|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623534|NCT02346240|18771776|P4|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623535|NCT02346240|18771777|P3|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623536|NCT02346240|18771778|P2|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623537|NCT02346240|18771779|P1|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623538|NCT02346240|18771756|P24|COMPLETED|Open-Label Period (Week 48 to Week 144)||8
7623539|NCT02346240|18771757|P23|COMPLETED|Open-Label Period (Week 48 to Week 144)||27
7623540|NCT02346240|18771758|P22|COMPLETED|Open-Label Period (Week 48 to Week 144)||146
7623541|NCT02346240|18771759|P21|COMPLETED|Open-Label Period (Week 48 to Week 144)||45
7623542|NCT02346240|18771760|P20|COMPLETED|Open-Label Period (Week 48 to Week 144)||34
7623543|NCT02346240|18771761|P19|COMPLETED|Open-Label Period (Week 48 to Week 144)||105
7623544|NCT02346240|18771762|P18|COMPLETED|Open-Label Period (Week 48 to Week 144)||31
7623545|NCT02346240|18771763|P17|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623546|NCT02346240|18771764|P16|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623547|NCT02346240|18771765|P15|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623548|NCT02346240|18771766|P14|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623549|NCT02346240|18771767|P13|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623550|NCT02346240|18771768|P12|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623551|NCT02346240|18771769|P11|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623552|NCT02346240|18771770|P10|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623553|NCT02346240|18771771|P9|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623554|NCT02346240|18771772|P8|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623555|NCT02346240|18771773|P7|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623556|NCT02346240|18771774|P6|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623557|NCT02346240|18771775|P5|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623558|NCT02346240|18771776|P4|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623559|NCT02346240|18771777|P3|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623560|NCT02346240|18771778|P2|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623561|NCT02346240|18771779|P1|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
7623562|NCT02346240|18771756|P24|STARTED|Open-Label Period (Week 48 to Week 144)||16
7623563|NCT02346240|18771757|P23|STARTED|Open-Label Period (Week 48 to Week 144)||34
7623564|NCT02346240|18771758|P22|STARTED|Open-Label Period (Week 48 to Week 144)||177
7623565|NCT02346240|18771759|P21|STARTED|Open-Label Period (Week 48 to Week 144)||48
7623566|NCT02346240|18771760|P20|STARTED|Open-Label Period (Week 48 to Week 144)||41
7623567|NCT02346240|18771761|P19|STARTED|Open-Label Period (Week 48 to Week 144)||122
7623568|NCT02346240|18771762|P18|STARTED|Open-Label Period (Week 48 to Week 144)||34
7623569|NCT02346240|18771763|P17|STARTED|Open-Label Period (Week 48 to Week 144)||0
7623570|NCT02346240|18771764|P16|STARTED|Open-Label Period (Week 48 to Week 144)||0
7623571|NCT02346240|18771765|P15|STARTED|Open-Label Period (Week 48 to Week 144)||0
7623572|NCT02346240|18771766|P14|STARTED|Open-Label Period (Week 48 to Week 144)||0
7623573|NCT02346240|18771767|P13|STARTED|Open-Label Period (Week 48 to Week 144)||0
7623574|NCT02346240|18771768|P12|STARTED|Open-Label Period (Week 48 to Week 144)||0
7623575|NCT02346240|18771769|P11|STARTED|Open-Label Period (Week 48 to Week 144)||0
7623576|NCT02346240|18771770|P10|STARTED|Open-Label Period (Week 48 to Week 144)||0
7623577|NCT02346240|18771771|P9|STARTED|Open-Label Period (Week 48 to Week 144)||0
7623578|NCT02346240|18771772|P8|STARTED|Open-Label Period (Week 48 to Week 144)||0
7623579|NCT02346240|18771773|P7|STARTED|Open-Label Period (Week 48 to Week 144)||0
7623580|NCT02346240|18771774|P6|STARTED|Open-Label Period (Week 48 to Week 144)||0
7623581|NCT02346240|18771775|P5|STARTED|Open-Label Period (Week 48 to Week 144)||0
7623582|NCT02346240|18771776|P4|STARTED|Open-Label Period (Week 48 to Week 144)||0
7623583|NCT02346240|18771777|P3|STARTED|Open-Label Period (Week 48 to Week 144)||0
7623584|NCT02346240|18771778|P2|STARTED|Open-Label Period (Week 48 to Week 144)||0
7623585|NCT02346240|18771779|P1|STARTED|Open-Label Period (Week 48 to Week 144)||0
7623586|NCT02346240|18771756|P24|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623587|NCT02346240|18771757|P23|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623588|NCT02346240|18771758|P22|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623589|NCT02346240|18771759|P21|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623590|NCT02346240|18771760|P20|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623591|NCT02346240|18771761|P19|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623592|NCT02346240|18771762|P18|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623593|NCT02346240|18771763|P17|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
7623594|NCT02346240|18771764|P16|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||14
7623595|NCT02346240|18771765|P15|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||17
7623596|NCT02346240|18771766|P14|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||8
7623597|NCT02346240|18771767|P13|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623598|NCT02346240|18771768|P12|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||3
7623599|NCT02346240|18771769|P11|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
7623600|NCT02346240|18771770|P10|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
7623601|NCT02346240|18771771|P9|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||4
7623602|NCT02346240|18771772|P8|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
7623603|NCT02346240|18771773|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
7623604|NCT02346240|18771774|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
7623605|NCT02346240|18771775|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623606|NCT02346240|18771776|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623607|NCT02346240|18771777|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623608|NCT02346240|18771778|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623609|NCT02346240|18771779|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623610|NCT02346240|18771756|P24|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623611|NCT02346240|18771757|P23|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623612|NCT02346240|18771758|P22|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623613|NCT02346240|18771759|P21|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623614|NCT02346240|18771760|P20|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623615|NCT02346240|18771761|P19|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623616|NCT02346240|18771762|P18|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623617|NCT02346240|18771763|P17|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|29
7623618|NCT02346240|18771764|P16|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|35
7623619|NCT02346240|18771765|P15|COMPLETED|Maintenance Period (Week 16 to Week 48)|3 subjects completed the Maintenance Period but did not enter the Open-Label Period.|68
7623620|NCT02346240|18771766|P14|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|45
7623621|NCT02346240|18771767|P13|COMPLETED|Maintenance Period (Week 16 to Week 48)||49
7623622|NCT02346240|18771768|P12|COMPLETED|Maintenance Period (Week 16 to Week 48)||47
7623623|NCT02346240|18771769|P11|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
7623624|NCT02346240|18771770|P10|COMPLETED|Maintenance Period (Week 16 to Week 48)||43
7623625|NCT02346240|18771771|P9|COMPLETED|Maintenance Period (Week 16 to Week 48)||40
7623626|NCT02346240|18771772|P8|COMPLETED|Maintenance Period (Week 16 to Week 48)||20
7623627|NCT02346240|18771773|P7|COMPLETED|Maintenance Period (Week 16 to Week 48)||48
7623628|NCT02346240|18771774|P6|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
7623629|NCT02346240|18771775|P5|COMPLETED|Maintenance Period (Week 16 to Week 48)||2
7623630|NCT02346240|18771776|P4|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623631|NCT02346240|18771777|P3|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623632|NCT02346240|18771778|P2|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623633|NCT02346240|18771779|P1|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7623634|NCT02346240|18771756|P24|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7623635|NCT02346240|18771757|P23|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7623636|NCT02346240|18771758|P22|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7623637|NCT02346240|18771759|P21|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7623638|NCT02346240|18771760|P20|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7623639|NCT02346240|18771761|P19|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7623640|NCT02346240|18771762|P18|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7623641|NCT02346240|18771763|P17|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||29
7623642|NCT02346240|18771764|P16|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||35
7623643|NCT02346240|18771765|P15|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||68
7623644|NCT02346240|18771766|P14|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||45
7623645|NCT02346240|18771767|P13|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||49
7623646|NCT02346240|18771768|P12|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||47
7623647|NCT02346240|18771769|P11|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
7623648|NCT02346240|18771770|P10|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||43
7623649|NCT02346240|18771771|P9|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||40
7623650|NCT02346240|18771772|P8|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||20
7623651|NCT02346240|18771773|P7|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||48
7623652|NCT02346240|18771774|P6|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
7623653|NCT02346240|18771775|P5|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||2
7623654|NCT02346240|18771776|P4|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7623655|NCT02346240|18771777|P3|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7623656|NCT02346240|18771778|P2|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7623657|NCT02346240|18771779|P1|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7623658|NCT02346240|18771756|P24|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
7623659|NCT02346240|18771757|P23|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
7623660|NCT02346240|18771758|P22|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
7623661|NCT02346240|18771759|P21|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
7623662|NCT02346240|18771760|P20|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
7623663|NCT02346240|18771761|P19|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
7623664|NCT02346240|18771762|P18|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
7623665|NCT02346240|18771763|P17|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||30
7623666|NCT02346240|18771764|P16|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||36
7623667|NCT02346240|18771765|P15|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||71
7623668|NCT02346240|18771766|P14|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||46
7623669|NCT02346240|18771767|P13|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||49
7623670|NCT02346240|18771768|P12|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||47
7623671|NCT02346240|18771769|P11|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
7623672|NCT02346240|18771770|P10|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||43
7623673|NCT02346240|18771771|P9|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||40
7623674|NCT02346240|18771772|P8|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||20
7623675|NCT02346240|18771773|P7|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||48
7623676|NCT02346240|18771774|P6|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
7623677|NCT02346240|18771775|P5|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||2
7623678|NCT02346240|18771776|P4|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
7623679|NCT02346240|18771777|P3|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
7623680|NCT02346240|18771778|P2|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
7623681|NCT02346240|18771779|P1|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
7623682|NCT02346240|18771756|P24|STARTED|Maintenance Period (Week 16 to Week 48)||0
7623683|NCT02346240|18771757|P23|STARTED|Maintenance Period (Week 16 to Week 48)||0
7623684|NCT02346240|18771758|P22|STARTED|Maintenance Period (Week 16 to Week 48)||0
7623685|NCT02346240|18771759|P21|STARTED|Maintenance Period (Week 16 to Week 48)||0
7623686|NCT02346240|18771760|P20|STARTED|Maintenance Period (Week 16 to Week 48)||0
7623687|NCT02346240|18771761|P19|STARTED|Maintenance Period (Week 16 to Week 48)||0
7623688|NCT02346240|18771762|P18|STARTED|Maintenance Period (Week 16 to Week 48)||0
7623689|NCT02346240|18771763|P17|STARTED|Maintenance Period (Week 16 to Week 48)||36
7623690|NCT02346240|18771764|P16|STARTED|Maintenance Period (Week 16 to Week 48)||49
7623691|NCT02346240|18771765|P15|STARTED|Maintenance Period (Week 16 to Week 48)||85
7623692|NCT02346240|18771766|P14|STARTED|Maintenance Period (Week 16 to Week 48)||53
7623693|NCT02346240|18771767|P13|STARTED|Maintenance Period (Week 16 to Week 48)||49
7623694|NCT02346240|18771768|P12|STARTED|Maintenance Period (Week 16 to Week 48)||50
7623695|NCT02346240|18771769|P11|STARTED|Maintenance Period (Week 16 to Week 48)||25
7623696|NCT02346240|18771770|P10|STARTED|Maintenance Period (Week 16 to Week 48)||44
7623697|NCT02346240|18771771|P9|STARTED|Maintenance Period (Week 16 to Week 48)||44
7623698|NCT02346240|18771772|P8|STARTED|Maintenance Period (Week 16 to Week 48)||22
7623699|NCT02346240|18771773|P7|STARTED|Maintenance Period (Week 16 to Week 48)||50
7623700|NCT02346240|18771774|P6|STARTED|Maintenance Period (Week 16 to Week 48)||24
7623701|NCT02346240|18771775|P5|STARTED|Maintenance Period (Week 16 to Week 48)||2
7623702|NCT02346240|18771776|P4|STARTED|Maintenance Period (Week 16 to Week 48)||0
7623703|NCT02346240|18771777|P3|STARTED|Maintenance Period (Week 16 to Week 48)||0
7623704|NCT02346240|18771778|P2|STARTED|Maintenance Period (Week 16 to Week 48)||0
7623705|NCT02346240|18771779|P1|STARTED|Maintenance Period (Week 16 to Week 48)||0
7623706|NCT02346240|18771756|P24|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
7623707|NCT02346240|18771757|P23|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
7623708|NCT02346240|18771758|P22|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
7623709|NCT02346240|18771759|P21|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
7623710|NCT02346240|18771760|P20|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
7623711|NCT02346240|18771761|P19|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
7623712|NCT02346240|18771762|P18|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
7623713|NCT02346240|18771763|P17|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
7623714|NCT02346240|18771764|P16|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
7623715|NCT02346240|18771765|P15|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
7623716|NCT02346240|18771766|P14|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
7623717|NCT02346240|18771767|P13|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
7623718|NCT02346240|18771768|P12|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
7623719|NCT02346240|18771769|P11|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
7623720|NCT02346240|18771770|P10|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
7623721|NCT02346240|18771771|P9|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
7623722|NCT02346240|18771772|P8|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
7623723|NCT02346240|18771773|P7|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
7623724|NCT02346240|18771774|P6|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
7623725|NCT02346240|18771775|P5|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
7623726|NCT02346240|18771776|P4|NOT COMPLETED|Initial Period (Baseline to Week 16)||7
7623727|NCT02346240|18771777|P3|NOT COMPLETED|Initial Period (Baseline to Week 16)||6
7623728|NCT02346240|18771778|P2|NOT COMPLETED|Initial Period (Baseline to Week 16)||11
7623729|NCT02346240|18771779|P1|NOT COMPLETED|Initial Period (Baseline to Week 16)||2
7623730|NCT02346240|18771756|P24|COMPLETED|Initial Period (Baseline to Week 16)||0
7623731|NCT02346240|18771757|P23|COMPLETED|Initial Period (Baseline to Week 16)||0
7623732|NCT02346240|18771758|P22|COMPLETED|Initial Period (Baseline to Week 16)||0
7623733|NCT02346240|18771759|P21|COMPLETED|Initial Period (Baseline to Week 16)||0
7623734|NCT02346240|18771760|P20|COMPLETED|Initial Period (Baseline to Week 16)||0
7623735|NCT02346240|18771761|P19|COMPLETED|Initial Period (Baseline to Week 16)||0
7623736|NCT02346240|18771762|P18|COMPLETED|Initial Period (Baseline to Week 16)||0
7623737|NCT02346240|18771763|P17|COMPLETED|Initial Period (Baseline to Week 16)||0
7623738|NCT02346240|18771764|P16|COMPLETED|Initial Period (Baseline to Week 16)||0
7623739|NCT02346240|18771765|P15|COMPLETED|Initial Period (Baseline to Week 16)||0
7623740|NCT02346240|18771766|P14|COMPLETED|Initial Period (Baseline to Week 16)||0
7623741|NCT02346240|18771767|P13|COMPLETED|Initial Period (Baseline to Week 16)||0
7623742|NCT02346240|18771768|P12|COMPLETED|Initial Period (Baseline to Week 16)||0
7623743|NCT02346240|18771769|P11|COMPLETED|Initial Period (Baseline to Week 16)||0
7623744|NCT02346240|18771770|P10|COMPLETED|Initial Period (Baseline to Week 16)||0
7623745|NCT02346240|18771771|P9|COMPLETED|Initial Period (Baseline to Week 16)||0
7623746|NCT02346240|18771772|P8|COMPLETED|Initial Period (Baseline to Week 16)||0
7623747|NCT02346240|18771773|P7|COMPLETED|Initial Period (Baseline to Week 16)||0
7623748|NCT02346240|18771774|P6|COMPLETED|Initial Period (Baseline to Week 16)||0
7623749|NCT02346240|18771775|P5|COMPLETED|Initial Period (Baseline to Week 16)||0
7623750|NCT02346240|18771776|P4|COMPLETED|Initial Period (Baseline to Week 16)||160
7623751|NCT02346240|18771777|P3|COMPLETED|Initial Period (Baseline to Week 16)||159
7623752|NCT02346240|18771778|P2|COMPLETED|Initial Period (Baseline to Week 16)||159
7623753|NCT02346240|18771779|P1|COMPLETED|Initial Period (Baseline to Week 16)||55
7623754|NCT02346240|18771756|P24|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
7623755|NCT02346240|18771757|P23|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
7623756|NCT02346240|18771758|P22|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
7623757|NCT02346240|18771759|P21|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
7623758|NCT02346240|18771760|P20|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
7623827|NCT02346136|18771819|P1|NOT COMPLETED|Overall Study||22
7623759|NCT02346240|18771761|P19|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
7623760|NCT02346240|18771762|P18|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
7623761|NCT02346240|18771763|P17|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
7623762|NCT02346240|18771764|P16|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
7623763|NCT02346240|18771765|P15|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
7623764|NCT02346240|18771766|P14|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
7623765|NCT02346240|18771767|P13|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
7623766|NCT02346240|18771768|P12|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
7623767|NCT02346240|18771769|P11|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
7623768|NCT02346240|18771770|P10|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
7623769|NCT02346240|18771771|P9|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
7623770|NCT02346240|18771772|P8|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
7623771|NCT02346240|18771773|P7|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
7623772|NCT02346240|18771774|P6|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
7623773|NCT02346240|18771775|P5|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
7623774|NCT02346240|18771776|P4|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||160
7623775|NCT02346240|18771777|P3|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
7623776|NCT02346240|18771778|P2|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
7623777|NCT02346240|18771779|P1|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||55
7623778|NCT02346240|18771756|P24|Completed Week 16|Initial Period (Baseline to Week 16)||0
7623779|NCT02346240|18771757|P23|Completed Week 16|Initial Period (Baseline to Week 16)||0
7623780|NCT02346240|18771758|P22|Completed Week 16|Initial Period (Baseline to Week 16)||0
7623781|NCT02346240|18771759|P21|Completed Week 16|Initial Period (Baseline to Week 16)||0
7623782|NCT02346240|18771760|P20|Completed Week 16|Initial Period (Baseline to Week 16)||0
7623783|NCT02346240|18771761|P19|Completed Week 16|Initial Period (Baseline to Week 16)||0
7623784|NCT02346240|18771762|P18|Completed Week 16|Initial Period (Baseline to Week 16)||0
7623785|NCT02346240|18771763|P17|Completed Week 16|Initial Period (Baseline to Week 16)||0
7623786|NCT02346240|18771764|P16|Completed Week 16|Initial Period (Baseline to Week 16)||0
7623787|NCT02346240|18771765|P15|Completed Week 16|Initial Period (Baseline to Week 16)||0
7623788|NCT02346240|18771766|P14|Completed Week 16|Initial Period (Baseline to Week 16)||0
7623789|NCT02346240|18771767|P13|Completed Week 16|Initial Period (Baseline to Week 16)||0
7623790|NCT02346240|18771768|P12|Completed Week 16|Initial Period (Baseline to Week 16)||0
7623791|NCT02346240|18771769|P11|Completed Week 16|Initial Period (Baseline to Week 16)||0
7623792|NCT02346240|18771770|P10|Completed Week 16|Initial Period (Baseline to Week 16)||0
7623793|NCT02346240|18771771|P9|Completed Week 16|Initial Period (Baseline to Week 16)||0
7623794|NCT02346240|18771772|P8|Completed Week 16|Initial Period (Baseline to Week 16)||0
7623795|NCT02346240|18771773|P7|Completed Week 16|Initial Period (Baseline to Week 16)||0
7623796|NCT02346240|18771774|P6|Completed Week 16|Initial Period (Baseline to Week 16)||0
7623797|NCT02346240|18771775|P5|Completed Week 16|Initial Period (Baseline to Week 16)||0
7623798|NCT02346240|18771776|P4|Completed Week 16|Initial Period (Baseline to Week 16)||162
7623799|NCT02346240|18771777|P3|Completed Week 16|Initial Period (Baseline to Week 16)||159
7623800|NCT02346240|18771778|P2|Completed Week 16|Initial Period (Baseline to Week 16)||159
7623801|NCT02346240|18771779|P1|Completed Week 16|Initial Period (Baseline to Week 16)||55
7623802|NCT02346240|18771756|P24|STARTED|Initial Period (Baseline to Week 16)||0
7623803|NCT02346240|18771757|P23|STARTED|Initial Period (Baseline to Week 16)||0
7623804|NCT02346240|18771758|P22|STARTED|Initial Period (Baseline to Week 16)||0
7623805|NCT02346240|18771759|P21|STARTED|Initial Period (Baseline to Week 16)||0
7623806|NCT02346240|18771760|P20|STARTED|Initial Period (Baseline to Week 16)||0
7623807|NCT02346240|18771761|P19|STARTED|Initial Period (Baseline to Week 16)||0
7623808|NCT02346240|18771762|P18|STARTED|Initial Period (Baseline to Week 16)||0
7623809|NCT02346240|18771763|P17|STARTED|Initial Period (Baseline to Week 16)||0
7623810|NCT02346240|18771764|P16|STARTED|Initial Period (Baseline to Week 16)||0
7623811|NCT02346240|18771765|P15|STARTED|Initial Period (Baseline to Week 16)||0
7623812|NCT02346240|18771766|P14|STARTED|Initial Period (Baseline to Week 16)||0
7623813|NCT02346240|18771767|P13|STARTED|Initial Period (Baseline to Week 16)||0
7623814|NCT02346240|18771768|P12|STARTED|Initial Period (Baseline to Week 16)||0
7623815|NCT02346240|18771769|P11|STARTED|Initial Period (Baseline to Week 16)||0
7623816|NCT02346240|18771770|P10|STARTED|Initial Period (Baseline to Week 16)||0
7623817|NCT02346240|18771771|P9|STARTED|Initial Period (Baseline to Week 16)||0
7623818|NCT02346240|18771772|P8|STARTED|Initial Period (Baseline to Week 16)||0
7623819|NCT02346240|18771773|P7|STARTED|Initial Period (Baseline to Week 16)||0
7623820|NCT02346240|18771774|P6|STARTED|Initial Period (Baseline to Week 16)||0
7623821|NCT02346240|18771775|P5|STARTED|Initial Period (Baseline to Week 16)||0
7623822|NCT02346240|18771776|P4|STARTED|Initial Period (Baseline to Week 16)||167
7623823|NCT02346240|18771777|P3|STARTED|Initial Period (Baseline to Week 16)||165
7623824|NCT02346240|18771778|P2|STARTED|Initial Period (Baseline to Week 16)||170
7623825|NCT02346240|18771779|P1|STARTED|Initial Period (Baseline to Week 16)||57
7623826|NCT02346136|18771818|P2|NOT COMPLETED|Overall Study||23
7623828|NCT02346136|18771818|P2|COMPLETED|Overall Study||64
7623829|NCT02346136|18771819|P1|COMPLETED|Overall Study||71
7623830|NCT02346136|18771818|P2|STARTED|Overall Study||87
7623831|NCT02346136|18771819|P1|STARTED|Overall Study||93
7623832|NCT02345889|18771855|P4|NOT COMPLETED|Overall Study||16
7623833|NCT02345889|18771856|P3|NOT COMPLETED|Overall Study||20
7623834|NCT02345889|18771857|P2|NOT COMPLETED|Overall Study||17
7623835|NCT02345889|18771858|P1|NOT COMPLETED|Overall Study||21
7623836|NCT02345889|18771855|P4|COMPLETED|Overall Study||299
7623837|NCT02345889|18771856|P3|COMPLETED|Overall Study||295
7623838|NCT02345889|18771857|P2|COMPLETED|Overall Study||299
7623839|NCT02345889|18771858|P1|COMPLETED|Overall Study||295
7623840|NCT02345889|18771855|P4|STARTED|Overall Study||315
7623841|NCT02345889|18771856|P3|STARTED|Overall Study||315
7623842|NCT02345889|18771857|P2|STARTED|Overall Study||316
7623843|NCT02345889|18771858|P1|STARTED|Overall Study||316
7623844|NCT02345811|18771924|P2|NOT COMPLETED|Second Intervention||0
7623845|NCT02345811|18771925|P1|NOT COMPLETED|Second Intervention||0
7623846|NCT02345811|18771924|P2|COMPLETED|Second Intervention||16
7623847|NCT02345811|18771925|P1|COMPLETED|Second Intervention||16
7623848|NCT02345811|18771924|P2|STARTED|Second Intervention||16
7623849|NCT02345811|18771925|P1|STARTED|Second Intervention||16
7623850|NCT02345811|18771924|P2|NOT COMPLETED|First Intervention||1
7623851|NCT02345811|18771925|P1|NOT COMPLETED|First Intervention||1
7623852|NCT02345811|18771924|P2|COMPLETED|First Intervention||16
7623853|NCT02345811|18771925|P1|COMPLETED|First Intervention||16
7623854|NCT02345811|18771924|P2|STARTED|First Intervention||17
7623855|NCT02345811|18771925|P1|STARTED|First Intervention||17
7623856|NCT02345772|18771955|P1|NOT COMPLETED|Overall Study||4
7623857|NCT02345772|18771955|P1|COMPLETED|Overall Study||0
7623858|NCT02345772|18771955|P1|STARTED|Overall Study||4
7623859|NCT02345720|18771961|P1|NOT COMPLETED|Overall Study||0
7623860|NCT02345720|18771961|P1|COMPLETED|Overall Study||20
7623861|NCT02345720|18771961|P1|STARTED|Overall Study||20
7623862|NCT02345642|18771969|P2|NOT COMPLETED|Overall Study||0
7623863|NCT02345642|18771970|P1|NOT COMPLETED|Overall Study||0
7623864|NCT02345642|18771969|P2|COMPLETED|Overall Study||10
7623865|NCT02345642|18771970|P1|COMPLETED|Overall Study||10
7623866|NCT02345642|18771969|P2|STARTED|Overall Study||10
7623867|NCT02345642|18771970|P1|STARTED|Overall Study||10
7623868|NCT02345512|18771976|P1|NOT COMPLETED|Overall Study||2
7623869|NCT02345512|18771976|P1|COMPLETED|Overall Study||9
7623870|NCT02345512|18771976|P1|STARTED|Overall Study||11
7623871|NCT02345486|18771997|P2|NOT COMPLETED|Overall Study||0
7623872|NCT02345486|18771998|P1|NOT COMPLETED|Overall Study||0
7623873|NCT02345486|18771997|P2|COMPLETED|Overall Study||520
7623874|NCT02345486|18771998|P1|COMPLETED|Overall Study||454
7623875|NCT02345486|18771997|P2|STARTED|Overall Study||520
7623876|NCT02345486|18771998|P1|STARTED|Overall Study||454
7623877|NCT02345460|18772046|P1|NOT COMPLETED|Overall Study||0
7623878|NCT02345460|18772046|P1|COMPLETED|Overall Study||1
7623879|NCT02345460|18772046|P1|STARTED|Overall Study||1
7623880|NCT02345369|18772059|P2|NOT COMPLETED|Overall Study||0
7623881|NCT02345369|18772060|P1|NOT COMPLETED|Overall Study||0
7623882|NCT02345369|18772059|P2|COMPLETED|Overall Study||0
7623883|NCT02345369|18772060|P1|COMPLETED|Overall Study||0
7623884|NCT02345369|18772059|P2|STARTED|Overall Study||0
7623885|NCT02345369|18772060|P1|STARTED|Overall Study||0
7623886|NCT02345330|18772070|P1|NOT COMPLETED|Overall Study||3
7623887|NCT02345330|18772070|P1|COMPLETED|Overall Study||1
7623888|NCT02345330|18772070|P1|STARTED|Overall Study||4
7623889|NCT02345252|18772082|P2|NOT COMPLETED|Open-Label Extension Phase||0
7623890|NCT02345252|18772083|P1|NOT COMPLETED|Open-Label Extension Phase||0
7623891|NCT02345252|18772082|P2|COMPLETED|Open-Label Extension Phase||17
7623892|NCT02345252|18772083|P1|COMPLETED|Open-Label Extension Phase||19
7623893|NCT02345252|18772082|P2|STARTED|Open-Label Extension Phase|250 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|17
7623894|NCT02345252|18772083|P1|STARTED|Open-Label Extension Phase|257 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|19
7623895|NCT02345252|18772082|P2|NOT COMPLETED|Double-Blind Phase||49
7623896|NCT02345252|18772083|P1|NOT COMPLETED|Double-Blind Phase||40
7623897|NCT02345252|18772082|P2|COMPLETED|Double-Blind Phase||267
7623898|NCT02345252|18772083|P1|COMPLETED|Double-Blind Phase||276
7623899|NCT02345252|18772082|P2|STARTED|Double-Blind Phase||316
7623900|NCT02345252|18772083|P1|STARTED|Double-Blind Phase||316
7623901|NCT02345226|18772111|P2|NOT COMPLETED|Open-Label Extension Phase||1
7623902|NCT02345226|18772112|P1|NOT COMPLETED|Open-Label Extension Phase||0
7623903|NCT02345226|18772111|P2|COMPLETED|Open-Label Extension Phase||20
7623904|NCT02345226|18772112|P1|COMPLETED|Open-Label Extension Phase||25
7623905|NCT02345226|18772111|P2|STARTED|Open-Label Extension Phase|349 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|21
7623906|NCT02345226|18772112|P1|STARTED|Open-Label Extension Phase|346 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|25
7623907|NCT02345226|18772111|P2|NOT COMPLETED|Double-Blind Phase||71
7623908|NCT02345226|18772112|P1|NOT COMPLETED|Double-Blind Phase||69
7623909|NCT02345226|18772111|P2|COMPLETED|Double-Blind Phase||370
7623910|NCT02345226|18772112|P1|COMPLETED|Double-Blind Phase||371
7623911|NCT02345226|18772111|P2|STARTED|Double-Blind Phase||441
7623912|NCT02345226|18772112|P1|STARTED|Double-Blind Phase||440
7623913|NCT02345161|18772144|P2|NOT COMPLETED|Overall Study||57
7623914|NCT02345161|18772145|P1|NOT COMPLETED|Overall Study||45
7623915|NCT02345161|18772144|P2|COMPLETED|Overall Study||842
7623916|NCT02345161|18772145|P1|COMPLETED|Overall Study||866
7623917|NCT02345161|18772144|P2|STARTED|Overall Study||899
7623918|NCT02345161|18772145|P1|STARTED|Overall Study||911
7623919|NCT02345070|18772250|P3|NOT COMPLETED|Overall Study||23
7623920|NCT02345070|18772251|P2|NOT COMPLETED|Overall Study||11
7623921|NCT02345070|18772252|P1|NOT COMPLETED|Overall Study||20
7623922|NCT02345070|18772250|P3|COMPLETED|Overall Study||85
7623923|NCT02345070|18772251|P2|COMPLETED|Overall Study||98
7623924|NCT02345070|18772252|P1|COMPLETED|Overall Study||90
7623925|NCT02345070|18772250|P3|Treated|Overall Study||108
7623926|NCT02345070|18772251|P2|Treated|Overall Study||108
7623927|NCT02345070|18772252|P1|Treated|Overall Study||109
7623928|NCT02345070|18772250|P3|STARTED|Overall Study||108
7623929|NCT02345070|18772251|P2|STARTED|Overall Study||109
7623930|NCT02345070|18772252|P1|STARTED|Overall Study||110
7623931|NCT02345031|18772268|P2|NOT COMPLETED|Overall Study||1
7623932|NCT02345031|18772269|P1|NOT COMPLETED|Overall Study||1
7623933|NCT02345031|18772268|P2|COMPLETED|Overall Study||39
7623934|NCT02345031|18772269|P1|COMPLETED|Overall Study||37
7623935|NCT02345031|18772268|P2|STARTED|Overall Study||40
7623936|NCT02345031|18772269|P1|STARTED|Overall Study||38
7623937|NCT02344745|18772285|P2|NOT COMPLETED|Overall Study||0
7623938|NCT02344745|18772286|P1|NOT COMPLETED|Overall Study||2
7623939|NCT02344745|18772285|P2|COMPLETED|Overall Study||40
7623940|NCT02344745|18772286|P1|COMPLETED|Overall Study||38
7623941|NCT02344745|18772285|P2|STARTED|Overall Study||40
7623942|NCT02344745|18772286|P1|STARTED|Overall Study||40
7623943|NCT02344628|18772300|P2|NOT COMPLETED|Overall Study||86
7623944|NCT02344628|18772301|P1|NOT COMPLETED|Overall Study||91
7623945|NCT02344628|18772300|P2|COMPLETED|Overall Study|4/52 clinical data was available for 286. Serological data 6/12 for 218. Both were available for 206|206
7623946|NCT02344628|18772301|P1|COMPLETED|Overall Study|4/52 clinical data was available for 283. Serological data 6/12 for 212. Both were available for 200|200
7623947|NCT02344628|18772300|P2|STARTED|Overall Study||292
7623948|NCT02344628|18772301|P1|STARTED|Overall Study||291
7623949|NCT02344576|18772315|P4|NOT COMPLETED|12-Month Medical Record Follow-Up||0
7623950|NCT02344576|18772316|P3|NOT COMPLETED|12-Month Medical Record Follow-Up||0
7623951|NCT02344576|18772317|P2|NOT COMPLETED|12-Month Medical Record Follow-Up||0
7623952|NCT02344576|18772318|P1|NOT COMPLETED|12-Month Medical Record Follow-Up||0
7623953|NCT02344576|18772315|P4|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
7623954|NCT02344576|18772316|P3|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
7623955|NCT02344576|18772317|P2|COMPLETED|12-Month Medical Record Follow-Up||67
7623956|NCT02344576|18772318|P1|COMPLETED|12-Month Medical Record Follow-Up||98
7623957|NCT02344576|18772315|P4|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
7623958|NCT02344576|18772316|P3|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
7623959|NCT02344576|18772317|P2|STARTED|12-Month Medical Record Follow-Up||67
7623960|NCT02344576|18772318|P1|STARTED|12-Month Medical Record Follow-Up||98
7623961|NCT02344576|18772315|P4|NOT COMPLETED|6-Month Follow-Up||8
7623962|NCT02344576|18772316|P3|NOT COMPLETED|6-Month Follow-Up||14
7623963|NCT02344576|18772317|P2|NOT COMPLETED|6-Month Follow-Up||19
7623964|NCT02344576|18772318|P1|NOT COMPLETED|6-Month Follow-Up||19
7623965|NCT02344576|18772315|P4|COMPLETED|6-Month Follow-Up||50
7623966|NCT02344576|18772316|P3|COMPLETED|6-Month Follow-Up||78
7623967|NCT02344576|18772317|P2|COMPLETED|6-Month Follow-Up||67
7623968|NCT02344576|18772318|P1|COMPLETED|6-Month Follow-Up||98
7623969|NCT02344576|18772315|P4|Completed 6-Month Survey|6-Month Follow-Up||50
7623970|NCT02344576|18772316|P3|Completed 6-Month Survey|6-Month Follow-Up||78
7623971|NCT02344576|18772317|P2|Completed 6-Month Survey|6-Month Follow-Up||67
7623972|NCT02344576|18772318|P1|Completed 6-Month Survey|6-Month Follow-Up||98
7623973|NCT02344576|18772315|P4|STARTED|6-Month Follow-Up||58
7623974|NCT02344576|18772316|P3|STARTED|6-Month Follow-Up||92
7623975|NCT02344576|18772317|P2|STARTED|6-Month Follow-Up||86
7623976|NCT02344576|18772318|P1|STARTED|6-Month Follow-Up||117
7623977|NCT02344576|18772315|P4|NOT COMPLETED|1-Month Follow-Up||13
7623978|NCT02344576|18772316|P3|NOT COMPLETED|1-Month Follow-Up||19
7623979|NCT02344576|18772317|P2|NOT COMPLETED|1-Month Follow-Up||27
7623980|NCT02344576|18772318|P1|NOT COMPLETED|1-Month Follow-Up||18
7623981|NCT02344576|18772315|P4|COMPLETED|1-Month Follow-Up|Includes 5 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|58
7623982|NCT02344576|18772316|P3|COMPLETED|1-Month Follow-Up|Includes 3 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|92
7623983|NCT02344576|18772317|P2|COMPLETED|1-Month Follow-Up|Includes 7 patients who were still enrolled at 1-month but did not complete the 1-month survey.|86
7623984|NCT02344576|18772318|P1|COMPLETED|1-Month Follow-Up|Includes 13 patients who were still enrolled at 1-month but did not complete the 1-month survey.|117
7623985|NCT02344576|18772315|P4|Completed 1-Month Survey|1-Month Follow-Up||53
7623986|NCT02344576|18772316|P3|Completed 1-Month Survey|1-Month Follow-Up||89
7623987|NCT02344576|18772317|P2|Completed 1-Month Survey|1-Month Follow-Up||79
7623988|NCT02344576|18772318|P1|Completed 1-Month Survey|1-Month Follow-Up||104
7623989|NCT02344576|18772315|P4|STARTED|1-Month Follow-Up||71
7623990|NCT02344576|18772316|P3|STARTED|1-Month Follow-Up||111
7623991|NCT02344576|18772317|P2|STARTED|1-Month Follow-Up||113
7623992|NCT02344576|18772318|P1|STARTED|1-Month Follow-Up||135
7623993|NCT02344576|18772315|P4|NOT COMPLETED|Enrollment||0
7623994|NCT02344576|18772316|P3|NOT COMPLETED|Enrollment||0
7623995|NCT02344576|18772317|P2|NOT COMPLETED|Enrollment||8
7623996|NCT02344576|18772318|P1|NOT COMPLETED|Enrollment||7
7623997|NCT02344576|18772315|P4|COMPLETED|Enrollment||71
7623998|NCT02344576|18772316|P3|COMPLETED|Enrollment||111
7623999|NCT02344576|18772317|P2|COMPLETED|Enrollment||113
7624000|NCT02344576|18772318|P1|COMPLETED|Enrollment||135
7624001|NCT02344576|18772315|P4|Agreed to Survey Data Collection|Enrollment||71
7624002|NCT02344576|18772316|P3|Agreed to Survey Data Collection|Enrollment||111
7624003|NCT02344576|18772317|P2|Agreed to Survey Data Collection|Enrollment||113
7624004|NCT02344576|18772318|P1|Agreed to Survey Data Collection|Enrollment||135
7624005|NCT02344576|18772315|P4|STARTED|Enrollment||71
7624006|NCT02344576|18772316|P3|STARTED|Enrollment||111
7624007|NCT02344576|18772317|P2|STARTED|Enrollment|Includes 8 patients who agreed to medical record review only and were excluded from further analysis|121
7624008|NCT02344576|18772318|P1|STARTED|Enrollment|Includes 7 patients who agreed to medical record review only and were excluded from further analysis|142
7624009|NCT02344407|18772364|P3|NOT COMPLETED|Overall Study||6
7624010|NCT02344407|18772365|P2|NOT COMPLETED|Overall Study||9
7624011|NCT02344407|18772366|P1|NOT COMPLETED|Overall Study||8
7624012|NCT02344407|18772364|P3|COMPLETED|Overall Study||494
7624013|NCT02344407|18772365|P2|COMPLETED|Overall Study||491
7624014|NCT02344407|18772366|P1|COMPLETED|Overall Study||492
7624015|NCT02344407|18772364|P3|STARTED|Overall Study||500
7624016|NCT02344407|18772365|P2|STARTED|Overall Study||500
7624017|NCT02344407|18772366|P1|STARTED|Overall Study||500
7624018|NCT02344342|18772381|P4|NOT COMPLETED|Overall Study||10
7624019|NCT02344342|18772382|P3|NOT COMPLETED|Overall Study||14
7624020|NCT02344342|18772383|P2|NOT COMPLETED|Overall Study||9
7624021|NCT02344342|18772384|P1|NOT COMPLETED|Overall Study||11
7624022|NCT02344342|18772381|P4|COMPLETED|Overall Study||3
7624023|NCT02344342|18772382|P3|COMPLETED|Overall Study||0
7624024|NCT02344342|18772383|P2|COMPLETED|Overall Study||2
7624025|NCT02344342|18772384|P1|COMPLETED|Overall Study||2
7624026|NCT02344342|18772381|P4|STARTED|Overall Study||13
7624027|NCT02344342|18772382|P3|STARTED|Overall Study||14
7624028|NCT02344342|18772383|P2|STARTED|Overall Study||11
7624029|NCT02344342|18772384|P1|STARTED|Overall Study||13
7624030|NCT02344251|18772408|P2|NOT COMPLETED|Overall Study||0
7624031|NCT02344251|18772409|P1|NOT COMPLETED|Overall Study||0
7624032|NCT02344251|18772408|P2|COMPLETED|Overall Study||20
7624033|NCT02344251|18772409|P1|COMPLETED|Overall Study||20
7624034|NCT02344251|18772408|P2|STARTED|Overall Study||20
7624035|NCT02344251|18772409|P1|STARTED|Overall Study||20
7624036|NCT02344238|18772420|P3|NOT COMPLETED|Overall Study||0
7624037|NCT02344238|18772421|P2|NOT COMPLETED|Overall Study||0
7624038|NCT02344238|18772422|P1|NOT COMPLETED|Overall Study||0
7624039|NCT02344238|18772420|P3|COMPLETED|Overall Study||20
7624040|NCT02344238|18772421|P2|COMPLETED|Overall Study||20
7624041|NCT02344238|18772422|P1|COMPLETED|Overall Study||20
7624042|NCT02344238|18772420|P3|STARTED|Overall Study||20
7624043|NCT02344238|18772421|P2|STARTED|Overall Study||20
7624044|NCT02344238|18772422|P1|STARTED|Overall Study||20
7624045|NCT02344225|18772434|P3|NOT COMPLETED|Overall Study||0
7624046|NCT02344225|18772435|P2|NOT COMPLETED|Overall Study||0
7624047|NCT02344225|18772436|P1|NOT COMPLETED|Overall Study||0
7624048|NCT02344225|18772434|P3|COMPLETED|Overall Study||5
7624049|NCT02344225|18772435|P2|COMPLETED|Overall Study||3
7624050|NCT02344225|18772436|P1|COMPLETED|Overall Study||6
7624051|NCT02344225|18772434|P3|STARTED|Overall Study||5
7624052|NCT02344225|18772435|P2|STARTED|Overall Study||3
7624053|NCT02344225|18772436|P1|STARTED|Overall Study||6
7624054|NCT02344173|18772450|P1|NOT COMPLETED|12-month Visit||96
7624055|NCT02344173|18772450|P1|COMPLETED|12-month Visit||1932
7624056|NCT02344173|18772450|P1|STARTED|12-month Visit||2028
7624057|NCT02344173|18772450|P1|NOT COMPLETED|Procedure||7
7624058|NCT02344173|18772450|P1|COMPLETED|Procedure||2028
7624059|NCT02344173|18772450|P1|STARTED|Procedure||2035
7624060|NCT02344173|18772450|P1|NOT COMPLETED|Enrollment||0
7624061|NCT02344173|18772450|P1|COMPLETED|Enrollment||2035
7624062|NCT02344173|18772450|P1|STARTED|Enrollment||2035
7624063|NCT02344004|18772458|P2|NOT COMPLETED|Overall Study||14
7624064|NCT02344004|18772459|P1|NOT COMPLETED|Overall Study||61
7624065|NCT02344004|18772458|P2|COMPLETED|Overall Study||98
7624066|NCT02344004|18772459|P1|COMPLETED|Overall Study||163
7624067|NCT02344004|18772458|P2|STARTED|Overall Study||112
7624068|NCT02344004|18772459|P1|STARTED|Overall Study||224
7624069|NCT02343939|18772486|P9|NOT COMPLETED|Overall Study||7
7624070|NCT02343939|18772487|P8|NOT COMPLETED|Overall Study||37
7624071|NCT02343939|18772488|P7|NOT COMPLETED|Overall Study||15
7624072|NCT02343939|18772489|P6|NOT COMPLETED|Overall Study||17
7624073|NCT02343939|18772490|P5|NOT COMPLETED|Overall Study||8
7624074|NCT02343939|18772491|P4|NOT COMPLETED|Overall Study||6
7624075|NCT02343939|18772492|P3|NOT COMPLETED|Overall Study||5
7624076|NCT02343939|18772493|P2|NOT COMPLETED|Overall Study||48
7624077|NCT02343939|18772494|P1|NOT COMPLETED|Overall Study||3
7624078|NCT02343939|18772486|P9|COMPLETED|Overall Study||0
7624079|NCT02343939|18772487|P8|COMPLETED|Overall Study||0
7624080|NCT02343939|18772488|P7|COMPLETED|Overall Study||0
7624081|NCT02343939|18772489|P6|COMPLETED|Overall Study||0
7624082|NCT02343939|18772490|P5|COMPLETED|Overall Study||0
7624083|NCT02343939|18772491|P4|COMPLETED|Overall Study||0
7624084|NCT02343939|18772492|P3|COMPLETED|Overall Study||0
7624085|NCT02343939|18772493|P2|COMPLETED|Overall Study||2
7624086|NCT02343939|18772494|P1|COMPLETED|Overall Study||0
7624087|NCT02343939|18772486|P9|STARTED|Overall Study||7
7624088|NCT02343939|18772487|P8|STARTED|Overall Study||37
7624089|NCT02343939|18772488|P7|STARTED|Overall Study||15
7624090|NCT02343939|18772489|P6|STARTED|Overall Study||17
7624091|NCT02343939|18772490|P5|STARTED|Overall Study||8
7624092|NCT02343939|18772491|P4|STARTED|Overall Study||6
7624093|NCT02343939|18772492|P3|STARTED|Overall Study||5
7624094|NCT02343939|18772493|P2|STARTED|Overall Study||50
7624095|NCT02343939|18772494|P1|STARTED|Overall Study||3
7624096|NCT02343627|18772606|P2|NOT COMPLETED|Overall Study||1
7624097|NCT02343627|18772607|P1|NOT COMPLETED|Overall Study||12
7624098|NCT02343627|18772606|P2|COMPLETED|Overall Study||11
7624099|NCT02343627|18772607|P1|COMPLETED|Overall Study||23
7624100|NCT02343627|18772606|P2|STARTED|Overall Study||12
7624101|NCT02343627|18772607|P1|STARTED|Overall Study||35
7624102|NCT02343575|18772615|P2|NOT COMPLETED|Overall Study||0
7624103|NCT02343575|18772616|P1|NOT COMPLETED|Overall Study||0
7624104|NCT02343575|18772615|P2|COMPLETED|Overall Study||2
7624105|NCT02343575|18772616|P1|COMPLETED|Overall Study||1
7624106|NCT02343575|18772615|P2|STARTED|Overall Study||2
7624107|NCT02343575|18772616|P1|STARTED|Overall Study||1
7624108|NCT02343458|18772636|P4|NOT COMPLETED|Overall Study||38
7624109|NCT02343458|18772637|P3|NOT COMPLETED|Overall Study||63
7624110|NCT02343458|18772638|P2|NOT COMPLETED|Overall Study||66
7624111|NCT02343458|18772639|P1|NOT COMPLETED|Overall Study||61
7624112|NCT02343458|18772636|P4|COMPLETED|Overall Study||200
7624113|NCT02343458|18772637|P3|COMPLETED|Overall Study||417
7624114|NCT02343458|18772638|P2|COMPLETED|Overall Study||417
7624115|NCT02343458|18772639|P1|COMPLETED|Overall Study||494
7624116|NCT02343458|18772636|P4|STARTED|Overall Study||238
7624117|NCT02343458|18772637|P3|STARTED|Overall Study||480
7624118|NCT02343458|18772638|P2|STARTED|Overall Study||483
7624119|NCT02343458|18772639|P1|STARTED|Overall Study||555
7624120|NCT02343406|18772718|P5|NOT COMPLETED|Overall Study||5
7624121|NCT02343406|18772719|P4|NOT COMPLETED|Overall Study||26
7624122|NCT02343406|18772720|P3|NOT COMPLETED|Overall Study||58
7624123|NCT02343406|18772721|P2|NOT COMPLETED|Overall Study||86
7624124|NCT02343406|18772722|P1|NOT COMPLETED|Overall Study||88
7624125|NCT02343406|18772718|P5|COMPLETED|Overall Study||1
7624126|NCT02343406|18772719|P4|COMPLETED|Overall Study||0
7624127|NCT02343406|18772720|P3|COMPLETED|Overall Study||2
7624128|NCT02343406|18772721|P2|COMPLETED|Overall Study||0
7624129|NCT02343406|18772722|P1|COMPLETED|Overall Study||0
7624130|NCT02343406|18772718|P5|STARTED|Overall Study||6
7624131|NCT02343406|18772719|P4|STARTED|Overall Study||26
7624132|NCT02343406|18772720|P3|STARTED|Overall Study||60
7624133|NCT02343406|18772721|P2|STARTED|Overall Study||86
7624134|NCT02343406|18772722|P1|STARTED|Overall Study||88
7624135|NCT02343380|18772757|P2|NOT COMPLETED|Overall Study||0
7624136|NCT02343380|18772758|P1|NOT COMPLETED|Overall Study||0
7624137|NCT02343380|18772757|P2|COMPLETED|Overall Study|Morning test (second week)|10
7624138|NCT02343380|18772758|P1|COMPLETED|Overall Study|Evening test (second week)|10
7624139|NCT02343380|18772757|P2|STARTED|Overall Study|Evening test (first week)|10
7624140|NCT02343380|18772758|P1|STARTED|Overall Study|Morning test (first week)|10
7624141|NCT02343276|18772776|P2|NOT COMPLETED|Overall Study||0
7624142|NCT02343276|18772777|P1|NOT COMPLETED|Overall Study||0
7624143|NCT02343276|18772776|P2|COMPLETED|Overall Study||164
7624144|NCT02343276|18772777|P1|COMPLETED|Overall Study||164
7624145|NCT02343276|18772776|P2|STARTED|Overall Study||164
7624146|NCT02343276|18772777|P1|STARTED|Overall Study||164
7624147|NCT02343263|18772790|P3|NOT COMPLETED|Overall Study||1
7624148|NCT02343263|18772791|P2|NOT COMPLETED|Overall Study||3
7624149|NCT02343263|18772792|P1|NOT COMPLETED|Overall Study||5
7624150|NCT02343263|18772790|P3|COMPLETED|Overall Study||0
7624151|NCT02343263|18772791|P2|COMPLETED|Overall Study||0
7624152|NCT02343263|18772792|P1|COMPLETED|Overall Study|Study closed due for administrative reasons|0
7624153|NCT02343263|18772790|P3|STARTED|Overall Study||1
7624154|NCT02343263|18772791|P2|STARTED|Overall Study||3
7624155|NCT02343263|18772792|P1|STARTED|Overall Study|Study closed due for administrative reasons|5
7624156|NCT02343159|18772821|P3|NOT COMPLETED|Overall Study||30
7624157|NCT02343159|18772822|P2|NOT COMPLETED|Overall Study||26
7624158|NCT02343159|18772823|P1|NOT COMPLETED|Overall Study||26
7624159|NCT02343159|18772821|P3|COMPLETED|Overall Study||0
7624160|NCT02343159|18772822|P2|COMPLETED|Overall Study||1
7624161|NCT02343159|18772823|P1|COMPLETED|Overall Study||1
7624162|NCT02343159|18772821|P3|STARTED|Overall Study||30
7624163|NCT02343159|18772822|P2|STARTED|Overall Study||27
7624164|NCT02343159|18772823|P1|STARTED|Overall Study||27
7624165|NCT02343081|18772850|P2|NOT COMPLETED|Second Intervention (Day 4)||0
7624166|NCT02343081|18772851|P1|NOT COMPLETED|Second Intervention (Day 4)||0
7624167|NCT02343081|18772850|P2|COMPLETED|Second Intervention (Day 4)||8
7624168|NCT02343081|18772851|P1|COMPLETED|Second Intervention (Day 4)||8
7624169|NCT02343081|18772850|P2|Received Intervention|Second Intervention (Day 4)||8
7624170|NCT02343081|18772851|P1|Received Intervention|Second Intervention (Day 4)||8
7624171|NCT02343081|18772850|P2|STARTED|Second Intervention (Day 4)||8
7624172|NCT02343081|18772851|P1|STARTED|Second Intervention (Day 4)||8
7624173|NCT02343081|18772850|P2|NOT COMPLETED|Washout (10 Hours)||0
7624174|NCT02343081|18772851|P1|NOT COMPLETED|Washout (10 Hours)||0
7624175|NCT02343081|18772850|P2|COMPLETED|Washout (10 Hours)||8
7624176|NCT02343081|18772851|P1|COMPLETED|Washout (10 Hours)||8
7624177|NCT02343081|18772850|P2|STARTED|Washout (10 Hours)||8
7624178|NCT02343081|18772851|P1|STARTED|Washout (10 Hours)||8
7624179|NCT02343081|18772850|P2|NOT COMPLETED|First Intervention (Day 3)||0
7624180|NCT02343081|18772851|P1|NOT COMPLETED|First Intervention (Day 3)||0
7624181|NCT02343081|18772850|P2|COMPLETED|First Intervention (Day 3)||8
7624182|NCT02343081|18772851|P1|COMPLETED|First Intervention (Day 3)||8
7624183|NCT02343081|18772850|P2|Received Intervention|First Intervention (Day 3)||8
7624184|NCT02343081|18772851|P1|Received Intervention|First Intervention (Day 3)||8
7624185|NCT02343081|18772850|P2|STARTED|First Intervention (Day 3)||8
7624186|NCT02343081|18772851|P1|STARTED|First Intervention (Day 3)||8
7624187|NCT02343003|18772867|P2|NOT COMPLETED|Overall Study||7
7624188|NCT02343003|18772868|P1|NOT COMPLETED|Overall Study||18
7624189|NCT02343003|18772867|P2|COMPLETED|Overall Study||68
7624190|NCT02343003|18772868|P1|COMPLETED|Overall Study||58
7624191|NCT02343003|18772867|P2|STARTED|Overall Study||75
7624192|NCT02343003|18772868|P1|STARTED|Overall Study||76
7624193|NCT02342886|18772889|P5|NOT COMPLETED|Overall Study||3
7624194|NCT02342886|18772890|P4|NOT COMPLETED|Overall Study||9
7624195|NCT02342886|18772891|P3|NOT COMPLETED|Overall Study||15
7624196|NCT02342886|18772892|P2|NOT COMPLETED|Overall Study||8
7624197|NCT02342886|18772893|P1|NOT COMPLETED|Overall Study||8
7624198|NCT02342886|18772889|P5|COMPLETED|Overall Study||10
7624199|NCT02342886|18772890|P4|COMPLETED|Overall Study||59
7624200|NCT02342886|18772891|P3|COMPLETED|Overall Study||52
7624201|NCT02342886|18772892|P2|COMPLETED|Overall Study||63
7624202|NCT02342886|18772893|P1|COMPLETED|Overall Study||57
7624203|NCT02342886|18772889|P5|Completed Month 24 Follow-Up|Overall Study||10
7624204|NCT02342886|18772890|P4|Completed Month 24 Follow-Up|Overall Study||53
7624205|NCT02342886|18772891|P3|Completed Month 24 Follow-Up|Overall Study||46
7624206|NCT02342886|18772892|P2|Completed Month 24 Follow-Up|Overall Study||47
7624207|NCT02342886|18772893|P1|Completed Month 24 Follow-Up|Overall Study||40
7624208|NCT02342886|18772889|P5|Completed Month 12 Follow-Up|Overall Study||10
7624209|NCT02342886|18772890|P4|Completed Month 12 Follow-Up|Overall Study||57
7624210|NCT02342886|18772891|P3|Completed Month 12 Follow-Up|Overall Study||49
7624211|NCT02342886|18772892|P2|Completed Month 12 Follow-Up|Overall Study||52
7624212|NCT02342886|18772893|P1|Completed Month 12 Follow-Up|Overall Study||43
7624213|NCT02342886|18772889|P5|STARTED|Overall Study||13
7624214|NCT02342886|18772890|P4|STARTED|Overall Study||68
7624215|NCT02342886|18772891|P3|STARTED|Overall Study||67
7624216|NCT02342886|18772892|P2|STARTED|Overall Study||71
7624217|NCT02342886|18772893|P1|STARTED|Overall Study||65
7624218|NCT02342743|18772910|P1|NOT COMPLETED|Treatment Period||11
7624219|NCT02342743|18772910|P1|COMPLETED|Treatment Period||47
7624220|NCT02342743|18772910|P1|STARTED|Treatment Period|7 patients didn't meet inclusion criteria for treatment period, evaluated at the end of the baseline|58
7624221|NCT02342743|18772910|P1|NOT COMPLETED|Baseline Period||15
7624222|NCT02342743|18772910|P1|COMPLETED|Baseline Period||58
7624223|NCT02342743|18772910|P1|STARTED|Baseline Period||73
7624224|NCT02342704|18772923|P2|NOT COMPLETED|Overall Study||51
7624225|NCT02342704|18772924|P1|NOT COMPLETED|Overall Study||53
7624226|NCT02342704|18772923|P2|COMPLETED|Overall Study||3
7624227|NCT02342704|18772924|P1|COMPLETED|Overall Study||1
7624228|NCT02342704|18772923|P2|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
7624229|NCT02342704|18772924|P1|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
7624230|NCT02342678|18772952|P2|NOT COMPLETED|Overall Study||5
7624231|NCT02342678|18772953|P1|NOT COMPLETED|Overall Study||1
7624232|NCT02342678|18772952|P2|COMPLETED|Overall Study||23
7624233|NCT02342678|18772953|P1|COMPLETED|Overall Study||27
7624234|NCT02342678|18772952|P2|STARTED|Overall Study||28
7624235|NCT02342678|18772953|P1|STARTED|Overall Study||28
7624236|NCT02342561|18772973|P1|NOT COMPLETED|Overall Study||0
7624237|NCT02342561|18772973|P1|COMPLETED|Overall Study||20
7624238|NCT02342561|18772973|P1|STARTED|Overall Study||20
7624239|NCT02342548|18772984|P3|NOT COMPLETED|Overall Study||43
7624240|NCT02342548|18772985|P2|NOT COMPLETED|Overall Study||62
7624241|NCT02342548|18772986|P1|NOT COMPLETED|Overall Study||34
7624242|NCT02342548|18772984|P3|COMPLETED|Overall Study||23
7624243|NCT02342548|18772985|P2|COMPLETED|Overall Study||9
7624244|NCT02342548|18772986|P1|COMPLETED|Overall Study||17
7624245|NCT02342548|18772984|P3|STARTED|Overall Study||66
7624246|NCT02342548|18772985|P2|STARTED|Overall Study||71
7624247|NCT02342548|18772986|P1|STARTED|Overall Study||51
7624248|NCT02342535|18773024|P1|NOT COMPLETED|Overall Study||0
7624249|NCT02342535|18773024|P1|COMPLETED|Overall Study|30 women in aerobic class and 38 kids in kids exercise class|68
7624250|NCT02342535|18773024|P1|STARTED|Overall Study|30 women who participated in the aerobic exercise class and 38 children.|68
7624251|NCT02342418|18773030|P2|NOT COMPLETED|Overall Study||1
7624252|NCT02342418|18773031|P1|NOT COMPLETED|Overall Study||0
7624253|NCT02342418|18773030|P2|COMPLETED|Overall Study||9
7624254|NCT02342418|18773031|P1|COMPLETED|Overall Study||9
7624255|NCT02342418|18773030|P2|STARTED|Overall Study||10
7624256|NCT02342418|18773031|P1|STARTED|Overall Study||9
7624257|NCT02342379|18773039|P1|NOT COMPLETED|Overall Study||0
7624258|NCT02342379|18773039|P1|COMPLETED|Overall Study||35
7624259|NCT02342379|18773039|P1|STARTED|Overall Study||35
7624260|NCT02342314|18773046|P17|NOT COMPLETED|Part B||0
7624261|NCT02342314|18773047|P16|NOT COMPLETED|Part B||0
7624262|NCT02342314|18773048|P15|NOT COMPLETED|Part B||0
7624263|NCT02342314|18773049|P14|NOT COMPLETED|Part B||0
7624264|NCT02342314|18773050|P13|NOT COMPLETED|Part B||0
7624265|NCT02342314|18773051|P12|NOT COMPLETED|Part B||0
7624266|NCT02342314|18773052|P11|NOT COMPLETED|Part B||0
7624267|NCT02342314|18773053|P10|NOT COMPLETED|Part B||0
7624268|NCT02342314|18773054|P9|NOT COMPLETED|Part B||0
7624269|NCT02342314|18773055|P8|NOT COMPLETED|Part B||0
7624270|NCT02342314|18773056|P7|NOT COMPLETED|Part B||0
7624271|NCT02342314|18773057|P6|NOT COMPLETED|Part B||0
7624272|NCT02342314|18773058|P5|NOT COMPLETED|Part B||0
7624273|NCT02342314|18773059|P4|NOT COMPLETED|Part B||0
7624274|NCT02342314|18773060|P3|NOT COMPLETED|Part B||0
7624275|NCT02342314|18773061|P2|NOT COMPLETED|Part B||0
7624276|NCT02342314|18773062|P1|NOT COMPLETED|Part B||0
7624277|NCT02342314|18773046|P17|COMPLETED|Part B||6
7624278|NCT02342314|18773047|P16|COMPLETED|Part B||3
7624279|NCT02342314|18773048|P15|COMPLETED|Part B||3
7624280|NCT02342314|18773049|P14|COMPLETED|Part B||3
7624281|NCT02342314|18773050|P13|COMPLETED|Part B||3
7624282|NCT02342314|18773051|P12|COMPLETED|Part B||3
7624283|NCT02342314|18773052|P11|COMPLETED|Part B||3
7624284|NCT02342314|18773053|P10|COMPLETED|Part B||3
7624285|NCT02342314|18773054|P9|COMPLETED|Part B||3
7624286|NCT02342314|18773055|P8|COMPLETED|Part B||3
7624287|NCT02342314|18773056|P7|COMPLETED|Part B||11
7624288|NCT02342314|18773057|P6|COMPLETED|Part B||0
7624289|NCT02342314|18773058|P5|COMPLETED|Part B||0
7624290|NCT02342314|18773059|P4|COMPLETED|Part B||0
7624291|NCT02342314|18773060|P3|COMPLETED|Part B||0
7624292|NCT02342314|18773061|P2|COMPLETED|Part B||0
7624293|NCT02342314|18773062|P1|COMPLETED|Part B||0
7624294|NCT02342314|18773046|P17|STARTED|Part B|Participants received rGlucagon in Part B.|6
7624295|NCT02342314|18773047|P16|STARTED|Part B|Participants received LY3185643 in Part B.|3
7624296|NCT02342314|18773048|P15|STARTED|Part B|Participants received LY3185643 in Part B.|3
7624297|NCT02342314|18773049|P14|STARTED|Part B|Participants received LY3185643 in Part B.|3
7624298|NCT02342314|18773050|P13|STARTED|Part B|Participants received LY3185643 in Part B.|3
7624299|NCT02342314|18773051|P12|STARTED|Part B|Participants received LY3185643 in Part B.|3
7624300|NCT02342314|18773052|P11|STARTED|Part B|Participants received LY3185643 in Part B.|3
7624301|NCT02342314|18773053|P10|STARTED|Part B|Participants received LY3185643 in Part B.|3
7624302|NCT02342314|18773054|P9|STARTED|Part B|Participants received LY3185643 in Part B.|3
7624303|NCT02342314|18773055|P8|STARTED|Part B|Participants received LY3185643 in Part B.|3
7624304|NCT02342314|18773056|P7|STARTED|Part B|Participants received placebo in Part B.|11
7624305|NCT02342314|18773057|P6|STARTED|Part B|Participants received LY3143753 in Part A.|0
7624306|NCT02342314|18773058|P5|STARTED|Part B|Participants received LY3143753 in Part A.|0
7624307|NCT02342314|18773059|P4|STARTED|Part B|Participants received LY3143753 in Part A.|0
7624308|NCT02342314|18773060|P3|STARTED|Part B|Participants received LY3143753 in Part A.|0
7624309|NCT02342314|18773061|P2|STARTED|Part B|Participants received LY3143753 in Part A.|0
7624310|NCT02342314|18773062|P1|STARTED|Part B|Participants received placebo in Part A.|0
7624311|NCT02342314|18773046|P17|NOT COMPLETED|Part A||0
7624312|NCT02342314|18773047|P16|NOT COMPLETED|Part A||0
7624313|NCT02342314|18773048|P15|NOT COMPLETED|Part A||0
7624314|NCT02342314|18773049|P14|NOT COMPLETED|Part A||0
7624315|NCT02342314|18773050|P13|NOT COMPLETED|Part A||0
7624316|NCT02342314|18773051|P12|NOT COMPLETED|Part A||0
7624317|NCT02342314|18773052|P11|NOT COMPLETED|Part A||0
7624318|NCT02342314|18773053|P10|NOT COMPLETED|Part A||0
7624319|NCT02342314|18773054|P9|NOT COMPLETED|Part A||0
7624320|NCT02342314|18773055|P8|NOT COMPLETED|Part A||0
7624321|NCT02342314|18773056|P7|NOT COMPLETED|Part A||0
7624322|NCT02342314|18773057|P6|NOT COMPLETED|Part A||0
7624323|NCT02342314|18773058|P5|NOT COMPLETED|Part A||0
7624324|NCT02342314|18773059|P4|NOT COMPLETED|Part A||0
7624325|NCT02342314|18773060|P3|NOT COMPLETED|Part A||0
7624326|NCT02342314|18773061|P2|NOT COMPLETED|Part A||0
7624327|NCT02342314|18773062|P1|NOT COMPLETED|Part A||0
7624328|NCT02342314|18773046|P17|COMPLETED|Part A||0
7624329|NCT02342314|18773047|P16|COMPLETED|Part A||0
7624330|NCT02342314|18773048|P15|COMPLETED|Part A||0
7624331|NCT02342314|18773049|P14|COMPLETED|Part A||0
7624332|NCT02342314|18773050|P13|COMPLETED|Part A||0
7624333|NCT02342314|18773051|P12|COMPLETED|Part A||0
7624334|NCT02342314|18773052|P11|COMPLETED|Part A||0
7624335|NCT02342314|18773053|P10|COMPLETED|Part A||0
7624336|NCT02342314|18773054|P9|COMPLETED|Part A||0
7624337|NCT02342314|18773055|P8|COMPLETED|Part A||0
7624338|NCT02342314|18773056|P7|COMPLETED|Part A||0
7624339|NCT02342314|18773057|P6|COMPLETED|Part A||3
7624340|NCT02342314|18773058|P5|COMPLETED|Part A||6
7624341|NCT02342314|18773059|P4|COMPLETED|Part A||3
7624342|NCT02342314|18773060|P3|COMPLETED|Part A||3
7624343|NCT02342314|18773061|P2|COMPLETED|Part A||3
7624344|NCT02342314|18773062|P1|COMPLETED|Part A||6
7624345|NCT02342314|18773046|P17|STARTED|Part A||0
7624346|NCT02342314|18773047|P16|STARTED|Part A||0
7624347|NCT02342314|18773048|P15|STARTED|Part A||0
7624348|NCT02342314|18773049|P14|STARTED|Part A||0
7624349|NCT02342314|18773050|P13|STARTED|Part A||0
7624350|NCT02342314|18773051|P12|STARTED|Part A||0
7624351|NCT02342314|18773052|P11|STARTED|Part A||0
7624352|NCT02342314|18773053|P10|STARTED|Part A||0
7624353|NCT02342314|18773054|P9|STARTED|Part A||0
7624354|NCT02342314|18773055|P8|STARTED|Part A||0
7624355|NCT02342314|18773056|P7|STARTED|Part A||0
7624356|NCT02342314|18773057|P6|STARTED|Part A||3
7624357|NCT02342314|18773058|P5|STARTED|Part A||6
7624358|NCT02342314|18773059|P4|STARTED|Part A||3
7624359|NCT02342314|18773060|P3|STARTED|Part A||3
7624360|NCT02342314|18773061|P2|STARTED|Part A||3
7624361|NCT02342314|18773062|P1|STARTED|Part A||6
7624362|NCT02342288|18773210|P2|NOT COMPLETED|Overall Study||6
7624363|NCT02342288|18773211|P1|NOT COMPLETED|Overall Study||5
7624364|NCT02342288|18773210|P2|COMPLETED|Overall Study||27
7624365|NCT02342288|18773211|P1|COMPLETED|Overall Study||25
7624366|NCT02342288|18773210|P2|STARTED|Overall Study|various issues listed below caused removal of subjects|33
7624367|NCT02342288|18773211|P1|STARTED|Overall Study|16 patients were not randomized to either arm.|30
7624368|NCT02342223|18773217|P1|NOT COMPLETED|Overall Study||1
7624369|NCT02342223|18773217|P1|COMPLETED|Overall Study||19
7624370|NCT02342223|18773217|P1|STARTED|Overall Study||20
7624371|NCT02342197|18773228|P2|NOT COMPLETED|Overall Study||2
7624372|NCT02342197|18773229|P1|NOT COMPLETED|Overall Study||3
7624373|NCT02342197|18773228|P2|COMPLETED|Overall Study||28
7624374|NCT02342197|18773229|P1|COMPLETED|Overall Study||27
7624375|NCT02342197|18773228|P2|STARTED|Overall Study||30
7624376|NCT02342197|18773229|P1|STARTED|Overall Study||30
7624377|NCT02342171|18773237|P2|NOT COMPLETED|Overall Study||89
7624378|NCT02342171|18773238|P1|NOT COMPLETED|Overall Study||15
7624379|NCT02342171|18773237|P2|COMPLETED|Overall Study||418
7624380|NCT02342171|18773238|P1|COMPLETED|Overall Study||84
7624381|NCT02342171|18773237|P2|STARTED|Overall Study||507
7624382|NCT02342171|18773238|P1|STARTED|Overall Study||99
7624383|NCT02341859|18773254|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7624384|NCT02341859|18773255|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7624385|NCT02341859|18773254|P2|COMPLETED|Second Intervention (1 Day)||9
7624386|NCT02341859|18773255|P1|COMPLETED|Second Intervention (1 Day)||10
7624387|NCT02341859|18773254|P2|STARTED|Second Intervention (1 Day)||9
7624388|NCT02341859|18773255|P1|STARTED|Second Intervention (1 Day)||10
7624389|NCT02341859|18773254|P2|NOT COMPLETED|First Intervention (1 Day)||0
7624390|NCT02341859|18773255|P1|NOT COMPLETED|First Intervention (1 Day)||0
7624391|NCT02341859|18773254|P2|COMPLETED|First Intervention (1 Day)||9
7624392|NCT02341859|18773255|P1|COMPLETED|First Intervention (1 Day)||10
7624393|NCT02341859|18773254|P2|STARTED|First Intervention (1 Day)||9
7624394|NCT02341859|18773255|P1|STARTED|First Intervention (1 Day)||10
7624395|NCT02341599|18773413|P5|NOT COMPLETED|Overall Study||0
7624396|NCT02341599|18773414|P4|NOT COMPLETED|Overall Study||0
7624397|NCT02341599|18773415|P3|NOT COMPLETED|Overall Study||0
7624398|NCT02341599|18773416|P2|NOT COMPLETED|Overall Study||0
7624399|NCT02341599|18773417|P1|NOT COMPLETED|Overall Study||0
7624400|NCT02341599|18773413|P5|COMPLETED|Overall Study||8
7624401|NCT02341599|18773414|P4|COMPLETED|Overall Study||8
7624402|NCT02341599|18773415|P3|COMPLETED|Overall Study||8
7624403|NCT02341599|18773416|P2|COMPLETED|Overall Study||8
7624404|NCT02341599|18773417|P1|COMPLETED|Overall Study||8
7624405|NCT02341599|18773413|P5|STARTED|Overall Study||8
7624406|NCT02341599|18773414|P4|STARTED|Overall Study||8
7624407|NCT02341599|18773415|P3|STARTED|Overall Study||8
7624408|NCT02341599|18773416|P2|STARTED|Overall Study||8
7624409|NCT02341599|18773417|P1|STARTED|Overall Study||8
7624410|NCT02341495|18773485|P1|NOT COMPLETED|Overall Study||0
7624411|NCT02341495|18773485|P1|COMPLETED|Overall Study||4
7624412|NCT02341495|18773485|P1|STARTED|Overall Study||4
7624413|NCT02341482|18773492|P1|NOT COMPLETED|Overall Study||1
7624414|NCT02341482|18773492|P1|COMPLETED|Overall Study||12
7624415|NCT02341482|18773492|P1|STARTED|Overall Study||13
7624416|NCT02341456|18773521|P3|NOT COMPLETED|Overall Study||4
7624417|NCT02341456|18773522|P2|NOT COMPLETED|Overall Study||6
7624418|NCT02341456|18773523|P1|NOT COMPLETED|Overall Study||4
7624419|NCT02341456|18773521|P3|COMPLETED|Overall Study||2
7624420|NCT02341456|18773522|P2|COMPLETED|Overall Study||0
7624421|NCT02341456|18773523|P1|COMPLETED|Overall Study||3
7624422|NCT02341456|18773521|P3|STARTED|Overall Study||6
7624423|NCT02341456|18773522|P2|STARTED|Overall Study||6
7624424|NCT02341456|18773523|P1|STARTED|Overall Study||7
7624425|NCT02341417|18773648|P3|NOT COMPLETED|Overall Study||1
7624426|NCT02341417|18773649|P2|NOT COMPLETED|Overall Study||2
7624427|NCT02341417|18773650|P1|NOT COMPLETED|Overall Study||2
7624428|NCT02341417|18773648|P3|COMPLETED|Overall Study||0
7624429|NCT02341417|18773649|P2|COMPLETED|Overall Study||12
7624430|NCT02341417|18773650|P1|COMPLETED|Overall Study||11
7624431|NCT02341417|18773648|P3|STARTED|Overall Study||1
7624432|NCT02341417|18773649|P2|STARTED|Overall Study||14
7624433|NCT02341417|18773650|P1|STARTED|Overall Study||13
7624434|NCT02341144|18773694|P2|NOT COMPLETED|Overall Study||1
7624435|NCT02341144|18773695|P1|NOT COMPLETED|Overall Study||2
7624436|NCT02341144|18773694|P2|COMPLETED|Overall Study||30
7624437|NCT02341144|18773695|P1|COMPLETED|Overall Study||28
7624438|NCT02341144|18773694|P2|STARTED|Overall Study||31
7624439|NCT02341144|18773695|P1|STARTED|Overall Study||30
7624440|NCT02340975|18773715|P6|NOT COMPLETED|Overall Study||19
7624441|NCT02340975|18773716|P5|NOT COMPLETED|Overall Study||25
7624442|NCT02340975|18773717|P4|NOT COMPLETED|Overall Study||12
7624443|NCT02340975|18773718|P3|NOT COMPLETED|Overall Study||24
7624444|NCT02340975|18773719|P2|NOT COMPLETED|Overall Study||27
7624445|NCT02340975|18773720|P1|NOT COMPLETED|Overall Study||6
7624446|NCT02340975|18773715|P6|COMPLETED|Overall Study||0
7624447|NCT02340975|18773716|P5|COMPLETED|Overall Study||0
7624448|NCT02340975|18773717|P4|COMPLETED|Overall Study||0
7624449|NCT02340975|18773718|P3|COMPLETED|Overall Study||0
7624450|NCT02340975|18773719|P2|COMPLETED|Overall Study||0
7624451|NCT02340975|18773720|P1|COMPLETED|Overall Study||0
7624452|NCT02340975|18773715|P6|STARTED|Overall Study||19
7624453|NCT02340975|18773716|P5|STARTED|Overall Study||25
7624454|NCT02340975|18773717|P4|STARTED|Overall Study||12
7624455|NCT02340975|18773718|P3|STARTED|Overall Study||24
7624456|NCT02340975|18773719|P2|STARTED|Overall Study||27
7624457|NCT02340975|18773720|P1|STARTED|Overall Study||6
7624458|NCT02340962|18773834|P2|NOT COMPLETED|Overall Study||0
7624459|NCT02340962|18773835|P1|NOT COMPLETED|Overall Study||1
7624460|NCT02340962|18773834|P2|COMPLETED|Overall Study||12
7624461|NCT02340962|18773835|P1|COMPLETED|Overall Study||12
7624462|NCT02340962|18773834|P2|STARTED|Overall Study||12
7624463|NCT02340962|18773835|P1|STARTED|Overall Study||13
7624464|NCT02340819|18773855|P1|NOT COMPLETED|Overall Study||4
7624465|NCT02340819|18773855|P1|COMPLETED|Overall Study||7
7624466|NCT02340819|18773855|P1|Completed Stage 4|Overall Study||7
7624467|NCT02340819|18773855|P1|Started Stage 4|Overall Study||7
7624468|NCT02340819|18773855|P1|Completed Stage 3|Overall Study||7
7624469|NCT02340819|18773855|P1|Started Stage 3|Overall Study||8
7624470|NCT02340819|18773855|P1|Completed Stage 2|Overall Study||9
7624471|NCT02340819|18773855|P1|Started Stage 2|Overall Study||11
7624472|NCT02340819|18773855|P1|STARTED|Overall Study||11
7624473|NCT02340806|18773884|P2|NOT COMPLETED|Overall Study||4
7624474|NCT02340806|18773885|P1|NOT COMPLETED|Overall Study||6
7624475|NCT02340806|18773884|P2|COMPLETED|Overall Study||108
7624476|NCT02340806|18773885|P1|COMPLETED|Overall Study||102
7624477|NCT02340806|18773884|P2|STARTED|Overall Study||112
7624478|NCT02340806|18773885|P1|STARTED|Overall Study||108
7624479|NCT02340780|18773911|P1|NOT COMPLETED|Overall Study||1
7624480|NCT02340780|18773911|P1|COMPLETED|Overall Study||13
7624481|NCT02340780|18773911|P1|STARTED|Overall Study|A total of 14 patients enrolled, one patient was found ineligible after the enrollment.|14
7624482|NCT02340767|18773925|P9|NOT COMPLETED|Overall Study||0
7624483|NCT02340767|18773926|P8|NOT COMPLETED|Overall Study||0
7624484|NCT02340767|18773927|P7|NOT COMPLETED|Overall Study||0
7624485|NCT02340767|18773928|P6|NOT COMPLETED|Overall Study||0
7624486|NCT02340767|18773929|P5|NOT COMPLETED|Overall Study||0
7624487|NCT02340767|18773930|P4|NOT COMPLETED|Overall Study||0
7624488|NCT02340767|18773931|P3|NOT COMPLETED|Overall Study||0
7624489|NCT02340767|18773932|P2|NOT COMPLETED|Overall Study||0
7624490|NCT02340767|18773933|P1|NOT COMPLETED|Overall Study||0
7624491|NCT02340767|18773925|P9|COMPLETED|Overall Study||531
7624492|NCT02340767|18773926|P8|COMPLETED|Overall Study||444
7624493|NCT02340767|18773927|P7|COMPLETED|Overall Study||525
7624494|NCT02340767|18773928|P6|COMPLETED|Overall Study||526
7624495|NCT02340767|18773929|P5|COMPLETED|Overall Study||474
7624496|NCT02340767|18773930|P4|COMPLETED|Overall Study||500
7624497|NCT02340767|18773931|P3|COMPLETED|Overall Study||29
7624498|NCT02340767|18773932|P2|COMPLETED|Overall Study||28
7624499|NCT02340767|18773933|P1|COMPLETED|Overall Study||28
7624500|NCT02340767|18773925|P9|STARTED|Overall Study||531
7624501|NCT02340767|18773926|P8|STARTED|Overall Study||444
7624502|NCT02340767|18773927|P7|STARTED|Overall Study||525
7624503|NCT02340767|18773928|P6|STARTED|Overall Study||526
7624504|NCT02340767|18773929|P5|STARTED|Overall Study||474
7624505|NCT02340767|18773930|P4|STARTED|Overall Study||500
7624506|NCT02340767|18773931|P3|STARTED|Overall Study||29
7624507|NCT02340767|18773932|P2|STARTED|Overall Study||28
7624508|NCT02340767|18773933|P1|STARTED|Overall Study||28
7624509|NCT02340728|18773951|P2|NOT COMPLETED|Overall Study||0
7624510|NCT02340728|18773952|P1|NOT COMPLETED|Overall Study||0
7624511|NCT02340728|18773951|P2|COMPLETED|Overall Study||11
7624512|NCT02340728|18773952|P1|COMPLETED|Overall Study||13
7624513|NCT02340728|18773951|P2|STARTED|Overall Study||11
7624514|NCT02340728|18773952|P1|STARTED|Overall Study||13
7624515|NCT02340715|18773962|P1|NOT COMPLETED|Overall Study||0
7624516|NCT02340715|18773962|P1|COMPLETED|Overall Study|158|158
7624517|NCT02340715|18773962|P1|STARTED|Overall Study|158|158
7624518|NCT02340676|18773966|P1|NOT COMPLETED|Overall Study||0
7624519|NCT02340676|18773966|P1|COMPLETED|Overall Study||25
7624520|NCT02340676|18773966|P1|STARTED|Overall Study||25
7624521|NCT02340663|18773979|P2|NOT COMPLETED|Overall Study||1
7624522|NCT02340663|18773980|P1|NOT COMPLETED|Overall Study||5
7624523|NCT02340663|18773979|P2|COMPLETED|Overall Study||31
7624524|NCT02340663|18773980|P1|COMPLETED|Overall Study||30
7624525|NCT02340663|18773979|P2|4 Month Follow-up, Assessments|Overall Study||31
7624526|NCT02340663|18773980|P1|4 Month Follow-up, Assessments|Overall Study||30
7624527|NCT02340663|18773979|P2|1 Week Follow-up, Assessments|Overall Study||31
7624528|NCT02340663|18773980|P1|1 Week Follow-up, Assessments|Overall Study||33
7624529|NCT02340663|18773979|P2|Splint Delivery, Assessments|Overall Study||31
7624530|NCT02340663|18773980|P1|Splint Delivery, Assessments|Overall Study||33
7624531|NCT02340663|18773979|P2|Clinical Exam, Impressions|Overall Study||32
7624532|NCT02340663|18773980|P1|Clinical Exam, Impressions|Overall Study||35
7624533|NCT02340663|18773979|P2|STARTED|Overall Study||32
7624534|NCT02340663|18773980|P1|STARTED|Overall Study||35
7624535|NCT02340520|18774036|P1|NOT COMPLETED|Overall Study||3
7624536|NCT02340520|18774036|P1|COMPLETED|Overall Study||8
7624537|NCT02340520|18774036|P1|STARTED|Overall Study||11
7624538|NCT02340338|18774048|P7|NOT COMPLETED|Overall Study||0
7624539|NCT02340338|18774049|P6|NOT COMPLETED|Overall Study||0
7624540|NCT02340338|18774050|P5|NOT COMPLETED|Overall Study||0
7624541|NCT02340338|18774051|P4|NOT COMPLETED|Overall Study||0
7624542|NCT02340338|18774052|P3|NOT COMPLETED|Overall Study||0
7624543|NCT02340338|18774053|P2|NOT COMPLETED|Overall Study||0
7624544|NCT02340338|18774054|P1|NOT COMPLETED|Overall Study||0
7624545|NCT02340338|18774048|P7|COMPLETED|Overall Study||12
7624546|NCT02340338|18774049|P6|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9
7624547|NCT02340338|18774050|P5|COMPLETED|Overall Study||9
7624548|NCT02340338|18774051|P4|COMPLETED|Overall Study||9
7624549|NCT02340338|18774052|P3|COMPLETED|Overall Study||3
7624550|NCT02340338|18774053|P2|COMPLETED|Overall Study||2
7624551|NCT02340338|18774054|P1|COMPLETED|Overall Study||2
7624643|NCT02339415|18774233|P2|STARTED|Second Period||20
7624552|NCT02340338|18774048|P7|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12
7624553|NCT02340338|18774049|P6|STARTED|Overall Study|9 vaccine + 3 placebo|9
7624554|NCT02340338|18774050|P5|STARTED|Overall Study|9 vaccine + 3 placebo|9
7624555|NCT02340338|18774051|P4|STARTED|Overall Study|9 vaccine + 3 placebo|9
7624556|NCT02340338|18774052|P3|STARTED|Overall Study|3 vaccine + 1 placebo|3
7624557|NCT02340338|18774053|P2|STARTED|Overall Study|2 vaccine + 1 placebo|2
7624558|NCT02340338|18774054|P1|STARTED|Overall Study|2 vaccine + 1 placebo|2
7624559|NCT02340299|18774079|P2|NOT COMPLETED|Overall Study||0
7624560|NCT02340299|18774080|P1|NOT COMPLETED|Overall Study||0
7624561|NCT02340299|18774079|P2|COMPLETED|Overall Study||2
7624562|NCT02340299|18774080|P1|COMPLETED|Overall Study||4
7624563|NCT02340299|18774079|P2|STARTED|Overall Study||2
7624564|NCT02340299|18774080|P1|STARTED|Overall Study||4
7624565|NCT02340221|18774088|P2|NOT COMPLETED|Overall Study||417
7624566|NCT02340221|18774089|P1|NOT COMPLETED|Overall Study||214
7624567|NCT02340221|18774088|P2|COMPLETED|Overall Study||0
7624568|NCT02340221|18774089|P1|COMPLETED|Overall Study||0
7624569|NCT02340221|18774088|P2|STARTED|Overall Study||417
7624570|NCT02340221|18774089|P1|STARTED|Overall Study||214
7624571|NCT02340104|18774113|P1|NOT COMPLETED|Overall Study||0
7624572|NCT02340104|18774113|P1|COMPLETED|Overall Study||8
7624573|NCT02340104|18774113|P1|STARTED|Overall Study||8
7624574|NCT02340091|18774118|P1|NOT COMPLETED|Overall Study||2
7624575|NCT02340091|18774118|P1|COMPLETED|Overall Study||60
7624576|NCT02340091|18774118|P1|STARTED|Overall Study|All Study Participants|62
7624577|NCT02340078|18774123|P1|NOT COMPLETED|Overall Study||1
7624578|NCT02340078|18774123|P1|COMPLETED|Overall Study||61
7624579|NCT02340078|18774123|P1|STARTED|Overall Study||62
7624580|NCT02340000|18774130|P2|NOT COMPLETED|Time Period 2||15
7624581|NCT02340000|18774131|P1|NOT COMPLETED|Time Period 2||19
7624582|NCT02340000|18774130|P2|COMPLETED|Time Period 2||52
7624583|NCT02340000|18774131|P1|COMPLETED|Time Period 2||50
7624584|NCT02340000|18774130|P2|STARTED|Time Period 2||67
7624585|NCT02340000|18774131|P1|STARTED|Time Period 2||69
7624586|NCT02340000|18774130|P2|NOT COMPLETED|Time Period 1||15
7624587|NCT02340000|18774131|P1|NOT COMPLETED|Time Period 1||12
7624588|NCT02340000|18774130|P2|COMPLETED|Time Period 1||74
7624589|NCT02340000|18774131|P1|COMPLETED|Time Period 1||78
7624590|NCT02340000|18774130|P2|STARTED|Time Period 1||89
7624591|NCT02340000|18774131|P1|STARTED|Time Period 1||90
7624592|NCT02339909|18774161|P3|NOT COMPLETED|Overall Study||71
7624593|NCT02339909|18774162|P2|NOT COMPLETED|Overall Study||63
7624594|NCT02339909|18774163|P1|NOT COMPLETED|Overall Study||89
7624595|NCT02339909|18774161|P3|COMPLETED|Overall Study||304
7624596|NCT02339909|18774162|P2|COMPLETED|Overall Study||312
7624597|NCT02339909|18774163|P1|COMPLETED|Overall Study||435
7624598|NCT02339909|18774161|P3|STARTED|Overall Study||375
7624599|NCT02339909|18774162|P2|STARTED|Overall Study||375
7624600|NCT02339909|18774163|P1|STARTED|Overall Study||524
7624601|NCT02339831|18774176|P2|NOT COMPLETED|Overall Study||7
7624602|NCT02339831|18774177|P1|NOT COMPLETED|Overall Study||20
7624603|NCT02339831|18774176|P2|COMPLETED|Overall Study||45
7624604|NCT02339831|18774177|P1|COMPLETED|Overall Study||38
7624605|NCT02339831|18774176|P2|Lost to Follow Up|Overall Study||7
7624606|NCT02339831|18774177|P1|Lost to Follow Up|Overall Study||20
7624607|NCT02339831|18774176|P2|STARTED|Overall Study||52
7624608|NCT02339831|18774177|P1|STARTED|Overall Study||58
7624609|NCT02339584|18774201|P2|NOT COMPLETED|Overall Study||15
7624610|NCT02339584|18774202|P1|NOT COMPLETED|Overall Study||15
7624611|NCT02339584|18774201|P2|COMPLETED|Overall Study||176
7624612|NCT02339584|18774202|P1|COMPLETED|Overall Study||173
7624613|NCT02339584|18774201|P2|STARTED|Overall Study||191
7624614|NCT02339584|18774202|P1|STARTED|Overall Study||188
7624615|NCT02339558|18774208|P1|NOT COMPLETED|Overall Study||0
7624616|NCT02339558|18774208|P1|COMPLETED|Overall Study||45
7624617|NCT02339558|18774208|P1|STARTED|Overall Study||45
7624618|NCT02339545|18774217|P1|NOT COMPLETED|Overall Study||0
7624619|NCT02339545|18774217|P1|COMPLETED|Overall Study||15
7624620|NCT02339545|18774217|P1|STARTED|Overall Study||15
7624621|NCT02339506|18774222|P2|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
7624622|NCT02339506|18774223|P1|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
7624623|NCT02339506|18774222|P2|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
7624624|NCT02339506|18774223|P1|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
7624625|NCT02339506|18774222|P2|STARTED|Period 3 (Placebo or Cosyntropin)||10
7624626|NCT02339506|18774223|P1|STARTED|Period 3 (Placebo or Cosyntropin)||10
7624627|NCT02339506|18774222|P2|NOT COMPLETED|Washout (Period 2)||0
7624628|NCT02339506|18774223|P1|NOT COMPLETED|Washout (Period 2)||2
7624629|NCT02339506|18774222|P2|COMPLETED|Washout (Period 2)||10
7624630|NCT02339506|18774223|P1|COMPLETED|Washout (Period 2)||10
7624631|NCT02339506|18774222|P2|STARTED|Washout (Period 2)||10
7624632|NCT02339506|18774223|P1|STARTED|Washout (Period 2)||12
7624633|NCT02339506|18774222|P2|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||1
7624634|NCT02339506|18774223|P1|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||0
7624635|NCT02339506|18774222|P2|COMPLETED|Period 1 (Placebo or Cosyntropin)||10
7624636|NCT02339506|18774223|P1|COMPLETED|Period 1 (Placebo or Cosyntropin)||12
7624637|NCT02339506|18774222|P2|STARTED|Period 1 (Placebo or Cosyntropin)||11
7624638|NCT02339506|18774223|P1|STARTED|Period 1 (Placebo or Cosyntropin)||12
7624639|NCT02339415|18774233|P2|NOT COMPLETED|Second Period||2
7624640|NCT02339415|18774234|P1|NOT COMPLETED|Second Period||1
7624641|NCT02339415|18774233|P2|COMPLETED|Second Period||18
7624642|NCT02339415|18774234|P1|COMPLETED|Second Period||19
7624644|NCT02339415|18774234|P1|STARTED|Second Period||20
7624645|NCT02339415|18774233|P2|NOT COMPLETED|Washout||0
7624646|NCT02339415|18774234|P1|NOT COMPLETED|Washout||0
7624647|NCT02339415|18774233|P2|COMPLETED|Washout||20
7624648|NCT02339415|18774234|P1|COMPLETED|Washout||20
7624649|NCT02339415|18774233|P2|STARTED|Washout||20
7624650|NCT02339415|18774234|P1|STARTED|Washout||20
7624651|NCT02339415|18774233|P2|NOT COMPLETED|First Period||2
7624652|NCT02339415|18774234|P1|NOT COMPLETED|First Period||2
7624653|NCT02339415|18774233|P2|COMPLETED|First Period||20
7624654|NCT02339415|18774234|P1|COMPLETED|First Period||20
7624655|NCT02339415|18774233|P2|Received at Least One Dose|First Period||20
7624656|NCT02339415|18774234|P1|Received at Least One Dose|First Period||21
7624657|NCT02339415|18774233|P2|STARTED|First Period||22
7624658|NCT02339415|18774234|P1|STARTED|First Period||22
7624659|NCT02339389|18774244|P1|NOT COMPLETED|Overall Study||16
7624660|NCT02339389|18774244|P1|COMPLETED|Overall Study||41
7624661|NCT02339389|18774244|P1|STARTED|Overall Study||57
7624662|NCT02339285|18774252|P3|NOT COMPLETED|Overall Study||2
7624663|NCT02339285|18774253|P2|NOT COMPLETED|Overall Study||3
7624664|NCT02339285|18774254|P1|NOT COMPLETED|Overall Study||1
7624665|NCT02339285|18774252|P3|COMPLETED|Overall Study||9
7624666|NCT02339285|18774253|P2|COMPLETED|Overall Study||8
7624667|NCT02339285|18774254|P1|COMPLETED|Overall Study||9
7624668|NCT02339285|18774252|P3|4 Week Follow-up Visit|Overall Study||9
7624669|NCT02339285|18774253|P2|4 Week Follow-up Visit|Overall Study||8
7624670|NCT02339285|18774254|P1|4 Week Follow-up Visit|Overall Study||9
7624671|NCT02339285|18774252|P3|2 Week Follow-up|Overall Study||10
7624672|NCT02339285|18774253|P2|2 Week Follow-up|Overall Study||10
7624673|NCT02339285|18774254|P1|2 Week Follow-up|Overall Study||9
7624674|NCT02339285|18774252|P3|Completed Intervention|Overall Study||10
7624675|NCT02339285|18774253|P2|Completed Intervention|Overall Study||10
7624676|NCT02339285|18774254|P1|Completed Intervention|Overall Study||10
7624677|NCT02339285|18774252|P3|STARTED|Overall Study||11
7624678|NCT02339285|18774253|P2|STARTED|Overall Study||11
7624679|NCT02339285|18774254|P1|STARTED|Overall Study||10
7624680|NCT02339246|18774282|P3|NOT COMPLETED|Third Period (7 Days)||0
7624681|NCT02339246|18774283|P2|NOT COMPLETED|Third Period (7 Days)||0
7624682|NCT02339246|18774284|P1|NOT COMPLETED|Third Period (7 Days)||0
7624683|NCT02339246|18774282|P3|COMPLETED|Third Period (7 Days)||0
7624684|NCT02339246|18774283|P2|COMPLETED|Third Period (7 Days)||16
7624685|NCT02339246|18774284|P1|COMPLETED|Third Period (7 Days)||15
7624686|NCT02339246|18774282|P3|STARTED|Third Period (7 Days)||0
7624687|NCT02339246|18774283|P2|STARTED|Third Period (7 Days)||16
7624688|NCT02339246|18774284|P1|STARTED|Third Period (7 Days)||15
7624689|NCT02339246|18774282|P3|NOT COMPLETED|Second Intervention (7 Days)||0
7624690|NCT02339246|18774283|P2|NOT COMPLETED|Second Intervention (7 Days)||0
7624691|NCT02339246|18774284|P1|NOT COMPLETED|Second Intervention (7 Days)||0
7624692|NCT02339246|18774282|P3|COMPLETED|Second Intervention (7 Days)||0
7624693|NCT02339246|18774283|P2|COMPLETED|Second Intervention (7 Days)||15
7624694|NCT02339246|18774284|P1|COMPLETED|Second Intervention (7 Days)||16
7624695|NCT02339246|18774282|P3|STARTED|Second Intervention (7 Days)||0
7624696|NCT02339246|18774283|P2|STARTED|Second Intervention (7 Days)||15
7624697|NCT02339246|18774284|P1|STARTED|Second Intervention (7 Days)||16
7624698|NCT02339246|18774282|P3|NOT COMPLETED|First Intervention (7 Days)||0
7624699|NCT02339246|18774283|P2|NOT COMPLETED|First Intervention (7 Days)||0
7624700|NCT02339246|18774284|P1|NOT COMPLETED|First Intervention (7 Days)||0
7624701|NCT02339246|18774282|P3|COMPLETED|First Intervention (7 Days)||31
7624702|NCT02339246|18774283|P2|COMPLETED|First Intervention (7 Days)||0
7624703|NCT02339246|18774284|P1|COMPLETED|First Intervention (7 Days)||0
7624704|NCT02339246|18774282|P3|STARTED|First Intervention (7 Days)||31
7624705|NCT02339246|18774283|P2|STARTED|First Intervention (7 Days)||0
7624706|NCT02339246|18774284|P1|STARTED|First Intervention (7 Days)||0
7624707|NCT02339155|18774300|P2|NOT COMPLETED|Overall Study||21
7624708|NCT02339155|18774301|P1|NOT COMPLETED|Overall Study||15
7624709|NCT02339155|18774300|P2|COMPLETED|Overall Study||266
7624710|NCT02339155|18774301|P1|COMPLETED|Overall Study||271
7624711|NCT02339155|18774300|P2|Received Study Treatment|Overall Study||281
7624712|NCT02339155|18774301|P1|Received Study Treatment|Overall Study||285
7624713|NCT02339155|18774300|P2|STARTED|Overall Study||287
7624714|NCT02339155|18774301|P1|STARTED|Overall Study||286
7624715|NCT02339038|18774327|P1|NOT COMPLETED|Overall Study||600
7624716|NCT02339038|18774327|P1|COMPLETED|Overall Study||0
7624717|NCT02339038|18774327|P1|STARTED|Overall Study||600
7624718|NCT02338973|18774331|P1|NOT COMPLETED|Overall Study||0
7624719|NCT02338973|18774331|P1|COMPLETED|Overall Study||4
7624720|NCT02338973|18774331|P1|Enhanced S-Cone Syndrome (ESCS)|Overall Study||2
7624721|NCT02338973|18774331|P1|Rod-cone Dystrophy (RCD)|Overall Study||2
7624722|NCT02338973|18774331|P1|STARTED|Overall Study||4
7624723|NCT02338882|18774507|P2|NOT COMPLETED|Overall Study||3
7624724|NCT02338882|18774508|P1|NOT COMPLETED|Overall Study||7
7624725|NCT02338882|18774507|P2|COMPLETED|Overall Study||47
7624726|NCT02338882|18774508|P1|COMPLETED|Overall Study||43
7624727|NCT02338882|18774507|P2|STARTED|Overall Study||50
7624728|NCT02338882|18774508|P1|STARTED|Overall Study||50
7624729|NCT02338843|18774546|P2|NOT COMPLETED|Overall Study||58
7624730|NCT02338843|18774547|P1|NOT COMPLETED|Overall Study||44
7624731|NCT02338843|18774546|P2|COMPLETED|Overall Study||100
7624732|NCT02338843|18774547|P1|COMPLETED|Overall Study||119
7624733|NCT02338843|18774546|P2|STARTED|Overall Study||158
7624734|NCT02338843|18774547|P1|STARTED|Overall Study||163
7624735|NCT02338713|18774553|P1|NOT COMPLETED|Overall Study||0
7624736|NCT02338713|18774553|P1|COMPLETED|Overall Study||27
7624737|NCT02338713|18774553|P1|STARTED|Overall Study||27
7624738|NCT02338492|18774575|P1|NOT COMPLETED|Overall Study||45
7624739|NCT02338492|18774575|P1|COMPLETED|Overall Study||36
7624740|NCT02338492|18774575|P1|Treatment Failure|Overall Study||2
7624741|NCT02338492|18774575|P1|Device Implanted|Overall Study||79
7624742|NCT02338492|18774575|P1|Enrolled|Overall Study||81
7624743|NCT02338492|18774575|P1|STARTED|Overall Study||81
7624744|NCT02338362|18774591|P2|NOT COMPLETED|Overall Study||1
7624745|NCT02338362|18774592|P1|NOT COMPLETED|Overall Study||1
7624746|NCT02338362|18774591|P2|COMPLETED|Overall Study||10
7624747|NCT02338362|18774592|P1|COMPLETED|Overall Study||10
7624748|NCT02338362|18774591|P2|STARTED|Overall Study||11
7624749|NCT02338362|18774592|P1|STARTED|Overall Study||11
7624750|NCT02338336|18774608|P4|NOT COMPLETED|Overall Study||0
7624751|NCT02338336|18774609|P3|NOT COMPLETED|Overall Study||0
7624752|NCT02338336|18774610|P2|NOT COMPLETED|Overall Study||0
7624753|NCT02338336|18774611|P1|NOT COMPLETED|Overall Study||2
7624754|NCT02338336|18774608|P4|COMPLETED|Overall Study||4
7624755|NCT02338336|18774609|P3|COMPLETED|Overall Study||7
7624756|NCT02338336|18774610|P2|COMPLETED|Overall Study||17
7624757|NCT02338336|18774611|P1|COMPLETED|Overall Study||24
7624758|NCT02338336|18774608|P4|STARTED|Overall Study||4
7624759|NCT02338336|18774609|P3|STARTED|Overall Study||7
7624760|NCT02338336|18774610|P2|STARTED|Overall Study||17
7624761|NCT02338336|18774611|P1|STARTED|Overall Study||26
7624762|NCT02338193|18774622|P3|NOT COMPLETED|Overall Study||10
7624763|NCT02338193|18774623|P2|NOT COMPLETED|Overall Study||4
7624764|NCT02338193|18774624|P1|NOT COMPLETED|Overall Study||3
7624765|NCT02338193|18774622|P3|COMPLETED|Overall Study||15
7624766|NCT02338193|18774623|P2|COMPLETED|Overall Study||17
7624767|NCT02338193|18774624|P1|COMPLETED|Overall Study||17
7624768|NCT02338193|18774622|P3|STARTED|Overall Study||25
7624769|NCT02338193|18774623|P2|STARTED|Overall Study||21
7624770|NCT02338193|18774624|P1|STARTED|Overall Study||20
7624771|NCT02338154|18774677|P1|NOT COMPLETED|Overall Study||143
7624772|NCT02338154|18774677|P1|COMPLETED|Overall Study||373
7624773|NCT02338154|18774677|P1|INTUITY (Study Valve Cohort)|Overall Study||493
7624774|NCT02338154|18774677|P1|Enrolled Cohort (Intent to Treat)|Overall Study||516
7624775|NCT02338154|18774677|P1|STARTED|Overall Study||516
7624776|NCT02338076|18774773|P1|NOT COMPLETED|Overall Study||0
7624777|NCT02338076|18774773|P1|COMPLETED|Overall Study||20
7624778|NCT02338076|18774773|P1|STARTED|Overall Study||20
7624779|NCT02337959|18774791|P3|NOT COMPLETED|Overall Study||0
7624780|NCT02337959|18774792|P2|NOT COMPLETED|Overall Study||3
7624781|NCT02337959|18774793|P1|NOT COMPLETED|Overall Study||0
7624782|NCT02337959|18774791|P3|COMPLETED|Overall Study||7
7624783|NCT02337959|18774792|P2|COMPLETED|Overall Study||7
7624784|NCT02337959|18774793|P1|COMPLETED|Overall Study||10
7624785|NCT02337959|18774791|P3|STARTED|Overall Study||7
7624786|NCT02337959|18774792|P2|STARTED|Overall Study||10
7624787|NCT02337959|18774793|P1|STARTED|Overall Study||10
7624788|NCT02337946|18774801|P3|NOT COMPLETED|Protocol Treatment 2 Period||50
7624789|NCT02337946|18774802|P2|NOT COMPLETED|Protocol Treatment 2 Period||51
7624790|NCT02337946|18774803|P1|NOT COMPLETED|Protocol Treatment 2 Period||0
7624791|NCT02337946|18774801|P3|COMPLETED|Protocol Treatment 2 Period||7
7624792|NCT02337946|18774802|P2|COMPLETED|Protocol Treatment 2 Period||5
7624793|NCT02337946|18774803|P1|COMPLETED|Protocol Treatment 2 Period||0
7624794|NCT02337946|18774801|P3|Safety Population|Protocol Treatment 2 Period||54
7624795|NCT02337946|18774802|P2|Safety Population|Protocol Treatment 2 Period||56
7624796|NCT02337946|18774803|P1|Safety Population|Protocol Treatment 2 Period||0
7624797|NCT02337946|18774801|P3|STARTED|Protocol Treatment 2 Period||57
7624798|NCT02337946|18774802|P2|STARTED|Protocol Treatment 2 Period||56
7624799|NCT02337946|18774803|P1|STARTED|Protocol Treatment 2 Period||0
7624800|NCT02337946|18774801|P3|NOT COMPLETED|In-between Period||0
7624801|NCT02337946|18774802|P2|NOT COMPLETED|In-between Period||0
7624802|NCT02337946|18774803|P1|NOT COMPLETED|In-between Period||1
7624803|NCT02337946|18774801|P3|COMPLETED|In-between Period||0
7624804|NCT02337946|18774802|P2|COMPLETED|In-between Period||0
7624805|NCT02337946|18774803|P1|COMPLETED|In-between Period||113
7624806|NCT02337946|18774801|P3|STARTED|In-between Period||0
7624807|NCT02337946|18774802|P2|STARTED|In-between Period||0
7624808|NCT02337946|18774803|P1|STARTED|In-between Period||114
7624809|NCT02337946|18774801|P3|NOT COMPLETED|Protocol Treatment 1 Period||0
7624810|NCT02337946|18774802|P2|NOT COMPLETED|Protocol Treatment 1 Period||0
7624811|NCT02337946|18774803|P1|NOT COMPLETED|Protocol Treatment 1 Period||50
7624812|NCT02337946|18774801|P3|COMPLETED|Protocol Treatment 1 Period||0
7624813|NCT02337946|18774802|P2|COMPLETED|Protocol Treatment 1 Period||0
7624814|NCT02337946|18774803|P1|COMPLETED|Protocol Treatment 1 Period||114
7624815|NCT02337946|18774801|P3|STARTED|Protocol Treatment 1 Period||0
7624816|NCT02337946|18774802|P2|STARTED|Protocol Treatment 1 Period||0
7624817|NCT02337946|18774803|P1|STARTED|Protocol Treatment 1 Period||164
7624818|NCT02337933|18774827|P2|NOT COMPLETED|Overall Study||0
7624819|NCT02337933|18774828|P1|NOT COMPLETED|Overall Study||0
7624820|NCT02337933|18774827|P2|COMPLETED|Overall Study||12
7624821|NCT02337933|18774828|P1|COMPLETED|Overall Study||12
7624822|NCT02337933|18774827|P2|STARTED|Overall Study||12
7624823|NCT02337933|18774828|P1|STARTED|Overall Study||12
7624824|NCT02337907|18774864|P6|NOT COMPLETED|Overall Study||1
7624825|NCT02337907|18774865|P5|NOT COMPLETED|Overall Study||10
7624826|NCT02337907|18774866|P4|NOT COMPLETED|Overall Study||4
7624827|NCT02337907|18774867|P3|NOT COMPLETED|Overall Study||1
7624828|NCT02337907|18774868|P2|NOT COMPLETED|Overall Study||4
7624829|NCT02337907|18774869|P1|NOT COMPLETED|Overall Study||4
7624830|NCT02337907|18774864|P6|COMPLETED|Overall Study||4
7624831|NCT02337907|18774865|P5|COMPLETED|Overall Study||96
7624832|NCT02337907|18774866|P4|COMPLETED|Overall Study||51
7624833|NCT02337907|18774867|P3|COMPLETED|Overall Study||54
7624834|NCT02337907|18774868|P2|COMPLETED|Overall Study||49
7624835|NCT02337907|18774869|P1|COMPLETED|Overall Study||51
7624836|NCT02337907|18774864|P6|STARTED|Overall Study||5
7624837|NCT02337907|18774865|P5|STARTED|Overall Study||106
7624838|NCT02337907|18774866|P4|STARTED|Overall Study||55
7624839|NCT02337907|18774867|P3|STARTED|Overall Study||55
7624840|NCT02337907|18774868|P2|STARTED|Overall Study||53
7624841|NCT02337907|18774869|P1|STARTED|Overall Study||55
7624842|NCT02337764|18774904|P1|NOT COMPLETED|Overall Study||60
7624843|NCT02337764|18774904|P1|COMPLETED|Overall Study||162
7624844|NCT02337764|18774904|P1|STARTED|Overall Study||222
7624845|NCT02337751|18774917|P2|NOT COMPLETED|Overall Study||16
7624846|NCT02337751|18774918|P1|NOT COMPLETED|Overall Study||11
7624847|NCT02337751|18774917|P2|COMPLETED|Overall Study||87
7624848|NCT02337751|18774918|P1|COMPLETED|Overall Study||84
7624849|NCT02337751|18774917|P2|STARTED|Overall Study||103
7624850|NCT02337751|18774918|P1|STARTED|Overall Study||95
7624851|NCT02337738|18774937|P3|NOT COMPLETED|Overall Study||26
7624852|NCT02337738|18774938|P2|NOT COMPLETED|Overall Study||30
7624853|NCT02337738|18774939|P1|NOT COMPLETED|Overall Study||22
7624854|NCT02337738|18774937|P3|COMPLETED|Overall Study||103
7624855|NCT02337738|18774938|P2|COMPLETED|Overall Study||104
7624856|NCT02337738|18774939|P1|COMPLETED|Overall Study||119
7624857|NCT02337738|18774937|P3|STARTED|Overall Study||129
7624858|NCT02337738|18774938|P2|STARTED|Overall Study||134
7624859|NCT02337738|18774939|P1|STARTED|Overall Study||141
7624860|NCT02337725|18774979|P2|NOT COMPLETED|Overall Study||8
7624861|NCT02337725|18774980|P1|NOT COMPLETED|Overall Study||26
7624862|NCT02337725|18774979|P2|COMPLETED|Overall Study||110
7624863|NCT02337725|18774980|P1|COMPLETED|Overall Study||100
7624864|NCT02337725|18774979|P2|STARTED|Overall Study||118
7624865|NCT02337725|18774980|P1|STARTED|Overall Study||126
7624866|NCT02337491|18775004|P2|NOT COMPLETED|Overall Study||30
7624867|NCT02337491|18775005|P1|NOT COMPLETED|Overall Study||50
7624868|NCT02337491|18775004|P2|COMPLETED|Overall Study||0
7624869|NCT02337491|18775005|P1|COMPLETED|Overall Study||0
7624870|NCT02337491|18775004|P2|STARTED|Overall Study||30
7624871|NCT02337491|18775005|P1|STARTED|Overall Study||50
7624872|NCT02337478|18775019|P1|NOT COMPLETED|Overall Study||5
7624873|NCT02337478|18775019|P1|COMPLETED|Overall Study||0
7624874|NCT02337478|18775019|P1|STARTED|Overall Study||5
7624875|NCT02337387|18775029|P4|NOT COMPLETED|Overall Study||3
7624876|NCT02337387|18775030|P3|NOT COMPLETED|Overall Study||3
7624877|NCT02337387|18775031|P2|NOT COMPLETED|Overall Study||8
7624878|NCT02337387|18775032|P1|NOT COMPLETED|Overall Study||14
7624879|NCT02337387|18775029|P4|COMPLETED|Overall Study||0
7624880|NCT02337387|18775030|P3|COMPLETED|Overall Study||0
7624881|NCT02337387|18775031|P2|COMPLETED|Overall Study||0
7624882|NCT02337387|18775032|P1|COMPLETED|Overall Study||0
7624883|NCT02337387|18775029|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
7624884|NCT02337387|18775030|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
7624885|NCT02337387|18775031|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
7624886|NCT02337387|18775032|P1|Received at Least 1 Dose of Study Drug|Overall Study||14
7624887|NCT02337387|18775029|P4|STARTED|Overall Study||3
7624888|NCT02337387|18775030|P3|STARTED|Overall Study||3
7624889|NCT02337387|18775031|P2|STARTED|Overall Study||8
7624890|NCT02337387|18775032|P1|STARTED|Overall Study||14
7624891|NCT02337361|18775050|P2|NOT COMPLETED|6-month Follow-up||4
7624892|NCT02337361|18775051|P1|NOT COMPLETED|6-month Follow-up||2
7624893|NCT02337361|18775050|P2|COMPLETED|6-month Follow-up||68
7624894|NCT02337361|18775051|P1|COMPLETED|6-month Follow-up||78
7624895|NCT02337361|18775050|P2|STARTED|6-month Follow-up||72
7624896|NCT02337361|18775051|P1|STARTED|6-month Follow-up||80
7624897|NCT02337361|18775050|P2|NOT COMPLETED|3-month Follow-up||14
7624898|NCT02337361|18775051|P1|NOT COMPLETED|3-month Follow-up||19
7624899|NCT02337361|18775050|P2|COMPLETED|3-month Follow-up||72
7624900|NCT02337361|18775051|P1|COMPLETED|3-month Follow-up||80
7624901|NCT02337361|18775050|P2|STARTED|3-month Follow-up||86
7624902|NCT02337361|18775051|P1|STARTED|3-month Follow-up||99
7624903|NCT02337361|18775050|P2|NOT COMPLETED|Baseline Assessment||0
7624904|NCT02337361|18775051|P1|NOT COMPLETED|Baseline Assessment||0
7624905|NCT02337361|18775050|P2|COMPLETED|Baseline Assessment||86
7624906|NCT02337361|18775051|P1|COMPLETED|Baseline Assessment||99
7624907|NCT02337361|18775050|P2|STARTED|Baseline Assessment||86
7624908|NCT02337361|18775051|P1|STARTED|Baseline Assessment||99
7624909|NCT02337218|18775071|P2|NOT COMPLETED|Overall Study||0
7624910|NCT02337218|18775072|P1|NOT COMPLETED|Overall Study||0
7624911|NCT02337218|18775071|P2|COMPLETED|Overall Study||11
7624912|NCT02337218|18775072|P1|COMPLETED|Overall Study||17
7624913|NCT02337218|18775071|P2|STARTED|Overall Study||11
7624914|NCT02337218|18775072|P1|STARTED|Overall Study||17
7624915|NCT02337062|18775084|P2|NOT COMPLETED|Overall Study||19
7624916|NCT02337062|18775085|P1|NOT COMPLETED|Overall Study||17
7624917|NCT02337062|18775084|P2|COMPLETED|Overall Study||556
7624918|NCT02337062|18775085|P1|COMPLETED|Overall Study||555
7624919|NCT02337062|18775084|P2|STARTED|Overall Study||575
7624920|NCT02337062|18775085|P1|STARTED|Overall Study||572
7624921|NCT02336958|18775103|P2|NOT COMPLETED|Overall Study||0
7624922|NCT02336958|18775104|P1|NOT COMPLETED|Overall Study||0
7624923|NCT02336958|18775103|P2|COMPLETED|Overall Study||20
7624924|NCT02336958|18775104|P1|COMPLETED|Overall Study||20
7624925|NCT02336958|18775103|P2|STARTED|Overall Study||20
7624926|NCT02336958|18775104|P1|STARTED|Overall Study||20
7624927|NCT02336815|18775114|P2|NOT COMPLETED|Overall Study||123
7624928|NCT02336815|18775115|P1|NOT COMPLETED|Overall Study||79
7624929|NCT02336815|18775114|P2|COMPLETED|Overall Study||0
7624930|NCT02336815|18775115|P1|COMPLETED|Overall Study||0
7624931|NCT02336815|18775114|P2|STARTED|Overall Study||123
7624932|NCT02336815|18775115|P1|STARTED|Overall Study||79
7624933|NCT02336763|18775142|P1|NOT COMPLETED|Overall Study||0
7624934|NCT02336763|18775142|P1|COMPLETED|Overall Study||2
7624935|NCT02336763|18775142|P1|STARTED|Overall Study||2
7624936|NCT02336737|18775152|P1|NOT COMPLETED|Overall Study||13
7624937|NCT02336737|18775152|P1|COMPLETED|Overall Study||147
7624938|NCT02336737|18775152|P1|STARTED|Overall Study||160
7624939|NCT02336607|18775163|P4|NOT COMPLETED|Overall Study||87
7624940|NCT02336607|18775164|P3|NOT COMPLETED|Overall Study||6
7624941|NCT02336607|18775165|P2|NOT COMPLETED|Overall Study||10
7624942|NCT02336607|18775166|P1|NOT COMPLETED|Overall Study||4
7624943|NCT02336607|18775163|P4|COMPLETED|Overall Study||180
7624944|NCT02336607|18775164|P3|COMPLETED|Overall Study||86
7624945|NCT02336607|18775165|P2|COMPLETED|Overall Study||75
7624946|NCT02336607|18775166|P1|COMPLETED|Overall Study||81
7624947|NCT02336607|18775163|P4|Patients Included in Safety Population|Overall Study||260
7624948|NCT02336607|18775164|P3|Patients Included in Safety Population|Overall Study||92
7624949|NCT02336607|18775165|P2|Patients Included in Safety Population|Overall Study||85
7624950|NCT02336607|18775166|P1|Patients Included in Safety Population|Overall Study||85
7624951|NCT02336607|18775163|P4|Patients Included in PP Population|Overall Study||162
7624952|NCT02336607|18775164|P3|Patients Included in PP Population|Overall Study||75
7624953|NCT02336607|18775165|P2|Patients Included in PP Population|Overall Study||75
7624954|NCT02336607|18775166|P1|Patients Included in PP Population|Overall Study||78
7624955|NCT02336607|18775163|P4|Patients Included in ITT Population|Overall Study||222
7624956|NCT02336607|18775164|P3|Patients Included in ITT Population|Overall Study||91
7624957|NCT02336607|18775165|P2|Patients Included in ITT Population|Overall Study||84
7624958|NCT02336607|18775166|P1|Patients Included in ITT Population|Overall Study||84
7624959|NCT02336607|18775163|P4|STARTED|Overall Study||267
7624960|NCT02336607|18775164|P3|STARTED|Overall Study||92
7624961|NCT02336607|18775165|P2|STARTED|Overall Study||85
7624962|NCT02336607|18775166|P1|STARTED|Overall Study||85
7624963|NCT02336594|18775224|P4|NOT COMPLETED|Overall Study||0
7624964|NCT02336594|18775225|P3|NOT COMPLETED|Overall Study||0
7624965|NCT02336594|18775226|P2|NOT COMPLETED|Overall Study||0
7624966|NCT02336594|18775227|P1|NOT COMPLETED|Overall Study||0
7624967|NCT02336594|18775224|P4|COMPLETED|Overall Study||4
7624968|NCT02336594|18775225|P3|COMPLETED|Overall Study||4
7624969|NCT02336594|18775226|P2|COMPLETED|Overall Study||4
7624970|NCT02336594|18775227|P1|COMPLETED|Overall Study||3
7624971|NCT02336594|18775224|P4|STARTED|Overall Study||4
7624972|NCT02336594|18775225|P3|STARTED|Overall Study||4
7624973|NCT02336594|18775226|P2|STARTED|Overall Study||4
7624974|NCT02336594|18775227|P1|STARTED|Overall Study||3
7624975|NCT02336555|18775269|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||1
7624976|NCT02336555|18775270|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7624977|NCT02336555|18775269|P2|COMPLETED|Treatment Period 2 (28 Days)||15
7624978|NCT02336555|18775270|P1|COMPLETED|Treatment Period 2 (28 Days)||16
7624979|NCT02336555|18775269|P2|STARTED|Treatment Period 2 (28 Days)||16
7624980|NCT02336555|18775270|P1|STARTED|Treatment Period 2 (28 Days)||16
7624981|NCT02336555|18775269|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||1
7624982|NCT02336555|18775270|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||2
7624983|NCT02336555|18775269|P2|COMPLETED|Treatment Period 1 (28 Days)||16
7624984|NCT02336555|18775270|P1|COMPLETED|Treatment Period 1 (28 Days)||16
7624985|NCT02336555|18775269|P2|STARTED|Treatment Period 1 (28 Days)||17
7624986|NCT02336555|18775270|P1|STARTED|Treatment Period 1 (28 Days)||18
7624987|NCT02336451|18775283|P5|NOT COMPLETED|Overall Study||18
7624988|NCT02336451|18775284|P4|NOT COMPLETED|Overall Study||44
7624989|NCT02336451|18775285|P3|NOT COMPLETED|Overall Study||12
7624990|NCT02336451|18775286|P2|NOT COMPLETED|Overall Study||40
7624991|NCT02336451|18775287|P1|NOT COMPLETED|Overall Study||42
7624992|NCT02336451|18775283|P5|COMPLETED|Overall Study||0
7624993|NCT02336451|18775284|P4|COMPLETED|Overall Study||0
7624994|NCT02336451|18775285|P3|COMPLETED|Overall Study||0
7624995|NCT02336451|18775286|P2|COMPLETED|Overall Study||0
7624996|NCT02336451|18775287|P1|COMPLETED|Overall Study||0
7624997|NCT02336451|18775283|P5|STARTED|Overall Study||18
7624998|NCT02336451|18775284|P4|STARTED|Overall Study||44
7624999|NCT02336451|18775285|P3|STARTED|Overall Study||12
7625000|NCT02336451|18775286|P2|STARTED|Overall Study||40
7625001|NCT02336451|18775287|P1|STARTED|Overall Study||42
7625002|NCT02336438|18775431|P1|NOT COMPLETED|Overall Study||1
7625003|NCT02336438|18775431|P1|COMPLETED|Overall Study||10
7625004|NCT02336438|18775431|P1|STARTED|Overall Study||11
7625005|NCT02336425|18775444|P4|NOT COMPLETED|Overall Study||3
7625006|NCT02336425|18775445|P3|NOT COMPLETED|Overall Study||3
7625007|NCT02336425|18775446|P2|NOT COMPLETED|Overall Study||2
7625008|NCT02336425|18775447|P1|NOT COMPLETED|Overall Study||2
7625009|NCT02336425|18775444|P4|COMPLETED|Overall Study||0
7625010|NCT02336425|18775445|P3|COMPLETED|Overall Study||0
7625011|NCT02336425|18775446|P2|COMPLETED|Overall Study||0
7625012|NCT02336425|18775447|P1|COMPLETED|Overall Study||0
7625013|NCT02336425|18775444|P4|STARTED|Overall Study||3
7625014|NCT02336425|18775445|P3|STARTED|Overall Study||3
7625015|NCT02336425|18775446|P2|STARTED|Overall Study||2
7625016|NCT02336425|18775447|P1|STARTED|Overall Study||2
7625017|NCT02336373|18775497|P1|NOT COMPLETED|Overall Study||18
7625018|NCT02336373|18775497|P1|COMPLETED|Overall Study||14
7625019|NCT02336373|18775497|P1|STARTED|Overall Study||32
7625020|NCT02336360|18775512|P1|NOT COMPLETED|Overall Study||0
7625021|NCT02336360|18775512|P1|COMPLETED|Overall Study||6
7625022|NCT02336360|18775512|P1|STARTED|Overall Study||6
7625023|NCT02336282|18775516|P1|NOT COMPLETED|Overall Study||5
7625024|NCT02336282|18775516|P1|COMPLETED|Overall Study||28
7625025|NCT02336282|18775516|P1|STARTED|Overall Study||33
7625026|NCT02336178|18775540|P1|NOT COMPLETED|Overall Study||4
7625027|NCT02336178|18775540|P1|COMPLETED|Overall Study||66
7625028|NCT02336178|18775540|P1|STARTED|Overall Study||70
7625029|NCT02336165|18775631|P5|NOT COMPLETED|Overall Study||22
7625030|NCT02336165|18775632|P4|NOT COMPLETED|Overall Study||31
7625031|NCT02336165|18775633|P3|NOT COMPLETED|Overall Study||31
7625032|NCT02336165|18775634|P2|NOT COMPLETED|Overall Study||25
7625033|NCT02336165|18775635|P1|NOT COMPLETED|Overall Study||34
7625034|NCT02336165|18775631|P5|COMPLETED|Overall Study||0
7625035|NCT02336165|18775632|P4|COMPLETED|Overall Study||2
7625036|NCT02336165|18775633|P3|COMPLETED|Overall Study||2
7625037|NCT02336165|18775634|P2|COMPLETED|Overall Study||6
7625038|NCT02336165|18775635|P1|COMPLETED|Overall Study||6
7625039|NCT02336165|18775631|P5|STARTED|Overall Study||22
7625040|NCT02336165|18775632|P4|STARTED|Overall Study||33
7625041|NCT02336165|18775633|P3|STARTED|Overall Study||33
7625042|NCT02336165|18775634|P2|STARTED|Overall Study||31
7625043|NCT02336165|18775635|P1|STARTED|Overall Study||40
7625044|NCT02336074|18775669|P2|NOT COMPLETED|Overall Study||2
7625045|NCT02336074|18775670|P1|NOT COMPLETED|Overall Study||0
7625046|NCT02336074|18775669|P2|COMPLETED|Overall Study||28
7625047|NCT02336074|18775670|P1|COMPLETED|Overall Study||30
7625048|NCT02336074|18775669|P2|STARTED|Overall Study||30
7625049|NCT02336074|18775670|P1|STARTED|Overall Study||30
7625050|NCT02335983|18775693|P6|NOT COMPLETED|Overall Study||32
7625051|NCT02335983|18775694|P5|NOT COMPLETED|Overall Study||8
7625052|NCT02335983|18775695|P4|NOT COMPLETED|Overall Study||9
7625053|NCT02335983|18775696|P3|NOT COMPLETED|Overall Study||32
7625054|NCT02335983|18775697|P2|NOT COMPLETED|Overall Study||9
7625055|NCT02335983|18775698|P1|NOT COMPLETED|Overall Study||8
7625056|NCT02335983|18775693|P6|COMPLETED|Overall Study||1
7625057|NCT02335983|18775694|P5|COMPLETED|Overall Study||1
7625058|NCT02335983|18775695|P4|COMPLETED|Overall Study||0
7625059|NCT02335983|18775696|P3|COMPLETED|Overall Study||2
7625060|NCT02335983|18775697|P2|COMPLETED|Overall Study||3
7625061|NCT02335983|18775698|P1|COMPLETED|Overall Study||2
7625062|NCT02335983|18775693|P6|STARTED|Overall Study||33
7625063|NCT02335983|18775694|P5|STARTED|Overall Study||9
7625064|NCT02335983|18775695|P4|STARTED|Overall Study||9
7625065|NCT02335983|18775696|P3|STARTED|Overall Study||34
7625066|NCT02335983|18775697|P2|STARTED|Overall Study||12
7625067|NCT02335983|18775698|P1|STARTED|Overall Study||10
7625068|NCT02335710|18775782|P2|NOT COMPLETED|Overall Study||0
7625069|NCT02335710|18775783|P1|NOT COMPLETED|Overall Study||0
7625070|NCT02335710|18775782|P2|COMPLETED|Overall Study||10
7625071|NCT02335710|18775783|P1|COMPLETED|Overall Study||40
7625072|NCT02335710|18775782|P2|STARTED|Overall Study||10
7625073|NCT02335710|18775783|P1|STARTED|Overall Study||40
7625074|NCT02335658|18775805|P2|NOT COMPLETED|Overall Study||44
7625075|NCT02335658|18775806|P1|NOT COMPLETED|Overall Study||40
7625076|NCT02335658|18775805|P2|COMPLETED|Overall Study||59
7625077|NCT02335658|18775806|P1|COMPLETED|Overall Study|57 subjects in Cohort 1 and 59 subjects in Cohort 2 completed the study.|57
7625078|NCT02335658|18775805|P2|STARTED|Overall Study||103
7625079|NCT02335658|18775806|P1|STARTED|Overall Study|97 subjects in Cohort 1 and 103 subjects in Cohort 2 started to receive DSP-5423P.|97
7625080|NCT02335502|18775816|P1|NOT COMPLETED|Overall Study||17
7625081|NCT02335502|18775816|P1|COMPLETED|Overall Study||49
7625082|NCT02335502|18775816|P1|Receiving Permanent System|Overall Study||56
7625083|NCT02335502|18775816|P1|Received Trial System|Overall Study||65
7625084|NCT02335502|18775816|P1|STARTED|Overall Study||66
7625085|NCT02335489|18775821|P1|NOT COMPLETED|Overall Study||10
7625086|NCT02335489|18775821|P1|COMPLETED|Overall Study||0
7625087|NCT02335489|18775821|P1|Receiving Permanent System|Overall Study||8
7625088|NCT02335489|18775821|P1|Received Trial System|Overall Study||9
7625089|NCT02335489|18775821|P1|STARTED|Overall Study||10
7625090|NCT02335450|18775825|P1|NOT COMPLETED|Overall Study||1
7625091|NCT02335450|18775825|P1|COMPLETED|Overall Study||4
7625092|NCT02335450|18775825|P1|STARTED|Overall Study||5
7625093|NCT02335424|18775829|P1|NOT COMPLETED|Overall Study||374
7625094|NCT02335424|18775829|P1|COMPLETED|Overall Study||0
7625095|NCT02335424|18775829|P1|Treated|Overall Study||370
7625096|NCT02335424|18775829|P1|STARTED|Overall Study||374
7625097|NCT02335346|18775862|P1|NOT COMPLETED|Overall Study||12
7625098|NCT02335346|18775862|P1|COMPLETED|Overall Study||81
7625099|NCT02335346|18775862|P1|Received At Least 1 Dose of Study Drug|Overall Study||93
7625100|NCT02335346|18775862|P1|STARTED|Overall Study||93
7625101|NCT02335294|18775880|P6|NOT COMPLETED|Overall Study||1
7625102|NCT02335294|18775881|P5|NOT COMPLETED|Overall Study||2
7625103|NCT02335294|18775882|P4|NOT COMPLETED|Overall Study||3
7625104|NCT02335294|18775883|P3|NOT COMPLETED|Overall Study||1
7625105|NCT02335294|18775884|P2|NOT COMPLETED|Overall Study||4
7625106|NCT02335294|18775885|P1|NOT COMPLETED|Overall Study||3
7625107|NCT02335294|18775880|P6|COMPLETED|Overall Study||19
7625108|NCT02335294|18775881|P5|COMPLETED|Overall Study||39
7625109|NCT02335294|18775882|P4|COMPLETED|Overall Study||36
7625110|NCT02335294|18775883|P3|COMPLETED|Overall Study||18
7625111|NCT02335294|18775884|P2|COMPLETED|Overall Study||38
7625112|NCT02335294|18775885|P1|COMPLETED|Overall Study||36
7625113|NCT02335294|18775880|P6|STARTED|Overall Study||20
7625114|NCT02335294|18775881|P5|STARTED|Overall Study||41
7625115|NCT02335294|18775882|P4|STARTED|Overall Study||39
7625116|NCT02335294|18775883|P3|STARTED|Overall Study||19
7625117|NCT02335294|18775884|P2|STARTED|Overall Study||42
7625118|NCT02335294|18775885|P1|STARTED|Overall Study||39
7625119|NCT02335229|18775901|P1|NOT COMPLETED|Overall Study||7
7625120|NCT02335229|18775901|P1|COMPLETED|Overall Study||23
7625121|NCT02335229|18775901|P1|Received Permanent System|Overall Study||26
7625122|NCT02335229|18775901|P1|Received Trial System|Overall Study||10
7625123|NCT02335229|18775901|P1|STARTED|Overall Study||30
7625124|NCT02335216|18775906|P1|NOT COMPLETED|Overall Study||13
7625125|NCT02335216|18775906|P1|COMPLETED|Overall Study||9
7625126|NCT02335216|18775906|P1|Received Permanent System|Overall Study||13
7625127|NCT02335216|18775906|P1|Received Trial System|Overall Study||16
7625128|NCT02335216|18775906|P1|STARTED|Overall Study||22
7625129|NCT02335125|18775913|P2|NOT COMPLETED|Overall Study||0
7625130|NCT02335125|18775914|P1|NOT COMPLETED|Overall Study||0
7625131|NCT02335125|18775913|P2|COMPLETED|Overall Study||20
7625132|NCT02335125|18775914|P1|COMPLETED|Overall Study||20
7625133|NCT02335125|18775913|P2|STARTED|Overall Study||20
7625134|NCT02335125|18775914|P1|STARTED|Overall Study||20
7625135|NCT02334982|18775939|P7|NOT COMPLETED|Overall Study||0
7625136|NCT02334982|18775940|P6|NOT COMPLETED|Overall Study||0
7625137|NCT02334982|18775941|P5|NOT COMPLETED|Overall Study||0
7625138|NCT02334982|18775942|P4|NOT COMPLETED|Overall Study||0
7625139|NCT02334982|18775943|P3|NOT COMPLETED|Overall Study||0
7625140|NCT02334982|18775944|P2|NOT COMPLETED|Overall Study||0
7625141|NCT02334982|18775945|P1|NOT COMPLETED|Overall Study||0
7625142|NCT02334982|18775939|P7|COMPLETED|Overall Study||12
7625143|NCT02334982|18775940|P6|COMPLETED|Overall Study||6
7625144|NCT02334982|18775941|P5|COMPLETED|Overall Study||6
7625145|NCT02334982|18775942|P4|COMPLETED|Overall Study||6
7625146|NCT02334982|18775943|P3|COMPLETED|Overall Study||6
7625147|NCT02334982|18775944|P2|COMPLETED|Overall Study||5
7625148|NCT02334982|18775945|P1|COMPLETED|Overall Study||6
7625149|NCT02334982|18775939|P7|STARTED|Overall Study||12
7625150|NCT02334982|18775940|P6|STARTED|Overall Study||6
7625151|NCT02334982|18775941|P5|STARTED|Overall Study||6
7625152|NCT02334982|18775942|P4|STARTED|Overall Study||6
7625153|NCT02334982|18775943|P3|STARTED|Overall Study||6
7625154|NCT02334982|18775944|P2|STARTED|Overall Study||5
7625155|NCT02334982|18775945|P1|STARTED|Overall Study||6
7625156|NCT02334813|18776051|P2|NOT COMPLETED|Overall Study||1
7625157|NCT02334813|18776052|P1|NOT COMPLETED|Overall Study||3
7625158|NCT02334813|18776051|P2|COMPLETED|Overall Study||13
7625159|NCT02334813|18776052|P1|COMPLETED|Overall Study||9
7625160|NCT02334813|18776051|P2|STARTED|Overall Study||14
7625161|NCT02334813|18776052|P1|STARTED|Overall Study||12
7625162|NCT02334800|18776062|P4|NOT COMPLETED|Overall Study||0
7625163|NCT02334800|18776063|P3|NOT COMPLETED|Overall Study||0
7625164|NCT02334800|18776064|P2|NOT COMPLETED|Overall Study||0
7625165|NCT02334800|18776065|P1|NOT COMPLETED|Overall Study||0
7625166|NCT02334800|18776062|P4|COMPLETED|Overall Study||7
7625167|NCT02334800|18776063|P3|COMPLETED|Overall Study||7
7625168|NCT02334800|18776064|P2|COMPLETED|Overall Study||7
7625169|NCT02334800|18776065|P1|COMPLETED|Overall Study||7
7625170|NCT02334800|18776062|P4|Received Treatment|Overall Study||7
7625171|NCT02334800|18776063|P3|Received Treatment|Overall Study||7
7625172|NCT02334800|18776064|P2|Received Treatment|Overall Study||7
7625173|NCT02334800|18776065|P1|Received Treatment|Overall Study||7
7625174|NCT02334800|18776062|P4|STARTED|Overall Study||7
7625175|NCT02334800|18776063|P3|STARTED|Overall Study||7
7625176|NCT02334800|18776064|P2|STARTED|Overall Study||7
7625177|NCT02334800|18776065|P1|STARTED|Overall Study||7
7625178|NCT02334787|18776159|P4|NOT COMPLETED|Overall Study||0
7625179|NCT02334787|18776160|P3|NOT COMPLETED|Overall Study||0
7625180|NCT02334787|18776161|P2|NOT COMPLETED|Overall Study||0
7625181|NCT02334787|18776162|P1|NOT COMPLETED|Overall Study||0
7625182|NCT02334787|18776159|P4|COMPLETED|Overall Study||8
7625183|NCT02334787|18776160|P3|COMPLETED|Overall Study||8
7625184|NCT02334787|18776161|P2|COMPLETED|Overall Study||8
7625185|NCT02334787|18776162|P1|COMPLETED|Overall Study||8
7625186|NCT02334787|18776159|P4|STARTED|Overall Study||8
7625187|NCT02334787|18776160|P3|STARTED|Overall Study||8
7625188|NCT02334787|18776161|P2|STARTED|Overall Study||8
7625189|NCT02334787|18776162|P1|STARTED|Overall Study||8
7625190|NCT02334748|18776184|P1|NOT COMPLETED|Overall Study||8
7625191|NCT02334748|18776184|P1|COMPLETED|Overall Study||23
7625192|NCT02334748|18776184|P1|STARTED|Overall Study||31
7625193|NCT02334527|18776189|P1|NOT COMPLETED|Overall Study||0
7625194|NCT02334527|18776189|P1|COMPLETED|Overall Study||12
7625195|NCT02334527|18776189|P1|STARTED|Overall Study||12
7625196|NCT02334436|18776200|P2|NOT COMPLETED|Overall Study||1
7625197|NCT02334436|18776201|P1|NOT COMPLETED|Overall Study||9
7625198|NCT02334436|18776200|P2|COMPLETED|Overall Study||77
7625199|NCT02334436|18776201|P1|COMPLETED|Overall Study||237
7625200|NCT02334436|18776200|P2|STARTED|Overall Study||78
7625201|NCT02334436|18776201|P1|STARTED|Overall Study||246
7625202|NCT02334423|18776215|P2|NOT COMPLETED|Overall Study||3
7625203|NCT02334423|18776216|P1|NOT COMPLETED|Overall Study||10
7625204|NCT02334423|18776215|P2|COMPLETED|Overall Study||81
7625205|NCT02334423|18776216|P1|COMPLETED|Overall Study||236
7625206|NCT02334423|18776215|P2|STARTED|Overall Study||84
7625207|NCT02334423|18776216|P1|STARTED|Overall Study||246
7625208|NCT02334384|18776230|P2|NOT COMPLETED|Overall Study||1
7625209|NCT02334384|18776231|P1|NOT COMPLETED|Overall Study||1
7625210|NCT02334384|18776230|P2|COMPLETED|Overall Study||1
7625211|NCT02334384|18776231|P1|COMPLETED|Overall Study||3
7625212|NCT02334384|18776230|P2|STARTED|Overall Study||2
7625213|NCT02334384|18776231|P1|STARTED|Overall Study||4
7625214|NCT02334358|18776237|P1|NOT COMPLETED|Overall Study||9
7625215|NCT02334358|18776237|P1|COMPLETED|Overall Study||494
7625216|NCT02334358|18776237|P1|STARTED|Overall Study||503
7625217|NCT02334306|18776243|P2|NOT COMPLETED|Open-label Period||0
7625218|NCT02334306|18776244|P1|NOT COMPLETED|Open-label Period||0
7625219|NCT02334306|18776243|P2|COMPLETED|Open-label Period||14
7625220|NCT02334306|18776244|P1|COMPLETED|Open-label Period||15
7625221|NCT02334306|18776243|P2|STARTED|Open-label Period||14
7625222|NCT02334306|18776244|P1|STARTED|Open-label Period||15
7625223|NCT02334306|18776243|P2|NOT COMPLETED|Double-blind Period||2
7625224|NCT02334306|18776244|P1|NOT COMPLETED|Double-blind Period||1
7625225|NCT02334306|18776243|P2|COMPLETED|Double-blind Period||14
7625226|NCT02334306|18776244|P1|COMPLETED|Double-blind Period||15
7625227|NCT02334306|18776243|P2|STARTED|Double-blind Period||16
7625228|NCT02334306|18776244|P1|STARTED|Double-blind Period||16
7625229|NCT02334267|18776266|P2|NOT COMPLETED|Overall Study||0
7625230|NCT02334267|18776267|P1|NOT COMPLETED|Overall Study||1
7625231|NCT02334267|18776266|P2|COMPLETED|Overall Study||5
7625232|NCT02334267|18776267|P1|COMPLETED|Overall Study||5
7625233|NCT02334267|18776266|P2|STARTED|Overall Study||5
7625234|NCT02334267|18776267|P1|STARTED|Overall Study||6
7625235|NCT02334215|18776282|P3|NOT COMPLETED|Overall Study||15
7625236|NCT02334215|18776283|P2|NOT COMPLETED|Overall Study||6
7625237|NCT02334215|18776284|P1|NOT COMPLETED|Overall Study||7
7625238|NCT02334215|18776282|P3|COMPLETED|Overall Study||61
7625239|NCT02334215|18776283|P2|COMPLETED|Overall Study||68
7625240|NCT02334215|18776284|P1|COMPLETED|Overall Study||68
7625241|NCT02334215|18776282|P3|STARTED|Overall Study||76
7625242|NCT02334215|18776283|P2|STARTED|Overall Study||74
7625243|NCT02334215|18776284|P1|STARTED|Overall Study||75
7625244|NCT02334059|18776346|P3|NOT COMPLETED|Overall Study||0
7625245|NCT02334059|18776347|P2|NOT COMPLETED|Overall Study||0
7625246|NCT02334059|18776348|P1|NOT COMPLETED|Overall Study||0
7625247|NCT02334059|18776346|P3|COMPLETED|Overall Study||37
7625248|NCT02334059|18776347|P2|COMPLETED|Overall Study||34
7625249|NCT02334059|18776348|P1|COMPLETED|Overall Study||37
7625250|NCT02334059|18776346|P3|STARTED|Overall Study||37
7625251|NCT02334059|18776347|P2|STARTED|Overall Study||34
7625252|NCT02334059|18776348|P1|STARTED|Overall Study||37
7625253|NCT02333630|18776364|P2|NOT COMPLETED|Overall Study||2
7625254|NCT02333630|18776365|P1|NOT COMPLETED|Overall Study||5
7625255|NCT02333630|18776364|P2|COMPLETED|Overall Study||98
7625256|NCT02333630|18776365|P1|COMPLETED|Overall Study||95
7625257|NCT02333630|18776364|P2|STARTED|Overall Study||100
7625258|NCT02333630|18776365|P1|STARTED|Overall Study||100
7625259|NCT02333487|18776380|P3|NOT COMPLETED|Overall Study||0
7625260|NCT02333487|18776381|P2|NOT COMPLETED|Overall Study||2
7625261|NCT02333487|18776382|P1|NOT COMPLETED|Overall Study||0
7625262|NCT02333487|18776380|P3|COMPLETED|Overall Study||8
7625263|NCT02333487|18776381|P2|COMPLETED|Overall Study||6
7625264|NCT02333487|18776382|P1|COMPLETED|Overall Study||6
7625265|NCT02333487|18776380|P3|STARTED|Overall Study||8
7625266|NCT02333487|18776381|P2|STARTED|Overall Study||8
7625267|NCT02333487|18776382|P1|STARTED|Overall Study||6
7625268|NCT02333383|18776393|P1|NOT COMPLETED|Overall Study||41
7625269|NCT02333383|18776393|P1|COMPLETED|Overall Study||160
7625270|NCT02333383|18776393|P1|STARTED|Overall Study||201
7625271|NCT02333331|18776407|P4|NOT COMPLETED|Overall Study||3
7625272|NCT02333331|18776408|P3|NOT COMPLETED|Overall Study||18
7625273|NCT02333331|18776409|P2|NOT COMPLETED|Overall Study||6
7625274|NCT02333331|18776410|P1|NOT COMPLETED|Overall Study||2
7625275|NCT02333331|18776407|P4|COMPLETED|Overall Study||64
7625276|NCT02333331|18776408|P3|COMPLETED|Overall Study||95
7625277|NCT02333331|18776409|P2|COMPLETED|Overall Study||12
7625278|NCT02333331|18776410|P1|COMPLETED|Overall Study||17
7625279|NCT02333331|18776407|P4|STARTED|Overall Study||67
7625280|NCT02333331|18776408|P3|STARTED|Overall Study||113
7625281|NCT02333331|18776409|P2|STARTED|Overall Study||18
7625282|NCT02333331|18776410|P1|STARTED|Overall Study||19
7625283|NCT02333071|18776438|P2|NOT COMPLETED|Open Label Extension||75
7625284|NCT02333071|18776439|P1|NOT COMPLETED|Open Label Extension||144
7625285|NCT02333071|18776438|P2|COMPLETED|Open Label Extension||49
7625286|NCT02333071|18776439|P1|COMPLETED|Open Label Extension||95
7625287|NCT02333071|18776438|P2|STARTED|Open Label Extension||124
7625288|NCT02333071|18776439|P1|STARTED|Open Label Extension||239
7625289|NCT02333071|18776438|P2|NOT COMPLETED|Core Study||137
7625290|NCT02333071|18776439|P1|NOT COMPLETED|Core Study||52
7625291|NCT02333071|18776438|P2|COMPLETED|Core Study||190
7625292|NCT02333071|18776439|P1|COMPLETED|Core Study||274
7625293|NCT02333071|18776438|P2|Received Intervention|Core Study||324
7625294|NCT02333071|18776439|P1|Received Intervention|Core Study||319
7625295|NCT02333071|18776438|P2|STARTED|Core Study||327
7625296|NCT02333071|18776439|P1|STARTED|Core Study||326
7625297|NCT02333045|18776477|P2|NOT COMPLETED|Overall Study||0
7625298|NCT02333045|18776478|P1|NOT COMPLETED|Overall Study||0
7625299|NCT02333045|18776477|P2|COMPLETED|Overall Study||3
7625300|NCT02333045|18776478|P1|COMPLETED|Overall Study||1
7625301|NCT02333045|18776477|P2|STARTED|Overall Study||3
7625302|NCT02333045|18776478|P1|STARTED|Overall Study||1
7625303|NCT02332915|18776490|P2|NOT COMPLETED|Overall Study||6
7625304|NCT02332915|18776491|P1|NOT COMPLETED|Overall Study||6
7625305|NCT02332915|18776490|P2|COMPLETED|Overall Study||12
7625306|NCT02332915|18776491|P1|COMPLETED|Overall Study||12
7625307|NCT02332915|18776490|P2|STARTED|Overall Study||18
7625308|NCT02332915|18776491|P1|STARTED|Overall Study||18
7625309|NCT02332902|18776499|P1|NOT COMPLETED|Overall Study||7
7625310|NCT02332902|18776499|P1|COMPLETED|Overall Study||17
7625311|NCT02332902|18776499|P1|STARTED|Overall Study||24
7625312|NCT02332889|18776504|P1|NOT COMPLETED|Overall Study||1
7625313|NCT02332889|18776504|P1|COMPLETED|Overall Study||0
7625314|NCT02332889|18776504|P1|STARTED|Overall Study||1
7625315|NCT02332876|18776510|P2|NOT COMPLETED|Overall Study||1
7625316|NCT02332876|18776511|P1|NOT COMPLETED|Overall Study||1
7625317|NCT02332876|18776510|P2|COMPLETED|Overall Study||43
7625318|NCT02332876|18776511|P1|COMPLETED|Overall Study||42
7625319|NCT02332876|18776510|P2|STARTED|Overall Study||44
7625320|NCT02332876|18776511|P1|STARTED|Overall Study||43
7625321|NCT02332863|18776519|P2|NOT COMPLETED|Overall Study||0
7625322|NCT02332863|18776520|P1|NOT COMPLETED|Overall Study||0
7625323|NCT02332863|18776519|P2|COMPLETED|Overall Study||22
7625324|NCT02332863|18776520|P1|COMPLETED|Overall Study||22
7625325|NCT02332863|18776519|P2|STARTED|Overall Study||22
7625326|NCT02332863|18776520|P1|STARTED|Overall Study||22
7625327|NCT02332824|18776546|P6|NOT COMPLETED|Overall Study||1
7625328|NCT02332824|18776547|P5|NOT COMPLETED|Overall Study||4
7625329|NCT02332824|18776548|P4|NOT COMPLETED|Overall Study||2
7625330|NCT02332824|18776549|P3|NOT COMPLETED|Overall Study||2
7625331|NCT02332824|18776550|P2|NOT COMPLETED|Overall Study||1
7625332|NCT02332824|18776551|P1|NOT COMPLETED|Overall Study||6
7625333|NCT02332824|18776546|P6|COMPLETED|Overall Study||69
7625334|NCT02332824|18776547|P5|COMPLETED|Overall Study||65
7625335|NCT02332824|18776548|P4|COMPLETED|Overall Study||66
7625336|NCT02332824|18776549|P3|COMPLETED|Overall Study||72
7625337|NCT02332824|18776550|P2|COMPLETED|Overall Study||66
7625338|NCT02332824|18776551|P1|COMPLETED|Overall Study||61
7625339|NCT02332824|18776546|P6|STARTED|Overall Study||70
7625340|NCT02332824|18776547|P5|STARTED|Overall Study||69
7625341|NCT02332824|18776548|P4|STARTED|Overall Study||68
7625342|NCT02332824|18776549|P3|STARTED|Overall Study||74
7625343|NCT02332824|18776550|P2|STARTED|Overall Study||67
7625344|NCT02332824|18776551|P1|STARTED|Overall Study||67
7625345|NCT02332798|18776592|P3|NOT COMPLETED|Overall Study||1
7625346|NCT02332798|18776593|P2|NOT COMPLETED|Overall Study||2
7625347|NCT02332798|18776594|P1|NOT COMPLETED|Overall Study||1
7625348|NCT02332798|18776592|P3|COMPLETED|Overall Study||11
7625349|NCT02332798|18776593|P2|COMPLETED|Overall Study||12
7625350|NCT02332798|18776594|P1|COMPLETED|Overall Study||12
7625351|NCT02332798|18776592|P3|STARTED|Overall Study||12
7625352|NCT02332798|18776593|P2|STARTED|Overall Study||14
7625353|NCT02332798|18776594|P1|STARTED|Overall Study||13
7625354|NCT02332720|18776667|P23|NOT COMPLETED|Part C||0
7625355|NCT02332720|18776668|P22|NOT COMPLETED|Part C||0
7625356|NCT02332720|18776669|P21|NOT COMPLETED|Part C||0
7625357|NCT02332720|18776670|P20|NOT COMPLETED|Part C||0
7625358|NCT02332720|18776671|P19|NOT COMPLETED|Part C||0
7625359|NCT02332720|18776672|P18|NOT COMPLETED|Part C||0
7625360|NCT02332720|18776673|P17|NOT COMPLETED|Part C||0
7625361|NCT02332720|18776674|P16|NOT COMPLETED|Part C||0
7625362|NCT02332720|18776675|P15|NOT COMPLETED|Part C||0
7625363|NCT02332720|18776676|P14|NOT COMPLETED|Part C||0
7625364|NCT02332720|18776677|P13|NOT COMPLETED|Part C||0
7625365|NCT02332720|18776678|P12|NOT COMPLETED|Part C||0
7625366|NCT02332720|18776679|P11|NOT COMPLETED|Part C||0
7625367|NCT02332720|18776680|P10|NOT COMPLETED|Part C||0
7625368|NCT02332720|18776681|P9|NOT COMPLETED|Part C||0
7625369|NCT02332720|18776682|P8|NOT COMPLETED|Part C||0
7625370|NCT02332720|18776683|P7|NOT COMPLETED|Part C||0
7625371|NCT02332720|18776684|P6|NOT COMPLETED|Part C||0
7625372|NCT02332720|18776685|P5|NOT COMPLETED|Part C||0
7625373|NCT02332720|18776686|P4|NOT COMPLETED|Part C||0
7625374|NCT02332720|18776687|P3|NOT COMPLETED|Part C||0
7625375|NCT02332720|18776688|P2|NOT COMPLETED|Part C||0
7625376|NCT02332720|18776689|P1|NOT COMPLETED|Part C||0
7625377|NCT02332720|18776667|P23|COMPLETED|Part C||0
7625378|NCT02332720|18776668|P22|COMPLETED|Part C||0
7625379|NCT02332720|18776669|P21|COMPLETED|Part C||0
7625380|NCT02332720|18776670|P20|COMPLETED|Part C||0
7625381|NCT02332720|18776671|P19|COMPLETED|Part C||0
7625382|NCT02332720|18776672|P18|COMPLETED|Part C||0
7625383|NCT02332720|18776673|P17|COMPLETED|Part C||0
7625384|NCT02332720|18776674|P16|COMPLETED|Part C||0
7625385|NCT02332720|18776675|P15|COMPLETED|Part C||0
7625386|NCT02332720|18776676|P14|COMPLETED|Part C||0
7625387|NCT02332720|18776677|P13|COMPLETED|Part C||0
7625388|NCT02332720|18776678|P12|COMPLETED|Part C||0
7625389|NCT02332720|18776679|P11|COMPLETED|Part C||0
7625390|NCT02332720|18776680|P10|COMPLETED|Part C||0
7625391|NCT02332720|18776681|P9|COMPLETED|Part C||0
7625392|NCT02332720|18776682|P8|COMPLETED|Part C||0
7625393|NCT02332720|18776683|P7|COMPLETED|Part C||0
7625394|NCT02332720|18776684|P6|COMPLETED|Part C||0
7625395|NCT02332720|18776685|P5|COMPLETED|Part C||0
7625396|NCT02332720|18776686|P4|COMPLETED|Part C||2
7625397|NCT02332720|18776687|P3|COMPLETED|Part C||3
7625398|NCT02332720|18776688|P2|COMPLETED|Part C||1
7625399|NCT02332720|18776689|P1|COMPLETED|Part C||2
7625400|NCT02332720|18776667|P23|STARTED|Part C|Part B participants were not included in Part C.|0
7625401|NCT02332720|18776668|P22|STARTED|Part C||0
7625402|NCT02332720|18776669|P21|STARTED|Part C|Part B participants were not included in Part C.|0
7625403|NCT02332720|18776670|P20|STARTED|Part C|Part B participants were not included in Part C.|0
7625404|NCT02332720|18776671|P19|STARTED|Part C|Part B participants were not included in Part C.|0
7625405|NCT02332720|18776672|P18|STARTED|Part C|Part B participants were not included in Part C.|0
7625406|NCT02332720|18776673|P17|STARTED|Part C|Part B participants were not included in Part C.|0
7625407|NCT02332720|18776674|P16|STARTED|Part C|Part B participants were not included in Part C.|0
7625408|NCT02332720|18776675|P15|STARTED|Part C|Part B participants were not included in Part C.|0
7625409|NCT02332720|18776676|P14|STARTED|Part C|Part B participants were not included in Part C.|0
7625410|NCT02332720|18776677|P13|STARTED|Part C|Part B participants were not included in Part C.|0
7625411|NCT02332720|18776678|P12|STARTED|Part C|Part B participants were not included in Part C.|0
7625412|NCT02332720|18776679|P11|STARTED|Part C|Part B participants were not included in Part C.|0
7625413|NCT02332720|18776680|P10|STARTED|Part C|Part B participants were not included in Part C.|0
7625414|NCT02332720|18776681|P9|STARTED|Part C|Part B participants were not included in Part C.|0
7625415|NCT02332720|18776682|P8|STARTED|Part C|Part B participants were not included in Part C.|0
7625416|NCT02332720|18776683|P7|STARTED|Part C|Part B participants were not included in Part C.|0
7625417|NCT02332720|18776684|P6|STARTED|Part C|Part B participants were not included in Part C.|0
7625418|NCT02332720|18776685|P5|STARTED|Part C|Part B participants were not included in Part C.|0
7625419|NCT02332720|18776686|P4|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
7625420|NCT02332720|18776687|P3|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|3
7625421|NCT02332720|18776688|P2|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|1
7625422|NCT02332720|18776689|P1|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
7625423|NCT02332720|18776667|P23|NOT COMPLETED|Part A and Part B||0
7625424|NCT02332720|18776668|P22|NOT COMPLETED|Part A and Part B||0
7625425|NCT02332720|18776669|P21|NOT COMPLETED|Part A and Part B||0
7625426|NCT02332720|18776670|P20|NOT COMPLETED|Part A and Part B||1
7625427|NCT02332720|18776671|P19|NOT COMPLETED|Part A and Part B||1
7625428|NCT02332720|18776672|P18|NOT COMPLETED|Part A and Part B||1
7625429|NCT02332720|18776673|P17|NOT COMPLETED|Part A and Part B||0
7625430|NCT02332720|18776674|P16|NOT COMPLETED|Part A and Part B||1
7625431|NCT02332720|18776675|P15|NOT COMPLETED|Part A and Part B||0
7625432|NCT02332720|18776676|P14|NOT COMPLETED|Part A and Part B||0
7625433|NCT02332720|18776677|P13|NOT COMPLETED|Part A and Part B||0
7625434|NCT02332720|18776678|P12|NOT COMPLETED|Part A and Part B||0
7625435|NCT02332720|18776679|P11|NOT COMPLETED|Part A and Part B||0
7625436|NCT02332720|18776680|P10|NOT COMPLETED|Part A and Part B||0
7625437|NCT02332720|18776681|P9|NOT COMPLETED|Part A and Part B||0
7625438|NCT02332720|18776682|P8|NOT COMPLETED|Part A and Part B||1
7625439|NCT02332720|18776683|P7|NOT COMPLETED|Part A and Part B||1
7625440|NCT02332720|18776684|P6|NOT COMPLETED|Part A and Part B||3
7625441|NCT02332720|18776685|P5|NOT COMPLETED|Part A and Part B||0
7625442|NCT02332720|18776686|P4|NOT COMPLETED|Part A and Part B||0
7625443|NCT02332720|18776687|P3|NOT COMPLETED|Part A and Part B||0
7625444|NCT02332720|18776688|P2|NOT COMPLETED|Part A and Part B||0
7625445|NCT02332720|18776689|P1|NOT COMPLETED|Part A and Part B||1
7625446|NCT02332720|18776667|P23|COMPLETED|Part A and Part B||4
7625447|NCT02332720|18776668|P22|COMPLETED|Part A and Part B||0
7625448|NCT02332720|18776669|P21|COMPLETED|Part A and Part B||7
7625449|NCT02332720|18776670|P20|COMPLETED|Part A and Part B||24
7625450|NCT02332720|18776671|P19|COMPLETED|Part A and Part B||20
7625451|NCT02332720|18776672|P18|COMPLETED|Part A and Part B||13
7625452|NCT02332720|18776673|P17|COMPLETED|Part A and Part B||15
7625453|NCT02332720|18776674|P16|COMPLETED|Part A and Part B||13
7625454|NCT02332720|18776675|P15|COMPLETED|Part A and Part B||16
7625455|NCT02332720|18776676|P14|COMPLETED|Part A and Part B||13
7625456|NCT02332720|18776677|P13|COMPLETED|Part A and Part B||16
7625457|NCT02332720|18776678|P12|COMPLETED|Part A and Part B||15
7625458|NCT02332720|18776679|P11|COMPLETED|Part A and Part B||14
7625459|NCT02332720|18776680|P10|COMPLETED|Part A and Part B||14
7625460|NCT02332720|18776681|P9|COMPLETED|Part A and Part B||15
7625461|NCT02332720|18776682|P8|COMPLETED|Part A and Part B||34
7625462|NCT02332720|18776683|P7|COMPLETED|Part A and Part B||36
7625463|NCT02332720|18776684|P6|COMPLETED|Part A and Part B||33
7625464|NCT02332720|18776685|P5|COMPLETED|Part A and Part B||16
7625465|NCT02332720|18776686|P4|COMPLETED|Part A and Part B||22
7625466|NCT02332720|18776687|P3|COMPLETED|Part A and Part B||22
7625467|NCT02332720|18776688|P2|COMPLETED|Part A and Part B||21
7625468|NCT02332720|18776689|P1|COMPLETED|Part A and Part B||20
7625469|NCT02332720|18776667|P23|Treated|Part A and Part B||4
7625470|NCT02332720|18776668|P22|Treated|Part A and Part B||0
7625471|NCT02332720|18776669|P21|Treated|Part A and Part B||7
7625472|NCT02332720|18776670|P20|Treated|Part A and Part B||25
7625473|NCT02332720|18776671|P19|Treated|Part A and Part B||20
7625474|NCT02332720|18776672|P18|Treated|Part A and Part B||14
7625475|NCT02332720|18776673|P17|Treated|Part A and Part B||15
7625476|NCT02332720|18776674|P16|Treated|Part A and Part B||14
7625477|NCT02332720|18776675|P15|Treated|Part A and Part B||16
7625478|NCT02332720|18776676|P14|Treated|Part A and Part B||13
7625479|NCT02332720|18776677|P13|Treated|Part A and Part B||16
7625480|NCT02332720|18776678|P12|Treated|Part A and Part B||15
7625481|NCT02332720|18776679|P11|Treated|Part A and Part B||14
7625482|NCT02332720|18776680|P10|Treated|Part A and Part B||14
7625483|NCT02332720|18776681|P9|Treated|Part A and Part B||15
7625484|NCT02332720|18776682|P8|Treated|Part A and Part B||35
7625485|NCT02332720|18776683|P7|Treated|Part A and Part B||37
7625486|NCT02332720|18776684|P6|Treated|Part A and Part B||36
7625487|NCT02332720|18776685|P5|Treated|Part A and Part B||16
7625488|NCT02332720|18776686|P4|Treated|Part A and Part B||22
7625489|NCT02332720|18776687|P3|Treated|Part A and Part B||22
7625490|NCT02332720|18776688|P2|Treated|Part A and Part B||21
7625491|NCT02332720|18776689|P1|Treated|Part A and Part B||21
7625492|NCT02332720|18776667|P23|STARTED|Part A and Part B||4
7625493|NCT02332720|18776668|P22|STARTED|Part A and Part B||0
7625494|NCT02332720|18776669|P21|STARTED|Part A and Part B||7
7625495|NCT02332720|18776670|P20|STARTED|Part A and Part B||25
7625496|NCT02332720|18776671|P19|STARTED|Part A and Part B||21
7625497|NCT02332720|18776672|P18|STARTED|Part A and Part B||14
7625498|NCT02332720|18776673|P17|STARTED|Part A and Part B||15
7625499|NCT02332720|18776674|P16|STARTED|Part A and Part B||14
7625500|NCT02332720|18776675|P15|STARTED|Part A and Part B||16
7625501|NCT02332720|18776676|P14|STARTED|Part A and Part B||13
7625502|NCT02332720|18776677|P13|STARTED|Part A and Part B||16
7625503|NCT02332720|18776678|P12|STARTED|Part A and Part B||15
7625504|NCT02332720|18776679|P11|STARTED|Part A and Part B||14
7625505|NCT02332720|18776680|P10|STARTED|Part A and Part B||14
7625506|NCT02332720|18776681|P9|STARTED|Part A and Part B||15
7625507|NCT02332720|18776682|P8|STARTED|Part A and Part B||35
7625508|NCT02332720|18776683|P7|STARTED|Part A and Part B||37
7625509|NCT02332720|18776684|P6|STARTED|Part A and Part B||36
7625510|NCT02332720|18776685|P5|STARTED|Part A and Part B||16
7625511|NCT02332720|18776686|P4|STARTED|Part A and Part B||22
7625512|NCT02332720|18776687|P3|STARTED|Part A and Part B||22
7625513|NCT02332720|18776688|P2|STARTED|Part A and Part B||21
7625514|NCT02332720|18776689|P1|STARTED|Part A and Part B||21
7625515|NCT02332707|18776825|P18|NOT COMPLETED|Overall Study||0
7625516|NCT02332707|18776826|P17|NOT COMPLETED|Overall Study||0
7625517|NCT02332707|18776827|P16|NOT COMPLETED|Overall Study||0
7625518|NCT02332707|18776828|P15|NOT COMPLETED|Overall Study||0
7625519|NCT02332707|18776829|P14|NOT COMPLETED|Overall Study||0
7625520|NCT02332707|18776830|P13|NOT COMPLETED|Overall Study||5
7625521|NCT02332707|18776831|P12|NOT COMPLETED|Overall Study||0
7625522|NCT02332707|18776832|P11|NOT COMPLETED|Overall Study||2
7625523|NCT02332707|18776833|P10|NOT COMPLETED|Overall Study||3
7625524|NCT02332707|18776834|P9|NOT COMPLETED|Overall Study||0
7625525|NCT02332707|18776835|P8|NOT COMPLETED|Overall Study||0
7625526|NCT02332707|18776836|P7|NOT COMPLETED|Overall Study||0
7625527|NCT02332707|18776837|P6|NOT COMPLETED|Overall Study||1
7625528|NCT02332707|18776838|P5|NOT COMPLETED|Overall Study||0
7625529|NCT02332707|18776839|P4|NOT COMPLETED|Overall Study||1
7625530|NCT02332707|18776840|P3|NOT COMPLETED|Overall Study||1
7625531|NCT02332707|18776841|P2|NOT COMPLETED|Overall Study||0
7625532|NCT02332707|18776842|P1|NOT COMPLETED|Overall Study||0
7625533|NCT02332707|18776825|P18|COMPLETED|Overall Study||16
7625534|NCT02332707|18776826|P17|COMPLETED|Overall Study||30
7625535|NCT02332707|18776827|P16|COMPLETED|Overall Study||26
7625536|NCT02332707|18776828|P15|COMPLETED|Overall Study||16
7625537|NCT02332707|18776829|P14|COMPLETED|Overall Study||15
7625538|NCT02332707|18776830|P13|COMPLETED|Overall Study||35
7625539|NCT02332707|18776831|P12|COMPLETED|Overall Study||35
7625540|NCT02332707|18776832|P11|COMPLETED|Overall Study||29
7625541|NCT02332707|18776833|P10|COMPLETED|Overall Study||28
7625542|NCT02332707|18776834|P9|COMPLETED|Overall Study||48
7625543|NCT02332707|18776835|P8|COMPLETED|Overall Study||16
7625544|NCT02332707|18776836|P7|COMPLETED|Overall Study||15
7625545|NCT02332707|18776837|P6|COMPLETED|Overall Study||22
7625546|NCT02332707|18776838|P5|COMPLETED|Overall Study||23
7625547|NCT02332707|18776839|P4|COMPLETED|Overall Study||13
7625548|NCT02332707|18776840|P3|COMPLETED|Overall Study||15
7625549|NCT02332707|18776841|P2|COMPLETED|Overall Study||24
7625550|NCT02332707|18776842|P1|COMPLETED|Overall Study||23
7625551|NCT02332707|18776825|P18|STARTED|Overall Study||16
7625552|NCT02332707|18776826|P17|STARTED|Overall Study||30
7625553|NCT02332707|18776827|P16|STARTED|Overall Study||26
7625554|NCT02332707|18776828|P15|STARTED|Overall Study||16
7625555|NCT02332707|18776829|P14|STARTED|Overall Study||15
7625556|NCT02332707|18776830|P13|STARTED|Overall Study||40
7625557|NCT02332707|18776831|P12|STARTED|Overall Study||35
7625558|NCT02332707|18776832|P11|STARTED|Overall Study||31
7625559|NCT02332707|18776833|P10|STARTED|Overall Study||31
7625560|NCT02332707|18776834|P9|STARTED|Overall Study||48
7625561|NCT02332707|18776835|P8|STARTED|Overall Study||16
7625562|NCT02332707|18776836|P7|STARTED|Overall Study||15
7625563|NCT02332707|18776837|P6|STARTED|Overall Study||23
7625564|NCT02332707|18776838|P5|STARTED|Overall Study||23
7625565|NCT02332707|18776839|P4|STARTED|Overall Study||14
7625566|NCT02332707|18776840|P3|STARTED|Overall Study||16
7625567|NCT02332707|18776841|P2|STARTED|Overall Study||24
7625568|NCT02332707|18776842|P1|STARTED|Overall Study||23
7625569|NCT02332590|18776936|P2|NOT COMPLETED|Overall Study||19
7625570|NCT02332590|18776937|P1|NOT COMPLETED|Overall Study||29
7625571|NCT02332590|18776936|P2|COMPLETED|Overall Study|All 165 participants entered open-label treatment period.|165
7625572|NCT02332590|18776937|P1|COMPLETED|Overall Study|155 participants entered open-label treatment period and 1 did not enroll.|156
7625573|NCT02332590|18776936|P2|Treated|Overall Study||184
7625574|NCT02332590|18776937|P1|Treated|Overall Study||184
7625575|NCT02332590|18776936|P2|STARTED|Overall Study||184
7625576|NCT02332590|18776937|P1|STARTED|Overall Study||185
7625577|NCT02332239|18777001|P2|NOT COMPLETED|Overall Study||6
7625578|NCT02332239|18777002|P1|NOT COMPLETED|Overall Study||4
7625579|NCT02332239|18777001|P2|COMPLETED|Overall Study||52
7625580|NCT02332239|18777002|P1|COMPLETED|Overall Study||54
7625581|NCT02332239|18777001|P2|STARTED|Overall Study||58
7625582|NCT02332239|18777002|P1|STARTED|Overall Study||58
7625583|NCT02331992|18777015|P1|NOT COMPLETED|Overall Study||0
7625584|NCT02331992|18777015|P1|COMPLETED|Overall Study||34
7625585|NCT02331992|18777015|P1|STARTED|Overall Study||34
7625586|NCT02331940|18777022|P2|NOT COMPLETED|Overall Study||5
7625587|NCT02331940|18777023|P1|NOT COMPLETED|Overall Study||7
7625588|NCT02331940|18777022|P2|COMPLETED|Overall Study||95
7625589|NCT02331940|18777023|P1|COMPLETED|Overall Study||93
7625590|NCT02331940|18777022|P2|STARTED|Overall Study||100
7625591|NCT02331940|18777023|P1|STARTED|Overall Study||100
7625592|NCT02331680|18777038|P3|NOT COMPLETED|Overall Study||15
7625593|NCT02331680|18777039|P2|NOT COMPLETED|Overall Study||4
7625594|NCT02331680|18777040|P1|NOT COMPLETED|Overall Study||6
7625595|NCT02331680|18777038|P3|COMPLETED|Overall Study||29
7625596|NCT02331680|18777039|P2|COMPLETED|Overall Study||36
7625597|NCT02331680|18777040|P1|COMPLETED|Overall Study||34
7625598|NCT02331680|18777038|P3|STARTED|Overall Study||44
7625599|NCT02331680|18777039|P2|STARTED|Overall Study||40
7625600|NCT02331680|18777040|P1|STARTED|Overall Study||40
7625601|NCT02331589|18777053|P2|NOT COMPLETED|Overall Study||5
7625602|NCT02331589|18777054|P1|NOT COMPLETED|Overall Study||5
7625603|NCT02331589|18777053|P2|COMPLETED|Overall Study||31
7625604|NCT02331589|18777054|P1|COMPLETED|Overall Study||34
7625605|NCT02331589|18777053|P2|STARTED|Overall Study||36
7625606|NCT02331589|18777054|P1|STARTED|Overall Study||39
7625607|NCT02331446|18777070|P4|NOT COMPLETED|Overall Study||3
7625608|NCT02331446|18777071|P3|NOT COMPLETED|Overall Study||3
7625609|NCT02331446|18777072|P2|NOT COMPLETED|Overall Study||5
7625610|NCT02331446|18777073|P1|NOT COMPLETED|Overall Study||4
7625611|NCT02331446|18777070|P4|COMPLETED|Overall Study||8
7625612|NCT02331446|18777071|P3|COMPLETED|Overall Study||8
7625613|NCT02331446|18777072|P2|COMPLETED|Overall Study||6
7625614|NCT02331446|18777073|P1|COMPLETED|Overall Study||5
7625615|NCT02331446|18777070|P4|STARTED|Overall Study||11
7625616|NCT02331446|18777071|P3|STARTED|Overall Study||11
7625617|NCT02331446|18777072|P2|STARTED|Overall Study||11
7625618|NCT02331446|18777073|P1|STARTED|Overall Study||9
7625619|NCT02331407|18777143|P1|NOT COMPLETED|Overall Study||0
7625620|NCT02331407|18777143|P1|COMPLETED|Overall Study||9
7625621|NCT02331407|18777143|P1|STARTED|Overall Study||9
7625622|NCT02331394|18777149|P1|NOT COMPLETED|Overall Study||1
7625623|NCT02331394|18777149|P1|COMPLETED|Overall Study|14 patients, 1 dropped out|14
7625624|NCT02331394|18777149|P1|STARTED|Overall Study||15
7625625|NCT02331368|18777160|P1|NOT COMPLETED|Overall Study||3
7625626|NCT02331368|18777160|P1|COMPLETED|Overall Study||29
7625627|NCT02331368|18777160|P1|STARTED|Overall Study||32
7625628|NCT02331108|18777172|P6|NOT COMPLETED|Overall Study||2
7625629|NCT02331108|18777173|P5|NOT COMPLETED|Overall Study||2
7625630|NCT02331108|18777174|P4|NOT COMPLETED|Overall Study||1
7625631|NCT02331108|18777175|P3|NOT COMPLETED|Overall Study||1
7625632|NCT02331108|18777176|P2|NOT COMPLETED|Overall Study||2
7625633|NCT02331108|18777177|P1|NOT COMPLETED|Overall Study||1
7625634|NCT02331108|18777172|P6|COMPLETED|Overall Study||50
7625635|NCT02331108|18777173|P5|COMPLETED|Overall Study||50
7625636|NCT02331108|18777174|P4|COMPLETED|Overall Study||50
7625637|NCT02331108|18777175|P3|COMPLETED|Overall Study||50
7625638|NCT02331108|18777176|P2|COMPLETED|Overall Study||50
7625639|NCT02331108|18777177|P1|COMPLETED|Overall Study||50
7625640|NCT02331108|18777172|P6|STARTED|Overall Study||52
7625641|NCT02331108|18777173|P5|STARTED|Overall Study||52
7625642|NCT02331108|18777174|P4|STARTED|Overall Study||51
7625643|NCT02331108|18777175|P3|STARTED|Overall Study||51
7625644|NCT02331108|18777176|P2|STARTED|Overall Study||52
7625645|NCT02331108|18777177|P1|STARTED|Overall Study||51
7625646|NCT02331095|18777201|P2|NOT COMPLETED|Overall Study||1
7625647|NCT02331095|18777202|P1|NOT COMPLETED|Overall Study||4
7625648|NCT02331095|18777201|P2|COMPLETED|Overall Study||9
7625649|NCT02331095|18777202|P1|COMPLETED|Overall Study||7
7625650|NCT02331095|18777201|P2|STARTED|Overall Study||10
7625651|NCT02331095|18777202|P1|STARTED|Overall Study||11
7625652|NCT02330978|18777228|P1|NOT COMPLETED|The Second Patient Included at Study||0
7625653|NCT02330978|18777228|P1|COMPLETED|The Second Patient Included at Study||1
7625654|NCT02330978|18777228|P1|STARTED|The Second Patient Included at Study||1
7625655|NCT02330978|18777228|P1|NOT COMPLETED|The First Patient Included at Study||0
7625656|NCT02330978|18777228|P1|COMPLETED|The First Patient Included at Study||1
7625657|NCT02330978|18777228|P1|STARTED|The First Patient Included at Study||1
7625658|NCT02330627|18777234|P2|NOT COMPLETED|Overall Study||1
7625659|NCT02330627|18777235|P1|NOT COMPLETED|Overall Study||1
7625660|NCT02330627|18777234|P2|COMPLETED|Overall Study||12
7625661|NCT02330627|18777235|P1|COMPLETED|Overall Study||15
7625662|NCT02330627|18777234|P2|STARTED|Overall Study||13
7625663|NCT02330627|18777235|P1|STARTED|Overall Study||16
7625664|NCT02330588|18777254|P5|NOT COMPLETED|Overall Study||19
7625665|NCT02330588|18777255|P4|NOT COMPLETED|Overall Study||22
7625666|NCT02330588|18777256|P3|NOT COMPLETED|Overall Study||15
7625667|NCT02330588|18777257|P2|NOT COMPLETED|Overall Study||18
7625668|NCT02330588|18777258|P1|NOT COMPLETED|Overall Study||16
7625669|NCT02330588|18777254|P5|COMPLETED|Overall Study||28
7625670|NCT02330588|18777255|P4|COMPLETED|Overall Study||24
7625671|NCT02330588|18777256|P3|COMPLETED|Overall Study||31
7625672|NCT02330588|18777257|P2|COMPLETED|Overall Study||25
7625673|NCT02330588|18777258|P1|COMPLETED|Overall Study||28
7625674|NCT02330588|18777254|P5|STARTED|Overall Study||47
7625675|NCT02330588|18777255|P4|STARTED|Overall Study||46
7625676|NCT02330588|18777256|P3|STARTED|Overall Study||46
7625677|NCT02330588|18777257|P2|STARTED|Overall Study||43
7625678|NCT02330588|18777258|P1|STARTED|Overall Study||44
7625679|NCT02330549|18777285|P2|NOT COMPLETED|Overall Study||1
7625680|NCT02330549|18777286|P1|NOT COMPLETED|Overall Study||4
7625681|NCT02330549|18777285|P2|COMPLETED|Overall Study||24
7625682|NCT02330549|18777286|P1|COMPLETED|Overall Study||16
7625683|NCT02330549|18777285|P2|STARTED|Overall Study||25
7625684|NCT02330549|18777286|P1|STARTED|Overall Study||20
7625685|NCT02330523|18777401|P2|NOT COMPLETED|Overall Study||0
7625686|NCT02330523|18777402|P1|NOT COMPLETED|Overall Study||0
7625687|NCT02330523|18777401|P2|COMPLETED|Overall Study||19
7625688|NCT02330523|18777402|P1|COMPLETED|Overall Study||21
7625689|NCT02330523|18777401|P2|STARTED|Overall Study||19
7625690|NCT02330523|18777402|P1|STARTED|Overall Study||21
7625691|NCT02330341|18777414|P2|NOT COMPLETED|Overall Study||1
7625692|NCT02330341|18777415|P1|NOT COMPLETED|Overall Study||0
7625693|NCT02330341|18777414|P2|COMPLETED|Overall Study||11
7625694|NCT02330341|18777415|P1|COMPLETED|Overall Study||12
7625695|NCT02330341|18777414|P2|STARTED|Overall Study||12
7625696|NCT02330341|18777415|P1|STARTED|Overall Study||12
7625697|NCT02330276|18777456|P3|NOT COMPLETED|Overall Study||0
7625698|NCT02330276|18777457|P2|NOT COMPLETED|Overall Study||0
7625699|NCT02330276|18777458|P1|NOT COMPLETED|Overall Study||0
7625700|NCT02330276|18777456|P3|COMPLETED|Overall Study||4
7625701|NCT02330276|18777457|P2|COMPLETED|Overall Study||4
7625702|NCT02330276|18777458|P1|COMPLETED|Overall Study||4
7625703|NCT02330276|18777456|P3|STARTED|Overall Study||4
7625704|NCT02330276|18777457|P2|STARTED|Overall Study||4
7625705|NCT02330276|18777458|P1|STARTED|Overall Study||4
7625706|NCT02330172|18777480|P2|NOT COMPLETED|Overall Study||1
7625707|NCT02330172|18777481|P1|NOT COMPLETED|Overall Study||3
7625708|NCT02330172|18777480|P2|COMPLETED|Overall Study||21
7625709|NCT02330172|18777481|P1|COMPLETED|Overall Study||19
7625710|NCT02330172|18777480|P2|STARTED|Overall Study||22
7625711|NCT02330172|18777481|P1|STARTED|Overall Study||22
7625712|NCT02330094|18777491|P2|NOT COMPLETED|Overall Study||0
7625713|NCT02330094|18777492|P1|NOT COMPLETED|Overall Study||0
7625714|NCT02330094|18777491|P2|COMPLETED|Overall Study||8
7625715|NCT02330094|18777492|P1|COMPLETED|Overall Study||8
7625716|NCT02330094|18777491|P2|STARTED|Overall Study||8
7625717|NCT02330094|18777492|P1|STARTED|Overall Study||8
7625718|NCT02330081|18777502|P1|NOT COMPLETED|Overall Study||8
7625719|NCT02330081|18777502|P1|COMPLETED|Overall Study||14
7625720|NCT02330081|18777502|P1|STARTED|Overall Study||22
7625721|NCT02330055|18777523|P2|NOT COMPLETED|Overall Study||9
7625722|NCT02330055|18777524|P1|NOT COMPLETED|Overall Study||10
7625723|NCT02330055|18777523|P2|COMPLETED|Overall Study||40
7625724|NCT02330055|18777524|P1|COMPLETED|Overall Study||40
7625725|NCT02330055|18777523|P2|STARTED|Overall Study||49
7625726|NCT02330055|18777524|P1|STARTED|Overall Study||50
7625727|NCT02329964|18777544|P2|NOT COMPLETED|Overall Study||0
7625728|NCT02329964|18777545|P1|NOT COMPLETED|Overall Study||0
7625729|NCT02329964|18777544|P2|COMPLETED|Overall Study||40
7625730|NCT02329964|18777545|P1|COMPLETED|Overall Study||40
7625731|NCT02329964|18777544|P2|STARTED|Overall Study||40
7625732|NCT02329964|18777545|P1|STARTED|Overall Study||40
7625733|NCT02329743|18777570|P3|NOT COMPLETED|Overall Study||8
7625734|NCT02329743|18777571|P2|NOT COMPLETED|Overall Study||7
7625735|NCT02329743|18777572|P1|NOT COMPLETED|Overall Study||6
7625736|NCT02329743|18777570|P3|COMPLETED|Overall Study||77
7625737|NCT02329743|18777571|P2|COMPLETED|Overall Study||80
7625738|NCT02329743|18777572|P1|COMPLETED|Overall Study||78
7625739|NCT02329743|18777570|P3|STARTED|Overall Study||85
7625740|NCT02329743|18777571|P2|STARTED|Overall Study||87
7625741|NCT02329743|18777572|P1|STARTED|Overall Study||84
7625742|NCT02329730|18777587|P12|NOT COMPLETED|Overall Study||0
7625743|NCT02329730|18777588|P11|NOT COMPLETED|Overall Study||0
7625744|NCT02329730|18777589|P10|NOT COMPLETED|Overall Study||1
7625745|NCT02329730|18777590|P9|NOT COMPLETED|Overall Study||1
7625746|NCT02329730|18777591|P8|NOT COMPLETED|Overall Study||1
7625747|NCT02329730|18777592|P7|NOT COMPLETED|Overall Study||1
7625748|NCT02329730|18777593|P6|NOT COMPLETED|Overall Study||2
7625749|NCT02329730|18777594|P5|NOT COMPLETED|Overall Study||3
7625750|NCT02329730|18777595|P4|NOT COMPLETED|Overall Study||0
7625751|NCT02329730|18777596|P3|NOT COMPLETED|Overall Study||0
7625752|NCT02329730|18777597|P2|NOT COMPLETED|Overall Study||0
7625753|NCT02329730|18777598|P1|NOT COMPLETED|Overall Study||0
7625754|NCT02329730|18777587|P12|COMPLETED|Overall Study||8
7625755|NCT02329730|18777588|P11|COMPLETED|Overall Study||8
7625756|NCT02329730|18777589|P10|COMPLETED|Overall Study||7
7625757|NCT02329730|18777590|P9|COMPLETED|Overall Study||7
7625758|NCT02329730|18777591|P8|COMPLETED|Overall Study||13
7625759|NCT02329730|18777592|P7|COMPLETED|Overall Study||13
7625760|NCT02329730|18777593|P6|COMPLETED|Overall Study||12
7625761|NCT02329730|18777594|P5|COMPLETED|Overall Study||11
7625762|NCT02329730|18777595|P4|COMPLETED|Overall Study||14
7625763|NCT02329730|18777596|P3|COMPLETED|Overall Study||14
7625764|NCT02329730|18777597|P2|COMPLETED|Overall Study||14
7625765|NCT02329730|18777598|P1|COMPLETED|Overall Study||14
7625766|NCT02329730|18777587|P12|STARTED|Overall Study||8
7625767|NCT02329730|18777588|P11|STARTED|Overall Study||8
7625768|NCT02329730|18777589|P10|STARTED|Overall Study||8
7625769|NCT02329730|18777590|P9|STARTED|Overall Study||8
7625770|NCT02329730|18777591|P8|STARTED|Overall Study||14
7625771|NCT02329730|18777592|P7|STARTED|Overall Study||14
7625772|NCT02329730|18777593|P6|STARTED|Overall Study||14
7625773|NCT02329730|18777594|P5|STARTED|Overall Study||14
7625774|NCT02329730|18777595|P4|STARTED|Overall Study||14
7625775|NCT02329730|18777596|P3|STARTED|Overall Study||14
7625776|NCT02329730|18777597|P2|STARTED|Overall Study||14
7625777|NCT02329730|18777598|P1|STARTED|Overall Study||14
7625778|NCT02329600|18777675|P3|NOT COMPLETED|Overall Study||0
7625779|NCT02329600|18777676|P2|NOT COMPLETED|Overall Study||0
7625780|NCT02329600|18777677|P1|NOT COMPLETED|Overall Study||0
7625781|NCT02329600|18777675|P3|COMPLETED|Overall Study||15
7625782|NCT02329600|18777676|P2|COMPLETED|Overall Study||15
7625783|NCT02329600|18777677|P1|COMPLETED|Overall Study||10
7625784|NCT02329600|18777675|P3|STARTED|Overall Study||15
7625785|NCT02329600|18777676|P2|STARTED|Overall Study||15
7625786|NCT02329600|18777677|P1|STARTED|Overall Study||10
7625787|NCT02329587|18777690|P2|NOT COMPLETED|1-month Follow-up||1
7625788|NCT02329587|18777691|P1|NOT COMPLETED|1-month Follow-up||0
7625789|NCT02329587|18777690|P2|COMPLETED|1-month Follow-up||5
7625790|NCT02329587|18777691|P1|COMPLETED|1-month Follow-up||4
7625791|NCT02329587|18777690|P2|STARTED|1-month Follow-up||6
7625792|NCT02329587|18777691|P1|STARTED|1-month Follow-up||4
7625793|NCT02329587|18777690|P2|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
7625794|NCT02329587|18777691|P1|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
7625795|NCT02329587|18777690|P2|COMPLETED|Baseline Thru Post-treatment Assessment||6
7625796|NCT02329587|18777691|P1|COMPLETED|Baseline Thru Post-treatment Assessment||4
7625797|NCT02329587|18777690|P2|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||4
7625798|NCT02329587|18777691|P1|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||3
7625799|NCT02329587|18777690|P2|STARTED|Baseline Thru Post-treatment Assessment||7
7625800|NCT02329587|18777691|P1|STARTED|Baseline Thru Post-treatment Assessment||5
7625801|NCT02329431|18777709|P2|NOT COMPLETED|Overall Study||13
7625802|NCT02329431|18777710|P1|NOT COMPLETED|Overall Study||20
7625803|NCT02329431|18777709|P2|COMPLETED|Overall Study||76
7625804|NCT02329431|18777710|P1|COMPLETED|Overall Study||72
7625805|NCT02329431|18777709|P2|Baseline Interview|Overall Study||85
7625806|NCT02329431|18777710|P1|Baseline Interview|Overall Study||87
7625807|NCT02329431|18777709|P2|STARTED|Overall Study||89
7625808|NCT02329431|18777710|P1|STARTED|Overall Study||92
7625809|NCT02329223|18777729|P3|NOT COMPLETED|Overall Study||6
7625810|NCT02329223|18777730|P2|NOT COMPLETED|Overall Study||3
7625811|NCT02329223|18777731|P1|NOT COMPLETED|Overall Study||1
7625812|NCT02329223|18777729|P3|COMPLETED|Overall Study||68
7625813|NCT02329223|18777730|P2|COMPLETED|Overall Study||68
7625814|NCT02329223|18777731|P1|COMPLETED|Overall Study||72
7625815|NCT02329223|18777729|P3|Safety Set|Overall Study||74
7625816|NCT02329223|18777730|P2|Safety Set|Overall Study||71
7625817|NCT02329223|18777731|P1|Safety Set|Overall Study||73
7625818|NCT02329223|18777729|P3|Full Analysis Set|Overall Study||74
7625819|NCT02329223|18777730|P2|Full Analysis Set|Overall Study||70
7625820|NCT02329223|18777731|P1|Full Analysis Set|Overall Study||73
7625821|NCT02329223|18777729|P3|STARTED|Overall Study||74
7625822|NCT02329223|18777730|P2|STARTED|Overall Study||71
7625823|NCT02329223|18777731|P1|STARTED|Overall Study||73
7625824|NCT02329015|18777764|P2|NOT COMPLETED|Overall Study||0
7625825|NCT02329015|18777765|P1|NOT COMPLETED|Overall Study||0
7625826|NCT02329015|18777764|P2|COMPLETED|Overall Study||64
7625827|NCT02329015|18777765|P1|COMPLETED|Overall Study||48
7625828|NCT02329015|18777764|P2|STARTED|Overall Study||64
7625829|NCT02329015|18777765|P1|STARTED|Overall Study||48
7625830|NCT02328937|18777781|P6|NOT COMPLETED|Period 3||0
7625831|NCT02328937|18777782|P5|NOT COMPLETED|Period 3||0
7625832|NCT02328937|18777783|P4|NOT COMPLETED|Period 3||0
7625833|NCT02328937|18777784|P3|NOT COMPLETED|Period 3||0
7625834|NCT02328937|18777785|P2|NOT COMPLETED|Period 3||0
7625835|NCT02328937|18777786|P1|NOT COMPLETED|Period 3||0
7625836|NCT02328937|18777781|P6|COMPLETED|Period 3||6
7625837|NCT02328937|18777782|P5|COMPLETED|Period 3||6
7625838|NCT02328937|18777783|P4|COMPLETED|Period 3||5
7625839|NCT02328937|18777784|P3|COMPLETED|Period 3||6
7625840|NCT02328937|18777785|P2|COMPLETED|Period 3||6
7625841|NCT02328937|18777786|P1|COMPLETED|Period 3||7
7625842|NCT02328937|18777781|P6|STARTED|Period 3||6
7625843|NCT02328937|18777782|P5|STARTED|Period 3||6
7625844|NCT02328937|18777783|P4|STARTED|Period 3||5
7625845|NCT02328937|18777784|P3|STARTED|Period 3||6
7625846|NCT02328937|18777785|P2|STARTED|Period 3||6
7625847|NCT02328937|18777786|P1|STARTED|Period 3||7
7625848|NCT02328937|18777781|P6|NOT COMPLETED|Period 2||0
7625849|NCT02328937|18777782|P5|NOT COMPLETED|Period 2||0
7625850|NCT02328937|18777783|P4|NOT COMPLETED|Period 2||0
7625851|NCT02328937|18777784|P3|NOT COMPLETED|Period 2||1
7625852|NCT02328937|18777785|P2|NOT COMPLETED|Period 2||0
7625853|NCT02328937|18777786|P1|NOT COMPLETED|Period 2||0
7625854|NCT02328937|18777781|P6|COMPLETED|Period 2||6
7625855|NCT02328937|18777782|P5|COMPLETED|Period 2||6
7625856|NCT02328937|18777783|P4|COMPLETED|Period 2||5
7625857|NCT02328937|18777784|P3|COMPLETED|Period 2||6
7625858|NCT02328937|18777785|P2|COMPLETED|Period 2||6
7625859|NCT02328937|18777786|P1|COMPLETED|Period 2||7
7625860|NCT02328937|18777781|P6|STARTED|Period 2||6
7625861|NCT02328937|18777782|P5|STARTED|Period 2||6
7625862|NCT02328937|18777783|P4|STARTED|Period 2||5
7625863|NCT02328937|18777784|P3|STARTED|Period 2||7
7625864|NCT02328937|18777785|P2|STARTED|Period 2||6
7625865|NCT02328937|18777786|P1|STARTED|Period 2||7
7625866|NCT02328937|18777781|P6|NOT COMPLETED|Period 1||0
7625867|NCT02328937|18777782|P5|NOT COMPLETED|Period 1||0
7625868|NCT02328937|18777783|P4|NOT COMPLETED|Period 1||1
7625869|NCT02328937|18777784|P3|NOT COMPLETED|Period 1||0
7625870|NCT02328937|18777785|P2|NOT COMPLETED|Period 1||0
7625871|NCT02328937|18777786|P1|NOT COMPLETED|Period 1||0
7625872|NCT02328937|18777781|P6|COMPLETED|Period 1||6
7625873|NCT02328937|18777782|P5|COMPLETED|Period 1||6
7625874|NCT02328937|18777783|P4|COMPLETED|Period 1||5
7625875|NCT02328937|18777784|P3|COMPLETED|Period 1||7
7625876|NCT02328937|18777785|P2|COMPLETED|Period 1||6
7625877|NCT02328937|18777786|P1|COMPLETED|Period 1||7
7625878|NCT02328937|18777781|P6|STARTED|Period 1||6
7625879|NCT02328937|18777782|P5|STARTED|Period 1||6
7625880|NCT02328937|18777783|P4|STARTED|Period 1||6
7625881|NCT02328937|18777784|P3|STARTED|Period 1||7
7625882|NCT02328937|18777785|P2|STARTED|Period 1||6
7625883|NCT02328937|18777786|P1|STARTED|Period 1||7
7625884|NCT02328807|18777797|P1|NOT COMPLETED|Overall Study||0
7625885|NCT02328807|18777797|P1|COMPLETED|Overall Study||6
7625886|NCT02328807|18777797|P1|STARTED|Overall Study||6
7625887|NCT02328547|18777806|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
7625888|NCT02328547|18777807|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
7625889|NCT02328547|18777806|P2|COMPLETED|Second Intervention (12 Weeks)||23
7625890|NCT02328547|18777807|P1|COMPLETED|Second Intervention (12 Weeks)||22
7625891|NCT02328547|18777806|P2|STARTED|Second Intervention (12 Weeks)||23
7625892|NCT02328547|18777807|P1|STARTED|Second Intervention (12 Weeks)||22
7625893|NCT02328547|18777806|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
7625894|NCT02328547|18777807|P1|NOT COMPLETED|First Intervention (12 Weeks)||3
7625895|NCT02328547|18777806|P2|COMPLETED|First Intervention (12 Weeks)||23
7625896|NCT02328547|18777807|P1|COMPLETED|First Intervention (12 Weeks)||22
7625897|NCT02328547|18777806|P2|STARTED|First Intervention (12 Weeks)||23
7625898|NCT02328547|18777807|P1|STARTED|First Intervention (12 Weeks)||25
7625899|NCT02328404|18777847|P2|NOT COMPLETED|Overall Study||1
7625900|NCT02328404|18777848|P1|NOT COMPLETED|Overall Study||1
7625901|NCT02328404|18777847|P2|COMPLETED|Overall Study||29
7625902|NCT02328404|18777848|P1|COMPLETED|Overall Study||29
7625903|NCT02328404|18777847|P2|STARTED|Overall Study||30
7625904|NCT02328404|18777848|P1|STARTED|Overall Study||30
7625905|NCT02328326|18777884|P2|NOT COMPLETED|Overall Study||8
7625906|NCT02328326|18777885|P1|NOT COMPLETED|Overall Study||22
7625907|NCT02328326|18777884|P2|COMPLETED|Overall Study||224
7625908|NCT02328326|18777885|P1|COMPLETED|Overall Study||224
7625909|NCT02328326|18777884|P2|6-month Follow Up|Overall Study|We were unable to reach 9 participants. 1 patient died, 1 care partner withdrew before completion.|221
7625910|NCT02328326|18777885|P1|6-month Follow Up|Overall Study|We were unable to reach 15 participants. 1 patient died, 1 care partner withdrew before completion.|221
7625911|NCT02328326|18777884|P2|STARTED|Overall Study|1 participant dyad withdrew from the study between assignment to control arm and 6-month follow up.|232
7625912|NCT02328326|18777885|P1|STARTED|Overall Study|3 participant dyads withdrew before 6-month follow up. 3 more care partners withdrew and 1 died.|246
7625913|NCT02328105|18777893|P1|NOT COMPLETED|Overall Study||11
7625914|NCT02328105|18777893|P1|COMPLETED|Overall Study||0
7625915|NCT02328105|18777893|P1|STARTED|Overall Study||11
7625916|NCT02328040|18777902|P2|NOT COMPLETED|Second Intervention (2 Days)||0
7625917|NCT02328040|18777903|P1|NOT COMPLETED|Second Intervention (2 Days)||0
7625918|NCT02328040|18777902|P2|COMPLETED|Second Intervention (2 Days)||8
7625919|NCT02328040|18777903|P1|COMPLETED|Second Intervention (2 Days)||7
7625920|NCT02328040|18777902|P2|STARTED|Second Intervention (2 Days)||8
7625921|NCT02328040|18777903|P1|STARTED|Second Intervention (2 Days)||7
7625922|NCT02328040|18777902|P2|NOT COMPLETED|First Intervention (2 Days)||1
7625923|NCT02328040|18777903|P1|NOT COMPLETED|First Intervention (2 Days)||1
7625924|NCT02328040|18777902|P2|COMPLETED|First Intervention (2 Days)||8
7625925|NCT02328040|18777903|P1|COMPLETED|First Intervention (2 Days)||7
7625926|NCT02328040|18777902|P2|STARTED|First Intervention (2 Days)||9
7625927|NCT02328040|18777903|P1|STARTED|First Intervention (2 Days)||8
7625928|NCT02328027|18777913|P2|NOT COMPLETED|Overall Study||1
7625929|NCT02328027|18777914|P1|NOT COMPLETED|Overall Study||0
7625930|NCT02328027|18777913|P2|COMPLETED|Overall Study||10
7625931|NCT02328027|18777914|P1|COMPLETED|Overall Study||5
7625932|NCT02328027|18777913|P2|STARTED|Overall Study||11
7625933|NCT02328027|18777914|P1|STARTED|Overall Study||5
7625934|NCT02327741|18777931|P2|NOT COMPLETED|Overall Study||0
7625935|NCT02327741|18777932|P1|NOT COMPLETED|Overall Study||0
7625936|NCT02327741|18777931|P2|COMPLETED|Overall Study||508
7625937|NCT02327741|18777932|P1|COMPLETED|Overall Study||502
7625938|NCT02327741|18777931|P2|STARTED|Overall Study||508
7625939|NCT02327741|18777932|P1|STARTED|Overall Study||502
7625940|NCT02327429|18777950|P1|NOT COMPLETED|Overall Study||2
7625941|NCT02327429|18777950|P1|COMPLETED|Overall Study||17
7625942|NCT02327429|18777950|P1|STARTED|Overall Study||19
7625943|NCT02327325|18777973|P3|NOT COMPLETED|Overall Study||5
7625944|NCT02327325|18777974|P2|NOT COMPLETED|Overall Study||4
7625945|NCT02327325|18777975|P1|NOT COMPLETED|Overall Study||1
7625946|NCT02327325|18777973|P3|COMPLETED|Overall Study||15
7625947|NCT02327325|18777974|P2|COMPLETED|Overall Study||16
7625948|NCT02327325|18777975|P1|COMPLETED|Overall Study||19
7625949|NCT02327325|18777973|P3|STARTED|Overall Study||20
7625950|NCT02327325|18777974|P2|STARTED|Overall Study||20
7625951|NCT02327325|18777975|P1|STARTED|Overall Study||20
7625952|NCT02327260|18777998|P3|NOT COMPLETED|Overall Study||2
7625953|NCT02327260|18777999|P2|NOT COMPLETED|Overall Study||4
7625954|NCT02327260|18778000|P1|NOT COMPLETED|Overall Study||6
7625955|NCT02327260|18777998|P3|COMPLETED|Overall Study||15
7625956|NCT02327260|18777999|P2|COMPLETED|Overall Study||20
7625957|NCT02327260|18778000|P1|COMPLETED|Overall Study||14
7625958|NCT02327260|18777998|P3|STARTED|Overall Study||17
7625959|NCT02327260|18777999|P2|STARTED|Overall Study||24
7625960|NCT02327260|18778000|P1|STARTED|Overall Study||20
7625961|NCT02327169|18778047|P15|NOT COMPLETED|Overall Study||10
7625962|NCT02327169|18778048|P14|NOT COMPLETED|Overall Study||7
7625963|NCT02327169|18778049|P13|NOT COMPLETED|Overall Study||1
7625964|NCT02327169|18778050|P12|NOT COMPLETED|Overall Study||7
7625965|NCT02327169|18778051|P11|NOT COMPLETED|Overall Study||6
7625966|NCT02327169|18778052|P10|NOT COMPLETED|Overall Study||8
7625967|NCT02327169|18778053|P9|NOT COMPLETED|Overall Study||6
7625968|NCT02327169|18778054|P8|NOT COMPLETED|Overall Study||4
7625969|NCT02327169|18778055|P7|NOT COMPLETED|Overall Study||3
7625970|NCT02327169|18778056|P6|NOT COMPLETED|Overall Study||4
7625971|NCT02327169|18778057|P5|NOT COMPLETED|Overall Study||8
7625972|NCT02327169|18778058|P4|NOT COMPLETED|Overall Study||3
7625973|NCT02327169|18778059|P3|NOT COMPLETED|Overall Study||7
7625974|NCT02327169|18778060|P2|NOT COMPLETED|Overall Study||3
7625975|NCT02327169|18778061|P1|NOT COMPLETED|Overall Study||4
7625976|NCT02327169|18778047|P15|COMPLETED|Overall Study||0
7625977|NCT02327169|18778048|P14|COMPLETED|Overall Study||0
7625978|NCT02327169|18778049|P13|COMPLETED|Overall Study||0
7625979|NCT02327169|18778050|P12|COMPLETED|Overall Study||0
7625980|NCT02327169|18778051|P11|COMPLETED|Overall Study||0
7625981|NCT02327169|18778052|P10|COMPLETED|Overall Study||0
7625982|NCT02327169|18778053|P9|COMPLETED|Overall Study||0
7625983|NCT02327169|18778054|P8|COMPLETED|Overall Study||0
7625984|NCT02327169|18778055|P7|COMPLETED|Overall Study||0
7625985|NCT02327169|18778056|P6|COMPLETED|Overall Study||0
7625986|NCT02327169|18778057|P5|COMPLETED|Overall Study||0
7625987|NCT02327169|18778058|P4|COMPLETED|Overall Study||0
7625988|NCT02327169|18778059|P3|COMPLETED|Overall Study||0
7625989|NCT02327169|18778060|P2|COMPLETED|Overall Study||0
7625990|NCT02327169|18778061|P1|COMPLETED|Overall Study||0
7625991|NCT02327169|18778047|P15|STARTED|Overall Study||10
7625992|NCT02327169|18778048|P14|STARTED|Overall Study||7
7625993|NCT02327169|18778049|P13|STARTED|Overall Study||1
7625994|NCT02327169|18778050|P12|STARTED|Overall Study||7
7625995|NCT02327169|18778051|P11|STARTED|Overall Study||6
7625996|NCT02327169|18778052|P10|STARTED|Overall Study||8
7625997|NCT02327169|18778053|P9|STARTED|Overall Study||6
7625998|NCT02327169|18778054|P8|STARTED|Overall Study||4
7625999|NCT02327169|18778055|P7|STARTED|Overall Study||3
7626000|NCT02327169|18778056|P6|STARTED|Overall Study||4
7626001|NCT02327169|18778057|P5|STARTED|Overall Study||8
7626002|NCT02327169|18778058|P4|STARTED|Overall Study||3
7626003|NCT02327169|18778059|P3|STARTED|Overall Study||7
7626004|NCT02327169|18778060|P2|STARTED|Overall Study||3
7626005|NCT02327169|18778061|P1|STARTED|Overall Study||4
7626006|NCT02327143|18778282|P2|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
7626007|NCT02327143|18778283|P1|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
7626008|NCT02327143|18778282|P2|COMPLETED|Day 1: Time 6 Hrs - to Day 9||11
7626009|NCT02327143|18778283|P1|COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
7626010|NCT02327143|18778282|P2|STARTED|Day 1: Time 6 Hrs - to Day 9||11
7626011|NCT02327143|18778283|P1|STARTED|Day 1: Time 6 Hrs - to Day 9||0
7626012|NCT02327143|18778282|P2|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
7626013|NCT02327143|18778283|P1|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
7626014|NCT02327143|18778282|P2|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
7626015|NCT02327143|18778283|P1|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||11
7626016|NCT02327143|18778282|P2|STARTED|Day 1: Time 0 Hrs to 6 Hrs||0
7626017|NCT02327143|18778283|P1|STARTED|Day 1: Time 0 Hrs to 6 Hrs||11
7626018|NCT02327130|18778291|P1|NOT COMPLETED|Overall Study||12
7626019|NCT02327130|18778291|P1|COMPLETED|Overall Study||20
7626020|NCT02327130|18778291|P1|STARTED|Overall Study||32
7626021|NCT02327117|18778300|P2|NOT COMPLETED|Overall Study||0
7626022|NCT02327117|18778301|P1|NOT COMPLETED|Overall Study||0
7626023|NCT02327117|18778300|P2|COMPLETED|Overall Study||45
7626024|NCT02327117|18778301|P1|COMPLETED|Overall Study||45
7626025|NCT02327117|18778300|P2|STARTED|Overall Study||45
7626026|NCT02327117|18778301|P1|STARTED|Overall Study||45
7626027|NCT02327013|18778310|P5|NOT COMPLETED|Overall Study||4
7626028|NCT02327013|18778311|P4|NOT COMPLETED|Overall Study||1
7626029|NCT02327013|18778312|P3|NOT COMPLETED|Overall Study||42
7626030|NCT02327013|18778313|P2|NOT COMPLETED|Overall Study||16
7626031|NCT02327013|18778314|P1|NOT COMPLETED|Overall Study||13
7626032|NCT02327013|18778310|P5|COMPLETED|Overall Study||12
7626033|NCT02327013|18778311|P4|COMPLETED|Overall Study||20
7626034|NCT02327013|18778312|P3|COMPLETED|Overall Study||54
7626035|NCT02327013|18778313|P2|COMPLETED|Overall Study||29
7626036|NCT02327013|18778314|P1|COMPLETED|Overall Study||36
7626037|NCT02327013|18778310|P5|STARTED|Overall Study||16
7626038|NCT02327013|18778311|P4|STARTED|Overall Study||21
7626039|NCT02327013|18778312|P3|STARTED|Overall Study||96
7626040|NCT02327013|18778313|P2|STARTED|Overall Study||45
7626041|NCT02327013|18778314|P1|STARTED|Overall Study||49
7626042|NCT02326844|18778487|P1|NOT COMPLETED|Overall Study||0
7626043|NCT02326844|18778487|P1|COMPLETED|Overall Study||3
7626044|NCT02326844|18778487|P1|STARTED|Overall Study||3
7626045|NCT02326649|18778496|P1|NOT COMPLETED|Overall Study||12
7626046|NCT02326649|18778496|P1|COMPLETED|Overall Study||21
7626047|NCT02326649|18778496|P1|STARTED|Overall Study||33
7626048|NCT02326597|18778502|P2|NOT COMPLETED|Overall Study||32
7626049|NCT02326597|18778503|P1|NOT COMPLETED|Overall Study||42
7626050|NCT02326597|18778502|P2|COMPLETED|Overall Study||28
7626051|NCT02326597|18778503|P1|COMPLETED|Overall Study||18
7626052|NCT02326597|18778502|P2|STARTED|Overall Study||60
7626053|NCT02326597|18778503|P1|STARTED|Overall Study||60
7626054|NCT02326363|18778523|P2|NOT COMPLETED|Overall Study||56
7626055|NCT02326363|18778524|P1|NOT COMPLETED|Overall Study||51
7626056|NCT02326363|18778523|P2|COMPLETED|Overall Study||50
7626057|NCT02326363|18778524|P1|COMPLETED|Overall Study||47
7626058|NCT02326363|18778523|P2|STARTED|Overall Study||106
7626059|NCT02326363|18778524|P1|STARTED|Overall Study||98
7626060|NCT02326298|18778549|P14|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
7626061|NCT02326298|18778550|P13|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||19
7626062|NCT02326298|18778551|P12|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||20
7626063|NCT02326298|18778552|P11|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626064|NCT02326298|18778553|P10|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626065|NCT02326298|18778554|P9|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626066|NCT02326298|18778555|P8|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626067|NCT02326298|18778556|P7|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626068|NCT02326298|18778557|P6|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626069|NCT02326298|18778558|P5|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626070|NCT02326298|18778559|P4|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626071|NCT02326298|18778560|P3|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626072|NCT02326298|18778561|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626073|NCT02326298|18778562|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626074|NCT02326298|18778549|P14|COMPLETED|Open-label Period (Week 48 to Week 144)||44
7626075|NCT02326298|18778550|P13|COMPLETED|Open-label Period (Week 48 to Week 144)||51
7626076|NCT02326298|18778551|P12|COMPLETED|Open-label Period (Week 48 to Week 144)||54
7626077|NCT02326298|18778552|P11|COMPLETED|Open-label Period (Week 48 to Week 144)||3
7626078|NCT02326298|18778553|P10|COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626079|NCT02326298|18778554|P9|COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626080|NCT02326298|18778555|P8|COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626081|NCT02326298|18778556|P7|COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626082|NCT02326298|18778557|P6|COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626083|NCT02326298|18778558|P5|COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626084|NCT02326298|18778559|P4|COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626085|NCT02326298|18778560|P3|COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626086|NCT02326298|18778561|P2|COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626087|NCT02326298|18778562|P1|COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626088|NCT02326298|18778549|P14|STARTED|Open-label Period (Week 48 to Week 144)||53
7626089|NCT02326298|18778550|P13|STARTED|Open-label Period (Week 48 to Week 144)||70
7626090|NCT02326298|18778551|P12|STARTED|Open-label Period (Week 48 to Week 144)||74
7626091|NCT02326298|18778552|P11|STARTED|Open-label Period (Week 48 to Week 144)||3
7626092|NCT02326298|18778553|P10|STARTED|Open-label Period (Week 48 to Week 144)||0
7626093|NCT02326298|18778554|P9|STARTED|Open-label Period (Week 48 to Week 144)||0
7626094|NCT02326298|18778555|P8|STARTED|Open-label Period (Week 48 to Week 144)||0
7626095|NCT02326298|18778556|P7|STARTED|Open-label Period (Week 48 to Week 144)||0
7626096|NCT02326298|18778557|P6|STARTED|Open-label Period (Week 48 to Week 144)||0
7626097|NCT02326298|18778558|P5|STARTED|Open-label Period (Week 48 to Week 144)||0
7626098|NCT02326298|18778559|P4|STARTED|Open-label Period (Week 48 to Week 144)||0
7626099|NCT02326298|18778560|P3|STARTED|Open-label Period (Week 48 to Week 144)||0
7626100|NCT02326298|18778561|P2|STARTED|Open-label Period (Week 48 to Week 144)||0
7626101|NCT02326298|18778562|P1|STARTED|Open-label Period (Week 48 to Week 144)||0
7626102|NCT02326298|18778549|P14|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626103|NCT02326298|18778550|P13|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626104|NCT02326298|18778551|P12|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626105|NCT02326298|18778552|P11|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626106|NCT02326298|18778553|P10|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
7626107|NCT02326298|18778554|P9|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
7626108|NCT02326298|18778555|P8|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
7626109|NCT02326298|18778556|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
7626110|NCT02326298|18778557|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
7626111|NCT02326298|18778558|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626112|NCT02326298|18778559|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626113|NCT02326298|18778560|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626114|NCT02326298|18778561|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626115|NCT02326298|18778562|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626116|NCT02326298|18778549|P14|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626117|NCT02326298|18778550|P13|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626118|NCT02326298|18778551|P12|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626119|NCT02326298|18778552|P11|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626120|NCT02326298|18778553|P10|COMPLETED|Maintenance Period (Week 16 to Week 48)||7
7626121|NCT02326298|18778554|P9|COMPLETED|Maintenance Period (Week 16 to Week 48)||13
7626122|NCT02326298|18778555|P8|COMPLETED|Maintenance Period (Week 16 to Week 48)||33
7626123|NCT02326298|18778556|P7|COMPLETED|Maintenance Period (Week 16 to Week 48)||70
7626124|NCT02326298|18778557|P6|COMPLETED|Maintenance Period (Week 16 to Week 48)||69
7626125|NCT02326298|18778558|P5|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
7626126|NCT02326298|18778559|P4|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
7626127|NCT02326298|18778560|P3|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626128|NCT02326298|18778561|P2|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626129|NCT02326298|18778562|P1|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626130|NCT02326298|18778549|P14|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7626131|NCT02326298|18778550|P13|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7626132|NCT02326298|18778551|P12|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7626133|NCT02326298|18778552|P11|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7626134|NCT02326298|18778553|P10|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||7
7626135|NCT02326298|18778554|P9|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||13
7626136|NCT02326298|18778555|P8|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||33
7626137|NCT02326298|18778556|P7|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||70
7626138|NCT02326298|18778557|P6|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||69
7626139|NCT02326298|18778558|P5|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
7626140|NCT02326298|18778559|P4|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
7626141|NCT02326298|18778560|P3|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7626142|NCT02326298|18778561|P2|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7626143|NCT02326298|18778562|P1|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7626144|NCT02326298|18778549|P14|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
7626145|NCT02326298|18778550|P13|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
7626146|NCT02326298|18778551|P12|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
7626147|NCT02326298|18778552|P11|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
7626148|NCT02326298|18778553|P10|Completed Week 48|Maintenance Period (Week 16 to Week 48)||7
7626149|NCT02326298|18778554|P9|Completed Week 48|Maintenance Period (Week 16 to Week 48)||13
7626150|NCT02326298|18778555|P8|Completed Week 48|Maintenance Period (Week 16 to Week 48)||33
7626151|NCT02326298|18778556|P7|Completed Week 48|Maintenance Period (Week 16 to Week 48)||70
7626152|NCT02326298|18778557|P6|Completed Week 48|Maintenance Period (Week 16 to Week 48)||71
7626153|NCT02326298|18778558|P5|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
7626154|NCT02326298|18778559|P4|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
7626155|NCT02326298|18778560|P3|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
7626156|NCT02326298|18778561|P2|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
7626157|NCT02326298|18778562|P1|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
7626158|NCT02326298|18778549|P14|STARTED|Maintenance Period (Week 16 to Week 48)||0
7626159|NCT02326298|18778550|P13|STARTED|Maintenance Period (Week 16 to Week 48)||0
7626160|NCT02326298|18778551|P12|STARTED|Maintenance Period (Week 16 to Week 48)||0
7626161|NCT02326298|18778552|P11|STARTED|Maintenance Period (Week 16 to Week 48)||0
7626162|NCT02326298|18778553|P10|STARTED|Maintenance Period (Week 16 to Week 48)||8
7626163|NCT02326298|18778554|P9|STARTED|Maintenance Period (Week 16 to Week 48)||18
7626164|NCT02326298|18778555|P8|STARTED|Maintenance Period (Week 16 to Week 48)||38
7626165|NCT02326298|18778556|P7|STARTED|Maintenance Period (Week 16 to Week 48)||77
7626166|NCT02326298|18778557|P6|STARTED|Maintenance Period (Week 16 to Week 48)||74
7626167|NCT02326298|18778558|P5|STARTED|Maintenance Period (Week 16 to Week 48)||5
7626168|NCT02326298|18778559|P4|STARTED|Maintenance Period (Week 16 to Week 48)||3
7626169|NCT02326298|18778560|P3|STARTED|Maintenance Period (Week 16 to Week 48)||0
7626170|NCT02326298|18778561|P2|STARTED|Maintenance Period (Week 16 to Week 48)||0
7626171|NCT02326298|18778562|P1|STARTED|Maintenance Period (Week 16 to Week 48)||0
7626172|NCT02326298|18778549|P14|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626173|NCT02326298|18778550|P13|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626174|NCT02326298|18778551|P12|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626175|NCT02326298|18778552|P11|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626176|NCT02326298|18778553|P10|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626177|NCT02326298|18778554|P9|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626178|NCT02326298|18778555|P8|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626179|NCT02326298|18778556|P7|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626180|NCT02326298|18778557|P6|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626181|NCT02326298|18778558|P5|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626182|NCT02326298|18778559|P4|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626183|NCT02326298|18778560|P3|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
7626184|NCT02326298|18778561|P2|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
7626185|NCT02326298|18778562|P1|NOT COMPLETED|Initial Period (Week 0 to Week 16)||5
7626186|NCT02326298|18778549|P14|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626187|NCT02326298|18778550|P13|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626188|NCT02326298|18778551|P12|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626189|NCT02326298|18778552|P11|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626190|NCT02326298|18778553|P10|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626191|NCT02326298|18778554|P9|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626192|NCT02326298|18778555|P8|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626193|NCT02326298|18778556|P7|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626194|NCT02326298|18778557|P6|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626195|NCT02326298|18778558|P5|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626196|NCT02326298|18778559|P4|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626197|NCT02326298|18778560|P3|COMPLETED|Initial Period (Week 0 to Week 16)||85
7626198|NCT02326298|18778561|P2|COMPLETED|Initial Period (Week 0 to Week 16)||92
7626199|NCT02326298|18778562|P1|COMPLETED|Initial Period (Week 0 to Week 16)||46
7626200|NCT02326298|18778549|P14|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626201|NCT02326298|18778550|P13|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626202|NCT02326298|18778551|P12|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626203|NCT02326298|18778552|P11|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626204|NCT02326298|18778553|P10|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626205|NCT02326298|18778554|P9|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626206|NCT02326298|18778555|P8|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626207|NCT02326298|18778556|P7|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626208|NCT02326298|18778557|P6|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626209|NCT02326298|18778558|P5|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626210|NCT02326298|18778559|P4|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626211|NCT02326298|18778560|P3|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||85
7626212|NCT02326298|18778561|P2|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||92
7626213|NCT02326298|18778562|P1|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||46
7626214|NCT02326298|18778549|P14|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626215|NCT02326298|18778550|P13|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626216|NCT02326298|18778551|P12|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626217|NCT02326298|18778552|P11|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626218|NCT02326298|18778553|P10|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626219|NCT02326298|18778554|P9|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626220|NCT02326298|18778555|P8|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626221|NCT02326298|18778556|P7|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626222|NCT02326298|18778557|P6|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626223|NCT02326298|18778558|P5|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626224|NCT02326298|18778559|P4|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626225|NCT02326298|18778560|P3|Completed Week 16|Initial Period (Week 0 to Week 16)||87
7626226|NCT02326298|18778561|P2|Completed Week 16|Initial Period (Week 0 to Week 16)||92
7626227|NCT02326298|18778562|P1|Completed Week 16|Initial Period (Week 0 to Week 16)||46
7626228|NCT02326298|18778549|P14|STARTED|Initial Period (Week 0 to Week 16)||0
7626229|NCT02326298|18778550|P13|STARTED|Initial Period (Week 0 to Week 16)||0
7626230|NCT02326298|18778551|P12|STARTED|Initial Period (Week 0 to Week 16)||0
7626231|NCT02326298|18778552|P11|STARTED|Initial Period (Week 0 to Week 16)||0
7626232|NCT02326298|18778553|P10|STARTED|Initial Period (Week 0 to Week 16)||0
7626233|NCT02326298|18778554|P9|STARTED|Initial Period (Week 0 to Week 16)||0
7626234|NCT02326298|18778555|P8|STARTED|Initial Period (Week 0 to Week 16)||0
7626235|NCT02326298|18778556|P7|STARTED|Initial Period (Week 0 to Week 16)||0
7626236|NCT02326298|18778557|P6|STARTED|Initial Period (Week 0 to Week 16)||0
7626237|NCT02326298|18778558|P5|STARTED|Initial Period (Week 0 to Week 16)||0
7626238|NCT02326298|18778559|P4|STARTED|Initial Period (Week 0 to Week 16)||0
7626239|NCT02326298|18778560|P3|STARTED|Initial Period (Week 0 to Week 16)||88
7626240|NCT02326298|18778561|P2|STARTED|Initial Period (Week 0 to Week 16)||95
7626241|NCT02326298|18778562|P1|STARTED|Initial Period (Week 0 to Week 16)||51
7626242|NCT02326272|18778585|P15|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
7626243|NCT02326272|18778586|P14|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626244|NCT02326272|18778587|P13|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||11
7626245|NCT02326272|18778588|P12|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||15
7626246|NCT02326272|18778589|P11|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||3
7626247|NCT02326272|18778590|P10|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626248|NCT02326272|18778591|P9|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626249|NCT02326272|18778592|P8|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626250|NCT02326272|18778593|P7|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626251|NCT02326272|18778594|P6|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626252|NCT02326272|18778595|P5|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626253|NCT02326272|18778596|P4|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626254|NCT02326272|18778597|P3|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626255|NCT02326272|18778598|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626256|NCT02326272|18778599|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626257|NCT02326272|18778585|P15|COMPLETED|Open-label Period (Week 48 to Week 144)||31
7626258|NCT02326272|18778586|P14|COMPLETED|Open-label Period (Week 48 to Week 144)||1
7626259|NCT02326272|18778587|P13|COMPLETED|Open-label Period (Week 48 to Week 144)||48
7626260|NCT02326272|18778588|P12|COMPLETED|Open-label Period (Week 48 to Week 144)||51
7626261|NCT02326272|18778589|P11|COMPLETED|Open-label Period (Week 48 to Week 144)||2
7626262|NCT02326272|18778590|P10|COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626263|NCT02326272|18778591|P9|COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626264|NCT02326272|18778592|P8|COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626265|NCT02326272|18778593|P7|COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626266|NCT02326272|18778594|P6|COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626267|NCT02326272|18778595|P5|COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626268|NCT02326272|18778596|P4|COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626269|NCT02326272|18778597|P3|COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626270|NCT02326272|18778598|P2|COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626271|NCT02326272|18778599|P1|COMPLETED|Open-label Period (Week 48 to Week 144)||0
7626272|NCT02326272|18778585|P15|STARTED|Open-label Period (Week 48 to Week 144)||40
7626273|NCT02326272|18778586|P14|STARTED|Open-label Period (Week 48 to Week 144)||1
7626274|NCT02326272|18778587|P13|STARTED|Open-label Period (Week 48 to Week 144)||59
7626275|NCT02326272|18778588|P12|STARTED|Open-label Period (Week 48 to Week 144)||66
7626276|NCT02326272|18778589|P11|STARTED|Open-label Period (Week 48 to Week 144)||5
7626277|NCT02326272|18778590|P10|STARTED|Open-label Period (Week 48 to Week 144)||0
7626278|NCT02326272|18778591|P9|STARTED|Open-label Period (Week 48 to Week 144)||0
7626279|NCT02326272|18778592|P8|STARTED|Open-label Period (Week 48 to Week 144)||0
7626280|NCT02326272|18778593|P7|STARTED|Open-label Period (Week 48 to Week 144)||0
7626281|NCT02326272|18778594|P6|STARTED|Open-label Period (Week 48 to Week 144)||0
7626282|NCT02326272|18778595|P5|STARTED|Open-label Period (Week 48 to Week 144)||0
7626283|NCT02326272|18778596|P4|STARTED|Open-label Period (Week 48 to Week 144)||0
7626284|NCT02326272|18778597|P3|STARTED|Open-label Period (Week 48 to Week 144)||0
7626285|NCT02326272|18778598|P2|STARTED|Open-label Period (Week 48 to Week 144)||0
7626286|NCT02326272|18778599|P1|STARTED|Open-label Period (Week 48 to Week 144)||0
7626287|NCT02326272|18778585|P15|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626288|NCT02326272|18778586|P14|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626289|NCT02326272|18778587|P13|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626290|NCT02326272|18778588|P12|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626291|NCT02326272|18778589|P11|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626292|NCT02326272|18778590|P10|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
7626293|NCT02326272|18778591|P9|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
7626294|NCT02326272|18778592|P8|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
7626295|NCT02326272|18778593|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||9
7626296|NCT02326272|18778594|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||13
7626297|NCT02326272|18778595|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
7626298|NCT02326272|18778596|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
7626299|NCT02326272|18778597|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626300|NCT02326272|18778598|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626301|NCT02326272|18778599|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626302|NCT02326272|18778585|P15|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626303|NCT02326272|18778586|P14|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626304|NCT02326272|18778587|P13|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626305|NCT02326272|18778588|P12|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626306|NCT02326272|18778589|P11|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626307|NCT02326272|18778590|P10|COMPLETED|Maintenance Period (Week 16 to Week 48)||10
7626308|NCT02326272|18778591|P9|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
7626309|NCT02326272|18778592|P8|COMPLETED|Maintenance Period (Week 16 to Week 48)||27
7626310|NCT02326272|18778593|P7|COMPLETED|Maintenance Period (Week 16 to Week 48)||60
7626311|NCT02326272|18778594|P6|COMPLETED|Maintenance Period (Week 16 to Week 48)||63
7626312|NCT02326272|18778595|P5|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
7626313|NCT02326272|18778596|P4|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
7626314|NCT02326272|18778597|P3|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626315|NCT02326272|18778598|P2|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626316|NCT02326272|18778599|P1|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
7626317|NCT02326272|18778585|P15|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7626318|NCT02326272|18778586|P14|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7626319|NCT02326272|18778587|P13|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7626320|NCT02326272|18778588|P12|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7626321|NCT02326272|18778589|P11|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7626322|NCT02326272|18778590|P10|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||10
7626323|NCT02326272|18778591|P9|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
7626324|NCT02326272|18778592|P8|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||27
7626325|NCT02326272|18778593|P7|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||60
7626326|NCT02326272|18778594|P6|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||63
7626327|NCT02326272|18778595|P5|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
7626328|NCT02326272|18778596|P4|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
7626477|NCT02325791|18778741|P2|NOT COMPLETED|Overall Study||25
7626329|NCT02326272|18778597|P3|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7626330|NCT02326272|18778598|P2|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7626331|NCT02326272|18778599|P1|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
7626332|NCT02326272|18778585|P15|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
7626333|NCT02326272|18778586|P14|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
7626334|NCT02326272|18778587|P13|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
7626335|NCT02326272|18778588|P12|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
7626336|NCT02326272|18778589|P11|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
7626337|NCT02326272|18778590|P10|Completed Week 48|Maintenance Period (Week 16 to Week 48)||10
7626338|NCT02326272|18778591|P9|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
7626339|NCT02326272|18778592|P8|Completed Week 48|Maintenance Period (Week 16 to Week 48)||27
7626340|NCT02326272|18778593|P7|Completed Week 48|Maintenance Period (Week 16 to Week 48)||61
7626341|NCT02326272|18778594|P6|Completed Week 48|Maintenance Period (Week 16 to Week 48)||64
7626342|NCT02326272|18778595|P5|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
7626343|NCT02326272|18778596|P4|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
7626344|NCT02326272|18778597|P3|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
7626345|NCT02326272|18778598|P2|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
7626346|NCT02326272|18778599|P1|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
7626347|NCT02326272|18778585|P15|STARTED|Maintenance Period (Week 16 to Week 48)||0
7626348|NCT02326272|18778586|P14|STARTED|Maintenance Period (Week 16 to Week 48)||0
7626349|NCT02326272|18778587|P13|STARTED|Maintenance Period (Week 16 to Week 48)||0
7626350|NCT02326272|18778588|P12|STARTED|Maintenance Period (Week 16 to Week 48)||0
7626351|NCT02326272|18778589|P11|STARTED|Maintenance Period (Week 16 to Week 48)||0
7626352|NCT02326272|18778590|P10|STARTED|Maintenance Period (Week 16 to Week 48)||12
7626353|NCT02326272|18778591|P9|STARTED|Maintenance Period (Week 16 to Week 48)||8
7626354|NCT02326272|18778592|P8|STARTED|Maintenance Period (Week 16 to Week 48)||34
7626355|NCT02326272|18778593|P7|STARTED|Maintenance Period (Week 16 to Week 48)||69
7626356|NCT02326272|18778594|P6|STARTED|Maintenance Period (Week 16 to Week 48)||76
7626357|NCT02326272|18778595|P5|STARTED|Maintenance Period (Week 16 to Week 48)||5
7626358|NCT02326272|18778596|P4|STARTED|Maintenance Period (Week 16 to Week 48)||6
7626359|NCT02326272|18778597|P3|STARTED|Maintenance Period (Week 16 to Week 48)||0
7626360|NCT02326272|18778598|P2|STARTED|Maintenance Period (Week 16 to Week 48)||0
7626361|NCT02326272|18778599|P1|STARTED|Maintenance Period (Week 16 to Week 48)||0
7626362|NCT02326272|18778585|P15|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626363|NCT02326272|18778586|P14|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626364|NCT02326272|18778587|P13|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626365|NCT02326272|18778588|P12|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626366|NCT02326272|18778589|P11|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626367|NCT02326272|18778590|P10|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626368|NCT02326272|18778591|P9|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626369|NCT02326272|18778592|P8|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626370|NCT02326272|18778593|P7|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626371|NCT02326272|18778594|P6|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626372|NCT02326272|18778595|P5|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626373|NCT02326272|18778596|P4|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
7626374|NCT02326272|18778597|P3|NOT COMPLETED|Initial Period (Week 0 to Week 16)||6
7626375|NCT02326272|18778598|P2|NOT COMPLETED|Initial Period (Week 0 to Week 16)||7
7626376|NCT02326272|18778599|P1|NOT COMPLETED|Initial Period (Week 0 to Week 16)||4
7626377|NCT02326272|18778585|P15|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626378|NCT02326272|18778586|P14|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626379|NCT02326272|18778587|P13|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626380|NCT02326272|18778588|P12|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626381|NCT02326272|18778589|P11|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626382|NCT02326272|18778590|P10|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626383|NCT02326272|18778591|P9|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626384|NCT02326272|18778592|P8|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626385|NCT02326272|18778593|P7|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626386|NCT02326272|18778594|P6|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626387|NCT02326272|18778595|P5|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626388|NCT02326272|18778596|P4|COMPLETED|Initial Period (Week 0 to Week 16)||0
7626389|NCT02326272|18778597|P3|COMPLETED|Initial Period (Week 0 to Week 16)||81
7626390|NCT02326272|18778598|P2|COMPLETED|Initial Period (Week 0 to Week 16)||84
7626391|NCT02326272|18778599|P1|COMPLETED|Initial Period (Week 0 to Week 16)||45
7626392|NCT02326272|18778585|P15|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626393|NCT02326272|18778586|P14|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626394|NCT02326272|18778587|P13|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626395|NCT02326272|18778588|P12|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626396|NCT02326272|18778589|P11|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626397|NCT02326272|18778590|P10|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626398|NCT02326272|18778591|P9|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626399|NCT02326272|18778592|P8|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626400|NCT02326272|18778593|P7|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626401|NCT02326272|18778594|P6|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626402|NCT02326272|18778595|P5|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626403|NCT02326272|18778596|P4|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
7626404|NCT02326272|18778597|P3|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||81
7626405|NCT02326272|18778598|P2|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||84
7626406|NCT02326272|18778599|P1|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||45
7626407|NCT02326272|18778585|P15|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626408|NCT02326272|18778586|P14|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626409|NCT02326272|18778587|P13|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626410|NCT02326272|18778588|P12|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626411|NCT02326272|18778589|P11|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626412|NCT02326272|18778590|P10|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626413|NCT02326272|18778591|P9|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626414|NCT02326272|18778592|P8|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626415|NCT02326272|18778593|P7|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626416|NCT02326272|18778594|P6|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626417|NCT02326272|18778595|P5|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626418|NCT02326272|18778596|P4|Completed Week 16|Initial Period (Week 0 to Week 16)||0
7626419|NCT02326272|18778597|P3|Completed Week 16|Initial Period (Week 0 to Week 16)||83
7626420|NCT02326272|18778598|P2|Completed Week 16|Initial Period (Week 0 to Week 16)||84
7626421|NCT02326272|18778599|P1|Completed Week 16|Initial Period (Week 0 to Week 16)||45
7626422|NCT02326272|18778585|P15|STARTED|Initial Period (Week 0 to Week 16)||0
7626423|NCT02326272|18778586|P14|STARTED|Initial Period (Week 0 to Week 16)||0
7626424|NCT02326272|18778587|P13|STARTED|Initial Period (Week 0 to Week 16)||0
7626425|NCT02326272|18778588|P12|STARTED|Initial Period (Week 0 to Week 16)||0
7626426|NCT02326272|18778589|P11|STARTED|Initial Period (Week 0 to Week 16)||0
7626427|NCT02326272|18778590|P10|STARTED|Initial Period (Week 0 to Week 16)||0
7626428|NCT02326272|18778591|P9|STARTED|Initial Period (Week 0 to Week 16)||0
7626429|NCT02326272|18778592|P8|STARTED|Initial Period (Week 0 to Week 16)||0
7626430|NCT02326272|18778593|P7|STARTED|Initial Period (Week 0 to Week 16)||0
7626431|NCT02326272|18778594|P6|STARTED|Initial Period (Week 0 to Week 16)||0
7626432|NCT02326272|18778595|P5|STARTED|Initial Period (Week 0 to Week 16)||0
7626433|NCT02326272|18778596|P4|STARTED|Initial Period (Week 0 to Week 16)||0
7626434|NCT02326272|18778597|P3|STARTED|Initial Period (Week 0 to Week 16)||87
7626435|NCT02326272|18778598|P2|STARTED|Initial Period (Week 0 to Week 16)||91
7626436|NCT02326272|18778599|P1|STARTED|Initial Period (Week 0 to Week 16)||49
7626437|NCT02326233|18778621|P2|NOT COMPLETED|Overall Study||1
7626438|NCT02326233|18778622|P1|NOT COMPLETED|Overall Study||0
7626439|NCT02326233|18778621|P2|COMPLETED|Overall Study||94
7626440|NCT02326233|18778622|P1|COMPLETED|Overall Study||95
7626441|NCT02326233|18778621|P2|STARTED|Overall Study||95
7626442|NCT02326233|18778622|P1|STARTED|Overall Study||95
7626443|NCT02326220|18778636|P3|NOT COMPLETED|Open-label Treatment Period||2
7626444|NCT02326220|18778637|P2|NOT COMPLETED|Open-label Treatment Period||0
7626445|NCT02326220|18778638|P1|NOT COMPLETED|Open-label Treatment Period||0
7626446|NCT02326220|18778636|P3|COMPLETED|Open-label Treatment Period||27
7626447|NCT02326220|18778637|P2|COMPLETED|Open-label Treatment Period||0
7626448|NCT02326220|18778638|P1|COMPLETED|Open-label Treatment Period||0
7626449|NCT02326220|18778636|P3|STARTED|Open-label Treatment Period|29 participants: 9 from Placebo and 20 from Alirocumab 150 mg arm entered in open-label period.|29
7626450|NCT02326220|18778637|P2|STARTED|Open-label Treatment Period||0
7626451|NCT02326220|18778638|P1|STARTED|Open-label Treatment Period||0
7626452|NCT02326220|18778636|P3|NOT COMPLETED|Double-blind Treatment Period||0
7626453|NCT02326220|18778637|P2|NOT COMPLETED|Double-blind Treatment Period||4
7626454|NCT02326220|18778638|P1|NOT COMPLETED|Double-blind Treatment Period||1
7626455|NCT02326220|18778636|P3|COMPLETED|Double-blind Treatment Period||0
7626456|NCT02326220|18778637|P2|COMPLETED|Double-blind Treatment Period||37
7626457|NCT02326220|18778638|P1|COMPLETED|Double-blind Treatment Period||20
7626458|NCT02326220|18778636|P3|STARTED|Double-blind Treatment Period||0
7626459|NCT02326220|18778637|P2|STARTED|Double-blind Treatment Period|Out of 41 participants, 20 participants entered in open label treatment period.|41
7626460|NCT02326220|18778638|P1|STARTED|Double-blind Treatment Period|Out of 21 participants, 9 participants entered in open label treatment period|21
7626461|NCT02326025|18778691|P2|NOT COMPLETED|Overall Study||5
7626462|NCT02326025|18778692|P1|NOT COMPLETED|Overall Study||5
7626463|NCT02326025|18778691|P2|COMPLETED|Overall Study||19
7626464|NCT02326025|18778692|P1|COMPLETED|Overall Study||20
7626465|NCT02326025|18778691|P2|Received at Least 1 Dose of Study Drug|Overall Study||24
7626466|NCT02326025|18778692|P1|Received at Least 1 Dose of Study Drug|Overall Study||25
7626467|NCT02326025|18778691|P2|STARTED|Overall Study||24
7626468|NCT02326025|18778692|P1|STARTED|Overall Study||25
7626469|NCT02325856|18778726|P2|NOT COMPLETED|Overall Study||27
7626470|NCT02325856|18778727|P1|NOT COMPLETED|Overall Study||20
7626471|NCT02325856|18778726|P2|COMPLETED|Overall Study||123
7626472|NCT02325856|18778727|P1|COMPLETED|Overall Study||128
7626473|NCT02325856|18778726|P2|STARTED|Overall Study||150
7626474|NCT02325856|18778727|P1|STARTED|Overall Study||148
7626475|NCT02325791|18778739|P4|NOT COMPLETED|Overall Study||26
7626476|NCT02325791|18778740|P3|NOT COMPLETED|Overall Study||25
7626478|NCT02325791|18778742|P1|NOT COMPLETED|Overall Study||0
7626479|NCT02325791|18778739|P4|COMPLETED|Overall Study||355
7626480|NCT02325791|18778740|P3|COMPLETED|Overall Study||360
7626481|NCT02325791|18778741|P2|COMPLETED|Overall Study||358
7626482|NCT02325791|18778742|P1|COMPLETED|Overall Study||23
7626483|NCT02325791|18778739|P4|STARTED|Overall Study||381
7626484|NCT02325791|18778740|P3|STARTED|Overall Study||385
7626485|NCT02325791|18778741|P2|STARTED|Overall Study||383
7626486|NCT02325791|18778742|P1|STARTED|Overall Study||23
7626487|NCT02325739|18778772|P11|NOT COMPLETED|Phase II Part||20
7626488|NCT02325739|18778773|P10|NOT COMPLETED|Phase II Part||36
7626489|NCT02325739|18778774|P9|NOT COMPLETED|Phase II Part||30
7626490|NCT02325739|18778775|P8|NOT COMPLETED|Phase II Part||0
7626491|NCT02325739|18778776|P7|NOT COMPLETED|Phase II Part||0
7626492|NCT02325739|18778777|P6|NOT COMPLETED|Phase II Part||0
7626493|NCT02325739|18778778|P5|NOT COMPLETED|Phase II Part||0
7626494|NCT02325739|18778779|P4|NOT COMPLETED|Phase II Part||0
7626495|NCT02325739|18778780|P3|NOT COMPLETED|Phase II Part||0
7626496|NCT02325739|18778781|P2|NOT COMPLETED|Phase II Part||0
7626497|NCT02325739|18778782|P1|NOT COMPLETED|Phase II Part||0
7626498|NCT02325739|18778772|P11|COMPLETED|Phase II Part||0
7626499|NCT02325739|18778773|P10|COMPLETED|Phase II Part||0
7626500|NCT02325739|18778774|P9|COMPLETED|Phase II Part||0
7626501|NCT02325739|18778775|P8|COMPLETED|Phase II Part||0
7626502|NCT02325739|18778776|P7|COMPLETED|Phase II Part||0
7626503|NCT02325739|18778777|P6|COMPLETED|Phase II Part||0
7626504|NCT02325739|18778778|P5|COMPLETED|Phase II Part||0
7626505|NCT02325739|18778779|P4|COMPLETED|Phase II Part||0
7626506|NCT02325739|18778780|P3|COMPLETED|Phase II Part||0
7626507|NCT02325739|18778781|P2|COMPLETED|Phase II Part||0
7626508|NCT02325739|18778782|P1|COMPLETED|Phase II Part||0
7626509|NCT02325739|18778772|P11|STARTED|Phase II Part||20
7626510|NCT02325739|18778773|P10|STARTED|Phase II Part||36
7626511|NCT02325739|18778774|P9|STARTED|Phase II Part||30
7626512|NCT02325739|18778775|P8|STARTED|Phase II Part||0
7626513|NCT02325739|18778776|P7|STARTED|Phase II Part||0
7626514|NCT02325739|18778777|P6|STARTED|Phase II Part||0
7626515|NCT02325739|18778778|P5|STARTED|Phase II Part||0
7626516|NCT02325739|18778779|P4|STARTED|Phase II Part||0
7626517|NCT02325739|18778780|P3|STARTED|Phase II Part||0
7626518|NCT02325739|18778781|P2|STARTED|Phase II Part||0
7626519|NCT02325739|18778782|P1|STARTED|Phase II Part||0
7626520|NCT02325739|18778772|P11|NOT COMPLETED|Phase I Part||0
7626521|NCT02325739|18778773|P10|NOT COMPLETED|Phase I Part||0
7626522|NCT02325739|18778774|P9|NOT COMPLETED|Phase I Part||0
7626523|NCT02325739|18778775|P8|NOT COMPLETED|Phase I Part||6
7626524|NCT02325739|18778776|P7|NOT COMPLETED|Phase I Part||6
7626525|NCT02325739|18778777|P6|NOT COMPLETED|Phase I Part||7
7626526|NCT02325739|18778778|P5|NOT COMPLETED|Phase I Part||19
7626527|NCT02325739|18778779|P4|NOT COMPLETED|Phase I Part||26
7626528|NCT02325739|18778780|P3|NOT COMPLETED|Phase I Part||5
7626529|NCT02325739|18778781|P2|NOT COMPLETED|Phase I Part||6
7626530|NCT02325739|18778782|P1|NOT COMPLETED|Phase I Part||11
7626531|NCT02325739|18778772|P11|COMPLETED|Phase I Part||0
7626532|NCT02325739|18778773|P10|COMPLETED|Phase I Part||0
7626533|NCT02325739|18778774|P9|COMPLETED|Phase I Part||0
7626534|NCT02325739|18778775|P8|COMPLETED|Phase I Part||0
7626535|NCT02325739|18778776|P7|COMPLETED|Phase I Part||0
7626536|NCT02325739|18778777|P6|COMPLETED|Phase I Part||0
7626537|NCT02325739|18778778|P5|COMPLETED|Phase I Part||0
7626538|NCT02325739|18778779|P4|COMPLETED|Phase I Part||0
7626539|NCT02325739|18778780|P3|COMPLETED|Phase I Part||0
7626540|NCT02325739|18778781|P2|COMPLETED|Phase I Part||0
7626541|NCT02325739|18778782|P1|COMPLETED|Phase I Part||0
7626542|NCT02325739|18778772|P11|STARTED|Phase I Part||0
7626543|NCT02325739|18778773|P10|STARTED|Phase I Part||0
7626544|NCT02325739|18778774|P9|STARTED|Phase I Part||0
7626545|NCT02325739|18778775|P8|STARTED|Phase I Part||6
7626546|NCT02325739|18778776|P7|STARTED|Phase I Part||6
7626547|NCT02325739|18778777|P6|STARTED|Phase I Part||7
7626548|NCT02325739|18778778|P5|STARTED|Phase I Part||19
7626549|NCT02325739|18778779|P4|STARTED|Phase I Part||26
7626550|NCT02325739|18778780|P3|STARTED|Phase I Part||5
7626551|NCT02325739|18778781|P2|STARTED|Phase I Part||6
7626552|NCT02325739|18778782|P1|STARTED|Phase I Part||11
7626553|NCT02325713|18778912|P16|NOT COMPLETED|Intervention Period 4 (2 Days)||0
7626554|NCT02325713|18778913|P15|NOT COMPLETED|Intervention Period 4 (2 Days)||0
7626555|NCT02325713|18778914|P14|NOT COMPLETED|Intervention Period 4 (2 Days)||0
7626556|NCT02325713|18778915|P13|NOT COMPLETED|Intervention Period 4 (2 Days)||0
7626557|NCT02325713|18778916|P12|NOT COMPLETED|Intervention Period 4 (2 Days)||0
7626558|NCT02325713|18778917|P11|NOT COMPLETED|Intervention Period 4 (2 Days)||0
7626559|NCT02325713|18778918|P10|NOT COMPLETED|Intervention Period 4 (2 Days)||0
7626560|NCT02325713|18778919|P9|NOT COMPLETED|Intervention Period 4 (2 Days)||0
7626561|NCT02325713|18778920|P8|NOT COMPLETED|Intervention Period 4 (2 Days)||0
7626562|NCT02325713|18778921|P7|NOT COMPLETED|Intervention Period 4 (2 Days)||0
7626563|NCT02325713|18778922|P6|NOT COMPLETED|Intervention Period 4 (2 Days)||0
7626564|NCT02325713|18778923|P5|NOT COMPLETED|Intervention Period 4 (2 Days)||0
7626565|NCT02325713|18778924|P4|NOT COMPLETED|Intervention Period 4 (2 Days)||0
7626566|NCT02325713|18778925|P3|NOT COMPLETED|Intervention Period 4 (2 Days)||0
7626567|NCT02325713|18778926|P2|NOT COMPLETED|Intervention Period 4 (2 Days)||0
7626568|NCT02325713|18778927|P1|NOT COMPLETED|Intervention Period 4 (2 Days)||0
7626569|NCT02325713|18778912|P16|COMPLETED|Intervention Period 4 (2 Days)||2
7626570|NCT02325713|18778913|P15|COMPLETED|Intervention Period 4 (2 Days)||2
7626571|NCT02325713|18778914|P14|COMPLETED|Intervention Period 4 (2 Days)||2
7626572|NCT02325713|18778915|P13|COMPLETED|Intervention Period 4 (2 Days)||2
7626573|NCT02325713|18778916|P12|COMPLETED|Intervention Period 4 (2 Days)||2
7626574|NCT02325713|18778917|P11|COMPLETED|Intervention Period 4 (2 Days)||1
7626575|NCT02325713|18778918|P10|COMPLETED|Intervention Period 4 (2 Days)||1
7626576|NCT02325713|18778919|P9|COMPLETED|Intervention Period 4 (2 Days)||2
7626577|NCT02325713|18778920|P8|COMPLETED|Intervention Period 4 (2 Days)||2
7626578|NCT02325713|18778921|P7|COMPLETED|Intervention Period 4 (2 Days)||2
7626579|NCT02325713|18778922|P6|COMPLETED|Intervention Period 4 (2 Days)||2
7626580|NCT02325713|18778923|P5|COMPLETED|Intervention Period 4 (2 Days)||2
7626581|NCT02325713|18778924|P4|COMPLETED|Intervention Period 4 (2 Days)||2
7626582|NCT02325713|18778925|P3|COMPLETED|Intervention Period 4 (2 Days)||2
7626583|NCT02325713|18778926|P2|COMPLETED|Intervention Period 4 (2 Days)||2
7626584|NCT02325713|18778927|P1|COMPLETED|Intervention Period 4 (2 Days)||1
7626585|NCT02325713|18778912|P16|STARTED|Intervention Period 4 (2 Days)||2
7626586|NCT02325713|18778913|P15|STARTED|Intervention Period 4 (2 Days)||2
7626587|NCT02325713|18778914|P14|STARTED|Intervention Period 4 (2 Days)||2
7626588|NCT02325713|18778915|P13|STARTED|Intervention Period 4 (2 Days)||2
7626589|NCT02325713|18778916|P12|STARTED|Intervention Period 4 (2 Days)||2
7626590|NCT02325713|18778917|P11|STARTED|Intervention Period 4 (2 Days)||1
7626591|NCT02325713|18778918|P10|STARTED|Intervention Period 4 (2 Days)||1
7626592|NCT02325713|18778919|P9|STARTED|Intervention Period 4 (2 Days)||2
7626593|NCT02325713|18778920|P8|STARTED|Intervention Period 4 (2 Days)||2
7626594|NCT02325713|18778921|P7|STARTED|Intervention Period 4 (2 Days)||2
7626595|NCT02325713|18778922|P6|STARTED|Intervention Period 4 (2 Days)||2
7626596|NCT02325713|18778923|P5|STARTED|Intervention Period 4 (2 Days)||2
7626597|NCT02325713|18778924|P4|STARTED|Intervention Period 4 (2 Days)||2
7626598|NCT02325713|18778925|P3|STARTED|Intervention Period 4 (2 Days)||2
7626599|NCT02325713|18778926|P2|STARTED|Intervention Period 4 (2 Days)||2
7626600|NCT02325713|18778927|P1|STARTED|Intervention Period 4 (2 Days)||1
7626601|NCT02325713|18778912|P16|NOT COMPLETED|Intervention Period 3 (2 Days)||0
7626602|NCT02325713|18778913|P15|NOT COMPLETED|Intervention Period 3 (2 Days)||0
7626603|NCT02325713|18778914|P14|NOT COMPLETED|Intervention Period 3 (2 Days)||0
7626604|NCT02325713|18778915|P13|NOT COMPLETED|Intervention Period 3 (2 Days)||0
7626605|NCT02325713|18778916|P12|NOT COMPLETED|Intervention Period 3 (2 Days)||0
7626606|NCT02325713|18778917|P11|NOT COMPLETED|Intervention Period 3 (2 Days)||0
7626607|NCT02325713|18778918|P10|NOT COMPLETED|Intervention Period 3 (2 Days)||1
7626608|NCT02325713|18778919|P9|NOT COMPLETED|Intervention Period 3 (2 Days)||0
7626609|NCT02325713|18778920|P8|NOT COMPLETED|Intervention Period 3 (2 Days)||0
7626610|NCT02325713|18778921|P7|NOT COMPLETED|Intervention Period 3 (2 Days)||0
7626611|NCT02325713|18778922|P6|NOT COMPLETED|Intervention Period 3 (2 Days)||0
7626612|NCT02325713|18778923|P5|NOT COMPLETED|Intervention Period 3 (2 Days)||0
7626613|NCT02325713|18778924|P4|NOT COMPLETED|Intervention Period 3 (2 Days)||0
7626614|NCT02325713|18778925|P3|NOT COMPLETED|Intervention Period 3 (2 Days)||0
7626615|NCT02325713|18778926|P2|NOT COMPLETED|Intervention Period 3 (2 Days)||0
7626616|NCT02325713|18778927|P1|NOT COMPLETED|Intervention Period 3 (2 Days)||0
7626617|NCT02325713|18778912|P16|COMPLETED|Intervention Period 3 (2 Days)||2
7626618|NCT02325713|18778913|P15|COMPLETED|Intervention Period 3 (2 Days)||2
7626619|NCT02325713|18778914|P14|COMPLETED|Intervention Period 3 (2 Days)||2
7626620|NCT02325713|18778915|P13|COMPLETED|Intervention Period 3 (2 Days)||2
7626621|NCT02325713|18778916|P12|COMPLETED|Intervention Period 3 (2 Days)||2
7626622|NCT02325713|18778917|P11|COMPLETED|Intervention Period 3 (2 Days)||1
7626623|NCT02325713|18778918|P10|COMPLETED|Intervention Period 3 (2 Days)||1
7626624|NCT02325713|18778919|P9|COMPLETED|Intervention Period 3 (2 Days)||2
7626625|NCT02325713|18778920|P8|COMPLETED|Intervention Period 3 (2 Days)||2
7626626|NCT02325713|18778921|P7|COMPLETED|Intervention Period 3 (2 Days)||2
7626627|NCT02325713|18778922|P6|COMPLETED|Intervention Period 3 (2 Days)||2
7626628|NCT02325713|18778923|P5|COMPLETED|Intervention Period 3 (2 Days)||2
7626629|NCT02325713|18778924|P4|COMPLETED|Intervention Period 3 (2 Days)||2
7626630|NCT02325713|18778925|P3|COMPLETED|Intervention Period 3 (2 Days)||2
7626631|NCT02325713|18778926|P2|COMPLETED|Intervention Period 3 (2 Days)||2
7626632|NCT02325713|18778927|P1|COMPLETED|Intervention Period 3 (2 Days)||1
7626633|NCT02325713|18778912|P16|STARTED|Intervention Period 3 (2 Days)||2
7626634|NCT02325713|18778913|P15|STARTED|Intervention Period 3 (2 Days)||2
7626635|NCT02325713|18778914|P14|STARTED|Intervention Period 3 (2 Days)||2
7626636|NCT02325713|18778915|P13|STARTED|Intervention Period 3 (2 Days)||2
7626637|NCT02325713|18778916|P12|STARTED|Intervention Period 3 (2 Days)||2
7626638|NCT02325713|18778917|P11|STARTED|Intervention Period 3 (2 Days)||1
7626639|NCT02325713|18778918|P10|STARTED|Intervention Period 3 (2 Days)||2
7626640|NCT02325713|18778919|P9|STARTED|Intervention Period 3 (2 Days)||2
7626641|NCT02325713|18778920|P8|STARTED|Intervention Period 3 (2 Days)||2
7626642|NCT02325713|18778921|P7|STARTED|Intervention Period 3 (2 Days)||2
7626643|NCT02325713|18778922|P6|STARTED|Intervention Period 3 (2 Days)||2
7626644|NCT02325713|18778923|P5|STARTED|Intervention Period 3 (2 Days)||2
7626645|NCT02325713|18778924|P4|STARTED|Intervention Period 3 (2 Days)||2
7626646|NCT02325713|18778925|P3|STARTED|Intervention Period 3 (2 Days)||2
7626647|NCT02325713|18778926|P2|STARTED|Intervention Period 3 (2 Days)||2
7626648|NCT02325713|18778927|P1|STARTED|Intervention Period 3 (2 Days)||1
7626649|NCT02325713|18778912|P16|NOT COMPLETED|Intervention Period 2 (2 Days)||0
7626650|NCT02325713|18778913|P15|NOT COMPLETED|Intervention Period 2 (2 Days)||0
7626651|NCT02325713|18778914|P14|NOT COMPLETED|Intervention Period 2 (2 Days)||0
7626652|NCT02325713|18778915|P13|NOT COMPLETED|Intervention Period 2 (2 Days)||0
7626653|NCT02325713|18778916|P12|NOT COMPLETED|Intervention Period 2 (2 Days)||0
7626654|NCT02325713|18778917|P11|NOT COMPLETED|Intervention Period 2 (2 Days)||0
7626655|NCT02325713|18778918|P10|NOT COMPLETED|Intervention Period 2 (2 Days)||0
7626656|NCT02325713|18778919|P9|NOT COMPLETED|Intervention Period 2 (2 Days)||0
7626657|NCT02325713|18778920|P8|NOT COMPLETED|Intervention Period 2 (2 Days)||0
7626658|NCT02325713|18778921|P7|NOT COMPLETED|Intervention Period 2 (2 Days)||0
7626659|NCT02325713|18778922|P6|NOT COMPLETED|Intervention Period 2 (2 Days)||0
7626660|NCT02325713|18778923|P5|NOT COMPLETED|Intervention Period 2 (2 Days)||0
7626661|NCT02325713|18778924|P4|NOT COMPLETED|Intervention Period 2 (2 Days)||0
7626662|NCT02325713|18778925|P3|NOT COMPLETED|Intervention Period 2 (2 Days)||0
7626663|NCT02325713|18778926|P2|NOT COMPLETED|Intervention Period 2 (2 Days)||0
7626664|NCT02325713|18778927|P1|NOT COMPLETED|Intervention Period 2 (2 Days)||1
7626665|NCT02325713|18778912|P16|COMPLETED|Intervention Period 2 (2 Days)||2
7626666|NCT02325713|18778913|P15|COMPLETED|Intervention Period 2 (2 Days)||2
7626667|NCT02325713|18778914|P14|COMPLETED|Intervention Period 2 (2 Days)||2
7626668|NCT02325713|18778915|P13|COMPLETED|Intervention Period 2 (2 Days)||2
7626669|NCT02325713|18778916|P12|COMPLETED|Intervention Period 2 (2 Days)||2
7626670|NCT02325713|18778917|P11|COMPLETED|Intervention Period 2 (2 Days)||1
7626671|NCT02325713|18778918|P10|COMPLETED|Intervention Period 2 (2 Days)||2
7626672|NCT02325713|18778919|P9|COMPLETED|Intervention Period 2 (2 Days)||2
7626673|NCT02325713|18778920|P8|COMPLETED|Intervention Period 2 (2 Days)||2
7626674|NCT02325713|18778921|P7|COMPLETED|Intervention Period 2 (2 Days)||2
7626675|NCT02325713|18778922|P6|COMPLETED|Intervention Period 2 (2 Days)||2
7626676|NCT02325713|18778923|P5|COMPLETED|Intervention Period 2 (2 Days)||2
7626677|NCT02325713|18778924|P4|COMPLETED|Intervention Period 2 (2 Days)||2
7626678|NCT02325713|18778925|P3|COMPLETED|Intervention Period 2 (2 Days)||2
7626679|NCT02325713|18778926|P2|COMPLETED|Intervention Period 2 (2 Days)||2
7626680|NCT02325713|18778927|P1|COMPLETED|Intervention Period 2 (2 Days)||1
7626681|NCT02325713|18778912|P16|STARTED|Intervention Period 2 (2 Days)||2
7626682|NCT02325713|18778913|P15|STARTED|Intervention Period 2 (2 Days)||2
7626683|NCT02325713|18778914|P14|STARTED|Intervention Period 2 (2 Days)||2
7626684|NCT02325713|18778915|P13|STARTED|Intervention Period 2 (2 Days)||2
7626685|NCT02325713|18778916|P12|STARTED|Intervention Period 2 (2 Days)||2
7626686|NCT02325713|18778917|P11|STARTED|Intervention Period 2 (2 Days)||1
7626687|NCT02325713|18778918|P10|STARTED|Intervention Period 2 (2 Days)||2
7626688|NCT02325713|18778919|P9|STARTED|Intervention Period 2 (2 Days)||2
7626689|NCT02325713|18778920|P8|STARTED|Intervention Period 2 (2 Days)||2
7626690|NCT02325713|18778921|P7|STARTED|Intervention Period 2 (2 Days)||2
7626691|NCT02325713|18778922|P6|STARTED|Intervention Period 2 (2 Days)||2
7626692|NCT02325713|18778923|P5|STARTED|Intervention Period 2 (2 Days)||2
7626693|NCT02325713|18778924|P4|STARTED|Intervention Period 2 (2 Days)||2
7626694|NCT02325713|18778925|P3|STARTED|Intervention Period 2 (2 Days)||2
7626695|NCT02325713|18778926|P2|STARTED|Intervention Period 2 (2 Days)||2
7626696|NCT02325713|18778927|P1|STARTED|Intervention Period 2 (2 Days)||2
7626697|NCT02325713|18778912|P16|NOT COMPLETED|Intervention Period 1 (2 Days)||0
7626698|NCT02325713|18778913|P15|NOT COMPLETED|Intervention Period 1 (2 Days)||0
7626699|NCT02325713|18778914|P14|NOT COMPLETED|Intervention Period 1 (2 Days)||0
7626700|NCT02325713|18778915|P13|NOT COMPLETED|Intervention Period 1 (2 Days)||0
7626701|NCT02325713|18778916|P12|NOT COMPLETED|Intervention Period 1 (2 Days)||0
7626702|NCT02325713|18778917|P11|NOT COMPLETED|Intervention Period 1 (2 Days)||1
7626703|NCT02325713|18778918|P10|NOT COMPLETED|Intervention Period 1 (2 Days)||0
7626704|NCT02325713|18778919|P9|NOT COMPLETED|Intervention Period 1 (2 Days)||0
7626705|NCT02325713|18778920|P8|NOT COMPLETED|Intervention Period 1 (2 Days)||0
7626706|NCT02325713|18778921|P7|NOT COMPLETED|Intervention Period 1 (2 Days)||0
7626707|NCT02325713|18778922|P6|NOT COMPLETED|Intervention Period 1 (2 Days)||0
7626708|NCT02325713|18778923|P5|NOT COMPLETED|Intervention Period 1 (2 Days)||0
7626709|NCT02325713|18778924|P4|NOT COMPLETED|Intervention Period 1 (2 Days)||0
7626710|NCT02325713|18778925|P3|NOT COMPLETED|Intervention Period 1 (2 Days)||0
7626711|NCT02325713|18778926|P2|NOT COMPLETED|Intervention Period 1 (2 Days)||0
7626712|NCT02325713|18778927|P1|NOT COMPLETED|Intervention Period 1 (2 Days)||0
7626713|NCT02325713|18778912|P16|COMPLETED|Intervention Period 1 (2 Days)||2
7626714|NCT02325713|18778913|P15|COMPLETED|Intervention Period 1 (2 Days)||2
7626715|NCT02325713|18778914|P14|COMPLETED|Intervention Period 1 (2 Days)||2
7626716|NCT02325713|18778915|P13|COMPLETED|Intervention Period 1 (2 Days)||2
7626717|NCT02325713|18778916|P12|COMPLETED|Intervention Period 1 (2 Days)||2
7626718|NCT02325713|18778917|P11|COMPLETED|Intervention Period 1 (2 Days)||1
7626719|NCT02325713|18778918|P10|COMPLETED|Intervention Period 1 (2 Days)||2
7626720|NCT02325713|18778919|P9|COMPLETED|Intervention Period 1 (2 Days)||2
7626721|NCT02325713|18778920|P8|COMPLETED|Intervention Period 1 (2 Days)||2
7626722|NCT02325713|18778921|P7|COMPLETED|Intervention Period 1 (2 Days)||2
7626723|NCT02325713|18778922|P6|COMPLETED|Intervention Period 1 (2 Days)||2
7626724|NCT02325713|18778923|P5|COMPLETED|Intervention Period 1 (2 Days)||2
7626725|NCT02325713|18778924|P4|COMPLETED|Intervention Period 1 (2 Days)||2
7626726|NCT02325713|18778925|P3|COMPLETED|Intervention Period 1 (2 Days)||2
7626727|NCT02325713|18778926|P2|COMPLETED|Intervention Period 1 (2 Days)||2
7626728|NCT02325713|18778927|P1|COMPLETED|Intervention Period 1 (2 Days)||2
7626729|NCT02325713|18778912|P16|STARTED|Intervention Period 1 (2 Days)||2
7626730|NCT02325713|18778913|P15|STARTED|Intervention Period 1 (2 Days)||2
7626731|NCT02325713|18778914|P14|STARTED|Intervention Period 1 (2 Days)||2
7626732|NCT02325713|18778915|P13|STARTED|Intervention Period 1 (2 Days)||2
7626733|NCT02325713|18778916|P12|STARTED|Intervention Period 1 (2 Days)||2
7626734|NCT02325713|18778917|P11|STARTED|Intervention Period 1 (2 Days)||2
7626735|NCT02325713|18778918|P10|STARTED|Intervention Period 1 (2 Days)||2
7626736|NCT02325713|18778919|P9|STARTED|Intervention Period 1 (2 Days)||2
7626737|NCT02325713|18778920|P8|STARTED|Intervention Period 1 (2 Days)||2
7626738|NCT02325713|18778921|P7|STARTED|Intervention Period 1 (2 Days)||2
7626739|NCT02325713|18778922|P6|STARTED|Intervention Period 1 (2 Days)||2
7626740|NCT02325713|18778923|P5|STARTED|Intervention Period 1 (2 Days)||2
7626741|NCT02325713|18778924|P4|STARTED|Intervention Period 1 (2 Days)||2
7626742|NCT02325713|18778925|P3|STARTED|Intervention Period 1 (2 Days)||2
7626743|NCT02325713|18778926|P2|STARTED|Intervention Period 1 (2 Days)||2
7626744|NCT02325713|18778927|P1|STARTED|Intervention Period 1 (2 Days)||2
7626745|NCT02325687|18779023|P3|NOT COMPLETED|Overall Study||6
7626746|NCT02325687|18779024|P2|NOT COMPLETED|Overall Study||3
7626747|NCT02325687|18779025|P1|NOT COMPLETED|Overall Study||4
7626748|NCT02325687|18779023|P3|COMPLETED|Overall Study||13
7626749|NCT02325687|18779024|P2|COMPLETED|Overall Study||12
7626750|NCT02325687|18779025|P1|COMPLETED|Overall Study||12
7626751|NCT02325687|18779023|P3|STARTED|Overall Study||19
7626752|NCT02325687|18779024|P2|STARTED|Overall Study||15
7626753|NCT02325687|18779025|P1|STARTED|Overall Study||16
7626754|NCT02325518|18779041|P2|NOT COMPLETED|Overall Study||3
7626755|NCT02325518|18779042|P1|NOT COMPLETED|Overall Study||4
7626756|NCT02325518|18779041|P2|COMPLETED|Overall Study||100
7626757|NCT02325518|18779042|P1|COMPLETED|Overall Study||94
7626758|NCT02325518|18779041|P2|Per Protocol Set (PPS)|Overall Study||97
7626759|NCT02325518|18779042|P1|Per Protocol Set (PPS)|Overall Study||92
7626760|NCT02325518|18779041|P2|Full Analysis Set (FAS)|Overall Study||101
7626761|NCT02325518|18779042|P1|Full Analysis Set (FAS)|Overall Study||98
7626762|NCT02325518|18779041|P2|Safety Set|Overall Study||103
7626763|NCT02325518|18779042|P1|Safety Set|Overall Study||98
7626764|NCT02325518|18779041|P2|STARTED|Overall Study||103
7626765|NCT02325518|18779042|P1|STARTED|Overall Study||98
7626766|NCT02325401|18779051|P3|NOT COMPLETED|Overall Study||1
7626767|NCT02325401|18779052|P2|NOT COMPLETED|Overall Study||1
7626768|NCT02325401|18779053|P1|NOT COMPLETED|Overall Study||0
7626769|NCT02325401|18779051|P3|COMPLETED|Overall Study||4
7626770|NCT02325401|18779052|P2|COMPLETED|Overall Study||8
7626771|NCT02325401|18779053|P1|COMPLETED|Overall Study||6
7626772|NCT02325401|18779051|P3|STARTED|Overall Study||5
7626773|NCT02325401|18779052|P2|STARTED|Overall Study||9
7626774|NCT02325401|18779053|P1|STARTED|Overall Study||6
7626775|NCT02325219|18779076|P5|NOT COMPLETED|After Controlled Period (Week 16 - 52)||1
7626776|NCT02325219|18779077|P4|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
7626777|NCT02325219|18779078|P3|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
7626778|NCT02325219|18779079|P2|NOT COMPLETED|After Controlled Period (Week 16 - 52)||3
7626779|NCT02325219|18779080|P1|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
7626780|NCT02325219|18779076|P5|COMPLETED|After Controlled Period (Week 16 - 52)||25
7626781|NCT02325219|18779077|P4|COMPLETED|After Controlled Period (Week 16 - 52)||26
7626782|NCT02325219|18779078|P3|COMPLETED|After Controlled Period (Week 16 - 52)||62
7626783|NCT02325219|18779079|P2|COMPLETED|After Controlled Period (Week 16 - 52)||60
7626784|NCT02325219|18779080|P1|COMPLETED|After Controlled Period (Week 16 - 52)||0
7626785|NCT02325219|18779076|P5|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 100 mg.|26
7626786|NCT02325219|18779077|P4|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 50 mg.|26
7626787|NCT02325219|18779078|P3|STARTED|After Controlled Period (Week 16 - 52)||62
7626788|NCT02325219|18779079|P2|STARTED|After Controlled Period (Week 16 - 52)||63
7626789|NCT02325219|18779080|P1|STARTED|After Controlled Period (Week 16 - 52)||0
7626790|NCT02325219|18779076|P5|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
7626791|NCT02325219|18779077|P4|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
7626792|NCT02325219|18779078|P3|NOT COMPLETED|Controlled Period (Week 0 - 16)||1
7626793|NCT02325219|18779079|P2|NOT COMPLETED|Controlled Period (Week 0 - 16)||2
7626794|NCT02325219|18779080|P1|NOT COMPLETED|Controlled Period (Week 0 - 16)||12
7626795|NCT02325219|18779076|P5|COMPLETED|Controlled Period (Week 0 - 16)||0
7626796|NCT02325219|18779077|P4|COMPLETED|Controlled Period (Week 0 - 16)||0
7626797|NCT02325219|18779078|P3|COMPLETED|Controlled Period (Week 0 - 16)||62
7626798|NCT02325219|18779079|P2|COMPLETED|Controlled Period (Week 0 - 16)||63
7626799|NCT02325219|18779080|P1|COMPLETED|Controlled Period (Week 0 - 16)||52
7626800|NCT02325219|18779076|P5|STARTED|Controlled Period (Week 0 - 16)||0
7626801|NCT02325219|18779077|P4|STARTED|Controlled Period (Week 0 - 16)||0
7626802|NCT02325219|18779078|P3|STARTED|Controlled Period (Week 0 - 16)||63
7626803|NCT02325219|18779079|P2|STARTED|Controlled Period (Week 0 - 16)||65
7626804|NCT02325219|18779080|P1|STARTED|Controlled Period (Week 0 - 16)||64
7626805|NCT02324972|18779254|P2|NOT COMPLETED|Overall Study||5
7626806|NCT02324972|18779255|P1|NOT COMPLETED|Overall Study||7
7626807|NCT02324972|18779254|P2|COMPLETED|Overall Study||23
7626808|NCT02324972|18779255|P1|COMPLETED|Overall Study||19
7626809|NCT02324972|18779254|P2|STARTED|Overall Study||28
7626810|NCT02324972|18779255|P1|STARTED|Overall Study||26
7626811|NCT02324842|18779272|P3|NOT COMPLETED|Overall Study||2
7626812|NCT02324842|18779273|P2|NOT COMPLETED|Overall Study||1
7626813|NCT02324842|18779274|P1|NOT COMPLETED|Overall Study||1
7626814|NCT02324842|18779272|P3|COMPLETED|Overall Study||13
7626815|NCT02324842|18779273|P2|COMPLETED|Overall Study||14
7626816|NCT02324842|18779274|P1|COMPLETED|Overall Study||14
7626817|NCT02324842|18779272|P3|STARTED|Overall Study||15
7626818|NCT02324842|18779273|P2|STARTED|Overall Study||15
7626819|NCT02324842|18779274|P1|STARTED|Overall Study||15
7626820|NCT02324816|18779303|P1|NOT COMPLETED|Overall Study||0
7626821|NCT02324816|18779303|P1|COMPLETED|Overall Study||19
7626822|NCT02324816|18779303|P1|STARTED|Overall Study||19
7626823|NCT02324699|18779308|P1|NOT COMPLETED|Overall Study||1
7626824|NCT02324699|18779308|P1|COMPLETED|Overall Study||0
7626825|NCT02324699|18779308|P1|STARTED|Overall Study||1
7626826|NCT02324673|18779318|P3|NOT COMPLETED|Overall Study||0
7626827|NCT02324673|18779319|P2|NOT COMPLETED|Overall Study||0
7626828|NCT02324673|18779320|P1|NOT COMPLETED|Overall Study||0
7626829|NCT02324673|18779318|P3|COMPLETED|Overall Study||21
7626830|NCT02324673|18779319|P2|COMPLETED|Overall Study||20
7626831|NCT02324673|18779320|P1|COMPLETED|Overall Study||20
7626832|NCT02324673|18779318|P3|STARTED|Overall Study||21
7626833|NCT02324673|18779319|P2|STARTED|Overall Study||20
7626834|NCT02324673|18779320|P1|STARTED|Overall Study||20
7626835|NCT02324660|18779421|P1|NOT COMPLETED|Overall Study||32
7626836|NCT02324660|18779421|P1|COMPLETED|Overall Study||137
7626837|NCT02324660|18779421|P1|STARTED|Overall Study||169
7626838|NCT02324569|18779428|P2|NOT COMPLETED|Overall Study||21
7626839|NCT02324569|18779429|P1|NOT COMPLETED|Overall Study||16
7626840|NCT02324569|18779428|P2|COMPLETED|Overall Study||103
7626841|NCT02324569|18779429|P1|COMPLETED|Overall Study||100
7626842|NCT02324569|18779428|P2|STARTED|Overall Study||124
7626843|NCT02324569|18779429|P1|STARTED|Overall Study||116
7626844|NCT02324543|18779459|P6|NOT COMPLETED|Overall Study||0
7626845|NCT02324543|18779460|P5|NOT COMPLETED|Overall Study||0
7626846|NCT02324543|18779461|P4|NOT COMPLETED|Overall Study||0
7626847|NCT02324543|18779462|P3|NOT COMPLETED|Overall Study||0
7626848|NCT02324543|18779463|P2|NOT COMPLETED|Overall Study||0
7626849|NCT02324543|18779464|P1|NOT COMPLETED|Overall Study||0
7626850|NCT02324543|18779459|P6|COMPLETED|Overall Study||24
7626851|NCT02324543|18779460|P5|COMPLETED|Overall Study||4
7626852|NCT02324543|18779461|P4|COMPLETED|Overall Study||4
7626853|NCT02324543|18779462|P3|COMPLETED|Overall Study||3
7626854|NCT02324543|18779463|P2|COMPLETED|Overall Study||6
7626855|NCT02324543|18779464|P1|COMPLETED|Overall Study||6
7626856|NCT02324543|18779459|P6|STARTED|Overall Study||24
7626857|NCT02324543|18779460|P5|STARTED|Overall Study||4
7626858|NCT02324543|18779461|P4|STARTED|Overall Study||4
7626859|NCT02324543|18779462|P3|STARTED|Overall Study||3
7626860|NCT02324543|18779463|P2|STARTED|Overall Study||6
7626861|NCT02324543|18779464|P1|STARTED|Overall Study||6
7626862|NCT02324504|18779478|P1|NOT COMPLETED|Overall Study||0
7626863|NCT02324504|18779478|P1|COMPLETED|Overall Study||60
7626864|NCT02324504|18779478|P1|STARTED|Overall Study||60
7626865|NCT02324465|18779487|P2|NOT COMPLETED|Overall Study||1
7626866|NCT02324465|18779488|P1|NOT COMPLETED|Overall Study||0
7626867|NCT02324465|18779487|P2|COMPLETED|Overall Study||21
7626868|NCT02324465|18779488|P1|COMPLETED|Overall Study||18
7626869|NCT02324465|18779487|P2|STARTED|Overall Study||22
7626870|NCT02324465|18779488|P1|STARTED|Overall Study||18
7626871|NCT02324361|18779502|P2|NOT COMPLETED|Overall Study||2
7626872|NCT02324361|18779503|P1|NOT COMPLETED|Overall Study||5
7626873|NCT02324361|18779502|P2|COMPLETED|Overall Study||22
7626874|NCT02324361|18779503|P1|COMPLETED|Overall Study||19
7626875|NCT02324361|18779502|P2|STARTED|Overall Study||24
7626876|NCT02324361|18779503|P1|STARTED|Overall Study||24
7626877|NCT02324335|18779517|P2|NOT COMPLETED|Overall Study||9
7626878|NCT02324335|18779518|P1|NOT COMPLETED|Overall Study||9
7626879|NCT02324335|18779517|P2|COMPLETED|Overall Study||20
7626880|NCT02324335|18779518|P1|COMPLETED|Overall Study||21
7626881|NCT02324335|18779517|P2|STARTED|Overall Study||29
7626882|NCT02324335|18779518|P1|STARTED|Overall Study||30
7626883|NCT02324270|18779533|P3|NOT COMPLETED|Overall Study||5
7626884|NCT02324270|18779534|P2|NOT COMPLETED|Overall Study||7
7626885|NCT02324270|18779535|P1|NOT COMPLETED|Overall Study||5
7626886|NCT02324270|18779533|P3|COMPLETED|Overall Study||216
7626887|NCT02324270|18779534|P2|COMPLETED|Overall Study||212
7626888|NCT02324270|18779535|P1|COMPLETED|Overall Study||213
7626889|NCT02324270|18779533|P3|PP Population|Overall Study||171
7626890|NCT02324270|18779534|P2|PP Population|Overall Study||177
7626891|NCT02324270|18779535|P1|PP Population|Overall Study||180
7626892|NCT02324270|18779533|P3|mITT Population|Overall Study||217
7626893|NCT02324270|18779534|P2|mITT Population|Overall Study||216
7626894|NCT02324270|18779535|P1|mITT Population|Overall Study||214
7626895|NCT02324270|18779533|P3|Safety Population|Overall Study||217
7626896|NCT02324270|18779534|P2|Safety Population|Overall Study||216
7626897|NCT02324270|18779535|P1|Safety Population|Overall Study||214
7626898|NCT02324270|18779533|P3|STARTED|Overall Study||221
7626899|NCT02324270|18779534|P2|STARTED|Overall Study||219
7626900|NCT02324270|18779535|P1|STARTED|Overall Study||218
7626901|NCT02324205|18779545|P1|NOT COMPLETED|Overall Study||37
7626902|NCT02324205|18779545|P1|COMPLETED|Overall Study||159
7626903|NCT02324205|18779545|P1|STARTED|Overall Study||196
7626904|NCT02324153|18779557|P2|NOT COMPLETED|Overall Study||1
7626905|NCT02324153|18779558|P1|NOT COMPLETED|Overall Study||8
7626906|NCT02324153|18779557|P2|COMPLETED|Overall Study||38
7626907|NCT02324153|18779558|P1|COMPLETED|Overall Study||33
7626908|NCT02324153|18779557|P2|STARTED|Overall Study||39
7626909|NCT02324153|18779558|P1|STARTED|Overall Study||41
7626910|NCT02324075|18779570|P2|NOT COMPLETED|Overall Study||9
7626911|NCT02324075|18779571|P1|NOT COMPLETED|Overall Study||3
7626912|NCT02324075|18779570|P2|COMPLETED|Overall Study||605
7626913|NCT02324075|18779571|P1|COMPLETED|Overall Study||609
7626914|NCT02324075|18779570|P2|STARTED|Overall Study||614
7626915|NCT02324075|18779571|P1|STARTED|Overall Study||612
7626916|NCT02324049|18779589|P1|NOT COMPLETED|Part C||11
7626917|NCT02324049|18779589|P1|COMPLETED|Part C||0
7626918|NCT02324049|18779589|P1|Safety Analysis Set|Part C||11
7626919|NCT02324049|18779589|P1|STARTED|Part C||11
7626920|NCT02324049|18779589|P1|NOT COMPLETED|Part B||0
7626921|NCT02324049|18779589|P1|COMPLETED|Part B||11
7626922|NCT02324049|18779589|P1|Safety Analysis Set|Part B||11
7626923|NCT02324049|18779589|P1|STARTED|Part B||11
7626924|NCT02324049|18779589|P1|NOT COMPLETED|Part A||0
7626925|NCT02324049|18779589|P1|COMPLETED|Part A||11
7626926|NCT02324049|18779589|P1|Safety Analysis Set|Part A|Participants with informed consent, confirmed MPS IIIB diagnosis, and received any amount of SBC-103|11
7626927|NCT02324049|18779589|P1|STARTED|Part A||11
7626928|NCT02323854|18779593|P1|NOT COMPLETED|Overall Study||0
7626929|NCT02323854|18779593|P1|COMPLETED|Overall Study||15
7626930|NCT02323854|18779593|P1|STARTED|Overall Study||15
7626931|NCT02323646|18779602|P3|NOT COMPLETED|Treatment Course 2||3
7626932|NCT02323646|18779603|P2|NOT COMPLETED|Treatment Course 2||1
7626933|NCT02323646|18779604|P1|NOT COMPLETED|Treatment Course 2||1
7626934|NCT02323646|18779602|P3|COMPLETED|Treatment Course 2||9
7626935|NCT02323646|18779603|P2|COMPLETED|Treatment Course 2||9
7626936|NCT02323646|18779604|P1|COMPLETED|Treatment Course 2||10
7626937|NCT02323646|18779602|P3|STARTED|Treatment Course 2||12
7626938|NCT02323646|18779603|P2|STARTED|Treatment Course 2||10
7626939|NCT02323646|18779604|P1|STARTED|Treatment Course 2||11
7626940|NCT02323646|18779602|P3|NOT COMPLETED|Treatment Course 1||3
7626941|NCT02323646|18779603|P2|NOT COMPLETED|Treatment Course 1||3
7626942|NCT02323646|18779604|P1|NOT COMPLETED|Treatment Course 1||3
7626943|NCT02323646|18779602|P3|COMPLETED|Treatment Course 1||12
7626944|NCT02323646|18779603|P2|COMPLETED|Treatment Course 1||10
7626945|NCT02323646|18779604|P1|COMPLETED|Treatment Course 1||11
7626946|NCT02323646|18779602|P3|STARTED|Treatment Course 1||15
7626947|NCT02323646|18779603|P2|STARTED|Treatment Course 1||13
7626948|NCT02323646|18779604|P1|STARTED|Treatment Course 1||14
7626949|NCT02323204|18779652|P4|NOT COMPLETED|6-month Follow-up Survey Completion||44
7626950|NCT02323204|18779653|P3|NOT COMPLETED|6-month Follow-up Survey Completion||41
7626951|NCT02323204|18779654|P2|NOT COMPLETED|6-month Follow-up Survey Completion||50
7626952|NCT02323204|18779655|P1|NOT COMPLETED|6-month Follow-up Survey Completion||49
7626953|NCT02323204|18779652|P4|COMPLETED|6-month Follow-up Survey Completion||112
7626954|NCT02323204|18779653|P3|COMPLETED|6-month Follow-up Survey Completion||113
7626955|NCT02323204|18779654|P2|COMPLETED|6-month Follow-up Survey Completion||96
7626956|NCT02323204|18779655|P1|COMPLETED|6-month Follow-up Survey Completion||96
7626957|NCT02323204|18779652|P4|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
7626958|NCT02323204|18779653|P3|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
7626959|NCT02323204|18779654|P2|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
7626960|NCT02323204|18779655|P1|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
7626961|NCT02323204|18779652|P4|NOT COMPLETED|3-month Follow-up Survey Completion||44
7626962|NCT02323204|18779653|P3|NOT COMPLETED|3-month Follow-up Survey Completion||41
7626963|NCT02323204|18779654|P2|NOT COMPLETED|3-month Follow-up Survey Completion||47
7626964|NCT02323204|18779655|P1|NOT COMPLETED|3-month Follow-up Survey Completion||54
7626965|NCT02323204|18779652|P4|COMPLETED|3-month Follow-up Survey Completion||112
7626966|NCT02323204|18779653|P3|COMPLETED|3-month Follow-up Survey Completion||113
7626967|NCT02323204|18779654|P2|COMPLETED|3-month Follow-up Survey Completion||99
7626968|NCT02323204|18779655|P1|COMPLETED|3-month Follow-up Survey Completion||91
7626969|NCT02323204|18779652|P4|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
7626970|NCT02323204|18779653|P3|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
7626971|NCT02323204|18779654|P2|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
7626972|NCT02323204|18779655|P1|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
7626973|NCT02323204|18779652|P4|NOT COMPLETED|6-week Follow-up Intervention Booster||36
7626974|NCT02323204|18779653|P3|NOT COMPLETED|6-week Follow-up Intervention Booster||0
7626975|NCT02323204|18779654|P2|NOT COMPLETED|6-week Follow-up Intervention Booster||43
7626976|NCT02323204|18779655|P1|NOT COMPLETED|6-week Follow-up Intervention Booster||0
7626977|NCT02323204|18779652|P4|COMPLETED|6-week Follow-up Intervention Booster||120
7626978|NCT02323204|18779653|P3|COMPLETED|6-week Follow-up Intervention Booster||0
7626979|NCT02323204|18779654|P2|COMPLETED|6-week Follow-up Intervention Booster||103
7626980|NCT02323204|18779655|P1|COMPLETED|6-week Follow-up Intervention Booster||0
7626981|NCT02323204|18779652|P4|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|156
7627069|NCT02322788|18779797|P4|NOT COMPLETED|Visit 6||0
7626982|NCT02323204|18779653|P3|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
7626983|NCT02323204|18779654|P2|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|146
7626984|NCT02323204|18779655|P1|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
7626985|NCT02323204|18779652|P4|NOT COMPLETED|6-week Follow-up Survey Completion||37
7626986|NCT02323204|18779653|P3|NOT COMPLETED|6-week Follow-up Survey Completion||42
7626987|NCT02323204|18779654|P2|NOT COMPLETED|6-week Follow-up Survey Completion||36
7626988|NCT02323204|18779655|P1|NOT COMPLETED|6-week Follow-up Survey Completion||41
7626989|NCT02323204|18779652|P4|COMPLETED|6-week Follow-up Survey Completion||119
7626990|NCT02323204|18779653|P3|COMPLETED|6-week Follow-up Survey Completion||112
7626991|NCT02323204|18779654|P2|COMPLETED|6-week Follow-up Survey Completion||110
7626992|NCT02323204|18779655|P1|COMPLETED|6-week Follow-up Survey Completion||104
7626993|NCT02323204|18779652|P4|STARTED|6-week Follow-up Survey Completion||156
7626994|NCT02323204|18779653|P3|STARTED|6-week Follow-up Survey Completion||154
7626995|NCT02323204|18779654|P2|STARTED|6-week Follow-up Survey Completion||146
7626996|NCT02323204|18779655|P1|STARTED|6-week Follow-up Survey Completion||145
7626997|NCT02323204|18779652|P4|NOT COMPLETED|Baseline Survey Completion||3
7626998|NCT02323204|18779653|P3|NOT COMPLETED|Baseline Survey Completion||5
7626999|NCT02323204|18779654|P2|NOT COMPLETED|Baseline Survey Completion||9
7627000|NCT02323204|18779655|P1|NOT COMPLETED|Baseline Survey Completion||10
7627001|NCT02323204|18779652|P4|COMPLETED|Baseline Survey Completion||156
7627002|NCT02323204|18779653|P3|COMPLETED|Baseline Survey Completion||154
7627003|NCT02323204|18779654|P2|COMPLETED|Baseline Survey Completion||146
7627004|NCT02323204|18779655|P1|COMPLETED|Baseline Survey Completion||145
7627005|NCT02323204|18779652|P4|STARTED|Baseline Survey Completion||159
7627006|NCT02323204|18779653|P3|STARTED|Baseline Survey Completion||159
7627007|NCT02323204|18779654|P2|STARTED|Baseline Survey Completion||155
7627008|NCT02323204|18779655|P1|STARTED|Baseline Survey Completion||155
7627009|NCT02323048|18779710|P5|NOT COMPLETED|Overall Study||0
7627010|NCT02323048|18779711|P4|NOT COMPLETED|Overall Study||0
7627011|NCT02323048|18779712|P3|NOT COMPLETED|Overall Study||0
7627012|NCT02323048|18779713|P2|NOT COMPLETED|Overall Study||2
7627013|NCT02323048|18779714|P1|NOT COMPLETED|Overall Study||1
7627014|NCT02323048|18779710|P5|COMPLETED|Overall Study||9
7627015|NCT02323048|18779711|P4|COMPLETED|Overall Study||7
7627016|NCT02323048|18779712|P3|COMPLETED|Overall Study||23
7627017|NCT02323048|18779713|P2|COMPLETED|Overall Study||24
7627018|NCT02323048|18779714|P1|COMPLETED|Overall Study||24
7627019|NCT02323048|18779710|P5|STARTED|Overall Study||9
7627020|NCT02323048|18779711|P4|STARTED|Overall Study||7
7627021|NCT02323048|18779712|P3|STARTED|Overall Study||23
7627022|NCT02323048|18779713|P2|STARTED|Overall Study||26
7627023|NCT02323048|18779714|P1|STARTED|Overall Study||25
7627024|NCT02322892|18779728|P2|NOT COMPLETED|Overall Study||3
7627025|NCT02322892|18779729|P1|NOT COMPLETED|Overall Study||2
7627026|NCT02322892|18779728|P2|COMPLETED|Overall Study|Received thiamine|31
7627027|NCT02322892|18779729|P1|COMPLETED|Overall Study|Received placebo|33
7627028|NCT02322892|18779728|P2|STARTED|Overall Study|Number randomized|34
7627029|NCT02322892|18779729|P1|STARTED|Overall Study|Number randomized|35
7627030|NCT02322879|18779745|P2|NOT COMPLETED|Second Intervention||0
7627031|NCT02322879|18779746|P1|NOT COMPLETED|Second Intervention||0
7627032|NCT02322879|18779745|P2|COMPLETED|Second Intervention||10
7627033|NCT02322879|18779746|P1|COMPLETED|Second Intervention||10
7627034|NCT02322879|18779745|P2|STARTED|Second Intervention||10
7627035|NCT02322879|18779746|P1|STARTED|Second Intervention||10
7627036|NCT02322879|18779745|P2|NOT COMPLETED|Washout||0
7627037|NCT02322879|18779746|P1|NOT COMPLETED|Washout||0
7627038|NCT02322879|18779745|P2|COMPLETED|Washout||10
7627039|NCT02322879|18779746|P1|COMPLETED|Washout||10
7627040|NCT02322879|18779745|P2|STARTED|Washout||10
7627041|NCT02322879|18779746|P1|STARTED|Washout||10
7627042|NCT02322879|18779745|P2|NOT COMPLETED|First Intervention||0
7627043|NCT02322879|18779746|P1|NOT COMPLETED|First Intervention||1
7627044|NCT02322879|18779745|P2|COMPLETED|First Intervention||10
7627045|NCT02322879|18779746|P1|COMPLETED|First Intervention||10
7627046|NCT02322879|18779745|P2|STARTED|First Intervention||10
7627047|NCT02322879|18779746|P1|STARTED|First Intervention||11
7627048|NCT02322866|18779754|P2|NOT COMPLETED|Overall Study||86
7627049|NCT02322866|18779755|P1|NOT COMPLETED|Overall Study||71
7627050|NCT02322866|18779754|P2|COMPLETED|Overall Study||433
7627051|NCT02322866|18779755|P1|COMPLETED|Overall Study||444
7627052|NCT02322866|18779754|P2|STARTED|Overall Study||519
7627053|NCT02322866|18779755|P1|STARTED|Overall Study||515
7627054|NCT02322814|18779782|P5|NOT COMPLETED|Overall Study||31
7627055|NCT02322814|18779783|P4|NOT COMPLETED|Overall Study||32
7627056|NCT02322814|18779784|P3|NOT COMPLETED|Overall Study||47
7627057|NCT02322814|18779785|P2|NOT COMPLETED|Overall Study||43
7627058|NCT02322814|18779786|P1|NOT COMPLETED|Overall Study||16
7627059|NCT02322814|18779782|P5|COMPLETED|Overall Study||0
7627060|NCT02322814|18779783|P4|COMPLETED|Overall Study||0
7627061|NCT02322814|18779784|P3|COMPLETED|Overall Study||0
7627062|NCT02322814|18779785|P2|COMPLETED|Overall Study||0
7627063|NCT02322814|18779786|P1|COMPLETED|Overall Study||0
7627064|NCT02322814|18779782|P5|STARTED|Overall Study||31
7627065|NCT02322814|18779783|P4|STARTED|Overall Study||32
7627066|NCT02322814|18779784|P3|STARTED|Overall Study||47
7627067|NCT02322814|18779785|P2|STARTED|Overall Study||43
7627068|NCT02322814|18779786|P1|STARTED|Overall Study||16
7627070|NCT02322788|18779798|P3|NOT COMPLETED|Visit 6||0
7627071|NCT02322788|18779799|P2|NOT COMPLETED|Visit 6||0
7627072|NCT02322788|18779800|P1|NOT COMPLETED|Visit 6||0
7627073|NCT02322788|18779797|P4|COMPLETED|Visit 6||15
7627074|NCT02322788|18779798|P3|COMPLETED|Visit 6||15
7627075|NCT02322788|18779799|P2|COMPLETED|Visit 6||16
7627076|NCT02322788|18779800|P1|COMPLETED|Visit 6||14
7627077|NCT02322788|18779797|P4|STARTED|Visit 6||15
7627078|NCT02322788|18779798|P3|STARTED|Visit 6||15
7627079|NCT02322788|18779799|P2|STARTED|Visit 6||16
7627080|NCT02322788|18779800|P1|STARTED|Visit 6||14
7627081|NCT02322788|18779797|P4|NOT COMPLETED|Visit 5||0
7627082|NCT02322788|18779798|P3|NOT COMPLETED|Visit 5||0
7627083|NCT02322788|18779799|P2|NOT COMPLETED|Visit 5||0
7627084|NCT02322788|18779800|P1|NOT COMPLETED|Visit 5||0
7627085|NCT02322788|18779797|P4|COMPLETED|Visit 5||14
7627086|NCT02322788|18779798|P3|COMPLETED|Visit 5||15
7627087|NCT02322788|18779799|P2|COMPLETED|Visit 5||15
7627088|NCT02322788|18779800|P1|COMPLETED|Visit 5||16
7627089|NCT02322788|18779797|P4|STARTED|Visit 5||14
7627090|NCT02322788|18779798|P3|STARTED|Visit 5||15
7627091|NCT02322788|18779799|P2|STARTED|Visit 5||15
7627092|NCT02322788|18779800|P1|STARTED|Visit 5||16
7627093|NCT02322788|18779797|P4|NOT COMPLETED|Visit 4||0
7627094|NCT02322788|18779798|P3|NOT COMPLETED|Visit 4||0
7627095|NCT02322788|18779799|P2|NOT COMPLETED|Visit 4||0
7627096|NCT02322788|18779800|P1|NOT COMPLETED|Visit 4||0
7627097|NCT02322788|18779797|P4|COMPLETED|Visit 4||15
7627098|NCT02322788|18779798|P3|COMPLETED|Visit 4||16
7627099|NCT02322788|18779799|P2|COMPLETED|Visit 4||14
7627100|NCT02322788|18779800|P1|COMPLETED|Visit 4||15
7627101|NCT02322788|18779797|P4|STARTED|Visit 4||15
7627102|NCT02322788|18779798|P3|STARTED|Visit 4||16
7627103|NCT02322788|18779799|P2|STARTED|Visit 4||14
7627104|NCT02322788|18779800|P1|STARTED|Visit 4||15
7627105|NCT02322788|18779797|P4|NOT COMPLETED|Visit 3||0
7627106|NCT02322788|18779798|P3|NOT COMPLETED|Visit 3||0
7627107|NCT02322788|18779799|P2|NOT COMPLETED|Visit 3||0
7627108|NCT02322788|18779800|P1|NOT COMPLETED|Visit 3||0
7627109|NCT02322788|18779797|P4|COMPLETED|Visit 3||16
7627110|NCT02322788|18779798|P3|COMPLETED|Visit 3||14
7627111|NCT02322788|18779799|P2|COMPLETED|Visit 3||15
7627112|NCT02322788|18779800|P1|COMPLETED|Visit 3||15
7627113|NCT02322788|18779797|P4|STARTED|Visit 3||16
7627114|NCT02322788|18779798|P3|STARTED|Visit 3||14
7627115|NCT02322788|18779799|P2|STARTED|Visit 3||15
7627116|NCT02322788|18779800|P1|STARTED|Visit 3||15
7627117|NCT02322775|18779812|P2|NOT COMPLETED|Overall Study||6
7627118|NCT02322775|18779813|P1|NOT COMPLETED|Overall Study||5
7627119|NCT02322775|18779812|P2|COMPLETED|Overall Study||99
7627120|NCT02322775|18779813|P1|COMPLETED|Overall Study||101
7627121|NCT02322775|18779812|P2|STARTED|Overall Study||105
7627122|NCT02322775|18779813|P1|STARTED|Overall Study||106
7627123|NCT02322749|18779839|P6|NOT COMPLETED|Period 3||0
7627124|NCT02322749|18779840|P5|NOT COMPLETED|Period 3||0
7627125|NCT02322749|18779841|P4|NOT COMPLETED|Period 3||0
7627126|NCT02322749|18779842|P3|NOT COMPLETED|Period 3||1
7627127|NCT02322749|18779843|P2|NOT COMPLETED|Period 3||0
7627128|NCT02322749|18779844|P1|NOT COMPLETED|Period 3||0
7627129|NCT02322749|18779839|P6|COMPLETED|Period 3||8
7627130|NCT02322749|18779840|P5|COMPLETED|Period 3||8
7627131|NCT02322749|18779841|P4|COMPLETED|Period 3||6
7627132|NCT02322749|18779842|P3|COMPLETED|Period 3||7
7627133|NCT02322749|18779843|P2|COMPLETED|Period 3||8
7627134|NCT02322749|18779844|P1|COMPLETED|Period 3||8
7627135|NCT02322749|18779839|P6|STARTED|Period 3||8
7627136|NCT02322749|18779840|P5|STARTED|Period 3||8
7627137|NCT02322749|18779841|P4|STARTED|Period 3||6
7627138|NCT02322749|18779842|P3|STARTED|Period 3||8
7627139|NCT02322749|18779843|P2|STARTED|Period 3||8
7627140|NCT02322749|18779844|P1|STARTED|Period 3||8
7627141|NCT02322749|18779839|P6|NOT COMPLETED|Period 2||0
7627142|NCT02322749|18779840|P5|NOT COMPLETED|Period 2||0
7627143|NCT02322749|18779841|P4|NOT COMPLETED|Period 2||2
7627144|NCT02322749|18779842|P3|NOT COMPLETED|Period 2||0
7627145|NCT02322749|18779843|P2|NOT COMPLETED|Period 2||0
7627146|NCT02322749|18779844|P1|NOT COMPLETED|Period 2||0
7627147|NCT02322749|18779839|P6|COMPLETED|Period 2||8
7627148|NCT02322749|18779840|P5|COMPLETED|Period 2||8
7627149|NCT02322749|18779841|P4|COMPLETED|Period 2||6
7627150|NCT02322749|18779842|P3|COMPLETED|Period 2||8
7627151|NCT02322749|18779843|P2|COMPLETED|Period 2||8
7627152|NCT02322749|18779844|P1|COMPLETED|Period 2||8
7627153|NCT02322749|18779839|P6|STARTED|Period 2||8
7627154|NCT02322749|18779840|P5|STARTED|Period 2||8
7627155|NCT02322749|18779841|P4|STARTED|Period 2||8
7627156|NCT02322749|18779842|P3|STARTED|Period 2||8
7627157|NCT02322749|18779843|P2|STARTED|Period 2||8
7627158|NCT02322749|18779844|P1|STARTED|Period 2||8
7627159|NCT02322749|18779839|P6|NOT COMPLETED|Period 1||0
7627160|NCT02322749|18779840|P5|NOT COMPLETED|Period 1||0
7627161|NCT02322749|18779841|P4|NOT COMPLETED|Period 1||0
7627162|NCT02322749|18779842|P3|NOT COMPLETED|Period 1||0
7627163|NCT02322749|18779843|P2|NOT COMPLETED|Period 1||0
7627164|NCT02322749|18779844|P1|NOT COMPLETED|Period 1||0
7627165|NCT02322749|18779839|P6|COMPLETED|Period 1||8
7627166|NCT02322749|18779840|P5|COMPLETED|Period 1||8
7627167|NCT02322749|18779841|P4|COMPLETED|Period 1||8
7627168|NCT02322749|18779842|P3|COMPLETED|Period 1||8
7627169|NCT02322749|18779843|P2|COMPLETED|Period 1||8
7627170|NCT02322749|18779844|P1|COMPLETED|Period 1||8
7627171|NCT02322749|18779839|P6|STARTED|Period 1||8
7627172|NCT02322749|18779840|P5|STARTED|Period 1||8
7627173|NCT02322749|18779841|P4|STARTED|Period 1||8
7627174|NCT02322749|18779842|P3|STARTED|Period 1||8
7627175|NCT02322749|18779843|P2|STARTED|Period 1||8
7627176|NCT02322749|18779844|P1|STARTED|Period 1||8
7627177|NCT02322710|18779869|P2|NOT COMPLETED|Overall Study||26
7627178|NCT02322710|18779870|P1|NOT COMPLETED|Overall Study||20
7627179|NCT02322710|18779869|P2|COMPLETED|Overall Study||73
7627180|NCT02322710|18779870|P1|COMPLETED|Overall Study||85
7627181|NCT02322710|18779869|P2|Full Analysis Population|Overall Study||98
7627182|NCT02322710|18779870|P1|Full Analysis Population|Overall Study||105
7627183|NCT02322710|18779869|P2|Safety Population|Overall Study||99
7627184|NCT02322710|18779870|P1|Safety Population|Overall Study||105
7627185|NCT02322710|18779869|P2|STARTED|Overall Study||99
7627186|NCT02322710|18779870|P1|STARTED|Overall Study||105
7627187|NCT02322528|18779876|P1|NOT COMPLETED|Overall Study||0
7627188|NCT02322528|18779876|P1|COMPLETED|Overall Study||10
7627189|NCT02322528|18779876|P1|STARTED|Overall Study||10
7627190|NCT02322411|18779883|P2|NOT COMPLETED|Overall Study||7
7627191|NCT02322411|18779884|P1|NOT COMPLETED|Overall Study||5
7627192|NCT02322411|18779883|P2|COMPLETED|Overall Study||9
7627193|NCT02322411|18779884|P1|COMPLETED|Overall Study||9
7627194|NCT02322411|18779883|P2|All Baseline Measures Analyzed|Overall Study||16
7627195|NCT02322411|18779884|P1|All Baseline Measures Analyzed|Overall Study||13
7627196|NCT02322411|18779883|P2|Randomized|Overall Study||16
7627197|NCT02322411|18779884|P1|Randomized|Overall Study||14
7627198|NCT02322411|18779883|P2|STARTED|Overall Study||16
7627199|NCT02322411|18779884|P1|STARTED|Overall Study||14
7627200|NCT02322333|18779904|P2|NOT COMPLETED|Overall Study||16
7627201|NCT02322333|18779905|P1|NOT COMPLETED|Overall Study||17
7627202|NCT02322333|18779904|P2|COMPLETED|Overall Study||61
7627203|NCT02322333|18779905|P1|COMPLETED|Overall Study||63
7627204|NCT02322333|18779904|P2|STARTED|Overall Study||77
7627205|NCT02322333|18779905|P1|STARTED|Overall Study||80
7627206|NCT02322320|18779928|P3|NOT COMPLETED|Overall Study||0
7627207|NCT02322320|18779929|P2|NOT COMPLETED|Overall Study||0
7627208|NCT02322320|18779930|P1|NOT COMPLETED|Overall Study||0
7627209|NCT02322320|18779928|P3|COMPLETED|Overall Study||89
7627210|NCT02322320|18779929|P2|COMPLETED|Overall Study||86
7627211|NCT02322320|18779930|P1|COMPLETED|Overall Study||98
7627212|NCT02322320|18779928|P3|STARTED|Overall Study||89
7627213|NCT02322320|18779929|P2|STARTED|Overall Study||86
7627214|NCT02322320|18779930|P1|STARTED|Overall Study||98
7627215|NCT02322281|18779953|P3|NOT COMPLETED|Overall Study||74
7627216|NCT02322281|18779954|P2|NOT COMPLETED|Overall Study||22
7627217|NCT02322281|18779955|P1|NOT COMPLETED|Overall Study||53
7627218|NCT02322281|18779953|P3|COMPLETED|Overall Study|Patients who are off study for any reason.|0
7627219|NCT02322281|18779954|P2|COMPLETED|Overall Study|Patients who are off study for any reason.|0
7627220|NCT02322281|18779955|P1|COMPLETED|Overall Study|Patients who are off study for any reason.|0
7627221|NCT02322281|18779953|P3|Crossed Over to Rociletinib 625 mg BID|Overall Study||3
7627222|NCT02322281|18779954|P2|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
7627223|NCT02322281|18779955|P1|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
7627224|NCT02322281|18779953|P3|Crossed Over to Rociletinib 500 mg BID|Overall Study||36
7627225|NCT02322281|18779954|P2|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
7627226|NCT02322281|18779955|P1|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
7627227|NCT02322281|18779953|P3|STARTED|Overall Study||74
7627228|NCT02322281|18779954|P2|STARTED|Overall Study||22
7627229|NCT02322281|18779955|P1|STARTED|Overall Study||53
7627230|NCT02322242|18779978|P2|NOT COMPLETED|Overall Study||0
7627231|NCT02322242|18779979|P1|NOT COMPLETED|Overall Study||0
7627232|NCT02322242|18779978|P2|COMPLETED|Overall Study||90
7627233|NCT02322242|18779979|P1|COMPLETED|Overall Study||92
7627234|NCT02322242|18779978|P2|1 Week Follow-up|Overall Study|1 lost to follow-up for secondary outcomes|89
7627235|NCT02322242|18779979|P1|1 Week Follow-up|Overall Study|2 lost to follow-up for secondary outcomes|90
7627236|NCT02322242|18779978|P2|Primary Outcome|Overall Study||90
7627237|NCT02322242|18779979|P1|Primary Outcome|Overall Study||92
7627238|NCT02322242|18779978|P2|STARTED|Overall Study||90
7627239|NCT02322242|18779979|P1|STARTED|Overall Study||92
7627240|NCT02322229|18780003|P1|NOT COMPLETED|Overall Study||2
7627241|NCT02322229|18780003|P1|COMPLETED|Overall Study||50
7627242|NCT02322229|18780003|P1|STARTED|Overall Study||52
7627243|NCT02322216|18780015|P2|NOT COMPLETED|Overall Study||4
7627244|NCT02322216|18780016|P1|NOT COMPLETED|Overall Study||2
7627245|NCT02322216|18780015|P2|COMPLETED|Overall Study||123
7627246|NCT02322216|18780016|P1|COMPLETED|Overall Study||124
7627247|NCT02322216|18780015|P2|Per Protocol Set (PPS)|Overall Study||122
7627248|NCT02322216|18780016|P1|Per Protocol Set (PPS)|Overall Study||123
7627249|NCT02322216|18780015|P2|Treated (Safety Set)|Overall Study||126
7627250|NCT02322216|18780016|P1|Treated (Safety Set)|Overall Study||126
7627251|NCT02322216|18780015|P2|STARTED|Overall Study||127
7627252|NCT02322216|18780016|P1|STARTED|Overall Study||126
7627253|NCT02322190|18780023|P2|NOT COMPLETED|Overall Study||0
7627254|NCT02322190|18780024|P1|NOT COMPLETED|Overall Study||1
7627255|NCT02322190|18780023|P2|COMPLETED|Overall Study||0
7627256|NCT02322190|18780024|P1|COMPLETED|Overall Study||4
7627257|NCT02322190|18780023|P2|STARTED|Overall Study||0
7627258|NCT02322190|18780024|P1|STARTED|Overall Study||5
7627259|NCT02322047|18780036|P4|NOT COMPLETED|Overall Study||2
7627260|NCT02322047|18780037|P3|NOT COMPLETED|Overall Study||1
7627261|NCT02322047|18780038|P2|NOT COMPLETED|Overall Study||1
7627262|NCT02322047|18780039|P1|NOT COMPLETED|Overall Study||2
7627263|NCT02322047|18780036|P4|COMPLETED|Overall Study||7
7627264|NCT02322047|18780037|P3|COMPLETED|Overall Study||6
7627265|NCT02322047|18780038|P2|COMPLETED|Overall Study||6
7627266|NCT02322047|18780039|P1|COMPLETED|Overall Study||6
7627267|NCT02322047|18780036|P4|STARTED|Overall Study||9
7627268|NCT02322047|18780037|P3|STARTED|Overall Study||7
7627269|NCT02322047|18780038|P2|STARTED|Overall Study||7
7627270|NCT02322047|18780039|P1|STARTED|Overall Study||8
7627271|NCT02321930|18780061|P1|NOT COMPLETED|Overall Study||1
7627272|NCT02321930|18780061|P1|COMPLETED|Overall Study||24
7627273|NCT02321930|18780061|P1|STARTED|Overall Study||25
7627274|NCT02321800|18780071|P2|NOT COMPLETED|Overall Study||11
7627275|NCT02321800|18780072|P1|NOT COMPLETED|Overall Study||20
7627276|NCT02321800|18780071|P2|COMPLETED|Overall Study||138
7627277|NCT02321800|18780072|P1|COMPLETED|Overall Study||283
7627278|NCT02321800|18780071|P2|Received Study Drug|Overall Study||148
7627279|NCT02321800|18780072|P1|Received Study Drug|Overall Study||300
7627280|NCT02321800|18780071|P2|STARTED|Overall Study||149
7627281|NCT02321800|18780072|P1|STARTED|Overall Study||303
7627282|NCT02321748|18780122|P2|NOT COMPLETED|Overall Study||0
7627283|NCT02321748|18780123|P1|NOT COMPLETED|Overall Study||0
7627284|NCT02321748|18780122|P2|COMPLETED|Overall Study||12
7627285|NCT02321748|18780123|P1|COMPLETED|Overall Study||12
7627286|NCT02321748|18780122|P2|Second Intervention (4 Days)|Overall Study||12
7627287|NCT02321748|18780123|P1|Second Intervention (4 Days)|Overall Study||12
7627288|NCT02321748|18780122|P2|Wasout (2weeks)|Overall Study||12
7627289|NCT02321748|18780123|P1|Wasout (2weeks)|Overall Study||12
7627290|NCT02321748|18780122|P2|First Intervention (4 Days)|Overall Study||12
7627291|NCT02321748|18780123|P1|First Intervention (4 Days)|Overall Study||12
7627292|NCT02321748|18780122|P2|STARTED|Overall Study||12
7627293|NCT02321748|18780123|P1|STARTED|Overall Study||12
7627294|NCT02321527|18780155|P1|NOT COMPLETED|Overall Study||1
7627295|NCT02321527|18780155|P1|COMPLETED|Overall Study||20
7627296|NCT02321527|18780155|P1|STARTED|Overall Study||21
7627297|NCT02321462|18780161|P2|NOT COMPLETED|Overall Study||3
7627298|NCT02321462|18780162|P1|NOT COMPLETED|Overall Study||6
7627299|NCT02321462|18780161|P2|COMPLETED|Overall Study||146
7627300|NCT02321462|18780162|P1|COMPLETED|Overall Study||141
7627301|NCT02321462|18780161|P2|Safety Population|Overall Study||147
7627302|NCT02321462|18780162|P1|Safety Population|Overall Study||147
7627303|NCT02321462|18780161|P2|Treated Patients|Overall Study||147
7627304|NCT02321462|18780162|P1|Treated Patients|Overall Study||147
7627305|NCT02321462|18780161|P2|ITT Population|Overall Study||148
7627306|NCT02321462|18780162|P1|ITT Population|Overall Study||146
7627307|NCT02321462|18780161|P2|STARTED|Overall Study||149
7627308|NCT02321462|18780162|P1|STARTED|Overall Study||147
7627309|NCT02321436|18780184|P2|NOT COMPLETED|Overall Study||1
7627310|NCT02321436|18780185|P1|NOT COMPLETED|Overall Study||1
7627311|NCT02321436|18780184|P2|COMPLETED|Overall Study||13
7627312|NCT02321436|18780185|P1|COMPLETED|Overall Study||27
7627313|NCT02321436|18780184|P2|STARTED|Overall Study||14
7627314|NCT02321436|18780185|P1|STARTED|Overall Study||28
7627315|NCT02321319|18780201|P1|NOT COMPLETED|Overall Study||5
7627316|NCT02321319|18780201|P1|COMPLETED|Overall Study||0
7627317|NCT02321319|18780201|P1|STARTED|Overall Study||5
7627318|NCT02321111|18780205|P6|NOT COMPLETED|Infusion3||0
7627319|NCT02321111|18780206|P5|NOT COMPLETED|Infusion3||0
7627320|NCT02321111|18780207|P4|NOT COMPLETED|Infusion3||0
7627321|NCT02321111|18780208|P3|NOT COMPLETED|Infusion3||0
7627322|NCT02321111|18780209|P2|NOT COMPLETED|Infusion3||0
7627323|NCT02321111|18780210|P1|NOT COMPLETED|Infusion3||0
7627324|NCT02321111|18780205|P6|COMPLETED|Infusion3||0
7627325|NCT02321111|18780206|P5|COMPLETED|Infusion3||0
7627326|NCT02321111|18780207|P4|COMPLETED|Infusion3||1
7627327|NCT02321111|18780208|P3|COMPLETED|Infusion3||4
7627328|NCT02321111|18780209|P2|COMPLETED|Infusion3||4
7627329|NCT02321111|18780210|P1|COMPLETED|Infusion3||1
7627330|NCT02321111|18780205|P6|STARTED|Infusion3||0
7627331|NCT02321111|18780206|P5|STARTED|Infusion3||0
7627332|NCT02321111|18780207|P4|STARTED|Infusion3||1
7627333|NCT02321111|18780208|P3|STARTED|Infusion3||4
7627334|NCT02321111|18780209|P2|STARTED|Infusion3||4
7627335|NCT02321111|18780210|P1|STARTED|Infusion3||1
7627336|NCT02321111|18780205|P6|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
7627337|NCT02321111|18780206|P5|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
7627338|NCT02321111|18780207|P4|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
7627339|NCT02321111|18780208|P3|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
7627340|NCT02321111|18780209|P2|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
7627341|NCT02321111|18780210|P1|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
7627342|NCT02321111|18780205|P6|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
7627343|NCT02321111|18780206|P5|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
7627344|NCT02321111|18780207|P4|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
7627345|NCT02321111|18780208|P3|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
7627346|NCT02321111|18780209|P2|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
7627347|NCT02321111|18780210|P1|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
7627348|NCT02321111|18780205|P6|STARTED|Washout2 (3-4weeks Between Infusions)||0
7627349|NCT02321111|18780206|P5|STARTED|Washout2 (3-4weeks Between Infusions)||0
7627350|NCT02321111|18780207|P4|STARTED|Washout2 (3-4weeks Between Infusions)||1
7627351|NCT02321111|18780208|P3|STARTED|Washout2 (3-4weeks Between Infusions)||4
7627352|NCT02321111|18780209|P2|STARTED|Washout2 (3-4weeks Between Infusions)||4
7627353|NCT02321111|18780210|P1|STARTED|Washout2 (3-4weeks Between Infusions)||1
7627354|NCT02321111|18780205|P6|NOT COMPLETED|Infusion2||0
7627355|NCT02321111|18780206|P5|NOT COMPLETED|Infusion2||0
7627356|NCT02321111|18780207|P4|NOT COMPLETED|Infusion2||0
7627357|NCT02321111|18780208|P3|NOT COMPLETED|Infusion2||0
7627358|NCT02321111|18780209|P2|NOT COMPLETED|Infusion2||0
7627359|NCT02321111|18780210|P1|NOT COMPLETED|Infusion2||0
7627360|NCT02321111|18780205|P6|COMPLETED|Infusion2||0
7627361|NCT02321111|18780206|P5|COMPLETED|Infusion2||0
7627362|NCT02321111|18780207|P4|COMPLETED|Infusion2||1
7627363|NCT02321111|18780208|P3|COMPLETED|Infusion2||4
7627364|NCT02321111|18780209|P2|COMPLETED|Infusion2||4
7627365|NCT02321111|18780210|P1|COMPLETED|Infusion2||1
7627366|NCT02321111|18780205|P6|STARTED|Infusion2||0
7627367|NCT02321111|18780206|P5|STARTED|Infusion2||0
7627368|NCT02321111|18780207|P4|STARTED|Infusion2||1
7627369|NCT02321111|18780208|P3|STARTED|Infusion2||4
7627370|NCT02321111|18780209|P2|STARTED|Infusion2||4
7627371|NCT02321111|18780210|P1|STARTED|Infusion2||1
7627372|NCT02321111|18780205|P6|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
7627373|NCT02321111|18780206|P5|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
7627374|NCT02321111|18780207|P4|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
7627375|NCT02321111|18780208|P3|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
7627376|NCT02321111|18780209|P2|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
7627377|NCT02321111|18780210|P1|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
7627378|NCT02321111|18780205|P6|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
7627379|NCT02321111|18780206|P5|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
7627380|NCT02321111|18780207|P4|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
7627381|NCT02321111|18780208|P3|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
7627382|NCT02321111|18780209|P2|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
7627383|NCT02321111|18780210|P1|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
7627384|NCT02321111|18780205|P6|STARTED|Washout1 (3-4weeks Between Infusions)||0
7627385|NCT02321111|18780206|P5|STARTED|Washout1 (3-4weeks Between Infusions)||0
7627386|NCT02321111|18780207|P4|STARTED|Washout1 (3-4weeks Between Infusions)||1
7627387|NCT02321111|18780208|P3|STARTED|Washout1 (3-4weeks Between Infusions)||4
7627388|NCT02321111|18780209|P2|STARTED|Washout1 (3-4weeks Between Infusions)||4
7627389|NCT02321111|18780210|P1|STARTED|Washout1 (3-4weeks Between Infusions)||1
7627390|NCT02321111|18780205|P6|NOT COMPLETED|Infusion1||0
7627391|NCT02321111|18780206|P5|NOT COMPLETED|Infusion1||0
7627392|NCT02321111|18780207|P4|NOT COMPLETED|Infusion1||0
7627393|NCT02321111|18780208|P3|NOT COMPLETED|Infusion1||0
7627394|NCT02321111|18780209|P2|NOT COMPLETED|Infusion1||0
7627395|NCT02321111|18780210|P1|NOT COMPLETED|Infusion1||0
7627396|NCT02321111|18780205|P6|COMPLETED|Infusion1||0
7627397|NCT02321111|18780206|P5|COMPLETED|Infusion1||0
7627398|NCT02321111|18780207|P4|COMPLETED|Infusion1||1
7627399|NCT02321111|18780208|P3|COMPLETED|Infusion1||4
7627400|NCT02321111|18780209|P2|COMPLETED|Infusion1||4
7627401|NCT02321111|18780210|P1|COMPLETED|Infusion1||1
7627402|NCT02321111|18780205|P6|STARTED|Infusion1||0
7627403|NCT02321111|18780206|P5|STARTED|Infusion1||0
7627404|NCT02321111|18780207|P4|STARTED|Infusion1||1
7627405|NCT02321111|18780208|P3|STARTED|Infusion1||4
7627406|NCT02321111|18780209|P2|STARTED|Infusion1||4
7627407|NCT02321111|18780210|P1|STARTED|Infusion1||1
7627408|NCT02321098|18780233|P3|NOT COMPLETED|Additional 15 Months Treatment||8
7627409|NCT02321098|18780234|P2|NOT COMPLETED|Additional 15 Months Treatment||0
7627410|NCT02321098|18780235|P1|NOT COMPLETED|Additional 15 Months Treatment||0
7627411|NCT02321098|18780233|P3|COMPLETED|Additional 15 Months Treatment||21
7627412|NCT02321098|18780234|P2|COMPLETED|Additional 15 Months Treatment||0
7627413|NCT02321098|18780235|P1|COMPLETED|Additional 15 Months Treatment||0
7627414|NCT02321098|18780233|P3|STARTED|Additional 15 Months Treatment||29
7627415|NCT02321098|18780234|P2|STARTED|Additional 15 Months Treatment||0
7627416|NCT02321098|18780235|P1|STARTED|Additional 15 Months Treatment||0
7627417|NCT02321098|18780233|P3|NOT COMPLETED|12 Weeks Treament||0
7627418|NCT02321098|18780234|P2|NOT COMPLETED|12 Weeks Treament||1
7627419|NCT02321098|18780235|P1|NOT COMPLETED|12 Weeks Treament||1
7627420|NCT02321098|18780233|P3|COMPLETED|12 Weeks Treament||0
7627421|NCT02321098|18780234|P2|COMPLETED|12 Weeks Treament||23
7627422|NCT02321098|18780235|P1|COMPLETED|12 Weeks Treament||25
7627423|NCT02321098|18780233|P3|STARTED|12 Weeks Treament||0
7627424|NCT02321098|18780234|P2|STARTED|12 Weeks Treament||24
7627425|NCT02321098|18780235|P1|STARTED|12 Weeks Treament||26
7627426|NCT02320903|18780247|P3|NOT COMPLETED|Overall Study||16
7627427|NCT02320903|18780248|P2|NOT COMPLETED|Overall Study||16
7627428|NCT02320903|18780249|P1|NOT COMPLETED|Overall Study||8
7627429|NCT02320903|18780247|P3|COMPLETED|Overall Study||16
7627430|NCT02320903|18780248|P2|COMPLETED|Overall Study||16
7627431|NCT02320903|18780249|P1|COMPLETED|Overall Study||16
7627432|NCT02320903|18780247|P3|STARTED|Overall Study||32
7627433|NCT02320903|18780248|P2|STARTED|Overall Study||32
7627434|NCT02320903|18780249|P1|STARTED|Overall Study||24
7627435|NCT02320838|18780282|P5|NOT COMPLETED|Third Intervention (1 Day)||0
7627436|NCT02320838|18780283|P4|NOT COMPLETED|Third Intervention (1 Day)||0
7627437|NCT02320838|18780284|P3|NOT COMPLETED|Third Intervention (1 Day)||0
7627438|NCT02320838|18780285|P2|NOT COMPLETED|Third Intervention (1 Day)||0
7627439|NCT02320838|18780286|P1|NOT COMPLETED|Third Intervention (1 Day)||0
7627440|NCT02320838|18780282|P5|COMPLETED|Third Intervention (1 Day)||7
7627441|NCT02320838|18780283|P4|COMPLETED|Third Intervention (1 Day)||7
7627442|NCT02320838|18780284|P3|COMPLETED|Third Intervention (1 Day)||8
7627443|NCT02320838|18780285|P2|COMPLETED|Third Intervention (1 Day)||8
7627444|NCT02320838|18780286|P1|COMPLETED|Third Intervention (1 Day)||8
7627445|NCT02320838|18780282|P5|STARTED|Third Intervention (1 Day)||7
7627446|NCT02320838|18780283|P4|STARTED|Third Intervention (1 Day)||7
7627447|NCT02320838|18780284|P3|STARTED|Third Intervention (1 Day)||8
7627448|NCT02320838|18780285|P2|STARTED|Third Intervention (1 Day)||8
7627449|NCT02320838|18780286|P1|STARTED|Third Intervention (1 Day)||8
7627450|NCT02320838|18780282|P5|NOT COMPLETED|Washout (1 Day)||0
7627451|NCT02320838|18780283|P4|NOT COMPLETED|Washout (1 Day)||0
7627452|NCT02320838|18780284|P3|NOT COMPLETED|Washout (1 Day)||0
7627453|NCT02320838|18780285|P2|NOT COMPLETED|Washout (1 Day)||0
7627454|NCT02320838|18780286|P1|NOT COMPLETED|Washout (1 Day)||0
7627455|NCT02320838|18780282|P5|COMPLETED|Washout (1 Day)||7
7627456|NCT02320838|18780283|P4|COMPLETED|Washout (1 Day)||7
7627457|NCT02320838|18780284|P3|COMPLETED|Washout (1 Day)||8
7627458|NCT02320838|18780285|P2|COMPLETED|Washout (1 Day)||8
7627459|NCT02320838|18780286|P1|COMPLETED|Washout (1 Day)||8
7627460|NCT02320838|18780282|P5|STARTED|Washout (1 Day)||7
7627461|NCT02320838|18780283|P4|STARTED|Washout (1 Day)||7
7627462|NCT02320838|18780284|P3|STARTED|Washout (1 Day)||8
7627463|NCT02320838|18780285|P2|STARTED|Washout (1 Day)||8
7627464|NCT02320838|18780286|P1|STARTED|Washout (1 Day)||8
7627465|NCT02320838|18780282|P5|NOT COMPLETED|Second Intervention (1 Day)||0
7627466|NCT02320838|18780283|P4|NOT COMPLETED|Second Intervention (1 Day)||0
7627467|NCT02320838|18780284|P3|NOT COMPLETED|Second Intervention (1 Day)||0
7627468|NCT02320838|18780285|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7627469|NCT02320838|18780286|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7627470|NCT02320838|18780282|P5|COMPLETED|Second Intervention (1 Day)||7
7627471|NCT02320838|18780283|P4|COMPLETED|Second Intervention (1 Day)||7
7627472|NCT02320838|18780284|P3|COMPLETED|Second Intervention (1 Day)||8
7627473|NCT02320838|18780285|P2|COMPLETED|Second Intervention (1 Day)||8
7627474|NCT02320838|18780286|P1|COMPLETED|Second Intervention (1 Day)||8
7627475|NCT02320838|18780282|P5|STARTED|Second Intervention (1 Day)||7
7627476|NCT02320838|18780283|P4|STARTED|Second Intervention (1 Day)||7
7627477|NCT02320838|18780284|P3|STARTED|Second Intervention (1 Day)||8
7627478|NCT02320838|18780285|P2|STARTED|Second Intervention (1 Day)||8
7627479|NCT02320838|18780286|P1|STARTED|Second Intervention (1 Day)||8
7627480|NCT02320838|18780282|P5|NOT COMPLETED|Washout (1 Day)||0
7627481|NCT02320838|18780283|P4|NOT COMPLETED|Washout (1 Day)||0
7627482|NCT02320838|18780284|P3|NOT COMPLETED|Washout (1 Day)||0
7627483|NCT02320838|18780285|P2|NOT COMPLETED|Washout (1 Day)||0
7627484|NCT02320838|18780286|P1|NOT COMPLETED|Washout (1 Day)||0
7627485|NCT02320838|18780282|P5|COMPLETED|Washout (1 Day)||7
7627486|NCT02320838|18780283|P4|COMPLETED|Washout (1 Day)||7
7627487|NCT02320838|18780284|P3|COMPLETED|Washout (1 Day)||8
7627488|NCT02320838|18780285|P2|COMPLETED|Washout (1 Day)||8
7627489|NCT02320838|18780286|P1|COMPLETED|Washout (1 Day)||8
7627490|NCT02320838|18780282|P5|STARTED|Washout (1 Day)||7
7627491|NCT02320838|18780283|P4|STARTED|Washout (1 Day)||7
7627492|NCT02320838|18780284|P3|STARTED|Washout (1 Day)||8
7627493|NCT02320838|18780285|P2|STARTED|Washout (1 Day)||8
7627494|NCT02320838|18780286|P1|STARTED|Washout (1 Day)||8
7627495|NCT02320838|18780282|P5|NOT COMPLETED|First Intervention (1 Day)||0
7627496|NCT02320838|18780283|P4|NOT COMPLETED|First Intervention (1 Day)||0
7627497|NCT02320838|18780284|P3|NOT COMPLETED|First Intervention (1 Day)||0
7627498|NCT02320838|18780285|P2|NOT COMPLETED|First Intervention (1 Day)||0
7627499|NCT02320838|18780286|P1|NOT COMPLETED|First Intervention (1 Day)||0
7627500|NCT02320838|18780282|P5|COMPLETED|First Intervention (1 Day)||7
7627501|NCT02320838|18780283|P4|COMPLETED|First Intervention (1 Day)||7
7627502|NCT02320838|18780284|P3|COMPLETED|First Intervention (1 Day)||8
7627503|NCT02320838|18780285|P2|COMPLETED|First Intervention (1 Day)||8
7627504|NCT02320838|18780286|P1|COMPLETED|First Intervention (1 Day)||8
7627505|NCT02320838|18780282|P5|STARTED|First Intervention (1 Day)||7
7627506|NCT02320838|18780283|P4|STARTED|First Intervention (1 Day)||7
7627507|NCT02320838|18780284|P3|STARTED|First Intervention (1 Day)||8
7627508|NCT02320838|18780285|P2|STARTED|First Intervention (1 Day)||8
7627509|NCT02320838|18780286|P1|STARTED|First Intervention (1 Day)||8
7627510|NCT02320825|18780353|P2|NOT COMPLETED|Overall Study||0
7627511|NCT02320825|18780354|P1|NOT COMPLETED|Overall Study||0
7627512|NCT02320825|18780353|P2|COMPLETED|Overall Study||8
7627513|NCT02320825|18780354|P1|COMPLETED|Overall Study||8
7627514|NCT02320825|18780353|P2|STARTED|Overall Study||8
7627515|NCT02320825|18780354|P1|STARTED|Overall Study||8
7627516|NCT02320812|18780364|P1|NOT COMPLETED|Overall Study||0
7627517|NCT02320812|18780364|P1|COMPLETED|Overall Study||28
7627518|NCT02320812|18780364|P1|STARTED|Overall Study||28
7627519|NCT02320721|18780374|P2|NOT COMPLETED|Overall Study||34
7627520|NCT02320721|18780375|P1|NOT COMPLETED|Overall Study||27
7627521|NCT02320721|18780374|P2|COMPLETED|Overall Study||472
7627522|NCT02320721|18780375|P1|COMPLETED|Overall Study||481
7627523|NCT02320721|18780374|P2|Treated (Safety Population)|Overall Study||505
7627524|NCT02320721|18780375|P1|Treated (Safety Population)|Overall Study||508
7627525|NCT02320721|18780374|P2|STARTED|Overall Study||506
7627526|NCT02320721|18780375|P1|STARTED|Overall Study||508
7627527|NCT02320695|18780403|P1|NOT COMPLETED|Overall Study||0
7627528|NCT02320695|18780403|P1|COMPLETED|Overall Study||60
7627529|NCT02320695|18780403|P1|Pain Relief Ointment|Overall Study||60
7627530|NCT02320695|18780403|P1|Original Ointment|Overall Study||60
7627531|NCT02320695|18780403|P1|Antibiotic/Pain Relieving Ointment|Overall Study||60
7627532|NCT02320695|18780403|P1|Pain Relieving Cream|Overall Study||59
7627533|NCT02320695|18780403|P1|Alcohol|Overall Study||60
7627534|NCT02320695|18780403|P1|Saline|Overall Study||60
7627535|NCT02320695|18780403|P1|STARTED|Overall Study||60
7627536|NCT02320487|18780430|P1|NOT COMPLETED|Overall Study||21
7627537|NCT02320487|18780430|P1|COMPLETED|Overall Study|Completed = completed the 6-cycle Treatment Period.|81
7627538|NCT02320487|18780430|P1|STARTED|Overall Study||102
7627539|NCT02320396|18780450|P2|NOT COMPLETED|Overall Study||4
7627540|NCT02320396|18780451|P1|NOT COMPLETED|Overall Study||4
7627541|NCT02320396|18780450|P2|COMPLETED|Overall Study||221
7627542|NCT02320396|18780451|P1|COMPLETED|Overall Study||220
7627543|NCT02320396|18780450|P2|Treated (Full Analysis Set)|Overall Study||225
7627544|NCT02320396|18780451|P1|Treated (Full Analysis Set)|Overall Study||223
7627545|NCT02320396|18780450|P2|STARTED|Overall Study||225
7627546|NCT02320396|18780451|P1|STARTED|Overall Study||224
7627547|NCT02320227|18780481|P1|NOT COMPLETED|Overall Study||0
7627548|NCT02320227|18780481|P1|COMPLETED|Overall Study||30
7627549|NCT02320227|18780481|P1|STARTED|Overall Study||30
7627550|NCT02320214|18780486|P1|NOT COMPLETED|Overall Study||0
7627551|NCT02320214|18780486|P1|COMPLETED|Overall Study||30
7627552|NCT02320214|18780486|P1|STARTED|Overall Study||30
7627553|NCT02320175|18780493|P2|NOT COMPLETED|Overall Study||0
7627554|NCT02320175|18780494|P1|NOT COMPLETED|Overall Study||0
7627555|NCT02320175|18780493|P2|COMPLETED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
7627556|NCT02320175|18780494|P1|COMPLETED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
7627557|NCT02320175|18780493|P2|STARTED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
7627558|NCT02320175|18780494|P1|STARTED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
7627559|NCT02320149|18780510|P2|NOT COMPLETED|Overall Study||80
7627560|NCT02320149|18780511|P1|NOT COMPLETED|Overall Study||63
7627561|NCT02320149|18780510|P2|COMPLETED|Overall Study||405
7627562|NCT02320149|18780511|P1|COMPLETED|Overall Study||420
7627563|NCT02320149|18780510|P2|STARTED|Overall Study||485
7627564|NCT02320149|18780511|P1|STARTED|Overall Study||483
7627565|NCT02320123|18780551|P2|NOT COMPLETED|Overall Study||11
7627566|NCT02320123|18780552|P1|NOT COMPLETED|Overall Study||10
7627567|NCT02320123|18780551|P2|COMPLETED|Overall Study||1
7627568|NCT02320123|18780552|P1|COMPLETED|Overall Study||0
7627569|NCT02320123|18780551|P2|STARTED|Overall Study||12
7627570|NCT02320123|18780552|P1|STARTED|Overall Study||10
7627571|NCT02319967|18780577|P3|NOT COMPLETED|Overall Study||45
7627572|NCT02319967|18780578|P2|NOT COMPLETED|Overall Study||44
7627573|NCT02319967|18780579|P1|NOT COMPLETED|Overall Study||48
7627574|NCT02319967|18780577|P3|COMPLETED|Overall Study||76
7627575|NCT02319967|18780578|P2|COMPLETED|Overall Study||82
7627576|NCT02319967|18780579|P1|COMPLETED|Overall Study||78
7627577|NCT02319967|18780577|P3|STARTED|Overall Study||121
7627578|NCT02319967|18780578|P2|STARTED|Overall Study||126
7627579|NCT02319967|18780579|P1|STARTED|Overall Study||126
7627580|NCT02319824|18780635|P1|NOT COMPLETED|Overall Study||0
7627581|NCT02319824|18780635|P1|COMPLETED|Overall Study||2
7627582|NCT02319824|18780635|P1|STARTED|Overall Study||2
7627583|NCT02319759|18780643|P5|NOT COMPLETED|Week 24 - 56||2
7627584|NCT02319759|18780644|P4|NOT COMPLETED|Week 24 - 56||2
7627585|NCT02319759|18780645|P3|NOT COMPLETED|Week 24 - 56||2
7627586|NCT02319759|18780646|P2|NOT COMPLETED|Week 24 - 56||1
7627587|NCT02319759|18780647|P1|NOT COMPLETED|Week 24 - 56||0
7627588|NCT02319759|18780643|P5|COMPLETED|Week 24 - 56||8
7627589|NCT02319759|18780644|P4|COMPLETED|Week 24 - 56||15
7627590|NCT02319759|18780645|P3|COMPLETED|Week 24 - 56||84
7627591|NCT02319759|18780646|P2|COMPLETED|Week 24 - 56||28
7627592|NCT02319759|18780647|P1|COMPLETED|Week 24 - 56||0
7627593|NCT02319759|18780643|P5|STARTED|Week 24 - 56||10
7627594|NCT02319759|18780644|P4|STARTED|Week 24 - 56||17
7627595|NCT02319759|18780645|P3|STARTED|Week 24 - 56||86
7627596|NCT02319759|18780646|P2|STARTED|Week 24 - 56||29
7627597|NCT02319759|18780647|P1|STARTED|Week 24 - 56||0
7627598|NCT02319759|18780643|P5|NOT COMPLETED|Week 16 - 24||0
7627599|NCT02319759|18780644|P4|NOT COMPLETED|Week 16 - 24||0
7627600|NCT02319759|18780645|P3|NOT COMPLETED|Week 16 - 24||3
7627601|NCT02319759|18780646|P2|NOT COMPLETED|Week 16 - 24||0
7627602|NCT02319759|18780647|P1|NOT COMPLETED|Week 16 - 24||2
7627603|NCT02319759|18780643|P5|COMPLETED|Week 16 - 24||10
7627604|NCT02319759|18780644|P4|COMPLETED|Week 16 - 24||17
7627605|NCT02319759|18780645|P3|COMPLETED|Week 16 - 24||86
7627606|NCT02319759|18780646|P2|COMPLETED|Week 16 - 24||0
7627607|NCT02319759|18780647|P1|COMPLETED|Week 16 - 24||29
7627608|NCT02319759|18780643|P5|STARTED|Week 16 - 24||10
7627609|NCT02319759|18780644|P4|STARTED|Week 16 - 24||17
7627610|NCT02319759|18780645|P3|STARTED|Week 16 - 24||89
7627611|NCT02319759|18780646|P2|STARTED|Week 16 - 24||0
7627612|NCT02319759|18780647|P1|STARTED|Week 16 - 24||31
7627613|NCT02319759|18780643|P5|NOT COMPLETED|Week 0 - 16||0
7627614|NCT02319759|18780644|P4|NOT COMPLETED|Week 0 - 16||0
7627615|NCT02319759|18780645|P3|NOT COMPLETED|Week 0 - 16||1
7627616|NCT02319759|18780646|P2|NOT COMPLETED|Week 0 - 16||0
7627617|NCT02319759|18780647|P1|NOT COMPLETED|Week 0 - 16||1
7627618|NCT02319759|18780643|P5|COMPLETED|Week 0 - 16||0
7627619|NCT02319759|18780644|P4|COMPLETED|Week 0 - 16||0
7627620|NCT02319759|18780645|P3|COMPLETED|Week 0 - 16||99
7627621|NCT02319759|18780646|P2|COMPLETED|Week 0 - 16||0
7627622|NCT02319759|18780647|P1|COMPLETED|Week 0 - 16||48
7627623|NCT02319759|18780643|P5|STARTED|Week 0 - 16||0
7627624|NCT02319759|18780644|P4|STARTED|Week 0 - 16||0
7627625|NCT02319759|18780645|P3|STARTED|Week 0 - 16||100
7627626|NCT02319759|18780646|P2|STARTED|Week 0 - 16||0
7627627|NCT02319759|18780647|P1|STARTED|Week 0 - 16||49
7627628|NCT02319668|18780744|P2|NOT COMPLETED|Overall Study||2
7627629|NCT02319668|18780745|P1|NOT COMPLETED|Overall Study||0
7627630|NCT02319668|18780744|P2|COMPLETED|Overall Study||17
7627631|NCT02319668|18780745|P1|COMPLETED|Overall Study||19
7627632|NCT02319668|18780744|P2|STARTED|Overall Study||19
7627633|NCT02319668|18780745|P1|STARTED|Overall Study||19
7627634|NCT02319642|18780759|P2|NOT COMPLETED|Overall Study||6
7627635|NCT02319642|18780760|P1|NOT COMPLETED|Overall Study||4
7627636|NCT02319642|18780759|P2|COMPLETED|Overall Study||245
7627637|NCT02319642|18780760|P1|COMPLETED|Overall Study||91
7627638|NCT02319642|18780759|P2|STARTED|Overall Study||251
7627639|NCT02319642|18780760|P1|STARTED|Overall Study||95
7627640|NCT02319525|18780780|P2|NOT COMPLETED|Overall Study||1
7627641|NCT02319525|18780781|P1|NOT COMPLETED|Overall Study||2
7627642|NCT02319525|18780780|P2|COMPLETED|Overall Study||147
7627643|NCT02319525|18780781|P1|COMPLETED|Overall Study||151
7627644|NCT02319525|18780780|P2|Primary Research Completion|Overall Study||147
7627645|NCT02319525|18780781|P1|Primary Research Completion|Overall Study||151
7627646|NCT02319525|18780780|P2|STARTED|Overall Study||148
7627647|NCT02319525|18780781|P1|STARTED|Overall Study||153
7627648|NCT02319486|18780799|P1|NOT COMPLETED|Overall Study||0
7627649|NCT02319486|18780799|P1|COMPLETED|Overall Study||26
7627650|NCT02319486|18780799|P1|STARTED|Overall Study||26
7627651|NCT02319317|18780807|P2|NOT COMPLETED|Overall Study||0
7627652|NCT02319317|18780808|P1|NOT COMPLETED|Overall Study||0
7627653|NCT02319317|18780807|P2|COMPLETED|Overall Study||29
7627654|NCT02319317|18780808|P1|COMPLETED|Overall Study||31
7627655|NCT02319317|18780807|P2|STARTED|Overall Study||29
7627656|NCT02319317|18780808|P1|STARTED|Overall Study||31
7627657|NCT02319174|18780814|P1|NOT COMPLETED|Overall Study||1
7627658|NCT02319174|18780814|P1|COMPLETED|Overall Study||42
7627659|NCT02319174|18780814|P1|STARTED|Overall Study||43
7627660|NCT02319148|18780823|P4|NOT COMPLETED|Second Intervention Period||2
7627661|NCT02319148|18780824|P3|NOT COMPLETED|Second Intervention Period||1
7627662|NCT02319148|18780825|P2|NOT COMPLETED|Second Intervention Period||1
7627663|NCT02319148|18780826|P1|NOT COMPLETED|Second Intervention Period||0
7627664|NCT02319148|18780823|P4|COMPLETED|Second Intervention Period||6
7627665|NCT02319148|18780824|P3|COMPLETED|Second Intervention Period||6
7627666|NCT02319148|18780825|P2|COMPLETED|Second Intervention Period||6
7627667|NCT02319148|18780826|P1|COMPLETED|Second Intervention Period||0
7627668|NCT02319148|18780823|P4|STARTED|Second Intervention Period||8
7627669|NCT02319148|18780824|P3|STARTED|Second Intervention Period||7
7627670|NCT02319148|18780825|P2|STARTED|Second Intervention Period||7
7627671|NCT02319148|18780826|P1|STARTED|Second Intervention Period||0
7627672|NCT02319148|18780823|P4|NOT COMPLETED|Washout Period 4 Days||0
7627673|NCT02319148|18780824|P3|NOT COMPLETED|Washout Period 4 Days||0
7627674|NCT02319148|18780825|P2|NOT COMPLETED|Washout Period 4 Days||0
7627675|NCT02319148|18780826|P1|NOT COMPLETED|Washout Period 4 Days||0
7627676|NCT02319148|18780823|P4|COMPLETED|Washout Period 4 Days||0
7627677|NCT02319148|18780824|P3|COMPLETED|Washout Period 4 Days||0
7627678|NCT02319148|18780825|P2|COMPLETED|Washout Period 4 Days||0
7627679|NCT02319148|18780826|P1|COMPLETED|Washout Period 4 Days||22
7627680|NCT02319148|18780823|P4|STARTED|Washout Period 4 Days||0
7627681|NCT02319148|18780824|P3|STARTED|Washout Period 4 Days||0
7627682|NCT02319148|18780825|P2|STARTED|Washout Period 4 Days||0
7627683|NCT02319148|18780826|P1|STARTED|Washout Period 4 Days||22
7627684|NCT02319148|18780823|P4|NOT COMPLETED|First Intervention Period||0
7627685|NCT02319148|18780824|P3|NOT COMPLETED|First Intervention Period||0
7627686|NCT02319148|18780825|P2|NOT COMPLETED|First Intervention Period||0
7627687|NCT02319148|18780826|P1|NOT COMPLETED|First Intervention Period||0
7627688|NCT02319148|18780823|P4|COMPLETED|First Intervention Period||0
7627689|NCT02319148|18780824|P3|COMPLETED|First Intervention Period||0
7627690|NCT02319148|18780825|P2|COMPLETED|First Intervention Period||0
7627691|NCT02319148|18780826|P1|COMPLETED|First Intervention Period||22
7627692|NCT02319148|18780823|P4|STARTED|First Intervention Period||0
7627693|NCT02319148|18780824|P3|STARTED|First Intervention Period||0
7627694|NCT02319148|18780825|P2|STARTED|First Intervention Period||0
7627695|NCT02319148|18780826|P1|STARTED|First Intervention Period||22
7627696|NCT02319044|18780889|P3|NOT COMPLETED|Overall Study||67
7627697|NCT02319044|18780890|P2|NOT COMPLETED|Overall Study||60
7627698|NCT02319044|18780891|P1|NOT COMPLETED|Overall Study||122
7627699|NCT02319044|18780889|P3|COMPLETED|Overall Study||0
7627700|NCT02319044|18780890|P2|COMPLETED|Overall Study||7
7627701|NCT02319044|18780891|P1|COMPLETED|Overall Study||11
7627702|NCT02319044|18780889|P3|STARTED|Overall Study||67
7627703|NCT02319044|18780890|P2|STARTED|Overall Study||67
7627704|NCT02319044|18780891|P1|STARTED|Overall Study||133
7627705|NCT02319031|18780947|P2|NOT COMPLETED|Follow-Up Period||0
7627706|NCT02319031|18780948|P1|NOT COMPLETED|Follow-Up Period||0
7627707|NCT02319031|18780947|P2|COMPLETED|Follow-Up Period||26
7627708|NCT02319031|18780948|P1|COMPLETED|Follow-Up Period||23
7627709|NCT02319031|18780947|P2|STARTED|Follow-Up Period||26
7627710|NCT02319031|18780948|P1|STARTED|Follow-Up Period||23
7627711|NCT02319031|18780947|P2|NOT COMPLETED|Treatment Period||0
7627712|NCT02319031|18780948|P1|NOT COMPLETED|Treatment Period||1
7627713|NCT02319031|18780947|P2|COMPLETED|Treatment Period||26
7627714|NCT02319031|18780948|P1|COMPLETED|Treatment Period||23
7627715|NCT02319031|18780947|P2|STARTED|Treatment Period||26
7627716|NCT02319031|18780948|P1|STARTED|Treatment Period||24
7627717|NCT02319005|18780960|P2|NOT COMPLETED|Overall Study||15
7627718|NCT02319005|18780961|P1|NOT COMPLETED|Overall Study||48
7627719|NCT02319005|18780960|P2|COMPLETED|Overall Study||51
7627720|NCT02319005|18780961|P1|COMPLETED|Overall Study||92
7627721|NCT02319005|18780960|P2|STARTED|Overall Study||66
7627722|NCT02319005|18780961|P1|STARTED|Overall Study||140
7627723|NCT02318992|18780984|P3|NOT COMPLETED|Overall Study||4
7627724|NCT02318992|18780985|P2|NOT COMPLETED|Overall Study||2
7627725|NCT02318992|18780986|P1|NOT COMPLETED|Overall Study||2
7627726|NCT02318992|18780984|P3|COMPLETED|Overall Study||20
7627727|NCT02318992|18780985|P2|COMPLETED|Overall Study||25
7627728|NCT02318992|18780986|P1|COMPLETED|Overall Study||25
7627729|NCT02318992|18780984|P3|STARTED|Overall Study||24
7627730|NCT02318992|18780985|P2|STARTED|Overall Study||27
7627731|NCT02318992|18780986|P1|STARTED|Overall Study||27
7627732|NCT02318979|18780999|P2|NOT COMPLETED|Overall Study||0
7627733|NCT02318979|18781000|P1|NOT COMPLETED|Overall Study||0
7627734|NCT02318979|18780999|P2|COMPLETED|Overall Study||15
7627735|NCT02318979|18781000|P1|COMPLETED|Overall Study||15
7627736|NCT02318979|18780999|P2|STARTED|Overall Study||15
7627737|NCT02318979|18781000|P1|STARTED|Overall Study||15
7627738|NCT02318940|18781012|P2|NOT COMPLETED|Overall Study||0
7627739|NCT02318940|18781013|P1|NOT COMPLETED|Overall Study||1
7627740|NCT02318940|18781012|P2|COMPLETED|Overall Study||50
7627741|NCT02318940|18781013|P1|COMPLETED|Overall Study||49
7627742|NCT02318940|18781012|P2|STARTED|Overall Study||50
7627743|NCT02318940|18781013|P1|STARTED|Overall Study|in the last patient we lost the record.|50
7627744|NCT02318901|18781028|P3|NOT COMPLETED|Overall Study||10
7627745|NCT02318901|18781029|P2|NOT COMPLETED|Overall Study||1
7627746|NCT02318901|18781030|P1|NOT COMPLETED|Overall Study||5
7627747|NCT02318901|18781028|P3|COMPLETED|Overall Study||0
7627748|NCT02318901|18781029|P2|COMPLETED|Overall Study||0
7627749|NCT02318901|18781030|P1|COMPLETED|Overall Study||0
7627750|NCT02318901|18781028|P3|STARTED|Overall Study||10
7627751|NCT02318901|18781029|P2|STARTED|Overall Study||1
7627752|NCT02318901|18781030|P1|STARTED|Overall Study||5
7627753|NCT02318797|18781055|P2|NOT COMPLETED|Overall Study||102
7627754|NCT02318797|18781056|P1|NOT COMPLETED|Overall Study||88
7627755|NCT02318797|18781055|P2|COMPLETED|Overall Study||611
7627756|NCT02318797|18781056|P1|COMPLETED|Overall Study||428
7627757|NCT02318797|18781055|P2|STARTED|Overall Study||713
7627758|NCT02318797|18781056|P1|STARTED|Overall Study||516
7627759|NCT02318719|18781098|P5|NOT COMPLETED|Open-label Extension Phase||55
7627760|NCT02318719|18781099|P4|NOT COMPLETED|Open-label Extension Phase||0
7627761|NCT02318719|18781100|P3|NOT COMPLETED|Open-label Extension Phase||0
7627762|NCT02318719|18781101|P2|NOT COMPLETED|Open-label Extension Phase||0
7627763|NCT02318719|18781102|P1|NOT COMPLETED|Open-label Extension Phase||0
7627764|NCT02318719|18781098|P5|COMPLETED|Open-label Extension Phase||184
7627765|NCT02318719|18781099|P4|COMPLETED|Open-label Extension Phase||0
7627766|NCT02318719|18781100|P3|COMPLETED|Open-label Extension Phase||0
7627767|NCT02318719|18781101|P2|COMPLETED|Open-label Extension Phase||0
7627768|NCT02318719|18781102|P1|COMPLETED|Open-label Extension Phase||0
7627769|NCT02318719|18781098|P5|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|239
7627770|NCT02318719|18781099|P4|STARTED|Open-label Extension Phase||0
7627771|NCT02318719|18781100|P3|STARTED|Open-label Extension Phase||0
7627772|NCT02318719|18781101|P2|STARTED|Open-label Extension Phase||0
7627773|NCT02318719|18781102|P1|STARTED|Open-label Extension Phase||0
7627774|NCT02318719|18781098|P5|NOT COMPLETED|Double-blind Phase||0
7627775|NCT02318719|18781099|P4|NOT COMPLETED|Double-blind Phase||15
7627776|NCT02318719|18781100|P3|NOT COMPLETED|Double-blind Phase||25
7627777|NCT02318719|18781101|P2|NOT COMPLETED|Double-blind Phase||16
7627778|NCT02318719|18781102|P1|NOT COMPLETED|Double-blind Phase||38
7627779|NCT02318719|18781098|P5|COMPLETED|Double-blind Phase||0
7627780|NCT02318719|18781099|P4|COMPLETED|Double-blind Phase||140
7627781|NCT02318719|18781100|P3|COMPLETED|Double-blind Phase||128
7627782|NCT02318719|18781101|P2|COMPLETED|Double-blind Phase||137
7627783|NCT02318719|18781102|P1|COMPLETED|Double-blind Phase||266
7627784|NCT02318719|18781098|P5|Did Not Receive Treatment|Double-blind Phase||0
7627785|NCT02318719|18781099|P4|Did Not Receive Treatment|Double-blind Phase||0
7627786|NCT02318719|18781100|P3|Did Not Receive Treatment|Double-blind Phase||0
7627787|NCT02318719|18781101|P2|Did Not Receive Treatment|Double-blind Phase||1
7627788|NCT02318719|18781102|P1|Did Not Receive Treatment|Double-blind Phase||1
7627789|NCT02318719|18781098|P5|STARTED|Double-blind Phase||0
7627790|NCT02318719|18781099|P4|STARTED|Double-blind Phase||155
7627791|NCT02318719|18781100|P3|STARTED|Double-blind Phase||153
7627792|NCT02318719|18781101|P2|STARTED|Double-blind Phase||153
7627793|NCT02318719|18781102|P1|STARTED|Double-blind Phase||304
7627794|NCT02318706|18781118|P5|NOT COMPLETED|Open-label Extension Phase||42
7627795|NCT02318706|18781119|P4|NOT COMPLETED|Open-label Extension Phase||0
7627796|NCT02318706|18781120|P3|NOT COMPLETED|Open-label Extension Phase||0
7627797|NCT02318706|18781121|P2|NOT COMPLETED|Open-label Extension Phase||0
7627798|NCT02318706|18781122|P1|NOT COMPLETED|Open-label Extension Phase||0
7627799|NCT02318706|18781118|P5|COMPLETED|Open-label Extension Phase||172
7627800|NCT02318706|18781119|P4|COMPLETED|Open-label Extension Phase||0
7627801|NCT02318706|18781120|P3|COMPLETED|Open-label Extension Phase||0
7627802|NCT02318706|18781121|P2|COMPLETED|Open-label Extension Phase||0
7627803|NCT02318706|18781122|P1|COMPLETED|Open-label Extension Phase||0
7627804|NCT02318706|18781118|P5|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|214
7627805|NCT02318706|18781119|P4|STARTED|Open-label Extension Phase||0
7627806|NCT02318706|18781120|P3|STARTED|Open-label Extension Phase||0
7627807|NCT02318706|18781121|P2|STARTED|Open-label Extension Phase||0
7627808|NCT02318706|18781122|P1|STARTED|Open-label Extension Phase||0
7627809|NCT02318706|18781118|P5|NOT COMPLETED|Double-blind Phase||0
7627810|NCT02318706|18781119|P4|NOT COMPLETED|Double-blind Phase||24
7627811|NCT02318706|18781120|P3|NOT COMPLETED|Double-blind Phase||18
7627812|NCT02318706|18781121|P2|NOT COMPLETED|Double-blind Phase||12
7627813|NCT02318706|18781122|P1|NOT COMPLETED|Double-blind Phase||25
7627814|NCT02318706|18781118|P5|COMPLETED|Double-blind Phase||0
7627815|NCT02318706|18781119|P4|COMPLETED|Double-blind Phase||142
7627816|NCT02318706|18781120|P3|COMPLETED|Double-blind Phase||150
7627817|NCT02318706|18781121|P2|COMPLETED|Double-blind Phase||154
7627818|NCT02318706|18781122|P1|COMPLETED|Double-blind Phase||309
7627819|NCT02318706|18781118|P5|STARTED|Double-blind Phase||0
7627820|NCT02318706|18781119|P4|STARTED|Double-blind Phase||166
7627821|NCT02318706|18781120|P3|STARTED|Double-blind Phase||168
7627822|NCT02318706|18781121|P2|STARTED|Double-blind Phase||166
7627823|NCT02318706|18781122|P1|STARTED|Double-blind Phase||334
7627824|NCT02318693|18781136|P2|NOT COMPLETED|Overall Study||1
7627825|NCT02318693|18781137|P1|NOT COMPLETED|Overall Study||0
7627826|NCT02318693|18781136|P2|COMPLETED|Overall Study||26
7627827|NCT02318693|18781137|P1|COMPLETED|Overall Study||26
7627828|NCT02318693|18781136|P2|Treated|Overall Study|1 randomized participant did not receive treatment.|26
7627829|NCT02318693|18781137|P1|Treated|Overall Study||26
7627830|NCT02318693|18781136|P2|STARTED|Overall Study||27
7627831|NCT02318693|18781137|P1|STARTED|Overall Study||26
7627832|NCT02318667|18781151|P1|NOT COMPLETED|Overall Study||9
7627833|NCT02318667|18781151|P1|COMPLETED|Overall Study||29
7627834|NCT02318667|18781151|P1|STARTED|Overall Study||38
7627835|NCT02318602|18781170|P3|NOT COMPLETED|Overall Study||2
7627836|NCT02318602|18781171|P2|NOT COMPLETED|Overall Study||4
7627837|NCT02318602|18781172|P1|NOT COMPLETED|Overall Study||1
7627838|NCT02318602|18781170|P3|COMPLETED|Overall Study||15
7627839|NCT02318602|18781171|P2|COMPLETED|Overall Study||22
7627840|NCT02318602|18781172|P1|COMPLETED|Overall Study||8
7627841|NCT02318602|18781170|P3|STARTED|Overall Study||17
7627842|NCT02318602|18781171|P2|STARTED|Overall Study||26
7627843|NCT02318602|18781172|P1|STARTED|Overall Study||9
7627844|NCT02318368|18781205|P2|NOT COMPLETED|Overall Study||3
7627845|NCT02318368|18781206|P1|NOT COMPLETED|Overall Study||7
7627846|NCT02318368|18781205|P2|COMPLETED|Overall Study||0
7627847|NCT02318368|18781206|P1|COMPLETED|Overall Study||0
7627848|NCT02318368|18781205|P2|STARTED|Overall Study||3
7627849|NCT02318368|18781206|P1|STARTED|Overall Study||7
7627850|NCT02318329|18781224|P10|NOT COMPLETED|Overall Study||52
7627851|NCT02318329|18781225|P9|NOT COMPLETED|Overall Study||6
7627852|NCT02318329|18781226|P8|NOT COMPLETED|Overall Study||1
7627853|NCT02318329|18781227|P7|NOT COMPLETED|Overall Study||1
7627854|NCT02318329|18781228|P6|NOT COMPLETED|Overall Study||3
7627855|NCT02318329|18781229|P5|NOT COMPLETED|Overall Study||3
7627856|NCT02318329|18781230|P4|NOT COMPLETED|Overall Study||3
7627857|NCT02318329|18781231|P3|NOT COMPLETED|Overall Study||3
7627858|NCT02318329|18781232|P2|NOT COMPLETED|Overall Study||4
7627859|NCT02318329|18781233|P1|NOT COMPLETED|Overall Study||3
7627860|NCT02318329|18781224|P10|COMPLETED|Overall Study||0
7627861|NCT02318329|18781225|P9|COMPLETED|Overall Study||0
7627862|NCT02318329|18781226|P8|COMPLETED|Overall Study||0
7627863|NCT02318329|18781227|P7|COMPLETED|Overall Study||0
7627864|NCT02318329|18781228|P6|COMPLETED|Overall Study||0
7627865|NCT02318329|18781229|P5|COMPLETED|Overall Study||0
7627866|NCT02318329|18781230|P4|COMPLETED|Overall Study||0
7627867|NCT02318329|18781231|P3|COMPLETED|Overall Study||0
7627868|NCT02318329|18781232|P2|COMPLETED|Overall Study||0
7627869|NCT02318329|18781233|P1|COMPLETED|Overall Study||0
7627870|NCT02318329|18781224|P10|STARTED|Overall Study||52
7627871|NCT02318329|18781225|P9|STARTED|Overall Study||6
7627872|NCT02318329|18781226|P8|STARTED|Overall Study||1
7627873|NCT02318329|18781227|P7|STARTED|Overall Study||1
7627874|NCT02318329|18781228|P6|STARTED|Overall Study||3
7627875|NCT02318329|18781229|P5|STARTED|Overall Study||3
7627876|NCT02318329|18781230|P4|STARTED|Overall Study||3
7627877|NCT02318329|18781231|P3|STARTED|Overall Study||3
7627878|NCT02318329|18781232|P2|STARTED|Overall Study||4
7627879|NCT02318329|18781233|P1|STARTED|Overall Study||3
7627880|NCT02318303|18781296|P7|NOT COMPLETED|Overall Study||2
7627881|NCT02318303|18781297|P6|NOT COMPLETED|Overall Study||6
7627882|NCT02318303|18781298|P5|NOT COMPLETED|Overall Study||5
7627883|NCT02318303|18781299|P4|NOT COMPLETED|Overall Study||3
7627884|NCT02318303|18781300|P3|NOT COMPLETED|Overall Study||3
7627885|NCT02318303|18781301|P2|NOT COMPLETED|Overall Study||3
7627886|NCT02318303|18781302|P1|NOT COMPLETED|Overall Study||4
7627887|NCT02318303|18781296|P7|COMPLETED|Overall Study||158
7627888|NCT02318303|18781297|P6|COMPLETED|Overall Study||153
7627889|NCT02318303|18781298|P5|COMPLETED|Overall Study||152
7627890|NCT02318303|18781299|P4|COMPLETED|Overall Study||155
7627891|NCT02318303|18781300|P3|COMPLETED|Overall Study||157
7627892|NCT02318303|18781301|P2|COMPLETED|Overall Study||155
7627893|NCT02318303|18781302|P1|COMPLETED|Overall Study||155
7627894|NCT02318303|18781296|P7|STARTED|Overall Study||160
7627895|NCT02318303|18781297|P6|STARTED|Overall Study||159
7627896|NCT02318303|18781298|P5|STARTED|Overall Study||157
7627897|NCT02318303|18781299|P4|STARTED|Overall Study||158
7627898|NCT02318303|18781300|P3|STARTED|Overall Study||160
7627899|NCT02318303|18781301|P2|STARTED|Overall Study||158
7627900|NCT02318303|18781302|P1|STARTED|Overall Study||159
7627901|NCT02318277|18781326|P8|NOT COMPLETED|Overall Study||93
7627902|NCT02318277|18781327|P7|NOT COMPLETED|Overall Study||49
7627903|NCT02318277|18781328|P6|NOT COMPLETED|Overall Study||9
7627904|NCT02318277|18781329|P5|NOT COMPLETED|Overall Study||8
7627905|NCT02318277|18781330|P4|NOT COMPLETED|Overall Study||4
7627906|NCT02318277|18781331|P3|NOT COMPLETED|Overall Study||4
7627907|NCT02318277|18781332|P2|NOT COMPLETED|Overall Study||3
7627908|NCT02318277|18781333|P1|NOT COMPLETED|Overall Study||6
7627909|NCT02318277|18781326|P8|COMPLETED|Overall Study||0
7627910|NCT02318277|18781327|P7|COMPLETED|Overall Study||0
7627911|NCT02318277|18781328|P6|COMPLETED|Overall Study||0
7627912|NCT02318277|18781329|P5|COMPLETED|Overall Study||0
7627913|NCT02318277|18781330|P4|COMPLETED|Overall Study||0
7627914|NCT02318277|18781331|P3|COMPLETED|Overall Study||0
7627915|NCT02318277|18781332|P2|COMPLETED|Overall Study||0
7627916|NCT02318277|18781333|P1|COMPLETED|Overall Study||0
7627917|NCT02318277|18781326|P8|STARTED|Overall Study||93
7627918|NCT02318277|18781327|P7|STARTED|Overall Study||49
7627919|NCT02318277|18781328|P6|STARTED|Overall Study||9
7627920|NCT02318277|18781329|P5|STARTED|Overall Study||8
7627921|NCT02318277|18781330|P4|STARTED|Overall Study||4
7627922|NCT02318277|18781331|P3|STARTED|Overall Study||4
7627923|NCT02318277|18781332|P2|STARTED|Overall Study||3
7627924|NCT02318277|18781333|P1|STARTED|Overall Study||6
7627925|NCT02317809|18781396|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
7627926|NCT02317809|18781397|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
7627927|NCT02317809|18781396|P2|COMPLETED|Second Intervention Period (8 Days)||17
7627928|NCT02317809|18781397|P1|COMPLETED|Second Intervention Period (8 Days)||14
7627929|NCT02317809|18781396|P2|STARTED|Second Intervention Period (8 Days)||17
7627930|NCT02317809|18781397|P1|STARTED|Second Intervention Period (8 Days)||14
7627931|NCT02317809|18781396|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
7627932|NCT02317809|18781397|P1|NOT COMPLETED|First Intervention Period (8 Days)||3
7627933|NCT02317809|18781396|P2|COMPLETED|First Intervention Period (8 Days)||17
7627934|NCT02317809|18781397|P1|COMPLETED|First Intervention Period (8 Days)||14
7627935|NCT02317809|18781396|P2|STARTED|First Intervention Period (8 Days)||17
7627936|NCT02317809|18781397|P1|STARTED|First Intervention Period (8 Days)||17
7627937|NCT02317744|18781449|P2|NOT COMPLETED|Overall Study||2
7627938|NCT02317744|18781450|P1|NOT COMPLETED|Overall Study||1
7627939|NCT02317744|18781449|P2|COMPLETED|Overall Study|One Placebo participant stopped the treatment but completed assessments.|8
7627940|NCT02317744|18781450|P1|COMPLETED|Overall Study|One NB participant stopped the treatment but completed assessments.|11
7627941|NCT02317744|18781449|P2|Completed Treatment|Overall Study||7
7627942|NCT02317744|18781450|P1|Completed Treatment|Overall Study||10
7627943|NCT02317744|18781449|P2|STARTED|Overall Study||10
7627944|NCT02317744|18781450|P1|STARTED|Overall Study||12
7627945|NCT02317692|18781464|P2|NOT COMPLETED|Overall Study||0
7627946|NCT02317692|18781465|P1|NOT COMPLETED|Overall Study||6
7627947|NCT02317692|18781464|P2|COMPLETED|Overall Study||77
7627948|NCT02317692|18781465|P1|COMPLETED|Overall Study||63
7627949|NCT02317692|18781464|P2|STARTED|Overall Study||77
7627950|NCT02317692|18781465|P1|STARTED|Overall Study||69
7627951|NCT02317614|18781485|P2|NOT COMPLETED|Overall Study||2
7627952|NCT02317614|18781486|P1|NOT COMPLETED|Overall Study||3
7627953|NCT02317614|18781485|P2|COMPLETED|Overall Study||23
7627954|NCT02317614|18781486|P1|COMPLETED|Overall Study||23
7627955|NCT02317614|18781485|P2|STARTED|Overall Study||25
7627956|NCT02317614|18781486|P1|STARTED|Overall Study||26
7627957|NCT02317575|18781502|P5|NOT COMPLETED|Period 5||0
7627958|NCT02317575|18781503|P4|NOT COMPLETED|Period 5||0
7627959|NCT02317575|18781504|P3|NOT COMPLETED|Period 5||0
7627960|NCT02317575|18781505|P2|NOT COMPLETED|Period 5||0
7627961|NCT02317575|18781506|P1|NOT COMPLETED|Period 5||0
7627962|NCT02317575|18781502|P5|COMPLETED|Period 5||6
7627963|NCT02317575|18781503|P4|COMPLETED|Period 5||6
7627964|NCT02317575|18781504|P3|COMPLETED|Period 5||6
7627965|NCT02317575|18781505|P2|COMPLETED|Period 5||5
7627966|NCT02317575|18781506|P1|COMPLETED|Period 5||4
7627967|NCT02317575|18781502|P5|STARTED|Period 5||6
7627968|NCT02317575|18781503|P4|STARTED|Period 5||6
7627969|NCT02317575|18781504|P3|STARTED|Period 5||6
7627970|NCT02317575|18781505|P2|STARTED|Period 5||5
7627971|NCT02317575|18781506|P1|STARTED|Period 5||4
7627972|NCT02317575|18781502|P5|NOT COMPLETED|Period 4||0
7627973|NCT02317575|18781503|P4|NOT COMPLETED|Period 4||0
7627974|NCT02317575|18781504|P3|NOT COMPLETED|Period 4||0
7627975|NCT02317575|18781505|P2|NOT COMPLETED|Period 4||0
7627976|NCT02317575|18781506|P1|NOT COMPLETED|Period 4||0
7627977|NCT02317575|18781502|P5|COMPLETED|Period 4||6
7627978|NCT02317575|18781503|P4|COMPLETED|Period 4||6
7627979|NCT02317575|18781504|P3|COMPLETED|Period 4||6
7627980|NCT02317575|18781505|P2|COMPLETED|Period 4||5
7627981|NCT02317575|18781506|P1|COMPLETED|Period 4||4
7627982|NCT02317575|18781502|P5|STARTED|Period 4||6
7627983|NCT02317575|18781503|P4|STARTED|Period 4||6
7627984|NCT02317575|18781504|P3|STARTED|Period 4||6
7627985|NCT02317575|18781505|P2|STARTED|Period 4||5
7627986|NCT02317575|18781506|P1|STARTED|Period 4||4
7627987|NCT02317575|18781502|P5|NOT COMPLETED|Period 3||0
7627988|NCT02317575|18781503|P4|NOT COMPLETED|Period 3||0
7627989|NCT02317575|18781504|P3|NOT COMPLETED|Period 3||0
7627990|NCT02317575|18781505|P2|NOT COMPLETED|Period 3||0
7627991|NCT02317575|18781506|P1|NOT COMPLETED|Period 3||0
7627992|NCT02317575|18781502|P5|COMPLETED|Period 3||6
7627993|NCT02317575|18781503|P4|COMPLETED|Period 3||6
7627994|NCT02317575|18781504|P3|COMPLETED|Period 3||6
7627995|NCT02317575|18781505|P2|COMPLETED|Period 3||5
7627996|NCT02317575|18781506|P1|COMPLETED|Period 3||4
7627997|NCT02317575|18781502|P5|STARTED|Period 3||6
7627998|NCT02317575|18781503|P4|STARTED|Period 3||6
7627999|NCT02317575|18781504|P3|STARTED|Period 3||6
7628000|NCT02317575|18781505|P2|STARTED|Period 3||5
7628001|NCT02317575|18781506|P1|STARTED|Period 3||4
7628002|NCT02317575|18781502|P5|NOT COMPLETED|Period 2||0
7628003|NCT02317575|18781503|P4|NOT COMPLETED|Period 2||0
7628004|NCT02317575|18781504|P3|NOT COMPLETED|Period 2||0
7628005|NCT02317575|18781505|P2|NOT COMPLETED|Period 2||0
7628006|NCT02317575|18781506|P1|NOT COMPLETED|Period 2||0
7628007|NCT02317575|18781502|P5|COMPLETED|Period 2||6
7628008|NCT02317575|18781503|P4|COMPLETED|Period 2||6
7628009|NCT02317575|18781504|P3|COMPLETED|Period 2||6
7628010|NCT02317575|18781505|P2|COMPLETED|Period 2||5
7628011|NCT02317575|18781506|P1|COMPLETED|Period 2||4
7628012|NCT02317575|18781502|P5|STARTED|Period 2||6
7628013|NCT02317575|18781503|P4|STARTED|Period 2||6
7628014|NCT02317575|18781504|P3|STARTED|Period 2||6
7628015|NCT02317575|18781505|P2|STARTED|Period 2||5
7628016|NCT02317575|18781506|P1|STARTED|Period 2||4
7628017|NCT02317575|18781502|P5|NOT COMPLETED|Period 1||0
7628018|NCT02317575|18781503|P4|NOT COMPLETED|Period 1||0
7628019|NCT02317575|18781504|P3|NOT COMPLETED|Period 1||0
7628020|NCT02317575|18781505|P2|NOT COMPLETED|Period 1||1
7628021|NCT02317575|18781506|P1|NOT COMPLETED|Period 1||1
7628022|NCT02317575|18781502|P5|COMPLETED|Period 1||6
7628023|NCT02317575|18781503|P4|COMPLETED|Period 1||6
7628024|NCT02317575|18781504|P3|COMPLETED|Period 1||6
7628025|NCT02317575|18781505|P2|COMPLETED|Period 1||5
7628026|NCT02317575|18781506|P1|COMPLETED|Period 1||4
7628027|NCT02317575|18781502|P5|Received at Least 1 Dose of Study Drug|Period 1||6
7628028|NCT02317575|18781503|P4|Received at Least 1 Dose of Study Drug|Period 1||6
7628029|NCT02317575|18781504|P3|Received at Least 1 Dose of Study Drug|Period 1||6
7628030|NCT02317575|18781505|P2|Received at Least 1 Dose of Study Drug|Period 1||5
7628031|NCT02317575|18781506|P1|Received at Least 1 Dose of Study Drug|Period 1||5
7628032|NCT02317575|18781502|P5|STARTED|Period 1||6
7628033|NCT02317575|18781503|P4|STARTED|Period 1||6
7628034|NCT02317575|18781504|P3|STARTED|Period 1||6
7628035|NCT02317575|18781505|P2|STARTED|Period 1||6
7628036|NCT02317575|18781506|P1|STARTED|Period 1||5
7628037|NCT02317549|18781532|P2|NOT COMPLETED|Overall Study||0
7628038|NCT02317549|18781533|P1|NOT COMPLETED|Overall Study||0
7628039|NCT02317549|18781532|P2|COMPLETED|Overall Study||3
7628040|NCT02317549|18781533|P1|COMPLETED|Overall Study||5
7628041|NCT02317549|18781532|P2|STARTED|Overall Study||3
7628042|NCT02317549|18781533|P1|STARTED|Overall Study||5
7628043|NCT02317510|18781541|P2|NOT COMPLETED|Overall Study||1
7628044|NCT02317510|18781542|P1|NOT COMPLETED|Overall Study||0
7628045|NCT02317510|18781541|P2|COMPLETED|Overall Study||24
7628046|NCT02317510|18781542|P1|COMPLETED|Overall Study||25
7628047|NCT02317510|18781541|P2|STARTED|Overall Study||25
7628048|NCT02317510|18781542|P1|STARTED|Overall Study||25
7628049|NCT02317276|18781570|P1|NOT COMPLETED|Overall Study||6
7628050|NCT02317276|18781570|P1|COMPLETED|Overall Study||5
7628051|NCT02317276|18781570|P1|STARTED|Overall Study||11
7628052|NCT02317016|18781574|P1|NOT COMPLETED|Part B: Day 35 to End Part B (AZD9291)||31
7628053|NCT02317016|18781574|P1|COMPLETED|Part B: Day 35 to End Part B (AZD9291)||11
7628054|NCT02317016|18781574|P1|STARTED|Part B: Day 35 to End Part B (AZD9291)|41 completed Part A + 1 entered Part B without completing Part A (due to AE) = 42 started Part B|42
7628055|NCT02317016|18781574|P1|NOT COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||2
7628056|NCT02317016|18781574|P1|COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||41
7628057|NCT02317016|18781574|P1|STARTED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||43
7628058|NCT02317016|18781574|P1|NOT COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||1
7628059|NCT02317016|18781574|P1|COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||43
7628060|NCT02317016|18781574|P1|STARTED|Part A: Day 4-31 (AZD9291 Alone)||44
7628061|NCT02317016|18781574|P1|NOT COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||0
7628062|NCT02317016|18781574|P1|COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||44
7628063|NCT02317016|18781574|P1|STARTED|Part A: Day 1-3 (Rosuvastatin Alone)||44
7628064|NCT02316847|18781602|P2|NOT COMPLETED|Overall Study||86
7628065|NCT02316847|18781603|P1|NOT COMPLETED|Overall Study||9
7628066|NCT02316847|18781602|P2|COMPLETED|Overall Study||13
7628067|NCT02316847|18781603|P1|COMPLETED|Overall Study||0
7628068|NCT02316847|18781602|P2|STARTED|Overall Study||99
7628069|NCT02316847|18781603|P1|STARTED|Overall Study||9
7628070|NCT02316769|18781614|P2|NOT COMPLETED|Overall Study||0
7628071|NCT02316769|18781615|P1|NOT COMPLETED|Overall Study||2
7628072|NCT02316769|18781614|P2|COMPLETED|Overall Study||33
7628073|NCT02316769|18781615|P1|COMPLETED|Overall Study||31
7628074|NCT02316769|18781614|P2|STARTED|Overall Study||33
7628075|NCT02316769|18781615|P1|STARTED|Overall Study||33
7628076|NCT02316717|18781626|P3|NOT COMPLETED|Overall Study||3
7628077|NCT02316717|18781627|P2|NOT COMPLETED|Overall Study||7
7628078|NCT02316717|18781628|P1|NOT COMPLETED|Overall Study||11
7628079|NCT02316717|18781626|P3|COMPLETED|Overall Study||41
7628080|NCT02316717|18781627|P2|COMPLETED|Overall Study||39
7628081|NCT02316717|18781628|P1|COMPLETED|Overall Study||32
7628082|NCT02316717|18781626|P3|STARTED|Overall Study||44
7628083|NCT02316717|18781627|P2|STARTED|Overall Study||46
7628084|NCT02316717|18781628|P1|STARTED|Overall Study||43
7628085|NCT02316678|18781758|P2|NOT COMPLETED|Overall Study||0
7628086|NCT02316678|18781759|P1|NOT COMPLETED|Overall Study||0
7628087|NCT02316678|18781758|P2|COMPLETED|Overall Study||7694
7628088|NCT02316678|18781759|P1|COMPLETED|Overall Study||1879
7628089|NCT02316678|18781758|P2|STARTED|Overall Study||7694
7628090|NCT02316678|18781759|P1|STARTED|Overall Study||1879
7628091|NCT02316613|18781765|P1|NOT COMPLETED|Overall Study||104
7628092|NCT02316613|18781765|P1|COMPLETED|Overall Study||156
7628093|NCT02316613|18781765|P1|Overall Population|Overall Study||241
7628094|NCT02316613|18781765|P1|Safety Population|Overall Study||255
7628095|NCT02316613|18781765|P1|STARTED|Overall Study||260
7628096|NCT02316548|18781804|P2|NOT COMPLETED|Overall Study||1
7628097|NCT02316548|18781805|P1|NOT COMPLETED|Overall Study||0
7628098|NCT02316548|18781804|P2|COMPLETED|Overall Study|Eligible patients on study until study termination|6
7628099|NCT02316548|18781805|P1|COMPLETED|Overall Study|Eligible patients on study until study termination|6
7628100|NCT02316548|18781804|P2|Eligible With Adverse Event Data|Overall Study||2
7628101|NCT02316548|18781805|P1|Eligible With Adverse Event Data|Overall Study||4
7628102|NCT02316548|18781804|P2|Eligible With Disease Assessment|Overall Study||1
7628103|NCT02316548|18781805|P1|Eligible With Disease Assessment|Overall Study||4
7628104|NCT02316548|18781804|P2|Eligible Population|Overall Study||6
7628105|NCT02316548|18781805|P1|Eligible Population|Overall Study||6
7628106|NCT02316548|18781804|P2|STARTED|Overall Study|Randomized|7
7628107|NCT02316548|18781805|P1|STARTED|Overall Study|Randomized|6
7628108|NCT02316470|18781819|P4|NOT COMPLETED|Overall Study||2
7628109|NCT02316470|18781820|P3|NOT COMPLETED|Overall Study||5
7628110|NCT02316470|18781821|P2|NOT COMPLETED|Overall Study||6
7628111|NCT02316470|18781822|P1|NOT COMPLETED|Overall Study||5
7628112|NCT02316470|18781819|P4|COMPLETED|Overall Study||46
7628113|NCT02316470|18781820|P3|COMPLETED|Overall Study||147
7628114|NCT02316470|18781821|P2|COMPLETED|Overall Study||146
7628115|NCT02316470|18781822|P1|COMPLETED|Overall Study||143
7628116|NCT02316470|18781819|P4|STARTED|Overall Study||48
7628117|NCT02316470|18781820|P3|STARTED|Overall Study||152
7628118|NCT02316470|18781821|P2|STARTED|Overall Study||152
7628119|NCT02316470|18781822|P1|STARTED|Overall Study||148
7628120|NCT02316366|18781918|P2|NOT COMPLETED|Overall Study||0
7628121|NCT02316366|18781919|P1|NOT COMPLETED|Overall Study||0
7628122|NCT02316366|18781918|P2|COMPLETED|Overall Study||40
7628123|NCT02316366|18781919|P1|COMPLETED|Overall Study||40
7628124|NCT02316366|18781918|P2|STARTED|Overall Study||40
7628125|NCT02316366|18781919|P1|STARTED|Overall Study||40
7628126|NCT02316353|18781935|P2|NOT COMPLETED|Overall Study||8
7628127|NCT02316353|18781936|P1|NOT COMPLETED|Overall Study||8
7628128|NCT02316353|18781935|P2|COMPLETED|Overall Study||55
7628129|NCT02316353|18781936|P1|COMPLETED|Overall Study||55
7628130|NCT02316353|18781935|P2|STARTED|Overall Study||63
7628131|NCT02316353|18781936|P1|STARTED|Overall Study|7 subjects assigned to the CSL830 (40) Arm, were titrated up to the 60 IU/kg arm during the study|63
7628132|NCT02316171|18781956|P4|NOT COMPLETED|Overall Study||0
7628133|NCT02316171|18781957|P3|NOT COMPLETED|Overall Study||0
7628134|NCT02316171|18781958|P2|NOT COMPLETED|Overall Study||0
7628135|NCT02316171|18781959|P1|NOT COMPLETED|Overall Study||1
7628136|NCT02316171|18781956|P4|COMPLETED|Overall Study||3
7628137|NCT02316171|18781957|P3|COMPLETED|Overall Study||3
7628138|NCT02316171|18781958|P2|COMPLETED|Overall Study||6
7628139|NCT02316171|18781959|P1|COMPLETED|Overall Study||3
7628140|NCT02316171|18781956|P4|STARTED|Overall Study||3
7628141|NCT02316171|18781957|P3|STARTED|Overall Study||3
7628142|NCT02316171|18781958|P2|STARTED|Overall Study||6
7628143|NCT02316171|18781959|P1|STARTED|Overall Study||4
7628144|NCT02316002|18781965|P1|NOT COMPLETED|Overall Study||6
7628145|NCT02316002|18781965|P1|COMPLETED|Overall Study||45
7628146|NCT02316002|18781965|P1|STARTED|Overall Study||51
7628147|NCT02315989|18781969|P1|NOT COMPLETED|Overall Study||0
7628148|NCT02315989|18781969|P1|COMPLETED|Overall Study||6
7628149|NCT02315989|18781969|P1|STARTED|Overall Study||6
7628150|NCT02315872|18781979|P2|NOT COMPLETED|Overall Study||1
7628151|NCT02315872|18781980|P1|NOT COMPLETED|Overall Study||3
7628152|NCT02315872|18781979|P2|COMPLETED|Overall Study||3
7628153|NCT02315872|18781980|P1|COMPLETED|Overall Study||1
7628154|NCT02315872|18781979|P2|STARTED|Overall Study||4
7628155|NCT02315872|18781980|P1|STARTED|Overall Study||4
7628156|NCT02315755|18781992|P1|NOT COMPLETED|Overall Study||0
7628157|NCT02315755|18781992|P1|COMPLETED|Overall Study|Participants who died, were considered as 'completed'.|102
7628158|NCT02315755|18781992|P1|STARTED|Overall Study||102
7628159|NCT02315703|18782029|P8|NOT COMPLETED|Overall Study||7
7628160|NCT02315703|18782030|P7|NOT COMPLETED|Overall Study||13
7628161|NCT02315703|18782031|P6|NOT COMPLETED|Overall Study||6
7628162|NCT02315703|18782032|P5|NOT COMPLETED|Overall Study||8
7628163|NCT02315703|18782033|P4|NOT COMPLETED|Overall Study||9
7628164|NCT02315703|18782034|P3|NOT COMPLETED|Overall Study||5
7628165|NCT02315703|18782035|P2|NOT COMPLETED|Overall Study||10
7628166|NCT02315703|18782036|P1|NOT COMPLETED|Overall Study||6
7628167|NCT02315703|18782029|P8|COMPLETED|Overall Study||42
7628168|NCT02315703|18782030|P7|COMPLETED|Overall Study||37
7628169|NCT02315703|18782031|P6|COMPLETED|Overall Study||43
7628170|NCT02315703|18782032|P5|COMPLETED|Overall Study||41
7628171|NCT02315703|18782033|P4|COMPLETED|Overall Study||39
7628172|NCT02315703|18782034|P3|COMPLETED|Overall Study||44
7628173|NCT02315703|18782035|P2|COMPLETED|Overall Study||39
7628174|NCT02315703|18782036|P1|COMPLETED|Overall Study||44
7628175|NCT02315703|18782029|P8|STARTED|Overall Study||49
7628176|NCT02315703|18782030|P7|STARTED|Overall Study||50
7628177|NCT02315703|18782031|P6|STARTED|Overall Study||49
7628178|NCT02315703|18782032|P5|STARTED|Overall Study||49
7628179|NCT02315703|18782033|P4|STARTED|Overall Study||48
7628180|NCT02315703|18782034|P3|STARTED|Overall Study||49
7628181|NCT02315703|18782035|P2|STARTED|Overall Study||49
7628182|NCT02315703|18782036|P1|STARTED|Overall Study||50
7628183|NCT02315664|18782136|P2|NOT COMPLETED|Overall Study||4
7628184|NCT02315664|18782137|P1|NOT COMPLETED|Overall Study||1
7628185|NCT02315664|18782136|P2|COMPLETED|Overall Study||27
7628186|NCT02315664|18782137|P1|COMPLETED|Overall Study||29
7628187|NCT02315664|18782136|P2|STARTED|Overall Study||31
7628188|NCT02315664|18782137|P1|STARTED|Overall Study||30
7628189|NCT02315625|18782159|P2|NOT COMPLETED|Second Intervention||1
7628190|NCT02315625|18782160|P1|NOT COMPLETED|Second Intervention||4
7628191|NCT02315625|18782159|P2|COMPLETED|Second Intervention||1
7628192|NCT02315625|18782160|P1|COMPLETED|Second Intervention||9
7628193|NCT02315625|18782159|P2|STARTED|Second Intervention||2
7628194|NCT02315625|18782160|P1|STARTED|Second Intervention||13
7628195|NCT02315625|18782159|P2|NOT COMPLETED|First Intervention||0
7628196|NCT02315625|18782160|P1|NOT COMPLETED|First Intervention||1
7628197|NCT02315625|18782159|P2|COMPLETED|First Intervention||2
7628198|NCT02315625|18782160|P1|COMPLETED|First Intervention||13
7628199|NCT02315625|18782159|P2|STARTED|First Intervention||2
7628200|NCT02315625|18782160|P1|STARTED|First Intervention||14
7628201|NCT02315560|18782174|P1|NOT COMPLETED|Overall Study||3
7628202|NCT02315560|18782174|P1|COMPLETED|Overall Study||22
7628203|NCT02315560|18782174|P1|STARTED|Overall Study||25
7628204|NCT02315430|18782179|P1|NOT COMPLETED|Overall Study||0
7628205|NCT02315430|18782179|P1|COMPLETED|Overall Study||13
7628206|NCT02315430|18782179|P1|STARTED|Overall Study||13
7628207|NCT02315352|18782189|P8|NOT COMPLETED|Fifth Intervention (Day 2)||0
7628208|NCT02315352|18782190|P7|NOT COMPLETED|Fifth Intervention (Day 2)||0
7628209|NCT02315352|18782191|P6|NOT COMPLETED|Fifth Intervention (Day 2)||0
7628210|NCT02315352|18782192|P5|NOT COMPLETED|Fifth Intervention (Day 2)||0
7628211|NCT02315352|18782193|P4|NOT COMPLETED|Fifth Intervention (Day 2)||0
7628212|NCT02315352|18782194|P3|NOT COMPLETED|Fifth Intervention (Day 2)||0
7628213|NCT02315352|18782195|P2|NOT COMPLETED|Fifth Intervention (Day 2)||0
7628214|NCT02315352|18782196|P1|NOT COMPLETED|Fifth Intervention (Day 2)||0
7628215|NCT02315352|18782189|P8|COMPLETED|Fifth Intervention (Day 2)||8
7628216|NCT02315352|18782190|P7|COMPLETED|Fifth Intervention (Day 2)||9
7628217|NCT02315352|18782191|P6|COMPLETED|Fifth Intervention (Day 2)||7
7628218|NCT02315352|18782192|P5|COMPLETED|Fifth Intervention (Day 2)||8
7628219|NCT02315352|18782193|P4|COMPLETED|Fifth Intervention (Day 2)||8
7628220|NCT02315352|18782194|P3|COMPLETED|Fifth Intervention (Day 2)||7
7628221|NCT02315352|18782195|P2|COMPLETED|Fifth Intervention (Day 2)||0
7628222|NCT02315352|18782196|P1|COMPLETED|Fifth Intervention (Day 2)||0
7628223|NCT02315352|18782189|P8|STARTED|Fifth Intervention (Day 2)||8
7628224|NCT02315352|18782190|P7|STARTED|Fifth Intervention (Day 2)||9
7628225|NCT02315352|18782191|P6|STARTED|Fifth Intervention (Day 2)||7
7628226|NCT02315352|18782192|P5|STARTED|Fifth Intervention (Day 2)||8
7628227|NCT02315352|18782193|P4|STARTED|Fifth Intervention (Day 2)||8
7628228|NCT02315352|18782194|P3|STARTED|Fifth Intervention (Day 2)||7
7628229|NCT02315352|18782195|P2|STARTED|Fifth Intervention (Day 2)||0
7628230|NCT02315352|18782196|P1|STARTED|Fifth Intervention (Day 2)||0
7628231|NCT02315352|18782189|P8|NOT COMPLETED|Fourth Intervention (Day 2)||0
7628232|NCT02315352|18782190|P7|NOT COMPLETED|Fourth Intervention (Day 2)||0
7628233|NCT02315352|18782191|P6|NOT COMPLETED|Fourth Intervention (Day 2)||0
7628234|NCT02315352|18782192|P5|NOT COMPLETED|Fourth Intervention (Day 2)||0
7628235|NCT02315352|18782193|P4|NOT COMPLETED|Fourth Intervention (Day 2)||0
7628236|NCT02315352|18782194|P3|NOT COMPLETED|Fourth Intervention (Day 2)||0
7628237|NCT02315352|18782195|P2|NOT COMPLETED|Fourth Intervention (Day 2)||0
7628238|NCT02315352|18782196|P1|NOT COMPLETED|Fourth Intervention (Day 2)||0
7628239|NCT02315352|18782189|P8|COMPLETED|Fourth Intervention (Day 2)||8
7628240|NCT02315352|18782190|P7|COMPLETED|Fourth Intervention (Day 2)||9
7628241|NCT02315352|18782191|P6|COMPLETED|Fourth Intervention (Day 2)||7
7628242|NCT02315352|18782192|P5|COMPLETED|Fourth Intervention (Day 2)||8
7628243|NCT02315352|18782193|P4|COMPLETED|Fourth Intervention (Day 2)||8
7628244|NCT02315352|18782194|P3|COMPLETED|Fourth Intervention (Day 2)||7
7628245|NCT02315352|18782195|P2|COMPLETED|Fourth Intervention (Day 2)||0
7628246|NCT02315352|18782196|P1|COMPLETED|Fourth Intervention (Day 2)||0
7628247|NCT02315352|18782189|P8|STARTED|Fourth Intervention (Day 2)||8
7628248|NCT02315352|18782190|P7|STARTED|Fourth Intervention (Day 2)||9
7628249|NCT02315352|18782191|P6|STARTED|Fourth Intervention (Day 2)||7
7628250|NCT02315352|18782192|P5|STARTED|Fourth Intervention (Day 2)||8
7628251|NCT02315352|18782193|P4|STARTED|Fourth Intervention (Day 2)||8
7628252|NCT02315352|18782194|P3|STARTED|Fourth Intervention (Day 2)||7
7628253|NCT02315352|18782195|P2|STARTED|Fourth Intervention (Day 2)||0
7628254|NCT02315352|18782196|P1|STARTED|Fourth Intervention (Day 2)||0
7628255|NCT02315352|18782189|P8|NOT COMPLETED|Third Intervention (Day 2)||0
7628256|NCT02315352|18782190|P7|NOT COMPLETED|Third Intervention (Day 2)||0
7628257|NCT02315352|18782191|P6|NOT COMPLETED|Third Intervention (Day 2)||0
7628258|NCT02315352|18782192|P5|NOT COMPLETED|Third Intervention (Day 2)||0
7628259|NCT02315352|18782193|P4|NOT COMPLETED|Third Intervention (Day 2)||0
7628260|NCT02315352|18782194|P3|NOT COMPLETED|Third Intervention (Day 2)||0
7628261|NCT02315352|18782195|P2|NOT COMPLETED|Third Intervention (Day 2)||0
7628262|NCT02315352|18782196|P1|NOT COMPLETED|Third Intervention (Day 2)||0
7628263|NCT02315352|18782189|P8|COMPLETED|Third Intervention (Day 2)||8
7628264|NCT02315352|18782190|P7|COMPLETED|Third Intervention (Day 2)||9
7628265|NCT02315352|18782191|P6|COMPLETED|Third Intervention (Day 2)||7
7628266|NCT02315352|18782192|P5|COMPLETED|Third Intervention (Day 2)||8
7628267|NCT02315352|18782193|P4|COMPLETED|Third Intervention (Day 2)||8
7628268|NCT02315352|18782194|P3|COMPLETED|Third Intervention (Day 2)||7
7628269|NCT02315352|18782195|P2|COMPLETED|Third Intervention (Day 2)||0
7628270|NCT02315352|18782196|P1|COMPLETED|Third Intervention (Day 2)||0
7628271|NCT02315352|18782189|P8|STARTED|Third Intervention (Day 2)||8
7628272|NCT02315352|18782190|P7|STARTED|Third Intervention (Day 2)||9
7628273|NCT02315352|18782191|P6|STARTED|Third Intervention (Day 2)||7
7628274|NCT02315352|18782192|P5|STARTED|Third Intervention (Day 2)||8
7628275|NCT02315352|18782193|P4|STARTED|Third Intervention (Day 2)||8
7628276|NCT02315352|18782194|P3|STARTED|Third Intervention (Day 2)||7
7628277|NCT02315352|18782195|P2|STARTED|Third Intervention (Day 2)||0
7628278|NCT02315352|18782196|P1|STARTED|Third Intervention (Day 2)||0
7628279|NCT02315352|18782189|P8|NOT COMPLETED|Second Intervention (Day 1)||0
7628280|NCT02315352|18782190|P7|NOT COMPLETED|Second Intervention (Day 1)||0
7628281|NCT02315352|18782191|P6|NOT COMPLETED|Second Intervention (Day 1)||0
7628282|NCT02315352|18782192|P5|NOT COMPLETED|Second Intervention (Day 1)||0
7628283|NCT02315352|18782193|P4|NOT COMPLETED|Second Intervention (Day 1)||0
7628284|NCT02315352|18782194|P3|NOT COMPLETED|Second Intervention (Day 1)||0
7628285|NCT02315352|18782195|P2|NOT COMPLETED|Second Intervention (Day 1)||0
7628286|NCT02315352|18782196|P1|NOT COMPLETED|Second Intervention (Day 1)||0
7628287|NCT02315352|18782189|P8|COMPLETED|Second Intervention (Day 1)||0
7628288|NCT02315352|18782190|P7|COMPLETED|Second Intervention (Day 1)||0
7628289|NCT02315352|18782191|P6|COMPLETED|Second Intervention (Day 1)||0
7628290|NCT02315352|18782192|P5|COMPLETED|Second Intervention (Day 1)||0
7628291|NCT02315352|18782193|P4|COMPLETED|Second Intervention (Day 1)||0
7628292|NCT02315352|18782194|P3|COMPLETED|Second Intervention (Day 1)||0
7628293|NCT02315352|18782195|P2|COMPLETED|Second Intervention (Day 1)||24
7628294|NCT02315352|18782196|P1|COMPLETED|Second Intervention (Day 1)|Out of 24 subjects completing this period, 1 discontinued before assignment to any sequence on Day 2|24
7628295|NCT02315352|18782189|P8|STARTED|Second Intervention (Day 1)||0
7628296|NCT02315352|18782190|P7|STARTED|Second Intervention (Day 1)||0
7628297|NCT02315352|18782191|P6|STARTED|Second Intervention (Day 1)||0
7628298|NCT02315352|18782192|P5|STARTED|Second Intervention (Day 1)||0
7628299|NCT02315352|18782193|P4|STARTED|Second Intervention (Day 1)||0
7628300|NCT02315352|18782194|P3|STARTED|Second Intervention (Day 1)||0
7628301|NCT02315352|18782195|P2|STARTED|Second Intervention (Day 1)||24
7628302|NCT02315352|18782196|P1|STARTED|Second Intervention (Day 1)||24
7628303|NCT02315352|18782189|P8|NOT COMPLETED|First Intervention (Day 1)||0
7628304|NCT02315352|18782190|P7|NOT COMPLETED|First Intervention (Day 1)||0
7628305|NCT02315352|18782191|P6|NOT COMPLETED|First Intervention (Day 1)||0
7628306|NCT02315352|18782192|P5|NOT COMPLETED|First Intervention (Day 1)||0
7628307|NCT02315352|18782193|P4|NOT COMPLETED|First Intervention (Day 1)||0
7628308|NCT02315352|18782194|P3|NOT COMPLETED|First Intervention (Day 1)||0
7628309|NCT02315352|18782195|P2|NOT COMPLETED|First Intervention (Day 1)||0
7628310|NCT02315352|18782196|P1|NOT COMPLETED|First Intervention (Day 1)||0
7628311|NCT02315352|18782189|P8|COMPLETED|First Intervention (Day 1)||0
7628312|NCT02315352|18782190|P7|COMPLETED|First Intervention (Day 1)||0
7628313|NCT02315352|18782191|P6|COMPLETED|First Intervention (Day 1)||0
7628314|NCT02315352|18782192|P5|COMPLETED|First Intervention (Day 1)||0
7628315|NCT02315352|18782193|P4|COMPLETED|First Intervention (Day 1)||0
7628316|NCT02315352|18782194|P3|COMPLETED|First Intervention (Day 1)||0
7628317|NCT02315352|18782195|P2|COMPLETED|First Intervention (Day 1)||24
7628318|NCT02315352|18782196|P1|COMPLETED|First Intervention (Day 1)||24
7628319|NCT02315352|18782189|P8|STARTED|First Intervention (Day 1)||0
7628320|NCT02315352|18782190|P7|STARTED|First Intervention (Day 1)||0
7628321|NCT02315352|18782191|P6|STARTED|First Intervention (Day 1)||0
7628322|NCT02315352|18782192|P5|STARTED|First Intervention (Day 1)||0
7628323|NCT02315352|18782193|P4|STARTED|First Intervention (Day 1)||0
7628324|NCT02315352|18782194|P3|STARTED|First Intervention (Day 1)||0
7628325|NCT02315352|18782195|P2|STARTED|First Intervention (Day 1)||24
7628326|NCT02315352|18782196|P1|STARTED|First Intervention (Day 1)||24
7628327|NCT02315261|18782223|P1|NOT COMPLETED|Overall Study||0
7628328|NCT02315261|18782223|P1|COMPLETED|Overall Study||364
7628329|NCT02315261|18782223|P1|STARTED|Overall Study||364
7628330|NCT02314936|18782234|P4|NOT COMPLETED|Overall Study||0
7628331|NCT02314936|18782235|P3|NOT COMPLETED|Overall Study||2
7628332|NCT02314936|18782236|P2|NOT COMPLETED|Overall Study||0
7628333|NCT02314936|18782237|P1|NOT COMPLETED|Overall Study||0
7628334|NCT02314936|18782234|P4|COMPLETED|Overall Study||48
7628335|NCT02314936|18782235|P3|COMPLETED|Overall Study||46
7628336|NCT02314936|18782236|P2|COMPLETED|Overall Study||48
7628337|NCT02314936|18782237|P1|COMPLETED|Overall Study||48
7628338|NCT02314936|18782234|P4|STARTED|Overall Study||48
7628339|NCT02314936|18782235|P3|STARTED|Overall Study||48
7628340|NCT02314936|18782236|P2|STARTED|Overall Study||48
7628341|NCT02314936|18782237|P1|STARTED|Overall Study||48
7628342|NCT02314923|18782433|P10|NOT COMPLETED|Overall Study||0
7628343|NCT02314923|18782434|P9|NOT COMPLETED|Overall Study||2
7628344|NCT02314923|18782435|P8|NOT COMPLETED|Overall Study||5
7628345|NCT02314923|18782436|P7|NOT COMPLETED|Overall Study||5
7628346|NCT02314923|18782437|P6|NOT COMPLETED|Overall Study||1
7628347|NCT02314923|18782438|P5|NOT COMPLETED|Overall Study||1
7628348|NCT02314923|18782439|P4|NOT COMPLETED|Overall Study||1
7628349|NCT02314923|18782440|P3|NOT COMPLETED|Overall Study||2
7628350|NCT02314923|18782441|P2|NOT COMPLETED|Overall Study||4
7628351|NCT02314923|18782442|P1|NOT COMPLETED|Overall Study||3
7628352|NCT02314923|18782433|P10|COMPLETED|Overall Study||20
7628353|NCT02314923|18782434|P9|COMPLETED|Overall Study||46
7628354|NCT02314923|18782435|P8|COMPLETED|Overall Study||42
7628355|NCT02314923|18782436|P7|COMPLETED|Overall Study||43
7628356|NCT02314923|18782437|P6|COMPLETED|Overall Study||19
7628357|NCT02314923|18782438|P5|COMPLETED|Overall Study||73
7628358|NCT02314923|18782439|P4|COMPLETED|Overall Study||63
7628359|NCT02314923|18782440|P3|COMPLETED|Overall Study||62
7628360|NCT02314923|18782441|P2|COMPLETED|Overall Study||60
7628361|NCT02314923|18782442|P1|COMPLETED|Overall Study||61
7628362|NCT02314923|18782433|P10|Treated|Overall Study||20
7628363|NCT02314923|18782434|P9|Treated|Overall Study||48
7628364|NCT02314923|18782435|P8|Treated|Overall Study||47
7628365|NCT02314923|18782436|P7|Treated|Overall Study|One participant did not receive vaccination due to missing blood sample at randomization.|47
7628366|NCT02314923|18782437|P6|Treated|Overall Study||20
7628367|NCT02314923|18782438|P5|Treated|Overall Study||74
7628368|NCT02314923|18782439|P4|Treated|Overall Study||64
7628369|NCT02314923|18782440|P3|Treated|Overall Study||64
7628370|NCT02314923|18782441|P2|Treated|Overall Study||64
7628371|NCT02314923|18782442|P1|Treated|Overall Study||64
7628372|NCT02314923|18782433|P10|STARTED|Overall Study||20
7628373|NCT02314923|18782434|P9|STARTED|Overall Study||48
7628374|NCT02314923|18782435|P8|STARTED|Overall Study||47
7628375|NCT02314923|18782436|P7|STARTED|Overall Study||48
7628376|NCT02314923|18782437|P6|STARTED|Overall Study||20
7628377|NCT02314923|18782438|P5|STARTED|Overall Study||74
7628378|NCT02314923|18782439|P4|STARTED|Overall Study||64
7628379|NCT02314923|18782440|P3|STARTED|Overall Study||64
7628380|NCT02314923|18782441|P2|STARTED|Overall Study||64
7628381|NCT02314923|18782442|P1|STARTED|Overall Study||64
7628382|NCT02314689|18782535|P1|NOT COMPLETED|Overall Study||0
7628383|NCT02314689|18782535|P1|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4
7628384|NCT02314689|18782535|P1|STARTED|Overall Study||4
7628385|NCT02314637|18782541|P2|NOT COMPLETED|Overall Study||14
7628386|NCT02314637|18782542|P1|NOT COMPLETED|Overall Study||16
7628387|NCT02314637|18782541|P2|COMPLETED|Overall Study||75
7628388|NCT02314637|18782542|P1|COMPLETED|Overall Study||135
7628389|NCT02314637|18782541|P2|STARTED|Overall Study||89
7628390|NCT02314637|18782542|P1|STARTED|Overall Study||151
7628391|NCT02314598|18782552|P1|NOT COMPLETED|Overall Study||0
7628392|NCT02314598|18782552|P1|COMPLETED|Overall Study||46
7628393|NCT02314598|18782552|P1|STARTED|Overall Study||46
7628394|NCT02314546|18782561|P3|NOT COMPLETED|Overall Study||0
7628395|NCT02314546|18782562|P2|NOT COMPLETED|Overall Study||0
7628396|NCT02314546|18782563|P1|NOT COMPLETED|Overall Study||0
7628397|NCT02314546|18782561|P3|COMPLETED|Overall Study||5
7628398|NCT02314546|18782562|P2|COMPLETED|Overall Study||5
7628399|NCT02314546|18782563|P1|COMPLETED|Overall Study||5
7628400|NCT02314546|18782561|P3|STARTED|Overall Study||5
7628401|NCT02314546|18782562|P2|STARTED|Overall Study||5
7628402|NCT02314546|18782563|P1|STARTED|Overall Study||5
7628403|NCT02314520|18782591|P2|NOT COMPLETED|Overall Study||0
7628404|NCT02314520|18782592|P1|NOT COMPLETED|Overall Study||0
7628405|NCT02314520|18782591|P2|COMPLETED|Overall Study||80
7628406|NCT02314520|18782592|P1|COMPLETED|Overall Study||72
7628407|NCT02314520|18782591|P2|STARTED|Overall Study||80
7628408|NCT02314520|18782592|P1|STARTED|Overall Study||72
7628409|NCT02314260|18782604|P1|NOT COMPLETED|Overall Study||0
7628410|NCT02314260|18782604|P1|COMPLETED|Overall Study||80
7628411|NCT02314260|18782604|P1|STARTED|Overall Study||80
7628412|NCT02314247|18782613|P3|NOT COMPLETED|Overall Study||1
7628413|NCT02314247|18782614|P2|NOT COMPLETED|Overall Study||6
7628414|NCT02314247|18782615|P1|NOT COMPLETED|Overall Study||9
7628415|NCT02314247|18782613|P3|COMPLETED|Overall Study||0
7628416|NCT02314247|18782614|P2|COMPLETED|Overall Study||0
7628417|NCT02314247|18782615|P1|COMPLETED|Overall Study||0
7628418|NCT02314247|18782613|P3|STARTED|Overall Study||1
7628419|NCT02314247|18782614|P2|STARTED|Overall Study||6
7628420|NCT02314247|18782615|P1|STARTED|Overall Study||9
7628421|NCT02314143|18782640|P3|NOT COMPLETED|Overall Study||9
7628422|NCT02314143|18782641|P2|NOT COMPLETED|Overall Study||10
7628423|NCT02314143|18782642|P1|NOT COMPLETED|Overall Study||8
7628424|NCT02314143|18782640|P3|COMPLETED|Overall Study||7
7628425|NCT02314143|18782641|P2|COMPLETED|Overall Study||6
7628426|NCT02314143|18782642|P1|COMPLETED|Overall Study||8
7628427|NCT02314143|18782640|P3|STARTED|Overall Study||16
7628428|NCT02314143|18782641|P2|STARTED|Overall Study||16
7628429|NCT02314143|18782642|P1|STARTED|Overall Study||16
7628430|NCT02314117|18782688|P2|NOT COMPLETED|Overall Study||38
7628431|NCT02314117|18782689|P1|NOT COMPLETED|Overall Study||41
7628432|NCT02314117|18782688|P2|COMPLETED|Overall Study||281
7628433|NCT02314117|18782689|P1|COMPLETED|Overall Study||285
7628434|NCT02314117|18782688|P2|Alive But Off Treatment|Overall Study||50
7628435|NCT02314117|18782689|P1|Alive But Off Treatment|Overall Study||46
7628436|NCT02314117|18782688|P2|Death|Overall Study||231
7628437|NCT02314117|18782689|P1|Death|Overall Study||239
7628438|NCT02314117|18782688|P2|Received at Least One Dose of Study Drug|Overall Study||315
7628439|NCT02314117|18782689|P1|Received at Least One Dose of Study Drug|Overall Study||323
7628440|NCT02314117|18782688|P2|STARTED|Overall Study||319
7628441|NCT02314117|18782689|P1|STARTED|Overall Study||326
7628442|NCT02314104|18782720|P3|NOT COMPLETED|Overall Study||18
7628443|NCT02314104|18782721|P2|NOT COMPLETED|Overall Study||20
7628444|NCT02314104|18782722|P1|NOT COMPLETED|Overall Study||14
7628445|NCT02314104|18782720|P3|COMPLETED|Overall Study||53
7628446|NCT02314104|18782721|P2|COMPLETED|Overall Study||58
7628447|NCT02314104|18782722|P1|COMPLETED|Overall Study||57
7628448|NCT02314104|18782720|P3|STARTED|Overall Study||71
7628449|NCT02314104|18782721|P2|STARTED|Overall Study||78
7628450|NCT02314104|18782722|P1|STARTED|Overall Study||71
7628451|NCT02314052|18782742|P6|NOT COMPLETED|Cycles 6 -10.5||0
7628452|NCT02314052|18782743|P5|NOT COMPLETED|Cycles 6 -10.5||0
7628453|NCT02314052|18782744|P4|NOT COMPLETED|Cycles 6 -10.5||0
7628454|NCT02314052|18782745|P3|NOT COMPLETED|Cycles 6 -10.5||0
7628455|NCT02314052|18782746|P2|NOT COMPLETED|Cycles 6 -10.5||0
7628456|NCT02314052|18782747|P1|NOT COMPLETED|Cycles 6 -10.5||0
7628457|NCT02314052|18782742|P6|COMPLETED|Cycles 6 -10.5||0
7628458|NCT02314052|18782743|P5|COMPLETED|Cycles 6 -10.5|Subject 02-014 only completed 1 of 2 doses in cycle 6|2
7628459|NCT02314052|18782744|P4|COMPLETED|Cycles 6 -10.5||1
7628460|NCT02314052|18782745|P3|COMPLETED|Cycles 6 -10.5||0
7628461|NCT02314052|18782746|P2|COMPLETED|Cycles 6 -10.5||0
7628462|NCT02314052|18782747|P1|COMPLETED|Cycles 6 -10.5||0
7628463|NCT02314052|18782742|P6|STARTED|Cycles 6 -10.5||0
7628464|NCT02314052|18782743|P5|STARTED|Cycles 6 -10.5||2
7628465|NCT02314052|18782744|P4|STARTED|Cycles 6 -10.5||1
7628466|NCT02314052|18782745|P3|STARTED|Cycles 6 -10.5||0
7628467|NCT02314052|18782746|P2|STARTED|Cycles 6 -10.5||0
7628468|NCT02314052|18782747|P1|STARTED|Cycles 6 -10.5||0
7628469|NCT02314052|18782742|P6|NOT COMPLETED|Cycle Five||0
7628470|NCT02314052|18782743|P5|NOT COMPLETED|Cycle Five||0
7628471|NCT02314052|18782744|P4|NOT COMPLETED|Cycle Five||0
7628472|NCT02314052|18782745|P3|NOT COMPLETED|Cycle Five||1
7628473|NCT02314052|18782746|P2|NOT COMPLETED|Cycle Five||2
7628474|NCT02314052|18782747|P1|NOT COMPLETED|Cycle Five||0
7628475|NCT02314052|18782742|P6|COMPLETED|Cycle Five||0
7628476|NCT02314052|18782743|P5|COMPLETED|Cycle Five||2
7628477|NCT02314052|18782744|P4|COMPLETED|Cycle Five|subject missed cycle four but returned for cycle 5|1
7628478|NCT02314052|18782745|P3|COMPLETED|Cycle Five||0
7628479|NCT02314052|18782746|P2|COMPLETED|Cycle Five||0
7628480|NCT02314052|18782747|P1|COMPLETED|Cycle Five||0
7628481|NCT02314052|18782742|P6|STARTED|Cycle Five||0
7628482|NCT02314052|18782743|P5|STARTED|Cycle Five||2
7628483|NCT02314052|18782744|P4|STARTED|Cycle Five|subject missed cycle four but returned for cycle 5|1
7628484|NCT02314052|18782745|P3|STARTED|Cycle Five||1
7628485|NCT02314052|18782746|P2|STARTED|Cycle Five||2
7628486|NCT02314052|18782747|P1|STARTED|Cycle Five||0
7628487|NCT02314052|18782742|P6|NOT COMPLETED|Cycle Four||3
7628488|NCT02314052|18782743|P5|NOT COMPLETED|Cycle Four||0
7628489|NCT02314052|18782744|P4|NOT COMPLETED|Cycle Four||1
7628490|NCT02314052|18782745|P3|NOT COMPLETED|Cycle Four||1
7628491|NCT02314052|18782746|P2|NOT COMPLETED|Cycle Four||0
7628492|NCT02314052|18782747|P1|NOT COMPLETED|Cycle Four||3
7628493|NCT02314052|18782742|P6|COMPLETED|Cycle Four||0
7628494|NCT02314052|18782743|P5|COMPLETED|Cycle Four||2
7628495|NCT02314052|18782744|P4|COMPLETED|Cycle Four||0
7628496|NCT02314052|18782745|P3|COMPLETED|Cycle Four||1
7628497|NCT02314052|18782746|P2|COMPLETED|Cycle Four||2
7628498|NCT02314052|18782747|P1|COMPLETED|Cycle Four||0
7628499|NCT02314052|18782742|P6|STARTED|Cycle Four||3
7628500|NCT02314052|18782743|P5|STARTED|Cycle Four||2
7628501|NCT02314052|18782744|P4|STARTED|Cycle Four||1
7628502|NCT02314052|18782745|P3|STARTED|Cycle Four||2
7628503|NCT02314052|18782746|P2|STARTED|Cycle Four||2
7628504|NCT02314052|18782747|P1|STARTED|Cycle Four||3
7628505|NCT02314052|18782742|P6|NOT COMPLETED|Cycle Three||0
7628506|NCT02314052|18782743|P5|NOT COMPLETED|Cycle Three||0
7628507|NCT02314052|18782744|P4|NOT COMPLETED|Cycle Three||0
7628508|NCT02314052|18782745|P3|NOT COMPLETED|Cycle Three||0
7628509|NCT02314052|18782746|P2|NOT COMPLETED|Cycle Three||0
7628510|NCT02314052|18782747|P1|NOT COMPLETED|Cycle Three||0
7628511|NCT02314052|18782742|P6|COMPLETED|Cycle Three||3
7628512|NCT02314052|18782743|P5|COMPLETED|Cycle Three||2
7628513|NCT02314052|18782744|P4|COMPLETED|Cycle Three||1
7628514|NCT02314052|18782745|P3|COMPLETED|Cycle Three||2
7628515|NCT02314052|18782746|P2|COMPLETED|Cycle Three|1 of 2 completers in cohort 2 (subject 02-005) only completed 1 of 2 infusions during this cycle|2
7628516|NCT02314052|18782747|P1|COMPLETED|Cycle Three||3
7628517|NCT02314052|18782742|P6|STARTED|Cycle Three||3
7628518|NCT02314052|18782743|P5|STARTED|Cycle Three||2
7628519|NCT02314052|18782744|P4|STARTED|Cycle Three||1
7628520|NCT02314052|18782745|P3|STARTED|Cycle Three||2
7628521|NCT02314052|18782746|P2|STARTED|Cycle Three||2
7628522|NCT02314052|18782747|P1|STARTED|Cycle Three||3
7628523|NCT02314052|18782742|P6|NOT COMPLETED|Cycle Two||0
7628524|NCT02314052|18782743|P5|NOT COMPLETED|Cycle Two||4
7628525|NCT02314052|18782744|P4|NOT COMPLETED|Cycle Two||1
7628526|NCT02314052|18782745|P3|NOT COMPLETED|Cycle Two||1
7628527|NCT02314052|18782746|P2|NOT COMPLETED|Cycle Two||1
7628528|NCT02314052|18782747|P1|NOT COMPLETED|Cycle Two||0
7628529|NCT02314052|18782742|P6|COMPLETED|Cycle Two||3
7628530|NCT02314052|18782743|P5|COMPLETED|Cycle Two||2
7628531|NCT02314052|18782744|P4|COMPLETED|Cycle Two||1
7628532|NCT02314052|18782745|P3|COMPLETED|Cycle Two||2
7628533|NCT02314052|18782746|P2|COMPLETED|Cycle Two||2
7628534|NCT02314052|18782747|P1|COMPLETED|Cycle Two||3
7628535|NCT02314052|18782742|P6|STARTED|Cycle Two||3
7628536|NCT02314052|18782743|P5|STARTED|Cycle Two||6
7628537|NCT02314052|18782744|P4|STARTED|Cycle Two||2
7628538|NCT02314052|18782745|P3|STARTED|Cycle Two||3
7628539|NCT02314052|18782746|P2|STARTED|Cycle Two||3
7628540|NCT02314052|18782747|P1|STARTED|Cycle Two||3
7628541|NCT02314052|18782742|P6|NOT COMPLETED|Cycle One||0
7628542|NCT02314052|18782743|P5|NOT COMPLETED|Cycle One||0
7628543|NCT02314052|18782744|P4|NOT COMPLETED|Cycle One||1
7628544|NCT02314052|18782745|P3|NOT COMPLETED|Cycle One||0
7628545|NCT02314052|18782746|P2|NOT COMPLETED|Cycle One||0
7628546|NCT02314052|18782747|P1|NOT COMPLETED|Cycle One||0
7628547|NCT02314052|18782742|P6|COMPLETED|Cycle One||3
7628548|NCT02314052|18782743|P5|COMPLETED|Cycle One||6
7628549|NCT02314052|18782744|P4|COMPLETED|Cycle One||2
7628550|NCT02314052|18782745|P3|COMPLETED|Cycle One||3
7628551|NCT02314052|18782746|P2|COMPLETED|Cycle One||3
7628552|NCT02314052|18782747|P1|COMPLETED|Cycle One||3
7628553|NCT02314052|18782742|P6|STARTED|Cycle One||3
7628554|NCT02314052|18782743|P5|STARTED|Cycle One||6
7628555|NCT02314052|18782744|P4|STARTED|Cycle One||3
7628556|NCT02314052|18782745|P3|STARTED|Cycle One||3
7628557|NCT02314052|18782746|P2|STARTED|Cycle One||3
7628558|NCT02314052|18782747|P1|STARTED|Cycle One||3
7628559|NCT02314026|18782815|P1|NOT COMPLETED|Overall Study||28
7628560|NCT02314026|18782815|P1|COMPLETED|Overall Study||107
7628561|NCT02314026|18782815|P1|STARTED|Overall Study||135
7628562|NCT02314000|18782823|P2|NOT COMPLETED|Overall Study||8
7628563|NCT02314000|18782824|P1|NOT COMPLETED|Overall Study||13
7628564|NCT02314000|18782823|P2|COMPLETED|Overall Study||57
7628565|NCT02314000|18782824|P1|COMPLETED|Overall Study||62
7628566|NCT02314000|18782823|P2|STARTED|Overall Study||65
7628567|NCT02314000|18782824|P1|STARTED|Overall Study||75
7628568|NCT02313909|18782833|P2|NOT COMPLETED|Overall Study||50
7628569|NCT02313909|18782834|P1|NOT COMPLETED|Overall Study||57
7628570|NCT02313909|18782833|P2|COMPLETED|Overall Study||3554
7628571|NCT02313909|18782834|P1|COMPLETED|Overall Study||3552
7628572|NCT02313909|18782833|P2|Treated|Overall Study||3559
7628573|NCT02313909|18782834|P1|Treated|Overall Study||3562
7628574|NCT02313909|18782833|P2|STARTED|Overall Study||3604
7628575|NCT02313909|18782834|P1|STARTED|Overall Study||3609
7628576|NCT02313766|18782857|P3|NOT COMPLETED|Overall Study||0
7628577|NCT02313766|18782858|P2|NOT COMPLETED|Overall Study||3
7628578|NCT02313766|18782859|P1|NOT COMPLETED|Overall Study||1
7628579|NCT02313766|18782857|P3|COMPLETED|Overall Study||50
7628580|NCT02313766|18782858|P2|COMPLETED|Overall Study||47
7628581|NCT02313766|18782859|P1|COMPLETED|Overall Study||49
7628582|NCT02313766|18782857|P3|STARTED|Overall Study||50
7628583|NCT02313766|18782858|P2|STARTED|Overall Study||50
7628584|NCT02313766|18782859|P1|STARTED|Overall Study||50
7628585|NCT02313675|18782877|P4|NOT COMPLETED|Overall Study||0
7628586|NCT02313675|18782878|P3|NOT COMPLETED|Overall Study||0
7628587|NCT02313675|18782879|P2|NOT COMPLETED|Overall Study||0
7628588|NCT02313675|18782880|P1|NOT COMPLETED|Overall Study||0
7628589|NCT02313675|18782877|P4|COMPLETED|Overall Study||11
7628590|NCT02313675|18782878|P3|COMPLETED|Overall Study||11
7628591|NCT02313675|18782879|P2|COMPLETED|Overall Study||11
7628592|NCT02313675|18782880|P1|COMPLETED|Overall Study||11
7628593|NCT02313675|18782877|P4|STARTED|Overall Study||11
7628594|NCT02313675|18782878|P3|STARTED|Overall Study||11
7628595|NCT02313675|18782879|P2|STARTED|Overall Study||11
7628596|NCT02313675|18782880|P1|STARTED|Overall Study||11
7628597|NCT02313558|18782896|P2|NOT COMPLETED|Overall Study||4
7628598|NCT02313558|18782897|P1|NOT COMPLETED|Overall Study||6
7628599|NCT02313558|18782896|P2|COMPLETED|Overall Study||46
7628600|NCT02313558|18782897|P1|COMPLETED|Overall Study||44
7628601|NCT02313558|18782896|P2|STARTED|Overall Study||50
7628602|NCT02313558|18782897|P1|STARTED|Overall Study||50
7628603|NCT02313506|18782911|P2|NOT COMPLETED|Overall Study||0
7628604|NCT02313506|18782912|P1|NOT COMPLETED|Overall Study||0
7628605|NCT02313506|18782911|P2|COMPLETED|Overall Study||17
7628606|NCT02313506|18782912|P1|COMPLETED|Overall Study||17
7628607|NCT02313506|18782911|P2|STARTED|Overall Study||17
7628608|NCT02313506|18782912|P1|STARTED|Overall Study||17
7628609|NCT02313454|18782932|P2|NOT COMPLETED|Treatment 2||0
7628610|NCT02313454|18782933|P1|NOT COMPLETED|Treatment 2||0
7628611|NCT02313454|18782932|P2|COMPLETED|Treatment 2||10
7628612|NCT02313454|18782933|P1|COMPLETED|Treatment 2||8
7628613|NCT02313454|18782932|P2|STARTED|Treatment 2|1 participant did not receive the second application.|10
7628614|NCT02313454|18782933|P1|STARTED|Treatment 2|1 participant did not receive the second application.|8
7628615|NCT02313454|18782932|P2|NOT COMPLETED|Treatment 1||0
7628616|NCT02313454|18782933|P1|NOT COMPLETED|Treatment 1||0
7628617|NCT02313454|18782932|P2|COMPLETED|Treatment 1||11
7628618|NCT02313454|18782933|P1|COMPLETED|Treatment 1||9
7628619|NCT02313454|18782932|P2|STARTED|Treatment 1||11
7628620|NCT02313454|18782933|P1|STARTED|Treatment 1||9
7628621|NCT02313233|18782943|P2|NOT COMPLETED|Overall Study||3
7628622|NCT02313233|18782944|P1|NOT COMPLETED|Overall Study||2
7628623|NCT02313233|18782943|P2|COMPLETED|Overall Study||18
7628624|NCT02313233|18782944|P1|COMPLETED|Overall Study||18
7628625|NCT02313233|18782943|P2|STARTED|Overall Study||21
7628626|NCT02313233|18782944|P1|STARTED|Overall Study||20
7628627|NCT02313155|18782966|P2|NOT COMPLETED|Overall Study||1
7628628|NCT02313155|18782967|P1|NOT COMPLETED|Overall Study||0
7628629|NCT02313155|18782966|P2|COMPLETED|Overall Study||54
7628630|NCT02313155|18782967|P1|COMPLETED|Overall Study||55
7628631|NCT02313155|18782966|P2|STARTED|Overall Study||55
7628632|NCT02313155|18782967|P1|STARTED|Overall Study||55
7628633|NCT02312934|18783017|P2|NOT COMPLETED|Overall Study||0
7628634|NCT02312934|18783018|P1|NOT COMPLETED|Overall Study||2
7628635|NCT02312934|18783017|P2|COMPLETED|Overall Study||11
7628636|NCT02312934|18783018|P1|COMPLETED|Overall Study||9
7628637|NCT02312934|18783017|P2|STARTED|Overall Study||11
7628638|NCT02312934|18783018|P1|STARTED|Overall Study||11
7628639|NCT02312882|18783026|P1|NOT COMPLETED|Overall Study||4
7628640|NCT02312882|18783026|P1|COMPLETED|Overall Study||36
7628641|NCT02312882|18783026|P1|STARTED|Overall Study||40
7628642|NCT02312856|18783030|P1|NOT COMPLETED|Overall Study||4
7628643|NCT02312856|18783030|P1|COMPLETED|Overall Study||30
7628644|NCT02312856|18783030|P1|STARTED|Overall Study||34
7628645|NCT02312765|18783036|P2|NOT COMPLETED|Overall Study||36
7628646|NCT02312765|18783037|P1|NOT COMPLETED|Overall Study||55
7628647|NCT02312765|18783036|P2|COMPLETED|Overall Study||36
7628648|NCT02312765|18783037|P1|COMPLETED|Overall Study||19
7628649|NCT02312765|18783036|P2|STARTED|Overall Study||72
7628650|NCT02312765|18783037|P1|STARTED|Overall Study||74
7628651|NCT02312739|18783045|P2|NOT COMPLETED|Overall Study||2
7628652|NCT02312739|18783046|P1|NOT COMPLETED|Overall Study||6
7628653|NCT02312739|18783045|P2|COMPLETED|Overall Study||34
7628654|NCT02312739|18783046|P1|COMPLETED|Overall Study||30
7628655|NCT02312739|18783045|P2|Withdrawn Prior to Procedure|Overall Study||2
7628656|NCT02312739|18783046|P1|Withdrawn Prior to Procedure|Overall Study||6
7628657|NCT02312739|18783045|P2|STARTED|Overall Study||36
7628658|NCT02312739|18783046|P1|STARTED|Overall Study||36
7628659|NCT02312726|18783060|P3|NOT COMPLETED|Overall Study||67
7628660|NCT02312726|18783061|P2|NOT COMPLETED|Overall Study||0
7628661|NCT02312726|18783062|P1|NOT COMPLETED|Overall Study||0
7628662|NCT02312726|18783060|P3|COMPLETED|Overall Study||0
7628663|NCT02312726|18783061|P2|COMPLETED|Overall Study||30
7628664|NCT02312726|18783062|P1|COMPLETED|Overall Study||38
7628665|NCT02312726|18783060|P3|STARTED|Overall Study||67
7628666|NCT02312726|18783061|P2|STARTED|Overall Study||30
7628667|NCT02312726|18783062|P1|STARTED|Overall Study||38
7628668|NCT02312713|18783077|P3|NOT COMPLETED|Overall Study||5
7628669|NCT02312713|18783078|P2|NOT COMPLETED|Overall Study||30
7628670|NCT02312713|18783079|P1|NOT COMPLETED|Overall Study||11
7628671|NCT02312713|18783077|P3|COMPLETED|Overall Study||63
7628672|NCT02312713|18783078|P2|COMPLETED|Overall Study||112
7628673|NCT02312713|18783079|P1|COMPLETED|Overall Study||129
7628674|NCT02312713|18783077|P3|STARTED|Overall Study||68
7628675|NCT02312713|18783078|P2|STARTED|Overall Study||142
7628676|NCT02312713|18783079|P1|STARTED|Overall Study||140
7628677|NCT02312687|18783123|P1|NOT COMPLETED|Overall Study||1
7628678|NCT02312687|18783123|P1|COMPLETED|Overall Study||19
7628679|NCT02312687|18783123|P1|STARTED|Overall Study||20
7628680|NCT02312622|18783154|P3|NOT COMPLETED|Overall Study||0
7628681|NCT02312622|18783155|P2|NOT COMPLETED|Overall Study||0
7628682|NCT02312622|18783156|P1|NOT COMPLETED|Overall Study||0
7628683|NCT02312622|18783154|P3|COMPLETED|Overall Study||12
7628684|NCT02312622|18783155|P2|COMPLETED|Overall Study||3
7628685|NCT02312622|18783156|P1|COMPLETED|Overall Study||12
7628686|NCT02312622|18783154|P3|STARTED|Overall Study||12
7628687|NCT02312622|18783155|P2|STARTED|Overall Study||3
7628688|NCT02312622|18783156|P1|STARTED|Overall Study||12
7628689|NCT02312310|18783184|P4|NOT COMPLETED|Overall Study||0
7628690|NCT02312310|18783185|P3|NOT COMPLETED|Overall Study||3
7628691|NCT02312310|18783186|P2|NOT COMPLETED|Overall Study||2
7628692|NCT02312310|18783187|P1|NOT COMPLETED|Overall Study||2
7628693|NCT02312310|18783184|P4|COMPLETED|Overall Study||52
7628694|NCT02312310|18783185|P3|COMPLETED|Overall Study||50
7628695|NCT02312310|18783186|P2|COMPLETED|Overall Study||51
7628696|NCT02312310|18783187|P1|COMPLETED|Overall Study||51
7628697|NCT02312310|18783184|P4|STARTED|Overall Study||52
7628698|NCT02312310|18783185|P3|STARTED|Overall Study||53
7628699|NCT02312310|18783186|P2|STARTED|Overall Study||53
7628700|NCT02312310|18783187|P1|STARTED|Overall Study||53
7628701|NCT02312258|18783215|P2|NOT COMPLETED|Overall Study||359
7628702|NCT02312258|18783216|P1|NOT COMPLETED|Overall Study||251
7628703|NCT02312258|18783215|P2|COMPLETED|Overall Study||66
7628704|NCT02312258|18783216|P1|COMPLETED|Overall Study||30
7628705|NCT02312258|18783215|P2|STARTED|Overall Study||425
7628706|NCT02312258|18783216|P1|STARTED|Overall Study||281
7628707|NCT02312219|18783224|P2|NOT COMPLETED|Overall Study||6
7628708|NCT02312219|18783225|P1|NOT COMPLETED|Overall Study||1
7628709|NCT02312219|18783224|P2|COMPLETED|Overall Study||16
7628710|NCT02312219|18783225|P1|COMPLETED|Overall Study||12
7628711|NCT02312219|18783224|P2|STARTED|Overall Study||22
7628712|NCT02312219|18783225|P1|STARTED|Overall Study||13
7628713|NCT02312206|18783235|P2|NOT COMPLETED|Overall Study||130
7628714|NCT02312206|18783236|P1|NOT COMPLETED|Overall Study||130
7628715|NCT02312206|18783235|P2|COMPLETED|Overall Study||0
7628716|NCT02312206|18783236|P1|COMPLETED|Overall Study||0
7628717|NCT02312206|18783235|P2|Informed Consent Obtained|Overall Study||130
7628718|NCT02312206|18783236|P1|Informed Consent Obtained|Overall Study||130
7628719|NCT02312206|18783235|P2|STARTED|Overall Study||130
7628720|NCT02312206|18783236|P1|STARTED|Overall Study||130
7628721|NCT02312154|18783242|P1|NOT COMPLETED|Overall Study||1
7628722|NCT02312154|18783242|P1|COMPLETED|Overall Study||24
7628723|NCT02312154|18783242|P1|STARTED|Overall Study||25
7628724|NCT02312063|18783259|P2|NOT COMPLETED|Overall Study||1
7628725|NCT02312063|18783260|P1|NOT COMPLETED|Overall Study||0
7628726|NCT02312063|18783259|P2|COMPLETED|Overall Study||24
7628727|NCT02312063|18783260|P1|COMPLETED|Overall Study||23
7628728|NCT02312063|18783259|P2|STARTED|Overall Study||25
7628729|NCT02312063|18783260|P1|STARTED|Overall Study||23
7628730|NCT02311972|18783270|P2|NOT COMPLETED|Overall Study||0
7628731|NCT02311972|18783271|P1|NOT COMPLETED|Overall Study||0
7628732|NCT02311972|18783270|P2|COMPLETED|Overall Study||8
7628733|NCT02311972|18783271|P1|COMPLETED|Overall Study||12
7628734|NCT02311972|18783270|P2|STARTED|Overall Study||8
7628735|NCT02311972|18783271|P1|STARTED|Overall Study||12
7628736|NCT02311907|18783290|P2|NOT COMPLETED|Overall Study||0
7628737|NCT02311907|18783291|P1|NOT COMPLETED|Overall Study||0
7628738|NCT02311907|18783290|P2|COMPLETED|Overall Study||91
7628739|NCT02311907|18783291|P1|COMPLETED|Overall Study||94
7628740|NCT02311907|18783290|P2|STARTED|Overall Study||91
7628741|NCT02311907|18783291|P1|STARTED|Overall Study||94
7628742|NCT02311894|18783313|P1|NOT COMPLETED|Overall Study||4
7628743|NCT02311894|18783313|P1|COMPLETED|Overall Study||78
7628744|NCT02311894|18783313|P1|Modified ITT Population|Overall Study||81
7628745|NCT02311894|18783313|P1|STARTED|Overall Study||82
7628746|NCT02311881|18783325|P3|NOT COMPLETED|Overall Study||41
7628747|NCT02311881|18783326|P2|NOT COMPLETED|Overall Study||43
7628748|NCT02311881|18783327|P1|NOT COMPLETED|Overall Study||35
7628749|NCT02311881|18783325|P3|COMPLETED|Overall Study||196
7628750|NCT02311881|18783326|P2|COMPLETED|Overall Study||193
7628751|NCT02311881|18783327|P1|COMPLETED|Overall Study||200
7628752|NCT02311881|18783325|P3|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|237
7628753|NCT02311881|18783326|P2|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|236
7628754|NCT02311881|18783327|P1|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|234
7628755|NCT02311881|18783325|P3|STARTED|Overall Study|Started refers to all randomized participants.|237
7628756|NCT02311881|18783326|P2|STARTED|Overall Study|Started refers to all randomized participants.|236
7628757|NCT02311881|18783327|P1|STARTED|Overall Study|Started refers to all randomized participants.|235
7628758|NCT02311478|18783362|P1|NOT COMPLETED|Overall Study||7
7628759|NCT02311478|18783362|P1|COMPLETED|Overall Study||72
7628760|NCT02311478|18783362|P1|IUD Insertion|Overall Study||78
7628761|NCT02311478|18783362|P1|STARTED|Overall Study||79
7628762|NCT02311361|18783371|P4|NOT COMPLETED|Overall Study||1
7628763|NCT02311361|18783372|P3|NOT COMPLETED|Overall Study||0
7628764|NCT02311361|18783373|P2|NOT COMPLETED|Overall Study||1
7628765|NCT02311361|18783374|P1|NOT COMPLETED|Overall Study||0
7628766|NCT02311361|18783371|P4|COMPLETED|Overall Study||20
7628767|NCT02311361|18783372|P3|COMPLETED|Overall Study||19
7628768|NCT02311361|18783373|P2|COMPLETED|Overall Study||10
7628769|NCT02311361|18783374|P1|COMPLETED|Overall Study||14
7628770|NCT02311361|18783371|P4|Received Radiation Therapy Only|Overall Study||1
7628771|NCT02311361|18783372|P3|Received Radiation Therapy Only|Overall Study||1
7628772|NCT02311361|18783373|P2|Received Radiation Therapy Only|Overall Study||1
7628773|NCT02311361|18783374|P1|Received Radiation Therapy Only|Overall Study||0
7628774|NCT02311361|18783371|P4|STARTED|Overall Study||21
7628775|NCT02311361|18783372|P3|STARTED|Overall Study||19
7628776|NCT02311361|18783373|P2|STARTED|Overall Study||11
7628777|NCT02311361|18783374|P1|STARTED|Overall Study||14
7628778|NCT02311309|18783411|P3|NOT COMPLETED|Overall Study||0
7628779|NCT02311309|18783412|P2|NOT COMPLETED|Overall Study||0
7628780|NCT02311309|18783413|P1|NOT COMPLETED|Overall Study||0
7628781|NCT02311309|18783411|P3|COMPLETED|Overall Study||863
7628782|NCT02311309|18783412|P2|COMPLETED|Overall Study||35
7628783|NCT02311309|18783413|P1|COMPLETED|Overall Study||541
7628784|NCT02311309|18783411|P3|STARTED|Overall Study||863
7628785|NCT02311309|18783412|P2|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35
7628786|NCT02311309|18783413|P1|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541
7628787|NCT02311153|18783426|P2|NOT COMPLETED|Overall Study||7
7628788|NCT02311153|18783427|P1|NOT COMPLETED|Overall Study||5
7628789|NCT02311153|18783426|P2|COMPLETED|Overall Study||42
7628790|NCT02311153|18783427|P1|COMPLETED|Overall Study||48
7628791|NCT02311153|18783426|P2|STARTED|Overall Study||49
7628792|NCT02311153|18783427|P1|STARTED|Overall Study||53
7628793|NCT02310906|18783447|P4|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||8
7628794|NCT02310906|18783448|P3|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||2
7628795|NCT02310906|18783449|P2|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
7628796|NCT02310906|18783450|P1|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
7628797|NCT02310906|18783447|P4|COMPLETED|Part 2: Open Label Phase (168 Weeks)||6
7628798|NCT02310906|18783448|P3|COMPLETED|Part 2: Open Label Phase (168 Weeks)||23
7628799|NCT02310906|18783449|P2|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
7628800|NCT02310906|18783450|P1|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
7628801|NCT02310906|18783447|P4|STARTED|Part 2: Open Label Phase (168 Weeks)||14
7628802|NCT02310906|18783448|P3|STARTED|Part 2: Open Label Phase (168 Weeks)|4 participants from Part 1(Placebo) + 8 participants from Part 1(Golodirsen) +13 new participants|25
7628803|NCT02310906|18783449|P2|STARTED|Part 2: Open Label Phase (168 Weeks)||0
7628804|NCT02310906|18783450|P1|STARTED|Part 2: Open Label Phase (168 Weeks)||0
7628805|NCT02310906|18783447|P4|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
7628806|NCT02310906|18783448|P3|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
7628807|NCT02310906|18783449|P2|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
7628808|NCT02310906|18783450|P1|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
7628809|NCT02310906|18783447|P4|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
7628810|NCT02310906|18783448|P3|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
7628811|NCT02310906|18783449|P2|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||8
7628812|NCT02310906|18783450|P1|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||4
7628813|NCT02310906|18783447|P4|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
7628814|NCT02310906|18783448|P3|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
7628815|NCT02310906|18783449|P2|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
7628816|NCT02310906|18783450|P1|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
7628817|NCT02310906|18783447|P4|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
7628818|NCT02310906|18783448|P3|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
7628819|NCT02310906|18783449|P2|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
7628820|NCT02310906|18783450|P1|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
7628821|NCT02310906|18783447|P4|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
7628822|NCT02310906|18783448|P3|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
7628823|NCT02310906|18783449|P2|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
7628824|NCT02310906|18783450|P1|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
7628825|NCT02310906|18783447|P4|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
7628826|NCT02310906|18783448|P3|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
7628827|NCT02310906|18783449|P2|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
7628828|NCT02310906|18783450|P1|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
7628829|NCT02310906|18783447|P4|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
7628830|NCT02310906|18783448|P3|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
7628831|NCT02310906|18783449|P2|STARTED|Part 1: Double Blind Phase (12 Weeks)||8
7628832|NCT02310906|18783450|P1|STARTED|Part 1: Double Blind Phase (12 Weeks)||4
7628833|NCT02310789|18783529|P1|NOT COMPLETED|Overall Study||1
7628834|NCT02310789|18783529|P1|COMPLETED|Overall Study||7
7628835|NCT02310789|18783529|P1|STARTED|Overall Study||8
7628836|NCT02310776|18783534|P1|NOT COMPLETED|Overall Study||0
7628837|NCT02310776|18783534|P1|COMPLETED|Overall Study||501
7628838|NCT02310776|18783534|P1|STARTED|Overall Study||501
7628839|NCT02310763|18783541|P3|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
7628840|NCT02310763|18783542|P2|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
7628841|NCT02310763|18783543|P1|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
7628842|NCT02310763|18783541|P3|COMPLETED|Period 2 (Weeks 49 to 96)||22
7628843|NCT02310763|18783542|P2|COMPLETED|Period 2 (Weeks 49 to 96)||21
7628844|NCT02310763|18783543|P1|COMPLETED|Period 2 (Weeks 49 to 96)||22
7628845|NCT02310763|18783541|P3|STARTED|Period 2 (Weeks 49 to 96)||38
7628846|NCT02310763|18783542|P2|STARTED|Period 2 (Weeks 49 to 96)||37
7628847|NCT02310763|18783543|P1|STARTED|Period 2 (Weeks 49 to 96)||38
7628848|NCT02310763|18783541|P3|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
7628849|NCT02310763|18783542|P2|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
7628850|NCT02310763|18783543|P1|NOT COMPLETED|Period 1 (Weeks 1 to 48)||3
7628851|NCT02310763|18783541|P3|COMPLETED|Period 1 (Weeks 1 to 48)||38
7628852|NCT02310763|18783542|P2|COMPLETED|Period 1 (Weeks 1 to 48)||37
7628853|NCT02310763|18783543|P1|COMPLETED|Period 1 (Weeks 1 to 48)||38
7628854|NCT02310763|18783541|P3|STARTED|Period 1 (Weeks 1 to 48)||40
7628855|NCT02310763|18783542|P2|STARTED|Period 1 (Weeks 1 to 48)||39
7628856|NCT02310763|18783543|P1|STARTED|Period 1 (Weeks 1 to 48)||41
7628857|NCT02310750|18783746|P16|NOT COMPLETED|HP MAD and Fasted/Fed||0
7628858|NCT02310750|18783747|P15|NOT COMPLETED|HP MAD and Fasted/Fed||0
7628859|NCT02310750|18783748|P14|NOT COMPLETED|HP MAD and Fasted/Fed||0
7628860|NCT02310750|18783749|P13|NOT COMPLETED|HP MAD and Fasted/Fed||0
7628861|NCT02310750|18783750|P12|NOT COMPLETED|HP MAD and Fasted/Fed||0
7628862|NCT02310750|18783751|P11|NOT COMPLETED|HP MAD and Fasted/Fed||0
7628863|NCT02310750|18783752|P10|NOT COMPLETED|HP MAD and Fasted/Fed||0
7628864|NCT02310750|18783753|P9|NOT COMPLETED|HP MAD and Fasted/Fed||0
7628865|NCT02310750|18783754|P8|NOT COMPLETED|HP MAD and Fasted/Fed||0
7628866|NCT02310750|18783755|P7|NOT COMPLETED|HP MAD and Fasted/Fed||0
7628867|NCT02310750|18783756|P6|NOT COMPLETED|HP MAD and Fasted/Fed||0
7628868|NCT02310750|18783757|P5|NOT COMPLETED|HP MAD and Fasted/Fed||1
7628869|NCT02310750|18783758|P4|NOT COMPLETED|HP MAD and Fasted/Fed||0
7628870|NCT02310750|18783759|P3|NOT COMPLETED|HP MAD and Fasted/Fed||0
7628871|NCT02310750|18783760|P2|NOT COMPLETED|HP MAD and Fasted/Fed||0
7628872|NCT02310750|18783761|P1|NOT COMPLETED|HP MAD and Fasted/Fed||0
7628873|NCT02310750|18783746|P16|COMPLETED|HP MAD and Fasted/Fed||2
7628874|NCT02310750|18783747|P15|COMPLETED|HP MAD and Fasted/Fed||2
7628875|NCT02310750|18783748|P14|COMPLETED|HP MAD and Fasted/Fed||2
7628876|NCT02310750|18783749|P13|COMPLETED|HP MAD and Fasted/Fed||2
7628877|NCT02310750|18783750|P12|COMPLETED|HP MAD and Fasted/Fed||2
7628878|NCT02310750|18783751|P11|COMPLETED|HP MAD and Fasted/Fed||2
7628879|NCT02310750|18783752|P10|COMPLETED|HP MAD and Fasted/Fed||0
7628880|NCT02310750|18783753|P9|COMPLETED|HP MAD and Fasted/Fed||0
7628881|NCT02310750|18783754|P8|COMPLETED|HP MAD and Fasted/Fed||0
7628882|NCT02310750|18783755|P7|COMPLETED|HP MAD and Fasted/Fed||2
7628883|NCT02310750|18783756|P6|COMPLETED|HP MAD and Fasted/Fed||0
7628884|NCT02310750|18783757|P5|COMPLETED|HP MAD and Fasted/Fed||4
7628885|NCT02310750|18783758|P4|COMPLETED|HP MAD and Fasted/Fed||0
7628886|NCT02310750|18783759|P3|COMPLETED|HP MAD and Fasted/Fed||0
7628887|NCT02310750|18783760|P2|COMPLETED|HP MAD and Fasted/Fed||0
7628888|NCT02310750|18783761|P1|COMPLETED|HP MAD and Fasted/Fed||0
7628889|NCT02310750|18783746|P16|STARTED|HP MAD and Fasted/Fed||2
7628890|NCT02310750|18783747|P15|STARTED|HP MAD and Fasted/Fed||2
7628891|NCT02310750|18783748|P14|STARTED|HP MAD and Fasted/Fed||2
7628892|NCT02310750|18783749|P13|STARTED|HP MAD and Fasted/Fed||2
7628893|NCT02310750|18783750|P12|STARTED|HP MAD and Fasted/Fed||2
7628894|NCT02310750|18783751|P11|STARTED|HP MAD and Fasted/Fed||2
7628895|NCT02310750|18783752|P10|STARTED|HP MAD and Fasted/Fed||0
7628896|NCT02310750|18783753|P9|STARTED|HP MAD and Fasted/Fed||0
7628897|NCT02310750|18783754|P8|STARTED|HP MAD and Fasted/Fed||0
7628898|NCT02310750|18783755|P7|STARTED|HP MAD and Fasted/Fed||2
7628899|NCT02310750|18783756|P6|STARTED|HP MAD and Fasted/Fed||0
7628900|NCT02310750|18783757|P5|STARTED|HP MAD and Fasted/Fed||5
7628901|NCT02310750|18783758|P4|STARTED|HP MAD and Fasted/Fed||0
7628902|NCT02310750|18783759|P3|STARTED|HP MAD and Fasted/Fed||0
7628903|NCT02310750|18783760|P2|STARTED|HP MAD and Fasted/Fed||0
7628904|NCT02310750|18783761|P1|STARTED|HP MAD and Fasted/Fed||0
7628905|NCT02310750|18783746|P16|NOT COMPLETED|HP Washout 2||0
7628906|NCT02310750|18783747|P15|NOT COMPLETED|HP Washout 2||0
7628907|NCT02310750|18783748|P14|NOT COMPLETED|HP Washout 2||0
7628908|NCT02310750|18783749|P13|NOT COMPLETED|HP Washout 2||0
7628909|NCT02310750|18783750|P12|NOT COMPLETED|HP Washout 2||0
7628910|NCT02310750|18783751|P11|NOT COMPLETED|HP Washout 2||0
7628911|NCT02310750|18783752|P10|NOT COMPLETED|HP Washout 2||0
7628912|NCT02310750|18783753|P9|NOT COMPLETED|HP Washout 2||0
7628913|NCT02310750|18783754|P8|NOT COMPLETED|HP Washout 2||0
7628914|NCT02310750|18783755|P7|NOT COMPLETED|HP Washout 2||7
7628915|NCT02310750|18783756|P6|NOT COMPLETED|HP Washout 2||0
7628916|NCT02310750|18783757|P5|NOT COMPLETED|HP Washout 2||1
7628917|NCT02310750|18783758|P4|NOT COMPLETED|HP Washout 2||0
7628918|NCT02310750|18783759|P3|NOT COMPLETED|HP Washout 2||0
7628919|NCT02310750|18783760|P2|NOT COMPLETED|HP Washout 2||0
7628920|NCT02310750|18783761|P1|NOT COMPLETED|HP Washout 2||0
7628921|NCT02310750|18783746|P16|COMPLETED|HP Washout 2||2
7628922|NCT02310750|18783747|P15|COMPLETED|HP Washout 2||2
7628923|NCT02310750|18783748|P14|COMPLETED|HP Washout 2||2
7628924|NCT02310750|18783749|P13|COMPLETED|HP Washout 2||2
7628925|NCT02310750|18783750|P12|COMPLETED|HP Washout 2||2
7628926|NCT02310750|18783751|P11|COMPLETED|HP Washout 2||2
7628927|NCT02310750|18783752|P10|COMPLETED|HP Washout 2||0
7628928|NCT02310750|18783753|P9|COMPLETED|HP Washout 2||0
7628929|NCT02310750|18783754|P8|COMPLETED|HP Washout 2||0
7628930|NCT02310750|18783755|P7|COMPLETED|HP Washout 2||2
7628931|NCT02310750|18783756|P6|COMPLETED|HP Washout 2||0
7628932|NCT02310750|18783757|P5|COMPLETED|HP Washout 2||5
7628933|NCT02310750|18783758|P4|COMPLETED|HP Washout 2||0
7628934|NCT02310750|18783759|P3|COMPLETED|HP Washout 2||0
7628935|NCT02310750|18783760|P2|COMPLETED|HP Washout 2||0
7628936|NCT02310750|18783761|P1|COMPLETED|HP Washout 2||0
7628937|NCT02310750|18783746|P16|STARTED|HP Washout 2||2
7628938|NCT02310750|18783747|P15|STARTED|HP Washout 2||2
7628939|NCT02310750|18783748|P14|STARTED|HP Washout 2||2
7628940|NCT02310750|18783749|P13|STARTED|HP Washout 2||2
7628941|NCT02310750|18783750|P12|STARTED|HP Washout 2||2
7628942|NCT02310750|18783751|P11|STARTED|HP Washout 2||2
7628943|NCT02310750|18783752|P10|STARTED|HP Washout 2||0
7628944|NCT02310750|18783753|P9|STARTED|HP Washout 2||0
7628945|NCT02310750|18783754|P8|STARTED|HP Washout 2||0
7628946|NCT02310750|18783755|P7|STARTED|HP Washout 2||9
7628947|NCT02310750|18783756|P6|STARTED|HP Washout 2||0
7628948|NCT02310750|18783757|P5|STARTED|HP Washout 2||6
7628949|NCT02310750|18783758|P4|STARTED|HP Washout 2||0
7628950|NCT02310750|18783759|P3|STARTED|HP Washout 2||0
7628951|NCT02310750|18783760|P2|STARTED|HP Washout 2||0
7628952|NCT02310750|18783761|P1|STARTED|HP Washout 2||0
7628953|NCT02310750|18783746|P16|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
7628954|NCT02310750|18783747|P15|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
7628955|NCT02310750|18783748|P14|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
7628956|NCT02310750|18783749|P13|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
7628957|NCT02310750|18783750|P12|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
7628958|NCT02310750|18783751|P11|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
7628959|NCT02310750|18783752|P10|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
7628960|NCT02310750|18783753|P9|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8
7628961|NCT02310750|18783754|P8|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
7628962|NCT02310750|18783755|P7|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
7628963|NCT02310750|18783756|P6|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
7628964|NCT02310750|18783757|P5|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
7628965|NCT02310750|18783758|P4|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1
7628966|NCT02310750|18783759|P3|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
7628967|NCT02310750|18783760|P2|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
7628968|NCT02310750|18783761|P1|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
7628969|NCT02310750|18783746|P16|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
7628970|NCT02310750|18783747|P15|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
7628971|NCT02310750|18783748|P14|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
7628972|NCT02310750|18783749|P13|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
7628973|NCT02310750|18783750|P12|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
7628974|NCT02310750|18783751|P11|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
7628975|NCT02310750|18783752|P10|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
7628976|NCT02310750|18783753|P9|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
7628977|NCT02310750|18783754|P8|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
7628978|NCT02310750|18783755|P7|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
7628979|NCT02310750|18783756|P6|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
7628980|NCT02310750|18783757|P5|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
7628981|NCT02310750|18783758|P4|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
7628982|NCT02310750|18783759|P3|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
7628983|NCT02310750|18783760|P2|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
7628984|NCT02310750|18783761|P1|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
7628985|NCT02310750|18783746|P16|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
7628986|NCT02310750|18783747|P15|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
7628987|NCT02310750|18783748|P14|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
7628988|NCT02310750|18783749|P13|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
7628989|NCT02310750|18783750|P12|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
7628990|NCT02310750|18783751|P11|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
7628991|NCT02310750|18783752|P10|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
7628992|NCT02310750|18783753|P9|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14
7628993|NCT02310750|18783754|P8|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
7628994|NCT02310750|18783755|P7|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
7628995|NCT02310750|18783756|P6|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
7628996|NCT02310750|18783757|P5|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
7628997|NCT02310750|18783758|P4|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
7628998|NCT02310750|18783759|P3|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
7628999|NCT02310750|18783760|P2|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
7629000|NCT02310750|18783761|P1|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
7629001|NCT02310750|18783746|P16|NOT COMPLETED|HP Washout 1||0
7629002|NCT02310750|18783747|P15|NOT COMPLETED|HP Washout 1||0
7629003|NCT02310750|18783748|P14|NOT COMPLETED|HP Washout 1||0
7629004|NCT02310750|18783749|P13|NOT COMPLETED|HP Washout 1||0
7629005|NCT02310750|18783750|P12|NOT COMPLETED|HP Washout 1||0
7629006|NCT02310750|18783751|P11|NOT COMPLETED|HP Washout 1||0
7629007|NCT02310750|18783752|P10|NOT COMPLETED|HP Washout 1||0
7629008|NCT02310750|18783753|P9|NOT COMPLETED|HP Washout 1||0
7629009|NCT02310750|18783754|P8|NOT COMPLETED|HP Washout 1||0
7629010|NCT02310750|18783755|P7|NOT COMPLETED|HP Washout 1||3
7629011|NCT02310750|18783756|P6|NOT COMPLETED|HP Washout 1||2
7629012|NCT02310750|18783757|P5|NOT COMPLETED|HP Washout 1||2
7629013|NCT02310750|18783758|P4|NOT COMPLETED|HP Washout 1||1
7629014|NCT02310750|18783759|P3|NOT COMPLETED|HP Washout 1||1
7629015|NCT02310750|18783760|P2|NOT COMPLETED|HP Washout 1||0
7629016|NCT02310750|18783761|P1|NOT COMPLETED|HP Washout 1||0
7629017|NCT02310750|18783746|P16|COMPLETED|HP Washout 1||2
7629018|NCT02310750|18783747|P15|COMPLETED|HP Washout 1||2
7629019|NCT02310750|18783748|P14|COMPLETED|HP Washout 1||2
7629020|NCT02310750|18783749|P13|COMPLETED|HP Washout 1||2
7629021|NCT02310750|18783750|P12|COMPLETED|HP Washout 1||2
7629022|NCT02310750|18783751|P11|COMPLETED|HP Washout 1||2
7629023|NCT02310750|18783752|P10|COMPLETED|HP Washout 1||0
7629024|NCT02310750|18783753|P9|COMPLETED|HP Washout 1||0
7629025|NCT02310750|18783754|P8|COMPLETED|HP Washout 1||0
7629026|NCT02310750|18783755|P7|COMPLETED|HP Washout 1||9
7629027|NCT02310750|18783756|P6|COMPLETED|HP Washout 1||6
7629028|NCT02310750|18783757|P5|COMPLETED|HP Washout 1||6
7629029|NCT02310750|18783758|P4|COMPLETED|HP Washout 1||4
7629030|NCT02310750|18783759|P3|COMPLETED|HP Washout 1||5
7629031|NCT02310750|18783760|P2|COMPLETED|HP Washout 1||0
7629032|NCT02310750|18783761|P1|COMPLETED|HP Washout 1||0
7629033|NCT02310750|18783746|P16|STARTED|HP Washout 1||2
7629034|NCT02310750|18783747|P15|STARTED|HP Washout 1||2
7629035|NCT02310750|18783748|P14|STARTED|HP Washout 1||2
7629036|NCT02310750|18783749|P13|STARTED|HP Washout 1||2
7629037|NCT02310750|18783750|P12|STARTED|HP Washout 1||2
7629038|NCT02310750|18783751|P11|STARTED|HP Washout 1||2
7629039|NCT02310750|18783752|P10|STARTED|HP Washout 1||0
7629040|NCT02310750|18783753|P9|STARTED|HP Washout 1||0
7629041|NCT02310750|18783754|P8|STARTED|HP Washout 1||0
7629042|NCT02310750|18783755|P7|STARTED|HP Washout 1||12
7629043|NCT02310750|18783756|P6|STARTED|HP Washout 1||8
7629044|NCT02310750|18783757|P5|STARTED|HP Washout 1||8
7629045|NCT02310750|18783758|P4|STARTED|HP Washout 1||5
7629046|NCT02310750|18783759|P3|STARTED|HP Washout 1||6
7629047|NCT02310750|18783760|P2|STARTED|HP Washout 1||0
7629048|NCT02310750|18783761|P1|STARTED|HP Washout 1||0
7629049|NCT02310750|18783746|P16|NOT COMPLETED|HP Period 1||0
7629050|NCT02310750|18783747|P15|NOT COMPLETED|HP Period 1||0
7629051|NCT02310750|18783748|P14|NOT COMPLETED|HP Period 1||0
7629052|NCT02310750|18783749|P13|NOT COMPLETED|HP Period 1||0
7629053|NCT02310750|18783750|P12|NOT COMPLETED|HP Period 1||0
7629054|NCT02310750|18783751|P11|NOT COMPLETED|HP Period 1||0
7629055|NCT02310750|18783752|P10|NOT COMPLETED|HP Period 1||0
7629056|NCT02310750|18783753|P9|NOT COMPLETED|HP Period 1||0
7629057|NCT02310750|18783754|P8|NOT COMPLETED|HP Period 1||0
7629058|NCT02310750|18783755|P7|NOT COMPLETED|HP Period 1||1
7629059|NCT02310750|18783756|P6|NOT COMPLETED|HP Period 1||0
7629060|NCT02310750|18783757|P5|NOT COMPLETED|HP Period 1||0
7629061|NCT02310750|18783758|P4|NOT COMPLETED|HP Period 1||1
7629062|NCT02310750|18783759|P3|NOT COMPLETED|HP Period 1||0
7629063|NCT02310750|18783760|P2|NOT COMPLETED|HP Period 1||0
7629064|NCT02310750|18783761|P1|NOT COMPLETED|HP Period 1||1
7629065|NCT02310750|18783746|P16|COMPLETED|HP Period 1||2
7629066|NCT02310750|18783747|P15|COMPLETED|HP Period 1||2
7629067|NCT02310750|18783748|P14|COMPLETED|HP Period 1||2
7629068|NCT02310750|18783749|P13|COMPLETED|HP Period 1||2
7629069|NCT02310750|18783750|P12|COMPLETED|HP Period 1||2
7629070|NCT02310750|18783751|P11|COMPLETED|HP Period 1||2
7629071|NCT02310750|18783752|P10|COMPLETED|HP Period 1||0
7629072|NCT02310750|18783753|P9|COMPLETED|HP Period 1||0
7629073|NCT02310750|18783754|P8|COMPLETED|HP Period 1||0
7629074|NCT02310750|18783755|P7|COMPLETED|HP Period 1||12
7629075|NCT02310750|18783756|P6|COMPLETED|HP Period 1||8
7629076|NCT02310750|18783757|P5|COMPLETED|HP Period 1||8
7629077|NCT02310750|18783758|P4|COMPLETED|HP Period 1||5
7629078|NCT02310750|18783759|P3|COMPLETED|HP Period 1||6
7629079|NCT02310750|18783760|P2|COMPLETED|HP Period 1||6
7629080|NCT02310750|18783761|P1|COMPLETED|HP Period 1||6
7629081|NCT02310750|18783746|P16|STARTED|HP Period 1||2
7629082|NCT02310750|18783747|P15|STARTED|HP Period 1||2
7629083|NCT02310750|18783748|P14|STARTED|HP Period 1||2
7629084|NCT02310750|18783749|P13|STARTED|HP Period 1||2
7629085|NCT02310750|18783750|P12|STARTED|HP Period 1||2
7629086|NCT02310750|18783751|P11|STARTED|HP Period 1||2
7629087|NCT02310750|18783752|P10|STARTED|HP Period 1||0
7629088|NCT02310750|18783753|P9|STARTED|HP Period 1||0
7629089|NCT02310750|18783754|P8|STARTED|HP Period 1||0
7629090|NCT02310750|18783755|P7|STARTED|HP Period 1||13
7629091|NCT02310750|18783756|P6|STARTED|HP Period 1||8
7629092|NCT02310750|18783757|P5|STARTED|HP Period 1||8
7629093|NCT02310750|18783758|P4|STARTED|HP Period 1||6
7629094|NCT02310750|18783759|P3|STARTED|HP Period 1||6
7629095|NCT02310750|18783760|P2|STARTED|HP Period 1||6
7629096|NCT02310750|18783761|P1|STARTED|HP Period 1||7
7629097|NCT02310672|18784200|P1|NOT COMPLETED|Overall Study||15
7629098|NCT02310672|18784200|P1|COMPLETED|Overall Study||72
7629099|NCT02310672|18784200|P1|STARTED|Overall Study||87
7629100|NCT02310646|18784213|P2|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
7629101|NCT02310646|18784214|P1|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
7629102|NCT02310646|18784213|P2|COMPLETED|Second Intervention (Day 8 - Day 14)||104
7629103|NCT02310646|18784214|P1|COMPLETED|Second Intervention (Day 8 - Day 14)||107
7629104|NCT02310646|18784213|P2|STARTED|Second Intervention (Day 8 - Day 14)||104
7629105|NCT02310646|18784214|P1|STARTED|Second Intervention (Day 8 - Day 14)||107
7629106|NCT02310646|18784213|P2|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0
7629107|NCT02310646|18784214|P1|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2
7629108|NCT02310646|18784213|P2|COMPLETED|First Intervention (Day 1 - Day 7)||104
7629109|NCT02310646|18784214|P1|COMPLETED|First Intervention (Day 1 - Day 7)||107
7629110|NCT02310646|18784213|P2|STARTED|First Intervention (Day 1 - Day 7)||104
7629111|NCT02310646|18784214|P1|STARTED|First Intervention (Day 1 - Day 7)||109
7629112|NCT02310581|18784242|P4|NOT COMPLETED|Overall Study||1
7629113|NCT02310581|18784243|P3|NOT COMPLETED|Overall Study||1
7629114|NCT02310581|18784244|P2|NOT COMPLETED|Overall Study||2
7629115|NCT02310581|18784245|P1|NOT COMPLETED|Overall Study||3
7629116|NCT02310581|18784242|P4|COMPLETED|Overall Study||9
7629117|NCT02310581|18784243|P3|COMPLETED|Overall Study||9
7629118|NCT02310581|18784244|P2|COMPLETED|Overall Study||9
7629119|NCT02310581|18784245|P1|COMPLETED|Overall Study||6
7629120|NCT02310581|18784242|P4|STARTED|Overall Study||10
7629121|NCT02310581|18784243|P3|STARTED|Overall Study||10
7629122|NCT02310581|18784244|P2|STARTED|Overall Study||11
7629123|NCT02310581|18784245|P1|STARTED|Overall Study||9
7629124|NCT02310568|18784284|P5|NOT COMPLETED|Stage 2 (4 Weeks)||1
7629125|NCT02310568|18784285|P4|NOT COMPLETED|Stage 2 (4 Weeks)||5
7629126|NCT02310568|18784286|P3|NOT COMPLETED|Stage 2 (4 Weeks)||1
7629127|NCT02310568|18784287|P2|NOT COMPLETED|Stage 2 (4 Weeks)||1
7629128|NCT02310568|18784288|P1|NOT COMPLETED|Stage 2 (4 Weeks)||1
7629129|NCT02310568|18784284|P5|COMPLETED|Stage 2 (4 Weeks)||19
7629130|NCT02310568|18784285|P4|COMPLETED|Stage 2 (4 Weeks)||17
7629131|NCT02310568|18784286|P3|COMPLETED|Stage 2 (4 Weeks)||13
7629132|NCT02310568|18784287|P2|COMPLETED|Stage 2 (4 Weeks)||12
7629133|NCT02310568|18784288|P1|COMPLETED|Stage 2 (4 Weeks)||11
7629134|NCT02310568|18784284|P5|STARTED|Stage 2 (4 Weeks)||20
7629135|NCT02310568|18784285|P4|STARTED|Stage 2 (4 Weeks)||22
7629136|NCT02310568|18784286|P3|STARTED|Stage 2 (4 Weeks)||14
7629137|NCT02310568|18784287|P2|STARTED|Stage 2 (4 Weeks)||13
7629138|NCT02310568|18784288|P1|STARTED|Stage 2 (4 Weeks)||12
7629139|NCT02310568|18784284|P5|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
7629140|NCT02310568|18784285|P4|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
7629141|NCT02310568|18784286|P3|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
7629142|NCT02310568|18784287|P2|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
7629143|NCT02310568|18784288|P1|NOT COMPLETED|Stage 1 ( 4 Weeks)||3
7629144|NCT02310568|18784284|P5|COMPLETED|Stage 1 ( 4 Weeks)||20
7629145|NCT02310568|18784285|P4|COMPLETED|Stage 1 ( 4 Weeks)||22
7629146|NCT02310568|18784286|P3|COMPLETED|Stage 1 ( 4 Weeks)||14
7629147|NCT02310568|18784287|P2|COMPLETED|Stage 1 ( 4 Weeks)||13
7629148|NCT02310568|18784288|P1|COMPLETED|Stage 1 ( 4 Weeks)||12
7629149|NCT02310568|18784284|P5|STARTED|Stage 1 ( 4 Weeks)||21
7629150|NCT02310568|18784285|P4|STARTED|Stage 1 ( 4 Weeks)||24
7629151|NCT02310568|18784286|P3|STARTED|Stage 1 ( 4 Weeks)||15
7629152|NCT02310568|18784287|P2|STARTED|Stage 1 ( 4 Weeks)||15
7629153|NCT02310568|18784288|P1|STARTED|Stage 1 ( 4 Weeks)||15
7629154|NCT02310126|18784368|P2|NOT COMPLETED|Period 2 (15 Minutes)||0
7629155|NCT02310126|18784369|P1|NOT COMPLETED|Period 2 (15 Minutes)||0
7629156|NCT02310126|18784368|P2|COMPLETED|Period 2 (15 Minutes)||95
7629157|NCT02310126|18784369|P1|COMPLETED|Period 2 (15 Minutes)||94
7629158|NCT02310126|18784368|P2|Myopes|Period 2 (15 Minutes)||63
7629159|NCT02310126|18784369|P1|Myopes|Period 2 (15 Minutes)||56
7629160|NCT02310126|18784368|P2|Hyperopes|Period 2 (15 Minutes)||32
7629161|NCT02310126|18784369|P1|Hyperopes|Period 2 (15 Minutes)||38
7629162|NCT02310126|18784368|P2|STARTED|Period 2 (15 Minutes)||95
7629163|NCT02310126|18784369|P1|STARTED|Period 2 (15 Minutes)||94
7629164|NCT02310126|18784368|P2|NOT COMPLETED|Period 1 (15 Minutes)||2
7629165|NCT02310126|18784369|P1|NOT COMPLETED|Period 1 (15 Minutes)||0
7629166|NCT02310126|18784368|P2|COMPLETED|Period 1 (15 Minutes)||95
7629167|NCT02310126|18784369|P1|COMPLETED|Period 1 (15 Minutes)||94
7629168|NCT02310126|18784368|P2|Myopes|Period 1 (15 Minutes)||64
7629169|NCT02310126|18784369|P1|Myopes|Period 1 (15 Minutes)||56
7629170|NCT02310126|18784368|P2|Hyperopes|Period 1 (15 Minutes)||33
7629171|NCT02310126|18784369|P1|Hyperopes|Period 1 (15 Minutes)||38
7629172|NCT02310126|18784368|P2|STARTED|Period 1 (15 Minutes)||97
7629173|NCT02310126|18784369|P1|STARTED|Period 1 (15 Minutes)||94
7629174|NCT02310100|18784375|P1|NOT COMPLETED|Overall Study||18
7629175|NCT02310100|18784375|P1|COMPLETED|Overall Study||160
7629176|NCT02310100|18784375|P1|STARTED|Overall Study|First enrollment|178
7629177|NCT02309944|18784382|P2|NOT COMPLETED|Overall Study||0
7629178|NCT02309944|18784383|P1|NOT COMPLETED|Overall Study||0
7629179|NCT02309944|18784382|P2|COMPLETED|Overall Study||43
7629180|NCT02309944|18784383|P1|COMPLETED|Overall Study||38
7629181|NCT02309944|18784382|P2|STARTED|Overall Study||43
7629182|NCT02309944|18784383|P1|STARTED|Overall Study||38
7629183|NCT02309723|18784394|P3|NOT COMPLETED|Overall Study||24
7629184|NCT02309723|18784395|P2|NOT COMPLETED|Overall Study||23
7629185|NCT02309723|18784396|P1|NOT COMPLETED|Overall Study||24
7629186|NCT02309723|18784394|P3|COMPLETED|Overall Study||105
7629187|NCT02309723|18784395|P2|COMPLETED|Overall Study||105
7629188|NCT02309723|18784396|P1|COMPLETED|Overall Study||105
7629189|NCT02309723|18784394|P3|STARTED|Overall Study||129
7629190|NCT02309723|18784395|P2|STARTED|Overall Study||128
7629191|NCT02309723|18784396|P1|STARTED|Overall Study||129
7629192|NCT02309489|18784412|P2|NOT COMPLETED|Overall Study||14
7629193|NCT02309489|18784413|P1|NOT COMPLETED|Overall Study||15
7629194|NCT02309489|18784412|P2|COMPLETED|Overall Study||547
7629195|NCT02309489|18784413|P1|COMPLETED|Overall Study||568
7629196|NCT02309489|18784412|P2|Follow-up at 3 Months Postpartum|Overall Study||541
7629197|NCT02309489|18784413|P1|Follow-up at 3 Months Postpartum|Overall Study||560
7629198|NCT02309489|18784412|P2|STARTED|Overall Study||561
7629199|NCT02309489|18784413|P1|STARTED|Overall Study||583
7629200|NCT02309411|18784439|P3|NOT COMPLETED|Overall Study||0
7629201|NCT02309411|18784440|P2|NOT COMPLETED|Overall Study||1
7629202|NCT02309411|18784441|P1|NOT COMPLETED|Overall Study||2
7629203|NCT02309411|18784439|P3|COMPLETED|Overall Study||6
7629204|NCT02309411|18784440|P2|COMPLETED|Overall Study||14
7629205|NCT02309411|18784441|P1|COMPLETED|Overall Study||23
7629206|NCT02309411|18784439|P3|STARTED|Overall Study||6
7629207|NCT02309411|18784440|P2|STARTED|Overall Study||15
7629208|NCT02309411|18784441|P1|STARTED|Overall Study||25
7629209|NCT02309372|18784462|P2|NOT COMPLETED|Overall Study||2
7629210|NCT02309372|18784463|P1|NOT COMPLETED|Overall Study||3
7629211|NCT02309372|18784462|P2|COMPLETED|Overall Study||25
7629212|NCT02309372|18784463|P1|COMPLETED|Overall Study||24
7629213|NCT02309372|18784462|P2|STARTED|Overall Study||27
7629214|NCT02309372|18784463|P1|STARTED|Overall Study||27
7629215|NCT02309359|18784480|P5|NOT COMPLETED|Overall Study||9
7629216|NCT02309359|18784481|P4|NOT COMPLETED|Overall Study||12
7629217|NCT02309359|18784482|P3|NOT COMPLETED|Overall Study||11
7629218|NCT02309359|18784483|P2|NOT COMPLETED|Overall Study||8
7629219|NCT02309359|18784484|P1|NOT COMPLETED|Overall Study||12
7629220|NCT02309359|18784480|P5|COMPLETED|Overall Study||60
7629221|NCT02309359|18784481|P4|COMPLETED|Overall Study||57
7629222|NCT02309359|18784482|P3|COMPLETED|Overall Study||57
7629223|NCT02309359|18784483|P2|COMPLETED|Overall Study||62
7629224|NCT02309359|18784484|P1|COMPLETED|Overall Study||57
7629225|NCT02309359|18784480|P5|STARTED|Overall Study||69
7629226|NCT02309359|18784481|P4|STARTED|Overall Study||69
7629227|NCT02309359|18784482|P3|STARTED|Overall Study||68
7629228|NCT02309359|18784483|P2|STARTED|Overall Study||70
7629229|NCT02309359|18784484|P1|STARTED|Overall Study||69
7629230|NCT02309294|18784611|P1|NOT COMPLETED|Overall Study||2
7629231|NCT02309294|18784611|P1|COMPLETED|Overall Study||41
7629232|NCT02309294|18784611|P1|STARTED|Overall Study||43
7629233|NCT02309138|18784617|P2|NOT COMPLETED|Overall Study||18
7629234|NCT02309138|18784618|P1|NOT COMPLETED|Overall Study||48
7629235|NCT02309138|18784617|P2|COMPLETED|Overall Study||443
7629236|NCT02309138|18784618|P1|COMPLETED|Overall Study||412
7629237|NCT02309138|18784617|P2|STARTED|Overall Study||461
7629238|NCT02309138|18784618|P1|STARTED|Overall Study||460
7629239|NCT02309112|18784641|P3|NOT COMPLETED|Overall Study||1
7629240|NCT02309112|18784642|P2|NOT COMPLETED|Overall Study||1
7629241|NCT02309112|18784643|P1|NOT COMPLETED|Overall Study||1
7629242|NCT02309112|18784641|P3|COMPLETED|Overall Study||4
7629243|NCT02309112|18784642|P2|COMPLETED|Overall Study||4
7629244|NCT02309112|18784643|P1|COMPLETED|Overall Study||4
7629245|NCT02309112|18784641|P3|Completed Yoga Intervention|Overall Study||4
7629246|NCT02309112|18784642|P2|Completed Yoga Intervention|Overall Study||5
7629247|NCT02309112|18784643|P1|Completed Yoga Intervention|Overall Study||4
7629248|NCT02309112|18784641|P3|STARTED|Overall Study||5
7629249|NCT02309112|18784642|P2|STARTED|Overall Study||5
7629250|NCT02309112|18784643|P1|STARTED|Overall Study||5
7629251|NCT02309099|18784666|P2|NOT COMPLETED|Overall Study||0
7629252|NCT02309099|18784667|P1|NOT COMPLETED|Overall Study||2
7629253|NCT02309099|18784666|P2|COMPLETED|Overall Study||3
7629254|NCT02309099|18784667|P1|COMPLETED|Overall Study|5 participants completed the study (2 did not complete due to adverse event)|5
7629255|NCT02309099|18784666|P2|Cochlear Implant Use/Follow-Up|Overall Study||3
7629256|NCT02309099|18784667|P1|Cochlear Implant Use/Follow-Up|Overall Study|5 participants completed cochlear implant use/follow-up (2 did not complete due to adverse event)|5
7629257|NCT02309099|18784666|P2|Initial Activation|Overall Study||3
7629258|NCT02309099|18784667|P1|Initial Activation|Overall Study||7
7629259|NCT02309099|18784666|P2|Cochlear Implantation|Overall Study||3
7629260|NCT02309099|18784667|P1|Cochlear Implantation|Overall Study||7
7629261|NCT02309099|18784666|P2|STARTED|Overall Study||3
7629262|NCT02309099|18784667|P1|STARTED|Overall Study||7
7629263|NCT02308839|18784713|P1|NOT COMPLETED|Overall Study||109
7629264|NCT02308839|18784713|P1|COMPLETED|Overall Study||72
7629265|NCT02308839|18784713|P1|STARTED|Overall Study||181
7629266|NCT02308787|18784723|P1|NOT COMPLETED|Overall Study||0
7629267|NCT02308787|18784723|P1|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
7629268|NCT02308787|18784723|P1|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
7629269|NCT02308748|18784738|P10|NOT COMPLETED|Period 5||0
7629270|NCT02308748|18784739|P9|NOT COMPLETED|Period 5||1
7629271|NCT02308748|18784740|P8|NOT COMPLETED|Period 5||0
7629272|NCT02308748|18784741|P7|NOT COMPLETED|Period 5||0
7629273|NCT02308748|18784742|P6|NOT COMPLETED|Period 5||0
7629274|NCT02308748|18784743|P5|NOT COMPLETED|Period 5||0
7629275|NCT02308748|18784744|P4|NOT COMPLETED|Period 5||0
7629276|NCT02308748|18784745|P3|NOT COMPLETED|Period 5||0
7629277|NCT02308748|18784746|P2|NOT COMPLETED|Period 5||0
7629278|NCT02308748|18784747|P1|NOT COMPLETED|Period 5||1
7629279|NCT02308748|18784738|P10|COMPLETED|Period 5||2
7629280|NCT02308748|18784739|P9|COMPLETED|Period 5||1
7629281|NCT02308748|18784740|P8|COMPLETED|Period 5||1
7629282|NCT02308748|18784741|P7|COMPLETED|Period 5||2
7629283|NCT02308748|18784742|P6|COMPLETED|Period 5||3
7629284|NCT02308748|18784743|P5|COMPLETED|Period 5||2
7629285|NCT02308748|18784744|P4|COMPLETED|Period 5||2
7629286|NCT02308748|18784745|P3|COMPLETED|Period 5||1
7629287|NCT02308748|18784746|P2|COMPLETED|Period 5||2
7629288|NCT02308748|18784747|P1|COMPLETED|Period 5||1
7629289|NCT02308748|18784738|P10|STARTED|Period 5||2
7629290|NCT02308748|18784739|P9|STARTED|Period 5||2
7629291|NCT02308748|18784740|P8|STARTED|Period 5||1
7629292|NCT02308748|18784741|P7|STARTED|Period 5||2
7629293|NCT02308748|18784742|P6|STARTED|Period 5||3
7629294|NCT02308748|18784743|P5|STARTED|Period 5||2
7629295|NCT02308748|18784744|P4|STARTED|Period 5||2
7629296|NCT02308748|18784745|P3|STARTED|Period 5||1
7629297|NCT02308748|18784746|P2|STARTED|Period 5||2
7629298|NCT02308748|18784747|P1|STARTED|Period 5||2
7629299|NCT02308748|18784738|P10|NOT COMPLETED|Period 4||0
7629300|NCT02308748|18784739|P9|NOT COMPLETED|Period 4||0
7629301|NCT02308748|18784740|P8|NOT COMPLETED|Period 4||0
7629302|NCT02308748|18784741|P7|NOT COMPLETED|Period 4||0
7629303|NCT02308748|18784742|P6|NOT COMPLETED|Period 4||0
7629304|NCT02308748|18784743|P5|NOT COMPLETED|Period 4||0
7629305|NCT02308748|18784744|P4|NOT COMPLETED|Period 4||0
7629306|NCT02308748|18784745|P3|NOT COMPLETED|Period 4||0
7629307|NCT02308748|18784746|P2|NOT COMPLETED|Period 4||0
7629308|NCT02308748|18784747|P1|NOT COMPLETED|Period 4||0
7629309|NCT02308748|18784738|P10|COMPLETED|Period 4||2
7629310|NCT02308748|18784739|P9|COMPLETED|Period 4||2
7629311|NCT02308748|18784740|P8|COMPLETED|Period 4||1
7629312|NCT02308748|18784741|P7|COMPLETED|Period 4||2
7629313|NCT02308748|18784742|P6|COMPLETED|Period 4||3
7629314|NCT02308748|18784743|P5|COMPLETED|Period 4||2
7629315|NCT02308748|18784744|P4|COMPLETED|Period 4||2
7629316|NCT02308748|18784745|P3|COMPLETED|Period 4||1
7629317|NCT02308748|18784746|P2|COMPLETED|Period 4||2
7629318|NCT02308748|18784747|P1|COMPLETED|Period 4||2
7629319|NCT02308748|18784738|P10|STARTED|Period 4||2
7629320|NCT02308748|18784739|P9|STARTED|Period 4||2
7629321|NCT02308748|18784740|P8|STARTED|Period 4||1
7629322|NCT02308748|18784741|P7|STARTED|Period 4||2
7629323|NCT02308748|18784742|P6|STARTED|Period 4||3
7629324|NCT02308748|18784743|P5|STARTED|Period 4||2
7629325|NCT02308748|18784744|P4|STARTED|Period 4||2
7629326|NCT02308748|18784745|P3|STARTED|Period 4||1
7629327|NCT02308748|18784746|P2|STARTED|Period 4||2
7629328|NCT02308748|18784747|P1|STARTED|Period 4||2
7629329|NCT02308748|18784738|P10|NOT COMPLETED|Period 3||1
7629330|NCT02308748|18784739|P9|NOT COMPLETED|Period 3||0
7629331|NCT02308748|18784740|P8|NOT COMPLETED|Period 3||0
7629332|NCT02308748|18784741|P7|NOT COMPLETED|Period 3||0
7629333|NCT02308748|18784742|P6|NOT COMPLETED|Period 3||0
7629334|NCT02308748|18784743|P5|NOT COMPLETED|Period 3||0
7629335|NCT02308748|18784744|P4|NOT COMPLETED|Period 3||0
7629336|NCT02308748|18784745|P3|NOT COMPLETED|Period 3||0
7629337|NCT02308748|18784746|P2|NOT COMPLETED|Period 3||0
7629338|NCT02308748|18784747|P1|NOT COMPLETED|Period 3||0
7629339|NCT02308748|18784738|P10|COMPLETED|Period 3||2
7629340|NCT02308748|18784739|P9|COMPLETED|Period 3||2
7629341|NCT02308748|18784740|P8|COMPLETED|Period 3||1
7629342|NCT02308748|18784741|P7|COMPLETED|Period 3||2
7629343|NCT02308748|18784742|P6|COMPLETED|Period 3||3
7629344|NCT02308748|18784743|P5|COMPLETED|Period 3||2
7629345|NCT02308748|18784744|P4|COMPLETED|Period 3||2
7629346|NCT02308748|18784745|P3|COMPLETED|Period 3||1
7629347|NCT02308748|18784746|P2|COMPLETED|Period 3||2
7629348|NCT02308748|18784747|P1|COMPLETED|Period 3||2
7629349|NCT02308748|18784738|P10|STARTED|Period 3||3
7629350|NCT02308748|18784739|P9|STARTED|Period 3||2
7629351|NCT02308748|18784740|P8|STARTED|Period 3||1
7629352|NCT02308748|18784741|P7|STARTED|Period 3||2
7629353|NCT02308748|18784742|P6|STARTED|Period 3||3
7629354|NCT02308748|18784743|P5|STARTED|Period 3||2
7629355|NCT02308748|18784744|P4|STARTED|Period 3||2
7629356|NCT02308748|18784745|P3|STARTED|Period 3||1
7629357|NCT02308748|18784746|P2|STARTED|Period 3||2
7629358|NCT02308748|18784747|P1|STARTED|Period 3||2
7629359|NCT02308748|18784738|P10|NOT COMPLETED|Period 2||0
7629360|NCT02308748|18784739|P9|NOT COMPLETED|Period 2||0
7629361|NCT02308748|18784740|P8|NOT COMPLETED|Period 2||1
7629362|NCT02308748|18784741|P7|NOT COMPLETED|Period 2||0
7629363|NCT02308748|18784742|P6|NOT COMPLETED|Period 2||0
7629364|NCT02308748|18784743|P5|NOT COMPLETED|Period 2||0
7629365|NCT02308748|18784744|P4|NOT COMPLETED|Period 2||0
7629366|NCT02308748|18784745|P3|NOT COMPLETED|Period 2||0
7629367|NCT02308748|18784746|P2|NOT COMPLETED|Period 2||0
7629368|NCT02308748|18784747|P1|NOT COMPLETED|Period 2||0
7629369|NCT02308748|18784738|P10|COMPLETED|Period 2||3
7629370|NCT02308748|18784739|P9|COMPLETED|Period 2||2
7629371|NCT02308748|18784740|P8|COMPLETED|Period 2||1
7629372|NCT02308748|18784741|P7|COMPLETED|Period 2||2
7629373|NCT02308748|18784742|P6|COMPLETED|Period 2||3
7629374|NCT02308748|18784743|P5|COMPLETED|Period 2||2
7629375|NCT02308748|18784744|P4|COMPLETED|Period 2||2
7629376|NCT02308748|18784745|P3|COMPLETED|Period 2||1
7629377|NCT02308748|18784746|P2|COMPLETED|Period 2||2
7629378|NCT02308748|18784747|P1|COMPLETED|Period 2||2
7629379|NCT02308748|18784738|P10|STARTED|Period 2||3
7629380|NCT02308748|18784739|P9|STARTED|Period 2||2
7629381|NCT02308748|18784740|P8|STARTED|Period 2||2
7629382|NCT02308748|18784741|P7|STARTED|Period 2||2
7629383|NCT02308748|18784742|P6|STARTED|Period 2||3
7629384|NCT02308748|18784743|P5|STARTED|Period 2||2
7629385|NCT02308748|18784744|P4|STARTED|Period 2||2
7629386|NCT02308748|18784745|P3|STARTED|Period 2||1
7629387|NCT02308748|18784746|P2|STARTED|Period 2||2
7629388|NCT02308748|18784747|P1|STARTED|Period 2||2
7629389|NCT02308748|18784738|P10|NOT COMPLETED|Period 1||0
7629390|NCT02308748|18784739|P9|NOT COMPLETED|Period 1||0
7629391|NCT02308748|18784740|P8|NOT COMPLETED|Period 1||0
7629392|NCT02308748|18784741|P7|NOT COMPLETED|Period 1||0
7629393|NCT02308748|18784742|P6|NOT COMPLETED|Period 1||0
7629394|NCT02308748|18784743|P5|NOT COMPLETED|Period 1||0
7629395|NCT02308748|18784744|P4|NOT COMPLETED|Period 1||0
7629396|NCT02308748|18784745|P3|NOT COMPLETED|Period 1||1
7629397|NCT02308748|18784746|P2|NOT COMPLETED|Period 1||0
7629398|NCT02308748|18784747|P1|NOT COMPLETED|Period 1||0
7629399|NCT02308748|18784738|P10|COMPLETED|Period 1||3
7629400|NCT02308748|18784739|P9|COMPLETED|Period 1||2
7629401|NCT02308748|18784740|P8|COMPLETED|Period 1||2
7629402|NCT02308748|18784741|P7|COMPLETED|Period 1||2
7629403|NCT02308748|18784742|P6|COMPLETED|Period 1||3
7629404|NCT02308748|18784743|P5|COMPLETED|Period 1||2
7629405|NCT02308748|18784744|P4|COMPLETED|Period 1||2
7629406|NCT02308748|18784745|P3|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1
7629407|NCT02308748|18784746|P2|COMPLETED|Period 1||2
7629408|NCT02308748|18784747|P1|COMPLETED|Period 1||2
7629409|NCT02308748|18784738|P10|STARTED|Period 1||3
7629410|NCT02308748|18784739|P9|STARTED|Period 1||2
7629411|NCT02308748|18784740|P8|STARTED|Period 1||2
7629412|NCT02308748|18784741|P7|STARTED|Period 1||2
7629413|NCT02308748|18784742|P6|STARTED|Period 1||3
7629414|NCT02308748|18784743|P5|STARTED|Period 1||2
7629415|NCT02308748|18784744|P4|STARTED|Period 1||2
7629416|NCT02308748|18784745|P3|STARTED|Period 1||2
7629417|NCT02308748|18784746|P2|STARTED|Period 1||2
7629418|NCT02308748|18784747|P1|STARTED|Period 1||2
7629419|NCT02308696|18784761|P2|NOT COMPLETED|Overall Study||31
7629420|NCT02308696|18784762|P1|NOT COMPLETED|Overall Study||53
7629421|NCT02308696|18784761|P2|COMPLETED|Overall Study||203
7629422|NCT02308696|18784762|P1|COMPLETED|Overall Study||169
7629423|NCT02308696|18784761|P2|STARTED|Overall Study||234
7629424|NCT02308696|18784762|P1|STARTED|Overall Study||222
7629425|NCT02308540|18784796|P6|NOT COMPLETED|Overall Study||1
7629426|NCT02308540|18784797|P5|NOT COMPLETED|Overall Study||0
7629427|NCT02308540|18784798|P4|NOT COMPLETED|Overall Study||0
7629428|NCT02308540|18784799|P3|NOT COMPLETED|Overall Study||0
7629429|NCT02308540|18784800|P2|NOT COMPLETED|Overall Study||0
7629430|NCT02308540|18784801|P1|NOT COMPLETED|Overall Study||0
7629431|NCT02308540|18784796|P6|COMPLETED|Overall Study||99
7629432|NCT02308540|18784797|P5|COMPLETED|Overall Study||100
7629433|NCT02308540|18784798|P4|COMPLETED|Overall Study||56
7629434|NCT02308540|18784799|P3|COMPLETED|Overall Study||56
7629435|NCT02308540|18784800|P2|COMPLETED|Overall Study||17
7629436|NCT02308540|18784801|P1|COMPLETED|Overall Study||17
7629437|NCT02308540|18784796|P6|Vaccinated|Overall Study||100
7629438|NCT02308540|18784797|P5|Vaccinated|Overall Study||100
7629439|NCT02308540|18784798|P4|Vaccinated|Overall Study||56
7629440|NCT02308540|18784799|P3|Vaccinated|Overall Study||56
7629441|NCT02308540|18784800|P2|Vaccinated|Overall Study||17
7629442|NCT02308540|18784801|P1|Vaccinated|Overall Study||17
7629443|NCT02308540|18784796|P6|Randomized|Overall Study||100
7629444|NCT02308540|18784797|P5|Randomized|Overall Study||100
7629445|NCT02308540|18784798|P4|Randomized|Overall Study||56
7629446|NCT02308540|18784799|P3|Randomized|Overall Study||56
7629447|NCT02308540|18784800|P2|Randomized|Overall Study||17
7629448|NCT02308540|18784801|P1|Randomized|Overall Study||17
7629449|NCT02308540|18784796|P6|STARTED|Overall Study||100
7629450|NCT02308540|18784797|P5|STARTED|Overall Study||100
7629451|NCT02308540|18784798|P4|STARTED|Overall Study||56
7629452|NCT02308540|18784799|P3|STARTED|Overall Study||56
7629453|NCT02308540|18784800|P2|STARTED|Overall Study||17
7629454|NCT02308540|18784801|P1|STARTED|Overall Study||17
7629455|NCT02308475|18784865|P1|NOT COMPLETED|Overall Study||0
7629456|NCT02308475|18784865|P1|COMPLETED|Overall Study||2
7629457|NCT02308475|18784865|P1|STARTED|Overall Study||2
7629458|NCT02308371|18784873|P2|NOT COMPLETED|Overall Study||0
7629459|NCT02308371|18784874|P1|NOT COMPLETED|Overall Study||0
7629460|NCT02308371|18784873|P2|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50
7629461|NCT02308371|18784874|P1|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50
7629462|NCT02308371|18784873|P2|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50
7629463|NCT02308371|18784874|P1|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50
7629464|NCT02308228|18784890|P2|NOT COMPLETED|Overall Study||7
7629465|NCT02308228|18784891|P1|NOT COMPLETED|Overall Study||8
7629466|NCT02308228|18784890|P2|COMPLETED|Overall Study||48
7629467|NCT02308228|18784891|P1|COMPLETED|Overall Study||46
7629468|NCT02308228|18784890|P2|STARTED|Overall Study||55
7629469|NCT02308228|18784891|P1|STARTED|Overall Study||54
7629470|NCT02308189|18784905|P2|NOT COMPLETED|Overall Study||1
7629471|NCT02308189|18784906|P1|NOT COMPLETED|Overall Study||1
7629472|NCT02308189|18784905|P2|COMPLETED|Overall Study||14
7629473|NCT02308189|18784906|P1|COMPLETED|Overall Study||16
7629474|NCT02308189|18784905|P2|STARTED|Overall Study||15
7629475|NCT02308189|18784906|P1|STARTED|Overall Study||17
7629476|NCT02308163|18784920|P5|NOT COMPLETED|Overall Study||34
7629477|NCT02308163|18784921|P4|NOT COMPLETED|Overall Study||13
7629478|NCT02308163|18784922|P3|NOT COMPLETED|Overall Study||14
7629479|NCT02308163|18784923|P2|NOT COMPLETED|Overall Study||18
7629480|NCT02308163|18784924|P1|NOT COMPLETED|Overall Study||31
7629481|NCT02308163|18784920|P5|COMPLETED|Overall Study||167
7629482|NCT02308163|18784921|P4|COMPLETED|Overall Study||39
7629483|NCT02308163|18784922|P3|COMPLETED|Overall Study||36
7629484|NCT02308163|18784923|P2|COMPLETED|Overall Study||84
7629485|NCT02308163|18784924|P1|COMPLETED|Overall Study||73
7629486|NCT02308163|18784920|P5|STARTED|Overall Study||201
7629487|NCT02308163|18784921|P4|STARTED|Overall Study||52
7629488|NCT02308163|18784922|P3|STARTED|Overall Study||50
7629489|NCT02308163|18784923|P2|STARTED|Overall Study||102
7629490|NCT02308163|18784924|P1|STARTED|Overall Study||104
7629491|NCT02308124|18785234|P3|NOT COMPLETED|Overall Study||8
7629492|NCT02308124|18785235|P2|NOT COMPLETED|Overall Study||8
7629493|NCT02308124|18785236|P1|NOT COMPLETED|Overall Study||6
7629494|NCT02308124|18785234|P3|COMPLETED|Overall Study||21
7629495|NCT02308124|18785235|P2|COMPLETED|Overall Study||21
7629496|NCT02308124|18785236|P1|COMPLETED|Overall Study||23
7629497|NCT02308124|18785234|P3|STARTED|Overall Study||29
7629498|NCT02308124|18785235|P2|STARTED|Overall Study||29
7629499|NCT02308124|18785236|P1|STARTED|Overall Study||29
7629500|NCT02308046|18785258|P2|NOT COMPLETED|Overall Study||38
7629501|NCT02308046|18785259|P1|NOT COMPLETED|Overall Study||34
7629502|NCT02308046|18785258|P2|COMPLETED|Overall Study||67
7629503|NCT02308046|18785259|P1|COMPLETED|Overall Study||73
7629504|NCT02308046|18785258|P2|STARTED|Overall Study||105
7629505|NCT02308046|18785259|P1|STARTED|Overall Study||107
7629506|NCT02308033|18785275|P2|NOT COMPLETED|Overall Study||19
7629507|NCT02308033|18785276|P1|NOT COMPLETED|Overall Study||26
7629508|NCT02308033|18785275|P2|COMPLETED|Overall Study||83
7629509|NCT02308033|18785276|P1|COMPLETED|Overall Study||76
7629510|NCT02308033|18785275|P2|STARTED|Overall Study||102
7629511|NCT02308033|18785276|P1|STARTED|Overall Study||102
7629512|NCT02308020|18785296|P6|NOT COMPLETED|Overall Study||5
7629513|NCT02308020|18785297|P5|NOT COMPLETED|Overall Study||4
7629514|NCT02308020|18785298|P4|NOT COMPLETED|Overall Study||4
7629515|NCT02308020|18785299|P3|NOT COMPLETED|Overall Study||3
7629516|NCT02308020|18785300|P2|NOT COMPLETED|Overall Study||20
7629517|NCT02308020|18785301|P1|NOT COMPLETED|Overall Study||4
7629518|NCT02308020|18785296|P6|COMPLETED|Overall Study||12
7629519|NCT02308020|18785297|P5|COMPLETED|Overall Study||19
7629520|NCT02308020|18785298|P4|COMPLETED|Overall Study||24
7629521|NCT02308020|18785299|P3|COMPLETED|Overall Study||6
7629522|NCT02308020|18785300|P2|COMPLETED|Overall Study||38
7629523|NCT02308020|18785301|P1|COMPLETED|Overall Study||23
7629524|NCT02308020|18785296|P6|Received at Least One Dose of Study Drug|Overall Study||17
7629525|NCT02308020|18785297|P5|Received at Least One Dose of Study Drug|Overall Study||23
7629526|NCT02308020|18785298|P4|Received at Least One Dose of Study Drug|Overall Study||28
7629527|NCT02308020|18785299|P3|Received at Least One Dose of Study Drug|Overall Study||9
7629528|NCT02308020|18785300|P2|Received at Least One Dose of Study Drug|Overall Study||58
7629529|NCT02308020|18785301|P1|Received at Least One Dose of Study Drug|Overall Study||27
7629530|NCT02308020|18785296|P6|STARTED|Overall Study||17
7629531|NCT02308020|18785297|P5|STARTED|Overall Study||23
7629532|NCT02308020|18785298|P4|STARTED|Overall Study||28
7629533|NCT02308020|18785299|P3|STARTED|Overall Study||9
7629534|NCT02308020|18785300|P2|STARTED|Overall Study||58
7629535|NCT02308020|18785301|P1|STARTED|Overall Study||27
7629536|NCT02308007|18785358|P3|NOT COMPLETED|Overall Study||75
7629537|NCT02308007|18785359|P2|NOT COMPLETED|Overall Study||75
7629538|NCT02308007|18785360|P1|NOT COMPLETED|Overall Study||76
7629539|NCT02308007|18785358|P3|COMPLETED|Overall Study||82
7629540|NCT02308007|18785359|P2|COMPLETED|Overall Study||84
7629541|NCT02308007|18785360|P1|COMPLETED|Overall Study||83
7629542|NCT02308007|18785358|P3|STARTED|Overall Study||157
7629543|NCT02308007|18785359|P2|STARTED|Overall Study||159
7629544|NCT02308007|18785360|P1|STARTED|Overall Study||159
7629545|NCT02307916|18785385|P2|NOT COMPLETED|Overall Study||1
7629546|NCT02307916|18785386|P1|NOT COMPLETED|Overall Study||2
7629547|NCT02307916|18785385|P2|COMPLETED|Overall Study||14
7629548|NCT02307916|18785386|P1|COMPLETED|Overall Study||40
7629549|NCT02307916|18785385|P2|STARTED|Overall Study||15
7629550|NCT02307916|18785386|P1|STARTED|Overall Study||42
7629551|NCT02307838|18785403|P3|NOT COMPLETED|Overall Study||0
7629552|NCT02307838|18785404|P2|NOT COMPLETED|Overall Study||0
7629553|NCT02307838|18785405|P1|NOT COMPLETED|Overall Study||0
7629554|NCT02307838|18785403|P3|COMPLETED|Overall Study||55
7629555|NCT02307838|18785404|P2|COMPLETED|Overall Study||64
7629556|NCT02307838|18785405|P1|COMPLETED|Overall Study||56
7629557|NCT02307838|18785403|P3|STARTED|Overall Study||55
7629558|NCT02307838|18785404|P2|STARTED|Overall Study||64
7629559|NCT02307838|18785405|P1|STARTED|Overall Study||56
7629560|NCT02307682|18785451|P3|NOT COMPLETED|Overall Study||64
7629561|NCT02307682|18785452|P2|NOT COMPLETED|Overall Study||57
7629562|NCT02307682|18785453|P1|NOT COMPLETED|Overall Study||50
7629563|NCT02307682|18785451|P3|COMPLETED|Overall Study||297
7629564|NCT02307682|18785452|P2|COMPLETED|Overall Study||304
7629565|NCT02307682|18785453|P1|COMPLETED|Overall Study||310
7629566|NCT02307682|18785451|P3|Randomized and Treated|Overall Study||360
7629567|NCT02307682|18785452|P2|Randomized and Treated|Overall Study||360
7629568|NCT02307682|18785453|P1|Randomized and Treated|Overall Study||358
7629569|NCT02307682|18785451|P3|STARTED|Overall Study||361
7629570|NCT02307682|18785452|P2|STARTED|Overall Study||361
7629571|NCT02307682|18785453|P1|STARTED|Overall Study||360
7629572|NCT02307552|18785553|P1|NOT COMPLETED|Overall Study||0
7629573|NCT02307552|18785553|P1|COMPLETED|Overall Study||1
7629574|NCT02307552|18785553|P1|STARTED|Overall Study||1
7629575|NCT02307526|18785557|P1|NOT COMPLETED|Day 2 - 60 mg of Pyridostigmine||0
7629576|NCT02307526|18785557|P1|COMPLETED|Day 2 - 60 mg of Pyridostigmine||10
7629577|NCT02307526|18785557|P1|STARTED|Day 2 - 60 mg of Pyridostigmine||10
7629578|NCT02307526|18785557|P1|NOT COMPLETED|Day 1 - No Drug||0
7629579|NCT02307526|18785557|P1|COMPLETED|Day 1 - No Drug||10
7629580|NCT02307526|18785557|P1|STARTED|Day 1 - No Drug||10
7629581|NCT02307513|18785569|P2|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||15
7629582|NCT02307513|18785570|P1|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||20
7629583|NCT02307513|18785569|P2|COMPLETED|Active Treatment Phase (Weeks 13-64)||68
7629584|NCT02307513|18785570|P1|COMPLETED|Active Treatment Phase (Weeks 13-64)||75
7629585|NCT02307513|18785569|P2|STARTED|Active Treatment Phase (Weeks 13-64)||83
7629586|NCT02307513|18785570|P1|STARTED|Active Treatment Phase (Weeks 13-64)|1 participant completed Week 12; did not enter into active treatment|95
7629587|NCT02307513|18785569|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||20
7629588|NCT02307513|18785570|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||8
7629589|NCT02307513|18785569|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||83
7629590|NCT02307513|18785570|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||96
7629591|NCT02307513|18785569|P2|STARTED|Placebo Controlled Phase (Weeks 0-12)||103
7629592|NCT02307513|18785570|P1|STARTED|Placebo Controlled Phase (Weeks 0-12)||104
7629593|NCT02307318|18785611|P1|NOT COMPLETED|Overall Study||0
7629594|NCT02307318|18785611|P1|COMPLETED|Overall Study||51
7629595|NCT02307318|18785611|P1|STARTED|Overall Study||51
7629596|NCT02307266|18785621|P3|NOT COMPLETED|Overall Study||6
7629597|NCT02307266|18785622|P2|NOT COMPLETED|Overall Study||1
7629598|NCT02307266|18785623|P1|NOT COMPLETED|Overall Study||8
7629599|NCT02307266|18785621|P3|COMPLETED|Overall Study||25
7629600|NCT02307266|18785622|P2|COMPLETED|Overall Study||32
7629601|NCT02307266|18785623|P1|COMPLETED|Overall Study||25
7629602|NCT02307266|18785621|P3|STARTED|Overall Study||31
7629603|NCT02307266|18785622|P2|STARTED|Overall Study||33
7629604|NCT02307266|18785623|P1|STARTED|Overall Study||33
7629605|NCT02307188|18785631|P1|NOT COMPLETED|Overall Study||4
7629606|NCT02307188|18785631|P1|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1
7629607|NCT02307188|18785631|P1|STARTED|Overall Study||5
7629608|NCT02307123|18785635|P1|NOT COMPLETED|Overall Study||0
7629609|NCT02307123|18785635|P1|COMPLETED|Overall Study||483
7629610|NCT02307123|18785635|P1|STARTED|Overall Study||483
7629611|NCT02306928|18785640|P1|NOT COMPLETED|Overall Study||0
7629612|NCT02306928|18785640|P1|COMPLETED|Overall Study||15
7629613|NCT02306928|18785640|P1|STARTED|Overall Study||15
7629614|NCT02306850|18785648|P1|NOT COMPLETED|Overall Study||2
7629615|NCT02306850|18785648|P1|COMPLETED|Overall Study||8
7629616|NCT02306850|18785648|P1|STARTED|Overall Study||10
7629617|NCT02306759|18785655|P2|NOT COMPLETED|Overall Study||0
7629618|NCT02306759|18785656|P1|NOT COMPLETED|Overall Study||0
7629619|NCT02306759|18785655|P2|COMPLETED|Overall Study||30
7629620|NCT02306759|18785656|P1|COMPLETED|Overall Study||30
7629621|NCT02306759|18785655|P2|STARTED|Overall Study||30
7629622|NCT02306759|18785656|P1|STARTED|Overall Study||30
7629623|NCT02306694|18785670|P1|NOT COMPLETED|Overall Study||4
7629624|NCT02306694|18785670|P1|COMPLETED|Overall Study||12
7629625|NCT02306694|18785670|P1|STARTED|Overall Study||16
7629626|NCT02306265|18785680|P1|NOT COMPLETED|Overall Study||1
7629627|NCT02306265|18785680|P1|COMPLETED|Overall Study||249
7629628|NCT02306265|18785680|P1|STARTED|Overall Study||250
7629629|NCT02305888|18785689|P3|NOT COMPLETED|Overall Study||1
7629630|NCT02305888|18785690|P2|NOT COMPLETED|Overall Study||1
7629631|NCT02305888|18785691|P1|NOT COMPLETED|Overall Study||0
7629632|NCT02305888|18785689|P3|COMPLETED|Overall Study||62
7629633|NCT02305888|18785690|P2|COMPLETED|Overall Study||62
7629634|NCT02305888|18785691|P1|COMPLETED|Overall Study||63
7629635|NCT02305888|18785689|P3|STARTED|Overall Study||63
7629636|NCT02305888|18785690|P2|STARTED|Overall Study||63
7629637|NCT02305888|18785691|P1|STARTED|Overall Study||63
7629638|NCT02305849|18785711|P4|NOT COMPLETED|Overall Study||19
7629639|NCT02305849|18785712|P3|NOT COMPLETED|Overall Study||18
7629640|NCT02305849|18785713|P2|NOT COMPLETED|Overall Study||28
7629641|NCT02305849|18785714|P1|NOT COMPLETED|Overall Study||27
7629642|NCT02305849|18785711|P4|COMPLETED|Overall Study||66
7629643|NCT02305849|18785712|P3|COMPLETED|Overall Study||67
7629644|NCT02305849|18785713|P2|COMPLETED|Overall Study||146
7629645|NCT02305849|18785714|P1|COMPLETED|Overall Study||148
7629646|NCT02305849|18785711|P4|STARTED|Overall Study||85
7629647|NCT02305849|18785712|P3|STARTED|Overall Study||85
7629648|NCT02305849|18785713|P2|STARTED|Overall Study||174
7629649|NCT02305849|18785714|P1|STARTED|Overall Study||175
7629650|NCT02305797|18785948|P2|NOT COMPLETED|Overall Study||38
7629651|NCT02305797|18785949|P1|NOT COMPLETED|Overall Study||45
7629652|NCT02305797|18785948|P2|COMPLETED|Overall Study||210
7629653|NCT02305797|18785949|P1|COMPLETED|Overall Study||202
7629654|NCT02305797|18785948|P2|STARTED|Overall Study||248
7629655|NCT02305797|18785949|P1|STARTED|Overall Study||247
7629656|NCT02305758|18785959|P2|NOT COMPLETED|Overall Study||65
7629657|NCT02305758|18785960|P1|NOT COMPLETED|Overall Study||65
7629658|NCT02305758|18785959|P2|COMPLETED|Overall Study||0
7629659|NCT02305758|18785960|P1|COMPLETED|Overall Study||0
7629660|NCT02305758|18785959|P2|STARTED|Overall Study||65
7629661|NCT02305758|18785960|P1|STARTED|Overall Study||65
7629662|NCT02305732|18785970|P1|NOT COMPLETED|Overall Study||18
7629663|NCT02305732|18785970|P1|COMPLETED|Overall Study||72
7629664|NCT02305732|18785970|P1|STARTED|Overall Study||90
7629665|NCT02305446|18785978|P1|NOT COMPLETED|Overall Study||1
7629666|NCT02305446|18785978|P1|COMPLETED|Overall Study||54
7629667|NCT02305446|18785978|P1|STARTED|Overall Study||55
7629668|NCT02305381|18785986|P3|NOT COMPLETED|Overall Study||7
7629669|NCT02305381|18785987|P2|NOT COMPLETED|Overall Study||5
7629670|NCT02305381|18785988|P1|NOT COMPLETED|Overall Study||5
7629671|NCT02305381|18785986|P3|COMPLETED|Overall Study|Subjects who completed the trial.|126
7629672|NCT02305381|18785987|P2|COMPLETED|Overall Study|Subjects who completed the trial.|127
7629673|NCT02305381|18785988|P1|COMPLETED|Overall Study|Subjects who completed the trial.|127
7629674|NCT02305381|18785986|P3|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|13
7629675|NCT02305381|18785987|P2|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial|16
7629676|NCT02305381|18785988|P1|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|14
7629677|NCT02305381|18785986|P3|Exposed|Overall Study||133
7629678|NCT02305381|18785987|P2|Exposed|Overall Study||131
7629679|NCT02305381|18785988|P1|Exposed|Overall Study||132
7629680|NCT02305381|18785986|P3|STARTED|Overall Study||133
7629681|NCT02305381|18785987|P2|STARTED|Overall Study||132
7629682|NCT02305381|18785988|P1|STARTED|Overall Study||132
7629683|NCT02305329|18786021|P4|NOT COMPLETED|Overall Study||0
7629684|NCT02305329|18786022|P3|NOT COMPLETED|Overall Study||0
7629685|NCT02305329|18786023|P2|NOT COMPLETED|Overall Study||1
7629686|NCT02305329|18786024|P1|NOT COMPLETED|Overall Study||0
7629687|NCT02305329|18786021|P4|COMPLETED|Overall Study||14
7629688|NCT02305329|18786022|P3|COMPLETED|Overall Study||14
7629689|NCT02305329|18786023|P2|COMPLETED|Overall Study||13
7629690|NCT02305329|18786024|P1|COMPLETED|Overall Study||14
7629691|NCT02305329|18786021|P4|Period 2|Overall Study||14
7629692|NCT02305329|18786022|P3|Period 2|Overall Study||14
7629693|NCT02305329|18786023|P2|Period 2|Overall Study||13
7629694|NCT02305329|18786024|P1|Period 2|Overall Study||14
7629695|NCT02305329|18786021|P4|Period 1|Overall Study||14
7629696|NCT02305329|18786022|P3|Period 1|Overall Study||14
7629697|NCT02305329|18786023|P2|Period 1|Overall Study||14
7629698|NCT02305329|18786024|P1|Period 1|Overall Study||14
7629699|NCT02305329|18786021|P4|STARTED|Overall Study||14
7629700|NCT02305329|18786022|P3|STARTED|Overall Study||14
7629701|NCT02305329|18786023|P2|STARTED|Overall Study||14
7629702|NCT02305329|18786024|P1|STARTED|Overall Study||14
7629703|NCT02305316|18786048|P2|NOT COMPLETED|Overall Study||0
7629704|NCT02305316|18786049|P1|NOT COMPLETED|Overall Study||0
7629705|NCT02305316|18786048|P2|COMPLETED|Overall Study||14
7629706|NCT02305316|18786049|P1|COMPLETED|Overall Study||14
7629707|NCT02305316|18786048|P2|STARTED|Overall Study||14
7629708|NCT02305316|18786049|P1|STARTED|Overall Study||14
7629709|NCT02305277|18786067|P6|NOT COMPLETED|Overall Study||0
7629710|NCT02305277|18786068|P5|NOT COMPLETED|Overall Study||1
7629711|NCT02305277|18786069|P4|NOT COMPLETED|Overall Study||0
7629712|NCT02305277|18786070|P3|NOT COMPLETED|Overall Study||0
7629713|NCT02305277|18786071|P2|NOT COMPLETED|Overall Study||0
7629714|NCT02305277|18786072|P1|NOT COMPLETED|Overall Study||1
7629715|NCT02305277|18786067|P6|COMPLETED|Overall Study||14
7629716|NCT02305277|18786068|P5|COMPLETED|Overall Study||13
7629717|NCT02305277|18786069|P4|COMPLETED|Overall Study||14
7629718|NCT02305277|18786070|P3|COMPLETED|Overall Study||14
7629719|NCT02305277|18786071|P2|COMPLETED|Overall Study||14
7629720|NCT02305277|18786072|P1|COMPLETED|Overall Study||14
7629721|NCT02305277|18786067|P6|Received TBM|Overall Study||14
7629722|NCT02305277|18786068|P5|Received TBM|Overall Study||14
7629723|NCT02305277|18786069|P4|Received TBM|Overall Study||14
7629724|NCT02305277|18786070|P3|Received TBM|Overall Study||14
7629725|NCT02305277|18786071|P2|Received TBM|Overall Study||14
7629726|NCT02305277|18786072|P1|Received TBM|Overall Study||15
7629727|NCT02305277|18786067|P6|Received CM|Overall Study||14
7629728|NCT02305277|18786068|P5|Received CM|Overall Study||14
7629729|NCT02305277|18786069|P4|Received CM|Overall Study||14
7629730|NCT02305277|18786070|P3|Received CM|Overall Study||14
7629731|NCT02305277|18786071|P2|Received CM|Overall Study||14
7629732|NCT02305277|18786072|P1|Received CM|Overall Study||15
7629733|NCT02305277|18786067|P6|STARTED|Overall Study||14
7629734|NCT02305277|18786068|P5|STARTED|Overall Study||14
7629735|NCT02305277|18786069|P4|STARTED|Overall Study||14
7629736|NCT02305277|18786070|P3|STARTED|Overall Study||14
7629737|NCT02305277|18786071|P2|STARTED|Overall Study||14
7629738|NCT02305277|18786072|P1|STARTED|Overall Study||15
7629739|NCT02305238|18786101|P3|NOT COMPLETED|Overall Study||8
7629740|NCT02305238|18786102|P2|NOT COMPLETED|Overall Study||19
7629741|NCT02305238|18786103|P1|NOT COMPLETED|Overall Study||16
7629742|NCT02305238|18786101|P3|COMPLETED|Overall Study||0
7629743|NCT02305238|18786102|P2|COMPLETED|Overall Study||104
7629744|NCT02305238|18786103|P1|COMPLETED|Overall Study||108
7629745|NCT02305238|18786101|P3|BCVA Post-randomization Assessment|Overall Study||0
7629746|NCT02305238|18786102|P2|BCVA Post-randomization Assessment|Overall Study||123
7629747|NCT02305238|18786103|P1|BCVA Post-randomization Assessment|Overall Study||123
7629748|NCT02305238|18786101|P3|Randomized|Overall Study||0
7629749|NCT02305238|18786102|P2|Randomized|Overall Study||123
7629750|NCT02305238|18786103|P1|Randomized|Overall Study||124
7629751|NCT02305238|18786101|P3|Treated|Overall Study||7
7629752|NCT02305238|18786102|P2|Treated|Overall Study||123
7629753|NCT02305238|18786103|P1|Treated|Overall Study||124
7629754|NCT02305238|18786101|P3|STARTED|Overall Study||8
7629755|NCT02305238|18786102|P2|STARTED|Overall Study||123
7629756|NCT02305238|18786103|P1|STARTED|Overall Study||124
7629757|NCT02305017|18786120|P2|NOT COMPLETED|Overall Study||0
7629758|NCT02305017|18786121|P1|NOT COMPLETED|Overall Study||0
7629759|NCT02305017|18786120|P2|COMPLETED|Overall Study||14
7629760|NCT02305017|18786121|P1|COMPLETED|Overall Study||14
7629761|NCT02305017|18786120|P2|STARTED|Overall Study||14
7629762|NCT02305017|18786121|P1|STARTED|Overall Study||14
7629763|NCT02304926|18786135|P2|NOT COMPLETED|Overall Study||1
7629764|NCT02304926|18786136|P1|NOT COMPLETED|Overall Study||2
7629765|NCT02304926|18786135|P2|COMPLETED|Overall Study||19
7629766|NCT02304926|18786136|P1|COMPLETED|Overall Study||20
7629767|NCT02304926|18786135|P2|STARTED|Overall Study||20
7629768|NCT02304926|18786136|P1|STARTED|Overall Study||22
7629769|NCT02304705|18786182|P2|NOT COMPLETED|Overall Study||7
7629770|NCT02304705|18786183|P1|NOT COMPLETED|Overall Study||4
7629771|NCT02304705|18786182|P2|COMPLETED|Overall Study||10
7629772|NCT02304705|18786183|P1|COMPLETED|Overall Study||12
7629773|NCT02304705|18786182|P2|STARTED|Overall Study||17
7629774|NCT02304705|18786183|P1|STARTED|Overall Study||16
7629775|NCT02304484|18786189|P1|NOT COMPLETED|Overall Study||25
7629776|NCT02304484|18786189|P1|COMPLETED|Overall Study||745
7629777|NCT02304484|18786189|P1|STARTED|Overall Study||770
7629778|NCT02304432|18786194|P4|NOT COMPLETED|Second Open Label DCS||0
7629779|NCT02304432|18786195|P3|NOT COMPLETED|Second Open Label DCS||0
7629780|NCT02304432|18786196|P2|NOT COMPLETED|Second Open Label DCS||0
7629781|NCT02304432|18786197|P1|NOT COMPLETED|Second Open Label DCS||0
7629782|NCT02304432|18786194|P4|COMPLETED|Second Open Label DCS||2
7629783|NCT02304432|18786195|P3|COMPLETED|Second Open Label DCS||0
7629784|NCT02304432|18786196|P2|COMPLETED|Second Open Label DCS||0
7629785|NCT02304432|18786197|P1|COMPLETED|Second Open Label DCS||0
7629786|NCT02304432|18786194|P4|STARTED|Second Open Label DCS||2
7629787|NCT02304432|18786195|P3|STARTED|Second Open Label DCS||0
7629788|NCT02304432|18786196|P2|STARTED|Second Open Label DCS||0
7629789|NCT02304432|18786197|P1|STARTED|Second Open Label DCS||0
7629790|NCT02304432|18786194|P4|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
7629791|NCT02304432|18786195|P3|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
7629792|NCT02304432|18786196|P2|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
7629793|NCT02304432|18786197|P1|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
7629794|NCT02304432|18786194|P4|COMPLETED|Double-Blind DCS Placebo Crossover||0
7629795|NCT02304432|18786195|P3|COMPLETED|Double-Blind DCS Placebo Crossover||1
7629796|NCT02304432|18786196|P2|COMPLETED|Double-Blind DCS Placebo Crossover||1
7629797|NCT02304432|18786197|P1|COMPLETED|Double-Blind DCS Placebo Crossover||0
7629798|NCT02304432|18786194|P4|STARTED|Double-Blind DCS Placebo Crossover||0
7629799|NCT02304432|18786195|P3|STARTED|Double-Blind DCS Placebo Crossover||1
7629800|NCT02304432|18786196|P2|STARTED|Double-Blind DCS Placebo Crossover||1
7629801|NCT02304432|18786197|P1|STARTED|Double-Blind DCS Placebo Crossover||0
7629802|NCT02304432|18786194|P4|NOT COMPLETED|Open Label DCS||0
7629803|NCT02304432|18786195|P3|NOT COMPLETED|Open Label DCS||0
7629804|NCT02304432|18786196|P2|NOT COMPLETED|Open Label DCS||0
7629805|NCT02304432|18786197|P1|NOT COMPLETED|Open Label DCS||0
7629806|NCT02304432|18786194|P4|COMPLETED|Open Label DCS||0
7629807|NCT02304432|18786195|P3|COMPLETED|Open Label DCS||0
7629808|NCT02304432|18786196|P2|COMPLETED|Open Label DCS||0
7629809|NCT02304432|18786197|P1|COMPLETED|Open Label DCS||2
7629810|NCT02304432|18786194|P4|STARTED|Open Label DCS||0
7629811|NCT02304432|18786195|P3|STARTED|Open Label DCS||0
7629812|NCT02304432|18786196|P2|STARTED|Open Label DCS||0
7629813|NCT02304432|18786197|P1|STARTED|Open Label DCS||2
7629814|NCT02304406|18786229|P1|NOT COMPLETED|Overall Study||0
7629815|NCT02304406|18786229|P1|COMPLETED|Overall Study||449
7629816|NCT02304406|18786229|P1|STARTED|Overall Study||449
7629817|NCT02304380|18786252|P6|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
7629818|NCT02304380|18786253|P5|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
7629819|NCT02304380|18786254|P4|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
7629820|NCT02304380|18786255|P3|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
7629821|NCT02304380|18786256|P2|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
7629822|NCT02304380|18786257|P1|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
7629823|NCT02304380|18786252|P6|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
7629824|NCT02304380|18786253|P5|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
7629825|NCT02304380|18786254|P4|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
7629826|NCT02304380|18786255|P3|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
7629827|NCT02304380|18786256|P2|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
7629828|NCT02304380|18786257|P1|COMPLETED|ACO Stakeholder Interviews (Aim 1)||24
7629829|NCT02304380|18786252|P6|STARTED|ACO Stakeholder Interviews (Aim 1)||0
7629830|NCT02304380|18786253|P5|STARTED|ACO Stakeholder Interviews (Aim 1)||0
7629831|NCT02304380|18786254|P4|STARTED|ACO Stakeholder Interviews (Aim 1)||0
7629832|NCT02304380|18786255|P3|STARTED|ACO Stakeholder Interviews (Aim 1)||0
7629833|NCT02304380|18786256|P2|STARTED|ACO Stakeholder Interviews (Aim 1)||0
7629834|NCT02304380|18786257|P1|STARTED|ACO Stakeholder Interviews (Aim 1)||24
7629835|NCT02304380|18786252|P6|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
7629836|NCT02304380|18786253|P5|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
7629837|NCT02304380|18786254|P4|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
7629838|NCT02304380|18786255|P3|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
7629839|NCT02304380|18786256|P2|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
7629840|NCT02304380|18786257|P1|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
7629841|NCT02304380|18786252|P6|COMPLETED|Interviews & Focus Groups (Aim 1)||0
7629842|NCT02304380|18786253|P5|COMPLETED|Interviews & Focus Groups (Aim 1)||0
7629843|NCT02304380|18786254|P4|COMPLETED|Interviews & Focus Groups (Aim 1)||0
7629844|NCT02304380|18786255|P3|COMPLETED|Interviews & Focus Groups (Aim 1)||33
7629845|NCT02304380|18786256|P2|COMPLETED|Interviews & Focus Groups (Aim 1)||35
7629846|NCT02304380|18786257|P1|COMPLETED|Interviews & Focus Groups (Aim 1)||0
7629847|NCT02304380|18786252|P6|STARTED|Interviews & Focus Groups (Aim 1)||0
7629848|NCT02304380|18786253|P5|STARTED|Interviews & Focus Groups (Aim 1)||0
7629849|NCT02304380|18786254|P4|STARTED|Interviews & Focus Groups (Aim 1)||0
7629850|NCT02304380|18786255|P3|STARTED|Interviews & Focus Groups (Aim 1)||33
7629851|NCT02304380|18786256|P2|STARTED|Interviews & Focus Groups (Aim 1)||35
7629852|NCT02304380|18786257|P1|STARTED|Interviews & Focus Groups (Aim 1)||0
7629853|NCT02304380|18786252|P6|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
7629854|NCT02304380|18786253|P5|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
7629855|NCT02304380|18786254|P4|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||34
7629856|NCT02304380|18786255|P3|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
7629857|NCT02304380|18786256|P2|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
7629858|NCT02304380|18786257|P1|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
7629859|NCT02304380|18786252|P6|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
7629860|NCT02304380|18786253|P5|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
7629861|NCT02304380|18786254|P4|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)|68 Caregivers/Patients of the 2,062 surveyed were included in the Interviews and Focus Group .|2062
7629862|NCT02304380|18786255|P3|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
7629863|NCT02304380|18786256|P2|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
7629864|NCT02304380|18786257|P1|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
7629865|NCT02304380|18786252|P6|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
7629866|NCT02304380|18786253|P5|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
7629867|NCT02304380|18786254|P4|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||2096
7629868|NCT02304380|18786255|P3|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
7629869|NCT02304380|18786256|P2|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
7629870|NCT02304380|18786257|P1|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
7629871|NCT02304380|18786252|P6|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
7629872|NCT02304380|18786253|P5|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
7629873|NCT02304380|18786254|P4|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
7629874|NCT02304380|18786255|P3|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
7629875|NCT02304380|18786256|P2|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
7629876|NCT02304380|18786257|P1|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
7629877|NCT02304380|18786252|P6|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|Not included in any other portion of the study.|47026
7629878|NCT02304380|18786253|P5|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|2,096 Caregivers of the 17,356 claims were included in the Caregiver Survey.|17356
7629879|NCT02304380|18786254|P4|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
7629880|NCT02304380|18786255|P3|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
7629881|NCT02304380|18786256|P2|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
7629882|NCT02304380|18786257|P1|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
7629883|NCT02304380|18786252|P6|STARTED|Pediatric Claims Data Analysis (Aim 3)||47026
7629884|NCT02304380|18786253|P5|STARTED|Pediatric Claims Data Analysis (Aim 3)||17356
7629885|NCT02304380|18786254|P4|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
7629886|NCT02304380|18786255|P3|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
7629887|NCT02304380|18786256|P2|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
7629888|NCT02304380|18786257|P1|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
7629889|NCT02304367|18786307|P1|NOT COMPLETED|Overall Study||17
7629890|NCT02304367|18786307|P1|COMPLETED|Overall Study||0
7629891|NCT02304367|18786307|P1|Completed 144 Weeks of Study Drug|Overall Study||11
7629892|NCT02304367|18786307|P1|Completed 48 Weeks of Study Drug|Overall Study||16
7629893|NCT02304367|18786307|P1|STARTED|Overall Study||17
7629894|NCT02304159|18786367|P2|NOT COMPLETED|Overall Study||2
7629895|NCT02304159|18786368|P1|NOT COMPLETED|Overall Study||2
7629896|NCT02304159|18786367|P2|COMPLETED|Overall Study||16
7629897|NCT02304159|18786368|P1|COMPLETED|Overall Study||19
7629898|NCT02304159|18786367|P2|STARTED|Overall Study||18
7629899|NCT02304159|18786368|P1|STARTED|Overall Study||21
7629900|NCT02303743|18786380|P2|NOT COMPLETED|Overall Study||0
7629901|NCT02303743|18786381|P1|NOT COMPLETED|Overall Study||0
7629902|NCT02303743|18786380|P2|COMPLETED|Overall Study||152
7629903|NCT02303743|18786381|P1|COMPLETED|Overall Study||108
7629904|NCT02303743|18786380|P2|STARTED|Overall Study||152
7629905|NCT02303743|18786381|P1|STARTED|Overall Study||108
7629906|NCT02303704|18786391|P2|NOT COMPLETED|Overall Study||9
7629907|NCT02303704|18786392|P1|NOT COMPLETED|Overall Study||5
7629908|NCT02303704|18786391|P2|COMPLETED|Overall Study||219
7629909|NCT02303704|18786392|P1|COMPLETED|Overall Study||215
7629910|NCT02303704|18786391|P2|STARTED|Overall Study||228
7629911|NCT02303704|18786392|P1|STARTED|Overall Study||220
7629912|NCT02303574|18786420|P10|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
7629913|NCT02303574|18786421|P9|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
7629914|NCT02303574|18786422|P8|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||1
7629915|NCT02303574|18786423|P7|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
7629916|NCT02303574|18786424|P6|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
7629917|NCT02303574|18786425|P5|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
7629918|NCT02303574|18786426|P4|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
7629919|NCT02303574|18786427|P3|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
7629920|NCT02303574|18786428|P2|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
7629921|NCT02303574|18786429|P1|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
7629922|NCT02303574|18786420|P10|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||12
7629923|NCT02303574|18786421|P9|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||10
7629924|NCT02303574|18786422|P8|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||7
7629925|NCT02303574|18786423|P7|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||6
7629926|NCT02303574|18786424|P6|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
7629927|NCT02303574|18786425|P5|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
7629928|NCT02303574|18786426|P4|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
7629929|NCT02303574|18786427|P3|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
7629930|NCT02303574|18786428|P2|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
7629931|NCT02303574|18786429|P1|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
7629932|NCT02303574|18786420|P10|STARTED|Part 2 - Multiple Ascending Dose (MAD)|Participants took AZD7986 matching placebo for 28 days (fasted/fed state, based on part 1b results)|12
7629933|NCT02303574|18786421|P9|STARTED|Part 2 - Multiple Ascending Dose (MAD)||10
7629934|NCT02303574|18786422|P8|STARTED|Part 2 - Multiple Ascending Dose (MAD)||8
7629935|NCT02303574|18786423|P7|STARTED|Part 2 - Multiple Ascending Dose (MAD)||6
7629936|NCT02303574|18786424|P6|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
7629937|NCT02303574|18786425|P5|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
7629938|NCT02303574|18786426|P4|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
7629939|NCT02303574|18786427|P3|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
7629940|NCT02303574|18786428|P2|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
7629941|NCT02303574|18786429|P1|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
7629942|NCT02303574|18786420|P10|NOT COMPLETED|Part 1b (Fed State) - SAD||0
7629943|NCT02303574|18786421|P9|NOT COMPLETED|Part 1b (Fed State) - SAD||0
7629944|NCT02303574|18786422|P8|NOT COMPLETED|Part 1b (Fed State) - SAD||0
7629945|NCT02303574|18786423|P7|NOT COMPLETED|Part 1b (Fed State) - SAD||0
7629946|NCT02303574|18786424|P6|NOT COMPLETED|Part 1b (Fed State) - SAD||0
7629947|NCT02303574|18786425|P5|NOT COMPLETED|Part 1b (Fed State) - SAD||0
7629948|NCT02303574|18786426|P4|NOT COMPLETED|Part 1b (Fed State) - SAD||0
7629949|NCT02303574|18786427|P3|NOT COMPLETED|Part 1b (Fed State) - SAD||0
7629950|NCT02303574|18786428|P2|NOT COMPLETED|Part 1b (Fed State) - SAD||0
7629951|NCT02303574|18786429|P1|NOT COMPLETED|Part 1b (Fed State) - SAD||0
7629952|NCT02303574|18786420|P10|COMPLETED|Part 1b (Fed State) - SAD||3
7629953|NCT02303574|18786421|P9|COMPLETED|Part 1b (Fed State) - SAD||0
7629954|NCT02303574|18786422|P8|COMPLETED|Part 1b (Fed State) - SAD||0
7629955|NCT02303574|18786423|P7|COMPLETED|Part 1b (Fed State) - SAD||0
7629956|NCT02303574|18786424|P6|COMPLETED|Part 1b (Fed State) - SAD||5
7629957|NCT02303574|18786425|P5|COMPLETED|Part 1b (Fed State) - SAD||0
7629958|NCT02303574|18786426|P4|COMPLETED|Part 1b (Fed State) - SAD||0
7629959|NCT02303574|18786427|P3|COMPLETED|Part 1b (Fed State) - SAD||0
7629960|NCT02303574|18786428|P2|COMPLETED|Part 1b (Fed State) - SAD||0
7629961|NCT02303574|18786429|P1|COMPLETED|Part 1b (Fed State) - SAD||0
7629962|NCT02303574|18786420|P10|STARTED|Part 1b (Fed State) - SAD|Participants received AZD7986 matching placebo on Day 1 in fed state.|3
7629963|NCT02303574|18786421|P9|STARTED|Part 1b (Fed State) - SAD||0
7629964|NCT02303574|18786422|P8|STARTED|Part 1b (Fed State) - SAD||0
7629965|NCT02303574|18786423|P7|STARTED|Part 1b (Fed State) - SAD||0
7629966|NCT02303574|18786424|P6|STARTED|Part 1b (Fed State) - SAD||5
7629967|NCT02303574|18786425|P5|STARTED|Part 1b (Fed State) - SAD||0
7629968|NCT02303574|18786426|P4|STARTED|Part 1b (Fed State) - SAD||0
7629969|NCT02303574|18786427|P3|STARTED|Part 1b (Fed State) - SAD||0
7629970|NCT02303574|18786428|P2|STARTED|Part 1b (Fed State) - SAD||0
7629971|NCT02303574|18786429|P1|STARTED|Part 1b (Fed State) - SAD||0
7629972|NCT02303574|18786420|P10|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
7629973|NCT02303574|18786421|P9|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
7629974|NCT02303574|18786422|P8|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
7629975|NCT02303574|18786423|P7|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
7629976|NCT02303574|18786424|P6|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
7629977|NCT02303574|18786425|P5|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
7629978|NCT02303574|18786426|P4|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
7629979|NCT02303574|18786427|P3|NOT COMPLETED|Part 1a (Fasted State)- SAD||1
7629980|NCT02303574|18786428|P2|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
7629981|NCT02303574|18786429|P1|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
7629982|NCT02303574|18786420|P10|COMPLETED|Part 1a (Fasted State)- SAD||15
7629983|NCT02303574|18786421|P9|COMPLETED|Part 1a (Fasted State)- SAD||0
7629984|NCT02303574|18786422|P8|COMPLETED|Part 1a (Fasted State)- SAD||0
7629985|NCT02303574|18786423|P7|COMPLETED|Part 1a (Fasted State)- SAD||0
7629986|NCT02303574|18786424|P6|COMPLETED|Part 1a (Fasted State)- SAD||0
7629987|NCT02303574|18786425|P5|COMPLETED|Part 1a (Fasted State)- SAD||6
7629988|NCT02303574|18786426|P4|COMPLETED|Part 1a (Fasted State)- SAD||6
7629989|NCT02303574|18786427|P3|COMPLETED|Part 1a (Fasted State)- SAD||5
7629990|NCT02303574|18786428|P2|COMPLETED|Part 1a (Fasted State)- SAD||6
7629991|NCT02303574|18786429|P1|COMPLETED|Part 1a (Fasted State)- SAD||6
7629992|NCT02303574|18786420|P10|STARTED|Part 1a (Fasted State)- SAD|Participants received AZD7986 matching placebo on Day 1 in fasted state.|15
7629993|NCT02303574|18786421|P9|STARTED|Part 1a (Fasted State)- SAD||0
7629994|NCT02303574|18786422|P8|STARTED|Part 1a (Fasted State)- SAD||0
7629995|NCT02303574|18786423|P7|STARTED|Part 1a (Fasted State)- SAD||0
7629996|NCT02303574|18786424|P6|STARTED|Part 1a (Fasted State)- SAD||0
7629997|NCT02303574|18786425|P5|STARTED|Part 1a (Fasted State)- SAD||6
7629998|NCT02303574|18786426|P4|STARTED|Part 1a (Fasted State)- SAD||6
7629999|NCT02303574|18786427|P3|STARTED|Part 1a (Fasted State)- SAD||6
7630000|NCT02303574|18786428|P2|STARTED|Part 1a (Fasted State)- SAD||6
7630001|NCT02303574|18786429|P1|STARTED|Part 1a (Fasted State)- SAD||6
7630002|NCT02303548|18786643|P2|NOT COMPLETED|Overall Study||0
7630003|NCT02303548|18786644|P1|NOT COMPLETED|Overall Study||0
7630004|NCT02303548|18786643|P2|COMPLETED|Overall Study||25
7630005|NCT02303548|18786644|P1|COMPLETED|Overall Study||25
7630006|NCT02303548|18786643|P2|STARTED|Overall Study||25
7630007|NCT02303548|18786644|P1|STARTED|Overall Study||25
7630008|NCT02303262|18786650|P1|NOT COMPLETED|Overall Study||2
7630009|NCT02303262|18786650|P1|COMPLETED|Overall Study||18
7630010|NCT02303262|18786650|P1|STARTED|Overall Study||20
7630011|NCT02303041|18786658|P2|NOT COMPLETED|Overall Study||2
7630012|NCT02303041|18786659|P1|NOT COMPLETED|Overall Study||1
7630013|NCT02303041|18786658|P2|COMPLETED|Overall Study||4
7630014|NCT02303041|18786659|P1|COMPLETED|Overall Study||3
7630015|NCT02303041|18786658|P2|STARTED|Overall Study||6
7630016|NCT02303041|18786659|P1|STARTED|Overall Study||4
7630017|NCT02302859|18786675|P2|NOT COMPLETED|Overall Study||2
7630018|NCT02302859|18786676|P1|NOT COMPLETED|Overall Study||1
7630019|NCT02302859|18786675|P2|COMPLETED|Overall Study||4
7630020|NCT02302859|18786676|P1|COMPLETED|Overall Study||1
7630021|NCT02302859|18786675|P2|STARTED|Overall Study||6
7630022|NCT02302859|18786676|P1|STARTED|Overall Study||2
7630023|NCT02302846|18786682|P1|NOT COMPLETED|Overall Study||1
7630024|NCT02302846|18786682|P1|COMPLETED|Overall Study||4
7630025|NCT02302846|18786682|P1|STARTED|Overall Study||5
7630026|NCT02302807|18786688|P2|NOT COMPLETED|Overall Study||467
7630027|NCT02302807|18786689|P1|NOT COMPLETED|Overall Study||464
7630028|NCT02302807|18786688|P2|COMPLETED|Overall Study|Participants still receiving atezolizumab had opportunity to continue treatment in extension study.|0
7630029|NCT02302807|18786689|P1|COMPLETED|Overall Study|Participants still on chemotherapy were discontinued where that treatment was available locally.|0
7630030|NCT02302807|18786688|P2|Received Treatment|Overall Study||459
7630031|NCT02302807|18786689|P1|Received Treatment|Overall Study||443
7630032|NCT02302807|18786688|P2|STARTED|Overall Study||467
7630033|NCT02302807|18786689|P1|STARTED|Overall Study||464
7630034|NCT02302716|18786736|P2|NOT COMPLETED|Overall Study||19
7630035|NCT02302716|18786737|P1|NOT COMPLETED|Overall Study||19
7630036|NCT02302716|18786736|P2|COMPLETED|Overall Study||225
7630037|NCT02302716|18786737|P1|COMPLETED|Overall Study||230
7630038|NCT02302716|18786736|P2|Received at Least 1 Dose of Study Drug|Overall Study||244
7630039|NCT02302716|18786737|P1|Received at Least 1 Dose of Study Drug|Overall Study||249
7630040|NCT02302716|18786736|P2|STARTED|Overall Study||244
7630041|NCT02302716|18786737|P1|STARTED|Overall Study||249
7630042|NCT02302365|18786763|P1|NOT COMPLETED|0-24 Hour Period||0
7630043|NCT02302365|18786763|P1|COMPLETED|0-24 Hour Period||32
7630044|NCT02302365|18786763|P1|STARTED|0-24 Hour Period|2 of 3 study sites collected additional safety data; 32 pts. 0-24 hour data, 43 pts. 0-2 hour data|32
7630045|NCT02302365|18786763|P1|NOT COMPLETED|0-2 Hour Period||2
7630046|NCT02302365|18786763|P1|COMPLETED|0-2 Hour Period|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41
7630047|NCT02302365|18786763|P1|STARTED|0-2 Hour Period|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43
7630048|NCT02302339|18786785|P4|NOT COMPLETED|Overall Study||0
7630049|NCT02302339|18786786|P3|NOT COMPLETED|Overall Study||1
7630050|NCT02302339|18786787|P2|NOT COMPLETED|Overall Study||2
7630051|NCT02302339|18786788|P1|NOT COMPLETED|Overall Study||1
7630052|NCT02302339|18786785|P4|COMPLETED|Overall Study||7
7630053|NCT02302339|18786786|P3|COMPLETED|Overall Study||28
7630054|NCT02302339|18786787|P2|COMPLETED|Overall Study||32
7630055|NCT02302339|18786788|P1|COMPLETED|Overall Study||61
7630056|NCT02302339|18786785|P4|STARTED|Overall Study||7
7630057|NCT02302339|18786786|P3|STARTED|Overall Study||29
7630058|NCT02302339|18786787|P2|STARTED|Overall Study||34
7630059|NCT02302339|18786788|P1|STARTED|Overall Study||62
7630060|NCT02302222|18786821|P2|NOT COMPLETED|Overall Study||6
7630061|NCT02302222|18786822|P1|NOT COMPLETED|Overall Study||1
7630062|NCT02302222|18786821|P2|COMPLETED|Overall Study||31
7630063|NCT02302222|18786822|P1|COMPLETED|Overall Study||33
7630064|NCT02302222|18786821|P2|STARTED|Overall Study||37
7630065|NCT02302222|18786822|P1|STARTED|Overall Study||34
7630066|NCT02302092|18786830|P2|NOT COMPLETED|Overall Study||0
7630067|NCT02302092|18786831|P1|NOT COMPLETED|Overall Study||0
7630068|NCT02302092|18786830|P2|COMPLETED|Overall Study||7
7630069|NCT02302092|18786831|P1|COMPLETED|Overall Study||6
7630070|NCT02302092|18786830|P2|STARTED|Overall Study||7
7630071|NCT02302092|18786831|P1|STARTED|Overall Study||6
7630072|NCT02302066|18786861|P4|NOT COMPLETED|Overall Study||41
7630073|NCT02302066|18786862|P3|NOT COMPLETED|Overall Study||172
7630074|NCT02302066|18786863|P2|NOT COMPLETED|Overall Study||75
7630075|NCT02302066|18786864|P1|NOT COMPLETED|Overall Study||33
7630076|NCT02302066|18786861|P4|COMPLETED|Overall Study||158
7630077|NCT02302066|18786862|P3|COMPLETED|Overall Study||830
7630078|NCT02302066|18786863|P2|COMPLETED|Overall Study||323
7630079|NCT02302066|18786864|P1|COMPLETED|Overall Study||168
7630080|NCT02302066|18786861|P4|Per-Protocol Set (PPS)|Overall Study||81
7630081|NCT02302066|18786862|P3|Per-Protocol Set (PPS)|Overall Study||174
7630082|NCT02302066|18786863|P2|Per-Protocol Set (PPS)|Overall Study||171
7630083|NCT02302066|18786864|P1|Per-Protocol Set (PPS)|Overall Study||83
7630084|NCT02302066|18786861|P4|Immunogenicity Subset|Overall Study||94
7630085|NCT02302066|18786862|P3|Immunogenicity Subset|Overall Study||192
7630086|NCT02302066|18786863|P2|Immunogenicity Subset|Overall Study||187
7630087|NCT02302066|18786864|P1|Immunogenicity Subset|Overall Study||92
7630088|NCT02302066|18786861|P4|Safety Analysis Set|Overall Study||198
7630089|NCT02302066|18786862|P3|Safety Analysis Set|Overall Study||998
7630090|NCT02302066|18786863|P2|Safety Analysis Set|Overall Study||398
7630091|NCT02302066|18786864|P1|Safety Analysis Set|Overall Study||200
7630092|NCT02302066|18786861|P4|STARTED|Overall Study||199
7630093|NCT02302066|18786862|P3|STARTED|Overall Study||1002
7630094|NCT02302066|18786863|P2|STARTED|Overall Study||398
7630095|NCT02302066|18786864|P1|STARTED|Overall Study||201
7630096|NCT02301988|18786908|P2|NOT COMPLETED|Overall Study||9
7630097|NCT02301988|18786909|P1|NOT COMPLETED|Overall Study||10
7630098|NCT02301988|18786908|P2|COMPLETED|Overall Study||66
7630099|NCT02301988|18786909|P1|COMPLETED|Overall Study||66
7630100|NCT02301988|18786908|P2|STARTED|Overall Study||75
7630101|NCT02301988|18786909|P1|STARTED|Overall Study||76
7630102|NCT02301975|18786942|P3|NOT COMPLETED|Overall Study||22
7630103|NCT02301975|18786943|P2|NOT COMPLETED|Overall Study||25
7630104|NCT02301975|18786944|P1|NOT COMPLETED|Overall Study||31
7630105|NCT02301975|18786942|P3|COMPLETED|Overall Study||477
7630106|NCT02301975|18786943|P2|COMPLETED|Overall Study||476
7630107|NCT02301975|18786944|P1|COMPLETED|Overall Study||473
7630108|NCT02301975|18786942|P3|STARTED|Overall Study||499
7630109|NCT02301975|18786943|P2|STARTED|Overall Study||501
7630110|NCT02301975|18786944|P1|STARTED|Overall Study||504
7630111|NCT02301936|18786972|P2|NOT COMPLETED|Overall Study||0
7630112|NCT02301936|18786973|P1|NOT COMPLETED|Overall Study||1
7630113|NCT02301936|18786972|P2|COMPLETED|Overall Study||1
7630114|NCT02301936|18786973|P1|COMPLETED|Overall Study||8
7630115|NCT02301936|18786972|P2|STARTED|Overall Study||1
7630116|NCT02301936|18786973|P1|STARTED|Overall Study||9
7630117|NCT02301897|18786998|P3|NOT COMPLETED|Treatment Course 2||1
7630118|NCT02301897|18786999|P2|NOT COMPLETED|Treatment Course 2||5
7630119|NCT02301897|18787000|P1|NOT COMPLETED|Treatment Course 2||1
7630120|NCT02301897|18786998|P3|COMPLETED|Treatment Course 2||7
7630121|NCT02301897|18786999|P2|COMPLETED|Treatment Course 2||9
7630122|NCT02301897|18787000|P1|COMPLETED|Treatment Course 2||8
7630123|NCT02301897|18786998|P3|STARTED|Treatment Course 2||8
7630124|NCT02301897|18786999|P2|STARTED|Treatment Course 2||14
7630125|NCT02301897|18787000|P1|STARTED|Treatment Course 2||9
7630126|NCT02301897|18786998|P3|NOT COMPLETED|Treatment Course 1||6
7630127|NCT02301897|18786999|P2|NOT COMPLETED|Treatment Course 1||3
7630128|NCT02301897|18787000|P1|NOT COMPLETED|Treatment Course 1||3
7630129|NCT02301897|18786998|P3|COMPLETED|Treatment Course 1||8
7630130|NCT02301897|18786999|P2|COMPLETED|Treatment Course 1||14
7630131|NCT02301897|18787000|P1|COMPLETED|Treatment Course 1||9
7630132|NCT02301897|18786998|P3|STARTED|Treatment Course 1||14
7630133|NCT02301897|18786999|P2|STARTED|Treatment Course 1||17
7630134|NCT02301897|18787000|P1|STARTED|Treatment Course 1||12
7630135|NCT02301793|18787049|P2|NOT COMPLETED|During and Post Education Study Period||49
7630136|NCT02301793|18787050|P1|NOT COMPLETED|During and Post Education Study Period||83
7630137|NCT02301793|18787049|P2|COMPLETED|During and Post Education Study Period||396
7630138|NCT02301793|18787050|P1|COMPLETED|During and Post Education Study Period||405
7630139|NCT02301793|18787049|P2|STARTED|During and Post Education Study Period||445
7630140|NCT02301793|18787050|P1|STARTED|During and Post Education Study Period||488
7630141|NCT02301793|18787049|P2|NOT COMPLETED|Pre Education Study Period||0
7630142|NCT02301793|18787050|P1|NOT COMPLETED|Pre Education Study Period||0
7630143|NCT02301793|18787049|P2|COMPLETED|Pre Education Study Period|Nurses had not been randomized|0
7630144|NCT02301793|18787050|P1|COMPLETED|Pre Education Study Period|Nurses had not been randomized|0
7630145|NCT02301793|18787049|P2|STARTED|Pre Education Study Period|Nurses had not been randomized|0
7630146|NCT02301793|18787050|P1|STARTED|Pre Education Study Period|Nurses had not been randomized|0
7630147|NCT02301624|18787066|P2|NOT COMPLETED|Open-label Maintenance Phase||17
7630148|NCT02301624|18787067|P1|NOT COMPLETED|Open-label Maintenance Phase||12
7630149|NCT02301624|18787066|P2|COMPLETED|Open-label Maintenance Phase||44
7630150|NCT02301624|18787067|P1|COMPLETED|Open-label Maintenance Phase||43
7630151|NCT02301624|18787066|P2|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||61
7630152|NCT02301624|18787067|P1|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||55
7630153|NCT02301624|18787066|P2|STARTED|Open-label Maintenance Phase||61
7630154|NCT02301624|18787067|P1|STARTED|Open-label Maintenance Phase||55
7630155|NCT02301624|18787066|P2|NOT COMPLETED|Blind Induction Phase||0
7630156|NCT02301624|18787067|P1|NOT COMPLETED|Blind Induction Phase||1
7630157|NCT02301624|18787066|P2|COMPLETED|Blind Induction Phase||61
7630158|NCT02301624|18787067|P1|COMPLETED|Blind Induction Phase||55
7630159|NCT02301624|18787066|P2|Received at Least 1 Dose of Study Drug|Blind Induction Phase||61
7630160|NCT02301624|18787067|P1|Received at Least 1 Dose of Study Drug|Blind Induction Phase||56
7630161|NCT02301624|18787066|P2|STARTED|Blind Induction Phase||61
7630162|NCT02301624|18787067|P1|STARTED|Blind Induction Phase||56
7630163|NCT02301546|18787078|P2|NOT COMPLETED|Long Term Effectiveness (~1 Year)||7
7630164|NCT02301546|18787079|P1|NOT COMPLETED|Long Term Effectiveness (~1 Year)||12
7630165|NCT02301546|18787078|P2|COMPLETED|Long Term Effectiveness (~1 Year)||51
7630166|NCT02301546|18787079|P1|COMPLETED|Long Term Effectiveness (~1 Year)||43
7630167|NCT02301546|18787078|P2|STARTED|Long Term Effectiveness (~1 Year)||58
7630168|NCT02301546|18787079|P1|STARTED|Long Term Effectiveness (~1 Year)||55
7630169|NCT02301546|18787078|P2|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||15
7630170|NCT02301546|18787079|P1|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||18
7630171|NCT02301546|18787078|P2|COMPLETED|Short-term Effectiveness (~13 Weeks)||58
7630172|NCT02301546|18787079|P1|COMPLETED|Short-term Effectiveness (~13 Weeks)||55
7630173|NCT02301546|18787078|P2|STARTED|Short-term Effectiveness (~13 Weeks)||73
7630174|NCT02301546|18787079|P1|STARTED|Short-term Effectiveness (~13 Weeks)||73
7630175|NCT02301429|18787085|P1|NOT COMPLETED|Overall Study||3
7630176|NCT02301429|18787085|P1|COMPLETED|Overall Study||13
7630177|NCT02301429|18787085|P1|STARTED|Overall Study||16
7630178|NCT02301416|18787091|P2|NOT COMPLETED|Overall Study||0
7630179|NCT02301416|18787092|P1|NOT COMPLETED|Overall Study||10
7630180|NCT02301416|18787091|P2|COMPLETED|Overall Study||40
7630181|NCT02301416|18787092|P1|COMPLETED|Overall Study||15
7630182|NCT02301416|18787091|P2|STARTED|Overall Study||40
7630183|NCT02301416|18787092|P1|STARTED|Overall Study||25
7630184|NCT02301403|18787131|P2|NOT COMPLETED|Overall Study||41
7630185|NCT02301403|18787132|P1|NOT COMPLETED|Overall Study||28
7630186|NCT02301403|18787131|P2|COMPLETED|Overall Study||267
7630187|NCT02301403|18787132|P1|COMPLETED|Overall Study||287
7630188|NCT02301403|18787131|P2|STARTED|Overall Study||308
7630189|NCT02301403|18787132|P1|STARTED|Overall Study||315
7630190|NCT02301390|18787140|P2|NOT COMPLETED|Overall Study||13
7630191|NCT02301390|18787141|P1|NOT COMPLETED|Overall Study||10
7630192|NCT02301390|18787140|P2|COMPLETED|Overall Study||13
7630193|NCT02301390|18787141|P1|COMPLETED|Overall Study||17
7630194|NCT02301390|18787140|P2|STARTED|Overall Study||26
7630195|NCT02301390|18787141|P1|STARTED|Overall Study||27
7630196|NCT02301377|18787155|P2|NOT COMPLETED|Overall Study||0
7630197|NCT02301377|18787156|P1|NOT COMPLETED|Overall Study||0
7630198|NCT02301377|18787155|P2|COMPLETED|Overall Study||2
7630199|NCT02301377|18787156|P1|COMPLETED|Overall Study||3
7630200|NCT02301377|18787155|P2|STARTED|Overall Study||2
7630201|NCT02301377|18787156|P1|STARTED|Overall Study||3
7630202|NCT02301364|18787166|P1|NOT COMPLETED|Overall Study||0
7630203|NCT02301364|18787166|P1|COMPLETED|Overall Study||4
7630204|NCT02301364|18787166|P1|STARTED|Overall Study||4
7630205|NCT02301299|18787173|P1|NOT COMPLETED|Overall Study||0
7630206|NCT02301299|18787173|P1|COMPLETED|Overall Study||1322
7630207|NCT02301299|18787173|P1|STARTED|Overall Study||1322
7630208|NCT02301169|18787182|P2|NOT COMPLETED|Overall Study||0
7630209|NCT02301169|18787183|P1|NOT COMPLETED|Overall Study||1
7630210|NCT02301169|18787182|P2|COMPLETED|Overall Study||21
7630211|NCT02301169|18787183|P1|COMPLETED|Overall Study||20
7630212|NCT02301169|18787182|P2|STARTED|Overall Study||21
7630213|NCT02301169|18787183|P1|STARTED|Overall Study||21
7630214|NCT02301143|18787197|P2|NOT COMPLETED|Investigator's Choice||10
7630215|NCT02301143|18787198|P1|NOT COMPLETED|Investigator's Choice||0
7630216|NCT02301143|18787197|P2|COMPLETED|Investigator's Choice|3 participants completed nab-Paclitaxel+Gemcitabine,18 completed chemoradiation,16 had surgery.|37
7630217|NCT02301143|18787198|P1|COMPLETED|Investigator's Choice||0
7630218|NCT02301143|18787197|P2|STARTED|Investigator's Choice|12 participants continued nab-Paclitaxel/Gemcitabine; 18 started chemoradiation;17 underwent surgery|47
7630219|NCT02301143|18787198|P1|STARTED|Investigator's Choice||0
7630220|NCT02301143|18787197|P2|NOT COMPLETED|Induction Period||0
7630221|NCT02301143|18787198|P1|NOT COMPLETED|Induction Period||45
7630222|NCT02301143|18787197|P2|COMPLETED|Induction Period||0
7630223|NCT02301143|18787198|P1|COMPLETED|Induction Period||62
7630224|NCT02301143|18787197|P2|STARTED|Induction Period||0
7630225|NCT02301143|18787198|P1|STARTED|Induction Period||107
7630226|NCT02301039|18787217|P3|NOT COMPLETED|Overall Study||0
7630227|NCT02301039|18787218|P2|NOT COMPLETED|Overall Study||0
7630228|NCT02301039|18787219|P1|NOT COMPLETED|Overall Study||0
7630229|NCT02301039|18787217|P3|COMPLETED|Overall Study||60
7630230|NCT02301039|18787218|P2|COMPLETED|Overall Study||42
7630231|NCT02301039|18787219|P1|COMPLETED|Overall Study||42
7630232|NCT02301039|18787217|P3|STARTED|Overall Study||60
7630233|NCT02301039|18787218|P2|STARTED|Overall Study||42
7630234|NCT02301039|18787219|P1|STARTED|Overall Study||42
7630235|NCT02300987|18787241|P2|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
7630236|NCT02300987|18787242|P1|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
7630237|NCT02300987|18787241|P2|COMPLETED|Secondary Phase : Cross-over to LEE011||1
7630238|NCT02300987|18787242|P1|COMPLETED|Secondary Phase : Cross-over to LEE011||0
7630239|NCT02300987|18787241|P2|STARTED|Secondary Phase : Cross-over to LEE011||2
7630240|NCT02300987|18787242|P1|STARTED|Secondary Phase : Cross-over to LEE011||1
7630241|NCT02300987|18787241|P2|NOT COMPLETED|Primary Phase : Prior to Cross-over||2
7630242|NCT02300987|18787242|P1|NOT COMPLETED|Primary Phase : Prior to Cross-over||6
7630243|NCT02300987|18787241|P2|COMPLETED|Primary Phase : Prior to Cross-over||0
7630244|NCT02300987|18787242|P1|COMPLETED|Primary Phase : Prior to Cross-over||2
7630245|NCT02300987|18787241|P2|STARTED|Primary Phase : Prior to Cross-over||2
7630246|NCT02300987|18787242|P1|STARTED|Primary Phase : Prior to Cross-over||8
7630247|NCT02300727|18787267|P6|NOT COMPLETED|Overall Study||0
7630248|NCT02300727|18787268|P5|NOT COMPLETED|Overall Study||0
7630249|NCT02300727|18787269|P4|NOT COMPLETED|Overall Study||1
7630250|NCT02300727|18787270|P3|NOT COMPLETED|Overall Study||0
7630251|NCT02300727|18787271|P2|NOT COMPLETED|Overall Study||0
7630252|NCT02300727|18787272|P1|NOT COMPLETED|Overall Study||0
7630253|NCT02300727|18787267|P6|COMPLETED|Overall Study||0
7630254|NCT02300727|18787268|P5|COMPLETED|Overall Study||0
7630255|NCT02300727|18787269|P4|COMPLETED|Overall Study||2
7630256|NCT02300727|18787270|P3|COMPLETED|Overall Study||3
7630257|NCT02300727|18787271|P2|COMPLETED|Overall Study||0
7630258|NCT02300727|18787272|P1|COMPLETED|Overall Study||0
7630259|NCT02300727|18787267|P6|STARTED|Overall Study||0
7630260|NCT02300727|18787268|P5|STARTED|Overall Study||0
7630261|NCT02300727|18787269|P4|STARTED|Overall Study||3
7630262|NCT02300727|18787270|P3|STARTED|Overall Study||3
7630263|NCT02300727|18787271|P2|STARTED|Overall Study||0
7630264|NCT02300727|18787272|P1|STARTED|Overall Study||0
7630265|NCT02300610|18787289|P3|NOT COMPLETED|Overall Study||1
7630266|NCT02300610|18787290|P2|NOT COMPLETED|Overall Study||0
7630267|NCT02300610|18787291|P1|NOT COMPLETED|Overall Study||1
7630268|NCT02300610|18787289|P3|COMPLETED|Overall Study||3
7630269|NCT02300610|18787290|P2|COMPLETED|Overall Study||3
7630270|NCT02300610|18787291|P1|COMPLETED|Overall Study||2
7630271|NCT02300610|18787289|P3|STARTED|Overall Study||4
7630272|NCT02300610|18787290|P2|STARTED|Overall Study||3
7630273|NCT02300610|18787291|P1|STARTED|Overall Study||3
7630274|NCT02300558|18787306|P1|NOT COMPLETED|Open-Label (OL) Extension Phase||32
7630275|NCT02300558|18787306|P1|COMPLETED|Open-Label (OL) Extension Phase||0
7630276|NCT02300558|18787306|P1|STARTED|Open-Label (OL) Extension Phase||32
7630277|NCT02300558|18787306|P1|NOT COMPLETED|Single Blind Phase (24 Weeks)||6
7630278|NCT02300558|18787306|P1|COMPLETED|Single Blind Phase (24 Weeks)||35
7630279|NCT02300558|18787306|P1|STARTED|Single Blind Phase (24 Weeks)||41
7630280|NCT02300545|18787317|P1|NOT COMPLETED|Overall Study||0
7630281|NCT02300545|18787317|P1|COMPLETED|Overall Study||56
7630282|NCT02300545|18787317|P1|STARTED|Overall Study||56
7630283|NCT02300311|18787328|P2|NOT COMPLETED|Overall Study||0
7630284|NCT02300311|18787329|P1|NOT COMPLETED|Overall Study||19
7630285|NCT02300311|18787328|P2|COMPLETED|Overall Study||69
7630286|NCT02300311|18787329|P1|COMPLETED|Overall Study||50
7630287|NCT02300311|18787328|P2|STARTED|Overall Study||69
7630288|NCT02300311|18787329|P1|STARTED|Overall Study||69
7630289|NCT02300298|18787341|P2|NOT COMPLETED|Disposition for Docetaxel||10
7630290|NCT02300298|18787342|P1|NOT COMPLETED|Disposition for Docetaxel||0
7630291|NCT02300298|18787341|P2|COMPLETED|Disposition for Docetaxel||0
7630292|NCT02300298|18787342|P1|COMPLETED|Disposition for Docetaxel||0
7630293|NCT02300298|18787341|P2|STARTED|Disposition for Docetaxel||10
7630294|NCT02300298|18787342|P1|STARTED|Disposition for Docetaxel||0
7630295|NCT02300298|18787341|P2|NOT COMPLETED|Disposition for Nintedanib||0
7630296|NCT02300298|18787342|P1|NOT COMPLETED|Disposition for Nintedanib||10
7630297|NCT02300298|18787341|P2|COMPLETED|Disposition for Nintedanib||0
7630298|NCT02300298|18787342|P1|COMPLETED|Disposition for Nintedanib||0
7630299|NCT02300298|18787341|P2|STARTED|Disposition for Nintedanib||0
7630300|NCT02300298|18787342|P1|STARTED|Disposition for Nintedanib||10
7630301|NCT02300259|18787355|P3|NOT COMPLETED|Period 2||1
7630302|NCT02300259|18787356|P2|NOT COMPLETED|Period 2||0
7630303|NCT02300259|18787357|P1|NOT COMPLETED|Period 2||1
7630304|NCT02300259|18787355|P3|COMPLETED|Period 2||13
7630305|NCT02300259|18787356|P2|COMPLETED|Period 2||0
7630306|NCT02300259|18787357|P1|COMPLETED|Period 2||15
7630307|NCT02300259|18787355|P3|STARTED|Period 2||14
7630308|NCT02300259|18787356|P2|STARTED|Period 2|There was no period 2 for Group 2.|0
7630309|NCT02300259|18787357|P1|STARTED|Period 2||16
7630310|NCT02300259|18787355|P3|NOT COMPLETED|Period 1||2
7630311|NCT02300259|18787356|P2|NOT COMPLETED|Period 1||0
7630312|NCT02300259|18787357|P1|NOT COMPLETED|Period 1||0
7630313|NCT02300259|18787355|P3|COMPLETED|Period 1||14
7630314|NCT02300259|18787356|P2|COMPLETED|Period 1||16
7630315|NCT02300259|18787357|P1|COMPLETED|Period 1||16
7630316|NCT02300259|18787355|P3|Received at Least One Dose of Study Drug|Period 1||16
7630317|NCT02300259|18787356|P2|Received at Least One Dose of Study Drug|Period 1||16
7630318|NCT02300259|18787357|P1|Received at Least One Dose of Study Drug|Period 1||16
7630319|NCT02300259|18787355|P3|STARTED|Period 1||16
7630320|NCT02300259|18787356|P2|STARTED|Period 1||16
7630321|NCT02300259|18787357|P1|STARTED|Period 1||16
7630322|NCT02300129|18787386|P4|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
7630323|NCT02300129|18787387|P3|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
7630324|NCT02300129|18787388|P2|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
7630325|NCT02300129|18787389|P1|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
7630326|NCT02300129|18787386|P4|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
7630327|NCT02300129|18787387|P3|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7
7630328|NCT02300129|18787388|P2|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4
7630329|NCT02300129|18787389|P1|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
7630330|NCT02300129|18787386|P4|STARTED|Period 2 Treatment 2 (2 Weeks)||10
7630331|NCT02300129|18787387|P3|STARTED|Period 2 Treatment 2 (2 Weeks)||7
7630332|NCT02300129|18787388|P2|STARTED|Period 2 Treatment 2 (2 Weeks)||4
7630333|NCT02300129|18787389|P1|STARTED|Period 2 Treatment 2 (2 Weeks)||10
7630334|NCT02300129|18787386|P4|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
7630335|NCT02300129|18787387|P3|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
7630336|NCT02300129|18787388|P2|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
7630337|NCT02300129|18787389|P1|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
7630338|NCT02300129|18787386|P4|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
7630339|NCT02300129|18787387|P3|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7
7630340|NCT02300129|18787388|P2|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4
7630341|NCT02300129|18787389|P1|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
7630342|NCT02300129|18787386|P4|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11
7630343|NCT02300129|18787387|P3|STARTED|Period 2 Treatment 1 (2 Weeks)||7
7630344|NCT02300129|18787388|P2|STARTED|Period 2 Treatment 1 (2 Weeks)||4
7630345|NCT02300129|18787389|P1|STARTED|Period 2 Treatment 1 (2 Weeks)||11
7630346|NCT02300129|18787386|P4|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
7630347|NCT02300129|18787387|P3|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
7630348|NCT02300129|18787388|P2|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
7630349|NCT02300129|18787389|P1|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
7630350|NCT02300129|18787386|P4|COMPLETED|Period 1 Session 3 (Day 5)||11
7630351|NCT02300129|18787387|P3|COMPLETED|Period 1 Session 3 (Day 5)||7
7630352|NCT02300129|18787388|P2|COMPLETED|Period 1 Session 3 (Day 5)||4
7630353|NCT02300129|18787389|P1|COMPLETED|Period 1 Session 3 (Day 5)||11
7630354|NCT02300129|18787386|P4|STARTED|Period 1 Session 3 (Day 5)||11
7630355|NCT02300129|18787387|P3|STARTED|Period 1 Session 3 (Day 5)||7
7630356|NCT02300129|18787388|P2|STARTED|Period 1 Session 3 (Day 5)||4
7630357|NCT02300129|18787389|P1|STARTED|Period 1 Session 3 (Day 5)||11
7630358|NCT02300129|18787386|P4|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
7630359|NCT02300129|18787387|P3|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
7630360|NCT02300129|18787388|P2|NOT COMPLETED|Period 1 Session 2 (Day 3)||1
7630361|NCT02300129|18787389|P1|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
7630362|NCT02300129|18787386|P4|COMPLETED|Period 1 Session 2 (Day 3)||11
7630363|NCT02300129|18787387|P3|COMPLETED|Period 1 Session 2 (Day 3)||7
7630364|NCT02300129|18787388|P2|COMPLETED|Period 1 Session 2 (Day 3)||4
7630365|NCT02300129|18787389|P1|COMPLETED|Period 1 Session 2 (Day 3)||11
7630366|NCT02300129|18787386|P4|STARTED|Period 1 Session 2 (Day 3)||11
7630367|NCT02300129|18787387|P3|STARTED|Period 1 Session 2 (Day 3)||7
7630368|NCT02300129|18787388|P2|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5
7630369|NCT02300129|18787389|P1|STARTED|Period 1 Session 2 (Day 3)||11
7630370|NCT02300129|18787386|P4|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
7630371|NCT02300129|18787387|P3|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
7630372|NCT02300129|18787388|P2|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
7630373|NCT02300129|18787389|P1|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
7630374|NCT02300129|18787386|P4|COMPLETED|Period 1 Session 1 (Day 1)||11
7630375|NCT02300129|18787387|P3|COMPLETED|Period 1 Session 1 (Day 1)||7
7630376|NCT02300129|18787388|P2|COMPLETED|Period 1 Session 1 (Day 1)||5
7630377|NCT02300129|18787389|P1|COMPLETED|Period 1 Session 1 (Day 1)||11
7630378|NCT02300129|18787386|P4|STARTED|Period 1 Session 1 (Day 1)||11
7630379|NCT02300129|18787387|P3|STARTED|Period 1 Session 1 (Day 1)||7
7630380|NCT02300129|18787388|P2|STARTED|Period 1 Session 1 (Day 1)||5
7630381|NCT02300129|18787389|P1|STARTED|Period 1 Session 1 (Day 1)||11
7630382|NCT02300103|18787399|P1|NOT COMPLETED|Overall Study||6
7630383|NCT02300103|18787399|P1|COMPLETED|Overall Study||63
7630384|NCT02300103|18787399|P1|STARTED|Overall Study||69
7630385|NCT02300077|18787411|P3|NOT COMPLETED|Overall Study||0
7630386|NCT02300077|18787412|P2|NOT COMPLETED|Overall Study||0
7630387|NCT02300077|18787413|P1|NOT COMPLETED|Overall Study||0
7630388|NCT02300077|18787411|P3|COMPLETED|Overall Study||21
7630389|NCT02300077|18787412|P2|COMPLETED|Overall Study||18
7630390|NCT02300077|18787413|P1|COMPLETED|Overall Study||21
7630391|NCT02300077|18787411|P3|STARTED|Overall Study||21
7630392|NCT02300077|18787412|P2|STARTED|Overall Study||18
7630393|NCT02300077|18787413|P1|STARTED|Overall Study||21
7630394|NCT02300025|18787434|P4|NOT COMPLETED|Overall Study||0
7630395|NCT02300025|18787435|P3|NOT COMPLETED|Overall Study||0
7630396|NCT02300025|18787436|P2|NOT COMPLETED|Overall Study||0
7630397|NCT02300025|18787437|P1|NOT COMPLETED|Overall Study||0
7630398|NCT02300025|18787434|P4|COMPLETED|Overall Study||6
7630399|NCT02300025|18787435|P3|COMPLETED|Overall Study||6
7630400|NCT02300025|18787436|P2|COMPLETED|Overall Study||6
7630401|NCT02300025|18787437|P1|COMPLETED|Overall Study||10
7630402|NCT02300025|18787434|P4|STARTED|Overall Study||6
7630403|NCT02300025|18787435|P3|STARTED|Overall Study||6
7630404|NCT02300025|18787436|P2|STARTED|Overall Study||6
7630405|NCT02300025|18787437|P1|STARTED|Overall Study||10
7630406|NCT02299934|18787479|P1|NOT COMPLETED|Overall Study||13
7630407|NCT02299934|18787479|P1|COMPLETED|Overall Study||0
7630408|NCT02299934|18787479|P1|STARTED|Overall Study||13
7630409|NCT02299869|18787494|P4|NOT COMPLETED|Overall Study||0
7630410|NCT02299869|18787495|P3|NOT COMPLETED|Overall Study||0
7630411|NCT02299869|18787496|P2|NOT COMPLETED|Overall Study||0
7630412|NCT02299869|18787497|P1|NOT COMPLETED|Overall Study||0
7630413|NCT02299869|18787494|P4|COMPLETED|Overall Study||10
7630414|NCT02299869|18787495|P3|COMPLETED|Overall Study||10
7630415|NCT02299869|18787496|P2|COMPLETED|Overall Study||10
7630416|NCT02299869|18787497|P1|COMPLETED|Overall Study||10
7630417|NCT02299869|18787494|P4|STARTED|Overall Study||10
7630418|NCT02299869|18787495|P3|STARTED|Overall Study||10
7630419|NCT02299869|18787496|P2|STARTED|Overall Study||10
7630420|NCT02299869|18787497|P1|STARTED|Overall Study||10
7630421|NCT02299791|18787522|P2|NOT COMPLETED|Overall Study||0
7630422|NCT02299791|18787523|P1|NOT COMPLETED|Overall Study||0
7630423|NCT02299791|18787522|P2|COMPLETED|Overall Study||2803
7630424|NCT02299791|18787523|P1|COMPLETED|Overall Study||2053
7630425|NCT02299791|18787522|P2|STARTED|Overall Study||2803
7630426|NCT02299791|18787523|P1|STARTED|Overall Study||2053
7630427|NCT02299635|18787529|P1|NOT COMPLETED|Overall Study||19
7630428|NCT02299635|18787529|P1|COMPLETED|Overall Study||0
7630429|NCT02299635|18787529|P1|STARTED|Overall Study||19
7630430|NCT02299570|18787551|P3|NOT COMPLETED|Overall Study||2
7630431|NCT02299570|18787552|P2|NOT COMPLETED|Overall Study||0
7630432|NCT02299570|18787553|P1|NOT COMPLETED|Overall Study||4
7630433|NCT02299570|18787551|P3|COMPLETED|Overall Study||42
7630434|NCT02299570|18787552|P2|COMPLETED|Overall Study||44
7630435|NCT02299570|18787553|P1|COMPLETED|Overall Study||41
7630436|NCT02299570|18787551|P3|STARTED|Overall Study||44
7630437|NCT02299570|18787552|P2|STARTED|Overall Study||44
7630438|NCT02299570|18787553|P1|STARTED|Overall Study||45
7630439|NCT02299479|18787561|P1|NOT COMPLETED|Overall Study||2
7630440|NCT02299479|18787561|P1|COMPLETED|Overall Study||18
7630441|NCT02299479|18787561|P1|STARTED|Overall Study||20
7630442|NCT02299427|18787569|P2|NOT COMPLETED|Overall Study||3
7630443|NCT02299427|18787570|P1|NOT COMPLETED|Overall Study||23
7630444|NCT02299427|18787569|P2|COMPLETED|Overall Study||31
7630445|NCT02299427|18787570|P1|COMPLETED|Overall Study||12
7630446|NCT02299427|18787569|P2|STARTED|Overall Study||34
7630447|NCT02299427|18787570|P1|STARTED|Overall Study||35
7630448|NCT02299388|18787580|P2|NOT COMPLETED|Overall Study||1
7630449|NCT02299388|18787581|P1|NOT COMPLETED|Overall Study||0
7630450|NCT02299388|18787580|P2|COMPLETED|Overall Study||4
7630451|NCT02299388|18787581|P1|COMPLETED|Overall Study||6
7630452|NCT02299388|18787580|P2|STARTED|Overall Study||5
7630453|NCT02299388|18787581|P1|STARTED|Overall Study||6
7630454|NCT02299375|18787591|P2|NOT COMPLETED|Overall Study||80
7630455|NCT02299375|18787592|P1|NOT COMPLETED|Overall Study||80
7630456|NCT02299375|18787591|P2|COMPLETED|Overall Study||10
7630457|NCT02299375|18787592|P1|COMPLETED|Overall Study||14
7630458|NCT02299375|18787591|P2|STARTED|Overall Study||90
7630459|NCT02299375|18787592|P1|STARTED|Overall Study||94
7630460|NCT02299349|18787642|P2|NOT COMPLETED|Overall Study||0
7630461|NCT02299349|18787643|P1|NOT COMPLETED|Overall Study||0
7630462|NCT02299349|18787642|P2|COMPLETED|Overall Study||35
7630463|NCT02299349|18787643|P1|COMPLETED|Overall Study||35
7630464|NCT02299349|18787642|P2|STARTED|Overall Study||35
7630465|NCT02299349|18787643|P1|STARTED|Overall Study||35
7630466|NCT02299336|18787651|P1|NOT COMPLETED|Overall Study||14
7630467|NCT02299336|18787651|P1|COMPLETED|Overall Study||46
7630468|NCT02299336|18787651|P1|STARTED|Overall Study||60
7630469|NCT02299297|18787667|P1|NOT COMPLETED|Overall Study||1
7630470|NCT02299297|18787667|P1|COMPLETED|Overall Study||11
7630471|NCT02299297|18787667|P1|STARTED|Overall Study||12
7630472|NCT02299258|18787677|P2|NOT COMPLETED|Overall Study||1
7630473|NCT02299258|18787678|P1|NOT COMPLETED|Overall Study||1
7630474|NCT02299258|18787677|P2|COMPLETED|Overall Study||30
7630475|NCT02299258|18787678|P1|COMPLETED|Overall Study||31
7630476|NCT02299258|18787677|P2|STARTED|Overall Study||31
7630477|NCT02299258|18787678|P1|STARTED|Overall Study||32
7630478|NCT02299206|18787686|P1|NOT COMPLETED|Overall Study||2
7630479|NCT02299206|18787686|P1|COMPLETED|Overall Study||2
7630480|NCT02299206|18787686|P1|STARTED|Overall Study||4
7630481|NCT02299167|18787694|P1|NOT COMPLETED|Overall Study||11
7630482|NCT02299167|18787694|P1|COMPLETED|Overall Study||24
7630483|NCT02299167|18787694|P1|Adverse Effects|Overall Study||24
7630484|NCT02299167|18787694|P1|Success Rate|Overall Study||24
7630485|NCT02299167|18787694|P1|Dural Puncture|Overall Study||24
7630486|NCT02299167|18787694|P1|STARTED|Overall Study||35
7630487|NCT02299089|18787706|P4|NOT COMPLETED|Overall Study||0
7630488|NCT02299089|18787707|P3|NOT COMPLETED|Overall Study||0
7630489|NCT02299089|18787708|P2|NOT COMPLETED|Overall Study||0
7630490|NCT02299089|18787709|P1|NOT COMPLETED|Overall Study||0
7630491|NCT02299089|18787706|P4|COMPLETED|Overall Study||4
7630492|NCT02299089|18787707|P3|COMPLETED|Overall Study||1
7630493|NCT02299089|18787708|P2|COMPLETED|Overall Study||4
7630494|NCT02299089|18787709|P1|COMPLETED|Overall Study||3
7630495|NCT02299089|18787706|P4|STARTED|Overall Study||4
7630496|NCT02299089|18787707|P3|STARTED|Overall Study||1
7630497|NCT02299089|18787708|P2|STARTED|Overall Study||4
7630498|NCT02299089|18787709|P1|STARTED|Overall Study||3
7630499|NCT02299076|18787755|P2|NOT COMPLETED|Overall Study||14
7630500|NCT02299076|18787756|P1|NOT COMPLETED|Overall Study||20
7630501|NCT02299076|18787755|P2|COMPLETED|Overall Study||212
7630502|NCT02299076|18787756|P1|COMPLETED|Overall Study||210
7630503|NCT02299076|18787755|P2|STARTED|Overall Study||226
7630504|NCT02299076|18787756|P1|STARTED|Overall Study||230
7630505|NCT02299050|18787764|P1|NOT COMPLETED|Overall Study||8
7630506|NCT02299050|18787764|P1|COMPLETED|Overall Study||15
7630507|NCT02299050|18787764|P1|STARTED|Overall Study||23
7630508|NCT02298946|18787777|P2|NOT COMPLETED|Overall Study||1
7630509|NCT02298946|18787778|P1|NOT COMPLETED|Overall Study||4
7630510|NCT02298946|18787777|P2|COMPLETED|Overall Study||8
7630511|NCT02298946|18787778|P1|COMPLETED|Overall Study||4
7630512|NCT02298946|18787777|P2|STARTED|Overall Study||9
7630513|NCT02298946|18787778|P1|STARTED|Overall Study||8
7630514|NCT02298933|18787802|P1|NOT COMPLETED|Overall Study||0
7630515|NCT02298933|18787802|P1|COMPLETED|Overall Study||10
7630516|NCT02298933|18787802|P1|STARTED|Overall Study||10
7630517|NCT02298868|18787806|P1|NOT COMPLETED|Overall Study||3
7630518|NCT02298868|18787806|P1|COMPLETED|Overall Study||7
7630519|NCT02298868|18787806|P1|STARTED|Overall Study||10
7630520|NCT02298842|18787820|P2|NOT COMPLETED|Second Platelet Donation (Day 6-8)||6
7630521|NCT02298842|18787821|P1|NOT COMPLETED|Second Platelet Donation (Day 6-8)||8
7630522|NCT02298842|18787820|P2|COMPLETED|Second Platelet Donation (Day 6-8)||30
7630523|NCT02298842|18787821|P1|COMPLETED|Second Platelet Donation (Day 6-8)||30
7630524|NCT02298842|18787820|P2|STARTED|Second Platelet Donation (Day 6-8)||36
7630525|NCT02298842|18787821|P1|STARTED|Second Platelet Donation (Day 6-8)||38
7630526|NCT02298842|18787820|P2|NOT COMPLETED|First Platelet Donation (Day 0)||5
7630527|NCT02298842|18787821|P1|NOT COMPLETED|First Platelet Donation (Day 0)||6
7630528|NCT02298842|18787820|P2|COMPLETED|First Platelet Donation (Day 0)||36
7630529|NCT02298842|18787821|P1|COMPLETED|First Platelet Donation (Day 0)||38
7630530|NCT02298842|18787820|P2|STARTED|First Platelet Donation (Day 0)||41
7630531|NCT02298842|18787821|P1|STARTED|First Platelet Donation (Day 0)||44
7630532|NCT02298803|18787847|P1|NOT COMPLETED|Overall Study||0
7630533|NCT02298803|18787847|P1|COMPLETED|Overall Study||30
7630534|NCT02298803|18787847|P1|STARTED|Overall Study||30
7630535|NCT02298361|18787859|P3|NOT COMPLETED|Overall Study||0
7630536|NCT02298361|18787860|P2|NOT COMPLETED|Overall Study||0
7630537|NCT02298361|18787861|P1|NOT COMPLETED|Overall Study||0
7630538|NCT02298361|18787859|P3|COMPLETED|Overall Study||12227
7630539|NCT02298361|18787860|P2|COMPLETED|Overall Study||12784
7630540|NCT02298361|18787861|P1|COMPLETED|Overall Study||2240
7630541|NCT02298361|18787859|P3|STARTED|Overall Study||12227
7630542|NCT02298361|18787860|P2|STARTED|Overall Study||12784
7630543|NCT02298361|18787861|P1|STARTED|Overall Study||2240
7630544|NCT02298322|18787875|P1|NOT COMPLETED|Overall Study||0
7630545|NCT02298322|18787875|P1|COMPLETED|Overall Study||60
7630546|NCT02298322|18787875|P1|STARTED|Overall Study||60
7630547|NCT02298192|18787884|P2|NOT COMPLETED|Overall Study||6
7630548|NCT02298192|18787885|P1|NOT COMPLETED|Overall Study||19
7630549|NCT02298192|18787884|P2|COMPLETED|Overall Study||204
7630550|NCT02298192|18787885|P1|COMPLETED|Overall Study||191
7630551|NCT02298192|18787884|P2|STARTED|Overall Study||210
7630552|NCT02298192|18787885|P1|STARTED|Overall Study||210
7630553|NCT02298179|18787909|P12|NOT COMPLETED|Overall Study||0
7630554|NCT02298179|18787910|P11|NOT COMPLETED|Overall Study||0
7630555|NCT02298179|18787911|P10|NOT COMPLETED|Overall Study||0
7630556|NCT02298179|18787912|P9|NOT COMPLETED|Overall Study||0
7630557|NCT02298179|18787913|P8|NOT COMPLETED|Overall Study||1
7630558|NCT02298179|18787914|P7|NOT COMPLETED|Overall Study||0
7630559|NCT02298179|18787915|P6|NOT COMPLETED|Overall Study||0
7630560|NCT02298179|18787916|P5|NOT COMPLETED|Overall Study||0
7630561|NCT02298179|18787917|P4|NOT COMPLETED|Overall Study||0
7630562|NCT02298179|18787918|P3|NOT COMPLETED|Overall Study||1
7630563|NCT02298179|18787919|P2|NOT COMPLETED|Overall Study||0
7630564|NCT02298179|18787920|P1|NOT COMPLETED|Overall Study||0
7630565|NCT02298179|18787909|P12|COMPLETED|Overall Study||24
7630566|NCT02298179|18787910|P11|COMPLETED|Overall Study||24
7630567|NCT02298179|18787911|P10|COMPLETED|Overall Study||24
7630568|NCT02298179|18787912|P9|COMPLETED|Overall Study||24
7630569|NCT02298179|18787913|P8|COMPLETED|Overall Study||23
7630570|NCT02298179|18787914|P7|COMPLETED|Overall Study||24
7630571|NCT02298179|18787915|P6|COMPLETED|Overall Study||24
7630572|NCT02298179|18787916|P5|COMPLETED|Overall Study||24
7630573|NCT02298179|18787917|P4|COMPLETED|Overall Study||24
7630574|NCT02298179|18787918|P3|COMPLETED|Overall Study||23
7630575|NCT02298179|18787919|P2|COMPLETED|Overall Study||24
7630576|NCT02298179|18787920|P1|COMPLETED|Overall Study||24
7630577|NCT02298179|18787909|P12|STARTED|Overall Study||24
7630578|NCT02298179|18787910|P11|STARTED|Overall Study||24
7630579|NCT02298179|18787911|P10|STARTED|Overall Study||24
7630580|NCT02298179|18787912|P9|STARTED|Overall Study||24
7630581|NCT02298179|18787913|P8|STARTED|Overall Study||24
7630582|NCT02298179|18787914|P7|STARTED|Overall Study||24
7630583|NCT02298179|18787915|P6|STARTED|Overall Study||24
7630584|NCT02298179|18787916|P5|STARTED|Overall Study||24
7630585|NCT02298179|18787917|P4|STARTED|Overall Study||24
7630586|NCT02298179|18787918|P3|STARTED|Overall Study||24
7630587|NCT02298179|18787919|P2|STARTED|Overall Study||24
7630588|NCT02298179|18787920|P1|STARTED|Overall Study||24
7630589|NCT02297841|18788162|P1|NOT COMPLETED|Overall Study||8
7630590|NCT02297841|18788162|P1|COMPLETED|Overall Study||201
7630591|NCT02297841|18788162|P1|Challenge Phase|Overall Study||201
7630592|NCT02297841|18788162|P1|Induction Phase|Overall Study||209
7630593|NCT02297841|18788162|P1|STARTED|Overall Study||209
7630594|NCT02297815|18788168|P2|NOT COMPLETED|Overall Study||140
7630595|NCT02297815|18788169|P1|NOT COMPLETED|Overall Study||236
7630596|NCT02297815|18788168|P2|COMPLETED|Overall Study||728
7630597|NCT02297815|18788169|P1|COMPLETED|Overall Study||1368
7630598|NCT02297815|18788168|P2|14-20 Day Interview|Overall Study||728
7630599|NCT02297815|18788169|P1|14-20 Day Interview|Overall Study||1368
7630600|NCT02297815|18788168|P2|5-10 Day Interview|Overall Study||868
7630601|NCT02297815|18788169|P1|5-10 Day Interview|Overall Study||1604
7630602|NCT02297815|18788168|P2|STARTED|Overall Study||868
7630603|NCT02297815|18788169|P1|STARTED|Overall Study||1604
7630604|NCT02297516|18788187|P2|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||1
7630605|NCT02297516|18788188|P1|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||0
7630606|NCT02297516|18788187|P2|COMPLETED|Combination Treatment Phase (up to 18 m)||30
7630607|NCT02297516|18788188|P1|COMPLETED|Combination Treatment Phase (up to 18 m)||31
7630608|NCT02297516|18788187|P2|STARTED|Combination Treatment Phase (up to 18 m)||31
7630609|NCT02297516|18788188|P1|STARTED|Combination Treatment Phase (up to 18 m)||31
7630610|NCT02297516|18788187|P2|NOT COMPLETED|Single Treatment Phase (6 Months)||2
7630611|NCT02297516|18788188|P1|NOT COMPLETED|Single Treatment Phase (6 Months)||1
7630612|NCT02297516|18788187|P2|COMPLETED|Single Treatment Phase (6 Months)||31
7630613|NCT02297516|18788188|P1|COMPLETED|Single Treatment Phase (6 Months)||31
7630614|NCT02297516|18788187|P2|STARTED|Single Treatment Phase (6 Months)||33
7630615|NCT02297516|18788188|P1|STARTED|Single Treatment Phase (6 Months)||32
7630616|NCT02297503|18788209|P2|NOT COMPLETED|Overall Study||4
7630617|NCT02297503|18788210|P1|NOT COMPLETED|Overall Study||2
7630618|NCT02297503|18788209|P2|COMPLETED|Overall Study||27
7630619|NCT02297503|18788210|P1|COMPLETED|Overall Study||28
7630620|NCT02297503|18788209|P2|Second Combined Treatment|Overall Study||28
7630621|NCT02297503|18788210|P1|Second Combined Treatment|Overall Study||28
7630622|NCT02297503|18788209|P2|First Combined Treatment|Overall Study||28
7630623|NCT02297503|18788210|P1|First Combined Treatment|Overall Study||28
7630624|NCT02297503|18788209|P2|Initial Single Treatment|Overall Study||31
7630625|NCT02297503|18788210|P1|Initial Single Treatment|Overall Study||29
7630626|NCT02297503|18788209|P2|STARTED|Overall Study||31
7630627|NCT02297503|18788210|P1|STARTED|Overall Study||30
7630628|NCT02297412|18788237|P2|NOT COMPLETED|Overall Study||1
7630629|NCT02297412|18788238|P1|NOT COMPLETED|Overall Study||1
7630630|NCT02297412|18788237|P2|COMPLETED|Overall Study||23
7630631|NCT02297412|18788238|P1|COMPLETED|Overall Study||22
7630632|NCT02297412|18788237|P2|STARTED|Overall Study||24
7630633|NCT02297412|18788238|P1|STARTED|Overall Study||23
7630634|NCT02297308|18788248|P1|NOT COMPLETED|Overall Study||0
7630635|NCT02297308|18788248|P1|COMPLETED|Overall Study||90
7630636|NCT02297308|18788248|P1|STARTED|Overall Study||90
7630637|NCT02297230|18788257|P4|NOT COMPLETED|Overall Study||0
7630638|NCT02297230|18788258|P3|NOT COMPLETED|Overall Study||0
7630639|NCT02297230|18788259|P2|NOT COMPLETED|Overall Study||0
7630640|NCT02297230|18788260|P1|NOT COMPLETED|Overall Study||0
7630641|NCT02297230|18788257|P4|COMPLETED|Overall Study||11
7630642|NCT02297230|18788258|P3|COMPLETED|Overall Study||11
7630643|NCT02297230|18788259|P2|COMPLETED|Overall Study||11
7630644|NCT02297230|18788260|P1|COMPLETED|Overall Study||11
7630645|NCT02297230|18788257|P4|STARTED|Overall Study||11
7630646|NCT02297230|18788258|P3|STARTED|Overall Study||11
7630647|NCT02297230|18788259|P2|STARTED|Overall Study||11
7630648|NCT02297230|18788260|P1|STARTED|Overall Study||11
7630649|NCT02297100|18788284|P2|NOT COMPLETED|Overall Study||0
7630650|NCT02297100|18788285|P1|NOT COMPLETED|Overall Study||0
7630651|NCT02297100|18788284|P2|COMPLETED|Overall Study||14
7630652|NCT02297100|18788285|P1|COMPLETED|Overall Study||13
7630653|NCT02297100|18788284|P2|STARTED|Overall Study||14
7630654|NCT02297100|18788285|P1|STARTED|Overall Study||13
7630655|NCT02296931|18788299|P2|NOT COMPLETED|Overall Study||2
7630656|NCT02296931|18788300|P1|NOT COMPLETED|Overall Study||0
7630657|NCT02296931|18788299|P2|COMPLETED|Overall Study||22
7630658|NCT02296931|18788300|P1|COMPLETED|Overall Study||10
7630659|NCT02296931|18788299|P2|STARTED|Overall Study||24
7630660|NCT02296931|18788300|P1|STARTED|Overall Study||10
7630661|NCT02296892|18788309|P3|NOT COMPLETED|Overall Study||5
7630662|NCT02296892|18788310|P2|NOT COMPLETED|Overall Study||4
7630663|NCT02296892|18788311|P1|NOT COMPLETED|Overall Study||12
7630664|NCT02296892|18788309|P3|COMPLETED|Overall Study||68
7630665|NCT02296892|18788310|P2|COMPLETED|Overall Study||59
7630666|NCT02296892|18788311|P1|COMPLETED|Overall Study||298
7630667|NCT02296892|18788309|P3|Complete Trial Treatment Period|Overall Study||69
7630668|NCT02296892|18788310|P2|Complete Trial Treatment Period|Overall Study||59
7630669|NCT02296892|18788311|P1|Complete Trial Treatment Period|Overall Study||303
7630670|NCT02296892|18788309|P3|Safety Population|Overall Study||69
7630671|NCT02296892|18788310|P2|Safety Population|Overall Study||59
7630672|NCT02296892|18788311|P1|Safety Population|Overall Study||303
7630673|NCT02296892|18788309|P3|STARTED|Overall Study||73
7630674|NCT02296892|18788310|P2|STARTED|Overall Study||63
7630675|NCT02296892|18788311|P1|STARTED|Overall Study||310
7630676|NCT02296853|18788330|P2|NOT COMPLETED|Overall Study||0
7630677|NCT02296853|18788331|P1|NOT COMPLETED|Overall Study||0
7630678|NCT02296853|18788330|P2|COMPLETED|Overall Study||10
7630679|NCT02296853|18788331|P1|COMPLETED|Overall Study||10
7630680|NCT02296853|18788330|P2|STARTED|Overall Study||10
7630681|NCT02296853|18788331|P1|STARTED|Overall Study||10
7630682|NCT02296840|18788347|P2|NOT COMPLETED|Overall Study||19
7630683|NCT02296840|18788348|P1|NOT COMPLETED|Overall Study||9
7630684|NCT02296840|18788347|P2|COMPLETED|Overall Study||8
7630685|NCT02296840|18788348|P1|COMPLETED|Overall Study||9
7630686|NCT02296840|18788347|P2|STARTED|Overall Study||27
7630687|NCT02296840|18788348|P1|STARTED|Overall Study||18
7630688|NCT02296775|18788359|P3|NOT COMPLETED|Recovery and Follow-up||4
7630689|NCT02296775|18788360|P2|NOT COMPLETED|Recovery and Follow-up||5
7630690|NCT02296775|18788361|P1|NOT COMPLETED|Recovery and Follow-up||5
7630691|NCT02296775|18788359|P3|COMPLETED|Recovery and Follow-up||79
7630692|NCT02296775|18788360|P2|COMPLETED|Recovery and Follow-up||79
7630693|NCT02296775|18788361|P1|COMPLETED|Recovery and Follow-up||82
7630694|NCT02296775|18788359|P3|STARTED|Recovery and Follow-up||83
7630695|NCT02296775|18788360|P2|STARTED|Recovery and Follow-up||84
7630696|NCT02296775|18788361|P1|STARTED|Recovery and Follow-up||87
7630697|NCT02296775|18788359|P3|NOT COMPLETED|Treatment and Evaluation||10
7630698|NCT02296775|18788360|P2|NOT COMPLETED|Treatment and Evaluation||8
7630699|NCT02296775|18788361|P1|NOT COMPLETED|Treatment and Evaluation||4
7630700|NCT02296775|18788359|P3|COMPLETED|Treatment and Evaluation||83
7630701|NCT02296775|18788360|P2|COMPLETED|Treatment and Evaluation||84
7630702|NCT02296775|18788361|P1|COMPLETED|Treatment and Evaluation||87
7630703|NCT02296775|18788359|P3|STARTED|Treatment and Evaluation||93
7630704|NCT02296775|18788360|P2|STARTED|Treatment and Evaluation||92
7630705|NCT02296775|18788361|P1|STARTED|Treatment and Evaluation||91
7630706|NCT02296606|18788429|P1|NOT COMPLETED|Overall Study||0
7630707|NCT02296606|18788429|P1|COMPLETED|Overall Study||127
7630708|NCT02296606|18788429|P1|STARTED|Overall Study||127
7630709|NCT02296502|18788437|P4|NOT COMPLETED|Overall Study||0
7630710|NCT02296502|18788438|P3|NOT COMPLETED|Overall Study||0
7630711|NCT02296502|18788439|P2|NOT COMPLETED|Overall Study||0
7630712|NCT02296502|18788440|P1|NOT COMPLETED|Overall Study||0
7630713|NCT02296502|18788437|P4|COMPLETED|Overall Study||160
7630714|NCT02296502|18788438|P3|COMPLETED|Overall Study||30
7630715|NCT02296502|18788439|P2|COMPLETED|Overall Study||1
7630716|NCT02296502|18788440|P1|COMPLETED|Overall Study||248
7630717|NCT02296502|18788437|P4|STARTED|Overall Study||160
7630718|NCT02296502|18788438|P3|STARTED|Overall Study||30
7630719|NCT02296502|18788439|P2|STARTED|Overall Study||1
7630720|NCT02296502|18788440|P1|STARTED|Overall Study||248
7630721|NCT02296476|18788456|P3|NOT COMPLETED|Overall Study||2
7630722|NCT02296476|18788457|P2|NOT COMPLETED|Overall Study||4
7630723|NCT02296476|18788458|P1|NOT COMPLETED|Overall Study||6
7630724|NCT02296476|18788456|P3|COMPLETED|Overall Study||0
7630725|NCT02296476|18788457|P2|COMPLETED|Overall Study||0
7630726|NCT02296476|18788458|P1|COMPLETED|Overall Study||0
7630727|NCT02296476|18788456|P3|STARTED|Overall Study||2
7630728|NCT02296476|18788457|P2|STARTED|Overall Study||4
7630729|NCT02296476|18788458|P1|STARTED|Overall Study||6
7630730|NCT02296424|18788513|P4|NOT COMPLETED|Part 2||0
7630731|NCT02296424|18788514|P3|NOT COMPLETED|Part 2||3
7630732|NCT02296424|18788515|P2|NOT COMPLETED|Part 2||0
7630733|NCT02296424|18788516|P1|NOT COMPLETED|Part 2||0
7630734|NCT02296424|18788513|P4|COMPLETED|Part 2||37
7630735|NCT02296424|18788514|P3|COMPLETED|Part 2||35
7630736|NCT02296424|18788515|P2|COMPLETED|Part 2||0
7630737|NCT02296424|18788516|P1|COMPLETED|Part 2||0
7630738|NCT02296424|18788513|P4|STARTED|Part 2||37
7630739|NCT02296424|18788514|P3|STARTED|Part 2||38
7630740|NCT02296424|18788515|P2|STARTED|Part 2||0
7630741|NCT02296424|18788516|P1|STARTED|Part 2||0
7630742|NCT02296424|18788513|P4|NOT COMPLETED|Part 1||0
7630743|NCT02296424|18788514|P3|NOT COMPLETED|Part 1||0
7630744|NCT02296424|18788515|P2|NOT COMPLETED|Part 1||33
7630745|NCT02296424|18788516|P1|NOT COMPLETED|Part 1||23
7630746|NCT02296424|18788513|P4|COMPLETED|Part 1||0
7630747|NCT02296424|18788514|P3|COMPLETED|Part 1||0
7630748|NCT02296424|18788515|P2|COMPLETED|Part 1||65
7630749|NCT02296424|18788516|P1|COMPLETED|Part 1||61
7630750|NCT02296424|18788513|P4|STARTED|Part 1||0
7630751|NCT02296424|18788514|P3|STARTED|Part 1||0
7630752|NCT02296424|18788515|P2|STARTED|Part 1||98
7630753|NCT02296424|18788516|P1|STARTED|Part 1|16 patients immediately went into Part II|84
7630754|NCT02296346|18788529|P2|NOT COMPLETED|Overall Study||6
7630755|NCT02296346|18788530|P1|NOT COMPLETED|Overall Study||5
7630756|NCT02296346|18788529|P2|COMPLETED|Overall Study||0
7630757|NCT02296346|18788530|P1|COMPLETED|Overall Study||2
7630758|NCT02296346|18788529|P2|STARTED|Overall Study||6
7630759|NCT02296346|18788530|P1|STARTED|Overall Study||7
7630760|NCT02296320|18788541|P3|NOT COMPLETED|Overall Study||37
7630761|NCT02296320|18788542|P2|NOT COMPLETED|Overall Study||5
7630762|NCT02296320|18788543|P1|NOT COMPLETED|Overall Study||35
7630763|NCT02296320|18788541|P3|COMPLETED|Overall Study||59
7630764|NCT02296320|18788542|P2|COMPLETED|Overall Study||10
7630765|NCT02296320|18788543|P1|COMPLETED|Overall Study||67
7630766|NCT02296320|18788541|P3|Treated|Overall Study||96
7630767|NCT02296320|18788542|P2|Treated|Overall Study||15
7630768|NCT02296320|18788543|P1|Treated|Overall Study||100
7630769|NCT02296320|18788541|P3|STARTED|Overall Study||96
7630770|NCT02296320|18788542|P2|STARTED|Overall Study||15
7630771|NCT02296320|18788543|P1|STARTED|Overall Study||102
7630772|NCT02296242|18788582|P5|NOT COMPLETED|Overall Study||21
7630773|NCT02296242|18788583|P4|NOT COMPLETED|Overall Study||14
7630774|NCT02296242|18788584|P3|NOT COMPLETED|Overall Study||7
7630775|NCT02296242|18788585|P2|NOT COMPLETED|Overall Study||6
7630776|NCT02296242|18788586|P1|NOT COMPLETED|Overall Study||5
7630777|NCT02296242|18788582|P5|COMPLETED|Overall Study||0
7630778|NCT02296242|18788583|P4|COMPLETED|Overall Study||0
7630779|NCT02296242|18788584|P3|COMPLETED|Overall Study||0
7630780|NCT02296242|18788585|P2|COMPLETED|Overall Study||0
7630781|NCT02296242|18788586|P1|COMPLETED|Overall Study||0
7630782|NCT02296242|18788582|P5|STARTED|Overall Study||21
7630783|NCT02296242|18788583|P4|STARTED|Overall Study||14
7630784|NCT02296242|18788584|P3|STARTED|Overall Study||7
7630785|NCT02296242|18788585|P2|STARTED|Overall Study||6
7630786|NCT02296242|18788586|P1|STARTED|Overall Study||5
7630787|NCT02296190|18788614|P6|NOT COMPLETED|Overall Study||0
7630788|NCT02296190|18788615|P5|NOT COMPLETED|Overall Study||16
7630789|NCT02296190|18788616|P4|NOT COMPLETED|Overall Study||23
7630790|NCT02296190|18788617|P3|NOT COMPLETED|Overall Study||12
7630791|NCT02296190|18788618|P2|NOT COMPLETED|Overall Study||21
7630792|NCT02296190|18788619|P1|NOT COMPLETED|Overall Study||14
7630793|NCT02296190|18788614|P6|COMPLETED|Overall Study||9
7630794|NCT02296190|18788615|P5|COMPLETED|Overall Study||20
7630795|NCT02296190|18788616|P4|COMPLETED|Overall Study||20
7630796|NCT02296190|18788617|P3|COMPLETED|Overall Study||23
7630797|NCT02296190|18788618|P2|COMPLETED|Overall Study||20
7630798|NCT02296190|18788619|P1|COMPLETED|Overall Study||21
7630799|NCT02296190|18788614|P6|STARTED|Overall Study||9
7630800|NCT02296190|18788615|P5|STARTED|Overall Study||36
7630801|NCT02296190|18788616|P4|STARTED|Overall Study||43
7630802|NCT02296190|18788617|P3|STARTED|Overall Study||35
7630803|NCT02296190|18788618|P2|STARTED|Overall Study||41
7630804|NCT02296190|18788619|P1|STARTED|Overall Study||35
7630805|NCT02296164|18788632|P1|NOT COMPLETED|Overall Study||110
7630806|NCT02296164|18788632|P1|COMPLETED|Overall Study||188
7630807|NCT02296164|18788632|P1|STARTED|Overall Study|2 patients not eligible as were not on Valchlor at time of study start|298
7630808|NCT02296138|18788638|P2|NOT COMPLETED|Overall Study||500
7630809|NCT02296138|18788639|P1|NOT COMPLETED|Overall Study||661
7630810|NCT02296138|18788638|P2|COMPLETED|Overall Study||3451
7630811|NCT02296138|18788639|P1|COMPLETED|Overall Study||3291
7630812|NCT02296138|18788638|P2|Treated|Overall Study||3939
7630813|NCT02296138|18788639|P1|Treated|Overall Study||3941
7630814|NCT02296138|18788638|P2|STARTED|Overall Study||3951
7630815|NCT02296138|18788639|P1|STARTED|Overall Study||3952
7630816|NCT02296125|18788655|P4|NOT COMPLETED|Overall Study||62
7630817|NCT02296125|18788656|P3|NOT COMPLETED|Overall Study||56
7630818|NCT02296125|18788657|P2|NOT COMPLETED|Overall Study||264
7630819|NCT02296125|18788658|P1|NOT COMPLETED|Overall Study||218
7630820|NCT02296125|18788655|P4|COMPLETED|Overall Study||3
7630821|NCT02296125|18788656|P3|COMPLETED|Overall Study||15
7630822|NCT02296125|18788657|P2|COMPLETED|Overall Study||13
7630823|NCT02296125|18788658|P1|COMPLETED|Overall Study||61
7630824|NCT02296125|18788655|P4|STARTED|Overall Study|There were 7 participants who were in both the Global and China Extension SoC EGFR-TKI Arm.|65
7630825|NCT02296125|18788656|P3|STARTED|Overall Study|There were 12 participants who were in both the Global and China Extension Osimertinib Arm.|71
7630826|NCT02296125|18788657|P2|STARTED|Overall Study|183 participant received gefitinib and 93 participants received erlotinib.|277
7630827|NCT02296125|18788658|P1|STARTED|Overall Study||279
7630828|NCT02296112|18788710|P1|NOT COMPLETED|Overall Study||9
7630829|NCT02296112|18788710|P1|COMPLETED|Overall Study||0
7630830|NCT02296112|18788710|P1|STARTED|Overall Study||9
7630831|NCT02296099|18788725|P2|NOT COMPLETED|Overall Study||2
7630832|NCT02296099|18788726|P1|NOT COMPLETED|Overall Study||3
7630833|NCT02296099|18788725|P2|COMPLETED|Overall Study||55
7630834|NCT02296099|18788726|P1|COMPLETED|Overall Study||54
7630835|NCT02296099|18788725|P2|STARTED|Overall Study||57
7630836|NCT02296099|18788726|P1|STARTED|Overall Study||57
7630837|NCT02295995|18788752|P2|NOT COMPLETED|Overall Study||1
7630838|NCT02295995|18788753|P1|NOT COMPLETED|Overall Study||5
7630839|NCT02295995|18788752|P2|COMPLETED|Overall Study||17
7630840|NCT02295995|18788753|P1|COMPLETED|Overall Study||31
7630841|NCT02295995|18788752|P2|STARTED|Overall Study||18
7630842|NCT02295995|18788753|P1|STARTED|Overall Study||36
7630843|NCT02295774|18788764|P1|NOT COMPLETED|Overall Study||3
7630844|NCT02295774|18788764|P1|COMPLETED|Overall Study||10
7630845|NCT02295774|18788764|P1|STARTED|Overall Study||13
7630846|NCT02295735|18788771|P2|NOT COMPLETED|Overall Study||27
7630847|NCT02295735|18788772|P1|NOT COMPLETED|Overall Study||26
7630848|NCT02295735|18788771|P2|COMPLETED|Overall Study||210
7630849|NCT02295735|18788772|P1|COMPLETED|Overall Study||212
7630850|NCT02295735|18788771|P2|STARTED|Overall Study||237
7630851|NCT02295735|18788772|P1|STARTED|Overall Study||238
7630852|NCT02295644|18788804|P4|NOT COMPLETED|Overall Study||2
7630853|NCT02295644|18788805|P3|NOT COMPLETED|Overall Study||1
7630854|NCT02295644|18788806|P2|NOT COMPLETED|Overall Study||0
7630855|NCT02295644|18788807|P1|NOT COMPLETED|Overall Study||0
7630856|NCT02295644|18788804|P4|COMPLETED|Overall Study||5
7630857|NCT02295644|18788805|P3|COMPLETED|Overall Study||6
7630858|NCT02295644|18788806|P2|COMPLETED|Overall Study||7
7630859|NCT02295644|18788807|P1|COMPLETED|Overall Study||7
7630860|NCT02295644|18788804|P4|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
7630861|NCT02295644|18788805|P3|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
7630862|NCT02295644|18788806|P2|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
7630863|NCT02295644|18788807|P1|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
7630864|NCT02295553|18788829|P4|NOT COMPLETED|Overall Study||1
7630865|NCT02295553|18788830|P3|NOT COMPLETED|Overall Study||1
7630866|NCT02295553|18788831|P2|NOT COMPLETED|Overall Study||0
7630867|NCT02295553|18788832|P1|NOT COMPLETED|Overall Study||0
7630868|NCT02295553|18788829|P4|COMPLETED|Overall Study||13
7630869|NCT02295553|18788830|P3|COMPLETED|Overall Study||13
7630870|NCT02295553|18788831|P2|COMPLETED|Overall Study||14
7630871|NCT02295553|18788832|P1|COMPLETED|Overall Study||14
7630872|NCT02295553|18788829|P4|STARTED|Overall Study||14
7630873|NCT02295553|18788830|P3|STARTED|Overall Study||14
7630874|NCT02295553|18788831|P2|STARTED|Overall Study||14
7630875|NCT02295553|18788832|P1|STARTED|Overall Study||14
7630876|NCT02295280|18788856|P2|NOT COMPLETED|Overall Study||1
7630877|NCT02295280|18788857|P1|NOT COMPLETED|Overall Study||0
7630878|NCT02295280|18788856|P2|COMPLETED|Overall Study||34
7630879|NCT02295280|18788857|P1|COMPLETED|Overall Study||35
7630880|NCT02295280|18788856|P2|STARTED|Overall Study||35
7630881|NCT02295280|18788857|P1|STARTED|Overall Study||35
7630882|NCT02295020|18788865|P2|NOT COMPLETED|Overall Study||3
7630883|NCT02295020|18788866|P1|NOT COMPLETED|Overall Study||3
7630884|NCT02295020|18788865|P2|COMPLETED|Overall Study||17
7630885|NCT02295020|18788866|P1|COMPLETED|Overall Study||17
7630886|NCT02295020|18788865|P2|STARTED|Overall Study||20
7630887|NCT02295020|18788866|P1|STARTED|Overall Study||20
7630888|NCT02294981|18788896|P1|NOT COMPLETED|Overall Study||1
7630889|NCT02294981|18788896|P1|COMPLETED|Overall Study||3
7630890|NCT02294981|18788896|P1|STARTED|Overall Study||4
7630891|NCT02294786|18788902|P2|NOT COMPLETED|Overall Study||14
7630892|NCT02294786|18788903|P1|NOT COMPLETED|Overall Study||11
7630893|NCT02294786|18788902|P2|COMPLETED|Overall Study||18
7630894|NCT02294786|18788903|P1|COMPLETED|Overall Study||19
7630895|NCT02294786|18788902|P2|ITT Population|Overall Study||32
7630896|NCT02294786|18788903|P1|ITT Population|Overall Study||30
7630897|NCT02294786|18788902|P2|Safety Population|Overall Study|The subject was included in the No-Octreotide arm.|33
7630898|NCT02294786|18788903|P1|Safety Population|Overall Study|One subject randomized to Octreotide received only 0.1 mg dose.|29
7630899|NCT02294786|18788902|P2|STARTED|Overall Study||32
7630900|NCT02294786|18788903|P1|STARTED|Overall Study||30
7630901|NCT02294773|18788950|P2|NOT COMPLETED|Overall Study||2
7630902|NCT02294773|18788951|P1|NOT COMPLETED|Overall Study||0
7630903|NCT02294773|18788950|P2|COMPLETED|Overall Study||4
7630904|NCT02294773|18788951|P1|COMPLETED|Overall Study||7
7630905|NCT02294773|18788950|P2|STARTED|Overall Study||6
7630906|NCT02294773|18788951|P1|STARTED|Overall Study||7
7630907|NCT02294734|18788967|P2|NOT COMPLETED|Overall Study||8
7630908|NCT02294734|18788968|P1|NOT COMPLETED|Overall Study||14
7630909|NCT02294734|18788967|P2|COMPLETED|Overall Study||55
7630910|NCT02294734|18788968|P1|COMPLETED|Overall Study||49
7630911|NCT02294734|18788967|P2|STARTED|Overall Study||63
7630912|NCT02294734|18788968|P1|STARTED|Overall Study||63
7630913|NCT02294682|18789020|P2|NOT COMPLETED|Overall Study||0
7630914|NCT02294682|18789021|P1|NOT COMPLETED|Overall Study||1
7630915|NCT02294682|18789020|P2|COMPLETED|Overall Study||53
7630916|NCT02294682|18789021|P1|COMPLETED|Overall Study||52
7630917|NCT02294682|18789020|P2|STARTED|Overall Study||53
7630918|NCT02294682|18789021|P1|STARTED|Overall Study||53
7630919|NCT02294604|18789064|P3|NOT COMPLETED|Overall Study||0
7630920|NCT02294604|18789065|P2|NOT COMPLETED|Overall Study||3
7630921|NCT02294604|18789066|P1|NOT COMPLETED|Overall Study||1
7630922|NCT02294604|18789064|P3|COMPLETED|Overall Study||80
7630923|NCT02294604|18789065|P2|COMPLETED|Overall Study||77
7630924|NCT02294604|18789066|P1|COMPLETED|Overall Study||79
7630925|NCT02294604|18789064|P3|STARTED|Overall Study||80
7630926|NCT02294604|18789065|P2|STARTED|Overall Study||80
7630927|NCT02294604|18789066|P1|STARTED|Overall Study||80
7630928|NCT02294474|18789085|P2|NOT COMPLETED|Overall Study||22
7630929|NCT02294474|18789086|P1|NOT COMPLETED|Overall Study||25
7630930|NCT02294474|18789085|P2|COMPLETED|Overall Study||230
7630931|NCT02294474|18789086|P1|COMPLETED|Overall Study||228
7630932|NCT02294474|18789085|P2|STARTED|Overall Study||252
7630933|NCT02294474|18789086|P1|STARTED|Overall Study||253
7630934|NCT02294461|18789110|P2|NOT COMPLETED|Overall Study||131
7630935|NCT02294461|18789111|P1|NOT COMPLETED|Overall Study||62
7630936|NCT02294461|18789110|P2|COMPLETED|Overall Study||59
7630937|NCT02294461|18789111|P1|COMPLETED|Overall Study|Participants still receiving treatment as of 20 Sept 2016. Data cutoff date: 20 Sep 2015/20 Jan 2016|136
7630938|NCT02294461|18789110|P2|Treated/Received Study Drug|Overall Study||190
7630939|NCT02294461|18789111|P1|Treated/Received Study Drug|Overall Study||198
7630940|NCT02294461|18789110|P2|STARTED|Overall Study||190
7630941|NCT02294461|18789111|P1|STARTED|Overall Study||198
7630942|NCT02294396|18789167|P4|NOT COMPLETED|Overall Study||37
7630943|NCT02294396|18789168|P3|NOT COMPLETED|Overall Study||35
7630944|NCT02294396|18789169|P2|NOT COMPLETED|Overall Study||33
7630945|NCT02294396|18789170|P1|NOT COMPLETED|Overall Study||40
7630946|NCT02294396|18789167|P4|COMPLETED|Overall Study||123
7630947|NCT02294396|18789168|P3|COMPLETED|Overall Study||126
7630948|NCT02294396|18789169|P2|COMPLETED|Overall Study||128
7630949|NCT02294396|18789170|P1|COMPLETED|Overall Study||127
7630950|NCT02294396|18789167|P4|STARTED|Overall Study||160
7630951|NCT02294396|18789168|P3|STARTED|Overall Study||161
7630952|NCT02294396|18789169|P2|STARTED|Overall Study||161
7630953|NCT02294396|18789170|P1|STARTED|Overall Study||167
7630954|NCT02294318|18789242|P2|NOT COMPLETED|Overall Study||2
7630955|NCT02294318|18789243|P1|NOT COMPLETED|Overall Study||3
7630956|NCT02294318|18789242|P2|COMPLETED|Overall Study||21
7630957|NCT02294318|18789243|P1|COMPLETED|Overall Study||21
7630958|NCT02294318|18789242|P2|STARTED|Overall Study||23
7630959|NCT02294318|18789243|P1|STARTED|Overall Study||24
7630960|NCT02294253|18789255|P1|NOT COMPLETED|Overall Study||15
7630961|NCT02294253|18789255|P1|COMPLETED|Overall Study||15
7630962|NCT02294253|18789255|P1|STARTED|Overall Study||30
7630963|NCT02294227|18789262|P3|NOT COMPLETED|Overall Study||19
7630964|NCT02294227|18789263|P2|NOT COMPLETED|Overall Study||25
7630965|NCT02294227|18789264|P1|NOT COMPLETED|Overall Study||25
7630966|NCT02294227|18789262|P3|COMPLETED|Overall Study||95
7630967|NCT02294227|18789263|P2|COMPLETED|Overall Study||88
7630968|NCT02294227|18789264|P1|COMPLETED|Overall Study||89
7630969|NCT02294227|18789262|P3|STARTED|Overall Study||114
7630970|NCT02294227|18789263|P2|STARTED|Overall Study||113
7630971|NCT02294227|18789264|P1|STARTED|Overall Study||114
7630972|NCT02294175|18789290|P2|NOT COMPLETED|Overall Study||6
7630973|NCT02294175|18789291|P1|NOT COMPLETED|Overall Study||5
7630974|NCT02294175|18789290|P2|COMPLETED|Overall Study||16
7630975|NCT02294175|18789291|P1|COMPLETED|Overall Study||18
7630976|NCT02294175|18789290|P2|STARTED|Overall Study||22
7630977|NCT02294175|18789291|P1|STARTED|Overall Study||23
7630978|NCT02294058|18789318|P3|NOT COMPLETED|Overall Study||29
7630979|NCT02294058|18789319|P2|NOT COMPLETED|Overall Study||26
7630980|NCT02294058|18789320|P1|NOT COMPLETED|Overall Study||36
7630981|NCT02294058|18789318|P3|COMPLETED|Overall Study||418
7630982|NCT02294058|18789319|P2|COMPLETED|Overall Study||425
7630983|NCT02294058|18789320|P1|COMPLETED|Overall Study||412
7630984|NCT02294058|18789318|P3|Safety Population|Overall Study||448
7630985|NCT02294058|18789319|P2|Safety Population|Overall Study||453
7630986|NCT02294058|18789320|P1|Safety Population|Overall Study||445
7630987|NCT02294058|18789318|P3|STARTED|Overall Study||447
7630988|NCT02294058|18789319|P2|STARTED|Overall Study||451
7630989|NCT02294058|18789320|P1|STARTED|Overall Study||448
7630990|NCT02294019|18789358|P1|NOT COMPLETED|Overall Study||103
7630991|NCT02294019|18789358|P1|COMPLETED|Overall Study||635
7630992|NCT02294019|18789358|P1|STARTED|Overall Study||738
7630993|NCT02293902|18789366|P5|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||6
7630994|NCT02293902|18789367|P4|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||1
7630995|NCT02293902|18789368|P3|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||2
7630996|NCT02293902|18789369|P2|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||8
7630997|NCT02293902|18789370|P1|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
7630998|NCT02293902|18789366|P5|COMPLETED|Single-Blind Period (Week 25 to Week 52)|18 rescued and 13 not rescued completed.|31
7630999|NCT02293902|18789367|P4|COMPLETED|Single-Blind Period (Week 25 to Week 52)|20 rescued and 13 not rescued completed.|33
7631000|NCT02293902|18789368|P3|COMPLETED|Single-Blind Period (Week 25 to Week 52)|8 rescued and 60 not rescued completed.|68
7631001|NCT02293902|18789369|P2|COMPLETED|Single-Blind Period (Week 25 to Week 52)|5 rescued and 61 not rescued completed.|66
7631002|NCT02293902|18789370|P1|COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
7631003|NCT02293902|18789366|P5|STARTED|Single-Blind Period (Week 25 to Week 52)|15 participants not rescued were switched and 22 rescued continued open label treatment.|37
7631004|NCT02293902|18789367|P4|STARTED|Single-Blind Period (Week 25 to Week 52)|14 participants not rescued were switched and 20 rescued continued open label treatment.|34
7631005|NCT02293902|18789368|P3|STARTED|Single-Blind Period (Week 25 to Week 52)|62 participants not rescued continued same treatment and 8 rescued continued open label treatment.|70
7631006|NCT02293902|18789369|P2|STARTED|Single-Blind Period (Week 25 to Week 52)|68 participants not rescued continued same treatment and 6 rescued continued open label treatment.|74
7631007|NCT02293902|18789370|P1|STARTED|Single-Blind Period (Week 25 to Week 52)||0
7631008|NCT02293902|18789366|P5|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
7631009|NCT02293902|18789367|P4|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
7631010|NCT02293902|18789368|P3|NOT COMPLETED|Double-Blind Period (Up to Week 24)||10
7631011|NCT02293902|18789369|P2|NOT COMPLETED|Double-Blind Period (Up to Week 24)||7
7631012|NCT02293902|18789370|P1|NOT COMPLETED|Double-Blind Period (Up to Week 24)||11
7631013|NCT02293902|18789366|P5|COMPLETED|Double-Blind Period (Up to Week 24)||0
7631014|NCT02293902|18789367|P4|COMPLETED|Double-Blind Period (Up to Week 24)||0
7631015|NCT02293902|18789368|P3|COMPLETED|Double-Blind Period (Up to Week 24)|8 rescued and 62 not rescued completed.|70
7631016|NCT02293902|18789369|P2|COMPLETED|Double-Blind Period (Up to Week 24)|6 rescued and 68 not rescued completed.|74
7631017|NCT02293902|18789370|P1|COMPLETED|Double-Blind Period (Up to Week 24)|42 rescued and 29 not rescued completed.|71
7631018|NCT02293902|18789366|P5|Rescued|Double-Blind Period (Up to Week 24)||0
7631019|NCT02293902|18789367|P4|Rescued|Double-Blind Period (Up to Week 24)||0
7631020|NCT02293902|18789368|P3|Rescued|Double-Blind Period (Up to Week 24)||8
7631021|NCT02293902|18789369|P2|Rescued|Double-Blind Period (Up to Week 24)||6
7631022|NCT02293902|18789370|P1|Rescued|Double-Blind Period (Up to Week 24)||44
7631023|NCT02293902|18789366|P5|Treated|Double-Blind Period (Up to Week 24)||0
7631024|NCT02293902|18789367|P4|Treated|Double-Blind Period (Up to Week 24)||0
7631025|NCT02293902|18789368|P3|Treated|Double-Blind Period (Up to Week 24)||80
7631026|NCT02293902|18789369|P2|Treated|Double-Blind Period (Up to Week 24)||81
7631027|NCT02293902|18789370|P1|Treated|Double-Blind Period (Up to Week 24)||81
7631028|NCT02293902|18789366|P5|STARTED|Double-Blind Period (Up to Week 24)||0
7631029|NCT02293902|18789367|P4|STARTED|Double-Blind Period (Up to Week 24)||0
7631030|NCT02293902|18789368|P3|STARTED|Double-Blind Period (Up to Week 24)||80
7631031|NCT02293902|18789369|P2|STARTED|Double-Blind Period (Up to Week 24)||81
7631032|NCT02293902|18789370|P1|STARTED|Double-Blind Period (Up to Week 24)||82
7631033|NCT02293863|18789432|P3|NOT COMPLETED|Overall Study||9
7631034|NCT02293863|18789433|P2|NOT COMPLETED|Overall Study||13
7631035|NCT02293863|18789434|P1|NOT COMPLETED|Overall Study||9
7631036|NCT02293863|18789432|P3|COMPLETED|Overall Study||38
7631037|NCT02293863|18789433|P2|COMPLETED|Overall Study||42
7631038|NCT02293863|18789434|P1|COMPLETED|Overall Study||47
7631039|NCT02293863|18789432|P3|STARTED|Overall Study||47
7631040|NCT02293863|18789433|P2|STARTED|Overall Study||55
7631041|NCT02293863|18789434|P1|STARTED|Overall Study||56
7631042|NCT02293798|18789497|P1|NOT COMPLETED|Overall Study||0
7631043|NCT02293798|18789497|P1|COMPLETED|Overall Study|2 units of SERI Mesh placed in each patient|13
7631044|NCT02293798|18789497|P1|STARTED|Overall Study|2 units of SERI Mesh placed in each patient|13
7631045|NCT02293538|18789503|P2|NOT COMPLETED|Overall Study||2
7631046|NCT02293538|18789504|P1|NOT COMPLETED|Overall Study||1
7631047|NCT02293538|18789503|P2|COMPLETED|Overall Study||69
7631048|NCT02293538|18789504|P1|COMPLETED|Overall Study||72
7631049|NCT02293538|18789503|P2|STARTED|Overall Study||71
7631050|NCT02293538|18789504|P1|STARTED|Overall Study||73
7631051|NCT02293512|18789521|P4|NOT COMPLETED|Overall Study||2
7631052|NCT02293512|18789522|P3|NOT COMPLETED|Overall Study||3
7631053|NCT02293512|18789523|P2|NOT COMPLETED|Overall Study||6
7631054|NCT02293512|18789524|P1|NOT COMPLETED|Overall Study||4
7631055|NCT02293512|18789521|P4|COMPLETED|Overall Study||8
7631056|NCT02293512|18789522|P3|COMPLETED|Overall Study||7
7631057|NCT02293512|18789523|P2|COMPLETED|Overall Study||4
7631058|NCT02293512|18789524|P1|COMPLETED|Overall Study||6
7631059|NCT02293512|18789521|P4|STARTED|Overall Study||10
7631060|NCT02293512|18789522|P3|STARTED|Overall Study||10
7631061|NCT02293512|18789523|P2|STARTED|Overall Study||10
7631062|NCT02293512|18789524|P1|STARTED|Overall Study||10
7631063|NCT02293460|18789534|P1|NOT COMPLETED|Overall Study||6
7631064|NCT02293460|18789534|P1|COMPLETED|Overall Study||37
7631065|NCT02293460|18789534|P1|STARTED|Overall Study||43
7631066|NCT02293395|18789540|P2|NOT COMPLETED|Overall Study||7
7631067|NCT02293395|18789541|P1|NOT COMPLETED|Overall Study||9
7631068|NCT02293395|18789540|P2|COMPLETED|Overall Study||1511
7631069|NCT02293395|18789541|P1|COMPLETED|Overall Study||1510
7631070|NCT02293395|18789540|P2|Treated|Overall Study||1506
7631071|NCT02293395|18789541|P1|Treated|Overall Study||1510
7631072|NCT02293395|18789540|P2|STARTED|Overall Study||1518
7631073|NCT02293395|18789541|P1|STARTED|Overall Study||1519
7631074|NCT02293044|18789547|P1|NOT COMPLETED|Overall Study||0
7631075|NCT02293044|18789547|P1|COMPLETED|Overall Study||15
7631076|NCT02293044|18789547|P1|STARTED|Overall Study||15
7631077|NCT02292927|18789554|P2|NOT COMPLETED|Overall Study||7
7631078|NCT02292927|18789555|P1|NOT COMPLETED|Overall Study||13
7631079|NCT02292927|18789554|P2|COMPLETED|Overall Study||5
7631080|NCT02292927|18789555|P1|COMPLETED|Overall Study||0
7631081|NCT02292927|18789554|P2|STARTED|Overall Study||12
7631082|NCT02292927|18789555|P1|STARTED|Overall Study||13
7631083|NCT02292849|18789572|P3|NOT COMPLETED|Overall Study||2
7631084|NCT02292849|18789573|P2|NOT COMPLETED|Overall Study||2
7631085|NCT02292849|18789574|P1|NOT COMPLETED|Overall Study||4
7631086|NCT02292849|18789572|P3|COMPLETED|Overall Study||8
7631087|NCT02292849|18789573|P2|COMPLETED|Overall Study||6
7631088|NCT02292849|18789574|P1|COMPLETED|Overall Study||7
7631089|NCT02292849|18789572|P3|STARTED|Overall Study||10
7631090|NCT02292849|18789573|P2|STARTED|Overall Study||8
7631091|NCT02292849|18789574|P1|STARTED|Overall Study||11
7631092|NCT02292784|18789585|P3|NOT COMPLETED|Overall Study||21
7631093|NCT02292784|18789586|P2|NOT COMPLETED|Overall Study||20
7631094|NCT02292784|18789587|P1|NOT COMPLETED|Overall Study||1
7631095|NCT02292784|18789585|P3|COMPLETED|Overall Study||28
7631096|NCT02292784|18789586|P2|COMPLETED|Overall Study||24
7631097|NCT02292784|18789587|P1|COMPLETED|Overall Study||4
7631098|NCT02292784|18789585|P3|STARTED|Overall Study||49
7631099|NCT02292784|18789586|P2|STARTED|Overall Study||44
7631100|NCT02292784|18789587|P1|STARTED|Overall Study||5
7631101|NCT02292771|18789654|P2|NOT COMPLETED|Overall Study||2
7631102|NCT02292771|18789655|P1|NOT COMPLETED|Overall Study||4
7631103|NCT02292771|18789654|P2|COMPLETED|Overall Study||48
7631104|NCT02292771|18789655|P1|COMPLETED|Overall Study||43
7631105|NCT02292771|18789654|P2|STARTED|Overall Study||50
7631106|NCT02292771|18789655|P1|STARTED|Overall Study||47
7631107|NCT02292758|18789747|P2|NOT COMPLETED|Overall Study||0
7631108|NCT02292758|18789748|P1|NOT COMPLETED|Overall Study||0
7631109|NCT02292758|18789747|P2|COMPLETED|Overall Study||17
7631110|NCT02292758|18789748|P1|COMPLETED|Overall Study||19
7631111|NCT02292758|18789747|P2|STARTED|Overall Study||17
7631112|NCT02292758|18789748|P1|STARTED|Overall Study||19
7631113|NCT02292719|18789778|P6|NOT COMPLETED|Overall Study||0
7631114|NCT02292719|18789779|P5|NOT COMPLETED|Overall Study||1
7631115|NCT02292719|18789780|P4|NOT COMPLETED|Overall Study||1
7631116|NCT02292719|18789781|P3|NOT COMPLETED|Overall Study||1
7631117|NCT02292719|18789782|P2|NOT COMPLETED|Overall Study||0
7631118|NCT02292719|18789783|P1|NOT COMPLETED|Overall Study||0
7631119|NCT02292719|18789778|P6|COMPLETED|Overall Study||10
7631120|NCT02292719|18789779|P5|COMPLETED|Overall Study||20
7631121|NCT02292719|18789780|P4|COMPLETED|Overall Study||8
7631122|NCT02292719|18789781|P3|COMPLETED|Overall Study||9
7631123|NCT02292719|18789782|P2|COMPLETED|Overall Study||11
7631124|NCT02292719|18789783|P1|COMPLETED|Overall Study||9
7631125|NCT02292719|18789778|P6|STARTED|Overall Study||10
7631126|NCT02292719|18789779|P5|STARTED|Overall Study||21
7631127|NCT02292719|18789780|P4|STARTED|Overall Study||9
7631128|NCT02292719|18789781|P3|STARTED|Overall Study||10
7631129|NCT02292719|18789782|P2|STARTED|Overall Study||11
7631130|NCT02292719|18789783|P1|STARTED|Overall Study||9
7631131|NCT02292537|18789811|P2|NOT COMPLETED|Overall Study||0
7631132|NCT02292537|18789812|P1|NOT COMPLETED|Overall Study||0
7631133|NCT02292537|18789811|P2|COMPLETED|Overall Study||84
7631134|NCT02292537|18789812|P1|COMPLETED|Overall Study||42
7631135|NCT02292537|18789811|P2|Completed Treatment|Overall Study|1 participant completed the study but did not complete treatments due to early study closure|83
7631136|NCT02292537|18789812|P1|Completed Treatment|Overall Study||42
7631137|NCT02292537|18789811|P2|STARTED|Overall Study||84
7631138|NCT02292537|18789812|P1|STARTED|Overall Study||42
7631139|NCT02292446|18789846|P1|NOT COMPLETED|Overall Study||20
7631140|NCT02292446|18789846|P1|COMPLETED|Overall Study||141
7631141|NCT02292446|18789846|P1|STARTED|Overall Study||161
7631142|NCT02292433|18789862|P3|NOT COMPLETED|Third Intervention Period (7 Days)||0
7631143|NCT02292433|18789863|P2|NOT COMPLETED|Third Intervention Period (7 Days)||0
7631144|NCT02292433|18789864|P1|NOT COMPLETED|Third Intervention Period (7 Days)||0
7631145|NCT02292433|18789862|P3|COMPLETED|Third Intervention Period (7 Days)||4
7631146|NCT02292433|18789863|P2|COMPLETED|Third Intervention Period (7 Days)||4
7631147|NCT02292433|18789864|P1|COMPLETED|Third Intervention Period (7 Days)||4
7631148|NCT02292433|18789862|P3|STARTED|Third Intervention Period (7 Days)||4
7631149|NCT02292433|18789863|P2|STARTED|Third Intervention Period (7 Days)||4
7631150|NCT02292433|18789864|P1|STARTED|Third Intervention Period (7 Days)||4
7631151|NCT02292433|18789862|P3|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
7631152|NCT02292433|18789863|P2|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
7631153|NCT02292433|18789864|P1|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
7631154|NCT02292433|18789862|P3|COMPLETED|Second Washout Period (7 to 14 Days)||4
7631155|NCT02292433|18789863|P2|COMPLETED|Second Washout Period (7 to 14 Days)||4
7631156|NCT02292433|18789864|P1|COMPLETED|Second Washout Period (7 to 14 Days)||4
7631157|NCT02292433|18789862|P3|STARTED|Second Washout Period (7 to 14 Days)||4
7631158|NCT02292433|18789863|P2|STARTED|Second Washout Period (7 to 14 Days)||4
7631159|NCT02292433|18789864|P1|STARTED|Second Washout Period (7 to 14 Days)||4
7631160|NCT02292433|18789862|P3|NOT COMPLETED|Second Intervention Period (7 Days)||0
7631161|NCT02292433|18789863|P2|NOT COMPLETED|Second Intervention Period (7 Days)||0
7631162|NCT02292433|18789864|P1|NOT COMPLETED|Second Intervention Period (7 Days)||0
7631163|NCT02292433|18789862|P3|COMPLETED|Second Intervention Period (7 Days)||4
7631164|NCT02292433|18789863|P2|COMPLETED|Second Intervention Period (7 Days)||4
7631165|NCT02292433|18789864|P1|COMPLETED|Second Intervention Period (7 Days)||4
7631166|NCT02292433|18789862|P3|STARTED|Second Intervention Period (7 Days)||4
7631167|NCT02292433|18789863|P2|STARTED|Second Intervention Period (7 Days)||4
7631168|NCT02292433|18789864|P1|STARTED|Second Intervention Period (7 Days)||4
7631169|NCT02292433|18789862|P3|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
7631170|NCT02292433|18789863|P2|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
7631171|NCT02292433|18789864|P1|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
7631172|NCT02292433|18789862|P3|COMPLETED|First Washout Period (7 to 14 Days)||4
7631173|NCT02292433|18789863|P2|COMPLETED|First Washout Period (7 to 14 Days)||4
7631174|NCT02292433|18789864|P1|COMPLETED|First Washout Period (7 to 14 Days)||4
7631175|NCT02292433|18789862|P3|STARTED|First Washout Period (7 to 14 Days)||4
7631176|NCT02292433|18789863|P2|STARTED|First Washout Period (7 to 14 Days)||4
7631177|NCT02292433|18789864|P1|STARTED|First Washout Period (7 to 14 Days)||4
7631178|NCT02292433|18789862|P3|NOT COMPLETED|First Intervention Period (7 Days)||0
7631179|NCT02292433|18789863|P2|NOT COMPLETED|First Intervention Period (7 Days)||0
7631180|NCT02292433|18789864|P1|NOT COMPLETED|First Intervention Period (7 Days)||0
7631181|NCT02292433|18789862|P3|COMPLETED|First Intervention Period (7 Days)||4
7631182|NCT02292433|18789863|P2|COMPLETED|First Intervention Period (7 Days)||4
7631183|NCT02292433|18789864|P1|COMPLETED|First Intervention Period (7 Days)||4
7631184|NCT02292433|18789862|P3|STARTED|First Intervention Period (7 Days)||4
7631185|NCT02292433|18789863|P2|STARTED|First Intervention Period (7 Days)||4
7631186|NCT02292433|18789864|P1|STARTED|First Intervention Period (7 Days)||4
7631187|NCT02292212|18789935|P1|NOT COMPLETED|Post-ViE Phase||0
7631188|NCT02292212|18789935|P1|COMPLETED|Post-ViE Phase||14
7631189|NCT02292212|18789935|P1|STARTED|Post-ViE Phase||14
7631190|NCT02292212|18789935|P1|NOT COMPLETED|ViE Phase||3
7631191|NCT02292212|18789935|P1|COMPLETED|ViE Phase||14
7631192|NCT02292212|18789935|P1|STARTED|ViE Phase||17
7631193|NCT02292212|18789935|P1|NOT COMPLETED|Pre-ViE Phase||0
7631194|NCT02292212|18789935|P1|COMPLETED|Pre-ViE Phase||17
7631195|NCT02292212|18789935|P1|STARTED|Pre-ViE Phase||17
7631196|NCT02292186|18789967|P1|NOT COMPLETED|Overall Study||18
7631197|NCT02292186|18789967|P1|COMPLETED|Overall Study||7
7631198|NCT02292186|18789967|P1|STARTED|Overall Study||25
7631199|NCT02292082|18789977|P2|NOT COMPLETED|Overall Study||0
7631200|NCT02292082|18789978|P1|NOT COMPLETED|Overall Study||0
7631201|NCT02292082|18789977|P2|COMPLETED|Overall Study||55
7631202|NCT02292082|18789978|P1|COMPLETED|Overall Study||56
7631203|NCT02292082|18789977|P2|STARTED|Overall Study||55
7631204|NCT02292082|18789978|P1|STARTED|Overall Study||56
7631205|NCT02291913|18790004|P1|NOT COMPLETED|Overall Study||48
7631206|NCT02291913|18790004|P1|COMPLETED|Overall Study||0
7631207|NCT02291913|18790004|P1|STARTED|Overall Study||48
7631208|NCT02291861|18790017|P4|NOT COMPLETED|Overall Study||10
7631209|NCT02291861|18790018|P3|NOT COMPLETED|Overall Study||9
7631210|NCT02291861|18790019|P2|NOT COMPLETED|Overall Study||8
7631211|NCT02291861|18790020|P1|NOT COMPLETED|Overall Study||7
7631212|NCT02291861|18790017|P4|COMPLETED|Overall Study||65
7631213|NCT02291861|18790018|P3|COMPLETED|Overall Study||65
7631214|NCT02291861|18790019|P2|COMPLETED|Overall Study||67
7631215|NCT02291861|18790020|P1|COMPLETED|Overall Study||67
7631216|NCT02291861|18790017|P4|Modified Intent to Treat Pop (mITT)|Overall Study||55
7631217|NCT02291861|18790018|P3|Modified Intent to Treat Pop (mITT)|Overall Study||49
7631218|NCT02291861|18790019|P2|Modified Intent to Treat Pop (mITT)|Overall Study||60
7631219|NCT02291861|18790020|P1|Modified Intent to Treat Pop (mITT)|Overall Study||58
7631220|NCT02291861|18790017|P4|Safety Population|Overall Study||74
7631221|NCT02291861|18790018|P3|Safety Population|Overall Study||73
7631222|NCT02291861|18790019|P2|Safety Population|Overall Study||74
7631223|NCT02291861|18790020|P1|Safety Population|Overall Study||72
7631224|NCT02291861|18790017|P4|STARTED|Overall Study||75
7631225|NCT02291861|18790018|P3|STARTED|Overall Study||74
7631226|NCT02291861|18790019|P2|STARTED|Overall Study||75
7631227|NCT02291861|18790020|P1|STARTED|Overall Study||74
7631228|NCT02291718|18790061|P3|NOT COMPLETED|Overall Study||0
7631229|NCT02291718|18790062|P2|NOT COMPLETED|Overall Study||0
7631230|NCT02291718|18790063|P1|NOT COMPLETED|Overall Study||0
7631231|NCT02291718|18790061|P3|COMPLETED|Overall Study||50
7631232|NCT02291718|18790062|P2|COMPLETED|Overall Study||50
7631233|NCT02291718|18790063|P1|COMPLETED|Overall Study||50
7631234|NCT02291718|18790061|P3|STARTED|Overall Study||50
7631235|NCT02291718|18790062|P2|STARTED|Overall Study||50
7631236|NCT02291718|18790063|P1|STARTED|Overall Study||50
7631237|NCT02291679|18790083|P3|NOT COMPLETED|Overall Study||59
7631238|NCT02291679|18790084|P2|NOT COMPLETED|Overall Study||42
7631239|NCT02291679|18790085|P1|NOT COMPLETED|Overall Study||44
7631240|NCT02291679|18790083|P3|COMPLETED|Overall Study||352
7631241|NCT02291679|18790084|P2|COMPLETED|Overall Study||369
7631242|NCT02291679|18790085|P1|COMPLETED|Overall Study||357
7631243|NCT02291679|18790083|P3|STARTED|Overall Study||411
7631244|NCT02291679|18790084|P2|STARTED|Overall Study||411
7631245|NCT02291679|18790085|P1|STARTED|Overall Study||401
7631246|NCT02291549|18790116|P2|NOT COMPLETED|Overall Study||1
7631247|NCT02291549|18790117|P1|NOT COMPLETED|Overall Study||1
7631248|NCT02291549|18790116|P2|COMPLETED|Overall Study||98
7631249|NCT02291549|18790117|P1|COMPLETED|Overall Study||200
7631250|NCT02291549|18790116|P2|STARTED|Overall Study||99
7631251|NCT02291549|18790117|P1|STARTED|Overall Study||201
7631252|NCT02291510|18790139|P4|NOT COMPLETED|Overall Study||1
7631253|NCT02291510|18790140|P3|NOT COMPLETED|Overall Study||0
7631254|NCT02291510|18790141|P2|NOT COMPLETED|Overall Study||0
7631255|NCT02291510|18790142|P1|NOT COMPLETED|Overall Study||0
7631256|NCT02291510|18790139|P4|COMPLETED|Overall Study||4
7631257|NCT02291510|18790140|P3|COMPLETED|Overall Study||5
7631258|NCT02291510|18790141|P2|COMPLETED|Overall Study||5
7631259|NCT02291510|18790142|P1|COMPLETED|Overall Study||5
7631260|NCT02291510|18790139|P4|Completed Treatment D|Overall Study||5
7631261|NCT02291510|18790140|P3|Completed Treatment D|Overall Study||5
7631262|NCT02291510|18790141|P2|Completed Treatment D|Overall Study||5
7631263|NCT02291510|18790142|P1|Completed Treatment D|Overall Study||5
7631264|NCT02291510|18790139|P4|Completed Treatment C|Overall Study||4
7631265|NCT02291510|18790140|P3|Completed Treatment C|Overall Study||5
7631266|NCT02291510|18790141|P2|Completed Treatment C|Overall Study||5
7631267|NCT02291510|18790142|P1|Completed Treatment C|Overall Study||5
7631268|NCT02291510|18790139|P4|Completed Treatment B|Overall Study||4
7631269|NCT02291510|18790140|P3|Completed Treatment B|Overall Study||5
7631270|NCT02291510|18790141|P2|Completed Treatment B|Overall Study||5
7631271|NCT02291510|18790142|P1|Completed Treatment B|Overall Study||5
7631272|NCT02291510|18790139|P4|Completed Treatment A|Overall Study||5
7631273|NCT02291510|18790140|P3|Completed Treatment A|Overall Study||5
7631274|NCT02291510|18790141|P2|Completed Treatment A|Overall Study||5
7631275|NCT02291510|18790142|P1|Completed Treatment A|Overall Study||5
7631276|NCT02291510|18790139|P4|STARTED|Overall Study||5
7631277|NCT02291510|18790140|P3|STARTED|Overall Study||5
7631278|NCT02291510|18790141|P2|STARTED|Overall Study||5
7631279|NCT02291510|18790142|P1|STARTED|Overall Study||5
7631280|NCT02291419|18790158|P2|NOT COMPLETED|Overall Study||5
7631281|NCT02291419|18790159|P1|NOT COMPLETED|Overall Study||1
7631282|NCT02291419|18790158|P2|COMPLETED|Overall Study||0
7631283|NCT02291419|18790159|P1|COMPLETED|Overall Study||0
7631284|NCT02291419|18790158|P2|STARTED|Overall Study||5
7631285|NCT02291419|18790159|P1|STARTED|Overall Study||1
7631286|NCT02291302|18790179|P4|NOT COMPLETED|Overall Study||0
7631287|NCT02291302|18790180|P3|NOT COMPLETED|Overall Study||0
7631288|NCT02291302|18790181|P2|NOT COMPLETED|Overall Study||0
7631289|NCT02291302|18790182|P1|NOT COMPLETED|Overall Study||0
7631290|NCT02291302|18790179|P4|COMPLETED|Overall Study||59
7631291|NCT02291302|18790180|P3|COMPLETED|Overall Study||59
7631292|NCT02291302|18790181|P2|COMPLETED|Overall Study||59
7631293|NCT02291302|18790182|P1|COMPLETED|Overall Study||59
7631294|NCT02291302|18790179|P4|STARTED|Overall Study||59
7631295|NCT02291302|18790180|P3|STARTED|Overall Study||59
7631296|NCT02291302|18790181|P2|STARTED|Overall Study||59
7631297|NCT02291302|18790182|P1|STARTED|Overall Study||59
7631298|NCT02291289|18790196|P12|NOT COMPLETED|Maintenance Treatment Phase||16
7631299|NCT02291289|18790197|P11|NOT COMPLETED|Maintenance Treatment Phase||31
7631300|NCT02291289|18790198|P10|NOT COMPLETED|Maintenance Treatment Phase||0
7631301|NCT02291289|18790199|P9|NOT COMPLETED|Maintenance Treatment Phase||2
7631302|NCT02291289|18790200|P8|NOT COMPLETED|Maintenance Treatment Phase||2
7631303|NCT02291289|18790201|P7|NOT COMPLETED|Maintenance Treatment Phase||0
7631304|NCT02291289|18790202|P6|NOT COMPLETED|Maintenance Treatment Phase||129
7631305|NCT02291289|18790203|P5|NOT COMPLETED|Maintenance Treatment Phase||252
7631306|NCT02291289|18790204|P4|NOT COMPLETED|Maintenance Treatment Phase||0
7631307|NCT02291289|18790205|P3|NOT COMPLETED|Maintenance Treatment Phase||16
7631308|NCT02291289|18790206|P2|NOT COMPLETED|Maintenance Treatment Phase||24
7631309|NCT02291289|18790207|P1|NOT COMPLETED|Maintenance Treatment Phase||0
7631310|NCT02291289|18790196|P12|COMPLETED|Maintenance Treatment Phase||18
7631311|NCT02291289|18790197|P11|COMPLETED|Maintenance Treatment Phase||34
7631312|NCT02291289|18790198|P10|COMPLETED|Maintenance Treatment Phase||0
7631313|NCT02291289|18790199|P9|COMPLETED|Maintenance Treatment Phase||0
7631314|NCT02291289|18790200|P8|COMPLETED|Maintenance Treatment Phase||1
7631315|NCT02291289|18790201|P7|COMPLETED|Maintenance Treatment Phase||0
7631316|NCT02291289|18790202|P6|COMPLETED|Maintenance Treatment Phase||19
7631317|NCT02291289|18790203|P5|COMPLETED|Maintenance Treatment Phase||45
7631318|NCT02291289|18790204|P4|COMPLETED|Maintenance Treatment Phase||0
7631319|NCT02291289|18790205|P3|COMPLETED|Maintenance Treatment Phase||4
7631320|NCT02291289|18790206|P2|COMPLETED|Maintenance Treatment Phase||16
7631321|NCT02291289|18790207|P1|COMPLETED|Maintenance Treatment Phase||0
7631322|NCT02291289|18790196|P12|Dosed|Maintenance Treatment Phase||34
7631323|NCT02291289|18790197|P11|Dosed|Maintenance Treatment Phase||64
7631324|NCT02291289|18790198|P10|Dosed|Maintenance Treatment Phase||0
7631325|NCT02291289|18790199|P9|Dosed|Maintenance Treatment Phase||2
7631326|NCT02291289|18790200|P8|Dosed|Maintenance Treatment Phase||3
7631327|NCT02291289|18790201|P7|Dosed|Maintenance Treatment Phase||0
7631328|NCT02291289|18790202|P6|Dosed|Maintenance Treatment Phase||143
7631329|NCT02291289|18790203|P5|Dosed|Maintenance Treatment Phase||293
7631330|NCT02291289|18790204|P4|Dosed|Maintenance Treatment Phase||0
7631331|NCT02291289|18790205|P3|Dosed|Maintenance Treatment Phase||18
7631332|NCT02291289|18790206|P2|Dosed|Maintenance Treatment Phase||40
7631333|NCT02291289|18790207|P1|Dosed|Maintenance Treatment Phase||0
7631334|NCT02291289|18790196|P12|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|34
7631335|NCT02291289|18790197|P11|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|65
7631336|NCT02291289|18790198|P10|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
7631337|NCT02291289|18790199|P9|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|2
7631338|NCT02291289|18790200|P8|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|3
7631339|NCT02291289|18790201|P7|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
7631340|NCT02291289|18790202|P6|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|148
7631341|NCT02291289|18790203|P5|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|297
7631342|NCT02291289|18790204|P4|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
7631343|NCT02291289|18790205|P3|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|20
7631344|NCT02291289|18790206|P2|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|40
7631345|NCT02291289|18790207|P1|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
7631346|NCT02291289|18790196|P12|NOT COMPLETED|Induction Treatment||0
7631347|NCT02291289|18790197|P11|NOT COMPLETED|Induction Treatment||0
7631348|NCT02291289|18790198|P10|NOT COMPLETED|Induction Treatment||1
7631349|NCT02291289|18790199|P9|NOT COMPLETED|Induction Treatment||0
7631350|NCT02291289|18790200|P8|NOT COMPLETED|Induction Treatment||0
7631351|NCT02291289|18790201|P7|NOT COMPLETED|Induction Treatment||0
7631352|NCT02291289|18790202|P6|NOT COMPLETED|Induction Treatment||0
7631353|NCT02291289|18790203|P5|NOT COMPLETED|Induction Treatment||0
7631354|NCT02291289|18790204|P4|NOT COMPLETED|Induction Treatment||9
7631355|NCT02291289|18790205|P3|NOT COMPLETED|Induction Treatment||0
7631356|NCT02291289|18790206|P2|NOT COMPLETED|Induction Treatment||0
7631357|NCT02291289|18790207|P1|NOT COMPLETED|Induction Treatment||2
7631358|NCT02291289|18790196|P12|COMPLETED|Induction Treatment||0
7631359|NCT02291289|18790197|P11|COMPLETED|Induction Treatment||0
7631360|NCT02291289|18790198|P10|COMPLETED|Induction Treatment||98
7631361|NCT02291289|18790199|P9|COMPLETED|Induction Treatment||0
7631362|NCT02291289|18790200|P8|COMPLETED|Induction Treatment||0
7631363|NCT02291289|18790201|P7|COMPLETED|Induction Treatment||5
7631364|NCT02291289|18790202|P6|COMPLETED|Induction Treatment||0
7631365|NCT02291289|18790203|P5|COMPLETED|Induction Treatment||0
7631366|NCT02291289|18790204|P4|COMPLETED|Induction Treatment||436
7631367|NCT02291289|18790205|P3|COMPLETED|Induction Treatment||0
7631368|NCT02291289|18790206|P2|COMPLETED|Induction Treatment||0
7631369|NCT02291289|18790207|P1|COMPLETED|Induction Treatment||58
7631370|NCT02291289|18790196|P12|STARTED|Induction Treatment||0
7631371|NCT02291289|18790197|P11|STARTED|Induction Treatment||0
7631372|NCT02291289|18790198|P10|STARTED|Induction Treatment||99
7631373|NCT02291289|18790199|P9|STARTED|Induction Treatment||0
7631374|NCT02291289|18790200|P8|STARTED|Induction Treatment||0
7631375|NCT02291289|18790201|P7|STARTED|Induction Treatment||5
7631376|NCT02291289|18790202|P6|STARTED|Induction Treatment||0
7631377|NCT02291289|18790203|P5|STARTED|Induction Treatment||0
7631378|NCT02291289|18790204|P4|STARTED|Induction Treatment||445
7631379|NCT02291289|18790205|P3|STARTED|Induction Treatment||0
7631380|NCT02291289|18790206|P2|STARTED|Induction Treatment||0
7631381|NCT02291289|18790207|P1|STARTED|Induction Treatment||60
7631382|NCT02291237|18790271|P2|NOT COMPLETED|Overall Study||86
7631383|NCT02291237|18790272|P1|NOT COMPLETED|Overall Study||86
7631384|NCT02291237|18790271|P2|COMPLETED|Overall Study||0
7631385|NCT02291237|18790272|P1|COMPLETED|Overall Study||0
7631386|NCT02291237|18790271|P2|STARTED|Overall Study||86
7631387|NCT02291237|18790272|P1|STARTED|Overall Study||86
7631388|NCT02291029|18790294|P6|NOT COMPLETED|Overall Study||0
7631389|NCT02291029|18790295|P5|NOT COMPLETED|Overall Study||0
7631390|NCT02291029|18790296|P4|NOT COMPLETED|Overall Study||0
7631391|NCT02291029|18790297|P3|NOT COMPLETED|Overall Study||1
7631392|NCT02291029|18790298|P2|NOT COMPLETED|Overall Study||1
7631393|NCT02291029|18790299|P1|NOT COMPLETED|Overall Study||0
7631394|NCT02291029|18790294|P6|COMPLETED|Overall Study||12
7631395|NCT02291029|18790295|P5|COMPLETED|Overall Study||13
7631396|NCT02291029|18790296|P4|COMPLETED|Overall Study||11
7631397|NCT02291029|18790297|P3|COMPLETED|Overall Study||20
7631398|NCT02291029|18790298|P2|COMPLETED|Overall Study||3
7631399|NCT02291029|18790299|P1|COMPLETED|Overall Study||8
7631400|NCT02291029|18790294|P6|STARTED|Overall Study||12
7631401|NCT02291029|18790295|P5|STARTED|Overall Study||13
7631402|NCT02291029|18790296|P4|STARTED|Overall Study||11
7631403|NCT02291029|18790297|P3|STARTED|Overall Study||21
7631404|NCT02291029|18790298|P2|STARTED|Overall Study||4
7631405|NCT02291029|18790299|P1|STARTED|Overall Study||8
7631406|NCT02291016|18790345|P2|NOT COMPLETED|Visit 2||0
7631407|NCT02291016|18790346|P1|NOT COMPLETED|Visit 2||1
7631408|NCT02291016|18790345|P2|COMPLETED|Visit 2||5
7631409|NCT02291016|18790346|P1|COMPLETED|Visit 2|Patients did not meet visit 2 FEV1 criteria ( 15% or closer to value at visit 1)|1
7631410|NCT02291016|18790345|P2|STARTED|Visit 2||5
7631411|NCT02291016|18790346|P1|STARTED|Visit 2||2
7631412|NCT02291016|18790345|P2|NOT COMPLETED|Visit 1||0
7631413|NCT02291016|18790346|P1|NOT COMPLETED|Visit 1||0
7631414|NCT02291016|18790345|P2|COMPLETED|Visit 1||5
7631415|NCT02291016|18790346|P1|COMPLETED|Visit 1||2
7631416|NCT02291016|18790345|P2|STARTED|Visit 1||5
7631417|NCT02291016|18790346|P1|STARTED|Visit 1||2
7631418|NCT02290925|18790370|P2|NOT COMPLETED|Second Period of 3 Months||4
7631419|NCT02290925|18790371|P1|NOT COMPLETED|Second Period of 3 Months||1
7631420|NCT02290925|18790370|P2|COMPLETED|Second Period of 3 Months||65
7631421|NCT02290925|18790371|P1|COMPLETED|Second Period of 3 Months||57
7631422|NCT02290925|18790370|P2|STARTED|Second Period of 3 Months||69
7631423|NCT02290925|18790371|P1|STARTED|Second Period of 3 Months||58
7631424|NCT02290925|18790370|P2|NOT COMPLETED|First Period of Three Months||2
7631425|NCT02290925|18790371|P1|NOT COMPLETED|First Period of Three Months||4
7631426|NCT02290925|18790370|P2|COMPLETED|First Period of Three Months||69
7631427|NCT02290925|18790371|P1|COMPLETED|First Period of Three Months||58
7631428|NCT02290925|18790370|P2|STARTED|First Period of Three Months||71
7631429|NCT02290925|18790371|P1|STARTED|First Period of Three Months||62
7631430|NCT02290873|18790386|P3|NOT COMPLETED|Overall Study||2
7631431|NCT02290873|18790387|P2|NOT COMPLETED|Overall Study||1
7631432|NCT02290873|18790388|P1|NOT COMPLETED|Overall Study||2
7631433|NCT02290873|18790386|P3|COMPLETED|Overall Study||101
7631434|NCT02290873|18790387|P2|COMPLETED|Overall Study||59
7631435|NCT02290873|18790388|P1|COMPLETED|Overall Study||296
7631436|NCT02290873|18790386|P3|Safety Population|Overall Study||102
7631437|NCT02290873|18790387|P2|Safety Population|Overall Study||60
7631438|NCT02290873|18790388|P1|Safety Population|Overall Study||296
7631439|NCT02290873|18790386|P3|Modified Intention to Treat (mITT)|Overall Study||102
7631440|NCT02290873|18790387|P2|Modified Intention to Treat (mITT)|Overall Study||60
7631441|NCT02290873|18790388|P1|Modified Intention to Treat (mITT)|Overall Study||296
7631442|NCT02290873|18790386|P3|STARTED|Overall Study||103
7631443|NCT02290873|18790387|P2|STARTED|Overall Study||60
7631444|NCT02290873|18790388|P1|STARTED|Overall Study||298
7631445|NCT02290821|18790407|P2|NOT COMPLETED|Overall Study||3
7631446|NCT02290821|18790408|P1|NOT COMPLETED|Overall Study||6
7631447|NCT02290821|18790407|P2|COMPLETED|Overall Study||103
7631448|NCT02290821|18790408|P1|COMPLETED|Overall Study||103
7631449|NCT02290821|18790407|P2|STARTED|Overall Study||106
7631450|NCT02290821|18790408|P1|STARTED|Overall Study||109
7631451|NCT02290691|18790416|P2|NOT COMPLETED|Overall Study||9
7631452|NCT02290691|18790417|P1|NOT COMPLETED|Overall Study||8
7631453|NCT02290691|18790416|P2|COMPLETED|Overall Study||479
7631454|NCT02290691|18790417|P1|COMPLETED|Overall Study||488
7631455|NCT02290691|18790416|P2|STARTED|Overall Study||488
7631456|NCT02290691|18790417|P1|STARTED|Overall Study||496
7631457|NCT02290613|18790433|P2|NOT COMPLETED|Overall Study||4
7631458|NCT02290613|18790434|P1|NOT COMPLETED|Overall Study||2
7631459|NCT02290613|18790433|P2|COMPLETED|Overall Study||15
7631460|NCT02290613|18790434|P1|COMPLETED|Overall Study||17
7631461|NCT02290613|18790433|P2|STARTED|Overall Study||19
7631462|NCT02290613|18790434|P1|STARTED|Overall Study||19
7631463|NCT02290574|18790482|P1|NOT COMPLETED|Overall Study||1
7631464|NCT02290574|18790482|P1|COMPLETED|Overall Study||13
7631465|NCT02290574|18790482|P1|STARTED|Overall Study||14
7631466|NCT02290509|18790492|P2|NOT COMPLETED|Overall Study||14
7631467|NCT02290509|18790493|P1|NOT COMPLETED|Overall Study||49
7631468|NCT02290509|18790492|P2|COMPLETED|Overall Study||325
7631469|NCT02290509|18790493|P1|COMPLETED|Overall Study||962
7631470|NCT02290509|18790492|P2|STARTED|Overall Study||339
7631471|NCT02290509|18790493|P1|STARTED|Overall Study||1011
7631472|NCT02290444|18790507|P2|NOT COMPLETED|Overall Study||2
7631473|NCT02290444|18790508|P1|NOT COMPLETED|Overall Study||1
7631474|NCT02290444|18790507|P2|COMPLETED|Overall Study||32
7631475|NCT02290444|18790508|P1|COMPLETED|Overall Study||29
7631476|NCT02290444|18790507|P2|STARTED|Overall Study||34
7631477|NCT02290444|18790508|P1|STARTED|Overall Study||30
7631478|NCT02290431|18790530|P1|NOT COMPLETED|Overall Study||27
7631479|NCT02290431|18790530|P1|COMPLETED|Overall Study||4
7631480|NCT02290431|18790530|P1|Entered Treatment Phase 2|Overall Study||17
7631481|NCT02290431|18790530|P1|Subjects Entered Survival f/u Phase|Overall Study||24
7631482|NCT02290431|18790530|P1|Subjs. Ntered Post-treatment Eval. Phase|Overall Study||31
7631483|NCT02290431|18790530|P1|Subjects Completed Study Per Protocol|Overall Study||8
7631484|NCT02290431|18790530|P1|Subjects. Discont. Prematurely|Overall Study||27
7631485|NCT02290431|18790530|P1|STARTED|Overall Study||31
7631486|NCT02290340|18790553|P4|NOT COMPLETED|Overall Study||2
7631487|NCT02290340|18790554|P3|NOT COMPLETED|Overall Study||0
7631488|NCT02290340|18790555|P2|NOT COMPLETED|Overall Study||0
7631489|NCT02290340|18790556|P1|NOT COMPLETED|Overall Study||2
7631490|NCT02290340|18790553|P4|COMPLETED|Overall Study||30
7631491|NCT02290340|18790554|P3|COMPLETED|Overall Study||31
7631492|NCT02290340|18790555|P2|COMPLETED|Overall Study||8
7631493|NCT02290340|18790556|P1|COMPLETED|Overall Study||16
7631494|NCT02290340|18790553|P4|STARTED|Overall Study||32
7631495|NCT02290340|18790554|P3|STARTED|Overall Study||31
7631496|NCT02290340|18790555|P2|STARTED|Overall Study||8
7631497|NCT02290340|18790556|P1|STARTED|Overall Study||18
7631498|NCT02290223|18790601|P2|NOT COMPLETED|12 Months||11
7631499|NCT02290223|18790602|P1|NOT COMPLETED|12 Months||16
7631500|NCT02290223|18790601|P2|COMPLETED|12 Months||176
7631501|NCT02290223|18790602|P1|COMPLETED|12 Months||166
7631502|NCT02290223|18790601|P2|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=0).|187
7631503|NCT02290223|18790602|P1|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=7).|182
7631504|NCT02290223|18790601|P2|NOT COMPLETED|6 Months||6
7631505|NCT02290223|18790602|P1|NOT COMPLETED|6 Months||16
7631506|NCT02290223|18790601|P2|COMPLETED|6 Months||181
7631507|NCT02290223|18790602|P1|COMPLETED|6 Months||173
7631508|NCT02290223|18790601|P2|STARTED|6 Months||187
7631509|NCT02290223|18790602|P1|STARTED|6 Months||189
7631510|NCT02290223|18790601|P2|NOT COMPLETED|Baseline||0
7631511|NCT02290223|18790602|P1|NOT COMPLETED|Baseline||0
7631512|NCT02290223|18790601|P2|COMPLETED|Baseline||187
7631513|NCT02290223|18790602|P1|COMPLETED|Baseline||189
7631514|NCT02290223|18790601|P2|STARTED|Baseline||187
7631515|NCT02290223|18790602|P1|STARTED|Baseline||189
7631516|NCT02290184|18790662|P2|NOT COMPLETED|Overall Study||0
7631517|NCT02290184|18790663|P1|NOT COMPLETED|Overall Study||0
7631518|NCT02290184|18790662|P2|COMPLETED|Overall Study|6-month follow up visit - completed 3-month intervention and competed study|23
7631519|NCT02290184|18790663|P1|COMPLETED|Overall Study|6-month follow-up visit - completed the 3-month maintenance phase and completed study|22
7631520|NCT02290184|18790662|P2|3-month Follow-up|Overall Study|Completed initial 3-month control period and transition to receive the 3-month intervention|23
7631521|NCT02290184|18790663|P1|3-month Follow-up|Overall Study|Completed initial 3-month intervention and now transition to a 3-month maintenance phase|22
7631522|NCT02290184|18790662|P2|STARTED|Overall Study||23
7631523|NCT02290184|18790663|P1|STARTED|Overall Study||22
7631524|NCT02290106|18790677|P2|NOT COMPLETED|Overall Study||2
7631525|NCT02290106|18790678|P1|NOT COMPLETED|Overall Study||1
7631526|NCT02290106|18790677|P2|COMPLETED|Overall Study||23
7631527|NCT02290106|18790678|P1|COMPLETED|Overall Study||24
7631528|NCT02290106|18790677|P2|STARTED|Overall Study||25
7631529|NCT02290106|18790678|P1|STARTED|Overall Study||25
7631530|NCT02289989|18790698|P2|NOT COMPLETED|Overall Study||0
7631531|NCT02289989|18790699|P1|NOT COMPLETED|Overall Study||0
7631532|NCT02289989|18790698|P2|COMPLETED|Overall Study||1
7631533|NCT02289989|18790699|P1|COMPLETED|Overall Study||0
7631534|NCT02289989|18790698|P2|STARTED|Overall Study||1
7631535|NCT02289989|18790699|P1|STARTED|Overall Study||0
7631536|NCT02289963|18790717|P2|NOT COMPLETED|Overall Study||10
7631537|NCT02289963|18790718|P1|NOT COMPLETED|Overall Study||5
7631538|NCT02289963|18790717|P2|COMPLETED|Overall Study||87
7631539|NCT02289963|18790718|P1|COMPLETED|Overall Study||97
7631540|NCT02289963|18790717|P2|Treated|Overall Study||97
7631541|NCT02289963|18790718|P1|Treated|Overall Study||102
7631542|NCT02289963|18790717|P2|STARTED|Overall Study|Randomized|97
7631543|NCT02289963|18790718|P1|STARTED|Overall Study|Randomized|102
7631544|NCT02289898|18790769|P3|NOT COMPLETED|Overall Study||56
7631545|NCT02289898|18790770|P2|NOT COMPLETED|Overall Study||53
7631546|NCT02289898|18790771|P1|NOT COMPLETED|Overall Study||52
7631547|NCT02289898|18790769|P3|COMPLETED|Overall Study||9
7631548|NCT02289898|18790770|P2|COMPLETED|Overall Study||18
7631549|NCT02289898|18790771|P1|COMPLETED|Overall Study||16
7631550|NCT02289898|18790769|P3|STARTED|Overall Study||65
7631551|NCT02289898|18790770|P2|STARTED|Overall Study||71
7631552|NCT02289898|18790771|P1|STARTED|Overall Study||68
7631553|NCT02289833|18790780|P2|NOT COMPLETED|Overall Study||17
7631554|NCT02289833|18790781|P1|NOT COMPLETED|Overall Study||27
7631555|NCT02289833|18790780|P2|COMPLETED|Overall Study||3
7631556|NCT02289833|18790781|P1|COMPLETED|Overall Study||2
7631557|NCT02289833|18790780|P2|STARTED|Overall Study||20
7631558|NCT02289833|18790781|P1|STARTED|Overall Study||29
7631559|NCT02289820|18790817|P7|NOT COMPLETED|Overall Study||2
7631560|NCT02289820|18790818|P6|NOT COMPLETED|Overall Study||1
7631561|NCT02289820|18790819|P5|NOT COMPLETED|Overall Study||0
7631562|NCT02289820|18790820|P4|NOT COMPLETED|Overall Study||2
7631563|NCT02289820|18790821|P3|NOT COMPLETED|Overall Study||6
7631564|NCT02289820|18790822|P2|NOT COMPLETED|Overall Study||2
7631565|NCT02289820|18790823|P1|NOT COMPLETED|Overall Study||2
7631566|NCT02289820|18790817|P7|COMPLETED|Overall Study||37
7631567|NCT02289820|18790818|P6|COMPLETED|Overall Study||39
7631568|NCT02289820|18790819|P5|COMPLETED|Overall Study||40
7631569|NCT02289820|18790820|P4|COMPLETED|Overall Study||37
7631570|NCT02289820|18790821|P3|COMPLETED|Overall Study||38
7631571|NCT02289820|18790822|P2|COMPLETED|Overall Study||18
7631572|NCT02289820|18790823|P1|COMPLETED|Overall Study||37
7631573|NCT02289820|18790817|P7|STARTED|Overall Study||39
7631574|NCT02289820|18790818|P6|STARTED|Overall Study||40
7631575|NCT02289820|18790819|P5|STARTED|Overall Study||40
7631576|NCT02289820|18790820|P4|STARTED|Overall Study||39
7631577|NCT02289820|18790821|P3|STARTED|Overall Study||44
7631578|NCT02289820|18790822|P2|STARTED|Overall Study||20
7631579|NCT02289820|18790823|P1|STARTED|Overall Study||39
7631580|NCT02289755|18790934|P1|NOT COMPLETED|Follow up Period [4 Days]||0
7631581|NCT02289755|18790934|P1|COMPLETED|Follow up Period [4 Days]||16
7631582|NCT02289755|18790934|P1|STARTED|Follow up Period [4 Days]||16
7631583|NCT02289755|18790934|P1|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0
7631584|NCT02289755|18790934|P1|COMPLETED|ALLN-177 Treatment Period [4 Days]||16
7631585|NCT02289755|18790934|P1|STARTED|ALLN-177 Treatment Period [4 Days]||16
7631586|NCT02289755|18790934|P1|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0
7631587|NCT02289755|18790934|P1|COMPLETED|Baseline Period [No Treatment, 3 Days]||16
7631588|NCT02289755|18790934|P1|STARTED|Baseline Period [No Treatment, 3 Days]||16
7631589|NCT02289742|18790941|P4|NOT COMPLETED|Third Wear Period||1
7631590|NCT02289742|18790942|P3|NOT COMPLETED|Third Wear Period||0
7631591|NCT02289742|18790943|P2|NOT COMPLETED|Third Wear Period||1
7631592|NCT02289742|18790944|P1|NOT COMPLETED|Third Wear Period||0
7631593|NCT02289742|18790941|P4|COMPLETED|Third Wear Period||8
7631594|NCT02289742|18790942|P3|COMPLETED|Third Wear Period||11
7631595|NCT02289742|18790943|P2|COMPLETED|Third Wear Period||10
7631596|NCT02289742|18790944|P1|COMPLETED|Third Wear Period||11
7631597|NCT02289742|18790941|P4|STARTED|Third Wear Period||9
7631598|NCT02289742|18790942|P3|STARTED|Third Wear Period||11
7631599|NCT02289742|18790943|P2|STARTED|Third Wear Period||11
7631600|NCT02289742|18790944|P1|STARTED|Third Wear Period||11
7631601|NCT02289742|18790941|P4|NOT COMPLETED|Second Wear Period||0
7631602|NCT02289742|18790942|P3|NOT COMPLETED|Second Wear Period||0
7631603|NCT02289742|18790943|P2|NOT COMPLETED|Second Wear Period||0
7631604|NCT02289742|18790944|P1|NOT COMPLETED|Second Wear Period||0
7631605|NCT02289742|18790941|P4|COMPLETED|Second Wear Period||9
7631606|NCT02289742|18790942|P3|COMPLETED|Second Wear Period||11
7631607|NCT02289742|18790943|P2|COMPLETED|Second Wear Period||11
7631608|NCT02289742|18790944|P1|COMPLETED|Second Wear Period||11
7631609|NCT02289742|18790941|P4|STARTED|Second Wear Period||9
7631610|NCT02289742|18790942|P3|STARTED|Second Wear Period||11
7631611|NCT02289742|18790943|P2|STARTED|Second Wear Period||11
7631612|NCT02289742|18790944|P1|STARTED|Second Wear Period||11
7631613|NCT02289742|18790941|P4|NOT COMPLETED|First Wear Period||1
7631614|NCT02289742|18790942|P3|NOT COMPLETED|First Wear Period||1
7631615|NCT02289742|18790943|P2|NOT COMPLETED|First Wear Period||1
7631616|NCT02289742|18790944|P1|NOT COMPLETED|First Wear Period||0
7631617|NCT02289742|18790941|P4|COMPLETED|First Wear Period||9
7631618|NCT02289742|18790942|P3|COMPLETED|First Wear Period||11
7631619|NCT02289742|18790943|P2|COMPLETED|First Wear Period||11
7631620|NCT02289742|18790944|P1|COMPLETED|First Wear Period||11
7631621|NCT02289742|18790941|P4|Treated|First Wear Period||9
7631622|NCT02289742|18790942|P3|Treated|First Wear Period||12
7631623|NCT02289742|18790943|P2|Treated|First Wear Period||11
7631624|NCT02289742|18790944|P1|Treated|First Wear Period||11
7631625|NCT02289742|18790941|P4|STARTED|First Wear Period||10
7631626|NCT02289742|18790942|P3|STARTED|First Wear Period||12
7631627|NCT02289742|18790943|P2|STARTED|First Wear Period||12
7631628|NCT02289742|18790944|P1|STARTED|First Wear Period||11
7631629|NCT02289729|18790961|P1|NOT COMPLETED|Overall Study||6
7631630|NCT02289729|18790961|P1|COMPLETED|Overall Study||53
7631631|NCT02289729|18790961|P1|STARTED|Overall Study||59
7631632|NCT02289690|18791025|P10|NOT COMPLETED|Overall Study||61
7631633|NCT02289690|18791026|P9|NOT COMPLETED|Overall Study||59
7631634|NCT02289690|18791027|P8|NOT COMPLETED|Overall Study||61
7631635|NCT02289690|18791028|P7|NOT COMPLETED|Overall Study||4
7631636|NCT02289690|18791029|P6|NOT COMPLETED|Overall Study||14
7631637|NCT02289690|18791030|P5|NOT COMPLETED|Overall Study||8
7631638|NCT02289690|18791031|P4|NOT COMPLETED|Overall Study||3
7631639|NCT02289690|18791032|P3|NOT COMPLETED|Overall Study||4
7631640|NCT02289690|18791033|P2|NOT COMPLETED|Overall Study||3
7631641|NCT02289690|18791034|P1|NOT COMPLETED|Overall Study||4
7631642|NCT02289690|18791025|P10|COMPLETED|Overall Study||0
7631643|NCT02289690|18791026|P9|COMPLETED|Overall Study||0
7631644|NCT02289690|18791027|P8|COMPLETED|Overall Study||0
7631645|NCT02289690|18791028|P7|COMPLETED|Overall Study||0
7631646|NCT02289690|18791029|P6|COMPLETED|Overall Study||0
7631647|NCT02289690|18791030|P5|COMPLETED|Overall Study||0
7631648|NCT02289690|18791031|P4|COMPLETED|Overall Study||0
7631649|NCT02289690|18791032|P3|COMPLETED|Overall Study||0
7631650|NCT02289690|18791033|P2|COMPLETED|Overall Study||0
7631651|NCT02289690|18791034|P1|COMPLETED|Overall Study||0
7631652|NCT02289690|18791025|P10|Received Study Drug|Overall Study||60
7631653|NCT02289690|18791026|P9|Received Study Drug|Overall Study||58
7631654|NCT02289690|18791027|P8|Received Study Drug|Overall Study||60
7631655|NCT02289690|18791028|P7|Received Study Drug|Overall Study||4
7631656|NCT02289690|18791029|P6|Received Study Drug|Overall Study||14
7631657|NCT02289690|18791030|P5|Received Study Drug|Overall Study||8
7631658|NCT02289690|18791031|P4|Received Study Drug|Overall Study||3
7631659|NCT02289690|18791032|P3|Received Study Drug|Overall Study||4
7631660|NCT02289690|18791033|P2|Received Study Drug|Overall Study||3
7631661|NCT02289690|18791034|P1|Received Study Drug|Overall Study||4
7631662|NCT02289690|18791025|P10|STARTED|Overall Study||61
7631663|NCT02289690|18791026|P9|STARTED|Overall Study||59
7631664|NCT02289690|18791027|P8|STARTED|Overall Study||61
7631665|NCT02289690|18791028|P7|STARTED|Overall Study||4
7631666|NCT02289690|18791029|P6|STARTED|Overall Study||14
7631667|NCT02289690|18791030|P5|STARTED|Overall Study||8
7631668|NCT02289690|18791031|P4|STARTED|Overall Study||3
7631669|NCT02289690|18791032|P3|STARTED|Overall Study||4
7631670|NCT02289690|18791033|P2|STARTED|Overall Study||3
7631671|NCT02289690|18791034|P1|STARTED|Overall Study||4
7631672|NCT02289469|18791122|P2|NOT COMPLETED|Overall Study||0
7631673|NCT02289469|18791123|P1|NOT COMPLETED|Overall Study||6
7631674|NCT02289469|18791122|P2|COMPLETED|Overall Study||244
7631675|NCT02289469|18791123|P1|COMPLETED|Overall Study||244
7631676|NCT02289469|18791122|P2|STARTED|Overall Study||244
7631677|NCT02289469|18791123|P1|STARTED|Overall Study||250
7631678|NCT02289456|18791131|P1|NOT COMPLETED|Monotherapy Period||16
7631679|NCT02289456|18791131|P1|COMPLETED|Monotherapy Period||0
7631680|NCT02289456|18791131|P1|STARTED|Monotherapy Period||16
7631681|NCT02289456|18791131|P1|NOT COMPLETED|Induction Period||24
7631682|NCT02289456|18791131|P1|COMPLETED|Induction Period||16
7631683|NCT02289456|18791131|P1|Treated Population|Induction Period||40
7631684|NCT02289456|18791131|P1|STARTED|Induction Period||40
7631685|NCT02289417|18791154|P9|NOT COMPLETED|Extension Phase Weeks 52-104||6
7631686|NCT02289417|18791155|P8|NOT COMPLETED|Extension Phase Weeks 52-104||7
7631687|NCT02289417|18791156|P7|NOT COMPLETED|Extension Phase Weeks 52-104||0
7631688|NCT02289417|18791157|P6|NOT COMPLETED|Extension Phase Weeks 52-104||0
7631689|NCT02289417|18791158|P5|NOT COMPLETED|Extension Phase Weeks 52-104||0
7631690|NCT02289417|18791159|P4|NOT COMPLETED|Extension Phase Weeks 52-104||0
7631691|NCT02289417|18791160|P3|NOT COMPLETED|Extension Phase Weeks 52-104||0
7631692|NCT02289417|18791161|P2|NOT COMPLETED|Extension Phase Weeks 52-104||0
7631693|NCT02289417|18791162|P1|NOT COMPLETED|Extension Phase Weeks 52-104||0
7631694|NCT02289417|18791154|P9|COMPLETED|Extension Phase Weeks 52-104||48
7631695|NCT02289417|18791155|P8|COMPLETED|Extension Phase Weeks 52-104||38
7631696|NCT02289417|18791156|P7|COMPLETED|Extension Phase Weeks 52-104||0
7631697|NCT02289417|18791157|P6|COMPLETED|Extension Phase Weeks 52-104||0
7631698|NCT02289417|18791158|P5|COMPLETED|Extension Phase Weeks 52-104||0
7631699|NCT02289417|18791159|P4|COMPLETED|Extension Phase Weeks 52-104||0
7631700|NCT02289417|18791160|P3|COMPLETED|Extension Phase Weeks 52-104||0
7631701|NCT02289417|18791161|P2|COMPLETED|Extension Phase Weeks 52-104||0
7631702|NCT02289417|18791162|P1|COMPLETED|Extension Phase Weeks 52-104||0
7631703|NCT02289417|18791154|P9|STARTED|Extension Phase Weeks 52-104||54
7631704|NCT02289417|18791155|P8|STARTED|Extension Phase Weeks 52-104||45
7631705|NCT02289417|18791156|P7|STARTED|Extension Phase Weeks 52-104||0
7631706|NCT02289417|18791157|P6|STARTED|Extension Phase Weeks 52-104||0
7631707|NCT02289417|18791158|P5|STARTED|Extension Phase Weeks 52-104||0
7631708|NCT02289417|18791159|P4|STARTED|Extension Phase Weeks 52-104||0
7631709|NCT02289417|18791160|P3|STARTED|Extension Phase Weeks 52-104||0
7631710|NCT02289417|18791161|P2|STARTED|Extension Phase Weeks 52-104||0
7631711|NCT02289417|18791162|P1|STARTED|Extension Phase Weeks 52-104||0
7631712|NCT02289417|18791154|P9|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
7631713|NCT02289417|18791155|P8|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
7631714|NCT02289417|18791156|P7|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
7631715|NCT02289417|18791157|P6|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
7631716|NCT02289417|18791158|P5|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
7631717|NCT02289417|18791159|P4|NOT COMPLETED|Active Treatment Phase Weeks 12-52||9
7631718|NCT02289417|18791160|P3|NOT COMPLETED|Active Treatment Phase Weeks 12-52||10
7631719|NCT02289417|18791161|P2|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
7631720|NCT02289417|18791162|P1|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
7631721|NCT02289417|18791154|P9|COMPLETED|Active Treatment Phase Weeks 12-52||0
7631722|NCT02289417|18791155|P8|COMPLETED|Active Treatment Phase Weeks 12-52||0
7631723|NCT02289417|18791156|P7|COMPLETED|Active Treatment Phase Weeks 12-52||5
7631724|NCT02289417|18791157|P6|COMPLETED|Active Treatment Phase Weeks 12-52||7
7631725|NCT02289417|18791158|P5|COMPLETED|Active Treatment Phase Weeks 12-52||20
7631726|NCT02289417|18791159|P4|COMPLETED|Active Treatment Phase Weeks 12-52||17
7631727|NCT02289417|18791160|P3|COMPLETED|Active Treatment Phase Weeks 12-52||32
7631728|NCT02289417|18791161|P2|COMPLETED|Active Treatment Phase Weeks 12-52||39
7631729|NCT02289417|18791162|P1|COMPLETED|Active Treatment Phase Weeks 12-52||0
7631730|NCT02289417|18791154|P9|STARTED|Active Treatment Phase Weeks 12-52||0
7631731|NCT02289417|18791155|P8|STARTED|Active Treatment Phase Weeks 12-52||0
7631732|NCT02289417|18791156|P7|STARTED|Active Treatment Phase Weeks 12-52|Week 12 TMS were missing for 3 participants|7
7631733|NCT02289417|18791157|P6|STARTED|Active Treatment Phase Weeks 12-52|1 participant went only to Week 20|12
7631734|NCT02289417|18791158|P5|STARTED|Active Treatment Phase Weeks 12-52||25
7631735|NCT02289417|18791159|P4|STARTED|Active Treatment Phase Weeks 12-52||26
7631736|NCT02289417|18791160|P3|STARTED|Active Treatment Phase Weeks 12-52||42
7631737|NCT02289417|18791161|P2|STARTED|Active Treatment Phase Weeks 12-52||41
7631738|NCT02289417|18791162|P1|STARTED|Active Treatment Phase Weeks 12-52||0
7631739|NCT02289417|18791154|P9|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
7631740|NCT02289417|18791155|P8|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
7631741|NCT02289417|18791156|P7|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
7631742|NCT02289417|18791157|P6|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
7631743|NCT02289417|18791158|P5|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
7631744|NCT02289417|18791159|P4|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
7631745|NCT02289417|18791160|P3|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||3
7631746|NCT02289417|18791161|P2|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||4
7631747|NCT02289417|18791162|P1|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||7
7631748|NCT02289417|18791154|P9|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
7631749|NCT02289417|18791155|P8|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
7631750|NCT02289417|18791156|P7|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
7631751|NCT02289417|18791157|P6|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
7631752|NCT02289417|18791158|P5|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
7631753|NCT02289417|18791159|P4|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
7631754|NCT02289417|18791160|P3|COMPLETED|Placebo-Controlled Phase Weeks 0-12||52
7631843|NCT02288325|18791364|P3|STARTED|Stabilization Period||0
7631755|NCT02289417|18791161|P2|COMPLETED|Placebo-Controlled Phase Weeks 0-12||53
7631756|NCT02289417|18791162|P1|COMPLETED|Placebo-Controlled Phase Weeks 0-12||51
7631757|NCT02289417|18791154|P9|STARTED|Placebo-Controlled Phase Weeks 0-12||0
7631758|NCT02289417|18791155|P8|STARTED|Placebo-Controlled Phase Weeks 0-12||0
7631759|NCT02289417|18791156|P7|STARTED|Placebo-Controlled Phase Weeks 0-12||0
7631760|NCT02289417|18791157|P6|STARTED|Placebo-Controlled Phase Weeks 0-12||0
7631761|NCT02289417|18791158|P5|STARTED|Placebo-Controlled Phase Weeks 0-12||0
7631762|NCT02289417|18791159|P4|STARTED|Placebo-Controlled Phase Weeks 0-12||0
7631763|NCT02289417|18791160|P3|STARTED|Placebo-Controlled Phase Weeks 0-12||55
7631764|NCT02289417|18791161|P2|STARTED|Placebo-Controlled Phase Weeks 0-12||57
7631765|NCT02289417|18791162|P1|STARTED|Placebo-Controlled Phase Weeks 0-12||58
7631766|NCT02289352|18791211|P3|NOT COMPLETED|Overall Study||0
7631767|NCT02289352|18791212|P2|NOT COMPLETED|Overall Study||1
7631768|NCT02289352|18791213|P1|NOT COMPLETED|Overall Study||1
7631769|NCT02289352|18791211|P3|COMPLETED|Overall Study||64
7631770|NCT02289352|18791212|P2|COMPLETED|Overall Study||198
7631771|NCT02289352|18791213|P1|COMPLETED|Overall Study||198
7631772|NCT02289352|18791211|P3|PP Population|Overall Study||54
7631773|NCT02289352|18791212|P2|PP Population|Overall Study||173
7631774|NCT02289352|18791213|P1|PP Population|Overall Study||173
7631775|NCT02289352|18791211|P3|mITT Population|Overall Study||58
7631776|NCT02289352|18791212|P2|mITT Population|Overall Study||193
7631777|NCT02289352|18791213|P1|mITT Population|Overall Study||191
7631778|NCT02289352|18791211|P3|Safety Population|Overall Study||64
7631779|NCT02289352|18791212|P2|Safety Population|Overall Study||199
7631780|NCT02289352|18791213|P1|Safety Population|Overall Study||199
7631781|NCT02289352|18791211|P3|STARTED|Overall Study||64
7631782|NCT02289352|18791212|P2|STARTED|Overall Study||199
7631783|NCT02289352|18791213|P1|STARTED|Overall Study||199
7631784|NCT02289222|18791224|P1|NOT COMPLETED|Overall Study||0
7631785|NCT02289222|18791224|P1|COMPLETED|Overall Study||48
7631786|NCT02289222|18791224|P1|STARTED|Overall Study||48
7631787|NCT02289157|18791232|P2|NOT COMPLETED|Overall Study||0
7631788|NCT02289157|18791233|P1|NOT COMPLETED|Overall Study||0
7631789|NCT02289157|18791232|P2|COMPLETED|Overall Study||219
7631790|NCT02289157|18791233|P1|COMPLETED|Overall Study||222
7631791|NCT02289157|18791232|P2|No Post op Check or Follow up Phone Call|Overall Study||4
7631792|NCT02289157|18791233|P1|No Post op Check or Follow up Phone Call|Overall Study||2
7631793|NCT02289157|18791232|P2|STARTED|Overall Study||219
7631794|NCT02289157|18791233|P1|STARTED|Overall Study||222
7631795|NCT02289105|18791267|P2|NOT COMPLETED|Overall Study||0
7631796|NCT02289105|18791268|P1|NOT COMPLETED|Overall Study||0
7631797|NCT02289105|18791267|P2|COMPLETED|Overall Study||637
7631798|NCT02289105|18791268|P1|COMPLETED|Overall Study||642
7631799|NCT02289105|18791267|P2|STARTED|Overall Study||637
7631800|NCT02289105|18791268|P1|STARTED|Overall Study||642
7631801|NCT02289079|18791280|P2|NOT COMPLETED|Overall Study||1
7631802|NCT02289079|18791281|P1|NOT COMPLETED|Overall Study||2
7631803|NCT02289079|18791280|P2|COMPLETED|Overall Study||29
7631804|NCT02289079|18791281|P1|COMPLETED|Overall Study||28
7631805|NCT02289079|18791280|P2|STARTED|Overall Study||30
7631806|NCT02289079|18791281|P1|STARTED|Overall Study||30
7631807|NCT02288819|18791293|P1|NOT COMPLETED|Overall Study||0
7631808|NCT02288819|18791293|P1|COMPLETED|Overall Study||50
7631809|NCT02288819|18791293|P1|STARTED|Overall Study||50
7631810|NCT02288559|18791310|P4|NOT COMPLETED|Overall Study||2
7631811|NCT02288559|18791311|P3|NOT COMPLETED|Overall Study||11
7631812|NCT02288559|18791312|P2|NOT COMPLETED|Overall Study||1
7631813|NCT02288559|18791313|P1|NOT COMPLETED|Overall Study||1
7631814|NCT02288559|18791310|P4|COMPLETED|Overall Study||20
7631815|NCT02288559|18791311|P3|COMPLETED|Overall Study||35
7631816|NCT02288559|18791312|P2|COMPLETED|Overall Study||10
7631817|NCT02288559|18791313|P1|COMPLETED|Overall Study||9
7631818|NCT02288559|18791310|P4|STARTED|Overall Study||22
7631819|NCT02288559|18791311|P3|STARTED|Overall Study||46
7631820|NCT02288559|18791312|P2|STARTED|Overall Study||11
7631821|NCT02288559|18791313|P1|STARTED|Overall Study||10
7631822|NCT02288364|18791339|P2|NOT COMPLETED|Overall Study||0
7631823|NCT02288364|18791340|P1|NOT COMPLETED|Overall Study||0
7631824|NCT02288364|18791339|P2|COMPLETED|Overall Study||44
7631825|NCT02288364|18791340|P1|COMPLETED|Overall Study||42
7631826|NCT02288364|18791339|P2|STARTED|Overall Study||44
7631827|NCT02288364|18791340|P1|STARTED|Overall Study||42
7631828|NCT02288325|18791364|P3|NOT COMPLETED|Double-blind Treatment Period||26
7631829|NCT02288325|18791365|P2|NOT COMPLETED|Double-blind Treatment Period||24
7631830|NCT02288325|18791366|P1|NOT COMPLETED|Double-blind Treatment Period||0
7631831|NCT02288325|18791364|P3|COMPLETED|Double-blind Treatment Period||139
7631832|NCT02288325|18791365|P2|COMPLETED|Double-blind Treatment Period||135
7631833|NCT02288325|18791366|P1|COMPLETED|Double-blind Treatment Period||0
7631834|NCT02288325|18791364|P3|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|165
7631835|NCT02288325|18791365|P2|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|159
7631836|NCT02288325|18791366|P1|STARTED|Double-blind Treatment Period||0
7631837|NCT02288325|18791364|P3|NOT COMPLETED|Stabilization Period||0
7631838|NCT02288325|18791365|P2|NOT COMPLETED|Stabilization Period||0
7631839|NCT02288325|18791366|P1|NOT COMPLETED|Stabilization Period||98
7631840|NCT02288325|18791364|P3|COMPLETED|Stabilization Period||0
7631841|NCT02288325|18791365|P2|COMPLETED|Stabilization Period||0
7631842|NCT02288325|18791366|P1|COMPLETED|Stabilization Period||331
7631844|NCT02288325|18791365|P2|STARTED|Stabilization Period||0
7631845|NCT02288325|18791366|P1|STARTED|Stabilization Period|70 participants did not enter Stabilization Period (69 did not meet entry criteria; 1 other reason)|429
7631846|NCT02288325|18791364|P3|NOT COMPLETED|Run-in Period||0
7631847|NCT02288325|18791365|P2|NOT COMPLETED|Run-in Period||0
7631848|NCT02288325|18791366|P1|NOT COMPLETED|Run-in Period||145
7631849|NCT02288325|18791364|P3|COMPLETED|Run-in Period||0
7631850|NCT02288325|18791365|P2|COMPLETED|Run-in Period||0
7631851|NCT02288325|18791366|P1|COMPLETED|Run-in Period||499
7631852|NCT02288325|18791364|P3|STARTED|Run-in Period||0
7631853|NCT02288325|18791365|P2|STARTED|Run-in Period||0
7631854|NCT02288325|18791366|P1|STARTED|Run-in Period||644
7631855|NCT02288312|18791376|P3|NOT COMPLETED|Overall Study||0
7631856|NCT02288312|18791377|P2|NOT COMPLETED|Overall Study||0
7631857|NCT02288312|18791378|P1|NOT COMPLETED|Overall Study||1
7631858|NCT02288312|18791376|P3|COMPLETED|Overall Study||6
7631859|NCT02288312|18791377|P2|COMPLETED|Overall Study||6
7631860|NCT02288312|18791378|P1|COMPLETED|Overall Study||5
7631861|NCT02288312|18791376|P3|STARTED|Overall Study||6
7631862|NCT02288312|18791377|P2|STARTED|Overall Study||6
7631863|NCT02288312|18791378|P1|STARTED|Overall Study||6
7631864|NCT02288273|18791397|P2|NOT COMPLETED|Overall Study||8
7631865|NCT02288273|18791398|P1|NOT COMPLETED|Overall Study||8
7631866|NCT02288273|18791397|P2|COMPLETED|Overall Study||48
7631867|NCT02288273|18791398|P1|COMPLETED|Overall Study||53
7631868|NCT02288273|18791397|P2|STARTED|Overall Study||56
7631869|NCT02288273|18791398|P1|STARTED|Overall Study||61
7631870|NCT02288182|18791418|P2|NOT COMPLETED|Overall Study||2
7631871|NCT02288182|18791419|P1|NOT COMPLETED|Overall Study||0
7631872|NCT02288182|18791418|P2|COMPLETED|Overall Study||25
7631873|NCT02288182|18791419|P1|COMPLETED|Overall Study||25
7631874|NCT02288182|18791418|P2|STARTED|Overall Study||27
7631875|NCT02288182|18791419|P1|STARTED|Overall Study||25
7631876|NCT02288091|18791431|P1|NOT COMPLETED|Overall Study||8
7631877|NCT02288091|18791431|P1|COMPLETED|Overall Study||24
7631878|NCT02288091|18791431|P1|Randomized/Treated|Overall Study||25
7631879|NCT02288091|18791431|P1|STARTED|Overall Study||32
7631880|NCT02287922|18791443|P4|NOT COMPLETED|Overall Study||7
7631881|NCT02287922|18791444|P3|NOT COMPLETED|Overall Study||7
7631882|NCT02287922|18791445|P2|NOT COMPLETED|Overall Study||2
7631883|NCT02287922|18791446|P1|NOT COMPLETED|Overall Study||3
7631884|NCT02287922|18791443|P4|COMPLETED|Overall Study||57
7631885|NCT02287922|18791444|P3|COMPLETED|Overall Study||56
7631886|NCT02287922|18791445|P2|COMPLETED|Overall Study||60
7631887|NCT02287922|18791446|P1|COMPLETED|Overall Study||59
7631888|NCT02287922|18791443|P4|STARTED|Overall Study||64
7631889|NCT02287922|18791444|P3|STARTED|Overall Study||63
7631890|NCT02287922|18791445|P2|STARTED|Overall Study||62
7631891|NCT02287922|18791446|P1|STARTED|Overall Study||62
7631892|NCT02287909|18791539|P4|NOT COMPLETED|Overall Study||1
7631893|NCT02287909|18791540|P3|NOT COMPLETED|Overall Study||0
7631894|NCT02287909|18791541|P2|NOT COMPLETED|Overall Study||1
7631895|NCT02287909|18791542|P1|NOT COMPLETED|Overall Study||2
7631896|NCT02287909|18791539|P4|COMPLETED|Overall Study||19
7631897|NCT02287909|18791540|P3|COMPLETED|Overall Study||20
7631898|NCT02287909|18791541|P2|COMPLETED|Overall Study||19
7631899|NCT02287909|18791542|P1|COMPLETED|Overall Study||18
7631900|NCT02287909|18791539|P4|STARTED|Overall Study||20
7631901|NCT02287909|18791540|P3|STARTED|Overall Study||20
7631902|NCT02287909|18791541|P2|STARTED|Overall Study||20
7631903|NCT02287909|18791542|P1|STARTED|Overall Study||20
7631904|NCT02287896|18791554|P2|NOT COMPLETED|Second Injection Visit||1
7631905|NCT02287896|18791555|P1|NOT COMPLETED|Second Injection Visit||0
7631906|NCT02287896|18791554|P2|COMPLETED|Second Injection Visit||25
7631907|NCT02287896|18791555|P1|COMPLETED|Second Injection Visit||36
7631908|NCT02287896|18791554|P2|STARTED|Second Injection Visit||26
7631909|NCT02287896|18791555|P1|STARTED|Second Injection Visit||36
7631910|NCT02287896|18791554|P2|NOT COMPLETED|First Injection Visit||0
7631911|NCT02287896|18791555|P1|NOT COMPLETED|First Injection Visit||0
7631912|NCT02287896|18791554|P2|COMPLETED|First Injection Visit||26
7631913|NCT02287896|18791555|P1|COMPLETED|First Injection Visit||36
7631914|NCT02287896|18791554|P2|STARTED|First Injection Visit||26
7631915|NCT02287896|18791555|P1|STARTED|First Injection Visit||36
7631916|NCT02287896|18791554|P2|NOT COMPLETED|Screening Visit V1||0
7631917|NCT02287896|18791555|P1|NOT COMPLETED|Screening Visit V1||0
7631918|NCT02287896|18791554|P2|COMPLETED|Screening Visit V1||26
7631919|NCT02287896|18791555|P1|COMPLETED|Screening Visit V1||36
7631920|NCT02287896|18791554|P2|STARTED|Screening Visit V1||26
7631921|NCT02287896|18791555|P1|STARTED|Screening Visit V1||36
7631922|NCT02287883|18791573|P2|NOT COMPLETED|Overall Study||426
7631923|NCT02287883|18791574|P1|NOT COMPLETED|Overall Study||459
7631924|NCT02287883|18791573|P2|COMPLETED|Overall Study||669
7631925|NCT02287883|18791574|P1|COMPLETED|Overall Study||622
7631926|NCT02287883|18791573|P2|One-year Follow-up Survey|Overall Study||669
7631927|NCT02287883|18791574|P1|One-year Follow-up Survey|Overall Study||622
7631928|NCT02287883|18791573|P2|STARTED|Overall Study||1095
7631929|NCT02287883|18791574|P1|STARTED|Overall Study||1081
7631930|NCT02287818|18791586|P2|NOT COMPLETED|Overall Study||13
7631931|NCT02287818|18791587|P1|NOT COMPLETED|Overall Study||7
7631932|NCT02287818|18791586|P2|COMPLETED|Overall Study||54
7631933|NCT02287818|18791587|P1|COMPLETED|Overall Study||53
7631934|NCT02287818|18791586|P2|STARTED|Overall Study||67
7631935|NCT02287818|18791587|P1|STARTED|Overall Study||60
7631936|NCT02287779|18791601|P8|NOT COMPLETED|Overall Study||0
7631937|NCT02287779|18791602|P7|NOT COMPLETED|Overall Study||0
7631938|NCT02287779|18791603|P6|NOT COMPLETED|Overall Study||0
7631939|NCT02287779|18791604|P5|NOT COMPLETED|Overall Study||0
7631940|NCT02287779|18791605|P4|NOT COMPLETED|Overall Study||0
7631941|NCT02287779|18791606|P3|NOT COMPLETED|Overall Study||0
7631942|NCT02287779|18791607|P2|NOT COMPLETED|Overall Study||0
7631943|NCT02287779|18791608|P1|NOT COMPLETED|Overall Study||0
7631944|NCT02287779|18791601|P8|COMPLETED|Overall Study||9
7631945|NCT02287779|18791602|P7|COMPLETED|Overall Study||9
7631946|NCT02287779|18791603|P6|COMPLETED|Overall Study||9
7631947|NCT02287779|18791604|P5|COMPLETED|Overall Study||9
7631948|NCT02287779|18791605|P4|COMPLETED|Overall Study||9
7631949|NCT02287779|18791606|P3|COMPLETED|Overall Study||9
7631950|NCT02287779|18791607|P2|COMPLETED|Overall Study||9
7631951|NCT02287779|18791608|P1|COMPLETED|Overall Study||21
7631952|NCT02287779|18791601|P8|STARTED|Overall Study||9
7631953|NCT02287779|18791602|P7|STARTED|Overall Study||9
7631954|NCT02287779|18791603|P6|STARTED|Overall Study||9
7631955|NCT02287779|18791604|P5|STARTED|Overall Study||9
7631956|NCT02287779|18791605|P4|STARTED|Overall Study||9
7631957|NCT02287779|18791606|P3|STARTED|Overall Study||9
7631958|NCT02287779|18791607|P2|STARTED|Overall Study||9
7631959|NCT02287779|18791608|P1|STARTED|Overall Study||21
7631960|NCT02287688|18791746|P1|NOT COMPLETED|Overall Study||0
7631961|NCT02287688|18791746|P1|COMPLETED|Overall Study||138
7631962|NCT02287688|18791746|P1|STARTED|Overall Study||138
7631963|NCT02287675|18791757|P2|NOT COMPLETED|Overall Study||0
7631964|NCT02287675|18791758|P1|NOT COMPLETED|Overall Study||0
7631965|NCT02287675|18791757|P2|COMPLETED|Overall Study||18
7631966|NCT02287675|18791758|P1|COMPLETED|Overall Study||22
7631967|NCT02287675|18791757|P2|STARTED|Overall Study||18
7631968|NCT02287675|18791758|P1|STARTED|Overall Study||22
7631969|NCT02287636|18791774|P1|NOT COMPLETED|Overall Study||0
7631970|NCT02287636|18791774|P1|COMPLETED|Overall Study||13
7631971|NCT02287636|18791774|P1|STARTED|Overall Study||13
7631972|NCT02287623|18791785|P2|NOT COMPLETED|Overall Study||1
7631973|NCT02287623|18791786|P1|NOT COMPLETED|Overall Study||0
7631974|NCT02287623|18791785|P2|COMPLETED|Overall Study||29
7631975|NCT02287623|18791786|P1|COMPLETED|Overall Study||30
7631976|NCT02287623|18791785|P2|STARTED|Overall Study||30
7631977|NCT02287623|18791786|P1|STARTED|Overall Study||30
7631978|NCT02287610|18791802|P1|NOT COMPLETED|Overall Study||16
7631979|NCT02287610|18791802|P1|COMPLETED|Overall Study||48
7631980|NCT02287610|18791802|P1|Per Protocol Follow-Up|Overall Study||56
7631981|NCT02287610|18791802|P1|STARTED|Overall Study||64
7631982|NCT02287584|18791838|P6|NOT COMPLETED|the Open-label Phase||57
7631983|NCT02287584|18791839|P5|NOT COMPLETED|the Open-label Phase||62
7631984|NCT02287584|18791840|P4|NOT COMPLETED|the Open-label Phase||57
7631985|NCT02287584|18791841|P3|NOT COMPLETED|the Open-label Phase||0
7631986|NCT02287584|18791842|P2|NOT COMPLETED|the Open-label Phase||0
7631987|NCT02287584|18791843|P1|NOT COMPLETED|the Open-label Phase||0
7631988|NCT02287584|18791838|P6|COMPLETED|the Open-label Phase||104
7631989|NCT02287584|18791839|P5|COMPLETED|the Open-label Phase||87
7631990|NCT02287584|18791840|P4|COMPLETED|the Open-label Phase||81
7631991|NCT02287584|18791841|P3|COMPLETED|the Open-label Phase||0
7631992|NCT02287584|18791842|P2|COMPLETED|the Open-label Phase||0
7631993|NCT02287584|18791843|P1|COMPLETED|the Open-label Phase||0
7631994|NCT02287584|18791838|P6|Treated|the Open-label Phase||157
7631995|NCT02287584|18791839|P5|Treated|the Open-label Phase||143
7631996|NCT02287584|18791840|P4|Treated|the Open-label Phase||131
7631997|NCT02287584|18791841|P3|Treated|the Open-label Phase||0
7631998|NCT02287584|18791842|P2|Treated|the Open-label Phase||0
7631999|NCT02287584|18791843|P1|Treated|the Open-label Phase||0
7632000|NCT02287584|18791838|P6|STARTED|the Open-label Phase||161
7632001|NCT02287584|18791839|P5|STARTED|the Open-label Phase||149
7632002|NCT02287584|18791840|P4|STARTED|the Open-label Phase||138
7632003|NCT02287584|18791841|P3|STARTED|the Open-label Phase||0
7632004|NCT02287584|18791842|P2|STARTED|the Open-label Phase||0
7632005|NCT02287584|18791843|P1|STARTED|the Open-label Phase||0
7632006|NCT02287584|18791838|P6|NOT COMPLETED|the Double-blind Phase||0
7632007|NCT02287584|18791839|P5|NOT COMPLETED|the Double-blind Phase||0
7632008|NCT02287584|18791840|P4|NOT COMPLETED|the Double-blind Phase||0
7632009|NCT02287584|18791841|P3|NOT COMPLETED|the Double-blind Phase||33
7632010|NCT02287584|18791842|P2|NOT COMPLETED|the Double-blind Phase||47
7632011|NCT02287584|18791843|P1|NOT COMPLETED|the Double-blind Phase||52
7632012|NCT02287584|18791838|P6|COMPLETED|the Double-blind Phase||0
7632013|NCT02287584|18791839|P5|COMPLETED|the Double-blind Phase||0
7632014|NCT02287584|18791840|P4|COMPLETED|the Double-blind Phase||0
7632015|NCT02287584|18791841|P3|COMPLETED|the Double-blind Phase||161
7632016|NCT02287584|18791842|P2|COMPLETED|the Double-blind Phase||149
7632017|NCT02287584|18791843|P1|COMPLETED|the Double-blind Phase||138
7632018|NCT02287584|18791838|P6|STARTED|the Double-blind Phase||0
7632019|NCT02287584|18791839|P5|STARTED|the Double-blind Phase||0
7632020|NCT02287584|18791840|P4|STARTED|the Double-blind Phase||0
7632021|NCT02287584|18791841|P3|STARTED|the Double-blind Phase||194
7632022|NCT02287584|18791842|P2|STARTED|the Double-blind Phase||196
7632023|NCT02287584|18791843|P1|STARTED|the Double-blind Phase||190
7632024|NCT02287467|18791862|P2|NOT COMPLETED|Overall Study||9
7632025|NCT02287467|18791863|P1|NOT COMPLETED|Overall Study||12
7632026|NCT02287467|18791862|P2|COMPLETED|Overall Study||152
7632027|NCT02287467|18791863|P1|COMPLETED|Overall Study||156
7632028|NCT02287467|18791862|P2|STARTED|Overall Study||161
7632029|NCT02287467|18791863|P1|STARTED|Overall Study||168
7632030|NCT02287415|18791905|P1|NOT COMPLETED|Overall Study||0
7632031|NCT02287415|18791905|P1|COMPLETED|Overall Study||13
7632032|NCT02287415|18791905|P1|STARTED|Overall Study||13
7632033|NCT02287402|18791911|P1|NOT COMPLETED|Follow-up||3
7632034|NCT02287402|18791911|P1|COMPLETED|Follow-up||103
7632035|NCT02287402|18791911|P1|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106
7632036|NCT02287402|18791911|P1|NOT COMPLETED|Treatment Period||27
7632037|NCT02287402|18791911|P1|COMPLETED|Treatment Period||170
7632038|NCT02287402|18791911|P1|STARTED|Treatment Period||197
7632039|NCT02287376|18791926|P1|NOT COMPLETED|Overall Study||0
7632040|NCT02287376|18791926|P1|COMPLETED|Overall Study||25
7632041|NCT02287376|18791926|P1|STARTED|Overall Study||25
7632042|NCT02287350|18791969|P1|NOT COMPLETED|Overall Study||3
7632043|NCT02287350|18791969|P1|COMPLETED|Overall Study||48
7632044|NCT02287350|18791969|P1|STARTED|Overall Study||51
7632045|NCT02287038|18792016|P2|NOT COMPLETED|Overall Study||3
7632046|NCT02287038|18792017|P1|NOT COMPLETED|Overall Study||5
7632047|NCT02287038|18792016|P2|COMPLETED|Overall Study||18
7632048|NCT02287038|18792017|P1|COMPLETED|Overall Study||18
7632049|NCT02287038|18792016|P2|STARTED|Overall Study||21
7632050|NCT02287038|18792017|P1|STARTED|Overall Study||23
7632051|NCT02287025|18792027|P2|NOT COMPLETED|Overall Study||9
7632052|NCT02287025|18792028|P1|NOT COMPLETED|Overall Study||10
7632053|NCT02287025|18792027|P2|COMPLETED|Overall Study||2
7632054|NCT02287025|18792028|P1|COMPLETED|Overall Study||2
7632055|NCT02287025|18792027|P2|STARTED|Overall Study||11
7632056|NCT02287025|18792028|P1|STARTED|Overall Study||12
7632057|NCT02286960|18792039|P2|NOT COMPLETED|Overall Study||3
7632058|NCT02286960|18792040|P1|NOT COMPLETED|Overall Study||3
7632059|NCT02286960|18792039|P2|COMPLETED|Overall Study||14
7632060|NCT02286960|18792040|P1|COMPLETED|Overall Study||16
7632061|NCT02286960|18792039|P2|STARTED|Overall Study||17
7632062|NCT02286960|18792040|P1|STARTED|Overall Study||19
7632063|NCT02286947|18792052|P1|NOT COMPLETED|Overall Study||2
7632064|NCT02286947|18792052|P1|COMPLETED|Overall Study||22
7632065|NCT02286947|18792052|P1|STARTED|Overall Study||24
7632066|NCT02286921|18792063|P2|NOT COMPLETED|Overall Study||0
7632067|NCT02286921|18792064|P1|NOT COMPLETED|Overall Study||0
7632068|NCT02286921|18792063|P2|COMPLETED|Overall Study||101
7632069|NCT02286921|18792064|P1|COMPLETED|Overall Study||94
7632070|NCT02286921|18792063|P2|STARTED|Overall Study||101
7632071|NCT02286921|18792064|P1|STARTED|Overall Study||94
7632072|NCT02286895|18792098|P2|NOT COMPLETED|Assessed for Measles Seroconversion||39
7632073|NCT02286895|18792099|P1|NOT COMPLETED|Assessed for Measles Seroconversion||48
7632074|NCT02286895|18792098|P2|COMPLETED|Assessed for Measles Seroconversion||261
7632075|NCT02286895|18792099|P1|COMPLETED|Assessed for Measles Seroconversion||252
7632076|NCT02286895|18792098|P2|STARTED|Assessed for Measles Seroconversion||300
7632077|NCT02286895|18792099|P1|STARTED|Assessed for Measles Seroconversion||300
7632078|NCT02286895|18792098|P2|NOT COMPLETED|Randomized and Vaccinated||0
7632079|NCT02286895|18792099|P1|NOT COMPLETED|Randomized and Vaccinated||0
7632080|NCT02286895|18792098|P2|COMPLETED|Randomized and Vaccinated||300
7632081|NCT02286895|18792099|P1|COMPLETED|Randomized and Vaccinated||300
7632082|NCT02286895|18792098|P2|STARTED|Randomized and Vaccinated||300
7632083|NCT02286895|18792099|P1|STARTED|Randomized and Vaccinated||300
7632084|NCT02286713|18792143|P2|NOT COMPLETED|Six Month Follow-Up||27
7632085|NCT02286713|18792144|P1|NOT COMPLETED|Six Month Follow-Up||32
7632086|NCT02286713|18792143|P2|COMPLETED|Six Month Follow-Up||225
7632087|NCT02286713|18792144|P1|COMPLETED|Six Month Follow-Up||218
7632088|NCT02286713|18792143|P2|STARTED|Six Month Follow-Up||252
7632089|NCT02286713|18792144|P1|STARTED|Six Month Follow-Up||250
7632090|NCT02286713|18792143|P2|NOT COMPLETED|Three Month Follow-Up||26
7632091|NCT02286713|18792144|P1|NOT COMPLETED|Three Month Follow-Up||28
7632092|NCT02286713|18792143|P2|COMPLETED|Three Month Follow-Up||228
7632093|NCT02286713|18792144|P1|COMPLETED|Three Month Follow-Up||224
7632094|NCT02286713|18792143|P2|STARTED|Three Month Follow-Up||254
7632095|NCT02286713|18792144|P1|STARTED|Three Month Follow-Up||252
7632096|NCT02286713|18792143|P2|NOT COMPLETED|One Week Follow-Up||24
7632097|NCT02286713|18792144|P1|NOT COMPLETED|One Week Follow-Up||24
7632098|NCT02286713|18792143|P2|COMPLETED|One Week Follow-Up||233
7632099|NCT02286713|18792144|P1|COMPLETED|One Week Follow-Up||235
7632100|NCT02286713|18792143|P2|STARTED|One Week Follow-Up||257
7632101|NCT02286713|18792144|P1|STARTED|One Week Follow-Up||259
7632102|NCT02286518|18792170|P14|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632103|NCT02286518|18792171|P13|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632104|NCT02286518|18792172|P12|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632105|NCT02286518|18792173|P11|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632106|NCT02286518|18792174|P10|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632107|NCT02286518|18792175|P9|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632108|NCT02286518|18792176|P8|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632109|NCT02286518|18792177|P7|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632110|NCT02286518|18792178|P6|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632111|NCT02286518|18792179|P5|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632112|NCT02286518|18792180|P4|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632113|NCT02286518|18792181|P3|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632114|NCT02286518|18792182|P2|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632115|NCT02286518|18792183|P1|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632116|NCT02286518|18792170|P14|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632117|NCT02286518|18792171|P13|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632118|NCT02286518|18792172|P12|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632119|NCT02286518|18792173|P11|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632120|NCT02286518|18792174|P10|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632121|NCT02286518|18792175|P9|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
7632122|NCT02286518|18792176|P8|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
7632123|NCT02286518|18792177|P7|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632124|NCT02286518|18792178|P6|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632125|NCT02286518|18792179|P5|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632126|NCT02286518|18792180|P4|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632127|NCT02286518|18792181|P3|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632128|NCT02286518|18792182|P2|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632129|NCT02286518|18792183|P1|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
7632130|NCT02286518|18792170|P14|STARTED|Crossover Treatment (Part 2: 3 Days)||0
7632131|NCT02286518|18792171|P13|STARTED|Crossover Treatment (Part 2: 3 Days)||0
7632132|NCT02286518|18792172|P12|STARTED|Crossover Treatment (Part 2: 3 Days)||0
7632133|NCT02286518|18792173|P11|STARTED|Crossover Treatment (Part 2: 3 Days)||0
7632134|NCT02286518|18792174|P10|STARTED|Crossover Treatment (Part 2: 3 Days)||0
7632135|NCT02286518|18792175|P9|STARTED|Crossover Treatment (Part 2: 3 Days)||6
7632136|NCT02286518|18792176|P8|STARTED|Crossover Treatment (Part 2: 3 Days)||6
7632137|NCT02286518|18792177|P7|STARTED|Crossover Treatment (Part 2: 3 Days)||0
7632138|NCT02286518|18792178|P6|STARTED|Crossover Treatment (Part 2: 3 Days)||0
7632139|NCT02286518|18792179|P5|STARTED|Crossover Treatment (Part 2: 3 Days)||0
7632140|NCT02286518|18792180|P4|STARTED|Crossover Treatment (Part 2: 3 Days)||0
7632141|NCT02286518|18792181|P3|STARTED|Crossover Treatment (Part 2: 3 Days)||0
7632142|NCT02286518|18792182|P2|STARTED|Crossover Treatment (Part 2: 3 Days)||0
7632143|NCT02286518|18792183|P1|STARTED|Crossover Treatment (Part 2: 3 Days)||0
7632144|NCT02286518|18792170|P14|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632145|NCT02286518|18792171|P13|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632146|NCT02286518|18792172|P12|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632147|NCT02286518|18792173|P11|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632148|NCT02286518|18792174|P10|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632149|NCT02286518|18792175|P9|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632150|NCT02286518|18792176|P8|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632151|NCT02286518|18792177|P7|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632152|NCT02286518|18792178|P6|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632153|NCT02286518|18792179|P5|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632154|NCT02286518|18792180|P4|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632155|NCT02286518|18792181|P3|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632156|NCT02286518|18792182|P2|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632157|NCT02286518|18792183|P1|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632158|NCT02286518|18792170|P14|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632159|NCT02286518|18792171|P13|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632160|NCT02286518|18792172|P12|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632161|NCT02286518|18792173|P11|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632162|NCT02286518|18792174|P10|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632163|NCT02286518|18792175|P9|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
7632164|NCT02286518|18792176|P8|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
7632165|NCT02286518|18792177|P7|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632166|NCT02286518|18792178|P6|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632167|NCT02286518|18792179|P5|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632168|NCT02286518|18792180|P4|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632169|NCT02286518|18792181|P3|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632170|NCT02286518|18792182|P2|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632171|NCT02286518|18792183|P1|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
7632172|NCT02286518|18792170|P14|STARTED|Washout Crossover Period(Part 2:14 Days)||0
7632173|NCT02286518|18792171|P13|STARTED|Washout Crossover Period(Part 2:14 Days)||0
7632174|NCT02286518|18792172|P12|STARTED|Washout Crossover Period(Part 2:14 Days)||0
7632175|NCT02286518|18792173|P11|STARTED|Washout Crossover Period(Part 2:14 Days)||0
7632176|NCT02286518|18792174|P10|STARTED|Washout Crossover Period(Part 2:14 Days)||0
7632177|NCT02286518|18792175|P9|STARTED|Washout Crossover Period(Part 2:14 Days)||6
7632178|NCT02286518|18792176|P8|STARTED|Washout Crossover Period(Part 2:14 Days)||6
7632179|NCT02286518|18792177|P7|STARTED|Washout Crossover Period(Part 2:14 Days)||0
7632180|NCT02286518|18792178|P6|STARTED|Washout Crossover Period(Part 2:14 Days)||0
7632181|NCT02286518|18792179|P5|STARTED|Washout Crossover Period(Part 2:14 Days)||0
7632182|NCT02286518|18792180|P4|STARTED|Washout Crossover Period(Part 2:14 Days)||0
7632183|NCT02286518|18792181|P3|STARTED|Washout Crossover Period(Part 2:14 Days)||0
7632184|NCT02286518|18792182|P2|STARTED|Washout Crossover Period(Part 2:14 Days)||0
7632185|NCT02286518|18792183|P1|STARTED|Washout Crossover Period(Part 2:14 Days)||0
7632186|NCT02286518|18792170|P14|NOT COMPLETED|All Parts (16 Days)||0
7632187|NCT02286518|18792171|P13|NOT COMPLETED|All Parts (16 Days)||0
7632188|NCT02286518|18792172|P12|NOT COMPLETED|All Parts (16 Days)||0
7632189|NCT02286518|18792173|P11|NOT COMPLETED|All Parts (16 Days)||0
7632190|NCT02286518|18792174|P10|NOT COMPLETED|All Parts (16 Days)||0
7632191|NCT02286518|18792175|P9|NOT COMPLETED|All Parts (16 Days)||0
7632192|NCT02286518|18792176|P8|NOT COMPLETED|All Parts (16 Days)||0
7632193|NCT02286518|18792177|P7|NOT COMPLETED|All Parts (16 Days)||0
7632194|NCT02286518|18792178|P6|NOT COMPLETED|All Parts (16 Days)||0
7632195|NCT02286518|18792179|P5|NOT COMPLETED|All Parts (16 Days)||0
7632196|NCT02286518|18792180|P4|NOT COMPLETED|All Parts (16 Days)||0
7632197|NCT02286518|18792181|P3|NOT COMPLETED|All Parts (16 Days)||0
7632198|NCT02286518|18792182|P2|NOT COMPLETED|All Parts (16 Days)||0
7632199|NCT02286518|18792183|P1|NOT COMPLETED|All Parts (16 Days)||0
7632200|NCT02286518|18792170|P14|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
7632201|NCT02286518|18792171|P13|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
7632202|NCT02286518|18792172|P12|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
7632203|NCT02286518|18792173|P11|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
7632204|NCT02286518|18792174|P10|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4
7632205|NCT02286518|18792175|P9|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6
7632206|NCT02286518|18792176|P8|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6
7632207|NCT02286518|18792177|P7|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
7632208|NCT02286518|18792178|P6|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
7632209|NCT02286518|18792179|P5|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
7632210|NCT02286518|18792180|P4|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
7632211|NCT02286518|18792181|P3|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
7632212|NCT02286518|18792182|P2|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
7632213|NCT02286518|18792183|P1|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
7632214|NCT02286518|18792170|P14|STARTED|All Parts (16 Days)||6
7632215|NCT02286518|18792171|P13|STARTED|All Parts (16 Days)||6
7632216|NCT02286518|18792172|P12|STARTED|All Parts (16 Days)||6
7632217|NCT02286518|18792173|P11|STARTED|All Parts (16 Days)||6
7632218|NCT02286518|18792174|P10|STARTED|All Parts (16 Days)||4
7632219|NCT02286518|18792175|P9|STARTED|All Parts (16 Days)||6
7632220|NCT02286518|18792176|P8|STARTED|All Parts (16 Days)||6
7632221|NCT02286518|18792177|P7|STARTED|All Parts (16 Days)||6
7632222|NCT02286518|18792178|P6|STARTED|All Parts (16 Days)||6
7632223|NCT02286518|18792179|P5|STARTED|All Parts (16 Days)||6
7632224|NCT02286518|18792180|P4|STARTED|All Parts (16 Days)||6
7632225|NCT02286518|18792181|P3|STARTED|All Parts (16 Days)||6
7632226|NCT02286518|18792182|P2|STARTED|All Parts (16 Days)||6
7632227|NCT02286518|18792183|P1|STARTED|All Parts (16 Days)||6
7632228|NCT02286466|18792325|P2|NOT COMPLETED|Overall Study||10
7632229|NCT02286466|18792326|P1|NOT COMPLETED|Overall Study||7
7632230|NCT02286466|18792325|P2|COMPLETED|Overall Study||63
7632231|NCT02286466|18792326|P1|COMPLETED|Overall Study||65
7632232|NCT02286466|18792325|P2|Post Self-report|Overall Study||68
7632233|NCT02286466|18792326|P1|Post Self-report|Overall Study||67
7632234|NCT02286466|18792325|P2|Baseline Clinician Assessment|Overall Study||72
7632235|NCT02286466|18792326|P1|Baseline Clinician Assessment|Overall Study||72
7632236|NCT02286466|18792325|P2|STARTED|Overall Study||73
7632237|NCT02286466|18792326|P1|STARTED|Overall Study||72
7632238|NCT02286193|18792338|P1|NOT COMPLETED|Overall Study||204
7632239|NCT02286193|18792338|P1|COMPLETED|Overall Study||418
7632240|NCT02286193|18792338|P1|STARTED|Overall Study||622
7632241|NCT02286102|18792345|P2|NOT COMPLETED|Overall Study||1
7632242|NCT02286102|18792346|P1|NOT COMPLETED|Overall Study||1
7632243|NCT02286102|18792345|P2|COMPLETED|Overall Study||33
7632244|NCT02286102|18792346|P1|COMPLETED|Overall Study||35
7632245|NCT02286102|18792345|P2|STARTED|Overall Study||34
7632246|NCT02286102|18792346|P1|STARTED|Overall Study||36
7632247|NCT02285998|18792358|P2|NOT COMPLETED|Overall Study||253
7632248|NCT02285998|18792359|P1|NOT COMPLETED|Overall Study||246
7632249|NCT02285998|18792358|P2|COMPLETED|Overall Study||4236
7632250|NCT02285998|18792359|P1|COMPLETED|Overall Study||4228
7632251|NCT02285998|18792358|P2|STARTED|Overall Study||4489
7632252|NCT02285998|18792359|P1|STARTED|Overall Study||4474
7632253|NCT02285920|18792387|P4|NOT COMPLETED|Overall Study||1
7632254|NCT02285920|18792388|P3|NOT COMPLETED|Overall Study||5
7632255|NCT02285920|18792389|P2|NOT COMPLETED|Overall Study||4
7632256|NCT02285920|18792390|P1|NOT COMPLETED|Overall Study||4
7632257|NCT02285920|18792387|P4|COMPLETED|Overall Study||24
7632258|NCT02285920|18792388|P3|COMPLETED|Overall Study||21
7632259|NCT02285920|18792389|P2|COMPLETED|Overall Study||23
7632260|NCT02285920|18792390|P1|COMPLETED|Overall Study||47
7632261|NCT02285920|18792387|P4|STARTED|Overall Study||25
7632262|NCT02285920|18792388|P3|STARTED|Overall Study||26
7632263|NCT02285920|18792389|P2|STARTED|Overall Study||27
7632264|NCT02285920|18792390|P1|STARTED|Overall Study||51
7632265|NCT02285907|18792452|P1|NOT COMPLETED|Overall Study||0
7632266|NCT02285907|18792452|P1|COMPLETED|Overall Study||21
7632267|NCT02285907|18792452|P1|Began 4th Intervention|Overall Study||21
7632268|NCT02285907|18792452|P1|Began 3rd Intervention|Overall Study||21
7632269|NCT02285907|18792452|P1|Began 2nd Intervention|Overall Study||21
7632270|NCT02285907|18792452|P1|Began 1st Intervention|Overall Study||21
7632271|NCT02285907|18792452|P1|STARTED|Overall Study||21
7632272|NCT02285855|18792480|P2|NOT COMPLETED|Overall Study||1
7632273|NCT02285855|18792481|P1|NOT COMPLETED|Overall Study||2
7632274|NCT02285855|18792480|P2|COMPLETED|Overall Study||1
7632275|NCT02285855|18792481|P1|COMPLETED|Overall Study||14
7632276|NCT02285855|18792480|P2|Randomized|Overall Study||2
7632277|NCT02285855|18792481|P1|Randomized|Overall Study||16
7632278|NCT02285855|18792480|P2|STARTED|Overall Study||2
7632279|NCT02285855|18792481|P1|STARTED|Overall Study||16
7632280|NCT02285777|18792489|P2|NOT COMPLETED|Overall Study||3
7632281|NCT02285777|18792490|P1|NOT COMPLETED|Overall Study||5
7632282|NCT02285777|18792489|P2|COMPLETED|Overall Study||91
7632283|NCT02285777|18792490|P1|COMPLETED|Overall Study||90
7632284|NCT02285777|18792489|P2|STARTED|Overall Study||94
7632285|NCT02285777|18792490|P1|STARTED|Overall Study||95
7632286|NCT02285634|18792546|P4|NOT COMPLETED|Overall Study||1
7632287|NCT02285634|18792547|P3|NOT COMPLETED|Overall Study||4
7632288|NCT02285634|18792548|P2|NOT COMPLETED|Overall Study||0
7632289|NCT02285634|18792549|P1|NOT COMPLETED|Overall Study||0
7632290|NCT02285634|18792546|P4|COMPLETED|Overall Study||17
7632291|NCT02285634|18792547|P3|COMPLETED|Overall Study||11
7632292|NCT02285634|18792548|P2|COMPLETED|Overall Study||20
7632293|NCT02285634|18792549|P1|COMPLETED|Overall Study||15
7632294|NCT02285634|18792546|P4|STARTED|Overall Study||18
7632295|NCT02285634|18792547|P3|STARTED|Overall Study||15
7632296|NCT02285634|18792548|P2|STARTED|Overall Study||20
7632297|NCT02285634|18792549|P1|STARTED|Overall Study||15
7632298|NCT02285283|18792573|P2|NOT COMPLETED|Overall Study||9
7632299|NCT02285283|18792574|P1|NOT COMPLETED|Overall Study||4
7632300|NCT02285283|18792573|P2|COMPLETED|Overall Study||20
7632301|NCT02285283|18792574|P1|COMPLETED|Overall Study||25
7632302|NCT02285283|18792573|P2|STARTED|Overall Study||29
7632303|NCT02285283|18792574|P1|STARTED|Overall Study||29
7632304|NCT02285270|18792582|P1|NOT COMPLETED|Overall Study||5
7632305|NCT02285270|18792582|P1|COMPLETED|Overall Study||5
7632306|NCT02285270|18792582|P1|STARTED|Overall Study||10
7632307|NCT02285153|18792590|P2|NOT COMPLETED|Overall Study||0
7632308|NCT02285153|18792591|P1|NOT COMPLETED|Overall Study||1
7632309|NCT02285153|18792590|P2|COMPLETED|Overall Study||8
7632310|NCT02285153|18792591|P1|COMPLETED|Overall Study||6
7632311|NCT02285153|18792590|P2|STARTED|Overall Study||8
7632312|NCT02285153|18792591|P1|STARTED|Overall Study||7
7632313|NCT02285062|18792605|P2|NOT COMPLETED|Overall Study||84
7632314|NCT02285062|18792606|P1|NOT COMPLETED|Overall Study||78
7632315|NCT02285062|18792605|P2|COMPLETED|Overall Study||201
7632316|NCT02285062|18792606|P1|COMPLETED|Overall Study||207
7632317|NCT02285062|18792605|P2|Ongoing Study Treatment|Overall Study||0
7632318|NCT02285062|18792606|P1|Ongoing Study Treatment|Overall Study||0
7632319|NCT02285062|18792605|P2|Received Study Treatment|Overall Study||284
7632320|NCT02285062|18792606|P1|Received Study Treatment|Overall Study||283
7632321|NCT02285062|18792605|P2|STARTED|Overall Study||285
7632322|NCT02285062|18792606|P1|STARTED|Overall Study||285
7632323|NCT02285023|18792642|P1|NOT COMPLETED|Overall Study||0
7632324|NCT02285023|18792642|P1|COMPLETED|Overall Study||166
7632325|NCT02285023|18792642|P1|STARTED|Overall Study||166
7632326|NCT02285010|18792654|P2|NOT COMPLETED|Overall Study||1
7632327|NCT02285010|18792655|P1|NOT COMPLETED|Overall Study||5
7632328|NCT02285010|18792654|P2|COMPLETED|Overall Study||61
7632329|NCT02285010|18792655|P1|COMPLETED|Overall Study||58
7632330|NCT02285010|18792654|P2|STARTED|Overall Study||62
7632331|NCT02285010|18792655|P1|STARTED|Overall Study||63
7632332|NCT02284906|18792672|P3|NOT COMPLETED|Overall Study||19
7632333|NCT02284906|18792673|P2|NOT COMPLETED|Overall Study||18
7632334|NCT02284906|18792674|P1|NOT COMPLETED|Overall Study||3
7632335|NCT02284906|18792672|P3|COMPLETED|Overall Study||0
7632336|NCT02284906|18792673|P2|COMPLETED|Overall Study||0
7632337|NCT02284906|18792674|P1|COMPLETED|Overall Study||0
7632338|NCT02284906|18792672|P3|STARTED|Overall Study||19
7632339|NCT02284906|18792673|P2|STARTED|Overall Study||18
7632340|NCT02284906|18792674|P1|STARTED|Overall Study||3
7632341|NCT02284893|18792687|P2|NOT COMPLETED|52 Week (Long Term)||13
7632342|NCT02284893|18792688|P1|NOT COMPLETED|52 Week (Long Term)||11
7632343|NCT02284893|18792687|P2|COMPLETED|52 Week (Long Term)||180
7632344|NCT02284893|18792688|P1|COMPLETED|52 Week (Long Term)||198
7632345|NCT02284893|18792687|P2|STARTED|52 Week (Long Term)||193
7632346|NCT02284893|18792688|P1|STARTED|52 Week (Long Term)||209
7632347|NCT02284893|18792687|P2|NOT COMPLETED|26 Week (Short Term)||31
7632348|NCT02284893|18792688|P1|NOT COMPLETED|26 Week (Short Term)||19
7632349|NCT02284893|18792687|P2|COMPLETED|26 Week (Short Term)||198
7632350|NCT02284893|18792688|P1|COMPLETED|26 Week (Short Term)||213
7632351|NCT02284893|18792687|P2|STARTED|26 Week (Short Term)||229
7632352|NCT02284893|18792688|P1|STARTED|26 Week (Short Term)||232
7632353|NCT02284880|18792702|P4|NOT COMPLETED|Overall Study||0
7632354|NCT02284880|18792703|P3|NOT COMPLETED|Overall Study||2
7632355|NCT02284880|18792704|P2|NOT COMPLETED|Overall Study||0
7632356|NCT02284880|18792705|P1|NOT COMPLETED|Overall Study||0
7632357|NCT02284880|18792702|P4|COMPLETED|Overall Study||10
7632358|NCT02284880|18792703|P3|COMPLETED|Overall Study||8
7632359|NCT02284880|18792704|P2|COMPLETED|Overall Study||9
7632360|NCT02284880|18792705|P1|COMPLETED|Overall Study||11
7632361|NCT02284880|18792702|P4|Second Period (4 Days)|Overall Study||10
7632362|NCT02284880|18792703|P3|Second Period (4 Days)|Overall Study||8
7632363|NCT02284880|18792704|P2|Second Period (4 Days)|Overall Study||9
7632364|NCT02284880|18792705|P1|Second Period (4 Days)|Overall Study||11
7632365|NCT02284880|18792702|P4|Wash-out Period (7 Days)|Overall Study||10
7632366|NCT02284880|18792703|P3|Wash-out Period (7 Days)|Overall Study||10
7632367|NCT02284880|18792704|P2|Wash-out Period (7 Days)|Overall Study||9
7632368|NCT02284880|18792705|P1|Wash-out Period (7 Days)|Overall Study||11
7632369|NCT02284880|18792702|P4|First Period (4 Days)|Overall Study||10
7632370|NCT02284880|18792703|P3|First Period (4 Days)|Overall Study||10
7632371|NCT02284880|18792704|P2|First Period (4 Days)|Overall Study||9
7632372|NCT02284880|18792705|P1|First Period (4 Days)|Overall Study||11
7632373|NCT02284880|18792702|P4|STARTED|Overall Study||10
7632374|NCT02284880|18792703|P3|STARTED|Overall Study||10
7632375|NCT02284880|18792704|P2|STARTED|Overall Study||9
7632376|NCT02284880|18792705|P1|STARTED|Overall Study||11
7632377|NCT02284867|18792721|P2|NOT COMPLETED|Overall Study||0
7632378|NCT02284867|18792722|P1|NOT COMPLETED|Overall Study||0
7632379|NCT02284867|18792721|P2|COMPLETED|Overall Study||30
7632380|NCT02284867|18792722|P1|COMPLETED|Overall Study||30
7632381|NCT02284867|18792721|P2|STARTED|Overall Study||30
7632382|NCT02284867|18792722|P1|STARTED|Overall Study||30
7632383|NCT02284854|18792732|P2|NOT COMPLETED|Overall Study||0
7632384|NCT02284854|18792733|P1|NOT COMPLETED|Overall Study||5
7632385|NCT02284854|18792732|P2|COMPLETED|Overall Study||20
7632386|NCT02284854|18792733|P1|COMPLETED|Overall Study||18
7632387|NCT02284854|18792732|P2|STARTED|Overall Study||20
7632388|NCT02284854|18792733|P1|STARTED|Overall Study||23
7632389|NCT02284828|18792750|P1|NOT COMPLETED|Overall Study||4
7632390|NCT02284828|18792750|P1|COMPLETED|Overall Study||22
7632391|NCT02284828|18792750|P1|STARTED|Overall Study||26
7632392|NCT02284568|18792765|P3|NOT COMPLETED|Overall Study||95
7632393|NCT02284568|18792766|P2|NOT COMPLETED|Overall Study||46
7632394|NCT02284568|18792767|P1|NOT COMPLETED|Overall Study||31
7632395|NCT02284568|18792765|P3|COMPLETED|Overall Study||0
7632396|NCT02284568|18792766|P2|COMPLETED|Overall Study||93
7632397|NCT02284568|18792767|P1|COMPLETED|Overall Study||109
7632398|NCT02284568|18792765|P3|Completed Week 48 MRI - on Treatment|Overall Study||0
7632399|NCT02284568|18792766|P2|Completed Week 48 MRI - on Treatment|Overall Study||107
7632400|NCT02284568|18792767|P1|Completed Week 48 MRI - on Treatment|Overall Study||113
7632401|NCT02284568|18792765|P3|Safety Population|Overall Study||95
7632402|NCT02284568|18792766|P2|Safety Population|Overall Study||138
7632403|NCT02284568|18792767|P1|Safety Population|Overall Study||140
7632404|NCT02284568|18792765|P3|STARTED|Overall Study|Intent to treat (ITT) population|95
7632405|NCT02284568|18792766|P2|STARTED|Overall Study|Intent to treat (ITT) population|139
7632406|NCT02284568|18792767|P1|STARTED|Overall Study|Intent to treat (ITT) population|140
7632407|NCT02284555|18792793|P1|NOT COMPLETED|Overall Study||0
7632408|NCT02284555|18792793|P1|COMPLETED|Overall Study||12
7632409|NCT02284555|18792793|P1|STARTED|Overall Study||12
7632410|NCT02284516|18792800|P2|NOT COMPLETED|Overall Study||36
7632411|NCT02284516|18792801|P1|NOT COMPLETED|Overall Study||38
7632412|NCT02284516|18792800|P2|COMPLETED|Overall Study||319
7632413|NCT02284516|18792801|P1|COMPLETED|Overall Study||318
7632414|NCT02284516|18792800|P2|Safety Population|Overall Study|Two placebo participants were included in Lifitegrast arm for safety analysis set (N=357).|357
7632415|NCT02284516|18792801|P1|Safety Population|Overall Study|Two placebo participants were considered for Lifitegrast arm; Placebo safety analysis set (N= 354).|354
7632416|NCT02284516|18792800|P2|STARTED|Overall Study||355
7632417|NCT02284516|18792801|P1|STARTED|Overall Study||356
7632418|NCT02284464|18792811|P2|NOT COMPLETED|Overall Study||17
7632419|NCT02284464|18792812|P1|NOT COMPLETED|Overall Study||13
7632420|NCT02284464|18792811|P2|COMPLETED|Overall Study||36
7632421|NCT02284464|18792812|P1|COMPLETED|Overall Study||39
7632422|NCT02284464|18792811|P2|STARTED|Overall Study||53
7632423|NCT02284464|18792812|P1|STARTED|Overall Study||52
7632424|NCT02284399|18792840|P2|NOT COMPLETED|Overall Study||0
7632425|NCT02284399|18792841|P1|NOT COMPLETED|Overall Study||0
7632426|NCT02284399|18792840|P2|COMPLETED|Overall Study||3074
7632427|NCT02284399|18792841|P1|COMPLETED|Overall Study||1414
7632428|NCT02284399|18792840|P2|STARTED|Overall Study||3074
7632429|NCT02284399|18792841|P1|STARTED|Overall Study||1414
7632430|NCT02284386|18792849|P1|NOT COMPLETED|Overall Study||0
7632431|NCT02284386|18792849|P1|COMPLETED|Overall Study||15
7632432|NCT02284386|18792849|P1|STARTED|Overall Study||15
7632433|NCT02284373|18792861|P3|NOT COMPLETED|Overall Study||0
7632434|NCT02284373|18792862|P2|NOT COMPLETED|Overall Study||3
7632435|NCT02284373|18792863|P1|NOT COMPLETED|Overall Study||0
7632436|NCT02284373|18792861|P3|COMPLETED|Overall Study||29
7632437|NCT02284373|18792862|P2|COMPLETED|Overall Study||2
7632438|NCT02284373|18792863|P1|COMPLETED|Overall Study||5
7632439|NCT02284373|18792861|P3|STARTED|Overall Study||29
7632440|NCT02284373|18792862|P2|STARTED|Overall Study||5
7632441|NCT02284373|18792863|P1|STARTED|Overall Study||5
7632442|NCT02284347|18792871|P1|NOT COMPLETED|Overall Study||3
7632443|NCT02284347|18792871|P1|COMPLETED|Overall Study||48
7632444|NCT02284347|18792871|P1|STARTED|Overall Study||51
7632445|NCT02284243|18792879|P2|NOT COMPLETED|Overall Study||3
7632446|NCT02284243|18792880|P1|NOT COMPLETED|Overall Study||4
7632447|NCT02284243|18792879|P2|COMPLETED|Overall Study||81
7632448|NCT02284243|18792880|P1|COMPLETED|Overall Study||80
7632449|NCT02284243|18792879|P2|STARTED|Overall Study||84
7632450|NCT02284243|18792880|P1|STARTED|Overall Study||84
7632451|NCT02284178|18792900|P2|NOT COMPLETED|Overall Study||54
7632452|NCT02284178|18792901|P1|NOT COMPLETED|Overall Study||49
7632453|NCT02284178|18792900|P2|COMPLETED|Overall Study||204
7632454|NCT02284178|18792901|P1|COMPLETED|Overall Study||206
7632455|NCT02284178|18792900|P2|STARTED|Overall Study||258
7632456|NCT02284178|18792901|P1|STARTED|Overall Study||255
7632457|NCT02284165|18792924|P3|NOT COMPLETED|Overall Study||0
7632458|NCT02284165|18792925|P2|NOT COMPLETED|Overall Study||0
7632459|NCT02284165|18792926|P1|NOT COMPLETED|Overall Study||0
7632460|NCT02284165|18792924|P3|COMPLETED|Overall Study||70996
7632461|NCT02284165|18792925|P2|COMPLETED|Overall Study||40272
7632462|NCT02284165|18792926|P1|COMPLETED|Overall Study||36448
7632463|NCT02284165|18792924|P3|STARTED|Overall Study||70996
7632464|NCT02284165|18792925|P2|STARTED|Overall Study||40272
7632465|NCT02284165|18792926|P1|STARTED|Overall Study||36448
7632466|NCT02284009|18792944|P2|NOT COMPLETED|Overall Study||10
7632467|NCT02284009|18792945|P1|NOT COMPLETED|Overall Study||6
7632468|NCT02284009|18792944|P2|COMPLETED|Overall Study||40
7632469|NCT02284009|18792945|P1|COMPLETED|Overall Study||11
7632470|NCT02284009|18792944|P2|STARTED|Overall Study||50
7632471|NCT02284009|18792945|P1|STARTED|Overall Study||17
7632472|NCT02283840|18792990|P3|NOT COMPLETED|Overall Study||0
7632473|NCT02283840|18792991|P2|NOT COMPLETED|Overall Study||1
7632474|NCT02283840|18792992|P1|NOT COMPLETED|Overall Study||0
7632475|NCT02283840|18792990|P3|COMPLETED|Overall Study||20
7632476|NCT02283840|18792991|P2|COMPLETED|Overall Study||19
7632477|NCT02283840|18792992|P1|COMPLETED|Overall Study||20
7632478|NCT02283840|18792990|P3|STARTED|Overall Study||20
7632479|NCT02283840|18792991|P2|STARTED|Overall Study||20
7632480|NCT02283840|18792992|P1|STARTED|Overall Study||20
7632481|NCT02283827|18793011|P2|NOT COMPLETED|Overall Study||3
7632482|NCT02283827|18793012|P1|NOT COMPLETED|Overall Study||1
7632483|NCT02283827|18793011|P2|COMPLETED|Overall Study||13
7632484|NCT02283827|18793012|P1|COMPLETED|Overall Study||15
7632485|NCT02283827|18793011|P2|STARTED|Overall Study||16
7632486|NCT02283827|18793012|P1|STARTED|Overall Study||16
7632487|NCT02283814|18793029|P2|NOT COMPLETED|Overall Study||2
7632488|NCT02283814|18793030|P1|NOT COMPLETED|Overall Study||3
7632489|NCT02283814|18793029|P2|COMPLETED|Overall Study||14
7632490|NCT02283814|18793030|P1|COMPLETED|Overall Study||13
7632491|NCT02283814|18793029|P2|STARTED|Overall Study||16
7632492|NCT02283814|18793030|P1|STARTED|Overall Study||16
7632493|NCT02283788|18793044|P4|NOT COMPLETED|Overall Study||2
7632494|NCT02283788|18793045|P3|NOT COMPLETED|Overall Study||5
7632495|NCT02283788|18793046|P2|NOT COMPLETED|Overall Study||4
7632496|NCT02283788|18793047|P1|NOT COMPLETED|Overall Study||1
7632497|NCT02283788|18793044|P4|COMPLETED|Overall Study||14
7632498|NCT02283788|18793045|P3|COMPLETED|Overall Study||12
7632499|NCT02283788|18793046|P2|COMPLETED|Overall Study||13
7632500|NCT02283788|18793047|P1|COMPLETED|Overall Study||16
7632501|NCT02283788|18793044|P4|STARTED|Overall Study||16
7632502|NCT02283788|18793045|P3|STARTED|Overall Study||17
7632503|NCT02283788|18793046|P2|STARTED|Overall Study||17
7632504|NCT02283788|18793047|P1|STARTED|Overall Study||17
7632505|NCT02283762|18793059|P2|NOT COMPLETED|Long-term Extension Phase (LTE)||14
7632506|NCT02283762|18793060|P1|NOT COMPLETED|Long-term Extension Phase (LTE)||10
7632507|NCT02283762|18793059|P2|COMPLETED|Long-term Extension Phase (LTE)||31
7632508|NCT02283762|18793060|P1|COMPLETED|Long-term Extension Phase (LTE)||32
7632509|NCT02283762|18793059|P2|STARTED|Long-term Extension Phase (LTE)|Of the 46 patients who completed the main treatment phase, 1 patient did not enter the LTE phase|45
7632510|NCT02283762|18793060|P1|STARTED|Long-term Extension Phase (LTE)||42
7632511|NCT02283762|18793059|P2|NOT COMPLETED|Main Treatment Phase (MT)||15
7632512|NCT02283762|18793060|P1|NOT COMPLETED|Main Treatment Phase (MT)||18
7632513|NCT02283762|18793059|P2|COMPLETED|Main Treatment Phase (MT)||46
7632514|NCT02283762|18793060|P1|COMPLETED|Main Treatment Phase (MT)||42
7632515|NCT02283762|18793059|P2|STARTED|Main Treatment Phase (MT)||61
7632516|NCT02283762|18793060|P1|STARTED|Main Treatment Phase (MT)||60
7632517|NCT02283749|18793078|P1|NOT COMPLETED|Overall Study||0
7632518|NCT02283749|18793078|P1|COMPLETED|Overall Study||5
7632519|NCT02283749|18793078|P1|STARTED|Overall Study||5
7632520|NCT02283658|18793084|P1|NOT COMPLETED|Overall Study||1
7632521|NCT02283658|18793084|P1|COMPLETED|Overall Study||19
7632522|NCT02283658|18793084|P1|STARTED|Overall Study||20
7632523|NCT02283528|18793095|P2|NOT COMPLETED|Overall Study||0
7632524|NCT02283528|18793096|P1|NOT COMPLETED|Overall Study||0
7632525|NCT02283528|18793095|P2|COMPLETED|Overall Study||24
7632526|NCT02283528|18793096|P1|COMPLETED|Overall Study||26
7632527|NCT02283528|18793095|P2|STARTED|Overall Study||24
7632528|NCT02283528|18793096|P1|STARTED|Overall Study||26
7632529|NCT02283411|18793106|P1|NOT COMPLETED|Overall Study||31
7632530|NCT02283411|18793106|P1|COMPLETED|Overall Study||125
7632531|NCT02283411|18793106|P1|STARTED|Overall Study||156
7632532|NCT02283268|18793114|P1|NOT COMPLETED|Overall Study||1
7632533|NCT02283268|18793114|P1|COMPLETED|Overall Study||14
7632534|NCT02283268|18793114|P1|STARTED|Overall Study||15
7632535|NCT02282982|18793175|P1|NOT COMPLETED|Overall Study||206
7632536|NCT02282982|18793175|P1|COMPLETED|Overall Study||153
7632537|NCT02282982|18793175|P1|Attended Follow-up Visit|Overall Study||349
7632538|NCT02282982|18793175|P1|Attended Visit 5|Overall Study||83
7632539|NCT02282982|18793175|P1|Attended Visit 4|Overall Study||194
7632540|NCT02282982|18793175|P1|Attended Visit 3|Overall Study||298
7632541|NCT02282982|18793175|P1|Attended Visit 2|Overall Study||341
7632542|NCT02282982|18793175|P1|Attended Visit 1|Overall Study||359
7632543|NCT02282982|18793175|P1|STARTED|Overall Study||359
7632544|NCT02282930|18793190|P1|NOT COMPLETED|Overall Study||1
7632545|NCT02282930|18793190|P1|COMPLETED|Overall Study||19
7632546|NCT02282930|18793190|P1|STARTED|Overall Study||20
7632547|NCT02282904|18793195|P1|NOT COMPLETED|Overall Study||0
7632548|NCT02282904|18793195|P1|COMPLETED|Overall Study|Patient accrual was stopped early, and the protocol closed after completing followup|7
7632549|NCT02282904|18793195|P1|STARTED|Overall Study||7
7632550|NCT02282813|18793203|P3|NOT COMPLETED|Overall Study||3
7632551|NCT02282813|18793204|P2|NOT COMPLETED|Overall Study||23
7632552|NCT02282813|18793205|P1|NOT COMPLETED|Overall Study||12
7632553|NCT02282813|18793203|P3|COMPLETED|Overall Study||39
7632554|NCT02282813|18793204|P2|COMPLETED|Overall Study||130
7632555|NCT02282813|18793205|P1|COMPLETED|Overall Study||91
7632556|NCT02282813|18793203|P3|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42
7632557|NCT02282813|18793204|P2|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153
7632558|NCT02282813|18793205|P1|STARTED|Overall Study|ITT Population|103
7632559|NCT02282722|18793224|P2|NOT COMPLETED|Overall Study||19
7632560|NCT02282722|18793225|P1|NOT COMPLETED|Overall Study||23
7632561|NCT02282722|18793224|P2|COMPLETED|Overall Study||73
7632562|NCT02282722|18793225|P1|COMPLETED|Overall Study||71
7632563|NCT02282722|18793224|P2|3-month Assessment|Overall Study||73
7632564|NCT02282722|18793225|P1|3-month Assessment|Overall Study||71
7632565|NCT02282722|18793224|P2|2-week Assessment|Overall Study||75
7632566|NCT02282722|18793225|P1|2-week Assessment|Overall Study||79
7632567|NCT02282722|18793224|P2|STARTED|Overall Study||92
7632568|NCT02282722|18793225|P1|STARTED|Overall Study||94
7632569|NCT02282631|18793251|P2|NOT COMPLETED|Overall Study||0
7632570|NCT02282631|18793252|P1|NOT COMPLETED|Overall Study||2
7632571|NCT02282631|18793251|P2|COMPLETED|Overall Study||15
7632572|NCT02282631|18793252|P1|COMPLETED|Overall Study||12
7632573|NCT02282631|18793251|P2|STARTED|Overall Study||15
7632574|NCT02282631|18793252|P1|STARTED|Overall Study|The two dropouts happened on the 2nd and 3rd weeks post-baseline, respectively|14
7632575|NCT02282605|18793293|P3|NOT COMPLETED|Overall Study||0
7632576|NCT02282605|18793294|P2|NOT COMPLETED|Overall Study||0
7632577|NCT02282605|18793295|P1|NOT COMPLETED|Overall Study||3
7632578|NCT02282605|18793293|P3|COMPLETED|Overall Study||24
7632579|NCT02282605|18793294|P2|COMPLETED|Overall Study||12
7632580|NCT02282605|18793295|P1|COMPLETED|Overall Study||24
7632581|NCT02282605|18793293|P3|STARTED|Overall Study||24
7632582|NCT02282605|18793294|P2|STARTED|Overall Study||12
7632583|NCT02282605|18793295|P1|STARTED|Overall Study||27
7632584|NCT02282527|18793317|P2|NOT COMPLETED|Overall Study||1
7632585|NCT02282527|18793318|P1|NOT COMPLETED|Overall Study||1
7632586|NCT02282527|18793317|P2|COMPLETED|Overall Study||15
7632587|NCT02282527|18793318|P1|COMPLETED|Overall Study||15
7632588|NCT02282527|18793317|P2|STARTED|Overall Study||16
7632589|NCT02282527|18793318|P1|STARTED|Overall Study||16
7632590|NCT02282293|18793330|P2|NOT COMPLETED|Overall Study||3
7632591|NCT02282293|18793331|P1|NOT COMPLETED|Overall Study||3
7632592|NCT02282293|18793330|P2|COMPLETED|Overall Study||97
7632593|NCT02282293|18793331|P1|COMPLETED|Overall Study||97
7632594|NCT02282293|18793330|P2|STARTED|Overall Study||100
7632595|NCT02282293|18793331|P1|STARTED|Overall Study||100
7632596|NCT02282163|18793349|P1|NOT COMPLETED|Overall Study||1
7632597|NCT02282163|18793349|P1|COMPLETED|Overall Study||12
7632598|NCT02282163|18793349|P1|STARTED|Overall Study||13
7632599|NCT02282111|18793364|P2|NOT COMPLETED|Overall Study||8
7632600|NCT02282111|18793365|P1|NOT COMPLETED|Overall Study||7
7632601|NCT02282111|18793364|P2|COMPLETED|Overall Study||22
7632602|NCT02282111|18793365|P1|COMPLETED|Overall Study||19
7632603|NCT02282111|18793364|P2|STARTED|Overall Study||30
7632604|NCT02282111|18793365|P1|STARTED|Overall Study||26
7632605|NCT02282020|18793381|P2|NOT COMPLETED|Overall Study||87
7632606|NCT02282020|18793382|P1|NOT COMPLETED|Overall Study||135
7632607|NCT02282020|18793381|P2|COMPLETED|Overall Study||1
7632608|NCT02282020|18793382|P1|COMPLETED|Overall Study||43
7632609|NCT02282020|18793381|P2|Received Treatment|Overall Study||76
7632610|NCT02282020|18793382|P1|Received Treatment|Overall Study||178
7632611|NCT02282020|18793381|P2|STARTED|Overall Study||88
7632612|NCT02282020|18793382|P1|STARTED|Overall Study||178
7632613|NCT02281955|18793427|P1|NOT COMPLETED|Overall Study||1
7632614|NCT02281955|18793427|P1|COMPLETED|Overall Study||113
7632615|NCT02281955|18793427|P1|STARTED|Overall Study||114
7632616|NCT02281851|18793438|P2|NOT COMPLETED|Overall Study||0
7632617|NCT02281851|18793439|P1|NOT COMPLETED|Overall Study||0
7632618|NCT02281851|18793438|P2|COMPLETED|Overall Study||10
7632619|NCT02281851|18793439|P1|COMPLETED|Overall Study||4
7632620|NCT02281851|18793438|P2|STARTED|Overall Study||10
7632621|NCT02281851|18793439|P1|STARTED|Overall Study||4
7632622|NCT02281773|18793450|P5|NOT COMPLETED|Overall Study||30
7632623|NCT02281773|18793451|P4|NOT COMPLETED|Overall Study||21
7632624|NCT02281773|18793452|P3|NOT COMPLETED|Overall Study||18
7632625|NCT02281773|18793453|P2|NOT COMPLETED|Overall Study||15
7632626|NCT02281773|18793454|P1|NOT COMPLETED|Overall Study||11
7632627|NCT02281773|18793450|P5|COMPLETED|Overall Study||143
7632628|NCT02281773|18793451|P4|COMPLETED|Overall Study||65
7632629|NCT02281773|18793452|P3|COMPLETED|Overall Study||67
7632630|NCT02281773|18793453|P2|COMPLETED|Overall Study||70
7632631|NCT02281773|18793454|P1|COMPLETED|Overall Study||76
7632632|NCT02281773|18793450|P5|STARTED|Overall Study|Started are the treated patients|173
7632633|NCT02281773|18793451|P4|STARTED|Overall Study||86
7632634|NCT02281773|18793452|P3|STARTED|Overall Study||85
7632635|NCT02281773|18793453|P2|STARTED|Overall Study|Started are the treated patients|85
7632636|NCT02281773|18793454|P1|STARTED|Overall Study||87
7632637|NCT02281591|18793515|P4|NOT COMPLETED|Overall Study||0
7632638|NCT02281591|18793516|P3|NOT COMPLETED|Overall Study||0
7632639|NCT02281591|18793517|P2|NOT COMPLETED|Overall Study||0
7632640|NCT02281591|18793518|P1|NOT COMPLETED|Overall Study||0
7632641|NCT02281591|18793515|P4|COMPLETED|Overall Study||8
7632642|NCT02281591|18793516|P3|COMPLETED|Overall Study||8
7632643|NCT02281591|18793517|P2|COMPLETED|Overall Study||8
7632644|NCT02281591|18793518|P1|COMPLETED|Overall Study||8
7632645|NCT02281591|18793515|P4|STARTED|Overall Study||8
7632646|NCT02281591|18793516|P3|STARTED|Overall Study||8
7632647|NCT02281591|18793517|P2|STARTED|Overall Study||8
7632648|NCT02281591|18793518|P1|STARTED|Overall Study||8
7632649|NCT02281552|18793542|P2|NOT COMPLETED|Overall Study||10
7632650|NCT02281552|18793543|P1|NOT COMPLETED|Overall Study||4
7632651|NCT02281552|18793542|P2|COMPLETED|Overall Study||95
7632652|NCT02281552|18793543|P1|COMPLETED|Overall Study||100
7632653|NCT02281552|18793542|P2|STARTED|Overall Study||105
7632654|NCT02281552|18793543|P1|STARTED|Overall Study||104
7632655|NCT02281526|18793583|P2|NOT COMPLETED|Overall Study||0
7632656|NCT02281526|18793584|P1|NOT COMPLETED|Overall Study||1
7632657|NCT02281526|18793583|P2|COMPLETED|Overall Study||8
7632658|NCT02281526|18793584|P1|COMPLETED|Overall Study||8
7632659|NCT02281526|18793583|P2|STARTED|Overall Study||8
7632660|NCT02281526|18793584|P1|STARTED|Overall Study||9
7632661|NCT02281500|18793592|P1|NOT COMPLETED|Overall Study||0
7632662|NCT02281500|18793592|P1|COMPLETED|Overall Study||22
7632663|NCT02281500|18793592|P1|STARTED|Overall Study||22
7632664|NCT02281448|18793623|P2|NOT COMPLETED|Overall Study||1
7632665|NCT02281448|18793624|P1|NOT COMPLETED|Overall Study||2
7632666|NCT02281448|18793623|P2|COMPLETED|Overall Study||9
7632667|NCT02281448|18793624|P1|COMPLETED|Overall Study||8
7632668|NCT02281448|18793623|P2|STARTED|Overall Study||10
7632669|NCT02281448|18793624|P1|STARTED|Overall Study||10
7632670|NCT02281422|18793637|P5|NOT COMPLETED|Overall Study||0
7632671|NCT02281422|18793638|P4|NOT COMPLETED|Overall Study||0
7632672|NCT02281422|18793639|P3|NOT COMPLETED|Overall Study||0
7632673|NCT02281422|18793640|P2|NOT COMPLETED|Overall Study||0
7632674|NCT02281422|18793641|P1|NOT COMPLETED|Overall Study||0
7632675|NCT02281422|18793637|P5|COMPLETED|Overall Study||8
7632676|NCT02281422|18793638|P4|COMPLETED|Overall Study||8
7632677|NCT02281422|18793639|P3|COMPLETED|Overall Study||8
7632678|NCT02281422|18793640|P2|COMPLETED|Overall Study||8
7632679|NCT02281422|18793641|P1|COMPLETED|Overall Study||8
7632680|NCT02281422|18793637|P5|STARTED|Overall Study||8
7632681|NCT02281422|18793638|P4|STARTED|Overall Study||8
7632682|NCT02281422|18793639|P3|STARTED|Overall Study||8
7632683|NCT02281422|18793640|P2|STARTED|Overall Study||8
7632684|NCT02281422|18793641|P1|STARTED|Overall Study||8
7632685|NCT02281357|18793665|P2|NOT COMPLETED|Overall Study||4
7632686|NCT02281357|18793666|P1|NOT COMPLETED|Overall Study||7
7632687|NCT02281357|18793665|P2|COMPLETED|Overall Study||66
7632688|NCT02281357|18793666|P1|COMPLETED|Overall Study||63
7632689|NCT02281357|18793665|P2|STARTED|Overall Study||70
7632690|NCT02281357|18793666|P1|STARTED|Overall Study||70
7632691|NCT02281344|18793678|P1|NOT COMPLETED|Overall Study||0
7632692|NCT02281344|18793678|P1|COMPLETED|Overall Study||6
7632693|NCT02281344|18793678|P1|STARTED|Overall Study||6
7632694|NCT02281318|18793685|P2|NOT COMPLETED|Overall Study||5
7632695|NCT02281318|18793686|P1|NOT COMPLETED|Overall Study||14
7632696|NCT02281318|18793685|P2|COMPLETED|Overall Study||269
7632697|NCT02281318|18793686|P1|COMPLETED|Overall Study||263
7632698|NCT02281318|18793685|P2|STARTED|Overall Study||274
7632699|NCT02281318|18793686|P1|STARTED|Overall Study||277
7632700|NCT02281136|18793698|P1|NOT COMPLETED|Overall Study||0
7632701|NCT02281136|18793698|P1|COMPLETED|Overall Study||29
7632702|NCT02281136|18793698|P1|STARTED|Overall Study||29
7632703|NCT02281084|18793734|P4|NOT COMPLETED|Overall Study||5
7632704|NCT02281084|18793735|P3|NOT COMPLETED|Overall Study||4
7632705|NCT02281084|18793736|P2|NOT COMPLETED|Overall Study||18
7632706|NCT02281084|18793737|P1|NOT COMPLETED|Overall Study||22
7632707|NCT02281084|18793734|P4|COMPLETED|Overall Study||0
7632708|NCT02281084|18793735|P3|COMPLETED|Overall Study||2
7632709|NCT02281084|18793736|P2|COMPLETED|Overall Study||4
7632710|NCT02281084|18793737|P1|COMPLETED|Overall Study||10
7632711|NCT02281084|18793734|P4|STARTED|Overall Study||5
7632712|NCT02281084|18793735|P3|STARTED|Overall Study||6
7632713|NCT02281084|18793736|P2|STARTED|Overall Study||22
7632714|NCT02281084|18793737|P1|STARTED|Overall Study||32
7632715|NCT02280863|18793793|P2|NOT COMPLETED|Integrated Platform||1
7632716|NCT02280863|18793794|P1|NOT COMPLETED|Integrated Platform||0
7632717|NCT02280863|18793793|P2|COMPLETED|Integrated Platform||14
7632718|NCT02280863|18793794|P1|COMPLETED|Integrated Platform||9
7632719|NCT02280863|18793793|P2|STARTED|Integrated Platform||15
7632720|NCT02280863|18793794|P1|STARTED|Integrated Platform|One additional participant was enrolled for part 2.|9
7632721|NCT02280863|18793793|P2|NOT COMPLETED|Android Platform||0
7632722|NCT02280863|18793794|P1|NOT COMPLETED|Android Platform||0
7632723|NCT02280863|18793793|P2|COMPLETED|Android Platform||0
7632724|NCT02280863|18793794|P1|COMPLETED|Android Platform||8
7632725|NCT02280863|18793793|P2|STARTED|Android Platform||0
7632726|NCT02280863|18793794|P1|STARTED|Android Platform||8
7632727|NCT02280811|18793824|P5|NOT COMPLETED|Retreated at the MTD||0
7632728|NCT02280811|18793825|P4|NOT COMPLETED|Retreated at the MTD||0
7632729|NCT02280811|18793826|P3|NOT COMPLETED|Retreated at the MTD||0
7632730|NCT02280811|18793827|P2|NOT COMPLETED|Retreated at the MTD||0
7632731|NCT02280811|18793828|P1|NOT COMPLETED|Retreated at the MTD||0
7632732|NCT02280811|18793824|P5|COMPLETED|Retreated at the MTD||1
7632733|NCT02280811|18793825|P4|COMPLETED|Retreated at the MTD||0
7632734|NCT02280811|18793826|P3|COMPLETED|Retreated at the MTD||0
7632735|NCT02280811|18793827|P2|COMPLETED|Retreated at the MTD||0
7632736|NCT02280811|18793828|P1|COMPLETED|Retreated at the MTD||0
7632737|NCT02280811|18793824|P5|STARTED|Retreated at the MTD|Patient originally started in Grp1(HPV-16 E6mTCR PBL 1x10^9+HD IL-2) and was retreated at the MTD.|1
7632738|NCT02280811|18793825|P4|STARTED|Retreated at the MTD||0
7632739|NCT02280811|18793826|P3|STARTED|Retreated at the MTD||0
7632740|NCT02280811|18793827|P2|STARTED|Retreated at the MTD||0
7632741|NCT02280811|18793828|P1|STARTED|Retreated at the MTD||0
7632742|NCT02280811|18793824|P5|NOT COMPLETED|Drug Administration||0
7632743|NCT02280811|18793825|P4|NOT COMPLETED|Drug Administration||0
7632744|NCT02280811|18793826|P3|NOT COMPLETED|Drug Administration||0
7632745|NCT02280811|18793827|P2|NOT COMPLETED|Drug Administration||0
7632746|NCT02280811|18793828|P1|NOT COMPLETED|Drug Administration||0
7632747|NCT02280811|18793824|P5|COMPLETED|Drug Administration||2
7632748|NCT02280811|18793825|P4|COMPLETED|Drug Administration||6
7632749|NCT02280811|18793826|P3|COMPLETED|Drug Administration||1
7632750|NCT02280811|18793827|P2|COMPLETED|Drug Administration||2
7632751|NCT02280811|18793828|P1|COMPLETED|Drug Administration||1
7632752|NCT02280811|18793824|P5|STARTED|Drug Administration||2
7632753|NCT02280811|18793825|P4|STARTED|Drug Administration||6
7632754|NCT02280811|18793826|P3|STARTED|Drug Administration||1
7632755|NCT02280811|18793827|P2|STARTED|Drug Administration||2
7632756|NCT02280811|18793828|P1|STARTED|Drug Administration||1
7632757|NCT02280655|18793869|P2|NOT COMPLETED|Overall Study||0
7632758|NCT02280655|18793870|P1|NOT COMPLETED|Overall Study||0
7632759|NCT02280655|18793869|P2|COMPLETED|Overall Study||18
7632760|NCT02280655|18793870|P1|COMPLETED|Overall Study||25
7632761|NCT02280655|18793869|P2|STARTED|Overall Study||18
7632762|NCT02280655|18793870|P1|STARTED|Overall Study||25
7632763|NCT02280499|18793878|P1|NOT COMPLETED|Overall Study||61
7632764|NCT02280499|18793878|P1|COMPLETED|Overall Study||26
7632765|NCT02280499|18793878|P1|STARTED|Overall Study||87
7632766|NCT02280473|18793886|P2|NOT COMPLETED|Overall Study||3
7632767|NCT02280473|18793887|P1|NOT COMPLETED|Overall Study||1
7632768|NCT02280473|18793886|P2|COMPLETED|Overall Study||91
7632769|NCT02280473|18793887|P1|COMPLETED|Overall Study||93
7632770|NCT02280473|18793886|P2|STARTED|Overall Study||94
7632771|NCT02280473|18793887|P1|STARTED|Overall Study||94
7632772|NCT02280421|18793903|P2|NOT COMPLETED|Second Intervention(2 Weeks)||0
7632773|NCT02280421|18793904|P1|NOT COMPLETED|Second Intervention(2 Weeks)||0
7632774|NCT02280421|18793903|P2|COMPLETED|Second Intervention(2 Weeks)||12
7632775|NCT02280421|18793904|P1|COMPLETED|Second Intervention(2 Weeks)||12
7632776|NCT02280421|18793903|P2|Received Intervention|Second Intervention(2 Weeks)||12
7632777|NCT02280421|18793904|P1|Received Intervention|Second Intervention(2 Weeks)||12
7632778|NCT02280421|18793903|P2|STARTED|Second Intervention(2 Weeks)||12
7632779|NCT02280421|18793904|P1|STARTED|Second Intervention(2 Weeks)||12
7632780|NCT02280421|18793903|P2|NOT COMPLETED|Washout (2 Weeks)||1
7632781|NCT02280421|18793904|P1|NOT COMPLETED|Washout (2 Weeks)||1
7632782|NCT02280421|18793903|P2|COMPLETED|Washout (2 Weeks)||11
7632783|NCT02280421|18793904|P1|COMPLETED|Washout (2 Weeks)||11
7632784|NCT02280421|18793903|P2|STARTED|Washout (2 Weeks)||12
7632785|NCT02280421|18793904|P1|STARTED|Washout (2 Weeks)||12
7632786|NCT02280421|18793903|P2|NOT COMPLETED|First Intervention(2 Weeks)||0
7632787|NCT02280421|18793904|P1|NOT COMPLETED|First Intervention(2 Weeks)||0
7632788|NCT02280421|18793903|P2|COMPLETED|First Intervention(2 Weeks)||12
7632789|NCT02280421|18793904|P1|COMPLETED|First Intervention(2 Weeks)||12
7632790|NCT02280421|18793903|P2|Received Intervention|First Intervention(2 Weeks)||12
7632791|NCT02280421|18793904|P1|Received Intervention|First Intervention(2 Weeks)||12
7632792|NCT02280421|18793903|P2|STARTED|First Intervention(2 Weeks)||12
7632793|NCT02280421|18793904|P1|STARTED|First Intervention(2 Weeks)||12
7632794|NCT02280408|18793970|P4|NOT COMPLETED|Overall Study||0
7632795|NCT02280408|18793971|P3|NOT COMPLETED|Overall Study||0
7632796|NCT02280408|18793972|P2|NOT COMPLETED|Overall Study||2
7632797|NCT02280408|18793973|P1|NOT COMPLETED|Overall Study||0
7632798|NCT02280408|18793970|P4|COMPLETED|Overall Study||9
7632799|NCT02280408|18793971|P3|COMPLETED|Overall Study||10
7632800|NCT02280408|18793972|P2|COMPLETED|Overall Study||8
7632801|NCT02280408|18793973|P1|COMPLETED|Overall Study||10
7632802|NCT02280408|18793970|P4|Vaccination 2|Overall Study||9
7632803|NCT02280408|18793971|P3|Vaccination 2|Overall Study||10
7632804|NCT02280408|18793972|P2|Vaccination 2|Overall Study||10
7632805|NCT02280408|18793973|P1|Vaccination 2|Overall Study||10
7632806|NCT02280408|18793970|P4|Vaccination 1|Overall Study||9
7632807|NCT02280408|18793971|P3|Vaccination 1|Overall Study||10
7632808|NCT02280408|18793972|P2|Vaccination 1|Overall Study||10
7632809|NCT02280408|18793973|P1|Vaccination 1|Overall Study||10
7632810|NCT02280408|18793970|P4|STARTED|Overall Study||9
7632811|NCT02280408|18793971|P3|STARTED|Overall Study||10
7632812|NCT02280408|18793972|P2|STARTED|Overall Study||10
7632813|NCT02280408|18793973|P1|STARTED|Overall Study||10
7632814|NCT02280304|18794045|P2|NOT COMPLETED|Overall Study||8
7632815|NCT02280304|18794046|P1|NOT COMPLETED|Overall Study||7
7632816|NCT02280304|18794045|P2|COMPLETED|Overall Study|A non completer received the allocated intervention before being lost to follow-up.|10
7632817|NCT02280304|18794046|P1|COMPLETED|Overall Study||12
7632818|NCT02280304|18794045|P2|STARTED|Overall Study||18
7632819|NCT02280304|18794046|P1|STARTED|Overall Study||19
7632820|NCT02280291|18794067|P4|NOT COMPLETED|Overall Study||8
7632821|NCT02280291|18794068|P3|NOT COMPLETED|Overall Study||3
7632822|NCT02280291|18794069|P2|NOT COMPLETED|Overall Study||2
7632823|NCT02280291|18794070|P1|NOT COMPLETED|Overall Study||4
7632824|NCT02280291|18794067|P4|COMPLETED|Overall Study||18
7632825|NCT02280291|18794068|P3|COMPLETED|Overall Study||21
7632826|NCT02280291|18794069|P2|COMPLETED|Overall Study||23
7632827|NCT02280291|18794070|P1|COMPLETED|Overall Study||21
7632828|NCT02280291|18794067|P4|STARTED|Overall Study||26
7632829|NCT02280291|18794068|P3|STARTED|Overall Study||24
7632830|NCT02280291|18794069|P2|STARTED|Overall Study||25
7632831|NCT02280291|18794070|P1|STARTED|Overall Study||25
7632832|NCT02280252|18794082|P1|NOT COMPLETED|Overall Study||0
7632833|NCT02280252|18794082|P1|COMPLETED|Overall Study||0
7632834|NCT02280252|18794082|P1|STARTED|Overall Study||0
7632835|NCT02280226|18794089|P1|NOT COMPLETED|Overall Study||0
7632836|NCT02280226|18794089|P1|COMPLETED|Overall Study||17
7632837|NCT02280226|18794089|P1|STARTED|Overall Study||17
7632838|NCT02280200|18794096|P2|NOT COMPLETED|Overall Study||3
7632839|NCT02280200|18794097|P1|NOT COMPLETED|Overall Study||3
7632840|NCT02280200|18794096|P2|COMPLETED|Overall Study||10
7632841|NCT02280200|18794097|P1|COMPLETED|Overall Study||12
7632842|NCT02280200|18794096|P2|STARTED|Overall Study||13
7632843|NCT02280200|18794097|P1|STARTED|Overall Study||15
7632844|NCT02280187|18794111|P1|NOT COMPLETED|Overall Study||218
7632845|NCT02280187|18794111|P1|COMPLETED|Overall Study||182
7632846|NCT02280187|18794111|P1|STARTED|Overall Study||400
7632847|NCT02280122|18794129|P3|NOT COMPLETED|Overall Study||0
7632848|NCT02280122|18794130|P2|NOT COMPLETED|Overall Study||0
7632849|NCT02280122|18794131|P1|NOT COMPLETED|Overall Study||0
7632850|NCT02280122|18794129|P3|COMPLETED|Overall Study||30
7632851|NCT02280122|18794130|P2|COMPLETED|Overall Study||15
7632852|NCT02280122|18794131|P1|COMPLETED|Overall Study||15
7632853|NCT02280122|18794129|P3|STARTED|Overall Study||30
7632854|NCT02280122|18794130|P2|STARTED|Overall Study||15
7632855|NCT02280122|18794131|P1|STARTED|Overall Study||15
7632856|NCT02280096|18794139|P2|NOT COMPLETED|Overall Study||1
7632857|NCT02280096|18794140|P1|NOT COMPLETED|Overall Study||2
7632858|NCT02280096|18794139|P2|COMPLETED|Overall Study||10
7632859|NCT02280096|18794140|P1|COMPLETED|Overall Study||11
7632860|NCT02280096|18794139|P2|STARTED|Overall Study||11
7632861|NCT02280096|18794140|P1|STARTED|Overall Study||13
7632862|NCT02280044|18794170|P2|NOT COMPLETED|Overall Study||2
7632863|NCT02280044|18794171|P1|NOT COMPLETED|Overall Study||0
7632864|NCT02280044|18794170|P2|COMPLETED|Overall Study||13
7632865|NCT02280044|18794171|P1|COMPLETED|Overall Study||15
7632866|NCT02280044|18794170|P2|STARTED|Overall Study||15
7632867|NCT02280044|18794171|P1|STARTED|Overall Study||15
7632868|NCT02279862|18794181|P2|NOT COMPLETED|Overall Study||25
7632869|NCT02279862|18794182|P1|NOT COMPLETED|Overall Study||26
7632870|NCT02279862|18794181|P2|COMPLETED|Overall Study|Completed treatment in induction period|2
7632871|NCT02279862|18794182|P1|COMPLETED|Overall Study|Completed treatment in induction period|0
7632872|NCT02279862|18794181|P2|Treated|Overall Study||26
7632873|NCT02279862|18794182|P1|Treated|Overall Study||25
7632874|NCT02279862|18794181|P2|STARTED|Overall Study||27
7632875|NCT02279862|18794182|P1|STARTED|Overall Study||26
7632876|NCT02279732|18794200|P2|NOT COMPLETED|Overall Study||106
7632877|NCT02279732|18794201|P1|NOT COMPLETED|Overall Study||98
7632878|NCT02279732|18794200|P2|COMPLETED|Overall Study||0
7632879|NCT02279732|18794201|P1|COMPLETED|Overall Study||0
7632880|NCT02279732|18794200|P2|STARTED|Overall Study||106
7632881|NCT02279732|18794201|P1|STARTED|Overall Study||98
7632882|NCT02279667|18794214|P3|NOT COMPLETED|Overall Study||0
7632883|NCT02279667|18794215|P2|NOT COMPLETED|Overall Study||0
7632884|NCT02279667|18794216|P1|NOT COMPLETED|Overall Study||0
7632885|NCT02279667|18794214|P3|COMPLETED|Overall Study||6
7632886|NCT02279667|18794215|P2|COMPLETED|Overall Study||6
7632887|NCT02279667|18794216|P1|COMPLETED|Overall Study||6
7632888|NCT02279667|18794214|P3|STARTED|Overall Study||6
7632889|NCT02279667|18794215|P2|STARTED|Overall Study||6
7632890|NCT02279667|18794216|P1|STARTED|Overall Study||6
7632891|NCT02279641|18794236|P2|NOT COMPLETED|Overall Study||0
7632892|NCT02279641|18794237|P1|NOT COMPLETED|Overall Study||0
7632893|NCT02279641|18794236|P2|COMPLETED|Overall Study||6
7632894|NCT02279641|18794237|P1|COMPLETED|Overall Study||6
7632895|NCT02279641|18794236|P2|STARTED|Overall Study||6
7632896|NCT02279641|18794237|P1|STARTED|Overall Study||6
7632897|NCT02279498|18794293|P2|NOT COMPLETED|Overall Study||4
7632898|NCT02279498|18794294|P1|NOT COMPLETED|Overall Study||18
7632899|NCT02279498|18794293|P2|COMPLETED|Overall Study||59
7632900|NCT02279498|18794294|P1|COMPLETED|Overall Study||47
7632901|NCT02279498|18794293|P2|STARTED|Overall Study||63
7632902|NCT02279498|18794294|P1|STARTED|Overall Study||65
7632903|NCT02279420|18794303|P1|NOT COMPLETED|Overall Study||23
7632904|NCT02279420|18794303|P1|COMPLETED|Overall Study||50
7632905|NCT02279420|18794303|P1|STARTED|Overall Study||73
7632906|NCT02279407|18794311|P4|NOT COMPLETED|Overall Study||1
7632907|NCT02279407|18794312|P3|NOT COMPLETED|Overall Study||5
7632908|NCT02279407|18794313|P2|NOT COMPLETED|Overall Study||1
7632909|NCT02279407|18794314|P1|NOT COMPLETED|Overall Study||2
7632910|NCT02279407|18794311|P4|COMPLETED|Overall Study||20
7632911|NCT02279407|18794312|P3|COMPLETED|Overall Study||15
7632912|NCT02279407|18794313|P2|COMPLETED|Overall Study||20
7632913|NCT02279407|18794314|P1|COMPLETED|Overall Study||20
7632914|NCT02279407|18794311|P4|STARTED|Overall Study||21
7632915|NCT02279407|18794312|P3|STARTED|Overall Study||20
7632916|NCT02279407|18794313|P2|STARTED|Overall Study||21
7632917|NCT02279407|18794314|P1|STARTED|Overall Study||22
7632918|NCT02279173|18794325|P1|NOT COMPLETED|Overall Study||94
7632919|NCT02279173|18794325|P1|COMPLETED|Overall Study||109
7632920|NCT02279173|18794325|P1|Enrolled Under Protocol Supplement|Overall Study||79
7632921|NCT02279173|18794325|P1|Received Treatment|Overall Study||203
7632922|NCT02279173|18794325|P1|STARTED|Overall Study||203
7632923|NCT02279160|18794344|P2|NOT COMPLETED|Overall Study||2
7632924|NCT02279160|18794345|P1|NOT COMPLETED|Overall Study||6
7632925|NCT02279160|18794344|P2|COMPLETED|Overall Study||19
7632926|NCT02279160|18794345|P1|COMPLETED|Overall Study||34
7632927|NCT02279160|18794344|P2|STARTED|Overall Study||21
7632928|NCT02279160|18794345|P1|STARTED|Overall Study||40
7632929|NCT02279108|18794355|P2|NOT COMPLETED|Overall Study||1
7632930|NCT02279108|18794356|P1|NOT COMPLETED|Overall Study||0
7632931|NCT02279108|18794355|P2|COMPLETED|Overall Study||49
7632932|NCT02279108|18794356|P1|COMPLETED|Overall Study||50
7632933|NCT02279108|18794355|P2|STARTED|Overall Study||50
7632934|NCT02279108|18794356|P1|STARTED|Overall Study||50
7632935|NCT02279082|18794378|P1|NOT COMPLETED|Overall Study||33
7632936|NCT02279082|18794378|P1|COMPLETED|Overall Study||134
7632937|NCT02279082|18794378|P1|STARTED|Overall Study|Intentions were to have 173 participants, but only 167 participants received study drug.|167
7632938|NCT02279043|18794385|P3|NOT COMPLETED|Overall Study||0
7632939|NCT02279043|18794386|P2|NOT COMPLETED|Overall Study||89
7632940|NCT02279043|18794387|P1|NOT COMPLETED|Overall Study||47
7632941|NCT02279043|18794385|P3|COMPLETED|Overall Study||140
7632942|NCT02279043|18794386|P2|COMPLETED|Overall Study||226
7632943|NCT02279043|18794387|P1|COMPLETED|Overall Study||128
7632944|NCT02279043|18794385|P3|STARTED|Overall Study||140
7632945|NCT02279043|18794386|P2|STARTED|Overall Study||315
7632946|NCT02279043|18794387|P1|STARTED|Overall Study||175
7632947|NCT02278952|18794417|P1|NOT COMPLETED|Overall Study||6
7632948|NCT02278952|18794417|P1|COMPLETED|Overall Study|The number of biopsy samples assayed during the time the patient was enrolled in the study.|44
7632949|NCT02278952|18794417|P1|STARTED|Overall Study|The number of biopsy procedures performed during the time the patient was enrolled in the study.|50
7632950|NCT02278939|18794429|P2|NOT COMPLETED|Overall Study||1
7632951|NCT02278939|18794430|P1|NOT COMPLETED|Overall Study||5
7632952|NCT02278939|18794429|P2|COMPLETED|Overall Study||33
7632953|NCT02278939|18794430|P1|COMPLETED|Overall Study||28
7632954|NCT02278939|18794429|P2|STARTED|Overall Study||34
7632955|NCT02278939|18794430|P1|STARTED|Overall Study||33
7632956|NCT02278783|18794442|P1|NOT COMPLETED|Overall Study||0
7632957|NCT02278783|18794442|P1|COMPLETED|Overall Study||1
7632958|NCT02278783|18794442|P1|STARTED|Overall Study||1
7632959|NCT02278640|18794449|P1|NOT COMPLETED|Overall Study||0
7632960|NCT02278640|18794449|P1|COMPLETED|Overall Study||40
7632961|NCT02278640|18794449|P1|STARTED|Overall Study||40
7632962|NCT02278614|18794458|P2|NOT COMPLETED|Overall Study||5
7632963|NCT02278614|18794459|P1|NOT COMPLETED|Overall Study||5
7632964|NCT02278614|18794458|P2|COMPLETED|Overall Study||110
7632965|NCT02278614|18794459|P1|COMPLETED|Overall Study||122
7632966|NCT02278614|18794458|P2|STARTED|Overall Study||115
7632967|NCT02278614|18794459|P1|STARTED|Overall Study||127
7632968|NCT02278562|18794468|P3|NOT COMPLETED|Overall Study||0
7632969|NCT02278562|18794469|P2|NOT COMPLETED|Overall Study||0
7632970|NCT02278562|18794470|P1|NOT COMPLETED|Overall Study||0
7632971|NCT02278562|18794468|P3|COMPLETED|Overall Study||8
7632972|NCT02278562|18794469|P2|COMPLETED|Overall Study||7
7632973|NCT02278562|18794470|P1|COMPLETED|Overall Study||9
7632974|NCT02278562|18794468|P3|STARTED|Overall Study||8
7632975|NCT02278562|18794469|P2|STARTED|Overall Study||7
7632976|NCT02278562|18794470|P1|STARTED|Overall Study||9
7632977|NCT02278484|18794484|P1|NOT COMPLETED|Overall Study||0
7632978|NCT02278484|18794484|P1|COMPLETED|Overall Study||50
7632979|NCT02278484|18794484|P1|STARTED|Overall Study||50
7632980|NCT02278471|18794493|P2|NOT COMPLETED|Overall Study||20
7632981|NCT02278471|18794494|P1|NOT COMPLETED|Overall Study||8
7632982|NCT02278471|18794493|P2|COMPLETED|Overall Study||128
7632983|NCT02278471|18794494|P1|COMPLETED|Overall Study||147
7632984|NCT02278471|18794493|P2|STARTED|Overall Study||148
7632985|NCT02278471|18794494|P1|STARTED|Overall Study||155
7632986|NCT02278367|18794512|P2|NOT COMPLETED|Overall Study||0
7632987|NCT02278367|18794513|P1|NOT COMPLETED|Overall Study||10
7632988|NCT02278367|18794512|P2|COMPLETED|Overall Study||110
7632989|NCT02278367|18794513|P1|COMPLETED|Overall Study||59
7632990|NCT02278367|18794512|P2|STARTED|Overall Study||110
7632991|NCT02278367|18794513|P1|STARTED|Overall Study||69
7632992|NCT02278354|18794523|P2|NOT COMPLETED|Overall Study||3
7632993|NCT02278354|18794524|P1|NOT COMPLETED|Overall Study||4
7632994|NCT02278354|18794523|P2|COMPLETED|Overall Study||20
7632995|NCT02278354|18794524|P1|COMPLETED|Overall Study||8
7632996|NCT02278354|18794523|P2|Flortaucipir PET Scan|Overall Study||20
7632997|NCT02278354|18794524|P1|Flortaucipir PET Scan|Overall Study||10
7632998|NCT02278354|18794523|P2|STARTED|Overall Study||23
7632999|NCT02278354|18794524|P1|STARTED|Overall Study||12
7633000|NCT02278341|18794538|P2|NOT COMPLETED|Overall Study||92
7633001|NCT02278341|18794539|P1|NOT COMPLETED|Overall Study||118
7633002|NCT02278341|18794538|P2|COMPLETED|Overall Study||329
7633003|NCT02278341|18794539|P1|COMPLETED|Overall Study||297
7633004|NCT02278341|18794538|P2|Received Treatment|Overall Study||420
7633005|NCT02278341|18794539|P1|Received Treatment|Overall Study||414
7633006|NCT02278341|18794538|P2|STARTED|Overall Study||421
7633007|NCT02278341|18794539|P1|STARTED|Overall Study||415
7633008|NCT02278328|18794633|P3|NOT COMPLETED|Third Washout (1 Week)||0
7633009|NCT02278328|18794634|P2|NOT COMPLETED|Third Washout (1 Week)||0
7633010|NCT02278328|18794635|P1|NOT COMPLETED|Third Washout (1 Week)||0
7633011|NCT02278328|18794633|P3|COMPLETED|Third Washout (1 Week)||6
7633012|NCT02278328|18794634|P2|COMPLETED|Third Washout (1 Week)||6
7633013|NCT02278328|18794635|P1|COMPLETED|Third Washout (1 Week)||9
7633014|NCT02278328|18794633|P3|STARTED|Third Washout (1 Week)||6
7633015|NCT02278328|18794634|P2|STARTED|Third Washout (1 Week)||6
7633016|NCT02278328|18794635|P1|STARTED|Third Washout (1 Week)||9
7633017|NCT02278328|18794633|P3|NOT COMPLETED|Third Intervention (1 Day)||0
7633018|NCT02278328|18794634|P2|NOT COMPLETED|Third Intervention (1 Day)||0
7633019|NCT02278328|18794635|P1|NOT COMPLETED|Third Intervention (1 Day)||0
7633020|NCT02278328|18794633|P3|COMPLETED|Third Intervention (1 Day)||6
7633021|NCT02278328|18794634|P2|COMPLETED|Third Intervention (1 Day)||6
7633022|NCT02278328|18794635|P1|COMPLETED|Third Intervention (1 Day)||9
7633023|NCT02278328|18794633|P3|STARTED|Third Intervention (1 Day)||6
7633024|NCT02278328|18794634|P2|STARTED|Third Intervention (1 Day)||6
7633025|NCT02278328|18794635|P1|STARTED|Third Intervention (1 Day)||9
7633026|NCT02278328|18794633|P3|NOT COMPLETED|Second Washout (1 Week)||0
7633027|NCT02278328|18794634|P2|NOT COMPLETED|Second Washout (1 Week)||0
7633028|NCT02278328|18794635|P1|NOT COMPLETED|Second Washout (1 Week)||0
7633029|NCT02278328|18794633|P3|COMPLETED|Second Washout (1 Week)||6
7633030|NCT02278328|18794634|P2|COMPLETED|Second Washout (1 Week)||6
7633031|NCT02278328|18794635|P1|COMPLETED|Second Washout (1 Week)||9
7633032|NCT02278328|18794633|P3|STARTED|Second Washout (1 Week)||6
7633033|NCT02278328|18794634|P2|STARTED|Second Washout (1 Week)||6
7633034|NCT02278328|18794635|P1|STARTED|Second Washout (1 Week)||9
7633035|NCT02278328|18794633|P3|NOT COMPLETED|Second Intervention (1 Day)||0
7633036|NCT02278328|18794634|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7633037|NCT02278328|18794635|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7633038|NCT02278328|18794633|P3|COMPLETED|Second Intervention (1 Day)||6
7633039|NCT02278328|18794634|P2|COMPLETED|Second Intervention (1 Day)||6
7633040|NCT02278328|18794635|P1|COMPLETED|Second Intervention (1 Day)||9
7633041|NCT02278328|18794633|P3|STARTED|Second Intervention (1 Day)||6
7633042|NCT02278328|18794634|P2|STARTED|Second Intervention (1 Day)||6
7633043|NCT02278328|18794635|P1|STARTED|Second Intervention (1 Day)||9
7633044|NCT02278328|18794633|P3|NOT COMPLETED|Washout (1 Week)||0
7633045|NCT02278328|18794634|P2|NOT COMPLETED|Washout (1 Week)||0
7633046|NCT02278328|18794635|P1|NOT COMPLETED|Washout (1 Week)||0
7633047|NCT02278328|18794633|P3|COMPLETED|Washout (1 Week)||6
7633048|NCT02278328|18794634|P2|COMPLETED|Washout (1 Week)||6
7633049|NCT02278328|18794635|P1|COMPLETED|Washout (1 Week)||9
7633050|NCT02278328|18794633|P3|STARTED|Washout (1 Week)||6
7633051|NCT02278328|18794634|P2|STARTED|Washout (1 Week)||6
7633052|NCT02278328|18794635|P1|STARTED|Washout (1 Week)||9
7633053|NCT02278328|18794633|P3|NOT COMPLETED|First Intervention (1 Day)||0
7633054|NCT02278328|18794634|P2|NOT COMPLETED|First Intervention (1 Day)||0
7633055|NCT02278328|18794635|P1|NOT COMPLETED|First Intervention (1 Day)||0
7633056|NCT02278328|18794633|P3|COMPLETED|First Intervention (1 Day)||6
7633057|NCT02278328|18794634|P2|COMPLETED|First Intervention (1 Day)||6
7633058|NCT02278328|18794635|P1|COMPLETED|First Intervention (1 Day)||9
7633059|NCT02278328|18794633|P3|STARTED|First Intervention (1 Day)||6
7633060|NCT02278328|18794634|P2|STARTED|First Intervention (1 Day)||6
7633061|NCT02278328|18794635|P1|STARTED|First Intervention (1 Day)||9
7633062|NCT02278328|18794633|P3|NOT COMPLETED|Neuropsych Screening||2
7633063|NCT02278328|18794634|P2|NOT COMPLETED|Neuropsych Screening||1
7633064|NCT02278328|18794635|P1|NOT COMPLETED|Neuropsych Screening||1
7633065|NCT02278328|18794633|P3|COMPLETED|Neuropsych Screening||6
7633066|NCT02278328|18794634|P2|COMPLETED|Neuropsych Screening||6
7633067|NCT02278328|18794635|P1|COMPLETED|Neuropsych Screening||9
7633068|NCT02278328|18794633|P3|STARTED|Neuropsych Screening||8
7633069|NCT02278328|18794634|P2|STARTED|Neuropsych Screening||7
7633070|NCT02278328|18794635|P1|STARTED|Neuropsych Screening||10
7633071|NCT02278263|18794648|P3|NOT COMPLETED|Overall Study||9
7633072|NCT02278263|18794649|P2|NOT COMPLETED|Overall Study||0
7633073|NCT02278263|18794650|P1|NOT COMPLETED|Overall Study||7
7633074|NCT02278263|18794648|P3|COMPLETED|Overall Study||51
7633075|NCT02278263|18794649|P2|COMPLETED|Overall Study|Correction|60
7633076|NCT02278263|18794650|P1|COMPLETED|Overall Study||23
7633077|NCT02278263|18794648|P3|STARTED|Overall Study||60
7633078|NCT02278263|18794649|P2|STARTED|Overall Study||60
7633079|NCT02278263|18794650|P1|STARTED|Overall Study||30
7633080|NCT02278237|18794676|P1|NOT COMPLETED|Overall Study||7
7633081|NCT02278237|18794676|P1|COMPLETED|Overall Study||83
7633082|NCT02278237|18794676|P1|STARTED|Overall Study||90
7633083|NCT02278146|18794682|P2|NOT COMPLETED|Overall Study||2
7633084|NCT02278146|18794683|P1|NOT COMPLETED|Overall Study||0
7633085|NCT02278146|18794682|P2|COMPLETED|Overall Study||8
7633086|NCT02278146|18794683|P1|COMPLETED|Overall Study||6
7633087|NCT02278146|18794682|P2|STARTED|Overall Study||10
7633088|NCT02278146|18794683|P1|STARTED|Overall Study||6
7633089|NCT02278120|18794695|P2|NOT COMPLETED|Overall Study||216
7633090|NCT02278120|18794696|P1|NOT COMPLETED|Overall Study||161
7633091|NCT02278120|18794695|P2|COMPLETED|Overall Study||121
7633092|NCT02278120|18794696|P1|COMPLETED|Overall Study||174
7633093|NCT02278120|18794695|P2|STARTED|Overall Study||337
7633094|NCT02278120|18794696|P1|STARTED|Overall Study||335
7633095|NCT02278003|18794712|P2|NOT COMPLETED|Overall Study||0
7633096|NCT02278003|18794713|P1|NOT COMPLETED|Overall Study||19
7633097|NCT02278003|18794712|P2|COMPLETED|Overall Study||20
7633098|NCT02278003|18794713|P1|COMPLETED|Overall Study||30
7633099|NCT02278003|18794712|P2|STARTED|Overall Study||20
7633100|NCT02278003|18794713|P1|STARTED|Overall Study||49
7633101|NCT02277990|18794723|P2|NOT COMPLETED|Overall Study||376
7633102|NCT02277990|18794724|P1|NOT COMPLETED|Overall Study||366
7633103|NCT02277990|18794723|P2|COMPLETED|Overall Study||3112
7633104|NCT02277990|18794724|P1|COMPLETED|Overall Study||3129
7633105|NCT02277990|18794723|P2|STARTED|Overall Study||3488
7633106|NCT02277990|18794724|P1|STARTED|Overall Study||3495
7633107|NCT02277925|18794738|P2|NOT COMPLETED|Overall Study||15
7633108|NCT02277925|18794739|P1|NOT COMPLETED|Overall Study||7
7633109|NCT02277925|18794738|P2|COMPLETED|Overall Study||87
7633110|NCT02277925|18794739|P1|COMPLETED|Overall Study||95
7633111|NCT02277925|18794738|P2|Surgery|Overall Study||101
7633112|NCT02277925|18794739|P1|Surgery|Overall Study||99
7633113|NCT02277925|18794738|P2|STARTED|Overall Study||102
7633114|NCT02277925|18794739|P1|STARTED|Overall Study||102
7633115|NCT02277769|18794752|P3|NOT COMPLETED|Overall Study||18
7633116|NCT02277769|18794753|P2|NOT COMPLETED|Overall Study||13
7633117|NCT02277769|18794754|P1|NOT COMPLETED|Overall Study||46
7633118|NCT02277769|18794752|P3|COMPLETED|Overall Study||221
7633119|NCT02277769|18794753|P2|COMPLETED|Overall Study||220
7633120|NCT02277769|18794754|P1|COMPLETED|Overall Study||190
7633121|NCT02277769|18794752|P3|Safety Population|Overall Study|2 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|237
7633122|NCT02277769|18794753|P2|Safety Population|Overall Study|3 participants (1 [placebo] + 2 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|236
7633123|NCT02277769|18794754|P1|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|234
7633124|NCT02277769|18794752|P3|Treated|Overall Study||239
7633125|NCT02277769|18794753|P2|Treated|Overall Study||233
7633126|NCT02277769|18794754|P1|Treated|Overall Study||235
7633127|NCT02277769|18794752|P3|STARTED|Overall Study||239
7633128|NCT02277769|18794753|P2|STARTED|Overall Study||233
7633129|NCT02277769|18794754|P1|STARTED|Overall Study||236
7633130|NCT02277743|18794825|P3|NOT COMPLETED|Overall Study||26
7633131|NCT02277743|18794826|P2|NOT COMPLETED|Overall Study||16
7633132|NCT02277743|18794827|P1|NOT COMPLETED|Overall Study||40
7633133|NCT02277743|18794825|P3|COMPLETED|Overall Study||197
7633134|NCT02277743|18794826|P2|COMPLETED|Overall Study||208
7633135|NCT02277743|18794827|P1|COMPLETED|Overall Study||184
7633136|NCT02277743|18794825|P3|Safety Population|Overall Study|5 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|218
7633137|NCT02277743|18794826|P2|Safety Population|Overall Study|6 participants (1 [placebo] + 5 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|229
7633138|NCT02277743|18794827|P1|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|222
7633139|NCT02277743|18794825|P3|Treated|Overall Study||223
7633140|NCT02277743|18794826|P2|Treated|Overall Study||223
7633141|NCT02277743|18794827|P1|Treated|Overall Study||223
7633142|NCT02277743|18794825|P3|STARTED|Overall Study||223
7633143|NCT02277743|18794826|P2|STARTED|Overall Study||224
7633144|NCT02277743|18794827|P1|STARTED|Overall Study||224
7633145|NCT02277691|18794895|P1|NOT COMPLETED|Overall Study||46
7633146|NCT02277691|18794895|P1|COMPLETED|Overall Study||295
7633147|NCT02277691|18794895|P1|STARTED|Overall Study||341
7633148|NCT02277665|18794907|P2|NOT COMPLETED|Overall Study||0
7633149|NCT02277665|18794908|P1|NOT COMPLETED|Overall Study||0
7633150|NCT02277665|18794907|P2|COMPLETED|Overall Study||34
7633151|NCT02277665|18794908|P1|COMPLETED|Overall Study||33
7633152|NCT02277665|18794907|P2|STARTED|Overall Study||34
7633153|NCT02277665|18794908|P1|STARTED|Overall Study||33
7633154|NCT02277639|18794926|P2|NOT COMPLETED|Overall Study||0
7633155|NCT02277639|18794927|P1|NOT COMPLETED|Overall Study||0
7633156|NCT02277639|18794926|P2|COMPLETED|Overall Study||2
7633157|NCT02277639|18794927|P1|COMPLETED|Overall Study||0
7633158|NCT02277639|18794926|P2|STARTED|Overall Study||2
7633159|NCT02277639|18794927|P1|STARTED|Overall Study||0
7633160|NCT02277626|18794933|P2|NOT COMPLETED|Overall Study||0
7633161|NCT02277626|18794934|P1|NOT COMPLETED|Overall Study||0
7633162|NCT02277626|18794933|P2|COMPLETED|Overall Study||9
7633163|NCT02277626|18794934|P1|COMPLETED|Overall Study||6
7633164|NCT02277626|18794933|P2|STARTED|Overall Study||9
7633165|NCT02277626|18794934|P1|STARTED|Overall Study||6
7633166|NCT02277548|18794950|P2|NOT COMPLETED|Overall Study||2
7633167|NCT02277548|18794951|P1|NOT COMPLETED|Overall Study||0
7633168|NCT02277548|18794950|P2|COMPLETED|Overall Study||9
7633169|NCT02277548|18794951|P1|COMPLETED|Overall Study||9
7633170|NCT02277548|18794950|P2|STARTED|Overall Study||11
7633171|NCT02277548|18794951|P1|STARTED|Overall Study||9
7633172|NCT02277444|18794957|P1|NOT COMPLETED|Overall Study||130
7633173|NCT02277444|18794957|P1|COMPLETED|Overall Study||0
7633174|NCT02277444|18794957|P1|Treated|Overall Study||127
7633175|NCT02277444|18794957|P1|STARTED|Overall Study||130
7633176|NCT02277249|18794966|P2|NOT COMPLETED|Overall Study||0
7633177|NCT02277249|18794967|P1|NOT COMPLETED|Overall Study||0
7633178|NCT02277249|18794966|P2|COMPLETED|Overall Study||30
7633179|NCT02277249|18794967|P1|COMPLETED|Overall Study||30
7633180|NCT02277249|18794966|P2|STARTED|Overall Study||30
7633181|NCT02277249|18794967|P1|STARTED|Overall Study||30
7633182|NCT02277119|18794976|P3|NOT COMPLETED|Overall Study||8
7633183|NCT02277119|18794977|P2|NOT COMPLETED|Overall Study||4
7633184|NCT02277119|18794978|P1|NOT COMPLETED|Overall Study||3
7633185|NCT02277119|18794976|P3|COMPLETED|Overall Study||19
7633186|NCT02277119|18794977|P2|COMPLETED|Overall Study||20
7633187|NCT02277119|18794978|P1|COMPLETED|Overall Study||55
7633188|NCT02277119|18794976|P3|STARTED|Overall Study||27
7633189|NCT02277119|18794977|P2|STARTED|Overall Study||24
7633190|NCT02277119|18794978|P1|STARTED|Overall Study||58
7633191|NCT02277093|18794995|P1|NOT COMPLETED|Overall Study||0
7633192|NCT02277093|18794995|P1|COMPLETED|Overall Study||11
7633193|NCT02277093|18794995|P1|STARTED|Overall Study||11
7633194|NCT02277054|18795003|P1|NOT COMPLETED|Overall Study||0
7633195|NCT02277054|18795003|P1|COMPLETED|Overall Study||5
7633196|NCT02277054|18795003|P1|STARTED|Overall Study||5
7633197|NCT02276963|18795009|P1|NOT COMPLETED|Overall Study||3
7633198|NCT02276963|18795009|P1|COMPLETED|Overall Study||3
7633199|NCT02276963|18795009|P1|STARTED|Overall Study||6
7633200|NCT02276872|18795016|P3|NOT COMPLETED|Overall Study||0
7633201|NCT02276872|18795017|P2|NOT COMPLETED|Overall Study||0
7633202|NCT02276872|18795018|P1|NOT COMPLETED|Overall Study||1
7633203|NCT02276872|18795016|P3|COMPLETED|Overall Study||12
7633204|NCT02276872|18795017|P2|COMPLETED|Overall Study||10
7633205|NCT02276872|18795018|P1|COMPLETED|Overall Study||9
7633206|NCT02276872|18795016|P3|STARTED|Overall Study||12
7633207|NCT02276872|18795017|P2|STARTED|Overall Study||10
7633208|NCT02276872|18795018|P1|STARTED|Overall Study||10
7633209|NCT02276807|18795094|P2|NOT COMPLETED|Overall Study||17
7633210|NCT02276807|18795095|P1|NOT COMPLETED|Overall Study||18
7633211|NCT02276807|18795094|P2|COMPLETED|Overall Study||55
7633212|NCT02276807|18795095|P1|COMPLETED|Overall Study||50
7633213|NCT02276807|18795094|P2|12-week Assessment|Overall Study||63
7633214|NCT02276807|18795095|P1|12-week Assessment|Overall Study||57
7633215|NCT02276807|18795094|P2|STARTED|Overall Study||72
7633216|NCT02276807|18795095|P1|STARTED|Overall Study||68
7633217|NCT02276638|18795112|P3|NOT COMPLETED|Overall Study||0
7633218|NCT02276638|18795113|P2|NOT COMPLETED|Overall Study||0
7633219|NCT02276638|18795114|P1|NOT COMPLETED|Overall Study||0
7633220|NCT02276638|18795112|P3|COMPLETED|Overall Study||23
7633221|NCT02276638|18795113|P2|COMPLETED|Overall Study||28
7633222|NCT02276638|18795114|P1|COMPLETED|Overall Study||28
7633223|NCT02276638|18795112|P3|STARTED|Overall Study||23
7633224|NCT02276638|18795113|P2|STARTED|Overall Study||28
7633225|NCT02276638|18795114|P1|STARTED|Overall Study||28
7633226|NCT02276612|18795130|P2|NOT COMPLETED|Overall Study||0
7633227|NCT02276612|18795131|P1|NOT COMPLETED|Overall Study||4
7633228|NCT02276612|18795130|P2|COMPLETED|Overall Study||10
7633229|NCT02276612|18795131|P1|COMPLETED|Overall Study||46
7633230|NCT02276612|18795130|P2|STARTED|Overall Study||10
7633231|NCT02276612|18795131|P1|STARTED|Overall Study||50
7633232|NCT02276560|18795154|P3|NOT COMPLETED|Overall Study||0
7633233|NCT02276560|18795155|P2|NOT COMPLETED|Overall Study||0
7633234|NCT02276560|18795156|P1|NOT COMPLETED|Overall Study||1
7633235|NCT02276560|18795154|P3|COMPLETED|Overall Study||0
7633236|NCT02276560|18795155|P2|COMPLETED|Overall Study||0
7633237|NCT02276560|18795156|P1|COMPLETED|Overall Study||0
7633238|NCT02276560|18795154|P3|STARTED|Overall Study||0
7633239|NCT02276560|18795155|P2|STARTED|Overall Study||0
7633240|NCT02276560|18795156|P1|STARTED|Overall Study||1
7633241|NCT02276482|18795166|P2|NOT COMPLETED|Overall Study||1
7633242|NCT02276482|18795167|P1|NOT COMPLETED|Overall Study||3
7633243|NCT02276482|18795166|P2|COMPLETED|Overall Study||28
7633244|NCT02276482|18795167|P1|COMPLETED|Overall Study||88
7633245|NCT02276482|18795166|P2|STARTED|Overall Study||29
7633246|NCT02276482|18795167|P1|STARTED|Overall Study||91
7633247|NCT02276274|18795191|P2|NOT COMPLETED|Second Intervention Period||0
7633248|NCT02276274|18795192|P1|NOT COMPLETED|Second Intervention Period||0
7633249|NCT02276274|18795191|P2|COMPLETED|Second Intervention Period||6
7633250|NCT02276274|18795192|P1|COMPLETED|Second Intervention Period||6
7633251|NCT02276274|18795191|P2|STARTED|Second Intervention Period||6
7633252|NCT02276274|18795192|P1|STARTED|Second Intervention Period||6
7633253|NCT02276274|18795191|P2|NOT COMPLETED|Washout Period (at Least 15 Days)||0
7633254|NCT02276274|18795192|P1|NOT COMPLETED|Washout Period (at Least 15 Days)||0
7633255|NCT02276274|18795191|P2|COMPLETED|Washout Period (at Least 15 Days)||6
7633256|NCT02276274|18795192|P1|COMPLETED|Washout Period (at Least 15 Days)||6
7633257|NCT02276274|18795191|P2|STARTED|Washout Period (at Least 15 Days)||6
7633258|NCT02276274|18795192|P1|STARTED|Washout Period (at Least 15 Days)||6
7633259|NCT02276274|18795191|P2|NOT COMPLETED|First Intervention Period||0
7633260|NCT02276274|18795192|P1|NOT COMPLETED|First Intervention Period||0
7633261|NCT02276274|18795191|P2|COMPLETED|First Intervention Period||6
7633262|NCT02276274|18795192|P1|COMPLETED|First Intervention Period||6
7633263|NCT02276274|18795191|P2|STARTED|First Intervention Period||6
7633264|NCT02276274|18795192|P1|STARTED|First Intervention Period||6
7633265|NCT02276222|18795302|P2|NOT COMPLETED|Overall Study||64
7633266|NCT02276222|18795303|P1|NOT COMPLETED|Overall Study||185
7633267|NCT02276222|18795302|P2|COMPLETED|Overall Study||402
7633268|NCT02276222|18795303|P1|COMPLETED|Overall Study|one subject withdrew at randomization due to a pre-treatment event prior to being dosed|436
7633269|NCT02276222|18795302|P2|STARTED|Overall Study||466
7633270|NCT02276222|18795303|P1|STARTED|Overall Study||621
7633271|NCT02276053|18795327|P1|NOT COMPLETED|Overall Study||14
7633272|NCT02276053|18795327|P1|COMPLETED|Overall Study||79
7633273|NCT02276053|18795327|P1|STARTED|Overall Study||93
7633274|NCT02276040|18795343|P1|NOT COMPLETED|Overall Study||15
7633275|NCT02276040|18795343|P1|COMPLETED|Overall Study||11
7633276|NCT02276040|18795343|P1|STARTED|Overall Study||26
7633277|NCT02276027|18795351|P4|NOT COMPLETED|Overall Study||22
7633278|NCT02276027|18795352|P3|NOT COMPLETED|Overall Study||20
7633279|NCT02276027|18795353|P2|NOT COMPLETED|Overall Study||16
7633280|NCT02276027|18795354|P1|NOT COMPLETED|Overall Study||2
7633281|NCT02276027|18795351|P4|COMPLETED|Overall Study||0
7633282|NCT02276027|18795352|P3|COMPLETED|Overall Study||6
7633283|NCT02276027|18795353|P2|COMPLETED|Overall Study||0
7633284|NCT02276027|18795354|P1|COMPLETED|Overall Study||0
7633285|NCT02276027|18795351|P4|STARTED|Overall Study||22
7633286|NCT02276027|18795352|P3|STARTED|Overall Study||26
7633287|NCT02276027|18795353|P2|STARTED|Overall Study||16
7633288|NCT02276027|18795354|P1|STARTED|Overall Study||2
7633289|NCT02275923|18795396|P1|NOT COMPLETED|Overall Study||2
7633290|NCT02275923|18795396|P1|COMPLETED|Overall Study||7
7633291|NCT02275923|18795396|P1|STARTED|Overall Study||9
7633292|NCT02275780|18795403|P2|NOT COMPLETED|Extension Study: up to 192 Weeks||233
7633293|NCT02275780|18795404|P1|NOT COMPLETED|Extension Study: up to 192 Weeks||260
7633294|NCT02275780|18795403|P2|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
7633295|NCT02275780|18795404|P1|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
7633296|NCT02275780|18795403|P2|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|233
7633297|NCT02275780|18795404|P1|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|260
7633298|NCT02275780|18795403|P2|NOT COMPLETED|Base Study: 96 Weeks||111
7633299|NCT02275780|18795404|P1|NOT COMPLETED|Base Study: 96 Weeks||93
7633300|NCT02275780|18795403|P2|COMPLETED|Base Study: 96 Weeks||273
7633301|NCT02275780|18795404|P1|COMPLETED|Base Study: 96 Weeks||292
7633302|NCT02275780|18795403|P2|Treated|Base Study: 96 Weeks||383
7633303|NCT02275780|18795404|P1|Treated|Base Study: 96 Weeks||383
7633304|NCT02275780|18795403|P2|STARTED|Base Study: 96 Weeks||384
7633305|NCT02275780|18795404|P1|STARTED|Base Study: 96 Weeks||385
7633306|NCT02275767|18795443|P3|NOT COMPLETED|Overall Study||3
7633307|NCT02275767|18795444|P2|NOT COMPLETED|Overall Study||4
7633308|NCT02275767|18795445|P1|NOT COMPLETED|Overall Study||2
7633309|NCT02275767|18795443|P3|COMPLETED|Overall Study||19
7633310|NCT02275767|18795444|P2|COMPLETED|Overall Study||18
7633311|NCT02275767|18795445|P1|COMPLETED|Overall Study||20
7633312|NCT02275767|18795443|P3|STARTED|Overall Study||22
7633313|NCT02275767|18795444|P2|STARTED|Overall Study||22
7633314|NCT02275767|18795445|P1|STARTED|Overall Study||22
7633315|NCT02275611|18795460|P4|NOT COMPLETED|Outpatient Drinking||0
7633316|NCT02275611|18795461|P3|NOT COMPLETED|Outpatient Drinking||0
7633317|NCT02275611|18795462|P2|NOT COMPLETED|Outpatient Drinking||0
7633318|NCT02275611|18795463|P1|NOT COMPLETED|Outpatient Drinking||0
7633319|NCT02275611|18795460|P4|COMPLETED|Outpatient Drinking||3
7633320|NCT02275611|18795461|P3|COMPLETED|Outpatient Drinking||6
7633321|NCT02275611|18795462|P2|COMPLETED|Outpatient Drinking||0
7633322|NCT02275611|18795463|P1|COMPLETED|Outpatient Drinking||0
7633323|NCT02275611|18795460|P4|STARTED|Outpatient Drinking||3
7633324|NCT02275611|18795461|P3|STARTED|Outpatient Drinking||6
7633325|NCT02275611|18795462|P2|STARTED|Outpatient Drinking||0
7633326|NCT02275611|18795463|P1|STARTED|Outpatient Drinking||0
7633327|NCT02275611|18795460|P4|NOT COMPLETED|Inpatient Withdrawal||0
7633328|NCT02275611|18795461|P3|NOT COMPLETED|Inpatient Withdrawal||0
7633329|NCT02275611|18795462|P2|NOT COMPLETED|Inpatient Withdrawal||0
7633330|NCT02275611|18795463|P1|NOT COMPLETED|Inpatient Withdrawal||1
7633331|NCT02275611|18795460|P4|COMPLETED|Inpatient Withdrawal||0
7633332|NCT02275611|18795461|P3|COMPLETED|Inpatient Withdrawal||0
7633333|NCT02275611|18795462|P2|COMPLETED|Inpatient Withdrawal||4
7633334|NCT02275611|18795463|P1|COMPLETED|Inpatient Withdrawal||4
7633335|NCT02275611|18795460|P4|STARTED|Inpatient Withdrawal||0
7633336|NCT02275611|18795461|P3|STARTED|Inpatient Withdrawal||0
7633337|NCT02275611|18795462|P2|STARTED|Inpatient Withdrawal||4
7633338|NCT02275611|18795463|P1|STARTED|Inpatient Withdrawal||5
7633339|NCT02275546|18795475|P2|NOT COMPLETED|Treatment Period 2||2
7633340|NCT02275546|18795476|P1|NOT COMPLETED|Treatment Period 2||2
7633341|NCT02275546|18795475|P2|COMPLETED|Treatment Period 2||81
7633342|NCT02275546|18795476|P1|COMPLETED|Treatment Period 2||79
7633343|NCT02275546|18795475|P2|STARTED|Treatment Period 2||83
7633344|NCT02275546|18795476|P1|STARTED|Treatment Period 2||81
7633345|NCT02275546|18795475|P2|NOT COMPLETED|Treatment Period 1||0
7633346|NCT02275546|18795476|P1|NOT COMPLETED|Treatment Period 1||0
7633347|NCT02275546|18795475|P2|COMPLETED|Treatment Period 1||83
7633348|NCT02275546|18795476|P1|COMPLETED|Treatment Period 1||81
7633349|NCT02275546|18795475|P2|STARTED|Treatment Period 1||83
7633350|NCT02275546|18795476|P1|STARTED|Treatment Period 1||81
7633351|NCT02275481|18795486|P2|NOT COMPLETED|Overall Study||3
7633352|NCT02275481|18795487|P1|NOT COMPLETED|Overall Study||9
7633353|NCT02275481|18795486|P2|COMPLETED|Overall Study||31
7633354|NCT02275481|18795487|P1|COMPLETED|Overall Study||23
7633355|NCT02275481|18795486|P2|STARTED|Overall Study||34
7633356|NCT02275481|18795487|P1|STARTED|Overall Study||32
7633357|NCT02275364|18795493|P2|NOT COMPLETED|Period 4||0
7633358|NCT02275364|18795494|P1|NOT COMPLETED|Period 4||0
7633359|NCT02275364|18795493|P2|COMPLETED|Period 4||14
7633360|NCT02275364|18795494|P1|COMPLETED|Period 4||12
7633361|NCT02275364|18795493|P2|STARTED|Period 4||14
7633362|NCT02275364|18795494|P1|STARTED|Period 4||12
7633363|NCT02275364|18795493|P2|NOT COMPLETED|Period 3||0
7633364|NCT02275364|18795494|P1|NOT COMPLETED|Period 3||0
7633365|NCT02275364|18795493|P2|COMPLETED|Period 3||14
7633366|NCT02275364|18795494|P1|COMPLETED|Period 3||12
7633367|NCT02275364|18795493|P2|STARTED|Period 3||14
7633368|NCT02275364|18795494|P1|STARTED|Period 3||12
7633369|NCT02275364|18795493|P2|NOT COMPLETED|Washout Period 2||0
7633370|NCT02275364|18795494|P1|NOT COMPLETED|Washout Period 2||0
7633371|NCT02275364|18795493|P2|COMPLETED|Washout Period 2||14
7633372|NCT02275364|18795494|P1|COMPLETED|Washout Period 2||12
7633373|NCT02275364|18795493|P2|STARTED|Washout Period 2||14
7633374|NCT02275364|18795494|P1|STARTED|Washout Period 2||12
7633375|NCT02275364|18795493|P2|NOT COMPLETED|Period 2||0
7633376|NCT02275364|18795494|P1|NOT COMPLETED|Period 2||0
7633377|NCT02275364|18795493|P2|COMPLETED|Period 2||14
7633378|NCT02275364|18795494|P1|COMPLETED|Period 2||12
7633379|NCT02275364|18795493|P2|STARTED|Period 2||14
7633380|NCT02275364|18795494|P1|STARTED|Period 2||12
7633381|NCT02275364|18795493|P2|NOT COMPLETED|Washout Period 1||0
7633382|NCT02275364|18795494|P1|NOT COMPLETED|Washout Period 1||0
7633383|NCT02275364|18795493|P2|COMPLETED|Washout Period 1||14
7633384|NCT02275364|18795494|P1|COMPLETED|Washout Period 1||12
7633385|NCT02275364|18795493|P2|STARTED|Washout Period 1||14
7633386|NCT02275364|18795494|P1|STARTED|Washout Period 1||12
7633387|NCT02275364|18795493|P2|NOT COMPLETED|Period 1||0
7633388|NCT02275364|18795494|P1|NOT COMPLETED|Period 1||2
7633389|NCT02275364|18795493|P2|COMPLETED|Period 1||14
7633390|NCT02275364|18795494|P1|COMPLETED|Period 1||12
7633391|NCT02275364|18795493|P2|STARTED|Period 1||14
7633392|NCT02275364|18795494|P1|STARTED|Period 1||14
7633393|NCT02275338|18795523|P1|NOT COMPLETED|Overall Study||33
7633394|NCT02275338|18795523|P1|COMPLETED|Overall Study||19
7633395|NCT02275338|18795523|P1|Started Phase 2|Overall Study||21
7633396|NCT02275338|18795523|P1|Completed Phase 1|Overall Study||25
7633397|NCT02275338|18795523|P1|STARTED|Overall Study||52
7633398|NCT02275156|18795538|P3|NOT COMPLETED|Overall Study||0
7633399|NCT02275156|18795539|P2|NOT COMPLETED|Overall Study||0
7633400|NCT02275156|18795540|P1|NOT COMPLETED|Overall Study||0
7633401|NCT02275156|18795538|P3|COMPLETED|Overall Study||6
7633402|NCT02275156|18795539|P2|COMPLETED|Overall Study||6
7633403|NCT02275156|18795540|P1|COMPLETED|Overall Study||6
7633404|NCT02275156|18795538|P3|STARTED|Overall Study||6
7633405|NCT02275156|18795539|P2|STARTED|Overall Study||6
7633406|NCT02275156|18795540|P1|STARTED|Overall Study||6
7633407|NCT02275117|18795572|P5|NOT COMPLETED|Overall Study||36
7633408|NCT02275117|18795573|P4|NOT COMPLETED|Overall Study||33
7633409|NCT02275117|18795574|P3|NOT COMPLETED|Overall Study||42
7633410|NCT02275117|18795575|P2|NOT COMPLETED|Overall Study||37
7633411|NCT02275117|18795576|P1|NOT COMPLETED|Overall Study||34
7633412|NCT02275117|18795572|P5|COMPLETED|Overall Study||98
7633413|NCT02275117|18795573|P4|COMPLETED|Overall Study||100
7633414|NCT02275117|18795574|P3|COMPLETED|Overall Study||92
7633415|NCT02275117|18795575|P2|COMPLETED|Overall Study||96
7633416|NCT02275117|18795576|P1|COMPLETED|Overall Study||97
7633417|NCT02275117|18795572|P5|Randomized and Treated|Overall Study||121
7633418|NCT02275117|18795573|P4|Randomized and Treated|Overall Study||130
7633419|NCT02275117|18795574|P3|Randomized and Treated|Overall Study||122
7633420|NCT02275117|18795575|P2|Randomized and Treated|Overall Study||123
7633421|NCT02275117|18795576|P1|Randomized and Treated|Overall Study||120
7633422|NCT02275117|18795572|P5|STARTED|Overall Study||134
7633423|NCT02275117|18795573|P4|STARTED|Overall Study||133
7633424|NCT02275117|18795574|P3|STARTED|Overall Study||134
7633425|NCT02275117|18795575|P2|STARTED|Overall Study||133
7633426|NCT02275117|18795576|P1|STARTED|Overall Study||131
7633427|NCT02275065|18795688|P5|NOT COMPLETED|Overall Study||0
7633428|NCT02275065|18795689|P4|NOT COMPLETED|Overall Study||1
7633429|NCT02275065|18795690|P3|NOT COMPLETED|Overall Study||1
7633430|NCT02275065|18795691|P2|NOT COMPLETED|Overall Study||0
7633431|NCT02275065|18795692|P1|NOT COMPLETED|Overall Study||1
7633432|NCT02275065|18795688|P5|COMPLETED|Overall Study||4
7633433|NCT02275065|18795689|P4|COMPLETED|Overall Study||4
7633434|NCT02275065|18795690|P3|COMPLETED|Overall Study||4
7633435|NCT02275065|18795691|P2|COMPLETED|Overall Study||4
7633436|NCT02275065|18795692|P1|COMPLETED|Overall Study||4
7633437|NCT02275065|18795688|P5|STARTED|Overall Study||4
7633438|NCT02275065|18795689|P4|STARTED|Overall Study||5
7633439|NCT02275065|18795690|P3|STARTED|Overall Study||5
7633440|NCT02275065|18795691|P2|STARTED|Overall Study||4
7633441|NCT02275065|18795692|P1|STARTED|Overall Study||5
7633442|NCT02275052|18795773|P4|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14
7633443|NCT02275052|18795774|P3|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5
7633444|NCT02275052|18795775|P2|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
7633445|NCT02275052|18795776|P1|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
7633446|NCT02275052|18795773|P4|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72
7633447|NCT02275052|18795774|P3|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88
7633448|NCT02275052|18795775|P2|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
7633449|NCT02275052|18795776|P1|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
7633450|NCT02275052|18795773|P4|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86
7633451|NCT02275052|18795774|P3|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93
7633452|NCT02275052|18795775|P2|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
7633453|NCT02275052|18795776|P1|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
7633454|NCT02275052|18795773|P4|NOT COMPLETED|Washout Period (12-17 Days)||0
7633455|NCT02275052|18795774|P3|NOT COMPLETED|Washout Period (12-17 Days)||0
7633456|NCT02275052|18795775|P2|NOT COMPLETED|Washout Period (12-17 Days)||0
7633457|NCT02275052|18795776|P1|NOT COMPLETED|Washout Period (12-17 Days)||4
7633458|NCT02275052|18795773|P4|COMPLETED|Washout Period (12-17 Days)||0
7633459|NCT02275052|18795774|P3|COMPLETED|Washout Period (12-17 Days)||0
7633460|NCT02275052|18795775|P2|COMPLETED|Washout Period (12-17 Days)||93
7633461|NCT02275052|18795776|P1|COMPLETED|Washout Period (12-17 Days)||86
7633462|NCT02275052|18795773|P4|STARTED|Washout Period (12-17 Days)||0
7633463|NCT02275052|18795774|P3|STARTED|Washout Period (12-17 Days)||0
7633464|NCT02275052|18795775|P2|STARTED|Washout Period (12-17 Days)||93
7633465|NCT02275052|18795776|P1|STARTED|Washout Period (12-17 Days)||90
7633466|NCT02275052|18795773|P4|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
7633467|NCT02275052|18795774|P3|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
7633468|NCT02275052|18795775|P2|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6
7633469|NCT02275052|18795776|P1|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9
7633470|NCT02275052|18795773|P4|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
7633471|NCT02275052|18795774|P3|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
7633472|NCT02275052|18795775|P2|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93
7633473|NCT02275052|18795776|P1|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90
7633474|NCT02275052|18795773|P4|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
7633475|NCT02275052|18795774|P3|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
7633476|NCT02275052|18795775|P2|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
7633477|NCT02275052|18795776|P1|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
7633478|NCT02274948|18795790|P2|NOT COMPLETED|Overall Study||91
7633479|NCT02274948|18795791|P1|NOT COMPLETED|Overall Study||98
7633480|NCT02274948|18795790|P2|COMPLETED|Overall Study||82
7633481|NCT02274948|18795791|P1|COMPLETED|Overall Study||68
7633482|NCT02274948|18795790|P2|STARTED|Overall Study||173
7633483|NCT02274948|18795791|P1|STARTED|Overall Study||166
7633484|NCT02274870|18795807|P2|NOT COMPLETED|Overall Study||0
7633485|NCT02274870|18795808|P1|NOT COMPLETED|Overall Study||0
7633486|NCT02274870|18795807|P2|COMPLETED|Overall Study||33
7633487|NCT02274870|18795808|P1|COMPLETED|Overall Study||32
7633488|NCT02274870|18795807|P2|STARTED|Overall Study||33
7633489|NCT02274870|18795808|P1|STARTED|Overall Study||32
7633490|NCT02274857|18795834|P2|NOT COMPLETED|Overall Study||6
7633491|NCT02274857|18795835|P1|NOT COMPLETED|Overall Study||20
7633492|NCT02274857|18795834|P2|COMPLETED|Overall Study||165
7633493|NCT02274857|18795835|P1|COMPLETED|Overall Study||159
7633494|NCT02274857|18795834|P2|Completed Per Protocol|Overall Study||114
7633495|NCT02274857|18795835|P1|Completed Per Protocol|Overall Study||102
7633496|NCT02274857|18795834|P2|STARTED|Overall Study||171
7633497|NCT02274857|18795835|P1|STARTED|Overall Study||179
7633498|NCT02274844|18795850|P2|NOT COMPLETED|Overall Study||32
7633499|NCT02274844|18795851|P1|NOT COMPLETED|Overall Study||38
7633500|NCT02274844|18795850|P2|COMPLETED|Overall Study||238
7633501|NCT02274844|18795851|P1|COMPLETED|Overall Study||165
7633502|NCT02274844|18795850|P2|STARTED|Overall Study||270
7633503|NCT02274844|18795851|P1|STARTED|Overall Study||203
7633504|NCT02274792|18795887|P1|NOT COMPLETED|Overall Study||25
7633505|NCT02274792|18795887|P1|COMPLETED|Overall Study||107
7633506|NCT02274792|18795887|P1|Received Treatment|Overall Study||131
7633507|NCT02274792|18795887|P1|STARTED|Overall Study||132
7633508|NCT02274766|18795897|P2|NOT COMPLETED|Overall Study||9
7633509|NCT02274766|18795898|P1|NOT COMPLETED|Overall Study||4
7633510|NCT02274766|18795897|P2|COMPLETED|Overall Study||29
7633511|NCT02274766|18795898|P1|COMPLETED|Overall Study||35
7633512|NCT02274766|18795897|P2|Received Study Drug|Overall Study||37
7633513|NCT02274766|18795898|P1|Received Study Drug|Overall Study||38
7633514|NCT02274766|18795897|P2|STARTED|Overall Study||38
7633515|NCT02274766|18795898|P1|STARTED|Overall Study||39
7633516|NCT02274688|18795908|P2|NOT COMPLETED|Overall Study||13
7633517|NCT02274688|18795909|P1|NOT COMPLETED|Overall Study||14
7633518|NCT02274688|18795908|P2|COMPLETED|Overall Study||72
7633519|NCT02274688|18795909|P1|COMPLETED|Overall Study||72
7633520|NCT02274688|18795908|P2|STARTED|Overall Study||85
7633521|NCT02274688|18795909|P1|STARTED|Overall Study||86
7633522|NCT02274675|18795931|P1|NOT COMPLETED|Overall Study||0
7633523|NCT02274675|18795931|P1|COMPLETED|Overall Study||7
7633524|NCT02274675|18795931|P1|STARTED|Overall Study||7
7633525|NCT02274649|18795943|P2|NOT COMPLETED|Overall Study||12
7633526|NCT02274649|18795944|P1|NOT COMPLETED|Overall Study||24
7633527|NCT02274649|18795943|P2|COMPLETED|Overall Study||81
7633528|NCT02274649|18795944|P1|COMPLETED|Overall Study||77
7633529|NCT02274649|18795943|P2|STARTED|Overall Study||93
7633530|NCT02274649|18795944|P1|STARTED|Overall Study||101
7633531|NCT02274558|18795965|P3|NOT COMPLETED|Overall Study||9
7633532|NCT02274558|18795966|P2|NOT COMPLETED|Overall Study||13
7633533|NCT02274558|18795967|P1|NOT COMPLETED|Overall Study||7
7633534|NCT02274558|18795965|P3|COMPLETED|Overall Study||71
7633535|NCT02274558|18795966|P2|COMPLETED|Overall Study||63
7633536|NCT02274558|18795967|P1|COMPLETED|Overall Study||71
7633537|NCT02274558|18795965|P3|Included in the Safety Analysis Set|Overall Study||79
7633538|NCT02274558|18795966|P2|Included in the Safety Analysis Set|Overall Study||72
7633539|NCT02274558|18795967|P1|Included in the Safety Analysis Set|Overall Study||76
7633540|NCT02274558|18795965|P3|STARTED|Overall Study||80
7633541|NCT02274558|18795966|P2|STARTED|Overall Study||76
7633542|NCT02274558|18795967|P1|STARTED|Overall Study||78
7633543|NCT02274493|18795981|P1|NOT COMPLETED|Overall Study||1
7633544|NCT02274493|18795981|P1|COMPLETED|Overall Study||14
7633545|NCT02274493|18795981|P1|STARTED|Overall Study||15
7633546|NCT02274311|18795988|P1|NOT COMPLETED|Three Months of Clomiphene Wash-out||1
7633547|NCT02274311|18795988|P1|COMPLETED|Three Months of Clomiphene Wash-out||15
7633548|NCT02274311|18795988|P1|STARTED|Three Months of Clomiphene Wash-out||16
7633549|NCT02274311|18795988|P1|NOT COMPLETED|Three Months of Clomiphene Treatment||0
7633550|NCT02274311|18795988|P1|COMPLETED|Three Months of Clomiphene Treatment||16
7633551|NCT02274311|18795988|P1|STARTED|Three Months of Clomiphene Treatment||16
7633552|NCT02273973|18795996|P2|NOT COMPLETED|Overall Study||8
7633553|NCT02273973|18795997|P1|NOT COMPLETED|Overall Study||9
7633554|NCT02273973|18795996|P2|COMPLETED|Overall Study||160
7633555|NCT02273973|18795997|P1|COMPLETED|Overall Study||157
7633556|NCT02273973|18795996|P2|STARTED|Overall Study||168
7633557|NCT02273973|18795997|P1|STARTED|Overall Study||166
7633558|NCT02273960|18796041|P4|NOT COMPLETED|Long Term Extension||1
7633559|NCT02273960|18796042|P3|NOT COMPLETED|Long Term Extension||0
7633560|NCT02273960|18796043|P2|NOT COMPLETED|Long Term Extension||0
7633561|NCT02273960|18796044|P1|NOT COMPLETED|Long Term Extension||0
7633562|NCT02273960|18796041|P4|COMPLETED|Long Term Extension||3
7633563|NCT02273960|18796042|P3|COMPLETED|Long Term Extension||1
7633564|NCT02273960|18796043|P2|COMPLETED|Long Term Extension||0
7633565|NCT02273960|18796044|P1|COMPLETED|Long Term Extension||0
7633566|NCT02273960|18796041|P4|STARTED|Long Term Extension||4
7633567|NCT02273960|18796042|P3|STARTED|Long Term Extension||1
7633568|NCT02273960|18796043|P2|STARTED|Long Term Extension||0
7633569|NCT02273960|18796044|P1|STARTED|Long Term Extension||0
7633570|NCT02273960|18796041|P4|NOT COMPLETED|Short Term Period||6
7633571|NCT02273960|18796042|P3|NOT COMPLETED|Short Term Period||4
7633572|NCT02273960|18796043|P2|NOT COMPLETED|Short Term Period||6
7633573|NCT02273960|18796044|P1|NOT COMPLETED|Short Term Period||5
7633574|NCT02273960|18796041|P4|COMPLETED|Short Term Period||4
7633575|NCT02273960|18796042|P3|COMPLETED|Short Term Period||1
7633576|NCT02273960|18796043|P2|COMPLETED|Short Term Period||0
7633577|NCT02273960|18796044|P1|COMPLETED|Short Term Period||0
7633578|NCT02273960|18796041|P4|STARTED|Short Term Period||10
7633579|NCT02273960|18796042|P3|STARTED|Short Term Period||5
7633580|NCT02273960|18796043|P2|STARTED|Short Term Period||6
7633581|NCT02273960|18796044|P1|STARTED|Short Term Period||5
7633582|NCT02273908|18796088|P2|NOT COMPLETED|Overall Study||5
7633583|NCT02273908|18796089|P1|NOT COMPLETED|Overall Study||33
7633584|NCT02273908|18796088|P2|COMPLETED|Overall Study||169
7633585|NCT02273908|18796089|P1|COMPLETED|Overall Study||124
7633586|NCT02273908|18796088|P2|STARTED|Overall Study||174
7633587|NCT02273908|18796089|P1|STARTED|Overall Study||157
7633588|NCT02273752|18796111|P1|NOT COMPLETED|Overall Study||2
7633589|NCT02273752|18796111|P1|COMPLETED|Overall Study||0
7633590|NCT02273752|18796111|P1|STARTED|Overall Study||2
7633591|NCT02273323|18796122|P2|NOT COMPLETED|Overall Study||0
7633592|NCT02273323|18796123|P1|NOT COMPLETED|Overall Study||0
7633593|NCT02273323|18796122|P2|COMPLETED|Overall Study||15
7633594|NCT02273323|18796123|P1|COMPLETED|Overall Study||15
7633595|NCT02273323|18796122|P2|STARTED|Overall Study||15
7633596|NCT02273323|18796123|P1|STARTED|Overall Study||15
7633597|NCT02273310|18796141|P2|NOT COMPLETED|Overall Study||3
7633598|NCT02273310|18796142|P1|NOT COMPLETED|Overall Study||18
7633599|NCT02273310|18796141|P2|COMPLETED|Overall Study||38
7633600|NCT02273310|18796142|P1|COMPLETED|Overall Study||24
7633601|NCT02273310|18796141|P2|STARTED|Overall Study||41
7633602|NCT02273310|18796142|P1|STARTED|Overall Study||42
7633603|NCT02273206|18796155|P2|NOT COMPLETED|Overall Study||42
7633604|NCT02273206|18796156|P1|NOT COMPLETED|Overall Study||25
7633605|NCT02273206|18796155|P2|COMPLETED|Overall Study||337
7633606|NCT02273206|18796156|P1|COMPLETED|Overall Study||353
7633607|NCT02273206|18796155|P2|STARTED|Overall Study||379
7633608|NCT02273206|18796156|P1|STARTED|Overall Study||378
7633609|NCT02273180|18796202|P2|NOT COMPLETED|Overall Study||19
7633610|NCT02273180|18796203|P1|NOT COMPLETED|Overall Study||27
7633611|NCT02273180|18796202|P2|COMPLETED|Overall Study||235
7633612|NCT02273180|18796203|P1|COMPLETED|Overall Study||226
7633613|NCT02273180|18796202|P2|Treated|Overall Study||254
7633614|NCT02273180|18796203|P1|Treated|Overall Study||252
7633615|NCT02273180|18796202|P2|STARTED|Overall Study||254
7633616|NCT02273180|18796203|P1|STARTED|Overall Study||253
7633617|NCT02273167|18796228|P3|NOT COMPLETED|Overall Study||21
7633618|NCT02273167|18796229|P2|NOT COMPLETED|Overall Study||23
7633619|NCT02273167|18796230|P1|NOT COMPLETED|Overall Study||24
7633620|NCT02273167|18796228|P3|COMPLETED|Overall Study||262
7633621|NCT02273167|18796229|P2|COMPLETED|Overall Study||260
7633622|NCT02273167|18796230|P1|COMPLETED|Overall Study||259
7633623|NCT02273167|18796228|P3|STARTED|Overall Study||283
7633624|NCT02273167|18796229|P2|STARTED|Overall Study||283
7633625|NCT02273167|18796230|P1|STARTED|Overall Study||283
7633626|NCT02273141|18796255|P2|NOT COMPLETED|Overall Study||25
7633627|NCT02273141|18796256|P1|NOT COMPLETED|Overall Study||17
7633628|NCT02273141|18796255|P2|COMPLETED|Overall Study||233
7633629|NCT02273141|18796256|P1|COMPLETED|Overall Study||240
7633630|NCT02273141|18796255|P2|STARTED|Overall Study||258
7633631|NCT02273141|18796256|P1|STARTED|Overall Study||257
7633632|NCT02273115|18796276|P4|NOT COMPLETED|Overall Study||1
7633633|NCT02273115|18796277|P3|NOT COMPLETED|Overall Study||0
7633634|NCT02273115|18796278|P2|NOT COMPLETED|Overall Study||0
7633635|NCT02273115|18796279|P1|NOT COMPLETED|Overall Study||0
7633636|NCT02273115|18796276|P4|COMPLETED|Overall Study||71
7633637|NCT02273115|18796277|P3|COMPLETED|Overall Study||67
7633638|NCT02273115|18796278|P2|COMPLETED|Overall Study||90
7633639|NCT02273115|18796279|P1|COMPLETED|Overall Study||94
7633640|NCT02273115|18796276|P4|STARTED|Overall Study||72
7633641|NCT02273115|18796277|P3|STARTED|Overall Study||67
7633642|NCT02273115|18796278|P2|STARTED|Overall Study||90
7633643|NCT02273115|18796279|P1|STARTED|Overall Study||94
7633644|NCT02273063|18796321|P1|NOT COMPLETED|Overall Study||5
7633645|NCT02273063|18796321|P1|COMPLETED|Overall Study||35
7633646|NCT02273063|18796321|P1|STARTED|Overall Study||40
7633647|NCT02273050|18796329|P3|NOT COMPLETED|Overall Study||29
7633648|NCT02273050|18796330|P2|NOT COMPLETED|Overall Study||22
7633649|NCT02273050|18796331|P1|NOT COMPLETED|Overall Study||24
7633650|NCT02273050|18796329|P3|COMPLETED|Overall Study||185
7633651|NCT02273050|18796330|P2|COMPLETED|Overall Study||194
7633652|NCT02273050|18796331|P1|COMPLETED|Overall Study||186
7633653|NCT02273050|18796329|P3|STARTED|Overall Study||214
7633654|NCT02273050|18796330|P2|STARTED|Overall Study||216
7633655|NCT02273050|18796331|P1|STARTED|Overall Study||210
7633656|NCT02273037|18796359|P2|NOT COMPLETED|Overall Study||8
7633657|NCT02273037|18796360|P1|NOT COMPLETED|Overall Study||8
7633658|NCT02273037|18796359|P2|COMPLETED|Overall Study||992
7633659|NCT02273037|18796360|P1|COMPLETED|Overall Study||979
7633660|NCT02273037|18796359|P2|STARTED|Overall Study||1000
7633661|NCT02273037|18796360|P1|STARTED|Overall Study||987
7633662|NCT02272985|18796370|P1|NOT COMPLETED|Overall Study||3
7633663|NCT02272985|18796370|P1|COMPLETED|Overall Study||12
7633664|NCT02272985|18796370|P1|STARTED|Overall Study||15
7633665|NCT02272816|18796375|P1|NOT COMPLETED|Overall Study||1
7633666|NCT02272816|18796375|P1|COMPLETED|Overall Study||47
7633667|NCT02272816|18796375|P1|STARTED|Overall Study||48
7633668|NCT02272803|18796383|P2|NOT COMPLETED|Overall Study||17
7633669|NCT02272803|18796384|P1|NOT COMPLETED|Overall Study||9
7633670|NCT02272803|18796383|P2|COMPLETED|Overall Study|Completed = Still receiving treatment|25
7633671|NCT02272803|18796384|P1|COMPLETED|Overall Study|Completed = Still receiving treatment|31
7633672|NCT02272803|18796383|P2|STARTED|Overall Study||42
7633673|NCT02272803|18796384|P1|STARTED|Overall Study||40
7633674|NCT02272790|18796401|P6|NOT COMPLETED|Overall Study||0
7633675|NCT02272790|18796402|P5|NOT COMPLETED|Overall Study||0
7633676|NCT02272790|18796403|P4|NOT COMPLETED|Overall Study||0
7633677|NCT02272790|18796404|P3|NOT COMPLETED|Overall Study||0
7633678|NCT02272790|18796405|P2|NOT COMPLETED|Overall Study||1
7633679|NCT02272790|18796406|P1|NOT COMPLETED|Overall Study||0
7633680|NCT02272790|18796401|P6|COMPLETED|Overall Study||6
7633681|NCT02272790|18796402|P5|COMPLETED|Overall Study||6
7633682|NCT02272790|18796403|P4|COMPLETED|Overall Study||12
7633683|NCT02272790|18796404|P3|COMPLETED|Overall Study||23
7633684|NCT02272790|18796405|P2|COMPLETED|Overall Study||38
7633685|NCT02272790|18796406|P1|COMPLETED|Overall Study||9
7633686|NCT02272790|18796401|P6|STARTED|Overall Study||6
7633687|NCT02272790|18796402|P5|STARTED|Overall Study||6
7633688|NCT02272790|18796403|P4|STARTED|Overall Study||12
7633689|NCT02272790|18796404|P3|STARTED|Overall Study||23
7633690|NCT02272790|18796405|P2|STARTED|Overall Study||39
7633691|NCT02272790|18796406|P1|STARTED|Overall Study||9
7633692|NCT02272777|18796542|P2|NOT COMPLETED|Overall Study||4
7633693|NCT02272777|18796543|P1|NOT COMPLETED|Overall Study||4
7633694|NCT02272777|18796542|P2|COMPLETED|Overall Study||109
7633695|NCT02272777|18796543|P1|COMPLETED|Overall Study||108
7633696|NCT02272777|18796542|P2|STARTED|Overall Study||113
7633697|NCT02272777|18796543|P1|STARTED|Overall Study||112
7633698|NCT02272725|18796551|P2|NOT COMPLETED|Overall Study||0
7633699|NCT02272725|18796552|P1|NOT COMPLETED|Overall Study||2
7633700|NCT02272725|18796551|P2|COMPLETED|Overall Study||42
7633701|NCT02272725|18796552|P1|COMPLETED|Overall Study||47
7633702|NCT02272725|18796551|P2|STARTED|Overall Study||42
7633703|NCT02272725|18796552|P1|STARTED|Overall Study||49
7633704|NCT02272686|18796562|P1|NOT COMPLETED|Overall Study||0
7633705|NCT02272686|18796562|P1|COMPLETED|Overall Study||1
7633706|NCT02272686|18796562|P1|STARTED|Overall Study||1
7633707|NCT02272413|18796569|P2|NOT COMPLETED|Post-switch Period||46
7633708|NCT02272413|18796570|P1|NOT COMPLETED|Post-switch Period||42
7633709|NCT02272413|18796569|P2|COMPLETED|Post-switch Period||0
7633710|NCT02272413|18796570|P1|COMPLETED|Post-switch Period||0
7633711|NCT02272413|18796569|P2|STARTED|Post-switch Period|Started for this period|46
7633712|NCT02272413|18796570|P1|STARTED|Post-switch Period|Started for this period|42
7633713|NCT02272413|18796569|P2|NOT COMPLETED|Pre-switch Period||282
7633714|NCT02272413|18796570|P1|NOT COMPLETED|Pre-switch Period||293
7633715|NCT02272413|18796569|P2|COMPLETED|Pre-switch Period||46
7633716|NCT02272413|18796570|P1|COMPLETED|Pre-switch Period||42
7633717|NCT02272413|18796569|P2|STARTED|Pre-switch Period|Started for this period|328
7633718|NCT02272413|18796570|P1|STARTED|Pre-switch Period|Started for this period|335
7633719|NCT02272413|18796569|P2|NOT COMPLETED|Randomized Through Treatment Start||5
7633720|NCT02272413|18796570|P1|NOT COMPLETED|Randomized Through Treatment Start||3
7633721|NCT02272413|18796569|P2|COMPLETED|Randomized Through Treatment Start||328
7633722|NCT02272413|18796570|P1|COMPLETED|Randomized Through Treatment Start||335
7633723|NCT02272413|18796569|P2|Treated|Randomized Through Treatment Start||328
7633724|NCT02272413|18796570|P1|Treated|Randomized Through Treatment Start||335
7633725|NCT02272413|18796569|P2|STARTED|Randomized Through Treatment Start|Started for this period|333
7633726|NCT02272413|18796570|P1|STARTED|Randomized Through Treatment Start|Started for this period|338
7633727|NCT02272244|18796588|P2|NOT COMPLETED|Overall Study||0
7633728|NCT02272244|18796589|P1|NOT COMPLETED|Overall Study||0
7633729|NCT02272244|18796588|P2|COMPLETED|Overall Study||197
7633730|NCT02272244|18796589|P1|COMPLETED|Overall Study||203
7633731|NCT02272244|18796588|P2|STARTED|Overall Study||197
7633732|NCT02272244|18796589|P1|STARTED|Overall Study||203
7633733|NCT02271984|18796601|P12|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
7633734|NCT02271984|18796602|P11|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
7633735|NCT02271984|18796603|P10|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
7633736|NCT02271984|18796604|P9|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
7633737|NCT02271984|18796605|P8|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
7633738|NCT02271984|18796606|P7|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
7633739|NCT02271984|18796607|P6|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
7633740|NCT02271984|18796608|P5|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
7633741|NCT02271984|18796609|P4|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
7633742|NCT02271984|18796610|P3|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
7633743|NCT02271984|18796611|P2|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
7633744|NCT02271984|18796612|P1|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
7633745|NCT02271984|18796601|P12|COMPLETED|Fifth Intervention Period (1 Day)||3
7633746|NCT02271984|18796602|P11|COMPLETED|Fifth Intervention Period (1 Day)||3
7633747|NCT02271984|18796603|P10|COMPLETED|Fifth Intervention Period (1 Day)||3
7633748|NCT02271984|18796604|P9|COMPLETED|Fifth Intervention Period (1 Day)||3
7633749|NCT02271984|18796605|P8|COMPLETED|Fifth Intervention Period (1 Day)||2
7633750|NCT02271984|18796606|P7|COMPLETED|Fifth Intervention Period (1 Day)||3
7633751|NCT02271984|18796607|P6|COMPLETED|Fifth Intervention Period (1 Day)||2
7633752|NCT02271984|18796608|P5|COMPLETED|Fifth Intervention Period (1 Day)||3
7633753|NCT02271984|18796609|P4|COMPLETED|Fifth Intervention Period (1 Day)||3
7633754|NCT02271984|18796610|P3|COMPLETED|Fifth Intervention Period (1 Day)||3
7633755|NCT02271984|18796611|P2|COMPLETED|Fifth Intervention Period (1 Day)||3
7633756|NCT02271984|18796612|P1|COMPLETED|Fifth Intervention Period (1 Day)||3
7633757|NCT02271984|18796601|P12|STARTED|Fifth Intervention Period (1 Day)||3
7633758|NCT02271984|18796602|P11|STARTED|Fifth Intervention Period (1 Day)||3
7633759|NCT02271984|18796603|P10|STARTED|Fifth Intervention Period (1 Day)||3
7633760|NCT02271984|18796604|P9|STARTED|Fifth Intervention Period (1 Day)||3
7633761|NCT02271984|18796605|P8|STARTED|Fifth Intervention Period (1 Day)||2
7633762|NCT02271984|18796606|P7|STARTED|Fifth Intervention Period (1 Day)||3
7633763|NCT02271984|18796607|P6|STARTED|Fifth Intervention Period (1 Day)||2
7633764|NCT02271984|18796608|P5|STARTED|Fifth Intervention Period (1 Day)||3
7633765|NCT02271984|18796609|P4|STARTED|Fifth Intervention Period (1 Day)||3
7633766|NCT02271984|18796610|P3|STARTED|Fifth Intervention Period (1 Day)||3
7633767|NCT02271984|18796611|P2|STARTED|Fifth Intervention Period (1 Day)||3
7633768|NCT02271984|18796612|P1|STARTED|Fifth Intervention Period (1 Day)||3
7633769|NCT02271984|18796601|P12|NOT COMPLETED|Washout Period 4 (7 Days)||0
7633770|NCT02271984|18796602|P11|NOT COMPLETED|Washout Period 4 (7 Days)||0
7633771|NCT02271984|18796603|P10|NOT COMPLETED|Washout Period 4 (7 Days)||0
7633772|NCT02271984|18796604|P9|NOT COMPLETED|Washout Period 4 (7 Days)||0
7633773|NCT02271984|18796605|P8|NOT COMPLETED|Washout Period 4 (7 Days)||1
7633774|NCT02271984|18796606|P7|NOT COMPLETED|Washout Period 4 (7 Days)||0
7633775|NCT02271984|18796607|P6|NOT COMPLETED|Washout Period 4 (7 Days)||1
7633776|NCT02271984|18796608|P5|NOT COMPLETED|Washout Period 4 (7 Days)||0
7633777|NCT02271984|18796609|P4|NOT COMPLETED|Washout Period 4 (7 Days)||0
7633778|NCT02271984|18796610|P3|NOT COMPLETED|Washout Period 4 (7 Days)||0
7633779|NCT02271984|18796611|P2|NOT COMPLETED|Washout Period 4 (7 Days)||0
7633780|NCT02271984|18796612|P1|NOT COMPLETED|Washout Period 4 (7 Days)||0
7633781|NCT02271984|18796601|P12|COMPLETED|Washout Period 4 (7 Days)||3
7633782|NCT02271984|18796602|P11|COMPLETED|Washout Period 4 (7 Days)||3
7633783|NCT02271984|18796603|P10|COMPLETED|Washout Period 4 (7 Days)||3
7633784|NCT02271984|18796604|P9|COMPLETED|Washout Period 4 (7 Days)||3
7633785|NCT02271984|18796605|P8|COMPLETED|Washout Period 4 (7 Days)||2
7633786|NCT02271984|18796606|P7|COMPLETED|Washout Period 4 (7 Days)||3
7633787|NCT02271984|18796607|P6|COMPLETED|Washout Period 4 (7 Days)||2
7633788|NCT02271984|18796608|P5|COMPLETED|Washout Period 4 (7 Days)||3
7633789|NCT02271984|18796609|P4|COMPLETED|Washout Period 4 (7 Days)||3
7633790|NCT02271984|18796610|P3|COMPLETED|Washout Period 4 (7 Days)||3
7633791|NCT02271984|18796611|P2|COMPLETED|Washout Period 4 (7 Days)||3
7633792|NCT02271984|18796612|P1|COMPLETED|Washout Period 4 (7 Days)||3
7633793|NCT02271984|18796601|P12|STARTED|Washout Period 4 (7 Days)||3
7633794|NCT02271984|18796602|P11|STARTED|Washout Period 4 (7 Days)||3
7633795|NCT02271984|18796603|P10|STARTED|Washout Period 4 (7 Days)||3
7633796|NCT02271984|18796604|P9|STARTED|Washout Period 4 (7 Days)||3
7633797|NCT02271984|18796605|P8|STARTED|Washout Period 4 (7 Days)||3
7633798|NCT02271984|18796606|P7|STARTED|Washout Period 4 (7 Days)||3
7633799|NCT02271984|18796607|P6|STARTED|Washout Period 4 (7 Days)||3
7633800|NCT02271984|18796608|P5|STARTED|Washout Period 4 (7 Days)||3
7633801|NCT02271984|18796609|P4|STARTED|Washout Period 4 (7 Days)||3
7633802|NCT02271984|18796610|P3|STARTED|Washout Period 4 (7 Days)||3
7633803|NCT02271984|18796611|P2|STARTED|Washout Period 4 (7 Days)||3
7633804|NCT02271984|18796612|P1|STARTED|Washout Period 4 (7 Days)||3
7633805|NCT02271984|18796601|P12|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
7633806|NCT02271984|18796602|P11|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
7633807|NCT02271984|18796603|P10|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
7633808|NCT02271984|18796604|P9|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
7633809|NCT02271984|18796605|P8|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
7633810|NCT02271984|18796606|P7|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
7633811|NCT02271984|18796607|P6|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
7633812|NCT02271984|18796608|P5|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
7633813|NCT02271984|18796609|P4|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
7633814|NCT02271984|18796610|P3|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
7633815|NCT02271984|18796611|P2|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
7633816|NCT02271984|18796612|P1|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
7633817|NCT02271984|18796601|P12|COMPLETED|Fourth Intervention Period (Day 1)||3
7633818|NCT02271984|18796602|P11|COMPLETED|Fourth Intervention Period (Day 1)||3
7633819|NCT02271984|18796603|P10|COMPLETED|Fourth Intervention Period (Day 1)||3
7633820|NCT02271984|18796604|P9|COMPLETED|Fourth Intervention Period (Day 1)||3
7633821|NCT02271984|18796605|P8|COMPLETED|Fourth Intervention Period (Day 1)||3
7633822|NCT02271984|18796606|P7|COMPLETED|Fourth Intervention Period (Day 1)||3
7633823|NCT02271984|18796607|P6|COMPLETED|Fourth Intervention Period (Day 1)||3
7633824|NCT02271984|18796608|P5|COMPLETED|Fourth Intervention Period (Day 1)||3
7633825|NCT02271984|18796609|P4|COMPLETED|Fourth Intervention Period (Day 1)||3
7633826|NCT02271984|18796610|P3|COMPLETED|Fourth Intervention Period (Day 1)||3
7633827|NCT02271984|18796611|P2|COMPLETED|Fourth Intervention Period (Day 1)||3
7633828|NCT02271984|18796612|P1|COMPLETED|Fourth Intervention Period (Day 1)||3
7633829|NCT02271984|18796601|P12|STARTED|Fourth Intervention Period (Day 1)||3
7633830|NCT02271984|18796602|P11|STARTED|Fourth Intervention Period (Day 1)||3
7633831|NCT02271984|18796603|P10|STARTED|Fourth Intervention Period (Day 1)||3
7633832|NCT02271984|18796604|P9|STARTED|Fourth Intervention Period (Day 1)||3
7633833|NCT02271984|18796605|P8|STARTED|Fourth Intervention Period (Day 1)||3
7633834|NCT02271984|18796606|P7|STARTED|Fourth Intervention Period (Day 1)||3
7633835|NCT02271984|18796607|P6|STARTED|Fourth Intervention Period (Day 1)||3
7633836|NCT02271984|18796608|P5|STARTED|Fourth Intervention Period (Day 1)||3
7633837|NCT02271984|18796609|P4|STARTED|Fourth Intervention Period (Day 1)||3
7633838|NCT02271984|18796610|P3|STARTED|Fourth Intervention Period (Day 1)||3
7633839|NCT02271984|18796611|P2|STARTED|Fourth Intervention Period (Day 1)||3
7633840|NCT02271984|18796612|P1|STARTED|Fourth Intervention Period (Day 1)||3
7633841|NCT02271984|18796601|P12|NOT COMPLETED|Washout Period 3 (7 Days)||0
7633842|NCT02271984|18796602|P11|NOT COMPLETED|Washout Period 3 (7 Days)||0
7633843|NCT02271984|18796603|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
7633844|NCT02271984|18796604|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
7633845|NCT02271984|18796605|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
7633846|NCT02271984|18796606|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
7633847|NCT02271984|18796607|P6|NOT COMPLETED|Washout Period 3 (7 Days)||0
7633848|NCT02271984|18796608|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
7633849|NCT02271984|18796609|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
7633850|NCT02271984|18796610|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
7633851|NCT02271984|18796611|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
7633852|NCT02271984|18796612|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
7633853|NCT02271984|18796601|P12|COMPLETED|Washout Period 3 (7 Days)||3
7633854|NCT02271984|18796602|P11|COMPLETED|Washout Period 3 (7 Days)||3
7633855|NCT02271984|18796603|P10|COMPLETED|Washout Period 3 (7 Days)||3
7633856|NCT02271984|18796604|P9|COMPLETED|Washout Period 3 (7 Days)||3
7633857|NCT02271984|18796605|P8|COMPLETED|Washout Period 3 (7 Days)||3
7633858|NCT02271984|18796606|P7|COMPLETED|Washout Period 3 (7 Days)||3
7633859|NCT02271984|18796607|P6|COMPLETED|Washout Period 3 (7 Days)||3
7633860|NCT02271984|18796608|P5|COMPLETED|Washout Period 3 (7 Days)||3
7633861|NCT02271984|18796609|P4|COMPLETED|Washout Period 3 (7 Days)||3
7633862|NCT02271984|18796610|P3|COMPLETED|Washout Period 3 (7 Days)||3
7633863|NCT02271984|18796611|P2|COMPLETED|Washout Period 3 (7 Days)||3
7633864|NCT02271984|18796612|P1|COMPLETED|Washout Period 3 (7 Days)||3
7633865|NCT02271984|18796601|P12|STARTED|Washout Period 3 (7 Days)||3
7633866|NCT02271984|18796602|P11|STARTED|Washout Period 3 (7 Days)||3
7633867|NCT02271984|18796603|P10|STARTED|Washout Period 3 (7 Days)||3
7633868|NCT02271984|18796604|P9|STARTED|Washout Period 3 (7 Days)||3
7633869|NCT02271984|18796605|P8|STARTED|Washout Period 3 (7 Days)||3
7633870|NCT02271984|18796606|P7|STARTED|Washout Period 3 (7 Days)||3
7633871|NCT02271984|18796607|P6|STARTED|Washout Period 3 (7 Days)||3
7633872|NCT02271984|18796608|P5|STARTED|Washout Period 3 (7 Days)||3
7633873|NCT02271984|18796609|P4|STARTED|Washout Period 3 (7 Days)||3
7633874|NCT02271984|18796610|P3|STARTED|Washout Period 3 (7 Days)||3
7633875|NCT02271984|18796611|P2|STARTED|Washout Period 3 (7 Days)||3
7633876|NCT02271984|18796612|P1|STARTED|Washout Period 3 (7 Days)||3
7633877|NCT02271984|18796601|P12|NOT COMPLETED|Third Intervention Period (1 Day)||0
7633878|NCT02271984|18796602|P11|NOT COMPLETED|Third Intervention Period (1 Day)||0
7633879|NCT02271984|18796603|P10|NOT COMPLETED|Third Intervention Period (1 Day)||0
7633880|NCT02271984|18796604|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
7633881|NCT02271984|18796605|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
7633882|NCT02271984|18796606|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
7633883|NCT02271984|18796607|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
7633884|NCT02271984|18796608|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
7633885|NCT02271984|18796609|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
7633886|NCT02271984|18796610|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
7633887|NCT02271984|18796611|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
7633888|NCT02271984|18796612|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
7633889|NCT02271984|18796601|P12|COMPLETED|Third Intervention Period (1 Day)||3
7633890|NCT02271984|18796602|P11|COMPLETED|Third Intervention Period (1 Day)||3
7633891|NCT02271984|18796603|P10|COMPLETED|Third Intervention Period (1 Day)||3
7633892|NCT02271984|18796604|P9|COMPLETED|Third Intervention Period (1 Day)||3
7633893|NCT02271984|18796605|P8|COMPLETED|Third Intervention Period (1 Day)||3
7633894|NCT02271984|18796606|P7|COMPLETED|Third Intervention Period (1 Day)||3
7633895|NCT02271984|18796607|P6|COMPLETED|Third Intervention Period (1 Day)||3
7633896|NCT02271984|18796608|P5|COMPLETED|Third Intervention Period (1 Day)||3
7633897|NCT02271984|18796609|P4|COMPLETED|Third Intervention Period (1 Day)||3
7633898|NCT02271984|18796610|P3|COMPLETED|Third Intervention Period (1 Day)||3
7633899|NCT02271984|18796611|P2|COMPLETED|Third Intervention Period (1 Day)||3
7633900|NCT02271984|18796612|P1|COMPLETED|Third Intervention Period (1 Day)||3
7633901|NCT02271984|18796601|P12|STARTED|Third Intervention Period (1 Day)||3
7633902|NCT02271984|18796602|P11|STARTED|Third Intervention Period (1 Day)||3
7633903|NCT02271984|18796603|P10|STARTED|Third Intervention Period (1 Day)||3
7633904|NCT02271984|18796604|P9|STARTED|Third Intervention Period (1 Day)||3
7633905|NCT02271984|18796605|P8|STARTED|Third Intervention Period (1 Day)||3
7633906|NCT02271984|18796606|P7|STARTED|Third Intervention Period (1 Day)||3
7633907|NCT02271984|18796607|P6|STARTED|Third Intervention Period (1 Day)||3
7633908|NCT02271984|18796608|P5|STARTED|Third Intervention Period (1 Day)||3
7633909|NCT02271984|18796609|P4|STARTED|Third Intervention Period (1 Day)||3
7633910|NCT02271984|18796610|P3|STARTED|Third Intervention Period (1 Day)||3
7633911|NCT02271984|18796611|P2|STARTED|Third Intervention Period (1 Day)||3
7633912|NCT02271984|18796612|P1|STARTED|Third Intervention Period (1 Day)||3
7633913|NCT02271984|18796601|P12|NOT COMPLETED|Washout Period 2 (7 Days)||0
7633914|NCT02271984|18796602|P11|NOT COMPLETED|Washout Period 2 (7 Days)||0
7633915|NCT02271984|18796603|P10|NOT COMPLETED|Washout Period 2 (7 Days)||0
7633916|NCT02271984|18796604|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
7633917|NCT02271984|18796605|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
7633918|NCT02271984|18796606|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
7633919|NCT02271984|18796607|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
7633920|NCT02271984|18796608|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
7633921|NCT02271984|18796609|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
7633922|NCT02271984|18796610|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
7633923|NCT02271984|18796611|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
7633924|NCT02271984|18796612|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
7633925|NCT02271984|18796601|P12|COMPLETED|Washout Period 2 (7 Days)||3
7633926|NCT02271984|18796602|P11|COMPLETED|Washout Period 2 (7 Days)||3
7633927|NCT02271984|18796603|P10|COMPLETED|Washout Period 2 (7 Days)||3
7633928|NCT02271984|18796604|P9|COMPLETED|Washout Period 2 (7 Days)||3
7633929|NCT02271984|18796605|P8|COMPLETED|Washout Period 2 (7 Days)||3
7633930|NCT02271984|18796606|P7|COMPLETED|Washout Period 2 (7 Days)||3
7633931|NCT02271984|18796607|P6|COMPLETED|Washout Period 2 (7 Days)||3
7633932|NCT02271984|18796608|P5|COMPLETED|Washout Period 2 (7 Days)||3
7633933|NCT02271984|18796609|P4|COMPLETED|Washout Period 2 (7 Days)||3
7633934|NCT02271984|18796610|P3|COMPLETED|Washout Period 2 (7 Days)||3
7633935|NCT02271984|18796611|P2|COMPLETED|Washout Period 2 (7 Days)||3
7633936|NCT02271984|18796612|P1|COMPLETED|Washout Period 2 (7 Days)||3
7633937|NCT02271984|18796601|P12|STARTED|Washout Period 2 (7 Days)||3
7633938|NCT02271984|18796602|P11|STARTED|Washout Period 2 (7 Days)||3
7633939|NCT02271984|18796603|P10|STARTED|Washout Period 2 (7 Days)||3
7633940|NCT02271984|18796604|P9|STARTED|Washout Period 2 (7 Days)||3
7633941|NCT02271984|18796605|P8|STARTED|Washout Period 2 (7 Days)||3
7633942|NCT02271984|18796606|P7|STARTED|Washout Period 2 (7 Days)||3
7633943|NCT02271984|18796607|P6|STARTED|Washout Period 2 (7 Days)||3
7633944|NCT02271984|18796608|P5|STARTED|Washout Period 2 (7 Days)||3
7633945|NCT02271984|18796609|P4|STARTED|Washout Period 2 (7 Days)||3
7633946|NCT02271984|18796610|P3|STARTED|Washout Period 2 (7 Days)||3
7633947|NCT02271984|18796611|P2|STARTED|Washout Period 2 (7 Days)||3
7633948|NCT02271984|18796612|P1|STARTED|Washout Period 2 (7 Days)||3
7633949|NCT02271984|18796601|P12|NOT COMPLETED|Second Intervention Period (1 Day)||0
7633950|NCT02271984|18796602|P11|NOT COMPLETED|Second Intervention Period (1 Day)||0
7633951|NCT02271984|18796603|P10|NOT COMPLETED|Second Intervention Period (1 Day)||0
7633952|NCT02271984|18796604|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
7633953|NCT02271984|18796605|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
7633954|NCT02271984|18796606|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
7633955|NCT02271984|18796607|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
7633956|NCT02271984|18796608|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
7633957|NCT02271984|18796609|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
7633958|NCT02271984|18796610|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
7633959|NCT02271984|18796611|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
7633960|NCT02271984|18796612|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
7633961|NCT02271984|18796601|P12|COMPLETED|Second Intervention Period (1 Day)||3
7633962|NCT02271984|18796602|P11|COMPLETED|Second Intervention Period (1 Day)||3
7633963|NCT02271984|18796603|P10|COMPLETED|Second Intervention Period (1 Day)||3
7633964|NCT02271984|18796604|P9|COMPLETED|Second Intervention Period (1 Day)||3
7633965|NCT02271984|18796605|P8|COMPLETED|Second Intervention Period (1 Day)||3
7633966|NCT02271984|18796606|P7|COMPLETED|Second Intervention Period (1 Day)||3
7633967|NCT02271984|18796607|P6|COMPLETED|Second Intervention Period (1 Day)||3
7633968|NCT02271984|18796608|P5|COMPLETED|Second Intervention Period (1 Day)||3
7633969|NCT02271984|18796609|P4|COMPLETED|Second Intervention Period (1 Day)||3
7633970|NCT02271984|18796610|P3|COMPLETED|Second Intervention Period (1 Day)||3
7633971|NCT02271984|18796611|P2|COMPLETED|Second Intervention Period (1 Day)||3
7633972|NCT02271984|18796612|P1|COMPLETED|Second Intervention Period (1 Day)||3
7633973|NCT02271984|18796601|P12|STARTED|Second Intervention Period (1 Day)||3
7633974|NCT02271984|18796602|P11|STARTED|Second Intervention Period (1 Day)||3
7633975|NCT02271984|18796603|P10|STARTED|Second Intervention Period (1 Day)||3
7633976|NCT02271984|18796604|P9|STARTED|Second Intervention Period (1 Day)||3
7633977|NCT02271984|18796605|P8|STARTED|Second Intervention Period (1 Day)||3
7633978|NCT02271984|18796606|P7|STARTED|Second Intervention Period (1 Day)||3
7633979|NCT02271984|18796607|P6|STARTED|Second Intervention Period (1 Day)||3
7633980|NCT02271984|18796608|P5|STARTED|Second Intervention Period (1 Day)||3
7633981|NCT02271984|18796609|P4|STARTED|Second Intervention Period (1 Day)||3
7633982|NCT02271984|18796610|P3|STARTED|Second Intervention Period (1 Day)||3
7633983|NCT02271984|18796611|P2|STARTED|Second Intervention Period (1 Day)||3
7633984|NCT02271984|18796612|P1|STARTED|Second Intervention Period (1 Day)||3
7633985|NCT02271984|18796601|P12|NOT COMPLETED|Washout Period 1 (7 Days)||0
7633986|NCT02271984|18796602|P11|NOT COMPLETED|Washout Period 1 (7 Days)||0
7633987|NCT02271984|18796603|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
7633988|NCT02271984|18796604|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
7633989|NCT02271984|18796605|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
7633990|NCT02271984|18796606|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
7633991|NCT02271984|18796607|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
7633992|NCT02271984|18796608|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
7633993|NCT02271984|18796609|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
7633994|NCT02271984|18796610|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
7633995|NCT02271984|18796611|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
7633996|NCT02271984|18796612|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
7633997|NCT02271984|18796601|P12|COMPLETED|Washout Period 1 (7 Days)||3
7633998|NCT02271984|18796602|P11|COMPLETED|Washout Period 1 (7 Days)||3
7633999|NCT02271984|18796603|P10|COMPLETED|Washout Period 1 (7 Days)||3
7634000|NCT02271984|18796604|P9|COMPLETED|Washout Period 1 (7 Days)||3
7634001|NCT02271984|18796605|P8|COMPLETED|Washout Period 1 (7 Days)||3
7634002|NCT02271984|18796606|P7|COMPLETED|Washout Period 1 (7 Days)||3
7634003|NCT02271984|18796607|P6|COMPLETED|Washout Period 1 (7 Days)||3
7634004|NCT02271984|18796608|P5|COMPLETED|Washout Period 1 (7 Days)||3
7634005|NCT02271984|18796609|P4|COMPLETED|Washout Period 1 (7 Days)||3
7634006|NCT02271984|18796610|P3|COMPLETED|Washout Period 1 (7 Days)||3
7634007|NCT02271984|18796611|P2|COMPLETED|Washout Period 1 (7 Days)||3
7634008|NCT02271984|18796612|P1|COMPLETED|Washout Period 1 (7 Days)||3
7634009|NCT02271984|18796601|P12|STARTED|Washout Period 1 (7 Days)||3
7634010|NCT02271984|18796602|P11|STARTED|Washout Period 1 (7 Days)||3
7634011|NCT02271984|18796603|P10|STARTED|Washout Period 1 (7 Days)||3
7634012|NCT02271984|18796604|P9|STARTED|Washout Period 1 (7 Days)||3
7634013|NCT02271984|18796605|P8|STARTED|Washout Period 1 (7 Days)||3
7634014|NCT02271984|18796606|P7|STARTED|Washout Period 1 (7 Days)||3
7634015|NCT02271984|18796607|P6|STARTED|Washout Period 1 (7 Days)||3
7634016|NCT02271984|18796608|P5|STARTED|Washout Period 1 (7 Days)||3
7634017|NCT02271984|18796609|P4|STARTED|Washout Period 1 (7 Days)||3
7634018|NCT02271984|18796610|P3|STARTED|Washout Period 1 (7 Days)||3
7634019|NCT02271984|18796611|P2|STARTED|Washout Period 1 (7 Days)||3
7634020|NCT02271984|18796612|P1|STARTED|Washout Period 1 (7 Days)||3
7634021|NCT02271984|18796601|P12|NOT COMPLETED|First Intervention Period (1 Day)||0
7634022|NCT02271984|18796602|P11|NOT COMPLETED|First Intervention Period (1 Day)||0
7634023|NCT02271984|18796603|P10|NOT COMPLETED|First Intervention Period (1 Day)||0
7634024|NCT02271984|18796604|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
7634025|NCT02271984|18796605|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
7634026|NCT02271984|18796606|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
7634027|NCT02271984|18796607|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
7634028|NCT02271984|18796608|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
7634029|NCT02271984|18796609|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
7634030|NCT02271984|18796610|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
7634031|NCT02271984|18796611|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
7634032|NCT02271984|18796612|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
7634033|NCT02271984|18796601|P12|COMPLETED|First Intervention Period (1 Day)||3
7634034|NCT02271984|18796602|P11|COMPLETED|First Intervention Period (1 Day)||3
7634035|NCT02271984|18796603|P10|COMPLETED|First Intervention Period (1 Day)||3
7634036|NCT02271984|18796604|P9|COMPLETED|First Intervention Period (1 Day)||3
7634037|NCT02271984|18796605|P8|COMPLETED|First Intervention Period (1 Day)||3
7634038|NCT02271984|18796606|P7|COMPLETED|First Intervention Period (1 Day)||3
7634039|NCT02271984|18796607|P6|COMPLETED|First Intervention Period (1 Day)||3
7634040|NCT02271984|18796608|P5|COMPLETED|First Intervention Period (1 Day)||3
7634041|NCT02271984|18796609|P4|COMPLETED|First Intervention Period (1 Day)||3
7634042|NCT02271984|18796610|P3|COMPLETED|First Intervention Period (1 Day)||3
7634043|NCT02271984|18796611|P2|COMPLETED|First Intervention Period (1 Day)||3
7634044|NCT02271984|18796612|P1|COMPLETED|First Intervention Period (1 Day)||3
7634045|NCT02271984|18796601|P12|STARTED|First Intervention Period (1 Day)||3
7634046|NCT02271984|18796602|P11|STARTED|First Intervention Period (1 Day)||3
7634047|NCT02271984|18796603|P10|STARTED|First Intervention Period (1 Day)||3
7634048|NCT02271984|18796604|P9|STARTED|First Intervention Period (1 Day)||3
7634049|NCT02271984|18796605|P8|STARTED|First Intervention Period (1 Day)||3
7634050|NCT02271984|18796606|P7|STARTED|First Intervention Period (1 Day)||3
7634051|NCT02271984|18796607|P6|STARTED|First Intervention Period (1 Day)||3
7634052|NCT02271984|18796608|P5|STARTED|First Intervention Period (1 Day)||3
7634053|NCT02271984|18796609|P4|STARTED|First Intervention Period (1 Day)||3
7634054|NCT02271984|18796610|P3|STARTED|First Intervention Period (1 Day)||3
7634055|NCT02271984|18796611|P2|STARTED|First Intervention Period (1 Day)||3
7634056|NCT02271984|18796612|P1|STARTED|First Intervention Period (1 Day)||3
7634057|NCT02271945|18796701|P2|NOT COMPLETED|Overall Study||5
7634058|NCT02271945|18796702|P1|NOT COMPLETED|Overall Study||5
7634059|NCT02271945|18796701|P2|COMPLETED|Overall Study||0
7634060|NCT02271945|18796702|P1|COMPLETED|Overall Study||0
7634061|NCT02271945|18796701|P2|STARTED|Overall Study||5
7634062|NCT02271945|18796702|P1|STARTED|Overall Study||5
7634063|NCT02271906|18796738|P1|NOT COMPLETED|Overall Study||0
7634064|NCT02271906|18796738|P1|COMPLETED|Overall Study||2
7634065|NCT02271906|18796738|P1|STARTED|Overall Study||2
7634066|NCT02271880|18796745|P2|NOT COMPLETED|Overall Study||4
7634067|NCT02271880|18796746|P1|NOT COMPLETED|Overall Study||3
7634068|NCT02271880|18796745|P2|COMPLETED|Overall Study||0
7634069|NCT02271880|18796746|P1|COMPLETED|Overall Study||0
7634070|NCT02271880|18796745|P2|STARTED|Overall Study||4
7634071|NCT02271880|18796746|P1|STARTED|Overall Study||3
7634072|NCT02271854|18796776|P1|NOT COMPLETED|Overall Study||4
7634073|NCT02271854|18796776|P1|COMPLETED|Overall Study||98
7634074|NCT02271854|18796776|P1|STARTED|Overall Study||102
7634075|NCT02271698|18796787|P4|NOT COMPLETED|Overall Study||0
7634076|NCT02271698|18796788|P3|NOT COMPLETED|Overall Study||0
7634077|NCT02271698|18796789|P2|NOT COMPLETED|Overall Study||0
7634078|NCT02271698|18796790|P1|NOT COMPLETED|Overall Study||0
7634079|NCT02271698|18796787|P4|COMPLETED|Overall Study||11
7634080|NCT02271698|18796788|P3|COMPLETED|Overall Study||10
7634081|NCT02271698|18796789|P2|COMPLETED|Overall Study||10
7634082|NCT02271698|18796790|P1|COMPLETED|Overall Study||11
7634083|NCT02271698|18796787|P4|STARTED|Overall Study||11
7634084|NCT02271698|18796788|P3|STARTED|Overall Study||10
7634085|NCT02271698|18796789|P2|STARTED|Overall Study||10
7634086|NCT02271698|18796790|P1|STARTED|Overall Study||11
7634087|NCT02271529|18796816|P1|NOT COMPLETED|Overall Study||1
7634088|NCT02271529|18796816|P1|COMPLETED|Overall Study||39
7634089|NCT02271529|18796816|P1|STARTED|Overall Study||40
7634090|NCT02271477|18796822|P2|NOT COMPLETED|Overall Study||0
7634091|NCT02271477|18796823|P1|NOT COMPLETED|Overall Study||0
7634092|NCT02271477|18796822|P2|COMPLETED|Overall Study||80
7634093|NCT02271477|18796823|P1|COMPLETED|Overall Study||80
7634094|NCT02271477|18796822|P2|STARTED|Overall Study||80
7634095|NCT02271477|18796823|P1|STARTED|Overall Study||80
7634096|NCT02271451|18796837|P2|NOT COMPLETED|Overall Study||1
7634097|NCT02271451|18796838|P1|NOT COMPLETED|Overall Study||0
7634098|NCT02271451|18796837|P2|COMPLETED|Overall Study|one subject does not have MRI data due to braces|7
7634099|NCT02271451|18796838|P1|COMPLETED|Overall Study||7
7634100|NCT02271451|18796837|P2|STARTED|Overall Study||8
7634101|NCT02271451|18796838|P1|STARTED|Overall Study||7
7634102|NCT02271425|18796844|P1|NOT COMPLETED|Overall Study||0
7634103|NCT02271425|18796844|P1|COMPLETED|Overall Study||8
7634104|NCT02271425|18796844|P1|STARTED|Overall Study||8
7634105|NCT02271386|18796853|P4|NOT COMPLETED|Intervention Period- 8 Months||0
7634106|NCT02271386|18796854|P3|NOT COMPLETED|Intervention Period- 8 Months||0
7634107|NCT02271386|18796855|P2|NOT COMPLETED|Intervention Period- 8 Months||0
7634108|NCT02271386|18796856|P1|NOT COMPLETED|Intervention Period- 8 Months||0
7634109|NCT02271386|18796853|P4|COMPLETED|Intervention Period- 8 Months||197
7634110|NCT02271386|18796854|P3|COMPLETED|Intervention Period- 8 Months||202
7634111|NCT02271386|18796855|P2|COMPLETED|Intervention Period- 8 Months||52
7634112|NCT02271386|18796856|P1|COMPLETED|Intervention Period- 8 Months||53
7634113|NCT02271386|18796853|P4|STARTED|Intervention Period- 8 Months||197
7634114|NCT02271386|18796854|P3|STARTED|Intervention Period- 8 Months||202
7634115|NCT02271386|18796855|P2|STARTED|Intervention Period- 8 Months||52
7634116|NCT02271386|18796856|P1|STARTED|Intervention Period- 8 Months||53
7634117|NCT02271386|18796853|P4|NOT COMPLETED|Baseline Period- 8 Months||0
7634118|NCT02271386|18796854|P3|NOT COMPLETED|Baseline Period- 8 Months||0
7634119|NCT02271386|18796855|P2|NOT COMPLETED|Baseline Period- 8 Months||0
7634120|NCT02271386|18796856|P1|NOT COMPLETED|Baseline Period- 8 Months||0
7634121|NCT02271386|18796853|P4|COMPLETED|Baseline Period- 8 Months||191
7634122|NCT02271386|18796854|P3|COMPLETED|Baseline Period- 8 Months||200
7634123|NCT02271386|18796855|P2|COMPLETED|Baseline Period- 8 Months||52
7634124|NCT02271386|18796856|P1|COMPLETED|Baseline Period- 8 Months||53
7634125|NCT02271386|18796853|P4|STARTED|Baseline Period- 8 Months||191
7634126|NCT02271386|18796854|P3|STARTED|Baseline Period- 8 Months||200
7634127|NCT02271386|18796855|P2|STARTED|Baseline Period- 8 Months||52
7634128|NCT02271386|18796856|P1|STARTED|Baseline Period- 8 Months||53
7634129|NCT02271217|18796921|P3|NOT COMPLETED|Overall Study||12
7634130|NCT02271217|18796922|P2|NOT COMPLETED|Overall Study||13
7634131|NCT02271217|18796923|P1|NOT COMPLETED|Overall Study||11
7634132|NCT02271217|18796921|P3|COMPLETED|Overall Study||113
7634133|NCT02271217|18796922|P2|COMPLETED|Overall Study||113
7634134|NCT02271217|18796923|P1|COMPLETED|Overall Study||115
7634135|NCT02271217|18796921|P3|STARTED|Overall Study||125
7634136|NCT02271217|18796922|P2|STARTED|Overall Study||126
7634137|NCT02271217|18796923|P1|STARTED|Overall Study||126
7634138|NCT02270983|18796937|P3|NOT COMPLETED|Overall Study||12
7634139|NCT02270983|18796938|P2|NOT COMPLETED|Overall Study||7
7634140|NCT02270983|18796939|P1|NOT COMPLETED|Overall Study||9
7634141|NCT02270983|18796937|P3|COMPLETED|Overall Study||76
7634142|NCT02270983|18796938|P2|COMPLETED|Overall Study||80
7634143|NCT02270983|18796939|P1|COMPLETED|Overall Study||70
7634144|NCT02270983|18796937|P3|STARTED|Overall Study||88
7634145|NCT02270983|18796938|P2|STARTED|Overall Study||87
7634146|NCT02270983|18796939|P1|STARTED|Overall Study||79
7634147|NCT02270957|18796964|P2|NOT COMPLETED|Overall Study||4
7634148|NCT02270957|18796965|P1|NOT COMPLETED|Overall Study||4
7634149|NCT02270957|18796964|P2|COMPLETED|Overall Study||31
7634150|NCT02270957|18796965|P1|COMPLETED|Overall Study||27
7634151|NCT02270957|18796964|P2|STARTED|Overall Study||35
7634152|NCT02270957|18796965|P1|STARTED|Overall Study||31
7634153|NCT02270944|18796977|P2|NOT COMPLETED|Overall Study||5
7634154|NCT02270944|18796978|P1|NOT COMPLETED|Overall Study||11
7634155|NCT02270944|18796977|P2|COMPLETED|Overall Study||516
7634156|NCT02270944|18796978|P1|COMPLETED|Overall Study||518
7634157|NCT02270944|18796977|P2|STARTED|Overall Study||521
7634158|NCT02270944|18796978|P1|STARTED|Overall Study||529
7634159|NCT02270684|18796996|P2|NOT COMPLETED|Overall Study||3
7634160|NCT02270684|18796997|P1|NOT COMPLETED|Overall Study||1
7634161|NCT02270684|18796996|P2|COMPLETED|Overall Study||0
7634162|NCT02270684|18796997|P1|COMPLETED|Overall Study||0
7634163|NCT02270684|18796996|P2|STARTED|Overall Study||3
7634164|NCT02270684|18796997|P1|STARTED|Overall Study||1
7634165|NCT02270671|18797005|P2|NOT COMPLETED|Overall Study||5
7634166|NCT02270671|18797006|P1|NOT COMPLETED|Overall Study||5
7634167|NCT02270671|18797005|P2|COMPLETED|Overall Study||61
7634168|NCT02270671|18797006|P1|COMPLETED|Overall Study||59
7634169|NCT02270671|18797005|P2|STARTED|Overall Study||66
7634170|NCT02270671|18797006|P1|STARTED|Overall Study||64
7634171|NCT02270645|18797022|P2|NOT COMPLETED|Overall Study||0
7634172|NCT02270645|18797023|P1|NOT COMPLETED|Overall Study||2
7634173|NCT02270645|18797022|P2|COMPLETED|Overall Study||4
7634174|NCT02270645|18797023|P1|COMPLETED|Overall Study||6
7634175|NCT02270645|18797022|P2|STARTED|Overall Study||4
7634176|NCT02270645|18797023|P1|STARTED|Overall Study||8
7634177|NCT02270515|18797031|P1|NOT COMPLETED|Intervention Period 3: 12-18 Months||24
7634178|NCT02270515|18797031|P1|COMPLETED|Intervention Period 3: 12-18 Months||103
7634179|NCT02270515|18797031|P1|STARTED|Intervention Period 3: 12-18 Months||127
7634180|NCT02270515|18797031|P1|NOT COMPLETED|Intervention Period 2: 6-12 Months||32
7634181|NCT02270515|18797031|P1|COMPLETED|Intervention Period 2: 6-12 Months||127
7634182|NCT02270515|18797031|P1|STARTED|Intervention Period 2: 6-12 Months||159
7634183|NCT02270515|18797031|P1|NOT COMPLETED|Intervention Period 1: 0-6 Months||16
7634184|NCT02270515|18797031|P1|COMPLETED|Intervention Period 1: 0-6 Months||159
7634185|NCT02270515|18797031|P1|STARTED|Intervention Period 1: 0-6 Months||175
7634186|NCT02270255|18797048|P2|NOT COMPLETED|Overall Study||0
7634187|NCT02270255|18797049|P1|NOT COMPLETED|Overall Study||1
7634188|NCT02270255|18797048|P2|COMPLETED|Overall Study||22
7634189|NCT02270255|18797049|P1|COMPLETED|Overall Study||21
7634190|NCT02270255|18797048|P2|Complete Data From Home Survey|Overall Study||22
7634191|NCT02270255|18797049|P1|Complete Data From Home Survey|Overall Study||21
7634192|NCT02270255|18797048|P2|Complete Data at Discharge PACU|Overall Study||22
7634193|NCT02270255|18797049|P1|Complete Data at Discharge PACU|Overall Study||22
7634194|NCT02270255|18797048|P2|STARTED|Overall Study||22
7634195|NCT02270255|18797049|P1|STARTED|Overall Study||22
7634196|NCT02270242|18797059|P2|NOT COMPLETED|Overall Study||53
7634197|NCT02270242|18797060|P1|NOT COMPLETED|Overall Study||59
7634198|NCT02270242|18797059|P2|COMPLETED|Overall Study||3511
7634199|NCT02270242|18797060|P1|COMPLETED|Overall Study||3496
7634200|NCT02270242|18797059|P2|STARTED|Overall Study||3564
7634201|NCT02270242|18797060|P1|STARTED|Overall Study||3555
7634202|NCT02270060|18797071|P3|NOT COMPLETED|Overall Study||0
7634203|NCT02270060|18797072|P2|NOT COMPLETED|Overall Study||0
7634204|NCT02270060|18797073|P1|NOT COMPLETED|Overall Study||0
7634205|NCT02270060|18797071|P3|COMPLETED|Overall Study||20
7634206|NCT02270060|18797072|P2|COMPLETED|Overall Study||20
7634207|NCT02270060|18797073|P1|COMPLETED|Overall Study||20
7634208|NCT02270060|18797071|P3|STARTED|Overall Study||20
7634209|NCT02270060|18797072|P2|STARTED|Overall Study||20
7634210|NCT02270060|18797073|P1|STARTED|Overall Study||20
7634211|NCT02269943|18797101|P2|NOT COMPLETED|Follow-Up Survival Period||26
7634212|NCT02269943|18797102|P1|NOT COMPLETED|Follow-Up Survival Period||5
7634213|NCT02269943|18797101|P2|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
7634214|NCT02269943|18797102|P1|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
7634215|NCT02269943|18797101|P2|STARTED|Follow-Up Survival Period||26
7634216|NCT02269943|18797102|P1|STARTED|Follow-Up Survival Period||5
7634217|NCT02269943|18797101|P2|NOT COMPLETED|Treatment Period||30
7634218|NCT02269943|18797102|P1|NOT COMPLETED|Treatment Period||6
7634219|NCT02269943|18797101|P2|COMPLETED|Treatment Period|Not applicable according to the study design|0
7634220|NCT02269943|18797102|P1|COMPLETED|Treatment Period|Not applicable according to the study design|0
7634221|NCT02269943|18797101|P2|Investigational Product (IP) Stopped|Treatment Period||30
7634222|NCT02269943|18797102|P1|Investigational Product (IP) Stopped|Treatment Period||6
7634223|NCT02269943|18797101|P2|STARTED|Treatment Period||30
7634224|NCT02269943|18797102|P1|STARTED|Treatment Period||6
7634225|NCT02269917|18797132|P2|NOT COMPLETED|Overall Study||383
7634226|NCT02269917|18797133|P1|NOT COMPLETED|Overall Study||766
7634227|NCT02269917|18797132|P2|COMPLETED|Overall Study||0
7634228|NCT02269917|18797133|P1|COMPLETED|Overall Study||0
7634229|NCT02269917|18797132|P2|Treated|Overall Study||378
7634230|NCT02269917|18797133|P1|Treated|Overall Study||763
7634231|NCT02269917|18797132|P2|STARTED|Overall Study||383
7634232|NCT02269917|18797133|P1|STARTED|Overall Study||766
7634233|NCT02269787|18797186|P2|NOT COMPLETED|Overall Study||10
7634234|NCT02269787|18797187|P1|NOT COMPLETED|Overall Study||22
7634235|NCT02269787|18797186|P2|COMPLETED|Overall Study||140
7634236|NCT02269787|18797187|P1|COMPLETED|Overall Study||126
7634237|NCT02269787|18797186|P2|STARTED|Overall Study||150
7634238|NCT02269787|18797187|P1|STARTED|Overall Study||148
7634239|NCT02269709|18797193|P1|NOT COMPLETED|Six Month Follow-up||12
7634240|NCT02269709|18797193|P1|COMPLETED|Six Month Follow-up||5
7634241|NCT02269709|18797193|P1|STARTED|Six Month Follow-up||17
7634242|NCT02269709|18797193|P1|NOT COMPLETED|Prior to Hospital Discharge||0
7634243|NCT02269709|18797193|P1|COMPLETED|Prior to Hospital Discharge||17
7634244|NCT02269709|18797193|P1|STARTED|Prior to Hospital Discharge||17
7634245|NCT02269709|18797193|P1|NOT COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||1
7634246|NCT02269709|18797193|P1|COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||17
7634247|NCT02269709|18797193|P1|STARTED|Follow-up #1 (24-72 Hours Post-surgery)||18
7634248|NCT02269709|18797193|P1|NOT COMPLETED|Time of Enrollment||3
7634249|NCT02269709|18797193|P1|COMPLETED|Time of Enrollment||18
7634250|NCT02269709|18797193|P1|STARTED|Time of Enrollment||21
7634251|NCT02269657|18797198|P1|NOT COMPLETED|Overall Study||3
7634252|NCT02269657|18797198|P1|COMPLETED|Overall Study||37
7634253|NCT02269657|18797198|P1|STARTED|Overall Study||40
7634254|NCT02269631|18797214|P2|NOT COMPLETED|Overall Study||0
7634255|NCT02269631|18797215|P1|NOT COMPLETED|Overall Study||0
7634256|NCT02269631|18797214|P2|COMPLETED|Overall Study||5
7634257|NCT02269631|18797215|P1|COMPLETED|Overall Study||7
7634258|NCT02269631|18797214|P2|STARTED|Overall Study||5
7634259|NCT02269631|18797215|P1|STARTED|Overall Study||7
7634260|NCT02269488|18797229|P1|NOT COMPLETED|Overall Study||0
7634261|NCT02269488|18797229|P1|COMPLETED|Overall Study||100
7634262|NCT02269488|18797229|P1|STARTED|Overall Study||100
7634263|NCT02269475|18797235|P2|NOT COMPLETED|Overall Study||1
7634264|NCT02269475|18797236|P1|NOT COMPLETED|Overall Study||3
7634265|NCT02269475|18797235|P2|COMPLETED|Overall Study||432
7634266|NCT02269475|18797236|P1|COMPLETED|Overall Study||865
7634267|NCT02269475|18797235|P2|Per Protocol Population|Overall Study||430
7634268|NCT02269475|18797236|P1|Per Protocol Population|Overall Study||849
7634269|NCT02269475|18797235|P2|Received IP (Safety Population)|Overall Study||433
7634270|NCT02269475|18797236|P1|Received IP (Safety Population)|Overall Study||868
7634271|NCT02269475|18797235|P2|STARTED|Overall Study||433
7634272|NCT02269475|18797236|P1|STARTED|Overall Study||868
7634273|NCT02269423|18797251|P4|NOT COMPLETED|Overall Study||1
7634274|NCT02269423|18797252|P3|NOT COMPLETED|Overall Study||0
7634275|NCT02269423|18797253|P2|NOT COMPLETED|Overall Study||1
7634276|NCT02269423|18797254|P1|NOT COMPLETED|Overall Study||0
7634277|NCT02269423|18797251|P4|COMPLETED|Overall Study||8
7634278|NCT02269423|18797252|P3|COMPLETED|Overall Study||10
7634279|NCT02269423|18797253|P2|COMPLETED|Overall Study||9
7634280|NCT02269423|18797254|P1|COMPLETED|Overall Study||10
7634281|NCT02269423|18797251|P4|STARTED|Overall Study||9
7634282|NCT02269423|18797252|P3|STARTED|Overall Study||10
7634283|NCT02269423|18797253|P2|STARTED|Overall Study||10
7634284|NCT02269423|18797254|P1|STARTED|Overall Study||10
7634285|NCT02269241|18797316|P1|NOT COMPLETED|Overall Study||1200
7634286|NCT02269241|18797316|P1|COMPLETED|Overall Study||352
7634287|NCT02269241|18797316|P1|STARTED|Overall Study||1552
7634288|NCT02269098|18797330|P2|NOT COMPLETED|Overall Study||9
7634289|NCT02269098|18797331|P1|NOT COMPLETED|Overall Study||14
7634290|NCT02269098|18797330|P2|COMPLETED|Overall Study||41
7634291|NCT02269098|18797331|P1|COMPLETED|Overall Study||37
7634292|NCT02269098|18797330|P2|STARTED|Overall Study||50
7634293|NCT02269098|18797331|P1|STARTED|Overall Study||51
7634294|NCT02268994|18797347|P2|NOT COMPLETED|Overall Study||35
7634295|NCT02268994|18797348|P1|NOT COMPLETED|Overall Study||31
7634296|NCT02268994|18797347|P2|COMPLETED|Overall Study||81
7634297|NCT02268994|18797348|P1|COMPLETED|Overall Study||86
7634298|NCT02268994|18797347|P2|STARTED|Overall Study||116
7634299|NCT02268994|18797348|P1|STARTED|Overall Study||117
7634300|NCT02268955|18797366|P2|NOT COMPLETED|Overall Study||2
7634301|NCT02268955|18797367|P1|NOT COMPLETED|Overall Study||2
7634302|NCT02268955|18797366|P2|COMPLETED|Overall Study||9
7634303|NCT02268955|18797367|P1|COMPLETED|Overall Study||9
7634304|NCT02268955|18797366|P2|STARTED|Overall Study||11
7634305|NCT02268955|18797367|P1|STARTED|Overall Study||11
7634306|NCT02268942|18797373|P1|NOT COMPLETED|Overall Study||0
7634307|NCT02268942|18797373|P1|COMPLETED|Overall Study||144
7634308|NCT02268942|18797373|P1|STARTED|Overall Study||144
7634309|NCT02268877|18797380|P2|NOT COMPLETED|Overall Study||5
7634310|NCT02268877|18797381|P1|NOT COMPLETED|Overall Study||4
7634311|NCT02268877|18797380|P2|COMPLETED|Overall Study|106 patients received the intervention.|106
7634312|NCT02268877|18797381|P1|COMPLETED|Overall Study||118
7634313|NCT02268877|18797380|P2|STARTED|Overall Study|111 patients were randomized to this arm.|111
7634314|NCT02268877|18797381|P1|STARTED|Overall Study||122
7634315|NCT02268864|18797392|P3|NOT COMPLETED|Overall Study||0
7634316|NCT02268864|18797393|P2|NOT COMPLETED|Overall Study||1
7634317|NCT02268864|18797394|P1|NOT COMPLETED|Overall Study||2
7634318|NCT02268864|18797392|P3|COMPLETED|Overall Study||64
7634319|NCT02268864|18797393|P2|COMPLETED|Overall Study||24
7634320|NCT02268864|18797394|P1|COMPLETED|Overall Study||15
7634321|NCT02268864|18797392|P3|STARTED|Overall Study||64
7634322|NCT02268864|18797393|P2|STARTED|Overall Study||25
7634323|NCT02268864|18797394|P1|STARTED|Overall Study||17
7634324|NCT02268851|18797422|P6|NOT COMPLETED|Overall Study||11
7634325|NCT02268851|18797423|P5|NOT COMPLETED|Overall Study||7
7634326|NCT02268851|18797424|P4|NOT COMPLETED|Overall Study||3
7634327|NCT02268851|18797425|P3|NOT COMPLETED|Overall Study||1
7634328|NCT02268851|18797426|P2|NOT COMPLETED|Overall Study||3
7634329|NCT02268851|18797427|P1|NOT COMPLETED|Overall Study||1
7634330|NCT02268851|18797422|P6|COMPLETED|Overall Study||4
7634331|NCT02268851|18797423|P5|COMPLETED|Overall Study||8
7634332|NCT02268851|18797424|P4|COMPLETED|Overall Study||0
7634333|NCT02268851|18797425|P3|COMPLETED|Overall Study||3
7634334|NCT02268851|18797426|P2|COMPLETED|Overall Study||0
7634335|NCT02268851|18797427|P1|COMPLETED|Overall Study||2
7634336|NCT02268851|18797422|P6|STARTED|Overall Study||15
7634337|NCT02268851|18797423|P5|STARTED|Overall Study||15
7634338|NCT02268851|18797424|P4|STARTED|Overall Study||3
7634339|NCT02268851|18797425|P3|STARTED|Overall Study||4
7634340|NCT02268851|18797426|P2|STARTED|Overall Study||3
7634341|NCT02268851|18797427|P1|STARTED|Overall Study||3
7634342|NCT02268812|18797445|P4|NOT COMPLETED|Overall Study||14
7634343|NCT02268812|18797446|P3|NOT COMPLETED|Overall Study||9
7634344|NCT02268812|18797447|P2|NOT COMPLETED|Overall Study||32
7634345|NCT02268812|18797448|P1|NOT COMPLETED|Overall Study||16
7634346|NCT02268812|18797445|P4|COMPLETED|Overall Study||26
7634347|NCT02268812|18797446|P3|COMPLETED|Overall Study||21
7634348|NCT02268812|18797447|P2|COMPLETED|Overall Study||40
7634349|NCT02268812|18797448|P1|COMPLETED|Overall Study||61
7634350|NCT02268812|18797445|P4|STARTED|Overall Study||40
7634351|NCT02268812|18797446|P3|STARTED|Overall Study||30
7634352|NCT02268812|18797447|P2|STARTED|Overall Study||72
7634353|NCT02268812|18797448|P1|STARTED|Overall Study||77
7634354|NCT02268786|18797480|P2|NOT COMPLETED|Overall Study||18
7634355|NCT02268786|18797481|P1|NOT COMPLETED|Overall Study||56
7634356|NCT02268786|18797480|P2|COMPLETED|Overall Study||313
7634357|NCT02268786|18797481|P1|COMPLETED|Overall Study||274
7634358|NCT02268786|18797480|P2|STARTED|Overall Study||331
7634359|NCT02268786|18797481|P1|STARTED|Overall Study||330
7634360|NCT02268526|18797490|P3|NOT COMPLETED|Overall Study||5
7634361|NCT02268526|18797491|P2|NOT COMPLETED|Overall Study||21
7634362|NCT02268526|18797492|P1|NOT COMPLETED|Overall Study||1
7634363|NCT02268526|18797490|P3|COMPLETED|Overall Study||16
7634364|NCT02268526|18797491|P2|COMPLETED|Overall Study||38
7634365|NCT02268526|18797492|P1|COMPLETED|Overall Study||5
7634366|NCT02268526|18797490|P3|PD Analysis Set (Cohort 2)|Overall Study||17
7634367|NCT02268526|18797491|P2|PD Analysis Set (Cohort 2)|Overall Study||42
7634368|NCT02268526|18797492|P1|PD Analysis Set (Cohort 2)|Overall Study||0
7634369|NCT02268526|18797490|P3|STARTED|Overall Study||21
7634370|NCT02268526|18797491|P2|STARTED|Overall Study||59
7634371|NCT02268526|18797492|P1|STARTED|Overall Study||6
7634372|NCT02268396|18797513|P1|NOT COMPLETED|Overall Study||12
7634373|NCT02268396|18797513|P1|COMPLETED|Overall Study||126
7634374|NCT02268396|18797513|P1|STARTED|Overall Study||138
7634375|NCT02268214|18797525|P3|NOT COMPLETED|Overall Study||42
7634376|NCT02268214|18797526|P2|NOT COMPLETED|Overall Study||41
7634377|NCT02268214|18797527|P1|NOT COMPLETED|Overall Study||42
7634378|NCT02268214|18797525|P3|COMPLETED|Overall Study||218
7634379|NCT02268214|18797526|P2|COMPLETED|Overall Study||255
7634380|NCT02268214|18797527|P1|COMPLETED|Overall Study||235
7634381|NCT02268214|18797525|P3|COMPLETED 24 WEEK PERIOD|Overall Study||232
7634382|NCT02268214|18797526|P2|COMPLETED 24 WEEK PERIOD|Overall Study||273
7634383|NCT02268214|18797527|P1|COMPLETED 24 WEEK PERIOD|Overall Study||252
7634384|NCT02268214|18797525|P3|STARTED|Overall Study||260
7634385|NCT02268214|18797526|P2|STARTED|Overall Study||296
7634386|NCT02268214|18797527|P1|STARTED|Overall Study||277
7634387|NCT02268175|18797555|P2|NOT COMPLETED|Overall Study||0
7634388|NCT02268175|18797556|P1|NOT COMPLETED|Overall Study||0
7634389|NCT02268175|18797555|P2|COMPLETED|Overall Study||25
7634390|NCT02268175|18797556|P1|COMPLETED|Overall Study||50
7634391|NCT02268175|18797555|P2|STARTED|Overall Study||25
7634392|NCT02268175|18797556|P1|STARTED|Overall Study||50
7634393|NCT02268058|18797574|P4|NOT COMPLETED|Overall Study||0
7634394|NCT02268058|18797575|P3|NOT COMPLETED|Overall Study||0
7634395|NCT02268058|18797576|P2|NOT COMPLETED|Overall Study||0
7634396|NCT02268058|18797577|P1|NOT COMPLETED|Overall Study||1
7634397|NCT02268058|18797574|P4|COMPLETED|Overall Study||20
7634398|NCT02268058|18797575|P3|COMPLETED|Overall Study||20
7634399|NCT02268058|18797576|P2|COMPLETED|Overall Study||20
7634400|NCT02268058|18797577|P1|COMPLETED|Overall Study||19
7634401|NCT02268058|18797574|P4|STARTED|Overall Study||20
7634402|NCT02268058|18797575|P3|STARTED|Overall Study||20
7634403|NCT02268058|18797576|P2|STARTED|Overall Study||20
7634404|NCT02268058|18797577|P1|STARTED|Overall Study||20
7634405|NCT02268045|18797601|P2|NOT COMPLETED|Overall Study||20
7634406|NCT02268045|18797602|P1|NOT COMPLETED|Overall Study||16
7634407|NCT02268045|18797601|P2|COMPLETED|Overall Study||116
7634408|NCT02268045|18797602|P1|COMPLETED|Overall Study||120
7634409|NCT02268045|18797601|P2|STARTED|Overall Study||136
7634410|NCT02268045|18797602|P1|STARTED|Overall Study||136
7634411|NCT02267850|18797626|P2|NOT COMPLETED|Overall Study||2
7634412|NCT02267850|18797627|P1|NOT COMPLETED|Overall Study||1
7634413|NCT02267850|18797626|P2|COMPLETED|Overall Study||12
7634414|NCT02267850|18797627|P1|COMPLETED|Overall Study||14
7634415|NCT02267850|18797626|P2|STARTED|Overall Study||14
7634416|NCT02267850|18797627|P1|STARTED|Overall Study||15
7634417|NCT02267837|18797635|P2|NOT COMPLETED|Overall Study||0
7634418|NCT02267837|18797636|P1|NOT COMPLETED|Overall Study||0
7634419|NCT02267837|18797635|P2|COMPLETED|Overall Study||9
7634420|NCT02267837|18797636|P1|COMPLETED|Overall Study||11
7634421|NCT02267837|18797635|P2|STARTED|Overall Study||9
7634422|NCT02267837|18797636|P1|STARTED|Overall Study||11
7634423|NCT02267824|18797644|P2|NOT COMPLETED|Overall Study||1
7634424|NCT02267824|18797645|P1|NOT COMPLETED|Overall Study||10
7634425|NCT02267824|18797644|P2|COMPLETED|Overall Study||17
7634426|NCT02267824|18797645|P1|COMPLETED|Overall Study||73
7634427|NCT02267824|18797644|P2|STARTED|Overall Study||18
7634428|NCT02267824|18797645|P1|STARTED|Overall Study||83
7634429|NCT02267811|18797653|P2|NOT COMPLETED|Overall Study||2
7634430|NCT02267811|18797654|P1|NOT COMPLETED|Overall Study||1
7634431|NCT02267811|18797653|P2|COMPLETED|Overall Study||15
7634432|NCT02267811|18797654|P1|COMPLETED|Overall Study||15
7634433|NCT02267811|18797653|P2|STARTED|Overall Study||17
7634434|NCT02267811|18797654|P1|STARTED|Overall Study||16
7634435|NCT02267746|18797667|P3|NOT COMPLETED|Overall Study||21
7634436|NCT02267746|18797668|P2|NOT COMPLETED|Overall Study||22
7634437|NCT02267746|18797669|P1|NOT COMPLETED|Overall Study||21
7634438|NCT02267746|18797667|P3|COMPLETED|Overall Study||278
7634439|NCT02267746|18797668|P2|COMPLETED|Overall Study||274
7634440|NCT02267746|18797669|P1|COMPLETED|Overall Study||277
7634441|NCT02267746|18797667|P3|STARTED|Overall Study||299
7634442|NCT02267746|18797668|P2|STARTED|Overall Study||296
7634443|NCT02267746|18797669|P1|STARTED|Overall Study||298
7634444|NCT02267629|18797683|P1|NOT COMPLETED|Overall Study||0
7634445|NCT02267629|18797683|P1|COMPLETED|Overall Study||7
7634446|NCT02267629|18797683|P1|STARTED|Overall Study||7
7634447|NCT02267603|18797688|P1|NOT COMPLETED|Overall Study||44
7634448|NCT02267603|18797688|P1|COMPLETED|Overall Study||6
7634449|NCT02267603|18797688|P1|STARTED|Overall Study||50
7634450|NCT02267577|18797692|P1|NOT COMPLETED|Overall Study||4
7634451|NCT02267577|18797692|P1|COMPLETED|Overall Study||81
7634452|NCT02267577|18797692|P1|STARTED|Overall Study||85
7634453|NCT02267538|18797699|P2|NOT COMPLETED|Overall Study||0
7634454|NCT02267538|18797700|P1|NOT COMPLETED|Overall Study||0
7634455|NCT02267538|18797699|P2|COMPLETED|Overall Study||143
7634456|NCT02267538|18797700|P1|COMPLETED|Overall Study||142
7634457|NCT02267538|18797699|P2|STARTED|Overall Study||143
7634458|NCT02267538|18797700|P1|STARTED|Overall Study||142
7634459|NCT02267447|18797720|P2|NOT COMPLETED|Overall Study||0
7634460|NCT02267447|18797721|P1|NOT COMPLETED|Overall Study||0
7634461|NCT02267447|18797720|P2|COMPLETED|Overall Study||26968
7634462|NCT02267447|18797721|P1|COMPLETED|Overall Study||77251
7634463|NCT02267447|18797720|P2|STARTED|Overall Study||26968
7634464|NCT02267447|18797721|P1|STARTED|Overall Study||77251
7634465|NCT02267382|18797734|P5|NOT COMPLETED|Overall Study||7
7634466|NCT02267382|18797735|P4|NOT COMPLETED|Overall Study||6
7634467|NCT02267382|18797736|P3|NOT COMPLETED|Overall Study||9
7634468|NCT02267382|18797737|P2|NOT COMPLETED|Overall Study||10
7634469|NCT02267382|18797738|P1|NOT COMPLETED|Overall Study||7
7634470|NCT02267382|18797734|P5|COMPLETED|Overall Study||39
7634471|NCT02267382|18797735|P4|COMPLETED|Overall Study||35
7634472|NCT02267382|18797736|P3|COMPLETED|Overall Study||34
7634473|NCT02267382|18797737|P2|COMPLETED|Overall Study||33
7634474|NCT02267382|18797738|P1|COMPLETED|Overall Study||35
7634475|NCT02267382|18797734|P5|STARTED|Overall Study||46
7634476|NCT02267382|18797735|P4|STARTED|Overall Study||41
7634477|NCT02267382|18797736|P3|STARTED|Overall Study||43
7634478|NCT02267382|18797737|P2|STARTED|Overall Study||43
7634479|NCT02267382|18797738|P1|STARTED|Overall Study||42
7634480|NCT02267356|18797755|P5|NOT COMPLETED|Study Extension||0
7634481|NCT02267356|18797756|P4|NOT COMPLETED|Study Extension||2
7634482|NCT02267356|18797757|P3|NOT COMPLETED|Study Extension||1
7634483|NCT02267356|18797758|P2|NOT COMPLETED|Study Extension||0
7634484|NCT02267356|18797759|P1|NOT COMPLETED|Study Extension||1
7634485|NCT02267356|18797755|P5|COMPLETED|Study Extension||26
7634486|NCT02267356|18797756|P4|COMPLETED|Study Extension||30
7634487|NCT02267356|18797757|P3|COMPLETED|Study Extension||29
7634488|NCT02267356|18797758|P2|COMPLETED|Study Extension||37
7634489|NCT02267356|18797759|P1|COMPLETED|Study Extension||32
7634490|NCT02267356|18797755|P5|STARTED|Study Extension||26
7634491|NCT02267356|18797756|P4|STARTED|Study Extension||32
7634492|NCT02267356|18797757|P3|STARTED|Study Extension||30
7634493|NCT02267356|18797758|P2|STARTED|Study Extension||37
7634494|NCT02267356|18797759|P1|STARTED|Study Extension||33
7634495|NCT02267356|18797755|P5|NOT COMPLETED|Initial Study||5
7634496|NCT02267356|18797756|P4|NOT COMPLETED|Initial Study||11
7634497|NCT02267356|18797757|P3|NOT COMPLETED|Initial Study||10
7634498|NCT02267356|18797758|P2|NOT COMPLETED|Initial Study||5
7634499|NCT02267356|18797759|P1|NOT COMPLETED|Initial Study||6
7634500|NCT02267356|18797755|P5|COMPLETED|Initial Study||42
7634501|NCT02267356|18797756|P4|COMPLETED|Initial Study||43
7634502|NCT02267356|18797757|P3|COMPLETED|Initial Study||42
7634503|NCT02267356|18797758|P2|COMPLETED|Initial Study||48
7634504|NCT02267356|18797759|P1|COMPLETED|Initial Study||47
7634505|NCT02267356|18797755|P5|STARTED|Initial Study||47
7634506|NCT02267356|18797756|P4|STARTED|Initial Study||54
7634507|NCT02267356|18797757|P3|STARTED|Initial Study||52
7634508|NCT02267356|18797758|P2|STARTED|Initial Study||53
7634509|NCT02267356|18797759|P1|STARTED|Initial Study||53
7634510|NCT02267317|18797779|P6|NOT COMPLETED|Infusion2||0
7634511|NCT02267317|18797780|P5|NOT COMPLETED|Infusion2||0
7634512|NCT02267317|18797781|P4|NOT COMPLETED|Infusion2||0
7634513|NCT02267317|18797782|P3|NOT COMPLETED|Infusion2||0
7634514|NCT02267317|18797783|P2|NOT COMPLETED|Infusion2||0
7634515|NCT02267317|18797784|P1|NOT COMPLETED|Infusion2||0
7634516|NCT02267317|18797779|P6|COMPLETED|Infusion2||1
7634517|NCT02267317|18797780|P5|COMPLETED|Infusion2||0
7634518|NCT02267317|18797781|P4|COMPLETED|Infusion2||2
7634519|NCT02267317|18797782|P3|COMPLETED|Infusion2||1
7634520|NCT02267317|18797783|P2|COMPLETED|Infusion2||3
7634521|NCT02267317|18797784|P1|COMPLETED|Infusion2||6
7634522|NCT02267317|18797779|P6|STARTED|Infusion2||1
7634523|NCT02267317|18797780|P5|STARTED|Infusion2||0
7634524|NCT02267317|18797781|P4|STARTED|Infusion2||2
7634525|NCT02267317|18797782|P3|STARTED|Infusion2||1
7634526|NCT02267317|18797783|P2|STARTED|Infusion2||3
7634527|NCT02267317|18797784|P1|STARTED|Infusion2||6
7634528|NCT02267317|18797779|P6|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
7634529|NCT02267317|18797780|P5|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
7634530|NCT02267317|18797781|P4|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
7634531|NCT02267317|18797782|P3|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
7634532|NCT02267317|18797783|P2|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
7634533|NCT02267317|18797784|P1|NOT COMPLETED|Washout (3-4weeks Between Infusions)||2
7634534|NCT02267317|18797779|P6|COMPLETED|Washout (3-4weeks Between Infusions)||1
7634535|NCT02267317|18797780|P5|COMPLETED|Washout (3-4weeks Between Infusions)||0
7634536|NCT02267317|18797781|P4|COMPLETED|Washout (3-4weeks Between Infusions)||2
7634537|NCT02267317|18797782|P3|COMPLETED|Washout (3-4weeks Between Infusions)||1
7634538|NCT02267317|18797783|P2|COMPLETED|Washout (3-4weeks Between Infusions)||3
7634539|NCT02267317|18797784|P1|COMPLETED|Washout (3-4weeks Between Infusions)||6
7634540|NCT02267317|18797779|P6|STARTED|Washout (3-4weeks Between Infusions)||1
7634541|NCT02267317|18797780|P5|STARTED|Washout (3-4weeks Between Infusions)||0
7634542|NCT02267317|18797781|P4|STARTED|Washout (3-4weeks Between Infusions)||2
7634543|NCT02267317|18797782|P3|STARTED|Washout (3-4weeks Between Infusions)||1
7634544|NCT02267317|18797783|P2|STARTED|Washout (3-4weeks Between Infusions)||3
7634545|NCT02267317|18797784|P1|STARTED|Washout (3-4weeks Between Infusions)||8
7634546|NCT02267317|18797779|P6|NOT COMPLETED|Infusion1||0
7634547|NCT02267317|18797780|P5|NOT COMPLETED|Infusion1||0
7634548|NCT02267317|18797781|P4|NOT COMPLETED|Infusion1||0
7634549|NCT02267317|18797782|P3|NOT COMPLETED|Infusion1||0
7634550|NCT02267317|18797783|P2|NOT COMPLETED|Infusion1||0
7634551|NCT02267317|18797784|P1|NOT COMPLETED|Infusion1||0
7634552|NCT02267317|18797779|P6|COMPLETED|Infusion1||1
7634553|NCT02267317|18797780|P5|COMPLETED|Infusion1||0
7634554|NCT02267317|18797781|P4|COMPLETED|Infusion1||2
7634555|NCT02267317|18797782|P3|COMPLETED|Infusion1||1
7634556|NCT02267317|18797783|P2|COMPLETED|Infusion1||3
7634557|NCT02267317|18797784|P1|COMPLETED|Infusion1||8
7634558|NCT02267317|18797779|P6|STARTED|Infusion1||1
7634559|NCT02267317|18797780|P5|STARTED|Infusion1||0
7634560|NCT02267317|18797781|P4|STARTED|Infusion1||2
7634561|NCT02267317|18797782|P3|STARTED|Infusion1||1
7634562|NCT02267317|18797783|P2|STARTED|Infusion1||3
7634563|NCT02267317|18797784|P1|STARTED|Infusion1||8
7634564|NCT02267278|18797834|P1|NOT COMPLETED|Overall Study||5
7634565|NCT02267278|18797834|P1|COMPLETED|Overall Study||20
7634566|NCT02267278|18797834|P1|STARTED|Overall Study||25
7634567|NCT02267226|18797839|P1|NOT COMPLETED|Overall Study||7
7634568|NCT02267226|18797839|P1|COMPLETED|Overall Study||18
7634569|NCT02267226|18797839|P1|Surgical Prophylaxis Population|Overall Study||9
7634570|NCT02267226|18797839|P1|FAS-Bleeding Population|Overall Study||24
7634571|NCT02267226|18797839|P1|SAFETY Population|Overall Study||25
7634572|NCT02267226|18797839|P1|STARTED|Overall Study||25
7634573|NCT02267187|18797858|P1|NOT COMPLETED|Overall Study||5
7634574|NCT02267187|18797858|P1|COMPLETED|Overall Study||10
7634575|NCT02267187|18797858|P1|STARTED|Overall Study||15
7634576|NCT02267135|18797866|P2|NOT COMPLETED|Period 2 (Randomized Set)||1
7634577|NCT02267135|18797867|P1|NOT COMPLETED|Period 2 (Randomized Set)||4
7634578|NCT02267135|18797866|P2|COMPLETED|Period 2 (Randomized Set)||46
7634579|NCT02267135|18797867|P1|COMPLETED|Period 2 (Randomized Set)||46
7634580|NCT02267135|18797866|P2|STARTED|Period 2 (Randomized Set)||47
7634581|NCT02267135|18797867|P1|STARTED|Period 2 (Randomized Set)||50
7634582|NCT02267135|18797866|P2|NOT COMPLETED|Period 1 (Randomized Set)||4
7634583|NCT02267135|18797867|P1|NOT COMPLETED|Period 1 (Randomized Set)||1
7634584|NCT02267135|18797866|P2|COMPLETED|Period 1 (Randomized Set)||47
7634585|NCT02267135|18797867|P1|COMPLETED|Period 1 (Randomized Set)||50
7634586|NCT02267135|18797866|P2|STARTED|Period 1 (Randomized Set)||51
7634587|NCT02267135|18797867|P1|STARTED|Period 1 (Randomized Set)||51
7634588|NCT02267083|18797898|P1|NOT COMPLETED|Overall Study||19
7634589|NCT02267083|18797898|P1|COMPLETED|Overall Study||3
7634590|NCT02267083|18797898|P1|STARTED|Overall Study||22
7634591|NCT02266914|18797905|P1|NOT COMPLETED|Overall Study||9
7634592|NCT02266914|18797905|P1|COMPLETED|Overall Study||0
7634593|NCT02266914|18797905|P1|STARTED|Overall Study||9
7634594|NCT02266888|18797911|P4|NOT COMPLETED|Overall Study||7
7634595|NCT02266888|18797912|P3|NOT COMPLETED|Overall Study||11
7634596|NCT02266888|18797913|P2|NOT COMPLETED|Overall Study||4
7634597|NCT02266888|18797914|P1|NOT COMPLETED|Overall Study||7
7634598|NCT02266888|18797911|P4|COMPLETED|Overall Study||0
7634599|NCT02266888|18797912|P3|COMPLETED|Overall Study||0
7634600|NCT02266888|18797913|P2|COMPLETED|Overall Study||8
7634601|NCT02266888|18797914|P1|COMPLETED|Overall Study||8
7634602|NCT02266888|18797911|P4|STARTED|Overall Study||7
7634603|NCT02266888|18797912|P3|STARTED|Overall Study||11
7634604|NCT02266888|18797913|P2|STARTED|Overall Study||12
7634605|NCT02266888|18797914|P1|STARTED|Overall Study||15
7634606|NCT02266875|18797948|P2|NOT COMPLETED|Overall Study||0
7634607|NCT02266875|18797949|P1|NOT COMPLETED|Overall Study||11
7634608|NCT02266875|18797948|P2|COMPLETED|Overall Study||30
7634609|NCT02266875|18797949|P1|COMPLETED|Overall Study||29
7634610|NCT02266875|18797948|P2|STARTED|Overall Study||30
7634611|NCT02266875|18797949|P1|STARTED|Overall Study||40
7634612|NCT02266810|18797961|P2|NOT COMPLETED|Overall Study||1
7634613|NCT02266810|18797962|P1|NOT COMPLETED|Overall Study||1
7634614|NCT02266810|18797961|P2|COMPLETED|Overall Study|sinus sides|79
7634615|NCT02266810|18797962|P1|COMPLETED|Overall Study|sinus sides|79
7634616|NCT02266810|18797961|P2|STARTED|Overall Study|sinus sides|80
7634617|NCT02266810|18797962|P1|STARTED|Overall Study|sinus sides|80
7634618|NCT02266797|18797988|P2|NOT COMPLETED|Overall Study||1
7634619|NCT02266797|18797989|P1|NOT COMPLETED|Overall Study||0
7634620|NCT02266797|18797988|P2|COMPLETED|Overall Study||2
7634621|NCT02266797|18797989|P1|COMPLETED|Overall Study||1
7634622|NCT02266797|18797988|P2|STARTED|Overall Study||3
7634623|NCT02266797|18797989|P1|STARTED|Overall Study||1
7634624|NCT02266706|18798014|P9|NOT COMPLETED|Overall Study||0
7634625|NCT02266706|18798015|P8|NOT COMPLETED|Overall Study||0
7634626|NCT02266706|18798016|P7|NOT COMPLETED|Overall Study||1
7634627|NCT02266706|18798017|P6|NOT COMPLETED|Overall Study||2
7634628|NCT02266706|18798018|P5|NOT COMPLETED|Overall Study||0
7634629|NCT02266706|18798019|P4|NOT COMPLETED|Overall Study||1
7634630|NCT02266706|18798020|P3|NOT COMPLETED|Overall Study||1
7634631|NCT02266706|18798021|P2|NOT COMPLETED|Overall Study||1
7634632|NCT02266706|18798022|P1|NOT COMPLETED|Overall Study||0
7634633|NCT02266706|18798014|P9|COMPLETED|Overall Study||4
7634634|NCT02266706|18798015|P8|COMPLETED|Overall Study||2
7634635|NCT02266706|18798016|P7|COMPLETED|Overall Study||7
7634636|NCT02266706|18798017|P6|COMPLETED|Overall Study||5
7634637|NCT02266706|18798018|P5|COMPLETED|Overall Study||1
7634638|NCT02266706|18798019|P4|COMPLETED|Overall Study||3
7634639|NCT02266706|18798020|P3|COMPLETED|Overall Study||3
7634640|NCT02266706|18798021|P2|COMPLETED|Overall Study||6
7634641|NCT02266706|18798022|P1|COMPLETED|Overall Study||6
7634642|NCT02266706|18798014|P9|Treated|Overall Study||4
7634643|NCT02266706|18798015|P8|Treated|Overall Study||2
7634644|NCT02266706|18798016|P7|Treated|Overall Study||7
7634645|NCT02266706|18798017|P6|Treated|Overall Study||5
7634646|NCT02266706|18798018|P5|Treated|Overall Study||1
7634647|NCT02266706|18798019|P4|Treated|Overall Study||3
7634648|NCT02266706|18798020|P3|Treated|Overall Study||3
7634649|NCT02266706|18798021|P2|Treated|Overall Study||6
7634650|NCT02266706|18798022|P1|Treated|Overall Study||6
7634651|NCT02266706|18798014|P9|STARTED|Overall Study||4
7634652|NCT02266706|18798015|P8|STARTED|Overall Study||2
7634653|NCT02266706|18798016|P7|STARTED|Overall Study||8
7634654|NCT02266706|18798017|P6|STARTED|Overall Study||7
7634655|NCT02266706|18798018|P5|STARTED|Overall Study||1
7634656|NCT02266706|18798019|P4|STARTED|Overall Study||4
7634657|NCT02266706|18798020|P3|STARTED|Overall Study||4
7634658|NCT02266706|18798021|P2|STARTED|Overall Study||7
7634659|NCT02266706|18798022|P1|STARTED|Overall Study||6
7634660|NCT02266576|18798215|P2|NOT COMPLETED|Overall Study||15
7634661|NCT02266576|18798216|P1|NOT COMPLETED|Overall Study||17
7634662|NCT02266576|18798215|P2|COMPLETED|Overall Study||90
7634663|NCT02266576|18798216|P1|COMPLETED|Overall Study||85
7634664|NCT02266576|18798215|P2|STARTED|Overall Study||105
7634665|NCT02266576|18798216|P1|STARTED|Overall Study||102
7634666|NCT02266472|18798234|P2|NOT COMPLETED|Period 2+ Washout||0
7634667|NCT02266472|18798235|P1|NOT COMPLETED|Period 2+ Washout||0
7634668|NCT02266472|18798234|P2|COMPLETED|Period 2+ Washout||15
7634669|NCT02266472|18798235|P1|COMPLETED|Period 2+ Washout||15
7634670|NCT02266472|18798234|P2|STARTED|Period 2+ Washout||15
7634671|NCT02266472|18798235|P1|STARTED|Period 2+ Washout||15
7634672|NCT02266472|18798234|P2|NOT COMPLETED|Period 1+ Washout||0
7634673|NCT02266472|18798235|P1|NOT COMPLETED|Period 1+ Washout||0
7634674|NCT02266472|18798234|P2|COMPLETED|Period 1+ Washout||15
7634675|NCT02266472|18798235|P1|COMPLETED|Period 1+ Washout||15
7634676|NCT02266472|18798234|P2|STARTED|Period 1+ Washout||15
7634677|NCT02266472|18798235|P1|STARTED|Period 1+ Washout||15
7634678|NCT02266433|18798253|P2|NOT COMPLETED|Overall Study||53
7634679|NCT02266433|18798254|P1|NOT COMPLETED|Overall Study||59
7634680|NCT02266433|18798253|P2|COMPLETED|Overall Study||65
7634681|NCT02266433|18798254|P1|COMPLETED|Overall Study||68
7634682|NCT02266433|18798253|P2|STARTED|Overall Study||118
7634683|NCT02266433|18798254|P1|STARTED|Overall Study||127
7634684|NCT02266381|18798371|P3|NOT COMPLETED|Overall Study||4
7634685|NCT02266381|18798372|P2|NOT COMPLETED|Overall Study||5
7634686|NCT02266381|18798373|P1|NOT COMPLETED|Overall Study||3
7634687|NCT02266381|18798371|P3|COMPLETED|Overall Study||146
7634688|NCT02266381|18798372|P2|COMPLETED|Overall Study||145
7634689|NCT02266381|18798373|P1|COMPLETED|Overall Study||147
7634690|NCT02266381|18798371|P3|STARTED|Overall Study||150
7634691|NCT02266381|18798372|P2|STARTED|Overall Study||150
7634692|NCT02266381|18798373|P1|STARTED|Overall Study||150
7634693|NCT02266277|18798396|P6|NOT COMPLETED|Overall Study||0
7634694|NCT02266277|18798397|P5|NOT COMPLETED|Overall Study||0
7634695|NCT02266277|18798398|P4|NOT COMPLETED|Overall Study||0
7634696|NCT02266277|18798399|P3|NOT COMPLETED|Overall Study||0
7634697|NCT02266277|18798400|P2|NOT COMPLETED|Overall Study||0
7634698|NCT02266277|18798401|P1|NOT COMPLETED|Overall Study||0
7634699|NCT02266277|18798396|P6|COMPLETED|Overall Study||5000
7634700|NCT02266277|18798397|P5|COMPLETED|Overall Study||5000
7634701|NCT02266277|18798398|P4|COMPLETED|Overall Study||5000
7634702|NCT02266277|18798399|P3|COMPLETED|Overall Study||5000
7634703|NCT02266277|18798400|P2|COMPLETED|Overall Study||5000
7634704|NCT02266277|18798401|P1|COMPLETED|Overall Study||5000
7634705|NCT02266277|18798396|P6|STARTED|Overall Study||5000
7634706|NCT02266277|18798397|P5|STARTED|Overall Study||5000
7634707|NCT02266277|18798398|P4|STARTED|Overall Study||5000
7634708|NCT02266277|18798399|P3|STARTED|Overall Study||5000
7634709|NCT02266277|18798400|P2|STARTED|Overall Study||5000
7634710|NCT02266277|18798401|P1|STARTED|Overall Study||5000
7634711|NCT02266225|18798423|P1|NOT COMPLETED|Overall Study||16
7634712|NCT02266225|18798423|P1|COMPLETED|Overall Study||32
7634713|NCT02266225|18798423|P1|Enrolled in Intervention|Overall Study||44
7634714|NCT02266225|18798423|P1|STARTED|Overall Study||48
7634715|NCT02266147|18798448|P4|NOT COMPLETED|PART 2: Dose Expansion||9
7634716|NCT02266147|18798449|P3|NOT COMPLETED|PART 2: Dose Expansion||0
7634717|NCT02266147|18798450|P2|NOT COMPLETED|PART 2: Dose Expansion||0
7634718|NCT02266147|18798451|P1|NOT COMPLETED|PART 2: Dose Expansion||7
7634719|NCT02266147|18798448|P4|COMPLETED|PART 2: Dose Expansion||0
7634720|NCT02266147|18798449|P3|COMPLETED|PART 2: Dose Expansion||0
7634721|NCT02266147|18798450|P2|COMPLETED|PART 2: Dose Expansion||0
7634722|NCT02266147|18798451|P1|COMPLETED|PART 2: Dose Expansion||0
7634723|NCT02266147|18798448|P4|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|9
7634724|NCT02266147|18798449|P3|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
7634725|NCT02266147|18798450|P2|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
7634726|NCT02266147|18798451|P1|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|7
7634727|NCT02266147|18798448|P4|NOT COMPLETED|PART 1: Dose Escalation||4
7634728|NCT02266147|18798449|P3|NOT COMPLETED|PART 1: Dose Escalation||3
7634729|NCT02266147|18798450|P2|NOT COMPLETED|PART 1: Dose Escalation||3
7634730|NCT02266147|18798451|P1|NOT COMPLETED|PART 1: Dose Escalation||1
7634731|NCT02266147|18798448|P4|COMPLETED|PART 1: Dose Escalation||0
7634732|NCT02266147|18798449|P3|COMPLETED|PART 1: Dose Escalation||0
7634733|NCT02266147|18798450|P2|COMPLETED|PART 1: Dose Escalation||0
7634734|NCT02266147|18798451|P1|COMPLETED|PART 1: Dose Escalation||2
7634735|NCT02266147|18798448|P4|STARTED|PART 1: Dose Escalation||4
7634736|NCT02266147|18798449|P3|STARTED|PART 1: Dose Escalation||3
7634737|NCT02266147|18798450|P2|STARTED|PART 1: Dose Escalation||3
7634738|NCT02266147|18798451|P1|STARTED|PART 1: Dose Escalation||3
7634739|NCT02266108|18798483|P2|NOT COMPLETED|Overall Study||0
7634740|NCT02266108|18798484|P1|NOT COMPLETED|Overall Study||0
7634741|NCT02266108|18798483|P2|COMPLETED|Overall Study||71
7634742|NCT02266108|18798484|P1|COMPLETED|Overall Study||80
7634743|NCT02266108|18798483|P2|STARTED|Overall Study||71
7634744|NCT02266108|18798484|P1|STARTED|Overall Study||80
7634745|NCT02266004|18798494|P1|NOT COMPLETED|Overall Study||2
7634746|NCT02266004|18798494|P1|COMPLETED|Overall Study||7
7634747|NCT02266004|18798494|P1|STARTED|Overall Study||9
7634748|NCT02265965|18798511|P2|NOT COMPLETED|Overall Study||0
7634749|NCT02265965|18798512|P1|NOT COMPLETED|Overall Study||0
7634750|NCT02265965|18798511|P2|COMPLETED|Overall Study||11
7634751|NCT02265965|18798512|P1|COMPLETED|Overall Study||7
7634752|NCT02265965|18798511|P2|STARTED|Overall Study||11
7634753|NCT02265965|18798512|P1|STARTED|Overall Study||7
7634754|NCT02265952|18798532|P2|NOT COMPLETED|Open Label Extension (OLE) Period||8
7634755|NCT02265952|18798533|P1|NOT COMPLETED|Open Label Extension (OLE) Period||0
7634756|NCT02265952|18798532|P2|COMPLETED|Open Label Extension (OLE) Period||0
7634757|NCT02265952|18798533|P1|COMPLETED|Open Label Extension (OLE) Period||0
7634758|NCT02265952|18798532|P2|STARTED|Open Label Extension (OLE) Period||8
7634759|NCT02265952|18798533|P1|STARTED|Open Label Extension (OLE) Period||0
7634760|NCT02265952|18798532|P2|NOT COMPLETED|Main Study Period||0
7634761|NCT02265952|18798533|P1|NOT COMPLETED|Main Study Period||0
7634762|NCT02265952|18798532|P2|COMPLETED|Main Study Period||0
7634763|NCT02265952|18798533|P1|COMPLETED|Main Study Period||9
7634764|NCT02265952|18798532|P2|STARTED|Main Study Period||0
7634765|NCT02265952|18798533|P1|STARTED|Main Study Period||9
7634766|NCT02265848|18798561|P2|NOT COMPLETED|Overall Study||0
7634767|NCT02265848|18798562|P1|NOT COMPLETED|Overall Study||0
7634768|NCT02265848|18798561|P2|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11
7634769|NCT02265848|18798562|P1|COMPLETED|Overall Study||11
7634770|NCT02265848|18798561|P2|STARTED|Overall Study||11
7634771|NCT02265848|18798562|P1|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11
7634772|NCT02265796|18798576|P2|NOT COMPLETED|Overall Study||1
7634773|NCT02265796|18798577|P1|NOT COMPLETED|Overall Study||3
7634774|NCT02265796|18798576|P2|COMPLETED|Overall Study||24
7634775|NCT02265796|18798577|P1|COMPLETED|Overall Study||22
7634776|NCT02265796|18798576|P2|STARTED|Overall Study||25
7634777|NCT02265796|18798577|P1|STARTED|Overall Study||25
7634778|NCT02265783|18798587|P1|NOT COMPLETED|Overall Study||0
7634779|NCT02265783|18798587|P1|COMPLETED|Overall Study|All subjects completed, one excluded from the analysis due to an issue with the data collection|20
7634780|NCT02265783|18798587|P1|STARTED|Overall Study||20
7634781|NCT02265744|18798596|P5|NOT COMPLETED|Overall Study||13
7634782|NCT02265744|18798597|P4|NOT COMPLETED|Overall Study||23
7634783|NCT02265744|18798598|P3|NOT COMPLETED|Overall Study||17
7634784|NCT02265744|18798599|P2|NOT COMPLETED|Overall Study||15
7634785|NCT02265744|18798600|P1|NOT COMPLETED|Overall Study||20
7634786|NCT02265744|18798596|P5|COMPLETED|Overall Study||58
7634787|NCT02265744|18798597|P4|COMPLETED|Overall Study||47
7634788|NCT02265744|18798598|P3|COMPLETED|Overall Study||51
7634789|NCT02265744|18798599|P2|COMPLETED|Overall Study||53
7634790|NCT02265744|18798600|P1|COMPLETED|Overall Study||49
7634791|NCT02265744|18798596|P5|STARTED|Overall Study||71
7634792|NCT02265744|18798597|P4|STARTED|Overall Study||70
7634793|NCT02265744|18798598|P3|STARTED|Overall Study||68
7634794|NCT02265744|18798599|P2|STARTED|Overall Study||68
7634795|NCT02265744|18798600|P1|STARTED|Overall Study||69
7634796|NCT02265705|18798779|P7|NOT COMPLETED|Follow-up Period||11
7634797|NCT02265705|18798780|P6|NOT COMPLETED|Follow-up Period||1
7634798|NCT02265705|18798781|P5|NOT COMPLETED|Follow-up Period||0
7634799|NCT02265705|18798782|P4|NOT COMPLETED|Follow-up Period||0
7634800|NCT02265705|18798783|P3|NOT COMPLETED|Follow-up Period||0
7634801|NCT02265705|18798784|P2|NOT COMPLETED|Follow-up Period||0
7634802|NCT02265705|18798785|P1|NOT COMPLETED|Follow-up Period||0
7634803|NCT02265705|18798779|P7|COMPLETED|Follow-up Period||47
7634804|NCT02265705|18798780|P6|COMPLETED|Follow-up Period||1
7634805|NCT02265705|18798781|P5|COMPLETED|Follow-up Period||0
7634806|NCT02265705|18798782|P4|COMPLETED|Follow-up Period||0
7634807|NCT02265705|18798783|P3|COMPLETED|Follow-up Period||0
7634808|NCT02265705|18798784|P2|COMPLETED|Follow-up Period||0
7634809|NCT02265705|18798785|P1|COMPLETED|Follow-up Period||0
7634810|NCT02265705|18798779|P7|STARTED|Follow-up Period|Participants who ever took baricitinib and entered the post-treatment follow-up period.|58
7634811|NCT02265705|18798780|P6|STARTED|Follow-up Period|Participants from placebo who never rescued or switched and entered post-treatment follow-up period.|2
7634812|NCT02265705|18798781|P5|STARTED|Follow-up Period||0
7634813|NCT02265705|18798782|P4|STARTED|Follow-up Period||0
7634814|NCT02265705|18798783|P3|STARTED|Follow-up Period||0
7634815|NCT02265705|18798784|P2|STARTED|Follow-up Period||0
7634816|NCT02265705|18798785|P1|STARTED|Follow-up Period||0
7634817|NCT02265705|18798779|P7|NOT COMPLETED|Open Label Period||0
7634818|NCT02265705|18798780|P6|NOT COMPLETED|Open Label Period||0
7634819|NCT02265705|18798781|P5|NOT COMPLETED|Open Label Period||5
7634820|NCT02265705|18798782|P4|NOT COMPLETED|Open Label Period||2
7634821|NCT02265705|18798783|P3|NOT COMPLETED|Open Label Period||0
7634822|NCT02265705|18798784|P2|NOT COMPLETED|Open Label Period||0
7634823|NCT02265705|18798785|P1|NOT COMPLETED|Open Label Period||0
7634824|NCT02265705|18798779|P7|COMPLETED|Open Label Period||0
7634825|NCT02265705|18798780|P6|COMPLETED|Open Label Period||0
7634826|NCT02265705|18798781|P5|COMPLETED|Open Label Period||115
7634827|NCT02265705|18798782|P4|COMPLETED|Open Label Period||72
7634828|NCT02265705|18798783|P3|COMPLETED|Open Label Period||0
7634829|NCT02265705|18798784|P2|COMPLETED|Open Label Period||0
7634830|NCT02265705|18798785|P1|COMPLETED|Open Label Period||0
7634831|NCT02265705|18798779|P7|STARTED|Open Label Period||0
7634832|NCT02265705|18798780|P6|STARTED|Open Label Period||0
7634833|NCT02265705|18798781|P5|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|120
7634834|NCT02265705|18798782|P4|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|74
7634835|NCT02265705|18798783|P3|STARTED|Open Label Period||0
7634836|NCT02265705|18798784|P2|STARTED|Open Label Period||0
7634837|NCT02265705|18798785|P1|STARTED|Open Label Period||0
7634838|NCT02265705|18798779|P7|NOT COMPLETED|Rescue Period||0
7634839|NCT02265705|18798780|P6|NOT COMPLETED|Rescue Period||0
7634840|NCT02265705|18798781|P5|NOT COMPLETED|Rescue Period||0
7634841|NCT02265705|18798782|P4|NOT COMPLETED|Rescue Period||0
7634842|NCT02265705|18798783|P3|NOT COMPLETED|Rescue Period||3
7634843|NCT02265705|18798784|P2|NOT COMPLETED|Rescue Period||0
7634844|NCT02265705|18798785|P1|NOT COMPLETED|Rescue Period||0
7634845|NCT02265705|18798779|P7|COMPLETED|Rescue Period||0
7634846|NCT02265705|18798780|P6|COMPLETED|Rescue Period||0
7634847|NCT02265705|18798781|P5|COMPLETED|Rescue Period||0
7634848|NCT02265705|18798782|P4|COMPLETED|Rescue Period||0
7634849|NCT02265705|18798783|P3|COMPLETED|Rescue Period||74
7634850|NCT02265705|18798784|P2|COMPLETED|Rescue Period||0
7634851|NCT02265705|18798785|P1|COMPLETED|Rescue Period||0
7634852|NCT02265705|18798779|P7|STARTED|Rescue Period||0
7634853|NCT02265705|18798780|P6|STARTED|Rescue Period||0
7634854|NCT02265705|18798781|P5|STARTED|Rescue Period||0
7634855|NCT02265705|18798782|P4|STARTED|Rescue Period||0
7634856|NCT02265705|18798783|P3|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|77
7634857|NCT02265705|18798784|P2|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
7634858|NCT02265705|18798785|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
7634859|NCT02265705|18798779|P7|NOT COMPLETED|Treatment Period Week 0-24||0
7634860|NCT02265705|18798780|P6|NOT COMPLETED|Treatment Period Week 0-24||0
7634861|NCT02265705|18798781|P5|NOT COMPLETED|Treatment Period Week 0-24||0
7634862|NCT02265705|18798782|P4|NOT COMPLETED|Treatment Period Week 0-24||0
7634863|NCT02265705|18798783|P3|NOT COMPLETED|Treatment Period Week 0-24||0
7634864|NCT02265705|18798784|P2|NOT COMPLETED|Treatment Period Week 0-24||9
7634865|NCT02265705|18798785|P1|NOT COMPLETED|Treatment Period Week 0-24||12
7634866|NCT02265705|18798779|P7|COMPLETED|Treatment Period Week 0-24||0
7634867|NCT02265705|18798780|P6|COMPLETED|Treatment Period Week 0-24||0
7634868|NCT02265705|18798781|P5|COMPLETED|Treatment Period Week 0-24||0
7634869|NCT02265705|18798782|P4|COMPLETED|Treatment Period Week 0-24||0
7634870|NCT02265705|18798783|P3|COMPLETED|Treatment Period Week 0-24||0
7634871|NCT02265705|18798784|P2|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|136
7634872|NCT02265705|18798785|P1|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|133
7634873|NCT02265705|18798779|P7|Rescued|Treatment Period Week 0-24||0
7634874|NCT02265705|18798780|P6|Rescued|Treatment Period Week 0-24||0
7634875|NCT02265705|18798781|P5|Rescued|Treatment Period Week 0-24||0
7634876|NCT02265705|18798782|P4|Rescued|Treatment Period Week 0-24||0
7634877|NCT02265705|18798783|P3|Rescued|Treatment Period Week 0-24||0
7634878|NCT02265705|18798784|P2|Rescued|Treatment Period Week 0-24||17
7634879|NCT02265705|18798785|P1|Rescued|Treatment Period Week 0-24||59
7634880|NCT02265705|18798779|P7|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
7634881|NCT02265705|18798780|P6|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
7634882|NCT02265705|18798781|P5|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
7634883|NCT02265705|18798782|P4|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
7634972|NCT02264821|18798970|P3|STARTED|Overall Study|Double Blind|64
7634884|NCT02265705|18798783|P3|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
7634885|NCT02265705|18798784|P2|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
7634886|NCT02265705|18798785|P1|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
7634887|NCT02265705|18798779|P7|STARTED|Treatment Period Week 0-24||0
7634888|NCT02265705|18798780|P6|STARTED|Treatment Period Week 0-24||0
7634889|NCT02265705|18798781|P5|STARTED|Treatment Period Week 0-24||0
7634890|NCT02265705|18798782|P4|STARTED|Treatment Period Week 0-24||0
7634891|NCT02265705|18798783|P3|STARTED|Treatment Period Week 0-24||0
7634892|NCT02265705|18798784|P2|STARTED|Treatment Period Week 0-24||145
7634893|NCT02265705|18798785|P1|STARTED|Treatment Period Week 0-24||145
7634894|NCT02265510|18798824|P14|NOT COMPLETED|Overall Study||10
7634895|NCT02265510|18798825|P13|NOT COMPLETED|Overall Study||9
7634896|NCT02265510|18798826|P12|NOT COMPLETED|Overall Study||16
7634897|NCT02265510|18798827|P11|NOT COMPLETED|Overall Study||5
7634898|NCT02265510|18798828|P10|NOT COMPLETED|Overall Study||7
7634899|NCT02265510|18798829|P9|NOT COMPLETED|Overall Study||4
7634900|NCT02265510|18798830|P8|NOT COMPLETED|Overall Study||4
7634901|NCT02265510|18798831|P7|NOT COMPLETED|Overall Study||3
7634902|NCT02265510|18798832|P6|NOT COMPLETED|Overall Study||6
7634903|NCT02265510|18798833|P5|NOT COMPLETED|Overall Study||3
7634904|NCT02265510|18798834|P4|NOT COMPLETED|Overall Study||4
7634905|NCT02265510|18798835|P3|NOT COMPLETED|Overall Study||6
7634906|NCT02265510|18798836|P2|NOT COMPLETED|Overall Study||3
7634907|NCT02265510|18798837|P1|NOT COMPLETED|Overall Study||3
7634908|NCT02265510|18798824|P14|COMPLETED|Overall Study||0
7634909|NCT02265510|18798825|P13|COMPLETED|Overall Study||0
7634910|NCT02265510|18798826|P12|COMPLETED|Overall Study||0
7634911|NCT02265510|18798827|P11|COMPLETED|Overall Study||0
7634912|NCT02265510|18798828|P10|COMPLETED|Overall Study||0
7634913|NCT02265510|18798829|P9|COMPLETED|Overall Study||0
7634914|NCT02265510|18798830|P8|COMPLETED|Overall Study||0
7634915|NCT02265510|18798831|P7|COMPLETED|Overall Study||0
7634916|NCT02265510|18798832|P6|COMPLETED|Overall Study||0
7634917|NCT02265510|18798833|P5|COMPLETED|Overall Study||0
7634918|NCT02265510|18798834|P4|COMPLETED|Overall Study||0
7634919|NCT02265510|18798835|P3|COMPLETED|Overall Study||0
7634920|NCT02265510|18798836|P2|COMPLETED|Overall Study||0
7634921|NCT02265510|18798837|P1|COMPLETED|Overall Study||0
7634922|NCT02265510|18798824|P14|STARTED|Overall Study||10
7634923|NCT02265510|18798825|P13|STARTED|Overall Study||9
7634924|NCT02265510|18798826|P12|STARTED|Overall Study||16
7634925|NCT02265510|18798827|P11|STARTED|Overall Study||5
7634926|NCT02265510|18798828|P10|STARTED|Overall Study||7
7634927|NCT02265510|18798829|P9|STARTED|Overall Study||4
7634928|NCT02265510|18798830|P8|STARTED|Overall Study||4
7634929|NCT02265510|18798831|P7|STARTED|Overall Study||3
7634930|NCT02265510|18798832|P6|STARTED|Overall Study||6
7634931|NCT02265510|18798833|P5|STARTED|Overall Study||3
7634932|NCT02265510|18798834|P4|STARTED|Overall Study||4
7634933|NCT02265510|18798835|P3|STARTED|Overall Study||6
7634934|NCT02265510|18798836|P2|STARTED|Overall Study||3
7634935|NCT02265510|18798837|P1|STARTED|Overall Study||3
7634936|NCT02265341|18798925|P1|NOT COMPLETED|Overall Study||0
7634937|NCT02265341|18798925|P1|COMPLETED|Overall Study||12
7634938|NCT02265341|18798925|P1|STARTED|Overall Study||12
7634939|NCT02265237|18798937|P4|NOT COMPLETED|As Treated (Overall Study)||1
7634940|NCT02265237|18798938|P3|NOT COMPLETED|As Treated (Overall Study)||10
7634941|NCT02265237|18798939|P2|NOT COMPLETED|As Treated (Overall Study)||3
7634942|NCT02265237|18798940|P1|NOT COMPLETED|As Treated (Overall Study)||5
7634943|NCT02265237|18798937|P4|COMPLETED|As Treated (Overall Study)||2
7634944|NCT02265237|18798938|P3|COMPLETED|As Treated (Overall Study)||51
7634945|NCT02265237|18798939|P2|COMPLETED|As Treated (Overall Study)||57
7634946|NCT02265237|18798940|P1|COMPLETED|As Treated (Overall Study)||55
7634947|NCT02265237|18798937|P4|STARTED|As Treated (Overall Study)||3
7634948|NCT02265237|18798938|P3|STARTED|As Treated (Overall Study)||61
7634949|NCT02265237|18798939|P2|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
7634950|NCT02265237|18798940|P1|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
7634951|NCT02265237|18798937|P4|NOT COMPLETED|As Enrolled (Overall Study)||1
7634952|NCT02265237|18798938|P3|NOT COMPLETED|As Enrolled (Overall Study)||10
7634953|NCT02265237|18798939|P2|NOT COMPLETED|As Enrolled (Overall Study)||3
7634954|NCT02265237|18798940|P1|NOT COMPLETED|As Enrolled (Overall Study)||5
7634955|NCT02265237|18798937|P4|COMPLETED|As Enrolled (Overall Study)||2
7634956|NCT02265237|18798938|P3|COMPLETED|As Enrolled (Overall Study)||51
7634957|NCT02265237|18798939|P2|COMPLETED|As Enrolled (Overall Study)||58
7634958|NCT02265237|18798940|P1|COMPLETED|As Enrolled (Overall Study)||54
7634959|NCT02265237|18798937|P4|STARTED|As Enrolled (Overall Study)||3
7634960|NCT02265237|18798938|P3|STARTED|As Enrolled (Overall Study)||61
7634961|NCT02265237|18798939|P2|STARTED|As Enrolled (Overall Study)||61
7634962|NCT02265237|18798940|P1|STARTED|As Enrolled (Overall Study)||59
7634963|NCT02264977|18798959|P1|NOT COMPLETED|Overall Study||5
7634964|NCT02264977|18798959|P1|COMPLETED|Overall Study||4
7634965|NCT02264977|18798959|P1|STARTED|Overall Study||9
7634966|NCT02264821|18798970|P3|NOT COMPLETED|Overall Study||6
7634967|NCT02264821|18798971|P2|NOT COMPLETED|Overall Study||3
7634968|NCT02264821|18798972|P1|NOT COMPLETED|Overall Study||1
7634969|NCT02264821|18798970|P3|COMPLETED|Overall Study||58
7634970|NCT02264821|18798971|P2|COMPLETED|Overall Study||61
7634971|NCT02264821|18798972|P1|COMPLETED|Overall Study||63
7634973|NCT02264821|18798971|P2|STARTED|Overall Study|Double Blind|64
7634974|NCT02264821|18798972|P1|STARTED|Overall Study|Double Blind|64
7634975|NCT02264574|18798985|P2|NOT COMPLETED|Overall Study||30
7634976|NCT02264574|18798986|P1|NOT COMPLETED|Overall Study||29
7634977|NCT02264574|18798985|P2|COMPLETED|Overall Study||86
7634978|NCT02264574|18798986|P1|COMPLETED|Overall Study||84
7634979|NCT02264574|18798985|P2|STARTED|Overall Study||116
7634980|NCT02264574|18798986|P1|STARTED|Overall Study||113
7634981|NCT02264353|18799022|P2|NOT COMPLETED|Overall Study||0
7634982|NCT02264353|18799023|P1|NOT COMPLETED|Overall Study||3
7634983|NCT02264353|18799022|P2|COMPLETED|Overall Study||24
7634984|NCT02264353|18799023|P1|COMPLETED|Overall Study||17
7634985|NCT02264353|18799022|P2|STARTED|Overall Study||24
7634986|NCT02264353|18799023|P1|STARTED|Overall Study||20
7634987|NCT02264249|18799036|P3|NOT COMPLETED|Overall Study||0
7634988|NCT02264249|18799037|P2|NOT COMPLETED|Overall Study||0
7634989|NCT02264249|18799038|P1|NOT COMPLETED|Overall Study||0
7634990|NCT02264249|18799036|P3|COMPLETED|Overall Study||241
7634991|NCT02264249|18799037|P2|COMPLETED|Overall Study||187
7634992|NCT02264249|18799038|P1|COMPLETED|Overall Study||21
7634993|NCT02264249|18799036|P3|STARTED|Overall Study||241
7634994|NCT02264249|18799037|P2|STARTED|Overall Study||187
7634995|NCT02264249|18799038|P1|STARTED|Overall Study||21
7634996|NCT02263911|18799052|P4|NOT COMPLETED|Period 5||0
7634997|NCT02263911|18799053|P3|NOT COMPLETED|Period 5||0
7634998|NCT02263911|18799054|P2|NOT COMPLETED|Period 5||0
7634999|NCT02263911|18799055|P1|NOT COMPLETED|Period 5||0
7635000|NCT02263911|18799052|P4|COMPLETED|Period 5||4
7635001|NCT02263911|18799053|P3|COMPLETED|Period 5||4
7635002|NCT02263911|18799054|P2|COMPLETED|Period 5||4
7635003|NCT02263911|18799055|P1|COMPLETED|Period 5||4
7635004|NCT02263911|18799052|P4|STARTED|Period 5||4
7635005|NCT02263911|18799053|P3|STARTED|Period 5||4
7635006|NCT02263911|18799054|P2|STARTED|Period 5||4
7635007|NCT02263911|18799055|P1|STARTED|Period 5||4
7635008|NCT02263911|18799052|P4|NOT COMPLETED|Period 4 Washout||0
7635009|NCT02263911|18799053|P3|NOT COMPLETED|Period 4 Washout||0
7635010|NCT02263911|18799054|P2|NOT COMPLETED|Period 4 Washout||0
7635011|NCT02263911|18799055|P1|NOT COMPLETED|Period 4 Washout||0
7635012|NCT02263911|18799052|P4|COMPLETED|Period 4 Washout||4
7635013|NCT02263911|18799053|P3|COMPLETED|Period 4 Washout||4
7635014|NCT02263911|18799054|P2|COMPLETED|Period 4 Washout||4
7635015|NCT02263911|18799055|P1|COMPLETED|Period 4 Washout||4
7635016|NCT02263911|18799052|P4|STARTED|Period 4 Washout||4
7635017|NCT02263911|18799053|P3|STARTED|Period 4 Washout||4
7635018|NCT02263911|18799054|P2|STARTED|Period 4 Washout||4
7635019|NCT02263911|18799055|P1|STARTED|Period 4 Washout||4
7635020|NCT02263911|18799052|P4|NOT COMPLETED|Period 4||0
7635021|NCT02263911|18799053|P3|NOT COMPLETED|Period 4||0
7635022|NCT02263911|18799054|P2|NOT COMPLETED|Period 4||0
7635023|NCT02263911|18799055|P1|NOT COMPLETED|Period 4||0
7635024|NCT02263911|18799052|P4|COMPLETED|Period 4||4
7635025|NCT02263911|18799053|P3|COMPLETED|Period 4||4
7635026|NCT02263911|18799054|P2|COMPLETED|Period 4||4
7635027|NCT02263911|18799055|P1|COMPLETED|Period 4||4
7635028|NCT02263911|18799052|P4|STARTED|Period 4||4
7635029|NCT02263911|18799053|P3|STARTED|Period 4||4
7635030|NCT02263911|18799054|P2|STARTED|Period 4||4
7635031|NCT02263911|18799055|P1|STARTED|Period 4||4
7635032|NCT02263911|18799052|P4|NOT COMPLETED|Period 3 Washout||0
7635033|NCT02263911|18799053|P3|NOT COMPLETED|Period 3 Washout||0
7635034|NCT02263911|18799054|P2|NOT COMPLETED|Period 3 Washout||0
7635035|NCT02263911|18799055|P1|NOT COMPLETED|Period 3 Washout||0
7635036|NCT02263911|18799052|P4|COMPLETED|Period 3 Washout||4
7635037|NCT02263911|18799053|P3|COMPLETED|Period 3 Washout||4
7635038|NCT02263911|18799054|P2|COMPLETED|Period 3 Washout||4
7635039|NCT02263911|18799055|P1|COMPLETED|Period 3 Washout||4
7635040|NCT02263911|18799052|P4|STARTED|Period 3 Washout||4
7635041|NCT02263911|18799053|P3|STARTED|Period 3 Washout||4
7635042|NCT02263911|18799054|P2|STARTED|Period 3 Washout||4
7635043|NCT02263911|18799055|P1|STARTED|Period 3 Washout||4
7635044|NCT02263911|18799052|P4|NOT COMPLETED|Period 3||0
7635045|NCT02263911|18799053|P3|NOT COMPLETED|Period 3||0
7635046|NCT02263911|18799054|P2|NOT COMPLETED|Period 3||0
7635047|NCT02263911|18799055|P1|NOT COMPLETED|Period 3||0
7635048|NCT02263911|18799052|P4|COMPLETED|Period 3||4
7635049|NCT02263911|18799053|P3|COMPLETED|Period 3||4
7635050|NCT02263911|18799054|P2|COMPLETED|Period 3||4
7635051|NCT02263911|18799055|P1|COMPLETED|Period 3||4
7635052|NCT02263911|18799052|P4|STARTED|Period 3||4
7635053|NCT02263911|18799053|P3|STARTED|Period 3||4
7635054|NCT02263911|18799054|P2|STARTED|Period 3||4
7635055|NCT02263911|18799055|P1|STARTED|Period 3||4
7635056|NCT02263911|18799052|P4|NOT COMPLETED|Period 2 Washout||0
7635057|NCT02263911|18799053|P3|NOT COMPLETED|Period 2 Washout||0
7635058|NCT02263911|18799054|P2|NOT COMPLETED|Period 2 Washout||0
7635059|NCT02263911|18799055|P1|NOT COMPLETED|Period 2 Washout||0
7635060|NCT02263911|18799052|P4|COMPLETED|Period 2 Washout||4
7635061|NCT02263911|18799053|P3|COMPLETED|Period 2 Washout||4
7635062|NCT02263911|18799054|P2|COMPLETED|Period 2 Washout||4
7635063|NCT02263911|18799055|P1|COMPLETED|Period 2 Washout||4
7635064|NCT02263911|18799052|P4|STARTED|Period 2 Washout||4
7635065|NCT02263911|18799053|P3|STARTED|Period 2 Washout||4
7635066|NCT02263911|18799054|P2|STARTED|Period 2 Washout||4
7635067|NCT02263911|18799055|P1|STARTED|Period 2 Washout||4
7635068|NCT02263911|18799052|P4|NOT COMPLETED|Period 2||0
7635069|NCT02263911|18799053|P3|NOT COMPLETED|Period 2||0
7635070|NCT02263911|18799054|P2|NOT COMPLETED|Period 2||0
7635071|NCT02263911|18799055|P1|NOT COMPLETED|Period 2||0
7635072|NCT02263911|18799052|P4|COMPLETED|Period 2||4
7635073|NCT02263911|18799053|P3|COMPLETED|Period 2||4
7635074|NCT02263911|18799054|P2|COMPLETED|Period 2||4
7635075|NCT02263911|18799055|P1|COMPLETED|Period 2||4
7635076|NCT02263911|18799052|P4|STARTED|Period 2||4
7635077|NCT02263911|18799053|P3|STARTED|Period 2||4
7635078|NCT02263911|18799054|P2|STARTED|Period 2||4
7635079|NCT02263911|18799055|P1|STARTED|Period 2||4
7635080|NCT02263911|18799052|P4|NOT COMPLETED|Period 1 Washout||0
7635081|NCT02263911|18799053|P3|NOT COMPLETED|Period 1 Washout||0
7635082|NCT02263911|18799054|P2|NOT COMPLETED|Period 1 Washout||0
7635083|NCT02263911|18799055|P1|NOT COMPLETED|Period 1 Washout||0
7635084|NCT02263911|18799052|P4|COMPLETED|Period 1 Washout||4
7635085|NCT02263911|18799053|P3|COMPLETED|Period 1 Washout||4
7635086|NCT02263911|18799054|P2|COMPLETED|Period 1 Washout||4
7635087|NCT02263911|18799055|P1|COMPLETED|Period 1 Washout||4
7635088|NCT02263911|18799052|P4|STARTED|Period 1 Washout||4
7635089|NCT02263911|18799053|P3|STARTED|Period 1 Washout||4
7635090|NCT02263911|18799054|P2|STARTED|Period 1 Washout||4
7635091|NCT02263911|18799055|P1|STARTED|Period 1 Washout||4
7635092|NCT02263911|18799052|P4|NOT COMPLETED|Period 1||0
7635093|NCT02263911|18799053|P3|NOT COMPLETED|Period 1||0
7635094|NCT02263911|18799054|P2|NOT COMPLETED|Period 1||0
7635095|NCT02263911|18799055|P1|NOT COMPLETED|Period 1||0
7635096|NCT02263911|18799052|P4|COMPLETED|Period 1||4
7635097|NCT02263911|18799053|P3|COMPLETED|Period 1||4
7635098|NCT02263911|18799054|P2|COMPLETED|Period 1||4
7635099|NCT02263911|18799055|P1|COMPLETED|Period 1||4
7635100|NCT02263911|18799052|P4|STARTED|Period 1||4
7635101|NCT02263911|18799053|P3|STARTED|Period 1||4
7635102|NCT02263911|18799054|P2|STARTED|Period 1||4
7635103|NCT02263911|18799055|P1|STARTED|Period 1||4
7635104|NCT02263833|18799077|P1|NOT COMPLETED|Overall Study||0
7635105|NCT02263833|18799077|P1|COMPLETED|Overall Study||742
7635106|NCT02263833|18799077|P1|STARTED|Overall Study||742
7635107|NCT02263547|18799082|P1|NOT COMPLETED|Overall Study||3
7635108|NCT02263547|18799082|P1|COMPLETED|Overall Study||11
7635109|NCT02263547|18799082|P1|STARTED|Overall Study||14
7635110|NCT02263365|18799089|P2|NOT COMPLETED|Overall Study||18
7635111|NCT02263365|18799090|P1|NOT COMPLETED|Overall Study||22
7635112|NCT02263365|18799089|P2|COMPLETED|Overall Study||0
7635113|NCT02263365|18799090|P1|COMPLETED|Overall Study||0
7635114|NCT02263365|18799089|P2|STARTED|Overall Study||18
7635115|NCT02263365|18799090|P1|STARTED|Overall Study||22
7635116|NCT02263326|18799104|P2|NOT COMPLETED|Overall Study||1
7635117|NCT02263326|18799105|P1|NOT COMPLETED|Overall Study||1
7635118|NCT02263326|18799104|P2|COMPLETED|Overall Study||44
7635119|NCT02263326|18799105|P1|COMPLETED|Overall Study||43
7635120|NCT02263326|18799104|P2|STARTED|Overall Study||45
7635121|NCT02263326|18799105|P1|STARTED|Overall Study||44
7635122|NCT02263131|18799127|P2|NOT COMPLETED|Overall Study||1
7635123|NCT02263131|18799128|P1|NOT COMPLETED|Overall Study||10
7635124|NCT02263131|18799127|P2|COMPLETED|Overall Study||68
7635125|NCT02263131|18799128|P1|COMPLETED|Overall Study||337
7635126|NCT02263131|18799127|P2|STARTED|Overall Study||69
7635127|NCT02263131|18799128|P1|STARTED|Overall Study||347
7635128|NCT02263118|18799150|P4|NOT COMPLETED|Overall Study||2
7635129|NCT02263118|18799151|P3|NOT COMPLETED|Overall Study||8
7635130|NCT02263118|18799152|P2|NOT COMPLETED|Overall Study||8
7635131|NCT02263118|18799153|P1|NOT COMPLETED|Overall Study||4
7635132|NCT02263118|18799150|P4|COMPLETED|Overall Study||12
7635133|NCT02263118|18799151|P3|COMPLETED|Overall Study||22
7635134|NCT02263118|18799152|P2|COMPLETED|Overall Study||24
7635135|NCT02263118|18799153|P1|COMPLETED|Overall Study||20
7635136|NCT02263118|18799150|P4|STARTED|Overall Study||14
7635137|NCT02263118|18799151|P3|STARTED|Overall Study||30
7635138|NCT02263118|18799152|P2|STARTED|Overall Study||32
7635139|NCT02263118|18799153|P1|STARTED|Overall Study||24
7635140|NCT02263079|18799178|P3|NOT COMPLETED|Overall Study||0
7635141|NCT02263079|18799179|P2|NOT COMPLETED|Overall Study||8
7635142|NCT02263079|18799180|P1|NOT COMPLETED|Overall Study||3
7635143|NCT02263079|18799178|P3|COMPLETED|Overall Study|Completed study but not included in the analysis|3
7635144|NCT02263079|18799179|P2|COMPLETED|Overall Study||25
7635145|NCT02263079|18799180|P1|COMPLETED|Overall Study||23
7635146|NCT02263079|18799178|P3|STARTED|Overall Study||3
7635147|NCT02263079|18799179|P2|STARTED|Overall Study||33
7635148|NCT02263079|18799180|P1|STARTED|Overall Study||26
7635149|NCT02263040|18799208|P2|NOT COMPLETED|Overall Study||0
7635150|NCT02263040|18799209|P1|NOT COMPLETED|Overall Study||0
7635151|NCT02263040|18799208|P2|COMPLETED|Overall Study||83
7635152|NCT02263040|18799209|P1|COMPLETED|Overall Study||87
7635153|NCT02263040|18799208|P2|STARTED|Overall Study||83
7635154|NCT02263040|18799209|P1|STARTED|Overall Study||87
7635155|NCT02263014|18799239|P2|NOT COMPLETED|Overall Study||0
7635156|NCT02263014|18799240|P1|NOT COMPLETED|Overall Study||0
7635157|NCT02263014|18799239|P2|COMPLETED|Overall Study||208
7635158|NCT02263014|18799240|P1|COMPLETED|Overall Study||44
7635159|NCT02263014|18799239|P2|STARTED|Overall Study||208
7635160|NCT02263014|18799240|P1|STARTED|Overall Study||44
7635161|NCT02262754|18799251|P3|NOT COMPLETED|Overall Study||9
7635162|NCT02262754|18799252|P2|NOT COMPLETED|Overall Study||9
7635163|NCT02262754|18799253|P1|NOT COMPLETED|Overall Study||16
7635164|NCT02262754|18799251|P3|COMPLETED|Overall Study||65
7635165|NCT02262754|18799252|P2|COMPLETED|Overall Study||65
7635166|NCT02262754|18799253|P1|COMPLETED|Overall Study||58
7635167|NCT02262754|18799251|P3|STARTED|Overall Study||74
7635168|NCT02262754|18799252|P2|STARTED|Overall Study||74
7635169|NCT02262754|18799253|P1|STARTED|Overall Study||74
7635170|NCT02262728|18799328|P2|NOT COMPLETED|Follow-up Phase (3 Years)||3
7635171|NCT02262728|18799329|P1|NOT COMPLETED|Follow-up Phase (3 Years)||4
7635172|NCT02262728|18799328|P2|COMPLETED|Follow-up Phase (3 Years)||18
7635173|NCT02262728|18799329|P1|COMPLETED|Follow-up Phase (3 Years)||15
7635174|NCT02262728|18799328|P2|STARTED|Follow-up Phase (3 Years)||21
7635175|NCT02262728|18799329|P1|STARTED|Follow-up Phase (3 Years)||19
7635176|NCT02262728|18799328|P2|NOT COMPLETED|Treatment Period (12 Weeks)||0
7635177|NCT02262728|18799329|P1|NOT COMPLETED|Treatment Period (12 Weeks)||0
7635178|NCT02262728|18799328|P2|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|21
7635179|NCT02262728|18799329|P1|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|19
7635180|NCT02262728|18799328|P2|STARTED|Treatment Period (12 Weeks)||21
7635181|NCT02262728|18799329|P1|STARTED|Treatment Period (12 Weeks)||19
7635182|NCT02262507|18799359|P1|NOT COMPLETED|Overall Study||0
7635183|NCT02262507|18799359|P1|COMPLETED|Overall Study||410
7635184|NCT02262507|18799359|P1|STARTED|Overall Study||410
7635185|NCT02262377|18799366|P2|NOT COMPLETED|Overall Study||6
7635186|NCT02262377|18799367|P1|NOT COMPLETED|Overall Study||12
7635187|NCT02262377|18799366|P2|COMPLETED|Overall Study||73
7635188|NCT02262377|18799367|P1|COMPLETED|Overall Study||68
7635189|NCT02262377|18799366|P2|STARTED|Overall Study||79
7635190|NCT02262377|18799367|P1|STARTED|Overall Study||80
7635191|NCT02262364|18799382|P1|NOT COMPLETED|Follow-Up Through 12 Months||0
7635192|NCT02262364|18799382|P1|COMPLETED|Follow-Up Through 12 Months||10
7635193|NCT02262364|18799382|P1|STARTED|Follow-Up Through 12 Months||10
7635194|NCT02262364|18799382|P1|NOT COMPLETED|Injection With APS||0
7635195|NCT02262364|18799382|P1|COMPLETED|Injection With APS||10
7635196|NCT02262364|18799382|P1|STARTED|Injection With APS||10
7635197|NCT02262364|18799382|P1|NOT COMPLETED|Blood Draw for Device Processing||1
7635198|NCT02262364|18799382|P1|COMPLETED|Blood Draw for Device Processing||10
7635199|NCT02262364|18799382|P1|STARTED|Blood Draw for Device Processing||11
7635200|NCT02262364|18799382|P1|NOT COMPLETED|Study Enrollment||0
7635201|NCT02262364|18799382|P1|COMPLETED|Study Enrollment||11
7635202|NCT02262364|18799382|P1|STARTED|Study Enrollment||11
7635203|NCT02262260|18799391|P2|NOT COMPLETED|Overall Study||10
7635204|NCT02262260|18799392|P1|NOT COMPLETED|Overall Study||11
7635205|NCT02262260|18799391|P2|COMPLETED|Overall Study||32
7635206|NCT02262260|18799392|P1|COMPLETED|Overall Study||34
7635207|NCT02262260|18799391|P2|STARTED|Overall Study||42
7635208|NCT02262260|18799392|P1|STARTED|Overall Study||45
7635209|NCT02262130|18799410|P1|NOT COMPLETED|Overall Study||0
7635210|NCT02262130|18799410|P1|COMPLETED|Overall Study||10
7635211|NCT02262130|18799410|P1|STARTED|Overall Study||10
7635212|NCT02262078|18799420|P2|NOT COMPLETED|Overall Study||0
7635213|NCT02262078|18799421|P1|NOT COMPLETED|Overall Study||0
7635214|NCT02262078|18799420|P2|COMPLETED|Overall Study||13
7635215|NCT02262078|18799421|P1|COMPLETED|Overall Study||13
7635216|NCT02262078|18799420|P2|STARTED|Overall Study||13
7635217|NCT02262078|18799421|P1|STARTED|Overall Study||13
7635218|NCT02262039|18799429|P2|NOT COMPLETED|Overall Study||0
7635219|NCT02262039|18799430|P1|NOT COMPLETED|Overall Study||0
7635220|NCT02262039|18799429|P2|COMPLETED|Overall Study||27
7635221|NCT02262039|18799430|P1|COMPLETED|Overall Study||14
7635222|NCT02262039|18799429|P2|STARTED|Overall Study||27
7635223|NCT02262039|18799430|P1|STARTED|Overall Study||14
7635224|NCT02261974|18799450|P2|NOT COMPLETED|Overall Study||7
7635225|NCT02261974|18799451|P1|NOT COMPLETED|Overall Study||15
7635226|NCT02261974|18799450|P2|COMPLETED|Overall Study||56
7635227|NCT02261974|18799451|P1|COMPLETED|Overall Study||108
7635228|NCT02261974|18799450|P2|Treated|Overall Study||57
7635229|NCT02261974|18799451|P1|Treated|Overall Study||117
7635230|NCT02261974|18799450|P2|STARTED|Overall Study||63
7635231|NCT02261974|18799451|P1|STARTED|Overall Study||123
7635232|NCT02261948|18799467|P2|NOT COMPLETED|Overall Study||0
7635233|NCT02261948|18799468|P1|NOT COMPLETED|Overall Study||0
7635234|NCT02261948|18799467|P2|COMPLETED|Overall Study||19
7635235|NCT02261948|18799468|P1|COMPLETED|Overall Study||23
7635236|NCT02261948|18799467|P2|STARTED|Overall Study||19
7635237|NCT02261948|18799468|P1|STARTED|Overall Study||23
7635238|NCT02261818|18799478|P1|NOT COMPLETED|Overall Study||3
7635239|NCT02261818|18799478|P1|COMPLETED|Overall Study||27
7635240|NCT02261818|18799478|P1|STARTED|Overall Study||30
7635241|NCT02261805|18799482|P3|NOT COMPLETED|Overall Study||0
7635242|NCT02261805|18799483|P2|NOT COMPLETED|Overall Study||0
7635243|NCT02261805|18799484|P1|NOT COMPLETED|Overall Study||0
7635244|NCT02261805|18799482|P3|COMPLETED|Overall Study||2
7635245|NCT02261805|18799483|P2|COMPLETED|Overall Study||6
7635246|NCT02261805|18799484|P1|COMPLETED|Overall Study||3
7635247|NCT02261805|18799482|P3|STARTED|Overall Study||2
7635248|NCT02261805|18799483|P2|STARTED|Overall Study||6
7635249|NCT02261805|18799484|P1|STARTED|Overall Study||3
7635250|NCT02261714|18799492|P1|NOT COMPLETED|Overall Study||28
7635251|NCT02261714|18799492|P1|COMPLETED|Overall Study||4
7635252|NCT02261714|18799492|P1|STARTED|Overall Study||32
7635253|NCT02261597|18799501|P2|NOT COMPLETED|Overall Study||0
7635254|NCT02261597|18799502|P1|NOT COMPLETED|Overall Study||0
7635255|NCT02261597|18799501|P2|COMPLETED|Overall Study||22
7635256|NCT02261597|18799502|P1|COMPLETED|Overall Study||22
7635257|NCT02261597|18799501|P2|STARTED|Overall Study||22
7635258|NCT02261597|18799502|P1|STARTED|Overall Study||22
7635259|NCT02261493|18799515|P3|NOT COMPLETED|Overall Study||26
7635260|NCT02261493|18799516|P2|NOT COMPLETED|Overall Study||47
7635261|NCT02261493|18799517|P1|NOT COMPLETED|Overall Study||30
7635262|NCT02261493|18799515|P3|COMPLETED|Overall Study||287
7635263|NCT02261493|18799516|P2|COMPLETED|Overall Study||271
7635264|NCT02261493|18799517|P1|COMPLETED|Overall Study||126
7635265|NCT02261493|18799515|P3|STARTED|Overall Study||313
7635266|NCT02261493|18799516|P2|STARTED|Overall Study||318
7635267|NCT02261493|18799517|P1|STARTED|Overall Study||156
7635268|NCT02261467|18799545|P2|NOT COMPLETED|Overall Study||37
7635269|NCT02261467|18799546|P1|NOT COMPLETED|Overall Study||21
7635270|NCT02261467|18799545|P2|COMPLETED|Overall Study||253
7635271|NCT02261467|18799546|P1|COMPLETED|Overall Study||80
7635272|NCT02261467|18799545|P2|STARTED|Overall Study||290
7635273|NCT02261467|18799546|P1|STARTED|Overall Study||101
7635274|NCT02261428|18799566|P2|NOT COMPLETED|Overall Study||0
7635275|NCT02261428|18799567|P1|NOT COMPLETED|Overall Study||0
7635276|NCT02261428|18799566|P2|COMPLETED|Overall Study||10
7635277|NCT02261428|18799567|P1|COMPLETED|Overall Study||10
7635278|NCT02261428|18799566|P2|STARTED|Overall Study|Washout (30 minutes)|10
7635279|NCT02261428|18799567|P1|STARTED|Overall Study|Washout (30 minutes)|10
7635280|NCT02260986|18799588|P3|NOT COMPLETED|Overall Study||41
7635281|NCT02260986|18799589|P2|NOT COMPLETED|Overall Study||13
7635282|NCT02260986|18799590|P1|NOT COMPLETED|Overall Study||90
7635283|NCT02260986|18799588|P3|COMPLETED|Overall Study||278
7635284|NCT02260986|18799589|P2|COMPLETED|Overall Study||93
7635285|NCT02260986|18799590|P1|COMPLETED|Overall Study||225
7635286|NCT02260986|18799588|P3|Safety Population|Overall Study|4 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|315
7635287|NCT02260986|18799589|P2|Safety Population|Overall Study|4 participants from Dupilumab 300 mg qw arm analyzed in Dupilumab 300 mg q2w arm|110
7635288|NCT02260986|18799590|P1|Safety Population|Overall Study||315
7635289|NCT02260986|18799588|P3|STARTED|Overall Study||319
7635290|NCT02260986|18799589|P2|STARTED|Overall Study||106
7635291|NCT02260986|18799590|P1|STARTED|Overall Study||315
7635292|NCT02260934|18799708|P2|NOT COMPLETED|Overall Study||4
7635293|NCT02260934|18799709|P1|NOT COMPLETED|Overall Study||3
7635294|NCT02260934|18799708|P2|COMPLETED|Overall Study|At primary outcome timepoint: Eleven participants engaged in ongoing scheduled study visits.|17
7635295|NCT02260934|18799709|P1|COMPLETED|Overall Study|At primary outcome timepoint: Ten participants engaged in ongoing scheduled study visits.|19
7635296|NCT02260934|18799708|P2|STARTED|Overall Study||21
7635297|NCT02260934|18799709|P1|STARTED|Overall Study||22
7635298|NCT02260921|18799747|P2|NOT COMPLETED|Overall Study||4
7635299|NCT02260921|18799748|P1|NOT COMPLETED|Overall Study||14
7635300|NCT02260921|18799747|P2|COMPLETED|Overall Study||55
7635301|NCT02260921|18799748|P1|COMPLETED|Overall Study||107
7635302|NCT02260921|18799747|P2|Per-Protocol Population|Overall Study||56
7635303|NCT02260921|18799748|P1|Per-Protocol Population|Overall Study||112
7635304|NCT02260921|18799747|P2|STARTED|Overall Study||59
7635305|NCT02260921|18799748|P1|STARTED|Overall Study||121
7635306|NCT02260882|18799772|P2|NOT COMPLETED|Overall Study||1
7635307|NCT02260882|18799773|P1|NOT COMPLETED|Overall Study||0
7635308|NCT02260882|18799772|P2|COMPLETED|Overall Study||81
7635309|NCT02260882|18799773|P1|COMPLETED|Overall Study||161
7635310|NCT02260882|18799772|P2|STARTED|Overall Study||82
7635311|NCT02260882|18799773|P1|STARTED|Overall Study||161
7635312|NCT02260817|18799797|P2|NOT COMPLETED|Overall Study||37
7635313|NCT02260817|18799798|P1|NOT COMPLETED|Overall Study||0
7635314|NCT02260817|18799797|P2|COMPLETED|Overall Study||58
7635315|NCT02260817|18799798|P1|COMPLETED|Overall Study||14
7635316|NCT02260817|18799797|P2|STARTED|Overall Study||95
7635317|NCT02260817|18799798|P1|STARTED|Overall Study||14
7635318|NCT02260791|18799846|P2|NOT COMPLETED|Overall Study||34
7635319|NCT02260791|18799847|P1|NOT COMPLETED|Overall Study||33
7635320|NCT02260791|18799846|P2|COMPLETED|Overall Study||328
7635321|NCT02260791|18799847|P1|COMPLETED|Overall Study||333
7635322|NCT02260791|18799846|P2|STARTED|Overall Study||362
7635323|NCT02260791|18799847|P1|STARTED|Overall Study||366
7635324|NCT02260648|18799886|P3|NOT COMPLETED|Overall Study||8
7635325|NCT02260648|18799887|P2|NOT COMPLETED|Overall Study||13
7635326|NCT02260648|18799888|P1|NOT COMPLETED|Overall Study||18
7635327|NCT02260648|18799886|P3|COMPLETED|Overall Study||42
7635328|NCT02260648|18799887|P2|COMPLETED|Overall Study||33
7635329|NCT02260648|18799888|P1|COMPLETED|Overall Study||35
7635330|NCT02260648|18799886|P3|Received at Least One Dose of Study Drug|Overall Study||50
7635331|NCT02260648|18799887|P2|Received at Least One Dose of Study Drug|Overall Study||46
7635332|NCT02260648|18799888|P1|Received at Least One Dose of Study Drug|Overall Study||53
7635333|NCT02260648|18799886|P3|STARTED|Overall Study||50
7635334|NCT02260648|18799887|P2|STARTED|Overall Study||46
7635335|NCT02260648|18799888|P1|STARTED|Overall Study||53
7635336|NCT02260635|18799916|P2|NOT COMPLETED|Open-Label Extension||25
7635337|NCT02260635|18799917|P1|NOT COMPLETED|Open-Label Extension||26
7635338|NCT02260635|18799916|P2|COMPLETED|Open-Label Extension||0
7635339|NCT02260635|18799917|P1|COMPLETED|Open-Label Extension||0
7635340|NCT02260635|18799916|P2|Received at Least One Dose of Study Drug|Open-Label Extension||25
7635341|NCT02260635|18799917|P1|Received at Least One Dose of Study Drug|Open-Label Extension||26
7635342|NCT02260635|18799916|P2|STARTED|Open-Label Extension||25
7635343|NCT02260635|18799917|P1|STARTED|Open-Label Extension||26
7635344|NCT02260635|18799916|P2|NOT COMPLETED|Double-Blind Treatment Period||2
7635345|NCT02260635|18799917|P1|NOT COMPLETED|Double-Blind Treatment Period||1
7635346|NCT02260635|18799916|P2|COMPLETED|Double-Blind Treatment Period||25
7635347|NCT02260635|18799917|P1|COMPLETED|Double-Blind Treatment Period||26
7635348|NCT02260635|18799916|P2|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||26
7635349|NCT02260635|18799917|P1|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||27
7635350|NCT02260635|18799916|P2|STARTED|Double-Blind Treatment Period||27
7635351|NCT02260635|18799917|P1|STARTED|Double-Blind Treatment Period||27
7635352|NCT02260622|18799939|P2|NOT COMPLETED|Overall Study||0
7635353|NCT02260622|18799940|P1|NOT COMPLETED|Overall Study||0
7635354|NCT02260622|18799939|P2|COMPLETED|Overall Study||9
7635355|NCT02260622|18799940|P1|COMPLETED|Overall Study||11
7635356|NCT02260622|18799939|P2|STARTED|Overall Study||9
7635357|NCT02260622|18799940|P1|STARTED|Overall Study||11
7635358|NCT02260492|18799969|P3|NOT COMPLETED|Overall Study||5
7635359|NCT02260492|18799970|P2|NOT COMPLETED|Overall Study||13
7635360|NCT02260492|18799971|P1|NOT COMPLETED|Overall Study||23
7635361|NCT02260492|18799969|P3|COMPLETED|Overall Study||37
7635362|NCT02260492|18799970|P2|COMPLETED|Overall Study||406
7635363|NCT02260492|18799971|P1|COMPLETED|Overall Study||395
7635364|NCT02260492|18799969|P3|Completed Day 1|Overall Study||42
7635365|NCT02260492|18799970|P2|Completed Day 1|Overall Study||419
7635366|NCT02260492|18799971|P1|Completed Day 1|Overall Study||418
7635367|NCT02260492|18799969|P3|STARTED|Overall Study||42
7635368|NCT02260492|18799970|P2|STARTED|Overall Study||419
7635369|NCT02260492|18799971|P1|STARTED|Overall Study||418
7635370|NCT02260440|18799985|P1|NOT COMPLETED|Overall Study||0
7635371|NCT02260440|18799985|P1|COMPLETED|Overall Study||31
7635372|NCT02260440|18799985|P1|STARTED|Overall Study||31
7635373|NCT02260401|18799993|P2|NOT COMPLETED|Overall Study||12
7635374|NCT02260401|18799994|P1|NOT COMPLETED|Overall Study||5
7635375|NCT02260401|18799993|P2|COMPLETED|Overall Study||73
7635376|NCT02260401|18799994|P1|COMPLETED|Overall Study||75
7635377|NCT02260401|18799993|P2|STARTED|Overall Study||85
7635378|NCT02260401|18799994|P1|STARTED|Overall Study||80
7635379|NCT02260388|18800004|P4|NOT COMPLETED|Overall Study||4
7635380|NCT02260388|18800005|P3|NOT COMPLETED|Overall Study||3
7635381|NCT02260388|18800006|P2|NOT COMPLETED|Overall Study||8
7635382|NCT02260388|18800007|P1|NOT COMPLETED|Overall Study||2
7635383|NCT02260388|18800004|P4|COMPLETED|Overall Study||65
7635384|NCT02260388|18800005|P3|COMPLETED|Overall Study||70
7635385|NCT02260388|18800006|P2|COMPLETED|Overall Study||118
7635386|NCT02260388|18800007|P1|COMPLETED|Overall Study||132
7635387|NCT02260388|18800004|P4|STARTED|Overall Study||69
7635388|NCT02260388|18800005|P3|STARTED|Overall Study||73
7635389|NCT02260388|18800006|P2|STARTED|Overall Study||126
7635390|NCT02260388|18800007|P1|STARTED|Overall Study||134
7635391|NCT02260180|18800036|P3|NOT COMPLETED|Overall Study||1
7635392|NCT02260180|18800037|P2|NOT COMPLETED|Overall Study||0
7635393|NCT02260180|18800038|P1|NOT COMPLETED|Overall Study||2
7635394|NCT02260180|18800036|P3|COMPLETED|Overall Study||40
7635395|NCT02260180|18800037|P2|COMPLETED|Overall Study||39
7635396|NCT02260180|18800038|P1|COMPLETED|Overall Study||37
7635397|NCT02260180|18800036|P3|STARTED|Overall Study||41
7635398|NCT02260180|18800037|P2|STARTED|Overall Study||39
7635399|NCT02260180|18800038|P1|STARTED|Overall Study||39
7635400|NCT02260154|18800049|P1|NOT COMPLETED|Overall Study||2
7635401|NCT02260154|18800049|P1|COMPLETED|Overall Study||218
7635402|NCT02260154|18800049|P1|STARTED|Overall Study||220
7635403|NCT02259699|18800065|P2|NOT COMPLETED|Overall Study||20
7635404|NCT02259699|18800066|P1|NOT COMPLETED|Overall Study||27
7635405|NCT02259699|18800065|P2|COMPLETED|Overall Study||40
7635406|NCT02259699|18800066|P1|COMPLETED|Overall Study||37
7635407|NCT02259699|18800065|P2|STARTED|Overall Study||60
7635408|NCT02259699|18800066|P1|STARTED|Overall Study||64
7635409|NCT02259608|18800081|P1|NOT COMPLETED|Overall Study||0
7635410|NCT02259608|18800081|P1|COMPLETED|Overall Study||15
7635411|NCT02259608|18800081|P1|STARTED|Overall Study||15
7635412|NCT02259582|18800089|P3|NOT COMPLETED|Overall Study||21
7635413|NCT02259582|18800090|P2|NOT COMPLETED|Overall Study||17
7635414|NCT02259582|18800091|P1|NOT COMPLETED|Overall Study||16
7635415|NCT02259582|18800089|P3|COMPLETED|Overall Study||8
7635416|NCT02259582|18800090|P2|COMPLETED|Overall Study||11
7635417|NCT02259582|18800091|P1|COMPLETED|Overall Study||9
7635418|NCT02259582|18800089|P3|STARTED|Overall Study||29
7635419|NCT02259582|18800090|P2|STARTED|Overall Study||28
7635420|NCT02259582|18800091|P1|STARTED|Overall Study||25
7635421|NCT02259400|18800101|P2|NOT COMPLETED|Overall Study||2
7635422|NCT02259400|18800102|P1|NOT COMPLETED|Overall Study||0
7635423|NCT02259400|18800101|P2|COMPLETED|Overall Study||60
7635424|NCT02259400|18800102|P1|COMPLETED|Overall Study||62
7635425|NCT02259400|18800101|P2|STARTED|Overall Study||62
7635426|NCT02259400|18800102|P1|STARTED|Overall Study||62
7635427|NCT02259348|18800134|P1|NOT COMPLETED|Overall Study||10
7635428|NCT02259348|18800134|P1|COMPLETED|Overall Study||2
7635429|NCT02259348|18800134|P1|One Year Post-transplant|Overall Study||2
7635430|NCT02259348|18800134|P1|STARTED|Overall Study||12
7635431|NCT02259114|18800151|P5|NOT COMPLETED|Overall Study||6
7635432|NCT02259114|18800152|P4|NOT COMPLETED|Overall Study||3
7635433|NCT02259114|18800153|P3|NOT COMPLETED|Overall Study||13
7635434|NCT02259114|18800154|P2|NOT COMPLETED|Overall Study||4
7635435|NCT02259114|18800155|P1|NOT COMPLETED|Overall Study||21
7635436|NCT02259114|18800151|P5|COMPLETED|Overall Study||0
7635437|NCT02259114|18800152|P4|COMPLETED|Overall Study||0
7635438|NCT02259114|18800153|P3|COMPLETED|Overall Study||0
7635439|NCT02259114|18800154|P2|COMPLETED|Overall Study||0
7635440|NCT02259114|18800155|P1|COMPLETED|Overall Study||0
7635441|NCT02259114|18800151|P5|Treated|Overall Study||6
7635442|NCT02259114|18800152|P4|Treated|Overall Study||3
7635443|NCT02259114|18800153|P3|Treated|Overall Study||13
7635444|NCT02259114|18800154|P2|Treated|Overall Study||4
7635445|NCT02259114|18800155|P1|Treated|Overall Study|One participant was randomized but did not receive treatment due to a protocol violation.|20
7635446|NCT02259114|18800151|P5|STARTED|Overall Study||6
7635447|NCT02259114|18800152|P4|STARTED|Overall Study||3
7635448|NCT02259114|18800153|P3|STARTED|Overall Study||13
7635449|NCT02259114|18800154|P2|STARTED|Overall Study||4
7635450|NCT02259114|18800155|P1|STARTED|Overall Study||21
7635451|NCT02259088|18800214|P2|NOT COMPLETED|Overall Study||14
7635452|NCT02259088|18800215|P1|NOT COMPLETED|Overall Study||28
7635453|NCT02259088|18800214|P2|COMPLETED|Overall Study||63
7635454|NCT02259088|18800215|P1|COMPLETED|Overall Study||279
7635455|NCT02259088|18800214|P2|Treated (Safety Analysis Set)|Overall Study||75
7635456|NCT02259088|18800215|P1|Treated (Safety Analysis Set)|Overall Study||307
7635457|NCT02259088|18800214|P2|Full Analysis Set|Overall Study||77
7635458|NCT02259088|18800215|P1|Full Analysis Set|Overall Study||307
7635459|NCT02259088|18800214|P2|STARTED|Overall Study||77
7635460|NCT02259088|18800215|P1|STARTED|Overall Study||307
7635461|NCT02259010|18800260|P1|NOT COMPLETED|Overall Study||5
7635462|NCT02259010|18800260|P1|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|19
7635463|NCT02259010|18800260|P1|STARTED|Overall Study||24
7635464|NCT02258542|18800289|P4|NOT COMPLETED|Overall Study||5
7635465|NCT02258542|18800290|P3|NOT COMPLETED|Overall Study||8
7635466|NCT02258542|18800291|P2|NOT COMPLETED|Overall Study||49
7635467|NCT02258542|18800292|P1|NOT COMPLETED|Overall Study||42
7635468|NCT02258542|18800289|P4|COMPLETED|Overall Study|48 enrolled into study MELTEMI|92
7635469|NCT02258542|18800290|P3|COMPLETED|Overall Study|51 enrolled into study MELTEMI|92
7635470|NCT02258542|18800291|P2|COMPLETED|Overall Study|178 enrolled into study MELTEMI|924
7635471|NCT02258542|18800292|P1|COMPLETED|Overall Study|170 enrolled into study MELTEMI|911
7635472|NCT02258542|18800289|P4|Adolescents Only|Overall Study||0
7635473|NCT02258542|18800290|P3|Adolescents Only|Overall Study||0
7635474|NCT02258542|18800291|P2|Adolescents Only|Overall Study||61
7635475|NCT02258542|18800292|P1|Adolescents Only|Overall Study||25
7635476|NCT02258542|18800289|P4|Treated|Overall Study||97
7635477|NCT02258542|18800290|P3|Treated|Overall Study||100
7635478|NCT02258542|18800291|P2|Treated|Overall Study||971
7635479|NCT02258542|18800292|P1|Treated|Overall Study||953
7635480|NCT02258542|18800289|P4|STARTED|Overall Study||97
7635481|NCT02258542|18800290|P3|STARTED|Overall Study||100
7635482|NCT02258542|18800291|P2|STARTED|Overall Study||973
7635483|NCT02258542|18800292|P1|STARTED|Overall Study||953
7635484|NCT02258529|18800516|P1|NOT COMPLETED|Overall Study||10
7635485|NCT02258529|18800516|P1|COMPLETED|Overall Study||0
7635486|NCT02258529|18800516|P1|STARTED|Overall Study||10
7635487|NCT02258477|18800528|P4|NOT COMPLETED|Fourth Intervention (1 Week)||0
7635488|NCT02258477|18800529|P3|NOT COMPLETED|Fourth Intervention (1 Week)||0
7635489|NCT02258477|18800530|P2|NOT COMPLETED|Fourth Intervention (1 Week)||0
7635490|NCT02258477|18800531|P1|NOT COMPLETED|Fourth Intervention (1 Week)||0
7635491|NCT02258477|18800528|P4|COMPLETED|Fourth Intervention (1 Week)||8
7635492|NCT02258477|18800529|P3|COMPLETED|Fourth Intervention (1 Week)||8
7635493|NCT02258477|18800530|P2|COMPLETED|Fourth Intervention (1 Week)||8
7635494|NCT02258477|18800531|P1|COMPLETED|Fourth Intervention (1 Week)||9
7635495|NCT02258477|18800528|P4|STARTED|Fourth Intervention (1 Week)||8
7635496|NCT02258477|18800529|P3|STARTED|Fourth Intervention (1 Week)||8
7635497|NCT02258477|18800530|P2|STARTED|Fourth Intervention (1 Week)||8
7635498|NCT02258477|18800531|P1|STARTED|Fourth Intervention (1 Week)||9
7635499|NCT02258477|18800528|P4|NOT COMPLETED|Third Intervention (1 Week)||0
7635500|NCT02258477|18800529|P3|NOT COMPLETED|Third Intervention (1 Week)||0
7635501|NCT02258477|18800530|P2|NOT COMPLETED|Third Intervention (1 Week)||0
7635502|NCT02258477|18800531|P1|NOT COMPLETED|Third Intervention (1 Week)||0
7635503|NCT02258477|18800528|P4|COMPLETED|Third Intervention (1 Week)||8
7635504|NCT02258477|18800529|P3|COMPLETED|Third Intervention (1 Week)||8
7635505|NCT02258477|18800530|P2|COMPLETED|Third Intervention (1 Week)||8
7635506|NCT02258477|18800531|P1|COMPLETED|Third Intervention (1 Week)||9
7635507|NCT02258477|18800528|P4|STARTED|Third Intervention (1 Week)||8
7635508|NCT02258477|18800529|P3|STARTED|Third Intervention (1 Week)||8
7635509|NCT02258477|18800530|P2|STARTED|Third Intervention (1 Week)||8
7635510|NCT02258477|18800531|P1|STARTED|Third Intervention (1 Week)||9
7635511|NCT02258477|18800528|P4|NOT COMPLETED|Second Intervention (1 Week)||1
7635512|NCT02258477|18800529|P3|NOT COMPLETED|Second Intervention (1 Week)||1
7635513|NCT02258477|18800530|P2|NOT COMPLETED|Second Intervention (1 Week)||0
7635514|NCT02258477|18800531|P1|NOT COMPLETED|Second Intervention (1 Week)||0
7635515|NCT02258477|18800528|P4|COMPLETED|Second Intervention (1 Week)||8
7635516|NCT02258477|18800529|P3|COMPLETED|Second Intervention (1 Week)||8
7635517|NCT02258477|18800530|P2|COMPLETED|Second Intervention (1 Week)||8
7635518|NCT02258477|18800531|P1|COMPLETED|Second Intervention (1 Week)||9
7635519|NCT02258477|18800528|P4|STARTED|Second Intervention (1 Week)||9
7635520|NCT02258477|18800529|P3|STARTED|Second Intervention (1 Week)||9
7635521|NCT02258477|18800530|P2|STARTED|Second Intervention (1 Week)||8
7635522|NCT02258477|18800531|P1|STARTED|Second Intervention (1 Week)||9
7635523|NCT02258477|18800528|P4|NOT COMPLETED|First Intervention (1 Week)||0
7635524|NCT02258477|18800529|P3|NOT COMPLETED|First Intervention (1 Week)||0
7635525|NCT02258477|18800530|P2|NOT COMPLETED|First Intervention (1 Week)||1
7635526|NCT02258477|18800531|P1|NOT COMPLETED|First Intervention (1 Week)||1
7635527|NCT02258477|18800528|P4|COMPLETED|First Intervention (1 Week)||9
7635528|NCT02258477|18800529|P3|COMPLETED|First Intervention (1 Week)||9
7635529|NCT02258477|18800530|P2|COMPLETED|First Intervention (1 Week)||8
7635530|NCT02258477|18800531|P1|COMPLETED|First Intervention (1 Week)||9
7635531|NCT02258477|18800528|P4|STARTED|First Intervention (1 Week)||9
7635532|NCT02258477|18800529|P3|STARTED|First Intervention (1 Week)||9
7635533|NCT02258477|18800530|P2|STARTED|First Intervention (1 Week)||9
7635534|NCT02258477|18800531|P1|STARTED|First Intervention (1 Week)||10
7635535|NCT02258464|18800548|P2|NOT COMPLETED|Overall Study||25
7635536|NCT02258464|18800549|P1|NOT COMPLETED|Overall Study||17
7635537|NCT02258464|18800548|P2|COMPLETED|Overall Study||25
7635538|NCT02258464|18800549|P1|COMPLETED|Overall Study||32
7635539|NCT02258464|18800548|P2|STARTED|Overall Study||50
7635540|NCT02258464|18800549|P1|STARTED|Overall Study||49
7635541|NCT02258412|18800574|P3|NOT COMPLETED|Overall Study||0
7635542|NCT02258412|18800575|P2|NOT COMPLETED|Overall Study||0
7635543|NCT02258412|18800576|P1|NOT COMPLETED|Overall Study||0
7635544|NCT02258412|18800574|P3|COMPLETED|Overall Study||61
7635545|NCT02258412|18800575|P2|COMPLETED|Overall Study||25
7635546|NCT02258412|18800576|P1|COMPLETED|Overall Study||26
7635547|NCT02258412|18800574|P3|STARTED|Overall Study||61
7635548|NCT02258412|18800575|P2|STARTED|Overall Study||25
7635549|NCT02258412|18800576|P1|STARTED|Overall Study||26
7635550|NCT02258373|18800585|P2|NOT COMPLETED|Overall Study||2
7635551|NCT02258373|18800586|P1|NOT COMPLETED|Overall Study||7
7635552|NCT02258373|18800585|P2|COMPLETED|Overall Study||75
7635553|NCT02258373|18800586|P1|COMPLETED|Overall Study||142
7635554|NCT02258373|18800585|P2|STARTED|Overall Study||77
7635555|NCT02258373|18800586|P1|STARTED|Overall Study||149
7635556|NCT02258334|18800630|P4|NOT COMPLETED|Overall Study||0
7635557|NCT02258334|18800631|P3|NOT COMPLETED|Overall Study||0
7635558|NCT02258334|18800632|P2|NOT COMPLETED|Overall Study||0
7635559|NCT02258334|18800633|P1|NOT COMPLETED|Overall Study||1
7635560|NCT02258334|18800630|P4|COMPLETED|Overall Study||52
7635561|NCT02258334|18800631|P3|COMPLETED|Overall Study||52
7635562|NCT02258334|18800632|P2|COMPLETED|Overall Study||54
7635563|NCT02258334|18800633|P1|COMPLETED|Overall Study||49
7635564|NCT02258334|18800630|P4|STARTED|Overall Study||52
7635565|NCT02258334|18800631|P3|STARTED|Overall Study||52
7635566|NCT02258334|18800632|P2|STARTED|Overall Study||54
7635567|NCT02258334|18800633|P1|STARTED|Overall Study||50
7635568|NCT02258256|18800659|P1|NOT COMPLETED|Overall Study||0
7635569|NCT02258256|18800659|P1|COMPLETED|Overall Study||11
7635570|NCT02258256|18800659|P1|STARTED|Overall Study||11
7635571|NCT02258217|18800663|P1|NOT COMPLETED|Overall Study||0
7635572|NCT02258217|18800663|P1|COMPLETED|Overall Study||30
7635573|NCT02258217|18800663|P1|STARTED|Overall Study||30
7635574|NCT02258152|18800677|P2|NOT COMPLETED|Overall Study||4
7635575|NCT02258152|18800678|P1|NOT COMPLETED|Overall Study||6
7635576|NCT02258152|18800677|P2|COMPLETED|Overall Study||34
7635577|NCT02258152|18800678|P1|COMPLETED|Overall Study||38
7635578|NCT02258152|18800677|P2|STARTED|Overall Study||38
7635579|NCT02258152|18800678|P1|STARTED|Overall Study||44
7635580|NCT02258139|18800686|P1|NOT COMPLETED|Overall Study||8
7635581|NCT02258139|18800686|P1|COMPLETED|Overall Study||30
7635582|NCT02258139|18800686|P1|STARTED|Overall Study||38
7635583|NCT02257970|18800696|P4|NOT COMPLETED|Part 3||7
7635584|NCT02257970|18800697|P3|NOT COMPLETED|Part 3||7
7635585|NCT02257970|18800698|P2|NOT COMPLETED|Part 3||0
7635586|NCT02257970|18800699|P1|NOT COMPLETED|Part 3||0
7635587|NCT02257970|18800696|P4|COMPLETED|Part 3||14
7635588|NCT02257970|18800697|P3|COMPLETED|Part 3||16
7635589|NCT02257970|18800698|P2|COMPLETED|Part 3||0
7635590|NCT02257970|18800699|P1|COMPLETED|Part 3||0
7635591|NCT02257970|18800696|P4|STARTED|Part 3||21
7635592|NCT02257970|18800697|P3|STARTED|Part 3||23
7635593|NCT02257970|18800698|P2|STARTED|Part 3||0
7635594|NCT02257970|18800699|P1|STARTED|Part 3||0
7635595|NCT02257970|18800696|P4|NOT COMPLETED|Part 2||0
7635596|NCT02257970|18800697|P3|NOT COMPLETED|Part 2||0
7635597|NCT02257970|18800698|P2|NOT COMPLETED|Part 2||7
7635598|NCT02257970|18800699|P1|NOT COMPLETED|Part 2||0
7635599|NCT02257970|18800696|P4|COMPLETED|Part 2||0
7635600|NCT02257970|18800697|P3|COMPLETED|Part 2||0
7635601|NCT02257970|18800698|P2|COMPLETED|Part 2||16
7635602|NCT02257970|18800699|P1|COMPLETED|Part 2||0
7635603|NCT02257970|18800696|P4|STARTED|Part 2||0
7635604|NCT02257970|18800697|P3|STARTED|Part 2||0
7635605|NCT02257970|18800698|P2|STARTED|Part 2||23
7635606|NCT02257970|18800699|P1|STARTED|Part 2||0
7635607|NCT02257970|18800696|P4|NOT COMPLETED|Part 1||0
7635608|NCT02257970|18800697|P3|NOT COMPLETED|Part 1||0
7635609|NCT02257970|18800698|P2|NOT COMPLETED|Part 1||0
7635610|NCT02257970|18800699|P1|NOT COMPLETED|Part 1||0
7635611|NCT02257970|18800696|P4|COMPLETED|Part 1||0
7635612|NCT02257970|18800697|P3|COMPLETED|Part 1||0
7635613|NCT02257970|18800698|P2|COMPLETED|Part 1||0
7635614|NCT02257970|18800699|P1|COMPLETED|Part 1||50
7635615|NCT02257970|18800696|P4|STARTED|Part 1||0
7635616|NCT02257970|18800697|P3|STARTED|Part 1||0
7635617|NCT02257970|18800698|P2|STARTED|Part 1||0
7635618|NCT02257970|18800699|P1|STARTED|Part 1||50
7635619|NCT02257918|18800725|P3|NOT COMPLETED|Overall Study||2
7635620|NCT02257918|18800726|P2|NOT COMPLETED|Overall Study||1
7635621|NCT02257918|18800727|P1|NOT COMPLETED|Overall Study||4
7635622|NCT02257918|18800725|P3|COMPLETED|Overall Study||39
7635623|NCT02257918|18800726|P2|COMPLETED|Overall Study||66
7635624|NCT02257918|18800727|P1|COMPLETED|Overall Study||68
7635625|NCT02257918|18800725|P3|Test of Cure Visit|Overall Study||40
7635626|NCT02257918|18800726|P2|Test of Cure Visit|Overall Study||67
7635627|NCT02257918|18800727|P1|Test of Cure Visit|Overall Study||72
7635628|NCT02257918|18800725|P3|STARTED|Overall Study||41
7635629|NCT02257918|18800726|P2|STARTED|Overall Study||67
7635630|NCT02257918|18800727|P1|STARTED|Overall Study||72
7635631|NCT02257684|18800777|P1|NOT COMPLETED|Overall Study||4
7635632|NCT02257684|18800777|P1|COMPLETED|Overall Study||0
7635633|NCT02257684|18800777|P1|STARTED|Overall Study||4
7635634|NCT02257632|18800787|P2|NOT COMPLETED|Overall Study||3
7635635|NCT02257632|18800788|P1|NOT COMPLETED|Overall Study||1
7635636|NCT02257632|18800787|P2|COMPLETED|Overall Study||19
7635637|NCT02257632|18800788|P1|COMPLETED|Overall Study||18
7635638|NCT02257632|18800787|P2|Per-Protocol Set (PPS)|Overall Study||20
7635639|NCT02257632|18800788|P1|Per-Protocol Set (PPS)|Overall Study||17
7635640|NCT02257632|18800787|P2|Safety Set (SAF)|Overall Study||21
7635641|NCT02257632|18800788|P1|Safety Set (SAF)|Overall Study||19
7635642|NCT02257632|18800787|P2|Full Analysis Set (FAS)|Overall Study||21
7635643|NCT02257632|18800788|P1|Full Analysis Set (FAS)|Overall Study||19
7635644|NCT02257632|18800787|P2|STARTED|Overall Study||22
7635645|NCT02257632|18800788|P1|STARTED|Overall Study||19
7635646|NCT02257541|18800805|P5|NOT COMPLETED|Overall Study||0
7635647|NCT02257541|18800806|P4|NOT COMPLETED|Overall Study||0
7635648|NCT02257541|18800807|P3|NOT COMPLETED|Overall Study||0
7635649|NCT02257541|18800808|P2|NOT COMPLETED|Overall Study||0
7635650|NCT02257541|18800809|P1|NOT COMPLETED|Overall Study||0
7635651|NCT02257541|18800805|P5|COMPLETED|Overall Study||1
7635652|NCT02257541|18800806|P4|COMPLETED|Overall Study||3
7635653|NCT02257541|18800807|P3|COMPLETED|Overall Study||1
7635654|NCT02257541|18800808|P2|COMPLETED|Overall Study||8
7635655|NCT02257541|18800809|P1|COMPLETED|Overall Study||3
7635656|NCT02257541|18800805|P5|STARTED|Overall Study||1
7635657|NCT02257541|18800806|P4|STARTED|Overall Study||3
7635658|NCT02257541|18800807|P3|STARTED|Overall Study||1
7635659|NCT02257541|18800808|P2|STARTED|Overall Study||8
7635660|NCT02257541|18800809|P1|STARTED|Overall Study||3
7635661|NCT02257528|18800828|P1|NOT COMPLETED|Overall Study||1
7635662|NCT02257528|18800828|P1|COMPLETED|Overall Study||25
7635663|NCT02257528|18800828|P1|STARTED|Overall Study||26
7635664|NCT02257489|18800844|P9|NOT COMPLETED|Overall Study||0
7635665|NCT02257489|18800845|P8|NOT COMPLETED|Overall Study||0
7635666|NCT02257489|18800846|P7|NOT COMPLETED|Overall Study||0
7635667|NCT02257489|18800847|P6|NOT COMPLETED|Overall Study||0
7635668|NCT02257489|18800848|P5|NOT COMPLETED|Overall Study||0
7635669|NCT02257489|18800849|P4|NOT COMPLETED|Overall Study||1
7635670|NCT02257489|18800850|P3|NOT COMPLETED|Overall Study||0
7635671|NCT02257489|18800851|P2|NOT COMPLETED|Overall Study||0
7635672|NCT02257489|18800852|P1|NOT COMPLETED|Overall Study||0
7635673|NCT02257489|18800844|P9|COMPLETED|Overall Study||6
7635674|NCT02257489|18800845|P8|COMPLETED|Overall Study||10
7635675|NCT02257489|18800846|P7|COMPLETED|Overall Study||6
7635676|NCT02257489|18800847|P6|COMPLETED|Overall Study||6
7635677|NCT02257489|18800848|P5|COMPLETED|Overall Study||6
7635678|NCT02257489|18800849|P4|COMPLETED|Overall Study||5
7635679|NCT02257489|18800850|P3|COMPLETED|Overall Study||6
7635680|NCT02257489|18800851|P2|COMPLETED|Overall Study||6
7635681|NCT02257489|18800852|P1|COMPLETED|Overall Study||6
7635682|NCT02257489|18800844|P9|STARTED|Overall Study||6
7635683|NCT02257489|18800845|P8|STARTED|Overall Study||10
7635684|NCT02257489|18800846|P7|STARTED|Overall Study||6
7635685|NCT02257489|18800847|P6|STARTED|Overall Study||6
7635686|NCT02257489|18800848|P5|STARTED|Overall Study||6
7635687|NCT02257489|18800849|P4|STARTED|Overall Study||6
7635688|NCT02257489|18800850|P3|STARTED|Overall Study||6
7635689|NCT02257489|18800851|P2|STARTED|Overall Study||6
7635690|NCT02257489|18800852|P1|STARTED|Overall Study||6
7635691|NCT02257385|18800888|P2|NOT COMPLETED|Overall Study||22
7635692|NCT02257385|18800889|P1|NOT COMPLETED|Overall Study||22
7635693|NCT02257385|18800888|P2|COMPLETED|Overall Study||457
7635694|NCT02257385|18800889|P1|COMPLETED|Overall Study||460
7635695|NCT02257385|18800888|P2|STARTED|Overall Study||479
7635696|NCT02257385|18800889|P1|STARTED|Overall Study||482
7635697|NCT02257372|18800899|P2|NOT COMPLETED|Overall Study||10
7635698|NCT02257372|18800900|P1|NOT COMPLETED|Overall Study||7
7635699|NCT02257372|18800899|P2|COMPLETED|Overall Study||109
7635700|NCT02257372|18800900|P1|COMPLETED|Overall Study||110
7635701|NCT02257372|18800899|P2|STARTED|Overall Study||119
7635702|NCT02257372|18800900|P1|STARTED|Overall Study||117
7635703|NCT02257099|18800908|P1|NOT COMPLETED|Overall Study||0
7635704|NCT02257099|18800908|P1|COMPLETED|Overall Study||20
7635705|NCT02257099|18800908|P1|STARTED|Overall Study||20
7635706|NCT02256982|18800917|P2|NOT COMPLETED|Overall Study||1
7635707|NCT02256982|18800918|P1|NOT COMPLETED|Overall Study||0
7635708|NCT02256982|18800917|P2|COMPLETED|Overall Study||1
7635709|NCT02256982|18800918|P1|COMPLETED|Overall Study||1
7635710|NCT02256982|18800917|P2|STARTED|Overall Study||2
7635711|NCT02256982|18800918|P1|STARTED|Overall Study||1
7635712|NCT02256969|18800927|P3|NOT COMPLETED|Overall Study||1
7635713|NCT02256969|18800928|P2|NOT COMPLETED|Overall Study||1
7635714|NCT02256969|18800929|P1|NOT COMPLETED|Overall Study||2
7635715|NCT02256969|18800927|P3|COMPLETED|Overall Study||14
7635716|NCT02256969|18800928|P2|COMPLETED|Overall Study||14
7635717|NCT02256969|18800929|P1|COMPLETED|Overall Study||13
7635718|NCT02256969|18800927|P3|STARTED|Overall Study||15
7635719|NCT02256969|18800928|P2|STARTED|Overall Study||15
7635720|NCT02256969|18800929|P1|STARTED|Overall Study||15
7635721|NCT02256917|18800946|P1|NOT COMPLETED|Prophylactic Treatment Phase II||4
7635722|NCT02256917|18800946|P1|COMPLETED|Prophylactic Treatment Phase II||52
7635723|NCT02256917|18800946|P1|STARTED|Prophylactic Treatment Phase II||56
7635724|NCT02256917|18800946|P1|NOT COMPLETED|Prophylactic Treatment Phase I||1
7635725|NCT02256917|18800946|P1|COMPLETED|Prophylactic Treatment Phase I||56
7635726|NCT02256917|18800946|P1|STARTED|Prophylactic Treatment Phase I||57
7635727|NCT02256917|18800946|P1|NOT COMPLETED|Pharmacokinetic (PK) Evaluation Phase||0
7635728|NCT02256917|18800946|P1|COMPLETED|Pharmacokinetic (PK) Evaluation Phase||58
7635729|NCT02256917|18800946|P1|STARTED|Pharmacokinetic (PK) Evaluation Phase||58
7635730|NCT02256891|18800967|P2|NOT COMPLETED|Overall Study||13
7635731|NCT02256891|18800968|P1|NOT COMPLETED|Overall Study||12
7635732|NCT02256891|18800967|P2|COMPLETED|Overall Study||29
7635733|NCT02256891|18800968|P1|COMPLETED|Overall Study||43
7635734|NCT02256891|18800967|P2|STARTED|Overall Study||42
7635735|NCT02256891|18800968|P1|STARTED|Overall Study||55
7635736|NCT02256839|18800994|P2|NOT COMPLETED|Overall Study||3
7635737|NCT02256839|18800995|P1|NOT COMPLETED|Overall Study||2
7635738|NCT02256839|18800994|P2|COMPLETED|Overall Study||212
7635739|NCT02256839|18800995|P1|COMPLETED|Overall Study||51
7635740|NCT02256839|18800994|P2|STARTED|Overall Study||215
7635741|NCT02256839|18800995|P1|STARTED|Overall Study||53
7635742|NCT02256553|18801001|P1|NOT COMPLETED|Period III||3
7635743|NCT02256553|18801001|P1|COMPLETED|Period III||91
7635744|NCT02256553|18801001|P1|STARTED|Period III||94
7635745|NCT02256553|18801001|P1|NOT COMPLETED|Period II||2
7635746|NCT02256553|18801001|P1|COMPLETED|Period II||94
7635747|NCT02256553|18801001|P1|STARTED|Period II||96
7635748|NCT02256553|18801001|P1|NOT COMPLETED|Period I||6
7635749|NCT02256553|18801001|P1|COMPLETED|Period I||96
7635750|NCT02256553|18801001|P1|STARTED|Period I||102
7635751|NCT02256540|18801010|P3|NOT COMPLETED|Overall Study||2
7635752|NCT02256540|18801011|P2|NOT COMPLETED|Overall Study||1
7635753|NCT02256540|18801012|P1|NOT COMPLETED|Overall Study||0
7635754|NCT02256540|18801010|P3|COMPLETED|Overall Study||4
7635755|NCT02256540|18801011|P2|COMPLETED|Overall Study||5
7635756|NCT02256540|18801012|P1|COMPLETED|Overall Study||6
7635757|NCT02256540|18801010|P3|STARTED|Overall Study||6
7635758|NCT02256540|18801011|P2|STARTED|Overall Study||6
7635759|NCT02256540|18801012|P1|STARTED|Overall Study||6
7635760|NCT02256488|18801030|P4|NOT COMPLETED|Overall Study||6
7635761|NCT02256488|18801031|P3|NOT COMPLETED|Overall Study||10
7635762|NCT02256488|18801032|P2|NOT COMPLETED|Overall Study||6
7635763|NCT02256488|18801033|P1|NOT COMPLETED|Overall Study||8
7635764|NCT02256488|18801030|P4|COMPLETED|Overall Study||384
7635765|NCT02256488|18801031|P3|COMPLETED|Overall Study||382
7635766|NCT02256488|18801032|P2|COMPLETED|Overall Study||386
7635767|NCT02256488|18801033|P1|COMPLETED|Overall Study||379
7635768|NCT02256488|18801030|P4|STARTED|Overall Study||390
7635769|NCT02256488|18801031|P3|STARTED|Overall Study||392
7635770|NCT02256488|18801032|P2|STARTED|Overall Study||392
7635771|NCT02256488|18801033|P1|STARTED|Overall Study||387
7635772|NCT02256436|18801049|P2|NOT COMPLETED|Overall Study||272
7635773|NCT02256436|18801050|P1|NOT COMPLETED|Overall Study||270
7635774|NCT02256436|18801049|P2|COMPLETED|Overall Study||0
7635775|NCT02256436|18801050|P1|COMPLETED|Overall Study||0
7635776|NCT02256436|18801049|P2|Treated|Overall Study||255
7635777|NCT02256436|18801050|P1|Treated|Overall Study||266
7635778|NCT02256436|18801049|P2|STARTED|Overall Study||272
7635779|NCT02256436|18801050|P1|STARTED|Overall Study||270
7635780|NCT02256384|18801086|P1|NOT COMPLETED|Overall Study||14
7635781|NCT02256384|18801086|P1|COMPLETED|Overall Study||62
7635782|NCT02256384|18801086|P1|STARTED|Overall Study||76
7635783|NCT02256358|18801097|P2|NOT COMPLETED|Overall Study||1
7635784|NCT02256358|18801098|P1|NOT COMPLETED|Overall Study||0
7635785|NCT02256358|18801097|P2|COMPLETED|Overall Study||33
7635786|NCT02256358|18801098|P1|COMPLETED|Overall Study||34
7635787|NCT02256358|18801097|P2|STARTED|Overall Study||34
7635788|NCT02256358|18801098|P1|STARTED|Overall Study||34
7635789|NCT02256345|18801106|P2|NOT COMPLETED|Overall Study||0
7635790|NCT02256345|18801107|P1|NOT COMPLETED|Overall Study||0
7635791|NCT02256345|18801106|P2|COMPLETED|Overall Study||3
7635792|NCT02256345|18801107|P1|COMPLETED|Overall Study||9
7635793|NCT02256345|18801106|P2|STARTED|Overall Study||3
7635794|NCT02256345|18801107|P1|STARTED|Overall Study||9
7635795|NCT02256267|18801119|P1|NOT COMPLETED|Period 2 (Day 7 to Day 14)||1
7635796|NCT02256267|18801119|P1|COMPLETED|Period 2 (Day 7 to Day 14)||22
7635797|NCT02256267|18801119|P1|Received LY2835219 + Rifampin|Period 2 (Day 7 to Day 14)||23
7635798|NCT02256267|18801119|P1|STARTED|Period 2 (Day 7 to Day 14)||23
7635799|NCT02256267|18801119|P1|NOT COMPLETED|Period 2 (Day 1 to Day 6)||0
7635800|NCT02256267|18801119|P1|COMPLETED|Period 2 (Day 1 to Day 6)||23
7635801|NCT02256267|18801119|P1|Received at Least 1 Dose of Rifampin|Period 2 (Day 1 to Day 6)||23
7635802|NCT02256267|18801119|P1|STARTED|Period 2 (Day 1 to Day 6)||23
7635803|NCT02256267|18801119|P1|NOT COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||1
7635804|NCT02256267|18801119|P1|COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||23
7635805|NCT02256267|18801119|P1|Received at Least 1 Dose of LY2835219|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
7635806|NCT02256267|18801119|P1|STARTED|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
7635807|NCT02256189|18801130|P2|NOT COMPLETED|Overall Study||0
7635808|NCT02256189|18801131|P1|NOT COMPLETED|Overall Study||0
7635809|NCT02256189|18801130|P2|COMPLETED|Overall Study||13
7635810|NCT02256189|18801131|P1|COMPLETED|Overall Study||15
7635811|NCT02256189|18801130|P2|STARTED|Overall Study||13
7635812|NCT02256189|18801131|P1|STARTED|Overall Study||15
7635813|NCT02256111|18801141|P2|NOT COMPLETED|Overall Study||0
7635814|NCT02256111|18801142|P1|NOT COMPLETED|Overall Study||0
7635815|NCT02256111|18801141|P2|COMPLETED|Overall Study||13
7635816|NCT02256111|18801142|P1|COMPLETED|Overall Study||13
7635817|NCT02256111|18801141|P2|STARTED|Overall Study||13
7635818|NCT02256111|18801142|P1|STARTED|Overall Study||13
7635819|NCT02256072|18801177|P2|NOT COMPLETED|Overall Study||29
7635820|NCT02256072|18801178|P1|NOT COMPLETED|Overall Study||42
7635821|NCT02256072|18801177|P2|COMPLETED|Overall Study||162
7635822|NCT02256072|18801178|P1|COMPLETED|Overall Study|Completed the 3-month follow-up|152
7635823|NCT02256072|18801177|P2|Completed 1 Month Follow-Up|Overall Study||179
7635824|NCT02256072|18801178|P1|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167
7635825|NCT02256072|18801177|P2|STARTED|Overall Study||191
7635826|NCT02256072|18801178|P1|STARTED|Overall Study||194
7635827|NCT02255981|18801192|P1|NOT COMPLETED|Overall Study||4
7635828|NCT02255981|18801192|P1|COMPLETED|Overall Study|2 eyes of the final 29 subjects were excluded.|29
7635829|NCT02255981|18801192|P1|STARTED|Overall Study|Both eyes of each patient were included except 2 that not were treatable|33
7635830|NCT02255760|18801207|P5|NOT COMPLETED|Overall Study||0
7635831|NCT02255760|18801208|P4|NOT COMPLETED|Overall Study||0
7635832|NCT02255760|18801209|P3|NOT COMPLETED|Overall Study||0
7635833|NCT02255760|18801210|P2|NOT COMPLETED|Overall Study||1
7635834|NCT02255760|18801211|P1|NOT COMPLETED|Overall Study||0
7635835|NCT02255760|18801207|P5|COMPLETED|Overall Study||9
7635836|NCT02255760|18801208|P4|COMPLETED|Overall Study||15
7635837|NCT02255760|18801209|P3|COMPLETED|Overall Study||15
7635838|NCT02255760|18801210|P2|COMPLETED|Overall Study||2
7635839|NCT02255760|18801211|P1|COMPLETED|Overall Study||14
7635840|NCT02255760|18801207|P5|STARTED|Overall Study||9
7635841|NCT02255760|18801208|P4|STARTED|Overall Study||15
7635842|NCT02255760|18801209|P3|STARTED|Overall Study||15
7635843|NCT02255760|18801210|P2|STARTED|Overall Study||3
7635844|NCT02255760|18801211|P1|STARTED|Overall Study||14
7635845|NCT02255565|18801266|P3|NOT COMPLETED|Overall Study||0
7635846|NCT02255565|18801267|P2|NOT COMPLETED|Overall Study||1
7635847|NCT02255565|18801268|P1|NOT COMPLETED|Overall Study||0
7635848|NCT02255565|18801266|P3|COMPLETED|Overall Study||9
7635849|NCT02255565|18801267|P2|COMPLETED|Overall Study||8
7635850|NCT02255565|18801268|P1|COMPLETED|Overall Study||9
7635851|NCT02255565|18801266|P3|STARTED|Overall Study||9
7635852|NCT02255565|18801267|P2|STARTED|Overall Study||9
7635853|NCT02255565|18801268|P1|STARTED|Overall Study||9
7635854|NCT02255552|18801329|P2|NOT COMPLETED|Overall Study||15
7635855|NCT02255552|18801330|P1|NOT COMPLETED|Overall Study||1
7635856|NCT02255552|18801329|P2|COMPLETED|Overall Study||15
7635857|NCT02255552|18801330|P1|COMPLETED|Overall Study||78
7635858|NCT02255552|18801329|P2|STARTED|Overall Study||30
7635859|NCT02255552|18801330|P1|STARTED|Overall Study||79
7635860|NCT02255500|18801347|P2|NOT COMPLETED|Overall Study||0
7635861|NCT02255500|18801348|P1|NOT COMPLETED|Overall Study||1
7635862|NCT02255500|18801347|P2|COMPLETED|Overall Study||7
7635863|NCT02255500|18801348|P1|COMPLETED|Overall Study||15
7635864|NCT02255500|18801347|P2|STARTED|Overall Study||7
7635865|NCT02255500|18801348|P1|STARTED|Overall Study||16
7635866|NCT02255461|18801369|P5|NOT COMPLETED|Overall Study||2
7635867|NCT02255461|18801370|P4|NOT COMPLETED|Overall Study||0
7635868|NCT02255461|18801371|P3|NOT COMPLETED|Overall Study||1
7635869|NCT02255461|18801372|P2|NOT COMPLETED|Overall Study||2
7635870|NCT02255461|18801373|P1|NOT COMPLETED|Overall Study||0
7635871|NCT02255461|18801369|P5|COMPLETED|Overall Study||8
7635872|NCT02255461|18801370|P4|COMPLETED|Overall Study||4
7635873|NCT02255461|18801371|P3|COMPLETED|Overall Study||5
7635874|NCT02255461|18801372|P2|COMPLETED|Overall Study||10
7635875|NCT02255461|18801373|P1|COMPLETED|Overall Study||3
7635876|NCT02255461|18801369|P5|STARTED|Overall Study||10
7635877|NCT02255461|18801370|P4|STARTED|Overall Study||4
7635878|NCT02255461|18801371|P3|STARTED|Overall Study||6
7635879|NCT02255461|18801372|P2|STARTED|Overall Study||12
7635880|NCT02255461|18801373|P1|STARTED|Overall Study||3
7635881|NCT02255422|18801452|P7|NOT COMPLETED|Overall Study||2
7635882|NCT02255422|18801453|P6|NOT COMPLETED|Overall Study||0
7635883|NCT02255422|18801454|P5|NOT COMPLETED|Overall Study||0
7635884|NCT02255422|18801455|P4|NOT COMPLETED|Overall Study||0
7635885|NCT02255422|18801456|P3|NOT COMPLETED|Overall Study||1
7635886|NCT02255422|18801457|P2|NOT COMPLETED|Overall Study||0
7635887|NCT02255422|18801458|P1|NOT COMPLETED|Overall Study||0
7635888|NCT02255422|18801452|P7|COMPLETED|Overall Study||8
7635889|NCT02255422|18801453|P6|COMPLETED|Overall Study||6
7635890|NCT02255422|18801454|P5|COMPLETED|Overall Study||6
7635891|NCT02255422|18801455|P4|COMPLETED|Overall Study||6
7635892|NCT02255422|18801456|P3|COMPLETED|Overall Study||5
7635893|NCT02255422|18801457|P2|COMPLETED|Overall Study||6
7635894|NCT02255422|18801458|P1|COMPLETED|Overall Study||13
7635895|NCT02255422|18801452|P7|STARTED|Overall Study||10
7635896|NCT02255422|18801453|P6|STARTED|Overall Study||6
7635897|NCT02255422|18801454|P5|STARTED|Overall Study||6
7635898|NCT02255422|18801455|P4|STARTED|Overall Study||6
7635899|NCT02255422|18801456|P3|STARTED|Overall Study||6
7635900|NCT02255422|18801457|P2|STARTED|Overall Study||6
7635901|NCT02255422|18801458|P1|STARTED|Overall Study||13
7635902|NCT02255357|18801483|P2|NOT COMPLETED|Overall Study||10
7635903|NCT02255357|18801484|P1|NOT COMPLETED|Overall Study||7
7635904|NCT02255357|18801483|P2|COMPLETED|Overall Study||5
7635905|NCT02255357|18801484|P1|COMPLETED|Overall Study||4
7635906|NCT02255357|18801483|P2|STARTED|Overall Study||15
7635907|NCT02255357|18801484|P1|STARTED|Overall Study||11
7635908|NCT02255279|18801492|P2|NOT COMPLETED|Overall Study||9
7635909|NCT02255279|18801493|P1|NOT COMPLETED|Overall Study||5
7635910|NCT02255279|18801492|P2|COMPLETED|Overall Study||134
7635911|NCT02255279|18801493|P1|COMPLETED|Overall Study||139
7635912|NCT02255279|18801492|P2|STARTED|Overall Study||143
7635913|NCT02255279|18801493|P1|STARTED|Overall Study||144
7635914|NCT02255175|18801521|P2|NOT COMPLETED|Overall Study||12
7635915|NCT02255175|18801522|P1|NOT COMPLETED|Overall Study||17
7635916|NCT02255175|18801521|P2|COMPLETED|Overall Study||19
7635917|NCT02255175|18801522|P1|COMPLETED|Overall Study||16
7635918|NCT02255175|18801521|P2|STARTED|Overall Study||31
7635919|NCT02255175|18801522|P1|STARTED|Overall Study||33
7635920|NCT02255149|18801546|P1|NOT COMPLETED|Overall Study||5
7635921|NCT02255149|18801546|P1|COMPLETED|Overall Study||5
7635922|NCT02255149|18801546|P1|STARTED|Overall Study||10
7635923|NCT02255110|18801550|P1|NOT COMPLETED|Overall Study||0
7635924|NCT02255110|18801550|P1|COMPLETED|Overall Study||6
7635925|NCT02255110|18801550|P1|STARTED|Overall Study||6
7635926|NCT02255097|18801562|P1|NOT COMPLETED|Overall Study||172
7635927|NCT02255097|18801562|P1|COMPLETED|Overall Study||0
7635928|NCT02255097|18801562|P1|Treated|Overall Study||171
7635929|NCT02255097|18801562|P1|STARTED|Overall Study||172
7635930|NCT02254772|18801583|P1|NOT COMPLETED|Overall Study||2
7635931|NCT02254772|18801583|P1|COMPLETED|Overall Study||7
7635932|NCT02254772|18801583|P1|STARTED|Overall Study||9
7635933|NCT02254681|18801589|P1|NOT COMPLETED|Overall Study||6
7635934|NCT02254681|18801589|P1|COMPLETED|Overall Study||0
7635935|NCT02254681|18801589|P1|STARTED|Overall Study||6
7635936|NCT02254551|18801599|P1|NOT COMPLETED|Maintenance||0
7635937|NCT02254551|18801599|P1|COMPLETED|Maintenance||0
7635938|NCT02254551|18801599|P1|STARTED|Maintenance||0
7635939|NCT02254551|18801599|P1|NOT COMPLETED|Expansion||0
7635940|NCT02254551|18801599|P1|COMPLETED|Expansion||0
7635941|NCT02254551|18801599|P1|STARTED|Expansion||0
7635942|NCT02254551|18801599|P1|NOT COMPLETED|Dose Escalation||3
7635943|NCT02254551|18801599|P1|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4
7635944|NCT02254551|18801599|P1|Cohort 3: LDE225 800mg|Dose Escalation||0
7635945|NCT02254551|18801599|P1|Cohort 2: LDE225 600mg|Dose Escalation||0
7635946|NCT02254551|18801599|P1|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7
7635947|NCT02254551|18801599|P1|STARTED|Dose Escalation||7
7635948|NCT02254486|18801609|P2|NOT COMPLETED|Overall Study||55
7635949|NCT02254486|18801610|P1|NOT COMPLETED|Overall Study||50
7635950|NCT02254486|18801609|P2|COMPLETED|Overall Study||255
7635951|NCT02254486|18801610|P1|COMPLETED|Overall Study||261
7635952|NCT02254486|18801609|P2|STARTED|Overall Study||310
7635953|NCT02254486|18801610|P1|STARTED|Overall Study||311
7635954|NCT02254473|18801628|P2|NOT COMPLETED|Overall Study||1
7635955|NCT02254473|18801629|P1|NOT COMPLETED|Overall Study||2
7635956|NCT02254473|18801628|P2|COMPLETED|Overall Study||2
7635957|NCT02254473|18801629|P1|COMPLETED|Overall Study||7
7635958|NCT02254473|18801628|P2|STARTED|Overall Study||3
7635959|NCT02254473|18801629|P1|STARTED|Overall Study||9
7635960|NCT02254460|18801649|P2|NOT COMPLETED|Overall Study||0
7635961|NCT02254460|18801650|P1|NOT COMPLETED|Overall Study||1
7635962|NCT02254460|18801649|P2|COMPLETED|Overall Study||12
7635963|NCT02254460|18801650|P1|COMPLETED|Overall Study||12
7635964|NCT02254460|18801649|P2|STARTED|Overall Study||12
7635965|NCT02254460|18801650|P1|STARTED|Overall Study||13
7635966|NCT02254421|18801658|P2|NOT COMPLETED|Overall Study||3
7635967|NCT02254421|18801659|P1|NOT COMPLETED|Overall Study||2
7635968|NCT02254421|18801658|P2|COMPLETED|Overall Study||26
7635969|NCT02254421|18801659|P1|COMPLETED|Overall Study||29
7635970|NCT02254421|18801658|P2|STARTED|Overall Study||29
7635971|NCT02254421|18801659|P1|STARTED|Overall Study||31
7635972|NCT02254408|18801673|P2|NOT COMPLETED|Overall Study||10
7635973|NCT02254408|18801674|P1|NOT COMPLETED|Overall Study||8
7635974|NCT02254408|18801673|P2|COMPLETED|Overall Study||83
7635975|NCT02254408|18801674|P1|COMPLETED|Overall Study||88
7635976|NCT02254408|18801673|P2|STARTED|Overall Study||93
7635977|NCT02254408|18801674|P1|STARTED|Overall Study||96
7635978|NCT02254304|18801686|P2|NOT COMPLETED|Overall Study||4
7635979|NCT02254304|18801687|P1|NOT COMPLETED|Overall Study||14
7635980|NCT02254304|18801686|P2|COMPLETED|Overall Study||13
7635981|NCT02254304|18801687|P1|COMPLETED|Overall Study||75
7635982|NCT02254304|18801686|P2|STARTED|Overall Study||17
7635983|NCT02254304|18801687|P1|STARTED|Overall Study||89
7635984|NCT02254291|18801747|P3|NOT COMPLETED|Overall Study||2
7635985|NCT02254291|18801748|P2|NOT COMPLETED|Overall Study||3
7635986|NCT02254291|18801749|P1|NOT COMPLETED|Overall Study||0
7635987|NCT02254291|18801747|P3|COMPLETED|Overall Study||101
7635988|NCT02254291|18801748|P2|COMPLETED|Overall Study||99
7635989|NCT02254291|18801749|P1|COMPLETED|Overall Study||103
7635990|NCT02254291|18801747|P3|Exposed|Overall Study||103
7635991|NCT02254291|18801748|P2|Exposed|Overall Study||102
7635992|NCT02254291|18801749|P1|Exposed|Overall Study||103
7635993|NCT02254291|18801747|P3|STARTED|Overall Study||103
7635994|NCT02254291|18801748|P2|STARTED|Overall Study||102
7635995|NCT02254291|18801749|P1|STARTED|Overall Study||103
7635996|NCT02254278|18801765|P2|NOT COMPLETED|Overall Study||1
7635997|NCT02254278|18801766|P1|NOT COMPLETED|Overall Study||1
7635998|NCT02254278|18801765|P2|COMPLETED|Overall Study||149
7635999|NCT02254278|18801766|P1|COMPLETED|Overall Study||157
7636000|NCT02254278|18801765|P2|Negative Post-treatment PET|Overall Study||57
7636001|NCT02254278|18801766|P1|Negative Post-treatment PET|Overall Study||58
7636002|NCT02254278|18801765|P2|Started Study Treatment|Overall Study||147
7636003|NCT02254278|18801766|P1|Started Study Treatment|Overall Study||152
7636004|NCT02254278|18801765|P2|Eligible|Overall Study||149
7636005|NCT02254278|18801766|P1|Eligible|Overall Study||157
7636006|NCT02254278|18801765|P2|STARTED|Overall Study||150
7636007|NCT02254278|18801766|P1|STARTED|Overall Study||158
7636008|NCT02254265|18801786|P3|NOT COMPLETED|Overall Study||8
7636009|NCT02254265|18801787|P2|NOT COMPLETED|Overall Study||12
7636010|NCT02254265|18801788|P1|NOT COMPLETED|Overall Study||9
7636011|NCT02254265|18801786|P3|COMPLETED|Overall Study||144
7636012|NCT02254265|18801787|P2|COMPLETED|Overall Study||140
7636013|NCT02254265|18801788|P1|COMPLETED|Overall Study||142
7636014|NCT02254265|18801786|P3|STARTED|Overall Study||152
7636015|NCT02254265|18801787|P2|STARTED|Overall Study||152
7636016|NCT02254265|18801788|P1|STARTED|Overall Study||151
7636017|NCT02254252|18801813|P2|NOT COMPLETED|Overall Study||2
7636018|NCT02254252|18801814|P1|NOT COMPLETED|Overall Study||3
7636019|NCT02254252|18801813|P2|COMPLETED|Overall Study||25
7636020|NCT02254252|18801814|P1|COMPLETED|Overall Study||24
7636021|NCT02254252|18801813|P2|STARTED|Overall Study||27
7636022|NCT02254252|18801814|P1|STARTED|Overall Study||27
7636023|NCT02253992|18801827|P3|NOT COMPLETED|Overall Study||144
7636024|NCT02253992|18801828|P2|NOT COMPLETED|Overall Study||4
7636025|NCT02253992|18801829|P1|NOT COMPLETED|Overall Study||6
7636026|NCT02253992|18801827|P3|COMPLETED|Overall Study||6
7636027|NCT02253992|18801828|P2|COMPLETED|Overall Study||0
7636028|NCT02253992|18801829|P1|COMPLETED|Overall Study||0
7636029|NCT02253992|18801827|P3|STARTED|Overall Study||150
7636030|NCT02253992|18801828|P2|STARTED|Overall Study||4
7636031|NCT02253992|18801829|P1|STARTED|Overall Study||6
7636032|NCT02253654|18801895|P2|NOT COMPLETED|Overall Study||18
7636033|NCT02253654|18801896|P1|NOT COMPLETED|Overall Study||23
7636034|NCT02253654|18801895|P2|COMPLETED|Overall Study||90
7636035|NCT02253654|18801896|P1|COMPLETED|Overall Study||85
7636036|NCT02253654|18801895|P2|Received Treatment|Overall Study||107
7636037|NCT02253654|18801896|P1|Received Treatment|Overall Study||104
7636038|NCT02253654|18801895|P2|STARTED|Overall Study||108
7636039|NCT02253654|18801896|P1|STARTED|Overall Study||108
7636040|NCT02253537|18801916|P1|NOT COMPLETED|Overall Study||0
7636041|NCT02253537|18801916|P1|COMPLETED|Overall Study||15
7636042|NCT02253537|18801916|P1|STARTED|Overall Study||15
7636043|NCT02253433|18801922|P2|NOT COMPLETED|Overall Study||55
7636044|NCT02253433|18801923|P1|NOT COMPLETED|Overall Study||16
7636045|NCT02253433|18801922|P2|COMPLETED|Overall Study||79
7636046|NCT02253433|18801923|P1|COMPLETED|Overall Study||114
7636047|NCT02253433|18801922|P2|STARTED|Overall Study||134
7636048|NCT02253433|18801923|P1|STARTED|Overall Study||130
7636049|NCT02253394|18801933|P2|NOT COMPLETED|Overall Study||0
7636050|NCT02253394|18801934|P1|NOT COMPLETED|Overall Study||0
7636051|NCT02253394|18801933|P2|COMPLETED|Overall Study||2
7636052|NCT02253394|18801934|P1|COMPLETED|Overall Study||0
7636053|NCT02253394|18801933|P2|STARTED|Overall Study|Ambrisentan 5 or 10 mg QD + placebo (90 d) first, then washout (21 d), then +Spiro 50 mg QD (90 d).|2
7636054|NCT02253394|18801934|P1|STARTED|Overall Study||0
7636055|NCT02253173|18801944|P4|NOT COMPLETED|Overall Study||14
7636056|NCT02253173|18801945|P3|NOT COMPLETED|Overall Study||13
7636057|NCT02253173|18801946|P2|NOT COMPLETED|Overall Study||17
7636058|NCT02253173|18801947|P1|NOT COMPLETED|Overall Study||16
7636059|NCT02253173|18801944|P4|COMPLETED|Overall Study||178
7636060|NCT02253173|18801945|P3|COMPLETED|Overall Study||177
7636061|NCT02253173|18801946|P2|COMPLETED|Overall Study||174
7636062|NCT02253173|18801947|P1|COMPLETED|Overall Study||175
7636063|NCT02253173|18801944|P4|STARTED|Overall Study||192
7636064|NCT02253173|18801945|P3|STARTED|Overall Study||190
7636065|NCT02253173|18801946|P2|STARTED|Overall Study||191
7636066|NCT02253173|18801947|P1|STARTED|Overall Study||191
7636067|NCT02253160|18802144|P3|NOT COMPLETED|Overall Study||0
7636068|NCT02253160|18802145|P2|NOT COMPLETED|Overall Study||0
7636069|NCT02253160|18802146|P1|NOT COMPLETED|Overall Study||0
7636070|NCT02253160|18802144|P3|COMPLETED|Overall Study||10
7636071|NCT02253160|18802145|P2|COMPLETED|Overall Study||12
7636072|NCT02253160|18802146|P1|COMPLETED|Overall Study||1
7636073|NCT02253160|18802144|P3|STARTED|Overall Study||10
7636074|NCT02253160|18802145|P2|STARTED|Overall Study||12
7636075|NCT02253160|18802146|P1|STARTED|Overall Study||1
7636076|NCT02253147|18802182|P1|NOT COMPLETED|Overall Study||47
7636077|NCT02253147|18802182|P1|COMPLETED|Overall Study||71
7636078|NCT02253147|18802182|P1|N Patients at W52|Overall Study||84
7636079|NCT02253147|18802182|P1|N Patients at W36|Overall Study||86
7636080|NCT02253147|18802182|P1|N Patients at W24 (Primary Outcome)|Overall Study||88
7636081|NCT02253147|18802182|P1|STARTED|Overall Study||118
7636082|NCT02252965|18802216|P2|NOT COMPLETED|Overall Study||43
7636083|NCT02252965|18802217|P1|NOT COMPLETED|Overall Study||40
7636084|NCT02252965|18802216|P2|COMPLETED|Overall Study||222
7636085|NCT02252965|18802217|P1|COMPLETED|Overall Study||227
7636086|NCT02252965|18802216|P2|Safety Population|Overall Study||264
7636087|NCT02252965|18802217|P1|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261
7636088|NCT02252965|18802216|P2|STARTED|Overall Study||265
7636089|NCT02252965|18802217|P1|STARTED|Overall Study||267
7636090|NCT02252939|18802244|P1|NOT COMPLETED|Overall Study||3
7636091|NCT02252939|18802244|P1|COMPLETED|Overall Study||59
7636092|NCT02252939|18802244|P1|STARTED|Overall Study||62
7636093|NCT02252744|18802253|P1|NOT COMPLETED|Overall Study||0
7636094|NCT02252744|18802253|P1|COMPLETED|Overall Study||286
7636095|NCT02252744|18802253|P1|STARTED|Overall Study||286
7636096|NCT02252718|18802257|P1|NOT COMPLETED|Overall Study||0
7636097|NCT02252718|18802257|P1|COMPLETED|Overall Study||100
7636098|NCT02252718|18802257|P1|STARTED|Overall Study||100
7636099|NCT02252666|18802261|P1|NOT COMPLETED|Overall Study||0
7636100|NCT02252666|18802261|P1|COMPLETED|Overall Study||6
7636101|NCT02252666|18802261|P1|STARTED|Overall Study||6
7636102|NCT02252588|18802285|P2|NOT COMPLETED|Overall Study||0
7636103|NCT02252588|18802286|P1|NOT COMPLETED|Overall Study||4
7636104|NCT02252588|18802285|P2|COMPLETED|Overall Study||20
7636105|NCT02252588|18802286|P1|COMPLETED|Overall Study||20
7636106|NCT02252588|18802285|P2|STARTED|Overall Study||20
7636107|NCT02252588|18802286|P1|STARTED|Overall Study||24
7636108|NCT02252562|18802298|P2|NOT COMPLETED|Overall Study||0
7636109|NCT02252562|18802299|P1|NOT COMPLETED|Overall Study||0
7636110|NCT02252562|18802298|P2|COMPLETED|Overall Study||1636
7636111|NCT02252562|18802299|P1|COMPLETED|Overall Study||1620
7636112|NCT02252562|18802298|P2|STARTED|Overall Study||1636
7636113|NCT02252562|18802299|P1|STARTED|Overall Study||1620
7636114|NCT02252536|18802314|P2|NOT COMPLETED|Overall Study||3
7636115|NCT02252536|18802315|P1|NOT COMPLETED|Overall Study||5
7636116|NCT02252536|18802314|P2|COMPLETED|Overall Study||170
7636117|NCT02252536|18802315|P1|COMPLETED|Overall Study||168
7636118|NCT02252536|18802314|P2|STARTED|Overall Study||173
7636119|NCT02252536|18802315|P1|STARTED|Overall Study||173
7636120|NCT02252445|18802349|P2|NOT COMPLETED|Overall Study||0
7636121|NCT02252445|18802350|P1|NOT COMPLETED|Overall Study||0
7636122|NCT02252445|18802349|P2|COMPLETED|Overall Study||41
7636123|NCT02252445|18802350|P1|COMPLETED|Overall Study||41
7636124|NCT02252445|18802349|P2|STARTED|Overall Study||41
7636125|NCT02252445|18802350|P1|STARTED|Overall Study||41
7636126|NCT02252406|18802376|P2|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||1
7636127|NCT02252406|18802377|P1|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||3
7636128|NCT02252406|18802376|P2|COMPLETED|Titrated to Ranolazine 1000mg BID||13
7636129|NCT02252406|18802377|P1|COMPLETED|Titrated to Ranolazine 1000mg BID||9
7636130|NCT02252406|18802376|P2|STARTED|Titrated to Ranolazine 1000mg BID||14
7636131|NCT02252406|18802377|P1|STARTED|Titrated to Ranolazine 1000mg BID||12
7636132|NCT02252406|18802376|P2|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||3
7636133|NCT02252406|18802377|P1|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||4
7636134|NCT02252406|18802376|P2|COMPLETED|Starting Dose Ranolazine 500 mg BID||14
7636135|NCT02252406|18802377|P1|COMPLETED|Starting Dose Ranolazine 500 mg BID||12
7636136|NCT02252406|18802376|P2|STARTED|Starting Dose Ranolazine 500 mg BID||17
7636137|NCT02252406|18802377|P1|STARTED|Starting Dose Ranolazine 500 mg BID||16
7636138|NCT02252354|18802387|P2|NOT COMPLETED|Overall Study||0
7636139|NCT02252354|18802388|P1|NOT COMPLETED|Overall Study||0
7636140|NCT02252354|18802387|P2|COMPLETED|Overall Study||6
7636141|NCT02252354|18802388|P1|COMPLETED|Overall Study||6
7636142|NCT02252354|18802387|P2|STARTED|Overall Study||6
7636143|NCT02252354|18802388|P1|STARTED|Overall Study||6
7636144|NCT02252211|18802435|P3|NOT COMPLETED|Overall Study||1
7636145|NCT02252211|18802436|P2|NOT COMPLETED|Overall Study||3
7636146|NCT02252211|18802437|P1|NOT COMPLETED|Overall Study||5
7636147|NCT02252211|18802435|P3|COMPLETED|Overall Study||0
7636148|NCT02252211|18802436|P2|COMPLETED|Overall Study||0
7636149|NCT02252211|18802437|P1|COMPLETED|Overall Study||0
7636150|NCT02252211|18802435|P3|Received Further Doses (Through Dose 24)|Overall Study||0
7636151|NCT02252211|18802436|P2|Received Further Doses (Through Dose 24)|Overall Study||0
7636152|NCT02252211|18802437|P1|Received Further Doses (Through Dose 24)|Overall Study||1
7636153|NCT02252211|18802435|P3|Received Dose 4 (Day 36)|Overall Study||0
7636154|NCT02252211|18802436|P2|Received Dose 4 (Day 36)|Overall Study||1
7636155|NCT02252211|18802437|P1|Received Dose 4 (Day 36)|Overall Study||1
7636156|NCT02252211|18802435|P3|Received Dose 3 (Day 22)|Overall Study||0
7636157|NCT02252211|18802436|P2|Received Dose 3 (Day 22)|Overall Study||3
7636158|NCT02252211|18802437|P1|Received Dose 3 (Day 22)|Overall Study||3
7636159|NCT02252211|18802435|P3|Received Dose 2 (Day 8)|Overall Study||0
7636160|NCT02252211|18802436|P2|Received Dose 2 (Day 8)|Overall Study||3
7636161|NCT02252211|18802437|P1|Received Dose 2 (Day 8)|Overall Study||4
7636162|NCT02252211|18802435|P3|Received Dose 1 (Day 1)|Overall Study||0
7636163|NCT02252211|18802436|P2|Received Dose 1 (Day 1)|Overall Study||3
7636164|NCT02252211|18802437|P1|Received Dose 1 (Day 1)|Overall Study||4
7636165|NCT02252211|18802435|P3|STARTED|Overall Study||1
7636166|NCT02252211|18802436|P2|STARTED|Overall Study||3
7636167|NCT02252211|18802437|P1|STARTED|Overall Study||5
7636168|NCT02252172|18802474|P2|NOT COMPLETED|Overall Study||299
7636169|NCT02252172|18802475|P1|NOT COMPLETED|Overall Study||279
7636170|NCT02252172|18802474|P2|COMPLETED|Overall Study||69
7636171|NCT02252172|18802475|P1|COMPLETED|Overall Study||90
7636172|NCT02252172|18802474|P2|Treated|Overall Study||364
7636173|NCT02252172|18802475|P1|Treated|Overall Study||365
7636174|NCT02252172|18802474|P2|STARTED|Overall Study||368
7636175|NCT02252172|18802475|P1|STARTED|Overall Study||369
7636176|NCT02252146|18802487|P1|NOT COMPLETED|Overall Study||6
7636177|NCT02252146|18802487|P1|COMPLETED|Overall Study||0
7636178|NCT02252146|18802487|P1|STARTED|Overall Study||6
7636179|NCT02252133|18802491|P2|NOT COMPLETED|Period 2||0
7636180|NCT02252133|18802492|P1|NOT COMPLETED|Period 2||0
7636181|NCT02252133|18802491|P2|COMPLETED|Period 2||24
7636182|NCT02252133|18802492|P1|COMPLETED|Period 2||23
7636183|NCT02252133|18802491|P2|STARTED|Period 2||24
7636184|NCT02252133|18802492|P1|STARTED|Period 2||23
7636185|NCT02252133|18802491|P2|NOT COMPLETED|Period 1||0
7636186|NCT02252133|18802492|P1|NOT COMPLETED|Period 1||0
7636187|NCT02252133|18802491|P2|COMPLETED|Period 1||24
7636188|NCT02252133|18802492|P1|COMPLETED|Period 1||23
7636189|NCT02252133|18802491|P2|STARTED|Period 1||24
7636190|NCT02252133|18802492|P1|STARTED|Period 1||23
7636191|NCT02252068|18802501|P3|NOT COMPLETED|Overall Study||0
7636192|NCT02252068|18802502|P2|NOT COMPLETED|Overall Study||0
7636193|NCT02252068|18802503|P1|NOT COMPLETED|Overall Study||2
7636194|NCT02252068|18802501|P3|COMPLETED|Overall Study||13
7636195|NCT02252068|18802502|P2|COMPLETED|Overall Study||13
7636196|NCT02252068|18802503|P1|COMPLETED|Overall Study||3
7636197|NCT02252068|18802501|P3|STARTED|Overall Study||13
7636198|NCT02252068|18802502|P2|STARTED|Overall Study||13
7636199|NCT02252068|18802503|P1|STARTED|Overall Study||5
7636200|NCT02252042|18802528|P2|NOT COMPLETED|Overall Study||248
7636201|NCT02252042|18802529|P1|NOT COMPLETED|Overall Study||247
7636202|NCT02252042|18802528|P2|COMPLETED|Overall Study||0
7636203|NCT02252042|18802529|P1|COMPLETED|Overall Study||0
7636204|NCT02252042|18802528|P2|Treated|Overall Study|14 participants were randomized but did not receive study treatment.|234
7636205|NCT02252042|18802529|P1|Treated|Overall Study|1 participant was randomized but did not receive study treatment.|246
7636206|NCT02252042|18802528|P2|STARTED|Overall Study||248
7636207|NCT02252042|18802529|P1|STARTED|Overall Study||247
7636208|NCT02252016|18802569|P2|NOT COMPLETED|Overall Study||3
7636209|NCT02252016|18802570|P1|NOT COMPLETED|Overall Study||3
7636210|NCT02252016|18802569|P2|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|49
7636211|NCT02252016|18802570|P1|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|104
7636212|NCT02252016|18802569|P2|STARTED|Overall Study||52
7636213|NCT02252016|18802570|P1|STARTED|Overall Study||107
7636214|NCT02251990|18802584|P2|NOT COMPLETED|Period 3 (DTG Follow-up)||0
7636215|NCT02251990|18802585|P1|NOT COMPLETED|Period 3 (DTG Follow-up)||0
7636216|NCT02251990|18802584|P2|COMPLETED|Period 3 (DTG Follow-up)|Completed 24 weeks of follow-up|121
7636217|NCT02251990|18802585|P1|COMPLETED|Period 3 (DTG Follow-up)||0
7636218|NCT02251990|18802584|P2|STARTED|Period 3 (DTG Follow-up)|3 participants that discontinued treatment in Period 2 were included in Follow-up.|121
7636219|NCT02251990|18802585|P1|STARTED|Period 3 (DTG Follow-up)|The ITG completed the study with Period 2|0
7636220|NCT02251990|18802584|P2|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||3
7636221|NCT02251990|18802585|P1|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||0
7636222|NCT02251990|18802584|P2|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 12 weeks of Grazoprevir/Elbasvir|118
7636223|NCT02251990|18802585|P1|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 24 weeks of follow-up|360
7636224|NCT02251990|18802584|P2|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|1 participant completing Period 1 was not eligible for Period 2 and was not treated.|121
7636225|NCT02251990|18802585|P1|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|2 participants that did not complete Period 1 treatment were included in Follow-up.|360
7636226|NCT02251990|18802584|P2|NOT COMPLETED|Period 1 (Double-blind [DB])||1
7636227|NCT02251990|18802585|P1|NOT COMPLETED|Period 1 (Double-blind [DB])||8
7636228|NCT02251990|18802584|P2|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Placebo|122
7636229|NCT02251990|18802585|P1|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Grazoprevir/Elbasvir|358
7636230|NCT02251990|18802584|P2|Treated|Period 1 (Double-blind [DB])|Started Placebo|123
7636231|NCT02251990|18802585|P1|Treated|Period 1 (Double-blind [DB])|Started Grazoprevir/Elbasvir|365
7636232|NCT02251990|18802584|P2|STARTED|Period 1 (Double-blind [DB])||123
7636233|NCT02251990|18802585|P1|STARTED|Period 1 (Double-blind [DB])||366
7636234|NCT02251938|18802600|P1|NOT COMPLETED|Overall Study||17
7636235|NCT02251938|18802600|P1|COMPLETED|Overall Study||43
7636236|NCT02251938|18802600|P1|STARTED|Overall Study||60
7636237|NCT02251912|18802613|P2|NOT COMPLETED|Overall Study||5
7636238|NCT02251912|18802614|P1|NOT COMPLETED|Overall Study||2
7636239|NCT02251912|18802613|P2|COMPLETED|Overall Study||5
7636240|NCT02251912|18802614|P1|COMPLETED|Overall Study||10
7636241|NCT02251912|18802613|P2|STARTED|Overall Study||10
7636242|NCT02251912|18802614|P1|STARTED|Overall Study||12
7636243|NCT02251886|18802628|P4|NOT COMPLETED|Overall Study||0
7636244|NCT02251886|18802629|P3|NOT COMPLETED|Overall Study||0
7636245|NCT02251886|18802630|P2|NOT COMPLETED|Overall Study||0
7636246|NCT02251886|18802631|P1|NOT COMPLETED|Overall Study||0
7636247|NCT02251886|18802628|P4|COMPLETED|Overall Study||54
7636248|NCT02251886|18802629|P3|COMPLETED|Overall Study||44
7636249|NCT02251886|18802630|P2|COMPLETED|Overall Study||54
7636250|NCT02251886|18802631|P1|COMPLETED|Overall Study||48
7636251|NCT02251886|18802628|P4|STARTED|Overall Study||54
7636252|NCT02251886|18802629|P3|STARTED|Overall Study||44
7636253|NCT02251886|18802630|P2|STARTED|Overall Study||54
7636254|NCT02251886|18802631|P1|STARTED|Overall Study||48
7636255|NCT02251743|18802643|P2|NOT COMPLETED|Overall Study||1
7636256|NCT02251743|18802644|P1|NOT COMPLETED|Overall Study||1
7636257|NCT02251743|18802643|P2|COMPLETED|Overall Study||58
7636258|NCT02251743|18802644|P1|COMPLETED|Overall Study||84
7636259|NCT02251743|18802643|P2|STARTED|Overall Study||59
7636260|NCT02251743|18802644|P1|STARTED|Overall Study||85
7636261|NCT02251717|18802652|P2|NOT COMPLETED|Overall Study||1
7636262|NCT02251717|18802653|P1|NOT COMPLETED|Overall Study||1
7636263|NCT02251717|18802652|P2|COMPLETED|Overall Study||56
7636264|NCT02251717|18802653|P1|COMPLETED|Overall Study||56
7636265|NCT02251717|18802652|P2|STARTED|Overall Study||57
7636266|NCT02251717|18802653|P1|STARTED|Overall Study||57
7636267|NCT02251652|18802665|P1|NOT COMPLETED|Overall Study||1
7636268|NCT02251652|18802665|P1|COMPLETED|Overall Study||16
7636269|NCT02251652|18802665|P1|STARTED|Overall Study||17
7636270|NCT02251613|18802675|P1|NOT COMPLETED|Overall Study||0
7636271|NCT02251613|18802675|P1|COMPLETED|Overall Study||50
7636272|NCT02251613|18802675|P1|STARTED|Overall Study||50
7636273|NCT02251561|18802683|P1|NOT COMPLETED|Overall Study||0
7636274|NCT02251561|18802683|P1|COMPLETED|Overall Study||28
7636275|NCT02251561|18802683|P1|STARTED|Overall Study||28
7636276|NCT02251548|18802691|P1|NOT COMPLETED|Overall Study||85
7636277|NCT02251548|18802691|P1|COMPLETED|Overall Study||0
7636278|NCT02251548|18802691|P1|STARTED|Overall Study||85
7636279|NCT02251379|18802699|P2|NOT COMPLETED|Overall Study||20
7636280|NCT02251379|18802700|P1|NOT COMPLETED|Overall Study||20
7636281|NCT02251379|18802699|P2|COMPLETED|Overall Study||58
7636282|NCT02251379|18802700|P1|COMPLETED|Overall Study||57
7636283|NCT02251379|18802699|P2|STARTED|Overall Study||78
7636284|NCT02251379|18802700|P1|STARTED|Overall Study||77
7636285|NCT02251275|18802721|P5|NOT COMPLETED|Overall Study||1
7636286|NCT02251275|18802722|P4|NOT COMPLETED|Overall Study||1
7636287|NCT02251275|18802723|P3|NOT COMPLETED|Overall Study||94
7636288|NCT02251275|18802724|P2|NOT COMPLETED|Overall Study||147
7636289|NCT02251275|18802725|P1|NOT COMPLETED|Overall Study||72
7636290|NCT02251275|18802721|P5|COMPLETED|Overall Study||2
7636291|NCT02251275|18802722|P4|COMPLETED|Overall Study||5
7636292|NCT02251275|18802723|P3|COMPLETED|Overall Study||624
7636293|NCT02251275|18802724|P2|COMPLETED|Overall Study||423
7636294|NCT02251275|18802725|P1|COMPLETED|Overall Study||434
7636295|NCT02251275|18802721|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
7636296|NCT02251275|18802722|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
7636297|NCT02251275|18802723|P3|Received at Least 1 Dose of Study Drug|Overall Study||717
7636298|NCT02251275|18802724|P2|Received at Least 1 Dose of Study Drug|Overall Study||569
7636299|NCT02251275|18802725|P1|Received at Least 1 Dose of Study Drug|Overall Study||505
7636300|NCT02251275|18802721|P5|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|3
7636301|NCT02251275|18802722|P4|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|6
7636302|NCT02251275|18802723|P3|STARTED|Overall Study||718
7636303|NCT02251275|18802724|P2|STARTED|Overall Study||570
7636304|NCT02251275|18802725|P1|STARTED|Overall Study||506
7636305|NCT02251236|18802740|P3|NOT COMPLETED|Overall Study||0
7636306|NCT02251236|18802741|P2|NOT COMPLETED|Overall Study||0
7636307|NCT02251236|18802742|P1|NOT COMPLETED|Overall Study||0
7636308|NCT02251236|18802740|P3|COMPLETED|Overall Study||0
7636309|NCT02251236|18802741|P2|COMPLETED|Overall Study||5
7636310|NCT02251236|18802742|P1|COMPLETED|Overall Study||9
7636311|NCT02251236|18802740|P3|STARTED|Overall Study||0
7636312|NCT02251236|18802741|P2|STARTED|Overall Study||5
7636313|NCT02251236|18802742|P1|STARTED|Overall Study||9
7636314|NCT02250807|18802759|P1|NOT COMPLETED|Overall Study||0
7636315|NCT02250807|18802759|P1|COMPLETED|Overall Study||40
7636316|NCT02250807|18802759|P1|STARTED|Overall Study||40
7636317|NCT02250703|18802771|P2|NOT COMPLETED|Overall Study||1
7636318|NCT02250703|18802772|P1|NOT COMPLETED|Overall Study||1
7636319|NCT02250703|18802771|P2|COMPLETED|Overall Study||36
7636320|NCT02250703|18802772|P1|COMPLETED|Overall Study||37
7636321|NCT02250703|18802771|P2|STARTED|Overall Study||37
7636322|NCT02250703|18802772|P1|STARTED|Overall Study||38
7636323|NCT02250612|18802789|P5|NOT COMPLETED|Overall Study||1
7636324|NCT02250612|18802790|P4|NOT COMPLETED|Overall Study||0
7636325|NCT02250612|18802791|P3|NOT COMPLETED|Overall Study||2
7636326|NCT02250612|18802792|P2|NOT COMPLETED|Overall Study||2
7636327|NCT02250612|18802793|P1|NOT COMPLETED|Overall Study||1
7636328|NCT02250612|18802789|P5|COMPLETED|Overall Study||36
7636329|NCT02250612|18802790|P4|COMPLETED|Overall Study||33
7636330|NCT02250612|18802791|P3|COMPLETED|Overall Study||35
7636331|NCT02250612|18802792|P2|COMPLETED|Overall Study||38
7636332|NCT02250612|18802793|P1|COMPLETED|Overall Study||36
7636333|NCT02250612|18802789|P5|STARTED|Overall Study||37
7636334|NCT02250612|18802790|P4|STARTED|Overall Study||33
7636335|NCT02250612|18802791|P3|STARTED|Overall Study||37
7636336|NCT02250612|18802792|P2|STARTED|Overall Study||40
7636337|NCT02250612|18802793|P1|STARTED|Overall Study||37
7636338|NCT02250521|18802815|P1|NOT COMPLETED|Overall Study||1
7636339|NCT02250521|18802815|P1|COMPLETED|Overall Study||99
7636340|NCT02250521|18802815|P1|STARTED|Overall Study||100
7636341|NCT02250443|18802829|P1|NOT COMPLETED|Overall Study||10
7636342|NCT02250443|18802829|P1|COMPLETED|Overall Study||0
7636343|NCT02250443|18802829|P1|STARTED|Overall Study||10
7636344|NCT02250417|18802842|P2|NOT COMPLETED|Second Intervention (1 Night)||0
7636345|NCT02250417|18802843|P1|NOT COMPLETED|Second Intervention (1 Night)||0
7636346|NCT02250417|18802842|P2|COMPLETED|Second Intervention (1 Night)||6
7636347|NCT02250417|18802843|P1|COMPLETED|Second Intervention (1 Night)||6
7636348|NCT02250417|18802842|P2|STARTED|Second Intervention (1 Night)||6
7636349|NCT02250417|18802843|P1|STARTED|Second Intervention (1 Night)||6
7636350|NCT02250417|18802842|P2|NOT COMPLETED|First Intervention (1 Night)||0
7636351|NCT02250417|18802843|P1|NOT COMPLETED|First Intervention (1 Night)||0
7636352|NCT02250417|18802842|P2|COMPLETED|First Intervention (1 Night)||6
7636353|NCT02250417|18802843|P1|COMPLETED|First Intervention (1 Night)||6
7636354|NCT02250417|18802842|P2|STARTED|First Intervention (1 Night)||6
7636355|NCT02250417|18802843|P1|STARTED|First Intervention (1 Night)||6
7636356|NCT02250326|18802858|P3|NOT COMPLETED|Follow-Up Period||38
7636357|NCT02250326|18802859|P2|NOT COMPLETED|Follow-Up Period||30
7636358|NCT02250326|18802860|P1|NOT COMPLETED|Follow-Up Period||49
7636359|NCT02250326|18802858|P3|COMPLETED|Follow-Up Period||26
7636360|NCT02250326|18802859|P2|COMPLETED|Follow-Up Period||13
7636361|NCT02250326|18802860|P1|COMPLETED|Follow-Up Period||18
7636362|NCT02250326|18802858|P3|STARTED|Follow-Up Period||64
7636363|NCT02250326|18802859|P2|STARTED|Follow-Up Period||43
7636364|NCT02250326|18802860|P1|STARTED|Follow-Up Period||67
7636365|NCT02250326|18802858|P3|NOT COMPLETED|Treatment Period||77
7636366|NCT02250326|18802859|P2|NOT COMPLETED|Treatment Period||64
7636367|NCT02250326|18802860|P1|NOT COMPLETED|Treatment Period||81
7636368|NCT02250326|18802858|P3|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|3
7636369|NCT02250326|18802859|P2|COMPLETED|Treatment Period|Data Cut-off Date = 23 December 2017|15
7636370|NCT02250326|18802860|P1|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|0
7636371|NCT02250326|18802858|P3|Treated Population|Treatment Period||79
7636372|NCT02250326|18802859|P2|Treated Population|Treatment Period||78
7636373|NCT02250326|18802860|P1|Treated Population|Treatment Period||79
7636374|NCT02250326|18802858|P3|STARTED|Treatment Period||80
7636375|NCT02250326|18802859|P2|STARTED|Treatment Period||79
7636376|NCT02250326|18802860|P1|STARTED|Treatment Period||81
7636377|NCT02250274|18802893|P2|NOT COMPLETED|Overall Study||6
7636378|NCT02250274|18802894|P1|NOT COMPLETED|Overall Study||7
7636379|NCT02250274|18802893|P2|COMPLETED|Overall Study||40
7636380|NCT02250274|18802894|P1|COMPLETED|Overall Study||78
7636381|NCT02250274|18802893|P2|STARTED|Overall Study||46
7636382|NCT02250274|18802894|P1|STARTED|Overall Study||85
7636383|NCT02250183|18802910|P1|NOT COMPLETED|Overall Study||8
7636384|NCT02250183|18802910|P1|COMPLETED|Overall Study||13
7636385|NCT02250183|18802910|P1|STARTED|Overall Study||21
7636386|NCT02250092|18802921|P2|NOT COMPLETED|Overall Study||0
7636387|NCT02250092|18802922|P1|NOT COMPLETED|Overall Study||0
7636388|NCT02250092|18802921|P2|COMPLETED|Overall Study||10
7636389|NCT02250092|18802922|P1|COMPLETED|Overall Study||10
7636390|NCT02250092|18802921|P2|STARTED|Overall Study||10
7636391|NCT02250092|18802922|P1|STARTED|Overall Study||10
7636392|NCT02249949|18802932|P1|NOT COMPLETED|Overall Study||2
7636393|NCT02249949|18802932|P1|COMPLETED|Overall Study||11
7636394|NCT02249949|18802932|P1|STARTED|Overall Study||13
7636395|NCT02249832|18802939|P1|NOT COMPLETED|Overall Study||13
7636396|NCT02249832|18802939|P1|COMPLETED|Overall Study||42
7636397|NCT02249832|18802939|P1|STARTED|Overall Study||55
7636398|NCT02249819|18802951|P2|NOT COMPLETED|Overall Study||0
7636399|NCT02249819|18802952|P1|NOT COMPLETED|Overall Study||0
7636400|NCT02249819|18802951|P2|COMPLETED|Overall Study||7
7636401|NCT02249819|18802952|P1|COMPLETED|Overall Study||8
7636402|NCT02249819|18802951|P2|STARTED|Overall Study||7
7636403|NCT02249819|18802952|P1|STARTED|Overall Study||8
7636404|NCT02249793|18802958|P1|NOT COMPLETED|Session 2, 48-Hours Healthy Volunteers||0
7636405|NCT02249793|18802958|P1|COMPLETED|Session 2, 48-Hours Healthy Volunteers||6
7636406|NCT02249793|18802958|P1|STARTED|Session 2, 48-Hours Healthy Volunteers||6
7636407|NCT02249793|18802958|P1|NOT COMPLETED|Session 1, 48-hours Healthy Volunteers||0
7636408|NCT02249793|18802958|P1|COMPLETED|Session 1, 48-hours Healthy Volunteers||6
7636409|NCT02249793|18802958|P1|STARTED|Session 1, 48-hours Healthy Volunteers||6
7636410|NCT02249767|18802983|P3|NOT COMPLETED|Overall Study||8
7636411|NCT02249767|18802984|P2|NOT COMPLETED|Overall Study||9
7636412|NCT02249767|18802985|P1|NOT COMPLETED|Overall Study||8
7636413|NCT02249767|18802983|P3|COMPLETED|Overall Study||107
7636414|NCT02249767|18802984|P2|COMPLETED|Overall Study||220
7636415|NCT02249767|18802985|P1|COMPLETED|Overall Study||222
7636416|NCT02249767|18802983|P3|STARTED|Overall Study||115
7636417|NCT02249767|18802984|P2|STARTED|Overall Study||229
7636418|NCT02249767|18802985|P1|STARTED|Overall Study||230
7636419|NCT02249728|18802993|P1|NOT COMPLETED|Part Two (up to 6 Days)||0
7636420|NCT02249728|18802993|P1|COMPLETED|Part Two (up to 6 Days)||6
7636421|NCT02249728|18802993|P1|STARTED|Part Two (up to 6 Days)||6
7636422|NCT02249728|18802993|P1|NOT COMPLETED|Part One (4 Days)||0
7636423|NCT02249728|18802993|P1|COMPLETED|Part One (4 Days)||6
7636424|NCT02249728|18802993|P1|STARTED|Part One (4 Days)||6
7636425|NCT02249585|18803006|P3|NOT COMPLETED|Overall Study||0
7636426|NCT02249585|18803007|P2|NOT COMPLETED|Overall Study||0
7636427|NCT02249585|18803008|P1|NOT COMPLETED|Overall Study||0
7636428|NCT02249585|18803006|P3|COMPLETED|Overall Study||44
7636429|NCT02249585|18803007|P2|COMPLETED|Overall Study||44
7636430|NCT02249585|18803008|P1|COMPLETED|Overall Study||43
7636431|NCT02249585|18803006|P3|STARTED|Overall Study||44
7636432|NCT02249585|18803007|P2|STARTED|Overall Study||44
7636433|NCT02249585|18803008|P1|STARTED|Overall Study||43
7636434|NCT02249377|18803033|P2|NOT COMPLETED|Overall Study||24
7636435|NCT02249377|18803034|P1|NOT COMPLETED|Overall Study||25
7636436|NCT02249377|18803033|P2|COMPLETED|Overall Study||1
7636437|NCT02249377|18803034|P1|COMPLETED|Overall Study||0
7636438|NCT02249377|18803033|P2|STARTED|Overall Study||25
7636439|NCT02249377|18803034|P1|STARTED|Overall Study||25
7636440|NCT02249182|18803051|P5|NOT COMPLETED|Treatment Phase||0
7636441|NCT02249182|18803052|P4|NOT COMPLETED|Treatment Phase||0
7636442|NCT02249182|18803053|P3|NOT COMPLETED|Treatment Phase||0
7636443|NCT02249182|18803054|P2|NOT COMPLETED|Treatment Phase||0
7636444|NCT02249182|18803055|P1|NOT COMPLETED|Treatment Phase||4
7636445|NCT02249182|18803051|P5|COMPLETED|Treatment Phase||34
7636446|NCT02249182|18803052|P4|COMPLETED|Treatment Phase||2
7636447|NCT02249182|18803053|P3|COMPLETED|Treatment Phase||1
7636448|NCT02249182|18803054|P2|COMPLETED|Treatment Phase||89
7636449|NCT02249182|18803055|P1|COMPLETED|Treatment Phase||96
7636450|NCT02249182|18803051|P5|STARTED|Treatment Phase|17 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|34
7636451|NCT02249182|18803052|P4|STARTED|Treatment Phase|2 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|2
7636452|NCT02249182|18803053|P3|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|1
7636453|NCT02249182|18803054|P2|STARTED|Treatment Phase|77 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|89
7636454|NCT02249182|18803055|P1|STARTED|Treatment Phase|90 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|100
7636455|NCT02249182|18803051|P5|NOT COMPLETED|PK Lead-In Phase||0
7636456|NCT02249182|18803052|P4|NOT COMPLETED|PK Lead-In Phase||0
7636457|NCT02249182|18803053|P3|NOT COMPLETED|PK Lead-In Phase||0
7636458|NCT02249182|18803054|P2|NOT COMPLETED|PK Lead-In Phase||0
7636459|NCT02249182|18803055|P1|NOT COMPLETED|PK Lead-In Phase||0
7636460|NCT02249182|18803051|P5|COMPLETED|PK Lead-In Phase||17
7636461|NCT02249182|18803052|P4|COMPLETED|PK Lead-In Phase||0
7636462|NCT02249182|18803053|P3|COMPLETED|PK Lead-In Phase||0
7636463|NCT02249182|18803054|P2|COMPLETED|PK Lead-In Phase||12
7636464|NCT02249182|18803055|P1|COMPLETED|PK Lead-In Phase||10
7636465|NCT02249182|18803051|P5|STARTED|PK Lead-In Phase||17
7636466|NCT02249182|18803052|P4|STARTED|PK Lead-In Phase||0
7636467|NCT02249182|18803053|P3|STARTED|PK Lead-In Phase||0
7636468|NCT02249182|18803054|P2|STARTED|PK Lead-In Phase||12
7636469|NCT02249182|18803055|P1|STARTED|PK Lead-In Phase||10
7636470|NCT02249143|18803143|P2|NOT COMPLETED|Overall Study||4
7636471|NCT02249143|18803144|P1|NOT COMPLETED|Overall Study||2
7636472|NCT02249143|18803143|P2|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
7636473|NCT02249143|18803144|P1|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
7636474|NCT02249143|18803143|P2|STARTED|Overall Study|randomized|26
7636475|NCT02249143|18803144|P1|STARTED|Overall Study||24
7636476|NCT02249104|18803170|P1|NOT COMPLETED|Overall Study||3
7636477|NCT02249104|18803170|P1|COMPLETED|Overall Study||25
7636478|NCT02249104|18803170|P1|STARTED|Overall Study||28
7636479|NCT02249065|18803179|P1|NOT COMPLETED|Overall Study||29
7636480|NCT02249065|18803179|P1|COMPLETED|Overall Study||176
7636481|NCT02249065|18803179|P1|Treated|Overall Study||181
7636482|NCT02249065|18803179|P1|STARTED|Overall Study||205
7636483|NCT02249052|18803187|P1|NOT COMPLETED|Overall Study||0
7636484|NCT02249052|18803187|P1|COMPLETED|Overall Study||19
7636485|NCT02249052|18803187|P1|STARTED|Overall Study||19
7636486|NCT02248974|18803205|P2|NOT COMPLETED|1-Month Follow-Up||3
7636487|NCT02248974|18803206|P1|NOT COMPLETED|1-Month Follow-Up||2
7636488|NCT02248974|18803205|P2|COMPLETED|1-Month Follow-Up||31
7636489|NCT02248974|18803206|P1|COMPLETED|1-Month Follow-Up||27
7636490|NCT02248974|18803205|P2|STARTED|1-Month Follow-Up||34
7636491|NCT02248974|18803206|P1|STARTED|1-Month Follow-Up||29
7636492|NCT02248974|18803205|P2|NOT COMPLETED|1-Week Follow-Up||17
7636493|NCT02248974|18803206|P1|NOT COMPLETED|1-Week Follow-Up||8
7636494|NCT02248974|18803205|P2|COMPLETED|1-Week Follow-Up||34
7636495|NCT02248974|18803206|P1|COMPLETED|1-Week Follow-Up||29
7636496|NCT02248974|18803205|P2|STARTED|1-Week Follow-Up||51
7636497|NCT02248974|18803206|P1|STARTED|1-Week Follow-Up||37
7636498|NCT02248974|18803205|P2|NOT COMPLETED|1-Day Follow-Up||0
7636499|NCT02248974|18803206|P1|NOT COMPLETED|1-Day Follow-Up||10
7636500|NCT02248974|18803205|P2|COMPLETED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
7636501|NCT02248974|18803206|P1|COMPLETED|1-Day Follow-Up||37
7636502|NCT02248974|18803205|P2|STARTED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
7636503|NCT02248974|18803206|P1|STARTED|1-Day Follow-Up||47
7636504|NCT02248974|18803205|P2|NOT COMPLETED|Baseline||0
7636505|NCT02248974|18803206|P1|NOT COMPLETED|Baseline||0
7636506|NCT02248974|18803205|P2|COMPLETED|Baseline||51
7636507|NCT02248974|18803206|P1|COMPLETED|Baseline||47
7636508|NCT02248974|18803205|P2|STARTED|Baseline||51
7636509|NCT02248974|18803206|P1|STARTED|Baseline||47
7636510|NCT02248961|18803284|P2|NOT COMPLETED|Overall Study||2
7636511|NCT02248961|18803285|P1|NOT COMPLETED|Overall Study||3
7636512|NCT02248961|18803284|P2|COMPLETED|Overall Study||88
7636513|NCT02248961|18803285|P1|COMPLETED|Overall Study||86
7636514|NCT02248961|18803284|P2|STARTED|Overall Study||90
7636515|NCT02248961|18803285|P1|STARTED|Overall Study||89
7636516|NCT02248922|18803305|P2|NOT COMPLETED|Overall Study||0
7636517|NCT02248922|18803306|P1|NOT COMPLETED|Overall Study||0
7636518|NCT02248922|18803305|P2|COMPLETED|Overall Study||12
7636519|NCT02248922|18803306|P1|COMPLETED|Overall Study||5
7636520|NCT02248922|18803305|P2|STARTED|Overall Study||12
7636521|NCT02248922|18803306|P1|STARTED|Overall Study||5
7636522|NCT02248857|18803320|P3|NOT COMPLETED|6 Month||17
7636523|NCT02248857|18803321|P2|NOT COMPLETED|6 Month||29
7636524|NCT02248857|18803322|P1|NOT COMPLETED|6 Month||28
7636525|NCT02248857|18803320|P3|COMPLETED|6 Month||106
7636526|NCT02248857|18803321|P2|COMPLETED|6 Month||136
7636527|NCT02248857|18803322|P1|COMPLETED|6 Month||120
7636528|NCT02248857|18803320|P3|STARTED|6 Month|127 baseline - 4 who withdrew = 123|123
7636529|NCT02248857|18803321|P2|STARTED|6 Month|168 baseline - 3 who withdrew = 165|165
7636530|NCT02248857|18803322|P1|STARTED|6 Month|157 baseline - 9 who withdrew = 148|148
7636531|NCT02248857|18803320|P3|NOT COMPLETED|3 Month||31
7636532|NCT02248857|18803321|P2|NOT COMPLETED|3 Month||34
7636533|NCT02248857|18803322|P1|NOT COMPLETED|3 Month||46
7636534|NCT02248857|18803320|P3|COMPLETED|3 Month||96
7636535|NCT02248857|18803321|P2|COMPLETED|3 Month||134
7636536|NCT02248857|18803322|P1|COMPLETED|3 Month||111
7636537|NCT02248857|18803320|P3|STARTED|3 Month||127
7636538|NCT02248857|18803321|P2|STARTED|3 Month||168
7636539|NCT02248857|18803322|P1|STARTED|3 Month||157
7636540|NCT02248857|18803320|P3|NOT COMPLETED|Baseline||0
7636541|NCT02248857|18803321|P2|NOT COMPLETED|Baseline||0
7636542|NCT02248857|18803322|P1|NOT COMPLETED|Baseline||0
7636543|NCT02248857|18803320|P3|COMPLETED|Baseline||127
7636544|NCT02248857|18803321|P2|COMPLETED|Baseline||168
7636545|NCT02248857|18803322|P1|COMPLETED|Baseline||157
7636546|NCT02248857|18803320|P3|STARTED|Baseline||127
7636547|NCT02248857|18803321|P2|STARTED|Baseline||168
7636548|NCT02248857|18803322|P1|STARTED|Baseline||157
7636549|NCT02248818|18803359|P9|NOT COMPLETED|Randomised Study||0
7636550|NCT02248818|18803360|P8|NOT COMPLETED|Randomised Study||0
7636551|NCT02248818|18803361|P7|NOT COMPLETED|Randomised Study||0
7636552|NCT02248818|18803362|P6|NOT COMPLETED|Randomised Study||8
7636553|NCT02248818|18803363|P5|NOT COMPLETED|Randomised Study||0
7636554|NCT02248818|18803364|P4|NOT COMPLETED|Randomised Study||0
7636555|NCT02248818|18803365|P3|NOT COMPLETED|Randomised Study||0
7636556|NCT02248818|18803366|P2|NOT COMPLETED|Randomised Study||0
7636557|NCT02248818|18803367|P1|NOT COMPLETED|Randomised Study||0
7636558|NCT02248818|18803359|P9|COMPLETED|Randomised Study||0
7636559|NCT02248818|18803360|P8|COMPLETED|Randomised Study||4
7636560|NCT02248818|18803361|P7|COMPLETED|Randomised Study||6
7636561|NCT02248818|18803362|P6|COMPLETED|Randomised Study||0
7636562|NCT02248818|18803363|P5|COMPLETED|Randomised Study||6
7636563|NCT02248818|18803364|P4|COMPLETED|Randomised Study||6
7636564|NCT02248818|18803365|P3|COMPLETED|Randomised Study||6
7636565|NCT02248818|18803366|P2|COMPLETED|Randomised Study||6
7636566|NCT02248818|18803367|P1|COMPLETED|Randomised Study||6
7636567|NCT02248818|18803359|P9|STARTED|Randomised Study||0
7636568|NCT02248818|18803360|P8|STARTED|Randomised Study||4
7636569|NCT02248818|18803361|P7|STARTED|Randomised Study||6
7636570|NCT02248818|18803362|P6|STARTED|Randomised Study||8
7636571|NCT02248818|18803363|P5|STARTED|Randomised Study||6
7636572|NCT02248818|18803364|P4|STARTED|Randomised Study||6
7636573|NCT02248818|18803365|P3|STARTED|Randomised Study||6
7636574|NCT02248818|18803366|P2|STARTED|Randomised Study||6
7636575|NCT02248818|18803367|P1|STARTED|Randomised Study||6
7636576|NCT02248818|18803359|P9|NOT COMPLETED|Screening||107
7636577|NCT02248818|18803360|P8|NOT COMPLETED|Screening||0
7636578|NCT02248818|18803361|P7|NOT COMPLETED|Screening||0
7636579|NCT02248818|18803362|P6|NOT COMPLETED|Screening||0
7636580|NCT02248818|18803363|P5|NOT COMPLETED|Screening||0
7636581|NCT02248818|18803364|P4|NOT COMPLETED|Screening||0
7636582|NCT02248818|18803365|P3|NOT COMPLETED|Screening||0
7636583|NCT02248818|18803366|P2|NOT COMPLETED|Screening||0
7636584|NCT02248818|18803367|P1|NOT COMPLETED|Screening||0
7636585|NCT02248818|18803359|P9|COMPLETED|Screening||48
7636586|NCT02248818|18803360|P8|COMPLETED|Screening||0
7636587|NCT02248818|18803361|P7|COMPLETED|Screening||0
7636588|NCT02248818|18803362|P6|COMPLETED|Screening||0
7636589|NCT02248818|18803363|P5|COMPLETED|Screening||0
7636590|NCT02248818|18803364|P4|COMPLETED|Screening||0
7636591|NCT02248818|18803365|P3|COMPLETED|Screening||0
7636592|NCT02248818|18803366|P2|COMPLETED|Screening||0
7636593|NCT02248818|18803367|P1|COMPLETED|Screening||0
7636594|NCT02248818|18803359|P9|STARTED|Screening||155
7636595|NCT02248818|18803360|P8|STARTED|Screening||0
7636596|NCT02248818|18803361|P7|STARTED|Screening||0
7636597|NCT02248818|18803362|P6|STARTED|Screening||0
7636598|NCT02248818|18803363|P5|STARTED|Screening||0
7636599|NCT02248818|18803364|P4|STARTED|Screening||0
7636600|NCT02248818|18803365|P3|STARTED|Screening||0
7636601|NCT02248818|18803366|P2|STARTED|Screening||0
7636602|NCT02248818|18803367|P1|STARTED|Screening||0
7636603|NCT02248766|18803505|P1|NOT COMPLETED|Overall Study||0
7636604|NCT02248766|18803505|P1|COMPLETED|Overall Study||30
7636605|NCT02248766|18803505|P1|STARTED|Overall Study||30
7636606|NCT02248740|18803519|P2|NOT COMPLETED|Overall Study||18
7636607|NCT02248740|18803520|P1|NOT COMPLETED|Overall Study||18
7636608|NCT02248740|18803519|P2|COMPLETED|Overall Study||0
7636609|NCT02248740|18803520|P1|COMPLETED|Overall Study||0
7636610|NCT02248740|18803519|P2|STARTED|Overall Study||18
7636611|NCT02248740|18803520|P1|STARTED|Overall Study||18
7636612|NCT02248727|18803530|P1|NOT COMPLETED|Overall Study||0
7636613|NCT02248727|18803530|P1|COMPLETED|Overall Study||30
7636614|NCT02248727|18803530|P1|STARTED|Overall Study||30
7636615|NCT02248714|18803543|P2|NOT COMPLETED|Overall Study||4
7636616|NCT02248714|18803544|P1|NOT COMPLETED|Overall Study||4
7636617|NCT02248714|18803543|P2|COMPLETED|Overall Study||61
7636618|NCT02248714|18803544|P1|COMPLETED|Overall Study||62
7636619|NCT02248714|18803543|P2|STARTED|Overall Study||65
7636620|NCT02248714|18803544|P1|STARTED|Overall Study||66
7636621|NCT02248675|18803582|P2|NOT COMPLETED|Overall Study||1
7636622|NCT02248675|18803583|P1|NOT COMPLETED|Overall Study||3
7636623|NCT02248675|18803582|P2|COMPLETED|Overall Study||27
7636624|NCT02248675|18803583|P1|COMPLETED|Overall Study||23
7636625|NCT02248675|18803582|P2|STARTED|Overall Study||28
7636626|NCT02248675|18803583|P1|STARTED|Overall Study||26
7636627|NCT02248662|18803597|P2|NOT COMPLETED|Overall Study||30515
7636628|NCT02248662|18803598|P1|NOT COMPLETED|Overall Study||4563
7636629|NCT02248662|18803597|P2|COMPLETED|Overall Study||2679
7636630|NCT02248662|18803598|P1|COMPLETED|Overall Study||757
7636631|NCT02248662|18803597|P2|STARTED|Overall Study||33194
7636632|NCT02248662|18803598|P1|STARTED|Overall Study||5320
7636633|NCT02248649|18803610|P2|NOT COMPLETED|Overall Study||21
7636634|NCT02248649|18803611|P1|NOT COMPLETED|Overall Study||21
7636635|NCT02248649|18803610|P2|COMPLETED|Overall Study||59
7636636|NCT02248649|18803611|P1|COMPLETED|Overall Study||59
7636637|NCT02248649|18803610|P2|STARTED|Overall Study||80
7636638|NCT02248649|18803611|P1|STARTED|Overall Study||80
7636639|NCT02248636|18803623|P2|NOT COMPLETED|Overall Study||3
7636640|NCT02248636|18803624|P1|NOT COMPLETED|Overall Study||6
7636641|NCT02248636|18803623|P2|COMPLETED|Overall Study||32
7636642|NCT02248636|18803624|P1|COMPLETED|Overall Study||20
7636643|NCT02248636|18803623|P2|STARTED|Overall Study||35
7636644|NCT02248636|18803624|P1|STARTED|Overall Study||26
7636645|NCT02248558|18803642|P2|NOT COMPLETED|Overall Study||45
7636646|NCT02248558|18803643|P1|NOT COMPLETED|Overall Study||52
7636647|NCT02248558|18803642|P2|COMPLETED|Overall Study||307
7636648|NCT02248558|18803643|P1|COMPLETED|Overall Study||317
7636649|NCT02248558|18803642|P2|STARTED|Overall Study||352
7636650|NCT02248558|18803643|P1|STARTED|Overall Study||369
7636651|NCT02248480|18803655|P2|NOT COMPLETED|Overall Study||14
7636652|NCT02248480|18803656|P1|NOT COMPLETED|Overall Study||17
7636653|NCT02248480|18803655|P2|COMPLETED|Overall Study||162
7636654|NCT02248480|18803656|P1|COMPLETED|Overall Study||161
7636655|NCT02248480|18803655|P2|Efficacy Population|Overall Study||176
7636656|NCT02248480|18803656|P1|Efficacy Population|Overall Study||177
7636657|NCT02248480|18803655|P2|STARTED|Overall Study||176
7636658|NCT02248480|18803656|P1|STARTED|Overall Study||178
7636659|NCT02248285|18803696|P2|NOT COMPLETED|Overall Study||287
7636660|NCT02248285|18803697|P1|NOT COMPLETED|Overall Study||101
7636661|NCT02248285|18803696|P2|COMPLETED|Overall Study||571
7636662|NCT02248285|18803697|P1|COMPLETED|Overall Study||586
7636663|NCT02248285|18803696|P2|STARTED|Overall Study||858
7636664|NCT02248285|18803697|P1|STARTED|Overall Study||687
7636665|NCT02248246|18803703|P1|NOT COMPLETED|Overall Study||0
7636666|NCT02248246|18803703|P1|COMPLETED|Overall Study||40
7636667|NCT02248246|18803703|P1|STARTED|Overall Study||40
7636668|NCT02248103|18803710|P2|NOT COMPLETED|Overall Study||0
7636669|NCT02248103|18803711|P1|NOT COMPLETED|Overall Study||0
7636670|NCT02248103|18803710|P2|COMPLETED|Overall Study||10
7636671|NCT02248103|18803711|P1|COMPLETED|Overall Study||10
7636672|NCT02248103|18803710|P2|STARTED|Overall Study||10
7636673|NCT02248103|18803711|P1|STARTED|Overall Study||10
7636674|NCT02247960|18803723|P2|NOT COMPLETED|Catheter Removed||10
7636675|NCT02247960|18803724|P1|NOT COMPLETED|Catheter Removed||7
7636676|NCT02247960|18803723|P2|COMPLETED|Catheter Removed||74
7636677|NCT02247960|18803724|P1|COMPLETED|Catheter Removed||76
7636678|NCT02247960|18803723|P2|STARTED|Catheter Removed||84
7636679|NCT02247960|18803724|P1|STARTED|Catheter Removed||83
7636680|NCT02247960|18803723|P2|NOT COMPLETED|Patient Consent and Randomization||6
7636681|NCT02247960|18803724|P1|NOT COMPLETED|Patient Consent and Randomization||2
7636682|NCT02247960|18803723|P2|COMPLETED|Patient Consent and Randomization||84
7636683|NCT02247960|18803724|P1|COMPLETED|Patient Consent and Randomization||83
7636684|NCT02247960|18803723|P2|STARTED|Patient Consent and Randomization||90
7636685|NCT02247960|18803724|P1|STARTED|Patient Consent and Randomization||85
7636686|NCT02247804|18803737|P3|NOT COMPLETED|Treatment Period 3||10
7636687|NCT02247804|18803738|P2|NOT COMPLETED|Treatment Period 3||10
7636688|NCT02247804|18803739|P1|NOT COMPLETED|Treatment Period 3||11
7636689|NCT02247804|18803737|P3|COMPLETED|Treatment Period 3||167
7636690|NCT02247804|18803738|P2|COMPLETED|Treatment Period 3||173
7636691|NCT02247804|18803739|P1|COMPLETED|Treatment Period 3||147
7636692|NCT02247804|18803737|P3|STARTED|Treatment Period 3||177
7636693|NCT02247804|18803738|P2|STARTED|Treatment Period 3||183
7636694|NCT02247804|18803739|P1|STARTED|Treatment Period 3||158
7636695|NCT02247804|18803737|P3|NOT COMPLETED|Treatment Period 2||8
7636696|NCT02247804|18803738|P2|NOT COMPLETED|Treatment Period 2||5
7636697|NCT02247804|18803739|P1|NOT COMPLETED|Treatment Period 2||8
7636698|NCT02247804|18803737|P3|COMPLETED|Treatment Period 2||179
7636699|NCT02247804|18803738|P2|COMPLETED|Treatment Period 2||186
7636700|NCT02247804|18803739|P1|COMPLETED|Treatment Period 2||164
7636701|NCT02247804|18803737|P3|STARTED|Treatment Period 2||187
7636702|NCT02247804|18803738|P2|STARTED|Treatment Period 2||191
7636703|NCT02247804|18803739|P1|STARTED|Treatment Period 2||172
7636704|NCT02247804|18803737|P3|NOT COMPLETED|Treatment Period 1||8
7636705|NCT02247804|18803738|P2|NOT COMPLETED|Treatment Period 1||4
7636706|NCT02247804|18803739|P1|NOT COMPLETED|Treatment Period 1||22
7636707|NCT02247804|18803737|P3|COMPLETED|Treatment Period 1||190
7636708|NCT02247804|18803738|P2|COMPLETED|Treatment Period 1||194
7636709|NCT02247804|18803739|P1|COMPLETED|Treatment Period 1||176
7636710|NCT02247804|18803737|P3|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
7636711|NCT02247804|18803738|P2|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
7636712|NCT02247804|18803739|P1|Received (Sham or Bimatoprost SR)|Treatment Period 1||193
7636713|NCT02247804|18803737|P3|STARTED|Treatment Period 1||198
7636714|NCT02247804|18803738|P2|STARTED|Treatment Period 1||198
7636715|NCT02247804|18803739|P1|STARTED|Treatment Period 1||198
7636716|NCT02247765|18803768|P1|NOT COMPLETED|Overall Study||0
7636717|NCT02247765|18803768|P1|COMPLETED|Overall Study||18
7636718|NCT02247765|18803768|P1|STARTED|Overall Study||18
7636719|NCT02247739|18803773|P6|NOT COMPLETED|Overall Study||1
7636720|NCT02247739|18803774|P5|NOT COMPLETED|Overall Study||1
7636721|NCT02247739|18803775|P4|NOT COMPLETED|Overall Study||0
7636722|NCT02247739|18803776|P3|NOT COMPLETED|Overall Study||1
7636723|NCT02247739|18803777|P2|NOT COMPLETED|Overall Study||3
7636724|NCT02247739|18803778|P1|NOT COMPLETED|Overall Study||0
7636725|NCT02247739|18803773|P6|COMPLETED|Overall Study||4
7636726|NCT02247739|18803774|P5|COMPLETED|Overall Study||5
7636727|NCT02247739|18803775|P4|COMPLETED|Overall Study||5
7636728|NCT02247739|18803776|P3|COMPLETED|Overall Study||4
7636729|NCT02247739|18803777|P2|COMPLETED|Overall Study||3
7636730|NCT02247739|18803778|P1|COMPLETED|Overall Study||5
7636731|NCT02247739|18803773|P6|STARTED|Overall Study||5
7636732|NCT02247739|18803774|P5|STARTED|Overall Study||6
7636733|NCT02247739|18803775|P4|STARTED|Overall Study||5
7636734|NCT02247739|18803776|P3|STARTED|Overall Study||5
7636735|NCT02247739|18803777|P2|STARTED|Overall Study||6
7636736|NCT02247739|18803778|P1|STARTED|Overall Study||5
7636737|NCT02247531|18803797|P3|NOT COMPLETED|Overall Study||110
7636738|NCT02247531|18803798|P2|NOT COMPLETED|Overall Study||125
7636739|NCT02247531|18803799|P1|NOT COMPLETED|Overall Study||106
7636740|NCT02247531|18803797|P3|COMPLETED|Overall Study||214
7636741|NCT02247531|18803798|P2|COMPLETED|Overall Study||205
7636742|NCT02247531|18803799|P1|COMPLETED|Overall Study||215
7636743|NCT02247531|18803797|P3|STARTED|Overall Study||324
7636744|NCT02247531|18803798|P2|STARTED|Overall Study||330
7636745|NCT02247531|18803799|P1|STARTED|Overall Study||321
7636746|NCT02247479|18803849|P3|NOT COMPLETED|Overall Study||138
7636747|NCT02247479|18803850|P2|NOT COMPLETED|Overall Study||138
7636748|NCT02247479|18803851|P1|NOT COMPLETED|Overall Study||142
7636749|NCT02247479|18803849|P3|COMPLETED|Overall Study||165
7636750|NCT02247479|18803850|P2|COMPLETED|Overall Study||160
7636751|NCT02247479|18803851|P1|COMPLETED|Overall Study||163
7636752|NCT02247479|18803849|P3|STARTED|Overall Study||303
7636753|NCT02247479|18803850|P2|STARTED|Overall Study||298
7636754|NCT02247479|18803851|P1|STARTED|Overall Study||305
7636755|NCT02247466|18803900|P2|NOT COMPLETED|Overall Study||3
7636756|NCT02247466|18803901|P1|NOT COMPLETED|Overall Study||0
7636757|NCT02247466|18803900|P2|COMPLETED|Overall Study||15
7636758|NCT02247466|18803901|P1|COMPLETED|Overall Study||19
7636759|NCT02247466|18803900|P2|STARTED|Overall Study||18
7636760|NCT02247466|18803901|P1|STARTED|Overall Study||19
7636761|NCT02247440|18803919|P1|NOT COMPLETED|Overall Study||4
7636762|NCT02247440|18803919|P1|COMPLETED|Overall Study||14
7636763|NCT02247440|18803919|P1|STARTED|Overall Study||18
7636764|NCT02247401|18803932|P3|NOT COMPLETED|Overall Study||2
7636765|NCT02247401|18803933|P2|NOT COMPLETED|Overall Study||2
7636766|NCT02247401|18803934|P1|NOT COMPLETED|Overall Study||6
7636767|NCT02247401|18803932|P3|COMPLETED|Overall Study||27
7636768|NCT02247401|18803933|P2|COMPLETED|Overall Study||29
7636769|NCT02247401|18803934|P1|COMPLETED|Overall Study||94
7636770|NCT02247401|18803932|P3|STARTED|Overall Study||29
7636771|NCT02247401|18803933|P2|STARTED|Overall Study||31
7636772|NCT02247401|18803934|P1|STARTED|Overall Study||100
7636773|NCT02247245|18803955|P4|NOT COMPLETED|Overall Study||0
7636774|NCT02247245|18803956|P3|NOT COMPLETED|Overall Study||0
7636775|NCT02247245|18803957|P2|NOT COMPLETED|Overall Study||0
7636776|NCT02247245|18803958|P1|NOT COMPLETED|Overall Study||0
7636777|NCT02247245|18803955|P4|COMPLETED|Overall Study||7
7636778|NCT02247245|18803956|P3|COMPLETED|Overall Study||7
7636779|NCT02247245|18803957|P2|COMPLETED|Overall Study||13
7636780|NCT02247245|18803958|P1|COMPLETED|Overall Study||13
7636781|NCT02247245|18803955|P4|STARTED|Overall Study||7
7636782|NCT02247245|18803956|P3|STARTED|Overall Study||7
7636783|NCT02247245|18803957|P2|STARTED|Overall Study||13
7636784|NCT02247245|18803958|P1|STARTED|Overall Study||13
7636785|NCT02247063|18803970|P2|NOT COMPLETED|Overall Study||0
7636786|NCT02247063|18803971|P1|NOT COMPLETED|Overall Study||0
7636787|NCT02247063|18803970|P2|COMPLETED|Overall Study||12
7636788|NCT02247063|18803971|P1|COMPLETED|Overall Study||12
7636789|NCT02247063|18803970|P2|STARTED|Overall Study||12
7636790|NCT02247063|18803971|P1|STARTED|Overall Study||12
7636791|NCT02247011|18803981|P1|NOT COMPLETED|Overall Study||125
7636792|NCT02247011|18803981|P1|COMPLETED|Overall Study||975
7636793|NCT02247011|18803981|P1|STARTED|Overall Study||1100
7636794|NCT02246998|18804002|P4|NOT COMPLETED|Overall Study||2
7636795|NCT02246998|18804003|P3|NOT COMPLETED|Overall Study||3
7636796|NCT02246998|18804004|P2|NOT COMPLETED|Overall Study||3
7636797|NCT02246998|18804005|P1|NOT COMPLETED|Overall Study||2
7636798|NCT02246998|18804002|P4|COMPLETED|Overall Study||16
7636799|NCT02246998|18804003|P3|COMPLETED|Overall Study||15
7636800|NCT02246998|18804004|P2|COMPLETED|Overall Study||15
7636801|NCT02246998|18804005|P1|COMPLETED|Overall Study||16
7636802|NCT02246998|18804002|P4|STARTED|Overall Study||18
7636803|NCT02246998|18804003|P3|STARTED|Overall Study||18
7636804|NCT02246998|18804004|P2|STARTED|Overall Study||18
7636805|NCT02246998|18804005|P1|STARTED|Overall Study||18
7636806|NCT02246777|18804115|P1|NOT COMPLETED|Overall Study||3
7636807|NCT02246777|18804115|P1|COMPLETED|Overall Study||29
7636808|NCT02246777|18804115|P1|STARTED|Overall Study||32
7636809|NCT02246764|18804131|P3|NOT COMPLETED|Overall Study||4
7636810|NCT02246764|18804132|P2|NOT COMPLETED|Overall Study||32
7636811|NCT02246764|18804133|P1|NOT COMPLETED|Overall Study||18
7636812|NCT02246764|18804131|P3|COMPLETED|Overall Study||19
7636813|NCT02246764|18804132|P2|COMPLETED|Overall Study||4
7636814|NCT02246764|18804133|P1|COMPLETED|Overall Study||16
7636815|NCT02246764|18804131|P3|STARTED|Overall Study||23
7636816|NCT02246764|18804132|P2|STARTED|Overall Study||36
7636817|NCT02246764|18804133|P1|STARTED|Overall Study||34
7636818|NCT02246673|18804146|P5|NOT COMPLETED|Overall Study||1
7636819|NCT02246673|18804147|P4|NOT COMPLETED|Overall Study||2
7636820|NCT02246673|18804148|P3|NOT COMPLETED|Overall Study||0
7636821|NCT02246673|18804149|P2|NOT COMPLETED|Overall Study||0
7636822|NCT02246673|18804150|P1|NOT COMPLETED|Overall Study||1
7636823|NCT02246673|18804146|P5|COMPLETED|Overall Study||11
7636824|NCT02246673|18804147|P4|COMPLETED|Overall Study||12
7636825|NCT02246673|18804148|P3|COMPLETED|Overall Study||12
7636826|NCT02246673|18804149|P2|COMPLETED|Overall Study||12
7636827|NCT02246673|18804150|P1|COMPLETED|Overall Study||13
7636828|NCT02246673|18804146|P5|STARTED|Overall Study||12
7636829|NCT02246673|18804147|P4|STARTED|Overall Study||14
7636830|NCT02246673|18804148|P3|STARTED|Overall Study||12
7636831|NCT02246673|18804149|P2|STARTED|Overall Study||12
7636832|NCT02246673|18804150|P1|STARTED|Overall Study||14
7636833|NCT02246660|18804258|P3|NOT COMPLETED|Overall Study||1
7636834|NCT02246660|18804259|P2|NOT COMPLETED|Overall Study||1
7636835|NCT02246660|18804260|P1|NOT COMPLETED|Overall Study||0
7636836|NCT02246660|18804258|P3|COMPLETED|Overall Study||21
7636837|NCT02246660|18804259|P2|COMPLETED|Overall Study||20
7636838|NCT02246660|18804260|P1|COMPLETED|Overall Study||23
7636839|NCT02246660|18804258|P3|STARTED|Overall Study||22
7636840|NCT02246660|18804259|P2|STARTED|Overall Study||21
7636841|NCT02246660|18804260|P1|STARTED|Overall Study||23
7636842|NCT02246647|18804270|P2|NOT COMPLETED|Overall Study||1
7636843|NCT02246647|18804271|P1|NOT COMPLETED|Overall Study||1
7636844|NCT02246647|18804270|P2|COMPLETED|Overall Study||19
7636845|NCT02246647|18804271|P1|COMPLETED|Overall Study||18
7636846|NCT02246647|18804270|P2|STARTED|Overall Study||20
7636847|NCT02246647|18804271|P1|STARTED|Overall Study||19
7636848|NCT02246621|18804305|P2|NOT COMPLETED|Overall Study||135
7636849|NCT02246621|18804306|P1|NOT COMPLETED|Overall Study||265
7636850|NCT02246621|18804305|P2|COMPLETED|Overall Study||30
7636851|NCT02246621|18804306|P1|COMPLETED|Overall Study||63
7636852|NCT02246621|18804305|P2|Received At Least One Dose of Study Drug|Overall Study||161
7636853|NCT02246621|18804306|P1|Received At Least One Dose of Study Drug|Overall Study||327
7636854|NCT02246621|18804305|P2|STARTED|Overall Study||165
7636855|NCT02246621|18804306|P1|STARTED|Overall Study||328
7636856|NCT02246608|18804334|P2|NOT COMPLETED|Overall Study||10
7636857|NCT02246608|18804335|P1|NOT COMPLETED|Overall Study||12
7636858|NCT02246608|18804334|P2|COMPLETED|Overall Study||11
7636859|NCT02246608|18804335|P1|COMPLETED|Overall Study||10
7636860|NCT02246608|18804334|P2|STARTED|Overall Study||21
7636861|NCT02246608|18804335|P1|STARTED|Overall Study||22
7636862|NCT02246582|18804343|P2|NOT COMPLETED|Overall Study||4
7636863|NCT02246582|18804344|P1|NOT COMPLETED|Overall Study||3
7636864|NCT02246582|18804343|P2|COMPLETED|Overall Study||41
7636865|NCT02246582|18804344|P1|COMPLETED|Overall Study||41
7636866|NCT02246582|18804343|P2|STARTED|Overall Study||45
7636867|NCT02246582|18804344|P1|STARTED|Overall Study||44
7636868|NCT02246439|18804352|P2|NOT COMPLETED|Overall Study||11
7636869|NCT02246439|18804353|P1|NOT COMPLETED|Overall Study||12
7636870|NCT02246439|18804352|P2|COMPLETED|Overall Study||118
7636871|NCT02246439|18804353|P1|COMPLETED|Overall Study||180
7636872|NCT02246439|18804352|P2|Randomized|Overall Study||132
7636873|NCT02246439|18804353|P1|Randomized|Overall Study||198
7636874|NCT02246439|18804352|P2|STARTED|Overall Study|3 participants that enrolled in the study did not receive allocated intervention.|129
7636875|NCT02246439|18804353|P1|STARTED|Overall Study|6 participants that enrolled in the study did not receive allocated intervention.|192
7636876|NCT02246413|18804391|P2|NOT COMPLETED|24-months (Secondary Outcome)||32
7636877|NCT02246413|18804392|P1|NOT COMPLETED|24-months (Secondary Outcome)||51
7636878|NCT02246413|18804391|P2|COMPLETED|24-months (Secondary Outcome)||173
7636879|NCT02246413|18804392|P1|COMPLETED|24-months (Secondary Outcome)||153
7636880|NCT02246413|18804391|P2|STARTED|24-months (Secondary Outcome)||205
7636881|NCT02246413|18804392|P1|STARTED|24-months (Secondary Outcome)||204
7636882|NCT02246413|18804391|P2|NOT COMPLETED|12-months (Primary Outcome)||30
7636883|NCT02246413|18804392|P1|NOT COMPLETED|12-months (Primary Outcome)||35
7636884|NCT02246413|18804391|P2|COMPLETED|12-months (Primary Outcome)||175
7636885|NCT02246413|18804392|P1|COMPLETED|12-months (Primary Outcome)||169
7636886|NCT02246413|18804391|P2|STARTED|12-months (Primary Outcome)||205
7636887|NCT02246413|18804392|P1|STARTED|12-months (Primary Outcome)||204
7636888|NCT02246309|18804472|P2|NOT COMPLETED|Overall Study||0
7636889|NCT02246309|18804473|P1|NOT COMPLETED|Overall Study||0
7636890|NCT02246309|18804472|P2|COMPLETED|Overall Study||15
7636891|NCT02246309|18804473|P1|COMPLETED|Overall Study||16
7636892|NCT02246309|18804472|P2|STARTED|Overall Study||15
7636893|NCT02246309|18804473|P1|STARTED|Overall Study|16 patients going through Time Lapse System and 15 through Standard Embryo Culture.|16
7636894|NCT02246218|18804485|P2|NOT COMPLETED|Overall Study||6
7636895|NCT02246218|18804486|P1|NOT COMPLETED|Overall Study||4
7636896|NCT02246218|18804485|P2|COMPLETED|Overall Study||10
7636897|NCT02246218|18804486|P1|COMPLETED|Overall Study||6
7636898|NCT02246218|18804485|P2|STARTED|Overall Study||16
7636899|NCT02246218|18804486|P1|STARTED|Overall Study||10
7636900|NCT02246166|18804546|P2|NOT COMPLETED|Overall Study||0
7636901|NCT02246166|18804547|P1|NOT COMPLETED|Overall Study||1
7636902|NCT02246166|18804546|P2|COMPLETED|Overall Study||27
7636903|NCT02246166|18804547|P1|COMPLETED|Overall Study||25
7636904|NCT02246166|18804546|P2|STARTED|Overall Study||27
7636905|NCT02246166|18804547|P1|STARTED|Overall Study||26
7636906|NCT02246114|18804583|P2|NOT COMPLETED|Overall Study||0
7636907|NCT02246114|18804584|P1|NOT COMPLETED|Overall Study||1
7636908|NCT02246114|18804583|P2|COMPLETED|Overall Study||0
7636909|NCT02246114|18804584|P1|COMPLETED|Overall Study||0
7636910|NCT02246114|18804583|P2|STARTED|Overall Study||0
7636911|NCT02246114|18804584|P1|STARTED|Overall Study||1
7636912|NCT02246062|18804594|P4|NOT COMPLETED|Overall Study||0
7636913|NCT02246062|18804595|P3|NOT COMPLETED|Overall Study||0
7636914|NCT02246062|18804596|P2|NOT COMPLETED|Overall Study||0
7636915|NCT02246062|18804597|P1|NOT COMPLETED|Overall Study||0
7636916|NCT02246062|18804594|P4|COMPLETED|Overall Study||21
7636917|NCT02246062|18804595|P3|COMPLETED|Overall Study||21
7636918|NCT02246062|18804596|P2|COMPLETED|Overall Study||21
7636919|NCT02246062|18804597|P1|COMPLETED|Overall Study||21
7636920|NCT02246062|18804594|P4|STARTED|Overall Study||21
7636921|NCT02246062|18804595|P3|STARTED|Overall Study||21
7636922|NCT02246062|18804596|P2|STARTED|Overall Study||21
7636923|NCT02246062|18804597|P1|STARTED|Overall Study||21
7636924|NCT02246010|18804617|P2|NOT COMPLETED|Overall Study||0
7636925|NCT02246010|18804618|P1|NOT COMPLETED|Overall Study||0
7636926|NCT02246010|18804617|P2|COMPLETED|Overall Study||2
7636927|NCT02246010|18804618|P1|COMPLETED|Overall Study||4
7636928|NCT02246010|18804617|P2|STARTED|Overall Study||2
7636929|NCT02246010|18804618|P1|STARTED|Overall Study||4
7636930|NCT02245737|18804635|P3|NOT COMPLETED|Overall Study||571
7636931|NCT02245737|18804636|P2|NOT COMPLETED|Overall Study||555
7636932|NCT02245737|18804637|P1|NOT COMPLETED|Overall Study||553
7636933|NCT02245737|18804635|P3|COMPLETED|Overall Study||168
7636934|NCT02245737|18804636|P2|COMPLETED|Overall Study||184
7636935|NCT02245737|18804637|P1|COMPLETED|Overall Study||187
7636936|NCT02245737|18804635|P3|Received at Least 1 Dose of Study Drug|Overall Study||735
7636937|NCT02245737|18804636|P2|Received at Least 1 Dose of Study Drug|Overall Study||736
7636938|NCT02245737|18804637|P1|Received at Least 1 Dose of Study Drug|Overall Study||738
7636939|NCT02245737|18804635|P3|STARTED|Overall Study||739
7636940|NCT02245737|18804636|P2|STARTED|Overall Study||739
7636941|NCT02245737|18804637|P1|STARTED|Overall Study||740
7636942|NCT02245620|18804694|P2|NOT COMPLETED|Overall Study||1
7636943|NCT02245620|18804695|P1|NOT COMPLETED|Overall Study||1
7636944|NCT02245620|18804694|P2|COMPLETED|Overall Study||20
7636945|NCT02245620|18804695|P1|COMPLETED|Overall Study||19
7636946|NCT02245620|18804694|P2|STARTED|Overall Study||21
7636947|NCT02245620|18804695|P1|STARTED|Overall Study||20
7636948|NCT02245568|18804707|P1|NOT COMPLETED|Overall Study||853
7636949|NCT02245568|18804707|P1|COMPLETED|Overall Study||60
7636950|NCT02245568|18804707|P1|STARTED|Overall Study||913
7636951|NCT02245516|18804713|P2|NOT COMPLETED|Overall Study||3
7636952|NCT02245516|18804714|P1|NOT COMPLETED|Overall Study||0
7636953|NCT02245516|18804713|P2|COMPLETED|Overall Study||4
7636954|NCT02245516|18804714|P1|COMPLETED|Overall Study||9
7636955|NCT02245516|18804713|P2|STARTED|Overall Study||7
7636956|NCT02245516|18804714|P1|STARTED|Overall Study||9
7636957|NCT02245412|18804729|P3|NOT COMPLETED|Follow-Up Period||2
7636958|NCT02245412|18804730|P2|NOT COMPLETED|Follow-Up Period||2
7636959|NCT02245412|18804731|P1|NOT COMPLETED|Follow-Up Period||5
7636960|NCT02245412|18804729|P3|COMPLETED|Follow-Up Period||0
7636961|NCT02245412|18804730|P2|COMPLETED|Follow-Up Period||2
7636962|NCT02245412|18804731|P1|COMPLETED|Follow-Up Period||8
7636963|NCT02245412|18804729|P3|STARTED|Follow-Up Period||2
7636964|NCT02245412|18804730|P2|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|4
7636965|NCT02245412|18804731|P1|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|13
7636966|NCT02245412|18804729|P3|NOT COMPLETED|Treatment Period||0
7636967|NCT02245412|18804730|P2|NOT COMPLETED|Treatment Period||3
7636968|NCT02245412|18804731|P1|NOT COMPLETED|Treatment Period||5
7636969|NCT02245412|18804729|P3|COMPLETED|Treatment Period||2
7636970|NCT02245412|18804730|P2|COMPLETED|Treatment Period||3
7636971|NCT02245412|18804731|P1|COMPLETED|Treatment Period||12
7636972|NCT02245412|18804729|P3|Modified Full Analysis Set (mFAS)|Treatment Period||2
7636973|NCT02245412|18804730|P2|Modified Full Analysis Set (mFAS)|Treatment Period||6
7636974|NCT02245412|18804731|P1|Modified Full Analysis Set (mFAS)|Treatment Period||16
7636975|NCT02245412|18804729|P3|Received at Least 1 Dose of Study Drug|Treatment Period||2
7636976|NCT02245412|18804730|P2|Received at Least 1 Dose of Study Drug|Treatment Period||6
7636977|NCT02245412|18804731|P1|Received at Least 1 Dose of Study Drug|Treatment Period||17
7636978|NCT02245412|18804729|P3|STARTED|Treatment Period||2
7636979|NCT02245412|18804730|P2|STARTED|Treatment Period||6
7636980|NCT02245412|18804731|P1|STARTED|Treatment Period||17
7636981|NCT02245360|18804750|P2|NOT COMPLETED|Overall Study||2
7636982|NCT02245360|18804751|P1|NOT COMPLETED|Overall Study||5
7636983|NCT02245360|18804750|P2|COMPLETED|Overall Study||52
7636984|NCT02245360|18804751|P1|COMPLETED|Overall Study||48
7636985|NCT02245360|18804750|P2|STARTED|Overall Study||54
7636986|NCT02245360|18804751|P1|STARTED|Overall Study||53
7636987|NCT02245308|18804761|P2|NOT COMPLETED|Overall Study||0
7636988|NCT02245308|18804762|P1|NOT COMPLETED|Overall Study||0
7636989|NCT02245308|18804761|P2|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|64
7636990|NCT02245308|18804762|P1|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|63
7636991|NCT02245308|18804761|P2|STARTED|Overall Study||64
7636992|NCT02245308|18804762|P1|STARTED|Overall Study||63
7636993|NCT02245217|18804770|P1|NOT COMPLETED|Overall Study||2
7636994|NCT02245217|18804770|P1|COMPLETED|Overall Study||7
7636995|NCT02245217|18804770|P1|STARTED|Overall Study||9
7636996|NCT02244996|18804778|P2|NOT COMPLETED|Overall Study||6
7636997|NCT02244996|18804779|P1|NOT COMPLETED|Overall Study||2
7636998|NCT02244996|18804778|P2|COMPLETED|Overall Study||19
7636999|NCT02244996|18804779|P1|COMPLETED|Overall Study||23
7637000|NCT02244996|18804778|P2|STARTED|Overall Study||25
7637001|NCT02244996|18804779|P1|STARTED|Overall Study||25
7637002|NCT02244957|18804793|P2|NOT COMPLETED|Overall Study||0
7637003|NCT02244957|18804794|P1|NOT COMPLETED|Overall Study||1
7637004|NCT02244957|18804793|P2|COMPLETED|Overall Study||16
7637005|NCT02244957|18804794|P1|COMPLETED|Overall Study||6
7637006|NCT02244957|18804793|P2|STARTED|Overall Study||16
7637007|NCT02244957|18804794|P1|STARTED|Overall Study||7
7637008|NCT02244944|18804838|P1|NOT COMPLETED|Overall Study||2
7637009|NCT02244944|18804838|P1|COMPLETED|Overall Study||0
7637010|NCT02244944|18804838|P1|STARTED|Overall Study||2
7637011|NCT02244918|18804846|P2|NOT COMPLETED|Overall Study||0
7637012|NCT02244918|18804847|P1|NOT COMPLETED|Overall Study||0
7637013|NCT02244918|18804846|P2|COMPLETED|Overall Study||93
7637014|NCT02244918|18804847|P1|COMPLETED|Overall Study||185
7637015|NCT02244918|18804846|P2|Week 12|Overall Study||83
7637016|NCT02244918|18804847|P1|Week 12|Overall Study||160
7637017|NCT02244918|18804846|P2|STARTED|Overall Study||93
7637018|NCT02244918|18804847|P1|STARTED|Overall Study||185
7637019|NCT02244840|18804863|P1|NOT COMPLETED|Overall Study||0
7637020|NCT02244840|18804863|P1|COMPLETED|Overall Study||40
7637021|NCT02244840|18804863|P1|STARTED|Overall Study||40
7637022|NCT02244619|18804869|P2|NOT COMPLETED|Overall Study||21
7637023|NCT02244619|18804870|P1|NOT COMPLETED|Overall Study||8
7637024|NCT02244619|18804869|P2|COMPLETED|Overall Study||245
7637025|NCT02244619|18804870|P1|COMPLETED|Overall Study||241
7637026|NCT02244619|18804869|P2|STARTED|Overall Study||266
7637027|NCT02244619|18804870|P1|STARTED|Overall Study||249
7637028|NCT02244580|18804888|P1|NOT COMPLETED|Overall Study||241
7637029|NCT02244580|18804888|P1|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769
7637030|NCT02244580|18804888|P1|STARTED|Overall Study||1010
7637031|NCT02244424|18804898|P2|NOT COMPLETED|Overall Study||10
7637032|NCT02244424|18804899|P1|NOT COMPLETED|Overall Study||20
7637033|NCT02244424|18804898|P2|COMPLETED|Overall Study|Data were collected on all of the infants of teen moms (n = 26).|52
7637034|NCT02244424|18804899|P1|COMPLETED|Overall Study|Data were collected on all of the infants of the teen moms (n = 41).|82
7637035|NCT02244424|18804898|P2|Mothers|Overall Study||31
7637036|NCT02244424|18804899|P1|Mothers|Overall Study||51
7637037|NCT02244424|18804898|P2|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|31
7637038|NCT02244424|18804899|P1|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|51
7637039|NCT02244424|18804898|P2|STARTED|Overall Study|Teen participants received the MIHP standard care. Data were collected on infants.|62
7637040|NCT02244424|18804899|P1|STARTED|Overall Study|Teens were the participants who received the intervention. Data were collected on the infants.|102
7637041|NCT02243943|18804907|P2|NOT COMPLETED|Overall Study||0
7637042|NCT02243943|18804908|P1|NOT COMPLETED|Overall Study||0
7637043|NCT02243943|18804907|P2|COMPLETED|Overall Study||50
7637044|NCT02243943|18804908|P1|COMPLETED|Overall Study||50
7637045|NCT02243943|18804907|P2|STARTED|Overall Study||50
7637046|NCT02243943|18804908|P1|STARTED|Overall Study||50
7637047|NCT02243696|18804918|P1|NOT COMPLETED|Overall Study||1694
7637048|NCT02243696|18804918|P1|COMPLETED|Overall Study||0
7637049|NCT02243696|18804918|P1|STARTED|Overall Study||1694
7637050|NCT02243605|18804930|P2|NOT COMPLETED|Stage 2 - Final Analysis Population||3
7637051|NCT02243605|18804931|P1|NOT COMPLETED|Stage 2 - Final Analysis Population||6
7637052|NCT02243605|18804930|P2|COMPLETED|Stage 2 - Final Analysis Population||42
7637053|NCT02243605|18804931|P1|COMPLETED|Stage 2 - Final Analysis Population||39
7637054|NCT02243605|18804930|P2|STARTED|Stage 2 - Final Analysis Population||45
7637055|NCT02243605|18804931|P1|STARTED|Stage 2 - Final Analysis Population||45
7637056|NCT02243605|18804930|P2|NOT COMPLETED|Stage 1 - Interim Analysis Population||1
7637057|NCT02243605|18804931|P1|NOT COMPLETED|Stage 1 - Interim Analysis Population||2
7637058|NCT02243605|18804930|P2|COMPLETED|Stage 1 - Interim Analysis Population||21
7637059|NCT02243605|18804931|P1|COMPLETED|Stage 1 - Interim Analysis Population||21
7637060|NCT02243605|18804930|P2|STARTED|Stage 1 - Interim Analysis Population||22
7637061|NCT02243605|18804931|P1|STARTED|Stage 1 - Interim Analysis Population||23
7637062|NCT02243579|18804939|P1|NOT COMPLETED|Overall Study||20
7637063|NCT02243579|18804939|P1|COMPLETED|Overall Study||4
7637064|NCT02243579|18804939|P1|STARTED|Overall Study||24
7637065|NCT02243527|18804950|P2|NOT COMPLETED|Overall Study||0
7637066|NCT02243527|18804951|P1|NOT COMPLETED|Overall Study||0
7637067|NCT02243527|18804950|P2|COMPLETED|Overall Study||13
7637068|NCT02243527|18804951|P1|COMPLETED|Overall Study||12
7637069|NCT02243527|18804950|P2|STARTED|Overall Study||13
7637070|NCT02243527|18804951|P1|STARTED|Overall Study||12
7637071|NCT02243371|18804965|P2|NOT COMPLETED|Overall Study||32
7637072|NCT02243371|18804966|P1|NOT COMPLETED|Overall Study||37
7637073|NCT02243371|18804965|P2|COMPLETED|Overall Study||10
7637074|NCT02243371|18804966|P1|COMPLETED|Overall Study||14
7637075|NCT02243371|18804965|P2|STARTED|Overall Study||42
7637076|NCT02243371|18804966|P1|STARTED|Overall Study||51
7637077|NCT02243306|18804986|P2|NOT COMPLETED|Overall Study||3
7637078|NCT02243306|18804987|P1|NOT COMPLETED|Overall Study||0
7637079|NCT02243306|18804986|P2|COMPLETED|Overall Study||4
7637080|NCT02243306|18804987|P1|COMPLETED|Overall Study||1
7637081|NCT02243306|18804986|P2|STARTED|Overall Study||7
7637082|NCT02243306|18804987|P1|STARTED|Overall Study||1
7637083|NCT02243293|18805062|P22|NOT COMPLETED|Overall Study||3
7637084|NCT02243293|18805063|P21|NOT COMPLETED|Overall Study||2
7637085|NCT02243293|18805064|P20|NOT COMPLETED|Overall Study||1
7637086|NCT02243293|18805065|P19|NOT COMPLETED|Overall Study||0
7637087|NCT02243293|18805066|P18|NOT COMPLETED|Overall Study||1
7637088|NCT02243293|18805067|P17|NOT COMPLETED|Overall Study||3
7637089|NCT02243293|18805068|P16|NOT COMPLETED|Overall Study||1
7637090|NCT02243293|18805069|P15|NOT COMPLETED|Overall Study||1
7637091|NCT02243293|18805070|P14|NOT COMPLETED|Overall Study||0
7637092|NCT02243293|18805071|P13|NOT COMPLETED|Overall Study||0
7637093|NCT02243293|18805072|P12|NOT COMPLETED|Overall Study||3
7637094|NCT02243293|18805073|P11|NOT COMPLETED|Overall Study||0
7637095|NCT02243293|18805074|P10|NOT COMPLETED|Overall Study||2
7637096|NCT02243293|18805075|P9|NOT COMPLETED|Overall Study||0
7637097|NCT02243293|18805076|P8|NOT COMPLETED|Overall Study||0
7637098|NCT02243293|18805077|P7|NOT COMPLETED|Overall Study||3
7637099|NCT02243293|18805078|P6|NOT COMPLETED|Overall Study||0
7637100|NCT02243293|18805079|P5|NOT COMPLETED|Overall Study||1
7637101|NCT02243293|18805080|P4|NOT COMPLETED|Overall Study||1
7637102|NCT02243293|18805081|P3|NOT COMPLETED|Overall Study||1
7637103|NCT02243293|18805082|P2|NOT COMPLETED|Overall Study||1
7637104|NCT02243293|18805083|P1|NOT COMPLETED|Overall Study||2
7637105|NCT02243293|18805062|P22|COMPLETED|Overall Study||55
7637106|NCT02243293|18805063|P21|COMPLETED|Overall Study||143
7637107|NCT02243293|18805064|P20|COMPLETED|Overall Study||47
7637108|NCT02243293|18805065|P19|COMPLETED|Overall Study||22
7637109|NCT02243293|18805066|P18|COMPLETED|Overall Study||21
7637110|NCT02243293|18805067|P17|COMPLETED|Overall Study||37
7637111|NCT02243293|18805068|P16|COMPLETED|Overall Study||26
7637112|NCT02243293|18805069|P15|COMPLETED|Overall Study||27
7637113|NCT02243293|18805070|P14|COMPLETED|Overall Study||0
7637114|NCT02243293|18805071|P13|COMPLETED|Overall Study||0
7637115|NCT02243293|18805072|P12|COMPLETED|Overall Study||50
7637116|NCT02243293|18805073|P11|COMPLETED|Overall Study||0
7637117|NCT02243293|18805074|P10|COMPLETED|Overall Study||53
7637118|NCT02243293|18805075|P9|COMPLETED|Overall Study||0
7637119|NCT02243293|18805076|P8|COMPLETED|Overall Study||0
7637120|NCT02243293|18805077|P7|COMPLETED|Overall Study||27
7637121|NCT02243293|18805078|P6|COMPLETED|Overall Study||31
7637122|NCT02243293|18805079|P5|COMPLETED|Overall Study||30
7637123|NCT02243293|18805080|P4|COMPLETED|Overall Study||29
7637124|NCT02243293|18805081|P3|COMPLETED|Overall Study||24
7637125|NCT02243293|18805082|P2|COMPLETED|Overall Study||23
7637126|NCT02243293|18805083|P1|COMPLETED|Overall Study||23
7637127|NCT02243293|18805062|P22|STARTED|Overall Study||58
7637128|NCT02243293|18805063|P21|STARTED|Overall Study||145
7637129|NCT02243293|18805064|P20|STARTED|Overall Study||48
7637130|NCT02243293|18805065|P19|STARTED|Overall Study||22
7637131|NCT02243293|18805066|P18|STARTED|Overall Study||22
7637132|NCT02243293|18805067|P17|STARTED|Overall Study||40
7637133|NCT02243293|18805068|P16|STARTED|Overall Study||27
7637134|NCT02243293|18805069|P15|STARTED|Overall Study||28
7637135|NCT02243293|18805070|P14|STARTED|Overall Study||0
7637136|NCT02243293|18805071|P13|STARTED|Overall Study||0
7637137|NCT02243293|18805072|P12|STARTED|Overall Study||53
7637138|NCT02243293|18805073|P11|STARTED|Overall Study||0
7637139|NCT02243293|18805074|P10|STARTED|Overall Study||55
7637140|NCT02243293|18805075|P9|STARTED|Overall Study||0
7637141|NCT02243293|18805076|P8|STARTED|Overall Study||0
7637142|NCT02243293|18805077|P7|STARTED|Overall Study||30
7637143|NCT02243293|18805078|P6|STARTED|Overall Study||31
7637144|NCT02243293|18805079|P5|STARTED|Overall Study||31
7637145|NCT02243293|18805080|P4|STARTED|Overall Study||30
7637146|NCT02243293|18805081|P3|STARTED|Overall Study||25
7637147|NCT02243293|18805082|P2|STARTED|Overall Study||24
7637148|NCT02243293|18805083|P1|STARTED|Overall Study||25
7637149|NCT02243280|18805182|P11|NOT COMPLETED|Treated||3
7637150|NCT02243280|18805183|P10|NOT COMPLETED|Treated||0
7637151|NCT02243280|18805184|P9|NOT COMPLETED|Treated||1
7637152|NCT02243280|18805185|P8|NOT COMPLETED|Treated||0
7637153|NCT02243280|18805186|P7|NOT COMPLETED|Treated||0
7637154|NCT02243280|18805187|P6|NOT COMPLETED|Treated||0
7637155|NCT02243280|18805188|P5|NOT COMPLETED|Treated||0
7637156|NCT02243280|18805189|P4|NOT COMPLETED|Treated||0
7637157|NCT02243280|18805190|P3|NOT COMPLETED|Treated||0
7637158|NCT02243280|18805191|P2|NOT COMPLETED|Treated||0
7637159|NCT02243280|18805192|P1|NOT COMPLETED|Treated||1
7637160|NCT02243280|18805182|P11|COMPLETED|Treated||31
7637161|NCT02243280|18805183|P10|COMPLETED|Treated||0
7637162|NCT02243280|18805184|P9|COMPLETED|Treated||31
7637163|NCT02243280|18805185|P8|COMPLETED|Treated||0
7637164|NCT02243280|18805186|P7|COMPLETED|Treated||0
7637165|NCT02243280|18805187|P6|COMPLETED|Treated||27
7637166|NCT02243280|18805188|P5|COMPLETED|Treated||0
7637167|NCT02243280|18805189|P4|COMPLETED|Treated||0
7637168|NCT02243280|18805190|P3|COMPLETED|Treated||0
7637169|NCT02243280|18805191|P2|COMPLETED|Treated||39
7637170|NCT02243280|18805192|P1|COMPLETED|Treated||41
7637171|NCT02243280|18805182|P11|Completed Treatment|Treated||33
7637172|NCT02243280|18805183|P10|Completed Treatment|Treated||0
7637173|NCT02243280|18805184|P9|Completed Treatment|Treated||32
7637174|NCT02243280|18805185|P8|Completed Treatment|Treated||0
7637175|NCT02243280|18805186|P7|Completed Treatment|Treated||0
7637176|NCT02243280|18805187|P6|Completed Treatment|Treated||27
7637177|NCT02243280|18805188|P5|Completed Treatment|Treated||0
7637178|NCT02243280|18805189|P4|Completed Treatment|Treated||0
7637179|NCT02243280|18805190|P3|Completed Treatment|Treated||0
7637180|NCT02243280|18805191|P2|Completed Treatment|Treated||38
7637181|NCT02243280|18805192|P1|Completed Treatment|Treated||42
7637182|NCT02243280|18805182|P11|STARTED|Treated||34
7637183|NCT02243280|18805183|P10|STARTED|Treated||0
7637184|NCT02243280|18805184|P9|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|32
7637185|NCT02243280|18805185|P8|STARTED|Treated||0
7637186|NCT02243280|18805186|P7|STARTED|Treated||0
7637187|NCT02243280|18805187|P6|STARTED|Treated||27
7637188|NCT02243280|18805188|P5|STARTED|Treated||0
7637189|NCT02243280|18805189|P4|STARTED|Treated||0
7637190|NCT02243280|18805190|P3|STARTED|Treated||0
7637191|NCT02243280|18805191|P2|STARTED|Treated||39
7637192|NCT02243280|18805192|P1|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|42
7637193|NCT02243280|18805182|P11|NOT COMPLETED|Enrolled||0
7637194|NCT02243280|18805183|P10|NOT COMPLETED|Enrolled||0
7637195|NCT02243280|18805184|P9|NOT COMPLETED|Enrolled||0
7637196|NCT02243280|18805185|P8|NOT COMPLETED|Enrolled||0
7637197|NCT02243280|18805186|P7|NOT COMPLETED|Enrolled||0
7637198|NCT02243280|18805187|P6|NOT COMPLETED|Enrolled||0
7637199|NCT02243280|18805188|P5|NOT COMPLETED|Enrolled||0
7637200|NCT02243280|18805189|P4|NOT COMPLETED|Enrolled||0
7637201|NCT02243280|18805190|P3|NOT COMPLETED|Enrolled||0
7637202|NCT02243280|18805191|P2|NOT COMPLETED|Enrolled||0
7637203|NCT02243280|18805192|P1|NOT COMPLETED|Enrolled||0
7637204|NCT02243280|18805182|P11|COMPLETED|Enrolled||34
7637205|NCT02243280|18805183|P10|COMPLETED|Enrolled||0
7637206|NCT02243280|18805184|P9|COMPLETED|Enrolled||34
7637207|NCT02243280|18805185|P8|COMPLETED|Enrolled||0
7637208|NCT02243280|18805186|P7|COMPLETED|Enrolled||0
7637209|NCT02243280|18805187|P6|COMPLETED|Enrolled||27
7637210|NCT02243280|18805188|P5|COMPLETED|Enrolled||0
7637211|NCT02243280|18805189|P4|COMPLETED|Enrolled||0
7637212|NCT02243280|18805190|P3|COMPLETED|Enrolled||0
7637213|NCT02243280|18805191|P2|COMPLETED|Enrolled||39
7637214|NCT02243280|18805192|P1|COMPLETED|Enrolled||40
7637215|NCT02243280|18805182|P11|STARTED|Enrolled||34
7637216|NCT02243280|18805183|P10|STARTED|Enrolled||0
7637217|NCT02243280|18805184|P9|STARTED|Enrolled||34
7637218|NCT02243280|18805185|P8|STARTED|Enrolled||0
7637219|NCT02243280|18805186|P7|STARTED|Enrolled||0
7637220|NCT02243280|18805187|P6|STARTED|Enrolled||27
7637221|NCT02243280|18805188|P5|STARTED|Enrolled||0
7637222|NCT02243280|18805189|P4|STARTED|Enrolled||0
7637223|NCT02243280|18805190|P3|STARTED|Enrolled||0
7637224|NCT02243280|18805191|P2|STARTED|Enrolled||39
7637225|NCT02243280|18805192|P1|STARTED|Enrolled||40
7637226|NCT02243202|18805247|P4|NOT COMPLETED|Overall Study||23
7637227|NCT02243202|18805248|P3|NOT COMPLETED|Overall Study||31
7637228|NCT02243202|18805249|P2|NOT COMPLETED|Overall Study||25
7637229|NCT02243202|18805250|P1|NOT COMPLETED|Overall Study||25
7637230|NCT02243202|18805247|P4|COMPLETED|Overall Study||61
7637231|NCT02243202|18805248|P3|COMPLETED|Overall Study||53
7637232|NCT02243202|18805249|P2|COMPLETED|Overall Study||60
7637233|NCT02243202|18805250|P1|COMPLETED|Overall Study||57
7637234|NCT02243202|18805247|P4|Treated|Overall Study||83
7637235|NCT02243202|18805248|P3|Treated|Overall Study||84
7637236|NCT02243202|18805249|P2|Treated|Overall Study||85
7637237|NCT02243202|18805250|P1|Treated|Overall Study||82
7637238|NCT02243202|18805247|P4|STARTED|Overall Study||84
7637239|NCT02243202|18805248|P3|STARTED|Overall Study||84
7637240|NCT02243202|18805249|P2|STARTED|Overall Study||85
7637241|NCT02243202|18805250|P1|STARTED|Overall Study||82
7637242|NCT02243176|18805286|P2|NOT COMPLETED|Overall Study||15
7637243|NCT02243176|18805287|P1|NOT COMPLETED|Overall Study||14
7637244|NCT02243176|18805286|P2|COMPLETED|Overall Study||229
7637245|NCT02243176|18805287|P1|COMPLETED|Overall Study||230
7637246|NCT02243176|18805286|P2|STARTED|Overall Study||244
7637247|NCT02243176|18805287|P1|STARTED|Overall Study|3 of the randomized subjects withdrew before taking any medication|244
7637248|NCT02243046|18805312|P3|NOT COMPLETED|Overall Study||4
7637249|NCT02243046|18805313|P2|NOT COMPLETED|Overall Study||1
7637250|NCT02243046|18805314|P1|NOT COMPLETED|Overall Study||1
7637251|NCT02243046|18805312|P3|COMPLETED|Overall Study||49
7637252|NCT02243046|18805313|P2|COMPLETED|Overall Study||53
7637253|NCT02243046|18805314|P1|COMPLETED|Overall Study||54
7637254|NCT02243046|18805312|P3|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49
7637255|NCT02243046|18805313|P2|6 Month|Overall Study||53
7637256|NCT02243046|18805314|P1|6 Month|Overall Study||54
7637257|NCT02243046|18805312|P3|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51
7637258|NCT02243046|18805313|P2|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53
7637259|NCT02243046|18805314|P1|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54
7637260|NCT02243046|18805312|P3|STARTED|Overall Study||53
7637261|NCT02243046|18805313|P2|STARTED|Overall Study||54
7637262|NCT02243046|18805314|P1|STARTED|Overall Study||55
7637263|NCT02243020|18805339|P2|NOT COMPLETED|Overall Study||0
7637264|NCT02243020|18805340|P1|NOT COMPLETED|Overall Study||0
7637265|NCT02243020|18805339|P2|COMPLETED|Overall Study||9
7637266|NCT02243020|18805340|P1|COMPLETED|Overall Study||8
7637267|NCT02243020|18805339|P2|STARTED|Overall Study||9
7637268|NCT02243020|18805340|P1|STARTED|Overall Study||8
7637269|NCT02243007|18805350|P2|NOT COMPLETED|Overall Study||0
7637270|NCT02243007|18805351|P1|NOT COMPLETED|Overall Study||0
7637271|NCT02243007|18805350|P2|COMPLETED|Overall Study||3
7637272|NCT02243007|18805351|P1|COMPLETED|Overall Study||4
7637273|NCT02243007|18805350|P2|STARTED|Overall Study||3
7637274|NCT02243007|18805351|P1|STARTED|Overall Study||4
7637275|NCT02242994|18805373|P1|NOT COMPLETED|Overall Study||0
7637276|NCT02242994|18805373|P1|COMPLETED|Overall Study||5
7637277|NCT02242994|18805373|P1|STARTED|Overall Study||5
7637278|NCT02242981|18805378|P1|NOT COMPLETED|Overall Study||1
7637279|NCT02242981|18805378|P1|COMPLETED|Overall Study||5
7637280|NCT02242981|18805378|P1|Received Study Drug|Overall Study||6
7637281|NCT02242981|18805378|P1|STARTED|Overall Study||6
7637282|NCT02242942|18805389|P3|NOT COMPLETED|Overall Study||13
7637283|NCT02242942|18805390|P2|NOT COMPLETED|Overall Study||216
7637284|NCT02242942|18805391|P1|NOT COMPLETED|Overall Study||216
7637285|NCT02242942|18805389|P3|COMPLETED|Overall Study||0
7637286|NCT02242942|18805390|P2|COMPLETED|Overall Study||0
7637287|NCT02242942|18805391|P1|COMPLETED|Overall Study||0
7637288|NCT02242942|18805389|P3|Treated|Overall Study||13
7637289|NCT02242942|18805390|P2|Treated|Overall Study||212
7637290|NCT02242942|18805391|P1|Treated|Overall Study||214
7637291|NCT02242942|18805389|P3|STARTED|Overall Study||13
7637292|NCT02242942|18805390|P2|STARTED|Overall Study||216
7637293|NCT02242942|18805391|P1|STARTED|Overall Study||216
7637294|NCT02242903|18805425|P7|NOT COMPLETED|Overall Study||0
7637295|NCT02242903|18805426|P6|NOT COMPLETED|Overall Study||0
7637296|NCT02242903|18805427|P5|NOT COMPLETED|Overall Study||0
7637297|NCT02242903|18805428|P4|NOT COMPLETED|Overall Study||0
7637298|NCT02242903|18805429|P3|NOT COMPLETED|Overall Study||0
7637299|NCT02242903|18805430|P2|NOT COMPLETED|Overall Study||0
7637300|NCT02242903|18805431|P1|NOT COMPLETED|Overall Study||1
7637301|NCT02242903|18805425|P7|COMPLETED|Overall Study||6
7637302|NCT02242903|18805426|P6|COMPLETED|Overall Study||6
7637303|NCT02242903|18805427|P5|COMPLETED|Overall Study||6
7637304|NCT02242903|18805428|P4|COMPLETED|Overall Study||6
7637305|NCT02242903|18805429|P3|COMPLETED|Overall Study||6
7637306|NCT02242903|18805430|P2|COMPLETED|Overall Study||6
7637307|NCT02242903|18805431|P1|COMPLETED|Overall Study||11
7637308|NCT02242903|18805425|P7|Received at Least One Dose of Study Drug|Overall Study||6
7637309|NCT02242903|18805426|P6|Received at Least One Dose of Study Drug|Overall Study||6
7637310|NCT02242903|18805427|P5|Received at Least One Dose of Study Drug|Overall Study||6
7637311|NCT02242903|18805428|P4|Received at Least One Dose of Study Drug|Overall Study||6
7637312|NCT02242903|18805429|P3|Received at Least One Dose of Study Drug|Overall Study||6
7637313|NCT02242903|18805430|P2|Received at Least One Dose of Study Drug|Overall Study||6
7637314|NCT02242903|18805431|P1|Received at Least One Dose of Study Drug|Overall Study||12
7637315|NCT02242903|18805425|P7|STARTED|Overall Study||6
7637316|NCT02242903|18805426|P6|STARTED|Overall Study||6
7637317|NCT02242903|18805427|P5|STARTED|Overall Study||6
7637318|NCT02242903|18805428|P4|STARTED|Overall Study||6
7637319|NCT02242903|18805429|P3|STARTED|Overall Study||6
7637320|NCT02242903|18805430|P2|STARTED|Overall Study||6
7637321|NCT02242903|18805431|P1|STARTED|Overall Study||12
7637322|NCT02242643|18805461|P2|NOT COMPLETED|Overall Study||78
7637323|NCT02242643|18805462|P1|NOT COMPLETED|Overall Study||75
7637324|NCT02242643|18805461|P2|COMPLETED|Overall Study||1139
7637325|NCT02242643|18805462|P1|COMPLETED|Overall Study||1132
7637326|NCT02242643|18805461|P2|STARTED|Overall Study||1217
7637327|NCT02242643|18805462|P1|STARTED|Overall Study||1207
7637328|NCT02242630|18805498|P4|NOT COMPLETED|Overall Study||0
7637329|NCT02242630|18805499|P3|NOT COMPLETED|Overall Study||0
7637330|NCT02242630|18805500|P2|NOT COMPLETED|Overall Study||0
7637331|NCT02242630|18805501|P1|NOT COMPLETED|Overall Study||0
7637332|NCT02242630|18805498|P4|COMPLETED|Overall Study||16
7637333|NCT02242630|18805499|P3|COMPLETED|Overall Study||15
7637334|NCT02242630|18805500|P2|COMPLETED|Overall Study||15
7637335|NCT02242630|18805501|P1|COMPLETED|Overall Study||15
7637336|NCT02242630|18805498|P4|STARTED|Overall Study||16
7637337|NCT02242630|18805499|P3|STARTED|Overall Study||15
7637338|NCT02242630|18805500|P2|STARTED|Overall Study||15
7637339|NCT02242630|18805501|P1|STARTED|Overall Study||15
7637340|NCT02242487|18805517|P2|NOT COMPLETED|Overall Study||47
7637341|NCT02242487|18805518|P1|NOT COMPLETED|Overall Study||62
7637342|NCT02242487|18805517|P2|COMPLETED|Overall Study||117
7637343|NCT02242487|18805518|P1|COMPLETED|Overall Study||99
7637344|NCT02242487|18805517|P2|STARTED|Overall Study||164
7637345|NCT02242487|18805518|P1|STARTED|Overall Study||161
7637346|NCT02242305|18805534|P2|NOT COMPLETED|Overall Study||10
7637347|NCT02242305|18805535|P1|NOT COMPLETED|Overall Study||6
7637348|NCT02242305|18805534|P2|COMPLETED|Overall Study||141
7637349|NCT02242305|18805535|P1|COMPLETED|Overall Study||145
7637350|NCT02242305|18805534|P2|STARTED|Overall Study||151
7637351|NCT02242305|18805535|P1|STARTED|Overall Study||151
7637352|NCT02242201|18805556|P3|NOT COMPLETED|Overall Study||1
7637353|NCT02242201|18805557|P2|NOT COMPLETED|Overall Study||1
7637354|NCT02242201|18805558|P1|NOT COMPLETED|Overall Study||4
7637355|NCT02242201|18805556|P3|COMPLETED|Overall Study||54
7637356|NCT02242201|18805557|P2|COMPLETED|Overall Study||54
7637357|NCT02242201|18805558|P1|COMPLETED|Overall Study||51
7637358|NCT02242201|18805556|P3|STARTED|Overall Study||55
7637359|NCT02242201|18805557|P2|STARTED|Overall Study||55
7637360|NCT02242201|18805558|P1|STARTED|Overall Study||55
7637361|NCT02242019|18805590|P1|NOT COMPLETED|Overall Study||0
7637362|NCT02242019|18805590|P1|COMPLETED|Overall Study||109
7637363|NCT02242019|18805590|P1|STARTED|Overall Study||109
7637364|NCT02241889|18805596|P6|NOT COMPLETED|Overall Study||1
7637365|NCT02241889|18805597|P5|NOT COMPLETED|Overall Study||0
7637366|NCT02241889|18805598|P4|NOT COMPLETED|Overall Study||0
7637367|NCT02241889|18805599|P3|NOT COMPLETED|Overall Study||1
7637368|NCT02241889|18805600|P2|NOT COMPLETED|Overall Study||0
7637369|NCT02241889|18805601|P1|NOT COMPLETED|Overall Study||0
7637370|NCT02241889|18805596|P6|COMPLETED|Overall Study||3
7637371|NCT02241889|18805597|P5|COMPLETED|Overall Study||5
7637372|NCT02241889|18805598|P4|COMPLETED|Overall Study||3
7637373|NCT02241889|18805599|P3|COMPLETED|Overall Study||2
7637374|NCT02241889|18805600|P2|COMPLETED|Overall Study||4
7637375|NCT02241889|18805601|P1|COMPLETED|Overall Study||4
7637376|NCT02241889|18805596|P6|STARTED|Overall Study||4
7637377|NCT02241889|18805597|P5|STARTED|Overall Study||5
7637378|NCT02241889|18805598|P4|STARTED|Overall Study||3
7637379|NCT02241889|18805599|P3|STARTED|Overall Study||3
7637380|NCT02241889|18805600|P2|STARTED|Overall Study||4
7637381|NCT02241889|18805601|P1|STARTED|Overall Study||4
7637382|NCT02241785|18805636|P1|NOT COMPLETED|Overall Study||47
7637383|NCT02241785|18805636|P1|COMPLETED|Overall Study||0
7637384|NCT02241785|18805636|P1|STARTED|Overall Study||47
7637385|NCT02241733|18805646|P2|NOT COMPLETED|Overall Study||10
7637386|NCT02241733|18805647|P1|NOT COMPLETED|Overall Study||15
7637387|NCT02241733|18805646|P2|COMPLETED|Overall Study||30
7637388|NCT02241733|18805647|P1|COMPLETED|Overall Study||25
7637389|NCT02241733|18805646|P2|STARTED|Overall Study||40
7637390|NCT02241733|18805647|P1|STARTED|Overall Study||40
7637391|NCT02241720|18805659|P1|NOT COMPLETED|Overall Study||4
7637392|NCT02241720|18805659|P1|COMPLETED|Overall Study||1
7637393|NCT02241720|18805659|P1|STARTED|Overall Study||5
7637394|NCT02241655|18805665|P2|NOT COMPLETED|Overall Study||0
7637395|NCT02241655|18805666|P1|NOT COMPLETED|Overall Study||0
7637396|NCT02241655|18805665|P2|COMPLETED|Overall Study||618
7637397|NCT02241655|18805666|P1|COMPLETED|Overall Study||614
7637398|NCT02241655|18805665|P2|STARTED|Overall Study||618
7637399|NCT02241655|18805666|P1|STARTED|Overall Study||614
7637400|NCT02241551|18805686|P2|NOT COMPLETED|Overall Study||0
7637401|NCT02241551|18805687|P1|NOT COMPLETED|Overall Study||1
7637402|NCT02241551|18805686|P2|COMPLETED|Overall Study||0
7637403|NCT02241551|18805687|P1|COMPLETED|Overall Study||0
7637404|NCT02241551|18805686|P2|STARTED|Overall Study||0
7637405|NCT02241551|18805687|P1|STARTED|Overall Study||1
7637406|NCT02241512|18805709|P2|NOT COMPLETED|Overall Study||0
7637407|NCT02241512|18805710|P1|NOT COMPLETED|Overall Study||1
7637408|NCT02241512|18805709|P2|COMPLETED|Overall Study||29
7637409|NCT02241512|18805710|P1|COMPLETED|Overall Study||29
7637410|NCT02241512|18805709|P2|STARTED|Overall Study||29
7637411|NCT02241512|18805710|P1|STARTED|Overall Study||30
7637412|NCT02241486|18805722|P1|NOT COMPLETED|Overall Study||0
7637413|NCT02241486|18805722|P1|COMPLETED|Overall Study||2
7637414|NCT02241486|18805722|P1|STARTED|Overall Study||2
7637415|NCT02241343|18805726|P1|NOT COMPLETED|Overall Study||1
7637416|NCT02241343|18805726|P1|COMPLETED|Overall Study||0
7637417|NCT02241343|18805726|P1|STARTED|Overall Study||1
7637418|NCT02241187|18805731|P1|NOT COMPLETED|Overall Study||2
7637419|NCT02241187|18805731|P1|COMPLETED|Overall Study||0
7637420|NCT02241187|18805731|P1|STARTED|Overall Study||2
7637421|NCT02240810|18805738|P2|NOT COMPLETED|Overall Study||60
7637422|NCT02240810|18805739|P1|NOT COMPLETED|Overall Study||60
7637423|NCT02240810|18805738|P2|COMPLETED|Overall Study||2621
7637424|NCT02240810|18805739|P1|COMPLETED|Overall Study||1441
7637425|NCT02240810|18805738|P2|STARTED|Overall Study|correct typo|2681
7637426|NCT02240810|18805739|P1|STARTED|Overall Study||1501
7637427|NCT02240706|18805763|P7|NOT COMPLETED|Overall Study||0
7637428|NCT02240706|18805764|P6|NOT COMPLETED|Overall Study||0
7637429|NCT02240706|18805765|P5|NOT COMPLETED|Overall Study||11
7637430|NCT02240706|18805766|P4|NOT COMPLETED|Overall Study||4
7637431|NCT02240706|18805767|P3|NOT COMPLETED|Overall Study||6
7637432|NCT02240706|18805768|P2|NOT COMPLETED|Overall Study||3
7637433|NCT02240706|18805769|P1|NOT COMPLETED|Overall Study||3
7637434|NCT02240706|18805763|P7|COMPLETED|Overall Study||0
7637435|NCT02240706|18805764|P6|COMPLETED|Overall Study||0
7637436|NCT02240706|18805765|P5|COMPLETED|Overall Study||0
7637437|NCT02240706|18805766|P4|COMPLETED|Overall Study||0
7637438|NCT02240706|18805767|P3|COMPLETED|Overall Study||0
7637439|NCT02240706|18805768|P2|COMPLETED|Overall Study||0
7637440|NCT02240706|18805769|P1|COMPLETED|Overall Study||0
7637441|NCT02240706|18805763|P7|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0
7637442|NCT02240706|18805764|P6|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0
7637443|NCT02240706|18805765|P5|STARTED|Overall Study||11
7637444|NCT02240706|18805766|P4|STARTED|Overall Study||4
7637445|NCT02240706|18805767|P3|STARTED|Overall Study||6
7637446|NCT02240706|18805768|P2|STARTED|Overall Study||3
7637447|NCT02240706|18805769|P1|STARTED|Overall Study||3
7637448|NCT02240693|18805829|P5|NOT COMPLETED|Overall Study||1
7637449|NCT02240693|18805830|P4|NOT COMPLETED|Overall Study||1
7637450|NCT02240693|18805831|P3|NOT COMPLETED|Overall Study||4
7637451|NCT02240693|18805832|P2|NOT COMPLETED|Overall Study||0
7637452|NCT02240693|18805833|P1|NOT COMPLETED|Overall Study||0
7637453|NCT02240693|18805829|P5|COMPLETED|Overall Study||42
7637454|NCT02240693|18805830|P4|COMPLETED|Overall Study||20
7637455|NCT02240693|18805831|P3|COMPLETED|Overall Study||17
7637456|NCT02240693|18805832|P2|COMPLETED|Overall Study||21
7637457|NCT02240693|18805833|P1|COMPLETED|Overall Study||22
7637458|NCT02240693|18805829|P5|STARTED|Overall Study||43
7637459|NCT02240693|18805830|P4|STARTED|Overall Study||21
7637460|NCT02240693|18805831|P3|STARTED|Overall Study||21
7637461|NCT02240693|18805832|P2|STARTED|Overall Study||21
7637462|NCT02240693|18805833|P1|STARTED|Overall Study||22
7637463|NCT02240680|18805869|P4|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||7
7637464|NCT02240680|18805870|P3|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||8
7637465|NCT02240680|18805871|P2|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
7637466|NCT02240680|18805872|P1|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
7637467|NCT02240680|18805869|P4|COMPLETED|Japanese Patients (Up to 52 Weeks)||45
7637468|NCT02240680|18805870|P3|COMPLETED|Japanese Patients (Up to 52 Weeks)||42
7637469|NCT02240680|18805871|P2|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
7637470|NCT02240680|18805872|P1|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
7637471|NCT02240680|18805869|P4|STARTED|Japanese Patients (Up to 52 Weeks)||52
7637472|NCT02240680|18805870|P3|STARTED|Japanese Patients (Up to 52 Weeks)||50
7637473|NCT02240680|18805871|P2|STARTED|Japanese Patients (Up to 52 Weeks)||0
7637474|NCT02240680|18805872|P1|STARTED|Japanese Patients (Up to 52 Weeks)||0
7637475|NCT02240680|18805869|P4|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
7637476|NCT02240680|18805870|P3|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
7637477|NCT02240680|18805871|P2|NOT COMPLETED|Overall Study (Up to 24 Weeks)||8
7637478|NCT02240680|18805872|P1|NOT COMPLETED|Overall Study (Up to 24 Weeks)||15
7637479|NCT02240680|18805869|P4|COMPLETED|Overall Study (Up to 24 Weeks)||0
7637480|NCT02240680|18805870|P3|COMPLETED|Overall Study (Up to 24 Weeks)||0
7637481|NCT02240680|18805871|P2|COMPLETED|Overall Study (Up to 24 Weeks)||143
7637482|NCT02240680|18805872|P1|COMPLETED|Overall Study (Up to 24 Weeks)||136
7637483|NCT02240680|18805869|P4|STARTED|Overall Study (Up to 24 Weeks)||0
7637484|NCT02240680|18805870|P3|STARTED|Overall Study (Up to 24 Weeks)||0
7637485|NCT02240680|18805871|P2|STARTED|Overall Study (Up to 24 Weeks)||151
7637486|NCT02240680|18805872|P1|STARTED|Overall Study (Up to 24 Weeks)||151
7637487|NCT02240667|18805892|P2|NOT COMPLETED|Overall Study||0
7637488|NCT02240667|18805893|P1|NOT COMPLETED|Overall Study||0
7637489|NCT02240667|18805892|P2|COMPLETED|Overall Study||650
7637490|NCT02240667|18805893|P1|COMPLETED|Overall Study||771
7637491|NCT02240667|18805892|P2|STARTED|Overall Study||650
7637492|NCT02240667|18805893|P1|STARTED|Overall Study||771
7637493|NCT02240654|18805908|P5|NOT COMPLETED|Overall Study||0
7637494|NCT02240654|18805909|P4|NOT COMPLETED|Overall Study||0
7637495|NCT02240654|18805910|P3|NOT COMPLETED|Overall Study||0
7637496|NCT02240654|18805911|P2|NOT COMPLETED|Overall Study||0
7637497|NCT02240654|18805912|P1|NOT COMPLETED|Overall Study||0
7637498|NCT02240654|18805908|P5|COMPLETED|Overall Study||1285
7637499|NCT02240654|18805909|P4|COMPLETED|Overall Study||2150
7637500|NCT02240654|18805910|P3|COMPLETED|Overall Study||28619
7637501|NCT02240654|18805911|P2|COMPLETED|Overall Study||2813
7637502|NCT02240654|18805912|P1|COMPLETED|Overall Study||1706
7637503|NCT02240654|18805908|P5|STARTED|Overall Study||1285
7637504|NCT02240654|18805909|P4|STARTED|Overall Study||2150
7637505|NCT02240654|18805910|P3|STARTED|Overall Study||28619
7637506|NCT02240654|18805911|P2|STARTED|Overall Study||2813
7637507|NCT02240654|18805912|P1|STARTED|Overall Study||1706
7637508|NCT02240628|18805926|P2|NOT COMPLETED|Overall Study||5
7637509|NCT02240628|18805927|P1|NOT COMPLETED|Overall Study||6
7637510|NCT02240628|18805926|P2|COMPLETED|Overall Study||33
7637511|NCT02240628|18805927|P1|COMPLETED|Overall Study||32
7637512|NCT02240628|18805926|P2|STARTED|Overall Study||38
7637513|NCT02240628|18805927|P1|STARTED|Overall Study||38
7637514|NCT02240589|18805937|P2|NOT COMPLETED|Overall Study||2
7637515|NCT02240589|18805938|P1|NOT COMPLETED|Overall Study||2
7637516|NCT02240589|18805937|P2|COMPLETED|Overall Study||4
7637517|NCT02240589|18805938|P1|COMPLETED|Overall Study||3
7637518|NCT02240589|18805937|P2|STARTED|Overall Study||6
7637519|NCT02240589|18805938|P1|STARTED|Overall Study||5
7637520|NCT02240368|18805961|P3|NOT COMPLETED|Overall Study||1
7637521|NCT02240368|18805962|P2|NOT COMPLETED|Overall Study||0
7637522|NCT02240368|18805963|P1|NOT COMPLETED|Overall Study||1
7637523|NCT02240368|18805961|P3|COMPLETED|Overall Study||18
7637524|NCT02240368|18805962|P2|COMPLETED|Overall Study||22
7637525|NCT02240368|18805963|P1|COMPLETED|Overall Study||8
7637526|NCT02240368|18805961|P3|STARTED|Overall Study||19
7637527|NCT02240368|18805962|P2|STARTED|Overall Study||22
7637528|NCT02240368|18805963|P1|STARTED|Overall Study||9
7637529|NCT02240329|18805980|P1|NOT COMPLETED|Overall Study||0
7637530|NCT02240329|18805980|P1|COMPLETED|Overall Study||4
7637531|NCT02240329|18805980|P1|Determination of Urge to Cough|Overall Study||4
7637532|NCT02240329|18805980|P1|STARTED|Overall Study||4
7637533|NCT02240186|18805985|P1|NOT COMPLETED|Overall Study||27
7637534|NCT02240186|18805985|P1|COMPLETED|Overall Study||23
7637535|NCT02240186|18805985|P1|STARTED|Overall Study||50
7637536|NCT02240121|18805995|P2|NOT COMPLETED|Overall Study||20
7637537|NCT02240121|18805996|P1|NOT COMPLETED|Overall Study||18
7637538|NCT02240121|18805995|P2|COMPLETED|Overall Study||20
7637539|NCT02240121|18805996|P1|COMPLETED|Overall Study||22
7637540|NCT02240121|18805995|P2|STARTED|Overall Study||40
7637541|NCT02240121|18805996|P1|STARTED|Overall Study||40
7637542|NCT02240108|18806024|P2|NOT COMPLETED|Overall Study||25
7637543|NCT02240108|18806025|P1|NOT COMPLETED|Overall Study||14
7637544|NCT02240108|18806024|P2|COMPLETED|Overall Study||21
7637545|NCT02240108|18806025|P1|COMPLETED|Overall Study||21
7637546|NCT02240108|18806024|P2|Intent-to-treat (ITT) Population|Overall Study||45
7637547|NCT02240108|18806025|P1|Intent-to-treat (ITT) Population|Overall Study||35
7637548|NCT02240108|18806024|P2|STARTED|Overall Study||46
7637549|NCT02240108|18806025|P1|STARTED|Overall Study||35
7637550|NCT02240030|18806054|P3|NOT COMPLETED|Overall Study||15
7637551|NCT02240030|18806055|P2|NOT COMPLETED|Overall Study||17
7637552|NCT02240030|18806056|P1|NOT COMPLETED|Overall Study||17
7637553|NCT02240030|18806054|P3|COMPLETED|Overall Study||97
7637554|NCT02240030|18806055|P2|COMPLETED|Overall Study||97
7637555|NCT02240030|18806056|P1|COMPLETED|Overall Study||96
7637556|NCT02240030|18806054|P3|STARTED|Overall Study||112
7637557|NCT02240030|18806055|P2|STARTED|Overall Study||114
7637558|NCT02240030|18806056|P1|STARTED|Overall Study||113
7637559|NCT02239978|18806080|P2|NOT COMPLETED|Overall Study||0
7637560|NCT02239978|18806081|P1|NOT COMPLETED|Overall Study||2
7637561|NCT02239978|18806080|P2|COMPLETED|Overall Study||12
7637562|NCT02239978|18806081|P1|COMPLETED|Overall Study||28
7637563|NCT02239978|18806080|P2|STARTED|Overall Study||12
7637564|NCT02239978|18806081|P1|STARTED|Overall Study||30
7637565|NCT02239939|18806098|P2|NOT COMPLETED|Overall Study||2
7637566|NCT02239939|18806099|P1|NOT COMPLETED|Overall Study||2
7637567|NCT02239939|18806098|P2|COMPLETED|Overall Study||15
7637568|NCT02239939|18806099|P1|COMPLETED|Overall Study||18
7637569|NCT02239939|18806098|P2|STARTED|Overall Study||17
7637570|NCT02239939|18806099|P1|STARTED|Overall Study||20
7637571|NCT02239926|18806115|P2|NOT COMPLETED|Overall Study||1
7637572|NCT02239926|18806116|P1|NOT COMPLETED|Overall Study||0
7637573|NCT02239926|18806115|P2|COMPLETED|Overall Study||1
7637574|NCT02239926|18806116|P1|COMPLETED|Overall Study||0
7637575|NCT02239926|18806115|P2|STARTED|Overall Study||2
7637576|NCT02239926|18806116|P1|STARTED|Overall Study||0
7637577|NCT02239770|18806130|P6|NOT COMPLETED|Part 2||0
7637578|NCT02239770|18806131|P5|NOT COMPLETED|Part 2||0
7637579|NCT02239770|18806132|P4|NOT COMPLETED|Part 2||0
7637580|NCT02239770|18806133|P3|NOT COMPLETED|Part 2||0
7637581|NCT02239770|18806134|P2|NOT COMPLETED|Part 2||0
7637582|NCT02239770|18806135|P1|NOT COMPLETED|Part 2||0
7637583|NCT02239770|18806130|P6|COMPLETED|Part 2||4
7637584|NCT02239770|18806131|P5|COMPLETED|Part 2||4
7637585|NCT02239770|18806132|P4|COMPLETED|Part 2||4
7637586|NCT02239770|18806133|P3|COMPLETED|Part 2||0
7637587|NCT02239770|18806134|P2|COMPLETED|Part 2||0
7637588|NCT02239770|18806135|P1|COMPLETED|Part 2||0
7637589|NCT02239770|18806130|P6|STARTED|Part 2||4
7637590|NCT02239770|18806131|P5|STARTED|Part 2||4
7637591|NCT02239770|18806132|P4|STARTED|Part 2||4
7637592|NCT02239770|18806133|P3|STARTED|Part 2||0
7637593|NCT02239770|18806134|P2|STARTED|Part 2||0
7637594|NCT02239770|18806135|P1|STARTED|Part 2||0
7637595|NCT02239770|18806130|P6|NOT COMPLETED|Part 1||0
7637596|NCT02239770|18806131|P5|NOT COMPLETED|Part 1||0
7637597|NCT02239770|18806132|P4|NOT COMPLETED|Part 1||0
7637598|NCT02239770|18806133|P3|NOT COMPLETED|Part 1||0
7637599|NCT02239770|18806134|P2|NOT COMPLETED|Part 1||0
7637600|NCT02239770|18806135|P1|NOT COMPLETED|Part 1||0
7637601|NCT02239770|18806130|P6|COMPLETED|Part 1||0
7637602|NCT02239770|18806131|P5|COMPLETED|Part 1||0
7637603|NCT02239770|18806132|P4|COMPLETED|Part 1||0
7637604|NCT02239770|18806133|P3|COMPLETED|Part 1||4
7637605|NCT02239770|18806134|P2|COMPLETED|Part 1||4
7637606|NCT02239770|18806135|P1|COMPLETED|Part 1||4
7637607|NCT02239770|18806130|P6|STARTED|Part 1||0
7637608|NCT02239770|18806131|P5|STARTED|Part 1||0
7637609|NCT02239770|18806132|P4|STARTED|Part 1||0
7637610|NCT02239770|18806133|P3|STARTED|Part 1||4
7637611|NCT02239770|18806134|P2|STARTED|Part 1||4
7637612|NCT02239770|18806135|P1|STARTED|Part 1||4
7637613|NCT02239744|18806163|P2|NOT COMPLETED|Period 2||0
7637614|NCT02239744|18806164|P1|NOT COMPLETED|Period 2||0
7637615|NCT02239744|18806163|P2|COMPLETED|Period 2||18
7637616|NCT02239744|18806164|P1|COMPLETED|Period 2||17
7637617|NCT02239744|18806163|P2|STARTED|Period 2||18
7637618|NCT02239744|18806164|P1|STARTED|Period 2||17
7637619|NCT02239744|18806163|P2|NOT COMPLETED|Period 1||0
7637620|NCT02239744|18806164|P1|NOT COMPLETED|Period 1||0
7637621|NCT02239744|18806163|P2|COMPLETED|Period 1||18
7637622|NCT02239744|18806164|P1|COMPLETED|Period 1||17
7637623|NCT02239744|18806163|P2|STARTED|Period 1||18
7637624|NCT02239744|18806164|P1|STARTED|Period 1||17
7637625|NCT02239692|18806178|P2|NOT COMPLETED|Overall Study||13
7637626|NCT02239692|18806179|P1|NOT COMPLETED|Overall Study||6
7637627|NCT02239692|18806178|P2|COMPLETED|Overall Study||118
7637628|NCT02239692|18806179|P1|COMPLETED|Overall Study||67
7637629|NCT02239692|18806178|P2|Safety Analysis Set|Overall Study||125
7637630|NCT02239692|18806179|P1|Safety Analysis Set|Overall Study||70
7637631|NCT02239692|18806178|P2|Per-protocol Analysis Set|Overall Study||120
7637632|NCT02239692|18806179|P1|Per-protocol Analysis Set|Overall Study||66
7637633|NCT02239692|18806178|P2|Intention-to-treat Analysis Set|Overall Study||131
7637634|NCT02239692|18806179|P1|Intention-to-treat Analysis Set|Overall Study||73
7637635|NCT02239692|18806178|P2|STARTED|Overall Study||131
7637636|NCT02239692|18806179|P1|STARTED|Overall Study||73
7637637|NCT02239679|18806198|P3|NOT COMPLETED|Overall Study||1
7637638|NCT02239679|18806199|P2|NOT COMPLETED|Overall Study||3
7637639|NCT02239679|18806200|P1|NOT COMPLETED|Overall Study||3
7637640|NCT02239679|18806198|P3|COMPLETED|Overall Study||53
7637641|NCT02239679|18806199|P2|COMPLETED|Overall Study||56
7637642|NCT02239679|18806200|P1|COMPLETED|Overall Study||50
7637643|NCT02239679|18806198|P3|STARTED|Overall Study||54
7637644|NCT02239679|18806199|P2|STARTED|Overall Study||59
7637645|NCT02239679|18806200|P1|STARTED|Overall Study||53
7637646|NCT02239640|18806412|P1|NOT COMPLETED|Overall Study||217
7637647|NCT02239640|18806412|P1|COMPLETED|Overall Study||767
7637648|NCT02239640|18806412|P1|STARTED|Overall Study||984
7637649|NCT02239601|18806424|P2|NOT COMPLETED|Overall Study||6
7637650|NCT02239601|18806425|P1|NOT COMPLETED|Overall Study||7
7637651|NCT02239601|18806424|P2|COMPLETED|Overall Study||26
7637652|NCT02239601|18806425|P1|COMPLETED|Overall Study||22
7637653|NCT02239601|18806424|P2|STARTED|Overall Study||32
7637654|NCT02239601|18806425|P1|STARTED|Overall Study||29
7637655|NCT02239562|18806449|P6|NOT COMPLETED|Overall Study||0
7637656|NCT02239562|18806450|P5|NOT COMPLETED|Overall Study||0
7637657|NCT02239562|18806451|P4|NOT COMPLETED|Overall Study||0
7637658|NCT02239562|18806452|P3|NOT COMPLETED|Overall Study||0
7637659|NCT02239562|18806453|P2|NOT COMPLETED|Overall Study||0
7637660|NCT02239562|18806454|P1|NOT COMPLETED|Overall Study||0
7637661|NCT02239562|18806449|P6|COMPLETED|Overall Study||6
7637662|NCT02239562|18806450|P5|COMPLETED|Overall Study||6
7637663|NCT02239562|18806451|P4|COMPLETED|Overall Study||6
7637664|NCT02239562|18806452|P3|COMPLETED|Overall Study||6
7637665|NCT02239562|18806453|P2|COMPLETED|Overall Study||6
7637666|NCT02239562|18806454|P1|COMPLETED|Overall Study||6
7637667|NCT02239562|18806449|P6|STARTED|Overall Study||6
7637668|NCT02239562|18806450|P5|STARTED|Overall Study||6
7637669|NCT02239562|18806451|P4|STARTED|Overall Study||6
7637670|NCT02239562|18806452|P3|STARTED|Overall Study||6
7637671|NCT02239562|18806453|P2|STARTED|Overall Study||6
7637672|NCT02239562|18806454|P1|STARTED|Overall Study||6
7637673|NCT02239536|18806478|P2|NOT COMPLETED|Overall Study||17
7637674|NCT02239536|18806479|P1|NOT COMPLETED|Overall Study||23
7637675|NCT02239536|18806478|P2|COMPLETED|Overall Study||155
7637676|NCT02239536|18806479|P1|COMPLETED|Overall Study||167
7637677|NCT02239536|18806478|P2|STARTED|Overall Study||172
7637678|NCT02239536|18806479|P1|STARTED|Overall Study||190
7637679|NCT02239510|18806489|P2|NOT COMPLETED|Overall Study||1
7637680|NCT02239510|18806490|P1|NOT COMPLETED|Overall Study||2
7637681|NCT02239510|18806489|P2|COMPLETED|Overall Study||3
7637682|NCT02239510|18806490|P1|COMPLETED|Overall Study||3
7637683|NCT02239510|18806489|P2|STARTED|Overall Study||4
7637684|NCT02239510|18806490|P1|STARTED|Overall Study||5
7637685|NCT02239380|18806502|P1|NOT COMPLETED|Overall Study||0
7637686|NCT02239380|18806502|P1|COMPLETED|Overall Study||26
7637687|NCT02239380|18806502|P1|STARTED|Overall Study||26
7637688|NCT02239328|18806512|P1|NOT COMPLETED|Overall Study||8
7637689|NCT02239328|18806512|P1|COMPLETED|Overall Study||174
7637690|NCT02239328|18806512|P1|STARTED|Overall Study||182
7637691|NCT02239289|18806516|P1|NOT COMPLETED|Overall Study||0
7637692|NCT02239289|18806516|P1|COMPLETED|Overall Study||21
7637693|NCT02239289|18806516|P1|STARTED|Overall Study||21
7637694|NCT02239120|18806537|P2|NOT COMPLETED|Overall Study||72
7637695|NCT02239120|18806538|P1|NOT COMPLETED|Overall Study||75
7637696|NCT02239120|18806537|P2|COMPLETED|Overall Study||2623
7637697|NCT02239120|18806538|P1|COMPLETED|Overall Study||2620
7637698|NCT02239120|18806537|P2|STARTED|Overall Study||2695
7637699|NCT02239120|18806538|P1|STARTED|Overall Study||2695
7637700|NCT02239094|18806562|P1|NOT COMPLETED|Overall Study||2
7637701|NCT02239094|18806562|P1|COMPLETED|Overall Study||18
7637702|NCT02239094|18806562|P1|STARTED|Overall Study||20
7637703|NCT02238977|18806569|P2|NOT COMPLETED|Overall Study||0
7637704|NCT02238977|18806570|P1|NOT COMPLETED|Overall Study||0
7637705|NCT02238977|18806569|P2|COMPLETED|Overall Study||1
7637706|NCT02238977|18806570|P1|COMPLETED|Overall Study||0
7637707|NCT02238977|18806569|P2|STARTED|Overall Study||1
7637708|NCT02238977|18806570|P1|STARTED|Overall Study||0
7637709|NCT02238925|18806576|P1|NOT COMPLETED|Overall Study||25
7637710|NCT02238925|18806576|P1|COMPLETED|Overall Study||1
7637711|NCT02238925|18806576|P1|STARTED|Overall Study||26
7637712|NCT02238847|18806586|P2|NOT COMPLETED|Overall Study||24
7637713|NCT02238847|18806587|P1|NOT COMPLETED|Overall Study||22
7637714|NCT02238847|18806586|P2|COMPLETED|Overall Study||36
7637715|NCT02238847|18806587|P1|COMPLETED|Overall Study||37
7637716|NCT02238847|18806586|P2|STARTED|Overall Study||60
7637717|NCT02238847|18806587|P1|STARTED|Overall Study||59
7637718|NCT02238782|18806611|P1|NOT COMPLETED|Overall Study||0
7637719|NCT02238782|18806611|P1|COMPLETED|Overall Study||12
7637720|NCT02238782|18806611|P1|Subjects Treated|Overall Study||12
7637721|NCT02238782|18806611|P1|STARTED|Overall Study||12
7637722|NCT02238483|18806617|P2|NOT COMPLETED|Overall Study||14
7637723|NCT02238483|18806618|P1|NOT COMPLETED|Overall Study||15
7637724|NCT02238483|18806617|P2|COMPLETED|Overall Study||91
7637725|NCT02238483|18806618|P1|COMPLETED|Overall Study||93
7637726|NCT02238483|18806617|P2|STARTED|Overall Study||105
7637727|NCT02238483|18806618|P1|STARTED|Overall Study||108
7637728|NCT02238379|18806656|P2|NOT COMPLETED|Overall Study||0
7637729|NCT02238379|18806657|P1|NOT COMPLETED|Overall Study||1
7637730|NCT02238379|18806656|P2|COMPLETED|Overall Study||14
7637731|NCT02238379|18806657|P1|COMPLETED|Overall Study||11
7637732|NCT02238379|18806656|P2|STARTED|Overall Study||14
7637733|NCT02238379|18806657|P1|STARTED|Overall Study||12
7637734|NCT02238080|18806683|P1|NOT COMPLETED|Overall Study||25
7637735|NCT02238080|18806683|P1|COMPLETED|Overall Study||172
7637736|NCT02238080|18806683|P1|STARTED|Overall Study||197
7637737|NCT02238067|18806697|P1|NOT COMPLETED|Overall Study||45
7637738|NCT02238067|18806697|P1|COMPLETED|Overall Study||151
7637739|NCT02238067|18806697|P1|STARTED|Overall Study||196
7637740|NCT02238028|18806720|P2|NOT COMPLETED|Overall Study||2
7637741|NCT02238028|18806721|P1|NOT COMPLETED|Overall Study||2
7637742|NCT02238028|18806720|P2|COMPLETED|Overall Study||12
7637743|NCT02238028|18806721|P1|COMPLETED|Overall Study||12
7637744|NCT02238028|18806720|P2|STARTED|Overall Study||14
7637745|NCT02238028|18806721|P1|STARTED|Overall Study||14
7637746|NCT02237989|18806742|P2|NOT COMPLETED|Overall Study||0
7637747|NCT02237989|18806743|P1|NOT COMPLETED|Overall Study||0
7637748|NCT02237989|18806742|P2|COMPLETED|Overall Study||20
7637749|NCT02237989|18806743|P1|COMPLETED|Overall Study||19
7637750|NCT02237989|18806742|P2|STARTED|Overall Study||20
7637751|NCT02237989|18806743|P1|STARTED|Overall Study||19
7637752|NCT02237950|18806759|P2|NOT COMPLETED|Overall Study||48
7637753|NCT02237950|18806760|P1|NOT COMPLETED|Overall Study||48
7637754|NCT02237950|18806759|P2|COMPLETED|Overall Study||243
7637755|NCT02237950|18806760|P1|COMPLETED|Overall Study||247
7637756|NCT02237950|18806759|P2|STARTED|Overall Study||291
7637757|NCT02237950|18806760|P1|STARTED|Overall Study||295
7637758|NCT02237911|18806785|P3|NOT COMPLETED|Overall Study||3
7637759|NCT02237911|18806786|P2|NOT COMPLETED|Overall Study||8
7637760|NCT02237911|18806787|P1|NOT COMPLETED|Overall Study||7
7637761|NCT02237911|18806785|P3|COMPLETED|Overall Study||45
7637762|NCT02237911|18806786|P2|COMPLETED|Overall Study||88
7637763|NCT02237911|18806787|P1|COMPLETED|Overall Study||89
7637764|NCT02237911|18806785|P3|6 Months|Overall Study||45
7637765|NCT02237911|18806786|P2|6 Months|Overall Study||88
7637766|NCT02237911|18806787|P1|6 Months|Overall Study||89
7637767|NCT02237911|18806785|P3|3 Months|Overall Study||44
7637768|NCT02237911|18806786|P2|3 Months|Overall Study||87
7637769|NCT02237911|18806787|P1|3 Months|Overall Study||90
7637770|NCT02237911|18806785|P3|STARTED|Overall Study||48
7637771|NCT02237911|18806786|P2|STARTED|Overall Study||96
7637772|NCT02237911|18806787|P1|STARTED|Overall Study||96
7637773|NCT02237898|18806803|P2|NOT COMPLETED|Overall Study||12
7637774|NCT02237898|18806804|P1|NOT COMPLETED|Overall Study||7
7637775|NCT02237898|18806803|P2|COMPLETED|Overall Study||2
7637776|NCT02237898|18806804|P1|COMPLETED|Overall Study||5
7637777|NCT02237898|18806803|P2|Completed 15 Month Follow-up|Overall Study||8
7637778|NCT02237898|18806804|P1|Completed 15 Month Follow-up|Overall Study||8
7637779|NCT02237898|18806803|P2|Completed 9 Month Follow-up|Overall Study||7
7637780|NCT02237898|18806804|P1|Completed 9 Month Follow-up|Overall Study||6
7637781|NCT02237898|18806803|P2|Completed 3 Month Follow-up|Overall Study||6
7637782|NCT02237898|18806804|P1|Completed 3 Month Follow-up|Overall Study||6
7637783|NCT02237898|18806803|P2|Completed 12 Weeks of CM|Overall Study||2
7637784|NCT02237898|18806804|P1|Completed 12 Weeks of CM|Overall Study||7
7637785|NCT02237898|18806803|P2|STARTED|Overall Study||14
7637786|NCT02237898|18806804|P1|STARTED|Overall Study||12
7637787|NCT02237196|18806827|P4|NOT COMPLETED|Overall Study||11
7637788|NCT02237196|18806828|P3|NOT COMPLETED|Overall Study||10
7637789|NCT02237196|18806829|P2|NOT COMPLETED|Overall Study||6
7637790|NCT02237196|18806830|P1|NOT COMPLETED|Overall Study||8
7637791|NCT02237196|18806827|P4|COMPLETED|Overall Study||17
7637792|NCT02237196|18806828|P3|COMPLETED|Overall Study||20
7637793|NCT02237196|18806829|P2|COMPLETED|Overall Study||25
7637794|NCT02237196|18806830|P1|COMPLETED|Overall Study||24
7637795|NCT02237196|18806827|P4|STARTED|Overall Study||28
7637796|NCT02237196|18806828|P3|STARTED|Overall Study||30
7637797|NCT02237196|18806829|P2|STARTED|Overall Study||31
7637798|NCT02237196|18806830|P1|STARTED|Overall Study||32
7637799|NCT02237118|18806874|P2|NOT COMPLETED|Overall Study||1
7637800|NCT02237118|18806875|P1|NOT COMPLETED|Overall Study||1
7637801|NCT02237118|18806874|P2|COMPLETED|Overall Study||62
7637802|NCT02237118|18806875|P1|COMPLETED|Overall Study||59
7637803|NCT02237118|18806874|P2|STARTED|Overall Study||63
7637804|NCT02237118|18806875|P1|STARTED|Overall Study||60
7637805|NCT02237092|18806889|P1|NOT COMPLETED|Overall Study||0
7637806|NCT02237092|18806889|P1|COMPLETED|Overall Study||196
7637807|NCT02237092|18806889|P1|STARTED|Overall Study||196
7637808|NCT02237001|18806906|P1|NOT COMPLETED|Overall Study||11
7637809|NCT02237001|18806906|P1|COMPLETED|Overall Study||19
7637810|NCT02237001|18806906|P1|24 Month Follow-up|Overall Study||19
7637811|NCT02237001|18806906|P1|12 Month Follow-up|Overall Study||21
7637812|NCT02237001|18806906|P1|6 Month Follow-up|Overall Study||27
7637813|NCT02237001|18806906|P1|STARTED|Overall Study||30
7637814|NCT02236767|18806918|P1|NOT COMPLETED|Overall Study||0
7637815|NCT02236767|18806918|P1|COMPLETED|Overall Study||1
7637816|NCT02236767|18806918|P1|STARTED|Overall Study||1
7637817|NCT02236611|18806924|P2|NOT COMPLETED|Overall Study||34
7637818|NCT02236611|18806925|P1|NOT COMPLETED|Overall Study||26
7637819|NCT02236611|18806924|P2|COMPLETED|Overall Study||484
7637820|NCT02236611|18806925|P1|COMPLETED|Overall Study||490
7637821|NCT02236611|18806924|P2|STARTED|Overall Study||518
7637822|NCT02236611|18806925|P1|STARTED|Overall Study||516
7637823|NCT02236598|18806933|P2|NOT COMPLETED|Overall Study||2
7637824|NCT02236598|18806934|P1|NOT COMPLETED|Overall Study||0
7637825|NCT02236598|18806933|P2|COMPLETED|Overall Study||12
7637826|NCT02236598|18806934|P1|COMPLETED|Overall Study||15
7637827|NCT02236598|18806933|P2|STARTED|Overall Study||14
7637828|NCT02236598|18806934|P1|STARTED|Overall Study||15
7637829|NCT02236559|18806948|P2|NOT COMPLETED|Overall Study||12
7637830|NCT02236559|18806949|P1|NOT COMPLETED|Overall Study||12
7637831|NCT02236559|18806948|P2|COMPLETED|Overall Study||104
7637832|NCT02236559|18806949|P1|COMPLETED|Overall Study||100
7637833|NCT02236559|18806948|P2|STARTED|Overall Study||116
7637834|NCT02236559|18806949|P1|STARTED|Overall Study||112
7637835|NCT02236546|18806975|P1|NOT COMPLETED|Overall Study||0
7637836|NCT02236546|18806975|P1|COMPLETED|Overall Study||3
7637837|NCT02236546|18806975|P1|STARTED|Overall Study||3
7637838|NCT02236520|18806986|P4|NOT COMPLETED|Overall Study||1
7637839|NCT02236520|18806987|P3|NOT COMPLETED|Overall Study||0
7637840|NCT02236520|18806988|P2|NOT COMPLETED|Overall Study||5
7637841|NCT02236520|18806989|P1|NOT COMPLETED|Overall Study||2
7637842|NCT02236520|18806986|P4|COMPLETED|Overall Study||14
7637843|NCT02236520|18806987|P3|COMPLETED|Overall Study||15
7637844|NCT02236520|18806988|P2|COMPLETED|Overall Study||8
7637845|NCT02236520|18806989|P1|COMPLETED|Overall Study||14
7637846|NCT02236520|18806986|P4|STARTED|Overall Study||15
7637847|NCT02236520|18806987|P3|STARTED|Overall Study||15
7637848|NCT02236520|18806988|P2|STARTED|Overall Study||13
7637849|NCT02236520|18806989|P1|STARTED|Overall Study||16
7637850|NCT02236338|18807001|P2|NOT COMPLETED|Overall Study||0
7637851|NCT02236338|18807002|P1|NOT COMPLETED|Overall Study||0
7637852|NCT02236338|18807001|P2|COMPLETED|Overall Study||100
7637853|NCT02236338|18807002|P1|COMPLETED|Overall Study||100
7637854|NCT02236338|18807001|P2|STARTED|Overall Study||100
7637855|NCT02236338|18807002|P1|STARTED|Overall Study||100
7637856|NCT02236130|18807016|P2|NOT COMPLETED|Overall Study||12
7637857|NCT02236130|18807017|P1|NOT COMPLETED|Overall Study||7
7637858|NCT02236130|18807016|P2|COMPLETED|Overall Study||15
7637859|NCT02236130|18807017|P1|COMPLETED|Overall Study||15
7637860|NCT02236130|18807016|P2|STARTED|Overall Study||27
7637861|NCT02236130|18807017|P1|STARTED|Overall Study||22
7637862|NCT02235987|18807025|P1|NOT COMPLETED|Overall Study||1
7637863|NCT02235987|18807025|P1|COMPLETED|Overall Study||19
7637864|NCT02235987|18807025|P1|Received 1800 µg DG3173|Overall Study||19
7637865|NCT02235987|18807025|P1|Received 900 µg DG3173|Overall Study||19
7637866|NCT02235987|18807025|P1|Received 300 µg DG3173|Overall Study||20
7637867|NCT02235987|18807025|P1|Received 100 µg DG3173|Overall Study||20
7637868|NCT02235987|18807025|P1|Received Octreotide|Overall Study||20
7637869|NCT02235987|18807025|P1|STARTED|Overall Study||20
7637870|NCT02235870|18807040|P2|NOT COMPLETED|Overall Study||61
7637871|NCT02235870|18807041|P1|NOT COMPLETED|Overall Study||38
7637872|NCT02235870|18807040|P2|COMPLETED|Overall Study||128
7637873|NCT02235870|18807041|P1|COMPLETED|Overall Study||160
7637874|NCT02235870|18807040|P2|Crossover (Week 24)|Overall Study||138
7637875|NCT02235870|18807041|P1|Crossover (Week 24)|Overall Study||170
7637876|NCT02235870|18807040|P2|Completed Phase I (Week 24)|Overall Study||179
7637877|NCT02235870|18807041|P1|Completed Phase I (Week 24)|Overall Study||182
7637878|NCT02235870|18807040|P2|STARTED|Overall Study||189
7637879|NCT02235870|18807041|P1|STARTED|Overall Study||198
7637880|NCT02235831|18807050|P6|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
7637881|NCT02235831|18807051|P5|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
7637882|NCT02235831|18807052|P4|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
7637883|NCT02235831|18807053|P3|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
7637884|NCT02235831|18807054|P2|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
7637885|NCT02235831|18807055|P1|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
7637886|NCT02235831|18807050|P6|COMPLETED|Period 3, Third 5 Days of Wear||4
7637887|NCT02235831|18807051|P5|COMPLETED|Period 3, Third 5 Days of Wear||4
7637888|NCT02235831|18807052|P4|COMPLETED|Period 3, Third 5 Days of Wear||4
7637889|NCT02235831|18807053|P3|COMPLETED|Period 3, Third 5 Days of Wear||4
7637890|NCT02235831|18807054|P2|COMPLETED|Period 3, Third 5 Days of Wear||4
7637891|NCT02235831|18807055|P1|COMPLETED|Period 3, Third 5 Days of Wear||4
7637892|NCT02235831|18807050|P6|STARTED|Period 3, Third 5 Days of Wear||4
7637893|NCT02235831|18807051|P5|STARTED|Period 3, Third 5 Days of Wear||4
7637894|NCT02235831|18807052|P4|STARTED|Period 3, Third 5 Days of Wear||4
7637895|NCT02235831|18807053|P3|STARTED|Period 3, Third 5 Days of Wear||4
7637896|NCT02235831|18807054|P2|STARTED|Period 3, Third 5 Days of Wear||4
7637897|NCT02235831|18807055|P1|STARTED|Period 3, Third 5 Days of Wear||4
7637898|NCT02235831|18807050|P6|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
7637899|NCT02235831|18807051|P5|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
7637900|NCT02235831|18807052|P4|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
7637901|NCT02235831|18807053|P3|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
7637902|NCT02235831|18807054|P2|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
7637903|NCT02235831|18807055|P1|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
7637904|NCT02235831|18807050|P6|COMPLETED|Period 2, Second 5 Days of Wear||4
7637905|NCT02235831|18807051|P5|COMPLETED|Period 2, Second 5 Days of Wear||4
7637906|NCT02235831|18807052|P4|COMPLETED|Period 2, Second 5 Days of Wear||4
7637907|NCT02235831|18807053|P3|COMPLETED|Period 2, Second 5 Days of Wear||4
7637908|NCT02235831|18807054|P2|COMPLETED|Period 2, Second 5 Days of Wear||4
7637909|NCT02235831|18807055|P1|COMPLETED|Period 2, Second 5 Days of Wear||4
7637910|NCT02235831|18807050|P6|STARTED|Period 2, Second 5 Days of Wear||4
7637911|NCT02235831|18807051|P5|STARTED|Period 2, Second 5 Days of Wear||4
7637912|NCT02235831|18807052|P4|STARTED|Period 2, Second 5 Days of Wear||4
7637913|NCT02235831|18807053|P3|STARTED|Period 2, Second 5 Days of Wear||4
7637914|NCT02235831|18807054|P2|STARTED|Period 2, Second 5 Days of Wear||4
7637915|NCT02235831|18807055|P1|STARTED|Period 2, Second 5 Days of Wear||4
7637916|NCT02235831|18807050|P6|NOT COMPLETED|Period 1, First 5 Days of Wear||0
7637917|NCT02235831|18807051|P5|NOT COMPLETED|Period 1, First 5 Days of Wear||0
7637918|NCT02235831|18807052|P4|NOT COMPLETED|Period 1, First 5 Days of Wear||0
7637919|NCT02235831|18807053|P3|NOT COMPLETED|Period 1, First 5 Days of Wear||0
7637920|NCT02235831|18807054|P2|NOT COMPLETED|Period 1, First 5 Days of Wear||0
7637921|NCT02235831|18807055|P1|NOT COMPLETED|Period 1, First 5 Days of Wear||0
7637922|NCT02235831|18807050|P6|COMPLETED|Period 1, First 5 Days of Wear||4
7637923|NCT02235831|18807051|P5|COMPLETED|Period 1, First 5 Days of Wear||4
7637924|NCT02235831|18807052|P4|COMPLETED|Period 1, First 5 Days of Wear||4
7637925|NCT02235831|18807053|P3|COMPLETED|Period 1, First 5 Days of Wear||4
7637926|NCT02235831|18807054|P2|COMPLETED|Period 1, First 5 Days of Wear||4
7637927|NCT02235831|18807055|P1|COMPLETED|Period 1, First 5 Days of Wear||4
7637928|NCT02235831|18807050|P6|STARTED|Period 1, First 5 Days of Wear||4
7637929|NCT02235831|18807051|P5|STARTED|Period 1, First 5 Days of Wear||4
7637930|NCT02235831|18807052|P4|STARTED|Period 1, First 5 Days of Wear||4
7637931|NCT02235831|18807053|P3|STARTED|Period 1, First 5 Days of Wear||4
7637932|NCT02235831|18807054|P2|STARTED|Period 1, First 5 Days of Wear||4
7637933|NCT02235831|18807055|P1|STARTED|Period 1, First 5 Days of Wear||4
7637934|NCT02235493|18807062|P1|NOT COMPLETED|Overall Study||0
7637935|NCT02235493|18807062|P1|COMPLETED|Overall Study||6
7637936|NCT02235493|18807062|P1|STARTED|Overall Study||6
7637937|NCT02235454|18807067|P1|NOT COMPLETED|Overall Study||2
7637938|NCT02235454|18807067|P1|COMPLETED|Overall Study||55
7637939|NCT02235454|18807067|P1|STARTED|Overall Study||57
7637940|NCT02235311|18807073|P2|NOT COMPLETED|Overall Study||2
7637941|NCT02235311|18807074|P1|NOT COMPLETED|Overall Study||0
7637942|NCT02235311|18807073|P2|COMPLETED|Overall Study||0
7637943|NCT02235311|18807074|P1|COMPLETED|Overall Study||1
7637944|NCT02235311|18807073|P2|STARTED|Overall Study||2
7637945|NCT02235311|18807074|P1|STARTED|Overall Study||1
7637946|NCT02235285|18807086|P1|NOT COMPLETED|Overall Study||13
7637947|NCT02235285|18807086|P1|COMPLETED|Overall Study||149
7637948|NCT02235285|18807086|P1|STARTED|Overall Study||162
7637949|NCT02235077|18807092|P2|NOT COMPLETED|Overall Study||19
7637950|NCT02235077|18807093|P1|NOT COMPLETED|Overall Study||18
7637951|NCT02235077|18807092|P2|COMPLETED|Overall Study||159
7637952|NCT02235077|18807093|P1|COMPLETED|Overall Study||164
7637953|NCT02235077|18807092|P2|STARTED|Overall Study||178
7637954|NCT02235077|18807093|P1|STARTED|Overall Study||182
7637955|NCT02235064|18807121|P2|NOT COMPLETED|Overall Study||0
7637956|NCT02235064|18807122|P1|NOT COMPLETED|Overall Study||0
7637957|NCT02235064|18807121|P2|COMPLETED|Overall Study||1
7637958|NCT02235064|18807122|P1|COMPLETED|Overall Study||1
7637959|NCT02235064|18807121|P2|STARTED|Overall Study||1
7637960|NCT02235064|18807122|P1|STARTED|Overall Study||1
7637961|NCT02234843|18807158|P10|NOT COMPLETED|Overall Study||0
7637962|NCT02234843|18807159|P9|NOT COMPLETED|Overall Study||1
7637963|NCT02234843|18807160|P8|NOT COMPLETED|Overall Study||2
7637964|NCT02234843|18807161|P7|NOT COMPLETED|Overall Study||2
7637965|NCT02234843|18807162|P6|NOT COMPLETED|Overall Study||13
7637966|NCT02234843|18807163|P5|NOT COMPLETED|Overall Study||2
7637967|NCT02234843|18807164|P4|NOT COMPLETED|Overall Study||5
7637968|NCT02234843|18807165|P3|NOT COMPLETED|Overall Study||3
7637969|NCT02234843|18807166|P2|NOT COMPLETED|Overall Study||6
7637970|NCT02234843|18807167|P1|NOT COMPLETED|Overall Study||22
7637971|NCT02234843|18807158|P10|COMPLETED|Overall Study||8
7637972|NCT02234843|18807159|P9|COMPLETED|Overall Study||8
7637973|NCT02234843|18807160|P8|COMPLETED|Overall Study||20
7637974|NCT02234843|18807161|P7|COMPLETED|Overall Study||32
7637975|NCT02234843|18807162|P6|COMPLETED|Overall Study||79
7637976|NCT02234843|18807163|P5|COMPLETED|Overall Study||14
7637977|NCT02234843|18807164|P4|COMPLETED|Overall Study||16
7637978|NCT02234843|18807165|P3|COMPLETED|Overall Study||44
7637979|NCT02234843|18807166|P2|COMPLETED|Overall Study||61
7637980|NCT02234843|18807167|P1|COMPLETED|Overall Study||162
7637981|NCT02234843|18807158|P10|STARTED|Overall Study||8
7637982|NCT02234843|18807159|P9|STARTED|Overall Study||9
7637983|NCT02234843|18807160|P8|STARTED|Overall Study||22
7637984|NCT02234843|18807161|P7|STARTED|Overall Study||34
7637985|NCT02234843|18807162|P6|STARTED|Overall Study||92
7637986|NCT02234843|18807163|P5|STARTED|Overall Study||16
7637987|NCT02234843|18807164|P4|STARTED|Overall Study||21
7637988|NCT02234843|18807165|P3|STARTED|Overall Study||47
7637989|NCT02234843|18807166|P2|STARTED|Overall Study||67
7637990|NCT02234843|18807167|P1|STARTED|Overall Study||184
7637991|NCT02234752|18807274|P1|NOT COMPLETED|Overall Study||1
7637992|NCT02234752|18807274|P1|COMPLETED|Overall Study||2
7637993|NCT02234752|18807274|P1|STARTED|Overall Study||3
7637994|NCT02234713|18807287|P2|NOT COMPLETED|Overall Study||5
7637995|NCT02234713|18807288|P1|NOT COMPLETED|Overall Study||6
7637996|NCT02234713|18807287|P2|COMPLETED|Overall Study||27
7637997|NCT02234713|18807288|P1|COMPLETED|Overall Study||25
7637998|NCT02234713|18807287|P2|STARTED|Overall Study||32
7637999|NCT02234713|18807288|P1|STARTED|Overall Study||31
7638000|NCT02234687|18807313|P3|NOT COMPLETED|Overall Study||4
7638001|NCT02234687|18807314|P2|NOT COMPLETED|Overall Study||4
7638002|NCT02234687|18807315|P1|NOT COMPLETED|Overall Study||6
7638003|NCT02234687|18807313|P3|COMPLETED|Overall Study||0
7638004|NCT02234687|18807314|P2|COMPLETED|Overall Study||0
7638005|NCT02234687|18807315|P1|COMPLETED|Overall Study|Study Terminated. No outcome measures were analyzed|0
7638006|NCT02234687|18807313|P3|STARTED|Overall Study||4
7638007|NCT02234687|18807314|P2|STARTED|Overall Study||4
7638008|NCT02234687|18807315|P1|STARTED|Overall Study|Study Terminated. No outcome measures were analyzed|6
7638009|NCT02234622|18807325|P2|NOT COMPLETED|Overall Study||36
7638010|NCT02234622|18807326|P1|NOT COMPLETED|Overall Study||43
7638011|NCT02234622|18807325|P2|COMPLETED|Overall Study||68
7638012|NCT02234622|18807326|P1|COMPLETED|Overall Study||65
7638013|NCT02234622|18807325|P2|STARTED|Overall Study||104
7638014|NCT02234622|18807326|P1|STARTED|Overall Study||108
7638015|NCT02234583|18807346|P2|NOT COMPLETED|Overall Study||556
7638016|NCT02234583|18807347|P1|NOT COMPLETED|Overall Study||413
7638017|NCT02234583|18807346|P2|COMPLETED|Overall Study||685
7638018|NCT02234583|18807347|P1|COMPLETED|Overall Study||434
7638019|NCT02234583|18807346|P2|STARTED|Overall Study||1241
7638020|NCT02234583|18807347|P1|STARTED|Overall Study||847
7638021|NCT02234570|18807383|P8|NOT COMPLETED|Overall Study||0
7638022|NCT02234570|18807384|P7|NOT COMPLETED|Overall Study||0
7638023|NCT02234570|18807385|P6|NOT COMPLETED|Overall Study||0
7638024|NCT02234570|18807386|P5|NOT COMPLETED|Overall Study||0
7638025|NCT02234570|18807387|P4|NOT COMPLETED|Overall Study||0
7638026|NCT02234570|18807388|P3|NOT COMPLETED|Overall Study||0
7638027|NCT02234570|18807389|P2|NOT COMPLETED|Overall Study||0
7638028|NCT02234570|18807390|P1|NOT COMPLETED|Overall Study||0
7638029|NCT02234570|18807383|P8|COMPLETED|Overall Study||14
7638030|NCT02234570|18807384|P7|COMPLETED|Overall Study||8
7638031|NCT02234570|18807385|P6|COMPLETED|Overall Study||8
7638032|NCT02234570|18807386|P5|COMPLETED|Overall Study||8
7638033|NCT02234570|18807387|P4|COMPLETED|Overall Study||8
7638034|NCT02234570|18807388|P3|COMPLETED|Overall Study||8
7638035|NCT02234570|18807389|P2|COMPLETED|Overall Study||8
7638036|NCT02234570|18807390|P1|COMPLETED|Overall Study||8
7638037|NCT02234570|18807383|P8|STARTED|Overall Study||14
7638038|NCT02234570|18807384|P7|STARTED|Overall Study||8
7638039|NCT02234570|18807385|P6|STARTED|Overall Study||8
7638040|NCT02234570|18807386|P5|STARTED|Overall Study||8
7638041|NCT02234570|18807387|P4|STARTED|Overall Study||8
7638042|NCT02234570|18807388|P3|STARTED|Overall Study||8
7638043|NCT02234570|18807389|P2|STARTED|Overall Study||8
7638044|NCT02234570|18807390|P1|STARTED|Overall Study||8
7638045|NCT02234479|18807466|P2|NOT COMPLETED|Overall Study||3
7638046|NCT02234479|18807467|P1|NOT COMPLETED|Overall Study||1
7638047|NCT02234479|18807466|P2|COMPLETED|Overall Study||15
7638048|NCT02234479|18807467|P1|COMPLETED|Overall Study||15
7638049|NCT02234479|18807466|P2|STARTED|Overall Study||18
7638050|NCT02234479|18807467|P1|STARTED|Overall Study||16
7638051|NCT02234427|18807473|P1|NOT COMPLETED|Overall Study||1
7638052|NCT02234427|18807473|P1|COMPLETED|Overall Study|One individual withdrew after first visit|33
7638053|NCT02234427|18807473|P1|STARTED|Overall Study||34
7638054|NCT02234362|18807477|P1|NOT COMPLETED|Overall Study||26
7638055|NCT02234362|18807477|P1|COMPLETED|Overall Study||21
7638056|NCT02234362|18807477|P1|Received at Least One Dose of Medication|Overall Study||27
7638057|NCT02234362|18807477|P1|STARTED|Overall Study||47
7638058|NCT02234323|18807494|P1|NOT COMPLETED|All Treated||18
7638059|NCT02234323|18807494|P1|COMPLETED|All Treated||85
7638060|NCT02234323|18807494|P1|Immune Tolerance Induction (ITI)|All Treated|1/81 on episodic and 14/89 on prophylactic regimen had inhibitors and were switched directly to ITI.|15
7638061|NCT02234323|18807494|P1|Prophylactic Treatment Regimen|All Treated|69 participants among the 81 who started in episodic regimen, switched to the prophylactic regimen.|89
7638062|NCT02234323|18807494|P1|Episodic Treatment Regimen|All Treated|Participants were treated in more than one regimen and counted in all categories wherever applicable|81
7638063|NCT02234323|18807494|P1|STARTED|All Treated||103
7638064|NCT02234323|18807494|P1|NOT COMPLETED|All Enrolled||5
7638065|NCT02234323|18807494|P1|COMPLETED|All Enrolled|These participants received at least one dose of study drug.|103
7638066|NCT02234323|18807494|P1|STARTED|All Enrolled||108
7638067|NCT02234310|18807507|P1|NOT COMPLETED|Overall Study||6
7638068|NCT02234310|18807507|P1|COMPLETED|Overall Study||27
7638069|NCT02234310|18807507|P1|Prophylactic Treatment Regimen|Overall Study|17 participants among the 22 who started in episodic regimen, switched to the prophylactic regimen.|28
7638070|NCT02234310|18807507|P1|Episodic Treatment Regimen|Overall Study|Participants were treated in more than one regimen and counted in all categories wherever applicable|22
7638071|NCT02234310|18807507|P1|STARTED|Overall Study||33
7638072|NCT02234284|18807521|P2|NOT COMPLETED|Overall Study||9
7638073|NCT02234284|18807522|P1|NOT COMPLETED|Overall Study||25
7638074|NCT02234284|18807521|P2|COMPLETED|Overall Study||83
7638075|NCT02234284|18807522|P1|COMPLETED|Overall Study||75
7638076|NCT02234284|18807521|P2|STARTED|Overall Study||92
7638077|NCT02234284|18807522|P1|STARTED|Overall Study||100
7638078|NCT02234180|18807570|P2|NOT COMPLETED|Overall Study||0
7638079|NCT02234180|18807571|P1|NOT COMPLETED|Overall Study||0
7638080|NCT02234180|18807570|P2|COMPLETED|Overall Study||1
7638081|NCT02234180|18807571|P1|COMPLETED|Overall Study||2
7638082|NCT02234180|18807570|P2|STARTED|Overall Study||1
7638083|NCT02234180|18807571|P1|STARTED|Overall Study||2
7638084|NCT02234141|18807581|P7|NOT COMPLETED|Long-Term Treatment Period||10
7638085|NCT02234141|18807582|P6|NOT COMPLETED|Long-Term Treatment Period||12
7638086|NCT02234141|18807583|P5|NOT COMPLETED|Long-Term Treatment Period||10
7638087|NCT02234141|18807584|P4|NOT COMPLETED|Long-Term Treatment Period||0
7638088|NCT02234141|18807585|P3|NOT COMPLETED|Long-Term Treatment Period||33
7638089|NCT02234141|18807586|P2|NOT COMPLETED|Long-Term Treatment Period||31
7638090|NCT02234141|18807587|P1|NOT COMPLETED|Long-Term Treatment Period||33
7638091|NCT02234141|18807581|P7|COMPLETED|Long-Term Treatment Period||0
7638092|NCT02234141|18807582|P6|COMPLETED|Long-Term Treatment Period||0
7638093|NCT02234141|18807583|P5|COMPLETED|Long-Term Treatment Period||0
7638094|NCT02234141|18807584|P4|COMPLETED|Long-Term Treatment Period||0
7638095|NCT02234141|18807585|P3|COMPLETED|Long-Term Treatment Period||0
7638096|NCT02234141|18807586|P2|COMPLETED|Long-Term Treatment Period||0
7638097|NCT02234141|18807587|P1|COMPLETED|Long-Term Treatment Period||0
7638098|NCT02234141|18807581|P7|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
7638099|NCT02234141|18807582|P6|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|12
7638100|NCT02234141|18807583|P5|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
7638101|NCT02234141|18807584|P4|STARTED|Long-Term Treatment Period|Participants were rerandomized to receive selonsertib during the Long-Term Treatment Phase.|0
7638102|NCT02234141|18807585|P3|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
7638103|NCT02234141|18807586|P2|STARTED|Long-Term Treatment Period|1 participant who completed the Period 1 did not continue into the Long-Term Treatment Phase.|31
7638104|NCT02234141|18807587|P1|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
7638105|NCT02234141|18807581|P7|NOT COMPLETED|Treatment Period (24 Weeks)||0
7638106|NCT02234141|18807582|P6|NOT COMPLETED|Treatment Period (24 Weeks)||0
7638107|NCT02234141|18807583|P5|NOT COMPLETED|Treatment Period (24 Weeks)||0
7638108|NCT02234141|18807584|P4|NOT COMPLETED|Treatment Period (24 Weeks)||5
7638109|NCT02234141|18807585|P3|NOT COMPLETED|Treatment Period (24 Weeks)||2
7638110|NCT02234141|18807586|P2|NOT COMPLETED|Treatment Period (24 Weeks)||6
7638111|NCT02234141|18807587|P1|NOT COMPLETED|Treatment Period (24 Weeks)||4
7638112|NCT02234141|18807581|P7|COMPLETED|Treatment Period (24 Weeks)||0
7638113|NCT02234141|18807582|P6|COMPLETED|Treatment Period (24 Weeks)||0
7638114|NCT02234141|18807583|P5|COMPLETED|Treatment Period (24 Weeks)||0
7638115|NCT02234141|18807584|P4|COMPLETED|Treatment Period (24 Weeks)||32
7638116|NCT02234141|18807585|P3|COMPLETED|Treatment Period (24 Weeks)||35
7638117|NCT02234141|18807586|P2|COMPLETED|Treatment Period (24 Weeks)||32
7638118|NCT02234141|18807587|P1|COMPLETED|Treatment Period (24 Weeks)||35
7638119|NCT02234141|18807581|P7|STARTED|Treatment Period (24 Weeks)||0
7638120|NCT02234141|18807582|P6|STARTED|Treatment Period (24 Weeks)||0
7638121|NCT02234141|18807583|P5|STARTED|Treatment Period (24 Weeks)||0
7638122|NCT02234141|18807584|P4|STARTED|Treatment Period (24 Weeks)||37
7638123|NCT02234141|18807585|P3|STARTED|Treatment Period (24 Weeks)||37
7638124|NCT02234141|18807586|P2|STARTED|Treatment Period (24 Weeks)||38
7638125|NCT02234141|18807587|P1|STARTED|Treatment Period (24 Weeks)||39
7638126|NCT02234128|18807672|P3|NOT COMPLETED|Overall Study||4
7638127|NCT02234128|18807673|P2|NOT COMPLETED|Overall Study||2
7638128|NCT02234128|18807674|P1|NOT COMPLETED|Overall Study||5
7638129|NCT02234128|18807672|P3|COMPLETED|Overall Study||48
7638130|NCT02234128|18807673|P2|COMPLETED|Overall Study||29
7638131|NCT02234128|18807674|P1|COMPLETED|Overall Study||30
7638132|NCT02234128|18807672|P3|STARTED|Overall Study||52
7638133|NCT02234128|18807673|P2|STARTED|Overall Study||31
7638134|NCT02234128|18807674|P1|STARTED|Overall Study||35
7638135|NCT02234115|18807685|P1|NOT COMPLETED|Overall Study||15
7638136|NCT02234115|18807685|P1|COMPLETED|Overall Study||122
7638137|NCT02234115|18807685|P1|PK Subgroup|Overall Study||31
7638138|NCT02234115|18807685|P1|PP|Overall Study||124
7638139|NCT02234115|18807685|P1|ITT|Overall Study||137
7638140|NCT02234115|18807685|P1|STARTED|Overall Study||137
7638141|NCT02234063|18807692|P2|NOT COMPLETED|Overall Study||43
7638142|NCT02234063|18807693|P1|NOT COMPLETED|Overall Study||255
7638143|NCT02234063|18807692|P2|COMPLETED|Overall Study||212
7638144|NCT02234063|18807693|P1|COMPLETED|Overall Study||1540
7638145|NCT02234063|18807692|P2|STARTED|Overall Study||255
7638146|NCT02234063|18807693|P1|STARTED|Overall Study||1795
7638147|NCT02234011|18807713|P1|NOT COMPLETED|Overall Study||0
7638148|NCT02234011|18807713|P1|COMPLETED|Overall Study||0
7638149|NCT02234011|18807713|P1|STARTED|Overall Study||0
7638150|NCT02233998|18807720|P3|NOT COMPLETED|Overall Study||0
7638151|NCT02233998|18807721|P2|NOT COMPLETED|Overall Study||0
7638152|NCT02233998|18807722|P1|NOT COMPLETED|Overall Study||0
7638153|NCT02233998|18807720|P3|COMPLETED|Overall Study||53
7638154|NCT02233998|18807721|P2|COMPLETED|Overall Study||52
7638155|NCT02233998|18807722|P1|COMPLETED|Overall Study||53
7638156|NCT02233998|18807720|P3|STARTED|Overall Study||53
7638157|NCT02233998|18807721|P2|STARTED|Overall Study||52
7638158|NCT02233998|18807722|P1|STARTED|Overall Study||53
7638159|NCT02233985|18807756|P2|NOT COMPLETED|Overall Study||0
7638160|NCT02233985|18807757|P1|NOT COMPLETED|Overall Study||0
7638161|NCT02233985|18807756|P2|COMPLETED|Overall Study||31
7638162|NCT02233985|18807757|P1|COMPLETED|Overall Study||33
7638163|NCT02233985|18807756|P2|STARTED|Overall Study||31
7638164|NCT02233985|18807757|P1|STARTED|Overall Study||33
7638165|NCT02233842|18807765|P1|NOT COMPLETED|Questionnaire 3 Version 2||0
7638166|NCT02233842|18807765|P1|COMPLETED|Questionnaire 3 Version 2||5
7638167|NCT02233842|18807765|P1|STARTED|Questionnaire 3 Version 2||5
7638168|NCT02233842|18807765|P1|NOT COMPLETED|Questionnaire 3 Version 1||0
7638169|NCT02233842|18807765|P1|COMPLETED|Questionnaire 3 Version 1||5
7638170|NCT02233842|18807765|P1|STARTED|Questionnaire 3 Version 1||5
7638171|NCT02233842|18807765|P1|NOT COMPLETED|Questionnaire 2 Version 2||0
7638172|NCT02233842|18807765|P1|COMPLETED|Questionnaire 2 Version 2||5
7638173|NCT02233842|18807765|P1|STARTED|Questionnaire 2 Version 2||5
7638174|NCT02233842|18807765|P1|NOT COMPLETED|Questionnaire 2 Version 1||0
7638175|NCT02233842|18807765|P1|COMPLETED|Questionnaire 2 Version 1||5
7638176|NCT02233842|18807765|P1|STARTED|Questionnaire 2 Version 1||5
7638177|NCT02233842|18807765|P1|NOT COMPLETED|Questionnaire 1 Version 2||0
7638178|NCT02233842|18807765|P1|COMPLETED|Questionnaire 1 Version 2||5
7638179|NCT02233842|18807765|P1|STARTED|Questionnaire 1 Version 2||5
7638180|NCT02233842|18807765|P1|NOT COMPLETED|Questionnaire 1 Version 1||0
7638181|NCT02233842|18807765|P1|COMPLETED|Questionnaire 1 Version 1||5
7638182|NCT02233842|18807765|P1|STARTED|Questionnaire 1 Version 1||5
7638183|NCT02233803|18807772|P2|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
7638184|NCT02233803|18807773|P1|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
7638185|NCT02233803|18807772|P2|COMPLETED|Treatment Period 2 (4-Wks)||91
7638186|NCT02233803|18807773|P1|COMPLETED|Treatment Period 2 (4-Wks)||93
7638187|NCT02233803|18807772|P2|STARTED|Treatment Period 2 (4-Wks)||93
7638188|NCT02233803|18807773|P1|STARTED|Treatment Period 2 (4-Wks)||95
7638189|NCT02233803|18807772|P2|NOT COMPLETED|Washout Period (4-Wks)||2
7638190|NCT02233803|18807773|P1|NOT COMPLETED|Washout Period (4-Wks)||2
7638191|NCT02233803|18807772|P2|COMPLETED|Washout Period (4-Wks)||93
7638192|NCT02233803|18807773|P1|COMPLETED|Washout Period (4-Wks)||95
7638193|NCT02233803|18807772|P2|STARTED|Washout Period (4-Wks)||95
7638194|NCT02233803|18807773|P1|STARTED|Washout Period (4-Wks)||97
7638195|NCT02233803|18807772|P2|NOT COMPLETED|Treatment Period 1 (4-Wks)||4
7638196|NCT02233803|18807773|P1|NOT COMPLETED|Treatment Period 1 (4-Wks)||3
7638197|NCT02233803|18807772|P2|COMPLETED|Treatment Period 1 (4-Wks)||95
7638198|NCT02233803|18807773|P1|COMPLETED|Treatment Period 1 (4-Wks)||97
7638199|NCT02233803|18807772|P2|STARTED|Treatment Period 1 (4-Wks)||99
7638200|NCT02233803|18807773|P1|STARTED|Treatment Period 1 (4-Wks)||100
7638201|NCT02233751|18807785|P2|NOT COMPLETED|Overall Study||0
7638202|NCT02233751|18807786|P1|NOT COMPLETED|Overall Study||0
7638203|NCT02233751|18807785|P2|COMPLETED|Overall Study||6
7638204|NCT02233751|18807786|P1|COMPLETED|Overall Study||6
7638205|NCT02233751|18807785|P2|STARTED|Overall Study||6
7638206|NCT02233751|18807786|P1|STARTED|Overall Study||6
7638207|NCT02233738|18807806|P2|NOT COMPLETED|Overall Study||16
7638208|NCT02233738|18807807|P1|NOT COMPLETED|Overall Study||8
7638209|NCT02233738|18807806|P2|COMPLETED|Overall Study||75
7638210|NCT02233738|18807807|P1|COMPLETED|Overall Study||85
7638211|NCT02233738|18807806|P2|6 Month Follow-Up|Overall Study||75
7638212|NCT02233738|18807807|P1|6 Month Follow-Up|Overall Study||85
7638213|NCT02233738|18807806|P2|3 Month Follow-Up|Overall Study||77
7638214|NCT02233738|18807807|P1|3 Month Follow-Up|Overall Study||87
7638215|NCT02233738|18807806|P2|1 Month Follow-Up|Overall Study||82
7638216|NCT02233738|18807807|P1|1 Month Follow-Up|Overall Study||89
7638217|NCT02233738|18807806|P2|STARTED|Overall Study||91
7638218|NCT02233738|18807807|P1|STARTED|Overall Study||93
7638219|NCT02233647|18807977|P1|NOT COMPLETED|Overall Study||1
7638220|NCT02233647|18807977|P1|COMPLETED|Overall Study||10
7638221|NCT02233647|18807977|P1|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
7638222|NCT02233647|18807977|P1|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
7638223|NCT02233647|18807977|P1|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
7638224|NCT02233647|18807977|P1|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
7638225|NCT02233647|18807977|P1|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10
7638226|NCT02233647|18807977|P1|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
7638227|NCT02233647|18807977|P1|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
7638228|NCT02233647|18807977|P1|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
7638229|NCT02233647|18807977|P1|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
7638230|NCT02233647|18807977|P1|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10
7638231|NCT02233647|18807977|P1|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
7638232|NCT02233647|18807977|P1|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
7638233|NCT02233647|18807977|P1|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
7638234|NCT02233647|18807977|P1|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
7638235|NCT02233647|18807977|P1|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
7638236|NCT02233647|18807977|P1|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
7638237|NCT02233647|18807977|P1|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
7638238|NCT02233647|18807977|P1|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
7638239|NCT02233647|18807977|P1|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
7638240|NCT02233647|18807977|P1|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
7638241|NCT02233647|18807977|P1|STARTED|Overall Study||11
7638242|NCT02233543|18808006|P2|NOT COMPLETED|Period 2||1
7638243|NCT02233543|18808007|P1|NOT COMPLETED|Period 2||2
7638244|NCT02233543|18808006|P2|COMPLETED|Period 2||12
7638245|NCT02233543|18808007|P1|COMPLETED|Period 2|1 participant erroneously received QVA149 during both periods.|17
7638246|NCT02233543|18808006|P2|STARTED|Period 2||13
7638247|NCT02233543|18808007|P1|STARTED|Period 2||19
7638248|NCT02233543|18808006|P2|NOT COMPLETED|Period 1||3
7638249|NCT02233543|18808007|P1|NOT COMPLETED|Period 1||3
7638250|NCT02233543|18808006|P2|COMPLETED|Period 1||13
7638251|NCT02233543|18808007|P1|COMPLETED|Period 1||19
7638252|NCT02233543|18808006|P2|STARTED|Period 1||16
7638253|NCT02233543|18808007|P1|STARTED|Period 1||22
7638254|NCT02233517|18808017|P2|NOT COMPLETED|Overall Study||4
7638255|NCT02233517|18808018|P1|NOT COMPLETED|Overall Study||7
7638256|NCT02233517|18808017|P2|COMPLETED|Overall Study||13
7638257|NCT02233517|18808018|P1|COMPLETED|Overall Study||12
7638258|NCT02233517|18808017|P2|STARTED|Overall Study||17
7638259|NCT02233517|18808018|P1|STARTED|Overall Study||19
7638260|NCT02233478|18808044|P6|NOT COMPLETED|Third Intervention (1 Day)||0
7638261|NCT02233478|18808045|P5|NOT COMPLETED|Third Intervention (1 Day)||0
7638262|NCT02233478|18808046|P4|NOT COMPLETED|Third Intervention (1 Day)||0
7638263|NCT02233478|18808047|P3|NOT COMPLETED|Third Intervention (1 Day)||0
7638264|NCT02233478|18808048|P2|NOT COMPLETED|Third Intervention (1 Day)||0
7638265|NCT02233478|18808049|P1|NOT COMPLETED|Third Intervention (1 Day)||0
7638266|NCT02233478|18808044|P6|COMPLETED|Third Intervention (1 Day)||3
7638267|NCT02233478|18808045|P5|COMPLETED|Third Intervention (1 Day)||3
7638268|NCT02233478|18808046|P4|COMPLETED|Third Intervention (1 Day)||3
7638269|NCT02233478|18808047|P3|COMPLETED|Third Intervention (1 Day)||3
7638270|NCT02233478|18808048|P2|COMPLETED|Third Intervention (1 Day)||3
7638271|NCT02233478|18808049|P1|COMPLETED|Third Intervention (1 Day)||3
7638272|NCT02233478|18808044|P6|STARTED|Third Intervention (1 Day)||3
7638273|NCT02233478|18808045|P5|STARTED|Third Intervention (1 Day)||3
7638274|NCT02233478|18808046|P4|STARTED|Third Intervention (1 Day)||3
7638275|NCT02233478|18808047|P3|STARTED|Third Intervention (1 Day)||3
7638276|NCT02233478|18808048|P2|STARTED|Third Intervention (1 Day)||3
7638277|NCT02233478|18808049|P1|STARTED|Third Intervention (1 Day)||3
7638278|NCT02233478|18808044|P6|NOT COMPLETED|Washout (7 Days)||0
7638279|NCT02233478|18808045|P5|NOT COMPLETED|Washout (7 Days)||0
7638280|NCT02233478|18808046|P4|NOT COMPLETED|Washout (7 Days)||0
7638281|NCT02233478|18808047|P3|NOT COMPLETED|Washout (7 Days)||0
7638282|NCT02233478|18808048|P2|NOT COMPLETED|Washout (7 Days)||0
7638283|NCT02233478|18808049|P1|NOT COMPLETED|Washout (7 Days)||0
7638284|NCT02233478|18808044|P6|COMPLETED|Washout (7 Days)||3
7638285|NCT02233478|18808045|P5|COMPLETED|Washout (7 Days)||3
7638286|NCT02233478|18808046|P4|COMPLETED|Washout (7 Days)||3
7638287|NCT02233478|18808047|P3|COMPLETED|Washout (7 Days)||3
7638288|NCT02233478|18808048|P2|COMPLETED|Washout (7 Days)||3
7638289|NCT02233478|18808049|P1|COMPLETED|Washout (7 Days)||3
7638290|NCT02233478|18808044|P6|STARTED|Washout (7 Days)||3
7638291|NCT02233478|18808045|P5|STARTED|Washout (7 Days)||3
7638292|NCT02233478|18808046|P4|STARTED|Washout (7 Days)||3
7638293|NCT02233478|18808047|P3|STARTED|Washout (7 Days)||3
7638294|NCT02233478|18808048|P2|STARTED|Washout (7 Days)||3
7638295|NCT02233478|18808049|P1|STARTED|Washout (7 Days)||3
7638296|NCT02233478|18808044|P6|NOT COMPLETED|Second Intervention (1 Day)||0
7638297|NCT02233478|18808045|P5|NOT COMPLETED|Second Intervention (1 Day)||0
7638298|NCT02233478|18808046|P4|NOT COMPLETED|Second Intervention (1 Day)||0
7638299|NCT02233478|18808047|P3|NOT COMPLETED|Second Intervention (1 Day)||0
7638300|NCT02233478|18808048|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7638301|NCT02233478|18808049|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7638302|NCT02233478|18808044|P6|COMPLETED|Second Intervention (1 Day)||3
7638303|NCT02233478|18808045|P5|COMPLETED|Second Intervention (1 Day)||3
7638304|NCT02233478|18808046|P4|COMPLETED|Second Intervention (1 Day)||3
7638305|NCT02233478|18808047|P3|COMPLETED|Second Intervention (1 Day)||3
7638306|NCT02233478|18808048|P2|COMPLETED|Second Intervention (1 Day)||3
7638307|NCT02233478|18808049|P1|COMPLETED|Second Intervention (1 Day)||3
7638308|NCT02233478|18808044|P6|STARTED|Second Intervention (1 Day)||3
7638309|NCT02233478|18808045|P5|STARTED|Second Intervention (1 Day)||3
7638310|NCT02233478|18808046|P4|STARTED|Second Intervention (1 Day)||3
7638311|NCT02233478|18808047|P3|STARTED|Second Intervention (1 Day)||3
7638312|NCT02233478|18808048|P2|STARTED|Second Intervention (1 Day)||3
7638313|NCT02233478|18808049|P1|STARTED|Second Intervention (1 Day)||3
7638314|NCT02233478|18808044|P6|NOT COMPLETED|Washout (7 Days)||0
7638315|NCT02233478|18808045|P5|NOT COMPLETED|Washout (7 Days)||0
7638316|NCT02233478|18808046|P4|NOT COMPLETED|Washout (7 Days)||0
7638317|NCT02233478|18808047|P3|NOT COMPLETED|Washout (7 Days)||0
7638318|NCT02233478|18808048|P2|NOT COMPLETED|Washout (7 Days)||0
7638319|NCT02233478|18808049|P1|NOT COMPLETED|Washout (7 Days)||0
7638320|NCT02233478|18808044|P6|COMPLETED|Washout (7 Days)||3
7638321|NCT02233478|18808045|P5|COMPLETED|Washout (7 Days)||3
7638322|NCT02233478|18808046|P4|COMPLETED|Washout (7 Days)||3
7638323|NCT02233478|18808047|P3|COMPLETED|Washout (7 Days)||3
7638324|NCT02233478|18808048|P2|COMPLETED|Washout (7 Days)||3
7638325|NCT02233478|18808049|P1|COMPLETED|Washout (7 Days)||3
7638326|NCT02233478|18808044|P6|STARTED|Washout (7 Days)||3
7638327|NCT02233478|18808045|P5|STARTED|Washout (7 Days)||3
7638328|NCT02233478|18808046|P4|STARTED|Washout (7 Days)||3
7638329|NCT02233478|18808047|P3|STARTED|Washout (7 Days)||3
7638330|NCT02233478|18808048|P2|STARTED|Washout (7 Days)||3
7638331|NCT02233478|18808049|P1|STARTED|Washout (7 Days)||3
7638332|NCT02233478|18808044|P6|NOT COMPLETED|First Intervention (1 Day)||0
7638333|NCT02233478|18808045|P5|NOT COMPLETED|First Intervention (1 Day)||0
7638334|NCT02233478|18808046|P4|NOT COMPLETED|First Intervention (1 Day)||0
7638335|NCT02233478|18808047|P3|NOT COMPLETED|First Intervention (1 Day)||0
7638336|NCT02233478|18808048|P2|NOT COMPLETED|First Intervention (1 Day)||0
7638337|NCT02233478|18808049|P1|NOT COMPLETED|First Intervention (1 Day)||0
7638338|NCT02233478|18808044|P6|COMPLETED|First Intervention (1 Day)||3
7638339|NCT02233478|18808045|P5|COMPLETED|First Intervention (1 Day)||3
7638340|NCT02233478|18808046|P4|COMPLETED|First Intervention (1 Day)||3
7638341|NCT02233478|18808047|P3|COMPLETED|First Intervention (1 Day)||3
7638342|NCT02233478|18808048|P2|COMPLETED|First Intervention (1 Day)||3
7638343|NCT02233478|18808049|P1|COMPLETED|First Intervention (1 Day)||3
7638344|NCT02233478|18808044|P6|STARTED|First Intervention (1 Day)||3
7638345|NCT02233478|18808045|P5|STARTED|First Intervention (1 Day)||3
7638346|NCT02233478|18808046|P4|STARTED|First Intervention (1 Day)||3
7638347|NCT02233478|18808047|P3|STARTED|First Intervention (1 Day)||3
7638348|NCT02233478|18808048|P2|STARTED|First Intervention (1 Day)||3
7638349|NCT02233478|18808049|P1|STARTED|First Intervention (1 Day)||3
7638350|NCT02233413|18808059|P2|NOT COMPLETED|Overall Study||14
7638351|NCT02233413|18808060|P1|NOT COMPLETED|Overall Study||11
7638352|NCT02233413|18808059|P2|COMPLETED|Overall Study||19
7638353|NCT02233413|18808060|P1|COMPLETED|Overall Study||24
7638354|NCT02233413|18808059|P2|STARTED|Overall Study||33
7638355|NCT02233413|18808060|P1|STARTED|Overall Study||35
7638356|NCT02233309|18808072|P1|NOT COMPLETED|Overall Study||5
7638357|NCT02233309|18808072|P1|COMPLETED|Overall Study||31
7638358|NCT02233309|18808072|P1|STARTED|Overall Study||36
7638359|NCT02233296|18808078|P2|NOT COMPLETED|Overall Study||0
7638360|NCT02233296|18808079|P1|NOT COMPLETED|Overall Study||0
7638361|NCT02233296|18808078|P2|COMPLETED|Overall Study||14
7638362|NCT02233296|18808079|P1|COMPLETED|Overall Study||16
7638363|NCT02233296|18808078|P2|STARTED|Overall Study||14
7638364|NCT02233296|18808079|P1|STARTED|Overall Study||16
7638365|NCT02233101|18808097|P2|NOT COMPLETED|Overall Study||1
7638366|NCT02233101|18808098|P1|NOT COMPLETED|Overall Study||12
7638367|NCT02233101|18808097|P2|COMPLETED|Overall Study||80
7638368|NCT02233101|18808098|P1|COMPLETED|Overall Study||74
7638369|NCT02233101|18808097|P2|STARTED|Overall Study||81
7638370|NCT02233101|18808098|P1|STARTED|Overall Study||86
7638371|NCT02232984|18808106|P1|NOT COMPLETED|Overall Study||77
7638372|NCT02232984|18808106|P1|COMPLETED|Overall Study|Total number of subjects who completed study|672
7638373|NCT02232984|18808106|P1|Successfully Implanted|Overall Study|Successfully implanted subjects|675
7638374|NCT02232984|18808106|P1|STARTED|Overall Study|Enrolled subjects|749
7638375|NCT02232893|18808117|P2|NOT COMPLETED|Overall Study||7
7638376|NCT02232893|18808118|P1|NOT COMPLETED|Overall Study||4
7638377|NCT02232893|18808117|P2|COMPLETED|Overall Study||27
7638378|NCT02232893|18808118|P1|COMPLETED|Overall Study||31
7638379|NCT02232893|18808117|P2|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|19
7638380|NCT02232893|18808118|P1|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|24
7638381|NCT02232893|18808117|P2|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|32
7638382|NCT02232893|18808118|P1|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|34
7638383|NCT02232893|18808117|P2|STARTED|Overall Study||34
7638384|NCT02232893|18808118|P1|STARTED|Overall Study||35
7638385|NCT02232880|18808124|P1|NOT COMPLETED|Overall Study||1
7638386|NCT02232880|18808124|P1|COMPLETED|Overall Study||0
7638387|NCT02232880|18808124|P1|STARTED|Overall Study||1
7638388|NCT02232802|18808133|P2|NOT COMPLETED|Washout||0
7638389|NCT02232802|18808134|P1|NOT COMPLETED|Washout||0
7638390|NCT02232802|18808133|P2|COMPLETED|Washout||22
7638391|NCT02232802|18808134|P1|COMPLETED|Washout||22
7638392|NCT02232802|18808133|P2|STARTED|Washout||22
7638393|NCT02232802|18808134|P1|STARTED|Washout||22
7638394|NCT02232802|18808133|P2|NOT COMPLETED|Period 2||0
7638395|NCT02232802|18808134|P1|NOT COMPLETED|Period 2||0
7638396|NCT02232802|18808133|P2|COMPLETED|Period 2||22
7638397|NCT02232802|18808134|P1|COMPLETED|Period 2||22
7638398|NCT02232802|18808133|P2|STARTED|Period 2||22
7638399|NCT02232802|18808134|P1|STARTED|Period 2||22
7638400|NCT02232802|18808133|P2|NOT COMPLETED|Washout||0
7638401|NCT02232802|18808134|P1|NOT COMPLETED|Washout||0
7638402|NCT02232802|18808133|P2|COMPLETED|Washout||22
7638403|NCT02232802|18808134|P1|COMPLETED|Washout||22
7638404|NCT02232802|18808133|P2|STARTED|Washout||22
7638405|NCT02232802|18808134|P1|STARTED|Washout||22
7638406|NCT02232802|18808133|P2|NOT COMPLETED|Period 1||1
7638407|NCT02232802|18808134|P1|NOT COMPLETED|Period 1||2
7638408|NCT02232802|18808133|P2|COMPLETED|Period 1||22
7638409|NCT02232802|18808134|P1|COMPLETED|Period 1||22
7638410|NCT02232802|18808133|P2|STARTED|Period 1||23
7638411|NCT02232802|18808134|P1|STARTED|Period 1||24
7638412|NCT02232698|18808200|P2|NOT COMPLETED|Overall Study||20
7638413|NCT02232698|18808201|P1|NOT COMPLETED|Overall Study||10
7638414|NCT02232698|18808200|P2|COMPLETED|Overall Study||101
7638415|NCT02232698|18808201|P1|COMPLETED|Overall Study||110
7638416|NCT02232698|18808200|P2|STARTED|Overall Study||121
7638417|NCT02232698|18808201|P1|STARTED|Overall Study||120
7638418|NCT02232425|18808224|P2|NOT COMPLETED|Overall Study||8
7638419|NCT02232425|18808225|P1|NOT COMPLETED|Overall Study||14
7638420|NCT02232425|18808224|P2|COMPLETED|Overall Study||22
7638421|NCT02232425|18808225|P1|COMPLETED|Overall Study||44
7638422|NCT02232425|18808224|P2|STARTED|Overall Study||30
7638423|NCT02232425|18808225|P1|STARTED|Overall Study||58
7638424|NCT02232243|18808258|P3|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
7638425|NCT02232243|18808259|P2|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
7638426|NCT02232243|18808260|P1|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
7638427|NCT02232243|18808258|P3|COMPLETED|Third Dose(200mg HCQ Twice Daily)||3
7638428|NCT02232243|18808259|P2|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
7638429|NCT02232243|18808260|P1|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
7638430|NCT02232243|18808258|P3|STARTED|Third Dose(200mg HCQ Twice Daily)||3
7638431|NCT02232243|18808259|P2|STARTED|Third Dose(200mg HCQ Twice Daily)||0
7638432|NCT02232243|18808260|P1|STARTED|Third Dose(200mg HCQ Twice Daily)||0
7638433|NCT02232243|18808258|P3|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
7638434|NCT02232243|18808259|P2|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||1
7638435|NCT02232243|18808260|P1|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
7638436|NCT02232243|18808258|P3|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
7638437|NCT02232243|18808259|P2|COMPLETED|Second Dose (400mg HCQ Twice Daily)||3
7638438|NCT02232243|18808260|P1|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
7638439|NCT02232243|18808258|P3|STARTED|Second Dose (400mg HCQ Twice Daily)||0
7638440|NCT02232243|18808259|P2|STARTED|Second Dose (400mg HCQ Twice Daily)||4
7638441|NCT02232243|18808260|P1|STARTED|Second Dose (400mg HCQ Twice Daily)||0
7638442|NCT02232243|18808258|P3|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
7638443|NCT02232243|18808259|P2|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
7638444|NCT02232243|18808260|P1|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
7638445|NCT02232243|18808258|P3|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
7638446|NCT02232243|18808259|P2|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
7638447|NCT02232243|18808260|P1|COMPLETED|First Dose (200mg HCQ Twice Daily)||3
7638448|NCT02232243|18808258|P3|STARTED|First Dose (200mg HCQ Twice Daily)||0
7638449|NCT02232243|18808259|P2|STARTED|First Dose (200mg HCQ Twice Daily)||0
7638450|NCT02232243|18808260|P1|STARTED|First Dose (200mg HCQ Twice Daily)||3
7638451|NCT02232178|18808272|P3|NOT COMPLETED|Overall Study||1
7638452|NCT02232178|18808273|P2|NOT COMPLETED|Overall Study||1
7638453|NCT02232178|18808274|P1|NOT COMPLETED|Overall Study||1
7638454|NCT02232178|18808272|P3|COMPLETED|Overall Study||12
7638455|NCT02232178|18808273|P2|COMPLETED|Overall Study||24
7638456|NCT02232178|18808274|P1|COMPLETED|Overall Study||25
7638457|NCT02232178|18808272|P3|Safety Population|Overall Study||12
7638458|NCT02232178|18808273|P2|Safety Population|Overall Study||24
7638459|NCT02232178|18808274|P1|Safety Population|Overall Study||26
7638460|NCT02232178|18808272|P3|Per Protocol PK Population|Overall Study||11
7638461|NCT02232178|18808273|P2|Per Protocol PK Population|Overall Study||24
7638462|NCT02232178|18808274|P1|Per Protocol PK Population|Overall Study||26
7638463|NCT02232178|18808272|P3|STARTED|Overall Study||13
7638464|NCT02232178|18808273|P2|STARTED|Overall Study||25
7638465|NCT02232178|18808274|P1|STARTED|Overall Study||26
7638466|NCT02232126|18808293|P2|NOT COMPLETED|Overall Study||0
7638467|NCT02232126|18808294|P1|NOT COMPLETED|Overall Study||0
7638468|NCT02232126|18808293|P2|COMPLETED|Overall Study||90
7638469|NCT02232126|18808294|P1|COMPLETED|Overall Study||91
7638470|NCT02232126|18808293|P2|STARTED|Overall Study||90
7638471|NCT02232126|18808294|P1|STARTED|Overall Study||91
7638472|NCT02232087|18808302|P6|NOT COMPLETED|Overall Study||3
7638473|NCT02232087|18808303|P5|NOT COMPLETED|Overall Study||1
7638474|NCT02232087|18808304|P4|NOT COMPLETED|Overall Study||1
7638475|NCT02232087|18808305|P3|NOT COMPLETED|Overall Study||0
7638476|NCT02232087|18808306|P2|NOT COMPLETED|Overall Study||2
7638477|NCT02232087|18808307|P1|NOT COMPLETED|Overall Study||2
7638478|NCT02232087|18808302|P6|COMPLETED|Overall Study||6
7638479|NCT02232087|18808303|P5|COMPLETED|Overall Study||7
7638480|NCT02232087|18808304|P4|COMPLETED|Overall Study||7
7638481|NCT02232087|18808305|P3|COMPLETED|Overall Study||8
7638482|NCT02232087|18808306|P2|COMPLETED|Overall Study||8
7638483|NCT02232087|18808307|P1|COMPLETED|Overall Study||7
7638484|NCT02232087|18808302|P6|STARTED|Overall Study||9
7638485|NCT02232087|18808303|P5|STARTED|Overall Study||8
7638486|NCT02232087|18808304|P4|STARTED|Overall Study||8
7638487|NCT02232087|18808305|P3|STARTED|Overall Study||8
7638488|NCT02232087|18808306|P2|STARTED|Overall Study||10
7638489|NCT02232087|18808307|P1|STARTED|Overall Study||9
7638490|NCT02232074|18808343|P2|NOT COMPLETED|Overall Study||45
7638491|NCT02232074|18808344|P1|NOT COMPLETED|Overall Study||41
7638492|NCT02232074|18808343|P2|COMPLETED|Overall Study||107
7638493|NCT02232074|18808344|P1|COMPLETED|Overall Study||113
7638494|NCT02232074|18808343|P2|STARTED|Overall Study||152
7638495|NCT02232074|18808344|P1|STARTED|Overall Study||154
7638496|NCT02232022|18808390|P1|NOT COMPLETED|Overall Study||2
7638497|NCT02232022|18808390|P1|COMPLETED|Overall Study||51
7638498|NCT02232022|18808390|P1|STARTED|Overall Study||53
7638499|NCT02232009|18808399|P1|NOT COMPLETED|Overall Study||0
7638500|NCT02232009|18808399|P1|COMPLETED|Overall Study||9
7638501|NCT02232009|18808399|P1|STARTED|Overall Study||9
7638502|NCT02231918|18808411|P3|NOT COMPLETED|Overall Study||1
7638503|NCT02231918|18808412|P2|NOT COMPLETED|Overall Study||1
7638504|NCT02231918|18808413|P1|NOT COMPLETED|Overall Study||0
7638505|NCT02231918|18808411|P3|COMPLETED|Overall Study||1
7638506|NCT02231918|18808412|P2|COMPLETED|Overall Study||14
7638507|NCT02231918|18808413|P1|COMPLETED|Overall Study||9
7638508|NCT02231918|18808411|P3|STARTED|Overall Study||2
7638509|NCT02231918|18808412|P2|STARTED|Overall Study||15
7638510|NCT02231918|18808413|P1|STARTED|Overall Study||9
7638511|NCT02231892|18808478|P3|NOT COMPLETED|Overall Study||45
7638512|NCT02231892|18808479|P2|NOT COMPLETED|Overall Study||12
7638513|NCT02231892|18808480|P1|NOT COMPLETED|Overall Study||11
7638514|NCT02231892|18808478|P3|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency Beh phase, but are only counted in Hi Freq MRI.|25
7638515|NCT02231892|18808479|P2|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency MRI phase, but are only counted in Hi Freq MRI.|5
7638516|NCT02231892|18808480|P1|COMPLETED|Overall Study||6
7638517|NCT02231892|18808478|P3|110% MT|Overall Study||27
7638518|NCT02231892|18808479|P2|110% MT|Overall Study||5
7638519|NCT02231892|18808480|P1|110% MT|Overall Study||7
7638520|NCT02231892|18808478|P3|100% MT|Overall Study||25
7638521|NCT02231892|18808479|P2|100% MT|Overall Study||6
7638522|NCT02231892|18808480|P1|100% MT|Overall Study||7
7638523|NCT02231892|18808478|P3|Sham|Overall Study||26
7638524|NCT02231892|18808479|P2|Sham|Overall Study||5
7638525|NCT02231892|18808480|P1|Sham|Overall Study||8
7638526|NCT02231892|18808478|P3|STARTED|Overall Study||70
7638527|NCT02231892|18808479|P2|STARTED|Overall Study||17
7638528|NCT02231892|18808480|P1|STARTED|Overall Study||17
7638529|NCT02231762|18808497|P4|NOT COMPLETED|Maintenance Phase||5
7638530|NCT02231762|18808498|P3|NOT COMPLETED|Maintenance Phase||5
7638531|NCT02231762|18808499|P2|NOT COMPLETED|Maintenance Phase||3
7638532|NCT02231762|18808500|P1|NOT COMPLETED|Maintenance Phase||0
7638533|NCT02231762|18808497|P4|COMPLETED|Maintenance Phase||7
7638534|NCT02231762|18808498|P3|COMPLETED|Maintenance Phase||9
7638535|NCT02231762|18808499|P2|COMPLETED|Maintenance Phase||8
7638536|NCT02231762|18808500|P1|COMPLETED|Maintenance Phase||0
7638537|NCT02231762|18808497|P4|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|12
7638538|NCT02231762|18808498|P3|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|14
7638539|NCT02231762|18808499|P2|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|11
7638540|NCT02231762|18808500|P1|STARTED|Maintenance Phase|This arm was not included in period 2 (maintenance phase).|0
7638541|NCT02231762|18808497|P4|NOT COMPLETED|Combination Phase||0
7638542|NCT02231762|18808498|P3|NOT COMPLETED|Combination Phase||0
7638543|NCT02231762|18808499|P2|NOT COMPLETED|Combination Phase||0
7638544|NCT02231762|18808500|P1|NOT COMPLETED|Combination Phase||20
7638545|NCT02231762|18808497|P4|COMPLETED|Combination Phase||0
7638546|NCT02231762|18808498|P3|COMPLETED|Combination Phase||0
7638547|NCT02231762|18808499|P2|COMPLETED|Combination Phase||0
7638548|NCT02231762|18808500|P1|COMPLETED|Combination Phase||37
7638549|NCT02231762|18808497|P4|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
7638550|NCT02231762|18808498|P3|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
7638551|NCT02231762|18808499|P2|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
7638552|NCT02231762|18808500|P1|STARTED|Combination Phase||57
7638553|NCT02231749|18808533|P2|NOT COMPLETED|Overall Study||449
7638554|NCT02231749|18808534|P1|NOT COMPLETED|Overall Study||422
7638555|NCT02231749|18808533|P2|COMPLETED|Overall Study||97
7638556|NCT02231749|18808534|P1|COMPLETED|Overall Study||128
7638557|NCT02231749|18808533|P2|Received Treatment|Overall Study||535
7638558|NCT02231749|18808534|P1|Received Treatment|Overall Study||547
7638559|NCT02231749|18808533|P2|STARTED|Overall Study||546
7638560|NCT02231749|18808534|P1|STARTED|Overall Study||550
7638561|NCT02231580|18808552|P2|NOT COMPLETED|Overall Study||0
7638562|NCT02231580|18808553|P1|NOT COMPLETED|Overall Study||5
7638563|NCT02231580|18808552|P2|COMPLETED|Overall Study||3
7638564|NCT02231580|18808553|P1|COMPLETED|Overall Study||9
7638565|NCT02231580|18808552|P2|Cohort 2|Overall Study||1
7638566|NCT02231580|18808553|P1|Cohort 2|Overall Study||6
7638567|NCT02231580|18808552|P2|Cohort 1|Overall Study||2
7638568|NCT02231580|18808553|P1|Cohort 1|Overall Study||8
7638569|NCT02231580|18808552|P2|STARTED|Overall Study||3
7638570|NCT02231580|18808553|P1|STARTED|Overall Study||14
7638571|NCT02231177|18808609|P6|NOT COMPLETED|Treatment Period 3 (21 Days)||0
7638572|NCT02231177|18808610|P5|NOT COMPLETED|Treatment Period 3 (21 Days)||0
7638573|NCT02231177|18808611|P4|NOT COMPLETED|Treatment Period 3 (21 Days)||0
7638574|NCT02231177|18808612|P3|NOT COMPLETED|Treatment Period 3 (21 Days)||0
7638575|NCT02231177|18808613|P2|NOT COMPLETED|Treatment Period 3 (21 Days)||0
7638576|NCT02231177|18808614|P1|NOT COMPLETED|Treatment Period 3 (21 Days)||0
7638577|NCT02231177|18808609|P6|COMPLETED|Treatment Period 3 (21 Days)||9
7638578|NCT02231177|18808610|P5|COMPLETED|Treatment Period 3 (21 Days)||8
7638579|NCT02231177|18808611|P4|COMPLETED|Treatment Period 3 (21 Days)||7
7638580|NCT02231177|18808612|P3|COMPLETED|Treatment Period 3 (21 Days)||8
7638581|NCT02231177|18808613|P2|COMPLETED|Treatment Period 3 (21 Days)||7
7638582|NCT02231177|18808614|P1|COMPLETED|Treatment Period 3 (21 Days)||8
7638583|NCT02231177|18808609|P6|STARTED|Treatment Period 3 (21 Days)||9
7638584|NCT02231177|18808610|P5|STARTED|Treatment Period 3 (21 Days)||8
7638585|NCT02231177|18808611|P4|STARTED|Treatment Period 3 (21 Days)||7
7638586|NCT02231177|18808612|P3|STARTED|Treatment Period 3 (21 Days)||8
7638587|NCT02231177|18808613|P2|STARTED|Treatment Period 3 (21 Days)||7
7638588|NCT02231177|18808614|P1|STARTED|Treatment Period 3 (21 Days)||8
7638589|NCT02231177|18808609|P6|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7638590|NCT02231177|18808610|P5|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7638591|NCT02231177|18808611|P4|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7638592|NCT02231177|18808612|P3|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7638593|NCT02231177|18808613|P2|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7638594|NCT02231177|18808614|P1|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7638595|NCT02231177|18808609|P6|COMPLETED|Treatment Period 2 (21 Days)||9
7638596|NCT02231177|18808610|P5|COMPLETED|Treatment Period 2 (21 Days)||8
7638597|NCT02231177|18808611|P4|COMPLETED|Treatment Period 2 (21 Days)||7
7638598|NCT02231177|18808612|P3|COMPLETED|Treatment Period 2 (21 Days)||8
7638599|NCT02231177|18808613|P2|COMPLETED|Treatment Period 2 (21 Days)||7
7638600|NCT02231177|18808614|P1|COMPLETED|Treatment Period 2 (21 Days)||8
7638601|NCT02231177|18808609|P6|STARTED|Treatment Period 2 (21 Days)||9
7638602|NCT02231177|18808610|P5|STARTED|Treatment Period 2 (21 Days)||8
7638603|NCT02231177|18808611|P4|STARTED|Treatment Period 2 (21 Days)||7
7638604|NCT02231177|18808612|P3|STARTED|Treatment Period 2 (21 Days)||8
7638605|NCT02231177|18808613|P2|STARTED|Treatment Period 2 (21 Days)||7
7638606|NCT02231177|18808614|P1|STARTED|Treatment Period 2 (21 Days)||8
7638607|NCT02231177|18808609|P6|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7638608|NCT02231177|18808610|P5|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7638609|NCT02231177|18808611|P4|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7638610|NCT02231177|18808612|P3|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7638611|NCT02231177|18808613|P2|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7638612|NCT02231177|18808614|P1|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7638613|NCT02231177|18808609|P6|COMPLETED|Treatment Period 1 (21 Days)||9
7638614|NCT02231177|18808610|P5|COMPLETED|Treatment Period 1 (21 Days)||8
7638615|NCT02231177|18808611|P4|COMPLETED|Treatment Period 1 (21 Days)||7
7638616|NCT02231177|18808612|P3|COMPLETED|Treatment Period 1 (21 Days)||8
7638617|NCT02231177|18808613|P2|COMPLETED|Treatment Period 1 (21 Days)||7
7638618|NCT02231177|18808614|P1|COMPLETED|Treatment Period 1 (21 Days)||8
7638619|NCT02231177|18808609|P6|STARTED|Treatment Period 1 (21 Days)||9
7638620|NCT02231177|18808610|P5|STARTED|Treatment Period 1 (21 Days)||8
7638621|NCT02231177|18808611|P4|STARTED|Treatment Period 1 (21 Days)||7
7638622|NCT02231177|18808612|P3|STARTED|Treatment Period 1 (21 Days)||8
7638623|NCT02231177|18808613|P2|STARTED|Treatment Period 1 (21 Days)||7
7638624|NCT02231177|18808614|P1|STARTED|Treatment Period 1 (21 Days)||8
7638625|NCT02231164|18808670|P2|NOT COMPLETED|Overall Study||6
7638626|NCT02231164|18808671|P1|NOT COMPLETED|Overall Study||6
7638627|NCT02231164|18808670|P2|COMPLETED|Overall Study||0
7638628|NCT02231164|18808671|P1|COMPLETED|Overall Study||0
7638629|NCT02231164|18808670|P2|STARTED|Overall Study||6
7638630|NCT02231164|18808671|P1|STARTED|Overall Study||6
7638631|NCT02230995|18808679|P2|NOT COMPLETED|Period 2 + Washout||0
7638632|NCT02230995|18808680|P1|NOT COMPLETED|Period 2 + Washout||0
7638633|NCT02230995|18808679|P2|COMPLETED|Period 2 + Washout||15
7638634|NCT02230995|18808680|P1|COMPLETED|Period 2 + Washout||15
7638635|NCT02230995|18808679|P2|STARTED|Period 2 + Washout||15
7638636|NCT02230995|18808680|P1|STARTED|Period 2 + Washout||15
7638637|NCT02230995|18808679|P2|NOT COMPLETED|Period 1 + Washout||0
7638638|NCT02230995|18808680|P1|NOT COMPLETED|Period 1 + Washout||0
7638639|NCT02230995|18808679|P2|COMPLETED|Period 1 + Washout||15
7638640|NCT02230995|18808680|P1|COMPLETED|Period 1 + Washout||15
7638641|NCT02230995|18808679|P2|STARTED|Period 1 + Washout||15
7638642|NCT02230995|18808680|P1|STARTED|Period 1 + Washout||15
7638643|NCT02230956|18808699|P3|NOT COMPLETED|Overall Study||7
7638644|NCT02230956|18808700|P2|NOT COMPLETED|Overall Study||6
7638645|NCT02230956|18808701|P1|NOT COMPLETED|Overall Study||5
7638646|NCT02230956|18808699|P3|COMPLETED|Overall Study||82
7638647|NCT02230956|18808700|P2|COMPLETED|Overall Study||37
7638648|NCT02230956|18808701|P1|COMPLETED|Overall Study||39
7638649|NCT02230956|18808699|P3|STARTED|Overall Study||89
7638650|NCT02230956|18808700|P2|STARTED|Overall Study||43
7638651|NCT02230956|18808701|P1|STARTED|Overall Study||44
7638652|NCT02230904|18808723|P2|NOT COMPLETED|Overall Study||1
7638653|NCT02230904|18808724|P1|NOT COMPLETED|Overall Study||0
7638654|NCT02230904|18808723|P2|COMPLETED|Overall Study||27
7638655|NCT02230904|18808724|P1|COMPLETED|Overall Study||29
7638656|NCT02230904|18808723|P2|STARTED|Overall Study||28
7638657|NCT02230904|18808724|P1|STARTED|Overall Study||29
7638658|NCT02230761|18808746|P2|NOT COMPLETED|Overall Study||1
7638659|NCT02230761|18808747|P1|NOT COMPLETED|Overall Study||0
7638660|NCT02230761|18808746|P2|COMPLETED|Overall Study||29
7638661|NCT02230761|18808747|P1|COMPLETED|Overall Study||60
7638662|NCT02230761|18808746|P2|STARTED|Overall Study||30
7638663|NCT02230761|18808747|P1|STARTED|Overall Study||60
7638664|NCT02230683|18808757|P1|NOT COMPLETED|Overall Study||1
7638665|NCT02230683|18808757|P1|COMPLETED|Overall Study||22
7638666|NCT02230683|18808757|P1|STARTED|Overall Study||23
7638667|NCT02230670|18808774|P2|NOT COMPLETED|Overall Study||8
7638668|NCT02230670|18808775|P1|NOT COMPLETED|Overall Study||4
7638669|NCT02230670|18808774|P2|COMPLETED|Overall Study||34
7638670|NCT02230670|18808775|P1|COMPLETED|Overall Study||40
7638671|NCT02230670|18808774|P2|STARTED|Overall Study|One subject randomized to placebo withdrew from the study before receiving any study treatment.|42
7638672|NCT02230670|18808775|P1|STARTED|Overall Study||44
7638673|NCT02230579|18808792|P7|NOT COMPLETED|Overall Study||0
7638674|NCT02230579|18808793|P6|NOT COMPLETED|Overall Study||0
7638675|NCT02230579|18808794|P5|NOT COMPLETED|Overall Study||0
7638676|NCT02230579|18808795|P4|NOT COMPLETED|Overall Study||0
7638677|NCT02230579|18808796|P3|NOT COMPLETED|Overall Study||0
7638678|NCT02230579|18808797|P2|NOT COMPLETED|Overall Study||0
7638679|NCT02230579|18808798|P1|NOT COMPLETED|Overall Study||0
7638680|NCT02230579|18808792|P7|COMPLETED|Overall Study||12
7638681|NCT02230579|18808793|P6|COMPLETED|Overall Study||6
7638682|NCT02230579|18808794|P5|COMPLETED|Overall Study||6
7638683|NCT02230579|18808795|P4|COMPLETED|Overall Study||6
7638684|NCT02230579|18808796|P3|COMPLETED|Overall Study||6
7638685|NCT02230579|18808797|P2|COMPLETED|Overall Study||6
7638686|NCT02230579|18808798|P1|COMPLETED|Overall Study||6
7638687|NCT02230579|18808792|P7|STARTED|Overall Study||12
7638688|NCT02230579|18808793|P6|STARTED|Overall Study||6
7638689|NCT02230579|18808794|P5|STARTED|Overall Study||6
7638690|NCT02230579|18808795|P4|STARTED|Overall Study||6
7638691|NCT02230579|18808796|P3|STARTED|Overall Study||6
7638692|NCT02230579|18808797|P2|STARTED|Overall Study||6
7638693|NCT02230579|18808798|P1|STARTED|Overall Study||6
7638694|NCT02230566|18808836|P4|NOT COMPLETED|Overall Study||0
7638695|NCT02230566|18808837|P3|NOT COMPLETED|Overall Study||0
7638696|NCT02230566|18808838|P2|NOT COMPLETED|Overall Study||0
7638697|NCT02230566|18808839|P1|NOT COMPLETED|Overall Study||0
7638698|NCT02230566|18808836|P4|COMPLETED|Overall Study||3
7638699|NCT02230566|18808837|P3|COMPLETED|Overall Study||3
7638700|NCT02230566|18808838|P2|COMPLETED|Overall Study||3
7638701|NCT02230566|18808839|P1|COMPLETED|Overall Study||3
7638702|NCT02230566|18808836|P4|STARTED|Overall Study||3
7638703|NCT02230566|18808837|P3|STARTED|Overall Study||3
7638704|NCT02230566|18808838|P2|STARTED|Overall Study||3
7638705|NCT02230566|18808839|P1|STARTED|Overall Study||3
7638706|NCT02230540|18808854|P2|NOT COMPLETED|Overall Study||0
7638707|NCT02230540|18808855|P1|NOT COMPLETED|Overall Study||0
7638708|NCT02230540|18808854|P2|COMPLETED|Overall Study||0
7638709|NCT02230540|18808855|P1|COMPLETED|Overall Study||8
7638710|NCT02230540|18808854|P2|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0
7638711|NCT02230540|18808855|P1|STARTED|Overall Study||8
7638712|NCT02230384|18808861|P2|NOT COMPLETED|Phase 2 Wash Out||0
7638713|NCT02230384|18808862|P1|NOT COMPLETED|Phase 2 Wash Out||0
7638714|NCT02230384|18808861|P2|COMPLETED|Phase 2 Wash Out||30
7638715|NCT02230384|18808862|P1|COMPLETED|Phase 2 Wash Out||26
7638716|NCT02230384|18808861|P2|STARTED|Phase 2 Wash Out||30
7638717|NCT02230384|18808862|P1|STARTED|Phase 2 Wash Out||26
7638718|NCT02230384|18808861|P2|NOT COMPLETED|Phase 2 - Switch||1
7638719|NCT02230384|18808862|P1|NOT COMPLETED|Phase 2 - Switch||3
7638720|NCT02230384|18808861|P2|COMPLETED|Phase 2 - Switch||30
7638721|NCT02230384|18808862|P1|COMPLETED|Phase 2 - Switch||26
7638722|NCT02230384|18808861|P2|STARTED|Phase 2 - Switch||31
7638723|NCT02230384|18808862|P1|STARTED|Phase 2 - Switch||29
7638724|NCT02230384|18808861|P2|NOT COMPLETED|Phase 1 Wash Out||0
7638725|NCT02230384|18808862|P1|NOT COMPLETED|Phase 1 Wash Out||0
7638726|NCT02230384|18808861|P2|COMPLETED|Phase 1 Wash Out||31
7638727|NCT02230384|18808862|P1|COMPLETED|Phase 1 Wash Out||29
7638728|NCT02230384|18808861|P2|STARTED|Phase 1 Wash Out||31
7638729|NCT02230384|18808862|P1|STARTED|Phase 1 Wash Out||29
7638730|NCT02230384|18808861|P2|NOT COMPLETED|Phase 1||1
7638731|NCT02230384|18808862|P1|NOT COMPLETED|Phase 1||1
7638732|NCT02230384|18808861|P2|COMPLETED|Phase 1||31
7638733|NCT02230384|18808862|P1|COMPLETED|Phase 1||29
7638734|NCT02230384|18808861|P2|STARTED|Phase 1||32
7638735|NCT02230384|18808862|P1|STARTED|Phase 1||30
7638736|NCT02230332|18808882|P2|NOT COMPLETED|Overall Study||1
7638737|NCT02230332|18808883|P1|NOT COMPLETED|Overall Study||4
7638738|NCT02230332|18808882|P2|COMPLETED|Overall Study||39
7638739|NCT02230332|18808883|P1|COMPLETED|Overall Study||34
7638740|NCT02230332|18808882|P2|STARTED|Overall Study||40
7638741|NCT02230332|18808883|P1|STARTED|Overall Study||38
7638742|NCT02230306|18808899|P1|NOT COMPLETED|Overall Study||1
7638743|NCT02230306|18808899|P1|COMPLETED|Overall Study||4
7638744|NCT02230306|18808899|P1|STARTED|Overall Study||5
7638745|NCT02230085|18808910|P1|NOT COMPLETED|Overall Study||4
7638746|NCT02230085|18808910|P1|COMPLETED|Overall Study||106
7638747|NCT02230085|18808910|P1|STARTED|Overall Study||110
7638748|NCT02229864|18808914|P1|NOT COMPLETED|Overall Study||3
7638749|NCT02229864|18808914|P1|COMPLETED|Overall Study||9
7638750|NCT02229864|18808914|P1|STARTED|Overall Study||12
7638751|NCT02229851|18808938|P7|NOT COMPLETED|Extension Phase (Open-label Phase)||3
7638752|NCT02229851|18808939|P6|NOT COMPLETED|Extension Phase (Open-label Phase)||5
7638753|NCT02229851|18808940|P5|NOT COMPLETED|Extension Phase (Open-label Phase)||5
7638754|NCT02229851|18808941|P4|NOT COMPLETED|Extension Phase (Open-label Phase)||2
7638755|NCT02229851|18808942|P3|NOT COMPLETED|Extension Phase (Open-label Phase)||0
7638756|NCT02229851|18808943|P2|NOT COMPLETED|Extension Phase (Open-label Phase)||0
7638757|NCT02229851|18808944|P1|NOT COMPLETED|Extension Phase (Open-label Phase)||0
7638758|NCT02229851|18808938|P7|COMPLETED|Extension Phase (Open-label Phase)||48
7638759|NCT02229851|18808939|P6|COMPLETED|Extension Phase (Open-label Phase)||47
7638760|NCT02229851|18808940|P5|COMPLETED|Extension Phase (Open-label Phase)||109
7638761|NCT02229851|18808941|P4|COMPLETED|Extension Phase (Open-label Phase)||53
7638762|NCT02229851|18808942|P3|COMPLETED|Extension Phase (Open-label Phase)||0
7638763|NCT02229851|18808943|P2|COMPLETED|Extension Phase (Open-label Phase)||0
7638764|NCT02229851|18808944|P1|COMPLETED|Extension Phase (Open-label Phase)||0
7638765|NCT02229851|18808938|P7|STARTED|Extension Phase (Open-label Phase)||51
7638766|NCT02229851|18808939|P6|STARTED|Extension Phase (Open-label Phase)||52
7638767|NCT02229851|18808940|P5|STARTED|Extension Phase (Open-label Phase)||114
7638768|NCT02229851|18808941|P4|STARTED|Extension Phase (Open-label Phase)||55
7638769|NCT02229851|18808942|P3|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
7638770|NCT02229851|18808943|P2|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
7638771|NCT02229851|18808944|P1|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
7638772|NCT02229851|18808938|P7|NOT COMPLETED|Main Phase (Double-blind Phase)||0
7638773|NCT02229851|18808939|P6|NOT COMPLETED|Main Phase (Double-blind Phase)||0
7638774|NCT02229851|18808940|P5|NOT COMPLETED|Main Phase (Double-blind Phase)||0
7638775|NCT02229851|18808941|P4|NOT COMPLETED|Main Phase (Double-blind Phase)||0
7638776|NCT02229851|18808942|P3|NOT COMPLETED|Main Phase (Double-blind Phase)||6
7638777|NCT02229851|18808943|P2|NOT COMPLETED|Main Phase (Double-blind Phase)||16
7638778|NCT02229851|18808944|P1|NOT COMPLETED|Main Phase (Double-blind Phase)||6
7638779|NCT02229851|18808938|P7|COMPLETED|Main Phase (Double-blind Phase)||0
7638780|NCT02229851|18808939|P6|COMPLETED|Main Phase (Double-blind Phase)||0
7638781|NCT02229851|18808940|P5|COMPLETED|Main Phase (Double-blind Phase)||0
7638782|NCT02229851|18808941|P4|COMPLETED|Main Phase (Double-blind Phase)||0
7638783|NCT02229851|18808942|P3|COMPLETED|Main Phase (Double-blind Phase)||114
7638784|NCT02229851|18808943|P2|COMPLETED|Main Phase (Double-blind Phase)||103
7638785|NCT02229851|18808944|P1|COMPLETED|Main Phase (Double-blind Phase)||55
7638786|NCT02229851|18808938|P7|Safety Analysis Set|Main Phase (Double-blind Phase)||0
7638787|NCT02229851|18808939|P6|Safety Analysis Set|Main Phase (Double-blind Phase)||0
7638788|NCT02229851|18808940|P5|Safety Analysis Set|Main Phase (Double-blind Phase)||0
7638789|NCT02229851|18808941|P4|Safety Analysis Set|Main Phase (Double-blind Phase)||0
7638790|NCT02229851|18808942|P3|Safety Analysis Set|Main Phase (Double-blind Phase)||120
7638791|NCT02229851|18808943|P2|Safety Analysis Set|Main Phase (Double-blind Phase)||119
7638792|NCT02229851|18808944|P1|Safety Analysis Set|Main Phase (Double-blind Phase)||61
7638793|NCT02229851|18808938|P7|Full Analysis Set|Main Phase (Double-blind Phase)||0
7638794|NCT02229851|18808939|P6|Full Analysis Set|Main Phase (Double-blind Phase)||0
7638795|NCT02229851|18808940|P5|Full Analysis Set|Main Phase (Double-blind Phase)||0
7638796|NCT02229851|18808941|P4|Full Analysis Set|Main Phase (Double-blind Phase)||0
7638797|NCT02229851|18808942|P3|Full Analysis Set|Main Phase (Double-blind Phase)||120
7638798|NCT02229851|18808943|P2|Full Analysis Set|Main Phase (Double-blind Phase)||119
7638799|NCT02229851|18808944|P1|Full Analysis Set|Main Phase (Double-blind Phase)||61
7638800|NCT02229851|18808938|P7|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
7638801|NCT02229851|18808939|P6|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
7638802|NCT02229851|18808940|P5|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
7638803|NCT02229851|18808941|P4|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
7638804|NCT02229851|18808942|P3|STARTED|Main Phase (Double-blind Phase)||120
7638805|NCT02229851|18808943|P2|STARTED|Main Phase (Double-blind Phase)||119
7638806|NCT02229851|18808944|P1|STARTED|Main Phase (Double-blind Phase)||61
7638807|NCT02229552|18809376|P1|NOT COMPLETED|2-Year Follow up||26
7638808|NCT02229552|18809376|P1|COMPLETED|2-Year Follow up||205
7638809|NCT02229552|18809376|P1|STARTED|2-Year Follow up|All baseline participants were eligible for year 2 follow up, regardless of completion of year 1.|231
7638810|NCT02229552|18809376|P1|NOT COMPLETED|1-year Follow up||25
7638811|NCT02229552|18809376|P1|COMPLETED|1-year Follow up||206
7638812|NCT02229552|18809376|P1|STARTED|1-year Follow up||231
7638813|NCT02229552|18809376|P1|NOT COMPLETED|Baseline||6
7638814|NCT02229552|18809376|P1|COMPLETED|Baseline||231
7638815|NCT02229552|18809376|P1|STARTED|Baseline||237
7638816|NCT02229539|18809383|P3|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10
7638817|NCT02229539|18809384|P2|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7
7638818|NCT02229539|18809385|P1|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9
7638819|NCT02229539|18809383|P3|COMPLETED|Cycle 2 (Optional Continuation Phase)||22
7638820|NCT02229539|18809384|P2|COMPLETED|Cycle 2 (Optional Continuation Phase)||29
7638821|NCT02229539|18809385|P1|COMPLETED|Cycle 2 (Optional Continuation Phase)||26
7638822|NCT02229539|18809383|P3|STARTED|Cycle 2 (Optional Continuation Phase)||32
7638823|NCT02229539|18809384|P2|STARTED|Cycle 2 (Optional Continuation Phase)||36
7638824|NCT02229539|18809385|P1|STARTED|Cycle 2 (Optional Continuation Phase)||35
7638825|NCT02229539|18809383|P3|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
7638826|NCT02229539|18809384|P2|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5
7638827|NCT02229539|18809385|P1|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
7638828|NCT02229539|18809383|P3|COMPLETED|Cycle 1 (Treatment Per Protocol)||72
7638829|NCT02229539|18809384|P2|COMPLETED|Cycle 1 (Treatment Per Protocol)||71
7638830|NCT02229539|18809385|P1|COMPLETED|Cycle 1 (Treatment Per Protocol)||74
7638831|NCT02229539|18809383|P3|STARTED|Cycle 1 (Treatment Per Protocol)||75
7638832|NCT02229539|18809384|P2|STARTED|Cycle 1 (Treatment Per Protocol)||76
7638833|NCT02229539|18809385|P1|STARTED|Cycle 1 (Treatment Per Protocol)||77
7638834|NCT02229513|18809395|P2|NOT COMPLETED|Overall Study||0
7638835|NCT02229513|18809396|P1|NOT COMPLETED|Overall Study||0
7638836|NCT02229513|18809395|P2|COMPLETED|Overall Study||100
7638837|NCT02229513|18809396|P1|COMPLETED|Overall Study||100
7638838|NCT02229513|18809395|P2|STARTED|Overall Study||100
7638839|NCT02229513|18809396|P1|STARTED|Overall Study||100
7638840|NCT02229487|18809432|P2|NOT COMPLETED|Overall Study||0
7638841|NCT02229487|18809433|P1|NOT COMPLETED|Overall Study||0
7638842|NCT02229487|18809432|P2|COMPLETED|Overall Study||27
7638843|NCT02229487|18809433|P1|COMPLETED|Overall Study||24
7638844|NCT02229487|18809432|P2|STARTED|Overall Study||27
7638845|NCT02229487|18809433|P1|STARTED|Overall Study||24
7638846|NCT02229474|18809441|P2|NOT COMPLETED|Overall Study||3
7638847|NCT02229474|18809442|P1|NOT COMPLETED|Overall Study||0
7638848|NCT02229474|18809441|P2|COMPLETED|Overall Study||15
7638849|NCT02229474|18809442|P1|COMPLETED|Overall Study||16
7638850|NCT02229474|18809441|P2|STARTED|Overall Study||18
7638851|NCT02229474|18809442|P1|STARTED|Overall Study||16
7638852|NCT02229461|18809475|P6|NOT COMPLETED|Overall Study||0
7638853|NCT02229461|18809476|P5|NOT COMPLETED|Overall Study||0
7638854|NCT02229461|18809477|P4|NOT COMPLETED|Overall Study||0
7638855|NCT02229461|18809478|P3|NOT COMPLETED|Overall Study||0
7638856|NCT02229461|18809479|P2|NOT COMPLETED|Overall Study||0
7638857|NCT02229461|18809480|P1|NOT COMPLETED|Overall Study||0
7638858|NCT02229461|18809475|P6|COMPLETED|Overall Study||17
7638859|NCT02229461|18809476|P5|COMPLETED|Overall Study||17
7638860|NCT02229461|18809477|P4|COMPLETED|Overall Study||17
7638861|NCT02229461|18809478|P3|COMPLETED|Overall Study||17
7638862|NCT02229461|18809479|P2|COMPLETED|Overall Study||17
7638863|NCT02229461|18809480|P1|COMPLETED|Overall Study||17
7638864|NCT02229461|18809475|P6|STARTED|Overall Study|Randomized and received treatment|17
7638865|NCT02229461|18809476|P5|STARTED|Overall Study|Randomized and received treatment|17
7638866|NCT02229461|18809477|P4|STARTED|Overall Study|Randomized and received treatment|17
7638867|NCT02229461|18809478|P3|STARTED|Overall Study|Randomized and received treatment|17
7638868|NCT02229461|18809479|P2|STARTED|Overall Study|Randomized and received treatment|17
7638869|NCT02229461|18809480|P1|STARTED|Overall Study|Randomized and received treatment|17
7638870|NCT02229396|18809516|P3|NOT COMPLETED|Overall Study||95
7638871|NCT02229396|18809517|P2|NOT COMPLETED|Overall Study||77
7638872|NCT02229396|18809518|P1|NOT COMPLETED|Overall Study||78
7638873|NCT02229396|18809516|P3|COMPLETED|Overall Study||136
7638874|NCT02229396|18809517|P2|COMPLETED|Overall Study||154
7638875|NCT02229396|18809518|P1|COMPLETED|Overall Study||155
7638876|NCT02229396|18809516|P3|Completed 52-Week Study Period|Overall Study||177
7638877|NCT02229396|18809517|P2|Completed 52-Week Study Period|Overall Study||193
7638878|NCT02229396|18809518|P1|Completed 52-Week Study Period|Overall Study||194
7638879|NCT02229396|18809516|P3|Completed 28-Week Study Period|Overall Study||193
7638880|NCT02229396|18809517|P2|Completed 28-Week Study Period|Overall Study||202
7638881|NCT02229396|18809518|P1|Completed 28-Week Study Period|Overall Study||208
7638882|NCT02229396|18809516|P3|Intent-to-Treat (ITT) Analysis Set|Overall Study||227
7638883|NCT02229396|18809517|P2|Intent-to-Treat (ITT) Analysis Set|Overall Study||228
7638884|NCT02229396|18809518|P1|Intent-to-Treat (ITT) Analysis Set|Overall Study||230
7638885|NCT02229396|18809516|P3|Safety Analysis Set|Overall Study||230
7638886|NCT02229396|18809517|P2|Safety Analysis Set|Overall Study||231
7638887|NCT02229396|18809518|P1|Safety Analysis Set|Overall Study||233
7638888|NCT02229396|18809516|P3|Randomization Code Allocated|Overall Study||231
7638889|NCT02229396|18809517|P2|Randomization Code Allocated|Overall Study||231
7638890|NCT02229396|18809518|P1|Randomization Code Allocated|Overall Study||233
7638891|NCT02229396|18809516|P3|STARTED|Overall Study||231
7638892|NCT02229396|18809517|P2|STARTED|Overall Study||231
7638893|NCT02229396|18809518|P1|STARTED|Overall Study||233
7638894|NCT02229383|18809549|P2|NOT COMPLETED|Overall Study||22
7638895|NCT02229383|18809550|P1|NOT COMPLETED|Overall Study||20
7638896|NCT02229383|18809549|P2|COMPLETED|Overall Study||207
7638897|NCT02229383|18809550|P1|COMPLETED|Overall Study||212
7638898|NCT02229383|18809549|P2|Intent-to-treat (ITT) Analysis Set|Overall Study||228
7638899|NCT02229383|18809550|P1|Intent-to-treat (ITT) Analysis Set|Overall Study||230
7638900|NCT02229383|18809549|P2|Safety Analysis Set|Overall Study||229
7638901|NCT02229383|18809550|P1|Safety Analysis Set|Overall Study||231
7638902|NCT02229383|18809549|P2|Received Treatment|Overall Study||229
7638903|NCT02229383|18809550|P1|Received Treatment|Overall Study||231
7638904|NCT02229383|18809549|P2|STARTED|Overall Study||229
7638905|NCT02229383|18809550|P1|STARTED|Overall Study||232
7638906|NCT02229318|18809568|P1|NOT COMPLETED|Overall Study||0
7638907|NCT02229318|18809568|P1|COMPLETED|Overall Study|September 15th 2014 11 completed|11
7638908|NCT02229318|18809568|P1|STARTED|Overall Study|September 6th 2014 11 enrolled|11
7638909|NCT02229227|18809575|P2|NOT COMPLETED|Overall Study||62
7638910|NCT02229227|18809576|P1|NOT COMPLETED|Overall Study||51
7638911|NCT02229227|18809575|P2|COMPLETED|Overall Study||350
7638912|NCT02229227|18809576|P1|COMPLETED|Overall Study||351
7638913|NCT02229227|18809575|P2|STARTED|Overall Study||412
7638914|NCT02229227|18809576|P1|STARTED|Overall Study||402
7638915|NCT02229214|18809661|P2|NOT COMPLETED|Overall Study||0
7638916|NCT02229214|18809662|P1|NOT COMPLETED|Overall Study||6
7638917|NCT02229214|18809661|P2|COMPLETED|Overall Study||10
7638918|NCT02229214|18809662|P1|COMPLETED|Overall Study||35
7638919|NCT02229214|18809661|P2|STARTED|Overall Study||10
7638920|NCT02229214|18809662|P1|STARTED|Overall Study||41
7638921|NCT02228980|18809686|P4|NOT COMPLETED|Overall Study||3
7638922|NCT02228980|18809687|P3|NOT COMPLETED|Overall Study||2
7638923|NCT02228980|18809688|P2|NOT COMPLETED|Overall Study||3
7638924|NCT02228980|18809689|P1|NOT COMPLETED|Overall Study||24
7638925|NCT02228980|18809686|P4|COMPLETED|Overall Study||148
7638926|NCT02228980|18809687|P3|COMPLETED|Overall Study||149
7638927|NCT02228980|18809688|P2|COMPLETED|Overall Study||147
7638928|NCT02228980|18809689|P1|COMPLETED|Overall Study||126
7638929|NCT02228980|18809686|P4|STARTED|Overall Study||151
7638930|NCT02228980|18809687|P3|STARTED|Overall Study||151
7638931|NCT02228980|18809688|P2|STARTED|Overall Study||150
7638932|NCT02228980|18809689|P1|STARTED|Overall Study||150
7638933|NCT02228967|18809713|P2|NOT COMPLETED|Overall Study||160
7638934|NCT02228967|18809714|P1|NOT COMPLETED|Overall Study||159
7638935|NCT02228967|18809713|P2|COMPLETED|Overall Study||228
7638936|NCT02228967|18809714|P1|COMPLETED|Overall Study||244
7638937|NCT02228967|18809713|P2|STARTED|Overall Study||388
7638938|NCT02228967|18809714|P1|STARTED|Overall Study||403
7638939|NCT02228824|18809760|P2|NOT COMPLETED|Overall Study||22
7638940|NCT02228824|18809761|P1|NOT COMPLETED|Overall Study||29
7638941|NCT02228824|18809760|P2|COMPLETED|Overall Study||98
7638942|NCT02228824|18809761|P1|COMPLETED|Overall Study||89
7638943|NCT02228824|18809760|P2|STARTED|Overall Study||120
7638944|NCT02228824|18809761|P1|STARTED|Overall Study||118
7638945|NCT02228720|18809775|P1|NOT COMPLETED|Open Label - Day 90||0
7638946|NCT02228720|18809775|P1|COMPLETED|Open Label - Day 90||14
7638947|NCT02228720|18809775|P1|STARTED|Open Label - Day 90||14
7638948|NCT02228720|18809775|P1|NOT COMPLETED|Open Label - Day 30||1
7638949|NCT02228720|18809775|P1|COMPLETED|Open Label - Day 30||14
7638950|NCT02228720|18809775|P1|STARTED|Open Label - Day 30||15
7638951|NCT02228720|18809775|P1|NOT COMPLETED|Open Label - Baseline||0
7638952|NCT02228720|18809775|P1|COMPLETED|Open Label - Baseline||15
7638953|NCT02228720|18809775|P1|STARTED|Open Label - Baseline||15
7638954|NCT02228681|18809785|P2|NOT COMPLETED|Overall Study||0
7638955|NCT02228681|18809786|P1|NOT COMPLETED|Overall Study||0
7638956|NCT02228681|18809785|P2|COMPLETED|Overall Study||37
7638957|NCT02228681|18809786|P1|COMPLETED|Overall Study||37
7638958|NCT02228681|18809785|P2|STARTED|Overall Study||37
7638959|NCT02228681|18809786|P1|STARTED|Overall Study||37
7638960|NCT02228590|18809798|P1|NOT COMPLETED|Overall Study||1
7638961|NCT02228590|18809798|P1|COMPLETED|Overall Study||19
7638962|NCT02228590|18809798|P1|STARTED|Overall Study||20
7638963|NCT02228564|18809811|P1|NOT COMPLETED|Overall Study||49
7638964|NCT02228564|18809811|P1|COMPLETED|Overall Study||106
7638965|NCT02228564|18809811|P1|STARTED|Overall Study||155
7638966|NCT02228499|18809828|P2|NOT COMPLETED|Overall Study||26
7638967|NCT02228499|18809829|P1|NOT COMPLETED|Overall Study||23
7638968|NCT02228499|18809828|P2|COMPLETED|Overall Study||10
7638969|NCT02228499|18809829|P1|COMPLETED|Overall Study||7
7638970|NCT02228499|18809828|P2|STARTED|Overall Study||36
7638971|NCT02228499|18809829|P1|STARTED|Overall Study||30
7638972|NCT02228460|18809835|P1|NOT COMPLETED|Overall Study||2
7638973|NCT02228460|18809835|P1|COMPLETED|Overall Study||9
7638974|NCT02228460|18809835|P1|STARTED|Overall Study||11
7638975|NCT02228395|18809858|P3|NOT COMPLETED|Third Intervention Period||0
7638976|NCT02228395|18809859|P2|NOT COMPLETED|Third Intervention Period||0
7638977|NCT02228395|18809860|P1|NOT COMPLETED|Third Intervention Period||0
7638978|NCT02228395|18809858|P3|COMPLETED|Third Intervention Period||3
7638979|NCT02228395|18809859|P2|COMPLETED|Third Intervention Period||3
7638980|NCT02228395|18809860|P1|COMPLETED|Third Intervention Period||3
7638981|NCT02228395|18809858|P3|STARTED|Third Intervention Period||3
7638982|NCT02228395|18809859|P2|STARTED|Third Intervention Period||3
7638983|NCT02228395|18809860|P1|STARTED|Third Intervention Period||3
7638984|NCT02228395|18809858|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
7638985|NCT02228395|18809859|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
7638986|NCT02228395|18809860|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
7638987|NCT02228395|18809858|P3|COMPLETED|Washout Period (at Least 10 Days)||3
7638988|NCT02228395|18809859|P2|COMPLETED|Washout Period (at Least 10 Days)||3
7638989|NCT02228395|18809860|P1|COMPLETED|Washout Period (at Least 10 Days)||3
7638990|NCT02228395|18809858|P3|STARTED|Washout Period (at Least 10 Days)||3
7638991|NCT02228395|18809859|P2|STARTED|Washout Period (at Least 10 Days)||3
7638992|NCT02228395|18809860|P1|STARTED|Washout Period (at Least 10 Days)||3
7638993|NCT02228395|18809858|P3|NOT COMPLETED|Second Intervention Period||0
7638994|NCT02228395|18809859|P2|NOT COMPLETED|Second Intervention Period||0
7638995|NCT02228395|18809860|P1|NOT COMPLETED|Second Intervention Period||0
7638996|NCT02228395|18809858|P3|COMPLETED|Second Intervention Period||3
7638997|NCT02228395|18809859|P2|COMPLETED|Second Intervention Period||3
7638998|NCT02228395|18809860|P1|COMPLETED|Second Intervention Period||3
7638999|NCT02228395|18809858|P3|STARTED|Second Intervention Period||3
7639000|NCT02228395|18809859|P2|STARTED|Second Intervention Period||3
7639001|NCT02228395|18809860|P1|STARTED|Second Intervention Period||3
7639002|NCT02228395|18809858|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
7639003|NCT02228395|18809859|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
7639004|NCT02228395|18809860|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
7639005|NCT02228395|18809858|P3|COMPLETED|Washout Period (at Least 10 Days)||3
7639006|NCT02228395|18809859|P2|COMPLETED|Washout Period (at Least 10 Days)||3
7639007|NCT02228395|18809860|P1|COMPLETED|Washout Period (at Least 10 Days)||3
7639008|NCT02228395|18809858|P3|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
7639009|NCT02228395|18809859|P2|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
7639010|NCT02228395|18809860|P1|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
7639011|NCT02228395|18809858|P3|NOT COMPLETED|First Intervention Period||1
7639012|NCT02228395|18809859|P2|NOT COMPLETED|First Intervention Period||1
7639013|NCT02228395|18809860|P1|NOT COMPLETED|First Intervention Period||1
7639014|NCT02228395|18809858|P3|COMPLETED|First Intervention Period||2
7639015|NCT02228395|18809859|P2|COMPLETED|First Intervention Period||2
7639016|NCT02228395|18809860|P1|COMPLETED|First Intervention Period||2
7639017|NCT02228395|18809858|P3|STARTED|First Intervention Period||3
7639018|NCT02228395|18809859|P2|STARTED|First Intervention Period||3
7639019|NCT02228395|18809860|P1|STARTED|First Intervention Period||3
7639020|NCT02228174|18809924|P1|NOT COMPLETED|Overall Study||5
7639021|NCT02228174|18809924|P1|COMPLETED|Overall Study||142
7639022|NCT02228174|18809924|P1|Full Analysis Population|Overall Study|Subjects who didn't become pregnant or diagnosed with an interfering medical condition at 12-months|143
7639023|NCT02228174|18809924|P1|STARTED|Overall Study||147
7639024|NCT02228096|18809946|P1|NOT COMPLETED|Overall Study||71
7639025|NCT02228096|18809946|P1|COMPLETED|Overall Study|Completed = study follow-up completed|4
7639026|NCT02228096|18809946|P1|Enrolled and Infused|Overall Study||64
7639027|NCT02228096|18809946|P1|Enrolled But Not Infused|Overall Study||11
7639028|NCT02228096|18809946|P1|Enrolled Into Long-term f/u Protocol|Overall Study||31
7639029|NCT02228096|18809946|P1|STARTED|Overall Study||75
7639030|NCT02227875|18810048|P2|NOT COMPLETED|Overall Study||33
7639031|NCT02227875|18810049|P1|NOT COMPLETED|Overall Study||37
7639032|NCT02227875|18810048|P2|COMPLETED|Overall Study||250
7639033|NCT02227875|18810049|P1|COMPLETED|Overall Study||240
7639034|NCT02227875|18810048|P2|STARTED|Overall Study||283
7639035|NCT02227875|18810049|P1|STARTED|Overall Study||277
7639036|NCT02227862|18810069|P2|NOT COMPLETED|Overall Study||22
7639037|NCT02227862|18810070|P1|NOT COMPLETED|Overall Study||19
7639038|NCT02227862|18810069|P2|COMPLETED|Overall Study||256
7639039|NCT02227862|18810070|P1|COMPLETED|Overall Study||261
7639040|NCT02227862|18810069|P2|Week 24|Overall Study||263
7639041|NCT02227862|18810070|P1|Week 24|Overall Study||269
7639042|NCT02227862|18810069|P2|STARTED|Overall Study||278
7639043|NCT02227862|18810070|P1|STARTED|Overall Study||280
7639044|NCT02227849|18810100|P1|NOT COMPLETED|Overall Study||8
7639045|NCT02227849|18810100|P1|COMPLETED|Overall Study||63
7639046|NCT02227849|18810100|P1|STARTED|Overall Study||71
7639047|NCT02227836|18810108|P1|NOT COMPLETED|Overall Study||0
7639048|NCT02227836|18810108|P1|COMPLETED|Overall Study||8
7639049|NCT02227836|18810108|P1|STARTED|Overall Study||8
7639050|NCT02227810|18810114|P2|NOT COMPLETED|Overall Study||5
7639051|NCT02227810|18810115|P1|NOT COMPLETED|Overall Study||2
7639052|NCT02227810|18810114|P2|COMPLETED|Overall Study||29
7639053|NCT02227810|18810115|P1|COMPLETED|Overall Study||17
7639054|NCT02227810|18810114|P2|STARTED|Overall Study||34
7639055|NCT02227810|18810115|P1|STARTED|Overall Study||19
7639056|NCT02227784|18810131|P5|NOT COMPLETED|Open-Label Extension Phase (OLE)||248
7639057|NCT02227784|18810132|P4|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
7639058|NCT02227784|18810133|P3|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
7639059|NCT02227784|18810134|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
7639060|NCT02227784|18810135|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
7639061|NCT02227784|18810131|P5|COMPLETED|Open-Label Extension Phase (OLE)||0
7639062|NCT02227784|18810132|P4|COMPLETED|Open-Label Extension Phase (OLE)||0
7639063|NCT02227784|18810133|P3|COMPLETED|Open-Label Extension Phase (OLE)||0
7639064|NCT02227784|18810134|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
7639065|NCT02227784|18810135|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
7639066|NCT02227784|18810131|P5|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||247
7639067|NCT02227784|18810132|P4|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
7639068|NCT02227784|18810133|P3|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
7639069|NCT02227784|18810134|P2|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
7639070|NCT02227784|18810135|P1|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
7639071|NCT02227784|18810131|P5|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|248
7639072|NCT02227784|18810132|P4|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
7639073|NCT02227784|18810133|P3|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
7639074|NCT02227784|18810134|P2|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
7639075|NCT02227784|18810135|P1|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
7639076|NCT02227784|18810131|P5|NOT COMPLETED|Double-Blind Phase||0
7639077|NCT02227784|18810132|P4|NOT COMPLETED|Double-Blind Phase||39
7639078|NCT02227784|18810133|P3|NOT COMPLETED|Double-Blind Phase||21
7639079|NCT02227784|18810134|P2|NOT COMPLETED|Double-Blind Phase||18
7639080|NCT02227784|18810135|P1|NOT COMPLETED|Double-Blind Phase||40
7639081|NCT02227784|18810131|P5|COMPLETED|Double-Blind Phase||0
7639082|NCT02227784|18810132|P4|COMPLETED|Double-Blind Phase||88
7639083|NCT02227784|18810133|P3|COMPLETED|Double-Blind Phase||41
7639084|NCT02227784|18810134|P2|COMPLETED|Double-Blind Phase||36
7639085|NCT02227784|18810135|P1|COMPLETED|Double-Blind Phase||83
7639086|NCT02227784|18810131|P5|STARTED|Double-Blind Phase||0
7639087|NCT02227784|18810132|P4|STARTED|Double-Blind Phase||127
7639088|NCT02227784|18810133|P3|STARTED|Double-Blind Phase||62
7639089|NCT02227784|18810134|P2|STARTED|Double-Blind Phase||54
7639090|NCT02227784|18810135|P1|STARTED|Double-Blind Phase||123
7639091|NCT02227758|18810170|P1|NOT COMPLETED|Overall Study||67
7639092|NCT02227758|18810170|P1|COMPLETED|Overall Study||45
7639093|NCT02227758|18810170|P1|STARTED|Overall Study||112
7639094|NCT02227706|18810184|P2|NOT COMPLETED|Overall Study||0
7639095|NCT02227706|18810185|P1|NOT COMPLETED|Overall Study||0
7639096|NCT02227706|18810184|P2|COMPLETED|Overall Study||20
7639097|NCT02227706|18810185|P1|COMPLETED|Overall Study||20
7639098|NCT02227706|18810184|P2|STARTED|Overall Study||20
7639099|NCT02227706|18810185|P1|STARTED|Overall Study||20
7639100|NCT02227693|18810231|P4|NOT COMPLETED|Overall Study||0
7639101|NCT02227693|18810232|P3|NOT COMPLETED|Overall Study||0
7639102|NCT02227693|18810233|P2|NOT COMPLETED|Overall Study||0
7639103|NCT02227693|18810234|P1|NOT COMPLETED|Overall Study||0
7639104|NCT02227693|18810231|P4|COMPLETED|Overall Study||10
7639105|NCT02227693|18810232|P3|COMPLETED|Overall Study||11
7639106|NCT02227693|18810233|P2|COMPLETED|Overall Study||7
7639107|NCT02227693|18810234|P1|COMPLETED|Overall Study||11
7639108|NCT02227693|18810231|P4|STARTED|Overall Study||10
7639109|NCT02227693|18810232|P3|STARTED|Overall Study||11
7639110|NCT02227693|18810233|P2|STARTED|Overall Study||7
7639111|NCT02227693|18810234|P1|STARTED|Overall Study||11
7639112|NCT02227485|18810290|P2|NOT COMPLETED|Second Follow-up||2
7639113|NCT02227485|18810291|P1|NOT COMPLETED|Second Follow-up||2
7639114|NCT02227485|18810290|P2|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36
7639115|NCT02227485|18810291|P1|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34
7639116|NCT02227485|18810290|P2|STARTED|Second Follow-up||38
7639117|NCT02227485|18810291|P1|STARTED|Second Follow-up||36
7639118|NCT02227485|18810290|P2|NOT COMPLETED|First Follow-up||2
7639119|NCT02227485|18810291|P1|NOT COMPLETED|First Follow-up||4
7639120|NCT02227485|18810290|P2|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38
7639121|NCT02227485|18810291|P1|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36
7639122|NCT02227485|18810290|P2|STARTED|First Follow-up||40
7639123|NCT02227485|18810291|P1|STARTED|First Follow-up||40
7639124|NCT02227368|18810309|P2|NOT COMPLETED|Overall Study||4
7639125|NCT02227368|18810310|P1|NOT COMPLETED|Overall Study||2
7639126|NCT02227368|18810309|P2|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|20
7639127|NCT02227368|18810310|P1|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|14
7639128|NCT02227368|18810309|P2|Sujects Who Completed Treatment|Overall Study||17
7639129|NCT02227368|18810310|P1|Sujects Who Completed Treatment|Overall Study||10
7639130|NCT02227368|18810309|P2|Sujects Who Received Treatment|Overall Study||24
7639131|NCT02227368|18810310|P1|Sujects Who Received Treatment|Overall Study||16
7639132|NCT02227368|18810309|P2|STARTED|Overall Study||24
7639133|NCT02227368|18810310|P1|STARTED|Overall Study||16
7639134|NCT02227329|18810320|P2|NOT COMPLETED|Overall Study||0
7639135|NCT02227329|18810321|P1|NOT COMPLETED|Overall Study||0
7639136|NCT02227329|18810320|P2|COMPLETED|Overall Study||20
7639137|NCT02227329|18810321|P1|COMPLETED|Overall Study||18
7639138|NCT02227329|18810320|P2|STARTED|Overall Study||20
7639139|NCT02227329|18810321|P1|STARTED|Overall Study||18
7639140|NCT02227316|18810331|P4|NOT COMPLETED|Overall Study||0
7639141|NCT02227316|18810332|P3|NOT COMPLETED|Overall Study||0
7639142|NCT02227316|18810333|P2|NOT COMPLETED|Overall Study||0
7639143|NCT02227316|18810334|P1|NOT COMPLETED|Overall Study||0
7639144|NCT02227316|18810331|P4|COMPLETED|Overall Study||16
7639145|NCT02227316|18810332|P3|COMPLETED|Overall Study||16
7639146|NCT02227316|18810333|P2|COMPLETED|Overall Study||4
7639147|NCT02227316|18810334|P1|COMPLETED|Overall Study||4
7639148|NCT02227316|18810331|P4|STARTED|Overall Study||16
7639149|NCT02227316|18810332|P3|STARTED|Overall Study||16
7639150|NCT02227316|18810333|P2|STARTED|Overall Study||4
7639151|NCT02227316|18810334|P1|STARTED|Overall Study||4
7639152|NCT02227238|18810366|P2|NOT COMPLETED|Overall Study||67
7639153|NCT02227238|18810367|P1|NOT COMPLETED|Overall Study||37
7639154|NCT02227238|18810366|P2|COMPLETED|Overall Study||245
7639155|NCT02227238|18810367|P1|COMPLETED|Overall Study||275
7639156|NCT02227238|18810366|P2|STARTED|Overall Study||312
7639157|NCT02227238|18810367|P1|STARTED|Overall Study||312
7639158|NCT02227147|18810433|P2|NOT COMPLETED|Follow-up Period||5
7639159|NCT02227147|18810434|P1|NOT COMPLETED|Follow-up Period||3
7639160|NCT02227147|18810433|P2|COMPLETED|Follow-up Period||16
7639161|NCT02227147|18810434|P1|COMPLETED|Follow-up Period||15
7639162|NCT02227147|18810433|P2|STARTED|Follow-up Period||21
7639163|NCT02227147|18810434|P1|STARTED|Follow-up Period||18
7639164|NCT02227147|18810433|P2|NOT COMPLETED|Controlled Treatment Period||3
7639165|NCT02227147|18810434|P1|NOT COMPLETED|Controlled Treatment Period||6
7639166|NCT02227147|18810433|P2|COMPLETED|Controlled Treatment Period||21
7639167|NCT02227147|18810434|P1|COMPLETED|Controlled Treatment Period||18
7639168|NCT02227147|18810433|P2|STARTED|Controlled Treatment Period||24
7639169|NCT02227147|18810434|P1|STARTED|Controlled Treatment Period||24
7639170|NCT02227121|18810457|P1|NOT COMPLETED|Overall Study||0
7639171|NCT02227121|18810457|P1|COMPLETED|Overall Study||16
7639172|NCT02227121|18810457|P1|STARTED|Overall Study||16
7639173|NCT02227108|18810461|P1|NOT COMPLETED|Overall Study||31
7639174|NCT02227108|18810461|P1|COMPLETED|Overall Study||1
7639175|NCT02227108|18810461|P1|Treated|Overall Study||30
7639176|NCT02227108|18810461|P1|STARTED|Overall Study||32
7639177|NCT02226965|18810488|P1|NOT COMPLETED|Overall Study||41
7639178|NCT02226965|18810488|P1|COMPLETED|Overall Study||4
7639179|NCT02226965|18810488|P1|STARTED|Overall Study||45
7639180|NCT02226653|18810500|P2|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
7639181|NCT02226653|18810501|P1|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
7639182|NCT02226653|18810500|P2|COMPLETED|Washout Period 5 (at Least 21 Days)||23
7639183|NCT02226653|18810501|P1|COMPLETED|Washout Period 5 (at Least 21 Days)||23
7639184|NCT02226653|18810500|P2|STARTED|Washout Period 5 (at Least 21 Days)||23
7639185|NCT02226653|18810501|P1|STARTED|Washout Period 5 (at Least 21 Days)||23
7639186|NCT02226653|18810500|P2|NOT COMPLETED|Treatment Period 5 Fed State||1
7639187|NCT02226653|18810501|P1|NOT COMPLETED|Treatment Period 5 Fed State||0
7639188|NCT02226653|18810500|P2|COMPLETED|Treatment Period 5 Fed State||23
7639189|NCT02226653|18810501|P1|COMPLETED|Treatment Period 5 Fed State||23
7639190|NCT02226653|18810500|P2|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||24
7639191|NCT02226653|18810501|P1|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||23
7639192|NCT02226653|18810500|P2|STARTED|Treatment Period 5 Fed State||24
7639193|NCT02226653|18810501|P1|STARTED|Treatment Period 5 Fed State||23
7639194|NCT02226653|18810500|P2|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
7639195|NCT02226653|18810501|P1|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
7639196|NCT02226653|18810500|P2|COMPLETED|Washout Period 4 (at Least 21 Days)||24
7639197|NCT02226653|18810501|P1|COMPLETED|Washout Period 4 (at Least 21 Days)||23
7639198|NCT02226653|18810500|P2|STARTED|Washout Period 4 (at Least 21 Days)||24
7639199|NCT02226653|18810501|P1|STARTED|Washout Period 4 (at Least 21 Days)||23
7639200|NCT02226653|18810500|P2|NOT COMPLETED|Treatment Period 4 Fasted State||0
7639201|NCT02226653|18810501|P1|NOT COMPLETED|Treatment Period 4 Fasted State||0
7639202|NCT02226653|18810500|P2|COMPLETED|Treatment Period 4 Fasted State||24
7639203|NCT02226653|18810501|P1|COMPLETED|Treatment Period 4 Fasted State||23
7639204|NCT02226653|18810500|P2|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||24
7639205|NCT02226653|18810501|P1|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||23
7639206|NCT02226653|18810500|P2|STARTED|Treatment Period 4 Fasted State||24
7639207|NCT02226653|18810501|P1|STARTED|Treatment Period 4 Fasted State||23
7639208|NCT02226653|18810500|P2|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
7639209|NCT02226653|18810501|P1|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
7639210|NCT02226653|18810500|P2|COMPLETED|Washout Period 3 (at Least 21 Days)||24
7639211|NCT02226653|18810501|P1|COMPLETED|Washout Period 3 (at Least 21 Days)||23
7639212|NCT02226653|18810500|P2|STARTED|Washout Period 3 (at Least 21 Days)||24
7639213|NCT02226653|18810501|P1|STARTED|Washout Period 3 (at Least 21 Days)||23
7639214|NCT02226653|18810500|P2|NOT COMPLETED|Treatment Period 3 Fasted State||0
7639215|NCT02226653|18810501|P1|NOT COMPLETED|Treatment Period 3 Fasted State||0
7639216|NCT02226653|18810500|P2|COMPLETED|Treatment Period 3 Fasted State||24
7639217|NCT02226653|18810501|P1|COMPLETED|Treatment Period 3 Fasted State||23
7639218|NCT02226653|18810500|P2|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||24
7639219|NCT02226653|18810501|P1|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||23
7639220|NCT02226653|18810500|P2|STARTED|Treatment Period 3 Fasted State||24
7639221|NCT02226653|18810501|P1|STARTED|Treatment Period 3 Fasted State||23
7639222|NCT02226653|18810500|P2|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
7639223|NCT02226653|18810501|P1|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
7639224|NCT02226653|18810500|P2|COMPLETED|Washout Period 2 (at Least 21 Days)||24
7639225|NCT02226653|18810501|P1|COMPLETED|Washout Period 2 (at Least 21 Days)||23
7639226|NCT02226653|18810500|P2|STARTED|Washout Period 2 (at Least 21 Days)||24
7639227|NCT02226653|18810501|P1|STARTED|Washout Period 2 (at Least 21 Days)||23
7639228|NCT02226653|18810500|P2|NOT COMPLETED|Treatment Period 2 Fasted State||0
7639229|NCT02226653|18810501|P1|NOT COMPLETED|Treatment Period 2 Fasted State||1
7639230|NCT02226653|18810500|P2|COMPLETED|Treatment Period 2 Fasted State||24
7639231|NCT02226653|18810501|P1|COMPLETED|Treatment Period 2 Fasted State||23
7639232|NCT02226653|18810500|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
7639233|NCT02226653|18810501|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
7639234|NCT02226653|18810500|P2|STARTED|Treatment Period 2 Fasted State||24
7639235|NCT02226653|18810501|P1|STARTED|Treatment Period 2 Fasted State||24
7639236|NCT02226653|18810500|P2|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
7639237|NCT02226653|18810501|P1|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
7639238|NCT02226653|18810500|P2|COMPLETED|Washout Period 1 (at Least 21 Days)||24
7639239|NCT02226653|18810501|P1|COMPLETED|Washout Period 1 (at Least 21 Days)||24
7639240|NCT02226653|18810500|P2|STARTED|Washout Period 1 (at Least 21 Days)||24
7639241|NCT02226653|18810501|P1|STARTED|Washout Period 1 (at Least 21 Days)||24
7639242|NCT02226653|18810500|P2|NOT COMPLETED|Treatment Period 1 Fasted State||0
7639243|NCT02226653|18810501|P1|NOT COMPLETED|Treatment Period 1 Fasted State||0
7639244|NCT02226653|18810500|P2|COMPLETED|Treatment Period 1 Fasted State||24
7639245|NCT02226653|18810501|P1|COMPLETED|Treatment Period 1 Fasted State||24
7639246|NCT02226653|18810500|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
7639247|NCT02226653|18810501|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
7639248|NCT02226653|18810500|P2|STARTED|Treatment Period 1 Fasted State||24
7639249|NCT02226653|18810501|P1|STARTED|Treatment Period 1 Fasted State||24
7639250|NCT02226562|18810525|P2|NOT COMPLETED|Overall Study||1
7639251|NCT02226562|18810526|P1|NOT COMPLETED|Overall Study||0
7639252|NCT02226562|18810525|P2|COMPLETED|Overall Study|Lost to follow up|95
7639253|NCT02226562|18810526|P1|COMPLETED|Overall Study||95
7639254|NCT02226562|18810525|P2|STARTED|Overall Study||96
7639255|NCT02226562|18810526|P1|STARTED|Overall Study||95
7639256|NCT02226549|18810544|P2|NOT COMPLETED|Overall Study||1
7639257|NCT02226549|18810545|P1|NOT COMPLETED|Overall Study||1
7639258|NCT02226549|18810544|P2|COMPLETED|Overall Study||23
7639259|NCT02226549|18810545|P1|COMPLETED|Overall Study||22
7639260|NCT02226549|18810544|P2|STARTED|Overall Study||24
7639261|NCT02226549|18810545|P1|STARTED|Overall Study||23
7639262|NCT02226198|18810555|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
7639263|NCT02226198|18810556|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
7639264|NCT02226198|18810557|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
7639265|NCT02226198|18810555|P3|COMPLETED|Maintenance Phase (12 Weeks)||0
7639266|NCT02226198|18810556|P2|COMPLETED|Maintenance Phase (12 Weeks)||0
7639267|NCT02226198|18810557|P1|COMPLETED|Maintenance Phase (12 Weeks)||13
7639268|NCT02226198|18810555|P3|STARTED|Maintenance Phase (12 Weeks)||0
7639269|NCT02226198|18810556|P2|STARTED|Maintenance Phase (12 Weeks)||0
7639270|NCT02226198|18810557|P1|STARTED|Maintenance Phase (12 Weeks)||13
7639271|NCT02226198|18810555|P3|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
7639272|NCT02226198|18810556|P2|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
7639273|NCT02226198|18810557|P1|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
7639274|NCT02226198|18810555|P3|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7
7639275|NCT02226198|18810556|P2|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6
7639276|NCT02226198|18810557|P1|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
7639277|NCT02226198|18810555|P3|STARTED|Cross-Over: Second Interv. (6 Weeks)||7
7639278|NCT02226198|18810556|P2|STARTED|Cross-Over: Second Interv. (6 Weeks)||6
7639279|NCT02226198|18810557|P1|STARTED|Cross-Over: Second Interv. (6 Weeks)||0
7639280|NCT02226198|18810555|P3|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
7639281|NCT02226198|18810556|P2|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1
7639282|NCT02226198|18810557|P1|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
7639283|NCT02226198|18810555|P3|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7
7639284|NCT02226198|18810556|P2|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6
7639285|NCT02226198|18810557|P1|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
7639286|NCT02226198|18810555|P3|STARTED|Cross-Over: First Intervention (6 Weeks)||7
7639287|NCT02226198|18810556|P2|STARTED|Cross-Over: First Intervention (6 Weeks)||7
7639288|NCT02226198|18810557|P1|STARTED|Cross-Over: First Intervention (6 Weeks)||0
7639289|NCT02226198|18810555|P3|NOT COMPLETED|Lead-in Phase||0
7639290|NCT02226198|18810556|P2|NOT COMPLETED|Lead-in Phase||0
7639291|NCT02226198|18810557|P1|NOT COMPLETED|Lead-in Phase||1
7639292|NCT02226198|18810555|P3|COMPLETED|Lead-in Phase||0
7639293|NCT02226198|18810556|P2|COMPLETED|Lead-in Phase||0
7639294|NCT02226198|18810557|P1|COMPLETED|Lead-in Phase||10
7639295|NCT02226198|18810555|P3|STARTED|Lead-in Phase||0
7639296|NCT02226198|18810556|P2|STARTED|Lead-in Phase||0
7639297|NCT02226198|18810557|P1|STARTED|Lead-in Phase||11
7639298|NCT02226172|18810630|P1|NOT COMPLETED|Overall Study||17
7639299|NCT02226172|18810630|P1|COMPLETED|Overall Study||4
7639300|NCT02226172|18810630|P1|STARTED|Overall Study||21
7639301|NCT02226159|18810663|P2|NOT COMPLETED|Overall Study||6
7639302|NCT02226159|18810664|P1|NOT COMPLETED|Overall Study||6
7639303|NCT02226159|18810663|P2|COMPLETED|Overall Study||26
7639304|NCT02226159|18810664|P1|COMPLETED|Overall Study||27
7639305|NCT02226159|18810663|P2|STARTED|Overall Study||32
7639306|NCT02226159|18810664|P1|STARTED|Overall Study||33
7639307|NCT02226120|18810694|P1|NOT COMPLETED|Overall Study||320
7639308|NCT02226120|18810694|P1|COMPLETED|Overall Study||1660
7639309|NCT02226120|18810694|P1|STARTED|Overall Study||1980
7639310|NCT02226003|18810701|P3|NOT COMPLETED|Overall Study||6
7639311|NCT02226003|18810702|P2|NOT COMPLETED|Overall Study||1
7639312|NCT02226003|18810703|P1|NOT COMPLETED|Overall Study||2
7639313|NCT02226003|18810701|P3|COMPLETED|Overall Study||91
7639314|NCT02226003|18810702|P2|COMPLETED|Overall Study||95
7639315|NCT02226003|18810703|P1|COMPLETED|Overall Study||96
7639316|NCT02226003|18810701|P3|STARTED|Overall Study||97
7639317|NCT02226003|18810702|P2|STARTED|Overall Study||96
7639318|NCT02226003|18810703|P1|STARTED|Overall Study||98
7639319|NCT02225925|18810735|P1|NOT COMPLETED|Overall Study||0
7639320|NCT02225925|18810735|P1|COMPLETED|Overall Study||45
7639321|NCT02225925|18810735|P1|STARTED|Overall Study||45
7639322|NCT02225860|18810748|P2|NOT COMPLETED|Overall Study||0
7639323|NCT02225860|18810749|P1|NOT COMPLETED|Overall Study||1
7639324|NCT02225860|18810748|P2|COMPLETED|Overall Study||17
7639325|NCT02225860|18810749|P1|COMPLETED|Overall Study||16
7639326|NCT02225860|18810748|P2|STARTED|Overall Study||17
7639327|NCT02225860|18810749|P1|STARTED|Overall Study||17
7639328|NCT02225743|18810759|P1|NOT COMPLETED|Overall Study||18
7639329|NCT02225743|18810759|P1|COMPLETED|Overall Study|18 patients chose not to participate on the day of surgery.|102
7639330|NCT02225743|18810759|P1|STARTED|Overall Study||120
7639331|NCT02225587|18810765|P2|NOT COMPLETED|Overall Study||38
7639332|NCT02225587|18810766|P1|NOT COMPLETED|Overall Study||28
7639333|NCT02225587|18810765|P2|COMPLETED|Overall Study||162
7639334|NCT02225587|18810766|P1|COMPLETED|Overall Study||172
7639335|NCT02225587|18810765|P2|Vaccination 3|Overall Study||164
7639336|NCT02225587|18810766|P1|Vaccination 3|Overall Study||172
7639337|NCT02225587|18810765|P2|Vaccination 2|Overall Study||185
7639338|NCT02225587|18810766|P1|Vaccination 2|Overall Study||188
7639339|NCT02225587|18810765|P2|STARTED|Overall Study||200
7639340|NCT02225587|18810766|P1|STARTED|Overall Study||200
7639341|NCT02225353|18810795|P3|NOT COMPLETED|Overall Study||15
7639342|NCT02225353|18810796|P2|NOT COMPLETED|Overall Study||6
7639343|NCT02225353|18810797|P1|NOT COMPLETED|Overall Study||4
7639344|NCT02225353|18810795|P3|COMPLETED|Overall Study||75
7639345|NCT02225353|18810796|P2|COMPLETED|Overall Study||84
7639346|NCT02225353|18810797|P1|COMPLETED|Overall Study||87
7639347|NCT02225353|18810795|P3|STARTED|Overall Study||90
7639348|NCT02225353|18810796|P2|STARTED|Overall Study||90
7639349|NCT02225353|18810797|P1|STARTED|Overall Study||91
7639350|NCT02225132|18810820|P1|NOT COMPLETED|Overall Study||0
7639351|NCT02225132|18810820|P1|COMPLETED|Overall Study||10
7639352|NCT02225132|18810820|P1|STARTED|Overall Study||10
7639353|NCT02225106|18810825|P1|NOT COMPLETED|Overall Study||0
7639354|NCT02225106|18810825|P1|COMPLETED|Overall Study||11
7639355|NCT02225106|18810825|P1|STARTED|Overall Study||11
7639356|NCT02225080|18810829|P1|NOT COMPLETED|Overall Study||0
7639357|NCT02225080|18810829|P1|COMPLETED|Overall Study||100
7639358|NCT02225080|18810829|P1|STARTED|Overall Study||100
7639359|NCT02224846|18810838|P2|NOT COMPLETED|Period 2 (Month 12 to Month 24)||74
7639360|NCT02224846|18810839|P1|NOT COMPLETED|Period 2 (Month 12 to Month 24)||42
7639361|NCT02224846|18810838|P2|COMPLETED|Period 2 (Month 12 to Month 24)||283
7639362|NCT02224846|18810839|P1|COMPLETED|Period 2 (Month 12 to Month 24)||131
7639363|NCT02224846|18810838|P2|STARTED|Period 2 (Month 12 to Month 24)||357
7639364|NCT02224846|18810839|P1|STARTED|Period 2 (Month 12 to Month 24)||173
7639365|NCT02224846|18810838|P2|NOT COMPLETED|Period 2 (Month 3 to Month 12)||31
7639366|NCT02224846|18810839|P1|NOT COMPLETED|Period 2 (Month 3 to Month 12)||19
7639367|NCT02224846|18810838|P2|COMPLETED|Period 2 (Month 3 to Month 12)||357
7639368|NCT02224846|18810839|P1|COMPLETED|Period 2 (Month 3 to Month 12)||173
7639369|NCT02224846|18810838|P2|STARTED|Period 2 (Month 3 to Month 12)||388
7639370|NCT02224846|18810839|P1|STARTED|Period 2 (Month 3 to Month 12)||192
7639371|NCT02224846|18810838|P2|NOT COMPLETED|Period 1 (Month 3)||36
7639372|NCT02224846|18810839|P1|NOT COMPLETED|Period 1 (Month 3)||19
7639373|NCT02224846|18810838|P2|COMPLETED|Period 1 (Month 3)||388
7639374|NCT02224846|18810839|P1|COMPLETED|Period 1 (Month 3)||192
7639375|NCT02224846|18810838|P2|Received at Least One Dose of Study Drug|Period 1 (Month 3)||421
7639376|NCT02224846|18810839|P1|Received at Least One Dose of Study Drug|Period 1 (Month 3)||210
7639377|NCT02224846|18810838|P2|STARTED|Period 1 (Month 3)||424
7639378|NCT02224846|18810839|P1|STARTED|Period 1 (Month 3)||211
7639379|NCT02224820|18810859|P1|NOT COMPLETED|Overall Study||0
7639380|NCT02224820|18810859|P1|COMPLETED|Overall Study|One patient did not receive full dose|8
7639381|NCT02224820|18810859|P1|STARTED|Overall Study||8
7639382|NCT02224755|18810869|P2|NOT COMPLETED|Two Year Follow up Post-implant||226
7639383|NCT02224755|18810870|P1|NOT COMPLETED|Two Year Follow up Post-implant||258
7639384|NCT02224755|18810869|P2|COMPLETED|Two Year Follow up Post-implant||289
7639385|NCT02224755|18810870|P1|COMPLETED|Two Year Follow up Post-implant||247
7639386|NCT02224755|18810869|P2|STARTED|Two Year Follow up Post-implant||515
7639387|NCT02224755|18810870|P1|STARTED|Two Year Follow up Post-implant||505
7639388|NCT02224755|18810869|P2|NOT COMPLETED|Randomization to Device Implant||1
7639389|NCT02224755|18810870|P1|NOT COMPLETED|Randomization to Device Implant||7
7639390|NCT02224755|18810869|P2|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate 3 LVAS implant|515
7639391|NCT02224755|18810870|P1|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate II LVAS implant|505
7639392|NCT02224755|18810869|P2|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate 3|516
7639393|NCT02224755|18810870|P1|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate II|512
7639394|NCT02224729|18810894|P1|NOT COMPLETED|Overall Study||0
7639395|NCT02224729|18810894|P1|COMPLETED|Overall Study||24
7639396|NCT02224729|18810894|P1|STARTED|Overall Study||24
7639397|NCT02224703|18810905|P3|NOT COMPLETED|Overall Study||0
7639398|NCT02224703|18810906|P2|NOT COMPLETED|Overall Study||6
7639399|NCT02224703|18810907|P1|NOT COMPLETED|Overall Study||3
7639400|NCT02224703|18810905|P3|COMPLETED|Overall Study||65
7639401|NCT02224703|18810906|P2|COMPLETED|Overall Study||61
7639402|NCT02224703|18810907|P1|COMPLETED|Overall Study||64
7639403|NCT02224703|18810905|P3|Intent to Treat (ITT) Analysis Set|Overall Study||65
7639404|NCT02224703|18810906|P2|Intent to Treat (ITT) Analysis Set|Overall Study||67
7639405|NCT02224703|18810907|P1|Intent to Treat (ITT) Analysis Set|Overall Study||66
7639406|NCT02224703|18810905|P3|Safety Analysis Set|Overall Study||65
7639407|NCT02224703|18810906|P2|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|69
7639408|NCT02224703|18810907|P1|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|64
7639409|NCT02224703|18810905|P3|Received at Least 1 Dose of Study Drug|Overall Study||65
7639410|NCT02224703|18810906|P2|Received at Least 1 Dose of Study Drug|Overall Study||67
7639411|NCT02224703|18810907|P1|Received at Least 1 Dose of Study Drug|Overall Study||66
7639412|NCT02224703|18810905|P3|STARTED|Overall Study||65
7639413|NCT02224703|18810906|P2|STARTED|Overall Study||67
7639414|NCT02224703|18810907|P1|STARTED|Overall Study||67
7639415|NCT02224690|18810926|P2|NOT COMPLETED|Overall Study||1
7639416|NCT02224690|18810927|P1|NOT COMPLETED|Overall Study||14
7639417|NCT02224690|18810926|P2|COMPLETED|Overall Study||84
7639418|NCT02224690|18810927|P1|COMPLETED|Overall Study||72
7639419|NCT02224690|18810926|P2|Intent to Treat (ITT) Analysis Set|Overall Study||85
7639420|NCT02224690|18810927|P1|Intent to Treat (ITT) Analysis Set|Overall Study||86
7639421|NCT02224690|18810926|P2|Safety Analysis Set|Overall Study||85
7639422|NCT02224690|18810927|P1|Safety Analysis Set|Overall Study||86
7639423|NCT02224690|18810926|P2|STARTED|Overall Study||85
7639424|NCT02224690|18810927|P1|STARTED|Overall Study||86
7639425|NCT02224664|18810939|P5|NOT COMPLETED|Dose Escalation Period (21 Days)||11
7639426|NCT02224664|18810940|P4|NOT COMPLETED|Dose Escalation Period (21 Days)||3
7639427|NCT02224664|18810941|P3|NOT COMPLETED|Dose Escalation Period (21 Days)||2
7639428|NCT02224664|18810942|P2|NOT COMPLETED|Dose Escalation Period (21 Days)||0
7639429|NCT02224664|18810943|P1|NOT COMPLETED|Dose Escalation Period (21 Days)||0
7639430|NCT02224664|18810939|P5|COMPLETED|Dose Escalation Period (21 Days)||8
7639431|NCT02224664|18810940|P4|COMPLETED|Dose Escalation Period (21 Days)||3
7639432|NCT02224664|18810941|P3|COMPLETED|Dose Escalation Period (21 Days)||9
7639433|NCT02224664|18810942|P2|COMPLETED|Dose Escalation Period (21 Days)||9
7639434|NCT02224664|18810943|P1|COMPLETED|Dose Escalation Period (21 Days)||0
7639435|NCT02224664|18810939|P5|STARTED|Dose Escalation Period (21 Days)||19
7639436|NCT02224664|18810940|P4|STARTED|Dose Escalation Period (21 Days)||6
7639437|NCT02224664|18810941|P3|STARTED|Dose Escalation Period (21 Days)||11
7639438|NCT02224664|18810942|P2|STARTED|Dose Escalation Period (21 Days)||9
7639439|NCT02224664|18810943|P1|STARTED|Dose Escalation Period (21 Days)||0
7639440|NCT02224664|18810939|P5|NOT COMPLETED|Lead-in Period (3 Days)||0
7639441|NCT02224664|18810940|P4|NOT COMPLETED|Lead-in Period (3 Days)||0
7639442|NCT02224664|18810941|P3|NOT COMPLETED|Lead-in Period (3 Days)||0
7639443|NCT02224664|18810942|P2|NOT COMPLETED|Lead-in Period (3 Days)||0
7639444|NCT02224664|18810943|P1|NOT COMPLETED|Lead-in Period (3 Days)||5
7639445|NCT02224664|18810939|P5|COMPLETED|Lead-in Period (3 Days)||0
7639446|NCT02224664|18810940|P4|COMPLETED|Lead-in Period (3 Days)||0
7639447|NCT02224664|18810941|P3|COMPLETED|Lead-in Period (3 Days)||0
7639448|NCT02224664|18810942|P2|COMPLETED|Lead-in Period (3 Days)||0
7639449|NCT02224664|18810943|P1|COMPLETED|Lead-in Period (3 Days)||45
7639450|NCT02224664|18810939|P5|STARTED|Lead-in Period (3 Days)||0
7639451|NCT02224664|18810940|P4|STARTED|Lead-in Period (3 Days)||0
7639452|NCT02224664|18810941|P3|STARTED|Lead-in Period (3 Days)||0
7639453|NCT02224664|18810942|P2|STARTED|Lead-in Period (3 Days)||0
7639454|NCT02224664|18810943|P1|STARTED|Lead-in Period (3 Days)||50
7639455|NCT02224638|18811025|P2|NOT COMPLETED|Overall Study||1
7639456|NCT02224638|18811026|P1|NOT COMPLETED|Overall Study||1
7639457|NCT02224638|18811025|P2|COMPLETED|Overall Study||9
7639458|NCT02224638|18811026|P1|COMPLETED|Overall Study||10
7639459|NCT02224638|18811025|P2|STARTED|Overall Study||10
7639460|NCT02224638|18811026|P1|STARTED|Overall Study||11
7639461|NCT02224625|18811034|P1|NOT COMPLETED|Sensitization||55
7639462|NCT02224625|18811034|P1|COMPLETED|Sensitization||194
7639463|NCT02224625|18811034|P1|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249
7639464|NCT02224625|18811034|P1|NOT COMPLETED|Irritation||6
7639465|NCT02224625|18811034|P1|COMPLETED|Irritation||33
7639466|NCT02224625|18811034|P1|STARTED|Irritation||39
7639467|NCT02224612|18811046|P2|NOT COMPLETED|Overall Study||0
7639468|NCT02224612|18811047|P1|NOT COMPLETED|Overall Study||0
7639469|NCT02224612|18811046|P2|COMPLETED|Overall Study||48
7639470|NCT02224612|18811047|P1|COMPLETED|Overall Study||48
7639471|NCT02224612|18811046|P2|STARTED|Overall Study||48
7639472|NCT02224612|18811047|P1|STARTED|Overall Study||48
7639473|NCT02224599|18811055|P1|NOT COMPLETED|Overall Study||2
7639474|NCT02224599|18811055|P1|COMPLETED|Overall Study||1
7639475|NCT02224599|18811055|P1|STARTED|Overall Study||3
7639476|NCT02224560|18811064|P3|NOT COMPLETED|Overall Study||2
7639477|NCT02224560|18811065|P2|NOT COMPLETED|Overall Study||2
7639478|NCT02224560|18811066|P1|NOT COMPLETED|Overall Study||9
7639479|NCT02224560|18811064|P3|COMPLETED|Overall Study||74
7639480|NCT02224560|18811065|P2|COMPLETED|Overall Study||71
7639481|NCT02224560|18811066|P1|COMPLETED|Overall Study||67
7639482|NCT02224560|18811064|P3|Intent to Treat (ITT) Analysis Set|Overall Study||76
7639483|NCT02224560|18811065|P2|Intent to Treat (ITT) Analysis Set|Overall Study||73
7639484|NCT02224560|18811066|P1|Intent to Treat (ITT) Analysis Set|Overall Study||76
7639485|NCT02224560|18811064|P3|Safety Analysis Set|Overall Study||76
7639486|NCT02224560|18811065|P2|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|67
7639487|NCT02224560|18811066|P1|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|82
7639488|NCT02224560|18811064|P3|STARTED|Overall Study||76
7639489|NCT02224560|18811065|P2|STARTED|Overall Study||73
7639490|NCT02224560|18811066|P1|STARTED|Overall Study||76
7639491|NCT02224508|18811085|P2|NOT COMPLETED|Overall Study||0
7639492|NCT02224508|18811086|P1|NOT COMPLETED|Overall Study||0
7639493|NCT02224508|18811085|P2|COMPLETED|Overall Study||653
7639494|NCT02224508|18811086|P1|COMPLETED|Overall Study||935
7639495|NCT02224508|18811085|P2|STARTED|Overall Study|Number of patients surveyed in the control segment of the health plan (contracted care).|653
7639496|NCT02224508|18811086|P1|STARTED|Overall Study|Number of patients surveyed in intervention segment of the health plan (group practice).|935
7639497|NCT02224404|18811096|P1|NOT COMPLETED|Overall Study||0
7639498|NCT02224404|18811096|P1|COMPLETED|Overall Study||21
7639499|NCT02224404|18811096|P1|STARTED|Overall Study||21
7639500|NCT02224313|18811103|P2|NOT COMPLETED|Overall Study||1
7639501|NCT02224313|18811104|P1|NOT COMPLETED|Overall Study||3
7639502|NCT02224313|18811103|P2|COMPLETED|Overall Study||9
7639503|NCT02224313|18811104|P1|COMPLETED|Overall Study||7
7639504|NCT02224313|18811103|P2|STARTED|Overall Study||10
7639505|NCT02224313|18811104|P1|STARTED|Overall Study||10
7639506|NCT02224274|18811114|P2|NOT COMPLETED|Overall Study||0
7639507|NCT02224274|18811115|P1|NOT COMPLETED|Overall Study||1
7639508|NCT02224274|18811114|P2|COMPLETED|Overall Study||20
7639509|NCT02224274|18811115|P1|COMPLETED|Overall Study||16
7639510|NCT02224274|18811114|P2|STARTED|Overall Study||20
7639511|NCT02224274|18811115|P1|STARTED|Overall Study||17
7639512|NCT02224157|18811127|P2|NOT COMPLETED|Overall Study||111
7639513|NCT02224157|18811128|P1|NOT COMPLETED|Overall Study||110
7639514|NCT02224157|18811127|P2|COMPLETED|Overall Study||1983
7639515|NCT02224157|18811128|P1|COMPLETED|Overall Study||1985
7639516|NCT02224157|18811127|P2|Patients Who Completed Treatment|Overall Study||1903
7639517|NCT02224157|18811128|P1|Patients Who Completed Treatment|Overall Study||1924
7639518|NCT02224157|18811127|P2|STARTED|Overall Study||2094
7639519|NCT02224157|18811128|P1|STARTED|Overall Study||2095
7639520|NCT02224053|18811152|P1|NOT COMPLETED|AZD9291 Alone||0
7639521|NCT02224053|18811152|P1|COMPLETED|AZD9291 Alone||47
7639522|NCT02224053|18811152|P1|STARTED|AZD9291 Alone||47
7639523|NCT02224053|18811152|P1|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21
7639524|NCT02224053|18811152|P1|COMPLETED|AZD9291 and Omeprazole Co-administration||47
7639525|NCT02224053|18811152|P1|STARTED|AZD9291 and Omeprazole Co-administration||68
7639526|NCT02223871|18811184|P1|NOT COMPLETED|Overall Study||0
7639527|NCT02223871|18811184|P1|COMPLETED|Overall Study||8
7639528|NCT02223871|18811184|P1|STARTED|Overall Study||8
7639529|NCT02223858|18811198|P2|NOT COMPLETED|Overall Study||26
7639530|NCT02223858|18811199|P1|NOT COMPLETED|Overall Study||24
7639531|NCT02223858|18811198|P2|COMPLETED|Overall Study||154
7639532|NCT02223858|18811199|P1|COMPLETED|Overall Study||156
7639533|NCT02223858|18811198|P2|6-month Follow-up|Overall Study||154
7639534|NCT02223858|18811199|P1|6-month Follow-up|Overall Study||156
7639535|NCT02223858|18811198|P2|3-month Follow-up|Overall Study||154
7639536|NCT02223858|18811199|P1|3-month Follow-up|Overall Study||155
7639537|NCT02223858|18811198|P2|1-month Follow-up|Overall Study||150
7639538|NCT02223858|18811199|P1|1-month Follow-up|Overall Study||156
7639539|NCT02223858|18811198|P2|STARTED|Overall Study||180
7639540|NCT02223858|18811199|P1|STARTED|Overall Study||180
7639541|NCT02223793|18811212|P3|NOT COMPLETED|Overall Study||13
7639542|NCT02223793|18811213|P2|NOT COMPLETED|Overall Study||9
7639543|NCT02223793|18811214|P1|NOT COMPLETED|Overall Study||17
7639544|NCT02223793|18811212|P3|COMPLETED|Overall Study||185
7639545|NCT02223793|18811213|P2|COMPLETED|Overall Study||190
7639546|NCT02223793|18811214|P1|COMPLETED|Overall Study||168
7639547|NCT02223793|18811212|P3|STARTED|Overall Study||198
7639548|NCT02223793|18811213|P2|STARTED|Overall Study||199
7639549|NCT02223793|18811214|P1|STARTED|Overall Study||185
7639550|NCT02223754|18811227|P2|NOT COMPLETED|Period 2||3
7639551|NCT02223754|18811228|P1|NOT COMPLETED|Period 2||3
7639552|NCT02223754|18811227|P2|COMPLETED|Period 2||141
7639553|NCT02223754|18811228|P1|COMPLETED|Period 2||156
7639554|NCT02223754|18811227|P2|STARTED|Period 2||144
7639555|NCT02223754|18811228|P1|STARTED|Period 2||159
7639556|NCT02223754|18811227|P2|NOT COMPLETED|Period 1||15
7639557|NCT02223754|18811228|P1|NOT COMPLETED|Period 1||4
7639558|NCT02223754|18811227|P2|COMPLETED|Period 1||144
7639559|NCT02223754|18811228|P1|COMPLETED|Period 1||159
7639560|NCT02223754|18811227|P2|STARTED|Period 1||159
7639561|NCT02223754|18811228|P1|STARTED|Period 1||163
7639562|NCT02223715|18811248|P1|NOT COMPLETED|Overall Study||104
7639563|NCT02223715|18811248|P1|COMPLETED|Overall Study||496
7639564|NCT02223715|18811248|P1|STARTED|Overall Study||600
7639565|NCT02223702|18811257|P2|NOT COMPLETED|Overall Study||4
7639566|NCT02223702|18811258|P1|NOT COMPLETED|Overall Study||1
7639567|NCT02223702|18811257|P2|COMPLETED|Overall Study||15
7639568|NCT02223702|18811258|P1|COMPLETED|Overall Study||19
7639569|NCT02223702|18811257|P2|STARTED|Overall Study||19
7639570|NCT02223702|18811258|P1|STARTED|Overall Study||20
7639571|NCT02223689|18811266|P1|NOT COMPLETED|Overall Study||0
7639572|NCT02223689|18811266|P1|COMPLETED|Overall Study||35
7639573|NCT02223689|18811266|P1|STARTED|Overall Study||35
7639574|NCT02223650|18811273|P2|NOT COMPLETED|Overall Study||0
7639575|NCT02223650|18811274|P1|NOT COMPLETED|Overall Study||0
7639576|NCT02223650|18811273|P2|COMPLETED|Overall Study||31
7639577|NCT02223650|18811274|P1|COMPLETED|Overall Study||27
7639578|NCT02223650|18811273|P2|STARTED|Overall Study||31
7639579|NCT02223650|18811274|P1|STARTED|Overall Study||27
7639580|NCT02223637|18811304|P1|NOT COMPLETED|Overall Study||0
7639581|NCT02223637|18811304|P1|COMPLETED|Overall Study||82
7639582|NCT02223637|18811304|P1|STARTED|Overall Study||82
7639583|NCT02223546|18811327|P1|NOT COMPLETED|Overall Study||0
7639584|NCT02223546|18811327|P1|COMPLETED|Overall Study||15
7639585|NCT02223546|18811327|P1|STARTED|Overall Study||15
7639586|NCT02223520|18811334|P2|NOT COMPLETED|Overall Study||0
7639587|NCT02223520|18811335|P1|NOT COMPLETED|Overall Study||0
7639588|NCT02223520|18811334|P2|COMPLETED|Overall Study|107 neonates of these parents were enrolled. 6 were lost to follow-up.|160
7639589|NCT02223520|18811335|P1|COMPLETED|Overall Study|101 neonates of these parents were enrolled. 12 were lost to follow-up.|147
7639590|NCT02223520|18811334|P2|STARTED|Overall Study||160
7639591|NCT02223520|18811335|P1|STARTED|Overall Study||147
7639592|NCT02223455|18811344|P3|NOT COMPLETED|Overall Study||0
7639593|NCT02223455|18811345|P2|NOT COMPLETED|Overall Study||0
7639594|NCT02223455|18811346|P1|NOT COMPLETED|Overall Study||0
7639595|NCT02223455|18811344|P3|COMPLETED|Overall Study|Participant level data not collected.|0
7639596|NCT02223455|18811345|P2|COMPLETED|Overall Study|Participant level data not collected.|0
7639597|NCT02223455|18811346|P1|COMPLETED|Overall Study|Participant level data not collected.|0
7639598|NCT02223455|18811344|P3|STARTED|Overall Study|Participant level data not collected.|0
7639599|NCT02223455|18811345|P2|STARTED|Overall Study|Participant level data not collected.|0
7639600|NCT02223455|18811346|P1|STARTED|Overall Study|Participant level data not collected.|0
7639601|NCT02223429|18811358|P4|NOT COMPLETED|Overall Study||0
7639602|NCT02223429|18811359|P3|NOT COMPLETED|Overall Study||0
7639603|NCT02223429|18811360|P2|NOT COMPLETED|Overall Study||0
7639604|NCT02223429|18811361|P1|NOT COMPLETED|Overall Study||1
7639605|NCT02223429|18811358|P4|COMPLETED|Overall Study||8
7639606|NCT02223429|18811359|P3|COMPLETED|Overall Study||8
7639607|NCT02223429|18811360|P2|COMPLETED|Overall Study||8
7639608|NCT02223429|18811361|P1|COMPLETED|Overall Study||7
7639609|NCT02223429|18811358|P4|STARTED|Overall Study||8
7639610|NCT02223429|18811359|P3|STARTED|Overall Study||8
7639611|NCT02223429|18811360|P2|STARTED|Overall Study||8
7639612|NCT02223429|18811361|P1|STARTED|Overall Study||8
7639613|NCT02223390|18811391|P2|NOT COMPLETED|Overall Study||4
7639614|NCT02223390|18811392|P1|NOT COMPLETED|Overall Study||9
7639615|NCT02223390|18811391|P2|COMPLETED|Overall Study||28
7639616|NCT02223390|18811392|P1|COMPLETED|Overall Study||23
7639617|NCT02223390|18811391|P2|STARTED|Overall Study||32
7639618|NCT02223390|18811392|P1|STARTED|Overall Study||32
7639619|NCT02223364|18811403|P3|NOT COMPLETED|Overall Study||3
7639620|NCT02223364|18811404|P2|NOT COMPLETED|Overall Study||0
7639621|NCT02223364|18811405|P1|NOT COMPLETED|Overall Study||5
7639622|NCT02223364|18811403|P3|COMPLETED|Overall Study||52
7639623|NCT02223364|18811404|P2|COMPLETED|Overall Study||55
7639624|NCT02223364|18811405|P1|COMPLETED|Overall Study||50
7639625|NCT02223364|18811403|P3|STARTED|Overall Study||55
7639626|NCT02223364|18811404|P2|STARTED|Overall Study||55
7639627|NCT02223364|18811405|P1|STARTED|Overall Study||55
7639628|NCT02223351|18811457|P2|NOT COMPLETED|Overall Study||0
7639629|NCT02223351|18811458|P1|NOT COMPLETED|Overall Study||0
7639630|NCT02223351|18811457|P2|COMPLETED|Overall Study||24
7639631|NCT02223351|18811458|P1|COMPLETED|Overall Study||24
7639632|NCT02223351|18811457|P2|Second Intervention (8 Days)|Overall Study||24
7639633|NCT02223351|18811458|P1|Second Intervention (8 Days)|Overall Study||24
7639634|NCT02223351|18811457|P2|Wasout (2weeks)|Overall Study||24
7639635|NCT02223351|18811458|P1|Wasout (2weeks)|Overall Study||24
7639636|NCT02223351|18811457|P2|First Intervention (8 Days)|Overall Study||24
7639637|NCT02223351|18811458|P1|First Intervention (8 Days)|Overall Study||24
7639638|NCT02223351|18811457|P2|STARTED|Overall Study||24
7639639|NCT02223351|18811458|P1|STARTED|Overall Study||24
7639640|NCT02223338|18811518|P2|NOT COMPLETED|Overall Study||0
7639641|NCT02223338|18811519|P1|NOT COMPLETED|Overall Study||0
7639642|NCT02223338|18811518|P2|COMPLETED|Overall Study||60
7639643|NCT02223338|18811519|P1|COMPLETED|Overall Study||60
7639644|NCT02223338|18811518|P2|STARTED|Overall Study||60
7639645|NCT02223338|18811519|P1|STARTED|Overall Study||60
7639646|NCT02223260|18811527|P1|NOT COMPLETED|Overall Study||0
7639647|NCT02223260|18811527|P1|COMPLETED|Overall Study||8
7639648|NCT02223260|18811527|P1|STARTED|Overall Study||8
7639649|NCT02223065|18811545|P2|NOT COMPLETED|Overall Study||0
7639650|NCT02223065|18811546|P1|NOT COMPLETED|Overall Study||0
7639651|NCT02223065|18811545|P2|COMPLETED|Overall Study||18
7639652|NCT02223065|18811546|P1|COMPLETED|Overall Study||18
7639653|NCT02223065|18811545|P2|STARTED|Overall Study||18
7639654|NCT02223065|18811546|P1|STARTED|Overall Study||18
7639655|NCT02222922|18811571|P9|NOT COMPLETED|Overall Study||6
7639656|NCT02222922|18811572|P8|NOT COMPLETED|Overall Study||4
7639657|NCT02222922|18811573|P7|NOT COMPLETED|Overall Study||2
7639658|NCT02222922|18811574|P6|NOT COMPLETED|Overall Study||3
7639659|NCT02222922|18811575|P5|NOT COMPLETED|Overall Study||38
7639660|NCT02222922|18811576|P4|NOT COMPLETED|Overall Study||3
7639661|NCT02222922|18811577|P3|NOT COMPLETED|Overall Study||1
7639662|NCT02222922|18811578|P2|NOT COMPLETED|Overall Study||0
7639663|NCT02222922|18811579|P1|NOT COMPLETED|Overall Study||1
7639664|NCT02222922|18811571|P9|COMPLETED|Overall Study||6
7639665|NCT02222922|18811572|P8|COMPLETED|Overall Study||6
7639666|NCT02222922|18811573|P7|COMPLETED|Overall Study||1
7639667|NCT02222922|18811574|P6|COMPLETED|Overall Study||3
7639668|NCT02222922|18811575|P5|COMPLETED|Overall Study||58
7639669|NCT02222922|18811576|P4|COMPLETED|Overall Study||2
7639670|NCT02222922|18811577|P3|COMPLETED|Overall Study||1
7639671|NCT02222922|18811578|P2|COMPLETED|Overall Study||2
7639672|NCT02222922|18811579|P1|COMPLETED|Overall Study||1
7639673|NCT02222922|18811571|P9|Received Treatment|Overall Study||12
7639674|NCT02222922|18811572|P8|Received Treatment|Overall Study||10
7639675|NCT02222922|18811573|P7|Received Treatment|Overall Study||3
7639676|NCT02222922|18811574|P6|Received Treatment|Overall Study||6
7639677|NCT02222922|18811575|P5|Received Treatment|Overall Study||96
7639678|NCT02222922|18811576|P4|Received Treatment|Overall Study||4
7639679|NCT02222922|18811577|P3|Received Treatment|Overall Study||2
7639680|NCT02222922|18811578|P2|Received Treatment|Overall Study||2
7639681|NCT02222922|18811579|P1|Received Treatment|Overall Study||2
7639682|NCT02222922|18811571|P9|STARTED|Overall Study||12
7639683|NCT02222922|18811572|P8|STARTED|Overall Study||10
7639684|NCT02222922|18811573|P7|STARTED|Overall Study||3
7639685|NCT02222922|18811574|P6|STARTED|Overall Study||6
7639686|NCT02222922|18811575|P5|STARTED|Overall Study||96
7639687|NCT02222922|18811576|P4|STARTED|Overall Study||5
7639688|NCT02222922|18811577|P3|STARTED|Overall Study||2
7639689|NCT02222922|18811578|P2|STARTED|Overall Study||2
7639690|NCT02222922|18811579|P1|STARTED|Overall Study||2
7639691|NCT02222870|18811929|P2|NOT COMPLETED|Overall Study||0
7639692|NCT02222870|18811930|P1|NOT COMPLETED|Overall Study||0
7639693|NCT02222870|18811929|P2|COMPLETED|Overall Study||30
7639694|NCT02222870|18811930|P1|COMPLETED|Overall Study||30
7639695|NCT02222870|18811929|P2|STARTED|Overall Study||30
7639696|NCT02222870|18811930|P1|STARTED|Overall Study||30
7639697|NCT02222818|18811946|P2|NOT COMPLETED|Period 2||0
7639698|NCT02222818|18811947|P1|NOT COMPLETED|Period 2||0
7639699|NCT02222818|18811946|P2|COMPLETED|Period 2|End of CAFR evaluation period|30
7639700|NCT02222818|18811947|P1|COMPLETED|Period 2|End of CAFRPlus evaluation period|33
7639701|NCT02222818|18811946|P2|STARTED|Period 2|Start of CAFR evaluation period|30
7639702|NCT02222818|18811947|P1|STARTED|Period 2|Start of CAFRPlus evaluation period|33
7639703|NCT02222818|18811946|P2|NOT COMPLETED|Period 1||3
7639704|NCT02222818|18811947|P1|NOT COMPLETED|Period 1||0
7639705|NCT02222818|18811946|P2|COMPLETED|Period 1|End of CAFRPlus evaluation period|30
7639706|NCT02222818|18811947|P1|COMPLETED|Period 1|End of CAFR evaluation period|33
7639707|NCT02222818|18811946|P2|STARTED|Period 1|Start of CAFRPlus evaluation period|33
7639708|NCT02222818|18811947|P1|STARTED|Period 1|Start of CAFR evaluation period|33
7639709|NCT02222714|18811959|P5|NOT COMPLETED|Overall Study||7
7639710|NCT02222714|18811960|P4|NOT COMPLETED|Overall Study||4
7639711|NCT02222714|18811961|P3|NOT COMPLETED|Overall Study||4
7639712|NCT02222714|18811962|P2|NOT COMPLETED|Overall Study||2
7639713|NCT02222714|18811963|P1|NOT COMPLETED|Overall Study||0
7639714|NCT02222714|18811959|P5|COMPLETED|Overall Study||37
7639715|NCT02222714|18811960|P4|COMPLETED|Overall Study||11
7639716|NCT02222714|18811961|P3|COMPLETED|Overall Study||8
7639717|NCT02222714|18811962|P2|COMPLETED|Overall Study||22
7639718|NCT02222714|18811963|P1|COMPLETED|Overall Study||15
7639719|NCT02222714|18811959|P5|STARTED|Overall Study||44
7639720|NCT02222714|18811960|P4|STARTED|Overall Study||15
7639721|NCT02222714|18811961|P3|STARTED|Overall Study||12
7639722|NCT02222714|18811962|P2|STARTED|Overall Study||24
7639723|NCT02222714|18811963|P1|STARTED|Overall Study||15
7639724|NCT02222688|18812009|P7|NOT COMPLETED|Overall Study||1
7639725|NCT02222688|18812010|P6|NOT COMPLETED|Overall Study||0
7639726|NCT02222688|18812011|P5|NOT COMPLETED|Overall Study||1
7639727|NCT02222688|18812012|P4|NOT COMPLETED|Overall Study||2
7639728|NCT02222688|18812013|P3|NOT COMPLETED|Overall Study||0
7639729|NCT02222688|18812014|P2|NOT COMPLETED|Overall Study||0
7639730|NCT02222688|18812015|P1|NOT COMPLETED|Overall Study||1
7639731|NCT02222688|18812009|P7|COMPLETED|Overall Study||5
7639732|NCT02222688|18812010|P6|COMPLETED|Overall Study||3
7639733|NCT02222688|18812011|P5|COMPLETED|Overall Study||2
7639734|NCT02222688|18812012|P4|COMPLETED|Overall Study||3
7639735|NCT02222688|18812013|P3|COMPLETED|Overall Study||3
7639736|NCT02222688|18812014|P2|COMPLETED|Overall Study||3
7639737|NCT02222688|18812015|P1|COMPLETED|Overall Study||3
7639738|NCT02222688|18812009|P7|STARTED|Overall Study||6
7639739|NCT02222688|18812010|P6|STARTED|Overall Study||3
7639740|NCT02222688|18812011|P5|STARTED|Overall Study||3
7639741|NCT02222688|18812012|P4|STARTED|Overall Study||5
7639742|NCT02222688|18812013|P3|STARTED|Overall Study||3
7639743|NCT02222688|18812014|P2|STARTED|Overall Study||3
7639744|NCT02222688|18812015|P1|STARTED|Overall Study||4
7639745|NCT02222558|18812053|P6|NOT COMPLETED|Period 3||1
7639746|NCT02222558|18812054|P5|NOT COMPLETED|Period 3||0
7639747|NCT02222558|18812055|P4|NOT COMPLETED|Period 3||0
7639748|NCT02222558|18812056|P3|NOT COMPLETED|Period 3||0
7639749|NCT02222558|18812057|P2|NOT COMPLETED|Period 3||0
7639750|NCT02222558|18812058|P1|NOT COMPLETED|Period 3||0
7639751|NCT02222558|18812053|P6|COMPLETED|Period 3||7
7639752|NCT02222558|18812054|P5|COMPLETED|Period 3||8
7639753|NCT02222558|18812055|P4|COMPLETED|Period 3||1
7639754|NCT02222558|18812056|P3|COMPLETED|Period 3||4
7639755|NCT02222558|18812057|P2|COMPLETED|Period 3||0
7639756|NCT02222558|18812058|P1|COMPLETED|Period 3||0
7639757|NCT02222558|18812053|P6|STARTED|Period 3||8
7639758|NCT02222558|18812054|P5|STARTED|Period 3||8
7639759|NCT02222558|18812055|P4|STARTED|Period 3||1
7639760|NCT02222558|18812056|P3|STARTED|Period 3||4
7639761|NCT02222558|18812057|P2|STARTED|Period 3||0
7639762|NCT02222558|18812058|P1|STARTED|Period 3||0
7639845|NCT02221947|18812284|P1|NOT COMPLETED|Overall Study||0
7639763|NCT02222558|18812053|P6|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7639764|NCT02222558|18812054|P5|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7639765|NCT02222558|18812055|P4|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7639766|NCT02222558|18812056|P3|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7639767|NCT02222558|18812057|P2|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7639768|NCT02222558|18812058|P1|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7639769|NCT02222558|18812053|P6|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7639770|NCT02222558|18812054|P5|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7639771|NCT02222558|18812055|P4|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7639772|NCT02222558|18812056|P3|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7639773|NCT02222558|18812057|P2|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21
7639774|NCT02222558|18812058|P1|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7639775|NCT02222558|18812053|P6|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
7639776|NCT02222558|18812054|P5|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
7639777|NCT02222558|18812055|P4|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
7639778|NCT02222558|18812056|P3|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
7639779|NCT02222558|18812057|P2|STARTED|Period 2: Two Times Daily Dosing 90 mg||21
7639780|NCT02222558|18812058|P1|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
7639781|NCT02222558|18812053|P6|NOT COMPLETED|Period 1: Single Dose||0
7639782|NCT02222558|18812054|P5|NOT COMPLETED|Period 1: Single Dose||0
7639783|NCT02222558|18812055|P4|NOT COMPLETED|Period 1: Single Dose||0
7639784|NCT02222558|18812056|P3|NOT COMPLETED|Period 1: Single Dose||0
7639785|NCT02222558|18812057|P2|NOT COMPLETED|Period 1: Single Dose||0
7639786|NCT02222558|18812058|P1|NOT COMPLETED|Period 1: Single Dose||4
7639787|NCT02222558|18812053|P6|COMPLETED|Period 1: Single Dose||0
7639788|NCT02222558|18812054|P5|COMPLETED|Period 1: Single Dose||0
7639789|NCT02222558|18812055|P4|COMPLETED|Period 1: Single Dose||0
7639790|NCT02222558|18812056|P3|COMPLETED|Period 1: Single Dose||0
7639791|NCT02222558|18812057|P2|COMPLETED|Period 1: Single Dose||0
7639792|NCT02222558|18812058|P1|COMPLETED|Period 1: Single Dose||21
7639793|NCT02222558|18812053|P6|STARTED|Period 1: Single Dose||0
7639794|NCT02222558|18812054|P5|STARTED|Period 1: Single Dose||0
7639795|NCT02222558|18812055|P4|STARTED|Period 1: Single Dose||0
7639796|NCT02222558|18812056|P3|STARTED|Period 1: Single Dose||0
7639797|NCT02222558|18812057|P2|STARTED|Period 1: Single Dose||0
7639798|NCT02222558|18812058|P1|STARTED|Period 1: Single Dose||25
7639799|NCT02222493|18812074|P2|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
7639800|NCT02222493|18812075|P1|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||31
7639801|NCT02222493|18812074|P2|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
7639802|NCT02222493|18812075|P1|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||474
7639803|NCT02222493|18812074|P2|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||0
7639804|NCT02222493|18812075|P1|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||505
7639805|NCT02222493|18812074|P2|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||17
7639806|NCT02222493|18812075|P1|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||43
7639807|NCT02222493|18812074|P2|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||126
7639808|NCT02222493|18812075|P1|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||380
7639809|NCT02222493|18812074|P2|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||143
7639810|NCT02222493|18812075|P1|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||423
7639811|NCT02222493|18812074|P2|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||40
7639812|NCT02222493|18812075|P1|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||44
7639813|NCT02222493|18812074|P2|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||286
7639814|NCT02222493|18812075|P1|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||280
7639815|NCT02222493|18812074|P2|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||326
7639816|NCT02222493|18812075|P1|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||323
7639817|NCT02222493|18812074|P2|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||326
7639818|NCT02222493|18812075|P1|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||324
7639819|NCT02222337|18812193|P2|NOT COMPLETED|Overall Study||24
7639820|NCT02222337|18812194|P1|NOT COMPLETED|Overall Study||26
7639821|NCT02222337|18812193|P2|COMPLETED|Overall Study||108
7639822|NCT02222337|18812194|P1|COMPLETED|Overall Study||114
7639823|NCT02222337|18812193|P2|STARTED|Overall Study|132 participants were enrolled but 2 withdrew and never provided any data.|132
7639824|NCT02222337|18812194|P1|STARTED|Overall Study||140
7639825|NCT02222246|18812226|P2|NOT COMPLETED|Overall Study||27
7639826|NCT02222246|18812227|P1|NOT COMPLETED|Overall Study||27
7639827|NCT02222246|18812226|P2|COMPLETED|Overall Study||26
7639828|NCT02222246|18812227|P1|COMPLETED|Overall Study||26
7639829|NCT02222246|18812226|P2|STARTED|Overall Study||53
7639830|NCT02222246|18812227|P1|STARTED|Overall Study||53
7639831|NCT02222207|18812255|P1|NOT COMPLETED|Overall Study||4
7639832|NCT02222207|18812255|P1|COMPLETED|Overall Study||48
7639833|NCT02222207|18812255|P1|Treated and Valid for Full Analysis Set|Overall Study||51
7639834|NCT02222207|18812255|P1|STARTED|Overall Study||52
7639835|NCT02222181|18812262|P1|NOT COMPLETED|Overall Study||108
7639836|NCT02222181|18812262|P1|COMPLETED|Overall Study||55
7639837|NCT02222181|18812262|P1|STARTED|Overall Study||163
7639838|NCT02222129|18812274|P2|NOT COMPLETED|Overall Study||0
7639839|NCT02222129|18812275|P1|NOT COMPLETED|Overall Study||0
7639840|NCT02222129|18812274|P2|COMPLETED|Overall Study||106
7639841|NCT02222129|18812275|P1|COMPLETED|Overall Study||100
7639842|NCT02222129|18812274|P2|STARTED|Overall Study||106
7639843|NCT02222129|18812275|P1|STARTED|Overall Study||100
7639844|NCT02221947|18812283|P2|NOT COMPLETED|Overall Study||0
7639846|NCT02221947|18812283|P2|COMPLETED|Overall Study||3
7639847|NCT02221947|18812284|P1|COMPLETED|Overall Study||6
7639848|NCT02221947|18812283|P2|STARTED|Overall Study||3
7639849|NCT02221947|18812284|P1|STARTED|Overall Study||6
7639850|NCT02221882|18812302|P6|NOT COMPLETED|Overall Study||2
7639851|NCT02221882|18812303|P5|NOT COMPLETED|Overall Study||2
7639852|NCT02221882|18812304|P4|NOT COMPLETED|Overall Study||2
7639853|NCT02221882|18812305|P3|NOT COMPLETED|Overall Study||4
7639854|NCT02221882|18812306|P2|NOT COMPLETED|Overall Study||1
7639855|NCT02221882|18812307|P1|NOT COMPLETED|Overall Study||0
7639856|NCT02221882|18812302|P6|COMPLETED|Overall Study||2
7639857|NCT02221882|18812303|P5|COMPLETED|Overall Study||3
7639858|NCT02221882|18812304|P4|COMPLETED|Overall Study||1
7639859|NCT02221882|18812305|P3|COMPLETED|Overall Study||7
7639860|NCT02221882|18812306|P2|COMPLETED|Overall Study||2
7639861|NCT02221882|18812307|P1|COMPLETED|Overall Study||3
7639862|NCT02221882|18812302|P6|Received at Least One Dose of Study Drug|Overall Study||4
7639863|NCT02221882|18812303|P5|Received at Least One Dose of Study Drug|Overall Study||5
7639864|NCT02221882|18812304|P4|Received at Least One Dose of Study Drug|Overall Study||3
7639865|NCT02221882|18812305|P3|Received at Least One Dose of Study Drug|Overall Study||11
7639866|NCT02221882|18812306|P2|Received at Least One Dose of Study Drug|Overall Study||3
7639867|NCT02221882|18812307|P1|Received at Least One Dose of Study Drug|Overall Study||3
7639868|NCT02221882|18812302|P6|STARTED|Overall Study||4
7639869|NCT02221882|18812303|P5|STARTED|Overall Study||5
7639870|NCT02221882|18812304|P4|STARTED|Overall Study||3
7639871|NCT02221882|18812305|P3|STARTED|Overall Study||11
7639872|NCT02221882|18812306|P2|STARTED|Overall Study||3
7639873|NCT02221882|18812307|P1|STARTED|Overall Study||3
7639874|NCT02221869|18812350|P3|NOT COMPLETED|Overall Study||10
7639875|NCT02221869|18812351|P2|NOT COMPLETED|Overall Study||0
7639876|NCT02221869|18812352|P1|NOT COMPLETED|Overall Study||1
7639877|NCT02221869|18812350|P3|COMPLETED|Overall Study||33
7639878|NCT02221869|18812351|P2|COMPLETED|Overall Study||32
7639879|NCT02221869|18812352|P1|COMPLETED|Overall Study||30
7639880|NCT02221869|18812350|P3|STARTED|Overall Study||43
7639881|NCT02221869|18812351|P2|STARTED|Overall Study||32
7639882|NCT02221869|18812352|P1|STARTED|Overall Study||31
7639883|NCT02221739|18812366|P1|NOT COMPLETED|Overall Study||18
7639884|NCT02221739|18812366|P1|COMPLETED|Overall Study||21
7639885|NCT02221739|18812366|P1|STARTED|Overall Study||39
7639886|NCT02221674|18812374|P3|NOT COMPLETED|Overall Study||0
7639887|NCT02221674|18812375|P2|NOT COMPLETED|Overall Study||0
7639888|NCT02221674|18812376|P1|NOT COMPLETED|Overall Study||1
7639889|NCT02221674|18812374|P3|COMPLETED|Overall Study||5
7639890|NCT02221674|18812375|P2|COMPLETED|Overall Study||6
7639891|NCT02221674|18812376|P1|COMPLETED|Overall Study||7
7639892|NCT02221674|18812374|P3|STARTED|Overall Study||5
7639893|NCT02221674|18812375|P2|STARTED|Overall Study||6
7639894|NCT02221674|18812376|P1|STARTED|Overall Study||8
7639895|NCT02221648|18812392|P2|NOT COMPLETED|Overall Study||3
7639896|NCT02221648|18812393|P1|NOT COMPLETED|Overall Study||3
7639897|NCT02221648|18812392|P2|COMPLETED|Overall Study||18
7639898|NCT02221648|18812393|P1|COMPLETED|Overall Study||19
7639899|NCT02221648|18812392|P2|STARTED|Overall Study||21
7639900|NCT02221648|18812393|P1|STARTED|Overall Study||22
7639901|NCT02221557|18812403|P1|NOT COMPLETED|Overall Study||3
7639902|NCT02221557|18812403|P1|COMPLETED|Overall Study||5
7639903|NCT02221557|18812403|P1|STARTED|Overall Study||8
7639904|NCT02221349|18812409|P2|NOT COMPLETED|Overall Study||0
7639905|NCT02221349|18812410|P1|NOT COMPLETED|Overall Study||1
7639906|NCT02221349|18812409|P2|COMPLETED|Overall Study||15
7639907|NCT02221349|18812410|P1|COMPLETED|Overall Study||14
7639908|NCT02221349|18812409|P2|STARTED|Overall Study||15
7639909|NCT02221349|18812410|P1|STARTED|Overall Study||15
7639910|NCT02221284|18812422|P1|NOT COMPLETED|Overall Study||61
7639911|NCT02221284|18812422|P1|COMPLETED|Overall Study||903
7639912|NCT02221284|18812422|P1|STARTED|Overall Study||964
7639913|NCT02221219|18812454|P4|NOT COMPLETED|Overall Study||0
7639914|NCT02221219|18812455|P3|NOT COMPLETED|Overall Study||0
7639915|NCT02221219|18812456|P2|NOT COMPLETED|Overall Study||0
7639916|NCT02221219|18812457|P1|NOT COMPLETED|Overall Study||0
7639917|NCT02221219|18812454|P4|COMPLETED|Overall Study||92
7639918|NCT02221219|18812455|P3|COMPLETED|Overall Study||41
7639919|NCT02221219|18812456|P2|COMPLETED|Overall Study||87
7639920|NCT02221219|18812457|P1|COMPLETED|Overall Study||36
7639921|NCT02221219|18812454|P4|STARTED|Overall Study||92
7639922|NCT02221219|18812455|P3|STARTED|Overall Study||41
7639923|NCT02221219|18812456|P2|STARTED|Overall Study||87
7639924|NCT02221219|18812457|P1|STARTED|Overall Study||36
7639925|NCT02221037|18812471|P4|NOT COMPLETED|Overall Study||0
7639926|NCT02221037|18812472|P3|NOT COMPLETED|Overall Study||1
7639927|NCT02221037|18812473|P2|NOT COMPLETED|Overall Study||0
7639928|NCT02221037|18812474|P1|NOT COMPLETED|Overall Study||0
7639929|NCT02221037|18812471|P4|COMPLETED|Overall Study||9
7639930|NCT02221037|18812472|P3|COMPLETED|Overall Study||7
7639931|NCT02221037|18812473|P2|COMPLETED|Overall Study||11
7639932|NCT02221037|18812474|P1|COMPLETED|Overall Study||5
7639933|NCT02221037|18812471|P4|STARTED|Overall Study||9
7639934|NCT02221037|18812472|P3|STARTED|Overall Study||8
7639935|NCT02221037|18812473|P2|STARTED|Overall Study||11
7639936|NCT02221037|18812474|P1|STARTED|Overall Study||5
7639937|NCT02220998|18812560|P2|NOT COMPLETED|Overall Study||11
7639938|NCT02220998|18812561|P1|NOT COMPLETED|Overall Study||7
7639939|NCT02220998|18812560|P2|COMPLETED|Overall Study||123
7639940|NCT02220998|18812561|P1|COMPLETED|Overall Study||128
7639941|NCT02220998|18812560|P2|STARTED|Overall Study||134
7639942|NCT02220998|18812561|P1|STARTED|Overall Study||135
7639943|NCT02220920|18812579|P2|NOT COMPLETED|Overall Study||3
7639944|NCT02220920|18812580|P1|NOT COMPLETED|Overall Study||3
7639945|NCT02220920|18812579|P2|COMPLETED|Overall Study||67
7639946|NCT02220920|18812580|P1|COMPLETED|Overall Study||73
7639947|NCT02220920|18812579|P2|STARTED|Overall Study||70
7639948|NCT02220920|18812580|P1|STARTED|Overall Study||76
7639949|NCT02220907|18812594|P1|NOT COMPLETED|Overall Study||11
7639950|NCT02220907|18812594|P1|COMPLETED|Overall Study||142
7639951|NCT02220907|18812594|P1|STARTED|Overall Study||153
7639952|NCT02220894|18812603|P2|NOT COMPLETED|Overall Study||637
7639953|NCT02220894|18812604|P1|NOT COMPLETED|Overall Study||637
7639954|NCT02220894|18812603|P2|COMPLETED|Overall Study||0
7639955|NCT02220894|18812604|P1|COMPLETED|Overall Study||0
7639956|NCT02220894|18812603|P2|Treated|Overall Study||615
7639957|NCT02220894|18812604|P1|Treated|Overall Study||636
7639958|NCT02220894|18812603|P2|STARTED|Overall Study||637
7639959|NCT02220894|18812604|P1|STARTED|Overall Study|1 additional participant was randomized in error|637
7639960|NCT02220855|18812630|P1|NOT COMPLETED|Overall Study||14
7639961|NCT02220855|18812630|P1|COMPLETED|Overall Study||0
7639962|NCT02220855|18812630|P1|STARTED|Overall Study||14
7639963|NCT02220764|18812640|P2|NOT COMPLETED|Overall Study||1
7639964|NCT02220764|18812641|P1|NOT COMPLETED|Overall Study||4
7639965|NCT02220764|18812640|P2|COMPLETED|Overall Study||7
7639966|NCT02220764|18812641|P1|COMPLETED|Overall Study||20
7639967|NCT02220764|18812640|P2|STARTED|Overall Study||8
7639968|NCT02220764|18812641|P1|STARTED|Overall Study||24
7639969|NCT02220725|18812655|P4|NOT COMPLETED|Overall Study||2
7639970|NCT02220725|18812656|P3|NOT COMPLETED|Overall Study||0
7639971|NCT02220725|18812657|P2|NOT COMPLETED|Overall Study||0
7639972|NCT02220725|18812658|P1|NOT COMPLETED|Overall Study||0
7639973|NCT02220725|18812655|P4|COMPLETED|Overall Study||24
7639974|NCT02220725|18812656|P3|COMPLETED|Overall Study||13
7639975|NCT02220725|18812657|P2|COMPLETED|Overall Study||27
7639976|NCT02220725|18812658|P1|COMPLETED|Overall Study||14
7639977|NCT02220725|18812655|P4|STARTED|Overall Study||26
7639978|NCT02220725|18812656|P3|STARTED|Overall Study||13
7639979|NCT02220725|18812657|P2|STARTED|Overall Study||27
7639980|NCT02220725|18812658|P1|STARTED|Overall Study||14
7639981|NCT02220205|18812688|P2|NOT COMPLETED|Overall Study||0
7639982|NCT02220205|18812689|P1|NOT COMPLETED|Overall Study||1
7639983|NCT02220205|18812688|P2|COMPLETED|Overall Study||30
7639984|NCT02220205|18812689|P1|COMPLETED|Overall Study||29
7639985|NCT02220205|18812688|P2|STARTED|Overall Study||30
7639986|NCT02220205|18812689|P1|STARTED|Overall Study||30
7639987|NCT02219997|18812699|P3|NOT COMPLETED|Second Filter||0
7639988|NCT02219997|18812700|P2|NOT COMPLETED|Second Filter||0
7639989|NCT02219997|18812701|P1|NOT COMPLETED|Second Filter||0
7639990|NCT02219997|18812699|P3|COMPLETED|Second Filter||18
7639991|NCT02219997|18812700|P2|COMPLETED|Second Filter||17
7639992|NCT02219997|18812701|P1|COMPLETED|Second Filter||0
7639993|NCT02219997|18812699|P3|STARTED|Second Filter||18
7639994|NCT02219997|18812700|P2|STARTED|Second Filter||17
7639995|NCT02219997|18812701|P1|STARTED|Second Filter||0
7639996|NCT02219997|18812699|P3|NOT COMPLETED|First Filter||0
7639997|NCT02219997|18812700|P2|NOT COMPLETED|First Filter||0
7639998|NCT02219997|18812701|P1|NOT COMPLETED|First Filter||0
7639999|NCT02219997|18812699|P3|COMPLETED|First Filter||18
7640000|NCT02219997|18812700|P2|COMPLETED|First Filter||17
7640001|NCT02219997|18812701|P1|COMPLETED|First Filter||33
7640002|NCT02219997|18812699|P3|STARTED|First Filter||18
7640003|NCT02219997|18812700|P2|STARTED|First Filter||17
7640004|NCT02219997|18812701|P1|STARTED|First Filter||33
7640005|NCT02219932|18812714|P2|NOT COMPLETED|Overall Study||51
7640006|NCT02219932|18812715|P1|NOT COMPLETED|Overall Study||65
7640007|NCT02219932|18812714|P2|COMPLETED|Overall Study||266
7640008|NCT02219932|18812715|P1|COMPLETED|Overall Study||254
7640009|NCT02219932|18812714|P2|Randomized, Not Treated|Overall Study||1
7640010|NCT02219932|18812715|P1|Randomized, Not Treated|Overall Study||0
7640011|NCT02219932|18812714|P2|STARTED|Overall Study||317
7640012|NCT02219932|18812715|P1|STARTED|Overall Study||319
7640013|NCT02219685|18812731|P2|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
7640014|NCT02219685|18812732|P1|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
7640015|NCT02219685|18812731|P2|COMPLETED|Open-Label (After Posttreatment Week 4)||14
7640016|NCT02219685|18812732|P1|COMPLETED|Open-Label (After Posttreatment Week 4)||0
7640017|NCT02219685|18812731|P2|STARTED|Open-Label (After Posttreatment Week 4)||14
7640018|NCT02219685|18812732|P1|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0
7640019|NCT02219685|18812731|P2|NOT COMPLETED|Blinded Treatment Phase||0
7640020|NCT02219685|18812732|P1|NOT COMPLETED|Blinded Treatment Phase||2
7640021|NCT02219685|18812731|P2|COMPLETED|Blinded Treatment Phase||14
7640022|NCT02219685|18812732|P1|COMPLETED|Blinded Treatment Phase||24
7640023|NCT02219685|18812731|P2|STARTED|Blinded Treatment Phase||14
7640024|NCT02219685|18812732|P1|STARTED|Blinded Treatment Phase||26
7640025|NCT02219516|18812780|P4|NOT COMPLETED|Overall Study||0
7640026|NCT02219516|18812781|P3|NOT COMPLETED|Overall Study||0
7640027|NCT02219516|18812782|P2|NOT COMPLETED|Overall Study||0
7640028|NCT02219516|18812783|P1|NOT COMPLETED|Overall Study||0
7640029|NCT02219516|18812780|P4|COMPLETED|Overall Study||8
7640030|NCT02219516|18812781|P3|COMPLETED|Overall Study||7
7640031|NCT02219516|18812782|P2|COMPLETED|Overall Study||8
7640032|NCT02219516|18812783|P1|COMPLETED|Overall Study||8
7640033|NCT02219516|18812780|P4|STARTED|Overall Study||8
7640034|NCT02219516|18812781|P3|STARTED|Overall Study||7
7640035|NCT02219516|18812782|P2|STARTED|Overall Study||8
7640036|NCT02219516|18812783|P1|STARTED|Overall Study||8
7640037|NCT02219503|18812829|P1|NOT COMPLETED|Overall Study||0
7640038|NCT02219503|18812829|P1|COMPLETED|Overall Study||60
7640039|NCT02219503|18812829|P1|STARTED|Overall Study||60
7640040|NCT02219477|18812838|P3|NOT COMPLETED|Overall Study||1
7640041|NCT02219477|18812839|P2|NOT COMPLETED|Overall Study||2
7640042|NCT02219477|18812840|P1|NOT COMPLETED|Overall Study||0
7640043|NCT02219477|18812838|P3|COMPLETED|Overall Study||2
7640044|NCT02219477|18812839|P2|COMPLETED|Overall Study||22
7640045|NCT02219477|18812840|P1|COMPLETED|Overall Study||9
7640046|NCT02219477|18812838|P3|STARTED|Overall Study||3
7640047|NCT02219477|18812839|P2|STARTED|Overall Study||24
7640048|NCT02219477|18812840|P1|STARTED|Overall Study||9
7640049|NCT02219464|18812868|P2|NOT COMPLETED|Overall Study||0
7640050|NCT02219464|18812869|P1|NOT COMPLETED|Overall Study||3
7640051|NCT02219464|18812868|P2|COMPLETED|Overall Study||30
7640052|NCT02219464|18812869|P1|COMPLETED|Overall Study||27
7640053|NCT02219464|18812868|P2|STARTED|Overall Study||30
7640054|NCT02219464|18812869|P1|STARTED|Overall Study||30
7640055|NCT02219334|18812879|P2|NOT COMPLETED|Overall Study||3
7640056|NCT02219334|18812880|P1|NOT COMPLETED|Overall Study||8
7640057|NCT02219334|18812879|P2|COMPLETED|Overall Study||20
7640058|NCT02219334|18812880|P1|COMPLETED|Overall Study||24
7640059|NCT02219334|18812879|P2|STARTED|Overall Study||23
7640060|NCT02219334|18812880|P1|STARTED|Overall Study||32
7640061|NCT02219321|18812892|P2|NOT COMPLETED|Overall Study||0
7640062|NCT02219321|18812893|P1|NOT COMPLETED|Overall Study||0
7640063|NCT02219321|18812892|P2|COMPLETED|Overall Study||2
7640064|NCT02219321|18812893|P1|COMPLETED|Overall Study||1
7640065|NCT02219321|18812892|P2|STARTED|Overall Study||2
7640066|NCT02219321|18812893|P1|STARTED|Overall Study||1
7640067|NCT02219308|18812903|P2|NOT COMPLETED|Overall Study||2
7640068|NCT02219308|18812904|P1|NOT COMPLETED|Overall Study||1
7640069|NCT02219308|18812903|P2|COMPLETED|Overall Study||33
7640070|NCT02219308|18812904|P1|COMPLETED|Overall Study||31
7640071|NCT02219308|18812903|P2|STARTED|Overall Study||35
7640072|NCT02219308|18812904|P1|STARTED|Overall Study||32
7640073|NCT02219282|18812914|P2|NOT COMPLETED|Overall Study||1
7640074|NCT02219282|18812915|P1|NOT COMPLETED|Overall Study||1
7640075|NCT02219282|18812914|P2|COMPLETED|Overall Study||32
7640076|NCT02219282|18812915|P1|COMPLETED|Overall Study||32
7640077|NCT02219282|18812914|P2|STARTED|Overall Study||33
7640078|NCT02219282|18812915|P1|STARTED|Overall Study||33
7640079|NCT02219256|18812941|P12|NOT COMPLETED|Overall Study||0
7640080|NCT02219256|18812942|P11|NOT COMPLETED|Overall Study||0
7640081|NCT02219256|18812943|P10|NOT COMPLETED|Overall Study||0
7640082|NCT02219256|18812944|P9|NOT COMPLETED|Overall Study||0
7640083|NCT02219256|18812945|P8|NOT COMPLETED|Overall Study||0
7640084|NCT02219256|18812946|P7|NOT COMPLETED|Overall Study||0
7640085|NCT02219256|18812947|P6|NOT COMPLETED|Overall Study||0
7640086|NCT02219256|18812948|P5|NOT COMPLETED|Overall Study||0
7640087|NCT02219256|18812949|P4|NOT COMPLETED|Overall Study||0
7640088|NCT02219256|18812950|P3|NOT COMPLETED|Overall Study||0
7640089|NCT02219256|18812951|P2|NOT COMPLETED|Overall Study||0
7640090|NCT02219256|18812952|P1|NOT COMPLETED|Overall Study||0
7640091|NCT02219256|18812941|P12|COMPLETED|Overall Study||6
7640092|NCT02219256|18812942|P11|COMPLETED|Overall Study||6
7640093|NCT02219256|18812943|P10|COMPLETED|Overall Study||6
7640094|NCT02219256|18812944|P9|COMPLETED|Overall Study||6
7640095|NCT02219256|18812945|P8|COMPLETED|Overall Study||8
7640096|NCT02219256|18812946|P7|COMPLETED|Overall Study||6
7640097|NCT02219256|18812947|P6|COMPLETED|Overall Study||6
7640098|NCT02219256|18812948|P5|COMPLETED|Overall Study||6
7640099|NCT02219256|18812949|P4|COMPLETED|Overall Study||4
7640100|NCT02219256|18812950|P3|COMPLETED|Overall Study||4
7640101|NCT02219256|18812951|P2|COMPLETED|Overall Study||4
7640102|NCT02219256|18812952|P1|COMPLETED|Overall Study||12
7640103|NCT02219256|18812941|P12|STARTED|Overall Study||6
7640104|NCT02219256|18812942|P11|STARTED|Overall Study||6
7640105|NCT02219256|18812943|P10|STARTED|Overall Study||6
7640106|NCT02219256|18812944|P9|STARTED|Overall Study||6
7640107|NCT02219256|18812945|P8|STARTED|Overall Study||8
7640108|NCT02219256|18812946|P7|STARTED|Overall Study||6
7640109|NCT02219256|18812947|P6|STARTED|Overall Study||6
7640110|NCT02219256|18812948|P5|STARTED|Overall Study||6
7640111|NCT02219256|18812949|P4|STARTED|Overall Study||4
7640112|NCT02219256|18812950|P3|STARTED|Overall Study||4
7640113|NCT02219256|18812951|P2|STARTED|Overall Study||4
7640114|NCT02219256|18812952|P1|STARTED|Overall Study||12
7640115|NCT02219087|18813064|P2|NOT COMPLETED|Overall Study||1
7640116|NCT02219087|18813065|P1|NOT COMPLETED|Overall Study||0
7640117|NCT02219087|18813064|P2|COMPLETED|Overall Study|Randomization envelope pulled out of sequence for consented patient. Excluded by request of IRB|29
7640118|NCT02219087|18813065|P1|COMPLETED|Overall Study||30
7640119|NCT02219087|18813064|P2|STARTED|Overall Study||30
7640120|NCT02219087|18813065|P1|STARTED|Overall Study||30
7640121|NCT02219048|18813085|P2|NOT COMPLETED|Overall Study||21
7640122|NCT02219048|18813086|P1|NOT COMPLETED|Overall Study||21
7640123|NCT02219048|18813085|P2|COMPLETED|Overall Study||4
7640124|NCT02219048|18813086|P1|COMPLETED|Overall Study||5
7640125|NCT02219048|18813085|P2|STARTED|Overall Study||25
7640126|NCT02219048|18813086|P1|STARTED|Overall Study||26
7640127|NCT02219009|18813112|P2|NOT COMPLETED|Overall Study||8
7640128|NCT02219009|18813113|P1|NOT COMPLETED|Overall Study||10
7640129|NCT02219009|18813112|P2|COMPLETED|Overall Study||22
7640130|NCT02219009|18813113|P1|COMPLETED|Overall Study||27
7640131|NCT02219009|18813112|P2|STARTED|Overall Study||30
7640132|NCT02219009|18813113|P1|STARTED|Overall Study||37
7640133|NCT02218736|18813125|P2|NOT COMPLETED|Overall Study||9
7640134|NCT02218736|18813126|P1|NOT COMPLETED|Overall Study||12
7640135|NCT02218736|18813125|P2|COMPLETED|Overall Study||35
7640136|NCT02218736|18813126|P1|COMPLETED|Overall Study||33
7640137|NCT02218736|18813125|P2|STARTED|Overall Study||44
7640138|NCT02218736|18813126|P1|STARTED|Overall Study||45
7640139|NCT02218697|18813138|P2|NOT COMPLETED|Overall Study||6
7640140|NCT02218697|18813139|P1|NOT COMPLETED|Overall Study||2
7640141|NCT02218697|18813138|P2|COMPLETED|Overall Study||171
7640142|NCT02218697|18813139|P1|COMPLETED|Overall Study||177
7640143|NCT02218697|18813138|P2|STARTED|Overall Study||177
7640144|NCT02218697|18813139|P1|STARTED|Overall Study||179
7640145|NCT02218541|18813179|P2|NOT COMPLETED|Overall Study||2
7640146|NCT02218541|18813180|P1|NOT COMPLETED|Overall Study||6
7640147|NCT02218541|18813179|P2|COMPLETED|Overall Study||9
7640148|NCT02218541|18813180|P1|COMPLETED|Overall Study||5
7640149|NCT02218541|18813179|P2|STARTED|Overall Study||11
7640150|NCT02218541|18813180|P1|STARTED|Overall Study||11
7640151|NCT02218463|18813192|P2|NOT COMPLETED|Overall Study||3
7640152|NCT02218463|18813193|P1|NOT COMPLETED|Overall Study||3
7640153|NCT02218463|18813192|P2|COMPLETED|Overall Study||19
7640154|NCT02218463|18813193|P1|COMPLETED|Overall Study||18
7640155|NCT02218463|18813192|P2|STARTED|Overall Study||22
7640156|NCT02218463|18813193|P1|STARTED|Overall Study||21
7640157|NCT02218424|18813203|P2|NOT COMPLETED|Overall Study||0
7640158|NCT02218424|18813204|P1|NOT COMPLETED|Overall Study||0
7640159|NCT02218424|18813203|P2|COMPLETED|Overall Study||30
7640160|NCT02218424|18813204|P1|COMPLETED|Overall Study||30
7640161|NCT02218424|18813203|P2|STARTED|Overall Study||30
7640162|NCT02218424|18813204|P1|STARTED|Overall Study||30
7640163|NCT02218372|18813226|P2|NOT COMPLETED|Overall Study||6
7640164|NCT02218372|18813227|P1|NOT COMPLETED|Overall Study||5
7640165|NCT02218372|18813226|P2|COMPLETED|Overall Study||42
7640166|NCT02218372|18813227|P1|COMPLETED|Overall Study||95
7640167|NCT02218372|18813226|P2|Treated|Overall Study||44
7640168|NCT02218372|18813227|P1|Treated|Overall Study||98
7640169|NCT02218372|18813226|P2|STARTED|Overall Study||48
7640170|NCT02218372|18813227|P1|STARTED|Overall Study||100
7640171|NCT02218320|18813285|P2|NOT COMPLETED|Overall Study||0
7640172|NCT02218320|18813286|P1|NOT COMPLETED|Overall Study||0
7640173|NCT02218320|18813285|P2|COMPLETED|Overall Study|Last participant contact on this arm was October 2015|10
7640174|NCT02218320|18813286|P1|COMPLETED|Overall Study|Last participant contact on this arm was June 2015|10
7640175|NCT02218320|18813285|P2|STARTED|Overall Study|First participant contact on this arm was December 2014|10
7640176|NCT02218320|18813286|P1|STARTED|Overall Study|First participant visit on this arm Dec 2014|10
7640177|NCT02218307|18813298|P2|NOT COMPLETED|Overall Study||1
7640178|NCT02218307|18813299|P1|NOT COMPLETED|Overall Study||9
7640179|NCT02218307|18813298|P2|COMPLETED|Overall Study||33
7640180|NCT02218307|18813299|P1|COMPLETED|Overall Study||25
7640181|NCT02218307|18813298|P2|STARTED|Overall Study||34
7640182|NCT02218307|18813299|P1|STARTED|Overall Study||34
7640183|NCT02218268|18813307|P2|NOT COMPLETED|Final Phase (2 Hours)||0
7640184|NCT02218268|18813308|P1|NOT COMPLETED|Final Phase (2 Hours)||0
7640185|NCT02218268|18813307|P2|COMPLETED|Final Phase (2 Hours)||21
7640186|NCT02218268|18813308|P1|COMPLETED|Final Phase (2 Hours)||19
7640187|NCT02218268|18813307|P2|STARTED|Final Phase (2 Hours)||21
7640188|NCT02218268|18813308|P1|STARTED|Final Phase (2 Hours)||19
7640189|NCT02218268|18813307|P2|NOT COMPLETED|24 Hour Washout||9
7640190|NCT02218268|18813308|P1|NOT COMPLETED|24 Hour Washout||11
7640191|NCT02218268|18813307|P2|COMPLETED|24 Hour Washout||21
7640192|NCT02218268|18813308|P1|COMPLETED|24 Hour Washout||19
7640193|NCT02218268|18813307|P2|STARTED|24 Hour Washout||30
7640194|NCT02218268|18813308|P1|STARTED|24 Hour Washout||30
7640195|NCT02218268|18813307|P2|NOT COMPLETED|First Phase (2 Hours)||0
7640196|NCT02218268|18813308|P1|NOT COMPLETED|First Phase (2 Hours)||0
7640197|NCT02218268|18813307|P2|COMPLETED|First Phase (2 Hours)||30
7640198|NCT02218268|18813308|P1|COMPLETED|First Phase (2 Hours)||30
7640199|NCT02218268|18813307|P2|STARTED|First Phase (2 Hours)||30
7640200|NCT02218268|18813308|P1|STARTED|First Phase (2 Hours)||30
7640201|NCT02218242|18813314|P1|NOT COMPLETED|Overall Study||0
7640202|NCT02218242|18813314|P1|COMPLETED|Overall Study||9
7640203|NCT02218242|18813314|P1|STARTED|Overall Study||9
7640204|NCT02218216|18813320|P3|NOT COMPLETED|Overall Study||0
7640205|NCT02218216|18813321|P2|NOT COMPLETED|Overall Study||0
7640206|NCT02218216|18813322|P1|NOT COMPLETED|Overall Study||6
7640207|NCT02218216|18813320|P3|COMPLETED|Overall Study||3
7640208|NCT02218216|18813321|P2|COMPLETED|Overall Study||2
7640209|NCT02218216|18813322|P1|COMPLETED|Overall Study||8
7640210|NCT02218216|18813320|P3|STARTED|Overall Study||3
7640211|NCT02218216|18813321|P2|STARTED|Overall Study||2
7640212|NCT02218216|18813322|P1|STARTED|Overall Study||14
7640213|NCT02218203|18813330|P1|NOT COMPLETED|Overall Study||0
7640214|NCT02218203|18813330|P1|COMPLETED|Overall Study|2 subjects did not complete the placebo, medium dose, and high dose dex/lido combination arms.|26
7640215|NCT02218203|18813330|P1|High Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
7640216|NCT02218203|18813330|P1|High Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
7640217|NCT02218203|18813330|P1|High Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
7640218|NCT02218203|18813330|P1|High Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
7640219|NCT02218203|18813330|P1|Medium Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
7640220|NCT02218203|18813330|P1|Medium Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
7640221|NCT02218203|18813330|P1|Medium Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
7640222|NCT02218203|18813330|P1|Medium Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
7640223|NCT02218203|18813330|P1|Low Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||26
7640224|NCT02218203|18813330|P1|Low Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||26
7640225|NCT02218203|18813330|P1|Low Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||26
7640226|NCT02218203|18813330|P1|Low Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||26
7640227|NCT02218203|18813330|P1|Placebo Dex v. 4mg/km LBM Lidocaine|Overall Study||24
7640228|NCT02218203|18813330|P1|Placebo Dex v. 2mg/km LBM Lidocaine|Overall Study||24
7640229|NCT02218203|18813330|P1|Placebo Dex v. 1mg/km LBM Lidocaine|Overall Study||24
7640230|NCT02218203|18813330|P1|Placebo Dex v. 0mg/km LBM Lidocaine|Overall Study||24
7640231|NCT02218203|18813330|P1|STARTED|Overall Study||26
7640232|NCT02218190|18813354|P2|NOT COMPLETED|Overall Study||0
7640233|NCT02218190|18813355|P1|NOT COMPLETED|Overall Study||0
7640234|NCT02218190|18813354|P2|COMPLETED|Overall Study||13
7640235|NCT02218190|18813355|P1|COMPLETED|Overall Study||13
7640236|NCT02218190|18813354|P2|STARTED|Overall Study||13
7640237|NCT02218190|18813355|P1|STARTED|Overall Study||13
7640238|NCT02218164|18813365|P1|NOT COMPLETED|Overall Study||0
7640239|NCT02218164|18813365|P1|COMPLETED|Overall Study||8
7640240|NCT02218164|18813365|P1|STARTED|Overall Study||8
7640241|NCT02218008|18813375|P6|NOT COMPLETED|Stage 2 (S2)||6
7640242|NCT02218008|18813376|P5|NOT COMPLETED|Stage 2 (S2)||4
7640243|NCT02218008|18813377|P4|NOT COMPLETED|Stage 2 (S2)||4
7640244|NCT02218008|18813378|P3|NOT COMPLETED|Stage 2 (S2)||0
7640245|NCT02218008|18813379|P2|NOT COMPLETED|Stage 2 (S2)||0
7640246|NCT02218008|18813380|P1|NOT COMPLETED|Stage 2 (S2)||0
7640247|NCT02218008|18813375|P6|COMPLETED|Stage 2 (S2)||57
7640248|NCT02218008|18813376|P5|COMPLETED|Stage 2 (S2)||58
7640249|NCT02218008|18813377|P4|COMPLETED|Stage 2 (S2)||58
7640250|NCT02218008|18813378|P3|COMPLETED|Stage 2 (S2)||0
7640251|NCT02218008|18813379|P2|COMPLETED|Stage 2 (S2)||0
7640252|NCT02218008|18813380|P1|COMPLETED|Stage 2 (S2)||0
7640253|NCT02218008|18813375|P6|STARTED|Stage 2 (S2)||63
7640254|NCT02218008|18813376|P5|STARTED|Stage 2 (S2)||62
7640255|NCT02218008|18813377|P4|STARTED|Stage 2 (S2)||62
7640256|NCT02218008|18813378|P3|STARTED|Stage 2 (S2)||0
7640257|NCT02218008|18813379|P2|STARTED|Stage 2 (S2)||0
7640258|NCT02218008|18813380|P1|STARTED|Stage 2 (S2)||0
7640259|NCT02218008|18813375|P6|NOT COMPLETED|Stage 1 (S1)||0
7640260|NCT02218008|18813376|P5|NOT COMPLETED|Stage 1 (S1)||0
7640261|NCT02218008|18813377|P4|NOT COMPLETED|Stage 1 (S1)||0
7640262|NCT02218008|18813378|P3|NOT COMPLETED|Stage 1 (S1)||15
7640263|NCT02218008|18813379|P2|NOT COMPLETED|Stage 1 (S1)||7
7640264|NCT02218008|18813380|P1|NOT COMPLETED|Stage 1 (S1)||22
7640265|NCT02218008|18813375|P6|COMPLETED|Stage 1 (S1)||0
7640266|NCT02218008|18813376|P5|COMPLETED|Stage 1 (S1)||0
7640267|NCT02218008|18813377|P4|COMPLETED|Stage 1 (S1)||0
7640268|NCT02218008|18813378|P3|COMPLETED|Stage 1 (S1)||48
7640269|NCT02218008|18813379|P2|COMPLETED|Stage 1 (S1)||56
7640270|NCT02218008|18813380|P1|COMPLETED|Stage 1 (S1)||258
7640271|NCT02218008|18813375|P6|STARTED|Stage 1 (S1)||0
7640272|NCT02218008|18813376|P5|STARTED|Stage 1 (S1)||0
7640273|NCT02218008|18813377|P4|STARTED|Stage 1 (S1)||0
7640274|NCT02218008|18813378|P3|STARTED|Stage 1 (S1)||63
7640275|NCT02218008|18813379|P2|STARTED|Stage 1 (S1)||63
7640276|NCT02218008|18813380|P1|STARTED|Stage 1 (S1)||280
7640277|NCT02217982|18813426|P2|NOT COMPLETED|Overall Study||1
7640278|NCT02217982|18813427|P1|NOT COMPLETED|Overall Study||1
7640279|NCT02217982|18813426|P2|COMPLETED|Overall Study||3
7640280|NCT02217982|18813427|P1|COMPLETED|Overall Study|Trial closed before patient finished|0
7640281|NCT02217982|18813426|P2|STARTED|Overall Study||4
7640282|NCT02217982|18813427|P1|STARTED|Overall Study||1
7640283|NCT02217904|18813440|P7|NOT COMPLETED|Overall Study||0
7640284|NCT02217904|18813441|P6|NOT COMPLETED|Overall Study||0
7640285|NCT02217904|18813442|P5|NOT COMPLETED|Overall Study||0
7640286|NCT02217904|18813443|P4|NOT COMPLETED|Overall Study||0
7640287|NCT02217904|18813444|P3|NOT COMPLETED|Overall Study||0
7640288|NCT02217904|18813445|P2|NOT COMPLETED|Overall Study||0
7640289|NCT02217904|18813446|P1|NOT COMPLETED|Overall Study||0
7640290|NCT02217904|18813440|P7|COMPLETED|Overall Study||0
7640291|NCT02217904|18813441|P6|COMPLETED|Overall Study||0
7640292|NCT02217904|18813442|P5|COMPLETED|Overall Study||6
7640293|NCT02217904|18813443|P4|COMPLETED|Overall Study||6
7640294|NCT02217904|18813444|P3|COMPLETED|Overall Study||6
7640295|NCT02217904|18813445|P2|COMPLETED|Overall Study||6
7640296|NCT02217904|18813446|P1|COMPLETED|Overall Study||6
7640297|NCT02217904|18813440|P7|STARTED|Overall Study||0
7640298|NCT02217904|18813441|P6|STARTED|Overall Study||0
7640299|NCT02217904|18813442|P5|STARTED|Overall Study||6
7640300|NCT02217904|18813443|P4|STARTED|Overall Study||6
7640301|NCT02217904|18813444|P3|STARTED|Overall Study||6
7640302|NCT02217904|18813445|P2|STARTED|Overall Study||6
7640303|NCT02217904|18813446|P1|STARTED|Overall Study||6
7640304|NCT02217878|18813510|P2|NOT COMPLETED|Overall Study||2
7640305|NCT02217878|18813511|P1|NOT COMPLETED|Overall Study||2
7640306|NCT02217878|18813510|P2|COMPLETED|Overall Study||35
7640307|NCT02217878|18813511|P1|COMPLETED|Overall Study||35
7640308|NCT02217878|18813510|P2|STARTED|Overall Study||37
7640309|NCT02217878|18813511|P1|STARTED|Overall Study||37
7640310|NCT02217800|18813591|P1|NOT COMPLETED|Overall Study||0
7640311|NCT02217800|18813591|P1|COMPLETED|Overall Study||8
7640312|NCT02217800|18813591|P1|STARTED|Overall Study||8
7640313|NCT02217618|18813603|P1|NOT COMPLETED|Overall Study||0
7640314|NCT02217618|18813603|P1|COMPLETED|Overall Study||16
7640315|NCT02217618|18813603|P1|Received Study Drug|Overall Study||16
7640316|NCT02217618|18813603|P1|STARTED|Overall Study||16
7640317|NCT02217566|18813609|P1|NOT COMPLETED|Overall Study||11
7640318|NCT02217566|18813609|P1|COMPLETED|Overall Study||35
7640319|NCT02217566|18813609|P1|STARTED|Overall Study||46
7640320|NCT02217527|18813620|P2|NOT COMPLETED|Drug Condition 2: Second Study Phase||1
7640321|NCT02217527|18813621|P1|NOT COMPLETED|Drug Condition 2: Second Study Phase||0
7640322|NCT02217527|18813620|P2|COMPLETED|Drug Condition 2: Second Study Phase||14
7640323|NCT02217527|18813621|P1|COMPLETED|Drug Condition 2: Second Study Phase||17
7640324|NCT02217527|18813620|P2|STARTED|Drug Condition 2: Second Study Phase||15
7640325|NCT02217527|18813621|P1|STARTED|Drug Condition 2: Second Study Phase||17
7640326|NCT02217527|18813620|P2|NOT COMPLETED|Drug Condition 1: First Study Phase||3
7640327|NCT02217527|18813621|P1|NOT COMPLETED|Drug Condition 1: First Study Phase||1
7640328|NCT02217527|18813620|P2|COMPLETED|Drug Condition 1: First Study Phase||15
7640329|NCT02217527|18813621|P1|COMPLETED|Drug Condition 1: First Study Phase||17
7640330|NCT02217527|18813620|P2|STARTED|Drug Condition 1: First Study Phase||18
7640331|NCT02217527|18813621|P1|STARTED|Drug Condition 1: First Study Phase||18
7640332|NCT02217475|18813634|P3|NOT COMPLETED|Treatment Period 2 (Year 2)||12
7640333|NCT02217475|18813635|P2|NOT COMPLETED|Treatment Period 2 (Year 2)||2
7640334|NCT02217475|18813636|P1|NOT COMPLETED|Treatment Period 2 (Year 2)||2
7640335|NCT02217475|18813634|P3|COMPLETED|Treatment Period 2 (Year 2)||109
7640336|NCT02217475|18813635|P2|COMPLETED|Treatment Period 2 (Year 2)||59
7640337|NCT02217475|18813636|P1|COMPLETED|Treatment Period 2 (Year 2)||58
7640338|NCT02217475|18813634|P3|STARTED|Treatment Period 2 (Year 2)||121
7640339|NCT02217475|18813635|P2|STARTED|Treatment Period 2 (Year 2)||61
7640340|NCT02217475|18813636|P1|STARTED|Treatment Period 2 (Year 2)||60
7640341|NCT02217475|18813634|P3|NOT COMPLETED|Discontinued After Period 1||3
7640342|NCT02217475|18813635|P2|NOT COMPLETED|Discontinued After Period 1||3
7640343|NCT02217475|18813636|P1|NOT COMPLETED|Discontinued After Period 1||2
7640344|NCT02217475|18813634|P3|COMPLETED|Discontinued After Period 1||121
7640345|NCT02217475|18813635|P2|COMPLETED|Discontinued After Period 1||61
7640346|NCT02217475|18813636|P1|COMPLETED|Discontinued After Period 1||60
7640347|NCT02217475|18813634|P3|STARTED|Discontinued After Period 1||124
7640348|NCT02217475|18813635|P2|STARTED|Discontinued After Period 1||64
7640349|NCT02217475|18813636|P1|STARTED|Discontinued After Period 1||62
7640350|NCT02217475|18813634|P3|NOT COMPLETED|Treatment Period 1 (Year 1)||21
7640351|NCT02217475|18813635|P2|NOT COMPLETED|Treatment Period 1 (Year 1)||8
7640352|NCT02217475|18813636|P1|NOT COMPLETED|Treatment Period 1 (Year 1)||10
7640353|NCT02217475|18813634|P3|COMPLETED|Treatment Period 1 (Year 1)||124
7640354|NCT02217475|18813635|P2|COMPLETED|Treatment Period 1 (Year 1)||64
7640355|NCT02217475|18813636|P1|COMPLETED|Treatment Period 1 (Year 1)||62
7640356|NCT02217475|18813634|P3|Safety Analysis Set|Treatment Period 1 (Year 1)||144
7640357|NCT02217475|18813635|P2|Safety Analysis Set|Treatment Period 1 (Year 1)||72
7640358|NCT02217475|18813636|P1|Safety Analysis Set|Treatment Period 1 (Year 1)||72
7640359|NCT02217475|18813634|P3|STARTED|Treatment Period 1 (Year 1)||145
7640360|NCT02217475|18813635|P2|STARTED|Treatment Period 1 (Year 1)||72
7640361|NCT02217475|18813636|P1|STARTED|Treatment Period 1 (Year 1)||72
7640362|NCT02217436|18813753|P2|NOT COMPLETED|Overall Study||2
7640363|NCT02217436|18813754|P1|NOT COMPLETED|Overall Study||1
7640364|NCT02217436|18813753|P2|COMPLETED|Overall Study||38
7640365|NCT02217436|18813754|P1|COMPLETED|Overall Study||39
7640366|NCT02217436|18813753|P2|STARTED|Overall Study||40
7640367|NCT02217436|18813754|P1|STARTED|Overall Study||40
7640368|NCT02217410|18813765|P3|NOT COMPLETED|Overall Study||5
7640369|NCT02217410|18813766|P2|NOT COMPLETED|Overall Study||4
7640370|NCT02217410|18813767|P1|NOT COMPLETED|Overall Study||1
7640371|NCT02217410|18813765|P3|COMPLETED|Overall Study||13
7640372|NCT02217410|18813766|P2|COMPLETED|Overall Study||30
7640373|NCT02217410|18813767|P1|COMPLETED|Overall Study||6
7640374|NCT02217410|18813765|P3|STARTED|Overall Study||18
7640375|NCT02217410|18813766|P2|STARTED|Overall Study||34
7640376|NCT02217410|18813767|P1|STARTED|Overall Study||7
7640377|NCT02217280|18813790|P1|NOT COMPLETED|Overall Study||4
7640378|NCT02217280|18813790|P1|COMPLETED|Overall Study||16
7640379|NCT02217280|18813790|P1|STARTED|Overall Study||20
7640380|NCT02216812|18813797|P2|NOT COMPLETED|Overall Study||5
7640381|NCT02216812|18813798|P1|NOT COMPLETED|Overall Study||10
7640382|NCT02216812|18813797|P2|COMPLETED|Overall Study||62
7640383|NCT02216812|18813798|P1|COMPLETED|Overall Study||57
7640384|NCT02216812|18813797|P2|STARTED|Overall Study||67
7640385|NCT02216812|18813798|P1|STARTED|Overall Study||67
7640386|NCT02216773|18813814|P2|NOT COMPLETED|Overall Study||5
7640387|NCT02216773|18813815|P1|NOT COMPLETED|Overall Study||12
7640388|NCT02216773|18813814|P2|COMPLETED|Overall Study||24
7640389|NCT02216773|18813815|P1|COMPLETED|Overall Study||16
7640390|NCT02216773|18813814|P2|Underwent Procedure (PVE/RALPPS)|Overall Study||26
7640391|NCT02216773|18813815|P1|Underwent Procedure (PVE/RALPPS)|Overall Study||24
7640392|NCT02216773|18813814|P2|STARTED|Overall Study||29
7640393|NCT02216773|18813815|P1|STARTED|Overall Study||28
7640394|NCT02216695|18813825|P1|NOT COMPLETED|Overall Study||0
7640395|NCT02216695|18813825|P1|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882
7640396|NCT02216695|18813825|P1|STARTED|Overall Study||64882
7640397|NCT02216591|18813836|P2|NOT COMPLETED|Overall Study||1
7640398|NCT02216591|18813837|P1|NOT COMPLETED|Overall Study||0
7640399|NCT02216591|18813836|P2|COMPLETED|Overall Study||9
7640400|NCT02216591|18813837|P1|COMPLETED|Overall Study||11
7640401|NCT02216591|18813836|P2|STARTED|Overall Study||10
7640402|NCT02216591|18813837|P1|STARTED|Overall Study||11
7640403|NCT02216526|18813850|P3|NOT COMPLETED|Overall Study||8
7640404|NCT02216526|18813851|P2|NOT COMPLETED|Overall Study||3
7640405|NCT02216526|18813852|P1|NOT COMPLETED|Overall Study||5
7640406|NCT02216526|18813850|P3|COMPLETED|Overall Study||36
7640407|NCT02216526|18813851|P2|COMPLETED|Overall Study||41
7640408|NCT02216526|18813852|P1|COMPLETED|Overall Study||40
7640409|NCT02216526|18813850|P3|STARTED|Overall Study||44
7640410|NCT02216526|18813851|P2|STARTED|Overall Study||44
7640411|NCT02216526|18813852|P1|STARTED|Overall Study||45
7640412|NCT02216422|18813962|P1|NOT COMPLETED|Overall Study||0
7640413|NCT02216422|18813962|P1|COMPLETED|Overall Study||36
7640414|NCT02216422|18813962|P1|STARTED|Overall Study||36
7640415|NCT02216357|18813970|P2|NOT COMPLETED|Overall Study||1
7640416|NCT02216357|18813971|P1|NOT COMPLETED|Overall Study||2
7640417|NCT02216357|18813970|P2|COMPLETED|Overall Study||4
7640418|NCT02216357|18813971|P1|COMPLETED|Overall Study||12
7640419|NCT02216357|18813970|P2|STARTED|Overall Study||5
7640420|NCT02216357|18813971|P1|STARTED|Overall Study||14
7640421|NCT02216214|18813997|P2|NOT COMPLETED|Overall Study||36
7640422|NCT02216214|18813998|P1|NOT COMPLETED|Overall Study||43
7640423|NCT02216214|18813997|P2|COMPLETED|Overall Study||409
7640424|NCT02216214|18813998|P1|COMPLETED|Overall Study||400
7640425|NCT02216214|18813997|P2|Treated|Overall Study||445
7640426|NCT02216214|18813998|P1|Treated|Overall Study||442
7640427|NCT02216214|18813997|P2|STARTED|Overall Study||445
7640428|NCT02216214|18813998|P1|STARTED|Overall Study||443
7640429|NCT02216136|18814057|P3|NOT COMPLETED|Overall Study||0
7640430|NCT02216136|18814058|P2|NOT COMPLETED|Overall Study||0
7640431|NCT02216136|18814059|P1|NOT COMPLETED|Overall Study||0
7640432|NCT02216136|18814057|P3|COMPLETED|Overall Study||0
7640433|NCT02216136|18814058|P2|COMPLETED|Overall Study||90
7640434|NCT02216136|18814059|P1|COMPLETED|Overall Study||72
7640435|NCT02216136|18814057|P3|STARTED|Overall Study||0
7640436|NCT02216136|18814058|P2|STARTED|Overall Study||90
7640437|NCT02216136|18814059|P1|STARTED|Overall Study||72
7640438|NCT02216123|18814069|P2|NOT COMPLETED|Overall Study||2
7640439|NCT02216123|18814070|P1|NOT COMPLETED|Overall Study||6
7640440|NCT02216123|18814069|P2|COMPLETED|Overall Study||83
7640441|NCT02216123|18814070|P1|COMPLETED|Overall Study||160
7640442|NCT02216123|18814069|P2|STARTED|Overall Study||85
7640443|NCT02216123|18814070|P1|STARTED|Overall Study||166
7640444|NCT02216097|18814136|P2|NOT COMPLETED|Overall Study||0
7640445|NCT02216097|18814137|P1|NOT COMPLETED|Overall Study||0
7640446|NCT02216097|18814136|P2|COMPLETED|Overall Study||6
7640447|NCT02216097|18814137|P1|COMPLETED|Overall Study||8
7640448|NCT02216097|18814136|P2|STARTED|Overall Study||6
7640449|NCT02216097|18814137|P1|STARTED|Overall Study||8
7640450|NCT02215967|18814163|P4|NOT COMPLETED|Overall Study||3
7640451|NCT02215967|18814164|P3|NOT COMPLETED|Overall Study||1
7640452|NCT02215967|18814165|P2|NOT COMPLETED|Overall Study||0
7640453|NCT02215967|18814166|P1|NOT COMPLETED|Overall Study||0
7640454|NCT02215967|18814163|P4|COMPLETED|Overall Study||16
7640455|NCT02215967|18814164|P3|COMPLETED|Overall Study||4
7640456|NCT02215967|18814165|P2|COMPLETED|Overall Study||3
7640457|NCT02215967|18814166|P1|COMPLETED|Overall Study||3
7640458|NCT02215967|18814163|P4|STARTED|Overall Study||19
7640459|NCT02215967|18814164|P3|STARTED|Overall Study||5
7640460|NCT02215967|18814165|P2|STARTED|Overall Study||3
7640461|NCT02215967|18814166|P1|STARTED|Overall Study||3
7640462|NCT02215954|18814187|P3|NOT COMPLETED|Overall Study||6
7640463|NCT02215954|18814188|P2|NOT COMPLETED|Overall Study||1
7640464|NCT02215954|18814189|P1|NOT COMPLETED|Overall Study||1
7640465|NCT02215954|18814187|P3|COMPLETED|Overall Study||205
7640466|NCT02215954|18814188|P2|COMPLETED|Overall Study||211
7640467|NCT02215954|18814189|P1|COMPLETED|Overall Study||213
7640468|NCT02215954|18814187|P3|Safety Analysis Set|Overall Study||208
7640469|NCT02215954|18814188|P2|Safety Analysis Set|Overall Study||211
7640470|NCT02215954|18814189|P1|Safety Analysis Set|Overall Study||213
7640471|NCT02215954|18814187|P3|Per Protocol (PP) Analysis Set|Overall Study||205
7640472|NCT02215954|18814188|P2|Per Protocol (PP) Analysis Set|Overall Study||208
7640473|NCT02215954|18814189|P1|Per Protocol (PP) Analysis Set|Overall Study||212
7640474|NCT02215954|18814187|P3|Intention-To-Treat (ITT) Analysis Set|Overall Study||211
7640475|NCT02215954|18814188|P2|Intention-To-Treat (ITT) Analysis Set|Overall Study||212
7640476|NCT02215954|18814189|P1|Intention-To-Treat (ITT) Analysis Set|Overall Study||214
7640477|NCT02215954|18814187|P3|STARTED|Overall Study||211
7640478|NCT02215954|18814188|P2|STARTED|Overall Study||212
7640479|NCT02215954|18814189|P1|STARTED|Overall Study||214
7640480|NCT02215616|18814213|P4|NOT COMPLETED|Overall Study||13
7640481|NCT02215616|18814214|P3|NOT COMPLETED|Overall Study||14
7640482|NCT02215616|18814215|P2|NOT COMPLETED|Overall Study||17
7640483|NCT02215616|18814216|P1|NOT COMPLETED|Overall Study||11
7640484|NCT02215616|18814213|P4|COMPLETED|Overall Study||17
7640485|NCT02215616|18814214|P3|COMPLETED|Overall Study||93
7640486|NCT02215616|18814215|P2|COMPLETED|Overall Study||90
7640487|NCT02215616|18814216|P1|COMPLETED|Overall Study||97
7640488|NCT02215616|18814213|P4|Received at Least 1 Dose of Study Drug|Overall Study||29
7640489|NCT02215616|18814214|P3|Received at Least 1 Dose of Study Drug|Overall Study||106
7640490|NCT02215616|18814215|P2|Received at Least 1 Dose of Study Drug|Overall Study||107
7640491|NCT02215616|18814216|P1|Received at Least 1 Dose of Study Drug|Overall Study||108
7640492|NCT02215616|18814213|P4|STARTED|Overall Study||30
7640493|NCT02215616|18814214|P3|STARTED|Overall Study||107
7640494|NCT02215616|18814215|P2|STARTED|Overall Study||107
7640495|NCT02215616|18814216|P1|STARTED|Overall Study||108
7640496|NCT02215369|18814230|P1|NOT COMPLETED|Overall Study||42
7640497|NCT02215369|18814230|P1|COMPLETED|Overall Study||70
7640498|NCT02215369|18814230|P1|STARTED|Overall Study||112
7640499|NCT02215252|18814238|P3|NOT COMPLETED|Overall Study||4
7640500|NCT02215252|18814239|P2|NOT COMPLETED|Overall Study||8
7640501|NCT02215252|18814240|P1|NOT COMPLETED|Overall Study||2
7640502|NCT02215252|18814238|P3|COMPLETED|Overall Study||41
7640503|NCT02215252|18814239|P2|COMPLETED|Overall Study||38
7640504|NCT02215252|18814240|P1|COMPLETED|Overall Study||42
7640505|NCT02215252|18814238|P3|STARTED|Overall Study||45
7640506|NCT02215252|18814239|P2|STARTED|Overall Study||46
7640507|NCT02215252|18814240|P1|STARTED|Overall Study||44
7640508|NCT02215200|18814300|P3|NOT COMPLETED|Overall Study||1
7640509|NCT02215200|18814301|P2|NOT COMPLETED|Overall Study||1
7640510|NCT02215200|18814302|P1|NOT COMPLETED|Overall Study||0
7640511|NCT02215200|18814300|P3|COMPLETED|Overall Study||30
7640512|NCT02215200|18814301|P2|COMPLETED|Overall Study||28
7640513|NCT02215200|18814302|P1|COMPLETED|Overall Study||29
7640514|NCT02215200|18814300|P3|STARTED|Overall Study||31
7640515|NCT02215200|18814301|P2|STARTED|Overall Study||29
7640516|NCT02215200|18814302|P1|STARTED|Overall Study||29
7640517|NCT02215161|18814310|P1|NOT COMPLETED|Overall Study||0
7640518|NCT02215161|18814310|P1|COMPLETED|Overall Study||14
7640519|NCT02215161|18814310|P1|STARTED|Overall Study||14
7640520|NCT02215096|18814328|P5|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
7640521|NCT02215096|18814329|P4|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
7640522|NCT02215096|18814330|P3|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
7640523|NCT02215096|18814331|P2|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
7640524|NCT02215096|18814332|P1|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||0
7640525|NCT02215096|18814328|P5|COMPLETED|Combination TP (Up to Maximum 654 Days)||1
7640526|NCT02215096|18814329|P4|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
7640527|NCT02215096|18814330|P3|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
7640528|NCT02215096|18814331|P2|COMPLETED|Combination TP (Up to Maximum 654 Days)||9
7640529|NCT02215096|18814332|P1|COMPLETED|Combination TP (Up to Maximum 654 Days)||0
7640530|NCT02215096|18814328|P5|STARTED|Combination TP (Up to Maximum 654 Days)||2
7640531|NCT02215096|18814329|P4|STARTED|Combination TP (Up to Maximum 654 Days)||12
7640532|NCT02215096|18814330|P3|STARTED|Combination TP (Up to Maximum 654 Days)||11
7640533|NCT02215096|18814331|P2|STARTED|Combination TP (Up to Maximum 654 Days)||11
7640534|NCT02215096|18814332|P1|STARTED|Combination TP (Up to Maximum 654 Days)||0
7640535|NCT02215096|18814328|P5|NOT COMPLETED|Run-In Period (Up to Week 2)||0
7640536|NCT02215096|18814329|P4|NOT COMPLETED|Run-In Period (Up to Week 2)||0
7640537|NCT02215096|18814330|P3|NOT COMPLETED|Run-In Period (Up to Week 2)||0
7640538|NCT02215096|18814331|P2|NOT COMPLETED|Run-In Period (Up to Week 2)||0
7640539|NCT02215096|18814332|P1|NOT COMPLETED|Run-In Period (Up to Week 2)||1
7640540|NCT02215096|18814328|P5|COMPLETED|Run-In Period (Up to Week 2)||0
7640541|NCT02215096|18814329|P4|COMPLETED|Run-In Period (Up to Week 2)||0
7640542|NCT02215096|18814330|P3|COMPLETED|Run-In Period (Up to Week 2)||0
7640543|NCT02215096|18814331|P2|COMPLETED|Run-In Period (Up to Week 2)||0
7640544|NCT02215096|18814332|P1|COMPLETED|Run-In Period (Up to Week 2)||36
7640545|NCT02215096|18814328|P5|STARTED|Run-In Period (Up to Week 2)||0
7640546|NCT02215096|18814329|P4|STARTED|Run-In Period (Up to Week 2)||0
7640547|NCT02215096|18814330|P3|STARTED|Run-In Period (Up to Week 2)||0
7640548|NCT02215096|18814331|P2|STARTED|Run-In Period (Up to Week 2)||0
7640549|NCT02215096|18814332|P1|STARTED|Run-In Period (Up to Week 2)||37
7640550|NCT02215070|18814417|P1|NOT COMPLETED|Overall Study||6
7640551|NCT02215070|18814417|P1|COMPLETED|Overall Study||20
7640552|NCT02215070|18814417|P1|STARTED|Overall Study||26
7640553|NCT02214628|18814425|P2|NOT COMPLETED|Overall Study||29
7640554|NCT02214628|18814426|P1|NOT COMPLETED|Overall Study||27
7640555|NCT02214628|18814425|P2|COMPLETED|Overall Study||9
7640556|NCT02214628|18814426|P1|COMPLETED|Overall Study||36
7640557|NCT02214628|18814425|P2|STARTED|Overall Study||38
7640558|NCT02214628|18814426|P1|STARTED|Overall Study||63
7640559|NCT02214615|18814436|P2|NOT COMPLETED|Second Intervention||0
7640560|NCT02214615|18814437|P1|NOT COMPLETED|Second Intervention||0
7640561|NCT02214615|18814436|P2|COMPLETED|Second Intervention||1
7640562|NCT02214615|18814437|P1|COMPLETED|Second Intervention||1
7640563|NCT02214615|18814436|P2|STARTED|Second Intervention||1
7640564|NCT02214615|18814437|P1|STARTED|Second Intervention||1
7640565|NCT02214615|18814436|P2|NOT COMPLETED|Washout||0
7640566|NCT02214615|18814437|P1|NOT COMPLETED|Washout||0
7640567|NCT02214615|18814436|P2|COMPLETED|Washout||1
7640568|NCT02214615|18814437|P1|COMPLETED|Washout||1
7640569|NCT02214615|18814436|P2|STARTED|Washout||1
7640570|NCT02214615|18814437|P1|STARTED|Washout||1
7640571|NCT02214615|18814436|P2|NOT COMPLETED|First Intervention||0
7640572|NCT02214615|18814437|P1|NOT COMPLETED|First Intervention||0
7640573|NCT02214615|18814436|P2|COMPLETED|First Intervention||1
7640574|NCT02214615|18814437|P1|COMPLETED|First Intervention||1
7640575|NCT02214615|18814436|P2|STARTED|First Intervention||1
7640576|NCT02214615|18814437|P1|STARTED|First Intervention||1
7640577|NCT02214420|18814447|P2|NOT COMPLETED|Overall Study||0
7640578|NCT02214420|18814448|P1|NOT COMPLETED|Overall Study||1
7640579|NCT02214420|18814447|P2|COMPLETED|Overall Study||10
7640580|NCT02214420|18814448|P1|COMPLETED|Overall Study||13
7640581|NCT02214420|18814447|P2|STARTED|Overall Study||10
7640582|NCT02214420|18814448|P1|STARTED|Overall Study||14
7640583|NCT02214290|18814454|P2|NOT COMPLETED|Second Intervention (7 Days)||0
7640584|NCT02214290|18814455|P1|NOT COMPLETED|Second Intervention (7 Days)||0
7640585|NCT02214290|18814454|P2|COMPLETED|Second Intervention (7 Days)||8
7640586|NCT02214290|18814455|P1|COMPLETED|Second Intervention (7 Days)||8
7640587|NCT02214290|18814454|P2|STARTED|Second Intervention (7 Days)||8
7640588|NCT02214290|18814455|P1|STARTED|Second Intervention (7 Days)||8
7640589|NCT02214290|18814454|P2|NOT COMPLETED|Washout (14 Days)||0
7640590|NCT02214290|18814455|P1|NOT COMPLETED|Washout (14 Days)||0
7640591|NCT02214290|18814454|P2|COMPLETED|Washout (14 Days)||8
7640592|NCT02214290|18814455|P1|COMPLETED|Washout (14 Days)||8
7640593|NCT02214290|18814454|P2|STARTED|Washout (14 Days)||8
7640594|NCT02214290|18814455|P1|STARTED|Washout (14 Days)||8
7640595|NCT02214290|18814454|P2|NOT COMPLETED|First Intervention (7 Days)||0
7640596|NCT02214290|18814455|P1|NOT COMPLETED|First Intervention (7 Days)||0
7640597|NCT02214290|18814454|P2|COMPLETED|First Intervention (7 Days)||8
7640598|NCT02214290|18814455|P1|COMPLETED|First Intervention (7 Days)||8
7640599|NCT02214290|18814454|P2|STARTED|First Intervention (7 Days)||8
7640600|NCT02214290|18814455|P1|STARTED|First Intervention (7 Days)||8
7640601|NCT02214277|18814468|P3|NOT COMPLETED|Overall Study||34
7640602|NCT02214277|18814469|P2|NOT COMPLETED|Overall Study||25
7640603|NCT02214277|18814470|P1|NOT COMPLETED|Overall Study||19
7640604|NCT02214277|18814468|P3|COMPLETED|Overall Study||85
7640605|NCT02214277|18814469|P2|COMPLETED|Overall Study||96
7640606|NCT02214277|18814470|P1|COMPLETED|Overall Study||104
7640607|NCT02214277|18814468|P3|STARTED|Overall Study||119
7640608|NCT02214277|18814469|P2|STARTED|Overall Study||121
7640609|NCT02214277|18814470|P1|STARTED|Overall Study||123
7640610|NCT02214238|18814480|P2|NOT COMPLETED|Overall Study||6
7640611|NCT02214238|18814481|P1|NOT COMPLETED|Overall Study||6
7640612|NCT02214238|18814480|P2|COMPLETED|Overall Study||17
7640613|NCT02214238|18814481|P1|COMPLETED|Overall Study||20
7640614|NCT02214238|18814480|P2|STARTED|Overall Study||23
7640615|NCT02214238|18814481|P1|STARTED|Overall Study||26
7640616|NCT02214225|18814494|P3|NOT COMPLETED|Overall Study||22
7640617|NCT02214225|18814495|P2|NOT COMPLETED|Overall Study||19
7640618|NCT02214225|18814496|P1|NOT COMPLETED|Overall Study||55
7640619|NCT02214225|18814494|P3|COMPLETED|Overall Study||850
7640620|NCT02214225|18814495|P2|COMPLETED|Overall Study||852
7640621|NCT02214225|18814496|P1|COMPLETED|Overall Study||1686
7640622|NCT02214225|18814494|P3|STARTED|Overall Study||872
7640623|NCT02214225|18814495|P2|STARTED|Overall Study||871
7640624|NCT02214225|18814496|P1|STARTED|Overall Study||1741
7640625|NCT02214186|18814555|P2|NOT COMPLETED|Overall Study||2
7640626|NCT02214186|18814556|P1|NOT COMPLETED|Overall Study||2
7640627|NCT02214186|18814555|P2|COMPLETED|Overall Study||21
7640628|NCT02214186|18814556|P1|COMPLETED|Overall Study||21
7640629|NCT02214186|18814555|P2|STARTED|Overall Study||23
7640630|NCT02214186|18814556|P1|STARTED|Overall Study||23
7640631|NCT02214147|18814581|P3|NOT COMPLETED|Overall Study||0
7640632|NCT02214147|18814582|P2|NOT COMPLETED|Overall Study||0
7640633|NCT02214147|18814583|P1|NOT COMPLETED|Overall Study||0
7640634|NCT02214147|18814581|P3|COMPLETED|Overall Study||8
7640635|NCT02214147|18814582|P2|COMPLETED|Overall Study||12
7640636|NCT02214147|18814583|P1|COMPLETED|Overall Study||16
7640637|NCT02214147|18814581|P3|STARTED|Overall Study||8
7640638|NCT02214147|18814582|P2|STARTED|Overall Study||12
7640639|NCT02214147|18814583|P1|STARTED|Overall Study||16
7640640|NCT02214121|18814624|P3|NOT COMPLETED|Part B||1
7640641|NCT02214121|18814625|P2|NOT COMPLETED|Part B||3
7640642|NCT02214121|18814626|P1|NOT COMPLETED|Part B||0
7640643|NCT02214121|18814624|P3|COMPLETED|Part B||7
7640644|NCT02214121|18814625|P2|COMPLETED|Part B||14
7640645|NCT02214121|18814626|P1|COMPLETED|Part B||0
7640646|NCT02214121|18814624|P3|STARTED|Part B||8
7640647|NCT02214121|18814625|P2|STARTED|Part B||17
7640648|NCT02214121|18814626|P1|STARTED|Part B||0
7640649|NCT02214121|18814624|P3|NOT COMPLETED|Part A||0
7640650|NCT02214121|18814625|P2|NOT COMPLETED|Part A||0
7640651|NCT02214121|18814626|P1|NOT COMPLETED|Part A||7
7640652|NCT02214121|18814624|P3|COMPLETED|Part A||0
7640653|NCT02214121|18814625|P2|COMPLETED|Part A||0
7640654|NCT02214121|18814626|P1|COMPLETED|Part A||39
7640655|NCT02214121|18814624|P3|STARTED|Part A||0
7640656|NCT02214121|18814625|P2|STARTED|Part A||0
7640657|NCT02214121|18814626|P1|STARTED|Part A||46
7640658|NCT02214017|18814705|P2|NOT COMPLETED|Overall Study||0
7640659|NCT02214017|18814706|P1|NOT COMPLETED|Overall Study||0
7640660|NCT02214017|18814705|P2|COMPLETED|Overall Study||18
7640661|NCT02214017|18814706|P1|COMPLETED|Overall Study||22
7640662|NCT02214017|18814705|P2|STARTED|Overall Study||18
7640663|NCT02214017|18814706|P1|STARTED|Overall Study||22
7640664|NCT02213926|18814716|P1|NOT COMPLETED|Overall Study||70
7640665|NCT02213926|18814716|P1|COMPLETED|Overall Study||54
7640666|NCT02213926|18814716|P1|STARTED|Overall Study||124
7640667|NCT02213900|18814722|P2|NOT COMPLETED|Overall Study||0
7640668|NCT02213900|18814723|P1|NOT COMPLETED|Overall Study||0
7640669|NCT02213900|18814722|P2|COMPLETED|Overall Study||67
7640670|NCT02213900|18814723|P1|COMPLETED|Overall Study||68
7640671|NCT02213900|18814722|P2|STARTED|Overall Study||67
7640672|NCT02213900|18814723|P1|STARTED|Overall Study||68
7640673|NCT02213666|18814735|P1|NOT COMPLETED|Overall Study||1
7640674|NCT02213666|18814735|P1|COMPLETED|Overall Study||71
7640675|NCT02213666|18814735|P1|STARTED|Overall Study||72
7640676|NCT02213510|18814741|P2|NOT COMPLETED|Overall Study||1
7640677|NCT02213510|18814742|P1|NOT COMPLETED|Overall Study||1
7640678|NCT02213510|18814741|P2|COMPLETED|Overall Study||18
7640679|NCT02213510|18814742|P1|COMPLETED|Overall Study||20
7640680|NCT02213510|18814741|P2|STARTED|Overall Study||19
7640681|NCT02213510|18814742|P1|STARTED|Overall Study||21
7640682|NCT02213263|18814770|P2|NOT COMPLETED|Overall Study||26
7640683|NCT02213263|18814771|P1|NOT COMPLETED|Overall Study||28
7640684|NCT02213263|18814770|P2|COMPLETED|Overall Study||170
7640685|NCT02213263|18814771|P1|COMPLETED|Overall Study||170
7640686|NCT02213263|18814770|P2|Treated|Overall Study||196
7640687|NCT02213263|18814771|P1|Treated|Overall Study||197
7640688|NCT02213263|18814770|P2|STARTED|Overall Study||196
7640689|NCT02213263|18814771|P1|STARTED|Overall Study||198
7640690|NCT02213250|18814807|P2|NOT COMPLETED|Overall Study||0
7640691|NCT02213250|18814808|P1|NOT COMPLETED|Overall Study||0
7640692|NCT02213250|18814807|P2|COMPLETED|Overall Study||8
7640693|NCT02213250|18814808|P1|COMPLETED|Overall Study||4
7640694|NCT02213250|18814807|P2|STARTED|Overall Study||8
7640695|NCT02213250|18814808|P1|STARTED|Overall Study||4
7640696|NCT02213198|18814839|P2|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7
7640697|NCT02213198|18814840|P1|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23
7640698|NCT02213198|18814839|P2|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60
7640699|NCT02213198|18814840|P1|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102
7640700|NCT02213198|18814839|P2|STARTED|Follow up 2 6 Months Post TCC Treatment||67
7640701|NCT02213198|18814840|P1|STARTED|Follow up 2 6 Months Post TCC Treatment||125
7640702|NCT02213198|18814839|P2|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41
7640703|NCT02213198|18814840|P1|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93
7640704|NCT02213198|18814839|P2|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67
7640705|NCT02213198|18814840|P1|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125
7640706|NCT02213198|18814839|P2|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108
7640707|NCT02213198|18814840|P1|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218
7640708|NCT02213198|18814839|P2|NOT COMPLETED|Baseline||51
7640709|NCT02213198|18814840|P1|NOT COMPLETED|Baseline||88
7640710|NCT02213198|18814839|P2|COMPLETED|Baseline||108
7640711|NCT02213198|18814840|P1|COMPLETED|Baseline||218
7640712|NCT02213198|18814839|P2|STARTED|Baseline||159
7640713|NCT02213198|18814840|P1|STARTED|Baseline||306
7640714|NCT02213133|18814851|P3|NOT COMPLETED|Overall Study||3
7640715|NCT02213133|18814852|P2|NOT COMPLETED|Overall Study||5
7640716|NCT02213133|18814853|P1|NOT COMPLETED|Overall Study||37
7640717|NCT02213133|18814851|P3|COMPLETED|Overall Study||0
7640718|NCT02213133|18814852|P2|COMPLETED|Overall Study||0
7640719|NCT02213133|18814853|P1|COMPLETED|Overall Study||0
7640720|NCT02213133|18814851|P3|Treated|Overall Study||1
7640721|NCT02213133|18814852|P2|Treated|Overall Study||4
7640722|NCT02213133|18814853|P1|Treated|Overall Study||33
7640723|NCT02213133|18814851|P3|STARTED|Overall Study||3
7640724|NCT02213133|18814852|P2|STARTED|Overall Study||5
7640725|NCT02213133|18814853|P1|STARTED|Overall Study||37
7640726|NCT02213094|18814869|P2|NOT COMPLETED|Overall Study||0
7640727|NCT02213094|18814870|P1|NOT COMPLETED|Overall Study||1
7640728|NCT02213094|18814869|P2|COMPLETED|Overall Study||5
7640729|NCT02213094|18814870|P1|COMPLETED|Overall Study|One subject stopped study agent early because of elevation in LFTs > 3x ULN|4
7640730|NCT02213094|18814869|P2|STARTED|Overall Study||5
7640731|NCT02213094|18814870|P1|STARTED|Overall Study||5
7640732|NCT02213055|18814878|P2|NOT COMPLETED|Overall Study||0
7640733|NCT02213055|18814879|P1|NOT COMPLETED|Overall Study||39
7640734|NCT02213055|18814878|P2|COMPLETED|Overall Study||0
7640735|NCT02213055|18814879|P1|COMPLETED|Overall Study||58
7640736|NCT02213055|18814878|P2|STARTED|Overall Study||0
7640737|NCT02213055|18814879|P1|STARTED|Overall Study||97
7640738|NCT02212977|18814887|P2|NOT COMPLETED|Overall Study||6
7640739|NCT02212977|18814888|P1|NOT COMPLETED|Overall Study||5
7640740|NCT02212977|18814887|P2|COMPLETED|Overall Study||48
7640741|NCT02212977|18814888|P1|COMPLETED|Overall Study||50
7640742|NCT02212977|18814887|P2|STARTED|Overall Study||54
7640743|NCT02212977|18814888|P1|STARTED|Overall Study||55
7640744|NCT02212834|18814904|P2|NOT COMPLETED|Overall Study||0
7640745|NCT02212834|18814905|P1|NOT COMPLETED|Overall Study||0
7640746|NCT02212834|18814904|P2|COMPLETED|Overall Study||2506
7640747|NCT02212834|18814905|P1|COMPLETED|Overall Study||33938
7640748|NCT02212834|18814904|P2|STARTED|Overall Study||2506
7640749|NCT02212834|18814905|P1|STARTED|Overall Study||33938
7640750|NCT02212730|18814913|P2|NOT COMPLETED|Overall Study||1
7640751|NCT02212730|18814914|P1|NOT COMPLETED|Overall Study||2
7640752|NCT02212730|18814913|P2|COMPLETED|Overall Study||3
7640753|NCT02212730|18814914|P1|COMPLETED|Overall Study||4
7640754|NCT02212730|18814913|P2|Received Post-RCC Pembrolizumab|Overall Study||1
7640755|NCT02212730|18814914|P1|Received Post-RCC Pembrolizumab|Overall Study||1
7640756|NCT02212730|18814913|P2|Underwent RCC|Overall Study||3
7640757|NCT02212730|18814914|P1|Underwent RCC|Overall Study||4
7640758|NCT02212730|18814913|P2|Received Neoadjuvant Pembrolizumab|Overall Study||0
7640759|NCT02212730|18814914|P1|Received Neoadjuvant Pembrolizumab|Overall Study||4
7640760|NCT02212730|18814913|P2|STARTED|Overall Study||4
7640761|NCT02212730|18814914|P1|STARTED|Overall Study||6
7640762|NCT02212678|18814936|P1|NOT COMPLETED|Overall Study||1
7640763|NCT02212678|18814936|P1|COMPLETED|Overall Study||7
7640764|NCT02212678|18814936|P1|STARTED|Overall Study||8
7640765|NCT02212587|18814940|P1|NOT COMPLETED|Overall Study||1
7640766|NCT02212587|18814940|P1|COMPLETED|Overall Study||9
7640767|NCT02212587|18814940|P1|STARTED|Overall Study||10
7640768|NCT02212457|18814956|P6|NOT COMPLETED|Overall Study||13
7640769|NCT02212457|18814957|P5|NOT COMPLETED|Overall Study||15
7640770|NCT02212457|18814958|P4|NOT COMPLETED|Overall Study||11
7640771|NCT02212457|18814959|P3|NOT COMPLETED|Overall Study||16
7640772|NCT02212457|18814960|P2|NOT COMPLETED|Overall Study||21
7640773|NCT02212457|18814961|P1|NOT COMPLETED|Overall Study||19
7640774|NCT02212457|18814956|P6|COMPLETED|Overall Study||147
7640775|NCT02212457|18814957|P5|COMPLETED|Overall Study||137
7640776|NCT02212457|18814958|P4|COMPLETED|Overall Study||123
7640777|NCT02212457|18814959|P3|COMPLETED|Overall Study||141
7640778|NCT02212457|18814960|P2|COMPLETED|Overall Study||211
7640779|NCT02212457|18814961|P1|COMPLETED|Overall Study||209
7640780|NCT02212457|18814956|P6|STARTED|Overall Study||160
7640781|NCT02212457|18814957|P5|STARTED|Overall Study||152
7640782|NCT02212457|18814958|P4|STARTED|Overall Study||134
7640783|NCT02212457|18814959|P3|STARTED|Overall Study||157
7640784|NCT02212457|18814960|P2|STARTED|Overall Study||232
7640785|NCT02212457|18814961|P1|STARTED|Overall Study||228
7640786|NCT02212301|18815085|P2|NOT COMPLETED|Period 2||0
7640787|NCT02212301|18815086|P1|NOT COMPLETED|Period 2||0
7640788|NCT02212301|18815085|P2|COMPLETED|Period 2||21
7640789|NCT02212301|18815086|P1|COMPLETED|Period 2||21
7640790|NCT02212301|18815085|P2|STARTED|Period 2||21
7640791|NCT02212301|18815086|P1|STARTED|Period 2||21
7640792|NCT02212301|18815085|P2|NOT COMPLETED|Period 1||1
7640793|NCT02212301|18815086|P1|NOT COMPLETED|Period 1||0
7640794|NCT02212301|18815085|P2|COMPLETED|Period 1||21
7640795|NCT02212301|18815086|P1|COMPLETED|Period 1||21
7640796|NCT02212301|18815085|P2|STARTED|Period 1||22
7640797|NCT02212301|18815086|P1|STARTED|Period 1||21
7640798|NCT02212197|18815097|P3|NOT COMPLETED|Overall Study||0
7640799|NCT02212197|18815098|P2|NOT COMPLETED|Overall Study||0
7640800|NCT02212197|18815099|P1|NOT COMPLETED|Overall Study||1
7640801|NCT02212197|18815097|P3|COMPLETED|Overall Study||17
7640802|NCT02212197|18815098|P2|COMPLETED|Overall Study||15
7640803|NCT02212197|18815099|P1|COMPLETED|Overall Study||18
7640804|NCT02212197|18815097|P3|STARTED|Overall Study||17
7640805|NCT02212197|18815098|P2|STARTED|Overall Study||15
7640806|NCT02212197|18815099|P1|STARTED|Overall Study||19
7640807|NCT02212106|18815124|P2|NOT COMPLETED|Overall Study||4
7640808|NCT02212106|18815125|P1|NOT COMPLETED|Overall Study||10
7640809|NCT02212106|18815124|P2|COMPLETED|Overall Study||96
7640810|NCT02212106|18815125|P1|COMPLETED|Overall Study||292
7640811|NCT02212106|18815124|P2|STARTED|Overall Study||100
7640812|NCT02212106|18815125|P1|STARTED|Overall Study||302
7640813|NCT02212028|18815143|P2|NOT COMPLETED|Overall Study||0
7640814|NCT02212028|18815144|P1|NOT COMPLETED|Overall Study||0
7640815|NCT02212028|18815143|P2|COMPLETED|Overall Study||26
7640816|NCT02212028|18815144|P1|COMPLETED|Overall Study||26
7640817|NCT02212028|18815143|P2|STARTED|Overall Study||26
7640818|NCT02212028|18815144|P1|STARTED|Overall Study||26
7640819|NCT02211638|18815152|P1|NOT COMPLETED|Overall Study||983
7640820|NCT02211638|18815152|P1|COMPLETED|Overall Study||17130
7640821|NCT02211638|18815152|P1|STARTED|Overall Study||18113
7640822|NCT02211534|18815163|P2|NOT COMPLETED|Overall Study||5
7640823|NCT02211534|18815164|P1|NOT COMPLETED|Overall Study||13
7640824|NCT02211534|18815163|P2|COMPLETED|Overall Study||6
7640825|NCT02211534|18815164|P1|COMPLETED|Overall Study||11
7640826|NCT02211534|18815163|P2|STARTED|Overall Study||11
7640827|NCT02211534|18815164|P1|STARTED|Overall Study||24
7640828|NCT02211495|18815186|P2|NOT COMPLETED|Overall Study||0
7640829|NCT02211495|18815187|P1|NOT COMPLETED|Overall Study||0
7640830|NCT02211495|18815186|P2|COMPLETED|Overall Study||4
7640831|NCT02211495|18815187|P1|COMPLETED|Overall Study||4
7640832|NCT02211495|18815186|P2|STARTED|Overall Study||4
7640833|NCT02211495|18815187|P1|STARTED|Overall Study||4
7640834|NCT02211313|18815199|P2|NOT COMPLETED|Overall Study||3
7640835|NCT02211313|18815200|P1|NOT COMPLETED|Overall Study||6
7640836|NCT02211313|18815199|P2|COMPLETED|Overall Study||20
7640837|NCT02211313|18815200|P1|COMPLETED|Overall Study||12
7640838|NCT02211313|18815199|P2|STARTED|Overall Study||23
7640839|NCT02211313|18815200|P1|STARTED|Overall Study||18
7640840|NCT02211261|18815217|P11|NOT COMPLETED|Overall Study||0
7640841|NCT02211261|18815218|P10|NOT COMPLETED|Overall Study||2
7640842|NCT02211261|18815219|P9|NOT COMPLETED|Overall Study||0
7640843|NCT02211261|18815220|P8|NOT COMPLETED|Overall Study||1
7640844|NCT02211261|18815221|P7|NOT COMPLETED|Overall Study||0
7640845|NCT02211261|18815222|P6|NOT COMPLETED|Overall Study||1
7640846|NCT02211261|18815223|P5|NOT COMPLETED|Overall Study||2
7640847|NCT02211261|18815224|P4|NOT COMPLETED|Overall Study||0
7640848|NCT02211261|18815225|P3|NOT COMPLETED|Overall Study||1
7640849|NCT02211261|18815226|P2|NOT COMPLETED|Overall Study||0
7640850|NCT02211261|18815227|P1|NOT COMPLETED|Overall Study||0
7640851|NCT02211261|18815217|P11|COMPLETED|Overall Study||8
7640852|NCT02211261|18815218|P10|COMPLETED|Overall Study||14
7640853|NCT02211261|18815219|P9|COMPLETED|Overall Study||8
7640854|NCT02211261|18815220|P8|COMPLETED|Overall Study||7
7640855|NCT02211261|18815221|P7|COMPLETED|Overall Study||6
7640856|NCT02211261|18815222|P6|COMPLETED|Overall Study||1
7640857|NCT02211261|18815223|P5|COMPLETED|Overall Study||7
7640858|NCT02211261|18815224|P4|COMPLETED|Overall Study||6
7640859|NCT02211261|18815225|P3|COMPLETED|Overall Study||5
7640860|NCT02211261|18815226|P2|COMPLETED|Overall Study||6
7640861|NCT02211261|18815227|P1|COMPLETED|Overall Study||9
7640862|NCT02211261|18815217|P11|STARTED|Overall Study||8
7640863|NCT02211261|18815218|P10|STARTED|Overall Study||16
7640864|NCT02211261|18815219|P9|STARTED|Overall Study||8
7640865|NCT02211261|18815220|P8|STARTED|Overall Study||8
7640866|NCT02211261|18815221|P7|STARTED|Overall Study||6
7640867|NCT02211261|18815222|P6|STARTED|Overall Study||2
7640868|NCT02211261|18815223|P5|STARTED|Overall Study||9
7640869|NCT02211261|18815224|P4|STARTED|Overall Study||6
7640870|NCT02211261|18815225|P3|STARTED|Overall Study||6
7640871|NCT02211261|18815226|P2|STARTED|Overall Study||6
7640872|NCT02211261|18815227|P1|STARTED|Overall Study||9
7640873|NCT02211131|18815350|P2|NOT COMPLETED|Overall Study||76
7640874|NCT02211131|18815351|P1|NOT COMPLETED|Overall Study||74
7640875|NCT02211131|18815350|P2|COMPLETED|Overall Study||0
7640876|NCT02211131|18815351|P1|COMPLETED|Overall Study||0
7640877|NCT02211131|18815350|P2|STARTED|Overall Study||76
7640878|NCT02211131|18815351|P1|STARTED|Overall Study||74
7640879|NCT02211014|18815385|P2|NOT COMPLETED|Overall Study||6
7640880|NCT02211014|18815386|P1|NOT COMPLETED|Overall Study||2
7640881|NCT02211014|18815385|P2|COMPLETED|Overall Study||8
7640882|NCT02211014|18815386|P1|COMPLETED|Overall Study||11
7640883|NCT02211014|18815385|P2|STARTED|Overall Study||14
7640884|NCT02211014|18815386|P1|STARTED|Overall Study||13
7640885|NCT02210780|18815412|P2|NOT COMPLETED|Overall Study||8
7640886|NCT02210780|18815413|P1|NOT COMPLETED|Overall Study||5
7640887|NCT02210780|18815412|P2|COMPLETED|Overall Study||89
7640888|NCT02210780|18815413|P1|COMPLETED|Overall Study||92
7640889|NCT02210780|18815412|P2|STARTED|Overall Study||97
7640890|NCT02210780|18815413|P1|STARTED|Overall Study||97
7640891|NCT02210689|18815442|P3|NOT COMPLETED|Overall Study||23
7640892|NCT02210689|18815443|P2|NOT COMPLETED|Overall Study||47
7640893|NCT02210689|18815444|P1|NOT COMPLETED|Overall Study||52
7640894|NCT02210689|18815442|P3|COMPLETED|Overall Study||99
7640895|NCT02210689|18815443|P2|COMPLETED|Overall Study||193
7640896|NCT02210689|18815444|P1|COMPLETED|Overall Study||190
7640897|NCT02210689|18815442|P3|PP Population|Overall Study||84
7640898|NCT02210689|18815443|P2|PP Population|Overall Study||169
7640899|NCT02210689|18815444|P1|PP Population|Overall Study||164
7640900|NCT02210689|18815442|P3|mITT Population|Overall Study||107
7640901|NCT02210689|18815443|P2|mITT Population|Overall Study||207
7640902|NCT02210689|18815444|P1|mITT Population|Overall Study||199
7640903|NCT02210689|18815442|P3|Safety Population|Overall Study||122
7640904|NCT02210689|18815443|P2|Safety Population|Overall Study||236
7640905|NCT02210689|18815444|P1|Safety Population|Overall Study||233
7640906|NCT02210689|18815442|P3|STARTED|Overall Study||122
7640907|NCT02210689|18815443|P2|STARTED|Overall Study||240
7640908|NCT02210689|18815444|P1|STARTED|Overall Study||242
7640909|NCT02210221|18815452|P1|NOT COMPLETED|Overall Study||50
7640910|NCT02210221|18815452|P1|COMPLETED|Overall Study||4509
7640911|NCT02210221|18815452|P1|STARTED|Overall Study||4559
7640912|NCT02210208|18815467|P1|NOT COMPLETED|Period B (Donor Site)||7
7640913|NCT02210208|18815467|P1|COMPLETED|Period B (Donor Site)||12
7640914|NCT02210208|18815467|P1|STARTED|Period B (Donor Site)|6 subjects was decided by the Physician not to be included in the Part B.|19
7640915|NCT02210208|18815467|P1|NOT COMPLETED|Period A (Graft Site)||2
7640916|NCT02210208|18815467|P1|COMPLETED|Period A (Graft Site)||23
7640917|NCT02210208|18815467|P1|STARTED|Period A (Graft Site)||25
7640918|NCT02210195|18815476|P2|NOT COMPLETED|Overall Study||0
7640919|NCT02210195|18815477|P1|NOT COMPLETED|Overall Study||4
7640920|NCT02210195|18815476|P2|COMPLETED|Overall Study||10
7640921|NCT02210195|18815477|P1|COMPLETED|Overall Study||6
7640922|NCT02210195|18815476|P2|STARTED|Overall Study||10
7640923|NCT02210195|18815477|P1|STARTED|Overall Study||10
7640924|NCT02210091|18815487|P2|NOT COMPLETED|Overall Study||2
7640925|NCT02210091|18815488|P1|NOT COMPLETED|Overall Study||0
7640926|NCT02210091|18815487|P2|COMPLETED|Overall Study||32
7640927|NCT02210091|18815488|P1|COMPLETED|Overall Study||32
7640928|NCT02210091|18815487|P2|STARTED|Overall Study||34
7640929|NCT02210091|18815488|P1|STARTED|Overall Study||32
7640930|NCT02210065|18815560|P1|NOT COMPLETED|Overall Study||0
7640931|NCT02210065|18815560|P1|COMPLETED|Overall Study||1
7640932|NCT02210065|18815560|P1|STARTED|Overall Study||1
7640933|NCT02210052|18815565|P1|NOT COMPLETED|Overall Study||0
7640934|NCT02210052|18815565|P1|COMPLETED|Overall Study||6
7640935|NCT02210052|18815565|P1|STARTED|Overall Study||6
7640936|NCT02210039|18815569|P1|NOT COMPLETED|Overall Study||0
7640937|NCT02210039|18815569|P1|COMPLETED|Overall Study||6
7640938|NCT02210039|18815569|P1|STARTED|Overall Study||6
7640939|NCT02210000|18815575|P2|NOT COMPLETED|Overall Study||21
7640940|NCT02210000|18815576|P1|NOT COMPLETED|Overall Study||19
7640941|NCT02210000|18815575|P2|COMPLETED|Overall Study||36
7640942|NCT02210000|18815576|P1|COMPLETED|Overall Study||38
7640943|NCT02210000|18815575|P2|STARTED|Overall Study||57
7640944|NCT02210000|18815576|P1|STARTED|Overall Study||57
7640945|NCT02209766|18815602|P5|NOT COMPLETED|Overall Study||0
7640946|NCT02209766|18815603|P4|NOT COMPLETED|Overall Study||1
7640947|NCT02209766|18815604|P3|NOT COMPLETED|Overall Study||0
7640948|NCT02209766|18815605|P2|NOT COMPLETED|Overall Study||0
7640949|NCT02209766|18815606|P1|NOT COMPLETED|Overall Study||0
7640950|NCT02209766|18815602|P5|COMPLETED|Overall Study||6
7640951|NCT02209766|18815603|P4|COMPLETED|Overall Study||2
7640952|NCT02209766|18815604|P3|COMPLETED|Overall Study||6
7640953|NCT02209766|18815605|P2|COMPLETED|Overall Study||3
7640954|NCT02209766|18815606|P1|COMPLETED|Overall Study||6
7640955|NCT02209766|18815602|P5|STARTED|Overall Study||6
7640956|NCT02209766|18815603|P4|STARTED|Overall Study||3
7640957|NCT02209766|18815604|P3|STARTED|Overall Study||6
7640958|NCT02209766|18815605|P2|STARTED|Overall Study||3
7640959|NCT02209766|18815606|P1|STARTED|Overall Study||6
7640960|NCT02209610|18815654|P2|NOT COMPLETED|Overall Study||0
7640961|NCT02209610|18815655|P1|NOT COMPLETED|Overall Study||0
7640962|NCT02209610|18815654|P2|COMPLETED|Overall Study||16
7640963|NCT02209610|18815655|P1|COMPLETED|Overall Study||16
7640964|NCT02209610|18815654|P2|STARTED|Overall Study||16
7640965|NCT02209610|18815655|P1|STARTED|Overall Study||16
7640966|NCT02209597|18815665|P1|NOT COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||0
7640967|NCT02209597|18815665|P1|COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
7640968|NCT02209597|18815665|P1|STARTED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
7640969|NCT02209597|18815665|P1|NOT COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||0
7640970|NCT02209597|18815665|P1|COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
7640971|NCT02209597|18815665|P1|STARTED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
7640972|NCT02209597|18815665|P1|NOT COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||4
7640973|NCT02209597|18815665|P1|COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||67
7640974|NCT02209597|18815665|P1|STARTED|Phase 2 (Randomized: 1 Brand, 3 Generic)||71
7640975|NCT02209597|18815665|P1|NOT COMPLETED|Phase 1 Current Tx (Non-randomized)||3
7640976|NCT02209597|18815665|P1|COMPLETED|Phase 1 Current Tx (Non-randomized)||71
7640977|NCT02209597|18815665|P1|STARTED|Phase 1 Current Tx (Non-randomized)||74
7640978|NCT02209532|18815677|P2|NOT COMPLETED|Overall Study||1
7640979|NCT02209532|18815678|P1|NOT COMPLETED|Overall Study||3
7640980|NCT02209532|18815677|P2|COMPLETED|Overall Study||89
7640981|NCT02209532|18815678|P1|COMPLETED|Overall Study||87
7640982|NCT02209532|18815677|P2|STARTED|Overall Study||90
7640983|NCT02209532|18815678|P1|STARTED|Overall Study||90
7640984|NCT02209519|18815696|P2|NOT COMPLETED|Overall Study||0
7640985|NCT02209519|18815697|P1|NOT COMPLETED|Overall Study||0
7640986|NCT02209519|18815696|P2|COMPLETED|Overall Study||107
7640987|NCT02209519|18815697|P1|COMPLETED|Overall Study||107
7640988|NCT02209519|18815696|P2|STARTED|Overall Study||107
7640989|NCT02209519|18815697|P1|STARTED|Overall Study||107
7640990|NCT02209506|18815710|P5|NOT COMPLETED|Overall Study||1
7640991|NCT02209506|18815711|P4|NOT COMPLETED|Overall Study||0
7640992|NCT02209506|18815712|P3|NOT COMPLETED|Overall Study||0
7640993|NCT02209506|18815713|P2|NOT COMPLETED|Overall Study||0
7640994|NCT02209506|18815714|P1|NOT COMPLETED|Overall Study||0
7640995|NCT02209506|18815710|P5|COMPLETED|Overall Study||5
7640996|NCT02209506|18815711|P4|COMPLETED|Overall Study||2
7640997|NCT02209506|18815712|P3|COMPLETED|Overall Study||6
7640998|NCT02209506|18815713|P2|COMPLETED|Overall Study||6
7640999|NCT02209506|18815714|P1|COMPLETED|Overall Study||3
7641000|NCT02209506|18815710|P5|STARTED|Overall Study||6
7641001|NCT02209506|18815711|P4|STARTED|Overall Study||2
7641002|NCT02209506|18815712|P3|STARTED|Overall Study||6
7641003|NCT02209506|18815713|P2|STARTED|Overall Study||6
7641004|NCT02209506|18815714|P1|STARTED|Overall Study||3
7641005|NCT02209454|18815789|P2|NOT COMPLETED|Second Period||0
7641006|NCT02209454|18815790|P1|NOT COMPLETED|Second Period||1
7641007|NCT02209454|18815789|P2|COMPLETED|Second Period||13
7641008|NCT02209454|18815790|P1|COMPLETED|Second Period||12
7641009|NCT02209454|18815789|P2|STARTED|Second Period||13
7641010|NCT02209454|18815790|P1|STARTED|Second Period||13
7641011|NCT02209454|18815789|P2|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
7641012|NCT02209454|18815790|P1|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
7641013|NCT02209454|18815789|P2|COMPLETED|Washout Period a Minimum of a 7 Day||13
7641014|NCT02209454|18815790|P1|COMPLETED|Washout Period a Minimum of a 7 Day||13
7641015|NCT02209454|18815789|P2|STARTED|Washout Period a Minimum of a 7 Day||13
7641016|NCT02209454|18815790|P1|STARTED|Washout Period a Minimum of a 7 Day||13
7641017|NCT02209454|18815789|P2|NOT COMPLETED|First Period||0
7641018|NCT02209454|18815790|P1|NOT COMPLETED|First Period||0
7641019|NCT02209454|18815789|P2|COMPLETED|First Period||13
7641020|NCT02209454|18815790|P1|COMPLETED|First Period||13
7641021|NCT02209454|18815789|P2|STARTED|First Period||13
7641022|NCT02209454|18815790|P1|STARTED|First Period||13
7641023|NCT02209272|18815806|P2|NOT COMPLETED|Overall Study||0
7641024|NCT02209272|18815807|P1|NOT COMPLETED|Overall Study||0
7641025|NCT02209272|18815806|P2|COMPLETED|Overall Study||36
7641026|NCT02209272|18815807|P1|COMPLETED|Overall Study||32
7641027|NCT02209272|18815806|P2|STARTED|Overall Study||36
7641028|NCT02209272|18815807|P1|STARTED|Overall Study||32
7641029|NCT02209259|18815820|P3|NOT COMPLETED|Overall Study||0
7641030|NCT02209259|18815821|P2|NOT COMPLETED|Overall Study||0
7641031|NCT02209259|18815822|P1|NOT COMPLETED|Overall Study||0
7641032|NCT02209259|18815820|P3|COMPLETED|Overall Study||56
7641033|NCT02209259|18815821|P2|COMPLETED|Overall Study||56
7641034|NCT02209259|18815822|P1|COMPLETED|Overall Study||56
7641035|NCT02209259|18815820|P3|STARTED|Overall Study||56
7641036|NCT02209259|18815821|P2|STARTED|Overall Study||56
7641037|NCT02209259|18815822|P1|STARTED|Overall Study||56
7641038|NCT02209181|18815840|P4|NOT COMPLETED|Overall Study||0
7641039|NCT02209181|18815841|P3|NOT COMPLETED|Overall Study||1
7641040|NCT02209181|18815842|P2|NOT COMPLETED|Overall Study||1
7641041|NCT02209181|18815843|P1|NOT COMPLETED|Overall Study||1
7641042|NCT02209181|18815840|P4|COMPLETED|Overall Study||66
7641043|NCT02209181|18815841|P3|COMPLETED|Overall Study||68
7641044|NCT02209181|18815842|P2|COMPLETED|Overall Study||66
7641045|NCT02209181|18815843|P1|COMPLETED|Overall Study||66
7641046|NCT02209181|18815840|P4|STARTED|Overall Study||66
7641047|NCT02209181|18815841|P3|STARTED|Overall Study||69
7641048|NCT02209181|18815842|P2|STARTED|Overall Study||67
7641049|NCT02209181|18815843|P1|STARTED|Overall Study||67
7641050|NCT02209064|18816005|P1|NOT COMPLETED|Overall Study||0
7641051|NCT02209064|18816005|P1|COMPLETED|Overall Study||25
7641052|NCT02209064|18816005|P1|STARTED|Overall Study||25
7641053|NCT02208999|18816014|P1|NOT COMPLETED|Overall Study||1
7641054|NCT02208999|18816014|P1|COMPLETED|Overall Study||105
7641055|NCT02208999|18816014|P1|STARTED|Overall Study||106
7641056|NCT02208843|18816036|P1|NOT COMPLETED|Overall Study||60
7641057|NCT02208843|18816036|P1|COMPLETED|Overall Study||0
7641058|NCT02208843|18816036|P1|STARTED|Overall Study||60
7641059|NCT02208349|18816044|P2|NOT COMPLETED|Sixth 6 Month||0
7641060|NCT02208349|18816045|P1|NOT COMPLETED|Sixth 6 Month||0
7641061|NCT02208349|18816044|P2|COMPLETED|Sixth 6 Month||2
7641062|NCT02208349|18816045|P1|COMPLETED|Sixth 6 Month||3
7641063|NCT02208349|18816044|P2|STARTED|Sixth 6 Month||2
7641064|NCT02208349|18816045|P1|STARTED|Sixth 6 Month||3
7641065|NCT02208349|18816044|P2|NOT COMPLETED|Fifth 6 Month||0
7641066|NCT02208349|18816045|P1|NOT COMPLETED|Fifth 6 Month||0
7641067|NCT02208349|18816044|P2|COMPLETED|Fifth 6 Month||2
7641068|NCT02208349|18816045|P1|COMPLETED|Fifth 6 Month||7
7641069|NCT02208349|18816044|P2|STARTED|Fifth 6 Month||2
7641070|NCT02208349|18816045|P1|STARTED|Fifth 6 Month||7
7641071|NCT02208349|18816044|P2|NOT COMPLETED|Fourth 6 Month||0
7641072|NCT02208349|18816045|P1|NOT COMPLETED|Fourth 6 Month||0
7641073|NCT02208349|18816044|P2|COMPLETED|Fourth 6 Month||2
7641074|NCT02208349|18816045|P1|COMPLETED|Fourth 6 Month||14
7641075|NCT02208349|18816044|P2|STARTED|Fourth 6 Month||2
7641076|NCT02208349|18816045|P1|STARTED|Fourth 6 Month||14
7641077|NCT02208349|18816044|P2|NOT COMPLETED|Third 6 Month||0
7641078|NCT02208349|18816045|P1|NOT COMPLETED|Third 6 Month||0
7641079|NCT02208349|18816044|P2|COMPLETED|Third 6 Month||3
7641080|NCT02208349|18816045|P1|COMPLETED|Third 6 Month||6
7641081|NCT02208349|18816044|P2|STARTED|Third 6 Month||3
7641082|NCT02208349|18816045|P1|STARTED|Third 6 Month||6
7641083|NCT02208349|18816044|P2|NOT COMPLETED|Second 6 Months||0
7641084|NCT02208349|18816045|P1|NOT COMPLETED|Second 6 Months||0
7641085|NCT02208349|18816044|P2|COMPLETED|Second 6 Months||7
7641086|NCT02208349|18816045|P1|COMPLETED|Second 6 Months||11
7641087|NCT02208349|18816044|P2|STARTED|Second 6 Months||7
7641088|NCT02208349|18816045|P1|STARTED|Second 6 Months||11
7641089|NCT02208349|18816044|P2|NOT COMPLETED|Initial 6 Months||0
7641090|NCT02208349|18816045|P1|NOT COMPLETED|Initial 6 Months||0
7641091|NCT02208349|18816044|P2|COMPLETED|Initial 6 Months||9
7641092|NCT02208349|18816045|P1|COMPLETED|Initial 6 Months||16
7641093|NCT02208349|18816044|P2|STARTED|Initial 6 Months||9
7641094|NCT02208349|18816045|P1|STARTED|Initial 6 Months||16
7641095|NCT02208310|18816055|P2|NOT COMPLETED|Overall Study||5
7641096|NCT02208310|18816056|P1|NOT COMPLETED|Overall Study||6
7641097|NCT02208310|18816055|P2|COMPLETED|Overall Study||0
7641098|NCT02208310|18816056|P1|COMPLETED|Overall Study||0
7641099|NCT02208310|18816055|P2|Day 180|Overall Study||1
7641100|NCT02208310|18816056|P1|Day 180|Overall Study||0
7641101|NCT02208310|18816055|P2|STARTED|Overall Study||5
7641102|NCT02208310|18816056|P1|STARTED|Overall Study||6
7641103|NCT02208297|18816088|P2|NOT COMPLETED|Overall Study||56
7641104|NCT02208297|18816089|P1|NOT COMPLETED|Overall Study||22
7641105|NCT02208297|18816088|P2|COMPLETED|Overall Study||107
7641106|NCT02208297|18816089|P1|COMPLETED|Overall Study||141
7641107|NCT02208297|18816088|P2|STARTED|Overall Study||163
7641108|NCT02208297|18816089|P1|STARTED|Overall Study||163
7641109|NCT02208089|18816107|P2|NOT COMPLETED|Overall Study||0
7641110|NCT02208089|18816108|P1|NOT COMPLETED|Overall Study||7
7641111|NCT02208089|18816107|P2|COMPLETED|Overall Study||47
7641112|NCT02208089|18816108|P1|COMPLETED|Overall Study||40
7641113|NCT02208089|18816107|P2|STARTED|Overall Study||47
7641114|NCT02208089|18816108|P1|STARTED|Overall Study||47
7641115|NCT02208063|18816124|P2|NOT COMPLETED|Overall Study||11
7641116|NCT02208063|18816125|P1|NOT COMPLETED|Overall Study||12
7641117|NCT02208063|18816124|P2|COMPLETED|Overall Study||50
7641118|NCT02208063|18816125|P1|COMPLETED|Overall Study||48
7641119|NCT02208063|18816124|P2|Microbiological All Treated|Overall Study||52
7641120|NCT02208063|18816125|P1|Microbiological All Treated|Overall Study||47
7641121|NCT02208063|18816124|P2|Randomized and Treated|Overall Study||60
7641122|NCT02208063|18816125|P1|Randomized and Treated|Overall Study||58
7641123|NCT02208063|18816124|P2|STARTED|Overall Study||61
7641124|NCT02208063|18816125|P1|STARTED|Overall Study||60
7641125|NCT02208037|18816140|P3|NOT COMPLETED|Overall Study||1
7641126|NCT02208037|18816141|P2|NOT COMPLETED|Overall Study||1
7641127|NCT02208037|18816142|P1|NOT COMPLETED|Overall Study||4
7641128|NCT02208037|18816140|P3|COMPLETED|Overall Study||92
7641129|NCT02208037|18816141|P2|COMPLETED|Overall Study||92
7641130|NCT02208037|18816142|P1|COMPLETED|Overall Study||89
7641131|NCT02208037|18816140|P3|STARTED|Overall Study||93
7641132|NCT02208037|18816141|P2|STARTED|Overall Study||93
7641133|NCT02208037|18816142|P1|STARTED|Overall Study||93
7641134|NCT02207972|18816191|P2|NOT COMPLETED|Overall Study||0
7641135|NCT02207972|18816192|P1|NOT COMPLETED|Overall Study||0
7641136|NCT02207972|18816191|P2|COMPLETED|Overall Study||24
7641137|NCT02207972|18816192|P1|COMPLETED|Overall Study||22
7641138|NCT02207972|18816191|P2|STARTED|Overall Study||24
7641139|NCT02207972|18816192|P1|STARTED|Overall Study||22
7641140|NCT02207907|18816204|P2|NOT COMPLETED|Overall Study||8
7641141|NCT02207907|18816205|P1|NOT COMPLETED|Overall Study||11
7641142|NCT02207907|18816204|P2|COMPLETED|Overall Study||115
7641143|NCT02207907|18816205|P1|COMPLETED|Overall Study||113
7641144|NCT02207907|18816204|P2|STARTED|Overall Study||123
7641145|NCT02207907|18816205|P1|STARTED|Overall Study||124
7641146|NCT02207829|18816223|P2|NOT COMPLETED|Overall Study||34
7641147|NCT02207829|18816224|P1|NOT COMPLETED|Overall Study||42
7641148|NCT02207829|18816223|P2|COMPLETED|Overall Study||474
7641149|NCT02207829|18816224|P1|COMPLETED|Overall Study||467
7641150|NCT02207829|18816223|P2|STARTED|Overall Study||508
7641151|NCT02207829|18816224|P1|STARTED|Overall Study||509
7641152|NCT02207816|18816233|P3|NOT COMPLETED|Overall Study||67
7641153|NCT02207816|18816234|P2|NOT COMPLETED|Overall Study||86
7641154|NCT02207816|18816235|P1|NOT COMPLETED|Overall Study||51
7641155|NCT02207816|18816233|P3|COMPLETED|Overall Study||961
7641156|NCT02207816|18816234|P2|COMPLETED|Overall Study||924
7641157|NCT02207816|18816235|P1|COMPLETED|Overall Study||995
7641158|NCT02207816|18816233|P3|STARTED|Overall Study||1028
7641159|NCT02207816|18816234|P2|STARTED|Overall Study||1010
7641160|NCT02207816|18816235|P1|STARTED|Overall Study||1046
7641161|NCT02207803|18816380|P2|NOT COMPLETED|Overall Study||17
7641162|NCT02207803|18816381|P1|NOT COMPLETED|Overall Study||15
7641163|NCT02207803|18816380|P2|COMPLETED|Overall Study||108
7641164|NCT02207803|18816381|P1|COMPLETED|Overall Study||110
7641165|NCT02207803|18816380|P2|STARTED|Overall Study||125
7641166|NCT02207803|18816381|P1|STARTED|Overall Study||125
7641167|NCT02207725|18816393|P4|NOT COMPLETED|Overall Study||1
7641168|NCT02207725|18816394|P3|NOT COMPLETED|Overall Study||1
7641169|NCT02207725|18816395|P2|NOT COMPLETED|Overall Study||1
7641170|NCT02207725|18816396|P1|NOT COMPLETED|Overall Study||0
7641171|NCT02207725|18816393|P4|COMPLETED|Overall Study||24
7641172|NCT02207725|18816394|P3|COMPLETED|Overall Study||8
7641173|NCT02207725|18816395|P2|COMPLETED|Overall Study||24
7641174|NCT02207725|18816396|P1|COMPLETED|Overall Study||9
7641175|NCT02207725|18816393|P4|STARTED|Overall Study||25
7641176|NCT02207725|18816394|P3|STARTED|Overall Study||9
7641177|NCT02207725|18816395|P2|STARTED|Overall Study||25
7641178|NCT02207725|18816396|P1|STARTED|Overall Study||9
7641179|NCT02207634|18816426|P2|NOT COMPLETED|Overall Study||31
7641180|NCT02207634|18816427|P1|NOT COMPLETED|Overall Study||22
7641181|NCT02207634|18816426|P2|COMPLETED|Overall Study||953
7641182|NCT02207634|18816427|P1|COMPLETED|Overall Study||968
7641183|NCT02207634|18816426|P2|Received Treatment|Overall Study||983
7641184|NCT02207634|18816427|P1|Received Treatment|Overall Study||990
7641185|NCT02207634|18816426|P2|STARTED|Overall Study||984
7641186|NCT02207634|18816427|P1|STARTED|Overall Study||990
7641187|NCT02207621|18816442|P3|NOT COMPLETED|Overall Study||168
7641188|NCT02207621|18816443|P2|NOT COMPLETED|Overall Study||47
7641189|NCT02207621|18816444|P1|NOT COMPLETED|Overall Study||105
7641190|NCT02207621|18816442|P3|COMPLETED|Overall Study||86
7641191|NCT02207621|18816443|P2|COMPLETED|Overall Study||204
7641192|NCT02207621|18816444|P1|COMPLETED|Overall Study||146
7641193|NCT02207621|18816442|P3|STARTED|Overall Study||254
7641194|NCT02207621|18816443|P2|STARTED|Overall Study||251
7641195|NCT02207621|18816444|P1|STARTED|Overall Study||251
7641196|NCT02207608|18816457|P2|NOT COMPLETED|Overall Study||0
7641197|NCT02207608|18816458|P1|NOT COMPLETED|Overall Study||1
7641198|NCT02207608|18816457|P2|COMPLETED|Overall Study||15
7641199|NCT02207608|18816458|P1|COMPLETED|Overall Study||14
7641200|NCT02207608|18816457|P2|STARTED|Overall Study||15
7641201|NCT02207608|18816458|P1|STARTED|Overall Study||15
7641202|NCT02207569|18816464|P1|NOT COMPLETED|6 Months - 1 Year||9
7641203|NCT02207569|18816464|P1|COMPLETED|6 Months - 1 Year||213
7641204|NCT02207569|18816464|P1|STARTED|6 Months - 1 Year||222
7641205|NCT02207569|18816464|P1|NOT COMPLETED|30 Days to 6 Months||11
7641206|NCT02207569|18816464|P1|COMPLETED|30 Days to 6 Months||222
7641207|NCT02207569|18816464|P1|STARTED|30 Days to 6 Months||233
7641208|NCT02207569|18816464|P1|NOT COMPLETED|Implant to 30 Days||4
7641209|NCT02207569|18816464|P1|COMPLETED|Implant to 30 Days||233
7641210|NCT02207569|18816464|P1|STARTED|Implant to 30 Days||237
7641211|NCT02207569|18816464|P1|NOT COMPLETED|Enrolled to Implant||4
7641212|NCT02207569|18816464|P1|COMPLETED|Enrolled to Implant|237 actual implants|237
7641213|NCT02207569|18816464|P1|STARTED|Enrolled to Implant|241 entered procedure room for implant|241
7641214|NCT02207556|18816484|P2|NOT COMPLETED|Overall Study||5
7641215|NCT02207556|18816485|P1|NOT COMPLETED|Overall Study||2
7641216|NCT02207556|18816484|P2|COMPLETED|Overall Study||20
7641217|NCT02207556|18816485|P1|COMPLETED|Overall Study||5
7641218|NCT02207556|18816484|P2|STARTED|Overall Study||25
7641219|NCT02207556|18816485|P1|STARTED|Overall Study||7
7641220|NCT02207530|18816490|P1|NOT COMPLETED|Overall Study||91
7641221|NCT02207530|18816490|P1|COMPLETED|Overall Study||21
7641222|NCT02207530|18816490|P1|STARTED|Overall Study||112
7641223|NCT02207491|18816504|P2|NOT COMPLETED|Overall Study||13
7641224|NCT02207491|18816505|P1|NOT COMPLETED|Overall Study||31
7641225|NCT02207491|18816504|P2|COMPLETED|Overall Study||196
7641226|NCT02207491|18816505|P1|COMPLETED|Overall Study||171
7641227|NCT02207491|18816504|P2|STARTED|Overall Study||209
7641228|NCT02207491|18816505|P1|STARTED|Overall Study||202
7641229|NCT02207478|18816515|P2|NOT COMPLETED|Overall Study||0
7641230|NCT02207478|18816516|P1|NOT COMPLETED|Overall Study||0
7641231|NCT02207478|18816515|P2|COMPLETED|Overall Study||46
7641232|NCT02207478|18816516|P1|COMPLETED|Overall Study||40
7641233|NCT02207478|18816515|P2|STARTED|Overall Study||46
7641234|NCT02207478|18816516|P1|STARTED|Overall Study||40
7641235|NCT02207413|18816530|P6|NOT COMPLETED|Overall Study||13
7641236|NCT02207413|18816531|P5|NOT COMPLETED|Overall Study||7
7641237|NCT02207413|18816532|P4|NOT COMPLETED|Overall Study||1
7641238|NCT02207413|18816533|P3|NOT COMPLETED|Overall Study||0
7641239|NCT02207413|18816534|P2|NOT COMPLETED|Overall Study||0
7641240|NCT02207413|18816535|P1|NOT COMPLETED|Overall Study||1
7641241|NCT02207413|18816530|P6|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461
7641242|NCT02207413|18816531|P5|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459
7641243|NCT02207413|18816532|P4|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410
7641244|NCT02207413|18816533|P3|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410
7641245|NCT02207413|18816534|P2|COMPLETED|Overall Study||60
7641246|NCT02207413|18816535|P1|COMPLETED|Overall Study||59
7641247|NCT02207413|18816530|P6|STARTED|Overall Study||474
7641248|NCT02207413|18816531|P5|STARTED|Overall Study||466
7641249|NCT02207413|18816532|P4|STARTED|Overall Study||411
7641250|NCT02207413|18816533|P3|STARTED|Overall Study||410
7641251|NCT02207413|18816534|P2|STARTED|Overall Study||60
7641252|NCT02207413|18816535|P1|STARTED|Overall Study||60
7641253|NCT02207400|18816631|P2|NOT COMPLETED|Overall Study||14
7641254|NCT02207400|18816632|P1|NOT COMPLETED|Overall Study||16
7641255|NCT02207400|18816631|P2|COMPLETED|Overall Study||109
7641256|NCT02207400|18816632|P1|COMPLETED|Overall Study||107
7641257|NCT02207400|18816631|P2|STARTED|Overall Study||123
7641258|NCT02207400|18816632|P1|STARTED|Overall Study||123
7641259|NCT02207374|18816653|P3|NOT COMPLETED|Overall Study||6
7641260|NCT02207374|18816654|P2|NOT COMPLETED|Overall Study||10
7641261|NCT02207374|18816655|P1|NOT COMPLETED|Overall Study||6
7641262|NCT02207374|18816653|P3|COMPLETED|Overall Study||115
7641263|NCT02207374|18816654|P2|COMPLETED|Overall Study||231
7641264|NCT02207374|18816655|P1|COMPLETED|Overall Study||233
7641265|NCT02207374|18816653|P3|Exposed|Overall Study||120
7641266|NCT02207374|18816654|P2|Exposed|Overall Study||241
7641267|NCT02207374|18816655|P1|Exposed|Overall Study||239
7641268|NCT02207374|18816653|P3|STARTED|Overall Study||121
7641269|NCT02207374|18816654|P2|STARTED|Overall Study||241
7641270|NCT02207374|18816655|P1|STARTED|Overall Study||239
7641271|NCT02207322|18816671|P2|NOT COMPLETED|Overall Study||10
7641272|NCT02207322|18816672|P1|NOT COMPLETED|Overall Study||9
7641273|NCT02207322|18816671|P2|COMPLETED|Overall Study|6-month|71
7641274|NCT02207322|18816672|P1|COMPLETED|Overall Study|6-month|70
7641275|NCT02207322|18816671|P2|3-month|Overall Study||75
7641276|NCT02207322|18816672|P1|3-month|Overall Study||74
7641277|NCT02207322|18816671|P2|Week-2|Overall Study||80
7641278|NCT02207322|18816672|P1|Week-2|Overall Study||77
7641279|NCT02207322|18816671|P2|STARTED|Overall Study||81
7641280|NCT02207322|18816672|P1|STARTED|Overall Study||79
7641281|NCT02207244|18816719|P9|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||8
7641282|NCT02207244|18816720|P8|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||13
7641283|NCT02207244|18816721|P7|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||8
7641284|NCT02207244|18816722|P6|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
7641285|NCT02207244|18816723|P5|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
7641286|NCT02207244|18816724|P4|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
7641287|NCT02207244|18816725|P3|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
7641288|NCT02207244|18816726|P2|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
7641289|NCT02207244|18816727|P1|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
7641290|NCT02207244|18816719|P9|COMPLETED|Withdrawal, Retreatment Period:Week28-48||220
7641291|NCT02207244|18816720|P8|COMPLETED|Withdrawal, Retreatment Period:Week28-48||457
7641292|NCT02207244|18816721|P7|COMPLETED|Withdrawal, Retreatment Period:Week28-48||219
7641293|NCT02207244|18816722|P6|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
7641294|NCT02207244|18816723|P5|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
7641295|NCT02207244|18816724|P4|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
7641296|NCT02207244|18816725|P3|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
7641297|NCT02207244|18816726|P2|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
7641298|NCT02207244|18816727|P1|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
7641299|NCT02207244|18816719|P9|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||34
7641300|NCT02207244|18816720|P8|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||16
7641301|NCT02207244|18816721|P7|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||4
7641302|NCT02207244|18816722|P6|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
7641303|NCT02207244|18816723|P5|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
7641304|NCT02207244|18816724|P4|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
7641305|NCT02207244|18816725|P3|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
7641306|NCT02207244|18816726|P2|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
7641307|NCT02207244|18816727|P1|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
7641308|NCT02207244|18816719|P9|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
7641309|NCT02207244|18816720|P8|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||193
7641310|NCT02207244|18816721|P7|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
7641311|NCT02207244|18816722|P6|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
7641312|NCT02207244|18816723|P5|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
7641313|NCT02207244|18816724|P4|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
7641314|NCT02207244|18816725|P3|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
7641315|NCT02207244|18816726|P2|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
7641316|NCT02207244|18816727|P1|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
7641317|NCT02207244|18816719|P9|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||82
7641318|NCT02207244|18816720|P8|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||166
7641319|NCT02207244|18816721|P7|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||143
7641320|NCT02207244|18816722|P6|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
7641321|NCT02207244|18816723|P5|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
7641322|NCT02207244|18816724|P4|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
7641323|NCT02207244|18816725|P3|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
7641324|NCT02207244|18816726|P2|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
7641325|NCT02207244|18816727|P1|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
7641326|NCT02207244|18816719|P9|Non-Responders|Withdrawal, Retreatment Period:Week28-48||112
7641327|NCT02207244|18816720|P8|Non-Responders|Withdrawal, Retreatment Period:Week28-48||95
7641328|NCT02207244|18816721|P7|Non-Responders|Withdrawal, Retreatment Period:Week28-48||80
7641329|NCT02207244|18816722|P6|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
7641330|NCT02207244|18816723|P5|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
7641331|NCT02207244|18816724|P4|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
7641332|NCT02207244|18816725|P3|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
7641333|NCT02207244|18816726|P2|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
7641334|NCT02207244|18816727|P1|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
7641335|NCT02207244|18816719|P9|STARTED|Withdrawal, Retreatment Period:Week28-48||228
7641336|NCT02207244|18816720|P8|STARTED|Withdrawal, Retreatment Period:Week28-48||470
7641337|NCT02207244|18816721|P7|STARTED|Withdrawal, Retreatment Period:Week28-48||227
7641338|NCT02207244|18816722|P6|STARTED|Withdrawal, Retreatment Period:Week28-48||0
7641339|NCT02207244|18816723|P5|STARTED|Withdrawal, Retreatment Period:Week28-48||0
7641340|NCT02207244|18816724|P4|STARTED|Withdrawal, Retreatment Period:Week28-48||0
7641341|NCT02207244|18816725|P3|STARTED|Withdrawal, Retreatment Period:Week28-48||0
7641342|NCT02207244|18816726|P2|STARTED|Withdrawal, Retreatment Period:Week28-48||0
7641343|NCT02207244|18816727|P1|STARTED|Withdrawal, Retreatment Period:Week28-48||0
7641344|NCT02207244|18816719|P9|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
7641345|NCT02207244|18816720|P8|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
7641346|NCT02207244|18816721|P7|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
7641347|NCT02207244|18816722|P6|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||9
7641348|NCT02207244|18816723|P5|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||8
7641349|NCT02207244|18816724|P4|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||6
7641350|NCT02207244|18816725|P3|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
7641351|NCT02207244|18816726|P2|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
7641352|NCT02207244|18816727|P1|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
7641353|NCT02207244|18816719|P9|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
7641354|NCT02207244|18816720|P8|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
7641355|NCT02207244|18816721|P7|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
7641356|NCT02207244|18816722|P6|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||228
7641357|NCT02207244|18816723|P5|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||470
7641358|NCT02207244|18816724|P4|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||227
7641359|NCT02207244|18816725|P3|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
7641360|NCT02207244|18816726|P2|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
7641361|NCT02207244|18816727|P1|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
7641362|NCT02207244|18816719|P9|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
7641363|NCT02207244|18816720|P8|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
7641364|NCT02207244|18816721|P7|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
7641365|NCT02207244|18816722|P6|STARTED|Placebo Crossover and ACP: Week 16 - 28||237
7641366|NCT02207244|18816723|P5|STARTED|Placebo Crossover and ACP: Week 16 - 28||478
7641367|NCT02207244|18816724|P4|STARTED|Placebo Crossover and ACP: Week 16 - 28||233
7641368|NCT02207244|18816725|P3|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
7641369|NCT02207244|18816726|P2|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
7641370|NCT02207244|18816727|P1|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
7641371|NCT02207244|18816719|P9|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
7641372|NCT02207244|18816720|P8|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
7641373|NCT02207244|18816721|P7|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
7641374|NCT02207244|18816722|P6|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
7641375|NCT02207244|18816723|P5|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
7641376|NCT02207244|18816724|P4|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
7641377|NCT02207244|18816725|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||11
7641378|NCT02207244|18816726|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||18
7641379|NCT02207244|18816727|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||15
7641380|NCT02207244|18816719|P9|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
7641381|NCT02207244|18816720|P8|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
7641382|NCT02207244|18816721|P7|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
7641383|NCT02207244|18816722|P6|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
7641384|NCT02207244|18816723|P5|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
7641385|NCT02207244|18816724|P4|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
7641386|NCT02207244|18816725|P3|COMPLETED|Placebo Controlled Period: Week 0 - 16||237
7641466|NCT02206607|18816864|P2|COMPLETED|Fourth Intervention Period||9
7641387|NCT02207244|18816726|P2|COMPLETED|Placebo Controlled Period: Week 0 - 16||478
7641388|NCT02207244|18816727|P1|COMPLETED|Placebo Controlled Period: Week 0 - 16||233
7641389|NCT02207244|18816719|P9|Treated|Placebo Controlled Period: Week 0 - 16||0
7641390|NCT02207244|18816720|P8|Treated|Placebo Controlled Period: Week 0 - 16||0
7641391|NCT02207244|18816721|P7|Treated|Placebo Controlled Period: Week 0 - 16||0
7641392|NCT02207244|18816722|P6|Treated|Placebo Controlled Period: Week 0 - 16||0
7641393|NCT02207244|18816723|P5|Treated|Placebo Controlled Period: Week 0 - 16||0
7641394|NCT02207244|18816724|P4|Treated|Placebo Controlled Period: Week 0 - 16||0
7641395|NCT02207244|18816725|P3|Treated|Placebo Controlled Period: Week 0 - 16||248
7641396|NCT02207244|18816726|P2|Treated|Placebo Controlled Period: Week 0 - 16||494
7641397|NCT02207244|18816727|P1|Treated|Placebo Controlled Period: Week 0 - 16||248
7641398|NCT02207244|18816719|P9|STARTED|Placebo Controlled Period: Week 0 - 16||0
7641399|NCT02207244|18816720|P8|STARTED|Placebo Controlled Period: Week 0 - 16||0
7641400|NCT02207244|18816721|P7|STARTED|Placebo Controlled Period: Week 0 - 16||0
7641401|NCT02207244|18816722|P6|STARTED|Placebo Controlled Period: Week 0 - 16||0
7641402|NCT02207244|18816723|P5|STARTED|Placebo Controlled Period: Week 0 - 16||0
7641403|NCT02207244|18816724|P4|STARTED|Placebo Controlled Period: Week 0 - 16||0
7641404|NCT02207244|18816725|P3|STARTED|Placebo Controlled Period: Week 0 - 16||248
7641405|NCT02207244|18816726|P2|STARTED|Placebo Controlled Period: Week 0 - 16||496
7641406|NCT02207244|18816727|P1|STARTED|Placebo Controlled Period: Week 0 - 16||248
7641407|NCT02207231|18816768|P3|NOT COMPLETED|Active Controlled Period: Week 16 - 48||42
7641408|NCT02207231|18816769|P2|NOT COMPLETED|Active Controlled Period: Week 16 - 48||21
7641409|NCT02207231|18816770|P1|NOT COMPLETED|Active Controlled Period: Week 16 - 48||3
7641410|NCT02207231|18816768|P3|COMPLETED|Active Controlled Period: Week 16 - 48||282
7641411|NCT02207231|18816769|P2|COMPLETED|Active Controlled Period: Week 16 - 48||301
7641412|NCT02207231|18816770|P1|COMPLETED|Active Controlled Period: Week 16 - 48||162
7641413|NCT02207231|18816768|P3|STARTED|Active Controlled Period: Week 16 - 48||324
7641414|NCT02207231|18816769|P2|STARTED|Active Controlled Period: Week 16 - 48||322
7641415|NCT02207231|18816770|P1|STARTED|Active Controlled Period: Week 16 - 48|2 participants did not cross-over.|165
7641416|NCT02207231|18816768|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||10
7641417|NCT02207231|18816769|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
7641418|NCT02207231|18816770|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
7641419|NCT02207231|18816768|P3|COMPLETED|Placebo Controlled Period: Week 0 - 16||324
7641420|NCT02207231|18816769|P2|COMPLETED|Placebo Controlled Period: Week 0 - 16||322
7641421|NCT02207231|18816770|P1|COMPLETED|Placebo Controlled Period: Week 0 - 16||167
7641422|NCT02207231|18816768|P3|Treated|Placebo Controlled Period: Week 0 - 16||333
7641423|NCT02207231|18816769|P2|Treated|Placebo Controlled Period: Week 0 - 16||329
7641424|NCT02207231|18816770|P1|Treated|Placebo Controlled Period: Week 0 - 16||174
7641425|NCT02207231|18816768|P3|STARTED|Placebo Controlled Period: Week 0 - 16||334
7641426|NCT02207231|18816769|P2|STARTED|Placebo Controlled Period: Week 0 - 16||329
7641427|NCT02207231|18816770|P1|STARTED|Placebo Controlled Period: Week 0 - 16||174
7641428|NCT02207088|18816802|P1|NOT COMPLETED|Overall Study||2
7641429|NCT02207088|18816802|P1|COMPLETED|Overall Study||66
7641430|NCT02207088|18816802|P1|STARTED|Overall Study||68
7641431|NCT02206828|18816808|P1|NOT COMPLETED|Overall Study||7
7641432|NCT02206828|18816808|P1|COMPLETED|Overall Study||93
7641433|NCT02206828|18816808|P1|STARTED|Overall Study||100
7641434|NCT02206776|18816837|P2|NOT COMPLETED|Overall Study||0
7641435|NCT02206776|18816838|P1|NOT COMPLETED|Overall Study||0
7641436|NCT02206776|18816837|P2|COMPLETED|Overall Study||1
7641437|NCT02206776|18816838|P1|COMPLETED|Overall Study||1
7641438|NCT02206776|18816837|P2|STARTED|Overall Study||1
7641439|NCT02206776|18816838|P1|STARTED|Overall Study||1
7641440|NCT02206620|18816844|P2|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||2
7641441|NCT02206620|18816845|P1|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||0
7641442|NCT02206620|18816844|P2|COMPLETED|Phase II - Second Intervention (6 Weeks)||24
7641443|NCT02206620|18816845|P1|COMPLETED|Phase II - Second Intervention (6 Weeks)||21
7641444|NCT02206620|18816844|P2|STARTED|Phase II - Second Intervention (6 Weeks)||26
7641445|NCT02206620|18816845|P1|STARTED|Phase II - Second Intervention (6 Weeks)||21
7641446|NCT02206620|18816844|P2|NOT COMPLETED|Washout (6 Weeks)||0
7641447|NCT02206620|18816845|P1|NOT COMPLETED|Washout (6 Weeks)||0
7641448|NCT02206620|18816844|P2|COMPLETED|Washout (6 Weeks)||26
7641449|NCT02206620|18816845|P1|COMPLETED|Washout (6 Weeks)||21
7641450|NCT02206620|18816844|P2|STARTED|Washout (6 Weeks)||26
7641451|NCT02206620|18816845|P1|STARTED|Washout (6 Weeks)||21
7641452|NCT02206620|18816844|P2|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
7641453|NCT02206620|18816845|P1|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
7641454|NCT02206620|18816844|P2|COMPLETED|Phase I - First Intervention (6 Weeks)||26
7641455|NCT02206620|18816845|P1|COMPLETED|Phase I - First Intervention (6 Weeks)||21
7641456|NCT02206620|18816844|P2|STARTED|Phase I - First Intervention (6 Weeks)||27
7641457|NCT02206620|18816845|P1|STARTED|Phase I - First Intervention (6 Weeks)||22
7641458|NCT02206607|18816861|P5|NOT COMPLETED|Fourth Intervention Period||0
7641459|NCT02206607|18816862|P4|NOT COMPLETED|Fourth Intervention Period||0
7641460|NCT02206607|18816863|P3|NOT COMPLETED|Fourth Intervention Period||0
7641461|NCT02206607|18816864|P2|NOT COMPLETED|Fourth Intervention Period||0
7641462|NCT02206607|18816865|P1|NOT COMPLETED|Fourth Intervention Period||0
7641463|NCT02206607|18816861|P5|COMPLETED|Fourth Intervention Period||10
7641464|NCT02206607|18816862|P4|COMPLETED|Fourth Intervention Period||10
7641465|NCT02206607|18816863|P3|COMPLETED|Fourth Intervention Period||9
7641467|NCT02206607|18816865|P1|COMPLETED|Fourth Intervention Period||0
7641468|NCT02206607|18816861|P5|STARTED|Fourth Intervention Period||10
7641469|NCT02206607|18816862|P4|STARTED|Fourth Intervention Period||10
7641470|NCT02206607|18816863|P3|STARTED|Fourth Intervention Period||9
7641471|NCT02206607|18816864|P2|STARTED|Fourth Intervention Period||9
7641472|NCT02206607|18816865|P1|STARTED|Fourth Intervention Period||0
7641473|NCT02206607|18816861|P5|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
7641474|NCT02206607|18816862|P4|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
7641475|NCT02206607|18816863|P3|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
7641476|NCT02206607|18816864|P2|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
7641477|NCT02206607|18816865|P1|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
7641478|NCT02206607|18816861|P5|COMPLETED|Third Washout Period 5 to 10 Days||10
7641479|NCT02206607|18816862|P4|COMPLETED|Third Washout Period 5 to 10 Days||10
7641480|NCT02206607|18816863|P3|COMPLETED|Third Washout Period 5 to 10 Days||9
7641481|NCT02206607|18816864|P2|COMPLETED|Third Washout Period 5 to 10 Days||9
7641482|NCT02206607|18816865|P1|COMPLETED|Third Washout Period 5 to 10 Days||0
7641483|NCT02206607|18816861|P5|STARTED|Third Washout Period 5 to 10 Days||10
7641484|NCT02206607|18816862|P4|STARTED|Third Washout Period 5 to 10 Days||10
7641485|NCT02206607|18816863|P3|STARTED|Third Washout Period 5 to 10 Days||9
7641486|NCT02206607|18816864|P2|STARTED|Third Washout Period 5 to 10 Days||9
7641487|NCT02206607|18816865|P1|STARTED|Third Washout Period 5 to 10 Days||0
7641488|NCT02206607|18816861|P5|NOT COMPLETED|Third Intervention Period||0
7641489|NCT02206607|18816862|P4|NOT COMPLETED|Third Intervention Period||0
7641490|NCT02206607|18816863|P3|NOT COMPLETED|Third Intervention Period||0
7641491|NCT02206607|18816864|P2|NOT COMPLETED|Third Intervention Period||0
7641492|NCT02206607|18816865|P1|NOT COMPLETED|Third Intervention Period||0
7641493|NCT02206607|18816861|P5|COMPLETED|Third Intervention Period||10
7641494|NCT02206607|18816862|P4|COMPLETED|Third Intervention Period||10
7641495|NCT02206607|18816863|P3|COMPLETED|Third Intervention Period||9
7641496|NCT02206607|18816864|P2|COMPLETED|Third Intervention Period||9
7641497|NCT02206607|18816865|P1|COMPLETED|Third Intervention Period||0
7641498|NCT02206607|18816861|P5|STARTED|Third Intervention Period||10
7641499|NCT02206607|18816862|P4|STARTED|Third Intervention Period||10
7641500|NCT02206607|18816863|P3|STARTED|Third Intervention Period||9
7641501|NCT02206607|18816864|P2|STARTED|Third Intervention Period||9
7641502|NCT02206607|18816865|P1|STARTED|Third Intervention Period||0
7641503|NCT02206607|18816861|P5|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
7641504|NCT02206607|18816862|P4|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
7641505|NCT02206607|18816863|P3|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
7641506|NCT02206607|18816864|P2|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
7641507|NCT02206607|18816865|P1|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
7641508|NCT02206607|18816861|P5|COMPLETED|Second Washout Period 5 to 10 Days||10
7641509|NCT02206607|18816862|P4|COMPLETED|Second Washout Period 5 to 10 Days||10
7641510|NCT02206607|18816863|P3|COMPLETED|Second Washout Period 5 to 10 Days||9
7641511|NCT02206607|18816864|P2|COMPLETED|Second Washout Period 5 to 10 Days||9
7641512|NCT02206607|18816865|P1|COMPLETED|Second Washout Period 5 to 10 Days||0
7641513|NCT02206607|18816861|P5|STARTED|Second Washout Period 5 to 10 Days||10
7641514|NCT02206607|18816862|P4|STARTED|Second Washout Period 5 to 10 Days||10
7641515|NCT02206607|18816863|P3|STARTED|Second Washout Period 5 to 10 Days||9
7641516|NCT02206607|18816864|P2|STARTED|Second Washout Period 5 to 10 Days||9
7641517|NCT02206607|18816865|P1|STARTED|Second Washout Period 5 to 10 Days||0
7641518|NCT02206607|18816861|P5|NOT COMPLETED|Second Intervention Period||0
7641519|NCT02206607|18816862|P4|NOT COMPLETED|Second Intervention Period||1
7641520|NCT02206607|18816863|P3|NOT COMPLETED|Second Intervention Period||0
7641521|NCT02206607|18816864|P2|NOT COMPLETED|Second Intervention Period||0
7641522|NCT02206607|18816865|P1|NOT COMPLETED|Second Intervention Period||0
7641523|NCT02206607|18816861|P5|COMPLETED|Second Intervention Period||10
7641524|NCT02206607|18816862|P4|COMPLETED|Second Intervention Period||10
7641525|NCT02206607|18816863|P3|COMPLETED|Second Intervention Period||9
7641526|NCT02206607|18816864|P2|COMPLETED|Second Intervention Period||9
7641527|NCT02206607|18816865|P1|COMPLETED|Second Intervention Period||0
7641528|NCT02206607|18816861|P5|STARTED|Second Intervention Period||10
7641529|NCT02206607|18816862|P4|STARTED|Second Intervention Period||11
7641530|NCT02206607|18816863|P3|STARTED|Second Intervention Period||9
7641531|NCT02206607|18816864|P2|STARTED|Second Intervention Period||9
7641532|NCT02206607|18816865|P1|STARTED|Second Intervention Period||0
7641533|NCT02206607|18816861|P5|NOT COMPLETED|First Washout Period 5 to 10 Days||0
7641534|NCT02206607|18816862|P4|NOT COMPLETED|First Washout Period 5 to 10 Days||0
7641535|NCT02206607|18816863|P3|NOT COMPLETED|First Washout Period 5 to 10 Days||0
7641536|NCT02206607|18816864|P2|NOT COMPLETED|First Washout Period 5 to 10 Days||0
7641537|NCT02206607|18816865|P1|NOT COMPLETED|First Washout Period 5 to 10 Days||0
7641538|NCT02206607|18816861|P5|COMPLETED|First Washout Period 5 to 10 Days||10
7641539|NCT02206607|18816862|P4|COMPLETED|First Washout Period 5 to 10 Days||11
7641540|NCT02206607|18816863|P3|COMPLETED|First Washout Period 5 to 10 Days||9
7641541|NCT02206607|18816864|P2|COMPLETED|First Washout Period 5 to 10 Days||9
7641542|NCT02206607|18816865|P1|COMPLETED|First Washout Period 5 to 10 Days||0
7641543|NCT02206607|18816861|P5|STARTED|First Washout Period 5 to 10 Days||10
7641544|NCT02206607|18816862|P4|STARTED|First Washout Period 5 to 10 Days||11
7641545|NCT02206607|18816863|P3|STARTED|First Washout Period 5 to 10 Days||9
7641546|NCT02206607|18816864|P2|STARTED|First Washout Period 5 to 10 Days||9
7641547|NCT02206607|18816865|P1|STARTED|First Washout Period 5 to 10 Days||0
7641548|NCT02206607|18816861|P5|NOT COMPLETED|First Intervention Period||0
7641549|NCT02206607|18816862|P4|NOT COMPLETED|First Intervention Period||0
7641550|NCT02206607|18816863|P3|NOT COMPLETED|First Intervention Period||0
7641551|NCT02206607|18816864|P2|NOT COMPLETED|First Intervention Period||0
7641552|NCT02206607|18816865|P1|NOT COMPLETED|First Intervention Period||0
7641553|NCT02206607|18816861|P5|COMPLETED|First Intervention Period||10
7641554|NCT02206607|18816862|P4|COMPLETED|First Intervention Period||11
7641555|NCT02206607|18816863|P3|COMPLETED|First Intervention Period||9
7641556|NCT02206607|18816864|P2|COMPLETED|First Intervention Period||9
7641557|NCT02206607|18816865|P1|COMPLETED|First Intervention Period||0
7641558|NCT02206607|18816861|P5|STARTED|First Intervention Period||10
7641559|NCT02206607|18816862|P4|STARTED|First Intervention Period||11
7641560|NCT02206607|18816863|P3|STARTED|First Intervention Period||9
7641561|NCT02206607|18816864|P2|STARTED|First Intervention Period||9
7641562|NCT02206607|18816865|P1|STARTED|First Intervention Period||0
7641563|NCT02206607|18816861|P5|NOT COMPLETED|Open-Label Run-In||0
7641564|NCT02206607|18816862|P4|NOT COMPLETED|Open-Label Run-In||0
7641565|NCT02206607|18816863|P3|NOT COMPLETED|Open-Label Run-In||0
7641566|NCT02206607|18816864|P2|NOT COMPLETED|Open-Label Run-In||0
7641567|NCT02206607|18816865|P1|NOT COMPLETED|Open-Label Run-In||3
7641568|NCT02206607|18816861|P5|COMPLETED|Open-Label Run-In||0
7641569|NCT02206607|18816862|P4|COMPLETED|Open-Label Run-In||0
7641570|NCT02206607|18816863|P3|COMPLETED|Open-Label Run-In||0
7641571|NCT02206607|18816864|P2|COMPLETED|Open-Label Run-In||0
7641572|NCT02206607|18816865|P1|COMPLETED|Open-Label Run-In||39
7641573|NCT02206607|18816861|P5|STARTED|Open-Label Run-In||0
7641574|NCT02206607|18816862|P4|STARTED|Open-Label Run-In||0
7641575|NCT02206607|18816863|P3|STARTED|Open-Label Run-In||0
7641576|NCT02206607|18816864|P2|STARTED|Open-Label Run-In||0
7641577|NCT02206607|18816865|P1|STARTED|Open-Label Run-In||42
7641578|NCT02206217|18816919|P2|NOT COMPLETED|Overall Study||14
7641579|NCT02206217|18816920|P1|NOT COMPLETED|Overall Study||9
7641580|NCT02206217|18816919|P2|COMPLETED|Overall Study||79
7641581|NCT02206217|18816920|P1|COMPLETED|Overall Study||81
7641582|NCT02206217|18816919|P2|STARTED|Overall Study||93
7641583|NCT02206217|18816920|P1|STARTED|Overall Study||90
7641584|NCT02206152|18816928|P1|NOT COMPLETED|NAC, Then Placebo||0
7641585|NCT02206152|18816928|P1|COMPLETED|NAC, Then Placebo||10
7641586|NCT02206152|18816928|P1|STARTED|NAC, Then Placebo||10
7641587|NCT02206152|18816928|P1|NOT COMPLETED|Placebo, Then NAC||0
7641588|NCT02206152|18816928|P1|COMPLETED|Placebo, Then NAC||10
7641589|NCT02206152|18816928|P1|STARTED|Placebo, Then NAC||10
7641590|NCT02206152|18816928|P1|NOT COMPLETED|Pre-Randomization||2
7641591|NCT02206152|18816928|P1|COMPLETED|Pre-Randomization||20
7641592|NCT02206152|18816928|P1|STARTED|Pre-Randomization||22
7641593|NCT02205983|18816938|P4|NOT COMPLETED|Overall Study||0
7641594|NCT02205983|18816939|P3|NOT COMPLETED|Overall Study||0
7641595|NCT02205983|18816940|P2|NOT COMPLETED|Overall Study||0
7641596|NCT02205983|18816941|P1|NOT COMPLETED|Overall Study||0
7641597|NCT02205983|18816938|P4|COMPLETED|Overall Study||13
7641598|NCT02205983|18816939|P3|COMPLETED|Overall Study||13
7641599|NCT02205983|18816940|P2|COMPLETED|Overall Study||12
7641600|NCT02205983|18816941|P1|COMPLETED|Overall Study||12
7641601|NCT02205983|18816938|P4|STARTED|Overall Study||13
7641602|NCT02205983|18816939|P3|STARTED|Overall Study||13
7641603|NCT02205983|18816940|P2|STARTED|Overall Study||12
7641604|NCT02205983|18816941|P1|STARTED|Overall Study||12
7641605|NCT02205814|18816955|P4|NOT COMPLETED|Overall Study||4
7641606|NCT02205814|18816956|P3|NOT COMPLETED|Overall Study||5
7641607|NCT02205814|18816957|P2|NOT COMPLETED|Overall Study||1
7641608|NCT02205814|18816958|P1|NOT COMPLETED|Overall Study||2
7641609|NCT02205814|18816955|P4|COMPLETED|Overall Study||104
7641610|NCT02205814|18816956|P3|COMPLETED|Overall Study||103
7641611|NCT02205814|18816957|P2|COMPLETED|Overall Study||109
7641612|NCT02205814|18816958|P1|COMPLETED|Overall Study||108
7641613|NCT02205814|18816955|P4|STARTED|Overall Study||108
7641614|NCT02205814|18816956|P3|STARTED|Overall Study||108
7641615|NCT02205814|18816957|P2|STARTED|Overall Study||110
7641616|NCT02205814|18816958|P1|STARTED|Overall Study||110
7641617|NCT02205801|18816984|P4|NOT COMPLETED|Overall Study||0
7641618|NCT02205801|18816985|P3|NOT COMPLETED|Overall Study||0
7641619|NCT02205801|18816986|P2|NOT COMPLETED|Overall Study||0
7641620|NCT02205801|18816987|P1|NOT COMPLETED|Overall Study||0
7641621|NCT02205801|18816984|P4|COMPLETED|Overall Study||8
7641622|NCT02205801|18816985|P3|COMPLETED|Overall Study||9
7641623|NCT02205801|18816986|P2|COMPLETED|Overall Study||8
7641624|NCT02205801|18816987|P1|COMPLETED|Overall Study||11
7641625|NCT02205801|18816984|P4|STARTED|Overall Study||8
7641626|NCT02205801|18816985|P3|STARTED|Overall Study||9
7641627|NCT02205801|18816986|P2|STARTED|Overall Study||8
7641628|NCT02205801|18816987|P1|STARTED|Overall Study||11
7641629|NCT02205476|18817011|P2|NOT COMPLETED|Overall Study||3
7641630|NCT02205476|18817012|P1|NOT COMPLETED|Overall Study||7
7641631|NCT02205476|18817011|P2|COMPLETED|Overall Study||0
7641632|NCT02205476|18817012|P1|COMPLETED|Overall Study||0
7641633|NCT02205476|18817011|P2|STARTED|Overall Study||3
7641634|NCT02205476|18817012|P1|STARTED|Overall Study||7
7641635|NCT02205333|18817051|P9|NOT COMPLETED|Overall Study||0
7641636|NCT02205333|18817052|P8|NOT COMPLETED|Overall Study||2
7641637|NCT02205333|18817053|P7|NOT COMPLETED|Overall Study||5
7641638|NCT02205333|18817054|P6|NOT COMPLETED|Overall Study||3
7641639|NCT02205333|18817055|P5|NOT COMPLETED|Overall Study||5
7641640|NCT02205333|18817056|P4|NOT COMPLETED|Overall Study||7
7641641|NCT02205333|18817057|P3|NOT COMPLETED|Overall Study||2
7641642|NCT02205333|18817058|P2|NOT COMPLETED|Overall Study||6
7641643|NCT02205333|18817059|P1|NOT COMPLETED|Overall Study||6
7641644|NCT02205333|18817051|P9|COMPLETED|Overall Study||1
7641645|NCT02205333|18817052|P8|COMPLETED|Overall Study||1
7641646|NCT02205333|18817053|P7|COMPLETED|Overall Study||2
7641647|NCT02205333|18817054|P6|COMPLETED|Overall Study||4
7641648|NCT02205333|18817055|P5|COMPLETED|Overall Study||1
7641649|NCT02205333|18817056|P4|COMPLETED|Overall Study||0
7641650|NCT02205333|18817057|P3|COMPLETED|Overall Study||1
7641651|NCT02205333|18817058|P2|COMPLETED|Overall Study||0
7641652|NCT02205333|18817059|P1|COMPLETED|Overall Study||2
7641653|NCT02205333|18817051|P9|STARTED|Overall Study||1
7641654|NCT02205333|18817052|P8|STARTED|Overall Study||3
7641655|NCT02205333|18817053|P7|STARTED|Overall Study||7
7641656|NCT02205333|18817054|P6|STARTED|Overall Study||7
7641657|NCT02205333|18817055|P5|STARTED|Overall Study||6
7641658|NCT02205333|18817056|P4|STARTED|Overall Study||7
7641659|NCT02205333|18817057|P3|STARTED|Overall Study||3
7641660|NCT02205333|18817058|P2|STARTED|Overall Study||6
7641661|NCT02205333|18817059|P1|STARTED|Overall Study||8
7641662|NCT02205307|18817234|P2|NOT COMPLETED|Overall Study||6
7641663|NCT02205307|18817235|P1|NOT COMPLETED|Overall Study||17
7641664|NCT02205307|18817234|P2|COMPLETED|Overall Study||163
7641665|NCT02205307|18817235|P1|COMPLETED|Overall Study||161
7641666|NCT02205307|18817234|P2|STARTED|Overall Study||169
7641667|NCT02205307|18817235|P1|STARTED|Overall Study||178
7641668|NCT02205177|18817247|P2|NOT COMPLETED|Overall Study||0
7641669|NCT02205177|18817248|P1|NOT COMPLETED|Overall Study||2
7641670|NCT02205177|18817247|P2|COMPLETED|Overall Study||2
7641671|NCT02205177|18817248|P1|COMPLETED|Overall Study||6
7641672|NCT02205177|18817247|P2|STARTED|Overall Study||2
7641673|NCT02205177|18817248|P1|STARTED|Overall Study||8
7641674|NCT02204982|18817258|P2|NOT COMPLETED|Overall Study||7
7641675|NCT02204982|18817259|P1|NOT COMPLETED|Overall Study||4
7641676|NCT02204982|18817258|P2|COMPLETED|Overall Study||0
7641677|NCT02204982|18817259|P1|COMPLETED|Overall Study||2
7641678|NCT02204982|18817258|P2|STARTED|Overall Study||7
7641679|NCT02204982|18817259|P1|STARTED|Overall Study||6
7641680|NCT02204917|18817267|P1|NOT COMPLETED|Overall Study||1
7641681|NCT02204917|18817267|P1|COMPLETED|Overall Study||30
7641682|NCT02204917|18817267|P1|STARTED|Overall Study||31
7641683|NCT02204761|18817274|P1|NOT COMPLETED|Overall Study||0
7641684|NCT02204761|18817274|P1|COMPLETED|Overall Study||6
7641685|NCT02204761|18817274|P1|STARTED|Overall Study||6
7641686|NCT02204748|18817281|P1|NOT COMPLETED|Overall Study||0
7641687|NCT02204748|18817281|P1|COMPLETED|Overall Study||5
7641688|NCT02204748|18817281|P1|STARTED|Overall Study||5
7641689|NCT02204657|18817295|P2|NOT COMPLETED|Overall Study||0
7641690|NCT02204657|18817296|P1|NOT COMPLETED|Overall Study||7
7641691|NCT02204657|18817295|P2|COMPLETED|Overall Study||25
7641692|NCT02204657|18817296|P1|COMPLETED|Overall Study||25
7641693|NCT02204657|18817295|P2|STARTED|Overall Study||25
7641694|NCT02204657|18817296|P1|STARTED|Overall Study||32
7641695|NCT02204579|18817304|P1|NOT COMPLETED|Overall Study||2
7641696|NCT02204579|18817304|P1|COMPLETED|Overall Study||5
7641697|NCT02204579|18817304|P1|Treated|Overall Study||5
7641698|NCT02204579|18817304|P1|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5
7641699|NCT02204579|18817304|P1|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2
7641700|NCT02204579|18817304|P1|STARTED|Overall Study||7
7641701|NCT02204566|18817356|P1|NOT COMPLETED|Overall Study||4
7641702|NCT02204566|18817356|P1|COMPLETED|Overall Study||1
7641703|NCT02204566|18817356|P1|STARTED|Overall Study||5
7641704|NCT02204449|18817362|P2|NOT COMPLETED|Overall Study||11
7641705|NCT02204449|18817363|P1|NOT COMPLETED|Overall Study||7
7641706|NCT02204449|18817362|P2|COMPLETED|Overall Study||37
7641707|NCT02204449|18817363|P1|COMPLETED|Overall Study||39
7641708|NCT02204449|18817362|P2|STARTED|Overall Study||48
7641709|NCT02204449|18817363|P1|STARTED|Overall Study||46
7641710|NCT02204410|18817373|P1|NOT COMPLETED|Overall Study||11
7641711|NCT02204410|18817373|P1|COMPLETED|Overall Study||10
7641712|NCT02204410|18817373|P1|STARTED|Overall Study||21
7641713|NCT02204371|18817378|P1|NOT COMPLETED|Overall Study||1
7641714|NCT02204371|18817378|P1|COMPLETED|Overall Study||6
7641715|NCT02204371|18817378|P1|STARTED|Overall Study||7
7641716|NCT02204319|18817401|P1|NOT COMPLETED|Overall Study||3
7641717|NCT02204319|18817401|P1|COMPLETED|Overall Study|3 did not complete study.|7
7641718|NCT02204319|18817401|P1|STARTED|Overall Study||10
7641719|NCT02204293|18817409|P6|NOT COMPLETED|LTE Phase||7
7641720|NCT02204293|18817410|P5|NOT COMPLETED|LTE Phase||0
7641721|NCT02204293|18817411|P4|NOT COMPLETED|LTE Phase||0
7641722|NCT02204293|18817412|P3|NOT COMPLETED|LTE Phase||0
7641723|NCT02204293|18817413|P2|NOT COMPLETED|LTE Phase||0
7641724|NCT02204293|18817414|P1|NOT COMPLETED|LTE Phase||0
7641725|NCT02204293|18817409|P6|COMPLETED|LTE Phase||0
7641726|NCT02204293|18817410|P5|COMPLETED|LTE Phase||0
7641727|NCT02204293|18817411|P4|COMPLETED|LTE Phase||0
7641728|NCT02204293|18817412|P3|COMPLETED|LTE Phase||0
7641729|NCT02204293|18817413|P2|COMPLETED|LTE Phase||0
7641730|NCT02204293|18817414|P1|COMPLETED|LTE Phase||0
7641731|NCT02204293|18817409|P6|STARTED|LTE Phase||7
7641732|NCT02204293|18817410|P5|STARTED|LTE Phase||0
7641733|NCT02204293|18817411|P4|STARTED|LTE Phase||0
7641734|NCT02204293|18817412|P3|STARTED|LTE Phase||0
7641735|NCT02204293|18817413|P2|STARTED|LTE Phase||0
7641736|NCT02204293|18817414|P1|STARTED|LTE Phase||0
7641737|NCT02204293|18817409|P6|NOT COMPLETED|Core Study Part 2||0
7641738|NCT02204293|18817410|P5|NOT COMPLETED|Core Study Part 2||0
7641739|NCT02204293|18817411|P4|NOT COMPLETED|Core Study Part 2||0
7641740|NCT02204293|18817412|P3|NOT COMPLETED|Core Study Part 2||0
7641741|NCT02204293|18817413|P2|NOT COMPLETED|Core Study Part 2||0
7641742|NCT02204293|18817414|P1|NOT COMPLETED|Core Study Part 2||0
7641743|NCT02204293|18817409|P6|COMPLETED|Core Study Part 2||0
7641744|NCT02204293|18817410|P5|COMPLETED|Core Study Part 2||7
7641745|NCT02204293|18817411|P4|COMPLETED|Core Study Part 2||4
7641746|NCT02204293|18817412|P3|COMPLETED|Core Study Part 2||12
7641747|NCT02204293|18817413|P2|COMPLETED|Core Study Part 2||0
7641748|NCT02204293|18817414|P1|COMPLETED|Core Study Part 2||0
7641749|NCT02204293|18817409|P6|Safety Population|Core Study Part 2||0
7641750|NCT02204293|18817410|P5|Safety Population|Core Study Part 2||7
7641751|NCT02204293|18817411|P4|Safety Population|Core Study Part 2||2
7641752|NCT02204293|18817412|P3|Safety Population|Core Study Part 2|Included 2 participants from placebo arm who received canakinumab at Week 4.|14
7641753|NCT02204293|18817413|P2|Safety Population|Core Study Part 2||0
7641754|NCT02204293|18817414|P1|Safety Population|Core Study Part 2||0
7641755|NCT02204293|18817409|P6|STARTED|Core Study Part 2||0
7641756|NCT02204293|18817410|P5|STARTED|Core Study Part 2||7
7641757|NCT02204293|18817411|P4|STARTED|Core Study Part 2||4
7641758|NCT02204293|18817412|P3|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|12
7641759|NCT02204293|18817413|P2|STARTED|Core Study Part 2||0
7641760|NCT02204293|18817414|P1|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|0
7641761|NCT02204293|18817409|P6|NOT COMPLETED|Core Study Part I||0
7641762|NCT02204293|18817410|P5|NOT COMPLETED|Core Study Part I||0
7641763|NCT02204293|18817411|P4|NOT COMPLETED|Core Study Part I||0
7641764|NCT02204293|18817412|P3|NOT COMPLETED|Core Study Part I||0
7641765|NCT02204293|18817413|P2|NOT COMPLETED|Core Study Part I||3
7641766|NCT02204293|18817414|P1|NOT COMPLETED|Core Study Part I||2
7641767|NCT02204293|18817409|P6|COMPLETED|Core Study Part I||0
7641768|NCT02204293|18817410|P5|COMPLETED|Core Study Part I||0
7641769|NCT02204293|18817411|P4|COMPLETED|Core Study Part I||0
7641770|NCT02204293|18817412|P3|COMPLETED|Core Study Part I||0
7641771|NCT02204293|18817413|P2|COMPLETED|Core Study Part I||14
7641772|NCT02204293|18817414|P1|COMPLETED|Core Study Part I||17
7641773|NCT02204293|18817409|P6|Safety Population|Core Study Part I||0
7641774|NCT02204293|18817410|P5|Safety Population|Core Study Part I||0
7641775|NCT02204293|18817411|P4|Safety Population|Core Study Part I||0
7641776|NCT02204293|18817412|P3|Safety Population|Core Study Part I||0
7641777|NCT02204293|18817413|P2|Safety Population|Core Study Part I||15
7641778|NCT02204293|18817414|P1|Safety Population|Core Study Part I|2 participants from placebo arm received canakinumab at Week 4, included in Safety population.|20
7641779|NCT02204293|18817409|P6|Intention-to-treat Population|Core Study Part I||0
7641780|NCT02204293|18817410|P5|Intention-to-treat Population|Core Study Part I||0
7641781|NCT02204293|18817411|P4|Intention-to-treat Population|Core Study Part I||0
7641782|NCT02204293|18817412|P3|Intention-to-treat Population|Core Study Part I||0
7641783|NCT02204293|18817413|P2|Intention-to-treat Population|Core Study Part I||17
7641784|NCT02204293|18817414|P1|Intention-to-treat Population|Core Study Part I|One participant left the study before treatment was started.|18
7641785|NCT02204293|18817409|P6|STARTED|Core Study Part I||0
7641786|NCT02204293|18817410|P5|STARTED|Core Study Part I||0
7641787|NCT02204293|18817411|P4|STARTED|Core Study Part I||0
7641788|NCT02204293|18817412|P3|STARTED|Core Study Part I||0
7641789|NCT02204293|18817413|P2|STARTED|Core Study Part I||17
7641790|NCT02204293|18817414|P1|STARTED|Core Study Part I||19
7641791|NCT02204176|18817483|P3|NOT COMPLETED|Overall Study||16
7641792|NCT02204176|18817484|P2|NOT COMPLETED|Overall Study||12
7641793|NCT02204176|18817485|P1|NOT COMPLETED|Overall Study||10
7641794|NCT02204176|18817483|P3|COMPLETED|Overall Study||58
7641795|NCT02204176|18817484|P2|COMPLETED|Overall Study||61
7641796|NCT02204176|18817485|P1|COMPLETED|Overall Study||64
7641797|NCT02204176|18817483|P3|STARTED|Overall Study||74
7641798|NCT02204176|18817484|P2|STARTED|Overall Study||73
7641799|NCT02204176|18817485|P1|STARTED|Overall Study||74
7641800|NCT02204150|18817508|P1|NOT COMPLETED|Overall Study||0
7641801|NCT02204150|18817508|P1|COMPLETED|Overall Study||56
7641802|NCT02204150|18817508|P1|STARTED|Overall Study||56
7641803|NCT02204124|18817514|P2|NOT COMPLETED|Overall Study||0
7641804|NCT02204124|18817515|P1|NOT COMPLETED|Overall Study||0
7641805|NCT02204124|18817514|P2|COMPLETED|Overall Study||19
7641806|NCT02204124|18817515|P1|COMPLETED|Overall Study||13
7641807|NCT02204124|18817514|P2|STARTED|Overall Study||19
7641808|NCT02204124|18817515|P1|STARTED|Overall Study||13
7641809|NCT02204007|18817535|P2|NOT COMPLETED|Overall Study||1
7641810|NCT02204007|18817536|P1|NOT COMPLETED|Overall Study||1
7641811|NCT02204007|18817535|P2|COMPLETED|Overall Study||17
7641812|NCT02204007|18817536|P1|COMPLETED|Overall Study||17
7641813|NCT02204007|18817535|P2|STARTED|Overall Study||18
7641814|NCT02204007|18817536|P1|STARTED|Overall Study||18
7641815|NCT02203916|18817547|P3|NOT COMPLETED|Overall Study||11
7641816|NCT02203916|18817548|P2|NOT COMPLETED|Overall Study||10
7641817|NCT02203916|18817549|P1|NOT COMPLETED|Overall Study||8
7641818|NCT02203916|18817547|P3|COMPLETED|Overall Study||120
7641819|NCT02203916|18817548|P2|COMPLETED|Overall Study||122
7641820|NCT02203916|18817549|P1|COMPLETED|Overall Study||57
7641821|NCT02203916|18817547|P3|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130
7641822|NCT02203916|18817548|P2|Safety Analysis Set (SAS)|Overall Study||132
7641823|NCT02203916|18817549|P1|Safety Analysis Set (SAS)|Overall Study||65
7641824|NCT02203916|18817547|P3|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130
7641825|NCT02203916|18817548|P2|Full Analysis Set (FAS)|Overall Study||132
7641826|NCT02203916|18817549|P1|Full Analysis Set (FAS)|Overall Study||65
7641827|NCT02203916|18817547|P3|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131
7641828|NCT02203916|18817548|P2|STARTED|Overall Study||132
7641829|NCT02203916|18817549|P1|STARTED|Overall Study||65
7641830|NCT02203851|18817569|P1|NOT COMPLETED|Overall Study||11
7641831|NCT02203851|18817569|P1|COMPLETED|Overall Study||99
7641832|NCT02203851|18817569|P1|STARTED|Overall Study||110
7641833|NCT02203838|18817607|P4|NOT COMPLETED|Overall Study||18
7641834|NCT02203838|18817608|P3|NOT COMPLETED|Overall Study||16
7641835|NCT02203838|18817609|P2|NOT COMPLETED|Overall Study||22
7641836|NCT02203838|18817610|P1|NOT COMPLETED|Overall Study||210
7641837|NCT02203838|18817607|P4|COMPLETED|Overall Study||15
7641838|NCT02203838|18817608|P3|COMPLETED|Overall Study||15
7641839|NCT02203838|18817609|P2|COMPLETED|Overall Study||6
7641840|NCT02203838|18817610|P1|COMPLETED|Overall Study||198
7641841|NCT02203838|18817607|P4|STARTED|Overall Study||33
7641842|NCT02203838|18817608|P3|STARTED|Overall Study||31
7641843|NCT02203838|18817609|P2|STARTED|Overall Study||28
7641844|NCT02203838|18817610|P1|STARTED|Overall Study||408
7641845|NCT02203786|18817644|P4|NOT COMPLETED|Overall Study||0
7641846|NCT02203786|18817645|P3|NOT COMPLETED|Overall Study||2
7641847|NCT02203786|18817646|P2|NOT COMPLETED|Overall Study||0
7641848|NCT02203786|18817647|P1|NOT COMPLETED|Overall Study||0
7641849|NCT02203786|18817644|P4|COMPLETED|Overall Study||15
7641850|NCT02203786|18817645|P3|COMPLETED|Overall Study||15
7641851|NCT02203786|18817646|P2|COMPLETED|Overall Study||15
7641852|NCT02203786|18817647|P1|COMPLETED|Overall Study||15
7641853|NCT02203786|18817644|P4|STARTED|Overall Study||15
7641854|NCT02203786|18817645|P3|STARTED|Overall Study||17
7641855|NCT02203786|18817646|P2|STARTED|Overall Study||15
7641856|NCT02203786|18817647|P1|STARTED|Overall Study||15
7641857|NCT02203747|18817679|P2|NOT COMPLETED|Overall Study||0
7641858|NCT02203747|18817680|P1|NOT COMPLETED|Overall Study||0
7641859|NCT02203747|18817679|P2|COMPLETED|Overall Study||34
7641860|NCT02203747|18817680|P1|COMPLETED|Overall Study||45
7641861|NCT02203747|18817679|P2|STARTED|Overall Study||34
7641862|NCT02203747|18817680|P1|STARTED|Overall Study||45
7641863|NCT02203721|18817690|P2|NOT COMPLETED|Overall Study||3
7641864|NCT02203721|18817691|P1|NOT COMPLETED|Overall Study||1
7641865|NCT02203721|18817690|P2|COMPLETED|Overall Study||148
7641866|NCT02203721|18817691|P1|COMPLETED|Overall Study||147
7641867|NCT02203721|18817690|P2|STARTED|Overall Study||151
7641868|NCT02203721|18817691|P1|STARTED|Overall Study||148
7641869|NCT02203630|18817701|P2|NOT COMPLETED|Overall Study||0
7641870|NCT02203630|18817702|P1|NOT COMPLETED|Overall Study||0
7641871|NCT02203630|18817701|P2|COMPLETED|Overall Study||9
7641872|NCT02203630|18817702|P1|COMPLETED|Overall Study||8
7641873|NCT02203630|18817701|P2|STARTED|Overall Study||9
7641874|NCT02203630|18817702|P1|STARTED|Overall Study||8
7641875|NCT02203591|18817780|P8|NOT COMPLETED|Overall Study||13
7641876|NCT02203591|18817781|P7|NOT COMPLETED|Overall Study||29
7641877|NCT02203591|18817782|P6|NOT COMPLETED|Overall Study||35
7641878|NCT02203591|18817783|P5|NOT COMPLETED|Overall Study||34
7641879|NCT02203591|18817784|P4|NOT COMPLETED|Overall Study||45
7641880|NCT02203591|18817785|P3|NOT COMPLETED|Overall Study||151
7641881|NCT02203591|18817786|P2|NOT COMPLETED|Overall Study||142
7641882|NCT02203591|18817787|P1|NOT COMPLETED|Overall Study||147
7641883|NCT02203591|18817780|P8|COMPLETED|Overall Study||61
7641884|NCT02203591|18817781|P7|COMPLETED|Overall Study||219
7641885|NCT02203591|18817782|P6|COMPLETED|Overall Study||209
7641886|NCT02203591|18817783|P5|COMPLETED|Overall Study||208
7641887|NCT02203591|18817784|P4|COMPLETED|Overall Study||59
7641888|NCT02203591|18817785|P3|COMPLETED|Overall Study||196
7641889|NCT02203591|18817786|P2|COMPLETED|Overall Study||202
7641890|NCT02203591|18817787|P1|COMPLETED|Overall Study||196
7641891|NCT02203591|18817780|P8|STARTED|Overall Study||74
7641892|NCT02203591|18817781|P7|STARTED|Overall Study||248
7641893|NCT02203591|18817782|P6|STARTED|Overall Study||244
7641894|NCT02203591|18817783|P5|STARTED|Overall Study||242
7641895|NCT02203591|18817784|P4|STARTED|Overall Study||104
7641896|NCT02203591|18817785|P3|STARTED|Overall Study||347
7641897|NCT02203591|18817786|P2|STARTED|Overall Study||344
7641898|NCT02203591|18817787|P1|STARTED|Overall Study||343
7641899|NCT02203578|18817872|P1|NOT COMPLETED|Overall Study||0
7641900|NCT02203578|18817872|P1|COMPLETED|Overall Study||1
7641901|NCT02203578|18817872|P1|STARTED|Overall Study||1
7641902|NCT02203565|18817884|P1|NOT COMPLETED|Overall Study||1
7641903|NCT02203565|18817884|P1|COMPLETED|Overall Study||19
7641904|NCT02203565|18817884|P1|STARTED|Overall Study||20
7641905|NCT02203357|18817891|P3|NOT COMPLETED|Overall Study||70
7641906|NCT02203357|18817892|P2|NOT COMPLETED|Overall Study||66
7641907|NCT02203357|18817893|P1|NOT COMPLETED|Overall Study||58
7641908|NCT02203357|18817891|P3|COMPLETED|Overall Study||55
7641909|NCT02203357|18817892|P2|COMPLETED|Overall Study||45
7641910|NCT02203357|18817893|P1|COMPLETED|Overall Study||59
7641911|NCT02203357|18817891|P3|mon24|Overall Study||55
7641912|NCT02203357|18817892|P2|mon24|Overall Study||45
7641913|NCT02203357|18817893|P1|mon24|Overall Study||59
7641914|NCT02203357|18817891|P3|mon12|Overall Study||122
7641915|NCT02203357|18817892|P2|mon12|Overall Study||101
7641916|NCT02203357|18817893|P1|mon12|Overall Study||113
7641917|NCT02203357|18817891|P3|mon7/2/3|Overall Study||124
7641918|NCT02203357|18817892|P2|mon7/2/3|Overall Study||110
7641919|NCT02203357|18817893|P1|mon7/2/3|Overall Study||114
7641920|NCT02203357|18817891|P3|STARTED|Overall Study||125
7641921|NCT02203357|18817892|P2|STARTED|Overall Study||111
7641922|NCT02203357|18817893|P1|STARTED|Overall Study||117
7641923|NCT02203331|18817916|P6|NOT COMPLETED|Overall Study||7
7641924|NCT02203331|18817917|P5|NOT COMPLETED|Overall Study||7
7641925|NCT02203331|18817918|P4|NOT COMPLETED|Overall Study||7
7641926|NCT02203331|18817919|P3|NOT COMPLETED|Overall Study||5
7641927|NCT02203331|18817920|P2|NOT COMPLETED|Overall Study||14
7641928|NCT02203331|18817921|P1|NOT COMPLETED|Overall Study||7
7641929|NCT02203331|18817916|P6|COMPLETED|Overall Study||46
7641930|NCT02203331|18817917|P5|COMPLETED|Overall Study||46
7641931|NCT02203331|18817918|P4|COMPLETED|Overall Study||46
7641932|NCT02203331|18817919|P3|COMPLETED|Overall Study||50
7641933|NCT02203331|18817920|P2|COMPLETED|Overall Study||39
7641934|NCT02203331|18817921|P1|COMPLETED|Overall Study||45
7641935|NCT02203331|18817916|P6|Treated|Overall Study||53
7641936|NCT02203331|18817917|P5|Treated|Overall Study||50
7641937|NCT02203331|18817918|P4|Treated|Overall Study||49
7641938|NCT02203331|18817919|P3|Treated|Overall Study||54
7641939|NCT02203331|18817920|P2|Treated|Overall Study||50
7641940|NCT02203331|18817921|P1|Treated|Overall Study||49
7641941|NCT02203331|18817916|P6|STARTED|Overall Study||53
7641942|NCT02203331|18817917|P5|STARTED|Overall Study||53
7641943|NCT02203331|18817918|P4|STARTED|Overall Study||53
7641944|NCT02203331|18817919|P3|STARTED|Overall Study||55
7641945|NCT02203331|18817920|P2|STARTED|Overall Study||53
7641946|NCT02203331|18817921|P1|STARTED|Overall Study||52
7641947|NCT02203162|18817971|P1|NOT COMPLETED|Overall Study||0
7641948|NCT02203162|18817971|P1|COMPLETED|Overall Study||30
7641949|NCT02203162|18817971|P1|STARTED|Overall Study||30
7641950|NCT02203149|18817980|P5|NOT COMPLETED|Part 2||1
7641951|NCT02203149|18817981|P4|NOT COMPLETED|Part 2||3
7641952|NCT02203149|18817982|P3|NOT COMPLETED|Part 2||1
7641953|NCT02203149|18817983|P2|NOT COMPLETED|Part 2||0
7641954|NCT02203149|18817984|P1|NOT COMPLETED|Part 2||0
7641955|NCT02203149|18817980|P5|COMPLETED|Part 2||34
7641956|NCT02203149|18817981|P4|COMPLETED|Part 2||71
7641957|NCT02203149|18817982|P3|COMPLETED|Part 2||226
7641958|NCT02203149|18817983|P2|COMPLETED|Part 2||0
7641959|NCT02203149|18817984|P1|COMPLETED|Part 2||0
7641960|NCT02203149|18817980|P5|Started Deferred Active Treatment|Part 2||0
7641961|NCT02203149|18817981|P4|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73
7641962|NCT02203149|18817982|P3|Started Deferred Active Treatment|Part 2||0
7641963|NCT02203149|18817983|P2|Started Deferred Active Treatment|Part 2||0
7641964|NCT02203149|18817984|P1|Started Deferred Active Treatment|Part 2||0
7641965|NCT02203149|18817980|P5|STARTED|Part 2||35
7641966|NCT02203149|18817981|P4|STARTED|Part 2||74
7641967|NCT02203149|18817982|P3|STARTED|Part 2||227
7641968|NCT02203149|18817983|P2|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
7641969|NCT02203149|18817984|P1|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
7641970|NCT02203149|18817980|P5|NOT COMPLETED|Part 1||0
7641971|NCT02203149|18817981|P4|NOT COMPLETED|Part 1||0
7641972|NCT02203149|18817982|P3|NOT COMPLETED|Part 1||0
7641973|NCT02203149|18817983|P2|NOT COMPLETED|Part 1||1
7641974|NCT02203149|18817984|P1|NOT COMPLETED|Part 1||0
7641975|NCT02203149|18817980|P5|COMPLETED|Part 1||0
7641976|NCT02203149|18817981|P4|COMPLETED|Part 1||0
7641977|NCT02203149|18817982|P3|COMPLETED|Part 1||0
7641978|NCT02203149|18817983|P2|COMPLETED|Part 1||31
7641979|NCT02203149|18817984|P1|COMPLETED|Part 1||31
7641980|NCT02203149|18817980|P5|STARTED|Part 1||0
7641981|NCT02203149|18817981|P4|STARTED|Part 1||0
7641982|NCT02203149|18817982|P3|STARTED|Part 1||0
7641983|NCT02203149|18817983|P2|STARTED|Part 1||32
7641984|NCT02203149|18817984|P1|STARTED|Part 1||31
7641985|NCT02203071|18818019|P2|NOT COMPLETED|Overall Study||1
7641986|NCT02203071|18818020|P1|NOT COMPLETED|Overall Study||3
7641987|NCT02203071|18818019|P2|COMPLETED|Overall Study||5
7641988|NCT02203071|18818020|P1|COMPLETED|Overall Study||10
7641989|NCT02203071|18818019|P2|STARTED|Overall Study||6
7641990|NCT02203071|18818020|P1|STARTED|Overall Study||13
7641991|NCT02203032|18818036|P4|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||46
7641992|NCT02203032|18818037|P3|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||26
7641993|NCT02203032|18818038|P2|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||15
7641994|NCT02203032|18818039|P1|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||0
7641995|NCT02203032|18818036|P4|COMPLETED|Blinded Phase (Week 16 to Week 44)||539
7641996|NCT02203032|18818037|P3|COMPLETED|Blinded Phase (Week 16 to Week 44)||107
7641997|NCT02203032|18818038|P2|COMPLETED|Blinded Phase (Week 16 to Week 44)||120
7641998|NCT02203032|18818039|P1|COMPLETED|Blinded Phase (Week 16 to Week 44)||0
7641999|NCT02203032|18818036|P4|STARTED|Blinded Phase (Week 16 to Week 44)||585
7642000|NCT02203032|18818037|P3|STARTED|Blinded Phase (Week 16 to Week 44)||133
7642001|NCT02203032|18818038|P2|STARTED|Blinded Phase (Week 16 to Week 44)||135
7642002|NCT02203032|18818039|P1|STARTED|Blinded Phase (Week 16 to Week 44)||0
7642003|NCT02203032|18818036|P4|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
7642004|NCT02203032|18818037|P3|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
7642005|NCT02203032|18818038|P2|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
7642006|NCT02203032|18818039|P1|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||19
7642007|NCT02203032|18818036|P4|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
7642008|NCT02203032|18818037|P3|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
7642102|NCT02202746|18818366|P1|STARTED|Overall Study||109
7642009|NCT02203032|18818038|P2|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
7642010|NCT02203032|18818039|P1|COMPLETED|Open Label Run-in (Week 0 to Week 16)||853
7642011|NCT02203032|18818036|P4|Treated|Open Label Run-in (Week 0 to Week 16)||0
7642012|NCT02203032|18818037|P3|Treated|Open Label Run-in (Week 0 to Week 16)||0
7642013|NCT02203032|18818038|P2|Treated|Open Label Run-in (Week 0 to Week 16)||0
7642014|NCT02203032|18818039|P1|Treated|Open Label Run-in (Week 0 to Week 16)||871
7642015|NCT02203032|18818036|P4|STARTED|Open Label Run-in (Week 0 to Week 16)||0
7642016|NCT02203032|18818037|P3|STARTED|Open Label Run-in (Week 0 to Week 16)||0
7642017|NCT02203032|18818038|P2|STARTED|Open Label Run-in (Week 0 to Week 16)||0
7642018|NCT02203032|18818039|P1|STARTED|Open Label Run-in (Week 0 to Week 16)||872
7642019|NCT02203019|18818055|P2|NOT COMPLETED|Overall Study||0
7642020|NCT02203019|18818056|P1|NOT COMPLETED|Overall Study||0
7642021|NCT02203019|18818055|P2|COMPLETED|Overall Study||17
7642022|NCT02203019|18818056|P1|COMPLETED|Overall Study||19
7642023|NCT02203019|18818055|P2|STARTED|Overall Study||17
7642024|NCT02203019|18818056|P1|STARTED|Overall Study||19
7642025|NCT02202980|18818082|P14|NOT COMPLETED|Overall Study||0
7642026|NCT02202980|18818083|P13|NOT COMPLETED|Overall Study||11
7642027|NCT02202980|18818084|P12|NOT COMPLETED|Overall Study||3
7642028|NCT02202980|18818085|P11|NOT COMPLETED|Overall Study||0
7642029|NCT02202980|18818086|P10|NOT COMPLETED|Overall Study||0
7642030|NCT02202980|18818087|P9|NOT COMPLETED|Overall Study||4
7642031|NCT02202980|18818088|P8|NOT COMPLETED|Overall Study||3
7642032|NCT02202980|18818089|P7|NOT COMPLETED|Overall Study||11
7642033|NCT02202980|18818090|P6|NOT COMPLETED|Overall Study||1
7642034|NCT02202980|18818091|P5|NOT COMPLETED|Overall Study||6
7642035|NCT02202980|18818092|P4|NOT COMPLETED|Overall Study||4
7642036|NCT02202980|18818093|P3|NOT COMPLETED|Overall Study||10
7642037|NCT02202980|18818094|P2|NOT COMPLETED|Overall Study||2
7642038|NCT02202980|18818095|P1|NOT COMPLETED|Overall Study||1
7642039|NCT02202980|18818082|P14|COMPLETED|Overall Study||4
7642040|NCT02202980|18818083|P13|COMPLETED|Overall Study||19
7642041|NCT02202980|18818084|P12|COMPLETED|Overall Study||25
7642042|NCT02202980|18818085|P11|COMPLETED|Overall Study||19
7642043|NCT02202980|18818086|P10|COMPLETED|Overall Study||17
7642044|NCT02202980|18818087|P9|COMPLETED|Overall Study||14
7642045|NCT02202980|18818088|P8|COMPLETED|Overall Study||12
7642046|NCT02202980|18818089|P7|COMPLETED|Overall Study||4
7642047|NCT02202980|18818090|P6|COMPLETED|Overall Study||14
7642048|NCT02202980|18818091|P5|COMPLETED|Overall Study||7
7642049|NCT02202980|18818092|P4|COMPLETED|Overall Study||28
7642050|NCT02202980|18818093|P3|COMPLETED|Overall Study||17
7642051|NCT02202980|18818094|P2|COMPLETED|Overall Study||24
7642052|NCT02202980|18818095|P1|COMPLETED|Overall Study||13
7642053|NCT02202980|18818082|P14|STARTED|Overall Study||4
7642054|NCT02202980|18818083|P13|STARTED|Overall Study||30
7642055|NCT02202980|18818084|P12|STARTED|Overall Study||28
7642056|NCT02202980|18818085|P11|STARTED|Overall Study||19
7642057|NCT02202980|18818086|P10|STARTED|Overall Study||17
7642058|NCT02202980|18818087|P9|STARTED|Overall Study||18
7642059|NCT02202980|18818088|P8|STARTED|Overall Study||15
7642060|NCT02202980|18818089|P7|STARTED|Overall Study||15
7642061|NCT02202980|18818090|P6|STARTED|Overall Study||15
7642062|NCT02202980|18818091|P5|STARTED|Overall Study||13
7642063|NCT02202980|18818092|P4|STARTED|Overall Study||32
7642064|NCT02202980|18818093|P3|STARTED|Overall Study||27
7642065|NCT02202980|18818094|P2|STARTED|Overall Study||26
7642066|NCT02202980|18818095|P1|STARTED|Overall Study||14
7642067|NCT02202850|18818183|P2|NOT COMPLETED|Overall Study||6
7642068|NCT02202850|18818184|P1|NOT COMPLETED|Overall Study||24
7642069|NCT02202850|18818183|P2|COMPLETED|Overall Study||8
7642070|NCT02202850|18818184|P1|COMPLETED|Overall Study||46
7642071|NCT02202850|18818183|P2|STARTED|Overall Study||14
7642072|NCT02202850|18818184|P1|STARTED|Overall Study||70
7642073|NCT02202837|18818236|P2|NOT COMPLETED|Overall Study||5
7642074|NCT02202837|18818237|P1|NOT COMPLETED|Overall Study||53
7642075|NCT02202837|18818236|P2|COMPLETED|Overall Study||12
7642076|NCT02202837|18818237|P1|COMPLETED|Overall Study||87
7642077|NCT02202837|18818236|P2|STARTED|Overall Study||17
7642078|NCT02202837|18818237|P1|STARTED|Overall Study||140
7642079|NCT02202785|18818288|P3|NOT COMPLETED|Overall Study||17
7642080|NCT02202785|18818289|P2|NOT COMPLETED|Overall Study||15
7642081|NCT02202785|18818290|P1|NOT COMPLETED|Overall Study||11
7642082|NCT02202785|18818288|P3|COMPLETED|Overall Study||0
7642083|NCT02202785|18818289|P2|COMPLETED|Overall Study||0
7642084|NCT02202785|18818290|P1|COMPLETED|Overall Study||0
7642085|NCT02202785|18818288|P3|STARTED|Overall Study||17
7642086|NCT02202785|18818289|P2|STARTED|Overall Study||15
7642087|NCT02202785|18818290|P1|STARTED|Overall Study||11
7642088|NCT02202759|18818327|P3|NOT COMPLETED|Overall Study||14
7642089|NCT02202759|18818328|P2|NOT COMPLETED|Overall Study||15
7642090|NCT02202759|18818329|P1|NOT COMPLETED|Overall Study||9
7642091|NCT02202759|18818327|P3|COMPLETED|Overall Study||0
7642092|NCT02202759|18818328|P2|COMPLETED|Overall Study||0
7642093|NCT02202759|18818329|P1|COMPLETED|Overall Study||0
7642094|NCT02202759|18818327|P3|STARTED|Overall Study||14
7642095|NCT02202759|18818328|P2|STARTED|Overall Study||15
7642096|NCT02202759|18818329|P1|STARTED|Overall Study||9
7642097|NCT02202746|18818365|P2|NOT COMPLETED|Overall Study||0
7642098|NCT02202746|18818366|P1|NOT COMPLETED|Overall Study||0
7642099|NCT02202746|18818365|P2|COMPLETED|Overall Study||69
7642100|NCT02202746|18818366|P1|COMPLETED|Overall Study||109
7642101|NCT02202746|18818365|P2|STARTED|Overall Study||69
7642103|NCT02202616|18818396|P1|NOT COMPLETED|Overall Study||100
7642104|NCT02202616|18818396|P1|COMPLETED|Overall Study||301
7642105|NCT02202616|18818396|P1|Intent to Treat Set (ITT)|Overall Study||338
7642106|NCT02202616|18818396|P1|STARTED|Overall Study||401
7642107|NCT02202551|18818411|P4|NOT COMPLETED|Overall Study||22
7642108|NCT02202551|18818412|P3|NOT COMPLETED|Overall Study||10
7642109|NCT02202551|18818413|P2|NOT COMPLETED|Overall Study||37
7642110|NCT02202551|18818414|P1|NOT COMPLETED|Overall Study||25
7642111|NCT02202551|18818411|P4|COMPLETED|Overall Study||39
7642112|NCT02202551|18818412|P3|COMPLETED|Overall Study||14
7642113|NCT02202551|18818413|P2|COMPLETED|Overall Study||41
7642114|NCT02202551|18818414|P1|COMPLETED|Overall Study||35
7642115|NCT02202551|18818411|P4|STARTED|Overall Study||61
7642116|NCT02202551|18818412|P3|STARTED|Overall Study||24
7642117|NCT02202551|18818413|P2|STARTED|Overall Study||78
7642118|NCT02202551|18818414|P1|STARTED|Overall Study||60
7642119|NCT02202538|18818432|P1|NOT COMPLETED|Overall Study||8
7642120|NCT02202538|18818432|P1|COMPLETED|Overall Study||45
7642121|NCT02202538|18818432|P1|Screen Failure|Overall Study||2
7642122|NCT02202538|18818432|P1|STARTED|Overall Study||53
7642123|NCT02202499|18818446|P3|NOT COMPLETED|Overall Study||2
7642124|NCT02202499|18818447|P2|NOT COMPLETED|Overall Study||0
7642125|NCT02202499|18818448|P1|NOT COMPLETED|Overall Study||2
7642126|NCT02202499|18818446|P3|COMPLETED|Overall Study||19
7642127|NCT02202499|18818447|P2|COMPLETED|Overall Study||20
7642128|NCT02202499|18818448|P1|COMPLETED|Overall Study||19
7642129|NCT02202499|18818446|P3|STARTED|Overall Study||21
7642130|NCT02202499|18818447|P2|STARTED|Overall Study||20
7642131|NCT02202499|18818448|P1|STARTED|Overall Study||21
7642132|NCT02202434|18818475|P4|NOT COMPLETED|Overall Study||37
7642133|NCT02202434|18818476|P3|NOT COMPLETED|Overall Study||15
7642134|NCT02202434|18818477|P2|NOT COMPLETED|Overall Study||69
7642135|NCT02202434|18818478|P1|NOT COMPLETED|Overall Study||109
7642136|NCT02202434|18818475|P4|COMPLETED|Overall Study||258
7642137|NCT02202434|18818476|P3|COMPLETED|Overall Study||87
7642138|NCT02202434|18818477|P2|COMPLETED|Overall Study||236
7642139|NCT02202434|18818478|P1|COMPLETED|Overall Study||498
7642140|NCT02202434|18818475|P4|STARTED|Overall Study||295
7642141|NCT02202434|18818476|P3|STARTED|Overall Study||102
7642142|NCT02202434|18818477|P2|STARTED|Overall Study||305
7642143|NCT02202434|18818478|P1|STARTED|Overall Study||607
7642144|NCT02202317|18818602|P1|NOT COMPLETED|Overall Study||1
7642145|NCT02202317|18818602|P1|COMPLETED|Overall Study||8
7642146|NCT02202317|18818602|P1|STARTED|Overall Study||9
7642147|NCT02202252|18818610|P2|NOT COMPLETED|Overall Study||0
7642148|NCT02202252|18818611|P1|NOT COMPLETED|Overall Study||0
7642149|NCT02202252|18818610|P2|COMPLETED|Overall Study||30
7642150|NCT02202252|18818611|P1|COMPLETED|Overall Study||30
7642151|NCT02202252|18818610|P2|STARTED|Overall Study||30
7642152|NCT02202252|18818611|P1|STARTED|Overall Study||30
7642153|NCT02202161|18818629|P8|NOT COMPLETED|Overall Study||6
7642154|NCT02202161|18818630|P7|NOT COMPLETED|Overall Study||0
7642155|NCT02202161|18818631|P6|NOT COMPLETED|Overall Study||1
7642156|NCT02202161|18818632|P5|NOT COMPLETED|Overall Study||1
7642157|NCT02202161|18818633|P4|NOT COMPLETED|Overall Study||0
7642158|NCT02202161|18818634|P3|NOT COMPLETED|Overall Study||0
7642159|NCT02202161|18818635|P2|NOT COMPLETED|Overall Study||1
7642160|NCT02202161|18818636|P1|NOT COMPLETED|Overall Study||1
7642161|NCT02202161|18818629|P8|COMPLETED|Overall Study||0
7642162|NCT02202161|18818630|P7|COMPLETED|Overall Study||13
7642163|NCT02202161|18818631|P6|COMPLETED|Overall Study||9
7642164|NCT02202161|18818632|P5|COMPLETED|Overall Study||8
7642165|NCT02202161|18818633|P4|COMPLETED|Overall Study||9
7642166|NCT02202161|18818634|P3|COMPLETED|Overall Study||5
7642167|NCT02202161|18818635|P2|COMPLETED|Overall Study||4
7642168|NCT02202161|18818636|P1|COMPLETED|Overall Study||12
7642169|NCT02202161|18818629|P8|STARTED|Overall Study||6
7642170|NCT02202161|18818630|P7|STARTED|Overall Study||13
7642171|NCT02202161|18818631|P6|STARTED|Overall Study||10
7642172|NCT02202161|18818632|P5|STARTED|Overall Study||9
7642173|NCT02202161|18818633|P4|STARTED|Overall Study||9
7642174|NCT02202161|18818634|P3|STARTED|Overall Study||5
7642175|NCT02202161|18818635|P2|STARTED|Overall Study||5
7642176|NCT02202161|18818636|P1|STARTED|Overall Study||13
7642177|NCT02202135|18818790|P1|NOT COMPLETED|Overall Study||0
7642178|NCT02202135|18818790|P1|COMPLETED|Overall Study||4
7642179|NCT02202135|18818790|P1|STARTED|Overall Study||4
7642180|NCT02202109|18818796|P2|NOT COMPLETED|Overall Study||87
7642181|NCT02202109|18818797|P1|NOT COMPLETED|Overall Study||90
7642182|NCT02202109|18818796|P2|COMPLETED|Overall Study||213
7642183|NCT02202109|18818797|P1|COMPLETED|Overall Study||212
7642184|NCT02202109|18818796|P2|STARTED|Overall Study||300
7642185|NCT02202109|18818797|P1|STARTED|Overall Study||302
7642186|NCT02202044|18818807|P1|NOT COMPLETED|Overall Study||0
7642187|NCT02202044|18818807|P1|COMPLETED|Overall Study||0
7642188|NCT02202044|18818807|P1|STARTED|Overall Study||0
7642189|NCT02202031|18818814|P2|NOT COMPLETED|Overall Study||5
7642190|NCT02202031|18818815|P1|NOT COMPLETED|Overall Study||5
7642191|NCT02202031|18818814|P2|COMPLETED|Overall Study||74
7642192|NCT02202031|18818815|P1|COMPLETED|Overall Study||77
7642193|NCT02202031|18818814|P2|STARTED|Overall Study||79
7642194|NCT02202031|18818815|P1|STARTED|Overall Study||82
7642195|NCT02201953|18818863|P2|NOT COMPLETED|Overall Study||56
7642196|NCT02201953|18818864|P1|NOT COMPLETED|Overall Study||20
7642197|NCT02201953|18818863|P2|COMPLETED|Overall Study||224
7642198|NCT02201953|18818864|P1|COMPLETED|Overall Study||258
7642199|NCT02201953|18818863|P2|STARTED|Overall Study||280
7642200|NCT02201953|18818864|P1|STARTED|Overall Study||278
7642201|NCT02201940|18818882|P2|NOT COMPLETED|Overall Study||116
7642202|NCT02201940|18818883|P1|NOT COMPLETED|Overall Study||12
7642203|NCT02201940|18818882|P2|COMPLETED|Overall Study||0
7642204|NCT02201940|18818883|P1|COMPLETED|Overall Study||613
7642205|NCT02201940|18818882|P2|STARTED|Overall Study||116
7642206|NCT02201940|18818883|P1|STARTED|Overall Study||625
7642207|NCT02201901|18818902|P3|NOT COMPLETED|Overall Study||13
7642208|NCT02201901|18818903|P2|NOT COMPLETED|Overall Study||9
7642209|NCT02201901|18818904|P1|NOT COMPLETED|Overall Study||15
7642210|NCT02201901|18818902|P3|COMPLETED|Overall Study||77
7642211|NCT02201901|18818903|P2|COMPLETED|Overall Study||79
7642212|NCT02201901|18818904|P1|COMPLETED|Overall Study||75
7642213|NCT02201901|18818902|P3|STARTED|Overall Study||90
7642214|NCT02201901|18818903|P2|STARTED|Overall Study||88
7642215|NCT02201901|18818904|P1|STARTED|Overall Study||90
7642216|NCT02201784|18818935|P2|NOT COMPLETED|Overall Study||0
7642217|NCT02201784|18818936|P1|NOT COMPLETED|Overall Study||2
7642218|NCT02201784|18818935|P2|COMPLETED|Overall Study||30
7642219|NCT02201784|18818936|P1|COMPLETED|Overall Study||28
7642220|NCT02201784|18818935|P2|STARTED|Overall Study||30
7642221|NCT02201784|18818936|P1|STARTED|Overall Study||30
7642222|NCT02201771|18818953|P3|NOT COMPLETED|Overall Study||10
7642223|NCT02201771|18818954|P2|NOT COMPLETED|Overall Study||10
7642224|NCT02201771|18818955|P1|NOT COMPLETED|Overall Study||13
7642225|NCT02201771|18818953|P3|COMPLETED|Overall Study||156
7642226|NCT02201771|18818954|P2|COMPLETED|Overall Study||158
7642227|NCT02201771|18818955|P1|COMPLETED|Overall Study||153
7642228|NCT02201771|18818953|P3|STARTED|Overall Study||166
7642229|NCT02201771|18818954|P2|STARTED|Overall Study||168
7642230|NCT02201771|18818955|P1|STARTED|Overall Study||166
7642231|NCT02201524|18818982|P4|NOT COMPLETED|Overall Study||4
7642232|NCT02201524|18818983|P3|NOT COMPLETED|Overall Study||4
7642233|NCT02201524|18818984|P2|NOT COMPLETED|Overall Study||3
7642234|NCT02201524|18818985|P1|NOT COMPLETED|Overall Study||2
7642235|NCT02201524|18818982|P4|COMPLETED|Overall Study||10
7642236|NCT02201524|18818983|P3|COMPLETED|Overall Study||12
7642237|NCT02201524|18818984|P2|COMPLETED|Overall Study||12
7642238|NCT02201524|18818985|P1|COMPLETED|Overall Study||12
7642239|NCT02201524|18818982|P4|STARTED|Overall Study||14
7642240|NCT02201524|18818983|P3|STARTED|Overall Study||16
7642241|NCT02201524|18818984|P2|STARTED|Overall Study||15
7642242|NCT02201524|18818985|P1|STARTED|Overall Study||14
7642243|NCT02201472|18819067|P1|NOT COMPLETED|Overall Study||2
7642244|NCT02201472|18819067|P1|COMPLETED|Overall Study||0
7642245|NCT02201472|18819067|P1|STARTED|Overall Study||2
7642246|NCT02201446|18819073|P2|NOT COMPLETED|Overall Study||0
7642247|NCT02201446|18819074|P1|NOT COMPLETED|Overall Study||0
7642248|NCT02201446|18819073|P2|COMPLETED|Overall Study||58
7642249|NCT02201446|18819074|P1|COMPLETED|Overall Study||81
7642250|NCT02201446|18819073|P2|STARTED|Overall Study||58
7642251|NCT02201446|18819074|P1|STARTED|Overall Study||81
7642252|NCT02201420|18819102|P1|NOT COMPLETED|Overall Study||0
7642253|NCT02201420|18819102|P1|COMPLETED|Overall Study||5
7642254|NCT02201420|18819102|P1|STARTED|Overall Study||5
7642255|NCT02201394|18819107|P1|NOT COMPLETED|Maintenance Dose||0
7642256|NCT02201394|18819107|P1|COMPLETED|Maintenance Dose||20
7642257|NCT02201394|18819107|P1|STARTED|Maintenance Dose||20
7642258|NCT02201394|18819107|P1|NOT COMPLETED|Loading Dose||0
7642259|NCT02201394|18819107|P1|COMPLETED|Loading Dose||20
7642260|NCT02201394|18819107|P1|STARTED|Loading Dose||20
7642261|NCT02201329|18819114|P1|NOT COMPLETED|Overall Study||5
7642262|NCT02201329|18819114|P1|COMPLETED|Overall Study||0
7642263|NCT02201329|18819114|P1|STARTED|Overall Study||5
7642264|NCT02201290|18819122|P1|NOT COMPLETED|Overall Study||5
7642265|NCT02201290|18819122|P1|COMPLETED|Overall Study||4
7642266|NCT02201290|18819122|P1|STARTED|Overall Study||9
7642267|NCT02201277|18819128|P2|NOT COMPLETED|Overall Study||5
7642268|NCT02201277|18819129|P1|NOT COMPLETED|Overall Study||7
7642269|NCT02201277|18819128|P2|COMPLETED|Overall Study||16
7642270|NCT02201277|18819129|P1|COMPLETED|Overall Study||17
7642271|NCT02201277|18819128|P2|Failed Retrieval (Referred Elsewhere)|Overall Study||0
7642272|NCT02201277|18819129|P1|Failed Retrieval (Referred Elsewhere)|Overall Study||1
7642273|NCT02201277|18819128|P2|Complicated Retrieval|Overall Study||0
7642274|NCT02201277|18819129|P1|Complicated Retrieval|Overall Study||2
7642275|NCT02201277|18819128|P2|Death (Before Removal)|Overall Study||4
7642276|NCT02201277|18819129|P1|Death (Before Removal)|Overall Study||3
7642277|NCT02201277|18819128|P2|Lost to Follow up|Overall Study||1
7642278|NCT02201277|18819129|P1|Lost to Follow up|Overall Study||2
7642279|NCT02201277|18819128|P2|Filter Ruled to be Permanent|Overall Study||2
7642280|NCT02201277|18819129|P1|Filter Ruled to be Permanent|Overall Study||2
7642281|NCT02201277|18819128|P2|Signed ICF But Did Not Enroll|Overall Study||1
7642282|NCT02201277|18819129|P1|Signed ICF But Did Not Enroll|Overall Study|Physician had preference for a specific filter so patient not randomized.|0
7642283|NCT02201277|18819128|P2|Filter Retrieval|Overall Study||16
7642284|NCT02201277|18819129|P1|Filter Retrieval|Overall Study||17
7642285|NCT02201277|18819128|P2|STARTED|Overall Study|1 patient was withdrawn after signing consent due to physician preference for the option filter.|21
7642286|NCT02201277|18819129|P1|STARTED|Overall Study|24 patients were consented but 1 patient had denali filter placed twice.|24
7642287|NCT02201212|18819149|P1|NOT COMPLETED|Overall Study||0
7642288|NCT02201212|18819149|P1|COMPLETED|Overall Study||30
7642289|NCT02201212|18819149|P1|STARTED|Overall Study||30
7642290|NCT02201108|18819159|P2|NOT COMPLETED|Overall Study||7
7642291|NCT02201108|18819160|P1|NOT COMPLETED|Overall Study||4
7642292|NCT02201108|18819159|P2|COMPLETED|Overall Study||102
7642293|NCT02201108|18819160|P1|COMPLETED|Overall Study||53
7642294|NCT02201108|18819159|P2|On-going Participants|Overall Study||58
7642295|NCT02201108|18819160|P1|On-going Participants|Overall Study||0
7642296|NCT02201108|18819159|P2|STARTED|Overall Study||109
7642297|NCT02201108|18819160|P1|STARTED|Overall Study||57
7642298|NCT02201056|18819212|P7|NOT COMPLETED|Overall Study||0
7642299|NCT02201056|18819213|P6|NOT COMPLETED|Overall Study||0
7642300|NCT02201056|18819214|P5|NOT COMPLETED|Overall Study||0
7642301|NCT02201056|18819215|P4|NOT COMPLETED|Overall Study||0
7642302|NCT02201056|18819216|P3|NOT COMPLETED|Overall Study||0
7642303|NCT02201056|18819217|P2|NOT COMPLETED|Overall Study||0
7642304|NCT02201056|18819218|P1|NOT COMPLETED|Overall Study||0
7642305|NCT02201056|18819212|P7|COMPLETED|Overall Study||6
7642306|NCT02201056|18819213|P6|COMPLETED|Overall Study||6
7642307|NCT02201056|18819214|P5|COMPLETED|Overall Study||6
7642308|NCT02201056|18819215|P4|COMPLETED|Overall Study||6
7642309|NCT02201056|18819216|P3|COMPLETED|Overall Study||6
7642310|NCT02201056|18819217|P2|COMPLETED|Overall Study||6
7642311|NCT02201056|18819218|P1|COMPLETED|Overall Study||12
7642312|NCT02201056|18819212|P7|STARTED|Overall Study||6
7642313|NCT02201056|18819213|P6|STARTED|Overall Study||6
7642314|NCT02201056|18819214|P5|STARTED|Overall Study||6
7642315|NCT02201056|18819215|P4|STARTED|Overall Study||6
7642316|NCT02201056|18819216|P3|STARTED|Overall Study||6
7642317|NCT02201056|18819217|P2|STARTED|Overall Study||6
7642318|NCT02201056|18819218|P1|STARTED|Overall Study||12
7642319|NCT02200770|18819275|P2|NOT COMPLETED|Open-label Period (OLP)||162
7642320|NCT02200770|18819276|P1|NOT COMPLETED|Open-label Period (OLP)||51
7642321|NCT02200770|18819275|P2|COMPLETED|Open-label Period (OLP)||0
7642322|NCT02200770|18819276|P1|COMPLETED|Open-label Period (OLP)||0
7642323|NCT02200770|18819275|P2|STARTED|Open-label Period (OLP)|Enrolment into OLP was optional; out of 169 participants who completed RCP, only 162 entered in OLP.|162
7642324|NCT02200770|18819276|P1|STARTED|Open-label Period (OLP)|Enrolment into OLP was optional; out of 54 participants who completed RCP, only 51 entered in OLP.|51
7642325|NCT02200770|18819275|P2|NOT COMPLETED|Randomized-controlled Period (RCP)||6
7642326|NCT02200770|18819276|P1|NOT COMPLETED|Randomized-controlled Period (RCP)||2
7642327|NCT02200770|18819275|P2|COMPLETED|Randomized-controlled Period (RCP)||169
7642328|NCT02200770|18819276|P1|COMPLETED|Randomized-controlled Period (RCP)||54
7642329|NCT02200770|18819275|P2|Treated|Randomized-controlled Period (RCP)||174
7642330|NCT02200770|18819276|P1|Treated|Randomized-controlled Period (RCP)||56
7642331|NCT02200770|18819275|P2|STARTED|Randomized-controlled Period (RCP)||175
7642332|NCT02200770|18819276|P1|STARTED|Randomized-controlled Period (RCP)||56
7642333|NCT02200614|18819307|P2|NOT COMPLETED|Open Label||23
7642334|NCT02200614|18819308|P1|NOT COMPLETED|Open Label||125
7642335|NCT02200614|18819307|P2|COMPLETED|Open Label||147
7642336|NCT02200614|18819308|P1|COMPLETED|Open Label||466
7642337|NCT02200614|18819307|P2|STARTED|Open Label|Not all participants from treatment period entered follow-up|170
7642338|NCT02200614|18819308|P1|STARTED|Open Label|Not all participants from treatment period entered follow-up|591
7642339|NCT02200614|18819307|P2|NOT COMPLETED|Double Blind Treatment||384
7642340|NCT02200614|18819308|P1|NOT COMPLETED|Double Blind Treatment||364
7642341|NCT02200614|18819307|P2|COMPLETED|Double Blind Treatment||170
7642342|NCT02200614|18819308|P1|COMPLETED|Double Blind Treatment||591
7642343|NCT02200614|18819307|P2|STARTED|Double Blind Treatment||554
7642344|NCT02200614|18819308|P1|STARTED|Double Blind Treatment||955
7642345|NCT02200536|18819333|P3|NOT COMPLETED|Overall Study||0
7642346|NCT02200536|18819334|P2|NOT COMPLETED|Overall Study||0
7642347|NCT02200536|18819335|P1|NOT COMPLETED|Overall Study||0
7642348|NCT02200536|18819333|P3|COMPLETED|Overall Study||30
7642349|NCT02200536|18819334|P2|COMPLETED|Overall Study||30
7642350|NCT02200536|18819335|P1|COMPLETED|Overall Study||32
7642351|NCT02200536|18819333|P3|STARTED|Overall Study||30
7642352|NCT02200536|18819334|P2|STARTED|Overall Study||30
7642353|NCT02200536|18819335|P1|STARTED|Overall Study||32
7642354|NCT02200523|18819348|P2|NOT COMPLETED|Overall Study||0
7642355|NCT02200523|18819349|P1|NOT COMPLETED|Overall Study||0
7642356|NCT02200523|18819348|P2|COMPLETED|Overall Study||20
7642357|NCT02200523|18819349|P1|COMPLETED|Overall Study||20
7642358|NCT02200523|18819348|P2|STARTED|Overall Study||20
7642359|NCT02200523|18819349|P1|STARTED|Overall Study||20
7642360|NCT02200510|18819357|P2|NOT COMPLETED|Overall Study||3
7642361|NCT02200510|18819358|P1|NOT COMPLETED|Overall Study||9
7642362|NCT02200510|18819357|P2|COMPLETED|Overall Study|This number is the number of participants with both baseline and post data.|44
7642363|NCT02200510|18819358|P1|COMPLETED|Overall Study|This is the number of participants with baseline and post data.|22
7642364|NCT02200510|18819357|P2|STARTED|Overall Study|Number who only completed portal or completed it before self-management (could do 6 months later).|47
7642365|NCT02200510|18819358|P1|STARTED|Overall Study|Number who only completed self-management or completed it before portal (could do 6 months later).|31
7642366|NCT02200458|18819364|P1|NOT COMPLETED|Overall Study||0
7642367|NCT02200458|18819364|P1|COMPLETED|Overall Study||62
7642368|NCT02200458|18819364|P1|STARTED|Overall Study||62
7642369|NCT02200445|18819371|P3|NOT COMPLETED|Overall Study||2
7642370|NCT02200445|18819372|P2|NOT COMPLETED|Overall Study||4
7642371|NCT02200445|18819373|P1|NOT COMPLETED|Overall Study||1
7642372|NCT02200445|18819371|P3|COMPLETED|Overall Study||3
7642373|NCT02200445|18819372|P2|COMPLETED|Overall Study||13
7642374|NCT02200445|18819373|P1|COMPLETED|Overall Study||3
7642375|NCT02200445|18819371|P3|STARTED|Overall Study||5
7642376|NCT02200445|18819372|P2|STARTED|Overall Study||17
7642377|NCT02200445|18819373|P1|STARTED|Overall Study||4
7642378|NCT02200328|18819389|P2|NOT COMPLETED|Overall Study||33
7642379|NCT02200328|18819390|P1|NOT COMPLETED|Overall Study||43
7642380|NCT02200328|18819389|P2|COMPLETED|Overall Study||0
7642381|NCT02200328|18819390|P1|COMPLETED|Overall Study||0
7642382|NCT02200328|18819389|P2|STARTED|Overall Study||33
7642383|NCT02200328|18819390|P1|STARTED|Overall Study||43
7642384|NCT02200211|18819402|P4|NOT COMPLETED|Overall Study||2
7642385|NCT02200211|18819403|P3|NOT COMPLETED|Overall Study||1
7642386|NCT02200211|18819404|P2|NOT COMPLETED|Overall Study||7
7642387|NCT02200211|18819405|P1|NOT COMPLETED|Overall Study||8
7642388|NCT02200211|18819402|P4|COMPLETED|Overall Study||58
7642389|NCT02200211|18819403|P3|COMPLETED|Overall Study||39
7642390|NCT02200211|18819404|P2|COMPLETED|Overall Study||188
7642391|NCT02200211|18819405|P1|COMPLETED|Overall Study||182
7642392|NCT02200211|18819402|P4|Included in 16-week Primary Analysis|Overall Study||56
7642393|NCT02200211|18819403|P3|Included in 16-week Primary Analysis|Overall Study||39
7642394|NCT02200211|18819404|P2|Included in 16-week Primary Analysis|Overall Study||186
7642395|NCT02200211|18819405|P1|Included in 16-week Primary Analysis|Overall Study||177
7642396|NCT02200211|18819402|P4|STARTED|Overall Study||60
7642397|NCT02200211|18819403|P3|STARTED|Overall Study||40
7642398|NCT02200211|18819404|P2|STARTED|Overall Study||195
7642399|NCT02200211|18819405|P1|STARTED|Overall Study||190
7642400|NCT02200055|18819501|P1|NOT COMPLETED|Overall Study||0
7642401|NCT02200055|18819501|P1|COMPLETED|Overall Study||86
7642402|NCT02200055|18819501|P1|STARTED|Overall Study||86
7642403|NCT02200042|18819518|P2|NOT COMPLETED|Overall Study||1
7642404|NCT02200042|18819519|P1|NOT COMPLETED|Overall Study||0
7642405|NCT02200042|18819518|P2|COMPLETED|Overall Study||0
7642406|NCT02200042|18819519|P1|COMPLETED|Overall Study||0
7642407|NCT02200042|18819518|P2|STARTED|Overall Study||1
7642408|NCT02200042|18819519|P1|STARTED|Overall Study||0
7642409|NCT02199964|18819537|P2|NOT COMPLETED|Overall Study||0
7642410|NCT02199964|18819538|P1|NOT COMPLETED|Overall Study||0
7642411|NCT02199964|18819537|P2|COMPLETED|Overall Study||2
7642412|NCT02199964|18819538|P1|COMPLETED|Overall Study||2
7642413|NCT02199964|18819537|P2|STARTED|Overall Study||2
7642414|NCT02199964|18819538|P1|STARTED|Overall Study||2
7642415|NCT02199795|18819548|P2|NOT COMPLETED|Overall Study||0
7642416|NCT02199795|18819549|P1|NOT COMPLETED|Overall Study||2
7642417|NCT02199795|18819548|P2|COMPLETED|Overall Study||3
7642418|NCT02199795|18819549|P1|COMPLETED|Overall Study||2
7642419|NCT02199795|18819548|P2|STARTED|Overall Study||3
7642420|NCT02199795|18819549|P1|STARTED|Overall Study||4
7642421|NCT02199717|18819561|P1|NOT COMPLETED|Overall Study||0
7642422|NCT02199717|18819561|P1|COMPLETED|Overall Study||66
7642423|NCT02199717|18819561|P1|STARTED|Overall Study||66
7642424|NCT02199691|18819572|P4|NOT COMPLETED|Overall Study||30
7642425|NCT02199691|18819573|P3|NOT COMPLETED|Overall Study||27
7642426|NCT02199691|18819574|P2|NOT COMPLETED|Overall Study||7
7642427|NCT02199691|18819575|P1|NOT COMPLETED|Overall Study||10
7642428|NCT02199691|18819572|P4|COMPLETED|Overall Study||270
7642429|NCT02199691|18819573|P3|COMPLETED|Overall Study||376
7642430|NCT02199691|18819574|P2|COMPLETED|Overall Study||500
7642431|NCT02199691|18819575|P1|COMPLETED|Overall Study||495
7642432|NCT02199691|18819572|P4|Safety Analysis Set (SafAS)|Overall Study||296
7642433|NCT02199691|18819573|P3|Safety Analysis Set (SafAS)|Overall Study||392
7642434|NCT02199691|18819574|P2|Safety Analysis Set (SafAS)|Overall Study||501
7642435|NCT02199691|18819575|P1|Safety Analysis Set (SafAS)|Overall Study||503
7642436|NCT02199691|18819572|P4|STARTED|Overall Study||300
7642437|NCT02199691|18819573|P3|STARTED|Overall Study||403
7642438|NCT02199691|18819574|P2|STARTED|Overall Study||507
7642439|NCT02199691|18819575|P1|STARTED|Overall Study||505
7642440|NCT02199652|18819597|P2|NOT COMPLETED|Overall Study||7
7642441|NCT02199652|18819598|P1|NOT COMPLETED|Overall Study||7
7642442|NCT02199652|18819597|P2|COMPLETED|Overall Study||3
7642443|NCT02199652|18819598|P1|COMPLETED|Overall Study||3
7642444|NCT02199652|18819597|P2|STARTED|Overall Study||10
7642445|NCT02199652|18819598|P1|STARTED|Overall Study||10
7642446|NCT02199574|18819608|P1|NOT COMPLETED|Overall Study||0
7642447|NCT02199574|18819608|P1|COMPLETED|Overall Study||12
7642448|NCT02199574|18819608|P1|STARTED|Overall Study||12
7642449|NCT02199509|18819617|P2|NOT COMPLETED|Overall Study||1
7642450|NCT02199509|18819618|P1|NOT COMPLETED|Overall Study||1
7642451|NCT02199509|18819617|P2|COMPLETED|Overall Study||3
7642452|NCT02199509|18819618|P1|COMPLETED|Overall Study||2
7642453|NCT02199509|18819617|P2|STARTED|Overall Study||4
7642454|NCT02199509|18819618|P1|STARTED|Overall Study||3
7642455|NCT02199496|18819632|P2|NOT COMPLETED|Ustekinumab-Multi-dose||0
7642456|NCT02199496|18819633|P1|NOT COMPLETED|Ustekinumab-Multi-dose||0
7642457|NCT02199496|18819632|P2|COMPLETED|Ustekinumab-Multi-dose||2
7642458|NCT02199496|18819633|P1|COMPLETED|Ustekinumab-Multi-dose||3
7642459|NCT02199496|18819632|P2|STARTED|Ustekinumab-Multi-dose|Cohort 2 only participated in multi-dose phase 2|2
7642460|NCT02199496|18819633|P1|STARTED|Ustekinumab-Multi-dose||3
7642461|NCT02199496|18819632|P2|NOT COMPLETED|Ustekinumab-Single Dose||0
7642462|NCT02199496|18819633|P1|NOT COMPLETED|Ustekinumab-Single Dose||0
7642463|NCT02199496|18819632|P2|COMPLETED|Ustekinumab-Single Dose||0
7642464|NCT02199496|18819633|P1|COMPLETED|Ustekinumab-Single Dose||3
7642465|NCT02199496|18819632|P2|STARTED|Ustekinumab-Single Dose||0
7642466|NCT02199496|18819633|P1|STARTED|Ustekinumab-Single Dose||3
7642467|NCT02199314|18819641|P1|NOT COMPLETED|Overall Study||16
7642468|NCT02199314|18819641|P1|COMPLETED|Overall Study||14
7642469|NCT02199314|18819641|P1|STARTED|Overall Study||30
7642470|NCT02199197|18819647|P2|NOT COMPLETED|Overall Study||2
7642471|NCT02199197|18819648|P1|NOT COMPLETED|Overall Study||0
7642472|NCT02199197|18819647|P2|COMPLETED|Overall Study||12
7642473|NCT02199197|18819648|P1|COMPLETED|Overall Study||35
7642474|NCT02199197|18819647|P2|STARTED|Overall Study||14
7642475|NCT02199197|18819648|P1|STARTED|Overall Study||35
7642476|NCT02199080|18819668|P1|NOT COMPLETED|Overall Study||12
7642477|NCT02199080|18819668|P1|COMPLETED|Overall Study||2494
7642478|NCT02199080|18819668|P1|STARTED|Overall Study||2506
7642479|NCT02199041|18819678|P1|NOT COMPLETED|Overall Study||0
7642480|NCT02199041|18819678|P1|COMPLETED|Overall Study||12
7642481|NCT02199041|18819678|P1|STARTED|Overall Study||12
7642482|NCT02199028|18819693|P2|NOT COMPLETED|Week 4||0
7642483|NCT02199028|18819694|P1|NOT COMPLETED|Week 4||0
7642484|NCT02199028|18819693|P2|COMPLETED|Week 4||15
7642485|NCT02199028|18819694|P1|COMPLETED|Week 4||13
7642486|NCT02199028|18819693|P2|STARTED|Week 4||15
7642487|NCT02199028|18819694|P1|STARTED|Week 4||13
7642488|NCT02199028|18819693|P2|NOT COMPLETED|Week 3||0
7642489|NCT02199028|18819694|P1|NOT COMPLETED|Week 3||1
7642490|NCT02199028|18819693|P2|COMPLETED|Week 3||15
7642491|NCT02199028|18819694|P1|COMPLETED|Week 3||13
7642492|NCT02199028|18819693|P2|STARTED|Week 3||15
7642493|NCT02199028|18819694|P1|STARTED|Week 3||14
7642494|NCT02199028|18819693|P2|NOT COMPLETED|Week 2||0
7642495|NCT02199028|18819694|P1|NOT COMPLETED|Week 2||0
7642496|NCT02199028|18819693|P2|COMPLETED|Week 2||15
7642497|NCT02199028|18819694|P1|COMPLETED|Week 2||14
7642498|NCT02199028|18819693|P2|STARTED|Week 2||15
7642499|NCT02199028|18819694|P1|STARTED|Week 2||14
7642500|NCT02199028|18819693|P2|NOT COMPLETED|Week 1||0
7642501|NCT02199028|18819694|P1|NOT COMPLETED|Week 1||1
7642502|NCT02199028|18819693|P2|COMPLETED|Week 1||15
7642503|NCT02199028|18819694|P1|COMPLETED|Week 1||14
7642504|NCT02199028|18819693|P2|STARTED|Week 1||15
7642505|NCT02199028|18819694|P1|STARTED|Week 1||15
7642506|NCT02198963|18819703|P1|NOT COMPLETED|Overall Study||7
7642507|NCT02198963|18819703|P1|COMPLETED|Overall Study||36
7642508|NCT02198963|18819703|P1|STARTED|Overall Study||43
7642509|NCT02198833|18819714|P2|NOT COMPLETED|Overall Study||0
7642510|NCT02198833|18819715|P1|NOT COMPLETED|Overall Study||0
7642511|NCT02198833|18819714|P2|COMPLETED|Overall Study||1
7642512|NCT02198833|18819715|P1|COMPLETED|Overall Study||1
7642513|NCT02198833|18819714|P2|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed.|1
7642514|NCT02198833|18819715|P1|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed|1
7642515|NCT02198651|18819727|P5|NOT COMPLETED|Open-label Rescue Period||0
7642516|NCT02198651|18819728|P4|NOT COMPLETED|Open-label Rescue Period||3
7642517|NCT02198651|18819729|P3|NOT COMPLETED|Open-label Rescue Period||0
7642518|NCT02198651|18819730|P2|NOT COMPLETED|Open-label Rescue Period||0
7642519|NCT02198651|18819731|P1|NOT COMPLETED|Open-label Rescue Period||0
7642520|NCT02198651|18819727|P5|COMPLETED|Open-label Rescue Period||8
7642521|NCT02198651|18819728|P4|COMPLETED|Open-label Rescue Period||28
7642522|NCT02198651|18819729|P3|COMPLETED|Open-label Rescue Period||0
7642523|NCT02198651|18819730|P2|COMPLETED|Open-label Rescue Period||0
7642524|NCT02198651|18819731|P1|COMPLETED|Open-label Rescue Period||0
7642525|NCT02198651|18819727|P5|Correctly Entered Open-label Rescue|Open-label Rescue Period||8
7642526|NCT02198651|18819728|P4|Correctly Entered Open-label Rescue|Open-label Rescue Period||30
7642527|NCT02198651|18819729|P3|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
7642528|NCT02198651|18819730|P2|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
7642529|NCT02198651|18819731|P1|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
7642530|NCT02198651|18819727|P5|STARTED|Open-label Rescue Period||8
7642531|NCT02198651|18819728|P4|STARTED|Open-label Rescue Period||31
7642532|NCT02198651|18819729|P3|STARTED|Open-label Rescue Period||0
7642533|NCT02198651|18819730|P2|STARTED|Open-label Rescue Period||0
7642534|NCT02198651|18819731|P1|STARTED|Open-label Rescue Period||0
7642535|NCT02198651|18819727|P5|NOT COMPLETED|Double-blind Period||0
7642536|NCT02198651|18819728|P4|NOT COMPLETED|Double-blind Period||0
7642537|NCT02198651|18819729|P3|NOT COMPLETED|Double-blind Period||1
7642538|NCT02198651|18819730|P2|NOT COMPLETED|Double-blind Period||9
7642539|NCT02198651|18819731|P1|NOT COMPLETED|Double-blind Period||0
7642540|NCT02198651|18819727|P5|COMPLETED|Double-blind Period||0
7642541|NCT02198651|18819728|P4|COMPLETED|Double-blind Period||0
7642542|NCT02198651|18819729|P3|COMPLETED|Double-blind Period||19
7642543|NCT02198651|18819730|P2|COMPLETED|Double-blind Period||93
7642544|NCT02198651|18819731|P1|COMPLETED|Double-blind Period||0
7642545|NCT02198651|18819727|P5|STARTED|Double-blind Period||0
7642546|NCT02198651|18819728|P4|STARTED|Double-blind Period||0
7642547|NCT02198651|18819729|P3|STARTED|Double-blind Period||20
7642548|NCT02198651|18819730|P2|STARTED|Double-blind Period||102
7642549|NCT02198651|18819731|P1|STARTED|Double-blind Period||0
7642550|NCT02198651|18819727|P5|NOT COMPLETED|Lead-in Period||0
7642551|NCT02198651|18819728|P4|NOT COMPLETED|Lead-in Period||0
7642552|NCT02198651|18819729|P3|NOT COMPLETED|Lead-in Period||0
7642553|NCT02198651|18819730|P2|NOT COMPLETED|Lead-in Period||0
7642554|NCT02198651|18819731|P1|NOT COMPLETED|Lead-in Period||37
7642555|NCT02198651|18819727|P5|COMPLETED|Lead-in Period||0
7642556|NCT02198651|18819728|P4|COMPLETED|Lead-in Period||0
7642557|NCT02198651|18819729|P3|COMPLETED|Lead-in Period||0
7642558|NCT02198651|18819730|P2|COMPLETED|Lead-in Period||0
7642559|NCT02198651|18819731|P1|COMPLETED|Lead-in Period||112
7642560|NCT02198651|18819727|P5|Participants Treated in Lead-In Period|Lead-in Period||0
7642561|NCT02198651|18819728|P4|Participants Treated in Lead-In Period|Lead-in Period||0
7642562|NCT02198651|18819729|P3|Participants Treated in Lead-In Period|Lead-in Period||0
7642563|NCT02198651|18819730|P2|Participants Treated in Lead-In Period|Lead-in Period||0
7642564|NCT02198651|18819731|P1|Participants Treated in Lead-In Period|Lead-in Period||146
7642565|NCT02198651|18819727|P5|STARTED|Lead-in Period||0
7642566|NCT02198651|18819728|P4|STARTED|Lead-in Period||0
7642567|NCT02198651|18819729|P3|STARTED|Lead-in Period||0
7642568|NCT02198651|18819730|P2|STARTED|Lead-in Period||0
7642569|NCT02198651|18819731|P1|STARTED|Lead-in Period||149
7642570|NCT02198430|18819816|P2|NOT COMPLETED|Overall Study||0
7642571|NCT02198430|18819817|P1|NOT COMPLETED|Overall Study||0
7642572|NCT02198430|18819816|P2|COMPLETED|Overall Study||51
7642573|NCT02198430|18819817|P1|COMPLETED|Overall Study||53
7642574|NCT02198430|18819816|P2|STARTED|Overall Study||51
7642575|NCT02198430|18819817|P1|STARTED|Overall Study||53
7642576|NCT02198235|18819832|P3|NOT COMPLETED|Overall Study||2
7642577|NCT02198235|18819833|P2|NOT COMPLETED|Overall Study||2
7642578|NCT02198235|18819834|P1|NOT COMPLETED|Overall Study||3
7642579|NCT02198235|18819832|P3|COMPLETED|Overall Study||28
7642580|NCT02198235|18819833|P2|COMPLETED|Overall Study||28
7642581|NCT02198235|18819834|P1|COMPLETED|Overall Study||27
7642582|NCT02198235|18819832|P3|STARTED|Overall Study||30
7642583|NCT02198235|18819833|P2|STARTED|Overall Study||30
7642584|NCT02198235|18819834|P1|STARTED|Overall Study||30
7642585|NCT02198040|18819854|P3|NOT COMPLETED|Overall Study||1
7642586|NCT02198040|18819855|P2|NOT COMPLETED|Overall Study||1
7642587|NCT02198040|18819856|P1|NOT COMPLETED|Overall Study||0
7642588|NCT02198040|18819854|P3|COMPLETED|Overall Study||8
7642589|NCT02198040|18819855|P2|COMPLETED|Overall Study||8
7642590|NCT02198040|18819856|P1|COMPLETED|Overall Study||9
7642591|NCT02198040|18819854|P3|STARTED|Overall Study||9
7642592|NCT02198040|18819855|P2|STARTED|Overall Study||9
7642593|NCT02198040|18819856|P1|STARTED|Overall Study||9
7642594|NCT02197806|18819886|P4|NOT COMPLETED|Overall Study||1
7642595|NCT02197806|18819887|P3|NOT COMPLETED|Overall Study||0
7642596|NCT02197806|18819888|P2|NOT COMPLETED|Overall Study||1
7642597|NCT02197806|18819889|P1|NOT COMPLETED|Overall Study||0
7642598|NCT02197806|18819886|P4|COMPLETED|Overall Study||16
7642599|NCT02197806|18819887|P3|COMPLETED|Overall Study||16
7642600|NCT02197806|18819888|P2|COMPLETED|Overall Study||16
7642601|NCT02197806|18819889|P1|COMPLETED|Overall Study||15
7642602|NCT02197806|18819886|P4|STARTED|Overall Study||17
7642603|NCT02197806|18819887|P3|STARTED|Overall Study||16
7642604|NCT02197806|18819888|P2|STARTED|Overall Study||17
7642605|NCT02197806|18819889|P1|STARTED|Overall Study||15
7642606|NCT02197767|18819899|P1|NOT COMPLETED|Overall Study||0
7642607|NCT02197767|18819899|P1|COMPLETED|Overall Study||11
7642608|NCT02197767|18819899|P1|STARTED|Overall Study||11
7642609|NCT02197572|18819904|P1|NOT COMPLETED|Overall Study||44
7642610|NCT02197572|18819904|P1|COMPLETED|Overall Study||0
7642611|NCT02197572|18819904|P1|STARTED|Overall Study||44
7642612|NCT02197520|18819921|P2|NOT COMPLETED|Period 2||2
7642613|NCT02197520|18819922|P1|NOT COMPLETED|Period 2||1
7642614|NCT02197520|18819921|P2|COMPLETED|Period 2||10
7642615|NCT02197520|18819922|P1|COMPLETED|Period 2||10
7642616|NCT02197520|18819921|P2|STARTED|Period 2||12
7642617|NCT02197520|18819922|P1|STARTED|Period 2||11
7642618|NCT02197520|18819921|P2|NOT COMPLETED|Period 1||0
7642619|NCT02197520|18819922|P1|NOT COMPLETED|Period 1||1
7642620|NCT02197520|18819921|P2|COMPLETED|Period 1||12
7642621|NCT02197520|18819922|P1|COMPLETED|Period 1||11
7642622|NCT02197520|18819921|P2|STARTED|Period 1||12
7642623|NCT02197520|18819922|P1|STARTED|Period 1||12
7642624|NCT02197481|18819940|P2|NOT COMPLETED|Overall Study||0
7642625|NCT02197481|18819941|P1|NOT COMPLETED|Overall Study||0
7642626|NCT02197481|18819940|P2|COMPLETED|Overall Study||43
7642627|NCT02197481|18819941|P1|COMPLETED|Overall Study|February 2016|43
7642628|NCT02197481|18819940|P2|STARTED|Overall Study||43
7642629|NCT02197481|18819941|P1|STARTED|Overall Study|October 2014|43
7642630|NCT02197455|18819961|P1|NOT COMPLETED|Overall Study||0
7642631|NCT02197455|18819961|P1|COMPLETED|Overall Study||30
7642632|NCT02197455|18819961|P1|STARTED|Overall Study||30
7642633|NCT02197416|18819969|P3|NOT COMPLETED|Overall Study||8
7642634|NCT02197416|18819970|P2|NOT COMPLETED|Overall Study||4
7642635|NCT02197416|18819971|P1|NOT COMPLETED|Overall Study||1
7642636|NCT02197416|18819969|P3|COMPLETED|Overall Study||153
7642637|NCT02197416|18819970|P2|COMPLETED|Overall Study||39
7642638|NCT02197416|18819971|P1|COMPLETED|Overall Study||8
7642639|NCT02197416|18819969|P3|STARTED|Overall Study||161
7642640|NCT02197416|18819970|P2|STARTED|Overall Study||43
7642641|NCT02197416|18819971|P1|STARTED|Overall Study||9
7642642|NCT02197377|18820009|P2|NOT COMPLETED|Overall Study||3
7642643|NCT02197377|18820010|P1|NOT COMPLETED|Overall Study||0
7642644|NCT02197377|18820009|P2|COMPLETED|Overall Study||27
7642645|NCT02197377|18820010|P1|COMPLETED|Overall Study||30
7642646|NCT02197377|18820009|P2|STARTED|Overall Study||30
7642647|NCT02197377|18820010|P1|STARTED|Overall Study||30
7642648|NCT02197273|18820020|P2|NOT COMPLETED|Overall Study||0
7642649|NCT02197273|18820021|P1|NOT COMPLETED|Overall Study||0
7642650|NCT02197273|18820020|P2|COMPLETED|Overall Study||104
7642651|NCT02197273|18820021|P1|COMPLETED|Overall Study||107
7642652|NCT02197273|18820020|P2|STARTED|Overall Study||104
7642653|NCT02197273|18820021|P1|STARTED|Overall Study||107
7642654|NCT02197247|18820031|P1|NOT COMPLETED|Part B: Day 78 to End Part B (AZD9291)||15
7642655|NCT02197247|18820031|P1|COMPLETED|Part B: Day 78 to End Part B (AZD9291)||19
7642656|NCT02197247|18820031|P1|STARTED|Part B: Day 78 to End Part B (AZD9291)|32 completed Part A + 2 entered Part B without completing Part A (both due to AE) =34 started Part B|34
7642657|NCT02197247|18820031|P1|NOT COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||5
7642658|NCT02197247|18820031|P1|COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||32
7642659|NCT02197247|18820031|P1|STARTED|Part A: Day 50-77 (AZD9291 Alone)||37
7642660|NCT02197247|18820031|P1|NOT COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||4
7642661|NCT02197247|18820031|P1|COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||37
7642662|NCT02197247|18820031|P1|STARTED|Part A: Day 29-49 (AZD9291+Rifampicin)||41
7642663|NCT02197247|18820031|P1|NOT COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||0
7642664|NCT02197247|18820031|P1|COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||41
7642665|NCT02197247|18820031|P1|STARTED|Part A: Day 1-28 (AZD9291 Alone)||41
7642666|NCT02197234|18820076|P1|NOT COMPLETED|Part B: Day 33 to End Part B (AZD9291)||30
7642667|NCT02197234|18820076|P1|COMPLETED|Part B: Day 33 to End Part B (AZD9291)||20
7642668|NCT02197234|18820076|P1|STARTED|Part B: Day 33 to End Part B (AZD9291)|49 completed Part A + 1 entered Part B without completing Part A (due to AE) = 50 started Part B|50
7642669|NCT02197234|18820076|P1|NOT COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||0
7642670|NCT02197234|18820076|P1|COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
7642671|NCT02197234|18820076|P1|STARTED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
7642672|NCT02197234|18820076|P1|NOT COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||3
7642673|NCT02197234|18820076|P1|COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||49
7642674|NCT02197234|18820076|P1|STARTED|Part A: Day 3-30 (AZD9291 Alone)||52
7642675|NCT02197234|18820076|P1|NOT COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||0
7642676|NCT02197234|18820076|P1|COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||52
7642677|NCT02197234|18820076|P1|STARTED|Part A: Day 1-2 (Simvastatin Alone)||52
7642678|NCT02197130|18820098|P3|NOT COMPLETED|Overall Study||32
7642679|NCT02197130|18820099|P2|NOT COMPLETED|Overall Study||8
7642680|NCT02197130|18820100|P1|NOT COMPLETED|Overall Study||16
7642681|NCT02197130|18820098|P3|COMPLETED|Overall Study||56
7642682|NCT02197130|18820099|P2|COMPLETED|Overall Study||81
7642683|NCT02197130|18820100|P1|COMPLETED|Overall Study||79
7642684|NCT02197130|18820098|P3|Received Treatment|Overall Study||87
7642685|NCT02197130|18820099|P2|Received Treatment|Overall Study||88
7642686|NCT02197130|18820100|P1|Received Treatment|Overall Study||95
7642687|NCT02197130|18820098|P3|STARTED|Overall Study||88
7642688|NCT02197130|18820099|P2|STARTED|Overall Study||89
7642689|NCT02197130|18820100|P1|STARTED|Overall Study||95
7642690|NCT02197078|18820162|P12|NOT COMPLETED|Overall Study||0
7642691|NCT02197078|18820163|P11|NOT COMPLETED|Overall Study||0
7642692|NCT02197078|18820164|P10|NOT COMPLETED|Overall Study||0
7642693|NCT02197078|18820165|P9|NOT COMPLETED|Overall Study||0
7642694|NCT02197078|18820166|P8|NOT COMPLETED|Overall Study||0
7642695|NCT02197078|18820167|P7|NOT COMPLETED|Overall Study||0
7642696|NCT02197078|18820168|P6|NOT COMPLETED|Overall Study||0
7642697|NCT02197078|18820169|P5|NOT COMPLETED|Overall Study||0
7642698|NCT02197078|18820170|P4|NOT COMPLETED|Overall Study||0
7642699|NCT02197078|18820171|P3|NOT COMPLETED|Overall Study||0
7642700|NCT02197078|18820172|P2|NOT COMPLETED|Overall Study||0
7642701|NCT02197078|18820173|P1|NOT COMPLETED|Overall Study||0
7642702|NCT02197078|18820162|P12|COMPLETED|Overall Study||15742
7642703|NCT02197078|18820163|P11|COMPLETED|Overall Study||15742
7642704|NCT02197078|18820164|P10|COMPLETED|Overall Study||18996
7642705|NCT02197078|18820165|P9|COMPLETED|Overall Study||18996
7642706|NCT02197078|18820166|P8|COMPLETED|Overall Study||25135
7642707|NCT02197078|18820167|P7|COMPLETED|Overall Study||25135
7642708|NCT02197078|18820168|P6|COMPLETED|Overall Study||9538
7642709|NCT02197078|18820169|P5|COMPLETED|Overall Study||9538
7642710|NCT02197078|18820170|P4|COMPLETED|Overall Study||10614
7642711|NCT02197078|18820171|P3|COMPLETED|Overall Study||10614
7642712|NCT02197078|18820172|P2|COMPLETED|Overall Study||14688
7642713|NCT02197078|18820173|P1|COMPLETED|Overall Study||14688
7642714|NCT02197078|18820162|P12|STARTED|Overall Study||15742
7642715|NCT02197078|18820163|P11|STARTED|Overall Study||15742
7642716|NCT02197078|18820164|P10|STARTED|Overall Study||18996
7642717|NCT02197078|18820165|P9|STARTED|Overall Study||18996
7642718|NCT02197078|18820166|P8|STARTED|Overall Study||25135
7642719|NCT02197078|18820167|P7|STARTED|Overall Study||25135
7642720|NCT02197078|18820168|P6|STARTED|Overall Study||9538
7642721|NCT02197078|18820169|P5|STARTED|Overall Study||9538
7642722|NCT02197078|18820170|P4|STARTED|Overall Study||10614
7642723|NCT02197078|18820171|P3|STARTED|Overall Study||10614
7642724|NCT02197078|18820172|P2|STARTED|Overall Study||14688
7642725|NCT02197078|18820173|P1|STARTED|Overall Study||14688
7642726|NCT02197065|18820285|P2|NOT COMPLETED|Overall Study||0
7642727|NCT02197065|18820286|P1|NOT COMPLETED|Overall Study||0
7642728|NCT02197065|18820285|P2|COMPLETED|Overall Study||10
7642729|NCT02197065|18820286|P1|COMPLETED|Overall Study||10
7642730|NCT02197065|18820285|P2|STARTED|Overall Study||10
7642731|NCT02197065|18820286|P1|STARTED|Overall Study||10
7642732|NCT02196922|18820297|P2|NOT COMPLETED|Overall Study||0
7642733|NCT02196922|18820298|P1|NOT COMPLETED|Overall Study||0
7642734|NCT02196922|18820297|P2|COMPLETED|Overall Study||46
7642735|NCT02196922|18820298|P1|COMPLETED|Overall Study||58
7642736|NCT02196922|18820297|P2|STARTED|Overall Study||46
7642737|NCT02196922|18820298|P1|STARTED|Overall Study||58
7642738|NCT02196857|18820308|P1|NOT COMPLETED|Overall Study||0
7642739|NCT02196857|18820308|P1|COMPLETED|Overall Study||16
7642740|NCT02196857|18820308|P1|STARTED|Overall Study||16
7642741|NCT02196831|18820315|P2|NOT COMPLETED|Overall Study||4
7642742|NCT02196831|18820316|P1|NOT COMPLETED|Overall Study||9
7642743|NCT02196831|18820315|P2|COMPLETED|Overall Study||26
7642744|NCT02196831|18820316|P1|COMPLETED|Overall Study||21
7642745|NCT02196831|18820315|P2|Received Follow-up Imaging|Overall Study||28
7642746|NCT02196831|18820316|P1|Received Follow-up Imaging|Overall Study||26
7642747|NCT02196831|18820315|P2|STARTED|Overall Study||30
7642748|NCT02196831|18820316|P1|STARTED|Overall Study||30
7642749|NCT02196766|18820329|P2|NOT COMPLETED|Second Intervention (7 Days)||0
7642750|NCT02196766|18820330|P1|NOT COMPLETED|Second Intervention (7 Days)||0
7642751|NCT02196766|18820329|P2|COMPLETED|Second Intervention (7 Days)||15
7642752|NCT02196766|18820330|P1|COMPLETED|Second Intervention (7 Days)||15
7642753|NCT02196766|18820329|P2|STARTED|Second Intervention (7 Days)||15
7642754|NCT02196766|18820330|P1|STARTED|Second Intervention (7 Days)||15
7642755|NCT02196766|18820329|P2|NOT COMPLETED|First Intervention (7 Days)||0
7642756|NCT02196766|18820330|P1|NOT COMPLETED|First Intervention (7 Days)||0
7642757|NCT02196766|18820329|P2|COMPLETED|First Intervention (7 Days)||15
7642758|NCT02196766|18820330|P1|COMPLETED|First Intervention (7 Days)||15
7642759|NCT02196766|18820329|P2|STARTED|First Intervention (7 Days)||15
7642760|NCT02196766|18820330|P1|STARTED|First Intervention (7 Days)||15
7642761|NCT02196714|18820346|P4|NOT COMPLETED|Overall Study||0
7642762|NCT02196714|18820347|P3|NOT COMPLETED|Overall Study||1
7642763|NCT02196714|18820348|P2|NOT COMPLETED|Overall Study||0
7642764|NCT02196714|18820349|P1|NOT COMPLETED|Overall Study||0
7642765|NCT02196714|18820346|P4|COMPLETED|Overall Study||24
7642766|NCT02196714|18820347|P3|COMPLETED|Overall Study||23
7642767|NCT02196714|18820348|P2|COMPLETED|Overall Study||23
7642768|NCT02196714|18820349|P1|COMPLETED|Overall Study||24
7642769|NCT02196714|18820346|P4|STARTED|Overall Study||24
7642770|NCT02196714|18820347|P3|STARTED|Overall Study||24
7642771|NCT02196714|18820348|P2|STARTED|Overall Study||23
7642772|NCT02196714|18820349|P1|STARTED|Overall Study||24
7642773|NCT02196701|18820471|P1|NOT COMPLETED|Overall Study||3
7642774|NCT02196701|18820471|P1|COMPLETED|Overall Study||43
7642775|NCT02196701|18820471|P1|STARTED|Overall Study||46
7642776|NCT02196688|18820529|P2|NOT COMPLETED|Overall Study||1
7642777|NCT02196688|18820530|P1|NOT COMPLETED|Overall Study||7
7642778|NCT02196688|18820529|P2|COMPLETED|Overall Study||23
7642779|NCT02196688|18820530|P1|COMPLETED|Overall Study||40
7642780|NCT02196688|18820529|P2|STARTED|Overall Study||24
7642781|NCT02196688|18820530|P1|STARTED|Overall Study||47
7642782|NCT02196675|18820545|P3|NOT COMPLETED|Overall Study||1
7642783|NCT02196675|18820546|P2|NOT COMPLETED|Overall Study||2
7642784|NCT02196675|18820547|P1|NOT COMPLETED|Overall Study||2
7642785|NCT02196675|18820545|P3|COMPLETED|Overall Study||7
7642786|NCT02196675|18820546|P2|COMPLETED|Overall Study||68
7642787|NCT02196675|18820547|P1|COMPLETED|Overall Study||25
7642788|NCT02196675|18820545|P3|STARTED|Overall Study||8
7642789|NCT02196675|18820546|P2|STARTED|Overall Study||70
7642790|NCT02196675|18820547|P1|STARTED|Overall Study||27
7642791|NCT02196558|18820570|P3|NOT COMPLETED|Extension Phase (40 Weeks)||1
7642792|NCT02196558|18820571|P2|NOT COMPLETED|Extension Phase (40 Weeks)||3
7642793|NCT02196558|18820572|P1|NOT COMPLETED|Extension Phase (40 Weeks)||2
7642794|NCT02196558|18820570|P3|COMPLETED|Extension Phase (40 Weeks)||5
7642795|NCT02196558|18820571|P2|COMPLETED|Extension Phase (40 Weeks)||8
7642796|NCT02196558|18820572|P1|COMPLETED|Extension Phase (40 Weeks)||9
7642797|NCT02196558|18820570|P3|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|6
7642798|NCT02196558|18820571|P2|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
7642799|NCT02196558|18820572|P1|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
7642800|NCT02196558|18820570|P3|NOT COMPLETED|Treatment Phase (12 Weeks)||2
7642801|NCT02196558|18820571|P2|NOT COMPLETED|Treatment Phase (12 Weeks)||3
7642802|NCT02196558|18820572|P1|NOT COMPLETED|Treatment Phase (12 Weeks)||0
7642803|NCT02196558|18820570|P3|COMPLETED|Treatment Phase (12 Weeks)||8
7642804|NCT02196558|18820571|P2|COMPLETED|Treatment Phase (12 Weeks)||12
7642805|NCT02196558|18820572|P1|COMPLETED|Treatment Phase (12 Weeks)||12
7642806|NCT02196558|18820570|P3|STARTED|Treatment Phase (12 Weeks)||10
7642807|NCT02196558|18820571|P2|STARTED|Treatment Phase (12 Weeks)||15
7642808|NCT02196558|18820572|P1|STARTED|Treatment Phase (12 Weeks)||12
7642809|NCT02196506|18820588|P4|NOT COMPLETED|Phase A+||14
7642810|NCT02196506|18820589|P3|NOT COMPLETED|Phase A+||0
7642811|NCT02196506|18820590|P2|NOT COMPLETED|Phase A+||0
7642812|NCT02196506|18820591|P1|NOT COMPLETED|Phase A+||0
7642813|NCT02196506|18820588|P4|COMPLETED|Phase A+||308
7642814|NCT02196506|18820589|P3|COMPLETED|Phase A+||0
7642815|NCT02196506|18820590|P2|COMPLETED|Phase A+||0
7642816|NCT02196506|18820591|P1|COMPLETED|Phase A+||0
7642817|NCT02196506|18820588|P4|STARTED|Phase A+||322
7642818|NCT02196506|18820589|P3|STARTED|Phase A+||0
7642819|NCT02196506|18820590|P2|STARTED|Phase A+||0
7642820|NCT02196506|18820591|P1|STARTED|Phase A+||0
7642821|NCT02196506|18820588|P4|NOT COMPLETED|Phase B||0
7642822|NCT02196506|18820589|P3|NOT COMPLETED|Phase B||6
7642823|NCT02196506|18820590|P2|NOT COMPLETED|Phase B||15
7642824|NCT02196506|18820591|P1|NOT COMPLETED|Phase B||0
7642825|NCT02196506|18820588|P4|COMPLETED|Phase B||0
7642826|NCT02196506|18820589|P3|COMPLETED|Phase B||196
7642827|NCT02196506|18820590|P2|COMPLETED|Phase B||177
7642828|NCT02196506|18820591|P1|COMPLETED|Phase B||0
7642829|NCT02196506|18820588|P4|STARTED|Phase B||0
7642830|NCT02196506|18820589|P3|STARTED|Phase B||202
7642831|NCT02196506|18820590|P2|STARTED|Phase B||192
7642832|NCT02196506|18820591|P1|STARTED|Phase B||0
7642833|NCT02196506|18820588|P4|NOT COMPLETED|Phase A||0
7642834|NCT02196506|18820589|P3|NOT COMPLETED|Phase A||0
7642835|NCT02196506|18820590|P2|NOT COMPLETED|Phase A||0
7642836|NCT02196506|18820591|P1|NOT COMPLETED|Phase A||121
7642837|NCT02196506|18820588|P4|COMPLETED|Phase A||0
7642838|NCT02196506|18820589|P3|COMPLETED|Phase A||0
7642839|NCT02196506|18820590|P2|COMPLETED|Phase A||0
7642840|NCT02196506|18820591|P1|COMPLETED|Phase A||716
7642841|NCT02196506|18820588|P4|STARTED|Phase A||0
7642842|NCT02196506|18820589|P3|STARTED|Phase A||0
7642843|NCT02196506|18820590|P2|STARTED|Phase A||0
7642844|NCT02196506|18820591|P1|STARTED|Phase A||837
7642845|NCT02196259|18820606|P3|NOT COMPLETED|Overall Study||1
7642846|NCT02196259|18820607|P2|NOT COMPLETED|Overall Study||3
7642847|NCT02196259|18820608|P1|NOT COMPLETED|Overall Study||0
7642848|NCT02196259|18820606|P3|COMPLETED|Overall Study||2
7642849|NCT02196259|18820607|P2|COMPLETED|Overall Study||4
7642850|NCT02196259|18820608|P1|COMPLETED|Overall Study||3
7642851|NCT02196259|18820606|P3|STARTED|Overall Study||3
7642852|NCT02196259|18820607|P2|STARTED|Overall Study||7
7642853|NCT02196259|18820608|P1|STARTED|Overall Study||3
7642854|NCT02196168|18820617|P2|NOT COMPLETED|Overall Study||0
7642855|NCT02196168|18820618|P1|NOT COMPLETED|Overall Study||0
7642856|NCT02196168|18820617|P2|COMPLETED|Overall Study||0
7642857|NCT02196168|18820618|P1|COMPLETED|Overall Study||6
7642858|NCT02196168|18820617|P2|STARTED|Overall Study||0
7642859|NCT02196168|18820618|P1|STARTED|Overall Study||6
7642860|NCT02196077|18820636|P1|NOT COMPLETED|Overall Study||47
7642861|NCT02196077|18820636|P1|COMPLETED|Overall Study||133
7642862|NCT02196077|18820636|P1|FF MDI 9.6 μg|Overall Study||157
7642863|NCT02196077|18820636|P1|BD MDI 320 μg|Overall Study||108
7642864|NCT02196077|18820636|P1|BFF MDI 80/9.6 μg|Overall Study||103
7642865|NCT02196077|18820636|P1|BFF MDI 160/9.6 μg|Overall Study||106
7642866|NCT02196077|18820636|P1|BFF MDI 320/9.6 μg|Overall Study||155
7642867|NCT02196077|18820636|P1|STARTED|Overall Study||180
7642868|NCT02195986|18820686|P3|NOT COMPLETED|Overall Study||2
7642869|NCT02195986|18820687|P2|NOT COMPLETED|Overall Study||5
7642870|NCT02195986|18820688|P1|NOT COMPLETED|Overall Study||3
7642871|NCT02195986|18820686|P3|COMPLETED|Overall Study||71
7642872|NCT02195986|18820687|P2|COMPLETED|Overall Study||142
7642873|NCT02195986|18820688|P1|COMPLETED|Overall Study||143
7642874|NCT02195986|18820686|P3|STARTED|Overall Study||73
7642875|NCT02195986|18820687|P2|STARTED|Overall Study||147
7642876|NCT02195986|18820688|P1|STARTED|Overall Study||146
7642877|NCT02195895|18820703|P1|NOT COMPLETED|Overall Study||0
7642878|NCT02195895|18820703|P1|COMPLETED|Overall Study||17
7642879|NCT02195895|18820703|P1|STARTED|Overall Study||17
7642880|NCT02195869|18820711|P1|NOT COMPLETED|Overall Study||42
7642881|NCT02195869|18820711|P1|COMPLETED|Overall Study||0
7642882|NCT02195869|18820711|P1|All-Treated Population|Overall Study||42
7642883|NCT02195869|18820711|P1|STARTED|Overall Study|Phase 1b: 6 patients, 420 mg, no DLT observed. Phase 2: 42 patients, 420 mg|42
7642884|NCT02195713|18820724|P2|NOT COMPLETED|Overall Study||0
7642885|NCT02195713|18820725|P1|NOT COMPLETED|Overall Study||0
7642886|NCT02195713|18820724|P2|COMPLETED|Overall Study||10
7642887|NCT02195713|18820725|P1|COMPLETED|Overall Study||10
7642888|NCT02195713|18820724|P2|STARTED|Overall Study||10
7642889|NCT02195713|18820725|P1|STARTED|Overall Study||10
7642890|NCT02195700|18820733|P2|NOT COMPLETED|Overall Study||7
7642891|NCT02195700|18820734|P1|NOT COMPLETED|Overall Study||6
7642892|NCT02195700|18820733|P2|COMPLETED|Overall Study||52
7642893|NCT02195700|18820734|P1|COMPLETED|Overall Study||52
7642894|NCT02195700|18820733|P2|Maintenance Period|Overall Study||54
7642895|NCT02195700|18820734|P1|Maintenance Period|Overall Study||53
7642896|NCT02195700|18820733|P2|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|57
7642897|NCT02195700|18820734|P1|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|56
7642898|NCT02195700|18820733|P2|Safety and ITT Populations|Overall Study||59
7642899|NCT02195700|18820734|P1|Safety and ITT Populations|Overall Study||58
7642900|NCT02195700|18820733|P2|STARTED|Overall Study||59
7642901|NCT02195700|18820734|P1|STARTED|Overall Study||58
7642902|NCT02195687|18820756|P2|NOT COMPLETED|Overall Study||2
7642903|NCT02195687|18820757|P1|NOT COMPLETED|Overall Study||5
7642904|NCT02195687|18820756|P2|COMPLETED|Overall Study||99
7642905|NCT02195687|18820757|P1|COMPLETED|Overall Study||311
7642906|NCT02195687|18820756|P2|STARTED|Overall Study||101
7642907|NCT02195687|18820757|P1|STARTED|Overall Study||316
7642908|NCT02195622|18820775|P2|NOT COMPLETED|Overall Study||0
7642909|NCT02195622|18820776|P1|NOT COMPLETED|Overall Study||0
7642910|NCT02195622|18820775|P2|COMPLETED|Overall Study||37
7642911|NCT02195622|18820776|P1|COMPLETED|Overall Study||37
7642912|NCT02195622|18820775|P2|STARTED|Overall Study||37
7642913|NCT02195622|18820776|P1|STARTED|Overall Study||37
7642914|NCT02195583|18820782|P1|NOT COMPLETED|Overall Study||9
7642915|NCT02195583|18820782|P1|COMPLETED|Overall Study||53
7642916|NCT02195583|18820782|P1|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60
7642917|NCT02195583|18820782|P1|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59
7642918|NCT02195583|18820782|P1|Sodium Fluoride (250 Ppm)|Overall Study||55
7643009|NCT02195011|18821273|P1|STARTED|Overall Study||25
7642919|NCT02195583|18820782|P1|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58
7642920|NCT02195583|18820782|P1|Sodium Fluoride (0 Ppm)|Overall Study||59
7642921|NCT02195583|18820782|P1|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57
7642922|NCT02195583|18820782|P1|STARTED|Overall Study||62
7642923|NCT02195531|18820817|P3|NOT COMPLETED|Overall Study||1
7642924|NCT02195531|18820818|P2|NOT COMPLETED|Overall Study||1
7642925|NCT02195531|18820819|P1|NOT COMPLETED|Overall Study||1
7642926|NCT02195531|18820817|P3|COMPLETED|Overall Study||55
7642927|NCT02195531|18820818|P2|COMPLETED|Overall Study||48
7642928|NCT02195531|18820819|P1|COMPLETED|Overall Study||63
7642929|NCT02195531|18820817|P3|STARTED|Overall Study||56
7642930|NCT02195531|18820818|P2|STARTED|Overall Study||49
7642931|NCT02195531|18820819|P1|STARTED|Overall Study||64
7642932|NCT02195518|18820844|P1|NOT COMPLETED|Overall Study||9
7642933|NCT02195518|18820844|P1|COMPLETED|Overall Study||204
7642934|NCT02195518|18820844|P1|STARTED|Overall Study||213
7642935|NCT02195479|18820867|P2|NOT COMPLETED|Overall Study||350
7642936|NCT02195479|18820868|P1|NOT COMPLETED|Overall Study||356
7642937|NCT02195479|18820867|P2|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
7642938|NCT02195479|18820868|P1|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
7642939|NCT02195479|18820867|P2|Treated|Overall Study||346
7642940|NCT02195479|18820868|P1|Treated|Overall Study||354
7642941|NCT02195479|18820867|P2|STARTED|Overall Study||350
7642942|NCT02195479|18820868|P1|STARTED|Overall Study||356
7642943|NCT02195427|18820906|P2|NOT COMPLETED|Overall Study||27
7642944|NCT02195427|18820907|P1|NOT COMPLETED|Overall Study||26
7642945|NCT02195427|18820906|P2|COMPLETED|Overall Study||47
7642946|NCT02195427|18820907|P1|COMPLETED|Overall Study||47
7642947|NCT02195427|18820906|P2|N Patients at W52|Overall Study||56
7642948|NCT02195427|18820907|P1|N Patients at W52|Overall Study||63
7642949|NCT02195427|18820906|P2|N Patients at W36|Overall Study||59
7642950|NCT02195427|18820907|P1|N Patients at W36|Overall Study||65
7642951|NCT02195427|18820906|P2|N Patients at W24 (Primary Outcome)|Overall Study||62
7642952|NCT02195427|18820907|P1|N Patients at W24 (Primary Outcome)|Overall Study||67
7642953|NCT02195427|18820906|P2|STARTED|Overall Study||74
7642954|NCT02195427|18820907|P1|STARTED|Overall Study||73
7642955|NCT02195414|18820969|P1|NOT COMPLETED|Overall Study||0
7642956|NCT02195414|18820969|P1|COMPLETED|Overall Study||31
7642957|NCT02195414|18820969|P1|Primary Endpoint|Overall Study||31
7642958|NCT02195414|18820969|P1|STARTED|Overall Study||31
7642959|NCT02195349|18820987|P11|NOT COMPLETED|Overall Study||0
7642960|NCT02195349|18820988|P10|NOT COMPLETED|Overall Study||0
7642961|NCT02195349|18820989|P9|NOT COMPLETED|Overall Study||0
7642962|NCT02195349|18820990|P8|NOT COMPLETED|Overall Study||0
7642963|NCT02195349|18820991|P7|NOT COMPLETED|Overall Study||0
7642964|NCT02195349|18820992|P6|NOT COMPLETED|Overall Study||0
7642965|NCT02195349|18820993|P5|NOT COMPLETED|Overall Study||0
7642966|NCT02195349|18820994|P4|NOT COMPLETED|Overall Study||0
7642967|NCT02195349|18820995|P3|NOT COMPLETED|Overall Study||0
7642968|NCT02195349|18820996|P2|NOT COMPLETED|Overall Study||0
7642969|NCT02195349|18820997|P1|NOT COMPLETED|Overall Study||0
7642970|NCT02195349|18820987|P11|COMPLETED|Overall Study||6
7642971|NCT02195349|18820988|P10|COMPLETED|Overall Study||6
7642972|NCT02195349|18820989|P9|COMPLETED|Overall Study||6
7642973|NCT02195349|18820990|P8|COMPLETED|Overall Study||9
7642974|NCT02195349|18820991|P7|COMPLETED|Overall Study||6
7642975|NCT02195349|18820992|P6|COMPLETED|Overall Study||6
7642976|NCT02195349|18820993|P5|COMPLETED|Overall Study||6
7642977|NCT02195349|18820994|P4|COMPLETED|Overall Study||6
7642978|NCT02195349|18820995|P3|COMPLETED|Overall Study||1
7642979|NCT02195349|18820996|P2|COMPLETED|Overall Study||1
7642980|NCT02195349|18820997|P1|COMPLETED|Overall Study||14
7642981|NCT02195349|18820987|P11|STARTED|Overall Study||6
7642982|NCT02195349|18820988|P10|STARTED|Overall Study||6
7642983|NCT02195349|18820989|P9|STARTED|Overall Study||6
7642984|NCT02195349|18820990|P8|STARTED|Overall Study||9
7642985|NCT02195349|18820991|P7|STARTED|Overall Study||6
7642986|NCT02195349|18820992|P6|STARTED|Overall Study||6
7642987|NCT02195349|18820993|P5|STARTED|Overall Study||6
7642988|NCT02195349|18820994|P4|STARTED|Overall Study||6
7642989|NCT02195349|18820995|P3|STARTED|Overall Study||1
7642990|NCT02195349|18820996|P2|STARTED|Overall Study||1
7642991|NCT02195349|18820997|P1|STARTED|Overall Study||14
7642992|NCT02195310|18821250|P2|NOT COMPLETED|Overall Study||16
7642993|NCT02195310|18821251|P1|NOT COMPLETED|Overall Study||20
7642994|NCT02195310|18821250|P2|COMPLETED|Overall Study||153
7642995|NCT02195310|18821251|P1|COMPLETED|Overall Study||153
7642996|NCT02195310|18821250|P2|STARTED|Overall Study||169
7642997|NCT02195310|18821251|P1|STARTED|Overall Study||173
7642998|NCT02195232|18821259|P2|NOT COMPLETED|Overall Study||3
7642999|NCT02195232|18821260|P1|NOT COMPLETED|Overall Study||4
7643000|NCT02195232|18821259|P2|COMPLETED|Overall Study|Evaluated for VTE and safety|29
7643001|NCT02195232|18821260|P1|COMPLETED|Overall Study|Evaluated for VTE and safety|28
7643002|NCT02195232|18821259|P2|STARTED|Overall Study|patients consented|32
7643003|NCT02195232|18821260|P1|STARTED|Overall Study|patients consented|32
7643004|NCT02195011|18821272|P2|NOT COMPLETED|Overall Study||1
7643005|NCT02195011|18821273|P1|NOT COMPLETED|Overall Study||25
7643006|NCT02195011|18821272|P2|COMPLETED|Overall Study||0
7643007|NCT02195011|18821273|P1|COMPLETED|Overall Study||0
7643008|NCT02195011|18821272|P2|STARTED|Overall Study||1
7643010|NCT02194998|18821289|P4|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
7643011|NCT02194998|18821290|P3|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
7643012|NCT02194998|18821291|P2|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
7643013|NCT02194998|18821292|P1|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
7643014|NCT02194998|18821289|P4|COMPLETED|Post-HCV Treatment Follow-Up||4
7643015|NCT02194998|18821290|P3|COMPLETED|Post-HCV Treatment Follow-Up||14
7643016|NCT02194998|18821291|P2|COMPLETED|Post-HCV Treatment Follow-Up||5
7643017|NCT02194998|18821292|P1|COMPLETED|Post-HCV Treatment Follow-Up||20
7643018|NCT02194998|18821289|P4|STARTED|Post-HCV Treatment Follow-Up||4
7643019|NCT02194998|18821290|P3|STARTED|Post-HCV Treatment Follow-Up||15
7643020|NCT02194998|18821291|P2|STARTED|Post-HCV Treatment Follow-Up||5
7643021|NCT02194998|18821292|P1|STARTED|Post-HCV Treatment Follow-Up||21
7643022|NCT02194998|18821289|P4|NOT COMPLETED|On-HCV Treatment||0
7643023|NCT02194998|18821290|P3|NOT COMPLETED|On-HCV Treatment||0
7643024|NCT02194998|18821291|P2|NOT COMPLETED|On-HCV Treatment||1
7643025|NCT02194998|18821292|P1|NOT COMPLETED|On-HCV Treatment||0
7643026|NCT02194998|18821289|P4|COMPLETED|On-HCV Treatment||4
7643027|NCT02194998|18821290|P3|COMPLETED|On-HCV Treatment||15
7643028|NCT02194998|18821291|P2|COMPLETED|On-HCV Treatment||5
7643029|NCT02194998|18821292|P1|COMPLETED|On-HCV Treatment||21
7643030|NCT02194998|18821289|P4|STARTED|On-HCV Treatment||4
7643031|NCT02194998|18821290|P3|STARTED|On-HCV Treatment||15
7643032|NCT02194998|18821291|P2|STARTED|On-HCV Treatment||6
7643033|NCT02194998|18821292|P1|STARTED|On-HCV Treatment||21
7643034|NCT02194985|18821354|P1|NOT COMPLETED|Overall Study||11
7643035|NCT02194985|18821354|P1|COMPLETED|Overall Study||73
7643036|NCT02194985|18821354|P1|Received at Least 1 Dose of Study Drug|Overall Study||84
7643037|NCT02194985|18821354|P1|STARTED|Overall Study||84
7643038|NCT02194933|18821368|P2|NOT COMPLETED|Overall Study||9
7643039|NCT02194933|18821369|P1|NOT COMPLETED|Overall Study||3
7643040|NCT02194933|18821368|P2|COMPLETED|Overall Study||10
7643041|NCT02194933|18821369|P1|COMPLETED|Overall Study||16
7643042|NCT02194933|18821368|P2|STARTED|Overall Study||19
7643043|NCT02194933|18821369|P1|STARTED|Overall Study||19
7643044|NCT02194699|18821423|P2|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||52
7643045|NCT02194699|18821424|P1|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||50
7643046|NCT02194699|18821423|P2|COMPLETED|With Potential to Receive 52 Weeks of IP||365
7643047|NCT02194699|18821424|P1|COMPLETED|With Potential to Receive 52 Weeks of IP||370
7643048|NCT02194699|18821423|P2|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|417
7643049|NCT02194699|18821424|P1|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|420
7643050|NCT02194699|18821423|P2|NOT COMPLETED|Randomised||11
7643051|NCT02194699|18821424|P1|NOT COMPLETED|Randomised||8
7643052|NCT02194699|18821423|P2|COMPLETED|Randomised||417
7643053|NCT02194699|18821424|P1|COMPLETED|Randomised||420
7643054|NCT02194699|18821423|P2|STARTED|Randomised||428
7643055|NCT02194699|18821424|P1|STARTED|Randomised||428
7643056|NCT02194621|18821532|P3|NOT COMPLETED|Overall Study||9
7643057|NCT02194621|18821533|P2|NOT COMPLETED|Overall Study||6
7643058|NCT02194621|18821534|P1|NOT COMPLETED|Overall Study||6
7643059|NCT02194621|18821532|P3|COMPLETED|Overall Study||34
7643060|NCT02194621|18821533|P2|COMPLETED|Overall Study||36
7643061|NCT02194621|18821534|P1|COMPLETED|Overall Study||37
7643062|NCT02194621|18821532|P3|STARTED|Overall Study||43
7643063|NCT02194621|18821533|P2|STARTED|Overall Study||42
7643064|NCT02194621|18821534|P1|STARTED|Overall Study||43
7643065|NCT02194465|18821558|P7|NOT COMPLETED|Overall Study||2
7643066|NCT02194465|18821559|P6|NOT COMPLETED|Overall Study||4
7643067|NCT02194465|18821560|P5|NOT COMPLETED|Overall Study||9
7643068|NCT02194465|18821561|P4|NOT COMPLETED|Overall Study||8
7643069|NCT02194465|18821562|P3|NOT COMPLETED|Overall Study||8
7643070|NCT02194465|18821563|P2|NOT COMPLETED|Overall Study||7
7643071|NCT02194465|18821564|P1|NOT COMPLETED|Overall Study||9
7643072|NCT02194465|18821558|P7|COMPLETED|Overall Study||24
7643073|NCT02194465|18821559|P6|COMPLETED|Overall Study||21
7643074|NCT02194465|18821560|P5|COMPLETED|Overall Study||42
7643075|NCT02194465|18821561|P4|COMPLETED|Overall Study||41
7643076|NCT02194465|18821562|P3|COMPLETED|Overall Study||44
7643077|NCT02194465|18821563|P2|COMPLETED|Overall Study||43
7643078|NCT02194465|18821564|P1|COMPLETED|Overall Study||42
7643079|NCT02194465|18821558|P7|Received at Least 1 Dose of Study Drug|Overall Study||26
7643080|NCT02194465|18821559|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
7643081|NCT02194465|18821560|P5|Received at Least 1 Dose of Study Drug|Overall Study||51
7643082|NCT02194465|18821561|P4|Received at Least 1 Dose of Study Drug|Overall Study||49
7643083|NCT02194465|18821562|P3|Received at Least 1 Dose of Study Drug|Overall Study||51
7643084|NCT02194465|18821563|P2|Received at Least 1 Dose of Study Drug|Overall Study||50
7643085|NCT02194465|18821564|P1|Received at Least 1 Dose of Study Drug|Overall Study||51
7643086|NCT02194465|18821558|P7|STARTED|Overall Study||26
7643087|NCT02194465|18821559|P6|STARTED|Overall Study||25
7643088|NCT02194465|18821560|P5|STARTED|Overall Study||51
7643089|NCT02194465|18821561|P4|STARTED|Overall Study||49
7643090|NCT02194465|18821562|P3|STARTED|Overall Study||52
7643091|NCT02194465|18821563|P2|STARTED|Overall Study||50
7643092|NCT02194465|18821564|P1|STARTED|Overall Study||51
7643093|NCT02194088|18821607|P2|NOT COMPLETED|Overall Study||0
7643094|NCT02194088|18821608|P1|NOT COMPLETED|Overall Study||0
7643095|NCT02194088|18821607|P2|COMPLETED|Overall Study||25
7643096|NCT02194088|18821608|P1|COMPLETED|Overall Study||75
7643097|NCT02194088|18821607|P2|STARTED|Overall Study||25
7643098|NCT02194088|18821608|P1|STARTED|Overall Study||75
7643099|NCT02194062|18821621|P3|NOT COMPLETED|Overall Study||5
7643100|NCT02194062|18821622|P2|NOT COMPLETED|Overall Study||2
7643101|NCT02194062|18821623|P1|NOT COMPLETED|Overall Study||2
7643102|NCT02194062|18821621|P3|COMPLETED|Overall Study||7
7643103|NCT02194062|18821622|P2|COMPLETED|Overall Study||8
7643104|NCT02194062|18821623|P1|COMPLETED|Overall Study||8
7643105|NCT02194062|18821621|P3|STARTED|Overall Study||12
7643106|NCT02194062|18821622|P2|STARTED|Overall Study||10
7643107|NCT02194062|18821623|P1|STARTED|Overall Study||10
7643108|NCT02193880|18821634|P1|NOT COMPLETED|Overall Study||3
7643109|NCT02193880|18821634|P1|COMPLETED|Overall Study||4
7643110|NCT02193880|18821634|P1|STARTED|Overall Study||7
7643111|NCT02193867|18821639|P1|NOT COMPLETED|Overall Study||4
7643112|NCT02193867|18821639|P1|COMPLETED|Overall Study||6
7643113|NCT02193867|18821639|P1|Completed 18 Months Of Treatment|Overall Study||8
7643114|NCT02193867|18821639|P1|Received At Least 1 Dose Of Study Drug|Overall Study||10
7643115|NCT02193867|18821639|P1|STARTED|Overall Study||10
7643116|NCT02193828|18821657|P4|NOT COMPLETED|Overall Study||1
7643117|NCT02193828|18821658|P3|NOT COMPLETED|Overall Study||1
7643118|NCT02193828|18821659|P2|NOT COMPLETED|Overall Study||0
7643119|NCT02193828|18821660|P1|NOT COMPLETED|Overall Study||0
7643120|NCT02193828|18821657|P4|COMPLETED|Overall Study||16
7643121|NCT02193828|18821658|P3|COMPLETED|Overall Study||22
7643122|NCT02193828|18821659|P2|COMPLETED|Overall Study||18
7643123|NCT02193828|18821660|P1|COMPLETED|Overall Study||18
7643124|NCT02193828|18821657|P4|STARTED|Overall Study||17
7643125|NCT02193828|18821658|P3|STARTED|Overall Study||23
7643126|NCT02193828|18821659|P2|STARTED|Overall Study||18
7643127|NCT02193828|18821660|P1|STARTED|Overall Study||18
7643128|NCT02193815|18821698|P1|NOT COMPLETED|Overall Study||0
7643129|NCT02193815|18821698|P1|COMPLETED|Overall Study||15
7643130|NCT02193815|18821698|P1|STARTED|Overall Study||15
7643131|NCT02193776|18821737|P4|NOT COMPLETED|Overall Study||2
7643132|NCT02193776|18821738|P3|NOT COMPLETED|Overall Study||2
7643133|NCT02193776|18821739|P2|NOT COMPLETED|Overall Study||7
7643134|NCT02193776|18821740|P1|NOT COMPLETED|Overall Study||8
7643135|NCT02193776|18821737|P4|COMPLETED|Overall Study||58
7643136|NCT02193776|18821738|P3|COMPLETED|Overall Study||59
7643137|NCT02193776|18821739|P2|COMPLETED|Overall Study||53
7643138|NCT02193776|18821740|P1|COMPLETED|Overall Study||51
7643139|NCT02193776|18821737|P4|Completed Day 140 Follow-up|Overall Study||58
7643140|NCT02193776|18821738|P3|Completed Day 140 Follow-up|Overall Study||58
7643141|NCT02193776|18821739|P2|Completed Day 140 Follow-up|Overall Study||52
7643142|NCT02193776|18821740|P1|Completed Day 140 Follow-up|Overall Study||52
7643143|NCT02193776|18821737|P4|Completed Day 70 Follow-up|Overall Study||60
7643144|NCT02193776|18821738|P3|Completed Day 70 Follow-up|Overall Study||60
7643145|NCT02193776|18821739|P2|Completed Day 70 Follow-up|Overall Study||56
7643146|NCT02193776|18821740|P1|Completed Day 70 Follow-up|Overall Study||54
7643147|NCT02193776|18821737|P4|STARTED|Overall Study||60
7643148|NCT02193776|18821738|P3|STARTED|Overall Study||61
7643149|NCT02193776|18821739|P2|STARTED|Overall Study||60
7643150|NCT02193776|18821740|P1|STARTED|Overall Study||59
7643151|NCT02193490|18821756|P2|NOT COMPLETED|Overall Study||2
7643152|NCT02193490|18821757|P1|NOT COMPLETED|Overall Study||4
7643153|NCT02193490|18821756|P2|COMPLETED|Overall Study||20
7643154|NCT02193490|18821757|P1|COMPLETED|Overall Study||21
7643155|NCT02193490|18821756|P2|STARTED|Overall Study||22
7643156|NCT02193490|18821757|P1|STARTED|Overall Study||25
7643157|NCT02193178|18821767|P1|NOT COMPLETED|Overall Study||2
7643158|NCT02193178|18821767|P1|COMPLETED|Overall Study||13
7643159|NCT02193178|18821767|P1|STARTED|Overall Study||15
7643160|NCT02193165|18821817|P3|NOT COMPLETED|6 Week Product Use||0
7643161|NCT02193165|18821818|P2|NOT COMPLETED|6 Week Product Use||1
7643162|NCT02193165|18821819|P1|NOT COMPLETED|6 Week Product Use||0
7643163|NCT02193165|18821817|P3|COMPLETED|6 Week Product Use||39
7643164|NCT02193165|18821818|P2|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38
7643165|NCT02193165|18821819|P1|COMPLETED|6 Week Product Use||39
7643166|NCT02193165|18821817|P3|STARTED|6 Week Product Use||39
7643167|NCT02193165|18821818|P2|STARTED|6 Week Product Use||39
7643168|NCT02193165|18821819|P1|STARTED|6 Week Product Use||39
7643169|NCT02193165|18821817|P3|NOT COMPLETED|4 Week Product Use||1
7643170|NCT02193165|18821818|P2|NOT COMPLETED|4 Week Product Use||1
7643171|NCT02193165|18821819|P1|NOT COMPLETED|4 Week Product Use||1
7643172|NCT02193165|18821817|P3|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
7643173|NCT02193165|18821818|P2|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
7643174|NCT02193165|18821819|P1|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
7643175|NCT02193165|18821817|P3|STARTED|4 Week Product Use||40
7643176|NCT02193165|18821818|P2|STARTED|4 Week Product Use||40
7643177|NCT02193165|18821819|P1|STARTED|4 Week Product Use||40
7643178|NCT02193152|18821842|P1|NOT COMPLETED|Overall Study||0
7643179|NCT02193152|18821842|P1|COMPLETED|Overall Study||16
7643180|NCT02193152|18821842|P1|STARTED|Overall Study||16
7643181|NCT02193087|18821854|P4|NOT COMPLETED|Overall Study||79
7643182|NCT02193087|18821855|P3|NOT COMPLETED|Overall Study||7
7643183|NCT02193087|18821856|P2|NOT COMPLETED|Overall Study||14
7643184|NCT02193087|18821857|P1|NOT COMPLETED|Overall Study||37
7643185|NCT02193087|18821854|P4|COMPLETED|Overall Study||524
7643186|NCT02193087|18821855|P3|COMPLETED|Overall Study||93
7643187|NCT02193087|18821856|P2|COMPLETED|Overall Study||86
7643188|NCT02193087|18821857|P1|COMPLETED|Overall Study||162
7643189|NCT02193087|18821854|P4|Received Vaccination|Overall Study||602
7643190|NCT02193087|18821855|P3|Received Vaccination|Overall Study||100
7643191|NCT02193087|18821856|P2|Received Vaccination|Overall Study||97
7643192|NCT02193087|18821857|P1|Received Vaccination|Overall Study||197
7643193|NCT02193087|18821854|P4|STARTED|Overall Study||603
7643194|NCT02193087|18821855|P3|STARTED|Overall Study||100
7643195|NCT02193087|18821856|P2|STARTED|Overall Study||100
7643196|NCT02193087|18821857|P1|STARTED|Overall Study||199
7643197|NCT02193074|18821902|P2|NOT COMPLETED|Overall Study||15
7643198|NCT02193074|18821903|P1|NOT COMPLETED|Overall Study||17
7643199|NCT02193074|18821902|P2|COMPLETED|Overall Study||65
7643200|NCT02193074|18821903|P1|COMPLETED|Overall Study||24
7643201|NCT02193074|18821902|P2|Completed Due to Early Study Termination|Overall Study||39
7643202|NCT02193074|18821903|P1|Completed Due to Early Study Termination|Overall Study||13
7643203|NCT02193074|18821902|P2|Completed During Follow-Up Period|Overall Study||26
7643204|NCT02193074|18821903|P1|Completed During Follow-Up Period|Overall Study||11
7643205|NCT02193074|18821902|P2|STARTED|Overall Study|Randomized and received double-blind treatment.|80
7643206|NCT02193074|18821903|P1|STARTED|Overall Study|Randomized and received double-blind treatment.|41
7643207|NCT02192905|18821935|P1|NOT COMPLETED|Overall Study||1
7643208|NCT02192905|18821935|P1|COMPLETED|Overall Study|Reporting a minimum of current weight at 16-week follow-up|42
7643209|NCT02192905|18821935|P1|STARTED|Overall Study||43
7643210|NCT02192879|18821949|P3|NOT COMPLETED|Overall Study||0
7643211|NCT02192879|18821950|P2|NOT COMPLETED|Overall Study||0
7643212|NCT02192879|18821951|P1|NOT COMPLETED|Overall Study||0
7643213|NCT02192879|18821949|P3|COMPLETED|Overall Study||3
7643214|NCT02192879|18821950|P2|COMPLETED|Overall Study||4
7643215|NCT02192879|18821951|P1|COMPLETED|Overall Study||3
7643216|NCT02192879|18821949|P3|STARTED|Overall Study||3
7643217|NCT02192879|18821950|P2|STARTED|Overall Study||4
7643218|NCT02192879|18821951|P1|STARTED|Overall Study||3
7643219|NCT02192814|18821977|P1|NOT COMPLETED|Overall Study||0
7643220|NCT02192814|18821977|P1|COMPLETED|Overall Study||9
7643221|NCT02192814|18821977|P1|STARTED|Overall Study||9
7643222|NCT02192775|18821988|P1|NOT COMPLETED|Overall Study||2
7643223|NCT02192775|18821988|P1|COMPLETED|Overall Study||0
7643224|NCT02192775|18821988|P1|STARTED|Overall Study||2
7643225|NCT02192684|18821994|P2|NOT COMPLETED|Overall Study||0
7643226|NCT02192684|18821995|P1|NOT COMPLETED|Overall Study||0
7643227|NCT02192684|18821994|P2|COMPLETED|Overall Study||15
7643228|NCT02192684|18821995|P1|COMPLETED|Overall Study||30
7643229|NCT02192684|18821994|P2|STARTED|Overall Study||15
7643230|NCT02192684|18821995|P1|STARTED|Overall Study||30
7643231|NCT02192606|18822003|P2|NOT COMPLETED|Overall Study||4
7643232|NCT02192606|18822004|P1|NOT COMPLETED|Overall Study||2
7643233|NCT02192606|18822003|P2|COMPLETED|Overall Study||24
7643234|NCT02192606|18822004|P1|COMPLETED|Overall Study||27
7643235|NCT02192606|18822003|P2|STARTED|Overall Study||28
7643236|NCT02192606|18822004|P1|STARTED|Overall Study||29
7643237|NCT02192541|18822014|P2|NOT COMPLETED|Overall Study||0
7643238|NCT02192541|18822015|P1|NOT COMPLETED|Overall Study||0
7643239|NCT02192541|18822014|P2|COMPLETED|Overall Study||3
7643240|NCT02192541|18822015|P1|COMPLETED|Overall Study||2
7643241|NCT02192541|18822014|P2|Evaluable for Response|Overall Study||3
7643242|NCT02192541|18822015|P1|Evaluable for Response|Overall Study||1
7643243|NCT02192541|18822014|P2|Treated|Overall Study||3
7643244|NCT02192541|18822015|P1|Treated|Overall Study||2
7643245|NCT02192541|18822014|P2|STARTED|Overall Study||3
7643246|NCT02192541|18822015|P1|STARTED|Overall Study||2
7643247|NCT02192307|18822037|P2|NOT COMPLETED|Overall Study||0
7643248|NCT02192307|18822038|P1|NOT COMPLETED|Overall Study||0
7643249|NCT02192307|18822037|P2|COMPLETED|Overall Study||30
7643250|NCT02192307|18822038|P1|COMPLETED|Overall Study||30
7643251|NCT02192307|18822037|P2|STARTED|Overall Study||30
7643252|NCT02192307|18822038|P1|STARTED|Overall Study||30
7643253|NCT02192190|18822052|P6|NOT COMPLETED|Overall Study||29
7643254|NCT02192190|18822053|P5|NOT COMPLETED|Overall Study||30
7643255|NCT02192190|18822054|P4|NOT COMPLETED|Overall Study||26
7643256|NCT02192190|18822055|P3|NOT COMPLETED|Overall Study||25
7643257|NCT02192190|18822056|P2|NOT COMPLETED|Overall Study||29
7643258|NCT02192190|18822057|P1|NOT COMPLETED|Overall Study||54
7643259|NCT02192190|18822052|P6|COMPLETED|Overall Study||9
7643260|NCT02192190|18822053|P5|COMPLETED|Overall Study||9
7643261|NCT02192190|18822054|P4|COMPLETED|Overall Study||12
7643262|NCT02192190|18822055|P3|COMPLETED|Overall Study||13
7643263|NCT02192190|18822056|P2|COMPLETED|Overall Study||10
7643264|NCT02192190|18822057|P1|COMPLETED|Overall Study||22
7643265|NCT02192190|18822052|P6|Received at Least 1 Dose of Study Drug|Overall Study||37
7643266|NCT02192190|18822053|P5|Received at Least 1 Dose of Study Drug|Overall Study||38
7643267|NCT02192190|18822054|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
7643268|NCT02192190|18822055|P3|Received at Least 1 Dose of Study Drug|Overall Study||38
7643269|NCT02192190|18822056|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
7643270|NCT02192190|18822057|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
7643271|NCT02192190|18822052|P6|STARTED|Overall Study||38
7643272|NCT02192190|18822053|P5|STARTED|Overall Study||39
7643273|NCT02192190|18822054|P4|STARTED|Overall Study||38
7643274|NCT02192190|18822055|P3|STARTED|Overall Study||38
7643275|NCT02192190|18822056|P2|STARTED|Overall Study||39
7643276|NCT02192190|18822057|P1|STARTED|Overall Study||76
7643277|NCT02192164|18822101|P1|NOT COMPLETED|Overall Study||14
7643278|NCT02192164|18822101|P1|COMPLETED|Overall Study||112
7643279|NCT02192164|18822101|P1|Etanercept Treated Population|Overall Study||112
7643280|NCT02192164|18822101|P1|STARTED|Overall Study||126
7643281|NCT02192099|18822117|P1|NOT COMPLETED|Overall Study||61
7643282|NCT02192099|18822117|P1|COMPLETED|Overall Study||0
7643283|NCT02192099|18822117|P1|STARTED|Overall Study||61
7643284|NCT02191865|18822124|P3|NOT COMPLETED|Overall Study||0
7643285|NCT02191865|18822125|P2|NOT COMPLETED|Overall Study||0
7643286|NCT02191865|18822126|P1|NOT COMPLETED|Overall Study||0
7643287|NCT02191865|18822124|P3|COMPLETED|Overall Study||17
7643288|NCT02191865|18822125|P2|COMPLETED|Overall Study||8
7643289|NCT02191865|18822126|P1|COMPLETED|Overall Study||8
7643290|NCT02191865|18822124|P3|STARTED|Overall Study||17
7643291|NCT02191865|18822125|P2|STARTED|Overall Study||8
7643292|NCT02191865|18822126|P1|STARTED|Overall Study||8
7643293|NCT02191618|18822146|P1|NOT COMPLETED|Overall Study||7
7643294|NCT02191618|18822146|P1|COMPLETED|Overall Study||143
7643295|NCT02191618|18822146|P1|STARTED|Overall Study||150
7643296|NCT02191605|18822156|P5|NOT COMPLETED|Overall Study||4
7643297|NCT02191605|18822157|P4|NOT COMPLETED|Overall Study||3
7643298|NCT02191605|18822158|P3|NOT COMPLETED|Overall Study||7
7643299|NCT02191605|18822159|P2|NOT COMPLETED|Overall Study||4
7643300|NCT02191605|18822160|P1|NOT COMPLETED|Overall Study||9
7643301|NCT02191605|18822156|P5|COMPLETED|Overall Study||3
7643302|NCT02191605|18822157|P4|COMPLETED|Overall Study||5
7643303|NCT02191605|18822158|P3|COMPLETED|Overall Study||8
7643304|NCT02191605|18822159|P2|COMPLETED|Overall Study||11
7643305|NCT02191605|18822160|P1|COMPLETED|Overall Study||6
7643306|NCT02191605|18822156|P5|Completed Intervention Portion|Overall Study||7
7643307|NCT02191605|18822157|P4|Completed Intervention Portion|Overall Study||8
7643308|NCT02191605|18822158|P3|Completed Intervention Portion|Overall Study||15
7643309|NCT02191605|18822159|P2|Completed Intervention Portion|Overall Study||15
7643310|NCT02191605|18822160|P1|Completed Intervention Portion|Overall Study||15
7643311|NCT02191605|18822156|P5|STARTED|Overall Study||7
7643312|NCT02191605|18822157|P4|STARTED|Overall Study||8
7643313|NCT02191605|18822158|P3|STARTED|Overall Study||15
7643314|NCT02191605|18822159|P2|STARTED|Overall Study||15
7643315|NCT02191605|18822160|P1|STARTED|Overall Study||15
7643316|NCT02191579|18822179|P2|NOT COMPLETED|Treatment 2||25
7643317|NCT02191579|18822180|P1|NOT COMPLETED|Treatment 2||0
7643318|NCT02191579|18822179|P2|COMPLETED|Treatment 2||55
7643319|NCT02191579|18822180|P1|COMPLETED|Treatment 2||0
7643320|NCT02191579|18822179|P2|STARTED|Treatment 2||80
7643321|NCT02191579|18822180|P1|STARTED|Treatment 2||0
7643322|NCT02191579|18822179|P2|NOT COMPLETED|Treatment 1||58
7643323|NCT02191579|18822180|P1|NOT COMPLETED|Treatment 1||27
7643324|NCT02191579|18822179|P2|COMPLETED|Treatment 1||84
7643325|NCT02191579|18822180|P1|COMPLETED|Treatment 1||113
7643326|NCT02191579|18822179|P2|STARTED|Treatment 1||142
7643327|NCT02191579|18822180|P1|STARTED|Treatment 1||140
7643328|NCT02191397|18822194|P2|NOT COMPLETED|Overall Study||70
7643329|NCT02191397|18822195|P1|NOT COMPLETED|Overall Study||83
7643330|NCT02191397|18822194|P2|COMPLETED|Overall Study||198
7643331|NCT02191397|18822195|P1|COMPLETED|Overall Study||183
7643332|NCT02191397|18822194|P2|STARTED|Overall Study||268
7643333|NCT02191397|18822195|P1|STARTED|Overall Study||266
7643334|NCT02191267|18822256|P3|NOT COMPLETED|Overall Study||0
7643335|NCT02191267|18822257|P2|NOT COMPLETED|Overall Study||0
7643336|NCT02191267|18822258|P1|NOT COMPLETED|Overall Study||1
7643337|NCT02191267|18822256|P3|COMPLETED|Overall Study||4
7643338|NCT02191267|18822257|P2|COMPLETED|Overall Study||6
7643339|NCT02191267|18822258|P1|COMPLETED|Overall Study||19
7643340|NCT02191267|18822256|P3|STARTED|Overall Study||4
7643341|NCT02191267|18822257|P2|STARTED|Overall Study||6
7643342|NCT02191267|18822258|P1|STARTED|Overall Study||20
7643343|NCT02191137|18822269|P1|NOT COMPLETED|Follow-up||5
7643344|NCT02191137|18822269|P1|COMPLETED|Follow-up||60
7643345|NCT02191137|18822269|P1|STARTED|Follow-up||65
7643346|NCT02191137|18822269|P1|NOT COMPLETED|Treatment||10
7643347|NCT02191137|18822269|P1|COMPLETED|Treatment||65
7643348|NCT02191137|18822269|P1|STARTED|Treatment||75
7643349|NCT02191046|18822299|P2|NOT COMPLETED|Overall Study||1
7643350|NCT02191046|18822300|P1|NOT COMPLETED|Overall Study||5
7643351|NCT02191046|18822299|P2|COMPLETED|Overall Study|exclude 1 patient because low compliance|38
7643352|NCT02191046|18822300|P1|COMPLETED|Overall Study|exclude 5 patients because low compliance|36
7643353|NCT02191046|18822299|P2|STARTED|Overall Study||39
7643354|NCT02191046|18822300|P1|STARTED|Overall Study||41
7643355|NCT02191033|18822308|P2|NOT COMPLETED|Overall Study||1
7643356|NCT02191033|18822309|P1|NOT COMPLETED|Overall Study||2
7643357|NCT02191033|18822308|P2|COMPLETED|Overall Study||19
7643358|NCT02191033|18822309|P1|COMPLETED|Overall Study||18
7643359|NCT02191033|18822308|P2|STARTED|Overall Study||20
7643360|NCT02191033|18822309|P1|STARTED|Overall Study||20
7643361|NCT02190903|18822321|P2|NOT COMPLETED|Overall Study||0
7643362|NCT02190903|18822322|P1|NOT COMPLETED|Overall Study||0
7643363|NCT02190903|18822321|P2|COMPLETED|Overall Study||6
7643364|NCT02190903|18822322|P1|COMPLETED|Overall Study||6
7643365|NCT02190903|18822321|P2|STARTED|Overall Study||6
7643366|NCT02190903|18822322|P1|STARTED|Overall Study||6
7643367|NCT02190747|18822331|P3|NOT COMPLETED|Overall Study||0
7643368|NCT02190747|18822332|P2|NOT COMPLETED|Overall Study||0
7643369|NCT02190747|18822333|P1|NOT COMPLETED|Overall Study||0
7643370|NCT02190747|18822331|P3|COMPLETED|Overall Study||10
7643371|NCT02190747|18822332|P2|COMPLETED|Overall Study||9
7643372|NCT02190747|18822333|P1|COMPLETED|Overall Study||21
7643373|NCT02190747|18822331|P3|STARTED|Overall Study||10
7643374|NCT02190747|18822332|P2|STARTED|Overall Study||9
7643375|NCT02190747|18822333|P1|STARTED|Overall Study||21
7643376|NCT02190721|18822407|P3|NOT COMPLETED|Overall Study||0
7643377|NCT02190721|18822408|P2|NOT COMPLETED|Overall Study||1
7643378|NCT02190721|18822409|P1|NOT COMPLETED|Overall Study||0
7643379|NCT02190721|18822407|P3|COMPLETED|Overall Study||18
7643380|NCT02190721|18822408|P2|COMPLETED|Overall Study||29
7643381|NCT02190721|18822409|P1|COMPLETED|Overall Study||2
7643382|NCT02190721|18822407|P3|Completed 90 Day Follow-up|Overall Study||18
7643383|NCT02190721|18822408|P2|Completed 90 Day Follow-up|Overall Study||29
7643384|NCT02190721|18822409|P1|Completed 90 Day Follow-up|Overall Study||2
7643385|NCT02190721|18822407|P3|Completed 30 Day Follow-up|Overall Study||18
7643386|NCT02190721|18822408|P2|Completed 30 Day Follow-up|Overall Study||29
7643387|NCT02190721|18822409|P1|Completed 30 Day Follow-up|Overall Study||2
7643388|NCT02190721|18822407|P3|Completed Treatment|Overall Study||18
7643389|NCT02190721|18822408|P2|Completed Treatment|Overall Study||30
7643390|NCT02190721|18822409|P1|Completed Treatment|Overall Study||2
7643391|NCT02190721|18822407|P3|STARTED|Overall Study||18
7643392|NCT02190721|18822408|P2|STARTED|Overall Study||30
7643393|NCT02190721|18822409|P1|STARTED|Overall Study||2
7643394|NCT02190604|18822532|P19|NOT COMPLETED|Part 3 (Patients)||0
7643395|NCT02190604|18822533|P18|NOT COMPLETED|Part 3 (Patients)||0
7643396|NCT02190604|18822534|P17|NOT COMPLETED|Part 3 (Patients)||0
7643397|NCT02190604|18822535|P16|NOT COMPLETED|Part 3 (Patients)||0
7643398|NCT02190604|18822536|P15|NOT COMPLETED|Part 3 (Patients)||0
7643399|NCT02190604|18822537|P14|NOT COMPLETED|Part 3 (Patients)||0
7643400|NCT02190604|18822538|P13|NOT COMPLETED|Part 3 (Patients)||0
7643401|NCT02190604|18822539|P12|NOT COMPLETED|Part 3 (Patients)||0
7643402|NCT02190604|18822540|P11|NOT COMPLETED|Part 3 (Patients)||0
7643403|NCT02190604|18822541|P10|NOT COMPLETED|Part 3 (Patients)||0
7643404|NCT02190604|18822542|P9|NOT COMPLETED|Part 3 (Patients)||0
7643405|NCT02190604|18822543|P8|NOT COMPLETED|Part 3 (Patients)||0
7643406|NCT02190604|18822544|P7|NOT COMPLETED|Part 3 (Patients)||0
7643407|NCT02190604|18822545|P6|NOT COMPLETED|Part 3 (Patients)||0
7643408|NCT02190604|18822546|P5|NOT COMPLETED|Part 3 (Patients)||0
7643409|NCT02190604|18822547|P4|NOT COMPLETED|Part 3 (Patients)||0
7643410|NCT02190604|18822548|P3|NOT COMPLETED|Part 3 (Patients)||0
7643411|NCT02190604|18822549|P2|NOT COMPLETED|Part 3 (Patients)||0
7643412|NCT02190604|18822550|P1|NOT COMPLETED|Part 3 (Patients)||0
7643413|NCT02190604|18822532|P19|COMPLETED|Part 3 (Patients)||12
7643414|NCT02190604|18822533|P18|COMPLETED|Part 3 (Patients)||19
7643415|NCT02190604|18822534|P17|COMPLETED|Part 3 (Patients)||12
7643416|NCT02190604|18822535|P16|COMPLETED|Part 3 (Patients)||6
7643417|NCT02190604|18822536|P15|COMPLETED|Part 3 (Patients)||0
7643418|NCT02190604|18822537|P14|COMPLETED|Part 3 (Patients)||0
7643419|NCT02190604|18822538|P13|COMPLETED|Part 3 (Patients)||0
7643420|NCT02190604|18822539|P12|COMPLETED|Part 3 (Patients)||0
7643421|NCT02190604|18822540|P11|COMPLETED|Part 3 (Patients)||0
7643422|NCT02190604|18822541|P10|COMPLETED|Part 3 (Patients)||0
7643423|NCT02190604|18822542|P9|COMPLETED|Part 3 (Patients)||0
7643424|NCT02190604|18822543|P8|COMPLETED|Part 3 (Patients)||0
7643425|NCT02190604|18822544|P7|COMPLETED|Part 3 (Patients)||0
7643426|NCT02190604|18822545|P6|COMPLETED|Part 3 (Patients)||0
7643427|NCT02190604|18822546|P5|COMPLETED|Part 3 (Patients)||0
7643428|NCT02190604|18822547|P4|COMPLETED|Part 3 (Patients)||0
7643429|NCT02190604|18822548|P3|COMPLETED|Part 3 (Patients)||0
7643430|NCT02190604|18822549|P2|COMPLETED|Part 3 (Patients)||0
7643431|NCT02190604|18822550|P1|COMPLETED|Part 3 (Patients)||0
7643432|NCT02190604|18822532|P19|STARTED|Part 3 (Patients)||12
7643433|NCT02190604|18822533|P18|STARTED|Part 3 (Patients)||19
7643434|NCT02190604|18822534|P17|STARTED|Part 3 (Patients)||12
7643435|NCT02190604|18822535|P16|STARTED|Part 3 (Patients)||6
7643436|NCT02190604|18822536|P15|STARTED|Part 3 (Patients)||0
7643437|NCT02190604|18822537|P14|STARTED|Part 3 (Patients)||0
7643438|NCT02190604|18822538|P13|STARTED|Part 3 (Patients)||0
7643439|NCT02190604|18822539|P12|STARTED|Part 3 (Patients)||0
7643440|NCT02190604|18822540|P11|STARTED|Part 3 (Patients)||0
7643441|NCT02190604|18822541|P10|STARTED|Part 3 (Patients)||0
7643442|NCT02190604|18822542|P9|STARTED|Part 3 (Patients)||0
7643443|NCT02190604|18822543|P8|STARTED|Part 3 (Patients)||0
7643444|NCT02190604|18822544|P7|STARTED|Part 3 (Patients)||0
7643445|NCT02190604|18822545|P6|STARTED|Part 3 (Patients)||0
7643446|NCT02190604|18822546|P5|STARTED|Part 3 (Patients)||0
7643447|NCT02190604|18822547|P4|STARTED|Part 3 (Patients)||0
7643448|NCT02190604|18822548|P3|STARTED|Part 3 (Patients)||0
7643449|NCT02190604|18822549|P2|STARTED|Part 3 (Patients)||0
7643450|NCT02190604|18822550|P1|STARTED|Part 3 (Patients)||0
7643451|NCT02190604|18822532|P19|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
7643452|NCT02190604|18822533|P18|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
7643453|NCT02190604|18822534|P17|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
7643454|NCT02190604|18822535|P16|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
7643455|NCT02190604|18822536|P15|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||2
7643456|NCT02190604|18822537|P14|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||1
7643457|NCT02190604|18822538|P13|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
7643458|NCT02190604|18822539|P12|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
7643459|NCT02190604|18822540|P11|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
7643460|NCT02190604|18822541|P10|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
7643461|NCT02190604|18822542|P9|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
7643462|NCT02190604|18822543|P8|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
7643463|NCT02190604|18822544|P7|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
7643464|NCT02190604|18822545|P6|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
7643465|NCT02190604|18822546|P5|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
7643466|NCT02190604|18822547|P4|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
7643467|NCT02190604|18822548|P3|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
7643468|NCT02190604|18822549|P2|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
7643469|NCT02190604|18822550|P1|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
7643470|NCT02190604|18822532|P19|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
7643471|NCT02190604|18822533|P18|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
7643472|NCT02190604|18822534|P17|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
7643473|NCT02190604|18822535|P16|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
7643474|NCT02190604|18822536|P15|COMPLETED|Part 1 and 2 (Healthy Volunteers)||8
7643475|NCT02190604|18822537|P14|COMPLETED|Part 1 and 2 (Healthy Volunteers)||5
7643476|NCT02190604|18822538|P13|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
7643477|NCT02190604|18822539|P12|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
7643478|NCT02190604|18822540|P11|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
7643479|NCT02190604|18822541|P10|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
7643480|NCT02190604|18822542|P9|COMPLETED|Part 1 and 2 (Healthy Volunteers)||16
7643481|NCT02190604|18822543|P8|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
7643482|NCT02190604|18822544|P7|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
7643483|NCT02190604|18822545|P6|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
7643484|NCT02190604|18822546|P5|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
7643485|NCT02190604|18822547|P4|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
7643486|NCT02190604|18822548|P3|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
7643487|NCT02190604|18822549|P2|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
7643488|NCT02190604|18822550|P1|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
7643489|NCT02190604|18822532|P19|STARTED|Part 1 and 2 (Healthy Volunteers)||0
7643490|NCT02190604|18822533|P18|STARTED|Part 1 and 2 (Healthy Volunteers)||0
7643491|NCT02190604|18822534|P17|STARTED|Part 1 and 2 (Healthy Volunteers)||0
7643492|NCT02190604|18822535|P16|STARTED|Part 1 and 2 (Healthy Volunteers)||0
7643493|NCT02190604|18822536|P15|STARTED|Part 1 and 2 (Healthy Volunteers)||10
7643494|NCT02190604|18822537|P14|STARTED|Part 1 and 2 (Healthy Volunteers)||6
7643495|NCT02190604|18822538|P13|STARTED|Part 1 and 2 (Healthy Volunteers)||6
7643496|NCT02190604|18822539|P12|STARTED|Part 1 and 2 (Healthy Volunteers)||6
7643497|NCT02190604|18822540|P11|STARTED|Part 1 and 2 (Healthy Volunteers)||6
7643498|NCT02190604|18822541|P10|STARTED|Part 1 and 2 (Healthy Volunteers)||6
7643499|NCT02190604|18822542|P9|STARTED|Part 1 and 2 (Healthy Volunteers)||16
7643500|NCT02190604|18822543|P8|STARTED|Part 1 and 2 (Healthy Volunteers)||6
7643501|NCT02190604|18822544|P7|STARTED|Part 1 and 2 (Healthy Volunteers)||6
7643502|NCT02190604|18822545|P6|STARTED|Part 1 and 2 (Healthy Volunteers)||6
7643503|NCT02190604|18822546|P5|STARTED|Part 1 and 2 (Healthy Volunteers)||6
7643504|NCT02190604|18822547|P4|STARTED|Part 1 and 2 (Healthy Volunteers)||6
7643505|NCT02190604|18822548|P3|STARTED|Part 1 and 2 (Healthy Volunteers)||6
7643506|NCT02190604|18822549|P2|STARTED|Part 1 and 2 (Healthy Volunteers)||6
7643507|NCT02190604|18822550|P1|STARTED|Part 1 and 2 (Healthy Volunteers)||6
7643508|NCT02190591|18822741|P2|NOT COMPLETED|Overall Study||11
7643509|NCT02190591|18822742|P1|NOT COMPLETED|Overall Study||2
7643510|NCT02190591|18822741|P2|COMPLETED|Overall Study||91
7643511|NCT02190591|18822742|P1|COMPLETED|Overall Study||100
7643512|NCT02190591|18822741|P2|STARTED|Overall Study||102
7643513|NCT02190591|18822742|P1|STARTED|Overall Study||102
7643514|NCT02190552|18822752|P1|NOT COMPLETED|Overall Study||4
7643515|NCT02190552|18822752|P1|COMPLETED|Overall Study||36
7643516|NCT02190552|18822752|P1|STARTED|Overall Study||40
7643517|NCT02190435|18822765|P2|NOT COMPLETED|Overall Study||0
7643518|NCT02190435|18822766|P1|NOT COMPLETED|Overall Study||15
7643519|NCT02190435|18822765|P2|COMPLETED|Overall Study||24
7643520|NCT02190435|18822766|P1|COMPLETED|Overall Study||26
7643521|NCT02190435|18822765|P2|STARTED|Overall Study||24
7643522|NCT02190435|18822766|P1|STARTED|Overall Study||41
7643523|NCT02190279|18822777|P3|NOT COMPLETED|Overall Study||3
7643524|NCT02190279|18822778|P2|NOT COMPLETED|Overall Study||0
7643525|NCT02190279|18822779|P1|NOT COMPLETED|Overall Study||3
7643526|NCT02190279|18822777|P3|COMPLETED|Overall Study||28
7643527|NCT02190279|18822778|P2|COMPLETED|Overall Study||69
7643528|NCT02190279|18822779|P1|COMPLETED|Overall Study||13
7643529|NCT02190279|18822777|P3|STARTED|Overall Study||31
7643530|NCT02190279|18822778|P2|STARTED|Overall Study||69
7643531|NCT02190279|18822779|P1|STARTED|Overall Study||16
7643532|NCT02190045|18822800|P2|NOT COMPLETED|Overall Study||0
7643533|NCT02190045|18822801|P1|NOT COMPLETED|Overall Study||3
7643534|NCT02190045|18822800|P2|COMPLETED|Overall Study||15
7643535|NCT02190045|18822801|P1|COMPLETED|Overall Study||12
7643536|NCT02190045|18822800|P2|STARTED|Overall Study||15
7643537|NCT02190045|18822801|P1|STARTED|Overall Study||15
7643538|NCT02189954|18822809|P2|NOT COMPLETED|Overall Study||0
7643539|NCT02189954|18822810|P1|NOT COMPLETED|Overall Study||0
7643540|NCT02189954|18822809|P2|COMPLETED|Overall Study||45
7643541|NCT02189954|18822810|P1|COMPLETED|Overall Study||45
7643542|NCT02189954|18822809|P2|STARTED|Overall Study||45
7643543|NCT02189954|18822810|P1|STARTED|Overall Study||45
7643544|NCT02189941|18822818|P3|NOT COMPLETED|Overall Study||1
7643545|NCT02189941|18822819|P2|NOT COMPLETED|Overall Study||0
7643546|NCT02189941|18822820|P1|NOT COMPLETED|Overall Study||0
7643547|NCT02189941|18822818|P3|COMPLETED|Overall Study||2
7643548|NCT02189941|18822819|P2|COMPLETED|Overall Study||4
7643549|NCT02189941|18822820|P1|COMPLETED|Overall Study||4
7643550|NCT02189941|18822818|P3|STARTED|Overall Study||3
7643551|NCT02189941|18822819|P2|STARTED|Overall Study||4
7643552|NCT02189941|18822820|P1|STARTED|Overall Study||4
7643553|NCT02189915|18822843|P1|NOT COMPLETED|Overall Study||3
7643554|NCT02189915|18822843|P1|COMPLETED|Overall Study||11
7643555|NCT02189915|18822843|P1|STARTED|Overall Study||14
7643556|NCT02189889|18822850|P2|NOT COMPLETED|Overall Study||0
7643557|NCT02189889|18822851|P1|NOT COMPLETED|Overall Study||0
7643558|NCT02189889|18822850|P2|COMPLETED|Overall Study||3
7643559|NCT02189889|18822851|P1|COMPLETED|Overall Study||2
7643560|NCT02189889|18822850|P2|STARTED|Overall Study||3
7643561|NCT02189889|18822851|P1|STARTED|Overall Study||2
7643562|NCT02189863|18822865|P2|NOT COMPLETED|Second 2 Weeks||0
7643563|NCT02189863|18822866|P1|NOT COMPLETED|Second 2 Weeks||0
7643564|NCT02189863|18822865|P2|COMPLETED|Second 2 Weeks||13
7643565|NCT02189863|18822866|P1|COMPLETED|Second 2 Weeks||8
7643566|NCT02189863|18822865|P2|STARTED|Second 2 Weeks||13
7643567|NCT02189863|18822866|P1|STARTED|Second 2 Weeks||8
7643568|NCT02189863|18822865|P2|NOT COMPLETED|First 2 Weeks||2
7643569|NCT02189863|18822866|P1|NOT COMPLETED|First 2 Weeks||4
7643570|NCT02189863|18822865|P2|COMPLETED|First 2 Weeks||13
7643571|NCT02189863|18822866|P1|COMPLETED|First 2 Weeks||8
7643572|NCT02189863|18822865|P2|STARTED|First 2 Weeks||15
7643573|NCT02189863|18822866|P1|STARTED|First 2 Weeks||12
7643574|NCT02189837|18822881|P4|NOT COMPLETED|Overall Study||2
7643575|NCT02189837|18822882|P3|NOT COMPLETED|Overall Study||3
7643576|NCT02189837|18822883|P2|NOT COMPLETED|Overall Study||1
7643577|NCT02189837|18822884|P1|NOT COMPLETED|Overall Study||2
7643578|NCT02189837|18822881|P4|COMPLETED|Overall Study||19
7643579|NCT02189837|18822882|P3|COMPLETED|Overall Study||20
7643580|NCT02189837|18822883|P2|COMPLETED|Overall Study||22
7643581|NCT02189837|18822884|P1|COMPLETED|Overall Study||20
7643582|NCT02189837|18822881|P4|Received Treatment|Overall Study||20
7643583|NCT02189837|18822882|P3|Received Treatment|Overall Study||22
7643584|NCT02189837|18822883|P2|Received Treatment|Overall Study||22
7643585|NCT02189837|18822884|P1|Received Treatment|Overall Study||21
7643586|NCT02189837|18822881|P4|STARTED|Overall Study||21
7643587|NCT02189837|18822882|P3|STARTED|Overall Study||23
7643588|NCT02189837|18822883|P2|STARTED|Overall Study||23
7643589|NCT02189837|18822884|P1|STARTED|Overall Study||22
7643590|NCT02189759|18822914|P4|NOT COMPLETED|Overall Study||5
7643591|NCT02189759|18822915|P3|NOT COMPLETED|Overall Study||2
7643592|NCT02189759|18822916|P2|NOT COMPLETED|Overall Study||0
7643593|NCT02189759|18822917|P1|NOT COMPLETED|Overall Study||0
7643594|NCT02189759|18822914|P4|COMPLETED|Overall Study||84
7643595|NCT02189759|18822915|P3|COMPLETED|Overall Study||81
7643596|NCT02189759|18822916|P2|COMPLETED|Overall Study||101
7643597|NCT02189759|18822917|P1|COMPLETED|Overall Study||102
7643598|NCT02189759|18822914|P4|STARTED|Overall Study||89
7643599|NCT02189759|18822915|P3|STARTED|Overall Study||83
7643600|NCT02189759|18822916|P2|STARTED|Overall Study||101
7643601|NCT02189759|18822917|P1|STARTED|Overall Study||102
7643602|NCT02189668|18822937|P2|NOT COMPLETED|Overall Study||0
7643603|NCT02189668|18822938|P1|NOT COMPLETED|Overall Study||0
7643604|NCT02189668|18822937|P2|COMPLETED|Overall Study||9
7643605|NCT02189668|18822938|P1|COMPLETED|Overall Study||5
7643606|NCT02189668|18822937|P2|STARTED|Overall Study||9
7643607|NCT02189668|18822938|P1|STARTED|Overall Study||5
7643608|NCT02189629|18822946|P1|NOT COMPLETED|Overall Study||105
7643609|NCT02189629|18822946|P1|COMPLETED|Overall Study||348
7643610|NCT02189629|18822946|P1|STARTED|Overall Study||453
7643611|NCT02189473|18822953|P2|NOT COMPLETED|Overall Study||25
7643612|NCT02189473|18822954|P1|NOT COMPLETED|Overall Study||23
7643613|NCT02189473|18822953|P2|COMPLETED|Overall Study||77
7643614|NCT02189473|18822954|P1|COMPLETED|Overall Study||78
7643615|NCT02189473|18822953|P2|STARTED|Overall Study||102
7643616|NCT02189473|18822954|P1|STARTED|Overall Study||101
7643617|NCT02189382|18822976|P2|NOT COMPLETED|Overall Study||0
7643618|NCT02189382|18822977|P1|NOT COMPLETED|Overall Study||0
7643619|NCT02189382|18822976|P2|COMPLETED|Overall Study||35
7643620|NCT02189382|18822977|P1|COMPLETED|Overall Study||35
7643621|NCT02189382|18822976|P2|STARTED|Overall Study||35
7643622|NCT02189382|18822977|P1|STARTED|Overall Study||35
7643623|NCT02189317|18822987|P2|NOT COMPLETED|Overall Study||0
7643624|NCT02189317|18822988|P1|NOT COMPLETED|Overall Study||0
7643625|NCT02189317|18822987|P2|COMPLETED|Overall Study||16
7643626|NCT02189317|18822988|P1|COMPLETED|Overall Study||16
7643627|NCT02189317|18822987|P2|STARTED|Overall Study||16
7643628|NCT02189317|18822988|P1|STARTED|Overall Study||16
7643629|NCT02189252|18823002|P4|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
7643630|NCT02189252|18823003|P3|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
7643631|NCT02189252|18823004|P2|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
7643632|NCT02189252|18823005|P1|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
7643633|NCT02189252|18823002|P4|COMPLETED|Period 2 (Visit6b, Week 12)||4
7643634|NCT02189252|18823003|P3|COMPLETED|Period 2 (Visit6b, Week 12)||3
7643635|NCT02189252|18823004|P2|COMPLETED|Period 2 (Visit6b, Week 12)||2
7643636|NCT02189252|18823005|P1|COMPLETED|Period 2 (Visit6b, Week 12)||4
7643637|NCT02189252|18823002|P4|STARTED|Period 2 (Visit6b, Week 12)||4
7643638|NCT02189252|18823003|P3|STARTED|Period 2 (Visit6b, Week 12)||3
7643639|NCT02189252|18823004|P2|STARTED|Period 2 (Visit6b, Week 12)||2
7643640|NCT02189252|18823005|P1|STARTED|Period 2 (Visit6b, Week 12)||4
7643641|NCT02189252|18823002|P4|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
7643642|NCT02189252|18823003|P3|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
7643643|NCT02189252|18823004|P2|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2
7643644|NCT02189252|18823005|P1|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
7643645|NCT02189252|18823002|P4|COMPLETED|Period 1 (Visit 4b, Week 4)||4
7643646|NCT02189252|18823003|P3|COMPLETED|Period 1 (Visit 4b, Week 4)||3
7643647|NCT02189252|18823004|P2|COMPLETED|Period 1 (Visit 4b, Week 4)||2
7643648|NCT02189252|18823005|P1|COMPLETED|Period 1 (Visit 4b, Week 4)||4
7643649|NCT02189252|18823002|P4|STARTED|Period 1 (Visit 4b, Week 4)||4
7643650|NCT02189252|18823003|P3|STARTED|Period 1 (Visit 4b, Week 4)||3
7643651|NCT02189252|18823004|P2|STARTED|Period 1 (Visit 4b, Week 4)||4
7643652|NCT02189252|18823005|P1|STARTED|Period 1 (Visit 4b, Week 4)||4
7643653|NCT02189161|18823037|P1|NOT COMPLETED|Overall Study||0
7643654|NCT02189161|18823037|P1|COMPLETED|Overall Study||10
7643655|NCT02189161|18823037|P1|STARTED|Overall Study||10
7643656|NCT02189122|18823045|P2|NOT COMPLETED|Overall Study||0
7643657|NCT02189122|18823046|P1|NOT COMPLETED|Overall Study||0
7643658|NCT02189122|18823045|P2|COMPLETED|Overall Study||18
7643659|NCT02189122|18823046|P1|COMPLETED|Overall Study||18
7643660|NCT02189122|18823045|P2|STARTED|Overall Study||18
7643661|NCT02189122|18823046|P1|STARTED|Overall Study||18
7643662|NCT02188849|18823064|P2|NOT COMPLETED|Overall Study||8
7643663|NCT02188849|18823065|P1|NOT COMPLETED|Overall Study||3
7643664|NCT02188849|18823064|P2|COMPLETED|Overall Study||17
7643665|NCT02188849|18823065|P1|COMPLETED|Overall Study||22
7643666|NCT02188849|18823064|P2|STARTED|Overall Study||25
7643667|NCT02188849|18823065|P1|STARTED|Overall Study||25
7643668|NCT02188784|18823079|P2|NOT COMPLETED|Overall Study||13
7643669|NCT02188784|18823080|P1|NOT COMPLETED|Overall Study||9
7643670|NCT02188784|18823079|P2|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|101
7643671|NCT02188784|18823080|P1|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|102
7643672|NCT02188784|18823079|P2|STARTED|Overall Study||114
7643673|NCT02188784|18823080|P1|STARTED|Overall Study||111
7643674|NCT02188719|18823100|P4|NOT COMPLETED|Overall Study||0
7643675|NCT02188719|18823101|P3|NOT COMPLETED|Overall Study||0
7643676|NCT02188719|18823102|P2|NOT COMPLETED|Overall Study||1
7643677|NCT02188719|18823103|P1|NOT COMPLETED|Overall Study||0
7643678|NCT02188719|18823100|P4|COMPLETED|Overall Study||0
7643679|NCT02188719|18823101|P3|COMPLETED|Overall Study||0
7643680|NCT02188719|18823102|P2|COMPLETED|Overall Study||8
7643681|NCT02188719|18823103|P1|COMPLETED|Overall Study||6
7643682|NCT02188719|18823100|P4|STARTED|Overall Study||0
7643683|NCT02188719|18823101|P3|STARTED|Overall Study||0
7643684|NCT02188719|18823102|P2|STARTED|Overall Study||9
7643685|NCT02188719|18823103|P1|STARTED|Overall Study||6
7643686|NCT02188589|18823127|P1|NOT COMPLETED|Overall Study||5
7643687|NCT02188589|18823127|P1|COMPLETED|Overall Study||25
7643688|NCT02188589|18823127|P1|24 Months|Overall Study||25
7643689|NCT02188589|18823127|P1|12 Months|Overall Study||30
7643690|NCT02188589|18823127|P1|6 Months|Overall Study||30
7643691|NCT02188589|18823127|P1|STARTED|Overall Study||30
7643692|NCT02188576|18823135|P2|NOT COMPLETED|Overall Study||0
7643693|NCT02188576|18823136|P1|NOT COMPLETED|Overall Study||0
7643694|NCT02188576|18823135|P2|COMPLETED|Overall Study||34
7643695|NCT02188576|18823136|P1|COMPLETED|Overall Study||32
7643696|NCT02188576|18823135|P2|STARTED|Overall Study||34
7643697|NCT02188576|18823136|P1|STARTED|Overall Study||32
7643698|NCT02187887|18823146|P2|NOT COMPLETED|Overall Study||4
7643699|NCT02187887|18823147|P1|NOT COMPLETED|Overall Study||5
7643700|NCT02187887|18823146|P2|COMPLETED|Overall Study||396
7643701|NCT02187887|18823147|P1|COMPLETED|Overall Study||388
7643702|NCT02187887|18823146|P2|STARTED|Overall Study||400
7643703|NCT02187887|18823147|P1|STARTED|Overall Study||393
7643704|NCT02187861|18823159|P4|NOT COMPLETED|Overall Study||32
7643705|NCT02187861|18823160|P3|NOT COMPLETED|Overall Study||32
7643706|NCT02187861|18823161|P2|NOT COMPLETED|Overall Study||48
7643707|NCT02187861|18823162|P1|NOT COMPLETED|Overall Study||6
7643708|NCT02187861|18823159|P4|COMPLETED|Overall Study||19
7643709|NCT02187861|18823160|P3|COMPLETED|Overall Study||19
7643710|NCT02187861|18823161|P2|COMPLETED|Overall Study||4
7643711|NCT02187861|18823162|P1|COMPLETED|Overall Study||3
7643712|NCT02187861|18823159|P4|Treated|Overall Study||50
7643713|NCT02187861|18823160|P3|Treated|Overall Study||49
7643714|NCT02187861|18823161|P2|Treated|Overall Study||52
7643715|NCT02187861|18823162|P1|Treated|Overall Study||9
7643716|NCT02187861|18823159|P4|STARTED|Overall Study||51
7643717|NCT02187861|18823160|P3|STARTED|Overall Study||51
7643718|NCT02187861|18823161|P2|STARTED|Overall Study||52
7643719|NCT02187861|18823162|P1|STARTED|Overall Study||9
7643720|NCT02187809|18823258|P1|NOT COMPLETED|Overall Study||3
7643721|NCT02187809|18823258|P1|COMPLETED|Overall Study||0
7643722|NCT02187809|18823258|P1|Treated|Overall Study||1
7643723|NCT02187809|18823258|P1|STARTED|Overall Study||3
7643724|NCT02187783|18823268|P1|NOT COMPLETED|Overall Study||106
7643725|NCT02187783|18823268|P1|COMPLETED|Overall Study||0
7643726|NCT02187783|18823268|P1|Patients With Solid Tumors|Overall Study||105
7643727|NCT02187783|18823268|P1|STARTED|Overall Study||106
7643728|NCT02187744|18823279|P2|NOT COMPLETED|Treatment||5
7643729|NCT02187744|18823280|P1|NOT COMPLETED|Treatment||4
7643730|NCT02187744|18823279|P2|COMPLETED|Treatment||107
7643731|NCT02187744|18823280|P1|COMPLETED|Treatment||109
7643732|NCT02187744|18823279|P2|STARTED|Treatment||112
7643733|NCT02187744|18823280|P1|STARTED|Treatment||113
7643734|NCT02187744|18823279|P2|NOT COMPLETED|Study||6
7643735|NCT02187744|18823280|P1|NOT COMPLETED|Study||4
7643736|NCT02187744|18823279|P2|COMPLETED|Study||106
7643737|NCT02187744|18823280|P1|COMPLETED|Study||109
7643738|NCT02187744|18823279|P2|STARTED|Study|Received treatment|112
7643739|NCT02187744|18823280|P1|STARTED|Study|Received treatment|113
7643740|NCT02187471|18823300|P4|NOT COMPLETED|Overall Study||80
7643741|NCT02187471|18823301|P3|NOT COMPLETED|Overall Study||86
7643742|NCT02187471|18823302|P2|NOT COMPLETED|Overall Study||82
7643743|NCT02187471|18823303|P1|NOT COMPLETED|Overall Study||76
7643744|NCT02187471|18823300|P4|COMPLETED|Overall Study||246
7643745|NCT02187471|18823301|P3|COMPLETED|Overall Study||240
7643746|NCT02187471|18823302|P2|COMPLETED|Overall Study||242
7643747|NCT02187471|18823303|P1|COMPLETED|Overall Study||249
7643748|NCT02187471|18823300|P4|STARTED|Overall Study||326
7643749|NCT02187471|18823301|P3|STARTED|Overall Study||326
7643750|NCT02187471|18823302|P2|STARTED|Overall Study||324
7643751|NCT02187471|18823303|P1|STARTED|Overall Study||325
7643752|NCT02187172|18823359|P2|NOT COMPLETED|Overall Study||6
7643753|NCT02187172|18823360|P1|NOT COMPLETED|Overall Study||3
7643754|NCT02187172|18823359|P2|COMPLETED|Overall Study||15
7643755|NCT02187172|18823360|P1|COMPLETED|Overall Study||19
7643756|NCT02187172|18823359|P2|RCT Phase Completed|Overall Study||19
7643757|NCT02187172|18823360|P1|RCT Phase Completed|Overall Study||22
7643758|NCT02187172|18823359|P2|STARTED|Overall Study||21
7643759|NCT02187172|18823360|P1|STARTED|Overall Study||22
7643760|NCT02187159|18823528|P4|NOT COMPLETED|Overall Study||96
7643761|NCT02187159|18823529|P3|NOT COMPLETED|Overall Study||77
7643762|NCT02187159|18823530|P2|NOT COMPLETED|Overall Study||79
7643763|NCT02187159|18823531|P1|NOT COMPLETED|Overall Study||69
7643764|NCT02187159|18823528|P4|COMPLETED|Overall Study||221
7643765|NCT02187159|18823529|P3|COMPLETED|Overall Study||241
7643766|NCT02187159|18823530|P2|COMPLETED|Overall Study||238
7643767|NCT02187159|18823531|P1|COMPLETED|Overall Study||249
7643768|NCT02187159|18823528|P4|STARTED|Overall Study||317
7643769|NCT02187159|18823529|P3|STARTED|Overall Study||318
7643770|NCT02187159|18823530|P2|STARTED|Overall Study||317
7643771|NCT02187159|18823531|P1|STARTED|Overall Study||318
7643772|NCT02187055|18823588|P3|NOT COMPLETED|Overall Study||74
7643773|NCT02187055|18823589|P2|NOT COMPLETED|Overall Study||73
7643774|NCT02187055|18823590|P1|NOT COMPLETED|Overall Study||69
7643775|NCT02187055|18823588|P3|COMPLETED|Overall Study||312
7643776|NCT02187055|18823589|P2|COMPLETED|Overall Study||303
7643777|NCT02187055|18823590|P1|COMPLETED|Overall Study||315
7643778|NCT02187055|18823588|P3|STARTED|Overall Study|Treated|386
7643779|NCT02187055|18823589|P2|STARTED|Overall Study|Treated|376
7643780|NCT02187055|18823590|P1|STARTED|Overall Study|Treated|384
7643781|NCT02187042|18823690|P2|NOT COMPLETED|Overall Study||14
7643782|NCT02187042|18823691|P1|NOT COMPLETED|Overall Study||13
7643783|NCT02187042|18823690|P2|COMPLETED|Overall Study||13
7643784|NCT02187042|18823691|P1|COMPLETED|Overall Study||29
7643785|NCT02187042|18823690|P2|STARTED|Overall Study||27
7643786|NCT02187042|18823691|P1|STARTED|Overall Study||42
7643787|NCT02187029|18823737|P4|NOT COMPLETED|Overall Study||3
7643788|NCT02187029|18823738|P3|NOT COMPLETED|Overall Study||11
7643789|NCT02187029|18823739|P2|NOT COMPLETED|Overall Study||1
7643790|NCT02187029|18823740|P1|NOT COMPLETED|Overall Study||1
7643791|NCT02187029|18823737|P4|COMPLETED|Overall Study||6
7643792|NCT02187029|18823738|P3|COMPLETED|Overall Study||0
7643793|NCT02187029|18823739|P2|COMPLETED|Overall Study||2
7643794|NCT02187029|18823740|P1|COMPLETED|Overall Study||6
7643795|NCT02187029|18823737|P4|STARTED|Overall Study||9
7643796|NCT02187029|18823738|P3|STARTED|Overall Study||11
7643797|NCT02187029|18823739|P2|STARTED|Overall Study||3
7643798|NCT02187029|18823740|P1|STARTED|Overall Study||7
7643799|NCT02187016|18823816|P4|NOT COMPLETED|Overall Study||0
7643800|NCT02187016|18823817|P3|NOT COMPLETED|Overall Study||1
7643801|NCT02187016|18823818|P2|NOT COMPLETED|Overall Study||2
7643802|NCT02187016|18823819|P1|NOT COMPLETED|Overall Study||1
7643803|NCT02187016|18823816|P4|COMPLETED|Overall Study||51
7643804|NCT02187016|18823817|P3|COMPLETED|Overall Study||78
7643805|NCT02187016|18823818|P2|COMPLETED|Overall Study||78
7643806|NCT02187016|18823819|P1|COMPLETED|Overall Study||79
7643807|NCT02187016|18823816|P4|STARTED|Overall Study||51
7643808|NCT02187016|18823817|P3|STARTED|Overall Study||79
7643809|NCT02187016|18823818|P2|STARTED|Overall Study||80
7643810|NCT02187016|18823819|P1|STARTED|Overall Study||80
7643811|NCT02186938|18823851|P2|NOT COMPLETED|Overall Study||3
7643812|NCT02186938|18823852|P1|NOT COMPLETED|Overall Study||9
7643813|NCT02186938|18823851|P2|COMPLETED|Overall Study||44
7643814|NCT02186938|18823852|P1|COMPLETED|Overall Study||38
7643815|NCT02186938|18823851|P2|STARTED|Overall Study||47
7643816|NCT02186938|18823852|P1|STARTED|Overall Study|2012|47
7643817|NCT02186873|18823862|P2|NOT COMPLETED|Overall Study||8
7643818|NCT02186873|18823863|P1|NOT COMPLETED|Overall Study||9
7643819|NCT02186873|18823862|P2|COMPLETED|Overall Study||97
7643820|NCT02186873|18823863|P1|COMPLETED|Overall Study||94
7643821|NCT02186873|18823862|P2|End of Control Period|Overall Study|Participants continued to receive golimumab|105
7643822|NCT02186873|18823863|P1|End of Control Period|Overall Study|Participants taking placebo crossed over to golimumab|99
7643823|NCT02186873|18823862|P2|STARTED|Overall Study||105
7643824|NCT02186873|18823863|P1|STARTED|Overall Study||103
7643825|NCT02186847|18823888|P2|NOT COMPLETED|Overall Study||0
7643826|NCT02186847|18823889|P1|NOT COMPLETED|Overall Study||3
7643827|NCT02186847|18823888|P2|COMPLETED|Overall Study||86
7643828|NCT02186847|18823889|P1|COMPLETED|Overall Study||81
7643829|NCT02186847|18823888|P2|Eligible and Started Protocol Treatment|Overall Study||82
7643830|NCT02186847|18823889|P1|Eligible and Started Protocol Treatment|Overall Study||76
7643831|NCT02186847|18823888|P2|Eligible Population|Overall Study||86
7643832|NCT02186847|18823889|P1|Eligible Population|Overall Study||81
7643833|NCT02186847|18823888|P2|STARTED|Overall Study||86
7643834|NCT02186847|18823889|P1|STARTED|Overall Study||84
7643835|NCT02186834|18823903|P6|NOT COMPLETED|Treatment at RP2D||1
7643836|NCT02186834|18823904|P5|NOT COMPLETED|Treatment at RP2D||0
7643837|NCT02186834|18823905|P4|NOT COMPLETED|Treatment at RP2D||0
7643838|NCT02186834|18823906|P3|NOT COMPLETED|Treatment at RP2D||0
7643839|NCT02186834|18823907|P2|NOT COMPLETED|Treatment at RP2D||0
7643840|NCT02186834|18823908|P1|NOT COMPLETED|Treatment at RP2D||0
7643841|NCT02186834|18823903|P6|COMPLETED|Treatment at RP2D||13
7643842|NCT02186834|18823904|P5|COMPLETED|Treatment at RP2D||0
7643843|NCT02186834|18823905|P4|COMPLETED|Treatment at RP2D||0
7643844|NCT02186834|18823906|P3|COMPLETED|Treatment at RP2D||0
7643845|NCT02186834|18823907|P2|COMPLETED|Treatment at RP2D||0
7643846|NCT02186834|18823908|P1|COMPLETED|Treatment at RP2D||0
7643847|NCT02186834|18823903|P6|STARTED|Treatment at RP2D||14
7643848|NCT02186834|18823904|P5|STARTED|Treatment at RP2D||0
7643849|NCT02186834|18823905|P4|STARTED|Treatment at RP2D||0
7643850|NCT02186834|18823906|P3|STARTED|Treatment at RP2D||0
7643851|NCT02186834|18823907|P2|STARTED|Treatment at RP2D||0
7643852|NCT02186834|18823908|P1|STARTED|Treatment at RP2D||0
7643853|NCT02186834|18823903|P6|NOT COMPLETED|Dose Escalation||0
7643854|NCT02186834|18823904|P5|NOT COMPLETED|Dose Escalation||0
7643855|NCT02186834|18823905|P4|NOT COMPLETED|Dose Escalation||1
7643856|NCT02186834|18823906|P3|NOT COMPLETED|Dose Escalation||0
7643857|NCT02186834|18823907|P2|NOT COMPLETED|Dose Escalation||0
7643858|NCT02186834|18823908|P1|NOT COMPLETED|Dose Escalation||0
7643859|NCT02186834|18823903|P6|COMPLETED|Dose Escalation||0
7643860|NCT02186834|18823904|P5|COMPLETED|Dose Escalation||4
7643861|NCT02186834|18823905|P4|COMPLETED|Dose Escalation||6
7643862|NCT02186834|18823906|P3|COMPLETED|Dose Escalation||0
7643863|NCT02186834|18823907|P2|COMPLETED|Dose Escalation||3
7643864|NCT02186834|18823908|P1|COMPLETED|Dose Escalation||6
7643865|NCT02186834|18823903|P6|STARTED|Dose Escalation||0
7643866|NCT02186834|18823904|P5|STARTED|Dose Escalation||4
7643867|NCT02186834|18823905|P4|STARTED|Dose Escalation||7
7643868|NCT02186834|18823906|P3|STARTED|Dose Escalation||0
7643869|NCT02186834|18823907|P2|STARTED|Dose Escalation||3
7643870|NCT02186834|18823908|P1|STARTED|Dose Escalation||6
7643871|NCT02186808|18823919|P1|NOT COMPLETED|Overall Study||13
7643872|NCT02186808|18823919|P1|COMPLETED|Overall Study||67
7643873|NCT02186808|18823919|P1|STARTED|Overall Study||80
7643874|NCT02186795|18823926|P2|NOT COMPLETED|Overall Study||0
7643875|NCT02186795|18823927|P1|NOT COMPLETED|Overall Study||0
7643876|NCT02186795|18823926|P2|COMPLETED|Overall Study||24
7643877|NCT02186795|18823927|P1|COMPLETED|Overall Study||24
7643878|NCT02186795|18823926|P2|STARTED|Overall Study||24
7643879|NCT02186795|18823927|P1|STARTED|Overall Study||24
7643880|NCT02186665|18823935|P2|NOT COMPLETED|Overall Study||1
7643881|NCT02186665|18823936|P1|NOT COMPLETED|Overall Study||0
7643882|NCT02186665|18823935|P2|COMPLETED|Overall Study||10
7643883|NCT02186665|18823936|P1|COMPLETED|Overall Study||8
7643884|NCT02186665|18823935|P2|STARTED|Overall Study||11
7643885|NCT02186665|18823936|P1|STARTED|Overall Study||8
7643886|NCT02186652|18823944|P2|NOT COMPLETED|Overall Study||0
7643887|NCT02186652|18823945|P1|NOT COMPLETED|Overall Study||2
7643888|NCT02186652|18823944|P2|COMPLETED|Overall Study||22
7643889|NCT02186652|18823945|P1|COMPLETED|Overall Study||17
7643890|NCT02186652|18823944|P2|STARTED|Overall Study||22
7643891|NCT02186652|18823945|P1|STARTED|Overall Study||19
7643892|NCT02186587|18823972|P2|NOT COMPLETED|Overall Study||0
7643893|NCT02186587|18823973|P1|NOT COMPLETED|Overall Study||5
7643894|NCT02186587|18823972|P2|COMPLETED|Overall Study||0
7643895|NCT02186587|18823973|P1|COMPLETED|Overall Study||23
7643896|NCT02186587|18823972|P2|STARTED|Overall Study||0
7643897|NCT02186587|18823973|P1|STARTED|Overall Study||28
7643898|NCT02186561|18823978|P1|NOT COMPLETED|3 - Year Post Index Procedure Visit||13
7643899|NCT02186561|18823978|P1|COMPLETED|3 - Year Post Index Procedure Visit||128
7643900|NCT02186561|18823978|P1|STARTED|3 - Year Post Index Procedure Visit||141
7643901|NCT02186561|18823978|P1|NOT COMPLETED|2 - Year Post Index Procedure Visit||7
7643902|NCT02186561|18823978|P1|COMPLETED|2 - Year Post Index Procedure Visit||134
7643903|NCT02186561|18823978|P1|STARTED|2 - Year Post Index Procedure Visit||141
7643904|NCT02186561|18823978|P1|NOT COMPLETED|1- Year Post Index Procedure Visit||2
7643905|NCT02186561|18823978|P1|COMPLETED|1- Year Post Index Procedure Visit||139
7643906|NCT02186561|18823978|P1|STARTED|1- Year Post Index Procedure Visit||141
7643907|NCT02186561|18823978|P1|NOT COMPLETED|180- Day Post Index Procedure Visit||7
7643908|NCT02186561|18823978|P1|COMPLETED|180- Day Post Index Procedure Visit||134
7643909|NCT02186561|18823978|P1|STARTED|180- Day Post Index Procedure Visit||141
7643910|NCT02186561|18823978|P1|NOT COMPLETED|30-Day Post Index Procedure Visit||1
7643911|NCT02186561|18823978|P1|COMPLETED|30-Day Post Index Procedure Visit||140
7643912|NCT02186561|18823978|P1|STARTED|30-Day Post Index Procedure Visit||141
7643913|NCT02186561|18823978|P1|NOT COMPLETED|Subjects Implanted With Device||0
7643914|NCT02186561|18823978|P1|COMPLETED|Subjects Implanted With Device||141
7643915|NCT02186561|18823978|P1|STARTED|Subjects Implanted With Device||141
7643916|NCT02186561|18823978|P1|NOT COMPLETED|Enrollment||56
7643917|NCT02186561|18823978|P1|COMPLETED|Enrollment||141
7643918|NCT02186561|18823978|P1|STARTED|Enrollment||197
7643919|NCT02186509|18823988|P1|NOT COMPLETED|Overall Study||0
7643920|NCT02186509|18823988|P1|COMPLETED|Overall Study||17
7643921|NCT02186509|18823988|P1|STARTED|Overall Study||17
7643922|NCT02186301|18823998|P3|NOT COMPLETED|Overall Study||50
7643923|NCT02186301|18823999|P2|NOT COMPLETED|Overall Study||30
7643924|NCT02186301|18824000|P1|NOT COMPLETED|Overall Study||20
7643925|NCT02186301|18823998|P3|COMPLETED|Overall Study|Patients who are off study for any reason.|0
7643926|NCT02186301|18823999|P2|COMPLETED|Overall Study|Patients who are off study for any reason.|0
7643927|NCT02186301|18824000|P1|COMPLETED|Overall Study|Patients who are off study for any reason.|0
7643928|NCT02186301|18823998|P3|STARTED|Overall Study||50
7643929|NCT02186301|18823999|P2|STARTED|Overall Study||30
7643930|NCT02186301|18824000|P1|STARTED|Overall Study||20
7643931|NCT02186223|18824016|P1|NOT COMPLETED|Overall Study||21
7643932|NCT02186223|18824016|P1|COMPLETED|Overall Study||151
7643933|NCT02186223|18824016|P1|Device Placed|Overall Study||163
7643934|NCT02186223|18824016|P1|STARTED|Overall Study||172
7643935|NCT02186210|18824027|P2|NOT COMPLETED|Overall Study||0
7643936|NCT02186210|18824028|P1|NOT COMPLETED|Overall Study||0
7643937|NCT02186210|18824027|P2|COMPLETED|Overall Study||20
7643938|NCT02186210|18824028|P1|COMPLETED|Overall Study||20
7643939|NCT02186210|18824027|P2|STARTED|Overall Study||20
7643940|NCT02186210|18824028|P1|STARTED|Overall Study||20
7643941|NCT02186171|18824038|P2|NOT COMPLETED|Overall Study||15
7643942|NCT02186171|18824039|P1|NOT COMPLETED|Overall Study||4
7643943|NCT02186171|18824038|P2|COMPLETED|Overall Study||148
7643944|NCT02186171|18824039|P1|COMPLETED|Overall Study||78
7643945|NCT02186171|18824038|P2|Received Treatment|Overall Study||163
7643946|NCT02186171|18824039|P1|Received Treatment|Overall Study||81
7643947|NCT02186171|18824038|P2|STARTED|Overall Study||163
7643948|NCT02186171|18824039|P1|STARTED|Overall Study||82
7643949|NCT02185794|18824061|P6|NOT COMPLETED|Overall Study||16
7643950|NCT02185794|18824062|P5|NOT COMPLETED|Overall Study||3
7643951|NCT02185794|18824063|P4|NOT COMPLETED|Overall Study||8
7643952|NCT02185794|18824064|P3|NOT COMPLETED|Overall Study||16
7643953|NCT02185794|18824065|P2|NOT COMPLETED|Overall Study||13
7643954|NCT02185794|18824066|P1|NOT COMPLETED|Overall Study||5
7643955|NCT02185794|18824061|P6|COMPLETED|Overall Study||0
7643956|NCT02185794|18824062|P5|COMPLETED|Overall Study||4
7643957|NCT02185794|18824063|P4|COMPLETED|Overall Study||8
7643958|NCT02185794|18824064|P3|COMPLETED|Overall Study||17
7643959|NCT02185794|18824065|P2|COMPLETED|Overall Study||7
7643960|NCT02185794|18824066|P1|COMPLETED|Overall Study||4
7643961|NCT02185794|18824061|P6|STARTED|Overall Study||16
7643962|NCT02185794|18824062|P5|STARTED|Overall Study||7
7643963|NCT02185794|18824063|P4|STARTED|Overall Study||16
7643964|NCT02185794|18824064|P3|STARTED|Overall Study||33
7643965|NCT02185794|18824065|P2|STARTED|Overall Study||20
7643966|NCT02185794|18824066|P1|STARTED|Overall Study||9
7643967|NCT02185729|18824138|P1|NOT COMPLETED|24 Hours Into Dextrose Infusion||0
7643968|NCT02185729|18824138|P1|COMPLETED|24 Hours Into Dextrose Infusion||12
7643969|NCT02185729|18824138|P1|STARTED|24 Hours Into Dextrose Infusion||12
7643970|NCT02185729|18824138|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
7643971|NCT02185729|18824138|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
7643972|NCT02185729|18824138|P1|STARTED|4 Hours Into Dextrose Infusion||12
7643973|NCT02185729|18824138|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
7643974|NCT02185729|18824138|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
7643975|NCT02185729|18824138|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
7643976|NCT02185729|18824138|P1|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0
7643977|NCT02185729|18824138|P1|COMPLETED|24 Hours Into ClinOleic Infusion||12
7643978|NCT02185729|18824138|P1|STARTED|24 Hours Into ClinOleic Infusion||12
7643979|NCT02185729|18824138|P1|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0
7643980|NCT02185729|18824138|P1|COMPLETED|4 Hours Into ClinOleic Infusion||12
7643981|NCT02185729|18824138|P1|STARTED|4 Hours Into ClinOleic Infusion||12
7643982|NCT02185729|18824138|P1|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0
7643983|NCT02185729|18824138|P1|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12
7643984|NCT02185729|18824138|P1|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12
7643985|NCT02185729|18824138|P1|NOT COMPLETED|24 Hours Into Intralipid Infusion||0
7643986|NCT02185729|18824138|P1|COMPLETED|24 Hours Into Intralipid Infusion||12
7643987|NCT02185729|18824138|P1|STARTED|24 Hours Into Intralipid Infusion||12
7643988|NCT02185729|18824138|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
7643989|NCT02185729|18824138|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
7643990|NCT02185729|18824138|P1|STARTED|4 Hours Into Intralipid Infusion||12
7643991|NCT02185729|18824138|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
7643992|NCT02185729|18824138|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
7643993|NCT02185729|18824138|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
7643994|NCT02185729|18824138|P1|NOT COMPLETED|24 Hours Into Saline Infusion||0
7643995|NCT02185729|18824138|P1|COMPLETED|24 Hours Into Saline Infusion||12
7643996|NCT02185729|18824138|P1|STARTED|24 Hours Into Saline Infusion||12
7643997|NCT02185729|18824138|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
7643998|NCT02185729|18824138|P1|COMPLETED|4 Hours Into Saline Infusion||12
7643999|NCT02185729|18824138|P1|STARTED|4 Hours Into Saline Infusion||12
7644000|NCT02185729|18824138|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
7644001|NCT02185729|18824138|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
7644002|NCT02185729|18824138|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
7644003|NCT02185534|18824159|P6|NOT COMPLETED|Third Period||0
7644004|NCT02185534|18824160|P5|NOT COMPLETED|Third Period||0
7644005|NCT02185534|18824161|P4|NOT COMPLETED|Third Period||0
7644006|NCT02185534|18824162|P3|NOT COMPLETED|Third Period||0
7644007|NCT02185534|18824163|P2|NOT COMPLETED|Third Period||0
7644008|NCT02185534|18824164|P1|NOT COMPLETED|Third Period||0
7644009|NCT02185534|18824159|P6|COMPLETED|Third Period||13
7644010|NCT02185534|18824160|P5|COMPLETED|Third Period||13
7644011|NCT02185534|18824161|P4|COMPLETED|Third Period||13
7644012|NCT02185534|18824162|P3|COMPLETED|Third Period||14
7644013|NCT02185534|18824163|P2|COMPLETED|Third Period||14
7644014|NCT02185534|18824164|P1|COMPLETED|Third Period||13
7644015|NCT02185534|18824159|P6|STARTED|Third Period||13
7644016|NCT02185534|18824160|P5|STARTED|Third Period||13
7644017|NCT02185534|18824161|P4|STARTED|Third Period||13
7644018|NCT02185534|18824162|P3|STARTED|Third Period||14
7644019|NCT02185534|18824163|P2|STARTED|Third Period||14
7644020|NCT02185534|18824164|P1|STARTED|Third Period||13
7644021|NCT02185534|18824159|P6|NOT COMPLETED|Second Washout Period||0
7644022|NCT02185534|18824160|P5|NOT COMPLETED|Second Washout Period||0
7644023|NCT02185534|18824161|P4|NOT COMPLETED|Second Washout Period||0
7644024|NCT02185534|18824162|P3|NOT COMPLETED|Second Washout Period||0
7644025|NCT02185534|18824163|P2|NOT COMPLETED|Second Washout Period||0
7644026|NCT02185534|18824164|P1|NOT COMPLETED|Second Washout Period||0
7644027|NCT02185534|18824159|P6|COMPLETED|Second Washout Period||13
7644028|NCT02185534|18824160|P5|COMPLETED|Second Washout Period||13
7644029|NCT02185534|18824161|P4|COMPLETED|Second Washout Period||13
7644030|NCT02185534|18824162|P3|COMPLETED|Second Washout Period||14
7644031|NCT02185534|18824163|P2|COMPLETED|Second Washout Period||14
7644032|NCT02185534|18824164|P1|COMPLETED|Second Washout Period||13
7644033|NCT02185534|18824159|P6|STARTED|Second Washout Period||13
7644034|NCT02185534|18824160|P5|STARTED|Second Washout Period||13
7644035|NCT02185534|18824161|P4|STARTED|Second Washout Period||13
7644036|NCT02185534|18824162|P3|STARTED|Second Washout Period||14
7644037|NCT02185534|18824163|P2|STARTED|Second Washout Period||14
7644038|NCT02185534|18824164|P1|STARTED|Second Washout Period||13
7644039|NCT02185534|18824159|P6|NOT COMPLETED|Second Period||0
7644040|NCT02185534|18824160|P5|NOT COMPLETED|Second Period||0
7644041|NCT02185534|18824161|P4|NOT COMPLETED|Second Period||0
7644042|NCT02185534|18824162|P3|NOT COMPLETED|Second Period||0
7644043|NCT02185534|18824163|P2|NOT COMPLETED|Second Period||0
7644044|NCT02185534|18824164|P1|NOT COMPLETED|Second Period||0
7644045|NCT02185534|18824159|P6|COMPLETED|Second Period||13
7644046|NCT02185534|18824160|P5|COMPLETED|Second Period||13
7644047|NCT02185534|18824161|P4|COMPLETED|Second Period||13
7644048|NCT02185534|18824162|P3|COMPLETED|Second Period||14
7644049|NCT02185534|18824163|P2|COMPLETED|Second Period||14
7644050|NCT02185534|18824164|P1|COMPLETED|Second Period||13
7644051|NCT02185534|18824159|P6|STARTED|Second Period||13
7644052|NCT02185534|18824160|P5|STARTED|Second Period||13
7644053|NCT02185534|18824161|P4|STARTED|Second Period||13
7644054|NCT02185534|18824162|P3|STARTED|Second Period||14
7644055|NCT02185534|18824163|P2|STARTED|Second Period||14
7644056|NCT02185534|18824164|P1|STARTED|Second Period||13
7644057|NCT02185534|18824159|P6|NOT COMPLETED|First Washout Period||1
7644058|NCT02185534|18824160|P5|NOT COMPLETED|First Washout Period||1
7644059|NCT02185534|18824161|P4|NOT COMPLETED|First Washout Period||0
7644060|NCT02185534|18824162|P3|NOT COMPLETED|First Washout Period||0
7644061|NCT02185534|18824163|P2|NOT COMPLETED|First Washout Period||0
7644062|NCT02185534|18824164|P1|NOT COMPLETED|First Washout Period||1
7644063|NCT02185534|18824159|P6|COMPLETED|First Washout Period||13
7644064|NCT02185534|18824160|P5|COMPLETED|First Washout Period||13
7644065|NCT02185534|18824161|P4|COMPLETED|First Washout Period||13
7644066|NCT02185534|18824162|P3|COMPLETED|First Washout Period||14
7644067|NCT02185534|18824163|P2|COMPLETED|First Washout Period||14
7644068|NCT02185534|18824164|P1|COMPLETED|First Washout Period||13
7644069|NCT02185534|18824159|P6|STARTED|First Washout Period||14
7644070|NCT02185534|18824160|P5|STARTED|First Washout Period||14
7644071|NCT02185534|18824161|P4|STARTED|First Washout Period||13
7644072|NCT02185534|18824162|P3|STARTED|First Washout Period||14
7644073|NCT02185534|18824163|P2|STARTED|First Washout Period||14
7644074|NCT02185534|18824164|P1|STARTED|First Washout Period||14
7644075|NCT02185534|18824159|P6|NOT COMPLETED|First Period||0
7644076|NCT02185534|18824160|P5|NOT COMPLETED|First Period||0
7644077|NCT02185534|18824161|P4|NOT COMPLETED|First Period||1
7644078|NCT02185534|18824162|P3|NOT COMPLETED|First Period||0
7644079|NCT02185534|18824163|P2|NOT COMPLETED|First Period||0
7644080|NCT02185534|18824164|P1|NOT COMPLETED|First Period||0
7644081|NCT02185534|18824159|P6|COMPLETED|First Period||14
7644082|NCT02185534|18824160|P5|COMPLETED|First Period||14
7644083|NCT02185534|18824161|P4|COMPLETED|First Period||13
7644084|NCT02185534|18824162|P3|COMPLETED|First Period||14
7644085|NCT02185534|18824163|P2|COMPLETED|First Period||14
7644086|NCT02185534|18824164|P1|COMPLETED|First Period||14
7644087|NCT02185534|18824159|P6|STARTED|First Period||14
7644088|NCT02185534|18824160|P5|STARTED|First Period||14
7644089|NCT02185534|18824161|P4|STARTED|First Period||14
7644090|NCT02185534|18824162|P3|STARTED|First Period||14
7644091|NCT02185534|18824163|P2|STARTED|First Period||14
7644092|NCT02185534|18824164|P1|STARTED|First Period||14
7644093|NCT02185521|18824179|P1|NOT COMPLETED|Overall Study||2
7644094|NCT02185521|18824179|P1|COMPLETED|Overall Study||125
7644095|NCT02185521|18824179|P1|STARTED|Overall Study||127
7644096|NCT02185339|18824186|P2|NOT COMPLETED|Overall Study||1
7644097|NCT02185339|18824187|P1|NOT COMPLETED|Overall Study||0
7644098|NCT02185339|18824186|P2|COMPLETED|Overall Study||30
7644099|NCT02185339|18824187|P1|COMPLETED|Overall Study||30
7644100|NCT02185339|18824186|P2|STARTED|Overall Study||31
7644101|NCT02185339|18824187|P1|STARTED|Overall Study||30
7644102|NCT02185183|18824209|P1|NOT COMPLETED|Overall Study||0
7644103|NCT02185183|18824209|P1|COMPLETED|Overall Study||14
7644104|NCT02185183|18824209|P1|STARTED|Overall Study||14
7644105|NCT02185131|18824215|P2|NOT COMPLETED|Overall Study||1
7644106|NCT02185131|18824216|P1|NOT COMPLETED|Overall Study||1
7644107|NCT02185131|18824215|P2|COMPLETED|Overall Study||8
7644108|NCT02185131|18824216|P1|COMPLETED|Overall Study||6
7644109|NCT02185131|18824215|P2|STARTED|Overall Study||9
7644110|NCT02185131|18824216|P1|STARTED|Overall Study||7
7644111|NCT02185105|18824224|P1|NOT COMPLETED|Overall Study||0
7644112|NCT02185105|18824224|P1|COMPLETED|Overall Study||30
7644113|NCT02185105|18824224|P1|STARTED|Overall Study||30
7644114|NCT02185053|18824267|P3|NOT COMPLETED|Donepezil Dose Maintenance Phase||3
7644115|NCT02185053|18824268|P2|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
7644116|NCT02185053|18824269|P1|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
7644117|NCT02185053|18824267|P3|COMPLETED|Donepezil Dose Maintenance Phase||30
7644118|NCT02185053|18824268|P2|COMPLETED|Donepezil Dose Maintenance Phase||0
7644119|NCT02185053|18824269|P1|COMPLETED|Donepezil Dose Maintenance Phase||0
7644120|NCT02185053|18824267|P3|STARTED|Donepezil Dose Maintenance Phase||33
7644121|NCT02185053|18824268|P2|STARTED|Donepezil Dose Maintenance Phase||0
7644122|NCT02185053|18824269|P1|STARTED|Donepezil Dose Maintenance Phase||0
7644123|NCT02185053|18824267|P3|NOT COMPLETED|Donepezil Dose Escalation Phase||0
7644124|NCT02185053|18824268|P2|NOT COMPLETED|Donepezil Dose Escalation Phase||5
7644125|NCT02185053|18824269|P1|NOT COMPLETED|Donepezil Dose Escalation Phase||0
7644126|NCT02185053|18824267|P3|COMPLETED|Donepezil Dose Escalation Phase||0
7644127|NCT02185053|18824268|P2|COMPLETED|Donepezil Dose Escalation Phase||33
7644128|NCT02185053|18824269|P1|COMPLETED|Donepezil Dose Escalation Phase||0
7644129|NCT02185053|18824267|P3|STARTED|Donepezil Dose Escalation Phase||0
7644130|NCT02185053|18824268|P2|STARTED|Donepezil Dose Escalation Phase||38
7644131|NCT02185053|18824269|P1|STARTED|Donepezil Dose Escalation Phase||0
7644132|NCT02185053|18824267|P3|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
7644133|NCT02185053|18824268|P2|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
7644134|NCT02185053|18824269|P1|NOT COMPLETED|Solifenacin Dose Escalation Phase||3
7644135|NCT02185053|18824267|P3|COMPLETED|Solifenacin Dose Escalation Phase||0
7644136|NCT02185053|18824268|P2|COMPLETED|Solifenacin Dose Escalation Phase||0
7644137|NCT02185053|18824269|P1|COMPLETED|Solifenacin Dose Escalation Phase||38
7644138|NCT02185053|18824267|P3|STARTED|Solifenacin Dose Escalation Phase||0
7644139|NCT02185053|18824268|P2|STARTED|Solifenacin Dose Escalation Phase||0
7644140|NCT02185053|18824269|P1|STARTED|Solifenacin Dose Escalation Phase||41
7644141|NCT02185040|18824283|P7|NOT COMPLETED|Active Treatment Extension Phase||7
7644142|NCT02185040|18824284|P6|NOT COMPLETED|Active Treatment Extension Phase||3
7644143|NCT02185040|18824285|P5|NOT COMPLETED|Active Treatment Extension Phase||0
7644144|NCT02185040|18824286|P4|NOT COMPLETED|Active Treatment Extension Phase||0
7644145|NCT02185040|18824287|P3|NOT COMPLETED|Active Treatment Extension Phase||0
7644146|NCT02185040|18824288|P2|NOT COMPLETED|Active Treatment Extension Phase||0
7644147|NCT02185040|18824289|P1|NOT COMPLETED|Active Treatment Extension Phase||0
7644148|NCT02185040|18824283|P7|COMPLETED|Active Treatment Extension Phase||1
7644149|NCT02185040|18824284|P6|COMPLETED|Active Treatment Extension Phase||6
7644150|NCT02185040|18824285|P5|COMPLETED|Active Treatment Extension Phase||0
7644151|NCT02185040|18824286|P4|COMPLETED|Active Treatment Extension Phase||0
7644152|NCT02185040|18824287|P3|COMPLETED|Active Treatment Extension Phase||0
7644153|NCT02185040|18824288|P2|COMPLETED|Active Treatment Extension Phase||0
7644154|NCT02185040|18824289|P1|COMPLETED|Active Treatment Extension Phase||0
7644155|NCT02185040|18824283|P7|STARTED|Active Treatment Extension Phase||8
7644156|NCT02185040|18824284|P6|STARTED|Active Treatment Extension Phase||9
7644157|NCT02185040|18824285|P5|STARTED|Active Treatment Extension Phase||0
7644158|NCT02185040|18824286|P4|STARTED|Active Treatment Extension Phase||0
7644159|NCT02185040|18824287|P3|STARTED|Active Treatment Extension Phase||0
7644160|NCT02185040|18824288|P2|STARTED|Active Treatment Extension Phase||0
7644161|NCT02185040|18824289|P1|STARTED|Active Treatment Extension Phase||0
7644162|NCT02185040|18824283|P7|NOT COMPLETED|Part 1 Treatment Phase||0
7644163|NCT02185040|18824284|P6|NOT COMPLETED|Part 1 Treatment Phase||0
7644164|NCT02185040|18824285|P5|NOT COMPLETED|Part 1 Treatment Phase||3
7644165|NCT02185040|18824286|P4|NOT COMPLETED|Part 1 Treatment Phase||2
7644166|NCT02185040|18824287|P3|NOT COMPLETED|Part 1 Treatment Phase||1
7644167|NCT02185040|18824288|P2|NOT COMPLETED|Part 1 Treatment Phase||2
7644168|NCT02185040|18824289|P1|NOT COMPLETED|Part 1 Treatment Phase||1
7644169|NCT02185040|18824283|P7|COMPLETED|Part 1 Treatment Phase||0
7644170|NCT02185040|18824284|P6|COMPLETED|Part 1 Treatment Phase||0
7644171|NCT02185040|18824285|P5|COMPLETED|Part 1 Treatment Phase||6
7644172|NCT02185040|18824286|P4|COMPLETED|Part 1 Treatment Phase||7
7644173|NCT02185040|18824287|P3|COMPLETED|Part 1 Treatment Phase||7
7644174|NCT02185040|18824288|P2|COMPLETED|Part 1 Treatment Phase||6
7644175|NCT02185040|18824289|P1|COMPLETED|Part 1 Treatment Phase||7
7644176|NCT02185040|18824283|P7|STARTED|Part 1 Treatment Phase||0
7644177|NCT02185040|18824284|P6|STARTED|Part 1 Treatment Phase||0
7644178|NCT02185040|18824285|P5|STARTED|Part 1 Treatment Phase||9
7644179|NCT02185040|18824286|P4|STARTED|Part 1 Treatment Phase||9
7644180|NCT02185040|18824287|P3|STARTED|Part 1 Treatment Phase||8
7644181|NCT02185040|18824288|P2|STARTED|Part 1 Treatment Phase||8
7644182|NCT02185040|18824289|P1|STARTED|Part 1 Treatment Phase||8
7644183|NCT02185014|18824343|P1|NOT COMPLETED|Overall Study||54
7644184|NCT02185014|18824343|P1|COMPLETED|Overall Study||198
7644185|NCT02185014|18824343|P1|STARTED|Overall Study||252
7644186|NCT02184988|18824347|P1|NOT COMPLETED|Overall Study||55
7644187|NCT02184988|18824347|P1|COMPLETED|Overall Study||297
7644188|NCT02184988|18824347|P1|STARTED|Overall Study||352
7644189|NCT02184624|18824357|P5|NOT COMPLETED|Overall Study||0
7644190|NCT02184624|18824358|P4|NOT COMPLETED|Overall Study||0
7644191|NCT02184624|18824359|P3|NOT COMPLETED|Overall Study||0
7644192|NCT02184624|18824360|P2|NOT COMPLETED|Overall Study||0
7644193|NCT02184624|18824361|P1|NOT COMPLETED|Overall Study||0
7644194|NCT02184624|18824357|P5|COMPLETED|Overall Study||98
7644195|NCT02184624|18824358|P4|COMPLETED|Overall Study||118
7644196|NCT02184624|18824359|P3|COMPLETED|Overall Study||100
7644197|NCT02184624|18824360|P2|COMPLETED|Overall Study||80
7644198|NCT02184624|18824361|P1|COMPLETED|Overall Study||171
7644199|NCT02184624|18824357|P5|STARTED|Overall Study||98
7644200|NCT02184624|18824358|P4|STARTED|Overall Study||118
7644201|NCT02184624|18824359|P3|STARTED|Overall Study||100
7644202|NCT02184624|18824360|P2|STARTED|Overall Study||80
7644203|NCT02184624|18824361|P1|STARTED|Overall Study||171
7644204|NCT02184611|18824405|P2|NOT COMPLETED|Overall Study||28
7644205|NCT02184611|18824406|P1|NOT COMPLETED|Overall Study||21
7644206|NCT02184611|18824405|P2|COMPLETED|Overall Study||177
7644207|NCT02184611|18824406|P1|COMPLETED|Overall Study||80
7644208|NCT02184611|18824405|P2|STARTED|Overall Study||205
7644209|NCT02184611|18824406|P1|STARTED|Overall Study||101
7644210|NCT02184572|18824442|P2|NOT COMPLETED|Overall Study||30
7644211|NCT02184572|18824443|P1|NOT COMPLETED|Overall Study||47
7644212|NCT02184572|18824442|P2|COMPLETED|Overall Study||542
7644213|NCT02184572|18824443|P1|COMPLETED|Overall Study||1117
7644214|NCT02184572|18824442|P2|STARTED|Overall Study||572
7644215|NCT02184572|18824443|P1|STARTED|Overall Study||1164
7644216|NCT02184494|18824482|P3|NOT COMPLETED|Overall Study||0
7644217|NCT02184494|18824483|P2|NOT COMPLETED|Overall Study||2
7644218|NCT02184494|18824484|P1|NOT COMPLETED|Overall Study||1
7644219|NCT02184494|18824482|P3|COMPLETED|Overall Study||8
7644220|NCT02184494|18824483|P2|COMPLETED|Overall Study||11
7644221|NCT02184494|18824484|P1|COMPLETED|Overall Study||12
7644222|NCT02184494|18824482|P3|STARTED|Overall Study||8
7644223|NCT02184494|18824483|P2|STARTED|Overall Study||13
7644224|NCT02184494|18824484|P1|STARTED|Overall Study||13
7644225|NCT02184455|18824504|P1|NOT COMPLETED|Overall Study||1
7644226|NCT02184455|18824504|P1|COMPLETED|Overall Study||10
7644227|NCT02184455|18824504|P1|STARTED|Overall Study||11
7644228|NCT02184442|18824515|P2|NOT COMPLETED|Overall Study||76
7644229|NCT02184442|18824516|P1|NOT COMPLETED|Overall Study||64
7644230|NCT02184442|18824515|P2|COMPLETED|Overall Study||200
7644231|NCT02184442|18824516|P1|COMPLETED|Overall Study||220
7644232|NCT02184442|18824515|P2|Valve-Implant|Overall Study||263
7644233|NCT02184442|18824516|P1|Valve-Implant|Overall Study||280
7644234|NCT02184442|18824515|P2|As-Treated|Overall Study||271
7644235|NCT02184442|18824516|P1|As-Treated|Overall Study||282
7644236|NCT02184442|18824515|P2|STARTED|Overall Study||276
7644237|NCT02184442|18824516|P1|STARTED|Overall Study||284
7644238|NCT02184208|18824528|P1|NOT COMPLETED|Overall Study||56
7644239|NCT02184208|18824528|P1|COMPLETED|Overall Study||222
7644240|NCT02184208|18824528|P1|STARTED|Overall Study||278
7644241|NCT02184195|18824536|P2|NOT COMPLETED|Overall Study||35
7644242|NCT02184195|18824537|P1|NOT COMPLETED|Overall Study||43
7644243|NCT02184195|18824536|P2|COMPLETED|Overall Study||27
7644244|NCT02184195|18824537|P1|COMPLETED|Overall Study||49
7644245|NCT02184195|18824536|P2|STARTED|Overall Study||62
7644246|NCT02184195|18824537|P1|STARTED|Overall Study||92
7644247|NCT02184169|18824563|P2|NOT COMPLETED|Overall Study||0
7644248|NCT02184169|18824564|P1|NOT COMPLETED|Overall Study||0
7644249|NCT02184169|18824563|P2|COMPLETED|Overall Study||6
7644250|NCT02184169|18824564|P1|COMPLETED|Overall Study||21
7644251|NCT02184169|18824563|P2|STARTED|Overall Study||6
7644252|NCT02184169|18824564|P1|STARTED|Overall Study||21
7644253|NCT02184143|18824574|P2|NOT COMPLETED|Overall Study||7
7644254|NCT02184143|18824575|P1|NOT COMPLETED|Overall Study||10
7644255|NCT02184143|18824574|P2|COMPLETED|Overall Study|117 patients completed PROs. 100 actigraph valid wear time.|117
7644256|NCT02184143|18824575|P1|COMPLETED|Overall Study|114 patients completed PROs. 98 actigraph valid wear time.|114
7644257|NCT02184143|18824574|P2|STARTED|Overall Study|124 participants randomized; 121 received intervention|124
7644258|NCT02184143|18824575|P1|STARTED|Overall Study|124 participants randomized; 118 participant received intervention|124
7644259|NCT02183792|18824589|P2|NOT COMPLETED|Overall Study||0
7644260|NCT02183792|18824590|P1|NOT COMPLETED|Overall Study||0
7644261|NCT02183792|18824589|P2|COMPLETED|Overall Study||15
7644262|NCT02183792|18824590|P1|COMPLETED|Overall Study||18
7644263|NCT02183792|18824589|P2|STARTED|Overall Study||15
7644264|NCT02183792|18824590|P1|STARTED|Overall Study||18
7644265|NCT02183675|18824604|P6|NOT COMPLETED|Treatment Period 3 (10 Days)||0
7644266|NCT02183675|18824605|P5|NOT COMPLETED|Treatment Period 3 (10 Days)||0
7644267|NCT02183675|18824606|P4|NOT COMPLETED|Treatment Period 3 (10 Days)||0
7644268|NCT02183675|18824607|P3|NOT COMPLETED|Treatment Period 3 (10 Days)||0
7644269|NCT02183675|18824608|P2|NOT COMPLETED|Treatment Period 3 (10 Days)||0
7644270|NCT02183675|18824609|P1|NOT COMPLETED|Treatment Period 3 (10 Days)||0
7644271|NCT02183675|18824604|P6|COMPLETED|Treatment Period 3 (10 Days)||4
7644272|NCT02183675|18824605|P5|COMPLETED|Treatment Period 3 (10 Days)||6
7644273|NCT02183675|18824606|P4|COMPLETED|Treatment Period 3 (10 Days)||6
7644274|NCT02183675|18824607|P3|COMPLETED|Treatment Period 3 (10 Days)||6
7644275|NCT02183675|18824608|P2|COMPLETED|Treatment Period 3 (10 Days)||6
7644276|NCT02183675|18824609|P1|COMPLETED|Treatment Period 3 (10 Days)||6
7644277|NCT02183675|18824604|P6|STARTED|Treatment Period 3 (10 Days)||4
7644278|NCT02183675|18824605|P5|STARTED|Treatment Period 3 (10 Days)||6
7644279|NCT02183675|18824606|P4|STARTED|Treatment Period 3 (10 Days)||6
7644280|NCT02183675|18824607|P3|STARTED|Treatment Period 3 (10 Days)||6
7644281|NCT02183675|18824608|P2|STARTED|Treatment Period 3 (10 Days)||6
7644282|NCT02183675|18824609|P1|STARTED|Treatment Period 3 (10 Days)||6
7644283|NCT02183675|18824604|P6|NOT COMPLETED|Treatment Period 2 (10 Days)||2
7644284|NCT02183675|18824605|P5|NOT COMPLETED|Treatment Period 2 (10 Days)||0
7644285|NCT02183675|18824606|P4|NOT COMPLETED|Treatment Period 2 (10 Days)||0
7644286|NCT02183675|18824607|P3|NOT COMPLETED|Treatment Period 2 (10 Days)||0
7644287|NCT02183675|18824608|P2|NOT COMPLETED|Treatment Period 2 (10 Days)||0
7644288|NCT02183675|18824609|P1|NOT COMPLETED|Treatment Period 2 (10 Days)||0
7644289|NCT02183675|18824604|P6|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4
7644290|NCT02183675|18824605|P5|COMPLETED|Treatment Period 2 (10 Days)||6
7644291|NCT02183675|18824606|P4|COMPLETED|Treatment Period 2 (10 Days)||6
7644292|NCT02183675|18824607|P3|COMPLETED|Treatment Period 2 (10 Days)||6
7644293|NCT02183675|18824608|P2|COMPLETED|Treatment Period 2 (10 Days)||6
7644294|NCT02183675|18824609|P1|COMPLETED|Treatment Period 2 (10 Days)||6
7644295|NCT02183675|18824604|P6|STARTED|Treatment Period 2 (10 Days)||6
7644296|NCT02183675|18824605|P5|STARTED|Treatment Period 2 (10 Days)||6
7644297|NCT02183675|18824606|P4|STARTED|Treatment Period 2 (10 Days)||6
7644298|NCT02183675|18824607|P3|STARTED|Treatment Period 2 (10 Days)||6
7644299|NCT02183675|18824608|P2|STARTED|Treatment Period 2 (10 Days)||6
7644300|NCT02183675|18824609|P1|STARTED|Treatment Period 2 (10 Days)||6
7644301|NCT02183675|18824604|P6|NOT COMPLETED|Treatment Period 1 (10 Days)||0
7644302|NCT02183675|18824605|P5|NOT COMPLETED|Treatment Period 1 (10 Days)||0
7644303|NCT02183675|18824606|P4|NOT COMPLETED|Treatment Period 1 (10 Days)||0
7644304|NCT02183675|18824607|P3|NOT COMPLETED|Treatment Period 1 (10 Days)||0
7644305|NCT02183675|18824608|P2|NOT COMPLETED|Treatment Period 1 (10 Days)||0
7644306|NCT02183675|18824609|P1|NOT COMPLETED|Treatment Period 1 (10 Days)||0
7644307|NCT02183675|18824604|P6|COMPLETED|Treatment Period 1 (10 Days)||6
7644308|NCT02183675|18824605|P5|COMPLETED|Treatment Period 1 (10 Days)||6
7644309|NCT02183675|18824606|P4|COMPLETED|Treatment Period 1 (10 Days)||6
7644310|NCT02183675|18824607|P3|COMPLETED|Treatment Period 1 (10 Days)||6
7644311|NCT02183675|18824608|P2|COMPLETED|Treatment Period 1 (10 Days)||6
7644312|NCT02183675|18824609|P1|COMPLETED|Treatment Period 1 (10 Days)||6
7644313|NCT02183675|18824604|P6|STARTED|Treatment Period 1 (10 Days)||6
7644314|NCT02183675|18824605|P5|STARTED|Treatment Period 1 (10 Days)||6
7644315|NCT02183675|18824606|P4|STARTED|Treatment Period 1 (10 Days)||6
7644316|NCT02183675|18824607|P3|STARTED|Treatment Period 1 (10 Days)||6
7644317|NCT02183675|18824608|P2|STARTED|Treatment Period 1 (10 Days)||6
7644318|NCT02183675|18824609|P1|STARTED|Treatment Period 1 (10 Days)||6
7644319|NCT02183519|18824633|P2|NOT COMPLETED|Overall Study||3
7644320|NCT02183519|18824634|P1|NOT COMPLETED|Overall Study||3
7644321|NCT02183519|18824633|P2|COMPLETED|Overall Study||13
7644322|NCT02183519|18824634|P1|COMPLETED|Overall Study||25
7644323|NCT02183519|18824633|P2|STARTED|Overall Study||16
7644324|NCT02183519|18824634|P1|STARTED|Overall Study||28
7644325|NCT02182999|18824642|P2|NOT COMPLETED|Overall Study||3
7644326|NCT02182999|18824643|P1|NOT COMPLETED|Overall Study||5
7644327|NCT02182999|18824642|P2|COMPLETED|Overall Study||22
7644328|NCT02182999|18824643|P1|COMPLETED|Overall Study||20
7644329|NCT02182999|18824642|P2|STARTED|Overall Study||25
7644330|NCT02182999|18824643|P1|STARTED|Overall Study||25
7644331|NCT02182973|18824659|P2|NOT COMPLETED|Overall Study||0
7644332|NCT02182973|18824660|P1|NOT COMPLETED|Overall Study||3
7644333|NCT02182973|18824659|P2|COMPLETED|Overall Study||9
7644334|NCT02182973|18824660|P1|COMPLETED|Overall Study||9
7644335|NCT02182973|18824659|P2|STARTED|Overall Study||9
7644336|NCT02182973|18824660|P1|STARTED|Overall Study||12
7644337|NCT02182895|18824672|P2|NOT COMPLETED|Overall Study||4
7644338|NCT02182895|18824673|P1|NOT COMPLETED|Overall Study||2
7644339|NCT02182895|18824672|P2|COMPLETED|Overall Study||33
7644340|NCT02182895|18824673|P1|COMPLETED|Overall Study||33
7644341|NCT02182895|18824672|P2|STARTED|Overall Study||37
7644342|NCT02182895|18824673|P1|STARTED|Overall Study||35
7644343|NCT02182843|18824693|P1|NOT COMPLETED|Overall Study||10
7644344|NCT02182843|18824693|P1|COMPLETED|Overall Study||71
7644345|NCT02182843|18824693|P1|STARTED|Overall Study||81
7644346|NCT02182830|18824700|P2|NOT COMPLETED|Overall Study||15
7644347|NCT02182830|18824701|P1|NOT COMPLETED|Overall Study||15
7644348|NCT02182830|18824700|P2|COMPLETED|Overall Study||68
7644349|NCT02182830|18824701|P1|COMPLETED|Overall Study||68
7644350|NCT02182830|18824700|P2|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|80
7644351|NCT02182830|18824701|P1|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|77
7644352|NCT02182830|18824700|P2|Randomised Set (RS)|Overall Study|From started, 1 patient from one site was removed|82
7644353|NCT02182830|18824701|P1|Randomised Set (RS)|Overall Study|From started, 2 duplicate patients and 2 patients from one site were removed|79
7644354|NCT02182830|18824700|P2|STARTED|Overall Study||83
7644355|NCT02182830|18824701|P1|STARTED|Overall Study||83
7644356|NCT02182804|18824727|P1|NOT COMPLETED|Overall Study||0
7644357|NCT02182804|18824727|P1|COMPLETED|Overall Study||44
7644358|NCT02182804|18824727|P1|STARTED|Overall Study||44
7644359|NCT02182492|18824733|P2|NOT COMPLETED|Overall Study||8
7644360|NCT02182492|18824734|P1|NOT COMPLETED|Overall Study||7
7644361|NCT02182492|18824733|P2|COMPLETED|Overall Study|CRSsNP: 29; Non-Eos CRSwNP: 28; Eos CRSwNP: 29|86
7644362|NCT02182492|18824734|P1|COMPLETED|Overall Study|CRSsNP: 27; Non-Eos CRSwNP: 31; Eos CRSwNP: 28|86
7644363|NCT02182492|18824733|P2|STARTED|Overall Study|CRSsNP: 30; Non-Eos CRSwNP: 32; Eos CRSwNP: 32|94
7644364|NCT02182492|18824734|P1|STARTED|Overall Study|CRSsNP: 28; Non-Eos CRSwNP: 34; Eos CRSwNP: 31|93
7644365|NCT02182440|18824746|P4|NOT COMPLETED|Overall Study||30
7644366|NCT02182440|18824747|P3|NOT COMPLETED|Overall Study||11
7644367|NCT02182440|18824748|P2|NOT COMPLETED|Overall Study||14
7644368|NCT02182440|18824749|P1|NOT COMPLETED|Overall Study||45
7644369|NCT02182440|18824746|P4|COMPLETED|Overall Study||81
7644370|NCT02182440|18824747|P3|COMPLETED|Overall Study||24
7644371|NCT02182440|18824748|P2|COMPLETED|Overall Study||25
7644372|NCT02182440|18824749|P1|COMPLETED|Overall Study||71
7644373|NCT02182440|18824746|P4|Safety Population|Overall Study||109
7644374|NCT02182440|18824747|P3|Safety Population|Overall Study||35
7644375|NCT02182440|18824748|P2|Safety Population|Overall Study||38
7644376|NCT02182440|18824749|P1|Safety Population|Overall Study||112
7644377|NCT02182440|18824746|P4|ITTinterim|Overall Study||29
7644378|NCT02182440|18824747|P3|ITTinterim|Overall Study||32
7644379|NCT02182440|18824748|P2|ITTinterim|Overall Study||31
7644380|NCT02182440|18824749|P1|ITTinterim|Overall Study||30
7644381|NCT02182440|18824746|P4|ITTcombined|Overall Study||111
7644382|NCT02182440|18824747|P3|ITTcombined|Overall Study||32
7644383|NCT02182440|18824748|P2|ITTcombined|Overall Study||31
7644384|NCT02182440|18824749|P1|ITTcombined|Overall Study||116
7644385|NCT02182440|18824746|P4|STARTED|Overall Study||111
7644386|NCT02182440|18824747|P3|STARTED|Overall Study||35
7644387|NCT02182440|18824748|P2|STARTED|Overall Study||39
7644388|NCT02182440|18824749|P1|STARTED|Overall Study||116
7644389|NCT02182115|18824781|P2|NOT COMPLETED|Overall Study||0
7644390|NCT02182115|18824782|P1|NOT COMPLETED|Overall Study||0
7644391|NCT02182115|18824781|P2|COMPLETED|Overall Study||57
7644392|NCT02182115|18824782|P1|COMPLETED|Overall Study||53
7644393|NCT02182115|18824781|P2|STARTED|Overall Study||57
7644394|NCT02182115|18824782|P1|STARTED|Overall Study||53
7644395|NCT02181842|18824788|P1|NOT COMPLETED|Overall Study||2
7644396|NCT02181842|18824788|P1|COMPLETED|Overall Study||244
7644397|NCT02181842|18824788|P1|STARTED|Overall Study||246
7644398|NCT02181816|18824805|P1|NOT COMPLETED|Overall Study||59
7644399|NCT02181816|18824805|P1|COMPLETED|Overall Study||1031
7644400|NCT02181816|18824805|P1|STARTED|Overall Study||1090
7644401|NCT02181803|18824820|P9|NOT COMPLETED|Overall Study||0
7644402|NCT02181803|18824821|P8|NOT COMPLETED|Overall Study||1
7644403|NCT02181803|18824822|P7|NOT COMPLETED|Overall Study||1
7644404|NCT02181803|18824823|P6|NOT COMPLETED|Overall Study||0
7644405|NCT02181803|18824824|P5|NOT COMPLETED|Overall Study||0
7644406|NCT02181803|18824825|P4|NOT COMPLETED|Overall Study||2
7644407|NCT02181803|18824826|P3|NOT COMPLETED|Overall Study||0
7644408|NCT02181803|18824827|P2|NOT COMPLETED|Overall Study||4
7644409|NCT02181803|18824828|P1|NOT COMPLETED|Overall Study||0
7644410|NCT02181803|18824820|P9|COMPLETED|Overall Study||2
7644411|NCT02181803|18824821|P8|COMPLETED|Overall Study||0
7644412|NCT02181803|18824822|P7|COMPLETED|Overall Study||8
7644413|NCT02181803|18824823|P6|COMPLETED|Overall Study||6
7644414|NCT02181803|18824824|P5|COMPLETED|Overall Study||6
7644415|NCT02181803|18824825|P4|COMPLETED|Overall Study||11
7644416|NCT02181803|18824826|P3|COMPLETED|Overall Study||4
7644417|NCT02181803|18824827|P2|COMPLETED|Overall Study||9
7644418|NCT02181803|18824828|P1|COMPLETED|Overall Study||1
7644419|NCT02181803|18824820|P9|STARTED|Overall Study||2
7644420|NCT02181803|18824821|P8|STARTED|Overall Study||1
7644421|NCT02181803|18824822|P7|STARTED|Overall Study||9
7644422|NCT02181803|18824823|P6|STARTED|Overall Study||6
7644423|NCT02181803|18824824|P5|STARTED|Overall Study||6
7644424|NCT02181803|18824825|P4|STARTED|Overall Study||13
7644425|NCT02181803|18824826|P3|STARTED|Overall Study||4
7644426|NCT02181803|18824827|P2|STARTED|Overall Study||13
7644427|NCT02181803|18824828|P1|STARTED|Overall Study||1
7644428|NCT02181790|18824979|P2|NOT COMPLETED|Overall Study||0
7644429|NCT02181790|18824980|P1|NOT COMPLETED|Overall Study||2
7644430|NCT02181790|18824979|P2|COMPLETED|Overall Study||0
7644431|NCT02181790|18824980|P1|COMPLETED|Overall Study||0
7644432|NCT02181790|18824979|P2|STARTED|Overall Study||0
7644433|NCT02181790|18824980|P1|STARTED|Overall Study||2
7644434|NCT02181738|18824992|P4|NOT COMPLETED|Overall Study||2
7644435|NCT02181738|18824993|P3|NOT COMPLETED|Overall Study||10
7644436|NCT02181738|18824994|P2|NOT COMPLETED|Overall Study||9
7644437|NCT02181738|18824995|P1|NOT COMPLETED|Overall Study||2
7644438|NCT02181738|18824992|P4|COMPLETED|Overall Study||49
7644439|NCT02181738|18824993|P3|COMPLETED|Overall Study||90
7644440|NCT02181738|18824994|P2|COMPLETED|Overall Study||71
7644441|NCT02181738|18824995|P1|COMPLETED|Overall Study||61
7644442|NCT02181738|18824992|P4|STARTED|Overall Study||51
7644443|NCT02181738|18824993|P3|STARTED|Overall Study||100
7644444|NCT02181738|18824994|P2|STARTED|Overall Study||80
7644445|NCT02181738|18824995|P1|STARTED|Overall Study||63
7644446|NCT02181673|18825036|P3|NOT COMPLETED|Week 24-Week 60||17
7644447|NCT02181673|18825037|P2|NOT COMPLETED|Week 24-Week 60||8
7644448|NCT02181673|18825038|P1|NOT COMPLETED|Week 24-Week 60||0
7644449|NCT02181673|18825036|P3|COMPLETED|Week 24-Week 60||213
7644450|NCT02181673|18825037|P2|COMPLETED|Week 24-Week 60||214
7644451|NCT02181673|18825038|P1|COMPLETED|Week 24-Week 60||0
7644452|NCT02181673|18825036|P3|Treated|Week 24-Week 60||230
7644453|NCT02181673|18825037|P2|Treated|Week 24-Week 60||220
7644454|NCT02181673|18825038|P1|Treated|Week 24-Week 60||0
7644455|NCT02181673|18825036|P3|STARTED|Week 24-Week 60||230
7644456|NCT02181673|18825037|P2|STARTED|Week 24-Week 60||222
7644457|NCT02181673|18825038|P1|STARTED|Week 24-Week 60||0
7644458|NCT02181673|18825036|P3|NOT COMPLETED|Up to Week 24||11
7644459|NCT02181673|18825037|P2|NOT COMPLETED|Up to Week 24||0
7644460|NCT02181673|18825038|P1|NOT COMPLETED|Up to Week 24||17
7644461|NCT02181673|18825036|P3|COMPLETED|Up to Week 24||230
7644462|NCT02181673|18825037|P2|COMPLETED|Up to Week 24||0
7644463|NCT02181673|18825038|P1|COMPLETED|Up to Week 24||222
7644464|NCT02181673|18825036|P3|Treated|Up to Week 24||240
7644465|NCT02181673|18825037|P2|Treated|Up to Week 24||0
7644466|NCT02181673|18825038|P1|Treated|Up to Week 24||239
7644467|NCT02181673|18825036|P3|STARTED|Up to Week 24||241
7644468|NCT02181673|18825037|P2|STARTED|Up to Week 24||0
7644469|NCT02181673|18825038|P1|STARTED|Up to Week 24||239
7644470|NCT02181634|18825065|P1|NOT COMPLETED|Overall Study||72
7644471|NCT02181634|18825065|P1|COMPLETED|Overall Study||2
7644472|NCT02181634|18825065|P1|Eligible and Treated|Overall Study||73
7644473|NCT02181634|18825065|P1|STARTED|Overall Study||74
7644474|NCT02181530|18825076|P1|NOT COMPLETED|Overall Study||0
7644475|NCT02181530|18825076|P1|COMPLETED|Overall Study||43
7644476|NCT02181530|18825076|P1|STARTED|Overall Study||43
7644477|NCT02181517|18825089|P3|NOT COMPLETED|Overall Study||0
7644478|NCT02181517|18825090|P2|NOT COMPLETED|Overall Study||0
7644479|NCT02181517|18825091|P1|NOT COMPLETED|Overall Study||0
7644480|NCT02181517|18825089|P3|COMPLETED|Overall Study||5
7644481|NCT02181517|18825090|P2|COMPLETED|Overall Study||10
7644482|NCT02181517|18825091|P1|COMPLETED|Overall Study||10
7644483|NCT02181517|18825089|P3|STARTED|Overall Study||5
7644484|NCT02181517|18825090|P2|STARTED|Overall Study||10
7644485|NCT02181517|18825091|P1|STARTED|Overall Study||10
7644486|NCT02181504|18825114|P3|NOT COMPLETED|Overall Study||1
7644487|NCT02181504|18825115|P2|NOT COMPLETED|Overall Study||1
7644488|NCT02181504|18825116|P1|NOT COMPLETED|Overall Study||1
7644489|NCT02181504|18825114|P3|COMPLETED|Overall Study||4
7644490|NCT02181504|18825115|P2|COMPLETED|Overall Study||9
7644491|NCT02181504|18825116|P1|COMPLETED|Overall Study||9
7644492|NCT02181504|18825114|P3|STARTED|Overall Study||5
7644493|NCT02181504|18825115|P2|STARTED|Overall Study||10
7644494|NCT02181504|18825116|P1|STARTED|Overall Study||10
7644495|NCT02181426|18825140|P4|NOT COMPLETED|Overall Study||0
7644496|NCT02181426|18825141|P3|NOT COMPLETED|Overall Study||0
7644497|NCT02181426|18825142|P2|NOT COMPLETED|Overall Study||0
7644498|NCT02181426|18825143|P1|NOT COMPLETED|Overall Study||0
7644499|NCT02181426|18825140|P4|COMPLETED|Overall Study||28
7644500|NCT02181426|18825141|P3|COMPLETED|Overall Study||28
7644501|NCT02181426|18825142|P2|COMPLETED|Overall Study||28
7644502|NCT02181426|18825143|P1|COMPLETED|Overall Study||28
7644503|NCT02181426|18825140|P4|STARTED|Overall Study||28
7644504|NCT02181426|18825141|P3|STARTED|Overall Study||28
7644505|NCT02181426|18825142|P2|STARTED|Overall Study||28
7644506|NCT02181426|18825143|P1|STARTED|Overall Study||28
7644507|NCT02181413|18825155|P2|NOT COMPLETED|Overall Study||197
7644508|NCT02181413|18825156|P1|NOT COMPLETED|Overall Study||152
7644509|NCT02181413|18825155|P2|COMPLETED|Overall Study||198
7644510|NCT02181413|18825156|P1|COMPLETED|Overall Study||109
7644511|NCT02181413|18825155|P2|Per Protocol (PP) Population|Overall Study||387
7644512|NCT02181413|18825156|P1|Per Protocol (PP) Population|Overall Study||256
7644513|NCT02181413|18825155|P2|Safety Population|Overall Study||394
7644514|NCT02181413|18825156|P1|Safety Population|Overall Study||259
7644515|NCT02181413|18825155|P2|Intent-to-Treat (ITT) Population|Overall Study||395
7644516|NCT02181413|18825156|P1|Intent-to-Treat (ITT) Population|Overall Study||261
7644517|NCT02181413|18825155|P2|STARTED|Overall Study||395
7644518|NCT02181413|18825156|P1|STARTED|Overall Study||261
7644519|NCT02181400|18825165|P3|NOT COMPLETED|Overall Study||0
7644520|NCT02181400|18825166|P2|NOT COMPLETED|Overall Study||0
7644521|NCT02181400|18825167|P1|NOT COMPLETED|Overall Study||0
7644522|NCT02181400|18825165|P3|COMPLETED|Overall Study||7
7644523|NCT02181400|18825166|P2|COMPLETED|Overall Study||7
7644524|NCT02181400|18825167|P1|COMPLETED|Overall Study||7
7644525|NCT02181400|18825165|P3|STARTED|Overall Study||7
7644526|NCT02181400|18825166|P2|STARTED|Overall Study||7
7644527|NCT02181400|18825167|P1|STARTED|Overall Study||7
7644528|NCT02181387|18825192|P2|NOT COMPLETED|Overall Study||4
7644529|NCT02181387|18825193|P1|NOT COMPLETED|Overall Study||2
7644530|NCT02181387|18825192|P2|COMPLETED|Overall Study||15
7644531|NCT02181387|18825193|P1|COMPLETED|Overall Study||12
7644532|NCT02181387|18825192|P2|STARTED|Overall Study||19
7644533|NCT02181387|18825193|P1|STARTED|Overall Study||14
7644534|NCT02181296|18825201|P2|NOT COMPLETED|Overall Study||6
7644535|NCT02181296|18825202|P1|NOT COMPLETED|Overall Study||7
7644536|NCT02181296|18825201|P2|COMPLETED|Overall Study||19
7644537|NCT02181296|18825202|P1|COMPLETED|Overall Study||18
7644538|NCT02181296|18825201|P2|STARTED|Overall Study||25
7644539|NCT02181296|18825202|P1|STARTED|Overall Study||25
7644540|NCT02181231|18825216|P2|NOT COMPLETED|Overall Study||0
7644541|NCT02181231|18825217|P1|NOT COMPLETED|Overall Study||2
7644542|NCT02181231|18825216|P2|COMPLETED|Overall Study||6
7644543|NCT02181231|18825217|P1|COMPLETED|Overall Study||10
7644544|NCT02181231|18825216|P2|STARTED|Overall Study||6
7644545|NCT02181231|18825217|P1|STARTED|Overall Study||12
7644546|NCT02181140|18825233|P1|NOT COMPLETED|Overall Study||0
7644547|NCT02181140|18825233|P1|COMPLETED|Overall Study||56
7644548|NCT02181140|18825233|P1|STARTED|Overall Study||56
7644549|NCT02181127|18825239|P1|NOT COMPLETED|Overall Study||0
7644550|NCT02181127|18825239|P1|COMPLETED|Overall Study||22
7644551|NCT02181127|18825239|P1|STARTED|Overall Study||22
7644552|NCT02181075|18825285|P2|NOT COMPLETED|Overall Study||0
7644553|NCT02181075|18825286|P1|NOT COMPLETED|Overall Study||0
7644554|NCT02181075|18825285|P2|COMPLETED|Overall Study||4
7644555|NCT02181075|18825286|P1|COMPLETED|Overall Study||6
7644556|NCT02181075|18825285|P2|STARTED|Overall Study||4
7644557|NCT02181075|18825286|P1|STARTED|Overall Study||6
7644558|NCT02180893|18825304|P2|NOT COMPLETED|Overall Study||7
7644559|NCT02180893|18825305|P1|NOT COMPLETED|Overall Study||3
7644560|NCT02180893|18825304|P2|COMPLETED|Overall Study||23
7644561|NCT02180893|18825305|P1|COMPLETED|Overall Study||27
7644562|NCT02180893|18825304|P2|STARTED|Overall Study||30
7644563|NCT02180893|18825305|P1|STARTED|Overall Study||30
7644564|NCT02180867|18825324|P7|NOT COMPLETED|Overall Study||5
7644565|NCT02180867|18825325|P6|NOT COMPLETED|Overall Study||3
7644566|NCT02180867|18825326|P5|NOT COMPLETED|Overall Study||27
7644567|NCT02180867|18825327|P4|NOT COMPLETED|Overall Study||26
7644568|NCT02180867|18825328|P3|NOT COMPLETED|Overall Study||4
7644569|NCT02180867|18825329|P2|NOT COMPLETED|Overall Study||11
7644570|NCT02180867|18825330|P1|NOT COMPLETED|Overall Study||6
7644571|NCT02180867|18825324|P7|COMPLETED|Overall Study||1
7644572|NCT02180867|18825325|P6|COMPLETED|Overall Study||3
7644573|NCT02180867|18825326|P5|COMPLETED|Overall Study||21
7644574|NCT02180867|18825327|P4|COMPLETED|Overall Study||23
7644575|NCT02180867|18825328|P3|COMPLETED|Overall Study||6
7644576|NCT02180867|18825329|P2|COMPLETED|Overall Study||0
7644577|NCT02180867|18825330|P1|COMPLETED|Overall Study||4
7644578|NCT02180867|18825324|P7|Adult Patients|Overall Study||6
7644579|NCT02180867|18825325|P6|Adult Patients|Overall Study||5
7644580|NCT02180867|18825326|P5|Adult Patients|Overall Study||29
7644581|NCT02180867|18825327|P4|Adult Patients|Overall Study||31
7644582|NCT02180867|18825328|P3|Adult Patients|Overall Study||7
7644583|NCT02180867|18825329|P2|Adult Patients|Overall Study||7
7644584|NCT02180867|18825330|P1|Adult Patients|Overall Study||4
7644585|NCT02180867|18825324|P7|Pediatric Patients|Overall Study||0
7644586|NCT02180867|18825325|P6|Pediatric Patients|Overall Study||1
7644587|NCT02180867|18825326|P5|Pediatric Patients|Overall Study||19
7644588|NCT02180867|18825327|P4|Pediatric Patients|Overall Study||18
7644589|NCT02180867|18825328|P3|Pediatric Patients|Overall Study||3
7644590|NCT02180867|18825329|P2|Pediatric Patients|Overall Study||4
7644591|NCT02180867|18825330|P1|Pediatric Patients|Overall Study||6
7644592|NCT02180867|18825324|P7|STARTED|Overall Study||6
7644593|NCT02180867|18825325|P6|STARTED|Overall Study||6
7644594|NCT02180867|18825326|P5|STARTED|Overall Study||48
7644595|NCT02180867|18825327|P4|STARTED|Overall Study||49
7644596|NCT02180867|18825328|P3|STARTED|Overall Study||10
7644597|NCT02180867|18825329|P2|STARTED|Overall Study||11
7644598|NCT02180867|18825330|P1|STARTED|Overall Study||10
7644599|NCT02180828|18825361|P2|NOT COMPLETED|Overall Study||7
7644600|NCT02180828|18825362|P1|NOT COMPLETED|Overall Study||5
7644601|NCT02180828|18825361|P2|COMPLETED|Overall Study||113
7644602|NCT02180828|18825362|P1|COMPLETED|Overall Study||115
7644603|NCT02180828|18825361|P2|STARTED|Overall Study||120
7644604|NCT02180828|18825362|P1|STARTED|Overall Study||120
7644605|NCT02180724|18825386|P2|NOT COMPLETED|Overall Study||14
7644606|NCT02180724|18825387|P1|NOT COMPLETED|Overall Study||92
7644607|NCT02180724|18825386|P2|COMPLETED|Overall Study||0
7644608|NCT02180724|18825387|P1|COMPLETED|Overall Study||0
7644609|NCT02180724|18825386|P2|Discontinued Treatment|Overall Study||7
7644610|NCT02180724|18825387|P1|Discontinued Treatment|Overall Study||23
7644611|NCT02180724|18825386|P2|Discontinued Study|Overall Study||3
7644612|NCT02180724|18825387|P1|Discontinued Study|Overall Study||14
7644613|NCT02180724|18825386|P2|Received Study Medication|Overall Study||14
7644614|NCT02180724|18825387|P1|Received Study Medication|Overall Study||92
7644615|NCT02180724|18825386|P2|Enrolled|Overall Study||14
7644616|NCT02180724|18825387|P1|Enrolled|Overall Study||92
7644617|NCT02180724|18825386|P2|STARTED|Overall Study||14
7644618|NCT02180724|18825387|P1|STARTED|Overall Study||92
7644619|NCT02180659|18825401|P2|NOT COMPLETED|Overall Study||5
7644620|NCT02180659|18825402|P1|NOT COMPLETED|Overall Study||6
7644621|NCT02180659|18825401|P2|COMPLETED|Overall Study||84
7644622|NCT02180659|18825402|P1|COMPLETED|Overall Study||81
7644623|NCT02180659|18825401|P2|STARTED|Overall Study|N=90 randomized, however N=89 received study medication|89
7644624|NCT02180659|18825402|P1|STARTED|Overall Study||87
7644625|NCT02180646|18825424|P2|NOT COMPLETED|Second Intervention (7 Days)||0
7644626|NCT02180646|18825425|P1|NOT COMPLETED|Second Intervention (7 Days)||0
7644627|NCT02180646|18825424|P2|COMPLETED|Second Intervention (7 Days)||6
7644628|NCT02180646|18825425|P1|COMPLETED|Second Intervention (7 Days)||6
7644629|NCT02180646|18825424|P2|STARTED|Second Intervention (7 Days)||6
7644630|NCT02180646|18825425|P1|STARTED|Second Intervention (7 Days)||6
7644631|NCT02180646|18825424|P2|NOT COMPLETED|Washout (7 Days)||0
7644632|NCT02180646|18825425|P1|NOT COMPLETED|Washout (7 Days)||0
7644633|NCT02180646|18825424|P2|COMPLETED|Washout (7 Days)||6
7644634|NCT02180646|18825425|P1|COMPLETED|Washout (7 Days)||6
7644635|NCT02180646|18825424|P2|STARTED|Washout (7 Days)||6
7644636|NCT02180646|18825425|P1|STARTED|Washout (7 Days)||6
7644637|NCT02180646|18825424|P2|NOT COMPLETED|First Intervention (7 Days)||0
7644638|NCT02180646|18825425|P1|NOT COMPLETED|First Intervention (7 Days)||0
7644639|NCT02180646|18825424|P2|COMPLETED|First Intervention (7 Days)||6
7644640|NCT02180646|18825425|P1|COMPLETED|First Intervention (7 Days)||6
7644641|NCT02180646|18825424|P2|STARTED|First Intervention (7 Days)||6
7644642|NCT02180646|18825425|P1|STARTED|First Intervention (7 Days)||6
7644643|NCT02180438|18825437|P1|NOT COMPLETED|Overall Study||1
7644644|NCT02180438|18825437|P1|COMPLETED|Overall Study||29
7644645|NCT02180438|18825437|P1|STARTED|Overall Study||30
7644646|NCT02180230|18825452|P1|NOT COMPLETED|Overall Study||7
7644647|NCT02180230|18825452|P1|COMPLETED|Overall Study||31
7644648|NCT02180230|18825452|P1|STARTED|Overall Study||38
7644649|NCT02180217|18825460|P3|NOT COMPLETED|Overall Study||32
7644650|NCT02180217|18825461|P2|NOT COMPLETED|Overall Study||8
7644651|NCT02180217|18825462|P1|NOT COMPLETED|Overall Study||2
7644652|NCT02180217|18825460|P3|COMPLETED|Overall Study||34
7644653|NCT02180217|18825461|P2|COMPLETED|Overall Study||27
7644654|NCT02180217|18825462|P1|COMPLETED|Overall Study||34
7644655|NCT02180217|18825460|P3|Discontinued Extension Phase|Overall Study||7
7644656|NCT02180217|18825461|P2|Discontinued Extension Phase|Overall Study||3
7644657|NCT02180217|18825462|P1|Discontinued Extension Phase|Overall Study||1
7644658|NCT02180217|18825460|P3|Completed W48, Entered Ext. Phase|Overall Study||41
7644659|NCT02180217|18825461|P2|Completed W48, Entered Ext. Phase|Overall Study||30
7644660|NCT02180217|18825462|P1|Completed W48, Entered Ext. Phase|Overall Study||35
7644661|NCT02180217|18825460|P3|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
7644662|NCT02180217|18825461|P2|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
7644663|NCT02180217|18825462|P1|Completed W48, Did Not Enter Ext. Phase|Overall Study||1
7644664|NCT02180217|18825460|P3|Completed Week 48 (Core Phase)|Overall Study||44
7644665|NCT02180217|18825461|P2|Completed Week 48 (Core Phase)|Overall Study||33
7644666|NCT02180217|18825462|P1|Completed Week 48 (Core Phase)|Overall Study||36
7644667|NCT02180217|18825460|P3|Discontinued Prior to W48 But After W26|Overall Study||1
7644668|NCT02180217|18825461|P2|Discontinued Prior to W48 But After W26|Overall Study||2
7644669|NCT02180217|18825462|P1|Discontinued Prior to W48 But After W26|Overall Study||0
7644670|NCT02180217|18825460|P3|Discont. at/Prior to W26 But After W12|Overall Study||12
7644671|NCT02180217|18825461|P2|Discont. at/Prior to W26 But After W12|Overall Study||0
7644672|NCT02180217|18825462|P1|Discont. at/Prior to W26 But After W12|Overall Study||0
7644673|NCT02180217|18825460|P3|Discontinued at/Prior to Week 12 (W12)|Overall Study||7
7644674|NCT02180217|18825461|P2|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
7644675|NCT02180217|18825462|P1|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
7644676|NCT02180217|18825460|P3|STARTED|Overall Study||66
7644677|NCT02180217|18825461|P2|STARTED|Overall Study||35
7644678|NCT02180217|18825462|P1|STARTED|Overall Study||36
7644679|NCT02180165|18825477|P4|NOT COMPLETED|Overall Study||6
7644680|NCT02180165|18825478|P3|NOT COMPLETED|Overall Study||29
7644681|NCT02180165|18825479|P2|NOT COMPLETED|Overall Study||1
7644682|NCT02180165|18825480|P1|NOT COMPLETED|Overall Study||11
7644683|NCT02180165|18825477|P4|COMPLETED|Overall Study||25
7644684|NCT02180165|18825478|P3|COMPLETED|Overall Study||34
7644685|NCT02180165|18825479|P2|COMPLETED|Overall Study||6
7644686|NCT02180165|18825480|P1|COMPLETED|Overall Study||4
7644687|NCT02180165|18825477|P4|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|27
7644688|NCT02180165|18825478|P3|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|57
7644689|NCT02180165|18825479|P2|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|7
7644690|NCT02180165|18825480|P1|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|15
7644691|NCT02180165|18825477|P4|Treated Participants|Overall Study||31
7644692|NCT02180165|18825478|P3|Treated Participants|Overall Study||62
7644693|NCT02180165|18825479|P2|Treated Participants|Overall Study||7
7644694|NCT02180165|18825480|P1|Treated Participants|Overall Study||15
7644695|NCT02180165|18825477|P4|STARTED|Overall Study||31
7644696|NCT02180165|18825478|P3|STARTED|Overall Study||63
7644697|NCT02180165|18825479|P2|STARTED|Overall Study||7
7644698|NCT02180165|18825480|P1|STARTED|Overall Study||15
7644699|NCT02180100|18825568|P2|NOT COMPLETED|Overall Study||4
7644700|NCT02180100|18825569|P1|NOT COMPLETED|Overall Study||12
7644701|NCT02180100|18825568|P2|COMPLETED|Overall Study||66
7644702|NCT02180100|18825569|P1|COMPLETED|Overall Study||58
7644703|NCT02180100|18825568|P2|STARTED|Overall Study||70
7644704|NCT02180100|18825569|P1|STARTED|Overall Study||70
7644705|NCT02180061|18825579|P2|NOT COMPLETED|Overall Study||8
7644706|NCT02180061|18825580|P1|NOT COMPLETED|Overall Study||25
7644707|NCT02180061|18825579|P2|COMPLETED|Overall Study||0
7644708|NCT02180061|18825580|P1|COMPLETED|Overall Study||9
7644709|NCT02180061|18825579|P2|STARTED|Overall Study||8
7644710|NCT02180061|18825580|P1|STARTED|Overall Study||34
7644711|NCT02179918|18825599|P5|NOT COMPLETED|Overall Study||8
7644712|NCT02179918|18825600|P4|NOT COMPLETED|Overall Study||3
7644713|NCT02179918|18825601|P3|NOT COMPLETED|Overall Study||2
7644714|NCT02179918|18825602|P2|NOT COMPLETED|Overall Study||3
7644715|NCT02179918|18825603|P1|NOT COMPLETED|Overall Study||4
7644716|NCT02179918|18825599|P5|COMPLETED|Overall Study||1
7644717|NCT02179918|18825600|P4|COMPLETED|Overall Study||0
7644718|NCT02179918|18825601|P3|COMPLETED|Overall Study||1
7644719|NCT02179918|18825602|P2|COMPLETED|Overall Study||0
7644720|NCT02179918|18825603|P1|COMPLETED|Overall Study||1
7644721|NCT02179918|18825599|P5|STARTED|Overall Study||9
7644722|NCT02179918|18825600|P4|STARTED|Overall Study||3
7644723|NCT02179918|18825601|P3|STARTED|Overall Study||3
7644724|NCT02179918|18825602|P2|STARTED|Overall Study||3
7644725|NCT02179918|18825603|P1|STARTED|Overall Study||5
7644726|NCT02179892|18825729|P2|NOT COMPLETED|Overall Study||0
7644727|NCT02179892|18825730|P1|NOT COMPLETED|Overall Study||0
7644728|NCT02179892|18825729|P2|COMPLETED|Overall Study||4
7644729|NCT02179892|18825730|P1|COMPLETED|Overall Study||5
7644730|NCT02179892|18825729|P2|STARTED|Overall Study||4
7644731|NCT02179892|18825730|P1|STARTED|Overall Study||5
7644732|NCT02179788|18825744|P2|NOT COMPLETED|Overall Study||0
7644733|NCT02179788|18825745|P1|NOT COMPLETED|Overall Study||0
7644734|NCT02179788|18825744|P2|COMPLETED|Overall Study||5
7644735|NCT02179788|18825745|P1|COMPLETED|Overall Study||10
7644736|NCT02179788|18825744|P2|STARTED|Overall Study||5
7644737|NCT02179788|18825745|P1|STARTED|Overall Study||10
7644738|NCT02179671|18825756|P5|NOT COMPLETED|Overall Study||13
7644739|NCT02179671|18825757|P4|NOT COMPLETED|Overall Study||13
7644740|NCT02179671|18825758|P3|NOT COMPLETED|Overall Study||1
7644741|NCT02179671|18825759|P2|NOT COMPLETED|Overall Study||1
7644742|NCT02179671|18825760|P1|NOT COMPLETED|Overall Study||1
7644743|NCT02179671|18825756|P5|COMPLETED|Overall Study||1
7644744|NCT02179671|18825757|P4|COMPLETED|Overall Study||1
7644745|NCT02179671|18825758|P3|COMPLETED|Overall Study||1
7644746|NCT02179671|18825759|P2|COMPLETED|Overall Study||0
7644747|NCT02179671|18825760|P1|COMPLETED|Overall Study||0
7644748|NCT02179671|18825756|P5|STARTED|Overall Study||14
7644749|NCT02179671|18825757|P4|STARTED|Overall Study||14
7644750|NCT02179671|18825758|P3|STARTED|Overall Study||2
7644751|NCT02179671|18825759|P2|STARTED|Overall Study||1
7644752|NCT02179671|18825760|P1|STARTED|Overall Study||1
7644753|NCT02179424|18825796|P4|NOT COMPLETED|Overall Study||0
7644754|NCT02179424|18825797|P3|NOT COMPLETED|Overall Study||0
7644755|NCT02179424|18825798|P2|NOT COMPLETED|Overall Study||0
7644756|NCT02179424|18825799|P1|NOT COMPLETED|Overall Study||0
7644757|NCT02179424|18825796|P4|COMPLETED|Overall Study||39
7644758|NCT02179424|18825797|P3|COMPLETED|Overall Study||516
7644759|NCT02179424|18825798|P2|COMPLETED|Overall Study||11
7644760|NCT02179424|18825799|P1|COMPLETED|Overall Study||76
7644761|NCT02179424|18825796|P4|STARTED|Overall Study||39
7644762|NCT02179424|18825797|P3|STARTED|Overall Study||516
7644763|NCT02179424|18825798|P2|STARTED|Overall Study||11
7644764|NCT02179424|18825799|P1|STARTED|Overall Study||76
7644765|NCT02179398|18825816|P2|NOT COMPLETED|Overall Study||4
7644766|NCT02179398|18825817|P1|NOT COMPLETED|Overall Study||3
7644767|NCT02179398|18825816|P2|COMPLETED|Overall Study||140
7644768|NCT02179398|18825817|P1|COMPLETED|Overall Study||131
7644769|NCT02179398|18825816|P2|STARTED|Overall Study||144
7644770|NCT02179398|18825817|P1|STARTED|Overall Study||134
7644771|NCT02179190|18825835|P1|NOT COMPLETED|Follow-Up Post Barrel VRD Implanted||9
7644772|NCT02179190|18825835|P1|COMPLETED|Follow-Up Post Barrel VRD Implanted||111
7644773|NCT02179190|18825835|P1|STARTED|Follow-Up Post Barrel VRD Implanted||120
7644774|NCT02179190|18825835|P1|NOT COMPLETED|Index Procedure With Barrel VRD Attempt||7
7644775|NCT02179190|18825835|P1|COMPLETED|Index Procedure With Barrel VRD Attempt||120
7644776|NCT02179190|18825835|P1|STARTED|Index Procedure With Barrel VRD Attempt||127
7644777|NCT02179190|18825835|P1|NOT COMPLETED|Enrollment||11
7644778|NCT02179190|18825835|P1|COMPLETED|Enrollment||127
7644779|NCT02179190|18825835|P1|STARTED|Enrollment||138
7644780|NCT02179177|18825848|P2|NOT COMPLETED|Overall Study||2
7644781|NCT02179177|18825849|P1|NOT COMPLETED|Overall Study||2
7644782|NCT02179177|18825848|P2|COMPLETED|Overall Study||6
7644783|NCT02179177|18825849|P1|COMPLETED|Overall Study||6
7644784|NCT02179177|18825848|P2|STARTED|Overall Study||8
7644785|NCT02179177|18825849|P1|STARTED|Overall Study||8
7644786|NCT02179047|18825863|P2|NOT COMPLETED|Overall Study||0
7644787|NCT02179047|18825864|P1|NOT COMPLETED|Overall Study||7
7644788|NCT02179047|18825863|P2|COMPLETED|Overall Study||20
7644789|NCT02179047|18825864|P1|COMPLETED|Overall Study||187
7644790|NCT02179047|18825863|P2|STARTED|Overall Study||20
7644791|NCT02179047|18825864|P1|STARTED|Overall Study||194
7644792|NCT02178995|18825889|P9|NOT COMPLETED|Open Label||0
7644793|NCT02178995|18825890|P8|NOT COMPLETED|Open Label||0
7644794|NCT02178995|18825891|P7|NOT COMPLETED|Open Label||0
7644795|NCT02178995|18825892|P6|NOT COMPLETED|Open Label||0
7644796|NCT02178995|18825893|P5|NOT COMPLETED|Open Label||0
7644797|NCT02178995|18825894|P4|NOT COMPLETED|Open Label||0
7644798|NCT02178995|18825895|P3|NOT COMPLETED|Open Label||0
7644799|NCT02178995|18825896|P2|NOT COMPLETED|Open Label||0
7644800|NCT02178995|18825897|P1|NOT COMPLETED|Open Label||2
7644801|NCT02178995|18825889|P9|COMPLETED|Open Label||0
7644802|NCT02178995|18825890|P8|COMPLETED|Open Label||0
7644803|NCT02178995|18825891|P7|COMPLETED|Open Label||0
7644804|NCT02178995|18825892|P6|COMPLETED|Open Label||0
7644805|NCT02178995|18825893|P5|COMPLETED|Open Label||0
7644806|NCT02178995|18825894|P4|COMPLETED|Open Label||0
7644807|NCT02178995|18825895|P3|COMPLETED|Open Label||0
7644808|NCT02178995|18825896|P2|COMPLETED|Open Label||14
7644809|NCT02178995|18825897|P1|COMPLETED|Open Label||28
7644810|NCT02178995|18825889|P9|STARTED|Open Label||0
7644811|NCT02178995|18825890|P8|STARTED|Open Label||0
7644812|NCT02178995|18825891|P7|STARTED|Open Label||0
7644813|NCT02178995|18825892|P6|STARTED|Open Label||0
7644814|NCT02178995|18825893|P5|STARTED|Open Label||0
7644815|NCT02178995|18825894|P4|STARTED|Open Label||0
7644816|NCT02178995|18825895|P3|STARTED|Open Label||0
7644817|NCT02178995|18825896|P2|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14
7644818|NCT02178995|18825897|P1|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30
7644819|NCT02178995|18825889|P9|NOT COMPLETED|Double Blind||1
7644820|NCT02178995|18825890|P8|NOT COMPLETED|Double Blind||2
7644821|NCT02178995|18825891|P7|NOT COMPLETED|Double Blind||0
7644822|NCT02178995|18825892|P6|NOT COMPLETED|Double Blind||1
7644823|NCT02178995|18825893|P5|NOT COMPLETED|Double Blind||0
7644824|NCT02178995|18825894|P4|NOT COMPLETED|Double Blind||0
7644825|NCT02178995|18825895|P3|NOT COMPLETED|Double Blind||0
7644826|NCT02178995|18825896|P2|NOT COMPLETED|Double Blind||1
7644827|NCT02178995|18825897|P1|NOT COMPLETED|Double Blind||0
7644828|NCT02178995|18825889|P9|COMPLETED|Double Blind||0
7644829|NCT02178995|18825890|P8|COMPLETED|Double Blind||4
7644830|NCT02178995|18825891|P7|COMPLETED|Double Blind||5
7644831|NCT02178995|18825892|P6|COMPLETED|Double Blind||5
7644832|NCT02178995|18825893|P5|COMPLETED|Double Blind||6
7644833|NCT02178995|18825894|P4|COMPLETED|Double Blind||6
7644834|NCT02178995|18825895|P3|COMPLETED|Double Blind||5
7644835|NCT02178995|18825896|P2|COMPLETED|Double Blind||15
7644836|NCT02178995|18825897|P1|COMPLETED|Double Blind||0
7644837|NCT02178995|18825889|P9|STARTED|Double Blind||1
7644838|NCT02178995|18825890|P8|STARTED|Double Blind||6
7644839|NCT02178995|18825891|P7|STARTED|Double Blind||5
7644840|NCT02178995|18825892|P6|STARTED|Double Blind||6
7644841|NCT02178995|18825893|P5|STARTED|Double Blind||6
7644842|NCT02178995|18825894|P4|STARTED|Double Blind||6
7644843|NCT02178995|18825895|P3|STARTED|Double Blind||5
7644844|NCT02178995|18825896|P2|STARTED|Double Blind||16
7644845|NCT02178995|18825897|P1|STARTED|Double Blind||0
7644846|NCT02178800|18825970|P2|NOT COMPLETED|Overall Study||6
7644847|NCT02178800|18825971|P1|NOT COMPLETED|Overall Study||20
7644848|NCT02178800|18825970|P2|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|42
7644849|NCT02178800|18825971|P1|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|131
7644850|NCT02178800|18825970|P2|STARTED|Overall Study||48
7644851|NCT02178800|18825971|P1|STARTED|Overall Study||151
7644852|NCT02178787|18826005|P2|NOT COMPLETED|Overall Study||9
7644853|NCT02178787|18826006|P1|NOT COMPLETED|Overall Study||5
7644854|NCT02178787|18826005|P2|COMPLETED|Overall Study||30
7644855|NCT02178787|18826006|P1|COMPLETED|Overall Study||30
7644856|NCT02178787|18826005|P2|STARTED|Overall Study||39
7644857|NCT02178787|18826006|P1|STARTED|Overall Study||35
7644858|NCT02178722|18826019|P5|NOT COMPLETED|Overall Study||382
7644859|NCT02178722|18826020|P4|NOT COMPLETED|Overall Study||20
7644860|NCT02178722|18826021|P3|NOT COMPLETED|Overall Study||18
7644861|NCT02178722|18826022|P2|NOT COMPLETED|Overall Study||20
7644862|NCT02178722|18826023|P1|NOT COMPLETED|Overall Study||4
7644863|NCT02178722|18826019|P5|COMPLETED|Overall Study||0
7644864|NCT02178722|18826020|P4|COMPLETED|Overall Study||0
7644865|NCT02178722|18826021|P3|COMPLETED|Overall Study||0
7644866|NCT02178722|18826022|P2|COMPLETED|Overall Study||0
7644867|NCT02178722|18826023|P1|COMPLETED|Overall Study||0
7644868|NCT02178722|18826019|P5|STARTED|Overall Study||382
7644869|NCT02178722|18826020|P4|STARTED|Overall Study||20
7644870|NCT02178722|18826021|P3|STARTED|Overall Study||18
7644871|NCT02178722|18826022|P2|STARTED|Overall Study||20
7644872|NCT02178722|18826023|P1|STARTED|Overall Study||4
7644873|NCT02178709|18826035|P1|NOT COMPLETED|Overall Study||16
7644874|NCT02178709|18826035|P1|COMPLETED|Overall Study||32
7644875|NCT02178709|18826035|P1|STARTED|Overall Study||48
7644876|NCT02178696|18826046|P2|NOT COMPLETED|Open-label Antidepressant||7
7644877|NCT02178696|18826047|P1|NOT COMPLETED|Open-label Antidepressant||6
7644878|NCT02178696|18826046|P2|COMPLETED|Open-label Antidepressant||13
7644879|NCT02178696|18826047|P1|COMPLETED|Open-label Antidepressant||14
7644880|NCT02178696|18826046|P2|STARTED|Open-label Antidepressant||20
7644881|NCT02178696|18826047|P1|STARTED|Open-label Antidepressant||20
7644882|NCT02178696|18826046|P2|NOT COMPLETED|Second Assignment After Crossover||0
7644883|NCT02178696|18826047|P1|NOT COMPLETED|Second Assignment After Crossover||0
7644884|NCT02178696|18826046|P2|COMPLETED|Second Assignment After Crossover||20
7644885|NCT02178696|18826047|P1|COMPLETED|Second Assignment After Crossover||20
7644886|NCT02178696|18826046|P2|STARTED|Second Assignment After Crossover||20
7644887|NCT02178696|18826047|P1|STARTED|Second Assignment After Crossover||20
7644888|NCT02178696|18826046|P2|NOT COMPLETED|First Assignment and Washout||0
7644889|NCT02178696|18826047|P1|NOT COMPLETED|First Assignment and Washout||0
7644890|NCT02178696|18826046|P2|COMPLETED|First Assignment and Washout||20
7644891|NCT02178696|18826047|P1|COMPLETED|First Assignment and Washout||20
7644892|NCT02178696|18826046|P2|STARTED|First Assignment and Washout||20
7644893|NCT02178696|18826047|P1|STARTED|First Assignment and Washout||20
7644894|NCT02178592|18826062|P2|NOT COMPLETED|Overall Study||9
7644895|NCT02178592|18826063|P1|NOT COMPLETED|Overall Study||19
7644896|NCT02178592|18826062|P2|COMPLETED|Overall Study||35
7644897|NCT02178592|18826063|P1|COMPLETED|Overall Study||50
7644898|NCT02178592|18826062|P2|STARTED|Overall Study||44
7644899|NCT02178592|18826063|P1|STARTED|Overall Study||69
7644900|NCT02178553|18826091|P2|NOT COMPLETED|Overall Study||10
7644901|NCT02178553|18826092|P1|NOT COMPLETED|Overall Study||8
7644902|NCT02178553|18826091|P2|COMPLETED|Overall Study||39
7644903|NCT02178553|18826092|P1|COMPLETED|Overall Study||45
7644904|NCT02178553|18826091|P2|STARTED|Overall Study||49
7644905|NCT02178553|18826092|P1|STARTED|Overall Study||53
7644906|NCT02178540|18826104|P1|NOT COMPLETED|Overall Study||0
7644907|NCT02178540|18826104|P1|COMPLETED|Overall Study||45
7644908|NCT02178540|18826104|P1|STARTED|Overall Study||45
7644909|NCT02178475|18826111|P1|NOT COMPLETED|Overall Study||129
7644910|NCT02178475|18826111|P1|COMPLETED|Overall Study||814
7644911|NCT02178475|18826111|P1|Primary Analysis Set|Overall Study|All enrolled participants who met eligibility criteria|844
7644912|NCT02178475|18826111|P1|STARTED|Overall Study||943
7644913|NCT02178358|18826134|P3|NOT COMPLETED|Overall Study||4
7644914|NCT02178358|18826135|P2|NOT COMPLETED|Overall Study||3
7644915|NCT02178358|18826136|P1|NOT COMPLETED|Overall Study||0
7644916|NCT02178358|18826134|P3|COMPLETED|Overall Study||34
7644917|NCT02178358|18826135|P2|COMPLETED|Overall Study||71
7644918|NCT02178358|18826136|P1|COMPLETED|Overall Study||20
7644919|NCT02178358|18826134|P3|Received at Least 1 Dose of Study Drug|Overall Study||38
7644920|NCT02178358|18826135|P2|Received at Least 1 Dose of Study Drug|Overall Study||74
7644921|NCT02178358|18826136|P1|Received at Least 1 Dose of Study Drug|Overall Study||20
7644922|NCT02178358|18826134|P3|STARTED|Overall Study||38
7644923|NCT02178358|18826135|P2|STARTED|Overall Study||74
7644924|NCT02178358|18826136|P1|STARTED|Overall Study||20
7644925|NCT02178241|18826161|P1|NOT COMPLETED|Overall Study||0
7644926|NCT02178241|18826161|P1|COMPLETED|Overall Study||24
7644927|NCT02178241|18826161|P1|STARTED|Overall Study||24
7644928|NCT02178059|18826168|P2|NOT COMPLETED|Second Intervention||0
7644929|NCT02178059|18826169|P1|NOT COMPLETED|Second Intervention||0
7644930|NCT02178059|18826168|P2|COMPLETED|Second Intervention||17
7644931|NCT02178059|18826169|P1|COMPLETED|Second Intervention||16
7644932|NCT02178059|18826168|P2|STARTED|Second Intervention||17
7644933|NCT02178059|18826169|P1|STARTED|Second Intervention||16
7644934|NCT02178059|18826168|P2|NOT COMPLETED|Washout||0
7644935|NCT02178059|18826169|P1|NOT COMPLETED|Washout||1
7644936|NCT02178059|18826168|P2|COMPLETED|Washout||17
7644937|NCT02178059|18826169|P1|COMPLETED|Washout||16
7644938|NCT02178059|18826168|P2|STARTED|Washout||17
7644939|NCT02178059|18826169|P1|STARTED|Washout||17
7644940|NCT02178059|18826168|P2|NOT COMPLETED|First Intervention||0
7644941|NCT02178059|18826169|P1|NOT COMPLETED|First Intervention||0
7644942|NCT02178059|18826168|P2|COMPLETED|First Intervention||17
7644943|NCT02178059|18826169|P1|COMPLETED|First Intervention||17
7644944|NCT02178059|18826168|P2|STARTED|First Intervention||17
7644945|NCT02178059|18826169|P1|STARTED|First Intervention||17
7644946|NCT02177942|18826187|P2|NOT COMPLETED|Overall Study||88
7644947|NCT02177942|18826188|P1|NOT COMPLETED|Overall Study||77
7644948|NCT02177942|18826187|P2|COMPLETED|Overall Study||178
7644949|NCT02177942|18826188|P1|COMPLETED|Overall Study||185
7644950|NCT02177942|18826187|P2|STARTED|Overall Study||266
7644951|NCT02177942|18826188|P1|STARTED|Overall Study||262
7644952|NCT02177812|18826219|P9|NOT COMPLETED|Part 2 (Up to 14 Months)||0
7644953|NCT02177812|18826220|P8|NOT COMPLETED|Part 2 (Up to 14 Months)||0
7644954|NCT02177812|18826221|P7|NOT COMPLETED|Part 2 (Up to 14 Months)||0
7644955|NCT02177812|18826222|P6|NOT COMPLETED|Part 2 (Up to 14 Months)||0
7644956|NCT02177812|18826223|P5|NOT COMPLETED|Part 2 (Up to 14 Months)||0
7644957|NCT02177812|18826224|P4|NOT COMPLETED|Part 2 (Up to 14 Months)||0
7644958|NCT02177812|18826225|P3|NOT COMPLETED|Part 2 (Up to 14 Months)||0
7644959|NCT02177812|18826226|P2|NOT COMPLETED|Part 2 (Up to 14 Months)||0
7644960|NCT02177812|18826227|P1|NOT COMPLETED|Part 2 (Up to 14 Months)||0
7644961|NCT02177812|18826219|P9|COMPLETED|Part 2 (Up to 14 Months)||0
7644962|NCT02177812|18826220|P8|COMPLETED|Part 2 (Up to 14 Months)||0
7644963|NCT02177812|18826221|P7|COMPLETED|Part 2 (Up to 14 Months)||0
7644964|NCT02177812|18826222|P6|COMPLETED|Part 2 (Up to 14 Months)||0
7644965|NCT02177812|18826223|P5|COMPLETED|Part 2 (Up to 14 Months)||0
7644966|NCT02177812|18826224|P4|COMPLETED|Part 2 (Up to 14 Months)||0
7644967|NCT02177812|18826225|P3|COMPLETED|Part 2 (Up to 14 Months)||0
7644968|NCT02177812|18826226|P2|COMPLETED|Part 2 (Up to 14 Months)||0
7644969|NCT02177812|18826227|P1|COMPLETED|Part 2 (Up to 14 Months)||0
7644970|NCT02177812|18826219|P9|STARTED|Part 2 (Up to 14 Months)||0
7644971|NCT02177812|18826220|P8|STARTED|Part 2 (Up to 14 Months)||0
7644972|NCT02177812|18826221|P7|STARTED|Part 2 (Up to 14 Months)||0
7644973|NCT02177812|18826222|P6|STARTED|Part 2 (Up to 14 Months)||0
7644974|NCT02177812|18826223|P5|STARTED|Part 2 (Up to 14 Months)||0
7644975|NCT02177812|18826224|P4|STARTED|Part 2 (Up to 14 Months)||0
7644976|NCT02177812|18826225|P3|STARTED|Part 2 (Up to 14 Months)||0
7644977|NCT02177812|18826226|P2|STARTED|Part 2 (Up to 14 Months)||0
7644978|NCT02177812|18826227|P1|STARTED|Part 2 (Up to 14 Months)||0
7644979|NCT02177812|18826219|P9|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
7644980|NCT02177812|18826220|P8|NOT COMPLETED|Part 1 (Median of 4 Weeks)||2
7644981|NCT02177812|18826221|P7|NOT COMPLETED|Part 1 (Median of 4 Weeks)||9
7644982|NCT02177812|18826222|P6|NOT COMPLETED|Part 1 (Median of 4 Weeks)||3
7644983|NCT02177812|18826223|P5|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
7644984|NCT02177812|18826224|P4|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
7644985|NCT02177812|18826225|P3|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
7644986|NCT02177812|18826226|P2|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
7644987|NCT02177812|18826227|P1|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
7644988|NCT02177812|18826219|P9|COMPLETED|Part 1 (Median of 4 Weeks)||0
7644989|NCT02177812|18826220|P8|COMPLETED|Part 1 (Median of 4 Weeks)||4
7644990|NCT02177812|18826221|P7|COMPLETED|Part 1 (Median of 4 Weeks)||1
7644991|NCT02177812|18826222|P6|COMPLETED|Part 1 (Median of 4 Weeks)||1
7644992|NCT02177812|18826223|P5|COMPLETED|Part 1 (Median of 4 Weeks)||5
7644993|NCT02177812|18826224|P4|COMPLETED|Part 1 (Median of 4 Weeks)||4
7644994|NCT02177812|18826225|P3|COMPLETED|Part 1 (Median of 4 Weeks)||7
7644995|NCT02177812|18826226|P2|COMPLETED|Part 1 (Median of 4 Weeks)||2
7644996|NCT02177812|18826227|P1|COMPLETED|Part 1 (Median of 4 Weeks)||1
7644997|NCT02177812|18826219|P9|STARTED|Part 1 (Median of 4 Weeks)||0
7644998|NCT02177812|18826220|P8|STARTED|Part 1 (Median of 4 Weeks)||6
7644999|NCT02177812|18826221|P7|STARTED|Part 1 (Median of 4 Weeks)||10
7645000|NCT02177812|18826222|P6|STARTED|Part 1 (Median of 4 Weeks)||4
7645001|NCT02177812|18826223|P5|STARTED|Part 1 (Median of 4 Weeks)||6
7645002|NCT02177812|18826224|P4|STARTED|Part 1 (Median of 4 Weeks)||5
7645003|NCT02177812|18826225|P3|STARTED|Part 1 (Median of 4 Weeks)||7
7645004|NCT02177812|18826226|P2|STARTED|Part 1 (Median of 4 Weeks)||2
7645005|NCT02177812|18826227|P1|STARTED|Part 1 (Median of 4 Weeks)||1
7645006|NCT02177786|18826444|P4|NOT COMPLETED|Overall Study||13
7645007|NCT02177786|18826445|P3|NOT COMPLETED|Overall Study||18
7645008|NCT02177786|18826446|P2|NOT COMPLETED|Overall Study||14
7645009|NCT02177786|18826447|P1|NOT COMPLETED|Overall Study||6
7645010|NCT02177786|18826444|P4|COMPLETED|Overall Study||72
7645011|NCT02177786|18826445|P3|COMPLETED|Overall Study||66
7645012|NCT02177786|18826446|P2|COMPLETED|Overall Study||70
7645013|NCT02177786|18826447|P1|COMPLETED|Overall Study||75
7645014|NCT02177786|18826444|P4|Randomized and Treated|Overall Study||85
7645015|NCT02177786|18826445|P3|Randomized and Treated|Overall Study||83
7645016|NCT02177786|18826446|P2|Randomized and Treated|Overall Study||84
7645017|NCT02177786|18826447|P1|Randomized and Treated|Overall Study||81
7645018|NCT02177786|18826444|P4|STARTED|Overall Study||85
7645019|NCT02177786|18826445|P3|STARTED|Overall Study||84
7645020|NCT02177786|18826446|P2|STARTED|Overall Study||84
7645021|NCT02177786|18826447|P1|STARTED|Overall Study||81
7645022|NCT02177773|18826461|P1|NOT COMPLETED|Overall Study||0
7645023|NCT02177773|18826461|P1|COMPLETED|Overall Study||300
7645024|NCT02177773|18826461|P1|STARTED|Overall Study||300
7645025|NCT02177266|18826470|P2|NOT COMPLETED|Overall Study||1
7645026|NCT02177266|18826471|P1|NOT COMPLETED|Overall Study||1
7645027|NCT02177266|18826470|P2|COMPLETED|Overall Study||0
7645028|NCT02177266|18826471|P1|COMPLETED|Overall Study||0
7645029|NCT02177266|18826470|P2|STARTED|Overall Study||1
7645030|NCT02177266|18826471|P1|STARTED|Overall Study||1
7645031|NCT02177201|18826483|P2|NOT COMPLETED|Overall Study||3
7645032|NCT02177201|18826484|P1|NOT COMPLETED|Overall Study||3
7645033|NCT02177201|18826483|P2|COMPLETED|Overall Study||77
7645034|NCT02177201|18826484|P1|COMPLETED|Overall Study||77
7645035|NCT02177201|18826483|P2|STARTED|Overall Study||80
7645036|NCT02177201|18826484|P1|STARTED|Overall Study||80
7645037|NCT02177136|18826493|P3|NOT COMPLETED|Overall Study||4
7645038|NCT02177136|18826494|P2|NOT COMPLETED|Overall Study||5
7645039|NCT02177136|18826495|P1|NOT COMPLETED|Overall Study||6
7645040|NCT02177136|18826493|P3|COMPLETED|Overall Study||21
7645041|NCT02177136|18826494|P2|COMPLETED|Overall Study||21
7645042|NCT02177136|18826495|P1|COMPLETED|Overall Study||19
7645043|NCT02177136|18826493|P3|STARTED|Overall Study||25
7645044|NCT02177136|18826494|P2|STARTED|Overall Study||26
7645045|NCT02177136|18826495|P1|STARTED|Overall Study||25
7645046|NCT02177032|18826528|P4|NOT COMPLETED|Overall Study||0
7645047|NCT02177032|18826529|P3|NOT COMPLETED|Overall Study||3
7645048|NCT02177032|18826530|P2|NOT COMPLETED|Overall Study||2
7645049|NCT02177032|18826531|P1|NOT COMPLETED|Overall Study||5
7645050|NCT02177032|18826528|P4|COMPLETED|Overall Study||88
7645051|NCT02177032|18826529|P3|COMPLETED|Overall Study||351
7645052|NCT02177032|18826530|P2|COMPLETED|Overall Study||86
7645053|NCT02177032|18826531|P1|COMPLETED|Overall Study||350
7645054|NCT02177032|18826528|P4|STARTED|Overall Study||88
7645055|NCT02177032|18826529|P3|STARTED|Overall Study||354
7645056|NCT02177032|18826530|P2|STARTED|Overall Study||88
7645057|NCT02177032|18826531|P1|STARTED|Overall Study||355
7645058|NCT02176928|18826567|P2|NOT COMPLETED|Overall Study||4
7645059|NCT02176928|18826568|P1|NOT COMPLETED|Overall Study||2
7645060|NCT02176928|18826567|P2|COMPLETED|Overall Study||17
7645061|NCT02176928|18826568|P1|COMPLETED|Overall Study||19
7645062|NCT02176928|18826567|P2|STARTED|Overall Study||21
7645063|NCT02176928|18826568|P1|STARTED|Overall Study||21
7645064|NCT02176837|18826574|P1|NOT COMPLETED|Overall Study||6
7645065|NCT02176837|18826574|P1|COMPLETED|Overall Study||0
7645066|NCT02176837|18826574|P1|STARTED|Overall Study||6
7645067|NCT02176655|18826578|P1|NOT COMPLETED|Overall Study||6
7645068|NCT02176655|18826578|P1|COMPLETED|Overall Study||25
7645069|NCT02176655|18826578|P1|STARTED|Overall Study||31
7645070|NCT02176642|18826601|P2|NOT COMPLETED|Overall Study||1
7645071|NCT02176642|18826602|P1|NOT COMPLETED|Overall Study||0
7645072|NCT02176642|18826601|P2|COMPLETED|Overall Study||16
7645073|NCT02176642|18826602|P1|COMPLETED|Overall Study||18
7645074|NCT02176642|18826601|P2|STARTED|Overall Study||17
7645075|NCT02176642|18826602|P1|STARTED|Overall Study||18
7645076|NCT02176525|18826632|P8|NOT COMPLETED|Overall Study||0
7645077|NCT02176525|18826633|P7|NOT COMPLETED|Overall Study||1
7645078|NCT02176525|18826634|P6|NOT COMPLETED|Overall Study||1
7645079|NCT02176525|18826635|P5|NOT COMPLETED|Overall Study||1
7645080|NCT02176525|18826636|P4|NOT COMPLETED|Overall Study||1
7645081|NCT02176525|18826637|P3|NOT COMPLETED|Overall Study||0
7645082|NCT02176525|18826638|P2|NOT COMPLETED|Overall Study||0
7645083|NCT02176525|18826639|P1|NOT COMPLETED|Overall Study||1
7645084|NCT02176525|18826632|P8|COMPLETED|Overall Study||10
7645085|NCT02176525|18826633|P7|COMPLETED|Overall Study||8
7645086|NCT02176525|18826634|P6|COMPLETED|Overall Study||5
7645087|NCT02176525|18826635|P5|COMPLETED|Overall Study||7
7645088|NCT02176525|18826636|P4|COMPLETED|Overall Study||8
7645089|NCT02176525|18826637|P3|COMPLETED|Overall Study||9
7645090|NCT02176525|18826638|P2|COMPLETED|Overall Study||9
7645091|NCT02176525|18826639|P1|COMPLETED|Overall Study||14
7645092|NCT02176525|18826632|P8|STARTED|Overall Study||10
7645093|NCT02176525|18826633|P7|STARTED|Overall Study||9
7645094|NCT02176525|18826634|P6|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6
7645095|NCT02176525|18826635|P5|STARTED|Overall Study||8
7645096|NCT02176525|18826636|P4|STARTED|Overall Study||9
7645097|NCT02176525|18826637|P3|STARTED|Overall Study||9
7645098|NCT02176525|18826638|P2|STARTED|Overall Study||9
7645099|NCT02176525|18826639|P1|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15
7645100|NCT02176486|18826819|P3|NOT COMPLETED|Overall Study||0
7645101|NCT02176486|18826820|P2|NOT COMPLETED|Overall Study||0
7645102|NCT02176486|18826821|P1|NOT COMPLETED|Overall Study||0
7645103|NCT02176486|18826819|P3|COMPLETED|Overall Study||4
7645104|NCT02176486|18826820|P2|COMPLETED|Overall Study||5
7645105|NCT02176486|18826821|P1|COMPLETED|Overall Study||3
7645106|NCT02176486|18826819|P3|STARTED|Overall Study||4
7645107|NCT02176486|18826820|P2|STARTED|Overall Study||5
7645108|NCT02176486|18826821|P1|STARTED|Overall Study||3
7645109|NCT02176421|18826855|P1|NOT COMPLETED|Overall Study||5
7645110|NCT02176421|18826855|P1|COMPLETED|Overall Study||75
7645111|NCT02176421|18826855|P1|STARTED|Overall Study||80
7645112|NCT02176408|18826866|P2|NOT COMPLETED|Overall Study||4
7645113|NCT02176408|18826867|P1|NOT COMPLETED|Overall Study||6
7645114|NCT02176408|18826866|P2|COMPLETED|Overall Study||12
7645115|NCT02176408|18826867|P1|COMPLETED|Overall Study||9
7645116|NCT02176408|18826866|P2|STARTED|Overall Study||16
7645117|NCT02176408|18826867|P1|STARTED|Overall Study||15
7645118|NCT02176356|18826887|P1|NOT COMPLETED|Overall Study||23
7645119|NCT02176356|18826887|P1|COMPLETED|Overall Study||93
7645120|NCT02176356|18826887|P1|Eligible and Received Treatment|Overall Study||100
7645121|NCT02176356|18826887|P1|STARTED|Overall Study||116
7645122|NCT02176343|18826904|P1|NOT COMPLETED|Overall Study||0
7645123|NCT02176343|18826904|P1|COMPLETED|Overall Study||31
7645124|NCT02176343|18826904|P1|STARTED|Overall Study||31
7645125|NCT02176291|18826917|P2|NOT COMPLETED|Overall Study||0
7645126|NCT02176291|18826918|P1|NOT COMPLETED|Overall Study||5
7645127|NCT02176291|18826917|P2|COMPLETED|Overall Study||11
7645128|NCT02176291|18826918|P1|COMPLETED|Overall Study||15
7645129|NCT02176291|18826917|P2|STARTED|Overall Study||11
7645130|NCT02176291|18826918|P1|STARTED|Overall Study||20
7645131|NCT02176226|18826926|P1|NOT COMPLETED|Overall Study||9
7645132|NCT02176226|18826926|P1|COMPLETED|Overall Study||96
7645133|NCT02176226|18826926|P1|STARTED|Overall Study||105
7645134|NCT02176083|18826934|P2|NOT COMPLETED|Overall Study||0
7645135|NCT02176083|18826935|P1|NOT COMPLETED|Overall Study||0
7645136|NCT02176083|18826934|P2|COMPLETED|Overall Study||27
7645137|NCT02176083|18826935|P1|COMPLETED|Overall Study||11
7645138|NCT02176083|18826934|P2|STARTED|Overall Study||27
7645139|NCT02176083|18826935|P1|STARTED|Overall Study||11
7645140|NCT02176031|18826941|P1|NOT COMPLETED|Overall Study||12
7645141|NCT02176031|18826941|P1|COMPLETED|Overall Study||9
7645142|NCT02176031|18826941|P1|STARTED|Overall Study||21
7645143|NCT02176018|18826952|P2|NOT COMPLETED|Overall Study||6
7645144|NCT02176018|18826953|P1|NOT COMPLETED|Overall Study||5
7645145|NCT02176018|18826952|P2|COMPLETED|Overall Study||17
7645146|NCT02176018|18826953|P1|COMPLETED|Overall Study||17
7645147|NCT02176018|18826952|P2|STARTED|Overall Study||23
7645148|NCT02176018|18826953|P1|STARTED|Overall Study||22
7645149|NCT02176005|18826981|P4|NOT COMPLETED|Overall Study||0
7645150|NCT02176005|18826982|P3|NOT COMPLETED|Overall Study||0
7645151|NCT02176005|18826983|P2|NOT COMPLETED|Overall Study||0
7645152|NCT02176005|18826984|P1|NOT COMPLETED|Overall Study||0
7645153|NCT02176005|18826981|P4|COMPLETED|Overall Study||8
7645154|NCT02176005|18826982|P3|COMPLETED|Overall Study||8
7645155|NCT02176005|18826983|P2|COMPLETED|Overall Study||14
7645156|NCT02176005|18826984|P1|COMPLETED|Overall Study||14
7645157|NCT02176005|18826981|P4|STARTED|Overall Study||8
7645158|NCT02176005|18826982|P3|STARTED|Overall Study||8
7645159|NCT02176005|18826983|P2|STARTED|Overall Study||14
7645160|NCT02176005|18826984|P1|STARTED|Overall Study||14
7645161|NCT02175979|18827012|P2|NOT COMPLETED|Overall Study||8
7645162|NCT02175979|18827013|P1|NOT COMPLETED|Overall Study||7
7645163|NCT02175979|18827012|P2|COMPLETED|Overall Study||132
7645164|NCT02175979|18827013|P1|COMPLETED|Overall Study||133
7645165|NCT02175979|18827012|P2|STARTED|Overall Study||140
7645166|NCT02175979|18827013|P1|STARTED|Overall Study||140
7645167|NCT02175966|18827037|P2|NOT COMPLETED|Follow-up Period||6
7645168|NCT02175966|18827038|P1|NOT COMPLETED|Follow-up Period||10
7645169|NCT02175966|18827037|P2|COMPLETED|Follow-up Period||8
7645170|NCT02175966|18827038|P1|COMPLETED|Follow-up Period||4
7645171|NCT02175966|18827037|P2|STARTED|Follow-up Period||14
7645172|NCT02175966|18827038|P1|STARTED|Follow-up Period||14
7645173|NCT02175966|18827037|P2|NOT COMPLETED|Treatment Period||0
7645174|NCT02175966|18827038|P1|NOT COMPLETED|Treatment Period||0
7645175|NCT02175966|18827037|P2|COMPLETED|Treatment Period||14
7645176|NCT02175966|18827038|P1|COMPLETED|Treatment Period||14
7645177|NCT02175966|18827037|P2|STARTED|Treatment Period||14
7645178|NCT02175966|18827038|P1|STARTED|Treatment Period||14
7645179|NCT02175771|18827066|P9|NOT COMPLETED|Treatment Period||6
7645180|NCT02175771|18827067|P8|NOT COMPLETED|Treatment Period||17
7645181|NCT02175771|18827068|P7|NOT COMPLETED|Treatment Period||5
7645182|NCT02175771|18827069|P6|NOT COMPLETED|Treatment Period||10
7645183|NCT02175771|18827070|P5|NOT COMPLETED|Treatment Period||5
7645184|NCT02175771|18827071|P4|NOT COMPLETED|Treatment Period||13
7645185|NCT02175771|18827072|P3|NOT COMPLETED|Treatment Period||7
7645186|NCT02175771|18827073|P2|NOT COMPLETED|Treatment Period||16
7645187|NCT02175771|18827074|P1|NOT COMPLETED|Treatment Period||0
7645188|NCT02175771|18827066|P9|COMPLETED|Treatment Period||38
7645189|NCT02175771|18827067|P8|COMPLETED|Treatment Period||116
7645190|NCT02175771|18827068|P7|COMPLETED|Treatment Period||36
7645191|NCT02175771|18827069|P6|COMPLETED|Treatment Period||110
7645192|NCT02175771|18827070|P5|COMPLETED|Treatment Period||36
7645193|NCT02175771|18827071|P4|COMPLETED|Treatment Period||113
7645194|NCT02175771|18827072|P3|COMPLETED|Treatment Period||35
7645195|NCT02175771|18827073|P2|COMPLETED|Treatment Period||111
7645196|NCT02175771|18827074|P1|COMPLETED|Treatment Period||0
7645197|NCT02175771|18827066|P9|STARTED|Treatment Period||44
7645198|NCT02175771|18827067|P8|STARTED|Treatment Period||133
7645199|NCT02175771|18827068|P7|STARTED|Treatment Period||41
7645200|NCT02175771|18827069|P6|STARTED|Treatment Period||120
7645201|NCT02175771|18827070|P5|STARTED|Treatment Period||41
7645202|NCT02175771|18827071|P4|STARTED|Treatment Period||126
7645203|NCT02175771|18827072|P3|STARTED|Treatment Period||42
7645204|NCT02175771|18827073|P2|STARTED|Treatment Period||127
7645205|NCT02175771|18827074|P1|STARTED|Treatment Period||0
7645206|NCT02175771|18827066|P9|NOT COMPLETED|Run-In Period (Pre-assignment)||0
7645207|NCT02175771|18827067|P8|NOT COMPLETED|Run-In Period (Pre-assignment)||0
7645208|NCT02175771|18827068|P7|NOT COMPLETED|Run-In Period (Pre-assignment)||0
7645209|NCT02175771|18827069|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
7645210|NCT02175771|18827070|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
7645211|NCT02175771|18827071|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
7645212|NCT02175771|18827072|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
7645213|NCT02175771|18827073|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
7645214|NCT02175771|18827074|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||84
7645215|NCT02175771|18827066|P9|COMPLETED|Run-In Period (Pre-assignment)||0
7645216|NCT02175771|18827067|P8|COMPLETED|Run-In Period (Pre-assignment)||0
7645217|NCT02175771|18827068|P7|COMPLETED|Run-In Period (Pre-assignment)||0
7645218|NCT02175771|18827069|P6|COMPLETED|Run-In Period (Pre-assignment)||0
7645219|NCT02175771|18827070|P5|COMPLETED|Run-In Period (Pre-assignment)||0
7645220|NCT02175771|18827071|P4|COMPLETED|Run-In Period (Pre-assignment)||0
7645221|NCT02175771|18827072|P3|COMPLETED|Run-In Period (Pre-assignment)||0
7645222|NCT02175771|18827073|P2|COMPLETED|Run-In Period (Pre-assignment)||0
7645223|NCT02175771|18827074|P1|COMPLETED|Run-In Period (Pre-assignment)||674
7645224|NCT02175771|18827066|P9|STARTED|Run-In Period (Pre-assignment)||0
7645225|NCT02175771|18827067|P8|STARTED|Run-In Period (Pre-assignment)||0
7645226|NCT02175771|18827068|P7|STARTED|Run-In Period (Pre-assignment)||0
7645227|NCT02175771|18827069|P6|STARTED|Run-In Period (Pre-assignment)||0
7645228|NCT02175771|18827070|P5|STARTED|Run-In Period (Pre-assignment)||0
7645229|NCT02175771|18827071|P4|STARTED|Run-In Period (Pre-assignment)||0
7645230|NCT02175771|18827072|P3|STARTED|Run-In Period (Pre-assignment)||0
7645231|NCT02175771|18827073|P2|STARTED|Run-In Period (Pre-assignment)||0
7645232|NCT02175771|18827074|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled; two participants were enrolled but had no enrollment date in their records.|758
7645233|NCT02175758|18827138|P6|NOT COMPLETED|Treatment Phase||0
7645234|NCT02175758|18827139|P5|NOT COMPLETED|Treatment Phase||1
7645235|NCT02175758|18827140|P4|NOT COMPLETED|Treatment Phase||0
7645236|NCT02175758|18827141|P3|NOT COMPLETED|Treatment Phase||0
7645237|NCT02175758|18827142|P2|NOT COMPLETED|Treatment Phase||1
7645238|NCT02175758|18827143|P1|NOT COMPLETED|Treatment Phase||0
7645239|NCT02175758|18827138|P6|COMPLETED|Treatment Phase||8
7645240|NCT02175758|18827139|P5|COMPLETED|Treatment Phase||4
7645241|NCT02175758|18827140|P4|COMPLETED|Treatment Phase||28
7645242|NCT02175758|18827141|P3|COMPLETED|Treatment Phase||13
7645243|NCT02175758|18827142|P2|COMPLETED|Treatment Phase||38
7645244|NCT02175758|18827143|P1|COMPLETED|Treatment Phase||13
7645245|NCT02175758|18827138|P6|STARTED|Treatment Phase||8
7645246|NCT02175758|18827139|P5|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|5
7645247|NCT02175758|18827140|P4|STARTED|Treatment Phase|18 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|28
7645248|NCT02175758|18827141|P3|STARTED|Treatment Phase|11 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
7645249|NCT02175758|18827142|P2|STARTED|Treatment Phase|33 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|39
7645250|NCT02175758|18827143|P1|STARTED|Treatment Phase|9 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
7645251|NCT02175758|18827138|P6|NOT COMPLETED|PK Lead-in Phase||0
7645252|NCT02175758|18827139|P5|NOT COMPLETED|PK Lead-in Phase||0
7645253|NCT02175758|18827140|P4|NOT COMPLETED|PK Lead-in Phase||0
7645254|NCT02175758|18827141|P3|NOT COMPLETED|PK Lead-in Phase||0
7645255|NCT02175758|18827142|P2|NOT COMPLETED|PK Lead-in Phase||0
7645256|NCT02175758|18827143|P1|NOT COMPLETED|PK Lead-in Phase||0
7645257|NCT02175758|18827138|P6|COMPLETED|PK Lead-in Phase||8
7645258|NCT02175758|18827139|P5|COMPLETED|PK Lead-in Phase||4
7645259|NCT02175758|18827140|P4|COMPLETED|PK Lead-in Phase||10
7645260|NCT02175758|18827141|P3|COMPLETED|PK Lead-in Phase||2
7645261|NCT02175758|18827142|P2|COMPLETED|PK Lead-in Phase||6
7645262|NCT02175758|18827143|P1|COMPLETED|PK Lead-in Phase||4
7645263|NCT02175758|18827138|P6|STARTED|PK Lead-in Phase||8
7645264|NCT02175758|18827139|P5|STARTED|PK Lead-in Phase||4
7645265|NCT02175758|18827140|P4|STARTED|PK Lead-in Phase||10
7645266|NCT02175758|18827141|P3|STARTED|PK Lead-in Phase||2
7645267|NCT02175758|18827142|P2|STARTED|PK Lead-in Phase||6
7645268|NCT02175758|18827143|P1|STARTED|PK Lead-in Phase||4
7645269|NCT02175745|18827246|P1|NOT COMPLETED|Overall Study||1
7645270|NCT02175745|18827246|P1|COMPLETED|Overall Study||1
7645271|NCT02175745|18827246|P1|STARTED|Overall Study||2
7645272|NCT02175628|18827253|P2|NOT COMPLETED|Overall Study||0
7645273|NCT02175628|18827254|P1|NOT COMPLETED|Overall Study||0
7645274|NCT02175628|18827253|P2|COMPLETED|Overall Study||17
7645275|NCT02175628|18827254|P1|COMPLETED|Overall Study||6
7645276|NCT02175628|18827253|P2|STARTED|Overall Study||17
7645277|NCT02175628|18827254|P1|STARTED|Overall Study||6
7645278|NCT02175472|18827270|P2|NOT COMPLETED|Overall Study||2
7645279|NCT02175472|18827271|P1|NOT COMPLETED|Overall Study||7
7645280|NCT02175472|18827270|P2|COMPLETED|Overall Study||45
7645281|NCT02175472|18827271|P1|COMPLETED|Overall Study||38
7645282|NCT02175472|18827270|P2|STARTED|Overall Study||47
7645283|NCT02175472|18827271|P1|STARTED|Overall Study||45
7645284|NCT02175368|18827285|P1|NOT COMPLETED|Overall Study||1
7645285|NCT02175368|18827285|P1|COMPLETED|Overall Study||27
7645286|NCT02175368|18827285|P1|STARTED|Overall Study||28
7645287|NCT02175277|18827290|P1|NOT COMPLETED|Overall Study||1
7645288|NCT02175277|18827290|P1|COMPLETED|Overall Study||8
7645289|NCT02175277|18827290|P1|STARTED|Overall Study||9
7645290|NCT02175225|18827296|P2|NOT COMPLETED|Overall Study||11
7645291|NCT02175225|18827297|P1|NOT COMPLETED|Overall Study||8
7645292|NCT02175225|18827296|P2|COMPLETED|Overall Study||138
7645293|NCT02175225|18827297|P1|COMPLETED|Overall Study||137
7645294|NCT02175225|18827296|P2|180 Day Outcome Obtained|Overall Study||135
7645295|NCT02175225|18827297|P1|180 Day Outcome Obtained|Overall Study||135
7645296|NCT02175225|18827296|P2|90 Day Outcome Obtained|Overall Study||143
7645297|NCT02175225|18827297|P1|90 Day Outcome Obtained|Overall Study||140
7645298|NCT02175225|18827296|P2|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|147
7645299|NCT02175225|18827297|P1|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|144
7645300|NCT02175225|18827296|P2|STARTED|Overall Study||149
7645301|NCT02175225|18827297|P1|STARTED|Overall Study||145
7645302|NCT02175212|18827331|P2|NOT COMPLETED|Overall Study||147
7645303|NCT02175212|18827332|P1|NOT COMPLETED|Overall Study||163
7645304|NCT02175212|18827331|P2|COMPLETED|Overall Study||31
7645305|NCT02175212|18827332|P1|COMPLETED|Overall Study||14
7645306|NCT02175212|18827331|P2|STARTED|Overall Study||178
7645307|NCT02175212|18827332|P1|STARTED|Overall Study||177
7645308|NCT02175199|18827348|P2|NOT COMPLETED|Overall Study||5
7645309|NCT02175199|18827349|P1|NOT COMPLETED|Overall Study||3
7645310|NCT02175199|18827348|P2|COMPLETED|Overall Study||71
7645311|NCT02175199|18827349|P1|COMPLETED|Overall Study||71
7645312|NCT02175199|18827348|P2|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74
7645313|NCT02175199|18827349|P1|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72
7645314|NCT02175199|18827348|P2|STARTED|Overall Study||76
7645315|NCT02175199|18827349|P1|STARTED|Overall Study||74
7645316|NCT02175121|18827363|P5|NOT COMPLETED|Overall Study||1
7645317|NCT02175121|18827364|P4|NOT COMPLETED|Overall Study||1
7645318|NCT02175121|18827365|P3|NOT COMPLETED|Overall Study||2
7645319|NCT02175121|18827366|P2|NOT COMPLETED|Overall Study||1
7645320|NCT02175121|18827367|P1|NOT COMPLETED|Overall Study||1
7645321|NCT02175121|18827363|P5|COMPLETED|Overall Study||33
7645322|NCT02175121|18827364|P4|COMPLETED|Overall Study||34
7645323|NCT02175121|18827365|P3|COMPLETED|Overall Study||32
7645324|NCT02175121|18827366|P2|COMPLETED|Overall Study||34
7645325|NCT02175121|18827367|P1|COMPLETED|Overall Study||33
7645326|NCT02175121|18827363|P5|STARTED|Overall Study||34
7645327|NCT02175121|18827364|P4|STARTED|Overall Study||35
7645328|NCT02175121|18827365|P3|STARTED|Overall Study||34
7645329|NCT02175121|18827366|P2|STARTED|Overall Study||35
7645330|NCT02175121|18827367|P1|STARTED|Overall Study||34
7645331|NCT02174913|18827496|P2|NOT COMPLETED|Overall Study||0
7645332|NCT02174913|18827497|P1|NOT COMPLETED|Overall Study||0
7645333|NCT02174913|18827496|P2|COMPLETED|Overall Study||17
7645334|NCT02174913|18827497|P1|COMPLETED|Overall Study||17
7645335|NCT02174913|18827496|P2|STARTED|Overall Study||17
7645336|NCT02174913|18827497|P1|STARTED|Overall Study||17
7645337|NCT02174861|18827505|P1|NOT COMPLETED|Overall Study||158
7645338|NCT02174861|18827505|P1|COMPLETED|Overall Study||451
7645339|NCT02174861|18827505|P1|Enrolled in CHU Substudy|Overall Study||53
7645340|NCT02174861|18827505|P1|STARTED|Overall Study||609
7645341|NCT02174848|18827519|P2|NOT COMPLETED|Overall Study||6
7645342|NCT02174848|18827520|P1|NOT COMPLETED|Overall Study||7
7645343|NCT02174848|18827519|P2|COMPLETED|Overall Study||38
7645344|NCT02174848|18827520|P1|COMPLETED|Overall Study||17
7645345|NCT02174848|18827519|P2|Provided Post-baseline Efficacy Data|Overall Study||43
7645346|NCT02174848|18827520|P1|Provided Post-baseline Efficacy Data|Overall Study||19
7645347|NCT02174848|18827519|P2|STARTED|Overall Study||44
7645348|NCT02174848|18827520|P1|STARTED|Overall Study||24
7645349|NCT02174731|18827537|P2|NOT COMPLETED|Overall Study||65
7645350|NCT02174731|18827538|P1|NOT COMPLETED|Overall Study||69
7645351|NCT02174731|18827537|P2|COMPLETED|Overall Study||990
7645352|NCT02174731|18827538|P1|COMPLETED|Overall Study||982
7645353|NCT02174731|18827537|P2|Received Treatment|Overall Study||1053
7645354|NCT02174731|18827538|P1|Received Treatment|Overall Study||1048
7645355|NCT02174731|18827537|P2|STARTED|Overall Study||1055
7645356|NCT02174731|18827538|P1|STARTED|Overall Study||1051
7645357|NCT02174627|18827560|P2|NOT COMPLETED|Overall Study||130
7645358|NCT02174627|18827561|P1|NOT COMPLETED|Overall Study||84
7645359|NCT02174627|18827560|P2|COMPLETED|Overall Study||1247
7645360|NCT02174627|18827561|P1|COMPLETED|Overall Study||1300
7645361|NCT02174627|18827560|P2|Discontinued Treatment|Overall Study||801
7645362|NCT02174627|18827561|P1|Discontinued Treatment|Overall Study||499
7645363|NCT02174627|18827560|P2|Received Treatment|Overall Study||1376
7645364|NCT02174627|18827561|P1|Received Treatment|Overall Study||1384
7645365|NCT02174627|18827560|P2|STARTED|Overall Study||1377
7645366|NCT02174627|18827561|P1|STARTED|Overall Study||1384
7645367|NCT02174562|18827589|P2|NOT COMPLETED|Overall Study||5
7645368|NCT02174562|18827590|P1|NOT COMPLETED|Overall Study||9
7645369|NCT02174562|18827589|P2|COMPLETED|Overall Study||46
7645370|NCT02174562|18827590|P1|COMPLETED|Overall Study||41
7645371|NCT02174562|18827589|P2|STARTED|Overall Study||51
7645372|NCT02174562|18827590|P1|STARTED|Overall Study||50
7645373|NCT02174523|18827600|P2|NOT COMPLETED|Overall Study||0
7645374|NCT02174523|18827601|P1|NOT COMPLETED|Overall Study||1
7645375|NCT02174523|18827600|P2|COMPLETED|Overall Study||4
7645376|NCT02174523|18827601|P1|COMPLETED|Overall Study||9
7645377|NCT02174523|18827600|P2|STARTED|Overall Study||4
7645378|NCT02174523|18827601|P1|STARTED|Overall Study||10
7645379|NCT02174510|18827632|P4|NOT COMPLETED|Overall Study||0
7645380|NCT02174510|18827633|P3|NOT COMPLETED|Overall Study||0
7645381|NCT02174510|18827634|P2|NOT COMPLETED|Overall Study||0
7645382|NCT02174510|18827635|P1|NOT COMPLETED|Overall Study||0
7645383|NCT02174510|18827632|P4|COMPLETED|Overall Study||9
7645384|NCT02174510|18827633|P3|COMPLETED|Overall Study||12
7645385|NCT02174510|18827634|P2|COMPLETED|Overall Study||8
7645386|NCT02174510|18827635|P1|COMPLETED|Overall Study||8
7645387|NCT02174510|18827632|P4|STARTED|Overall Study||9
7645388|NCT02174510|18827633|P3|STARTED|Overall Study||12
7645389|NCT02174510|18827634|P2|STARTED|Overall Study||8
7645390|NCT02174510|18827635|P1|STARTED|Overall Study||8
7645391|NCT02174432|18827665|P1|NOT COMPLETED|Overall Study||20
7645392|NCT02174432|18827665|P1|COMPLETED|Overall Study||16
7645393|NCT02174432|18827665|P1|STARTED|Overall Study||36
7645394|NCT02174419|18827672|P3|NOT COMPLETED|Overall Study||2
7645395|NCT02174419|18827673|P2|NOT COMPLETED|Overall Study||6
7645396|NCT02174419|18827674|P1|NOT COMPLETED|Overall Study||4
7645397|NCT02174419|18827672|P3|COMPLETED|Overall Study||20
7645398|NCT02174419|18827673|P2|COMPLETED|Overall Study||12
7645399|NCT02174419|18827674|P1|COMPLETED|Overall Study||18
7645400|NCT02174419|18827672|P3|STARTED|Overall Study||22
7645401|NCT02174419|18827673|P2|STARTED|Overall Study||18
7645402|NCT02174419|18827674|P1|STARTED|Overall Study||22
7645403|NCT02174276|18827686|P4|NOT COMPLETED|OTEP (Weeks 48 to 144)||2
7645404|NCT02174276|18827687|P3|NOT COMPLETED|OTEP (Weeks 48 to 144)||3
7645405|NCT02174276|18827688|P2|NOT COMPLETED|OTEP (Weeks 48 to 144)||0
7645406|NCT02174276|18827689|P1|NOT COMPLETED|OTEP (Weeks 48 to 144)||1
7645407|NCT02174276|18827686|P4|COMPLETED|OTEP (Weeks 48 to 144)||50
7645408|NCT02174276|18827687|P3|COMPLETED|OTEP (Weeks 48 to 144)||48
7645409|NCT02174276|18827688|P2|COMPLETED|OTEP (Weeks 48 to 144)||54
7645410|NCT02174276|18827689|P1|COMPLETED|OTEP (Weeks 48 to 144)||25
7645411|NCT02174276|18827686|P4|STARTED|OTEP (Weeks 48 to 144)|3 Participants completed the study treatment phase but did not continue in OTEP.|52
7645412|NCT02174276|18827687|P3|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|51
7645413|NCT02174276|18827688|P2|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|54
7645414|NCT02174276|18827689|P1|STARTED|OTEP (Weeks 48 to 144)||26
7645415|NCT02174276|18827686|P4|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||0
7645416|NCT02174276|18827687|P3|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||3
7645417|NCT02174276|18827688|P2|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
7645418|NCT02174276|18827689|P1|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
7645419|NCT02174276|18827686|P4|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||55
7645420|NCT02174276|18827687|P3|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||53
7645421|NCT02174276|18827688|P2|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||56
7645422|NCT02174276|18827689|P1|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||26
7645423|NCT02174276|18827686|P4|STARTED|Study Treatment Phase (Weeks 1 to 48)||55
7645424|NCT02174276|18827687|P3|STARTED|Study Treatment Phase (Weeks 1 to 48)||56
7645425|NCT02174276|18827688|P2|STARTED|Study Treatment Phase (Weeks 1 to 48)||57
7645426|NCT02174276|18827689|P1|STARTED|Study Treatment Phase (Weeks 1 to 48)||27
7645427|NCT02174198|18827773|P2|NOT COMPLETED|Overall Study||0
7645428|NCT02174198|18827774|P1|NOT COMPLETED|Overall Study||0
7645429|NCT02174198|18827773|P2|COMPLETED|Overall Study||16
7645430|NCT02174198|18827774|P1|COMPLETED|Overall Study||16
7645431|NCT02174198|18827773|P2|STARTED|Overall Study||16
7645432|NCT02174198|18827774|P1|STARTED|Overall Study||16
7645433|NCT02173769|18827796|P1|NOT COMPLETED|Overall Study||4
7645434|NCT02173769|18827796|P1|COMPLETED|Overall Study||1854
7645435|NCT02173769|18827796|P1|STARTED|Overall Study||1858
7645436|NCT02173704|18827809|P2|NOT COMPLETED|Overall Study||4
7645437|NCT02173704|18827810|P1|NOT COMPLETED|Overall Study||13
7645438|NCT02173704|18827809|P2|COMPLETED|Overall Study||71
7645439|NCT02173704|18827810|P1|COMPLETED|Overall Study||137
7645440|NCT02173704|18827809|P2|STARTED|Overall Study||75
7645441|NCT02173704|18827810|P1|STARTED|Overall Study||150
7645442|NCT02173548|18827838|P2|NOT COMPLETED|Overall Study||2
7645443|NCT02173548|18827839|P1|NOT COMPLETED|Overall Study||1
7645444|NCT02173548|18827838|P2|COMPLETED|Overall Study||8
7645445|NCT02173548|18827839|P1|COMPLETED|Overall Study||20
7645446|NCT02173548|18827838|P2|STARTED|Overall Study||10
7645447|NCT02173548|18827839|P1|STARTED|Overall Study||21
7645448|NCT02173535|18827879|P20|NOT COMPLETED|Period 5||0
7645449|NCT02173535|18827880|P19|NOT COMPLETED|Period 5||0
7645450|NCT02173535|18827881|P18|NOT COMPLETED|Period 5||0
7645451|NCT02173535|18827882|P17|NOT COMPLETED|Period 5||0
7645452|NCT02173535|18827883|P16|NOT COMPLETED|Period 5||0
7645453|NCT02173535|18827884|P15|NOT COMPLETED|Period 5||0
7645454|NCT02173535|18827885|P14|NOT COMPLETED|Period 5||0
7645455|NCT02173535|18827886|P13|NOT COMPLETED|Period 5||0
7645456|NCT02173535|18827887|P12|NOT COMPLETED|Period 5||0
7645457|NCT02173535|18827888|P11|NOT COMPLETED|Period 5||0
7645458|NCT02173535|18827889|P10|NOT COMPLETED|Period 5||0
7645459|NCT02173535|18827890|P9|NOT COMPLETED|Period 5||0
7645460|NCT02173535|18827891|P8|NOT COMPLETED|Period 5||0
7645461|NCT02173535|18827892|P7|NOT COMPLETED|Period 5||0
7645462|NCT02173535|18827893|P6|NOT COMPLETED|Period 5||0
7645463|NCT02173535|18827894|P5|NOT COMPLETED|Period 5||0
7645464|NCT02173535|18827895|P4|NOT COMPLETED|Period 5||0
7645465|NCT02173535|18827896|P3|NOT COMPLETED|Period 5||0
7645466|NCT02173535|18827897|P2|NOT COMPLETED|Period 5||0
7645467|NCT02173535|18827898|P1|NOT COMPLETED|Period 5||0
7645468|NCT02173535|18827879|P20|COMPLETED|Period 5||12
7645469|NCT02173535|18827880|P19|COMPLETED|Period 5||12
7645470|NCT02173535|18827881|P18|COMPLETED|Period 5||12
7645471|NCT02173535|18827882|P17|COMPLETED|Period 5||12
7645472|NCT02173535|18827883|P16|COMPLETED|Period 5||12
7645473|NCT02173535|18827884|P15|COMPLETED|Period 5||12
7645474|NCT02173535|18827885|P14|COMPLETED|Period 5||12
7645475|NCT02173535|18827886|P13|COMPLETED|Period 5||12
7645476|NCT02173535|18827887|P12|COMPLETED|Period 5||12
7645477|NCT02173535|18827888|P11|COMPLETED|Period 5||12
7645478|NCT02173535|18827889|P10|COMPLETED|Period 5||12
7645479|NCT02173535|18827890|P9|COMPLETED|Period 5||12
7645480|NCT02173535|18827891|P8|COMPLETED|Period 5||12
7645481|NCT02173535|18827892|P7|COMPLETED|Period 5||12
7645482|NCT02173535|18827893|P6|COMPLETED|Period 5||12
7645483|NCT02173535|18827894|P5|COMPLETED|Period 5||12
7645484|NCT02173535|18827895|P4|COMPLETED|Period 5||12
7645485|NCT02173535|18827896|P3|COMPLETED|Period 5||12
7645486|NCT02173535|18827897|P2|COMPLETED|Period 5||12
7645487|NCT02173535|18827898|P1|COMPLETED|Period 5||12
7645488|NCT02173535|18827879|P20|STARTED|Period 5||12
7645489|NCT02173535|18827880|P19|STARTED|Period 5||12
7645490|NCT02173535|18827881|P18|STARTED|Period 5||12
7645491|NCT02173535|18827882|P17|STARTED|Period 5||12
7645492|NCT02173535|18827883|P16|STARTED|Period 5||12
7645493|NCT02173535|18827884|P15|STARTED|Period 5||12
7645494|NCT02173535|18827885|P14|STARTED|Period 5||12
7645495|NCT02173535|18827886|P13|STARTED|Period 5||12
7645496|NCT02173535|18827887|P12|STARTED|Period 5||12
7645497|NCT02173535|18827888|P11|STARTED|Period 5||12
7645498|NCT02173535|18827889|P10|STARTED|Period 5||12
7645499|NCT02173535|18827890|P9|STARTED|Period 5||12
7645500|NCT02173535|18827891|P8|STARTED|Period 5||12
7645501|NCT02173535|18827892|P7|STARTED|Period 5||12
7645502|NCT02173535|18827893|P6|STARTED|Period 5||12
7645503|NCT02173535|18827894|P5|STARTED|Period 5||12
7645504|NCT02173535|18827895|P4|STARTED|Period 5||12
7645505|NCT02173535|18827896|P3|STARTED|Period 5||12
7645506|NCT02173535|18827897|P2|STARTED|Period 5||12
7645507|NCT02173535|18827898|P1|STARTED|Period 5||12
7645508|NCT02173535|18827879|P20|NOT COMPLETED|Period 4||0
7645509|NCT02173535|18827880|P19|NOT COMPLETED|Period 4||0
7645510|NCT02173535|18827881|P18|NOT COMPLETED|Period 4||0
7645511|NCT02173535|18827882|P17|NOT COMPLETED|Period 4||0
7645512|NCT02173535|18827883|P16|NOT COMPLETED|Period 4||0
7645513|NCT02173535|18827884|P15|NOT COMPLETED|Period 4||0
7645514|NCT02173535|18827885|P14|NOT COMPLETED|Period 4||0
7645515|NCT02173535|18827886|P13|NOT COMPLETED|Period 4||0
7645516|NCT02173535|18827887|P12|NOT COMPLETED|Period 4||0
7645517|NCT02173535|18827888|P11|NOT COMPLETED|Period 4||0
7645518|NCT02173535|18827889|P10|NOT COMPLETED|Period 4||0
7645519|NCT02173535|18827890|P9|NOT COMPLETED|Period 4||0
7645520|NCT02173535|18827891|P8|NOT COMPLETED|Period 4||0
7645521|NCT02173535|18827892|P7|NOT COMPLETED|Period 4||0
7645522|NCT02173535|18827893|P6|NOT COMPLETED|Period 4||0
7645523|NCT02173535|18827894|P5|NOT COMPLETED|Period 4||0
7645524|NCT02173535|18827895|P4|NOT COMPLETED|Period 4||0
7645525|NCT02173535|18827896|P3|NOT COMPLETED|Period 4||0
7645526|NCT02173535|18827897|P2|NOT COMPLETED|Period 4||0
7645527|NCT02173535|18827898|P1|NOT COMPLETED|Period 4||0
7645528|NCT02173535|18827879|P20|COMPLETED|Period 4||12
7645529|NCT02173535|18827880|P19|COMPLETED|Period 4||12
7645530|NCT02173535|18827881|P18|COMPLETED|Period 4||12
7645531|NCT02173535|18827882|P17|COMPLETED|Period 4||12
7645532|NCT02173535|18827883|P16|COMPLETED|Period 4||12
7645533|NCT02173535|18827884|P15|COMPLETED|Period 4||12
7645534|NCT02173535|18827885|P14|COMPLETED|Period 4||12
7645535|NCT02173535|18827886|P13|COMPLETED|Period 4||12
7645536|NCT02173535|18827887|P12|COMPLETED|Period 4||12
7645537|NCT02173535|18827888|P11|COMPLETED|Period 4||12
7645538|NCT02173535|18827889|P10|COMPLETED|Period 4||12
7645539|NCT02173535|18827890|P9|COMPLETED|Period 4||12
7645540|NCT02173535|18827891|P8|COMPLETED|Period 4||12
7645541|NCT02173535|18827892|P7|COMPLETED|Period 4||12
7645542|NCT02173535|18827893|P6|COMPLETED|Period 4||12
7645543|NCT02173535|18827894|P5|COMPLETED|Period 4||12
7645544|NCT02173535|18827895|P4|COMPLETED|Period 4||12
7645545|NCT02173535|18827896|P3|COMPLETED|Period 4||12
7645546|NCT02173535|18827897|P2|COMPLETED|Period 4||12
7645547|NCT02173535|18827898|P1|COMPLETED|Period 4||12
7645548|NCT02173535|18827879|P20|STARTED|Period 4||12
7645549|NCT02173535|18827880|P19|STARTED|Period 4||12
7645550|NCT02173535|18827881|P18|STARTED|Period 4||12
7645551|NCT02173535|18827882|P17|STARTED|Period 4||12
7645552|NCT02173535|18827883|P16|STARTED|Period 4||12
7645553|NCT02173535|18827884|P15|STARTED|Period 4||12
7645554|NCT02173535|18827885|P14|STARTED|Period 4||12
7645555|NCT02173535|18827886|P13|STARTED|Period 4||12
7645556|NCT02173535|18827887|P12|STARTED|Period 4||12
7645557|NCT02173535|18827888|P11|STARTED|Period 4||12
7645558|NCT02173535|18827889|P10|STARTED|Period 4||12
7645559|NCT02173535|18827890|P9|STARTED|Period 4||12
7645560|NCT02173535|18827891|P8|STARTED|Period 4||12
7645561|NCT02173535|18827892|P7|STARTED|Period 4||12
7645562|NCT02173535|18827893|P6|STARTED|Period 4||12
7645563|NCT02173535|18827894|P5|STARTED|Period 4||12
7645564|NCT02173535|18827895|P4|STARTED|Period 4||12
7645565|NCT02173535|18827896|P3|STARTED|Period 4||12
7645566|NCT02173535|18827897|P2|STARTED|Period 4||12
7645567|NCT02173535|18827898|P1|STARTED|Period 4||12
7645568|NCT02173535|18827879|P20|NOT COMPLETED|Period 3||0
7645569|NCT02173535|18827880|P19|NOT COMPLETED|Period 3||0
7645570|NCT02173535|18827881|P18|NOT COMPLETED|Period 3||0
7645571|NCT02173535|18827882|P17|NOT COMPLETED|Period 3||0
7645572|NCT02173535|18827883|P16|NOT COMPLETED|Period 3||0
7645573|NCT02173535|18827884|P15|NOT COMPLETED|Period 3||0
7645574|NCT02173535|18827885|P14|NOT COMPLETED|Period 3||0
7645575|NCT02173535|18827886|P13|NOT COMPLETED|Period 3||0
7645576|NCT02173535|18827887|P12|NOT COMPLETED|Period 3||0
7645577|NCT02173535|18827888|P11|NOT COMPLETED|Period 3||0
7645578|NCT02173535|18827889|P10|NOT COMPLETED|Period 3||0
7645579|NCT02173535|18827890|P9|NOT COMPLETED|Period 3||0
7645580|NCT02173535|18827891|P8|NOT COMPLETED|Period 3||0
7645581|NCT02173535|18827892|P7|NOT COMPLETED|Period 3||0
7645582|NCT02173535|18827893|P6|NOT COMPLETED|Period 3||0
7645583|NCT02173535|18827894|P5|NOT COMPLETED|Period 3||0
7645584|NCT02173535|18827895|P4|NOT COMPLETED|Period 3||0
7645585|NCT02173535|18827896|P3|NOT COMPLETED|Period 3||0
7645586|NCT02173535|18827897|P2|NOT COMPLETED|Period 3||0
7645587|NCT02173535|18827898|P1|NOT COMPLETED|Period 3||0
7645588|NCT02173535|18827879|P20|COMPLETED|Period 3||12
7645589|NCT02173535|18827880|P19|COMPLETED|Period 3||12
7645590|NCT02173535|18827881|P18|COMPLETED|Period 3||12
7645591|NCT02173535|18827882|P17|COMPLETED|Period 3||12
7645592|NCT02173535|18827883|P16|COMPLETED|Period 3||12
7645593|NCT02173535|18827884|P15|COMPLETED|Period 3||12
7645594|NCT02173535|18827885|P14|COMPLETED|Period 3||12
7645595|NCT02173535|18827886|P13|COMPLETED|Period 3||12
7645596|NCT02173535|18827887|P12|COMPLETED|Period 3||12
7645597|NCT02173535|18827888|P11|COMPLETED|Period 3||12
7645598|NCT02173535|18827889|P10|COMPLETED|Period 3||12
7645599|NCT02173535|18827890|P9|COMPLETED|Period 3||12
7645600|NCT02173535|18827891|P8|COMPLETED|Period 3||12
7645601|NCT02173535|18827892|P7|COMPLETED|Period 3||12
7645602|NCT02173535|18827893|P6|COMPLETED|Period 3||12
7645603|NCT02173535|18827894|P5|COMPLETED|Period 3||12
7645604|NCT02173535|18827895|P4|COMPLETED|Period 3||12
7645605|NCT02173535|18827896|P3|COMPLETED|Period 3||12
7645606|NCT02173535|18827897|P2|COMPLETED|Period 3||12
7645607|NCT02173535|18827898|P1|COMPLETED|Period 3||12
7645608|NCT02173535|18827879|P20|STARTED|Period 3||12
7645609|NCT02173535|18827880|P19|STARTED|Period 3||12
7645610|NCT02173535|18827881|P18|STARTED|Period 3||12
7645611|NCT02173535|18827882|P17|STARTED|Period 3||12
7645612|NCT02173535|18827883|P16|STARTED|Period 3||12
7645613|NCT02173535|18827884|P15|STARTED|Period 3||12
7645614|NCT02173535|18827885|P14|STARTED|Period 3||12
7645615|NCT02173535|18827886|P13|STARTED|Period 3||12
7645616|NCT02173535|18827887|P12|STARTED|Period 3||12
7645617|NCT02173535|18827888|P11|STARTED|Period 3||12
7645618|NCT02173535|18827889|P10|STARTED|Period 3||12
7645619|NCT02173535|18827890|P9|STARTED|Period 3||12
7645620|NCT02173535|18827891|P8|STARTED|Period 3||12
7645621|NCT02173535|18827892|P7|STARTED|Period 3||12
7645622|NCT02173535|18827893|P6|STARTED|Period 3||12
7645623|NCT02173535|18827894|P5|STARTED|Period 3||12
7645624|NCT02173535|18827895|P4|STARTED|Period 3||12
7645625|NCT02173535|18827896|P3|STARTED|Period 3||12
7645626|NCT02173535|18827897|P2|STARTED|Period 3||12
7645627|NCT02173535|18827898|P1|STARTED|Period 3||12
7645628|NCT02173535|18827879|P20|NOT COMPLETED|Period 2||0
7645629|NCT02173535|18827880|P19|NOT COMPLETED|Period 2||0
7645630|NCT02173535|18827881|P18|NOT COMPLETED|Period 2||0
7645631|NCT02173535|18827882|P17|NOT COMPLETED|Period 2||0
7645632|NCT02173535|18827883|P16|NOT COMPLETED|Period 2||0
7645633|NCT02173535|18827884|P15|NOT COMPLETED|Period 2||0
7645634|NCT02173535|18827885|P14|NOT COMPLETED|Period 2||0
7645635|NCT02173535|18827886|P13|NOT COMPLETED|Period 2||0
7645636|NCT02173535|18827887|P12|NOT COMPLETED|Period 2||0
7645637|NCT02173535|18827888|P11|NOT COMPLETED|Period 2||0
7645638|NCT02173535|18827889|P10|NOT COMPLETED|Period 2||0
7645639|NCT02173535|18827890|P9|NOT COMPLETED|Period 2||0
7645640|NCT02173535|18827891|P8|NOT COMPLETED|Period 2||0
7645641|NCT02173535|18827892|P7|NOT COMPLETED|Period 2||0
7645642|NCT02173535|18827893|P6|NOT COMPLETED|Period 2||0
7645643|NCT02173535|18827894|P5|NOT COMPLETED|Period 2||0
7645644|NCT02173535|18827895|P4|NOT COMPLETED|Period 2||0
7645645|NCT02173535|18827896|P3|NOT COMPLETED|Period 2||0
7645646|NCT02173535|18827897|P2|NOT COMPLETED|Period 2||0
7645647|NCT02173535|18827898|P1|NOT COMPLETED|Period 2||0
7645648|NCT02173535|18827879|P20|COMPLETED|Period 2||12
7645649|NCT02173535|18827880|P19|COMPLETED|Period 2||12
7645650|NCT02173535|18827881|P18|COMPLETED|Period 2||12
7645651|NCT02173535|18827882|P17|COMPLETED|Period 2||12
7645652|NCT02173535|18827883|P16|COMPLETED|Period 2||12
7645653|NCT02173535|18827884|P15|COMPLETED|Period 2||12
7645654|NCT02173535|18827885|P14|COMPLETED|Period 2||12
7645655|NCT02173535|18827886|P13|COMPLETED|Period 2||12
7645656|NCT02173535|18827887|P12|COMPLETED|Period 2||12
7645657|NCT02173535|18827888|P11|COMPLETED|Period 2||12
7645658|NCT02173535|18827889|P10|COMPLETED|Period 2||12
7645659|NCT02173535|18827890|P9|COMPLETED|Period 2||12
7645660|NCT02173535|18827891|P8|COMPLETED|Period 2||12
7645661|NCT02173535|18827892|P7|COMPLETED|Period 2||12
7645662|NCT02173535|18827893|P6|COMPLETED|Period 2||12
7645663|NCT02173535|18827894|P5|COMPLETED|Period 2||12
7645664|NCT02173535|18827895|P4|COMPLETED|Period 2||12
7645665|NCT02173535|18827896|P3|COMPLETED|Period 2||12
7645666|NCT02173535|18827897|P2|COMPLETED|Period 2||12
7645667|NCT02173535|18827898|P1|COMPLETED|Period 2||12
7645668|NCT02173535|18827879|P20|STARTED|Period 2||12
7645669|NCT02173535|18827880|P19|STARTED|Period 2||12
7645670|NCT02173535|18827881|P18|STARTED|Period 2||12
7645671|NCT02173535|18827882|P17|STARTED|Period 2||12
7645672|NCT02173535|18827883|P16|STARTED|Period 2||12
7645673|NCT02173535|18827884|P15|STARTED|Period 2||12
7645674|NCT02173535|18827885|P14|STARTED|Period 2||12
7645675|NCT02173535|18827886|P13|STARTED|Period 2||12
7645676|NCT02173535|18827887|P12|STARTED|Period 2||12
7645677|NCT02173535|18827888|P11|STARTED|Period 2||12
7645678|NCT02173535|18827889|P10|STARTED|Period 2||12
7645679|NCT02173535|18827890|P9|STARTED|Period 2||12
7645680|NCT02173535|18827891|P8|STARTED|Period 2||12
7645681|NCT02173535|18827892|P7|STARTED|Period 2||12
7645682|NCT02173535|18827893|P6|STARTED|Period 2||12
7645683|NCT02173535|18827894|P5|STARTED|Period 2||12
7645684|NCT02173535|18827895|P4|STARTED|Period 2||12
7645685|NCT02173535|18827896|P3|STARTED|Period 2||12
7645686|NCT02173535|18827897|P2|STARTED|Period 2||12
7645687|NCT02173535|18827898|P1|STARTED|Period 2||12
7645688|NCT02173535|18827879|P20|NOT COMPLETED|Period 1||0
7645689|NCT02173535|18827880|P19|NOT COMPLETED|Period 1||0
7645690|NCT02173535|18827881|P18|NOT COMPLETED|Period 1||0
7645691|NCT02173535|18827882|P17|NOT COMPLETED|Period 1||0
7645692|NCT02173535|18827883|P16|NOT COMPLETED|Period 1||0
7645693|NCT02173535|18827884|P15|NOT COMPLETED|Period 1||0
7645694|NCT02173535|18827885|P14|NOT COMPLETED|Period 1||0
7645695|NCT02173535|18827886|P13|NOT COMPLETED|Period 1||0
7645696|NCT02173535|18827887|P12|NOT COMPLETED|Period 1||0
7645697|NCT02173535|18827888|P11|NOT COMPLETED|Period 1||0
7645698|NCT02173535|18827889|P10|NOT COMPLETED|Period 1||0
7645699|NCT02173535|18827890|P9|NOT COMPLETED|Period 1||0
7645700|NCT02173535|18827891|P8|NOT COMPLETED|Period 1||0
7645701|NCT02173535|18827892|P7|NOT COMPLETED|Period 1||0
7645702|NCT02173535|18827893|P6|NOT COMPLETED|Period 1||0
7645703|NCT02173535|18827894|P5|NOT COMPLETED|Period 1||0
7645704|NCT02173535|18827895|P4|NOT COMPLETED|Period 1||0
7645705|NCT02173535|18827896|P3|NOT COMPLETED|Period 1||0
7645706|NCT02173535|18827897|P2|NOT COMPLETED|Period 1||0
7645707|NCT02173535|18827898|P1|NOT COMPLETED|Period 1||0
7645708|NCT02173535|18827879|P20|COMPLETED|Period 1||12
7645709|NCT02173535|18827880|P19|COMPLETED|Period 1||12
7645710|NCT02173535|18827881|P18|COMPLETED|Period 1||12
7645711|NCT02173535|18827882|P17|COMPLETED|Period 1||12
7645712|NCT02173535|18827883|P16|COMPLETED|Period 1||12
7645713|NCT02173535|18827884|P15|COMPLETED|Period 1||12
7645714|NCT02173535|18827885|P14|COMPLETED|Period 1||12
7645715|NCT02173535|18827886|P13|COMPLETED|Period 1||12
7645716|NCT02173535|18827887|P12|COMPLETED|Period 1||12
7645717|NCT02173535|18827888|P11|COMPLETED|Period 1||12
7645718|NCT02173535|18827889|P10|COMPLETED|Period 1||12
7645719|NCT02173535|18827890|P9|COMPLETED|Period 1||12
7645720|NCT02173535|18827891|P8|COMPLETED|Period 1||12
7645721|NCT02173535|18827892|P7|COMPLETED|Period 1||12
7645722|NCT02173535|18827893|P6|COMPLETED|Period 1||12
7645723|NCT02173535|18827894|P5|COMPLETED|Period 1||12
7645724|NCT02173535|18827895|P4|COMPLETED|Period 1||12
7645725|NCT02173535|18827896|P3|COMPLETED|Period 1||12
7645726|NCT02173535|18827897|P2|COMPLETED|Period 1||12
7645727|NCT02173535|18827898|P1|COMPLETED|Period 1||12
7645728|NCT02173535|18827879|P20|STARTED|Period 1||12
7645729|NCT02173535|18827880|P19|STARTED|Period 1||12
7645730|NCT02173535|18827881|P18|STARTED|Period 1||12
7645731|NCT02173535|18827882|P17|STARTED|Period 1||12
7645732|NCT02173535|18827883|P16|STARTED|Period 1||12
7645733|NCT02173535|18827884|P15|STARTED|Period 1||12
7645734|NCT02173535|18827885|P14|STARTED|Period 1||12
7645735|NCT02173535|18827886|P13|STARTED|Period 1||12
7645736|NCT02173535|18827887|P12|STARTED|Period 1||12
7645737|NCT02173535|18827888|P11|STARTED|Period 1||12
7645738|NCT02173535|18827889|P10|STARTED|Period 1||12
7645739|NCT02173535|18827890|P9|STARTED|Period 1||12
7645740|NCT02173535|18827891|P8|STARTED|Period 1||12
7645741|NCT02173535|18827892|P7|STARTED|Period 1||12
7645742|NCT02173535|18827893|P6|STARTED|Period 1||12
7645743|NCT02173535|18827894|P5|STARTED|Period 1||12
7645744|NCT02173535|18827895|P4|STARTED|Period 1||12
7645745|NCT02173535|18827896|P3|STARTED|Period 1||12
7645746|NCT02173535|18827897|P2|STARTED|Period 1||12
7645747|NCT02173535|18827898|P1|STARTED|Period 1||12
7645748|NCT02173522|18827937|P2|NOT COMPLETED|Overall Study||0
7645749|NCT02173522|18827938|P1|NOT COMPLETED|Overall Study||0
7645750|NCT02173522|18827937|P2|COMPLETED|Overall Study||0
7645751|NCT02173522|18827938|P1|COMPLETED|Overall Study||4
7645752|NCT02173522|18827937|P2|STARTED|Overall Study||0
7645753|NCT02173522|18827938|P1|STARTED|Overall Study||4
7645754|NCT02173392|18827958|P2|NOT COMPLETED|Overall Study||4
7645755|NCT02173392|18827959|P1|NOT COMPLETED|Overall Study||14
7645756|NCT02173392|18827958|P2|COMPLETED|Overall Study||68
7645757|NCT02173392|18827959|P1|COMPLETED|Overall Study||59
7645758|NCT02173392|18827958|P2|STARTED|Overall Study||72
7645759|NCT02173392|18827959|P1|STARTED|Overall Study||73
7645760|NCT02173379|18827971|P2|NOT COMPLETED|Overall Study||77
7645761|NCT02173379|18827972|P1|NOT COMPLETED|Overall Study||91
7645762|NCT02173379|18827971|P2|COMPLETED|Overall Study||1231
7645763|NCT02173379|18827972|P1|COMPLETED|Overall Study||1205
7645764|NCT02173379|18827971|P2|STARTED|Overall Study||1308
7645765|NCT02173379|18827972|P1|STARTED|Overall Study||1296
7645766|NCT02173158|18828216|P1|NOT COMPLETED|Safety Phase||0
7645767|NCT02173158|18828216|P1|COMPLETED|Safety Phase||8
7645768|NCT02173158|18828216|P1|STARTED|Safety Phase||8
7645769|NCT02173158|18828216|P1|NOT COMPLETED|Efficacy Phase||1
7645770|NCT02173158|18828216|P1|COMPLETED|Efficacy Phase||8
7645771|NCT02173158|18828216|P1|STARTED|Efficacy Phase||9
7645772|NCT02173054|18828233|P3|NOT COMPLETED|Overall Study||1
7645773|NCT02173054|18828234|P2|NOT COMPLETED|Overall Study||0
7645774|NCT02173054|18828235|P1|NOT COMPLETED|Overall Study||1
7645775|NCT02173054|18828233|P3|COMPLETED|Overall Study||39
7645776|NCT02173054|18828234|P2|COMPLETED|Overall Study||40
7645777|NCT02173054|18828235|P1|COMPLETED|Overall Study||39
7645778|NCT02173054|18828233|P3|STARTED|Overall Study||40
7645779|NCT02173054|18828234|P2|STARTED|Overall Study||40
7645780|NCT02173054|18828235|P1|STARTED|Overall Study||40
7645781|NCT02172820|18828257|P2|NOT COMPLETED|Overall Study||0
7645782|NCT02172820|18828258|P1|NOT COMPLETED|Overall Study||0
7645783|NCT02172820|18828257|P2|COMPLETED|Overall Study||65
7645784|NCT02172820|18828258|P1|COMPLETED|Overall Study||65
7645785|NCT02172820|18828257|P2|STARTED|Overall Study||65
7645786|NCT02172820|18828258|P1|STARTED|Overall Study||65
7645787|NCT02172755|18828270|P2|NOT COMPLETED|Overall Study||4
7645788|NCT02172755|18828271|P1|NOT COMPLETED|Overall Study||2
7645789|NCT02172755|18828270|P2|COMPLETED|Overall Study||12
7645790|NCT02172755|18828271|P1|COMPLETED|Overall Study||12
7645791|NCT02172755|18828270|P2|STARTED|Overall Study||16
7645792|NCT02172755|18828271|P1|STARTED|Overall Study||14
7645793|NCT02172742|18828283|P2|NOT COMPLETED|Overall Study||0
7645794|NCT02172742|18828284|P1|NOT COMPLETED|Overall Study||1
7645795|NCT02172742|18828283|P2|COMPLETED|Overall Study||6
7645796|NCT02172742|18828284|P1|COMPLETED|Overall Study||6
7645797|NCT02172742|18828283|P2|STARTED|Overall Study||6
7645798|NCT02172742|18828284|P1|STARTED|Overall Study||7
7645799|NCT02172664|18828291|P2|NOT COMPLETED|Overall Study||6
7645800|NCT02172664|18828292|P1|NOT COMPLETED|Overall Study||6
7645801|NCT02172664|18828291|P2|COMPLETED|Overall Study||27
7645802|NCT02172664|18828292|P1|COMPLETED|Overall Study||27
7645803|NCT02172664|18828291|P2|STARTED|Overall Study||33
7645804|NCT02172664|18828292|P1|STARTED|Overall Study||33
7645805|NCT02172625|18828301|P2|NOT COMPLETED|Overall Study||3
7645806|NCT02172625|18828302|P1|NOT COMPLETED|Overall Study||0
7645807|NCT02172625|18828301|P2|COMPLETED|Overall Study||16
7645808|NCT02172625|18828302|P1|COMPLETED|Overall Study||19
7645809|NCT02172625|18828301|P2|STARTED|Overall Study||19
7645810|NCT02172625|18828302|P1|STARTED|Overall Study||19
7645811|NCT02172040|18828324|P4|NOT COMPLETED|Overall Study||1
7645812|NCT02172040|18828325|P3|NOT COMPLETED|Overall Study||2
7645813|NCT02172040|18828326|P2|NOT COMPLETED|Overall Study||3
7645814|NCT02172040|18828327|P1|NOT COMPLETED|Overall Study||0
7645815|NCT02172040|18828324|P4|COMPLETED|Overall Study||26
7645816|NCT02172040|18828325|P3|COMPLETED|Overall Study||29
7645817|NCT02172040|18828326|P2|COMPLETED|Overall Study||42
7645818|NCT02172040|18828327|P1|COMPLETED|Overall Study||49
7645819|NCT02172040|18828324|P4|STARTED|Overall Study||27
7645820|NCT02172040|18828325|P3|STARTED|Overall Study||31
7645821|NCT02172040|18828326|P2|STARTED|Overall Study||45
7645822|NCT02172040|18828327|P1|STARTED|Overall Study||49
7645823|NCT02171819|18828376|P3|NOT COMPLETED|Overall Study||0
7645824|NCT02171819|18828377|P2|NOT COMPLETED|Overall Study||0
7645825|NCT02171819|18828378|P1|NOT COMPLETED|Overall Study||0
7645826|NCT02171819|18828376|P3|COMPLETED|Overall Study||12
7645827|NCT02171819|18828377|P2|COMPLETED|Overall Study||32
7645828|NCT02171819|18828378|P1|COMPLETED|Overall Study||31
7645829|NCT02171819|18828376|P3|STARTED|Overall Study||12
7645830|NCT02171819|18828377|P2|STARTED|Overall Study||32
7645831|NCT02171819|18828378|P1|STARTED|Overall Study||31
7645832|NCT02171611|18828413|P6|NOT COMPLETED|Overall Study||0
7645833|NCT02171611|18828414|P5|NOT COMPLETED|Overall Study||0
7645834|NCT02171611|18828415|P4|NOT COMPLETED|Overall Study||0
7645835|NCT02171611|18828416|P3|NOT COMPLETED|Overall Study||0
7645836|NCT02171611|18828417|P2|NOT COMPLETED|Overall Study||0
7645837|NCT02171611|18828418|P1|NOT COMPLETED|Overall Study||0
7645838|NCT02171611|18828413|P6|COMPLETED|Overall Study||5
7645839|NCT02171611|18828414|P5|COMPLETED|Overall Study||5
7645840|NCT02171611|18828415|P4|COMPLETED|Overall Study||5
7645841|NCT02171611|18828416|P3|COMPLETED|Overall Study||5
7645842|NCT02171611|18828417|P2|COMPLETED|Overall Study||5
7645843|NCT02171611|18828418|P1|COMPLETED|Overall Study||5
7645844|NCT02171611|18828413|P6|STARTED|Overall Study||5
7645845|NCT02171611|18828414|P5|STARTED|Overall Study||5
7645846|NCT02171611|18828415|P4|STARTED|Overall Study||5
7645847|NCT02171611|18828416|P3|STARTED|Overall Study||5
7645848|NCT02171611|18828417|P2|STARTED|Overall Study||5
7645849|NCT02171611|18828418|P1|STARTED|Overall Study||5
7645850|NCT02171260|18828490|P4|NOT COMPLETED|Overall Study||5
7645851|NCT02171260|18828491|P3|NOT COMPLETED|Overall Study||5
7645852|NCT02171260|18828492|P2|NOT COMPLETED|Overall Study||6
7645853|NCT02171260|18828493|P1|NOT COMPLETED|Overall Study||6
7645854|NCT02171260|18828490|P4|COMPLETED|Overall Study||0
7645855|NCT02171260|18828491|P3|COMPLETED|Overall Study||0
7645856|NCT02171260|18828492|P2|COMPLETED|Overall Study||0
7645857|NCT02171260|18828493|P1|COMPLETED|Overall Study||0
7645858|NCT02171260|18828490|P4|STARTED|Overall Study||5
7645859|NCT02171260|18828491|P3|STARTED|Overall Study||5
7645860|NCT02171260|18828492|P2|STARTED|Overall Study||6
7645861|NCT02171260|18828493|P1|STARTED|Overall Study||6
7645862|NCT02171247|18828550|P2|NOT COMPLETED|Overall Study||0
7645863|NCT02171247|18828551|P1|NOT COMPLETED|Overall Study||0
7645864|NCT02171247|18828550|P2|COMPLETED|Overall Study||17
7645865|NCT02171247|18828551|P1|COMPLETED|Overall Study||16
7645866|NCT02171247|18828550|P2|STARTED|Overall Study||17
7645867|NCT02171247|18828551|P1|STARTED|Overall Study||16
7645868|NCT02171234|18828568|P5|NOT COMPLETED|Overall Study||0
7645869|NCT02171234|18828569|P4|NOT COMPLETED|Overall Study||0
7645870|NCT02171234|18828570|P3|NOT COMPLETED|Overall Study||0
7645871|NCT02171234|18828571|P2|NOT COMPLETED|Overall Study||0
7645872|NCT02171234|18828572|P1|NOT COMPLETED|Overall Study||0
7645873|NCT02171234|18828568|P5|COMPLETED|Overall Study||6
7645874|NCT02171234|18828569|P4|COMPLETED|Overall Study||6
7645875|NCT02171234|18828570|P3|COMPLETED|Overall Study||6
7645876|NCT02171234|18828571|P2|COMPLETED|Overall Study||6
7645877|NCT02171234|18828572|P1|COMPLETED|Overall Study||8
7645878|NCT02171234|18828568|P5|STARTED|Overall Study||6
7645879|NCT02171234|18828569|P4|STARTED|Overall Study||6
7645880|NCT02171234|18828570|P3|STARTED|Overall Study||6
7645881|NCT02171234|18828571|P2|STARTED|Overall Study||6
7645882|NCT02171234|18828572|P1|STARTED|Overall Study||8
7645883|NCT02171195|18828601|P9|NOT COMPLETED|Overall Study||0
7645884|NCT02171195|18828602|P8|NOT COMPLETED|Overall Study||0
7645885|NCT02171195|18828603|P7|NOT COMPLETED|Overall Study||0
7645886|NCT02171195|18828604|P6|NOT COMPLETED|Overall Study||0
7645887|NCT02171195|18828605|P5|NOT COMPLETED|Overall Study||0
7645888|NCT02171195|18828606|P4|NOT COMPLETED|Overall Study||0
7645889|NCT02171195|18828607|P3|NOT COMPLETED|Overall Study||0
7645890|NCT02171195|18828608|P2|NOT COMPLETED|Overall Study||0
7645891|NCT02171195|18828609|P1|NOT COMPLETED|Overall Study||0
7645892|NCT02171195|18828601|P9|COMPLETED|Overall Study||6
7645893|NCT02171195|18828602|P8|COMPLETED|Overall Study||6
7645894|NCT02171195|18828603|P7|COMPLETED|Overall Study||6
7645895|NCT02171195|18828604|P6|COMPLETED|Overall Study||6
7645896|NCT02171195|18828605|P5|COMPLETED|Overall Study||6
7645897|NCT02171195|18828606|P4|COMPLETED|Overall Study||6
7645898|NCT02171195|18828607|P3|COMPLETED|Overall Study||6
7645899|NCT02171195|18828608|P2|COMPLETED|Overall Study||6
7645900|NCT02171195|18828609|P1|COMPLETED|Overall Study||16
7645901|NCT02171195|18828601|P9|STARTED|Overall Study||6
7645902|NCT02171195|18828602|P8|STARTED|Overall Study||6
7645903|NCT02171195|18828603|P7|STARTED|Overall Study||6
7645904|NCT02171195|18828604|P6|STARTED|Overall Study||6
7645905|NCT02171195|18828605|P5|STARTED|Overall Study||6
7645906|NCT02171195|18828606|P4|STARTED|Overall Study||6
7645907|NCT02171195|18828607|P3|STARTED|Overall Study||6
7645908|NCT02171195|18828608|P2|STARTED|Overall Study||6
7645909|NCT02171195|18828609|P1|STARTED|Overall Study||16
7645910|NCT02171130|18828629|P1|NOT COMPLETED|Overall Study||28
7645911|NCT02171130|18828629|P1|COMPLETED|Overall Study|Including participants who completed the 6-month study but did not experience any hypoglycemia event|101
7645912|NCT02171130|18828629|P1|Experienced Hypoglycemic Event|Overall Study|Experienced at least one hypoglycemic event and received at least one dose of study drug.|87
7645913|NCT02171130|18828629|P1|Received at Least One Dose of Study Drug|Overall Study||87
7645914|NCT02171130|18828629|P1|STARTED|Overall Study||129
7645915|NCT02170870|18828643|P6|NOT COMPLETED|Overall Study||0
7645916|NCT02170870|18828644|P5|NOT COMPLETED|Overall Study||0
7645917|NCT02170870|18828645|P4|NOT COMPLETED|Overall Study||0
7645918|NCT02170870|18828646|P3|NOT COMPLETED|Overall Study||0
7645919|NCT02170870|18828647|P2|NOT COMPLETED|Overall Study||0
7645920|NCT02170870|18828648|P1|NOT COMPLETED|Overall Study||0
7645921|NCT02170870|18828643|P6|COMPLETED|Overall Study||20
7645922|NCT02170870|18828644|P5|COMPLETED|Overall Study||20
7645923|NCT02170870|18828645|P4|COMPLETED|Overall Study||20
7645924|NCT02170870|18828646|P3|COMPLETED|Overall Study||20
7645925|NCT02170870|18828647|P2|COMPLETED|Overall Study||11
7645926|NCT02170870|18828648|P1|COMPLETED|Overall Study||13
7645927|NCT02170870|18828643|P6|STARTED|Overall Study||20
7645928|NCT02170870|18828644|P5|STARTED|Overall Study||20
7645929|NCT02170870|18828645|P4|STARTED|Overall Study||20
7645930|NCT02170870|18828646|P3|STARTED|Overall Study||20
7645931|NCT02170870|18828647|P2|STARTED|Overall Study||11
7645932|NCT02170870|18828648|P1|STARTED|Overall Study||13
7645933|NCT02170779|18828670|P2|NOT COMPLETED|Overall Study||1
7645934|NCT02170779|18828671|P1|NOT COMPLETED|Overall Study||1
7645935|NCT02170779|18828670|P2|COMPLETED|Overall Study||19
7645936|NCT02170779|18828671|P1|COMPLETED|Overall Study||19
7645937|NCT02170779|18828670|P2|STARTED|Overall Study||20
7645938|NCT02170779|18828671|P1|STARTED|Overall Study||20
7645939|NCT02170727|18828695|P2|NOT COMPLETED|Overall Study||0
7645940|NCT02170727|18828696|P1|NOT COMPLETED|Overall Study||3
7645941|NCT02170727|18828695|P2|COMPLETED|Overall Study||31
7645942|NCT02170727|18828696|P1|COMPLETED|Overall Study||135
7645943|NCT02170727|18828695|P2|STARTED|Overall Study||31
7645944|NCT02170727|18828696|P1|STARTED|Overall Study||138
7645945|NCT02170688|18828727|P5|NOT COMPLETED|Overall Study||0
7645946|NCT02170688|18828728|P4|NOT COMPLETED|Overall Study||2
7645947|NCT02170688|18828729|P3|NOT COMPLETED|Overall Study||4
7645948|NCT02170688|18828730|P2|NOT COMPLETED|Overall Study||3
7645949|NCT02170688|18828731|P1|NOT COMPLETED|Overall Study||4
7645950|NCT02170688|18828727|P5|COMPLETED|Overall Study||25
7645951|NCT02170688|18828728|P4|COMPLETED|Overall Study||25
7645952|NCT02170688|18828729|P3|COMPLETED|Overall Study||25
7645953|NCT02170688|18828730|P2|COMPLETED|Overall Study||26
7645954|NCT02170688|18828731|P1|COMPLETED|Overall Study||25
7645955|NCT02170688|18828727|P5|STARTED|Overall Study||25
7645956|NCT02170688|18828728|P4|STARTED|Overall Study||27
7645957|NCT02170688|18828729|P3|STARTED|Overall Study||29
7645958|NCT02170688|18828730|P2|STARTED|Overall Study||29
7645959|NCT02170688|18828731|P1|STARTED|Overall Study||29
7645960|NCT02170662|18828750|P2|NOT COMPLETED|Overall Study||0
7645961|NCT02170662|18828751|P1|NOT COMPLETED|Overall Study||0
7645962|NCT02170662|18828750|P2|COMPLETED|Overall Study||6
7645963|NCT02170662|18828751|P1|COMPLETED|Overall Study||3
7645964|NCT02170662|18828750|P2|STARTED|Overall Study||6
7645965|NCT02170662|18828751|P1|STARTED|Overall Study||3
7645966|NCT02170649|18828763|P1|NOT COMPLETED|Fed Period||0
7645967|NCT02170649|18828763|P1|COMPLETED|Fed Period||12
7645968|NCT02170649|18828763|P1|STARTED|Fed Period||12
7645969|NCT02170649|18828763|P1|NOT COMPLETED|Fasting Period||0
7645970|NCT02170649|18828763|P1|COMPLETED|Fasting Period||12
7645971|NCT02170649|18828763|P1|STARTED|Fasting Period||12
7645972|NCT02170532|18828770|P1|NOT COMPLETED|Overall Study||0
7645973|NCT02170532|18828770|P1|COMPLETED|Overall Study||10
7645974|NCT02170532|18828770|P1|STARTED|Overall Study||10
7645975|NCT02170519|18828800|P2|NOT COMPLETED|Overall Study||0
7645976|NCT02170519|18828801|P1|NOT COMPLETED|Overall Study||0
7645977|NCT02170519|18828800|P2|COMPLETED|Overall Study||5
7645978|NCT02170519|18828801|P1|COMPLETED|Overall Study||22
7645979|NCT02170519|18828800|P2|STARTED|Overall Study||5
7645980|NCT02170519|18828801|P1|STARTED|Overall Study||22
7645981|NCT02170389|18828817|P1|NOT COMPLETED|Overall Study||1
7645982|NCT02170389|18828817|P1|COMPLETED|Overall Study||4
7645983|NCT02170389|18828817|P1|STARTED|Overall Study||5
7645984|NCT02170376|18828827|P5|NOT COMPLETED|Overall Study||0
7645985|NCT02170376|18828828|P4|NOT COMPLETED|Overall Study||0
7645986|NCT02170376|18828829|P3|NOT COMPLETED|Overall Study||0
7645987|NCT02170376|18828830|P2|NOT COMPLETED|Overall Study||1
7645988|NCT02170376|18828831|P1|NOT COMPLETED|Overall Study||0
7645989|NCT02170376|18828827|P5|COMPLETED|Overall Study||16
7645990|NCT02170376|18828828|P4|COMPLETED|Overall Study||16
7645991|NCT02170376|18828829|P3|COMPLETED|Overall Study||16
7645992|NCT02170376|18828830|P2|COMPLETED|Overall Study||15
7645993|NCT02170376|18828831|P1|COMPLETED|Overall Study||16
7645994|NCT02170376|18828827|P5|Pharmacokinetic Population|Overall Study||16
7645995|NCT02170376|18828828|P4|Pharmacokinetic Population|Overall Study||16
7645996|NCT02170376|18828829|P3|Pharmacokinetic Population|Overall Study||16
7645997|NCT02170376|18828830|P2|Pharmacokinetic Population|Overall Study||15
7645998|NCT02170376|18828831|P1|Pharmacokinetic Population|Overall Study||16
7645999|NCT02170376|18828827|P5|STARTED|Overall Study||16
7646000|NCT02170376|18828828|P4|STARTED|Overall Study||16
7646001|NCT02170376|18828829|P3|STARTED|Overall Study||16
7646002|NCT02170376|18828830|P2|STARTED|Overall Study||16
7646003|NCT02170376|18828831|P1|STARTED|Overall Study||16
7646004|NCT02170363|18828868|P1|NOT COMPLETED|Overall Study||0
7646005|NCT02170363|18828868|P1|COMPLETED|Overall Study|Followed to the 6-Month Primary Endpoint|50
7646006|NCT02170363|18828868|P1|STARTED|Overall Study||50
7646007|NCT02170298|18828882|P2|NOT COMPLETED|Overall Study||1
7646008|NCT02170298|18828883|P1|NOT COMPLETED|Overall Study||1
7646009|NCT02170298|18828882|P2|COMPLETED|Overall Study||4
7646010|NCT02170298|18828883|P1|COMPLETED|Overall Study||0
7646011|NCT02170298|18828882|P2|STARTED|Overall Study||5
7646012|NCT02170298|18828883|P1|STARTED|Overall Study||1
7646013|NCT02170220|18828893|P2|NOT COMPLETED|Overall Study||0
7646014|NCT02170220|18828894|P1|NOT COMPLETED|Overall Study||0
7646015|NCT02170220|18828893|P2|COMPLETED|Overall Study||6
7646016|NCT02170220|18828894|P1|COMPLETED|Overall Study||6
7646017|NCT02170220|18828893|P2|STARTED|Overall Study||6
7646018|NCT02170220|18828894|P1|STARTED|Overall Study||6
7646019|NCT02170207|18828920|P1|NOT COMPLETED|Overall Study||5
7646020|NCT02170207|18828920|P1|COMPLETED|Overall Study||58
7646021|NCT02170207|18828920|P1|STARTED|Overall Study||63
7646022|NCT02170077|18828931|P3|NOT COMPLETED|Overall Study||12
7646023|NCT02170077|18828932|P2|NOT COMPLETED|Overall Study||13
7646024|NCT02170077|18828933|P1|NOT COMPLETED|Overall Study||9
7646025|NCT02170077|18828931|P3|COMPLETED|Overall Study||35
7646026|NCT02170077|18828932|P2|COMPLETED|Overall Study||34
7646027|NCT02170077|18828933|P1|COMPLETED|Overall Study||41
7646028|NCT02170077|18828931|P3|Intent to Treat (ITT) Population|Overall Study||47
7646029|NCT02170077|18828932|P2|Intent to Treat (ITT) Population|Overall Study||46
7646030|NCT02170077|18828933|P1|Intent to Treat (ITT) Population|Overall Study||50
7646031|NCT02170077|18828931|P3|STARTED|Overall Study||47
7646032|NCT02170077|18828932|P2|STARTED|Overall Study||47
7646033|NCT02170077|18828933|P1|STARTED|Overall Study||50
7646034|NCT02170064|18828944|P3|NOT COMPLETED|Overall Study||1
7646035|NCT02170064|18828945|P2|NOT COMPLETED|Overall Study||2
7646036|NCT02170064|18828946|P1|NOT COMPLETED|Overall Study||6
7646037|NCT02170064|18828944|P3|COMPLETED|Overall Study||10
7646038|NCT02170064|18828945|P2|COMPLETED|Overall Study||7
7646039|NCT02170064|18828946|P1|COMPLETED|Overall Study||9
7646040|NCT02170064|18828944|P3|Efficacy Population (EP)|Overall Study||10
7646041|NCT02170064|18828945|P2|Efficacy Population (EP)|Overall Study||8
7646042|NCT02170064|18828946|P1|Efficacy Population (EP)|Overall Study||11
7646043|NCT02170064|18828944|P3|Pharmacokinetic Population (PKP)|Overall Study||10
7646044|NCT02170064|18828945|P2|Pharmacokinetic Population (PKP)|Overall Study||8
7646045|NCT02170064|18828946|P1|Pharmacokinetic Population (PKP)|Overall Study||11
7646046|NCT02170064|18828944|P3|Safety Population (SP)|Overall Study||11
7646047|NCT02170064|18828945|P2|Safety Population (SP)|Overall Study||8
7646048|NCT02170064|18828946|P1|Safety Population (SP)|Overall Study||12
7646049|NCT02170064|18828944|P3|STARTED|Overall Study||11
7646050|NCT02170064|18828945|P2|STARTED|Overall Study||9
7646051|NCT02170064|18828946|P1|STARTED|Overall Study||15
7646052|NCT02170051|18828962|P2|NOT COMPLETED|Overall Study||13
7646053|NCT02170051|18828963|P1|NOT COMPLETED|Overall Study||11
7646054|NCT02170051|18828962|P2|COMPLETED|Overall Study||16
7646055|NCT02170051|18828963|P1|COMPLETED|Overall Study||15
7646056|NCT02170051|18828962|P2|Tested at Post-treatment|Overall Study||16
7646057|NCT02170051|18828963|P1|Tested at Post-treatment|Overall Study||15
7646058|NCT02170051|18828962|P2|Tested at Mid-point|Overall Study||18
7646059|NCT02170051|18828963|P1|Tested at Mid-point|Overall Study||13
7646060|NCT02170051|18828962|P2|STARTED|Overall Study||29
7646061|NCT02170051|18828963|P1|STARTED|Overall Study||26
7646062|NCT02170025|18828983|P2|NOT COMPLETED|Overall Study||0
7646063|NCT02170025|18828984|P1|NOT COMPLETED|Overall Study||2
7646064|NCT02170025|18828983|P2|COMPLETED|Overall Study||7
7646065|NCT02170025|18828984|P1|COMPLETED|Overall Study||12
7646066|NCT02170025|18828983|P2|STARTED|Overall Study||7
7646067|NCT02170025|18828984|P1|STARTED|Overall Study||14
7646068|NCT02169895|18828996|P4|NOT COMPLETED|Overall Study||2
7646069|NCT02169895|18828997|P3|NOT COMPLETED|Overall Study||0
7646070|NCT02169895|18828998|P2|NOT COMPLETED|Overall Study||0
7646071|NCT02169895|18828999|P1|NOT COMPLETED|Overall Study||0
7646072|NCT02169895|18828996|P4|COMPLETED|Overall Study||2
7646073|NCT02169895|18828997|P3|COMPLETED|Overall Study||4
7646074|NCT02169895|18828998|P2|COMPLETED|Overall Study||4
7646075|NCT02169895|18828999|P1|COMPLETED|Overall Study||4
7646076|NCT02169895|18828996|P4|Placebo|Overall Study||4
7646077|NCT02169895|18828997|P3|Placebo|Overall Study||4
7646078|NCT02169895|18828998|P2|Placebo|Overall Study||4
7646079|NCT02169895|18828999|P1|Placebo|Overall Study||4
7646080|NCT02169895|18828996|P4|100 mg BIA 9-1067|Overall Study||2
7646081|NCT02169895|18828997|P3|100 mg BIA 9-1067|Overall Study||4
7646082|NCT02169895|18828998|P2|100 mg BIA 9-1067|Overall Study||4
7646083|NCT02169895|18828999|P1|100 mg BIA 9-1067|Overall Study||4
7646084|NCT02169895|18828996|P4|50 mg BIA 9-1067|Overall Study||4
7646085|NCT02169895|18828997|P3|50 mg BIA 9-1067|Overall Study||4
7646086|NCT02169895|18828998|P2|50 mg BIA 9-1067|Overall Study||4
7646087|NCT02169895|18828999|P1|50 mg BIA 9-1067|Overall Study||4
7646088|NCT02169895|18828996|P4|25 mg BIA 9-1067|Overall Study||4
7646089|NCT02169895|18828997|P3|25 mg BIA 9-1067|Overall Study||4
7646090|NCT02169895|18828998|P2|25 mg BIA 9-1067|Overall Study||4
7646091|NCT02169895|18828999|P1|25 mg BIA 9-1067|Overall Study||4
7646092|NCT02169895|18828996|P4|STARTED|Overall Study||4
7646093|NCT02169895|18828997|P3|STARTED|Overall Study||4
7646094|NCT02169895|18828998|P2|STARTED|Overall Study||4
7646095|NCT02169895|18828999|P1|STARTED|Overall Study||4
7646096|NCT02169869|18829019|P2|NOT COMPLETED|Overall Study||0
7646097|NCT02169869|18829020|P1|NOT COMPLETED|Overall Study||0
7646098|NCT02169869|18829019|P2|COMPLETED|Overall Study||16
7646099|NCT02169869|18829020|P1|COMPLETED|Overall Study||17
7646100|NCT02169869|18829019|P2|STARTED|Overall Study||16
7646101|NCT02169869|18829020|P1|STARTED|Overall Study||17
7646102|NCT02169674|18829028|P2|NOT COMPLETED|Overall Study||78
7646103|NCT02169674|18829029|P1|NOT COMPLETED|Overall Study||32
7646104|NCT02169674|18829028|P2|COMPLETED|Overall Study||135
7646105|NCT02169674|18829029|P1|COMPLETED|Overall Study||105
7646106|NCT02169674|18829028|P2|STARTED|Overall Study||213
7646107|NCT02169674|18829029|P1|STARTED|Overall Study||137
7646108|NCT02169505|18829043|P1|NOT COMPLETED|Overall Study||1
7646109|NCT02169505|18829043|P1|COMPLETED|Overall Study||1
7646110|NCT02169505|18829043|P1|STARTED|Overall Study||2
7646111|NCT02169479|18829058|P4|NOT COMPLETED|Overall Study||0
7646112|NCT02169479|18829059|P3|NOT COMPLETED|Overall Study||0
7646113|NCT02169479|18829060|P2|NOT COMPLETED|Overall Study||1
7646114|NCT02169479|18829061|P1|NOT COMPLETED|Overall Study||1
7646115|NCT02169479|18829058|P4|COMPLETED|Overall Study||4
7646116|NCT02169479|18829059|P3|COMPLETED|Overall Study||4
7646117|NCT02169479|18829060|P2|COMPLETED|Overall Study||3
7646118|NCT02169479|18829061|P1|COMPLETED|Overall Study||3
7646119|NCT02169479|18829058|P4|Placebo|Overall Study||4
7646120|NCT02169479|18829059|P3|Placebo|Overall Study||4
7646121|NCT02169479|18829060|P2|Placebo|Overall Study||3
7646122|NCT02169479|18829061|P1|Placebo|Overall Study||3
7646123|NCT02169479|18829058|P4|100 mg BIA 9-1067|Overall Study||4
7646124|NCT02169479|18829059|P3|100 mg BIA 9-1067|Overall Study||4
7646125|NCT02169479|18829060|P2|100 mg BIA 9-1067|Overall Study||4
7646126|NCT02169479|18829061|P1|100 mg BIA 9-1067|Overall Study||3
7646127|NCT02169479|18829058|P4|50 mg BIA 9-1067|Overall Study||4
7646128|NCT02169479|18829059|P3|50 mg BIA 9-1067|Overall Study||4
7646129|NCT02169479|18829060|P2|50 mg BIA 9-1067|Overall Study||4
7646130|NCT02169479|18829061|P1|50 mg BIA 9-1067|Overall Study||4
7646131|NCT02169479|18829058|P4|25 mg BIA 9-1067|Overall Study||4
7646132|NCT02169479|18829059|P3|25 mg BIA 9-1067|Overall Study||4
7646133|NCT02169479|18829060|P2|25 mg BIA 9-1067|Overall Study||3
7646134|NCT02169479|18829061|P1|25 mg BIA 9-1067|Overall Study||4
7646135|NCT02169479|18829058|P4|STARTED|Overall Study||4
7646136|NCT02169479|18829059|P3|STARTED|Overall Study||4
7646137|NCT02169479|18829060|P2|STARTED|Overall Study||4
7646138|NCT02169479|18829061|P1|STARTED|Overall Study||4
7646139|NCT02169466|18829083|P4|NOT COMPLETED|Overall Study||0
7646140|NCT02169466|18829084|P3|NOT COMPLETED|Overall Study||0
7646141|NCT02169466|18829085|P2|NOT COMPLETED|Overall Study||1
7646142|NCT02169466|18829086|P1|NOT COMPLETED|Overall Study||1
7646143|NCT02169466|18829083|P4|COMPLETED|Overall Study||5
7646144|NCT02169466|18829084|P3|COMPLETED|Overall Study||5
7646145|NCT02169466|18829085|P2|COMPLETED|Overall Study||5
7646146|NCT02169466|18829086|P1|COMPLETED|Overall Study||5
7646147|NCT02169466|18829083|P4|Placebo|Overall Study||5
7646148|NCT02169466|18829084|P3|Placebo|Overall Study||5
7646149|NCT02169466|18829085|P2|Placebo|Overall Study||6
7646150|NCT02169466|18829086|P1|Placebo|Overall Study||5
7646151|NCT02169466|18829083|P4|100 mg BIA 9-1067|Overall Study||5
7646152|NCT02169466|18829084|P3|100 mg BIA 9-1067|Overall Study||5
7646153|NCT02169466|18829085|P2|100 mg BIA 9-1067|Overall Study||6
7646154|NCT02169466|18829086|P1|100 mg BIA 9-1067|Overall Study||6
7646155|NCT02169466|18829083|P4|50 mg BIA 9-1067|Overall Study||5
7646156|NCT02169466|18829084|P3|50 mg BIA 9-1067|Overall Study||5
7646157|NCT02169466|18829085|P2|50 mg BIA 9-1067|Overall Study||6
7646158|NCT02169466|18829086|P1|50 mg BIA 9-1067|Overall Study||6
7646159|NCT02169466|18829083|P4|25 mg BIA 9-1067|Overall Study||5
7646160|NCT02169466|18829084|P3|25 mg BIA 9-1067|Overall Study||5
7646161|NCT02169466|18829085|P2|25 mg BIA 9-1067|Overall Study||5
7646162|NCT02169466|18829086|P1|25 mg BIA 9-1067|Overall Study||6
7646163|NCT02169466|18829083|P4|STARTED|Overall Study||5
7646164|NCT02169466|18829084|P3|STARTED|Overall Study||5
7646165|NCT02169466|18829085|P2|STARTED|Overall Study||6
7646166|NCT02169466|18829086|P1|STARTED|Overall Study||6
7646167|NCT02169453|18829112|P4|NOT COMPLETED|Overall Study||0
7646168|NCT02169453|18829113|P3|NOT COMPLETED|Overall Study||1
7646169|NCT02169453|18829114|P2|NOT COMPLETED|Overall Study||0
7646170|NCT02169453|18829115|P1|NOT COMPLETED|Overall Study||0
7646171|NCT02169453|18829112|P4|COMPLETED|Overall Study||3
7646172|NCT02169453|18829113|P3|COMPLETED|Overall Study||2
7646173|NCT02169453|18829114|P2|COMPLETED|Overall Study||3
7646174|NCT02169453|18829115|P1|COMPLETED|Overall Study||3
7646175|NCT02169453|18829112|P4|Placebo|Overall Study||3
7646176|NCT02169453|18829113|P3|Placebo|Overall Study||3
7646177|NCT02169453|18829114|P2|Placebo|Overall Study||3
7646178|NCT02169453|18829115|P1|Placebo|Overall Study||3
7646179|NCT02169453|18829112|P4|100 mg BIA 9-1067|Overall Study||3
7646180|NCT02169453|18829113|P3|100 mg BIA 9-1067|Overall Study||3
7646181|NCT02169453|18829114|P2|100 mg BIA 9-1067|Overall Study||3
7646182|NCT02169453|18829115|P1|100 mg BIA 9-1067|Overall Study||3
7646183|NCT02169453|18829112|P4|50 mg BIA 9-1067|Overall Study||3
7646184|NCT02169453|18829113|P3|50 mg BIA 9-1067|Overall Study||2
7646185|NCT02169453|18829114|P2|50 mg BIA 9-1067|Overall Study||3
7646186|NCT02169453|18829115|P1|50 mg BIA 9-1067|Overall Study||3
7646187|NCT02169453|18829112|P4|25 mg BIA 9-1067|Overall Study||3
7646188|NCT02169453|18829113|P3|25 mg BIA 9-1067|Overall Study||3
7646189|NCT02169453|18829114|P2|25 mg BIA 9-1067|Overall Study||3
7646190|NCT02169453|18829115|P1|25 mg BIA 9-1067|Overall Study||3
7646191|NCT02169453|18829112|P4|STARTED|Overall Study||3
7646192|NCT02169453|18829113|P3|STARTED|Overall Study||3
7646193|NCT02169453|18829114|P2|STARTED|Overall Study||3
7646194|NCT02169453|18829115|P1|STARTED|Overall Study||3
7646195|NCT02169440|18829147|P2|NOT COMPLETED|Overall Study||0
7646196|NCT02169440|18829148|P1|NOT COMPLETED|Overall Study||0
7646197|NCT02169440|18829147|P2|COMPLETED|Overall Study||10
7646198|NCT02169440|18829148|P1|COMPLETED|Overall Study||10
7646199|NCT02169440|18829147|P2|STARTED|Overall Study||10
7646200|NCT02169440|18829148|P1|STARTED|Overall Study||10
7646201|NCT02169427|18829161|P1|NOT COMPLETED|Overall Study||0
7646202|NCT02169427|18829161|P1|COMPLETED|Overall Study||6
7646203|NCT02169427|18829161|P1|STARTED|Overall Study||6
7646204|NCT02169414|18829171|P4|NOT COMPLETED|Overall Study||0
7646205|NCT02169414|18829172|P3|NOT COMPLETED|Overall Study||0
7646206|NCT02169414|18829173|P2|NOT COMPLETED|Overall Study||1
7646207|NCT02169414|18829174|P1|NOT COMPLETED|Overall Study||1
7646208|NCT02169414|18829171|P4|COMPLETED|Overall Study||18
7646209|NCT02169414|18829172|P3|COMPLETED|Overall Study||18
7646210|NCT02169414|18829173|P2|COMPLETED|Overall Study||18
7646211|NCT02169414|18829174|P1|COMPLETED|Overall Study||18
7646212|NCT02169414|18829171|P4|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
7646213|NCT02169414|18829172|P3|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
7646214|NCT02169414|18829173|P2|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
7646215|NCT02169414|18829174|P1|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
7646216|NCT02169414|18829171|P4|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
7646217|NCT02169414|18829172|P3|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
7646218|NCT02169414|18829173|P2|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19
7646219|NCT02169414|18829174|P1|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
7646220|NCT02169414|18829171|P4|STARTED|Overall Study||18
7646221|NCT02169414|18829172|P3|STARTED|Overall Study||18
7646222|NCT02169414|18829173|P2|STARTED|Overall Study||19
7646223|NCT02169414|18829174|P1|STARTED|Overall Study||19
7646224|NCT02169336|18829215|P3|NOT COMPLETED|Overall Study||3
7646225|NCT02169336|18829216|P2|NOT COMPLETED|Overall Study||4
7646226|NCT02169336|18829217|P1|NOT COMPLETED|Overall Study||4
7646227|NCT02169336|18829215|P3|COMPLETED|Overall Study||29
7646228|NCT02169336|18829216|P2|COMPLETED|Overall Study||28
7646229|NCT02169336|18829217|P1|COMPLETED|Overall Study||27
7646230|NCT02169336|18829215|P3|STARTED|Overall Study||32
7646231|NCT02169336|18829216|P2|STARTED|Overall Study||32
7646232|NCT02169336|18829217|P1|STARTED|Overall Study||31
7646233|NCT02169284|18829227|P2|NOT COMPLETED|Overall Study||1
7646234|NCT02169284|18829228|P1|NOT COMPLETED|Overall Study||0
7646235|NCT02169284|18829227|P2|COMPLETED|Overall Study||12
7646236|NCT02169284|18829228|P1|COMPLETED|Overall Study||24
7646237|NCT02169284|18829227|P2|STARTED|Overall Study||13
7646238|NCT02169284|18829228|P1|STARTED|Overall Study||24
7646239|NCT02169271|18829254|P2|NOT COMPLETED|Overall Study||2
7646240|NCT02169271|18829255|P1|NOT COMPLETED|Overall Study||1
7646241|NCT02169271|18829254|P2|COMPLETED|Overall Study||47
7646242|NCT02169271|18829255|P1|COMPLETED|Overall Study||48
7646243|NCT02169271|18829254|P2|STARTED|Overall Study||49
7646244|NCT02169271|18829255|P1|STARTED|Overall Study||49
7646245|NCT02169219|18829277|P1|NOT COMPLETED|Overall Study||6
7646246|NCT02169219|18829277|P1|COMPLETED|Overall Study||14
7646247|NCT02169219|18829277|P1|STARTED|Overall Study||20
7646248|NCT02169115|18829291|P3|NOT COMPLETED|Overall Study||0
7646249|NCT02169115|18829292|P2|NOT COMPLETED|Overall Study||0
7646250|NCT02169115|18829293|P1|NOT COMPLETED|Overall Study||0
7646251|NCT02169115|18829291|P3|COMPLETED|Overall Study||21
7646252|NCT02169115|18829292|P2|COMPLETED|Overall Study||21
7646253|NCT02169115|18829293|P1|COMPLETED|Overall Study||19
7646254|NCT02169115|18829291|P3|STARTED|Overall Study||21
7646255|NCT02169115|18829292|P2|STARTED|Overall Study||21
7646256|NCT02169115|18829293|P1|STARTED|Overall Study||19
7646257|NCT02168946|18829321|P2|NOT COMPLETED|Overall Study||5
7646258|NCT02168946|18829322|P1|NOT COMPLETED|Overall Study||12
7646259|NCT02168946|18829321|P2|COMPLETED|Overall Study||20
7646260|NCT02168946|18829322|P1|COMPLETED|Overall Study||38
7646261|NCT02168946|18829321|P2|STARTED|Overall Study||25
7646262|NCT02168946|18829322|P1|STARTED|Overall Study|2 additional subjects were randomized to Vabomere but did not receive study drug|50
7646263|NCT02168933|18829358|P1|NOT COMPLETED|Overall Study||1
7646264|NCT02168933|18829358|P1|COMPLETED|Overall Study||7
7646265|NCT02168933|18829358|P1|STARTED|Overall Study||8
7646266|NCT02168855|18829368|P2|NOT COMPLETED|Overall Study||11
7646267|NCT02168855|18829369|P1|NOT COMPLETED|Overall Study||12
7646268|NCT02168855|18829368|P2|COMPLETED|Overall Study||177
7646269|NCT02168855|18829369|P1|COMPLETED|Overall Study||169
7646270|NCT02168855|18829368|P2|STARTED|Overall Study||188
7646271|NCT02168855|18829369|P1|STARTED|Overall Study||181
7646272|NCT02168842|18829381|P2|NOT COMPLETED|Overall Study||8
7646273|NCT02168842|18829382|P1|NOT COMPLETED|Overall Study||8
7646274|NCT02168842|18829381|P2|COMPLETED|Overall Study||158
7646275|NCT02168842|18829382|P1|COMPLETED|Overall Study||162
7646276|NCT02168842|18829381|P2|STARTED|Overall Study||166
7646277|NCT02168842|18829382|P1|STARTED|Overall Study||170
7646278|NCT02168816|18829440|P2|NOT COMPLETED|Overall Study||2
7646279|NCT02168816|18829441|P1|NOT COMPLETED|Overall Study||2
7646280|NCT02168816|18829440|P2|COMPLETED|Overall Study||5
7646281|NCT02168816|18829441|P1|COMPLETED|Overall Study||3
7646282|NCT02168816|18829440|P2|STARTED|Overall Study||7
7646283|NCT02168816|18829441|P1|STARTED|Overall Study||5
7646284|NCT02168803|18829452|P3|NOT COMPLETED|Overall Study||6
7646285|NCT02168803|18829453|P2|NOT COMPLETED|Overall Study||3
7646286|NCT02168803|18829454|P1|NOT COMPLETED|Overall Study||2
7646287|NCT02168803|18829452|P3|COMPLETED|Overall Study||33
7646288|NCT02168803|18829453|P2|COMPLETED|Overall Study||29
7646289|NCT02168803|18829454|P1|COMPLETED|Overall Study||28
7646290|NCT02168803|18829452|P3|Received at Least 1 Dose of Study Drug|Overall Study||39
7646291|NCT02168803|18829453|P2|Received at Least 1 Dose of Study Drug|Overall Study||32
7646292|NCT02168803|18829454|P1|Received at Least 1 Dose of Study Drug|Overall Study||30
7646293|NCT02168803|18829452|P3|STARTED|Overall Study||39
7646294|NCT02168803|18829453|P2|STARTED|Overall Study||32
7646295|NCT02168803|18829454|P1|STARTED|Overall Study||30
7646296|NCT02168777|18829484|P3|NOT COMPLETED|Overall Study||11
7646297|NCT02168777|18829485|P2|NOT COMPLETED|Overall Study||7
7646298|NCT02168777|18829486|P1|NOT COMPLETED|Overall Study||2
7646299|NCT02168777|18829484|P3|COMPLETED|Overall Study||0
7646300|NCT02168777|18829485|P2|COMPLETED|Overall Study||0
7646301|NCT02168777|18829486|P1|COMPLETED|Overall Study||0
7646302|NCT02168777|18829484|P3|STARTED|Overall Study||11
7646303|NCT02168777|18829485|P2|STARTED|Overall Study||7
7646304|NCT02168777|18829486|P1|STARTED|Overall Study||2
7646305|NCT02168660|18829566|P3|NOT COMPLETED|Overall Study||15
7646306|NCT02168660|18829567|P2|NOT COMPLETED|Overall Study||17
7646307|NCT02168660|18829568|P1|NOT COMPLETED|Overall Study||16
7646308|NCT02168660|18829566|P3|COMPLETED|Overall Study||21
7646309|NCT02168660|18829567|P2|COMPLETED|Overall Study||18
7646310|NCT02168660|18829568|P1|COMPLETED|Overall Study||22
7646311|NCT02168660|18829566|P3|STARTED|Overall Study||36
7646312|NCT02168660|18829567|P2|STARTED|Overall Study||35
7646313|NCT02168660|18829568|P1|STARTED|Overall Study||38
7646314|NCT02168491|18829582|P1|NOT COMPLETED|Overall Study||1
7646315|NCT02168491|18829582|P1|COMPLETED|Overall Study||8
7646316|NCT02168491|18829582|P1|STARTED|Overall Study||9
7646317|NCT02168478|18829588|P1|NOT COMPLETED|Overall Study||4
7646318|NCT02168478|18829588|P1|COMPLETED|Overall Study||202
7646319|NCT02168478|18829588|P1|STARTED|Overall Study||206
7646320|NCT02168439|18829594|P2|NOT COMPLETED|Overall Study||2
7646321|NCT02168439|18829595|P1|NOT COMPLETED|Overall Study||0
7646322|NCT02168439|18829594|P2|COMPLETED|Overall Study||18
7646323|NCT02168439|18829595|P1|COMPLETED|Overall Study||20
7646324|NCT02168439|18829594|P2|STARTED|Overall Study||20
7646325|NCT02168439|18829595|P1|STARTED|Overall Study||20
7646326|NCT02168387|18829613|P2|NOT COMPLETED|Overall Study||3
7646327|NCT02168387|18829614|P1|NOT COMPLETED|Overall Study||7
7646328|NCT02168387|18829613|P2|COMPLETED|Overall Study||16
7646329|NCT02168387|18829614|P1|COMPLETED|Overall Study||13
7646330|NCT02168387|18829613|P2|STARTED|Overall Study||19
7646331|NCT02168387|18829614|P1|STARTED|Overall Study||20
7646332|NCT02168361|18829626|P2|NOT COMPLETED|Overall Study||10
7646333|NCT02168361|18829627|P1|NOT COMPLETED|Overall Study||5
7646334|NCT02168361|18829626|P2|COMPLETED|Overall Study||21
7646335|NCT02168361|18829627|P1|COMPLETED|Overall Study||57
7646336|NCT02168361|18829626|P2|STARTED|Overall Study||31
7646337|NCT02168361|18829627|P1|STARTED|Overall Study||62
7646338|NCT02168309|18829637|P2|NOT COMPLETED|Overall Study||0
7646339|NCT02168309|18829638|P1|NOT COMPLETED|Overall Study||0
7646340|NCT02168309|18829637|P2|COMPLETED|Overall Study||25
7646341|NCT02168309|18829638|P1|COMPLETED|Overall Study||25
7646342|NCT02168309|18829637|P2|STARTED|Overall Study||25
7646343|NCT02168309|18829638|P1|STARTED|Overall Study||25
7646344|NCT02168270|18829646|P1|NOT COMPLETED|Overall Study||4
7646345|NCT02168270|18829646|P1|COMPLETED|Overall Study||0
7646346|NCT02168270|18829646|P1|STARTED|Overall Study||4
7646347|NCT02168153|18829655|P2|NOT COMPLETED|Overall Study||0
7646348|NCT02168153|18829656|P1|NOT COMPLETED|Overall Study||3
7646349|NCT02168153|18829655|P2|COMPLETED|Overall Study||60
7646350|NCT02168153|18829656|P1|COMPLETED|Overall Study||57
7646351|NCT02168153|18829655|P2|STARTED|Overall Study||60
7646352|NCT02168153|18829656|P1|STARTED|Overall Study||60
7646353|NCT02168101|18829673|P3|NOT COMPLETED|Overall Study||1
7646354|NCT02168101|18829674|P2|NOT COMPLETED|Overall Study||2
7646355|NCT02168101|18829675|P1|NOT COMPLETED|Overall Study||2
7646356|NCT02168101|18829673|P3|COMPLETED|Overall Study||2
7646357|NCT02168101|18829674|P2|COMPLETED|Overall Study||1
7646358|NCT02168101|18829675|P1|COMPLETED|Overall Study||1
7646359|NCT02168101|18829673|P3|STARTED|Overall Study||3
7646360|NCT02168101|18829674|P2|STARTED|Overall Study||3
7646361|NCT02168101|18829675|P1|STARTED|Overall Study||3
7646362|NCT02168062|18829697|P3|NOT COMPLETED|Overall Study||0
7646363|NCT02168062|18829698|P2|NOT COMPLETED|Overall Study||0
7646364|NCT02168062|18829699|P1|NOT COMPLETED|Overall Study||0
7646365|NCT02168062|18829697|P3|COMPLETED|Overall Study||8
7646366|NCT02168062|18829698|P2|COMPLETED|Overall Study||26
7646367|NCT02168062|18829699|P1|COMPLETED|Overall Study||23
7646368|NCT02168062|18829697|P3|STARTED|Overall Study||8
7646369|NCT02168062|18829698|P2|STARTED|Overall Study||26
7646370|NCT02168062|18829699|P1|STARTED|Overall Study||23
7646371|NCT02167893|18829745|P1|NOT COMPLETED|Overall Study||163
7646372|NCT02167893|18829745|P1|COMPLETED|Overall Study||11125
7646373|NCT02167893|18829745|P1|STARTED|Overall Study||11288
7646374|NCT02167867|18829756|P2|NOT COMPLETED|Overall Study||0
7646375|NCT02167867|18829757|P1|NOT COMPLETED|Overall Study||0
7646376|NCT02167867|18829756|P2|COMPLETED|Overall Study||22
7646377|NCT02167867|18829757|P1|COMPLETED|Overall Study||22
7646378|NCT02167867|18829756|P2|STARTED|Overall Study||22
7646379|NCT02167867|18829757|P1|STARTED|Overall Study||22
7646380|NCT02167815|18829765|P2|NOT COMPLETED|Overall Study||0
7646381|NCT02167815|18829766|P1|NOT COMPLETED|Overall Study||0
7646382|NCT02167815|18829765|P2|COMPLETED|Overall Study||21
7646383|NCT02167815|18829766|P1|COMPLETED|Overall Study||9
7646384|NCT02167815|18829765|P2|STARTED|Overall Study||21
7646385|NCT02167815|18829766|P1|STARTED|Overall Study||9
7646386|NCT02167594|18829780|P3|NOT COMPLETED|Overall Study||0
7646387|NCT02167594|18829781|P2|NOT COMPLETED|Overall Study||1
7646388|NCT02167594|18829782|P1|NOT COMPLETED|Overall Study||2
7646389|NCT02167594|18829780|P3|COMPLETED|Overall Study||3
7646390|NCT02167594|18829781|P2|COMPLETED|Overall Study||5
7646391|NCT02167594|18829782|P1|COMPLETED|Overall Study||18
7646392|NCT02167594|18829780|P3|STARTED|Overall Study||3
7646393|NCT02167594|18829781|P2|STARTED|Overall Study||6
7646394|NCT02167594|18829782|P1|STARTED|Overall Study||20
7646395|NCT02167451|18829791|P1|NOT COMPLETED|Overall Study||1
7646396|NCT02167451|18829791|P1|COMPLETED|Overall Study||30
7646397|NCT02167451|18829791|P1|STARTED|Overall Study||31
7646398|NCT02167256|18829808|P2|NOT COMPLETED|Overall Study||10
7646399|NCT02167256|18829809|P1|NOT COMPLETED|Overall Study||21
7646400|NCT02167256|18829808|P2|COMPLETED|Overall Study||70
7646401|NCT02167256|18829809|P1|COMPLETED|Overall Study||58
7646402|NCT02167256|18829808|P2|STARTED|Overall Study||80
7646403|NCT02167256|18829809|P1|STARTED|Overall Study||79
7646404|NCT02167217|18829825|P1|NOT COMPLETED|Overall Study||2
7646405|NCT02167217|18829825|P1|COMPLETED|Overall Study||23
7646406|NCT02167217|18829825|P1|STARTED|Overall Study||25
7646407|NCT02167204|18829829|P1|NOT COMPLETED|Overall Study||0
7646408|NCT02167204|18829829|P1|COMPLETED|Overall Study||9
7646409|NCT02167204|18829829|P1|STARTED|Overall Study||9
7646410|NCT02167139|18829842|P4|NOT COMPLETED|Transition-extension||5
7646411|NCT02167139|18829843|P3|NOT COMPLETED|Transition-extension||8
7646412|NCT02167139|18829844|P2|NOT COMPLETED|Transition-extension||0
7646413|NCT02167139|18829845|P1|NOT COMPLETED|Transition-extension||6
7646414|NCT02167139|18829842|P4|COMPLETED|Transition-extension||124
7646415|NCT02167139|18829843|P3|COMPLETED|Transition-extension||117
7646416|NCT02167139|18829844|P2|COMPLETED|Transition-extension||0
7646417|NCT02167139|18829845|P1|COMPLETED|Transition-extension||248
7646418|NCT02167139|18829842|P4|STARTED|Transition-extension||129
7646419|NCT02167139|18829843|P3|STARTED|Transition-extension||125
7646420|NCT02167139|18829844|P2|STARTED|Transition-extension||0
7646421|NCT02167139|18829845|P1|STARTED|Transition-extension||254
7646422|NCT02167139|18829842|P4|NOT COMPLETED|Randomised, Double-blind||0
7646423|NCT02167139|18829843|P3|NOT COMPLETED|Randomised, Double-blind||0
7646424|NCT02167139|18829844|P2|NOT COMPLETED|Randomised, Double-blind||19
7646425|NCT02167139|18829845|P1|NOT COMPLETED|Randomised, Double-blind||17
7646426|NCT02167139|18829842|P4|COMPLETED|Randomised, Double-blind||0
7646427|NCT02167139|18829843|P3|COMPLETED|Randomised, Double-blind||0
7646428|NCT02167139|18829844|P2|COMPLETED|Randomised, Double-blind||254
7646429|NCT02167139|18829845|P1|COMPLETED|Randomised, Double-blind||254
7646430|NCT02167139|18829842|P4|STARTED|Randomised, Double-blind||0
7646431|NCT02167139|18829843|P3|STARTED|Randomised, Double-blind||0
7646432|NCT02167139|18829844|P2|STARTED|Randomised, Double-blind||273
7646433|NCT02167139|18829845|P1|STARTED|Randomised, Double-blind||271
7646434|NCT02167074|18829861|P2|NOT COMPLETED|Overall Study||0
7646435|NCT02167074|18829862|P1|NOT COMPLETED|Overall Study||0
7646436|NCT02167074|18829861|P2|COMPLETED|Overall Study||302
7646437|NCT02167074|18829862|P1|COMPLETED|Overall Study||306
7646438|NCT02167074|18829861|P2|STARTED|Overall Study||302
7646439|NCT02167074|18829862|P1|STARTED|Overall Study||306
7646440|NCT02167035|18829880|P2|NOT COMPLETED|Overall Study||6
7646441|NCT02167035|18829881|P1|NOT COMPLETED|Overall Study||5
7646442|NCT02167035|18829880|P2|COMPLETED|Overall Study||16
7646443|NCT02167035|18829881|P1|COMPLETED|Overall Study||16
7646444|NCT02167035|18829880|P2|STARTED|Overall Study||22
7646445|NCT02167035|18829881|P1|STARTED|Overall Study||21
7646446|NCT02166697|18829889|P1|NOT COMPLETED|Overall Study||347
7646447|NCT02166697|18829889|P1|COMPLETED|Overall Study||13804
7646448|NCT02166697|18829889|P1|STARTED|Overall Study||14151
7646449|NCT02166606|18829898|P1|NOT COMPLETED|Overall Study||78
7646450|NCT02166606|18829898|P1|COMPLETED|Overall Study||1106
7646451|NCT02166606|18829898|P1|Consent Eligible|Overall Study||1174
7646452|NCT02166606|18829898|P1|Actively Enrolled|Overall Study||1180
7646453|NCT02166606|18829898|P1|STARTED|Overall Study||1184
7646454|NCT02166476|18829905|P2|NOT COMPLETED|Overall Study||23
7646455|NCT02166476|18829906|P1|NOT COMPLETED|Overall Study||14
7646456|NCT02166476|18829905|P2|COMPLETED|Overall Study||250
7646457|NCT02166476|18829906|P1|COMPLETED|Overall Study||258
7646458|NCT02166476|18829905|P2|Received at Least 1 Dose of Study Drug|Overall Study||273
7646459|NCT02166476|18829906|P1|Received at Least 1 Dose of Study Drug|Overall Study||272
7646460|NCT02166476|18829905|P2|STARTED|Overall Study||273
7646461|NCT02166476|18829906|P1|STARTED|Overall Study||272
7646462|NCT02166346|18829939|P2|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||0
7646463|NCT02166346|18829940|P1|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||1
7646464|NCT02166346|18829939|P2|COMPLETED|Intervention - Phase 2 (After Crossover)||6
7646465|NCT02166346|18829940|P1|COMPLETED|Intervention - Phase 2 (After Crossover)||7
7646466|NCT02166346|18829939|P2|STARTED|Intervention - Phase 2 (After Crossover)||6
7646467|NCT02166346|18829940|P1|STARTED|Intervention - Phase 2 (After Crossover)||8
7646468|NCT02166346|18829939|P2|NOT COMPLETED|Intervention - Phase 1||2
7646469|NCT02166346|18829940|P1|NOT COMPLETED|Intervention - Phase 1||0
7646470|NCT02166346|18829939|P2|COMPLETED|Intervention - Phase 1||6
7646471|NCT02166346|18829940|P1|COMPLETED|Intervention - Phase 1||8
7646472|NCT02166346|18829939|P2|STARTED|Intervention - Phase 1||8
7646473|NCT02166346|18829940|P1|STARTED|Intervention - Phase 1||8
7646474|NCT02166346|18829939|P2|NOT COMPLETED|Screening and Randomization||4
7646475|NCT02166346|18829940|P1|NOT COMPLETED|Screening and Randomization||4
7646476|NCT02166346|18829939|P2|COMPLETED|Screening and Randomization||8
7646477|NCT02166346|18829940|P1|COMPLETED|Screening and Randomization||8
7646478|NCT02166346|18829939|P2|STARTED|Screening and Randomization||12
7646479|NCT02166346|18829940|P1|STARTED|Screening and Randomization||12
7646480|NCT02166047|18829960|P12|NOT COMPLETED|Overall Study||0
7646481|NCT02166047|18829961|P11|NOT COMPLETED|Overall Study||2
7646482|NCT02166047|18829962|P10|NOT COMPLETED|Overall Study||0
7646483|NCT02166047|18829963|P9|NOT COMPLETED|Overall Study||0
7646484|NCT02166047|18829964|P8|NOT COMPLETED|Overall Study||0
7646485|NCT02166047|18829965|P7|NOT COMPLETED|Overall Study||2
7646486|NCT02166047|18829966|P6|NOT COMPLETED|Overall Study||0
7646487|NCT02166047|18829967|P5|NOT COMPLETED|Overall Study||1
7646488|NCT02166047|18829968|P4|NOT COMPLETED|Overall Study||0
7646489|NCT02166047|18829969|P3|NOT COMPLETED|Overall Study||2
7646490|NCT02166047|18829970|P2|NOT COMPLETED|Overall Study||1
7646491|NCT02166047|18829971|P1|NOT COMPLETED|Overall Study||0
7646492|NCT02166047|18829960|P12|COMPLETED|Overall Study||6
7646493|NCT02166047|18829961|P11|COMPLETED|Overall Study||12
7646494|NCT02166047|18829962|P10|COMPLETED|Overall Study||17
7646495|NCT02166047|18829963|P9|COMPLETED|Overall Study||16
7646496|NCT02166047|18829964|P8|COMPLETED|Overall Study||5
7646497|NCT02166047|18829965|P7|COMPLETED|Overall Study||15
7646498|NCT02166047|18829966|P6|COMPLETED|Overall Study||17
7646499|NCT02166047|18829967|P5|COMPLETED|Overall Study||17
7646500|NCT02166047|18829968|P4|COMPLETED|Overall Study||5
7646501|NCT02166047|18829969|P3|COMPLETED|Overall Study||14
7646502|NCT02166047|18829970|P2|COMPLETED|Overall Study||14
7646503|NCT02166047|18829971|P1|COMPLETED|Overall Study||16
7646504|NCT02166047|18829960|P12|STARTED|Overall Study||6
7646505|NCT02166047|18829961|P11|STARTED|Overall Study||14
7646506|NCT02166047|18829962|P10|STARTED|Overall Study||17
7646507|NCT02166047|18829963|P9|STARTED|Overall Study||16
7646508|NCT02166047|18829964|P8|STARTED|Overall Study||5
7646509|NCT02166047|18829965|P7|STARTED|Overall Study||17
7646510|NCT02166047|18829966|P6|STARTED|Overall Study||17
7646511|NCT02166047|18829967|P5|STARTED|Overall Study||18
7646512|NCT02166047|18829968|P4|STARTED|Overall Study||5
7646513|NCT02166047|18829969|P3|STARTED|Overall Study||16
7646514|NCT02166047|18829970|P2|STARTED|Overall Study||15
7646515|NCT02166047|18829971|P1|STARTED|Overall Study||16
7646516|NCT02165904|18830093|P1|NOT COMPLETED|Overall Study||0
7646517|NCT02165904|18830093|P1|COMPLETED|Overall Study||10
7646518|NCT02165904|18830093|P1|STARTED|Overall Study||10
7646519|NCT02165839|18830114|P2|NOT COMPLETED|Overall Study||0
7646520|NCT02165839|18830115|P1|NOT COMPLETED|Overall Study||0
7646521|NCT02165839|18830114|P2|COMPLETED|Overall Study||73
7646522|NCT02165839|18830115|P1|COMPLETED|Overall Study||66
7646523|NCT02165839|18830114|P2|STARTED|Overall Study||73
7646524|NCT02165839|18830115|P1|STARTED|Overall Study||66
7646525|NCT02165826|18830138|P3|NOT COMPLETED|Down-Titration Period||7
7646526|NCT02165826|18830139|P2|NOT COMPLETED|Down-Titration Period||11
7646527|NCT02165826|18830140|P1|NOT COMPLETED|Down-Titration Period||7
7646528|NCT02165826|18830138|P3|COMPLETED|Down-Titration Period||31
7646529|NCT02165826|18830139|P2|COMPLETED|Down-Titration Period||28
7646530|NCT02165826|18830140|P1|COMPLETED|Down-Titration Period||20
7646531|NCT02165826|18830138|P3|Safety Analysis Set: Received Study Drug|Down-Titration Period||38
7646532|NCT02165826|18830139|P2|Safety Analysis Set: Received Study Drug|Down-Titration Period||39
7646533|NCT02165826|18830140|P1|Safety Analysis Set: Received Study Drug|Down-Titration Period||27
7646534|NCT02165826|18830138|P3|STARTED|Down-Titration Period||38
7646535|NCT02165826|18830139|P2|STARTED|Down-Titration Period||39
7646536|NCT02165826|18830140|P1|STARTED|Down-Titration Period||27
7646537|NCT02165826|18830138|P3|NOT COMPLETED|Main Treatment Period||109
7646538|NCT02165826|18830139|P2|NOT COMPLETED|Main Treatment Period||90
7646539|NCT02165826|18830140|P1|NOT COMPLETED|Main Treatment Period||81
7646540|NCT02165826|18830138|P3|COMPLETED|Main Treatment Period||334
7646541|NCT02165826|18830139|P2|COMPLETED|Main Treatment Period||349
7646542|NCT02165826|18830140|P1|COMPLETED|Main Treatment Period||360
7646543|NCT02165826|18830138|P3|Safety Analysis Set: Received Study Drug|Main Treatment Period||443
7646544|NCT02165826|18830139|P2|Safety Analysis Set: Received Study Drug|Main Treatment Period||437
7646545|NCT02165826|18830140|P1|Safety Analysis Set: Received Study Drug|Main Treatment Period||441
7646546|NCT02165826|18830138|P3|STARTED|Main Treatment Period||443
7646547|NCT02165826|18830139|P2|STARTED|Main Treatment Period||439
7646548|NCT02165826|18830140|P1|STARTED|Main Treatment Period||441
7646549|NCT02165761|18830199|P2|NOT COMPLETED|Overall Study||14
7646550|NCT02165761|18830200|P1|NOT COMPLETED|Overall Study||19
7646551|NCT02165761|18830199|P2|COMPLETED|Overall Study||5
7646552|NCT02165761|18830200|P1|COMPLETED|Overall Study||4
7646553|NCT02165761|18830199|P2|STARTED|Overall Study||19
7646554|NCT02165761|18830200|P1|STARTED|Overall Study||23
7646555|NCT02165735|18830208|P2|NOT COMPLETED|Overall Study||14
7646556|NCT02165735|18830209|P1|NOT COMPLETED|Overall Study||16
7646557|NCT02165735|18830208|P2|COMPLETED|Overall Study||166
7646558|NCT02165735|18830209|P1|COMPLETED|Overall Study||164
7646559|NCT02165735|18830208|P2|STARTED|Overall Study||180
7646560|NCT02165735|18830209|P1|STARTED|Overall Study||180
7646561|NCT02165722|18830237|P2|NOT COMPLETED|Overall Study||0
7646562|NCT02165722|18830238|P1|NOT COMPLETED|Overall Study||0
7646563|NCT02165722|18830237|P2|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|2202
7646564|NCT02165722|18830238|P1|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|1971
7646565|NCT02165722|18830237|P2|STARTED|Overall Study||2202
7646566|NCT02165722|18830238|P1|STARTED|Overall Study||1971
7646567|NCT02165605|18830250|P1|NOT COMPLETED|Overall Study||0
7646568|NCT02165605|18830250|P1|COMPLETED|Overall Study||28
7646569|NCT02165605|18830250|P1|STARTED|Overall Study||28
7646570|NCT02165462|18830263|P1|NOT COMPLETED|Overall Study||0
7646571|NCT02165462|18830263|P1|COMPLETED|Overall Study||17
7646572|NCT02165462|18830263|P1|STARTED|Overall Study||17
7646573|NCT02165397|18830283|P3|NOT COMPLETED|Overall Study||10
7646574|NCT02165397|18830284|P2|NOT COMPLETED|Overall Study||19
7646575|NCT02165397|18830285|P1|NOT COMPLETED|Overall Study||14
7646576|NCT02165397|18830283|P3|COMPLETED|Overall Study||21
7646577|NCT02165397|18830284|P2|COMPLETED|Overall Study||56
7646578|NCT02165397|18830285|P1|COMPLETED|Overall Study||61
7646579|NCT02165397|18830283|P3|STARTED|Overall Study||31
7646580|NCT02165397|18830284|P2|STARTED|Overall Study||75
7646581|NCT02165397|18830285|P1|STARTED|Overall Study||75
7646582|NCT02165384|18830308|P1|NOT COMPLETED|Overall Study||0
7646583|NCT02165384|18830308|P1|COMPLETED|Overall Study||199
7646584|NCT02165384|18830308|P1|STARTED|Overall Study||199
7646585|NCT02165202|18830315|P2|NOT COMPLETED|Injection Phase||6
7646586|NCT02165202|18830316|P1|NOT COMPLETED|Injection Phase||10
7646587|NCT02165202|18830315|P2|COMPLETED|Injection Phase||36
7646588|NCT02165202|18830316|P1|COMPLETED|Injection Phase||70
7646589|NCT02165202|18830315|P2|STARTED|Injection Phase|Participants who received at least one injection.|42
7646590|NCT02165202|18830316|P1|STARTED|Injection Phase|Participants who received at least one injection.|80
7646591|NCT02165202|18830315|P2|NOT COMPLETED|Oral Phase||3
7646592|NCT02165202|18830316|P1|NOT COMPLETED|Oral Phase||11
7646593|NCT02165202|18830315|P2|COMPLETED|Oral Phase||42
7646594|NCT02165202|18830316|P1|COMPLETED|Oral Phase||80
7646595|NCT02165202|18830315|P2|STARTED|Oral Phase|Participants Enrolled in the study|45
7646596|NCT02165202|18830316|P1|STARTED|Oral Phase|Participants Enrolled in the study|91
7646597|NCT02165124|18830322|P1|NOT COMPLETED|Overall Study||5
7646598|NCT02165124|18830322|P1|COMPLETED|Overall Study||15
7646599|NCT02165124|18830322|P1|STARTED|Overall Study||20
7646600|NCT02165111|18830328|P2|NOT COMPLETED|Overall Study||0
7646601|NCT02165111|18830329|P1|NOT COMPLETED|Overall Study||0
7646602|NCT02165111|18830328|P2|COMPLETED|Overall Study||40
7646603|NCT02165111|18830329|P1|COMPLETED|Overall Study||40
7646604|NCT02165111|18830328|P2|STARTED|Overall Study||40
7646605|NCT02165111|18830329|P1|STARTED|Overall Study||40
7646606|NCT02165072|18830345|P1|NOT COMPLETED|Overall Study||0
7646607|NCT02165072|18830345|P1|COMPLETED|Overall Study||30
7646608|NCT02165072|18830345|P1|STARTED|Overall Study||30
7646609|NCT02164981|18830353|P3|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||0
7646610|NCT02164981|18830354|P2|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
7646611|NCT02164981|18830355|P1|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
7646612|NCT02164981|18830353|P3|COMPLETED|Phase 2 (Day 14 - Day 28)||18
7646613|NCT02164981|18830354|P2|COMPLETED|Phase 2 (Day 14 - Day 28)||12
7646614|NCT02164981|18830355|P1|COMPLETED|Phase 2 (Day 14 - Day 28)||16
7646615|NCT02164981|18830353|P3|STARTED|Phase 2 (Day 14 - Day 28)||18
7646616|NCT02164981|18830354|P2|STARTED|Phase 2 (Day 14 - Day 28)||14
7646617|NCT02164981|18830355|P1|STARTED|Phase 2 (Day 14 - Day 28)||18
7646618|NCT02164981|18830353|P3|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
7646619|NCT02164981|18830354|P2|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||2
7646620|NCT02164981|18830355|P1|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
7646621|NCT02164981|18830353|P3|COMPLETED|Phase 1 (Day 0 - Day 14)||18
7646622|NCT02164981|18830354|P2|COMPLETED|Phase 1 (Day 0 - Day 14)||14
7646623|NCT02164981|18830355|P1|COMPLETED|Phase 1 (Day 0 - Day 14)||18
7646624|NCT02164981|18830353|P3|STARTED|Phase 1 (Day 0 - Day 14)||18
7646625|NCT02164981|18830354|P2|STARTED|Phase 1 (Day 0 - Day 14)||16
7646626|NCT02164981|18830355|P1|STARTED|Phase 1 (Day 0 - Day 14)||18
7646627|NCT02164981|18830353|P3|NOT COMPLETED|Started||0
7646628|NCT02164981|18830354|P2|NOT COMPLETED|Started||3
7646629|NCT02164981|18830355|P1|NOT COMPLETED|Started||5
7646630|NCT02164981|18830353|P3|COMPLETED|Started||18
7646631|NCT02164981|18830354|P2|COMPLETED|Started||16
7646632|NCT02164981|18830355|P1|COMPLETED|Started||18
7646633|NCT02164981|18830353|P3|STARTED|Started||18
7646634|NCT02164981|18830354|P2|STARTED|Started||19
7646635|NCT02164981|18830355|P1|STARTED|Started||23
7646636|NCT02164929|18830428|P4|NOT COMPLETED|Overall Study||2
7646637|NCT02164929|18830429|P3|NOT COMPLETED|Overall Study||1
7646638|NCT02164929|18830430|P2|NOT COMPLETED|Overall Study||0
7646639|NCT02164929|18830431|P1|NOT COMPLETED|Overall Study||1
7646640|NCT02164929|18830428|P4|COMPLETED|Overall Study||2
7646641|NCT02164929|18830429|P3|COMPLETED|Overall Study||4
7646642|NCT02164929|18830430|P2|COMPLETED|Overall Study||3
7646643|NCT02164929|18830431|P1|COMPLETED|Overall Study||3
7646644|NCT02164929|18830428|P4|STARTED|Overall Study||4
7646645|NCT02164929|18830429|P3|STARTED|Overall Study||5
7646646|NCT02164929|18830430|P2|STARTED|Overall Study||3
7646647|NCT02164929|18830431|P1|STARTED|Overall Study||4
7646648|NCT02164916|18830475|P2|NOT COMPLETED|Overall Study||54
7646649|NCT02164916|18830476|P1|NOT COMPLETED|Overall Study||52
7646650|NCT02164916|18830475|P2|COMPLETED|Overall Study||0
7646651|NCT02164916|18830476|P1|COMPLETED|Overall Study||0
7646652|NCT02164916|18830475|P2|Cross-over to Arm II|Overall Study||0
7646653|NCT02164916|18830476|P1|Cross-over to Arm II|Overall Study|Following disease progression on Arm 1. Note: these patients are also counted in 'Not Completed'.|24
7646654|NCT02164916|18830475|P2|Eligible|Overall Study||49
7646655|NCT02164916|18830476|P1|Eligible|Overall Study||50
7646656|NCT02164916|18830475|P2|STARTED|Overall Study||54
7646657|NCT02164916|18830476|P1|STARTED|Overall Study||52
7646658|NCT02164864|18830496|P3|NOT COMPLETED|Overall Study||132
7646659|NCT02164864|18830497|P2|NOT COMPLETED|Overall Study||60
7646660|NCT02164864|18830498|P1|NOT COMPLETED|Overall Study||95
7646661|NCT02164864|18830496|P3|COMPLETED|Overall Study||849
7646662|NCT02164864|18830497|P2|COMPLETED|Overall Study||703
7646663|NCT02164864|18830498|P1|COMPLETED|Overall Study||886
7646664|NCT02164864|18830496|P3|STARTED|Overall Study|Started are the Randomised/entered patients.|981
7646665|NCT02164864|18830497|P2|STARTED|Overall Study|Started are the Randomised/entered patients.|763
7646666|NCT02164864|18830498|P1|STARTED|Overall Study|Started are the Randomised/entered patients.|981
7646667|NCT02164721|18830557|P1|NOT COMPLETED|Overall Study||0
7646668|NCT02164721|18830557|P1|COMPLETED|Overall Study||30
7646669|NCT02164721|18830557|P1|STARTED|Overall Study||30
7646670|NCT02164539|18830573|P7|NOT COMPLETED|Treatment Phase C (1 Week)||2
7646671|NCT02164539|18830574|P6|NOT COMPLETED|Treatment Phase C (1 Week)||0
7646672|NCT02164539|18830575|P5|NOT COMPLETED|Treatment Phase C (1 Week)||0
7646673|NCT02164539|18830576|P4|NOT COMPLETED|Treatment Phase C (1 Week)||0
7646674|NCT02164539|18830577|P3|NOT COMPLETED|Treatment Phase C (1 Week)||0
7646675|NCT02164539|18830578|P2|NOT COMPLETED|Treatment Phase C (1 Week)||0
7646676|NCT02164539|18830579|P1|NOT COMPLETED|Treatment Phase C (1 Week)||1
7646677|NCT02164539|18830573|P7|COMPLETED|Treatment Phase C (1 Week)||78
7646678|NCT02164539|18830574|P6|COMPLETED|Treatment Phase C (1 Week)||82
7646679|NCT02164539|18830575|P5|COMPLETED|Treatment Phase C (1 Week)||84
7646680|NCT02164539|18830576|P4|COMPLETED|Treatment Phase C (1 Week)||0
7646681|NCT02164539|18830577|P3|COMPLETED|Treatment Phase C (1 Week)||0
7646682|NCT02164539|18830578|P2|COMPLETED|Treatment Phase C (1 Week)||0
7646683|NCT02164539|18830579|P1|COMPLETED|Treatment Phase C (1 Week)||78
7646684|NCT02164539|18830573|P7|STARTED|Treatment Phase C (1 Week)||80
7646685|NCT02164539|18830574|P6|STARTED|Treatment Phase C (1 Week)||82
7646686|NCT02164539|18830575|P5|STARTED|Treatment Phase C (1 Week)||84
7646687|NCT02164539|18830576|P4|STARTED|Treatment Phase C (1 Week)||0
7646688|NCT02164539|18830577|P3|STARTED|Treatment Phase C (1 Week)||0
7646689|NCT02164539|18830578|P2|STARTED|Treatment Phase C (1 Week)||0
7646690|NCT02164539|18830579|P1|STARTED|Treatment Phase C (1 Week)||79
7646691|NCT02164539|18830573|P7|NOT COMPLETED|Treatment Phase B (1 Week)||1
7646692|NCT02164539|18830574|P6|NOT COMPLETED|Treatment Phase B (1 Week)||0
7646693|NCT02164539|18830575|P5|NOT COMPLETED|Treatment Phase B (1 Week)||3
7646694|NCT02164539|18830576|P4|NOT COMPLETED|Treatment Phase B (1 Week)||0
7646695|NCT02164539|18830577|P3|NOT COMPLETED|Treatment Phase B (1 Week)||0
7646696|NCT02164539|18830578|P2|NOT COMPLETED|Treatment Phase B (1 Week)||0
7646697|NCT02164539|18830579|P1|NOT COMPLETED|Treatment Phase B (1 Week)||0
7646698|NCT02164539|18830573|P7|COMPLETED|Treatment Phase B (1 Week)||162
7646699|NCT02164539|18830574|P6|COMPLETED|Treatment Phase B (1 Week)||0
7646700|NCT02164539|18830575|P5|COMPLETED|Treatment Phase B (1 Week)||163
7646701|NCT02164539|18830576|P4|COMPLETED|Treatment Phase B (1 Week)||0
7646702|NCT02164539|18830577|P3|COMPLETED|Treatment Phase B (1 Week)||0
7646703|NCT02164539|18830578|P2|COMPLETED|Treatment Phase B (1 Week)||0
7646704|NCT02164539|18830579|P1|COMPLETED|Treatment Phase B (1 Week)||0
7646705|NCT02164539|18830573|P7|STARTED|Treatment Phase B (1 Week)||163
7646706|NCT02164539|18830574|P6|STARTED|Treatment Phase B (1 Week)||0
7646707|NCT02164539|18830575|P5|STARTED|Treatment Phase B (1 Week)||166
7646708|NCT02164539|18830576|P4|STARTED|Treatment Phase B (1 Week)||0
7646709|NCT02164539|18830577|P3|STARTED|Treatment Phase B (1 Week)||0
7646710|NCT02164539|18830578|P2|STARTED|Treatment Phase B (1 Week)||0
7646711|NCT02164539|18830579|P1|STARTED|Treatment Phase B (1 Week)||0
7646712|NCT02164539|18830573|P7|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
7646713|NCT02164539|18830574|P6|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
7646714|NCT02164539|18830575|P5|NOT COMPLETED|Treatment Phase A (4 Weeks)||3
7646715|NCT02164539|18830576|P4|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
7646716|NCT02164539|18830577|P3|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
7646717|NCT02164539|18830578|P2|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
7646718|NCT02164539|18830579|P1|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
7646719|NCT02164539|18830573|P7|COMPLETED|Treatment Phase A (4 Weeks)||0
7646720|NCT02164539|18830574|P6|COMPLETED|Treatment Phase A (4 Weeks)||83
7646721|NCT02164539|18830575|P5|COMPLETED|Treatment Phase A (4 Weeks)||82
7646722|NCT02164539|18830576|P4|COMPLETED|Treatment Phase A (4 Weeks)||44
7646723|NCT02164539|18830577|P3|COMPLETED|Treatment Phase A (4 Weeks)||39
7646724|NCT02164539|18830578|P2|COMPLETED|Treatment Phase A (4 Weeks)||42
7646725|NCT02164539|18830579|P1|COMPLETED|Treatment Phase A (4 Weeks)||39
7646726|NCT02164539|18830573|P7|STARTED|Treatment Phase A (4 Weeks)||0
7646727|NCT02164539|18830574|P6|STARTED|Treatment Phase A (4 Weeks)||84
7646728|NCT02164539|18830575|P5|STARTED|Treatment Phase A (4 Weeks)||85
7646729|NCT02164539|18830576|P4|STARTED|Treatment Phase A (4 Weeks)||46
7646730|NCT02164539|18830577|P3|STARTED|Treatment Phase A (4 Weeks)||40
7646731|NCT02164539|18830578|P2|STARTED|Treatment Phase A (4 Weeks)||42
7646732|NCT02164539|18830579|P1|STARTED|Treatment Phase A (4 Weeks)||41
7646733|NCT02164513|18830627|P3|NOT COMPLETED|Overall Study||295
7646734|NCT02164513|18830628|P2|NOT COMPLETED|Overall Study||536
7646735|NCT02164513|18830629|P1|NOT COMPLETED|Overall Study||437
7646736|NCT02164513|18830627|P3|COMPLETED|Overall Study||1775
7646737|NCT02164513|18830628|P2|COMPLETED|Overall Study||3598
7646738|NCT02164513|18830629|P1|COMPLETED|Overall Study||3714
7646739|NCT02164513|18830627|P3|WIP :Did Not Complete Study Treatment|Overall Study||0
7646740|NCT02164513|18830628|P2|WIP :Did Not Complete Study Treatment|Overall Study||1
7646741|NCT02164513|18830629|P1|WIP :Did Not Complete Study Treatment|Overall Study||1
7646742|NCT02164513|18830627|P3|WIP: Withdrawal by Participant|Overall Study||153
7646743|NCT02164513|18830628|P2|WIP: Withdrawal by Participant|Overall Study||296
7646744|NCT02164513|18830629|P1|WIP: Withdrawal by Participant|Overall Study||250
7646745|NCT02164513|18830627|P3|WIP: Investigator Discretion|Overall Study||15
7646746|NCT02164513|18830628|P2|WIP: Investigator Discretion|Overall Study||36
7646747|NCT02164513|18830629|P1|WIP: Investigator Discretion|Overall Study||33
7646748|NCT02164513|18830627|P3|WIP: Lost to Follow-up|Overall Study||14
7646749|NCT02164513|18830628|P2|WIP: Lost to Follow-up|Overall Study||25
7646750|NCT02164513|18830629|P1|WIP: Lost to Follow-up|Overall Study||21
7646751|NCT02164513|18830627|P3|WIP: Study Closed/Terminated|Overall Study||5
7646752|NCT02164513|18830628|P2|WIP: Study Closed/Terminated|Overall Study||2
7646753|NCT02164513|18830629|P1|WIP: Study Closed/Terminated|Overall Study||5
7646754|NCT02164513|18830627|P3|WIP (Other): Stopping Criteria Reached|Overall Study||2
7646755|NCT02164513|18830628|P2|WIP (Other): Stopping Criteria Reached|Overall Study||1
7646756|NCT02164513|18830629|P1|WIP (Other): Stopping Criteria Reached|Overall Study||4
7646757|NCT02164513|18830627|P3|Withdrew IP: Protocol Deviation|Overall Study||19
7646758|NCT02164513|18830628|P2|Withdrew IP: Protocol Deviation|Overall Study||41
7646759|NCT02164513|18830629|P1|Withdrew IP: Protocol Deviation|Overall Study||32
7646760|NCT02164513|18830627|P3|WIP: Lack of Efficacy|Overall Study||172
7646761|NCT02164513|18830628|P2|WIP: Lack of Efficacy|Overall Study||313
7646762|NCT02164513|18830629|P1|WIP: Lack of Efficacy|Overall Study||163
7646763|NCT02164513|18830627|P3|Withdrew IP (WIP): Adverse Event|Overall Study||186
7646764|NCT02164513|18830628|P2|Withdrew IP (WIP): Adverse Event|Overall Study||325
7646765|NCT02164513|18830629|P1|Withdrew IP (WIP): Adverse Event|Overall Study||249
7646766|NCT02164513|18830627|P3|Not Completed IP|Overall Study||566
7646767|NCT02164513|18830628|P2|Not Completed IP|Overall Study||1040
7646768|NCT02164513|18830629|P1|Not Completed IP|Overall Study||758
7646769|NCT02164513|18830627|P3|Completed Investigational Product (IP)|Overall Study||1504
7646770|NCT02164513|18830628|P2|Completed Investigational Product (IP)|Overall Study||3094
7646771|NCT02164513|18830629|P1|Completed Investigational Product (IP)|Overall Study||3393
7646772|NCT02164513|18830627|P3|STARTED|Overall Study||2070
7646773|NCT02164513|18830628|P2|STARTED|Overall Study||4134
7646774|NCT02164513|18830629|P1|STARTED|Overall Study||4151
7646775|NCT02164396|18830654|P3|NOT COMPLETED|Overall Study||0
7646776|NCT02164396|18830655|P2|NOT COMPLETED|Overall Study||0
7646777|NCT02164396|18830656|P1|NOT COMPLETED|Overall Study||0
7646778|NCT02164396|18830654|P3|COMPLETED|Overall Study||10
7646779|NCT02164396|18830655|P2|COMPLETED|Overall Study||10
7646780|NCT02164396|18830656|P1|COMPLETED|Overall Study||10
7646781|NCT02164396|18830654|P3|STARTED|Overall Study||10
7646782|NCT02164396|18830655|P2|STARTED|Overall Study||10
7646783|NCT02164396|18830656|P1|STARTED|Overall Study||10
7646784|NCT02164383|18830666|P2|NOT COMPLETED|Overall Study||0
7646785|NCT02164383|18830667|P1|NOT COMPLETED|Overall Study||1
7646786|NCT02164383|18830666|P2|COMPLETED|Overall Study||14
7646787|NCT02164383|18830667|P1|COMPLETED|Overall Study||15
7646788|NCT02164383|18830666|P2|STARTED|Overall Study||14
7646789|NCT02164383|18830667|P1|STARTED|Overall Study||16
7646790|NCT02164318|18830677|P4|NOT COMPLETED|Overall Study||1
7646791|NCT02164318|18830678|P3|NOT COMPLETED|Overall Study||0
7646792|NCT02164318|18830679|P2|NOT COMPLETED|Overall Study||1
7646793|NCT02164318|18830680|P1|NOT COMPLETED|Overall Study||0
7646794|NCT02164318|18830677|P4|COMPLETED|Overall Study||2
7646795|NCT02164318|18830678|P3|COMPLETED|Overall Study||1
7646796|NCT02164318|18830679|P2|COMPLETED|Overall Study||2
7646797|NCT02164318|18830680|P1|COMPLETED|Overall Study||4
7646798|NCT02164318|18830677|P4|STARTED|Overall Study||3
7646799|NCT02164318|18830678|P3|STARTED|Overall Study||1
7646800|NCT02164318|18830679|P2|STARTED|Overall Study||3
7646801|NCT02164318|18830680|P1|STARTED|Overall Study||4
7646802|NCT02164240|18830698|P3|NOT COMPLETED|Overall Study||0
7646803|NCT02164240|18830699|P2|NOT COMPLETED|Overall Study||0
7646804|NCT02164240|18830700|P1|NOT COMPLETED|Overall Study||0
7646805|NCT02164240|18830698|P3|COMPLETED|Overall Study||4
7646806|NCT02164240|18830699|P2|COMPLETED|Overall Study||5
7646807|NCT02164240|18830700|P1|COMPLETED|Overall Study||4
7646808|NCT02164240|18830698|P3|STARTED|Overall Study||4
7646809|NCT02164240|18830699|P2|STARTED|Overall Study||5
7646810|NCT02164240|18830700|P1|STARTED|Overall Study||4
7646811|NCT02163993|18830715|P5|NOT COMPLETED|Post-treatment Period||3
7646812|NCT02163993|18830716|P4|NOT COMPLETED|Post-treatment Period||2
7646813|NCT02163993|18830717|P3|NOT COMPLETED|Post-treatment Period||4
7646814|NCT02163993|18830718|P2|NOT COMPLETED|Post-treatment Period||6
7646815|NCT02163993|18830719|P1|NOT COMPLETED|Post-treatment Period||4
7646816|NCT02163993|18830715|P5|COMPLETED|Post-treatment Period||62
7646817|NCT02163993|18830716|P4|COMPLETED|Post-treatment Period||61
7646818|NCT02163993|18830717|P3|COMPLETED|Post-treatment Period||62
7646819|NCT02163993|18830718|P2|COMPLETED|Post-treatment Period||55
7646820|NCT02163993|18830719|P1|COMPLETED|Post-treatment Period||121
7646821|NCT02163993|18830715|P5|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|65
7646822|NCT02163993|18830716|P4|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|63
7646823|NCT02163993|18830717|P3|STARTED|Post-treatment Period||66
7646824|NCT02163993|18830718|P2|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|61
7646825|NCT02163993|18830719|P1|STARTED|Post-treatment Period|One participant discontinued after Treatment Period. Did not enter into Post-treatment Period.|125
7646826|NCT02163993|18830715|P5|NOT COMPLETED|Treatment Period||7
7646827|NCT02163993|18830716|P4|NOT COMPLETED|Treatment Period||9
7646828|NCT02163993|18830717|P3|NOT COMPLETED|Treatment Period||2
7646829|NCT02163993|18830718|P2|NOT COMPLETED|Treatment Period||9
7646830|NCT02163993|18830719|P1|NOT COMPLETED|Treatment Period||12
7646831|NCT02163993|18830715|P5|COMPLETED|Treatment Period||62
7646832|NCT02163993|18830716|P4|COMPLETED|Treatment Period||62
7646833|NCT02163993|18830717|P3|COMPLETED|Treatment Period||66
7646834|NCT02163993|18830718|P2|COMPLETED|Treatment Period||59
7646835|NCT02163993|18830719|P1|COMPLETED|Treatment Period||126
7646836|NCT02163993|18830715|P5|Received at Least 1 Dose of Study Drug|Treatment Period||67
7646837|NCT02163993|18830716|P4|Received at Least 1 Dose of Study Drug|Treatment Period||70
7646838|NCT02163993|18830717|P3|Received at Least 1 Dose of Study Drug|Treatment Period||68
7646839|NCT02163993|18830718|P2|Received at Least 1 Dose of Study Drug|Treatment Period||68
7646840|NCT02163993|18830719|P1|Received at Least 1 Dose of Study Drug|Treatment Period||137
7646841|NCT02163993|18830715|P5|STARTED|Treatment Period||69
7646842|NCT02163993|18830716|P4|STARTED|Treatment Period||71
7646843|NCT02163993|18830717|P3|STARTED|Treatment Period||68
7646844|NCT02163993|18830718|P2|STARTED|Treatment Period||68
7646845|NCT02163993|18830719|P1|STARTED|Treatment Period||138
7646846|NCT02163967|18830795|P6|NOT COMPLETED|Third Intervention/Day 3||0
7646847|NCT02163967|18830796|P5|NOT COMPLETED|Third Intervention/Day 3||0
7646848|NCT02163967|18830797|P4|NOT COMPLETED|Third Intervention/Day 3||0
7646849|NCT02163967|18830798|P3|NOT COMPLETED|Third Intervention/Day 3||0
7646850|NCT02163967|18830799|P2|NOT COMPLETED|Third Intervention/Day 3||0
7646851|NCT02163967|18830800|P1|NOT COMPLETED|Third Intervention/Day 3||0
7646852|NCT02163967|18830795|P6|COMPLETED|Third Intervention/Day 3||3
7646853|NCT02163967|18830796|P5|COMPLETED|Third Intervention/Day 3||3
7646854|NCT02163967|18830797|P4|COMPLETED|Third Intervention/Day 3||4
7646855|NCT02163967|18830798|P3|COMPLETED|Third Intervention/Day 3||2
7646856|NCT02163967|18830799|P2|COMPLETED|Third Intervention/Day 3||3
7646857|NCT02163967|18830800|P1|COMPLETED|Third Intervention/Day 3||3
7646858|NCT02163967|18830795|P6|STARTED|Third Intervention/Day 3||3
7646859|NCT02163967|18830796|P5|STARTED|Third Intervention/Day 3||3
7646860|NCT02163967|18830797|P4|STARTED|Third Intervention/Day 3||4
7646861|NCT02163967|18830798|P3|STARTED|Third Intervention/Day 3||2
7646862|NCT02163967|18830799|P2|STARTED|Third Intervention/Day 3||3
7646863|NCT02163967|18830800|P1|STARTED|Third Intervention/Day 3||3
7646864|NCT02163967|18830795|P6|NOT COMPLETED|Second Intevention/Day 2||0
7646865|NCT02163967|18830796|P5|NOT COMPLETED|Second Intevention/Day 2||0
7646866|NCT02163967|18830797|P4|NOT COMPLETED|Second Intevention/Day 2||0
7646867|NCT02163967|18830798|P3|NOT COMPLETED|Second Intevention/Day 2||0
7646868|NCT02163967|18830799|P2|NOT COMPLETED|Second Intevention/Day 2||0
7646869|NCT02163967|18830800|P1|NOT COMPLETED|Second Intevention/Day 2||0
7646870|NCT02163967|18830795|P6|COMPLETED|Second Intevention/Day 2||3
7646871|NCT02163967|18830796|P5|COMPLETED|Second Intevention/Day 2||3
7646872|NCT02163967|18830797|P4|COMPLETED|Second Intevention/Day 2||4
7646873|NCT02163967|18830798|P3|COMPLETED|Second Intevention/Day 2||2
7646874|NCT02163967|18830799|P2|COMPLETED|Second Intevention/Day 2||4
7646875|NCT02163967|18830800|P1|COMPLETED|Second Intevention/Day 2||3
7646876|NCT02163967|18830795|P6|STARTED|Second Intevention/Day 2||3
7646877|NCT02163967|18830796|P5|STARTED|Second Intevention/Day 2||3
7646878|NCT02163967|18830797|P4|STARTED|Second Intevention/Day 2||4
7646879|NCT02163967|18830798|P3|STARTED|Second Intevention/Day 2||2
7646880|NCT02163967|18830799|P2|STARTED|Second Intevention/Day 2||4
7646881|NCT02163967|18830800|P1|STARTED|Second Intevention/Day 2||3
7646882|NCT02163967|18830795|P6|NOT COMPLETED|First Intervention/ Day 1||0
7646883|NCT02163967|18830796|P5|NOT COMPLETED|First Intervention/ Day 1||0
7646884|NCT02163967|18830797|P4|NOT COMPLETED|First Intervention/ Day 1||0
7646885|NCT02163967|18830798|P3|NOT COMPLETED|First Intervention/ Day 1||0
7646886|NCT02163967|18830799|P2|NOT COMPLETED|First Intervention/ Day 1||0
7646887|NCT02163967|18830800|P1|NOT COMPLETED|First Intervention/ Day 1||0
7646888|NCT02163967|18830795|P6|COMPLETED|First Intervention/ Day 1||3
7646889|NCT02163967|18830796|P5|COMPLETED|First Intervention/ Day 1||3
7646890|NCT02163967|18830797|P4|COMPLETED|First Intervention/ Day 1||4
7646891|NCT02163967|18830798|P3|COMPLETED|First Intervention/ Day 1||3
7646892|NCT02163967|18830799|P2|COMPLETED|First Intervention/ Day 1||4
7646893|NCT02163967|18830800|P1|COMPLETED|First Intervention/ Day 1||4
7646894|NCT02163967|18830795|P6|STARTED|First Intervention/ Day 1||3
7646895|NCT02163967|18830796|P5|STARTED|First Intervention/ Day 1||3
7646896|NCT02163967|18830797|P4|STARTED|First Intervention/ Day 1||4
7646897|NCT02163967|18830798|P3|STARTED|First Intervention/ Day 1||3
7646898|NCT02163967|18830799|P2|STARTED|First Intervention/ Day 1||4
7646899|NCT02163967|18830800|P1|STARTED|First Intervention/ Day 1||4
7646900|NCT02163915|18830822|P5|NOT COMPLETED|Overall Study||4
7646901|NCT02163915|18830823|P4|NOT COMPLETED|Overall Study||3
7646902|NCT02163915|18830824|P3|NOT COMPLETED|Overall Study||2
7646903|NCT02163915|18830825|P2|NOT COMPLETED|Overall Study||0
7646904|NCT02163915|18830826|P1|NOT COMPLETED|Overall Study||3
7646905|NCT02163915|18830822|P5|COMPLETED|Overall Study||6
7646906|NCT02163915|18830823|P4|COMPLETED|Overall Study||6
7646907|NCT02163915|18830824|P3|COMPLETED|Overall Study||8
7646908|NCT02163915|18830825|P2|COMPLETED|Overall Study||8
7646909|NCT02163915|18830826|P1|COMPLETED|Overall Study||7
7646910|NCT02163915|18830822|P5|STARTED|Overall Study||10
7646911|NCT02163915|18830823|P4|STARTED|Overall Study||9
7646912|NCT02163915|18830824|P3|STARTED|Overall Study||10
7646913|NCT02163915|18830825|P2|STARTED|Overall Study||8
7646914|NCT02163915|18830826|P1|STARTED|Overall Study||10
7646915|NCT02163902|18830881|P2|NOT COMPLETED|Overall Study||13
7646916|NCT02163902|18830882|P1|NOT COMPLETED|Overall Study||11
7646917|NCT02163902|18830881|P2|COMPLETED|Overall Study||98
7646918|NCT02163902|18830882|P1|COMPLETED|Overall Study||102
7646919|NCT02163902|18830881|P2|STARTED|Overall Study||111
7646920|NCT02163902|18830882|P1|STARTED|Overall Study||113
7646921|NCT02163837|18830898|P1|NOT COMPLETED|Day 28 of Rifaximin Treatment||0
7646922|NCT02163837|18830898|P1|COMPLETED|Day 28 of Rifaximin Treatment||15
7646923|NCT02163837|18830898|P1|STARTED|Day 28 of Rifaximin Treatment||15
7646924|NCT02163837|18830898|P1|NOT COMPLETED|Before Rifaximin||0
7646925|NCT02163837|18830898|P1|COMPLETED|Before Rifaximin||15
7646926|NCT02163837|18830898|P1|STARTED|Before Rifaximin||15
7646927|NCT02163824|18830909|P3|NOT COMPLETED|Overall Study||2
7646928|NCT02163824|18830910|P2|NOT COMPLETED|Overall Study||1
7646929|NCT02163824|18830911|P1|NOT COMPLETED|Overall Study||2
7646930|NCT02163824|18830909|P3|COMPLETED|Overall Study||124
7646931|NCT02163824|18830910|P2|COMPLETED|Overall Study||124
7646932|NCT02163824|18830911|P1|COMPLETED|Overall Study||127
7646933|NCT02163824|18830909|P3|STARTED|Overall Study||126
7646934|NCT02163824|18830910|P2|STARTED|Overall Study||125
7646935|NCT02163824|18830911|P1|STARTED|Overall Study||129
7646936|NCT02163811|18830936|P2|NOT COMPLETED|Overall Study||16
7646937|NCT02163811|18830937|P1|NOT COMPLETED|Overall Study||36
7646938|NCT02163811|18830936|P2|COMPLETED|Overall Study||60
7646939|NCT02163811|18830937|P1|COMPLETED|Overall Study||35
7646940|NCT02163811|18830936|P2|STARTED|Overall Study||76
7646941|NCT02163811|18830937|P1|STARTED|Overall Study||71
7646942|NCT02163733|18830959|P3|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||24
7646943|NCT02163733|18830960|P2|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
7646944|NCT02163733|18830961|P1|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
7646945|NCT02163733|18830959|P3|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||14
7646946|NCT02163733|18830960|P2|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
7646947|NCT02163733|18830961|P1|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
7646948|NCT02163733|18830959|P3|STARTED|Part B: Day 15 to End Part B (AZD9291)|No patients completed previous period as relates to Part A and arm is applicable only for Part B.|38
7646949|NCT02163733|18830960|P2|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
7646950|NCT02163733|18830961|P1|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
7646951|NCT02163733|18830959|P3|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
7646952|NCT02163733|18830960|P2|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
7646953|NCT02163733|18830961|P1|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
7646954|NCT02163733|18830959|P3|COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
7646955|NCT02163733|18830960|P2|COMPLETED|Part A: Day 10-15 (2nd Intervention)||20
7646956|NCT02163733|18830961|P1|COMPLETED|Part A: Day 10-15 (2nd Intervention)||18
7646957|NCT02163733|18830959|P3|STARTED|Part A: Day 10-15 (2nd Intervention)||0
7646958|NCT02163733|18830960|P2|STARTED|Part A: Day 10-15 (2nd Intervention)||20
7646959|NCT02163733|18830961|P1|STARTED|Part A: Day 10-15 (2nd Intervention)||18
7646960|NCT02163733|18830959|P3|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
7646961|NCT02163733|18830960|P2|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
7646962|NCT02163733|18830961|P1|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
7646963|NCT02163733|18830959|P3|COMPLETED|Part A: Day 1-9 (1st Intervention)||0
7646964|NCT02163733|18830960|P2|COMPLETED|Part A: Day 1-9 (1st Intervention)||20
7646965|NCT02163733|18830961|P1|COMPLETED|Part A: Day 1-9 (1st Intervention)||18
7646966|NCT02163733|18830959|P3|STARTED|Part A: Day 1-9 (1st Intervention)||0
7646967|NCT02163733|18830960|P2|STARTED|Part A: Day 1-9 (1st Intervention)||20
7646968|NCT02163733|18830961|P1|STARTED|Part A: Day 1-9 (1st Intervention)||18
7646969|NCT02163577|18830998|P2|NOT COMPLETED|Overall Study||0
7646970|NCT02163577|18830999|P1|NOT COMPLETED|Overall Study||0
7646971|NCT02163577|18830998|P2|COMPLETED|Overall Study||26
7646972|NCT02163577|18830999|P1|COMPLETED|Overall Study||26
7646973|NCT02163577|18830998|P2|STARTED|Overall Study||26
7646974|NCT02163577|18830999|P1|STARTED|Overall Study||26
7646975|NCT02163538|18831063|P2|NOT COMPLETED|Overall Study||1
7646976|NCT02163538|18831064|P1|NOT COMPLETED|Overall Study||1
7646977|NCT02163538|18831063|P2|COMPLETED|Overall Study||70
7646978|NCT02163538|18831064|P1|COMPLETED|Overall Study||70
7646979|NCT02163538|18831063|P2|STARTED|Overall Study||71
7646980|NCT02163538|18831064|P1|STARTED|Overall Study||71
7646981|NCT02163499|18831080|P1|NOT COMPLETED|Extended Dosing Phase: ZS||280
7646982|NCT02163499|18831080|P1|COMPLETED|Extended Dosing Phase: ZS||466
7646983|NCT02163499|18831080|P1|STARTED|Extended Dosing Phase: ZS||746
7646984|NCT02163499|18831080|P1|NOT COMPLETED|Acute Phase: ZS 10 g TID||5
7646985|NCT02163499|18831080|P1|COMPLETED|Acute Phase: ZS 10 g TID||746
7646986|NCT02163499|18831080|P1|STARTED|Acute Phase: ZS 10 g TID||751
7646987|NCT02163486|18831090|P2|NOT COMPLETED|Overall Study||2
7646988|NCT02163486|18831091|P1|NOT COMPLETED|Overall Study||1
7646989|NCT02163486|18831090|P2|COMPLETED|Overall Study||50
7646990|NCT02163486|18831091|P1|COMPLETED|Overall Study||50
7646991|NCT02163486|18831090|P2|STARTED|Overall Study||52
7646992|NCT02163486|18831091|P1|STARTED|Overall Study||51
7646993|NCT02163447|18831108|P3|NOT COMPLETED|Overall Study||3
7646994|NCT02163447|18831109|P2|NOT COMPLETED|Overall Study||6
7646995|NCT02163447|18831110|P1|NOT COMPLETED|Overall Study||6
7646996|NCT02163447|18831108|P3|COMPLETED|Overall Study||97
7646997|NCT02163447|18831109|P2|COMPLETED|Overall Study||88
7646998|NCT02163447|18831110|P1|COMPLETED|Overall Study||100
7646999|NCT02163447|18831108|P3|Infants Born|Overall Study||100
7647000|NCT02163447|18831109|P2|Infants Born|Overall Study||93
7647001|NCT02163447|18831110|P1|Infants Born|Overall Study||101
7647002|NCT02163447|18831108|P3|STARTED|Overall Study||100
7647003|NCT02163447|18831109|P2|STARTED|Overall Study||94
7647004|NCT02163447|18831110|P1|STARTED|Overall Study||106
7647005|NCT02163421|18831175|P4|NOT COMPLETED|Overall Study||0
7647006|NCT02163421|18831176|P3|NOT COMPLETED|Overall Study||0
7647007|NCT02163421|18831177|P2|NOT COMPLETED|Overall Study||0
7647008|NCT02163421|18831178|P1|NOT COMPLETED|Overall Study||0
7647009|NCT02163421|18831175|P4|COMPLETED|Overall Study||12
7647010|NCT02163421|18831176|P3|COMPLETED|Overall Study||12
7647011|NCT02163421|18831177|P2|COMPLETED|Overall Study||12
7647012|NCT02163421|18831178|P1|COMPLETED|Overall Study||12
7647013|NCT02163421|18831175|P4|STARTED|Overall Study||12
7647014|NCT02163421|18831176|P3|STARTED|Overall Study||12
7647015|NCT02163421|18831177|P2|STARTED|Overall Study||12
7647016|NCT02163421|18831178|P1|STARTED|Overall Study||12
7647017|NCT02163395|18831185|P1|NOT COMPLETED|Overall Study||5
7647018|NCT02163395|18831185|P1|COMPLETED|Overall Study||39
7647019|NCT02163395|18831185|P1|STARTED|Overall Study||44
7647020|NCT02163187|18831194|P2|NOT COMPLETED|Overall Study||0
7647021|NCT02163187|18831195|P1|NOT COMPLETED|Overall Study||2
7647022|NCT02163187|18831194|P2|COMPLETED|Overall Study||0
7647023|NCT02163187|18831195|P1|COMPLETED|Overall Study||2
7647024|NCT02163187|18831194|P2|Treatment|Overall Study||0
7647025|NCT02163187|18831195|P1|Treatment|Overall Study||2
7647026|NCT02163187|18831194|P2|STARTED|Overall Study||0
7647027|NCT02163187|18831195|P1|STARTED|Overall Study||4
7647028|NCT02163057|18831205|P2|NOT COMPLETED|Overall Study||5
7647029|NCT02163057|18831206|P1|NOT COMPLETED|Overall Study||3
7647030|NCT02163057|18831205|P2|COMPLETED|Overall Study||11
7647031|NCT02163057|18831206|P1|COMPLETED|Overall Study||3
7647032|NCT02163057|18831205|P2|STARTED|Overall Study||16
7647033|NCT02163057|18831206|P1|STARTED|Overall Study||6
7647034|NCT02162992|18831228|P2|NOT COMPLETED|Overall Study||1
7647035|NCT02162992|18831229|P1|NOT COMPLETED|Overall Study||5
7647036|NCT02162992|18831228|P2|COMPLETED|Overall Study||99
7647037|NCT02162992|18831229|P1|COMPLETED|Overall Study||46
7647038|NCT02162992|18831228|P2|STARTED|Overall Study||100
7647039|NCT02162992|18831229|P1|STARTED|Overall Study||51
7647040|NCT02162979|18831239|P2|NOT COMPLETED|Overall Study||0
7647041|NCT02162979|18831240|P1|NOT COMPLETED|Overall Study||0
7647042|NCT02162979|18831239|P2|COMPLETED|Overall Study||0
7647043|NCT02162979|18831240|P1|COMPLETED|Overall Study||0
7647044|NCT02162979|18831239|P2|STARTED|Overall Study||0
7647045|NCT02162979|18831240|P1|STARTED|Overall Study||0
7647046|NCT02162862|18831253|P3|NOT COMPLETED|Overall Study||4
7647047|NCT02162862|18831254|P2|NOT COMPLETED|Overall Study||11
7647048|NCT02162862|18831255|P1|NOT COMPLETED|Overall Study||0
7647049|NCT02162862|18831253|P3|COMPLETED|Overall Study||29
7647050|NCT02162862|18831254|P2|COMPLETED|Overall Study||24
7647051|NCT02162862|18831255|P1|COMPLETED|Overall Study||31
7647052|NCT02162862|18831253|P3|STARTED|Overall Study||33
7647053|NCT02162862|18831254|P2|STARTED|Overall Study||35
7647054|NCT02162862|18831255|P1|STARTED|Overall Study||31
7647055|NCT02162771|18831268|P2|NOT COMPLETED|Maintenance Study Period (Part 2)||22
7647056|NCT02162771|18831269|P1|NOT COMPLETED|Maintenance Study Period (Part 2)||16
7647057|NCT02162771|18831268|P2|COMPLETED|Maintenance Study Period (Part 2)||38
7647058|NCT02162771|18831269|P1|COMPLETED|Maintenance Study Period (Part 2)||46
7647059|NCT02162771|18831268|P2|STARTED|Maintenance Study Period (Part 2)|Two subjects did not enter this period due to Withdrawal by subject and Non-responder, 1 for each.|60
7647060|NCT02162771|18831269|P1|STARTED|Maintenance Study Period (Part 2)||62
7647061|NCT02162771|18831268|P2|NOT COMPLETED|Core Study Period (Part 2)||8
7647062|NCT02162771|18831269|P1|NOT COMPLETED|Core Study Period (Part 2)||8
7647063|NCT02162771|18831268|P2|COMPLETED|Core Study Period (Part 2)||62
7647064|NCT02162771|18831269|P1|COMPLETED|Core Study Period (Part 2)||62
7647065|NCT02162771|18831268|P2|STARTED|Core Study Period (Part 2)||70
7647066|NCT02162771|18831269|P1|STARTED|Core Study Period (Part 2)||70
7647067|NCT02162758|18831283|P2|NOT COMPLETED|Overall Study||1
7647068|NCT02162758|18831284|P1|NOT COMPLETED|Overall Study||0
7647069|NCT02162758|18831283|P2|COMPLETED|Overall Study||2
7647070|NCT02162758|18831284|P1|COMPLETED|Overall Study||3
7647071|NCT02162758|18831283|P2|STARTED|Overall Study||3
7647072|NCT02162758|18831284|P1|STARTED|Overall Study||3
7647073|NCT02162680|18831299|P3|NOT COMPLETED|Overall Study||0
7647074|NCT02162680|18831300|P2|NOT COMPLETED|Overall Study||0
7647075|NCT02162680|18831301|P1|NOT COMPLETED|Overall Study||0
7647076|NCT02162680|18831299|P3|COMPLETED|Overall Study||32
7647077|NCT02162680|18831300|P2|COMPLETED|Overall Study||33
7647078|NCT02162680|18831301|P1|COMPLETED|Overall Study||33
7647079|NCT02162680|18831299|P3|STARTED|Overall Study||32
7647080|NCT02162680|18831300|P2|STARTED|Overall Study||33
7647081|NCT02162680|18831301|P1|STARTED|Overall Study||33
7647082|NCT02162667|18831311|P2|NOT COMPLETED|Adjuvant Period||13
7647083|NCT02162667|18831312|P1|NOT COMPLETED|Adjuvant Period||12
7647084|NCT02162667|18831311|P2|COMPLETED|Adjuvant Period||255
7647085|NCT02162667|18831312|P1|COMPLETED|Adjuvant Period||248
7647086|NCT02162667|18831311|P2|STARTED|Adjuvant Period||268
7647087|NCT02162667|18831312|P1|STARTED|Adjuvant Period||260
7647088|NCT02162667|18831311|P2|NOT COMPLETED|Neoadjuvant Period||17
7647089|NCT02162667|18831312|P1|NOT COMPLETED|Neoadjuvant Period||14
7647090|NCT02162667|18831311|P2|COMPLETED|Neoadjuvant Period||267
7647091|NCT02162667|18831312|P1|COMPLETED|Neoadjuvant Period||264
7647092|NCT02162667|18831311|P2|STARTED|Neoadjuvant Period||284
7647093|NCT02162667|18831312|P1|STARTED|Neoadjuvant Period||278
7647094|NCT02162576|18831338|P1|NOT COMPLETED|Overall Study||0
7647095|NCT02162576|18831338|P1|COMPLETED|Overall Study||95
7647096|NCT02162576|18831338|P1|STARTED|Overall Study||95
7647097|NCT02162446|18831344|P1|NOT COMPLETED|Overall Study||0
7647098|NCT02162446|18831344|P1|COMPLETED|Overall Study||12
7647099|NCT02162446|18831344|P1|STARTED|Overall Study||12
7647100|NCT02162433|18831379|P4|NOT COMPLETED|Overall Study||1
7647101|NCT02162433|18831380|P3|NOT COMPLETED|Overall Study||2
7647102|NCT02162433|18831381|P2|NOT COMPLETED|Overall Study||2
7647103|NCT02162433|18831382|P1|NOT COMPLETED|Overall Study||1
7647104|NCT02162433|18831379|P4|COMPLETED|Overall Study||22
7647105|NCT02162433|18831380|P3|COMPLETED|Overall Study||21
7647106|NCT02162433|18831381|P2|COMPLETED|Overall Study||21
7647107|NCT02162433|18831382|P1|COMPLETED|Overall Study||22
7647108|NCT02162433|18831379|P4|STARTED|Overall Study||23
7647109|NCT02162433|18831380|P3|STARTED|Overall Study||23
7647110|NCT02162433|18831381|P2|STARTED|Overall Study||23
7647111|NCT02162433|18831382|P1|STARTED|Overall Study||23
7647112|NCT02161757|18831419|P3|NOT COMPLETED|Treatment Through Study Completion||39
7647113|NCT02161757|18831420|P2|NOT COMPLETED|Treatment Through Study Completion||43
7647114|NCT02161757|18831421|P1|NOT COMPLETED|Treatment Through Study Completion||57
7647115|NCT02161757|18831419|P3|COMPLETED|Treatment Through Study Completion||361
7647116|NCT02161757|18831420|P2|COMPLETED|Treatment Through Study Completion||361
7647117|NCT02161757|18831421|P1|COMPLETED|Treatment Through Study Completion||341
7647118|NCT02161757|18831419|P3|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||360
7647119|NCT02161757|18831420|P2|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||355
7647120|NCT02161757|18831421|P1|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||332
7647121|NCT02161757|18831419|P3|STARTED|Treatment Through Study Completion||400
7647122|NCT02161757|18831420|P2|STARTED|Treatment Through Study Completion||404
7647123|NCT02161757|18831421|P1|STARTED|Treatment Through Study Completion||398
7647124|NCT02161757|18831419|P3|NOT COMPLETED|Randomised Through Start Treatment||0
7647125|NCT02161757|18831420|P2|NOT COMPLETED|Randomised Through Start Treatment||2
7647126|NCT02161757|18831421|P1|NOT COMPLETED|Randomised Through Start Treatment||3
7647127|NCT02161757|18831419|P3|COMPLETED|Randomised Through Start Treatment||400
7647128|NCT02161757|18831420|P2|COMPLETED|Randomised Through Start Treatment||404
7647129|NCT02161757|18831421|P1|COMPLETED|Randomised Through Start Treatment||398
7647130|NCT02161757|18831419|P3|STARTED|Randomised Through Start Treatment||400
7647131|NCT02161757|18831420|P2|STARTED|Randomised Through Start Treatment||406
7647132|NCT02161757|18831421|P1|STARTED|Randomised Through Start Treatment||401
7647133|NCT02161731|18831479|P2|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||2
7647134|NCT02161731|18831480|P1|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
7647135|NCT02161731|18831479|P2|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||22
7647136|NCT02161731|18831480|P1|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
7647137|NCT02161731|18831479|P2|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||24
7647138|NCT02161731|18831480|P1|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||0
7647139|NCT02161731|18831479|P2|STARTED|Period 2 (Day 7 Dosing to Day 23)||24
7647140|NCT02161731|18831480|P1|STARTED|Period 2 (Day 7 Dosing to Day 23)||0
7647141|NCT02161731|18831479|P2|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
7647142|NCT02161731|18831480|P1|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
7647143|NCT02161731|18831479|P2|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
7647144|NCT02161731|18831480|P1|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||24
7647145|NCT02161731|18831479|P2|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||0
7647146|NCT02161731|18831480|P1|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||24
7647147|NCT02161731|18831479|P2|STARTED|Period 1 (Day -1 to Day 7 Predose)||0
7647148|NCT02161731|18831480|P1|STARTED|Period 1 (Day -1 to Day 7 Predose)||24
7647149|NCT02161705|18831499|P2|NOT COMPLETED|Overall Study||0
7647150|NCT02161705|18831500|P1|NOT COMPLETED|Overall Study||0
7647151|NCT02161705|18831499|P2|COMPLETED|Overall Study||9
7647152|NCT02161705|18831500|P1|COMPLETED|Overall Study||9
7647153|NCT02161705|18831499|P2|STARTED|Overall Study||9
7647154|NCT02161705|18831500|P1|STARTED|Overall Study||9
7647155|NCT02161575|18831508|P1|NOT COMPLETED|Overall Study||11
7647156|NCT02161575|18831508|P1|COMPLETED|Overall Study||92
7647157|NCT02161575|18831508|P1|Safety (SAF) Population|Overall Study||100
7647158|NCT02161575|18831508|P1|Full Analysis Set (FAS) Population|Overall Study||100
7647159|NCT02161575|18831508|P1|STARTED|Overall Study||103
7647160|NCT02161562|18831528|P2|NOT COMPLETED|Overall Study||17
7647161|NCT02161562|18831529|P1|NOT COMPLETED|Overall Study||26
7647162|NCT02161562|18831528|P2|COMPLETED|Overall Study||119
7647163|NCT02161562|18831529|P1|COMPLETED|Overall Study||152
7647164|NCT02161562|18831528|P2|STARTED|Overall Study||136
7647165|NCT02161562|18831529|P1|STARTED|Overall Study||178
7647166|NCT02161549|18831557|P2|NOT COMPLETED|Overall Study||2
7647167|NCT02161549|18831558|P1|NOT COMPLETED|Overall Study||6
7647168|NCT02161549|18831557|P2|COMPLETED|Overall Study||29
7647169|NCT02161549|18831558|P1|COMPLETED|Overall Study||34
7647170|NCT02161549|18831557|P2|STARTED|Overall Study||31
7647171|NCT02161549|18831558|P1|STARTED|Overall Study||40
7647172|NCT02161536|18831567|P3|NOT COMPLETED|Overall Study||0
7647173|NCT02161536|18831568|P2|NOT COMPLETED|Overall Study||0
7647174|NCT02161536|18831569|P1|NOT COMPLETED|Overall Study||0
7647175|NCT02161536|18831567|P3|COMPLETED|Overall Study||20
7647176|NCT02161536|18831568|P2|COMPLETED|Overall Study||21
7647177|NCT02161536|18831569|P1|COMPLETED|Overall Study||6
7647178|NCT02161536|18831567|P3|STARTED|Overall Study||20
7647179|NCT02161536|18831568|P2|STARTED|Overall Study||21
7647180|NCT02161536|18831569|P1|STARTED|Overall Study||6
7647181|NCT02161484|18831579|P2|NOT COMPLETED|Overall Study||3
7647182|NCT02161484|18831580|P1|NOT COMPLETED|Overall Study||4
7647183|NCT02161484|18831579|P2|COMPLETED|Overall Study||2
7647184|NCT02161484|18831580|P1|COMPLETED|Overall Study||1
7647185|NCT02161484|18831579|P2|STARTED|Overall Study||5
7647186|NCT02161484|18831580|P1|STARTED|Overall Study||5
7647187|NCT02161458|18831606|P4|NOT COMPLETED|Overall Study||0
7647188|NCT02161458|18831607|P3|NOT COMPLETED|Overall Study||5
7647189|NCT02161458|18831608|P2|NOT COMPLETED|Overall Study||6
7647190|NCT02161458|18831609|P1|NOT COMPLETED|Overall Study||0
7647191|NCT02161458|18831606|P4|COMPLETED|Overall Study||8
7647192|NCT02161458|18831607|P3|COMPLETED|Overall Study||28
7647193|NCT02161458|18831608|P2|COMPLETED|Overall Study||29
7647194|NCT02161458|18831609|P1|COMPLETED|Overall Study||22
7647195|NCT02161458|18831606|P4|STARTED|Overall Study||8
7647196|NCT02161458|18831607|P3|STARTED|Overall Study||33
7647197|NCT02161458|18831608|P2|STARTED|Overall Study||35
7647198|NCT02161458|18831609|P1|STARTED|Overall Study||22
7647199|NCT02161406|18831621|P2|NOT COMPLETED|Overall Study||9
7647200|NCT02161406|18831622|P1|NOT COMPLETED|Overall Study||10
7647201|NCT02161406|18831621|P2|COMPLETED|Overall Study||35
7647202|NCT02161406|18831622|P1|COMPLETED|Overall Study||34
7647203|NCT02161406|18831621|P2|STARTED|Overall Study||44
7647204|NCT02161406|18831622|P1|STARTED|Overall Study||44
7647205|NCT02161185|18831696|P1|NOT COMPLETED|Treatment Phase||7
7647206|NCT02161185|18831696|P1|COMPLETED|Treatment Phase||0
7647207|NCT02161185|18831696|P1|STARTED|Treatment Phase||7
7647208|NCT02161185|18831696|P1|NOT COMPLETED|Test Dose Phase||0
7647209|NCT02161185|18831696|P1|COMPLETED|Test Dose Phase||7
7647210|NCT02161185|18831696|P1|STARTED|Test Dose Phase||7
7647211|NCT02161146|18831706|P5|NOT COMPLETED|Overall Study||1
7647212|NCT02161146|18831707|P4|NOT COMPLETED|Overall Study||3
7647213|NCT02161146|18831708|P3|NOT COMPLETED|Overall Study||0
7647214|NCT02161146|18831709|P2|NOT COMPLETED|Overall Study||4
7647215|NCT02161146|18831710|P1|NOT COMPLETED|Overall Study||1
7647216|NCT02161146|18831706|P5|COMPLETED|Overall Study||48
7647217|NCT02161146|18831707|P4|COMPLETED|Overall Study||45
7647218|NCT02161146|18831708|P3|COMPLETED|Overall Study||49
7647219|NCT02161146|18831709|P2|COMPLETED|Overall Study||43
7647220|NCT02161146|18831710|P1|COMPLETED|Overall Study||46
7647221|NCT02161146|18831706|P5|STARTED|Overall Study||49
7647222|NCT02161146|18831707|P4|STARTED|Overall Study||48
7647223|NCT02161146|18831708|P3|STARTED|Overall Study||49
7647224|NCT02161146|18831709|P2|STARTED|Overall Study||47
7647225|NCT02161146|18831710|P1|STARTED|Overall Study||47
7647226|NCT02161133|18831725|P2|NOT COMPLETED|Overall Study||11
7647227|NCT02161133|18831726|P1|NOT COMPLETED|Overall Study||19
7647228|NCT02161133|18831725|P2|COMPLETED|Overall Study||122
7647229|NCT02161133|18831726|P1|COMPLETED|Overall Study||116
7647230|NCT02161133|18831725|P2|STARTED|Overall Study||133
7647231|NCT02161133|18831726|P1|STARTED|Overall Study||135
7647232|NCT02161016|18831746|P1|NOT COMPLETED|Overall Study||1
7647233|NCT02161016|18831746|P1|COMPLETED|Overall Study||0
7647234|NCT02161016|18831746|P1|STARTED|Overall Study||1
7647235|NCT02160990|18831756|P2|NOT COMPLETED|Overall Study||0
7647236|NCT02160990|18831757|P1|NOT COMPLETED|Overall Study||0
7647237|NCT02160990|18831756|P2|COMPLETED|Overall Study||10
7647238|NCT02160990|18831757|P1|COMPLETED|Overall Study||10
7647239|NCT02160990|18831756|P2|STARTED|Overall Study||10
7647240|NCT02160990|18831757|P1|STARTED|Overall Study||10
7647241|NCT02160977|18831777|P2|NOT COMPLETED|Six Months After Surgery||1
7647242|NCT02160977|18831778|P1|NOT COMPLETED|Six Months After Surgery||2
7647243|NCT02160977|18831777|P2|COMPLETED|Six Months After Surgery||42
7647244|NCT02160977|18831778|P1|COMPLETED|Six Months After Surgery||42
7647245|NCT02160977|18831777|P2|STARTED|Six Months After Surgery||43
7647246|NCT02160977|18831778|P1|STARTED|Six Months After Surgery||44
7647247|NCT02160977|18831777|P2|NOT COMPLETED|Three Months After Surgery||2
7647248|NCT02160977|18831778|P1|NOT COMPLETED|Three Months After Surgery||0
7647249|NCT02160977|18831777|P2|COMPLETED|Three Months After Surgery||43
7647250|NCT02160977|18831778|P1|COMPLETED|Three Months After Surgery||44
7647251|NCT02160977|18831777|P2|STARTED|Three Months After Surgery||45
7647252|NCT02160977|18831778|P1|STARTED|Three Months After Surgery||44
7647253|NCT02160977|18831777|P2|NOT COMPLETED|Six Weeks After Surgery||0
7647254|NCT02160977|18831778|P1|NOT COMPLETED|Six Weeks After Surgery||1
7647255|NCT02160977|18831777|P2|COMPLETED|Six Weeks After Surgery||45
7647256|NCT02160977|18831778|P1|COMPLETED|Six Weeks After Surgery||44
7647257|NCT02160977|18831777|P2|STARTED|Six Weeks After Surgery||45
7647258|NCT02160977|18831778|P1|STARTED|Six Weeks After Surgery||45
7647259|NCT02160977|18831777|P2|NOT COMPLETED|One Week After Surgery||0
7647260|NCT02160977|18831778|P1|NOT COMPLETED|One Week After Surgery||0
7647261|NCT02160977|18831777|P2|COMPLETED|One Week After Surgery||45
7647262|NCT02160977|18831778|P1|COMPLETED|One Week After Surgery||45
7647263|NCT02160977|18831777|P2|STARTED|One Week After Surgery||45
7647264|NCT02160977|18831778|P1|STARTED|One Week After Surgery||45
7647265|NCT02160899|18831794|P6|NOT COMPLETED|Overall Study||0
7647266|NCT02160899|18831795|P5|NOT COMPLETED|Overall Study||2
7647267|NCT02160899|18831796|P4|NOT COMPLETED|Overall Study||1
7647268|NCT02160899|18831797|P3|NOT COMPLETED|Overall Study||0
7647269|NCT02160899|18831798|P2|NOT COMPLETED|Overall Study||1
7647270|NCT02160899|18831799|P1|NOT COMPLETED|Overall Study||0
7647271|NCT02160899|18831794|P6|COMPLETED|Overall Study||8
7647272|NCT02160899|18831795|P5|COMPLETED|Overall Study||0
7647273|NCT02160899|18831796|P4|COMPLETED|Overall Study||2
7647274|NCT02160899|18831797|P3|COMPLETED|Overall Study||21
7647275|NCT02160899|18831798|P2|COMPLETED|Overall Study||3
7647276|NCT02160899|18831799|P1|COMPLETED|Overall Study||26
7647277|NCT02160899|18831794|P6|STARTED|Overall Study||8
7647278|NCT02160899|18831795|P5|STARTED|Overall Study||2
7647279|NCT02160899|18831796|P4|STARTED|Overall Study||3
7647280|NCT02160899|18831797|P3|STARTED|Overall Study||21
7647281|NCT02160899|18831798|P2|STARTED|Overall Study||4
7647282|NCT02160899|18831799|P1|STARTED|Overall Study||26
7647283|NCT02160873|18831821|P2|NOT COMPLETED|Overall Study||0
7647284|NCT02160873|18831822|P1|NOT COMPLETED|Overall Study||0
7647285|NCT02160873|18831821|P2|COMPLETED|Overall Study||6
7647286|NCT02160873|18831822|P1|COMPLETED|Overall Study||6
7647287|NCT02160873|18831821|P2|STARTED|Overall Study||6
7647288|NCT02160873|18831822|P1|STARTED|Overall Study||6
7647289|NCT02160847|18831836|P2|NOT COMPLETED|Overall Study||0
7647290|NCT02160847|18831837|P1|NOT COMPLETED|Overall Study||0
7647291|NCT02160847|18831836|P2|COMPLETED|Overall Study||16
7647292|NCT02160847|18831837|P1|COMPLETED|Overall Study||16
7647293|NCT02160847|18831836|P2|STARTED|Overall Study||16
7647294|NCT02160847|18831837|P1|STARTED|Overall Study||16
7647295|NCT02160808|18831847|P2|NOT COMPLETED|Overall Study||0
7647296|NCT02160808|18831848|P1|NOT COMPLETED|Overall Study||0
7647297|NCT02160808|18831847|P2|COMPLETED|Overall Study||83
7647298|NCT02160808|18831848|P1|COMPLETED|Overall Study||87
7647299|NCT02160808|18831847|P2|STARTED|Overall Study||83
7647300|NCT02160808|18831848|P1|STARTED|Overall Study||87
7647301|NCT02160626|18831861|P3|NOT COMPLETED|Overall Study||1
7647302|NCT02160626|18831862|P2|NOT COMPLETED|Overall Study||1
7647303|NCT02160626|18831863|P1|NOT COMPLETED|Overall Study||1
7647304|NCT02160626|18831861|P3|COMPLETED|Overall Study||56
7647305|NCT02160626|18831862|P2|COMPLETED|Overall Study||56
7647306|NCT02160626|18831863|P1|COMPLETED|Overall Study||57
7647307|NCT02160626|18831861|P3|STARTED|Overall Study||57
7647308|NCT02160626|18831862|P2|STARTED|Overall Study||57
7647309|NCT02160626|18831863|P1|STARTED|Overall Study||58
7647310|NCT02160535|18831877|P1|NOT COMPLETED|Overall Study||3
7647311|NCT02160535|18831877|P1|COMPLETED|Overall Study||10
7647312|NCT02160535|18831877|P1|STARTED|Overall Study||13
7647313|NCT02160314|18831886|P2|NOT COMPLETED|Overall Study||13
7647314|NCT02160314|18831887|P1|NOT COMPLETED|Overall Study||1
7647315|NCT02160314|18831886|P2|COMPLETED|Overall Study||59
7647316|NCT02160314|18831887|P1|COMPLETED|Overall Study||72
7647317|NCT02160314|18831886|P2|STARTED|Overall Study||72
7647318|NCT02160314|18831887|P1|STARTED|Overall Study||73
7647319|NCT02160288|18831895|P2|NOT COMPLETED|Overall Study||0
7647320|NCT02160288|18831896|P1|NOT COMPLETED|Overall Study||0
7647321|NCT02160288|18831895|P2|COMPLETED|Overall Study||0
7647322|NCT02160288|18831896|P1|COMPLETED|Overall Study||1
7647323|NCT02160288|18831895|P2|STARTED|Overall Study||0
7647324|NCT02160288|18831896|P1|STARTED|Overall Study||1
7647325|NCT02160145|18831922|P3|NOT COMPLETED|Randomized Double-blind Period||28
7647326|NCT02160145|18831923|P2|NOT COMPLETED|Randomized Double-blind Period||29
7647327|NCT02160145|18831924|P1|NOT COMPLETED|Randomized Double-blind Period||0
7647328|NCT02160145|18831922|P3|COMPLETED|Randomized Double-blind Period||659
7647329|NCT02160145|18831923|P2|COMPLETED|Randomized Double-blind Period||654
7647330|NCT02160145|18831924|P1|COMPLETED|Randomized Double-blind Period||0
7647331|NCT02160145|18831922|P3|Off-treatment Completers|Randomized Double-blind Period||22
7647332|NCT02160145|18831923|P2|Off-treatment Completers|Randomized Double-blind Period||76
7647333|NCT02160145|18831924|P1|Off-treatment Completers|Randomized Double-blind Period||0
7647334|NCT02160145|18831922|P3|On-treatment Completers|Randomized Double-blind Period||637
7647335|NCT02160145|18831923|P2|On-treatment Completers|Randomized Double-blind Period||578
7647336|NCT02160145|18831924|P1|On-treatment Completers|Randomized Double-blind Period||0
7647337|NCT02160145|18831922|P3|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive placebo.|687
7647338|NCT02160145|18831923|P2|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive tolvaptan.|683
7647339|NCT02160145|18831924|P1|STARTED|Randomized Double-blind Period|1370 subjects were randomized to receive tolvaptan or placebo in the double-blind period.|0
7647340|NCT02160145|18831922|P3|NOT COMPLETED|Prerandomization Single-blind Period||0
7647341|NCT02160145|18831923|P2|NOT COMPLETED|Prerandomization Single-blind Period||0
7647342|NCT02160145|18831924|P1|NOT COMPLETED|Prerandomization Single-blind Period||149
7647343|NCT02160145|18831922|P3|COMPLETED|Prerandomization Single-blind Period||0
7647344|NCT02160145|18831923|P2|COMPLETED|Prerandomization Single-blind Period||0
7647345|NCT02160145|18831924|P1|COMPLETED|Prerandomization Single-blind Period||1370
7647346|NCT02160145|18831922|P3|Randomized|Prerandomization Single-blind Period||0
7647347|NCT02160145|18831923|P2|Randomized|Prerandomization Single-blind Period||0
7647348|NCT02160145|18831924|P1|Randomized|Prerandomization Single-blind Period||1370
7647349|NCT02160145|18831922|P3|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
7647350|NCT02160145|18831923|P2|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
7647351|NCT02160145|18831924|P1|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||1491
7647352|NCT02160145|18831922|P3|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
7647353|NCT02160145|18831923|P2|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
7647354|NCT02160145|18831924|P1|Treated in Placebo Run-in|Prerandomization Single-blind Period||1514
7647355|NCT02160145|18831922|P3|STARTED|Prerandomization Single-blind Period||0
7647356|NCT02160145|18831923|P2|STARTED|Prerandomization Single-blind Period||0
7647357|NCT02160145|18831924|P1|STARTED|Prerandomization Single-blind Period||1519
7647358|NCT02160041|18831937|P1|NOT COMPLETED|Overall Study||84
7647359|NCT02160041|18831937|P1|COMPLETED|Overall Study||0
7647360|NCT02160041|18831937|P1|STARTED|Overall Study||84
7647361|NCT02160002|18831949|P2|NOT COMPLETED|Overall Study||1
7647362|NCT02160002|18831950|P1|NOT COMPLETED|Overall Study||2
7647363|NCT02160002|18831949|P2|COMPLETED|Overall Study||178
7647364|NCT02160002|18831950|P1|COMPLETED|Overall Study||185
7647365|NCT02160002|18831949|P2|Primary Outcome|Overall Study||178
7647366|NCT02160002|18831950|P1|Primary Outcome|Overall Study||185
7647367|NCT02160002|18831949|P2|STARTED|Overall Study||179
7647368|NCT02160002|18831950|P1|STARTED|Overall Study||187
7647369|NCT02159976|18831982|P2|NOT COMPLETED|Overall Study||25
7647370|NCT02159976|18831983|P1|NOT COMPLETED|Overall Study||30
7647371|NCT02159976|18831982|P2|COMPLETED|Overall Study||170
7647372|NCT02159976|18831983|P1|COMPLETED|Overall Study||165
7647373|NCT02159976|18831982|P2|STARTED|Overall Study||195
7647374|NCT02159976|18831983|P1|STARTED|Overall Study||195
7647375|NCT02159950|18831997|P2|NOT COMPLETED|Overall Study||2
7647376|NCT02159950|18831998|P1|NOT COMPLETED|Overall Study||0
7647377|NCT02159950|18831997|P2|COMPLETED|Overall Study||0
7647378|NCT02159950|18831998|P1|COMPLETED|Overall Study||0
7647379|NCT02159950|18831997|P2|STARTED|Overall Study||2
7647380|NCT02159950|18831998|P1|STARTED|Overall Study||0
7647381|NCT02159898|18832032|P2|NOT COMPLETED|Overall Study||0
7647382|NCT02159898|18832033|P1|NOT COMPLETED|Overall Study||1
7647383|NCT02159898|18832032|P2|COMPLETED|Overall Study||30
7647384|NCT02159898|18832033|P1|COMPLETED|Overall Study||29
7647385|NCT02159898|18832032|P2|STARTED|Overall Study||30
7647386|NCT02159898|18832033|P1|STARTED|Overall Study||30
7647387|NCT02159859|18832041|P1|NOT COMPLETED|Overall Study||0
7647388|NCT02159859|18832041|P1|COMPLETED|Overall Study||7
7647389|NCT02159859|18832041|P1|STARTED|Overall Study||7
7647390|NCT02159807|18832057|P3|NOT COMPLETED|Overall Study||3
7647391|NCT02159807|18832058|P2|NOT COMPLETED|Overall Study||1
7647392|NCT02159807|18832059|P1|NOT COMPLETED|Overall Study||1
7647393|NCT02159807|18832057|P3|COMPLETED|Overall Study||48
7647394|NCT02159807|18832058|P2|COMPLETED|Overall Study||51
7647395|NCT02159807|18832059|P1|COMPLETED|Overall Study||66
7647396|NCT02159807|18832057|P3|STARTED|Overall Study||51
7647397|NCT02159807|18832058|P2|STARTED|Overall Study||52
7647398|NCT02159807|18832059|P1|STARTED|Overall Study||67
7647399|NCT02159768|18832073|P1|NOT COMPLETED|Overall Study||0
7647400|NCT02159768|18832073|P1|COMPLETED|Overall Study|Completed 27 July 2015|30
7647401|NCT02159768|18832073|P1|STARTED|Overall Study|Started 16 July 2014|30
7647402|NCT02159729|18832080|P2|NOT COMPLETED|Overall Study||21
7647403|NCT02159729|18832081|P1|NOT COMPLETED|Overall Study||42
7647404|NCT02159729|18832080|P2|COMPLETED|Overall Study||44
7647405|NCT02159729|18832081|P1|COMPLETED|Overall Study||98
7647406|NCT02159729|18832080|P2|STARTED|Overall Study||65
7647407|NCT02159729|18832081|P1|STARTED|Overall Study||140
7647408|NCT02159703|18832093|P1|NOT COMPLETED|Overall Study||0
7647409|NCT02159703|18832093|P1|COMPLETED|Overall Study||60
7647410|NCT02159703|18832093|P1|STARTED|Overall Study||60
7647411|NCT02159547|18832099|P2|NOT COMPLETED|Overall Study||0
7647412|NCT02159547|18832100|P1|NOT COMPLETED|Overall Study||0
7647413|NCT02159547|18832099|P2|COMPLETED|Overall Study||112
7647414|NCT02159547|18832100|P1|COMPLETED|Overall Study||112
7647415|NCT02159547|18832099|P2|STARTED|Overall Study||112
7647416|NCT02159547|18832100|P1|STARTED|Overall Study||112
7647417|NCT02159521|18832108|P1|NOT COMPLETED|Overall Study||18
7647418|NCT02159521|18832108|P1|COMPLETED|Overall Study||63
7647419|NCT02159521|18832108|P1|Received EkoSonic® Treatment|Overall Study||78
7647420|NCT02159521|18832108|P1|STARTED|Overall Study|4 participants had both limbs treated.|81
7647421|NCT02159482|18832129|P1|NOT COMPLETED|Overall Study||5
7647422|NCT02159482|18832129|P1|COMPLETED|Overall Study||6
7647423|NCT02159482|18832129|P1|STARTED|Overall Study||11
7647424|NCT02159469|18832134|P1|NOT COMPLETED|Overall Study||53
7647425|NCT02159469|18832134|P1|COMPLETED|Overall Study||97
7647426|NCT02159469|18832134|P1|Completed 12 Week|Overall Study||137
7647427|NCT02159469|18832134|P1|STARTED|Overall Study||150
7647428|NCT02159365|18832139|P1|NOT COMPLETED|Overall Study||70
7647429|NCT02159365|18832139|P1|COMPLETED|Overall Study|Completed = Still on treatment|0
7647430|NCT02159365|18832139|P1|STARTED|Overall Study||70
7647431|NCT02159352|18832146|P2|NOT COMPLETED|Overall Study||2
7647432|NCT02159352|18832147|P1|NOT COMPLETED|Overall Study||3
7647433|NCT02159352|18832146|P2|COMPLETED|Overall Study||12
7647434|NCT02159352|18832147|P1|COMPLETED|Overall Study||11
7647435|NCT02159352|18832146|P2|Phase 2 (Day 5-14)|Overall Study||12
7647436|NCT02159352|18832147|P1|Phase 2 (Day 5-14)|Overall Study||11
7647437|NCT02159352|18832146|P2|Phase 1 (Day 1- 4)|Overall Study||14
7647438|NCT02159352|18832147|P1|Phase 1 (Day 1- 4)|Overall Study||14
7647439|NCT02159352|18832146|P2|STARTED|Overall Study||14
7647440|NCT02159352|18832147|P1|STARTED|Overall Study||14
7647441|NCT02159183|18832199|P2|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||1
7647442|NCT02159183|18832200|P1|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||3
7647443|NCT02159183|18832199|P2|COMPLETED|Analysis of Primary Endpoint (12 Mts)||20
7647444|NCT02159183|18832200|P1|COMPLETED|Analysis of Primary Endpoint (12 Mts)||19
7647445|NCT02159183|18832199|P2|STARTED|Analysis of Primary Endpoint (12 Mts)||21
7647446|NCT02159183|18832200|P1|STARTED|Analysis of Primary Endpoint (12 Mts)||22
7647447|NCT02159183|18832199|P2|NOT COMPLETED|Analysis After the 36 Months Follow-up||2
7647448|NCT02159183|18832200|P1|NOT COMPLETED|Analysis After the 36 Months Follow-up||3
7647449|NCT02159183|18832199|P2|COMPLETED|Analysis After the 36 Months Follow-up||19
7647450|NCT02159183|18832200|P1|COMPLETED|Analysis After the 36 Months Follow-up||19
7647451|NCT02159183|18832199|P2|STARTED|Analysis After the 36 Months Follow-up||21
7647452|NCT02159183|18832200|P1|STARTED|Analysis After the 36 Months Follow-up||22
7647453|NCT02159118|18832226|P2|NOT COMPLETED|Overall Study||0
7647454|NCT02159118|18832227|P1|NOT COMPLETED|Overall Study||0
7647455|NCT02159118|18832226|P2|COMPLETED|Overall Study||22
7647456|NCT02159118|18832227|P1|COMPLETED|Overall Study||22
7647457|NCT02159118|18832226|P2|STARTED|Overall Study||22
7647458|NCT02159118|18832227|P1|STARTED|Overall Study||22
7647459|NCT02159079|18832251|P2|NOT COMPLETED|Overall Study||0
7647460|NCT02159079|18832252|P1|NOT COMPLETED|Overall Study||0
7647461|NCT02159079|18832251|P2|COMPLETED|Overall Study||15
7647462|NCT02159079|18832252|P1|COMPLETED|Overall Study||15
7647463|NCT02159079|18832251|P2|STARTED|Overall Study||15
7647464|NCT02159079|18832252|P1|STARTED|Overall Study||15
7647465|NCT02159053|18832273|P3|NOT COMPLETED|Overall Study||20
7647466|NCT02159053|18832274|P2|NOT COMPLETED|Overall Study||21
7647467|NCT02159053|18832275|P1|NOT COMPLETED|Overall Study||20
7647468|NCT02159053|18832273|P3|COMPLETED|Overall Study||97
7647469|NCT02159053|18832274|P2|COMPLETED|Overall Study||96
7647470|NCT02159053|18832275|P1|COMPLETED|Overall Study||96
7647471|NCT02159053|18832273|P3|Paticipants Week 16 Onwards|Overall Study||113
7647472|NCT02159053|18832274|P2|Paticipants Week 16 Onwards|Overall Study||117
7647473|NCT02159053|18832275|P1|Paticipants Week 16 Onwards|Overall Study||116
7647474|NCT02159053|18832273|P3|STARTED|Overall Study||117
7647475|NCT02159053|18832274|P2|STARTED|Overall Study||117
7647476|NCT02159053|18832275|P1|STARTED|Overall Study||116
7647477|NCT02159040|18832312|P1|NOT COMPLETED|Overall Study||1
7647478|NCT02159040|18832312|P1|COMPLETED|Overall Study||0
7647479|NCT02159040|18832312|P1|STARTED|Overall Study||1
7647480|NCT02158975|18832325|P1|NOT COMPLETED|Overall Study||1
7647481|NCT02158975|18832325|P1|COMPLETED|Overall Study||12
7647482|NCT02158975|18832325|P1|STARTED|Overall Study||13
7647483|NCT02158949|18832335|P2|NOT COMPLETED|Overall Study||11
7647484|NCT02158949|18832336|P1|NOT COMPLETED|Overall Study||6
7647485|NCT02158949|18832335|P2|COMPLETED|Overall Study||13
7647486|NCT02158949|18832336|P1|COMPLETED|Overall Study||18
7647487|NCT02158949|18832335|P2|STARTED|Overall Study||24
7647488|NCT02158949|18832336|P1|STARTED|Overall Study||24
7647489|NCT02158936|18832352|P2|NOT COMPLETED|Overall Study||177
7647490|NCT02158936|18832353|P1|NOT COMPLETED|Overall Study||179
7647491|NCT02158936|18832352|P2|COMPLETED|Overall Study||0
7647492|NCT02158936|18832353|P1|COMPLETED|Overall Study||0
7647493|NCT02158936|18832352|P2|Untreated|Overall Study||0
7647494|NCT02158936|18832353|P1|Untreated|Overall Study||2
7647495|NCT02158936|18832352|P2|Treated|Overall Study||177
7647496|NCT02158936|18832353|P1|Treated|Overall Study||177
7647497|NCT02158936|18832352|P2|STARTED|Overall Study||177
7647498|NCT02158936|18832353|P1|STARTED|Overall Study||179
7647499|NCT02158884|18832395|P1|NOT COMPLETED|12 Month Assessment||17
7647500|NCT02158884|18832395|P1|COMPLETED|12 Month Assessment||64
7647501|NCT02158884|18832395|P1|STARTED|12 Month Assessment||81
7647502|NCT02158884|18832395|P1|NOT COMPLETED|6 Month Assessment||20
7647503|NCT02158884|18832395|P1|COMPLETED|6 Month Assessment||61
7647504|NCT02158884|18832395|P1|STARTED|6 Month Assessment||81
7647505|NCT02158884|18832395|P1|NOT COMPLETED|Post Intervention (~4 Weeks)||10
7647506|NCT02158884|18832395|P1|COMPLETED|Post Intervention (~4 Weeks)||71
7647507|NCT02158884|18832395|P1|STARTED|Post Intervention (~4 Weeks)||81
7647508|NCT02158884|18832395|P1|NOT COMPLETED|Intervention: IDEO and PT Program||6
7647509|NCT02158884|18832395|P1|COMPLETED|Intervention: IDEO and PT Program||81
7647510|NCT02158884|18832395|P1|STARTED|Intervention: IDEO and PT Program||87
7647511|NCT02158884|18832395|P1|NOT COMPLETED|Baseline Assessment||4
7647512|NCT02158884|18832395|P1|COMPLETED|Baseline Assessment||87
7647513|NCT02158884|18832395|P1|STARTED|Baseline Assessment||91
7647514|NCT02158806|18832430|P2|NOT COMPLETED|Overall Study||5
7647515|NCT02158806|18832431|P1|NOT COMPLETED|Overall Study||4
7647516|NCT02158806|18832430|P2|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
7647517|NCT02158806|18832431|P1|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
7647518|NCT02158806|18832430|P2|STARTED|Overall Study||126
7647519|NCT02158806|18832431|P1|STARTED|Overall Study||125
7647520|NCT02158728|18832451|P1|NOT COMPLETED|Overall Study||27
7647521|NCT02158728|18832451|P1|COMPLETED|Overall Study||53
7647522|NCT02158728|18832451|P1|STARTED|Overall Study||80
7647523|NCT02158663|18832457|P2|NOT COMPLETED|Overall Study||4
7647524|NCT02158663|18832458|P1|NOT COMPLETED|Overall Study||5
7647525|NCT02158663|18832457|P2|COMPLETED|Overall Study||18
7647526|NCT02158663|18832458|P1|COMPLETED|Overall Study||17
7647527|NCT02158663|18832457|P2|STARTED|Overall Study||22
7647528|NCT02158663|18832458|P1|STARTED|Overall Study||22
7647529|NCT02158572|18832466|P1|NOT COMPLETED|Overall Study||1043
7647530|NCT02158572|18832466|P1|COMPLETED|Overall Study||989
7647531|NCT02158572|18832466|P1|STARTED|Overall Study||2032
7647532|NCT02158546|18832481|P4|NOT COMPLETED|Overall Study||6
7647533|NCT02158546|18832482|P3|NOT COMPLETED|Overall Study||4
7647534|NCT02158546|18832483|P2|NOT COMPLETED|Overall Study||17
7647535|NCT02158546|18832484|P1|NOT COMPLETED|Overall Study||19
7647536|NCT02158546|18832481|P4|COMPLETED|Overall Study||13
7647537|NCT02158546|18832482|P3|COMPLETED|Overall Study||14
7647538|NCT02158546|18832483|P2|COMPLETED|Overall Study||136
7647539|NCT02158546|18832484|P1|COMPLETED|Overall Study||133
7647540|NCT02158546|18832481|P4|STARTED|Overall Study||19
7647541|NCT02158546|18832482|P3|STARTED|Overall Study||18
7647542|NCT02158546|18832483|P2|STARTED|Overall Study||153
7647543|NCT02158546|18832484|P1|STARTED|Overall Study||152
7647544|NCT02158533|18832503|P6|NOT COMPLETED|Stage 2||6
7647545|NCT02158533|18832504|P5|NOT COMPLETED|Stage 2||4
7647546|NCT02158533|18832505|P4|NOT COMPLETED|Stage 2||3
7647547|NCT02158533|18832506|P3|NOT COMPLETED|Stage 2||0
7647548|NCT02158533|18832507|P2|NOT COMPLETED|Stage 2||0
7647549|NCT02158533|18832508|P1|NOT COMPLETED|Stage 2||0
7647550|NCT02158533|18832503|P6|COMPLETED|Stage 2||50
7647551|NCT02158533|18832504|P5|COMPLETED|Stage 2||52
7647552|NCT02158533|18832505|P4|COMPLETED|Stage 2||53
7647553|NCT02158533|18832506|P3|COMPLETED|Stage 2||0
7647554|NCT02158533|18832507|P2|COMPLETED|Stage 2||0
7647555|NCT02158533|18832508|P1|COMPLETED|Stage 2||0
7647556|NCT02158533|18832503|P6|STARTED|Stage 2||56
7647557|NCT02158533|18832504|P5|STARTED|Stage 2||56
7647558|NCT02158533|18832505|P4|STARTED|Stage 2||56
7647559|NCT02158533|18832506|P3|STARTED|Stage 2||0
7647560|NCT02158533|18832507|P2|STARTED|Stage 2||0
7647561|NCT02158533|18832508|P1|STARTED|Stage 2||0
7647562|NCT02158533|18832503|P6|NOT COMPLETED|Stage 1||0
7647563|NCT02158533|18832504|P5|NOT COMPLETED|Stage 1||0
7647564|NCT02158533|18832505|P4|NOT COMPLETED|Stage 1||0
7647565|NCT02158533|18832506|P3|NOT COMPLETED|Stage 1||8
7647566|NCT02158533|18832507|P2|NOT COMPLETED|Stage 1||8
7647567|NCT02158533|18832508|P1|NOT COMPLETED|Stage 1||14
7647568|NCT02158533|18832503|P6|COMPLETED|Stage 1||0
7647569|NCT02158533|18832504|P5|COMPLETED|Stage 1||0
7647570|NCT02158533|18832505|P4|COMPLETED|Stage 1||0
7647571|NCT02158533|18832506|P3|COMPLETED|Stage 1||52
7647572|NCT02158533|18832507|P2|COMPLETED|Stage 1||51
7647573|NCT02158533|18832508|P1|COMPLETED|Stage 1||251
7647574|NCT02158533|18832503|P6|STARTED|Stage 1||0
7647575|NCT02158533|18832504|P5|STARTED|Stage 1||0
7647576|NCT02158533|18832505|P4|STARTED|Stage 1||0
7647577|NCT02158533|18832506|P3|STARTED|Stage 1||60
7647578|NCT02158533|18832507|P2|STARTED|Stage 1||59
7647579|NCT02158533|18832508|P1|STARTED|Stage 1||265
7647580|NCT02158520|18832542|P2|NOT COMPLETED|Overall Study||0
7647581|NCT02158520|18832543|P1|NOT COMPLETED|Overall Study||0
7647582|NCT02158520|18832542|P2|COMPLETED|Overall Study||12
7647583|NCT02158520|18832543|P1|COMPLETED|Overall Study||12
7647584|NCT02158520|18832542|P2|Crossover Cohort|Overall Study||6
7647585|NCT02158520|18832543|P1|Crossover Cohort|Overall Study||4
7647586|NCT02158520|18832542|P2|Eligible for Crossover With AE Evaluated|Overall Study||7
7647587|NCT02158520|18832543|P1|Eligible for Crossover With AE Evaluated|Overall Study||7
7647588|NCT02158520|18832542|P2|Eligible for Crossover|Overall Study||8
7647589|NCT02158520|18832543|P1|Eligible for Crossover|Overall Study||8
7647590|NCT02158520|18832542|P2|AE Evaluated Prior to Crossover|Overall Study||12
7647591|NCT02158520|18832543|P1|AE Evaluated Prior to Crossover|Overall Study||12
7647592|NCT02158520|18832542|P2|STARTED|Overall Study||12
7647593|NCT02158520|18832543|P1|STARTED|Overall Study||12
7647594|NCT02158494|18832559|P2|NOT COMPLETED|Overall Study||1
7647595|NCT02158494|18832560|P1|NOT COMPLETED|Overall Study||0
7647596|NCT02158494|18832559|P2|COMPLETED|Overall Study||21
7647597|NCT02158494|18832560|P1|COMPLETED|Overall Study||22
7647598|NCT02158494|18832559|P2|STARTED|Overall Study||22
7647599|NCT02158494|18832560|P1|STARTED|Overall Study||22
7647600|NCT02158442|18832584|P2|NOT COMPLETED|Overall Study||0
7647601|NCT02158442|18832585|P1|NOT COMPLETED|Overall Study||2
7647602|NCT02158442|18832584|P2|COMPLETED|Overall Study||7
7647603|NCT02158442|18832585|P1|COMPLETED|Overall Study||6
7647604|NCT02158442|18832584|P2|STARTED|Overall Study||7
7647605|NCT02158442|18832585|P1|STARTED|Overall Study||8
7647606|NCT02158364|18832591|P1|NOT COMPLETED|Overall Study||60
7647607|NCT02158364|18832591|P1|COMPLETED|Overall Study||3271
7647608|NCT02158364|18832591|P1|STARTED|Overall Study||3331
7647609|NCT02158273|18832598|P2|NOT COMPLETED|Overall Study||3
7647610|NCT02158273|18832599|P1|NOT COMPLETED|Overall Study||3
7647611|NCT02158273|18832598|P2|COMPLETED|Overall Study||22
7647612|NCT02158273|18832599|P1|COMPLETED|Overall Study||22
7647613|NCT02158273|18832598|P2|STARTED|Overall Study||25
7647614|NCT02158273|18832599|P1|STARTED|Overall Study||25
7647615|NCT02158247|18832609|P1|NOT COMPLETED|Overall Study||5
7647616|NCT02158247|18832609|P1|COMPLETED|Overall Study||176
7647617|NCT02158247|18832609|P1|STARTED|Overall Study||181
7647618|NCT02158091|18832628|P3|NOT COMPLETED|Overall Study||0
7647619|NCT02158091|18832629|P2|NOT COMPLETED|Overall Study||1
7647620|NCT02158091|18832630|P1|NOT COMPLETED|Overall Study||2
7647621|NCT02158091|18832628|P3|COMPLETED|Overall Study||20
7647622|NCT02158091|18832629|P2|COMPLETED|Overall Study||5
7647623|NCT02158091|18832630|P1|COMPLETED|Overall Study||4
7647624|NCT02158091|18832628|P3|STARTED|Overall Study||20
7647625|NCT02158091|18832629|P2|STARTED|Overall Study||6
7647626|NCT02158091|18832630|P1|STARTED|Overall Study||6
7647627|NCT02158039|18832638|P1|NOT COMPLETED|Overall Study||10
7647628|NCT02158039|18832638|P1|COMPLETED|Overall Study||23
7647629|NCT02158039|18832638|P1|STARTED|Overall Study||33
7647630|NCT02157948|18832645|P2|NOT COMPLETED|Overall Study||9
7647631|NCT02157948|18832646|P1|NOT COMPLETED|Overall Study||9
7647632|NCT02157948|18832645|P2|COMPLETED|Overall Study||188
7647633|NCT02157948|18832646|P1|COMPLETED|Overall Study||188
7647634|NCT02157948|18832645|P2|Received Treatment|Overall Study||196
7647635|NCT02157948|18832646|P1|Received Treatment|Overall Study||196
7647636|NCT02157948|18832645|P2|STARTED|Overall Study||197
7647637|NCT02157948|18832646|P1|STARTED|Overall Study||197
7647638|NCT02157935|18832658|P2|NOT COMPLETED|Overall Study||65
7647639|NCT02157935|18832659|P1|NOT COMPLETED|Overall Study||39
7647640|NCT02157935|18832658|P2|COMPLETED|Overall Study||548
7647641|NCT02157935|18832659|P1|COMPLETED|Overall Study||567
7647642|NCT02157935|18832658|P2|STARTED|Overall Study||613
7647643|NCT02157935|18832659|P1|STARTED|Overall Study||606
7647644|NCT02157909|18832677|P2|NOT COMPLETED|Overall Study||0
7647645|NCT02157909|18832678|P1|NOT COMPLETED|Overall Study||0
7647646|NCT02157909|18832677|P2|COMPLETED|Overall Study||66
7647647|NCT02157909|18832678|P1|COMPLETED|Overall Study||66
7647648|NCT02157909|18832677|P2|STARTED|Overall Study||66
7647649|NCT02157909|18832678|P1|STARTED|Overall Study||66
7647650|NCT02157883|18832685|P1|NOT COMPLETED|Part B: Day 19 to End Part B (AZD9291)||22
7647651|NCT02157883|18832685|P1|COMPLETED|Part B: Day 19 to End Part B (AZD9291)||16
7647652|NCT02157883|18832685|P1|STARTED|Part B: Day 19 to End Part B (AZD9291)||38
7647653|NCT02157883|18832685|P1|NOT COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||1
7647654|NCT02157883|18832685|P1|COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||38
7647655|NCT02157883|18832685|P1|STARTED|Part A: Day 6-18 (AZD9291+Itraconozole)||39
7647656|NCT02157883|18832685|P1|NOT COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||0
7647657|NCT02157883|18832685|P1|COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||39
7647658|NCT02157883|18832685|P1|STARTED|Part A: Day 1-5 (AZD9291 Alone)||39
7647659|NCT02157779|18832716|P2|NOT COMPLETED|Overall Study||11
7647660|NCT02157779|18832717|P1|NOT COMPLETED|Overall Study||24
7647661|NCT02157779|18832716|P2|COMPLETED|Overall Study||34
7647662|NCT02157779|18832717|P1|COMPLETED|Overall Study||23
7647663|NCT02157779|18832716|P2|STARTED|Overall Study||45
7647664|NCT02157779|18832717|P1|STARTED|Overall Study||47
7647665|NCT02157623|18832739|P1|NOT COMPLETED|Overall Study||0
7647666|NCT02157623|18832739|P1|COMPLETED|Overall Study||3
7647667|NCT02157623|18832739|P1|STARTED|Overall Study|3 patients, each received red light on half of body and blue light on the contralateral side.|3
7647668|NCT02157519|18832751|P2|NOT COMPLETED|Overall Study||1
7647669|NCT02157519|18832752|P1|NOT COMPLETED|Overall Study||11
7647670|NCT02157519|18832751|P2|COMPLETED|Overall Study||89
7647671|NCT02157519|18832752|P1|COMPLETED|Overall Study||80
7647672|NCT02157519|18832751|P2|MEMScap Collected|Overall Study||86
7647673|NCT02157519|18832752|P1|MEMScap Collected|Overall Study||84
7647674|NCT02157519|18832751|P2|STARTED|Overall Study||90
7647675|NCT02157519|18832752|P1|STARTED|Overall Study||91
7647676|NCT02157506|18832775|P5|NOT COMPLETED|Overall Study||0
7647677|NCT02157506|18832776|P4|NOT COMPLETED|Overall Study||0
7647678|NCT02157506|18832777|P3|NOT COMPLETED|Overall Study||1
7647679|NCT02157506|18832778|P2|NOT COMPLETED|Overall Study||1
7647680|NCT02157506|18832779|P1|NOT COMPLETED|Overall Study||0
7647681|NCT02157506|18832775|P5|COMPLETED|Overall Study||7
7647682|NCT02157506|18832776|P4|COMPLETED|Overall Study||12
7647683|NCT02157506|18832777|P3|COMPLETED|Overall Study||8
7647684|NCT02157506|18832778|P2|COMPLETED|Overall Study||5
7647685|NCT02157506|18832779|P1|COMPLETED|Overall Study||12
7647686|NCT02157506|18832775|P5|STARTED|Overall Study||7
7647687|NCT02157506|18832776|P4|STARTED|Overall Study||12
7647688|NCT02157506|18832777|P3|STARTED|Overall Study||9
7647689|NCT02157506|18832778|P2|STARTED|Overall Study||6
7647690|NCT02157506|18832779|P1|STARTED|Overall Study||12
7647691|NCT02157376|18832838|P2|NOT COMPLETED|Overall Study||18
7647692|NCT02157376|18832839|P1|NOT COMPLETED|Overall Study||22
7647693|NCT02157376|18832838|P2|COMPLETED|Overall Study||138
7647694|NCT02157376|18832839|P1|COMPLETED|Overall Study||133
7647695|NCT02157376|18832838|P2|STARTED|Overall Study||156
7647696|NCT02157376|18832839|P1|STARTED|Overall Study||155
7647697|NCT02157298|18832849|P2|NOT COMPLETED|Overall Study||2
7647698|NCT02157298|18832850|P1|NOT COMPLETED|Overall Study||4
7647699|NCT02157298|18832849|P2|COMPLETED|Overall Study||58
7647700|NCT02157298|18832850|P1|COMPLETED|Overall Study||119
7647701|NCT02157298|18832849|P2|STARTED|Overall Study||60
7647702|NCT02157298|18832850|P1|STARTED|Overall Study||123
7647703|NCT02157168|18832867|P3|NOT COMPLETED|Overall Study||0
7647704|NCT02157168|18832868|P2|NOT COMPLETED|Overall Study||0
7647705|NCT02157168|18832869|P1|NOT COMPLETED|Overall Study||0
7647706|NCT02157168|18832867|P3|COMPLETED|Overall Study||1362
7647707|NCT02157168|18832868|P2|COMPLETED|Overall Study||159
7647708|NCT02157168|18832869|P1|COMPLETED|Overall Study||746
7647709|NCT02157168|18832867|P3|STARTED|Overall Study||1362
7647710|NCT02157168|18832868|P2|STARTED|Overall Study||159
7647711|NCT02157168|18832869|P1|STARTED|Overall Study||746
7647712|NCT02157116|18832889|P1|NOT COMPLETED|Overall Study||9
7647713|NCT02157116|18832889|P1|COMPLETED|Overall Study||4
7647714|NCT02157116|18832889|P1|STARTED|Overall Study|signed consent form|13
7647715|NCT02157103|18832898|P1|NOT COMPLETED|Overall Study||0
7647716|NCT02157103|18832898|P1|COMPLETED|Overall Study||3
7647717|NCT02157103|18832898|P1|STARTED|Overall Study||3
7647718|NCT02156908|18832906|P2|NOT COMPLETED|Overall Study||0
7647719|NCT02156908|18832907|P1|NOT COMPLETED|Overall Study||0
7647720|NCT02156908|18832906|P2|COMPLETED|Overall Study||3
7647721|NCT02156908|18832907|P1|COMPLETED|Overall Study||5
7647722|NCT02156908|18832906|P2|STARTED|Overall Study||3
7647723|NCT02156908|18832907|P1|STARTED|Overall Study||5
7647724|NCT02156804|18832915|P1|NOT COMPLETED|Overall Study||1
7647725|NCT02156804|18832915|P1|COMPLETED|Overall Study||1008
7647726|NCT02156804|18832915|P1|STARTED|Overall Study||1009
7647727|NCT02156687|18832925|P2|NOT COMPLETED|Overall Study||5
7647728|NCT02156687|18832926|P1|NOT COMPLETED|Overall Study||10
7647729|NCT02156687|18832925|P2|COMPLETED|Overall Study||24
7647730|NCT02156687|18832926|P1|COMPLETED|Overall Study||20
7647731|NCT02156687|18832925|P2|STARTED|Overall Study||29
7647732|NCT02156687|18832926|P1|STARTED|Overall Study||30
7647733|NCT02156674|18832946|P1|NOT COMPLETED|Overall Study||0
7647734|NCT02156674|18832946|P1|COMPLETED|Overall Study||1
7647735|NCT02156674|18832946|P1|STARTED|Overall Study||1
7647736|NCT02156492|18832957|P3|NOT COMPLETED|Period 3||0
7647737|NCT02156492|18832958|P2|NOT COMPLETED|Period 3||1
7647738|NCT02156492|18832959|P1|NOT COMPLETED|Period 3||0
7647739|NCT02156492|18832957|P3|COMPLETED|Period 3||22
7647740|NCT02156492|18832958|P2|COMPLETED|Period 3||22
7647741|NCT02156492|18832959|P1|COMPLETED|Period 3||0
7647742|NCT02156492|18832957|P3|STARTED|Period 3||22
7647743|NCT02156492|18832958|P2|STARTED|Period 3||23
7647744|NCT02156492|18832959|P1|STARTED|Period 3|Cohort A participated in Period 1 and Period 2 only.|0
7647745|NCT02156492|18832957|P3|NOT COMPLETED|Period 2||0
7647746|NCT02156492|18832958|P2|NOT COMPLETED|Period 2||0
7647747|NCT02156492|18832959|P1|NOT COMPLETED|Period 2||0
7647748|NCT02156492|18832957|P3|COMPLETED|Period 2||22
7647749|NCT02156492|18832958|P2|COMPLETED|Period 2||23
7647750|NCT02156492|18832959|P1|COMPLETED|Period 2||16
7647751|NCT02156492|18832957|P3|STARTED|Period 2||22
7647752|NCT02156492|18832958|P2|STARTED|Period 2||23
7647753|NCT02156492|18832959|P1|STARTED|Period 2||16
7647754|NCT02156492|18832957|P3|NOT COMPLETED|Period 1||0
7647755|NCT02156492|18832958|P2|NOT COMPLETED|Period 1||1
7647756|NCT02156492|18832959|P1|NOT COMPLETED|Period 1||0
7647757|NCT02156492|18832957|P3|COMPLETED|Period 1||22
7647758|NCT02156492|18832958|P2|COMPLETED|Period 1||23
7647759|NCT02156492|18832959|P1|COMPLETED|Period 1||16
7647760|NCT02156492|18832957|P3|Received at Least One Dose of Study Drug|Period 1||22
7647761|NCT02156492|18832958|P2|Received at Least One Dose of Study Drug|Period 1||24
7647762|NCT02156492|18832959|P1|Received at Least One Dose of Study Drug|Period 1||16
7647763|NCT02156492|18832957|P3|STARTED|Period 1||22
7647764|NCT02156492|18832958|P2|STARTED|Period 1||24
7647765|NCT02156492|18832959|P1|STARTED|Period 1||16
7647766|NCT02156466|18832985|P5|NOT COMPLETED|Overall Study||0
7647767|NCT02156466|18832986|P4|NOT COMPLETED|Overall Study||2
7647768|NCT02156466|18832987|P3|NOT COMPLETED|Overall Study||1
7647769|NCT02156466|18832988|P2|NOT COMPLETED|Overall Study||0
7647770|NCT02156466|18832989|P1|NOT COMPLETED|Overall Study||0
7647771|NCT02156466|18832985|P5|COMPLETED|Overall Study||8
7647772|NCT02156466|18832986|P4|COMPLETED|Overall Study||7
7647773|NCT02156466|18832987|P3|COMPLETED|Overall Study||7
7647774|NCT02156466|18832988|P2|COMPLETED|Overall Study||8
7647775|NCT02156466|18832989|P1|COMPLETED|Overall Study||8
7647776|NCT02156466|18832985|P5|STARTED|Overall Study||8
7647777|NCT02156466|18832986|P4|STARTED|Overall Study||9
7647778|NCT02156466|18832987|P3|STARTED|Overall Study||8
7647779|NCT02156466|18832988|P2|STARTED|Overall Study||8
7647780|NCT02156466|18832989|P1|STARTED|Overall Study||8
7647781|NCT02156271|18833170|P2|NOT COMPLETED|Overall Study||3
7647782|NCT02156271|18833171|P1|NOT COMPLETED|Overall Study||4
7647783|NCT02156271|18833170|P2|COMPLETED|Overall Study||10
7647784|NCT02156271|18833171|P1|COMPLETED|Overall Study||22
7647785|NCT02156271|18833170|P2|STARTED|Overall Study||13
7647786|NCT02156271|18833171|P1|STARTED|Overall Study||26
7647787|NCT02156258|18833206|P3|NOT COMPLETED|Overall Study||111
7647788|NCT02156258|18833207|P2|NOT COMPLETED|Overall Study||79
7647789|NCT02156258|18833208|P1|NOT COMPLETED|Overall Study||32
7647790|NCT02156258|18833206|P3|COMPLETED|Overall Study||244
7647791|NCT02156258|18833207|P2|COMPLETED|Overall Study||124
7647792|NCT02156258|18833208|P1|COMPLETED|Overall Study||642
7647793|NCT02156258|18833206|P3|STARTED|Overall Study||355
7647794|NCT02156258|18833207|P2|STARTED|Overall Study||203
7647795|NCT02156258|18833208|P1|STARTED|Overall Study||674
7647796|NCT02156167|18833216|P1|NOT COMPLETED|Overall Study||0
7647797|NCT02156167|18833216|P1|COMPLETED|Overall Study||15
7647798|NCT02156167|18833216|P1|STARTED|Overall Study||15
7647799|NCT02156076|18833224|P4|NOT COMPLETED|Follow-up Period||0
7647800|NCT02156076|18833225|P3|NOT COMPLETED|Follow-up Period||0
7647801|NCT02156076|18833226|P2|NOT COMPLETED|Follow-up Period||0
7647802|NCT02156076|18833227|P1|NOT COMPLETED|Follow-up Period||1
7647803|NCT02156076|18833224|P4|COMPLETED|Follow-up Period||4
7647804|NCT02156076|18833225|P3|COMPLETED|Follow-up Period||4
7647805|NCT02156076|18833226|P2|COMPLETED|Follow-up Period||5
7647806|NCT02156076|18833227|P1|COMPLETED|Follow-up Period||6
7647807|NCT02156076|18833224|P4|STARTED|Follow-up Period||4
7647808|NCT02156076|18833225|P3|STARTED|Follow-up Period||4
7647809|NCT02156076|18833226|P2|STARTED|Follow-up Period||5
7647810|NCT02156076|18833227|P1|STARTED|Follow-up Period||7
7647811|NCT02156076|18833224|P4|NOT COMPLETED|Treatment Period||2
7647812|NCT02156076|18833225|P3|NOT COMPLETED|Treatment Period||2
7647813|NCT02156076|18833226|P2|NOT COMPLETED|Treatment Period||2
7647814|NCT02156076|18833227|P1|NOT COMPLETED|Treatment Period||0
7647815|NCT02156076|18833224|P4|COMPLETED|Treatment Period||4
7647816|NCT02156076|18833225|P3|COMPLETED|Treatment Period||4
7647817|NCT02156076|18833226|P2|COMPLETED|Treatment Period||5
7647818|NCT02156076|18833227|P1|COMPLETED|Treatment Period||7
7647819|NCT02156076|18833224|P4|STARTED|Treatment Period||6
7647820|NCT02156076|18833225|P3|STARTED|Treatment Period||6
7647821|NCT02156076|18833226|P2|STARTED|Treatment Period||7
7647822|NCT02156076|18833227|P1|STARTED|Treatment Period||7
7647823|NCT02155985|18833284|P3|NOT COMPLETED|Overall Study||1
7647824|NCT02155985|18833285|P2|NOT COMPLETED|Overall Study||0
7647825|NCT02155985|18833286|P1|NOT COMPLETED|Overall Study||1
7647826|NCT02155985|18833284|P3|COMPLETED|Overall Study||39
7647827|NCT02155985|18833285|P2|COMPLETED|Overall Study||41
7647828|NCT02155985|18833286|P1|COMPLETED|Overall Study||39
7647829|NCT02155985|18833284|P3|STARTED|Overall Study||40
7647830|NCT02155985|18833285|P2|STARTED|Overall Study||41
7647831|NCT02155985|18833286|P1|STARTED|Overall Study||40
7647832|NCT02155881|18833353|P2|NOT COMPLETED|Overall Study||4
7647833|NCT02155881|18833354|P1|NOT COMPLETED|Overall Study||2
7647834|NCT02155881|18833353|P2|COMPLETED|Overall Study||36
7647835|NCT02155881|18833354|P1|COMPLETED|Overall Study||38
7647836|NCT02155881|18833353|P2|STARTED|Overall Study||40
7647837|NCT02155881|18833354|P1|STARTED|Overall Study||40
7647838|NCT02155829|18833376|P2|NOT COMPLETED|Overall Study||3
7647839|NCT02155829|18833377|P1|NOT COMPLETED|Overall Study||6
7647840|NCT02155829|18833376|P2|COMPLETED|Overall Study||35
7647841|NCT02155829|18833377|P1|COMPLETED|Overall Study||31
7647842|NCT02155829|18833376|P2|STARTED|Overall Study||38
7647843|NCT02155829|18833377|P1|STARTED|Overall Study||37
7647844|NCT02155738|18833399|P4|NOT COMPLETED|Overall Study||1
7647845|NCT02155738|18833400|P3|NOT COMPLETED|Overall Study||0
7647846|NCT02155738|18833401|P2|NOT COMPLETED|Overall Study||0
7647847|NCT02155738|18833402|P1|NOT COMPLETED|Overall Study||1
7647848|NCT02155738|18833399|P4|COMPLETED|Overall Study||50
7647849|NCT02155738|18833400|P3|COMPLETED|Overall Study||51
7647850|NCT02155738|18833401|P2|COMPLETED|Overall Study||52
7647851|NCT02155738|18833402|P1|COMPLETED|Overall Study||49
7647852|NCT02155738|18833399|P4|STARTED|Overall Study||51
7647853|NCT02155738|18833400|P3|STARTED|Overall Study||51
7647854|NCT02155738|18833401|P2|STARTED|Overall Study||52
7647855|NCT02155738|18833402|P1|STARTED|Overall Study||50
7647856|NCT02155725|18833422|P2|NOT COMPLETED|Follow-up Period||11
7647857|NCT02155725|18833423|P1|NOT COMPLETED|Follow-up Period||17
7647858|NCT02155725|18833422|P2|COMPLETED|Follow-up Period||202
7647859|NCT02155725|18833423|P1|COMPLETED|Follow-up Period||207
7647860|NCT02155725|18833422|P2|STARTED|Follow-up Period||213
7647861|NCT02155725|18833423|P1|STARTED|Follow-up Period||224
7647862|NCT02155725|18833422|P2|NOT COMPLETED|Treatment Period||0
7647863|NCT02155725|18833423|P1|NOT COMPLETED|Treatment Period||0
7647864|NCT02155725|18833422|P2|COMPLETED|Treatment Period||213
7647865|NCT02155725|18833423|P1|COMPLETED|Treatment Period||224
7647866|NCT02155725|18833422|P2|STARTED|Treatment Period||213
7647867|NCT02155725|18833423|P1|STARTED|Treatment Period||224
7647868|NCT02155712|18833439|P2|NOT COMPLETED|Secondary Objectives||134
7647869|NCT02155712|18833440|P1|NOT COMPLETED|Secondary Objectives||319
7647870|NCT02155712|18833439|P2|COMPLETED|Secondary Objectives||0
7647871|NCT02155712|18833440|P1|COMPLETED|Secondary Objectives||0
7647872|NCT02155712|18833439|P2|STARTED|Secondary Objectives|This period will be updated when posting secondary objective results.|134
7647873|NCT02155712|18833440|P1|STARTED|Secondary Objectives||319
7647874|NCT02155712|18833439|P2|NOT COMPLETED|Primary Objective||0
7647875|NCT02155712|18833440|P1|NOT COMPLETED|Primary Objective||60
7647876|NCT02155712|18833439|P2|COMPLETED|Primary Objective||0
7647877|NCT02155712|18833440|P1|COMPLETED|Primary Objective||259
7647878|NCT02155712|18833439|P2|STARTED|Primary Objective|Cohort 2 isn't included in primary obj analysis|0
7647879|NCT02155712|18833440|P1|STARTED|Primary Objective||319
7647880|NCT02155660|18833450|P4|NOT COMPLETED|Overall Study||61
7647881|NCT02155660|18833451|P3|NOT COMPLETED|Overall Study||60
7647882|NCT02155660|18833452|P2|NOT COMPLETED|Overall Study||73
7647883|NCT02155660|18833453|P1|NOT COMPLETED|Overall Study||58
7647884|NCT02155660|18833450|P4|COMPLETED|Overall Study||507
7647885|NCT02155660|18833451|P3|COMPLETED|Overall Study||502
7647886|NCT02155660|18833452|P2|COMPLETED|Overall Study||489
7647887|NCT02155660|18833453|P1|COMPLETED|Overall Study||504
7647888|NCT02155660|18833450|P4|STARTED|Overall Study||568
7647889|NCT02155660|18833451|P3|STARTED|Overall Study||562
7647890|NCT02155660|18833452|P2|STARTED|Overall Study||562
7647891|NCT02155660|18833453|P1|STARTED|Overall Study||562
7647892|NCT02155647|18833536|P2|NOT COMPLETED|Overall Study||52
7647893|NCT02155647|18833537|P1|NOT COMPLETED|Overall Study||41
7647894|NCT02155647|18833536|P2|COMPLETED|Overall Study||64
7647895|NCT02155647|18833537|P1|COMPLETED|Overall Study||47
7647896|NCT02155647|18833536|P2|STARTED|Overall Study||116
7647897|NCT02155647|18833537|P1|STARTED|Overall Study||88
7647898|NCT02155608|18833565|P2|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
7647899|NCT02155608|18833566|P1|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
7647900|NCT02155608|18833565|P2|COMPLETED|1b: 1 Week Blinded Post Treatment||28
7647901|NCT02155608|18833566|P1|COMPLETED|1b: 1 Week Blinded Post Treatment||31
7647902|NCT02155608|18833565|P2|STARTED|1b: 1 Week Blinded Post Treatment||29
7647903|NCT02155608|18833566|P1|STARTED|1b: 1 Week Blinded Post Treatment||32
7647904|NCT02155608|18833565|P2|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||1
7647905|NCT02155608|18833566|P1|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||0
7647906|NCT02155608|18833565|P2|COMPLETED|1a: 4 Week Double Blind Sham Controlled||29
7647907|NCT02155608|18833566|P1|COMPLETED|1a: 4 Week Double Blind Sham Controlled||32
7647908|NCT02155608|18833565|P2|STARTED|1a: 4 Week Double Blind Sham Controlled||30
7647909|NCT02155608|18833566|P1|STARTED|1a: 4 Week Double Blind Sham Controlled||32
7647910|NCT02155543|18833605|P7|NOT COMPLETED|Overall Study||0
7647911|NCT02155543|18833606|P6|NOT COMPLETED|Overall Study||0
7647912|NCT02155543|18833607|P5|NOT COMPLETED|Overall Study||0
7647913|NCT02155543|18833608|P4|NOT COMPLETED|Overall Study||0
7647914|NCT02155543|18833609|P3|NOT COMPLETED|Overall Study||0
7647915|NCT02155543|18833610|P2|NOT COMPLETED|Overall Study||0
7647916|NCT02155543|18833611|P1|NOT COMPLETED|Overall Study||0
7647917|NCT02155543|18833605|P7|COMPLETED|Overall Study||9
7647918|NCT02155543|18833606|P6|COMPLETED|Overall Study||3
7647919|NCT02155543|18833607|P5|COMPLETED|Overall Study||3
7647920|NCT02155543|18833608|P4|COMPLETED|Overall Study||9
7647921|NCT02155543|18833609|P3|COMPLETED|Overall Study||9
7647922|NCT02155543|18833610|P2|COMPLETED|Overall Study||9
7647923|NCT02155543|18833611|P1|COMPLETED|Overall Study||9
7647924|NCT02155543|18833605|P7|STARTED|Overall Study||9
7647925|NCT02155543|18833606|P6|STARTED|Overall Study||3
7647926|NCT02155543|18833607|P5|STARTED|Overall Study||3
7647927|NCT02155543|18833608|P4|STARTED|Overall Study||9
7647928|NCT02155543|18833609|P3|STARTED|Overall Study||9
7647929|NCT02155543|18833610|P2|STARTED|Overall Study||9
7647930|NCT02155543|18833611|P1|STARTED|Overall Study||9
7647931|NCT02155465|18833631|P7|NOT COMPLETED|Overall Study||0
7647932|NCT02155465|18833632|P6|NOT COMPLETED|Overall Study||0
7647933|NCT02155465|18833633|P5|NOT COMPLETED|Overall Study||0
7647934|NCT02155465|18833634|P4|NOT COMPLETED|Overall Study||0
7647935|NCT02155465|18833635|P3|NOT COMPLETED|Overall Study||0
7647936|NCT02155465|18833636|P2|NOT COMPLETED|Overall Study||0
7647937|NCT02155465|18833637|P1|NOT COMPLETED|Overall Study||0
7647938|NCT02155465|18833631|P7|COMPLETED|Overall Study||5
7647939|NCT02155465|18833632|P6|COMPLETED|Overall Study||2
7647940|NCT02155465|18833633|P5|COMPLETED|Overall Study||1
7647941|NCT02155465|18833634|P4|COMPLETED|Overall Study||2
7647942|NCT02155465|18833635|P3|COMPLETED|Overall Study||6
7647943|NCT02155465|18833636|P2|COMPLETED|Overall Study||3
7647944|NCT02155465|18833637|P1|COMPLETED|Overall Study||3
7647945|NCT02155465|18833631|P7|STARTED|Overall Study||5
7647946|NCT02155465|18833632|P6|STARTED|Overall Study||2
7647947|NCT02155465|18833633|P5|STARTED|Overall Study||1
7647948|NCT02155465|18833634|P4|STARTED|Overall Study||2
7647949|NCT02155465|18833635|P3|STARTED|Overall Study||6
7647950|NCT02155465|18833636|P2|STARTED|Overall Study||3
7647951|NCT02155465|18833637|P1|STARTED|Overall Study||3
7647952|NCT02155335|18833657|P2|NOT COMPLETED|Period 2||0
7647953|NCT02155335|18833658|P1|NOT COMPLETED|Period 2||0
7647954|NCT02155335|18833657|P2|COMPLETED|Period 2||49
7647955|NCT02155335|18833658|P1|COMPLETED|Period 2||50
7647956|NCT02155335|18833657|P2|STARTED|Period 2||49
7647957|NCT02155335|18833658|P1|STARTED|Period 2||50
7647958|NCT02155335|18833657|P2|NOT COMPLETED|Period 1||1
7647959|NCT02155335|18833658|P1|NOT COMPLETED|Period 1||0
7647960|NCT02155335|18833657|P2|COMPLETED|Period 1||49
7647961|NCT02155335|18833658|P1|COMPLETED|Period 1||50
7647962|NCT02155335|18833657|P2|Treated|Period 1||49
7647963|NCT02155335|18833658|P1|Treated|Period 1||50
7647964|NCT02155335|18833657|P2|STARTED|Period 1||50
7647965|NCT02155335|18833658|P1|STARTED|Period 1||50
7647966|NCT02155322|18833663|P1|NOT COMPLETED|Overall Study||14
7647967|NCT02155322|18833663|P1|COMPLETED|Overall Study||19
7647968|NCT02155322|18833663|P1|Treated|Overall Study|32 of 33 participants treated. 1 participant not treated at the discretion of the investigator.|32
7647969|NCT02155322|18833663|P1|STARTED|Overall Study||33
7647970|NCT02155309|18833670|P3|NOT COMPLETED|Overall Study||1
7647971|NCT02155309|18833671|P2|NOT COMPLETED|Overall Study||0
7647972|NCT02155309|18833672|P1|NOT COMPLETED|Overall Study||0
7647973|NCT02155309|18833670|P3|COMPLETED|Overall Study||12
7647974|NCT02155309|18833671|P2|COMPLETED|Overall Study||10
7647975|NCT02155309|18833672|P1|COMPLETED|Overall Study||13
7647976|NCT02155309|18833670|P3|STARTED|Overall Study||13
7647977|NCT02155309|18833671|P2|STARTED|Overall Study||10
7647978|NCT02155309|18833672|P1|STARTED|Overall Study||13
7647979|NCT02155283|18833679|P1|NOT COMPLETED|Overall Study||7
7647980|NCT02155283|18833679|P1|COMPLETED|Overall Study||9
7647981|NCT02155283|18833679|P1|STARTED|Overall Study||16
7647982|NCT02155257|18833687|P3|NOT COMPLETED|Overall Study||0
7647983|NCT02155257|18833688|P2|NOT COMPLETED|Overall Study||0
7647984|NCT02155257|18833689|P1|NOT COMPLETED|Overall Study||0
7647985|NCT02155257|18833687|P3|COMPLETED|Overall Study||10
7647986|NCT02155257|18833688|P2|COMPLETED|Overall Study||10
7647987|NCT02155257|18833689|P1|COMPLETED|Overall Study||10
7647988|NCT02155257|18833687|P3|STARTED|Overall Study||10
7647989|NCT02155257|18833688|P2|STARTED|Overall Study||10
7647990|NCT02155257|18833689|P1|STARTED|Overall Study||10
7647991|NCT02155101|18833705|P2|NOT COMPLETED|Overall Study||1
7647992|NCT02155101|18833706|P1|NOT COMPLETED|Overall Study||0
7647993|NCT02155101|18833705|P2|COMPLETED|Overall Study||80
7647994|NCT02155101|18833706|P1|COMPLETED|Overall Study||39
7647995|NCT02155101|18833705|P2|STARTED|Overall Study||81
7647996|NCT02155101|18833706|P1|STARTED|Overall Study||39
7647997|NCT02155010|18833718|P2|NOT COMPLETED|Overall Study||6
7647998|NCT02155010|18833719|P1|NOT COMPLETED|Overall Study||6
7647999|NCT02155010|18833718|P2|COMPLETED|Overall Study||31
7648000|NCT02155010|18833719|P1|COMPLETED|Overall Study||31
7648001|NCT02155010|18833718|P2|STARTED|Overall Study||37
7648002|NCT02155010|18833719|P1|STARTED|Overall Study||37
7648003|NCT02154906|18833729|P2|NOT COMPLETED|Overall Study||3
7648004|NCT02154906|18833730|P1|NOT COMPLETED|Overall Study||2
7648005|NCT02154906|18833729|P2|COMPLETED|Overall Study||17
7648006|NCT02154906|18833730|P1|COMPLETED|Overall Study||19
7648007|NCT02154906|18833729|P2|STARTED|Overall Study||20
7648008|NCT02154906|18833730|P1|STARTED|Overall Study||21
7648009|NCT02154763|18833740|P2|NOT COMPLETED|Overall Study||14
7648010|NCT02154763|18833741|P1|NOT COMPLETED|Overall Study||14
7648011|NCT02154763|18833740|P2|COMPLETED|Overall Study||46
7648012|NCT02154763|18833741|P1|COMPLETED|Overall Study||46
7648013|NCT02154763|18833740|P2|STARTED|Overall Study||60
7648014|NCT02154763|18833741|P1|STARTED|Overall Study||60
7648015|NCT02154581|18833855|P2|NOT COMPLETED|Overall Study||8
7648016|NCT02154581|18833856|P1|NOT COMPLETED|Overall Study||7
7648017|NCT02154581|18833855|P2|COMPLETED|Overall Study||12
7648018|NCT02154581|18833856|P1|COMPLETED|Overall Study||14
7648019|NCT02154581|18833855|P2|STARTED|Overall Study||20
7648020|NCT02154581|18833856|P1|STARTED|Overall Study||21
7648021|NCT02154477|18833874|P2|NOT COMPLETED|Overall Study||0
7648022|NCT02154477|18833875|P1|NOT COMPLETED|Overall Study||0
7648023|NCT02154477|18833874|P2|COMPLETED|Overall Study||8
7648024|NCT02154477|18833875|P1|COMPLETED|Overall Study||6
7648025|NCT02154477|18833874|P2|STARTED|Overall Study||8
7648026|NCT02154477|18833875|P1|STARTED|Overall Study||6
7648027|NCT02154425|18833881|P1|NOT COMPLETED|Sampling Period||0
7648028|NCT02154425|18833881|P1|COMPLETED|Sampling Period||17
7648029|NCT02154425|18833881|P1|STARTED|Sampling Period||17
7648030|NCT02154425|18833881|P1|NOT COMPLETED|Screening Period||1
7648031|NCT02154425|18833881|P1|COMPLETED|Screening Period||17
7648032|NCT02154425|18833881|P1|STARTED|Screening Period||18
7648033|NCT02154386|18833913|P2|NOT COMPLETED|Overall Study||2
7648034|NCT02154386|18833914|P1|NOT COMPLETED|Overall Study||1
7648035|NCT02154386|18833913|P2|COMPLETED|Overall Study||21
7648036|NCT02154386|18833914|P1|COMPLETED|Overall Study||22
7648037|NCT02154386|18833913|P2|STARTED|Overall Study||23
7648038|NCT02154386|18833914|P1|STARTED|Overall Study||23
7648039|NCT02154347|18833926|P2|NOT COMPLETED|Open-label Period||25
7648040|NCT02154347|18833927|P1|NOT COMPLETED|Open-label Period||7
7648041|NCT02154347|18833926|P2|COMPLETED|Open-label Period||88
7648042|NCT02154347|18833927|P1|COMPLETED|Open-label Period||50
7648043|NCT02154347|18833926|P2|STARTED|Open-label Period||113
7648044|NCT02154347|18833927|P1|STARTED|Open-label Period||57
7648045|NCT02154347|18833926|P2|NOT COMPLETED|Double-blind Period||4
7648046|NCT02154347|18833927|P1|NOT COMPLETED|Double-blind Period||3
7648047|NCT02154347|18833926|P2|COMPLETED|Double-blind Period||114
7648048|NCT02154347|18833927|P1|COMPLETED|Double-blind Period||57
7648049|NCT02154347|18833926|P2|STARTED|Double-blind Period||118
7648050|NCT02154347|18833927|P1|STARTED|Double-blind Period||60
7648051|NCT02154243|18833937|P3|NOT COMPLETED|Overall Study||0
7648052|NCT02154243|18833938|P2|NOT COMPLETED|Overall Study||0
7648053|NCT02154243|18833939|P1|NOT COMPLETED|Overall Study||0
7648054|NCT02154243|18833937|P3|COMPLETED|Overall Study||4
7648055|NCT02154243|18833938|P2|COMPLETED|Overall Study||4
7648056|NCT02154243|18833939|P1|COMPLETED|Overall Study||5
7648057|NCT02154243|18833937|P3|STARTED|Overall Study||4
7648058|NCT02154243|18833938|P2|STARTED|Overall Study||4
7648059|NCT02154243|18833939|P1|STARTED|Overall Study||5
7648060|NCT02154139|18833950|P1|NOT COMPLETED|Overall Study||7
7648061|NCT02154139|18833950|P1|COMPLETED|Overall Study||644
7648062|NCT02154139|18833950|P1|STARTED|Overall Study||651
7648063|NCT02154087|18833958|P1|NOT COMPLETED|Overall Study||1
7648064|NCT02154087|18833958|P1|COMPLETED|Overall Study||0
7648065|NCT02154087|18833958|P1|STARTED|Overall Study||1
7648066|NCT02154061|18833964|P2|NOT COMPLETED|Overall Study||0
7648067|NCT02154061|18833965|P1|NOT COMPLETED|Overall Study||2
7648068|NCT02154061|18833964|P2|COMPLETED|Overall Study||17
7648069|NCT02154061|18833965|P1|COMPLETED|Overall Study||14
7648070|NCT02154061|18833964|P2|STARTED|Overall Study||17
7648071|NCT02154061|18833965|P1|STARTED|Overall Study||16
7648072|NCT02154048|18833974|P3|NOT COMPLETED|Overall Study||0
7648073|NCT02154048|18833975|P2|NOT COMPLETED|Overall Study||0
7648074|NCT02154048|18833976|P1|NOT COMPLETED|Overall Study||0
7648075|NCT02154048|18833974|P3|COMPLETED|Overall Study||1
7648076|NCT02154048|18833975|P2|COMPLETED|Overall Study||2
7648077|NCT02154048|18833976|P1|COMPLETED|Overall Study||2
7648078|NCT02154048|18833974|P3|STARTED|Overall Study||1
7648079|NCT02154048|18833975|P2|STARTED|Overall Study||2
7648080|NCT02154048|18833976|P1|STARTED|Overall Study||2
7648081|NCT02153983|18833990|P6|NOT COMPLETED|Overall Study||0
7648082|NCT02153983|18833991|P5|NOT COMPLETED|Overall Study||0
7648083|NCT02153983|18833992|P4|NOT COMPLETED|Overall Study||0
7648084|NCT02153983|18833993|P3|NOT COMPLETED|Overall Study||2
7648085|NCT02153983|18833994|P2|NOT COMPLETED|Overall Study||3
7648086|NCT02153983|18833995|P1|NOT COMPLETED|Overall Study||0
7648087|NCT02153983|18833990|P6|COMPLETED|Overall Study||1
7648088|NCT02153983|18833991|P5|COMPLETED|Overall Study||19
7648089|NCT02153983|18833992|P4|COMPLETED|Overall Study||13
7648090|NCT02153983|18833993|P3|COMPLETED|Overall Study||2
7648091|NCT02153983|18833994|P2|COMPLETED|Overall Study||18
7648092|NCT02153983|18833995|P1|COMPLETED|Overall Study||19
7648093|NCT02153983|18833990|P6|STARTED|Overall Study||1
7648094|NCT02153983|18833991|P5|STARTED|Overall Study||19
7648095|NCT02153983|18833992|P4|STARTED|Overall Study||13
7648096|NCT02153983|18833993|P3|STARTED|Overall Study||4
7648097|NCT02153983|18833994|P2|STARTED|Overall Study||21
7648098|NCT02153983|18833995|P1|STARTED|Overall Study||19
7648099|NCT02153918|18834012|P1|NOT COMPLETED|Overall Study||1
7648100|NCT02153918|18834012|P1|COMPLETED|Overall Study||26
7648101|NCT02153918|18834012|P1|STARTED|Overall Study||27
7648102|NCT02153905|18834023|P2|NOT COMPLETED|Overall Study||0
7648103|NCT02153905|18834024|P1|NOT COMPLETED|Overall Study||1
7648104|NCT02153905|18834023|P2|COMPLETED|Overall Study||2
7648105|NCT02153905|18834024|P1|COMPLETED|Overall Study||0
7648106|NCT02153905|18834023|P2|STARTED|Overall Study||2
7648107|NCT02153905|18834024|P1|STARTED|Overall Study||1
7648108|NCT02153827|18834042|P2|NOT COMPLETED|Overall Study||9
7648109|NCT02153827|18834043|P1|NOT COMPLETED|Overall Study||3
7648110|NCT02153827|18834042|P2|COMPLETED|Overall Study||14
7648111|NCT02153827|18834043|P1|COMPLETED|Overall Study||22
7648112|NCT02153827|18834042|P2|STARTED|Overall Study||23
7648113|NCT02153827|18834043|P1|STARTED|Overall Study||25
7648114|NCT02153788|18834059|P2|NOT COMPLETED|Overall Study||1
7648115|NCT02153788|18834060|P1|NOT COMPLETED|Overall Study||2
7648116|NCT02153788|18834059|P2|COMPLETED|Overall Study||18
7648117|NCT02153788|18834060|P1|COMPLETED|Overall Study||23
7648118|NCT02153788|18834059|P2|STARTED|Overall Study||19
7648119|NCT02153788|18834060|P1|STARTED|Overall Study||25
7648120|NCT02153736|18834080|P2|NOT COMPLETED|Overall Study||2
7648121|NCT02153736|18834081|P1|NOT COMPLETED|Overall Study||2
7648122|NCT02153736|18834080|P2|COMPLETED|Overall Study||5
7648123|NCT02153736|18834081|P1|COMPLETED|Overall Study||5
7648124|NCT02153736|18834080|P2|STARTED|Overall Study||7
7648125|NCT02153736|18834081|P1|STARTED|Overall Study||7
7648126|NCT02153723|18834097|P1|NOT COMPLETED|Overall Study||0
7648127|NCT02153723|18834097|P1|COMPLETED|Overall Study||10
7648128|NCT02153723|18834097|P1|STARTED|Overall Study||10
7648129|NCT02153710|18834108|P2|NOT COMPLETED|Overall Study||0
7648130|NCT02153710|18834109|P1|NOT COMPLETED|Overall Study||0
7648131|NCT02153710|18834108|P2|COMPLETED|Overall Study||30
7648132|NCT02153710|18834109|P1|COMPLETED|Overall Study||28
7648133|NCT02153710|18834108|P2|STARTED|Overall Study||30
7648134|NCT02153710|18834109|P1|STARTED|Overall Study||28
7648135|NCT02153671|18834121|P2|NOT COMPLETED|Overall Study||0
7648136|NCT02153671|18834122|P1|NOT COMPLETED|Overall Study||0
7648137|NCT02153671|18834121|P2|COMPLETED|Overall Study||24
7648138|NCT02153671|18834122|P1|COMPLETED|Overall Study||19
7648139|NCT02153671|18834121|P2|STARTED|Overall Study||24
7648140|NCT02153671|18834122|P1|STARTED|Overall Study||19
7648141|NCT02153645|18834201|P3|NOT COMPLETED|Overall Study||10
7648142|NCT02153645|18834202|P2|NOT COMPLETED|Overall Study||10
7648143|NCT02153645|18834203|P1|NOT COMPLETED|Overall Study||13
7648144|NCT02153645|18834201|P3|COMPLETED|Overall Study||18
7648145|NCT02153645|18834202|P2|COMPLETED|Overall Study||19
7648146|NCT02153645|18834203|P1|COMPLETED|Overall Study||17
7648147|NCT02153645|18834201|P3|STARTED|Overall Study||28
7648148|NCT02153645|18834202|P2|STARTED|Overall Study||29
7648149|NCT02153645|18834203|P1|STARTED|Overall Study||30
7648150|NCT02153632|18834217|P3|NOT COMPLETED|Overall Study||19
7648151|NCT02153632|18834218|P2|NOT COMPLETED|Overall Study||19
7648152|NCT02153632|18834219|P1|NOT COMPLETED|Overall Study||18
7648153|NCT02153632|18834217|P3|COMPLETED|Overall Study||25
7648154|NCT02153632|18834218|P2|COMPLETED|Overall Study||27
7648155|NCT02153632|18834219|P1|COMPLETED|Overall Study||27
7648156|NCT02153632|18834217|P3|STARTED|Overall Study||44
7648157|NCT02153632|18834218|P2|STARTED|Overall Study||46
7648158|NCT02153632|18834219|P1|STARTED|Overall Study||45
7648159|NCT02153528|18834232|P2|NOT COMPLETED|Overall Study||0
7648160|NCT02153528|18834233|P1|NOT COMPLETED|Overall Study||0
7648161|NCT02153528|18834232|P2|COMPLETED|Overall Study||353
7648162|NCT02153528|18834233|P1|COMPLETED|Overall Study||348
7648163|NCT02153528|18834232|P2|STARTED|Overall Study||353
7648164|NCT02153528|18834233|P1|STARTED|Overall Study||348
7648165|NCT02153489|18834255|P2|NOT COMPLETED|Period 2||0
7648166|NCT02153489|18834256|P1|NOT COMPLETED|Period 2||0
7648167|NCT02153489|18834255|P2|COMPLETED|Period 2||15
7648168|NCT02153489|18834256|P1|COMPLETED|Period 2||15
7648169|NCT02153489|18834255|P2|STARTED|Period 2||15
7648170|NCT02153489|18834256|P1|STARTED|Period 2||15
7648171|NCT02153489|18834255|P2|NOT COMPLETED|Period 1||0
7648172|NCT02153489|18834256|P1|NOT COMPLETED|Period 1||0
7648173|NCT02153489|18834255|P2|COMPLETED|Period 1||15
7648174|NCT02153489|18834256|P1|COMPLETED|Period 1||15
7648175|NCT02153489|18834255|P2|STARTED|Period 1||15
7648176|NCT02153489|18834256|P1|STARTED|Period 1||15
7648177|NCT02153476|18834296|P2|NOT COMPLETED|Overall Study||0
7648178|NCT02153476|18834297|P1|NOT COMPLETED|Overall Study||1
7648179|NCT02153476|18834296|P2|COMPLETED|Overall Study||22
7648180|NCT02153476|18834297|P1|COMPLETED|Overall Study||22
7648181|NCT02153476|18834296|P2|STARTED|Overall Study||22
7648182|NCT02153476|18834297|P1|STARTED|Overall Study||23
7648183|NCT02153398|18834308|P5|NOT COMPLETED|Overall Study||0
7648184|NCT02153398|18834309|P4|NOT COMPLETED|Overall Study||1
7648185|NCT02153398|18834310|P3|NOT COMPLETED|Overall Study||1
7648186|NCT02153398|18834311|P2|NOT COMPLETED|Overall Study||0
7648187|NCT02153398|18834312|P1|NOT COMPLETED|Overall Study||1
7648188|NCT02153398|18834308|P5|COMPLETED|Overall Study||10
7648189|NCT02153398|18834309|P4|COMPLETED|Overall Study||9
7648190|NCT02153398|18834310|P3|COMPLETED|Overall Study||9
7648191|NCT02153398|18834311|P2|COMPLETED|Overall Study||10
7648192|NCT02153398|18834312|P1|COMPLETED|Overall Study||9
7648193|NCT02153398|18834308|P5|STARTED|Overall Study||10
7648194|NCT02153398|18834309|P4|STARTED|Overall Study||10
7648195|NCT02153398|18834310|P3|STARTED|Overall Study||10
7648196|NCT02153398|18834311|P2|STARTED|Overall Study||10
7648197|NCT02153398|18834312|P1|STARTED|Overall Study||10
7648198|NCT02153359|18834434|P2|NOT COMPLETED|Intervention 2 (1 Month)||2
7648199|NCT02153359|18834435|P1|NOT COMPLETED|Intervention 2 (1 Month)||0
7648200|NCT02153359|18834434|P2|COMPLETED|Intervention 2 (1 Month)||10
7648201|NCT02153359|18834435|P1|COMPLETED|Intervention 2 (1 Month)||11
7648202|NCT02153359|18834434|P2|STARTED|Intervention 2 (1 Month)||12
7648203|NCT02153359|18834435|P1|STARTED|Intervention 2 (1 Month)||11
7648204|NCT02153359|18834434|P2|NOT COMPLETED|Washout (at Least 1 Month)||0
7648205|NCT02153359|18834435|P1|NOT COMPLETED|Washout (at Least 1 Month)||0
7648206|NCT02153359|18834434|P2|COMPLETED|Washout (at Least 1 Month)||12
7648207|NCT02153359|18834435|P1|COMPLETED|Washout (at Least 1 Month)||11
7648208|NCT02153359|18834434|P2|STARTED|Washout (at Least 1 Month)||12
7648209|NCT02153359|18834435|P1|STARTED|Washout (at Least 1 Month)||11
7648210|NCT02153359|18834434|P2|NOT COMPLETED|Intervention 1 (1 Month)||0
7648211|NCT02153359|18834435|P1|NOT COMPLETED|Intervention 1 (1 Month)||0
7648212|NCT02153359|18834434|P2|COMPLETED|Intervention 1 (1 Month)||12
7648213|NCT02153359|18834435|P1|COMPLETED|Intervention 1 (1 Month)||11
7648214|NCT02153359|18834434|P2|STARTED|Intervention 1 (1 Month)||12
7648215|NCT02153359|18834435|P1|STARTED|Intervention 1 (1 Month)||11
7648216|NCT02153346|18834469|P1|NOT COMPLETED|Overall Study||11
7648217|NCT02153346|18834469|P1|COMPLETED|Overall Study||90
7648218|NCT02153346|18834469|P1|STARTED|Overall Study||101
7648219|NCT02153112|18834486|P10|NOT COMPLETED|Overall Study||14
7648220|NCT02153112|18834487|P9|NOT COMPLETED|Overall Study||15
7648221|NCT02153112|18834488|P8|NOT COMPLETED|Overall Study||2
7648222|NCT02153112|18834489|P7|NOT COMPLETED|Overall Study||8
7648223|NCT02153112|18834490|P6|NOT COMPLETED|Overall Study||2
7648224|NCT02153112|18834491|P5|NOT COMPLETED|Overall Study||3
7648225|NCT02153112|18834492|P4|NOT COMPLETED|Overall Study||2
7648226|NCT02153112|18834493|P3|NOT COMPLETED|Overall Study||3
7648227|NCT02153112|18834494|P2|NOT COMPLETED|Overall Study||2
7648228|NCT02153112|18834495|P1|NOT COMPLETED|Overall Study||4
7648229|NCT02153112|18834486|P10|COMPLETED|Overall Study||166
7648230|NCT02153112|18834487|P9|COMPLETED|Overall Study||165
7648231|NCT02153112|18834488|P8|COMPLETED|Overall Study||58
7648232|NCT02153112|18834489|P7|COMPLETED|Overall Study||52
7648233|NCT02153112|18834490|P6|COMPLETED|Overall Study||58
7648234|NCT02153112|18834491|P5|COMPLETED|Overall Study||57
7648235|NCT02153112|18834492|P4|COMPLETED|Overall Study||57
7648236|NCT02153112|18834493|P3|COMPLETED|Overall Study||58
7648237|NCT02153112|18834494|P2|COMPLETED|Overall Study||57
7648238|NCT02153112|18834495|P1|COMPLETED|Overall Study||57
7648239|NCT02153112|18834486|P10|STARTED|Overall Study||180
7648240|NCT02153112|18834487|P9|STARTED|Overall Study||180
7648241|NCT02153112|18834488|P8|STARTED|Overall Study||60
7648242|NCT02153112|18834489|P7|STARTED|Overall Study||60
7648243|NCT02153112|18834490|P6|STARTED|Overall Study||60
7648244|NCT02153112|18834491|P5|STARTED|Overall Study||60
7648245|NCT02153112|18834492|P4|STARTED|Overall Study||59
7648246|NCT02153112|18834493|P3|STARTED|Overall Study||61
7648247|NCT02153112|18834494|P2|STARTED|Overall Study||59
7648248|NCT02153112|18834495|P1|STARTED|Overall Study||61
7648249|NCT02153099|18834774|P7|NOT COMPLETED|Overall Study||0
7648250|NCT02153099|18834775|P6|NOT COMPLETED|Overall Study||0
7648251|NCT02153099|18834776|P5|NOT COMPLETED|Overall Study||0
7648252|NCT02153099|18834777|P4|NOT COMPLETED|Overall Study||0
7648253|NCT02153099|18834778|P3|NOT COMPLETED|Overall Study||0
7648254|NCT02153099|18834779|P2|NOT COMPLETED|Overall Study||0
7648255|NCT02153099|18834780|P1|NOT COMPLETED|Overall Study||0
7648256|NCT02153099|18834774|P7|COMPLETED|Overall Study||12
7648257|NCT02153099|18834775|P6|COMPLETED|Overall Study||6
7648258|NCT02153099|18834776|P5|COMPLETED|Overall Study||6
7648259|NCT02153099|18834777|P4|COMPLETED|Overall Study||6
7648260|NCT02153099|18834778|P3|COMPLETED|Overall Study||6
7648261|NCT02153099|18834779|P2|COMPLETED|Overall Study||6
7648262|NCT02153099|18834780|P1|COMPLETED|Overall Study||6
7648263|NCT02153099|18834774|P7|STARTED|Overall Study||12
7648264|NCT02153099|18834775|P6|STARTED|Overall Study||6
7648265|NCT02153099|18834776|P5|STARTED|Overall Study||6
7648266|NCT02153099|18834777|P4|STARTED|Overall Study||6
7648267|NCT02153099|18834778|P3|STARTED|Overall Study||6
7648268|NCT02153099|18834779|P2|STARTED|Overall Study||6
7648269|NCT02153099|18834780|P1|STARTED|Overall Study||6
7648270|NCT02153086|18834834|P1|NOT COMPLETED|Overall Study||4
7648271|NCT02153086|18834834|P1|COMPLETED|Overall Study||232
7648272|NCT02153086|18834834|P1|STARTED|Overall Study||236
7648273|NCT02153073|18834848|P1|NOT COMPLETED|Overall Study||298
7648274|NCT02153073|18834848|P1|COMPLETED|Overall Study||2786
7648275|NCT02153073|18834848|P1|STARTED|Overall Study||3084
7648276|NCT02152826|18834863|P2|NOT COMPLETED|Overall Study||1
7648277|NCT02152826|18834864|P1|NOT COMPLETED|Overall Study||1
7648278|NCT02152826|18834863|P2|COMPLETED|Overall Study||34
7648279|NCT02152826|18834864|P1|COMPLETED|Overall Study||44
7648280|NCT02152826|18834863|P2|STARTED|Overall Study||35
7648281|NCT02152826|18834864|P1|STARTED|Overall Study||45
7648282|NCT02152761|18834876|P4|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||2
7648283|NCT02152761|18834877|P3|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||0
7648284|NCT02152761|18834878|P2|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||7
7648285|NCT02152761|18834879|P1|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||4
7648286|NCT02152761|18834876|P4|COMPLETED|Epoch: Post-treatment Follow-up Epoch||66
7648287|NCT02152761|18834877|P3|COMPLETED|Epoch: Post-treatment Follow-up Epoch||30
7648288|NCT02152761|18834878|P2|COMPLETED|Epoch: Post-treatment Follow-up Epoch||47
7648289|NCT02152761|18834879|P1|COMPLETED|Epoch: Post-treatment Follow-up Epoch||63
7648290|NCT02152761|18834876|P4|STARTED|Epoch: Post-treatment Follow-up Epoch||68
7648291|NCT02152761|18834877|P3|STARTED|Epoch: Post-treatment Follow-up Epoch||30
7648292|NCT02152761|18834878|P2|STARTED|Epoch: Post-treatment Follow-up Epoch||54
7648293|NCT02152761|18834879|P1|STARTED|Epoch: Post-treatment Follow-up Epoch||67
7648294|NCT02152761|18834876|P4|NOT COMPLETED|Epoch: Treatment Epoch||8
7648295|NCT02152761|18834877|P3|NOT COMPLETED|Epoch: Treatment Epoch||5
7648296|NCT02152761|18834878|P2|NOT COMPLETED|Epoch: Treatment Epoch||20
7648297|NCT02152761|18834879|P1|NOT COMPLETED|Epoch: Treatment Epoch||11
7648298|NCT02152761|18834876|P4|COMPLETED|Epoch: Treatment Epoch||64
7648299|NCT02152761|18834877|P3|COMPLETED|Epoch: Treatment Epoch||29
7648300|NCT02152761|18834878|P2|COMPLETED|Epoch: Treatment Epoch||50
7648301|NCT02152761|18834879|P1|COMPLETED|Epoch: Treatment Epoch||64
7648302|NCT02152761|18834876|P4|STARTED|Epoch: Treatment Epoch||72
7648303|NCT02152761|18834877|P3|STARTED|Epoch: Treatment Epoch||34
7648304|NCT02152761|18834878|P2|STARTED|Epoch: Treatment Epoch||70
7648305|NCT02152761|18834879|P1|STARTED|Epoch: Treatment Epoch||75
7648306|NCT02152696|18834903|P3|NOT COMPLETED|Overall Study||1
7648307|NCT02152696|18834904|P2|NOT COMPLETED|Overall Study||1
7648308|NCT02152696|18834905|P1|NOT COMPLETED|Overall Study||0
7648309|NCT02152696|18834903|P3|COMPLETED|Overall Study||81
7648310|NCT02152696|18834904|P2|COMPLETED|Overall Study||86
7648311|NCT02152696|18834905|P1|COMPLETED|Overall Study||86
7648312|NCT02152696|18834903|P3|STARTED|Overall Study||82
7648313|NCT02152696|18834904|P2|STARTED|Overall Study||87
7648314|NCT02152696|18834905|P1|STARTED|Overall Study||86
7648315|NCT02152670|18834913|P1|NOT COMPLETED|Overall Study||0
7648316|NCT02152670|18834913|P1|COMPLETED|Overall Study||1
7648317|NCT02152670|18834913|P1|STARTED|Overall Study||1
7648318|NCT02152631|18834919|P2|NOT COMPLETED|Overall Study||26
7648319|NCT02152631|18834920|P1|NOT COMPLETED|Overall Study||66
7648320|NCT02152631|18834919|P2|COMPLETED|Overall Study||157
7648321|NCT02152631|18834920|P1|COMPLETED|Overall Study||204
7648322|NCT02152631|18834919|P2|Progressive Disease|Overall Study||137
7648323|NCT02152631|18834920|P1|Progressive Disease|Overall Study||174
7648324|NCT02152631|18834919|P2|Death Due to Any Cause|Overall Study||20
7648325|NCT02152631|18834920|P1|Death Due to Any Cause|Overall Study||30
7648326|NCT02152631|18834919|P2|Off Treatment|Overall Study||172
7648327|NCT02152631|18834920|P1|Off Treatment|Overall Study||246
7648328|NCT02152631|18834919|P2|Received at Least One Dose of Study Drug|Overall Study||175
7648329|NCT02152631|18834920|P1|Received at Least One Dose of Study Drug|Overall Study||265
7648330|NCT02152631|18834919|P2|STARTED|Overall Study||183
7648331|NCT02152631|18834920|P1|STARTED|Overall Study||270
7648332|NCT02152605|18834939|P2|NOT COMPLETED|Overall Study||18
7648333|NCT02152605|18834940|P1|NOT COMPLETED|Overall Study||19
7648334|NCT02152605|18834939|P2|COMPLETED|Overall Study||230
7648335|NCT02152605|18834940|P1|COMPLETED|Overall Study||229
7648336|NCT02152605|18834939|P2|STARTED|Overall Study||248
7648337|NCT02152605|18834940|P1|STARTED|Overall Study||248
7648338|NCT02152566|18834950|P1|NOT COMPLETED|Overall Study||3
7648339|NCT02152566|18834950|P1|COMPLETED|Overall Study||3
7648340|NCT02152566|18834950|P1|STARTED|Overall Study||6
7648341|NCT02152540|18834956|P2|NOT COMPLETED|Overall Study||0
7648342|NCT02152540|18834957|P1|NOT COMPLETED|Overall Study||0
7648343|NCT02152540|18834956|P2|COMPLETED|Overall Study||16
7648344|NCT02152540|18834957|P1|COMPLETED|Overall Study||17
7648345|NCT02152540|18834956|P2|STARTED|Overall Study||16
7648346|NCT02152540|18834957|P1|STARTED|Overall Study||17
7648347|NCT02152384|18834963|P2|NOT COMPLETED|Period 2||0
7648348|NCT02152384|18834964|P1|NOT COMPLETED|Period 2||0
7648349|NCT02152384|18834963|P2|COMPLETED|Period 2||12
7648350|NCT02152384|18834964|P1|COMPLETED|Period 2||13
7648351|NCT02152384|18834963|P2|STARTED|Period 2||12
7648352|NCT02152384|18834964|P1|STARTED|Period 2||13
7648353|NCT02152384|18834963|P2|NOT COMPLETED|Period 1||2
7648354|NCT02152384|18834964|P1|NOT COMPLETED|Period 1||1
7648355|NCT02152384|18834963|P2|COMPLETED|Period 1||12
7648356|NCT02152384|18834964|P1|COMPLETED|Period 1||13
7648357|NCT02152384|18834963|P2|Received at Least 1 Dose of Study Drug|Period 1||14
7648358|NCT02152384|18834964|P1|Received at Least 1 Dose of Study Drug|Period 1||14
7648359|NCT02152384|18834963|P2|STARTED|Period 1||14
7648360|NCT02152384|18834964|P1|STARTED|Period 1||14
7648361|NCT02152384|18834963|P2|NOT COMPLETED|Run In (1-5 Week Transition)||0
7648362|NCT02152384|18834964|P1|NOT COMPLETED|Run In (1-5 Week Transition)||0
7648363|NCT02152384|18834963|P2|COMPLETED|Run In (1-5 Week Transition)||14
7648364|NCT02152384|18834964|P1|COMPLETED|Run In (1-5 Week Transition)||14
7648365|NCT02152384|18834963|P2|STARTED|Run In (1-5 Week Transition)||14
7648366|NCT02152384|18834964|P1|STARTED|Run In (1-5 Week Transition)||14
7648367|NCT02152371|18834984|P2|NOT COMPLETED|Overall Study||16
7648368|NCT02152371|18834985|P1|NOT COMPLETED|Overall Study||12
7648369|NCT02152371|18834984|P2|COMPLETED|Overall Study||134
7648370|NCT02152371|18834985|P1|COMPLETED|Overall Study||138
7648371|NCT02152371|18834984|P2|Received at Least 1 Dose of Study Drug.|Overall Study||150
7648372|NCT02152371|18834985|P1|Received at Least 1 Dose of Study Drug.|Overall Study||150
7648373|NCT02152371|18834984|P2|STARTED|Overall Study||150
7648374|NCT02152371|18834985|P1|STARTED|Overall Study||150
7648375|NCT02152345|18835023|P2|NOT COMPLETED|Overall Study||5
7648376|NCT02152345|18835024|P1|NOT COMPLETED|Overall Study||4
7648377|NCT02152345|18835023|P2|COMPLETED|Overall Study|The last subject randomized to Standard Immunosuppression was on 25-Dec-2016.|24
7648378|NCT02152345|18835024|P1|COMPLETED|Overall Study|The last subject randomized to Belatacept was on 29-Dec-2016.|24
7648379|NCT02152345|18835023|P2|STARTED|Overall Study|The first subject randomized to Standard Immunosuppression was on 14-Jun-2014.|29
7648380|NCT02152345|18835024|P1|STARTED|Overall Study|The first subject randomized to Belatacept was on 15-Sep-2014.|28
7648381|NCT02152137|18835036|P1|NOT COMPLETED|Overall Study||4
7648382|NCT02152137|18835036|P1|COMPLETED|Overall Study||15
7648383|NCT02152137|18835036|P1|Originally Assigned to Arm B|Overall Study|With update #2, Arm B is closed and all patients should receive paclitaxel and efatutazone.|3
7648384|NCT02152137|18835036|P1|Originally Assigned to Arm A|Overall Study||16
7648385|NCT02152137|18835036|P1|STARTED|Overall Study||19
7648386|NCT02152007|18835044|P1|NOT COMPLETED|Overall Study||1
7648387|NCT02152007|18835044|P1|COMPLETED|Overall Study||14
7648388|NCT02152007|18835044|P1|STARTED|Overall Study||15
7648389|NCT02151994|18835053|P13|NOT COMPLETED|Food Effect (FE): Fed||0
7648390|NCT02151994|18835054|P12|NOT COMPLETED|Food Effect (FE): Fed||0
7648391|NCT02151994|18835055|P11|NOT COMPLETED|Food Effect (FE): Fed||0
7648392|NCT02151994|18835056|P10|NOT COMPLETED|Food Effect (FE): Fed||0
7648393|NCT02151994|18835057|P9|NOT COMPLETED|Food Effect (FE): Fed||0
7648394|NCT02151994|18835058|P8|NOT COMPLETED|Food Effect (FE): Fed||0
7648395|NCT02151994|18835059|P7|NOT COMPLETED|Food Effect (FE): Fed||0
7648396|NCT02151994|18835060|P6|NOT COMPLETED|Food Effect (FE): Fed||0
7648397|NCT02151994|18835061|P5|NOT COMPLETED|Food Effect (FE): Fed||0
7648398|NCT02151994|18835062|P4|NOT COMPLETED|Food Effect (FE): Fed||0
7648399|NCT02151994|18835063|P3|NOT COMPLETED|Food Effect (FE): Fed||0
7648400|NCT02151994|18835064|P2|NOT COMPLETED|Food Effect (FE): Fed||0
7648401|NCT02151994|18835065|P1|NOT COMPLETED|Food Effect (FE): Fed||0
7648402|NCT02151994|18835053|P13|COMPLETED|Food Effect (FE): Fed||12
7648403|NCT02151994|18835054|P12|COMPLETED|Food Effect (FE): Fed||0
7648404|NCT02151994|18835055|P11|COMPLETED|Food Effect (FE): Fed||0
7648405|NCT02151994|18835056|P10|COMPLETED|Food Effect (FE): Fed||0
7648406|NCT02151994|18835057|P9|COMPLETED|Food Effect (FE): Fed||0
7648407|NCT02151994|18835058|P8|COMPLETED|Food Effect (FE): Fed||0
7648408|NCT02151994|18835059|P7|COMPLETED|Food Effect (FE): Fed||0
7648409|NCT02151994|18835060|P6|COMPLETED|Food Effect (FE): Fed||0
7648410|NCT02151994|18835061|P5|COMPLETED|Food Effect (FE): Fed||0
7648411|NCT02151994|18835062|P4|COMPLETED|Food Effect (FE): Fed||0
7648412|NCT02151994|18835063|P3|COMPLETED|Food Effect (FE): Fed||0
7648413|NCT02151994|18835064|P2|COMPLETED|Food Effect (FE): Fed||0
7648414|NCT02151994|18835065|P1|COMPLETED|Food Effect (FE): Fed||0
7648415|NCT02151994|18835053|P13|STARTED|Food Effect (FE): Fed||12
7648416|NCT02151994|18835054|P12|STARTED|Food Effect (FE): Fed||0
7648417|NCT02151994|18835055|P11|STARTED|Food Effect (FE): Fed||0
7648418|NCT02151994|18835056|P10|STARTED|Food Effect (FE): Fed||0
7648419|NCT02151994|18835057|P9|STARTED|Food Effect (FE): Fed||0
7648420|NCT02151994|18835058|P8|STARTED|Food Effect (FE): Fed||0
7648421|NCT02151994|18835059|P7|STARTED|Food Effect (FE): Fed||0
7648422|NCT02151994|18835060|P6|STARTED|Food Effect (FE): Fed||0
7648423|NCT02151994|18835061|P5|STARTED|Food Effect (FE): Fed||0
7648424|NCT02151994|18835062|P4|STARTED|Food Effect (FE): Fed||0
7648425|NCT02151994|18835063|P3|STARTED|Food Effect (FE): Fed||0
7648426|NCT02151994|18835064|P2|STARTED|Food Effect (FE): Fed||0
7648427|NCT02151994|18835065|P1|STARTED|Food Effect (FE): Fed||0
7648428|NCT02151994|18835053|P13|NOT COMPLETED|Food Effect (FE): Fasted||0
7648429|NCT02151994|18835054|P12|NOT COMPLETED|Food Effect (FE): Fasted||0
7648430|NCT02151994|18835055|P11|NOT COMPLETED|Food Effect (FE): Fasted||0
7648431|NCT02151994|18835056|P10|NOT COMPLETED|Food Effect (FE): Fasted||0
7648432|NCT02151994|18835057|P9|NOT COMPLETED|Food Effect (FE): Fasted||0
7648433|NCT02151994|18835058|P8|NOT COMPLETED|Food Effect (FE): Fasted||0
7648434|NCT02151994|18835059|P7|NOT COMPLETED|Food Effect (FE): Fasted||0
7648435|NCT02151994|18835060|P6|NOT COMPLETED|Food Effect (FE): Fasted||0
7648436|NCT02151994|18835061|P5|NOT COMPLETED|Food Effect (FE): Fasted||0
7648437|NCT02151994|18835062|P4|NOT COMPLETED|Food Effect (FE): Fasted||0
7648438|NCT02151994|18835063|P3|NOT COMPLETED|Food Effect (FE): Fasted||0
7648439|NCT02151994|18835064|P2|NOT COMPLETED|Food Effect (FE): Fasted||0
7648440|NCT02151994|18835065|P1|NOT COMPLETED|Food Effect (FE): Fasted||0
7648441|NCT02151994|18835053|P13|COMPLETED|Food Effect (FE): Fasted||0
7648442|NCT02151994|18835054|P12|COMPLETED|Food Effect (FE): Fasted||12
7648443|NCT02151994|18835055|P11|COMPLETED|Food Effect (FE): Fasted||0
7648444|NCT02151994|18835056|P10|COMPLETED|Food Effect (FE): Fasted||0
7648445|NCT02151994|18835057|P9|COMPLETED|Food Effect (FE): Fasted||0
7648446|NCT02151994|18835058|P8|COMPLETED|Food Effect (FE): Fasted||0
7648447|NCT02151994|18835059|P7|COMPLETED|Food Effect (FE): Fasted||0
7648448|NCT02151994|18835060|P6|COMPLETED|Food Effect (FE): Fasted||0
7648449|NCT02151994|18835061|P5|COMPLETED|Food Effect (FE): Fasted||0
7648450|NCT02151994|18835062|P4|COMPLETED|Food Effect (FE): Fasted||0
7648451|NCT02151994|18835063|P3|COMPLETED|Food Effect (FE): Fasted||0
7648452|NCT02151994|18835064|P2|COMPLETED|Food Effect (FE): Fasted||0
7648453|NCT02151994|18835065|P1|COMPLETED|Food Effect (FE): Fasted||0
7648454|NCT02151994|18835053|P13|STARTED|Food Effect (FE): Fasted||0
7648455|NCT02151994|18835054|P12|STARTED|Food Effect (FE): Fasted||12
7648456|NCT02151994|18835055|P11|STARTED|Food Effect (FE): Fasted||0
7648457|NCT02151994|18835056|P10|STARTED|Food Effect (FE): Fasted||0
7648458|NCT02151994|18835057|P9|STARTED|Food Effect (FE): Fasted||0
7648459|NCT02151994|18835058|P8|STARTED|Food Effect (FE): Fasted||0
7648460|NCT02151994|18835059|P7|STARTED|Food Effect (FE): Fasted||0
7648461|NCT02151994|18835060|P6|STARTED|Food Effect (FE): Fasted||0
7648462|NCT02151994|18835061|P5|STARTED|Food Effect (FE): Fasted||0
7648463|NCT02151994|18835062|P4|STARTED|Food Effect (FE): Fasted||0
7648464|NCT02151994|18835063|P3|STARTED|Food Effect (FE): Fasted||0
7648465|NCT02151994|18835064|P2|STARTED|Food Effect (FE): Fasted||0
7648466|NCT02151994|18835065|P1|STARTED|Food Effect (FE): Fasted||0
7648467|NCT02151994|18835053|P13|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
7648468|NCT02151994|18835054|P12|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
7648469|NCT02151994|18835055|P11|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
7648470|NCT02151994|18835056|P10|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
7648471|NCT02151994|18835057|P9|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
7648472|NCT02151994|18835058|P8|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
7648473|NCT02151994|18835059|P7|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
7648474|NCT02151994|18835060|P6|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
7648475|NCT02151994|18835061|P5|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
7648476|NCT02151994|18835062|P4|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
7648477|NCT02151994|18835063|P3|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
7648478|NCT02151994|18835064|P2|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
7648479|NCT02151994|18835065|P1|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
7648480|NCT02151994|18835053|P13|COMPLETED|Multiple Ascending Dose (MAD)||0
7648481|NCT02151994|18835054|P12|COMPLETED|Multiple Ascending Dose (MAD)||0
7648482|NCT02151994|18835055|P11|COMPLETED|Multiple Ascending Dose (MAD)||0
7648483|NCT02151994|18835056|P10|COMPLETED|Multiple Ascending Dose (MAD)||0
7648484|NCT02151994|18835057|P9|COMPLETED|Multiple Ascending Dose (MAD)||6
7648485|NCT02151994|18835058|P8|COMPLETED|Multiple Ascending Dose (MAD)||0
7648486|NCT02151994|18835059|P7|COMPLETED|Multiple Ascending Dose (MAD)||6
7648487|NCT02151994|18835060|P6|COMPLETED|Multiple Ascending Dose (MAD)||6
7648488|NCT02151994|18835061|P5|COMPLETED|Multiple Ascending Dose (MAD)||6
7648489|NCT02151994|18835062|P4|COMPLETED|Multiple Ascending Dose (MAD)||6
7648490|NCT02151994|18835063|P3|COMPLETED|Multiple Ascending Dose (MAD)||0
7648491|NCT02151994|18835064|P2|COMPLETED|Multiple Ascending Dose (MAD)||0
7648492|NCT02151994|18835065|P1|COMPLETED|Multiple Ascending Dose (MAD)||10
7648493|NCT02151994|18835053|P13|STARTED|Multiple Ascending Dose (MAD)||0
7648494|NCT02151994|18835054|P12|STARTED|Multiple Ascending Dose (MAD)||0
7648495|NCT02151994|18835055|P11|STARTED|Multiple Ascending Dose (MAD)||0
7648496|NCT02151994|18835056|P10|STARTED|Multiple Ascending Dose (MAD)||0
7648497|NCT02151994|18835057|P9|STARTED|Multiple Ascending Dose (MAD)||6
7648498|NCT02151994|18835058|P8|STARTED|Multiple Ascending Dose (MAD)||0
7648499|NCT02151994|18835059|P7|STARTED|Multiple Ascending Dose (MAD)||6
7648500|NCT02151994|18835060|P6|STARTED|Multiple Ascending Dose (MAD)||6
7648501|NCT02151994|18835061|P5|STARTED|Multiple Ascending Dose (MAD)||6
7648502|NCT02151994|18835062|P4|STARTED|Multiple Ascending Dose (MAD)||6
7648503|NCT02151994|18835063|P3|STARTED|Multiple Ascending Dose (MAD)||0
7648504|NCT02151994|18835064|P2|STARTED|Multiple Ascending Dose (MAD)||0
7648505|NCT02151994|18835065|P1|STARTED|Multiple Ascending Dose (MAD)||10
7648506|NCT02151994|18835053|P13|NOT COMPLETED|Single Ascending Dose (SAD)||0
7648507|NCT02151994|18835054|P12|NOT COMPLETED|Single Ascending Dose (SAD)||0
7648508|NCT02151994|18835055|P11|NOT COMPLETED|Single Ascending Dose (SAD)||0
7648509|NCT02151994|18835056|P10|NOT COMPLETED|Single Ascending Dose (SAD)||0
7648510|NCT02151994|18835057|P9|NOT COMPLETED|Single Ascending Dose (SAD)||0
7648511|NCT02151994|18835058|P8|NOT COMPLETED|Single Ascending Dose (SAD)||0
7648512|NCT02151994|18835059|P7|NOT COMPLETED|Single Ascending Dose (SAD)||0
7648513|NCT02151994|18835060|P6|NOT COMPLETED|Single Ascending Dose (SAD)||0
7648514|NCT02151994|18835061|P5|NOT COMPLETED|Single Ascending Dose (SAD)||0
7648515|NCT02151994|18835062|P4|NOT COMPLETED|Single Ascending Dose (SAD)||0
7648516|NCT02151994|18835063|P3|NOT COMPLETED|Single Ascending Dose (SAD)||0
7648517|NCT02151994|18835064|P2|NOT COMPLETED|Single Ascending Dose (SAD)||0
7648518|NCT02151994|18835065|P1|NOT COMPLETED|Single Ascending Dose (SAD)||0
7648519|NCT02151994|18835053|P13|COMPLETED|Single Ascending Dose (SAD)||0
7648520|NCT02151994|18835054|P12|COMPLETED|Single Ascending Dose (SAD)||0
7648521|NCT02151994|18835055|P11|COMPLETED|Single Ascending Dose (SAD)||6
7648522|NCT02151994|18835056|P10|COMPLETED|Single Ascending Dose (SAD)||6
7648523|NCT02151994|18835057|P9|COMPLETED|Single Ascending Dose (SAD)||0
7648524|NCT02151994|18835058|P8|COMPLETED|Single Ascending Dose (SAD)||6
7648525|NCT02151994|18835059|P7|COMPLETED|Single Ascending Dose (SAD)||6
7648526|NCT02151994|18835060|P6|COMPLETED|Single Ascending Dose (SAD)||6
7648527|NCT02151994|18835061|P5|COMPLETED|Single Ascending Dose (SAD)||6
7648528|NCT02151994|18835062|P4|COMPLETED|Single Ascending Dose (SAD)||6
7648529|NCT02151994|18835063|P3|COMPLETED|Single Ascending Dose (SAD)||6
7648530|NCT02151994|18835064|P2|COMPLETED|Single Ascending Dose (SAD)||6
7648531|NCT02151994|18835065|P1|COMPLETED|Single Ascending Dose (SAD)||18
7648532|NCT02151994|18835053|P13|STARTED|Single Ascending Dose (SAD)||0
7648533|NCT02151994|18835054|P12|STARTED|Single Ascending Dose (SAD)||0
7648534|NCT02151994|18835055|P11|STARTED|Single Ascending Dose (SAD)||6
7648535|NCT02151994|18835056|P10|STARTED|Single Ascending Dose (SAD)||6
7648536|NCT02151994|18835057|P9|STARTED|Single Ascending Dose (SAD)||0
7648537|NCT02151994|18835058|P8|STARTED|Single Ascending Dose (SAD)||6
7648538|NCT02151994|18835059|P7|STARTED|Single Ascending Dose (SAD)||6
7648539|NCT02151994|18835060|P6|STARTED|Single Ascending Dose (SAD)||6
7648540|NCT02151994|18835061|P5|STARTED|Single Ascending Dose (SAD)||6
7648541|NCT02151994|18835062|P4|STARTED|Single Ascending Dose (SAD)||6
7648542|NCT02151994|18835063|P3|STARTED|Single Ascending Dose (SAD)||6
7648543|NCT02151994|18835064|P2|STARTED|Single Ascending Dose (SAD)||6
7648544|NCT02151994|18835065|P1|STARTED|Single Ascending Dose (SAD)||18
7648545|NCT02151981|18835105|P2|NOT COMPLETED|Overall Study||140
7648546|NCT02151981|18835106|P1|NOT COMPLETED|Overall Study||279
7648547|NCT02151981|18835105|P2|COMPLETED|Overall Study||0
7648548|NCT02151981|18835106|P1|COMPLETED|Overall Study||0
7648549|NCT02151981|18835105|P2|Crossed Over AZD9291|Overall Study|Patients randomised to chemotherapy were allowed to crossover to AZD9291 after progression|82
7648550|NCT02151981|18835106|P1|Crossed Over AZD9291|Overall Study||0
7648551|NCT02151981|18835105|P2|Did Not Receive Treatment|Overall Study||4
7648552|NCT02151981|18835106|P1|Did Not Receive Treatment|Overall Study||0
7648553|NCT02151981|18835105|P2|Received Randomised Treatment Only|Overall Study||54
7648554|NCT02151981|18835106|P1|Received Randomised Treatment Only|Overall Study||279
7648555|NCT02151981|18835105|P2|STARTED|Overall Study||140
7648556|NCT02151981|18835106|P1|STARTED|Overall Study||279
7648557|NCT02151903|18835124|P2|NOT COMPLETED|Overall Study||1
7648558|NCT02151903|18835125|P1|NOT COMPLETED|Overall Study||3
7648559|NCT02151903|18835124|P2|COMPLETED|Overall Study||1
7648560|NCT02151903|18835125|P1|COMPLETED|Overall Study||0
7648561|NCT02151903|18835124|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
7648562|NCT02151903|18835125|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
7648563|NCT02151903|18835124|P2|STARTED|Overall Study||2
7648564|NCT02151903|18835125|P1|STARTED|Overall Study||3
7648565|NCT02151877|18835143|P2|NOT COMPLETED|Overall Study||0
7648566|NCT02151877|18835144|P1|NOT COMPLETED|Overall Study||0
7648567|NCT02151877|18835143|P2|COMPLETED|Overall Study||12
7648568|NCT02151877|18835144|P1|COMPLETED|Overall Study||12
7648569|NCT02151877|18835143|P2|STARTED|Overall Study||12
7648570|NCT02151877|18835144|P1|STARTED|Overall Study||12
7648571|NCT02151851|18835162|P2|NOT COMPLETED|Overall Study||130
7648572|NCT02151851|18835163|P1|NOT COMPLETED|Overall Study||76
7648573|NCT02151851|18835162|P2|COMPLETED|Overall Study||186
7648574|NCT02151851|18835163|P1|COMPLETED|Overall Study||38
7648575|NCT02151851|18835162|P2|Included in the Safety Set|Overall Study||316
7648576|NCT02151851|18835163|P1|Included in the Safety Set|Overall Study||113
7648577|NCT02151851|18835162|P2|STARTED|Overall Study||316
7648578|NCT02151851|18835163|P1|STARTED|Overall Study||114
7648579|NCT02151786|18835175|P1|NOT COMPLETED|Overall Study||36
7648580|NCT02151786|18835175|P1|COMPLETED|Overall Study||1084
7648581|NCT02151786|18835175|P1|STARTED|Overall Study||1120
7648582|NCT02151773|18835186|P1|NOT COMPLETED|Overall Study||64
7648583|NCT02151773|18835186|P1|COMPLETED|Overall Study||3429
7648584|NCT02151773|18835186|P1|STARTED|Overall Study||3493
7648585|NCT02151682|18835193|P6|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||7
7648586|NCT02151682|18835194|P5|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
7648587|NCT02151682|18835195|P4|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
7648588|NCT02151682|18835196|P3|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
7648589|NCT02151682|18835197|P2|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
7648590|NCT02151682|18835198|P1|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
7648591|NCT02151682|18835193|P6|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||19
7648592|NCT02151682|18835194|P5|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
7648593|NCT02151682|18835195|P4|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
7648594|NCT02151682|18835196|P3|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
7648595|NCT02151682|18835197|P2|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
7648596|NCT02151682|18835198|P1|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
7648597|NCT02151682|18835193|P6|STARTED|Part 2: Observ. Aft. Tapent. Extension|19 tapentadol and 7 morphine completers (Part 1) who discontinued from tapentadol treatm. in Part 2.|26
7648598|NCT02151682|18835194|P5|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
7648599|NCT02151682|18835195|P4|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
7648600|NCT02151682|18835196|P3|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
7648601|NCT02151682|18835197|P2|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
7648602|NCT02151682|18835198|P1|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
7648603|NCT02151682|18835193|P6|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
7648604|NCT02151682|18835194|P5|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
7648605|NCT02151682|18835195|P4|NOT COMPLETED|Part 2: Tapent. Extension or Observation||4
7648606|NCT02151682|18835196|P3|NOT COMPLETED|Part 2: Tapent. Extension or Observation||28
7648607|NCT02151682|18835197|P2|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
7648608|NCT02151682|18835198|P1|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
7648609|NCT02151682|18835193|P6|COMPLETED|Part 2: Tapent. Extension or Observation||0
7648610|NCT02151682|18835194|P5|COMPLETED|Part 2: Tapent. Extension or Observation||14
7648611|NCT02151682|18835195|P4|COMPLETED|Part 2: Tapent. Extension or Observation||14
7648612|NCT02151682|18835196|P3|COMPLETED|Part 2: Tapent. Extension or Observation|12 Month of tapentadol treatment completed and final visit of Part 2 performed.|8
7648613|NCT02151682|18835197|P2|COMPLETED|Part 2: Tapent. Extension or Observation||0
7648614|NCT02151682|18835198|P1|COMPLETED|Part 2: Tapent. Extension or Observation||0
7648615|NCT02151682|18835193|P6|STARTED|Part 2: Tapent. Extension or Observation||0
7648616|NCT02151682|18835194|P5|STARTED|Part 2: Tapent. Extension or Observation|12 Completers and 2 non-completers from morphine treatment in Part 1.|14
7648617|NCT02151682|18835195|P4|STARTED|Part 2: Tapent. Extension or Observation|14 Completers and 4 of 5 non-completers on tapentadol in Part 1.|18
7648618|NCT02151682|18835196|P3|STARTED|Part 2: Tapent. Extension or Observation|26 Completers on tapentadol PR and 10 completers on morphine PR from Part 1.|36
7648619|NCT02151682|18835197|P2|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
7648620|NCT02151682|18835198|P1|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
7648621|NCT02151682|18835193|P6|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
7648622|NCT02151682|18835194|P5|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
7648623|NCT02151682|18835195|P4|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
7648624|NCT02151682|18835196|P3|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
7648625|NCT02151682|18835197|P2|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||5
7648626|NCT02151682|18835198|P1|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||2
7648627|NCT02151682|18835193|P6|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
7648628|NCT02151682|18835194|P5|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
7648629|NCT02151682|18835195|P4|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
7648630|NCT02151682|18835196|P3|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
7648631|NCT02151682|18835197|P2|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|40
7648632|NCT02151682|18835198|P1|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|22
7648633|NCT02151682|18835193|P6|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
7648634|NCT02151682|18835194|P5|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
7648635|NCT02151682|18835195|P4|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
7648636|NCT02151682|18835196|P3|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
7648637|NCT02151682|18835197|P2|STARTED|Part 1: 14 Days Morphine or Tapentadol||45
7648638|NCT02151682|18835198|P1|STARTED|Part 1: 14 Days Morphine or Tapentadol||24
7648639|NCT02151643|18835248|P5|NOT COMPLETED|Overall Study||3
7648640|NCT02151643|18835249|P4|NOT COMPLETED|Overall Study||7
7648641|NCT02151643|18835250|P3|NOT COMPLETED|Overall Study||4
7648642|NCT02151643|18835251|P2|NOT COMPLETED|Overall Study||4
7648643|NCT02151643|18835252|P1|NOT COMPLETED|Overall Study||6
7648644|NCT02151643|18835248|P5|COMPLETED|Overall Study||35
7648645|NCT02151643|18835249|P4|COMPLETED|Overall Study||32
7648646|NCT02151643|18835250|P3|COMPLETED|Overall Study||21
7648647|NCT02151643|18835251|P2|COMPLETED|Overall Study||21
7648648|NCT02151643|18835252|P1|COMPLETED|Overall Study||20
7648649|NCT02151643|18835248|P5|STARTED|Overall Study||38
7648650|NCT02151643|18835249|P4|STARTED|Overall Study||39
7648651|NCT02151643|18835250|P3|STARTED|Overall Study||25
7648652|NCT02151643|18835251|P2|STARTED|Overall Study||25
7648653|NCT02151643|18835252|P1|STARTED|Overall Study||26
7648654|NCT02151591|18835291|P2|NOT COMPLETED|Overall Study||3
7648655|NCT02151591|18835292|P1|NOT COMPLETED|Overall Study||6
7648656|NCT02151591|18835291|P2|COMPLETED|Overall Study||10
7648657|NCT02151591|18835292|P1|COMPLETED|Overall Study||7
7648658|NCT02151591|18835291|P2|STARTED|Overall Study||13
7648659|NCT02151591|18835292|P1|STARTED|Overall Study||13
7648660|NCT02151526|18835304|P2|NOT COMPLETED|Overall Study||0
7648661|NCT02151526|18835305|P1|NOT COMPLETED|Overall Study||0
7648662|NCT02151526|18835304|P2|COMPLETED|Overall Study||4
7648663|NCT02151526|18835305|P1|COMPLETED|Overall Study||3
7648664|NCT02151526|18835304|P2|STARTED|Overall Study||4
7648665|NCT02151526|18835305|P1|STARTED|Overall Study||3
7648666|NCT02151487|18835342|P4|NOT COMPLETED|Overall Study||3
7648667|NCT02151487|18835343|P3|NOT COMPLETED|Overall Study||4
7648668|NCT02151487|18835344|P2|NOT COMPLETED|Overall Study||5
7648669|NCT02151487|18835345|P1|NOT COMPLETED|Overall Study||2
7648670|NCT02151487|18835342|P4|COMPLETED|Overall Study||20
7648671|NCT02151487|18835343|P3|COMPLETED|Overall Study||16
7648672|NCT02151487|18835344|P2|COMPLETED|Overall Study||22
7648673|NCT02151487|18835345|P1|COMPLETED|Overall Study||25
7648674|NCT02151487|18835342|P4|STARTED|Overall Study||23
7648675|NCT02151487|18835343|P3|STARTED|Overall Study||20
7648676|NCT02151487|18835344|P2|STARTED|Overall Study||27
7648677|NCT02151487|18835345|P1|STARTED|Overall Study||27
7648678|NCT02151461|18835363|P4|NOT COMPLETED|Overall Study||4
7648679|NCT02151461|18835364|P3|NOT COMPLETED|Overall Study||3
7648680|NCT02151461|18835365|P2|NOT COMPLETED|Overall Study||1
7648681|NCT02151461|18835366|P1|NOT COMPLETED|Overall Study||6
7648682|NCT02151461|18835363|P4|COMPLETED|Overall Study||19
7648683|NCT02151461|18835364|P3|COMPLETED|Overall Study||21
7648684|NCT02151461|18835365|P2|COMPLETED|Overall Study||24
7648685|NCT02151461|18835366|P1|COMPLETED|Overall Study||18
7648686|NCT02151461|18835363|P4|STARTED|Overall Study||23
7648687|NCT02151461|18835364|P3|STARTED|Overall Study||24
7648688|NCT02151461|18835365|P2|STARTED|Overall Study||25
7648689|NCT02151461|18835366|P1|STARTED|Overall Study||24
7648690|NCT02151448|18835404|P1|NOT COMPLETED|Phase 2||0
7648691|NCT02151448|18835404|P1|COMPLETED|Phase 2||55
7648692|NCT02151448|18835404|P1|STARTED|Phase 2||55
7648693|NCT02151448|18835404|P1|NOT COMPLETED|Phase 1||0
7648694|NCT02151448|18835404|P1|COMPLETED|Phase 1||9
7648695|NCT02151448|18835404|P1|STARTED|Phase 1||9
7648696|NCT02151383|18835422|P3|NOT COMPLETED|Overall Study||0
7648697|NCT02151383|18835423|P2|NOT COMPLETED|Overall Study||0
7648698|NCT02151383|18835424|P1|NOT COMPLETED|Overall Study||0
7648699|NCT02151383|18835422|P3|COMPLETED|Overall Study||1
7648700|NCT02151383|18835423|P2|COMPLETED|Overall Study||3
7648701|NCT02151383|18835424|P1|COMPLETED|Overall Study||8
7648702|NCT02151383|18835422|P3|High-dose|Overall Study||0
7648703|NCT02151383|18835423|P2|High-dose|Overall Study||0
7648704|NCT02151383|18835424|P1|High-dose|Overall Study||6
7648705|NCT02151383|18835422|P3|Low-dose|Overall Study||1
7648706|NCT02151383|18835423|P2|Low-dose|Overall Study||3
7648707|NCT02151383|18835424|P1|Low-dose|Overall Study||2
7648708|NCT02151383|18835422|P3|STARTED|Overall Study||1
7648709|NCT02151383|18835423|P2|STARTED|Overall Study||3
7648710|NCT02151383|18835424|P1|STARTED|Overall Study||8
7648711|NCT02151331|18835482|P2|NOT COMPLETED|Overall Study||40
7648712|NCT02151331|18835483|P1|NOT COMPLETED|Overall Study||32
7648713|NCT02151331|18835482|P2|COMPLETED|Overall Study||52
7648714|NCT02151331|18835483|P1|COMPLETED|Overall Study||45
7648715|NCT02151331|18835482|P2|STARTED|Overall Study||92
7648716|NCT02151331|18835483|P1|STARTED|Overall Study||77
7648717|NCT02151266|18835498|P3|NOT COMPLETED|Overall Study||7
7648718|NCT02151266|18835499|P2|NOT COMPLETED|Overall Study||15
7648719|NCT02151266|18835500|P1|NOT COMPLETED|Overall Study||8
7648720|NCT02151266|18835498|P3|COMPLETED|Overall Study||14
7648721|NCT02151266|18835499|P2|COMPLETED|Overall Study||14
7648722|NCT02151266|18835500|P1|COMPLETED|Overall Study||11
7648723|NCT02151266|18835498|P3|STARTED|Overall Study||21
7648724|NCT02151266|18835499|P2|STARTED|Overall Study||29
7648725|NCT02151266|18835500|P1|STARTED|Overall Study||19
7648726|NCT02151253|18835526|P2|NOT COMPLETED|Overall Study||0
7648727|NCT02151253|18835527|P1|NOT COMPLETED|Overall Study||0
7648728|NCT02151253|18835526|P2|COMPLETED|Overall Study||15
7648729|NCT02151253|18835527|P1|COMPLETED|Overall Study||13
7648730|NCT02151253|18835526|P2|STARTED|Overall Study||15
7648731|NCT02151253|18835527|P1|STARTED|Overall Study||13
7648732|NCT02151149|18835543|P2|NOT COMPLETED|Follow-Up Period||37
7648733|NCT02151149|18835544|P1|NOT COMPLETED|Follow-Up Period||39
7648734|NCT02151149|18835543|P2|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|18
7648735|NCT02151149|18835544|P1|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|19
7648736|NCT02151149|18835543|P2|STARTED|Follow-Up Period||55
7648737|NCT02151149|18835544|P1|STARTED|Follow-Up Period||58
7648738|NCT02151149|18835543|P2|NOT COMPLETED|Treatment Period||71
7648739|NCT02151149|18835544|P1|NOT COMPLETED|Treatment Period||70
7648740|NCT02151149|18835543|P2|COMPLETED|Treatment Period||1
7648741|NCT02151149|18835544|P1|COMPLETED|Treatment Period||1
7648742|NCT02151149|18835543|P2|Treated Population|Treatment Period||70
7648743|NCT02151149|18835544|P1|Treated Population|Treatment Period||68
7648744|NCT02151149|18835543|P2|STARTED|Treatment Period|2 participants did not receive treatment|72
7648745|NCT02151149|18835544|P1|STARTED|Treatment Period|3 participants did not receive treatment|71
7648746|NCT02151110|18835576|P8|NOT COMPLETED|Overall Study||3
7648747|NCT02151110|18835577|P7|NOT COMPLETED|Overall Study||0
7648748|NCT02151110|18835578|P6|NOT COMPLETED|Overall Study||0
7648749|NCT02151110|18835579|P5|NOT COMPLETED|Overall Study||0
7648750|NCT02151110|18835580|P4|NOT COMPLETED|Overall Study||0
7648751|NCT02151110|18835581|P3|NOT COMPLETED|Overall Study||0
7648752|NCT02151110|18835582|P2|NOT COMPLETED|Overall Study||0
7648753|NCT02151110|18835583|P1|NOT COMPLETED|Overall Study||0
7648754|NCT02151110|18835576|P8|COMPLETED|Overall Study||5
7648755|NCT02151110|18835577|P7|COMPLETED|Overall Study||8
7648756|NCT02151110|18835578|P6|COMPLETED|Overall Study||8
7648757|NCT02151110|18835579|P5|COMPLETED|Overall Study||8
7648758|NCT02151110|18835580|P4|COMPLETED|Overall Study||8
7648759|NCT02151110|18835581|P3|COMPLETED|Overall Study||2
7648760|NCT02151110|18835582|P2|COMPLETED|Overall Study||2
7648761|NCT02151110|18835583|P1|COMPLETED|Overall Study||12
7648762|NCT02151110|18835576|P8|STARTED|Overall Study||8
7648763|NCT02151110|18835577|P7|STARTED|Overall Study||8
7648764|NCT02151110|18835578|P6|STARTED|Overall Study||8
7648765|NCT02151110|18835579|P5|STARTED|Overall Study||8
7648766|NCT02151110|18835580|P4|STARTED|Overall Study||8
7648767|NCT02151110|18835581|P3|STARTED|Overall Study||2
7648768|NCT02151110|18835582|P2|STARTED|Overall Study||2
7648769|NCT02151110|18835583|P1|STARTED|Overall Study||12
7648770|NCT02151058|18835676|P3|NOT COMPLETED|Overall Study||5
7648771|NCT02151058|18835677|P2|NOT COMPLETED|Overall Study||1
7648772|NCT02151058|18835678|P1|NOT COMPLETED|Overall Study||2
7648773|NCT02151058|18835676|P3|COMPLETED|Overall Study||86
7648774|NCT02151058|18835677|P2|COMPLETED|Overall Study||90
7648775|NCT02151058|18835678|P1|COMPLETED|Overall Study||43
7648776|NCT02151058|18835676|P3|STARTED|Overall Study||91
7648777|NCT02151058|18835677|P2|STARTED|Overall Study||91
7648778|NCT02151058|18835678|P1|STARTED|Overall Study||45
7648779|NCT02150954|18835712|P2|NOT COMPLETED|Overall Study||0
7648780|NCT02150954|18835713|P1|NOT COMPLETED|Overall Study||1
7648781|NCT02150954|18835712|P2|COMPLETED|Overall Study||59
7648782|NCT02150954|18835713|P1|COMPLETED|Overall Study||57
7648783|NCT02150954|18835712|P2|STARTED|Overall Study||59
7648784|NCT02150954|18835713|P1|STARTED|Overall Study||58
7648785|NCT02150863|18835738|P3|NOT COMPLETED|Overall Study||0
7648786|NCT02150863|18835739|P2|NOT COMPLETED|Overall Study||1
7648787|NCT02150863|18835740|P1|NOT COMPLETED|Overall Study||0
7648788|NCT02150863|18835738|P3|COMPLETED|Overall Study||0
7648789|NCT02150863|18835739|P2|COMPLETED|Overall Study||0
7648790|NCT02150863|18835740|P1|COMPLETED|Overall Study||0
7648791|NCT02150863|18835738|P3|STARTED|Overall Study||0
7648792|NCT02150863|18835739|P2|STARTED|Overall Study||1
7648793|NCT02150863|18835740|P1|STARTED|Overall Study||0
7648794|NCT02150837|18835750|P2|NOT COMPLETED|Overall Study||125
7648795|NCT02150837|18835751|P1|NOT COMPLETED|Overall Study||25
7648796|NCT02150837|18835750|P2|COMPLETED|Overall Study|There was no predefined study period to complete. 185 remained through the 12 wk primary endpoint.|185
7648797|NCT02150837|18835751|P1|COMPLETED|Overall Study|There was no predefined study period to complete. 37 remained through the 12 wk primary endpoint.|37
7648798|NCT02150837|18835750|P2|STARTED|Overall Study|478 charts were screened with 168 screen failures due to exclusion criteria.|310
7648799|NCT02150837|18835751|P1|STARTED|Overall Study|87 Charts were screened with 25 screen failures due to exclusion criteria.|62
7648800|NCT02150759|18835923|P2|NOT COMPLETED|Overall Study||2
7648801|NCT02150759|18835924|P1|NOT COMPLETED|Overall Study||1
7648802|NCT02150759|18835923|P2|COMPLETED|Overall Study||21
7648803|NCT02150759|18835924|P1|COMPLETED|Overall Study||22
7648804|NCT02150759|18835923|P2|STARTED|Overall Study||23
7648805|NCT02150759|18835924|P1|STARTED|Overall Study||23
7648806|NCT02150499|18835934|P2|NOT COMPLETED|Overall Study||0
7648807|NCT02150499|18835935|P1|NOT COMPLETED|Overall Study||0
7648808|NCT02150499|18835934|P2|COMPLETED|Overall Study||9
7648809|NCT02150499|18835935|P1|COMPLETED|Overall Study||9
7648810|NCT02150499|18835934|P2|STARTED|Overall Study||9
7648811|NCT02150499|18835935|P1|STARTED|Overall Study||9
7648812|NCT02150460|18835957|P2|NOT COMPLETED|Overall Study||0
7648813|NCT02150460|18835958|P1|NOT COMPLETED|Overall Study||0
7648814|NCT02150460|18835957|P2|COMPLETED|Overall Study||50
7648815|NCT02150460|18835958|P1|COMPLETED|Overall Study||50
7648816|NCT02150460|18835957|P2|STARTED|Overall Study||50
7648817|NCT02150460|18835958|P1|STARTED|Overall Study||50
7648818|NCT02150343|18835986|P4|NOT COMPLETED|Overall Study||10
7648819|NCT02150343|18835987|P3|NOT COMPLETED|Overall Study||12
7648820|NCT02150343|18835988|P2|NOT COMPLETED|Overall Study||20
7648821|NCT02150343|18835989|P1|NOT COMPLETED|Overall Study||21
7648822|NCT02150343|18835986|P4|COMPLETED|Overall Study||168
7648823|NCT02150343|18835987|P3|COMPLETED|Overall Study||166
7648824|NCT02150343|18835988|P2|COMPLETED|Overall Study||158
7648825|NCT02150343|18835989|P1|COMPLETED|Overall Study||159
7648826|NCT02150343|18835986|P4|STARTED|Overall Study||178
7648827|NCT02150343|18835987|P3|STARTED|Overall Study||178
7648828|NCT02150343|18835988|P2|STARTED|Overall Study||178
7648829|NCT02150343|18835989|P1|STARTED|Overall Study||180
7648830|NCT02150213|18836027|P1|NOT COMPLETED|Overall Study||2
7648831|NCT02150213|18836027|P1|COMPLETED|Overall Study||57
7648832|NCT02150213|18836027|P1|STARTED|Overall Study||59
7648833|NCT02150109|18836032|P1|NOT COMPLETED|Overall Study||0
7648834|NCT02150109|18836032|P1|COMPLETED|Overall Study||372
7648835|NCT02150109|18836032|P1|STARTED|Overall Study||372
7648836|NCT02150057|18836046|P2|NOT COMPLETED|Overall Study||4
7648837|NCT02150057|18836047|P1|NOT COMPLETED|Overall Study||6
7648838|NCT02150057|18836046|P2|COMPLETED|Overall Study||22
7648839|NCT02150057|18836047|P1|COMPLETED|Overall Study||19
7648840|NCT02150057|18836046|P2|STARTED|Overall Study||26
7648841|NCT02150057|18836047|P1|STARTED|Overall Study||25
7648842|NCT02150044|18836053|P1|NOT COMPLETED|Overall Study||0
7648843|NCT02150044|18836053|P1|COMPLETED|Overall Study||29
7648844|NCT02150044|18836053|P1|Study Cohort|Overall Study||13
7648845|NCT02150044|18836053|P1|Lead-In Subjects|Overall Study||16
7648846|NCT02150044|18836053|P1|STARTED|Overall Study||29
7648847|NCT02149875|18836062|P3|NOT COMPLETED|Overall Study||9
7648848|NCT02149875|18836063|P2|NOT COMPLETED|Overall Study||8
7648849|NCT02149875|18836064|P1|NOT COMPLETED|Overall Study||7
7648850|NCT02149875|18836062|P3|COMPLETED|Overall Study||20
7648851|NCT02149875|18836063|P2|COMPLETED|Overall Study||20
7648852|NCT02149875|18836064|P1|COMPLETED|Overall Study||20
7648853|NCT02149875|18836062|P3|STARTED|Overall Study||29
7648854|NCT02149875|18836063|P2|STARTED|Overall Study||28
7648855|NCT02149875|18836064|P1|STARTED|Overall Study||27
7648856|NCT02149836|18836075|P1|NOT COMPLETED|Overall Study||1
7648857|NCT02149836|18836075|P1|COMPLETED|Overall Study||17
7648858|NCT02149836|18836075|P1|STARTED|Overall Study||18
7648859|NCT02149524|18836084|P2|NOT COMPLETED|Overall Study||57
7648860|NCT02149524|18836085|P1|NOT COMPLETED|Overall Study||54
7648861|NCT02149524|18836084|P2|COMPLETED|Overall Study||380
7648862|NCT02149524|18836085|P1|COMPLETED|Overall Study||384
7648863|NCT02149524|18836084|P2|STARTED|Overall Study||437
7648864|NCT02149524|18836085|P1|STARTED|Overall Study||438
7648865|NCT02149420|18836102|P3|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
7648866|NCT02149420|18836103|P2|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
7648867|NCT02149420|18836104|P1|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||1
7648868|NCT02149420|18836102|P3|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
7648869|NCT02149420|18836103|P2|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
7648870|NCT02149420|18836104|P1|COMPLETED|Open Label VAY736 10 mg/kg Extension||4
7648871|NCT02149420|18836102|P3|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
7648872|NCT02149420|18836103|P2|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
7648873|NCT02149420|18836104|P1|STARTED|Open Label VAY736 10 mg/kg Extension|Patients received single dose of VAY736 10mg/kg at Week 24.|5
7648874|NCT02149420|18836102|P3|NOT COMPLETED|Core Study||2
7648875|NCT02149420|18836103|P2|NOT COMPLETED|Core Study||1
7648876|NCT02149420|18836104|P1|NOT COMPLETED|Core Study||0
7648877|NCT02149420|18836102|P3|COMPLETED|Core Study||10
7648878|NCT02149420|18836103|P2|COMPLETED|Core Study||5
7648879|NCT02149420|18836104|P1|COMPLETED|Core Study||9
7648880|NCT02149420|18836102|P3|PD (Pharmacodynamics) Analysis Set|Core Study||12
7648881|NCT02149420|18836103|P2|PD (Pharmacodynamics) Analysis Set|Core Study||6
7648882|NCT02149420|18836104|P1|PD (Pharmacodynamics) Analysis Set|Core Study||9
7648883|NCT02149420|18836102|P3|PK Analysis Set|Core Study||12
7648884|NCT02149420|18836103|P2|PK Analysis Set|Core Study||6
7648885|NCT02149420|18836104|P1|PK Analysis Set|Core Study|for patients entering open label VAY736 10 mg/kg at Week 24|5
7648886|NCT02149420|18836102|P3|Safety Analysis Set|Core Study||12
7648887|NCT02149420|18836103|P2|Safety Analysis Set|Core Study||6
7648888|NCT02149420|18836104|P1|Safety Analysis Set|Core Study||9
7648889|NCT02149420|18836102|P3|STARTED|Core Study||12
7648890|NCT02149420|18836103|P2|STARTED|Core Study||6
7648891|NCT02149420|18836104|P1|STARTED|Core Study||9
7648892|NCT02149342|18836154|P1|NOT COMPLETED|Overall Study||0
7648893|NCT02149342|18836154|P1|COMPLETED|Overall Study|14 patients|14
7648894|NCT02149342|18836154|P1|STARTED|Overall Study|14 patients|14
7648895|NCT02149303|18836166|P1|NOT COMPLETED|Overall Study||0
7648896|NCT02149303|18836166|P1|COMPLETED|Overall Study||191
7648897|NCT02149303|18836166|P1|STARTED|Overall Study||191
7648898|NCT02149290|18836172|P1|NOT COMPLETED|Overall Study||0
7648899|NCT02149290|18836172|P1|COMPLETED|Overall Study||198
7648900|NCT02149290|18836172|P1|STARTED|Overall Study||198
7648901|NCT02149264|18836180|P1|NOT COMPLETED|Overall Study||20
7648902|NCT02149264|18836180|P1|COMPLETED|Overall Study||139
7648903|NCT02149264|18836180|P1|STARTED|Overall Study|Of the 160 enrolled subjects, one discontinued before receiving treatment.|159
7648904|NCT02149199|18836196|P3|NOT COMPLETED|Overall Study||147
7648905|NCT02149199|18836197|P2|NOT COMPLETED|Overall Study||193
7648906|NCT02149199|18836198|P1|NOT COMPLETED|Overall Study||133
7648907|NCT02149199|18836196|P3|COMPLETED|Overall Study||1135
7648908|NCT02149199|18836197|P2|COMPLETED|Overall Study||1084
7648909|NCT02149199|18836198|P1|COMPLETED|Overall Study||1144
7648910|NCT02149199|18836196|P3|STARTED|Overall Study||1282
7648911|NCT02149199|18836197|P2|STARTED|Overall Study||1277
7648912|NCT02149199|18836198|P1|STARTED|Overall Study||1277
7648913|NCT02149173|18836263|P1|NOT COMPLETED|Overall Study||0
7648914|NCT02149173|18836263|P1|COMPLETED|Overall Study||29
7648915|NCT02149173|18836263|P1|STARTED|Overall Study||29
7648916|NCT02149108|18836277|P2|NOT COMPLETED|Overall Study||383
7648917|NCT02149108|18836278|P1|NOT COMPLETED|Overall Study||380
7648918|NCT02149108|18836277|P2|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|3
7648919|NCT02149108|18836278|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|2
7648920|NCT02149108|18836277|P2|STARTED|Overall Study|Randomised patients.|386
7648921|NCT02149108|18836278|P1|STARTED|Overall Study|Randomised patients.|382
7648922|NCT02148952|18836292|P2|NOT COMPLETED|Follow-Up||279
7648923|NCT02148952|18836293|P1|NOT COMPLETED|Follow-Up||265
7648924|NCT02148952|18836292|P2|COMPLETED|Follow-Up||77347
7648925|NCT02148952|18836293|P1|COMPLETED|Follow-Up||79798
7648926|NCT02148952|18836292|P2|STARTED|Follow-Up||77626
7648927|NCT02148952|18836293|P1|STARTED|Follow-Up||80063
7648928|NCT02148952|18836292|P2|NOT COMPLETED|Assessing Eligibility and Consent||3147
7648929|NCT02148952|18836293|P1|NOT COMPLETED|Assessing Eligibility and Consent||3103
7648930|NCT02148952|18836292|P2|COMPLETED|Assessing Eligibility and Consent||77626
7648931|NCT02148952|18836293|P1|COMPLETED|Assessing Eligibility and Consent||80063
7648932|NCT02148952|18836292|P2|STARTED|Assessing Eligibility and Consent||80773
7648933|NCT02148952|18836293|P1|STARTED|Assessing Eligibility and Consent||83166
7648934|NCT02148874|18836351|P2|NOT COMPLETED|Overall Study||2
7648935|NCT02148874|18836352|P1|NOT COMPLETED|Overall Study||7
7648936|NCT02148874|18836351|P2|COMPLETED|Overall Study||84
7648937|NCT02148874|18836352|P1|COMPLETED|Overall Study||194
7648938|NCT02148874|18836351|P2|STARTED|Overall Study||86
7648939|NCT02148874|18836352|P1|STARTED|Overall Study||201
7648940|NCT02148835|18836364|P2|NOT COMPLETED|Overall Study||0
7648941|NCT02148835|18836365|P1|NOT COMPLETED|Overall Study||0
7648942|NCT02148835|18836364|P2|COMPLETED|Overall Study||22
7648943|NCT02148835|18836365|P1|COMPLETED|Overall Study||22
7648944|NCT02148835|18836364|P2|STARTED|Overall Study||22
7648945|NCT02148835|18836365|P1|STARTED|Overall Study||22
7648946|NCT02148809|18836371|P1|NOT COMPLETED|Overall Study||0
7648947|NCT02148809|18836371|P1|COMPLETED|Overall Study||14
7648948|NCT02148809|18836371|P1|STARTED|Overall Study||14
7648949|NCT02148718|18836376|P1|NOT COMPLETED|Overall Study||31
7648950|NCT02148718|18836376|P1|COMPLETED|Overall Study||55
7648951|NCT02148718|18836376|P1|STARTED|Overall Study||86
7648952|NCT02148588|18836397|P1|NOT COMPLETED|Overall Study||0
7648953|NCT02148588|18836397|P1|COMPLETED|Overall Study||8
7648954|NCT02148588|18836397|P1|STARTED|Overall Study||8
7648955|NCT02148523|18836409|P3|NOT COMPLETED|Overall Study||0
7648956|NCT02148523|18836410|P2|NOT COMPLETED|Overall Study||0
7648957|NCT02148523|18836411|P1|NOT COMPLETED|Overall Study||0
7648958|NCT02148523|18836409|P3|COMPLETED|Overall Study||67
7648959|NCT02148523|18836410|P2|COMPLETED|Overall Study||67
7648960|NCT02148523|18836411|P1|COMPLETED|Overall Study||67
7648961|NCT02148523|18836409|P3|STARTED|Overall Study||67
7648962|NCT02148523|18836410|P2|STARTED|Overall Study||67
7648963|NCT02148523|18836411|P1|STARTED|Overall Study||67
7648964|NCT02148445|18836424|P2|NOT COMPLETED|Overall Study||3
7648965|NCT02148445|18836425|P1|NOT COMPLETED|Overall Study||1
7648966|NCT02148445|18836424|P2|COMPLETED|Overall Study||197
7648967|NCT02148445|18836425|P1|COMPLETED|Overall Study||197
7648968|NCT02148445|18836424|P2|STARTED|Overall Study||200
7648969|NCT02148445|18836425|P1|STARTED|Overall Study||198
7648970|NCT02148302|18836463|P2|NOT COMPLETED|Overall Study||0
7648971|NCT02148302|18836464|P1|NOT COMPLETED|Overall Study||0
7648972|NCT02148302|18836463|P2|COMPLETED|Overall Study||66
7648973|NCT02148302|18836464|P1|COMPLETED|Overall Study||57
7648974|NCT02148302|18836463|P2|STARTED|Overall Study||66
7648975|NCT02148302|18836464|P1|STARTED|Overall Study||57
7648976|NCT02148250|18836476|P2|NOT COMPLETED|Period 2||0
7648977|NCT02148250|18836477|P1|NOT COMPLETED|Period 2||0
7648978|NCT02148250|18836476|P2|COMPLETED|Period 2||6
7648979|NCT02148250|18836477|P1|COMPLETED|Period 2||6
7648980|NCT02148250|18836476|P2|STARTED|Period 2||6
7648981|NCT02148250|18836477|P1|STARTED|Period 2||6
7648982|NCT02148250|18836476|P2|NOT COMPLETED|Period 1||0
7648983|NCT02148250|18836477|P1|NOT COMPLETED|Period 1||0
7648984|NCT02148250|18836476|P2|COMPLETED|Period 1||6
7648985|NCT02148250|18836477|P1|COMPLETED|Period 1||6
7648986|NCT02148250|18836476|P2|STARTED|Period 1||6
7648987|NCT02148250|18836477|P1|STARTED|Period 1||6
7648988|NCT02148250|18836476|P2|NOT COMPLETED|Screening||0
7648989|NCT02148250|18836477|P1|NOT COMPLETED|Screening||5
7648990|NCT02148250|18836476|P2|COMPLETED|Screening||0
7648991|NCT02148250|18836477|P1|COMPLETED|Screening||12
7648992|NCT02148250|18836476|P2|STARTED|Screening||0
7648993|NCT02148250|18836477|P1|STARTED|Screening||17
7648994|NCT02148211|18836491|P1|NOT COMPLETED|Overall Study||352
7648995|NCT02148211|18836491|P1|COMPLETED|Overall Study||155
7648996|NCT02148211|18836491|P1|STARTED|Overall Study||507
7648997|NCT02148133|18836500|P1|NOT COMPLETED|Overall Study||5
7648998|NCT02148133|18836500|P1|COMPLETED|Overall Study||16
7648999|NCT02148133|18836500|P1|Pharmacokinetic Analysis Set (PAS)|Overall Study||21
7649000|NCT02148133|18836500|P1|Safety Set (SS)|Overall Study||21
7649001|NCT02148133|18836500|P1|STARTED|Overall Study||21
7649002|NCT02148107|18836522|P3|NOT COMPLETED|Overall Study||0
7649003|NCT02148107|18836523|P2|NOT COMPLETED|Overall Study||0
7649004|NCT02148107|18836524|P1|NOT COMPLETED|Overall Study||0
7649005|NCT02148107|18836522|P3|COMPLETED|Overall Study||3
7649006|NCT02148107|18836523|P2|COMPLETED|Overall Study||7
7649007|NCT02148107|18836524|P1|COMPLETED|Overall Study||8
7649008|NCT02148107|18836522|P3|STARTED|Overall Study||3
7649009|NCT02148107|18836523|P2|STARTED|Overall Study||7
7649010|NCT02148107|18836524|P1|STARTED|Overall Study||8
7649011|NCT02147990|18836543|P3|NOT COMPLETED|Overall Study||0
7649012|NCT02147990|18836544|P2|NOT COMPLETED|Overall Study||0
7649013|NCT02147990|18836545|P1|NOT COMPLETED|Overall Study||0
7649014|NCT02147990|18836543|P3|COMPLETED|Overall Study||63
7649015|NCT02147990|18836544|P2|COMPLETED|Overall Study||100
7649016|NCT02147990|18836545|P1|COMPLETED|Overall Study||154
7649017|NCT02147990|18836543|P3|STARTED|Overall Study||63
7649018|NCT02147990|18836544|P2|STARTED|Overall Study||100
7649019|NCT02147990|18836545|P1|STARTED|Overall Study||154
7649020|NCT02147899|18836610|P3|NOT COMPLETED|Overall Study||0
7649021|NCT02147899|18836611|P2|NOT COMPLETED|Overall Study||0
7649022|NCT02147899|18836612|P1|NOT COMPLETED|Overall Study||0
7649023|NCT02147899|18836610|P3|COMPLETED|Overall Study||72
7649024|NCT02147899|18836611|P2|COMPLETED|Overall Study||72
7649025|NCT02147899|18836612|P1|COMPLETED|Overall Study||71
7649026|NCT02147899|18836610|P3|STARTED|Overall Study||72
7649027|NCT02147899|18836611|P2|STARTED|Overall Study||72
7649028|NCT02147899|18836612|P1|STARTED|Overall Study||71
7649029|NCT02147834|18836631|P2|NOT COMPLETED|Overall Study||0
7649030|NCT02147834|18836632|P1|NOT COMPLETED|Overall Study||0
7649031|NCT02147834|18836631|P2|COMPLETED|Overall Study||2
7649032|NCT02147834|18836632|P1|COMPLETED|Overall Study||3
7649033|NCT02147834|18836631|P2|STARTED|Overall Study||2
7649034|NCT02147834|18836632|P1|STARTED|Overall Study||3
7649035|NCT02147769|18836642|P1|NOT COMPLETED|Overall Study||0
7649036|NCT02147769|18836642|P1|COMPLETED|Overall Study||111
7649037|NCT02147769|18836642|P1|STARTED|Overall Study||111
7649038|NCT02147691|18836649|P2|NOT COMPLETED|Overall Study||1
7649039|NCT02147691|18836650|P1|NOT COMPLETED|Overall Study||4
7649040|NCT02147691|18836649|P2|COMPLETED|Overall Study||11
7649041|NCT02147691|18836650|P1|COMPLETED|Overall Study||6
7649042|NCT02147691|18836649|P2|STARTED|Overall Study||12
7649043|NCT02147691|18836650|P1|STARTED|Overall Study||10
7649044|NCT02147613|18836696|P2|NOT COMPLETED|Overall Study||3
7649045|NCT02147613|18836697|P1|NOT COMPLETED|Overall Study||1
7649046|NCT02147613|18836696|P2|COMPLETED|Overall Study||6
7649047|NCT02147613|18836697|P1|COMPLETED|Overall Study||9
7649048|NCT02147613|18836696|P2|STARTED|Overall Study||9
7649049|NCT02147613|18836697|P1|STARTED|Overall Study||10
7649050|NCT02147587|18836709|P2|NOT COMPLETED|Overall Study||5
7649051|NCT02147587|18836710|P1|NOT COMPLETED|Overall Study||11
7649052|NCT02147587|18836709|P2|COMPLETED|Overall Study||50
7649053|NCT02147587|18836710|P1|COMPLETED|Overall Study||46
7649054|NCT02147587|18836709|P2|STARTED|Overall Study||55
7649055|NCT02147587|18836710|P1|STARTED|Overall Study||57
7649056|NCT02147561|18836730|P1|NOT COMPLETED|Overall Study||4
7649057|NCT02147561|18836730|P1|COMPLETED|Overall Study||276
7649058|NCT02147561|18836730|P1|STARTED|Overall Study||280
7649059|NCT02147522|18836738|P2|NOT COMPLETED|Overall Study||48
7649060|NCT02147522|18836739|P1|NOT COMPLETED|Overall Study||56
7649061|NCT02147522|18836738|P2|COMPLETED|Overall Study||122
7649062|NCT02147522|18836739|P1|COMPLETED|Overall Study||122
7649063|NCT02147522|18836738|P2|STARTED|Overall Study||170
7649064|NCT02147522|18836739|P1|STARTED|Overall Study||178
7649065|NCT02147353|18836751|P2|NOT COMPLETED|Overall Study||0
7649066|NCT02147353|18836752|P1|NOT COMPLETED|Overall Study||9
7649067|NCT02147353|18836751|P2|COMPLETED|Overall Study||21
7649068|NCT02147353|18836752|P1|COMPLETED|Overall Study||12
7649069|NCT02147353|18836751|P2|STARTED|Overall Study||21
7649070|NCT02147353|18836752|P1|STARTED|Overall Study||21
7649071|NCT02147301|18836770|P1|NOT COMPLETED|Overall Study||0
7649072|NCT02147301|18836770|P1|COMPLETED|Overall Study||17
7649073|NCT02147301|18836770|P1|STARTED|Overall Study||17
7649074|NCT02147288|18836785|P10|NOT COMPLETED|Overall Study||0
7649075|NCT02147288|18836786|P9|NOT COMPLETED|Overall Study||0
7649076|NCT02147288|18836787|P8|NOT COMPLETED|Overall Study||0
7649077|NCT02147288|18836788|P7|NOT COMPLETED|Overall Study||0
7649078|NCT02147288|18836789|P6|NOT COMPLETED|Overall Study||0
7649079|NCT02147288|18836790|P5|NOT COMPLETED|Overall Study||0
7649080|NCT02147288|18836791|P4|NOT COMPLETED|Overall Study||0
7649081|NCT02147288|18836792|P3|NOT COMPLETED|Overall Study||0
7649082|NCT02147288|18836793|P2|NOT COMPLETED|Overall Study||2
7649083|NCT02147288|18836794|P1|NOT COMPLETED|Overall Study||1
7649084|NCT02147288|18836785|P10|COMPLETED|Overall Study||0
7649085|NCT02147288|18836786|P9|COMPLETED|Overall Study||0
7649086|NCT02147288|18836787|P8|COMPLETED|Overall Study||0
7649087|NCT02147288|18836788|P7|COMPLETED|Overall Study||0
7649088|NCT02147288|18836789|P6|COMPLETED|Overall Study||0
7649089|NCT02147288|18836790|P5|COMPLETED|Overall Study||0
7649090|NCT02147288|18836791|P4|COMPLETED|Overall Study||0
7649091|NCT02147288|18836792|P3|COMPLETED|Overall Study||0
7649092|NCT02147288|18836793|P2|COMPLETED|Overall Study||22
7649093|NCT02147288|18836794|P1|COMPLETED|Overall Study||21
7649094|NCT02147288|18836785|P10|STARTED|Overall Study||0
7649095|NCT02147288|18836786|P9|STARTED|Overall Study||0
7649096|NCT02147288|18836787|P8|STARTED|Overall Study||0
7649097|NCT02147288|18836788|P7|STARTED|Overall Study||0
7649098|NCT02147288|18836789|P6|STARTED|Overall Study||0
7649099|NCT02147288|18836790|P5|STARTED|Overall Study||0
7649100|NCT02147288|18836791|P4|STARTED|Overall Study||0
7649101|NCT02147288|18836792|P3|STARTED|Overall Study||0
7649102|NCT02147288|18836793|P2|STARTED|Overall Study||24
7649103|NCT02147288|18836794|P1|STARTED|Overall Study||22
7649104|NCT02147197|18836803|P3|NOT COMPLETED|Overall Study||9
7649105|NCT02147197|18836804|P2|NOT COMPLETED|Overall Study||6
7649106|NCT02147197|18836805|P1|NOT COMPLETED|Overall Study||9
7649107|NCT02147197|18836803|P3|COMPLETED|Overall Study||39
7649108|NCT02147197|18836804|P2|COMPLETED|Overall Study||47
7649109|NCT02147197|18836805|P1|COMPLETED|Overall Study||47
7649110|NCT02147197|18836803|P3|STARTED|Overall Study||48
7649111|NCT02147197|18836804|P2|STARTED|Overall Study||53
7649112|NCT02147197|18836805|P1|STARTED|Overall Study||56
7649113|NCT02147184|18836824|P2|NOT COMPLETED|Overall Study||27
7649114|NCT02147184|18836825|P1|NOT COMPLETED|Overall Study||49
7649115|NCT02147184|18836824|P2|COMPLETED|Overall Study||110
7649116|NCT02147184|18836825|P1|COMPLETED|Overall Study||78
7649117|NCT02147184|18836824|P2|STARTED|Overall Study||137
7649118|NCT02147184|18836825|P1|STARTED|Overall Study||127
7649119|NCT02147158|18836849|P6|NOT COMPLETED|Off-Treatment Interval 2||4
7649120|NCT02147158|18836850|P5|NOT COMPLETED|Off-Treatment Interval 2||2
7649121|NCT02147158|18836851|P4|NOT COMPLETED|Off-Treatment Interval 2||11
7649122|NCT02147158|18836852|P3|NOT COMPLETED|Off-Treatment Interval 2||10
7649123|NCT02147158|18836853|P2|NOT COMPLETED|Off-Treatment Interval 2||4
7649124|NCT02147158|18836854|P1|NOT COMPLETED|Off-Treatment Interval 2||4
7649125|NCT02147158|18836849|P6|COMPLETED|Off-Treatment Interval 2||39
7649126|NCT02147158|18836850|P5|COMPLETED|Off-Treatment Interval 2||39
7649127|NCT02147158|18836851|P4|COMPLETED|Off-Treatment Interval 2||66
7649128|NCT02147158|18836852|P3|COMPLETED|Off-Treatment Interval 2||69
7649129|NCT02147158|18836853|P2|COMPLETED|Off-Treatment Interval 2||25
7649130|NCT02147158|18836854|P1|COMPLETED|Off-Treatment Interval 2||36
7649131|NCT02147158|18836849|P6|STARTED|Off-Treatment Interval 2||43
7649132|NCT02147158|18836850|P5|STARTED|Off-Treatment Interval 2||41
7649133|NCT02147158|18836851|P4|STARTED|Off-Treatment Interval 2||77
7649134|NCT02147158|18836852|P3|STARTED|Off-Treatment Interval 2||79
7649135|NCT02147158|18836853|P2|STARTED|Off-Treatment Interval 2||29
7649136|NCT02147158|18836854|P1|STARTED|Off-Treatment Interval 2||40
7649137|NCT02147158|18836849|P6|NOT COMPLETED|Treatment Course 2||2
7649138|NCT02147158|18836850|P5|NOT COMPLETED|Treatment Course 2||0
7649139|NCT02147158|18836851|P4|NOT COMPLETED|Treatment Course 2||5
7649140|NCT02147158|18836852|P3|NOT COMPLETED|Treatment Course 2||5
7649141|NCT02147158|18836853|P2|NOT COMPLETED|Treatment Course 2||5
7649142|NCT02147158|18836854|P1|NOT COMPLETED|Treatment Course 2||1
7649143|NCT02147158|18836849|P6|COMPLETED|Treatment Course 2||43
7649144|NCT02147158|18836850|P5|COMPLETED|Treatment Course 2||41
7649145|NCT02147158|18836851|P4|COMPLETED|Treatment Course 2||77
7649146|NCT02147158|18836852|P3|COMPLETED|Treatment Course 2||79
7649147|NCT02147158|18836853|P2|COMPLETED|Treatment Course 2||29
7649148|NCT02147158|18836854|P1|COMPLETED|Treatment Course 2||40
7649149|NCT02147158|18836849|P6|STARTED|Treatment Course 2||45
7649150|NCT02147158|18836850|P5|STARTED|Treatment Course 2||41
7649151|NCT02147158|18836851|P4|STARTED|Treatment Course 2||82
7649152|NCT02147158|18836852|P3|STARTED|Treatment Course 2||84
7649153|NCT02147158|18836853|P2|STARTED|Treatment Course 2||34
7649154|NCT02147158|18836854|P1|STARTED|Treatment Course 2||41
7649155|NCT02147158|18836849|P6|NOT COMPLETED|Off-Treatment Interval 1||5
7649156|NCT02147158|18836850|P5|NOT COMPLETED|Off-Treatment Interval 1||8
7649157|NCT02147158|18836851|P4|NOT COMPLETED|Off-Treatment Interval 1||15
7649158|NCT02147158|18836852|P3|NOT COMPLETED|Off-Treatment Interval 1||15
7649159|NCT02147158|18836853|P2|NOT COMPLETED|Off-Treatment Interval 1||4
7649160|NCT02147158|18836854|P1|NOT COMPLETED|Off-Treatment Interval 1||10
7649161|NCT02147158|18836849|P6|COMPLETED|Off-Treatment Interval 1||45
7649162|NCT02147158|18836850|P5|COMPLETED|Off-Treatment Interval 1||41
7649163|NCT02147158|18836851|P4|COMPLETED|Off-Treatment Interval 1||82
7649164|NCT02147158|18836852|P3|COMPLETED|Off-Treatment Interval 1||84
7649165|NCT02147158|18836853|P2|COMPLETED|Off-Treatment Interval 1||34
7649166|NCT02147158|18836854|P1|COMPLETED|Off-Treatment Interval 1||41
7649167|NCT02147158|18836849|P6|STARTED|Off-Treatment Interval 1||50
7649168|NCT02147158|18836850|P5|STARTED|Off-Treatment Interval 1||49
7649169|NCT02147158|18836851|P4|STARTED|Off-Treatment Interval 1||97
7649170|NCT02147158|18836852|P3|STARTED|Off-Treatment Interval 1||99
7649171|NCT02147158|18836853|P2|STARTED|Off-Treatment Interval 1||38
7649172|NCT02147158|18836854|P1|STARTED|Off-Treatment Interval 1||51
7649173|NCT02147158|18836849|P6|NOT COMPLETED|Treatment Course 1||8
7649174|NCT02147158|18836850|P5|NOT COMPLETED|Treatment Course 1||6
7649175|NCT02147158|18836851|P4|NOT COMPLETED|Treatment Course 1||13
7649176|NCT02147158|18836852|P3|NOT COMPLETED|Treatment Course 1||8
7649177|NCT02147158|18836853|P2|NOT COMPLETED|Treatment Course 1||9
7649178|NCT02147158|18836854|P1|NOT COMPLETED|Treatment Course 1||4
7649179|NCT02147158|18836849|P6|COMPLETED|Treatment Course 1||50
7649180|NCT02147158|18836850|P5|COMPLETED|Treatment Course 1||49
7649181|NCT02147158|18836851|P4|COMPLETED|Treatment Course 1||97
7649182|NCT02147158|18836852|P3|COMPLETED|Treatment Course 1||99
7649183|NCT02147158|18836853|P2|COMPLETED|Treatment Course 1||38
7649184|NCT02147158|18836854|P1|COMPLETED|Treatment Course 1||51
7649185|NCT02147158|18836849|P6|STARTED|Treatment Course 1||58
7649186|NCT02147158|18836850|P5|STARTED|Treatment Course 1||55
7649187|NCT02147158|18836851|P4|STARTED|Treatment Course 1||110
7649188|NCT02147158|18836852|P3|STARTED|Treatment Course 1||107
7649189|NCT02147158|18836853|P2|STARTED|Treatment Course 1||47
7649190|NCT02147158|18836854|P1|STARTED|Treatment Course 1||55
7649191|NCT02147132|18836883|P4|NOT COMPLETED|Overall Study||0
7649192|NCT02147132|18836884|P3|NOT COMPLETED|Overall Study||0
7649193|NCT02147132|18836885|P2|NOT COMPLETED|Overall Study||0
7649194|NCT02147132|18836886|P1|NOT COMPLETED|Overall Study||1
7649195|NCT02147132|18836883|P4|COMPLETED|Overall Study||2
7649196|NCT02147132|18836884|P3|COMPLETED|Overall Study||1
7649197|NCT02147132|18836885|P2|COMPLETED|Overall Study||2
7649198|NCT02147132|18836886|P1|COMPLETED|Overall Study||1
7649199|NCT02147132|18836883|P4|STARTED|Overall Study||2
7649200|NCT02147132|18836884|P3|STARTED|Overall Study||1
7649201|NCT02147132|18836885|P2|STARTED|Overall Study||2
7649202|NCT02147132|18836886|P1|STARTED|Overall Study||2
7649203|NCT02147093|18836906|P2|NOT COMPLETED|Period 2||0
7649204|NCT02147093|18836907|P1|NOT COMPLETED|Period 2||2
7649205|NCT02147093|18836906|P2|COMPLETED|Period 2||19
7649206|NCT02147093|18836907|P1|COMPLETED|Period 2||18
7649207|NCT02147093|18836906|P2|STARTED|Period 2||19
7649208|NCT02147093|18836907|P1|STARTED|Period 2||20
7649209|NCT02147093|18836906|P2|NOT COMPLETED|Period 1||1
7649210|NCT02147093|18836907|P1|NOT COMPLETED|Period 1||0
7649211|NCT02147093|18836906|P2|COMPLETED|Period 1||19
7649212|NCT02147093|18836907|P1|COMPLETED|Period 1||20
7649213|NCT02147093|18836906|P2|STARTED|Period 1||20
7649214|NCT02147093|18836907|P1|STARTED|Period 1||20
7649215|NCT02147067|18836917|P2|NOT COMPLETED|Overall Study||2
7649216|NCT02147067|18836918|P1|NOT COMPLETED|Overall Study||2
7649217|NCT02147067|18836917|P2|COMPLETED|Overall Study||11
7649218|NCT02147067|18836918|P1|COMPLETED|Overall Study||11
7649219|NCT02147067|18836917|P2|STARTED|Overall Study||13
7649220|NCT02147067|18836918|P1|STARTED|Overall Study||13
7649221|NCT02146599|18836944|P1|NOT COMPLETED|Overall Study||5
7649222|NCT02146599|18836944|P1|COMPLETED|Overall Study||296
7649223|NCT02146599|18836944|P1|STARTED|Overall Study||301
7649224|NCT02146482|18836950|P2|NOT COMPLETED|Overall Study||0
7649225|NCT02146482|18836951|P1|NOT COMPLETED|Overall Study||0
7649226|NCT02146482|18836950|P2|COMPLETED|Overall Study||25
7649227|NCT02146482|18836951|P1|COMPLETED|Overall Study||21
7649228|NCT02146482|18836950|P2|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25
7649229|NCT02146482|18836951|P1|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21
7649230|NCT02146430|18836961|P4|NOT COMPLETED|Overall Study||99
7649231|NCT02146430|18836962|P3|NOT COMPLETED|Overall Study||82
7649232|NCT02146430|18836963|P2|NOT COMPLETED|Overall Study||87
7649233|NCT02146430|18836964|P1|NOT COMPLETED|Overall Study||67
7649234|NCT02146430|18836961|P4|COMPLETED|Overall Study||224
7649235|NCT02146430|18836962|P3|COMPLETED|Overall Study||242
7649236|NCT02146430|18836963|P2|COMPLETED|Overall Study||236
7649237|NCT02146430|18836964|P1|COMPLETED|Overall Study||256
7649238|NCT02146430|18836961|P4|Modified Intent to Treat Set (mITT)|Overall Study||319
7649239|NCT02146430|18836962|P3|Modified Intent to Treat Set (mITT)|Overall Study||319
7649240|NCT02146430|18836963|P2|Modified Intent to Treat Set (mITT)|Overall Study||317
7649241|NCT02146430|18836964|P1|Modified Intent to Treat Set (mITT)|Overall Study||318
7649242|NCT02146430|18836961|P4|Safety Analysis Set|Overall Study||320
7649243|NCT02146430|18836962|P3|Safety Analysis Set|Overall Study||320
7649244|NCT02146430|18836963|P2|Safety Analysis Set|Overall Study||318
7649245|NCT02146430|18836964|P1|Safety Analysis Set|Overall Study||318
7649246|NCT02146430|18836961|P4|STARTED|Overall Study||323
7649247|NCT02146430|18836962|P3|STARTED|Overall Study||324
7649248|NCT02146430|18836963|P2|STARTED|Overall Study||323
7649249|NCT02146430|18836964|P1|STARTED|Overall Study||323
7649250|NCT02146365|18837024|P8|NOT COMPLETED|Overall Study||1
7649251|NCT02146365|18837025|P7|NOT COMPLETED|Overall Study||0
7649252|NCT02146365|18837026|P6|NOT COMPLETED|Overall Study||1
7649253|NCT02146365|18837027|P5|NOT COMPLETED|Overall Study||2
7649254|NCT02146365|18837028|P4|NOT COMPLETED|Overall Study||9
7649255|NCT02146365|18837029|P3|NOT COMPLETED|Overall Study||7
7649256|NCT02146365|18837030|P2|NOT COMPLETED|Overall Study||4
7649257|NCT02146365|18837031|P1|NOT COMPLETED|Overall Study||4
7649258|NCT02146365|18837024|P8|COMPLETED|Overall Study||24
7649259|NCT02146365|18837025|P7|COMPLETED|Overall Study||25
7649260|NCT02146365|18837026|P6|COMPLETED|Overall Study||24
7649261|NCT02146365|18837027|P5|COMPLETED|Overall Study||22
7649262|NCT02146365|18837028|P4|COMPLETED|Overall Study||41
7649263|NCT02146365|18837029|P3|COMPLETED|Overall Study||43
7649264|NCT02146365|18837030|P2|COMPLETED|Overall Study||45
7649265|NCT02146365|18837031|P1|COMPLETED|Overall Study||45
7649266|NCT02146365|18837024|P8|STARTED|Overall Study||25
7649267|NCT02146365|18837025|P7|STARTED|Overall Study||25
7649268|NCT02146365|18837026|P6|STARTED|Overall Study||25
7649269|NCT02146365|18837027|P5|STARTED|Overall Study||24
7649270|NCT02146365|18837028|P4|STARTED|Overall Study||50
7649271|NCT02146365|18837029|P3|STARTED|Overall Study||50
7649272|NCT02146365|18837030|P2|STARTED|Overall Study||49
7649273|NCT02146365|18837031|P1|STARTED|Overall Study||49
7649274|NCT02146352|18837157|P1|NOT COMPLETED|Overall Study||2
7649275|NCT02146352|18837157|P1|COMPLETED|Overall Study||28
7649276|NCT02146352|18837157|P1|7 Days Post-stent Removal|Overall Study||28
7649277|NCT02146352|18837157|P1|30 or 60 Days Post-procedure|Overall Study||30
7649278|NCT02146352|18837157|P1|STARTED|Overall Study||30
7649279|NCT02146326|18837175|P4|NOT COMPLETED|Overall Study||48
7649280|NCT02146326|18837176|P3|NOT COMPLETED|Overall Study||43
7649281|NCT02146326|18837177|P2|NOT COMPLETED|Overall Study||37
7649282|NCT02146326|18837178|P1|NOT COMPLETED|Overall Study||28
7649283|NCT02146326|18837175|P4|COMPLETED|Overall Study||210
7649284|NCT02146326|18837176|P3|COMPLETED|Overall Study||168
7649285|NCT02146326|18837177|P2|COMPLETED|Overall Study||66
7649286|NCT02146326|18837178|P1|COMPLETED|Overall Study||61
7649287|NCT02146326|18837175|P4|12 Months|Overall Study||210
7649288|NCT02146326|18837176|P3|12 Months|Overall Study||168
7649289|NCT02146326|18837177|P2|12 Months|Overall Study||66
7649290|NCT02146326|18837178|P1|12 Months|Overall Study||61
7649291|NCT02146326|18837175|P4|6 Months|Overall Study||235
7649292|NCT02146326|18837176|P3|6 Months|Overall Study||186
7649293|NCT02146326|18837177|P2|6 Months|Overall Study||71
7649294|NCT02146326|18837178|P1|6 Months|Overall Study||71
7649295|NCT02146326|18837175|P4|3 Months|Overall Study||0
7649296|NCT02146326|18837176|P3|3 Months|Overall Study||0
7649297|NCT02146326|18837177|P2|3 Months|Overall Study||83
7649298|NCT02146326|18837178|P1|3 Months|Overall Study||71
7649299|NCT02146326|18837175|P4|Baseline|Overall Study||258
7649300|NCT02146326|18837176|P3|Baseline|Overall Study||211
7649301|NCT02146326|18837177|P2|Baseline|Overall Study||103
7649302|NCT02146326|18837178|P1|Baseline|Overall Study||89
7649303|NCT02146326|18837175|P4|STARTED|Overall Study||258
7649304|NCT02146326|18837176|P3|STARTED|Overall Study||211
7649305|NCT02146326|18837177|P2|STARTED|Overall Study||103
7649306|NCT02146326|18837178|P1|STARTED|Overall Study||89
7649307|NCT02146274|18837340|P1|NOT COMPLETED|Overall Study||73
7649308|NCT02146274|18837340|P1|COMPLETED|Overall Study||1804
7649309|NCT02146274|18837340|P1|STARTED|Overall Study||1877
7649310|NCT02146248|18837347|P1|NOT COMPLETED|Overall Study||2
7649311|NCT02146248|18837347|P1|COMPLETED|Overall Study||9
7649312|NCT02146248|18837347|P1|HSG 5|Overall Study||1
7649313|NCT02146248|18837347|P1|HSG 4|Overall Study||7
7649314|NCT02146248|18837347|P1|HSG 3|Overall Study||9
7649315|NCT02146248|18837347|P1|HSG 2|Overall Study||10
7649316|NCT02146248|18837347|P1|HSG 1|Overall Study||10
7649317|NCT02146248|18837347|P1|Uterine Sounding|Overall Study|one subject dropped out after uterine sound before HSG #1|11
7649318|NCT02146248|18837347|P1|Enrolled|Overall Study||11
7649319|NCT02146248|18837347|P1|STARTED|Overall Study||11
7649320|NCT02146131|18837357|P2|NOT COMPLETED|Overall Study||56
7649321|NCT02146131|18837358|P1|NOT COMPLETED|Overall Study||61
7649322|NCT02146131|18837357|P2|COMPLETED|Overall Study||113
7649323|NCT02146131|18837358|P1|COMPLETED|Overall Study||109
7649324|NCT02146131|18837357|P2|STARTED|Overall Study||169
7649325|NCT02146131|18837358|P1|STARTED|Overall Study||170
7649326|NCT02146105|18837364|P1|NOT COMPLETED|Overall Study||6
7649327|NCT02146105|18837364|P1|COMPLETED|Overall Study||39
7649328|NCT02146105|18837364|P1|STARTED|Overall Study||45
7649329|NCT02146001|18837370|P2|NOT COMPLETED|Overall Study||0
7649330|NCT02146001|18837371|P1|NOT COMPLETED|Overall Study||0
7649331|NCT02146001|18837370|P2|COMPLETED|Overall Study||19
7649332|NCT02146001|18837371|P1|COMPLETED|Overall Study||19
7649333|NCT02146001|18837370|P2|STARTED|Overall Study||19
7649334|NCT02146001|18837371|P1|STARTED|Overall Study||19
7649335|NCT02145754|18837381|P1|NOT COMPLETED|Overall Study||0
7649336|NCT02145754|18837381|P1|COMPLETED|Overall Study||235
7649337|NCT02145754|18837381|P1|STARTED|Overall Study||235
7649338|NCT02145676|18837388|P3|NOT COMPLETED|Overall Study||0
7649339|NCT02145676|18837389|P2|NOT COMPLETED|Overall Study||0
7649340|NCT02145676|18837390|P1|NOT COMPLETED|Overall Study||0
7649341|NCT02145676|18837388|P3|COMPLETED|Overall Study||18
7649342|NCT02145676|18837389|P2|COMPLETED|Overall Study||18
7649343|NCT02145676|18837390|P1|COMPLETED|Overall Study||17
7649344|NCT02145676|18837388|P3|STARTED|Overall Study||18
7649345|NCT02145676|18837389|P2|STARTED|Overall Study||18
7649346|NCT02145676|18837390|P1|STARTED|Overall Study||17
7649347|NCT02145468|18837415|P2|NOT COMPLETED|Overall Study||8
7649348|NCT02145468|18837416|P1|NOT COMPLETED|Overall Study||5
7649349|NCT02145468|18837415|P2|COMPLETED|Overall Study||1723
7649350|NCT02145468|18837416|P1|COMPLETED|Overall Study||1753
7649351|NCT02145468|18837415|P2|STARTED|Overall Study||1731
7649352|NCT02145468|18837416|P1|STARTED|Overall Study||1758
7649353|NCT02145429|18837474|P2|NOT COMPLETED|Overall Study||11
7649354|NCT02145429|18837475|P1|NOT COMPLETED|Overall Study||16
7649355|NCT02145429|18837474|P2|COMPLETED|Overall Study||79
7649356|NCT02145429|18837475|P1|COMPLETED|Overall Study||75
7649357|NCT02145429|18837474|P2|STARTED|Overall Study||90
7649358|NCT02145429|18837475|P1|STARTED|Overall Study||91
7649359|NCT02145403|18837489|P4|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
7649360|NCT02145403|18837490|P3|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||1
7649361|NCT02145403|18837491|P2|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
7649362|NCT02145403|18837492|P1|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
7649363|NCT02145403|18837489|P4|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
7649364|NCT02145403|18837490|P3|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||36
7649365|NCT02145403|18837491|P2|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
7649366|NCT02145403|18837492|P1|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
7649367|NCT02145403|18837489|P4|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
7649368|NCT02145403|18837490|P3|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||37
7649369|NCT02145403|18837491|P2|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
7649370|NCT02145403|18837492|P1|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
7649371|NCT02145403|18837489|P4|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
7649372|NCT02145403|18837490|P3|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
7649373|NCT02145403|18837491|P2|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
7649374|NCT02145403|18837492|P1|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
7649375|NCT02145403|18837489|P4|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
7649376|NCT02145403|18837490|P3|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
7649377|NCT02145403|18837491|P2|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
7649378|NCT02145403|18837492|P1|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
7649379|NCT02145403|18837489|P4|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||4
7649380|NCT02145403|18837490|P3|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
7649381|NCT02145403|18837491|P2|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
7649382|NCT02145403|18837492|P1|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
7649383|NCT02145403|18837489|P4|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
7649384|NCT02145403|18837490|P3|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||1
7649385|NCT02145403|18837491|P2|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
7649386|NCT02145403|18837492|P1|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
7649387|NCT02145403|18837489|P4|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
7649388|NCT02145403|18837490|P3|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||3
7649389|NCT02145403|18837491|P2|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
7649390|NCT02145403|18837492|P1|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
7649391|NCT02145403|18837489|P4|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
7649392|NCT02145403|18837490|P3|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||4
7649393|NCT02145403|18837491|P2|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
7649394|NCT02145403|18837492|P1|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
7649395|NCT02145403|18837489|P4|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
7649396|NCT02145403|18837490|P3|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
7649397|NCT02145403|18837491|P2|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
7649398|NCT02145403|18837492|P1|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
7649399|NCT02145403|18837489|P4|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
7649400|NCT02145403|18837490|P3|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
7649401|NCT02145403|18837491|P2|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
7649402|NCT02145403|18837492|P1|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
7649403|NCT02145403|18837489|P4|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
7649404|NCT02145403|18837490|P3|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
7649405|NCT02145403|18837491|P2|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
7649406|NCT02145403|18837492|P1|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
7649407|NCT02145403|18837489|P4|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
7649408|NCT02145403|18837490|P3|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
7649409|NCT02145403|18837491|P2|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
7649410|NCT02145403|18837492|P1|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
7649411|NCT02145403|18837489|P4|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
7649412|NCT02145403|18837490|P3|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
7649413|NCT02145403|18837491|P2|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
7649414|NCT02145403|18837492|P1|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
7649415|NCT02145403|18837489|P4|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
7649416|NCT02145403|18837490|P3|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
7649417|NCT02145403|18837491|P2|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
7649418|NCT02145403|18837492|P1|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
7649419|NCT02145390|18837506|P1|NOT COMPLETED|Overall Study||1
7649420|NCT02145390|18837506|P1|COMPLETED|Overall Study||0
7649421|NCT02145390|18837506|P1|STARTED|Overall Study||1
7649422|NCT02145299|18837517|P2|NOT COMPLETED|Overall Study||0
7649423|NCT02145299|18837518|P1|NOT COMPLETED|Overall Study||0
7649424|NCT02145299|18837517|P2|COMPLETED|Overall Study||2
7649425|NCT02145299|18837518|P1|COMPLETED|Overall Study||6
7649426|NCT02145299|18837517|P2|STARTED|Overall Study||2
7649427|NCT02145299|18837518|P1|STARTED|Overall Study||6
7649428|NCT02145247|18837546|P2|NOT COMPLETED|Overall Study||0
7649429|NCT02145247|18837547|P1|NOT COMPLETED|Overall Study||0
7649430|NCT02145247|18837546|P2|COMPLETED|Overall Study||19
7649431|NCT02145247|18837547|P1|COMPLETED|Overall Study||20
7649432|NCT02145247|18837546|P2|STARTED|Overall Study||19
7649433|NCT02145247|18837547|P1|STARTED|Overall Study||20
7649434|NCT02145182|18837555|P2|NOT COMPLETED|Overall Study||16
7649435|NCT02145182|18837556|P1|NOT COMPLETED|Overall Study||18
7649436|NCT02145182|18837555|P2|COMPLETED|Overall Study||130
7649437|NCT02145182|18837556|P1|COMPLETED|Overall Study||124
7649438|NCT02145182|18837555|P2|Received at Least 1 Dose of Study Drug|Overall Study||146
7649439|NCT02145182|18837556|P1|Received at Least 1 Dose of Study Drug|Overall Study||142
7649440|NCT02145182|18837555|P2|STARTED|Overall Study||146
7649441|NCT02145182|18837556|P1|STARTED|Overall Study||142
7649442|NCT02145169|18837570|P1|NOT COMPLETED|Overall Study||0
7649443|NCT02145169|18837570|P1|COMPLETED|Overall Study||0
7649444|NCT02145169|18837570|P1|STARTED|Overall Study||0
7649445|NCT02145156|18837589|P3|NOT COMPLETED|Overall Study||41
7649446|NCT02145156|18837590|P2|NOT COMPLETED|Overall Study||52
7649447|NCT02145156|18837591|P1|NOT COMPLETED|Overall Study||60
7649448|NCT02145156|18837589|P3|COMPLETED|Overall Study||398
7649449|NCT02145156|18837590|P2|COMPLETED|Overall Study||373
7649450|NCT02145156|18837591|P1|COMPLETED|Overall Study||370
7649451|NCT02145156|18837589|P3|STARTED|Overall Study||439
7649452|NCT02145156|18837590|P2|STARTED|Overall Study||425
7649453|NCT02145156|18837591|P1|STARTED|Overall Study||430
7649454|NCT02145078|18837632|P1|NOT COMPLETED|Overall Study||4
7649455|NCT02145078|18837632|P1|COMPLETED|Overall Study||0
7649456|NCT02145078|18837632|P1|STARTED|Overall Study||4
7649457|NCT02145039|18837640|P1|NOT COMPLETED|Overall Study||0
7649458|NCT02145039|18837640|P1|COMPLETED|Overall Study||2
7649459|NCT02145039|18837640|P1|STARTED|Overall Study||2
7649460|NCT02145026|18837649|P1|NOT COMPLETED|Overall Study||12
7649461|NCT02145026|18837649|P1|COMPLETED|Overall Study||88
7649462|NCT02145026|18837649|P1|STARTED|Overall Study||100
7649463|NCT02144714|18837659|P3|NOT COMPLETED|Overall Study||0
7649464|NCT02144714|18837660|P2|NOT COMPLETED|Overall Study||0
7649465|NCT02144714|18837661|P1|NOT COMPLETED|Overall Study||0
7649466|NCT02144714|18837659|P3|COMPLETED|Overall Study||63
7649467|NCT02144714|18837660|P2|COMPLETED|Overall Study||63
7649468|NCT02144714|18837661|P1|COMPLETED|Overall Study||63
7649469|NCT02144714|18837659|P3|STARTED|Overall Study||63
7649470|NCT02144714|18837660|P2|STARTED|Overall Study||63
7649471|NCT02144714|18837661|P1|STARTED|Overall Study||63
7649472|NCT02144701|18837680|P2|NOT COMPLETED|Overall Study||3
7649473|NCT02144701|18837681|P1|NOT COMPLETED|Overall Study||9
7649474|NCT02144701|18837680|P2|COMPLETED|Overall Study||8
7649475|NCT02144701|18837681|P1|COMPLETED|Overall Study||13
7649476|NCT02144701|18837680|P2|STARTED|Overall Study||11
7649477|NCT02144701|18837681|P1|STARTED|Overall Study||22
7649478|NCT02144675|18837699|P2|NOT COMPLETED|Overall Study||0
7649479|NCT02144675|18837700|P1|NOT COMPLETED|Overall Study||0
7649480|NCT02144675|18837699|P2|COMPLETED|Overall Study||14
7649481|NCT02144675|18837700|P1|COMPLETED|Overall Study||13
7649482|NCT02144675|18837699|P2|STARTED|Overall Study||14
7649483|NCT02144675|18837700|P1|STARTED|Overall Study||13
7649484|NCT02144610|18837708|P2|NOT COMPLETED|Overall Study||22
7649485|NCT02144610|18837709|P1|NOT COMPLETED|Overall Study||23
7649486|NCT02144610|18837708|P2|COMPLETED|Overall Study||1
7649487|NCT02144610|18837709|P1|COMPLETED|Overall Study||0
7649488|NCT02144610|18837708|P2|STARTED|Overall Study||23
7649489|NCT02144610|18837709|P1|STARTED|Overall Study||23
7649490|NCT02144519|18837739|P2|NOT COMPLETED|Year 3||0
7649491|NCT02144519|18837740|P1|NOT COMPLETED|Year 3||0
7649492|NCT02144519|18837739|P2|COMPLETED|Year 3||760
7649493|NCT02144519|18837740|P1|COMPLETED|Year 3||894
7649494|NCT02144519|18837739|P2|STARTED|Year 3||760
7649495|NCT02144519|18837740|P1|STARTED|Year 3||894
7649496|NCT02144519|18837739|P2|NOT COMPLETED|Year 2||0
7649497|NCT02144519|18837740|P1|NOT COMPLETED|Year 2||0
7649498|NCT02144519|18837739|P2|COMPLETED|Year 2||864
7649499|NCT02144519|18837740|P1|COMPLETED|Year 2||763
7649500|NCT02144519|18837739|P2|STARTED|Year 2||864
7649501|NCT02144519|18837740|P1|STARTED|Year 2||763
7649502|NCT02144519|18837739|P2|NOT COMPLETED|Year 1||0
7649503|NCT02144519|18837740|P1|NOT COMPLETED|Year 1||0
7649504|NCT02144519|18837739|P2|COMPLETED|Year 1||870
7649505|NCT02144519|18837740|P1|COMPLETED|Year 1||895
7649506|NCT02144519|18837739|P2|STARTED|Year 1||870
7649507|NCT02144519|18837740|P1|STARTED|Year 1||895
7649508|NCT02144337|18837750|P2|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0
7649509|NCT02144337|18837751|P1|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3
7649510|NCT02144337|18837750|P2|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
7649511|NCT02144337|18837751|P1|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
7649512|NCT02144337|18837750|P2|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5
7649513|NCT02144337|18837751|P1|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8
7649514|NCT02144337|18837750|P2|NOT COMPLETED|T2 Follow-up (Post-intervention)||1
7649515|NCT02144337|18837751|P1|NOT COMPLETED|T2 Follow-up (Post-intervention)||4
7649516|NCT02144337|18837750|P2|COMPLETED|T2 Follow-up (Post-intervention)||4
7649517|NCT02144337|18837751|P1|COMPLETED|T2 Follow-up (Post-intervention)||4
7649518|NCT02144337|18837750|P2|STARTED|T2 Follow-up (Post-intervention)||5
7649519|NCT02144337|18837751|P1|STARTED|T2 Follow-up (Post-intervention)||8
7649520|NCT02144337|18837750|P2|NOT COMPLETED|Baseline 0 Months||0
7649521|NCT02144337|18837751|P1|NOT COMPLETED|Baseline 0 Months||0
7649522|NCT02144337|18837750|P2|COMPLETED|Baseline 0 Months||5
7649523|NCT02144337|18837751|P1|COMPLETED|Baseline 0 Months||8
7649524|NCT02144337|18837750|P2|STARTED|Baseline 0 Months||5
7649525|NCT02144337|18837751|P1|STARTED|Baseline 0 Months||8
7649526|NCT02144285|18837771|P10|NOT COMPLETED|Overall Study||0
7649527|NCT02144285|18837772|P9|NOT COMPLETED|Overall Study||0
7649528|NCT02144285|18837773|P8|NOT COMPLETED|Overall Study||0
7649529|NCT02144285|18837774|P7|NOT COMPLETED|Overall Study||0
7649530|NCT02144285|18837775|P6|NOT COMPLETED|Overall Study||0
7649531|NCT02144285|18837776|P5|NOT COMPLETED|Overall Study||1
7649532|NCT02144285|18837777|P4|NOT COMPLETED|Overall Study||0
7649533|NCT02144285|18837778|P3|NOT COMPLETED|Overall Study||0
7649534|NCT02144285|18837779|P2|NOT COMPLETED|Overall Study||0
7649535|NCT02144285|18837780|P1|NOT COMPLETED|Overall Study||0
7649536|NCT02144285|18837771|P10|COMPLETED|Overall Study||6
7649537|NCT02144285|18837772|P9|COMPLETED|Overall Study||2
7649538|NCT02144285|18837773|P8|COMPLETED|Overall Study||6
7649539|NCT02144285|18837774|P7|COMPLETED|Overall Study||6
7649540|NCT02144285|18837775|P6|COMPLETED|Overall Study||6
7649541|NCT02144285|18837776|P5|COMPLETED|Overall Study||5
7649542|NCT02144285|18837777|P4|COMPLETED|Overall Study||6
7649543|NCT02144285|18837778|P3|COMPLETED|Overall Study||6
7649544|NCT02144285|18837779|P2|COMPLETED|Overall Study||6
7649545|NCT02144285|18837780|P1|COMPLETED|Overall Study||14
7649546|NCT02144285|18837771|P10|Received At Least One Dose of Study Drug|Overall Study||6
7649547|NCT02144285|18837772|P9|Received At Least One Dose of Study Drug|Overall Study||2
7649548|NCT02144285|18837773|P8|Received At Least One Dose of Study Drug|Overall Study||6
7649549|NCT02144285|18837774|P7|Received At Least One Dose of Study Drug|Overall Study||6
7649550|NCT02144285|18837775|P6|Received At Least One Dose of Study Drug|Overall Study||6
7649551|NCT02144285|18837776|P5|Received At Least One Dose of Study Drug|Overall Study||6
7649552|NCT02144285|18837777|P4|Received At Least One Dose of Study Drug|Overall Study||6
7649553|NCT02144285|18837778|P3|Received At Least One Dose of Study Drug|Overall Study||6
7649554|NCT02144285|18837779|P2|Received At Least One Dose of Study Drug|Overall Study||6
7649555|NCT02144285|18837780|P1|Received At Least One Dose of Study Drug|Overall Study||14
7649556|NCT02144285|18837771|P10|STARTED|Overall Study||6
7649557|NCT02144285|18837772|P9|STARTED|Overall Study||2
7649558|NCT02144285|18837773|P8|STARTED|Overall Study||6
7649559|NCT02144285|18837774|P7|STARTED|Overall Study||6
7649560|NCT02144285|18837775|P6|STARTED|Overall Study||6
7649561|NCT02144285|18837776|P5|STARTED|Overall Study||6
7649562|NCT02144285|18837777|P4|STARTED|Overall Study||6
7649563|NCT02144285|18837778|P3|STARTED|Overall Study||6
7649564|NCT02144285|18837779|P2|STARTED|Overall Study||6
7649565|NCT02144285|18837780|P1|STARTED|Overall Study||14
7649566|NCT02144259|18837853|P3|NOT COMPLETED|Overall Study||18
7649567|NCT02144259|18837854|P2|NOT COMPLETED|Overall Study||5
7649568|NCT02144259|18837855|P1|NOT COMPLETED|Overall Study||10
7649569|NCT02144259|18837853|P3|COMPLETED|Overall Study||16
7649570|NCT02144259|18837854|P2|COMPLETED|Overall Study||28
7649571|NCT02144259|18837855|P1|COMPLETED|Overall Study||23
7649572|NCT02144259|18837853|P3|STARTED|Overall Study||34
7649573|NCT02144259|18837854|P2|STARTED|Overall Study||33
7649574|NCT02144259|18837855|P1|STARTED|Overall Study||33
7649575|NCT02144233|18837871|P2|NOT COMPLETED|Overall Study||0
7649576|NCT02144233|18837872|P1|NOT COMPLETED|Overall Study||0
7649577|NCT02144233|18837871|P2|COMPLETED|Overall Study||38
7649578|NCT02144233|18837872|P1|COMPLETED|Overall Study|The last participant was assessed at month 3 due to early study stop|39
7649579|NCT02144233|18837871|P2|STARTED|Overall Study||38
7649580|NCT02144233|18837872|P1|STARTED|Overall Study||39
7649581|NCT02144220|18837906|P1|NOT COMPLETED|Overall Study||19
7649582|NCT02144220|18837906|P1|COMPLETED|Overall Study||258
7649583|NCT02144220|18837906|P1|STARTED|Overall Study||277
7649584|NCT02144155|18837914|P1|NOT COMPLETED|Overall Study||0
7649585|NCT02144155|18837914|P1|COMPLETED|Overall Study||14
7649586|NCT02144155|18837914|P1|STARTED|Overall Study||14
7649587|NCT02144077|18837925|P2|NOT COMPLETED|Overall Study||11
7649588|NCT02144077|18837926|P1|NOT COMPLETED|Overall Study||10
7649589|NCT02144077|18837925|P2|COMPLETED|Overall Study||132
7649590|NCT02144077|18837926|P1|COMPLETED|Overall Study||128
7649591|NCT02144077|18837925|P2|STARTED|Overall Study||143
7649592|NCT02144077|18837926|P1|STARTED|Overall Study||138
7649593|NCT02144012|18837944|P2|NOT COMPLETED|Overall Study||15
7649594|NCT02144012|18837945|P1|NOT COMPLETED|Overall Study||34
7649595|NCT02144012|18837944|P2|COMPLETED|Overall Study||0
7649596|NCT02144012|18837945|P1|COMPLETED|Overall Study||0
7649597|NCT02144012|18837944|P2|STARTED|Overall Study||15
7649598|NCT02144012|18837945|P1|STARTED|Overall Study||34
7649599|NCT02143973|18837980|P1|NOT COMPLETED|Overall Study||66
7649600|NCT02143973|18837980|P1|COMPLETED|Overall Study||101
7649601|NCT02143973|18837980|P1|STARTED|Overall Study||167
7649602|NCT02143947|18837986|P2|NOT COMPLETED|Overall Study||2
7649603|NCT02143947|18837987|P1|NOT COMPLETED|Overall Study||4
7649604|NCT02143947|18837986|P2|COMPLETED|Overall Study||42
7649605|NCT02143947|18837987|P1|COMPLETED|Overall Study||32
7649606|NCT02143947|18837986|P2|STARTED|Overall Study||44
7649607|NCT02143947|18837987|P1|STARTED|Overall Study||36
7649608|NCT02143843|18837999|P1|NOT COMPLETED|Overall Study||12
7649609|NCT02143843|18837999|P1|COMPLETED|Overall Study||63
7649610|NCT02143843|18837999|P1|STARTED|Overall Study||75
7649611|NCT02143778|18838004|P1|NOT COMPLETED|Overall Study||3
7649612|NCT02143778|18838004|P1|COMPLETED|Overall Study||243
7649613|NCT02143778|18838004|P1|STARTED|Overall Study||246
7649614|NCT02143713|18838013|P4|NOT COMPLETED|Post-treatment Follow-up (12 Months)||27
7649615|NCT02143713|18838014|P3|NOT COMPLETED|Post-treatment Follow-up (12 Months)||29
7649616|NCT02143713|18838015|P2|NOT COMPLETED|Post-treatment Follow-up (12 Months)||24
7649617|NCT02143713|18838016|P1|NOT COMPLETED|Post-treatment Follow-up (12 Months)||12
7649618|NCT02143713|18838013|P4|COMPLETED|Post-treatment Follow-up (12 Months)||95
7649619|NCT02143713|18838014|P3|COMPLETED|Post-treatment Follow-up (12 Months)||96
7649620|NCT02143713|18838015|P2|COMPLETED|Post-treatment Follow-up (12 Months)||81
7649621|NCT02143713|18838016|P1|COMPLETED|Post-treatment Follow-up (12 Months)||73
7649622|NCT02143713|18838013|P4|STARTED|Post-treatment Follow-up (12 Months)||122
7649623|NCT02143713|18838014|P3|STARTED|Post-treatment Follow-up (12 Months)||125
7649624|NCT02143713|18838015|P2|STARTED|Post-treatment Follow-up (12 Months)||105
7649625|NCT02143713|18838016|P1|STARTED|Post-treatment Follow-up (12 Months)||85
7649626|NCT02143713|18838013|P4|NOT COMPLETED|Treatment Period (6 Months)||28
7649627|NCT02143713|18838014|P3|NOT COMPLETED|Treatment Period (6 Months)||22
7649628|NCT02143713|18838015|P2|NOT COMPLETED|Treatment Period (6 Months)||12
7649629|NCT02143713|18838016|P1|NOT COMPLETED|Treatment Period (6 Months)||20
7649630|NCT02143713|18838013|P4|COMPLETED|Treatment Period (6 Months)||112
7649631|NCT02143713|18838014|P3|COMPLETED|Treatment Period (6 Months)||120
7649632|NCT02143713|18838015|P2|COMPLETED|Treatment Period (6 Months)||99
7649633|NCT02143713|18838016|P1|COMPLETED|Treatment Period (6 Months)||82
7649634|NCT02143713|18838013|P4|Received Elagolix|Treatment Period (6 Months)||140
7649635|NCT02143713|18838014|P3|Received Elagolix|Treatment Period (6 Months)||142
7649636|NCT02143713|18838015|P2|Received Elagolix|Treatment Period (6 Months)||111
7649637|NCT02143713|18838016|P1|Received Elagolix|Treatment Period (6 Months)||102
7649638|NCT02143713|18838013|P4|STARTED|Treatment Period (6 Months)||140
7649639|NCT02143713|18838014|P3|STARTED|Treatment Period (6 Months)||142
7649640|NCT02143713|18838015|P2|STARTED|Treatment Period (6 Months)||111
7649641|NCT02143713|18838016|P1|STARTED|Treatment Period (6 Months)||102
7649642|NCT02143648|18838097|P3|NOT COMPLETED|Overall Study||24
7649643|NCT02143648|18838098|P2|NOT COMPLETED|Overall Study||42
7649644|NCT02143648|18838099|P1|NOT COMPLETED|Overall Study||54
7649645|NCT02143648|18838097|P3|COMPLETED|Overall Study||101
7649646|NCT02143648|18838098|P2|COMPLETED|Overall Study||78
7649647|NCT02143648|18838099|P1|COMPLETED|Overall Study||74
7649648|NCT02143648|18838097|P3|STARTED|Overall Study||125
7649649|NCT02143648|18838098|P2|STARTED|Overall Study||120
7649650|NCT02143648|18838099|P1|STARTED|Overall Study||128
7649651|NCT02143583|18838110|P3|NOT COMPLETED|Overall Study||2
7649652|NCT02143583|18838111|P2|NOT COMPLETED|Overall Study||0
7649653|NCT02143583|18838112|P1|NOT COMPLETED|Overall Study||1
7649654|NCT02143583|18838110|P3|COMPLETED|Overall Study||66
7649655|NCT02143583|18838111|P2|COMPLETED|Overall Study||66
7649656|NCT02143583|18838112|P1|COMPLETED|Overall Study||61
7649657|NCT02143583|18838110|P3|STARTED|Overall Study||68
7649658|NCT02143583|18838111|P2|STARTED|Overall Study||66
7649659|NCT02143583|18838112|P1|STARTED|Overall Study||62
7649660|NCT02143310|18838123|P1|NOT COMPLETED|Overall Study||107
7649661|NCT02143310|18838123|P1|COMPLETED|Overall Study||102
7649662|NCT02143310|18838123|P1|STARTED|Overall Study||209
7649663|NCT02143141|18838135|P2|NOT COMPLETED|Overall Study||0
7649664|NCT02143141|18838136|P1|NOT COMPLETED|Overall Study||1
7649665|NCT02143141|18838135|P2|COMPLETED|Overall Study||6
7649666|NCT02143141|18838136|P1|COMPLETED|Overall Study||6
7649667|NCT02143141|18838135|P2|STARTED|Overall Study||6
7649668|NCT02143141|18838136|P1|STARTED|Overall Study||7
7649669|NCT02143102|18838148|P2|NOT COMPLETED|Overall Study||0
7649670|NCT02143102|18838149|P1|NOT COMPLETED|Overall Study||11
7649671|NCT02143102|18838148|P2|COMPLETED|Overall Study||28
7649672|NCT02143102|18838149|P1|COMPLETED|Overall Study||86
7649673|NCT02143102|18838148|P2|STARTED|Overall Study||28
7649674|NCT02143102|18838149|P1|STARTED|Overall Study||97
7649675|NCT02143024|18838159|P2|NOT COMPLETED|Overall Study||1
7649676|NCT02143024|18838160|P1|NOT COMPLETED|Overall Study||2
7649677|NCT02143024|18838159|P2|COMPLETED|Overall Study||7
7649678|NCT02143024|18838160|P1|COMPLETED|Overall Study||13
7649679|NCT02143024|18838159|P2|Received Treatment|Overall Study||7
7649680|NCT02143024|18838160|P1|Received Treatment|Overall Study||13
7649681|NCT02143024|18838159|P2|STARTED|Overall Study||8
7649682|NCT02143024|18838160|P1|STARTED|Overall Study||15
7649683|NCT02142894|18838166|P1|NOT COMPLETED|Overall Study||8
7649684|NCT02142894|18838166|P1|COMPLETED|Overall Study||25
7649685|NCT02142894|18838166|P1|STARTED|Overall Study||33
7649686|NCT02142738|18838172|P2|NOT COMPLETED|Overall Study||151
7649687|NCT02142738|18838173|P1|NOT COMPLETED|Overall Study||154
7649688|NCT02142738|18838172|P2|COMPLETED|Overall Study||0
7649689|NCT02142738|18838173|P1|COMPLETED|Overall Study||0
7649690|NCT02142738|18838172|P2|Treated|Overall Study||150
7649691|NCT02142738|18838173|P1|Treated|Overall Study||154
7649692|NCT02142738|18838172|P2|STARTED|Overall Study||151
7649693|NCT02142738|18838173|P1|STARTED|Overall Study||154
7649694|NCT02142712|18838186|P4|NOT COMPLETED|Overall Study||0
7649695|NCT02142712|18838187|P3|NOT COMPLETED|Overall Study||1
7649696|NCT02142712|18838188|P2|NOT COMPLETED|Overall Study||1
7649697|NCT02142712|18838189|P1|NOT COMPLETED|Overall Study||1
7649698|NCT02142712|18838186|P4|COMPLETED|Overall Study||0
7649699|NCT02142712|18838187|P3|COMPLETED|Overall Study||0
7649700|NCT02142712|18838188|P2|COMPLETED|Overall Study||0
7649701|NCT02142712|18838189|P1|COMPLETED|Overall Study||0
7649702|NCT02142712|18838186|P4|STARTED|Overall Study||0
7649703|NCT02142712|18838187|P3|STARTED|Overall Study||1
7649704|NCT02142712|18838188|P2|STARTED|Overall Study||1
7649705|NCT02142712|18838189|P1|STARTED|Overall Study||1
7649706|NCT02142608|18838209|P1|NOT COMPLETED|Overall Study||5
7649707|NCT02142608|18838209|P1|COMPLETED|Overall Study||13
7649708|NCT02142608|18838209|P1|STARTED|Overall Study||18
7649709|NCT02142504|18838217|P3|NOT COMPLETED|Overall Study||43
7649710|NCT02142504|18838218|P2|NOT COMPLETED|Overall Study||42
7649711|NCT02142504|18838219|P1|NOT COMPLETED|Overall Study||31
7649712|NCT02142504|18838217|P3|COMPLETED|Overall Study||111
7649713|NCT02142504|18838218|P2|COMPLETED|Overall Study||105
7649714|NCT02142504|18838219|P1|COMPLETED|Overall Study||122
7649715|NCT02142504|18838217|P3|Received Booster (Second Vaccination)|Overall Study||116
7649716|NCT02142504|18838218|P2|Received Booster (Second Vaccination)|Overall Study||109
7649717|NCT02142504|18838219|P1|Received Booster (Second Vaccination)|Overall Study||126
7649718|NCT02142504|18838217|P3|Randomized and Received Treatment|Overall Study||154
7649719|NCT02142504|18838218|P2|Randomized and Received Treatment|Overall Study||145
7649720|NCT02142504|18838219|P1|Randomized and Received Treatment|Overall Study||153
7649721|NCT02142504|18838217|P3|STARTED|Overall Study||154
7649722|NCT02142504|18838218|P2|STARTED|Overall Study||147
7649723|NCT02142504|18838219|P1|STARTED|Overall Study||153
7649724|NCT02142387|18838307|P2|NOT COMPLETED|Overall Study||7630
7649725|NCT02142387|18838308|P1|NOT COMPLETED|Overall Study||1065
7649726|NCT02142387|18838307|P2|COMPLETED|Overall Study||8641
7649727|NCT02142387|18838308|P1|COMPLETED|Overall Study|Limited to the case where OHCA occurred in the private place.|1486
7649728|NCT02142387|18838307|P2|STARTED|Overall Study||16271
7649729|NCT02142387|18838308|P1|STARTED|Overall Study|Out-of-hospital cardiac arrest (OHCA) patients with presumed cardiac etiology.|2551
7649730|NCT02142361|18838318|P3|NOT COMPLETED|Overall Study||0
7649731|NCT02142361|18838319|P2|NOT COMPLETED|Overall Study||0
7649732|NCT02142361|18838320|P1|NOT COMPLETED|Overall Study||0
7649733|NCT02142361|18838318|P3|COMPLETED|Overall Study||20
7649734|NCT02142361|18838319|P2|COMPLETED|Overall Study||20
7649735|NCT02142361|18838320|P1|COMPLETED|Overall Study||20
7649736|NCT02142361|18838318|P3|STARTED|Overall Study||20
7649737|NCT02142361|18838319|P2|STARTED|Overall Study||20
7649738|NCT02142361|18838320|P1|STARTED|Overall Study||20
7649739|NCT02142283|18838421|P2|NOT COMPLETED|Overall Study||21
7649740|NCT02142283|18838422|P1|NOT COMPLETED|Overall Study||21
7649741|NCT02142283|18838421|P2|COMPLETED|Overall Study||78
7649742|NCT02142283|18838422|P1|COMPLETED|Overall Study||86
7649743|NCT02142283|18838421|P2|STARTED|Overall Study||99
7649744|NCT02142283|18838422|P1|STARTED|Overall Study||107
7649745|NCT02142153|18838452|P10|NOT COMPLETED|Overall Study||0
7649746|NCT02142153|18838453|P9|NOT COMPLETED|Overall Study||0
7649747|NCT02142153|18838454|P8|NOT COMPLETED|Overall Study||0
7649748|NCT02142153|18838455|P7|NOT COMPLETED|Overall Study||0
7649749|NCT02142153|18838456|P6|NOT COMPLETED|Overall Study||0
7649750|NCT02142153|18838457|P5|NOT COMPLETED|Overall Study||0
7649751|NCT02142153|18838458|P4|NOT COMPLETED|Overall Study||0
7649752|NCT02142153|18838459|P3|NOT COMPLETED|Overall Study||0
7649753|NCT02142153|18838460|P2|NOT COMPLETED|Overall Study||0
7649754|NCT02142153|18838461|P1|NOT COMPLETED|Overall Study||0
7649755|NCT02142153|18838452|P10|COMPLETED|Overall Study||2
7649756|NCT02142153|18838453|P9|COMPLETED|Overall Study||6
7649757|NCT02142153|18838454|P8|COMPLETED|Overall Study||2
7649758|NCT02142153|18838455|P7|COMPLETED|Overall Study||6
7649759|NCT02142153|18838456|P6|COMPLETED|Overall Study||2
7649760|NCT02142153|18838457|P5|COMPLETED|Overall Study||6
7649761|NCT02142153|18838458|P4|COMPLETED|Overall Study||2
7649762|NCT02142153|18838459|P3|COMPLETED|Overall Study||6
7649763|NCT02142153|18838460|P2|COMPLETED|Overall Study||2
7649764|NCT02142153|18838461|P1|COMPLETED|Overall Study||6
7649765|NCT02142153|18838452|P10|STARTED|Overall Study||2
7649766|NCT02142153|18838453|P9|STARTED|Overall Study||6
7649767|NCT02142153|18838454|P8|STARTED|Overall Study||2
7649768|NCT02142153|18838455|P7|STARTED|Overall Study||6
7649769|NCT02142153|18838456|P6|STARTED|Overall Study||2
7649770|NCT02142153|18838457|P5|STARTED|Overall Study||6
7649771|NCT02142153|18838458|P4|STARTED|Overall Study||2
7649772|NCT02142153|18838459|P3|STARTED|Overall Study||6
7649773|NCT02142153|18838460|P2|STARTED|Overall Study||2
7649774|NCT02142153|18838461|P1|STARTED|Overall Study||6
7649775|NCT02142049|18838498|P5|NOT COMPLETED|Overall Study||0
7649776|NCT02142049|18838499|P4|NOT COMPLETED|Overall Study||0
7649777|NCT02142049|18838500|P3|NOT COMPLETED|Overall Study||0
7649778|NCT02142049|18838501|P2|NOT COMPLETED|Overall Study||0
7649779|NCT02142049|18838502|P1|NOT COMPLETED|Overall Study||0
7649780|NCT02142049|18838498|P5|COMPLETED|Overall Study||20
7649781|NCT02142049|18838499|P4|COMPLETED|Overall Study||6
7649782|NCT02142049|18838500|P3|COMPLETED|Overall Study||3
7649783|NCT02142049|18838501|P2|COMPLETED|Overall Study||3
7649784|NCT02142049|18838502|P1|COMPLETED|Overall Study||3
7649785|NCT02142049|18838498|P5|STARTED|Overall Study||20
7649786|NCT02142049|18838499|P4|STARTED|Overall Study||6
7649787|NCT02142049|18838500|P3|STARTED|Overall Study||3
7649788|NCT02142049|18838501|P2|STARTED|Overall Study||3
7649789|NCT02142049|18838502|P1|STARTED|Overall Study||3
7649790|NCT02141997|18838531|P4|NOT COMPLETED|Overall Study||1
7649791|NCT02141997|18838532|P3|NOT COMPLETED|Overall Study||3
7649792|NCT02141997|18838533|P2|NOT COMPLETED|Overall Study||6
7649793|NCT02141997|18838534|P1|NOT COMPLETED|Overall Study||3
7649794|NCT02141997|18838531|P4|COMPLETED|Overall Study||54
7649795|NCT02141997|18838532|P3|COMPLETED|Overall Study||53
7649796|NCT02141997|18838533|P2|COMPLETED|Overall Study||49
7649797|NCT02141997|18838534|P1|COMPLETED|Overall Study||53
7649798|NCT02141997|18838531|P4|STARTED|Overall Study||55
7649799|NCT02141997|18838532|P3|STARTED|Overall Study||56
7649800|NCT02141997|18838533|P2|STARTED|Overall Study||55
7649801|NCT02141997|18838534|P1|STARTED|Overall Study||56
7649802|NCT02141984|18838572|P1|NOT COMPLETED|Overall Study||2
7649803|NCT02141984|18838572|P1|COMPLETED|Overall Study||26
7649804|NCT02141984|18838572|P1|STARTED|Overall Study||28
7649805|NCT02141867|18838579|P1|NOT COMPLETED|Overall Study||94
7649806|NCT02141867|18838579|P1|COMPLETED|Overall Study||3927
7649807|NCT02141867|18838579|P1|STARTED|Overall Study||4021
7649808|NCT02141854|18838591|P6|NOT COMPLETED|Treatment Period||38
7649809|NCT02141854|18838592|P5|NOT COMPLETED|Treatment Period||10
7649810|NCT02141854|18838593|P4|NOT COMPLETED|Treatment Period||11
7649811|NCT02141854|18838594|P3|NOT COMPLETED|Treatment Period||9
7649812|NCT02141854|18838595|P2|NOT COMPLETED|Treatment Period||10
7649813|NCT02141854|18838596|P1|NOT COMPLETED|Treatment Period||0
7649814|NCT02141854|18838591|P6|COMPLETED|Treatment Period||107
7649815|NCT02141854|18838592|P5|COMPLETED|Treatment Period||136
7649816|NCT02141854|18838593|P4|COMPLETED|Treatment Period||135
7649817|NCT02141854|18838594|P3|COMPLETED|Treatment Period||136
7649818|NCT02141854|18838595|P2|COMPLETED|Treatment Period||136
7649819|NCT02141854|18838596|P1|COMPLETED|Treatment Period||0
7649820|NCT02141854|18838591|P6|Full Analysis Set|Treatment Period||143
7649821|NCT02141854|18838592|P5|Full Analysis Set|Treatment Period||145
7649822|NCT02141854|18838593|P4|Full Analysis Set|Treatment Period||146
7649823|NCT02141854|18838594|P3|Full Analysis Set|Treatment Period||141
7649824|NCT02141854|18838595|P2|Full Analysis Set|Treatment Period||145
7649825|NCT02141854|18838596|P1|Full Analysis Set|Treatment Period||0
7649826|NCT02141854|18838591|P6|Safety Population|Treatment Period||144
7649827|NCT02141854|18838592|P5|Safety Population|Treatment Period||145
7649828|NCT02141854|18838593|P4|Safety Population|Treatment Period||146
7649829|NCT02141854|18838594|P3|Safety Population|Treatment Period||143
7649830|NCT02141854|18838595|P2|Safety Population|Treatment Period||145
7649831|NCT02141854|18838596|P1|Safety Population|Treatment Period||0
7649832|NCT02141854|18838591|P6|Intent to Treat Population|Treatment Period||145
7649833|NCT02141854|18838592|P5|Intent to Treat Population|Treatment Period||146
7649834|NCT02141854|18838593|P4|Intent to Treat Population|Treatment Period||146
7649835|NCT02141854|18838594|P3|Intent to Treat Population|Treatment Period||145
7649836|NCT02141854|18838595|P2|Intent to Treat Population|Treatment Period||146
7649837|NCT02141854|18838596|P1|Intent to Treat Population|Treatment Period||0
7649838|NCT02141854|18838591|P6|STARTED|Treatment Period||145
7649839|NCT02141854|18838592|P5|STARTED|Treatment Period||146
7649840|NCT02141854|18838593|P4|STARTED|Treatment Period||146
7649841|NCT02141854|18838594|P3|STARTED|Treatment Period||145
7649842|NCT02141854|18838595|P2|STARTED|Treatment Period||146
7649843|NCT02141854|18838596|P1|STARTED|Treatment Period||0
7649844|NCT02141854|18838591|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
7649845|NCT02141854|18838592|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
7649846|NCT02141854|18838593|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
7649847|NCT02141854|18838594|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
7649848|NCT02141854|18838595|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
7649849|NCT02141854|18838596|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||154
7649850|NCT02141854|18838591|P6|COMPLETED|Run-In Period (Pre-assignment)||0
7649851|NCT02141854|18838592|P5|COMPLETED|Run-In Period (Pre-assignment)||0
7649852|NCT02141854|18838593|P4|COMPLETED|Run-In Period (Pre-assignment)||0
7649853|NCT02141854|18838594|P3|COMPLETED|Run-In Period (Pre-assignment)||0
7649854|NCT02141854|18838595|P2|COMPLETED|Run-In Period (Pre-assignment)||0
7649855|NCT02141854|18838596|P1|COMPLETED|Run-In Period (Pre-assignment)||728
7649856|NCT02141854|18838591|P6|STARTED|Run-In Period (Pre-assignment)||0
7649857|NCT02141854|18838592|P5|STARTED|Run-In Period (Pre-assignment)||0
7649858|NCT02141854|18838593|P4|STARTED|Run-In Period (Pre-assignment)||0
7649859|NCT02141854|18838594|P3|STARTED|Run-In Period (Pre-assignment)||0
7649860|NCT02141854|18838595|P2|STARTED|Run-In Period (Pre-assignment)||0
7649861|NCT02141854|18838596|P1|STARTED|Run-In Period (Pre-assignment)||882
7649862|NCT02141659|18838654|P6|NOT COMPLETED|Overall Study||2
7649863|NCT02141659|18838655|P5|NOT COMPLETED|Overall Study||2
7649864|NCT02141659|18838656|P4|NOT COMPLETED|Overall Study||0
7649865|NCT02141659|18838657|P3|NOT COMPLETED|Overall Study||0
7649866|NCT02141659|18838658|P2|NOT COMPLETED|Overall Study||1
7649867|NCT02141659|18838659|P1|NOT COMPLETED|Overall Study||0
7649868|NCT02141659|18838654|P6|COMPLETED|Overall Study||13
7649869|NCT02141659|18838655|P5|COMPLETED|Overall Study||13
7649870|NCT02141659|18838656|P4|COMPLETED|Overall Study||3
7649871|NCT02141659|18838657|P3|COMPLETED|Overall Study||3
7649872|NCT02141659|18838658|P2|COMPLETED|Overall Study||3
7649873|NCT02141659|18838659|P1|COMPLETED|Overall Study||3
7649874|NCT02141659|18838654|P6|STARTED|Overall Study||15
7649875|NCT02141659|18838655|P5|STARTED|Overall Study||15
7649876|NCT02141659|18838656|P4|STARTED|Overall Study||3
7649877|NCT02141659|18838657|P3|STARTED|Overall Study||3
7649878|NCT02141659|18838658|P2|STARTED|Overall Study||4
7649879|NCT02141659|18838659|P1|STARTED|Overall Study||3
7649880|NCT02141633|18838715|P2|NOT COMPLETED|Overall Study||0
7649881|NCT02141633|18838716|P1|NOT COMPLETED|Overall Study||1
7649882|NCT02141633|18838715|P2|COMPLETED|Overall Study||15
7649883|NCT02141633|18838716|P1|COMPLETED|Overall Study||15
7649884|NCT02141633|18838715|P2|STARTED|Overall Study||15
7649885|NCT02141633|18838716|P1|STARTED|Overall Study||16
7649886|NCT02141620|18838724|P2|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
7649887|NCT02141620|18838725|P1|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
7649888|NCT02141620|18838724|P2|COMPLETED|Treatment Condition 2 (7 Days)||7
7649889|NCT02141620|18838725|P1|COMPLETED|Treatment Condition 2 (7 Days)||7
7649890|NCT02141620|18838724|P2|STARTED|Treatment Condition 2 (7 Days)||7
7649891|NCT02141620|18838725|P1|STARTED|Treatment Condition 2 (7 Days)||7
7649892|NCT02141620|18838724|P2|NOT COMPLETED|Treatment Condition 1 (7 Days)||0
7649893|NCT02141620|18838725|P1|NOT COMPLETED|Treatment Condition 1 (7 Days)||1
7649894|NCT02141620|18838724|P2|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7
7649895|NCT02141620|18838725|P1|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7
7649896|NCT02141620|18838724|P2|STARTED|Treatment Condition 1 (7 Days)||7
7649897|NCT02141620|18838725|P1|STARTED|Treatment Condition 1 (7 Days)||8
7649898|NCT02141581|18838786|P3|NOT COMPLETED|Overall Study||0
7649899|NCT02141581|18838787|P2|NOT COMPLETED|Overall Study||0
7649900|NCT02141581|18838788|P1|NOT COMPLETED|Overall Study||0
7649901|NCT02141581|18838786|P3|COMPLETED|Overall Study||25
7649902|NCT02141581|18838787|P2|COMPLETED|Overall Study||19
7649903|NCT02141581|18838788|P1|COMPLETED|Overall Study||42
7649904|NCT02141581|18838786|P3|STARTED|Overall Study||25
7649905|NCT02141581|18838787|P2|STARTED|Overall Study||19
7649906|NCT02141581|18838788|P1|STARTED|Overall Study||42
7649907|NCT02141555|18838801|P2|NOT COMPLETED|Overall Study||0
7649908|NCT02141555|18838802|P1|NOT COMPLETED|Overall Study||0
7649909|NCT02141555|18838801|P2|COMPLETED|Overall Study||2
7649910|NCT02141555|18838802|P1|COMPLETED|Overall Study||2
7649911|NCT02141555|18838801|P2|STARTED|Overall Study||2
7649912|NCT02141555|18838802|P1|STARTED|Overall Study||2
7649913|NCT02141516|18838817|P3|NOT COMPLETED|Overall Study||0
7649914|NCT02141516|18838818|P2|NOT COMPLETED|Overall Study||5
7649915|NCT02141516|18838819|P1|NOT COMPLETED|Overall Study||0
7649916|NCT02141516|18838817|P3|COMPLETED|Overall Study||87
7649917|NCT02141516|18838818|P2|COMPLETED|Overall Study||107
7649918|NCT02141516|18838819|P1|COMPLETED|Overall Study||40
7649919|NCT02141516|18838817|P3|STARTED|Overall Study||87
7649920|NCT02141516|18838818|P2|STARTED|Overall Study||112
7649921|NCT02141516|18838819|P1|STARTED|Overall Study||40
7649922|NCT02141490|18838870|P3|NOT COMPLETED|Overall Study||0
7649923|NCT02141490|18838871|P2|NOT COMPLETED|Overall Study||0
7649924|NCT02141490|18838872|P1|NOT COMPLETED|Overall Study||4
7649925|NCT02141490|18838870|P3|COMPLETED|Overall Study||3
7649926|NCT02141490|18838871|P2|COMPLETED|Overall Study||6
7649927|NCT02141490|18838872|P1|COMPLETED|Overall Study||30
7649928|NCT02141490|18838870|P3|STARTED|Overall Study||3
7649929|NCT02141490|18838871|P2|STARTED|Overall Study||6
7649930|NCT02141490|18838872|P1|STARTED|Overall Study||34
7649931|NCT02141451|18838889|P4|NOT COMPLETED|Overall Study||9
7649932|NCT02141451|18838890|P3|NOT COMPLETED|Overall Study||5
7649933|NCT02141451|18838891|P2|NOT COMPLETED|Overall Study||2
7649934|NCT02141451|18838892|P1|NOT COMPLETED|Overall Study||0
7649935|NCT02141451|18838889|P4|COMPLETED|Overall Study||7
7649936|NCT02141451|18838890|P3|COMPLETED|Overall Study||2
7649937|NCT02141451|18838891|P2|COMPLETED|Overall Study||2
7649938|NCT02141451|18838892|P1|COMPLETED|Overall Study||3
7649939|NCT02141451|18838889|P4|STARTED|Overall Study||16
7649940|NCT02141451|18838890|P3|STARTED|Overall Study||7
7649941|NCT02141451|18838891|P2|STARTED|Overall Study||4
7649942|NCT02141451|18838892|P1|STARTED|Overall Study||3
7649943|NCT02141399|18838917|P1|NOT COMPLETED|Overall Study||744
7649944|NCT02141399|18838917|P1|COMPLETED|Overall Study||741
7649945|NCT02141399|18838917|P1|STARTED|Overall Study||1485
7649946|NCT02141360|18838923|P3|NOT COMPLETED|Overall Study||0
7649947|NCT02141360|18838924|P2|NOT COMPLETED|Overall Study||0
7649948|NCT02141360|18838925|P1|NOT COMPLETED|Overall Study||7
7649949|NCT02141360|18838923|P3|COMPLETED|Overall Study||6
7649950|NCT02141360|18838924|P2|COMPLETED|Overall Study||6
7649951|NCT02141360|18838925|P1|COMPLETED|Overall Study||4
7649952|NCT02141360|18838923|P3|STARTED|Overall Study||6
7649953|NCT02141360|18838924|P2|STARTED|Overall Study||6
7649954|NCT02141360|18838925|P1|STARTED|Overall Study||11
7649955|NCT02141295|18838936|P3|NOT COMPLETED|Overall Study||95
7649956|NCT02141295|18838937|P2|NOT COMPLETED|Overall Study||94
7649957|NCT02141295|18838938|P1|NOT COMPLETED|Overall Study||6
7649958|NCT02141295|18838936|P3|COMPLETED|Overall Study||0
7649959|NCT02141295|18838937|P2|COMPLETED|Overall Study||0
7649960|NCT02141295|18838938|P1|COMPLETED|Overall Study||2
7649961|NCT02141295|18838936|P3|STARTED|Overall Study||95
7649962|NCT02141295|18838937|P2|STARTED|Overall Study||94
7649963|NCT02141295|18838938|P1|STARTED|Overall Study||8
7649964|NCT02141217|18838974|P2|NOT COMPLETED|Overall Study||8
7649965|NCT02141217|18838975|P1|NOT COMPLETED|Overall Study||11
7649966|NCT02141217|18838974|P2|COMPLETED|Overall Study||229
7649967|NCT02141217|18838975|P1|COMPLETED|Overall Study||223
7649968|NCT02141217|18838974|P2|ITT Population-Actual Treatment Received|Overall Study||235
7649969|NCT02141217|18838975|P1|ITT Population-Actual Treatment Received|Overall Study||236
7649970|NCT02141217|18838974|P2|ITT Population-Randomized Treatment Arm|Overall Study||237
7649971|NCT02141217|18838975|P1|ITT Population-Randomized Treatment Arm|Overall Study||234
7649972|NCT02141217|18838974|P2|STARTED|Overall Study||237
7649973|NCT02141217|18838975|P1|STARTED|Overall Study||234
7649974|NCT02141204|18838995|P2|NOT COMPLETED|Overall Study||15
7649975|NCT02141204|18838996|P1|NOT COMPLETED|Overall Study||15
7649976|NCT02141204|18838995|P2|COMPLETED|Overall Study||210
7649977|NCT02141204|18838996|P1|COMPLETED|Overall Study||209
7649978|NCT02141204|18838995|P2|STARTED|Overall Study||225
7649979|NCT02141204|18838996|P1|STARTED|Overall Study||224
7649980|NCT02140957|18839012|P2|NOT COMPLETED|Overall Study||23
7649981|NCT02140957|18839013|P1|NOT COMPLETED|Overall Study||27
7649982|NCT02140957|18839012|P2|COMPLETED|Overall Study||99
7649983|NCT02140957|18839013|P1|COMPLETED|Overall Study||102
7649984|NCT02140957|18839012|P2|STARTED|Overall Study||122
7649985|NCT02140957|18839013|P1|STARTED|Overall Study||129
7649986|NCT02140788|18839023|P4|NOT COMPLETED|Overall Study||0
7649987|NCT02140788|18839024|P3|NOT COMPLETED|Overall Study||0
7649988|NCT02140788|18839025|P2|NOT COMPLETED|Overall Study||0
7649989|NCT02140788|18839026|P1|NOT COMPLETED|Overall Study||0
7649990|NCT02140788|18839023|P4|COMPLETED|Overall Study||0
7649991|NCT02140788|18839024|P3|COMPLETED|Overall Study||0
7649992|NCT02140788|18839025|P2|COMPLETED|Overall Study||0
7649993|NCT02140788|18839026|P1|COMPLETED|Overall Study||0
7649994|NCT02140788|18839023|P4|STARTED|Overall Study||0
7649995|NCT02140788|18839024|P3|STARTED|Overall Study||0
7649996|NCT02140788|18839025|P2|STARTED|Overall Study||0
7649997|NCT02140788|18839026|P1|STARTED|Overall Study||0
7649998|NCT02140775|18839054|P2|NOT COMPLETED|Overall Study||7
7649999|NCT02140775|18839055|P1|NOT COMPLETED|Overall Study||30
7650000|NCT02140775|18839054|P2|COMPLETED|Overall Study||22
7650001|NCT02140775|18839055|P1|COMPLETED|Overall Study||57
7650002|NCT02140775|18839054|P2|STARTED|Overall Study||29
7650003|NCT02140775|18839055|P1|STARTED|Overall Study||87
7650004|NCT02140762|18839067|P2|NOT COMPLETED|Overall Study||12
7650005|NCT02140762|18839068|P1|NOT COMPLETED|Overall Study||17
7650006|NCT02140762|18839067|P2|COMPLETED|Overall Study||139
7650007|NCT02140762|18839068|P1|COMPLETED|Overall Study||137
7650008|NCT02140762|18839067|P2|STARTED|Overall Study||151
7650009|NCT02140762|18839068|P1|STARTED|Overall Study||154
7650010|NCT02140645|18839134|P6|NOT COMPLETED|Overall Study||70896
7650011|NCT02140645|18839135|P5|NOT COMPLETED|Overall Study||3286
7650012|NCT02140645|18839136|P4|NOT COMPLETED|Overall Study||13833
7650013|NCT02140645|18839137|P3|NOT COMPLETED|Overall Study||4236
7650014|NCT02140645|18839138|P2|NOT COMPLETED|Overall Study||61654
7650015|NCT02140645|18839139|P1|NOT COMPLETED|Overall Study||5489
7650016|NCT02140645|18839134|P6|COMPLETED|Overall Study||3050
7650017|NCT02140645|18839135|P5|COMPLETED|Overall Study||150
7650018|NCT02140645|18839136|P4|COMPLETED|Overall Study||530
7650019|NCT02140645|18839137|P3|COMPLETED|Overall Study||205
7650020|NCT02140645|18839138|P2|COMPLETED|Overall Study||3041
7650021|NCT02140645|18839139|P1|COMPLETED|Overall Study||243
7650022|NCT02140645|18839134|P6|STARTED|Overall Study||73946
7650023|NCT02140645|18839135|P5|STARTED|Overall Study||3436
7650024|NCT02140645|18839136|P4|STARTED|Overall Study||14363
7650025|NCT02140645|18839137|P3|STARTED|Overall Study||4441
7650026|NCT02140645|18839138|P2|STARTED|Overall Study||64695
7650027|NCT02140645|18839139|P1|STARTED|Overall Study||5732
7650028|NCT02140593|18839228|P2|NOT COMPLETED|Overall Study||0
7650029|NCT02140593|18839229|P1|NOT COMPLETED|Overall Study||0
7650030|NCT02140593|18839228|P2|COMPLETED|Overall Study||65
7650031|NCT02140593|18839229|P1|COMPLETED|Overall Study||63
7650032|NCT02140593|18839228|P2|STARTED|Overall Study||65
7650033|NCT02140593|18839229|P1|STARTED|Overall Study||63
7650034|NCT02140567|18839237|P1|NOT COMPLETED|Overall Study||6
7650035|NCT02140567|18839237|P1|COMPLETED|Overall Study||134
7650036|NCT02140567|18839237|P1|STARTED|Overall Study||140
7650037|NCT02140411|18839242|P1|NOT COMPLETED|Overall Study||1
7650038|NCT02140411|18839242|P1|COMPLETED|Overall Study||20
7650039|NCT02140411|18839242|P1|STARTED|Overall Study||21
7650040|NCT02140372|18839251|P1|NOT COMPLETED|Overall Study||0
7650041|NCT02140372|18839251|P1|COMPLETED|Overall Study||10
7650042|NCT02140372|18839251|P1|STARTED|Overall Study||10
7650043|NCT02140164|18839262|P1|NOT COMPLETED|Overall Study||2
7650044|NCT02140164|18839262|P1|COMPLETED|Overall Study||5
7650045|NCT02140164|18839262|P1|STARTED|Overall Study||7
7650046|NCT02140060|18839283|P6|NOT COMPLETED|Overall Study||1
7650047|NCT02140060|18839284|P5|NOT COMPLETED|Overall Study||1
7650048|NCT02140060|18839285|P4|NOT COMPLETED|Overall Study||2
7650049|NCT02140060|18839286|P3|NOT COMPLETED|Overall Study||0
7650050|NCT02140060|18839287|P2|NOT COMPLETED|Overall Study||0
7650051|NCT02140060|18839288|P1|NOT COMPLETED|Overall Study||0
7650052|NCT02140060|18839283|P6|COMPLETED|Overall Study||43
7650053|NCT02140060|18839284|P5|COMPLETED|Overall Study||44
7650054|NCT02140060|18839285|P4|COMPLETED|Overall Study||43
7650055|NCT02140060|18839286|P3|COMPLETED|Overall Study||44
7650056|NCT02140060|18839287|P2|COMPLETED|Overall Study||44
7650057|NCT02140060|18839288|P1|COMPLETED|Overall Study||44
7650058|NCT02140060|18839283|P6|STARTED|Overall Study||44
7650059|NCT02140060|18839284|P5|STARTED|Overall Study||45
7650060|NCT02140060|18839285|P4|STARTED|Overall Study||45
7650061|NCT02140060|18839286|P3|STARTED|Overall Study||44
7650062|NCT02140060|18839287|P2|STARTED|Overall Study||44
7650063|NCT02140060|18839288|P1|STARTED|Overall Study||44
7650064|NCT02139982|18839313|P10|NOT COMPLETED|Overall Study||0
7650065|NCT02139982|18839314|P9|NOT COMPLETED|Overall Study||0
7650066|NCT02139982|18839315|P8|NOT COMPLETED|Overall Study||0
7650067|NCT02139982|18839316|P7|NOT COMPLETED|Overall Study||0
7650068|NCT02139982|18839317|P6|NOT COMPLETED|Overall Study||0
7650069|NCT02139982|18839318|P5|NOT COMPLETED|Overall Study||0
7650070|NCT02139982|18839319|P4|NOT COMPLETED|Overall Study||1
7650071|NCT02139982|18839320|P3|NOT COMPLETED|Overall Study||0
7650072|NCT02139982|18839321|P2|NOT COMPLETED|Overall Study||1
7650073|NCT02139982|18839322|P1|NOT COMPLETED|Overall Study||0
7650074|NCT02139982|18839313|P10|COMPLETED|Overall Study||13
7650075|NCT02139982|18839314|P9|COMPLETED|Overall Study||13
7650076|NCT02139982|18839315|P8|COMPLETED|Overall Study||13
7650077|NCT02139982|18839316|P7|COMPLETED|Overall Study||13
7650078|NCT02139982|18839317|P6|COMPLETED|Overall Study||13
7650079|NCT02139982|18839318|P5|COMPLETED|Overall Study||13
7650080|NCT02139982|18839319|P4|COMPLETED|Overall Study||7
7650081|NCT02139982|18839320|P3|COMPLETED|Overall Study||8
7650082|NCT02139982|18839321|P2|COMPLETED|Overall Study||7
7650083|NCT02139982|18839322|P1|COMPLETED|Overall Study||8
7650084|NCT02139982|18839313|P10|STARTED|Overall Study||13
7650085|NCT02139982|18839314|P9|STARTED|Overall Study||13
7650086|NCT02139982|18839315|P8|STARTED|Overall Study||13
7650087|NCT02139982|18839316|P7|STARTED|Overall Study||13
7650088|NCT02139982|18839317|P6|STARTED|Overall Study||13
7650089|NCT02139982|18839318|P5|STARTED|Overall Study||13
7650090|NCT02139982|18839319|P4|STARTED|Overall Study||8
7650091|NCT02139982|18839320|P3|STARTED|Overall Study||8
7650092|NCT02139982|18839321|P2|STARTED|Overall Study||8
7650093|NCT02139982|18839322|P1|STARTED|Overall Study||8
7650094|NCT02139969|18839364|P1|NOT COMPLETED|Overall Study||0
7650095|NCT02139969|18839364|P1|COMPLETED|Overall Study||956
7650096|NCT02139969|18839364|P1|STARTED|Overall Study||956
7650097|NCT02139943|18839386|P3|NOT COMPLETED|Overall Study||7
7650098|NCT02139943|18839387|P2|NOT COMPLETED|Overall Study||6
7650099|NCT02139943|18839388|P1|NOT COMPLETED|Overall Study||10
7650100|NCT02139943|18839386|P3|COMPLETED|Overall Study||110
7650101|NCT02139943|18839387|P2|COMPLETED|Overall Study||111
7650102|NCT02139943|18839388|P1|COMPLETED|Overall Study||107
7650103|NCT02139943|18839386|P3|STARTED|Overall Study||117
7650104|NCT02139943|18839387|P2|STARTED|Overall Study||117
7650105|NCT02139943|18839388|P1|STARTED|Overall Study||117
7650106|NCT02139878|18839399|P2|NOT COMPLETED|Second Intervention (7 Days)||0
7650107|NCT02139878|18839400|P1|NOT COMPLETED|Second Intervention (7 Days)||0
7650108|NCT02139878|18839399|P2|COMPLETED|Second Intervention (7 Days)||10
7650109|NCT02139878|18839400|P1|COMPLETED|Second Intervention (7 Days)||9
7650110|NCT02139878|18839399|P2|STARTED|Second Intervention (7 Days)||10
7650111|NCT02139878|18839400|P1|STARTED|Second Intervention (7 Days)||9
7650112|NCT02139878|18839399|P2|NOT COMPLETED|Washout Period (8 Days)||0
7650113|NCT02139878|18839400|P1|NOT COMPLETED|Washout Period (8 Days)||0
7650114|NCT02139878|18839399|P2|COMPLETED|Washout Period (8 Days)||10
7650115|NCT02139878|18839400|P1|COMPLETED|Washout Period (8 Days)||9
7650116|NCT02139878|18839399|P2|STARTED|Washout Period (8 Days)||10
7650117|NCT02139878|18839400|P1|STARTED|Washout Period (8 Days)||9
7650118|NCT02139878|18839399|P2|NOT COMPLETED|First Intervention (7 Days)||0
7650119|NCT02139878|18839400|P1|NOT COMPLETED|First Intervention (7 Days)||1
7650120|NCT02139878|18839399|P2|COMPLETED|First Intervention (7 Days)||10
7650121|NCT02139878|18839400|P1|COMPLETED|First Intervention (7 Days)||9
7650122|NCT02139878|18839399|P2|STARTED|First Intervention (7 Days)||10
7650123|NCT02139878|18839400|P1|STARTED|First Intervention (7 Days)||10
7650124|NCT02139826|18839408|P1|NOT COMPLETED|Overall Study||1
7650125|NCT02139826|18839408|P1|COMPLETED|Overall Study||11
7650126|NCT02139826|18839408|P1|STARTED|Overall Study||12
7650127|NCT02139800|18839441|P2|NOT COMPLETED|Overall Study||21
7650128|NCT02139800|18839442|P1|NOT COMPLETED|Overall Study||13
7650129|NCT02139800|18839441|P2|COMPLETED|Overall Study||215
7650130|NCT02139800|18839442|P1|COMPLETED|Overall Study||211
7650131|NCT02139800|18839441|P2|STARTED|Overall Study||236
7650132|NCT02139800|18839442|P1|STARTED|Overall Study||224
7650133|NCT02139644|18839453|P6|NOT COMPLETED|Treatment Period||17
7650134|NCT02139644|18839454|P5|NOT COMPLETED|Treatment Period||8
7650135|NCT02139644|18839455|P4|NOT COMPLETED|Treatment Period||9
7650136|NCT02139644|18839456|P3|NOT COMPLETED|Treatment Period||8
7650137|NCT02139644|18839457|P2|NOT COMPLETED|Treatment Period||3
7650138|NCT02139644|18839458|P1|NOT COMPLETED|Treatment Period||0
7650139|NCT02139644|18839453|P6|COMPLETED|Treatment Period||113
7650140|NCT02139644|18839454|P5|COMPLETED|Treatment Period||121
7650141|NCT02139644|18839455|P4|COMPLETED|Treatment Period||121
7650142|NCT02139644|18839456|P3|COMPLETED|Treatment Period||121
7650143|NCT02139644|18839457|P2|COMPLETED|Treatment Period||126
7650144|NCT02139644|18839458|P1|COMPLETED|Treatment Period||0
7650145|NCT02139644|18839453|P6|STARTED|Treatment Period|Randomized|130
7650146|NCT02139644|18839454|P5|STARTED|Treatment Period|Randomized|129
7650147|NCT02139644|18839455|P4|STARTED|Treatment Period|Randomized|130
7650148|NCT02139644|18839456|P3|STARTED|Treatment Period|Randomized|129
7650149|NCT02139644|18839457|P2|STARTED|Treatment Period|Randomized|129
7650150|NCT02139644|18839458|P1|STARTED|Treatment Period||0
7650151|NCT02139644|18839453|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
7650152|NCT02139644|18839454|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
7650153|NCT02139644|18839455|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
7650154|NCT02139644|18839456|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
7650155|NCT02139644|18839457|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
7650156|NCT02139644|18839458|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||140
7650157|NCT02139644|18839453|P6|COMPLETED|Run-In Period (Pre-assignment)||0
7650158|NCT02139644|18839454|P5|COMPLETED|Run-In Period (Pre-assignment)||0
7650159|NCT02139644|18839455|P4|COMPLETED|Run-In Period (Pre-assignment)||0
7650160|NCT02139644|18839456|P3|COMPLETED|Run-In Period (Pre-assignment)||0
7650161|NCT02139644|18839457|P2|COMPLETED|Run-In Period (Pre-assignment)||0
7650162|NCT02139644|18839458|P1|COMPLETED|Run-In Period (Pre-assignment)||647
7650163|NCT02139644|18839453|P6|STARTED|Run-In Period (Pre-assignment)||0
7650164|NCT02139644|18839454|P5|STARTED|Run-In Period (Pre-assignment)||0
7650165|NCT02139644|18839455|P4|STARTED|Run-In Period (Pre-assignment)||0
7650166|NCT02139644|18839456|P3|STARTED|Run-In Period (Pre-assignment)||0
7650167|NCT02139644|18839457|P2|STARTED|Run-In Period (Pre-assignment)||0
7650168|NCT02139644|18839458|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled|787
7650169|NCT02139592|18839510|P1|NOT COMPLETED|Overall Study||8
7650170|NCT02139592|18839510|P1|COMPLETED|Overall Study||284
7650171|NCT02139592|18839510|P1|STARTED|Overall Study||292
7650172|NCT02139540|18839518|P2|NOT COMPLETED|Overall Study||0
7650173|NCT02139540|18839519|P1|NOT COMPLETED|Overall Study||1
7650174|NCT02139540|18839518|P2|COMPLETED|Overall Study||10
7650175|NCT02139540|18839519|P1|COMPLETED|Overall Study||10
7650176|NCT02139540|18839518|P2|STARTED|Overall Study||10
7650177|NCT02139540|18839519|P1|STARTED|Overall Study||11
7650178|NCT02139358|18839527|P1|NOT COMPLETED|Overall Study||0
7650179|NCT02139358|18839527|P1|COMPLETED|Overall Study||15
7650180|NCT02139358|18839527|P1|STARTED|Overall Study||15
7650181|NCT02139306|18839536|P2|NOT COMPLETED|Overall Study||14
7650182|NCT02139306|18839537|P1|NOT COMPLETED|Overall Study||13
7650183|NCT02139306|18839536|P2|COMPLETED|Overall Study||125
7650184|NCT02139306|18839537|P1|COMPLETED|Overall Study||127
7650185|NCT02139306|18839536|P2|STARTED|Overall Study||139
7650186|NCT02139306|18839537|P1|STARTED|Overall Study||140
7650187|NCT02139228|18839563|P2|NOT COMPLETED|Overall Study||0
7650188|NCT02139228|18839564|P1|NOT COMPLETED|Overall Study||0
7650189|NCT02139228|18839563|P2|COMPLETED|Overall Study||211
7650190|NCT02139228|18839564|P1|COMPLETED|Overall Study||215
7650191|NCT02139228|18839563|P2|STARTED|Overall Study||211
7650192|NCT02139228|18839564|P1|STARTED|Overall Study||215
7650193|NCT02139176|18839574|P2|NOT COMPLETED|Overall Study||0
7650194|NCT02139176|18839575|P1|NOT COMPLETED|Overall Study||0
7650195|NCT02139176|18839574|P2|COMPLETED|Overall Study||100
7650196|NCT02139176|18839575|P1|COMPLETED|Overall Study||100
7650197|NCT02139176|18839574|P2|STARTED|Overall Study||100
7650198|NCT02139176|18839575|P1|STARTED|Overall Study||100
7650199|NCT02139137|18839587|P2|NOT COMPLETED|Overall Study||10
7650200|NCT02139137|18839588|P1|NOT COMPLETED|Overall Study||7
7650201|NCT02139137|18839587|P2|COMPLETED|Overall Study||10
7650202|NCT02139137|18839588|P1|COMPLETED|Overall Study||15
7650203|NCT02139137|18839587|P2|STARTED|Overall Study||20
7650204|NCT02139137|18839588|P1|STARTED|Overall Study||22
7650205|NCT02139124|18839607|P5|NOT COMPLETED|Overall Study||13
7650206|NCT02139124|18839608|P4|NOT COMPLETED|Overall Study||12
7650207|NCT02139124|18839609|P3|NOT COMPLETED|Overall Study||4
7650208|NCT02139124|18839610|P2|NOT COMPLETED|Overall Study||4
7650209|NCT02139124|18839611|P1|NOT COMPLETED|Overall Study||9
7650210|NCT02139124|18839607|P5|COMPLETED|Overall Study||61
7650211|NCT02139124|18839608|P4|COMPLETED|Overall Study||61
7650212|NCT02139124|18839609|P3|COMPLETED|Overall Study||69
7650213|NCT02139124|18839610|P2|COMPLETED|Overall Study||73
7650214|NCT02139124|18839611|P1|COMPLETED|Overall Study||69
7650215|NCT02139124|18839607|P5|STARTED|Overall Study||74
7650216|NCT02139124|18839608|P4|STARTED|Overall Study||73
7650217|NCT02139124|18839609|P3|STARTED|Overall Study||73
7650218|NCT02139124|18839610|P2|STARTED|Overall Study||77
7650219|NCT02139124|18839611|P1|STARTED|Overall Study||78
7650220|NCT02139046|18839628|P5|NOT COMPLETED|Overall Study||57
7650221|NCT02139046|18839629|P4|NOT COMPLETED|Overall Study||68
7650222|NCT02139046|18839630|P3|NOT COMPLETED|Overall Study||59
7650223|NCT02139046|18839631|P2|NOT COMPLETED|Overall Study||54
7650224|NCT02139046|18839632|P1|NOT COMPLETED|Overall Study||62
7650225|NCT02139046|18839628|P5|COMPLETED|Overall Study||301
7650226|NCT02139046|18839629|P4|COMPLETED|Overall Study||290
7650227|NCT02139046|18839630|P3|COMPLETED|Overall Study||298
7650228|NCT02139046|18839631|P2|COMPLETED|Overall Study||305
7650229|NCT02139046|18839632|P1|COMPLETED|Overall Study|Completed=Completed Study Drug|296
7650230|NCT02139046|18839628|P5|Full Analysis Set|Overall Study||357
7650231|NCT02139046|18839629|P4|Full Analysis Set|Overall Study||357
7650232|NCT02139046|18839630|P3|Full Analysis Set|Overall Study||355
7650233|NCT02139046|18839631|P2|Full Analysis Set|Overall Study||357
7650234|NCT02139046|18839632|P1|Full Analysis Set|Overall Study||357
7650235|NCT02139046|18839628|P5|Safety Analysis Set|Overall Study||357
7650236|NCT02139046|18839629|P4|Safety Analysis Set|Overall Study||357
7650237|NCT02139046|18839630|P3|Safety Analysis Set|Overall Study||355
7650238|NCT02139046|18839631|P2|Safety Analysis Set|Overall Study||358
7650239|NCT02139046|18839632|P1|Safety Analysis Set|Overall Study||356
7650240|NCT02139046|18839628|P5|STARTED|Overall Study||358
7650241|NCT02139046|18839629|P4|STARTED|Overall Study||358
7650242|NCT02139046|18839630|P3|STARTED|Overall Study||357
7650243|NCT02139046|18839631|P2|STARTED|Overall Study||359
7650244|NCT02139046|18839632|P1|STARTED|Overall Study||358
7650245|NCT02139007|18839656|P2|NOT COMPLETED|Patient Participant Recruitment||1
7650246|NCT02139007|18839657|P1|NOT COMPLETED|Patient Participant Recruitment||2
7650247|NCT02139007|18839656|P2|COMPLETED|Patient Participant Recruitment||13
7650248|NCT02139007|18839657|P1|COMPLETED|Patient Participant Recruitment||11
7650249|NCT02139007|18839656|P2|STARTED|Patient Participant Recruitment||14
7650250|NCT02139007|18839657|P1|STARTED|Patient Participant Recruitment||13
7650251|NCT02139007|18839656|P2|NOT COMPLETED|Study Site Recruitment||4
7650252|NCT02139007|18839657|P1|NOT COMPLETED|Study Site Recruitment||3
7650253|NCT02139007|18839656|P2|COMPLETED|Study Site Recruitment||1
7650254|NCT02139007|18839657|P1|COMPLETED|Study Site Recruitment||1
7650255|NCT02139007|18839656|P2|STARTED|Study Site Recruitment||5
7650256|NCT02139007|18839657|P1|STARTED|Study Site Recruitment||4
7650257|NCT02138916|18839673|P3|NOT COMPLETED|Overall Study||59
7650258|NCT02138916|18839674|P2|NOT COMPLETED|Overall Study||60
7650259|NCT02138916|18839675|P1|NOT COMPLETED|Overall Study||57
7650260|NCT02138916|18839673|P3|COMPLETED|Overall Study||491
7650261|NCT02138916|18839674|P2|COMPLETED|Overall Study||492
7650262|NCT02138916|18839675|P1|COMPLETED|Overall Study||497
7650263|NCT02138916|18839673|P3|STARTED|Overall Study||550
7650264|NCT02138916|18839674|P2|STARTED|Overall Study||552
7650265|NCT02138916|18839675|P1|STARTED|Overall Study||554
7650266|NCT02138890|18839738|P2|NOT COMPLETED|Overall Study||0
7650267|NCT02138890|18839739|P1|NOT COMPLETED|Overall Study||1
7650268|NCT02138890|18839738|P2|COMPLETED|Overall Study||15
7650269|NCT02138890|18839739|P1|COMPLETED|Overall Study||30
7650270|NCT02138890|18839738|P2|STARTED|Overall Study||15
7650271|NCT02138890|18839739|P1|STARTED|Overall Study||31
7650272|NCT02138838|18839781|P2|NOT COMPLETED|Overall Study||11
7650273|NCT02138838|18839782|P1|NOT COMPLETED|Overall Study||8
7650274|NCT02138838|18839781|P2|COMPLETED|Overall Study||16
7650275|NCT02138838|18839782|P1|COMPLETED|Overall Study||20
7650276|NCT02138838|18839781|P2|Received Study Drug|Overall Study||25
7650277|NCT02138838|18839782|P1|Received Study Drug|Overall Study||28
7650278|NCT02138838|18839781|P2|STARTED|Overall Study||27
7650279|NCT02138838|18839782|P1|STARTED|Overall Study||28
7650280|NCT02138825|18839800|P2|NOT COMPLETED|Safety Follow-up||17
7650281|NCT02138825|18839801|P1|NOT COMPLETED|Safety Follow-up||22
7650282|NCT02138825|18839800|P2|COMPLETED|Safety Follow-up||47
7650283|NCT02138825|18839801|P1|COMPLETED|Safety Follow-up||50
7650284|NCT02138825|18839800|P2|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|64
7650285|NCT02138825|18839801|P1|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|72
7650286|NCT02138825|18839800|P2|NOT COMPLETED|Long-term Extension||38
7650287|NCT02138825|18839801|P1|NOT COMPLETED|Long-term Extension||32
7650288|NCT02138825|18839800|P2|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
7650289|NCT02138825|18839801|P1|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
7650290|NCT02138825|18839800|P2|STARTED|Long-term Extension||38
7650291|NCT02138825|18839801|P1|STARTED|Long-term Extension||32
7650292|NCT02138825|18839800|P2|NOT COMPLETED|Main Study Treatment||35
7650293|NCT02138825|18839801|P1|NOT COMPLETED|Main Study Treatment||40
7650294|NCT02138825|18839800|P2|COMPLETED|Main Study Treatment||39
7650295|NCT02138825|18839801|P1|COMPLETED|Main Study Treatment||33
7650296|NCT02138825|18839800|P2|STARTED|Main Study Treatment|safety population|74
7650297|NCT02138825|18839801|P1|STARTED|Main Study Treatment|safety population|73
7650298|NCT02138786|18839818|P3|NOT COMPLETED|Overall Study||8
7650299|NCT02138786|18839819|P2|NOT COMPLETED|Overall Study||15
7650300|NCT02138786|18839820|P1|NOT COMPLETED|Overall Study||3
7650301|NCT02138786|18839818|P3|COMPLETED|Overall Study||0
7650302|NCT02138786|18839819|P2|COMPLETED|Overall Study||0
7650303|NCT02138786|18839820|P1|COMPLETED|Overall Study||0
7650304|NCT02138786|18839818|P3|STARTED|Overall Study||8
7650305|NCT02138786|18839819|P2|STARTED|Overall Study||15
7650306|NCT02138786|18839820|P1|STARTED|Overall Study||3
7650307|NCT02138747|18839837|P4|NOT COMPLETED|Treatment Period 2||3
7650308|NCT02138747|18839838|P3|NOT COMPLETED|Treatment Period 2||2
7650309|NCT02138747|18839839|P2|NOT COMPLETED|Treatment Period 2||7
7650310|NCT02138747|18839840|P1|NOT COMPLETED|Treatment Period 2||17
7650311|NCT02138747|18839837|P4|COMPLETED|Treatment Period 2||24
7650312|NCT02138747|18839838|P3|COMPLETED|Treatment Period 2||24
7650313|NCT02138747|18839839|P2|COMPLETED|Treatment Period 2||125
7650314|NCT02138747|18839840|P1|COMPLETED|Treatment Period 2||121
7650315|NCT02138747|18839837|P4|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27
7650316|NCT02138747|18839838|P3|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26
7650317|NCT02138747|18839839|P2|STARTED|Treatment Period 2||132
7650318|NCT02138747|18839840|P1|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138
7650319|NCT02138747|18839837|P4|NOT COMPLETED|Treatment Period 1||4
7650320|NCT02138747|18839838|P3|NOT COMPLETED|Treatment Period 1||4
7650321|NCT02138747|18839839|P2|NOT COMPLETED|Treatment Period 1||25
7650322|NCT02138747|18839840|P1|NOT COMPLETED|Treatment Period 1||20
7650323|NCT02138747|18839837|P4|COMPLETED|Treatment Period 1||28
7650324|NCT02138747|18839838|P3|COMPLETED|Treatment Period 1||27
7650325|NCT02138747|18839839|P2|COMPLETED|Treatment Period 1||132
7650326|NCT02138747|18839840|P1|COMPLETED|Treatment Period 1||136
7650327|NCT02138747|18839837|P4|STARTED|Treatment Period 1||32
7650328|NCT02138747|18839838|P3|STARTED|Treatment Period 1||31
7650329|NCT02138747|18839839|P2|STARTED|Treatment Period 1||157
7650330|NCT02138747|18839840|P1|STARTED|Treatment Period 1||156
7650331|NCT02138578|18839875|P3|NOT COMPLETED|Overall Study||0
7650332|NCT02138578|18839876|P2|NOT COMPLETED|Overall Study||0
7650333|NCT02138578|18839877|P1|NOT COMPLETED|Overall Study||0
7650334|NCT02138578|18839875|P3|COMPLETED|Overall Study||3
7650335|NCT02138578|18839876|P2|COMPLETED|Overall Study||0
7650336|NCT02138578|18839877|P1|COMPLETED|Overall Study||1
7650337|NCT02138578|18839875|P3|STARTED|Overall Study||3
7650338|NCT02138578|18839876|P2|STARTED|Overall Study||0
7650339|NCT02138578|18839877|P1|STARTED|Overall Study||1
7650340|NCT02138461|18839905|P2|NOT COMPLETED|Overall Study||0
7650341|NCT02138461|18839906|P1|NOT COMPLETED|Overall Study||0
7650342|NCT02138461|18839905|P2|COMPLETED|Overall Study||110
7650343|NCT02138461|18839906|P1|COMPLETED|Overall Study||101
7650344|NCT02138461|18839905|P2|STARTED|Overall Study||110
7650345|NCT02138461|18839906|P1|STARTED|Overall Study||101
7650346|NCT02138253|18839914|P2|NOT COMPLETED|Overall Study||4
7650347|NCT02138253|18839915|P1|NOT COMPLETED|Overall Study||9
7650348|NCT02138253|18839914|P2|COMPLETED|Overall Study||19
7650349|NCT02138253|18839915|P1|COMPLETED|Overall Study||32
7650350|NCT02138253|18839914|P2|STARTED|Overall Study||23
7650351|NCT02138253|18839915|P1|STARTED|Overall Study||41
7650352|NCT02138240|18839943|P1|NOT COMPLETED|Overall Study||0
7650353|NCT02138240|18839943|P1|COMPLETED|Overall Study||34
7650354|NCT02138240|18839943|P1|STARTED|Overall Study||34
7650355|NCT02138227|18839955|P2|NOT COMPLETED|Overall Study||0
7650356|NCT02138227|18839956|P1|NOT COMPLETED|Overall Study||0
7650357|NCT02138227|18839955|P2|COMPLETED|Overall Study||218
7650358|NCT02138227|18839956|P1|COMPLETED|Overall Study||55
7650359|NCT02138227|18839955|P2|STARTED|Overall Study||218
7650360|NCT02138227|18839956|P1|STARTED|Overall Study||55
7650361|NCT02138214|18839990|P3|NOT COMPLETED|Overall Study||4
7650362|NCT02138214|18839991|P2|NOT COMPLETED|Overall Study||4
7650363|NCT02138214|18839992|P1|NOT COMPLETED|Overall Study||0
7650364|NCT02138214|18839990|P3|COMPLETED|Overall Study||26
7650365|NCT02138214|18839991|P2|COMPLETED|Overall Study||26
7650366|NCT02138214|18839992|P1|COMPLETED|Overall Study||30
7650367|NCT02138214|18839990|P3|Analyzed for Baseline Measures|Overall Study||30
7650368|NCT02138214|18839991|P2|Analyzed for Baseline Measures|Overall Study||29
7650369|NCT02138214|18839992|P1|Analyzed for Baseline Measures|Overall Study||30
7650370|NCT02138214|18839990|P3|STARTED|Overall Study||30
7650371|NCT02138214|18839991|P2|STARTED|Overall Study||30
7650372|NCT02138214|18839992|P1|STARTED|Overall Study||30
7650373|NCT02138136|18840013|P1|NOT COMPLETED|Overall Study||139
7650374|NCT02138136|18840013|P1|COMPLETED|Overall Study||280
7650375|NCT02138136|18840013|P1|Modified Intent to Treat (mITT)|Overall Study||418
7650376|NCT02138136|18840013|P1|Safety Analysis Set|Overall Study||419
7650377|NCT02138136|18840013|P1|STARTED|Overall Study||419
7650378|NCT02138110|18840020|P1|NOT COMPLETED|Overall Scaffold Implantation||3
7650379|NCT02138110|18840020|P1|COMPLETED|Overall Scaffold Implantation||16
7650380|NCT02138110|18840020|P1|6-month Follow-Up|Overall Scaffold Implantation||16
7650381|NCT02138110|18840020|P1|STARTED|Overall Scaffold Implantation||19
7650382|NCT02138110|18840020|P1|NOT COMPLETED|Enrolled for Scaffold Implantation||1
7650383|NCT02138110|18840020|P1|COMPLETED|Enrolled for Scaffold Implantation||19
7650384|NCT02138110|18840020|P1|STARTED|Enrolled for Scaffold Implantation||20
7650385|NCT02138110|18840020|P1|NOT COMPLETED|Enrolled in Study||0
7650386|NCT02138110|18840020|P1|COMPLETED|Enrolled in Study||20
7650387|NCT02138110|18840020|P1|STARTED|Enrolled in Study||20
7650388|NCT02138097|18840048|P2|NOT COMPLETED|Overall Study||0
7650389|NCT02138097|18840049|P1|NOT COMPLETED|Overall Study||0
7650390|NCT02138097|18840048|P2|COMPLETED|Overall Study||459722
7650391|NCT02138097|18840049|P1|COMPLETED|Overall Study||155345
7650392|NCT02138097|18840048|P2|STARTED|Overall Study||459722
7650393|NCT02138097|18840049|P1|STARTED|Overall Study||155345
7650394|NCT02138006|18840241|P2|NOT COMPLETED|Overall Study||0
7650395|NCT02138006|18840242|P1|NOT COMPLETED|Overall Study||0
7650396|NCT02138006|18840241|P2|COMPLETED|Overall Study||54
7650397|NCT02138006|18840242|P1|COMPLETED|Overall Study||48
7650398|NCT02138006|18840241|P2|STARTED|Overall Study||54
7650399|NCT02138006|18840242|P1|STARTED|Overall Study||48
7650400|NCT02137785|18840252|P2|NOT COMPLETED|Overall Study||4
7650401|NCT02137785|18840253|P1|NOT COMPLETED|Overall Study||3
7650402|NCT02137785|18840252|P2|COMPLETED|Overall Study||130
7650403|NCT02137785|18840253|P1|COMPLETED|Overall Study||132
7650404|NCT02137785|18840252|P2|STARTED|Overall Study||134
7650405|NCT02137785|18840253|P1|STARTED|Overall Study||135
7650406|NCT02137772|18840361|P2|NOT COMPLETED|Overall Study||75
7650407|NCT02137772|18840362|P1|NOT COMPLETED|Overall Study||132
7650408|NCT02137772|18840361|P2|COMPLETED|Overall Study||119
7650409|NCT02137772|18840362|P1|COMPLETED|Overall Study||244
7650410|NCT02137772|18840361|P2|Treated Participants|Overall Study||192
7650411|NCT02137772|18840362|P1|Treated Participants|Overall Study||373
7650412|NCT02137772|18840361|P2|STARTED|Overall Study|Randomized participants|194
7650413|NCT02137772|18840362|P1|STARTED|Overall Study|Randomized participants|376
7650414|NCT02137603|18840388|P2|NOT COMPLETED|Overall Study||0
7650415|NCT02137603|18840389|P1|NOT COMPLETED|Overall Study||2
7650416|NCT02137603|18840388|P2|COMPLETED|Overall Study||18
7650417|NCT02137603|18840389|P1|COMPLETED|Overall Study||16
7650418|NCT02137603|18840388|P2|STARTED|Overall Study||18
7650419|NCT02137603|18840389|P1|STARTED|Overall Study||18
7650420|NCT02137512|18840397|P1|NOT COMPLETED|5-Month 24/7 Closed-Loop||0
7650421|NCT02137512|18840397|P1|COMPLETED|5-Month 24/7 Closed-Loop||14
7650422|NCT02137512|18840397|P1|STARTED|5-Month 24/7 Closed-Loop||14
7650423|NCT02137512|18840397|P1|NOT COMPLETED|2-Week 24/7 Closed-Loop||0
7650424|NCT02137512|18840397|P1|COMPLETED|2-Week 24/7 Closed-Loop||30
7650425|NCT02137512|18840397|P1|STARTED|2-Week 24/7 Closed-Loop||30
7650426|NCT02137512|18840397|P1|NOT COMPLETED|2-Week Overnight-Only Closed-Loop||0
7650427|NCT02137512|18840397|P1|COMPLETED|2-Week Overnight-Only Closed-Loop||30
7650428|NCT02137512|18840397|P1|STARTED|2-Week Overnight-Only Closed-Loop||30
7650429|NCT02137512|18840397|P1|NOT COMPLETED|2-Week Baseline Sensor-Augmented Pump||0
7650430|NCT02137512|18840397|P1|COMPLETED|2-Week Baseline Sensor-Augmented Pump||30
7650431|NCT02137512|18840397|P1|STARTED|2-Week Baseline Sensor-Augmented Pump||30
7650432|NCT02137499|18840554|P4|NOT COMPLETED|Overall Study||0
7650433|NCT02137499|18840555|P3|NOT COMPLETED|Overall Study||0
7650434|NCT02137499|18840556|P2|NOT COMPLETED|Overall Study||0
7650435|NCT02137499|18840557|P1|NOT COMPLETED|Overall Study||0
7650436|NCT02137499|18840554|P4|COMPLETED|Overall Study||10
7650437|NCT02137499|18840555|P3|COMPLETED|Overall Study||10
7650438|NCT02137499|18840556|P2|COMPLETED|Overall Study||10
7650439|NCT02137499|18840557|P1|COMPLETED|Overall Study||10
7650440|NCT02137499|18840554|P4|STARTED|Overall Study||10
7650441|NCT02137499|18840555|P3|STARTED|Overall Study||10
7650442|NCT02137499|18840556|P2|STARTED|Overall Study||10
7650443|NCT02137499|18840557|P1|STARTED|Overall Study||10
7650444|NCT02137486|18840577|P2|NOT COMPLETED|Overall Study||0
7650445|NCT02137486|18840578|P1|NOT COMPLETED|Overall Study||0
7650446|NCT02137486|18840577|P2|COMPLETED|Overall Study||102
7650447|NCT02137486|18840578|P1|COMPLETED|Overall Study||112
7650448|NCT02137486|18840577|P2|STARTED|Overall Study||102
7650449|NCT02137486|18840578|P1|STARTED|Overall Study||112
7650450|NCT02137447|18840594|P1|NOT COMPLETED|Overall Study||0
7650451|NCT02137447|18840594|P1|COMPLETED|Overall Study||10
7650452|NCT02137447|18840594|P1|STARTED|Overall Study||10
7650453|NCT02137382|18840599|P2|NOT COMPLETED|Cross-over Period 2||0
7650454|NCT02137382|18840600|P1|NOT COMPLETED|Cross-over Period 2||0
7650455|NCT02137382|18840599|P2|COMPLETED|Cross-over Period 2||21
7650456|NCT02137382|18840600|P1|COMPLETED|Cross-over Period 2||18
7650457|NCT02137382|18840599|P2|STARTED|Cross-over Period 2||21
7650458|NCT02137382|18840600|P1|STARTED|Cross-over Period 2||18
7650459|NCT02137382|18840599|P2|NOT COMPLETED|Wash Out||0
7650460|NCT02137382|18840600|P1|NOT COMPLETED|Wash Out||0
7650461|NCT02137382|18840599|P2|COMPLETED|Wash Out||21
7650462|NCT02137382|18840600|P1|COMPLETED|Wash Out||18
7650463|NCT02137382|18840599|P2|STARTED|Wash Out||21
7650464|NCT02137382|18840600|P1|STARTED|Wash Out||18
7650465|NCT02137382|18840599|P2|NOT COMPLETED|Cross-over Period 1||0
7650466|NCT02137382|18840600|P1|NOT COMPLETED|Cross-over Period 1||2
7650467|NCT02137382|18840599|P2|COMPLETED|Cross-over Period 1||21
7650468|NCT02137382|18840600|P1|COMPLETED|Cross-over Period 1||18
7650469|NCT02137382|18840599|P2|STARTED|Cross-over Period 1||21
7650470|NCT02137382|18840600|P1|STARTED|Cross-over Period 1||20
7650471|NCT02137369|18840620|P2|NOT COMPLETED|Overall Study||2
7650472|NCT02137369|18840621|P1|NOT COMPLETED|Overall Study||8
7650473|NCT02137369|18840620|P2|COMPLETED|Overall Study||9
7650474|NCT02137369|18840621|P1|COMPLETED|Overall Study||41
7650475|NCT02137369|18840620|P2|STARTED|Overall Study||11
7650476|NCT02137369|18840621|P1|STARTED|Overall Study||49
7650477|NCT02137226|18840631|P5|NOT COMPLETED|Period 2 (Re - Randomization)||9
7650478|NCT02137226|18840632|P4|NOT COMPLETED|Period 2 (Re - Randomization)||8
7650479|NCT02137226|18840633|P3|NOT COMPLETED|Period 2 (Re - Randomization)||17
7650480|NCT02137226|18840634|P2|NOT COMPLETED|Period 2 (Re - Randomization)||0
7650481|NCT02137226|18840635|P1|NOT COMPLETED|Period 2 (Re - Randomization)||0
7650482|NCT02137226|18840631|P5|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|138
7650483|NCT02137226|18840632|P4|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|140
7650484|NCT02137226|18840633|P3|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|281
7650485|NCT02137226|18840634|P2|COMPLETED|Period 2 (Re - Randomization)||0
7650486|NCT02137226|18840635|P1|COMPLETED|Period 2 (Re - Randomization)||0
7650487|NCT02137226|18840631|P5|STARTED|Period 2 (Re - Randomization)||147
7650488|NCT02137226|18840632|P4|STARTED|Period 2 (Re - Randomization)||148
7650489|NCT02137226|18840633|P3|STARTED|Period 2 (Re - Randomization)||298
7650490|NCT02137226|18840634|P2|STARTED|Period 2 (Re - Randomization)||0
7650491|NCT02137226|18840635|P1|STARTED|Period 2 (Re - Randomization)||0
7650492|NCT02137226|18840631|P5|NOT COMPLETED|Period 1 (Initial Randomization)||0
7650493|NCT02137226|18840632|P4|NOT COMPLETED|Period 1 (Initial Randomization)||0
7650494|NCT02137226|18840633|P3|NOT COMPLETED|Period 1 (Initial Randomization)||0
7650495|NCT02137226|18840634|P2|NOT COMPLETED|Period 1 (Initial Randomization)||16
7650496|NCT02137226|18840635|P1|NOT COMPLETED|Period 1 (Initial Randomization)||20
7650497|NCT02137226|18840631|P5|COMPLETED|Period 1 (Initial Randomization)||0
7650498|NCT02137226|18840632|P4|COMPLETED|Period 1 (Initial Randomization)||0
7650499|NCT02137226|18840633|P3|COMPLETED|Period 1 (Initial Randomization)||0
7650500|NCT02137226|18840634|P2|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|305
7650501|NCT02137226|18840635|P1|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|304
7650502|NCT02137226|18840631|P5|STARTED|Period 1 (Initial Randomization)||0
7650503|NCT02137226|18840632|P4|STARTED|Period 1 (Initial Randomization)||0
7650504|NCT02137226|18840633|P3|STARTED|Period 1 (Initial Randomization)||0
7650505|NCT02137226|18840634|P2|STARTED|Period 1 (Initial Randomization)||321
7650506|NCT02137226|18840635|P1|STARTED|Period 1 (Initial Randomization)||324
7650507|NCT02137096|18840647|P1|NOT COMPLETED|Overall Study||0
7650508|NCT02137096|18840647|P1|COMPLETED|Overall Study||1
7650509|NCT02137096|18840647|P1|STARTED|Overall Study||1
7650510|NCT02136914|18840653|P2|NOT COMPLETED|Overall Study||21
7650511|NCT02136914|18840654|P1|NOT COMPLETED|Overall Study||21
7650512|NCT02136914|18840653|P2|COMPLETED|Overall Study||42
7650513|NCT02136914|18840654|P1|COMPLETED|Overall Study||42
7650514|NCT02136914|18840653|P2|Received Study Drug|Overall Study||63
7650515|NCT02136914|18840654|P1|Received Study Drug|Overall Study||60
7650516|NCT02136914|18840653|P2|STARTED|Overall Study||63
7650517|NCT02136914|18840654|P1|STARTED|Overall Study||63
7650518|NCT02136810|18840668|P1|NOT COMPLETED|Overall Study||0
7650519|NCT02136810|18840668|P1|COMPLETED|Overall Study||200
7650520|NCT02136810|18840668|P1|STARTED|Overall Study||200
7650521|NCT02136680|18840674|P2|NOT COMPLETED|Overall Study||29
7650522|NCT02136680|18840675|P1|NOT COMPLETED|Overall Study||32
7650523|NCT02136680|18840674|P2|COMPLETED|Overall Study||56
7650524|NCT02136680|18840675|P1|COMPLETED|Overall Study||80
7650525|NCT02136680|18840674|P2|Interview 3|Overall Study||56
7650526|NCT02136680|18840675|P1|Interview 3|Overall Study||80
7650527|NCT02136680|18840674|P2|Interview 2|Overall Study||70
7650528|NCT02136680|18840675|P1|Interview 2|Overall Study||97
7650529|NCT02136680|18840674|P2|Interview 1|Overall Study||85
7650530|NCT02136680|18840675|P1|Interview 1|Overall Study||112
7650531|NCT02136680|18840674|P2|STARTED|Overall Study||85
7650532|NCT02136680|18840675|P1|STARTED|Overall Study||112
7650533|NCT02136576|18840692|P3|NOT COMPLETED|Overall Study||0
7650534|NCT02136576|18840693|P2|NOT COMPLETED|Overall Study||0
7650535|NCT02136576|18840694|P1|NOT COMPLETED|Overall Study||2
7650536|NCT02136576|18840692|P3|COMPLETED|Overall Study||13
7650537|NCT02136576|18840693|P2|COMPLETED|Overall Study||13
7650538|NCT02136576|18840694|P1|COMPLETED|Overall Study||11
7650539|NCT02136576|18840692|P3|STARTED|Overall Study||13
7650540|NCT02136576|18840693|P2|STARTED|Overall Study||13
7650541|NCT02136576|18840694|P1|STARTED|Overall Study||13
7650542|NCT02136498|18840704|P2|NOT COMPLETED|Overall Study||0
7650543|NCT02136498|18840705|P1|NOT COMPLETED|Overall Study||0
7650544|NCT02136498|18840704|P2|COMPLETED|Overall Study||33
7650545|NCT02136498|18840705|P1|COMPLETED|Overall Study||33
7650546|NCT02136498|18840704|P2|STARTED|Overall Study||33
7650547|NCT02136498|18840705|P1|STARTED|Overall Study||33
7650548|NCT02136420|18840717|P10|NOT COMPLETED|Overall Study||0
7650549|NCT02136420|18840718|P9|NOT COMPLETED|Overall Study||0
7650550|NCT02136420|18840719|P8|NOT COMPLETED|Overall Study||0
7650551|NCT02136420|18840720|P7|NOT COMPLETED|Overall Study||0
7650552|NCT02136420|18840721|P6|NOT COMPLETED|Overall Study||0
7650553|NCT02136420|18840722|P5|NOT COMPLETED|Overall Study||0
7650554|NCT02136420|18840723|P4|NOT COMPLETED|Overall Study||0
7650555|NCT02136420|18840724|P3|NOT COMPLETED|Overall Study||0
7650556|NCT02136420|18840725|P2|NOT COMPLETED|Overall Study||0
7650557|NCT02136420|18840726|P1|NOT COMPLETED|Overall Study||1
7650558|NCT02136420|18840717|P10|COMPLETED|Overall Study||5
7650559|NCT02136420|18840718|P9|COMPLETED|Overall Study||5
7650560|NCT02136420|18840719|P8|COMPLETED|Overall Study||0
7650561|NCT02136420|18840720|P7|COMPLETED|Overall Study||0
7650562|NCT02136420|18840721|P6|COMPLETED|Overall Study||0
7650563|NCT02136420|18840722|P5|COMPLETED|Overall Study||10
7650564|NCT02136420|18840723|P4|COMPLETED|Overall Study||0
7650565|NCT02136420|18840724|P3|COMPLETED|Overall Study||0
7650566|NCT02136420|18840725|P2|COMPLETED|Overall Study||0
7650567|NCT02136420|18840726|P1|COMPLETED|Overall Study||9
7650568|NCT02136420|18840717|P10|STARTED|Overall Study||5
7650569|NCT02136420|18840718|P9|STARTED|Overall Study||5
7650570|NCT02136420|18840719|P8|STARTED|Overall Study||0
7650571|NCT02136420|18840720|P7|STARTED|Overall Study||0
7650572|NCT02136420|18840721|P6|STARTED|Overall Study||0
7650573|NCT02136420|18840722|P5|STARTED|Overall Study||10
7650574|NCT02136420|18840723|P4|STARTED|Overall Study||0
7650575|NCT02136420|18840724|P3|STARTED|Overall Study||0
7650576|NCT02136420|18840725|P2|STARTED|Overall Study||0
7650577|NCT02136420|18840726|P1|STARTED|Overall Study||10
7650578|NCT02136238|18840748|P3|NOT COMPLETED|Overall Study||0
7650579|NCT02136238|18840749|P2|NOT COMPLETED|Overall Study||0
7650580|NCT02136238|18840750|P1|NOT COMPLETED|Overall Study||0
7650581|NCT02136238|18840748|P3|COMPLETED|Overall Study||10
7650582|NCT02136238|18840749|P2|COMPLETED|Overall Study||4
7650583|NCT02136238|18840750|P1|COMPLETED|Overall Study||4
7650584|NCT02136238|18840748|P3|STARTED|Overall Study||10
7650585|NCT02136238|18840749|P2|STARTED|Overall Study||4
7650586|NCT02136238|18840750|P1|STARTED|Overall Study||4
7650587|NCT02136134|18840763|P2|NOT COMPLETED|Overall Study||251
7650588|NCT02136134|18840764|P1|NOT COMPLETED|Overall Study||247
7650589|NCT02136134|18840763|P2|COMPLETED|Overall Study||0
7650590|NCT02136134|18840764|P1|COMPLETED|Overall Study||0
7650591|NCT02136134|18840763|P2|Treated|Overall Study||243
7650592|NCT02136134|18840764|P1|Treated|Overall Study||237
7650593|NCT02136134|18840763|P2|STARTED|Overall Study||251
7650594|NCT02136134|18840764|P1|STARTED|Overall Study||247
7650595|NCT02136004|18840782|P1|NOT COMPLETED|Overall Study||1
7650596|NCT02136004|18840782|P1|COMPLETED|Overall Study||219
7650597|NCT02136004|18840782|P1|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220
7650598|NCT02135900|18840793|P1|NOT COMPLETED|Overall Study||0
7650599|NCT02135900|18840793|P1|COMPLETED|Overall Study||32
7650600|NCT02135900|18840793|P1|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32
7650601|NCT02135861|18840803|P3|NOT COMPLETED|Overall Study||0
7650602|NCT02135861|18840804|P2|NOT COMPLETED|Overall Study||0
7650603|NCT02135861|18840805|P1|NOT COMPLETED|Overall Study||0
7650604|NCT02135861|18840803|P3|COMPLETED|Overall Study||3
7650605|NCT02135861|18840804|P2|COMPLETED|Overall Study||12
7650606|NCT02135861|18840805|P1|COMPLETED|Overall Study||21
7650607|NCT02135861|18840803|P3|STARTED|Overall Study||3
7650608|NCT02135861|18840804|P2|STARTED|Overall Study||12
7650609|NCT02135861|18840805|P1|STARTED|Overall Study||21
7650610|NCT02135848|18840826|P2|NOT COMPLETED|Overall Study||1
7650611|NCT02135848|18840827|P1|NOT COMPLETED|Overall Study||3
7650612|NCT02135848|18840826|P2|COMPLETED|Overall Study||19
7650613|NCT02135848|18840827|P1|COMPLETED|Overall Study||23
7650614|NCT02135848|18840826|P2|STARTED|Overall Study||20
7650615|NCT02135848|18840827|P1|STARTED|Overall Study||26
7650616|NCT02135692|18840885|P1|NOT COMPLETED|Overall Study||339
7650617|NCT02135692|18840885|P1|COMPLETED|Overall Study||0
7650618|NCT02135692|18840885|P1|STARTED|Overall Study||339
7650619|NCT02135614|18840904|P2|NOT COMPLETED|Overall Study||5
7650620|NCT02135614|18840905|P1|NOT COMPLETED|Overall Study||8
7650621|NCT02135614|18840904|P2|COMPLETED|Overall Study||90
7650622|NCT02135614|18840905|P1|COMPLETED|Overall Study||86
7650623|NCT02135614|18840904|P2|STARTED|Overall Study||95
7650624|NCT02135614|18840905|P1|STARTED|Overall Study||94
7650625|NCT02135445|18840919|P2|NOT COMPLETED|Overall Study||0
7650626|NCT02135445|18840920|P1|NOT COMPLETED|Overall Study||2
7650627|NCT02135445|18840919|P2|COMPLETED|Overall Study||38
7650628|NCT02135445|18840920|P1|COMPLETED|Overall Study||63
7650629|NCT02135445|18840919|P2|STARTED|Overall Study||38
7650630|NCT02135445|18840920|P1|STARTED|Overall Study||65
7650631|NCT02135432|18840971|P2|NOT COMPLETED|Overall Study||0
7650632|NCT02135432|18840972|P1|NOT COMPLETED|Overall Study||0
7650633|NCT02135432|18840971|P2|COMPLETED|Overall Study||4
7650634|NCT02135432|18840972|P1|COMPLETED|Overall Study||8
7650635|NCT02135432|18840971|P2|STARTED|Overall Study||4
7650636|NCT02135432|18840972|P1|STARTED|Overall Study||8
7650637|NCT02135146|18840986|P2|NOT COMPLETED|Overall Study||0
7650638|NCT02135146|18840987|P1|NOT COMPLETED|Overall Study||0
7650639|NCT02135146|18840986|P2|COMPLETED|Overall Study||20
7650640|NCT02135146|18840987|P1|COMPLETED|Overall Study||20
7650641|NCT02135146|18840986|P2|STARTED|Overall Study||20
7650642|NCT02135146|18840987|P1|STARTED|Overall Study||20
7650643|NCT02135107|18841005|P4|NOT COMPLETED|Maintenance Therapy Period||20
7650644|NCT02135107|18841006|P3|NOT COMPLETED|Maintenance Therapy Period||15
7650645|NCT02135107|18841007|P2|NOT COMPLETED|Maintenance Therapy Period||0
7650646|NCT02135107|18841008|P1|NOT COMPLETED|Maintenance Therapy Period||0
7650647|NCT02135107|18841005|P4|COMPLETED|Maintenance Therapy Period||161
7650648|NCT02135107|18841006|P3|COMPLETED|Maintenance Therapy Period||163
7650649|NCT02135107|18841007|P2|COMPLETED|Maintenance Therapy Period||0
7650650|NCT02135107|18841008|P1|COMPLETED|Maintenance Therapy Period||0
7650651|NCT02135107|18841005|P4|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|181
7650652|NCT02135107|18841006|P3|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|178
7650653|NCT02135107|18841007|P2|STARTED|Maintenance Therapy Period|Treatment Phase only|0
7650654|NCT02135107|18841008|P1|STARTED|Maintenance Therapy Period|Treatment Phase only|0
7650655|NCT02135107|18841005|P4|NOT COMPLETED|Treatment Period||0
7650656|NCT02135107|18841006|P3|NOT COMPLETED|Treatment Period||0
7650657|NCT02135107|18841007|P2|NOT COMPLETED|Treatment Period||26
7650658|NCT02135107|18841008|P1|NOT COMPLETED|Treatment Period||132
7650659|NCT02135107|18841005|P4|COMPLETED|Treatment Period||0
7650660|NCT02135107|18841006|P3|COMPLETED|Treatment Period||0
7650661|NCT02135107|18841007|P2|COMPLETED|Treatment Period||54
7650662|NCT02135107|18841008|P1|COMPLETED|Treatment Period||305
7650663|NCT02135107|18841005|P4|STARTED|Treatment Period||0
7650664|NCT02135107|18841006|P3|STARTED|Treatment Period||0
7650665|NCT02135107|18841007|P2|STARTED|Treatment Period||80
7650666|NCT02135107|18841008|P1|STARTED|Treatment Period||437
7650667|NCT02135094|18841036|P2|NOT COMPLETED|Overall Study||0
7650668|NCT02135094|18841037|P1|NOT COMPLETED|Overall Study||0
7650669|NCT02135094|18841036|P2|COMPLETED|Overall Study||8
7650670|NCT02135094|18841037|P1|COMPLETED|Overall Study||25
7650671|NCT02135094|18841036|P2|Week 4|Overall Study||8
7650672|NCT02135094|18841037|P1|Week 4|Overall Study||25
7650673|NCT02135094|18841036|P2|Week 3|Overall Study||8
7650674|NCT02135094|18841037|P1|Week 3|Overall Study||25
7650675|NCT02135094|18841036|P2|Week 2|Overall Study||8
7650676|NCT02135094|18841037|P1|Week 2|Overall Study||25
7650677|NCT02135094|18841036|P2|STARTED|Overall Study||8
7650678|NCT02135094|18841037|P1|STARTED|Overall Study||25
7650679|NCT02135029|18841054|P3|NOT COMPLETED|Overall Study||3
7650680|NCT02135029|18841055|P2|NOT COMPLETED|Overall Study||5
7650681|NCT02135029|18841056|P1|NOT COMPLETED|Overall Study||4
7650682|NCT02135029|18841054|P3|COMPLETED|Overall Study||34
7650683|NCT02135029|18841055|P2|COMPLETED|Overall Study||69
7650684|NCT02135029|18841056|P1|COMPLETED|Overall Study||69
7650685|NCT02135029|18841054|P3|Treated|Overall Study||36
7650686|NCT02135029|18841055|P2|Treated|Overall Study||74
7650687|NCT02135029|18841056|P1|Treated|Overall Study||73
7650688|NCT02135029|18841054|P3|STARTED|Overall Study||37
7650689|NCT02135029|18841055|P2|STARTED|Overall Study||74
7650690|NCT02135029|18841056|P1|STARTED|Overall Study||73
7650691|NCT02135016|18841139|P3|NOT COMPLETED|Overall Study||0
7650692|NCT02135016|18841140|P2|NOT COMPLETED|Overall Study||0
7650693|NCT02135016|18841141|P1|NOT COMPLETED|Overall Study||0
7650694|NCT02135016|18841139|P3|COMPLETED|Overall Study||15
7650695|NCT02135016|18841140|P2|COMPLETED|Overall Study||15
7650696|NCT02135016|18841141|P1|COMPLETED|Overall Study||15
7650697|NCT02135016|18841139|P3|STARTED|Overall Study||15
7650698|NCT02135016|18841140|P2|STARTED|Overall Study||15
7650699|NCT02135016|18841141|P1|STARTED|Overall Study||15
7650700|NCT02134977|18841161|P1|NOT COMPLETED|Overall Study||102
7650701|NCT02134977|18841161|P1|COMPLETED|Overall Study||2714
7650702|NCT02134977|18841161|P1|STARTED|Overall Study||2816
7650703|NCT02134951|18841184|P2|NOT COMPLETED|Overall Study||0
7650704|NCT02134951|18841185|P1|NOT COMPLETED|Overall Study||0
7650705|NCT02134951|18841184|P2|COMPLETED|Overall Study|number of subjects with at least one valid scan|20
7650706|NCT02134951|18841185|P1|COMPLETED|Overall Study|number of subjects with at least one valid scan|39
7650707|NCT02134951|18841184|P2|STARTED|Overall Study||20
7650708|NCT02134951|18841185|P1|STARTED|Overall Study||39
7650709|NCT02134925|18841195|P2|NOT COMPLETED|Overall Study||6
7650710|NCT02134925|18841196|P1|NOT COMPLETED|Overall Study||2
7650711|NCT02134925|18841195|P2|COMPLETED|Overall Study||50
7650712|NCT02134925|18841196|P1|COMPLETED|Overall Study||52
7650713|NCT02134925|18841195|P2|Received at Least One Dose of Treatment|Overall Study||50
7650714|NCT02134925|18841196|P1|Received at Least One Dose of Treatment|Overall Study||53
7650715|NCT02134925|18841195|P2|STARTED|Overall Study||56
7650716|NCT02134925|18841196|P1|STARTED|Overall Study||54
7650717|NCT02134912|18841214|P2|NOT COMPLETED|Overall Study||0
7650718|NCT02134912|18841215|P1|NOT COMPLETED|Overall Study||0
7650719|NCT02134912|18841214|P2|COMPLETED|Overall Study||0
7650720|NCT02134912|18841215|P1|COMPLETED|Overall Study||0
7650721|NCT02134912|18841214|P2|STARTED|Overall Study||0
7650722|NCT02134912|18841215|P1|STARTED|Overall Study||0
7650723|NCT02134756|18841233|P2|NOT COMPLETED|Overall Study||2
7650724|NCT02134756|18841234|P1|NOT COMPLETED|Overall Study||1
7650725|NCT02134756|18841233|P2|COMPLETED|Overall Study||13
7650726|NCT02134756|18841234|P1|COMPLETED|Overall Study||14
7650727|NCT02134756|18841233|P2|STARTED|Overall Study||15
7650728|NCT02134756|18841234|P1|STARTED|Overall Study||15
7650729|NCT02134717|18841244|P1|NOT COMPLETED|Overall Study||0
7650730|NCT02134717|18841244|P1|COMPLETED|Overall Study||3
7650731|NCT02134717|18841244|P1|STARTED|Overall Study||3
7650732|NCT02134587|18841250|P1|NOT COMPLETED|Overall Study||30
7650733|NCT02134587|18841250|P1|COMPLETED|Overall Study||173
7650734|NCT02134587|18841250|P1|STARTED|Overall Study||203
7650735|NCT02134522|18841259|P1|NOT COMPLETED|Overall Study||0
7650736|NCT02134522|18841259|P1|COMPLETED|Overall Study||1
7650737|NCT02134522|18841259|P1|STARTED|Overall Study||1
7650738|NCT02134353|18841266|P2|NOT COMPLETED|Overall Study||24
7650739|NCT02134353|18841267|P1|NOT COMPLETED|Overall Study||26
7650740|NCT02134353|18841266|P2|COMPLETED|Overall Study||190
7650741|NCT02134353|18841267|P1|COMPLETED|Overall Study||183
7650742|NCT02134353|18841266|P2|STARTED|Overall Study||214
7650743|NCT02134353|18841267|P1|STARTED|Overall Study||209
7650744|NCT02134314|18841293|P2|NOT COMPLETED|Overall Study||1
7650745|NCT02134314|18841294|P1|NOT COMPLETED|Overall Study||1
7650746|NCT02134314|18841293|P2|COMPLETED|Overall Study||34
7650747|NCT02134314|18841294|P1|COMPLETED|Overall Study||34
7650748|NCT02134314|18841293|P2|STARTED|Overall Study||35
7650749|NCT02134314|18841294|P1|STARTED|Overall Study||35
7650750|NCT02134210|18841326|P2|NOT COMPLETED|Part Two: Weeks 13-48||28
7650751|NCT02134210|18841327|P1|NOT COMPLETED|Part Two: Weeks 13-48||30
7650752|NCT02134210|18841326|P2|COMPLETED|Part Two: Weeks 13-48||227
7650753|NCT02134210|18841327|P1|COMPLETED|Part Two: Weeks 13-48||211
7650754|NCT02134210|18841326|P2|STARTED|Part Two: Weeks 13-48||255
7650755|NCT02134210|18841327|P1|STARTED|Part Two: Weeks 13-48||241
7650756|NCT02134210|18841326|P2|NOT COMPLETED|Part One: Weeks 0-12||6
7650757|NCT02134210|18841327|P1|NOT COMPLETED|Part One: Weeks 0-12||19
7650758|NCT02134210|18841326|P2|COMPLETED|Part One: Weeks 0-12||255
7650759|NCT02134210|18841327|P1|COMPLETED|Part One: Weeks 0-12||241
7650760|NCT02134210|18841326|P2|STARTED|Part One: Weeks 0-12||261
7650761|NCT02134210|18841327|P1|STARTED|Part One: Weeks 0-12||260
7650762|NCT02134184|18841360|P3|NOT COMPLETED|Overall Study||0
7650763|NCT02134184|18841361|P2|NOT COMPLETED|Overall Study||0
7650764|NCT02134184|18841362|P1|NOT COMPLETED|Overall Study||0
7650765|NCT02134184|18841360|P3|COMPLETED|Overall Study||8
7650766|NCT02134184|18841361|P2|COMPLETED|Overall Study||37
7650767|NCT02134184|18841362|P1|COMPLETED|Overall Study||33
7650768|NCT02134184|18841360|P3|STARTED|Overall Study||8
7650769|NCT02134184|18841361|P2|STARTED|Overall Study||37
7650770|NCT02134184|18841362|P1|STARTED|Overall Study||33
7650771|NCT02134119|18841375|P2|NOT COMPLETED|Overall Study||0
7650772|NCT02134119|18841376|P1|NOT COMPLETED|Overall Study||0
7650773|NCT02134119|18841375|P2|COMPLETED|Overall Study||15
7650774|NCT02134119|18841376|P1|COMPLETED|Overall Study||30
7650775|NCT02134119|18841375|P2|STARTED|Overall Study||15
7650776|NCT02134119|18841376|P1|STARTED|Overall Study||30
7650777|NCT02134028|18841422|P8|NOT COMPLETED|Overall Study||3
7650778|NCT02134028|18841423|P7|NOT COMPLETED|Overall Study||4
7650779|NCT02134028|18841424|P6|NOT COMPLETED|Overall Study||14
7650780|NCT02134028|18841425|P5|NOT COMPLETED|Overall Study||14
7650781|NCT02134028|18841426|P4|NOT COMPLETED|Overall Study||105
7650782|NCT02134028|18841427|P3|NOT COMPLETED|Overall Study||52
7650783|NCT02134028|18841428|P2|NOT COMPLETED|Overall Study||42
7650784|NCT02134028|18841429|P1|NOT COMPLETED|Overall Study||9
7650785|NCT02134028|18841422|P8|COMPLETED|Overall Study||11
7650786|NCT02134028|18841423|P7|COMPLETED|Overall Study||15
7650787|NCT02134028|18841424|P6|COMPLETED|Overall Study||76
7650788|NCT02134028|18841425|P5|COMPLETED|Overall Study||83
7650789|NCT02134028|18841426|P4|COMPLETED|Overall Study||908
7650790|NCT02134028|18841427|P3|COMPLETED|Overall Study||465
7650791|NCT02134028|18841428|P2|COMPLETED|Overall Study||379
7650792|NCT02134028|18841429|P1|COMPLETED|Overall Study||102
7650793|NCT02134028|18841422|P8|STARTED|Overall Study||14
7650794|NCT02134028|18841423|P7|STARTED|Overall Study||19
7650795|NCT02134028|18841424|P6|STARTED|Overall Study||90
7650796|NCT02134028|18841425|P5|STARTED|Overall Study||97
7650797|NCT02134028|18841426|P4|STARTED|Overall Study||1013
7650798|NCT02134028|18841427|P3|STARTED|Overall Study||517
7650799|NCT02134028|18841428|P2|STARTED|Overall Study||421
7650800|NCT02134028|18841429|P1|STARTED|Overall Study||111
7650801|NCT02134015|18841587|P2|NOT COMPLETED|Overall Study||74
7650802|NCT02134015|18841588|P1|NOT COMPLETED|Overall Study||71
7650803|NCT02134015|18841587|P2|COMPLETED|Overall Study||0
7650804|NCT02134015|18841588|P1|COMPLETED|Overall Study||0
7650805|NCT02134015|18841587|P2|STARTED|Overall Study||74
7650806|NCT02134015|18841588|P1|STARTED|Overall Study||71
7650807|NCT02133781|18841611|P3|NOT COMPLETED|Overall Study||0
7650808|NCT02133781|18841612|P2|NOT COMPLETED|Overall Study||0
7650809|NCT02133781|18841613|P1|NOT COMPLETED|Overall Study||0
7650810|NCT02133781|18841611|P3|COMPLETED|Overall Study||21
7650811|NCT02133781|18841612|P2|COMPLETED|Overall Study||24
7650812|NCT02133781|18841613|P1|COMPLETED|Overall Study||6
7650813|NCT02133781|18841611|P3|STARTED|Overall Study||21
7650814|NCT02133781|18841612|P2|STARTED|Overall Study||24
7650815|NCT02133781|18841613|P1|STARTED|Overall Study||6
7650816|NCT02133742|18841624|P1|NOT COMPLETED|Period 2:Dose Expansion Phase (1344days)||52
7650817|NCT02133742|18841624|P1|COMPLETED|Period 2:Dose Expansion Phase (1344days)||0
7650818|NCT02133742|18841624|P1|STARTED|Period 2:Dose Expansion Phase (1344days)|Participants participated in dose finding phase continued treatment in dose expansion phase.|52
7650819|NCT02133742|18841624|P1|NOT COMPLETED|Period 1: Dose Finding Phase (6 Months)||0
7650820|NCT02133742|18841624|P1|COMPLETED|Period 1: Dose Finding Phase (6 Months)||11
7650821|NCT02133742|18841624|P1|STARTED|Period 1: Dose Finding Phase (6 Months)||11
7650822|NCT02133664|18841653|P2|NOT COMPLETED|Overall Study||7
7650823|NCT02133664|18841654|P1|NOT COMPLETED|Overall Study||5
7650824|NCT02133664|18841653|P2|COMPLETED|Overall Study||21
7650825|NCT02133664|18841654|P1|COMPLETED|Overall Study||21
7650826|NCT02133664|18841653|P2|STARTED|Overall Study||28
7650827|NCT02133664|18841654|P1|STARTED|Overall Study||26
7650828|NCT02133534|18841666|P1|NOT COMPLETED|Overall Study||0
7650829|NCT02133534|18841666|P1|COMPLETED|Overall Study||1
7650830|NCT02133534|18841666|P1|STARTED|Overall Study||1
7650831|NCT02133508|18841670|P1|NOT COMPLETED|Overall Study||15
7650832|NCT02133508|18841670|P1|COMPLETED|Overall Study||141
7650833|NCT02133508|18841670|P1|STARTED|Overall Study||156
7650834|NCT02133352|18841678|P1|NOT COMPLETED|Longer Term Extension||6
7650835|NCT02133352|18841678|P1|COMPLETED|Longer Term Extension||4
7650836|NCT02133352|18841678|P1|STARTED|Longer Term Extension||10
7650837|NCT02133352|18841678|P1|NOT COMPLETED|Main Study (180 Day)||0
7650838|NCT02133352|18841678|P1|COMPLETED|Main Study (180 Day)||10
7650839|NCT02133352|18841678|P1|STARTED|Main Study (180 Day)||10
7650840|NCT02133235|18841689|P2|NOT COMPLETED|Overall Study||0
7650841|NCT02133235|18841690|P1|NOT COMPLETED|Overall Study||0
7650842|NCT02133235|18841689|P2|COMPLETED|Overall Study||57
7650843|NCT02133235|18841690|P1|COMPLETED|Overall Study||55
7650844|NCT02133235|18841689|P2|STARTED|Overall Study||57
7650845|NCT02133235|18841690|P1|STARTED|Overall Study||55
7650846|NCT02133131|18841709|P7|NOT COMPLETED|Overall Study||12
7650847|NCT02133131|18841710|P6|NOT COMPLETED|Overall Study||14
7650848|NCT02133131|18841711|P5|NOT COMPLETED|Overall Study||15
7650849|NCT02133131|18841712|P4|NOT COMPLETED|Overall Study||6
7650850|NCT02133131|18841713|P3|NOT COMPLETED|Overall Study||1
7650851|NCT02133131|18841714|P2|NOT COMPLETED|Overall Study||5
7650852|NCT02133131|18841715|P1|NOT COMPLETED|Overall Study||5
7650853|NCT02133131|18841709|P7|COMPLETED|Overall Study||0
7650854|NCT02133131|18841710|P6|COMPLETED|Overall Study||0
7650855|NCT02133131|18841711|P5|COMPLETED|Overall Study||0
7650856|NCT02133131|18841712|P4|COMPLETED|Overall Study||15
7650857|NCT02133131|18841713|P3|COMPLETED|Overall Study||19
7650858|NCT02133131|18841714|P2|COMPLETED|Overall Study||25
7650859|NCT02133131|18841715|P1|COMPLETED|Overall Study||26
7650860|NCT02133131|18841709|P7|STARTED|Overall Study||12
7650861|NCT02133131|18841710|P6|STARTED|Overall Study||14
7650862|NCT02133131|18841711|P5|STARTED|Overall Study||15
7650863|NCT02133131|18841712|P4|STARTED|Overall Study||21
7650864|NCT02133131|18841713|P3|STARTED|Overall Study||20
7650865|NCT02133131|18841714|P2|STARTED|Overall Study||30
7650866|NCT02133131|18841715|P1|STARTED|Overall Study||31
7650867|NCT02133066|18841754|P2|NOT COMPLETED|Overall Study||0
7650868|NCT02133066|18841755|P1|NOT COMPLETED|Overall Study||0
7650869|NCT02133066|18841754|P2|COMPLETED|Overall Study||64
7650870|NCT02133066|18841755|P1|COMPLETED|Overall Study||64
7650871|NCT02133066|18841754|P2|STARTED|Overall Study||64
7650872|NCT02133066|18841755|P1|STARTED|Overall Study||64
7650873|NCT02133001|18841769|P2|NOT COMPLETED|Follow-Up Phase (Day 26-81)||3
7650874|NCT02133001|18841770|P1|NOT COMPLETED|Follow-Up Phase (Day 26-81)||2
7650875|NCT02133001|18841769|P2|COMPLETED|Follow-Up Phase (Day 26-81)||24
7650876|NCT02133001|18841770|P1|COMPLETED|Follow-Up Phase (Day 26-81)||20
7650877|NCT02133001|18841769|P2|STARTED|Follow-Up Phase (Day 26-81)||27
7650878|NCT02133001|18841770|P1|STARTED|Follow-Up Phase (Day 26-81)||22
7650879|NCT02133001|18841769|P2|NOT COMPLETED|Double Blind (Day 1-25)||9
7650880|NCT02133001|18841770|P1|NOT COMPLETED|Double Blind (Day 1-25)||10
7650881|NCT02133001|18841769|P2|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|27
7650882|NCT02133001|18841770|P1|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|22
7650883|NCT02133001|18841769|P2|Safety|Double Blind (Day 1-25)||35
7650884|NCT02133001|18841770|P1|Safety|Double Blind (Day 1-25)||31
7650885|NCT02133001|18841769|P2|STARTED|Double Blind (Day 1-25)||36
7650886|NCT02133001|18841770|P1|STARTED|Double Blind (Day 1-25)||32
7650887|NCT02132949|18841818|P2|NOT COMPLETED|Adjuvant Treatment Period||167
7650888|NCT02132949|18841819|P1|NOT COMPLETED|Adjuvant Treatment Period||149
7650889|NCT02132949|18841818|P2|COMPLETED|Adjuvant Treatment Period||23
7650890|NCT02132949|18841819|P1|COMPLETED|Adjuvant Treatment Period||29
7650891|NCT02132949|18841818|P2|STARTED|Adjuvant Treatment Period|Includes a participant who did not complete neoadjuvant treatment but started adjuvant treatment.|190
7650892|NCT02132949|18841819|P1|STARTED|Adjuvant Treatment Period|At clinical cutoff (03 March 2016), some participants had not yet received adjuvant treatment.|178
7650893|NCT02132949|18841818|P2|NOT COMPLETED|Neoadjuvant Treatment Period||12
7650894|NCT02132949|18841819|P1|NOT COMPLETED|Neoadjuvant Treatment Period||17
7650895|NCT02132949|18841818|P2|COMPLETED|Neoadjuvant Treatment Period||189
7650896|NCT02132949|18841819|P1|COMPLETED|Neoadjuvant Treatment Period||182
7650897|NCT02132949|18841818|P2|No Treatment|Neoadjuvant Treatment Period||3
7650898|NCT02132949|18841819|P1|No Treatment|Neoadjuvant Treatment Period||1
7650899|NCT02132949|18841818|P2|STARTED|Neoadjuvant Treatment Period||201
7650900|NCT02132949|18841819|P1|STARTED|Neoadjuvant Treatment Period|A participant enrolled in Cohort B received Cohort A treatment, hence counted under Cohort A.|199
7650901|NCT02132936|18841851|P4|NOT COMPLETED|Overall Study||14
7650902|NCT02132936|18841852|P3|NOT COMPLETED|Overall Study||14
7650903|NCT02132936|18841853|P2|NOT COMPLETED|Overall Study||9
7650904|NCT02132936|18841854|P1|NOT COMPLETED|Overall Study||10
7650905|NCT02132936|18841851|P4|COMPLETED|Overall Study||29
7650906|NCT02132936|18841852|P3|COMPLETED|Overall Study||174
7650907|NCT02132936|18841853|P2|COMPLETED|Overall Study||38
7650908|NCT02132936|18841854|P1|COMPLETED|Overall Study||175
7650909|NCT02132936|18841851|P4|STARTED|Overall Study||43
7650910|NCT02132936|18841852|P3|STARTED|Overall Study||188
7650911|NCT02132936|18841853|P2|STARTED|Overall Study||47
7650912|NCT02132936|18841854|P1|STARTED|Overall Study||185
7650913|NCT02132910|18841872|P2|NOT COMPLETED|Overall Study||0
7650914|NCT02132910|18841873|P1|NOT COMPLETED|Overall Study||0
7650915|NCT02132910|18841872|P2|COMPLETED|Overall Study||34
7650916|NCT02132910|18841873|P1|COMPLETED|Overall Study||34
7650917|NCT02132910|18841872|P2|STARTED|Overall Study||34
7650918|NCT02132910|18841873|P1|STARTED|Overall Study||34
7650919|NCT02132884|18841887|P2|NOT COMPLETED|Overall Study||0
7650920|NCT02132884|18841888|P1|NOT COMPLETED|Overall Study||0
7650921|NCT02132884|18841887|P2|COMPLETED|Overall Study||0
7650922|NCT02132884|18841888|P1|COMPLETED|Overall Study||0
7650923|NCT02132884|18841887|P2|STARTED|Overall Study||0
7650924|NCT02132884|18841888|P1|STARTED|Overall Study||0
7650925|NCT02132832|18841900|P2|NOT COMPLETED|Overall Study||7
7650926|NCT02132832|18841901|P1|NOT COMPLETED|Overall Study||3
7650927|NCT02132832|18841900|P2|COMPLETED|Overall Study||16
7650928|NCT02132832|18841901|P1|COMPLETED|Overall Study||16
7650929|NCT02132832|18841900|P2|STARTED|Overall Study||23
7650930|NCT02132832|18841901|P1|STARTED|Overall Study||19
7650931|NCT02132767|18841931|P2|NOT COMPLETED|Overall Study||15
7650932|NCT02132767|18841932|P1|NOT COMPLETED|Overall Study||17
7650933|NCT02132767|18841931|P2|COMPLETED|Overall Study||246
7650934|NCT02132767|18841932|P1|COMPLETED|Overall Study||245
7650935|NCT02132767|18841931|P2|STARTED|Overall Study||261
7650936|NCT02132767|18841932|P1|STARTED|Overall Study||262
7650937|NCT02132754|18841986|P34|NOT COMPLETED|Overall Study||23
7650938|NCT02132754|18841987|P33|NOT COMPLETED|Overall Study||4
7650939|NCT02132754|18841988|P32|NOT COMPLETED|Overall Study||3
7650940|NCT02132754|18841989|P31|NOT COMPLETED|Overall Study||3
7650941|NCT02132754|18841990|P30|NOT COMPLETED|Overall Study||3
7650942|NCT02132754|18841991|P29|NOT COMPLETED|Overall Study||3
7650943|NCT02132754|18841992|P28|NOT COMPLETED|Overall Study||3
7650944|NCT02132754|18841993|P27|NOT COMPLETED|Overall Study||4
7650945|NCT02132754|18841994|P26|NOT COMPLETED|Overall Study||3
7650946|NCT02132754|18841995|P25|NOT COMPLETED|Overall Study||3
7650947|NCT02132754|18841996|P24|NOT COMPLETED|Overall Study||3
7650948|NCT02132754|18841997|P23|NOT COMPLETED|Overall Study||3
7650949|NCT02132754|18841998|P22|NOT COMPLETED|Overall Study||5
7650950|NCT02132754|18841999|P21|NOT COMPLETED|Overall Study||3
7650951|NCT02132754|18842000|P20|NOT COMPLETED|Overall Study||4
7650952|NCT02132754|18842001|P19|NOT COMPLETED|Overall Study||3
7650953|NCT02132754|18842002|P18|NOT COMPLETED|Overall Study||3
7650954|NCT02132754|18842003|P17|NOT COMPLETED|Overall Study||4
7650955|NCT02132754|18842004|P16|NOT COMPLETED|Overall Study||5
7650956|NCT02132754|18842005|P15|NOT COMPLETED|Overall Study||3
7650957|NCT02132754|18842006|P14|NOT COMPLETED|Overall Study||3
7650958|NCT02132754|18842007|P13|NOT COMPLETED|Overall Study||4
7650959|NCT02132754|18842008|P12|NOT COMPLETED|Overall Study||3
7650960|NCT02132754|18842009|P11|NOT COMPLETED|Overall Study||3
7650961|NCT02132754|18842010|P10|NOT COMPLETED|Overall Study||6
7650962|NCT02132754|18842011|P9|NOT COMPLETED|Overall Study||1
7650963|NCT02132754|18842012|P8|NOT COMPLETED|Overall Study||1
7650964|NCT02132754|18842013|P7|NOT COMPLETED|Overall Study||1
7650965|NCT02132754|18842014|P6|NOT COMPLETED|Overall Study||1
7650966|NCT02132754|18842015|P5|NOT COMPLETED|Overall Study||1
7650967|NCT02132754|18842016|P4|NOT COMPLETED|Overall Study||1
7650968|NCT02132754|18842017|P3|NOT COMPLETED|Overall Study||1
7650969|NCT02132754|18842018|P2|NOT COMPLETED|Overall Study||1
7650970|NCT02132754|18842019|P1|NOT COMPLETED|Overall Study||1
7650971|NCT02132754|18841986|P34|COMPLETED|Overall Study||0
7650972|NCT02132754|18841987|P33|COMPLETED|Overall Study||0
7650973|NCT02132754|18841988|P32|COMPLETED|Overall Study||0
7650974|NCT02132754|18841989|P31|COMPLETED|Overall Study||0
7650975|NCT02132754|18841990|P30|COMPLETED|Overall Study||0
7650976|NCT02132754|18841991|P29|COMPLETED|Overall Study||0
7650977|NCT02132754|18841992|P28|COMPLETED|Overall Study||0
7650978|NCT02132754|18841993|P27|COMPLETED|Overall Study||0
7650979|NCT02132754|18841994|P26|COMPLETED|Overall Study||0
7650980|NCT02132754|18841995|P25|COMPLETED|Overall Study||0
7650981|NCT02132754|18841996|P24|COMPLETED|Overall Study||0
7650982|NCT02132754|18841997|P23|COMPLETED|Overall Study||0
7650983|NCT02132754|18841998|P22|COMPLETED|Overall Study||0
7650984|NCT02132754|18841999|P21|COMPLETED|Overall Study||0
7650985|NCT02132754|18842000|P20|COMPLETED|Overall Study||0
7650986|NCT02132754|18842001|P19|COMPLETED|Overall Study||0
7650987|NCT02132754|18842002|P18|COMPLETED|Overall Study||0
7650988|NCT02132754|18842003|P17|COMPLETED|Overall Study||0
7650989|NCT02132754|18842004|P16|COMPLETED|Overall Study||0
7650990|NCT02132754|18842005|P15|COMPLETED|Overall Study||0
7650991|NCT02132754|18842006|P14|COMPLETED|Overall Study||0
7650992|NCT02132754|18842007|P13|COMPLETED|Overall Study||0
7650993|NCT02132754|18842008|P12|COMPLETED|Overall Study||0
7650994|NCT02132754|18842009|P11|COMPLETED|Overall Study||0
7650995|NCT02132754|18842010|P10|COMPLETED|Overall Study||0
7650996|NCT02132754|18842011|P9|COMPLETED|Overall Study||0
7650997|NCT02132754|18842012|P8|COMPLETED|Overall Study||0
7650998|NCT02132754|18842013|P7|COMPLETED|Overall Study||0
7650999|NCT02132754|18842014|P6|COMPLETED|Overall Study||0
7651000|NCT02132754|18842015|P5|COMPLETED|Overall Study||0
7651001|NCT02132754|18842016|P4|COMPLETED|Overall Study||0
7651002|NCT02132754|18842017|P3|COMPLETED|Overall Study||0
7651003|NCT02132754|18842018|P2|COMPLETED|Overall Study||0
7651004|NCT02132754|18842019|P1|COMPLETED|Overall Study||0
7651005|NCT02132754|18841986|P34|Treated|Overall Study||23
7651006|NCT02132754|18841987|P33|Treated|Overall Study||4
7651007|NCT02132754|18841988|P32|Treated|Overall Study||3
7651008|NCT02132754|18841989|P31|Treated|Overall Study||3
7651009|NCT02132754|18841990|P30|Treated|Overall Study||3
7651010|NCT02132754|18841991|P29|Treated|Overall Study||3
7651011|NCT02132754|18841992|P28|Treated|Overall Study||3
7651012|NCT02132754|18841993|P27|Treated|Overall Study||4
7651013|NCT02132754|18841994|P26|Treated|Overall Study||3
7651014|NCT02132754|18841995|P25|Treated|Overall Study||3
7651015|NCT02132754|18841996|P24|Treated|Overall Study||3
7651016|NCT02132754|18841997|P23|Treated|Overall Study||3
7651017|NCT02132754|18841998|P22|Treated|Overall Study||4
7651018|NCT02132754|18841999|P21|Treated|Overall Study||3
7651019|NCT02132754|18842000|P20|Treated|Overall Study||3
7651020|NCT02132754|18842001|P19|Treated|Overall Study||3
7651021|NCT02132754|18842002|P18|Treated|Overall Study||3
7651022|NCT02132754|18842003|P17|Treated|Overall Study||4
7651023|NCT02132754|18842004|P16|Treated|Overall Study||5
7651024|NCT02132754|18842005|P15|Treated|Overall Study||3
7651025|NCT02132754|18842006|P14|Treated|Overall Study||3
7651026|NCT02132754|18842007|P13|Treated|Overall Study||3
7651027|NCT02132754|18842008|P12|Treated|Overall Study||3
7651028|NCT02132754|18842009|P11|Treated|Overall Study||3
7651029|NCT02132754|18842010|P10|Treated|Overall Study||6
7651030|NCT02132754|18842011|P9|Treated|Overall Study||1
7651031|NCT02132754|18842012|P8|Treated|Overall Study||1
7651032|NCT02132754|18842013|P7|Treated|Overall Study||1
7651033|NCT02132754|18842014|P6|Treated|Overall Study||1
7651034|NCT02132754|18842015|P5|Treated|Overall Study||1
7651035|NCT02132754|18842016|P4|Treated|Overall Study||1
7651036|NCT02132754|18842017|P3|Treated|Overall Study||1
7651037|NCT02132754|18842018|P2|Treated|Overall Study||1
7651038|NCT02132754|18842019|P1|Treated|Overall Study||1
7651039|NCT02132754|18841986|P34|STARTED|Overall Study||23
7651040|NCT02132754|18841987|P33|STARTED|Overall Study||4
7651041|NCT02132754|18841988|P32|STARTED|Overall Study||3
7651042|NCT02132754|18841989|P31|STARTED|Overall Study||3
7651043|NCT02132754|18841990|P30|STARTED|Overall Study||3
7651044|NCT02132754|18841991|P29|STARTED|Overall Study||3
7651045|NCT02132754|18841992|P28|STARTED|Overall Study||3
7651046|NCT02132754|18841993|P27|STARTED|Overall Study||4
7651047|NCT02132754|18841994|P26|STARTED|Overall Study||3
7651048|NCT02132754|18841995|P25|STARTED|Overall Study||3
7651049|NCT02132754|18841996|P24|STARTED|Overall Study||3
7651050|NCT02132754|18841997|P23|STARTED|Overall Study||3
7651051|NCT02132754|18841998|P22|STARTED|Overall Study||5
7651052|NCT02132754|18841999|P21|STARTED|Overall Study||3
7651053|NCT02132754|18842000|P20|STARTED|Overall Study||4
7651054|NCT02132754|18842001|P19|STARTED|Overall Study||3
7651055|NCT02132754|18842002|P18|STARTED|Overall Study||3
7651056|NCT02132754|18842003|P17|STARTED|Overall Study||4
7651057|NCT02132754|18842004|P16|STARTED|Overall Study||5
7651058|NCT02132754|18842005|P15|STARTED|Overall Study||3
7651059|NCT02132754|18842006|P14|STARTED|Overall Study||3
7651060|NCT02132754|18842007|P13|STARTED|Overall Study||4
7651061|NCT02132754|18842008|P12|STARTED|Overall Study||3
7651062|NCT02132754|18842009|P11|STARTED|Overall Study||3
7651063|NCT02132754|18842010|P10|STARTED|Overall Study||6
7651064|NCT02132754|18842011|P9|STARTED|Overall Study||1
7651065|NCT02132754|18842012|P8|STARTED|Overall Study||1
7651066|NCT02132754|18842013|P7|STARTED|Overall Study||1
7651067|NCT02132754|18842014|P6|STARTED|Overall Study||1
7651068|NCT02132754|18842015|P5|STARTED|Overall Study||1
7651069|NCT02132754|18842016|P4|STARTED|Overall Study||1
7651070|NCT02132754|18842017|P3|STARTED|Overall Study||1
7651071|NCT02132754|18842018|P2|STARTED|Overall Study||1
7651072|NCT02132754|18842019|P1|STARTED|Overall Study||1
7651073|NCT02132676|18842743|P2|NOT COMPLETED|Overall Study||0
7651074|NCT02132676|18842744|P1|NOT COMPLETED|Overall Study||0
7651075|NCT02132676|18842743|P2|COMPLETED|Overall Study||809
7651076|NCT02132676|18842744|P1|COMPLETED|Overall Study||727
7651077|NCT02132676|18842743|P2|STARTED|Overall Study||809
7651078|NCT02132676|18842744|P1|STARTED|Overall Study||727
7651079|NCT02132650|18842776|P2|NOT COMPLETED|Overall Study||4
7651080|NCT02132650|18842777|P1|NOT COMPLETED|Overall Study||3
7651081|NCT02132650|18842776|P2|COMPLETED|Overall Study||14
7651082|NCT02132650|18842777|P1|COMPLETED|Overall Study||17
7651083|NCT02132650|18842776|P2|Post-Intervention Assessment|Overall Study||17
7651084|NCT02132650|18842777|P1|Post-Intervention Assessment|Overall Study||19
7651085|NCT02132650|18842776|P2|STARTED|Overall Study||18
7651086|NCT02132650|18842777|P1|STARTED|Overall Study||20
7651087|NCT02132637|18842787|P2|NOT COMPLETED|Study Period 2 (Crossover)||1
7651088|NCT02132637|18842788|P1|NOT COMPLETED|Study Period 2 (Crossover)||2
7651089|NCT02132637|18842787|P2|COMPLETED|Study Period 2 (Crossover)||29
7651090|NCT02132637|18842788|P1|COMPLETED|Study Period 2 (Crossover)||31
7651091|NCT02132637|18842787|P2|STARTED|Study Period 2 (Crossover)||30
7651092|NCT02132637|18842788|P1|STARTED|Study Period 2 (Crossover)||33
7651093|NCT02132637|18842787|P2|NOT COMPLETED|Study Period 1||4
7651094|NCT02132637|18842788|P1|NOT COMPLETED|Study Period 1||1
7651095|NCT02132637|18842787|P2|COMPLETED|Study Period 1||30
7651096|NCT02132637|18842788|P1|COMPLETED|Study Period 1||33
7651097|NCT02132637|18842787|P2|Received at Least One Dose of Study Drug|Study Period 1||34
7651098|NCT02132637|18842788|P1|Received at Least One Dose of Study Drug|Study Period 1||34
7651099|NCT02132637|18842787|P2|STARTED|Study Period 1||34
7651100|NCT02132637|18842788|P1|STARTED|Study Period 1||34
7651101|NCT02132611|18842812|P1|NOT COMPLETED|Overall Study||2
7651102|NCT02132611|18842812|P1|COMPLETED|Overall Study||98
7651103|NCT02132611|18842812|P1|STARTED|Overall Study||100
7651104|NCT02132598|18842817|P1|NOT COMPLETED|Overall Study||0
7651105|NCT02132598|18842817|P1|COMPLETED|Overall Study||5
7651106|NCT02132598|18842817|P1|STARTED|Overall Study||5
7651107|NCT02132572|18842829|P1|NOT COMPLETED|Overall Study||0
7651108|NCT02132572|18842829|P1|COMPLETED|Overall Study||201
7651109|NCT02132572|18842829|P1|STARTED|Overall Study||201
7651110|NCT02132533|18842835|P2|NOT COMPLETED|Overall Study||0
7651111|NCT02132533|18842836|P1|NOT COMPLETED|Overall Study||0
7651112|NCT02132533|18842835|P2|COMPLETED|Overall Study||42
7651113|NCT02132533|18842836|P1|COMPLETED|Overall Study||46
7651114|NCT02132533|18842835|P2|STARTED|Overall Study||42
7651115|NCT02132533|18842836|P1|STARTED|Overall Study||46
7651116|NCT02132520|18842851|P3|NOT COMPLETED|Overall Study||0
7651117|NCT02132520|18842852|P2|NOT COMPLETED|Overall Study||0
7651118|NCT02132520|18842853|P1|NOT COMPLETED|Overall Study||0
7651119|NCT02132520|18842851|P3|COMPLETED|Overall Study||2
7651120|NCT02132520|18842852|P2|COMPLETED|Overall Study||1
7651121|NCT02132520|18842853|P1|COMPLETED|Overall Study||0
7651122|NCT02132520|18842851|P3|STARTED|Overall Study||2
7651123|NCT02132520|18842852|P2|STARTED|Overall Study||1
7651124|NCT02132520|18842853|P1|STARTED|Overall Study||0
7651125|NCT02132468|18842866|P1|NOT COMPLETED|Overall Study||7
7651126|NCT02132468|18842866|P1|COMPLETED|Overall Study||11
7651127|NCT02132468|18842866|P1|STARTED|Overall Study||18
7651128|NCT02132247|18842875|P2|NOT COMPLETED|Overall Study||0
7651129|NCT02132247|18842876|P1|NOT COMPLETED|Overall Study||1
7651130|NCT02132247|18842875|P2|COMPLETED|Overall Study||52
7651131|NCT02132247|18842876|P1|COMPLETED|Overall Study||51
7651132|NCT02132247|18842875|P2|STARTED|Overall Study||52
7651133|NCT02132247|18842876|P1|STARTED|Overall Study||52
7651134|NCT02132195|18842891|P3|NOT COMPLETED|Rescue Therapy||11
7651135|NCT02132195|18842892|P2|NOT COMPLETED|Rescue Therapy||0
7651136|NCT02132195|18842893|P1|NOT COMPLETED|Rescue Therapy||0
7651137|NCT02132195|18842891|P3|COMPLETED|Rescue Therapy||2
7651138|NCT02132195|18842892|P2|COMPLETED|Rescue Therapy||0
7651139|NCT02132195|18842893|P1|COMPLETED|Rescue Therapy||0
7651140|NCT02132195|18842891|P3|STARTED|Rescue Therapy||13
7651141|NCT02132195|18842892|P2|STARTED|Rescue Therapy||0
7651142|NCT02132195|18842893|P1|STARTED|Rescue Therapy||0
7651143|NCT02132195|18842891|P3|NOT COMPLETED|Initial Assignment||0
7651144|NCT02132195|18842892|P2|NOT COMPLETED|Initial Assignment||0
7651145|NCT02132195|18842893|P1|NOT COMPLETED|Initial Assignment||14
7651146|NCT02132195|18842891|P3|COMPLETED|Initial Assignment||0
7651147|NCT02132195|18842892|P2|COMPLETED|Initial Assignment||16
7651148|NCT02132195|18842893|P1|COMPLETED|Initial Assignment||1
7651149|NCT02132195|18842891|P3|STARTED|Initial Assignment||0
7651150|NCT02132195|18842892|P2|STARTED|Initial Assignment||16
7651151|NCT02132195|18842893|P1|STARTED|Initial Assignment||15
7651152|NCT02132169|18842909|P2|NOT COMPLETED|Overall Study||9
7651153|NCT02132169|18842910|P1|NOT COMPLETED|Overall Study||15
7651154|NCT02132169|18842909|P2|COMPLETED|Overall Study||162
7651155|NCT02132169|18842910|P1|COMPLETED|Overall Study||326
7651156|NCT02132169|18842909|P2|STARTED|Overall Study||171
7651157|NCT02132169|18842910|P1|STARTED|Overall Study||341
7651158|NCT02132117|18842924|P2|NOT COMPLETED|Overall Study||5
7651159|NCT02132117|18842925|P1|NOT COMPLETED|Overall Study||11
7651160|NCT02132117|18842924|P2|COMPLETED|Overall Study||216
7651161|NCT02132117|18842925|P1|COMPLETED|Overall Study||213
7651162|NCT02132117|18842924|P2|STARTED|Overall Study||221
7651163|NCT02132117|18842925|P1|STARTED|Overall Study||224
7651164|NCT02131766|18842941|P1|NOT COMPLETED|Overall Study||4
7651165|NCT02131766|18842941|P1|COMPLETED|Overall Study||40
7651166|NCT02131766|18842941|P1|STARTED|Overall Study||44
7651167|NCT02131662|18842957|P5|NOT COMPLETED|Overall Study||18
7651168|NCT02131662|18842958|P4|NOT COMPLETED|Overall Study||21
7651169|NCT02131662|18842959|P3|NOT COMPLETED|Overall Study||7
7651170|NCT02131662|18842960|P2|NOT COMPLETED|Overall Study||14
7651171|NCT02131662|18842961|P1|NOT COMPLETED|Overall Study||8
7651172|NCT02131662|18842957|P5|COMPLETED|Overall Study||43
7651173|NCT02131662|18842958|P4|COMPLETED|Overall Study||41
7651174|NCT02131662|18842959|P3|COMPLETED|Overall Study||56
7651175|NCT02131662|18842960|P2|COMPLETED|Overall Study||47
7651176|NCT02131662|18842961|P1|COMPLETED|Overall Study||54
7651177|NCT02131662|18842957|P5|Completed Follow-up|Overall Study||44
7651178|NCT02131662|18842958|P4|Completed Follow-up|Overall Study||42
7651179|NCT02131662|18842959|P3|Completed Follow-up|Overall Study||56
7651180|NCT02131662|18842960|P2|Completed Follow-up|Overall Study||47
7651181|NCT02131662|18842961|P1|Completed Follow-up|Overall Study||54
7651182|NCT02131662|18842957|P5|Completed Treatment|Overall Study||52
7651183|NCT02131662|18842958|P4|Completed Treatment|Overall Study||56
7651184|NCT02131662|18842959|P3|Completed Treatment|Overall Study||61
7651185|NCT02131662|18842960|P2|Completed Treatment|Overall Study||60
7651186|NCT02131662|18842961|P1|Completed Treatment|Overall Study||57
7651187|NCT02131662|18842957|P5|Treated|Overall Study||58
7651188|NCT02131662|18842958|P4|Treated|Overall Study||60
7651189|NCT02131662|18842959|P3|Treated|Overall Study||61
7651190|NCT02131662|18842960|P2|Treated|Overall Study||61
7651191|NCT02131662|18842961|P1|Treated|Overall Study||60
7651192|NCT02131662|18842957|P5|STARTED|Overall Study||61
7651193|NCT02131662|18842958|P4|STARTED|Overall Study||62
7651194|NCT02131662|18842959|P3|STARTED|Overall Study||63
7651195|NCT02131662|18842960|P2|STARTED|Overall Study||61
7651196|NCT02131662|18842961|P1|STARTED|Overall Study||62
7651197|NCT02131636|18843007|P2|NOT COMPLETED|Overall Study||5
7651198|NCT02131636|18843008|P1|NOT COMPLETED|Overall Study||12
7651199|NCT02131636|18843007|P2|COMPLETED|Overall Study||213
7651200|NCT02131636|18843008|P1|COMPLETED|Overall Study||210
7651201|NCT02131636|18843007|P2|STARTED|Overall Study||218
7651202|NCT02131636|18843008|P1|STARTED|Overall Study||222
7651203|NCT02131532|18843024|P1|NOT COMPLETED|Overall Study||4
7651204|NCT02131532|18843024|P1|COMPLETED|Overall Study||8
7651205|NCT02131532|18843024|P1|STARTED|Overall Study||12
7651206|NCT02131402|18843043|P1|NOT COMPLETED|Overall Study||0
7651207|NCT02131402|18843043|P1|COMPLETED|Overall Study||60
7651208|NCT02131402|18843043|P1|STARTED|Overall Study||60
7651209|NCT02131324|18843116|P2|NOT COMPLETED|Overall Study||3
7651210|NCT02131324|18843117|P1|NOT COMPLETED|Overall Study||2
7651211|NCT02131324|18843116|P2|COMPLETED|Overall Study||23
7651212|NCT02131324|18843117|P1|COMPLETED|Overall Study||22
7651213|NCT02131324|18843116|P2|Analyzed|Overall Study||24
7651214|NCT02131324|18843117|P1|Analyzed|Overall Study||22
7651215|NCT02131324|18843116|P2|STARTED|Overall Study|2 subjects randomized into DFD-06 not included in analysis as there was no post-baseline information|26
7651216|NCT02131324|18843117|P1|STARTED|Overall Study|2 subjects randomized into Comp01 not included in analysis as there was no post-baseline information|24
7651217|NCT02131311|18843123|P1|NOT COMPLETED|Overall Study||4
7651218|NCT02131311|18843123|P1|COMPLETED|Overall Study||86
7651219|NCT02131311|18843123|P1|STARTED|Overall Study||90
7651220|NCT02131272|18843135|P2|NOT COMPLETED|Overall Study||2
7651221|NCT02131272|18843136|P1|NOT COMPLETED|Overall Study||1
7651222|NCT02131272|18843135|P2|COMPLETED|Overall Study||20
7651223|NCT02131272|18843136|P1|COMPLETED|Overall Study||19
7651224|NCT02131272|18843135|P2|STARTED|Overall Study||22
7651225|NCT02131272|18843136|P1|STARTED|Overall Study||20
7651226|NCT02131259|18843154|P1|NOT COMPLETED|Overall Study||1225
7651227|NCT02131259|18843154|P1|COMPLETED|Overall Study|Completed is defined as 52 weeks follow-up after starting administration of GIOTRIF® tablets.|377
7651228|NCT02131259|18843154|P1|STARTED|Overall Study|Patients received treatment of GIOTRIF® Tablets|1602
7651229|NCT02131233|18843161|P2|NOT COMPLETED|Overall Study||42
7651230|NCT02131233|18843162|P1|NOT COMPLETED|Overall Study||66
7651231|NCT02131233|18843161|P2|COMPLETED|Overall Study|Completed to Week 96|227
7651232|NCT02131233|18843162|P1|COMPLETED|Overall Study|Completed to Week 96|467
7651233|NCT02131233|18843161|P2|Treated|Overall Study||266
7651234|NCT02131233|18843162|P1|Treated|Overall Study||531
7651235|NCT02131233|18843161|P2|STARTED|Overall Study|Enrolled participants|269
7651236|NCT02131233|18843162|P1|STARTED|Overall Study|Enrolled participants|533
7651237|NCT02131155|18843196|P2|NOT COMPLETED|Overall Study||11
7651238|NCT02131155|18843197|P1|NOT COMPLETED|Overall Study||25
7651239|NCT02131155|18843196|P2|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
7651240|NCT02131155|18843197|P1|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
7651241|NCT02131155|18843196|P2|STARTED|Overall Study|Started are treated patients.|11
7651242|NCT02131155|18843197|P1|STARTED|Overall Study|Started are treated patients.|25
7651243|NCT02131129|18843211|P2|NOT COMPLETED|Overall Study||0
7651244|NCT02131129|18843212|P1|NOT COMPLETED|Overall Study||1
7651245|NCT02131129|18843211|P2|COMPLETED|Overall Study||10
7651246|NCT02131129|18843212|P1|COMPLETED|Overall Study||9
7651247|NCT02131129|18843211|P2|STARTED|Overall Study||10
7651248|NCT02131129|18843212|P1|STARTED|Overall Study||10
7651249|NCT02131064|18843230|P2|NOT COMPLETED|Overall Study||34
7651250|NCT02131064|18843231|P1|NOT COMPLETED|Overall Study||25
7651251|NCT02131064|18843230|P2|COMPLETED|Overall Study||189
7651252|NCT02131064|18843231|P1|COMPLETED|Overall Study||196
7651253|NCT02131064|18843230|P2|STARTED|Overall Study||223
7651254|NCT02131064|18843231|P1|STARTED|Overall Study||221
7651255|NCT02130999|18843271|P2|NOT COMPLETED|Overall Study||0
7651256|NCT02130999|18843272|P1|NOT COMPLETED|Overall Study||0
7651257|NCT02130999|18843271|P2|COMPLETED|Overall Study||8
7651258|NCT02130999|18843272|P1|COMPLETED|Overall Study||6
7651259|NCT02130999|18843271|P2|STARTED|Overall Study||8
7651260|NCT02130999|18843272|P1|STARTED|Overall Study||6
7651261|NCT02130986|18843300|P2|NOT COMPLETED|Overall Study||164
7651262|NCT02130986|18843301|P1|NOT COMPLETED|Overall Study||155
7651263|NCT02130986|18843300|P2|COMPLETED|Overall Study||670
7651264|NCT02130986|18843301|P1|COMPLETED|Overall Study||675
7651265|NCT02130986|18843300|P2|STARTED|Overall Study||834
7651266|NCT02130986|18843301|P1|STARTED|Overall Study||830
7651267|NCT02130765|18843315|P4|NOT COMPLETED|Overall Study||0
7651268|NCT02130765|18843316|P3|NOT COMPLETED|Overall Study||0
7651269|NCT02130765|18843317|P2|NOT COMPLETED|Overall Study||0
7651270|NCT02130765|18843318|P1|NOT COMPLETED|Overall Study||4
7651271|NCT02130765|18843315|P4|COMPLETED|Overall Study||19
7651272|NCT02130765|18843316|P3|COMPLETED|Overall Study||26
7651273|NCT02130765|18843317|P2|COMPLETED|Overall Study||8
7651274|NCT02130765|18843318|P1|COMPLETED|Overall Study||7
7651275|NCT02130765|18843315|P4|STARTED|Overall Study||19
7651276|NCT02130765|18843316|P3|STARTED|Overall Study||26
7651277|NCT02130765|18843317|P2|STARTED|Overall Study||8
7651278|NCT02130765|18843318|P1|STARTED|Overall Study||11
7651279|NCT02130635|18843346|P9|NOT COMPLETED|Part B-Dose-Response Relationship||0
7651280|NCT02130635|18843347|P8|NOT COMPLETED|Part B-Dose-Response Relationship||0
7651281|NCT02130635|18843348|P7|NOT COMPLETED|Part B-Dose-Response Relationship||0
7651282|NCT02130635|18843349|P6|NOT COMPLETED|Part B-Dose-Response Relationship||0
7651283|NCT02130635|18843350|P5|NOT COMPLETED|Part B-Dose-Response Relationship||0
7651284|NCT02130635|18843351|P4|NOT COMPLETED|Part B-Dose-Response Relationship||0
7651285|NCT02130635|18843352|P3|NOT COMPLETED|Part B-Dose-Response Relationship||0
7651286|NCT02130635|18843353|P2|NOT COMPLETED|Part B-Dose-Response Relationship||0
7651287|NCT02130635|18843354|P1|NOT COMPLETED|Part B-Dose-Response Relationship||0
7651288|NCT02130635|18843346|P9|COMPLETED|Part B-Dose-Response Relationship||5
7651289|NCT02130635|18843347|P8|COMPLETED|Part B-Dose-Response Relationship||5
7651290|NCT02130635|18843348|P7|COMPLETED|Part B-Dose-Response Relationship||6
7651291|NCT02130635|18843349|P6|COMPLETED|Part B-Dose-Response Relationship||5
7651292|NCT02130635|18843350|P5|COMPLETED|Part B-Dose-Response Relationship||5
7651293|NCT02130635|18843351|P4|COMPLETED|Part B-Dose-Response Relationship||5
7651294|NCT02130635|18843352|P3|COMPLETED|Part B-Dose-Response Relationship||5
7651295|NCT02130635|18843353|P2|COMPLETED|Part B-Dose-Response Relationship||0
7651296|NCT02130635|18843354|P1|COMPLETED|Part B-Dose-Response Relationship||0
7651297|NCT02130635|18843346|P9|STARTED|Part B-Dose-Response Relationship||5
7651298|NCT02130635|18843347|P8|STARTED|Part B-Dose-Response Relationship||5
7651299|NCT02130635|18843348|P7|STARTED|Part B-Dose-Response Relationship||6
7651300|NCT02130635|18843349|P6|STARTED|Part B-Dose-Response Relationship||5
7651301|NCT02130635|18843350|P5|STARTED|Part B-Dose-Response Relationship||5
7651302|NCT02130635|18843351|P4|STARTED|Part B-Dose-Response Relationship||5
7651303|NCT02130635|18843352|P3|STARTED|Part B-Dose-Response Relationship||5
7651304|NCT02130635|18843353|P2|STARTED|Part B-Dose-Response Relationship||0
7651305|NCT02130635|18843354|P1|STARTED|Part B-Dose-Response Relationship||0
7651306|NCT02130635|18843346|P9|NOT COMPLETED|Part A-Safety and Tolerability||0
7651307|NCT02130635|18843347|P8|NOT COMPLETED|Part A-Safety and Tolerability||0
7651308|NCT02130635|18843348|P7|NOT COMPLETED|Part A-Safety and Tolerability||0
7651309|NCT02130635|18843349|P6|NOT COMPLETED|Part A-Safety and Tolerability||0
7651310|NCT02130635|18843350|P5|NOT COMPLETED|Part A-Safety and Tolerability||0
7651311|NCT02130635|18843351|P4|NOT COMPLETED|Part A-Safety and Tolerability||0
7651312|NCT02130635|18843352|P3|NOT COMPLETED|Part A-Safety and Tolerability||0
7651313|NCT02130635|18843353|P2|NOT COMPLETED|Part A-Safety and Tolerability||0
7651314|NCT02130635|18843354|P1|NOT COMPLETED|Part A-Safety and Tolerability||0
7651315|NCT02130635|18843346|P9|COMPLETED|Part A-Safety and Tolerability||0
7651316|NCT02130635|18843347|P8|COMPLETED|Part A-Safety and Tolerability||0
7651317|NCT02130635|18843348|P7|COMPLETED|Part A-Safety and Tolerability||0
7651318|NCT02130635|18843349|P6|COMPLETED|Part A-Safety and Tolerability||0
7651319|NCT02130635|18843350|P5|COMPLETED|Part A-Safety and Tolerability||0
7651320|NCT02130635|18843351|P4|COMPLETED|Part A-Safety and Tolerability||0
7651321|NCT02130635|18843352|P3|COMPLETED|Part A-Safety and Tolerability||0
7651322|NCT02130635|18843353|P2|COMPLETED|Part A-Safety and Tolerability||21
7651323|NCT02130635|18843354|P1|COMPLETED|Part A-Safety and Tolerability||7
7651324|NCT02130635|18843346|P9|STARTED|Part A-Safety and Tolerability||0
7651325|NCT02130635|18843347|P8|STARTED|Part A-Safety and Tolerability||0
7651326|NCT02130635|18843348|P7|STARTED|Part A-Safety and Tolerability||0
7651327|NCT02130635|18843349|P6|STARTED|Part A-Safety and Tolerability||0
7651328|NCT02130635|18843350|P5|STARTED|Part A-Safety and Tolerability||0
7651329|NCT02130635|18843351|P4|STARTED|Part A-Safety and Tolerability||0
7651330|NCT02130635|18843352|P3|STARTED|Part A-Safety and Tolerability||0
7651331|NCT02130635|18843353|P2|STARTED|Part A-Safety and Tolerability||21
7651332|NCT02130635|18843354|P1|STARTED|Part A-Safety and Tolerability||7
7651333|NCT02130622|18843528|P2|NOT COMPLETED|Overall Study||0
7651334|NCT02130622|18843529|P1|NOT COMPLETED|Overall Study||0
7651335|NCT02130622|18843528|P2|COMPLETED|Overall Study||1
7651336|NCT02130622|18843529|P1|COMPLETED|Overall Study||2
7651337|NCT02130622|18843528|P2|STARTED|Overall Study||1
7651338|NCT02130622|18843529|P1|STARTED|Overall Study||2
7651339|NCT02130583|18843543|P2|NOT COMPLETED|Overall Study||7
7651340|NCT02130583|18843544|P1|NOT COMPLETED|Overall Study||9
7651341|NCT02130583|18843543|P2|COMPLETED|Overall Study||19
7651342|NCT02130583|18843544|P1|COMPLETED|Overall Study||17
7651343|NCT02130583|18843543|P2|STARTED|Overall Study||26
7651344|NCT02130583|18843544|P1|STARTED|Overall Study||26
7651345|NCT02130570|18843564|P2|NOT COMPLETED|Overall Study||13
7651346|NCT02130570|18843565|P1|NOT COMPLETED|Overall Study||9
7651347|NCT02130570|18843564|P2|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|679
7651348|NCT02130570|18843565|P1|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|978
7651349|NCT02130570|18843564|P2|STARTED|Overall Study||692
7651350|NCT02130570|18843565|P1|STARTED|Overall Study||987
7651351|NCT02130557|18843583|P2|NOT COMPLETED|Overall Study||268
7651352|NCT02130557|18843584|P1|NOT COMPLETED|Overall Study||268
7651353|NCT02130557|18843583|P2|COMPLETED|Overall Study||0
7651354|NCT02130557|18843584|P1|COMPLETED|Overall Study||0
7651355|NCT02130557|18843583|P2|mITT Population|Overall Study||241
7651356|NCT02130557|18843584|P1|mITT Population|Overall Study||246
7651357|NCT02130557|18843583|P2|Treated|Overall Study||265
7651358|NCT02130557|18843584|P1|Treated|Overall Study||268
7651359|NCT02130557|18843583|P2|STARTED|Overall Study||268
7651360|NCT02130557|18843584|P1|STARTED|Overall Study||268
7651361|NCT02130284|18843616|P1|NOT COMPLETED|Overall Study||9
7651362|NCT02130284|18843616|P1|COMPLETED|Overall Study||71
7651363|NCT02130284|18843616|P1|STARTED|Overall Study||80
7651364|NCT02130258|18843629|P2|NOT COMPLETED|Overall Study||0
7651365|NCT02130258|18843630|P1|NOT COMPLETED|Overall Study||0
7651366|NCT02130258|18843629|P2|COMPLETED|Overall Study||11
7651367|NCT02130258|18843630|P1|COMPLETED|Overall Study||9
7651368|NCT02130258|18843629|P2|STARTED|Overall Study||11
7651369|NCT02130258|18843630|P1|STARTED|Overall Study||9
7651370|NCT02130193|18843642|P3|NOT COMPLETED|Part B: 52-week Double-blind Period||8
7651371|NCT02130193|18843643|P2|NOT COMPLETED|Part B: 52-week Double-blind Period||10
7651372|NCT02130193|18843644|P1|NOT COMPLETED|Part B: 52-week Double-blind Period||0
7651373|NCT02130193|18843642|P3|COMPLETED|Part B: 52-week Double-blind Period||37
7651374|NCT02130193|18843643|P2|COMPLETED|Part B: 52-week Double-blind Period||38
7651375|NCT02130193|18843644|P1|COMPLETED|Part B: 52-week Double-blind Period||0
7651376|NCT02130193|18843642|P3|STARTED|Part B: 52-week Double-blind Period||45
7651377|NCT02130193|18843643|P2|STARTED|Part B: 52-week Double-blind Period||48
7651378|NCT02130193|18843644|P1|STARTED|Part B: 52-week Double-blind Period||0
7651379|NCT02130193|18843642|P3|NOT COMPLETED|Part A: 4-week Open-label Period||0
7651380|NCT02130193|18843643|P2|NOT COMPLETED|Part A: 4-week Open-label Period||0
7651381|NCT02130193|18843644|P1|NOT COMPLETED|Part A: 4-week Open-label Period||0
7651382|NCT02130193|18843642|P3|COMPLETED|Part A: 4-week Open-label Period||0
7651383|NCT02130193|18843643|P2|COMPLETED|Part A: 4-week Open-label Period||0
7651384|NCT02130193|18843644|P1|COMPLETED|Part A: 4-week Open-label Period||9
7651385|NCT02130193|18843642|P3|STARTED|Part A: 4-week Open-label Period||0
7651386|NCT02130193|18843643|P2|STARTED|Part A: 4-week Open-label Period||0
7651387|NCT02130193|18843644|P1|STARTED|Part A: 4-week Open-label Period||9
7651388|NCT02130063|18843710|P2|NOT COMPLETED|Overall Study||17
7651389|NCT02130063|18843711|P1|NOT COMPLETED|Overall Study||25
7651390|NCT02130063|18843710|P2|COMPLETED|Overall Study||152
7651391|NCT02130063|18843711|P1|COMPLETED|Overall Study||317
7651392|NCT02130063|18843710|P2|STARTED|Overall Study||169
7651393|NCT02130063|18843711|P1|STARTED|Overall Study||342
7651394|NCT02130024|18843725|P2|NOT COMPLETED|Overall Study||31
7651395|NCT02130024|18843726|P1|NOT COMPLETED|Overall Study||25
7651396|NCT02130024|18843725|P2|COMPLETED|Overall Study||108
7651397|NCT02130024|18843726|P1|COMPLETED|Overall Study||117
7651398|NCT02130024|18843725|P2|Full Analysis Set (FAS)|Overall Study|2 patients had no post Baseline geographic atrophy (GA) data|137
7651399|NCT02130024|18843726|P1|Full Analysis Set (FAS)|Overall Study||141
7651400|NCT02130024|18843725|P2|Safety Set|Overall Study||139
7651401|NCT02130024|18843726|P1|Safety Set|Overall Study|One randomized patient did not receive treatment|141
7651402|NCT02130024|18843725|P2|STARTED|Overall Study||139
7651403|NCT02130024|18843726|P1|STARTED|Overall Study||142
7651404|NCT02129777|18843763|P7|NOT COMPLETED|Open-Label Period||48
7651405|NCT02129777|18843764|P6|NOT COMPLETED|Open-Label Period||12
7651406|NCT02129777|18843765|P5|NOT COMPLETED|Open-Label Period||0
7651407|NCT02129777|18843766|P4|NOT COMPLETED|Open-Label Period||0
7651408|NCT02129777|18843767|P3|NOT COMPLETED|Open-Label Period||0
7651409|NCT02129777|18843768|P2|NOT COMPLETED|Open-Label Period||0
7651410|NCT02129777|18843769|P1|NOT COMPLETED|Open-Label Period||0
7651411|NCT02129777|18843763|P7|COMPLETED|Open-Label Period||0
7651412|NCT02129777|18843764|P6|COMPLETED|Open-Label Period||0
7651413|NCT02129777|18843765|P5|COMPLETED|Open-Label Period||0
7651414|NCT02129777|18843766|P4|COMPLETED|Open-Label Period||0
7651415|NCT02129777|18843767|P3|COMPLETED|Open-Label Period||0
7651416|NCT02129777|18843768|P2|COMPLETED|Open-Label Period||0
7651417|NCT02129777|18843769|P1|COMPLETED|Open-Label Period||0
7651418|NCT02129777|18843763|P7|STARTED|Open-Label Period||48
7651419|NCT02129777|18843764|P6|STARTED|Open-Label Period||12
7651420|NCT02129777|18843765|P5|STARTED|Open-Label Period||0
7651421|NCT02129777|18843766|P4|STARTED|Open-Label Period||0
7651422|NCT02129777|18843767|P3|STARTED|Open-Label Period||0
7651423|NCT02129777|18843768|P2|STARTED|Open-Label Period||0
7651424|NCT02129777|18843769|P1|STARTED|Open-Label Period||0
7651425|NCT02129777|18843763|P7|NOT COMPLETED|Double-Blind Period||0
7651426|NCT02129777|18843764|P6|NOT COMPLETED|Double-Blind Period||0
7651427|NCT02129777|18843765|P5|NOT COMPLETED|Double-Blind Period||7
7651428|NCT02129777|18843766|P4|NOT COMPLETED|Double-Blind Period||7
7651429|NCT02129777|18843767|P3|NOT COMPLETED|Double-Blind Period||4
7651430|NCT02129777|18843768|P2|NOT COMPLETED|Double-Blind Period||8
7651431|NCT02129777|18843769|P1|NOT COMPLETED|Double-Blind Period||7
7651432|NCT02129777|18843763|P7|COMPLETED|Double-Blind Period||0
7651433|NCT02129777|18843764|P6|COMPLETED|Double-Blind Period||0
7651434|NCT02129777|18843765|P5|COMPLETED|Double-Blind Period||18
7651435|NCT02129777|18843766|P4|COMPLETED|Double-Blind Period||18
7651436|NCT02129777|18843767|P3|COMPLETED|Double-Blind Period||20
7651437|NCT02129777|18843768|P2|COMPLETED|Double-Blind Period||16
7651438|NCT02129777|18843769|P1|COMPLETED|Double-Blind Period||17
7651439|NCT02129777|18843763|P7|STARTED|Double-Blind Period||0
7651440|NCT02129777|18843764|P6|STARTED|Double-Blind Period||0
7651441|NCT02129777|18843765|P5|STARTED|Double-Blind Period||25
7651442|NCT02129777|18843766|P4|STARTED|Double-Blind Period||25
7651443|NCT02129777|18843767|P3|STARTED|Double-Blind Period||24
7651444|NCT02129777|18843768|P2|STARTED|Double-Blind Period||24
7651445|NCT02129777|18843769|P1|STARTED|Double-Blind Period||24
7651446|NCT02129725|18843875|P2|NOT COMPLETED|Overall Study||3
7651447|NCT02129725|18843876|P1|NOT COMPLETED|Overall Study||2
7651448|NCT02129725|18843875|P2|COMPLETED|Overall Study||4
7651449|NCT02129725|18843876|P1|COMPLETED|Overall Study||6
7651450|NCT02129725|18843875|P2|STARTED|Overall Study||7
7651451|NCT02129725|18843876|P1|STARTED|Overall Study||8
7651452|NCT02129660|18843887|P5|NOT COMPLETED|Overall Study||2
7651453|NCT02129660|18843888|P4|NOT COMPLETED|Overall Study||0
7651454|NCT02129660|18843889|P3|NOT COMPLETED|Overall Study||1
7651455|NCT02129660|18843890|P2|NOT COMPLETED|Overall Study||0
7651456|NCT02129660|18843891|P1|NOT COMPLETED|Overall Study||2
7651457|NCT02129660|18843887|P5|COMPLETED|Overall Study||20
7651458|NCT02129660|18843888|P4|COMPLETED|Overall Study||20
7651459|NCT02129660|18843889|P3|COMPLETED|Overall Study||21
7651460|NCT02129660|18843890|P2|COMPLETED|Overall Study||20
7651461|NCT02129660|18843891|P1|COMPLETED|Overall Study||19
7651462|NCT02129660|18843887|P5|STARTED|Overall Study||22
7651463|NCT02129660|18843888|P4|STARTED|Overall Study||20
7651464|NCT02129660|18843889|P3|STARTED|Overall Study||22
7651465|NCT02129660|18843890|P2|STARTED|Overall Study||20
7651466|NCT02129660|18843891|P1|STARTED|Overall Study||21
7651467|NCT02129608|18843936|P3|NOT COMPLETED|Overall Study||3
7651468|NCT02129608|18843937|P2|NOT COMPLETED|Overall Study||1
7651469|NCT02129608|18843938|P1|NOT COMPLETED|Overall Study||0
7651470|NCT02129608|18843936|P3|COMPLETED|Overall Study||12
7651471|NCT02129608|18843937|P2|COMPLETED|Overall Study||13
7651472|NCT02129608|18843938|P1|COMPLETED|Overall Study||15
7651473|NCT02129608|18843936|P3|End of Treatment|Overall Study||12
7651474|NCT02129608|18843937|P2|End of Treatment|Overall Study||13
7651475|NCT02129608|18843938|P1|End of Treatment|Overall Study||15
7651476|NCT02129608|18843936|P3|STARTED|Overall Study||15
7651477|NCT02129608|18843937|P2|STARTED|Overall Study||14
7651478|NCT02129608|18843938|P1|STARTED|Overall Study||15
7651479|NCT02129556|18843952|P4|NOT COMPLETED|Overall Study||0
7651480|NCT02129556|18843953|P3|NOT COMPLETED|Overall Study||3
7651481|NCT02129556|18843954|P2|NOT COMPLETED|Overall Study||0
7651482|NCT02129556|18843955|P1|NOT COMPLETED|Overall Study||0
7651483|NCT02129556|18843952|P4|COMPLETED|Overall Study||12
7651484|NCT02129556|18843953|P3|COMPLETED|Overall Study||37
7651485|NCT02129556|18843954|P2|COMPLETED|Overall Study||3
7651486|NCT02129556|18843955|P1|COMPLETED|Overall Study||3
7651487|NCT02129556|18843952|P4|STARTED|Overall Study||12
7651488|NCT02129556|18843953|P3|STARTED|Overall Study||40
7651489|NCT02129556|18843954|P2|STARTED|Overall Study||3
7651490|NCT02129556|18843955|P1|STARTED|Overall Study||3
7651491|NCT02129478|18843979|P1|NOT COMPLETED|Overall Study||0
7651492|NCT02129478|18843979|P1|COMPLETED|Overall Study||15
7651493|NCT02129478|18843979|P1|STARTED|Overall Study||15
7651494|NCT02129205|18843995|P10|NOT COMPLETED|Overall Study||0
7651495|NCT02129205|18843996|P9|NOT COMPLETED|Overall Study||2
7651496|NCT02129205|18843997|P8|NOT COMPLETED|Overall Study||2
7651497|NCT02129205|18843998|P7|NOT COMPLETED|Overall Study||4
7651498|NCT02129205|18843999|P6|NOT COMPLETED|Overall Study||4
7651499|NCT02129205|18844000|P5|NOT COMPLETED|Overall Study||3
7651500|NCT02129205|18844001|P4|NOT COMPLETED|Overall Study||0
7651501|NCT02129205|18844002|P3|NOT COMPLETED|Overall Study||0
7651502|NCT02129205|18844003|P2|NOT COMPLETED|Overall Study||0
7651503|NCT02129205|18844004|P1|NOT COMPLETED|Overall Study||1
7651504|NCT02129205|18843995|P10|COMPLETED|Overall Study||0
7651505|NCT02129205|18843996|P9|COMPLETED|Overall Study||0
7651506|NCT02129205|18843997|P8|COMPLETED|Overall Study||4
7651507|NCT02129205|18843998|P7|COMPLETED|Overall Study||2
7651508|NCT02129205|18843999|P6|COMPLETED|Overall Study||7
7651509|NCT02129205|18844000|P5|COMPLETED|Overall Study||4
7651510|NCT02129205|18844001|P4|COMPLETED|Overall Study||2
7651511|NCT02129205|18844002|P3|COMPLETED|Overall Study||2
7651512|NCT02129205|18844003|P2|COMPLETED|Overall Study||2
7651513|NCT02129205|18844004|P1|COMPLETED|Overall Study||1
7651514|NCT02129205|18843995|P10|STARTED|Overall Study||0
7651515|NCT02129205|18843996|P9|STARTED|Overall Study||2
7651516|NCT02129205|18843997|P8|STARTED|Overall Study||6
7651517|NCT02129205|18843998|P7|STARTED|Overall Study||6
7651518|NCT02129205|18843999|P6|STARTED|Overall Study||11
7651519|NCT02129205|18844000|P5|STARTED|Overall Study||7
7651520|NCT02129205|18844001|P4|STARTED|Overall Study||2
7651521|NCT02129205|18844002|P3|STARTED|Overall Study||2
7651522|NCT02129205|18844003|P2|STARTED|Overall Study||2
7651523|NCT02129205|18844004|P1|STARTED|Overall Study||2
7651524|NCT02129192|18844157|P2|NOT COMPLETED|Period 5||0
7651525|NCT02129192|18844158|P1|NOT COMPLETED|Period 5||0
7651526|NCT02129192|18844157|P2|COMPLETED|Period 5||0
7651527|NCT02129192|18844158|P1|COMPLETED|Period 5||36
7651528|NCT02129192|18844157|P2|STARTED|Period 5|This sequence consists of only 4 periods.|0
7651529|NCT02129192|18844158|P1|STARTED|Period 5||36
7651530|NCT02129192|18844157|P2|NOT COMPLETED|Period 4 Including Washout Period||0
7651531|NCT02129192|18844158|P1|NOT COMPLETED|Period 4 Including Washout Period||0
7651532|NCT02129192|18844157|P2|COMPLETED|Period 4 Including Washout Period||35
7651533|NCT02129192|18844158|P1|COMPLETED|Period 4 Including Washout Period||36
7651534|NCT02129192|18844157|P2|STARTED|Period 4 Including Washout Period||35
7651535|NCT02129192|18844158|P1|STARTED|Period 4 Including Washout Period||36
7651536|NCT02129192|18844157|P2|NOT COMPLETED|Period 3 Including Washout Period||0
7651537|NCT02129192|18844158|P1|NOT COMPLETED|Period 3 Including Washout Period||0
7651538|NCT02129192|18844157|P2|COMPLETED|Period 3 Including Washout Period||35
7651539|NCT02129192|18844158|P1|COMPLETED|Period 3 Including Washout Period||36
7651540|NCT02129192|18844157|P2|STARTED|Period 3 Including Washout Period||35
7651541|NCT02129192|18844158|P1|STARTED|Period 3 Including Washout Period||36
7651542|NCT02129192|18844157|P2|NOT COMPLETED|Period 2 Including Washout Period||0
7651543|NCT02129192|18844158|P1|NOT COMPLETED|Period 2 Including Washout Period||0
7651544|NCT02129192|18844157|P2|COMPLETED|Period 2 Including Washout Period||35
7651545|NCT02129192|18844158|P1|COMPLETED|Period 2 Including Washout Period||36
7651546|NCT02129192|18844157|P2|STARTED|Period 2 Including Washout Period||35
7651547|NCT02129192|18844158|P1|STARTED|Period 2 Including Washout Period||36
7651548|NCT02129192|18844157|P2|NOT COMPLETED|Period 1 Including Washout Period||1
7651549|NCT02129192|18844158|P1|NOT COMPLETED|Period 1 Including Washout Period||0
7651550|NCT02129192|18844157|P2|COMPLETED|Period 1 Including Washout Period|Withdrawal by one subject in washout period|35
7651551|NCT02129192|18844158|P1|COMPLETED|Period 1 Including Washout Period||36
7651552|NCT02129192|18844157|P2|STARTED|Period 1 Including Washout Period||36
7651553|NCT02129192|18844158|P1|STARTED|Period 1 Including Washout Period||36
7651554|NCT02129062|18844175|P1|NOT COMPLETED|Overall Study||3
7651555|NCT02129062|18844175|P1|COMPLETED|Overall Study||0
7651556|NCT02129062|18844175|P1|STARTED|Overall Study||3
7651557|NCT02128997|18844182|P2|NOT COMPLETED|Overall Study||11
7651558|NCT02128997|18844183|P1|NOT COMPLETED|Overall Study||6
7651559|NCT02128997|18844182|P2|COMPLETED|Overall Study||58
7651560|NCT02128997|18844183|P1|COMPLETED|Overall Study||61
7651561|NCT02128997|18844182|P2|STARTED|Overall Study||69
7651562|NCT02128997|18844183|P1|STARTED|Overall Study||67
7651563|NCT02128932|18844198|P3|NOT COMPLETED|Overall Study||18
7651564|NCT02128932|18844199|P2|NOT COMPLETED|Overall Study||19
7651565|NCT02128932|18844200|P1|NOT COMPLETED|Overall Study||27
7651566|NCT02128932|18844198|P3|COMPLETED|Overall Study||342
7651567|NCT02128932|18844199|P2|COMPLETED|Overall Study||341
7651568|NCT02128932|18844200|P1|COMPLETED|Overall Study||335
7651569|NCT02128932|18844198|P3|STARTED|Overall Study||360
7651570|NCT02128932|18844199|P2|STARTED|Overall Study||360
7651571|NCT02128932|18844200|P1|STARTED|Overall Study||362
7651572|NCT02128919|18844231|P2|NOT COMPLETED|Overall Study||1
7651573|NCT02128919|18844232|P1|NOT COMPLETED|Overall Study||3
7651574|NCT02128919|18844231|P2|COMPLETED|Overall Study||15
7651575|NCT02128919|18844232|P1|COMPLETED|Overall Study||14
7651576|NCT02128919|18844231|P2|STARTED|Overall Study||16
7651577|NCT02128919|18844232|P1|STARTED|Overall Study||17
7651578|NCT02128867|18844245|P3|NOT COMPLETED|Overall Study||4
7651579|NCT02128867|18844246|P2|NOT COMPLETED|Overall Study||2
7651580|NCT02128867|18844247|P1|NOT COMPLETED|Overall Study||3
7651581|NCT02128867|18844245|P3|COMPLETED|Overall Study||50
7651582|NCT02128867|18844246|P2|COMPLETED|Overall Study||50
7651583|NCT02128867|18844247|P1|COMPLETED|Overall Study||50
7651584|NCT02128867|18844245|P3|STARTED|Overall Study||54
7651585|NCT02128867|18844246|P2|STARTED|Overall Study||52
7651586|NCT02128867|18844247|P1|STARTED|Overall Study||53
7651587|NCT02128828|18844255|P1|NOT COMPLETED|Overall Study||3
7651588|NCT02128828|18844255|P1|COMPLETED|Overall Study||17
7651589|NCT02128828|18844255|P1|STARTED|Overall Study||20
7651590|NCT02128763|18844261|P2|NOT COMPLETED|Overall Study||16
7651591|NCT02128763|18844262|P1|NOT COMPLETED|Overall Study||20
7651592|NCT02128763|18844261|P2|COMPLETED|Overall Study||170
7651593|NCT02128763|18844262|P1|COMPLETED|Overall Study||329
7651594|NCT02128763|18844261|P2|STARTED|Overall Study||186
7651595|NCT02128763|18844262|P1|STARTED|Overall Study||349
7651596|NCT02128724|18844308|P4|NOT COMPLETED|Overall Study||3
7651597|NCT02128724|18844309|P3|NOT COMPLETED|Overall Study||0
7651598|NCT02128724|18844310|P2|NOT COMPLETED|Overall Study||1
7651599|NCT02128724|18844311|P1|NOT COMPLETED|Overall Study||1
7651600|NCT02128724|18844308|P4|COMPLETED|Overall Study||7
7651601|NCT02128724|18844309|P3|COMPLETED|Overall Study||3
7651602|NCT02128724|18844310|P2|COMPLETED|Overall Study||3
7651603|NCT02128724|18844311|P1|COMPLETED|Overall Study||3
7651604|NCT02128724|18844308|P4|STARTED|Overall Study||10
7651605|NCT02128724|18844309|P3|STARTED|Overall Study||3
7651606|NCT02128724|18844310|P2|STARTED|Overall Study||4
7651607|NCT02128724|18844311|P1|STARTED|Overall Study||4
7651608|NCT02128542|18844366|P2|NOT COMPLETED|Overall Study||0
7651609|NCT02128542|18844367|P1|NOT COMPLETED|Overall Study||4
7651610|NCT02128542|18844366|P2|COMPLETED|Overall Study||19
7651611|NCT02128542|18844367|P1|COMPLETED|Overall Study||43
7651612|NCT02128542|18844366|P2|STARTED|Overall Study||19
7651613|NCT02128542|18844367|P1|STARTED|Overall Study||47
7651614|NCT02128490|18844385|P5|NOT COMPLETED|Overall Study||7
7651615|NCT02128490|18844386|P4|NOT COMPLETED|Overall Study||6
7651616|NCT02128490|18844387|P3|NOT COMPLETED|Overall Study||5
7651617|NCT02128490|18844388|P2|NOT COMPLETED|Overall Study||6
7651618|NCT02128490|18844389|P1|NOT COMPLETED|Overall Study||5
7651619|NCT02128490|18844385|P5|COMPLETED|Overall Study||31
7651620|NCT02128490|18844386|P4|COMPLETED|Overall Study||31
7651621|NCT02128490|18844387|P3|COMPLETED|Overall Study||34
7651622|NCT02128490|18844388|P2|COMPLETED|Overall Study||31
7651623|NCT02128490|18844389|P1|COMPLETED|Overall Study||33
7651624|NCT02128490|18844385|P5|STARTED|Overall Study||38
7651625|NCT02128490|18844386|P4|STARTED|Overall Study||37
7651626|NCT02128490|18844387|P3|STARTED|Overall Study||39
7651627|NCT02128490|18844388|P2|STARTED|Overall Study||37
7651628|NCT02128490|18844389|P1|STARTED|Overall Study||38
7651629|NCT02128269|18844411|P1|NOT COMPLETED|Follow-up||0
7651630|NCT02128269|18844411|P1|COMPLETED|Follow-up||9
7651631|NCT02128269|18844411|P1|STARTED|Follow-up|All enrolled patients were followed for 12 weeks after their last infusion of ALXN1007.|9
7651632|NCT02128269|18844411|P1|NOT COMPLETED|Treatment Period||2
7651633|NCT02128269|18844411|P1|COMPLETED|Treatment Period||7
7651634|NCT02128269|18844411|P1|STARTED|Treatment Period||9
7651635|NCT02128217|18844417|P2|NOT COMPLETED|Overall Study||1
7651636|NCT02128217|18844418|P1|NOT COMPLETED|Overall Study||0
7651637|NCT02128217|18844417|P2|COMPLETED|Overall Study||26
7651638|NCT02128217|18844418|P1|COMPLETED|Overall Study||17
7651639|NCT02128217|18844417|P2|STARTED|Overall Study||27
7651640|NCT02128217|18844418|P1|STARTED|Overall Study||17
7651641|NCT02128074|18844460|P1|NOT COMPLETED|Overall Study||6
7651642|NCT02128074|18844460|P1|COMPLETED|Overall Study||26
7651643|NCT02128074|18844460|P1|STARTED|Overall Study||32
7651644|NCT02127970|18844466|P2|NOT COMPLETED|Overall Study||27
7651645|NCT02127970|18844467|P1|NOT COMPLETED|Overall Study||26
7651646|NCT02127970|18844466|P2|COMPLETED|Overall Study||322
7651647|NCT02127970|18844467|P1|COMPLETED|Overall Study||323
7651648|NCT02127970|18844466|P2|STARTED|Overall Study||349
7651649|NCT02127970|18844467|P1|STARTED|Overall Study||349
7651650|NCT02127931|18844489|P1|NOT COMPLETED|Overall Study||1
7651651|NCT02127931|18844489|P1|COMPLETED|Overall Study||17
7651652|NCT02127931|18844489|P1|STARTED|Overall Study||18
7651653|NCT02127892|18844499|P4|NOT COMPLETED|Overall Study||0
7651654|NCT02127892|18844500|P3|NOT COMPLETED|Overall Study||0
7651655|NCT02127892|18844501|P2|NOT COMPLETED|Overall Study||1
7651656|NCT02127892|18844502|P1|NOT COMPLETED|Overall Study||1
7651657|NCT02127892|18844499|P4|COMPLETED|Overall Study||0
7651658|NCT02127892|18844500|P3|COMPLETED|Overall Study||0
7651659|NCT02127892|18844501|P2|COMPLETED|Overall Study||1
7651660|NCT02127892|18844502|P1|COMPLETED|Overall Study||6
7651661|NCT02127892|18844499|P4|STARTED|Overall Study||0
7651662|NCT02127892|18844500|P3|STARTED|Overall Study||0
7651663|NCT02127892|18844501|P2|STARTED|Overall Study||2
7651664|NCT02127892|18844502|P1|STARTED|Overall Study||7
7651665|NCT02127723|18844528|P1|NOT COMPLETED|Overall Study||1
7651666|NCT02127723|18844528|P1|COMPLETED|Overall Study||19
7651667|NCT02127723|18844528|P1|STARTED|Overall Study||20
7651668|NCT02127710|18844538|P3|NOT COMPLETED|Overall Study||0
7651669|NCT02127710|18844539|P2|NOT COMPLETED|Overall Study||0
7651670|NCT02127710|18844540|P1|NOT COMPLETED|Overall Study||0
7651671|NCT02127710|18844538|P3|COMPLETED|Overall Study||19
7651672|NCT02127710|18844539|P2|COMPLETED|Overall Study||46
7651673|NCT02127710|18844540|P1|COMPLETED|Overall Study||44
7651674|NCT02127710|18844538|P3|STARTED|Overall Study||19
7651675|NCT02127710|18844539|P2|STARTED|Overall Study||46
7651676|NCT02127710|18844540|P1|STARTED|Overall Study||44
7651677|NCT02127632|18844582|P2|NOT COMPLETED|Overall Study||0
7651678|NCT02127632|18844583|P1|NOT COMPLETED|Overall Study||0
7651679|NCT02127632|18844582|P2|COMPLETED|Overall Study||50
7651680|NCT02127632|18844583|P1|COMPLETED|Overall Study||50
7651681|NCT02127632|18844582|P2|STARTED|Overall Study||50
7651682|NCT02127632|18844583|P1|STARTED|Overall Study||50
7651683|NCT02127567|18844593|P1|NOT COMPLETED|Overall Study||0
7651684|NCT02127567|18844593|P1|COMPLETED|Overall Study||41
7651685|NCT02127567|18844593|P1|STARTED|Overall Study|41 participants completed 123 domains, 3 domains were completed with the tool per participant|41
7651686|NCT02127372|18844615|P2|NOT COMPLETED|Overall Study||0
7651687|NCT02127372|18844616|P1|NOT COMPLETED|Overall Study||1
7651688|NCT02127372|18844615|P2|COMPLETED|Overall Study||28
7651689|NCT02127372|18844616|P1|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14
7651690|NCT02127372|18844615|P2|Started Study Treatment|Overall Study||28
7651691|NCT02127372|18844616|P1|Started Study Treatment|Overall Study||15
7651692|NCT02127372|18844615|P2|STARTED|Overall Study|Signed Consent|28
7651693|NCT02127372|18844616|P1|STARTED|Overall Study|Signed Consent|15
7651694|NCT02127307|18844626|P1|NOT COMPLETED|Overall Study||308
7651695|NCT02127307|18844626|P1|COMPLETED|Overall Study||656
7651696|NCT02127307|18844626|P1|STARTED|Overall Study||964
7651697|NCT02127281|18844632|P2|NOT COMPLETED|Overall Study||0
7651698|NCT02127281|18844633|P1|NOT COMPLETED|Overall Study||1
7651699|NCT02127281|18844632|P2|COMPLETED|Overall Study||80
7651700|NCT02127281|18844633|P1|COMPLETED|Overall Study||79
7651701|NCT02127281|18844632|P2|STARTED|Overall Study||80
7651702|NCT02127281|18844633|P1|STARTED|Overall Study||80
7651703|NCT02127125|18844668|P9|NOT COMPLETED|Overall Study||0
7651704|NCT02127125|18844669|P8|NOT COMPLETED|Overall Study||0
7651705|NCT02127125|18844670|P7|NOT COMPLETED|Overall Study||0
7651706|NCT02127125|18844671|P6|NOT COMPLETED|Overall Study||3
7651707|NCT02127125|18844672|P5|NOT COMPLETED|Overall Study||3
7651708|NCT02127125|18844673|P4|NOT COMPLETED|Overall Study||1
7651709|NCT02127125|18844674|P3|NOT COMPLETED|Overall Study||1
7651710|NCT02127125|18844675|P2|NOT COMPLETED|Overall Study||0
7651711|NCT02127125|18844676|P1|NOT COMPLETED|Overall Study||0
7651712|NCT02127125|18844668|P9|COMPLETED|Overall Study||1
7651713|NCT02127125|18844669|P8|COMPLETED|Overall Study||0
7651714|NCT02127125|18844670|P7|COMPLETED|Overall Study||2
7651715|NCT02127125|18844671|P6|COMPLETED|Overall Study||9
7651716|NCT02127125|18844672|P5|COMPLETED|Overall Study||9
7651717|NCT02127125|18844673|P4|COMPLETED|Overall Study||10
7651718|NCT02127125|18844674|P3|COMPLETED|Overall Study||8
7651719|NCT02127125|18844675|P2|COMPLETED|Overall Study||8
7651720|NCT02127125|18844676|P1|COMPLETED|Overall Study||6
7651721|NCT02127125|18844668|P9|STARTED|Overall Study||1
7651722|NCT02127125|18844669|P8|STARTED|Overall Study||0
7651723|NCT02127125|18844670|P7|STARTED|Overall Study||2
7651724|NCT02127125|18844671|P6|STARTED|Overall Study||12
7651725|NCT02127125|18844672|P5|STARTED|Overall Study||12
7651726|NCT02127125|18844673|P4|STARTED|Overall Study||11
7651727|NCT02127125|18844674|P3|STARTED|Overall Study||9
7651728|NCT02127125|18844675|P2|STARTED|Overall Study||8
7651729|NCT02127125|18844676|P1|STARTED|Overall Study||6
7651730|NCT02126969|18844716|P2|NOT COMPLETED|Overall Study||2
7651731|NCT02126969|18844717|P1|NOT COMPLETED|Overall Study||1
7651732|NCT02126969|18844716|P2|COMPLETED|Overall Study||20
7651733|NCT02126969|18844717|P1|COMPLETED|Overall Study||22
7651734|NCT02126969|18844716|P2|STARTED|Overall Study||22
7651735|NCT02126969|18844717|P1|STARTED|Overall Study||23
7651736|NCT02126839|18844729|P2|NOT COMPLETED|Overall Study||14
7651737|NCT02126839|18844730|P1|NOT COMPLETED|Overall Study||10
7651738|NCT02126839|18844729|P2|COMPLETED|Overall Study||80
7651739|NCT02126839|18844730|P1|COMPLETED|Overall Study||82
7651740|NCT02126839|18844729|P2|Full Analysis Set|Overall Study||92
7651741|NCT02126839|18844730|P1|Full Analysis Set|Overall Study||92
7651742|NCT02126839|18844729|P2|Safety Population|Overall Study||93
7651743|NCT02126839|18844730|P1|Safety Population|Overall Study||92
7651744|NCT02126839|18844729|P2|STARTED|Overall Study||94
7651745|NCT02126839|18844730|P1|STARTED|Overall Study||92
7651746|NCT02126826|18844747|P7|NOT COMPLETED|Overall Study||0
7651747|NCT02126826|18844748|P6|NOT COMPLETED|Overall Study||0
7651748|NCT02126826|18844749|P5|NOT COMPLETED|Overall Study||0
7651749|NCT02126826|18844750|P4|NOT COMPLETED|Overall Study||1
7651750|NCT02126826|18844751|P3|NOT COMPLETED|Overall Study||0
7651751|NCT02126826|18844752|P2|NOT COMPLETED|Overall Study||0
7651752|NCT02126826|18844753|P1|NOT COMPLETED|Overall Study||0
7651753|NCT02126826|18844747|P7|COMPLETED|Overall Study||8
7651754|NCT02126826|18844748|P6|COMPLETED|Overall Study||9
7651755|NCT02126826|18844749|P5|COMPLETED|Overall Study||5
7651756|NCT02126826|18844750|P4|COMPLETED|Overall Study||8
7651757|NCT02126826|18844751|P3|COMPLETED|Overall Study||9
7651758|NCT02126826|18844752|P2|COMPLETED|Overall Study||9
7651759|NCT02126826|18844753|P1|COMPLETED|Overall Study||9
7651760|NCT02126826|18844747|P7|STARTED|Overall Study||8
7651761|NCT02126826|18844748|P6|STARTED|Overall Study||9
7651762|NCT02126826|18844749|P5|STARTED|Overall Study||5
7651763|NCT02126826|18844750|P4|STARTED|Overall Study||9
7651764|NCT02126826|18844751|P3|STARTED|Overall Study||9
7651765|NCT02126826|18844752|P2|STARTED|Overall Study||9
7651766|NCT02126826|18844753|P1|STARTED|Overall Study||9
7651767|NCT02126748|18844807|P3|NOT COMPLETED|Overall Study||5
7651768|NCT02126748|18844808|P2|NOT COMPLETED|Overall Study||3
7651769|NCT02126748|18844809|P1|NOT COMPLETED|Overall Study||2
7651770|NCT02126748|18844807|P3|COMPLETED|Overall Study||31
7651771|NCT02126748|18844808|P2|COMPLETED|Overall Study||31
7651772|NCT02126748|18844809|P1|COMPLETED|Overall Study||31
7651773|NCT02126748|18844807|P3|STARTED|Overall Study||36
7651774|NCT02126748|18844808|P2|STARTED|Overall Study||34
7651775|NCT02126748|18844809|P1|STARTED|Overall Study||33
7651776|NCT02126670|18844821|P4|NOT COMPLETED|Overall Study||1
7651777|NCT02126670|18844822|P3|NOT COMPLETED|Overall Study||0
7651778|NCT02126670|18844823|P2|NOT COMPLETED|Overall Study||0
7651779|NCT02126670|18844824|P1|NOT COMPLETED|Overall Study||1
7651780|NCT02126670|18844821|P4|COMPLETED|Overall Study||24
7651781|NCT02126670|18844822|P3|COMPLETED|Overall Study||25
7651782|NCT02126670|18844823|P2|COMPLETED|Overall Study||24
7651783|NCT02126670|18844824|P1|COMPLETED|Overall Study||25
7651784|NCT02126670|18844821|P4|STARTED|Overall Study||25
7651785|NCT02126670|18844822|P3|STARTED|Overall Study||25
7651786|NCT02126670|18844823|P2|STARTED|Overall Study||24
7651787|NCT02126670|18844824|P1|STARTED|Overall Study||26
7651788|NCT02126319|18844840|P2|NOT COMPLETED|Overall Study||24
7651789|NCT02126319|18844841|P1|NOT COMPLETED|Overall Study||21
7651790|NCT02126319|18844840|P2|COMPLETED|Overall Study||43
7651791|NCT02126319|18844841|P1|COMPLETED|Overall Study||40
7651792|NCT02126319|18844840|P2|STARTED|Overall Study||67
7651793|NCT02126319|18844841|P1|STARTED|Overall Study||61
7651794|NCT02126306|18844867|P2|NOT COMPLETED|Overall Study||0
7651795|NCT02126306|18844868|P1|NOT COMPLETED|Overall Study||0
7651796|NCT02126306|18844867|P2|COMPLETED|Overall Study||13
7651797|NCT02126306|18844868|P1|COMPLETED|Overall Study||10
7651798|NCT02126306|18844867|P2|STARTED|Overall Study||13
7651799|NCT02126306|18844868|P1|STARTED|Overall Study||10
7651800|NCT02125877|18844876|P2|NOT COMPLETED|Overall Study||10
7651801|NCT02125877|18844877|P1|NOT COMPLETED|Overall Study||13
7651802|NCT02125877|18844876|P2|COMPLETED|Overall Study||77
7651803|NCT02125877|18844877|P1|COMPLETED|Overall Study||73
7651804|NCT02125877|18844876|P2|Safety Set|Overall Study||87
7651805|NCT02125877|18844877|P1|Safety Set|Overall Study||86
7651806|NCT02125877|18844876|P2|Pharmacokinetic Subset A|Overall Study||15
7651807|NCT02125877|18844877|P1|Pharmacokinetic Subset A|Overall Study||16
7651808|NCT02125877|18844876|P2|Pharmacokinetic Analysis Set|Overall Study||83
7651809|NCT02125877|18844877|P1|Pharmacokinetic Analysis Set|Overall Study||83
7651810|NCT02125877|18844876|P2|STARTED|Overall Study||87
7651811|NCT02125877|18844877|P1|STARTED|Overall Study||86
7651812|NCT02125838|18844907|P2|NOT COMPLETED|Overall Study||4
7651813|NCT02125838|18844908|P1|NOT COMPLETED|Overall Study||4
7651814|NCT02125838|18844907|P2|COMPLETED|Overall Study|Analysed (n=50 )|50
7651815|NCT02125838|18844908|P1|COMPLETED|Overall Study|Analysed (n=50 )|50
7651816|NCT02125838|18844907|P2|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions) (n= 2) NBA used (n= 2)|54
7651817|NCT02125838|18844908|P1|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions)(n= 2) NBA used (n= 2)|54
7651818|NCT02125734|18844926|P2|NOT COMPLETED|Period 2||1
7651819|NCT02125734|18844927|P1|NOT COMPLETED|Period 2||0
7651820|NCT02125734|18844926|P2|COMPLETED|Period 2||47
7651821|NCT02125734|18844927|P1|COMPLETED|Period 2||40
7651822|NCT02125734|18844926|P2|STARTED|Period 2||48
7651823|NCT02125734|18844927|P1|STARTED|Period 2||40
7651824|NCT02125734|18844926|P2|NOT COMPLETED|Period 1||0
7651825|NCT02125734|18844927|P1|NOT COMPLETED|Period 1||0
7651826|NCT02125734|18844926|P2|COMPLETED|Period 1||48
7651827|NCT02125734|18844927|P1|COMPLETED|Period 1||40
7651828|NCT02125734|18844926|P2|STARTED|Period 1||48
7651829|NCT02125734|18844927|P1|STARTED|Period 1||40
7651830|NCT02125604|18844937|P1|NOT COMPLETED|Overall Study||31
7651831|NCT02125604|18844937|P1|COMPLETED|Overall Study||180
7651832|NCT02125604|18844937|P1|STARTED|Overall Study|enrolled and received at least 1 dose of study drug|211
7651833|NCT02125461|18844953|P2|NOT COMPLETED|Overall Study||129
7651834|NCT02125461|18844954|P1|NOT COMPLETED|Overall Study||203
7651835|NCT02125461|18844953|P2|COMPLETED|Overall Study||108
7651836|NCT02125461|18844954|P1|COMPLETED|Overall Study||273
7651837|NCT02125461|18844953|P2|Completed 12 Months of Treatment|Overall Study||82
7651838|NCT02125461|18844954|P1|Completed 12 Months of Treatment|Overall Study||232
7651839|NCT02125461|18844953|P2|Safety Analysis Set|Overall Study||234
7651840|NCT02125461|18844954|P1|Safety Analysis Set|Overall Study||475
7651841|NCT02125461|18844953|P2|Receieved Treatment|Overall Study||236
7651842|NCT02125461|18844954|P1|Receieved Treatment|Overall Study||473
7651843|NCT02125461|18844953|P2|Full Analysis Set (FAS)|Overall Study||237
7651844|NCT02125461|18844954|P1|Full Analysis Set (FAS)|Overall Study||476
7651845|NCT02125461|18844953|P2|STARTED|Overall Study||237
7651846|NCT02125461|18844954|P1|STARTED|Overall Study||476
7651847|NCT02125331|18844985|P2|NOT COMPLETED|Overall Study||0
7651848|NCT02125331|18844986|P1|NOT COMPLETED|Overall Study||5
7651849|NCT02125331|18844985|P2|COMPLETED|Overall Study||25
7651850|NCT02125331|18844986|P1|COMPLETED|Overall Study||53
7651851|NCT02125331|18844985|P2|STARTED|Overall Study||25
7651852|NCT02125331|18844986|P1|STARTED|Overall Study||58
7651853|NCT02125292|18844992|P6|NOT COMPLETED|Third Intervention (1 Hour)||0
7651854|NCT02125292|18844993|P5|NOT COMPLETED|Third Intervention (1 Hour)||0
7651855|NCT02125292|18844994|P4|NOT COMPLETED|Third Intervention (1 Hour)||0
7651856|NCT02125292|18844995|P3|NOT COMPLETED|Third Intervention (1 Hour)||0
7651857|NCT02125292|18844996|P2|NOT COMPLETED|Third Intervention (1 Hour)||0
7651858|NCT02125292|18844997|P1|NOT COMPLETED|Third Intervention (1 Hour)||0
7651859|NCT02125292|18844992|P6|COMPLETED|Third Intervention (1 Hour)||3
7651860|NCT02125292|18844993|P5|COMPLETED|Third Intervention (1 Hour)||3
7651861|NCT02125292|18844994|P4|COMPLETED|Third Intervention (1 Hour)||3
7651862|NCT02125292|18844995|P3|COMPLETED|Third Intervention (1 Hour)||3
7651863|NCT02125292|18844996|P2|COMPLETED|Third Intervention (1 Hour)||3
7651864|NCT02125292|18844997|P1|COMPLETED|Third Intervention (1 Hour)||3
7651865|NCT02125292|18844992|P6|STARTED|Third Intervention (1 Hour)||3
7651866|NCT02125292|18844993|P5|STARTED|Third Intervention (1 Hour)||3
7651867|NCT02125292|18844994|P4|STARTED|Third Intervention (1 Hour)||3
7651868|NCT02125292|18844995|P3|STARTED|Third Intervention (1 Hour)||3
7651869|NCT02125292|18844996|P2|STARTED|Third Intervention (1 Hour)||3
7651870|NCT02125292|18844997|P1|STARTED|Third Intervention (1 Hour)||3
7651871|NCT02125292|18844992|P6|NOT COMPLETED|Washout (2 Hours)||0
7651872|NCT02125292|18844993|P5|NOT COMPLETED|Washout (2 Hours)||0
7651873|NCT02125292|18844994|P4|NOT COMPLETED|Washout (2 Hours)||0
7651874|NCT02125292|18844995|P3|NOT COMPLETED|Washout (2 Hours)||0
7651875|NCT02125292|18844996|P2|NOT COMPLETED|Washout (2 Hours)||0
7651876|NCT02125292|18844997|P1|NOT COMPLETED|Washout (2 Hours)||0
7651877|NCT02125292|18844992|P6|COMPLETED|Washout (2 Hours)||3
7651878|NCT02125292|18844993|P5|COMPLETED|Washout (2 Hours)||3
7651879|NCT02125292|18844994|P4|COMPLETED|Washout (2 Hours)||3
7651880|NCT02125292|18844995|P3|COMPLETED|Washout (2 Hours)||3
7651881|NCT02125292|18844996|P2|COMPLETED|Washout (2 Hours)||3
7651882|NCT02125292|18844997|P1|COMPLETED|Washout (2 Hours)||3
7651883|NCT02125292|18844992|P6|STARTED|Washout (2 Hours)||3
7651884|NCT02125292|18844993|P5|STARTED|Washout (2 Hours)||3
7651885|NCT02125292|18844994|P4|STARTED|Washout (2 Hours)||3
7651886|NCT02125292|18844995|P3|STARTED|Washout (2 Hours)||3
7651887|NCT02125292|18844996|P2|STARTED|Washout (2 Hours)||3
7651888|NCT02125292|18844997|P1|STARTED|Washout (2 Hours)||3
7651889|NCT02125292|18844992|P6|NOT COMPLETED|Second Intervention (1 Hour)||0
7651890|NCT02125292|18844993|P5|NOT COMPLETED|Second Intervention (1 Hour)||0
7651891|NCT02125292|18844994|P4|NOT COMPLETED|Second Intervention (1 Hour)||0
7651892|NCT02125292|18844995|P3|NOT COMPLETED|Second Intervention (1 Hour)||0
7651893|NCT02125292|18844996|P2|NOT COMPLETED|Second Intervention (1 Hour)||0
7651894|NCT02125292|18844997|P1|NOT COMPLETED|Second Intervention (1 Hour)||0
7651895|NCT02125292|18844992|P6|COMPLETED|Second Intervention (1 Hour)||3
7651896|NCT02125292|18844993|P5|COMPLETED|Second Intervention (1 Hour)||3
7651897|NCT02125292|18844994|P4|COMPLETED|Second Intervention (1 Hour)||3
7651898|NCT02125292|18844995|P3|COMPLETED|Second Intervention (1 Hour)||3
7651899|NCT02125292|18844996|P2|COMPLETED|Second Intervention (1 Hour)||3
7651900|NCT02125292|18844997|P1|COMPLETED|Second Intervention (1 Hour)||3
7651901|NCT02125292|18844992|P6|STARTED|Second Intervention (1 Hour)||3
7651902|NCT02125292|18844993|P5|STARTED|Second Intervention (1 Hour)||3
7651903|NCT02125292|18844994|P4|STARTED|Second Intervention (1 Hour)||3
7651904|NCT02125292|18844995|P3|STARTED|Second Intervention (1 Hour)||3
7651905|NCT02125292|18844996|P2|STARTED|Second Intervention (1 Hour)||3
7651906|NCT02125292|18844997|P1|STARTED|Second Intervention (1 Hour)||3
7651907|NCT02125292|18844992|P6|NOT COMPLETED|Washout (2 Hours)||0
7651908|NCT02125292|18844993|P5|NOT COMPLETED|Washout (2 Hours)||0
7651909|NCT02125292|18844994|P4|NOT COMPLETED|Washout (2 Hours)||0
7651910|NCT02125292|18844995|P3|NOT COMPLETED|Washout (2 Hours)||0
7651911|NCT02125292|18844996|P2|NOT COMPLETED|Washout (2 Hours)||0
7651912|NCT02125292|18844997|P1|NOT COMPLETED|Washout (2 Hours)||0
7651913|NCT02125292|18844992|P6|COMPLETED|Washout (2 Hours)||3
7651914|NCT02125292|18844993|P5|COMPLETED|Washout (2 Hours)||3
7651915|NCT02125292|18844994|P4|COMPLETED|Washout (2 Hours)||3
7651916|NCT02125292|18844995|P3|COMPLETED|Washout (2 Hours)||3
7651917|NCT02125292|18844996|P2|COMPLETED|Washout (2 Hours)||3
7651918|NCT02125292|18844997|P1|COMPLETED|Washout (2 Hours)||3
7651919|NCT02125292|18844992|P6|STARTED|Washout (2 Hours)||3
7651920|NCT02125292|18844993|P5|STARTED|Washout (2 Hours)||3
7651921|NCT02125292|18844994|P4|STARTED|Washout (2 Hours)||3
7651922|NCT02125292|18844995|P3|STARTED|Washout (2 Hours)||3
7651923|NCT02125292|18844996|P2|STARTED|Washout (2 Hours)||3
7651924|NCT02125292|18844997|P1|STARTED|Washout (2 Hours)||3
7651925|NCT02125292|18844992|P6|NOT COMPLETED|First Intervention (1 Hour)||0
7651926|NCT02125292|18844993|P5|NOT COMPLETED|First Intervention (1 Hour)||0
7651927|NCT02125292|18844994|P4|NOT COMPLETED|First Intervention (1 Hour)||0
7651928|NCT02125292|18844995|P3|NOT COMPLETED|First Intervention (1 Hour)||0
7651929|NCT02125292|18844996|P2|NOT COMPLETED|First Intervention (1 Hour)||0
7651930|NCT02125292|18844997|P1|NOT COMPLETED|First Intervention (1 Hour)||0
7651931|NCT02125292|18844992|P6|COMPLETED|First Intervention (1 Hour)||3
7651932|NCT02125292|18844993|P5|COMPLETED|First Intervention (1 Hour)||3
7651933|NCT02125292|18844994|P4|COMPLETED|First Intervention (1 Hour)||3
7651934|NCT02125292|18844995|P3|COMPLETED|First Intervention (1 Hour)||3
7651935|NCT02125292|18844996|P2|COMPLETED|First Intervention (1 Hour)||3
7651936|NCT02125292|18844997|P1|COMPLETED|First Intervention (1 Hour)||3
7651937|NCT02125292|18844992|P6|STARTED|First Intervention (1 Hour)||3
7651938|NCT02125292|18844993|P5|STARTED|First Intervention (1 Hour)||3
7651939|NCT02125292|18844994|P4|STARTED|First Intervention (1 Hour)||3
7651940|NCT02125292|18844995|P3|STARTED|First Intervention (1 Hour)||3
7651941|NCT02125292|18844996|P2|STARTED|First Intervention (1 Hour)||3
7651942|NCT02125292|18844997|P1|STARTED|First Intervention (1 Hour)||3
7651943|NCT02125279|18845018|P1|NOT COMPLETED|Overall Study||13
7651944|NCT02125279|18845018|P1|COMPLETED|Overall Study||41
7651945|NCT02125279|18845018|P1|STARTED|Overall Study||54
7651946|NCT02124889|18845047|P2|NOT COMPLETED|Overall Study||0
7651947|NCT02124889|18845048|P1|NOT COMPLETED|Overall Study||0
7651948|NCT02124889|18845047|P2|COMPLETED|Overall Study||12
7651949|NCT02124889|18845048|P1|COMPLETED|Overall Study||12
7651950|NCT02124889|18845047|P2|STARTED|Overall Study||12
7651951|NCT02124889|18845048|P1|STARTED|Overall Study||12
7651952|NCT02124863|18845054|P1|NOT COMPLETED|Overall Study||17
7651953|NCT02124863|18845054|P1|COMPLETED|Overall Study||50
7651954|NCT02124863|18845054|P1|STARTED|Overall Study||67
7651955|NCT02124811|18845062|P2|NOT COMPLETED|Overall Study||2
7651956|NCT02124811|18845063|P1|NOT COMPLETED|Overall Study||3
7651957|NCT02124811|18845062|P2|COMPLETED|Overall Study||3
7651958|NCT02124811|18845063|P1|COMPLETED|Overall Study||2
7651959|NCT02124811|18845062|P2|STARTED|Overall Study||5
7651960|NCT02124811|18845063|P1|STARTED|Overall Study||5
7651961|NCT02124798|18845079|P1|NOT COMPLETED|Overall Study||4
7651962|NCT02124798|18845079|P1|COMPLETED|Overall Study||91
7651963|NCT02124798|18845079|P1|STARTED|Overall Study||95
7651964|NCT02124707|18845085|P1|NOT COMPLETED|Overall Study||7
7651965|NCT02124707|18845085|P1|COMPLETED|Overall Study||7
7651966|NCT02124707|18845085|P1|STARTED|Overall Study||14
7651967|NCT02124603|18845093|P1|NOT COMPLETED|Overall Study||0
7651968|NCT02124603|18845093|P1|COMPLETED|Overall Study||120
7651969|NCT02124603|18845093|P1|STARTED|Overall Study||120
7651970|NCT02124564|18845099|P1|NOT COMPLETED|Taper Period||0
7651971|NCT02124564|18845099|P1|COMPLETED|Taper Period||2
7651972|NCT02124564|18845099|P1|STARTED|Taper Period||2
7651973|NCT02124564|18845099|P1|NOT COMPLETED|Treatment Period||7
7651974|NCT02124564|18845099|P1|COMPLETED|Treatment Period||12
7651975|NCT02124564|18845099|P1|Started Follow-Up Period|Treatment Period||13
7651976|NCT02124564|18845099|P1|Started Evaluation Period|Treatment Period||17
7651977|NCT02124564|18845099|P1|Started Monotherapy Period|Treatment Period||17
7651978|NCT02124564|18845099|P1|Started AED Withdrawal Period|Treatment Period||19
7651979|NCT02124564|18845099|P1|Started Titration Period|Treatment Period||19
7651980|NCT02124564|18845099|P1|Started Treatment Period|Treatment Period||19
7651981|NCT02124564|18845099|P1|STARTED|Treatment Period||19
7651982|NCT02124512|18845111|P2|NOT COMPLETED|Overall Study||0
7651983|NCT02124512|18845112|P1|NOT COMPLETED|Overall Study||0
7651984|NCT02124512|18845111|P2|COMPLETED|Overall Study||6
7651985|NCT02124512|18845112|P1|COMPLETED|Overall Study||6
7651986|NCT02124512|18845111|P2|STARTED|Overall Study||6
7651987|NCT02124512|18845112|P1|STARTED|Overall Study||6
7651988|NCT02124460|18845122|P2|NOT COMPLETED|Overall Study||24
7651989|NCT02124460|18845123|P1|NOT COMPLETED|Overall Study||33
7651990|NCT02124460|18845122|P2|COMPLETED|Overall Study||336
7651991|NCT02124460|18845123|P1|COMPLETED|Overall Study||328
7651992|NCT02124460|18845122|P2|STARTED|Overall Study||360
7651993|NCT02124460|18845123|P1|STARTED|Overall Study||361
7651994|NCT02124304|18845155|P2|NOT COMPLETED|Overall Study||0
7651995|NCT02124304|18845156|P1|NOT COMPLETED|Overall Study||0
7651996|NCT02124304|18845155|P2|COMPLETED|Overall Study||15
7651997|NCT02124304|18845156|P1|COMPLETED|Overall Study||15
7651998|NCT02124304|18845155|P2|STARTED|Overall Study||15
7651999|NCT02124304|18845156|P1|STARTED|Overall Study||15
7652000|NCT02124265|18845164|P1|NOT COMPLETED|Overall Study||1
7652001|NCT02124265|18845164|P1|COMPLETED|Overall Study||2
7652002|NCT02124265|18845164|P1|STARTED|Overall Study||3
7652003|NCT02124161|18845170|P2|NOT COMPLETED|Overall Study||15
7652004|NCT02124161|18845171|P1|NOT COMPLETED|Overall Study||16
7652005|NCT02124161|18845170|P2|COMPLETED|Overall Study||426
7652006|NCT02124161|18845171|P1|COMPLETED|Overall Study||425
7652007|NCT02124161|18845170|P2|Vaccination 2|Overall Study||432
7652008|NCT02124161|18845171|P1|Vaccination 2|Overall Study||431
7652009|NCT02124161|18845170|P2|Vaccination 1|Overall Study||437
7652010|NCT02124161|18845171|P1|Vaccination 1|Overall Study||439
7652011|NCT02124161|18845170|P2|STARTED|Overall Study||441
7652012|NCT02124161|18845171|P1|STARTED|Overall Study||441
7652013|NCT02124122|18845203|P2|NOT COMPLETED|Overall Study||0
7652014|NCT02124122|18845204|P1|NOT COMPLETED|Overall Study||0
7652015|NCT02124122|18845203|P2|COMPLETED|Overall Study||19
7652016|NCT02124122|18845204|P1|COMPLETED|Overall Study||41
7652017|NCT02124122|18845203|P2|STARTED|Overall Study||19
7652018|NCT02124122|18845204|P1|STARTED|Overall Study||41
7652019|NCT02124083|18845212|P1|NOT COMPLETED|Overall Study||1
7652020|NCT02124083|18845212|P1|COMPLETED|Overall Study||11
7652021|NCT02124083|18845212|P1|STARTED|Overall Study||12
7652022|NCT02124044|18845223|P2|NOT COMPLETED|Overall Study||1
7652023|NCT02124044|18845224|P1|NOT COMPLETED|Overall Study||0
7652024|NCT02124044|18845223|P2|COMPLETED|Overall Study||9
7652025|NCT02124044|18845224|P1|COMPLETED|Overall Study||20
7652026|NCT02124044|18845223|P2|STARTED|Overall Study||10
7652027|NCT02124044|18845224|P1|STARTED|Overall Study||20
7652028|NCT02124018|18845233|P3|NOT COMPLETED|Overall Study||0
7652029|NCT02124018|18845234|P2|NOT COMPLETED|Overall Study||0
7652030|NCT02124018|18845235|P1|NOT COMPLETED|Overall Study||0
7652031|NCT02124018|18845233|P3|COMPLETED|Overall Study|Numbers do not add up to 575 (enrolled) due to refusals of programmed ventricular stimulation|41
7652032|NCT02124018|18845234|P2|COMPLETED|Overall Study||111
7652033|NCT02124018|18845235|P1|COMPLETED|Overall Study||371
7652034|NCT02124018|18845233|P3|STARTED|Overall Study||41
7652035|NCT02124018|18845234|P2|STARTED|Overall Study||111
7652036|NCT02124018|18845235|P1|STARTED|Overall Study||371
7652037|NCT02123966|18845246|P1|NOT COMPLETED|Overall Study||1
7652038|NCT02123966|18845246|P1|COMPLETED|Overall Study||9
7652039|NCT02123966|18845246|P1|STARTED|Overall Study||10
7652040|NCT02123849|18845253|P2|NOT COMPLETED|Overall Study||9
7652041|NCT02123849|18845254|P1|NOT COMPLETED|Overall Study||4
7652042|NCT02123849|18845253|P2|COMPLETED|Overall Study||18
7652043|NCT02123849|18845254|P1|COMPLETED|Overall Study||23
7652044|NCT02123849|18845253|P2|STARTED|Overall Study||27
7652045|NCT02123849|18845254|P1|STARTED|Overall Study||27
7652046|NCT02123797|18845280|P5|NOT COMPLETED|6-month Follow up (Cumulative Counts)||3
7652047|NCT02123797|18845281|P4|NOT COMPLETED|6-month Follow up (Cumulative Counts)||113
7652048|NCT02123797|18845282|P3|NOT COMPLETED|6-month Follow up (Cumulative Counts)||66
7652049|NCT02123797|18845283|P2|NOT COMPLETED|6-month Follow up (Cumulative Counts)||128
7652050|NCT02123797|18845284|P1|NOT COMPLETED|6-month Follow up (Cumulative Counts)||55
7652051|NCT02123797|18845280|P5|COMPLETED|6-month Follow up (Cumulative Counts)||5
7652052|NCT02123797|18845281|P4|COMPLETED|6-month Follow up (Cumulative Counts)||31
7652053|NCT02123797|18845282|P3|COMPLETED|6-month Follow up (Cumulative Counts)||34
7652054|NCT02123797|18845283|P2|COMPLETED|6-month Follow up (Cumulative Counts)||178
7652055|NCT02123797|18845284|P1|COMPLETED|6-month Follow up (Cumulative Counts)||101
7652056|NCT02123797|18845280|P5|STARTED|6-month Follow up (Cumulative Counts)|Clinical providers received 12 month follow-up rather than 6-month follow-up at this stage.|8
7652057|NCT02123797|18845281|P4|STARTED|6-month Follow up (Cumulative Counts)||144
7652058|NCT02123797|18845282|P3|STARTED|6-month Follow up (Cumulative Counts)||100
7652059|NCT02123797|18845283|P2|STARTED|6-month Follow up (Cumulative Counts)||306
7652060|NCT02123797|18845284|P1|STARTED|6-month Follow up (Cumulative Counts)||156
7652061|NCT02123797|18845280|P5|NOT COMPLETED|3-month Follow up (Cumulative Counts)||3
7652062|NCT02123797|18845281|P4|NOT COMPLETED|3-month Follow up (Cumulative Counts)||82
7652063|NCT02123797|18845282|P3|NOT COMPLETED|3-month Follow up (Cumulative Counts)||50
7652064|NCT02123797|18845283|P2|NOT COMPLETED|3-month Follow up (Cumulative Counts)||117
7652065|NCT02123797|18845284|P1|NOT COMPLETED|3-month Follow up (Cumulative Counts)||57
7652066|NCT02123797|18845280|P5|COMPLETED|3-month Follow up (Cumulative Counts)||8
7652067|NCT02123797|18845281|P4|COMPLETED|3-month Follow up (Cumulative Counts)||62
7652068|NCT02123797|18845282|P3|COMPLETED|3-month Follow up (Cumulative Counts)||50
7652069|NCT02123797|18845283|P2|COMPLETED|3-month Follow up (Cumulative Counts)||189
7652070|NCT02123797|18845284|P1|COMPLETED|3-month Follow up (Cumulative Counts)||99
7652071|NCT02123797|18845280|P5|STARTED|3-month Follow up (Cumulative Counts)|Clinical providers received 6 month follow-up rather than 3 month follow-up at this stage.|11
7652072|NCT02123797|18845281|P4|STARTED|3-month Follow up (Cumulative Counts)||144
7652073|NCT02123797|18845282|P3|STARTED|3-month Follow up (Cumulative Counts)||100
7652074|NCT02123797|18845283|P2|STARTED|3-month Follow up (Cumulative Counts)||306
7652075|NCT02123797|18845284|P1|STARTED|3-month Follow up (Cumulative Counts)||156
7652076|NCT02123797|18845280|P5|NOT COMPLETED|Baseline Intervention||0
7652077|NCT02123797|18845281|P4|NOT COMPLETED|Baseline Intervention||0
7652078|NCT02123797|18845282|P3|NOT COMPLETED|Baseline Intervention||0
7652079|NCT02123797|18845283|P2|NOT COMPLETED|Baseline Intervention||42
7652080|NCT02123797|18845284|P1|NOT COMPLETED|Baseline Intervention||22
7652081|NCT02123797|18845280|P5|COMPLETED|Baseline Intervention||11
7652082|NCT02123797|18845281|P4|COMPLETED|Baseline Intervention||144
7652083|NCT02123797|18845282|P3|COMPLETED|Baseline Intervention||100
7652084|NCT02123797|18845283|P2|COMPLETED|Baseline Intervention||306
7652085|NCT02123797|18845284|P1|COMPLETED|Baseline Intervention||156
7652086|NCT02123797|18845280|P5|STARTED|Baseline Intervention||11
7652087|NCT02123797|18845281|P4|STARTED|Baseline Intervention||144
7652088|NCT02123797|18845282|P3|STARTED|Baseline Intervention||100
7652089|NCT02123797|18845283|P2|STARTED|Baseline Intervention||348
7652090|NCT02123797|18845284|P1|STARTED|Baseline Intervention||178
7652091|NCT02123745|18845383|P1|NOT COMPLETED|Overall Study||0
7652092|NCT02123745|18845383|P1|COMPLETED|Overall Study||71
7652093|NCT02123745|18845383|P1|STARTED|Overall Study||71
7652094|NCT02123576|18845393|P2|NOT COMPLETED|Overall Study||0
7652095|NCT02123576|18845394|P1|NOT COMPLETED|Overall Study||1
7652096|NCT02123576|18845393|P2|COMPLETED|Overall Study||6
7652097|NCT02123576|18845394|P1|COMPLETED|Overall Study||5
7652098|NCT02123576|18845393|P2|STARTED|Overall Study||6
7652099|NCT02123576|18845394|P1|STARTED|Overall Study||6
7652100|NCT02123511|18845412|P2|NOT COMPLETED|Overall Study||4
7652101|NCT02123511|18845413|P1|NOT COMPLETED|Overall Study||2
7652102|NCT02123511|18845412|P2|COMPLETED|Overall Study||12
7652103|NCT02123511|18845413|P1|COMPLETED|Overall Study||16
7652104|NCT02123511|18845412|P2|Eligible Patients|Overall Study||15
7652105|NCT02123511|18845413|P1|Eligible Patients|Overall Study||17
7652106|NCT02123511|18845412|P2|STARTED|Overall Study||16
7652107|NCT02123511|18845413|P1|STARTED|Overall Study||18
7652108|NCT02123472|18845437|P2|NOT COMPLETED|Period 2 (7 Days)||1
7652109|NCT02123472|18845438|P1|NOT COMPLETED|Period 2 (7 Days)||0
7652110|NCT02123472|18845437|P2|COMPLETED|Period 2 (7 Days)||13
7652111|NCT02123472|18845438|P1|COMPLETED|Period 2 (7 Days)||14
7652112|NCT02123472|18845437|P2|STARTED|Period 2 (7 Days)||14
7652113|NCT02123472|18845438|P1|STARTED|Period 2 (7 Days)||14
7652114|NCT02123472|18845437|P2|NOT COMPLETED|Washout Period (1 Day)||0
7652115|NCT02123472|18845438|P1|NOT COMPLETED|Washout Period (1 Day)||0
7652116|NCT02123472|18845437|P2|COMPLETED|Washout Period (1 Day)||14
7652117|NCT02123472|18845438|P1|COMPLETED|Washout Period (1 Day)||14
7652118|NCT02123472|18845437|P2|STARTED|Washout Period (1 Day)||14
7652119|NCT02123472|18845438|P1|STARTED|Washout Period (1 Day)||14
7652120|NCT02123472|18845437|P2|NOT COMPLETED|Period 1 (7 Days)||0
7652121|NCT02123472|18845438|P1|NOT COMPLETED|Period 1 (7 Days)||0
7652122|NCT02123472|18845437|P2|COMPLETED|Period 1 (7 Days)||14
7652123|NCT02123472|18845438|P1|COMPLETED|Period 1 (7 Days)||14
7652124|NCT02123472|18845437|P2|STARTED|Period 1 (7 Days)||14
7652125|NCT02123472|18845438|P1|STARTED|Period 1 (7 Days)||14
7652126|NCT02123459|18845448|P2|NOT COMPLETED|Period 2 (7 Days)||0
7652127|NCT02123459|18845449|P1|NOT COMPLETED|Period 2 (7 Days)||0
7652128|NCT02123459|18845448|P2|COMPLETED|Period 2 (7 Days)||14
7652129|NCT02123459|18845449|P1|COMPLETED|Period 2 (7 Days)||13
7652130|NCT02123459|18845448|P2|STARTED|Period 2 (7 Days)||14
7652131|NCT02123459|18845449|P1|STARTED|Period 2 (7 Days)||13
7652132|NCT02123459|18845448|P2|NOT COMPLETED|Washout Period (1 Day)||0
7652133|NCT02123459|18845449|P1|NOT COMPLETED|Washout Period (1 Day)||1
7652134|NCT02123459|18845448|P2|COMPLETED|Washout Period (1 Day)||14
7652135|NCT02123459|18845449|P1|COMPLETED|Washout Period (1 Day)||13
7652136|NCT02123459|18845448|P2|STARTED|Washout Period (1 Day)||14
7652137|NCT02123459|18845449|P1|STARTED|Washout Period (1 Day)||14
7652138|NCT02123459|18845448|P2|NOT COMPLETED|Period 1 (7 Days)||0
7652139|NCT02123459|18845449|P1|NOT COMPLETED|Period 1 (7 Days)||0
7652140|NCT02123459|18845448|P2|COMPLETED|Period 1 (7 Days)||14
7652141|NCT02123459|18845449|P1|COMPLETED|Period 1 (7 Days)||14
7652142|NCT02123459|18845448|P2|STARTED|Period 1 (7 Days)||14
7652143|NCT02123459|18845449|P1|STARTED|Period 1 (7 Days)||14
7652144|NCT02123446|18845459|P2|NOT COMPLETED|Period 2 (7 Days)||0
7652145|NCT02123446|18845460|P1|NOT COMPLETED|Period 2 (7 Days)||0
7652146|NCT02123446|18845459|P2|COMPLETED|Period 2 (7 Days)||14
7652147|NCT02123446|18845460|P1|COMPLETED|Period 2 (7 Days)||13
7652148|NCT02123446|18845459|P2|STARTED|Period 2 (7 Days)||14
7652149|NCT02123446|18845460|P1|STARTED|Period 2 (7 Days)||13
7652150|NCT02123446|18845459|P2|NOT COMPLETED|Washout Period (1 Day)||0
7652151|NCT02123446|18845460|P1|NOT COMPLETED|Washout Period (1 Day)||1
7652152|NCT02123446|18845459|P2|COMPLETED|Washout Period (1 Day)||14
7652153|NCT02123446|18845460|P1|COMPLETED|Washout Period (1 Day)||13
7652154|NCT02123446|18845459|P2|STARTED|Washout Period (1 Day)||14
7652155|NCT02123446|18845460|P1|STARTED|Washout Period (1 Day)||14
7652156|NCT02123446|18845459|P2|NOT COMPLETED|Period 1 (7 Days)||0
7652157|NCT02123446|18845460|P1|NOT COMPLETED|Period 1 (7 Days)||0
7652158|NCT02123446|18845459|P2|COMPLETED|Period 1 (7 Days)||14
7652159|NCT02123446|18845460|P1|COMPLETED|Period 1 (7 Days)||14
7652160|NCT02123446|18845459|P2|STARTED|Period 1 (7 Days)||14
7652161|NCT02123446|18845460|P1|STARTED|Period 1 (7 Days)||14
7652162|NCT02123329|18845472|P2|NOT COMPLETED|12 Month Outcome Measure||79
7652163|NCT02123329|18845473|P1|NOT COMPLETED|12 Month Outcome Measure||64
7652164|NCT02123329|18845472|P2|COMPLETED|12 Month Outcome Measure||88
7652165|NCT02123329|18845473|P1|COMPLETED|12 Month Outcome Measure||83
7652166|NCT02123329|18845472|P2|STARTED|12 Month Outcome Measure||167
7652167|NCT02123329|18845473|P1|STARTED|12 Month Outcome Measure||147
7652168|NCT02123329|18845472|P2|NOT COMPLETED|6 Month Outcome Measure||67
7652169|NCT02123329|18845473|P1|NOT COMPLETED|6 Month Outcome Measure||48
7652170|NCT02123329|18845472|P2|COMPLETED|6 Month Outcome Measure||100
7652171|NCT02123329|18845473|P1|COMPLETED|6 Month Outcome Measure||99
7652172|NCT02123329|18845472|P2|STARTED|6 Month Outcome Measure||167
7652173|NCT02123329|18845473|P1|STARTED|6 Month Outcome Measure||147
7652174|NCT02123329|18845472|P2|NOT COMPLETED|3 Month Outcome Measure||66
7652175|NCT02123329|18845473|P1|NOT COMPLETED|3 Month Outcome Measure||49
7652176|NCT02123329|18845472|P2|COMPLETED|3 Month Outcome Measure||101
7652177|NCT02123329|18845473|P1|COMPLETED|3 Month Outcome Measure||98
7652178|NCT02123329|18845472|P2|STARTED|3 Month Outcome Measure||167
7652179|NCT02123329|18845473|P1|STARTED|3 Month Outcome Measure||147
7652180|NCT02123251|18845501|P2|NOT COMPLETED|Overall Study||30
7652181|NCT02123251|18845502|P1|NOT COMPLETED|Overall Study||34
7652182|NCT02123251|18845501|P2|COMPLETED|Overall Study||131
7652183|NCT02123251|18845502|P1|COMPLETED|Overall Study||125
7652184|NCT02123251|18845501|P2|STARTED|Overall Study||161
7652185|NCT02123251|18845502|P1|STARTED|Overall Study||159
7652186|NCT02123134|18845528|P2|NOT COMPLETED|Overall Study||3
7652187|NCT02123134|18845529|P1|NOT COMPLETED|Overall Study||3
7652188|NCT02123134|18845528|P2|COMPLETED|Overall Study||24
7652189|NCT02123134|18845529|P1|COMPLETED|Overall Study||25
7652190|NCT02123134|18845528|P2|STARTED|Overall Study||27
7652191|NCT02123134|18845529|P1|STARTED|Overall Study||28
7652192|NCT02123017|18845550|P3|NOT COMPLETED|Overall Study||0
7652193|NCT02123017|18845551|P2|NOT COMPLETED|Overall Study||0
7652194|NCT02123017|18845552|P1|NOT COMPLETED|Overall Study||0
7652195|NCT02123017|18845550|P3|COMPLETED|Overall Study||12
7652196|NCT02123017|18845551|P2|COMPLETED|Overall Study||12
7652197|NCT02123017|18845552|P1|COMPLETED|Overall Study||8
7652198|NCT02123017|18845550|P3|STARTED|Overall Study||12
7652199|NCT02123017|18845551|P2|STARTED|Overall Study||12
7652200|NCT02123017|18845552|P1|STARTED|Overall Study||8
7652201|NCT02122952|18845571|P2|NOT COMPLETED|Overall Study||0
7652202|NCT02122952|18845572|P1|NOT COMPLETED|Overall Study||0
7652203|NCT02122952|18845571|P2|COMPLETED|Overall Study||12
7652204|NCT02122952|18845572|P1|COMPLETED|Overall Study||3
7652205|NCT02122952|18845571|P2|STARTED|Overall Study||12
7652206|NCT02122952|18845572|P1|STARTED|Overall Study||3
7652207|NCT02122887|18845586|P2|NOT COMPLETED|Overall Study||2
7652208|NCT02122887|18845587|P1|NOT COMPLETED|Overall Study||20
7652209|NCT02122887|18845586|P2|COMPLETED|Overall Study||39
7652210|NCT02122887|18845587|P1|COMPLETED|Overall Study||40
7652211|NCT02122887|18845586|P2|STARTED|Overall Study||41
7652212|NCT02122887|18845587|P1|STARTED|Overall Study||60
7652213|NCT02122796|18845609|P2|NOT COMPLETED|Visit 2||1
7652214|NCT02122796|18845610|P1|NOT COMPLETED|Visit 2||3
7652215|NCT02122796|18845609|P2|COMPLETED|Visit 2||14
7652216|NCT02122796|18845610|P1|COMPLETED|Visit 2||12
7652217|NCT02122796|18845609|P2|STARTED|Visit 2||15
7652218|NCT02122796|18845610|P1|STARTED|Visit 2||15
7652219|NCT02122796|18845609|P2|NOT COMPLETED|Visit 1||0
7652220|NCT02122796|18845610|P1|NOT COMPLETED|Visit 1||0
7652221|NCT02122796|18845609|P2|COMPLETED|Visit 1||15
7652222|NCT02122796|18845610|P1|COMPLETED|Visit 1||15
7652223|NCT02122796|18845609|P2|STARTED|Visit 1||15
7652224|NCT02122796|18845610|P1|STARTED|Visit 1||15
7652225|NCT02122783|18845625|P2|NOT COMPLETED|Overall Study||1
7652226|NCT02122783|18845626|P1|NOT COMPLETED|Overall Study||0
7652227|NCT02122783|18845625|P2|COMPLETED|Overall Study||2
7652228|NCT02122783|18845626|P1|COMPLETED|Overall Study||2
7652229|NCT02122783|18845625|P2|STARTED|Overall Study||3
7652230|NCT02122783|18845626|P1|STARTED|Overall Study||2
7652231|NCT02122770|18845640|P6|NOT COMPLETED|Part B: Standard of Care||13
7652232|NCT02122770|18845641|P5|NOT COMPLETED|Part B: Standard of Care||23
7652233|NCT02122770|18845642|P4|NOT COMPLETED|Part B: Standard of Care||0
7652234|NCT02122770|18845643|P3|NOT COMPLETED|Part B: Standard of Care||0
7652235|NCT02122770|18845644|P2|NOT COMPLETED|Part B: Standard of Care||0
7652236|NCT02122770|18845645|P1|NOT COMPLETED|Part B: Standard of Care||0
7652237|NCT02122770|18845640|P6|COMPLETED|Part B: Standard of Care||0
7652238|NCT02122770|18845641|P5|COMPLETED|Part B: Standard of Care||0
7652239|NCT02122770|18845642|P4|COMPLETED|Part B: Standard of Care||0
7652240|NCT02122770|18845643|P3|COMPLETED|Part B: Standard of Care||0
7652241|NCT02122770|18845644|P2|COMPLETED|Part B: Standard of Care||0
7652242|NCT02122770|18845645|P1|COMPLETED|Part B: Standard of Care||0
7652243|NCT02122770|18845640|P6|STARTED|Part B: Standard of Care||13
7652244|NCT02122770|18845641|P5|STARTED|Part B: Standard of Care||23
7652245|NCT02122770|18845642|P4|STARTED|Part B: Standard of Care||0
7652246|NCT02122770|18845643|P3|STARTED|Part B: Standard of Care||0
7652247|NCT02122770|18845644|P2|STARTED|Part B: Standard of Care||0
7652248|NCT02122770|18845645|P1|STARTED|Part B: Standard of Care||0
7652249|NCT02122770|18845640|P6|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
7652250|NCT02122770|18845641|P5|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
7652251|NCT02122770|18845642|P4|NOT COMPLETED|Part A: Drug-drug Interaction 2||3
7652252|NCT02122770|18845643|P3|NOT COMPLETED|Part A: Drug-drug Interaction 2||2
7652253|NCT02122770|18845644|P2|NOT COMPLETED|Part A: Drug-drug Interaction 2||6
7652254|NCT02122770|18845645|P1|NOT COMPLETED|Part A: Drug-drug Interaction 2||4
7652255|NCT02122770|18845640|P6|COMPLETED|Part A: Drug-drug Interaction 2||0
7652256|NCT02122770|18845641|P5|COMPLETED|Part A: Drug-drug Interaction 2||0
7652257|NCT02122770|18845642|P4|COMPLETED|Part A: Drug-drug Interaction 2||16
7652258|NCT02122770|18845643|P3|COMPLETED|Part A: Drug-drug Interaction 2||4
7652259|NCT02122770|18845644|P2|COMPLETED|Part A: Drug-drug Interaction 2||7
7652260|NCT02122770|18845645|P1|COMPLETED|Part A: Drug-drug Interaction 2||9
7652261|NCT02122770|18845640|P6|STARTED|Part A: Drug-drug Interaction 2||0
7652262|NCT02122770|18845641|P5|STARTED|Part A: Drug-drug Interaction 2||0
7652263|NCT02122770|18845642|P4|STARTED|Part A: Drug-drug Interaction 2||19
7652264|NCT02122770|18845643|P3|STARTED|Part A: Drug-drug Interaction 2||6
7652265|NCT02122770|18845644|P2|STARTED|Part A: Drug-drug Interaction 2||13
7652266|NCT02122770|18845645|P1|STARTED|Part A: Drug-drug Interaction 2||13
7652267|NCT02122549|18845725|P1|NOT COMPLETED|Overall Study||0
7652268|NCT02122549|18845725|P1|COMPLETED|Overall Study||59
7652269|NCT02122549|18845725|P1|STARTED|Overall Study||59
7652270|NCT02122471|18845732|P3|NOT COMPLETED|Overall Study||44
7652271|NCT02122471|18845733|P2|NOT COMPLETED|Overall Study||51
7652272|NCT02122471|18845734|P1|NOT COMPLETED|Overall Study||39
7652273|NCT02122471|18845732|P3|COMPLETED|Overall Study||405
7652274|NCT02122471|18845733|P2|COMPLETED|Overall Study||392
7652275|NCT02122471|18845734|P1|COMPLETED|Overall Study||406
7652276|NCT02122471|18845732|P3|STARTED|Overall Study||449
7652277|NCT02122471|18845733|P2|STARTED|Overall Study||443
7652278|NCT02122471|18845734|P1|STARTED|Overall Study||445
7652279|NCT02122445|18845754|P1|NOT COMPLETED|Overall Study||0
7652280|NCT02122445|18845754|P1|COMPLETED|Overall Study||20
7652281|NCT02122445|18845754|P1|STARTED|Overall Study||20
7652282|NCT02122406|18845759|P1|NOT COMPLETED|Overall Study||0
7652283|NCT02122406|18845759|P1|COMPLETED|Overall Study||200
7652284|NCT02122406|18845759|P1|STARTED|Overall Study||200
7652285|NCT02122380|18845765|P2|NOT COMPLETED|Second Intervention (30 Days)||2
7652286|NCT02122380|18845766|P1|NOT COMPLETED|Second Intervention (30 Days)||0
7652287|NCT02122380|18845765|P2|COMPLETED|Second Intervention (30 Days)||7
7652288|NCT02122380|18845766|P1|COMPLETED|Second Intervention (30 Days)||9
7652289|NCT02122380|18845765|P2|STARTED|Second Intervention (30 Days)||9
7652290|NCT02122380|18845766|P1|STARTED|Second Intervention (30 Days)||9
7652291|NCT02122380|18845765|P2|NOT COMPLETED|Washout (8 Weeks)||2
7652292|NCT02122380|18845766|P1|NOT COMPLETED|Washout (8 Weeks)||1
7652293|NCT02122380|18845765|P2|COMPLETED|Washout (8 Weeks)||9
7652294|NCT02122380|18845766|P1|COMPLETED|Washout (8 Weeks)||9
7652295|NCT02122380|18845765|P2|STARTED|Washout (8 Weeks)||11
7652296|NCT02122380|18845766|P1|STARTED|Washout (8 Weeks)||10
7652297|NCT02122380|18845765|P2|NOT COMPLETED|First Intervention (30 Days)||1
7652298|NCT02122380|18845766|P1|NOT COMPLETED|First Intervention (30 Days)||1
7652299|NCT02122380|18845765|P2|COMPLETED|First Intervention (30 Days)||11
7652300|NCT02122380|18845766|P1|COMPLETED|First Intervention (30 Days)||10
7652301|NCT02122380|18845765|P2|STARTED|First Intervention (30 Days)||12
7652302|NCT02122380|18845766|P1|STARTED|First Intervention (30 Days)||11
7652303|NCT02122341|18845782|P2|NOT COMPLETED|Overall Study||0
7652304|NCT02122341|18845783|P1|NOT COMPLETED|Overall Study||0
7652305|NCT02122341|18845782|P2|COMPLETED|Overall Study||18
7652306|NCT02122341|18845783|P1|COMPLETED|Overall Study||17
7652307|NCT02122341|18845782|P2|STARTED|Overall Study||18
7652308|NCT02122341|18845783|P1|STARTED|Overall Study||17
7652309|NCT02122146|18845805|P8|NOT COMPLETED|Part 3: Expansion||0
7652310|NCT02122146|18845806|P7|NOT COMPLETED|Part 3: Expansion||0
7652311|NCT02122146|18845807|P6|NOT COMPLETED|Part 3: Expansion||0
7652312|NCT02122146|18845808|P5|NOT COMPLETED|Part 3: Expansion||0
7652313|NCT02122146|18845809|P4|NOT COMPLETED|Part 3: Expansion||0
7652314|NCT02122146|18845810|P3|NOT COMPLETED|Part 3: Expansion||0
7652315|NCT02122146|18845811|P2|NOT COMPLETED|Part 3: Expansion||0
7652316|NCT02122146|18845812|P1|NOT COMPLETED|Part 3: Expansion||0
7652317|NCT02122146|18845805|P8|COMPLETED|Part 3: Expansion||0
7652318|NCT02122146|18845806|P7|COMPLETED|Part 3: Expansion||0
7652319|NCT02122146|18845807|P6|COMPLETED|Part 3: Expansion||0
7652320|NCT02122146|18845808|P5|COMPLETED|Part 3: Expansion||0
7652321|NCT02122146|18845809|P4|COMPLETED|Part 3: Expansion||0
7652322|NCT02122146|18845810|P3|COMPLETED|Part 3: Expansion||0
7652323|NCT02122146|18845811|P2|COMPLETED|Part 3: Expansion||0
7652324|NCT02122146|18845812|P1|COMPLETED|Part 3: Expansion||0
7652325|NCT02122146|18845805|P8|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
7652326|NCT02122146|18845806|P7|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
7652327|NCT02122146|18845807|P6|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
7652328|NCT02122146|18845808|P5|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
7652329|NCT02122146|18845809|P4|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
7652330|NCT02122146|18845810|P3|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
7652331|NCT02122146|18845811|P2|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
7652332|NCT02122146|18845812|P1|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
7652333|NCT02122146|18845805|P8|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
7652334|NCT02122146|18845806|P7|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
7652335|NCT02122146|18845807|P6|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
7652336|NCT02122146|18845808|P5|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
7652337|NCT02122146|18845809|P4|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
7652338|NCT02122146|18845810|P3|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
7652339|NCT02122146|18845811|P2|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
7652340|NCT02122146|18845812|P1|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
7652341|NCT02122146|18845805|P8|COMPLETED|Part 2: Maximum Tolerated Dose||0
7652342|NCT02122146|18845806|P7|COMPLETED|Part 2: Maximum Tolerated Dose||0
7652343|NCT02122146|18845807|P6|COMPLETED|Part 2: Maximum Tolerated Dose||0
7652344|NCT02122146|18845808|P5|COMPLETED|Part 2: Maximum Tolerated Dose||0
7652345|NCT02122146|18845809|P4|COMPLETED|Part 2: Maximum Tolerated Dose||0
7652346|NCT02122146|18845810|P3|COMPLETED|Part 2: Maximum Tolerated Dose||0
7652347|NCT02122146|18845811|P2|COMPLETED|Part 2: Maximum Tolerated Dose||0
7652348|NCT02122146|18845812|P1|COMPLETED|Part 2: Maximum Tolerated Dose||0
7652349|NCT02122146|18845805|P8|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
7652350|NCT02122146|18845806|P7|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
7652351|NCT02122146|18845807|P6|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
7652352|NCT02122146|18845808|P5|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
7652353|NCT02122146|18845809|P4|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
7652354|NCT02122146|18845810|P3|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
7652355|NCT02122146|18845811|P2|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
7652356|NCT02122146|18845812|P1|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
7652357|NCT02122146|18845805|P8|NOT COMPLETED|Part 1: Dose Escalation||2
7652358|NCT02122146|18845806|P7|NOT COMPLETED|Part 1: Dose Escalation||1
7652359|NCT02122146|18845807|P6|NOT COMPLETED|Part 1: Dose Escalation||1
7652360|NCT02122146|18845808|P5|NOT COMPLETED|Part 1: Dose Escalation||1
7652361|NCT02122146|18845809|P4|NOT COMPLETED|Part 1: Dose Escalation||1
7652362|NCT02122146|18845810|P3|NOT COMPLETED|Part 1: Dose Escalation||2
7652363|NCT02122146|18845811|P2|NOT COMPLETED|Part 1: Dose Escalation||1
7652364|NCT02122146|18845812|P1|NOT COMPLETED|Part 1: Dose Escalation||1
7652365|NCT02122146|18845805|P8|COMPLETED|Part 1: Dose Escalation||6
7652366|NCT02122146|18845806|P7|COMPLETED|Part 1: Dose Escalation||0
7652367|NCT02122146|18845807|P6|COMPLETED|Part 1: Dose Escalation||5
7652368|NCT02122146|18845808|P5|COMPLETED|Part 1: Dose Escalation||3
7652369|NCT02122146|18845809|P4|COMPLETED|Part 1: Dose Escalation||3
7652370|NCT02122146|18845810|P3|COMPLETED|Part 1: Dose Escalation||2
7652371|NCT02122146|18845811|P2|COMPLETED|Part 1: Dose Escalation||1
7652372|NCT02122146|18845812|P1|COMPLETED|Part 1: Dose Escalation||1
7652373|NCT02122146|18845805|P8|STARTED|Part 1: Dose Escalation||8
7652374|NCT02122146|18845806|P7|STARTED|Part 1: Dose Escalation||1
7652375|NCT02122146|18845807|P6|STARTED|Part 1: Dose Escalation||6
7652376|NCT02122146|18845808|P5|STARTED|Part 1: Dose Escalation||4
7652377|NCT02122146|18845809|P4|STARTED|Part 1: Dose Escalation||4
7652378|NCT02122146|18845810|P3|STARTED|Part 1: Dose Escalation||4
7652379|NCT02122146|18845811|P2|STARTED|Part 1: Dose Escalation||2
7652380|NCT02122146|18845812|P1|STARTED|Part 1: Dose Escalation||2
7652381|NCT02121912|18846049|P2|NOT COMPLETED|Overall Study||0
7652382|NCT02121912|18846050|P1|NOT COMPLETED|Overall Study||4
7652383|NCT02121912|18846049|P2|COMPLETED|Overall Study||25
7652384|NCT02121912|18846050|P1|COMPLETED|Overall Study||21
7652385|NCT02121912|18846049|P2|STARTED|Overall Study||25
7652386|NCT02121912|18846050|P1|STARTED|Overall Study||25
7652387|NCT02121860|18846064|P4|NOT COMPLETED|Overall Study||0
7652388|NCT02121860|18846065|P3|NOT COMPLETED|Overall Study||0
7652389|NCT02121860|18846066|P2|NOT COMPLETED|Overall Study||0
7652390|NCT02121860|18846067|P1|NOT COMPLETED|Overall Study||0
7652391|NCT02121860|18846064|P4|COMPLETED|Overall Study||8
7652392|NCT02121860|18846065|P3|COMPLETED|Overall Study||8
7652393|NCT02121860|18846066|P2|COMPLETED|Overall Study||12
7652394|NCT02121860|18846067|P1|COMPLETED|Overall Study||8
7652395|NCT02121860|18846064|P4|STARTED|Overall Study||8
7652396|NCT02121860|18846065|P3|STARTED|Overall Study||8
7652397|NCT02121860|18846066|P2|STARTED|Overall Study||12
7652398|NCT02121860|18846067|P1|STARTED|Overall Study||8
7652399|NCT02121847|18846086|P1|NOT COMPLETED|Overall Study||3
7652400|NCT02121847|18846086|P1|COMPLETED|Overall Study||37
7652401|NCT02121847|18846086|P1|STARTED|Overall Study||40
7652402|NCT02121834|18846112|P7|NOT COMPLETED|Overall Study||0
7652403|NCT02121834|18846113|P6|NOT COMPLETED|Overall Study||0
7652404|NCT02121834|18846114|P5|NOT COMPLETED|Overall Study||0
7652405|NCT02121834|18846115|P4|NOT COMPLETED|Overall Study||0
7652406|NCT02121834|18846116|P3|NOT COMPLETED|Overall Study||2
7652407|NCT02121834|18846117|P2|NOT COMPLETED|Overall Study||2
7652408|NCT02121834|18846118|P1|NOT COMPLETED|Overall Study||0
7652409|NCT02121834|18846112|P7|COMPLETED|Overall Study||3
7652410|NCT02121834|18846113|P6|COMPLETED|Overall Study||9
7652411|NCT02121834|18846114|P5|COMPLETED|Overall Study||9
7652412|NCT02121834|18846115|P4|COMPLETED|Overall Study||10
7652413|NCT02121834|18846116|P3|COMPLETED|Overall Study||7
7652414|NCT02121834|18846117|P2|COMPLETED|Overall Study||9
7652415|NCT02121834|18846118|P1|COMPLETED|Overall Study||12
7652416|NCT02121834|18846112|P7|Received at Least One Dose of Study Drug|Overall Study||3
7652417|NCT02121834|18846113|P6|Received at Least One Dose of Study Drug|Overall Study||9
7652418|NCT02121834|18846114|P5|Received at Least One Dose of Study Drug|Overall Study||9
7652419|NCT02121834|18846115|P4|Received at Least One Dose of Study Drug|Overall Study||10
7652420|NCT02121834|18846116|P3|Received at Least One Dose of Study Drug|Overall Study||9
7652421|NCT02121834|18846117|P2|Received at Least One Dose of Study Drug|Overall Study||11
7652422|NCT02121834|18846118|P1|Received at Least One Dose of Study Drug|Overall Study||12
7652423|NCT02121834|18846112|P7|STARTED|Overall Study||3
7652424|NCT02121834|18846113|P6|STARTED|Overall Study||9
7652425|NCT02121834|18846114|P5|STARTED|Overall Study||9
7652426|NCT02121834|18846115|P4|STARTED|Overall Study||10
7652427|NCT02121834|18846116|P3|STARTED|Overall Study||9
7652428|NCT02121834|18846117|P2|STARTED|Overall Study||11
7652429|NCT02121834|18846118|P1|STARTED|Overall Study||12
7652430|NCT02121808|18846144|P1|NOT COMPLETED|Overall Study||3
7652431|NCT02121808|18846144|P1|COMPLETED|Overall Study||17
7652432|NCT02121808|18846144|P1|STARTED|Overall Study||20
7652433|NCT02121795|18846155|P2|NOT COMPLETED|Open-Label Phase||10
7652434|NCT02121795|18846156|P1|NOT COMPLETED|Open-Label Phase||12
7652435|NCT02121795|18846155|P2|COMPLETED|Open-Label Phase||21
7652436|NCT02121795|18846156|P1|COMPLETED|Open-Label Phase||21
7652437|NCT02121795|18846155|P2|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|31
7652438|NCT02121795|18846156|P1|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|33
7652439|NCT02121795|18846155|P2|NOT COMPLETED|Double-Blind Phase||34
7652440|NCT02121795|18846156|P1|NOT COMPLETED|Double-Blind Phase||38
7652441|NCT02121795|18846155|P2|COMPLETED|Double-Blind Phase||300
7652442|NCT02121795|18846156|P1|COMPLETED|Double-Blind Phase||296
7652443|NCT02121795|18846155|P2|Safety Analysis Set|Double-Blind Phase||330
7652444|NCT02121795|18846156|P1|Safety Analysis Set|Double-Blind Phase||333
7652445|NCT02121795|18846155|P2|STARTED|Double-Blind Phase||334
7652446|NCT02121795|18846156|P1|STARTED|Double-Blind Phase||334
7652447|NCT02121756|18846184|P2|NOT COMPLETED|Overall Study||2
7652448|NCT02121756|18846185|P1|NOT COMPLETED|Overall Study||6
7652449|NCT02121756|18846184|P2|COMPLETED|Overall Study||17
7652450|NCT02121756|18846185|P1|COMPLETED|Overall Study||15
7652451|NCT02121756|18846184|P2|STARTED|Overall Study||19
7652452|NCT02121756|18846185|P1|STARTED|Overall Study||21
7652453|NCT02121535|18846222|P2|NOT COMPLETED|Period 4 (8 Trial Days)||0
7652454|NCT02121535|18846223|P1|NOT COMPLETED|Period 4 (8 Trial Days)||0
7652455|NCT02121535|18846222|P2|COMPLETED|Period 4 (8 Trial Days)||35
7652456|NCT02121535|18846223|P1|COMPLETED|Period 4 (8 Trial Days)||35
7652457|NCT02121535|18846222|P2|STARTED|Period 4 (8 Trial Days)||35
7652458|NCT02121535|18846223|P1|STARTED|Period 4 (8 Trial Days)||35
7652459|NCT02121535|18846222|P2|NOT COMPLETED|Period 3 (8 Trial Days)||0
7652460|NCT02121535|18846223|P1|NOT COMPLETED|Period 3 (8 Trial Days)||1
7652461|NCT02121535|18846222|P2|COMPLETED|Period 3 (8 Trial Days)||35
7652462|NCT02121535|18846223|P1|COMPLETED|Period 3 (8 Trial Days)|1 subject withdrew consent during the washout period between Period 3 and 4.|35
7652463|NCT02121535|18846222|P2|STARTED|Period 3 (8 Trial Days)||35
7652464|NCT02121535|18846223|P1|STARTED|Period 3 (8 Trial Days)||36
7652465|NCT02121535|18846222|P2|NOT COMPLETED|Period 2 (8 Trial Days)||0
7652466|NCT02121535|18846223|P1|NOT COMPLETED|Period 2 (8 Trial Days)||0
7652467|NCT02121535|18846222|P2|COMPLETED|Period 2 (8 Trial Days)||35
7652468|NCT02121535|18846223|P1|COMPLETED|Period 2 (8 Trial Days)||36
7652469|NCT02121535|18846222|P2|STARTED|Period 2 (8 Trial Days)||35
7652470|NCT02121535|18846223|P1|STARTED|Period 2 (8 Trial Days)||36
7652471|NCT02121535|18846222|P2|NOT COMPLETED|Period 1 (8 Trial Days)||1
7652472|NCT02121535|18846223|P1|NOT COMPLETED|Period 1 (8 Trial Days)||0
7652473|NCT02121535|18846222|P2|COMPLETED|Period 1 (8 Trial Days)|1 subject withdrew his consent during the washout period between Period 1 and 2.|35
7652474|NCT02121535|18846223|P1|COMPLETED|Period 1 (8 Trial Days)||36
7652475|NCT02121535|18846222|P2|STARTED|Period 1 (8 Trial Days)||36
7652476|NCT02121535|18846223|P1|STARTED|Period 1 (8 Trial Days)||36
7652477|NCT02121522|18846246|P1|NOT COMPLETED|Overall Study||1
7652478|NCT02121522|18846246|P1|COMPLETED|Overall Study||13
7652479|NCT02121522|18846246|P1|STARTED|Overall Study||14
7652480|NCT02121509|18846253|P4|NOT COMPLETED|Treatment Period-2 (4 Days)||0
7652481|NCT02121509|18846254|P3|NOT COMPLETED|Treatment Period-2 (4 Days)||0
7652482|NCT02121509|18846255|P2|NOT COMPLETED|Treatment Period-2 (4 Days)||0
7652483|NCT02121509|18846256|P1|NOT COMPLETED|Treatment Period-2 (4 Days)||0
7652484|NCT02121509|18846253|P4|COMPLETED|Treatment Period-2 (4 Days)||8
7652485|NCT02121509|18846254|P3|COMPLETED|Treatment Period-2 (4 Days)||8
7652486|NCT02121509|18846255|P2|COMPLETED|Treatment Period-2 (4 Days)||24
7652487|NCT02121509|18846256|P1|COMPLETED|Treatment Period-2 (4 Days)||28
7652488|NCT02121509|18846253|P4|STARTED|Treatment Period-2 (4 Days)||8
7652489|NCT02121509|18846254|P3|STARTED|Treatment Period-2 (4 Days)||8
7652490|NCT02121509|18846255|P2|STARTED|Treatment Period-2 (4 Days)||24
7652491|NCT02121509|18846256|P1|STARTED|Treatment Period-2 (4 Days)||28
7652492|NCT02121509|18846253|P4|NOT COMPLETED|Washout Period (35 Days)||0
7652493|NCT02121509|18846254|P3|NOT COMPLETED|Washout Period (35 Days)||0
7652494|NCT02121509|18846255|P2|NOT COMPLETED|Washout Period (35 Days)||4
7652495|NCT02121509|18846256|P1|NOT COMPLETED|Washout Period (35 Days)||2
7652496|NCT02121509|18846253|P4|COMPLETED|Washout Period (35 Days)||8
7652497|NCT02121509|18846254|P3|COMPLETED|Washout Period (35 Days)||8
7652498|NCT02121509|18846255|P2|COMPLETED|Washout Period (35 Days)||24
7652499|NCT02121509|18846256|P1|COMPLETED|Washout Period (35 Days)||28
7652500|NCT02121509|18846253|P4|STARTED|Washout Period (35 Days)||8
7652501|NCT02121509|18846254|P3|STARTED|Washout Period (35 Days)||8
7652502|NCT02121509|18846255|P2|STARTED|Washout Period (35 Days)||28
7652503|NCT02121509|18846256|P1|STARTED|Washout Period (35 Days)||30
7652504|NCT02121509|18846253|P4|NOT COMPLETED|Treatment Period-1 (4 Days)||0
7652505|NCT02121509|18846254|P3|NOT COMPLETED|Treatment Period-1 (4 Days)||0
7652506|NCT02121509|18846255|P2|NOT COMPLETED|Treatment Period-1 (4 Days)||0
7652507|NCT02121509|18846256|P1|NOT COMPLETED|Treatment Period-1 (4 Days)||0
7652508|NCT02121509|18846253|P4|COMPLETED|Treatment Period-1 (4 Days)||8
7652509|NCT02121509|18846254|P3|COMPLETED|Treatment Period-1 (4 Days)||8
7652510|NCT02121509|18846255|P2|COMPLETED|Treatment Period-1 (4 Days)||28
7652511|NCT02121509|18846256|P1|COMPLETED|Treatment Period-1 (4 Days)||30
7652512|NCT02121509|18846253|P4|STARTED|Treatment Period-1 (4 Days)||8
7652513|NCT02121509|18846254|P3|STARTED|Treatment Period-1 (4 Days)||8
7652514|NCT02121509|18846255|P2|STARTED|Treatment Period-1 (4 Days)||28
7652515|NCT02121509|18846256|P1|STARTED|Treatment Period-1 (4 Days)||30
7652516|NCT02121483|18846289|P3|NOT COMPLETED|Overall Study||0
7652517|NCT02121483|18846290|P2|NOT COMPLETED|Overall Study||0
7652518|NCT02121483|18846291|P1|NOT COMPLETED|Overall Study||0
7652519|NCT02121483|18846289|P3|COMPLETED|Overall Study||10
7652520|NCT02121483|18846290|P2|COMPLETED|Overall Study||8
7652521|NCT02121483|18846291|P1|COMPLETED|Overall Study||9
7652522|NCT02121483|18846289|P3|STARTED|Overall Study||10
7652523|NCT02121483|18846290|P2|STARTED|Overall Study||8
7652524|NCT02121483|18846291|P1|STARTED|Overall Study||9
7652525|NCT02121418|18846320|P1|NOT COMPLETED|Overall Study||0
7652526|NCT02121418|18846320|P1|COMPLETED|Overall Study||12
7652527|NCT02121418|18846320|P1|STARTED|Overall Study||12
7652528|NCT02121392|18846327|P2|NOT COMPLETED|After Placement of AC Block vs Sham||3
7652529|NCT02121392|18846328|P1|NOT COMPLETED|After Placement of AC Block vs Sham||3
7652530|NCT02121392|18846327|P2|COMPLETED|After Placement of AC Block vs Sham||38
7652531|NCT02121392|18846328|P1|COMPLETED|After Placement of AC Block vs Sham||32
7652532|NCT02121392|18846327|P2|STARTED|After Placement of AC Block vs Sham||41
7652533|NCT02121392|18846328|P1|STARTED|After Placement of AC Block vs Sham||35
7652534|NCT02121392|18846327|P2|NOT COMPLETED|Prior to Intervention||41
7652535|NCT02121392|18846328|P1|NOT COMPLETED|Prior to Intervention||48
7652536|NCT02121392|18846327|P2|COMPLETED|Prior to Intervention||41
7652537|NCT02121392|18846328|P1|COMPLETED|Prior to Intervention||35
7652538|NCT02121392|18846327|P2|STARTED|Prior to Intervention||82
7652539|NCT02121392|18846328|P1|STARTED|Prior to Intervention||83
7652540|NCT02121301|18846353|P3|NOT COMPLETED|Overall Study||1
7652541|NCT02121301|18846354|P2|NOT COMPLETED|Overall Study||4
7652542|NCT02121301|18846355|P1|NOT COMPLETED|Overall Study||1
7652543|NCT02121301|18846353|P3|COMPLETED|Overall Study||30
7652544|NCT02121301|18846354|P2|COMPLETED|Overall Study||26
7652545|NCT02121301|18846355|P1|COMPLETED|Overall Study||29
7652546|NCT02121301|18846353|P3|STARTED|Overall Study||31
7652547|NCT02121301|18846354|P2|STARTED|Overall Study||30
7652548|NCT02121301|18846355|P1|STARTED|Overall Study||30
7652549|NCT02121262|18846368|P2|NOT COMPLETED|Overall Study||10
7652550|NCT02121262|18846369|P1|NOT COMPLETED|Overall Study||31
7652551|NCT02121262|18846368|P2|COMPLETED|Overall Study||135
7652552|NCT02121262|18846369|P1|COMPLETED|Overall Study||108
7652553|NCT02121262|18846368|P2|Modified Intent-to-treat Population|Overall Study||145
7652554|NCT02121262|18846369|P1|Modified Intent-to-treat Population|Overall Study||127
7652555|NCT02121262|18846368|P2|Treated|Overall Study||145
7652556|NCT02121262|18846369|P1|Treated|Overall Study||129
7652557|NCT02121262|18846368|P2|STARTED|Overall Study||145
7652558|NCT02121262|18846369|P1|STARTED|Overall Study||139
7652559|NCT02121210|18846383|P2|NOT COMPLETED|Overall Study||9
7652560|NCT02121210|18846384|P1|NOT COMPLETED|Overall Study||7
7652561|NCT02121210|18846383|P2|COMPLETED|Overall Study||58
7652562|NCT02121210|18846384|P1|COMPLETED|Overall Study||58
7652563|NCT02121210|18846383|P2|STARTED|Overall Study||67
7652564|NCT02121210|18846384|P1|STARTED|Overall Study||65
7652565|NCT02121067|18846392|P1|NOT COMPLETED|Overall Study||0
7652566|NCT02121067|18846392|P1|COMPLETED|Overall Study||50
7652567|NCT02121067|18846392|P1|STARTED|Overall Study||50
7652568|NCT02121041|18846400|P2|NOT COMPLETED|Overall Study||6
7652569|NCT02121041|18846401|P1|NOT COMPLETED|Overall Study||1
7652570|NCT02121041|18846400|P2|COMPLETED|Overall Study||8
7652571|NCT02121041|18846401|P1|COMPLETED|Overall Study||13
7652572|NCT02121041|18846400|P2|STARTED|Overall Study||14
7652573|NCT02121041|18846401|P1|STARTED|Overall Study||14
7652574|NCT02120950|18846409|P3|NOT COMPLETED|Overall Study||15
7652575|NCT02120950|18846410|P2|NOT COMPLETED|Overall Study||14
7652576|NCT02120950|18846411|P1|NOT COMPLETED|Overall Study||20
7652577|NCT02120950|18846409|P3|COMPLETED|Overall Study||0
7652578|NCT02120950|18846410|P2|COMPLETED|Overall Study|Completed Treatment (Week 96)|147
7652579|NCT02120950|18846411|P1|COMPLETED|Overall Study|Completed Treatment (Week 96)|137
7652580|NCT02120950|18846409|P3|STARTED|Overall Study||15
7652581|NCT02120950|18846410|P2|STARTED|Overall Study||161
7652582|NCT02120950|18846411|P1|STARTED|Overall Study||157
7652583|NCT02120924|18846447|P3|NOT COMPLETED|Overall Study||29
7652584|NCT02120924|18846448|P2|NOT COMPLETED|Overall Study||46
7652585|NCT02120924|18846449|P1|NOT COMPLETED|Overall Study||42
7652586|NCT02120924|18846447|P3|COMPLETED|Overall Study||173
7652587|NCT02120924|18846448|P2|COMPLETED|Overall Study||357
7652588|NCT02120924|18846449|P1|COMPLETED|Overall Study||362
7652589|NCT02120924|18846447|P3|STARTED|Overall Study||202
7652590|NCT02120924|18846448|P2|STARTED|Overall Study||403
7652591|NCT02120924|18846449|P1|STARTED|Overall Study||404
7652592|NCT02120898|18846463|P3|NOT COMPLETED|Overall Study||4
7652593|NCT02120898|18846464|P2|NOT COMPLETED|Overall Study||6
7652594|NCT02120898|18846465|P1|NOT COMPLETED|Overall Study||9
7652595|NCT02120898|18846463|P3|COMPLETED|Overall Study||89
7652596|NCT02120898|18846464|P2|COMPLETED|Overall Study||181
7652597|NCT02120898|18846465|P1|COMPLETED|Overall Study||178
7652598|NCT02120898|18846463|P3|Intent-to-Treat (ITT) Population|Overall Study||93
7652599|NCT02120898|18846464|P2|Intent-to-Treat (ITT) Population|Overall Study||185
7652600|NCT02120898|18846465|P1|Intent-to-Treat (ITT) Population|Overall Study||183
7652601|NCT02120898|18846463|P3|Safety Population|Overall Study||93
7652602|NCT02120898|18846464|P2|Safety Population|Overall Study||187
7652603|NCT02120898|18846465|P1|Safety Population|Overall Study||187
7652604|NCT02120898|18846463|P3|STARTED|Overall Study||93
7652605|NCT02120898|18846464|P2|STARTED|Overall Study||187
7652606|NCT02120898|18846465|P1|STARTED|Overall Study||187
7652607|NCT02120833|18846487|P2|NOT COMPLETED|Overall Study||1
7652608|NCT02120833|18846488|P1|NOT COMPLETED|Overall Study||4
7652609|NCT02120833|18846487|P2|COMPLETED|Overall Study||11
7652610|NCT02120833|18846488|P1|COMPLETED|Overall Study||35
7652611|NCT02120833|18846487|P2|STARTED|Overall Study||12
7652612|NCT02120833|18846488|P1|STARTED|Overall Study||39
7652613|NCT02120794|18846642|P1|NOT COMPLETED|Overall Study||58
7652614|NCT02120794|18846642|P1|COMPLETED|Overall Study||136
7652615|NCT02120794|18846642|P1|STARTED|Overall Study||194
7652616|NCT02120716|18846651|P2|NOT COMPLETED|Overall Study||0
7652617|NCT02120716|18846652|P1|NOT COMPLETED|Overall Study||1
7652618|NCT02120716|18846651|P2|COMPLETED|Overall Study||19
7652619|NCT02120716|18846652|P1|COMPLETED|Overall Study||30
7652620|NCT02120716|18846651|P2|STARTED|Overall Study||19
7652621|NCT02120716|18846652|P1|STARTED|Overall Study||31
7652622|NCT02120664|18846666|P5|NOT COMPLETED|Overall Study||0
7652623|NCT02120664|18846667|P4|NOT COMPLETED|Overall Study||1
7652624|NCT02120664|18846668|P3|NOT COMPLETED|Overall Study||0
7652625|NCT02120664|18846669|P2|NOT COMPLETED|Overall Study||0
7652626|NCT02120664|18846670|P1|NOT COMPLETED|Overall Study||0
7652627|NCT02120664|18846666|P5|COMPLETED|Overall Study||10
7652628|NCT02120664|18846667|P4|COMPLETED|Overall Study||3
7652629|NCT02120664|18846668|P3|COMPLETED|Overall Study||7
7652630|NCT02120664|18846669|P2|COMPLETED|Overall Study||4
7652631|NCT02120664|18846670|P1|COMPLETED|Overall Study||10
7652632|NCT02120664|18846666|P5|STARTED|Overall Study||10
7652633|NCT02120664|18846667|P4|STARTED|Overall Study||4
7652634|NCT02120664|18846668|P3|STARTED|Overall Study||7
7652635|NCT02120664|18846669|P2|STARTED|Overall Study||4
7652636|NCT02120664|18846670|P1|STARTED|Overall Study||10
7652637|NCT02120625|18846688|P1|NOT COMPLETED|Overall Study||2
7652638|NCT02120625|18846688|P1|COMPLETED|Overall Study||6
7652639|NCT02120625|18846688|P1|STARTED|Overall Study||8
7652640|NCT02120456|18846704|P9|NOT COMPLETED|Part 2 Double-blind Phase||1
7652641|NCT02120456|18846705|P8|NOT COMPLETED|Part 2 Double-blind Phase||0
7652642|NCT02120456|18846706|P7|NOT COMPLETED|Part 2 Double-blind Phase||2
7652643|NCT02120456|18846707|P6|NOT COMPLETED|Part 2 Double-blind Phase||0
7652644|NCT02120456|18846708|P5|NOT COMPLETED|Part 2 Double-blind Phase||0
7652645|NCT02120456|18846709|P4|NOT COMPLETED|Part 2 Double-blind Phase||0
7652646|NCT02120456|18846710|P3|NOT COMPLETED|Part 2 Double-blind Phase||0
7652647|NCT02120456|18846711|P2|NOT COMPLETED|Part 2 Double-blind Phase||0
7652648|NCT02120456|18846712|P1|NOT COMPLETED|Part 2 Double-blind Phase||0
7652649|NCT02120456|18846704|P9|COMPLETED|Part 2 Double-blind Phase||62
7652650|NCT02120456|18846705|P8|COMPLETED|Part 2 Double-blind Phase||60
7652651|NCT02120456|18846706|P7|COMPLETED|Part 2 Double-blind Phase||30
7652652|NCT02120456|18846707|P6|COMPLETED|Part 2 Double-blind Phase||0
7652653|NCT02120456|18846708|P5|COMPLETED|Part 2 Double-blind Phase||0
7652654|NCT02120456|18846709|P4|COMPLETED|Part 2 Double-blind Phase||0
7652655|NCT02120456|18846710|P3|COMPLETED|Part 2 Double-blind Phase||0
7652656|NCT02120456|18846711|P2|COMPLETED|Part 2 Double-blind Phase||0
7652657|NCT02120456|18846712|P1|COMPLETED|Part 2 Double-blind Phase||0
7652658|NCT02120456|18846704|P9|STARTED|Part 2 Double-blind Phase||63
7652659|NCT02120456|18846705|P8|STARTED|Part 2 Double-blind Phase||60
7652660|NCT02120456|18846706|P7|STARTED|Part 2 Double-blind Phase||32
7652661|NCT02120456|18846707|P6|STARTED|Part 2 Double-blind Phase||0
7652662|NCT02120456|18846708|P5|STARTED|Part 2 Double-blind Phase||0
7652663|NCT02120456|18846709|P4|STARTED|Part 2 Double-blind Phase||0
7652664|NCT02120456|18846710|P3|STARTED|Part 2 Double-blind Phase||0
7652665|NCT02120456|18846711|P2|STARTED|Part 2 Double-blind Phase||0
7652666|NCT02120456|18846712|P1|STARTED|Part 2 Double-blind Phase||0
7652667|NCT02120456|18846704|P9|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7652668|NCT02120456|18846705|P8|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7652669|NCT02120456|18846706|P7|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7652670|NCT02120456|18846707|P6|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7652671|NCT02120456|18846708|P5|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7652672|NCT02120456|18846709|P4|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7652673|NCT02120456|18846710|P3|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7652674|NCT02120456|18846711|P2|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7652675|NCT02120456|18846712|P1|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7652676|NCT02120456|18846704|P9|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7652677|NCT02120456|18846705|P8|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7652678|NCT02120456|18846706|P7|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7652679|NCT02120456|18846707|P6|COMPLETED|Part 1 Open-label, Dose-escalation Phase||9
7652680|NCT02120456|18846708|P5|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
7652681|NCT02120456|18846709|P4|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
7652682|NCT02120456|18846710|P3|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
7652683|NCT02120456|18846711|P2|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
7652684|NCT02120456|18846712|P1|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
7652685|NCT02120456|18846704|P9|STARTED|Part 1 Open-label, Dose-escalation Phase||0
7652686|NCT02120456|18846705|P8|STARTED|Part 1 Open-label, Dose-escalation Phase||0
7652687|NCT02120456|18846706|P7|STARTED|Part 1 Open-label, Dose-escalation Phase||0
7652688|NCT02120456|18846707|P6|STARTED|Part 1 Open-label, Dose-escalation Phase||9
7652689|NCT02120456|18846708|P5|STARTED|Part 1 Open-label, Dose-escalation Phase||12
7652690|NCT02120456|18846709|P4|STARTED|Part 1 Open-label, Dose-escalation Phase||12
7652691|NCT02120456|18846710|P3|STARTED|Part 1 Open-label, Dose-escalation Phase||12
7652692|NCT02120456|18846711|P2|STARTED|Part 1 Open-label, Dose-escalation Phase||12
7652693|NCT02120456|18846712|P1|STARTED|Part 1 Open-label, Dose-escalation Phase||12
7652694|NCT02120443|18846738|P1|NOT COMPLETED|Overall Study||0
7652695|NCT02120443|18846738|P1|COMPLETED|Overall Study||43
7652696|NCT02120443|18846738|P1|STARTED|Overall Study||43
7652697|NCT02120417|18846746|P2|NOT COMPLETED|Overall Study||68
7652698|NCT02120417|18846747|P1|NOT COMPLETED|Overall Study||60
7652699|NCT02120417|18846746|P2|COMPLETED|Overall Study||5
7652700|NCT02120417|18846747|P1|COMPLETED|Overall Study||16
7652701|NCT02120417|18846746|P2|STARTED|Overall Study||73
7652702|NCT02120417|18846747|P1|STARTED|Overall Study||76
7652703|NCT02120352|18846765|P4|NOT COMPLETED|Maintenance Period (32 Weeks)||56
7652704|NCT02120352|18846766|P3|NOT COMPLETED|Maintenance Period (32 Weeks)||115
7652705|NCT02120352|18846767|P2|NOT COMPLETED|Maintenance Period (32 Weeks)||115
7652706|NCT02120352|18846768|P1|NOT COMPLETED|Maintenance Period (32 Weeks)||0
7652707|NCT02120352|18846765|P4|COMPLETED|Maintenance Period (32 Weeks)||0
7652708|NCT02120352|18846766|P3|COMPLETED|Maintenance Period (32 Weeks)||0
7652709|NCT02120352|18846767|P2|COMPLETED|Maintenance Period (32 Weeks)||0
7652710|NCT02120352|18846768|P1|COMPLETED|Maintenance Period (32 Weeks)||0
7652711|NCT02120352|18846765|P4|STARTED|Maintenance Period (32 Weeks)||56
7652712|NCT02120352|18846766|P3|STARTED|Maintenance Period (32 Weeks)||115
7652713|NCT02120352|18846767|P2|STARTED|Maintenance Period (32 Weeks)||115
7652714|NCT02120352|18846768|P1|STARTED|Maintenance Period (32 Weeks)||0
7652715|NCT02120352|18846765|P4|NOT COMPLETED|Induction Period (20 Weeks)||0
7652716|NCT02120352|18846766|P3|NOT COMPLETED|Induction Period (20 Weeks)||0
7652717|NCT02120352|18846767|P2|NOT COMPLETED|Induction Period (20 Weeks)||0
7652718|NCT02120352|18846768|P1|NOT COMPLETED|Induction Period (20 Weeks)||21
7652719|NCT02120352|18846765|P4|COMPLETED|Induction Period (20 Weeks)||0
7652720|NCT02120352|18846766|P3|COMPLETED|Induction Period (20 Weeks)||0
7652721|NCT02120352|18846767|P2|COMPLETED|Induction Period (20 Weeks)||0
7652722|NCT02120352|18846768|P1|COMPLETED|Induction Period (20 Weeks)||288
7652723|NCT02120352|18846765|P4|STARTED|Induction Period (20 Weeks)||0
7652724|NCT02120352|18846766|P3|STARTED|Induction Period (20 Weeks)||0
7652725|NCT02120352|18846767|P2|STARTED|Induction Period (20 Weeks)||0
7652726|NCT02120352|18846768|P1|STARTED|Induction Period (20 Weeks)||309
7652727|NCT02120300|18846919|P4|NOT COMPLETED|Overall Study||1
7652728|NCT02120300|18846920|P3|NOT COMPLETED|Overall Study||0
7652729|NCT02120300|18846921|P2|NOT COMPLETED|Overall Study||0
7652730|NCT02120300|18846922|P1|NOT COMPLETED|Overall Study||3
7652731|NCT02120300|18846919|P4|COMPLETED|Overall Study||5
7652732|NCT02120300|18846920|P3|COMPLETED|Overall Study||10
7652733|NCT02120300|18846921|P2|COMPLETED|Overall Study||5
7652734|NCT02120300|18846922|P1|COMPLETED|Overall Study||98
7652735|NCT02120300|18846919|P4|STARTED|Overall Study||6
7652736|NCT02120300|18846920|P3|STARTED|Overall Study||10
7652737|NCT02120300|18846921|P2|STARTED|Overall Study||5
7652738|NCT02120300|18846922|P1|STARTED|Overall Study||101
7652739|NCT02120287|18846958|P1|NOT COMPLETED|Overall Study||0
7652740|NCT02120287|18846958|P1|COMPLETED|Overall Study||16
7652741|NCT02120287|18846958|P1|STARTED|Overall Study||16
7652742|NCT02120261|18846978|P2|NOT COMPLETED|Overall Study||0
7652743|NCT02120261|18846979|P1|NOT COMPLETED|Overall Study||0
7652744|NCT02120261|18846978|P2|COMPLETED|Overall Study||25
7652745|NCT02120261|18846979|P1|COMPLETED|Overall Study||23
7652746|NCT02120261|18846978|P2|STARTED|Overall Study||25
7652747|NCT02120261|18846979|P1|STARTED|Overall Study||23
7652748|NCT02120157|18846993|P2|NOT COMPLETED|Overall Study||2
7652749|NCT02120157|18846994|P1|NOT COMPLETED|Overall Study||6
7652750|NCT02120157|18846993|P2|COMPLETED|Overall Study||11
7652751|NCT02120157|18846994|P1|COMPLETED|Overall Study||13
7652752|NCT02120157|18846993|P2|Undergoing Follow-up|Overall Study||8
7652753|NCT02120157|18846994|P1|Undergoing Follow-up|Overall Study||7
7652754|NCT02120157|18846993|P2|Completed 180 Days|Overall Study||3
7652755|NCT02120157|18846994|P1|Completed 180 Days|Overall Study||5
7652756|NCT02120157|18846993|P2|STARTED|Overall Study||13
7652757|NCT02120157|18846994|P1|STARTED|Overall Study||19
7652758|NCT02120027|18847004|P2|NOT COMPLETED|Overall Study||119
7652759|NCT02120027|18847005|P1|NOT COMPLETED|Overall Study||116
7652760|NCT02120027|18847004|P2|COMPLETED|Overall Study||160
7652761|NCT02120027|18847005|P1|COMPLETED|Overall Study||161
7652762|NCT02120027|18847004|P2|STARTED|Overall Study||279
7652763|NCT02120027|18847005|P1|STARTED|Overall Study||277
7652764|NCT02120001|18847021|P2|NOT COMPLETED|Overall Study||0
7652765|NCT02120001|18847022|P1|NOT COMPLETED|Overall Study||0
7652766|NCT02120001|18847021|P2|COMPLETED|Overall Study||19
7652767|NCT02120001|18847022|P1|COMPLETED|Overall Study||17
7652768|NCT02120001|18847021|P2|STARTED|Overall Study||19
7652769|NCT02120001|18847022|P1|STARTED|Overall Study||17
7652770|NCT02119936|18847030|P1|NOT COMPLETED|Overall Study||10
7652771|NCT02119936|18847030|P1|COMPLETED|Overall Study||0
7652772|NCT02119936|18847030|P1|STARTED|Overall Study||10
7652773|NCT02119871|18847041|P2|NOT COMPLETED|Overall Study||0
7652774|NCT02119871|18847042|P1|NOT COMPLETED|Overall Study||0
7652775|NCT02119871|18847041|P2|COMPLETED|Overall Study||10
7652776|NCT02119871|18847042|P1|COMPLETED|Overall Study||10
7652777|NCT02119871|18847041|P2|STARTED|Overall Study||10
7652778|NCT02119871|18847042|P1|STARTED|Overall Study||10
7652779|NCT02119676|18847064|P4|NOT COMPLETED|Overall Study||101
7652780|NCT02119676|18847065|P3|NOT COMPLETED|Overall Study||97
7652781|NCT02119676|18847066|P2|NOT COMPLETED|Overall Study||86
7652782|NCT02119676|18847067|P1|NOT COMPLETED|Overall Study||83
7652783|NCT02119676|18847064|P4|COMPLETED|Overall Study||10
7652784|NCT02119676|18847065|P3|COMPLETED|Overall Study||13
7652785|NCT02119676|18847066|P2|COMPLETED|Overall Study||2
7652786|NCT02119676|18847067|P1|COMPLETED|Overall Study||4
7652787|NCT02119676|18847064|P4|Treated Patients|Overall Study||106
7652788|NCT02119676|18847065|P3|Treated Patients|Overall Study||106
7652789|NCT02119676|18847066|P2|Treated Patients|Overall Study||86
7652790|NCT02119676|18847067|P1|Treated Patients|Overall Study||85
7652791|NCT02119676|18847064|P4|STARTED|Overall Study||111
7652792|NCT02119676|18847065|P3|STARTED|Overall Study||110
7652793|NCT02119676|18847066|P2|STARTED|Overall Study||88
7652794|NCT02119676|18847067|P1|STARTED|Overall Study||87
7652795|NCT02119663|18847099|P2|NOT COMPLETED|Overall Study||41
7652796|NCT02119663|18847100|P1|NOT COMPLETED|Overall Study||40
7652797|NCT02119663|18847099|P2|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|2
7652798|NCT02119663|18847100|P1|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|3
7652799|NCT02119663|18847099|P2|STARTED|Overall Study||43
7652800|NCT02119663|18847100|P1|STARTED|Overall Study||43
7652801|NCT02119650|18847118|P2|NOT COMPLETED|Overall Study||26
7652802|NCT02119650|18847119|P1|NOT COMPLETED|Overall Study||25
7652803|NCT02119650|18847118|P2|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|11
7652804|NCT02119650|18847119|P1|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|14
7652805|NCT02119650|18847118|P2|STARTED|Overall Study||37
7652806|NCT02119650|18847119|P1|STARTED|Overall Study||39
7652807|NCT02119455|18847135|P2|NOT COMPLETED|Overall Study||3
7652808|NCT02119455|18847136|P1|NOT COMPLETED|Overall Study||0
7652809|NCT02119455|18847135|P2|COMPLETED|Overall Study||17
7652810|NCT02119455|18847136|P1|COMPLETED|Overall Study||20
7652811|NCT02119455|18847135|P2|STARTED|Overall Study||20
7652812|NCT02119455|18847136|P1|STARTED|Overall Study||20
7652813|NCT02119442|18847150|P1|NOT COMPLETED|Overall Study||0
7652814|NCT02119442|18847150|P1|COMPLETED|Overall Study||90
7652815|NCT02119442|18847150|P1|STARTED|Overall Study||90
7652816|NCT02119325|18847154|P2|NOT COMPLETED|Period 2||0
7652817|NCT02119325|18847155|P1|NOT COMPLETED|Period 2||0
7652818|NCT02119325|18847154|P2|COMPLETED|Period 2||47
7652819|NCT02119325|18847155|P1|COMPLETED|Period 2||48
7652820|NCT02119325|18847154|P2|STARTED|Period 2||47
7652821|NCT02119325|18847155|P1|STARTED|Period 2||48
7652822|NCT02119325|18847154|P2|NOT COMPLETED|Washout Period 1||1
7652823|NCT02119325|18847155|P1|NOT COMPLETED|Washout Period 1||0
7652824|NCT02119325|18847154|P2|COMPLETED|Washout Period 1||47
7652825|NCT02119325|18847155|P1|COMPLETED|Washout Period 1||48
7652826|NCT02119325|18847154|P2|STARTED|Washout Period 1||48
7652827|NCT02119325|18847155|P1|STARTED|Washout Period 1||48
7652828|NCT02119325|18847154|P2|NOT COMPLETED|Period 1||0
7652829|NCT02119325|18847155|P1|NOT COMPLETED|Period 1||0
7652830|NCT02119325|18847154|P2|COMPLETED|Period 1||48
7652831|NCT02119325|18847155|P1|COMPLETED|Period 1||48
7652832|NCT02119325|18847154|P2|STARTED|Period 1||48
7652833|NCT02119325|18847155|P1|STARTED|Period 1||48
7652834|NCT02119299|18847199|P1|NOT COMPLETED|Overall Study||9
7652835|NCT02119299|18847199|P1|COMPLETED|Overall Study||67
7652836|NCT02119299|18847199|P1|STARTED|Overall Study||76
7652837|NCT02119286|18847213|P3|NOT COMPLETED|Overall Study||7
7652838|NCT02119286|18847214|P2|NOT COMPLETED|Overall Study||11
7652839|NCT02119286|18847215|P1|NOT COMPLETED|Overall Study||26
7652840|NCT02119286|18847213|P3|COMPLETED|Overall Study||200
7652841|NCT02119286|18847214|P2|COMPLETED|Overall Study||195
7652842|NCT02119286|18847215|P1|COMPLETED|Overall Study||180
7652843|NCT02119286|18847213|P3|STARTED|Overall Study||207
7652844|NCT02119286|18847214|P2|STARTED|Overall Study||206
7652845|NCT02119286|18847215|P1|STARTED|Overall Study||206
7652846|NCT02119260|18847233|P7|NOT COMPLETED|Overall Study||0
7652847|NCT02119260|18847234|P6|NOT COMPLETED|Overall Study||0
7652848|NCT02119260|18847235|P5|NOT COMPLETED|Overall Study||0
7652849|NCT02119260|18847236|P4|NOT COMPLETED|Overall Study||0
7652850|NCT02119260|18847237|P3|NOT COMPLETED|Overall Study||1
7652851|NCT02119260|18847238|P2|NOT COMPLETED|Overall Study||1
7652852|NCT02119260|18847239|P1|NOT COMPLETED|Overall Study||1
7652853|NCT02119260|18847233|P7|COMPLETED|Overall Study||2
7652854|NCT02119260|18847234|P6|COMPLETED|Overall Study||6
7652855|NCT02119260|18847235|P5|COMPLETED|Overall Study||13
7652856|NCT02119260|18847236|P4|COMPLETED|Overall Study||10
7652857|NCT02119260|18847237|P3|COMPLETED|Overall Study||7
7652858|NCT02119260|18847238|P2|COMPLETED|Overall Study||11
7652859|NCT02119260|18847239|P1|COMPLETED|Overall Study||8
7652860|NCT02119260|18847233|P7|STARTED|Overall Study||2
7652861|NCT02119260|18847234|P6|STARTED|Overall Study||6
7652862|NCT02119260|18847235|P5|STARTED|Overall Study||13
7652863|NCT02119260|18847236|P4|STARTED|Overall Study||10
7652864|NCT02119260|18847237|P3|STARTED|Overall Study||8
7652865|NCT02119260|18847238|P2|STARTED|Overall Study||12
7652866|NCT02119260|18847239|P1|STARTED|Overall Study||9
7652867|NCT02119156|18847312|P3|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||7
7652868|NCT02119156|18847313|P2|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||10
7652869|NCT02119156|18847314|P1|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
7652870|NCT02119156|18847312|P3|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||3
7652871|NCT02119156|18847313|P2|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||6
7652872|NCT02119156|18847314|P1|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
7652873|NCT02119156|18847312|P3|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|10
7652874|NCT02119156|18847313|P2|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|16
7652875|NCT02119156|18847314|P1|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Long-term discontinuation participants were not allowed in Maintenance period|0
7652876|NCT02119156|18847312|P3|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||1
7652877|NCT02119156|18847313|P2|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||2
7652878|NCT02119156|18847314|P1|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||6
7652879|NCT02119156|18847312|P3|COMPLETED|Treatment Phase (Up to 52 Weeks)||11
7652880|NCT02119156|18847313|P2|COMPLETED|Treatment Phase (Up to 52 Weeks)||27
7652881|NCT02119156|18847314|P1|COMPLETED|Treatment Phase (Up to 52 Weeks)||33
7652882|NCT02119156|18847312|P3|STARTED|Treatment Phase (Up to 52 Weeks)||12
7652883|NCT02119156|18847313|P2|STARTED|Treatment Phase (Up to 52 Weeks)||29
7652884|NCT02119156|18847314|P1|STARTED|Treatment Phase (Up to 52 Weeks)||39
7652885|NCT02119104|18847372|P1|NOT COMPLETED|Overall Study||16
7652886|NCT02119104|18847372|P1|COMPLETED|Overall Study||1071
7652887|NCT02119104|18847372|P1|STARTED|Overall Study||1087
7652888|NCT02119026|18847378|P2|NOT COMPLETED|2nd-line Treatment||2
7652889|NCT02119026|18847379|P1|NOT COMPLETED|2nd-line Treatment||9
7652890|NCT02119026|18847378|P2|COMPLETED|2nd-line Treatment||22
7652891|NCT02119026|18847379|P1|COMPLETED|2nd-line Treatment||23
7652892|NCT02119026|18847378|P2|STARTED|2nd-line Treatment||24
7652893|NCT02119026|18847379|P1|STARTED|2nd-line Treatment||32
7652894|NCT02119026|18847378|P2|NOT COMPLETED|1st-line Treatment||38
7652895|NCT02119026|18847379|P1|NOT COMPLETED|1st-line Treatment||26
7652896|NCT02119026|18847378|P2|COMPLETED|1st-line Treatment||24
7652897|NCT02119026|18847379|P1|COMPLETED|1st-line Treatment||32
7652898|NCT02119026|18847378|P2|STARTED|1st-line Treatment||62
7652899|NCT02119026|18847379|P1|STARTED|1st-line Treatment||58
7652900|NCT02118961|18847403|P2|NOT COMPLETED|Overall Study||0
7652901|NCT02118961|18847404|P1|NOT COMPLETED|Overall Study||1
7652902|NCT02118961|18847403|P2|COMPLETED|Overall Study||222
7652903|NCT02118961|18847404|P1|COMPLETED|Overall Study||223
7652904|NCT02118961|18847403|P2|STARTED|Overall Study||222
7652905|NCT02118961|18847404|P1|STARTED|Overall Study||224
7652906|NCT02118896|18847432|P10|NOT COMPLETED|Overall Study||2
7652907|NCT02118896|18847433|P9|NOT COMPLETED|Overall Study||4
7652908|NCT02118896|18847434|P8|NOT COMPLETED|Overall Study||2
7652909|NCT02118896|18847435|P7|NOT COMPLETED|Overall Study||2
7652910|NCT02118896|18847436|P6|NOT COMPLETED|Overall Study||28
7652911|NCT02118896|18847437|P5|NOT COMPLETED|Overall Study||17
7652912|NCT02118896|18847438|P4|NOT COMPLETED|Overall Study||24
7652913|NCT02118896|18847439|P3|NOT COMPLETED|Overall Study||14
7652914|NCT02118896|18847440|P2|NOT COMPLETED|Overall Study||15
7652915|NCT02118896|18847441|P1|NOT COMPLETED|Overall Study||17
7652916|NCT02118896|18847432|P10|COMPLETED|Overall Study||7
7652917|NCT02118896|18847433|P9|COMPLETED|Overall Study||84
7652918|NCT02118896|18847434|P8|COMPLETED|Overall Study||105
7652919|NCT02118896|18847435|P7|COMPLETED|Overall Study||83
7652920|NCT02118896|18847436|P6|COMPLETED|Overall Study||163
7652921|NCT02118896|18847437|P5|COMPLETED|Overall Study||113
7652922|NCT02118896|18847438|P4|COMPLETED|Overall Study||55
7652923|NCT02118896|18847439|P3|COMPLETED|Overall Study||53
7652924|NCT02118896|18847440|P2|COMPLETED|Overall Study||32
7652925|NCT02118896|18847441|P1|COMPLETED|Overall Study||30
7652926|NCT02118896|18847432|P10|STARTED|Overall Study||9
7652927|NCT02118896|18847433|P9|STARTED|Overall Study||88
7652928|NCT02118896|18847434|P8|STARTED|Overall Study||107
7652929|NCT02118896|18847435|P7|STARTED|Overall Study||85
7652930|NCT02118896|18847436|P6|STARTED|Overall Study||191
7652931|NCT02118896|18847437|P5|STARTED|Overall Study||130
7652932|NCT02118896|18847438|P4|STARTED|Overall Study||79
7652933|NCT02118896|18847439|P3|STARTED|Overall Study||67
7652934|NCT02118896|18847440|P2|STARTED|Overall Study||47
7652935|NCT02118896|18847441|P1|STARTED|Overall Study||47
7652936|NCT02118831|18847516|P3|NOT COMPLETED|Overall Study||0
7652937|NCT02118831|18847517|P2|NOT COMPLETED|Overall Study||0
7652938|NCT02118831|18847518|P1|NOT COMPLETED|Overall Study||0
7652939|NCT02118831|18847516|P3|COMPLETED|Overall Study||20
7652940|NCT02118831|18847517|P2|COMPLETED|Overall Study||15
7652941|NCT02118831|18847518|P1|COMPLETED|Overall Study||21
7652942|NCT02118831|18847516|P3|STARTED|Overall Study||20
7652943|NCT02118831|18847517|P2|STARTED|Overall Study||15
7652944|NCT02118831|18847518|P1|STARTED|Overall Study||21
7652945|NCT02118792|18847531|P2|NOT COMPLETED|Overall Study||37
7652946|NCT02118792|18847532|P1|NOT COMPLETED|Overall Study||31
7652947|NCT02118792|18847531|P2|COMPLETED|Overall Study||213
7652948|NCT02118792|18847532|P1|COMPLETED|Overall Study||483
7652949|NCT02118792|18847531|P2|Treated|Overall Study||250
7652950|NCT02118792|18847532|P1|Treated|Overall Study||513
7652951|NCT02118792|18847531|P2|STARTED|Overall Study||250
7652952|NCT02118792|18847532|P1|STARTED|Overall Study||514
7652953|NCT02118766|18847574|P2|NOT COMPLETED|Overall Study||31
7652954|NCT02118766|18847575|P1|NOT COMPLETED|Overall Study||30
7652955|NCT02118766|18847574|P2|COMPLETED|Overall Study||225
7652956|NCT02118766|18847575|P1|COMPLETED|Overall Study||477
7652957|NCT02118766|18847574|P2|Treated|Overall Study||256
7652958|NCT02118766|18847575|P1|Treated|Overall Study||503
7652959|NCT02118766|18847574|P2|STARTED|Overall Study||256
7652960|NCT02118766|18847575|P1|STARTED|Overall Study||507
7652961|NCT02118714|18847597|P1|NOT COMPLETED|Overall Study||3
7652962|NCT02118714|18847597|P1|COMPLETED|Overall Study||17
7652963|NCT02118714|18847597|P1|STARTED|Overall Study||20
7652964|NCT02118610|18847613|P2|NOT COMPLETED|Overall Study||1
7652965|NCT02118610|18847614|P1|NOT COMPLETED|Overall Study||1
7652966|NCT02118610|18847613|P2|COMPLETED|Overall Study||32
7652967|NCT02118610|18847614|P1|COMPLETED|Overall Study||29
7652968|NCT02118610|18847613|P2|STARTED|Overall Study||33
7652969|NCT02118610|18847614|P1|STARTED|Overall Study||30
7652970|NCT02118597|18847622|P1|NOT COMPLETED|Overall Study||16
7652971|NCT02118597|18847622|P1|COMPLETED|Overall Study||3
7652972|NCT02118597|18847622|P1|STARTED|Overall Study||19
7652973|NCT02118441|18847638|P2|NOT COMPLETED|Overall Study||1
7652974|NCT02118441|18847639|P1|NOT COMPLETED|Overall Study||3
7652975|NCT02118441|18847638|P2|COMPLETED|Overall Study||63
7652976|NCT02118441|18847639|P1|COMPLETED|Overall Study||62
7652977|NCT02118441|18847638|P2|STARTED|Overall Study||64
7652978|NCT02118441|18847639|P1|STARTED|Overall Study||65
7652979|NCT02118428|18847653|P3|NOT COMPLETED|Overall Study||1
7652980|NCT02118428|18847654|P2|NOT COMPLETED|Overall Study||9
7652981|NCT02118428|18847655|P1|NOT COMPLETED|Overall Study||13
7652982|NCT02118428|18847653|P3|COMPLETED|Overall Study||0
7652983|NCT02118428|18847654|P2|COMPLETED|Overall Study||104
7652984|NCT02118428|18847655|P1|COMPLETED|Overall Study||100
7652985|NCT02118428|18847653|P3|Received Study Transfusion|Overall Study||0
7652986|NCT02118428|18847654|P2|Received Study Transfusion|Overall Study||112
7652987|NCT02118428|18847655|P1|Received Study Transfusion|Overall Study||111
7652988|NCT02118428|18847653|P3|STARTED|Overall Study||1
7652989|NCT02118428|18847654|P2|STARTED|Overall Study||113
7652990|NCT02118428|18847655|P1|STARTED|Overall Study||113
7652991|NCT02118012|18847695|P2|NOT COMPLETED|Overall Study||2
7652992|NCT02118012|18847696|P1|NOT COMPLETED|Overall Study||0
7652993|NCT02118012|18847695|P2|COMPLETED|Overall Study||10
7652994|NCT02118012|18847696|P1|COMPLETED|Overall Study||12
7652995|NCT02118012|18847695|P2|Day 14|Overall Study||10
7652996|NCT02118012|18847696|P1|Day 14|Overall Study||12
7652997|NCT02118012|18847695|P2|Day 5|Overall Study||11
7652998|NCT02118012|18847696|P1|Day 5|Overall Study||12
7652999|NCT02118012|18847695|P2|STARTED|Overall Study||12
7653000|NCT02118012|18847696|P1|STARTED|Overall Study||12
7653001|NCT02117999|18847710|P2|NOT COMPLETED|Overall Study||0
7653002|NCT02117999|18847711|P1|NOT COMPLETED|Overall Study||0
7653003|NCT02117999|18847710|P2|COMPLETED|Overall Study||10
7653004|NCT02117999|18847711|P1|COMPLETED|Overall Study||20
7653005|NCT02117999|18847710|P2|Mean Kmax Change in Corneal Topography|Overall Study||10
7653006|NCT02117999|18847711|P1|Mean Kmax Change in Corneal Topography|Overall Study||20
7653007|NCT02117999|18847710|P2|STARTED|Overall Study||10
7653008|NCT02117999|18847711|P1|STARTED|Overall Study||20
7653009|NCT02117934|18847729|P2|NOT COMPLETED|Overall Study||215
7653010|NCT02117934|18847730|P1|NOT COMPLETED|Overall Study||500
7653011|NCT02117934|18847729|P2|COMPLETED|Overall Study||2567
7653012|NCT02117934|18847730|P1|COMPLETED|Overall Study||5092
7653013|NCT02117934|18847729|P2|STARTED|Overall Study||2782
7653014|NCT02117934|18847730|P1|STARTED|Overall Study||5592
7653015|NCT02117687|18847740|P2|NOT COMPLETED|Overall Study||4
7653016|NCT02117687|18847741|P1|NOT COMPLETED|Overall Study||1
7653017|NCT02117687|18847740|P2|COMPLETED|Overall Study||36
7653018|NCT02117687|18847741|P1|COMPLETED|Overall Study||39
7653019|NCT02117687|18847740|P2|STARTED|Overall Study||40
7653020|NCT02117687|18847741|P1|STARTED|Overall Study||40
7653021|NCT02117648|18847773|P1|NOT COMPLETED|Abemaciclib Safety-Extension Phase||20
7653022|NCT02117648|18847773|P1|COMPLETED|Abemaciclib Safety-Extension Phase||0
7653023|NCT02117648|18847773|P1|STARTED|Abemaciclib Safety-Extension Phase||20
7653024|NCT02117648|18847773|P1|NOT COMPLETED|Abemaciclib + Clarithromycin Period 2||4
7653025|NCT02117648|18847773|P1|COMPLETED|Abemaciclib + Clarithromycin Period 2||20
7653026|NCT02117648|18847773|P1|Received at Least 1 Dose of Study Drug|Abemaciclib + Clarithromycin Period 2||21
7653027|NCT02117648|18847773|P1|STARTED|Abemaciclib + Clarithromycin Period 2||24
7653028|NCT02117648|18847773|P1|NOT COMPLETED|Abemaciclib Alone Period 1||2
7653029|NCT02117648|18847773|P1|COMPLETED|Abemaciclib Alone Period 1||24
7653030|NCT02117648|18847773|P1|Received at Least 1 Dose of Study Drug|Abemaciclib Alone Period 1||26
7653031|NCT02117648|18847773|P1|STARTED|Abemaciclib Alone Period 1||26
7653032|NCT02117570|18847786|P3|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6
7653033|NCT02117570|18847787|P2|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3
7653034|NCT02117570|18847788|P1|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1
7653035|NCT02117570|18847786|P3|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54
7653036|NCT02117570|18847787|P2|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59
7653037|NCT02117570|18847788|P1|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20
7653038|NCT02117570|18847786|P3|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
7653039|NCT02117570|18847787|P2|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
7653040|NCT02117570|18847788|P1|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4
7653041|NCT02117570|18847786|P3|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50
7653042|NCT02117570|18847787|P2|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53
7653043|NCT02117570|18847788|P1|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17
7653044|NCT02117570|18847786|P3|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60
7653045|NCT02117570|18847787|P2|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61
7653046|NCT02117570|18847788|P1|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21
7653047|NCT02117570|18847786|P3|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60
7653048|NCT02117570|18847787|P2|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62
7653049|NCT02117570|18847788|P1|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21
7653050|NCT02117570|18847786|P3|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
7653051|NCT02117570|18847787|P2|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3
7653052|NCT02117570|18847788|P1|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
7653053|NCT02117570|18847786|P3|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17
7653054|NCT02117570|18847787|P2|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15
7653055|NCT02117570|18847788|P1|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5
7653056|NCT02117570|18847786|P3|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18
7653057|NCT02117570|18847787|P2|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17
7653058|NCT02117570|18847788|P1|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6
7653059|NCT02117570|18847786|P3|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
7653060|NCT02117570|18847787|P2|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
7653061|NCT02117570|18847788|P1|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6
7653062|NCT02117570|18847786|P3|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
7653063|NCT02117570|18847787|P2|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
7653064|NCT02117570|18847788|P1|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6
7653065|NCT02117570|18847786|P3|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
7653066|NCT02117570|18847787|P2|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
7653067|NCT02117570|18847788|P1|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6
7653068|NCT02117544|18847838|P2|NOT COMPLETED|Period 2||0
7653069|NCT02117544|18847839|P1|NOT COMPLETED|Period 2||0
7653070|NCT02117544|18847838|P2|COMPLETED|Period 2||55
7653071|NCT02117544|18847839|P1|COMPLETED|Period 2||52
7653072|NCT02117544|18847838|P2|STARTED|Period 2||55
7653073|NCT02117544|18847839|P1|STARTED|Period 2||52
7653074|NCT02117544|18847838|P2|NOT COMPLETED|Period 1||0
7653075|NCT02117544|18847839|P1|NOT COMPLETED|Period 1||2
7653076|NCT02117544|18847838|P2|COMPLETED|Period 1||55
7653077|NCT02117544|18847839|P1|COMPLETED|Period 1||52
7653078|NCT02117544|18847838|P2|Treated|Period 1||55
7653079|NCT02117544|18847839|P1|Treated|Period 1||52
7653080|NCT02117544|18847838|P2|STARTED|Period 1||55
7653081|NCT02117544|18847839|P1|STARTED|Period 1||54
7653082|NCT02117479|18847854|P2|NOT COMPLETED|Overall Study||156
7653083|NCT02117479|18847855|P1|NOT COMPLETED|Overall Study||156
7653084|NCT02117479|18847854|P2|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|4
7653085|NCT02117479|18847855|P1|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|5
7653086|NCT02117479|18847854|P2|STARTED|Overall Study||160
7653087|NCT02117479|18847855|P1|STARTED|Overall Study||161
7653088|NCT02117427|18847874|P3|NOT COMPLETED|Overall Study||0
7653089|NCT02117427|18847875|P2|NOT COMPLETED|Overall Study||5
7653090|NCT02117427|18847876|P1|NOT COMPLETED|Overall Study||5
7653091|NCT02117427|18847874|P3|COMPLETED|Overall Study||0
7653092|NCT02117427|18847875|P2|COMPLETED|Overall Study||0
7653093|NCT02117427|18847876|P1|COMPLETED|Overall Study||1
7653094|NCT02117427|18847874|P3|Long Term Safety Follow-up|Overall Study||0
7653095|NCT02117427|18847875|P2|Long Term Safety Follow-up|Overall Study||0
7653096|NCT02117427|18847876|P1|Long Term Safety Follow-up|Overall Study||1
7653097|NCT02117427|18847874|P3|Safety Follow-up|Overall Study||0
7653098|NCT02117427|18847875|P2|Safety Follow-up|Overall Study||0
7653099|NCT02117427|18847876|P1|Safety Follow-up|Overall Study||1
7653100|NCT02117427|18847874|P3|Implantation & Efficacy|Overall Study||0
7653101|NCT02117427|18847875|P2|Implantation & Efficacy|Overall Study||4
7653102|NCT02117427|18847876|P1|Implantation & Efficacy|Overall Study||6
7653103|NCT02117427|18847874|P3|Run in Phase & Harvest|Overall Study||0
7653104|NCT02117427|18847875|P2|Run in Phase & Harvest|Overall Study||4
7653105|NCT02117427|18847876|P1|Run in Phase & Harvest|Overall Study||6
7653106|NCT02117427|18847874|P3|STARTED|Overall Study||0
7653107|NCT02117427|18847875|P2|STARTED|Overall Study||5
7653108|NCT02117427|18847876|P1|STARTED|Overall Study||6
7653109|NCT02117414|18847886|P2|NOT COMPLETED|Overall Study||6
7653110|NCT02117414|18847887|P1|NOT COMPLETED|Overall Study||15
7653111|NCT02117414|18847886|P2|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82
7653112|NCT02117414|18847887|P1|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160
7653113|NCT02117414|18847886|P2|STARTED|Overall Study|Subjects randomized to the Control group.|88
7653114|NCT02117414|18847887|P1|STARTED|Overall Study|Subjects randomized to the MRI group.|175
7653115|NCT02117349|18847907|P2|NOT COMPLETED|Overall Study||1
7653116|NCT02117349|18847908|P1|NOT COMPLETED|Overall Study||3
7653117|NCT02117349|18847907|P2|COMPLETED|Overall Study||17
7653118|NCT02117349|18847908|P1|COMPLETED|Overall Study||34
7653119|NCT02117349|18847907|P2|Modified Intent-to-treat (mITT)|Overall Study||18
7653120|NCT02117349|18847908|P1|Modified Intent-to-treat (mITT)|Overall Study||36
7653121|NCT02117349|18847907|P2|Safety Population|Overall Study||18
7653122|NCT02117349|18847908|P1|Safety Population|Overall Study||36
7653123|NCT02117349|18847907|P2|Intent-to-treat Population|Overall Study||18
7653124|NCT02117349|18847908|P1|Intent-to-treat Population|Overall Study||37
7653125|NCT02117349|18847907|P2|STARTED|Overall Study||18
7653126|NCT02117349|18847908|P1|STARTED|Overall Study||37
7653127|NCT02117310|18847918|P1|NOT COMPLETED|Overall Study||0
7653128|NCT02117310|18847918|P1|COMPLETED|Overall Study||5
7653129|NCT02117310|18847918|P1|STARTED|Overall Study||5
7653130|NCT02117193|18847922|P1|NOT COMPLETED|Overall Study||0
7653131|NCT02117193|18847922|P1|COMPLETED|Overall Study||10
7653132|NCT02117193|18847922|P1|Placebo Intake + Sleep Deprivation|Overall Study||10
7653133|NCT02117193|18847922|P1|Alcohol Intake + Sleep Deprivation|Overall Study||10
7653134|NCT02117193|18847922|P1|Placebo Intake + Normal Sleep|Overall Study||10
7653135|NCT02117193|18847922|P1|Alcohol Intake + Normal Sleep|Overall Study||10
7653136|NCT02117193|18847922|P1|STARTED|Overall Study||10
7653137|NCT02117050|18847944|P1|NOT COMPLETED|Overall Study||1
7653138|NCT02117050|18847944|P1|COMPLETED|Overall Study||0
7653139|NCT02117050|18847944|P1|STARTED|Overall Study||1
7653140|NCT02117024|18847958|P2|NOT COMPLETED|Overall Study||20
7653141|NCT02117024|18847959|P1|NOT COMPLETED|Overall Study||44
7653142|NCT02117024|18847958|P2|COMPLETED|Overall Study||1
7653143|NCT02117024|18847959|P1|COMPLETED|Overall Study||1
7653144|NCT02117024|18847958|P2|STARTED|Overall Study||21
7653145|NCT02117024|18847959|P1|STARTED|Overall Study||45
7653146|NCT02116972|18847986|P3|NOT COMPLETED|Overall Study||19
7653147|NCT02116972|18847987|P2|NOT COMPLETED|Overall Study||17
7653148|NCT02116972|18847988|P1|NOT COMPLETED|Overall Study||19
7653149|NCT02116972|18847986|P3|COMPLETED|Overall Study||85
7653150|NCT02116972|18847987|P2|COMPLETED|Overall Study||87
7653151|NCT02116972|18847988|P1|COMPLETED|Overall Study||83
7653152|NCT02116972|18847986|P3|STARTED|Overall Study||104
7653153|NCT02116972|18847987|P2|STARTED|Overall Study||104
7653154|NCT02116972|18847988|P1|STARTED|Overall Study||102
7653155|NCT02116803|18848020|P2|NOT COMPLETED|Overall Study||2
7653156|NCT02116803|18848021|P1|NOT COMPLETED|Overall Study||10
7653157|NCT02116803|18848020|P2|COMPLETED|Overall Study||0
7653158|NCT02116803|18848021|P1|COMPLETED|Overall Study||0
7653159|NCT02116803|18848020|P2|STARTED|Overall Study||2
7653160|NCT02116803|18848021|P1|STARTED|Overall Study||10
7653161|NCT02116660|18848029|P2|NOT COMPLETED|Overall Study||4
7653162|NCT02116660|18848030|P1|NOT COMPLETED|Overall Study||2
7653163|NCT02116660|18848029|P2|COMPLETED|Overall Study||1
7653164|NCT02116660|18848030|P1|COMPLETED|Overall Study||4
7653165|NCT02116660|18848029|P2|STARTED|Overall Study||5
7653166|NCT02116660|18848030|P1|STARTED|Overall Study||6
7653167|NCT02116621|18848074|P2|NOT COMPLETED|Twelve Month Follow-up||12
7653168|NCT02116621|18848075|P1|NOT COMPLETED|Twelve Month Follow-up||16
7653169|NCT02116621|18848074|P2|COMPLETED|Twelve Month Follow-up||86
7653170|NCT02116621|18848075|P1|COMPLETED|Twelve Month Follow-up||84
7653171|NCT02116621|18848074|P2|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|98
7653172|NCT02116621|18848075|P1|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|100
7653173|NCT02116621|18848074|P2|NOT COMPLETED|Six Month Follow-up||3
7653174|NCT02116621|18848075|P1|NOT COMPLETED|Six Month Follow-up||4
7653175|NCT02116621|18848074|P2|COMPLETED|Six Month Follow-up||97
7653176|NCT02116621|18848075|P1|COMPLETED|Six Month Follow-up||99
7653177|NCT02116621|18848074|P2|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up|100
7653178|NCT02116621|18848075|P1|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up.|103
7653179|NCT02116621|18848074|P2|NOT COMPLETED|Three Month Follow-up||7
7653180|NCT02116621|18848075|P1|NOT COMPLETED|Three Month Follow-up||19
7653181|NCT02116621|18848074|P2|COMPLETED|Three Month Follow-up||96
7653182|NCT02116621|18848075|P1|COMPLETED|Three Month Follow-up||89
7653183|NCT02116621|18848074|P2|STARTED|Three Month Follow-up||103
7653184|NCT02116621|18848075|P1|STARTED|Three Month Follow-up||108
7653185|NCT02116621|18848074|P2|NOT COMPLETED|Baseline||4
7653186|NCT02116621|18848075|P1|NOT COMPLETED|Baseline||0
7653187|NCT02116621|18848074|P2|COMPLETED|Baseline||103
7653188|NCT02116621|18848075|P1|COMPLETED|Baseline||108
7653189|NCT02116621|18848074|P2|Completed Intervention Period|Baseline||103
7653190|NCT02116621|18848075|P1|Completed Intervention Period|Baseline||95
7653191|NCT02116621|18848074|P2|Completed Baseline Visit|Baseline||103
7653192|NCT02116621|18848075|P1|Completed Baseline Visit|Baseline||108
7653193|NCT02116621|18848074|P2|STARTED|Baseline||107
7653194|NCT02116621|18848075|P1|STARTED|Baseline||108
7653195|NCT02116582|18848163|P1|NOT COMPLETED|Overall Study||215
7653196|NCT02116582|18848163|P1|COMPLETED|Overall Study||0
7653197|NCT02116582|18848163|P1|Treated|Overall Study||214
7653198|NCT02116582|18848163|P1|STARTED|Overall Study||215
7653199|NCT02116530|18848173|P2|NOT COMPLETED|Overall Study||4
7653200|NCT02116530|18848174|P1|NOT COMPLETED|Overall Study||9
7653201|NCT02116530|18848173|P2|COMPLETED|Overall Study||184
7653202|NCT02116530|18848174|P1|COMPLETED|Overall Study||183
7653203|NCT02116530|18848173|P2|STARTED|Overall Study||188
7653204|NCT02116530|18848174|P1|STARTED|Overall Study||192
7653205|NCT02116361|18848192|P4|NOT COMPLETED|Overall Study||31
7653206|NCT02116361|18848193|P3|NOT COMPLETED|Overall Study||26
7653207|NCT02116361|18848194|P2|NOT COMPLETED|Overall Study||31
7653208|NCT02116361|18848195|P1|NOT COMPLETED|Overall Study||31
7653209|NCT02116361|18848192|P4|COMPLETED|Overall Study||34
7653210|NCT02116361|18848193|P3|COMPLETED|Overall Study||33
7653211|NCT02116361|18848194|P2|COMPLETED|Overall Study||34
7653212|NCT02116361|18848195|P1|COMPLETED|Overall Study||38
7653213|NCT02116361|18848192|P4|STARTED|Overall Study||65
7653214|NCT02116361|18848193|P3|STARTED|Overall Study||59
7653215|NCT02116361|18848194|P2|STARTED|Overall Study||65
7653216|NCT02116361|18848195|P1|STARTED|Overall Study||69
7653217|NCT02116322|18848225|P1|NOT COMPLETED|Overall Study||0
7653218|NCT02116322|18848225|P1|COMPLETED|Overall Study||1
7653219|NCT02116322|18848225|P1|STARTED|Overall Study||1
7653220|NCT02116309|18848232|P2|NOT COMPLETED|Overall Study||1
7653221|NCT02116309|18848233|P1|NOT COMPLETED|Overall Study||0
7653222|NCT02116309|18848232|P2|COMPLETED|Overall Study||477
7653223|NCT02116309|18848233|P1|COMPLETED|Overall Study||482
7653224|NCT02116309|18848232|P2|STARTED|Overall Study||478
7653225|NCT02116309|18848233|P1|STARTED|Overall Study||482
7653226|NCT02116205|18848245|P4|NOT COMPLETED|Overall Study||6
7653227|NCT02116205|18848246|P3|NOT COMPLETED|Overall Study||4
7653228|NCT02116205|18848247|P2|NOT COMPLETED|Overall Study||7
7653229|NCT02116205|18848248|P1|NOT COMPLETED|Overall Study||2
7653230|NCT02116205|18848245|P4|COMPLETED|Overall Study||27
7653231|NCT02116205|18848246|P3|COMPLETED|Overall Study||29
7653232|NCT02116205|18848247|P2|COMPLETED|Overall Study||26
7653233|NCT02116205|18848248|P1|COMPLETED|Overall Study||29
7653234|NCT02116205|18848245|P4|STARTED|Overall Study||33
7653235|NCT02116205|18848246|P3|STARTED|Overall Study||33
7653236|NCT02116205|18848247|P2|STARTED|Overall Study||33
7653237|NCT02116205|18848248|P1|STARTED|Overall Study||31
7653238|NCT02115984|18848268|P2|NOT COMPLETED|Overall Study||7
7653239|NCT02115984|18848269|P1|NOT COMPLETED|Overall Study||6
7653240|NCT02115984|18848268|P2|COMPLETED|Overall Study||16
7653241|NCT02115984|18848269|P1|COMPLETED|Overall Study||51
7653242|NCT02115984|18848268|P2|STARTED|Overall Study||23
7653243|NCT02115984|18848269|P1|STARTED|Overall Study||57
7653244|NCT02115828|18848275|P1|NOT COMPLETED|Overall Study||0
7653245|NCT02115828|18848275|P1|COMPLETED|Overall Study||9
7653246|NCT02115828|18848275|P1|STARTED|Overall Study||9
7653247|NCT02115815|18848290|P7|NOT COMPLETED|Overall Study||0
7653248|NCT02115815|18848291|P6|NOT COMPLETED|Overall Study||2
7653249|NCT02115815|18848292|P5|NOT COMPLETED|Overall Study||0
7653250|NCT02115815|18848293|P4|NOT COMPLETED|Overall Study||0
7653251|NCT02115815|18848294|P3|NOT COMPLETED|Overall Study||0
7653252|NCT02115815|18848295|P2|NOT COMPLETED|Overall Study||0
7653253|NCT02115815|18848296|P1|NOT COMPLETED|Overall Study||2
7653254|NCT02115815|18848290|P7|COMPLETED|Overall Study||20
7653255|NCT02115815|18848291|P6|COMPLETED|Overall Study||20
7653256|NCT02115815|18848292|P5|COMPLETED|Overall Study||20
7653257|NCT02115815|18848293|P4|COMPLETED|Overall Study||20
7653258|NCT02115815|18848294|P3|COMPLETED|Overall Study||20
7653259|NCT02115815|18848295|P2|COMPLETED|Overall Study||20
7653260|NCT02115815|18848296|P1|COMPLETED|Overall Study||22
7653261|NCT02115815|18848290|P7|STARTED|Overall Study||20
7653262|NCT02115815|18848291|P6|STARTED|Overall Study||22
7653263|NCT02115815|18848292|P5|STARTED|Overall Study||20
7653264|NCT02115815|18848293|P4|STARTED|Overall Study||20
7653265|NCT02115815|18848294|P3|STARTED|Overall Study||20
7653266|NCT02115815|18848295|P2|STARTED|Overall Study||20
7653267|NCT02115815|18848296|P1|STARTED|Overall Study||24
7653268|NCT02115750|18848391|P2|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||12
7653269|NCT02115750|18848392|P1|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||11
7653270|NCT02115750|18848391|P2|COMPLETED|Part 2: All Subjects Receive CHS-0214||272
7653271|NCT02115750|18848392|P1|COMPLETED|Part 2: All Subjects Receive CHS-0214||269
7653272|NCT02115750|18848391|P2|STARTED|Part 2: All Subjects Receive CHS-0214||284
7653273|NCT02115750|18848392|P1|STARTED|Part 2: All Subjects Receive CHS-0214||280
7653274|NCT02115750|18848391|P2|NOT COMPLETED|Part 1||12
7653275|NCT02115750|18848392|P1|NOT COMPLETED|Part 1||22
7653276|NCT02115750|18848391|P2|COMPLETED|Part 1||312
7653277|NCT02115750|18848392|P1|COMPLETED|Part 1||301
7653278|NCT02115750|18848391|P2|STARTED|Part 1||324
7653279|NCT02115750|18848392|P1|STARTED|Part 1||323
7653280|NCT02115646|18848410|P1|NOT COMPLETED|Overall Study||7
7653281|NCT02115646|18848410|P1|COMPLETED|Overall Study||22
7653282|NCT02115646|18848410|P1|STARTED|Overall Study||29
7653283|NCT02115633|18848425|P2|NOT COMPLETED|Overall Study||0
7653284|NCT02115633|18848426|P1|NOT COMPLETED|Overall Study||0
7653285|NCT02115633|18848425|P2|COMPLETED|Overall Study||16
7653286|NCT02115633|18848426|P1|COMPLETED|Overall Study||15
7653287|NCT02115633|18848425|P2|STARTED|Overall Study||16
7653288|NCT02115633|18848426|P1|STARTED|Overall Study||15
7653289|NCT02115607|18848438|P1|NOT COMPLETED|Overall Study||1
7653290|NCT02115607|18848438|P1|COMPLETED|Overall Study||16
7653291|NCT02115607|18848438|P1|STARTED|Overall Study||17
7653292|NCT02115581|18848447|P2|NOT COMPLETED|Overall Study||0
7653293|NCT02115581|18848448|P1|NOT COMPLETED|Overall Study||0
7653294|NCT02115581|18848447|P2|COMPLETED|Overall Study||21
7653295|NCT02115581|18848448|P1|COMPLETED|Overall Study||17
7653296|NCT02115581|18848447|P2|STARTED|Overall Study||21
7653297|NCT02115581|18848448|P1|STARTED|Overall Study||17
7653298|NCT02115542|18848458|P1|NOT COMPLETED|Overall Study||0
7653299|NCT02115542|18848458|P1|COMPLETED|Overall Study||39
7653300|NCT02115542|18848458|P1|STARTED|Overall Study||39
7653301|NCT02115386|18848464|P1|NOT COMPLETED|Overall Study||7
7653302|NCT02115386|18848464|P1|COMPLETED|Overall Study||0
7653303|NCT02115386|18848464|P1|STARTED|Overall Study||7
7653304|NCT02115373|18848477|P3|NOT COMPLETED|Overall Study||0
7653305|NCT02115373|18848478|P2|NOT COMPLETED|Overall Study||0
7653306|NCT02115373|18848479|P1|NOT COMPLETED|Overall Study||0
7653307|NCT02115373|18848477|P3|COMPLETED|Overall Study||49
7653308|NCT02115373|18848478|P2|COMPLETED|Overall Study||13
7653309|NCT02115373|18848479|P1|COMPLETED|Overall Study||4
7653310|NCT02115373|18848477|P3|STARTED|Overall Study||49
7653311|NCT02115373|18848478|P2|STARTED|Overall Study||13
7653312|NCT02115373|18848479|P1|STARTED|Overall Study||4
7653313|NCT02115347|18848545|P3|NOT COMPLETED|Overall Study||0
7653314|NCT02115347|18848546|P2|NOT COMPLETED|Overall Study||0
7653315|NCT02115347|18848547|P1|NOT COMPLETED|Overall Study||0
7653316|NCT02115347|18848545|P3|COMPLETED|Overall Study||0
7653317|NCT02115347|18848546|P2|COMPLETED|Overall Study||8
7653318|NCT02115347|18848547|P1|COMPLETED|Overall Study||8
7653319|NCT02115347|18848545|P3|STARTED|Overall Study||0
7653320|NCT02115347|18848546|P2|STARTED|Overall Study||8
7653321|NCT02115347|18848547|P1|STARTED|Overall Study||8
7653322|NCT02115321|18848567|P2|NOT COMPLETED|Overall Study||0
7653323|NCT02115321|18848568|P1|NOT COMPLETED|Overall Study||1
7653324|NCT02115321|18848567|P2|COMPLETED|Overall Study||10
7653325|NCT02115321|18848568|P1|COMPLETED|Overall Study||29
7653326|NCT02115321|18848567|P2|STARTED|Overall Study||10
7653327|NCT02115321|18848568|P1|STARTED|Overall Study||30
7653328|NCT02115308|18848590|P2|NOT COMPLETED|Overall Study||2
7653329|NCT02115308|18848591|P1|NOT COMPLETED|Overall Study||2
7653330|NCT02115308|18848590|P2|COMPLETED|Overall Study|Number of subjects recruited to the CAD group meeting all inclusion criteria.|23
7653331|NCT02115308|18848591|P1|COMPLETED|Overall Study|Number of subjects recruited to the Control group meeting all inclusion criteria.|13
7653332|NCT02115308|18848590|P2|STARTED|Overall Study|Number of subjects recruited for the CAD group.|25
7653333|NCT02115308|18848591|P1|STARTED|Overall Study|Number of subjects recruited for the CONTROL group.|15
7653334|NCT02115269|18848607|P1|NOT COMPLETED|Overall Study||57
7653335|NCT02115269|18848607|P1|COMPLETED|Overall Study||702
7653336|NCT02115269|18848607|P1|STARTED|Overall Study||759
7653337|NCT02115256|18848627|P2|NOT COMPLETED|Overall Study||1
7653338|NCT02115256|18848628|P1|NOT COMPLETED|Overall Study||0
7653339|NCT02115256|18848627|P2|COMPLETED|Overall Study||2
7653340|NCT02115256|18848628|P1|COMPLETED|Overall Study||3
7653341|NCT02115256|18848627|P2|STARTED|Overall Study||3
7653342|NCT02115256|18848628|P1|STARTED|Overall Study||3
7653343|NCT02115113|18848640|P3|NOT COMPLETED|Participants Randomized||0
7653344|NCT02115113|18848641|P2|NOT COMPLETED|Participants Randomized||0
7653345|NCT02115113|18848642|P1|NOT COMPLETED|Participants Randomized||2
7653346|NCT02115113|18848640|P3|COMPLETED|Participants Randomized||0
7653347|NCT02115113|18848641|P2|COMPLETED|Participants Randomized||26
7653348|NCT02115113|18848642|P1|COMPLETED|Participants Randomized||22
7653349|NCT02115113|18848640|P3|STARTED|Participants Randomized||0
7653350|NCT02115113|18848641|P2|STARTED|Participants Randomized||26
7653351|NCT02115113|18848642|P1|STARTED|Participants Randomized||24
7653352|NCT02115113|18848640|P3|NOT COMPLETED|Participants in Run-in Period||10
7653353|NCT02115113|18848641|P2|NOT COMPLETED|Participants in Run-in Period||0
7653354|NCT02115113|18848642|P1|NOT COMPLETED|Participants in Run-in Period||0
7653355|NCT02115113|18848640|P3|COMPLETED|Participants in Run-in Period||68
7653356|NCT02115113|18848641|P2|COMPLETED|Participants in Run-in Period||0
7653357|NCT02115113|18848642|P1|COMPLETED|Participants in Run-in Period||0
7653358|NCT02115113|18848640|P3|STARTED|Participants in Run-in Period||78
7653359|NCT02115113|18848641|P2|STARTED|Participants in Run-in Period||0
7653360|NCT02115113|18848642|P1|STARTED|Participants in Run-in Period||0
7653361|NCT02115048|18848657|P2|NOT COMPLETED|Overall Study||0
7653362|NCT02115048|18848658|P1|NOT COMPLETED|Overall Study||0
7653363|NCT02115048|18848657|P2|COMPLETED|Overall Study||21
7653364|NCT02115048|18848658|P1|COMPLETED|Overall Study||23
7653365|NCT02115048|18848657|P2|STARTED|Overall Study||21
7653366|NCT02115048|18848658|P1|STARTED|Overall Study||23
7653367|NCT02114931|18848674|P2|NOT COMPLETED|Overall Study||30
7653368|NCT02114931|18848675|P1|NOT COMPLETED|Overall Study||25
7653369|NCT02114931|18848674|P2|COMPLETED|Overall Study||207
7653370|NCT02114931|18848675|P1|COMPLETED|Overall Study||205
7653371|NCT02114931|18848674|P2|Received Treatment|Overall Study||237
7653372|NCT02114931|18848675|P1|Received Treatment|Overall Study|One participant was enrolled in error and did not receive treatment in the extension study|229
7653373|NCT02114931|18848674|P2|STARTED|Overall Study||237
7653374|NCT02114931|18848675|P1|STARTED|Overall Study||230
7653375|NCT02114892|18848691|P2|NOT COMPLETED|Overall Study||2
7653376|NCT02114892|18848692|P1|NOT COMPLETED|Overall Study||1
7653377|NCT02114892|18848691|P2|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10
7653378|NCT02114892|18848692|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
7653379|NCT02114892|18848691|P2|STARTED|Overall Study||12
7653380|NCT02114892|18848692|P1|STARTED|Overall Study||12
7653381|NCT02114879|18848728|P2|NOT COMPLETED|Overall Study||24
7653382|NCT02114879|18848729|P1|NOT COMPLETED|Overall Study||19
7653383|NCT02114879|18848728|P2|COMPLETED|Overall Study||90
7653384|NCT02114879|18848729|P1|COMPLETED|Overall Study||96
7653385|NCT02114879|18848728|P2|STARTED|Overall Study||114
7653386|NCT02114879|18848729|P1|STARTED|Overall Study||115
7653387|NCT02114697|18848747|P2|NOT COMPLETED|Overall Study||4
7653388|NCT02114697|18848748|P1|NOT COMPLETED|Overall Study||5
7653389|NCT02114697|18848747|P2|COMPLETED|Overall Study||0
7653390|NCT02114697|18848748|P1|COMPLETED|Overall Study||0
7653391|NCT02114697|18848747|P2|Completed Month 18 Visit|Overall Study||1
7653392|NCT02114697|18848748|P1|Completed Month 18 Visit|Overall Study||0
7653393|NCT02114697|18848747|P2|STARTED|Overall Study||4
7653394|NCT02114697|18848748|P1|STARTED|Overall Study||5
7653395|NCT02114684|18848756|P2|NOT COMPLETED|Overall Study||10
7653396|NCT02114684|18848757|P1|NOT COMPLETED|Overall Study||12
7653397|NCT02114684|18848756|P2|COMPLETED|Overall Study||88
7653398|NCT02114684|18848757|P1|COMPLETED|Overall Study||86
7653399|NCT02114684|18848756|P2|STARTED|Overall Study||98
7653400|NCT02114684|18848757|P1|STARTED|Overall Study||98
7653401|NCT02114515|18848775|P2|NOT COMPLETED|Overall Study||150
7653402|NCT02114515|18848776|P1|NOT COMPLETED|Overall Study||133
7653403|NCT02114515|18848775|P2|COMPLETED|Overall Study||368
7653404|NCT02114515|18848776|P1|COMPLETED|Overall Study||378
7653405|NCT02114515|18848775|P2|STARTED|Overall Study||518
7653406|NCT02114515|18848776|P1|STARTED|Overall Study||511
7653407|NCT02114385|18848822|P2|NOT COMPLETED|Overall Study||8
7653408|NCT02114385|18848823|P1|NOT COMPLETED|Overall Study||3
7653409|NCT02114385|18848822|P2|COMPLETED|Overall Study||243
7653410|NCT02114385|18848823|P1|COMPLETED|Overall Study||246
7653411|NCT02114385|18848822|P2|Vaccinated|Overall Study||251
7653412|NCT02114385|18848823|P1|Vaccinated|Overall Study||249
7653413|NCT02114385|18848822|P2|STARTED|Overall Study||251
7653414|NCT02114385|18848823|P1|STARTED|Overall Study||249
7653415|NCT02114307|18848847|P2|NOT COMPLETED|Overall Study||0
7653416|NCT02114307|18848848|P1|NOT COMPLETED|Overall Study||1
7653417|NCT02114307|18848847|P2|COMPLETED|Overall Study||11
7653418|NCT02114307|18848848|P1|COMPLETED|Overall Study||10
7653419|NCT02114307|18848847|P2|STARTED|Overall Study||11
7653420|NCT02114307|18848848|P1|STARTED|Overall Study||11
7653421|NCT02114268|18848864|P6|NOT COMPLETED|Overall Study||3
7653422|NCT02114268|18848865|P5|NOT COMPLETED|Overall Study||0
7653423|NCT02114268|18848866|P4|NOT COMPLETED|Overall Study||0
7653424|NCT02114268|18848867|P3|NOT COMPLETED|Overall Study||1
7653425|NCT02114268|18848868|P2|NOT COMPLETED|Overall Study||1
7653426|NCT02114268|18848869|P1|NOT COMPLETED|Overall Study||6
7653427|NCT02114268|18848864|P6|COMPLETED|Overall Study||75
7653428|NCT02114268|18848865|P5|COMPLETED|Overall Study||6
7653429|NCT02114268|18848866|P4|COMPLETED|Overall Study||6
7653430|NCT02114268|18848867|P3|COMPLETED|Overall Study||5
7653431|NCT02114268|18848868|P2|COMPLETED|Overall Study||5
7653432|NCT02114268|18848869|P1|COMPLETED|Overall Study||28
7653433|NCT02114268|18848864|P6|STARTED|Overall Study||78
7653434|NCT02114268|18848865|P5|STARTED|Overall Study||6
7653435|NCT02114268|18848866|P4|STARTED|Overall Study||6
7653436|NCT02114268|18848867|P3|STARTED|Overall Study||6
7653437|NCT02114268|18848868|P2|STARTED|Overall Study||6
7653438|NCT02114268|18848869|P1|STARTED|Overall Study||34
7653439|NCT02114216|18848922|P3|NOT COMPLETED|Overall Study||0
7653440|NCT02114216|18848923|P2|NOT COMPLETED|Overall Study||0
7653441|NCT02114216|18848924|P1|NOT COMPLETED|Overall Study||0
7653442|NCT02114216|18848922|P3|COMPLETED|Overall Study||14
7653443|NCT02114216|18848923|P2|COMPLETED|Overall Study||45
7653444|NCT02114216|18848924|P1|COMPLETED|Overall Study||16
7653445|NCT02114216|18848922|P3|STARTED|Overall Study||14
7653446|NCT02114216|18848923|P2|STARTED|Overall Study||45
7653447|NCT02114216|18848924|P1|STARTED|Overall Study||16
7653448|NCT02114203|18848938|P3|NOT COMPLETED|Overall Study||0
7653449|NCT02114203|18848939|P2|NOT COMPLETED|Overall Study||2
7653450|NCT02114203|18848940|P1|NOT COMPLETED|Overall Study||0
7653451|NCT02114203|18848938|P3|COMPLETED|Overall Study||7
7653452|NCT02114203|18848939|P2|COMPLETED|Overall Study||14
7653453|NCT02114203|18848940|P1|COMPLETED|Overall Study||7
7653454|NCT02114203|18848938|P3|STARTED|Overall Study||7
7653455|NCT02114203|18848939|P2|STARTED|Overall Study||16
7653456|NCT02114203|18848940|P1|STARTED|Overall Study||7
7653457|NCT02114177|18848974|P2|NOT COMPLETED|Overall Study||4
7653458|NCT02114177|18848975|P1|NOT COMPLETED|Overall Study||9
7653459|NCT02114177|18848974|P2|COMPLETED|Overall Study||151
7653460|NCT02114177|18848975|P1|COMPLETED|Overall Study||146
7653461|NCT02114177|18848974|P2|STARTED|Overall Study||155
7653462|NCT02114177|18848975|P1|STARTED|Overall Study||155
7653463|NCT02114151|18848999|P1|NOT COMPLETED|Overall Study||7
7653464|NCT02114151|18848999|P1|COMPLETED|Overall Study||96
7653465|NCT02114151|18848999|P1|STARTED|Overall Study||103
7653466|NCT02113956|18849016|P2|NOT COMPLETED|3 Month Post-intervention||2
7653467|NCT02113956|18849017|P1|NOT COMPLETED|3 Month Post-intervention||4
7653468|NCT02113956|18849016|P2|COMPLETED|3 Month Post-intervention||146
7653469|NCT02113956|18849017|P1|COMPLETED|3 Month Post-intervention||137
7653470|NCT02113956|18849016|P2|STARTED|3 Month Post-intervention||148
7653471|NCT02113956|18849017|P1|STARTED|3 Month Post-intervention||141
7653472|NCT02113956|18849016|P2|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||4
7653473|NCT02113956|18849017|P1|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||9
7653474|NCT02113956|18849016|P2|COMPLETED|Intervention End (5 Weeks Post Baseline)||148
7653475|NCT02113956|18849017|P1|COMPLETED|Intervention End (5 Weeks Post Baseline)||141
7653476|NCT02113956|18849016|P2|STARTED|Intervention End (5 Weeks Post Baseline)||152
7653477|NCT02113956|18849017|P1|STARTED|Intervention End (5 Weeks Post Baseline)||150
7653478|NCT02113579|18849051|P2|NOT COMPLETED|Overall Study||4
7653479|NCT02113579|18849052|P1|NOT COMPLETED|Overall Study||10
7653480|NCT02113579|18849051|P2|COMPLETED|Overall Study||185
7653481|NCT02113579|18849052|P1|COMPLETED|Overall Study||176
7653482|NCT02113579|18849051|P2|STARTED|Overall Study||189
7653483|NCT02113579|18849052|P1|STARTED|Overall Study||186
7653484|NCT02113449|18849076|P1|NOT COMPLETED|Overall Study||4
7653485|NCT02113449|18849076|P1|COMPLETED|Overall Study||143
7653486|NCT02113449|18849076|P1|STARTED|Overall Study||147
7653487|NCT02113436|18849092|P4|NOT COMPLETED|Period 2: 16 Weeks||11
7653488|NCT02113436|18849093|P3|NOT COMPLETED|Period 2: 16 Weeks||9
7653489|NCT02113436|18849094|P2|NOT COMPLETED|Period 2: 16 Weeks||0
7653490|NCT02113436|18849095|P1|NOT COMPLETED|Period 2: 16 Weeks||0
7653491|NCT02113436|18849092|P4|COMPLETED|Period 2: 16 Weeks||136
7653492|NCT02113436|18849093|P3|COMPLETED|Period 2: 16 Weeks||132
7653493|NCT02113436|18849094|P2|COMPLETED|Period 2: 16 Weeks||0
7653494|NCT02113436|18849095|P1|COMPLETED|Period 2: 16 Weeks||0
7653495|NCT02113436|18849092|P4|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|147
7653496|NCT02113436|18849093|P3|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|141
7653497|NCT02113436|18849094|P2|STARTED|Period 2: 16 Weeks||0
7653498|NCT02113436|18849095|P1|STARTED|Period 2: 16 Weeks||0
7653499|NCT02113436|18849092|P4|NOT COMPLETED|Period 1: 8 Weeks||0
7653500|NCT02113436|18849093|P3|NOT COMPLETED|Period 1: 8 Weeks||0
7653501|NCT02113436|18849094|P2|NOT COMPLETED|Period 1: 8 Weeks||2
7653502|NCT02113436|18849095|P1|NOT COMPLETED|Period 1: 8 Weeks||8
7653503|NCT02113436|18849092|P4|COMPLETED|Period 1: 8 Weeks||0
7653504|NCT02113436|18849093|P3|COMPLETED|Period 1: 8 Weeks||0
7653505|NCT02113436|18849094|P2|COMPLETED|Period 1: 8 Weeks||148
7653506|NCT02113436|18849095|P1|COMPLETED|Period 1: 8 Weeks||142
7653507|NCT02113436|18849092|P4|STARTED|Period 1: 8 Weeks||0
7653508|NCT02113436|18849093|P3|STARTED|Period 1: 8 Weeks||0
7653509|NCT02113436|18849094|P2|STARTED|Period 1: 8 Weeks||150
7653510|NCT02113436|18849095|P1|STARTED|Period 1: 8 Weeks||150
7653511|NCT02113410|18849118|P2|NOT COMPLETED|Overall Study||3
7653512|NCT02113410|18849119|P1|NOT COMPLETED|Overall Study||16
7653513|NCT02113410|18849118|P2|COMPLETED|Overall Study||63
7653514|NCT02113410|18849119|P1|COMPLETED|Overall Study||49
7653515|NCT02113410|18849118|P2|STARTED|Overall Study||66
7653516|NCT02113410|18849119|P1|STARTED|Overall Study||65
7653517|NCT02113241|18849145|P2|NOT COMPLETED|Overall Study||1
7653518|NCT02113241|18849146|P1|NOT COMPLETED|Overall Study||0
7653519|NCT02113241|18849145|P2|COMPLETED|Overall Study||11
7653520|NCT02113241|18849146|P1|COMPLETED|Overall Study||12
7653521|NCT02113241|18849145|P2|STARTED|Overall Study||12
7653522|NCT02113241|18849146|P1|STARTED|Overall Study||12
7653523|NCT02113189|18849201|P3|NOT COMPLETED|Overall Study||3
7653524|NCT02113189|18849202|P2|NOT COMPLETED|Overall Study||1
7653525|NCT02113189|18849203|P1|NOT COMPLETED|Overall Study||2
7653526|NCT02113189|18849201|P3|COMPLETED|Overall Study||2
7653527|NCT02113189|18849202|P2|COMPLETED|Overall Study||3
7653528|NCT02113189|18849203|P1|COMPLETED|Overall Study||2
7653529|NCT02113189|18849201|P3|STARTED|Overall Study||5
7653530|NCT02113189|18849202|P2|STARTED|Overall Study||4
7653531|NCT02113189|18849203|P1|STARTED|Overall Study||4
7653532|NCT02113124|18849219|P2|NOT COMPLETED|Overall Study||1
7653533|NCT02113124|18849220|P1|NOT COMPLETED|Overall Study||1
7653534|NCT02113124|18849219|P2|COMPLETED|Overall Study||24
7653535|NCT02113124|18849220|P1|COMPLETED|Overall Study||17
7653536|NCT02113124|18849219|P2|STARTED|Overall Study||25
7653537|NCT02113124|18849220|P1|STARTED|Overall Study||18
7653538|NCT02113007|18849226|P1|NOT COMPLETED|Overall Study||2
7653539|NCT02113007|18849226|P1|COMPLETED|Overall Study||0
7653540|NCT02113007|18849226|P1|STARTED|Overall Study||2
7653541|NCT02112994|18849232|P3|NOT COMPLETED|Overall Study||3
7653542|NCT02112994|18849233|P2|NOT COMPLETED|Overall Study||2
7653543|NCT02112994|18849234|P1|NOT COMPLETED|Overall Study||0
7653544|NCT02112994|18849232|P3|COMPLETED|Overall Study||6
7653545|NCT02112994|18849233|P2|COMPLETED|Overall Study||14
7653546|NCT02112994|18849234|P1|COMPLETED|Overall Study||6
7653547|NCT02112994|18849232|P3|Completed 96-week Treatment Period|Overall Study||8
7653548|NCT02112994|18849233|P2|Completed 96-week Treatment Period|Overall Study||14
7653549|NCT02112994|18849234|P1|Completed 96-week Treatment Period|Overall Study||6
7653550|NCT02112994|18849232|P3|Received 3 mg/kg QW|Overall Study||1
7653551|NCT02112994|18849233|P2|Received 3 mg/kg QW|Overall Study||1
7653552|NCT02112994|18849234|P1|Received 3 mg/kg QW|Overall Study||2
7653553|NCT02112994|18849232|P3|Received 3 mg/kg QOW|Overall Study||3
7653554|NCT02112994|18849233|P2|Received 3 mg/kg QOW|Overall Study||5
7653555|NCT02112994|18849234|P1|Received 3 mg/kg QOW|Overall Study||3
7653556|NCT02112994|18849232|P3|Received 1 mg/kg QW|Overall Study||0
7653557|NCT02112994|18849233|P2|Received 1 mg/kg QW|Overall Study||1
7653558|NCT02112994|18849234|P1|Received 1 mg/kg QW|Overall Study||1
7653559|NCT02112994|18849232|P3|Received 1 mg/kg QOW|Overall Study||9
7653560|NCT02112994|18849233|P2|Received 1 mg/kg QOW|Overall Study||16
7653561|NCT02112994|18849234|P1|Received 1 mg/kg QOW|Overall Study||6
7653562|NCT02112994|18849232|P3|Received 0.35 mg/kg QOW|Overall Study||1
7653563|NCT02112994|18849233|P2|Received 0.35 mg/kg QOW|Overall Study||0
7653564|NCT02112994|18849234|P1|Received 0.35 mg/kg QOW|Overall Study||0
7653565|NCT02112994|18849232|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
7653566|NCT02112994|18849233|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
7653567|NCT02112994|18849234|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
7653568|NCT02112994|18849232|P3|STARTED|Overall Study||9
7653569|NCT02112994|18849233|P2|STARTED|Overall Study||16
7653570|NCT02112994|18849234|P1|STARTED|Overall Study||6
7653571|NCT02112877|18849252|P2|NOT COMPLETED|Overall Study||13
7653572|NCT02112877|18849253|P1|NOT COMPLETED|Overall Study||2
7653573|NCT02112877|18849252|P2|COMPLETED|Overall Study||157
7653574|NCT02112877|18849253|P1|COMPLETED|Overall Study||28
7653575|NCT02112877|18849252|P2|STARTED|Overall Study||170
7653576|NCT02112877|18849253|P1|STARTED|Overall Study||30
7653577|NCT02112838|18849278|P3|NOT COMPLETED|Overall Study||1
7653578|NCT02112838|18849279|P2|NOT COMPLETED|Overall Study||2
7653579|NCT02112838|18849280|P1|NOT COMPLETED|Overall Study||5
7653580|NCT02112838|18849278|P3|COMPLETED|Overall Study||24
7653581|NCT02112838|18849279|P2|COMPLETED|Overall Study||24
7653582|NCT02112838|18849280|P1|COMPLETED|Overall Study||20
7653583|NCT02112838|18849278|P3|STARTED|Overall Study||25
7653584|NCT02112838|18849279|P2|STARTED|Overall Study||26
7653585|NCT02112838|18849280|P1|STARTED|Overall Study||25
7653586|NCT02112526|18849332|P2|NOT COMPLETED|Overall Study||9
7653587|NCT02112526|18849333|P1|NOT COMPLETED|Overall Study||11
7653588|NCT02112526|18849332|P2|COMPLETED|Overall Study||1
7653589|NCT02112526|18849333|P1|COMPLETED|Overall Study||0
7653590|NCT02112526|18849332|P2|Subjects Continuing Study Medication|Overall Study||1
7653591|NCT02112526|18849333|P1|Subjects Continuing Study Medication|Overall Study||0
7653592|NCT02112526|18849332|P2|Discontinued Study|Overall Study||9
7653593|NCT02112526|18849333|P1|Discontinued Study|Overall Study||11
7653594|NCT02112526|18849332|P2|Received Study Medication|Overall Study||10
7653595|NCT02112526|18849333|P1|Received Study Medication|Overall Study||11
7653596|NCT02112526|18849332|P2|Enrolled|Overall Study||10
7653597|NCT02112526|18849333|P1|Enrolled|Overall Study||11
7653598|NCT02112526|18849332|P2|STARTED|Overall Study||10
7653599|NCT02112526|18849333|P1|STARTED|Overall Study||11
7653600|NCT02112448|18849341|P2|NOT COMPLETED|Overall Study||10
7653601|NCT02112448|18849342|P1|NOT COMPLETED|Overall Study||8
7653602|NCT02112448|18849341|P2|COMPLETED|Overall Study||30
7653603|NCT02112448|18849342|P1|COMPLETED|Overall Study||30
7653604|NCT02112448|18849341|P2|STARTED|Overall Study||40
7653605|NCT02112448|18849342|P1|STARTED|Overall Study||38
7653606|NCT02112370|18849352|P2|NOT COMPLETED|Overall Study||0
7653607|NCT02112370|18849353|P1|NOT COMPLETED|Overall Study||0
7653608|NCT02112370|18849352|P2|COMPLETED|Overall Study||74
7653609|NCT02112370|18849353|P1|COMPLETED|Overall Study||74
7653610|NCT02112370|18849352|P2|STARTED|Overall Study||74
7653611|NCT02112370|18849353|P1|STARTED|Overall Study||74
7653612|NCT02112045|18849375|P2|NOT COMPLETED|Overall Study||0
7653613|NCT02112045|18849376|P1|NOT COMPLETED|Overall Study||1
7653614|NCT02112045|18849375|P2|COMPLETED|Overall Study||45
7653615|NCT02112045|18849376|P1|COMPLETED|Overall Study||44
7653616|NCT02112045|18849375|P2|STARTED|Overall Study||45
7653617|NCT02112045|18849376|P1|STARTED|Overall Study||45
7653618|NCT02111993|18849396|P2|NOT COMPLETED|Overall Study||4
7653619|NCT02111993|18849397|P1|NOT COMPLETED|Overall Study||5
7653620|NCT02111993|18849396|P2|COMPLETED|Overall Study||26
7653621|NCT02111993|18849397|P1|COMPLETED|Overall Study||25
7653622|NCT02111993|18849396|P2|STARTED|Overall Study||30
7653623|NCT02111993|18849397|P1|STARTED|Overall Study||30
7653624|NCT02111980|18849407|P1|NOT COMPLETED|Overall Study||0
7653625|NCT02111980|18849407|P1|COMPLETED|Overall Study||50
7653626|NCT02111980|18849407|P1|STARTED|Overall Study||50
7653627|NCT02111863|18849430|P1|NOT COMPLETED|Overall Study||0
7653628|NCT02111863|18849430|P1|COMPLETED|Overall Study||6
7653629|NCT02111863|18849430|P1|STARTED|Overall Study||6
7653630|NCT02111811|18849438|P2|NOT COMPLETED|Follow up Period (Aim 2)||17
7653631|NCT02111811|18849439|P1|NOT COMPLETED|Follow up Period (Aim 2)||28
7653632|NCT02111811|18849438|P2|COMPLETED|Follow up Period (Aim 2)||97
7653633|NCT02111811|18849439|P1|COMPLETED|Follow up Period (Aim 2)||111
7653634|NCT02111811|18849438|P2|STARTED|Follow up Period (Aim 2)|All subjects were approached for followup, 1 patient completed the 2nd followup and not the first.|114
7653635|NCT02111811|18849439|P1|STARTED|Follow up Period (Aim 2)||139
7653636|NCT02111811|18849438|P2|NOT COMPLETED|Treatment Phase||18
7653637|NCT02111811|18849439|P1|NOT COMPLETED|Treatment Phase||24
7653638|NCT02111811|18849438|P2|COMPLETED|Treatment Phase||96
7653639|NCT02111811|18849439|P1|COMPLETED|Treatment Phase||115
7653640|NCT02111811|18849438|P2|STARTED|Treatment Phase||114
7653641|NCT02111811|18849439|P1|STARTED|Treatment Phase||139
7653642|NCT02111785|18849452|P4|NOT COMPLETED|Overall Study||0
7653643|NCT02111785|18849453|P3|NOT COMPLETED|Overall Study||0
7653644|NCT02111785|18849454|P2|NOT COMPLETED|Overall Study||1
7653645|NCT02111785|18849455|P1|NOT COMPLETED|Overall Study||0
7653646|NCT02111785|18849452|P4|COMPLETED|Overall Study||1
7653647|NCT02111785|18849453|P3|COMPLETED|Overall Study||1
7653648|NCT02111785|18849454|P2|COMPLETED|Overall Study||4
7653649|NCT02111785|18849455|P1|COMPLETED|Overall Study||3
7653650|NCT02111785|18849452|P4|STARTED|Overall Study||1
7653651|NCT02111785|18849453|P3|STARTED|Overall Study||1
7653652|NCT02111785|18849454|P2|STARTED|Overall Study||5
7653653|NCT02111785|18849455|P1|STARTED|Overall Study||3
7653654|NCT02111772|18849483|P2|NOT COMPLETED|Overall Study||0
7653655|NCT02111772|18849484|P1|NOT COMPLETED|Overall Study||0
7653656|NCT02111772|18849483|P2|COMPLETED|Overall Study||14
7653657|NCT02111772|18849484|P1|COMPLETED|Overall Study||12
7653658|NCT02111772|18849483|P2|STARTED|Overall Study||14
7653659|NCT02111772|18849484|P1|STARTED|Overall Study||12
7653660|NCT02111746|18849494|P2|NOT COMPLETED|Overall Study||2
7653661|NCT02111746|18849495|P1|NOT COMPLETED|Overall Study||3
7653662|NCT02111746|18849494|P2|COMPLETED|Overall Study||169
7653663|NCT02111746|18849495|P1|COMPLETED|Overall Study||169
7653664|NCT02111746|18849494|P2|STARTED|Overall Study||171
7653665|NCT02111746|18849495|P1|STARTED|Overall Study||172
7653666|NCT02111603|18849517|P1|NOT COMPLETED|Overall Study||1
7653667|NCT02111603|18849517|P1|COMPLETED|Overall Study||12
7653668|NCT02111603|18849517|P1|STARTED|Overall Study||13
7653669|NCT02111564|18849528|P2|NOT COMPLETED|Overall Study||143
7653670|NCT02111564|18849529|P1|NOT COMPLETED|Overall Study||131
7653671|NCT02111564|18849528|P2|COMPLETED|Overall Study||5869
7653672|NCT02111564|18849529|P1|COMPLETED|Overall Study||5876
7653673|NCT02111564|18849528|P2|Treated|Overall Study||5980
7653674|NCT02111564|18849529|P1|Treated|Overall Study||5982
7653675|NCT02111564|18849528|P2|STARTED|Overall Study||6012
7653676|NCT02111564|18849529|P1|STARTED|Overall Study||6007
7653677|NCT02111447|18849551|P4|NOT COMPLETED|Overall Study||0
7653678|NCT02111447|18849552|P3|NOT COMPLETED|Overall Study||0
7653679|NCT02111447|18849553|P2|NOT COMPLETED|Overall Study||0
7653680|NCT02111447|18849554|P1|NOT COMPLETED|Overall Study||0
7653681|NCT02111447|18849551|P4|COMPLETED|Overall Study||0
7653682|NCT02111447|18849552|P3|COMPLETED|Overall Study||1
7653683|NCT02111447|18849553|P2|COMPLETED|Overall Study||5
7653684|NCT02111447|18849554|P1|COMPLETED|Overall Study||0
7653685|NCT02111447|18849551|P4|STARTED|Overall Study||0
7653686|NCT02111447|18849552|P3|STARTED|Overall Study||1
7653687|NCT02111447|18849553|P2|STARTED|Overall Study||5
7653688|NCT02111447|18849554|P1|STARTED|Overall Study||0
7653689|NCT02111369|18849568|P1|NOT COMPLETED|Overall Study||3
7653690|NCT02111369|18849568|P1|COMPLETED|Overall Study||15
7653691|NCT02111369|18849568|P1|STARTED|Overall Study||18
7653692|NCT02111252|18849576|P1|NOT COMPLETED|Overall Study||0
7653693|NCT02111252|18849576|P1|COMPLETED|Overall Study||55
7653694|NCT02111252|18849576|P1|STARTED|Overall Study||55
7653695|NCT02111213|18849592|P2|NOT COMPLETED|Overall Study||6
7653696|NCT02111213|18849593|P1|NOT COMPLETED|Overall Study||6
7653697|NCT02111213|18849592|P2|COMPLETED|Overall Study||117
7653698|NCT02111213|18849593|P1|COMPLETED|Overall Study||116
7653699|NCT02111213|18849592|P2|STARTED|Overall Study||123
7653700|NCT02111213|18849593|P1|STARTED|Overall Study||122
7653701|NCT02111200|18849607|P4|NOT COMPLETED|Overall Study||0
7653702|NCT02111200|18849608|P3|NOT COMPLETED|Overall Study||0
7653703|NCT02111200|18849609|P2|NOT COMPLETED|Overall Study||0
7653704|NCT02111200|18849610|P1|NOT COMPLETED|Overall Study||0
7653705|NCT02111200|18849607|P4|COMPLETED|Overall Study||1
7653706|NCT02111200|18849608|P3|COMPLETED|Overall Study||1
7653707|NCT02111200|18849609|P2|COMPLETED|Overall Study||2
7653708|NCT02111200|18849610|P1|COMPLETED|Overall Study||3
7653709|NCT02111200|18849607|P4|STARTED|Overall Study||1
7653710|NCT02111200|18849608|P3|STARTED|Overall Study||1
7653711|NCT02111200|18849609|P2|STARTED|Overall Study||2
7653712|NCT02111200|18849610|P1|STARTED|Overall Study||3
7653713|NCT02111187|18849626|P2|NOT COMPLETED|Overall Study||0
7653714|NCT02111187|18849627|P1|NOT COMPLETED|Overall Study||0
7653715|NCT02111187|18849626|P2|COMPLETED|Overall Study||7
7653716|NCT02111187|18849627|P1|COMPLETED|Overall Study||7
7653717|NCT02111187|18849626|P2|STARTED|Overall Study||7
7653718|NCT02111187|18849627|P1|STARTED|Overall Study||7
7653719|NCT02111174|18849641|P2|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
7653720|NCT02111174|18849642|P1|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||8
7653721|NCT02111174|18849641|P2|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||9
7653722|NCT02111174|18849642|P1|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
7653723|NCT02111174|18849641|P2|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||11
7653724|NCT02111174|18849642|P1|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||8
7653725|NCT02111174|18849641|P2|STARTED|Secondary Outcomes (2 and 3 Month f/u)||16
7653726|NCT02111174|18849642|P1|STARTED|Secondary Outcomes (2 and 3 Month f/u)||15
7653727|NCT02111174|18849641|P2|NOT COMPLETED|Treatment and Primary Outcome||2
7653728|NCT02111174|18849642|P1|NOT COMPLETED|Treatment and Primary Outcome||3
7653729|NCT02111174|18849641|P2|COMPLETED|Treatment and Primary Outcome||16
7653730|NCT02111174|18849642|P1|COMPLETED|Treatment and Primary Outcome||15
7653731|NCT02111174|18849641|P2|STARTED|Treatment and Primary Outcome||18
7653732|NCT02111174|18849642|P1|STARTED|Treatment and Primary Outcome||18
7653733|NCT02111096|18849671|P3|NOT COMPLETED|Overall Study||66
7653734|NCT02111096|18849672|P2|NOT COMPLETED|Overall Study||41
7653735|NCT02111096|18849673|P1|NOT COMPLETED|Overall Study||64
7653736|NCT02111096|18849671|P3|COMPLETED|Overall Study||2
7653737|NCT02111096|18849672|P2|COMPLETED|Overall Study||0
7653738|NCT02111096|18849673|P1|COMPLETED|Overall Study||1
7653739|NCT02111096|18849671|P3|Received at Least 1 Dose of Study Drug|Overall Study||68
7653740|NCT02111096|18849672|P2|Received at Least 1 Dose of Study Drug|Overall Study||41
7653741|NCT02111096|18849673|P1|Received at Least 1 Dose of Study Drug|Overall Study||65
7653742|NCT02111096|18849671|P3|STARTED|Overall Study||68
7653743|NCT02111096|18849672|P2|STARTED|Overall Study||41
7653744|NCT02111096|18849673|P1|STARTED|Overall Study||65
7653745|NCT02111083|18849721|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
7653746|NCT02111083|18849722|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
7653747|NCT02111083|18849721|P2|COMPLETED|Fourth Intervention (1 Day)||18
7653748|NCT02111083|18849722|P1|COMPLETED|Fourth Intervention (1 Day)||18
7653749|NCT02111083|18849721|P2|STARTED|Fourth Intervention (1 Day)||18
7653750|NCT02111083|18849722|P1|STARTED|Fourth Intervention (1 Day)||18
7653751|NCT02111083|18849721|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
7653752|NCT02111083|18849722|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
7653753|NCT02111083|18849721|P2|COMPLETED|Interval Between Dosing (7-8 Days)||18
7653754|NCT02111083|18849722|P1|COMPLETED|Interval Between Dosing (7-8 Days)||18
7653755|NCT02111083|18849721|P2|STARTED|Interval Between Dosing (7-8 Days)||19
7653756|NCT02111083|18849722|P1|STARTED|Interval Between Dosing (7-8 Days)||19
7653757|NCT02111083|18849721|P2|NOT COMPLETED|Third Intervention (1 Day)||0
7653758|NCT02111083|18849722|P1|NOT COMPLETED|Third Intervention (1 Day)||0
7653759|NCT02111083|18849721|P2|COMPLETED|Third Intervention (1 Day)||19
7653760|NCT02111083|18849722|P1|COMPLETED|Third Intervention (1 Day)||19
7653761|NCT02111083|18849721|P2|STARTED|Third Intervention (1 Day)||19
7653762|NCT02111083|18849722|P1|STARTED|Third Intervention (1 Day)||19
7653763|NCT02111083|18849721|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
7653764|NCT02111083|18849722|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
7653765|NCT02111083|18849721|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
7653766|NCT02111083|18849722|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
7653767|NCT02111083|18849721|P2|STARTED|Interval Between Dosing (7-8 Days)||19
7653768|NCT02111083|18849722|P1|STARTED|Interval Between Dosing (7-8 Days)||19
7653769|NCT02111083|18849721|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7653770|NCT02111083|18849722|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7653771|NCT02111083|18849721|P2|COMPLETED|Second Intervention (1 Day)||19
7653772|NCT02111083|18849722|P1|COMPLETED|Second Intervention (1 Day)||19
7653773|NCT02111083|18849721|P2|STARTED|Second Intervention (1 Day)||19
7653774|NCT02111083|18849722|P1|STARTED|Second Intervention (1 Day)||19
7653775|NCT02111083|18849721|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
7653776|NCT02111083|18849722|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
7653777|NCT02111083|18849721|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
7653778|NCT02111083|18849722|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
7653779|NCT02111083|18849721|P2|STARTED|Interval Between Dosing (7-8 Days)||19
7653780|NCT02111083|18849722|P1|STARTED|Interval Between Dosing (7-8 Days)||19
7653781|NCT02111083|18849721|P2|NOT COMPLETED|First Intervention (1 Day)||0
7653782|NCT02111083|18849722|P1|NOT COMPLETED|First Intervention (1 Day)||0
7653783|NCT02111083|18849721|P2|COMPLETED|First Intervention (1 Day)||19
7653784|NCT02111083|18849722|P1|COMPLETED|First Intervention (1 Day)||19
7653785|NCT02111083|18849721|P2|STARTED|First Intervention (1 Day)||19
7653786|NCT02111083|18849722|P1|STARTED|First Intervention (1 Day)||19
7653787|NCT02110901|18849742|P2|NOT COMPLETED|Overall Study||14
7653788|NCT02110901|18849743|P1|NOT COMPLETED|Overall Study||30
7653789|NCT02110901|18849742|P2|COMPLETED|Overall Study||88
7653790|NCT02110901|18849743|P1|COMPLETED|Overall Study||179
7653791|NCT02110901|18849742|P2|STARTED|Overall Study||102
7653792|NCT02110901|18849743|P1|STARTED|Overall Study||209
7653793|NCT02110706|18849757|P2|NOT COMPLETED|Overall Study||4
7653794|NCT02110706|18849758|P1|NOT COMPLETED|Overall Study||5
7653795|NCT02110706|18849757|P2|COMPLETED|Overall Study||23
7653796|NCT02110706|18849758|P1|COMPLETED|Overall Study||20
7653797|NCT02110706|18849757|P2|No. Completing Study Through Week 52|Overall Study||24
7653798|NCT02110706|18849758|P1|No. Completing Study Through Week 52|Overall Study||23
7653799|NCT02110706|18849757|P2|STARTED|Overall Study||27
7653800|NCT02110706|18849758|P1|STARTED|Overall Study||25
7653801|NCT02110693|18849770|P2|NOT COMPLETED|Overall Study||29
7653802|NCT02110693|18849771|P1|NOT COMPLETED|Overall Study||28
7653803|NCT02110693|18849770|P2|COMPLETED|Overall Study||1002
7653804|NCT02110693|18849771|P1|COMPLETED|Overall Study||998
7653805|NCT02110693|18849770|P2|STARTED|Overall Study||1031
7653806|NCT02110693|18849771|P1|STARTED|Overall Study||1026
7653807|NCT02110485|18849798|P2|NOT COMPLETED|Overall Study||19
7653808|NCT02110485|18849799|P1|NOT COMPLETED|Overall Study||7
7653809|NCT02110485|18849798|P2|COMPLETED|Overall Study||83
7653810|NCT02110485|18849799|P1|COMPLETED|Overall Study||91
7653811|NCT02110485|18849798|P2|STARTED|Overall Study||102
7653812|NCT02110485|18849799|P1|STARTED|Overall Study||98
7653813|NCT02110381|18849817|P2|NOT COMPLETED|Dual Modality||1
7653814|NCT02110381|18849818|P1|NOT COMPLETED|Dual Modality||2
7653815|NCT02110381|18849817|P2|COMPLETED|Dual Modality||7
7653816|NCT02110381|18849818|P1|COMPLETED|Dual Modality||5
7653817|NCT02110381|18849817|P2|Began Active Treatment|Dual Modality||7
7653818|NCT02110381|18849818|P1|Began Active Treatment|Dual Modality||7
7653819|NCT02110381|18849817|P2|STARTED|Dual Modality||8
7653820|NCT02110381|18849818|P1|STARTED|Dual Modality||7
7653821|NCT02110381|18849817|P2|NOT COMPLETED|Single Modality||1
7653822|NCT02110381|18849818|P1|NOT COMPLETED|Single Modality||2
7653823|NCT02110381|18849817|P2|COMPLETED|Single Modality||8
7653824|NCT02110381|18849818|P1|COMPLETED|Single Modality||7
7653825|NCT02110381|18849817|P2|STARTED|Single Modality||9
7653826|NCT02110381|18849818|P1|STARTED|Single Modality||9
7653827|NCT02110277|18849829|P1|NOT COMPLETED|Overall Study||2
7653828|NCT02110277|18849829|P1|COMPLETED|Overall Study||0
7653829|NCT02110277|18849829|P1|STARTED|Overall Study||2
7653830|NCT02110264|18849837|P3|NOT COMPLETED|Overall Study||9
7653831|NCT02110264|18849838|P2|NOT COMPLETED|Overall Study||12
7653832|NCT02110264|18849839|P1|NOT COMPLETED|Overall Study||18
7653833|NCT02110264|18849837|P3|COMPLETED|Overall Study||39
7653834|NCT02110264|18849838|P2|COMPLETED|Overall Study||38
7653835|NCT02110264|18849839|P1|COMPLETED|Overall Study||35
7653836|NCT02110264|18849837|P3|STARTED|Overall Study||48
7653837|NCT02110264|18849838|P2|STARTED|Overall Study||50
7653838|NCT02110264|18849839|P1|STARTED|Overall Study||53
7653839|NCT02110238|18849852|P2|NOT COMPLETED|14 Week Blinded Extension Phase||12
7653840|NCT02110238|18849853|P1|NOT COMPLETED|14 Week Blinded Extension Phase||12
7653841|NCT02110238|18849852|P2|COMPLETED|14 Week Blinded Extension Phase||188
7653842|NCT02110238|18849853|P1|COMPLETED|14 Week Blinded Extension Phase||190
7653843|NCT02110238|18849852|P2|STARTED|14 Week Blinded Extension Phase||200
7653844|NCT02110238|18849853|P1|STARTED|14 Week Blinded Extension Phase||202
7653845|NCT02110238|18849852|P2|NOT COMPLETED|12 Week Pivotal Phase||9
7653846|NCT02110238|18849853|P1|NOT COMPLETED|12 Week Pivotal Phase||10
7653847|NCT02110238|18849852|P2|COMPLETED|12 Week Pivotal Phase||200
7653848|NCT02110238|18849853|P1|COMPLETED|12 Week Pivotal Phase||202
7653849|NCT02110238|18849852|P2|STARTED|12 Week Pivotal Phase||209
7653850|NCT02110238|18849853|P1|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212
7653851|NCT02110225|18849862|P3|NOT COMPLETED|Overall Study||0
7653852|NCT02110225|18849863|P2|NOT COMPLETED|Overall Study||1
7653853|NCT02110225|18849864|P1|NOT COMPLETED|Overall Study||0
7653854|NCT02110225|18849862|P3|COMPLETED|Overall Study||10
7653855|NCT02110225|18849863|P2|COMPLETED|Overall Study||19
7653856|NCT02110225|18849864|P1|COMPLETED|Overall Study||20
7653857|NCT02110225|18849862|P3|STARTED|Overall Study||10
7653858|NCT02110225|18849863|P2|STARTED|Overall Study||20
7653859|NCT02110225|18849864|P1|STARTED|Overall Study||20
7653860|NCT02110147|18849916|P1|NOT COMPLETED|Overall Study||0
7653861|NCT02110147|18849916|P1|COMPLETED|Overall Study||4
7653862|NCT02110147|18849916|P1|STARTED|Overall Study||4
7653863|NCT02110095|18849922|P1|NOT COMPLETED|Overall Study||7
7653864|NCT02110095|18849922|P1|COMPLETED|Overall Study||8
7653865|NCT02110095|18849922|P1|STARTED|Overall Study||15
7653866|NCT02109939|18849929|P2|NOT COMPLETED|Overall Study||110
7653867|NCT02109939|18849930|P1|NOT COMPLETED|Overall Study||121
7653868|NCT02109939|18849929|P2|COMPLETED|Overall Study||607
7653869|NCT02109939|18849930|P1|COMPLETED|Overall Study||560
7653870|NCT02109939|18849929|P2|STARTED|Overall Study||717
7653871|NCT02109939|18849930|P1|STARTED|Overall Study||681
7653872|NCT02109809|18849953|P1|NOT COMPLETED|Overall Study||3
7653873|NCT02109809|18849953|P1|COMPLETED|Overall Study||1
7653874|NCT02109809|18849953|P1|STARTED|Overall Study||4
7653875|NCT02109731|18849959|P1|NOT COMPLETED|Overall Study||0
7653876|NCT02109731|18849959|P1|COMPLETED|Overall Study||15
7653877|NCT02109731|18849959|P1|STARTED|Overall Study||15
7653878|NCT02109640|18849965|P2|NOT COMPLETED|Overall Study||0
7653879|NCT02109640|18849966|P1|NOT COMPLETED|Overall Study||0
7653880|NCT02109640|18849965|P2|COMPLETED|Overall Study||23
7653881|NCT02109640|18849966|P1|COMPLETED|Overall Study||27
7653882|NCT02109640|18849965|P2|STARTED|Overall Study||23
7653883|NCT02109640|18849966|P1|STARTED|Overall Study||27
7653884|NCT02109562|18849979|P3|NOT COMPLETED|Overall Study||35
7653885|NCT02109562|18849980|P2|NOT COMPLETED|Overall Study||34
7653886|NCT02109562|18849981|P1|NOT COMPLETED|Overall Study||26
7653887|NCT02109562|18849979|P3|COMPLETED|Overall Study||84
7653888|NCT02109562|18849980|P2|COMPLETED|Overall Study||85
7653889|NCT02109562|18849981|P1|COMPLETED|Overall Study||90
7653890|NCT02109562|18849979|P3|Intent to Treat (ITT)|Overall Study||112
7653891|NCT02109562|18849980|P2|Intent to Treat (ITT)|Overall Study||114
7653892|NCT02109562|18849981|P1|Intent to Treat (ITT)|Overall Study||111
7653893|NCT02109562|18849979|P3|Safety|Overall Study||118
7653894|NCT02109562|18849980|P2|Safety|Overall Study||117
7653895|NCT02109562|18849981|P1|Safety|Overall Study||115
7653896|NCT02109562|18849979|P3|STARTED|Overall Study||119
7653897|NCT02109562|18849980|P2|STARTED|Overall Study||119
7653898|NCT02109562|18849981|P1|STARTED|Overall Study||116
7653899|NCT02109497|18849995|P1|NOT COMPLETED|Overall Study||1
7653900|NCT02109497|18849995|P1|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17
7653901|NCT02109497|18849995|P1|STARTED|Overall Study||18
7653902|NCT02109484|18850008|P8|NOT COMPLETED|Overall Study||3
7653903|NCT02109484|18850009|P7|NOT COMPLETED|Overall Study||3
7653904|NCT02109484|18850010|P6|NOT COMPLETED|Overall Study||1
7653905|NCT02109484|18850011|P5|NOT COMPLETED|Overall Study||4
7653906|NCT02109484|18850012|P4|NOT COMPLETED|Overall Study||1
7653907|NCT02109484|18850013|P3|NOT COMPLETED|Overall Study||0
7653908|NCT02109484|18850014|P2|NOT COMPLETED|Overall Study||0
7653909|NCT02109484|18850015|P1|NOT COMPLETED|Overall Study||0
7653910|NCT02109484|18850008|P8|COMPLETED|Overall Study||47
7653911|NCT02109484|18850009|P7|COMPLETED|Overall Study||47
7653912|NCT02109484|18850010|P6|COMPLETED|Overall Study||11
7653913|NCT02109484|18850011|P5|COMPLETED|Overall Study||46
7653914|NCT02109484|18850012|P4|COMPLETED|Overall Study||11
7653915|NCT02109484|18850013|P3|COMPLETED|Overall Study||12
7653916|NCT02109484|18850014|P2|COMPLETED|Overall Study||13
7653917|NCT02109484|18850015|P1|COMPLETED|Overall Study||5
7653918|NCT02109484|18850008|P8|STARTED|Overall Study||50
7653919|NCT02109484|18850009|P7|STARTED|Overall Study||50
7653920|NCT02109484|18850010|P6|STARTED|Overall Study||12
7653921|NCT02109484|18850011|P5|STARTED|Overall Study||50
7653922|NCT02109484|18850012|P4|STARTED|Overall Study||12
7653923|NCT02109484|18850013|P3|STARTED|Overall Study||12
7653924|NCT02109484|18850014|P2|STARTED|Overall Study||13
7653925|NCT02109484|18850015|P1|STARTED|Overall Study||5
7653926|NCT02109458|18850064|P1|NOT COMPLETED|Overall Study||0
7653927|NCT02109458|18850064|P1|COMPLETED|Overall Study||24
7653928|NCT02109458|18850064|P1|STARTED|Overall Study||24
7653929|NCT02109445|18850071|P1|NOT COMPLETED|Overall Study||3
7653930|NCT02109445|18850071|P1|COMPLETED|Overall Study||0
7653931|NCT02109445|18850071|P1|STARTED|Overall Study||3
7653932|NCT02109432|18850104|P1|NOT COMPLETED|Overall Study||1
7653933|NCT02109432|18850104|P1|COMPLETED|Overall Study||6
7653934|NCT02109432|18850104|P1|STARTED|Overall Study||7
7653935|NCT02109419|18850108|P1|NOT COMPLETED|Overall Study||0
7653936|NCT02109419|18850108|P1|COMPLETED|Overall Study||57
7653937|NCT02109419|18850108|P1|STARTED|Overall Study||57
7653938|NCT02109172|18850114|P6|NOT COMPLETED|Overall Study||1
7653939|NCT02109172|18850115|P5|NOT COMPLETED|Overall Study||1
7653940|NCT02109172|18850116|P4|NOT COMPLETED|Overall Study||1
7653941|NCT02109172|18850117|P3|NOT COMPLETED|Overall Study||1
7653942|NCT02109172|18850118|P2|NOT COMPLETED|Overall Study||0
7653943|NCT02109172|18850119|P1|NOT COMPLETED|Overall Study||1
7653944|NCT02109172|18850114|P6|COMPLETED|Overall Study||10
7653945|NCT02109172|18850115|P5|COMPLETED|Overall Study||9
7653946|NCT02109172|18850116|P4|COMPLETED|Overall Study||10
7653947|NCT02109172|18850117|P3|COMPLETED|Overall Study||9
7653948|NCT02109172|18850118|P2|COMPLETED|Overall Study||11
7653949|NCT02109172|18850119|P1|COMPLETED|Overall Study||10
7653950|NCT02109172|18850114|P6|STARTED|Overall Study||11
7653951|NCT02109172|18850115|P5|STARTED|Overall Study||10
7653952|NCT02109172|18850116|P4|STARTED|Overall Study||11
7653953|NCT02109172|18850117|P3|STARTED|Overall Study||10
7653954|NCT02109172|18850118|P2|STARTED|Overall Study||11
7653955|NCT02109172|18850119|P1|STARTED|Overall Study||11
7653956|NCT02109159|18850129|P2|NOT COMPLETED|Overall Study||0
7653957|NCT02109159|18850130|P1|NOT COMPLETED|Overall Study||0
7653958|NCT02109159|18850129|P2|COMPLETED|Overall Study||4175
7653959|NCT02109159|18850130|P1|COMPLETED|Overall Study||4178
7653960|NCT02109159|18850129|P2|STARTED|Overall Study||4175
7653961|NCT02109159|18850130|P1|STARTED|Overall Study||4178
7653962|NCT02109133|18850140|P2|NOT COMPLETED|Overall Study||0
7653963|NCT02109133|18850141|P1|NOT COMPLETED|Overall Study||1
7653964|NCT02109133|18850140|P2|COMPLETED|Overall Study||34
7653965|NCT02109133|18850141|P1|COMPLETED|Overall Study||32
7653966|NCT02109133|18850140|P2|STARTED|Overall Study||34
7653967|NCT02109133|18850141|P1|STARTED|Overall Study||33
7653968|NCT02109107|18850153|P1|NOT COMPLETED|Overall Study||2
7653969|NCT02109107|18850153|P1|COMPLETED|Overall Study||52
7653970|NCT02109107|18850153|P1|STARTED|Overall Study||54
7653971|NCT02109042|18850160|P1|NOT COMPLETED|Overall Study||15
7653972|NCT02109042|18850160|P1|COMPLETED|Overall Study||0
7653973|NCT02109042|18850160|P1|Receive at Least 1 Subsequent 90 mg Dose|Overall Study||15
7653974|NCT02109042|18850160|P1|Received 180 mg Loading Dose|Overall Study||15
7653975|NCT02109042|18850160|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
7653976|NCT02109042|18850160|P1|STARTED|Overall Study||15
7653977|NCT02109029|18850169|P6|NOT COMPLETED|Part B||1
7653978|NCT02109029|18850170|P5|NOT COMPLETED|Part B||1
7653979|NCT02109029|18850171|P4|NOT COMPLETED|Part B||0
7653980|NCT02109029|18850172|P3|NOT COMPLETED|Part B||0
7653981|NCT02109029|18850173|P2|NOT COMPLETED|Part B||0
7653982|NCT02109029|18850174|P1|NOT COMPLETED|Part B||0
7653983|NCT02109029|18850169|P6|COMPLETED|Part B||5
7653984|NCT02109029|18850170|P5|COMPLETED|Part B||5
7653985|NCT02109029|18850171|P4|COMPLETED|Part B||0
7653986|NCT02109029|18850172|P3|COMPLETED|Part B||0
7653987|NCT02109029|18850173|P2|COMPLETED|Part B||0
7653988|NCT02109029|18850174|P1|COMPLETED|Part B||0
7653989|NCT02109029|18850169|P6|Received at Least One Dose of Study Drug|Part B||6
7653990|NCT02109029|18850170|P5|Received at Least One Dose of Study Drug|Part B||6
7653991|NCT02109029|18850171|P4|Received at Least One Dose of Study Drug|Part B||0
7653992|NCT02109029|18850172|P3|Received at Least One Dose of Study Drug|Part B||0
7653993|NCT02109029|18850173|P2|Received at Least One Dose of Study Drug|Part B||0
7653994|NCT02109029|18850174|P1|Received at Least One Dose of Study Drug|Part B||0
7653995|NCT02109029|18850169|P6|STARTED|Part B|New participants entered Part B.|6
7653996|NCT02109029|18850170|P5|STARTED|Part B|New participants entered Part B.|6
7653997|NCT02109029|18850171|P4|STARTED|Part B||0
7653998|NCT02109029|18850172|P3|STARTED|Part B||0
7653999|NCT02109029|18850173|P2|STARTED|Part B||0
7654000|NCT02109029|18850174|P1|STARTED|Part B||0
7654001|NCT02109029|18850169|P6|NOT COMPLETED|Part A||0
7654002|NCT02109029|18850170|P5|NOT COMPLETED|Part A||0
7654003|NCT02109029|18850171|P4|NOT COMPLETED|Part A||0
7654004|NCT02109029|18850172|P3|NOT COMPLETED|Part A||0
7654005|NCT02109029|18850173|P2|NOT COMPLETED|Part A||0
7654006|NCT02109029|18850174|P1|NOT COMPLETED|Part A||0
7654007|NCT02109029|18850169|P6|COMPLETED|Part A||0
7654008|NCT02109029|18850170|P5|COMPLETED|Part A||0
7654009|NCT02109029|18850171|P4|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
7654010|NCT02109029|18850172|P3|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
7654011|NCT02109029|18850173|P2|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
7654012|NCT02109029|18850174|P1|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
7654013|NCT02109029|18850169|P6|Received One Dose of Study Drug|Part A||0
7654014|NCT02109029|18850170|P5|Received One Dose of Study Drug|Part A||0
7654015|NCT02109029|18850171|P4|Received One Dose of Study Drug|Part A||4
7654016|NCT02109029|18850172|P3|Received One Dose of Study Drug|Part A||4
7654017|NCT02109029|18850173|P2|Received One Dose of Study Drug|Part A||2
7654018|NCT02109029|18850174|P1|Received One Dose of Study Drug|Part A||2
7654019|NCT02109029|18850169|P6|STARTED|Part A||0
7654020|NCT02109029|18850170|P5|STARTED|Part A||0
7654021|NCT02109029|18850171|P4|STARTED|Part A||4
7654022|NCT02109029|18850172|P3|STARTED|Part A||4
7654023|NCT02109029|18850173|P2|STARTED|Part A||2
7654024|NCT02109029|18850174|P1|STARTED|Part A||2
7654025|NCT02108977|18850188|P2|NOT COMPLETED|Overall Study||1
7654026|NCT02108977|18850189|P1|NOT COMPLETED|Overall Study||10
7654027|NCT02108977|18850188|P2|COMPLETED|Overall Study||19
7654028|NCT02108977|18850189|P1|COMPLETED|Overall Study||8
7654029|NCT02108977|18850188|P2|STARTED|Overall Study||20
7654030|NCT02108977|18850189|P1|STARTED|Overall Study||18
7654031|NCT02108964|18850211|P8|NOT COMPLETED|Overall Study||12
7654032|NCT02108964|18850212|P7|NOT COMPLETED|Overall Study||11
7654033|NCT02108964|18850213|P6|NOT COMPLETED|Overall Study||5
7654034|NCT02108964|18850214|P5|NOT COMPLETED|Overall Study||25
7654035|NCT02108964|18850215|P4|NOT COMPLETED|Overall Study||6
7654036|NCT02108964|18850216|P3|NOT COMPLETED|Overall Study||65
7654037|NCT02108964|18850217|P2|NOT COMPLETED|Overall Study||32
7654038|NCT02108964|18850218|P1|NOT COMPLETED|Overall Study||14
7654039|NCT02108964|18850211|P8|COMPLETED|Overall Study||33
7654040|NCT02108964|18850212|P7|COMPLETED|Overall Study||0
7654041|NCT02108964|18850213|P6|COMPLETED|Overall Study||0
7654042|NCT02108964|18850214|P5|COMPLETED|Overall Study||3
7654043|NCT02108964|18850215|P4|COMPLETED|Overall Study||2
7654044|NCT02108964|18850216|P3|COMPLETED|Overall Study||8
7654045|NCT02108964|18850217|P2|COMPLETED|Overall Study||6
7654046|NCT02108964|18850218|P1|COMPLETED|Overall Study||3
7654047|NCT02108964|18850211|P8|STARTED|Overall Study||45
7654048|NCT02108964|18850212|P7|STARTED|Overall Study||11
7654049|NCT02108964|18850213|P6|STARTED|Overall Study||5
7654050|NCT02108964|18850214|P5|STARTED|Overall Study||28
7654051|NCT02108964|18850215|P4|STARTED|Overall Study||8
7654052|NCT02108964|18850216|P3|STARTED|Overall Study||73
7654053|NCT02108964|18850217|P2|STARTED|Overall Study||38
7654054|NCT02108964|18850218|P1|STARTED|Overall Study||17
7654055|NCT02108951|18850237|P1|NOT COMPLETED|Overall Study||16
7654056|NCT02108951|18850237|P1|COMPLETED|Overall Study||4
7654057|NCT02108951|18850237|P1|STARTED|Overall Study|Indicates patients in enrolled, full analysis and safety set|20
7654058|NCT02108912|18850256|P2|NOT COMPLETED|Overall Study||1
7654059|NCT02108912|18850257|P1|NOT COMPLETED|Overall Study||3
7654060|NCT02108912|18850256|P2|COMPLETED|Overall Study||6
7654061|NCT02108912|18850257|P1|COMPLETED|Overall Study||6
7654062|NCT02108912|18850256|P2|STARTED|Overall Study||7
7654063|NCT02108912|18850257|P1|STARTED|Overall Study||9
7654064|NCT02108691|18850267|P2|NOT COMPLETED|Overall Study||9
7654065|NCT02108691|18850268|P1|NOT COMPLETED|Overall Study||8
7654066|NCT02108691|18850267|P2|COMPLETED|Overall Study||31
7654067|NCT02108691|18850268|P1|COMPLETED|Overall Study||32
7654068|NCT02108691|18850267|P2|STARTED|Overall Study||40
7654069|NCT02108691|18850268|P1|STARTED|Overall Study||40
7654070|NCT02108652|18850286|P1|NOT COMPLETED|Overall Study||310
7654071|NCT02108652|18850286|P1|COMPLETED|Overall Study||0
7654072|NCT02108652|18850286|P1|STARTED|Overall Study||310
7654073|NCT02108457|18850309|P2|NOT COMPLETED|Overall Study||2
7654074|NCT02108457|18850310|P1|NOT COMPLETED|Overall Study||0
7654075|NCT02108457|18850309|P2|COMPLETED|Overall Study||10
7654076|NCT02108457|18850310|P1|COMPLETED|Overall Study||3
7654077|NCT02108457|18850309|P2|STARTED|Overall Study||12
7654078|NCT02108457|18850310|P1|STARTED|Overall Study||3
7654079|NCT02108288|18850319|P3|NOT COMPLETED|Overall Study||0
7654080|NCT02108288|18850320|P2|NOT COMPLETED|Overall Study||0
7654081|NCT02108288|18850321|P1|NOT COMPLETED|Overall Study||0
7654082|NCT02108288|18850319|P3|COMPLETED|Overall Study||10
7654083|NCT02108288|18850320|P2|COMPLETED|Overall Study||10
7654084|NCT02108288|18850321|P1|COMPLETED|Overall Study||10
7654085|NCT02108288|18850319|P3|STARTED|Overall Study||10
7654086|NCT02108288|18850320|P2|STARTED|Overall Study||10
7654087|NCT02108288|18850321|P1|STARTED|Overall Study||10
7654088|NCT02108223|18850337|P3|NOT COMPLETED|Overall Study||0
7654089|NCT02108223|18850338|P2|NOT COMPLETED|Overall Study||0
7654090|NCT02108223|18850339|P1|NOT COMPLETED|Overall Study||0
7654091|NCT02108223|18850337|P3|COMPLETED|Overall Study||35
7654092|NCT02108223|18850338|P2|COMPLETED|Overall Study||50
7654093|NCT02108223|18850339|P1|COMPLETED|Overall Study||52
7654094|NCT02108223|18850337|P3|STARTED|Overall Study||35
7654095|NCT02108223|18850338|P2|STARTED|Overall Study||50
7654096|NCT02108223|18850339|P1|STARTED|Overall Study||52
7654097|NCT02108171|18850361|P2|NOT COMPLETED|Overall Study||0
7654098|NCT02108171|18850362|P1|NOT COMPLETED|Overall Study||0
7654099|NCT02108171|18850361|P2|COMPLETED|Overall Study||41
7654100|NCT02108171|18850362|P1|COMPLETED|Overall Study||40
7654101|NCT02108171|18850361|P2|STARTED|Overall Study||41
7654102|NCT02108171|18850362|P1|STARTED|Overall Study||40
7654103|NCT02107898|18850464|P2|NOT COMPLETED|Overall Study||12
7654104|NCT02107898|18850465|P1|NOT COMPLETED|Overall Study||6
7654105|NCT02107898|18850464|P2|COMPLETED|Overall Study||132
7654106|NCT02107898|18850465|P1|COMPLETED|Overall Study||66
7654107|NCT02107898|18850464|P2|Treated|Overall Study||143
7654108|NCT02107898|18850465|P1|Treated|Overall Study||72
7654109|NCT02107898|18850464|P2|STARTED|Overall Study|Randomized|144
7654110|NCT02107898|18850465|P1|STARTED|Overall Study|Randomized|72
7654111|NCT02107859|18850517|P1|NOT COMPLETED|Overall Study||61
7654112|NCT02107859|18850517|P1|COMPLETED|Overall Study||0
7654113|NCT02107859|18850517|P1|Intent-to-treat (ITT) Population|Overall Study||60
7654114|NCT02107859|18850517|P1|As-treated Population|Overall Study||61
7654115|NCT02107859|18850517|P1|STARTED|Overall Study||61
7654116|NCT02107703|18850533|P2|NOT COMPLETED|Overall Study||175
7654117|NCT02107703|18850534|P1|NOT COMPLETED|Overall Study||361
7654118|NCT02107703|18850533|P2|COMPLETED|Overall Study||48
7654119|NCT02107703|18850534|P1|COMPLETED|Overall Study||85
7654120|NCT02107703|18850533|P2|Received at Least 1 Dose of Study Drug|Overall Study||223
7654121|NCT02107703|18850534|P1|Received at Least 1 Dose of Study Drug|Overall Study||441
7654122|NCT02107703|18850533|P2|STARTED|Overall Study||223
7654123|NCT02107703|18850534|P1|STARTED|Overall Study||446
7654124|NCT02107599|18850559|P1|NOT COMPLETED|Overall Study||0
7654125|NCT02107599|18850559|P1|COMPLETED|Overall Study||96
7654126|NCT02107599|18850559|P1|STARTED|Overall Study||96
7654127|NCT02107482|18850566|P1|NOT COMPLETED|Overall Study||4
7654128|NCT02107482|18850566|P1|COMPLETED|Overall Study||17
7654129|NCT02107482|18850566|P1|STARTED|Overall Study|21 participants enrolled. Total of 21 participants recvd both active and sham|21
7654130|NCT02107443|18850574|P2|NOT COMPLETED|Overall Study||83
7654131|NCT02107443|18850575|P1|NOT COMPLETED|Overall Study||98
7654132|NCT02107443|18850574|P2|COMPLETED|Overall Study||167
7654133|NCT02107443|18850575|P1|COMPLETED|Overall Study||198
7654134|NCT02107443|18850574|P2|STARTED|Overall Study||250
7654135|NCT02107443|18850575|P1|STARTED|Overall Study||296
7654136|NCT02107339|18850591|P2|NOT COMPLETED|Overall Study||4
7654137|NCT02107339|18850592|P1|NOT COMPLETED|Overall Study||1
7654138|NCT02107339|18850591|P2|COMPLETED|Overall Study||53
7654139|NCT02107339|18850592|P1|COMPLETED|Overall Study||62
7654140|NCT02107339|18850591|P2|STARTED|Overall Study||57
7654141|NCT02107339|18850592|P1|STARTED|Overall Study||63
7654142|NCT02107313|18850628|P2|NOT COMPLETED|Overall Study||1
7654143|NCT02107313|18850629|P1|NOT COMPLETED|Overall Study||0
7654144|NCT02107313|18850628|P2|COMPLETED|Overall Study||8
7654145|NCT02107313|18850629|P1|COMPLETED|Overall Study||9
7654146|NCT02107313|18850628|P2|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9
7654147|NCT02107313|18850629|P1|STARTED|Overall Study||9
7654148|NCT02107300|18850639|P2|NOT COMPLETED|Overall Study||0
7654149|NCT02107300|18850640|P1|NOT COMPLETED|Overall Study||0
7654150|NCT02107300|18850639|P2|COMPLETED|Overall Study||15
7654151|NCT02107300|18850640|P1|COMPLETED|Overall Study||16
7654152|NCT02107300|18850639|P2|STARTED|Overall Study||15
7654153|NCT02107300|18850640|P1|STARTED|Overall Study||16
7654154|NCT02107274|18850650|P2|NOT COMPLETED|Control Phase||2
7654155|NCT02107274|18850651|P1|NOT COMPLETED|Control Phase||3
7654156|NCT02107274|18850650|P2|COMPLETED|Control Phase||35
7654157|NCT02107274|18850651|P1|COMPLETED|Control Phase||33
7654158|NCT02107274|18850650|P2|STARTED|Control Phase||37
7654159|NCT02107274|18850651|P1|STARTED|Control Phase||36
7654160|NCT02107274|18850650|P2|NOT COMPLETED|Treatment vs. Placebo||2
7654161|NCT02107274|18850651|P1|NOT COMPLETED|Treatment vs. Placebo||3
7654162|NCT02107274|18850650|P2|COMPLETED|Treatment vs. Placebo||37
7654163|NCT02107274|18850651|P1|COMPLETED|Treatment vs. Placebo||36
7654164|NCT02107274|18850650|P2|STARTED|Treatment vs. Placebo||39
7654165|NCT02107274|18850651|P1|STARTED|Treatment vs. Placebo||39
7654166|NCT02107196|18850665|P2|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5
7654167|NCT02107196|18850666|P1|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23
7654168|NCT02107196|18850665|P2|COMPLETED|4-week Randomized Withdrawal (RW) Period||109
7654169|NCT02107196|18850666|P1|COMPLETED|4-week Randomized Withdrawal (RW) Period||315
7654170|NCT02107196|18850665|P2|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90
7654171|NCT02107196|18850666|P1|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272
7654172|NCT02107196|18850665|P2|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114
7654173|NCT02107196|18850666|P1|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338
7654174|NCT02107196|18850665|P2|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114
7654175|NCT02107196|18850666|P1|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338
7654176|NCT02107196|18850665|P2|NOT COMPLETED|12-week Treatment Period||39
7654177|NCT02107196|18850666|P1|NOT COMPLETED|12-week Treatment Period||44
7654178|NCT02107196|18850665|P2|COMPLETED|12-week Treatment Period||225
7654179|NCT02107196|18850666|P1|COMPLETED|12-week Treatment Period||227
7654180|NCT02107196|18850665|P2|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216
7654181|NCT02107196|18850666|P1|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221
7654182|NCT02107196|18850665|P2|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264
7654183|NCT02107196|18850666|P1|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271
7654184|NCT02107196|18850665|P2|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264
7654185|NCT02107196|18850666|P1|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271
7654186|NCT02107131|18850681|P2|NOT COMPLETED|Overall Study||9
7654187|NCT02107131|18850682|P1|NOT COMPLETED|Overall Study||8
7654188|NCT02107131|18850681|P2|COMPLETED|Overall Study||11
7654189|NCT02107131|18850682|P1|COMPLETED|Overall Study||12
7654190|NCT02107131|18850681|P2|STARTED|Overall Study||20
7654191|NCT02107131|18850682|P1|STARTED|Overall Study||20
7654192|NCT02107092|18850694|P1|NOT COMPLETED|Overall Study||44
7654193|NCT02107092|18850694|P1|COMPLETED|Overall Study||79
7654194|NCT02107092|18850694|P1|STARTED|Overall Study||123
7654195|NCT02107014|18850699|P1|NOT COMPLETED|Overall Study||1
7654196|NCT02107014|18850699|P1|COMPLETED|Overall Study||8
7654197|NCT02107014|18850699|P1|STARTED|Overall Study||9
7654198|NCT02106975|18850769|P2|NOT COMPLETED|Overall Study||39
7654199|NCT02106975|18850770|P1|NOT COMPLETED|Overall Study||25
7654200|NCT02106975|18850769|P2|COMPLETED|Overall Study||44
7654201|NCT02106975|18850770|P1|COMPLETED|Overall Study||59
7654202|NCT02106975|18850769|P2|STARTED|Overall Study||83
7654203|NCT02106975|18850770|P1|STARTED|Overall Study||84
7654204|NCT02106962|18850818|P2|NOT COMPLETED|Overall Study||0
7654205|NCT02106962|18850819|P1|NOT COMPLETED|Overall Study||0
7654206|NCT02106962|18850818|P2|COMPLETED|Overall Study||9
7654207|NCT02106962|18850819|P1|COMPLETED|Overall Study||8
7654208|NCT02106962|18850818|P2|STARTED|Overall Study||9
7654209|NCT02106962|18850819|P1|STARTED|Overall Study||8
7654210|NCT02106923|18850830|P6|NOT COMPLETED|Overall Study||1
7654211|NCT02106923|18850831|P5|NOT COMPLETED|Overall Study||0
7654212|NCT02106923|18850832|P4|NOT COMPLETED|Overall Study||0
7654213|NCT02106923|18850833|P3|NOT COMPLETED|Overall Study||0
7654214|NCT02106923|18850834|P2|NOT COMPLETED|Overall Study||0
7654215|NCT02106923|18850835|P1|NOT COMPLETED|Overall Study||0
7654216|NCT02106923|18850830|P6|COMPLETED|Overall Study||11
7654217|NCT02106923|18850831|P5|COMPLETED|Overall Study||12
7654218|NCT02106923|18850832|P4|COMPLETED|Overall Study||12
7654219|NCT02106923|18850833|P3|COMPLETED|Overall Study||12
7654220|NCT02106923|18850834|P2|COMPLETED|Overall Study||12
7654221|NCT02106923|18850835|P1|COMPLETED|Overall Study||12
7654222|NCT02106923|18850830|P6|STARTED|Overall Study||12
7654223|NCT02106923|18850831|P5|STARTED|Overall Study||12
7654224|NCT02106923|18850832|P4|STARTED|Overall Study||12
7654225|NCT02106923|18850833|P3|STARTED|Overall Study||12
7654226|NCT02106923|18850834|P2|STARTED|Overall Study||12
7654227|NCT02106923|18850835|P1|STARTED|Overall Study||12
7654228|NCT02106910|18850881|P2|NOT COMPLETED|Overall Study||1
7654229|NCT02106910|18850882|P1|NOT COMPLETED|Overall Study||1
7654230|NCT02106910|18850881|P2|COMPLETED|Overall Study||88
7654231|NCT02106910|18850882|P1|COMPLETED|Overall Study||48
7654232|NCT02106910|18850881|P2|STARTED|Overall Study||89
7654233|NCT02106910|18850882|P1|STARTED|Overall Study||49
7654234|NCT02106884|18850898|P2|NOT COMPLETED|Overall Study||1
7654235|NCT02106884|18850899|P1|NOT COMPLETED|Overall Study||0
7654236|NCT02106884|18850898|P2|COMPLETED|Overall Study|ITT analysis based on treatment assigned at baseline.|73
7654237|NCT02106884|18850899|P1|COMPLETED|Overall Study||72
7654238|NCT02106884|18850898|P2|STARTED|Overall Study||74
7654239|NCT02106884|18850899|P1|STARTED|Overall Study||72
7654240|NCT02106832|18850923|P4|NOT COMPLETED|Overall Study||15
7654241|NCT02106832|18850924|P3|NOT COMPLETED|Overall Study||16
7654242|NCT02106832|18850925|P2|NOT COMPLETED|Overall Study||25
7654243|NCT02106832|18850926|P1|NOT COMPLETED|Overall Study||23
7654244|NCT02106832|18850923|P4|COMPLETED|Overall Study||73
7654245|NCT02106832|18850924|P3|COMPLETED|Overall Study||70
7654246|NCT02106832|18850925|P2|COMPLETED|Overall Study||151
7654247|NCT02106832|18850926|P1|COMPLETED|Overall Study||148
7654248|NCT02106832|18850923|P4|Participants Received Treatment|Overall Study||88
7654249|NCT02106832|18850924|P3|Participants Received Treatment|Overall Study||86
7654250|NCT02106832|18850925|P2|Participants Received Treatment|Overall Study||174
7654251|NCT02106832|18850926|P1|Participants Received Treatment|Overall Study||171
7654252|NCT02106832|18850923|P4|STARTED|Overall Study||88
7654253|NCT02106832|18850924|P3|STARTED|Overall Study||86
7654254|NCT02106832|18850925|P2|STARTED|Overall Study||176
7654255|NCT02106832|18850926|P1|STARTED|Overall Study||171
7654256|NCT02106728|18850961|P2|NOT COMPLETED|Overall Study||0
7654257|NCT02106728|18850962|P1|NOT COMPLETED|Overall Study||0
7654258|NCT02106728|18850961|P2|COMPLETED|Overall Study||47
7654259|NCT02106728|18850962|P1|COMPLETED|Overall Study||70
7654260|NCT02106728|18850961|P2|STARTED|Overall Study||47
7654261|NCT02106728|18850962|P1|STARTED|Overall Study||70
7654262|NCT02106494|18850978|P2|NOT COMPLETED|Overall Study||25
7654263|NCT02106494|18850979|P1|NOT COMPLETED|Overall Study||26
7654264|NCT02106494|18850978|P2|COMPLETED|Overall Study||446
7654265|NCT02106494|18850979|P1|COMPLETED|Overall Study||445
7654266|NCT02106494|18850978|P2|Efficacy Population|Overall Study||452
7654267|NCT02106494|18850979|P1|Efficacy Population|Overall Study||450
7654268|NCT02106494|18850978|P2|Safety Population|Overall Study||459
7654269|NCT02106494|18850979|P1|Safety Population|Overall Study||456
7654270|NCT02106494|18850978|P2|STARTED|Overall Study||471
7654271|NCT02106494|18850979|P1|STARTED|Overall Study||471
7654272|NCT02106455|18850993|P1|NOT COMPLETED|Overall Study||8
7654273|NCT02106455|18850993|P1|COMPLETED|Overall Study||307
7654274|NCT02106455|18850993|P1|STARTED|Overall Study||315
7654275|NCT02106442|18851007|P1|NOT COMPLETED|Overall Study||37
7654276|NCT02106442|18851007|P1|COMPLETED|Overall Study||542
7654277|NCT02106442|18851007|P1|STARTED|Overall Study||579
7654278|NCT02106403|18851025|P6|NOT COMPLETED|Follow-Up Visit 3||1
7654279|NCT02106403|18851026|P5|NOT COMPLETED|Follow-Up Visit 3||0
7654280|NCT02106403|18851027|P4|NOT COMPLETED|Follow-Up Visit 3||0
7654281|NCT02106403|18851028|P3|NOT COMPLETED|Follow-Up Visit 3||0
7654282|NCT02106403|18851029|P2|NOT COMPLETED|Follow-Up Visit 3||0
7654283|NCT02106403|18851030|P1|NOT COMPLETED|Follow-Up Visit 3||0
7654284|NCT02106403|18851025|P6|COMPLETED|Follow-Up Visit 3||8
7654285|NCT02106403|18851026|P5|COMPLETED|Follow-Up Visit 3||8
7654286|NCT02106403|18851027|P4|COMPLETED|Follow-Up Visit 3||8
7654287|NCT02106403|18851028|P3|COMPLETED|Follow-Up Visit 3||9
7654288|NCT02106403|18851029|P2|COMPLETED|Follow-Up Visit 3||8
7654289|NCT02106403|18851030|P1|COMPLETED|Follow-Up Visit 3||8
7654290|NCT02106403|18851025|P6|STARTED|Follow-Up Visit 3||9
7654291|NCT02106403|18851026|P5|STARTED|Follow-Up Visit 3||8
7654292|NCT02106403|18851027|P4|STARTED|Follow-Up Visit 3||8
7654293|NCT02106403|18851028|P3|STARTED|Follow-Up Visit 3||9
7654294|NCT02106403|18851029|P2|STARTED|Follow-Up Visit 3||8
7654295|NCT02106403|18851030|P1|STARTED|Follow-Up Visit 3||8
7654296|NCT02106403|18851025|P6|NOT COMPLETED|Follow-Up Visit 2||0
7654297|NCT02106403|18851026|P5|NOT COMPLETED|Follow-Up Visit 2||0
7654298|NCT02106403|18851027|P4|NOT COMPLETED|Follow-Up Visit 2||0
7654299|NCT02106403|18851028|P3|NOT COMPLETED|Follow-Up Visit 2||0
7654300|NCT02106403|18851029|P2|NOT COMPLETED|Follow-Up Visit 2||0
7654301|NCT02106403|18851030|P1|NOT COMPLETED|Follow-Up Visit 2||0
7654302|NCT02106403|18851025|P6|COMPLETED|Follow-Up Visit 2||9
7654303|NCT02106403|18851026|P5|COMPLETED|Follow-Up Visit 2||8
7654304|NCT02106403|18851027|P4|COMPLETED|Follow-Up Visit 2||8
7654305|NCT02106403|18851028|P3|COMPLETED|Follow-Up Visit 2||9
7654306|NCT02106403|18851029|P2|COMPLETED|Follow-Up Visit 2||8
7654307|NCT02106403|18851030|P1|COMPLETED|Follow-Up Visit 2||8
7654308|NCT02106403|18851025|P6|STARTED|Follow-Up Visit 2||9
7654309|NCT02106403|18851026|P5|STARTED|Follow-Up Visit 2||8
7654310|NCT02106403|18851027|P4|STARTED|Follow-Up Visit 2||8
7654311|NCT02106403|18851028|P3|STARTED|Follow-Up Visit 2||9
7654312|NCT02106403|18851029|P2|STARTED|Follow-Up Visit 2||8
7654313|NCT02106403|18851030|P1|STARTED|Follow-Up Visit 2||8
7654314|NCT02106403|18851025|P6|NOT COMPLETED|Visit 1, Treatment Period 3||0
7654315|NCT02106403|18851026|P5|NOT COMPLETED|Visit 1, Treatment Period 3||0
7654316|NCT02106403|18851027|P4|NOT COMPLETED|Visit 1, Treatment Period 3||0
7654317|NCT02106403|18851028|P3|NOT COMPLETED|Visit 1, Treatment Period 3||0
7654318|NCT02106403|18851029|P2|NOT COMPLETED|Visit 1, Treatment Period 3||0
7654319|NCT02106403|18851030|P1|NOT COMPLETED|Visit 1, Treatment Period 3||0
7654320|NCT02106403|18851025|P6|COMPLETED|Visit 1, Treatment Period 3||9
7654321|NCT02106403|18851026|P5|COMPLETED|Visit 1, Treatment Period 3||8
7654322|NCT02106403|18851027|P4|COMPLETED|Visit 1, Treatment Period 3||8
7654323|NCT02106403|18851028|P3|COMPLETED|Visit 1, Treatment Period 3||9
7654324|NCT02106403|18851029|P2|COMPLETED|Visit 1, Treatment Period 3||8
7654325|NCT02106403|18851030|P1|COMPLETED|Visit 1, Treatment Period 3||8
7654326|NCT02106403|18851025|P6|STARTED|Visit 1, Treatment Period 3||9
7654327|NCT02106403|18851026|P5|STARTED|Visit 1, Treatment Period 3||8
7654328|NCT02106403|18851027|P4|STARTED|Visit 1, Treatment Period 3||8
7654329|NCT02106403|18851028|P3|STARTED|Visit 1, Treatment Period 3||9
7654330|NCT02106403|18851029|P2|STARTED|Visit 1, Treatment Period 3||8
7654331|NCT02106403|18851030|P1|STARTED|Visit 1, Treatment Period 3||8
7654332|NCT02106403|18851025|P6|NOT COMPLETED|Visit 1, Treatment Period 2||0
7654333|NCT02106403|18851026|P5|NOT COMPLETED|Visit 1, Treatment Period 2||0
7654334|NCT02106403|18851027|P4|NOT COMPLETED|Visit 1, Treatment Period 2||0
7654335|NCT02106403|18851028|P3|NOT COMPLETED|Visit 1, Treatment Period 2||0
7654336|NCT02106403|18851029|P2|NOT COMPLETED|Visit 1, Treatment Period 2||0
7654337|NCT02106403|18851030|P1|NOT COMPLETED|Visit 1, Treatment Period 2||0
7654338|NCT02106403|18851025|P6|COMPLETED|Visit 1, Treatment Period 2||9
7654339|NCT02106403|18851026|P5|COMPLETED|Visit 1, Treatment Period 2||8
7654340|NCT02106403|18851027|P4|COMPLETED|Visit 1, Treatment Period 2||8
7654341|NCT02106403|18851028|P3|COMPLETED|Visit 1, Treatment Period 2||9
7654342|NCT02106403|18851029|P2|COMPLETED|Visit 1, Treatment Period 2||8
7654343|NCT02106403|18851030|P1|COMPLETED|Visit 1, Treatment Period 2||8
7654344|NCT02106403|18851025|P6|STARTED|Visit 1, Treatment Period 2||9
7654345|NCT02106403|18851026|P5|STARTED|Visit 1, Treatment Period 2||8
7654346|NCT02106403|18851027|P4|STARTED|Visit 1, Treatment Period 2||8
7654347|NCT02106403|18851028|P3|STARTED|Visit 1, Treatment Period 2||9
7654348|NCT02106403|18851029|P2|STARTED|Visit 1, Treatment Period 2||8
7654349|NCT02106403|18851030|P1|STARTED|Visit 1, Treatment Period 2||8
7654350|NCT02106403|18851025|P6|NOT COMPLETED|Visit 1, Treatment Period 1||0
7654351|NCT02106403|18851026|P5|NOT COMPLETED|Visit 1, Treatment Period 1||0
7654352|NCT02106403|18851027|P4|NOT COMPLETED|Visit 1, Treatment Period 1||0
7654353|NCT02106403|18851028|P3|NOT COMPLETED|Visit 1, Treatment Period 1||0
7654354|NCT02106403|18851029|P2|NOT COMPLETED|Visit 1, Treatment Period 1||0
7654355|NCT02106403|18851030|P1|NOT COMPLETED|Visit 1, Treatment Period 1||0
7654356|NCT02106403|18851025|P6|COMPLETED|Visit 1, Treatment Period 1||9
7654357|NCT02106403|18851026|P5|COMPLETED|Visit 1, Treatment Period 1||8
7654358|NCT02106403|18851027|P4|COMPLETED|Visit 1, Treatment Period 1||8
7654359|NCT02106403|18851028|P3|COMPLETED|Visit 1, Treatment Period 1||9
7654360|NCT02106403|18851029|P2|COMPLETED|Visit 1, Treatment Period 1||8
7654361|NCT02106403|18851030|P1|COMPLETED|Visit 1, Treatment Period 1||8
7654362|NCT02106403|18851025|P6|STARTED|Visit 1, Treatment Period 1||9
7654363|NCT02106403|18851026|P5|STARTED|Visit 1, Treatment Period 1||8
7654364|NCT02106403|18851027|P4|STARTED|Visit 1, Treatment Period 1||8
7654365|NCT02106403|18851028|P3|STARTED|Visit 1, Treatment Period 1||9
7654366|NCT02106403|18851029|P2|STARTED|Visit 1, Treatment Period 1||8
7654367|NCT02106403|18851030|P1|STARTED|Visit 1, Treatment Period 1||8
7654368|NCT02106390|18851053|P3|NOT COMPLETED|Overall Study||43
7654369|NCT02106390|18851054|P2|NOT COMPLETED|Overall Study||48
7654370|NCT02106390|18851055|P1|NOT COMPLETED|Overall Study||49
7654371|NCT02106390|18851053|P3|COMPLETED|Overall Study||205
7654372|NCT02106390|18851054|P2|COMPLETED|Overall Study||202
7654373|NCT02106390|18851055|P1|COMPLETED|Overall Study||203
7654374|NCT02106390|18851053|P3|STARTED|Overall Study||248
7654375|NCT02106390|18851054|P2|STARTED|Overall Study||250
7654376|NCT02106390|18851055|P1|STARTED|Overall Study||252
7654377|NCT02106351|18851132|P3|NOT COMPLETED|Treatment Cycle 4||2
7654378|NCT02106351|18851133|P2|NOT COMPLETED|Treatment Cycle 4||1
7654379|NCT02106351|18851134|P1|NOT COMPLETED|Treatment Cycle 4||0
7654380|NCT02106351|18851132|P3|COMPLETED|Treatment Cycle 4||31
7654381|NCT02106351|18851133|P2|COMPLETED|Treatment Cycle 4||21
7654382|NCT02106351|18851134|P1|COMPLETED|Treatment Cycle 4||0
7654383|NCT02106351|18851132|P3|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|33
7654384|NCT02106351|18851133|P2|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|22
7654385|NCT02106351|18851134|P1|STARTED|Treatment Cycle 4||0
7654386|NCT02106351|18851132|P3|NOT COMPLETED|Treatment Cycle 3||5
7654387|NCT02106351|18851133|P2|NOT COMPLETED|Treatment Cycle 3||4
7654388|NCT02106351|18851134|P1|NOT COMPLETED|Treatment Cycle 3||0
7654389|NCT02106351|18851132|P3|COMPLETED|Treatment Cycle 3||53
7654390|NCT02106351|18851133|P2|COMPLETED|Treatment Cycle 3||45
7654391|NCT02106351|18851134|P1|COMPLETED|Treatment Cycle 3||0
7654392|NCT02106351|18851132|P3|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|58
7654393|NCT02106351|18851133|P2|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|49
7654394|NCT02106351|18851134|P1|STARTED|Treatment Cycle 3||0
7654395|NCT02106351|18851132|P3|NOT COMPLETED|Treatment Cycle 2||3
7654396|NCT02106351|18851133|P2|NOT COMPLETED|Treatment Cycle 2||5
7654397|NCT02106351|18851134|P1|NOT COMPLETED|Treatment Cycle 2||0
7654398|NCT02106351|18851132|P3|COMPLETED|Treatment Cycle 2||87
7654399|NCT02106351|18851133|P2|COMPLETED|Treatment Cycle 2||83
7654400|NCT02106351|18851134|P1|COMPLETED|Treatment Cycle 2||0
7654401|NCT02106351|18851132|P3|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|90
7654402|NCT02106351|18851133|P2|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|88
7654403|NCT02106351|18851134|P1|STARTED|Treatment Cycle 2|Subjects who received Dysport 2 U/kg in TC 1 were randomised to receive 8 or 16 U/kg in TCs 2-4.|0
7654404|NCT02106351|18851132|P3|NOT COMPLETED|Treatment Cycle 1||4
7654405|NCT02106351|18851133|P2|NOT COMPLETED|Treatment Cycle 1||3
7654406|NCT02106351|18851134|P1|NOT COMPLETED|Treatment Cycle 1||5
7654407|NCT02106351|18851132|P3|COMPLETED|Treatment Cycle 1||67
7654408|NCT02106351|18851133|P2|COMPLETED|Treatment Cycle 1||67
7654409|NCT02106351|18851134|P1|COMPLETED|Treatment Cycle 1||66
7654410|NCT02106351|18851132|P3|Received Treatment in TC 1|Treatment Cycle 1||70
7654411|NCT02106351|18851133|P2|Received Treatment in TC 1|Treatment Cycle 1||70
7654412|NCT02106351|18851134|P1|Received Treatment in TC 1|Treatment Cycle 1||70
7654413|NCT02106351|18851132|P3|STARTED|Treatment Cycle 1||71
7654414|NCT02106351|18851133|P2|STARTED|Treatment Cycle 1||70
7654415|NCT02106351|18851134|P1|STARTED|Treatment Cycle 1||71
7654416|NCT02106325|18851177|P2|NOT COMPLETED|Phase 3||1
7654417|NCT02106325|18851178|P1|NOT COMPLETED|Phase 3||2
7654418|NCT02106325|18851177|P2|COMPLETED|Phase 3||2
7654419|NCT02106325|18851178|P1|COMPLETED|Phase 3||0
7654420|NCT02106325|18851177|P2|STARTED|Phase 3||3
7654421|NCT02106325|18851178|P1|STARTED|Phase 3||2
7654422|NCT02106325|18851177|P2|NOT COMPLETED|Phase 2||3
7654423|NCT02106325|18851178|P1|NOT COMPLETED|Phase 2||2
7654424|NCT02106325|18851177|P2|COMPLETED|Phase 2||1
7654425|NCT02106325|18851178|P1|COMPLETED|Phase 2||2
7654426|NCT02106325|18851177|P2|STARTED|Phase 2||4
7654427|NCT02106325|18851178|P1|STARTED|Phase 2||4
7654428|NCT02106325|18851177|P2|NOT COMPLETED|Phase 1||2
7654429|NCT02106325|18851178|P1|NOT COMPLETED|Phase 1||2
7654430|NCT02106325|18851177|P2|COMPLETED|Phase 1||1
7654431|NCT02106325|18851178|P1|COMPLETED|Phase 1||3
7654432|NCT02106325|18851177|P2|STARTED|Phase 1||3
7654433|NCT02106325|18851178|P1|STARTED|Phase 1||5
7654434|NCT02106156|18851203|P3|NOT COMPLETED|Overall Study||0
7654435|NCT02106156|18851204|P2|NOT COMPLETED|Overall Study||40
7654436|NCT02106156|18851205|P1|NOT COMPLETED|Overall Study||2549
7654437|NCT02106156|18851203|P3|COMPLETED|Overall Study||518
7654438|NCT02106156|18851204|P2|COMPLETED|Overall Study||50
7654439|NCT02106156|18851205|P1|COMPLETED|Overall Study||7071
7654440|NCT02106156|18851203|P3|STARTED|Overall Study||518
7654441|NCT02106156|18851204|P2|STARTED|Overall Study||90
7654442|NCT02106156|18851205|P1|STARTED|Overall Study||9620
7654443|NCT02105987|18851229|P6|NOT COMPLETED|Continuation Phase||0
7654444|NCT02105987|18851230|P5|NOT COMPLETED|Continuation Phase||1
7654445|NCT02105987|18851231|P4|NOT COMPLETED|Continuation Phase||0
7654446|NCT02105987|18851232|P3|NOT COMPLETED|Continuation Phase||0
7654447|NCT02105987|18851233|P2|NOT COMPLETED|Continuation Phase||0
7654448|NCT02105987|18851234|P1|NOT COMPLETED|Continuation Phase||0
7654449|NCT02105987|18851229|P6|COMPLETED|Continuation Phase||23
7654450|NCT02105987|18851230|P5|COMPLETED|Continuation Phase||13
7654451|NCT02105987|18851231|P4|COMPLETED|Continuation Phase||0
7654452|NCT02105987|18851232|P3|COMPLETED|Continuation Phase||0
7654453|NCT02105987|18851233|P2|COMPLETED|Continuation Phase||0
7654454|NCT02105987|18851234|P1|COMPLETED|Continuation Phase||0
7654455|NCT02105987|18851229|P6|STARTED|Continuation Phase||23
7654456|NCT02105987|18851230|P5|STARTED|Continuation Phase||14
7654457|NCT02105987|18851231|P4|STARTED|Continuation Phase||0
7654458|NCT02105987|18851232|P3|STARTED|Continuation Phase||0
7654459|NCT02105987|18851233|P2|STARTED|Continuation Phase||0
7654460|NCT02105987|18851234|P1|STARTED|Continuation Phase||0
7654461|NCT02105987|18851229|P6|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
7654462|NCT02105987|18851230|P5|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
7654463|NCT02105987|18851231|P4|NOT COMPLETED|Late Switch Phase (24 Weeks)||14
7654464|NCT02105987|18851232|P3|NOT COMPLETED|Late Switch Phase (24 Weeks)||45
7654465|NCT02105987|18851233|P2|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
7654466|NCT02105987|18851234|P1|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
7654467|NCT02105987|18851229|P6|COMPLETED|Late Switch Phase (24 Weeks)||0
7654468|NCT02105987|18851230|P5|COMPLETED|Late Switch Phase (24 Weeks)||0
7654469|NCT02105987|18851231|P4|COMPLETED|Late Switch Phase (24 Weeks)||230
7654470|NCT02105987|18851232|P3|COMPLETED|Late Switch Phase (24 Weeks)||230
7654471|NCT02105987|18851233|P2|COMPLETED|Late Switch Phase (24 Weeks)||0
7654472|NCT02105987|18851234|P1|COMPLETED|Late Switch Phase (24 Weeks)||0
7654473|NCT02105987|18851229|P6|STARTED|Late Switch Phase (24 Weeks)||0
7654474|NCT02105987|18851230|P5|STARTED|Late Switch Phase (24 Weeks)||0
7654475|NCT02105987|18851231|P4|STARTED|Late Switch Phase (24 Weeks)||244
7654476|NCT02105987|18851232|P3|STARTED|Late Switch Phase (24 Weeks)||275
7654477|NCT02105987|18851233|P2|STARTED|Late Switch Phase (24 Weeks)||0
7654478|NCT02105987|18851234|P1|STARTED|Late Switch Phase (24 Weeks)||0
7654479|NCT02105987|18851229|P6|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
7654480|NCT02105987|18851230|P5|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
7654481|NCT02105987|18851231|P4|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
7654482|NCT02105987|18851232|P3|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
7654483|NCT02105987|18851233|P2|NOT COMPLETED|Early Switch Phase (24 Weeks)||34
7654484|NCT02105987|18851234|P1|NOT COMPLETED|Early Switch Phase (24 Weeks)||36
7654485|NCT02105987|18851229|P6|COMPLETED|Early Switch Phase (24 Weeks)||0
7654486|NCT02105987|18851230|P5|COMPLETED|Early Switch Phase (24 Weeks)||0
7654487|NCT02105987|18851231|P4|COMPLETED|Early Switch Phase (24 Weeks)||0
7654488|NCT02105987|18851232|P3|COMPLETED|Early Switch Phase (24 Weeks)||0
7654489|NCT02105987|18851233|P2|COMPLETED|Early Switch Phase (24 Weeks)||244
7654490|NCT02105987|18851234|P1|COMPLETED|Early Switch Phase (24 Weeks)||239
7654491|NCT02105987|18851229|P6|STARTED|Early Switch Phase (24 Weeks)||0
7654492|NCT02105987|18851230|P5|STARTED|Early Switch Phase (24 Weeks)||0
7654493|NCT02105987|18851231|P4|STARTED|Early Switch Phase (24 Weeks)||0
7654494|NCT02105987|18851232|P3|STARTED|Early Switch Phase (24 Weeks)||0
7654495|NCT02105987|18851233|P2|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278
7654496|NCT02105987|18851234|P1|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275
7654497|NCT02105974|18851288|P3|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58
7654498|NCT02105974|18851289|P2|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42
7654499|NCT02105974|18851290|P1|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0
7654500|NCT02105974|18851288|P3|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756
7654501|NCT02105974|18851289|P2|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764
7654502|NCT02105974|18851290|P1|COMPLETED|12 Week (Wk) Treatment Period (TP)||0
7654503|NCT02105974|18851288|P3|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754
7654504|NCT02105974|18851289|P2|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764
7654505|NCT02105974|18851290|P1|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0
7654506|NCT02105974|18851288|P3|STARTED|12 Week (Wk) Treatment Period (TP)||814
7654507|NCT02105974|18851289|P2|STARTED|12 Week (Wk) Treatment Period (TP)||806
7654508|NCT02105974|18851290|P1|STARTED|12 Week (Wk) Treatment Period (TP)||0
7654509|NCT02105974|18851288|P3|NOT COMPLETED|2 Week Run-in Period||0
7654510|NCT02105974|18851289|P2|NOT COMPLETED|2 Week Run-in Period||0
7654511|NCT02105974|18851290|P1|NOT COMPLETED|2 Week Run-in Period||801
7654512|NCT02105974|18851288|P3|COMPLETED|2 Week Run-in Period||0
7654513|NCT02105974|18851289|P2|COMPLETED|2 Week Run-in Period||0
7654514|NCT02105974|18851290|P1|COMPLETED|2 Week Run-in Period||1622
7654515|NCT02105974|18851288|P3|STARTED|2 Week Run-in Period||0
7654516|NCT02105974|18851289|P2|STARTED|2 Week Run-in Period||0
7654517|NCT02105974|18851290|P1|STARTED|2 Week Run-in Period||2423
7654518|NCT02105961|18851303|P3|NOT COMPLETED|Overall Study||30
7654519|NCT02105961|18851304|P2|NOT COMPLETED|Overall Study||17
7654520|NCT02105961|18851305|P1|NOT COMPLETED|Overall Study||41
7654521|NCT02105961|18851303|P3|COMPLETED|Overall Study||195
7654522|NCT02105961|18851304|P2|COMPLETED|Overall Study||206
7654523|NCT02105961|18851305|P1|COMPLETED|Overall Study||185
7654524|NCT02105961|18851303|P3|Withdrew IP Due to: Site Closed|Overall Study||1
7654525|NCT02105961|18851304|P2|Withdrew IP Due to: Site Closed|Overall Study||0
7654526|NCT02105961|18851305|P1|Withdrew IP Due to: Site Closed|Overall Study||1
7654527|NCT02105961|18851303|P3|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
7654528|NCT02105961|18851304|P2|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
7654529|NCT02105961|18851305|P1|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
7654530|NCT02105961|18851303|P3|Withdrew IP Due to: Physician Decision|Overall Study||1
7654531|NCT02105961|18851304|P2|Withdrew IP Due to: Physician Decision|Overall Study||3
7654532|NCT02105961|18851305|P1|Withdrew IP Due to: Physician Decision|Overall Study||2
7654533|NCT02105961|18851303|P3|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
7654534|NCT02105961|18851304|P2|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
7654535|NCT02105961|18851305|P1|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
7654536|NCT02105961|18851303|P3|Withdrew IP Due to: Protocol Deviation|Overall Study||1
7654537|NCT02105961|18851304|P2|Withdrew IP Due to: Protocol Deviation|Overall Study||0
7654538|NCT02105961|18851305|P1|Withdrew IP Due to: Protocol Deviation|Overall Study||2
7654539|NCT02105961|18851303|P3|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
7654540|NCT02105961|18851304|P2|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
7654541|NCT02105961|18851305|P1|Withdrew IP Due to: Lack of Efficacy|Overall Study||6
7654542|NCT02105961|18851303|P3|Withdrew IP Due to: Stopping Criteria|Overall Study||0
7654543|NCT02105961|18851304|P2|Withdrew IP Due to: Stopping Criteria|Overall Study||1
7654544|NCT02105961|18851305|P1|Withdrew IP Due to: Stopping Criteria|Overall Study||1
7654545|NCT02105961|18851303|P3|Withdrew IP Due to: Adverse Event|Overall Study||25
7654546|NCT02105961|18851304|P2|Withdrew IP Due to: Adverse Event|Overall Study||9
7654547|NCT02105961|18851305|P1|Withdrew IP Due to: Adverse Event|Overall Study||27
7654548|NCT02105961|18851303|P3|Not Completed IP|Overall Study||42
7654549|NCT02105961|18851304|P2|Not Completed IP|Overall Study||27
7654550|NCT02105961|18851305|P1|Not Completed IP|Overall Study||56
7654551|NCT02105961|18851303|P3|Completed Investigational Product (IP)|Overall Study||183
7654552|NCT02105961|18851304|P2|Completed Investigational Product (IP)|Overall Study||196
7654553|NCT02105961|18851305|P1|Completed Investigational Product (IP)|Overall Study||170
7654554|NCT02105961|18851303|P3|STARTED|Overall Study||225
7654555|NCT02105961|18851304|P2|STARTED|Overall Study||223
7654556|NCT02105961|18851305|P1|STARTED|Overall Study||226
7654557|NCT02105948|18851329|P4|NOT COMPLETED|Overall Study||27
7654558|NCT02105948|18851330|P3|NOT COMPLETED|Overall Study||28
7654559|NCT02105948|18851331|P2|NOT COMPLETED|Overall Study||20
7654560|NCT02105948|18851332|P1|NOT COMPLETED|Overall Study||27
7654561|NCT02105948|18851329|P4|COMPLETED|Overall Study||157
7654562|NCT02105948|18851330|P3|COMPLETED|Overall Study||162
7654563|NCT02105948|18851331|P2|COMPLETED|Overall Study||213
7654564|NCT02105948|18851332|P1|COMPLETED|Overall Study||202
7654565|NCT02105948|18851329|P4|Withdrew IP Due to: Stopping Criteria|Overall Study||1
7654566|NCT02105948|18851330|P3|Withdrew IP Due to: Stopping Criteria|Overall Study||0
7654567|NCT02105948|18851331|P2|Withdrew IP Due to: Stopping Criteria|Overall Study||0
7654568|NCT02105948|18851332|P1|Withdrew IP Due to: Stopping Criteria|Overall Study||0
7654569|NCT02105948|18851329|P4|Withdrew IP Due to: Physician Decision|Overall Study||2
7654570|NCT02105948|18851330|P3|Withdrew IP Due to: Physician Decision|Overall Study||4
7654571|NCT02105948|18851331|P2|Withdrew IP Due to: Physician Decision|Overall Study||1
7654572|NCT02105948|18851332|P1|Withdrew IP Due to: Physician Decision|Overall Study||2
7654573|NCT02105948|18851329|P4|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||15
7654574|NCT02105948|18851330|P3|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
7654575|NCT02105948|18851331|P2|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||8
7654576|NCT02105948|18851332|P1|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
7654577|NCT02105948|18851329|P4|Withdrew IP Due to: Lost to Follow-up|Overall Study||2
7654578|NCT02105948|18851330|P3|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
7654579|NCT02105948|18851331|P2|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
7654580|NCT02105948|18851332|P1|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
7654581|NCT02105948|18851329|P4|Withdrew IP Due to: Protocol Deviation|Overall Study||0
7654582|NCT02105948|18851330|P3|Withdrew IP Due to: Protocol Deviation|Overall Study||3
7654583|NCT02105948|18851331|P2|Withdrew IP Due to: Protocol Deviation|Overall Study||3
7654584|NCT02105948|18851332|P1|Withdrew IP Due to: Protocol Deviation|Overall Study||1
7654585|NCT02105948|18851329|P4|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
7654586|NCT02105948|18851330|P3|Withdrew IP Due to: Lack of Efficacy|Overall Study||8
7654587|NCT02105948|18851331|P2|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
7654588|NCT02105948|18851332|P1|Withdrew IP Due to: Lack of Efficacy|Overall Study||5
7654589|NCT02105948|18851329|P4|Withdrew IP Due to: Adverse Event|Overall Study||13
7654590|NCT02105948|18851330|P3|Withdrew IP Due to: Adverse Event|Overall Study||15
7654591|NCT02105948|18851331|P2|Withdrew IP Due to: Adverse Event|Overall Study||16
7654592|NCT02105948|18851332|P1|Withdrew IP Due to: Adverse Event|Overall Study||20
7654593|NCT02105948|18851329|P4|Not Completed IP|Overall Study||35
7654594|NCT02105948|18851330|P3|Not Completed IP|Overall Study||42
7654595|NCT02105948|18851331|P2|Not Completed IP|Overall Study||30
7654596|NCT02105948|18851332|P1|Not Completed IP|Overall Study||44
7654597|NCT02105948|18851329|P4|Completed Investigational Product (IP)|Overall Study||149
7654598|NCT02105948|18851330|P3|Completed Investigational Product (IP)|Overall Study||148
7654599|NCT02105948|18851331|P2|Completed Investigational Product (IP)|Overall Study||203
7654600|NCT02105948|18851332|P1|Completed Investigational Product (IP)|Overall Study||185
7654601|NCT02105948|18851329|P4|STARTED|Overall Study||184
7654602|NCT02105948|18851330|P3|STARTED|Overall Study||190
7654603|NCT02105948|18851331|P2|STARTED|Overall Study||233
7654604|NCT02105948|18851332|P1|STARTED|Overall Study||229
7654605|NCT02105740|18851360|P2|NOT COMPLETED|Overall Study||1
7654606|NCT02105740|18851361|P1|NOT COMPLETED|Overall Study||0
7654607|NCT02105740|18851360|P2|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|11
7654608|NCT02105740|18851361|P1|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|12
7654609|NCT02105740|18851360|P2|Second|Overall Study|Application of EVA and HADS scales. One accompanying lost|11
7654610|NCT02105740|18851361|P1|Second|Overall Study|Intervention with hypnosis and application of EVA scales and HADS (n = 12)|12
7654611|NCT02105740|18851360|P2|STARTED|Overall Study|Application of EVA and HADS scales|12
7654612|NCT02105740|18851361|P1|STARTED|Overall Study|Application of EVA and HADS scales and after that application of hypnosis intervention|12
7654613|NCT02105701|18851373|P4|NOT COMPLETED|Overall Study||2
7654614|NCT02105701|18851374|P3|NOT COMPLETED|Overall Study||3
7654615|NCT02105701|18851375|P2|NOT COMPLETED|Overall Study||1
7654616|NCT02105701|18851376|P1|NOT COMPLETED|Overall Study||4
7654617|NCT02105701|18851373|P4|COMPLETED|Overall Study||104
7654618|NCT02105701|18851374|P3|COMPLETED|Overall Study||102
7654619|NCT02105701|18851375|P2|COMPLETED|Overall Study||103
7654620|NCT02105701|18851376|P1|COMPLETED|Overall Study||101
7654621|NCT02105701|18851373|P4|STARTED|Overall Study||106
7654622|NCT02105701|18851374|P3|STARTED|Overall Study||105
7654623|NCT02105701|18851375|P2|STARTED|Overall Study||104
7654624|NCT02105701|18851376|P1|STARTED|Overall Study||105
7654625|NCT02105688|18851400|P2|NOT COMPLETED|Part B: Observational Follow-up||20
7654626|NCT02105688|18851401|P1|NOT COMPLETED|Part B: Observational Follow-up||37
7654627|NCT02105688|18851400|P2|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|48
7654628|NCT02105688|18851401|P1|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|94
7654629|NCT02105688|18851400|P2|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|68
7654630|NCT02105688|18851401|P1|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|131
7654631|NCT02105688|18851400|P2|NOT COMPLETED|Part A: Double-Blind||17
7654632|NCT02105688|18851401|P1|NOT COMPLETED|Part A: Double-Blind||20
7654633|NCT02105688|18851400|P2|COMPLETED|Part A: Double-Blind|Completed Part A|83
7654634|NCT02105688|18851401|P1|COMPLETED|Part A: Double-Blind|Completed Part A|181
7654635|NCT02105688|18851400|P2|STARTED|Part A: Double-Blind||100
7654636|NCT02105688|18851401|P1|STARTED|Part A: Double-Blind||201
7654637|NCT02105662|18851414|P1|NOT COMPLETED|Overall Study||6
7654638|NCT02105662|18851414|P1|COMPLETED|Overall Study||212
7654639|NCT02105662|18851414|P1|STARTED|Overall Study||218
7654640|NCT02105636|18851423|P2|NOT COMPLETED|Overall Study||108
7654641|NCT02105636|18851424|P1|NOT COMPLETED|Overall Study||195
7654642|NCT02105636|18851423|P2|COMPLETED|Overall Study|Completed=Still on Treatment|3
7654643|NCT02105636|18851424|P1|COMPLETED|Overall Study|Completed=Still on Treatment|41
7654644|NCT02105636|18851423|P2|STARTED|Overall Study||111
7654645|NCT02105636|18851424|P1|STARTED|Overall Study||236
7654646|NCT02105558|18851436|P2|NOT COMPLETED|Overall Study||0
7654647|NCT02105558|18851437|P1|NOT COMPLETED|Overall Study||0
7654648|NCT02105558|18851436|P2|COMPLETED|Overall Study||28
7654649|NCT02105558|18851437|P1|COMPLETED|Overall Study||15
7654650|NCT02105558|18851436|P2|STARTED|Overall Study||28
7654651|NCT02105558|18851437|P1|STARTED|Overall Study||15
7654652|NCT02105467|18851467|P2|NOT COMPLETED|Period 3||1
7654653|NCT02105467|18851468|P1|NOT COMPLETED|Period 3||0
7654654|NCT02105467|18851467|P2|COMPLETED|Period 3||102
7654655|NCT02105467|18851468|P1|COMPLETED|Period 3||0
7654656|NCT02105467|18851467|P2|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103
7654657|NCT02105467|18851468|P1|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0
7654658|NCT02105467|18851467|P2|NOT COMPLETED|Period 2||2
7654659|NCT02105467|18851468|P1|NOT COMPLETED|Period 2||2
7654660|NCT02105467|18851467|P2|COMPLETED|Period 2||102
7654661|NCT02105467|18851468|P1|COMPLETED|Period 2||312
7654662|NCT02105467|18851467|P2|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104
7654663|NCT02105467|18851468|P1|STARTED|Period 2||314
7654664|NCT02105467|18851467|P2|NOT COMPLETED|Period 1||0
7654665|NCT02105467|18851468|P1|NOT COMPLETED|Period 1||2
7654666|NCT02105467|18851467|P2|COMPLETED|Period 1||105
7654667|NCT02105467|18851468|P1|COMPLETED|Period 1||314
7654668|NCT02105467|18851467|P2|STARTED|Period 1||105
7654669|NCT02105467|18851468|P1|STARTED|Period 1||316
7654670|NCT02105454|18851480|P1|NOT COMPLETED|Overall Study||1
7654671|NCT02105454|18851480|P1|COMPLETED|Overall Study||78
7654672|NCT02105454|18851480|P1|STARTED|Overall Study||79
7654673|NCT02105415|18851489|P2|NOT COMPLETED|Overall Study||5
7654674|NCT02105415|18851490|P1|NOT COMPLETED|Overall Study||3
7654675|NCT02105415|18851489|P2|COMPLETED|Overall Study||79
7654676|NCT02105415|18851490|P1|COMPLETED|Overall Study||73
7654677|NCT02105415|18851489|P2|STARTED|Overall Study||84
7654678|NCT02105415|18851490|P1|STARTED|Overall Study||76
7654679|NCT02105324|18851512|P2|NOT COMPLETED|Period 2||0
7654680|NCT02105324|18851513|P1|NOT COMPLETED|Period 2||0
7654681|NCT02105324|18851512|P2|COMPLETED|Period 2||10
7654682|NCT02105324|18851513|P1|COMPLETED|Period 2||9
7654683|NCT02105324|18851512|P2|STARTED|Period 2||10
7654684|NCT02105324|18851513|P1|STARTED|Period 2||9
7654685|NCT02105324|18851512|P2|NOT COMPLETED|Period 1||0
7654686|NCT02105324|18851513|P1|NOT COMPLETED|Period 1||0
7654687|NCT02105324|18851512|P2|COMPLETED|Period 1||10
7654688|NCT02105324|18851513|P1|COMPLETED|Period 1||9
7654689|NCT02105324|18851512|P2|STARTED|Period 1||10
7654690|NCT02105324|18851513|P1|STARTED|Period 1||9
7654691|NCT02105285|18851592|P3|NOT COMPLETED|Overall Study||0
7654692|NCT02105285|18851593|P2|NOT COMPLETED|Overall Study||2
7654693|NCT02105285|18851594|P1|NOT COMPLETED|Overall Study||2
7654694|NCT02105285|18851592|P3|COMPLETED|Overall Study||37
7654695|NCT02105285|18851593|P2|COMPLETED|Overall Study||76
7654696|NCT02105285|18851594|P1|COMPLETED|Overall Study||76
7654697|NCT02105285|18851592|P3|STARTED|Overall Study||37
7654698|NCT02105285|18851593|P2|STARTED|Overall Study||78
7654699|NCT02105285|18851594|P1|STARTED|Overall Study||78
7654700|NCT02105272|18851613|P2|NOT COMPLETED|Overall Study||3
7654701|NCT02105272|18851614|P1|NOT COMPLETED|Overall Study||5
7654702|NCT02105272|18851613|P2|COMPLETED|Overall Study||116
7654703|NCT02105272|18851614|P1|COMPLETED|Overall Study||113
7654704|NCT02105272|18851613|P2|STARTED|Overall Study||119
7654705|NCT02105272|18851614|P1|STARTED|Overall Study||118
7654706|NCT02105246|18851632|P2|NOT COMPLETED|Overall Study||0
7654707|NCT02105246|18851633|P1|NOT COMPLETED|Overall Study||0
7654708|NCT02105246|18851632|P2|COMPLETED|Overall Study||597
7654709|NCT02105246|18851633|P1|COMPLETED|Overall Study||557
7654710|NCT02105246|18851632|P2|STARTED|Overall Study||597
7654711|NCT02105246|18851633|P1|STARTED|Overall Study||557
7654712|NCT02105116|18851643|P1|NOT COMPLETED|Overall Study||6
7654713|NCT02105116|18851643|P1|COMPLETED|Overall Study||0
7654714|NCT02105116|18851643|P1|STARTED|Overall Study||6
7654715|NCT02105012|18851650|P1|NOT COMPLETED|Overall Study||33
7654716|NCT02105012|18851650|P1|COMPLETED|Overall Study||114
7654717|NCT02105012|18851650|P1|Placebo MDI|Overall Study||127
7654718|NCT02105012|18851650|P1|BD MDI 40 µg|Overall Study||63
7654719|NCT02105012|18851650|P1|BD MDI 80 µg|Overall Study||64
7654720|NCT02105012|18851650|P1|BD MDI 160 µg|Overall Study||132
7654721|NCT02105012|18851650|P1|BD MDI 320 µg|Overall Study||124
7654722|NCT02105012|18851650|P1|STARTED|Overall Study||147
7654723|NCT02104947|18851684|P2|NOT COMPLETED|Overall Study||56
7654724|NCT02104947|18851685|P1|NOT COMPLETED|Overall Study||79
7654725|NCT02104947|18851684|P2|COMPLETED|Overall Study||146
7654726|NCT02104947|18851685|P1|COMPLETED|Overall Study||222
7654727|NCT02104947|18851684|P2|STARTED|Overall Study||202
7654728|NCT02104947|18851685|P1|STARTED|Overall Study||301
7654729|NCT02104895|18851703|P2|NOT COMPLETED|Overall Study||14
7654730|NCT02104895|18851704|P1|NOT COMPLETED|Overall Study||0
7654731|NCT02104895|18851703|P2|COMPLETED|Overall Study||246
7654732|NCT02104895|18851704|P1|COMPLETED|Overall Study||260
7654733|NCT02104895|18851703|P2|STARTED|Overall Study||260
7654734|NCT02104895|18851704|P1|STARTED|Overall Study||260
7654735|NCT02104830|18851717|P3|NOT COMPLETED|Overall Study||7
7654736|NCT02104830|18851718|P2|NOT COMPLETED|Overall Study||7
7654737|NCT02104830|18851719|P1|NOT COMPLETED|Overall Study||4
7654738|NCT02104830|18851717|P3|COMPLETED|Overall Study||36
7654739|NCT02104830|18851718|P2|COMPLETED|Overall Study||36
7654740|NCT02104830|18851719|P1|COMPLETED|Overall Study||38
7654741|NCT02104830|18851717|P3|STARTED|Overall Study||43
7654742|NCT02104830|18851718|P2|STARTED|Overall Study||43
7654743|NCT02104830|18851719|P1|STARTED|Overall Study||42
7654744|NCT02104804|18851744|P2|NOT COMPLETED|Overall Study||19
7654745|NCT02104804|18851745|P1|NOT COMPLETED|Overall Study||16
7654746|NCT02104804|18851744|P2|COMPLETED|Overall Study|Of the 19 who did not complete, 1 did not take study medication after randomization.|213
7654747|NCT02104804|18851745|P1|COMPLETED|Overall Study|Number of patients who completed 24 weeks of treatment|218
7654748|NCT02104804|18851744|P2|STARTED|Overall Study|Number of patients who were randomized|232
7654749|NCT02104804|18851745|P1|STARTED|Overall Study|Number of patients who were randomized|234
7654750|NCT02104765|18851768|P7|NOT COMPLETED|Overall Study||1
7654751|NCT02104765|18851769|P6|NOT COMPLETED|Overall Study||0
7654752|NCT02104765|18851770|P5|NOT COMPLETED|Overall Study||1
7654753|NCT02104765|18851771|P4|NOT COMPLETED|Overall Study||1
7654754|NCT02104765|18851772|P3|NOT COMPLETED|Overall Study||1
7654755|NCT02104765|18851773|P2|NOT COMPLETED|Overall Study||0
7654756|NCT02104765|18851774|P1|NOT COMPLETED|Overall Study||0
7654757|NCT02104765|18851768|P7|COMPLETED|Overall Study||7
7654758|NCT02104765|18851769|P6|COMPLETED|Overall Study||2
7654759|NCT02104765|18851770|P5|COMPLETED|Overall Study||7
7654760|NCT02104765|18851771|P4|COMPLETED|Overall Study||6
7654761|NCT02104765|18851772|P3|COMPLETED|Overall Study||5
7654762|NCT02104765|18851773|P2|COMPLETED|Overall Study||6
7654763|NCT02104765|18851774|P1|COMPLETED|Overall Study||8
7654764|NCT02104765|18851768|P7|Received at Least 1 Dose of Study Drug|Overall Study||8
7654765|NCT02104765|18851769|P6|Received at Least 1 Dose of Study Drug|Overall Study||2
7654766|NCT02104765|18851770|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
7654927|NCT02104739|18851820|P4|STARTED|First Intervention (1 Day)||8
7654767|NCT02104765|18851771|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
7654768|NCT02104765|18851772|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
7654769|NCT02104765|18851773|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
7654770|NCT02104765|18851774|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
7654771|NCT02104765|18851768|P7|STARTED|Overall Study||8
7654772|NCT02104765|18851769|P6|STARTED|Overall Study||2
7654773|NCT02104765|18851770|P5|STARTED|Overall Study||8
7654774|NCT02104765|18851771|P4|STARTED|Overall Study||7
7654775|NCT02104765|18851772|P3|STARTED|Overall Study||6
7654776|NCT02104765|18851773|P2|STARTED|Overall Study||6
7654777|NCT02104765|18851774|P1|STARTED|Overall Study||8
7654778|NCT02104752|18851802|P2|NOT COMPLETED|Overall Study||2
7654779|NCT02104752|18851803|P1|NOT COMPLETED|Overall Study||1
7654780|NCT02104752|18851802|P2|COMPLETED|Overall Study||19
7654781|NCT02104752|18851803|P1|COMPLETED|Overall Study||17
7654782|NCT02104752|18851802|P2|STARTED|Overall Study||21
7654783|NCT02104752|18851803|P1|STARTED|Overall Study||18
7654784|NCT02104739|18851817|P7|NOT COMPLETED|Extension Phase (6 Weeks)||1
7654785|NCT02104739|18851818|P6|NOT COMPLETED|Extension Phase (6 Weeks)||0
7654786|NCT02104739|18851819|P5|NOT COMPLETED|Extension Phase (6 Weeks)||0
7654787|NCT02104739|18851820|P4|NOT COMPLETED|Extension Phase (6 Weeks)||0
7654788|NCT02104739|18851821|P3|NOT COMPLETED|Extension Phase (6 Weeks)||0
7654789|NCT02104739|18851822|P2|NOT COMPLETED|Extension Phase (6 Weeks)||0
7654790|NCT02104739|18851823|P1|NOT COMPLETED|Extension Phase (6 Weeks)||0
7654791|NCT02104739|18851817|P7|COMPLETED|Extension Phase (6 Weeks)||7
7654792|NCT02104739|18851818|P6|COMPLETED|Extension Phase (6 Weeks)||0
7654793|NCT02104739|18851819|P5|COMPLETED|Extension Phase (6 Weeks)||0
7654794|NCT02104739|18851820|P4|COMPLETED|Extension Phase (6 Weeks)||0
7654795|NCT02104739|18851821|P3|COMPLETED|Extension Phase (6 Weeks)||0
7654796|NCT02104739|18851822|P2|COMPLETED|Extension Phase (6 Weeks)||0
7654797|NCT02104739|18851823|P1|COMPLETED|Extension Phase (6 Weeks)||0
7654798|NCT02104739|18851817|P7|STARTED|Extension Phase (6 Weeks)||8
7654799|NCT02104739|18851818|P6|STARTED|Extension Phase (6 Weeks)||0
7654800|NCT02104739|18851819|P5|STARTED|Extension Phase (6 Weeks)||0
7654801|NCT02104739|18851820|P4|STARTED|Extension Phase (6 Weeks)||0
7654802|NCT02104739|18851821|P3|STARTED|Extension Phase (6 Weeks)||0
7654803|NCT02104739|18851822|P2|STARTED|Extension Phase (6 Weeks)||0
7654804|NCT02104739|18851823|P1|STARTED|Extension Phase (6 Weeks)||0
7654805|NCT02104739|18851817|P7|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||1
7654806|NCT02104739|18851818|P6|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
7654807|NCT02104739|18851819|P5|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
7654808|NCT02104739|18851820|P4|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
7654809|NCT02104739|18851821|P3|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
7654810|NCT02104739|18851822|P2|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
7654811|NCT02104739|18851823|P1|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
7654812|NCT02104739|18851817|P7|COMPLETED|Washout (Min of 10 and Max of 323 Days)||7
7654813|NCT02104739|18851818|P6|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
7654814|NCT02104739|18851819|P5|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
7654815|NCT02104739|18851820|P4|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
7654816|NCT02104739|18851821|P3|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
7654817|NCT02104739|18851822|P2|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
7654818|NCT02104739|18851823|P1|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
7654819|NCT02104739|18851817|P7|STARTED|Washout (Min of 10 and Max of 323 Days)||8
7654820|NCT02104739|18851818|P6|STARTED|Washout (Min of 10 and Max of 323 Days)||0
7654821|NCT02104739|18851819|P5|STARTED|Washout (Min of 10 and Max of 323 Days)||0
7654822|NCT02104739|18851820|P4|STARTED|Washout (Min of 10 and Max of 323 Days)||0
7654823|NCT02104739|18851821|P3|STARTED|Washout (Min of 10 and Max of 323 Days)||0
7654824|NCT02104739|18851822|P2|STARTED|Washout (Min of 10 and Max of 323 Days)||0
7654825|NCT02104739|18851823|P1|STARTED|Washout (Min of 10 and Max of 323 Days)||0
7654826|NCT02104739|18851817|P7|NOT COMPLETED|Third Intervention (1 Day)||0
7654827|NCT02104739|18851818|P6|NOT COMPLETED|Third Intervention (1 Day)||0
7654828|NCT02104739|18851819|P5|NOT COMPLETED|Third Intervention (1 Day)||0
7654829|NCT02104739|18851820|P4|NOT COMPLETED|Third Intervention (1 Day)||0
7654830|NCT02104739|18851821|P3|NOT COMPLETED|Third Intervention (1 Day)||0
7654831|NCT02104739|18851822|P2|NOT COMPLETED|Third Intervention (1 Day)||0
7654832|NCT02104739|18851823|P1|NOT COMPLETED|Third Intervention (1 Day)||0
7654833|NCT02104739|18851817|P7|COMPLETED|Third Intervention (1 Day)||0
7654834|NCT02104739|18851818|P6|COMPLETED|Third Intervention (1 Day)||2
7654835|NCT02104739|18851819|P5|COMPLETED|Third Intervention (1 Day)||0
7654836|NCT02104739|18851820|P4|COMPLETED|Third Intervention (1 Day)||7
7654837|NCT02104739|18851821|P3|COMPLETED|Third Intervention (1 Day)||2
7654838|NCT02104739|18851822|P2|COMPLETED|Third Intervention (1 Day)||4
7654839|NCT02104739|18851823|P1|COMPLETED|Third Intervention (1 Day)||1
7654840|NCT02104739|18851817|P7|STARTED|Third Intervention (1 Day)||0
7654841|NCT02104739|18851818|P6|STARTED|Third Intervention (1 Day)||2
7654842|NCT02104739|18851819|P5|STARTED|Third Intervention (1 Day)||0
7654843|NCT02104739|18851820|P4|STARTED|Third Intervention (1 Day)||7
7654844|NCT02104739|18851821|P3|STARTED|Third Intervention (1 Day)||2
7654845|NCT02104739|18851822|P2|STARTED|Third Intervention (1 Day)||4
7654846|NCT02104739|18851823|P1|STARTED|Third Intervention (1 Day)||1
7654847|NCT02104739|18851817|P7|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
7654848|NCT02104739|18851818|P6|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
7654849|NCT02104739|18851819|P5|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
7654850|NCT02104739|18851820|P4|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
7654851|NCT02104739|18851821|P3|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
7654852|NCT02104739|18851822|P2|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
7654853|NCT02104739|18851823|P1|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
7654854|NCT02104739|18851817|P7|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
7654855|NCT02104739|18851818|P6|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
7654856|NCT02104739|18851819|P5|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
7654857|NCT02104739|18851820|P4|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
7654858|NCT02104739|18851821|P3|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
7654859|NCT02104739|18851822|P2|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
7654860|NCT02104739|18851823|P1|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
7654861|NCT02104739|18851817|P7|STARTED|Washout (Min of 10 and Max of 107 Days)||0
7654862|NCT02104739|18851818|P6|STARTED|Washout (Min of 10 and Max of 107 Days)||2
7654863|NCT02104739|18851819|P5|STARTED|Washout (Min of 10 and Max of 107 Days)||0
7654864|NCT02104739|18851820|P4|STARTED|Washout (Min of 10 and Max of 107 Days)||7
7654865|NCT02104739|18851821|P3|STARTED|Washout (Min of 10 and Max of 107 Days)||2
7654866|NCT02104739|18851822|P2|STARTED|Washout (Min of 10 and Max of 107 Days)||4
7654867|NCT02104739|18851823|P1|STARTED|Washout (Min of 10 and Max of 107 Days)||1
7654868|NCT02104739|18851817|P7|NOT COMPLETED|Second Intervention (1 Day)||0
7654869|NCT02104739|18851818|P6|NOT COMPLETED|Second Intervention (1 Day)||0
7654870|NCT02104739|18851819|P5|NOT COMPLETED|Second Intervention (1 Day)||0
7654871|NCT02104739|18851820|P4|NOT COMPLETED|Second Intervention (1 Day)||0
7654872|NCT02104739|18851821|P3|NOT COMPLETED|Second Intervention (1 Day)||0
7654873|NCT02104739|18851822|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7654874|NCT02104739|18851823|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7654875|NCT02104739|18851817|P7|COMPLETED|Second Intervention (1 Day)||0
7654876|NCT02104739|18851818|P6|COMPLETED|Second Intervention (1 Day)||2
7654877|NCT02104739|18851819|P5|COMPLETED|Second Intervention (1 Day)||0
7654878|NCT02104739|18851820|P4|COMPLETED|Second Intervention (1 Day)||7
7654879|NCT02104739|18851821|P3|COMPLETED|Second Intervention (1 Day)||2
7654880|NCT02104739|18851822|P2|COMPLETED|Second Intervention (1 Day)||4
7654881|NCT02104739|18851823|P1|COMPLETED|Second Intervention (1 Day)||1
7654882|NCT02104739|18851817|P7|STARTED|Second Intervention (1 Day)||0
7654883|NCT02104739|18851818|P6|STARTED|Second Intervention (1 Day)||2
7654884|NCT02104739|18851819|P5|STARTED|Second Intervention (1 Day)||0
7654885|NCT02104739|18851820|P4|STARTED|Second Intervention (1 Day)||7
7654886|NCT02104739|18851821|P3|STARTED|Second Intervention (1 Day)||2
7654887|NCT02104739|18851822|P2|STARTED|Second Intervention (1 Day)||4
7654888|NCT02104739|18851823|P1|STARTED|Second Intervention (1 Day)||1
7654889|NCT02104739|18851817|P7|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
7654890|NCT02104739|18851818|P6|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
7654891|NCT02104739|18851819|P5|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
7654892|NCT02104739|18851820|P4|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
7654893|NCT02104739|18851821|P3|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
7654894|NCT02104739|18851822|P2|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
7654895|NCT02104739|18851823|P1|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
7654896|NCT02104739|18851817|P7|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
7654897|NCT02104739|18851818|P6|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
7654898|NCT02104739|18851819|P5|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
7654899|NCT02104739|18851820|P4|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
7654900|NCT02104739|18851821|P3|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
7654901|NCT02104739|18851822|P2|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
7654902|NCT02104739|18851823|P1|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
7654903|NCT02104739|18851817|P7|STARTED|Washout (Min of 10 and Max of 107 Days)||0
7654904|NCT02104739|18851818|P6|STARTED|Washout (Min of 10 and Max of 107 Days)||2
7654905|NCT02104739|18851819|P5|STARTED|Washout (Min of 10 and Max of 107 Days)||0
7654906|NCT02104739|18851820|P4|STARTED|Washout (Min of 10 and Max of 107 Days)||7
7654907|NCT02104739|18851821|P3|STARTED|Washout (Min of 10 and Max of 107 Days)||2
7654908|NCT02104739|18851822|P2|STARTED|Washout (Min of 10 and Max of 107 Days)||4
7654909|NCT02104739|18851823|P1|STARTED|Washout (Min of 10 and Max of 107 Days)||1
7654910|NCT02104739|18851817|P7|NOT COMPLETED|First Intervention (1 Day)||0
7654911|NCT02104739|18851818|P6|NOT COMPLETED|First Intervention (1 Day)||0
7654912|NCT02104739|18851819|P5|NOT COMPLETED|First Intervention (1 Day)||0
7654913|NCT02104739|18851820|P4|NOT COMPLETED|First Intervention (1 Day)||1
7654914|NCT02104739|18851821|P3|NOT COMPLETED|First Intervention (1 Day)||0
7654915|NCT02104739|18851822|P2|NOT COMPLETED|First Intervention (1 Day)||1
7654916|NCT02104739|18851823|P1|NOT COMPLETED|First Intervention (1 Day)||0
7654917|NCT02104739|18851817|P7|COMPLETED|First Intervention (1 Day)||0
7654918|NCT02104739|18851818|P6|COMPLETED|First Intervention (1 Day)||3
7654919|NCT02104739|18851819|P5|COMPLETED|First Intervention (1 Day)||0
7654920|NCT02104739|18851820|P4|COMPLETED|First Intervention (1 Day)||7
7654921|NCT02104739|18851821|P3|COMPLETED|First Intervention (1 Day)||2
7654922|NCT02104739|18851822|P2|COMPLETED|First Intervention (1 Day)||4
7654923|NCT02104739|18851823|P1|COMPLETED|First Intervention (1 Day)||2
7654924|NCT02104739|18851817|P7|STARTED|First Intervention (1 Day)||0
7654925|NCT02104739|18851818|P6|STARTED|First Intervention (1 Day)||3
7654926|NCT02104739|18851819|P5|STARTED|First Intervention (1 Day)||0
7654928|NCT02104739|18851821|P3|STARTED|First Intervention (1 Day)||2
7654929|NCT02104739|18851822|P2|STARTED|First Intervention (1 Day)||5
7654930|NCT02104739|18851823|P1|STARTED|First Intervention (1 Day)||2
7654931|NCT02104583|18851886|P5|NOT COMPLETED|Overall Study||12
7654932|NCT02104583|18851887|P4|NOT COMPLETED|Overall Study||17
7654933|NCT02104583|18851888|P3|NOT COMPLETED|Overall Study||16
7654934|NCT02104583|18851889|P2|NOT COMPLETED|Overall Study||11
7654935|NCT02104583|18851890|P1|NOT COMPLETED|Overall Study||18
7654936|NCT02104583|18851886|P5|COMPLETED|Overall Study||63
7654937|NCT02104583|18851887|P4|COMPLETED|Overall Study||57
7654938|NCT02104583|18851888|P3|COMPLETED|Overall Study||54
7654939|NCT02104583|18851889|P2|COMPLETED|Overall Study||35
7654940|NCT02104583|18851890|P1|COMPLETED|Overall Study||30
7654941|NCT02104583|18851886|P5|STARTED|Overall Study||75
7654942|NCT02104583|18851887|P4|STARTED|Overall Study||74
7654943|NCT02104583|18851888|P3|STARTED|Overall Study||70
7654944|NCT02104583|18851889|P2|STARTED|Overall Study||46
7654945|NCT02104583|18851890|P1|STARTED|Overall Study||48
7654946|NCT02104505|18851953|P2|NOT COMPLETED|Second Intervention (14 Days)||1
7654947|NCT02104505|18851954|P1|NOT COMPLETED|Second Intervention (14 Days)||2
7654948|NCT02104505|18851953|P2|COMPLETED|Second Intervention (14 Days)||7
7654949|NCT02104505|18851954|P1|COMPLETED|Second Intervention (14 Days)||8
7654950|NCT02104505|18851953|P2|STARTED|Second Intervention (14 Days)||8
7654951|NCT02104505|18851954|P1|STARTED|Second Intervention (14 Days)||10
7654952|NCT02104505|18851953|P2|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
7654953|NCT02104505|18851954|P1|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
7654954|NCT02104505|18851953|P2|COMPLETED|Washout (Minimum 3 Weeks)||8
7654955|NCT02104505|18851954|P1|COMPLETED|Washout (Minimum 3 Weeks)||10
7654956|NCT02104505|18851953|P2|STARTED|Washout (Minimum 3 Weeks)||8
7654957|NCT02104505|18851954|P1|STARTED|Washout (Minimum 3 Weeks)||10
7654958|NCT02104505|18851953|P2|NOT COMPLETED|First Intervention (14 Days)||3
7654959|NCT02104505|18851954|P1|NOT COMPLETED|First Intervention (14 Days)||2
7654960|NCT02104505|18851953|P2|COMPLETED|First Intervention (14 Days)||8
7654961|NCT02104505|18851954|P1|COMPLETED|First Intervention (14 Days)||10
7654962|NCT02104505|18851953|P2|STARTED|First Intervention (14 Days)|one participant withdrew prior to receiving study drug|11
7654963|NCT02104505|18851954|P1|STARTED|First Intervention (14 Days)||12
7654964|NCT02104427|18851966|P1|NOT COMPLETED|Overall Study||0
7654965|NCT02104427|18851966|P1|COMPLETED|Overall Study||12
7654966|NCT02104427|18851966|P1|STARTED|Overall Study||12
7654967|NCT02104414|18851992|P3|NOT COMPLETED|Overall Study||0
7654968|NCT02104414|18851993|P2|NOT COMPLETED|Overall Study||0
7654969|NCT02104414|18851994|P1|NOT COMPLETED|Overall Study||0
7654970|NCT02104414|18851992|P3|COMPLETED|Overall Study||2
7654971|NCT02104414|18851993|P2|COMPLETED|Overall Study||4
7654972|NCT02104414|18851994|P1|COMPLETED|Overall Study||5
7654973|NCT02104414|18851992|P3|STARTED|Overall Study||2
7654974|NCT02104414|18851993|P2|STARTED|Overall Study||4
7654975|NCT02104414|18851994|P1|STARTED|Overall Study||5
7654976|NCT02104219|18852017|P1|NOT COMPLETED|Overall Study||0
7654977|NCT02104219|18852017|P1|COMPLETED|Overall Study||32
7654978|NCT02104219|18852017|P1|STARTED|Overall Study||32
7654979|NCT02104180|18852026|P2|NOT COMPLETED|Overall Study||0
7654980|NCT02104180|18852027|P1|NOT COMPLETED|Overall Study||1
7654981|NCT02104180|18852026|P2|COMPLETED|Overall Study||31
7654982|NCT02104180|18852027|P1|COMPLETED|Overall Study||30
7654983|NCT02104180|18852026|P2|STARTED|Overall Study||31
7654984|NCT02104180|18852027|P1|STARTED|Overall Study||31
7654985|NCT02104167|18852033|P1|NOT COMPLETED|Overall Study||0
7654986|NCT02104167|18852033|P1|COMPLETED|Overall Study||110
7654987|NCT02104167|18852033|P1|STARTED|Overall Study||110
7654988|NCT02104141|18852038|P1|NOT COMPLETED|Overall Study||0
7654989|NCT02104141|18852038|P1|COMPLETED|Overall Study||51
7654990|NCT02104141|18852038|P1|STARTED|Overall Study||51
7654991|NCT02103855|18852043|P1|NOT COMPLETED|Overall Study||2
7654992|NCT02103855|18852043|P1|COMPLETED|Overall Study||4
7654993|NCT02103855|18852043|P1|STARTED|Overall Study||6
7654994|NCT02103816|18852051|P1|NOT COMPLETED|Overall Study||8
7654995|NCT02103816|18852051|P1|COMPLETED|Overall Study||13
7654996|NCT02103816|18852051|P1|STARTED|Overall Study||21
7654997|NCT02103608|18852057|P1|NOT COMPLETED|Overall Study||2
7654998|NCT02103608|18852057|P1|COMPLETED|Overall Study||15
7654999|NCT02103608|18852057|P1|STARTED|Overall Study||17
7655000|NCT02103478|18852068|P9|NOT COMPLETED|Overall Study||14
7655001|NCT02103478|18852069|P8|NOT COMPLETED|Overall Study||16
7655002|NCT02103478|18852070|P7|NOT COMPLETED|Overall Study||25
7655003|NCT02103478|18852071|P6|NOT COMPLETED|Overall Study||25
7655004|NCT02103478|18852072|P5|NOT COMPLETED|Overall Study||19
7655005|NCT02103478|18852073|P4|NOT COMPLETED|Overall Study||6
7655006|NCT02103478|18852074|P3|NOT COMPLETED|Overall Study||6
7655007|NCT02103478|18852075|P2|NOT COMPLETED|Overall Study||6
7655008|NCT02103478|18852076|P1|NOT COMPLETED|Overall Study||7
7655009|NCT02103478|18852068|P9|COMPLETED|Overall Study||0
7655010|NCT02103478|18852069|P8|COMPLETED|Overall Study||0
7655011|NCT02103478|18852070|P7|COMPLETED|Overall Study||0
7655012|NCT02103478|18852071|P6|COMPLETED|Overall Study||0
7655013|NCT02103478|18852072|P5|COMPLETED|Overall Study||0
7655014|NCT02103478|18852073|P4|COMPLETED|Overall Study||0
7655015|NCT02103478|18852074|P3|COMPLETED|Overall Study||0
7655016|NCT02103478|18852075|P2|COMPLETED|Overall Study||0
7655017|NCT02103478|18852076|P1|COMPLETED|Overall Study||0
7655018|NCT02103478|18852068|P9|STARTED|Overall Study||14
7655019|NCT02103478|18852069|P8|STARTED|Overall Study||16
7655020|NCT02103478|18852070|P7|STARTED|Overall Study||25
7655021|NCT02103478|18852071|P6|STARTED|Overall Study||25
7655022|NCT02103478|18852072|P5|STARTED|Overall Study||19
7655023|NCT02103478|18852073|P4|STARTED|Overall Study||6
7655024|NCT02103478|18852074|P3|STARTED|Overall Study||6
7655025|NCT02103478|18852075|P2|STARTED|Overall Study||6
7655026|NCT02103478|18852076|P1|STARTED|Overall Study||7
7655027|NCT02103439|18852185|P2|NOT COMPLETED|Overall Study||3
7655028|NCT02103439|18852186|P1|NOT COMPLETED|Overall Study||3
7655029|NCT02103439|18852185|P2|COMPLETED|Overall Study||67
7655030|NCT02103439|18852186|P1|COMPLETED|Overall Study||67
7655031|NCT02103439|18852185|P2|STARTED|Overall Study||70
7655032|NCT02103439|18852186|P1|STARTED|Overall Study||70
7655033|NCT02103309|18852206|P2|NOT COMPLETED|Overall Study||0
7655034|NCT02103309|18852207|P1|NOT COMPLETED|Overall Study||0
7655035|NCT02103309|18852206|P2|COMPLETED|Overall Study||22
7655036|NCT02103309|18852207|P1|COMPLETED|Overall Study||20
7655037|NCT02103309|18852206|P2|STARTED|Overall Study||22
7655038|NCT02103309|18852207|P1|STARTED|Overall Study||20
7655039|NCT02103270|18852222|P3|NOT COMPLETED|Overall Study||24
7655040|NCT02103270|18852223|P2|NOT COMPLETED|Overall Study||6
7655041|NCT02103270|18852224|P1|NOT COMPLETED|Overall Study||9
7655042|NCT02103270|18852222|P3|COMPLETED|Overall Study||1
7655043|NCT02103270|18852223|P2|COMPLETED|Overall Study||29
7655044|NCT02103270|18852224|P1|COMPLETED|Overall Study||51
7655045|NCT02103270|18852222|P3|STARTED|Overall Study||25
7655046|NCT02103270|18852223|P2|STARTED|Overall Study||35
7655047|NCT02103270|18852224|P1|STARTED|Overall Study||60
7655048|NCT02103218|18852239|P4|NOT COMPLETED|Overall Study||7
7655049|NCT02103218|18852240|P3|NOT COMPLETED|Overall Study||4
7655050|NCT02103218|18852241|P2|NOT COMPLETED|Overall Study||8
7655051|NCT02103218|18852242|P1|NOT COMPLETED|Overall Study||5
7655052|NCT02103218|18852239|P4|COMPLETED|Overall Study||47
7655053|NCT02103218|18852240|P3|COMPLETED|Overall Study||44
7655054|NCT02103218|18852241|P2|COMPLETED|Overall Study||51
7655055|NCT02103218|18852242|P1|COMPLETED|Overall Study||46
7655056|NCT02103218|18852239|P4|STARTED|Overall Study||54
7655057|NCT02103218|18852240|P3|STARTED|Overall Study||48
7655058|NCT02103218|18852241|P2|STARTED|Overall Study||59
7655059|NCT02103218|18852242|P1|STARTED|Overall Study||51
7655060|NCT02103127|18852286|P1|NOT COMPLETED|Overall Study||3
7655061|NCT02103127|18852286|P1|COMPLETED|Overall Study||17
7655062|NCT02103127|18852286|P1|STARTED|Overall Study||20
7655063|NCT02103114|18852295|P2|NOT COMPLETED|Overall Study||1
7655064|NCT02103114|18852296|P1|NOT COMPLETED|Overall Study||0
7655065|NCT02103114|18852295|P2|COMPLETED|Overall Study||19
7655066|NCT02103114|18852296|P1|COMPLETED|Overall Study||20
7655067|NCT02103114|18852295|P2|STARTED|Overall Study||20
7655068|NCT02103114|18852296|P1|STARTED|Overall Study||20
7655069|NCT02103062|18852352|P2|NOT COMPLETED|Overall Study||23
7655070|NCT02103062|18852353|P1|NOT COMPLETED|Overall Study||18
7655071|NCT02103062|18852352|P2|COMPLETED|Overall Study||0
7655072|NCT02103062|18852353|P1|COMPLETED|Overall Study||0
7655073|NCT02103062|18852352|P2|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20
7655074|NCT02103062|18852353|P1|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17
7655075|NCT02103062|18852352|P2|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23
7655076|NCT02103062|18852353|P1|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18
7655077|NCT02103062|18852352|P2|STARTED|Overall Study||23
7655078|NCT02103062|18852353|P1|STARTED|Overall Study||18
7655079|NCT02102932|18852379|P8|NOT COMPLETED|Overall Study||0
7655080|NCT02102932|18852380|P7|NOT COMPLETED|Overall Study||0
7655081|NCT02102932|18852381|P6|NOT COMPLETED|Overall Study||0
7655082|NCT02102932|18852382|P5|NOT COMPLETED|Overall Study||0
7655083|NCT02102932|18852383|P4|NOT COMPLETED|Overall Study||0
7655084|NCT02102932|18852384|P3|NOT COMPLETED|Overall Study||0
7655085|NCT02102932|18852385|P2|NOT COMPLETED|Overall Study||0
7655086|NCT02102932|18852386|P1|NOT COMPLETED|Overall Study||0
7655087|NCT02102932|18852379|P8|COMPLETED|Overall Study||12
7655088|NCT02102932|18852380|P7|COMPLETED|Overall Study||12
7655089|NCT02102932|18852381|P6|COMPLETED|Overall Study||12
7655090|NCT02102932|18852382|P5|COMPLETED|Overall Study||12
7655091|NCT02102932|18852383|P4|COMPLETED|Overall Study||12
7655092|NCT02102932|18852384|P3|COMPLETED|Overall Study||12
7655093|NCT02102932|18852385|P2|COMPLETED|Overall Study||12
7655094|NCT02102932|18852386|P1|COMPLETED|Overall Study||12
7655095|NCT02102932|18852379|P8|STARTED|Overall Study||12
7655096|NCT02102932|18852380|P7|STARTED|Overall Study||12
7655097|NCT02102932|18852381|P6|STARTED|Overall Study||12
7655098|NCT02102932|18852382|P5|STARTED|Overall Study||12
7655099|NCT02102932|18852383|P4|STARTED|Overall Study||12
7655100|NCT02102932|18852384|P3|STARTED|Overall Study||12
7655101|NCT02102932|18852385|P2|STARTED|Overall Study||12
7655102|NCT02102932|18852386|P1|STARTED|Overall Study||12
7655103|NCT02102724|18852446|P2|NOT COMPLETED|Overall Study||1
7655104|NCT02102724|18852447|P1|NOT COMPLETED|Overall Study||2
7655105|NCT02102724|18852446|P2|COMPLETED|Overall Study||18
7655106|NCT02102724|18852447|P1|COMPLETED|Overall Study||16
7655107|NCT02102724|18852446|P2|STARTED|Overall Study||19
7655108|NCT02102724|18852447|P1|STARTED|Overall Study||18
7655109|NCT02102490|18852453|P1|NOT COMPLETED|Overall Study||7
7655110|NCT02102490|18852453|P1|COMPLETED|Overall Study||125
7655111|NCT02102490|18852453|P1|Received at Least 1 Dose of Study Drug|Overall Study||132
7655112|NCT02102490|18852453|P1|STARTED|Overall Study||132
7655113|NCT02102464|18852467|P3|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
7655114|NCT02102464|18852468|P2|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
7655115|NCT02102464|18852469|P1|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
7655116|NCT02102464|18852467|P3|COMPLETED|Crossover LipiFlow Treatment of Control||25
7655117|NCT02102464|18852468|P2|COMPLETED|Crossover LipiFlow Treatment of Control||0
7655118|NCT02102464|18852469|P1|COMPLETED|Crossover LipiFlow Treatment of Control||0
7655119|NCT02102464|18852467|P3|STARTED|Crossover LipiFlow Treatment of Control||25
7655120|NCT02102464|18852468|P2|STARTED|Crossover LipiFlow Treatment of Control||0
7655121|NCT02102464|18852469|P1|STARTED|Crossover LipiFlow Treatment of Control||0
7655122|NCT02102464|18852467|P3|NOT COMPLETED|Randomized Study||0
7655123|NCT02102464|18852468|P2|NOT COMPLETED|Randomized Study||1
7655124|NCT02102464|18852469|P1|NOT COMPLETED|Randomized Study||0
7655125|NCT02102464|18852467|P3|COMPLETED|Randomized Study||0
7655126|NCT02102464|18852468|P2|COMPLETED|Randomized Study||25
7655127|NCT02102464|18852469|P1|COMPLETED|Randomized Study||29
7655128|NCT02102464|18852467|P3|STARTED|Randomized Study||0
7655129|NCT02102464|18852468|P2|STARTED|Randomized Study||26
7655130|NCT02102464|18852469|P1|STARTED|Randomized Study||29
7655131|NCT02102399|18852488|P2|NOT COMPLETED|Overall Study||4
7655132|NCT02102399|18852489|P1|NOT COMPLETED|Overall Study||6
7655133|NCT02102399|18852488|P2|COMPLETED|Overall Study||17
7655134|NCT02102399|18852489|P1|COMPLETED|Overall Study||14
7655135|NCT02102399|18852488|P2|STARTED|Overall Study||21
7655136|NCT02102399|18852489|P1|STARTED|Overall Study||20
7655137|NCT02102230|18852540|P3|NOT COMPLETED|Overall Study||17
7655138|NCT02102230|18852541|P2|NOT COMPLETED|Overall Study||17
7655139|NCT02102230|18852542|P1|NOT COMPLETED|Overall Study||17
7655140|NCT02102230|18852540|P3|COMPLETED|Overall Study||24
7655141|NCT02102230|18852541|P2|COMPLETED|Overall Study||11
7655142|NCT02102230|18852542|P1|COMPLETED|Overall Study||25
7655143|NCT02102230|18852540|P3|STARTED|Overall Study||41
7655144|NCT02102230|18852541|P2|STARTED|Overall Study||28
7655145|NCT02102230|18852542|P1|STARTED|Overall Study||42
7655146|NCT02102204|18852559|P1|NOT COMPLETED|Overall Study||304
7655147|NCT02102204|18852559|P1|COMPLETED|Overall Study||598
7655148|NCT02102204|18852559|P1|Received Etelcalcetide|Overall Study||884
7655149|NCT02102204|18852559|P1|STARTED|Overall Study||902
7655150|NCT02102100|18852570|P2|NOT COMPLETED|Overall Study||7
7655151|NCT02102100|18852571|P1|NOT COMPLETED|Overall Study||9
7655152|NCT02102100|18852570|P2|COMPLETED|Overall Study||18
7655153|NCT02102100|18852571|P1|COMPLETED|Overall Study||23
7655154|NCT02102100|18852570|P2|STARTED|Overall Study||25
7655155|NCT02102100|18852571|P1|STARTED|Overall Study||32
7655156|NCT02101983|18852579|P2|NOT COMPLETED|Overall Study||0
7655157|NCT02101983|18852580|P1|NOT COMPLETED|Overall Study||1
7655158|NCT02101983|18852579|P2|COMPLETED|Overall Study||6
7655159|NCT02101983|18852580|P1|COMPLETED|Overall Study||4
7655160|NCT02101983|18852579|P2|STARTED|Overall Study||6
7655161|NCT02101983|18852580|P1|STARTED|Overall Study||5
7655162|NCT02101918|18852590|P1|NOT COMPLETED|Overall Study||0
7655163|NCT02101918|18852590|P1|COMPLETED|Overall Study||22
7655164|NCT02101918|18852590|P1|STARTED|Overall Study||22
7655165|NCT02101788|18852605|P2|NOT COMPLETED|Overall Study||14
7655166|NCT02101788|18852606|P1|NOT COMPLETED|Overall Study||10
7655167|NCT02101788|18852605|P2|COMPLETED|Overall Study||116
7655168|NCT02101788|18852606|P1|COMPLETED|Overall Study||120
7655169|NCT02101788|18852605|P2|Crossover From Arm A to Arm B|Overall Study||0
7655170|NCT02101788|18852606|P1|Crossover From Arm A to Arm B|Overall Study||88
7655171|NCT02101788|18852605|P2|STARTED|Overall Study||130
7655172|NCT02101788|18852606|P1|STARTED|Overall Study||130
7655173|NCT02101554|18852626|P3|NOT COMPLETED|Overall Study||1
7655174|NCT02101554|18852627|P2|NOT COMPLETED|Overall Study||5
7655175|NCT02101554|18852628|P1|NOT COMPLETED|Overall Study||3
7655176|NCT02101554|18852626|P3|COMPLETED|Overall Study||2
7655177|NCT02101554|18852627|P2|COMPLETED|Overall Study||5
7655178|NCT02101554|18852628|P1|COMPLETED|Overall Study||3
7655179|NCT02101554|18852626|P3|STARTED|Overall Study||3
7655180|NCT02101554|18852627|P2|STARTED|Overall Study||10
7655181|NCT02101554|18852628|P1|STARTED|Overall Study||6
7655182|NCT02101515|18852710|P2|NOT COMPLETED|Overall Study||0
7655183|NCT02101515|18852711|P1|NOT COMPLETED|Overall Study||0
7655184|NCT02101515|18852710|P2|COMPLETED|Overall Study||41
7655185|NCT02101515|18852711|P1|COMPLETED|Overall Study||37
7655186|NCT02101515|18852710|P2|STARTED|Overall Study||41
7655187|NCT02101515|18852711|P1|STARTED|Overall Study||37
7655188|NCT02101437|18852753|P4|NOT COMPLETED|Overall Study||0
7655189|NCT02101437|18852754|P3|NOT COMPLETED|Overall Study||0
7655190|NCT02101437|18852755|P2|NOT COMPLETED|Overall Study||0
7655191|NCT02101437|18852756|P1|NOT COMPLETED|Overall Study||0
7655192|NCT02101437|18852753|P4|COMPLETED|Overall Study||49
7655193|NCT02101437|18852754|P3|COMPLETED|Overall Study||52
7655194|NCT02101437|18852755|P2|COMPLETED|Overall Study||54
7655195|NCT02101437|18852756|P1|COMPLETED|Overall Study||20
7655196|NCT02101437|18852753|P4|STARTED|Overall Study||49
7655197|NCT02101437|18852754|P3|STARTED|Overall Study||52
7655198|NCT02101437|18852755|P2|STARTED|Overall Study||54
7655199|NCT02101437|18852756|P1|STARTED|Overall Study||20
7655200|NCT02101411|18852769|P3|NOT COMPLETED|Overall Study||10
7655201|NCT02101411|18852770|P2|NOT COMPLETED|Overall Study||7
7655202|NCT02101411|18852771|P1|NOT COMPLETED|Overall Study||4
7655203|NCT02101411|18852769|P3|COMPLETED|Overall Study||104
7655204|NCT02101411|18852770|P2|COMPLETED|Overall Study||102
7655205|NCT02101411|18852771|P1|COMPLETED|Overall Study||107
7655206|NCT02101411|18852769|P3|STARTED|Overall Study||114
7655207|NCT02101411|18852770|P2|STARTED|Overall Study||109
7655208|NCT02101411|18852771|P1|STARTED|Overall Study||111
7655209|NCT02101359|18852781|P2|NOT COMPLETED|Overall Study||19
7655210|NCT02101359|18852782|P1|NOT COMPLETED|Overall Study||29
7655211|NCT02101359|18852781|P2|COMPLETED|Overall Study||277
7655212|NCT02101359|18852782|P1|COMPLETED|Overall Study||266
7655213|NCT02101359|18852781|P2|STARTED|Overall Study||296
7655214|NCT02101359|18852782|P1|STARTED|Overall Study||295
7655215|NCT02101294|18852788|P1|NOT COMPLETED|Overall Study||11
7655216|NCT02101294|18852788|P1|COMPLETED|Overall Study||20
7655217|NCT02101294|18852788|P1|STARTED|Overall Study||31
7655218|NCT02101281|18852797|P2|NOT COMPLETED|Overall Study||1
7655219|NCT02101281|18852798|P1|NOT COMPLETED|Overall Study||0
7655220|NCT02101281|18852797|P2|COMPLETED|Overall Study||19
7655221|NCT02101281|18852798|P1|COMPLETED|Overall Study||20
7655222|NCT02101281|18852797|P2|STARTED|Overall Study||20
7655223|NCT02101281|18852798|P1|STARTED|Overall Study||20
7655224|NCT02101190|18852840|P2|NOT COMPLETED|Overall Study||0
7655225|NCT02101190|18852841|P1|NOT COMPLETED|Overall Study||0
7655226|NCT02101190|18852840|P2|COMPLETED|Overall Study||8
7655227|NCT02101190|18852841|P1|COMPLETED|Overall Study||8
7655228|NCT02101190|18852840|P2|STARTED|Overall Study||8
7655229|NCT02101190|18852841|P1|STARTED|Overall Study||8
7655230|NCT02101112|18852851|P6|NOT COMPLETED|Overall Study||0
7655231|NCT02101112|18852852|P5|NOT COMPLETED|Overall Study||1
7655232|NCT02101112|18852853|P4|NOT COMPLETED|Overall Study||0
7655233|NCT02101112|18852854|P3|NOT COMPLETED|Overall Study||1
7655234|NCT02101112|18852855|P2|NOT COMPLETED|Overall Study||0
7655235|NCT02101112|18852856|P1|NOT COMPLETED|Overall Study||0
7655236|NCT02101112|18852851|P6|COMPLETED|Overall Study||5
7655237|NCT02101112|18852852|P5|COMPLETED|Overall Study||5
7655238|NCT02101112|18852853|P4|COMPLETED|Overall Study||5
7655239|NCT02101112|18852854|P3|COMPLETED|Overall Study||5
7655240|NCT02101112|18852855|P2|COMPLETED|Overall Study||5
7655241|NCT02101112|18852856|P1|COMPLETED|Overall Study||6
7655242|NCT02101112|18852851|P6|STARTED|Overall Study||5
7655243|NCT02101112|18852852|P5|STARTED|Overall Study||6
7655244|NCT02101112|18852853|P4|STARTED|Overall Study||5
7655245|NCT02101112|18852854|P3|STARTED|Overall Study||6
7655246|NCT02101112|18852855|P2|STARTED|Overall Study||5
7655247|NCT02101112|18852856|P1|STARTED|Overall Study||6
7655248|NCT02101021|18852886|P5|NOT COMPLETED|Overall Study||4
7655249|NCT02101021|18852887|P4|NOT COMPLETED|Overall Study||3
7655250|NCT02101021|18852888|P3|NOT COMPLETED|Overall Study||7
7655251|NCT02101021|18852889|P2|NOT COMPLETED|Overall Study||4
7655252|NCT02101021|18852890|P1|NOT COMPLETED|Overall Study||7
7655253|NCT02101021|18852886|P5|COMPLETED|Overall Study||0
7655254|NCT02101021|18852887|P4|COMPLETED|Overall Study||0
7655255|NCT02101021|18852888|P3|COMPLETED|Overall Study||0
7655256|NCT02101021|18852889|P2|COMPLETED|Overall Study||0
7655257|NCT02101021|18852890|P1|COMPLETED|Overall Study||0
7655258|NCT02101021|18852886|P5|STARTED|Overall Study||4
7655259|NCT02101021|18852887|P4|STARTED|Overall Study||3
7655260|NCT02101021|18852888|P3|STARTED|Overall Study||7
7655261|NCT02101021|18852889|P2|STARTED|Overall Study||4
7655262|NCT02101021|18852890|P1|STARTED|Overall Study||7
7655263|NCT02101008|18852932|P1|NOT COMPLETED|Overall Study||0
7655264|NCT02101008|18852932|P1|COMPLETED|Overall Study||12
7655265|NCT02101008|18852932|P1|STARTED|Overall Study||12
7655266|NCT02100969|18852937|P1|NOT COMPLETED|Overall Study||1
7655267|NCT02100969|18852937|P1|COMPLETED|Overall Study||22
7655268|NCT02100969|18852937|P1|STARTED|Overall Study||23
7655269|NCT02100930|18852949|P1|NOT COMPLETED|Overall Study||0
7655270|NCT02100930|18852949|P1|COMPLETED|Overall Study||69
7655271|NCT02100930|18852949|P1|STARTED|Overall Study||69
7655272|NCT02100839|18852956|P2|NOT COMPLETED|Multiple Ascending Dose||0
7655273|NCT02100839|18852957|P1|NOT COMPLETED|Multiple Ascending Dose||4
7655274|NCT02100839|18852956|P2|COMPLETED|Multiple Ascending Dose||3
7655275|NCT02100839|18852957|P1|COMPLETED|Multiple Ascending Dose||9
7655276|NCT02100839|18852956|P2|STARTED|Multiple Ascending Dose||3
7655277|NCT02100839|18852957|P1|STARTED|Multiple Ascending Dose||13
7655278|NCT02100839|18852956|P2|NOT COMPLETED|Single Ascending Dose||0
7655279|NCT02100839|18852957|P1|NOT COMPLETED|Single Ascending Dose||0
7655280|NCT02100839|18852956|P2|COMPLETED|Single Ascending Dose||12
7655281|NCT02100839|18852957|P1|COMPLETED|Single Ascending Dose||24
7655282|NCT02100839|18852956|P2|STARTED|Single Ascending Dose||12
7655283|NCT02100839|18852957|P1|STARTED|Single Ascending Dose||24
7655284|NCT02100826|18852969|P2|NOT COMPLETED|Period 2 (7 Days)||0
7655285|NCT02100826|18852970|P1|NOT COMPLETED|Period 2 (7 Days)||0
7655286|NCT02100826|18852969|P2|COMPLETED|Period 2 (7 Days)||14
7655287|NCT02100826|18852970|P1|COMPLETED|Period 2 (7 Days)||14
7655288|NCT02100826|18852969|P2|STARTED|Period 2 (7 Days)||14
7655289|NCT02100826|18852970|P1|STARTED|Period 2 (7 Days)||14
7655290|NCT02100826|18852969|P2|NOT COMPLETED|Washout Period (1 Day)||0
7655291|NCT02100826|18852970|P1|NOT COMPLETED|Washout Period (1 Day)||0
7655292|NCT02100826|18852969|P2|COMPLETED|Washout Period (1 Day)||14
7655293|NCT02100826|18852970|P1|COMPLETED|Washout Period (1 Day)||14
7655294|NCT02100826|18852969|P2|STARTED|Washout Period (1 Day)||14
7655295|NCT02100826|18852970|P1|STARTED|Washout Period (1 Day)||14
7655296|NCT02100826|18852969|P2|NOT COMPLETED|Period 1 (7 Days)||0
7655297|NCT02100826|18852970|P1|NOT COMPLETED|Period 1 (7 Days)||0
7655298|NCT02100826|18852969|P2|COMPLETED|Period 1 (7 Days)||14
7655299|NCT02100826|18852970|P1|COMPLETED|Period 1 (7 Days)||14
7655300|NCT02100826|18852969|P2|STARTED|Period 1 (7 Days)||14
7655301|NCT02100826|18852970|P1|STARTED|Period 1 (7 Days)||14
7655302|NCT02100813|18852988|P8|NOT COMPLETED|Overall Study||1
7655303|NCT02100813|18852989|P7|NOT COMPLETED|Overall Study||0
7655304|NCT02100813|18852990|P6|NOT COMPLETED|Overall Study||0
7655305|NCT02100813|18852991|P5|NOT COMPLETED|Overall Study||0
7655306|NCT02100813|18852992|P4|NOT COMPLETED|Overall Study||0
7655307|NCT02100813|18852993|P3|NOT COMPLETED|Overall Study||0
7655308|NCT02100813|18852994|P2|NOT COMPLETED|Overall Study||0
7655309|NCT02100813|18852995|P1|NOT COMPLETED|Overall Study||0
7655310|NCT02100813|18852988|P8|COMPLETED|Overall Study||66
7655311|NCT02100813|18852989|P7|COMPLETED|Overall Study||64
7655312|NCT02100813|18852990|P6|COMPLETED|Overall Study||32
7655313|NCT02100813|18852991|P5|COMPLETED|Overall Study||12
7655314|NCT02100813|18852992|P4|COMPLETED|Overall Study||12
7655315|NCT02100813|18852993|P3|COMPLETED|Overall Study||12
7655316|NCT02100813|18852994|P2|COMPLETED|Overall Study||11
7655317|NCT02100813|18852995|P1|COMPLETED|Overall Study||10
7655318|NCT02100813|18852988|P8|STARTED|Overall Study||67
7655319|NCT02100813|18852989|P7|STARTED|Overall Study||64
7655320|NCT02100813|18852990|P6|STARTED|Overall Study||32
7655321|NCT02100813|18852991|P5|STARTED|Overall Study||12
7655322|NCT02100813|18852992|P4|STARTED|Overall Study||12
7655323|NCT02100813|18852993|P3|STARTED|Overall Study||12
7655324|NCT02100813|18852994|P2|STARTED|Overall Study||11
7655325|NCT02100813|18852995|P1|STARTED|Overall Study||10
7655326|NCT02100748|18853031|P12|NOT COMPLETED|Overall Study||0
7655327|NCT02100748|18853032|P11|NOT COMPLETED|Overall Study||2
7655328|NCT02100748|18853033|P10|NOT COMPLETED|Overall Study||2
7655329|NCT02100748|18853034|P9|NOT COMPLETED|Overall Study||3
7655330|NCT02100748|18853035|P8|NOT COMPLETED|Overall Study||4
7655331|NCT02100748|18853036|P7|NOT COMPLETED|Overall Study||2
7655332|NCT02100748|18853037|P6|NOT COMPLETED|Overall Study||0
7655333|NCT02100748|18853038|P5|NOT COMPLETED|Overall Study||2
7655334|NCT02100748|18853039|P4|NOT COMPLETED|Overall Study||1
7655335|NCT02100748|18853040|P3|NOT COMPLETED|Overall Study||1
7655336|NCT02100748|18853041|P2|NOT COMPLETED|Overall Study||1
7655337|NCT02100748|18853042|P1|NOT COMPLETED|Overall Study||2
7655338|NCT02100748|18853031|P12|COMPLETED|Overall Study||39
7655339|NCT02100748|18853032|P11|COMPLETED|Overall Study||26
7655340|NCT02100748|18853033|P10|COMPLETED|Overall Study||29
7655341|NCT02100748|18853034|P9|COMPLETED|Overall Study||33
7655342|NCT02100748|18853035|P8|COMPLETED|Overall Study||34
7655343|NCT02100748|18853036|P7|COMPLETED|Overall Study||18
7655344|NCT02100748|18853037|P6|COMPLETED|Overall Study||23
7655345|NCT02100748|18853038|P5|COMPLETED|Overall Study||23
7655346|NCT02100748|18853039|P4|COMPLETED|Overall Study||21
7655347|NCT02100748|18853040|P3|COMPLETED|Overall Study||21
7655348|NCT02100748|18853041|P2|COMPLETED|Overall Study||23
7655349|NCT02100748|18853042|P1|COMPLETED|Overall Study||23
7655350|NCT02100748|18853031|P12|STARTED|Overall Study||39
7655351|NCT02100748|18853032|P11|STARTED|Overall Study||28
7655352|NCT02100748|18853033|P10|STARTED|Overall Study||31
7655353|NCT02100748|18853034|P9|STARTED|Overall Study||36
7655354|NCT02100748|18853035|P8|STARTED|Overall Study||38
7655355|NCT02100748|18853036|P7|STARTED|Overall Study||20
7655356|NCT02100748|18853037|P6|STARTED|Overall Study||23
7655357|NCT02100748|18853038|P5|STARTED|Overall Study||25
7655358|NCT02100748|18853039|P4|STARTED|Overall Study||22
7655359|NCT02100748|18853040|P3|STARTED|Overall Study||22
7655360|NCT02100748|18853041|P2|STARTED|Overall Study||24
7655361|NCT02100748|18853042|P1|STARTED|Overall Study||25
7655362|NCT02100670|18853072|P4|NOT COMPLETED|Overall Study||1
7655363|NCT02100670|18853073|P3|NOT COMPLETED|Overall Study||4
7655364|NCT02100670|18853074|P2|NOT COMPLETED|Overall Study||7
7655365|NCT02100670|18853075|P1|NOT COMPLETED|Overall Study||13
7655366|NCT02100670|18853072|P4|COMPLETED|Overall Study||75
7655367|NCT02100670|18853073|P3|COMPLETED|Overall Study||74
7655368|NCT02100670|18853074|P2|COMPLETED|Overall Study||106
7655369|NCT02100670|18853075|P1|COMPLETED|Overall Study||105
7655370|NCT02100670|18853072|P4|STARTED|Overall Study||76
7655371|NCT02100670|18853073|P3|STARTED|Overall Study||78
7655372|NCT02100670|18853074|P2|STARTED|Overall Study||113
7655373|NCT02100670|18853075|P1|STARTED|Overall Study||118
7655374|NCT02100657|18853138|P3|NOT COMPLETED|Cohort 3: Dose Level 3||27
7655375|NCT02100657|18853139|P2|NOT COMPLETED|Cohort 3: Dose Level 3||0
7655376|NCT02100657|18853140|P1|NOT COMPLETED|Cohort 3: Dose Level 3||0
7655377|NCT02100657|18853138|P3|COMPLETED|Cohort 3: Dose Level 3||0
7655378|NCT02100657|18853139|P2|COMPLETED|Cohort 3: Dose Level 3||0
7655379|NCT02100657|18853140|P1|COMPLETED|Cohort 3: Dose Level 3||0
7655380|NCT02100657|18853138|P3|STARTED|Cohort 3: Dose Level 3||27
7655381|NCT02100657|18853139|P2|STARTED|Cohort 3: Dose Level 3||0
7655382|NCT02100657|18853140|P1|STARTED|Cohort 3: Dose Level 3||0
7655383|NCT02100657|18853138|P3|NOT COMPLETED|Cohort 2: Dose Level 2||0
7655384|NCT02100657|18853139|P2|NOT COMPLETED|Cohort 2: Dose Level 2||4
7655385|NCT02100657|18853140|P1|NOT COMPLETED|Cohort 2: Dose Level 2||0
7655386|NCT02100657|18853138|P3|COMPLETED|Cohort 2: Dose Level 2||0
7655387|NCT02100657|18853139|P2|COMPLETED|Cohort 2: Dose Level 2||0
7655388|NCT02100657|18853140|P1|COMPLETED|Cohort 2: Dose Level 2||0
7655389|NCT02100657|18853138|P3|STARTED|Cohort 2: Dose Level 2||0
7655390|NCT02100657|18853139|P2|STARTED|Cohort 2: Dose Level 2||4
7655391|NCT02100657|18853140|P1|STARTED|Cohort 2: Dose Level 2||0
7655392|NCT02100657|18853138|P3|NOT COMPLETED|Cohort 1: Dose Level 1||0
7655393|NCT02100657|18853139|P2|NOT COMPLETED|Cohort 1: Dose Level 1||0
7655394|NCT02100657|18853140|P1|NOT COMPLETED|Cohort 1: Dose Level 1||8
7655395|NCT02100657|18853138|P3|COMPLETED|Cohort 1: Dose Level 1||0
7655396|NCT02100657|18853139|P2|COMPLETED|Cohort 1: Dose Level 1||0
7655397|NCT02100657|18853140|P1|COMPLETED|Cohort 1: Dose Level 1||0
7655398|NCT02100657|18853138|P3|STARTED|Cohort 1: Dose Level 1||0
7655399|NCT02100657|18853139|P2|STARTED|Cohort 1: Dose Level 1||0
7655400|NCT02100657|18853140|P1|STARTED|Cohort 1: Dose Level 1||8
7655401|NCT02100644|18853178|P3|NOT COMPLETED|LTG and VPA Maintenance Phase||0
7655402|NCT02100644|18853179|P2|NOT COMPLETED|LTG and VPA Maintenance Phase||0
7655403|NCT02100644|18853180|P1|NOT COMPLETED|LTG and VPA Maintenance Phase||0
7655404|NCT02100644|18853178|P3|COMPLETED|LTG and VPA Maintenance Phase||20
7655405|NCT02100644|18853179|P2|COMPLETED|LTG and VPA Maintenance Phase||0
7655406|NCT02100644|18853180|P1|COMPLETED|LTG and VPA Maintenance Phase||0
7655407|NCT02100644|18853178|P3|STARTED|LTG and VPA Maintenance Phase||20
7655408|NCT02100644|18853179|P2|STARTED|LTG and VPA Maintenance Phase||0
7655409|NCT02100644|18853180|P1|STARTED|LTG and VPA Maintenance Phase||0
7655410|NCT02100644|18853178|P3|NOT COMPLETED|VPA Reduction Phase||0
7655411|NCT02100644|18853179|P2|NOT COMPLETED|VPA Reduction Phase||0
7655412|NCT02100644|18853180|P1|NOT COMPLETED|VPA Reduction Phase||0
7655413|NCT02100644|18853178|P3|COMPLETED|VPA Reduction Phase||0
7655414|NCT02100644|18853179|P2|COMPLETED|VPA Reduction Phase||20
7655415|NCT02100644|18853180|P1|COMPLETED|VPA Reduction Phase||0
7655416|NCT02100644|18853178|P3|STARTED|VPA Reduction Phase||0
7655417|NCT02100644|18853179|P2|STARTED|VPA Reduction Phase||20
7655418|NCT02100644|18853180|P1|STARTED|VPA Reduction Phase||0
7655419|NCT02100644|18853178|P3|NOT COMPLETED|LTG Escalation Phase||0
7655420|NCT02100644|18853179|P2|NOT COMPLETED|LTG Escalation Phase||0
7655421|NCT02100644|18853180|P1|NOT COMPLETED|LTG Escalation Phase||13
7655422|NCT02100644|18853178|P3|COMPLETED|LTG Escalation Phase||0
7655423|NCT02100644|18853179|P2|COMPLETED|LTG Escalation Phase||0
7655424|NCT02100644|18853180|P1|COMPLETED|LTG Escalation Phase||20
7655425|NCT02100644|18853178|P3|STARTED|LTG Escalation Phase||0
7655426|NCT02100644|18853179|P2|STARTED|LTG Escalation Phase||0
7655427|NCT02100644|18853180|P1|STARTED|LTG Escalation Phase||33
7655428|NCT02100579|18853192|P2|NOT COMPLETED|Overall Study||0
7655429|NCT02100579|18853193|P1|NOT COMPLETED|Overall Study||0
7655430|NCT02100579|18853192|P2|COMPLETED|Overall Study||20
7655431|NCT02100579|18853193|P1|COMPLETED|Overall Study||20
7655432|NCT02100579|18853192|P2|STARTED|Overall Study||20
7655433|NCT02100579|18853193|P1|STARTED|Overall Study||20
7655434|NCT02100514|18853205|P5|NOT COMPLETED|Extension Period||0
7655435|NCT02100514|18853206|P4|NOT COMPLETED|Extension Period||0
7655436|NCT02100514|18853207|P3|NOT COMPLETED|Extension Period||2
7655437|NCT02100514|18853208|P2|NOT COMPLETED|Extension Period||0
7655438|NCT02100514|18853209|P1|NOT COMPLETED|Extension Period||0
7655439|NCT02100514|18853205|P5|COMPLETED|Extension Period||56
7655440|NCT02100514|18853206|P4|COMPLETED|Extension Period||33
7655441|NCT02100514|18853207|P3|COMPLETED|Extension Period||42
7655442|NCT02100514|18853208|P2|COMPLETED|Extension Period||0
7655443|NCT02100514|18853209|P1|COMPLETED|Extension Period||0
7655444|NCT02100514|18853205|P5|STARTED|Extension Period||56
7655445|NCT02100514|18853206|P4|STARTED|Extension Period||33
7655446|NCT02100514|18853207|P3|STARTED|Extension Period||44
7655447|NCT02100514|18853208|P2|STARTED|Extension Period||0
7655448|NCT02100514|18853209|P1|STARTED|Extension Period||0
7655449|NCT02100514|18853205|P5|NOT COMPLETED|Treatment Period||0
7655450|NCT02100514|18853206|P4|NOT COMPLETED|Treatment Period||0
7655451|NCT02100514|18853207|P3|NOT COMPLETED|Treatment Period||0
7655452|NCT02100514|18853208|P2|NOT COMPLETED|Treatment Period||74
7655453|NCT02100514|18853209|P1|NOT COMPLETED|Treatment Period||29
7655454|NCT02100514|18853205|P5|COMPLETED|Treatment Period||0
7655455|NCT02100514|18853206|P4|COMPLETED|Treatment Period||0
7655456|NCT02100514|18853207|P3|COMPLETED|Treatment Period||0
7655457|NCT02100514|18853208|P2|COMPLETED|Treatment Period||425
7655458|NCT02100514|18853209|P1|COMPLETED|Treatment Period||218
7655459|NCT02100514|18853205|P5|STARTED|Treatment Period||0
7655460|NCT02100514|18853206|P4|STARTED|Treatment Period||0
7655461|NCT02100514|18853207|P3|STARTED|Treatment Period||0
7655462|NCT02100514|18853208|P2|STARTED|Treatment Period||499
7655463|NCT02100514|18853209|P1|STARTED|Treatment Period||247
7655464|NCT02100475|18853277|P2|NOT COMPLETED|Overall Study||2
7655465|NCT02100475|18853278|P1|NOT COMPLETED|Overall Study||2
7655466|NCT02100475|18853277|P2|COMPLETED|Overall Study||13
7655467|NCT02100475|18853278|P1|COMPLETED|Overall Study||14
7655468|NCT02100475|18853277|P2|STARTED|Overall Study||15
7655469|NCT02100475|18853278|P1|STARTED|Overall Study||16
7655470|NCT02100410|18853288|P6|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
7655471|NCT02100410|18853289|P5|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
7655472|NCT02100410|18853290|P4|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
7655473|NCT02100410|18853291|P3|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
7655474|NCT02100410|18853292|P2|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
7655475|NCT02100410|18853293|P1|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
7655476|NCT02100410|18853288|P6|COMPLETED|Exposure Pair 3, 30 Minutes||9
7655477|NCT02100410|18853289|P5|COMPLETED|Exposure Pair 3, 30 Minutes||8
7655478|NCT02100410|18853290|P4|COMPLETED|Exposure Pair 3, 30 Minutes||8
7655479|NCT02100410|18853291|P3|COMPLETED|Exposure Pair 3, 30 Minutes||8
7655480|NCT02100410|18853292|P2|COMPLETED|Exposure Pair 3, 30 Minutes||8
7655481|NCT02100410|18853293|P1|COMPLETED|Exposure Pair 3, 30 Minutes||8
7655482|NCT02100410|18853288|P6|STARTED|Exposure Pair 3, 30 Minutes||9
7655483|NCT02100410|18853289|P5|STARTED|Exposure Pair 3, 30 Minutes||8
7655484|NCT02100410|18853290|P4|STARTED|Exposure Pair 3, 30 Minutes||8
7655485|NCT02100410|18853291|P3|STARTED|Exposure Pair 3, 30 Minutes||8
7655486|NCT02100410|18853292|P2|STARTED|Exposure Pair 3, 30 Minutes||8
7655487|NCT02100410|18853293|P1|STARTED|Exposure Pair 3, 30 Minutes||8
7655488|NCT02100410|18853288|P6|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
7655489|NCT02100410|18853289|P5|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
7655490|NCT02100410|18853290|P4|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
7655491|NCT02100410|18853291|P3|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
7655492|NCT02100410|18853292|P2|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
7655493|NCT02100410|18853293|P1|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
7655494|NCT02100410|18853288|P6|COMPLETED|Exposure Pair 2, 30 Minutes||9
7655495|NCT02100410|18853289|P5|COMPLETED|Exposure Pair 2, 30 Minutes||8
7655496|NCT02100410|18853290|P4|COMPLETED|Exposure Pair 2, 30 Minutes||8
7655497|NCT02100410|18853291|P3|COMPLETED|Exposure Pair 2, 30 Minutes||8
7655498|NCT02100410|18853292|P2|COMPLETED|Exposure Pair 2, 30 Minutes||8
7655499|NCT02100410|18853293|P1|COMPLETED|Exposure Pair 2, 30 Minutes||8
7655500|NCT02100410|18853288|P6|STARTED|Exposure Pair 2, 30 Minutes||9
7655501|NCT02100410|18853289|P5|STARTED|Exposure Pair 2, 30 Minutes||8
7655502|NCT02100410|18853290|P4|STARTED|Exposure Pair 2, 30 Minutes||8
7655503|NCT02100410|18853291|P3|STARTED|Exposure Pair 2, 30 Minutes||8
7655504|NCT02100410|18853292|P2|STARTED|Exposure Pair 2, 30 Minutes||8
7655505|NCT02100410|18853293|P1|STARTED|Exposure Pair 2, 30 Minutes||8
7655506|NCT02100410|18853288|P6|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
7655507|NCT02100410|18853289|P5|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
7655508|NCT02100410|18853290|P4|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
7655509|NCT02100410|18853291|P3|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
7655510|NCT02100410|18853292|P2|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
7655511|NCT02100410|18853293|P1|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
7655512|NCT02100410|18853288|P6|COMPLETED|Exposure Pair 1, 30 Minutes||9
7655513|NCT02100410|18853289|P5|COMPLETED|Exposure Pair 1, 30 Minutes||8
7655514|NCT02100410|18853290|P4|COMPLETED|Exposure Pair 1, 30 Minutes||8
7655515|NCT02100410|18853291|P3|COMPLETED|Exposure Pair 1, 30 Minutes||8
7655516|NCT02100410|18853292|P2|COMPLETED|Exposure Pair 1, 30 Minutes||8
7655517|NCT02100410|18853293|P1|COMPLETED|Exposure Pair 1, 30 Minutes||8
7655518|NCT02100410|18853288|P6|STARTED|Exposure Pair 1, 30 Minutes||9
7655519|NCT02100410|18853289|P5|STARTED|Exposure Pair 1, 30 Minutes||8
7655520|NCT02100410|18853290|P4|STARTED|Exposure Pair 1, 30 Minutes||8
7655521|NCT02100410|18853291|P3|STARTED|Exposure Pair 1, 30 Minutes||8
7655522|NCT02100410|18853292|P2|STARTED|Exposure Pair 1, 30 Minutes||8
7655523|NCT02100410|18853293|P1|STARTED|Exposure Pair 1, 30 Minutes||8
7655524|NCT02100319|18853309|P1|NOT COMPLETED|Overall Study||16
7655525|NCT02100319|18853309|P1|COMPLETED|Overall Study||371
7655526|NCT02100319|18853309|P1|STARTED|Overall Study||387
7655527|NCT02100280|18853320|P2|NOT COMPLETED|Overall Study||4
7655528|NCT02100280|18853321|P1|NOT COMPLETED|Overall Study||4
7655529|NCT02100280|18853320|P2|COMPLETED|Overall Study||44
7655530|NCT02100280|18853321|P1|COMPLETED|Overall Study||44
7655531|NCT02100280|18853320|P2|STARTED|Overall Study||48
7655532|NCT02100280|18853321|P1|STARTED|Overall Study||48
7655533|NCT02100228|18853337|P2|NOT COMPLETED|Overall Study||90
7655534|NCT02100228|18853338|P1|NOT COMPLETED|Overall Study||75
7655535|NCT02100228|18853337|P2|COMPLETED|Overall Study||657
7655536|NCT02100228|18853338|P1|COMPLETED|Overall Study||678
7655537|NCT02100228|18853337|P2|STARTED|Overall Study|721 treated with Usual Care|747
7655538|NCT02100228|18853338|P1|STARTED|Overall Study|735 treated with Apixaban|753
7655539|NCT02100189|18853364|P1|NOT COMPLETED|Overall Study||0
7655540|NCT02100189|18853364|P1|COMPLETED|Overall Study||50
7655541|NCT02100189|18853364|P1|STARTED|Overall Study||50
7655542|NCT02100124|18853374|P3|NOT COMPLETED|Overall Study||3
7655543|NCT02100124|18853375|P2|NOT COMPLETED|Overall Study||11
7655544|NCT02100124|18853376|P1|NOT COMPLETED|Overall Study||6
7655545|NCT02100124|18853374|P3|COMPLETED|Overall Study||323
7655546|NCT02100124|18853375|P2|COMPLETED|Overall Study||318
7655547|NCT02100124|18853376|P1|COMPLETED|Overall Study||323
7655548|NCT02100124|18853374|P3|STARTED|Overall Study||326
7655549|NCT02100124|18853375|P2|STARTED|Overall Study||329
7655550|NCT02100124|18853376|P1|STARTED|Overall Study||329
7655551|NCT02100072|18853393|P1|NOT COMPLETED|Overall Study||0
7655552|NCT02100072|18853393|P1|COMPLETED|Overall Study||5
7655553|NCT02100072|18853393|P1|STARTED|Overall Study||5
7655554|NCT02100007|18853397|P1|NOT COMPLETED|Overall Study||0
7655555|NCT02100007|18853397|P1|COMPLETED|Overall Study||46
7655556|NCT02100007|18853397|P1|STARTED|Overall Study||46
7655557|NCT02099838|18853410|P2|NOT COMPLETED|Overall Study||2
7655558|NCT02099838|18853411|P1|NOT COMPLETED|Overall Study||4
7655559|NCT02099838|18853410|P2|COMPLETED|Overall Study||49
7655560|NCT02099838|18853411|P1|COMPLETED|Overall Study||43
7655561|NCT02099838|18853410|P2|STARTED|Overall Study||51
7655562|NCT02099838|18853411|P1|STARTED|Overall Study||47
7655563|NCT02099786|18853443|P2|NOT COMPLETED|Overall Study||8
7655564|NCT02099786|18853444|P1|NOT COMPLETED|Overall Study||3
7655565|NCT02099786|18853443|P2|COMPLETED|Overall Study||15
7655566|NCT02099786|18853444|P1|COMPLETED|Overall Study||21
7655567|NCT02099786|18853443|P2|Program Eval 3|Overall Study|One year post randomization|15
7655568|NCT02099786|18853444|P1|Program Eval 3|Overall Study|One year post randomization|21
7655569|NCT02099786|18853443|P2|Program Eval 2|Overall Study|One month post randomization|19
7655570|NCT02099786|18853444|P1|Program Eval 2|Overall Study|One month post randomization|23
7655571|NCT02099786|18853443|P2|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|23
7655572|NCT02099786|18853444|P1|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|24
7655573|NCT02099786|18853443|P2|STARTED|Overall Study||23
7655574|NCT02099786|18853444|P1|STARTED|Overall Study||24
7655575|NCT02099721|18853462|P6|NOT COMPLETED|Overall Study||20
7655576|NCT02099721|18853463|P5|NOT COMPLETED|Overall Study||27
7655577|NCT02099721|18853464|P4|NOT COMPLETED|Overall Study||71
7655578|NCT02099721|18853465|P3|NOT COMPLETED|Overall Study||85
7655579|NCT02099721|18853466|P2|NOT COMPLETED|Overall Study||127
7655580|NCT02099721|18853467|P1|NOT COMPLETED|Overall Study||76
7655581|NCT02099721|18853462|P6|COMPLETED|Overall Study||432
7655582|NCT02099721|18853463|P5|COMPLETED|Overall Study||304
7655583|NCT02099721|18853464|P4|COMPLETED|Overall Study||774
7655584|NCT02099721|18853465|P3|COMPLETED|Overall Study||983
7655585|NCT02099721|18853466|P2|COMPLETED|Overall Study|Not implanted secondary patients were automatically exited.|0
7655586|NCT02099721|18853467|P1|COMPLETED|Overall Study||990
7655587|NCT02099721|18853462|P6|STARTED|Overall Study||452
7655588|NCT02099721|18853463|P5|STARTED|Overall Study||331
7655589|NCT02099721|18853464|P4|STARTED|Overall Study||845
7655590|NCT02099721|18853465|P3|STARTED|Overall Study||1068
7655591|NCT02099721|18853466|P2|STARTED|Overall Study||127
7655592|NCT02099721|18853467|P1|STARTED|Overall Study||1066
7655593|NCT02099708|18853479|P1|NOT COMPLETED|Overall Study||200
7655594|NCT02099708|18853479|P1|COMPLETED|Overall Study||3302
7655595|NCT02099708|18853479|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302
7655596|NCT02099708|18853479|P1|STARTED|Overall Study|Number of cases.|3502
7655597|NCT02099682|18853490|P1|NOT COMPLETED|Overall Study||111
7655598|NCT02099682|18853490|P1|COMPLETED|Overall Study||3255
7655599|NCT02099682|18853490|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255
7655600|NCT02099682|18853490|P1|STARTED|Overall Study|Number of cases.|3366
7655601|NCT02099461|18853504|P3|NOT COMPLETED|Overall Study||0
7655602|NCT02099461|18853505|P2|NOT COMPLETED|Overall Study||0
7655603|NCT02099461|18853506|P1|NOT COMPLETED|Overall Study||0
7655604|NCT02099461|18853504|P3|COMPLETED|Overall Study||28
7655605|NCT02099461|18853505|P2|COMPLETED|Overall Study||27
7655606|NCT02099461|18853506|P1|COMPLETED|Overall Study||27
7655607|NCT02099461|18853504|P3|STARTED|Overall Study||28
7655608|NCT02099461|18853505|P2|STARTED|Overall Study||27
7655609|NCT02099461|18853506|P1|STARTED|Overall Study||27
7655610|NCT02099344|18853516|P2|NOT COMPLETED|Overall Study||0
7655611|NCT02099344|18853517|P1|NOT COMPLETED|Overall Study||1
7655612|NCT02099344|18853516|P2|COMPLETED|Overall Study||0
7655613|NCT02099344|18853517|P1|COMPLETED|Overall Study||0
7655614|NCT02099344|18853516|P2|STARTED|Overall Study||0
7655615|NCT02099344|18853517|P1|STARTED|Overall Study||1
7655616|NCT02099318|18853527|P2|NOT COMPLETED|Overall Study||0
7655617|NCT02099318|18853528|P1|NOT COMPLETED|Overall Study||0
7655618|NCT02099318|18853527|P2|COMPLETED|Overall Study||20
7655619|NCT02099318|18853528|P1|COMPLETED|Overall Study||20
7655620|NCT02099318|18853527|P2|STARTED|Overall Study||20
7655621|NCT02099318|18853528|P1|STARTED|Overall Study||20
7655622|NCT02099266|18853542|P1|NOT COMPLETED|Overall Study||0
7655623|NCT02099266|18853542|P1|COMPLETED|Overall Study||15
7655624|NCT02099266|18853542|P1|STARTED|Overall Study||15
7655625|NCT02099110|18853554|P5|NOT COMPLETED|Overall Study||27
7655626|NCT02099110|18853555|P4|NOT COMPLETED|Overall Study||22
7655627|NCT02099110|18853556|P3|NOT COMPLETED|Overall Study||28
7655628|NCT02099110|18853557|P2|NOT COMPLETED|Overall Study||31
7655629|NCT02099110|18853558|P1|NOT COMPLETED|Overall Study||24
7655630|NCT02099110|18853554|P5|COMPLETED|Overall Study||218
7655631|NCT02099110|18853555|P4|COMPLETED|Overall Study||221
7655632|NCT02099110|18853556|P3|COMPLETED|Overall Study||219
7655633|NCT02099110|18853557|P2|COMPLETED|Overall Study||217
7655634|NCT02099110|18853558|P1|COMPLETED|Overall Study||226
7655635|NCT02099110|18853554|P5|Treated|Overall Study||244
7655636|NCT02099110|18853555|P4|Treated|Overall Study||243
7655637|NCT02099110|18853556|P3|Treated|Overall Study||247
7655638|NCT02099110|18853557|P2|Treated|Overall Study||248
7655639|NCT02099110|18853558|P1|Treated|Overall Study||250
7655640|NCT02099110|18853554|P5|STARTED|Overall Study||245
7655641|NCT02099110|18853555|P4|STARTED|Overall Study||243
7655642|NCT02099110|18853556|P3|STARTED|Overall Study||247
7655643|NCT02099110|18853557|P2|STARTED|Overall Study||248
7655644|NCT02099110|18853558|P1|STARTED|Overall Study||250
7655645|NCT02099084|18853605|P2|NOT COMPLETED|Second Intervention||0
7655646|NCT02099084|18853606|P1|NOT COMPLETED|Second Intervention||0
7655647|NCT02099084|18853605|P2|COMPLETED|Second Intervention||4
7655648|NCT02099084|18853606|P1|COMPLETED|Second Intervention||4
7655649|NCT02099084|18853605|P2|STARTED|Second Intervention||4
7655650|NCT02099084|18853606|P1|STARTED|Second Intervention||4
7655651|NCT02099084|18853605|P2|NOT COMPLETED|Washout Period of 14 Days||0
7655652|NCT02099084|18853606|P1|NOT COMPLETED|Washout Period of 14 Days||0
7655653|NCT02099084|18853605|P2|COMPLETED|Washout Period of 14 Days||4
7655654|NCT02099084|18853606|P1|COMPLETED|Washout Period of 14 Days||4
7655655|NCT02099084|18853605|P2|STARTED|Washout Period of 14 Days||4
7655656|NCT02099084|18853606|P1|STARTED|Washout Period of 14 Days||4
7655657|NCT02099084|18853605|P2|NOT COMPLETED|First Intervention||0
7655658|NCT02099084|18853606|P1|NOT COMPLETED|First Intervention||0
7655659|NCT02099084|18853605|P2|COMPLETED|First Intervention||4
7655660|NCT02099084|18853606|P1|COMPLETED|First Intervention||4
7655661|NCT02099084|18853605|P2|STARTED|First Intervention||4
7655662|NCT02099084|18853606|P1|STARTED|First Intervention||4
7655663|NCT02099006|18853624|P1|NOT COMPLETED|Overall Study||1
7655664|NCT02099006|18853624|P1|COMPLETED|Overall Study||8
7655665|NCT02099006|18853624|P1|Received Gabapentin|Overall Study||8
7655666|NCT02099006|18853624|P1|Received Ketamine|Overall Study||6
7655667|NCT02099006|18853624|P1|Received Loperamide|Overall Study||7
7655668|NCT02099006|18853624|P1|Received Ketoprofen|Overall Study||3
7655669|NCT02099006|18853624|P1|Received Amitriptyline/ Baclofen|Overall Study||7
7655670|NCT02099006|18853624|P1|Received Placebo|Overall Study||9
7655671|NCT02099006|18853624|P1|STARTED|Overall Study||9
7655672|NCT02098993|18853634|P2|NOT COMPLETED|Overall Study||0
7655673|NCT02098993|18853635|P1|NOT COMPLETED|Overall Study||0
7655674|NCT02098993|18853634|P2|COMPLETED|Overall Study||3
7655675|NCT02098993|18853635|P1|COMPLETED|Overall Study||4
7655676|NCT02098993|18853634|P2|STARTED|Overall Study||3
7655677|NCT02098993|18853635|P1|STARTED|Overall Study||4
7655678|NCT02098746|18853659|P1|NOT COMPLETED|Overall Study||5
7655679|NCT02098746|18853659|P1|COMPLETED|Overall Study||289
7655680|NCT02098746|18853659|P1|STARTED|Overall Study||294
7655681|NCT02098733|18853667|P1|NOT COMPLETED|Overall Study||10
7655682|NCT02098733|18853667|P1|COMPLETED|Overall Study||1158
7655683|NCT02098733|18853667|P1|STARTED|Overall Study||1168
7655684|NCT02098395|18853681|P4|NOT COMPLETED|Overall Study||27
7655685|NCT02098395|18853682|P3|NOT COMPLETED|Overall Study||42
7655686|NCT02098395|18853683|P2|NOT COMPLETED|Overall Study||32
7655687|NCT02098395|18853684|P1|NOT COMPLETED|Overall Study||26
7655688|NCT02098395|18853681|P4|COMPLETED|Overall Study||180
7655689|NCT02098395|18853682|P3|COMPLETED|Overall Study||165
7655690|NCT02098395|18853683|P2|COMPLETED|Overall Study||177
7655691|NCT02098395|18853684|P1|COMPLETED|Overall Study||186
7655692|NCT02098395|18853681|P4|Exposed|Overall Study||206
7655693|NCT02098395|18853682|P3|Exposed|Overall Study||206
7655694|NCT02098395|18853683|P2|Exposed|Overall Study||209
7655695|NCT02098395|18853684|P1|Exposed|Overall Study||211
7655696|NCT02098395|18853681|P4|STARTED|Overall Study||207
7655697|NCT02098395|18853682|P3|STARTED|Overall Study||207
7655698|NCT02098395|18853683|P2|STARTED|Overall Study||209
7655699|NCT02098395|18853684|P1|STARTED|Overall Study||212
7655700|NCT02098369|18853705|P3|NOT COMPLETED|Overall Study||5
7655701|NCT02098369|18853706|P2|NOT COMPLETED|Overall Study||9
7655702|NCT02098369|18853707|P1|NOT COMPLETED|Overall Study||7
7655703|NCT02098369|18853705|P3|COMPLETED|Overall Study||143
7655704|NCT02098369|18853706|P2|COMPLETED|Overall Study||145
7655705|NCT02098369|18853707|P1|COMPLETED|Overall Study||135
7655706|NCT02098369|18853705|P3|STARTED|Overall Study||148
7655707|NCT02098369|18853706|P2|STARTED|Overall Study||154
7655708|NCT02098369|18853707|P1|STARTED|Overall Study||142
7655709|NCT02098304|18853736|P1|NOT COMPLETED|Overall Study||0
7655710|NCT02098304|18853736|P1|COMPLETED|Overall Study||42
7655711|NCT02098304|18853736|P1|STARTED|Overall Study||42
7655712|NCT02098109|18853745|P2|NOT COMPLETED|Overall Study||0
7655713|NCT02098109|18853746|P1|NOT COMPLETED|Overall Study||3
7655714|NCT02098109|18853745|P2|COMPLETED|Overall Study||51
7655715|NCT02098109|18853746|P1|COMPLETED|Overall Study||46
7655716|NCT02098109|18853745|P2|STARTED|Overall Study||51
7655717|NCT02098109|18853746|P1|STARTED|Overall Study||49
7655718|NCT02097992|18853772|P4|NOT COMPLETED|Treatment 3 (4 Weeks)||0
7655719|NCT02097992|18853773|P3|NOT COMPLETED|Treatment 3 (4 Weeks)||0
7655720|NCT02097992|18853774|P2|NOT COMPLETED|Treatment 3 (4 Weeks)||0
7655721|NCT02097992|18853775|P1|NOT COMPLETED|Treatment 3 (4 Weeks)||0
7655722|NCT02097992|18853772|P4|COMPLETED|Treatment 3 (4 Weeks)||2
7655723|NCT02097992|18853773|P3|COMPLETED|Treatment 3 (4 Weeks)||4
7655724|NCT02097992|18853774|P2|COMPLETED|Treatment 3 (4 Weeks)||3
7655725|NCT02097992|18853775|P1|COMPLETED|Treatment 3 (4 Weeks)||2
7655726|NCT02097992|18853772|P4|STARTED|Treatment 3 (4 Weeks)||2
7655727|NCT02097992|18853773|P3|STARTED|Treatment 3 (4 Weeks)||4
7655728|NCT02097992|18853774|P2|STARTED|Treatment 3 (4 Weeks)||3
7655729|NCT02097992|18853775|P1|STARTED|Treatment 3 (4 Weeks)||2
7655730|NCT02097992|18853772|P4|NOT COMPLETED|Washout (4 Weeks)||0
7655731|NCT02097992|18853773|P3|NOT COMPLETED|Washout (4 Weeks)||0
7655732|NCT02097992|18853774|P2|NOT COMPLETED|Washout (4 Weeks)||0
7655733|NCT02097992|18853775|P1|NOT COMPLETED|Washout (4 Weeks)||0
7655734|NCT02097992|18853772|P4|COMPLETED|Washout (4 Weeks)||2
7655735|NCT02097992|18853773|P3|COMPLETED|Washout (4 Weeks)||4
7655736|NCT02097992|18853774|P2|COMPLETED|Washout (4 Weeks)||3
7655737|NCT02097992|18853775|P1|COMPLETED|Washout (4 Weeks)||2
7655738|NCT02097992|18853772|P4|STARTED|Washout (4 Weeks)||2
7655739|NCT02097992|18853773|P3|STARTED|Washout (4 Weeks)||4
7655740|NCT02097992|18853774|P2|STARTED|Washout (4 Weeks)||3
7655741|NCT02097992|18853775|P1|STARTED|Washout (4 Weeks)||2
7655742|NCT02097992|18853772|P4|NOT COMPLETED|Treatment 2 (4 Weeks)||0
7655743|NCT02097992|18853773|P3|NOT COMPLETED|Treatment 2 (4 Weeks)||0
7655744|NCT02097992|18853774|P2|NOT COMPLETED|Treatment 2 (4 Weeks)||0
7655745|NCT02097992|18853775|P1|NOT COMPLETED|Treatment 2 (4 Weeks)||0
7655746|NCT02097992|18853772|P4|COMPLETED|Treatment 2 (4 Weeks)||2
7655747|NCT02097992|18853773|P3|COMPLETED|Treatment 2 (4 Weeks)||4
7655748|NCT02097992|18853774|P2|COMPLETED|Treatment 2 (4 Weeks)||3
7655749|NCT02097992|18853775|P1|COMPLETED|Treatment 2 (4 Weeks)||2
7655750|NCT02097992|18853772|P4|STARTED|Treatment 2 (4 Weeks)||2
7655751|NCT02097992|18853773|P3|STARTED|Treatment 2 (4 Weeks)||4
7655752|NCT02097992|18853774|P2|STARTED|Treatment 2 (4 Weeks)||3
7655753|NCT02097992|18853775|P1|STARTED|Treatment 2 (4 Weeks)||2
7655754|NCT02097992|18853772|P4|NOT COMPLETED|Treatment 1 (1 Day)||0
7655755|NCT02097992|18853773|P3|NOT COMPLETED|Treatment 1 (1 Day)||0
7655756|NCT02097992|18853774|P2|NOT COMPLETED|Treatment 1 (1 Day)||0
7655757|NCT02097992|18853775|P1|NOT COMPLETED|Treatment 1 (1 Day)||0
7655758|NCT02097992|18853772|P4|COMPLETED|Treatment 1 (1 Day)||2
7655759|NCT02097992|18853773|P3|COMPLETED|Treatment 1 (1 Day)||4
7655760|NCT02097992|18853774|P2|COMPLETED|Treatment 1 (1 Day)||3
7655761|NCT02097992|18853775|P1|COMPLETED|Treatment 1 (1 Day)||2
7655762|NCT02097992|18853772|P4|STARTED|Treatment 1 (1 Day)||2
7655763|NCT02097992|18853773|P3|STARTED|Treatment 1 (1 Day)||4
7655764|NCT02097992|18853774|P2|STARTED|Treatment 1 (1 Day)||3
7655765|NCT02097992|18853775|P1|STARTED|Treatment 1 (1 Day)||2
7655766|NCT02097849|18853785|P2|NOT COMPLETED|Overall Study||0
7655767|NCT02097849|18853786|P1|NOT COMPLETED|Overall Study||0
7655768|NCT02097849|18853785|P2|COMPLETED|Overall Study||38
7655769|NCT02097849|18853786|P1|COMPLETED|Overall Study||33
7655770|NCT02097849|18853785|P2|STARTED|Overall Study||38
7655771|NCT02097849|18853786|P1|STARTED|Overall Study||33
7655772|NCT02097823|18853824|P2|NOT COMPLETED|Overall Study||1
7655773|NCT02097823|18853825|P1|NOT COMPLETED|Overall Study||1
7655774|NCT02097823|18853824|P2|COMPLETED|Overall Study||3
7655775|NCT02097823|18853825|P1|COMPLETED|Overall Study||10
7655776|NCT02097823|18853824|P2|STARTED|Overall Study||4
7655777|NCT02097823|18853825|P1|STARTED|Overall Study||11
7655778|NCT02097745|18853840|P1|NOT COMPLETED|Overall Study||178
7655779|NCT02097745|18853840|P1|COMPLETED|Overall Study||157
7655780|NCT02097745|18853840|P1|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335
7655781|NCT02097732|18853864|P2|NOT COMPLETED|Overall Study||0
7655782|NCT02097732|18853865|P1|NOT COMPLETED|Overall Study||0
7655783|NCT02097732|18853864|P2|COMPLETED|Overall Study||3
7655784|NCT02097732|18853865|P1|COMPLETED|Overall Study||1
7655785|NCT02097732|18853864|P2|STARTED|Overall Study||3
7655786|NCT02097732|18853865|P1|STARTED|Overall Study||1
7655787|NCT02097719|18853878|P2|NOT COMPLETED|Overall Study||1
7655788|NCT02097719|18853879|P1|NOT COMPLETED|Overall Study||3
7655789|NCT02097719|18853878|P2|COMPLETED|Overall Study||50
7655790|NCT02097719|18853879|P1|COMPLETED|Overall Study||46
7655791|NCT02097719|18853878|P2|STARTED|Overall Study||51
7655792|NCT02097719|18853879|P1|STARTED|Overall Study||49
7655793|NCT02097641|18853887|P2|NOT COMPLETED|Overall Study||0
7655794|NCT02097641|18853888|P1|NOT COMPLETED|Overall Study||0
7655795|NCT02097641|18853887|P2|COMPLETED|Overall Study||20
7655796|NCT02097641|18853888|P1|COMPLETED|Overall Study||40
7655797|NCT02097641|18853887|P2|STARTED|Overall Study||20
7655798|NCT02097641|18853888|P1|STARTED|Overall Study||40
7655799|NCT02097537|18853930|P1|NOT COMPLETED|Overall Study||0
7655800|NCT02097537|18853930|P1|COMPLETED|Overall Study||10
7655801|NCT02097537|18853930|P1|Follow-Up|Overall Study||10
7655802|NCT02097537|18853930|P1|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10
7655803|NCT02097537|18853930|P1|STARTED|Overall Study||10
7655804|NCT02097472|18853944|P8|NOT COMPLETED|Assessed for Immunogenicity||1
7655805|NCT02097472|18853945|P7|NOT COMPLETED|Assessed for Immunogenicity||2
7655806|NCT02097472|18853946|P6|NOT COMPLETED|Assessed for Immunogenicity||2
7655807|NCT02097472|18853947|P5|NOT COMPLETED|Assessed for Immunogenicity||0
7655808|NCT02097472|18853948|P4|NOT COMPLETED|Assessed for Immunogenicity||2
7655809|NCT02097472|18853949|P3|NOT COMPLETED|Assessed for Immunogenicity||1
7655810|NCT02097472|18853950|P2|NOT COMPLETED|Assessed for Immunogenicity||0
7655811|NCT02097472|18853951|P1|NOT COMPLETED|Assessed for Immunogenicity||0
7655812|NCT02097472|18853944|P8|COMPLETED|Assessed for Immunogenicity||49
7655813|NCT02097472|18853945|P7|COMPLETED|Assessed for Immunogenicity||47
7655814|NCT02097472|18853946|P6|COMPLETED|Assessed for Immunogenicity||48
7655815|NCT02097472|18853947|P5|COMPLETED|Assessed for Immunogenicity||50
7655816|NCT02097472|18853948|P4|COMPLETED|Assessed for Immunogenicity||48
7655817|NCT02097472|18853949|P3|COMPLETED|Assessed for Immunogenicity||17
7655818|NCT02097472|18853950|P2|COMPLETED|Assessed for Immunogenicity||18
7655819|NCT02097472|18853951|P1|COMPLETED|Assessed for Immunogenicity||18
7655820|NCT02097472|18853944|P8|STARTED|Assessed for Immunogenicity||50
7655821|NCT02097472|18853945|P7|STARTED|Assessed for Immunogenicity||49
7655822|NCT02097472|18853946|P6|STARTED|Assessed for Immunogenicity||50
7655823|NCT02097472|18853947|P5|STARTED|Assessed for Immunogenicity||50
7655824|NCT02097472|18853948|P4|STARTED|Assessed for Immunogenicity||50
7655825|NCT02097472|18853949|P3|STARTED|Assessed for Immunogenicity||18
7655826|NCT02097472|18853950|P2|STARTED|Assessed for Immunogenicity||18
7655827|NCT02097472|18853951|P1|STARTED|Assessed for Immunogenicity||18
7655828|NCT02097472|18853944|P8|NOT COMPLETED|Received Vaccination 2||0
7655829|NCT02097472|18853945|P7|NOT COMPLETED|Received Vaccination 2||1
7655830|NCT02097472|18853946|P6|NOT COMPLETED|Received Vaccination 2||0
7655831|NCT02097472|18853947|P5|NOT COMPLETED|Received Vaccination 2||0
7655832|NCT02097472|18853948|P4|NOT COMPLETED|Received Vaccination 2||0
7655833|NCT02097472|18853949|P3|NOT COMPLETED|Received Vaccination 2||0
7655834|NCT02097472|18853950|P2|NOT COMPLETED|Received Vaccination 2||0
7655835|NCT02097472|18853951|P1|NOT COMPLETED|Received Vaccination 2||0
7655836|NCT02097472|18853944|P8|COMPLETED|Received Vaccination 2||50
7655837|NCT02097472|18853945|P7|COMPLETED|Received Vaccination 2||49
7655838|NCT02097472|18853946|P6|COMPLETED|Received Vaccination 2||50
7655839|NCT02097472|18853947|P5|COMPLETED|Received Vaccination 2||50
7655840|NCT02097472|18853948|P4|COMPLETED|Received Vaccination 2||50
7655841|NCT02097472|18853949|P3|COMPLETED|Received Vaccination 2||18
7655842|NCT02097472|18853950|P2|COMPLETED|Received Vaccination 2||18
7655843|NCT02097472|18853951|P1|COMPLETED|Received Vaccination 2||18
7655844|NCT02097472|18853944|P8|STARTED|Received Vaccination 2||50
7655845|NCT02097472|18853945|P7|STARTED|Received Vaccination 2||50
7655846|NCT02097472|18853946|P6|STARTED|Received Vaccination 2||50
7655847|NCT02097472|18853947|P5|STARTED|Received Vaccination 2||50
7655848|NCT02097472|18853948|P4|STARTED|Received Vaccination 2||50
7655849|NCT02097472|18853949|P3|STARTED|Received Vaccination 2||18
7655850|NCT02097472|18853950|P2|STARTED|Received Vaccination 2||18
7655851|NCT02097472|18853951|P1|STARTED|Received Vaccination 2||18
7655852|NCT02097472|18853944|P8|NOT COMPLETED|Received Vaccination 1||0
7655853|NCT02097472|18853945|P7|NOT COMPLETED|Received Vaccination 1||0
7655854|NCT02097472|18853946|P6|NOT COMPLETED|Received Vaccination 1||0
7655855|NCT02097472|18853947|P5|NOT COMPLETED|Received Vaccination 1||0
7655856|NCT02097472|18853948|P4|NOT COMPLETED|Received Vaccination 1||0
7655857|NCT02097472|18853949|P3|NOT COMPLETED|Received Vaccination 1||0
7655858|NCT02097472|18853950|P2|NOT COMPLETED|Received Vaccination 1||0
7655859|NCT02097472|18853951|P1|NOT COMPLETED|Received Vaccination 1||0
7655860|NCT02097472|18853944|P8|COMPLETED|Received Vaccination 1||50
7655861|NCT02097472|18853945|P7|COMPLETED|Received Vaccination 1||50
7655862|NCT02097472|18853946|P6|COMPLETED|Received Vaccination 1||50
7655863|NCT02097472|18853947|P5|COMPLETED|Received Vaccination 1||50
7655864|NCT02097472|18853948|P4|COMPLETED|Received Vaccination 1||50
7655865|NCT02097472|18853949|P3|COMPLETED|Received Vaccination 1||18
7655866|NCT02097472|18853950|P2|COMPLETED|Received Vaccination 1||18
7655867|NCT02097472|18853951|P1|COMPLETED|Received Vaccination 1||18
7655868|NCT02097472|18853944|P8|STARTED|Received Vaccination 1||50
7655869|NCT02097472|18853945|P7|STARTED|Received Vaccination 1||50
7655870|NCT02097472|18853946|P6|STARTED|Received Vaccination 1||50
7655871|NCT02097472|18853947|P5|STARTED|Received Vaccination 1||50
7655872|NCT02097472|18853948|P4|STARTED|Received Vaccination 1||50
7655873|NCT02097472|18853949|P3|STARTED|Received Vaccination 1||18
7655874|NCT02097472|18853950|P2|STARTED|Received Vaccination 1||18
7655875|NCT02097472|18853951|P1|STARTED|Received Vaccination 1||18
7655876|NCT02097420|18854372|P1|NOT COMPLETED|Overall Study||14
7655877|NCT02097420|18854372|P1|COMPLETED|Overall Study||6
7655878|NCT02097420|18854372|P1|STARTED|Overall Study||20
7655879|NCT02097303|18854385|P1|NOT COMPLETED|Overall Study||5
7655880|NCT02097303|18854385|P1|COMPLETED|Overall Study||31
7655881|NCT02097303|18854385|P1|STARTED|Overall Study||36
7655882|NCT02097290|18854395|P1|NOT COMPLETED|Overall Study||17
7655883|NCT02097290|18854395|P1|COMPLETED|Overall Study|Active subjects at the end of 3 month follow up visit for primary end point data collection|193
7655884|NCT02097290|18854395|P1|STARTED|Overall Study||210
7655885|NCT02097277|18854410|P5|NOT COMPLETED|Overall Study||1
7655886|NCT02097277|18854411|P4|NOT COMPLETED|Overall Study||4
7655887|NCT02097277|18854412|P3|NOT COMPLETED|Overall Study||2
7655888|NCT02097277|18854413|P2|NOT COMPLETED|Overall Study||3
7655889|NCT02097277|18854414|P1|NOT COMPLETED|Overall Study||2
7655890|NCT02097277|18854410|P5|COMPLETED|Overall Study||23
7655891|NCT02097277|18854411|P4|COMPLETED|Overall Study||20
7655892|NCT02097277|18854412|P3|COMPLETED|Overall Study||22
7655893|NCT02097277|18854413|P2|COMPLETED|Overall Study||21
7655894|NCT02097277|18854414|P1|COMPLETED|Overall Study||22
7655895|NCT02097277|18854410|P5|STARTED|Overall Study||24
7655896|NCT02097277|18854411|P4|STARTED|Overall Study||24
7655897|NCT02097277|18854412|P3|STARTED|Overall Study||24
7655898|NCT02097277|18854413|P2|STARTED|Overall Study||24
7655899|NCT02097277|18854414|P1|STARTED|Overall Study||24
7655900|NCT02097238|18854497|P1|NOT COMPLETED|Overall Study||19
7655901|NCT02097238|18854497|P1|COMPLETED|Overall Study||0
7655902|NCT02097238|18854497|P1|STARTED|Overall Study||19
7655903|NCT02097134|18854506|P1|NOT COMPLETED|Overall Study||9
7655904|NCT02097134|18854506|P1|COMPLETED|Overall Study||5
7655905|NCT02097134|18854506|P1|STARTED|Overall Study||14
7655906|NCT02097108|18854514|P1|NOT COMPLETED|Overall Study||2
7655907|NCT02097108|18854514|P1|COMPLETED|Overall Study||9
7655908|NCT02097108|18854514|P1|STARTED|Overall Study||11
7655909|NCT02097056|18854521|P1|NOT COMPLETED|Overall Study||58
7655910|NCT02097056|18854521|P1|COMPLETED|Overall Study||113
7655911|NCT02097056|18854521|P1|ParticipantsTreated|Overall Study||170
7655912|NCT02097056|18854521|P1|STARTED|Overall Study||171
7655913|NCT02097030|18854529|P2|NOT COMPLETED|Second Intervention (3 Days)||0
7655914|NCT02097030|18854530|P1|NOT COMPLETED|Second Intervention (3 Days)||0
7655915|NCT02097030|18854529|P2|COMPLETED|Second Intervention (3 Days)||16
7655916|NCT02097030|18854530|P1|COMPLETED|Second Intervention (3 Days)||14
7655917|NCT02097030|18854529|P2|STARTED|Second Intervention (3 Days)||16
7655918|NCT02097030|18854530|P1|STARTED|Second Intervention (3 Days)||14
7655919|NCT02097030|18854529|P2|NOT COMPLETED|First Intervention (3 Days)||1
7655920|NCT02097030|18854530|P1|NOT COMPLETED|First Intervention (3 Days)||1
7655921|NCT02097030|18854529|P2|COMPLETED|First Intervention (3 Days)||16
7655922|NCT02097030|18854530|P1|COMPLETED|First Intervention (3 Days)||14
7655923|NCT02097030|18854529|P2|STARTED|First Intervention (3 Days)||17
7655924|NCT02097030|18854530|P1|STARTED|First Intervention (3 Days)||15
7655925|NCT02096952|18854591|P1|NOT COMPLETED|Overall Study||1
7655926|NCT02096952|18854591|P1|COMPLETED|Overall Study||14
7655927|NCT02096952|18854591|P1|STARTED|Overall Study||15
7655928|NCT02096900|18854597|P2|NOT COMPLETED|Overall Study||2
7655929|NCT02096900|18854598|P1|NOT COMPLETED|Overall Study||4
7655930|NCT02096900|18854597|P2|COMPLETED|Overall Study||42
7655931|NCT02096900|18854598|P1|COMPLETED|Overall Study||38
7655932|NCT02096900|18854597|P2|STARTED|Overall Study|Allocated to Zolpidem|44
7655933|NCT02096900|18854598|P1|STARTED|Overall Study|Allocated to Midazolam|42
7655934|NCT02096861|18854616|P4|NOT COMPLETED|Overall Study||10
7655935|NCT02096861|18854617|P3|NOT COMPLETED|Overall Study||17
7655936|NCT02096861|18854618|P2|NOT COMPLETED|Overall Study||15
7655937|NCT02096861|18854619|P1|NOT COMPLETED|Overall Study||12
7655938|NCT02096861|18854616|P4|COMPLETED|Overall Study||45
7655939|NCT02096861|18854617|P3|COMPLETED|Overall Study||37
7655940|NCT02096861|18854618|P2|COMPLETED|Overall Study||40
7655941|NCT02096861|18854619|P1|COMPLETED|Overall Study||44
7655942|NCT02096861|18854616|P4|Drug Switching at Week 30|Overall Study||47
7655943|NCT02096861|18854617|P3|Drug Switching at Week 30|Overall Study||41
7655944|NCT02096861|18854618|P2|Drug Switching at Week 30|Overall Study||44
7655945|NCT02096861|18854619|P1|Drug Switching at Week 30|Overall Study||48
7655946|NCT02096861|18854616|P4|STARTED|Overall Study|Remicade followed by CT-P13 from Week 30|55
7655947|NCT02096861|18854617|P3|STARTED|Overall Study|Remicade followed by Remicade from Week 30|54
7655948|NCT02096861|18854618|P2|STARTED|Overall Study|CT-P13 followed by Remicade from Week 30|55
7655949|NCT02096861|18854619|P1|STARTED|Overall Study|CT-P13 followed by CT-P13 from Week 30|56
7655950|NCT02096835|18854650|P3|NOT COMPLETED|Overall Study||1
7655951|NCT02096835|18854651|P2|NOT COMPLETED|Overall Study||0
7655952|NCT02096835|18854652|P1|NOT COMPLETED|Overall Study||3
7655953|NCT02096835|18854650|P3|COMPLETED|Overall Study||50
7655954|NCT02096835|18854651|P2|COMPLETED|Overall Study||53
7655955|NCT02096835|18854652|P1|COMPLETED|Overall Study||50
7655956|NCT02096835|18854650|P3|STARTED|Overall Study||51
7655957|NCT02096835|18854651|P2|STARTED|Overall Study||53
7655958|NCT02096835|18854652|P1|STARTED|Overall Study||53
7655959|NCT02096744|18854669|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||1
7655960|NCT02096744|18854670|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
7655961|NCT02096744|18854669|P2|COMPLETED|Treatment Period 3 (7 Days)||27
7655962|NCT02096744|18854670|P1|COMPLETED|Treatment Period 3 (7 Days)||28
7655963|NCT02096744|18854669|P2|STARTED|Treatment Period 3 (7 Days)||28
7655964|NCT02096744|18854670|P1|STARTED|Treatment Period 3 (7 Days)||28
7655965|NCT02096744|18854669|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
7655966|NCT02096744|18854670|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
7655967|NCT02096744|18854669|P2|COMPLETED|Washout Period 2 (3 Days)||28
7655968|NCT02096744|18854670|P1|COMPLETED|Washout Period 2 (3 Days)||28
7655969|NCT02096744|18854669|P2|STARTED|Washout Period 2 (3 Days)||28
7655970|NCT02096744|18854670|P1|STARTED|Washout Period 2 (3 Days)||28
7655971|NCT02096744|18854669|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
7655972|NCT02096744|18854670|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
7655973|NCT02096744|18854669|P2|COMPLETED|Treatment Period 2 (7 Days)||28
7655974|NCT02096744|18854670|P1|COMPLETED|Treatment Period 2 (7 Days)||28
7655975|NCT02096744|18854669|P2|STARTED|Treatment Period 2 (7 Days)||28
7655976|NCT02096744|18854670|P1|STARTED|Treatment Period 2 (7 Days)||28
7655977|NCT02096744|18854669|P2|NOT COMPLETED|Washout Period 1(7 Days)||0
7655978|NCT02096744|18854670|P1|NOT COMPLETED|Washout Period 1(7 Days)||0
7655979|NCT02096744|18854669|P2|COMPLETED|Washout Period 1(7 Days)||28
7655980|NCT02096744|18854670|P1|COMPLETED|Washout Period 1(7 Days)||28
7655981|NCT02096744|18854669|P2|STARTED|Washout Period 1(7 Days)||28
7655982|NCT02096744|18854670|P1|STARTED|Washout Period 1(7 Days)||28
7655983|NCT02096744|18854669|P2|NOT COMPLETED|Treatment Period 1(7 Days)||1
7655984|NCT02096744|18854670|P1|NOT COMPLETED|Treatment Period 1(7 Days)||1
7655985|NCT02096744|18854669|P2|COMPLETED|Treatment Period 1(7 Days)||28
7655986|NCT02096744|18854670|P1|COMPLETED|Treatment Period 1(7 Days)||28
7655987|NCT02096744|18854669|P2|STARTED|Treatment Period 1(7 Days)||29
7655988|NCT02096744|18854670|P1|STARTED|Treatment Period 1(7 Days)||29
7655989|NCT02096731|18854685|P2|NOT COMPLETED|Overall Study||0
7655990|NCT02096731|18854686|P1|NOT COMPLETED|Overall Study||0
7655991|NCT02096731|18854685|P2|COMPLETED|Overall Study||88955
7655992|NCT02096731|18854686|P1|COMPLETED|Overall Study||26442
7655993|NCT02096731|18854685|P2|STARTED|Overall Study||88955
7655994|NCT02096731|18854686|P1|STARTED|Overall Study||26442
7655995|NCT02096718|18854703|P3|NOT COMPLETED|Overall Study||0
7655996|NCT02096718|18854704|P2|NOT COMPLETED|Overall Study||0
7655997|NCT02096718|18854705|P1|NOT COMPLETED|Overall Study||0
7655998|NCT02096718|18854703|P3|COMPLETED|Overall Study||14
7655999|NCT02096718|18854704|P2|COMPLETED|Overall Study||8
7656000|NCT02096718|18854705|P1|COMPLETED|Overall Study||8
7656001|NCT02096718|18854703|P3|STARTED|Overall Study||14
7656002|NCT02096718|18854704|P2|STARTED|Overall Study||8
7656003|NCT02096718|18854705|P1|STARTED|Overall Study||8
7656004|NCT02096705|18854724|P2|NOT COMPLETED|Follow-up||4
7656005|NCT02096705|18854725|P1|NOT COMPLETED|Follow-up||4
7656006|NCT02096705|18854724|P2|COMPLETED|Follow-up||135
7656007|NCT02096705|18854725|P1|COMPLETED|Follow-up||125
7656008|NCT02096705|18854724|P2|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|139
7656009|NCT02096705|18854725|P1|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|129
7656010|NCT02096705|18854724|P2|NOT COMPLETED|Treatment||5
7656011|NCT02096705|18854725|P1|NOT COMPLETED|Treatment||9
7656012|NCT02096705|18854724|P2|COMPLETED|Treatment||134
7656013|NCT02096705|18854725|P1|COMPLETED|Treatment||124
7656014|NCT02096705|18854724|P2|STARTED|Treatment||139
7656015|NCT02096705|18854725|P1|STARTED|Treatment||133
7656016|NCT02096692|18854737|P1|NOT COMPLETED|Overall Study||4
7656017|NCT02096692|18854737|P1|COMPLETED|Overall Study||150
7656018|NCT02096692|18854737|P1|STARTED|Overall Study||154
7656019|NCT02096679|18854743|P1|NOT COMPLETED|Overall Study||0
7656020|NCT02096679|18854743|P1|COMPLETED|Overall Study||8
7656021|NCT02096679|18854743|P1|STARTED|Overall Study||8
7656022|NCT02096588|18854768|P2|NOT COMPLETED|Overall Study||1
7656023|NCT02096588|18854769|P1|NOT COMPLETED|Overall Study||2
7656024|NCT02096588|18854768|P2|COMPLETED|Overall Study||15
7656025|NCT02096588|18854769|P1|COMPLETED|Overall Study||13
7656026|NCT02096588|18854768|P2|STARTED|Overall Study||16
7656027|NCT02096588|18854769|P1|STARTED|Overall Study||15
7656028|NCT02096575|18854779|P3|NOT COMPLETED|Overall Study||5
7656029|NCT02096575|18854780|P2|NOT COMPLETED|Overall Study||0
7656030|NCT02096575|18854781|P1|NOT COMPLETED|Overall Study||0
7656031|NCT02096575|18854779|P3|COMPLETED|Overall Study||0
7656032|NCT02096575|18854780|P2|COMPLETED|Overall Study||67
7656033|NCT02096575|18854781|P1|COMPLETED|Overall Study||68
7656034|NCT02096575|18854779|P3|STARTED|Overall Study||5
7656035|NCT02096575|18854780|P2|STARTED|Overall Study||67
7656036|NCT02096575|18854781|P1|STARTED|Overall Study||68
7656037|NCT02096471|18854795|P1|NOT COMPLETED|Overall Study||13
7656038|NCT02096471|18854795|P1|COMPLETED|Overall Study|Participants terminated the study if a partial response was not achieved and/or maintained.|6
7656039|NCT02096471|18854795|P1|STARTED|Overall Study||19
7656040|NCT02096458|18854806|P1|NOT COMPLETED|Overall Study||0
7656041|NCT02096458|18854806|P1|COMPLETED|Overall Study||8
7656042|NCT02096458|18854806|P1|STARTED|Overall Study||8
7656043|NCT02096276|18854812|P2|NOT COMPLETED|Overall Study||0
7656044|NCT02096276|18854813|P1|NOT COMPLETED|Overall Study||0
7656045|NCT02096276|18854812|P2|COMPLETED|Overall Study||55
7656046|NCT02096276|18854813|P1|COMPLETED|Overall Study||250
7656047|NCT02096276|18854812|P2|STARTED|Overall Study||55
7656048|NCT02096276|18854813|P1|STARTED|Overall Study||250
7656049|NCT02096263|18854822|P3|NOT COMPLETED|Overall Study||39
7656050|NCT02096263|18854823|P2|NOT COMPLETED|Overall Study||36
7656051|NCT02096263|18854824|P1|NOT COMPLETED|Overall Study||34
7656052|NCT02096263|18854822|P3|COMPLETED|Overall Study||157
7656053|NCT02096263|18854823|P2|COMPLETED|Overall Study||158
7656054|NCT02096263|18854824|P1|COMPLETED|Overall Study||161
7656055|NCT02096263|18854822|P3|STARTED|Overall Study||196
7656056|NCT02096263|18854823|P2|STARTED|Overall Study||194
7656057|NCT02096263|18854824|P1|STARTED|Overall Study||195
7656058|NCT02096107|18854960|P2|NOT COMPLETED|Overall Study||0
7656059|NCT02096107|18854961|P1|NOT COMPLETED|Overall Study||0
7656060|NCT02096107|18854960|P2|COMPLETED|Overall Study||30
7656061|NCT02096107|18854961|P1|COMPLETED|Overall Study||30
7656062|NCT02096107|18854960|P2|STARTED|Overall Study||30
7656063|NCT02096107|18854961|P1|STARTED|Overall Study||30
7656064|NCT02096081|18854979|P2|NOT COMPLETED|Overall Study||4
7656065|NCT02096081|18854980|P1|NOT COMPLETED|Overall Study||3
7656066|NCT02096081|18854979|P2|COMPLETED|Overall Study||124
7656067|NCT02096081|18854980|P1|COMPLETED|Overall Study||119
7656068|NCT02096081|18854979|P2|STARTED|Overall Study||128
7656069|NCT02096081|18854980|P1|STARTED|Overall Study||122
7656070|NCT02096042|18855012|P3|NOT COMPLETED|Overall Study||0
7656071|NCT02096042|18855013|P2|NOT COMPLETED|Overall Study||0
7656072|NCT02096042|18855014|P1|NOT COMPLETED|Overall Study||1
7656073|NCT02096042|18855012|P3|COMPLETED|Overall Study||0
7656074|NCT02096042|18855013|P2|COMPLETED|Overall Study||0
7656075|NCT02096042|18855014|P1|COMPLETED|Overall Study||0
7656076|NCT02096042|18855012|P3|STARTED|Overall Study||0
7656077|NCT02096042|18855013|P2|STARTED|Overall Study||0
7656078|NCT02096042|18855014|P1|STARTED|Overall Study||1
7656079|NCT02096029|18855023|P2|NOT COMPLETED|Overall Study||0
7656080|NCT02096029|18855024|P1|NOT COMPLETED|Overall Study||0
7656081|NCT02096029|18855023|P2|COMPLETED|Overall Study||593
7656082|NCT02096029|18855024|P1|COMPLETED|Overall Study||652
7656083|NCT02096029|18855023|P2|STARTED|Overall Study||593
7656084|NCT02096029|18855024|P1|STARTED|Overall Study||652
7656085|NCT02096003|18855036|P2|NOT COMPLETED|Overall Study||3
7656086|NCT02096003|18855037|P1|NOT COMPLETED|Overall Study||2
7656087|NCT02096003|18855036|P2|COMPLETED|Overall Study||37
7656088|NCT02096003|18855037|P1|COMPLETED|Overall Study||38
7656089|NCT02096003|18855036|P2|STARTED|Overall Study||40
7656090|NCT02096003|18855037|P1|STARTED|Overall Study||40
7656091|NCT02095951|18855053|P2|NOT COMPLETED|Overall Study||6
7656092|NCT02095951|18855054|P1|NOT COMPLETED|Overall Study||9
7656093|NCT02095951|18855053|P2|COMPLETED|Overall Study||8
7656094|NCT02095951|18855054|P1|COMPLETED|Overall Study||4
7656095|NCT02095951|18855053|P2|STARTED|Overall Study|1 participant with 2 episodes of catheter infection was enrolled twice in this group.|14
7656096|NCT02095951|18855054|P1|STARTED|Overall Study|2 participants with 4 episodes of catheter infection was enrolled twice in this group.|13
7656097|NCT02095873|18855074|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
7656098|NCT02095873|18855075|P1|NOT COMPLETED|Second Intervention (8 Weeks)||2
7656099|NCT02095873|18855074|P2|COMPLETED|Second Intervention (8 Weeks)||16
7656100|NCT02095873|18855075|P1|COMPLETED|Second Intervention (8 Weeks)||13
7656101|NCT02095873|18855074|P2|STARTED|Second Intervention (8 Weeks)||16
7656102|NCT02095873|18855075|P1|STARTED|Second Intervention (8 Weeks)||15
7656103|NCT02095873|18855074|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
7656104|NCT02095873|18855075|P1|NOT COMPLETED|First Intervention (8 Weeks)||1
7656105|NCT02095873|18855074|P2|COMPLETED|First Intervention (8 Weeks)||16
7656106|NCT02095873|18855075|P1|COMPLETED|First Intervention (8 Weeks)||15
7656107|NCT02095873|18855074|P2|STARTED|First Intervention (8 Weeks)||16
7656108|NCT02095873|18855075|P1|STARTED|First Intervention (8 Weeks)||16
7656109|NCT02095691|18855087|P1|NOT COMPLETED|Overall Study||1
7656110|NCT02095691|18855087|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18
7656197|NCT02094898|18855269|P1|COMPLETED|Overall Study||7
7656111|NCT02095691|18855087|P1|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19
7656112|NCT02095561|18855106|P2|NOT COMPLETED|Overall Study||0
7656113|NCT02095561|18855107|P1|NOT COMPLETED|Overall Study||0
7656114|NCT02095561|18855106|P2|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964
7656115|NCT02095561|18855107|P1|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049
7656116|NCT02095561|18855106|P2|HPV Tested at Health Centers|Overall Study||599
7656117|NCT02095561|18855107|P1|HPV Tested at Health Centers|Overall Study||99
7656118|NCT02095561|18855106|P2|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0
7656119|NCT02095561|18855107|P1|HPV Self-tested Women|Overall Study||2519
7656120|NCT02095561|18855106|P2|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0
7656121|NCT02095561|18855107|P1|Self-testing Acceptability|Overall Study||2616
7656122|NCT02095561|18855106|P2|STARTED|Overall Study||2964
7656123|NCT02095561|18855107|P1|STARTED|Overall Study||3049
7656124|NCT02095535|18855119|P1|NOT COMPLETED|Analysis||0
7656125|NCT02095535|18855119|P1|COMPLETED|Analysis||18
7656126|NCT02095535|18855119|P1|STARTED|Analysis||18
7656127|NCT02095535|18855119|P1|NOT COMPLETED|Recruitment||2
7656128|NCT02095535|18855119|P1|COMPLETED|Recruitment||18
7656129|NCT02095535|18855119|P1|STARTED|Recruitment||20
7656130|NCT02095340|18855126|P3|NOT COMPLETED|Overall Study||0
7656131|NCT02095340|18855127|P2|NOT COMPLETED|Overall Study||0
7656132|NCT02095340|18855128|P1|NOT COMPLETED|Overall Study||0
7656133|NCT02095340|18855126|P3|COMPLETED|Overall Study||105
7656134|NCT02095340|18855127|P2|COMPLETED|Overall Study||54
7656135|NCT02095340|18855128|P1|COMPLETED|Overall Study||51
7656136|NCT02095340|18855126|P3|STARTED|Overall Study||105
7656137|NCT02095340|18855127|P2|STARTED|Overall Study|Mother (not the child) received the training.|54
7656138|NCT02095340|18855128|P1|STARTED|Overall Study|Mother (not the child) received the training.|51
7656139|NCT02095223|18855141|P2|NOT COMPLETED|Overall Study||0
7656140|NCT02095223|18855142|P1|NOT COMPLETED|Overall Study||1
7656141|NCT02095223|18855141|P2|COMPLETED|Overall Study||2
7656142|NCT02095223|18855142|P1|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1
7656143|NCT02095223|18855141|P2|STARTED|Overall Study||2
7656144|NCT02095223|18855142|P1|STARTED|Overall Study||2
7656145|NCT02095197|18855152|P2|NOT COMPLETED|Overall Study||3
7656146|NCT02095197|18855153|P1|NOT COMPLETED|Overall Study||0
7656147|NCT02095197|18855152|P2|COMPLETED|Overall Study||36
7656148|NCT02095197|18855153|P1|COMPLETED|Overall Study||40
7656149|NCT02095197|18855152|P2|STARTED|Overall Study||39
7656150|NCT02095197|18855153|P1|STARTED|Overall Study||40
7656151|NCT02095158|18855165|P1|NOT COMPLETED|Overall Study||75
7656152|NCT02095158|18855165|P1|COMPLETED|Overall Study||365
7656153|NCT02095158|18855165|P1|STARTED|Overall Study||440
7656154|NCT02095145|18855172|P2|NOT COMPLETED|Overall Study||0
7656155|NCT02095145|18855173|P1|NOT COMPLETED|Overall Study||1
7656156|NCT02095145|18855172|P2|COMPLETED|Overall Study||15
7656157|NCT02095145|18855173|P1|COMPLETED|Overall Study||14
7656158|NCT02095145|18855172|P2|STARTED|Overall Study||15
7656159|NCT02095145|18855173|P1|STARTED|Overall Study||15
7656160|NCT02095106|18855219|P2|NOT COMPLETED|Second Intervention (14 Days)||1
7656161|NCT02095106|18855220|P1|NOT COMPLETED|Second Intervention (14 Days)||0
7656162|NCT02095106|18855219|P2|COMPLETED|Second Intervention (14 Days)||12
7656163|NCT02095106|18855220|P1|COMPLETED|Second Intervention (14 Days)||14
7656164|NCT02095106|18855219|P2|STARTED|Second Intervention (14 Days)||13
7656165|NCT02095106|18855220|P1|STARTED|Second Intervention (14 Days)||14
7656166|NCT02095106|18855219|P2|NOT COMPLETED|First Intervention (14 Days)||0
7656167|NCT02095106|18855220|P1|NOT COMPLETED|First Intervention (14 Days)||0
7656168|NCT02095106|18855219|P2|COMPLETED|First Intervention (14 Days)||13
7656169|NCT02095106|18855220|P1|COMPLETED|First Intervention (14 Days)||14
7656170|NCT02095106|18855219|P2|STARTED|First Intervention (14 Days)||13
7656171|NCT02095106|18855220|P1|STARTED|First Intervention (14 Days)||14
7656172|NCT02094937|18855236|P4|NOT COMPLETED|12 Weeks in Period 2||12
7656173|NCT02094937|18855237|P3|NOT COMPLETED|12 Weeks in Period 2||12
7656174|NCT02094937|18855238|P2|NOT COMPLETED|12 Weeks in Period 2||11
7656175|NCT02094937|18855239|P1|NOT COMPLETED|12 Weeks in Period 2||0
7656176|NCT02094937|18855236|P4|COMPLETED|12 Weeks in Period 2||112
7656177|NCT02094937|18855237|P3|COMPLETED|12 Weeks in Period 2||112
7656178|NCT02094937|18855238|P2|COMPLETED|12 Weeks in Period 2||112
7656179|NCT02094937|18855239|P1|COMPLETED|12 Weeks in Period 2||0
7656180|NCT02094937|18855236|P4|STARTED|12 Weeks in Period 2||124
7656181|NCT02094937|18855237|P3|STARTED|12 Weeks in Period 2||124
7656182|NCT02094937|18855238|P2|STARTED|12 Weeks in Period 2||123
7656183|NCT02094937|18855239|P1|STARTED|12 Weeks in Period 2||0
7656184|NCT02094937|18855236|P4|NOT COMPLETED|8 Weeks in Period 1||0
7656185|NCT02094937|18855237|P3|NOT COMPLETED|8 Weeks in Period 1||0
7656186|NCT02094937|18855238|P2|NOT COMPLETED|8 Weeks in Period 1||0
7656187|NCT02094937|18855239|P1|NOT COMPLETED|8 Weeks in Period 1||60
7656188|NCT02094937|18855236|P4|COMPLETED|8 Weeks in Period 1||0
7656189|NCT02094937|18855237|P3|COMPLETED|8 Weeks in Period 1||0
7656190|NCT02094937|18855238|P2|COMPLETED|8 Weeks in Period 1||0
7656191|NCT02094937|18855239|P1|COMPLETED|8 Weeks in Period 1||370
7656192|NCT02094937|18855236|P4|STARTED|8 Weeks in Period 1||0
7656193|NCT02094937|18855237|P3|STARTED|8 Weeks in Period 1||0
7656194|NCT02094937|18855238|P2|STARTED|8 Weeks in Period 1||0
7656195|NCT02094937|18855239|P1|STARTED|8 Weeks in Period 1||430
7656196|NCT02094898|18855269|P1|NOT COMPLETED|Overall Study||5
7656198|NCT02094898|18855269|P1|STARTED|Overall Study||12
7656199|NCT02094885|18855316|P2|NOT COMPLETED|Overall Study||5
7656200|NCT02094885|18855317|P1|NOT COMPLETED|Overall Study||2
7656201|NCT02094885|18855316|P2|COMPLETED|Overall Study||122
7656202|NCT02094885|18855317|P1|COMPLETED|Overall Study||123
7656203|NCT02094885|18855316|P2|STARTED|Overall Study||127
7656204|NCT02094885|18855317|P1|STARTED|Overall Study||125
7656205|NCT02094872|18855329|P1|NOT COMPLETED|Overall Study||29
7656206|NCT02094872|18855329|P1|COMPLETED|Overall Study||20
7656207|NCT02094872|18855329|P1|Patients Treated With MEK162|Overall Study||20
7656208|NCT02094872|18855329|P1|Received Standard of Care|Overall Study|7 standard-of-care patients crossed-over and received targeted therapy.|9
7656209|NCT02094872|18855329|P1|Received Targeted Therapy|Overall Study||20
7656210|NCT02094872|18855329|P1|Received Tumor-board Recommendation|Overall Study|1 individual withdrew consent after biopsy.|36
7656211|NCT02094872|18855329|P1|Received Biopsy|Overall Study||37
7656212|NCT02094872|18855329|P1|STARTED|Overall Study||49
7656213|NCT02094755|18855334|P1|NOT COMPLETED|Overall Study||0
7656214|NCT02094755|18855334|P1|COMPLETED|Overall Study||100
7656215|NCT02094755|18855334|P1|STARTED|Overall Study||100
7656216|NCT02094677|18855340|P2|NOT COMPLETED|Overall Study||1
7656217|NCT02094677|18855341|P1|NOT COMPLETED|Overall Study||3
7656218|NCT02094677|18855340|P2|COMPLETED|Overall Study||30
7656219|NCT02094677|18855341|P1|COMPLETED|Overall Study||40
7656220|NCT02094677|18855340|P2|STARTED|Overall Study||31
7656221|NCT02094677|18855341|P1|STARTED|Overall Study||43
7656222|NCT02094664|18855405|P2|NOT COMPLETED|Overall Study||0
7656223|NCT02094664|18855406|P1|NOT COMPLETED|Overall Study||0
7656224|NCT02094664|18855405|P2|COMPLETED|Overall Study||16
7656225|NCT02094664|18855406|P1|COMPLETED|Overall Study||16
7656226|NCT02094664|18855405|P2|STARTED|Overall Study||16
7656227|NCT02094664|18855406|P1|STARTED|Overall Study||16
7656228|NCT02094612|18855420|P2|NOT COMPLETED|Overall Study||70
7656229|NCT02094612|18855421|P1|NOT COMPLETED|Overall Study||79
7656230|NCT02094612|18855420|P2|COMPLETED|Overall Study||25
7656231|NCT02094612|18855421|P1|COMPLETED|Overall Study||33
7656232|NCT02094612|18855420|P2|6 Month Follow up|Overall Study||25
7656233|NCT02094612|18855421|P1|6 Month Follow up|Overall Study||33
7656234|NCT02094612|18855420|P2|3 Month Follow up|Overall Study||43
7656235|NCT02094612|18855421|P1|3 Month Follow up|Overall Study||50
7656236|NCT02094612|18855420|P2|1 Month Follow up|Overall Study||50
7656237|NCT02094612|18855421|P1|1 Month Follow up|Overall Study||67
7656238|NCT02094612|18855420|P2|STARTED|Overall Study||95
7656239|NCT02094612|18855421|P1|STARTED|Overall Study||112
7656240|NCT02094573|18855441|P2|NOT COMPLETED|Overall Study||110
7656241|NCT02094573|18855442|P1|NOT COMPLETED|Overall Study||112
7656242|NCT02094573|18855441|P2|COMPLETED|Overall Study||0
7656243|NCT02094573|18855442|P1|COMPLETED|Overall Study||0
7656244|NCT02094573|18855441|P2|Treated|Overall Study||110
7656245|NCT02094573|18855442|P1|Treated|Overall Study||109
7656246|NCT02094573|18855441|P2|STARTED|Overall Study||110
7656247|NCT02094573|18855442|P1|STARTED|Overall Study||112
7656248|NCT02094534|18855476|P2|NOT COMPLETED|Overall Study||0
7656249|NCT02094534|18855477|P1|NOT COMPLETED|Overall Study||0
7656250|NCT02094534|18855476|P2|COMPLETED|Overall Study||10
7656251|NCT02094534|18855477|P1|COMPLETED|Overall Study||15
7656252|NCT02094534|18855476|P2|STARTED|Overall Study||10
7656253|NCT02094534|18855477|P1|STARTED|Overall Study||15
7656254|NCT02094443|18855487|P2|NOT COMPLETED|Overall Study||17
7656255|NCT02094443|18855488|P1|NOT COMPLETED|Overall Study||15
7656256|NCT02094443|18855487|P2|COMPLETED|Overall Study||9
7656257|NCT02094443|18855488|P1|COMPLETED|Overall Study||11
7656258|NCT02094443|18855487|P2|Completed at Week 24|Overall Study||8
7656259|NCT02094443|18855488|P1|Completed at Week 24|Overall Study||11
7656260|NCT02094443|18855487|P2|Completed at Week 12|Overall Study||1
7656261|NCT02094443|18855488|P1|Completed at Week 12|Overall Study||0
7656262|NCT02094443|18855487|P2|STARTED|Overall Study||26
7656263|NCT02094443|18855488|P1|STARTED|Overall Study||26
7656264|NCT02094352|18855508|P2|NOT COMPLETED|Overall Study||0
7656265|NCT02094352|18855509|P1|NOT COMPLETED|Overall Study||0
7656266|NCT02094352|18855508|P2|COMPLETED|Overall Study||1
7656267|NCT02094352|18855509|P1|COMPLETED|Overall Study||2
7656268|NCT02094352|18855508|P2|STARTED|Overall Study||1
7656269|NCT02094352|18855509|P1|STARTED|Overall Study||2
7656270|NCT02094326|18855515|P1|NOT COMPLETED|Overall Study||0
7656271|NCT02094326|18855515|P1|COMPLETED|Overall Study||301
7656272|NCT02094326|18855515|P1|STARTED|Overall Study||301
7656273|NCT02094300|18855524|P1|NOT COMPLETED|Overall Study||20
7656274|NCT02094300|18855524|P1|COMPLETED|Overall Study||6
7656275|NCT02094300|18855524|P1|30 Days|Overall Study||24
7656276|NCT02094300|18855524|P1|STARTED|Overall Study||26
7656277|NCT02094261|18855528|P1|NOT COMPLETED|Overall Study||210
7656278|NCT02094261|18855528|P1|COMPLETED|Overall Study||0
7656279|NCT02094261|18855528|P1|STARTED|Overall Study||210
7656280|NCT02093962|18855537|P2|NOT COMPLETED|Overall Study||131
7656281|NCT02093962|18855538|P1|NOT COMPLETED|Overall Study||134
7656282|NCT02093962|18855537|P2|COMPLETED|Overall Study||0
7656283|NCT02093962|18855538|P1|COMPLETED|Overall Study||0
7656284|NCT02093962|18855537|P2|Received Treatment|Overall Study||130
7656285|NCT02093962|18855538|P1|Received Treatment|Overall Study||130
7656286|NCT02093962|18855537|P2|STARTED|Overall Study||131
7656287|NCT02093962|18855538|P1|STARTED|Overall Study||134
7656288|NCT02093949|18855546|P2|NOT COMPLETED|Overall Study||0
7656289|NCT02093949|18855547|P1|NOT COMPLETED|Overall Study||0
7656290|NCT02093949|18855546|P2|COMPLETED|Overall Study||47
7656291|NCT02093949|18855547|P1|COMPLETED|Overall Study||105
7656292|NCT02093949|18855546|P2|STARTED|Overall Study||47
7656293|NCT02093949|18855547|P1|STARTED|Overall Study||105
7656294|NCT02093923|18855570|P5|NOT COMPLETED|Overall Study||0
7656295|NCT02093923|18855571|P4|NOT COMPLETED|Overall Study||2
7656296|NCT02093923|18855572|P3|NOT COMPLETED|Overall Study||0
7656297|NCT02093923|18855573|P2|NOT COMPLETED|Overall Study||0
7656298|NCT02093923|18855574|P1|NOT COMPLETED|Overall Study||0
7656299|NCT02093923|18855570|P5|COMPLETED|Overall Study||13
7656300|NCT02093923|18855571|P4|COMPLETED|Overall Study||10
7656301|NCT02093923|18855572|P3|COMPLETED|Overall Study||5
7656302|NCT02093923|18855573|P2|COMPLETED|Overall Study||4
7656303|NCT02093923|18855574|P1|COMPLETED|Overall Study||4
7656304|NCT02093923|18855570|P5|Treated - 2 Doses:|Overall Study||13
7656305|NCT02093923|18855571|P4|Treated - 2 Doses:|Overall Study||10
7656306|NCT02093923|18855572|P3|Treated - 2 Doses:|Overall Study||5
7656307|NCT02093923|18855573|P2|Treated - 2 Doses:|Overall Study||4
7656308|NCT02093923|18855574|P1|Treated - 2 Doses:|Overall Study||4
7656309|NCT02093923|18855570|P5|Treated - 1 Dose Only:|Overall Study||0
7656310|NCT02093923|18855571|P4|Treated - 1 Dose Only:|Overall Study||1
7656311|NCT02093923|18855572|P3|Treated - 1 Dose Only:|Overall Study||0
7656312|NCT02093923|18855573|P2|Treated - 1 Dose Only:|Overall Study||0
7656313|NCT02093923|18855574|P1|Treated - 1 Dose Only:|Overall Study||0
7656314|NCT02093923|18855570|P5|Total Treated|Overall Study||13
7656315|NCT02093923|18855571|P4|Total Treated|Overall Study||11
7656316|NCT02093923|18855572|P3|Total Treated|Overall Study||5
7656317|NCT02093923|18855573|P2|Total Treated|Overall Study||4
7656318|NCT02093923|18855574|P1|Total Treated|Overall Study||4
7656319|NCT02093923|18855570|P5|STARTED|Overall Study||13
7656320|NCT02093923|18855571|P4|STARTED|Overall Study||12
7656321|NCT02093923|18855572|P3|STARTED|Overall Study||5
7656322|NCT02093923|18855573|P2|STARTED|Overall Study||4
7656323|NCT02093923|18855574|P1|STARTED|Overall Study||4
7656324|NCT02093897|18855629|P1|NOT COMPLETED|Overall Study||19
7656325|NCT02093897|18855629|P1|COMPLETED|Overall Study||65
7656326|NCT02093897|18855629|P1|STARTED|Overall Study||84
7656327|NCT02093819|18855657|P8|NOT COMPLETED|Overall Study||0
7656328|NCT02093819|18855658|P7|NOT COMPLETED|Overall Study||0
7656329|NCT02093819|18855659|P6|NOT COMPLETED|Overall Study||0
7656330|NCT02093819|18855660|P5|NOT COMPLETED|Overall Study||0
7656331|NCT02093819|18855661|P4|NOT COMPLETED|Overall Study||0
7656332|NCT02093819|18855662|P3|NOT COMPLETED|Overall Study||0
7656333|NCT02093819|18855663|P2|NOT COMPLETED|Overall Study||0
7656334|NCT02093819|18855664|P1|NOT COMPLETED|Overall Study||0
7656335|NCT02093819|18855657|P8|COMPLETED|Overall Study||6
7656336|NCT02093819|18855658|P7|COMPLETED|Overall Study||5
7656337|NCT02093819|18855659|P6|COMPLETED|Overall Study||6
7656338|NCT02093819|18855660|P5|COMPLETED|Overall Study||6
7656339|NCT02093819|18855661|P4|COMPLETED|Overall Study||6
7656340|NCT02093819|18855662|P3|COMPLETED|Overall Study||10
7656341|NCT02093819|18855663|P2|COMPLETED|Overall Study||6
7656342|NCT02093819|18855664|P1|COMPLETED|Overall Study||15
7656343|NCT02093819|18855657|P8|STARTED|Overall Study||6
7656344|NCT02093819|18855658|P7|STARTED|Overall Study||5
7656345|NCT02093819|18855659|P6|STARTED|Overall Study||6
7656346|NCT02093819|18855660|P5|STARTED|Overall Study||6
7656347|NCT02093819|18855661|P4|STARTED|Overall Study||6
7656348|NCT02093819|18855662|P3|STARTED|Overall Study||10
7656349|NCT02093819|18855663|P2|STARTED|Overall Study||6
7656350|NCT02093819|18855664|P1|STARTED|Overall Study||15
7656351|NCT02093793|18855701|P3|NOT COMPLETED|Overall Study||3
7656352|NCT02093793|18855702|P2|NOT COMPLETED|Overall Study||10
7656353|NCT02093793|18855703|P1|NOT COMPLETED|Overall Study||7
7656354|NCT02093793|18855701|P3|COMPLETED|Overall Study||65
7656355|NCT02093793|18855702|P2|COMPLETED|Overall Study||80
7656356|NCT02093793|18855703|P1|COMPLETED|Overall Study||91
7656357|NCT02093793|18855701|P3|STARTED|Overall Study||68
7656358|NCT02093793|18855702|P2|STARTED|Overall Study||90
7656359|NCT02093793|18855703|P1|STARTED|Overall Study||98
7656360|NCT02093702|18855713|P2|NOT COMPLETED|Overall Study||0
7656361|NCT02093702|18855714|P1|NOT COMPLETED|Overall Study||0
7656362|NCT02093702|18855713|P2|COMPLETED|Overall Study||3
7656363|NCT02093702|18855714|P1|COMPLETED|Overall Study||2
7656364|NCT02093702|18855713|P2|STARTED|Overall Study||3
7656365|NCT02093702|18855714|P1|STARTED|Overall Study||2
7656366|NCT02093689|18855745|P3|NOT COMPLETED|Overall Study||0
7656367|NCT02093689|18855746|P2|NOT COMPLETED|Overall Study||0
7656368|NCT02093689|18855747|P1|NOT COMPLETED|Overall Study||4
7656369|NCT02093689|18855745|P3|COMPLETED|Overall Study||0
7656370|NCT02093689|18855746|P2|COMPLETED|Overall Study||0
7656371|NCT02093689|18855747|P1|COMPLETED|Overall Study||14
7656372|NCT02093689|18855745|P3|STARTED|Overall Study||0
7656373|NCT02093689|18855746|P2|STARTED|Overall Study||0
7656374|NCT02093689|18855747|P1|STARTED|Overall Study||18
7656375|NCT02093663|18855753|P5|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||11
7656376|NCT02093663|18855754|P4|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||10
7656377|NCT02093663|18855755|P3|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
7656378|NCT02093663|18855756|P2|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
7656379|NCT02093663|18855757|P1|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
7656380|NCT02093663|18855753|P5|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||34
7656381|NCT02093663|18855754|P4|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||32
7656382|NCT02093663|18855755|P3|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
7656383|NCT02093663|18855756|P2|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
7656384|NCT02093663|18855757|P1|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
7656385|NCT02093663|18855753|P5|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
7656386|NCT02093663|18855754|P4|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
7656387|NCT02093663|18855755|P3|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
7656388|NCT02093663|18855756|P2|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
7656389|NCT02093663|18855757|P1|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
7656390|NCT02093663|18855753|P5|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||15
7656391|NCT02093663|18855754|P4|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||12
7656392|NCT02093663|18855755|P3|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
7656393|NCT02093663|18855756|P2|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
7656394|NCT02093663|18855757|P1|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
7656395|NCT02093663|18855753|P5|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
7656396|NCT02093663|18855754|P4|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
7656397|NCT02093663|18855755|P3|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
7656398|NCT02093663|18855756|P2|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
7656399|NCT02093663|18855757|P1|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
7656400|NCT02093663|18855753|P5|STARTED|Double Blind Maintenance Phase(26 Weeks)||45
7656401|NCT02093663|18855754|P4|STARTED|Double Blind Maintenance Phase(26 Weeks)||42
7656402|NCT02093663|18855755|P3|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
7656403|NCT02093663|18855756|P2|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
7656404|NCT02093663|18855757|P1|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
7656405|NCT02093663|18855753|P5|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
7656406|NCT02093663|18855754|P4|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
7656407|NCT02093663|18855755|P3|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||6
7656408|NCT02093663|18855756|P2|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
7656409|NCT02093663|18855757|P1|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
7656410|NCT02093663|18855753|P5|COMPLETED|Open Label Acute Phase (8 Weeks)||0
7656411|NCT02093663|18855754|P4|COMPLETED|Open Label Acute Phase (8 Weeks)||0
7656412|NCT02093663|18855755|P3|COMPLETED|Open Label Acute Phase (8 Weeks)||12
7656413|NCT02093663|18855756|P2|COMPLETED|Open Label Acute Phase (8 Weeks)||0
7656414|NCT02093663|18855757|P1|COMPLETED|Open Label Acute Phase (8 Weeks)||0
7656415|NCT02093663|18855753|P5|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
7656416|NCT02093663|18855754|P4|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
7656417|NCT02093663|18855755|P3|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||18
7656418|NCT02093663|18855756|P2|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
7656419|NCT02093663|18855757|P1|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
7656420|NCT02093663|18855753|P5|STARTED|Open Label Acute Phase (8 Weeks)||0
7656421|NCT02093663|18855754|P4|STARTED|Open Label Acute Phase (8 Weeks)||0
7656422|NCT02093663|18855755|P3|STARTED|Open Label Acute Phase (8 Weeks)||18
7656423|NCT02093663|18855756|P2|STARTED|Open Label Acute Phase (8 Weeks)||0
7656424|NCT02093663|18855757|P1|STARTED|Open Label Acute Phase (8 Weeks)||0
7656425|NCT02093663|18855753|P5|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
7656426|NCT02093663|18855754|P4|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
7656427|NCT02093663|18855755|P3|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
7656428|NCT02093663|18855756|P2|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||4
7656429|NCT02093663|18855757|P1|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||8
7656430|NCT02093663|18855753|P5|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
7656431|NCT02093663|18855754|P4|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
7656432|NCT02093663|18855755|P3|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
7656433|NCT02093663|18855756|P2|COMPLETED|Double Blind Acute Phase (8 Weeks)||22
7656434|NCT02093663|18855757|P1|COMPLETED|Double Blind Acute Phase (8 Weeks)||19
7656435|NCT02093663|18855753|P5|STARTED|Double Blind Acute Phase (8 Weeks)||0
7656436|NCT02093663|18855754|P4|STARTED|Double Blind Acute Phase (8 Weeks)||0
7656437|NCT02093663|18855755|P3|STARTED|Double Blind Acute Phase (8 Weeks)||0
7656438|NCT02093663|18855756|P2|STARTED|Double Blind Acute Phase (8 Weeks)||26
7656439|NCT02093663|18855757|P1|STARTED|Double Blind Acute Phase (8 Weeks)||27
7656440|NCT02093520|18855786|P2|NOT COMPLETED|Overall Study||22
7656441|NCT02093520|18855787|P1|NOT COMPLETED|Overall Study||6
7656442|NCT02093520|18855786|P2|COMPLETED|Overall Study||131
7656443|NCT02093520|18855787|P1|COMPLETED|Overall Study||143
7656444|NCT02093520|18855786|P2|STARTED|Overall Study||153
7656445|NCT02093520|18855787|P1|STARTED|Overall Study||149
7656446|NCT02093390|18855799|P2|NOT COMPLETED|Overall Study||1
7656447|NCT02093390|18855800|P1|NOT COMPLETED|Overall Study||0
7656448|NCT02093390|18855799|P2|COMPLETED|Overall Study||19
7656449|NCT02093390|18855800|P1|COMPLETED|Overall Study||20
7656450|NCT02093390|18855799|P2|STARTED|Overall Study||20
7656451|NCT02093390|18855800|P1|STARTED|Overall Study||20
7656452|NCT02093351|18855839|P4|NOT COMPLETED|Part B||63
7656453|NCT02093351|18855840|P3|NOT COMPLETED|Part B||0
7656454|NCT02093351|18855841|P2|NOT COMPLETED|Part B||0
7656455|NCT02093351|18855842|P1|NOT COMPLETED|Part B||0
7656456|NCT02093351|18855839|P4|COMPLETED|Part B||6
7656457|NCT02093351|18855840|P3|COMPLETED|Part B||0
7656458|NCT02093351|18855841|P2|COMPLETED|Part B||0
7656459|NCT02093351|18855842|P1|COMPLETED|Part B||0
7656460|NCT02093351|18855839|P4|STARTED|Part B|Eligible patients completing Part A entered Part B for continued access to olaparib.|69
7656461|NCT02093351|18855840|P3|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
7656462|NCT02093351|18855841|P2|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
7656463|NCT02093351|18855842|P1|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
7656464|NCT02093351|18855839|P4|NOT COMPLETED|Part A||0
7656465|NCT02093351|18855840|P3|NOT COMPLETED|Part A||3
7656466|NCT02093351|18855841|P2|NOT COMPLETED|Part A||2
7656467|NCT02093351|18855842|P1|NOT COMPLETED|Part A||2
7656468|NCT02093351|18855839|P4|COMPLETED|Part A||0
7656469|NCT02093351|18855840|P3|COMPLETED|Part A||23
7656470|NCT02093351|18855841|P2|COMPLETED|Part A||21
7656471|NCT02093351|18855842|P1|COMPLETED|Part A||28
7656472|NCT02093351|18855839|P4|Completing Treatment Period 3|Part A||0
7656473|NCT02093351|18855840|P3|Completing Treatment Period 3|Part A||23
7656474|NCT02093351|18855841|P2|Completing Treatment Period 3|Part A||21
7656475|NCT02093351|18855842|P1|Completing Treatment Period 3|Part A||28
7656476|NCT02093351|18855839|P4|Completing Treatment Period 2|Part A||0
7656477|NCT02093351|18855840|P3|Completing Treatment Period 2|Part A||23
7656478|NCT02093351|18855841|P2|Completing Treatment Period 2|Part A||21
7656479|NCT02093351|18855842|P1|Completing Treatment Period 2|Part A||29
7656480|NCT02093351|18855839|P4|Completing Treatment Period 1|Part A||0
7656481|NCT02093351|18855840|P3|Completing Treatment Period 1|Part A||23
7656482|NCT02093351|18855841|P2|Completing Treatment Period 1|Part A||22
7656483|NCT02093351|18855842|P1|Completing Treatment Period 1|Part A||29
7656484|NCT02093351|18855839|P4|STARTED|Part A||0
7656485|NCT02093351|18855840|P3|STARTED|Part A||26
7656486|NCT02093351|18855841|P2|STARTED|Part A||23
7656487|NCT02093351|18855842|P1|STARTED|Part A||30
7656488|NCT02093234|18855875|P3|NOT COMPLETED|Overall Study||4
7656489|NCT02093234|18855876|P2|NOT COMPLETED|Overall Study||4
7656490|NCT02093234|18855877|P1|NOT COMPLETED|Overall Study||3
7656491|NCT02093234|18855875|P3|COMPLETED|Overall Study||50
7656492|NCT02093234|18855876|P2|COMPLETED|Overall Study||52
7656493|NCT02093234|18855877|P1|COMPLETED|Overall Study||53
7656494|NCT02093234|18855875|P3|STARTED|Overall Study||54
7656495|NCT02093234|18855876|P2|STARTED|Overall Study||56
7656496|NCT02093234|18855877|P1|STARTED|Overall Study||56
7656497|NCT02093221|18855899|P5|NOT COMPLETED|Overall Study||8
7656498|NCT02093221|18855900|P4|NOT COMPLETED|Overall Study||8
7656499|NCT02093221|18855901|P3|NOT COMPLETED|Overall Study||9
7656500|NCT02093221|18855902|P2|NOT COMPLETED|Overall Study||8
7656501|NCT02093221|18855903|P1|NOT COMPLETED|Overall Study||10
7656502|NCT02093221|18855899|P5|COMPLETED|Overall Study||7
7656503|NCT02093221|18855900|P4|COMPLETED|Overall Study||7
7656504|NCT02093221|18855901|P3|COMPLETED|Overall Study||6
7656505|NCT02093221|18855902|P2|COMPLETED|Overall Study||8
7656506|NCT02093221|18855903|P1|COMPLETED|Overall Study||5
7656507|NCT02093221|18855899|P5|STARTED|Overall Study||15
7656508|NCT02093221|18855900|P4|STARTED|Overall Study||15
7656509|NCT02093221|18855901|P3|STARTED|Overall Study||15
7656510|NCT02093221|18855902|P2|STARTED|Overall Study||16
7656511|NCT02093221|18855903|P1|STARTED|Overall Study||15
7656512|NCT02093026|18855940|P1|NOT COMPLETED|Overall Study||193
7656513|NCT02093026|18855940|P1|COMPLETED|Overall Study|At predefined end-of-treatment date, 272 ongoing participants were designated as completed study.|272
7656514|NCT02093026|18855940|P1|STARTED|Overall Study||465
7656515|NCT02092961|18855962|P3|NOT COMPLETED|Overall Study||16
7656516|NCT02092961|18855963|P2|NOT COMPLETED|Overall Study||14
7656517|NCT02092961|18855964|P1|NOT COMPLETED|Overall Study||21
7656518|NCT02092961|18855962|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13
7656519|NCT02092961|18855963|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14
7656520|NCT02092961|18855964|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12
7656521|NCT02092961|18855962|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
7656522|NCT02092961|18855963|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5
7656523|NCT02092961|18855964|P1|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1
7656524|NCT02092961|18855962|P3|STARTED|Overall Study|Patients who received treatment|29
7656525|NCT02092961|18855963|P2|STARTED|Overall Study|Patients who received treatment|28
7656526|NCT02092961|18855964|P1|STARTED|Overall Study|Patients who received treatment|33
7656527|NCT02092909|18855989|P4|NOT COMPLETED|Overall Study||6
7656528|NCT02092909|18855990|P3|NOT COMPLETED|Overall Study||9
7656529|NCT02092909|18855991|P2|NOT COMPLETED|Overall Study||3
7656530|NCT02092909|18855992|P1|NOT COMPLETED|Overall Study||1
7656531|NCT02092909|18855989|P4|COMPLETED|Overall Study||0
7656532|NCT02092909|18855990|P3|COMPLETED|Overall Study||5
7656533|NCT02092909|18855991|P2|COMPLETED|Overall Study||2
7656534|NCT02092909|18855992|P1|COMPLETED|Overall Study||5
7656535|NCT02092909|18855989|P4|STARTED|Overall Study||6
7656536|NCT02092909|18855990|P3|STARTED|Overall Study||14
7656537|NCT02092909|18855991|P2|STARTED|Overall Study||5
7656538|NCT02092909|18855992|P1|STARTED|Overall Study||6
7656539|NCT02092857|18856021|P3|NOT COMPLETED|Overall Study||13
7656540|NCT02092857|18856022|P2|NOT COMPLETED|Overall Study||12
7656541|NCT02092857|18856023|P1|NOT COMPLETED|Overall Study||10
7656542|NCT02092857|18856021|P3|COMPLETED|Overall Study||16
7656543|NCT02092857|18856022|P2|COMPLETED|Overall Study||18
7656544|NCT02092857|18856023|P1|COMPLETED|Overall Study||20
7656545|NCT02092857|18856021|P3|STARTED|Overall Study||29
7656546|NCT02092857|18856022|P2|STARTED|Overall Study||30
7656547|NCT02092857|18856023|P1|STARTED|Overall Study||30
7656548|NCT02092662|18856033|P2|NOT COMPLETED|Overall Study||0
7656549|NCT02092662|18856034|P1|NOT COMPLETED|Overall Study||13
7656550|NCT02092662|18856033|P2|COMPLETED|Overall Study||19
7656551|NCT02092662|18856034|P1|COMPLETED|Overall Study||25
7656552|NCT02092662|18856033|P2|Recruited|Overall Study||19
7656553|NCT02092662|18856034|P1|Recruited|Overall Study||38
7656554|NCT02092662|18856033|P2|STARTED|Overall Study||19
7656555|NCT02092662|18856034|P1|STARTED|Overall Study||38
7656556|NCT02092649|18856043|P2|NOT COMPLETED|Overall Study||0
7656557|NCT02092649|18856044|P1|NOT COMPLETED|Overall Study||0
7656558|NCT02092649|18856043|P2|COMPLETED|Overall Study|13 participants finished study|13
7656559|NCT02092649|18856044|P1|COMPLETED|Overall Study|13 participants finished study|13
7656560|NCT02092649|18856043|P2|STARTED|Overall Study|13 participants recruited|13
7656561|NCT02092649|18856044|P1|STARTED|Overall Study|13 participants recruited|13
7656562|NCT02092610|18856062|P2|NOT COMPLETED|Overall Study||12
7656563|NCT02092610|18856063|P1|NOT COMPLETED|Overall Study||8
7656564|NCT02092610|18856062|P2|COMPLETED|Overall Study||40
7656565|NCT02092610|18856063|P1|COMPLETED|Overall Study||17
7656566|NCT02092610|18856062|P2|STARTED|Overall Study||52
7656567|NCT02092610|18856063|P1|STARTED|Overall Study||25
7656568|NCT02092441|18856077|P2|NOT COMPLETED|Overall Study||0
7656569|NCT02092441|18856078|P1|NOT COMPLETED|Overall Study||0
7656570|NCT02092441|18856077|P2|COMPLETED|Overall Study||43
7656571|NCT02092441|18856078|P1|COMPLETED|Overall Study||37
7656572|NCT02092441|18856077|P2|STARTED|Overall Study||43
7656573|NCT02092441|18856078|P1|STARTED|Overall Study||37
7656574|NCT02092415|18856088|P1|NOT COMPLETED|Overall Study||0
7656575|NCT02092415|18856088|P1|COMPLETED|Overall Study||10
7656576|NCT02092415|18856088|P1|STARTED|Overall Study||10
7656577|NCT02092389|18856093|P1|NOT COMPLETED|Overall Study||6
7656578|NCT02092389|18856093|P1|COMPLETED|Overall Study||4
7656579|NCT02092389|18856093|P1|STARTED|Overall Study||10
7656580|NCT02092350|18856105|P2|NOT COMPLETED|Overall Study||12
7656581|NCT02092350|18856106|P1|NOT COMPLETED|Overall Study||10
7656582|NCT02092350|18856105|P2|COMPLETED|Overall Study||102
7656583|NCT02092350|18856106|P1|COMPLETED|Overall Study||113
7656584|NCT02092350|18856105|P2|STARTED|Overall Study||114
7656585|NCT02092350|18856106|P1|STARTED|Overall Study||123
7656586|NCT02092324|18856123|P1|NOT COMPLETED|Overall Study||19
7656587|NCT02092324|18856123|P1|COMPLETED|Overall Study||32
7656588|NCT02092324|18856123|P1|Mutant CSF3R|Overall Study||26
7656589|NCT02092324|18856123|P1|Wildtype CSF3R|Overall Study||23
7656590|NCT02092324|18856123|P1|End of Cycle 6|Overall Study|This study has an accrual goal of 25 evaluable subjects who reach cycle 7, week 1.|25
7656591|NCT02092324|18856123|P1|STARTED|Overall Study||51
7656592|NCT02092311|18856143|P2|NOT COMPLETED|Overall Study||0
7656593|NCT02092311|18856144|P1|NOT COMPLETED|Overall Study||0
7656594|NCT02092311|18856143|P2|COMPLETED|Overall Study||285
7656595|NCT02092311|18856144|P1|COMPLETED|Overall Study||285
7656596|NCT02092311|18856143|P2|STARTED|Overall Study||285
7656597|NCT02092311|18856144|P1|STARTED|Overall Study||285
7656598|NCT02092285|18856154|P1|NOT COMPLETED|Maintenance Phase & Follow-up||110
7656599|NCT02092285|18856154|P1|COMPLETED|Maintenance Phase & Follow-up||60
7656600|NCT02092285|18856154|P1|STARTED|Maintenance Phase & Follow-up||170
7656601|NCT02092285|18856154|P1|NOT COMPLETED|Induction Phase||35
7656602|NCT02092285|18856154|P1|COMPLETED|Induction Phase||170
7656603|NCT02092285|18856154|P1|STARTED|Induction Phase||205
7656604|NCT02092220|18856158|P2|NOT COMPLETED|Period 2||1
7656605|NCT02092220|18856159|P1|NOT COMPLETED|Period 2||1
7656606|NCT02092220|18856158|P2|COMPLETED|Period 2||19
7656607|NCT02092220|18856159|P1|COMPLETED|Period 2||20
7656608|NCT02092220|18856158|P2|STARTED|Period 2||20
7656609|NCT02092220|18856159|P1|STARTED|Period 2||21
7656610|NCT02092220|18856158|P2|NOT COMPLETED|Period 1||2
7656611|NCT02092220|18856159|P1|NOT COMPLETED|Period 1||0
7656612|NCT02092220|18856158|P2|COMPLETED|Period 1||20
7656613|NCT02092220|18856159|P1|COMPLETED|Period 1||21
7656614|NCT02092220|18856158|P2|STARTED|Period 1||22
7656615|NCT02092220|18856159|P1|STARTED|Period 1||21
7656616|NCT02092168|18856219|P2|NOT COMPLETED|Overall Study||0
7656617|NCT02092168|18856220|P1|NOT COMPLETED|Overall Study||0
7656618|NCT02092168|18856219|P2|COMPLETED|Overall Study||12
7656619|NCT02092168|18856220|P1|COMPLETED|Overall Study||12
7656620|NCT02092168|18856219|P2|STARTED|Overall Study||12
7656621|NCT02092168|18856220|P1|STARTED|Overall Study||12
7656622|NCT02092116|18856232|P2|NOT COMPLETED|Overall Study||4
7656623|NCT02092116|18856233|P1|NOT COMPLETED|Overall Study||0
7656624|NCT02092116|18856232|P2|COMPLETED|Overall Study||16
7656625|NCT02092116|18856233|P1|COMPLETED|Overall Study||6
7656626|NCT02092116|18856232|P2|STARTED|Overall Study||20
7656627|NCT02092116|18856233|P1|STARTED|Overall Study||6
7656628|NCT02092025|18856242|P1|NOT COMPLETED|Overall Study||68
7656629|NCT02092025|18856242|P1|COMPLETED|Overall Study||3369
7656630|NCT02092025|18856242|P1|STARTED|Overall Study||3437
7656631|NCT02091986|18856251|P3|NOT COMPLETED|Overall Study||8
7656632|NCT02091986|18856252|P2|NOT COMPLETED|Overall Study||11
7656633|NCT02091986|18856253|P1|NOT COMPLETED|Overall Study||7
7656634|NCT02091986|18856251|P3|COMPLETED|Overall Study||84
7656635|NCT02091986|18856252|P2|COMPLETED|Overall Study||84
7656636|NCT02091986|18856253|P1|COMPLETED|Overall Study||85
7656637|NCT02091986|18856251|P3|STARTED|Overall Study||92
7656638|NCT02091986|18856252|P2|STARTED|Overall Study||95
7656639|NCT02091986|18856253|P1|STARTED|Overall Study||92
7656640|NCT02091960|18856300|P1|NOT COMPLETED|Overall Study||51
7656641|NCT02091960|18856300|P1|COMPLETED|Overall Study|Completed indicates participants with disease progression|52
7656642|NCT02091960|18856300|P1|Received Treatment|Overall Study||103
7656643|NCT02091960|18856300|P1|STARTED|Overall Study||103
7656644|NCT02091921|18856311|P1|NOT COMPLETED|Overall Study||3
7656645|NCT02091921|18856311|P1|COMPLETED|Overall Study||50
7656646|NCT02091921|18856311|P1|STARTED|Overall Study||53
7656647|NCT02091869|18856320|P2|NOT COMPLETED|Overall Study||3
7656648|NCT02091869|18856321|P1|NOT COMPLETED|Overall Study||0
7656649|NCT02091869|18856320|P2|COMPLETED|Overall Study||14
7656650|NCT02091869|18856321|P1|COMPLETED|Overall Study||17
7656651|NCT02091869|18856320|P2|STARTED|Overall Study||17
7656652|NCT02091869|18856321|P1|STARTED|Overall Study||17
7656653|NCT02091856|18856336|P3|NOT COMPLETED|Follow-up Assessment||0
7656654|NCT02091856|18856337|P2|NOT COMPLETED|Follow-up Assessment||3
7656655|NCT02091856|18856338|P1|NOT COMPLETED|Follow-up Assessment||5
7656656|NCT02091856|18856336|P3|COMPLETED|Follow-up Assessment||0
7656657|NCT02091856|18856337|P2|COMPLETED|Follow-up Assessment||9
7656658|NCT02091856|18856338|P1|COMPLETED|Follow-up Assessment||10
7656659|NCT02091856|18856336|P3|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0
7656660|NCT02091856|18856337|P2|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12
7656661|NCT02091856|18856338|P1|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15
7656662|NCT02091856|18856336|P3|NOT COMPLETED|Active Intervention Interval||7
7656663|NCT02091856|18856337|P2|NOT COMPLETED|Active Intervention Interval||7
7656664|NCT02091856|18856338|P1|NOT COMPLETED|Active Intervention Interval||19
7656665|NCT02091856|18856336|P3|COMPLETED|Active Intervention Interval||19
7656666|NCT02091856|18856337|P2|COMPLETED|Active Intervention Interval||12
7656667|NCT02091856|18856338|P1|COMPLETED|Active Intervention Interval||15
7656668|NCT02091856|18856336|P3|STARTED|Active Intervention Interval||26
7656669|NCT02091856|18856337|P2|STARTED|Active Intervention Interval||19
7656670|NCT02091856|18856338|P1|STARTED|Active Intervention Interval||34
7656671|NCT02091778|18856358|P1|NOT COMPLETED|Overall Study||1
7656672|NCT02091778|18856358|P1|COMPLETED|Overall Study||20
7656673|NCT02091778|18856358|P1|STARTED|Overall Study||21
7656674|NCT02091752|18856362|P1|NOT COMPLETED|Overall Study||3
7656675|NCT02091752|18856362|P1|COMPLETED|Overall Study||0
7656676|NCT02091752|18856362|P1|STARTED|Overall Study||3
7656677|NCT02091739|18856376|P5|NOT COMPLETED|EP: 48 Weeks||14
7656678|NCT02091739|18856377|P4|NOT COMPLETED|EP: 48 Weeks||8
7656679|NCT02091739|18856378|P3|NOT COMPLETED|EP: 48 Weeks||0
7656680|NCT02091739|18856379|P2|NOT COMPLETED|EP: 48 Weeks||0
7656681|NCT02091739|18856380|P1|NOT COMPLETED|EP: 48 Weeks||0
7656682|NCT02091739|18856376|P5|COMPLETED|EP: 48 Weeks||75
7656683|NCT02091739|18856377|P4|COMPLETED|EP: 48 Weeks||76
7656684|NCT02091739|18856378|P3|COMPLETED|EP: 48 Weeks||0
7656685|NCT02091739|18856379|P2|COMPLETED|EP: 48 Weeks||0
7656686|NCT02091739|18856380|P1|COMPLETED|EP: 48 Weeks||0
7656687|NCT02091739|18856376|P5|STARTED|EP: 48 Weeks||89
7656688|NCT02091739|18856377|P4|STARTED|EP: 48 Weeks||84
7656689|NCT02091739|18856378|P3|STARTED|EP: 48 Weeks||0
7656690|NCT02091739|18856379|P2|STARTED|EP: 48 Weeks||0
7656691|NCT02091739|18856380|P1|STARTED|EP: 48 Weeks||0
7656692|NCT02091739|18856376|P5|NOT COMPLETED|MP: 16 Weeks||0
7656693|NCT02091739|18856377|P4|NOT COMPLETED|MP: 16 Weeks||0
7656694|NCT02091739|18856378|P3|NOT COMPLETED|MP: 16 Weeks||2
7656695|NCT02091739|18856379|P2|NOT COMPLETED|MP: 16 Weeks||5
7656696|NCT02091739|18856380|P1|NOT COMPLETED|MP: 16 Weeks||4
7656697|NCT02091739|18856376|P5|COMPLETED|MP: 16 Weeks||0
7656698|NCT02091739|18856377|P4|COMPLETED|MP: 16 Weeks||0
7656699|NCT02091739|18856378|P3|COMPLETED|MP: 16 Weeks||72
7656700|NCT02091739|18856379|P2|COMPLETED|MP: 16 Weeks||69
7656701|NCT02091739|18856380|P1|COMPLETED|MP: 16 Weeks||32
7656702|NCT02091739|18856376|P5|STARTED|MP: 16 Weeks||0
7656703|NCT02091739|18856377|P4|STARTED|MP: 16 Weeks||0
7656704|NCT02091739|18856378|P3|STARTED|MP: 16 Weeks||74
7656705|NCT02091739|18856379|P2|STARTED|MP: 16 Weeks||74
7656706|NCT02091739|18856380|P1|STARTED|MP: 16 Weeks||36
7656707|NCT02091726|18856399|P1|NOT COMPLETED|Overall Study||6
7656708|NCT02091726|18856399|P1|COMPLETED|Overall Study||104
7656709|NCT02091726|18856399|P1|4 Week Followup|Overall Study||104
7656710|NCT02091726|18856399|P1|1 Week Followup|Overall Study||110
7656711|NCT02091726|18856399|P1|STARTED|Overall Study||110
7656712|NCT02091531|18856407|P1|NOT COMPLETED|Overall Study||0
7656713|NCT02091531|18856407|P1|COMPLETED|Overall Study||9
7656714|NCT02091531|18856407|P1|STARTED|Overall Study||9
7656715|NCT02091466|18856415|P2|NOT COMPLETED|Overall Study||0
7656716|NCT02091466|18856416|P1|NOT COMPLETED|Overall Study||0
7656717|NCT02091466|18856415|P2|COMPLETED|Overall Study||20
7656718|NCT02091466|18856416|P1|COMPLETED|Overall Study||20
7656719|NCT02091466|18856415|P2|STARTED|Overall Study||20
7656720|NCT02091466|18856416|P1|STARTED|Overall Study||20
7656721|NCT02091440|18856422|P1|NOT COMPLETED|Overall Study||2
7656722|NCT02091440|18856422|P1|COMPLETED|Overall Study||4
7656723|NCT02091440|18856422|P1|Overall Survival at 180 Days|Overall Study||6
7656724|NCT02091440|18856422|P1|Primary Endpoint (Success at 180 Days)|Overall Study||6
7656725|NCT02091440|18856422|P1|STARTED|Overall Study||6
7656726|NCT02091414|18856432|P1|NOT COMPLETED|Overall Study||4
7656727|NCT02091414|18856432|P1|COMPLETED|Overall Study||32
7656728|NCT02091414|18856432|P1|STARTED|Overall Study||36
7656729|NCT02091375|18856446|P2|NOT COMPLETED|Overall Study||3
7656730|NCT02091375|18856447|P1|NOT COMPLETED|Overall Study||9
7656731|NCT02091375|18856446|P2|COMPLETED|Overall Study||56
7656732|NCT02091375|18856447|P1|COMPLETED|Overall Study||52
7656733|NCT02091375|18856446|P2|Intention to Treat (ITT) Analysis Set|Overall Study||59
7656734|NCT02091375|18856447|P1|Intention to Treat (ITT) Analysis Set|Overall Study||61
7656735|NCT02091375|18856446|P2|Safety Analysis Set|Overall Study||59
7656736|NCT02091375|18856447|P1|Safety Analysis Set|Overall Study||61
7656737|NCT02091375|18856446|P2|STARTED|Overall Study||59
7656738|NCT02091375|18856447|P1|STARTED|Overall Study||61
7656739|NCT02091362|18856477|P2|NOT COMPLETED|Period 2||2
7656740|NCT02091362|18856478|P1|NOT COMPLETED|Period 2||2
7656741|NCT02091362|18856477|P2|COMPLETED|Period 2||128
7656742|NCT02091362|18856478|P1|COMPLETED|Period 2||125
7656743|NCT02091362|18856477|P2|STARTED|Period 2||130
7656744|NCT02091362|18856478|P1|STARTED|Period 2||127
7656745|NCT02091362|18856477|P2|NOT COMPLETED|Wash-out||3
7656746|NCT02091362|18856478|P1|NOT COMPLETED|Wash-out||1
7656747|NCT02091362|18856477|P2|COMPLETED|Wash-out||130
7656748|NCT02091362|18856478|P1|COMPLETED|Wash-out||127
7656749|NCT02091362|18856477|P2|STARTED|Wash-out||133
7656750|NCT02091362|18856478|P1|STARTED|Wash-out||128
7656751|NCT02091362|18856477|P2|NOT COMPLETED|Period 1||4
7656752|NCT02091362|18856478|P1|NOT COMPLETED|Period 1||5
7656753|NCT02091362|18856477|P2|COMPLETED|Period 1||133
7656754|NCT02091362|18856478|P1|COMPLETED|Period 1||128
7656755|NCT02091362|18856477|P2|STARTED|Period 1||137
7656756|NCT02091362|18856478|P1|STARTED|Period 1||133
7656757|NCT02091284|18856500|P2|NOT COMPLETED|Overall Study||1
7656758|NCT02091284|18856501|P1|NOT COMPLETED|Overall Study||3
7656759|NCT02091284|18856500|P2|COMPLETED|Overall Study||22
7656760|NCT02091284|18856501|P1|COMPLETED|Overall Study||23
7656761|NCT02091284|18856500|P2|STARTED|Overall Study|One subject from this group discontinued the protocol|23
7656762|NCT02091284|18856501|P1|STARTED|Overall Study|Two subjects from this group discontinued the protocol, data from one subject could not be included.|26
7656763|NCT02091206|18856523|P4|NOT COMPLETED|Taper Period||2
7656764|NCT02091206|18856524|P3|NOT COMPLETED|Taper Period||0
7656765|NCT02091206|18856525|P2|NOT COMPLETED|Taper Period||0
7656766|NCT02091206|18856526|P1|NOT COMPLETED|Taper Period||1
7656767|NCT02091206|18856523|P4|COMPLETED|Taper Period||5
7656768|NCT02091206|18856524|P3|COMPLETED|Taper Period||8
7656769|NCT02091206|18856525|P2|COMPLETED|Taper Period||7
7656770|NCT02091206|18856526|P1|COMPLETED|Taper Period||9
7656771|NCT02091206|18856523|P4|STARTED|Taper Period||7
7656772|NCT02091206|18856524|P3|STARTED|Taper Period||8
7656773|NCT02091206|18856525|P2|STARTED|Taper Period||7
7656774|NCT02091206|18856526|P1|STARTED|Taper Period||10
7656775|NCT02091206|18856523|P4|NOT COMPLETED|Treatment Period||0
7656776|NCT02091206|18856524|P3|NOT COMPLETED|Treatment Period||1
7656777|NCT02091206|18856525|P2|NOT COMPLETED|Treatment Period||1
7656778|NCT02091206|18856526|P1|NOT COMPLETED|Treatment Period||0
7656779|NCT02091206|18856523|P4|COMPLETED|Treatment Period||7
7656780|NCT02091206|18856524|P3|COMPLETED|Treatment Period||8
7656781|NCT02091206|18856525|P2|COMPLETED|Treatment Period||7
7656782|NCT02091206|18856526|P1|COMPLETED|Treatment Period||10
7656783|NCT02091206|18856523|P4|Safety Analysis Set|Treatment Period||7
7656784|NCT02091206|18856524|P3|Safety Analysis Set|Treatment Period||9
7656785|NCT02091206|18856525|P2|Safety Analysis Set|Treatment Period||8
7656786|NCT02091206|18856526|P1|Safety Analysis Set|Treatment Period||10
7656787|NCT02091206|18856523|P4|STARTED|Treatment Period||7
7656788|NCT02091206|18856524|P3|STARTED|Treatment Period||9
7656789|NCT02091206|18856525|P2|STARTED|Treatment Period||8
7656790|NCT02091206|18856526|P1|STARTED|Treatment Period||10
7656791|NCT02091167|18856545|P2|NOT COMPLETED|Overall Study||2
7656792|NCT02091167|18856546|P1|NOT COMPLETED|Overall Study||0
7656793|NCT02091167|18856545|P2|COMPLETED|Overall Study||14
7656794|NCT02091167|18856546|P1|COMPLETED|Overall Study||19
7656795|NCT02091167|18856545|P2|STARTED|Overall Study||16
7656796|NCT02091167|18856546|P1|STARTED|Overall Study||19
7656797|NCT02091102|18856554|P1|NOT COMPLETED|Overall Study||0
7656798|NCT02091102|18856554|P1|COMPLETED|Overall Study||20
7656799|NCT02091102|18856554|P1|STARTED|Overall Study||20
7656800|NCT02091089|18856562|P1|NOT COMPLETED|Overall Study||2
7656801|NCT02091089|18856562|P1|COMPLETED|Overall Study||18
7656802|NCT02091089|18856562|P1|STARTED|Overall Study||20
7656803|NCT02090959|18856570|P1|NOT COMPLETED|Overall Study||151
7656804|NCT02090959|18856570|P1|COMPLETED|Overall Study||68
7656805|NCT02090959|18856570|P1|As-treated Population|Overall Study||218
7656806|NCT02090959|18856570|P1|STARTED|Overall Study||219
7656807|NCT02090894|18856592|P1|NOT COMPLETED|Overall Study||0
7656808|NCT02090894|18856592|P1|COMPLETED|Overall Study||11
7656809|NCT02090894|18856592|P1|STARTED|Overall Study||11
7656810|NCT02090855|18856597|P1|NOT COMPLETED|Overall Study||2
7656811|NCT02090855|18856597|P1|COMPLETED|Overall Study||106
7656812|NCT02090855|18856597|P1|STARTED|Overall Study||108
7656813|NCT02090777|18856604|P1|NOT COMPLETED|Overall Study||0
7656814|NCT02090777|18856604|P1|COMPLETED|Overall Study||4
7656815|NCT02090777|18856604|P1|STARTED|Overall Study||4
7656816|NCT02090764|18856610|P2|NOT COMPLETED|Overall Study||20
7656817|NCT02090764|18856611|P1|NOT COMPLETED|Overall Study||6
7656818|NCT02090764|18856610|P2|COMPLETED|Overall Study||186
7656819|NCT02090764|18856611|P1|COMPLETED|Overall Study||200
7656820|NCT02090764|18856610|P2|STARTED|Overall Study||206
7656821|NCT02090764|18856611|P1|STARTED|Overall Study||206
7656822|NCT02090725|18856617|P1|NOT COMPLETED|Overall Study||4
7656823|NCT02090725|18856617|P1|COMPLETED|Overall Study||0
7656824|NCT02090725|18856617|P1|STARTED|Overall Study||4
7656825|NCT02090426|18856623|P2|NOT COMPLETED|Overall Study||6
7656826|NCT02090426|18856624|P1|NOT COMPLETED|Overall Study||12
7656827|NCT02090426|18856623|P2|COMPLETED|Overall Study||393
7656828|NCT02090426|18856624|P1|COMPLETED|Overall Study||389
7656829|NCT02090426|18856623|P2|Analysis Population|Overall Study||393
7656830|NCT02090426|18856624|P1|Analysis Population|Overall Study||389
7656831|NCT02090426|18856623|P2|STARTED|Overall Study||399
7656832|NCT02090426|18856624|P1|STARTED|Overall Study||401
7656833|NCT02090413|18856655|P3|NOT COMPLETED|Overall Study||23
7656834|NCT02090413|18856656|P2|NOT COMPLETED|Overall Study||20
7656835|NCT02090413|18856657|P1|NOT COMPLETED|Overall Study||19
7656836|NCT02090413|18856655|P3|COMPLETED|Overall Study||57
7656837|NCT02090413|18856656|P2|COMPLETED|Overall Study||60
7656838|NCT02090413|18856657|P1|COMPLETED|Overall Study||62
7656839|NCT02090413|18856655|P3|STARTED|Overall Study||80
7656840|NCT02090413|18856656|P2|STARTED|Overall Study||80
7656841|NCT02090413|18856657|P1|STARTED|Overall Study||81
7656842|NCT02090283|18856734|P3|NOT COMPLETED|Overall Study||10
7656843|NCT02090283|18856735|P2|NOT COMPLETED|Overall Study||15
7656844|NCT02090283|18856736|P1|NOT COMPLETED|Overall Study||17
7656845|NCT02090283|18856734|P3|COMPLETED|Overall Study||0
7656846|NCT02090283|18856735|P2|COMPLETED|Overall Study||0
7656847|NCT02090283|18856736|P1|COMPLETED|Overall Study||0
7656848|NCT02090283|18856734|P3|Received At Least 1 Dose Of Study Drug|Overall Study||10
7656849|NCT02090283|18856735|P2|Received At Least 1 Dose Of Study Drug|Overall Study||15
7656850|NCT02090283|18856736|P1|Received At Least 1 Dose Of Study Drug|Overall Study||17
7656851|NCT02090283|18856734|P3|STARTED|Overall Study||10
7656852|NCT02090283|18856735|P2|STARTED|Overall Study||15
7656853|NCT02090283|18856736|P1|STARTED|Overall Study||17
7656854|NCT02090088|18856747|P1|NOT COMPLETED|Overall Study||0
7656855|NCT02090088|18856747|P1|COMPLETED|Overall Study||4
7656856|NCT02090088|18856747|P1|Gave Birth|Overall Study||4
7656857|NCT02090088|18856747|P1|STARTED|Overall Study||4
7656858|NCT02090075|18856761|P2|NOT COMPLETED|Overall Study||3
7656859|NCT02090075|18856762|P1|NOT COMPLETED|Overall Study||7
7656860|NCT02090075|18856761|P2|COMPLETED|Overall Study||30
7656861|NCT02090075|18856762|P1|COMPLETED|Overall Study||26
7656862|NCT02090075|18856761|P2|STARTED|Overall Study||33
7656863|NCT02090075|18856762|P1|STARTED|Overall Study||33
7656864|NCT02089997|18856770|P1|NOT COMPLETED|Overall Study||246
7656865|NCT02089997|18856770|P1|COMPLETED|Overall Study||3058
7656866|NCT02089997|18856770|P1|STARTED|Overall Study||3304
7656867|NCT02089737|18856785|P1|NOT COMPLETED|Overall Study||6
7656868|NCT02089737|18856785|P1|COMPLETED|Overall Study||3085
7656869|NCT02089737|18856785|P1|STARTED|Overall Study||3091
7656870|NCT02089659|18856794|P3|NOT COMPLETED|Overall Study||0
7656871|NCT02089659|18856795|P2|NOT COMPLETED|Overall Study||0
7656872|NCT02089659|18856796|P1|NOT COMPLETED|Overall Study||0
7656873|NCT02089659|18856794|P3|COMPLETED|Overall Study||0
7656874|NCT02089659|18856795|P2|COMPLETED|Overall Study||8
7656875|NCT02089659|18856796|P1|COMPLETED|Overall Study||8
7656876|NCT02089659|18856794|P3|STARTED|Overall Study||0
7656877|NCT02089659|18856795|P2|STARTED|Overall Study||8
7656878|NCT02089659|18856796|P1|STARTED|Overall Study||8
7656879|NCT02089464|18856810|P2|NOT COMPLETED|Overall Study||16
7656880|NCT02089464|18856811|P1|NOT COMPLETED|Overall Study||28
7656881|NCT02089464|18856810|P2|COMPLETED|Overall Study||51
7656882|NCT02089464|18856811|P1|COMPLETED|Overall Study||104
7656883|NCT02089464|18856810|P2|STARTED|Overall Study||67
7656884|NCT02089464|18856811|P1|STARTED|Overall Study||132
7656885|NCT02089347|18856835|P2|NOT COMPLETED|Overall Study||0
7656886|NCT02089347|18856836|P1|NOT COMPLETED|Overall Study||1
7656887|NCT02089347|18856835|P2|COMPLETED|Overall Study||178
7656888|NCT02089347|18856836|P1|COMPLETED|Overall Study||355
7656889|NCT02089347|18856835|P2|STARTED|Overall Study||178
7656890|NCT02089347|18856836|P1|STARTED|Overall Study||356
7656891|NCT02089334|18856862|P4|NOT COMPLETED|Overall Study||7
7656892|NCT02089334|18856863|P3|NOT COMPLETED|Overall Study||1
7656893|NCT02089334|18856864|P2|NOT COMPLETED|Overall Study||0
7656894|NCT02089334|18856865|P1|NOT COMPLETED|Overall Study||0
7656895|NCT02089334|18856862|P4|COMPLETED|Overall Study||6
7656896|NCT02089334|18856863|P3|COMPLETED|Overall Study||3
7656897|NCT02089334|18856864|P2|COMPLETED|Overall Study||4
7656898|NCT02089334|18856865|P1|COMPLETED|Overall Study||3
7656899|NCT02089334|18856862|P4|Received Study Drug|Overall Study||11
7656900|NCT02089334|18856863|P3|Received Study Drug|Overall Study||3
7656901|NCT02089334|18856864|P2|Received Study Drug|Overall Study||4
7656902|NCT02089334|18856865|P1|Received Study Drug|Overall Study||3
7656903|NCT02089334|18856862|P4|STARTED|Overall Study||13
7656904|NCT02089334|18856863|P3|STARTED|Overall Study||4
7656905|NCT02089334|18856864|P2|STARTED|Overall Study||4
7656906|NCT02089334|18856865|P1|STARTED|Overall Study||3
7656907|NCT02089191|18856882|P2|NOT COMPLETED|Period 2, Second 12 Hours||0
7656908|NCT02089191|18856883|P1|NOT COMPLETED|Period 2, Second 12 Hours||0
7656909|NCT02089191|18856882|P2|COMPLETED|Period 2, Second 12 Hours||15
7656910|NCT02089191|18856883|P1|COMPLETED|Period 2, Second 12 Hours||15
7656911|NCT02089191|18856882|P2|STARTED|Period 2, Second 12 Hours||15
7656912|NCT02089191|18856883|P1|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15
7656913|NCT02089191|18856882|P2|NOT COMPLETED|Period 1, First 12 Hours||0
7656914|NCT02089191|18856883|P1|NOT COMPLETED|Period 1, First 12 Hours||0
7656915|NCT02089191|18856882|P2|COMPLETED|Period 1, First 12 Hours||15
7656916|NCT02089191|18856883|P1|COMPLETED|Period 1, First 12 Hours||16
7656917|NCT02089191|18856882|P2|STARTED|Period 1, First 12 Hours||15
7656918|NCT02089191|18856883|P1|STARTED|Period 1, First 12 Hours||16
7656919|NCT02089113|18856893|P2|NOT COMPLETED|Overall Study||0
7656920|NCT02089113|18856894|P1|NOT COMPLETED|Overall Study||1
7656921|NCT02089113|18856893|P2|COMPLETED|Overall Study||80
7656922|NCT02089113|18856894|P1|COMPLETED|Overall Study||160
7656923|NCT02089113|18856893|P2|STARTED|Overall Study||80
7656924|NCT02089113|18856894|P1|STARTED|Overall Study||161
7656925|NCT02088957|18856902|P2|NOT COMPLETED|Overall Study||0
7656926|NCT02088957|18856903|P1|NOT COMPLETED|Overall Study||1
7656927|NCT02088957|18856902|P2|COMPLETED|Overall Study||0
7656928|NCT02088957|18856903|P1|COMPLETED|Overall Study||0
7656929|NCT02088957|18856902|P2|STARTED|Overall Study||0
7656930|NCT02088957|18856903|P1|STARTED|Overall Study||1
7656931|NCT02088905|18856921|P2|NOT COMPLETED|Overall Study||1
7656932|NCT02088905|18856922|P1|NOT COMPLETED|Overall Study||5
7656933|NCT02088905|18856921|P2|COMPLETED|Overall Study||9
7656934|NCT02088905|18856922|P1|COMPLETED|Overall Study||8
7656935|NCT02088905|18856921|P2|Week 9|Overall Study||9
7656936|NCT02088905|18856922|P1|Week 9|Overall Study||10
7656937|NCT02088905|18856921|P2|STARTED|Overall Study||10
7656938|NCT02088905|18856922|P1|STARTED|Overall Study||13
7656939|NCT02088788|18856944|P2|NOT COMPLETED|Overall Study||41
7656940|NCT02088788|18856945|P1|NOT COMPLETED|Overall Study||30
7656941|NCT02088788|18856944|P2|COMPLETED|Overall Study||89
7656942|NCT02088788|18856945|P1|COMPLETED|Overall Study||105
7656943|NCT02088788|18856944|P2|STARTED|Overall Study||130
7656944|NCT02088788|18856945|P1|STARTED|Overall Study||135
7656945|NCT02088541|18856958|P5|NOT COMPLETED|Overall Study||58
7656946|NCT02088541|18856959|P4|NOT COMPLETED|Overall Study||44
7656947|NCT02088541|18856960|P3|NOT COMPLETED|Overall Study||117
7656948|NCT02088541|18856961|P2|NOT COMPLETED|Overall Study||27
7656949|NCT02088541|18856962|P1|NOT COMPLETED|Overall Study||71
7656950|NCT02088541|18856958|P5|COMPLETED|Overall Study||0
7656951|NCT02088541|18856959|P4|COMPLETED|Overall Study||0
7656952|NCT02088541|18856960|P3|COMPLETED|Overall Study||0
7656953|NCT02088541|18856961|P2|COMPLETED|Overall Study||0
7656954|NCT02088541|18856962|P1|COMPLETED|Overall Study||0
7656955|NCT02088541|18856958|P5|Intent-to-treat (ITT) Population|Overall Study||57
7656956|NCT02088541|18856959|P4|Intent-to-treat (ITT) Population|Overall Study||0
7656957|NCT02088541|18856960|P3|Intent-to-treat (ITT) Population|Overall Study|1 randomized to Selinexor 60mg (PV>=5) but treated with physician choice 2, counted under this arm.|118
7656958|NCT02088541|18856961|P2|Intent-to-treat (ITT) Population|Overall Study||0
7656959|NCT02088541|18856962|P1|Intent-to-treat (ITT) Population|Overall Study||0
7656960|NCT02088541|18856958|P5|Safety Population|Overall Study||45
7656961|NCT02088541|18856959|P4|Safety Population|Overall Study||39
7656962|NCT02088541|18856960|P3|Safety Population|Overall Study||115
7656963|NCT02088541|18856961|P2|Safety Population|Overall Study||27
7656964|NCT02088541|18856962|P1|Safety Population|Overall Study||71
7656965|NCT02088541|18856958|P5|STARTED|Overall Study||58
7656966|NCT02088541|18856959|P4|STARTED|Overall Study||44
7656967|NCT02088541|18856960|P3|STARTED|Overall Study||117
7656968|NCT02088541|18856961|P2|STARTED|Overall Study||27
7656969|NCT02088541|18856962|P1|STARTED|Overall Study||71
7656970|NCT02088385|18856995|P2|NOT COMPLETED|Overall Study||0
7656971|NCT02088385|18856996|P1|NOT COMPLETED|Overall Study||0
7656972|NCT02088385|18856995|P2|COMPLETED|Overall Study||10
7656973|NCT02088385|18856996|P1|COMPLETED|Overall Study||10
7656974|NCT02088385|18856995|P2|STARTED|Overall Study||10
7656975|NCT02088385|18856996|P1|STARTED|Overall Study||10
7656976|NCT02088216|18857006|P2|NOT COMPLETED|Overall Study||10
7656977|NCT02088216|18857007|P1|NOT COMPLETED|Overall Study||12
7656978|NCT02088216|18857006|P2|COMPLETED|Overall Study||70
7656979|NCT02088216|18857007|P1|COMPLETED|Overall Study||69
7656980|NCT02088216|18857006|P2|STARTED|Overall Study||80
7656981|NCT02088216|18857007|P1|STARTED|Overall Study||81
7656982|NCT02088177|18857033|P1|NOT COMPLETED|Overall Study||3
7656983|NCT02088177|18857033|P1|COMPLETED|Overall Study||9
7656984|NCT02088177|18857033|P1|STARTED|Overall Study||12
7656985|NCT02088073|18857043|P5|NOT COMPLETED|Maintanance Phase||7
7656986|NCT02088073|18857044|P4|NOT COMPLETED|Maintanance Phase||7
7656987|NCT02088073|18857045|P3|NOT COMPLETED|Maintanance Phase||5
7656988|NCT02088073|18857046|P2|NOT COMPLETED|Maintanance Phase||10
7656989|NCT02088073|18857047|P1|NOT COMPLETED|Maintanance Phase||0
7656990|NCT02088073|18857043|P5|COMPLETED|Maintanance Phase||49
7656991|NCT02088073|18857044|P4|COMPLETED|Maintanance Phase||44
7656992|NCT02088073|18857045|P3|COMPLETED|Maintanance Phase||40
7656993|NCT02088073|18857046|P2|COMPLETED|Maintanance Phase||75
7656994|NCT02088073|18857047|P1|COMPLETED|Maintanance Phase|251 subjects completed the AP; 240 were eligible to enter the MP. 237 entered the MP.|0
7656995|NCT02088073|18857043|P5|STARTED|Maintanance Phase||56
7656996|NCT02088073|18857044|P4|STARTED|Maintanance Phase||51
7656997|NCT02088073|18857045|P3|STARTED|Maintanance Phase||45
7656998|NCT02088073|18857046|P2|STARTED|Maintanance Phase||85
7656999|NCT02088073|18857047|P1|STARTED|Maintanance Phase||0
7657000|NCT02088073|18857043|P5|NOT COMPLETED|Acute Phase||0
7657001|NCT02088073|18857044|P4|NOT COMPLETED|Acute Phase||0
7657002|NCT02088073|18857045|P3|NOT COMPLETED|Acute Phase||0
7657003|NCT02088073|18857046|P2|NOT COMPLETED|Acute Phase||0
7657004|NCT02088073|18857047|P1|NOT COMPLETED|Acute Phase||7
7657005|NCT02088073|18857043|P5|COMPLETED|Acute Phase||0
7657006|NCT02088073|18857044|P4|COMPLETED|Acute Phase||0
7657007|NCT02088073|18857045|P3|COMPLETED|Acute Phase||0
7657008|NCT02088073|18857046|P2|COMPLETED|Acute Phase||0
7657009|NCT02088073|18857047|P1|COMPLETED|Acute Phase||251
7657010|NCT02088073|18857043|P5|STARTED|Acute Phase||0
7657011|NCT02088073|18857044|P4|STARTED|Acute Phase||0
7657012|NCT02088073|18857045|P3|STARTED|Acute Phase||0
7657013|NCT02088073|18857046|P2|STARTED|Acute Phase||0
7657014|NCT02088073|18857047|P1|STARTED|Acute Phase||258
7657015|NCT02088047|18857101|P2|NOT COMPLETED|Overall Study||0
7657016|NCT02088047|18857102|P1|NOT COMPLETED|Overall Study||1
7657017|NCT02088047|18857101|P2|COMPLETED|Overall Study||1
7657018|NCT02088047|18857102|P1|COMPLETED|Overall Study||2
7657019|NCT02088047|18857101|P2|STARTED|Overall Study||1
7657020|NCT02088047|18857102|P1|STARTED|Overall Study||3
7657021|NCT02088034|18857111|P3|NOT COMPLETED|Overall Study||2
7657022|NCT02088034|18857112|P2|NOT COMPLETED|Overall Study||2
7657023|NCT02088034|18857113|P1|NOT COMPLETED|Overall Study||3
7657024|NCT02088034|18857111|P3|COMPLETED|Overall Study||27
7657025|NCT02088034|18857112|P2|COMPLETED|Overall Study||28
7657026|NCT02088034|18857113|P1|COMPLETED|Overall Study||30
7657027|NCT02088034|18857111|P3|STARTED|Overall Study||29
7657028|NCT02088034|18857112|P2|STARTED|Overall Study||30
7657029|NCT02088034|18857113|P1|STARTED|Overall Study||33
7657030|NCT02087995|18857121|P1|NOT COMPLETED|Overall Study||0
7657031|NCT02087995|18857121|P1|COMPLETED|Overall Study||51
7657032|NCT02087995|18857121|P1|STARTED|Overall Study||51
7657033|NCT02087956|18857127|P2|NOT COMPLETED|Overall Study||5
7657034|NCT02087956|18857128|P1|NOT COMPLETED|Overall Study||6
7657035|NCT02087956|18857127|P2|COMPLETED|Overall Study||107
7657036|NCT02087956|18857128|P1|COMPLETED|Overall Study||105
7657037|NCT02087956|18857127|P2|STARTED|Overall Study||112
7657038|NCT02087956|18857128|P1|STARTED|Overall Study||111
7657039|NCT02087943|18857143|P5|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
7657040|NCT02087943|18857144|P4|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
7657041|NCT02087943|18857145|P3|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3
7657042|NCT02087943|18857146|P2|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
7657043|NCT02087943|18857147|P1|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
7657044|NCT02087943|18857143|P5|COMPLETED|Observational Follow-up Phase Week 24-30||22
7657045|NCT02087943|18857144|P4|COMPLETED|Observational Follow-up Phase Week 24-30||23
7657046|NCT02087943|18857145|P3|COMPLETED|Observational Follow-up Phase Week 24-30||45
7657047|NCT02087943|18857146|P2|COMPLETED|Observational Follow-up Phase Week 24-30||46
7657048|NCT02087943|18857147|P1|COMPLETED|Observational Follow-up Phase Week 24-30||0
7657049|NCT02087943|18857143|P5|STARTED|Observational Follow-up Phase Week 24-30||23
7657050|NCT02087943|18857144|P4|STARTED|Observational Follow-up Phase Week 24-30||24
7657051|NCT02087943|18857145|P3|STARTED|Observational Follow-up Phase Week 24-30||48
7657052|NCT02087943|18857146|P2|STARTED|Observational Follow-up Phase Week 24-30||46
7657053|NCT02087943|18857147|P1|STARTED|Observational Follow-up Phase Week 24-30||0
7657054|NCT02087943|18857143|P5|NOT COMPLETED|Active Treatment Phase Week 12-24||2
7657055|NCT02087943|18857144|P4|NOT COMPLETED|Active Treatment Phase Week 12-24||2
7657056|NCT02087943|18857145|P3|NOT COMPLETED|Active Treatment Phase Week 12-24||5
7657057|NCT02087943|18857146|P2|NOT COMPLETED|Active Treatment Phase Week 12-24||4
7657058|NCT02087943|18857147|P1|NOT COMPLETED|Active Treatment Phase Week 12-24||0
7657059|NCT02087943|18857143|P5|COMPLETED|Active Treatment Phase Week 12-24||21
7657060|NCT02087943|18857144|P4|COMPLETED|Active Treatment Phase Week 12-24||22
7657061|NCT02087943|18857145|P3|COMPLETED|Active Treatment Phase Week 12-24||44
7657062|NCT02087943|18857146|P2|COMPLETED|Active Treatment Phase Week 12-24||42
7657063|NCT02087943|18857147|P1|COMPLETED|Active Treatment Phase Week 12-24||0
7657064|NCT02087943|18857143|P5|STARTED|Active Treatment Phase Week 12-24||23
7657065|NCT02087943|18857144|P4|STARTED|Active Treatment Phase Week 12-24||24
7657066|NCT02087943|18857145|P3|STARTED|Active Treatment Phase Week 12-24||49
7657067|NCT02087943|18857146|P2|STARTED|Active Treatment Phase Week 12-24||46
7657068|NCT02087943|18857147|P1|STARTED|Active Treatment Phase Week 12-24||0
7657069|NCT02087943|18857143|P5|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
7657070|NCT02087943|18857144|P4|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
7657071|NCT02087943|18857145|P3|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13
7657072|NCT02087943|18857146|P2|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12
7657073|NCT02087943|18857147|P1|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14
7657074|NCT02087943|18857143|P5|COMPLETED|Placebo-Controlled Phase Week 0-12||0
7657075|NCT02087943|18857144|P4|COMPLETED|Placebo-Controlled Phase Week 0-12||0
7657076|NCT02087943|18857145|P3|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50
7657077|NCT02087943|18857146|P2|COMPLETED|Placebo-Controlled Phase Week 0-12||46
7657078|NCT02087943|18857147|P1|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50
7657079|NCT02087943|18857143|P5|Safety Population|Placebo-Controlled Phase Week 0-12||0
7657080|NCT02087943|18857144|P4|Safety Population|Placebo-Controlled Phase Week 0-12||0
7657081|NCT02087943|18857145|P3|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63
7657082|NCT02087943|18857146|P2|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58
7657083|NCT02087943|18857147|P1|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64
7657084|NCT02087943|18857143|P5|STARTED|Placebo-Controlled Phase Week 0-12||0
7657085|NCT02087943|18857144|P4|STARTED|Placebo-Controlled Phase Week 0-12||0
7657086|NCT02087943|18857145|P3|STARTED|Placebo-Controlled Phase Week 0-12||63
7657087|NCT02087943|18857146|P2|STARTED|Placebo-Controlled Phase Week 0-12||58
7657088|NCT02087943|18857147|P1|STARTED|Placebo-Controlled Phase Week 0-12||64
7657089|NCT02087904|18857175|P4|NOT COMPLETED|Overall Study||25
7657090|NCT02087904|18857176|P3|NOT COMPLETED|Overall Study||22
7657091|NCT02087904|18857177|P2|NOT COMPLETED|Overall Study||19
7657092|NCT02087904|18857178|P1|NOT COMPLETED|Overall Study||25
7657093|NCT02087904|18857175|P4|COMPLETED|Overall Study||64
7657094|NCT02087904|18857176|P3|COMPLETED|Overall Study||65
7657095|NCT02087904|18857177|P2|COMPLETED|Overall Study||70
7657096|NCT02087904|18857178|P1|COMPLETED|Overall Study||60
7657097|NCT02087904|18857175|P4|STARTED|Overall Study||89
7657098|NCT02087904|18857176|P3|STARTED|Overall Study||87
7657099|NCT02087904|18857177|P2|STARTED|Overall Study||89
7657100|NCT02087904|18857178|P1|STARTED|Overall Study||85
7657101|NCT02087774|18857294|P2|NOT COMPLETED|Overall Study||20
7657102|NCT02087774|18857295|P1|NOT COMPLETED|Overall Study||8
7657103|NCT02087774|18857294|P2|COMPLETED|Overall Study||130
7657104|NCT02087774|18857295|P1|COMPLETED|Overall Study||142
7657105|NCT02087774|18857294|P2|STARTED|Overall Study||150
7657106|NCT02087774|18857295|P1|STARTED|Overall Study||150
7657107|NCT02087748|18857303|P1|NOT COMPLETED|Overall Study||0
7657108|NCT02087748|18857303|P1|COMPLETED|Overall Study||24
7657109|NCT02087748|18857303|P1|STARTED|Overall Study||24
7657110|NCT02087670|18857315|P2|NOT COMPLETED|Overall Study||2
7657111|NCT02087670|18857316|P1|NOT COMPLETED|Overall Study||3
7657112|NCT02087670|18857315|P2|COMPLETED|Overall Study||20
7657113|NCT02087670|18857316|P1|COMPLETED|Overall Study||17
7657114|NCT02087670|18857315|P2|STARTED|Overall Study||22
7657115|NCT02087670|18857316|P1|STARTED|Overall Study||20
7657116|NCT02087514|18857330|P6|NOT COMPLETED|Overall Study||1
7657117|NCT02087514|18857331|P5|NOT COMPLETED|Overall Study||0
7657118|NCT02087514|18857332|P4|NOT COMPLETED|Overall Study||2
7657119|NCT02087514|18857333|P3|NOT COMPLETED|Overall Study||3
7657120|NCT02087514|18857334|P2|NOT COMPLETED|Overall Study||0
7657121|NCT02087514|18857335|P1|NOT COMPLETED|Overall Study||2
7657122|NCT02087514|18857330|P6|COMPLETED|Overall Study||9
7657123|NCT02087514|18857331|P5|COMPLETED|Overall Study||10
7657124|NCT02087514|18857332|P4|COMPLETED|Overall Study||8
7657125|NCT02087514|18857333|P3|COMPLETED|Overall Study||7
7657126|NCT02087514|18857334|P2|COMPLETED|Overall Study||10
7657127|NCT02087514|18857335|P1|COMPLETED|Overall Study||8
7657128|NCT02087514|18857330|P6|STARTED|Overall Study||10
7657129|NCT02087514|18857331|P5|STARTED|Overall Study||10
7657130|NCT02087514|18857332|P4|STARTED|Overall Study||10
7657131|NCT02087514|18857333|P3|STARTED|Overall Study||10
7657132|NCT02087514|18857334|P2|STARTED|Overall Study||10
7657133|NCT02087514|18857335|P1|STARTED|Overall Study||10
7657134|NCT02087423|18857352|P3|NOT COMPLETED|Overall Study||68
7657135|NCT02087423|18857353|P2|NOT COMPLETED|Overall Study||265
7657136|NCT02087423|18857354|P1|NOT COMPLETED|Overall Study||111
7657137|NCT02087423|18857352|P3|COMPLETED|Overall Study||0
7657138|NCT02087423|18857353|P2|COMPLETED|Overall Study||0
7657139|NCT02087423|18857354|P1|COMPLETED|Overall Study||0
7657140|NCT02087423|18857352|P3|Completed 12 Months of Treatment|Overall Study||26
7657141|NCT02087423|18857353|P2|Completed 12 Months of Treatment|Overall Study||60
7657142|NCT02087423|18857354|P1|Completed 12 Months of Treatment|Overall Study||18
7657143|NCT02087423|18857352|P3|STARTED|Overall Study|Treated|68
7657144|NCT02087423|18857353|P2|STARTED|Overall Study|Treated|265
7657145|NCT02087423|18857354|P1|STARTED|Overall Study|Treated|111
7657146|NCT02087241|18857383|P4|NOT COMPLETED|Overall Study||7
7657147|NCT02087241|18857384|P3|NOT COMPLETED|Overall Study||1
7657148|NCT02087241|18857385|P2|NOT COMPLETED|Overall Study||3
7657149|NCT02087241|18857386|P1|NOT COMPLETED|Overall Study||3
7657150|NCT02087241|18857383|P4|COMPLETED|Overall Study||0
7657151|NCT02087241|18857384|P3|COMPLETED|Overall Study||0
7657152|NCT02087241|18857385|P2|COMPLETED|Overall Study||0
7657153|NCT02087241|18857386|P1|COMPLETED|Overall Study||0
7657154|NCT02087241|18857383|P4|STARTED|Overall Study||7
7657155|NCT02087241|18857384|P3|STARTED|Overall Study||1
7657156|NCT02087241|18857385|P2|STARTED|Overall Study||3
7657157|NCT02087241|18857386|P1|STARTED|Overall Study||3
7657158|NCT02087176|18857412|P1|NOT COMPLETED|Overall Study||32
7657159|NCT02087176|18857412|P1|COMPLETED|Overall Study|The sponsor terminated the study early.|0
7657160|NCT02087176|18857412|P1|STARTED|Overall Study||32
7657161|NCT02087163|18857417|P1|NOT COMPLETED|Overall Study||17
7657162|NCT02087163|18857417|P1|COMPLETED|Overall Study||73
7657163|NCT02087163|18857417|P1|STARTED|Overall Study||90
7657164|NCT02087150|18857425|P3|NOT COMPLETED|Overall Study||11
7657165|NCT02087150|18857426|P2|NOT COMPLETED|Overall Study||34
7657166|NCT02087150|18857427|P1|NOT COMPLETED|Overall Study||10
7657167|NCT02087150|18857425|P3|COMPLETED|Overall Study||69
7657168|NCT02087150|18857426|P2|COMPLETED|Overall Study||128
7657169|NCT02087150|18857427|P1|COMPLETED|Overall Study||71
7657170|NCT02087150|18857425|P3|Received a Crossover MM ETBC Procedure|Overall Study||70
7657171|NCT02087150|18857426|P2|Received a Crossover MM ETBC Procedure|Overall Study||0
7657172|NCT02087150|18857427|P1|Received a Crossover MM ETBC Procedure|Overall Study||0
7657173|NCT02087150|18857425|P3|Had a Lead-in or Randomized ETBC Proc|Overall Study||0
7657174|NCT02087150|18857426|P2|Had a Lead-in or Randomized ETBC Proc|Overall Study||149
7657175|NCT02087150|18857427|P1|Had a Lead-in or Randomized ETBC Proc|Overall Study||80
7657176|NCT02087150|18857425|P3|STARTED|Overall Study||80
7657177|NCT02087150|18857426|P2|STARTED|Overall Study||162
7657178|NCT02087150|18857427|P1|STARTED|Overall Study||81
7657179|NCT02087085|18857446|P2|NOT COMPLETED|Overall Study||116
7657180|NCT02087085|18857447|P1|NOT COMPLETED|Overall Study||120
7657181|NCT02087085|18857446|P2|COMPLETED|Overall Study||40
7657182|NCT02087085|18857447|P1|COMPLETED|Overall Study||34
7657183|NCT02087085|18857446|P2|STARTED|Overall Study||156
7657184|NCT02087085|18857447|P1|STARTED|Overall Study||154
7657185|NCT02087059|18857457|P1|NOT COMPLETED|Overall Study||7
7657186|NCT02087059|18857457|P1|COMPLETED|Overall Study||44
7657187|NCT02087059|18857457|P1|STARTED|Overall Study||51
7657188|NCT02086968|18857467|P2|NOT COMPLETED|Overall Study||13
7657189|NCT02086968|18857468|P1|NOT COMPLETED|Overall Study||8
7657190|NCT02086968|18857467|P2|COMPLETED|Overall Study||85
7657191|NCT02086968|18857468|P1|COMPLETED|Overall Study||92
7657192|NCT02086968|18857467|P2|STARTED|Overall Study||98
7657193|NCT02086968|18857468|P1|STARTED|Overall Study||100
7657194|NCT02086786|18857476|P2|NOT COMPLETED|Overall Study||16
7657195|NCT02086786|18857477|P1|NOT COMPLETED|Overall Study||18
7657196|NCT02086786|18857476|P2|COMPLETED|Overall Study||19
7657197|NCT02086786|18857477|P1|COMPLETED|Overall Study||17
7657198|NCT02086786|18857476|P2|STARTED|Overall Study||35
7657199|NCT02086786|18857477|P1|STARTED|Overall Study||35
7657200|NCT02086708|18857501|P1|NOT COMPLETED|Overall Study||0
7657201|NCT02086708|18857501|P1|COMPLETED|Overall Study||24
7657202|NCT02086708|18857501|P1|STARTED|Overall Study||24
7657203|NCT02086682|18857515|P2|NOT COMPLETED|Overall Study||0
7657204|NCT02086682|18857516|P1|NOT COMPLETED|Overall Study||0
7657205|NCT02086682|18857515|P2|COMPLETED|Overall Study||182
7657206|NCT02086682|18857516|P1|COMPLETED|Overall Study||156
7657207|NCT02086682|18857515|P2|STARTED|Overall Study||182
7657208|NCT02086682|18857516|P1|STARTED|Overall Study||156
7657209|NCT02086591|18857522|P1|NOT COMPLETED|Overall Study||5
7657210|NCT02086591|18857522|P1|COMPLETED|Overall Study||2
7657211|NCT02086591|18857522|P1|STARTED|Overall Study||7
7657212|NCT02086565|18857530|P2|NOT COMPLETED|Overall Study||12
7657213|NCT02086565|18857531|P1|NOT COMPLETED|Overall Study||16
7657214|NCT02086565|18857530|P2|COMPLETED|Overall Study||138
7657215|NCT02086565|18857531|P1|COMPLETED|Overall Study||135
7657216|NCT02086565|18857530|P2|STARTED|Overall Study||150
7657217|NCT02086565|18857531|P1|STARTED|Overall Study||151
7657218|NCT02086552|18857545|P1|NOT COMPLETED|Overall Study||1
7657219|NCT02086552|18857545|P1|COMPLETED|Overall Study||27
7657220|NCT02086552|18857545|P1|STARTED|Overall Study||28
7657221|NCT02086500|18857554|P2|NOT COMPLETED|Overall Study||0
7657222|NCT02086500|18857555|P1|NOT COMPLETED|Overall Study||0
7657223|NCT02086500|18857554|P2|COMPLETED|Overall Study||456
7657224|NCT02086500|18857555|P1|COMPLETED|Overall Study||447
7657225|NCT02086500|18857554|P2|STARTED|Overall Study||456
7657226|NCT02086500|18857555|P1|STARTED|Overall Study||447
7657227|NCT02086331|18857573|P1|NOT COMPLETED|Overall Study||0
7657228|NCT02086331|18857573|P1|COMPLETED|Overall Study||5
7657229|NCT02086331|18857573|P1|STARTED|Overall Study||5
7657230|NCT02086162|18857588|P2|NOT COMPLETED|Overall Study||7
7657231|NCT02086162|18857589|P1|NOT COMPLETED|Overall Study||10
7657232|NCT02086162|18857588|P2|COMPLETED|Overall Study||77
7657233|NCT02086162|18857589|P1|COMPLETED|Overall Study||68
7657234|NCT02086162|18857588|P2|STARTED|Overall Study||84
7657235|NCT02086162|18857589|P1|STARTED|Overall Study||78
7657236|NCT02086110|18857601|P2|NOT COMPLETED|Overall Study||1
7657237|NCT02086110|18857602|P1|NOT COMPLETED|Overall Study||1
7657238|NCT02086110|18857601|P2|COMPLETED|Overall Study||5
7657239|NCT02086110|18857602|P1|COMPLETED|Overall Study||4
7657240|NCT02086110|18857601|P2|STARTED|Overall Study||6
7657241|NCT02086110|18857602|P1|STARTED|Overall Study||5
7657242|NCT02085785|18857613|P2|NOT COMPLETED|Overall Study||2
7657243|NCT02085785|18857614|P1|NOT COMPLETED|Overall Study||2
7657244|NCT02085785|18857613|P2|COMPLETED|Overall Study||6
7657245|NCT02085785|18857614|P1|COMPLETED|Overall Study||5
7657246|NCT02085785|18857613|P2|STARTED|Overall Study||8
7657247|NCT02085785|18857614|P1|STARTED|Overall Study||7
7657248|NCT02085720|18857626|P1|NOT COMPLETED|Overall Study||0
7657249|NCT02085720|18857626|P1|COMPLETED|Overall Study||819
7657250|NCT02085720|18857626|P1|STARTED|Overall Study||819
7657251|NCT02085551|18857634|P1|NOT COMPLETED|Overall Study||0
7657252|NCT02085551|18857634|P1|COMPLETED|Overall Study||85
7657253|NCT02085551|18857634|P1|STARTED|Overall Study||85
7657254|NCT02085473|18857643|P4|NOT COMPLETED|Overall Study||0
7657255|NCT02085473|18857644|P3|NOT COMPLETED|Overall Study||0
7657256|NCT02085473|18857645|P2|NOT COMPLETED|Overall Study||0
7657257|NCT02085473|18857646|P1|NOT COMPLETED|Overall Study||0
7657258|NCT02085473|18857643|P4|COMPLETED|Overall Study||15
7657259|NCT02085473|18857644|P3|COMPLETED|Overall Study||15
7657260|NCT02085473|18857645|P2|COMPLETED|Overall Study||15
7657261|NCT02085473|18857646|P1|COMPLETED|Overall Study||15
7657262|NCT02085473|18857643|P4|STARTED|Overall Study||15
7657263|NCT02085473|18857644|P3|STARTED|Overall Study||15
7657264|NCT02085473|18857645|P2|STARTED|Overall Study||15
7657265|NCT02085473|18857646|P1|STARTED|Overall Study||15
7657266|NCT02085447|18857708|P1|NOT COMPLETED|Overall Study||4
7657267|NCT02085447|18857708|P1|COMPLETED|Overall Study||26
7657268|NCT02085447|18857708|P1|STARTED|Overall Study||30
7657269|NCT02085356|18857737|P4|NOT COMPLETED|Overall Study||0
7657270|NCT02085356|18857738|P3|NOT COMPLETED|Overall Study||0
7657271|NCT02085356|18857739|P2|NOT COMPLETED|Overall Study||0
7657272|NCT02085356|18857740|P1|NOT COMPLETED|Overall Study||0
7657273|NCT02085356|18857737|P4|COMPLETED|Overall Study||361
7657274|NCT02085356|18857738|P3|COMPLETED|Overall Study||681
7657275|NCT02085356|18857739|P2|COMPLETED|Overall Study||348
7657276|NCT02085356|18857740|P1|COMPLETED|Overall Study||577
7657277|NCT02085356|18857737|P4|STARTED|Overall Study||361
7657278|NCT02085356|18857738|P3|STARTED|Overall Study||681
7657279|NCT02085356|18857739|P2|STARTED|Overall Study||348
7657280|NCT02085356|18857740|P1|STARTED|Overall Study||577
7657281|NCT02085252|18857768|P2|NOT COMPLETED|Overall Study||4
7657282|NCT02085252|18857769|P1|NOT COMPLETED|Overall Study||1
7657283|NCT02085252|18857768|P2|COMPLETED|Overall Study||53
7657284|NCT02085252|18857769|P1|COMPLETED|Overall Study||57
7657285|NCT02085252|18857768|P2|STARTED|Overall Study||57
7657286|NCT02085252|18857769|P1|STARTED|Overall Study||58
7657287|NCT02085161|18857793|P4|NOT COMPLETED|Overall Study||10
7657288|NCT02085161|18857794|P3|NOT COMPLETED|Overall Study||5
7657289|NCT02085161|18857795|P2|NOT COMPLETED|Overall Study||10
7657290|NCT02085161|18857796|P1|NOT COMPLETED|Overall Study||12
7657291|NCT02085161|18857793|P4|COMPLETED|Overall Study||66
7657292|NCT02085161|18857794|P3|COMPLETED|Overall Study||71
7657293|NCT02085161|18857795|P2|COMPLETED|Overall Study||66
7657294|NCT02085161|18857796|P1|COMPLETED|Overall Study||64
7657295|NCT02085161|18857793|P4|STARTED|Overall Study||76
7657296|NCT02085161|18857794|P3|STARTED|Overall Study||76
7657297|NCT02085161|18857795|P2|STARTED|Overall Study||76
7657298|NCT02085161|18857796|P1|STARTED|Overall Study||76
7657299|NCT02085135|18857837|P2|NOT COMPLETED|Overall Study||9
7657300|NCT02085135|18857838|P1|NOT COMPLETED|Overall Study||11
7657301|NCT02085135|18857837|P2|COMPLETED|Overall Study||23
7657302|NCT02085135|18857838|P1|COMPLETED|Overall Study||23
7657303|NCT02085135|18857837|P2|STARTED|Overall Study||32
7657304|NCT02085135|18857838|P1|STARTED|Overall Study||34
7657305|NCT02084797|18857844|P1|NOT COMPLETED|Overall Study||0
7657306|NCT02084797|18857844|P1|COMPLETED|Overall Study||10
7657307|NCT02084797|18857844|P1|STARTED|Overall Study||10
7657308|NCT02084706|18857853|P2|NOT COMPLETED|Overall Study||0
7657309|NCT02084706|18857854|P1|NOT COMPLETED|Overall Study||0
7657310|NCT02084706|18857853|P2|COMPLETED|Overall Study||31
7657311|NCT02084706|18857854|P1|COMPLETED|Overall Study||29
7657312|NCT02084706|18857853|P2|STARTED|Overall Study||31
7657313|NCT02084706|18857854|P1|STARTED|Overall Study||29
7657314|NCT02084628|18857860|P1|NOT COMPLETED|Overall Study||0
7657315|NCT02084628|18857860|P1|COMPLETED|Overall Study||1
7657316|NCT02084628|18857860|P1|STARTED|Overall Study||1
7657317|NCT02084511|18857877|P4|NOT COMPLETED|Overall Study||0
7657318|NCT02084511|18857878|P3|NOT COMPLETED|Overall Study||0
7657319|NCT02084511|18857879|P2|NOT COMPLETED|Overall Study||0
7657320|NCT02084511|18857880|P1|NOT COMPLETED|Overall Study||0
7657321|NCT02084511|18857877|P4|COMPLETED|Overall Study||20
7657322|NCT02084511|18857878|P3|COMPLETED|Overall Study||20
7657323|NCT02084511|18857879|P2|COMPLETED|Overall Study||20
7657324|NCT02084511|18857880|P1|COMPLETED|Overall Study||20
7657325|NCT02084511|18857877|P4|STARTED|Overall Study||20
7657326|NCT02084511|18857878|P3|STARTED|Overall Study||20
7657327|NCT02084511|18857879|P2|STARTED|Overall Study||20
7657328|NCT02084511|18857880|P1|STARTED|Overall Study||20
7657329|NCT02084238|18857910|P1|NOT COMPLETED|Overall Study||2
7657330|NCT02084238|18857910|P1|COMPLETED|Overall Study||38
7657331|NCT02084238|18857910|P1|STARTED|Overall Study||40
7657332|NCT02084160|18857921|P1|NOT COMPLETED|Overall Study||0
7657333|NCT02084160|18857921|P1|COMPLETED|Overall Study||579
7657334|NCT02084160|18857921|P1|STARTED|Overall Study||579
7657335|NCT02084147|18857925|P1|NOT COMPLETED|Overall Study||0
7657336|NCT02084147|18857925|P1|COMPLETED|Overall Study||72
7657337|NCT02084147|18857925|P1|STARTED|Overall Study||72
7657338|NCT02084134|18857935|P2|NOT COMPLETED|Overall Study||3
7657339|NCT02084134|18857936|P1|NOT COMPLETED|Overall Study||4
7657340|NCT02084134|18857935|P2|COMPLETED|Overall Study||17
7657341|NCT02084134|18857936|P1|COMPLETED|Overall Study||19
7657342|NCT02084134|18857935|P2|STARTED|Overall Study||20
7657343|NCT02084134|18857936|P1|STARTED|Overall Study||23
7657344|NCT02084082|18857946|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7657345|NCT02084082|18857947|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7657346|NCT02084082|18857948|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7657347|NCT02084082|18857949|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7657348|NCT02084082|18857946|P4|COMPLETED|Treatment Period 2 (4 Days)||6
7657349|NCT02084082|18857947|P3|COMPLETED|Treatment Period 2 (4 Days)||7
7657350|NCT02084082|18857948|P2|COMPLETED|Treatment Period 2 (4 Days)||26
7657351|NCT02084082|18857949|P1|COMPLETED|Treatment Period 2 (4 Days)||26
7657352|NCT02084082|18857946|P4|STARTED|Treatment Period 2 (4 Days)||6
7657353|NCT02084082|18857947|P3|STARTED|Treatment Period 2 (4 Days)||7
7657354|NCT02084082|18857948|P2|STARTED|Treatment Period 2 (4 Days)||26
7657355|NCT02084082|18857949|P1|STARTED|Treatment Period 2 (4 Days)||26
7657356|NCT02084082|18857946|P4|NOT COMPLETED|Washout Period 1 (35 Days)||2
7657357|NCT02084082|18857947|P3|NOT COMPLETED|Washout Period 1 (35 Days)||1
7657358|NCT02084082|18857948|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
7657359|NCT02084082|18857949|P1|NOT COMPLETED|Washout Period 1 (35 Days)||0
7657360|NCT02084082|18857946|P4|COMPLETED|Washout Period 1 (35 Days)||6
7657361|NCT02084082|18857947|P3|COMPLETED|Washout Period 1 (35 Days)||7
7657362|NCT02084082|18857948|P2|COMPLETED|Washout Period 1 (35 Days)||26
7657363|NCT02084082|18857949|P1|COMPLETED|Washout Period 1 (35 Days)||26
7657364|NCT02084082|18857946|P4|STARTED|Washout Period 1 (35 Days)||8
7657365|NCT02084082|18857947|P3|STARTED|Washout Period 1 (35 Days)||8
7657366|NCT02084082|18857948|P2|STARTED|Washout Period 1 (35 Days)||26
7657367|NCT02084082|18857949|P1|STARTED|Washout Period 1 (35 Days)||26
7657368|NCT02084082|18857946|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
7657369|NCT02084082|18857947|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
7657370|NCT02084082|18857948|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
7657371|NCT02084082|18857949|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
7657372|NCT02084082|18857946|P4|COMPLETED|Treatment Period 1 (4 Days)||8
7657373|NCT02084082|18857947|P3|COMPLETED|Treatment Period 1 (4 Days)||8
7657374|NCT02084082|18857948|P2|COMPLETED|Treatment Period 1 (4 Days)||26
7657375|NCT02084082|18857949|P1|COMPLETED|Treatment Period 1 (4 Days)||26
7657376|NCT02084082|18857946|P4|STARTED|Treatment Period 1 (4 Days)||8
7657377|NCT02084082|18857947|P3|STARTED|Treatment Period 1 (4 Days)||8
7657378|NCT02084082|18857948|P2|STARTED|Treatment Period 1 (4 Days)||26
7657379|NCT02084082|18857949|P1|STARTED|Treatment Period 1 (4 Days)||26
7657380|NCT02084069|18857981|P2|NOT COMPLETED|Overall Study||0
7657381|NCT02084069|18857982|P1|NOT COMPLETED|Overall Study||0
7657382|NCT02084069|18857981|P2|COMPLETED|Overall Study||29
7657383|NCT02084069|18857982|P1|COMPLETED|Overall Study||29
7657384|NCT02084069|18857981|P2|STARTED|Overall Study||29
7657385|NCT02084069|18857982|P1|STARTED|Overall Study||29
7657386|NCT02084056|18857990|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7657387|NCT02084056|18857991|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7657388|NCT02084056|18857992|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7657389|NCT02084056|18857993|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7657390|NCT02084056|18857990|P4|COMPLETED|Treatment Period 2 (4 Days)||8
7657391|NCT02084056|18857991|P3|COMPLETED|Treatment Period 2 (4 Days)||8
7657392|NCT02084056|18857992|P2|COMPLETED|Treatment Period 2 (4 Days)||30
7657393|NCT02084056|18857993|P1|COMPLETED|Treatment Period 2 (4 Days)||26
7657394|NCT02084056|18857990|P4|STARTED|Treatment Period 2 (4 Days)||8
7657395|NCT02084056|18857991|P3|STARTED|Treatment Period 2 (4 Days)||8
7657396|NCT02084056|18857992|P2|STARTED|Treatment Period 2 (4 Days)||30
7657397|NCT02084056|18857993|P1|STARTED|Treatment Period 2 (4 Days)||26
7657398|NCT02084056|18857990|P4|NOT COMPLETED|Washout Period 1 (35 Days)||0
7657399|NCT02084056|18857991|P3|NOT COMPLETED|Washout Period 1 (35 Days)||0
7657400|NCT02084056|18857992|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
7657401|NCT02084056|18857993|P1|NOT COMPLETED|Washout Period 1 (35 Days)||1
7657402|NCT02084056|18857990|P4|COMPLETED|Washout Period 1 (35 Days)||8
7657403|NCT02084056|18857991|P3|COMPLETED|Washout Period 1 (35 Days)||8
7657404|NCT02084056|18857992|P2|COMPLETED|Washout Period 1 (35 Days)||30
7657405|NCT02084056|18857993|P1|COMPLETED|Washout Period 1 (35 Days)||26
7657406|NCT02084056|18857990|P4|STARTED|Washout Period 1 (35 Days)||8
7657407|NCT02084056|18857991|P3|STARTED|Washout Period 1 (35 Days)||8
7657408|NCT02084056|18857992|P2|STARTED|Washout Period 1 (35 Days)||30
7657409|NCT02084056|18857993|P1|STARTED|Washout Period 1 (35 Days)||27
7657410|NCT02084056|18857990|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
7657411|NCT02084056|18857991|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
7657412|NCT02084056|18857992|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
7657413|NCT02084056|18857993|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||1
7657414|NCT02084056|18857990|P4|COMPLETED|Treatment Period 1 (4 Days)||8
7657415|NCT02084056|18857991|P3|COMPLETED|Treatment Period 1 (4 Days)||8
7657416|NCT02084056|18857992|P2|COMPLETED|Treatment Period 1 (4 Days)||30
7657417|NCT02084056|18857993|P1|COMPLETED|Treatment Period 1 (4 Days)||27
7657418|NCT02084056|18857990|P4|STARTED|Treatment Period 1 (4 Days)||8
7657419|NCT02084056|18857991|P3|STARTED|Treatment Period 1 (4 Days)||8
7657420|NCT02084056|18857992|P2|STARTED|Treatment Period 1 (4 Days)||30
7657421|NCT02084056|18857993|P1|STARTED|Treatment Period 1 (4 Days)||28
7657422|NCT02083965|18858025|P2|NOT COMPLETED|Treatment Period||0
7657423|NCT02083965|18858026|P1|NOT COMPLETED|Treatment Period||1
7657424|NCT02083965|18858025|P2|COMPLETED|Treatment Period||8
7657425|NCT02083965|18858026|P1|COMPLETED|Treatment Period||9
7657426|NCT02083965|18858025|P2|STARTED|Treatment Period|1 participant completed PK period 1 and 2, then chose to withdraw and did not enter treatment period|8
7657427|NCT02083965|18858026|P1|STARTED|Treatment Period||10
7657428|NCT02083965|18858025|P2|NOT COMPLETED|PK Period 2||0
7657429|NCT02083965|18858026|P1|NOT COMPLETED|PK Period 2||0
7657430|NCT02083965|18858025|P2|COMPLETED|PK Period 2||9
7657431|NCT02083965|18858026|P1|COMPLETED|PK Period 2||10
7657432|NCT02083965|18858025|P2|STARTED|PK Period 2||9
7657433|NCT02083965|18858026|P1|STARTED|PK Period 2||10
7657434|NCT02083965|18858025|P2|NOT COMPLETED|Washout Period||0
7657435|NCT02083965|18858026|P1|NOT COMPLETED|Washout Period||0
7657436|NCT02083965|18858025|P2|COMPLETED|Washout Period||9
7657437|NCT02083965|18858026|P1|COMPLETED|Washout Period||10
7657438|NCT02083965|18858025|P2|STARTED|Washout Period||9
7657439|NCT02083965|18858026|P1|STARTED|Washout Period||10
7657440|NCT02083965|18858025|P2|NOT COMPLETED|PK Period 1||0
7657441|NCT02083965|18858026|P1|NOT COMPLETED|PK Period 1||0
7657442|NCT02083965|18858025|P2|COMPLETED|PK Period 1||9
7657443|NCT02083965|18858026|P1|COMPLETED|PK Period 1||10
7657444|NCT02083965|18858025|P2|STARTED|PK Period 1||9
7657445|NCT02083965|18858026|P1|STARTED|PK Period 1||10
7657446|NCT02083861|18858084|P2|NOT COMPLETED|Overall Study||3
7657447|NCT02083861|18858085|P1|NOT COMPLETED|Overall Study||6
7657448|NCT02083861|18858084|P2|COMPLETED|Overall Study||33
7657449|NCT02083861|18858085|P1|COMPLETED|Overall Study||51
7657450|NCT02083861|18858084|P2|Treated|Overall Study||35
7657451|NCT02083861|18858085|P1|Treated|Overall Study||55
7657452|NCT02083861|18858084|P2|STARTED|Overall Study||36
7657453|NCT02083861|18858085|P1|STARTED|Overall Study||57
7657454|NCT02083809|18858099|P2|NOT COMPLETED|Overall Study||2
7657455|NCT02083809|18858100|P1|NOT COMPLETED|Overall Study||4
7657456|NCT02083809|18858099|P2|COMPLETED|Overall Study||82
7657457|NCT02083809|18858100|P1|COMPLETED|Overall Study||78
7657458|NCT02083809|18858099|P2|STARTED|Overall Study||84
7657459|NCT02083809|18858100|P1|STARTED|Overall Study||82
7657460|NCT02083783|18858108|P2|NOT COMPLETED|Overall Study||0
7657461|NCT02083783|18858109|P1|NOT COMPLETED|Overall Study||1
7657462|NCT02083783|18858108|P2|COMPLETED|Overall Study||48
7657463|NCT02083783|18858109|P1|COMPLETED|Overall Study||51
7657464|NCT02083783|18858108|P2|STARTED|Overall Study||48
7657465|NCT02083783|18858109|P1|STARTED|Overall Study||52
7657466|NCT02083679|18858121|P4|NOT COMPLETED|Overall Study||0
7657467|NCT02083679|18858122|P3|NOT COMPLETED|Overall Study||0
7657468|NCT02083679|18858123|P2|NOT COMPLETED|Overall Study||0
7657469|NCT02083679|18858124|P1|NOT COMPLETED|Overall Study||0
7657470|NCT02083679|18858121|P4|COMPLETED|Overall Study||3
7657471|NCT02083679|18858122|P3|COMPLETED|Overall Study||3
7657472|NCT02083679|18858123|P2|COMPLETED|Overall Study||6
7657473|NCT02083679|18858124|P1|COMPLETED|Overall Study||3
7657474|NCT02083679|18858121|P4|STARTED|Overall Study||3
7657475|NCT02083679|18858122|P3|STARTED|Overall Study||3
7657476|NCT02083679|18858123|P2|STARTED|Overall Study||6
7657477|NCT02083679|18858124|P1|STARTED|Overall Study||3
7657478|NCT02083653|18858141|P3|NOT COMPLETED|Overall Study||84
7657479|NCT02083653|18858142|P2|NOT COMPLETED|Overall Study||85
7657480|NCT02083653|18858143|P1|NOT COMPLETED|Overall Study||82
7657481|NCT02083653|18858141|P3|COMPLETED|Overall Study||1
7657482|NCT02083653|18858142|P2|COMPLETED|Overall Study||1
7657483|NCT02083653|18858143|P1|COMPLETED|Overall Study||1
7657484|NCT02083653|18858141|P3|STARTED|Overall Study||85
7657485|NCT02083653|18858142|P2|STARTED|Overall Study||86
7657486|NCT02083653|18858143|P1|STARTED|Overall Study||83
7657487|NCT02083406|18858189|P3|NOT COMPLETED|Overall Study||0
7657488|NCT02083406|18858190|P2|NOT COMPLETED|Overall Study||0
7657489|NCT02083406|18858191|P1|NOT COMPLETED|Overall Study||0
7657490|NCT02083406|18858189|P3|COMPLETED|Overall Study||7
7657491|NCT02083406|18858190|P2|COMPLETED|Overall Study||8
7657492|NCT02083406|18858191|P1|COMPLETED|Overall Study||7
7657493|NCT02083406|18858189|P3|STARTED|Overall Study||7
7657494|NCT02083406|18858190|P2|STARTED|Overall Study||8
7657495|NCT02083406|18858191|P1|STARTED|Overall Study||7
7657496|NCT02083380|18858211|P3|NOT COMPLETED|Overall Study||84
7657497|NCT02083380|18858212|P2|NOT COMPLETED|Overall Study||95
7657498|NCT02083380|18858213|P1|NOT COMPLETED|Overall Study||91
7657499|NCT02083380|18858211|P3|COMPLETED|Overall Study||65
7657500|NCT02083380|18858212|P2|COMPLETED|Overall Study||56
7657501|NCT02083380|18858213|P1|COMPLETED|Overall Study||57
7657502|NCT02083380|18858211|P3|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149
7657503|NCT02083380|18858212|P2|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151
7657504|NCT02083380|18858213|P1|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148
7657505|NCT02083263|18858308|P2|NOT COMPLETED|Overall Study||0
7657506|NCT02083263|18858309|P1|NOT COMPLETED|Overall Study||0
7657507|NCT02083263|18858308|P2|COMPLETED|Overall Study||16
7657508|NCT02083263|18858309|P1|COMPLETED|Overall Study||16
7657509|NCT02083263|18858308|P2|STARTED|Overall Study||16
7657510|NCT02083263|18858309|P1|STARTED|Overall Study||16
7657511|NCT02083185|18858318|P3|NOT COMPLETED|Overall Study||7
7657512|NCT02083185|18858319|P2|NOT COMPLETED|Overall Study||29
7657513|NCT02083185|18858320|P1|NOT COMPLETED|Overall Study||20
7657514|NCT02083185|18858318|P3|COMPLETED|Overall Study||17
7657515|NCT02083185|18858319|P2|COMPLETED|Overall Study||27
7657516|NCT02083185|18858320|P1|COMPLETED|Overall Study||36
7657517|NCT02083185|18858318|P3|Safety Population|Overall Study||24
7657518|NCT02083185|18858319|P2|Safety Population|Overall Study||54
7657519|NCT02083185|18858320|P1|Safety Population|Overall Study||56
7657520|NCT02083185|18858318|P3|STARTED|Overall Study||24
7657521|NCT02083185|18858319|P2|STARTED|Overall Study||56
7657522|NCT02083185|18858320|P1|STARTED|Overall Study||56
7657523|NCT02083107|18858378|P3|NOT COMPLETED|Overall Study||0
7657524|NCT02083107|18858379|P2|NOT COMPLETED|Overall Study||0
7657525|NCT02083107|18858380|P1|NOT COMPLETED|Overall Study||0
7657526|NCT02083107|18858378|P3|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
7657527|NCT02083107|18858379|P2|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
7657528|NCT02083107|18858380|P1|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
7657529|NCT02083107|18858378|P3|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
7657530|NCT02083107|18858379|P2|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
7657531|NCT02083107|18858380|P1|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
7657532|NCT02082977|18858425|P10|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
7657533|NCT02082977|18858426|P9|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
7657534|NCT02082977|18858427|P8|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
7657535|NCT02082977|18858428|P7|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
7657536|NCT02082977|18858429|P6|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
7657537|NCT02082977|18858430|P5|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
7657538|NCT02082977|18858431|P4|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
7657539|NCT02082977|18858432|P3|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
7657540|NCT02082977|18858433|P2|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
7657541|NCT02082977|18858434|P1|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
7657542|NCT02082977|18858425|P10|COMPLETED|Part 2 (Up to 3.2 Years)||0
7657543|NCT02082977|18858426|P9|COMPLETED|Part 2 (Up to 3.2 Years)||0
7657544|NCT02082977|18858427|P8|COMPLETED|Part 2 (Up to 3.2 Years)||0
7657545|NCT02082977|18858428|P7|COMPLETED|Part 2 (Up to 3.2 Years)||0
7657546|NCT02082977|18858429|P6|COMPLETED|Part 2 (Up to 3.2 Years)||0
7657547|NCT02082977|18858430|P5|COMPLETED|Part 2 (Up to 3.2 Years)||0
7657548|NCT02082977|18858431|P4|COMPLETED|Part 2 (Up to 3.2 Years)||0
7657549|NCT02082977|18858432|P3|COMPLETED|Part 2 (Up to 3.2 Years)||0
7657550|NCT02082977|18858433|P2|COMPLETED|Part 2 (Up to 3.2 Years)||0
7657551|NCT02082977|18858434|P1|COMPLETED|Part 2 (Up to 3.2 Years)||0
7657552|NCT02082977|18858425|P10|STARTED|Part 2 (Up to 3.2 Years)||0
7657553|NCT02082977|18858426|P9|STARTED|Part 2 (Up to 3.2 Years)||0
7657554|NCT02082977|18858427|P8|STARTED|Part 2 (Up to 3.2 Years)||0
7657555|NCT02082977|18858428|P7|STARTED|Part 2 (Up to 3.2 Years)||0
7657556|NCT02082977|18858429|P6|STARTED|Part 2 (Up to 3.2 Years)||0
7657557|NCT02082977|18858430|P5|STARTED|Part 2 (Up to 3.2 Years)||0
7657558|NCT02082977|18858431|P4|STARTED|Part 2 (Up to 3.2 Years)||0
7657559|NCT02082977|18858432|P3|STARTED|Part 2 (Up to 3.2 Years)||0
7657560|NCT02082977|18858433|P2|STARTED|Part 2 (Up to 3.2 Years)||0
7657561|NCT02082977|18858434|P1|STARTED|Part 2 (Up to 3.2 Years)||0
7657562|NCT02082977|18858425|P10|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
7657563|NCT02082977|18858426|P9|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
7657564|NCT02082977|18858427|P8|NOT COMPLETED|Part 1 (Up to 3.2 Years)||5
7657565|NCT02082977|18858428|P7|NOT COMPLETED|Part 1 (Up to 3.2 Years)||6
7657566|NCT02082977|18858429|P6|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
7657567|NCT02082977|18858430|P5|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
7657568|NCT02082977|18858431|P4|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
7657569|NCT02082977|18858432|P3|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
7657570|NCT02082977|18858433|P2|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
7657571|NCT02082977|18858434|P1|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
7657572|NCT02082977|18858425|P10|COMPLETED|Part 1 (Up to 3.2 Years)||0
7657573|NCT02082977|18858426|P9|COMPLETED|Part 1 (Up to 3.2 Years)||4
7657574|NCT02082977|18858427|P8|COMPLETED|Part 1 (Up to 3.2 Years)||7
7657575|NCT02082977|18858428|P7|COMPLETED|Part 1 (Up to 3.2 Years)||4
7657576|NCT02082977|18858429|P6|COMPLETED|Part 1 (Up to 3.2 Years)||1
7657577|NCT02082977|18858430|P5|COMPLETED|Part 1 (Up to 3.2 Years)||2
7657578|NCT02082977|18858431|P4|COMPLETED|Part 1 (Up to 3.2 Years)||1
7657579|NCT02082977|18858432|P3|COMPLETED|Part 1 (Up to 3.2 Years)||1
7657580|NCT02082977|18858433|P2|COMPLETED|Part 1 (Up to 3.2 Years)||1
7657581|NCT02082977|18858434|P1|COMPLETED|Part 1 (Up to 3.2 Years)||1
7657582|NCT02082977|18858425|P10|STARTED|Part 1 (Up to 3.2 Years)||0
7657583|NCT02082977|18858426|P9|STARTED|Part 1 (Up to 3.2 Years)||7
7657584|NCT02082977|18858427|P8|STARTED|Part 1 (Up to 3.2 Years)||12
7657585|NCT02082977|18858428|P7|STARTED|Part 1 (Up to 3.2 Years)||10
7657586|NCT02082977|18858429|P6|STARTED|Part 1 (Up to 3.2 Years)||4
7657587|NCT02082977|18858430|P5|STARTED|Part 1 (Up to 3.2 Years)||3
7657588|NCT02082977|18858431|P4|STARTED|Part 1 (Up to 3.2 Years)||1
7657589|NCT02082977|18858432|P3|STARTED|Part 1 (Up to 3.2 Years)||1
7657590|NCT02082977|18858433|P2|STARTED|Part 1 (Up to 3.2 Years)||1
7657591|NCT02082977|18858434|P1|STARTED|Part 1 (Up to 3.2 Years)||2
7657592|NCT02082912|18858688|P2|NOT COMPLETED|Overall Study||1
7657593|NCT02082912|18858689|P1|NOT COMPLETED|Overall Study||0
7657594|NCT02082912|18858688|P2|COMPLETED|Overall Study||6
7657595|NCT02082912|18858689|P1|COMPLETED|Overall Study||7
7657596|NCT02082912|18858688|P2|STARTED|Overall Study||7
7657597|NCT02082912|18858689|P1|STARTED|Overall Study||7
7657598|NCT02082769|18858706|P3|NOT COMPLETED|Overall Study||36
7657599|NCT02082769|18858707|P2|NOT COMPLETED|Overall Study||27
7657600|NCT02082769|18858708|P1|NOT COMPLETED|Overall Study||24
7657601|NCT02082769|18858706|P3|COMPLETED|Overall Study||132
7657602|NCT02082769|18858707|P2|COMPLETED|Overall Study||141
7657603|NCT02082769|18858708|P1|COMPLETED|Overall Study||144
7657604|NCT02082769|18858706|P3|STARTED|Overall Study||168
7657605|NCT02082769|18858707|P2|STARTED|Overall Study||168
7657606|NCT02082769|18858708|P1|STARTED|Overall Study||168
7657607|NCT02082678|18858724|P2|NOT COMPLETED|Overall Study||13
7657608|NCT02082678|18858725|P1|NOT COMPLETED|Overall Study||11
7657609|NCT02082678|18858724|P2|COMPLETED|Overall Study||22
7657610|NCT02082678|18858725|P1|COMPLETED|Overall Study||24
7657611|NCT02082678|18858724|P2|STARTED|Overall Study||35
7657612|NCT02082678|18858725|P1|STARTED|Overall Study||35
7657613|NCT02082522|18858737|P2|NOT COMPLETED|Overall Study||13
7657614|NCT02082522|18858738|P1|NOT COMPLETED|Overall Study||15
7657615|NCT02082522|18858737|P2|COMPLETED|Overall Study||0
7657616|NCT02082522|18858738|P1|COMPLETED|Overall Study||0
7657617|NCT02082522|18858737|P2|STARTED|Overall Study||13
7657618|NCT02082522|18858738|P1|STARTED|Overall Study||15
7657619|NCT02082483|18858788|P2|NOT COMPLETED|Overall Study||6
7657620|NCT02082483|18858789|P1|NOT COMPLETED|Overall Study||6
7657621|NCT02082483|18858788|P2|COMPLETED|Overall Study||67
7657622|NCT02082483|18858789|P1|COMPLETED|Overall Study||65
7657623|NCT02082483|18858788|P2|STARTED|Overall Study||73
7657624|NCT02082483|18858789|P1|STARTED|Overall Study||71
7657625|NCT02082392|18858806|P2|NOT COMPLETED|Overall Study||0
7657626|NCT02082392|18858807|P1|NOT COMPLETED|Overall Study||0
7657627|NCT02082392|18858806|P2|COMPLETED|Overall Study||1
7657628|NCT02082392|18858807|P1|COMPLETED|Overall Study||2
7657629|NCT02082392|18858806|P2|STARTED|Overall Study||1
7657630|NCT02082392|18858807|P1|STARTED|Overall Study||2
7657631|NCT02082340|18858841|P2|NOT COMPLETED|Overall Study||1
7657632|NCT02082340|18858842|P1|NOT COMPLETED|Overall Study||1
7657633|NCT02082340|18858841|P2|COMPLETED|Overall Study||197
7657634|NCT02082340|18858842|P1|COMPLETED|Overall Study||193
7657635|NCT02082340|18858841|P2|STARTED|Overall Study||198
7657636|NCT02082340|18858842|P1|STARTED|Overall Study||194
7657637|NCT02082288|18858848|P1|NOT COMPLETED|Overall Study||0
7657638|NCT02082288|18858848|P1|COMPLETED|Overall Study||243
7657639|NCT02082288|18858848|P1|STARTED|Overall Study||243
7657640|NCT02082262|18858852|P1|NOT COMPLETED|Overall Study||51
7657641|NCT02082262|18858852|P1|COMPLETED|Overall Study||89
7657642|NCT02082262|18858852|P1|STARTED|Overall Study||140
7657643|NCT02082210|18858862|P6|NOT COMPLETED|Overall Study||2
7657644|NCT02082210|18858863|P5|NOT COMPLETED|Overall Study||3
7657645|NCT02082210|18858864|P4|NOT COMPLETED|Overall Study||6
7657646|NCT02082210|18858865|P3|NOT COMPLETED|Overall Study||3
7657647|NCT02082210|18858866|P2|NOT COMPLETED|Overall Study||0
7657648|NCT02082210|18858867|P1|NOT COMPLETED|Overall Study||0
7657649|NCT02082210|18858862|P6|COMPLETED|Overall Study||13
7657650|NCT02082210|18858863|P5|COMPLETED|Overall Study||12
7657651|NCT02082210|18858864|P4|COMPLETED|Overall Study||39
7657652|NCT02082210|18858865|P3|COMPLETED|Overall Study||13
7657653|NCT02082210|18858866|P2|COMPLETED|Overall Study||3
7657654|NCT02082210|18858867|P1|COMPLETED|Overall Study||3
7657655|NCT02082210|18858862|P6|Received at Least One Dose of Study Drug|Overall Study||15
7657656|NCT02082210|18858863|P5|Received at Least One Dose of Study Drug|Overall Study||15
7657657|NCT02082210|18858864|P4|Received at Least One Dose of Study Drug|Overall Study||45
7657658|NCT02082210|18858865|P3|Received at Least One Dose of Study Drug|Overall Study||16
7657659|NCT02082210|18858866|P2|Received at Least One Dose of Study Drug|Overall Study||3
7657660|NCT02082210|18858867|P1|Received at Least One Dose of Study Drug|Overall Study||3
7657661|NCT02082210|18858862|P6|STARTED|Overall Study||15
7657662|NCT02082210|18858863|P5|STARTED|Overall Study||15
7657663|NCT02082210|18858864|P4|STARTED|Overall Study||45
7657664|NCT02082210|18858865|P3|STARTED|Overall Study||16
7657665|NCT02082210|18858866|P2|STARTED|Overall Study||3
7657666|NCT02082210|18858867|P1|STARTED|Overall Study||3
7657667|NCT02082184|18858915|P2|NOT COMPLETED|Overall Study||13
7657668|NCT02082184|18858916|P1|NOT COMPLETED|Overall Study||10
7657669|NCT02082184|18858915|P2|COMPLETED|Overall Study||62
7657670|NCT02082184|18858916|P1|COMPLETED|Overall Study||139
7657671|NCT02082184|18858915|P2|STARTED|Overall Study||75
7657672|NCT02082184|18858916|P1|STARTED|Overall Study||149
7657673|NCT02082158|18858941|P6|NOT COMPLETED|Overall Study||7
7657674|NCT02082158|18858942|P5|NOT COMPLETED|Overall Study||4
7657675|NCT02082158|18858943|P4|NOT COMPLETED|Overall Study||4
7657676|NCT02082158|18858944|P3|NOT COMPLETED|Overall Study||14
7657677|NCT02082158|18858945|P2|NOT COMPLETED|Overall Study||8
7657678|NCT02082158|18858946|P1|NOT COMPLETED|Overall Study||8
7657679|NCT02082158|18858941|P6|COMPLETED|Overall Study||56
7657680|NCT02082158|18858942|P5|COMPLETED|Overall Study||64
7657681|NCT02082158|18858943|P4|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68
7657682|NCT02082158|18858944|P3|COMPLETED|Overall Study||38
7657683|NCT02082158|18858945|P2|COMPLETED|Overall Study||53
7657684|NCT02082158|18858946|P1|COMPLETED|Overall Study||58
7657685|NCT02082158|18858941|P6|STARTED|Overall Study||63
7657686|NCT02082158|18858942|P5|STARTED|Overall Study||68
7657687|NCT02082158|18858943|P4|STARTED|Overall Study||72
7657688|NCT02082158|18858944|P3|STARTED|Overall Study||52
7657689|NCT02082158|18858945|P2|STARTED|Overall Study||61
7657690|NCT02082158|18858946|P1|STARTED|Overall Study||66
7657691|NCT02082145|18858968|P2|NOT COMPLETED|Overall Study||0
7657692|NCT02082145|18858969|P1|NOT COMPLETED|Overall Study||0
7657693|NCT02082145|18858968|P2|COMPLETED|Overall Study||9
7657694|NCT02082145|18858969|P1|COMPLETED|Overall Study||5
7657695|NCT02082145|18858968|P2|STARTED|Overall Study||9
7657696|NCT02082145|18858969|P1|STARTED|Overall Study||5
7657697|NCT02082119|18858981|P1|NOT COMPLETED|Overall Study||0
7657698|NCT02082119|18858981|P1|COMPLETED|Overall Study||82
7657699|NCT02082119|18858981|P1|STARTED|Overall Study||82
7657700|NCT02081963|18858987|P2|NOT COMPLETED|Overall Study||4
7657701|NCT02081963|18858988|P1|NOT COMPLETED|Overall Study||5
7657702|NCT02081963|18858987|P2|COMPLETED|Overall Study||69
7657703|NCT02081963|18858988|P1|COMPLETED|Overall Study||74
7657704|NCT02081963|18858987|P2|STARTED|Overall Study||73
7657705|NCT02081963|18858988|P1|STARTED|Overall Study||79
7657706|NCT02081950|18859002|P1|NOT COMPLETED|Treatment Period 2||0
7657707|NCT02081950|18859002|P1|COMPLETED|Treatment Period 2||14
7657708|NCT02081950|18859002|P1|STARTED|Treatment Period 2||14
7657709|NCT02081950|18859002|P1|NOT COMPLETED|Treatment Period 1||0
7657710|NCT02081950|18859002|P1|COMPLETED|Treatment Period 1||14
7657711|NCT02081950|18859002|P1|STARTED|Treatment Period 1||14
7657712|NCT02081859|18859076|P2|NOT COMPLETED|Overall Study||31
7657713|NCT02081859|18859077|P1|NOT COMPLETED|Overall Study||34
7657714|NCT02081859|18859076|P2|COMPLETED|Overall Study||119
7657715|NCT02081859|18859077|P1|COMPLETED|Overall Study||116
7657716|NCT02081859|18859076|P2|STARTED|Overall Study||150
7657717|NCT02081859|18859077|P1|STARTED|Overall Study||150
7657718|NCT02081846|18859087|P2|NOT COMPLETED|Overall Study||0
7657719|NCT02081846|18859088|P1|NOT COMPLETED|Overall Study||2
7657720|NCT02081846|18859087|P2|COMPLETED|Overall Study||749
7657721|NCT02081846|18859088|P1|COMPLETED|Overall Study||749
7657722|NCT02081846|18859087|P2|STARTED|Overall Study||749
7657723|NCT02081846|18859088|P1|STARTED|Overall Study||751
7657724|NCT02081807|18859114|P8|NOT COMPLETED|Overall Study||0
7657725|NCT02081807|18859115|P7|NOT COMPLETED|Overall Study||0
7657726|NCT02081807|18859116|P6|NOT COMPLETED|Overall Study||0
7657727|NCT02081807|18859117|P5|NOT COMPLETED|Overall Study||0
7657728|NCT02081807|18859118|P4|NOT COMPLETED|Overall Study||0
7657729|NCT02081807|18859119|P3|NOT COMPLETED|Overall Study||0
7657730|NCT02081807|18859120|P2|NOT COMPLETED|Overall Study||0
7657731|NCT02081807|18859121|P1|NOT COMPLETED|Overall Study||0
7657732|NCT02081807|18859114|P8|COMPLETED|Overall Study||19729
7657733|NCT02081807|18859115|P7|COMPLETED|Overall Study||40207
7657734|NCT02081807|18859116|P6|COMPLETED|Overall Study||76055
7657735|NCT02081807|18859117|P5|COMPLETED|Overall Study||27456
7657736|NCT02081807|18859118|P4|COMPLETED|Overall Study||9112
7657737|NCT02081807|18859119|P3|COMPLETED|Overall Study||14852
7657738|NCT02081807|18859120|P2|COMPLETED|Overall Study||26149
7657739|NCT02081807|18859121|P1|COMPLETED|Overall Study||7668
7657740|NCT02081807|18859114|P8|STARTED|Overall Study||19729
7657741|NCT02081807|18859115|P7|STARTED|Overall Study||40207
7657742|NCT02081807|18859116|P6|STARTED|Overall Study||76055
7657743|NCT02081807|18859117|P5|STARTED|Overall Study||27456
7657744|NCT02081807|18859118|P4|STARTED|Overall Study||9112
7657745|NCT02081807|18859119|P3|STARTED|Overall Study||14852
7657746|NCT02081807|18859120|P2|STARTED|Overall Study||26149
7657747|NCT02081807|18859121|P1|STARTED|Overall Study||7668
7657748|NCT02081690|18859257|P1|NOT COMPLETED|Overall Study||7
7657749|NCT02081690|18859257|P1|COMPLETED|Overall Study||81
7657750|NCT02081690|18859257|P1|STARTED|Overall Study||88
7657751|NCT02081677|18859268|P4|NOT COMPLETED|Overall Study||0
7657752|NCT02081677|18859269|P3|NOT COMPLETED|Overall Study||2
7657753|NCT02081677|18859270|P2|NOT COMPLETED|Overall Study||1
7657754|NCT02081677|18859271|P1|NOT COMPLETED|Overall Study||1
7657755|NCT02081677|18859268|P4|COMPLETED|Overall Study||19
7657756|NCT02081677|18859269|P3|COMPLETED|Overall Study||17
7657757|NCT02081677|18859270|P2|COMPLETED|Overall Study||18
7657758|NCT02081677|18859271|P1|COMPLETED|Overall Study||18
7657759|NCT02081677|18859268|P4|STARTED|Overall Study||19
7657760|NCT02081677|18859269|P3|STARTED|Overall Study||19
7657761|NCT02081677|18859270|P2|STARTED|Overall Study||19
7657762|NCT02081677|18859271|P1|STARTED|Overall Study||19
7657763|NCT02081638|18859363|P2|NOT COMPLETED|Overall Study||7
7657764|NCT02081638|18859364|P1|NOT COMPLETED|Overall Study||2
7657765|NCT02081638|18859363|P2|COMPLETED|Overall Study||20
7657766|NCT02081638|18859364|P1|COMPLETED|Overall Study||24
7657767|NCT02081638|18859363|P2|STARTED|Overall Study||27
7657768|NCT02081638|18859364|P1|STARTED|Overall Study||26
7657769|NCT02081599|18859376|P2|NOT COMPLETED|Period 2：Open-label Period||4
7657770|NCT02081599|18859377|P1|NOT COMPLETED|Period 2：Open-label Period||6
7657771|NCT02081599|18859376|P2|COMPLETED|Period 2：Open-label Period||71
7657772|NCT02081599|18859377|P1|COMPLETED|Period 2：Open-label Period||57
7657773|NCT02081599|18859376|P2|STARTED|Period 2：Open-label Period||75
7657774|NCT02081599|18859377|P1|STARTED|Period 2：Open-label Period||63
7657775|NCT02081599|18859376|P2|NOT COMPLETED|Period 1：Double-blind Period||2
7657776|NCT02081599|18859377|P1|NOT COMPLETED|Period 1：Double-blind Period||8
7657777|NCT02081599|18859376|P2|COMPLETED|Period 1：Double-blind Period||75
7657778|NCT02081599|18859377|P1|COMPLETED|Period 1：Double-blind Period||63
7657779|NCT02081599|18859376|P2|STARTED|Period 1：Double-blind Period||77
7657780|NCT02081599|18859377|P1|STARTED|Period 1：Double-blind Period||71
7657781|NCT02081586|18859395|P4|NOT COMPLETED|Overall Study||1
7657782|NCT02081586|18859396|P3|NOT COMPLETED|Overall Study||1
7657783|NCT02081586|18859397|P2|NOT COMPLETED|Overall Study||1
7657784|NCT02081586|18859398|P1|NOT COMPLETED|Overall Study||0
7657785|NCT02081586|18859395|P4|COMPLETED|Overall Study||2
7657786|NCT02081586|18859396|P3|COMPLETED|Overall Study||3
7657787|NCT02081586|18859397|P2|COMPLETED|Overall Study||2
7657788|NCT02081586|18859398|P1|COMPLETED|Overall Study||3
7657789|NCT02081586|18859395|P4|STARTED|Overall Study||3
7657790|NCT02081586|18859396|P3|STARTED|Overall Study||4
7657791|NCT02081586|18859397|P2|STARTED|Overall Study||3
7657792|NCT02081586|18859398|P1|STARTED|Overall Study||3
7657793|NCT02081573|18859425|P1|NOT COMPLETED|Overall Study||0
7657794|NCT02081573|18859425|P1|COMPLETED|Overall Study||10
7657795|NCT02081573|18859425|P1|STARTED|Overall Study||10
7657796|NCT02081534|18859441|P7|NOT COMPLETED|Overall Study||4
7657797|NCT02081534|18859442|P6|NOT COMPLETED|Overall Study||9
7657798|NCT02081534|18859443|P5|NOT COMPLETED|Overall Study||4
7657799|NCT02081534|18859444|P4|NOT COMPLETED|Overall Study||13
7657800|NCT02081534|18859445|P3|NOT COMPLETED|Overall Study||4
7657801|NCT02081534|18859446|P2|NOT COMPLETED|Overall Study||8
7657802|NCT02081534|18859447|P1|NOT COMPLETED|Overall Study||5
7657803|NCT02081534|18859441|P7|COMPLETED|Overall Study||22
7657804|NCT02081534|18859442|P6|COMPLETED|Overall Study||12
7657805|NCT02081534|18859443|P5|COMPLETED|Overall Study||18
7657806|NCT02081534|18859444|P4|COMPLETED|Overall Study||13
7657807|NCT02081534|18859445|P3|COMPLETED|Overall Study||19
7657808|NCT02081534|18859446|P2|COMPLETED|Overall Study||13
7657809|NCT02081534|18859447|P1|COMPLETED|Overall Study||18
7657810|NCT02081534|18859441|P7|STARTED|Overall Study||26
7657811|NCT02081534|18859442|P6|STARTED|Overall Study||21
7657812|NCT02081534|18859443|P5|STARTED|Overall Study||22
7657813|NCT02081534|18859444|P4|STARTED|Overall Study||26
7657814|NCT02081534|18859445|P3|STARTED|Overall Study||23
7657815|NCT02081534|18859446|P2|STARTED|Overall Study||21
7657816|NCT02081534|18859447|P1|STARTED|Overall Study||23
7657817|NCT02081456|18859472|P2|NOT COMPLETED|Overall Study||0
7657818|NCT02081456|18859473|P1|NOT COMPLETED|Overall Study||0
7657819|NCT02081456|18859472|P2|COMPLETED|Overall Study||12
7657820|NCT02081456|18859473|P1|COMPLETED|Overall Study||11
7657821|NCT02081456|18859472|P2|STARTED|Overall Study||12
7657822|NCT02081456|18859473|P1|STARTED|Overall Study||11
7657823|NCT02081443|18859487|P2|NOT COMPLETED|Overall Study||0
7657824|NCT02081443|18859488|P1|NOT COMPLETED|Overall Study||0
7657825|NCT02081443|18859487|P2|COMPLETED|Overall Study||30
7657826|NCT02081443|18859488|P1|COMPLETED|Overall Study||30
7657827|NCT02081443|18859487|P2|STARTED|Overall Study||30
7657828|NCT02081443|18859488|P1|STARTED|Overall Study||30
7657829|NCT02081417|18859500|P2|NOT COMPLETED|Overall Study||51
7657830|NCT02081417|18859501|P1|NOT COMPLETED|Overall Study||56
7657831|NCT02081417|18859500|P2|COMPLETED|Overall Study||115
7657832|NCT02081417|18859501|P1|COMPLETED|Overall Study||107
7657833|NCT02081417|18859500|P2|6-Month Follow-Up|Overall Study||92
7657834|NCT02081417|18859501|P1|6-Month Follow-Up|Overall Study||82
7657835|NCT02081417|18859500|P2|3-Month Follow-Up|Overall Study||95
7657836|NCT02081417|18859501|P1|3-Month Follow-Up|Overall Study||94
7657837|NCT02081417|18859500|P2|1st Interview Completed|Overall Study||145
7657838|NCT02081417|18859501|P1|1st Interview Completed|Overall Study||146
7657839|NCT02081417|18859500|P2|STARTED|Overall Study||166
7657840|NCT02081417|18859501|P1|STARTED|Overall Study|Randomized to intervention|163
7657841|NCT02081391|18859521|P4|NOT COMPLETED|24-hour Treatment and Trial Completion||0
7657842|NCT02081391|18859522|P3|NOT COMPLETED|24-hour Treatment and Trial Completion||1
7657843|NCT02081391|18859523|P2|NOT COMPLETED|24-hour Treatment and Trial Completion||18
7657844|NCT02081391|18859524|P1|NOT COMPLETED|24-hour Treatment and Trial Completion||27
7657845|NCT02081391|18859521|P4|COMPLETED|24-hour Treatment and Trial Completion||4
7657846|NCT02081391|18859522|P3|COMPLETED|24-hour Treatment and Trial Completion||9
7657847|NCT02081391|18859523|P2|COMPLETED|24-hour Treatment and Trial Completion||28
7657848|NCT02081391|18859524|P1|COMPLETED|24-hour Treatment and Trial Completion||63
7657849|NCT02081391|18859521|P4|STARTED|24-hour Treatment and Trial Completion||4
7657850|NCT02081391|18859522|P3|STARTED|24-hour Treatment and Trial Completion||10
7657851|NCT02081391|18859523|P2|STARTED|24-hour Treatment and Trial Completion||46
7657852|NCT02081391|18859524|P1|STARTED|24-hour Treatment and Trial Completion||90
7657853|NCT02081391|18859521|P4|NOT COMPLETED|12-hour Treatment||0
7657854|NCT02081391|18859522|P3|NOT COMPLETED|12-hour Treatment||1
7657855|NCT02081391|18859523|P2|NOT COMPLETED|12-hour Treatment||6
7657856|NCT02081391|18859524|P1|NOT COMPLETED|12-hour Treatment||18
7657857|NCT02081391|18859521|P4|COMPLETED|12-hour Treatment||4
7657858|NCT02081391|18859522|P3|COMPLETED|12-hour Treatment||10
7657859|NCT02081391|18859523|P2|COMPLETED|12-hour Treatment||46
7657860|NCT02081391|18859524|P1|COMPLETED|12-hour Treatment||90
7657861|NCT02081391|18859521|P4|STARTED|12-hour Treatment||4
7657862|NCT02081391|18859522|P3|STARTED|12-hour Treatment||11
7657863|NCT02081391|18859523|P2|STARTED|12-hour Treatment||52
7657864|NCT02081391|18859524|P1|STARTED|12-hour Treatment||108
7657865|NCT02081365|18859578|P2|NOT COMPLETED|Overall Study||23
7657866|NCT02081365|18859579|P1|NOT COMPLETED|Overall Study||30
7657867|NCT02081365|18859578|P2|COMPLETED|Overall Study||54
7657868|NCT02081365|18859579|P1|COMPLETED|Overall Study||44
7657869|NCT02081365|18859578|P2|Received Allocated Intervention|Overall Study||59
7657870|NCT02081365|18859579|P1|Received Allocated Intervention|Overall Study||46
7657871|NCT02081365|18859578|P2|STARTED|Overall Study||77
7657872|NCT02081365|18859579|P1|STARTED|Overall Study||74
7657873|NCT02081248|18859593|P2|NOT COMPLETED|Overall Study||13
7657874|NCT02081248|18859594|P1|NOT COMPLETED|Overall Study||22
7657875|NCT02081248|18859593|P2|COMPLETED|Overall Study||87
7657876|NCT02081248|18859594|P1|COMPLETED|Overall Study||76
7657877|NCT02081248|18859593|P2|STARTED|Overall Study||100
7657878|NCT02081248|18859594|P1|STARTED|Overall Study||98
7657879|NCT02081183|18859618|P2|NOT COMPLETED|Overall Study||4
7657880|NCT02081183|18859619|P1|NOT COMPLETED|Overall Study||4
7657881|NCT02081183|18859618|P2|COMPLETED|Overall Study||2
7657882|NCT02081183|18859619|P1|COMPLETED|Overall Study||1
7657883|NCT02081183|18859618|P2|STARTED|Overall Study||6
7657884|NCT02081183|18859619|P1|STARTED|Overall Study||5
7657885|NCT02081079|18859635|P2|NOT COMPLETED|Overall Study||2
7657886|NCT02081079|18859636|P1|NOT COMPLETED|Overall Study||4
7657887|NCT02081079|18859635|P2|COMPLETED|Overall Study||39
7657888|NCT02081079|18859636|P1|COMPLETED|Overall Study||40
7657889|NCT02081079|18859635|P2|STARTED|Overall Study||41
7657890|NCT02081079|18859636|P1|STARTED|Overall Study||44
7657891|NCT02081014|18859658|P6|NOT COMPLETED|Overall Study||0
7657892|NCT02081014|18859659|P5|NOT COMPLETED|Overall Study||0
7657893|NCT02081014|18859660|P4|NOT COMPLETED|Overall Study||0
7657894|NCT02081014|18859661|P3|NOT COMPLETED|Overall Study||0
7657895|NCT02081014|18859662|P2|NOT COMPLETED|Overall Study||0
7657896|NCT02081014|18859663|P1|NOT COMPLETED|Overall Study||0
7657897|NCT02081014|18859658|P6|COMPLETED|Overall Study||2
7657898|NCT02081014|18859659|P5|COMPLETED|Overall Study||2
7657899|NCT02081014|18859660|P4|COMPLETED|Overall Study||2
7657900|NCT02081014|18859661|P3|COMPLETED|Overall Study||2
7657901|NCT02081014|18859662|P2|COMPLETED|Overall Study||2
7657902|NCT02081014|18859663|P1|COMPLETED|Overall Study||2
7657903|NCT02081014|18859658|P6|STARTED|Overall Study||2
7657904|NCT02081014|18859659|P5|STARTED|Overall Study||2
7657905|NCT02081014|18859660|P4|STARTED|Overall Study||2
7657906|NCT02081014|18859661|P3|STARTED|Overall Study||2
7657907|NCT02081014|18859662|P2|STARTED|Overall Study||2
7657908|NCT02081014|18859663|P1|STARTED|Overall Study||2
7657909|NCT02081001|18859709|P12|NOT COMPLETED|Overall Study||0
7657910|NCT02081001|18859710|P11|NOT COMPLETED|Overall Study||0
7657911|NCT02081001|18859711|P10|NOT COMPLETED|Overall Study||0
7657912|NCT02081001|18859712|P9|NOT COMPLETED|Overall Study||0
7657913|NCT02081001|18859713|P8|NOT COMPLETED|Overall Study||0
7657914|NCT02081001|18859714|P7|NOT COMPLETED|Overall Study||0
7657915|NCT02081001|18859715|P6|NOT COMPLETED|Overall Study||0
7657916|NCT02081001|18859716|P5|NOT COMPLETED|Overall Study||1
7657917|NCT02081001|18859717|P4|NOT COMPLETED|Overall Study||0
7657918|NCT02081001|18859718|P3|NOT COMPLETED|Overall Study||0
7657919|NCT02081001|18859719|P2|NOT COMPLETED|Overall Study||0
7657920|NCT02081001|18859720|P1|NOT COMPLETED|Overall Study||0
7657921|NCT02081001|18859709|P12|COMPLETED|Overall Study||1
7657922|NCT02081001|18859710|P11|COMPLETED|Overall Study||2
7657923|NCT02081001|18859711|P10|COMPLETED|Overall Study||1
7657924|NCT02081001|18859712|P9|COMPLETED|Overall Study||2
7657925|NCT02081001|18859713|P8|COMPLETED|Overall Study||1
7657926|NCT02081001|18859714|P7|COMPLETED|Overall Study||2
7657927|NCT02081001|18859715|P6|COMPLETED|Overall Study||1
7657928|NCT02081001|18859716|P5|COMPLETED|Overall Study||2
7657929|NCT02081001|18859717|P4|COMPLETED|Overall Study||1
7657930|NCT02081001|18859718|P3|COMPLETED|Overall Study||2
7657931|NCT02081001|18859719|P2|COMPLETED|Overall Study||1
7657932|NCT02081001|18859720|P1|COMPLETED|Overall Study||2
7657933|NCT02081001|18859709|P12|STARTED|Overall Study||1
7657934|NCT02081001|18859710|P11|STARTED|Overall Study||2
7657935|NCT02081001|18859711|P10|STARTED|Overall Study||1
7657936|NCT02081001|18859712|P9|STARTED|Overall Study||2
7657937|NCT02081001|18859713|P8|STARTED|Overall Study||1
7657938|NCT02081001|18859714|P7|STARTED|Overall Study||2
7657939|NCT02081001|18859715|P6|STARTED|Overall Study||1
7657940|NCT02081001|18859716|P5|STARTED|Overall Study||3
7657941|NCT02081001|18859717|P4|STARTED|Overall Study||1
7657942|NCT02081001|18859718|P3|STARTED|Overall Study||2
7657943|NCT02081001|18859719|P2|STARTED|Overall Study||1
7657944|NCT02081001|18859720|P1|STARTED|Overall Study||2
7657945|NCT02080871|18859784|P1|NOT COMPLETED|Overall Study||2
7657946|NCT02080871|18859784|P1|COMPLETED|Overall Study||132
7657947|NCT02080871|18859784|P1|STARTED|Overall Study||134
7657948|NCT02080832|18859868|P3|NOT COMPLETED|Overall Study||16
7657949|NCT02080832|18859869|P2|NOT COMPLETED|Overall Study||12
7657950|NCT02080832|18859870|P1|NOT COMPLETED|Overall Study||9
7657951|NCT02080832|18859868|P3|COMPLETED|Overall Study||6
7657952|NCT02080832|18859869|P2|COMPLETED|Overall Study||5
7657953|NCT02080832|18859870|P1|COMPLETED|Overall Study||6
7657954|NCT02080832|18859868|P3|STARTED|Overall Study||22
7657955|NCT02080832|18859869|P2|STARTED|Overall Study||17
7657956|NCT02080832|18859870|P1|STARTED|Overall Study||15
7657957|NCT02080819|18859887|P3|NOT COMPLETED|Overall Study||22
7657958|NCT02080819|18859888|P2|NOT COMPLETED|Overall Study||26
7657959|NCT02080819|18859889|P1|NOT COMPLETED|Overall Study||25
7657960|NCT02080819|18859887|P3|COMPLETED|Overall Study||11
7657961|NCT02080819|18859888|P2|COMPLETED|Overall Study||9
7657962|NCT02080819|18859889|P1|COMPLETED|Overall Study||38
7657963|NCT02080819|18859887|P3|STARTED|Overall Study||33
7657964|NCT02080819|18859888|P2|STARTED|Overall Study||35
7657965|NCT02080819|18859889|P1|STARTED|Overall Study||63
7657966|NCT02080780|18859897|P1|NOT COMPLETED|Overall Study||0
7657967|NCT02080780|18859897|P1|COMPLETED|Overall Study||24
7657968|NCT02080780|18859897|P1|STARTED|Overall Study||24
7657969|NCT02080637|18859906|P2|NOT COMPLETED|Overall Study||0
7657970|NCT02080637|18859907|P1|NOT COMPLETED|Overall Study||0
7657971|NCT02080637|18859906|P2|COMPLETED|Overall Study||3
7657972|NCT02080637|18859907|P1|COMPLETED|Overall Study||13
7657973|NCT02080637|18859906|P2|STARTED|Overall Study||3
7657974|NCT02080637|18859907|P1|STARTED|Overall Study||13
7657975|NCT02080546|18859920|P2|NOT COMPLETED|Overall Study||11
7657976|NCT02080546|18859921|P1|NOT COMPLETED|Overall Study||8
7657977|NCT02080546|18859920|P2|COMPLETED|Overall Study||52
7657978|NCT02080546|18859921|P1|COMPLETED|Overall Study||49
7657979|NCT02080546|18859920|P2|STARTED|Overall Study||63
7657980|NCT02080546|18859921|P1|STARTED|Overall Study||57
7657981|NCT02080507|18859931|P2|NOT COMPLETED|Overall Study||0
7657982|NCT02080507|18859932|P1|NOT COMPLETED|Overall Study||0
7657983|NCT02080507|18859931|P2|COMPLETED|Overall Study||7
7657984|NCT02080507|18859932|P1|COMPLETED|Overall Study||5
7657985|NCT02080507|18859931|P2|STARTED|Overall Study||7
7657986|NCT02080507|18859932|P1|STARTED|Overall Study||5
7657987|NCT02080481|18859942|P2|NOT COMPLETED|Overall Study||0
7657988|NCT02080481|18859943|P1|NOT COMPLETED|Overall Study||1
7657989|NCT02080481|18859942|P2|COMPLETED|Overall Study||67
7657990|NCT02080481|18859943|P1|COMPLETED|Overall Study||67
7657991|NCT02080481|18859942|P2|STARTED|Overall Study||67
7657992|NCT02080481|18859943|P1|STARTED|Overall Study||68
7657993|NCT02080468|18859957|P2|NOT COMPLETED|Overall Study||2
7657994|NCT02080468|18859958|P1|NOT COMPLETED|Overall Study||2
7657995|NCT02080468|18859957|P2|COMPLETED|Overall Study||14
7657996|NCT02080468|18859958|P1|COMPLETED|Overall Study||14
7657997|NCT02080468|18859957|P2|STARTED|Overall Study||16
7657998|NCT02080468|18859958|P1|STARTED|Overall Study||16
7657999|NCT02080455|18860024|P2|NOT COMPLETED|Overall Study||0
7658000|NCT02080455|18860025|P1|NOT COMPLETED|Overall Study||0
7658001|NCT02080455|18860024|P2|COMPLETED|Overall Study||16
7658002|NCT02080455|18860025|P1|COMPLETED|Overall Study||16
7658003|NCT02080455|18860024|P2|STARTED|Overall Study||16
7658004|NCT02080455|18860025|P1|STARTED|Overall Study||16
7658005|NCT02080312|18860089|P1|NOT COMPLETED|Overall Study||0
7658006|NCT02080312|18860089|P1|COMPLETED|Overall Study||6
7658007|NCT02080312|18860089|P1|STARTED|Overall Study||6
7658008|NCT02080273|18860098|P3|NOT COMPLETED|Overall Study||0
7658009|NCT02080273|18860099|P2|NOT COMPLETED|Overall Study||0
7658010|NCT02080273|18860100|P1|NOT COMPLETED|Overall Study||0
7658011|NCT02080273|18860098|P3|COMPLETED|Overall Study||45
7658012|NCT02080273|18860099|P2|COMPLETED|Overall Study||45
7658013|NCT02080273|18860100|P1|COMPLETED|Overall Study||45
7658014|NCT02080273|18860098|P3|STARTED|Overall Study||45
7658015|NCT02080273|18860099|P2|STARTED|Overall Study||45
7658016|NCT02080273|18860100|P1|STARTED|Overall Study||45
7658017|NCT02080260|18860129|P1|NOT COMPLETED|Overall Study||19
7658018|NCT02080260|18860129|P1|COMPLETED|Overall Study|Defined as still alive in follow-up when the study was terminated and the database was locked.|1
7658019|NCT02080260|18860129|P1|STARTED|Overall Study||20
7658020|NCT02080195|18860137|P1|NOT COMPLETED|Overall Study||0
7658021|NCT02080195|18860137|P1|COMPLETED|Overall Study||1
7658022|NCT02080195|18860137|P1|STARTED|Overall Study||1
7658023|NCT02080091|18860146|P1|NOT COMPLETED|Overall Study||25
7658024|NCT02080091|18860146|P1|COMPLETED|Overall Study||0
7658025|NCT02080091|18860146|P1|STARTED|Overall Study||25
7658026|NCT02079987|18860154|P2|NOT COMPLETED|Overall Study||0
7658027|NCT02079987|18860155|P1|NOT COMPLETED|Overall Study||0
7658028|NCT02079987|18860154|P2|COMPLETED|Overall Study||544
7658029|NCT02079987|18860155|P1|COMPLETED|Overall Study||557
7658030|NCT02079987|18860154|P2|STARTED|Overall Study||544
7658031|NCT02079987|18860155|P1|STARTED|Overall Study||557
7658032|NCT02079909|18860174|P3|NOT COMPLETED|Overall Study||18
7658033|NCT02079909|18860175|P2|NOT COMPLETED|Overall Study||49
7658034|NCT02079909|18860176|P1|NOT COMPLETED|Overall Study||38
7658035|NCT02079909|18860174|P3|COMPLETED|Overall Study||140
7658036|NCT02079909|18860175|P2|COMPLETED|Overall Study||117
7658037|NCT02079909|18860176|P1|COMPLETED|Overall Study||120
7658038|NCT02079909|18860174|P3|STARTED|Overall Study||158
7658039|NCT02079909|18860175|P2|STARTED|Overall Study||166
7658040|NCT02079909|18860176|P1|STARTED|Overall Study||158
7658041|NCT02079844|18860193|P3|NOT COMPLETED|Treatment Period 3||0
7658042|NCT02079844|18860194|P2|NOT COMPLETED|Treatment Period 3||0
7658043|NCT02079844|18860195|P1|NOT COMPLETED|Treatment Period 3||0
7658044|NCT02079844|18860193|P3|COMPLETED|Treatment Period 3||5
7658045|NCT02079844|18860194|P2|COMPLETED|Treatment Period 3||5
7658046|NCT02079844|18860195|P1|COMPLETED|Treatment Period 3||5
7658047|NCT02079844|18860193|P3|STARTED|Treatment Period 3||5
7658048|NCT02079844|18860194|P2|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5
7658049|NCT02079844|18860195|P1|STARTED|Treatment Period 3||5
7658050|NCT02079844|18860193|P3|NOT COMPLETED|Treatment Period 2||0
7658051|NCT02079844|18860194|P2|NOT COMPLETED|Treatment Period 2||1
7658052|NCT02079844|18860195|P1|NOT COMPLETED|Treatment Period 2||0
7658053|NCT02079844|18860193|P3|COMPLETED|Treatment Period 2||5
7658054|NCT02079844|18860194|P2|COMPLETED|Treatment Period 2||6
7658055|NCT02079844|18860195|P1|COMPLETED|Treatment Period 2||5
7658056|NCT02079844|18860193|P3|STARTED|Treatment Period 2||5
7658057|NCT02079844|18860194|P2|STARTED|Treatment Period 2||7
7658058|NCT02079844|18860195|P1|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5
7658059|NCT02079844|18860193|P3|NOT COMPLETED|Treatment Period 1||2
7658060|NCT02079844|18860194|P2|NOT COMPLETED|Treatment Period 1||0
7658061|NCT02079844|18860195|P1|NOT COMPLETED|Treatment Period 1||0
7658062|NCT02079844|18860193|P3|COMPLETED|Treatment Period 1||5
7658063|NCT02079844|18860194|P2|COMPLETED|Treatment Period 1||7
7658064|NCT02079844|18860195|P1|COMPLETED|Treatment Period 1||6
7658065|NCT02079844|18860193|P3|STARTED|Treatment Period 1||7
7658066|NCT02079844|18860194|P2|STARTED|Treatment Period 1||7
7658067|NCT02079844|18860195|P1|STARTED|Treatment Period 1||6
7658068|NCT02079805|18860253|P2|NOT COMPLETED|Overall Study||2
7658069|NCT02079805|18860254|P1|NOT COMPLETED|Overall Study||0
7658070|NCT02079805|18860253|P2|COMPLETED|Overall Study||15
7658071|NCT02079805|18860254|P1|COMPLETED|Overall Study||16
7658072|NCT02079805|18860253|P2|STARTED|Overall Study||17
7658073|NCT02079805|18860254|P1|STARTED|Overall Study||16
7658074|NCT02079766|18860274|P2|NOT COMPLETED|Overall Study||0
7658075|NCT02079766|18860275|P1|NOT COMPLETED|Overall Study||2
7658076|NCT02079766|18860274|P2|COMPLETED|Overall Study||11
7658077|NCT02079766|18860275|P1|COMPLETED|Overall Study||28
7658078|NCT02079766|18860274|P2|STARTED|Overall Study||11
7658079|NCT02079766|18860275|P1|STARTED|Overall Study||30
7658080|NCT02079649|18860286|P4|NOT COMPLETED|Overall Study||2
7658081|NCT02079649|18860287|P3|NOT COMPLETED|Overall Study||1
7658082|NCT02079649|18860288|P2|NOT COMPLETED|Overall Study||0
7658083|NCT02079649|18860289|P1|NOT COMPLETED|Overall Study||1
7658084|NCT02079649|18860286|P4|COMPLETED|Overall Study||38
7658085|NCT02079649|18860287|P3|COMPLETED|Overall Study||40
7658086|NCT02079649|18860288|P2|COMPLETED|Overall Study||41
7658087|NCT02079649|18860289|P1|COMPLETED|Overall Study||41
7658088|NCT02079649|18860286|P4|Treated|Overall Study||40
7658089|NCT02079649|18860287|P3|Treated|Overall Study||40
7658090|NCT02079649|18860288|P2|Treated|Overall Study||41
7658091|NCT02079649|18860289|P1|Treated|Overall Study||41
7658092|NCT02079649|18860286|P4|STARTED|Overall Study||40
7658093|NCT02079649|18860287|P3|STARTED|Overall Study||41
7658094|NCT02079649|18860288|P2|STARTED|Overall Study||41
7658095|NCT02079649|18860289|P1|STARTED|Overall Study||42
7658096|NCT02079636|18860319|P15|NOT COMPLETED|Overall Study||5
7658097|NCT02079636|18860320|P14|NOT COMPLETED|Overall Study||0
7658098|NCT02079636|18860321|P13|NOT COMPLETED|Overall Study||3
7658099|NCT02079636|18860322|P12|NOT COMPLETED|Overall Study||2
7658100|NCT02079636|18860323|P11|NOT COMPLETED|Overall Study||2
7658101|NCT02079636|18860324|P10|NOT COMPLETED|Overall Study||3
7658102|NCT02079636|18860325|P9|NOT COMPLETED|Overall Study||0
7658103|NCT02079636|18860326|P8|NOT COMPLETED|Overall Study||1
7658104|NCT02079636|18860327|P7|NOT COMPLETED|Overall Study||1
7658105|NCT02079636|18860328|P6|NOT COMPLETED|Overall Study||6
7658106|NCT02079636|18860329|P5|NOT COMPLETED|Overall Study||2
7658107|NCT02079636|18860330|P4|NOT COMPLETED|Overall Study||12
7658108|NCT02079636|18860331|P3|NOT COMPLETED|Overall Study||0
7658109|NCT02079636|18860332|P2|NOT COMPLETED|Overall Study||2
7658110|NCT02079636|18860333|P1|NOT COMPLETED|Overall Study||3
7658111|NCT02079636|18860319|P15|COMPLETED|Overall Study||12
7658112|NCT02079636|18860320|P14|COMPLETED|Overall Study||3
7658113|NCT02079636|18860321|P13|COMPLETED|Overall Study||5
7658114|NCT02079636|18860322|P12|COMPLETED|Overall Study||4
7658115|NCT02079636|18860323|P11|COMPLETED|Overall Study||8
7658116|NCT02079636|18860324|P10|COMPLETED|Overall Study||6
7658117|NCT02079636|18860325|P9|COMPLETED|Overall Study||3
7658118|NCT02079636|18860326|P8|COMPLETED|Overall Study||3
7658119|NCT02079636|18860327|P7|COMPLETED|Overall Study||11
7658120|NCT02079636|18860328|P6|COMPLETED|Overall Study||13
7658121|NCT02079636|18860329|P5|COMPLETED|Overall Study||2
7658122|NCT02079636|18860330|P4|COMPLETED|Overall Study||9
7658123|NCT02079636|18860331|P3|COMPLETED|Overall Study||3
7658124|NCT02079636|18860332|P2|COMPLETED|Overall Study||13
7658125|NCT02079636|18860333|P1|COMPLETED|Overall Study||5
7658126|NCT02079636|18860319|P15|Received at Least One Dose of Study Drug|Overall Study||17
7658127|NCT02079636|18860320|P14|Received at Least One Dose of Study Drug|Overall Study||3
7658128|NCT02079636|18860321|P13|Received at Least One Dose of Study Drug|Overall Study||8
7658129|NCT02079636|18860322|P12|Received at Least One Dose of Study Drug|Overall Study||6
7658130|NCT02079636|18860323|P11|Received at Least One Dose of Study Drug|Overall Study||10
7658131|NCT02079636|18860324|P10|Received at Least One Dose of Study Drug|Overall Study||9
7658132|NCT02079636|18860325|P9|Received at Least One Dose of Study Drug|Overall Study||3
7658133|NCT02079636|18860326|P8|Received at Least One Dose of Study Drug|Overall Study||4
7658134|NCT02079636|18860327|P7|Received at Least One Dose of Study Drug|Overall Study||12
7658135|NCT02079636|18860328|P6|Received at Least One Dose of Study Drug|Overall Study||19
7658136|NCT02079636|18860329|P5|Received at Least One Dose of Study Drug|Overall Study||4
7658137|NCT02079636|18860330|P4|Received at Least One Dose of Study Drug|Overall Study||21
7658138|NCT02079636|18860331|P3|Received at Least One Dose of Study Drug|Overall Study||3
7658139|NCT02079636|18860332|P2|Received at Least One Dose of Study Drug|Overall Study||15
7658140|NCT02079636|18860333|P1|Received at Least One Dose of Study Drug|Overall Study||8
7658141|NCT02079636|18860319|P15|STARTED|Overall Study||17
7658142|NCT02079636|18860320|P14|STARTED|Overall Study||3
7658143|NCT02079636|18860321|P13|STARTED|Overall Study||8
7658144|NCT02079636|18860322|P12|STARTED|Overall Study||6
7658145|NCT02079636|18860323|P11|STARTED|Overall Study||10
7658146|NCT02079636|18860324|P10|STARTED|Overall Study||9
7658147|NCT02079636|18860325|P9|STARTED|Overall Study||3
7658148|NCT02079636|18860326|P8|STARTED|Overall Study||4
7658149|NCT02079636|18860327|P7|STARTED|Overall Study||12
7658150|NCT02079636|18860328|P6|STARTED|Overall Study||19
7658151|NCT02079636|18860329|P5|STARTED|Overall Study||4
7658152|NCT02079636|18860330|P4|STARTED|Overall Study||21
7658153|NCT02079636|18860331|P3|STARTED|Overall Study||3
7658154|NCT02079636|18860332|P2|STARTED|Overall Study||15
7658155|NCT02079636|18860333|P1|STARTED|Overall Study||8
7658156|NCT02079610|18860444|P2|NOT COMPLETED|Overall Study||1
7658157|NCT02079610|18860445|P1|NOT COMPLETED|Overall Study||1
7658158|NCT02079610|18860444|P2|COMPLETED|Overall Study||16
7658159|NCT02079610|18860445|P1|COMPLETED|Overall Study||18
7658160|NCT02079610|18860444|P2|STARTED|Overall Study||17
7658161|NCT02079610|18860445|P1|STARTED|Overall Study||19
7658162|NCT02079532|18860455|P1|NOT COMPLETED|Overall Study||29
7658163|NCT02079532|18860455|P1|COMPLETED|Overall Study||273
7658164|NCT02079532|18860455|P1|STARTED|Overall Study||302
7658165|NCT02079519|18860477|P1|NOT COMPLETED|Overall Study||10
7658166|NCT02079519|18860477|P1|COMPLETED|Overall Study||0
7658167|NCT02079519|18860477|P1|STARTED|Overall Study||10
7658168|NCT02079311|18860483|P2|NOT COMPLETED|Overall Study||1
7658169|NCT02079311|18860484|P1|NOT COMPLETED|Overall Study||0
7658170|NCT02079311|18860483|P2|COMPLETED|Overall Study||26
7658171|NCT02079311|18860484|P1|COMPLETED|Overall Study||28
7658172|NCT02079311|18860483|P2|STARTED|Overall Study||27
7658173|NCT02079311|18860484|P1|STARTED|Overall Study||28
7658174|NCT02079246|18860490|P2|NOT COMPLETED|OLEX-MEM||19
7658175|NCT02079246|18860491|P1|NOT COMPLETED|OLEX-MEM||0
7658176|NCT02079246|18860490|P2|COMPLETED|OLEX-MEM||82
7658177|NCT02079246|18860491|P1|COMPLETED|OLEX-MEM||0
7658178|NCT02079246|18860490|P2|STARTED|OLEX-MEM||101
7658179|NCT02079246|18860491|P1|STARTED|OLEX-MEM||0
7658180|NCT02079246|18860490|P2|NOT COMPLETED|OLEX||0
7658181|NCT02079246|18860491|P1|NOT COMPLETED|OLEX||228
7658182|NCT02079246|18860490|P2|COMPLETED|OLEX||0
7658183|NCT02079246|18860491|P1|COMPLETED|OLEX||1235
7658184|NCT02079246|18860490|P2|STARTED|OLEX||0
7658185|NCT02079246|18860491|P1|STARTED|OLEX||1463
7658186|NCT02079077|18860510|P2|NOT COMPLETED|Overall Study||9
7658187|NCT02079077|18860511|P1|NOT COMPLETED|Overall Study||6
7658188|NCT02079077|18860510|P2|COMPLETED|Overall Study||39
7658189|NCT02079077|18860511|P1|COMPLETED|Overall Study||37
7658190|NCT02079077|18860510|P2|STARTED|Overall Study||48
7658191|NCT02079077|18860511|P1|STARTED|Overall Study||43
7658192|NCT02079038|18860521|P2|NOT COMPLETED|Completed 6 Months||1
7658193|NCT02079038|18860522|P1|NOT COMPLETED|Completed 6 Months||2
7658194|NCT02079038|18860521|P2|COMPLETED|Completed 6 Months||50
7658195|NCT02079038|18860522|P1|COMPLETED|Completed 6 Months||103
7658196|NCT02079038|18860521|P2|STARTED|Completed 6 Months||51
7658197|NCT02079038|18860522|P1|STARTED|Completed 6 Months||105
7658198|NCT02079038|18860521|P2|NOT COMPLETED|Modified Intent to Treat Population||5
7658199|NCT02079038|18860522|P1|NOT COMPLETED|Modified Intent to Treat Population||7
7658200|NCT02079038|18860521|P2|COMPLETED|Modified Intent to Treat Population||51
7658201|NCT02079038|18860522|P1|COMPLETED|Modified Intent to Treat Population||105
7658202|NCT02079038|18860521|P2|STARTED|Modified Intent to Treat Population||56
7658203|NCT02079038|18860522|P1|STARTED|Modified Intent to Treat Population||112
7658204|NCT02079025|18860530|P2|NOT COMPLETED|Overall Study||0
7658205|NCT02079025|18860531|P1|NOT COMPLETED|Overall Study||0
7658206|NCT02079025|18860530|P2|COMPLETED|Overall Study||837
7658207|NCT02079025|18860531|P1|COMPLETED|Overall Study||839
7658208|NCT02079025|18860530|P2|STARTED|Overall Study||837
7658209|NCT02079025|18860531|P1|STARTED|Overall Study||839
7658210|NCT02078960|18860543|P3|NOT COMPLETED|Follow-up Period||0
7658211|NCT02078960|18860544|P2|NOT COMPLETED|Follow-up Period||1
7658212|NCT02078960|18860545|P1|NOT COMPLETED|Follow-up Period||2
7658213|NCT02078960|18860543|P3|COMPLETED|Follow-up Period||1
7658214|NCT02078960|18860544|P2|COMPLETED|Follow-up Period||1
7658215|NCT02078960|18860545|P1|COMPLETED|Follow-up Period||0
7658216|NCT02078960|18860543|P3|STARTED|Follow-up Period||1
7658217|NCT02078960|18860544|P2|STARTED|Follow-up Period||2
7658218|NCT02078960|18860545|P1|STARTED|Follow-up Period||2
7658219|NCT02078960|18860543|P3|NOT COMPLETED|Treatment Period||3
7658220|NCT02078960|18860544|P2|NOT COMPLETED|Treatment Period||3
7658221|NCT02078960|18860545|P1|NOT COMPLETED|Treatment Period||2
7658222|NCT02078960|18860543|P3|COMPLETED|Treatment Period||1
7658223|NCT02078960|18860544|P2|COMPLETED|Treatment Period||1
7658224|NCT02078960|18860545|P1|COMPLETED|Treatment Period||0
7658225|NCT02078960|18860543|P3|STARTED|Treatment Period||4
7658226|NCT02078960|18860544|P2|STARTED|Treatment Period||4
7658227|NCT02078960|18860545|P1|STARTED|Treatment Period||2
7658228|NCT02078882|18860567|P1|NOT COMPLETED|Overall Study||0
7658229|NCT02078882|18860567|P1|COMPLETED|Overall Study||16
7658230|NCT02078882|18860567|P1|STARTED|Overall Study||16
7658231|NCT02078817|18860579|P1|NOT COMPLETED|Overall Study||1
7658232|NCT02078817|18860579|P1|COMPLETED|Overall Study||13
7658233|NCT02078817|18860579|P1|STARTED|Overall Study||14
7658234|NCT02078752|18860601|P10|NOT COMPLETED|Overall Study||10
7658235|NCT02078752|18860602|P9|NOT COMPLETED|Overall Study||0
7658236|NCT02078752|18860603|P8|NOT COMPLETED|Overall Study||3
7658237|NCT02078752|18860604|P7|NOT COMPLETED|Overall Study||2
7658238|NCT02078752|18860605|P6|NOT COMPLETED|Overall Study||4
7658239|NCT02078752|18860606|P5|NOT COMPLETED|Overall Study||1
7658240|NCT02078752|18860607|P4|NOT COMPLETED|Overall Study||2
7658241|NCT02078752|18860608|P3|NOT COMPLETED|Overall Study||1
7658242|NCT02078752|18860609|P2|NOT COMPLETED|Overall Study||7
7658243|NCT02078752|18860610|P1|NOT COMPLETED|Overall Study||2
7658244|NCT02078752|18860601|P10|COMPLETED|Overall Study||2
7658245|NCT02078752|18860602|P9|COMPLETED|Overall Study||2
7658246|NCT02078752|18860603|P8|COMPLETED|Overall Study||3
7658247|NCT02078752|18860604|P7|COMPLETED|Overall Study||1
7658248|NCT02078752|18860605|P6|COMPLETED|Overall Study||5
7658249|NCT02078752|18860606|P5|COMPLETED|Overall Study||2
7658250|NCT02078752|18860607|P4|COMPLETED|Overall Study||5
7658251|NCT02078752|18860608|P3|COMPLETED|Overall Study||1
7658252|NCT02078752|18860609|P2|COMPLETED|Overall Study||6
7658253|NCT02078752|18860610|P1|COMPLETED|Overall Study||1
7658254|NCT02078752|18860601|P10|STARTED|Overall Study||12
7658255|NCT02078752|18860602|P9|STARTED|Overall Study||2
7658256|NCT02078752|18860603|P8|STARTED|Overall Study||6
7658257|NCT02078752|18860604|P7|STARTED|Overall Study||3
7658258|NCT02078752|18860605|P6|STARTED|Overall Study||9
7658259|NCT02078752|18860606|P5|STARTED|Overall Study||3
7658260|NCT02078752|18860607|P4|STARTED|Overall Study||7
7658261|NCT02078752|18860608|P3|STARTED|Overall Study||2
7658262|NCT02078752|18860609|P2|STARTED|Overall Study||13
7658263|NCT02078752|18860610|P1|STARTED|Overall Study||3
7658264|NCT02078713|18860886|P4|NOT COMPLETED|Overall Study||0
7658265|NCT02078713|18860887|P3|NOT COMPLETED|Overall Study||0
7658266|NCT02078713|18860888|P2|NOT COMPLETED|Overall Study||61
7658267|NCT02078713|18860889|P1|NOT COMPLETED|Overall Study||52
7658268|NCT02078713|18860886|P4|COMPLETED|Overall Study||13
7658269|NCT02078713|18860887|P3|COMPLETED|Overall Study||15
7658270|NCT02078713|18860888|P2|COMPLETED|Overall Study||290
7658271|NCT02078713|18860889|P1|COMPLETED|Overall Study||355
7658272|NCT02078713|18860886|P4|STARTED|Overall Study||13
7658273|NCT02078713|18860887|P3|STARTED|Overall Study||15
7658274|NCT02078713|18860888|P2|STARTED|Overall Study||351
7658275|NCT02078713|18860889|P1|STARTED|Overall Study||407
7658276|NCT02078557|18860941|P1|NOT COMPLETED|Overall Study||0
7658277|NCT02078557|18860941|P1|COMPLETED|Overall Study||4
7658278|NCT02078557|18860941|P1|STARTED|Overall Study||4
7658279|NCT02078492|18860950|P3|NOT COMPLETED|Overall Study||0
7658280|NCT02078492|18860951|P2|NOT COMPLETED|Overall Study||0
7658281|NCT02078492|18860952|P1|NOT COMPLETED|Overall Study||0
7658282|NCT02078492|18860950|P3|COMPLETED|Overall Study||80
7658283|NCT02078492|18860951|P2|COMPLETED|Overall Study||80
7658284|NCT02078492|18860952|P1|COMPLETED|Overall Study||80
7658285|NCT02078492|18860950|P3|STARTED|Overall Study||80
7658286|NCT02078492|18860951|P2|STARTED|Overall Study||80
7658287|NCT02078492|18860952|P1|STARTED|Overall Study||80
7658288|NCT02078219|18860974|P5|NOT COMPLETED|Overall Study||2
7658289|NCT02078219|18860975|P4|NOT COMPLETED|Overall Study||4
7658290|NCT02078219|18860976|P3|NOT COMPLETED|Overall Study||6
7658291|NCT02078219|18860977|P2|NOT COMPLETED|Overall Study||4
7658292|NCT02078219|18860978|P1|NOT COMPLETED|Overall Study||3
7658293|NCT02078219|18860974|P5|COMPLETED|Overall Study||39
7658294|NCT02078219|18860975|P4|COMPLETED|Overall Study||37
7658295|NCT02078219|18860976|P3|COMPLETED|Overall Study||35
7658296|NCT02078219|18860977|P2|COMPLETED|Overall Study||36
7658297|NCT02078219|18860978|P1|COMPLETED|Overall Study||38
7658298|NCT02078219|18860974|P5|STARTED|Overall Study||41
7658299|NCT02078219|18860975|P4|STARTED|Overall Study||41
7658300|NCT02078219|18860976|P3|STARTED|Overall Study||41
7658301|NCT02078219|18860977|P2|STARTED|Overall Study||40
7658302|NCT02078219|18860978|P1|STARTED|Overall Study||41
7658303|NCT02078193|18861005|P1|NOT COMPLETED|Overall Study||0
7658304|NCT02078193|18861005|P1|COMPLETED|Overall Study||3
7658305|NCT02078193|18861005|P1|STARTED|Overall Study||3
7658306|NCT02078180|18861011|P1|NOT COMPLETED|Overall Study||5
7658307|NCT02078180|18861011|P1|COMPLETED|Overall Study||29
7658308|NCT02078180|18861011|P1|XL 300|Overall Study||32
7658309|NCT02078180|18861011|P1|XL 150|Overall Study||31
7658310|NCT02078180|18861011|P1|SR150|Overall Study||32
7658311|NCT02078180|18861011|P1|SR100|Overall Study||31
7658312|NCT02078180|18861011|P1|IR100|Overall Study||31
7658313|NCT02078180|18861011|P1|IR75|Overall Study||30
7658314|NCT02078180|18861011|P1|STARTED|Overall Study||34
7658315|NCT02077465|18861028|P2|NOT COMPLETED|Overall Study||1
7658316|NCT02077465|18861029|P1|NOT COMPLETED|Overall Study||1
7658317|NCT02077465|18861028|P2|COMPLETED|Overall Study||2
7658318|NCT02077465|18861029|P1|COMPLETED|Overall Study||7
7658319|NCT02077465|18861028|P2|STARTED|Overall Study||3
7658320|NCT02077465|18861029|P1|STARTED|Overall Study||8
7658321|NCT02077374|18861052|P2|NOT COMPLETED|Overall Study||2
7658322|NCT02077374|18861053|P1|NOT COMPLETED|Overall Study||0
7658323|NCT02077374|18861052|P2|COMPLETED|Overall Study||17
7658324|NCT02077374|18861053|P1|COMPLETED|Overall Study||19
7658325|NCT02077374|18861052|P2|STARTED|Overall Study||19
7658326|NCT02077374|18861053|P1|STARTED|Overall Study||19
7658327|NCT02077140|18861074|P5|NOT COMPLETED|Overall Study||5
7658328|NCT02077140|18861075|P4|NOT COMPLETED|Overall Study||4
7658329|NCT02077140|18861076|P3|NOT COMPLETED|Overall Study||2
7658330|NCT02077140|18861077|P2|NOT COMPLETED|Overall Study||2
7658331|NCT02077140|18861078|P1|NOT COMPLETED|Overall Study||4
7658332|NCT02077140|18861074|P5|COMPLETED|Overall Study||43
7658333|NCT02077140|18861075|P4|COMPLETED|Overall Study||32
7658334|NCT02077140|18861076|P3|COMPLETED|Overall Study||34
7658335|NCT02077140|18861077|P2|COMPLETED|Overall Study||34
7658336|NCT02077140|18861078|P1|COMPLETED|Overall Study||32
7658337|NCT02077140|18861074|P5|STARTED|Overall Study||48
7658338|NCT02077140|18861075|P4|STARTED|Overall Study||36
7658339|NCT02077140|18861076|P3|STARTED|Overall Study||36
7658340|NCT02077140|18861077|P2|STARTED|Overall Study||36
7658341|NCT02077140|18861078|P1|STARTED|Overall Study||36
7658342|NCT02076919|18861177|P4|NOT COMPLETED|Overall Study||0
7658343|NCT02076919|18861178|P3|NOT COMPLETED|Overall Study||0
7658344|NCT02076919|18861179|P2|NOT COMPLETED|Overall Study||0
7658345|NCT02076919|18861180|P1|NOT COMPLETED|Overall Study||0
7658346|NCT02076919|18861177|P4|COMPLETED|Overall Study||12
7658347|NCT02076919|18861178|P3|COMPLETED|Overall Study||36
7658348|NCT02076919|18861179|P2|COMPLETED|Overall Study||8
7658349|NCT02076919|18861180|P1|COMPLETED|Overall Study||24
7658350|NCT02076919|18861177|P4|STARTED|Overall Study||12
7658351|NCT02076919|18861178|P3|STARTED|Overall Study||36
7658352|NCT02076919|18861179|P2|STARTED|Overall Study||8
7658353|NCT02076919|18861180|P1|STARTED|Overall Study||24
7658354|NCT02076776|18861281|P3|NOT COMPLETED|Overall Study||0
7658355|NCT02076776|18861282|P2|NOT COMPLETED|Overall Study||2
7658356|NCT02076776|18861283|P1|NOT COMPLETED|Overall Study||1
7658357|NCT02076776|18861281|P3|COMPLETED|Overall Study||6
7658358|NCT02076776|18861282|P2|COMPLETED|Overall Study||6
7658359|NCT02076776|18861283|P1|COMPLETED|Overall Study||5
7658360|NCT02076776|18861281|P3|STARTED|Overall Study||6
7658361|NCT02076776|18861282|P2|STARTED|Overall Study||8
7658362|NCT02076776|18861283|P1|STARTED|Overall Study||6
7658363|NCT02076425|18861299|P2|NOT COMPLETED|Overall Study||24
7658364|NCT02076425|18861300|P1|NOT COMPLETED|Overall Study||14
7658365|NCT02076425|18861299|P2|COMPLETED|Overall Study||91
7658366|NCT02076425|18861300|P1|COMPLETED|Overall Study||100
7658367|NCT02076425|18861299|P2|STARTED|Overall Study||115
7658368|NCT02076425|18861300|P1|STARTED|Overall Study||114
7658369|NCT02076412|18861312|P2|NOT COMPLETED|Overall Study||22
7658370|NCT02076412|18861313|P1|NOT COMPLETED|Overall Study||37
7658371|NCT02076412|18861312|P2|COMPLETED|Overall Study||2
7658372|NCT02076412|18861313|P1|COMPLETED|Overall Study||13
7658373|NCT02076412|18861312|P2|STARTED|Overall Study||24
7658374|NCT02076412|18861313|P1|STARTED|Overall Study||50
7658375|NCT02076399|18861333|P2|NOT COMPLETED|Overall Study||24
7658376|NCT02076399|18861334|P1|NOT COMPLETED|Overall Study||39
7658377|NCT02076399|18861333|P2|COMPLETED|Overall Study||1
7658378|NCT02076399|18861334|P1|COMPLETED|Overall Study||12
7658379|NCT02076399|18861333|P2|STARTED|Overall Study||25
7658380|NCT02076399|18861334|P1|STARTED|Overall Study||51
7658381|NCT02076334|18861356|P4|NOT COMPLETED|Overall Study||1
7658382|NCT02076334|18861357|P3|NOT COMPLETED|Overall Study||1
7658383|NCT02076334|18861358|P2|NOT COMPLETED|Overall Study||1
7658384|NCT02076334|18861359|P1|NOT COMPLETED|Overall Study||1
7658385|NCT02076334|18861356|P4|COMPLETED|Overall Study||20
7658386|NCT02076334|18861357|P3|COMPLETED|Overall Study||20
7658387|NCT02076334|18861358|P2|COMPLETED|Overall Study||20
7658388|NCT02076334|18861359|P1|COMPLETED|Overall Study||20
7658389|NCT02076334|18861356|P4|STARTED|Overall Study||21
7658390|NCT02076334|18861357|P3|STARTED|Overall Study||21
7658391|NCT02076334|18861358|P2|STARTED|Overall Study||21
7658392|NCT02076334|18861359|P1|STARTED|Overall Study||21
7658393|NCT02076321|18861375|P2|NOT COMPLETED|Overall Study||2
7658394|NCT02076321|18861376|P1|NOT COMPLETED|Overall Study||5
7658395|NCT02076321|18861375|P2|COMPLETED|Overall Study||49
7658396|NCT02076321|18861376|P1|COMPLETED|Overall Study||46
7658397|NCT02076321|18861375|P2|STARTED|Overall Study||51
7658398|NCT02076321|18861376|P1|STARTED|Overall Study||51
7658399|NCT02076243|18861382|P1|NOT COMPLETED|Overall Study||2
7658400|NCT02076243|18861382|P1|COMPLETED|Overall Study||0
7658401|NCT02076243|18861382|P1|STARTED|Overall Study||2
7658402|NCT02076178|18861392|P2|NOT COMPLETED|Injection Phase||7
7658403|NCT02076178|18861393|P1|NOT COMPLETED|Injection Phase||1
7658404|NCT02076178|18861392|P2|COMPLETED|Injection Phase||87
7658405|NCT02076178|18861393|P1|COMPLETED|Injection Phase||20
7658406|NCT02076178|18861392|P2|STARTED|Injection Phase||94
7658407|NCT02076178|18861393|P1|STARTED|Injection Phase||21
7658408|NCT02076178|18861392|P2|NOT COMPLETED|Oral Phase||12
7658409|NCT02076178|18861393|P1|NOT COMPLETED|Oral Phase||0
7658410|NCT02076178|18861392|P2|COMPLETED|Oral Phase||94
7658411|NCT02076178|18861393|P1|COMPLETED|Oral Phase||21
7658412|NCT02076178|18861392|P2|STARTED|Oral Phase||106
7658413|NCT02076178|18861393|P1|STARTED|Oral Phase||21
7658414|NCT02076165|18861427|P2|NOT COMPLETED|Overall Study||6
7658415|NCT02076165|18861428|P1|NOT COMPLETED|Overall Study||8
7658416|NCT02076165|18861427|P2|COMPLETED|Overall Study||69
7658417|NCT02076165|18861428|P1|COMPLETED|Overall Study||66
7658418|NCT02076165|18861427|P2|STARTED|Overall Study||75
7658419|NCT02076165|18861428|P1|STARTED|Overall Study||74
7658420|NCT02076100|18861459|P7|NOT COMPLETED|Overall Study||0
7658421|NCT02076100|18861460|P6|NOT COMPLETED|Overall Study||0
7658422|NCT02076100|18861461|P5|NOT COMPLETED|Overall Study||0
7658423|NCT02076100|18861462|P4|NOT COMPLETED|Overall Study||0
7658424|NCT02076100|18861463|P3|NOT COMPLETED|Overall Study||0
7658425|NCT02076100|18861464|P2|NOT COMPLETED|Overall Study||0
7658426|NCT02076100|18861465|P1|NOT COMPLETED|Overall Study||0
7658427|NCT02076100|18861459|P7|COMPLETED|Overall Study||4
7658428|NCT02076100|18861460|P6|COMPLETED|Overall Study||3
7658429|NCT02076100|18861461|P5|COMPLETED|Overall Study||3
7658430|NCT02076100|18861462|P4|COMPLETED|Overall Study||3
7658431|NCT02076100|18861463|P3|COMPLETED|Overall Study||3
7658432|NCT02076100|18861464|P2|COMPLETED|Overall Study||3
7658433|NCT02076100|18861465|P1|COMPLETED|Overall Study||3
7658434|NCT02076100|18861459|P7|STARTED|Overall Study||4
7658435|NCT02076100|18861460|P6|STARTED|Overall Study||3
7658436|NCT02076100|18861461|P5|STARTED|Overall Study||3
7658437|NCT02076100|18861462|P4|STARTED|Overall Study||3
7658438|NCT02076100|18861463|P3|STARTED|Overall Study||3
7658439|NCT02076100|18861464|P2|STARTED|Overall Study||3
7658440|NCT02076100|18861465|P1|STARTED|Overall Study||3
7658441|NCT02076022|18861498|P2|NOT COMPLETED|Overall Study||0
7658442|NCT02076022|18861499|P1|NOT COMPLETED|Overall Study||2
7658443|NCT02076022|18861498|P2|COMPLETED|Overall Study||3
7658444|NCT02076022|18861499|P1|COMPLETED|Overall Study||5
7658445|NCT02076022|18861498|P2|STARTED|Overall Study||3
7658446|NCT02076022|18861499|P1|STARTED|Overall Study||7
7658447|NCT02076009|18861511|P2|NOT COMPLETED|Overall Study||286
7658448|NCT02076009|18861512|P1|NOT COMPLETED|Overall Study||283
7658449|NCT02076009|18861511|P2|COMPLETED|Overall Study||0
7658450|NCT02076009|18861512|P1|COMPLETED|Overall Study||0
7658451|NCT02076009|18861511|P2|Treated|Overall Study||283
7658452|NCT02076009|18861512|P1|Treated|Overall Study||281
7658453|NCT02076009|18861511|P2|STARTED|Overall Study||286
7658454|NCT02076009|18861512|P1|STARTED|Overall Study||283
7658455|NCT02075840|18861534|P2|NOT COMPLETED|Overall Study||151
7658456|NCT02075840|18861535|P1|NOT COMPLETED|Overall Study||152
7658457|NCT02075840|18861534|P2|COMPLETED|Overall Study||0
7658458|NCT02075840|18861535|P1|COMPLETED|Overall Study||0
7658459|NCT02075840|18861534|P2|STARTED|Overall Study||151
7658460|NCT02075840|18861535|P1|STARTED|Overall Study||152
7658461|NCT02075658|18861591|P2|NOT COMPLETED|Overall Study||2
7658462|NCT02075658|18861592|P1|NOT COMPLETED|Overall Study||2
7658463|NCT02075658|18861591|P2|COMPLETED|Overall Study||28
7658464|NCT02075658|18861592|P1|COMPLETED|Overall Study||28
7658465|NCT02075658|18861591|P2|STARTED|Overall Study||30
7658466|NCT02075658|18861592|P1|STARTED|Overall Study||30
7658467|NCT02075632|18861602|P2|NOT COMPLETED|Overall Study||5
7658468|NCT02075632|18861603|P1|NOT COMPLETED|Overall Study||1
7658469|NCT02075632|18861602|P2|COMPLETED|Overall Study||143
7658470|NCT02075632|18861603|P1|COMPLETED|Overall Study||161
7658471|NCT02075632|18861602|P2|STARTED|Overall Study||148
7658472|NCT02075632|18861603|P1|STARTED|Overall Study||162
7658473|NCT02075606|18861613|P1|NOT COMPLETED|Overall Study||10
7658474|NCT02075606|18861613|P1|COMPLETED|Overall Study||40
7658475|NCT02075606|18861613|P1|STARTED|Overall Study||50
7658476|NCT02075541|18861637|P2|NOT COMPLETED|Overall Study||8
7658477|NCT02075541|18861638|P1|NOT COMPLETED|Overall Study||4
7658478|NCT02075541|18861637|P2|COMPLETED|Overall Study||64
7658479|NCT02075541|18861638|P1|COMPLETED|Overall Study||69
7658480|NCT02075541|18861637|P2|STARTED|Overall Study||72
7658481|NCT02075541|18861638|P1|STARTED|Overall Study||73
7658482|NCT02075515|18861687|P3|NOT COMPLETED|Overall Study||8
7658483|NCT02075515|18861688|P2|NOT COMPLETED|Overall Study||5
7658484|NCT02075515|18861689|P1|NOT COMPLETED|Overall Study||4
7658485|NCT02075515|18861687|P3|COMPLETED|Overall Study||208
7658486|NCT02075515|18861688|P2|COMPLETED|Overall Study||212
7658487|NCT02075515|18861689|P1|COMPLETED|Overall Study||214
7658488|NCT02075515|18861687|P3|STARTED|Overall Study||216
7658489|NCT02075515|18861688|P2|STARTED|Overall Study||217
7658490|NCT02075515|18861689|P1|STARTED|Overall Study||218
7658491|NCT02075476|18861726|P2|NOT COMPLETED|Overall Study||5
7658492|NCT02075476|18861727|P1|NOT COMPLETED|Overall Study||3
7658493|NCT02075476|18861726|P2|COMPLETED|Overall Study||15
7658494|NCT02075476|18861727|P1|COMPLETED|Overall Study||17
7658495|NCT02075476|18861726|P2|STARTED|Overall Study||20
7658496|NCT02075476|18861727|P1|STARTED|Overall Study||20
7658497|NCT02075463|18861737|P1|NOT COMPLETED|Overall Study||8
7658498|NCT02075463|18861737|P1|COMPLETED|Overall Study||7
7658499|NCT02075463|18861737|P1|STARTED|Overall Study||15
7658500|NCT02075411|18861766|P4|NOT COMPLETED|Overall Study||0
7658501|NCT02075411|18861767|P3|NOT COMPLETED|Overall Study||0
7658502|NCT02075411|18861768|P2|NOT COMPLETED|Overall Study||0
7658503|NCT02075411|18861769|P1|NOT COMPLETED|Overall Study||0
7658504|NCT02075411|18861766|P4|COMPLETED|Overall Study||1
7658505|NCT02075411|18861767|P3|COMPLETED|Overall Study||0
7658506|NCT02075411|18861768|P2|COMPLETED|Overall Study||0
7658507|NCT02075411|18861769|P1|COMPLETED|Overall Study||0
7658508|NCT02075411|18861766|P4|STARTED|Overall Study||1
7658509|NCT02075411|18861767|P3|STARTED|Overall Study||0
7658510|NCT02075411|18861768|P2|STARTED|Overall Study||0
7658511|NCT02075411|18861769|P1|STARTED|Overall Study||0
7658512|NCT02075320|18861787|P1|NOT COMPLETED|Overall Study||2
7658513|NCT02075320|18861787|P1|COMPLETED|Overall Study||48
7658514|NCT02075320|18861787|P1|STARTED|Overall Study||50
7658515|NCT02075255|18861797|P3|NOT COMPLETED|Overall Study||3
7658516|NCT02075255|18861798|P2|NOT COMPLETED|Overall Study||4
7658517|NCT02075255|18861799|P1|NOT COMPLETED|Overall Study||4
7658518|NCT02075255|18861797|P3|COMPLETED|Overall Study||72
7658519|NCT02075255|18861798|P2|COMPLETED|Overall Study||69
7658520|NCT02075255|18861799|P1|COMPLETED|Overall Study||68
7658521|NCT02075255|18861797|P3|STARTED|Overall Study||75
7658522|NCT02075255|18861798|P2|STARTED|Overall Study||73
7658523|NCT02075255|18861799|P1|STARTED|Overall Study||72
7658524|NCT02075203|18861909|P3|NOT COMPLETED|Overall Study||1
7658525|NCT02075203|18861910|P2|NOT COMPLETED|Overall Study||0
7658526|NCT02075203|18861911|P1|NOT COMPLETED|Overall Study||3
7658527|NCT02075203|18861909|P3|COMPLETED|Overall Study||328
7658528|NCT02075203|18861910|P2|COMPLETED|Overall Study||330
7658529|NCT02075203|18861911|P1|COMPLETED|Overall Study||327
7658530|NCT02075203|18861909|P3|STARTED|Overall Study||329
7658531|NCT02075203|18861910|P2|STARTED|Overall Study||330
7658532|NCT02075203|18861911|P1|STARTED|Overall Study||330
7658533|NCT02075125|18861930|P2|NOT COMPLETED|Overall Study||1
7658534|NCT02075125|18861931|P1|NOT COMPLETED|Overall Study||0
7658535|NCT02075125|18861930|P2|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19
7658536|NCT02075125|18861931|P1|COMPLETED|Overall Study||19
7658537|NCT02075125|18861930|P2|STARTED|Overall Study||20
7658538|NCT02075125|18861931|P1|STARTED|Overall Study||19
7658539|NCT02075073|18861952|P3|NOT COMPLETED|Overall Study||0
7658540|NCT02075073|18861953|P2|NOT COMPLETED|Overall Study||1
7658541|NCT02075073|18861954|P1|NOT COMPLETED|Overall Study||0
7658542|NCT02075073|18861952|P3|COMPLETED|Overall Study||36
7658543|NCT02075073|18861953|P2|COMPLETED|Overall Study||36
7658544|NCT02075073|18861954|P1|COMPLETED|Overall Study||36
7658545|NCT02075073|18861952|P3|STARTED|Overall Study||36
7658546|NCT02075073|18861953|P2|STARTED|Overall Study||37
7658547|NCT02075073|18861954|P1|STARTED|Overall Study||36
7658548|NCT02075021|18861971|P1|NOT COMPLETED|Overall Study||0
7658549|NCT02075021|18861971|P1|COMPLETED|Overall Study||3
7658550|NCT02075021|18861971|P1|STARTED|Overall Study||3
7658551|NCT02075008|18861976|P1|NOT COMPLETED|Overall Study||176
7658552|NCT02075008|18861976|P1|COMPLETED|Overall Study||94
7658553|NCT02075008|18861976|P1|STARTED|Overall Study||270
7658554|NCT02074995|18861980|P3|NOT COMPLETED|Overall Study||0
7658555|NCT02074995|18861981|P2|NOT COMPLETED|Overall Study||0
7658556|NCT02074995|18861982|P1|NOT COMPLETED|Overall Study||0
7658557|NCT02074995|18861980|P3|COMPLETED|Overall Study||0
7658558|NCT02074995|18861981|P2|COMPLETED|Overall Study||0
7658559|NCT02074995|18861982|P1|COMPLETED|Overall Study||1
7658560|NCT02074995|18861980|P3|STARTED|Overall Study||0
7658561|NCT02074995|18861981|P2|STARTED|Overall Study||0
7658562|NCT02074995|18861982|P1|STARTED|Overall Study||1
7658563|NCT02074982|18861999|P2|NOT COMPLETED|Overall Study||54
7658564|NCT02074982|18862000|P1|NOT COMPLETED|Overall Study||51
7658565|NCT02074982|18861999|P2|COMPLETED|Overall Study||285
7658566|NCT02074982|18862000|P1|COMPLETED|Overall Study||286
7658567|NCT02074982|18861999|P2|Safety Set (SF)|Overall Study||336
7658568|NCT02074982|18862000|P1|Safety Set (SF)|Overall Study||335
7658569|NCT02074982|18861999|P2|Full Analysis Set (FAS)|Overall Study||339
7658570|NCT02074982|18862000|P1|Full Analysis Set (FAS)|Overall Study||336
7658571|NCT02074982|18861999|P2|STARTED|Overall Study||339
7658572|NCT02074982|18862000|P1|STARTED|Overall Study||337
7658573|NCT02074904|18862012|P2|NOT COMPLETED|Overall Study||0
7658574|NCT02074904|18862013|P1|NOT COMPLETED|Overall Study||0
7658575|NCT02074904|18862012|P2|COMPLETED|Overall Study||0
7658576|NCT02074904|18862013|P1|COMPLETED|Overall Study||1
7658577|NCT02074904|18862012|P2|STARTED|Overall Study||0
7658578|NCT02074904|18862013|P1|STARTED|Overall Study||1
7658579|NCT02074735|18862029|P2|NOT COMPLETED|Overall Study||4
7658580|NCT02074735|18862030|P1|NOT COMPLETED|Overall Study||3
7658581|NCT02074735|18862029|P2|COMPLETED|Overall Study||29
7658582|NCT02074735|18862030|P1|COMPLETED|Overall Study||26
7658583|NCT02074735|18862029|P2|STARTED|Overall Study||33
7658584|NCT02074735|18862030|P1|STARTED|Overall Study||29
7658585|NCT02074709|18862038|P2|NOT COMPLETED|Overall Study||1
7658586|NCT02074709|18862039|P1|NOT COMPLETED|Overall Study||1
7658587|NCT02074709|18862038|P2|COMPLETED|Overall Study||29
7658588|NCT02074709|18862039|P1|COMPLETED|Overall Study||29
7658589|NCT02074709|18862038|P2|STARTED|Overall Study||30
7658590|NCT02074709|18862039|P1|STARTED|Overall Study||30
7658591|NCT02074553|18862047|P8|NOT COMPLETED|Intervention Period 4||0
7658592|NCT02074553|18862048|P7|NOT COMPLETED|Intervention Period 4||0
7658593|NCT02074553|18862049|P6|NOT COMPLETED|Intervention Period 4||0
7658594|NCT02074553|18862050|P5|NOT COMPLETED|Intervention Period 4||0
7658595|NCT02074553|18862051|P4|NOT COMPLETED|Intervention Period 4||0
7658596|NCT02074553|18862052|P3|NOT COMPLETED|Intervention Period 4||0
7658597|NCT02074553|18862053|P2|NOT COMPLETED|Intervention Period 4||0
7658598|NCT02074553|18862054|P1|NOT COMPLETED|Intervention Period 4||0
7658599|NCT02074553|18862047|P8|COMPLETED|Intervention Period 4||11
7658600|NCT02074553|18862048|P7|COMPLETED|Intervention Period 4||11
7658601|NCT02074553|18862049|P6|COMPLETED|Intervention Period 4||10
7658602|NCT02074553|18862050|P5|COMPLETED|Intervention Period 4||12
7658603|NCT02074553|18862051|P4|COMPLETED|Intervention Period 4||11
7658604|NCT02074553|18862052|P3|COMPLETED|Intervention Period 4||11
7658605|NCT02074553|18862053|P2|COMPLETED|Intervention Period 4||12
7658606|NCT02074553|18862054|P1|COMPLETED|Intervention Period 4||11
7658607|NCT02074553|18862047|P8|STARTED|Intervention Period 4||11
7658608|NCT02074553|18862048|P7|STARTED|Intervention Period 4||11
7658609|NCT02074553|18862049|P6|STARTED|Intervention Period 4||10
7658610|NCT02074553|18862050|P5|STARTED|Intervention Period 4||12
7658611|NCT02074553|18862051|P4|STARTED|Intervention Period 4||11
7658612|NCT02074553|18862052|P3|STARTED|Intervention Period 4||11
7658613|NCT02074553|18862053|P2|STARTED|Intervention Period 4||12
7658614|NCT02074553|18862054|P1|STARTED|Intervention Period 4||11
7658615|NCT02074553|18862047|P8|NOT COMPLETED|Washout Period 3||1
7658616|NCT02074553|18862048|P7|NOT COMPLETED|Washout Period 3||0
7658617|NCT02074553|18862049|P6|NOT COMPLETED|Washout Period 3||0
7658618|NCT02074553|18862050|P5|NOT COMPLETED|Washout Period 3||0
7658619|NCT02074553|18862051|P4|NOT COMPLETED|Washout Period 3||0
7658620|NCT02074553|18862052|P3|NOT COMPLETED|Washout Period 3||0
7658621|NCT02074553|18862053|P2|NOT COMPLETED|Washout Period 3||0
7658622|NCT02074553|18862054|P1|NOT COMPLETED|Washout Period 3||0
7658623|NCT02074553|18862047|P8|COMPLETED|Washout Period 3||11
7658624|NCT02074553|18862048|P7|COMPLETED|Washout Period 3||11
7658625|NCT02074553|18862049|P6|COMPLETED|Washout Period 3||10
7658626|NCT02074553|18862050|P5|COMPLETED|Washout Period 3||12
7658627|NCT02074553|18862051|P4|COMPLETED|Washout Period 3||11
7658628|NCT02074553|18862052|P3|COMPLETED|Washout Period 3||11
7658629|NCT02074553|18862053|P2|COMPLETED|Washout Period 3||12
7658630|NCT02074553|18862054|P1|COMPLETED|Washout Period 3||11
7658631|NCT02074553|18862047|P8|STARTED|Washout Period 3||12
7658632|NCT02074553|18862048|P7|STARTED|Washout Period 3||11
7658633|NCT02074553|18862049|P6|STARTED|Washout Period 3||10
7658634|NCT02074553|18862050|P5|STARTED|Washout Period 3||12
7658635|NCT02074553|18862051|P4|STARTED|Washout Period 3||11
7658636|NCT02074553|18862052|P3|STARTED|Washout Period 3||11
7658637|NCT02074553|18862053|P2|STARTED|Washout Period 3||12
7658638|NCT02074553|18862054|P1|STARTED|Washout Period 3||11
7658639|NCT02074553|18862047|P8|NOT COMPLETED|Intervention Period 3||0
7658640|NCT02074553|18862048|P7|NOT COMPLETED|Intervention Period 3||0
7658641|NCT02074553|18862049|P6|NOT COMPLETED|Intervention Period 3||0
7658642|NCT02074553|18862050|P5|NOT COMPLETED|Intervention Period 3||0
7658643|NCT02074553|18862051|P4|NOT COMPLETED|Intervention Period 3||0
7658644|NCT02074553|18862052|P3|NOT COMPLETED|Intervention Period 3||0
7658645|NCT02074553|18862053|P2|NOT COMPLETED|Intervention Period 3||0
7658646|NCT02074553|18862054|P1|NOT COMPLETED|Intervention Period 3||0
7658647|NCT02074553|18862047|P8|COMPLETED|Intervention Period 3||12
7658648|NCT02074553|18862048|P7|COMPLETED|Intervention Period 3||11
7658649|NCT02074553|18862049|P6|COMPLETED|Intervention Period 3||10
7658650|NCT02074553|18862050|P5|COMPLETED|Intervention Period 3||12
7658651|NCT02074553|18862051|P4|COMPLETED|Intervention Period 3||11
7658652|NCT02074553|18862052|P3|COMPLETED|Intervention Period 3||11
7658653|NCT02074553|18862053|P2|COMPLETED|Intervention Period 3||12
7658654|NCT02074553|18862054|P1|COMPLETED|Intervention Period 3||11
7658655|NCT02074553|18862047|P8|STARTED|Intervention Period 3||12
7658656|NCT02074553|18862048|P7|STARTED|Intervention Period 3||11
7658657|NCT02074553|18862049|P6|STARTED|Intervention Period 3||10
7658658|NCT02074553|18862050|P5|STARTED|Intervention Period 3||12
7658659|NCT02074553|18862051|P4|STARTED|Intervention Period 3||11
7658660|NCT02074553|18862052|P3|STARTED|Intervention Period 3||11
7658661|NCT02074553|18862053|P2|STARTED|Intervention Period 3||12
7658662|NCT02074553|18862054|P1|STARTED|Intervention Period 3||11
7658663|NCT02074553|18862047|P8|NOT COMPLETED|Washout Period 2||0
7658664|NCT02074553|18862048|P7|NOT COMPLETED|Washout Period 2||1
7658665|NCT02074553|18862049|P6|NOT COMPLETED|Washout Period 2||1
7658666|NCT02074553|18862050|P5|NOT COMPLETED|Washout Period 2||0
7658667|NCT02074553|18862051|P4|NOT COMPLETED|Washout Period 2||0
7658668|NCT02074553|18862052|P3|NOT COMPLETED|Washout Period 2||1
7658669|NCT02074553|18862053|P2|NOT COMPLETED|Washout Period 2||0
7658670|NCT02074553|18862054|P1|NOT COMPLETED|Washout Period 2||0
7658671|NCT02074553|18862047|P8|COMPLETED|Washout Period 2||12
7658672|NCT02074553|18862048|P7|COMPLETED|Washout Period 2||11
7658673|NCT02074553|18862049|P6|COMPLETED|Washout Period 2||10
7658674|NCT02074553|18862050|P5|COMPLETED|Washout Period 2||12
7658675|NCT02074553|18862051|P4|COMPLETED|Washout Period 2||11
7658676|NCT02074553|18862052|P3|COMPLETED|Washout Period 2||11
7658677|NCT02074553|18862053|P2|COMPLETED|Washout Period 2||12
7658678|NCT02074553|18862054|P1|COMPLETED|Washout Period 2||11
7658679|NCT02074553|18862047|P8|STARTED|Washout Period 2||12
7658680|NCT02074553|18862048|P7|STARTED|Washout Period 2||12
7658681|NCT02074553|18862049|P6|STARTED|Washout Period 2||11
7658682|NCT02074553|18862050|P5|STARTED|Washout Period 2||12
7658683|NCT02074553|18862051|P4|STARTED|Washout Period 2||11
7658684|NCT02074553|18862052|P3|STARTED|Washout Period 2||12
7658685|NCT02074553|18862053|P2|STARTED|Washout Period 2||12
7658686|NCT02074553|18862054|P1|STARTED|Washout Period 2||11
7658687|NCT02074553|18862047|P8|NOT COMPLETED|Intervention Period 2||0
7658688|NCT02074553|18862048|P7|NOT COMPLETED|Intervention Period 2||0
7658689|NCT02074553|18862049|P6|NOT COMPLETED|Intervention Period 2||0
7658690|NCT02074553|18862050|P5|NOT COMPLETED|Intervention Period 2||0
7658691|NCT02074553|18862051|P4|NOT COMPLETED|Intervention Period 2||0
7658692|NCT02074553|18862052|P3|NOT COMPLETED|Intervention Period 2||0
7658693|NCT02074553|18862053|P2|NOT COMPLETED|Intervention Period 2||0
7658694|NCT02074553|18862054|P1|NOT COMPLETED|Intervention Period 2||0
7658695|NCT02074553|18862047|P8|COMPLETED|Intervention Period 2||12
7658696|NCT02074553|18862048|P7|COMPLETED|Intervention Period 2||12
7658697|NCT02074553|18862049|P6|COMPLETED|Intervention Period 2||11
7658698|NCT02074553|18862050|P5|COMPLETED|Intervention Period 2||12
7658699|NCT02074553|18862051|P4|COMPLETED|Intervention Period 2||11
7658700|NCT02074553|18862052|P3|COMPLETED|Intervention Period 2||12
7658701|NCT02074553|18862053|P2|COMPLETED|Intervention Period 2||12
7658702|NCT02074553|18862054|P1|COMPLETED|Intervention Period 2||11
7658703|NCT02074553|18862047|P8|STARTED|Intervention Period 2||12
7658704|NCT02074553|18862048|P7|STARTED|Intervention Period 2||12
7658705|NCT02074553|18862049|P6|STARTED|Intervention Period 2||11
7658706|NCT02074553|18862050|P5|STARTED|Intervention Period 2||12
7658707|NCT02074553|18862051|P4|STARTED|Intervention Period 2||11
7658708|NCT02074553|18862052|P3|STARTED|Intervention Period 2||12
7658709|NCT02074553|18862053|P2|STARTED|Intervention Period 2||12
7658710|NCT02074553|18862054|P1|STARTED|Intervention Period 2||11
7658711|NCT02074553|18862047|P8|NOT COMPLETED|Washout Period 1||0
7658712|NCT02074553|18862048|P7|NOT COMPLETED|Washout Period 1||0
7658713|NCT02074553|18862049|P6|NOT COMPLETED|Washout Period 1||1
7658714|NCT02074553|18862050|P5|NOT COMPLETED|Washout Period 1||0
7658715|NCT02074553|18862051|P4|NOT COMPLETED|Washout Period 1||1
7658716|NCT02074553|18862052|P3|NOT COMPLETED|Washout Period 1||0
7658717|NCT02074553|18862053|P2|NOT COMPLETED|Washout Period 1||0
7658718|NCT02074553|18862054|P1|NOT COMPLETED|Washout Period 1||1
7658719|NCT02074553|18862047|P8|COMPLETED|Washout Period 1||12
7658720|NCT02074553|18862048|P7|COMPLETED|Washout Period 1||12
7658721|NCT02074553|18862049|P6|COMPLETED|Washout Period 1||11
7658722|NCT02074553|18862050|P5|COMPLETED|Washout Period 1||12
7658723|NCT02074553|18862051|P4|COMPLETED|Washout Period 1||11
7658724|NCT02074553|18862052|P3|COMPLETED|Washout Period 1||12
7658725|NCT02074553|18862053|P2|COMPLETED|Washout Period 1||12
7658726|NCT02074553|18862054|P1|COMPLETED|Washout Period 1||11
7658727|NCT02074553|18862047|P8|STARTED|Washout Period 1||12
7658728|NCT02074553|18862048|P7|STARTED|Washout Period 1||12
7658729|NCT02074553|18862049|P6|STARTED|Washout Period 1||12
7658730|NCT02074553|18862050|P5|STARTED|Washout Period 1||12
7658731|NCT02074553|18862051|P4|STARTED|Washout Period 1||12
7658732|NCT02074553|18862052|P3|STARTED|Washout Period 1||12
7658733|NCT02074553|18862053|P2|STARTED|Washout Period 1||12
7658734|NCT02074553|18862054|P1|STARTED|Washout Period 1||12
7658735|NCT02074553|18862047|P8|NOT COMPLETED|Intervention Period 1||0
7658736|NCT02074553|18862048|P7|NOT COMPLETED|Intervention Period 1||0
7658737|NCT02074553|18862049|P6|NOT COMPLETED|Intervention Period 1||0
7658738|NCT02074553|18862050|P5|NOT COMPLETED|Intervention Period 1||0
7658739|NCT02074553|18862051|P4|NOT COMPLETED|Intervention Period 1||1
7658740|NCT02074553|18862052|P3|NOT COMPLETED|Intervention Period 1||0
7658741|NCT02074553|18862053|P2|NOT COMPLETED|Intervention Period 1||0
7658742|NCT02074553|18862054|P1|NOT COMPLETED|Intervention Period 1||0
7658743|NCT02074553|18862047|P8|COMPLETED|Intervention Period 1||12
7658744|NCT02074553|18862048|P7|COMPLETED|Intervention Period 1||12
7658745|NCT02074553|18862049|P6|COMPLETED|Intervention Period 1||12
7658746|NCT02074553|18862050|P5|COMPLETED|Intervention Period 1||12
7658747|NCT02074553|18862051|P4|COMPLETED|Intervention Period 1||12
7658748|NCT02074553|18862052|P3|COMPLETED|Intervention Period 1||12
7658749|NCT02074553|18862053|P2|COMPLETED|Intervention Period 1||12
7658750|NCT02074553|18862054|P1|COMPLETED|Intervention Period 1||12
7658751|NCT02074553|18862047|P8|STARTED|Intervention Period 1||12
7658752|NCT02074553|18862048|P7|STARTED|Intervention Period 1||12
7658753|NCT02074553|18862049|P6|STARTED|Intervention Period 1||12
7658754|NCT02074553|18862050|P5|STARTED|Intervention Period 1||12
7658755|NCT02074553|18862051|P4|STARTED|Intervention Period 1||13
7658756|NCT02074553|18862052|P3|STARTED|Intervention Period 1||12
7658757|NCT02074553|18862053|P2|STARTED|Intervention Period 1||12
7658758|NCT02074553|18862054|P1|STARTED|Intervention Period 1||12
7658759|NCT02074514|18862236|P2|NOT COMPLETED|Overall Study||4
7658760|NCT02074514|18862237|P1|NOT COMPLETED|Overall Study||3
7658761|NCT02074514|18862236|P2|COMPLETED|Overall Study||54
7658762|NCT02074514|18862237|P1|COMPLETED|Overall Study||56
7658763|NCT02074514|18862236|P2|STARTED|Overall Study||58
7658764|NCT02074514|18862237|P1|STARTED|Overall Study||59
7658765|NCT02074384|18862258|P3|NOT COMPLETED|Overall Study||0
7658766|NCT02074384|18862259|P2|NOT COMPLETED|Overall Study||0
7658767|NCT02074384|18862260|P1|NOT COMPLETED|Overall Study||0
7658768|NCT02074384|18862258|P3|COMPLETED|Overall Study||17
7658769|NCT02074384|18862259|P2|COMPLETED|Overall Study||70
7658770|NCT02074384|18862260|P1|COMPLETED|Overall Study||74
7658771|NCT02074384|18862258|P3|STARTED|Overall Study||17
7658772|NCT02074384|18862259|P2|STARTED|Overall Study||70
7658773|NCT02074384|18862260|P1|STARTED|Overall Study||74
7658774|NCT02074358|18862268|P6|NOT COMPLETED|Overall Study||0
7658775|NCT02074358|18862269|P5|NOT COMPLETED|Overall Study||0
7658776|NCT02074358|18862270|P4|NOT COMPLETED|Overall Study||0
7658777|NCT02074358|18862271|P3|NOT COMPLETED|Overall Study||0
7658778|NCT02074358|18862272|P2|NOT COMPLETED|Overall Study||0
7658779|NCT02074358|18862273|P1|NOT COMPLETED|Overall Study||0
7658780|NCT02074358|18862268|P6|COMPLETED|Overall Study||2
7658781|NCT02074358|18862269|P5|COMPLETED|Overall Study||3
7658782|NCT02074358|18862270|P4|COMPLETED|Overall Study||2
7658783|NCT02074358|18862271|P3|COMPLETED|Overall Study||2
7658784|NCT02074358|18862272|P2|COMPLETED|Overall Study||3
7658785|NCT02074358|18862273|P1|COMPLETED|Overall Study||3
7658786|NCT02074358|18862268|P6|STARTED|Overall Study||2
7658787|NCT02074358|18862269|P5|STARTED|Overall Study||3
7658788|NCT02074358|18862270|P4|STARTED|Overall Study||2
7658789|NCT02074358|18862271|P3|STARTED|Overall Study||2
7658790|NCT02074358|18862272|P2|STARTED|Overall Study||3
7658791|NCT02074358|18862273|P1|STARTED|Overall Study||3
7658792|NCT02074345|18862362|P1|NOT COMPLETED|Overall Study||0
7658793|NCT02074345|18862362|P1|COMPLETED|Overall Study||31
7658794|NCT02074345|18862362|P1|STARTED|Overall Study||31
7658795|NCT02074059|18862378|P6|NOT COMPLETED|Overall Study||1
7658796|NCT02074059|18862379|P5|NOT COMPLETED|Overall Study||1
7658797|NCT02074059|18862380|P4|NOT COMPLETED|Overall Study||0
7658798|NCT02074059|18862381|P3|NOT COMPLETED|Overall Study||0
7658799|NCT02074059|18862382|P2|NOT COMPLETED|Overall Study||0
7658800|NCT02074059|18862383|P1|NOT COMPLETED|Overall Study||0
7658801|NCT02074059|18862378|P6|COMPLETED|Overall Study||39
7658802|NCT02074059|18862379|P5|COMPLETED|Overall Study||7
7658803|NCT02074059|18862380|P4|COMPLETED|Overall Study||8
7658804|NCT02074059|18862381|P3|COMPLETED|Overall Study||8
7658805|NCT02074059|18862382|P2|COMPLETED|Overall Study||8
7658806|NCT02074059|18862383|P1|COMPLETED|Overall Study||8
7658807|NCT02074059|18862378|P6|STARTED|Overall Study||40
7658808|NCT02074059|18862379|P5|STARTED|Overall Study||8
7658809|NCT02074059|18862380|P4|STARTED|Overall Study||8
7658810|NCT02074059|18862381|P3|STARTED|Overall Study||8
7658811|NCT02074059|18862382|P2|STARTED|Overall Study||8
7658812|NCT02074059|18862383|P1|STARTED|Overall Study||8
7658813|NCT02073968|18862421|P1|NOT COMPLETED|Overall Study||0
7658814|NCT02073968|18862421|P1|COMPLETED|Overall Study||35
7658815|NCT02073968|18862421|P1|STARTED|Overall Study||35
7658816|NCT02073929|18862427|P2|NOT COMPLETED|Overall Study||3
7658817|NCT02073929|18862428|P1|NOT COMPLETED|Overall Study||4
7658818|NCT02073929|18862427|P2|COMPLETED|Overall Study||21
7658819|NCT02073929|18862428|P1|COMPLETED|Overall Study||44
7658820|NCT02073929|18862427|P2|STARTED|Overall Study||24
7658821|NCT02073929|18862428|P1|STARTED|Overall Study||48
7658822|NCT02073747|18862456|P2|NOT COMPLETED|Overall Study||1
7658823|NCT02073747|18862457|P1|NOT COMPLETED|Overall Study||1
7658824|NCT02073747|18862456|P2|COMPLETED|Overall Study||14
7658825|NCT02073747|18862457|P1|COMPLETED|Overall Study||14
7658826|NCT02073747|18862456|P2|STARTED|Overall Study||15
7658827|NCT02073747|18862457|P1|STARTED|Overall Study||15
7658828|NCT02073682|18862465|P2|NOT COMPLETED|Overall Study||370
7658829|NCT02073682|18862466|P1|NOT COMPLETED|Overall Study||322
7658830|NCT02073682|18862465|P2|COMPLETED|Overall Study||154
7658831|NCT02073682|18862466|P1|COMPLETED|Overall Study||200
7658832|NCT02073682|18862465|P2|STARTED|Overall Study||524
7658833|NCT02073682|18862466|P1|STARTED|Overall Study||522
7658834|NCT02073656|18862484|P1|NOT COMPLETED|Retreatment Substudy||0
7658835|NCT02073656|18862484|P1|COMPLETED|Retreatment Substudy||9
7658836|NCT02073656|18862484|P1|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9
7658837|NCT02073656|18862484|P1|NOT COMPLETED|Primary Study||8
7658838|NCT02073656|18862484|P1|COMPLETED|Primary Study||327
7658839|NCT02073656|18862484|P1|STARTED|Primary Study||335
7658840|NCT02073643|18862500|P1|NOT COMPLETED|Overall Study||24
7658841|NCT02073643|18862500|P1|COMPLETED|Overall Study||180
7658842|NCT02073643|18862500|P1|STARTED|Overall Study||204
7658843|NCT02073565|18862511|P2|NOT COMPLETED|Cohort C||4
7658844|NCT02073565|18862512|P1|NOT COMPLETED|Cohort C||0
7658845|NCT02073565|18862511|P2|COMPLETED|Cohort C||211
7658846|NCT02073565|18862512|P1|COMPLETED|Cohort C||217
7658847|NCT02073565|18862511|P2|STARTED|Cohort C||215
7658848|NCT02073565|18862512|P1|STARTED|Cohort C||217
7658849|NCT02073565|18862511|P2|NOT COMPLETED|Cohort B||2
7658850|NCT02073565|18862512|P1|NOT COMPLETED|Cohort B||1
7658851|NCT02073565|18862511|P2|COMPLETED|Cohort B||54
7658852|NCT02073565|18862512|P1|COMPLETED|Cohort B||53
7658853|NCT02073565|18862511|P2|STARTED|Cohort B||56
7658854|NCT02073565|18862512|P1|STARTED|Cohort B||54
7658855|NCT02073565|18862511|P2|NOT COMPLETED|Cohort A||0
7658856|NCT02073565|18862512|P1|NOT COMPLETED|Cohort A||1
7658857|NCT02073565|18862511|P2|COMPLETED|Cohort A||14
7658858|NCT02073565|18862512|P1|COMPLETED|Cohort A||15
7658859|NCT02073565|18862511|P2|STARTED|Cohort A||14
7658860|NCT02073565|18862512|P1|STARTED|Cohort A||16
7658861|NCT02073565|18862511|P2|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||6
7658862|NCT02073565|18862512|P1|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||2
7658863|NCT02073565|18862511|P2|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||279
7658864|NCT02073565|18862512|P1|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||285
7658865|NCT02073565|18862511|P2|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||285
7658866|NCT02073565|18862512|P1|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||287
7658867|NCT02073461|18862527|P3|NOT COMPLETED|Overall Study||1
7658868|NCT02073461|18862528|P2|NOT COMPLETED|Overall Study||1
7658869|NCT02073461|18862529|P1|NOT COMPLETED|Overall Study||4
7658870|NCT02073461|18862527|P3|COMPLETED|Overall Study||78
7658871|NCT02073461|18862528|P2|COMPLETED|Overall Study||77
7658872|NCT02073461|18862529|P1|COMPLETED|Overall Study||75
7658873|NCT02073461|18862527|P3|STARTED|Overall Study||79
7658874|NCT02073461|18862528|P2|STARTED|Overall Study||78
7658875|NCT02073461|18862529|P1|STARTED|Overall Study||79
7658876|NCT02073448|18862558|P3|NOT COMPLETED|Overall Study||5
7658877|NCT02073448|18862559|P2|NOT COMPLETED|Overall Study||12
7658878|NCT02073448|18862560|P1|NOT COMPLETED|Overall Study||2
7658879|NCT02073448|18862558|P3|COMPLETED|Overall Study||99
7658880|NCT02073448|18862559|P2|COMPLETED|Overall Study||200
7658881|NCT02073448|18862560|P1|COMPLETED|Overall Study||99
7658882|NCT02073448|18862558|P3|STARTED|Overall Study||104
7658883|NCT02073448|18862559|P2|STARTED|Overall Study||212
7658884|NCT02073448|18862560|P1|STARTED|Overall Study||101
7658885|NCT02073435|18862588|P2|NOT COMPLETED|Overall Study||0
7658886|NCT02073435|18862589|P1|NOT COMPLETED|Overall Study||0
7658887|NCT02073435|18862588|P2|COMPLETED|Overall Study||96
7658888|NCT02073435|18862589|P1|COMPLETED|Overall Study||81
7658889|NCT02073435|18862588|P2|STARTED|Overall Study||96
7658890|NCT02073435|18862589|P1|STARTED|Overall Study||81
7658891|NCT02073331|18862597|P1|NOT COMPLETED|Overall Study||0
7658892|NCT02073331|18862597|P1|COMPLETED|Overall Study||1420
7658893|NCT02073331|18862597|P1|STARTED|Overall Study||1420
7658894|NCT02073279|18862603|P2|NOT COMPLETED|Open-label Extension Period||16
7658895|NCT02073279|18862604|P1|NOT COMPLETED|Open-label Extension Period||17
7658896|NCT02073279|18862603|P2|COMPLETED|Open-label Extension Period||0
7658897|NCT02073279|18862604|P1|COMPLETED|Open-label Extension Period||0
7658898|NCT02073279|18862603|P2|STARTED|Open-label Extension Period||16
7658899|NCT02073279|18862604|P1|STARTED|Open-label Extension Period||17
7658900|NCT02073279|18862603|P2|NOT COMPLETED|Double-blind Period||47
7658901|NCT02073279|18862604|P1|NOT COMPLETED|Double-blind Period||15
7658902|NCT02073279|18862603|P2|COMPLETED|Double-blind Period||16
7658903|NCT02073279|18862604|P1|COMPLETED|Double-blind Period||17
7658904|NCT02073279|18862603|P2|STARTED|Double-blind Period||63
7658905|NCT02073279|18862604|P1|STARTED|Double-blind Period||32
7658906|NCT02073162|18862678|P2|NOT COMPLETED|Overall Study||11
7658907|NCT02073162|18862679|P1|NOT COMPLETED|Overall Study||6
7658908|NCT02073162|18862678|P2|COMPLETED|Overall Study||1490
7658909|NCT02073162|18862679|P1|COMPLETED|Overall Study||1493
7658910|NCT02073162|18862678|P2|STARTED|Overall Study||1501
7658911|NCT02073162|18862679|P1|STARTED|Overall Study||1499
7658912|NCT02072980|18862707|P2|NOT COMPLETED|Period 2, Second Wear||1
7658913|NCT02072980|18862708|P1|NOT COMPLETED|Period 2, Second Wear||0
7658914|NCT02072980|18862707|P2|COMPLETED|Period 2, Second Wear||7
7658915|NCT02072980|18862708|P1|COMPLETED|Period 2, Second Wear||7
7658916|NCT02072980|18862707|P2|STARTED|Period 2, Second Wear||8
7658917|NCT02072980|18862708|P1|STARTED|Period 2, Second Wear||7
7658918|NCT02072980|18862707|P2|NOT COMPLETED|Period 1, First Wear||0
7658919|NCT02072980|18862708|P1|NOT COMPLETED|Period 1, First Wear||0
7658920|NCT02072980|18862707|P2|COMPLETED|Period 1, First Wear||8
7658921|NCT02072980|18862708|P1|COMPLETED|Period 1, First Wear||7
7658922|NCT02072980|18862707|P2|STARTED|Period 1, First Wear||8
7658923|NCT02072980|18862708|P1|STARTED|Period 1, First Wear||7
7658924|NCT02072941|18862716|P2|NOT COMPLETED|Overall Study||29
7658925|NCT02072941|18862717|P1|NOT COMPLETED|Overall Study||38
7658926|NCT02072941|18862716|P2|COMPLETED|Overall Study||197
7658927|NCT02072941|18862717|P1|COMPLETED|Overall Study||181
7658928|NCT02072941|18862716|P2|STARTED|Overall Study||226
7658929|NCT02072941|18862717|P1|STARTED|Overall Study||219
7658930|NCT02072928|18862725|P1|NOT COMPLETED|Overall Study||0
7658931|NCT02072928|18862725|P1|COMPLETED|Overall Study||55
7658932|NCT02072928|18862725|P1|STARTED|Overall Study||55
7658933|NCT02072824|18862732|P3|NOT COMPLETED|Overall Study||3
7658934|NCT02072824|18862733|P2|NOT COMPLETED|Overall Study||1
7658935|NCT02072824|18862734|P1|NOT COMPLETED|Overall Study||2
7658936|NCT02072824|18862732|P3|COMPLETED|Overall Study||67
7658937|NCT02072824|18862733|P2|COMPLETED|Overall Study||33
7658938|NCT02072824|18862734|P1|COMPLETED|Overall Study||69
7658939|NCT02072824|18862732|P3|STARTED|Overall Study||70
7658940|NCT02072824|18862733|P2|STARTED|Overall Study||34
7658941|NCT02072824|18862734|P1|STARTED|Overall Study||71
7658942|NCT02072668|18862769|P2|NOT COMPLETED|Second Intervention||0
7658943|NCT02072668|18862770|P1|NOT COMPLETED|Second Intervention||1
7658944|NCT02072668|18862769|P2|COMPLETED|Second Intervention||7
7658945|NCT02072668|18862770|P1|COMPLETED|Second Intervention||6
7658946|NCT02072668|18862769|P2|STARTED|Second Intervention||7
7658947|NCT02072668|18862770|P1|STARTED|Second Intervention||7
7658948|NCT02072668|18862769|P2|NOT COMPLETED|Washout (2 Weeks)||0
7658949|NCT02072668|18862770|P1|NOT COMPLETED|Washout (2 Weeks)||0
7658950|NCT02072668|18862769|P2|COMPLETED|Washout (2 Weeks)||7
7658951|NCT02072668|18862770|P1|COMPLETED|Washout (2 Weeks)||7
7658952|NCT02072668|18862769|P2|STARTED|Washout (2 Weeks)||7
7658953|NCT02072668|18862770|P1|STARTED|Washout (2 Weeks)||7
7658954|NCT02072668|18862769|P2|NOT COMPLETED|First Intervention||0
7658955|NCT02072668|18862770|P1|NOT COMPLETED|First Intervention||0
7658956|NCT02072668|18862769|P2|COMPLETED|First Intervention||7
7658957|NCT02072668|18862770|P1|COMPLETED|First Intervention||7
7658958|NCT02072668|18862769|P2|STARTED|First Intervention||7
7658959|NCT02072668|18862770|P1|STARTED|First Intervention||7
7658960|NCT02072434|18862810|P2|NOT COMPLETED|Overall Study||90
7658961|NCT02072434|18862811|P1|NOT COMPLETED|Overall Study||54
7658962|NCT02072434|18862810|P2|COMPLETED|Overall Study||1014
7658963|NCT02072434|18862811|P1|COMPLETED|Overall Study||1041
7658964|NCT02072434|18862810|P2|Safety Analysis Set|Overall Study||1082
7658965|NCT02072434|18862811|P1|Safety Analysis Set|Overall Study||1067
7658966|NCT02072434|18862810|P2|Received Study Drug|Overall Study||1082
7658967|NCT02072434|18862811|P1|Received Study Drug|Overall Study||1067
7658968|NCT02072434|18862810|P2|Intent to Treat Analysis Set|Overall Study||1104
7658969|NCT02072434|18862811|P1|Intent to Treat Analysis Set|Overall Study||1095
7658970|NCT02072434|18862810|P2|STARTED|Overall Study||1104
7658971|NCT02072434|18862811|P1|STARTED|Overall Study||1095
7658972|NCT02072421|18862821|P1|NOT COMPLETED|Overall Study||390
7658973|NCT02072421|18862821|P1|COMPLETED|Overall Study||2489
7658974|NCT02072421|18862821|P1|STARTED|Overall Study||2879
7658975|NCT02072226|18862831|P2|NOT COMPLETED|Overall Study||10
7658976|NCT02072226|18862832|P1|NOT COMPLETED|Overall Study||15
7658977|NCT02072226|18862831|P2|COMPLETED|Overall Study||147
7658978|NCT02072226|18862832|P1|COMPLETED|Overall Study||141
7658979|NCT02072226|18862831|P2|STARTED|Overall Study||157
7658980|NCT02072226|18862832|P1|STARTED|Overall Study||156
7658981|NCT02072200|18862854|P1|NOT COMPLETED|Overall Study||2
7658982|NCT02072200|18862854|P1|COMPLETED|Overall Study||145
7658983|NCT02072200|18862854|P1|STARTED|Overall Study||147
7658984|NCT02072174|18862862|P2|NOT COMPLETED|Overall Study||39
7658985|NCT02072174|18862863|P1|NOT COMPLETED|Overall Study||32
7658986|NCT02072174|18862862|P2|COMPLETED|Overall Study||240
7658987|NCT02072174|18862863|P1|COMPLETED|Overall Study||258
7658988|NCT02072174|18862862|P2|STARTED|Overall Study||279
7658989|NCT02072174|18862863|P1|STARTED|Overall Study||290
7658990|NCT02072096|18862887|P2|NOT COMPLETED|Overall Study||78
7658991|NCT02072096|18862888|P1|NOT COMPLETED|Overall Study||85
7658992|NCT02072096|18862887|P2|COMPLETED|Overall Study||15
7658993|NCT02072096|18862888|P1|COMPLETED|Overall Study||14
7658994|NCT02072096|18862887|P2|Received at Least One Dose of Study Drug|Overall Study||93
7658995|NCT02072096|18862888|P1|Received at Least One Dose of Study Drug|Overall Study||98
7658996|NCT02072096|18862887|P2|STARTED|Overall Study||93
7658997|NCT02072096|18862888|P1|STARTED|Overall Study||99
7658998|NCT02071914|18862913|P3|NOT COMPLETED|Overall Study||0
7658999|NCT02071914|18862914|P2|NOT COMPLETED|Overall Study||0
7659000|NCT02071914|18862915|P1|NOT COMPLETED|Overall Study||0
7659001|NCT02071914|18862913|P3|COMPLETED|Overall Study||27
7659002|NCT02071914|18862914|P2|COMPLETED|Overall Study||27
7659003|NCT02071914|18862915|P1|COMPLETED|Overall Study||27
7659004|NCT02071914|18862913|P3|STARTED|Overall Study||27
7659005|NCT02071914|18862914|P2|STARTED|Overall Study||27
7659006|NCT02071914|18862915|P1|STARTED|Overall Study||27
7659007|NCT02071901|18862923|P1|NOT COMPLETED|Overall Study||0
7659008|NCT02071901|18862923|P1|COMPLETED|Overall Study||31
7659009|NCT02071901|18862923|P1|STARTED|Overall Study||31
7659010|NCT02071849|18862939|P1|NOT COMPLETED|2-year Extended Follow-up||1
7659011|NCT02071849|18862939|P1|COMPLETED|2-year Extended Follow-up||14
7659012|NCT02071849|18862939|P1|STARTED|2-year Extended Follow-up||15
7659013|NCT02071849|18862939|P1|NOT COMPLETED|6-month Primary Endpoint||5
7659014|NCT02071849|18862939|P1|COMPLETED|6-month Primary Endpoint||15
7659015|NCT02071849|18862939|P1|STARTED|6-month Primary Endpoint||20
7659016|NCT02071823|18862973|P2|NOT COMPLETED|Overall Study||0
7659017|NCT02071823|18862974|P1|NOT COMPLETED|Overall Study||1
7659018|NCT02071823|18862973|P2|COMPLETED|Overall Study||6
7659019|NCT02071823|18862974|P1|COMPLETED|Overall Study||5
7659020|NCT02071823|18862973|P2|STARTED|Overall Study||6
7659021|NCT02071823|18862974|P1|STARTED|Overall Study||6
7659022|NCT02071810|18862989|P5|NOT COMPLETED|Overall Study||1
7659023|NCT02071810|18862990|P4|NOT COMPLETED|Overall Study||1
7659024|NCT02071810|18862991|P3|NOT COMPLETED|Overall Study||0
7659025|NCT02071810|18862992|P2|NOT COMPLETED|Overall Study||0
7659026|NCT02071810|18862993|P1|NOT COMPLETED|Overall Study||0
7659027|NCT02071810|18862989|P5|COMPLETED|Overall Study||8
7659028|NCT02071810|18862990|P4|COMPLETED|Overall Study||6
7659029|NCT02071810|18862991|P3|COMPLETED|Overall Study||6
7659030|NCT02071810|18862992|P2|COMPLETED|Overall Study||6
7659031|NCT02071810|18862993|P1|COMPLETED|Overall Study||6
7659032|NCT02071810|18862989|P5|STARTED|Overall Study||9
7659033|NCT02071810|18862990|P4|STARTED|Overall Study||7
7659034|NCT02071810|18862991|P3|STARTED|Overall Study||6
7659035|NCT02071810|18862992|P2|STARTED|Overall Study||6
7659036|NCT02071810|18862993|P1|STARTED|Overall Study||6
7659037|NCT02071771|18863005|P2|NOT COMPLETED|Period 2: Second 10 Days||0
7659038|NCT02071771|18863006|P1|NOT COMPLETED|Period 2: Second 10 Days||0
7659039|NCT02071771|18863005|P2|COMPLETED|Period 2: Second 10 Days||38
7659040|NCT02071771|18863006|P1|COMPLETED|Period 2: Second 10 Days||39
7659041|NCT02071771|18863005|P2|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38
7659042|NCT02071771|18863006|P1|STARTED|Period 2: Second 10 Days||39
7659043|NCT02071771|18863005|P2|NOT COMPLETED|Period 1: First 10 Days||0
7659044|NCT02071771|18863006|P1|NOT COMPLETED|Period 1: First 10 Days||2
7659045|NCT02071771|18863005|P2|COMPLETED|Period 1: First 10 Days||39
7659046|NCT02071771|18863006|P1|COMPLETED|Period 1: First 10 Days||39
7659047|NCT02071771|18863005|P2|Dispensed|Period 1: First 10 Days||39
7659048|NCT02071771|18863006|P1|Dispensed|Period 1: First 10 Days||39
7659049|NCT02071771|18863005|P2|STARTED|Period 1: First 10 Days||39
7659050|NCT02071771|18863006|P1|STARTED|Period 1: First 10 Days||41
7659051|NCT02071706|18863014|P1|NOT COMPLETED|Overall Study||3
7659052|NCT02071706|18863014|P1|COMPLETED|Overall Study||59
7659053|NCT02071706|18863014|P1|STARTED|Overall Study||62
7659054|NCT02071420|18863021|P2|NOT COMPLETED|Overall Study||3
7659055|NCT02071420|18863022|P1|NOT COMPLETED|Overall Study||3
7659056|NCT02071420|18863021|P2|COMPLETED|Overall Study||27
7659057|NCT02071420|18863022|P1|COMPLETED|Overall Study||27
7659058|NCT02071420|18863021|P2|STARTED|Overall Study||30
7659059|NCT02071420|18863022|P1|STARTED|Overall Study||30
7659060|NCT02071290|18863030|P2|NOT COMPLETED|Overall Study||7
7659061|NCT02071290|18863031|P1|NOT COMPLETED|Overall Study||4
7659062|NCT02071290|18863030|P2|COMPLETED|Overall Study||18
7659063|NCT02071290|18863031|P1|COMPLETED|Overall Study||21
7659064|NCT02071290|18863030|P2|STARTED|Overall Study||25
7659065|NCT02071290|18863031|P1|STARTED|Overall Study||25
7659066|NCT02071225|18863085|P1|NOT COMPLETED|Overall Study||30
7659067|NCT02071225|18863085|P1|COMPLETED|Overall Study||42
7659068|NCT02071225|18863085|P1|STARTED|Overall Study||72
7659069|NCT02071173|18863103|P1|NOT COMPLETED|Overall Study||1835
7659070|NCT02071173|18863103|P1|COMPLETED|Overall Study|Follow-up is ongoing. Data as of 5-Feb-2020.|409
7659071|NCT02071173|18863103|P1|ACUITY X4 Endpoint Population|Overall Study|536 with ACUITY X4 Spiral lead, 228 with ACUITY X4 Straight lead|764
7659072|NCT02071173|18863103|P1|RELIANCE 4-FRONT Endpoint Population|Overall Study|1507 with active fixation 4-FRONT lead, 37 with passive fixation 4-FRONT lead|1544
7659073|NCT02071173|18863103|P1|Implanted/Attempted With a Study Device|Overall Study||2200
7659074|NCT02071173|18863103|P1|STARTED|Overall Study||2244
7659075|NCT02071108|18863122|P1|NOT COMPLETED|Overall Study||0
7659076|NCT02071108|18863122|P1|COMPLETED|Overall Study||35
7659077|NCT02071108|18863122|P1|STARTED|Overall Study||35
7659078|NCT02071095|18863143|P2|NOT COMPLETED|Overall Study||0
7659079|NCT02071095|18863144|P1|NOT COMPLETED|Overall Study||0
7659080|NCT02071095|18863143|P2|COMPLETED|Overall Study||3
7659081|NCT02071095|18863144|P1|COMPLETED|Overall Study||12
7659082|NCT02071095|18863143|P2|STARTED|Overall Study||3
7659083|NCT02071095|18863144|P1|STARTED|Overall Study||12
7659084|NCT02071082|18863160|P2|NOT COMPLETED|Overall Study||7
7659085|NCT02071082|18863161|P1|NOT COMPLETED|Overall Study||2
7659086|NCT02071082|18863160|P2|COMPLETED|Overall Study||68
7659087|NCT02071082|18863161|P1|COMPLETED|Overall Study||2
7659088|NCT02071082|18863160|P2|STARTED|Overall Study||75
7659089|NCT02071082|18863161|P1|STARTED|Overall Study||4
7659090|NCT02070991|18863191|P2|NOT COMPLETED|Overall Study||0
7659091|NCT02070991|18863192|P1|NOT COMPLETED|Overall Study||3
7659092|NCT02070991|18863191|P2|COMPLETED|Overall Study||32
7659093|NCT02070991|18863192|P1|COMPLETED|Overall Study||28
7659094|NCT02070991|18863191|P2|STARTED|Overall Study||32
7659095|NCT02070991|18863192|P1|STARTED|Overall Study||31
7659096|NCT02070978|18863215|P3|NOT COMPLETED|Overall Study||53
7659097|NCT02070978|18863216|P2|NOT COMPLETED|Overall Study||53
7659098|NCT02070978|18863217|P1|NOT COMPLETED|Overall Study||47
7659099|NCT02070978|18863215|P3|COMPLETED|Overall Study||35
7659100|NCT02070978|18863216|P2|COMPLETED|Overall Study||29
7659101|NCT02070978|18863217|P1|COMPLETED|Overall Study||36
7659102|NCT02070978|18863215|P3|STARTED|Overall Study||88
7659103|NCT02070978|18863216|P2|STARTED|Overall Study||82
7659104|NCT02070978|18863217|P1|STARTED|Overall Study||83
7659105|NCT02070965|18863279|P3|NOT COMPLETED|Overall Study||1
7659106|NCT02070965|18863280|P2|NOT COMPLETED|Overall Study||2
7659107|NCT02070965|18863281|P1|NOT COMPLETED|Overall Study||2
7659108|NCT02070965|18863279|P3|COMPLETED|Overall Study||24
7659109|NCT02070965|18863280|P2|COMPLETED|Overall Study||21
7659110|NCT02070965|18863281|P1|COMPLETED|Overall Study||25
7659111|NCT02070965|18863279|P3|STARTED|Overall Study||25
7659112|NCT02070965|18863280|P2|STARTED|Overall Study||23
7659113|NCT02070965|18863281|P1|STARTED|Overall Study||27
7659114|NCT02070757|18863291|P2|NOT COMPLETED|Overall Study||114
7659115|NCT02070757|18863292|P1|NOT COMPLETED|Overall Study||117
7659116|NCT02070757|18863291|P2|COMPLETED|Overall Study||250
7659117|NCT02070757|18863292|P1|COMPLETED|Overall Study||245
7659118|NCT02070757|18863291|P2|Treated Participants|Overall Study||359
7659119|NCT02070757|18863292|P1|Treated Participants|Overall Study||361
7659120|NCT02070757|18863291|P2|STARTED|Overall Study||364
7659121|NCT02070757|18863292|P1|STARTED|Overall Study||362
7659122|NCT02070744|18863326|P5|NOT COMPLETED|OLE Phase (48 Weeks)||3
7659123|NCT02070744|18863327|P4|NOT COMPLETED|OLE Phase (48 Weeks)||0
7659124|NCT02070744|18863328|P3|NOT COMPLETED|OLE Phase (48 Weeks)||0
7659125|NCT02070744|18863329|P2|NOT COMPLETED|OLE Phase (48 Weeks)||0
7659126|NCT02070744|18863330|P1|NOT COMPLETED|OLE Phase (48 Weeks)||0
7659127|NCT02070744|18863326|P5|COMPLETED|OLE Phase (48 Weeks)||24
7659128|NCT02070744|18863327|P4|COMPLETED|OLE Phase (48 Weeks)||0
7659129|NCT02070744|18863328|P3|COMPLETED|OLE Phase (48 Weeks)||0
7659130|NCT02070744|18863329|P2|COMPLETED|OLE Phase (48 Weeks)||0
7659131|NCT02070744|18863330|P1|COMPLETED|OLE Phase (48 Weeks)||0
7659132|NCT02070744|18863326|P5|STARTED|OLE Phase (48 Weeks)|12 participants completed PC phase, but did not enter OLE phase.|27
7659133|NCT02070744|18863327|P4|STARTED|OLE Phase (48 Weeks)||0
7659134|NCT02070744|18863328|P3|STARTED|OLE Phase (48 Weeks)||0
7659135|NCT02070744|18863329|P2|STARTED|OLE Phase (48 Weeks)||0
7659136|NCT02070744|18863330|P1|STARTED|OLE Phase (48 Weeks)||0
7659137|NCT02070744|18863326|P5|NOT COMPLETED|PC Phase (12 Weeks)||0
7659138|NCT02070744|18863327|P4|NOT COMPLETED|PC Phase (12 Weeks)||1
7659139|NCT02070744|18863328|P3|NOT COMPLETED|PC Phase (12 Weeks)||0
7659140|NCT02070744|18863329|P2|NOT COMPLETED|PC Phase (12 Weeks)||0
7659141|NCT02070744|18863330|P1|NOT COMPLETED|PC Phase (12 Weeks)||0
7659142|NCT02070744|18863326|P5|COMPLETED|PC Phase (12 Weeks)||0
7659143|NCT02070744|18863327|P4|COMPLETED|PC Phase (12 Weeks)||13
7659144|NCT02070744|18863328|P3|COMPLETED|PC Phase (12 Weeks)||15
7659145|NCT02070744|18863329|P2|COMPLETED|PC Phase (12 Weeks)||5
7659146|NCT02070744|18863330|P1|COMPLETED|PC Phase (12 Weeks)||6
7659147|NCT02070744|18863326|P5|Treated|PC Phase (12 Weeks)||0
7659148|NCT02070744|18863327|P4|Treated|PC Phase (12 Weeks)||13
7659149|NCT02070744|18863328|P3|Treated|PC Phase (12 Weeks)||15
7659150|NCT02070744|18863329|P2|Treated|PC Phase (12 Weeks)||5
7659151|NCT02070744|18863330|P1|Treated|PC Phase (12 Weeks)||6
7659152|NCT02070744|18863326|P5|STARTED|PC Phase (12 Weeks)||0
7659153|NCT02070744|18863327|P4|STARTED|PC Phase (12 Weeks)||14
7659154|NCT02070744|18863328|P3|STARTED|PC Phase (12 Weeks)||15
7659155|NCT02070744|18863329|P2|STARTED|PC Phase (12 Weeks)||5
7659156|NCT02070744|18863330|P1|STARTED|PC Phase (12 Weeks)||6
7659157|NCT02070692|18863382|P2|NOT COMPLETED|Overall Study||12
7659158|NCT02070692|18863383|P1|NOT COMPLETED|Overall Study||10
7659159|NCT02070692|18863382|P2|COMPLETED|Overall Study||16
7659160|NCT02070692|18863383|P1|COMPLETED|Overall Study||18
7659161|NCT02070692|18863382|P2|STARTED|Overall Study||28
7659162|NCT02070692|18863383|P1|STARTED|Overall Study||28
7659163|NCT02070640|18863399|P2|NOT COMPLETED|Overall Study||0
7659164|NCT02070640|18863400|P1|NOT COMPLETED|Overall Study||11
7659165|NCT02070640|18863399|P2|COMPLETED|Overall Study||6
7659166|NCT02070640|18863400|P1|COMPLETED|Overall Study||82
7659167|NCT02070640|18863399|P2|STARTED|Overall Study||6
7659168|NCT02070640|18863400|P1|STARTED|Overall Study||93
7659169|NCT02070588|18863413|P3|NOT COMPLETED|Overall Study||0
7659170|NCT02070588|18863414|P2|NOT COMPLETED|Overall Study||1
7659171|NCT02070588|18863415|P1|NOT COMPLETED|Overall Study||39
7659172|NCT02070588|18863413|P3|COMPLETED|Overall Study||0
7659173|NCT02070588|18863414|P2|COMPLETED|Overall Study||25
7659174|NCT02070588|18863415|P1|COMPLETED|Overall Study||47
7659175|NCT02070588|18863413|P3|STARTED|Overall Study||0
7659176|NCT02070588|18863414|P2|STARTED|Overall Study||26
7659177|NCT02070588|18863415|P1|STARTED|Overall Study||86
7659178|NCT02070484|18863431|P2|NOT COMPLETED|Overall Study||0
7659179|NCT02070484|18863432|P1|NOT COMPLETED|Overall Study||1
7659180|NCT02070484|18863431|P2|COMPLETED|Overall Study||3
7659181|NCT02070484|18863432|P1|COMPLETED|Overall Study||2
7659182|NCT02070484|18863431|P2|STARTED|Overall Study||3
7659183|NCT02070484|18863432|P1|STARTED|Overall Study||3
7659184|NCT02070380|18863454|P4|NOT COMPLETED|Second Injection||5
7659185|NCT02070380|18863455|P3|NOT COMPLETED|Second Injection||1
7659186|NCT02070380|18863456|P2|NOT COMPLETED|Second Injection||2
7659187|NCT02070380|18863457|P1|NOT COMPLETED|Second Injection||0
7659188|NCT02070380|18863454|P4|COMPLETED|Second Injection||46
7659189|NCT02070380|18863455|P3|COMPLETED|Second Injection||50
7659190|NCT02070380|18863456|P2|COMPLETED|Second Injection||32
7659191|NCT02070380|18863457|P1|COMPLETED|Second Injection||31
7659192|NCT02070380|18863454|P4|STARTED|Second Injection||51
7659193|NCT02070380|18863455|P3|STARTED|Second Injection||51
7659194|NCT02070380|18863456|P2|STARTED|Second Injection||34
7659195|NCT02070380|18863457|P1|STARTED|Second Injection||31
7659196|NCT02070380|18863454|P4|NOT COMPLETED|Washout (no Second Injection/MRI)||3
7659197|NCT02070380|18863455|P3|NOT COMPLETED|Washout (no Second Injection/MRI)||2
7659198|NCT02070380|18863456|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||5
7659199|NCT02070380|18863457|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||0
7659200|NCT02070380|18863454|P4|COMPLETED|Washout (no Second Injection/MRI)||51
7659201|NCT02070380|18863455|P3|COMPLETED|Washout (no Second Injection/MRI)||51
7659202|NCT02070380|18863456|P2|COMPLETED|Washout (no Second Injection/MRI)||34
7659203|NCT02070380|18863457|P1|COMPLETED|Washout (no Second Injection/MRI)||31
7659204|NCT02070380|18863454|P4|STARTED|Washout (no Second Injection/MRI)||54
7659205|NCT02070380|18863455|P3|STARTED|Washout (no Second Injection/MRI)||53
7659206|NCT02070380|18863456|P2|STARTED|Washout (no Second Injection/MRI)||39
7659207|NCT02070380|18863457|P1|STARTED|Washout (no Second Injection/MRI)||31
7659208|NCT02070380|18863454|P4|NOT COMPLETED|First Injection||0
7659209|NCT02070380|18863455|P3|NOT COMPLETED|First Injection||0
7659210|NCT02070380|18863456|P2|NOT COMPLETED|First Injection||0
7659211|NCT02070380|18863457|P1|NOT COMPLETED|First Injection||0
7659212|NCT02070380|18863454|P4|COMPLETED|First Injection||54
7659213|NCT02070380|18863455|P3|COMPLETED|First Injection||53
7659214|NCT02070380|18863456|P2|COMPLETED|First Injection||39
7659215|NCT02070380|18863457|P1|COMPLETED|First Injection||31
7659216|NCT02070380|18863454|P4|STARTED|First Injection||54
7659217|NCT02070380|18863455|P3|STARTED|First Injection||53
7659218|NCT02070380|18863456|P2|STARTED|First Injection||39
7659219|NCT02070380|18863457|P1|STARTED|First Injection||31
7659220|NCT02070302|18863507|P2|NOT COMPLETED|Overall Study||0
7659221|NCT02070302|18863508|P1|NOT COMPLETED|Overall Study||0
7659222|NCT02070302|18863507|P2|COMPLETED|Overall Study||5
7659223|NCT02070302|18863508|P1|COMPLETED|Overall Study||5
7659224|NCT02070302|18863507|P2|STARTED|Overall Study||5
7659225|NCT02070302|18863508|P1|STARTED|Overall Study||5
7659226|NCT02070276|18863527|P3|NOT COMPLETED|Overall Study||0
7659227|NCT02070276|18863528|P2|NOT COMPLETED|Overall Study||0
7659228|NCT02070276|18863529|P1|NOT COMPLETED|Overall Study||0
7659229|NCT02070276|18863527|P3|COMPLETED|Overall Study||148
7659230|NCT02070276|18863528|P2|COMPLETED|Overall Study||132
7659231|NCT02070276|18863529|P1|COMPLETED|Overall Study||149
7659232|NCT02070276|18863527|P3|STARTED|Overall Study||148
7659233|NCT02070276|18863528|P2|STARTED|Overall Study||132
7659234|NCT02070276|18863529|P1|STARTED|Overall Study||149
7659235|NCT02070237|18863545|P2|NOT COMPLETED|Overall Study||3
7659236|NCT02070237|18863546|P1|NOT COMPLETED|Overall Study||3
7659237|NCT02070237|18863545|P2|COMPLETED|Overall Study||42
7659238|NCT02070237|18863546|P1|COMPLETED|Overall Study||42
7659239|NCT02070237|18863545|P2|STARTED|Overall Study||45
7659240|NCT02070237|18863546|P1|STARTED|Overall Study||45
7659241|NCT02069847|18863556|P2|NOT COMPLETED|Overall Study||0
7659242|NCT02069847|18863557|P1|NOT COMPLETED|Overall Study||0
7659243|NCT02069847|18863556|P2|COMPLETED|Overall Study||68
7659244|NCT02069847|18863557|P1|COMPLETED|Overall Study||22
7659245|NCT02069847|18863556|P2|STARTED|Overall Study||68
7659246|NCT02069847|18863557|P1|STARTED|Overall Study||22
7659247|NCT02069704|18863566|P2|NOT COMPLETED|Overall Study||0
7659248|NCT02069704|18863567|P1|NOT COMPLETED|Overall Study||0
7659249|NCT02069704|18863566|P2|COMPLETED|Overall Study||71
7659250|NCT02069704|18863567|P1|COMPLETED|Overall Study||69
7659251|NCT02069704|18863566|P2|STARTED|Overall Study||71
7659252|NCT02069704|18863567|P1|STARTED|Overall Study|Two patients were randomized but they did not received study treatment|69
7659253|NCT02069392|18863599|P2|NOT COMPLETED|Overall Study||2
7659254|NCT02069392|18863600|P1|NOT COMPLETED|Overall Study||4
7659255|NCT02069392|18863599|P2|COMPLETED|Overall Study||15
7659256|NCT02069392|18863600|P1|COMPLETED|Overall Study||10
7659257|NCT02069392|18863599|P2|STARTED|Overall Study||17
7659258|NCT02069392|18863600|P1|STARTED|Overall Study||14
7659259|NCT02069379|18863624|P4|NOT COMPLETED|Second Treatment Arm||0
7659260|NCT02069379|18863625|P3|NOT COMPLETED|Second Treatment Arm||1
7659261|NCT02069379|18863626|P2|NOT COMPLETED|Second Treatment Arm||0
7659262|NCT02069379|18863627|P1|NOT COMPLETED|Second Treatment Arm||0
7659263|NCT02069379|18863624|P4|COMPLETED|Second Treatment Arm||0
7659264|NCT02069379|18863625|P3|COMPLETED|Second Treatment Arm||0
7659265|NCT02069379|18863626|P2|COMPLETED|Second Treatment Arm||1
7659266|NCT02069379|18863627|P1|COMPLETED|Second Treatment Arm||0
7659267|NCT02069379|18863624|P4|STARTED|Second Treatment Arm|Insulin resistant women who are not randomized are not involved after initial baseline collection|0
7659268|NCT02069379|18863625|P3|STARTED|Second Treatment Arm||1
7659269|NCT02069379|18863626|P2|STARTED|Second Treatment Arm||1
7659270|NCT02069379|18863627|P1|STARTED|Second Treatment Arm|Controls are not involved after initial baseline collection|0
7659271|NCT02069379|18863624|P4|NOT COMPLETED|Washout Period (4 Weeks)||0
7659272|NCT02069379|18863625|P3|NOT COMPLETED|Washout Period (4 Weeks)||0
7659273|NCT02069379|18863626|P2|NOT COMPLETED|Washout Period (4 Weeks)||2
7659274|NCT02069379|18863627|P1|NOT COMPLETED|Washout Period (4 Weeks)||0
7659275|NCT02069379|18863624|P4|COMPLETED|Washout Period (4 Weeks)||0
7659276|NCT02069379|18863625|P3|COMPLETED|Washout Period (4 Weeks)||1
7659277|NCT02069379|18863626|P2|COMPLETED|Washout Period (4 Weeks)||1
7659278|NCT02069379|18863627|P1|COMPLETED|Washout Period (4 Weeks)||0
7659279|NCT02069379|18863624|P4|STARTED|Washout Period (4 Weeks)|Insulin resistant woman who were not randomized are not involved after initial baseline collection|0
7659280|NCT02069379|18863625|P3|STARTED|Washout Period (4 Weeks)||1
7659281|NCT02069379|18863626|P2|STARTED|Washout Period (4 Weeks)||3
7659282|NCT02069379|18863627|P1|STARTED|Washout Period (4 Weeks)|Controls are not involved after initial baseline collection|0
7659283|NCT02069379|18863624|P4|NOT COMPLETED|First Treatment Arm||0
7659284|NCT02069379|18863625|P3|NOT COMPLETED|First Treatment Arm||1
7659285|NCT02069379|18863626|P2|NOT COMPLETED|First Treatment Arm||1
7659286|NCT02069379|18863627|P1|NOT COMPLETED|First Treatment Arm||0
7659287|NCT02069379|18863624|P4|COMPLETED|First Treatment Arm||0
7659288|NCT02069379|18863625|P3|COMPLETED|First Treatment Arm||1
7659289|NCT02069379|18863626|P2|COMPLETED|First Treatment Arm||3
7659290|NCT02069379|18863627|P1|COMPLETED|First Treatment Arm||0
7659291|NCT02069379|18863624|P4|STARTED|First Treatment Arm|Insulin resistant woman not randomized are not involved after initial baseline collection|0
7659292|NCT02069379|18863625|P3|STARTED|First Treatment Arm||2
7659293|NCT02069379|18863626|P2|STARTED|First Treatment Arm||4
7659294|NCT02069379|18863627|P1|STARTED|First Treatment Arm|Controls are not involved after initial baseline collection|0
7659295|NCT02069379|18863624|P4|NOT COMPLETED|Baseline Measurements||2
7659296|NCT02069379|18863625|P3|NOT COMPLETED|Baseline Measurements||0
7659297|NCT02069379|18863626|P2|NOT COMPLETED|Baseline Measurements||0
7659298|NCT02069379|18863627|P1|NOT COMPLETED|Baseline Measurements||3
7659299|NCT02069379|18863624|P4|COMPLETED|Baseline Measurements||4
7659300|NCT02069379|18863625|P3|COMPLETED|Baseline Measurements||2
7659301|NCT02069379|18863626|P2|COMPLETED|Baseline Measurements||4
7659302|NCT02069379|18863627|P1|COMPLETED|Baseline Measurements||27
7659303|NCT02069379|18863624|P4|Baseline Measurements Taken|Baseline Measurements||6
7659304|NCT02069379|18863625|P3|Baseline Measurements Taken|Baseline Measurements||2
7659305|NCT02069379|18863626|P2|Baseline Measurements Taken|Baseline Measurements||4
7659306|NCT02069379|18863627|P1|Baseline Measurements Taken|Baseline Measurements||30
7659307|NCT02069379|18863624|P4|STARTED|Baseline Measurements||6
7659308|NCT02069379|18863625|P3|STARTED|Baseline Measurements||2
7659309|NCT02069379|18863626|P2|STARTED|Baseline Measurements||4
7659310|NCT02069379|18863627|P1|STARTED|Baseline Measurements||30
7659311|NCT02069353|18863653|P1|NOT COMPLETED|Overall Study||0
7659312|NCT02069353|18863653|P1|COMPLETED|Overall Study||4
7659313|NCT02069353|18863653|P1|STARTED|Overall Study||4
7659314|NCT02069184|18863664|P2|NOT COMPLETED|Overall Study||2
7659315|NCT02069184|18863665|P1|NOT COMPLETED|Overall Study||6
7659316|NCT02069184|18863664|P2|COMPLETED|Overall Study||31
7659317|NCT02069184|18863665|P1|COMPLETED|Overall Study||27
7659318|NCT02069184|18863664|P2|STARTED|Overall Study||33
7659319|NCT02069184|18863665|P1|STARTED|Overall Study||33
7659320|NCT02069119|18863687|P4|NOT COMPLETED|Overall Study||0
7659321|NCT02069119|18863688|P3|NOT COMPLETED|Overall Study||0
7659322|NCT02069119|18863689|P2|NOT COMPLETED|Overall Study||0
7659323|NCT02069119|18863690|P1|NOT COMPLETED|Overall Study||0
7659324|NCT02069119|18863687|P4|COMPLETED|Overall Study||4
7659325|NCT02069119|18863688|P3|COMPLETED|Overall Study||20
7659326|NCT02069119|18863689|P2|COMPLETED|Overall Study||4
7659327|NCT02069119|18863690|P1|COMPLETED|Overall Study||20
7659328|NCT02069119|18863687|P4|STARTED|Overall Study||4
7659329|NCT02069119|18863688|P3|STARTED|Overall Study||20
7659330|NCT02069119|18863689|P2|STARTED|Overall Study||4
7659331|NCT02069119|18863690|P1|STARTED|Overall Study||20
7659332|NCT02069093|18863714|P1|NOT COMPLETED|Overall Study||30
7659333|NCT02069093|18863714|P1|COMPLETED|Overall Study||56
7659334|NCT02069093|18863714|P1|Pharmacokinetic Analysis Set|Overall Study||50
7659335|NCT02069093|18863714|P1|STARTED|Overall Study||86
7659336|NCT02069041|18863723|P1|NOT COMPLETED|Overall Study||0
7659337|NCT02069041|18863723|P1|COMPLETED|Overall Study||8
7659338|NCT02069041|18863723|P1|Received at Least One Dose of Study Drug|Overall Study||8
7659339|NCT02069041|18863723|P1|STARTED|Overall Study||8
7659340|NCT02069015|18863733|P2|NOT COMPLETED|Overall Study||33
7659341|NCT02069015|18863734|P1|NOT COMPLETED|Overall Study||40
7659342|NCT02069015|18863733|P2|COMPLETED|Overall Study|180 day post ED discharge at CRC|35
7659343|NCT02069015|18863734|P1|COMPLETED|Overall Study|180 post ED discharge at CRC|31
7659344|NCT02069015|18863733|P2|90 Day|Overall Study|90 day post ED discharge|35
7659345|NCT02069015|18863734|P1|90 Day|Overall Study|90 day post ED discharge at CRC|32
7659346|NCT02069015|18863733|P2|30 Day|Overall Study|30 day post-discharge at CRC|43
7659347|NCT02069015|18863734|P1|30 Day|Overall Study|30 day post-discharge at CRC|38
7659348|NCT02069015|18863733|P2|7 Day|Overall Study|7 day post ED discharge at CRC|45
7659349|NCT02069015|18863734|P1|7 Day|Overall Study|7 day post ED discharge at Clinical Research Center (CRC)|44
7659350|NCT02069015|18863733|P2|STARTED|Overall Study||68
7659351|NCT02069015|18863734|P1|STARTED|Overall Study|Baseline and enrollment at Emergency Department (ED)|71
7659352|NCT02068885|18863744|P3|NOT COMPLETED|Overall Study||8
7659353|NCT02068885|18863745|P2|NOT COMPLETED|Overall Study||5
7659354|NCT02068885|18863746|P1|NOT COMPLETED|Overall Study||3
7659355|NCT02068885|18863744|P3|COMPLETED|Overall Study||46
7659356|NCT02068885|18863745|P2|COMPLETED|Overall Study||48
7659357|NCT02068885|18863746|P1|COMPLETED|Overall Study||54
7659358|NCT02068885|18863744|P3|Included in Intention-to-treat Analysis|Overall Study||54
7659359|NCT02068885|18863745|P2|Included in Intention-to-treat Analysis|Overall Study||52
7659360|NCT02068885|18863746|P1|Included in Intention-to-treat Analysis|Overall Study||56
7659361|NCT02068885|18863744|P3|Provided Data at End of Test Phase|Overall Study||46
7659362|NCT02068885|18863745|P2|Provided Data at End of Test Phase|Overall Study||48
7659363|NCT02068885|18863746|P1|Provided Data at End of Test Phase|Overall Study||54
7659364|NCT02068885|18863744|P3|Provided Data at Midpoint Test Phase|Overall Study||48
7659365|NCT02068885|18863745|P2|Provided Data at Midpoint Test Phase|Overall Study||50
7659366|NCT02068885|18863746|P1|Provided Data at Midpoint Test Phase|Overall Study||56
7659367|NCT02068885|18863744|P3|STARTED|Overall Study||54
7659368|NCT02068885|18863745|P2|STARTED|Overall Study||53
7659369|NCT02068885|18863746|P1|STARTED|Overall Study||57
7659370|NCT02068846|18863793|P2|NOT COMPLETED|Overall Study||1
7659371|NCT02068846|18863794|P1|NOT COMPLETED|Overall Study||1
7659372|NCT02068846|18863793|P2|COMPLETED|Overall Study||7
7659373|NCT02068846|18863794|P1|COMPLETED|Overall Study||8
7659374|NCT02068846|18863793|P2|STARTED|Overall Study||8
7659375|NCT02068846|18863794|P1|STARTED|Overall Study||9
7659376|NCT02068820|18863812|P2|NOT COMPLETED|Overall Study||0
7659377|NCT02068820|18863813|P1|NOT COMPLETED|Overall Study||0
7659378|NCT02068820|18863812|P2|COMPLETED|Overall Study||180
7659379|NCT02068820|18863813|P1|COMPLETED|Overall Study||20
7659380|NCT02068820|18863812|P2|STARTED|Overall Study||180
7659381|NCT02068820|18863813|P1|STARTED|Overall Study||20
7659382|NCT02068768|18863824|P1|NOT COMPLETED|Overall Study||7
7659383|NCT02068768|18863824|P1|COMPLETED|Overall Study||6
7659384|NCT02068768|18863824|P1|STARTED|Overall Study||13
7659385|NCT02068599|18863833|P3|NOT COMPLETED|Overall Study||13
7659386|NCT02068599|18863834|P2|NOT COMPLETED|Overall Study||10
7659387|NCT02068599|18863835|P1|NOT COMPLETED|Overall Study||11
7659388|NCT02068599|18863833|P3|COMPLETED|Overall Study||117
7659389|NCT02068599|18863834|P2|COMPLETED|Overall Study||119
7659390|NCT02068599|18863835|P1|COMPLETED|Overall Study||119
7659391|NCT02068599|18863833|P3|Full Analysis Set|Overall Study||130
7659392|NCT02068599|18863834|P2|Full Analysis Set|Overall Study||128
7659393|NCT02068599|18863835|P1|Full Analysis Set|Overall Study||129
7659394|NCT02068599|18863833|P3|Safety Analysis Set|Overall Study||130
7659395|NCT02068599|18863834|P2|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|128
7659396|NCT02068599|18863835|P1|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|129
7659397|NCT02068599|18863833|P3|STARTED|Overall Study||130
7659398|NCT02068599|18863834|P2|STARTED|Overall Study||129
7659399|NCT02068599|18863835|P1|STARTED|Overall Study||130
7659400|NCT02068547|18863875|P2|NOT COMPLETED|Overall Study||3
7659401|NCT02068547|18863876|P1|NOT COMPLETED|Overall Study||4
7659402|NCT02068547|18863875|P2|COMPLETED|Overall Study||1
7659403|NCT02068547|18863876|P1|COMPLETED|Overall Study||0
7659404|NCT02068547|18863875|P2|STARTED|Overall Study||4
7659405|NCT02068547|18863876|P1|STARTED|Overall Study||4
7659406|NCT02068508|18863886|P1|NOT COMPLETED|Overall Study||32
7659407|NCT02068508|18863886|P1|COMPLETED|Overall Study||1035
7659408|NCT02068508|18863886|P1|STARTED|Overall Study||1067
7659409|NCT02068495|18863896|P1|NOT COMPLETED|Overall Study||109
7659410|NCT02068495|18863896|P1|COMPLETED|Overall Study||3300
7659411|NCT02068495|18863896|P1|STARTED|Overall Study||3409
7659412|NCT02068443|18863908|P3|NOT COMPLETED|Overall Study||3
7659413|NCT02068443|18863909|P2|NOT COMPLETED|Overall Study||6
7659414|NCT02068443|18863910|P1|NOT COMPLETED|Overall Study||7
7659415|NCT02068443|18863908|P3|COMPLETED|Overall Study||148
7659416|NCT02068443|18863909|P2|COMPLETED|Overall Study||146
7659417|NCT02068443|18863910|P1|COMPLETED|Overall Study||64
7659418|NCT02068443|18863908|P3|STARTED|Overall Study||151
7659419|NCT02068443|18863909|P2|STARTED|Overall Study||152
7659420|NCT02068443|18863910|P1|STARTED|Overall Study||71
7659421|NCT02068222|18863945|P1|NOT COMPLETED|Overall Study||1
7659422|NCT02068222|18863945|P1|COMPLETED|Overall Study||9
7659423|NCT02068222|18863945|P1|STARTED|Overall Study||10
7659424|NCT02068157|18863952|P1|NOT COMPLETED|Overall Study||0
7659425|NCT02068157|18863952|P1|COMPLETED|Overall Study||3
7659426|NCT02068157|18863952|P1|STARTED|Overall Study||3
7659427|NCT02068027|18863959|P2|NOT COMPLETED|Overall Study||16
7659428|NCT02068027|18863960|P1|NOT COMPLETED|Overall Study||13
7659429|NCT02068027|18863959|P2|COMPLETED|Overall Study||114
7659430|NCT02068027|18863960|P1|COMPLETED|Overall Study||117
7659431|NCT02068027|18863959|P2|STARTED|Overall Study||130
7659432|NCT02068027|18863960|P1|STARTED|Overall Study||130
7659433|NCT02067858|18863968|P1|NOT COMPLETED|Overall Study||0
7659434|NCT02067858|18863968|P1|COMPLETED|Overall Study||6
7659435|NCT02067858|18863968|P1|STARTED|Overall Study||6
7659436|NCT02067728|18863976|P2|NOT COMPLETED|6 Month Measurements||97
7659437|NCT02067728|18863977|P1|NOT COMPLETED|6 Month Measurements||114
7659438|NCT02067728|18863976|P2|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113
7659439|NCT02067728|18863977|P1|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106
7659440|NCT02067728|18863976|P2|STARTED|6 Month Measurements||210
7659441|NCT02067728|18863977|P1|STARTED|6 Month Measurements||220
7659442|NCT02067728|18863976|P2|NOT COMPLETED|6 Month Follow up Survey||60
7659443|NCT02067728|18863977|P1|NOT COMPLETED|6 Month Follow up Survey||48
7659444|NCT02067728|18863976|P2|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150
7659445|NCT02067728|18863977|P1|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172
7659446|NCT02067728|18863976|P2|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210
7659447|NCT02067728|18863977|P1|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220
7659448|NCT02067728|18863976|P2|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28
7659449|NCT02067728|18863977|P1|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7
7659450|NCT02067728|18863976|P2|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182
7659451|NCT02067728|18863977|P1|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213
7659452|NCT02067728|18863976|P2|STARTED|Baseline - 1 Month Follow up Survey||210
7659453|NCT02067728|18863977|P1|STARTED|Baseline - 1 Month Follow up Survey||220
7659454|NCT02067676|18864011|P6|NOT COMPLETED|Overall Study||0
7659455|NCT02067676|18864012|P5|NOT COMPLETED|Overall Study||0
7659456|NCT02067676|18864013|P4|NOT COMPLETED|Overall Study||0
7659457|NCT02067676|18864014|P3|NOT COMPLETED|Overall Study||0
7659458|NCT02067676|18864015|P2|NOT COMPLETED|Overall Study||0
7659459|NCT02067676|18864016|P1|NOT COMPLETED|Overall Study||1
7659460|NCT02067676|18864011|P6|COMPLETED|Overall Study||8
7659461|NCT02067676|18864012|P5|COMPLETED|Overall Study||8
7659462|NCT02067676|18864013|P4|COMPLETED|Overall Study||8
7659463|NCT02067676|18864014|P3|COMPLETED|Overall Study||8
7659464|NCT02067676|18864015|P2|COMPLETED|Overall Study||8
7659465|NCT02067676|18864016|P1|COMPLETED|Overall Study||7
7659466|NCT02067676|18864011|P6|STARTED|Overall Study||8
7659467|NCT02067676|18864012|P5|STARTED|Overall Study||8
7659468|NCT02067676|18864013|P4|STARTED|Overall Study||8
7659469|NCT02067676|18864014|P3|STARTED|Overall Study||8
7659470|NCT02067676|18864015|P2|STARTED|Overall Study||8
7659471|NCT02067676|18864016|P1|STARTED|Overall Study||8
7659472|NCT02067663|18864056|P2|NOT COMPLETED|Overall Study||14
7659473|NCT02067663|18864057|P1|NOT COMPLETED|Overall Study||13
7659474|NCT02067663|18864056|P2|COMPLETED|Overall Study||41
7659475|NCT02067663|18864057|P1|COMPLETED|Overall Study||55
7659476|NCT02067663|18864056|P2|STARTED|Overall Study||55
7659477|NCT02067663|18864057|P1|STARTED|Overall Study||68
7659478|NCT02067611|18864077|P3|NOT COMPLETED|Overall Study||4
7659479|NCT02067611|18864078|P2|NOT COMPLETED|Overall Study||6
7659480|NCT02067611|18864079|P1|NOT COMPLETED|Overall Study||6
7659481|NCT02067611|18864077|P3|COMPLETED|Overall Study||68
7659482|NCT02067611|18864078|P2|COMPLETED|Overall Study||66
7659483|NCT02067611|18864079|P1|COMPLETED|Overall Study||66
7659484|NCT02067611|18864077|P3|STARTED|Overall Study||72
7659485|NCT02067611|18864078|P2|STARTED|Overall Study||72
7659486|NCT02067611|18864079|P1|STARTED|Overall Study||72
7659487|NCT02067585|18864117|P3|NOT COMPLETED|Overall Study||0
7659488|NCT02067585|18864118|P2|NOT COMPLETED|Overall Study||0
7659489|NCT02067585|18864119|P1|NOT COMPLETED|Overall Study||0
7659490|NCT02067585|18864117|P3|COMPLETED|Overall Study||16
7659491|NCT02067585|18864118|P2|COMPLETED|Overall Study||16
7659492|NCT02067585|18864119|P1|COMPLETED|Overall Study||16
7659493|NCT02067585|18864117|P3|STARTED|Overall Study||16
7659494|NCT02067585|18864118|P2|STARTED|Overall Study||16
7659495|NCT02067585|18864119|P1|STARTED|Overall Study||16
7659496|NCT02067533|18864156|P2|NOT COMPLETED|Overall Study||2
7659497|NCT02067533|18864157|P1|NOT COMPLETED|Overall Study||4
7659498|NCT02067533|18864156|P2|COMPLETED|Overall Study||44
7659499|NCT02067533|18864157|P1|COMPLETED|Overall Study||41
7659500|NCT02067533|18864156|P2|STARTED|Overall Study||46
7659501|NCT02067533|18864157|P1|STARTED|Overall Study||45
7659502|NCT02067468|18864166|P3|NOT COMPLETED|Overall Study||0
7659503|NCT02067468|18864167|P2|NOT COMPLETED|Overall Study||0
7659504|NCT02067468|18864168|P1|NOT COMPLETED|Overall Study||0
7659505|NCT02067468|18864166|P3|COMPLETED|Overall Study||889
7659506|NCT02067468|18864167|P2|COMPLETED|Overall Study||890
7659507|NCT02067468|18864168|P1|COMPLETED|Overall Study||882
7659508|NCT02067468|18864166|P3|Had at Least One Routine Colposcopy|Overall Study||462
7659509|NCT02067468|18864167|P2|Had at Least One Routine Colposcopy|Overall Study||372
7659510|NCT02067468|18864168|P1|Had at Least One Routine Colposcopy|Overall Study||772
7659511|NCT02067468|18864166|P3|Followed-up Through Medical Records|Overall Study||889
7659512|NCT02067468|18864167|P2|Followed-up Through Medical Records|Overall Study||890
7659513|NCT02067468|18864168|P1|Followed-up Through Medical Records|Overall Study||882
7659514|NCT02067468|18864166|P3|STARTED|Overall Study||889
7659515|NCT02067468|18864167|P2|STARTED|Overall Study||890
7659516|NCT02067468|18864168|P1|STARTED|Overall Study||882
7659517|NCT02067273|18864199|P2|NOT COMPLETED|Overall Study||3
7659518|NCT02067273|18864200|P1|NOT COMPLETED|Overall Study||0
7659519|NCT02067273|18864199|P2|COMPLETED|Overall Study||12
7659520|NCT02067273|18864200|P1|COMPLETED|Overall Study||5
7659521|NCT02067273|18864199|P2|STARTED|Overall Study||15
7659522|NCT02067273|18864200|P1|STARTED|Overall Study||5
7659523|NCT02067104|18864208|P2|NOT COMPLETED|Overall Study||5
7659524|NCT02067104|18864209|P1|NOT COMPLETED|Overall Study||4
7659525|NCT02067104|18864208|P2|COMPLETED|Overall Study||0
7659526|NCT02067104|18864209|P1|COMPLETED|Overall Study||0
7659527|NCT02067104|18864208|P2|STARTED|Overall Study||5
7659528|NCT02067104|18864209|P1|STARTED|Overall Study||4
7659529|NCT02067039|18864219|P2|NOT COMPLETED|Overall Study||508
7659530|NCT02067039|18864220|P1|NOT COMPLETED|Overall Study||573
7659531|NCT02067039|18864219|P2|COMPLETED|Overall Study||832
7659532|NCT02067039|18864220|P1|COMPLETED|Overall Study||752
7659533|NCT02067039|18864219|P2|9 Month Survey|Overall Study||838
7659534|NCT02067039|18864220|P1|9 Month Survey|Overall Study||748
7659535|NCT02067039|18864219|P2|6 Month Survey|Overall Study||756
7659536|NCT02067039|18864220|P1|6 Month Survey|Overall Study||735
7659537|NCT02067039|18864219|P2|3 Month Survey|Overall Study||766
7659538|NCT02067039|18864220|P1|3 Month Survey|Overall Study||824
7659539|NCT02067039|18864219|P2|STARTED|Overall Study||1340
7659540|NCT02067039|18864220|P1|STARTED|Overall Study||1325
7659541|NCT02067000|18864232|P1|NOT COMPLETED|Overall Study||50
7659542|NCT02067000|18864232|P1|COMPLETED|Overall Study||167
7659543|NCT02067000|18864232|P1|STARTED|Overall Study||217
7659544|NCT02066922|18864238|P1|NOT COMPLETED|Overall Study||1
7659545|NCT02066922|18864238|P1|COMPLETED|Overall Study||14
7659546|NCT02066922|18864238|P1|STARTED|Overall Study||15
7659547|NCT02066896|18864248|P2|NOT COMPLETED|Overall Study||0
7659548|NCT02066896|18864249|P1|NOT COMPLETED|Overall Study||0
7659549|NCT02066896|18864248|P2|COMPLETED|Overall Study||33
7659550|NCT02066896|18864249|P1|COMPLETED|Overall Study||33
7659551|NCT02066896|18864248|P2|STARTED|Overall Study||33
7659552|NCT02066896|18864249|P1|STARTED|Overall Study||33
7659553|NCT02066857|18864261|P2|NOT COMPLETED|Overall Study||1
7659554|NCT02066857|18864262|P1|NOT COMPLETED|Overall Study||1
7659555|NCT02066857|18864261|P2|COMPLETED|Overall Study||3
7659556|NCT02066857|18864262|P1|COMPLETED|Overall Study||0
7659557|NCT02066857|18864261|P2|STARTED|Overall Study||4
7659558|NCT02066857|18864262|P1|STARTED|Overall Study||1
7659559|NCT02066792|18864280|P4|NOT COMPLETED|Overall Study||9
7659560|NCT02066792|18864281|P3|NOT COMPLETED|Overall Study||8
7659561|NCT02066792|18864282|P2|NOT COMPLETED|Overall Study||5
7659562|NCT02066792|18864283|P1|NOT COMPLETED|Overall Study||7
7659563|NCT02066792|18864280|P4|COMPLETED|Overall Study||27
7659564|NCT02066792|18864281|P3|COMPLETED|Overall Study||30
7659565|NCT02066792|18864282|P2|COMPLETED|Overall Study||33
7659566|NCT02066792|18864283|P1|COMPLETED|Overall Study||33
7659567|NCT02066792|18864280|P4|STARTED|Overall Study||36
7659568|NCT02066792|18864281|P3|STARTED|Overall Study||38
7659569|NCT02066792|18864282|P2|STARTED|Overall Study||38
7659570|NCT02066792|18864283|P1|STARTED|Overall Study||40
7659571|NCT02066740|18864293|P1|NOT COMPLETED|Overall Study||2
7659572|NCT02066740|18864293|P1|COMPLETED|Overall Study||32
7659573|NCT02066740|18864293|P1|STARTED|Overall Study||34
7659574|NCT02066727|18864300|P2|NOT COMPLETED|Overall Study||0
7659575|NCT02066727|18864301|P1|NOT COMPLETED|Overall Study||0
7659576|NCT02066727|18864300|P2|COMPLETED|Overall Study||30
7659577|NCT02066727|18864301|P1|COMPLETED|Overall Study||30
7659578|NCT02066727|18864300|P2|STARTED|Overall Study||30
7659579|NCT02066727|18864301|P1|STARTED|Overall Study||30
7659580|NCT02066467|18864307|P1|NOT COMPLETED|Overall Study||215
7659581|NCT02066467|18864307|P1|COMPLETED|Overall Study||648
7659582|NCT02066467|18864307|P1|STARTED|Overall Study||863
7659583|NCT02066415|18864316|P3|NOT COMPLETED|Overall Study||8
7659584|NCT02066415|18864317|P2|NOT COMPLETED|Overall Study||7
7659585|NCT02066415|18864318|P1|NOT COMPLETED|Overall Study||21
7659586|NCT02066415|18864316|P3|COMPLETED|Overall Study||182
7659587|NCT02066415|18864317|P2|COMPLETED|Overall Study||184
7659588|NCT02066415|18864318|P1|COMPLETED|Overall Study||265
7659589|NCT02066415|18864316|P3|Received Study Drug|Overall Study||188
7659590|NCT02066415|18864317|P2|Received Study Drug|Overall Study||190
7659591|NCT02066415|18864318|P1|Received Study Drug|Overall Study||282
7659592|NCT02066415|18864316|P3|STARTED|Overall Study||190
7659593|NCT02066415|18864317|P2|STARTED|Overall Study||191
7659594|NCT02066415|18864318|P1|STARTED|Overall Study||286
7659595|NCT02066402|18864343|P2|NOT COMPLETED|Overall Study||23
7659596|NCT02066402|18864344|P1|NOT COMPLETED|Overall Study||26
7659597|NCT02066402|18864343|P2|COMPLETED|Overall Study||275
7659598|NCT02066402|18864344|P1|COMPLETED|Overall Study||274
7659599|NCT02066402|18864343|P2|Completed Study Treatment Period|Overall Study||256
7659600|NCT02066402|18864344|P1|Completed Study Treatment Period|Overall Study||261
7659601|NCT02066402|18864343|P2|Participants Received Treatment|Overall Study||297
7659602|NCT02066402|18864344|P1|Participants Received Treatment|Overall Study||292
7659603|NCT02066402|18864343|P2|STARTED|Overall Study||298
7659604|NCT02066402|18864344|P1|STARTED|Overall Study||300
7659605|NCT02066389|18864376|P6|NOT COMPLETED|Overall Study||5
7659606|NCT02066389|18864377|P5|NOT COMPLETED|Overall Study||7
7659607|NCT02066389|18864378|P4|NOT COMPLETED|Overall Study||3
7659608|NCT02066389|18864379|P3|NOT COMPLETED|Overall Study||6
7659609|NCT02066389|18864380|P2|NOT COMPLETED|Overall Study||1
7659610|NCT02066389|18864381|P1|NOT COMPLETED|Overall Study||5
7659611|NCT02066389|18864376|P6|COMPLETED|Overall Study||45
7659612|NCT02066389|18864377|P5|COMPLETED|Overall Study||43
7659613|NCT02066389|18864378|P4|COMPLETED|Overall Study||47
7659614|NCT02066389|18864379|P3|COMPLETED|Overall Study||44
7659615|NCT02066389|18864380|P2|COMPLETED|Overall Study||49
7659616|NCT02066389|18864381|P1|COMPLETED|Overall Study||45
7659617|NCT02066389|18864376|P6|Received Study Drug|Overall Study||49
7659618|NCT02066389|18864377|P5|Received Study Drug|Overall Study||50
7659619|NCT02066389|18864378|P4|Received Study Drug|Overall Study||50
7659620|NCT02066389|18864379|P3|Received Study Drug|Overall Study||50
7659621|NCT02066389|18864380|P2|Received Study Drug|Overall Study||50
7659622|NCT02066389|18864381|P1|Received Study Drug|Overall Study||50
7659623|NCT02066389|18864376|P6|STARTED|Overall Study||50
7659624|NCT02066389|18864377|P5|STARTED|Overall Study||50
7659625|NCT02066389|18864378|P4|STARTED|Overall Study||50
7659626|NCT02066389|18864379|P3|STARTED|Overall Study||50
7659627|NCT02066389|18864380|P2|STARTED|Overall Study||50
7659628|NCT02066389|18864381|P1|STARTED|Overall Study||50
7659629|NCT02066311|18864431|P1|NOT COMPLETED|Overall Study||5
7659630|NCT02066311|18864431|P1|COMPLETED|Overall Study|Stage 1 terminated 6/1/18 prior to completion of Stage 1 due to low enrollment and efficacy.|10
7659631|NCT02066311|18864431|P1|STARTED|Overall Study||15
7659632|NCT02066298|18864441|P6|NOT COMPLETED|Overall Study||12
7659633|NCT02066298|18864442|P5|NOT COMPLETED|Overall Study||9
7659634|NCT02066298|18864443|P4|NOT COMPLETED|Overall Study||6
7659635|NCT02066298|18864444|P3|NOT COMPLETED|Overall Study||10
7659636|NCT02066298|18864445|P2|NOT COMPLETED|Overall Study||8
7659637|NCT02066298|18864446|P1|NOT COMPLETED|Overall Study||9
7659638|NCT02066298|18864441|P6|COMPLETED|Overall Study||38
7659639|NCT02066298|18864442|P5|COMPLETED|Overall Study||38
7659640|NCT02066298|18864443|P4|COMPLETED|Overall Study||45
7659641|NCT02066298|18864444|P3|COMPLETED|Overall Study||40
7659642|NCT02066298|18864445|P2|COMPLETED|Overall Study||40
7659643|NCT02066298|18864446|P1|COMPLETED|Overall Study||40
7659644|NCT02066298|18864441|P6|Completed 3rd Period|Overall Study||38
7659645|NCT02066298|18864442|P5|Completed 3rd Period|Overall Study||38
7659646|NCT02066298|18864443|P4|Completed 3rd Period|Overall Study||45
7659647|NCT02066298|18864444|P3|Completed 3rd Period|Overall Study||40
7659648|NCT02066298|18864445|P2|Completed 3rd Period|Overall Study||40
7659649|NCT02066298|18864446|P1|Completed 3rd Period|Overall Study||40
7659650|NCT02066298|18864441|P6|Completed 2nd Period|Overall Study||41
7659651|NCT02066298|18864442|P5|Completed 2nd Period|Overall Study||42
7659652|NCT02066298|18864443|P4|Completed 2nd Period|Overall Study||46
7659653|NCT02066298|18864444|P3|Completed 2nd Period|Overall Study||41
7659654|NCT02066298|18864445|P2|Completed 2nd Period|Overall Study||41
7659655|NCT02066298|18864446|P1|Completed 2nd Period|Overall Study||41
7659656|NCT02066298|18864441|P6|Completed 1st Period|Overall Study||45
7659657|NCT02066298|18864442|P5|Completed 1st Period|Overall Study||46
7659658|NCT02066298|18864443|P4|Completed 1st Period|Overall Study||48
7659659|NCT02066298|18864444|P3|Completed 1st Period|Overall Study||45
7659660|NCT02066298|18864445|P2|Completed 1st Period|Overall Study||47
7659661|NCT02066298|18864446|P1|Completed 1st Period|Overall Study||44
7659662|NCT02066298|18864441|P6|STARTED|Overall Study||50
7659663|NCT02066298|18864442|P5|STARTED|Overall Study||47
7659664|NCT02066298|18864443|P4|STARTED|Overall Study||51
7659665|NCT02066298|18864444|P3|STARTED|Overall Study||50
7659666|NCT02066298|18864445|P2|STARTED|Overall Study||48
7659667|NCT02066298|18864446|P1|STARTED|Overall Study||49
7659668|NCT02066233|18864470|P2|NOT COMPLETED|Standard Endoscopy (Day 2)||0
7659669|NCT02066233|18864471|P1|NOT COMPLETED|Standard Endoscopy (Day 2)||0
7659670|NCT02066233|18864470|P2|COMPLETED|Standard Endoscopy (Day 2)||44
7659671|NCT02066233|18864471|P1|COMPLETED|Standard Endoscopy (Day 2)||44
7659672|NCT02066233|18864470|P2|STARTED|Standard Endoscopy (Day 2)||44
7659673|NCT02066233|18864471|P1|STARTED|Standard Endoscopy (Day 2)||44
7659674|NCT02066233|18864470|P2|NOT COMPLETED|EG Scan II (Day 1)||6
7659675|NCT02066233|18864471|P1|NOT COMPLETED|EG Scan II (Day 1)||6
7659676|NCT02066233|18864470|P2|COMPLETED|EG Scan II (Day 1)||44
7659677|NCT02066233|18864471|P1|COMPLETED|EG Scan II (Day 1)||44
7659678|NCT02066233|18864470|P2|STARTED|EG Scan II (Day 1)||50
7659679|NCT02066233|18864471|P1|STARTED|EG Scan II (Day 1)||50
7659680|NCT02066181|18864481|P2|NOT COMPLETED|Overall Study||1
7659681|NCT02066181|18864482|P1|NOT COMPLETED|Overall Study||1
7659682|NCT02066181|18864481|P2|COMPLETED|Overall Study||36
7659683|NCT02066181|18864482|P1|COMPLETED|Overall Study||49
7659684|NCT02066181|18864481|P2|Crossed Over|Overall Study||28
7659685|NCT02066181|18864482|P1|Crossed Over|Overall Study||0
7659686|NCT02066181|18864481|P2|STARTED|Overall Study||37
7659687|NCT02066181|18864482|P1|STARTED|Overall Study||50
7659688|NCT02066129|18864504|P2|NOT COMPLETED|Overall Study||33
7659689|NCT02066129|18864505|P1|NOT COMPLETED|Overall Study||29
7659690|NCT02066129|18864504|P2|COMPLETED|Overall Study||94
7659691|NCT02066129|18864505|P1|COMPLETED|Overall Study||98
7659692|NCT02066129|18864504|P2|STARTED|Overall Study||127
7659693|NCT02066129|18864505|P1|STARTED|Overall Study||127
7659694|NCT02066051|18864519|P1|NOT COMPLETED|Overall Study||1
7659695|NCT02066051|18864519|P1|COMPLETED|Overall Study||7
7659696|NCT02066051|18864519|P1|STARTED|Overall Study||8
7659697|NCT02065895|18864524|P6|NOT COMPLETED|Overall Study||0
7659698|NCT02065895|18864525|P5|NOT COMPLETED|Overall Study||0
7659699|NCT02065895|18864526|P4|NOT COMPLETED|Overall Study||1
7659700|NCT02065895|18864527|P3|NOT COMPLETED|Overall Study||0
7659701|NCT02065895|18864528|P2|NOT COMPLETED|Overall Study||1
7659702|NCT02065895|18864529|P1|NOT COMPLETED|Overall Study||1
7659703|NCT02065895|18864524|P6|COMPLETED|Overall Study||1
7659704|NCT02065895|18864525|P5|COMPLETED|Overall Study||1
7659705|NCT02065895|18864526|P4|COMPLETED|Overall Study||0
7659706|NCT02065895|18864527|P3|COMPLETED|Overall Study||1
7659707|NCT02065895|18864528|P2|COMPLETED|Overall Study||2
7659708|NCT02065895|18864529|P1|COMPLETED|Overall Study||0
7659709|NCT02065895|18864524|P6|STARTED|Overall Study||1
7659710|NCT02065895|18864525|P5|STARTED|Overall Study||1
7659711|NCT02065895|18864526|P4|STARTED|Overall Study||1
7659712|NCT02065895|18864527|P3|STARTED|Overall Study||1
7659713|NCT02065895|18864528|P2|STARTED|Overall Study||3
7659714|NCT02065895|18864529|P1|STARTED|Overall Study||1
7659715|NCT02065791|18864548|P2|NOT COMPLETED|Overall Study||15
7659716|NCT02065791|18864549|P1|NOT COMPLETED|Overall Study||25
7659717|NCT02065791|18864548|P2|COMPLETED|Overall Study||2187
7659718|NCT02065791|18864549|P1|COMPLETED|Overall Study||2174
7659719|NCT02065791|18864548|P2|Treated|Overall Study||2200
7659720|NCT02065791|18864549|P1|Treated|Overall Study||2197
7659721|NCT02065791|18864548|P2|STARTED|Overall Study||2202
7659722|NCT02065791|18864549|P1|STARTED|Overall Study||2199
7659723|NCT02065713|18864571|P2|NOT COMPLETED|Overall Study||1
7659724|NCT02065713|18864572|P1|NOT COMPLETED|Overall Study||1
7659725|NCT02065713|18864571|P2|COMPLETED|Overall Study||20
7659726|NCT02065713|18864572|P1|COMPLETED|Overall Study||22
7659727|NCT02065713|18864571|P2|STARTED|Overall Study||21
7659728|NCT02065713|18864572|P1|STARTED|Overall Study||23
7659729|NCT02065622|18864580|P5|NOT COMPLETED|Maintenance Study||46
7659730|NCT02065622|18864581|P4|NOT COMPLETED|Maintenance Study||104
7659731|NCT02065622|18864582|P3|NOT COMPLETED|Maintenance Study||124
7659732|NCT02065622|18864583|P2|NOT COMPLETED|Maintenance Study||0
7659733|NCT02065622|18864584|P1|NOT COMPLETED|Maintenance Study||0
7659734|NCT02065622|18864580|P5|COMPLETED|Maintenance Study||105
7659735|NCT02065622|18864581|P4|COMPLETED|Maintenance Study||246
7659736|NCT02065622|18864582|P3|COMPLETED|Maintenance Study||221
7659737|NCT02065622|18864583|P2|COMPLETED|Maintenance Study||0
7659738|NCT02065622|18864584|P1|COMPLETED|Maintenance Study||0
7659739|NCT02065622|18864580|P5|STARTED|Maintenance Study||151
7659740|NCT02065622|18864581|P4|STARTED|Maintenance Study||350
7659741|NCT02065622|18864582|P3|STARTED|Maintenance Study||345
7659742|NCT02065622|18864583|P2|STARTED|Maintenance Study||0
7659743|NCT02065622|18864584|P1|STARTED|Maintenance Study||0
7659744|NCT02065622|18864580|P5|NOT COMPLETED|Induction Study||0
7659745|NCT02065622|18864581|P4|NOT COMPLETED|Induction Study||0
7659746|NCT02065622|18864582|P3|NOT COMPLETED|Induction Study||0
7659747|NCT02065622|18864583|P2|NOT COMPLETED|Induction Study||59
7659748|NCT02065622|18864584|P1|NOT COMPLETED|Induction Study||47
7659749|NCT02065622|18864580|P5|COMPLETED|Induction Study||0
7659750|NCT02065622|18864581|P4|COMPLETED|Induction Study||0
7659751|NCT02065622|18864582|P3|COMPLETED|Induction Study||0
7659752|NCT02065622|18864583|P2|COMPLETED|Induction Study||514
7659753|NCT02065622|18864584|P1|COMPLETED|Induction Study||332
7659754|NCT02065622|18864580|P5|Enrolled in Japan Sub-Study|Induction Study||0
7659755|NCT02065622|18864581|P4|Enrolled in Japan Sub-Study|Induction Study||0
7659756|NCT02065622|18864582|P3|Enrolled in Japan Sub-Study|Induction Study||0
7659757|NCT02065622|18864583|P2|Enrolled in Japan Sub-Study|Induction Study||61
7659758|NCT02065622|18864584|P1|Enrolled in Japan Sub-Study|Induction Study||39
7659759|NCT02065622|18864580|P5|Enrolled in Main Study|Induction Study||0
7659760|NCT02065622|18864581|P4|Enrolled in Main Study|Induction Study||0
7659761|NCT02065622|18864582|P3|Enrolled in Main Study|Induction Study||0
7659762|NCT02065622|18864583|P2|Enrolled in Main Study|Induction Study||512
7659763|NCT02065622|18864584|P1|Enrolled in Main Study|Induction Study||340
7659764|NCT02065622|18864580|P5|STARTED|Induction Study||0
7659765|NCT02065622|18864581|P4|STARTED|Induction Study||0
7659766|NCT02065622|18864582|P3|STARTED|Induction Study||0
7659767|NCT02065622|18864583|P2|STARTED|Induction Study||573
7659768|NCT02065622|18864584|P1|STARTED|Induction Study||379
7659769|NCT02065557|18864686|P6|NOT COMPLETED|Maintenance Period||4
7659770|NCT02065557|18864687|P5|NOT COMPLETED|Maintenance Period||8
7659771|NCT02065557|18864688|P4|NOT COMPLETED|Maintenance Period||1
7659772|NCT02065557|18864689|P3|NOT COMPLETED|Maintenance Period||0
7659773|NCT02065557|18864690|P2|NOT COMPLETED|Maintenance Period||0
7659774|NCT02065557|18864691|P1|NOT COMPLETED|Maintenance Period||0
7659775|NCT02065557|18864686|P6|COMPLETED|Maintenance Period||32
7659776|NCT02065557|18864687|P5|COMPLETED|Maintenance Period||25
7659777|NCT02065557|18864688|P4|COMPLETED|Maintenance Period||11
7659778|NCT02065557|18864689|P3|COMPLETED|Maintenance Period||0
7659779|NCT02065557|18864690|P2|COMPLETED|Maintenance Period||0
7659780|NCT02065557|18864691|P1|COMPLETED|Maintenance Period||0
7659781|NCT02065557|18864686|P6|STARTED|Maintenance Period||36
7659782|NCT02065557|18864687|P5|STARTED|Maintenance Period||33
7659783|NCT02065557|18864688|P4|STARTED|Maintenance Period||12
7659784|NCT02065557|18864689|P3|STARTED|Maintenance Period||0
7659785|NCT02065557|18864690|P2|STARTED|Maintenance Period||0
7659786|NCT02065557|18864691|P1|STARTED|Maintenance Period||0
7659787|NCT02065557|18864686|P6|NOT COMPLETED|Induction Period||0
7659788|NCT02065557|18864687|P5|NOT COMPLETED|Induction Period||0
7659789|NCT02065557|18864688|P4|NOT COMPLETED|Induction Period||0
7659790|NCT02065557|18864689|P3|NOT COMPLETED|Induction Period||2
7659791|NCT02065557|18864690|P2|NOT COMPLETED|Induction Period||8
7659792|NCT02065557|18864691|P1|NOT COMPLETED|Induction Period||10
7659793|NCT02065557|18864686|P6|COMPLETED|Induction Period||0
7659794|NCT02065557|18864687|P5|COMPLETED|Induction Period||0
7659795|NCT02065557|18864688|P4|COMPLETED|Induction Period||0
7659796|NCT02065557|18864689|P3|COMPLETED|Induction Period||16
7659797|NCT02065557|18864690|P2|COMPLETED|Induction Period||43
7659798|NCT02065557|18864691|P1|COMPLETED|Induction Period||22
7659799|NCT02065557|18864686|P6|Enrolled in Japan Sub-study|Induction Period||0
7659800|NCT02065557|18864687|P5|Enrolled in Japan Sub-study|Induction Period||0
7659801|NCT02065557|18864688|P4|Enrolled in Japan Sub-study|Induction Period||0
7659802|NCT02065557|18864689|P3|Enrolled in Japan Sub-study|Induction Period||2
7659803|NCT02065557|18864690|P2|Enrolled in Japan Sub-study|Induction Period||4
7659804|NCT02065557|18864691|P1|Enrolled in Japan Sub-study|Induction Period||2
7659805|NCT02065557|18864686|P6|Enrolled in Main Study|Induction Period||0
7659806|NCT02065557|18864687|P5|Enrolled in Main Study|Induction Period||0
7659807|NCT02065557|18864688|P4|Enrolled in Main Study|Induction Period||0
7659808|NCT02065557|18864689|P3|Enrolled in Main Study|Induction Period||16
7659809|NCT02065557|18864690|P2|Enrolled in Main Study|Induction Period||47
7659810|NCT02065557|18864691|P1|Enrolled in Main Study|Induction Period||30
7659811|NCT02065557|18864686|P6|STARTED|Induction Period||0
7659812|NCT02065557|18864687|P5|STARTED|Induction Period||0
7659813|NCT02065557|18864688|P4|STARTED|Induction Period||0
7659814|NCT02065557|18864689|P3|STARTED|Induction Period||18
7659815|NCT02065557|18864690|P2|STARTED|Induction Period||51
7659816|NCT02065557|18864691|P1|STARTED|Induction Period||32
7659817|NCT02065518|18864752|P4|NOT COMPLETED|Overall Study||5
7659818|NCT02065518|18864753|P3|NOT COMPLETED|Overall Study||9
7659819|NCT02065518|18864754|P2|NOT COMPLETED|Overall Study||8
7659820|NCT02065518|18864755|P1|NOT COMPLETED|Overall Study||6
7659821|NCT02065518|18864752|P4|COMPLETED|Overall Study||15
7659822|NCT02065518|18864753|P3|COMPLETED|Overall Study||11
7659823|NCT02065518|18864754|P2|COMPLETED|Overall Study||11
7659824|NCT02065518|18864755|P1|COMPLETED|Overall Study||13
7659825|NCT02065518|18864752|P4|STARTED|Overall Study||20
7659826|NCT02065518|18864753|P3|STARTED|Overall Study||20
7659827|NCT02065518|18864754|P2|STARTED|Overall Study||19
7659828|NCT02065518|18864755|P1|STARTED|Overall Study||19
7659829|NCT02065479|18864807|P2|NOT COMPLETED|Overall Study||0
7659830|NCT02065479|18864808|P1|NOT COMPLETED|Overall Study||0
7659831|NCT02065479|18864807|P2|COMPLETED|Overall Study||32
7659832|NCT02065479|18864808|P1|COMPLETED|Overall Study||33
7659833|NCT02065479|18864807|P2|STARTED|Overall Study||32
7659834|NCT02065479|18864808|P1|STARTED|Overall Study||33
7659835|NCT02065453|18864816|P2|NOT COMPLETED|Overall Study||4
7659836|NCT02065453|18864817|P1|NOT COMPLETED|Overall Study||3
7659837|NCT02065453|18864816|P2|COMPLETED|Overall Study||21
7659838|NCT02065453|18864817|P1|COMPLETED|Overall Study||24
7659839|NCT02065453|18864816|P2|STARTED|Overall Study||25
7659840|NCT02065453|18864817|P1|STARTED|Overall Study||27
7659841|NCT02065336|18864830|P10|NOT COMPLETED|Extension Phase||8
7659842|NCT02065336|18864831|P9|NOT COMPLETED|Extension Phase||2
7659843|NCT02065336|18864832|P8|NOT COMPLETED|Extension Phase||0
7659844|NCT02065336|18864833|P7|NOT COMPLETED|Extension Phase||0
7659845|NCT02065336|18864834|P6|NOT COMPLETED|Extension Phase||0
7659846|NCT02065336|18864835|P5|NOT COMPLETED|Extension Phase||0
7659847|NCT02065336|18864836|P4|NOT COMPLETED|Extension Phase||0
7659848|NCT02065336|18864837|P3|NOT COMPLETED|Extension Phase||0
7659849|NCT02065336|18864838|P2|NOT COMPLETED|Extension Phase||0
7659850|NCT02065336|18864839|P1|NOT COMPLETED|Extension Phase||0
7659851|NCT02065336|18864830|P10|COMPLETED|Extension Phase||0
7659852|NCT02065336|18864831|P9|COMPLETED|Extension Phase||0
7659853|NCT02065336|18864832|P8|COMPLETED|Extension Phase||0
7659854|NCT02065336|18864833|P7|COMPLETED|Extension Phase||0
7659855|NCT02065336|18864834|P6|COMPLETED|Extension Phase||0
7659856|NCT02065336|18864835|P5|COMPLETED|Extension Phase||0
7659857|NCT02065336|18864836|P4|COMPLETED|Extension Phase||0
7659858|NCT02065336|18864837|P3|COMPLETED|Extension Phase||0
7659859|NCT02065336|18864838|P2|COMPLETED|Extension Phase||0
7659860|NCT02065336|18864839|P1|COMPLETED|Extension Phase||0
7659861|NCT02065336|18864830|P10|STARTED|Extension Phase||8
7659862|NCT02065336|18864831|P9|STARTED|Extension Phase||2
7659863|NCT02065336|18864832|P8|STARTED|Extension Phase||0
7659864|NCT02065336|18864833|P7|STARTED|Extension Phase||0
7659865|NCT02065336|18864834|P6|STARTED|Extension Phase||0
7659866|NCT02065336|18864835|P5|STARTED|Extension Phase||0
7659867|NCT02065336|18864836|P4|STARTED|Extension Phase||0
7659868|NCT02065336|18864837|P3|STARTED|Extension Phase||0
7659869|NCT02065336|18864838|P2|STARTED|Extension Phase||0
7659870|NCT02065336|18864839|P1|STARTED|Extension Phase||0
7659871|NCT02065336|18864830|P10|NOT COMPLETED|Main Study||0
7659872|NCT02065336|18864831|P9|NOT COMPLETED|Main Study||0
7659873|NCT02065336|18864832|P8|NOT COMPLETED|Main Study||0
7659874|NCT02065336|18864833|P7|NOT COMPLETED|Main Study||0
7659875|NCT02065336|18864834|P6|NOT COMPLETED|Main Study||0
7659876|NCT02065336|18864835|P5|NOT COMPLETED|Main Study||0
7659877|NCT02065336|18864836|P4|NOT COMPLETED|Main Study||0
7659878|NCT02065336|18864837|P3|NOT COMPLETED|Main Study||0
7659879|NCT02065336|18864838|P2|NOT COMPLETED|Main Study||0
7659880|NCT02065336|18864839|P1|NOT COMPLETED|Main Study||0
7659881|NCT02065336|18864830|P10|COMPLETED|Main Study||0
7659882|NCT02065336|18864831|P9|COMPLETED|Main Study||0
7659883|NCT02065336|18864832|P8|COMPLETED|Main Study||10
7659884|NCT02065336|18864833|P7|COMPLETED|Main Study||12
7659885|NCT02065336|18864834|P6|COMPLETED|Main Study||6
7659886|NCT02065336|18864835|P5|COMPLETED|Main Study||6
7659887|NCT02065336|18864836|P4|COMPLETED|Main Study||6
7659888|NCT02065336|18864837|P3|COMPLETED|Main Study||6
7659889|NCT02065336|18864838|P2|COMPLETED|Main Study||6
7659890|NCT02065336|18864839|P1|COMPLETED|Main Study||6
7659891|NCT02065336|18864830|P10|STARTED|Main Study||0
7659892|NCT02065336|18864831|P9|STARTED|Main Study||0
7659893|NCT02065336|18864832|P8|STARTED|Main Study||10
7659894|NCT02065336|18864833|P7|STARTED|Main Study||12
7659895|NCT02065336|18864834|P6|STARTED|Main Study||6
7659896|NCT02065336|18864835|P5|STARTED|Main Study||6
7659897|NCT02065336|18864836|P4|STARTED|Main Study||6
7659898|NCT02065336|18864837|P3|STARTED|Main Study||6
7659899|NCT02065336|18864838|P2|STARTED|Main Study||6
7659900|NCT02065336|18864839|P1|STARTED|Main Study||6
7659901|NCT02064985|18864934|P3|NOT COMPLETED|Overall Study||0
7659902|NCT02064985|18864935|P2|NOT COMPLETED|Overall Study||0
7659903|NCT02064985|18864936|P1|NOT COMPLETED|Overall Study||0
7659904|NCT02064985|18864934|P3|COMPLETED|Overall Study||12
7659905|NCT02064985|18864935|P2|COMPLETED|Overall Study||12
7659906|NCT02064985|18864936|P1|COMPLETED|Overall Study||12
7659907|NCT02064985|18864934|P3|STARTED|Overall Study||12
7659908|NCT02064985|18864935|P2|STARTED|Overall Study||12
7659909|NCT02064985|18864936|P1|STARTED|Overall Study||12
7659910|NCT02064959|18865099|P2|NOT COMPLETED|Overall Study||0
7659911|NCT02064959|18865100|P1|NOT COMPLETED|Overall Study||0
7659912|NCT02064959|18865099|P2|COMPLETED|Overall Study||16
7659913|NCT02064959|18865100|P1|COMPLETED|Overall Study||16
7659914|NCT02064959|18865099|P2|STARTED|Overall Study||16
7659915|NCT02064959|18865100|P1|STARTED|Overall Study||16
7659916|NCT02064920|18865116|P2|NOT COMPLETED|Overall Study||9
7659917|NCT02064920|18865117|P1|NOT COMPLETED|Overall Study||1
7659918|NCT02064920|18865116|P2|COMPLETED|Overall Study||21
7659919|NCT02064920|18865117|P1|COMPLETED|Overall Study||5
7659920|NCT02064920|18865116|P2|Treated|Overall Study|Two participants discontinued from study prior to treatment|28
7659921|NCT02064920|18865117|P1|Treated|Overall Study||6
7659922|NCT02064920|18865116|P2|STARTED|Overall Study||30
7659923|NCT02064920|18865117|P1|STARTED|Overall Study||6
7659924|NCT02064907|18865127|P2|NOT COMPLETED|Period 2||0
7659925|NCT02064907|18865128|P1|NOT COMPLETED|Period 2||0
7659926|NCT02064907|18865127|P2|COMPLETED|Period 2||26
7659927|NCT02064907|18865128|P1|COMPLETED|Period 2||26
7659928|NCT02064907|18865127|P2|STARTED|Period 2||26
7659929|NCT02064907|18865128|P1|STARTED|Period 2||26
7659930|NCT02064907|18865127|P2|NOT COMPLETED|Period 1||0
7659931|NCT02064907|18865128|P1|NOT COMPLETED|Period 1||0
7659932|NCT02064907|18865127|P2|COMPLETED|Period 1||26
7659933|NCT02064907|18865128|P1|COMPLETED|Period 1||26
7659934|NCT02064907|18865127|P2|STARTED|Period 1||26
7659935|NCT02064907|18865128|P1|STARTED|Period 1||26
7659936|NCT02064894|18865147|P3|NOT COMPLETED|Overall Study||115
7659937|NCT02064894|18865148|P2|NOT COMPLETED|Overall Study||102
7659938|NCT02064894|18865149|P1|NOT COMPLETED|Overall Study||43
7659939|NCT02064894|18865147|P3|COMPLETED|Overall Study||86
7659940|NCT02064894|18865148|P2|COMPLETED|Overall Study||99
7659941|NCT02064894|18865149|P1|COMPLETED|Overall Study||56
7659942|NCT02064894|18865147|P3|Avalaible at T-90|Overall Study||129
7659943|NCT02064894|18865148|P2|Avalaible at T-90|Overall Study||134
7659944|NCT02064894|18865149|P1|Avalaible at T-90|Overall Study||74
7659945|NCT02064894|18865147|P3|Available at T-60|Overall Study||177
7659946|NCT02064894|18865148|P2|Available at T-60|Overall Study||188
7659947|NCT02064894|18865149|P1|Available at T-60|Overall Study||91
7659948|NCT02064894|18865147|P3|STARTED|Overall Study|"Received allocated intervention (n=199)
~Did not receive allocated intervention (n=2)"|201
7659949|NCT02064894|18865148|P2|STARTED|Overall Study|"Received allocated intervention (n=198)
~Did not receive allocated intervention (n=3)"|201
7659950|NCT02064894|18865149|P1|STARTED|Overall Study|"Received allocated intervention (n=98)
~Did not receive intervention (n=1)"|99
7659951|NCT02064868|18865162|P2|NOT COMPLETED|Overall Study||13
7659952|NCT02064868|18865163|P1|NOT COMPLETED|Overall Study||34
7659953|NCT02064868|18865162|P2|COMPLETED|Overall Study||881
7659954|NCT02064868|18865163|P1|COMPLETED|Overall Study||1722
7659955|NCT02064868|18865162|P2|Per Protocol Set|Overall Study||627
7659956|NCT02064868|18865163|P1|Per Protocol Set|Overall Study||1155
7659957|NCT02064868|18865162|P2|Safety Set|Overall Study||894
7659958|NCT02064868|18865163|P1|Safety Set|Overall Study|The Safety Set includes one patient not randomized but treated with serelaxin|1729
7659959|NCT02064868|18865162|P2|Full Analysis Set|Overall Study||894
7659960|NCT02064868|18865163|P1|Full Analysis Set|Overall Study||1756
7659961|NCT02064868|18865162|P2|STARTED|Overall Study||894
7659962|NCT02064868|18865163|P1|STARTED|Overall Study||1756
7659963|NCT02064816|18865183|P2|NOT COMPLETED|Overall Study||8
7659964|NCT02064816|18865184|P1|NOT COMPLETED|Overall Study||8
7659965|NCT02064816|18865183|P2|COMPLETED|Overall Study||88
7659966|NCT02064816|18865184|P1|COMPLETED|Overall Study||96
7659967|NCT02064816|18865183|P2|STARTED|Overall Study||96
7659968|NCT02064816|18865184|P1|STARTED|Overall Study||104
7659969|NCT02064582|18865222|P1|NOT COMPLETED|Overall Study||0
7659970|NCT02064582|18865222|P1|COMPLETED|Overall Study||7
7659971|NCT02064582|18865222|P1|STARTED|Overall Study||7
7659972|NCT02064439|18865230|P3|NOT COMPLETED|Overall Study||182
7659973|NCT02064439|18865231|P2|NOT COMPLETED|Overall Study||138
7659974|NCT02064439|18865232|P1|NOT COMPLETED|Overall Study||143
7659975|NCT02064439|18865230|P3|COMPLETED|Overall Study||949
7659976|NCT02064439|18865231|P2|COMPLETED|Overall Study||969
7659977|NCT02064439|18865232|P1|COMPLETED|Overall Study||984
7659978|NCT02064439|18865230|P3|STARTED|Overall Study|FAS, randomized and received study medication|1131
7659979|NCT02064439|18865231|P2|STARTED|Overall Study|FAS, randomized and received study medication|1107
7659980|NCT02064439|18865232|P1|STARTED|Overall Study|Full Analysis Set (FAS), randomized and received study medication|1127
7659981|NCT02064387|18865261|P12|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||3
7659982|NCT02064387|18865262|P11|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||6
7659983|NCT02064387|18865263|P10|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
7659984|NCT02064387|18865264|P9|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
7659985|NCT02064387|18865265|P8|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
7659986|NCT02064387|18865266|P7|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
7659987|NCT02064387|18865267|P6|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
7659988|NCT02064387|18865268|P5|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
7659989|NCT02064387|18865269|P4|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
7659990|NCT02064387|18865270|P3|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
7659991|NCT02064387|18865271|P2|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
7659992|NCT02064387|18865272|P1|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
7659993|NCT02064387|18865261|P12|COMPLETED|Part 2 Max 35 Months Followup Duration||3
7659994|NCT02064387|18865262|P11|COMPLETED|Part 2 Max 35 Months Followup Duration||29
7659995|NCT02064387|18865263|P10|COMPLETED|Part 2 Max 35 Months Followup Duration||0
7659996|NCT02064387|18865264|P9|COMPLETED|Part 2 Max 35 Months Followup Duration||0
7659997|NCT02064387|18865265|P8|COMPLETED|Part 2 Max 35 Months Followup Duration||0
7659998|NCT02064387|18865266|P7|COMPLETED|Part 2 Max 35 Months Followup Duration||0
7659999|NCT02064387|18865267|P6|COMPLETED|Part 2 Max 35 Months Followup Duration||0
7660000|NCT02064387|18865268|P5|COMPLETED|Part 2 Max 35 Months Followup Duration||0
7660001|NCT02064387|18865269|P4|COMPLETED|Part 2 Max 35 Months Followup Duration||0
7660002|NCT02064387|18865270|P3|COMPLETED|Part 2 Max 35 Months Followup Duration||0
7660003|NCT02064387|18865271|P2|COMPLETED|Part 2 Max 35 Months Followup Duration||0
7660004|NCT02064387|18865272|P1|COMPLETED|Part 2 Max 35 Months Followup Duration||0
7660005|NCT02064387|18865261|P12|STARTED|Part 2 Max 35 Months Followup Duration||6
7660006|NCT02064387|18865262|P11|STARTED|Part 2 Max 35 Months Followup Duration||35
7660007|NCT02064387|18865263|P10|STARTED|Part 2 Max 35 Months Followup Duration||0
7660008|NCT02064387|18865264|P9|STARTED|Part 2 Max 35 Months Followup Duration||0
7660009|NCT02064387|18865265|P8|STARTED|Part 2 Max 35 Months Followup Duration||0
7660010|NCT02064387|18865266|P7|STARTED|Part 2 Max 35 Months Followup Duration||0
7660011|NCT02064387|18865267|P6|STARTED|Part 2 Max 35 Months Followup Duration||0
7660012|NCT02064387|18865268|P5|STARTED|Part 2 Max 35 Months Followup Duration||0
7660013|NCT02064387|18865269|P4|STARTED|Part 2 Max 35 Months Followup Duration||0
7660014|NCT02064387|18865270|P3|STARTED|Part 2 Max 35 Months Followup Duration||0
7660015|NCT02064387|18865271|P2|STARTED|Part 2 Max 35 Months Followup Duration||0
7660016|NCT02064387|18865272|P1|STARTED|Part 2 Max 35 Months Followup Duration||0
7660017|NCT02064387|18865261|P12|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
7660018|NCT02064387|18865262|P11|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
7660019|NCT02064387|18865263|P10|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
7660020|NCT02064387|18865264|P9|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
7660021|NCT02064387|18865265|P8|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
7660022|NCT02064387|18865266|P7|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
7660023|NCT02064387|18865267|P6|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
7660024|NCT02064387|18865268|P5|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
7660025|NCT02064387|18865269|P4|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
7660026|NCT02064387|18865270|P3|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
7660027|NCT02064387|18865271|P2|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
7660028|NCT02064387|18865272|P1|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
7660029|NCT02064387|18865261|P12|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
7660030|NCT02064387|18865262|P11|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
7660031|NCT02064387|18865263|P10|COMPLETED|Part 1 Max 23.5 Months Followup Duration||5
7660032|NCT02064387|18865264|P9|COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
7660033|NCT02064387|18865265|P8|COMPLETED|Part 1 Max 23.5 Months Followup Duration||6
7660034|NCT02064387|18865266|P7|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
7660035|NCT02064387|18865267|P6|COMPLETED|Part 1 Max 23.5 Months Followup Duration||3
7660036|NCT02064387|18865268|P5|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
7660037|NCT02064387|18865269|P4|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
7660038|NCT02064387|18865270|P3|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
7660039|NCT02064387|18865271|P2|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
7660040|NCT02064387|18865272|P1|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
7660041|NCT02064387|18865261|P12|STARTED|Part 1 Max 23.5 Months Followup Duration||0
7660042|NCT02064387|18865262|P11|STARTED|Part 1 Max 23.5 Months Followup Duration||0
7660043|NCT02064387|18865263|P10|STARTED|Part 1 Max 23.5 Months Followup Duration||6
7660044|NCT02064387|18865264|P9|STARTED|Part 1 Max 23.5 Months Followup Duration||3
7660045|NCT02064387|18865265|P8|STARTED|Part 1 Max 23.5 Months Followup Duration||8
7660046|NCT02064387|18865266|P7|STARTED|Part 1 Max 23.5 Months Followup Duration||4
7660047|NCT02064387|18865267|P6|STARTED|Part 1 Max 23.5 Months Followup Duration||3
7660048|NCT02064387|18865268|P5|STARTED|Part 1 Max 23.5 Months Followup Duration||4
7660049|NCT02064387|18865269|P4|STARTED|Part 1 Max 23.5 Months Followup Duration||4
7660050|NCT02064387|18865270|P3|STARTED|Part 1 Max 23.5 Months Followup Duration||4
7660051|NCT02064387|18865271|P2|STARTED|Part 1 Max 23.5 Months Followup Duration||1
7660052|NCT02064387|18865272|P1|STARTED|Part 1 Max 23.5 Months Followup Duration||1
7660053|NCT02064270|18865585|P2|NOT COMPLETED|Overall Study||32
7660054|NCT02064270|18865586|P1|NOT COMPLETED|Overall Study||62
7660055|NCT02064270|18865585|P2|COMPLETED|Overall Study||231
7660056|NCT02064270|18865586|P1|COMPLETED|Overall Study||201
7660057|NCT02064270|18865585|P2|STARTED|Overall Study||263
7660058|NCT02064270|18865586|P1|STARTED|Overall Study||263
7660059|NCT02064231|18865601|P4|NOT COMPLETED|Third Test Period (Own Product)||0
7660060|NCT02064231|18865602|P3|NOT COMPLETED|Third Test Period (Own Product)||0
7660061|NCT02064231|18865603|P2|NOT COMPLETED|Third Test Period (Own Product)||0
7660062|NCT02064231|18865604|P1|NOT COMPLETED|Third Test Period (Own Product)||0
7660063|NCT02064231|18865601|P4|COMPLETED|Third Test Period (Own Product)||1
7660064|NCT02064231|18865602|P3|COMPLETED|Third Test Period (Own Product)||0
7660065|NCT02064231|18865603|P2|COMPLETED|Third Test Period (Own Product)||8
7660066|NCT02064231|18865604|P1|COMPLETED|Third Test Period (Own Product)||8
7660067|NCT02064231|18865601|P4|STARTED|Third Test Period (Own Product)||1
7660068|NCT02064231|18865602|P3|STARTED|Third Test Period (Own Product)||0
7660069|NCT02064231|18865603|P2|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test C proceeded to test Own product afterwards|8
7660070|NCT02064231|18865604|P1|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test A proceeded to test Own product afterwards.|8
7660071|NCT02064231|18865601|P4|NOT COMPLETED|Second Test Period (Test B or Test D)||0
7660072|NCT02064231|18865602|P3|NOT COMPLETED|Second Test Period (Test B or Test D)||0
7660073|NCT02064231|18865603|P2|NOT COMPLETED|Second Test Period (Test B or Test D)||1
7660074|NCT02064231|18865604|P1|NOT COMPLETED|Second Test Period (Test B or Test D)||1
7660075|NCT02064231|18865601|P4|COMPLETED|Second Test Period (Test B or Test D)||1
7660076|NCT02064231|18865602|P3|COMPLETED|Second Test Period (Test B or Test D)||0
7660077|NCT02064231|18865603|P2|COMPLETED|Second Test Period (Test B or Test D)||7
7660078|NCT02064231|18865604|P1|COMPLETED|Second Test Period (Test B or Test D)||6
7660079|NCT02064231|18865601|P4|STARTED|Second Test Period (Test B or Test D)||1
7660080|NCT02064231|18865602|P3|STARTED|Second Test Period (Test B or Test D)||0
7660081|NCT02064231|18865603|P2|STARTED|Second Test Period (Test B or Test D)||8
7660082|NCT02064231|18865604|P1|STARTED|Second Test Period (Test B or Test D)||7
7660083|NCT02064231|18865601|P4|NOT COMPLETED|First Test Period (Test A or Test C)||0
7660084|NCT02064231|18865602|P3|NOT COMPLETED|First Test Period (Test A or Test C)||1
7660085|NCT02064231|18865603|P2|NOT COMPLETED|First Test Period (Test A or Test C)||4
7660086|NCT02064231|18865604|P1|NOT COMPLETED|First Test Period (Test A or Test C)||7
7660087|NCT02064231|18865601|P4|COMPLETED|First Test Period (Test A or Test C)||1
7660088|NCT02064231|18865602|P3|COMPLETED|First Test Period (Test A or Test C)||0
7660089|NCT02064231|18865603|P2|COMPLETED|First Test Period (Test A or Test C)||8
7660090|NCT02064231|18865604|P1|COMPLETED|First Test Period (Test A or Test C)||7
7660091|NCT02064231|18865601|P4|STARTED|First Test Period (Test A or Test C)||1
7660092|NCT02064231|18865602|P3|STARTED|First Test Period (Test A or Test C)||1
7660093|NCT02064231|18865603|P2|STARTED|First Test Period (Test A or Test C)||12
7660094|NCT02064231|18865604|P1|STARTED|First Test Period (Test A or Test C)||14
7660095|NCT02064205|18865616|P1|NOT COMPLETED|Overall Study||1
7660096|NCT02064205|18865616|P1|COMPLETED|Overall Study||31
7660097|NCT02064205|18865616|P1|Condition D|Overall Study||32
7660098|NCT02064205|18865616|P1|Condition C|Overall Study||31
7660099|NCT02064205|18865616|P1|Condition B|Overall Study||32
7660100|NCT02064205|18865616|P1|Condition A|Overall Study||32
7660101|NCT02064205|18865616|P1|STARTED|Overall Study||32
7660102|NCT02064166|18865634|P2|NOT COMPLETED|Overall Study||0
7660103|NCT02064166|18865635|P1|NOT COMPLETED|Overall Study||1
7660104|NCT02064166|18865634|P2|COMPLETED|Overall Study||6
7660105|NCT02064166|18865635|P1|COMPLETED|Overall Study||8
7660106|NCT02064166|18865634|P2|STARTED|Overall Study||6
7660107|NCT02064166|18865635|P1|STARTED|Overall Study||9
7660108|NCT02063880|18865665|P2|NOT COMPLETED|Overall Study||27
7660109|NCT02063880|18865666|P1|NOT COMPLETED|Overall Study||28
7660110|NCT02063880|18865665|P2|COMPLETED|Overall Study||66
7660111|NCT02063880|18865666|P1|COMPLETED|Overall Study||62
7660112|NCT02063880|18865665|P2|STARTED|Overall Study||93
7660113|NCT02063880|18865666|P1|STARTED|Overall Study||90
7660114|NCT02063867|18865678|P2|NOT COMPLETED|Overall Study||2965
7660115|NCT02063867|18865679|P1|NOT COMPLETED|Overall Study||4291
7660116|NCT02063867|18865678|P2|COMPLETED|Overall Study||180048
7660117|NCT02063867|18865679|P1|COMPLETED|Overall Study||152598
7660118|NCT02063867|18865678|P2|STARTED|Overall Study||183013
7660119|NCT02063867|18865679|P1|STARTED|Overall Study||156889
7660120|NCT02063854|18865704|P7|NOT COMPLETED|Overall Study||6
7660121|NCT02063854|18865705|P6|NOT COMPLETED|Overall Study||31
7660122|NCT02063854|18865706|P5|NOT COMPLETED|Overall Study||11
7660123|NCT02063854|18865707|P4|NOT COMPLETED|Overall Study||10
7660124|NCT02063854|18865708|P3|NOT COMPLETED|Overall Study||30
7660125|NCT02063854|18865709|P2|NOT COMPLETED|Overall Study||12
7660126|NCT02063854|18865710|P1|NOT COMPLETED|Overall Study||21
7660127|NCT02063854|18865704|P7|COMPLETED|Overall Study||60
7660128|NCT02063854|18865705|P6|COMPLETED|Overall Study||170
7660129|NCT02063854|18865706|P5|COMPLETED|Overall Study||54
7660130|NCT02063854|18865707|P4|COMPLETED|Overall Study||58
7660131|NCT02063854|18865708|P3|COMPLETED|Overall Study||176
7660132|NCT02063854|18865709|P2|COMPLETED|Overall Study||54
7660133|NCT02063854|18865710|P1|COMPLETED|Overall Study||178
7660134|NCT02063854|18865704|P7|Full Analysis Set: Received Study Drug|Overall Study||66
7660135|NCT02063854|18865705|P6|Full Analysis Set: Received Study Drug|Overall Study||200
7660136|NCT02063854|18865706|P5|Full Analysis Set: Received Study Drug|Overall Study||65
7660137|NCT02063854|18865707|P4|Full Analysis Set: Received Study Drug|Overall Study||68
7660138|NCT02063854|18865708|P3|Full Analysis Set: Received Study Drug|Overall Study||206
7660139|NCT02063854|18865709|P2|Full Analysis Set: Received Study Drug|Overall Study||66
7660140|NCT02063854|18865710|P1|Full Analysis Set: Received Study Drug|Overall Study||199
7660141|NCT02063854|18865704|P7|STARTED|Overall Study||66
7660142|NCT02063854|18865705|P6|STARTED|Overall Study||201
7660143|NCT02063854|18865706|P5|STARTED|Overall Study||65
7660144|NCT02063854|18865707|P4|STARTED|Overall Study||68
7660145|NCT02063854|18865708|P3|STARTED|Overall Study||206
7660146|NCT02063854|18865709|P2|STARTED|Overall Study||66
7660147|NCT02063854|18865710|P1|STARTED|Overall Study||199
7660148|NCT02063737|18865794|P2|NOT COMPLETED|Overall Study||4
7660149|NCT02063737|18865795|P1|NOT COMPLETED|Overall Study||11
7660150|NCT02063737|18865794|P2|COMPLETED|Overall Study||44
7660151|NCT02063737|18865795|P1|COMPLETED|Overall Study||41
7660152|NCT02063737|18865794|P2|STARTED|Overall Study||48
7660153|NCT02063737|18865795|P1|STARTED|Overall Study||52
7660154|NCT02063724|18865827|P1|NOT COMPLETED|Overall Study||1
7660155|NCT02063724|18865827|P1|COMPLETED|Overall Study||14
7660156|NCT02063724|18865827|P1|STARTED|Overall Study||15
7660157|NCT02063698|18865835|P2|NOT COMPLETED|Overall Study||2
7660158|NCT02063698|18865836|P1|NOT COMPLETED|Overall Study||1
7660159|NCT02063698|18865835|P2|COMPLETED|Overall Study||13
7660160|NCT02063698|18865836|P1|COMPLETED|Overall Study||14
7660161|NCT02063698|18865835|P2|STARTED|Overall Study||15
7660162|NCT02063698|18865836|P1|STARTED|Overall Study||15
7660163|NCT02063672|18865860|P2|NOT COMPLETED|Overall Study||22
7660164|NCT02063672|18865861|P1|NOT COMPLETED|Overall Study||35
7660165|NCT02063672|18865860|P2|COMPLETED|Overall Study||7
7660166|NCT02063672|18865861|P1|COMPLETED|Overall Study||18
7660167|NCT02063672|18865860|P2|STARTED|Overall Study||29
7660168|NCT02063672|18865861|P1|STARTED|Overall Study||53
7660169|NCT02063659|18865908|P4|NOT COMPLETED|Open-Label Extension Period (OLE)||20
7660170|NCT02063659|18865909|P3|NOT COMPLETED|Open-Label Extension Period (OLE)||0
7660171|NCT02063659|18865910|P2|NOT COMPLETED|Open-Label Extension Period (OLE)||0
7660172|NCT02063659|18865911|P1|NOT COMPLETED|Open-Label Extension Period (OLE)||0
7660173|NCT02063659|18865908|P4|COMPLETED|Open-Label Extension Period (OLE)||47
7660174|NCT02063659|18865909|P3|COMPLETED|Open-Label Extension Period (OLE)||0
7660175|NCT02063659|18865910|P2|COMPLETED|Open-Label Extension Period (OLE)||0
7660176|NCT02063659|18865911|P1|COMPLETED|Open-Label Extension Period (OLE)||0
7660177|NCT02063659|18865908|P4|STARTED|Open-Label Extension Period (OLE)||67
7660178|NCT02063659|18865909|P3|STARTED|Open-Label Extension Period (OLE)||0
7660179|NCT02063659|18865910|P2|STARTED|Open-Label Extension Period (OLE)||0
7660180|NCT02063659|18865911|P1|STARTED|Open-Label Extension Period (OLE)||0
7660181|NCT02063659|18865908|P4|NOT COMPLETED|Double-Blind Treatment Period||0
7660182|NCT02063659|18865909|P3|NOT COMPLETED|Double-Blind Treatment Period||3
7660183|NCT02063659|18865910|P2|NOT COMPLETED|Double-Blind Treatment Period||3
7660184|NCT02063659|18865911|P1|NOT COMPLETED|Double-Blind Treatment Period||2
7660185|NCT02063659|18865908|P4|COMPLETED|Double-Blind Treatment Period||0
7660186|NCT02063659|18865909|P3|COMPLETED|Double-Blind Treatment Period||22
7660187|NCT02063659|18865910|P2|COMPLETED|Double-Blind Treatment Period||22
7660188|NCT02063659|18865911|P1|COMPLETED|Double-Blind Treatment Period||24
7660189|NCT02063659|18865908|P4|STARTED|Double-Blind Treatment Period||0
7660190|NCT02063659|18865909|P3|STARTED|Double-Blind Treatment Period||25
7660191|NCT02063659|18865910|P2|STARTED|Double-Blind Treatment Period||25
7660192|NCT02063659|18865911|P1|STARTED|Double-Blind Treatment Period||26
7660193|NCT02063516|18865943|P2|NOT COMPLETED|Overall Study||0
7660194|NCT02063516|18865944|P1|NOT COMPLETED|Overall Study||0
7660195|NCT02063516|18865943|P2|COMPLETED|Overall Study||40
7660196|NCT02063516|18865944|P1|COMPLETED|Overall Study||40
7660197|NCT02063516|18865943|P2|STARTED|Overall Study||40
7660198|NCT02063516|18865944|P1|STARTED|Overall Study||40
7660199|NCT02063230|18865958|P4|NOT COMPLETED|Overall Study||0
7660200|NCT02063230|18865959|P3|NOT COMPLETED|Overall Study||0
7660201|NCT02063230|18865960|P2|NOT COMPLETED|Overall Study||0
7660202|NCT02063230|18865961|P1|NOT COMPLETED|Overall Study||0
7660203|NCT02063230|18865958|P4|COMPLETED|Overall Study||8
7660204|NCT02063230|18865959|P3|COMPLETED|Overall Study||8
7660205|NCT02063230|18865960|P2|COMPLETED|Overall Study||8
7660206|NCT02063230|18865961|P1|COMPLETED|Overall Study||8
7660207|NCT02063230|18865958|P4|Received Treatment|Overall Study||8
7660208|NCT02063230|18865959|P3|Received Treatment|Overall Study||8
7660209|NCT02063230|18865960|P2|Received Treatment|Overall Study||8
7660210|NCT02063230|18865961|P1|Received Treatment|Overall Study||8
7660211|NCT02063230|18865958|P4|STARTED|Overall Study||8
7660212|NCT02063230|18865959|P3|STARTED|Overall Study||8
7660213|NCT02063230|18865960|P2|STARTED|Overall Study||8
7660214|NCT02063230|18865961|P1|STARTED|Overall Study||8
7660215|NCT02063217|18865994|P3|NOT COMPLETED|Overall Study||0
7660216|NCT02063217|18865995|P2|NOT COMPLETED|Overall Study||0
7660217|NCT02063217|18865996|P1|NOT COMPLETED|Overall Study||1
7660218|NCT02063217|18865994|P3|COMPLETED|Overall Study||12
7660219|NCT02063217|18865995|P2|COMPLETED|Overall Study||12
7660220|NCT02063217|18865996|P1|COMPLETED|Overall Study||11
7660221|NCT02063217|18865994|P3|STARTED|Overall Study||12
7660222|NCT02063217|18865995|P2|STARTED|Overall Study||12
7660223|NCT02063217|18865996|P1|STARTED|Overall Study||12
7660224|NCT02063178|18866006|P2|NOT COMPLETED|Overall Study||47
7660225|NCT02063178|18866007|P1|NOT COMPLETED|Overall Study||29
7660226|NCT02063178|18866006|P2|COMPLETED|Overall Study||77
7660227|NCT02063178|18866007|P1|COMPLETED|Overall Study||95
7660228|NCT02063178|18866006|P2|STARTED|Overall Study||124
7660229|NCT02063178|18866007|P1|STARTED|Overall Study||124
7660230|NCT02063087|18866021|P2|NOT COMPLETED|7 Day Follow-up||0
7660231|NCT02063087|18866022|P1|NOT COMPLETED|7 Day Follow-up||0
7660232|NCT02063087|18866021|P2|COMPLETED|7 Day Follow-up||478
7660233|NCT02063087|18866022|P1|COMPLETED|7 Day Follow-up||493
7660234|NCT02063087|18866021|P2|STARTED|7 Day Follow-up||478
7660235|NCT02063087|18866022|P1|STARTED|7 Day Follow-up||493
7660236|NCT02063087|18866021|P2|NOT COMPLETED|Emergency Department Intervention||0
7660237|NCT02063087|18866022|P1|NOT COMPLETED|Emergency Department Intervention||0
7660238|NCT02063087|18866021|P2|COMPLETED|Emergency Department Intervention||478
7660239|NCT02063087|18866022|P1|COMPLETED|Emergency Department Intervention||493
7660240|NCT02063087|18866021|P2|STARTED|Emergency Department Intervention||478
7660241|NCT02063087|18866022|P1|STARTED|Emergency Department Intervention||493
7660242|NCT02063035|18866046|P2|NOT COMPLETED|Overall Study||0
7660243|NCT02063035|18866047|P1|NOT COMPLETED|Overall Study||0
7660244|NCT02063035|18866046|P2|COMPLETED|Overall Study||17
7660245|NCT02063035|18866047|P1|COMPLETED|Overall Study||12
7660246|NCT02063035|18866046|P2|STARTED|Overall Study||17
7660247|NCT02063035|18866047|P1|STARTED|Overall Study||12
7660248|NCT02062905|18866061|P2|NOT COMPLETED|Overall Study||2
7660249|NCT02062905|18866062|P1|NOT COMPLETED|Overall Study||7
7660250|NCT02062905|18866061|P2|COMPLETED|Overall Study||31
7660251|NCT02062905|18866062|P1|COMPLETED|Overall Study||28
7660252|NCT02062905|18866061|P2|STARTED|Overall Study||33
7660253|NCT02062905|18866062|P1|STARTED|Overall Study||35
7660254|NCT02062879|18866072|P2|NOT COMPLETED|Overall Study||1
7660255|NCT02062879|18866073|P1|NOT COMPLETED|Overall Study||4
7660256|NCT02062879|18866072|P2|COMPLETED|Overall Study||9
7660257|NCT02062879|18866073|P1|COMPLETED|Overall Study||6
7660258|NCT02062879|18866072|P2|STARTED|Overall Study||10
7660259|NCT02062879|18866073|P1|STARTED|Overall Study||10
7660260|NCT02062801|18866085|P2|NOT COMPLETED|Overall Study||4
7660261|NCT02062801|18866086|P1|NOT COMPLETED|Overall Study||2
7660262|NCT02062801|18866085|P2|COMPLETED|Overall Study||297
7660263|NCT02062801|18866086|P1|COMPLETED|Overall Study||299
7660264|NCT02062801|18866085|P2|STARTED|Overall Study||301
7660265|NCT02062801|18866086|P1|STARTED|Overall Study||301
7660266|NCT02062710|18866096|P6|NOT COMPLETED|Overall Study||0
7660267|NCT02062710|18866097|P5|NOT COMPLETED|Overall Study||0
7660268|NCT02062710|18866098|P4|NOT COMPLETED|Overall Study||0
7660269|NCT02062710|18866099|P3|NOT COMPLETED|Overall Study||0
7660270|NCT02062710|18866100|P2|NOT COMPLETED|Overall Study||0
7660271|NCT02062710|18866101|P1|NOT COMPLETED|Overall Study||0
7660272|NCT02062710|18866096|P6|COMPLETED|Overall Study||4
7660273|NCT02062710|18866097|P5|COMPLETED|Overall Study||3
7660274|NCT02062710|18866098|P4|COMPLETED|Overall Study||3
7660275|NCT02062710|18866099|P3|COMPLETED|Overall Study||5
7660276|NCT02062710|18866100|P2|COMPLETED|Overall Study||4
7660277|NCT02062710|18866101|P1|COMPLETED|Overall Study||3
7660278|NCT02062710|18866096|P6|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
7660279|NCT02062710|18866097|P5|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3
7660366|NCT02061774|18866282|P2|STARTED|Overall Study||11
7660280|NCT02062710|18866098|P4|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
7660281|NCT02062710|18866099|P3|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5
7660282|NCT02062710|18866100|P2|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
7660283|NCT02062710|18866101|P1|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
7660284|NCT02062658|18866109|P1|NOT COMPLETED|Overall Study||2
7660285|NCT02062658|18866109|P1|COMPLETED|Overall Study||8
7660286|NCT02062658|18866109|P1|STARTED|Overall Study||10
7660287|NCT02062645|18866113|P1|NOT COMPLETED|Overall Study||15
7660288|NCT02062645|18866113|P1|COMPLETED|Overall Study||100
7660289|NCT02062645|18866113|P1|STARTED|Overall Study||115
7660290|NCT02062632|18866121|P1|NOT COMPLETED|Overall Study||1
7660291|NCT02062632|18866121|P1|COMPLETED|Overall Study||2
7660292|NCT02062632|18866121|P1|STARTED|Overall Study||3
7660293|NCT02062580|18866130|P2|NOT COMPLETED|Overall Study||13
7660294|NCT02062580|18866131|P1|NOT COMPLETED|Overall Study||12
7660295|NCT02062580|18866130|P2|COMPLETED|Overall Study||65
7660296|NCT02062580|18866131|P1|COMPLETED|Overall Study||59
7660297|NCT02062580|18866130|P2|STARTED|Overall Study||78
7660298|NCT02062580|18866131|P1|STARTED|Overall Study||71
7660299|NCT02062502|18866141|P2|NOT COMPLETED|Overall Study||35
7660300|NCT02062502|18866142|P1|NOT COMPLETED|Overall Study||43
7660301|NCT02062502|18866141|P2|COMPLETED|Overall Study||270
7660302|NCT02062502|18866142|P1|COMPLETED|Overall Study||263
7660303|NCT02062502|18866141|P2|Vaccinated Dose 1|Overall Study||305
7660304|NCT02062502|18866142|P1|Vaccinated Dose 1|Overall Study||306
7660305|NCT02062502|18866141|P2|STARTED|Overall Study||305
7660306|NCT02062502|18866142|P1|STARTED|Overall Study||306
7660307|NCT02062450|18866162|P1|NOT COMPLETED|Overall Study||124
7660308|NCT02062450|18866162|P1|COMPLETED|Overall Study||255
7660309|NCT02062450|18866162|P1|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255
7660310|NCT02062450|18866162|P1|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379
7660311|NCT02062437|18866176|P1|NOT COMPLETED|Overall Study||52
7660312|NCT02062437|18866176|P1|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80
7660313|NCT02062437|18866176|P1|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132
7660314|NCT02062398|18866185|P1|NOT COMPLETED|Overall Study||1
7660315|NCT02062398|18866185|P1|COMPLETED|Overall Study||12
7660316|NCT02062398|18866185|P1|STARTED|Overall Study||13
7660317|NCT02062385|18866197|P4|NOT COMPLETED|Overall Study||9
7660318|NCT02062385|18866198|P3|NOT COMPLETED|Overall Study||12
7660319|NCT02062385|18866199|P2|NOT COMPLETED|Overall Study||65
7660320|NCT02062385|18866200|P1|NOT COMPLETED|Overall Study||78
7660321|NCT02062385|18866197|P4|COMPLETED|Overall Study||391
7660322|NCT02062385|18866198|P3|COMPLETED|Overall Study||388
7660323|NCT02062385|18866199|P2|COMPLETED|Overall Study||1555
7660324|NCT02062385|18866200|P1|COMPLETED|Overall Study||1542
7660325|NCT02062385|18866197|P4|Received Vaccination 3|Overall Study||392
7660326|NCT02062385|18866198|P3|Received Vaccination 3|Overall Study||389
7660327|NCT02062385|18866199|P2|Received Vaccination 3|Overall Study||1554
7660328|NCT02062385|18866200|P1|Received Vaccination 3|Overall Study||1543
7660329|NCT02062385|18866197|P4|Received Vaccination 2|Overall Study||393
7660330|NCT02062385|18866198|P3|Received Vaccination 2|Overall Study||392
7660331|NCT02062385|18866199|P2|Received Vaccination 2|Overall Study||1566
7660332|NCT02062385|18866200|P1|Received Vaccination 2|Overall Study||1554
7660333|NCT02062385|18866197|P4|Received Vaccination 1|Overall Study||400
7660334|NCT02062385|18866198|P3|Received Vaccination 1|Overall Study||400
7660335|NCT02062385|18866199|P2|Received Vaccination 1|Overall Study||1619
7660336|NCT02062385|18866200|P1|Received Vaccination 1|Overall Study||1618
7660337|NCT02062385|18866197|P4|STARTED|Overall Study||400
7660338|NCT02062385|18866198|P3|STARTED|Overall Study||400
7660339|NCT02062385|18866199|P2|STARTED|Overall Study||1620
7660340|NCT02062385|18866200|P1|STARTED|Overall Study||1620
7660341|NCT02062359|18866220|P1|NOT COMPLETED|Overall Study||0
7660342|NCT02062359|18866220|P1|COMPLETED|Overall Study||2
7660343|NCT02062359|18866220|P1|STARTED|Overall Study||2
7660344|NCT02062294|18866226|P1|NOT COMPLETED|Overall Study||0
7660345|NCT02062294|18866226|P1|COMPLETED|Overall Study||14
7660346|NCT02062294|18866226|P1|STARTED|Overall Study||14
7660347|NCT02062177|18866233|P2|NOT COMPLETED|Overall Study||0
7660348|NCT02062177|18866234|P1|NOT COMPLETED|Overall Study||0
7660349|NCT02062177|18866233|P2|COMPLETED|Overall Study||70
7660350|NCT02062177|18866234|P1|COMPLETED|Overall Study||70
7660351|NCT02062177|18866233|P2|STARTED|Overall Study||70
7660352|NCT02062177|18866234|P1|STARTED|Overall Study||70
7660353|NCT02062151|18866244|P1|NOT COMPLETED|Overall Study||1
7660354|NCT02062151|18866244|P1|COMPLETED|Overall Study||20
7660355|NCT02062151|18866244|P1|STARTED|Overall Study||21
7660356|NCT02061969|18866251|P2|NOT COMPLETED|Overall Study||0
7660357|NCT02061969|18866252|P1|NOT COMPLETED|Overall Study||0
7660358|NCT02061969|18866251|P2|COMPLETED|Overall Study||67
7660359|NCT02061969|18866252|P1|COMPLETED|Overall Study||73
7660360|NCT02061969|18866251|P2|STARTED|Overall Study||67
7660361|NCT02061969|18866252|P1|STARTED|Overall Study||73
7660362|NCT02061774|18866282|P2|NOT COMPLETED|Overall Study||0
7660363|NCT02061774|18866283|P1|NOT COMPLETED|Overall Study||0
7660364|NCT02061774|18866282|P2|COMPLETED|Overall Study||11
7660365|NCT02061774|18866283|P1|COMPLETED|Overall Study||10
7660367|NCT02061774|18866283|P1|STARTED|Overall Study||10
7660368|NCT02061748|18866297|P2|NOT COMPLETED|Overall Study||0
7660369|NCT02061748|18866298|P1|NOT COMPLETED|Overall Study||0
7660370|NCT02061748|18866297|P2|COMPLETED|Overall Study||30853
7660371|NCT02061748|18866298|P1|COMPLETED|Overall Study||7646
7660372|NCT02061748|18866297|P2|STARTED|Overall Study||30853
7660373|NCT02061748|18866298|P1|STARTED|Overall Study||7646
7660374|NCT02061696|18866372|P2|NOT COMPLETED|Overall Study||0
7660375|NCT02061696|18866373|P1|NOT COMPLETED|Overall Study||0
7660376|NCT02061696|18866372|P2|COMPLETED|Overall Study||22
7660377|NCT02061696|18866373|P1|COMPLETED|Overall Study||17
7660378|NCT02061696|18866372|P2|STARTED|Overall Study||22
7660379|NCT02061696|18866373|P1|STARTED|Overall Study||17
7660380|NCT02061683|18866397|P1|NOT COMPLETED|Overall Study||60
7660381|NCT02061683|18866397|P1|COMPLETED|Overall Study||203
7660382|NCT02061683|18866397|P1|STARTED|Overall Study||263
7660383|NCT02061592|18866404|P2|NOT COMPLETED|Period 2||1
7660384|NCT02061592|18866405|P1|NOT COMPLETED|Period 2||0
7660385|NCT02061592|18866404|P2|COMPLETED|Period 2||61
7660386|NCT02061592|18866405|P1|COMPLETED|Period 2||64
7660387|NCT02061592|18866404|P2|STARTED|Period 2||62
7660388|NCT02061592|18866405|P1|STARTED|Period 2||64
7660389|NCT02061592|18866404|P2|NOT COMPLETED|Period 1||0
7660390|NCT02061592|18866405|P1|NOT COMPLETED|Period 1||2
7660391|NCT02061592|18866404|P2|COMPLETED|Period 1||62
7660392|NCT02061592|18866405|P1|COMPLETED|Period 1||64
7660393|NCT02061592|18866404|P2|STARTED|Period 1||62
7660394|NCT02061592|18866405|P1|STARTED|Period 1||66
7660395|NCT02061540|18866417|P1|NOT COMPLETED|Overall Study||4
7660396|NCT02061540|18866417|P1|COMPLETED|Overall Study||23
7660397|NCT02061540|18866417|P1|Down-Titrated on LUM001 During the Study|Overall Study||5
7660398|NCT02061540|18866417|P1|STARTED|Overall Study||27
7660399|NCT02061397|18866430|P1|NOT COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||0
7660400|NCT02061397|18866430|P1|COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||10
7660401|NCT02061397|18866430|P1|STARTED|Simvastatin 40 mg Oral Daily for 2 Month||10
7660402|NCT02061397|18866430|P1|NOT COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||0
7660403|NCT02061397|18866430|P1|COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||10
7660404|NCT02061397|18866430|P1|STARTED|Simvastatin 20 mg Oral Daily for 2 Month||10
7660405|NCT02061358|18866444|P9|NOT COMPLETED|Overall Study||0
7660406|NCT02061358|18866445|P8|NOT COMPLETED|Overall Study||0
7660407|NCT02061358|18866446|P7|NOT COMPLETED|Overall Study||0
7660408|NCT02061358|18866447|P6|NOT COMPLETED|Overall Study||0
7660409|NCT02061358|18866448|P5|NOT COMPLETED|Overall Study||0
7660410|NCT02061358|18866449|P4|NOT COMPLETED|Overall Study||0
7660411|NCT02061358|18866450|P3|NOT COMPLETED|Overall Study||0
7660412|NCT02061358|18866451|P2|NOT COMPLETED|Overall Study||0
7660413|NCT02061358|18866452|P1|NOT COMPLETED|Overall Study||0
7660414|NCT02061358|18866444|P9|COMPLETED|Overall Study||16
7660415|NCT02061358|18866445|P8|COMPLETED|Overall Study||6
7660416|NCT02061358|18866446|P7|COMPLETED|Overall Study||6
7660417|NCT02061358|18866447|P6|COMPLETED|Overall Study||6
7660418|NCT02061358|18866448|P5|COMPLETED|Overall Study||6
7660419|NCT02061358|18866449|P4|COMPLETED|Overall Study||6
7660420|NCT02061358|18866450|P3|COMPLETED|Overall Study||6
7660421|NCT02061358|18866451|P2|COMPLETED|Overall Study||6
7660422|NCT02061358|18866452|P1|COMPLETED|Overall Study||6
7660423|NCT02061358|18866444|P9|STARTED|Overall Study||16
7660424|NCT02061358|18866445|P8|STARTED|Overall Study||6
7660425|NCT02061358|18866446|P7|STARTED|Overall Study||6
7660426|NCT02061358|18866447|P6|STARTED|Overall Study||6
7660427|NCT02061358|18866448|P5|STARTED|Overall Study||6
7660428|NCT02061358|18866449|P4|STARTED|Overall Study||6
7660429|NCT02061358|18866450|P3|STARTED|Overall Study||6
7660430|NCT02061358|18866451|P2|STARTED|Overall Study||6
7660431|NCT02061358|18866452|P1|STARTED|Overall Study||6
7660432|NCT02061280|18866590|P2|NOT COMPLETED|Overall Study||12
7660433|NCT02061280|18866591|P1|NOT COMPLETED|Overall Study||18
7660434|NCT02061280|18866590|P2|COMPLETED|Overall Study||25
7660435|NCT02061280|18866591|P1|COMPLETED|Overall Study||53
7660436|NCT02061280|18866590|P2|Randomized to Treatment|Overall Study||25
7660437|NCT02061280|18866591|P1|Randomized to Treatment|Overall Study||54
7660438|NCT02061280|18866590|P2|STARTED|Overall Study||37
7660439|NCT02061280|18866591|P1|STARTED|Overall Study||71
7660440|NCT02061202|18866623|P2|NOT COMPLETED|Overall Study||1
7660441|NCT02061202|18866624|P1|NOT COMPLETED|Overall Study||1
7660442|NCT02061202|18866623|P2|COMPLETED|Overall Study||17
7660443|NCT02061202|18866624|P1|COMPLETED|Overall Study||35
7660444|NCT02061202|18866623|P2|STARTED|Overall Study||18
7660445|NCT02061202|18866624|P1|STARTED|Overall Study||36
7660446|NCT02060903|18866650|P2|NOT COMPLETED|Overall Study||7
7660447|NCT02060903|18866651|P1|NOT COMPLETED|Overall Study||4
7660448|NCT02060903|18866650|P2|COMPLETED|Overall Study||185
7660449|NCT02060903|18866651|P1|COMPLETED|Overall Study||183
7660450|NCT02060903|18866650|P2|STARTED|Overall Study||192
7660451|NCT02060903|18866651|P1|STARTED|Overall Study||187
7660452|NCT02060890|18866657|P1|NOT COMPLETED|Overall Study||4
7660453|NCT02060890|18866657|P1|COMPLETED|Overall Study||16
7660454|NCT02060890|18866657|P1|STARTED|Overall Study||20
7660455|NCT02060838|18866666|P2|NOT COMPLETED|Overall Study||0
7660456|NCT02060838|18866667|P1|NOT COMPLETED|Overall Study||0
7660457|NCT02060838|18866666|P2|COMPLETED|Overall Study||22
7660458|NCT02060838|18866667|P1|COMPLETED|Overall Study||28
7660459|NCT02060838|18866666|P2|STARTED|Overall Study||22
7660460|NCT02060838|18866667|P1|STARTED|Overall Study||28
7660461|NCT02060539|18866675|P1|NOT COMPLETED|Overall Study||0
7660462|NCT02060539|18866675|P1|COMPLETED|Overall Study||19
7660463|NCT02060539|18866675|P1|STARTED|Overall Study||19
7660464|NCT02060526|18866723|P3|NOT COMPLETED|Overall Study||0
7660465|NCT02060526|18866724|P2|NOT COMPLETED|Overall Study||0
7660466|NCT02060526|18866725|P1|NOT COMPLETED|Overall Study||0
7660467|NCT02060526|18866723|P3|COMPLETED|Overall Study||7
7660468|NCT02060526|18866724|P2|COMPLETED|Overall Study||7
7660469|NCT02060526|18866725|P1|COMPLETED|Overall Study||7
7660470|NCT02060526|18866723|P3|STARTED|Overall Study||7
7660471|NCT02060526|18866724|P2|STARTED|Overall Study||7
7660472|NCT02060526|18866725|P1|STARTED|Overall Study||7
7660473|NCT02060461|18866761|P1|NOT COMPLETED|Overall Study||0
7660474|NCT02060461|18866761|P1|COMPLETED|Overall Study||33
7660475|NCT02060461|18866761|P1|STARTED|Overall Study||33
7660476|NCT02060383|18866772|P5|NOT COMPLETED|Extension Phase||7
7660477|NCT02060383|18866773|P4|NOT COMPLETED|Extension Phase||2
7660478|NCT02060383|18866774|P3|NOT COMPLETED|Extension Phase||3
7660479|NCT02060383|18866775|P2|NOT COMPLETED|Extension Phase||3
7660480|NCT02060383|18866776|P1|NOT COMPLETED|Extension Phase||3
7660481|NCT02060383|18866772|P5|COMPLETED|Extension Phase||46
7660482|NCT02060383|18866773|P4|COMPLETED|Extension Phase||19
7660483|NCT02060383|18866774|P3|COMPLETED|Extension Phase||7
7660484|NCT02060383|18866775|P2|COMPLETED|Extension Phase||14
7660485|NCT02060383|18866776|P1|COMPLETED|Extension Phase||14
7660486|NCT02060383|18866772|P5|STARTED|Extension Phase||53
7660487|NCT02060383|18866773|P4|STARTED|Extension Phase||21
7660488|NCT02060383|18866774|P3|STARTED|Extension Phase||10
7660489|NCT02060383|18866775|P2|STARTED|Extension Phase||17
7660490|NCT02060383|18866776|P1|STARTED|Extension Phase||17
7660491|NCT02060383|18866772|P5|NOT COMPLETED|Core Phase||8
7660492|NCT02060383|18866773|P4|NOT COMPLETED|Core Phase||7
7660493|NCT02060383|18866774|P3|NOT COMPLETED|Core Phase||0
7660494|NCT02060383|18866775|P2|NOT COMPLETED|Core Phase||6
7660495|NCT02060383|18866776|P1|NOT COMPLETED|Core Phase||3
7660496|NCT02060383|18866772|P5|COMPLETED|Core Phase||95
7660497|NCT02060383|18866773|P4|COMPLETED|Core Phase||39
7660498|NCT02060383|18866774|P3|COMPLETED|Core Phase||19
7660499|NCT02060383|18866775|P2|COMPLETED|Core Phase||37
7660500|NCT02060383|18866776|P1|COMPLETED|Core Phase||35
7660501|NCT02060383|18866772|P5|Completed Core/Did Not Enter Extension|Core Phase||42
7660502|NCT02060383|18866773|P4|Completed Core/Did Not Enter Extension|Core Phase||18
7660503|NCT02060383|18866774|P3|Completed Core/Did Not Enter Extension|Core Phase||9
7660504|NCT02060383|18866775|P2|Completed Core/Did Not Enter Extension|Core Phase||20
7660505|NCT02060383|18866776|P1|Completed Core/Did Not Enter Extension|Core Phase||18
7660506|NCT02060383|18866772|P5|Completed Core/Entered Extension|Core Phase||53
7660507|NCT02060383|18866773|P4|Completed Core/Entered Extension|Core Phase||21
7660508|NCT02060383|18866774|P3|Completed Core/Entered Extension|Core Phase||10
7660509|NCT02060383|18866775|P2|Completed Core/Entered Extension|Core Phase||17
7660510|NCT02060383|18866776|P1|Completed Core/Entered Extension|Core Phase||17
7660511|NCT02060383|18866772|P5|STARTED|Core Phase||103
7660512|NCT02060383|18866773|P4|STARTED|Core Phase||46
7660513|NCT02060383|18866774|P3|STARTED|Core Phase||19
7660514|NCT02060383|18866775|P2|STARTED|Core Phase||43
7660515|NCT02060383|18866776|P1|STARTED|Core Phase||38
7660516|NCT02060370|18866802|P1|NOT COMPLETED|Overall Study||1
7660517|NCT02060370|18866802|P1|COMPLETED|Overall Study||59
7660518|NCT02060370|18866802|P1|STARTED|Overall Study||60
7660519|NCT02060058|18866814|P3|NOT COMPLETED|Overall Study||0
7660520|NCT02060058|18866815|P2|NOT COMPLETED|Overall Study||0
7660521|NCT02060058|18866816|P1|NOT COMPLETED|Overall Study||0
7660522|NCT02060058|18866814|P3|COMPLETED|Overall Study||8
7660523|NCT02060058|18866815|P2|COMPLETED|Overall Study||0
7660524|NCT02060058|18866816|P1|COMPLETED|Overall Study||4
7660525|NCT02060058|18866814|P3|STARTED|Overall Study||8
7660526|NCT02060058|18866815|P2|STARTED|Overall Study||0
7660527|NCT02060058|18866816|P1|STARTED|Overall Study||4
7660528|NCT02059993|18866832|P2|NOT COMPLETED|Overall Study||4
7660529|NCT02059993|18866833|P1|NOT COMPLETED|Overall Study||2
7660530|NCT02059993|18866832|P2|COMPLETED|Overall Study||37
7660531|NCT02059993|18866833|P1|COMPLETED|Overall Study||40
7660532|NCT02059993|18866832|P2|STARTED|Overall Study||41
7660533|NCT02059993|18866833|P1|STARTED|Overall Study||42
7660534|NCT02059980|18866843|P2|NOT COMPLETED|Overall Study||1
7660535|NCT02059980|18866844|P1|NOT COMPLETED|Overall Study||2
7660536|NCT02059980|18866843|P2|COMPLETED|Overall Study||14
7660537|NCT02059980|18866844|P1|COMPLETED|Overall Study||16
7660538|NCT02059980|18866843|P2|STARTED|Overall Study||15
7660539|NCT02059980|18866844|P1|STARTED|Overall Study||18
7660540|NCT02059928|18866856|P1|NOT COMPLETED|Overall Study||0
7660541|NCT02059928|18866856|P1|COMPLETED|Overall Study||20
7660542|NCT02059928|18866856|P1|STARTED|Overall Study||20
7660543|NCT02059902|18866862|P2|NOT COMPLETED|Overall Study||4
7660544|NCT02059902|18866863|P1|NOT COMPLETED|Overall Study||4
7660545|NCT02059902|18866862|P2|COMPLETED|Overall Study||14
7660546|NCT02059902|18866863|P1|COMPLETED|Overall Study||14
7660547|NCT02059902|18866862|P2|STARTED|Overall Study||18
7660548|NCT02059902|18866863|P1|STARTED|Overall Study||18
7660549|NCT02059642|18866871|P2|NOT COMPLETED|Overall Study||24
7660550|NCT02059642|18866872|P1|NOT COMPLETED|Overall Study||27
7660551|NCT02059642|18866871|P2|COMPLETED|Overall Study||128
7660552|NCT02059642|18866872|P1|COMPLETED|Overall Study||121
7660553|NCT02059642|18866871|P2|STARTED|Overall Study||152
7660554|NCT02059642|18866872|P1|STARTED|Overall Study||148
7660555|NCT02059434|18866889|P9|NOT COMPLETED|Period 8||0
7660556|NCT02059434|18866890|P8|NOT COMPLETED|Period 8||0
7660557|NCT02059434|18866891|P7|NOT COMPLETED|Period 8||0
7660558|NCT02059434|18866892|P6|NOT COMPLETED|Period 8||0
7660559|NCT02059434|18866893|P5|NOT COMPLETED|Period 8||0
7660560|NCT02059434|18866894|P4|NOT COMPLETED|Period 8||0
7660561|NCT02059434|18866895|P3|NOT COMPLETED|Period 8||0
7660562|NCT02059434|18866896|P2|NOT COMPLETED|Period 8||0
7660563|NCT02059434|18866897|P1|NOT COMPLETED|Period 8||0
7660564|NCT02059434|18866889|P9|COMPLETED|Period 8||34
7660565|NCT02059434|18866890|P8|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
7660566|NCT02059434|18866891|P7|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
7660567|NCT02059434|18866892|P6|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
7660568|NCT02059434|18866893|P5|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
7660569|NCT02059434|18866894|P4|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
7660570|NCT02059434|18866895|P3|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
7660571|NCT02059434|18866896|P2|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
7660572|NCT02059434|18866897|P1|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
7660573|NCT02059434|18866889|P9|STARTED|Period 8||34
7660574|NCT02059434|18866890|P8|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
7660575|NCT02059434|18866891|P7|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
7660576|NCT02059434|18866892|P6|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
7660577|NCT02059434|18866893|P5|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
7660578|NCT02059434|18866894|P4|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
7660579|NCT02059434|18866895|P3|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
7660580|NCT02059434|18866896|P2|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
7660581|NCT02059434|18866897|P1|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
7660582|NCT02059434|18866889|P9|NOT COMPLETED|Washout Between Periods 7 and 8||2
7660583|NCT02059434|18866890|P8|NOT COMPLETED|Washout Between Periods 7 and 8||0
7660584|NCT02059434|18866891|P7|NOT COMPLETED|Washout Between Periods 7 and 8||0
7660585|NCT02059434|18866892|P6|NOT COMPLETED|Washout Between Periods 7 and 8||0
7660586|NCT02059434|18866893|P5|NOT COMPLETED|Washout Between Periods 7 and 8||0
7660587|NCT02059434|18866894|P4|NOT COMPLETED|Washout Between Periods 7 and 8||0
7660588|NCT02059434|18866895|P3|NOT COMPLETED|Washout Between Periods 7 and 8||0
7660589|NCT02059434|18866896|P2|NOT COMPLETED|Washout Between Periods 7 and 8||0
7660590|NCT02059434|18866897|P1|NOT COMPLETED|Washout Between Periods 7 and 8||0
7660591|NCT02059434|18866889|P9|COMPLETED|Washout Between Periods 7 and 8||34
7660592|NCT02059434|18866890|P8|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
7660593|NCT02059434|18866891|P7|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
7660594|NCT02059434|18866892|P6|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
7660595|NCT02059434|18866893|P5|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
7660596|NCT02059434|18866894|P4|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
7660597|NCT02059434|18866895|P3|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
7660598|NCT02059434|18866896|P2|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
7660599|NCT02059434|18866897|P1|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
7660600|NCT02059434|18866889|P9|STARTED|Washout Between Periods 7 and 8||36
7660601|NCT02059434|18866890|P8|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
7660602|NCT02059434|18866891|P7|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
7660603|NCT02059434|18866892|P6|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
7660604|NCT02059434|18866893|P5|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
7660605|NCT02059434|18866894|P4|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
7660606|NCT02059434|18866895|P3|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
7660607|NCT02059434|18866896|P2|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
7660608|NCT02059434|18866897|P1|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
7660609|NCT02059434|18866889|P9|NOT COMPLETED|Period 7||0
7660610|NCT02059434|18866890|P8|NOT COMPLETED|Period 7||0
7660611|NCT02059434|18866891|P7|NOT COMPLETED|Period 7||0
7660612|NCT02059434|18866892|P6|NOT COMPLETED|Period 7||0
7660613|NCT02059434|18866893|P5|NOT COMPLETED|Period 7||0
7660614|NCT02059434|18866894|P4|NOT COMPLETED|Period 7||0
7660615|NCT02059434|18866895|P3|NOT COMPLETED|Period 7||0
7660616|NCT02059434|18866896|P2|NOT COMPLETED|Period 7||0
7660617|NCT02059434|18866897|P1|NOT COMPLETED|Period 7||0
7660618|NCT02059434|18866889|P9|COMPLETED|Period 7||36
7660619|NCT02059434|18866890|P8|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
7660620|NCT02059434|18866891|P7|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
7660621|NCT02059434|18866892|P6|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
7660622|NCT02059434|18866893|P5|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
7660623|NCT02059434|18866894|P4|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
7660624|NCT02059434|18866895|P3|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
7660625|NCT02059434|18866896|P2|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
7660626|NCT02059434|18866897|P1|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
7660627|NCT02059434|18866889|P9|STARTED|Period 7||36
7660628|NCT02059434|18866890|P8|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
7660629|NCT02059434|18866891|P7|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
7660630|NCT02059434|18866892|P6|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
7660631|NCT02059434|18866893|P5|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
7660632|NCT02059434|18866894|P4|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
7660633|NCT02059434|18866895|P3|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
7660634|NCT02059434|18866896|P2|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
7660635|NCT02059434|18866897|P1|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
7660636|NCT02059434|18866889|P9|NOT COMPLETED|Washout Between Periods 6 and 7||1
7660637|NCT02059434|18866890|P8|NOT COMPLETED|Washout Between Periods 6 and 7||0
7660638|NCT02059434|18866891|P7|NOT COMPLETED|Washout Between Periods 6 and 7||0
7660639|NCT02059434|18866892|P6|NOT COMPLETED|Washout Between Periods 6 and 7||0
7660640|NCT02059434|18866893|P5|NOT COMPLETED|Washout Between Periods 6 and 7||0
7660641|NCT02059434|18866894|P4|NOT COMPLETED|Washout Between Periods 6 and 7||0
7660642|NCT02059434|18866895|P3|NOT COMPLETED|Washout Between Periods 6 and 7||0
7660643|NCT02059434|18866896|P2|NOT COMPLETED|Washout Between Periods 6 and 7||0
7660644|NCT02059434|18866897|P1|NOT COMPLETED|Washout Between Periods 6 and 7||0
7660645|NCT02059434|18866889|P9|COMPLETED|Washout Between Periods 6 and 7||36
7660646|NCT02059434|18866890|P8|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
7660647|NCT02059434|18866891|P7|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
7660648|NCT02059434|18866892|P6|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
7660649|NCT02059434|18866893|P5|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
7660650|NCT02059434|18866894|P4|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
7660651|NCT02059434|18866895|P3|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
7660652|NCT02059434|18866896|P2|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
7660653|NCT02059434|18866897|P1|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
7660654|NCT02059434|18866889|P9|STARTED|Washout Between Periods 6 and 7||37
7660655|NCT02059434|18866890|P8|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
7660656|NCT02059434|18866891|P7|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
7660657|NCT02059434|18866892|P6|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
7660658|NCT02059434|18866893|P5|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
7660659|NCT02059434|18866894|P4|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
7660660|NCT02059434|18866895|P3|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
7660661|NCT02059434|18866896|P2|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
7660662|NCT02059434|18866897|P1|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
7660663|NCT02059434|18866889|P9|NOT COMPLETED|Period 6||0
7660664|NCT02059434|18866890|P8|NOT COMPLETED|Period 6||0
7660665|NCT02059434|18866891|P7|NOT COMPLETED|Period 6||0
7660666|NCT02059434|18866892|P6|NOT COMPLETED|Period 6||0
7660667|NCT02059434|18866893|P5|NOT COMPLETED|Period 6||0
7660668|NCT02059434|18866894|P4|NOT COMPLETED|Period 6||0
7660669|NCT02059434|18866895|P3|NOT COMPLETED|Period 6||0
7660670|NCT02059434|18866896|P2|NOT COMPLETED|Period 6||0
7660671|NCT02059434|18866897|P1|NOT COMPLETED|Period 6||0
7660672|NCT02059434|18866889|P9|COMPLETED|Period 6||37
7660673|NCT02059434|18866890|P8|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
7660674|NCT02059434|18866891|P7|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
7660675|NCT02059434|18866892|P6|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
7660676|NCT02059434|18866893|P5|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
7660677|NCT02059434|18866894|P4|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
7660678|NCT02059434|18866895|P3|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
7660679|NCT02059434|18866896|P2|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
7660680|NCT02059434|18866897|P1|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
7660681|NCT02059434|18866889|P9|STARTED|Period 6||37
7660682|NCT02059434|18866890|P8|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
7660683|NCT02059434|18866891|P7|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
7660684|NCT02059434|18866892|P6|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
7660685|NCT02059434|18866893|P5|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
7660686|NCT02059434|18866894|P4|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
7660687|NCT02059434|18866895|P3|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
7660688|NCT02059434|18866896|P2|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
7660689|NCT02059434|18866897|P1|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
7660690|NCT02059434|18866889|P9|NOT COMPLETED|Washout Between Periods 5 and 6||0
7660691|NCT02059434|18866890|P8|NOT COMPLETED|Washout Between Periods 5 and 6||0
7660692|NCT02059434|18866891|P7|NOT COMPLETED|Washout Between Periods 5 and 6||0
7660693|NCT02059434|18866892|P6|NOT COMPLETED|Washout Between Periods 5 and 6||0
7660694|NCT02059434|18866893|P5|NOT COMPLETED|Washout Between Periods 5 and 6||0
7660695|NCT02059434|18866894|P4|NOT COMPLETED|Washout Between Periods 5 and 6||0
7660696|NCT02059434|18866895|P3|NOT COMPLETED|Washout Between Periods 5 and 6||0
7660697|NCT02059434|18866896|P2|NOT COMPLETED|Washout Between Periods 5 and 6||0
7660698|NCT02059434|18866897|P1|NOT COMPLETED|Washout Between Periods 5 and 6||0
7660699|NCT02059434|18866889|P9|COMPLETED|Washout Between Periods 5 and 6||37
7660700|NCT02059434|18866890|P8|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
7660701|NCT02059434|18866891|P7|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
7660702|NCT02059434|18866892|P6|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
7660703|NCT02059434|18866893|P5|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
7660704|NCT02059434|18866894|P4|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
7660705|NCT02059434|18866895|P3|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
7660706|NCT02059434|18866896|P2|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
7660707|NCT02059434|18866897|P1|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
7660708|NCT02059434|18866889|P9|STARTED|Washout Between Periods 5 and 6||37
7660709|NCT02059434|18866890|P8|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
7660710|NCT02059434|18866891|P7|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
7660711|NCT02059434|18866892|P6|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
7660712|NCT02059434|18866893|P5|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
7660713|NCT02059434|18866894|P4|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
7660714|NCT02059434|18866895|P3|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
7660715|NCT02059434|18866896|P2|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
7660716|NCT02059434|18866897|P1|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
7660717|NCT02059434|18866889|P9|NOT COMPLETED|Period 5||0
7660718|NCT02059434|18866890|P8|NOT COMPLETED|Period 5||0
7660719|NCT02059434|18866891|P7|NOT COMPLETED|Period 5||0
7660720|NCT02059434|18866892|P6|NOT COMPLETED|Period 5||0
7660721|NCT02059434|18866893|P5|NOT COMPLETED|Period 5||0
7660722|NCT02059434|18866894|P4|NOT COMPLETED|Period 5||0
7660723|NCT02059434|18866895|P3|NOT COMPLETED|Period 5||0
7660724|NCT02059434|18866896|P2|NOT COMPLETED|Period 5||0
7660725|NCT02059434|18866897|P1|NOT COMPLETED|Period 5||0
7660726|NCT02059434|18866889|P9|COMPLETED|Period 5||37
7660727|NCT02059434|18866890|P8|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
7660728|NCT02059434|18866891|P7|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
7660729|NCT02059434|18866892|P6|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
7660730|NCT02059434|18866893|P5|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
7660731|NCT02059434|18866894|P4|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
7660732|NCT02059434|18866895|P3|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
7660733|NCT02059434|18866896|P2|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
7660734|NCT02059434|18866897|P1|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
7660735|NCT02059434|18866889|P9|STARTED|Period 5||37
7660736|NCT02059434|18866890|P8|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
7660737|NCT02059434|18866891|P7|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
7660738|NCT02059434|18866892|P6|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
7660739|NCT02059434|18866893|P5|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
7660740|NCT02059434|18866894|P4|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
7660741|NCT02059434|18866895|P3|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
7660742|NCT02059434|18866896|P2|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
7660743|NCT02059434|18866897|P1|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
7660744|NCT02059434|18866889|P9|NOT COMPLETED|Washout Between Periods 4 and 5||1
7660745|NCT02059434|18866890|P8|NOT COMPLETED|Washout Between Periods 4 and 5||0
7660746|NCT02059434|18866891|P7|NOT COMPLETED|Washout Between Periods 4 and 5||0
7660747|NCT02059434|18866892|P6|NOT COMPLETED|Washout Between Periods 4 and 5||0
7660748|NCT02059434|18866893|P5|NOT COMPLETED|Washout Between Periods 4 and 5||0
7660749|NCT02059434|18866894|P4|NOT COMPLETED|Washout Between Periods 4 and 5||0
7660750|NCT02059434|18866895|P3|NOT COMPLETED|Washout Between Periods 4 and 5||0
7660751|NCT02059434|18866896|P2|NOT COMPLETED|Washout Between Periods 4 and 5||0
7660752|NCT02059434|18866897|P1|NOT COMPLETED|Washout Between Periods 4 and 5||0
7660753|NCT02059434|18866889|P9|COMPLETED|Washout Between Periods 4 and 5||37
7660754|NCT02059434|18866890|P8|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
7660755|NCT02059434|18866891|P7|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
7660756|NCT02059434|18866892|P6|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
7660757|NCT02059434|18866893|P5|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
7660758|NCT02059434|18866894|P4|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
7660759|NCT02059434|18866895|P3|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
7660760|NCT02059434|18866896|P2|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
7660761|NCT02059434|18866897|P1|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
7660762|NCT02059434|18866889|P9|STARTED|Washout Between Periods 4 and 5||38
7660763|NCT02059434|18866890|P8|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
7660764|NCT02059434|18866891|P7|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
7660765|NCT02059434|18866892|P6|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
7660766|NCT02059434|18866893|P5|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
7660767|NCT02059434|18866894|P4|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
7660768|NCT02059434|18866895|P3|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
7660769|NCT02059434|18866896|P2|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
7660770|NCT02059434|18866897|P1|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
7660771|NCT02059434|18866889|P9|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
7660772|NCT02059434|18866890|P8|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
7660773|NCT02059434|18866891|P7|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
7660774|NCT02059434|18866892|P6|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
7660775|NCT02059434|18866893|P5|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
7660776|NCT02059434|18866894|P4|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
7660777|NCT02059434|18866895|P3|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
7660778|NCT02059434|18866896|P2|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
7660779|NCT02059434|18866897|P1|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
7660780|NCT02059434|18866889|P9|COMPLETED|Period 4 (After Screening/run-in Period)||38
7660781|NCT02059434|18866890|P8|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
7660782|NCT02059434|18866891|P7|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
7660783|NCT02059434|18866892|P6|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
7660784|NCT02059434|18866893|P5|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
7660785|NCT02059434|18866894|P4|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
7660786|NCT02059434|18866895|P3|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
7660787|NCT02059434|18866896|P2|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
7660788|NCT02059434|18866897|P1|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
7660789|NCT02059434|18866889|P9|STARTED|Period 4 (After Screening/run-in Period)||38
7660790|NCT02059434|18866890|P8|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
7660791|NCT02059434|18866891|P7|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
7660792|NCT02059434|18866892|P6|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
7660793|NCT02059434|18866893|P5|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
7660794|NCT02059434|18866894|P4|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
7660795|NCT02059434|18866895|P3|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
7660796|NCT02059434|18866896|P2|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
7660797|NCT02059434|18866897|P1|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
7660798|NCT02059434|18866889|P9|NOT COMPLETED|Period 3||0
7660799|NCT02059434|18866890|P8|NOT COMPLETED|Period 3||0
7660800|NCT02059434|18866891|P7|NOT COMPLETED|Period 3||0
7660801|NCT02059434|18866892|P6|NOT COMPLETED|Period 3||0
7660802|NCT02059434|18866893|P5|NOT COMPLETED|Period 3||0
7660803|NCT02059434|18866894|P4|NOT COMPLETED|Period 3||0
7660804|NCT02059434|18866895|P3|NOT COMPLETED|Period 3||0
7660805|NCT02059434|18866896|P2|NOT COMPLETED|Period 3||0
7660806|NCT02059434|18866897|P1|NOT COMPLETED|Period 3||0
7660807|NCT02059434|18866889|P9|COMPLETED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
7660808|NCT02059434|18866890|P8|COMPLETED|Period 3||2
7660809|NCT02059434|18866891|P7|COMPLETED|Period 3||2
7660810|NCT02059434|18866892|P6|COMPLETED|Period 3||2
7660811|NCT02059434|18866893|P5|COMPLETED|Period 3||2
7660812|NCT02059434|18866894|P4|COMPLETED|Period 3||2
7660813|NCT02059434|18866895|P3|COMPLETED|Period 3||2
7660814|NCT02059434|18866896|P2|COMPLETED|Period 3||2
7660815|NCT02059434|18866897|P1|COMPLETED|Period 3||2
7660816|NCT02059434|18866889|P9|STARTED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
7660817|NCT02059434|18866890|P8|STARTED|Period 3||2
7660818|NCT02059434|18866891|P7|STARTED|Period 3||2
7660819|NCT02059434|18866892|P6|STARTED|Period 3||2
7660820|NCT02059434|18866893|P5|STARTED|Period 3||2
7660821|NCT02059434|18866894|P4|STARTED|Period 3||2
7660822|NCT02059434|18866895|P3|STARTED|Period 3||2
7660823|NCT02059434|18866896|P2|STARTED|Period 3||2
7660824|NCT02059434|18866897|P1|STARTED|Period 3||2
7660825|NCT02059434|18866889|P9|NOT COMPLETED|Washout Between Periods 2 and 3||0
7660826|NCT02059434|18866890|P8|NOT COMPLETED|Washout Between Periods 2 and 3||0
7660827|NCT02059434|18866891|P7|NOT COMPLETED|Washout Between Periods 2 and 3||0
7660828|NCT02059434|18866892|P6|NOT COMPLETED|Washout Between Periods 2 and 3||0
7660829|NCT02059434|18866893|P5|NOT COMPLETED|Washout Between Periods 2 and 3||0
7660830|NCT02059434|18866894|P4|NOT COMPLETED|Washout Between Periods 2 and 3||0
7660831|NCT02059434|18866895|P3|NOT COMPLETED|Washout Between Periods 2 and 3||0
7660832|NCT02059434|18866896|P2|NOT COMPLETED|Washout Between Periods 2 and 3||0
7660833|NCT02059434|18866897|P1|NOT COMPLETED|Washout Between Periods 2 and 3||0
7660834|NCT02059434|18866889|P9|COMPLETED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
7660835|NCT02059434|18866890|P8|COMPLETED|Washout Between Periods 2 and 3||2
7660836|NCT02059434|18866891|P7|COMPLETED|Washout Between Periods 2 and 3||2
7660837|NCT02059434|18866892|P6|COMPLETED|Washout Between Periods 2 and 3||2
7660838|NCT02059434|18866893|P5|COMPLETED|Washout Between Periods 2 and 3||2
7660839|NCT02059434|18866894|P4|COMPLETED|Washout Between Periods 2 and 3||2
7660840|NCT02059434|18866895|P3|COMPLETED|Washout Between Periods 2 and 3||2
7660841|NCT02059434|18866896|P2|COMPLETED|Washout Between Periods 2 and 3||2
7660842|NCT02059434|18866897|P1|COMPLETED|Washout Between Periods 2 and 3||2
7660843|NCT02059434|18866889|P9|STARTED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
7660844|NCT02059434|18866890|P8|STARTED|Washout Between Periods 2 and 3||2
7660845|NCT02059434|18866891|P7|STARTED|Washout Between Periods 2 and 3||2
7660846|NCT02059434|18866892|P6|STARTED|Washout Between Periods 2 and 3||2
7660847|NCT02059434|18866893|P5|STARTED|Washout Between Periods 2 and 3||2
7660848|NCT02059434|18866894|P4|STARTED|Washout Between Periods 2 and 3||2
7660849|NCT02059434|18866895|P3|STARTED|Washout Between Periods 2 and 3||2
7660850|NCT02059434|18866896|P2|STARTED|Washout Between Periods 2 and 3||2
7660851|NCT02059434|18866897|P1|STARTED|Washout Between Periods 2 and 3||2
7660852|NCT02059434|18866889|P9|NOT COMPLETED|Period 2||0
7660853|NCT02059434|18866890|P8|NOT COMPLETED|Period 2||0
7660854|NCT02059434|18866891|P7|NOT COMPLETED|Period 2||0
7660855|NCT02059434|18866892|P6|NOT COMPLETED|Period 2||0
7660856|NCT02059434|18866893|P5|NOT COMPLETED|Period 2||0
7660857|NCT02059434|18866894|P4|NOT COMPLETED|Period 2||0
7660858|NCT02059434|18866895|P3|NOT COMPLETED|Period 2||0
7660859|NCT02059434|18866896|P2|NOT COMPLETED|Period 2||0
7660860|NCT02059434|18866897|P1|NOT COMPLETED|Period 2||0
7660861|NCT02059434|18866889|P9|COMPLETED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
7660862|NCT02059434|18866890|P8|COMPLETED|Period 2||2
7660863|NCT02059434|18866891|P7|COMPLETED|Period 2||2
7660864|NCT02059434|18866892|P6|COMPLETED|Period 2||2
7660865|NCT02059434|18866893|P5|COMPLETED|Period 2||2
7660866|NCT02059434|18866894|P4|COMPLETED|Period 2||2
7660867|NCT02059434|18866895|P3|COMPLETED|Period 2||2
7660868|NCT02059434|18866896|P2|COMPLETED|Period 2||2
7660869|NCT02059434|18866897|P1|COMPLETED|Period 2||2
7660870|NCT02059434|18866889|P9|STARTED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
7660871|NCT02059434|18866890|P8|STARTED|Period 2||2
7660872|NCT02059434|18866891|P7|STARTED|Period 2||2
7660873|NCT02059434|18866892|P6|STARTED|Period 2||2
7660874|NCT02059434|18866893|P5|STARTED|Period 2||2
7660875|NCT02059434|18866894|P4|STARTED|Period 2||2
7660876|NCT02059434|18866895|P3|STARTED|Period 2||2
7660877|NCT02059434|18866896|P2|STARTED|Period 2||2
7660878|NCT02059434|18866897|P1|STARTED|Period 2||2
7660879|NCT02059434|18866889|P9|NOT COMPLETED|Washout Between Periods 1 and 2||0
7660880|NCT02059434|18866890|P8|NOT COMPLETED|Washout Between Periods 1 and 2||1
7660881|NCT02059434|18866891|P7|NOT COMPLETED|Washout Between Periods 1 and 2||0
7660882|NCT02059434|18866892|P6|NOT COMPLETED|Washout Between Periods 1 and 2||0
7660883|NCT02059434|18866893|P5|NOT COMPLETED|Washout Between Periods 1 and 2||0
7660884|NCT02059434|18866894|P4|NOT COMPLETED|Washout Between Periods 1 and 2||0
7660885|NCT02059434|18866895|P3|NOT COMPLETED|Washout Between Periods 1 and 2||0
7660886|NCT02059434|18866896|P2|NOT COMPLETED|Washout Between Periods 1 and 2||0
7660887|NCT02059434|18866897|P1|NOT COMPLETED|Washout Between Periods 1 and 2||0
7660888|NCT02059434|18866889|P9|COMPLETED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
7660889|NCT02059434|18866890|P8|COMPLETED|Washout Between Periods 1 and 2||2
7660890|NCT02059434|18866891|P7|COMPLETED|Washout Between Periods 1 and 2||2
7660891|NCT02059434|18866892|P6|COMPLETED|Washout Between Periods 1 and 2||2
7660892|NCT02059434|18866893|P5|COMPLETED|Washout Between Periods 1 and 2||2
7660893|NCT02059434|18866894|P4|COMPLETED|Washout Between Periods 1 and 2||2
7660894|NCT02059434|18866895|P3|COMPLETED|Washout Between Periods 1 and 2||2
7660895|NCT02059434|18866896|P2|COMPLETED|Washout Between Periods 1 and 2||2
7660896|NCT02059434|18866897|P1|COMPLETED|Washout Between Periods 1 and 2||2
7660897|NCT02059434|18866889|P9|STARTED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
7660898|NCT02059434|18866890|P8|STARTED|Washout Between Periods 1 and 2||3
7660899|NCT02059434|18866891|P7|STARTED|Washout Between Periods 1 and 2||2
7660900|NCT02059434|18866892|P6|STARTED|Washout Between Periods 1 and 2||2
7660901|NCT02059434|18866893|P5|STARTED|Washout Between Periods 1 and 2||2
7660902|NCT02059434|18866894|P4|STARTED|Washout Between Periods 1 and 2||2
7660903|NCT02059434|18866895|P3|STARTED|Washout Between Periods 1 and 2||2
7660904|NCT02059434|18866896|P2|STARTED|Washout Between Periods 1 and 2||2
7660905|NCT02059434|18866897|P1|STARTED|Washout Between Periods 1 and 2||2
7660906|NCT02059434|18866889|P9|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
7660907|NCT02059434|18866890|P8|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
7660908|NCT02059434|18866891|P7|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
7660909|NCT02059434|18866892|P6|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
7660910|NCT02059434|18866893|P5|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
7660911|NCT02059434|18866894|P4|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
7660912|NCT02059434|18866895|P3|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
7660913|NCT02059434|18866896|P2|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
7660914|NCT02059434|18866897|P1|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
7660915|NCT02059434|18866889|P9|COMPLETED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
7660916|NCT02059434|18866890|P8|COMPLETED|Period 1 (After Screening/run-in Period)||3
7660917|NCT02059434|18866891|P7|COMPLETED|Period 1 (After Screening/run-in Period)||2
7660918|NCT02059434|18866892|P6|COMPLETED|Period 1 (After Screening/run-in Period)||2
7660919|NCT02059434|18866893|P5|COMPLETED|Period 1 (After Screening/run-in Period)||2
7660920|NCT02059434|18866894|P4|COMPLETED|Period 1 (After Screening/run-in Period)||2
7660921|NCT02059434|18866895|P3|COMPLETED|Period 1 (After Screening/run-in Period)||2
7660922|NCT02059434|18866896|P2|COMPLETED|Period 1 (After Screening/run-in Period)||2
7660923|NCT02059434|18866897|P1|COMPLETED|Period 1 (After Screening/run-in Period)||2
7660924|NCT02059434|18866889|P9|STARTED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
7660925|NCT02059434|18866890|P8|STARTED|Period 1 (After Screening/run-in Period)||3
7660926|NCT02059434|18866891|P7|STARTED|Period 1 (After Screening/run-in Period)||2
7660927|NCT02059434|18866892|P6|STARTED|Period 1 (After Screening/run-in Period)||2
7660928|NCT02059434|18866893|P5|STARTED|Period 1 (After Screening/run-in Period)||2
7660929|NCT02059434|18866894|P4|STARTED|Period 1 (After Screening/run-in Period)||2
7660930|NCT02059434|18866895|P3|STARTED|Period 1 (After Screening/run-in Period)||2
7660931|NCT02059434|18866896|P2|STARTED|Period 1 (After Screening/run-in Period)||2
7660932|NCT02059434|18866897|P1|STARTED|Period 1 (After Screening/run-in Period)||2
7660933|NCT02059408|18866962|P3|NOT COMPLETED|Overall Study||358
7660934|NCT02059408|18866963|P2|NOT COMPLETED|Overall Study||330
7660935|NCT02059408|18866964|P1|NOT COMPLETED|Overall Study||0
7660936|NCT02059408|18866962|P3|COMPLETED|Overall Study||258
7660937|NCT02059408|18866963|P2|COMPLETED|Overall Study||269
7660938|NCT02059408|18866964|P1|COMPLETED|Overall Study||604
7660939|NCT02059408|18866962|P3|STARTED|Overall Study||616
7660940|NCT02059408|18866963|P2|STARTED|Overall Study||599
7660941|NCT02059408|18866964|P1|STARTED|Overall Study||604
7660942|NCT02059395|18866983|P2|NOT COMPLETED|Overall Study||4
7660943|NCT02059395|18866984|P1|NOT COMPLETED|Overall Study||2
7660944|NCT02059395|18866983|P2|COMPLETED|Overall Study||23
7660945|NCT02059395|18866984|P1|COMPLETED|Overall Study||20
7660946|NCT02059395|18866983|P2|STARTED|Overall Study||27
7660947|NCT02059395|18866984|P1|STARTED|Overall Study||22
7660948|NCT02059291|18866999|P25|NOT COMPLETED|Epoch 4||0
7660949|NCT02059291|18867000|P24|NOT COMPLETED|Epoch 4||1
7660950|NCT02059291|18867001|P23|NOT COMPLETED|Epoch 4||1
7660951|NCT02059291|18867002|P22|NOT COMPLETED|Epoch 4||0
7660952|NCT02059291|18867003|P21|NOT COMPLETED|Epoch 4||1
7660953|NCT02059291|18867004|P20|NOT COMPLETED|Epoch 4||0
7660954|NCT02059291|18867005|P19|NOT COMPLETED|Epoch 4||0
7660955|NCT02059291|18867006|P18|NOT COMPLETED|Epoch 4||0
7660956|NCT02059291|18867007|P17|NOT COMPLETED|Epoch 4||2
7660957|NCT02059291|18867008|P16|NOT COMPLETED|Epoch 4||0
7660958|NCT02059291|18867009|P15|NOT COMPLETED|Epoch 4||0
7660959|NCT02059291|18867010|P14|NOT COMPLETED|Epoch 4||0
7660960|NCT02059291|18867011|P13|NOT COMPLETED|Epoch 4||0
7660961|NCT02059291|18867012|P12|NOT COMPLETED|Epoch 4||0
7660962|NCT02059291|18867013|P11|NOT COMPLETED|Epoch 4||0
7660963|NCT02059291|18867014|P10|NOT COMPLETED|Epoch 4||0
7660964|NCT02059291|18867015|P9|NOT COMPLETED|Epoch 4||0
7660965|NCT02059291|18867016|P8|NOT COMPLETED|Epoch 4||0
7660966|NCT02059291|18867017|P7|NOT COMPLETED|Epoch 4||0
7660967|NCT02059291|18867018|P6|NOT COMPLETED|Epoch 4||0
7660968|NCT02059291|18867019|P5|NOT COMPLETED|Epoch 4||0
7660969|NCT02059291|18867020|P4|NOT COMPLETED|Epoch 4||0
7660970|NCT02059291|18867021|P3|NOT COMPLETED|Epoch 4||0
7660971|NCT02059291|18867022|P2|NOT COMPLETED|Epoch 4||0
7660972|NCT02059291|18867023|P1|NOT COMPLETED|Epoch 4||0
7660973|NCT02059291|18866999|P25|COMPLETED|Epoch 4||0
7660974|NCT02059291|18867000|P24|COMPLETED|Epoch 4||21
7660975|NCT02059291|18867001|P23|COMPLETED|Epoch 4||30
7660976|NCT02059291|18867002|P22|COMPLETED|Epoch 4||14
7660977|NCT02059291|18867003|P21|COMPLETED|Epoch 4||33
7660978|NCT02059291|18867004|P20|COMPLETED|Epoch 4||18
7660979|NCT02059291|18867005|P19|COMPLETED|Epoch 4||2
7660980|NCT02059291|18867006|P18|COMPLETED|Epoch 4||14
7660981|NCT02059291|18867007|P17|COMPLETED|Epoch 4||41
7660982|NCT02059291|18867008|P16|COMPLETED|Epoch 4||0
7660983|NCT02059291|18867009|P15|COMPLETED|Epoch 4||0
7660984|NCT02059291|18867010|P14|COMPLETED|Epoch 4||0
7660985|NCT02059291|18867011|P13|COMPLETED|Epoch 4||0
7660986|NCT02059291|18867012|P12|COMPLETED|Epoch 4||0
7660987|NCT02059291|18867013|P11|COMPLETED|Epoch 4||0
7660988|NCT02059291|18867014|P10|COMPLETED|Epoch 4||0
7660989|NCT02059291|18867015|P9|COMPLETED|Epoch 4||0
7660990|NCT02059291|18867016|P8|COMPLETED|Epoch 4||0
7660991|NCT02059291|18867017|P7|COMPLETED|Epoch 4||0
7660992|NCT02059291|18867018|P6|COMPLETED|Epoch 4||0
7660993|NCT02059291|18867019|P5|COMPLETED|Epoch 4||0
7660994|NCT02059291|18867020|P4|COMPLETED|Epoch 4||0
7660995|NCT02059291|18867021|P3|COMPLETED|Epoch 4||0
7660996|NCT02059291|18867022|P2|COMPLETED|Epoch 4||0
7660997|NCT02059291|18867023|P1|COMPLETED|Epoch 4||0
7660998|NCT02059291|18866999|P25|STARTED|Epoch 4||0
7660999|NCT02059291|18867000|P24|STARTED|Epoch 4||22
7661000|NCT02059291|18867001|P23|STARTED|Epoch 4||31
7661001|NCT02059291|18867002|P22|STARTED|Epoch 4||14
7661002|NCT02059291|18867003|P21|STARTED|Epoch 4||34
7661003|NCT02059291|18867004|P20|STARTED|Epoch 4||18
7661004|NCT02059291|18867005|P19|STARTED|Epoch 4||2
7661005|NCT02059291|18867006|P18|STARTED|Epoch 4||14
7661006|NCT02059291|18867007|P17|STARTED|Epoch 4||43
7661007|NCT02059291|18867008|P16|STARTED|Epoch 4||0
7661008|NCT02059291|18867009|P15|STARTED|Epoch 4||0
7661009|NCT02059291|18867010|P14|STARTED|Epoch 4||0
7661010|NCT02059291|18867011|P13|STARTED|Epoch 4||0
7661011|NCT02059291|18867012|P12|STARTED|Epoch 4||0
7661012|NCT02059291|18867013|P11|STARTED|Epoch 4||0
7661013|NCT02059291|18867014|P10|STARTED|Epoch 4||0
7661014|NCT02059291|18867015|P9|STARTED|Epoch 4||0
7661015|NCT02059291|18867016|P8|STARTED|Epoch 4||0
7661016|NCT02059291|18867017|P7|STARTED|Epoch 4||0
7661017|NCT02059291|18867018|P6|STARTED|Epoch 4||0
7661018|NCT02059291|18867019|P5|STARTED|Epoch 4||0
7661019|NCT02059291|18867020|P4|STARTED|Epoch 4||0
7661020|NCT02059291|18867021|P3|STARTED|Epoch 4||0
7661021|NCT02059291|18867022|P2|STARTED|Epoch 4||0
7661022|NCT02059291|18867023|P1|STARTED|Epoch 4||0
7661023|NCT02059291|18866999|P25|NOT COMPLETED|Epoch 3||0
7661024|NCT02059291|18867000|P24|NOT COMPLETED|Epoch 3||0
7661025|NCT02059291|18867001|P23|NOT COMPLETED|Epoch 3||0
7661026|NCT02059291|18867002|P22|NOT COMPLETED|Epoch 3||0
7661027|NCT02059291|18867003|P21|NOT COMPLETED|Epoch 3||0
7661028|NCT02059291|18867004|P20|NOT COMPLETED|Epoch 3||0
7661029|NCT02059291|18867005|P19|NOT COMPLETED|Epoch 3||0
7661030|NCT02059291|18867006|P18|NOT COMPLETED|Epoch 3||0
7661031|NCT02059291|18867007|P17|NOT COMPLETED|Epoch 3||0
7661032|NCT02059291|18867008|P16|NOT COMPLETED|Epoch 3||6
7661033|NCT02059291|18867009|P15|NOT COMPLETED|Epoch 3||0
7661034|NCT02059291|18867010|P14|NOT COMPLETED|Epoch 3||1
7661035|NCT02059291|18867011|P13|NOT COMPLETED|Epoch 3||0
7661036|NCT02059291|18867012|P12|NOT COMPLETED|Epoch 3||0
7661037|NCT02059291|18867013|P11|NOT COMPLETED|Epoch 3||0
7661038|NCT02059291|18867014|P10|NOT COMPLETED|Epoch 3||0
7661039|NCT02059291|18867015|P9|NOT COMPLETED|Epoch 3||0
7661040|NCT02059291|18867016|P8|NOT COMPLETED|Epoch 3||0
7661041|NCT02059291|18867017|P7|NOT COMPLETED|Epoch 3||0
7661042|NCT02059291|18867018|P6|NOT COMPLETED|Epoch 3||0
7661043|NCT02059291|18867019|P5|NOT COMPLETED|Epoch 3||0
7661044|NCT02059291|18867020|P4|NOT COMPLETED|Epoch 3||0
7661045|NCT02059291|18867021|P3|NOT COMPLETED|Epoch 3||0
7661046|NCT02059291|18867022|P2|NOT COMPLETED|Epoch 3||0
7661047|NCT02059291|18867023|P1|NOT COMPLETED|Epoch 3||0
7661048|NCT02059291|18866999|P25|COMPLETED|Epoch 3||0
7661049|NCT02059291|18867000|P24|COMPLETED|Epoch 3||0
7661050|NCT02059291|18867001|P23|COMPLETED|Epoch 3||0
7661051|NCT02059291|18867002|P22|COMPLETED|Epoch 3||0
7661052|NCT02059291|18867003|P21|COMPLETED|Epoch 3||0
7661053|NCT02059291|18867004|P20|COMPLETED|Epoch 3||0
7661054|NCT02059291|18867005|P19|COMPLETED|Epoch 3||0
7661055|NCT02059291|18867006|P18|COMPLETED|Epoch 3||0
7661056|NCT02059291|18867007|P17|COMPLETED|Epoch 3||0
7661057|NCT02059291|18867008|P16|COMPLETED|Epoch 3||120
7661058|NCT02059291|18867009|P15|COMPLETED|Epoch 3||5
7661059|NCT02059291|18867010|P14|COMPLETED|Epoch 3||3
7661060|NCT02059291|18867011|P13|COMPLETED|Epoch 3||7
7661061|NCT02059291|18867012|P12|COMPLETED|Epoch 3||6
7661062|NCT02059291|18867013|P11|COMPLETED|Epoch 3||10
7661063|NCT02059291|18867014|P10|COMPLETED|Epoch 3||9
7661064|NCT02059291|18867015|P9|COMPLETED|Epoch 3||0
7661065|NCT02059291|18867016|P8|COMPLETED|Epoch 3||1
7661066|NCT02059291|18867017|P7|COMPLETED|Epoch 3||2
7661067|NCT02059291|18867018|P6|COMPLETED|Epoch 3||0
7661068|NCT02059291|18867019|P5|COMPLETED|Epoch 3||0
7661069|NCT02059291|18867020|P4|COMPLETED|Epoch 3||0
7661070|NCT02059291|18867021|P3|COMPLETED|Epoch 3||0
7661071|NCT02059291|18867022|P2|COMPLETED|Epoch 3||0
7661072|NCT02059291|18867023|P1|COMPLETED|Epoch 3||0
7661073|NCT02059291|18866999|P25|STARTED|Epoch 3||0
7661074|NCT02059291|18867000|P24|STARTED|Epoch 3||0
7661075|NCT02059291|18867001|P23|STARTED|Epoch 3||0
7661076|NCT02059291|18867002|P22|STARTED|Epoch 3||0
7661077|NCT02059291|18867003|P21|STARTED|Epoch 3||0
7661078|NCT02059291|18867004|P20|STARTED|Epoch 3||0
7661079|NCT02059291|18867005|P19|STARTED|Epoch 3||0
7661080|NCT02059291|18867006|P18|STARTED|Epoch 3||0
7661081|NCT02059291|18867007|P17|STARTED|Epoch 3||0
7661082|NCT02059291|18867008|P16|STARTED|Epoch 3||126
7661083|NCT02059291|18867009|P15|STARTED|Epoch 3||5
7661084|NCT02059291|18867010|P14|STARTED|Epoch 3||4
7661085|NCT02059291|18867011|P13|STARTED|Epoch 3||7
7661086|NCT02059291|18867012|P12|STARTED|Epoch 3||6
7661087|NCT02059291|18867013|P11|STARTED|Epoch 3||10
7661088|NCT02059291|18867014|P10|STARTED|Epoch 3||9
7661089|NCT02059291|18867015|P9|STARTED|Epoch 3|Presented in Epoch 2.|0
7661090|NCT02059291|18867016|P8|STARTED|Epoch 3||1
7661091|NCT02059291|18867017|P7|STARTED|Epoch 3||2
7661092|NCT02059291|18867018|P6|STARTED|Epoch 3||0
7661093|NCT02059291|18867019|P5|STARTED|Epoch 3||0
7661094|NCT02059291|18867020|P4|STARTED|Epoch 3||0
7661095|NCT02059291|18867021|P3|STARTED|Epoch 3||0
7661096|NCT02059291|18867022|P2|STARTED|Epoch 3||0
7661097|NCT02059291|18867023|P1|STARTED|Epoch 3||0
7661098|NCT02059291|18866999|P25|NOT COMPLETED|Epoch 2||0
7661099|NCT02059291|18867000|P24|NOT COMPLETED|Epoch 2||0
7661100|NCT02059291|18867001|P23|NOT COMPLETED|Epoch 2||0
7661101|NCT02059291|18867002|P22|NOT COMPLETED|Epoch 2||0
7661102|NCT02059291|18867003|P21|NOT COMPLETED|Epoch 2||0
7661103|NCT02059291|18867004|P20|NOT COMPLETED|Epoch 2||0
7661104|NCT02059291|18867005|P19|NOT COMPLETED|Epoch 2||0
7661105|NCT02059291|18867006|P18|NOT COMPLETED|Epoch 2||0
7661106|NCT02059291|18867007|P17|NOT COMPLETED|Epoch 2||0
7661107|NCT02059291|18867008|P16|NOT COMPLETED|Epoch 2||0
7661108|NCT02059291|18867009|P15|NOT COMPLETED|Epoch 2||0
7661109|NCT02059291|18867010|P14|NOT COMPLETED|Epoch 2||0
7661110|NCT02059291|18867011|P13|NOT COMPLETED|Epoch 2||0
7661111|NCT02059291|18867012|P12|NOT COMPLETED|Epoch 2||0
7661112|NCT02059291|18867013|P11|NOT COMPLETED|Epoch 2||0
7661113|NCT02059291|18867014|P10|NOT COMPLETED|Epoch 2||0
7661114|NCT02059291|18867015|P9|NOT COMPLETED|Epoch 2||2
7661115|NCT02059291|18867016|P8|NOT COMPLETED|Epoch 2||1
7661116|NCT02059291|18867017|P7|NOT COMPLETED|Epoch 2||0
7661117|NCT02059291|18867018|P6|NOT COMPLETED|Epoch 2||2
7661118|NCT02059291|18867019|P5|NOT COMPLETED|Epoch 2||0
7661119|NCT02059291|18867020|P4|NOT COMPLETED|Epoch 2||2
7661120|NCT02059291|18867021|P3|NOT COMPLETED|Epoch 2||1
7661121|NCT02059291|18867022|P2|NOT COMPLETED|Epoch 2||1
7661122|NCT02059291|18867023|P1|NOT COMPLETED|Epoch 2||0
7661123|NCT02059291|18866999|P25|COMPLETED|Epoch 2||0
7661124|NCT02059291|18867000|P24|COMPLETED|Epoch 2||0
7661125|NCT02059291|18867001|P23|COMPLETED|Epoch 2||0
7661126|NCT02059291|18867002|P22|COMPLETED|Epoch 2||0
7661127|NCT02059291|18867003|P21|COMPLETED|Epoch 2||0
7661128|NCT02059291|18867004|P20|COMPLETED|Epoch 2||0
7661129|NCT02059291|18867005|P19|COMPLETED|Epoch 2||0
7661130|NCT02059291|18867006|P18|COMPLETED|Epoch 2||0
7661131|NCT02059291|18867007|P17|COMPLETED|Epoch 2||0
7661132|NCT02059291|18867008|P16|COMPLETED|Epoch 2||0
7661133|NCT02059291|18867009|P15|COMPLETED|Epoch 2||0
7661134|NCT02059291|18867010|P14|COMPLETED|Epoch 2||0
7661135|NCT02059291|18867011|P13|COMPLETED|Epoch 2||0
7661136|NCT02059291|18867012|P12|COMPLETED|Epoch 2||0
7661137|NCT02059291|18867013|P11|COMPLETED|Epoch 2||0
7661138|NCT02059291|18867014|P10|COMPLETED|Epoch 2||0
7661139|NCT02059291|18867015|P9|COMPLETED|Epoch 2||16
7661140|NCT02059291|18867016|P8|COMPLETED|Epoch 2||1
7661141|NCT02059291|18867017|P7|COMPLETED|Epoch 2||2
7661142|NCT02059291|18867018|P6|COMPLETED|Epoch 2||22
7661143|NCT02059291|18867019|P5|COMPLETED|Epoch 2||22
7661144|NCT02059291|18867020|P4|COMPLETED|Epoch 2||33
7661145|NCT02059291|18867021|P3|COMPLETED|Epoch 2||36
7661146|NCT02059291|18867022|P2|COMPLETED|Epoch 2||31
7661147|NCT02059291|18867023|P1|COMPLETED|Epoch 2||31
7661148|NCT02059291|18866999|P25|STARTED|Epoch 2||0
7661149|NCT02059291|18867000|P24|STARTED|Epoch 2||0
7661150|NCT02059291|18867001|P23|STARTED|Epoch 2||0
7661151|NCT02059291|18867002|P22|STARTED|Epoch 2||0
7661152|NCT02059291|18867003|P21|STARTED|Epoch 2||0
7661153|NCT02059291|18867004|P20|STARTED|Epoch 2||0
7661154|NCT02059291|18867005|P19|STARTED|Epoch 2||0
7661155|NCT02059291|18867006|P18|STARTED|Epoch 2||0
7661156|NCT02059291|18867007|P17|STARTED|Epoch 2||0
7661157|NCT02059291|18867008|P16|STARTED|Epoch 2||0
7661158|NCT02059291|18867009|P15|STARTED|Epoch 2||0
7661159|NCT02059291|18867010|P14|STARTED|Epoch 2||0
7661160|NCT02059291|18867011|P13|STARTED|Epoch 2||0
7661161|NCT02059291|18867012|P12|STARTED|Epoch 2||0
7661162|NCT02059291|18867013|P11|STARTED|Epoch 2||0
7661163|NCT02059291|18867014|P10|STARTED|Epoch 2||0
7661164|NCT02059291|18867015|P9|STARTED|Epoch 2|This Epoch 3 group is shown in Epoch 2 to account for the 203 patients enrolled in the study.|18
7661165|NCT02059291|18867016|P8|STARTED|Epoch 2||2
7661166|NCT02059291|18867017|P7|STARTED|Epoch 2||2
7661167|NCT02059291|18867018|P6|STARTED|Epoch 2||24
7661168|NCT02059291|18867019|P5|STARTED|Epoch 2||22
7661169|NCT02059291|18867020|P4|STARTED|Epoch 2||35
7661170|NCT02059291|18867021|P3|STARTED|Epoch 2||37
7661171|NCT02059291|18867022|P2|STARTED|Epoch 2||32
7661172|NCT02059291|18867023|P1|STARTED|Epoch 2||31
7661173|NCT02059278|18867077|P2|NOT COMPLETED|Overall Study||4
7661174|NCT02059278|18867078|P1|NOT COMPLETED|Overall Study||3
7661175|NCT02059278|18867077|P2|COMPLETED|Overall Study||166
7661176|NCT02059278|18867078|P1|COMPLETED|Overall Study||162
7661177|NCT02059278|18867077|P2|STARTED|Overall Study||170
7661178|NCT02059278|18867078|P1|STARTED|Overall Study||165
7661179|NCT02059265|18867092|P1|NOT COMPLETED|Overall Study||4
7661180|NCT02059265|18867092|P1|COMPLETED|Overall Study||28
7661181|NCT02059265|18867092|P1|STARTED|Overall Study||32
7661182|NCT02059213|18867102|P2|NOT COMPLETED|Overall Study||2
7661183|NCT02059213|18867103|P1|NOT COMPLETED|Overall Study||0
7661184|NCT02059213|18867102|P2|COMPLETED|Overall Study||40
7661185|NCT02059213|18867103|P1|COMPLETED|Overall Study||20
7661186|NCT02059213|18867102|P2|Initiated Treatment|Overall Study||40
7661187|NCT02059213|18867103|P1|Initiated Treatment|Overall Study||20
7661188|NCT02059213|18867102|P2|STARTED|Overall Study||42
7661189|NCT02059213|18867103|P1|STARTED|Overall Study||20
7661190|NCT02059187|18867124|P2|NOT COMPLETED|Overall Study||22
7661191|NCT02059187|18867125|P1|NOT COMPLETED|Overall Study||25
7661192|NCT02059187|18867124|P2|COMPLETED|Overall Study||244
7661193|NCT02059187|18867125|P1|COMPLETED|Overall Study||240
7661194|NCT02059187|18867124|P2|STARTED|Overall Study||266
7661195|NCT02059187|18867125|P1|STARTED|Overall Study||265
7661196|NCT02059174|18867151|P2|NOT COMPLETED|Period 4||0
7661197|NCT02059174|18867152|P1|NOT COMPLETED|Period 4||0
7661198|NCT02059174|18867151|P2|COMPLETED|Period 4||35
7661199|NCT02059174|18867152|P1|COMPLETED|Period 4||35
7661200|NCT02059174|18867151|P2|STARTED|Period 4||35
7661201|NCT02059174|18867152|P1|STARTED|Period 4||35
7661202|NCT02059174|18867151|P2|NOT COMPLETED|Period 3||0
7661203|NCT02059174|18867152|P1|NOT COMPLETED|Period 3||1
7661204|NCT02059174|18867151|P2|COMPLETED|Period 3||35
7661205|NCT02059174|18867152|P1|COMPLETED|Period 3||35
7661206|NCT02059174|18867151|P2|STARTED|Period 3||35
7661207|NCT02059174|18867152|P1|STARTED|Period 3||36
7661208|NCT02059174|18867151|P2|NOT COMPLETED|Period 2||2
7661209|NCT02059174|18867152|P1|NOT COMPLETED|Period 2||1
7661210|NCT02059174|18867151|P2|COMPLETED|Period 2||35
7661211|NCT02059174|18867152|P1|COMPLETED|Period 2||36
7661212|NCT02059174|18867151|P2|STARTED|Period 2||37
7661213|NCT02059174|18867152|P1|STARTED|Period 2||37
7661214|NCT02059174|18867151|P2|NOT COMPLETED|Period 1||2
7661215|NCT02059174|18867152|P1|NOT COMPLETED|Period 1||0
7661216|NCT02059174|18867151|P2|COMPLETED|Period 1||37
7661217|NCT02059174|18867152|P1|COMPLETED|Period 1||37
7661218|NCT02059174|18867151|P2|STARTED|Period 1||39
7661219|NCT02059174|18867152|P1|STARTED|Period 1||37
7661220|NCT02059161|18867176|P2|NOT COMPLETED|Overall Study||41
7661221|NCT02059161|18867177|P1|NOT COMPLETED|Overall Study||49
7661222|NCT02059161|18867176|P2|COMPLETED|Overall Study||222
7661223|NCT02059161|18867177|P1|COMPLETED|Overall Study||196
7661224|NCT02059161|18867176|P2|Treated|Overall Study||258
7661225|NCT02059161|18867177|P1|Treated|Overall Study||241
7661226|NCT02059161|18867176|P2|STARTED|Overall Study||263
7661227|NCT02059161|18867177|P1|STARTED|Overall Study||245
7661228|NCT02059148|18867237|P6|NOT COMPLETED|Treatment 3||0
7661229|NCT02059148|18867238|P5|NOT COMPLETED|Treatment 3||0
7661230|NCT02059148|18867239|P4|NOT COMPLETED|Treatment 3||0
7661231|NCT02059148|18867240|P3|NOT COMPLETED|Treatment 3||0
7661232|NCT02059148|18867241|P2|NOT COMPLETED|Treatment 3||0
7661233|NCT02059148|18867242|P1|NOT COMPLETED|Treatment 3||0
7661234|NCT02059148|18867237|P6|COMPLETED|Treatment 3||3
7661235|NCT02059148|18867238|P5|COMPLETED|Treatment 3||4
7661236|NCT02059148|18867239|P4|COMPLETED|Treatment 3||4
7661237|NCT02059148|18867240|P3|COMPLETED|Treatment 3||4
7661238|NCT02059148|18867241|P2|COMPLETED|Treatment 3||4
7661239|NCT02059148|18867242|P1|COMPLETED|Treatment 3||4
7661240|NCT02059148|18867237|P6|STARTED|Treatment 3||3
7661241|NCT02059148|18867238|P5|STARTED|Treatment 3||4
7661242|NCT02059148|18867239|P4|STARTED|Treatment 3||4
7661243|NCT02059148|18867240|P3|STARTED|Treatment 3||4
7661244|NCT02059148|18867241|P2|STARTED|Treatment 3||4
7661245|NCT02059148|18867242|P1|STARTED|Treatment 3||4
7661246|NCT02059148|18867237|P6|NOT COMPLETED|Treatment 2||0
7661247|NCT02059148|18867238|P5|NOT COMPLETED|Treatment 2||0
7661248|NCT02059148|18867239|P4|NOT COMPLETED|Treatment 2||0
7661249|NCT02059148|18867240|P3|NOT COMPLETED|Treatment 2||0
7661250|NCT02059148|18867241|P2|NOT COMPLETED|Treatment 2||0
7661251|NCT02059148|18867242|P1|NOT COMPLETED|Treatment 2||0
7661252|NCT02059148|18867237|P6|COMPLETED|Treatment 2||3
7661253|NCT02059148|18867238|P5|COMPLETED|Treatment 2||4
7661254|NCT02059148|18867239|P4|COMPLETED|Treatment 2||4
7661255|NCT02059148|18867240|P3|COMPLETED|Treatment 2||4
7661256|NCT02059148|18867241|P2|COMPLETED|Treatment 2||4
7661257|NCT02059148|18867242|P1|COMPLETED|Treatment 2||4
7661258|NCT02059148|18867237|P6|STARTED|Treatment 2||3
7661259|NCT02059148|18867238|P5|STARTED|Treatment 2||4
7661260|NCT02059148|18867239|P4|STARTED|Treatment 2||4
7661261|NCT02059148|18867240|P3|STARTED|Treatment 2||4
7661262|NCT02059148|18867241|P2|STARTED|Treatment 2||4
7661263|NCT02059148|18867242|P1|STARTED|Treatment 2||4
7661264|NCT02059148|18867237|P6|NOT COMPLETED|Treatment 1||1
7661265|NCT02059148|18867238|P5|NOT COMPLETED|Treatment 1||0
7661266|NCT02059148|18867239|P4|NOT COMPLETED|Treatment 1||0
7661267|NCT02059148|18867240|P3|NOT COMPLETED|Treatment 1||0
7661268|NCT02059148|18867241|P2|NOT COMPLETED|Treatment 1||0
7661269|NCT02059148|18867242|P1|NOT COMPLETED|Treatment 1||0
7661270|NCT02059148|18867237|P6|COMPLETED|Treatment 1||3
7661271|NCT02059148|18867238|P5|COMPLETED|Treatment 1||4
7661272|NCT02059148|18867239|P4|COMPLETED|Treatment 1||4
7661273|NCT02059148|18867240|P3|COMPLETED|Treatment 1||4
7661274|NCT02059148|18867241|P2|COMPLETED|Treatment 1||4
7661275|NCT02059148|18867242|P1|COMPLETED|Treatment 1||4
7661276|NCT02059148|18867237|P6|STARTED|Treatment 1||4
7661277|NCT02059148|18867238|P5|STARTED|Treatment 1||4
7661278|NCT02059148|18867239|P4|STARTED|Treatment 1||4
7661279|NCT02059148|18867240|P3|STARTED|Treatment 1||4
7661280|NCT02059148|18867241|P2|STARTED|Treatment 1||4
7661281|NCT02059148|18867242|P1|STARTED|Treatment 1||4
7661282|NCT02059135|18867261|P2|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
7661283|NCT02059135|18867262|P1|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
7661284|NCT02059135|18867261|P2|COMPLETED|Neonatal Follow-up (Safety Population)||50
7661285|NCT02059135|18867262|P1|COMPLETED|Neonatal Follow-up (Safety Population)||56
7661286|NCT02059135|18867261|P2|STARTED|Neonatal Follow-up (Safety Population)||54
7661287|NCT02059135|18867262|P1|STARTED|Neonatal Follow-up (Safety Population)||60
7661288|NCT02059135|18867261|P2|NOT COMPLETED|Maternal Follow-up (ITT Population)||7
7661289|NCT02059135|18867262|P1|NOT COMPLETED|Maternal Follow-up (ITT Population)||3
7661290|NCT02059135|18867261|P2|COMPLETED|Maternal Follow-up (ITT Population)||51
7661291|NCT02059135|18867262|P1|COMPLETED|Maternal Follow-up (ITT Population)||59
7661292|NCT02059135|18867261|P2|STARTED|Maternal Follow-up (ITT Population)||58
7661293|NCT02059135|18867262|P1|STARTED|Maternal Follow-up (ITT Population)||62
7661294|NCT02059070|18867276|P2|NOT COMPLETED|Overall Study||4
7661295|NCT02059070|18867277|P1|NOT COMPLETED|Overall Study||5
7661296|NCT02059070|18867276|P2|COMPLETED|Overall Study||16
7661297|NCT02059070|18867277|P1|COMPLETED|Overall Study||14
7661298|NCT02059070|18867276|P2|STARTED|Overall Study||20
7661299|NCT02059070|18867277|P1|STARTED|Overall Study||19
7661300|NCT02059057|18867289|P1|NOT COMPLETED|Overall Study||15
7661301|NCT02059057|18867289|P1|COMPLETED|Overall Study||87
7661302|NCT02059057|18867289|P1|STARTED|Overall Study||102
7661303|NCT02059005|18867298|P2|NOT COMPLETED|Overall Study||24
7661304|NCT02059005|18867299|P1|NOT COMPLETED|Overall Study||20
7661305|NCT02059005|18867298|P2|COMPLETED|Overall Study||24
7661306|NCT02059005|18867299|P1|COMPLETED|Overall Study||29
7661307|NCT02059005|18867298|P2|6 Month Assessment|Overall Study||24
7661308|NCT02059005|18867299|P1|6 Month Assessment|Overall Study||29
7661309|NCT02059005|18867298|P2|3 Month Assessment|Overall Study||33
7661310|NCT02059005|18867299|P1|3 Month Assessment|Overall Study||37
7661311|NCT02059005|18867298|P2|STARTED|Overall Study||48
7661312|NCT02059005|18867299|P1|STARTED|Overall Study||49
7661313|NCT02058992|18867309|P1|NOT COMPLETED|Overall Study||116
7661314|NCT02058992|18867309|P1|COMPLETED|Overall Study||3223
7661315|NCT02058992|18867309|P1|STARTED|Overall Study||3339
7661316|NCT02058966|18867318|P1|NOT COMPLETED|Fourth Intervention||0
7661317|NCT02058966|18867318|P1|COMPLETED|Fourth Intervention||12
7661318|NCT02058966|18867318|P1|Received Entacapone-Meth|Fourth Intervention||2
7661319|NCT02058966|18867318|P1|Received Entacapone-Placebo|Fourth Intervention||3
7661320|NCT02058966|18867318|P1|Received Placebo-Meth|Fourth Intervention||3
7661321|NCT02058966|18867318|P1|Received Placebo-Placebo|Fourth Intervention||4
7661322|NCT02058966|18867318|P1|STARTED|Fourth Intervention||12
7661323|NCT02058966|18867318|P1|NOT COMPLETED|Third Intervention||0
7661324|NCT02058966|18867318|P1|COMPLETED|Third Intervention||12
7661325|NCT02058966|18867318|P1|Received Entacapone-Meth|Third Intervention||3
7661326|NCT02058966|18867318|P1|Received Entacapone-Placebo|Third Intervention||1
7661327|NCT02058966|18867318|P1|Received Placebo-Meth|Third Intervention||4
7661328|NCT02058966|18867318|P1|Received Placebo-Placebo|Third Intervention||4
7661329|NCT02058966|18867318|P1|STARTED|Third Intervention||12
7661330|NCT02058966|18867318|P1|NOT COMPLETED|Second Intervention||0
7661331|NCT02058966|18867318|P1|COMPLETED|Second Intervention||13
7661332|NCT02058966|18867318|P1|Received Entacapone-Meth|Second Intervention||3
7661333|NCT02058966|18867318|P1|Received Entacapone-Placebo|Second Intervention||6
7661334|NCT02058966|18867318|P1|Received Placebo-Meth|Second Intervention||2
7661335|NCT02058966|18867318|P1|Received Placebo-Placebo|Second Intervention||2
7661336|NCT02058966|18867318|P1|STARTED|Second Intervention||13
7661337|NCT02058966|18867318|P1|NOT COMPLETED|First Intervention||1
7661338|NCT02058966|18867318|P1|COMPLETED|First Intervention||14
7661339|NCT02058966|18867318|P1|Received Entacapone-Meth|First Intervention||5
7661340|NCT02058966|18867318|P1|Received Entacapone-Placebo|First Intervention||2
7661341|NCT02058966|18867318|P1|Received Placebo-Meth|First Intervention||4
7661342|NCT02058966|18867318|P1|Received Placebo-Placebo|First Intervention||3
7661343|NCT02058966|18867318|P1|STARTED|First Intervention||15
7661344|NCT02058966|18867318|P1|NOT COMPLETED|Open-Label Methamphetamine||1
7661345|NCT02058966|18867318|P1|COMPLETED|Open-Label Methamphetamine||18
7661346|NCT02058966|18867318|P1|Received Methamphetamine|Open-Label Methamphetamine||18
7661347|NCT02058966|18867318|P1|STARTED|Open-Label Methamphetamine||19
7661348|NCT02058940|18867345|P1|NOT COMPLETED|Overall Study||1
7661349|NCT02058940|18867345|P1|COMPLETED|Overall Study||7
7661350|NCT02058940|18867345|P1|STARTED|Overall Study||8
7661351|NCT02058849|18867369|P2|NOT COMPLETED|Overall Study||1
7661352|NCT02058849|18867370|P1|NOT COMPLETED|Overall Study||7
7661353|NCT02058849|18867369|P2|COMPLETED|Overall Study||1
7661354|NCT02058849|18867370|P1|COMPLETED|Overall Study||4
7661355|NCT02058849|18867369|P2|STARTED|Overall Study||2
7661356|NCT02058849|18867370|P1|STARTED|Overall Study||11
7661357|NCT02058836|18867398|P2|NOT COMPLETED|Overall Study||1
7661358|NCT02058836|18867399|P1|NOT COMPLETED|Overall Study||1
7661359|NCT02058836|18867398|P2|COMPLETED|Overall Study||3
7661360|NCT02058836|18867399|P1|COMPLETED|Overall Study||3
7661361|NCT02058836|18867398|P2|STARTED|Overall Study||4
7661362|NCT02058836|18867399|P1|STARTED|Overall Study||4
7661363|NCT02058628|18867429|P2|NOT COMPLETED|Overall Study||8
7661364|NCT02058628|18867430|P1|NOT COMPLETED|Overall Study||7
7661365|NCT02058628|18867429|P2|COMPLETED|Overall Study||102
7661366|NCT02058628|18867430|P1|COMPLETED|Overall Study||104
7661367|NCT02058628|18867429|P2|STARTED|Overall Study||110
7661368|NCT02058628|18867430|P1|STARTED|Overall Study||111
7661369|NCT02058589|18867462|P2|NOT COMPLETED|Overall Study||2
7661370|NCT02058589|18867463|P1|NOT COMPLETED|Overall Study||2
7661371|NCT02058589|18867462|P2|COMPLETED|Overall Study||130
7661372|NCT02058589|18867463|P1|COMPLETED|Overall Study||130
7661373|NCT02058589|18867462|P2|STARTED|Overall Study||132
7661374|NCT02058589|18867463|P1|STARTED|Overall Study||132
7661375|NCT02058563|18867505|P2|NOT COMPLETED|Overall Study||24
7661376|NCT02058563|18867506|P1|NOT COMPLETED|Overall Study||28
7661377|NCT02058563|18867505|P2|COMPLETED|Overall Study||433
7661378|NCT02058563|18867506|P1|COMPLETED|Overall Study||426
7661379|NCT02058563|18867505|P2|STARTED|Overall Study||457
7661380|NCT02058563|18867506|P1|STARTED|Overall Study||454
7661381|NCT02058537|18867542|P1|NOT COMPLETED|Overall Study||1
7661382|NCT02058537|18867542|P1|COMPLETED|Overall Study||2
7661383|NCT02058537|18867542|P1|STARTED|Overall Study||3
7661384|NCT02058511|18867548|P1|NOT COMPLETED|Overall Study||0
7661385|NCT02058511|18867548|P1|COMPLETED|Overall Study||24
7661386|NCT02058511|18867548|P1|STARTED|Overall Study||24
7661387|NCT02058498|18867553|P1|NOT COMPLETED|Overall Study||4
7661388|NCT02058498|18867553|P1|COMPLETED|Overall Study||8
7661389|NCT02058498|18867553|P1|6 Weeks|Overall Study||8
7661390|NCT02058498|18867553|P1|STARTED|Overall Study||12
7661391|NCT02058368|18867561|P2|NOT COMPLETED|Overall Study||54
7661392|NCT02058368|18867562|P1|NOT COMPLETED|Overall Study||41
7661393|NCT02058368|18867561|P2|COMPLETED|Overall Study||251
7661394|NCT02058368|18867562|P1|COMPLETED|Overall Study||261
7661395|NCT02058368|18867561|P2|STARTED|Overall Study||305
7661396|NCT02058368|18867562|P1|STARTED|Overall Study||302
7661397|NCT02058290|18867614|P2|NOT COMPLETED|Overall Study||9
7661398|NCT02058290|18867615|P1|NOT COMPLETED|Overall Study||11
7661399|NCT02058290|18867614|P2|COMPLETED|Overall Study||36
7661400|NCT02058290|18867615|P1|COMPLETED|Overall Study||66
7661401|NCT02058290|18867614|P2|STARTED|Overall Study||45
7661402|NCT02058290|18867615|P1|STARTED|Overall Study||77
7661403|NCT02058251|18867631|P2|NOT COMPLETED|Overall Study||0
7661404|NCT02058251|18867632|P1|NOT COMPLETED|Overall Study||0
7661405|NCT02058251|18867631|P2|COMPLETED|Overall Study||38
7661406|NCT02058251|18867632|P1|COMPLETED|Overall Study||35
7661407|NCT02058251|18867631|P2|STARTED|Overall Study||38
7661408|NCT02058251|18867632|P1|STARTED|Overall Study||35
7661409|NCT02058160|18867642|P2|NOT COMPLETED|Overall Study||14
7661410|NCT02058160|18867643|P1|NOT COMPLETED|Overall Study||31
7661411|NCT02058160|18867642|P2|COMPLETED|Overall Study||355
7661412|NCT02058160|18867643|P1|COMPLETED|Overall Study||336
7661413|NCT02058160|18867642|P2|Treated|Overall Study||365
7661414|NCT02058160|18867643|P1|Treated|Overall Study||365
7661415|NCT02058160|18867642|P2|STARTED|Overall Study||369
7661416|NCT02058160|18867643|P1|STARTED|Overall Study||367
7661417|NCT02058147|18867680|P3|NOT COMPLETED|Overall Study||29
7661418|NCT02058147|18867681|P2|NOT COMPLETED|Overall Study||27
7661419|NCT02058147|18867682|P1|NOT COMPLETED|Overall Study||29
7661420|NCT02058147|18867680|P3|COMPLETED|Overall Study||205
7661421|NCT02058147|18867681|P2|COMPLETED|Overall Study||440
7661422|NCT02058147|18867682|P1|COMPLETED|Overall Study||440
7661423|NCT02058147|18867680|P3|Treated|Overall Study||233
7661424|NCT02058147|18867681|P2|Treated|Overall Study||467
7661425|NCT02058147|18867682|P1|Treated|Overall Study||469
7661426|NCT02058147|18867680|P3|STARTED|Overall Study||234
7661427|NCT02058147|18867681|P2|STARTED|Overall Study||467
7661428|NCT02058147|18867682|P1|STARTED|Overall Study||469
7661429|NCT02058108|18867733|P2|NOT COMPLETED|Overall Study||10
7661430|NCT02058108|18867734|P1|NOT COMPLETED|Overall Study||41
7661431|NCT02058108|18867733|P2|COMPLETED|Overall Study||0
7661432|NCT02058108|18867734|P1|COMPLETED|Overall Study||2
7661433|NCT02058108|18867733|P2|Switched to Telbivudine After Week 24|Overall Study||5
7661434|NCT02058108|18867734|P1|Switched to Telbivudine After Week 24|Overall Study||0
7661435|NCT02058108|18867733|P2|STARTED|Overall Study||10
7661436|NCT02058108|18867734|P1|STARTED|Overall Study||43
7661437|NCT02058095|18867760|P2|NOT COMPLETED|Overall Study||0
7661438|NCT02058095|18867761|P1|NOT COMPLETED|Overall Study||1
7661439|NCT02058095|18867760|P2|COMPLETED|Overall Study||7
7661440|NCT02058095|18867761|P1|COMPLETED|Overall Study||14
7661441|NCT02058095|18867760|P2|STARTED|Overall Study||7
7661442|NCT02058095|18867761|P1|STARTED|Overall Study||15
7661443|NCT02058069|18867771|P1|NOT COMPLETED|Overall Study||11
7661444|NCT02058069|18867771|P1|COMPLETED|Overall Study||89
7661445|NCT02058069|18867771|P1|STARTED|Overall Study||100
7661446|NCT02057952|18867783|P3|NOT COMPLETED|Overall Study||22
7661447|NCT02057952|18867784|P2|NOT COMPLETED|Overall Study||10
7661448|NCT02057952|18867785|P1|NOT COMPLETED|Overall Study||8
7661449|NCT02057952|18867783|P3|COMPLETED|Overall Study||28
7661450|NCT02057952|18867784|P2|COMPLETED|Overall Study||39
7661451|NCT02057952|18867785|P1|COMPLETED|Overall Study||43
7661452|NCT02057952|18867783|P3|STARTED|Overall Study||50
7661453|NCT02057952|18867784|P2|STARTED|Overall Study||49
7661454|NCT02057952|18867785|P1|STARTED|Overall Study||51
7661455|NCT02057939|18867820|P1|NOT COMPLETED|Overall Study||1
7661456|NCT02057939|18867820|P1|COMPLETED|Overall Study||37
7661457|NCT02057939|18867820|P1|STARTED|Overall Study||38
7661458|NCT02057874|18867830|P1|NOT COMPLETED|Overall Study||1
7661459|NCT02057874|18867830|P1|COMPLETED|Overall Study||1
7661460|NCT02057874|18867830|P1|STARTED|Overall Study||2
7661461|NCT02057835|18867848|P10|NOT COMPLETED|Overall Study||0
7661462|NCT02057835|18867849|P9|NOT COMPLETED|Overall Study||0
7661463|NCT02057835|18867850|P8|NOT COMPLETED|Overall Study||0
7661464|NCT02057835|18867851|P7|NOT COMPLETED|Overall Study||0
7661465|NCT02057835|18867852|P6|NOT COMPLETED|Overall Study||0
7661466|NCT02057835|18867853|P5|NOT COMPLETED|Overall Study||0
7661467|NCT02057835|18867854|P4|NOT COMPLETED|Overall Study||0
7661468|NCT02057835|18867855|P3|NOT COMPLETED|Overall Study||0
7661469|NCT02057835|18867856|P2|NOT COMPLETED|Overall Study||2
7661470|NCT02057835|18867857|P1|NOT COMPLETED|Overall Study||0
7661471|NCT02057835|18867848|P10|COMPLETED|Overall Study||6
7661472|NCT02057835|18867849|P9|COMPLETED|Overall Study||6
7661473|NCT02057835|18867850|P8|COMPLETED|Overall Study||6
7661474|NCT02057835|18867851|P7|COMPLETED|Overall Study||6
7661475|NCT02057835|18867852|P6|COMPLETED|Overall Study||8
7661476|NCT02057835|18867853|P5|COMPLETED|Overall Study||6
7661477|NCT02057835|18867854|P4|COMPLETED|Overall Study||6
7661478|NCT02057835|18867855|P3|COMPLETED|Overall Study||6
7661479|NCT02057835|18867856|P2|COMPLETED|Overall Study||4
7661480|NCT02057835|18867857|P1|COMPLETED|Overall Study||8
7661481|NCT02057835|18867848|P10|STARTED|Overall Study||6
7661482|NCT02057835|18867849|P9|STARTED|Overall Study||6
7661483|NCT02057835|18867850|P8|STARTED|Overall Study||6
7661484|NCT02057835|18867851|P7|STARTED|Overall Study||6
7661485|NCT02057835|18867852|P6|STARTED|Overall Study||8
7661486|NCT02057835|18867853|P5|STARTED|Overall Study||6
7661487|NCT02057835|18867854|P4|STARTED|Overall Study||6
7661488|NCT02057835|18867855|P3|STARTED|Overall Study||6
7661489|NCT02057835|18867856|P2|STARTED|Overall Study||6
7661490|NCT02057835|18867857|P1|STARTED|Overall Study||8
7661491|NCT02057757|18867936|P2|NOT COMPLETED|Overall Study||8
7661492|NCT02057757|18867937|P1|NOT COMPLETED|Overall Study||14
7661493|NCT02057757|18867936|P2|COMPLETED|Overall Study||121
7661494|NCT02057757|18867937|P1|COMPLETED|Overall Study||117
7661495|NCT02057757|18867936|P2|Intent to Treat|Overall Study||127
7661496|NCT02057757|18867937|P1|Intent to Treat|Overall Study||130
7661497|NCT02057757|18867936|P2|STARTED|Overall Study||129
7661498|NCT02057757|18867937|P1|STARTED|Overall Study||131
7661499|NCT02057692|18867991|P4|NOT COMPLETED|Overall Study||1
7661500|NCT02057692|18867992|P3|NOT COMPLETED|Overall Study||0
7661501|NCT02057692|18867993|P2|NOT COMPLETED|Overall Study||0
7661502|NCT02057692|18867994|P1|NOT COMPLETED|Overall Study||1
7661503|NCT02057692|18867991|P4|COMPLETED|Overall Study||11
7661504|NCT02057692|18867992|P3|COMPLETED|Overall Study||6
7661505|NCT02057692|18867993|P2|COMPLETED|Overall Study||11
7661506|NCT02057692|18867994|P1|COMPLETED|Overall Study||7
7661507|NCT02057692|18867991|P4|STARTED|Overall Study||12
7661508|NCT02057692|18867992|P3|STARTED|Overall Study||6
7661509|NCT02057692|18867993|P2|STARTED|Overall Study||11
7661510|NCT02057692|18867994|P1|STARTED|Overall Study||8
7661511|NCT02057640|18868024|P2|NOT COMPLETED|Phase II Portion of Study at DL2||0
7661512|NCT02057640|18868025|P1|NOT COMPLETED|Phase II Portion of Study at DL2||0
7661513|NCT02057640|18868024|P2|COMPLETED|Phase II Portion of Study at DL2||9
7661514|NCT02057640|18868025|P1|COMPLETED|Phase II Portion of Study at DL2||0
7661515|NCT02057640|18868024|P2|STARTED|Phase II Portion of Study at DL2||9
7661516|NCT02057640|18868025|P1|STARTED|Phase II Portion of Study at DL2||0
7661517|NCT02057640|18868024|P2|NOT COMPLETED|Weeks 1-4||0
7661518|NCT02057640|18868025|P1|NOT COMPLETED|Weeks 1-4||0
7661519|NCT02057640|18868024|P2|COMPLETED|Weeks 1-4||3
7661520|NCT02057640|18868025|P1|COMPLETED|Weeks 1-4||4
7661521|NCT02057640|18868024|P2|STARTED|Weeks 1-4||3
7661522|NCT02057640|18868025|P1|STARTED|Weeks 1-4|1 extra participant accidentally treated at DL1 (in addition to initial 3).|4
7661523|NCT02057575|18868040|P4|NOT COMPLETED|Overall Study||1
7661524|NCT02057575|18868041|P3|NOT COMPLETED|Overall Study||0
7661525|NCT02057575|18868042|P2|NOT COMPLETED|Overall Study||4
7661526|NCT02057575|18868043|P1|NOT COMPLETED|Overall Study||1
7661527|NCT02057575|18868040|P4|COMPLETED|Overall Study||72
7661528|NCT02057575|18868041|P3|COMPLETED|Overall Study||78
7661529|NCT02057575|18868042|P2|COMPLETED|Overall Study||69
7661530|NCT02057575|18868043|P1|COMPLETED|Overall Study||73
7661531|NCT02057575|18868040|P4|STARTED|Overall Study||73
7661532|NCT02057575|18868041|P3|STARTED|Overall Study||78
7661533|NCT02057575|18868042|P2|STARTED|Overall Study||73
7661534|NCT02057575|18868043|P1|STARTED|Overall Study||74
7661535|NCT02057549|18868055|P2|NOT COMPLETED|Overall Study||0
7661536|NCT02057549|18868056|P1|NOT COMPLETED|Overall Study||3
7661537|NCT02057549|18868055|P2|COMPLETED|Overall Study||18
7661538|NCT02057549|18868056|P1|COMPLETED|Overall Study||15
7661539|NCT02057549|18868055|P2|STARTED|Overall Study||18
7661540|NCT02057549|18868056|P1|STARTED|Overall Study||18
7661541|NCT02057523|18868076|P1|NOT COMPLETED|Overall Study||2
7661542|NCT02057523|18868076|P1|COMPLETED|Overall Study||0
7661543|NCT02057523|18868076|P1|STARTED|Overall Study||2
7661544|NCT02057458|18868081|P3|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
7661545|NCT02057458|18868082|P2|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
7661546|NCT02057458|18868083|P1|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||1
7661547|NCT02057458|18868081|P3|COMPLETED|Sub-Chronic Study (4 Weeks)||3
7661548|NCT02057458|18868082|P2|COMPLETED|Sub-Chronic Study (4 Weeks)||7
7661549|NCT02057458|18868083|P1|COMPLETED|Sub-Chronic Study (4 Weeks)||5
7661550|NCT02057458|18868081|P3|STARTED|Sub-Chronic Study (4 Weeks)||3
7661551|NCT02057458|18868082|P2|STARTED|Sub-Chronic Study (4 Weeks)||7
7661552|NCT02057458|18868083|P1|STARTED|Sub-Chronic Study (4 Weeks)||6
7661553|NCT02057458|18868081|P3|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
7661554|NCT02057458|18868082|P2|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
7661555|NCT02057458|18868083|P1|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
7661556|NCT02057458|18868081|P3|COMPLETED|Acute Study (1 Hour): Second Int.||0
7661557|NCT02057458|18868082|P2|COMPLETED|Acute Study (1 Hour): Second Int.||7
7661558|NCT02057458|18868083|P1|COMPLETED|Acute Study (1 Hour): Second Int.||6
7661559|NCT02057458|18868081|P3|STARTED|Acute Study (1 Hour): Second Int.||0
7661560|NCT02057458|18868082|P2|STARTED|Acute Study (1 Hour): Second Int.||7
7661561|NCT02057458|18868083|P1|STARTED|Acute Study (1 Hour): Second Int.||6
7661562|NCT02057458|18868081|P3|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
7661563|NCT02057458|18868082|P2|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
7661564|NCT02057458|18868083|P1|NOT COMPLETED|Acute Study (1 Hour): First Intervention||2
7661565|NCT02057458|18868081|P3|COMPLETED|Acute Study (1 Hour): First Intervention||0
7661566|NCT02057458|18868082|P2|COMPLETED|Acute Study (1 Hour): First Intervention||7
7661567|NCT02057458|18868083|P1|COMPLETED|Acute Study (1 Hour): First Intervention||6
7661568|NCT02057458|18868081|P3|STARTED|Acute Study (1 Hour): First Intervention||0
7661569|NCT02057458|18868082|P2|STARTED|Acute Study (1 Hour): First Intervention||7
7661570|NCT02057458|18868083|P1|STARTED|Acute Study (1 Hour): First Intervention||8
7661571|NCT02057458|18868081|P3|NOT COMPLETED|Met Inclusion Criteria||0
7661572|NCT02057458|18868082|P2|NOT COMPLETED|Met Inclusion Criteria||1
7661573|NCT02057458|18868083|P1|NOT COMPLETED|Met Inclusion Criteria||0
7661574|NCT02057458|18868081|P3|COMPLETED|Met Inclusion Criteria||3
7661575|NCT02057458|18868082|P2|COMPLETED|Met Inclusion Criteria||7
7661576|NCT02057458|18868083|P1|COMPLETED|Met Inclusion Criteria||8
7661577|NCT02057458|18868081|P3|STARTED|Met Inclusion Criteria||3
7661578|NCT02057458|18868082|P2|STARTED|Met Inclusion Criteria||8
7661579|NCT02057458|18868083|P1|STARTED|Met Inclusion Criteria||8
7661580|NCT02057458|18868081|P3|NOT COMPLETED|Recruited for Participation||0
7661581|NCT02057458|18868082|P2|NOT COMPLETED|Recruited for Participation||0
7661582|NCT02057458|18868083|P1|NOT COMPLETED|Recruited for Participation||0
7661583|NCT02057458|18868081|P3|COMPLETED|Recruited for Participation||3
7661584|NCT02057458|18868082|P2|COMPLETED|Recruited for Participation||8
7661585|NCT02057458|18868083|P1|COMPLETED|Recruited for Participation||8
7661586|NCT02057458|18868081|P3|STARTED|Recruited for Participation||3
7661587|NCT02057458|18868082|P2|STARTED|Recruited for Participation||8
7661588|NCT02057458|18868083|P1|STARTED|Recruited for Participation||8
7661589|NCT02057406|18868121|P3|NOT COMPLETED|Overall Study||4
7661590|NCT02057406|18868122|P2|NOT COMPLETED|Overall Study||3
7661591|NCT02057406|18868123|P1|NOT COMPLETED|Overall Study||1
7661592|NCT02057406|18868121|P3|COMPLETED|Overall Study||32
7661593|NCT02057406|18868122|P2|COMPLETED|Overall Study||33
7661594|NCT02057406|18868123|P1|COMPLETED|Overall Study||35
7661595|NCT02057406|18868121|P3|STARTED|Overall Study||36
7661596|NCT02057406|18868122|P2|STARTED|Overall Study||36
7661597|NCT02057406|18868123|P1|STARTED|Overall Study||36
7661598|NCT02057393|18868134|P1|NOT COMPLETED|Overall Study||2
7661599|NCT02057393|18868134|P1|COMPLETED|Overall Study||87
7661600|NCT02057393|18868134|P1|STARTED|Overall Study||89
7661601|NCT02057276|18868140|P2|NOT COMPLETED|Overall Study||0
7661602|NCT02057276|18868141|P1|NOT COMPLETED|Overall Study||0
7661603|NCT02057276|18868140|P2|COMPLETED|Overall Study||0
7661604|NCT02057276|18868141|P1|COMPLETED|Overall Study||0
7661605|NCT02057276|18868140|P2|STARTED|Overall Study||0
7661606|NCT02057276|18868141|P1|STARTED|Overall Study||0
7661607|NCT02057250|18868155|P5|NOT COMPLETED|Extension Phase||36
7661608|NCT02057250|18868156|P4|NOT COMPLETED|Extension Phase||0
7661609|NCT02057250|18868157|P3|NOT COMPLETED|Extension Phase||0
7661610|NCT02057250|18868158|P2|NOT COMPLETED|Extension Phase||0
7661611|NCT02057250|18868159|P1|NOT COMPLETED|Extension Phase||0
7661612|NCT02057250|18868155|P5|COMPLETED|Extension Phase||156
7661613|NCT02057250|18868156|P4|COMPLETED|Extension Phase||0
7661614|NCT02057250|18868157|P3|COMPLETED|Extension Phase||0
7661615|NCT02057250|18868158|P2|COMPLETED|Extension Phase||0
7661616|NCT02057250|18868159|P1|COMPLETED|Extension Phase||0
7661617|NCT02057250|18868155|P5|Treated|Extension Phase||188
7661618|NCT02057250|18868156|P4|Treated|Extension Phase||0
7661619|NCT02057250|18868157|P3|Treated|Extension Phase||0
7661620|NCT02057250|18868158|P2|Treated|Extension Phase||0
7661621|NCT02057250|18868159|P1|Treated|Extension Phase||0
7661622|NCT02057250|18868155|P5|STARTED|Extension Phase|9 participants who completed AID Assessment phase did not enter extension phase.|192
7661623|NCT02057250|18868156|P4|STARTED|Extension Phase||0
7661624|NCT02057250|18868157|P3|STARTED|Extension Phase||0
7661625|NCT02057250|18868158|P2|STARTED|Extension Phase||0
7661626|NCT02057250|18868159|P1|STARTED|Extension Phase||0
7661627|NCT02057250|18868155|P5|NOT COMPLETED|AID Assessment Phase||0
7661628|NCT02057250|18868156|P4|NOT COMPLETED|AID Assessment Phase||2
7661629|NCT02057250|18868157|P3|NOT COMPLETED|AID Assessment Phase||7
7661630|NCT02057250|18868158|P2|NOT COMPLETED|AID Assessment Phase||3
7661631|NCT02057250|18868159|P1|NOT COMPLETED|AID Assessment Phase||4
7661632|NCT02057250|18868155|P5|COMPLETED|AID Assessment Phase||0
7661633|NCT02057250|18868156|P4|COMPLETED|AID Assessment Phase||54
7661634|NCT02057250|18868157|P3|COMPLETED|AID Assessment Phase||45
7661635|NCT02057250|18868158|P2|COMPLETED|AID Assessment Phase||50
7661636|NCT02057250|18868159|P1|COMPLETED|AID Assessment Phase||52
7661637|NCT02057250|18868155|P5|STARTED|AID Assessment Phase||0
7661638|NCT02057250|18868156|P4|STARTED|AID Assessment Phase||56
7661639|NCT02057250|18868157|P3|STARTED|AID Assessment Phase||52
7661640|NCT02057250|18868158|P2|STARTED|AID Assessment Phase||53
7661641|NCT02057250|18868159|P1|STARTED|AID Assessment Phase||56
7661642|NCT02057237|18868172|P1|NOT COMPLETED|Overall Study||0
7661643|NCT02057237|18868172|P1|COMPLETED|Overall Study||1
7661644|NCT02057237|18868172|P1|STARTED|Overall Study||1
7661645|NCT02057198|18868180|P3|NOT COMPLETED|Overall Study||1
7661646|NCT02057198|18868181|P2|NOT COMPLETED|Overall Study||1
7661647|NCT02057198|18868182|P1|NOT COMPLETED|Overall Study||0
7661648|NCT02057198|18868180|P3|COMPLETED|Overall Study||10
7661649|NCT02057198|18868181|P2|COMPLETED|Overall Study||10
7661650|NCT02057198|18868182|P1|COMPLETED|Overall Study||11
7661651|NCT02057198|18868180|P3|STARTED|Overall Study||11
7661652|NCT02057198|18868181|P2|STARTED|Overall Study||11
7661653|NCT02057198|18868182|P1|STARTED|Overall Study||11
7661654|NCT02057081|18868207|P2|NOT COMPLETED|Overall Study||68
7661655|NCT02057081|18868208|P1|NOT COMPLETED|Overall Study||90
7661656|NCT02057081|18868207|P2|COMPLETED|Overall Study||44
7661657|NCT02057081|18868208|P1|COMPLETED|Overall Study||46
7661658|NCT02057081|18868207|P2|Post-Treatment Assessment|Overall Study||52
7661659|NCT02057081|18868208|P1|Post-Treatment Assessment|Overall Study||58
7661660|NCT02057081|18868207|P2|Completed Baseline|Overall Study||80
7661661|NCT02057081|18868208|P1|Completed Baseline|Overall Study||88
7661662|NCT02057081|18868207|P2|STARTED|Overall Study||112
7661663|NCT02057081|18868208|P1|STARTED|Overall Study||136
7661664|NCT02057068|18868218|P2|NOT COMPLETED|Overall Study||8
7661665|NCT02057068|18868219|P1|NOT COMPLETED|Overall Study||8
7661666|NCT02057068|18868218|P2|COMPLETED|Overall Study||28
7661667|NCT02057068|18868219|P1|COMPLETED|Overall Study||52
7661668|NCT02057068|18868218|P2|STARTED|Overall Study||36
7661669|NCT02057068|18868219|P1|STARTED|Overall Study||60
7661670|NCT02057042|18868231|P2|NOT COMPLETED|Overall Study||66
7661671|NCT02057042|18868232|P1|NOT COMPLETED|Overall Study||45
7661672|NCT02057042|18868231|P2|COMPLETED|Overall Study||101
7661673|NCT02057042|18868232|P1|COMPLETED|Overall Study||118
7661674|NCT02057042|18868231|P2|STARTED|Overall Study||167
7661675|NCT02057042|18868232|P1|STARTED|Overall Study||163
7661676|NCT02056834|18868248|P1|NOT COMPLETED|Overall Study||7
7661677|NCT02056834|18868248|P1|COMPLETED|Overall Study||29
7661678|NCT02056834|18868248|P1|6 Months|Overall Study||31
7661679|NCT02056834|18868248|P1|6 Weeks|Overall Study||34
7661680|NCT02056834|18868248|P1|STARTED|Overall Study||36
7661681|NCT02056652|18868269|P2|NOT COMPLETED|Overall Study||3
7661682|NCT02056652|18868270|P1|NOT COMPLETED|Overall Study||1
7661683|NCT02056652|18868269|P2|COMPLETED|Overall Study||58
7661684|NCT02056652|18868270|P1|COMPLETED|Overall Study||60
7661685|NCT02056652|18868269|P2|STARTED|Overall Study||61
7661686|NCT02056652|18868270|P1|STARTED|Overall Study||61
7661687|NCT02056639|18868288|P2|NOT COMPLETED|Overall Study||0
7661688|NCT02056639|18868289|P1|NOT COMPLETED|Overall Study||0
7661689|NCT02056639|18868288|P2|COMPLETED|Overall Study||23
7661690|NCT02056639|18868289|P1|COMPLETED|Overall Study||23
7661691|NCT02056639|18868288|P2|STARTED|Overall Study||23
7661692|NCT02056639|18868289|P1|STARTED|Overall Study||23
7661693|NCT02056626|18868307|P4|NOT COMPLETED|Overall Study||0
7661694|NCT02056626|18868308|P3|NOT COMPLETED|Overall Study||0
7661695|NCT02056626|18868309|P2|NOT COMPLETED|Overall Study||1
7661696|NCT02056626|18868310|P1|NOT COMPLETED|Overall Study||3
7661697|NCT02056626|18868307|P4|COMPLETED|Overall Study||14
7661698|NCT02056626|18868308|P3|COMPLETED|Overall Study||4
7661699|NCT02056626|18868309|P2|COMPLETED|Overall Study||12
7661700|NCT02056626|18868310|P1|COMPLETED|Overall Study||10
7661701|NCT02056626|18868307|P4|STARTED|Overall Study||14
7661702|NCT02056626|18868308|P3|STARTED|Overall Study||4
7661703|NCT02056626|18868309|P2|STARTED|Overall Study||13
7661704|NCT02056626|18868310|P1|STARTED|Overall Study||13
7661705|NCT02056431|18868330|P2|NOT COMPLETED|Overall Study||47
7661706|NCT02056431|18868331|P1|NOT COMPLETED|Overall Study||44
7661707|NCT02056431|18868330|P2|COMPLETED|Overall Study||619
7661708|NCT02056431|18868331|P1|COMPLETED|Overall Study||560
7661709|NCT02056431|18868330|P2|STARTED|Overall Study||666
7661710|NCT02056431|18868331|P1|STARTED|Overall Study||604
7661711|NCT02056392|18868345|P6|NOT COMPLETED|Overall Study||0
7661712|NCT02056392|18868346|P5|NOT COMPLETED|Overall Study||1
7661713|NCT02056392|18868347|P4|NOT COMPLETED|Overall Study||0
7661714|NCT02056392|18868348|P3|NOT COMPLETED|Overall Study||3
7661715|NCT02056392|18868349|P2|NOT COMPLETED|Overall Study||1
7661716|NCT02056392|18868350|P1|NOT COMPLETED|Overall Study||2
7661717|NCT02056392|18868345|P6|COMPLETED|Overall Study||9
7661718|NCT02056392|18868346|P5|COMPLETED|Overall Study||7
7661719|NCT02056392|18868347|P4|COMPLETED|Overall Study||9
7661720|NCT02056392|18868348|P3|COMPLETED|Overall Study||6
7661721|NCT02056392|18868349|P2|COMPLETED|Overall Study||8
7661722|NCT02056392|18868350|P1|COMPLETED|Overall Study||8
7661723|NCT02056392|18868345|P6|STARTED|Overall Study||9
7661724|NCT02056392|18868346|P5|STARTED|Overall Study||8
7661725|NCT02056392|18868347|P4|STARTED|Overall Study||9
7661726|NCT02056392|18868348|P3|STARTED|Overall Study||9
7661727|NCT02056392|18868349|P2|STARTED|Overall Study||9
7661728|NCT02056392|18868350|P1|STARTED|Overall Study||10
7661729|NCT02056340|18868387|P2|NOT COMPLETED|Overall Study||11
7661730|NCT02056340|18868388|P1|NOT COMPLETED|Overall Study||7
7661731|NCT02056340|18868387|P2|COMPLETED|Overall Study||46
7661732|NCT02056340|18868388|P1|COMPLETED|Overall Study||52
7661733|NCT02056340|18868387|P2|STARTED|Overall Study||57
7661734|NCT02056340|18868388|P1|STARTED|Overall Study||59
7661735|NCT02056301|18868398|P2|NOT COMPLETED|Overall Study||6
7661736|NCT02056301|18868399|P1|NOT COMPLETED|Overall Study||2
7661737|NCT02056301|18868398|P2|COMPLETED|Overall Study||23
7661738|NCT02056301|18868399|P1|COMPLETED|Overall Study||31
7661739|NCT02056301|18868398|P2|STARTED|Overall Study||29
7661740|NCT02056301|18868399|P1|STARTED|Overall Study||33
7661741|NCT02056171|18868411|P2|NOT COMPLETED|Overall Study||0
7661742|NCT02056171|18868412|P1|NOT COMPLETED|Overall Study||0
7661743|NCT02056171|18868411|P2|COMPLETED|Overall Study||3
7661744|NCT02056171|18868412|P1|COMPLETED|Overall Study||3
7661745|NCT02056171|18868411|P2|STARTED|Overall Study||3
7661746|NCT02056171|18868412|P1|STARTED|Overall Study||3
7661747|NCT02055976|18868431|P9|NOT COMPLETED|Overall Study||0
7661748|NCT02055976|18868432|P8|NOT COMPLETED|Overall Study||0
7661749|NCT02055976|18868433|P7|NOT COMPLETED|Overall Study||2
7661750|NCT02055976|18868434|P6|NOT COMPLETED|Overall Study||1
7661751|NCT02055976|18868435|P5|NOT COMPLETED|Overall Study||0
7661752|NCT02055976|18868436|P4|NOT COMPLETED|Overall Study||1
7661753|NCT02055976|18868437|P3|NOT COMPLETED|Overall Study||1
7661754|NCT02055976|18868438|P2|NOT COMPLETED|Overall Study||0
7661755|NCT02055976|18868439|P1|NOT COMPLETED|Overall Study||0
7661756|NCT02055976|18868431|P9|COMPLETED|Overall Study||23
7661757|NCT02055976|18868432|P8|COMPLETED|Overall Study||24
7661758|NCT02055976|18868433|P7|COMPLETED|Overall Study||23
7661759|NCT02055976|18868434|P6|COMPLETED|Overall Study||24
7661760|NCT02055976|18868435|P5|COMPLETED|Overall Study||22
7661761|NCT02055976|18868436|P4|COMPLETED|Overall Study||25
7661762|NCT02055976|18868437|P3|COMPLETED|Overall Study||23
7661763|NCT02055976|18868438|P2|COMPLETED|Overall Study||24
7661764|NCT02055976|18868439|P1|COMPLETED|Overall Study||25
7661765|NCT02055976|18868431|P9|STARTED|Overall Study||23
7661766|NCT02055976|18868432|P8|STARTED|Overall Study||24
7661767|NCT02055976|18868433|P7|STARTED|Overall Study||25
7661768|NCT02055976|18868434|P6|STARTED|Overall Study||25
7661769|NCT02055976|18868435|P5|STARTED|Overall Study||22
7661770|NCT02055976|18868436|P4|STARTED|Overall Study||26
7661771|NCT02055976|18868437|P3|STARTED|Overall Study||24
7661772|NCT02055976|18868438|P2|STARTED|Overall Study||24
7661773|NCT02055976|18868439|P1|STARTED|Overall Study||25
7661774|NCT02055898|18868860|P2|NOT COMPLETED|Second Intervention (5 Days)||0
7661775|NCT02055898|18868861|P1|NOT COMPLETED|Second Intervention (5 Days)||0
7661776|NCT02055898|18868860|P2|COMPLETED|Second Intervention (5 Days)||5
7661777|NCT02055898|18868861|P1|COMPLETED|Second Intervention (5 Days)||5
7661778|NCT02055898|18868860|P2|STARTED|Second Intervention (5 Days)||5
7661779|NCT02055898|18868861|P1|STARTED|Second Intervention (5 Days)||5
7661780|NCT02055898|18868860|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
7661781|NCT02055898|18868861|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
7661782|NCT02055898|18868860|P2|COMPLETED|Washout (at Least 14 Days)||5
7661783|NCT02055898|18868861|P1|COMPLETED|Washout (at Least 14 Days)||5
7661784|NCT02055898|18868860|P2|STARTED|Washout (at Least 14 Days)||5
7661785|NCT02055898|18868861|P1|STARTED|Washout (at Least 14 Days)||5
7661786|NCT02055898|18868860|P2|NOT COMPLETED|First Intervention (5 Days)||1
7661787|NCT02055898|18868861|P1|NOT COMPLETED|First Intervention (5 Days)||2
7661788|NCT02055898|18868860|P2|COMPLETED|First Intervention (5 Days)||5
7661789|NCT02055898|18868861|P1|COMPLETED|First Intervention (5 Days)||5
7661790|NCT02055898|18868860|P2|STARTED|First Intervention (5 Days)||6
7661791|NCT02055898|18868861|P1|STARTED|First Intervention (5 Days)||7
7661792|NCT02055820|18868883|P10|NOT COMPLETED|Phase II: Expansion||0
7661793|NCT02055820|18868884|P9|NOT COMPLETED|Phase II: Expansion||0
7661794|NCT02055820|18868885|P8|NOT COMPLETED|Phase II: Expansion||0
7661795|NCT02055820|18868886|P7|NOT COMPLETED|Phase II: Expansion||0
7661796|NCT02055820|18868887|P6|NOT COMPLETED|Phase II: Expansion||0
7661797|NCT02055820|18868888|P5|NOT COMPLETED|Phase II: Expansion||49
7661798|NCT02055820|18868889|P4|NOT COMPLETED|Phase II: Expansion||0
7661799|NCT02055820|18868890|P3|NOT COMPLETED|Phase II: Expansion||0
7661800|NCT02055820|18868891|P2|NOT COMPLETED|Phase II: Expansion||0
7661801|NCT02055820|18868892|P1|NOT COMPLETED|Phase II: Expansion||0
7661802|NCT02055820|18868883|P10|COMPLETED|Phase II: Expansion||0
7661803|NCT02055820|18868884|P9|COMPLETED|Phase II: Expansion||0
7661804|NCT02055820|18868885|P8|COMPLETED|Phase II: Expansion||0
7661805|NCT02055820|18868886|P7|COMPLETED|Phase II: Expansion||0
7661806|NCT02055820|18868887|P6|COMPLETED|Phase II: Expansion||0
7661807|NCT02055820|18868888|P5|COMPLETED|Phase II: Expansion||159
7661808|NCT02055820|18868889|P4|COMPLETED|Phase II: Expansion||0
7661809|NCT02055820|18868890|P3|COMPLETED|Phase II: Expansion||0
7661810|NCT02055820|18868891|P2|COMPLETED|Phase II: Expansion||0
7661811|NCT02055820|18868892|P1|COMPLETED|Phase II: Expansion||0
7661812|NCT02055820|18868883|P10|STARTED|Phase II: Expansion||0
7661813|NCT02055820|18868884|P9|STARTED|Phase II: Expansion||0
7661814|NCT02055820|18868885|P8|STARTED|Phase II: Expansion||0
7661815|NCT02055820|18868886|P7|STARTED|Phase II: Expansion||0
7661816|NCT02055820|18868887|P6|STARTED|Phase II: Expansion||0
7661817|NCT02055820|18868888|P5|STARTED|Phase II: Expansion||208
7661818|NCT02055820|18868889|P4|STARTED|Phase II: Expansion||0
7661819|NCT02055820|18868890|P3|STARTED|Phase II: Expansion||0
7661820|NCT02055820|18868891|P2|STARTED|Phase II: Expansion||0
7661821|NCT02055820|18868892|P1|STARTED|Phase II: Expansion||0
7661822|NCT02055820|18868883|P10|NOT COMPLETED|Phase I: Dose-Finding||0
7661823|NCT02055820|18868884|P9|NOT COMPLETED|Phase I: Dose-Finding||0
7661824|NCT02055820|18868885|P8|NOT COMPLETED|Phase I: Dose-Finding||0
7661825|NCT02055820|18868886|P7|NOT COMPLETED|Phase I: Dose-Finding||2
7661826|NCT02055820|18868887|P6|NOT COMPLETED|Phase I: Dose-Finding||2
7661827|NCT02055820|18868888|P5|NOT COMPLETED|Phase I: Dose-Finding||0
7661828|NCT02055820|18868889|P4|NOT COMPLETED|Phase I: Dose-Finding||3
7661829|NCT02055820|18868890|P3|NOT COMPLETED|Phase I: Dose-Finding||1
7661830|NCT02055820|18868891|P2|NOT COMPLETED|Phase I: Dose-Finding||0
7661831|NCT02055820|18868892|P1|NOT COMPLETED|Phase I: Dose-Finding||1
7661832|NCT02055820|18868883|P10|COMPLETED|Phase I: Dose-Finding||6
7661833|NCT02055820|18868884|P9|COMPLETED|Phase I: Dose-Finding||6
7661834|NCT02055820|18868885|P8|COMPLETED|Phase I: Dose-Finding||6
7661835|NCT02055820|18868886|P7|COMPLETED|Phase I: Dose-Finding||5
7661836|NCT02055820|18868887|P6|COMPLETED|Phase I: Dose-Finding||5
7661837|NCT02055820|18868888|P5|COMPLETED|Phase I: Dose-Finding||0
7661838|NCT02055820|18868889|P4|COMPLETED|Phase I: Dose-Finding||3
7661839|NCT02055820|18868890|P3|COMPLETED|Phase I: Dose-Finding||7
7661840|NCT02055820|18868891|P2|COMPLETED|Phase I: Dose-Finding||3
7661841|NCT02055820|18868892|P1|COMPLETED|Phase I: Dose-Finding||6
7661842|NCT02055820|18868883|P10|STARTED|Phase I: Dose-Finding||6
7661843|NCT02055820|18868884|P9|STARTED|Phase I: Dose-Finding||6
7661844|NCT02055820|18868885|P8|STARTED|Phase I: Dose-Finding||6
7661845|NCT02055820|18868886|P7|STARTED|Phase I: Dose-Finding||7
7661846|NCT02055820|18868887|P6|STARTED|Phase I: Dose-Finding||7
7661847|NCT02055820|18868888|P5|STARTED|Phase I: Dose-Finding||0
7661848|NCT02055820|18868889|P4|STARTED|Phase I: Dose-Finding||6
7661849|NCT02055820|18868890|P3|STARTED|Phase I: Dose-Finding||8
7661850|NCT02055820|18868891|P2|STARTED|Phase I: Dose-Finding||3
7661851|NCT02055820|18868892|P1|STARTED|Phase I: Dose-Finding||7
7661852|NCT02055638|18868996|P2|NOT COMPLETED|Overall Study||8
7661853|NCT02055638|18868997|P1|NOT COMPLETED|Overall Study||10
7661854|NCT02055638|18868996|P2|COMPLETED|Overall Study||40
7661855|NCT02055638|18868997|P1|COMPLETED|Overall Study||39
7661856|NCT02055638|18868996|P2|STARTED|Overall Study||48
7661857|NCT02055638|18868997|P1|STARTED|Overall Study||49
7661858|NCT02055547|18869003|P19|NOT COMPLETED|Overall Study||0
7661859|NCT02055547|18869004|P18|NOT COMPLETED|Overall Study||0
7661860|NCT02055547|18869005|P17|NOT COMPLETED|Overall Study||0
7661861|NCT02055547|18869006|P16|NOT COMPLETED|Overall Study||1
7661862|NCT02055547|18869007|P15|NOT COMPLETED|Overall Study||0
7661863|NCT02055547|18869008|P14|NOT COMPLETED|Overall Study||1
7661864|NCT02055547|18869009|P13|NOT COMPLETED|Overall Study||0
7661865|NCT02055547|18869010|P12|NOT COMPLETED|Overall Study||0
7661866|NCT02055547|18869011|P11|NOT COMPLETED|Overall Study||1
7661867|NCT02055547|18869012|P10|NOT COMPLETED|Overall Study||1
7661868|NCT02055547|18869013|P9|NOT COMPLETED|Overall Study||2
7661869|NCT02055547|18869014|P8|NOT COMPLETED|Overall Study||0
7661870|NCT02055547|18869015|P7|NOT COMPLETED|Overall Study||2
7661871|NCT02055547|18869016|P6|NOT COMPLETED|Overall Study||1
7661872|NCT02055547|18869017|P5|NOT COMPLETED|Overall Study||1
7661873|NCT02055547|18869018|P4|NOT COMPLETED|Overall Study||0
7661874|NCT02055547|18869019|P3|NOT COMPLETED|Overall Study||3
7661875|NCT02055547|18869020|P2|NOT COMPLETED|Overall Study||1
7661876|NCT02055547|18869021|P1|NOT COMPLETED|Overall Study||0
7661877|NCT02055547|18869003|P19|COMPLETED|Overall Study||2
7661878|NCT02055547|18869004|P18|COMPLETED|Overall Study||2
7661879|NCT02055547|18869005|P17|COMPLETED|Overall Study||2
7661880|NCT02055547|18869006|P16|COMPLETED|Overall Study||1
7661881|NCT02055547|18869007|P15|COMPLETED|Overall Study||2
7661882|NCT02055547|18869008|P14|COMPLETED|Overall Study||1
7661883|NCT02055547|18869009|P13|COMPLETED|Overall Study||2
7661884|NCT02055547|18869010|P12|COMPLETED|Overall Study||6
7661885|NCT02055547|18869011|P11|COMPLETED|Overall Study||5
7661886|NCT02055547|18869012|P10|COMPLETED|Overall Study||5
7661887|NCT02055547|18869013|P9|COMPLETED|Overall Study||4
7661888|NCT02055547|18869014|P8|COMPLETED|Overall Study||6
7661889|NCT02055547|18869015|P7|COMPLETED|Overall Study||0
7661890|NCT02055547|18869016|P6|COMPLETED|Overall Study||1
7661891|NCT02055547|18869017|P5|COMPLETED|Overall Study||1
7661892|NCT02055547|18869018|P4|COMPLETED|Overall Study||2
7661893|NCT02055547|18869019|P3|COMPLETED|Overall Study||2
7661894|NCT02055547|18869020|P2|COMPLETED|Overall Study||1
7661895|NCT02055547|18869021|P1|COMPLETED|Overall Study||2
7661896|NCT02055547|18869003|P19|STARTED|Overall Study||2
7661897|NCT02055547|18869004|P18|STARTED|Overall Study||2
7661898|NCT02055547|18869005|P17|STARTED|Overall Study||2
7661899|NCT02055547|18869006|P16|STARTED|Overall Study||2
7661900|NCT02055547|18869007|P15|STARTED|Overall Study||2
7661901|NCT02055547|18869008|P14|STARTED|Overall Study||2
7661902|NCT02055547|18869009|P13|STARTED|Overall Study||2
7661903|NCT02055547|18869010|P12|STARTED|Overall Study||6
7661904|NCT02055547|18869011|P11|STARTED|Overall Study||6
7661905|NCT02055547|18869012|P10|STARTED|Overall Study||6
7661906|NCT02055547|18869013|P9|STARTED|Overall Study||6
7661907|NCT02055547|18869014|P8|STARTED|Overall Study||6
7661908|NCT02055547|18869015|P7|STARTED|Overall Study||2
7661909|NCT02055547|18869016|P6|STARTED|Overall Study||2
7661910|NCT02055547|18869017|P5|STARTED|Overall Study||2
7661911|NCT02055547|18869018|P4|STARTED|Overall Study||2
7661912|NCT02055547|18869019|P3|STARTED|Overall Study||5
7661913|NCT02055547|18869020|P2|STARTED|Overall Study||2
7661914|NCT02055547|18869021|P1|STARTED|Overall Study||2
7661915|NCT02055430|18869170|P2|NOT COMPLETED|Overall Study||0
7661916|NCT02055430|18869171|P1|NOT COMPLETED|Overall Study||0
7661917|NCT02055430|18869170|P2|COMPLETED|Overall Study||45
7661918|NCT02055430|18869171|P1|COMPLETED|Overall Study||45
7661919|NCT02055430|18869170|P2|STARTED|Overall Study||45
7661920|NCT02055430|18869171|P1|STARTED|Overall Study||45
7661921|NCT02055404|18869177|P1|NOT COMPLETED|Overall Study||0
7661922|NCT02055404|18869177|P1|COMPLETED|Overall Study||3
7661923|NCT02055404|18869177|P1|STARTED|Overall Study||3
7661924|NCT02055365|18869190|P1|NOT COMPLETED|Overall Study||1
7661925|NCT02055365|18869190|P1|COMPLETED|Overall Study||9
7661926|NCT02055365|18869190|P1|STARTED|Overall Study||10
7661927|NCT02055352|18869203|P2|NOT COMPLETED|Overall Study||17
7661928|NCT02055352|18869204|P1|NOT COMPLETED|Overall Study||6
7661929|NCT02055352|18869203|P2|COMPLETED|Overall Study||96
7661930|NCT02055352|18869204|P1|COMPLETED|Overall Study||103
7661931|NCT02055352|18869203|P2|Per-Protocol Set (PPS)|Overall Study||111
7661932|NCT02055352|18869204|P1|Per-Protocol Set (PPS)|Overall Study||108
7661933|NCT02055352|18869203|P2|STARTED|Overall Study||113
7661934|NCT02055352|18869204|P1|STARTED|Overall Study||109
7661935|NCT02055118|18869221|P3|NOT COMPLETED|Overall Study||0
7661936|NCT02055118|18869222|P2|NOT COMPLETED|Overall Study||2
7661937|NCT02055118|18869223|P1|NOT COMPLETED|Overall Study||0
7661938|NCT02055118|18869221|P3|COMPLETED|Overall Study||9
7661939|NCT02055118|18869222|P2|COMPLETED|Overall Study||32
7661940|NCT02055118|18869223|P1|COMPLETED|Overall Study||15
7661941|NCT02055118|18869221|P3|STARTED|Overall Study||9
7661942|NCT02055118|18869222|P2|STARTED|Overall Study||34
7661943|NCT02055118|18869223|P1|STARTED|Overall Study||15
7661944|NCT02055053|18869282|P2|NOT COMPLETED|Overall Study||0
7661945|NCT02055053|18869283|P1|NOT COMPLETED|Overall Study||0
7661946|NCT02055053|18869282|P2|COMPLETED|Overall Study||35
7661947|NCT02055053|18869283|P1|COMPLETED|Overall Study||35
7661948|NCT02055053|18869282|P2|STARTED|Overall Study||35
7661949|NCT02055053|18869283|P1|STARTED|Overall Study||35
7661950|NCT02054910|18869293|P2|NOT COMPLETED|Overall Study||1
7661951|NCT02054910|18869294|P1|NOT COMPLETED|Overall Study||4
7661952|NCT02054910|18869293|P2|COMPLETED|Overall Study||0
7661953|NCT02054910|18869294|P1|COMPLETED|Overall Study||0
7661954|NCT02054910|18869293|P2|STARTED|Overall Study||1
7661955|NCT02054910|18869294|P1|STARTED|Overall Study||4
7661956|NCT02054897|18869313|P3|NOT COMPLETED|Overall Study||12
7661957|NCT02054897|18869314|P2|NOT COMPLETED|Overall Study||7
7661958|NCT02054897|18869315|P1|NOT COMPLETED|Overall Study||10
7661959|NCT02054897|18869313|P3|COMPLETED|Overall Study||117
7661960|NCT02054897|18869314|P2|COMPLETED|Overall Study||123
7661961|NCT02054897|18869315|P1|COMPLETED|Overall Study||119
7661962|NCT02054897|18869313|P3|Exposed|Overall Study||129
7661963|NCT02054897|18869314|P2|Exposed|Overall Study||130
7661964|NCT02054897|18869315|P1|Exposed|Overall Study||128
7661965|NCT02054897|18869313|P3|STARTED|Overall Study||129
7661966|NCT02054897|18869314|P2|STARTED|Overall Study||130
7661967|NCT02054897|18869315|P1|STARTED|Overall Study||129
7661968|NCT02054754|18869340|P6|NOT COMPLETED|Overall Study||0
7661969|NCT02054754|18869341|P5|NOT COMPLETED|Overall Study||0
7661970|NCT02054754|18869342|P4|NOT COMPLETED|Overall Study||0
7661971|NCT02054754|18869343|P3|NOT COMPLETED|Overall Study||0
7661972|NCT02054754|18869344|P2|NOT COMPLETED|Overall Study||0
7661973|NCT02054754|18869345|P1|NOT COMPLETED|Overall Study||0
7661974|NCT02054754|18869340|P6|COMPLETED|Overall Study||10
7661975|NCT02054754|18869341|P5|COMPLETED|Overall Study||6
7661976|NCT02054754|18869342|P4|COMPLETED|Overall Study||6
7661977|NCT02054754|18869343|P3|COMPLETED|Overall Study||6
7661978|NCT02054754|18869344|P2|COMPLETED|Overall Study||6
7661979|NCT02054754|18869345|P1|COMPLETED|Overall Study||6
7661980|NCT02054754|18869340|P6|STARTED|Overall Study||10
7661981|NCT02054754|18869341|P5|STARTED|Overall Study||6
7661982|NCT02054754|18869342|P4|STARTED|Overall Study||6
7661983|NCT02054754|18869343|P3|STARTED|Overall Study||6
7661984|NCT02054754|18869344|P2|STARTED|Overall Study||6
7661985|NCT02054754|18869345|P1|STARTED|Overall Study||6
7661986|NCT02054715|18869362|P2|NOT COMPLETED|Follow-up 2||19
7661987|NCT02054715|18869363|P1|NOT COMPLETED|Follow-up 2||19
7661988|NCT02054715|18869362|P2|COMPLETED|Follow-up 2||173
7661989|NCT02054715|18869363|P1|COMPLETED|Follow-up 2||192
7661990|NCT02054715|18869362|P2|STARTED|Follow-up 2||192
7661991|NCT02054715|18869363|P1|STARTED|Follow-up 2||211
7661992|NCT02054715|18869362|P2|NOT COMPLETED|Baseline/Follow-up 1||7
7661993|NCT02054715|18869363|P1|NOT COMPLETED|Baseline/Follow-up 1||8
7661994|NCT02054715|18869362|P2|COMPLETED|Baseline/Follow-up 1||192
7661995|NCT02054715|18869363|P1|COMPLETED|Baseline/Follow-up 1||211
7661996|NCT02054715|18869362|P2|STARTED|Baseline/Follow-up 1||199
7661997|NCT02054715|18869363|P1|STARTED|Baseline/Follow-up 1||219
7661998|NCT02054702|18869377|P2|NOT COMPLETED|Overall Study||12
7661999|NCT02054702|18869378|P1|NOT COMPLETED|Overall Study||24
7662000|NCT02054702|18869377|P2|COMPLETED|Overall Study||21
7662001|NCT02054702|18869378|P1|COMPLETED|Overall Study||40
7662002|NCT02054702|18869377|P2|STARTED|Overall Study||33
7662003|NCT02054702|18869378|P1|STARTED|Overall Study||64
7662004|NCT02054572|18869406|P1|NOT COMPLETED|Overall Study||0
7662005|NCT02054572|18869406|P1|COMPLETED|Overall Study||6
7662006|NCT02054572|18869406|P1|STARTED|Overall Study||6
7662007|NCT02054520|18869435|P6|NOT COMPLETED|Overall Study||3
7662008|NCT02054520|18869436|P5|NOT COMPLETED|Overall Study||5
7662009|NCT02054520|18869437|P4|NOT COMPLETED|Overall Study||6
7662010|NCT02054520|18869438|P3|NOT COMPLETED|Overall Study||6
7662011|NCT02054520|18869439|P2|NOT COMPLETED|Overall Study||5
7662012|NCT02054520|18869440|P1|NOT COMPLETED|Overall Study||9
7662013|NCT02054520|18869435|P6|COMPLETED|Overall Study||0
7662014|NCT02054520|18869436|P5|COMPLETED|Overall Study||0
7662015|NCT02054520|18869437|P4|COMPLETED|Overall Study||0
7662016|NCT02054520|18869438|P3|COMPLETED|Overall Study||0
7662017|NCT02054520|18869439|P2|COMPLETED|Overall Study||11
7662018|NCT02054520|18869440|P1|COMPLETED|Overall Study||2
7662019|NCT02054520|18869435|P6|STARTED|Overall Study||3
7662020|NCT02054520|18869436|P5|STARTED|Overall Study||5
7662021|NCT02054520|18869437|P4|STARTED|Overall Study||6
7662022|NCT02054520|18869438|P3|STARTED|Overall Study||6
7662023|NCT02054520|18869439|P2|STARTED|Overall Study||16
7662024|NCT02054520|18869440|P1|STARTED|Overall Study||11
7662025|NCT02054481|18869464|P4|NOT COMPLETED|Overall Study||1
7662026|NCT02054481|18869465|P3|NOT COMPLETED|Overall Study||2
7662027|NCT02054481|18869466|P2|NOT COMPLETED|Overall Study||2
7662028|NCT02054481|18869467|P1|NOT COMPLETED|Overall Study||4
7662029|NCT02054481|18869464|P4|COMPLETED|Overall Study||39
7662030|NCT02054481|18869465|P3|COMPLETED|Overall Study||40
7662031|NCT02054481|18869466|P2|COMPLETED|Overall Study||39
7662032|NCT02054481|18869467|P1|COMPLETED|Overall Study||39
7662033|NCT02054481|18869464|P4|STARTED|Overall Study||40
7662034|NCT02054481|18869465|P3|STARTED|Overall Study||42
7662035|NCT02054481|18869466|P2|STARTED|Overall Study||41
7662036|NCT02054481|18869467|P1|STARTED|Overall Study||43
7662037|NCT02054338|18869515|P2|NOT COMPLETED|Overall Study||501
7662038|NCT02054338|18869516|P1|NOT COMPLETED|Overall Study||503
7662039|NCT02054338|18869515|P2|COMPLETED|Overall Study||0
7662040|NCT02054338|18869516|P1|COMPLETED|Overall Study||0
7662041|NCT02054338|18869515|P2|STARTED|Overall Study||501
7662042|NCT02054338|18869516|P1|STARTED|Overall Study||503
7662043|NCT02054325|18869528|P2|NOT COMPLETED|Overall Study||5
7662044|NCT02054325|18869529|P1|NOT COMPLETED|Overall Study||8
7662045|NCT02054325|18869528|P2|COMPLETED|Overall Study||50
7662046|NCT02054325|18869529|P1|COMPLETED|Overall Study||43
7662047|NCT02054325|18869528|P2|STARTED|Overall Study||55
7662048|NCT02054325|18869529|P1|STARTED|Overall Study||51
7662049|NCT02054156|18869539|P2|NOT COMPLETED|Overall Study||81
7662050|NCT02054156|18869540|P1|NOT COMPLETED|Overall Study||75
7662051|NCT02054156|18869539|P2|COMPLETED|Overall Study||30
7662052|NCT02054156|18869540|P1|COMPLETED|Overall Study||35
7662053|NCT02054156|18869539|P2|STARTED|Overall Study||111
7662054|NCT02054156|18869540|P1|STARTED|Overall Study||110
7662055|NCT02054130|18869556|P4|NOT COMPLETED|Overall Study||22
7662056|NCT02054130|18869557|P3|NOT COMPLETED|Overall Study||15
7662057|NCT02054130|18869558|P2|NOT COMPLETED|Overall Study||11
7662058|NCT02054130|18869559|P1|NOT COMPLETED|Overall Study||8
7662059|NCT02054130|18869556|P4|COMPLETED|Overall Study||115
7662060|NCT02054130|18869557|P3|COMPLETED|Overall Study||122
7662061|NCT02054130|18869558|P2|COMPLETED|Overall Study||127
7662062|NCT02054130|18869559|P1|COMPLETED|Overall Study||130
7662063|NCT02054130|18869556|P4|STARTED|Overall Study||137
7662064|NCT02054130|18869557|P3|STARTED|Overall Study||137
7662065|NCT02054130|18869558|P2|STARTED|Overall Study||138
7662066|NCT02054130|18869559|P1|STARTED|Overall Study||138
7662067|NCT02053753|18869653|P2|NOT COMPLETED|Overall Study||8
7662068|NCT02053753|18869654|P1|NOT COMPLETED|Overall Study||7
7662069|NCT02053753|18869653|P2|COMPLETED|Overall Study||66
7662070|NCT02053753|18869654|P1|COMPLETED|Overall Study||65
7662071|NCT02053753|18869653|P2|Received Treatment|Overall Study||71
7662072|NCT02053753|18869654|P1|Received Treatment|Overall Study||71
7662073|NCT02053753|18869653|P2|STARTED|Overall Study||74
7662074|NCT02053753|18869654|P1|STARTED|Overall Study||72
7662075|NCT02053610|18869678|P2|NOT COMPLETED|Overall Study||67
7662076|NCT02053610|18869679|P1|NOT COMPLETED|Overall Study||42
7662077|NCT02053610|18869678|P2|COMPLETED|Overall Study|Completed=Completed Treatment|266
7662078|NCT02053610|18869679|P1|COMPLETED|Overall Study|Completed=Completed Treatment|288
7662079|NCT02053610|18869678|P2|Received Study Drug|Overall Study||331
7662080|NCT02053610|18869679|P1|Received Study Drug|Overall Study||326
7662081|NCT02053610|18869678|P2|STARTED|Overall Study||333
7662082|NCT02053610|18869679|P1|STARTED|Overall Study||330
7662083|NCT02053493|18869711|P2|NOT COMPLETED|Overall Study||1
7662084|NCT02053493|18869712|P1|NOT COMPLETED|Overall Study||1
7662085|NCT02053493|18869711|P2|COMPLETED|Overall Study||58
7662086|NCT02053493|18869712|P1|COMPLETED|Overall Study||50
7662087|NCT02053493|18869711|P2|STARTED|Overall Study||59
7662088|NCT02053493|18869712|P1|STARTED|Overall Study||51
7662089|NCT02053376|18869750|P1|NOT COMPLETED|Overall Study||0
7662090|NCT02053376|18869750|P1|COMPLETED|Overall Study||43
7662091|NCT02053376|18869750|P1|STARTED|Overall Study||43
7662092|NCT02053259|18869765|P4|NOT COMPLETED|Overall Study||0
7662093|NCT02053259|18869766|P3|NOT COMPLETED|Overall Study||0
7662094|NCT02053259|18869767|P2|NOT COMPLETED|Overall Study||0
7662095|NCT02053259|18869768|P1|NOT COMPLETED|Overall Study||0
7662096|NCT02053259|18869765|P4|COMPLETED|Overall Study||23
7662097|NCT02053259|18869766|P3|COMPLETED|Overall Study||24
7662098|NCT02053259|18869767|P2|COMPLETED|Overall Study||24
7662099|NCT02053259|18869768|P1|COMPLETED|Overall Study||25
7662100|NCT02053259|18869765|P4|STARTED|Overall Study||23
7662101|NCT02053259|18869766|P3|STARTED|Overall Study||24
7662102|NCT02053259|18869767|P2|STARTED|Overall Study||24
7662103|NCT02053259|18869768|P1|STARTED|Overall Study||25
7662104|NCT02053168|18869778|P1|NOT COMPLETED|Overall Study||3
7662105|NCT02053168|18869778|P1|COMPLETED|Overall Study||22
7662106|NCT02053168|18869778|P1|STARTED|Overall Study||25
7662107|NCT02052895|18869795|P3|NOT COMPLETED|Overall Study||0
7662108|NCT02052895|18869796|P2|NOT COMPLETED|Overall Study||0
7662109|NCT02052895|18869797|P1|NOT COMPLETED|Overall Study||0
7662110|NCT02052895|18869795|P3|COMPLETED|Overall Study||15
7662111|NCT02052895|18869796|P2|COMPLETED|Overall Study||15
7662112|NCT02052895|18869797|P1|COMPLETED|Overall Study||196
7662113|NCT02052895|18869795|P3|STARTED|Overall Study||15
7662114|NCT02052895|18869796|P2|STARTED|Overall Study||15
7662115|NCT02052895|18869797|P1|STARTED|Overall Study||196
7662116|NCT02052752|18869807|P3|NOT COMPLETED|Overall Study||0
7662117|NCT02052752|18869808|P2|NOT COMPLETED|Overall Study||0
7662118|NCT02052752|18869809|P1|NOT COMPLETED|Overall Study||0
7662119|NCT02052752|18869807|P3|COMPLETED|Overall Study||30
7662120|NCT02052752|18869808|P2|COMPLETED|Overall Study||30
7662121|NCT02052752|18869809|P1|COMPLETED|Overall Study||30
7662122|NCT02052752|18869807|P3|STARTED|Overall Study||30
7662123|NCT02052752|18869808|P2|STARTED|Overall Study||30
7662124|NCT02052752|18869809|P1|STARTED|Overall Study||30
7662125|NCT02052661|18869832|P1|NOT COMPLETED|Overall Study||0
7662126|NCT02052661|18869832|P1|COMPLETED|Overall Study||300
7662127|NCT02052661|18869832|P1|STARTED|Overall Study||300
7662128|NCT02052635|18869846|P2|NOT COMPLETED|Overall Study||0
7662129|NCT02052635|18869847|P1|NOT COMPLETED|Overall Study||0
7662130|NCT02052635|18869846|P2|COMPLETED|Overall Study||6
7662131|NCT02052635|18869847|P1|COMPLETED|Overall Study||7
7662132|NCT02052635|18869846|P2|STARTED|Overall Study||6
7662133|NCT02052635|18869847|P1|STARTED|Overall Study||7
7662134|NCT02052596|18869857|P2|NOT COMPLETED|Safety Phase||35
7662135|NCT02052596|18869858|P1|NOT COMPLETED|Safety Phase||27
7662136|NCT02052596|18869857|P2|COMPLETED|Safety Phase||383
7662137|NCT02052596|18869858|P1|COMPLETED|Safety Phase||385
7662138|NCT02052596|18869857|P2|STARTED|Safety Phase||418
7662139|NCT02052596|18869858|P1|STARTED|Safety Phase||412
7662140|NCT02052596|18869857|P2|NOT COMPLETED|Active Phase||20
7662141|NCT02052596|18869858|P1|NOT COMPLETED|Active Phase||16
7662142|NCT02052596|18869857|P2|COMPLETED|Active Phase||398
7662143|NCT02052596|18869858|P1|COMPLETED|Active Phase||396
7662144|NCT02052596|18869857|P2|STARTED|Active Phase||418
7662145|NCT02052596|18869858|P1|STARTED|Active Phase||412
7662146|NCT02052544|18869883|P1|NOT COMPLETED|Overall Study||0
7662147|NCT02052544|18869883|P1|COMPLETED|Overall Study|Last Subject Out|123
7662148|NCT02052544|18869883|P1|STARTED|Overall Study|First Subject In|123
7662149|NCT02052466|18869888|P1|NOT COMPLETED|Overall Study||2
7662150|NCT02052466|18869888|P1|COMPLETED|Overall Study||30
7662151|NCT02052466|18869888|P1|STARTED|Overall Study||32
7662152|NCT02052440|18869905|P2|NOT COMPLETED|Overall Study||1
7662153|NCT02052440|18869906|P1|NOT COMPLETED|Overall Study||0
7662154|NCT02052440|18869905|P2|COMPLETED|Overall Study||51
7662155|NCT02052440|18869906|P1|COMPLETED|Overall Study||50
7662156|NCT02052440|18869905|P2|STARTED|Overall Study||52
7662157|NCT02052440|18869906|P1|STARTED|Overall Study||50
7662158|NCT02052414|18869918|P1|NOT COMPLETED|Overall Study||17
7662159|NCT02052414|18869918|P1|COMPLETED|Overall Study||17
7662160|NCT02052414|18869918|P1|STARTED|Overall Study||34
7662161|NCT02052141|18869928|P2|NOT COMPLETED|Intervention Period 2||0
7662162|NCT02052141|18869929|P1|NOT COMPLETED|Intervention Period 2||0
7662163|NCT02052141|18869928|P2|COMPLETED|Intervention Period 2||7
7662164|NCT02052141|18869929|P1|COMPLETED|Intervention Period 2||5
7662165|NCT02052141|18869928|P2|STARTED|Intervention Period 2||7
7662166|NCT02052141|18869929|P1|STARTED|Intervention Period 2||5
7662167|NCT02052141|18869928|P2|NOT COMPLETED|Intervention Period 1||0
7662168|NCT02052141|18869929|P1|NOT COMPLETED|Intervention Period 1||0
7662169|NCT02052141|18869928|P2|COMPLETED|Intervention Period 1||7
7662170|NCT02052141|18869929|P1|COMPLETED|Intervention Period 1||5
7662171|NCT02052141|18869928|P2|STARTED|Intervention Period 1||7
7662172|NCT02052141|18869929|P1|STARTED|Intervention Period 1||5
7662173|NCT02052011|18869953|P2|NOT COMPLETED|Overall Study||2
7662174|NCT02052011|18869954|P1|NOT COMPLETED|Overall Study||4
7662175|NCT02052011|18869953|P2|COMPLETED|Overall Study||8
7662176|NCT02052011|18869954|P1|COMPLETED|Overall Study||17
7662177|NCT02052011|18869953|P2|STARTED|Overall Study||10
7662178|NCT02052011|18869954|P1|STARTED|Overall Study||21
7662179|NCT02051816|18869964|P4|NOT COMPLETED|Overall Study||0
7662180|NCT02051816|18869965|P3|NOT COMPLETED|Overall Study||0
7662181|NCT02051816|18869966|P2|NOT COMPLETED|Overall Study||0
7662182|NCT02051816|18869967|P1|NOT COMPLETED|Overall Study||0
7662183|NCT02051816|18869964|P4|COMPLETED|Overall Study||36
7662184|NCT02051816|18869965|P3|COMPLETED|Overall Study||37
7662185|NCT02051816|18869966|P2|COMPLETED|Overall Study||40
7662186|NCT02051816|18869967|P1|COMPLETED|Overall Study||37
7662187|NCT02051816|18869964|P4|STARTED|Overall Study||36
7662188|NCT02051816|18869965|P3|STARTED|Overall Study||37
7662189|NCT02051816|18869966|P2|STARTED|Overall Study||40
7662190|NCT02051816|18869967|P1|STARTED|Overall Study||37
7662191|NCT02051790|18870005|P1|NOT COMPLETED|Overall Study||0
7662192|NCT02051790|18870005|P1|COMPLETED|Overall Study||241
7662193|NCT02051790|18870005|P1|STARTED|Overall Study||241
7662194|NCT02051764|18870011|P2|NOT COMPLETED|Overall Study||7
7662195|NCT02051764|18870012|P1|NOT COMPLETED|Overall Study||0
7662196|NCT02051764|18870011|P2|COMPLETED|Overall Study||21
7662197|NCT02051764|18870012|P1|COMPLETED|Overall Study||16
7662198|NCT02051764|18870011|P2|STARTED|Overall Study||28
7662199|NCT02051764|18870012|P1|STARTED|Overall Study||16
7662200|NCT02051686|18870020|P2|NOT COMPLETED|Overall Study||0
7662201|NCT02051686|18870021|P1|NOT COMPLETED|Overall Study||0
7662202|NCT02051686|18870020|P2|COMPLETED|Overall Study||46
7662203|NCT02051686|18870021|P1|COMPLETED|Overall Study||42
7662204|NCT02051686|18870020|P2|STARTED|Overall Study||46
7662205|NCT02051686|18870021|P1|STARTED|Overall Study||42
7662206|NCT02051595|18870029|P1|NOT COMPLETED|Overall Study||0
7662207|NCT02051595|18870029|P1|COMPLETED|Overall Study||25
7662208|NCT02051595|18870029|P1|STARTED|Overall Study||25
7662209|NCT02051452|18870035|P2|NOT COMPLETED|Overall Study||0
7662210|NCT02051452|18870036|P1|NOT COMPLETED|Overall Study||0
7662211|NCT02051452|18870035|P2|COMPLETED|Overall Study||16
7662212|NCT02051452|18870036|P1|COMPLETED|Overall Study||16
7662213|NCT02051452|18870035|P2|STARTED|Overall Study||16
7662214|NCT02051452|18870036|P1|STARTED|Overall Study||16
7662215|NCT02051426|18870048|P2|NOT COMPLETED|Second Intervention||0
7662216|NCT02051426|18870049|P1|NOT COMPLETED|Second Intervention||0
7662217|NCT02051426|18870048|P2|COMPLETED|Second Intervention||19
7662218|NCT02051426|18870049|P1|COMPLETED|Second Intervention||16
7662219|NCT02051426|18870048|P2|STARTED|Second Intervention||19
7662220|NCT02051426|18870049|P1|STARTED|Second Intervention||16
7662221|NCT02051426|18870048|P2|NOT COMPLETED|Washout Period of 1 Month||0
7662222|NCT02051426|18870049|P1|NOT COMPLETED|Washout Period of 1 Month||0
7662223|NCT02051426|18870048|P2|COMPLETED|Washout Period of 1 Month||19
7662224|NCT02051426|18870049|P1|COMPLETED|Washout Period of 1 Month||16
7662225|NCT02051426|18870048|P2|STARTED|Washout Period of 1 Month||19
7662226|NCT02051426|18870049|P1|STARTED|Washout Period of 1 Month||16
7662227|NCT02051426|18870048|P2|NOT COMPLETED|First Intervention||0
7662228|NCT02051426|18870049|P1|NOT COMPLETED|First Intervention||0
7662229|NCT02051426|18870048|P2|COMPLETED|First Intervention||19
7662230|NCT02051426|18870049|P1|COMPLETED|First Intervention||16
7662231|NCT02051426|18870048|P2|STARTED|First Intervention||19
7662232|NCT02051426|18870049|P1|STARTED|First Intervention||16
7662233|NCT02051335|18870063|P4|NOT COMPLETED|Period 4||0
7662234|NCT02051335|18870064|P3|NOT COMPLETED|Period 4||0
7662235|NCT02051335|18870065|P2|NOT COMPLETED|Period 4||0
7662236|NCT02051335|18870066|P1|NOT COMPLETED|Period 4||0
7662237|NCT02051335|18870063|P4|COMPLETED|Period 4||4
7662238|NCT02051335|18870064|P3|COMPLETED|Period 4||5
7662239|NCT02051335|18870065|P2|COMPLETED|Period 4||7
7662240|NCT02051335|18870066|P1|COMPLETED|Period 4||7
7662241|NCT02051335|18870063|P4|STARTED|Period 4||4
7662242|NCT02051335|18870064|P3|STARTED|Period 4||5
7662243|NCT02051335|18870065|P2|STARTED|Period 4||7
7662244|NCT02051335|18870066|P1|STARTED|Period 4||7
7662245|NCT02051335|18870063|P4|NOT COMPLETED|Period 3||0
7662246|NCT02051335|18870064|P3|NOT COMPLETED|Period 3||0
7662247|NCT02051335|18870065|P2|NOT COMPLETED|Period 3||0
7662248|NCT02051335|18870066|P1|NOT COMPLETED|Period 3||0
7662249|NCT02051335|18870063|P4|COMPLETED|Period 3||4
7662250|NCT02051335|18870064|P3|COMPLETED|Period 3||5
7662251|NCT02051335|18870065|P2|COMPLETED|Period 3||7
7662252|NCT02051335|18870066|P1|COMPLETED|Period 3||7
7662253|NCT02051335|18870063|P4|STARTED|Period 3||4
7662254|NCT02051335|18870064|P3|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5
7662255|NCT02051335|18870065|P2|STARTED|Period 3||7
7662256|NCT02051335|18870066|P1|STARTED|Period 3||7
7662257|NCT02051335|18870063|P4|NOT COMPLETED|Period 2||0
7662258|NCT02051335|18870064|P3|NOT COMPLETED|Period 2||0
7662259|NCT02051335|18870065|P2|NOT COMPLETED|Period 2||0
7662260|NCT02051335|18870066|P1|NOT COMPLETED|Period 2||0
7662261|NCT02051335|18870063|P4|COMPLETED|Period 2||4
7662262|NCT02051335|18870064|P3|COMPLETED|Period 2||7
7662263|NCT02051335|18870065|P2|COMPLETED|Period 2||7
7662264|NCT02051335|18870066|P1|COMPLETED|Period 2||7
7662265|NCT02051335|18870063|P4|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4
7662266|NCT02051335|18870064|P3|STARTED|Period 2||7
7662267|NCT02051335|18870065|P2|STARTED|Period 2||7
7662268|NCT02051335|18870066|P1|STARTED|Period 2||7
7662269|NCT02051335|18870063|P4|NOT COMPLETED|Period 1||0
7662270|NCT02051335|18870064|P3|NOT COMPLETED|Period 1||0
7662271|NCT02051335|18870065|P2|NOT COMPLETED|Period 1||0
7662272|NCT02051335|18870066|P1|NOT COMPLETED|Period 1||0
7662273|NCT02051335|18870063|P4|COMPLETED|Period 1||6
7662274|NCT02051335|18870064|P3|COMPLETED|Period 1||7
7662275|NCT02051335|18870065|P2|COMPLETED|Period 1||7
7662276|NCT02051335|18870066|P1|COMPLETED|Period 1||7
7662277|NCT02051335|18870063|P4|STARTED|Period 1||6
7662278|NCT02051335|18870064|P3|STARTED|Period 1||7
7662279|NCT02051335|18870065|P2|STARTED|Period 1||7
7662280|NCT02051335|18870066|P1|STARTED|Period 1||7
7662281|NCT02051296|18870118|P2|NOT COMPLETED|Overall Study||9
7662282|NCT02051296|18870119|P1|NOT COMPLETED|Overall Study||8
7662283|NCT02051296|18870118|P2|COMPLETED|Overall Study||56
7662284|NCT02051296|18870119|P1|COMPLETED|Overall Study||58
7662285|NCT02051296|18870118|P2|Received Allocated Intervention|Overall Study||58
7662286|NCT02051296|18870119|P1|Received Allocated Intervention|Overall Study||59
7662287|NCT02051296|18870118|P2|STARTED|Overall Study||65
7662288|NCT02051296|18870119|P1|STARTED|Overall Study||66
7662289|NCT02050919|18870125|P1|NOT COMPLETED|Overall Study||0
7662290|NCT02050919|18870125|P1|COMPLETED|Overall Study||20
7662291|NCT02050919|18870125|P1|STARTED|Overall Study||20
7662292|NCT02050841|18870129|P1|NOT COMPLETED|Overall Study||1
7662293|NCT02050841|18870129|P1|COMPLETED|Overall Study||49
7662294|NCT02050841|18870129|P1|STARTED|Overall Study||50
7662295|NCT02050334|18870170|P2|NOT COMPLETED|Overall Study||0
7662296|NCT02050334|18870171|P1|NOT COMPLETED|Overall Study||0
7662297|NCT02050334|18870170|P2|COMPLETED|Overall Study||9
7662298|NCT02050334|18870171|P1|COMPLETED|Overall Study||9
7662299|NCT02050334|18870170|P2|STARTED|Overall Study||9
7662300|NCT02050334|18870171|P1|STARTED|Overall Study||9
7662301|NCT02050321|18870179|P1|NOT COMPLETED|Overall Study||2
7662302|NCT02050321|18870179|P1|COMPLETED|Overall Study||0
7662303|NCT02050321|18870179|P1|STARTED|Overall Study||2
7662304|NCT02050308|18870186|P2|NOT COMPLETED|Overall Study||102
7662305|NCT02050308|18870187|P1|NOT COMPLETED|Overall Study||99
7662306|NCT02050308|18870186|P2|COMPLETED|Overall Study||22
7662307|NCT02050308|18870187|P1|COMPLETED|Overall Study||28
7662308|NCT02050308|18870186|P2|STARTED|Overall Study||124
7662309|NCT02050308|18870187|P1|STARTED|Overall Study||127
7662310|NCT02050048|18870195|P2|NOT COMPLETED|Overall Study||2
7662311|NCT02050048|18870196|P1|NOT COMPLETED|Overall Study||5
7662312|NCT02050048|18870195|P2|COMPLETED|Overall Study||10
7662313|NCT02050048|18870196|P1|COMPLETED|Overall Study||9
7662314|NCT02050048|18870195|P2|STARTED|Overall Study||12
7662315|NCT02050048|18870196|P1|STARTED|Overall Study||14
7662316|NCT02049957|18870211|P9|NOT COMPLETED|Overall Study||8
7662317|NCT02049957|18870212|P8|NOT COMPLETED|Overall Study||35
7662318|NCT02049957|18870213|P7|NOT COMPLETED|Overall Study||8
7662319|NCT02049957|18870214|P6|NOT COMPLETED|Overall Study||43
7662320|NCT02049957|18870215|P5|NOT COMPLETED|Overall Study||6
7662321|NCT02049957|18870216|P4|NOT COMPLETED|Overall Study||3
7662322|NCT02049957|18870217|P3|NOT COMPLETED|Overall Study||3
7662323|NCT02049957|18870218|P2|NOT COMPLETED|Overall Study||6
7662324|NCT02049957|18870219|P1|NOT COMPLETED|Overall Study||6
7662325|NCT02049957|18870211|P9|COMPLETED|Overall Study||0
7662326|NCT02049957|18870212|P8|COMPLETED|Overall Study||0
7662327|NCT02049957|18870213|P7|COMPLETED|Overall Study||0
7662328|NCT02049957|18870214|P6|COMPLETED|Overall Study||0
7662329|NCT02049957|18870215|P5|COMPLETED|Overall Study||0
7662330|NCT02049957|18870216|P4|COMPLETED|Overall Study||0
7662331|NCT02049957|18870217|P3|COMPLETED|Overall Study||0
7662332|NCT02049957|18870218|P2|COMPLETED|Overall Study||0
7662333|NCT02049957|18870219|P1|COMPLETED|Overall Study||0
7662334|NCT02049957|18870211|P9|STARTED|Overall Study||8
7662335|NCT02049957|18870212|P8|STARTED|Overall Study||35
7662336|NCT02049957|18870213|P7|STARTED|Overall Study||8
7662337|NCT02049957|18870214|P6|STARTED|Overall Study||43
7662338|NCT02049957|18870215|P5|STARTED|Overall Study||6
7662339|NCT02049957|18870216|P4|STARTED|Overall Study||3
7662340|NCT02049957|18870217|P3|STARTED|Overall Study||3
7662341|NCT02049957|18870218|P2|STARTED|Overall Study||6
7662342|NCT02049957|18870219|P1|STARTED|Overall Study||6
7662343|NCT02049931|18870287|P3|NOT COMPLETED|Overall Study||3
7662344|NCT02049931|18870288|P2|NOT COMPLETED|Overall Study||5
7662345|NCT02049931|18870289|P1|NOT COMPLETED|Overall Study||3
7662346|NCT02049931|18870287|P3|COMPLETED|Overall Study||17
7662347|NCT02049931|18870288|P2|COMPLETED|Overall Study||15
7662348|NCT02049931|18870289|P1|COMPLETED|Overall Study||17
7662349|NCT02049931|18870287|P3|STARTED|Overall Study||20
7662350|NCT02049931|18870288|P2|STARTED|Overall Study||20
7662351|NCT02049931|18870289|P1|STARTED|Overall Study||20
7662352|NCT02049814|18870311|P2|NOT COMPLETED|Overall Study||27
7662353|NCT02049814|18870312|P1|NOT COMPLETED|Overall Study||29
7662354|NCT02049814|18870311|P2|COMPLETED|Overall Study||219
7662355|NCT02049814|18870312|P1|COMPLETED|Overall Study||219
7662356|NCT02049814|18870311|P2|Safety Set|Overall Study||245
7662357|NCT02049814|18870312|P1|Safety Set|Overall Study||248
7662358|NCT02049814|18870311|P2|STARTED|Overall Study||246
7662359|NCT02049814|18870312|P1|STARTED|Overall Study||248
7662360|NCT02049749|18870340|P2|NOT COMPLETED|Overall Study||0
7662361|NCT02049749|18870341|P1|NOT COMPLETED|Overall Study||0
7662362|NCT02049749|18870340|P2|COMPLETED|Overall Study|80 children plus 80 caregivers|160
7662363|NCT02049749|18870341|P1|COMPLETED|Overall Study||80
7662364|NCT02049749|18870340|P2|STARTED|Overall Study|80 children plus 80 caregivers|160
7662365|NCT02049749|18870341|P1|STARTED|Overall Study|40 children plus 40 caregivers|80
7662366|NCT02049502|18870349|P1|NOT COMPLETED|Overall Study||0
7662367|NCT02049502|18870349|P1|COMPLETED|Overall Study||8
7662368|NCT02049502|18870349|P1|STARTED|Overall Study||8
7662369|NCT02049476|18870354|P1|NOT COMPLETED|Overall Study||0
7662370|NCT02049476|18870354|P1|COMPLETED|Overall Study|20th patient completed the study|20
7662371|NCT02049476|18870354|P1|STARTED|Overall Study|First patient enrolled on 1/31/2014|20
7662372|NCT02049450|18870361|P1|NOT COMPLETED|Overall Study||4
7662373|NCT02049450|18870361|P1|COMPLETED|Overall Study|Completed = Completed Core phase of study|26
7662374|NCT02049450|18870361|P1|Entered Extension Phase|Overall Study|Of 26 who completed Core phase 18 moved into Ext. phase; All 18 eventually discontinued Ext. phase|18
7662375|NCT02049450|18870361|P1|Discontinued Treatment Prior to Week 30|Overall Study||4
7662376|NCT02049450|18870361|P1|STARTED|Overall Study||30
7662377|NCT02049437|18870377|P2|NOT COMPLETED|Washout 2||0
7662378|NCT02049437|18870378|P1|NOT COMPLETED|Washout 2||0
7662379|NCT02049437|18870377|P2|COMPLETED|Washout 2||16
7662380|NCT02049437|18870378|P1|COMPLETED|Washout 2||15
7662381|NCT02049437|18870377|P2|STARTED|Washout 2||16
7662382|NCT02049437|18870378|P1|STARTED|Washout 2||15
7662383|NCT02049437|18870377|P2|NOT COMPLETED|Period 2||0
7662384|NCT02049437|18870378|P1|NOT COMPLETED|Period 2||0
7662385|NCT02049437|18870377|P2|COMPLETED|Period 2||16
7662386|NCT02049437|18870378|P1|COMPLETED|Period 2||15
7662387|NCT02049437|18870377|P2|STARTED|Period 2||16
7662388|NCT02049437|18870378|P1|STARTED|Period 2||15
7662389|NCT02049437|18870377|P2|NOT COMPLETED|Washout 1||0
7662390|NCT02049437|18870378|P1|NOT COMPLETED|Washout 1||0
7662391|NCT02049437|18870377|P2|COMPLETED|Washout 1||16
7662392|NCT02049437|18870378|P1|COMPLETED|Washout 1||15
7662393|NCT02049437|18870377|P2|STARTED|Washout 1||16
7662394|NCT02049437|18870378|P1|STARTED|Washout 1||15
7662395|NCT02049437|18870377|P2|NOT COMPLETED|Period 1||1
7662396|NCT02049437|18870378|P1|NOT COMPLETED|Period 1||2
7662397|NCT02049437|18870377|P2|COMPLETED|Period 1|Dropout due to low trough levels|16
7662398|NCT02049437|18870378|P1|COMPLETED|Period 1||15
7662399|NCT02049437|18870377|P2|STARTED|Period 1||17
7662400|NCT02049437|18870378|P1|STARTED|Period 1||17
7662401|NCT02049385|18870388|P2|NOT COMPLETED|Second Intervention||2
7662402|NCT02049385|18870389|P1|NOT COMPLETED|Second Intervention||0
7662403|NCT02049385|18870388|P2|COMPLETED|Second Intervention||0
7662404|NCT02049385|18870389|P1|COMPLETED|Second Intervention||1
7662405|NCT02049385|18870388|P2|STARTED|Second Intervention||2
7662406|NCT02049385|18870389|P1|STARTED|Second Intervention||1
7662407|NCT02049385|18870388|P2|NOT COMPLETED|First Intervention||0
7662408|NCT02049385|18870389|P1|NOT COMPLETED|First Intervention||3
7662409|NCT02049385|18870388|P2|COMPLETED|First Intervention||2
7662410|NCT02049385|18870389|P1|COMPLETED|First Intervention||1
7662411|NCT02049385|18870388|P2|STARTED|First Intervention||2
7662412|NCT02049385|18870389|P1|STARTED|First Intervention||4
7662413|NCT02049307|18870397|P2|NOT COMPLETED|Overall Study||1
7662414|NCT02049307|18870398|P1|NOT COMPLETED|Overall Study||2
7662415|NCT02049307|18870397|P2|COMPLETED|Overall Study||55
7662416|NCT02049307|18870398|P1|COMPLETED|Overall Study||50
7662417|NCT02049307|18870397|P2|STARTED|Overall Study||56
7662418|NCT02049307|18870398|P1|STARTED|Overall Study||52
7662419|NCT02049151|18870408|P2|NOT COMPLETED|Overall Study||0
7662420|NCT02049151|18870409|P1|NOT COMPLETED|Overall Study||0
7662421|NCT02049151|18870408|P2|COMPLETED|Overall Study||17
7662422|NCT02049151|18870409|P1|COMPLETED|Overall Study||15
7662423|NCT02049151|18870408|P2|STARTED|Overall Study|1 subject did not receive treatment|17
7662424|NCT02049151|18870409|P1|STARTED|Overall Study|2 subjects did not receive treatment|15
7662425|NCT02048904|18870423|P1|NOT COMPLETED|Overall Study||77
7662426|NCT02048904|18870423|P1|COMPLETED|Overall Study||65
7662427|NCT02048904|18870423|P1|STARTED|Overall Study||142
7662428|NCT02048891|18870429|P2|NOT COMPLETED|Overall Study||0
7662429|NCT02048891|18870430|P1|NOT COMPLETED|Overall Study||0
7662430|NCT02048891|18870429|P2|COMPLETED|Overall Study||1
7662431|NCT02048891|18870430|P1|COMPLETED|Overall Study||2
7662432|NCT02048891|18870429|P2|STARTED|Overall Study||1
7662433|NCT02048891|18870430|P1|STARTED|Overall Study||2
7662434|NCT02048878|18870438|P2|NOT COMPLETED|Overall Study||3
7662435|NCT02048878|18870439|P1|NOT COMPLETED|Overall Study||1
7662436|NCT02048878|18870438|P2|COMPLETED|Overall Study||12
7662437|NCT02048878|18870439|P1|COMPLETED|Overall Study||12
7662438|NCT02048878|18870438|P2|STARTED|Overall Study||15
7662439|NCT02048878|18870439|P1|STARTED|Overall Study||13
7662440|NCT02048722|18870455|P1|NOT COMPLETED|Follow up for 5 Years||29
7662441|NCT02048722|18870455|P1|COMPLETED|Follow up for 5 Years||0
7662442|NCT02048722|18870455|P1|STARTED|Follow up for 5 Years|2 patients remain on treatment and have not gone into follow up phase yet.|29
7662443|NCT02048722|18870455|P1|NOT COMPLETED|Reached 1st Response/Continued Treatment||10
7662444|NCT02048722|18870455|P1|COMPLETED|Reached 1st Response/Continued Treatment||13
7662445|NCT02048722|18870455|P1|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||13
7662446|NCT02048722|18870455|P1|Assessed for First Response|Reached 1st Response/Continued Treatment||23
7662447|NCT02048722|18870455|P1|STARTED|Reached 1st Response/Continued Treatment||23
7662448|NCT02048722|18870455|P1|NOT COMPLETED|2 Cycles of Treatment||8
7662449|NCT02048722|18870455|P1|COMPLETED|2 Cycles of Treatment||23
7662450|NCT02048722|18870455|P1|Attempted 2nd Cycle|2 Cycles of Treatment||23
7662451|NCT02048722|18870455|P1|Attempted 1st Cycle|2 Cycles of Treatment||31
7662452|NCT02048722|18870455|P1|STARTED|2 Cycles of Treatment||31
7662453|NCT02048670|18870467|P2|NOT COMPLETED|Overall Study||0
7662454|NCT02048670|18870468|P1|NOT COMPLETED|Overall Study||0
7662455|NCT02048670|18870467|P2|COMPLETED|Overall Study||6
7662456|NCT02048670|18870468|P1|COMPLETED|Overall Study||6
7662457|NCT02048670|18870467|P2|STARTED|Overall Study||6
7662458|NCT02048670|18870468|P1|STARTED|Overall Study||6
7662459|NCT02048241|18870478|P2|NOT COMPLETED|Overall Study||1
7662460|NCT02048241|18870479|P1|NOT COMPLETED|Overall Study||0
7662461|NCT02048241|18870478|P2|COMPLETED|Overall Study||5
7662462|NCT02048241|18870479|P1|COMPLETED|Overall Study||5
7662463|NCT02048241|18870478|P2|STARTED|Overall Study||6
7662464|NCT02048241|18870479|P1|STARTED|Overall Study||5
7662465|NCT02048072|18870485|P1|NOT COMPLETED|Overall Study||4
7662466|NCT02048072|18870485|P1|COMPLETED|Overall Study||29
7662467|NCT02048072|18870485|P1|STARTED|Overall Study||33
7662468|NCT02047981|18870491|P2|NOT COMPLETED|MORDOR Stage II Year 3||2363
7662469|NCT02047981|18870492|P1|NOT COMPLETED|MORDOR Stage II Year 3||2886
7662470|NCT02047981|18870491|P2|COMPLETED|MORDOR Stage II Year 3||30931
7662471|NCT02047981|18870492|P1|COMPLETED|MORDOR Stage II Year 3||34611
7662472|NCT02047981|18870491|P2|STARTED|MORDOR Stage II Year 3||33294
7662473|NCT02047981|18870492|P1|STARTED|MORDOR Stage II Year 3||37497
7662474|NCT02047981|18870491|P2|NOT COMPLETED|MORDOR Stage I Year 1-2||8717
7662475|NCT02047981|18870492|P1|NOT COMPLETED|MORDOR Stage I Year 1-2||9397
7662476|NCT02047981|18870491|P2|COMPLETED|MORDOR Stage I Year 1-2||84474
7662477|NCT02047981|18870492|P1|COMPLETED|MORDOR Stage I Year 1-2||87650
7662478|NCT02047981|18870491|P2|STARTED|MORDOR Stage I Year 1-2||93191
7662479|NCT02047981|18870492|P1|STARTED|MORDOR Stage I Year 1-2||97047
7662480|NCT02047929|18870509|P3|NOT COMPLETED|Overall Study||0
7662481|NCT02047929|18870510|P2|NOT COMPLETED|Overall Study||0
7662482|NCT02047929|18870511|P1|NOT COMPLETED|Overall Study||0
7662483|NCT02047929|18870509|P3|COMPLETED|Overall Study||2248
7662484|NCT02047929|18870510|P2|COMPLETED|Overall Study||2523
7662485|NCT02047929|18870511|P1|COMPLETED|Overall Study||1503
7662486|NCT02047929|18870509|P3|Surveys Collected|Overall Study|Per protocol, practice did not receive any interaction from practice facilitator|0
7662487|NCT02047929|18870510|P2|Surveys Collected|Overall Study||2523
7662488|NCT02047929|18870511|P1|Surveys Collected|Overall Study||1503
7662489|NCT02047929|18870509|P3|Practice Refresher|Overall Study|Per protocol, practices did not receive any interaction from practice facilitator|0
7662490|NCT02047929|18870510|P2|Practice Refresher|Overall Study||2523
7662491|NCT02047929|18870511|P1|Practice Refresher|Overall Study||1503
7662492|NCT02047929|18870509|P3|Practice Rollout|Overall Study|Per protocol, practice did not receive any intervention from practice facilitator|0
7662493|NCT02047929|18870510|P2|Practice Rollout|Overall Study||2523
7662494|NCT02047929|18870511|P1|Practice Rollout|Overall Study||1503
7662495|NCT02047929|18870509|P3|STARTED|Overall Study||2248
7662496|NCT02047929|18870510|P2|STARTED|Overall Study||2523
7662497|NCT02047929|18870511|P1|STARTED|Overall Study||1503
7662498|NCT02047903|18870524|P1|NOT COMPLETED|Overall Study||59
7662499|NCT02047903|18870524|P1|COMPLETED|Overall Study||102
7662500|NCT02047903|18870524|P1|Treated|Overall Study||152
7662501|NCT02047903|18870524|P1|STARTED|Overall Study||161
7662502|NCT02047747|18870536|P1|NOT COMPLETED|Overall Study||3
7662503|NCT02047747|18870536|P1|COMPLETED|Overall Study||1
7662504|NCT02047747|18870536|P1|STARTED|Overall Study||4
7662505|NCT02047643|18870541|P2|NOT COMPLETED|Overall Study||0
7662506|NCT02047643|18870542|P1|NOT COMPLETED|Overall Study||0
7662507|NCT02047643|18870541|P2|COMPLETED|Overall Study||9
7662508|NCT02047643|18870542|P1|COMPLETED|Overall Study||9
7662509|NCT02047643|18870541|P2|STARTED|Overall Study||9
7662510|NCT02047643|18870542|P1|STARTED|Overall Study||9
7662511|NCT02047500|18870550|P1|NOT COMPLETED|Overall Study||19
7662512|NCT02047500|18870550|P1|COMPLETED|Overall Study||0
7662513|NCT02047500|18870550|P1|STARTED|Overall Study||19
7662514|NCT02047344|18870556|P2|NOT COMPLETED|Overall Study||0
7662515|NCT02047344|18870557|P1|NOT COMPLETED|Overall Study||0
7662516|NCT02047344|18870556|P2|COMPLETED|Overall Study||15
7662517|NCT02047344|18870557|P1|COMPLETED|Overall Study||16
7662518|NCT02047344|18870556|P2|STARTED|Overall Study||15
7662519|NCT02047344|18870557|P1|STARTED|Overall Study|one patient is not evaluable in process. however, evaluable to safety report.|16
7662520|NCT02047305|18870575|P1|NOT COMPLETED|Overall Study||0
7662521|NCT02047305|18870575|P1|COMPLETED|Overall Study||96
7662522|NCT02047305|18870575|P1|STARTED|Overall Study||96
7662523|NCT02047253|18870579|P1|NOT COMPLETED|Overall Study||8
7662524|NCT02047253|18870579|P1|COMPLETED|Overall Study||20
7662525|NCT02047253|18870579|P1|STARTED|Overall Study||28
7662526|NCT02047227|18870589|P2|NOT COMPLETED|Overall Study||130
7662527|NCT02047227|18870590|P1|NOT COMPLETED|Overall Study||144
7662528|NCT02047227|18870589|P2|COMPLETED|Overall Study||347
7662529|NCT02047227|18870590|P1|COMPLETED|Overall Study||318
7662530|NCT02047227|18870589|P2|Completed Ovarian Stimulation Phase|Overall Study||440
7662531|NCT02047227|18870590|P1|Completed Ovarian Stimulation Phase|Overall Study||424
7662532|NCT02047227|18870589|P2|STARTED|Overall Study||477
7662533|NCT02047227|18870590|P1|STARTED|Overall Study||462
7662534|NCT02047110|18870610|P4|NOT COMPLETED|OLE Treatment Period||0
7662535|NCT02047110|18870611|P3|NOT COMPLETED|OLE Treatment Period||1
7662536|NCT02047110|18870612|P2|NOT COMPLETED|OLE Treatment Period||0
7662537|NCT02047110|18870613|P1|NOT COMPLETED|OLE Treatment Period||0
7662538|NCT02047110|18870610|P4|COMPLETED|OLE Treatment Period||9
7662539|NCT02047110|18870611|P3|COMPLETED|OLE Treatment Period||4
7662540|NCT02047110|18870612|P2|COMPLETED|OLE Treatment Period||8
7662541|NCT02047110|18870613|P1|COMPLETED|OLE Treatment Period||4
7662542|NCT02047110|18870610|P4|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|9
7662543|NCT02047110|18870611|P3|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|5
7662544|NCT02047110|18870612|P2|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|8
7662545|NCT02047110|18870613|P1|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|4
7662546|NCT02047110|18870610|P4|NOT COMPLETED|Escape Treatment Period||2
7662547|NCT02047110|18870611|P3|NOT COMPLETED|Escape Treatment Period||3
7662548|NCT02047110|18870612|P2|NOT COMPLETED|Escape Treatment Period||6
7662549|NCT02047110|18870613|P1|NOT COMPLETED|Escape Treatment Period||3
7662550|NCT02047110|18870610|P4|COMPLETED|Escape Treatment Period||24
7662551|NCT02047110|18870611|P3|COMPLETED|Escape Treatment Period||20
7662552|NCT02047110|18870612|P2|COMPLETED|Escape Treatment Period||15
7662553|NCT02047110|18870613|P1|COMPLETED|Escape Treatment Period||23
7662554|NCT02047110|18870610|P4|STARTED|Escape Treatment Period|ASAS 20 nonresponders|26
7662555|NCT02047110|18870611|P3|STARTED|Escape Treatment Period|ASAS 20 nonresponders|23
7662556|NCT02047110|18870612|P2|STARTED|Escape Treatment Period|ASAS 20 nonresponders|21
7662557|NCT02047110|18870613|P1|STARTED|Escape Treatment Period|Assessment in SpondyloArthritis international Society (ASAS) 20 nonresponders|26
7662558|NCT02047110|18870610|P4|NOT COMPLETED|DB (Week 12 up to Week 24)||0
7662559|NCT02047110|18870611|P3|NOT COMPLETED|DB (Week 12 up to Week 24)||1
7662560|NCT02047110|18870612|P2|NOT COMPLETED|DB (Week 12 up to Week 24)||2
7662561|NCT02047110|18870613|P1|NOT COMPLETED|DB (Week 12 up to Week 24)||0
7662562|NCT02047110|18870610|P4|COMPLETED|DB (Week 12 up to Week 24)||12
7662563|NCT02047110|18870611|P3|COMPLETED|DB (Week 12 up to Week 24)||12
7662564|NCT02047110|18870612|P2|COMPLETED|DB (Week 12 up to Week 24)||15
7662565|NCT02047110|18870613|P1|COMPLETED|DB (Week 12 up to Week 24)||9
7662566|NCT02047110|18870610|P4|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|12
7662567|NCT02047110|18870611|P3|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|13
7662568|NCT02047110|18870612|P2|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|17
7662569|NCT02047110|18870613|P1|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|9
7662570|NCT02047110|18870610|P4|NOT COMPLETED|DB Treatment Period up to Week 24||2
7662571|NCT02047110|18870611|P3|NOT COMPLETED|DB Treatment Period up to Week 24||3
7662572|NCT02047110|18870612|P2|NOT COMPLETED|DB Treatment Period up to Week 24||2
7662573|NCT02047110|18870613|P1|NOT COMPLETED|DB Treatment Period up to Week 24||5
7662574|NCT02047110|18870610|P4|COMPLETED|DB Treatment Period up to Week 24||38
7662575|NCT02047110|18870611|P3|COMPLETED|DB Treatment Period up to Week 24||36
7662576|NCT02047110|18870612|P2|COMPLETED|DB Treatment Period up to Week 24||38
7662577|NCT02047110|18870613|P1|COMPLETED|DB Treatment Period up to Week 24||35
7662578|NCT02047110|18870610|P4|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
7662579|NCT02047110|18870611|P3|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|39
7662580|NCT02047110|18870612|P2|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
7662581|NCT02047110|18870613|P1|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
7662582|NCT02047045|18870656|P2|NOT COMPLETED|Follow-up Period (24 Weeks)||0
7662583|NCT02047045|18870657|P1|NOT COMPLETED|Follow-up Period (24 Weeks)||0
7662584|NCT02047045|18870656|P2|COMPLETED|Follow-up Period (24 Weeks)||262
7662585|NCT02047045|18870657|P1|COMPLETED|Follow-up Period (24 Weeks)||265
7662586|NCT02047045|18870656|P2|STARTED|Follow-up Period (24 Weeks)||262
7662587|NCT02047045|18870657|P1|STARTED|Follow-up Period (24 Weeks)||265
7662588|NCT02047045|18870656|P2|NOT COMPLETED|Treatment Period (8 Weeks )||3
7662589|NCT02047045|18870657|P1|NOT COMPLETED|Treatment Period (8 Weeks )||7
7662590|NCT02047045|18870656|P2|COMPLETED|Treatment Period (8 Weeks )||262
7662591|NCT02047045|18870657|P1|COMPLETED|Treatment Period (8 Weeks )||265
7662592|NCT02047045|18870656|P2|STARTED|Treatment Period (8 Weeks )||265
7662593|NCT02047045|18870657|P1|STARTED|Treatment Period (8 Weeks )||272
7662594|NCT02047045|18870656|P2|NOT COMPLETED|Baseline||15
7662595|NCT02047045|18870657|P1|NOT COMPLETED|Baseline||8
7662596|NCT02047045|18870656|P2|COMPLETED|Baseline||265
7662597|NCT02047045|18870657|P1|COMPLETED|Baseline||272
7662598|NCT02047045|18870656|P2|STARTED|Baseline||280
7662599|NCT02047045|18870657|P1|STARTED|Baseline||280
7662600|NCT02047032|18870691|P2|NOT COMPLETED|Overall Study||15
7662601|NCT02047032|18870692|P1|NOT COMPLETED|Overall Study||5
7662602|NCT02047032|18870691|P2|COMPLETED|Overall Study||235
7662603|NCT02047032|18870692|P1|COMPLETED|Overall Study||245
7662604|NCT02047032|18870691|P2|STARTED|Overall Study||250
7662605|NCT02047032|18870692|P1|STARTED|Overall Study||250
7662606|NCT02046993|18870721|P2|NOT COMPLETED|Overall Study||11
7662607|NCT02046993|18870722|P1|NOT COMPLETED|Overall Study||3
7662608|NCT02046993|18870721|P2|COMPLETED|Overall Study||94
7662609|NCT02046993|18870722|P1|COMPLETED|Overall Study||102
7662610|NCT02046993|18870721|P2|6th Month|Overall Study||94
7662611|NCT02046993|18870722|P1|6th Month|Overall Study||102
7662612|NCT02046993|18870721|P2|3rd Month|Overall Study||97
7662613|NCT02046993|18870722|P1|3rd Month|Overall Study||104
7662614|NCT02046993|18870721|P2|STARTED|Overall Study||105
7662615|NCT02046993|18870722|P1|STARTED|Overall Study||105
7662616|NCT02046980|18870741|P3|NOT COMPLETED|Overall Study||1
7662617|NCT02046980|18870742|P2|NOT COMPLETED|Overall Study||5
7662618|NCT02046980|18870743|P1|NOT COMPLETED|Overall Study||2
7662619|NCT02046980|18870741|P3|COMPLETED|Overall Study||72
7662620|NCT02046980|18870742|P2|COMPLETED|Overall Study||67
7662621|NCT02046980|18870743|P1|COMPLETED|Overall Study||70
7662622|NCT02046980|18870741|P3|STARTED|Overall Study||73
7662623|NCT02046980|18870742|P2|STARTED|Overall Study||72
7662624|NCT02046980|18870743|P1|STARTED|Overall Study||72
7662625|NCT02046941|18870751|P1|NOT COMPLETED|Overall Study||7
7662626|NCT02046941|18870751|P1|COMPLETED|Overall Study||10
7662627|NCT02046941|18870751|P1|STARTED|Overall Study||17
7662628|NCT02046902|18870760|P3|NOT COMPLETED|Overall Study||0
7662629|NCT02046902|18870761|P2|NOT COMPLETED|Overall Study||0
7662630|NCT02046902|18870762|P1|NOT COMPLETED|Overall Study||0
7662631|NCT02046902|18870760|P3|COMPLETED|Overall Study||137
7662632|NCT02046902|18870761|P2|COMPLETED|Overall Study||113
7662633|NCT02046902|18870762|P1|COMPLETED|Overall Study||336
7662634|NCT02046902|18870760|P3|STARTED|Overall Study||137
7662635|NCT02046902|18870761|P2|STARTED|Overall Study||113
7662636|NCT02046902|18870762|P1|STARTED|Overall Study||336
7662637|NCT02046863|18870773|P1|NOT COMPLETED|Overall Study||0
7662638|NCT02046863|18870773|P1|COMPLETED|Overall Study||7
7662639|NCT02046863|18870773|P1|STARTED|Overall Study||7
7662640|NCT02046772|18870779|P2|NOT COMPLETED|Overall Study||0
7662641|NCT02046772|18870780|P1|NOT COMPLETED|Overall Study||0
7662642|NCT02046772|18870779|P2|COMPLETED|Overall Study||33
7662643|NCT02046772|18870780|P1|COMPLETED|Overall Study||30
7662644|NCT02046772|18870779|P2|STARTED|Overall Study||33
7662645|NCT02046772|18870780|P1|STARTED|Overall Study||30
7662646|NCT02046616|18870794|P1|NOT COMPLETED|8-Week FU Period||1
7662647|NCT02046616|18870794|P1|COMPLETED|8-Week FU Period||113
7662648|NCT02046616|18870794|P1|STARTED|8-Week FU Period||114
7662649|NCT02046616|18870794|P1|NOT COMPLETED|24-Week Treatment Period||19
7662650|NCT02046616|18870794|P1|COMPLETED|24-Week Treatment Period||114
7662651|NCT02046616|18870794|P1|STARTED|24-Week Treatment Period||133
7662652|NCT02046603|18870816|P2|NOT COMPLETED|Overall Study||75
7662653|NCT02046603|18870817|P1|NOT COMPLETED|Overall Study||15
7662654|NCT02046603|18870816|P2|COMPLETED|Overall Study||65
7662655|NCT02046603|18870817|P1|COMPLETED|Overall Study||7
7662656|NCT02046603|18870816|P2|Received at Least 1 Dose of Tocilizumab|Overall Study||140
7662657|NCT02046603|18870817|P1|Received at Least 1 Dose of Tocilizumab|Overall Study||21
7662658|NCT02046603|18870816|P2|STARTED|Overall Study||140
7662659|NCT02046603|18870817|P1|STARTED|Overall Study||22
7662660|NCT02046564|18870896|P2|NOT COMPLETED|Overall Study||20
7662661|NCT02046564|18870897|P1|NOT COMPLETED|Overall Study||15
7662662|NCT02046564|18870896|P2|COMPLETED|Overall Study||183
7662663|NCT02046564|18870897|P1|COMPLETED|Overall Study||194
7662664|NCT02046564|18870896|P2|STARTED|Overall Study||203
7662665|NCT02046564|18870897|P1|STARTED|Overall Study||209
7662666|NCT02046525|18870921|P2|NOT COMPLETED|Overall Study||0
7662667|NCT02046525|18870922|P1|NOT COMPLETED|Overall Study||0
7662668|NCT02046525|18870921|P2|COMPLETED|Overall Study||5
7662669|NCT02046525|18870922|P1|COMPLETED|Overall Study||5
7662670|NCT02046525|18870921|P2|STARTED|Overall Study||5
7662671|NCT02046525|18870922|P1|STARTED|Overall Study||5
7662672|NCT02046382|18870930|P2|NOT COMPLETED|Overall Study||20
7662673|NCT02046382|18870931|P1|NOT COMPLETED|Overall Study||8
7662674|NCT02046382|18870930|P2|COMPLETED|Overall Study||47
7662675|NCT02046382|18870931|P1|COMPLETED|Overall Study||57
7662676|NCT02046382|18870930|P2|STARTED|Overall Study||67
7662677|NCT02046382|18870931|P1|STARTED|Overall Study||65
7662678|NCT02046369|18870945|P2|NOT COMPLETED|Overall Study||18
7662679|NCT02046369|18870946|P1|NOT COMPLETED|Overall Study||14
7662680|NCT02046369|18870945|P2|COMPLETED|Overall Study||156
7662681|NCT02046369|18870946|P1|COMPLETED|Overall Study||162
7662682|NCT02046369|18870945|P2|STARTED|Overall Study||174
7662683|NCT02046369|18870946|P1|STARTED|Overall Study||176
7662684|NCT02046317|18870964|P2|NOT COMPLETED|Overall Study||0
7662685|NCT02046317|18870965|P1|NOT COMPLETED|Overall Study||0
7662686|NCT02046317|18870964|P2|COMPLETED|Overall Study||8
7662687|NCT02046317|18870965|P1|COMPLETED|Overall Study||4
7662688|NCT02046317|18870964|P2|STARTED|Overall Study||8
7662689|NCT02046317|18870965|P1|STARTED|Overall Study||4
7662690|NCT02046265|18870977|P4|NOT COMPLETED|Overall Study||2
7662691|NCT02046265|18870978|P3|NOT COMPLETED|Overall Study||2
7662692|NCT02046265|18870979|P2|NOT COMPLETED|Overall Study||2
7662693|NCT02046265|18870980|P1|NOT COMPLETED|Overall Study||1
7662694|NCT02046265|18870977|P4|COMPLETED|Overall Study||12
7662695|NCT02046265|18870978|P3|COMPLETED|Overall Study||10
7662696|NCT02046265|18870979|P2|COMPLETED|Overall Study||15
7662697|NCT02046265|18870980|P1|COMPLETED|Overall Study||16
7662698|NCT02046265|18870977|P4|STARTED|Overall Study||14
7662699|NCT02046265|18870978|P3|STARTED|Overall Study||12
7662700|NCT02046265|18870979|P2|STARTED|Overall Study||17
7662701|NCT02046265|18870980|P1|STARTED|Overall Study||17
7662702|NCT02046226|18870990|P1|NOT COMPLETED|Overall Study||7
7662703|NCT02046226|18870990|P1|COMPLETED|Overall Study||0
7662704|NCT02046226|18870990|P1|STARTED|Overall Study||7
7662705|NCT02046200|18870997|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7662706|NCT02046200|18870998|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7662707|NCT02046200|18870997|P2|COMPLETED|Second Intervention (1 Day)||6
7662708|NCT02046200|18870998|P1|COMPLETED|Second Intervention (1 Day)||5
7662709|NCT02046200|18870997|P2|STARTED|Second Intervention (1 Day)||6
7662710|NCT02046200|18870998|P1|STARTED|Second Intervention (1 Day)||5
7662711|NCT02046200|18870997|P2|NOT COMPLETED|First Intervention (1 Day)||0
7662712|NCT02046200|18870998|P1|NOT COMPLETED|First Intervention (1 Day)||0
7662713|NCT02046200|18870997|P2|COMPLETED|First Intervention (1 Day)||6
7662714|NCT02046200|18870998|P1|COMPLETED|First Intervention (1 Day)||5
7662715|NCT02046200|18870997|P2|STARTED|First Intervention (1 Day)||6
7662716|NCT02046200|18870998|P1|STARTED|First Intervention (1 Day)||5
7662717|NCT02046148|18871038|P2|NOT COMPLETED|Overall Study||3
7662718|NCT02046148|18871039|P1|NOT COMPLETED|Overall Study||1
7662719|NCT02046148|18871038|P2|COMPLETED|Overall Study||23
7662720|NCT02046148|18871039|P1|COMPLETED|Overall Study||48
7662721|NCT02046148|18871038|P2|STARTED|Overall Study||26
7662722|NCT02046148|18871039|P1|STARTED|Overall Study||49
7662723|NCT02046135|18871101|P2|NOT COMPLETED|Overall Study||0
7662724|NCT02046135|18871102|P1|NOT COMPLETED|Overall Study||0
7662725|NCT02046135|18871101|P2|COMPLETED|Overall Study||25
7662726|NCT02046135|18871102|P1|COMPLETED|Overall Study||26
7662727|NCT02046135|18871101|P2|STARTED|Overall Study||25
7662728|NCT02046135|18871102|P1|STARTED|Overall Study||26
7662729|NCT02046122|18871116|P1|NOT COMPLETED|Overall Study||9
7662730|NCT02046122|18871116|P1|COMPLETED|Overall Study||8
7662731|NCT02046122|18871116|P1|STARTED|Overall Study||17
7662732|NCT02046070|18871130|P3|NOT COMPLETED|Overall Study||70
7662733|NCT02046070|18871131|P2|NOT COMPLETED|Overall Study||28
7662734|NCT02046070|18871132|P1|NOT COMPLETED|Overall Study||32
7662735|NCT02046070|18871130|P3|COMPLETED|Overall Study||8
7662736|NCT02046070|18871131|P2|COMPLETED|Overall Study||6
7662737|NCT02046070|18871132|P1|COMPLETED|Overall Study||4
7662738|NCT02046070|18871130|P3|STARTED|Overall Study||78
7662739|NCT02046070|18871131|P2|STARTED|Overall Study||34
7662740|NCT02046070|18871132|P1|STARTED|Overall Study||36
7662741|NCT02046005|18871179|P3|NOT COMPLETED|Overall Study||10
7662742|NCT02046005|18871180|P2|NOT COMPLETED|Overall Study||7
7662743|NCT02046005|18871181|P1|NOT COMPLETED|Overall Study||8
7662744|NCT02046005|18871179|P3|COMPLETED|Overall Study||70
7662745|NCT02046005|18871180|P2|COMPLETED|Overall Study||71
7662746|NCT02046005|18871181|P1|COMPLETED|Overall Study||72
7662747|NCT02046005|18871179|P3|STARTED|Overall Study||80
7662748|NCT02046005|18871180|P2|STARTED|Overall Study||78
7662749|NCT02046005|18871181|P1|STARTED|Overall Study||80
7662750|NCT02045979|18871192|P3|NOT COMPLETED|Overall Study||1
7662751|NCT02045979|18871193|P2|NOT COMPLETED|Overall Study||1
7662752|NCT02045979|18871194|P1|NOT COMPLETED|Overall Study||2
7662753|NCT02045979|18871192|P3|COMPLETED|Overall Study||107
7662754|NCT02045979|18871193|P2|COMPLETED|Overall Study||107
7662755|NCT02045979|18871194|P1|COMPLETED|Overall Study||106
7662756|NCT02045979|18871192|P3|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
7662757|NCT02045979|18871193|P2|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication..|108
7662758|NCT02045979|18871194|P1|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
7662759|NCT02045875|18871231|P2|NOT COMPLETED|Overall Study||3
7662760|NCT02045875|18871232|P1|NOT COMPLETED|Overall Study||7
7662761|NCT02045875|18871231|P2|COMPLETED|Overall Study||20
7662762|NCT02045875|18871232|P1|COMPLETED|Overall Study||20
7662763|NCT02045875|18871231|P2|STARTED|Overall Study||23
7662764|NCT02045875|18871232|P1|STARTED|Overall Study||27
7662765|NCT02045862|18871243|P3|NOT COMPLETED|Overall Study||126
7662766|NCT02045862|18871244|P2|NOT COMPLETED|Overall Study||40
7662767|NCT02045862|18871245|P1|NOT COMPLETED|Overall Study||39
7662768|NCT02045862|18871243|P3|COMPLETED|Overall Study||1092
7662769|NCT02045862|18871244|P2|COMPLETED|Overall Study||265
7662770|NCT02045862|18871245|P1|COMPLETED|Overall Study||267
7662771|NCT02045862|18871243|P3|Treated|Overall Study||1210
7662772|NCT02045862|18871244|P2|Treated|Overall Study||303
7662773|NCT02045862|18871245|P1|Treated|Overall Study||306
7662774|NCT02045862|18871243|P3|STARTED|Overall Study||1218
7662775|NCT02045862|18871244|P2|STARTED|Overall Study||305
7662776|NCT02045862|18871245|P1|STARTED|Overall Study||306
7662777|NCT02045836|18871426|P2|NOT COMPLETED|Overall Study||14
7662778|NCT02045836|18871427|P1|NOT COMPLETED|Overall Study||9
7662779|NCT02045836|18871426|P2|COMPLETED|Overall Study||419
7662780|NCT02045836|18871427|P1|COMPLETED|Overall Study||423
7662781|NCT02045836|18871426|P2|STARTED|Overall Study||433
7662782|NCT02045836|18871427|P1|STARTED|Overall Study||432
7662783|NCT02045797|18871459|P3|NOT COMPLETED|Overall Study||1
7662784|NCT02045797|18871460|P2|NOT COMPLETED|Overall Study||7
7662785|NCT02045797|18871461|P1|NOT COMPLETED|Overall Study||7
7662786|NCT02045797|18871459|P3|COMPLETED|Overall Study||24
7662787|NCT02045797|18871460|P2|COMPLETED|Overall Study||32
7662788|NCT02045797|18871461|P1|COMPLETED|Overall Study||51
7662789|NCT02045797|18871459|P3|STARTED|Overall Study||25
7662790|NCT02045797|18871460|P2|STARTED|Overall Study||39
7662791|NCT02045797|18871461|P1|STARTED|Overall Study||58
7662792|NCT02045732|18871606|P2|NOT COMPLETED|Overall Study||1
7662793|NCT02045732|18871607|P1|NOT COMPLETED|Overall Study||1
7662794|NCT02045732|18871606|P2|COMPLETED|Overall Study||2
7662795|NCT02045732|18871607|P1|COMPLETED|Overall Study||0
7662796|NCT02045732|18871606|P2|STARTED|Overall Study||3
7662797|NCT02045732|18871607|P1|STARTED|Overall Study||1
7662798|NCT02045511|18871627|P2|NOT COMPLETED|Overall Study||0
7662799|NCT02045511|18871628|P1|NOT COMPLETED|Overall Study||0
7662800|NCT02045511|18871627|P2|COMPLETED|Overall Study||7
7662801|NCT02045511|18871628|P1|COMPLETED|Overall Study||8
7662802|NCT02045511|18871627|P2|STARTED|Overall Study||7
7662803|NCT02045511|18871628|P1|STARTED|Overall Study||8
7662804|NCT02045433|18871644|P1|NOT COMPLETED|Overall Study||1
7662805|NCT02045433|18871644|P1|COMPLETED|Overall Study|Study was Prematurely ended due to toxicity|15
7662806|NCT02045433|18871644|P1|STARTED|Overall Study||16
7662807|NCT02045277|18871652|P4|NOT COMPLETED|Overall Study||2
7662808|NCT02045277|18871653|P3|NOT COMPLETED|Overall Study||12
7662809|NCT02045277|18871654|P2|NOT COMPLETED|Overall Study||1
7662810|NCT02045277|18871655|P1|NOT COMPLETED|Overall Study||4
7662811|NCT02045277|18871652|P4|COMPLETED|Overall Study||29
7662812|NCT02045277|18871653|P3|COMPLETED|Overall Study||47
7662813|NCT02045277|18871654|P2|COMPLETED|Overall Study||62
7662814|NCT02045277|18871655|P1|COMPLETED|Overall Study||55
7662815|NCT02045277|18871652|P4|STARTED|Overall Study||31
7662816|NCT02045277|18871653|P3|STARTED|Overall Study||59
7662817|NCT02045277|18871654|P2|STARTED|Overall Study||63
7662818|NCT02045277|18871655|P1|STARTED|Overall Study||59
7662819|NCT02045264|18871669|P1|NOT COMPLETED|Overall Study||0
7662820|NCT02045264|18871669|P1|COMPLETED|Overall Study||12
7662821|NCT02045264|18871669|P1|STARTED|Overall Study||12
7662822|NCT02045238|18871686|P2|NOT COMPLETED|Overall Study||1
7662823|NCT02045238|18871687|P1|NOT COMPLETED|Overall Study||7
7662824|NCT02045238|18871686|P2|COMPLETED|Overall Study||14
7662825|NCT02045238|18871687|P1|COMPLETED|Overall Study||9
7662826|NCT02045238|18871686|P2|STARTED|Overall Study||15
7662827|NCT02045238|18871687|P1|STARTED|Overall Study||16
7662828|NCT02045212|18871697|P2|NOT COMPLETED|Overall Study||1
7662829|NCT02045212|18871698|P1|NOT COMPLETED|Overall Study||2
7662830|NCT02045212|18871697|P2|COMPLETED|Overall Study||8
7662831|NCT02045212|18871698|P1|COMPLETED|Overall Study||11
7662832|NCT02045212|18871697|P2|STARTED|Overall Study||9
7662833|NCT02045212|18871698|P1|STARTED|Overall Study||13
7662834|NCT02045108|18871714|P4|NOT COMPLETED|Overall Study||1
7662835|NCT02045108|18871715|P3|NOT COMPLETED|Overall Study||2
7662836|NCT02045108|18871716|P2|NOT COMPLETED|Overall Study||3
7662837|NCT02045108|18871717|P1|NOT COMPLETED|Overall Study||1
7662838|NCT02045108|18871714|P4|COMPLETED|Overall Study||19
7662839|NCT02045108|18871715|P3|COMPLETED|Overall Study||18
7662840|NCT02045108|18871716|P2|COMPLETED|Overall Study||12
7662841|NCT02045108|18871717|P1|COMPLETED|Overall Study||21
7662842|NCT02045108|18871714|P4|STARTED|Overall Study||20
7662843|NCT02045108|18871715|P3|STARTED|Overall Study||20
7662844|NCT02045108|18871716|P2|STARTED|Overall Study||15
7662845|NCT02045108|18871717|P1|STARTED|Overall Study||22
7662846|NCT02045095|18871763|P7|NOT COMPLETED|Overall Study||1
7662847|NCT02045095|18871764|P6|NOT COMPLETED|Overall Study||8
7662848|NCT02045095|18871765|P5|NOT COMPLETED|Overall Study||5
7662849|NCT02045095|18871766|P4|NOT COMPLETED|Overall Study||4
7662850|NCT02045095|18871767|P3|NOT COMPLETED|Overall Study||4
7662851|NCT02045095|18871768|P2|NOT COMPLETED|Overall Study||4
7662852|NCT02045095|18871769|P1|NOT COMPLETED|Overall Study||3
7662853|NCT02045095|18871763|P7|COMPLETED|Overall Study||0
7662854|NCT02045095|18871764|P6|COMPLETED|Overall Study||0
7662855|NCT02045095|18871765|P5|COMPLETED|Overall Study||0
7662856|NCT02045095|18871766|P4|COMPLETED|Overall Study||0
7662857|NCT02045095|18871767|P3|COMPLETED|Overall Study||0
7662858|NCT02045095|18871768|P2|COMPLETED|Overall Study||0
7662859|NCT02045095|18871769|P1|COMPLETED|Overall Study||0
7662860|NCT02045095|18871763|P7|STARTED|Overall Study||1
7662861|NCT02045095|18871764|P6|STARTED|Overall Study||8
7662862|NCT02045095|18871765|P5|STARTED|Overall Study||5
7662863|NCT02045095|18871766|P4|STARTED|Overall Study||4
7662864|NCT02045095|18871767|P3|STARTED|Overall Study||4
7662865|NCT02045095|18871768|P2|STARTED|Overall Study||4
7662866|NCT02045095|18871769|P1|STARTED|Overall Study||3
7662867|NCT02044991|18871913|P2|NOT COMPLETED|Overall Study||0
7662868|NCT02044991|18871914|P1|NOT COMPLETED|Overall Study||0
7662869|NCT02044991|18871913|P2|COMPLETED|Overall Study||0
7662870|NCT02044991|18871914|P1|COMPLETED|Overall Study||2
7662871|NCT02044991|18871913|P2|STARTED|Overall Study||0
7662872|NCT02044991|18871914|P1|STARTED|Overall Study||2
7662873|NCT02044874|18871927|P3|NOT COMPLETED|Overall Study||60
7662874|NCT02044874|18871928|P2|NOT COMPLETED|Overall Study||55
7662875|NCT02044874|18871929|P1|NOT COMPLETED|Overall Study||30
7662876|NCT02044874|18871927|P3|COMPLETED|Overall Study||140
7662877|NCT02044874|18871928|P2|COMPLETED|Overall Study||147
7662878|NCT02044874|18871929|P1|COMPLETED|Overall Study||171
7662879|NCT02044874|18871927|P3|STARTED|Overall Study||200
7662880|NCT02044874|18871928|P2|STARTED|Overall Study||202
7662881|NCT02044874|18871929|P1|STARTED|Overall Study||201
7662882|NCT02044848|18871951|P2|NOT COMPLETED|Overall Study||3
7662883|NCT02044848|18871952|P1|NOT COMPLETED|Overall Study||2
7662884|NCT02044848|18871951|P2|COMPLETED|Overall Study||0
7662885|NCT02044848|18871952|P1|COMPLETED|Overall Study||0
7662886|NCT02044848|18871951|P2|STARTED|Overall Study||3
7662887|NCT02044848|18871952|P1|STARTED|Overall Study||2
7662888|NCT02044822|18871958|P1|NOT COMPLETED|Overall Study||93
7662889|NCT02044822|18871958|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|9
7662890|NCT02044822|18871958|P1|STARTED|Overall Study||102
7662891|NCT02044796|18871970|P10|NOT COMPLETED|Overall Study||0
7662892|NCT02044796|18871971|P9|NOT COMPLETED|Overall Study||0
7662893|NCT02044796|18871972|P8|NOT COMPLETED|Overall Study||0
7662894|NCT02044796|18871973|P7|NOT COMPLETED|Overall Study||0
7662895|NCT02044796|18871974|P6|NOT COMPLETED|Overall Study||0
7662896|NCT02044796|18871975|P5|NOT COMPLETED|Overall Study||0
7662897|NCT02044796|18871976|P4|NOT COMPLETED|Overall Study||0
7662898|NCT02044796|18871977|P3|NOT COMPLETED|Overall Study||0
7662899|NCT02044796|18871978|P2|NOT COMPLETED|Overall Study||0
7662900|NCT02044796|18871979|P1|NOT COMPLETED|Overall Study||0
7662901|NCT02044796|18871970|P10|COMPLETED|Overall Study||34
7662902|NCT02044796|18871971|P9|COMPLETED|Overall Study||106
7662903|NCT02044796|18871972|P8|COMPLETED|Overall Study||4
7662904|NCT02044796|18871973|P7|COMPLETED|Overall Study||6
7662905|NCT02044796|18871974|P6|COMPLETED|Overall Study||6
7662906|NCT02044796|18871975|P5|COMPLETED|Overall Study||10
7662907|NCT02044796|18871976|P4|COMPLETED|Overall Study||6
7662908|NCT02044796|18871977|P3|COMPLETED|Overall Study||9
7662909|NCT02044796|18871978|P2|COMPLETED|Overall Study||9
7662910|NCT02044796|18871979|P1|COMPLETED|Overall Study||9
7662911|NCT02044796|18871970|P10|STARTED|Overall Study||34
7662912|NCT02044796|18871971|P9|STARTED|Overall Study||106
7662913|NCT02044796|18871972|P8|STARTED|Overall Study||4
7662914|NCT02044796|18871973|P7|STARTED|Overall Study||6
7662915|NCT02044796|18871974|P6|STARTED|Overall Study||6
7662916|NCT02044796|18871975|P5|STARTED|Overall Study||10
7662917|NCT02044796|18871976|P4|STARTED|Overall Study||6
7662918|NCT02044796|18871977|P3|STARTED|Overall Study||9
7662919|NCT02044796|18871978|P2|STARTED|Overall Study||9
7662920|NCT02044796|18871979|P1|STARTED|Overall Study||9
7662921|NCT02044510|18872000|P2|NOT COMPLETED|Overall Study||2
7662922|NCT02044510|18872001|P1|NOT COMPLETED|Overall Study||1
7662923|NCT02044510|18872000|P2|COMPLETED|Overall Study||14
7662924|NCT02044510|18872001|P1|COMPLETED|Overall Study||15
7662925|NCT02044510|18872000|P2|STARTED|Overall Study||16
7662926|NCT02044510|18872001|P1|STARTED|Overall Study||16
7662927|NCT02044458|18872009|P2|NOT COMPLETED|Overall Study||8
7662928|NCT02044458|18872010|P1|NOT COMPLETED|Overall Study||3
7662929|NCT02044458|18872009|P2|COMPLETED|Overall Study||61
7662930|NCT02044458|18872010|P1|COMPLETED|Overall Study||62
7662931|NCT02044458|18872009|P2|STARTED|Overall Study||69
7662932|NCT02044458|18872010|P1|STARTED|Overall Study||65
7662933|NCT02044419|18872023|P3|NOT COMPLETED|Third Intervention||0
7662934|NCT02044419|18872024|P2|NOT COMPLETED|Third Intervention||0
7662935|NCT02044419|18872025|P1|NOT COMPLETED|Third Intervention||0
7662936|NCT02044419|18872023|P3|COMPLETED|Third Intervention||10
7662937|NCT02044419|18872024|P2|COMPLETED|Third Intervention||9
7662938|NCT02044419|18872025|P1|COMPLETED|Third Intervention||11
7662939|NCT02044419|18872023|P3|STARTED|Third Intervention||10
7662940|NCT02044419|18872024|P2|STARTED|Third Intervention||9
7662941|NCT02044419|18872025|P1|STARTED|Third Intervention||11
7662942|NCT02044419|18872023|P3|NOT COMPLETED|Second Intervention||0
7662943|NCT02044419|18872024|P2|NOT COMPLETED|Second Intervention||0
7662944|NCT02044419|18872025|P1|NOT COMPLETED|Second Intervention||0
7662945|NCT02044419|18872023|P3|COMPLETED|Second Intervention||10
7662946|NCT02044419|18872024|P2|COMPLETED|Second Intervention||9
7662947|NCT02044419|18872025|P1|COMPLETED|Second Intervention||11
7662948|NCT02044419|18872023|P3|STARTED|Second Intervention||10
7662949|NCT02044419|18872024|P2|STARTED|Second Intervention||9
7662950|NCT02044419|18872025|P1|STARTED|Second Intervention||11
7662951|NCT02044419|18872023|P3|NOT COMPLETED|First Intervention||1
7662952|NCT02044419|18872024|P2|NOT COMPLETED|First Intervention||1
7662953|NCT02044419|18872025|P1|NOT COMPLETED|First Intervention||0
7662954|NCT02044419|18872023|P3|COMPLETED|First Intervention||10
7662955|NCT02044419|18872024|P2|COMPLETED|First Intervention||9
7662956|NCT02044419|18872025|P1|COMPLETED|First Intervention||11
7662957|NCT02044419|18872023|P3|STARTED|First Intervention||11
7662958|NCT02044419|18872024|P2|STARTED|First Intervention||10
7662959|NCT02044419|18872025|P1|STARTED|First Intervention||11
7662960|NCT02044393|18872050|P2|NOT COMPLETED|Period 2||0
7662961|NCT02044393|18872051|P1|NOT COMPLETED|Period 2||0
7662962|NCT02044393|18872050|P2|COMPLETED|Period 2||10
7662963|NCT02044393|18872051|P1|COMPLETED|Period 2||10
7662964|NCT02044393|18872050|P2|STARTED|Period 2||10
7662965|NCT02044393|18872051|P1|STARTED|Period 2||10
7662966|NCT02044393|18872050|P2|NOT COMPLETED|Period 1||0
7662967|NCT02044393|18872051|P1|NOT COMPLETED|Period 1||0
7662968|NCT02044393|18872050|P2|COMPLETED|Period 1||10
7662969|NCT02044393|18872051|P1|COMPLETED|Period 1||10
7662970|NCT02044393|18872050|P2|STARTED|Period 1||10
7662971|NCT02044393|18872051|P1|STARTED|Period 1||10
7662972|NCT02044380|18872064|P1|NOT COMPLETED|Overall Study||0
7662973|NCT02044380|18872064|P1|COMPLETED|Overall Study||14
7662974|NCT02044380|18872064|P1|STARTED|Overall Study|Started are the treated patients|14
7662975|NCT02044367|18872068|P6|NOT COMPLETED|Overall Study||0
7662976|NCT02044367|18872069|P5|NOT COMPLETED|Overall Study||0
7662977|NCT02044367|18872070|P4|NOT COMPLETED|Overall Study||0
7662978|NCT02044367|18872071|P3|NOT COMPLETED|Overall Study||0
7662979|NCT02044367|18872072|P2|NOT COMPLETED|Overall Study||0
7662980|NCT02044367|18872073|P1|NOT COMPLETED|Overall Study||0
7662981|NCT02044367|18872068|P6|COMPLETED|Overall Study||9
7662982|NCT02044367|18872069|P5|COMPLETED|Overall Study||9
7662983|NCT02044367|18872070|P4|COMPLETED|Overall Study||9
7662984|NCT02044367|18872071|P3|COMPLETED|Overall Study||9
7662985|NCT02044367|18872072|P2|COMPLETED|Overall Study||9
7662986|NCT02044367|18872073|P1|COMPLETED|Overall Study||9
7662987|NCT02044367|18872068|P6|STARTED|Overall Study||9
7662988|NCT02044367|18872069|P5|STARTED|Overall Study||9
7662989|NCT02044367|18872070|P4|STARTED|Overall Study||9
7662990|NCT02044367|18872071|P3|STARTED|Overall Study||9
7662991|NCT02044367|18872072|P2|STARTED|Overall Study||9
7662992|NCT02044367|18872073|P1|STARTED|Overall Study||9
7662993|NCT02044302|18872096|P2|NOT COMPLETED|Overall Study||0
7662994|NCT02044302|18872097|P1|NOT COMPLETED|Overall Study||2
7662995|NCT02044302|18872096|P2|COMPLETED|Overall Study||0
7662996|NCT02044302|18872097|P1|COMPLETED|Overall Study||0
7662997|NCT02044302|18872096|P2|STARTED|Overall Study||0
7662998|NCT02044302|18872097|P1|STARTED|Overall Study||2
7662999|NCT02044159|18872105|P2|NOT COMPLETED|Overall Study||4
7663000|NCT02044159|18872106|P1|NOT COMPLETED|Overall Study||4
7663001|NCT02044159|18872105|P2|COMPLETED|Overall Study||26
7663002|NCT02044159|18872106|P1|COMPLETED|Overall Study||23
7663003|NCT02044159|18872105|P2|STARTED|Overall Study||30
7663004|NCT02044159|18872106|P1|STARTED|Overall Study||27
7663005|NCT02044094|18872119|P1|NOT COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||13
7663006|NCT02044094|18872119|P1|COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||17
7663007|NCT02044094|18872119|P1|STARTED|RBP-6000 Injection 2 (Day 29 to Week 12)||30
7663008|NCT02044094|18872119|P1|NOT COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||9
7663009|NCT02044094|18872119|P1|COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||30
7663010|NCT02044094|18872119|P1|Completers Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects that reached Day 28 + completed all challenges at Week 4 were considered study completers.|30
7663011|NCT02044094|18872119|P1|Intent to Treat Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects who receive >=1 dose of RBP-6000 and have >=1 complete sequence of hydromorphone challenges|38
7663012|NCT02044094|18872119|P1|STARTED|RBP-6000 Injection 1 (Day 1 to Day 28)||39
7663013|NCT02043938|18872176|P1|NOT COMPLETED|Overall Study||10
7663014|NCT02043938|18872176|P1|COMPLETED|Overall Study||36
7663015|NCT02043938|18872176|P1|STARTED|Overall Study||46
7663016|NCT02043860|18872186|P1|NOT COMPLETED|Overall Study||0
7663017|NCT02043860|18872186|P1|COMPLETED|Overall Study||2
7663018|NCT02043860|18872186|P1|STARTED|Overall Study||2
7663019|NCT02043808|18872192|P2|NOT COMPLETED|Overall Study||0
7663020|NCT02043808|18872193|P1|NOT COMPLETED|Overall Study||0
7663021|NCT02043808|18872192|P2|COMPLETED|Overall Study||12793
7663022|NCT02043808|18872193|P1|COMPLETED|Overall Study||12793
7663023|NCT02043808|18872192|P2|STARTED|Overall Study||12793
7663024|NCT02043808|18872193|P1|STARTED|Overall Study||12793
7663025|NCT02043782|18872231|P6|NOT COMPLETED|Period 3||0
7663026|NCT02043782|18872232|P5|NOT COMPLETED|Period 3||0
7663027|NCT02043782|18872233|P4|NOT COMPLETED|Period 3||0
7663028|NCT02043782|18872234|P3|NOT COMPLETED|Period 3||0
7663029|NCT02043782|18872235|P2|NOT COMPLETED|Period 3||0
7663030|NCT02043782|18872236|P1|NOT COMPLETED|Period 3||0
7663031|NCT02043782|18872231|P6|COMPLETED|Period 3||6
7663032|NCT02043782|18872232|P5|COMPLETED|Period 3||6
7663033|NCT02043782|18872233|P4|COMPLETED|Period 3||6
7663034|NCT02043782|18872234|P3|COMPLETED|Period 3||6
7663035|NCT02043782|18872235|P2|COMPLETED|Period 3||6
7663036|NCT02043782|18872236|P1|COMPLETED|Period 3||7
7663037|NCT02043782|18872231|P6|STARTED|Period 3||6
7663038|NCT02043782|18872232|P5|STARTED|Period 3||6
7663039|NCT02043782|18872233|P4|STARTED|Period 3||6
7663040|NCT02043782|18872234|P3|STARTED|Period 3||6
7663041|NCT02043782|18872235|P2|STARTED|Period 3||6
7663042|NCT02043782|18872236|P1|STARTED|Period 3||7
7663043|NCT02043782|18872231|P6|NOT COMPLETED|Period 2||0
7663044|NCT02043782|18872232|P5|NOT COMPLETED|Period 2||0
7663045|NCT02043782|18872233|P4|NOT COMPLETED|Period 2||0
7663046|NCT02043782|18872234|P3|NOT COMPLETED|Period 2||0
7663047|NCT02043782|18872235|P2|NOT COMPLETED|Period 2||0
7663048|NCT02043782|18872236|P1|NOT COMPLETED|Period 2||0
7663049|NCT02043782|18872231|P6|COMPLETED|Period 2||6
7663050|NCT02043782|18872232|P5|COMPLETED|Period 2||6
7663051|NCT02043782|18872233|P4|COMPLETED|Period 2||6
7663052|NCT02043782|18872234|P3|COMPLETED|Period 2||6
7663053|NCT02043782|18872235|P2|COMPLETED|Period 2||6
7663054|NCT02043782|18872236|P1|COMPLETED|Period 2||7
7663055|NCT02043782|18872231|P6|STARTED|Period 2||6
7663056|NCT02043782|18872232|P5|STARTED|Period 2||6
7663057|NCT02043782|18872233|P4|STARTED|Period 2||6
7663058|NCT02043782|18872234|P3|STARTED|Period 2||6
7663059|NCT02043782|18872235|P2|STARTED|Period 2||6
7663060|NCT02043782|18872236|P1|STARTED|Period 2||7
7663061|NCT02043782|18872231|P6|NOT COMPLETED|Period 1||0
7663062|NCT02043782|18872232|P5|NOT COMPLETED|Period 1||0
7663063|NCT02043782|18872233|P4|NOT COMPLETED|Period 1||0
7663064|NCT02043782|18872234|P3|NOT COMPLETED|Period 1||1
7663065|NCT02043782|18872235|P2|NOT COMPLETED|Period 1||0
7663066|NCT02043782|18872236|P1|NOT COMPLETED|Period 1||0
7663067|NCT02043782|18872231|P6|COMPLETED|Period 1||6
7663068|NCT02043782|18872232|P5|COMPLETED|Period 1||6
7663069|NCT02043782|18872233|P4|COMPLETED|Period 1||6
7663070|NCT02043782|18872234|P3|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6
7663071|NCT02043782|18872235|P2|COMPLETED|Period 1||6
7663072|NCT02043782|18872236|P1|COMPLETED|Period 1||7
7663073|NCT02043782|18872231|P6|STARTED|Period 1||6
7663074|NCT02043782|18872232|P5|STARTED|Period 1||6
7663075|NCT02043782|18872233|P4|STARTED|Period 1||6
7663076|NCT02043782|18872234|P3|STARTED|Period 1||7
7663077|NCT02043782|18872235|P2|STARTED|Period 1||6
7663078|NCT02043782|18872236|P1|STARTED|Period 1||7
7663079|NCT02043704|18872246|P2|NOT COMPLETED|Overall Study||7
7663080|NCT02043704|18872247|P1|NOT COMPLETED|Overall Study||3
7663081|NCT02043704|18872246|P2|COMPLETED|Overall Study||43
7663082|NCT02043704|18872247|P1|COMPLETED|Overall Study||47
7663083|NCT02043704|18872246|P2|STARTED|Overall Study||50
7663084|NCT02043704|18872247|P1|STARTED|Overall Study||50
7663085|NCT02043678|18872279|P2|NOT COMPLETED|Overall Study||405
7663086|NCT02043678|18872280|P1|NOT COMPLETED|Overall Study||401
7663087|NCT02043678|18872279|P2|COMPLETED|Overall Study||0
7663088|NCT02043678|18872280|P1|COMPLETED|Overall Study||0
7663089|NCT02043678|18872279|P2|Treated|Overall Study||396
7663090|NCT02043678|18872280|P1|Treated|Overall Study||390
7663091|NCT02043678|18872279|P2|STARTED|Overall Study||405
7663092|NCT02043678|18872280|P1|STARTED|Overall Study||401
7663093|NCT02043652|18872296|P1|NOT COMPLETED|Overall Study||26
7663094|NCT02043652|18872296|P1|COMPLETED|Overall Study||93
7663095|NCT02043652|18872296|P1|STARTED|Overall Study||119
7663096|NCT02043574|18872303|P2|NOT COMPLETED|Overall Study||6
7663097|NCT02043574|18872304|P1|NOT COMPLETED|Overall Study||6
7663098|NCT02043574|18872303|P2|COMPLETED|Overall Study||20
7663099|NCT02043574|18872304|P1|COMPLETED|Overall Study||19
7663100|NCT02043574|18872303|P2|STARTED|Overall Study||26
7663101|NCT02043574|18872304|P1|STARTED|Overall Study||25
7663102|NCT02043548|18872316|P2|NOT COMPLETED|Overall Study||1
7663103|NCT02043548|18872317|P1|NOT COMPLETED|Overall Study||1
7663104|NCT02043548|18872316|P2|COMPLETED|Overall Study||17
7663105|NCT02043548|18872317|P1|COMPLETED|Overall Study||17
7663106|NCT02043548|18872316|P2|STARTED|Overall Study||18
7663107|NCT02043548|18872317|P1|STARTED|Overall Study||18
7663108|NCT02043509|18872335|P2|NOT COMPLETED|Baseline to 2nd Follow-up||72
7663109|NCT02043509|18872336|P1|NOT COMPLETED|Baseline to 2nd Follow-up||74
7663110|NCT02043509|18872335|P2|COMPLETED|Baseline to 2nd Follow-up||132
7663111|NCT02043509|18872336|P1|COMPLETED|Baseline to 2nd Follow-up||129
7663112|NCT02043509|18872335|P2|STARTED|Baseline to 2nd Follow-up||204
7663113|NCT02043509|18872336|P1|STARTED|Baseline to 2nd Follow-up||203
7663114|NCT02043509|18872335|P2|NOT COMPLETED|Baseline to 1st Follow-up||47
7663115|NCT02043509|18872336|P1|NOT COMPLETED|Baseline to 1st Follow-up||65
7663116|NCT02043509|18872335|P2|COMPLETED|Baseline to 1st Follow-up||157
7663117|NCT02043509|18872336|P1|COMPLETED|Baseline to 1st Follow-up||138
7663118|NCT02043509|18872335|P2|STARTED|Baseline to 1st Follow-up||204
7663119|NCT02043509|18872336|P1|STARTED|Baseline to 1st Follow-up||203
7663120|NCT02043379|18872361|P2|NOT COMPLETED|Overall Study||0
7663121|NCT02043379|18872362|P1|NOT COMPLETED|Overall Study||0
7663122|NCT02043379|18872361|P2|COMPLETED|Overall Study||20
7663123|NCT02043379|18872362|P1|COMPLETED|Overall Study||30
7663124|NCT02043379|18872361|P2|STARTED|Overall Study||20
7663125|NCT02043379|18872362|P1|STARTED|Overall Study||30
7663126|NCT02043366|18872424|P6|NOT COMPLETED|Overall Study||2
7663127|NCT02043366|18872425|P5|NOT COMPLETED|Overall Study||2
7663128|NCT02043366|18872426|P4|NOT COMPLETED|Overall Study||2
7663129|NCT02043366|18872427|P3|NOT COMPLETED|Overall Study||2
7663130|NCT02043366|18872428|P2|NOT COMPLETED|Overall Study||2
7663131|NCT02043366|18872429|P1|NOT COMPLETED|Overall Study||2
7663132|NCT02043366|18872424|P6|COMPLETED|Overall Study||28
7663133|NCT02043366|18872425|P5|COMPLETED|Overall Study||28
7663134|NCT02043366|18872426|P4|COMPLETED|Overall Study||28
7663135|NCT02043366|18872427|P3|COMPLETED|Overall Study||28
7663136|NCT02043366|18872428|P2|COMPLETED|Overall Study||28
7663137|NCT02043366|18872429|P1|COMPLETED|Overall Study||28
7663138|NCT02043366|18872424|P6|STARTED|Overall Study||30
7663139|NCT02043366|18872425|P5|STARTED|Overall Study||30
7663140|NCT02043366|18872426|P4|STARTED|Overall Study||30
7663141|NCT02043366|18872427|P3|STARTED|Overall Study||30
7663142|NCT02043366|18872428|P2|STARTED|Overall Study||30
7663143|NCT02043366|18872429|P1|STARTED|Overall Study||30
7663144|NCT02043301|18872452|P3|NOT COMPLETED|Overall Study||0
7663145|NCT02043301|18872453|P2|NOT COMPLETED|Overall Study||1
7663146|NCT02043301|18872454|P1|NOT COMPLETED|Overall Study||0
7663147|NCT02043301|18872452|P3|COMPLETED|Overall Study||25
7663148|NCT02043301|18872453|P2|COMPLETED|Overall Study||24
7663149|NCT02043301|18872454|P1|COMPLETED|Overall Study||25
7663150|NCT02043301|18872452|P3|STARTED|Overall Study||25
7663151|NCT02043301|18872453|P2|STARTED|Overall Study||25
7663152|NCT02043301|18872454|P1|STARTED|Overall Study||25
7663153|NCT02043197|18872512|P1|NOT COMPLETED|Overall Study||8
7663154|NCT02043197|18872512|P1|COMPLETED|Overall Study||292
7663155|NCT02043197|18872512|P1|STARTED|Overall Study||300
7663156|NCT02043145|18872536|P3|NOT COMPLETED|Overall Study||0
7663157|NCT02043145|18872537|P2|NOT COMPLETED|Overall Study||0
7663158|NCT02043145|18872538|P1|NOT COMPLETED|Overall Study||0
7663159|NCT02043145|18872536|P3|COMPLETED|Overall Study||425
7663160|NCT02043145|18872537|P2|COMPLETED|Overall Study||247
7663161|NCT02043145|18872538|P1|COMPLETED|Overall Study||55
7663162|NCT02043145|18872536|P3|STARTED|Overall Study||425
7663163|NCT02043145|18872537|P2|STARTED|Overall Study||247
7663164|NCT02043145|18872538|P1|STARTED|Overall Study||55
7663165|NCT02043132|18872551|P2|NOT COMPLETED|Overall Study||9
7663166|NCT02043132|18872552|P1|NOT COMPLETED|Overall Study||5
7663167|NCT02043132|18872551|P2|COMPLETED|Overall Study||49
7663168|NCT02043132|18872552|P1|COMPLETED|Overall Study||53
7663169|NCT02043132|18872551|P2|STARTED|Overall Study||58
7663170|NCT02043132|18872552|P1|STARTED|Overall Study||58
7663171|NCT02043015|18872572|P1|NOT COMPLETED|Overall Study||28
7663172|NCT02043015|18872572|P1|COMPLETED|Overall Study||87
7663173|NCT02043015|18872572|P1|STARTED|Overall Study||115
7663174|NCT02042950|18872585|P1|NOT COMPLETED|Overall Study||4
7663175|NCT02042950|18872585|P1|COMPLETED|Overall Study||0
7663176|NCT02042950|18872585|P1|STARTED|Overall Study||4
7663177|NCT02042924|18872591|P1|NOT COMPLETED|Overall Study||1
7663178|NCT02042924|18872591|P1|COMPLETED|Overall Study||1
7663179|NCT02042924|18872591|P1|STARTED|Overall Study||2
7663180|NCT02042911|18872597|P1|NOT COMPLETED|Overall Study||1
7663181|NCT02042911|18872597|P1|COMPLETED|Overall Study||9
7663182|NCT02042911|18872597|P1|STARTED|Overall Study||10
7663183|NCT02042872|18872611|P2|NOT COMPLETED|Overall Study||5
7663184|NCT02042872|18872612|P1|NOT COMPLETED|Overall Study||0
7663185|NCT02042872|18872611|P2|COMPLETED|Overall Study||8
7663186|NCT02042872|18872612|P1|COMPLETED|Overall Study||8
7663187|NCT02042872|18872611|P2|STARTED|Overall Study||13
7663188|NCT02042872|18872612|P1|STARTED|Overall Study||8
7663189|NCT02042534|18872622|P2|NOT COMPLETED|Overall Study||0
7663190|NCT02042534|18872623|P1|NOT COMPLETED|Overall Study||0
7663191|NCT02042534|18872622|P2|COMPLETED|Overall Study||94
7663192|NCT02042534|18872623|P1|COMPLETED|Overall Study||101
7663193|NCT02042534|18872622|P2|STARTED|Overall Study||94
7663194|NCT02042534|18872623|P1|STARTED|Overall Study||101
7663195|NCT02042443|18872639|P2|NOT COMPLETED|Overall Study||26
7663196|NCT02042443|18872640|P1|NOT COMPLETED|Overall Study||27
7663197|NCT02042443|18872639|P2|COMPLETED|Overall Study||0
7663198|NCT02042443|18872640|P1|COMPLETED|Overall Study||0
7663199|NCT02042443|18872639|P2|Eligible and Analyzable|Overall Study||20
7663200|NCT02042443|18872640|P1|Eligible and Analyzable|Overall Study||24
7663201|NCT02042443|18872639|P2|STARTED|Overall Study||26
7663202|NCT02042443|18872640|P1|STARTED|Overall Study||27
7663203|NCT02042404|18872652|P2|NOT COMPLETED|Overall Study||0
7663204|NCT02042404|18872653|P1|NOT COMPLETED|Overall Study||5
7663205|NCT02042404|18872652|P2|COMPLETED|Overall Study||5
7663206|NCT02042404|18872653|P1|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38
7663207|NCT02042404|18872652|P2|STARTED|Overall Study||5
7663208|NCT02042404|18872653|P1|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43
7663209|NCT02042274|18872664|P1|NOT COMPLETED|Overall Study||0
7663210|NCT02042274|18872664|P1|COMPLETED|Overall Study||12
7663211|NCT02042274|18872664|P1|STARTED|Overall Study||12
7663212|NCT02042183|18872671|P2|NOT COMPLETED|Overall Study||36
7663213|NCT02042183|18872672|P1|NOT COMPLETED|Overall Study||65
7663214|NCT02042183|18872671|P2|COMPLETED|Overall Study||166
7663215|NCT02042183|18872672|P1|COMPLETED|Overall Study||339
7663216|NCT02042183|18872671|P2|Modified Intent-to-treat (mITT)|Overall Study||195
7663217|NCT02042183|18872672|P1|Modified Intent-to-treat (mITT)|Overall Study||399
7663218|NCT02042183|18872671|P2|Safety Population|Overall Study||195
7663219|NCT02042183|18872672|P1|Safety Population|Overall Study||400
7663220|NCT02042183|18872671|P2|STARTED|Overall Study||202
7663221|NCT02042183|18872672|P1|STARTED|Overall Study||404
7663222|NCT02042131|18872683|P3|NOT COMPLETED|Overall Study||0
7663223|NCT02042131|18872684|P2|NOT COMPLETED|Overall Study||0
7663224|NCT02042131|18872685|P1|NOT COMPLETED|Overall Study||0
7663225|NCT02042131|18872683|P3|COMPLETED|Overall Study||33
7663226|NCT02042131|18872684|P2|COMPLETED|Overall Study||32
7663227|NCT02042131|18872685|P1|COMPLETED|Overall Study||32
7663228|NCT02042131|18872683|P3|STARTED|Overall Study||33
7663229|NCT02042131|18872684|P2|STARTED|Overall Study||32
7663230|NCT02042131|18872685|P1|STARTED|Overall Study||32
7663231|NCT02042014|18872702|P1|NOT COMPLETED|Overall Study||8
7663232|NCT02042014|18872702|P1|COMPLETED|Overall Study||0
7663233|NCT02042014|18872702|P1|STARTED|Overall Study||8
7663234|NCT02041962|18872708|P2|NOT COMPLETED|Overall Study||84
7663235|NCT02041962|18872709|P1|NOT COMPLETED|Overall Study||81
7663236|NCT02041962|18872708|P2|COMPLETED|Overall Study||31
7663237|NCT02041962|18872709|P1|COMPLETED|Overall Study||42
7663238|NCT02041962|18872708|P2|Participants Completing 12 mo. f/up|Overall Study||31
7663239|NCT02041962|18872709|P1|Participants Completing 12 mo. f/up|Overall Study||42
7663240|NCT02041962|18872708|P2|Participants Completing 6 mo. f/up|Overall Study||44
7663241|NCT02041962|18872709|P1|Participants Completing 6 mo. f/up|Overall Study||69
7663242|NCT02041962|18872708|P2|STARTED|Overall Study||115
7663243|NCT02041962|18872709|P1|STARTED|Overall Study||123
7663244|NCT02041702|18872719|P2|NOT COMPLETED|Overall Study||9
7663245|NCT02041702|18872720|P1|NOT COMPLETED|Overall Study||11
7663246|NCT02041702|18872719|P2|COMPLETED|Overall Study||134
7663247|NCT02041702|18872720|P1|COMPLETED|Overall Study||129
7663248|NCT02041702|18872719|P2|Post MRI Scan/ Post Waiting|Overall Study||140
7663249|NCT02041702|18872720|P1|Post MRI Scan/ Post Waiting|Overall Study||129
7663250|NCT02041702|18872719|P2|Pre MRI Scan/ Pre Waitng|Overall Study||140
7663251|NCT02041702|18872720|P1|Pre MRI Scan/ Pre Waitng|Overall Study||129
7663252|NCT02041702|18872719|P2|STARTED|Overall Study||143
7663253|NCT02041702|18872720|P1|STARTED|Overall Study||140
7663254|NCT02041533|18872735|P2|NOT COMPLETED|Overall Study||258
7663255|NCT02041533|18872736|P1|NOT COMPLETED|Overall Study||228
7663256|NCT02041533|18872735|P2|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|12
7663257|NCT02041533|18872736|P1|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|43
7663258|NCT02041533|18872735|P2|Began Treatment|Overall Study||263
7663259|NCT02041533|18872736|P1|Began Treatment|Overall Study||267
7663260|NCT02041533|18872735|P2|STARTED|Overall Study||270
7663261|NCT02041533|18872736|P1|STARTED|Overall Study||271
7663262|NCT02041520|18872758|P2|NOT COMPLETED|Overall Study||7
7663263|NCT02041520|18872759|P1|NOT COMPLETED|Overall Study||6
7663264|NCT02041520|18872758|P2|COMPLETED|Overall Study||28
7663265|NCT02041520|18872759|P1|COMPLETED|Overall Study||29
7663266|NCT02041520|18872758|P2|STARTED|Overall Study|35 patients randomly assigned to placebo|35
7663267|NCT02041520|18872759|P1|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35
7663268|NCT02041377|18872779|P1|NOT COMPLETED|Overall Study||0
7663269|NCT02041377|18872779|P1|COMPLETED|Overall Study||134
7663270|NCT02041377|18872779|P1|STARTED|Overall Study||134
7663271|NCT02041325|18872789|P2|NOT COMPLETED|Overall Study||3
7663272|NCT02041325|18872790|P1|NOT COMPLETED|Overall Study||3
7663273|NCT02041325|18872789|P2|COMPLETED|Overall Study||13
7663274|NCT02041325|18872790|P1|COMPLETED|Overall Study||19
7663275|NCT02041325|18872789|P2|STARTED|Overall Study||16
7663276|NCT02041325|18872790|P1|STARTED|Overall Study||22
7663277|NCT02041286|18872802|P1|NOT COMPLETED|Overall Study||1
7663278|NCT02041286|18872802|P1|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135
7663279|NCT02041286|18872802|P1|STARTED|Overall Study||136
7663280|NCT02041221|18872816|P6|NOT COMPLETED|Part 2||0
7663281|NCT02041221|18872817|P5|NOT COMPLETED|Part 2||0
7663282|NCT02041221|18872818|P4|NOT COMPLETED|Part 2||0
7663283|NCT02041221|18872819|P3|NOT COMPLETED|Part 2||1
7663284|NCT02041221|18872820|P2|NOT COMPLETED|Part 2||0
7663285|NCT02041221|18872821|P1|NOT COMPLETED|Part 2||0
7663286|NCT02041221|18872816|P6|COMPLETED|Part 2||6
7663287|NCT02041221|18872817|P5|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
7663288|NCT02041221|18872818|P4|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
7663289|NCT02041221|18872819|P3|COMPLETED|Part 2||5
7663290|NCT02041221|18872820|P2|COMPLETED|Part 2||6
7663291|NCT02041221|18872821|P1|COMPLETED|Part 2||6
7663292|NCT02041221|18872816|P6|STARTED|Part 2||6
7663293|NCT02041221|18872817|P5|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
7663294|NCT02041221|18872818|P4|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0
7663295|NCT02041221|18872819|P3|STARTED|Part 2||6
7663296|NCT02041221|18872820|P2|STARTED|Part 2||6
7663297|NCT02041221|18872821|P1|STARTED|Part 2||6
7663298|NCT02041221|18872816|P6|NOT COMPLETED|Part 1||0
7663299|NCT02041221|18872817|P5|NOT COMPLETED|Part 1||0
7663300|NCT02041221|18872818|P4|NOT COMPLETED|Part 1||0
7663301|NCT02041221|18872819|P3|NOT COMPLETED|Part 1||0
7663302|NCT02041221|18872820|P2|NOT COMPLETED|Part 1||0
7663303|NCT02041221|18872821|P1|NOT COMPLETED|Part 1||0
7663304|NCT02041221|18872816|P6|COMPLETED|Part 1||10
7663305|NCT02041221|18872817|P5|COMPLETED|Part 1||6
7663306|NCT02041221|18872818|P4|COMPLETED|Part 1||6
7663307|NCT02041221|18872819|P3|COMPLETED|Part 1||6
7663308|NCT02041221|18872820|P2|COMPLETED|Part 1||6
7663309|NCT02041221|18872821|P1|COMPLETED|Part 1||6
7663310|NCT02041221|18872816|P6|STARTED|Part 1||10
7663311|NCT02041221|18872817|P5|STARTED|Part 1||6
7663312|NCT02041221|18872818|P4|STARTED|Part 1||6
7663313|NCT02041221|18872819|P3|STARTED|Part 1||6
7663314|NCT02041221|18872820|P2|STARTED|Part 1||6
7663315|NCT02041221|18872821|P1|STARTED|Part 1||6
7663316|NCT02041104|18872837|P2|NOT COMPLETED|Overall Study||7
7663317|NCT02041104|18872838|P1|NOT COMPLETED|Overall Study||1
7663318|NCT02041104|18872837|P2|COMPLETED|Overall Study||16
7663319|NCT02041104|18872838|P1|COMPLETED|Overall Study||27
7663320|NCT02041104|18872837|P2|STARTED|Overall Study||23
7663321|NCT02041104|18872838|P1|STARTED|Overall Study||28
7663322|NCT02041091|18872878|P2|NOT COMPLETED|Optional Safety Extension Period||82
7663323|NCT02041091|18872879|P1|NOT COMPLETED|Optional Safety Extension Period||85
7663324|NCT02041091|18872878|P2|COMPLETED|Optional Safety Extension Period||0
7663325|NCT02041091|18872879|P1|COMPLETED|Optional Safety Extension Period||0
7663326|NCT02041091|18872878|P2|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|82
7663327|NCT02041091|18872879|P1|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|85
7663328|NCT02041091|18872878|P2|NOT COMPLETED|Treatment||23
7663329|NCT02041091|18872879|P1|NOT COMPLETED|Treatment||22
7663330|NCT02041091|18872878|P2|COMPLETED|Treatment||91
7663331|NCT02041091|18872879|P1|COMPLETED|Treatment||90
7663332|NCT02041091|18872878|P2|Participated in Follow Up|Treatment||96
7663333|NCT02041091|18872879|P1|Participated in Follow Up|Treatment||106
7663334|NCT02041091|18872878|P2|Received At Least One Dose of Study Drug|Treatment||114
7663335|NCT02041091|18872879|P1|Received At Least One Dose of Study Drug|Treatment||112
7663336|NCT02041091|18872878|P2|STARTED|Treatment||114
7663337|NCT02041091|18872879|P1|STARTED|Treatment||112
7663338|NCT02040870|18872901|P1|NOT COMPLETED|Overall Study||103
7663339|NCT02040870|18872901|P1|COMPLETED|Overall Study||0
7663340|NCT02040870|18872901|P1|Discontinue From Study|Overall Study||26
7663341|NCT02040870|18872901|P1|Entered Survival Follow-up|Overall Study||75
7663342|NCT02040870|18872901|P1|Entered Post-treatment Follow-up|Overall Study||2
7663343|NCT02040870|18872901|P1|STARTED|Overall Study||103
7663344|NCT02040857|18872922|P1|NOT COMPLETED|Overall Study||60
7663345|NCT02040857|18872922|P1|COMPLETED|Overall Study||102
7663346|NCT02040857|18872922|P1|Treatment Discontinuation Evaluable|Overall Study|Evaluable population excludes participants who discontinue early for reasons unrelated to treatment.|152
7663347|NCT02040857|18872922|P1|STARTED|Overall Study||162
7663348|NCT02040844|18872935|P3|NOT COMPLETED|Overall Study||47
7663349|NCT02040844|18872936|P2|NOT COMPLETED|Overall Study||39
7663350|NCT02040844|18872937|P1|NOT COMPLETED|Overall Study||50
7663351|NCT02040844|18872935|P3|COMPLETED|Overall Study||97
7663352|NCT02040844|18872936|P2|COMPLETED|Overall Study||109
7663353|NCT02040844|18872937|P1|COMPLETED|Overall Study||88
7663354|NCT02040844|18872935|P3|STARTED|Overall Study||144
7663355|NCT02040844|18872936|P2|STARTED|Overall Study||148
7663356|NCT02040844|18872937|P1|STARTED|Overall Study||138
7663357|NCT02040805|18872962|P2|NOT COMPLETED|Overall Study||50
7663358|NCT02040805|18872963|P1|NOT COMPLETED|Overall Study||42
7663359|NCT02040805|18872962|P2|COMPLETED|Overall Study||113
7663360|NCT02040805|18872963|P1|COMPLETED|Overall Study||118
7663361|NCT02040805|18872962|P2|STARTED|Overall Study||163
7663362|NCT02040805|18872963|P1|STARTED|Overall Study||160
7663363|NCT02040792|18872980|P5|NOT COMPLETED|Overall Study||7
7663364|NCT02040792|18872981|P4|NOT COMPLETED|Overall Study||7
7663365|NCT02040792|18872982|P3|NOT COMPLETED|Overall Study||3
7663366|NCT02040792|18872983|P2|NOT COMPLETED|Overall Study||3
7663367|NCT02040792|18872984|P1|NOT COMPLETED|Overall Study||6
7663368|NCT02040792|18872980|P5|COMPLETED|Overall Study||67
7663369|NCT02040792|18872981|P4|COMPLETED|Overall Study||64
7663370|NCT02040792|18872982|P3|COMPLETED|Overall Study||68
7663371|NCT02040792|18872983|P2|COMPLETED|Overall Study||65
7663372|NCT02040792|18872984|P1|COMPLETED|Overall Study||64
7663373|NCT02040792|18872980|P5|STARTED|Overall Study||74
7663374|NCT02040792|18872981|P4|STARTED|Overall Study||71
7663375|NCT02040792|18872982|P3|STARTED|Overall Study||71
7663376|NCT02040792|18872983|P2|STARTED|Overall Study||68
7663377|NCT02040792|18872984|P1|STARTED|Overall Study||70
7663378|NCT02040779|18872999|P3|NOT COMPLETED|Overall Study||4
7663379|NCT02040779|18873000|P2|NOT COMPLETED|Overall Study||7
7663380|NCT02040779|18873001|P1|NOT COMPLETED|Overall Study||12
7663381|NCT02040779|18872999|P3|COMPLETED|Overall Study||88
7663382|NCT02040779|18873000|P2|COMPLETED|Overall Study||83
7663383|NCT02040779|18873001|P1|COMPLETED|Overall Study||79
7663384|NCT02040779|18872999|P3|Full Analysis Set (FAS)|Overall Study||92
7663385|NCT02040779|18873000|P2|Full Analysis Set (FAS)|Overall Study||88
7663386|NCT02040779|18873001|P1|Full Analysis Set (FAS)|Overall Study||90
7663387|NCT02040779|18872999|P3|STARTED|Overall Study||92
7663388|NCT02040779|18873000|P2|STARTED|Overall Study||90
7663389|NCT02040779|18873001|P1|STARTED|Overall Study||91
7663390|NCT02040766|18873041|P5|NOT COMPLETED|Overall Study||13
7663391|NCT02040766|18873042|P4|NOT COMPLETED|Overall Study||13
7663392|NCT02040766|18873043|P3|NOT COMPLETED|Overall Study||12
7663393|NCT02040766|18873044|P2|NOT COMPLETED|Overall Study||10
7663394|NCT02040766|18873045|P1|NOT COMPLETED|Overall Study||18
7663395|NCT02040766|18873041|P5|COMPLETED|Overall Study||112
7663396|NCT02040766|18873042|P4|COMPLETED|Overall Study||112
7663397|NCT02040766|18873043|P3|COMPLETED|Overall Study||113
7663398|NCT02040766|18873044|P2|COMPLETED|Overall Study||116
7663399|NCT02040766|18873045|P1|COMPLETED|Overall Study||109
7663400|NCT02040766|18873041|P5|STARTED|Overall Study||125
7663401|NCT02040766|18873042|P4|STARTED|Overall Study||125
7663402|NCT02040766|18873043|P3|STARTED|Overall Study||125
7663403|NCT02040766|18873044|P2|STARTED|Overall Study||126
7663404|NCT02040766|18873045|P1|STARTED|Overall Study||127
7663405|NCT02040623|18873086|P3|NOT COMPLETED|Overall Study||2
7663406|NCT02040623|18873087|P2|NOT COMPLETED|Overall Study||6
7663407|NCT02040623|18873088|P1|NOT COMPLETED|Overall Study||4
7663408|NCT02040623|18873086|P3|COMPLETED|Overall Study||10
7663409|NCT02040623|18873087|P2|COMPLETED|Overall Study||6
7663410|NCT02040623|18873088|P1|COMPLETED|Overall Study||7
7663411|NCT02040623|18873086|P3|STARTED|Overall Study||12
7663412|NCT02040623|18873087|P2|STARTED|Overall Study||12
7663413|NCT02040623|18873088|P1|STARTED|Overall Study||11
7663414|NCT02040584|18873098|P2|NOT COMPLETED|Overall Study||32
7663415|NCT02040584|18873099|P1|NOT COMPLETED|Overall Study||35
7663416|NCT02040584|18873098|P2|COMPLETED|Overall Study||74
7663417|NCT02040584|18873099|P1|COMPLETED|Overall Study||70
7663418|NCT02040584|18873098|P2|STARTED|Overall Study||106
7663419|NCT02040584|18873099|P1|STARTED|Overall Study||105
7663420|NCT02040532|18873132|P1|NOT COMPLETED|Overall Study||12
7663421|NCT02040532|18873132|P1|COMPLETED|Overall Study||20
7663422|NCT02040532|18873132|P1|Received at Least One Dose of Medication|Overall Study||26
7663423|NCT02040532|18873132|P1|STARTED|Overall Study||32
7663424|NCT02040428|18873145|P2|NOT COMPLETED|Overall Study||4
7663425|NCT02040428|18873146|P1|NOT COMPLETED|Overall Study||5
7663426|NCT02040428|18873145|P2|COMPLETED|Overall Study||77
7663427|NCT02040428|18873146|P1|COMPLETED|Overall Study||70
7663428|NCT02040428|18873145|P2|Intent to Treat (Randomized Subjects)|Overall Study||80
7663429|NCT02040428|18873146|P1|Intent to Treat (Randomized Subjects)|Overall Study||76
7663430|NCT02040428|18873145|P2|STARTED|Overall Study||81
7663431|NCT02040428|18873146|P1|STARTED|Overall Study||75
7663432|NCT02040259|18873158|P1|NOT COMPLETED|Overall Study||363
7663433|NCT02040259|18873158|P1|COMPLETED|Overall Study||1645
7663434|NCT02040259|18873158|P1|STARTED|Overall Study||2008
7663435|NCT02040116|18873166|P1|NOT COMPLETED|Overall Study||0
7663436|NCT02040116|18873166|P1|COMPLETED|Overall Study||19
7663437|NCT02040116|18873166|P1|STARTED|Overall Study||19
7663438|NCT02040077|18873177|P3|NOT COMPLETED|Overall Study||0
7663439|NCT02040077|18873178|P2|NOT COMPLETED|Overall Study||0
7663440|NCT02040077|18873179|P1|NOT COMPLETED|Overall Study||0
7663441|NCT02040077|18873177|P3|COMPLETED|Overall Study||25
7663442|NCT02040077|18873178|P2|COMPLETED|Overall Study||24
7663443|NCT02040077|18873179|P1|COMPLETED|Overall Study||27
7663444|NCT02040077|18873177|P3|STARTED|Overall Study||25
7663445|NCT02040077|18873178|P2|STARTED|Overall Study||24
7663446|NCT02040077|18873179|P1|STARTED|Overall Study||27
7663447|NCT02039947|18873194|P4|NOT COMPLETED|Overall Study||0
7663448|NCT02039947|18873195|P3|NOT COMPLETED|Overall Study||0
7663449|NCT02039947|18873196|P2|NOT COMPLETED|Overall Study||0
7663450|NCT02039947|18873197|P1|NOT COMPLETED|Overall Study||0
7663451|NCT02039947|18873194|P4|COMPLETED|Overall Study||17
7663452|NCT02039947|18873195|P3|COMPLETED|Overall Study||16
7663453|NCT02039947|18873196|P2|COMPLETED|Overall Study||16
7663454|NCT02039947|18873197|P1|COMPLETED|Overall Study||76
7663455|NCT02039947|18873194|P4|STARTED|Overall Study||17
7663456|NCT02039947|18873195|P3|STARTED|Overall Study||16
7663457|NCT02039947|18873196|P2|STARTED|Overall Study||16
7663458|NCT02039947|18873197|P1|STARTED|Overall Study||76
7663459|NCT02039908|18873232|P4|NOT COMPLETED|Phase 2-School Year||8
7663460|NCT02039908|18873233|P3|NOT COMPLETED|Phase 2-School Year||12
7663461|NCT02039908|18873234|P2|NOT COMPLETED|Phase 2-School Year||0
7663462|NCT02039908|18873235|P1|NOT COMPLETED|Phase 2-School Year||0
7663463|NCT02039908|18873232|P4|COMPLETED|Phase 2-School Year||116
7663464|NCT02039908|18873233|P3|COMPLETED|Phase 2-School Year||109
7663465|NCT02039908|18873234|P2|COMPLETED|Phase 2-School Year||0
7663466|NCT02039908|18873235|P1|COMPLETED|Phase 2-School Year||0
7663467|NCT02039908|18873232|P4|STARTED|Phase 2-School Year||124
7663468|NCT02039908|18873233|P3|STARTED|Phase 2-School Year||121
7663469|NCT02039908|18873234|P2|STARTED|Phase 2-School Year||0
7663470|NCT02039908|18873235|P1|STARTED|Phase 2-School Year||0
7663471|NCT02039908|18873232|P4|NOT COMPLETED|Phase 1-Summer||0
7663472|NCT02039908|18873233|P3|NOT COMPLETED|Phase 1-Summer||0
7663473|NCT02039908|18873234|P2|NOT COMPLETED|Phase 1-Summer||6
7663474|NCT02039908|18873235|P1|NOT COMPLETED|Phase 1-Summer||13
7663475|NCT02039908|18873232|P4|COMPLETED|Phase 1-Summer||0
7663476|NCT02039908|18873233|P3|COMPLETED|Phase 1-Summer||0
7663477|NCT02039908|18873234|P2|COMPLETED|Phase 1-Summer||132
7663478|NCT02039908|18873235|P1|COMPLETED|Phase 1-Summer||116
7663479|NCT02039908|18873232|P4|STARTED|Phase 1-Summer||0
7663480|NCT02039908|18873233|P3|STARTED|Phase 1-Summer||0
7663481|NCT02039908|18873234|P2|STARTED|Phase 1-Summer||138
7663482|NCT02039908|18873235|P1|STARTED|Phase 1-Summer||129
7663483|NCT02039856|18873249|P2|NOT COMPLETED|Overall Study||853
7663484|NCT02039856|18873250|P1|NOT COMPLETED|Overall Study||2027
7663485|NCT02039856|18873249|P2|COMPLETED|Overall Study||327
7663486|NCT02039856|18873250|P1|COMPLETED|Overall Study||693
7663487|NCT02039856|18873249|P2|Total 24-month Completed|Overall Study||327
7663488|NCT02039856|18873250|P1|Total 24-month Completed|Overall Study||693
7663489|NCT02039856|18873249|P2|24-month Completed Providers/Staff|Overall Study||105
7663490|NCT02039856|18873250|P1|24-month Completed Providers/Staff|Overall Study||174
7663491|NCT02039856|18873249|P2|24-month Started Providers/Staff|Overall Study||304
7663492|NCT02039856|18873250|P1|24-month Started Providers/Staff|Overall Study||565
7663493|NCT02039856|18873249|P2|24-month Completed - Patients|Overall Study||222
7663494|NCT02039856|18873250|P1|24-month Completed - Patients|Overall Study||519
7663495|NCT02039856|18873249|P2|24-month Started - Patients|Overall Study||442
7663496|NCT02039856|18873250|P1|24-month Started - Patients|Overall Study||953
7663497|NCT02039856|18873249|P2|24-month Started|Overall Study||746
7663498|NCT02039856|18873250|P1|24-month Started|Overall Study||1518
7663499|NCT02039856|18873249|P2|12-month Providers/Staff|Overall Study||0
7663500|NCT02039856|18873250|P1|12-month Providers/Staff|Overall Study||0
7663501|NCT02039856|18873249|P2|12-month Completed- Patients|Overall Study||241
7663502|NCT02039856|18873250|P1|12-month Completed- Patients|Overall Study||580
7663503|NCT02039856|18873249|P2|12-month Started-patients|Overall Study||442
7663504|NCT02039856|18873250|P1|12-month Started-patients|Overall Study||953
7663505|NCT02039856|18873249|P2|Total Baseline Completed|Overall Study||536
7663506|NCT02039856|18873250|P1|Total Baseline Completed|Overall Study||1147
7663507|NCT02039856|18873249|P2|Baseline Completed -Providers/Staff|Overall Study||94
7663508|NCT02039856|18873250|P1|Baseline Completed -Providers/Staff|Overall Study||194
7663509|NCT02039856|18873249|P2|Baseline Started - Providers/Staff|Overall Study||261
7663510|NCT02039856|18873250|P1|Baseline Started - Providers/Staff|Overall Study||537
7663511|NCT02039856|18873249|P2|Baseline Completed - Patients|Overall Study||442
7663512|NCT02039856|18873250|P1|Baseline Completed - Patients|Overall Study||953
7663513|NCT02039856|18873249|P2|Baseline Started - Patients|Overall Study||919
7663514|NCT02039856|18873250|P1|Baseline Started - Patients|Overall Study||2183
7663515|NCT02039856|18873249|P2|STARTED|Overall Study||1180
7663516|NCT02039856|18873250|P1|STARTED|Overall Study||2720
7663517|NCT02039817|18873272|P2|NOT COMPLETED|Overall Study||0
7663518|NCT02039817|18873273|P1|NOT COMPLETED|Overall Study||0
7663519|NCT02039817|18873272|P2|COMPLETED|Overall Study||8
7663520|NCT02039817|18873273|P1|COMPLETED|Overall Study||8
7663521|NCT02039817|18873272|P2|STARTED|Overall Study||8
7663522|NCT02039817|18873273|P1|STARTED|Overall Study||8
7663523|NCT02039778|18873282|P1|NOT COMPLETED|Overall Study||4
7663524|NCT02039778|18873282|P1|COMPLETED|Overall Study||0
7663525|NCT02039778|18873282|P1|STARTED|Overall Study||4
7663526|NCT02039726|18873292|P2|NOT COMPLETED|Overall Study||16
7663527|NCT02039726|18873293|P1|NOT COMPLETED|Overall Study||45
7663528|NCT02039726|18873292|P2|COMPLETED|Overall Study||106
7663529|NCT02039726|18873293|P1|COMPLETED|Overall Study||200
7663530|NCT02039726|18873292|P2|Did Not Receive Treatment|Overall Study||28
7663531|NCT02039726|18873293|P1|Did Not Receive Treatment|Overall Study||4
7663532|NCT02039726|18873292|P2|Ongoing (as of Data Cutoff)|Overall Study||16
7663533|NCT02039726|18873293|P1|Ongoing (as of Data Cutoff)|Overall Study||45
7663534|NCT02039726|18873292|P2|STARTED|Overall Study||122
7663535|NCT02039726|18873293|P1|STARTED|Overall Study||245
7663536|NCT02039687|18873305|P4|NOT COMPLETED|Overall Study||0
7663537|NCT02039687|18873306|P3|NOT COMPLETED|Overall Study||3
7663538|NCT02039687|18873307|P2|NOT COMPLETED|Overall Study||1
7663539|NCT02039687|18873308|P1|NOT COMPLETED|Overall Study||0
7663540|NCT02039687|18873305|P4|COMPLETED|Overall Study||16
7663541|NCT02039687|18873306|P3|COMPLETED|Overall Study||13
7663542|NCT02039687|18873307|P2|COMPLETED|Overall Study||15
7663543|NCT02039687|18873308|P1|COMPLETED|Overall Study||16
7663544|NCT02039687|18873305|P4|STARTED|Overall Study||16
7663545|NCT02039687|18873306|P3|STARTED|Overall Study||16
7663546|NCT02039687|18873307|P2|STARTED|Overall Study||16
7663547|NCT02039687|18873308|P1|STARTED|Overall Study||16
7663548|NCT02039674|18873348|P14|NOT COMPLETED|Overall Study||33
7663549|NCT02039674|18873349|P13|NOT COMPLETED|Overall Study||63
7663550|NCT02039674|18873350|P12|NOT COMPLETED|Overall Study||60
7663551|NCT02039674|18873351|P11|NOT COMPLETED|Overall Study||7
7663552|NCT02039674|18873352|P10|NOT COMPLETED|Overall Study||12
7663553|NCT02039674|18873353|P9|NOT COMPLETED|Overall Study||12
7663554|NCT02039674|18873354|P8|NOT COMPLETED|Overall Study||3
7663555|NCT02039674|18873355|P7|NOT COMPLETED|Overall Study||3
7663556|NCT02039674|18873356|P6|NOT COMPLETED|Overall Study||12
7663557|NCT02039674|18873357|P5|NOT COMPLETED|Overall Study||12
7663558|NCT02039674|18873358|P4|NOT COMPLETED|Overall Study||13
7663559|NCT02039674|18873359|P3|NOT COMPLETED|Overall Study||12
7663560|NCT02039674|18873360|P2|NOT COMPLETED|Overall Study||12
7663561|NCT02039674|18873361|P1|NOT COMPLETED|Overall Study||12
7663562|NCT02039674|18873348|P14|COMPLETED|Overall Study||0
7663563|NCT02039674|18873349|P13|COMPLETED|Overall Study||0
7663564|NCT02039674|18873350|P12|COMPLETED|Overall Study||0
7663565|NCT02039674|18873351|P11|COMPLETED|Overall Study||0
7663566|NCT02039674|18873352|P10|COMPLETED|Overall Study||0
7663567|NCT02039674|18873353|P9|COMPLETED|Overall Study||0
7663568|NCT02039674|18873354|P8|COMPLETED|Overall Study||0
7663569|NCT02039674|18873355|P7|COMPLETED|Overall Study||0
7663570|NCT02039674|18873356|P6|COMPLETED|Overall Study||0
7663571|NCT02039674|18873357|P5|COMPLETED|Overall Study||0
7663572|NCT02039674|18873358|P4|COMPLETED|Overall Study||0
7663573|NCT02039674|18873359|P3|COMPLETED|Overall Study||0
7663574|NCT02039674|18873360|P2|COMPLETED|Overall Study||0
7663575|NCT02039674|18873361|P1|COMPLETED|Overall Study||1
7663576|NCT02039674|18873348|P14|Treated|Overall Study||33
7663577|NCT02039674|18873349|P13|Treated|Overall Study||62
7663578|NCT02039674|18873350|P12|Treated|Overall Study||59
7663579|NCT02039674|18873351|P11|Treated|Overall Study||7
7663580|NCT02039674|18873352|P10|Treated|Overall Study||12
7663581|NCT02039674|18873353|P9|Treated|Overall Study||12
7663582|NCT02039674|18873354|P8|Treated|Overall Study||3
7663583|NCT02039674|18873355|P7|Treated|Overall Study||3
7663584|NCT02039674|18873356|P6|Treated|Overall Study||12
7663585|NCT02039674|18873357|P5|Treated|Overall Study||12
7663586|NCT02039674|18873358|P4|Treated|Overall Study||13
7663587|NCT02039674|18873359|P3|Treated|Overall Study||11
7663588|NCT02039674|18873360|P2|Treated|Overall Study||12
7663589|NCT02039674|18873361|P1|Treated|Overall Study||13
7663590|NCT02039674|18873348|P14|STARTED|Overall Study||33
7663591|NCT02039674|18873349|P13|STARTED|Overall Study||63
7663592|NCT02039674|18873350|P12|STARTED|Overall Study||60
7663593|NCT02039674|18873351|P11|STARTED|Overall Study||7
7663594|NCT02039674|18873352|P10|STARTED|Overall Study||12
7663595|NCT02039674|18873353|P9|STARTED|Overall Study||12
7663596|NCT02039674|18873354|P8|STARTED|Overall Study||3
7663597|NCT02039674|18873355|P7|STARTED|Overall Study||3
7663598|NCT02039674|18873356|P6|STARTED|Overall Study||12
7663599|NCT02039674|18873357|P5|STARTED|Overall Study||12
7663600|NCT02039674|18873358|P4|STARTED|Overall Study||13
7663601|NCT02039674|18873359|P3|STARTED|Overall Study||12
7663602|NCT02039674|18873360|P2|STARTED|Overall Study||12
7663603|NCT02039674|18873361|P1|STARTED|Overall Study||13
7663604|NCT02039505|18873403|P7|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||71
7663605|NCT02039505|18873404|P6|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
7663606|NCT02039505|18873405|P5|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
7663607|NCT02039505|18873406|P4|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
7663608|NCT02039505|18873407|P3|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
7663609|NCT02039505|18873408|P2|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
7663610|NCT02039505|18873409|P1|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
7663611|NCT02039505|18873403|P7|COMPLETED|Open-Label (Week 10 up to Week 154)||188
7663612|NCT02039505|18873404|P6|COMPLETED|Open-Label (Week 10 up to Week 154)||0
7663613|NCT02039505|18873405|P5|COMPLETED|Open-Label (Week 10 up to Week 154)||0
7663614|NCT02039505|18873406|P4|COMPLETED|Open-Label (Week 10 up to Week 154)||0
7663615|NCT02039505|18873407|P3|COMPLETED|Open-Label (Week 10 up to Week 154)||0
7663616|NCT02039505|18873408|P2|COMPLETED|Open-Label (Week 10 up to Week 154)||0
7663617|NCT02039505|18873409|P1|COMPLETED|Open-Label (Week 10 up to Week 154)||0
7663618|NCT02039505|18873403|P7|STARTED|Open-Label (Week 10 up to Week 154)||259
7663619|NCT02039505|18873404|P6|STARTED|Open-Label (Week 10 up to Week 154)||0
7663620|NCT02039505|18873405|P5|STARTED|Open-Label (Week 10 up to Week 154)||0
7663621|NCT02039505|18873406|P4|STARTED|Open-Label (Week 10 up to Week 154)||0
7663622|NCT02039505|18873407|P3|STARTED|Open-Label (Week 10 up to Week 154)||0
7663623|NCT02039505|18873408|P2|STARTED|Open-Label (Week 10 up to Week 154)||0
7663624|NCT02039505|18873409|P1|STARTED|Open-Label (Week 10 up to Week 154)||0
7663625|NCT02039505|18873403|P7|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
7663626|NCT02039505|18873404|P6|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||14
7663627|NCT02039505|18873405|P5|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||11
7663628|NCT02039505|18873406|P4|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||24
7663629|NCT02039505|18873407|P3|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
7663630|NCT02039505|18873408|P2|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
7663631|NCT02039505|18873409|P1|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
7663632|NCT02039505|18873403|P7|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
7663633|NCT02039505|18873404|P6|COMPLETED|Maintenance Phase (Week 14 to Week 60)||12
7663634|NCT02039505|18873405|P5|COMPLETED|Maintenance Phase (Week 14 to Week 60)||30
7663635|NCT02039505|18873406|P4|COMPLETED|Maintenance Phase (Week 14 to Week 60)||18
7663636|NCT02039505|18873407|P3|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
7663637|NCT02039505|18873408|P2|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
7663638|NCT02039505|18873409|P1|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
7663639|NCT02039505|18873403|P7|STARTED|Maintenance Phase (Week 14 to Week 60)||0
7663640|NCT02039505|18873404|P6|STARTED|Maintenance Phase (Week 14 to Week 60)||26
7663641|NCT02039505|18873405|P5|STARTED|Maintenance Phase (Week 14 to Week 60)||41
7663642|NCT02039505|18873406|P4|STARTED|Maintenance Phase (Week 14 to Week 60)||42
7663643|NCT02039505|18873407|P3|STARTED|Maintenance Phase (Week 14 to Week 60)||0
7663644|NCT02039505|18873408|P2|STARTED|Maintenance Phase (Week 14 to Week 60)||0
7663645|NCT02039505|18873409|P1|STARTED|Maintenance Phase (Week 14 to Week 60)||0
7663646|NCT02039505|18873403|P7|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
7663647|NCT02039505|18873404|P6|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
7663648|NCT02039505|18873405|P5|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
7663649|NCT02039505|18873406|P4|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
7663650|NCT02039505|18873407|P3|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||10
7663651|NCT02039505|18873408|P2|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||9
7663652|NCT02039505|18873409|P1|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||4
7663653|NCT02039505|18873403|P7|COMPLETED|Induction Phase (Week 0 to Week 14)||0
7663654|NCT02039505|18873404|P6|COMPLETED|Induction Phase (Week 0 to Week 14)||0
7663655|NCT02039505|18873405|P5|COMPLETED|Induction Phase (Week 0 to Week 14)||0
7663656|NCT02039505|18873406|P4|COMPLETED|Induction Phase (Week 0 to Week 14)||0
7663657|NCT02039505|18873407|P3|COMPLETED|Induction Phase (Week 0 to Week 14)||36
7663658|NCT02039505|18873408|P2|COMPLETED|Induction Phase (Week 0 to Week 14)||155
7663659|NCT02039505|18873409|P1|COMPLETED|Induction Phase (Week 0 to Week 14)||78
7663660|NCT02039505|18873403|P7|STARTED|Induction Phase (Week 0 to Week 14)||0
7663661|NCT02039505|18873404|P6|STARTED|Induction Phase (Week 0 to Week 14)||0
7663662|NCT02039505|18873405|P5|STARTED|Induction Phase (Week 0 to Week 14)||0
7663663|NCT02039505|18873406|P4|STARTED|Induction Phase (Week 0 to Week 14)||0
7663664|NCT02039505|18873407|P3|STARTED|Induction Phase (Week 0 to Week 14)||46
7663665|NCT02039505|18873408|P2|STARTED|Induction Phase (Week 0 to Week 14)||164
7663666|NCT02039505|18873409|P1|STARTED|Induction Phase (Week 0 to Week 14)||82
7663667|NCT02039427|18873485|P4|NOT COMPLETED|Overall Study||5
7663668|NCT02039427|18873486|P3|NOT COMPLETED|Overall Study||3
7663669|NCT02039427|18873487|P2|NOT COMPLETED|Overall Study||1
7663670|NCT02039427|18873488|P1|NOT COMPLETED|Overall Study||3
7663671|NCT02039427|18873485|P4|COMPLETED|Overall Study||43
7663672|NCT02039427|18873486|P3|COMPLETED|Overall Study||45
7663673|NCT02039427|18873487|P2|COMPLETED|Overall Study||47
7663674|NCT02039427|18873488|P1|COMPLETED|Overall Study||45
7663675|NCT02039427|18873485|P4|STARTED|Overall Study||48
7663676|NCT02039427|18873486|P3|STARTED|Overall Study||48
7663677|NCT02039427|18873487|P2|STARTED|Overall Study||48
7663678|NCT02039427|18873488|P1|STARTED|Overall Study||48
7663679|NCT02039414|18873508|P2|NOT COMPLETED|Overall Study||2
7663680|NCT02039414|18873509|P1|NOT COMPLETED|Overall Study||6
7663681|NCT02039414|18873508|P2|COMPLETED|Overall Study||16
7663682|NCT02039414|18873509|P1|COMPLETED|Overall Study||16
7663683|NCT02039414|18873508|P2|STARTED|Overall Study||18
7663684|NCT02039414|18873509|P1|STARTED|Overall Study||22
7663685|NCT02039375|18873521|P1|NOT COMPLETED|Overall Study||2
7663686|NCT02039375|18873521|P1|COMPLETED|Overall Study||33
7663687|NCT02039375|18873521|P1|STARTED|Overall Study||35
7663688|NCT02039219|18873532|P2|NOT COMPLETED|Follow up||1
7663689|NCT02039219|18873533|P1|NOT COMPLETED|Follow up||0
7663690|NCT02039219|18873532|P2|COMPLETED|Follow up||5
7663691|NCT02039219|18873533|P1|COMPLETED|Follow up||7
7663692|NCT02039219|18873532|P2|STARTED|Follow up||6
7663693|NCT02039219|18873533|P1|STARTED|Follow up||7
7663694|NCT02039219|18873532|P2|NOT COMPLETED|Treatment||2
7663695|NCT02039219|18873533|P1|NOT COMPLETED|Treatment||4
7663696|NCT02039219|18873532|P2|COMPLETED|Treatment||6
7663697|NCT02039219|18873533|P1|COMPLETED|Treatment||7
7663698|NCT02039219|18873532|P2|STARTED|Treatment||8
7663699|NCT02039219|18873533|P1|STARTED|Treatment||11
7663700|NCT02039115|18873573|P2|NOT COMPLETED|Overall Study||0
7663701|NCT02039115|18873574|P1|NOT COMPLETED|Overall Study||0
7663702|NCT02039115|18873573|P2|COMPLETED|Overall Study||0
7663703|NCT02039115|18873574|P1|COMPLETED|Overall Study||1
7663704|NCT02039115|18873573|P2|STARTED|Overall Study||0
7663705|NCT02039115|18873574|P1|STARTED|Overall Study||1
7663706|NCT02038959|18873582|P2|NOT COMPLETED|Overall Study||8
7663707|NCT02038959|18873583|P1|NOT COMPLETED|Overall Study||6
7663708|NCT02038959|18873582|P2|COMPLETED|Overall Study||89
7663709|NCT02038959|18873583|P1|COMPLETED|Overall Study||92
7663710|NCT02038959|18873582|P2|STARTED|Overall Study||97
7663711|NCT02038959|18873583|P1|STARTED|Overall Study||98
7663712|NCT02038946|18873609|P1|NOT COMPLETED|Overall Study||11
7663713|NCT02038946|18873609|P1|COMPLETED|Overall Study||81
7663714|NCT02038946|18873609|P1|STARTED|Overall Study||92
7663715|NCT02038933|18873620|P1|NOT COMPLETED|Follow-up||19
7663716|NCT02038933|18873620|P1|COMPLETED|Follow-up|Includes subjects still on-treatment and subjects off-treatment continuing in the Follow-up period.|102
7663717|NCT02038933|18873620|P1|STARTED|Follow-up||121
7663718|NCT02038933|18873620|P1|NOT COMPLETED|Treatment||114
7663719|NCT02038933|18873620|P1|COMPLETED|Treatment|Subjects continuing in the treatment period|7
7663720|NCT02038933|18873620|P1|STARTED|Treatment||121
7663721|NCT02038920|18873641|P6|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||77
7663722|NCT02038920|18873642|P5|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
7663723|NCT02038920|18873643|P4|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
7663724|NCT02038920|18873644|P3|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
7663725|NCT02038920|18873645|P2|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
7663726|NCT02038920|18873646|P1|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
7663727|NCT02038920|18873641|P6|COMPLETED|Open Label Cohort (Week 10 to 154)||57
7663728|NCT02038920|18873642|P5|COMPLETED|Open Label Cohort (Week 10 to 154)||0
7663729|NCT02038920|18873643|P4|COMPLETED|Open Label Cohort (Week 10 to 154)||0
7663730|NCT02038920|18873644|P3|COMPLETED|Open Label Cohort (Week 10 to 154)||0
7663731|NCT02038920|18873645|P2|COMPLETED|Open Label Cohort (Week 10 to 154)||0
7663732|NCT02038920|18873646|P1|COMPLETED|Open Label Cohort (Week 10 to 154)||0
7663733|NCT02038920|18873641|P6|STARTED|Open Label Cohort (Week 10 to 154)||134
7663734|NCT02038920|18873642|P5|STARTED|Open Label Cohort (Week 10 to 154)||0
7663735|NCT02038920|18873643|P4|STARTED|Open Label Cohort (Week 10 to 154)||0
7663736|NCT02038920|18873644|P3|STARTED|Open Label Cohort (Week 10 to 154)||0
7663737|NCT02038920|18873645|P2|STARTED|Open Label Cohort (Week 10 to 154)||0
7663738|NCT02038920|18873646|P1|STARTED|Open Label Cohort (Week 10 to 154)||0
7663739|NCT02038920|18873641|P6|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
7663740|NCT02038920|18873642|P5|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||12
7663741|NCT02038920|18873643|P4|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||8
7663742|NCT02038920|18873644|P3|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||5
7663743|NCT02038920|18873645|P2|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
7663744|NCT02038920|18873646|P1|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
7663745|NCT02038920|18873641|P6|COMPLETED|Maintenance Phase (Week 14 to 60)||0
7663746|NCT02038920|18873642|P5|COMPLETED|Maintenance Phase (Week 14 to 60)||5
7663747|NCT02038920|18873643|P4|COMPLETED|Maintenance Phase (Week 14 to 60)||4
7663748|NCT02038920|18873644|P3|COMPLETED|Maintenance Phase (Week 14 to 60)||7
7663749|NCT02038920|18873645|P2|COMPLETED|Maintenance Phase (Week 14 to 60)||0
7663750|NCT02038920|18873646|P1|COMPLETED|Maintenance Phase (Week 14 to 60)||0
7663751|NCT02038920|18873641|P6|STARTED|Maintenance Phase (Week 14 to 60)||0
7663752|NCT02038920|18873642|P5|STARTED|Maintenance Phase (Week 14 to 60)||17
7663753|NCT02038920|18873643|P4|STARTED|Maintenance Phase (Week 14 to 60)||12
7663754|NCT02038920|18873644|P3|STARTED|Maintenance Phase (Week 14 to 60)||12
7663755|NCT02038920|18873645|P2|STARTED|Maintenance Phase (Week 14 to 60)||0
7663756|NCT02038920|18873646|P1|STARTED|Maintenance Phase (Week 14 to 60)||0
7663757|NCT02038920|18873641|P6|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
7663758|NCT02038920|18873642|P5|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
7663759|NCT02038920|18873643|P4|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
7663760|NCT02038920|18873644|P3|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
7663761|NCT02038920|18873645|P2|NOT COMPLETED|Induction Phase (Week 0 to 14)||12
7663762|NCT02038920|18873646|P1|NOT COMPLETED|Induction Phase (Week 0 to 14)||6
7663763|NCT02038920|18873641|P6|COMPLETED|Induction Phase (Week 0 to 14)||0
7663764|NCT02038920|18873642|P5|COMPLETED|Induction Phase (Week 0 to 14)||0
7663765|NCT02038920|18873643|P4|COMPLETED|Induction Phase (Week 0 to 14)||0
7663766|NCT02038920|18873644|P3|COMPLETED|Induction Phase (Week 0 to 14)||0
7663767|NCT02038920|18873645|P2|COMPLETED|Induction Phase (Week 0 to 14)||66
7663768|NCT02038920|18873646|P1|COMPLETED|Induction Phase (Week 0 to 14)||73
7663769|NCT02038920|18873641|P6|STARTED|Induction Phase (Week 0 to 14)||0
7663770|NCT02038920|18873642|P5|STARTED|Induction Phase (Week 0 to 14)||0
7663771|NCT02038920|18873643|P4|STARTED|Induction Phase (Week 0 to 14)||0
7663772|NCT02038920|18873644|P3|STARTED|Induction Phase (Week 0 to 14)||0
7663773|NCT02038920|18873645|P2|STARTED|Induction Phase (Week 0 to 14)||78
7663774|NCT02038920|18873646|P1|STARTED|Induction Phase (Week 0 to 14)||79
7663775|NCT02038907|18873723|P14|NOT COMPLETED|Overall Study||0
7663776|NCT02038907|18873724|P13|NOT COMPLETED|Overall Study||0
7663777|NCT02038907|18873725|P12|NOT COMPLETED|Overall Study||0
7663778|NCT02038907|18873726|P11|NOT COMPLETED|Overall Study||2
7663779|NCT02038907|18873727|P10|NOT COMPLETED|Overall Study||0
7663780|NCT02038907|18873728|P9|NOT COMPLETED|Overall Study||0
7663781|NCT02038907|18873729|P8|NOT COMPLETED|Overall Study||0
7663782|NCT02038907|18873730|P7|NOT COMPLETED|Overall Study||0
7663783|NCT02038907|18873731|P6|NOT COMPLETED|Overall Study||0
7663784|NCT02038907|18873732|P5|NOT COMPLETED|Overall Study||0
7663785|NCT02038907|18873733|P4|NOT COMPLETED|Overall Study||0
7663786|NCT02038907|18873734|P3|NOT COMPLETED|Overall Study||0
7663787|NCT02038907|18873735|P2|NOT COMPLETED|Overall Study||0
7663788|NCT02038907|18873736|P1|NOT COMPLETED|Overall Study||0
7663789|NCT02038907|18873723|P14|COMPLETED|Overall Study||31
7663790|NCT02038907|18873724|P13|COMPLETED|Overall Study||29
7663791|NCT02038907|18873725|P12|COMPLETED|Overall Study||28
7663792|NCT02038907|18873726|P11|COMPLETED|Overall Study||27
7663793|NCT02038907|18873727|P10|COMPLETED|Overall Study||30
7663794|NCT02038907|18873728|P9|COMPLETED|Overall Study||29
7663795|NCT02038907|18873729|P8|COMPLETED|Overall Study||32
7663796|NCT02038907|18873730|P7|COMPLETED|Overall Study||30
7663797|NCT02038907|18873731|P6|COMPLETED|Overall Study||31
7663798|NCT02038907|18873732|P5|COMPLETED|Overall Study||30
7663799|NCT02038907|18873733|P4|COMPLETED|Overall Study||31
7663800|NCT02038907|18873734|P3|COMPLETED|Overall Study||30
7663801|NCT02038907|18873735|P2|COMPLETED|Overall Study||30
7663802|NCT02038907|18873736|P1|COMPLETED|Overall Study||30
7663803|NCT02038907|18873723|P14|STARTED|Overall Study||31
7663804|NCT02038907|18873724|P13|STARTED|Overall Study||29
7663805|NCT02038907|18873725|P12|STARTED|Overall Study||28
7663806|NCT02038907|18873726|P11|STARTED|Overall Study||29
7663807|NCT02038907|18873727|P10|STARTED|Overall Study||30
7663808|NCT02038907|18873728|P9|STARTED|Overall Study||29
7663809|NCT02038907|18873729|P8|STARTED|Overall Study||32
7663810|NCT02038907|18873730|P7|STARTED|Overall Study||30
7663811|NCT02038907|18873731|P6|STARTED|Overall Study||31
7663812|NCT02038907|18873732|P5|STARTED|Overall Study||30
7663813|NCT02038907|18873733|P4|STARTED|Overall Study||31
7663814|NCT02038907|18873734|P3|STARTED|Overall Study||30
7663815|NCT02038907|18873735|P2|STARTED|Overall Study||30
7663816|NCT02038907|18873736|P1|STARTED|Overall Study||30
7663817|NCT02038894|18874267|P3|NOT COMPLETED|Overall Study||0
7663818|NCT02038894|18874268|P2|NOT COMPLETED|Overall Study||0
7663819|NCT02038894|18874269|P1|NOT COMPLETED|Overall Study||0
7663820|NCT02038894|18874267|P3|COMPLETED|Overall Study||61
7663821|NCT02038894|18874268|P2|COMPLETED|Overall Study||58
7663822|NCT02038894|18874269|P1|COMPLETED|Overall Study||60
7663823|NCT02038894|18874267|P3|STARTED|Overall Study||61
7663824|NCT02038894|18874268|P2|STARTED|Overall Study||58
7663825|NCT02038894|18874269|P1|STARTED|Overall Study||60
7663826|NCT02038881|18874287|P3|NOT COMPLETED|Overall Study||1
7663827|NCT02038881|18874288|P2|NOT COMPLETED|Overall Study||0
7663828|NCT02038881|18874289|P1|NOT COMPLETED|Overall Study||3
7663829|NCT02038881|18874287|P3|COMPLETED|Overall Study||30
7663830|NCT02038881|18874288|P2|COMPLETED|Overall Study||29
7663831|NCT02038881|18874289|P1|COMPLETED|Overall Study||24
7663832|NCT02038881|18874287|P3|STARTED|Overall Study||31
7663833|NCT02038881|18874288|P2|STARTED|Overall Study||29
7663834|NCT02038881|18874289|P1|STARTED|Overall Study||27
7663835|NCT02038829|18874362|P12|NOT COMPLETED|Treatment Period 6||0
7663836|NCT02038829|18874363|P11|NOT COMPLETED|Treatment Period 6||0
7663837|NCT02038829|18874364|P10|NOT COMPLETED|Treatment Period 6||0
7663838|NCT02038829|18874365|P9|NOT COMPLETED|Treatment Period 6||0
7663839|NCT02038829|18874366|P8|NOT COMPLETED|Treatment Period 6||0
7663840|NCT02038829|18874367|P7|NOT COMPLETED|Treatment Period 6||0
7663841|NCT02038829|18874368|P6|NOT COMPLETED|Treatment Period 6||0
7663842|NCT02038829|18874369|P5|NOT COMPLETED|Treatment Period 6||0
7663843|NCT02038829|18874370|P4|NOT COMPLETED|Treatment Period 6||0
7663844|NCT02038829|18874371|P3|NOT COMPLETED|Treatment Period 6||1
7663845|NCT02038829|18874372|P2|NOT COMPLETED|Treatment Period 6||0
7663846|NCT02038829|18874373|P1|NOT COMPLETED|Treatment Period 6||0
7663847|NCT02038829|18874362|P12|COMPLETED|Treatment Period 6||8
7663848|NCT02038829|18874363|P11|COMPLETED|Treatment Period 6||7
7663849|NCT02038829|18874364|P10|COMPLETED|Treatment Period 6||8
7663850|NCT02038829|18874365|P9|COMPLETED|Treatment Period 6||7
7663851|NCT02038829|18874366|P8|COMPLETED|Treatment Period 6||8
7663852|NCT02038829|18874367|P7|COMPLETED|Treatment Period 6||7
7663853|NCT02038829|18874368|P6|COMPLETED|Treatment Period 6||7
7663854|NCT02038829|18874369|P5|COMPLETED|Treatment Period 6||7
7663855|NCT02038829|18874370|P4|COMPLETED|Treatment Period 6||8
7663856|NCT02038829|18874371|P3|COMPLETED|Treatment Period 6||7
7663857|NCT02038829|18874372|P2|COMPLETED|Treatment Period 6||7
7663858|NCT02038829|18874373|P1|COMPLETED|Treatment Period 6||7
7663859|NCT02038829|18874362|P12|STARTED|Treatment Period 6||8
7663860|NCT02038829|18874363|P11|STARTED|Treatment Period 6||7
7663861|NCT02038829|18874364|P10|STARTED|Treatment Period 6||8
7663862|NCT02038829|18874365|P9|STARTED|Treatment Period 6||7
7663863|NCT02038829|18874366|P8|STARTED|Treatment Period 6||8
7663864|NCT02038829|18874367|P7|STARTED|Treatment Period 6||7
7663865|NCT02038829|18874368|P6|STARTED|Treatment Period 6||7
7663866|NCT02038829|18874369|P5|STARTED|Treatment Period 6||7
7663867|NCT02038829|18874370|P4|STARTED|Treatment Period 6||8
7663868|NCT02038829|18874371|P3|STARTED|Treatment Period 6||8
7663869|NCT02038829|18874372|P2|STARTED|Treatment Period 6||7
7663870|NCT02038829|18874373|P1|STARTED|Treatment Period 6||7
7663871|NCT02038829|18874362|P12|NOT COMPLETED|Washout Period 5||0
7663872|NCT02038829|18874363|P11|NOT COMPLETED|Washout Period 5||0
7663873|NCT02038829|18874364|P10|NOT COMPLETED|Washout Period 5||0
7663874|NCT02038829|18874365|P9|NOT COMPLETED|Washout Period 5||0
7663875|NCT02038829|18874366|P8|NOT COMPLETED|Washout Period 5||0
7663876|NCT02038829|18874367|P7|NOT COMPLETED|Washout Period 5||0
7663877|NCT02038829|18874368|P6|NOT COMPLETED|Washout Period 5||0
7663878|NCT02038829|18874369|P5|NOT COMPLETED|Washout Period 5||0
7663879|NCT02038829|18874370|P4|NOT COMPLETED|Washout Period 5||0
7663880|NCT02038829|18874371|P3|NOT COMPLETED|Washout Period 5||0
7663881|NCT02038829|18874372|P2|NOT COMPLETED|Washout Period 5||0
7663882|NCT02038829|18874373|P1|NOT COMPLETED|Washout Period 5||0
7663883|NCT02038829|18874362|P12|COMPLETED|Washout Period 5||8
7663884|NCT02038829|18874363|P11|COMPLETED|Washout Period 5||7
7663885|NCT02038829|18874364|P10|COMPLETED|Washout Period 5||8
7663886|NCT02038829|18874365|P9|COMPLETED|Washout Period 5||7
7663887|NCT02038829|18874366|P8|COMPLETED|Washout Period 5||8
7663888|NCT02038829|18874367|P7|COMPLETED|Washout Period 5||7
7663889|NCT02038829|18874368|P6|COMPLETED|Washout Period 5||7
7663890|NCT02038829|18874369|P5|COMPLETED|Washout Period 5||7
7663891|NCT02038829|18874370|P4|COMPLETED|Washout Period 5||8
7663892|NCT02038829|18874371|P3|COMPLETED|Washout Period 5||8
7663893|NCT02038829|18874372|P2|COMPLETED|Washout Period 5||7
7663894|NCT02038829|18874373|P1|COMPLETED|Washout Period 5||7
7663895|NCT02038829|18874362|P12|STARTED|Washout Period 5||8
7663896|NCT02038829|18874363|P11|STARTED|Washout Period 5||7
7663897|NCT02038829|18874364|P10|STARTED|Washout Period 5||8
7663898|NCT02038829|18874365|P9|STARTED|Washout Period 5||7
7663899|NCT02038829|18874366|P8|STARTED|Washout Period 5||8
7663900|NCT02038829|18874367|P7|STARTED|Washout Period 5||7
7663901|NCT02038829|18874368|P6|STARTED|Washout Period 5||7
7663902|NCT02038829|18874369|P5|STARTED|Washout Period 5||7
7663903|NCT02038829|18874370|P4|STARTED|Washout Period 5||8
7663904|NCT02038829|18874371|P3|STARTED|Washout Period 5||8
7663905|NCT02038829|18874372|P2|STARTED|Washout Period 5||7
7663906|NCT02038829|18874373|P1|STARTED|Washout Period 5||7
7663907|NCT02038829|18874362|P12|NOT COMPLETED|Treatment Period 5||0
7663908|NCT02038829|18874363|P11|NOT COMPLETED|Treatment Period 5||0
7663909|NCT02038829|18874364|P10|NOT COMPLETED|Treatment Period 5||0
7663910|NCT02038829|18874365|P9|NOT COMPLETED|Treatment Period 5||0
7663911|NCT02038829|18874366|P8|NOT COMPLETED|Treatment Period 5||0
7663912|NCT02038829|18874367|P7|NOT COMPLETED|Treatment Period 5||0
7663913|NCT02038829|18874368|P6|NOT COMPLETED|Treatment Period 5||0
7663914|NCT02038829|18874369|P5|NOT COMPLETED|Treatment Period 5||0
7663915|NCT02038829|18874370|P4|NOT COMPLETED|Treatment Period 5||0
7663916|NCT02038829|18874371|P3|NOT COMPLETED|Treatment Period 5||0
7663917|NCT02038829|18874372|P2|NOT COMPLETED|Treatment Period 5||0
7663918|NCT02038829|18874373|P1|NOT COMPLETED|Treatment Period 5||0
7663919|NCT02038829|18874362|P12|COMPLETED|Treatment Period 5||8
7663920|NCT02038829|18874363|P11|COMPLETED|Treatment Period 5||7
7663921|NCT02038829|18874364|P10|COMPLETED|Treatment Period 5||8
7663922|NCT02038829|18874365|P9|COMPLETED|Treatment Period 5||7
7663923|NCT02038829|18874366|P8|COMPLETED|Treatment Period 5||8
7663924|NCT02038829|18874367|P7|COMPLETED|Treatment Period 5||7
7663925|NCT02038829|18874368|P6|COMPLETED|Treatment Period 5||7
7663926|NCT02038829|18874369|P5|COMPLETED|Treatment Period 5||7
7663927|NCT02038829|18874370|P4|COMPLETED|Treatment Period 5||8
7663928|NCT02038829|18874371|P3|COMPLETED|Treatment Period 5||8
7663929|NCT02038829|18874372|P2|COMPLETED|Treatment Period 5||7
7663930|NCT02038829|18874373|P1|COMPLETED|Treatment Period 5||7
7663931|NCT02038829|18874362|P12|STARTED|Treatment Period 5||8
7663932|NCT02038829|18874363|P11|STARTED|Treatment Period 5||7
7663933|NCT02038829|18874364|P10|STARTED|Treatment Period 5||8
7663934|NCT02038829|18874365|P9|STARTED|Treatment Period 5||7
7663935|NCT02038829|18874366|P8|STARTED|Treatment Period 5||8
7663936|NCT02038829|18874367|P7|STARTED|Treatment Period 5||7
7663937|NCT02038829|18874368|P6|STARTED|Treatment Period 5||7
7663938|NCT02038829|18874369|P5|STARTED|Treatment Period 5||7
7663939|NCT02038829|18874370|P4|STARTED|Treatment Period 5||8
7663940|NCT02038829|18874371|P3|STARTED|Treatment Period 5||8
7663941|NCT02038829|18874372|P2|STARTED|Treatment Period 5||7
7663942|NCT02038829|18874373|P1|STARTED|Treatment Period 5||7
7663943|NCT02038829|18874362|P12|NOT COMPLETED|Washout Period 4||0
7663944|NCT02038829|18874363|P11|NOT COMPLETED|Washout Period 4||0
7663945|NCT02038829|18874364|P10|NOT COMPLETED|Washout Period 4||0
7663946|NCT02038829|18874365|P9|NOT COMPLETED|Washout Period 4||0
7663947|NCT02038829|18874366|P8|NOT COMPLETED|Washout Period 4||0
7663948|NCT02038829|18874367|P7|NOT COMPLETED|Washout Period 4||1
7663949|NCT02038829|18874368|P6|NOT COMPLETED|Washout Period 4||0
7663950|NCT02038829|18874369|P5|NOT COMPLETED|Washout Period 4||0
7663951|NCT02038829|18874370|P4|NOT COMPLETED|Washout Period 4||0
7663952|NCT02038829|18874371|P3|NOT COMPLETED|Washout Period 4||0
7663953|NCT02038829|18874372|P2|NOT COMPLETED|Washout Period 4||0
7663954|NCT02038829|18874373|P1|NOT COMPLETED|Washout Period 4||0
7663955|NCT02038829|18874362|P12|COMPLETED|Washout Period 4||8
7663956|NCT02038829|18874363|P11|COMPLETED|Washout Period 4||7
7663957|NCT02038829|18874364|P10|COMPLETED|Washout Period 4||8
7663958|NCT02038829|18874365|P9|COMPLETED|Washout Period 4||7
7663959|NCT02038829|18874366|P8|COMPLETED|Washout Period 4||8
7663960|NCT02038829|18874367|P7|COMPLETED|Washout Period 4||7
7663961|NCT02038829|18874368|P6|COMPLETED|Washout Period 4||7
7663962|NCT02038829|18874369|P5|COMPLETED|Washout Period 4||7
7663963|NCT02038829|18874370|P4|COMPLETED|Washout Period 4||8
7663964|NCT02038829|18874371|P3|COMPLETED|Washout Period 4||8
7663965|NCT02038829|18874372|P2|COMPLETED|Washout Period 4||7
7663966|NCT02038829|18874373|P1|COMPLETED|Washout Period 4||7
7663967|NCT02038829|18874362|P12|STARTED|Washout Period 4||8
7663968|NCT02038829|18874363|P11|STARTED|Washout Period 4||7
7663969|NCT02038829|18874364|P10|STARTED|Washout Period 4||8
7663970|NCT02038829|18874365|P9|STARTED|Washout Period 4||7
7663971|NCT02038829|18874366|P8|STARTED|Washout Period 4||8
7663972|NCT02038829|18874367|P7|STARTED|Washout Period 4||8
7663973|NCT02038829|18874368|P6|STARTED|Washout Period 4||7
7663974|NCT02038829|18874369|P5|STARTED|Washout Period 4||7
7663975|NCT02038829|18874370|P4|STARTED|Washout Period 4||8
7663976|NCT02038829|18874371|P3|STARTED|Washout Period 4||8
7663977|NCT02038829|18874372|P2|STARTED|Washout Period 4||7
7663978|NCT02038829|18874373|P1|STARTED|Washout Period 4||7
7663979|NCT02038829|18874362|P12|NOT COMPLETED|Treatment Period 4||0
7663980|NCT02038829|18874363|P11|NOT COMPLETED|Treatment Period 4||0
7663981|NCT02038829|18874364|P10|NOT COMPLETED|Treatment Period 4||0
7663982|NCT02038829|18874365|P9|NOT COMPLETED|Treatment Period 4||0
7663983|NCT02038829|18874366|P8|NOT COMPLETED|Treatment Period 4||0
7663984|NCT02038829|18874367|P7|NOT COMPLETED|Treatment Period 4||0
7663985|NCT02038829|18874368|P6|NOT COMPLETED|Treatment Period 4||0
7663986|NCT02038829|18874369|P5|NOT COMPLETED|Treatment Period 4||0
7663987|NCT02038829|18874370|P4|NOT COMPLETED|Treatment Period 4||0
7663988|NCT02038829|18874371|P3|NOT COMPLETED|Treatment Period 4||0
7663989|NCT02038829|18874372|P2|NOT COMPLETED|Treatment Period 4||1
7663990|NCT02038829|18874373|P1|NOT COMPLETED|Treatment Period 4||0
7663991|NCT02038829|18874362|P12|COMPLETED|Treatment Period 4||8
7663992|NCT02038829|18874363|P11|COMPLETED|Treatment Period 4||7
7663993|NCT02038829|18874364|P10|COMPLETED|Treatment Period 4||8
7663994|NCT02038829|18874365|P9|COMPLETED|Treatment Period 4||7
7663995|NCT02038829|18874366|P8|COMPLETED|Treatment Period 4||8
7663996|NCT02038829|18874367|P7|COMPLETED|Treatment Period 4||8
7663997|NCT02038829|18874368|P6|COMPLETED|Treatment Period 4||7
7663998|NCT02038829|18874369|P5|COMPLETED|Treatment Period 4||7
7663999|NCT02038829|18874370|P4|COMPLETED|Treatment Period 4||8
7664000|NCT02038829|18874371|P3|COMPLETED|Treatment Period 4||8
7664001|NCT02038829|18874372|P2|COMPLETED|Treatment Period 4||7
7664002|NCT02038829|18874373|P1|COMPLETED|Treatment Period 4||7
7664003|NCT02038829|18874362|P12|STARTED|Treatment Period 4||8
7664004|NCT02038829|18874363|P11|STARTED|Treatment Period 4||7
7664005|NCT02038829|18874364|P10|STARTED|Treatment Period 4||8
7664006|NCT02038829|18874365|P9|STARTED|Treatment Period 4||7
7664007|NCT02038829|18874366|P8|STARTED|Treatment Period 4||8
7664008|NCT02038829|18874367|P7|STARTED|Treatment Period 4||8
7664009|NCT02038829|18874368|P6|STARTED|Treatment Period 4||7
7664010|NCT02038829|18874369|P5|STARTED|Treatment Period 4||7
7664011|NCT02038829|18874370|P4|STARTED|Treatment Period 4||8
7664012|NCT02038829|18874371|P3|STARTED|Treatment Period 4||8
7664013|NCT02038829|18874372|P2|STARTED|Treatment Period 4||8
7664014|NCT02038829|18874373|P1|STARTED|Treatment Period 4||7
7664015|NCT02038829|18874362|P12|NOT COMPLETED|Washout Period 3||0
7664016|NCT02038829|18874363|P11|NOT COMPLETED|Washout Period 3||0
7664017|NCT02038829|18874364|P10|NOT COMPLETED|Washout Period 3||0
7664018|NCT02038829|18874365|P9|NOT COMPLETED|Washout Period 3||0
7664019|NCT02038829|18874366|P8|NOT COMPLETED|Washout Period 3||0
7664020|NCT02038829|18874367|P7|NOT COMPLETED|Washout Period 3||0
7664021|NCT02038829|18874368|P6|NOT COMPLETED|Washout Period 3||0
7664022|NCT02038829|18874369|P5|NOT COMPLETED|Washout Period 3||0
7664023|NCT02038829|18874370|P4|NOT COMPLETED|Washout Period 3||0
7664024|NCT02038829|18874371|P3|NOT COMPLETED|Washout Period 3||0
7664025|NCT02038829|18874372|P2|NOT COMPLETED|Washout Period 3||0
7664026|NCT02038829|18874373|P1|NOT COMPLETED|Washout Period 3||0
7664027|NCT02038829|18874362|P12|COMPLETED|Washout Period 3||8
7664028|NCT02038829|18874363|P11|COMPLETED|Washout Period 3||7
7664029|NCT02038829|18874364|P10|COMPLETED|Washout Period 3||8
7664030|NCT02038829|18874365|P9|COMPLETED|Washout Period 3||7
7664031|NCT02038829|18874366|P8|COMPLETED|Washout Period 3||8
7664032|NCT02038829|18874367|P7|COMPLETED|Washout Period 3||8
7664033|NCT02038829|18874368|P6|COMPLETED|Washout Period 3||7
7664034|NCT02038829|18874369|P5|COMPLETED|Washout Period 3||7
7664035|NCT02038829|18874370|P4|COMPLETED|Washout Period 3||8
7664036|NCT02038829|18874371|P3|COMPLETED|Washout Period 3||8
7664037|NCT02038829|18874372|P2|COMPLETED|Washout Period 3||8
7664038|NCT02038829|18874373|P1|COMPLETED|Washout Period 3||7
7664039|NCT02038829|18874362|P12|STARTED|Washout Period 3||8
7664040|NCT02038829|18874363|P11|STARTED|Washout Period 3||7
7664041|NCT02038829|18874364|P10|STARTED|Washout Period 3||8
7664042|NCT02038829|18874365|P9|STARTED|Washout Period 3||7
7664043|NCT02038829|18874366|P8|STARTED|Washout Period 3||8
7664044|NCT02038829|18874367|P7|STARTED|Washout Period 3||8
7664045|NCT02038829|18874368|P6|STARTED|Washout Period 3||7
7664046|NCT02038829|18874369|P5|STARTED|Washout Period 3||7
7664047|NCT02038829|18874370|P4|STARTED|Washout Period 3||8
7664048|NCT02038829|18874371|P3|STARTED|Washout Period 3||8
7664049|NCT02038829|18874372|P2|STARTED|Washout Period 3||8
7664050|NCT02038829|18874373|P1|STARTED|Washout Period 3||7
7664051|NCT02038829|18874362|P12|NOT COMPLETED|Treatment Period 3||0
7664052|NCT02038829|18874363|P11|NOT COMPLETED|Treatment Period 3||0
7664053|NCT02038829|18874364|P10|NOT COMPLETED|Treatment Period 3||0
7664054|NCT02038829|18874365|P9|NOT COMPLETED|Treatment Period 3||0
7664055|NCT02038829|18874366|P8|NOT COMPLETED|Treatment Period 3||0
7664056|NCT02038829|18874367|P7|NOT COMPLETED|Treatment Period 3||0
7664057|NCT02038829|18874368|P6|NOT COMPLETED|Treatment Period 3||0
7664058|NCT02038829|18874369|P5|NOT COMPLETED|Treatment Period 3||0
7664059|NCT02038829|18874370|P4|NOT COMPLETED|Treatment Period 3||0
7664060|NCT02038829|18874371|P3|NOT COMPLETED|Treatment Period 3||0
7664061|NCT02038829|18874372|P2|NOT COMPLETED|Treatment Period 3||0
7664062|NCT02038829|18874373|P1|NOT COMPLETED|Treatment Period 3||0
7664063|NCT02038829|18874362|P12|COMPLETED|Treatment Period 3||8
7664064|NCT02038829|18874363|P11|COMPLETED|Treatment Period 3||7
7664065|NCT02038829|18874364|P10|COMPLETED|Treatment Period 3||8
7664066|NCT02038829|18874365|P9|COMPLETED|Treatment Period 3||7
7664067|NCT02038829|18874366|P8|COMPLETED|Treatment Period 3||8
7664068|NCT02038829|18874367|P7|COMPLETED|Treatment Period 3||8
7664069|NCT02038829|18874368|P6|COMPLETED|Treatment Period 3||7
7664070|NCT02038829|18874369|P5|COMPLETED|Treatment Period 3||7
7664071|NCT02038829|18874370|P4|COMPLETED|Treatment Period 3||8
7664072|NCT02038829|18874371|P3|COMPLETED|Treatment Period 3||8
7664073|NCT02038829|18874372|P2|COMPLETED|Treatment Period 3||8
7664074|NCT02038829|18874373|P1|COMPLETED|Treatment Period 3||7
7664075|NCT02038829|18874362|P12|STARTED|Treatment Period 3||8
7664076|NCT02038829|18874363|P11|STARTED|Treatment Period 3||7
7664077|NCT02038829|18874364|P10|STARTED|Treatment Period 3||8
7664078|NCT02038829|18874365|P9|STARTED|Treatment Period 3||7
7664079|NCT02038829|18874366|P8|STARTED|Treatment Period 3||8
7664080|NCT02038829|18874367|P7|STARTED|Treatment Period 3||8
7664081|NCT02038829|18874368|P6|STARTED|Treatment Period 3||7
7664082|NCT02038829|18874369|P5|STARTED|Treatment Period 3||7
7664083|NCT02038829|18874370|P4|STARTED|Treatment Period 3||8
7664084|NCT02038829|18874371|P3|STARTED|Treatment Period 3||8
7664085|NCT02038829|18874372|P2|STARTED|Treatment Period 3||8
7664086|NCT02038829|18874373|P1|STARTED|Treatment Period 3||7
7664087|NCT02038829|18874362|P12|NOT COMPLETED|Washout Period 2||0
7664088|NCT02038829|18874363|P11|NOT COMPLETED|Washout Period 2||0
7664089|NCT02038829|18874364|P10|NOT COMPLETED|Washout Period 2||0
7664090|NCT02038829|18874365|P9|NOT COMPLETED|Washout Period 2||1
7664091|NCT02038829|18874366|P8|NOT COMPLETED|Washout Period 2||0
7664092|NCT02038829|18874367|P7|NOT COMPLETED|Washout Period 2||0
7664093|NCT02038829|18874368|P6|NOT COMPLETED|Washout Period 2||1
7664094|NCT02038829|18874369|P5|NOT COMPLETED|Washout Period 2||0
7664095|NCT02038829|18874370|P4|NOT COMPLETED|Washout Period 2||0
7664096|NCT02038829|18874371|P3|NOT COMPLETED|Washout Period 2||0
7664097|NCT02038829|18874372|P2|NOT COMPLETED|Washout Period 2||0
7664098|NCT02038829|18874373|P1|NOT COMPLETED|Washout Period 2||0
7664099|NCT02038829|18874362|P12|COMPLETED|Washout Period 2||8
7664100|NCT02038829|18874363|P11|COMPLETED|Washout Period 2||7
7664101|NCT02038829|18874364|P10|COMPLETED|Washout Period 2||8
7664102|NCT02038829|18874365|P9|COMPLETED|Washout Period 2||7
7664103|NCT02038829|18874366|P8|COMPLETED|Washout Period 2||8
7664104|NCT02038829|18874367|P7|COMPLETED|Washout Period 2||8
7664105|NCT02038829|18874368|P6|COMPLETED|Washout Period 2||7
7664106|NCT02038829|18874369|P5|COMPLETED|Washout Period 2||7
7664107|NCT02038829|18874370|P4|COMPLETED|Washout Period 2||8
7664108|NCT02038829|18874371|P3|COMPLETED|Washout Period 2||8
7664109|NCT02038829|18874372|P2|COMPLETED|Washout Period 2||8
7664110|NCT02038829|18874373|P1|COMPLETED|Washout Period 2||7
7664111|NCT02038829|18874362|P12|STARTED|Washout Period 2||8
7664112|NCT02038829|18874363|P11|STARTED|Washout Period 2||7
7664113|NCT02038829|18874364|P10|STARTED|Washout Period 2||8
7664114|NCT02038829|18874365|P9|STARTED|Washout Period 2||8
7664115|NCT02038829|18874366|P8|STARTED|Washout Period 2||8
7664116|NCT02038829|18874367|P7|STARTED|Washout Period 2||8
7664117|NCT02038829|18874368|P6|STARTED|Washout Period 2||8
7664118|NCT02038829|18874369|P5|STARTED|Washout Period 2||7
7664119|NCT02038829|18874370|P4|STARTED|Washout Period 2||8
7664120|NCT02038829|18874371|P3|STARTED|Washout Period 2||8
7664121|NCT02038829|18874372|P2|STARTED|Washout Period 2||8
7664122|NCT02038829|18874373|P1|STARTED|Washout Period 2||7
7664123|NCT02038829|18874362|P12|NOT COMPLETED|Treatment Period 2||0
7664124|NCT02038829|18874363|P11|NOT COMPLETED|Treatment Period 2||1
7664125|NCT02038829|18874364|P10|NOT COMPLETED|Treatment Period 2||0
7664126|NCT02038829|18874365|P9|NOT COMPLETED|Treatment Period 2||0
7664127|NCT02038829|18874366|P8|NOT COMPLETED|Treatment Period 2||0
7664128|NCT02038829|18874367|P7|NOT COMPLETED|Treatment Period 2||0
7664129|NCT02038829|18874368|P6|NOT COMPLETED|Treatment Period 2||0
7664130|NCT02038829|18874369|P5|NOT COMPLETED|Treatment Period 2||0
7664131|NCT02038829|18874370|P4|NOT COMPLETED|Treatment Period 2||0
7664132|NCT02038829|18874371|P3|NOT COMPLETED|Treatment Period 2||0
7664133|NCT02038829|18874372|P2|NOT COMPLETED|Treatment Period 2||0
7664134|NCT02038829|18874373|P1|NOT COMPLETED|Treatment Period 2||1
7664135|NCT02038829|18874362|P12|COMPLETED|Treatment Period 2||8
7664136|NCT02038829|18874363|P11|COMPLETED|Treatment Period 2||7
7664137|NCT02038829|18874364|P10|COMPLETED|Treatment Period 2||8
7664138|NCT02038829|18874365|P9|COMPLETED|Treatment Period 2||8
7664139|NCT02038829|18874366|P8|COMPLETED|Treatment Period 2||8
7664140|NCT02038829|18874367|P7|COMPLETED|Treatment Period 2||8
7664141|NCT02038829|18874368|P6|COMPLETED|Treatment Period 2||8
7664142|NCT02038829|18874369|P5|COMPLETED|Treatment Period 2||7
7664143|NCT02038829|18874370|P4|COMPLETED|Treatment Period 2||8
7664144|NCT02038829|18874371|P3|COMPLETED|Treatment Period 2||8
7664145|NCT02038829|18874372|P2|COMPLETED|Treatment Period 2||8
7664146|NCT02038829|18874373|P1|COMPLETED|Treatment Period 2||7
7664147|NCT02038829|18874362|P12|STARTED|Treatment Period 2||8
7664148|NCT02038829|18874363|P11|STARTED|Treatment Period 2||8
7664149|NCT02038829|18874364|P10|STARTED|Treatment Period 2||8
7664150|NCT02038829|18874365|P9|STARTED|Treatment Period 2||8
7664151|NCT02038829|18874366|P8|STARTED|Treatment Period 2||8
7664152|NCT02038829|18874367|P7|STARTED|Treatment Period 2||8
7664153|NCT02038829|18874368|P6|STARTED|Treatment Period 2||8
7664154|NCT02038829|18874369|P5|STARTED|Treatment Period 2||7
7664155|NCT02038829|18874370|P4|STARTED|Treatment Period 2||8
7664156|NCT02038829|18874371|P3|STARTED|Treatment Period 2||8
7664157|NCT02038829|18874372|P2|STARTED|Treatment Period 2||8
7664158|NCT02038829|18874373|P1|STARTED|Treatment Period 2||8
7664159|NCT02038829|18874362|P12|NOT COMPLETED|Washout Period 1||0
7664160|NCT02038829|18874363|P11|NOT COMPLETED|Washout Period 1||0
7664161|NCT02038829|18874364|P10|NOT COMPLETED|Washout Period 1||0
7664162|NCT02038829|18874365|P9|NOT COMPLETED|Washout Period 1||0
7664163|NCT02038829|18874366|P8|NOT COMPLETED|Washout Period 1||0
7664164|NCT02038829|18874367|P7|NOT COMPLETED|Washout Period 1||0
7664165|NCT02038829|18874368|P6|NOT COMPLETED|Washout Period 1||0
7664166|NCT02038829|18874369|P5|NOT COMPLETED|Washout Period 1||1
7664167|NCT02038829|18874370|P4|NOT COMPLETED|Washout Period 1||0
7664168|NCT02038829|18874371|P3|NOT COMPLETED|Washout Period 1||0
7664169|NCT02038829|18874372|P2|NOT COMPLETED|Washout Period 1||0
7664170|NCT02038829|18874373|P1|NOT COMPLETED|Washout Period 1||0
7664171|NCT02038829|18874362|P12|COMPLETED|Washout Period 1||8
7664172|NCT02038829|18874363|P11|COMPLETED|Washout Period 1||8
7664173|NCT02038829|18874364|P10|COMPLETED|Washout Period 1||8
7664174|NCT02038829|18874365|P9|COMPLETED|Washout Period 1||8
7664175|NCT02038829|18874366|P8|COMPLETED|Washout Period 1||8
7664176|NCT02038829|18874367|P7|COMPLETED|Washout Period 1||8
7664177|NCT02038829|18874368|P6|COMPLETED|Washout Period 1||8
7664178|NCT02038829|18874369|P5|COMPLETED|Washout Period 1||7
7664179|NCT02038829|18874370|P4|COMPLETED|Washout Period 1||8
7664180|NCT02038829|18874371|P3|COMPLETED|Washout Period 1||8
7664181|NCT02038829|18874372|P2|COMPLETED|Washout Period 1||8
7664182|NCT02038829|18874373|P1|COMPLETED|Washout Period 1||8
7664183|NCT02038829|18874362|P12|STARTED|Washout Period 1||8
7664184|NCT02038829|18874363|P11|STARTED|Washout Period 1||8
7664185|NCT02038829|18874364|P10|STARTED|Washout Period 1||8
7664186|NCT02038829|18874365|P9|STARTED|Washout Period 1||8
7664187|NCT02038829|18874366|P8|STARTED|Washout Period 1||8
7664188|NCT02038829|18874367|P7|STARTED|Washout Period 1||8
7664189|NCT02038829|18874368|P6|STARTED|Washout Period 1||8
7664190|NCT02038829|18874369|P5|STARTED|Washout Period 1||8
7664191|NCT02038829|18874370|P4|STARTED|Washout Period 1||8
7664192|NCT02038829|18874371|P3|STARTED|Washout Period 1||8
7664193|NCT02038829|18874372|P2|STARTED|Washout Period 1||8
7664194|NCT02038829|18874373|P1|STARTED|Washout Period 1||8
7664195|NCT02038829|18874362|P12|NOT COMPLETED|Treatment Period 1||0
7664196|NCT02038829|18874363|P11|NOT COMPLETED|Treatment Period 1||0
7664197|NCT02038829|18874364|P10|NOT COMPLETED|Treatment Period 1||0
7664198|NCT02038829|18874365|P9|NOT COMPLETED|Treatment Period 1||0
7664199|NCT02038829|18874366|P8|NOT COMPLETED|Treatment Period 1||0
7664200|NCT02038829|18874367|P7|NOT COMPLETED|Treatment Period 1||0
7664201|NCT02038829|18874368|P6|NOT COMPLETED|Treatment Period 1||0
7664202|NCT02038829|18874369|P5|NOT COMPLETED|Treatment Period 1||0
7664203|NCT02038829|18874370|P4|NOT COMPLETED|Treatment Period 1||0
7664204|NCT02038829|18874371|P3|NOT COMPLETED|Treatment Period 1||0
7664205|NCT02038829|18874372|P2|NOT COMPLETED|Treatment Period 1||0
7664206|NCT02038829|18874373|P1|NOT COMPLETED|Treatment Period 1||0
7664207|NCT02038829|18874362|P12|COMPLETED|Treatment Period 1||8
7664208|NCT02038829|18874363|P11|COMPLETED|Treatment Period 1||8
7664209|NCT02038829|18874364|P10|COMPLETED|Treatment Period 1||8
7664210|NCT02038829|18874365|P9|COMPLETED|Treatment Period 1||8
7664211|NCT02038829|18874366|P8|COMPLETED|Treatment Period 1||8
7664212|NCT02038829|18874367|P7|COMPLETED|Treatment Period 1||8
7664213|NCT02038829|18874368|P6|COMPLETED|Treatment Period 1||8
7664214|NCT02038829|18874369|P5|COMPLETED|Treatment Period 1||8
7664215|NCT02038829|18874370|P4|COMPLETED|Treatment Period 1||8
7664216|NCT02038829|18874371|P3|COMPLETED|Treatment Period 1||8
7664217|NCT02038829|18874372|P2|COMPLETED|Treatment Period 1||8
7664218|NCT02038829|18874373|P1|COMPLETED|Treatment Period 1||8
7664219|NCT02038829|18874362|P12|STARTED|Treatment Period 1||8
7664220|NCT02038829|18874363|P11|STARTED|Treatment Period 1||8
7664221|NCT02038829|18874364|P10|STARTED|Treatment Period 1||8
7664222|NCT02038829|18874365|P9|STARTED|Treatment Period 1||8
7664223|NCT02038829|18874366|P8|STARTED|Treatment Period 1||8
7664224|NCT02038829|18874367|P7|STARTED|Treatment Period 1||8
7664225|NCT02038829|18874368|P6|STARTED|Treatment Period 1||8
7664226|NCT02038829|18874369|P5|STARTED|Treatment Period 1||8
7664227|NCT02038829|18874370|P4|STARTED|Treatment Period 1||8
7664228|NCT02038829|18874371|P3|STARTED|Treatment Period 1||8
7664229|NCT02038829|18874372|P2|STARTED|Treatment Period 1||8
7664230|NCT02038829|18874373|P1|STARTED|Treatment Period 1||8
7664231|NCT02038790|18874407|P2|NOT COMPLETED|Day 1 - Second Treatment||0
7664232|NCT02038790|18874408|P1|NOT COMPLETED|Day 1 - Second Treatment||0
7664233|NCT02038790|18874407|P2|COMPLETED|Day 1 - Second Treatment||16
7664234|NCT02038790|18874408|P1|COMPLETED|Day 1 - Second Treatment||15
7664235|NCT02038790|18874407|P2|STARTED|Day 1 - Second Treatment||16
7664236|NCT02038790|18874408|P1|STARTED|Day 1 - Second Treatment||15
7664237|NCT02038790|18874407|P2|NOT COMPLETED|Day 0 - First Treatment||1
7664238|NCT02038790|18874408|P1|NOT COMPLETED|Day 0 - First Treatment||1
7664239|NCT02038790|18874407|P2|COMPLETED|Day 0 - First Treatment||16
7664240|NCT02038790|18874408|P1|COMPLETED|Day 0 - First Treatment||15
7664241|NCT02038790|18874407|P2|STARTED|Day 0 - First Treatment||17
7664242|NCT02038790|18874408|P1|STARTED|Day 0 - First Treatment||16
7664243|NCT02038764|18874444|P5|NOT COMPLETED|Overall Study||1
7664244|NCT02038764|18874445|P4|NOT COMPLETED|Overall Study||0
7664245|NCT02038764|18874446|P3|NOT COMPLETED|Overall Study||2
7664246|NCT02038764|18874447|P2|NOT COMPLETED|Overall Study||1
7664247|NCT02038764|18874448|P1|NOT COMPLETED|Overall Study||1
7664248|NCT02038764|18874444|P5|COMPLETED|Overall Study||7
7664249|NCT02038764|18874445|P4|COMPLETED|Overall Study||5
7664250|NCT02038764|18874446|P3|COMPLETED|Overall Study||7
7664251|NCT02038764|18874447|P2|COMPLETED|Overall Study||7
7664252|NCT02038764|18874448|P1|COMPLETED|Overall Study||6
7664253|NCT02038764|18874444|P5|STARTED|Overall Study||8
7664254|NCT02038764|18874445|P4|STARTED|Overall Study||5
7664255|NCT02038764|18874446|P3|STARTED|Overall Study||9
7664256|NCT02038764|18874447|P2|STARTED|Overall Study||8
7664257|NCT02038764|18874448|P1|STARTED|Overall Study||7
7664258|NCT02038647|18874550|P2|NOT COMPLETED|Overall Study||89
7664259|NCT02038647|18874551|P1|NOT COMPLETED|Overall Study||89
7664260|NCT02038647|18874550|P2|COMPLETED|Overall Study||0
7664261|NCT02038647|18874551|P1|COMPLETED|Overall Study||0
7664262|NCT02038647|18874550|P2|STARTED|Overall Study||89
7664263|NCT02038647|18874551|P1|STARTED|Overall Study||89
7664264|NCT02038569|18874583|P1|NOT COMPLETED|Overall Study||5
7664265|NCT02038569|18874583|P1|COMPLETED|Overall Study||102
7664266|NCT02038569|18874583|P1|STARTED|Overall Study||107
7664267|NCT02038543|18874614|P4|NOT COMPLETED|Overall Study||2
7664268|NCT02038543|18874615|P3|NOT COMPLETED|Overall Study||0
7664269|NCT02038543|18874616|P2|NOT COMPLETED|Overall Study||0
7664270|NCT02038543|18874617|P1|NOT COMPLETED|Overall Study||0
7664271|NCT02038543|18874614|P4|COMPLETED|Overall Study||1
7664272|NCT02038543|18874615|P3|COMPLETED|Overall Study||8
7664273|NCT02038543|18874616|P2|COMPLETED|Overall Study||4
7664274|NCT02038543|18874617|P1|COMPLETED|Overall Study||7
7664275|NCT02038543|18874614|P4|STARTED|Overall Study||3
7664276|NCT02038543|18874615|P3|STARTED|Overall Study||8
7664277|NCT02038543|18874616|P2|STARTED|Overall Study||4
7664278|NCT02038543|18874617|P1|STARTED|Overall Study||7
7664279|NCT02038218|18874633|P2|NOT COMPLETED|Overall Study||0
7664280|NCT02038218|18874634|P1|NOT COMPLETED|Overall Study||0
7664281|NCT02038218|18874633|P2|COMPLETED|Overall Study|5 patients are included in a publication in progress|7
7664282|NCT02038218|18874634|P1|COMPLETED|Overall Study|22 patients are included in a publication in progress|22
7664283|NCT02038218|18874633|P2|STARTED|Overall Study|Drug tolerated - Arm 2: liver involvement - 85.5 mg/m2. No alterations of liver functions.|7
7664284|NCT02038218|18874634|P1|STARTED|Overall Study|Drug tolerated - Arm 1: No liver disease - 98.7 mg/m2. No alterations of liver functions.|22
7664285|NCT02038179|18874642|P2|NOT COMPLETED|Phase 2 (4 Weeks)||2
7664286|NCT02038179|18874643|P1|NOT COMPLETED|Phase 2 (4 Weeks)||2
7664287|NCT02038179|18874642|P2|COMPLETED|Phase 2 (4 Weeks)||38
7664288|NCT02038179|18874643|P1|COMPLETED|Phase 2 (4 Weeks)||44
7664289|NCT02038179|18874642|P2|STARTED|Phase 2 (4 Weeks)||40
7664290|NCT02038179|18874643|P1|STARTED|Phase 2 (4 Weeks)||46
7664291|NCT02038179|18874642|P2|NOT COMPLETED|Washout (2-4 Weeks)||2
7664292|NCT02038179|18874643|P1|NOT COMPLETED|Washout (2-4 Weeks)||2
7664293|NCT02038179|18874642|P2|COMPLETED|Washout (2-4 Weeks)||40
7664294|NCT02038179|18874643|P1|COMPLETED|Washout (2-4 Weeks)||46
7664295|NCT02038179|18874642|P2|STARTED|Washout (2-4 Weeks)||42
7664296|NCT02038179|18874643|P1|STARTED|Washout (2-4 Weeks)||48
7664297|NCT02038179|18874642|P2|NOT COMPLETED|Phase 1 (4 Weeks)||5
7664298|NCT02038179|18874643|P1|NOT COMPLETED|Phase 1 (4 Weeks)||4
7664299|NCT02038179|18874642|P2|COMPLETED|Phase 1 (4 Weeks)||42
7664300|NCT02038179|18874643|P1|COMPLETED|Phase 1 (4 Weeks)||48
7664301|NCT02038179|18874642|P2|STARTED|Phase 1 (4 Weeks)||47
7664302|NCT02038179|18874643|P1|STARTED|Phase 1 (4 Weeks)||52
7664303|NCT02038153|18874653|P1|NOT COMPLETED|Overall Study||1
7664304|NCT02038153|18874653|P1|COMPLETED|Overall Study||2
7664305|NCT02038153|18874653|P1|STARTED|Overall Study||3
7664306|NCT02038075|18874660|P2|NOT COMPLETED|Overall Study||0
7664307|NCT02038075|18874661|P1|NOT COMPLETED|Overall Study||3
7664308|NCT02038075|18874660|P2|COMPLETED|Overall Study||76
7664309|NCT02038075|18874661|P1|COMPLETED|Overall Study||73
7664310|NCT02038075|18874660|P2|STARTED|Overall Study||76
7664311|NCT02038075|18874661|P1|STARTED|Overall Study||76
7664312|NCT02038049|18874669|P2|NOT COMPLETED|Overall Study||0
7664313|NCT02038049|18874670|P1|NOT COMPLETED|Overall Study||1
7664314|NCT02038049|18874669|P2|COMPLETED|Overall Study||4
7664315|NCT02038049|18874670|P1|COMPLETED|Overall Study||3
7664316|NCT02038049|18874669|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||4
7664317|NCT02038049|18874670|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||4
7664318|NCT02038049|18874669|P2|STARTED|Overall Study||4
7664319|NCT02038049|18874670|P1|STARTED|Overall Study||4
7664320|NCT02038023|18874692|P1|NOT COMPLETED|Overall Study||1
7664321|NCT02038023|18874692|P1|COMPLETED|Overall Study||73
7664322|NCT02038023|18874692|P1|STARTED|Overall Study||74
7664323|NCT02038010|18874699|P4|NOT COMPLETED|Follow Up||0
7664324|NCT02038010|18874700|P3|NOT COMPLETED|Follow Up||0
7664325|NCT02038010|18874701|P2|NOT COMPLETED|Follow Up||3
7664326|NCT02038010|18874702|P1|NOT COMPLETED|Follow Up||7
7664327|NCT02038010|18874699|P4|COMPLETED|Follow Up||0
7664328|NCT02038010|18874700|P3|COMPLETED|Follow Up||0
7664329|NCT02038010|18874701|P2|COMPLETED|Follow Up||3
7664330|NCT02038010|18874702|P1|COMPLETED|Follow Up||4
7664331|NCT02038010|18874699|P4|STARTED|Follow Up||0
7664332|NCT02038010|18874700|P3|STARTED|Follow Up||0
7664333|NCT02038010|18874701|P2|STARTED|Follow Up||6
7664334|NCT02038010|18874702|P1|STARTED|Follow Up||11
7664335|NCT02038010|18874699|P4|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
7664336|NCT02038010|18874700|P3|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
7664337|NCT02038010|18874701|P2|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
7664338|NCT02038010|18874702|P1|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
7664339|NCT02038010|18874699|P4|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
7664340|NCT02038010|18874700|P3|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
7664341|NCT02038010|18874701|P2|COMPLETED|Completed 3 Cycles/Reached 1st Response||3
7664342|NCT02038010|18874702|P1|COMPLETED|Completed 3 Cycles/Reached 1st Response||9
7664343|NCT02038010|18874699|P4|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
7664344|NCT02038010|18874700|P3|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
7664345|NCT02038010|18874701|P2|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||3
7664346|NCT02038010|18874702|P1|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||9
7664347|NCT02038010|18874699|P4|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
7664348|NCT02038010|18874700|P3|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
7664349|NCT02038010|18874701|P2|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||4
7664350|NCT02038010|18874702|P1|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||10
7664351|NCT02038010|18874699|P4|STARTED|Completed 3 Cycles/Reached 1st Response||0
7664352|NCT02038010|18874700|P3|STARTED|Completed 3 Cycles/Reached 1st Response||0
7664353|NCT02038010|18874701|P2|STARTED|Completed 3 Cycles/Reached 1st Response||4
7664354|NCT02038010|18874702|P1|STARTED|Completed 3 Cycles/Reached 1st Response||10
7664355|NCT02038010|18874699|P4|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
7664356|NCT02038010|18874700|P3|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
7664357|NCT02038010|18874701|P2|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||2
7664358|NCT02038010|18874702|P1|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||1
7664359|NCT02038010|18874699|P4|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
7664360|NCT02038010|18874700|P3|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
7664361|NCT02038010|18874701|P2|COMPLETED|Completed 1st Cycle and Started Cycle 2||4
7664362|NCT02038010|18874702|P1|COMPLETED|Completed 1st Cycle and Started Cycle 2||10
7664363|NCT02038010|18874699|P4|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
7664364|NCT02038010|18874700|P3|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
7664365|NCT02038010|18874701|P2|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||4
7664366|NCT02038010|18874702|P1|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||10
7664367|NCT02038010|18874699|P4|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
7664368|NCT02038010|18874700|P3|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
7664369|NCT02038010|18874701|P2|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||5
7664370|NCT02038010|18874702|P1|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||11
7664371|NCT02038010|18874699|P4|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
7664372|NCT02038010|18874700|P3|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
7664373|NCT02038010|18874701|P2|STARTED|Completed 1st Cycle and Started Cycle 2||6
7664374|NCT02038010|18874702|P1|STARTED|Completed 1st Cycle and Started Cycle 2||11
7664375|NCT02037984|18874729|P8|NOT COMPLETED|Overall Study||12
7664376|NCT02037984|18874730|P7|NOT COMPLETED|Overall Study||17
7664377|NCT02037984|18874731|P6|NOT COMPLETED|Overall Study||12
7664378|NCT02037984|18874732|P5|NOT COMPLETED|Overall Study||12
7664379|NCT02037984|18874733|P4|NOT COMPLETED|Overall Study||21
7664380|NCT02037984|18874734|P3|NOT COMPLETED|Overall Study||12
7664381|NCT02037984|18874735|P2|NOT COMPLETED|Overall Study||0
7664382|NCT02037984|18874736|P1|NOT COMPLETED|Overall Study||1
7664383|NCT02037984|18874729|P8|COMPLETED|Overall Study||39
7664384|NCT02037984|18874730|P7|COMPLETED|Overall Study||33
7664385|NCT02037984|18874731|P6|COMPLETED|Overall Study||37
7664386|NCT02037984|18874732|P5|COMPLETED|Overall Study||38
7664387|NCT02037984|18874733|P4|COMPLETED|Overall Study||30
7664388|NCT02037984|18874734|P3|COMPLETED|Overall Study||38
7664389|NCT02037984|18874735|P2|COMPLETED|Overall Study||20
7664390|NCT02037984|18874736|P1|COMPLETED|Overall Study||19
7664391|NCT02037984|18874729|P8|STARTED|Overall Study||51
7664392|NCT02037984|18874730|P7|STARTED|Overall Study||50
7664393|NCT02037984|18874731|P6|STARTED|Overall Study||49
7664394|NCT02037984|18874732|P5|STARTED|Overall Study||50
7664395|NCT02037984|18874733|P4|STARTED|Overall Study||51
7664396|NCT02037984|18874734|P3|STARTED|Overall Study||50
7664397|NCT02037984|18874735|P2|STARTED|Overall Study||20
7664398|NCT02037984|18874736|P1|STARTED|Overall Study||20
7664399|NCT02037893|18874803|P4|NOT COMPLETED|Overall Study||0
7664400|NCT02037893|18874804|P3|NOT COMPLETED|Overall Study||1
7664401|NCT02037893|18874805|P2|NOT COMPLETED|Overall Study||0
7664402|NCT02037893|18874806|P1|NOT COMPLETED|Overall Study||0
7664403|NCT02037893|18874803|P4|COMPLETED|Overall Study||28
7664404|NCT02037893|18874804|P3|COMPLETED|Overall Study||26
7664405|NCT02037893|18874805|P2|COMPLETED|Overall Study||25
7664406|NCT02037893|18874806|P1|COMPLETED|Overall Study||32
7664407|NCT02037893|18874803|P4|STARTED|Overall Study||28
7664408|NCT02037893|18874804|P3|STARTED|Overall Study||27
7664409|NCT02037893|18874805|P2|STARTED|Overall Study||25
7664410|NCT02037893|18874806|P1|STARTED|Overall Study||32
7664411|NCT02037776|18874858|P2|NOT COMPLETED|Overall Study||4
7664412|NCT02037776|18874859|P1|NOT COMPLETED|Overall Study||5
7664413|NCT02037776|18874858|P2|COMPLETED|Overall Study||60
7664414|NCT02037776|18874859|P1|COMPLETED|Overall Study||56
7664415|NCT02037776|18874858|P2|STARTED|Overall Study||64
7664416|NCT02037776|18874859|P1|STARTED|Overall Study||61
7664417|NCT02037607|18874875|P1|NOT COMPLETED|Overall Study||9
7664418|NCT02037607|18874875|P1|COMPLETED|Overall Study||91
7664419|NCT02037607|18874875|P1|STARTED|Overall Study||100
7664420|NCT02037568|18874881|P2|NOT COMPLETED|Overall Study||39
7664421|NCT02037568|18874882|P1|NOT COMPLETED|Overall Study||36
7664422|NCT02037568|18874881|P2|COMPLETED|Overall Study||37
7664423|NCT02037568|18874882|P1|COMPLETED|Overall Study||47
7664424|NCT02037568|18874881|P2|Month 6 (Post Transplantation)|Overall Study||52
7664425|NCT02037568|18874882|P1|Month 6 (Post Transplantation)|Overall Study||63
7664426|NCT02037568|18874881|P2|Month 3 (Post Transplantation)|Overall Study||62
7664427|NCT02037568|18874882|P1|Month 3 (Post Transplantation)|Overall Study||66
7664428|NCT02037568|18874881|P2|Month 1.5 (Post Transplantation)|Overall Study||76
7664429|NCT02037568|18874882|P1|Month 1.5 (Post Transplantation)|Overall Study||79
7664430|NCT02037568|18874881|P2|STARTED|Overall Study||76
7664431|NCT02037568|18874882|P1|STARTED|Overall Study||83
7664432|NCT02037555|18874906|P2|NOT COMPLETED|Overall Study||21
7664433|NCT02037555|18874907|P1|NOT COMPLETED|Overall Study||23
7664434|NCT02037555|18874906|P2|COMPLETED|Overall Study||191
7664435|NCT02037555|18874907|P1|COMPLETED|Overall Study||190
7664436|NCT02037555|18874906|P2|Dosed and Operated On|Overall Study||196
7664437|NCT02037555|18874907|P1|Dosed and Operated On|Overall Study||200
7664438|NCT02037555|18874906|P2|Dosed|Overall Study||198
7664439|NCT02037555|18874907|P1|Dosed|Overall Study||201
7664440|NCT02037555|18874906|P2|STARTED|Overall Study||212
7664441|NCT02037555|18874907|P1|STARTED|Overall Study||213
7664442|NCT02037477|18874917|P4|NOT COMPLETED|Treatment Period 2||0
7664443|NCT02037477|18874918|P3|NOT COMPLETED|Treatment Period 2||0
7664444|NCT02037477|18874919|P2|NOT COMPLETED|Treatment Period 2||0
7664445|NCT02037477|18874920|P1|NOT COMPLETED|Treatment Period 2||0
7664446|NCT02037477|18874917|P4|COMPLETED|Treatment Period 2||5
7664447|NCT02037477|18874918|P3|COMPLETED|Treatment Period 2||4
7664448|NCT02037477|18874919|P2|COMPLETED|Treatment Period 2||5
7664449|NCT02037477|18874920|P1|COMPLETED|Treatment Period 2||5
7664450|NCT02037477|18874917|P4|STARTED|Treatment Period 2||5
7664451|NCT02037477|18874918|P3|STARTED|Treatment Period 2||4
7664452|NCT02037477|18874919|P2|STARTED|Treatment Period 2||5
7664453|NCT02037477|18874920|P1|STARTED|Treatment Period 2||5
7664454|NCT02037477|18874917|P4|NOT COMPLETED|Treatment Period 1||0
7664455|NCT02037477|18874918|P3|NOT COMPLETED|Treatment Period 1||1
7664456|NCT02037477|18874919|P2|NOT COMPLETED|Treatment Period 1||0
7664457|NCT02037477|18874920|P1|NOT COMPLETED|Treatment Period 1||0
7664458|NCT02037477|18874917|P4|COMPLETED|Treatment Period 1||5
7664459|NCT02037477|18874918|P3|COMPLETED|Treatment Period 1||4
7664460|NCT02037477|18874919|P2|COMPLETED|Treatment Period 1||5
7664461|NCT02037477|18874920|P1|COMPLETED|Treatment Period 1||5
7664462|NCT02037477|18874917|P4|STARTED|Treatment Period 1||5
7664463|NCT02037477|18874918|P3|STARTED|Treatment Period 1||5
7664464|NCT02037477|18874919|P2|STARTED|Treatment Period 1||5
7664465|NCT02037477|18874920|P1|STARTED|Treatment Period 1||5
7664466|NCT02037438|18874948|P2|NOT COMPLETED|Overall Study||355
7664467|NCT02037438|18874949|P1|NOT COMPLETED|Overall Study||346
7664468|NCT02037438|18874948|P2|COMPLETED|Overall Study||561
7664469|NCT02037438|18874949|P1|COMPLETED|Overall Study||574
7664470|NCT02037438|18874948|P2|STARTED|Overall Study||916
7664471|NCT02037438|18874949|P1|STARTED|Overall Study||920
7664472|NCT02037425|18874963|P1|NOT COMPLETED|Overall Study||26
7664473|NCT02037425|18874963|P1|COMPLETED|Overall Study||18
7664474|NCT02037425|18874963|P1|Randomized to Treatment|Overall Study||32
7664475|NCT02037425|18874963|P1|STARTED|Overall Study||44
7664476|NCT02037347|18875005|P1|NOT COMPLETED|Overall Study||0
7664477|NCT02037347|18875005|P1|COMPLETED|Overall Study||1
7664478|NCT02037347|18875005|P1|STARTED|Overall Study||1
7664479|NCT02037295|18875015|P4|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
7664480|NCT02037295|18875016|P3|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
7664481|NCT02037295|18875017|P2|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
7664482|NCT02037295|18875018|P1|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
7664483|NCT02037295|18875015|P4|COMPLETED|Phase 2: Vancomycin and Placebo||6
7664484|NCT02037295|18875016|P3|COMPLETED|Phase 2: Vancomycin and Placebo||4
7664485|NCT02037295|18875017|P2|COMPLETED|Phase 2: Vancomycin and Placebo||7
7664486|NCT02037295|18875018|P1|COMPLETED|Phase 2: Vancomycin and Placebo||8
7664487|NCT02037295|18875015|P4|STARTED|Phase 2: Vancomycin and Placebo||7
7664488|NCT02037295|18875016|P3|STARTED|Phase 2: Vancomycin and Placebo||4
7664489|NCT02037295|18875017|P2|STARTED|Phase 2: Vancomycin and Placebo||7
7664490|NCT02037295|18875018|P1|STARTED|Phase 2: Vancomycin and Placebo||9
7664491|NCT02037295|18875015|P4|NOT COMPLETED|Phase 1: Crossover UF and OF||0
7664492|NCT02037295|18875016|P3|NOT COMPLETED|Phase 1: Crossover UF and OF||0
7664493|NCT02037295|18875017|P2|NOT COMPLETED|Phase 1: Crossover UF and OF||0
7664494|NCT02037295|18875018|P1|NOT COMPLETED|Phase 1: Crossover UF and OF||0
7664495|NCT02037295|18875015|P4|COMPLETED|Phase 1: Crossover UF and OF||7
7664496|NCT02037295|18875016|P3|COMPLETED|Phase 1: Crossover UF and OF||4
7664497|NCT02037295|18875017|P2|COMPLETED|Phase 1: Crossover UF and OF||7
7664498|NCT02037295|18875018|P1|COMPLETED|Phase 1: Crossover UF and OF||9
7664499|NCT02037295|18875015|P4|STARTED|Phase 1: Crossover UF and OF||7
7664500|NCT02037295|18875016|P3|STARTED|Phase 1: Crossover UF and OF||4
7664501|NCT02037295|18875017|P2|STARTED|Phase 1: Crossover UF and OF||7
7664502|NCT02037295|18875018|P1|STARTED|Phase 1: Crossover UF and OF||9
7664503|NCT02037230|18875042|P4|NOT COMPLETED|Overall Study||6
7664504|NCT02037230|18875043|P3|NOT COMPLETED|Overall Study||6
7664505|NCT02037230|18875044|P2|NOT COMPLETED|Overall Study||6
7664506|NCT02037230|18875045|P1|NOT COMPLETED|Overall Study||1
7664507|NCT02037230|18875042|P4|COMPLETED|Overall Study||5
7664508|NCT02037230|18875043|P3|COMPLETED|Overall Study||3
7664509|NCT02037230|18875044|P2|COMPLETED|Overall Study||7
7664510|NCT02037230|18875045|P1|COMPLETED|Overall Study||0
7664511|NCT02037230|18875042|P4|Completed 4 Cycles of Treatment|Overall Study||9
7664512|NCT02037230|18875043|P3|Completed 4 Cycles of Treatment|Overall Study||7
7664513|NCT02037230|18875044|P2|Completed 4 Cycles of Treatment|Overall Study||9
7664514|NCT02037230|18875045|P1|Completed 4 Cycles of Treatment|Overall Study||1
7664515|NCT02037230|18875042|P4|STARTED|Overall Study||11
7664516|NCT02037230|18875043|P3|STARTED|Overall Study||9
7664517|NCT02037230|18875044|P2|STARTED|Overall Study||13
7664518|NCT02037230|18875045|P1|STARTED|Overall Study||1
7664519|NCT02037204|18875064|P1|NOT COMPLETED|Overall Study||0
7664520|NCT02037204|18875064|P1|COMPLETED|Overall Study||35
7664521|NCT02037204|18875064|P1|STARTED|Overall Study||35
7664522|NCT02037165|18875074|P5|NOT COMPLETED|Period 5 (2 Days)||0
7664523|NCT02037165|18875075|P4|NOT COMPLETED|Period 5 (2 Days)||0
7664524|NCT02037165|18875076|P3|NOT COMPLETED|Period 5 (2 Days)||0
7664525|NCT02037165|18875077|P2|NOT COMPLETED|Period 5 (2 Days)||0
7664526|NCT02037165|18875078|P1|NOT COMPLETED|Period 5 (2 Days)||0
7664527|NCT02037165|18875074|P5|COMPLETED|Period 5 (2 Days)||4
7664528|NCT02037165|18875075|P4|COMPLETED|Period 5 (2 Days)||5
7664529|NCT02037165|18875076|P3|COMPLETED|Period 5 (2 Days)||5
7664530|NCT02037165|18875077|P2|COMPLETED|Period 5 (2 Days)||5
7664531|NCT02037165|18875078|P1|COMPLETED|Period 5 (2 Days)||5
7664532|NCT02037165|18875074|P5|STARTED|Period 5 (2 Days)||4
7664533|NCT02037165|18875075|P4|STARTED|Period 5 (2 Days)||5
7664534|NCT02037165|18875076|P3|STARTED|Period 5 (2 Days)||5
7664535|NCT02037165|18875077|P2|STARTED|Period 5 (2 Days)||5
7664536|NCT02037165|18875078|P1|STARTED|Period 5 (2 Days)||5
7664537|NCT02037165|18875074|P5|NOT COMPLETED|Washout Period 4 (6 Days)||1
7664538|NCT02037165|18875075|P4|NOT COMPLETED|Washout Period 4 (6 Days)||0
7664539|NCT02037165|18875076|P3|NOT COMPLETED|Washout Period 4 (6 Days)||0
7664540|NCT02037165|18875077|P2|NOT COMPLETED|Washout Period 4 (6 Days)||0
7664541|NCT02037165|18875078|P1|NOT COMPLETED|Washout Period 4 (6 Days)||0
7664542|NCT02037165|18875074|P5|COMPLETED|Washout Period 4 (6 Days)||4
7664543|NCT02037165|18875075|P4|COMPLETED|Washout Period 4 (6 Days)||5
7664544|NCT02037165|18875076|P3|COMPLETED|Washout Period 4 (6 Days)||5
7664545|NCT02037165|18875077|P2|COMPLETED|Washout Period 4 (6 Days)||5
7664546|NCT02037165|18875078|P1|COMPLETED|Washout Period 4 (6 Days)||5
7664547|NCT02037165|18875074|P5|STARTED|Washout Period 4 (6 Days)||5
7664548|NCT02037165|18875075|P4|STARTED|Washout Period 4 (6 Days)||5
7664549|NCT02037165|18875076|P3|STARTED|Washout Period 4 (6 Days)||5
7664550|NCT02037165|18875077|P2|STARTED|Washout Period 4 (6 Days)||5
7664551|NCT02037165|18875078|P1|STARTED|Washout Period 4 (6 Days)||5
7664552|NCT02037165|18875074|P5|NOT COMPLETED|Period 4 (2 Days)||0
7664553|NCT02037165|18875075|P4|NOT COMPLETED|Period 4 (2 Days)||0
7664554|NCT02037165|18875076|P3|NOT COMPLETED|Period 4 (2 Days)||0
7664555|NCT02037165|18875077|P2|NOT COMPLETED|Period 4 (2 Days)||0
7664556|NCT02037165|18875078|P1|NOT COMPLETED|Period 4 (2 Days)||0
7664557|NCT02037165|18875074|P5|COMPLETED|Period 4 (2 Days)||5
7664558|NCT02037165|18875075|P4|COMPLETED|Period 4 (2 Days)||5
7664559|NCT02037165|18875076|P3|COMPLETED|Period 4 (2 Days)||5
7664560|NCT02037165|18875077|P2|COMPLETED|Period 4 (2 Days)||5
7664561|NCT02037165|18875078|P1|COMPLETED|Period 4 (2 Days)||5
7664562|NCT02037165|18875074|P5|STARTED|Period 4 (2 Days)||5
7664563|NCT02037165|18875075|P4|STARTED|Period 4 (2 Days)||5
7664564|NCT02037165|18875076|P3|STARTED|Period 4 (2 Days)||5
7664565|NCT02037165|18875077|P2|STARTED|Period 4 (2 Days)||5
7664566|NCT02037165|18875078|P1|STARTED|Period 4 (2 Days)||5
7664567|NCT02037165|18875074|P5|NOT COMPLETED|Washout Period 3 (6 Days)||0
7664568|NCT02037165|18875075|P4|NOT COMPLETED|Washout Period 3 (6 Days)||0
7664569|NCT02037165|18875076|P3|NOT COMPLETED|Washout Period 3 (6 Days)||0
7664570|NCT02037165|18875077|P2|NOT COMPLETED|Washout Period 3 (6 Days)||0
7664571|NCT02037165|18875078|P1|NOT COMPLETED|Washout Period 3 (6 Days)||0
7664572|NCT02037165|18875074|P5|COMPLETED|Washout Period 3 (6 Days)||5
7664573|NCT02037165|18875075|P4|COMPLETED|Washout Period 3 (6 Days)||5
7664574|NCT02037165|18875076|P3|COMPLETED|Washout Period 3 (6 Days)||5
7664575|NCT02037165|18875077|P2|COMPLETED|Washout Period 3 (6 Days)||5
7664576|NCT02037165|18875078|P1|COMPLETED|Washout Period 3 (6 Days)||5
7664577|NCT02037165|18875074|P5|STARTED|Washout Period 3 (6 Days)||5
7664578|NCT02037165|18875075|P4|STARTED|Washout Period 3 (6 Days)||5
7664579|NCT02037165|18875076|P3|STARTED|Washout Period 3 (6 Days)||5
7664580|NCT02037165|18875077|P2|STARTED|Washout Period 3 (6 Days)||5
7664581|NCT02037165|18875078|P1|STARTED|Washout Period 3 (6 Days)||5
7664582|NCT02037165|18875074|P5|NOT COMPLETED|Period 3 (2 Days)||0
7664583|NCT02037165|18875075|P4|NOT COMPLETED|Period 3 (2 Days)||0
7664584|NCT02037165|18875076|P3|NOT COMPLETED|Period 3 (2 Days)||0
7664585|NCT02037165|18875077|P2|NOT COMPLETED|Period 3 (2 Days)||0
7664586|NCT02037165|18875078|P1|NOT COMPLETED|Period 3 (2 Days)||0
7664587|NCT02037165|18875074|P5|COMPLETED|Period 3 (2 Days)||5
7664588|NCT02037165|18875075|P4|COMPLETED|Period 3 (2 Days)||5
7664589|NCT02037165|18875076|P3|COMPLETED|Period 3 (2 Days)||5
7664590|NCT02037165|18875077|P2|COMPLETED|Period 3 (2 Days)||5
7664591|NCT02037165|18875078|P1|COMPLETED|Period 3 (2 Days)||5
7664592|NCT02037165|18875074|P5|STARTED|Period 3 (2 Days)||5
7664593|NCT02037165|18875075|P4|STARTED|Period 3 (2 Days)||5
7664594|NCT02037165|18875076|P3|STARTED|Period 3 (2 Days)||5
7664595|NCT02037165|18875077|P2|STARTED|Period 3 (2 Days)||5
7664596|NCT02037165|18875078|P1|STARTED|Period 3 (2 Days)||5
7664597|NCT02037165|18875074|P5|NOT COMPLETED|Washout Period 2 (6 Days)||0
7664598|NCT02037165|18875075|P4|NOT COMPLETED|Washout Period 2 (6 Days)||0
7664599|NCT02037165|18875076|P3|NOT COMPLETED|Washout Period 2 (6 Days)||0
7664600|NCT02037165|18875077|P2|NOT COMPLETED|Washout Period 2 (6 Days)||0
7664601|NCT02037165|18875078|P1|NOT COMPLETED|Washout Period 2 (6 Days)||0
7664602|NCT02037165|18875074|P5|COMPLETED|Washout Period 2 (6 Days)||5
7664603|NCT02037165|18875075|P4|COMPLETED|Washout Period 2 (6 Days)||5
7664604|NCT02037165|18875076|P3|COMPLETED|Washout Period 2 (6 Days)||5
7664605|NCT02037165|18875077|P2|COMPLETED|Washout Period 2 (6 Days)||5
7664606|NCT02037165|18875078|P1|COMPLETED|Washout Period 2 (6 Days)||5
7664607|NCT02037165|18875074|P5|STARTED|Washout Period 2 (6 Days)||5
7664608|NCT02037165|18875075|P4|STARTED|Washout Period 2 (6 Days)||5
7664609|NCT02037165|18875076|P3|STARTED|Washout Period 2 (6 Days)||5
7664610|NCT02037165|18875077|P2|STARTED|Washout Period 2 (6 Days)||5
7664611|NCT02037165|18875078|P1|STARTED|Washout Period 2 (6 Days)||5
7664612|NCT02037165|18875074|P5|NOT COMPLETED|Period 2 (2 Days)||0
7664613|NCT02037165|18875075|P4|NOT COMPLETED|Period 2 (2 Days)||0
7664614|NCT02037165|18875076|P3|NOT COMPLETED|Period 2 (2 Days)||0
7664615|NCT02037165|18875077|P2|NOT COMPLETED|Period 2 (2 Days)||0
7664616|NCT02037165|18875078|P1|NOT COMPLETED|Period 2 (2 Days)||0
7664617|NCT02037165|18875074|P5|COMPLETED|Period 2 (2 Days)||5
7664618|NCT02037165|18875075|P4|COMPLETED|Period 2 (2 Days)||5
7664619|NCT02037165|18875076|P3|COMPLETED|Period 2 (2 Days)||5
7664620|NCT02037165|18875077|P2|COMPLETED|Period 2 (2 Days)||5
7664621|NCT02037165|18875078|P1|COMPLETED|Period 2 (2 Days)||5
7664622|NCT02037165|18875074|P5|STARTED|Period 2 (2 Days)||5
7664623|NCT02037165|18875075|P4|STARTED|Period 2 (2 Days)||5
7664624|NCT02037165|18875076|P3|STARTED|Period 2 (2 Days)||5
7664625|NCT02037165|18875077|P2|STARTED|Period 2 (2 Days)||5
7664626|NCT02037165|18875078|P1|STARTED|Period 2 (2 Days)||5
7664627|NCT02037165|18875074|P5|NOT COMPLETED|Washout Period 1 (6 Days)||0
7664628|NCT02037165|18875075|P4|NOT COMPLETED|Washout Period 1 (6 Days)||0
7664629|NCT02037165|18875076|P3|NOT COMPLETED|Washout Period 1 (6 Days)||0
7664630|NCT02037165|18875077|P2|NOT COMPLETED|Washout Period 1 (6 Days)||0
7664631|NCT02037165|18875078|P1|NOT COMPLETED|Washout Period 1 (6 Days)||0
7664632|NCT02037165|18875074|P5|COMPLETED|Washout Period 1 (6 Days)||5
7664633|NCT02037165|18875075|P4|COMPLETED|Washout Period 1 (6 Days)||5
7664634|NCT02037165|18875076|P3|COMPLETED|Washout Period 1 (6 Days)||5
7664635|NCT02037165|18875077|P2|COMPLETED|Washout Period 1 (6 Days)||5
7664636|NCT02037165|18875078|P1|COMPLETED|Washout Period 1 (6 Days)||5
7664637|NCT02037165|18875074|P5|STARTED|Washout Period 1 (6 Days)||5
7664638|NCT02037165|18875075|P4|STARTED|Washout Period 1 (6 Days)||5
7664639|NCT02037165|18875076|P3|STARTED|Washout Period 1 (6 Days)||5
7664640|NCT02037165|18875077|P2|STARTED|Washout Period 1 (6 Days)||5
7664641|NCT02037165|18875078|P1|STARTED|Washout Period 1 (6 Days)||5
7664642|NCT02037165|18875074|P5|NOT COMPLETED|Period 1 (2 Days)||0
7664643|NCT02037165|18875075|P4|NOT COMPLETED|Period 1 (2 Days)||0
7664644|NCT02037165|18875076|P3|NOT COMPLETED|Period 1 (2 Days)||0
7664645|NCT02037165|18875077|P2|NOT COMPLETED|Period 1 (2 Days)||0
7664646|NCT02037165|18875078|P1|NOT COMPLETED|Period 1 (2 Days)||0
7664647|NCT02037165|18875074|P5|COMPLETED|Period 1 (2 Days)||5
7664648|NCT02037165|18875075|P4|COMPLETED|Period 1 (2 Days)||5
7664649|NCT02037165|18875076|P3|COMPLETED|Period 1 (2 Days)||5
7664650|NCT02037165|18875077|P2|COMPLETED|Period 1 (2 Days)||5
7664651|NCT02037165|18875078|P1|COMPLETED|Period 1 (2 Days)||5
7664652|NCT02037165|18875074|P5|STARTED|Period 1 (2 Days)|randomized subjects|5
7664653|NCT02037165|18875075|P4|STARTED|Period 1 (2 Days)|randomized subjects|5
7664654|NCT02037165|18875076|P3|STARTED|Period 1 (2 Days)|randomized subjects|5
7664655|NCT02037165|18875077|P2|STARTED|Period 1 (2 Days)|randomized subjects|5
7664656|NCT02037165|18875078|P1|STARTED|Period 1 (2 Days)|randomized subjects|5
7664657|NCT02037061|18875123|P2|NOT COMPLETED|Overall Study||0
7664658|NCT02037061|18875124|P1|NOT COMPLETED|Overall Study||0
7664659|NCT02037061|18875123|P2|COMPLETED|Overall Study||24
7664660|NCT02037061|18875124|P1|COMPLETED|Overall Study||22
7664661|NCT02037061|18875123|P2|STARTED|Overall Study||24
7664662|NCT02037061|18875124|P1|STARTED|Overall Study||22
7664663|NCT02036840|18875134|P1|NOT COMPLETED|Overall Study||0
7664664|NCT02036840|18875134|P1|COMPLETED|Overall Study||513
7664665|NCT02036840|18875134|P1|STARTED|Overall Study||513
7664666|NCT02036775|18875138|P6|NOT COMPLETED|Treatment Period 3 (6 Days)||0
7664667|NCT02036775|18875139|P5|NOT COMPLETED|Treatment Period 3 (6 Days)||0
7664668|NCT02036775|18875140|P4|NOT COMPLETED|Treatment Period 3 (6 Days)||0
7664669|NCT02036775|18875141|P3|NOT COMPLETED|Treatment Period 3 (6 Days)||0
7664670|NCT02036775|18875142|P2|NOT COMPLETED|Treatment Period 3 (6 Days)||0
7664671|NCT02036775|18875143|P1|NOT COMPLETED|Treatment Period 3 (6 Days)||0
7664672|NCT02036775|18875138|P6|COMPLETED|Treatment Period 3 (6 Days)||3
7664673|NCT02036775|18875139|P5|COMPLETED|Treatment Period 3 (6 Days)||4
7664674|NCT02036775|18875140|P4|COMPLETED|Treatment Period 3 (6 Days)||4
7664675|NCT02036775|18875141|P3|COMPLETED|Treatment Period 3 (6 Days)||4
7664676|NCT02036775|18875142|P2|COMPLETED|Treatment Period 3 (6 Days)||4
7664677|NCT02036775|18875143|P1|COMPLETED|Treatment Period 3 (6 Days)||4
7664678|NCT02036775|18875138|P6|STARTED|Treatment Period 3 (6 Days)||3
7664679|NCT02036775|18875139|P5|STARTED|Treatment Period 3 (6 Days)||4
7664680|NCT02036775|18875140|P4|STARTED|Treatment Period 3 (6 Days)||4
7664681|NCT02036775|18875141|P3|STARTED|Treatment Period 3 (6 Days)||4
7664682|NCT02036775|18875142|P2|STARTED|Treatment Period 3 (6 Days)||4
7664683|NCT02036775|18875143|P1|STARTED|Treatment Period 3 (6 Days)||4
7664684|NCT02036775|18875138|P6|NOT COMPLETED|Treatment Period 2 (6 Days)||1
7664685|NCT02036775|18875139|P5|NOT COMPLETED|Treatment Period 2 (6 Days)||0
7664686|NCT02036775|18875140|P4|NOT COMPLETED|Treatment Period 2 (6 Days)||0
7664687|NCT02036775|18875141|P3|NOT COMPLETED|Treatment Period 2 (6 Days)||0
7664688|NCT02036775|18875142|P2|NOT COMPLETED|Treatment Period 2 (6 Days)||0
7664689|NCT02036775|18875143|P1|NOT COMPLETED|Treatment Period 2 (6 Days)||0
7664690|NCT02036775|18875138|P6|COMPLETED|Treatment Period 2 (6 Days)||3
7664691|NCT02036775|18875139|P5|COMPLETED|Treatment Period 2 (6 Days)||4
7664692|NCT02036775|18875140|P4|COMPLETED|Treatment Period 2 (6 Days)||4
7664693|NCT02036775|18875141|P3|COMPLETED|Treatment Period 2 (6 Days)||4
7664694|NCT02036775|18875142|P2|COMPLETED|Treatment Period 2 (6 Days)||4
7664695|NCT02036775|18875143|P1|COMPLETED|Treatment Period 2 (6 Days)||4
7664696|NCT02036775|18875138|P6|STARTED|Treatment Period 2 (6 Days)||4
7664697|NCT02036775|18875139|P5|STARTED|Treatment Period 2 (6 Days)||4
7664698|NCT02036775|18875140|P4|STARTED|Treatment Period 2 (6 Days)||4
7664699|NCT02036775|18875141|P3|STARTED|Treatment Period 2 (6 Days)||4
7664700|NCT02036775|18875142|P2|STARTED|Treatment Period 2 (6 Days)||4
7664701|NCT02036775|18875143|P1|STARTED|Treatment Period 2 (6 Days)||4
7664702|NCT02036775|18875138|P6|NOT COMPLETED|Treatment Period 1 (6 Days)||0
7664703|NCT02036775|18875139|P5|NOT COMPLETED|Treatment Period 1 (6 Days)||0
7664704|NCT02036775|18875140|P4|NOT COMPLETED|Treatment Period 1 (6 Days)||0
7664705|NCT02036775|18875141|P3|NOT COMPLETED|Treatment Period 1 (6 Days)||0
7664706|NCT02036775|18875142|P2|NOT COMPLETED|Treatment Period 1 (6 Days)||0
7664707|NCT02036775|18875143|P1|NOT COMPLETED|Treatment Period 1 (6 Days)||0
7664708|NCT02036775|18875138|P6|COMPLETED|Treatment Period 1 (6 Days)||4
7664709|NCT02036775|18875139|P5|COMPLETED|Treatment Period 1 (6 Days)||4
7664710|NCT02036775|18875140|P4|COMPLETED|Treatment Period 1 (6 Days)||4
7664711|NCT02036775|18875141|P3|COMPLETED|Treatment Period 1 (6 Days)||4
7664712|NCT02036775|18875142|P2|COMPLETED|Treatment Period 1 (6 Days)||4
7664713|NCT02036775|18875143|P1|COMPLETED|Treatment Period 1 (6 Days)||4
7664714|NCT02036775|18875138|P6|STARTED|Treatment Period 1 (6 Days)||4
7664715|NCT02036775|18875139|P5|STARTED|Treatment Period 1 (6 Days)||4
7664716|NCT02036775|18875140|P4|STARTED|Treatment Period 1 (6 Days)||4
7664717|NCT02036775|18875141|P3|STARTED|Treatment Period 1 (6 Days)||4
7664718|NCT02036775|18875142|P2|STARTED|Treatment Period 1 (6 Days)||4
7664719|NCT02036775|18875143|P1|STARTED|Treatment Period 1 (6 Days)||4
7664720|NCT02036645|18875193|P12|NOT COMPLETED|MAD Cohorts: Study Part 2||0
7664721|NCT02036645|18875194|P11|NOT COMPLETED|MAD Cohorts: Study Part 2||0
7664722|NCT02036645|18875195|P10|NOT COMPLETED|MAD Cohorts: Study Part 2||0
7664723|NCT02036645|18875196|P9|NOT COMPLETED|MAD Cohorts: Study Part 2||0
7664724|NCT02036645|18875197|P8|NOT COMPLETED|MAD Cohorts: Study Part 2||0
7664725|NCT02036645|18875198|P7|NOT COMPLETED|MAD Cohorts: Study Part 2||0
7664726|NCT02036645|18875199|P6|NOT COMPLETED|MAD Cohorts: Study Part 2||0
7664727|NCT02036645|18875200|P5|NOT COMPLETED|MAD Cohorts: Study Part 2||0
7664728|NCT02036645|18875201|P4|NOT COMPLETED|MAD Cohorts: Study Part 2||0
7664729|NCT02036645|18875202|P3|NOT COMPLETED|MAD Cohorts: Study Part 2||0
7664730|NCT02036645|18875203|P2|NOT COMPLETED|MAD Cohorts: Study Part 2||0
7664731|NCT02036645|18875204|P1|NOT COMPLETED|MAD Cohorts: Study Part 2||0
7664732|NCT02036645|18875193|P12|COMPLETED|MAD Cohorts: Study Part 2||6
7664733|NCT02036645|18875194|P11|COMPLETED|MAD Cohorts: Study Part 2||6
7664734|NCT02036645|18875195|P10|COMPLETED|MAD Cohorts: Study Part 2||6
7664735|NCT02036645|18875196|P9|COMPLETED|MAD Cohorts: Study Part 2||6
7664736|NCT02036645|18875197|P8|COMPLETED|MAD Cohorts: Study Part 2||8
7664737|NCT02036645|18875198|P7|COMPLETED|MAD Cohorts: Study Part 2||0
7664738|NCT02036645|18875199|P6|COMPLETED|MAD Cohorts: Study Part 2||0
7664739|NCT02036645|18875200|P5|COMPLETED|MAD Cohorts: Study Part 2||0
7664740|NCT02036645|18875201|P4|COMPLETED|MAD Cohorts: Study Part 2||0
7664741|NCT02036645|18875202|P3|COMPLETED|MAD Cohorts: Study Part 2||0
7664742|NCT02036645|18875203|P2|COMPLETED|MAD Cohorts: Study Part 2||0
7664743|NCT02036645|18875204|P1|COMPLETED|MAD Cohorts: Study Part 2||0
7664744|NCT02036645|18875193|P12|STARTED|MAD Cohorts: Study Part 2||6
7664745|NCT02036645|18875194|P11|STARTED|MAD Cohorts: Study Part 2||6
7664746|NCT02036645|18875195|P10|STARTED|MAD Cohorts: Study Part 2||6
7664747|NCT02036645|18875196|P9|STARTED|MAD Cohorts: Study Part 2||6
7664748|NCT02036645|18875197|P8|STARTED|MAD Cohorts: Study Part 2||8
7664749|NCT02036645|18875198|P7|STARTED|MAD Cohorts: Study Part 2||0
7664750|NCT02036645|18875199|P6|STARTED|MAD Cohorts: Study Part 2||0
7664751|NCT02036645|18875200|P5|STARTED|MAD Cohorts: Study Part 2||0
7664752|NCT02036645|18875201|P4|STARTED|MAD Cohorts: Study Part 2||0
7664753|NCT02036645|18875202|P3|STARTED|MAD Cohorts: Study Part 2||0
7664754|NCT02036645|18875203|P2|STARTED|MAD Cohorts: Study Part 2||0
7664755|NCT02036645|18875204|P1|STARTED|MAD Cohorts: Study Part 2|Pooled across Cohorts 7 to 9 (2 per cohort)|0
7664756|NCT02036645|18875193|P12|NOT COMPLETED|SAD Cohorts : Study Part 1||0
7664757|NCT02036645|18875194|P11|NOT COMPLETED|SAD Cohorts : Study Part 1||0
7664758|NCT02036645|18875195|P10|NOT COMPLETED|SAD Cohorts : Study Part 1||0
7664759|NCT02036645|18875196|P9|NOT COMPLETED|SAD Cohorts : Study Part 1||0
7664760|NCT02036645|18875197|P8|NOT COMPLETED|SAD Cohorts : Study Part 1||0
7664761|NCT02036645|18875198|P7|NOT COMPLETED|SAD Cohorts : Study Part 1||1
7664762|NCT02036645|18875199|P6|NOT COMPLETED|SAD Cohorts : Study Part 1||0
7664763|NCT02036645|18875200|P5|NOT COMPLETED|SAD Cohorts : Study Part 1||0
7664764|NCT02036645|18875201|P4|NOT COMPLETED|SAD Cohorts : Study Part 1||1
7664765|NCT02036645|18875202|P3|NOT COMPLETED|SAD Cohorts : Study Part 1||0
7664766|NCT02036645|18875203|P2|NOT COMPLETED|SAD Cohorts : Study Part 1||0
7664767|NCT02036645|18875204|P1|NOT COMPLETED|SAD Cohorts : Study Part 1||0
7664768|NCT02036645|18875193|P12|COMPLETED|SAD Cohorts : Study Part 1||0
7664769|NCT02036645|18875194|P11|COMPLETED|SAD Cohorts : Study Part 1||0
7664770|NCT02036645|18875195|P10|COMPLETED|SAD Cohorts : Study Part 1||0
7664771|NCT02036645|18875196|P9|COMPLETED|SAD Cohorts : Study Part 1||0
7664772|NCT02036645|18875197|P8|COMPLETED|SAD Cohorts : Study Part 1||0
7664773|NCT02036645|18875198|P7|COMPLETED|SAD Cohorts : Study Part 1||5
7664774|NCT02036645|18875199|P6|COMPLETED|SAD Cohorts : Study Part 1||6
7664775|NCT02036645|18875200|P5|COMPLETED|SAD Cohorts : Study Part 1||6
7664776|NCT02036645|18875201|P4|COMPLETED|SAD Cohorts : Study Part 1||5
7664777|NCT02036645|18875202|P3|COMPLETED|SAD Cohorts : Study Part 1||6
7664778|NCT02036645|18875203|P2|COMPLETED|SAD Cohorts : Study Part 1||3
7664779|NCT02036645|18875204|P1|COMPLETED|SAD Cohorts : Study Part 1||12
7664780|NCT02036645|18875193|P12|STARTED|SAD Cohorts : Study Part 1||0
7664781|NCT02036645|18875194|P11|STARTED|SAD Cohorts : Study Part 1||0
7664782|NCT02036645|18875195|P10|STARTED|SAD Cohorts : Study Part 1||0
7664783|NCT02036645|18875196|P9|STARTED|SAD Cohorts : Study Part 1||0
7664784|NCT02036645|18875197|P8|STARTED|SAD Cohorts : Study Part 1||0
7664785|NCT02036645|18875198|P7|STARTED|SAD Cohorts : Study Part 1||6
7664786|NCT02036645|18875199|P6|STARTED|SAD Cohorts : Study Part 1||6
7664787|NCT02036645|18875200|P5|STARTED|SAD Cohorts : Study Part 1||6
7664788|NCT02036645|18875201|P4|STARTED|SAD Cohorts : Study Part 1||6
7664789|NCT02036645|18875202|P3|STARTED|SAD Cohorts : Study Part 1||6
7664790|NCT02036645|18875203|P2|STARTED|SAD Cohorts : Study Part 1||3
7664791|NCT02036645|18875204|P1|STARTED|SAD Cohorts : Study Part 1|Pooled across cohorts 1-5 (2 per cohort)|12
7664792|NCT02036580|18875309|P3|NOT COMPLETED|Overall Study||0
7664793|NCT02036580|18875310|P2|NOT COMPLETED|Overall Study||1
7664794|NCT02036580|18875311|P1|NOT COMPLETED|Overall Study||1
7664795|NCT02036580|18875309|P3|COMPLETED|Overall Study||4
7664796|NCT02036580|18875310|P2|COMPLETED|Overall Study||7
7664797|NCT02036580|18875311|P1|COMPLETED|Overall Study||7
7664798|NCT02036580|18875309|P3|STARTED|Overall Study||4
7664799|NCT02036580|18875310|P2|STARTED|Overall Study||8
7664800|NCT02036580|18875311|P1|STARTED|Overall Study||8
7664801|NCT02036541|18875324|P1|NOT COMPLETED|Overall Study||16
7664802|NCT02036541|18875324|P1|COMPLETED|Overall Study||49
7664803|NCT02036541|18875324|P1|Completed Endpoint Visit|Overall Study||54
7664804|NCT02036541|18875324|P1|STARTED|Overall Study||65
7664805|NCT02036515|18875332|P3|NOT COMPLETED|Overall Study||14
7664806|NCT02036515|18875333|P2|NOT COMPLETED|Overall Study||12
7664807|NCT02036515|18875334|P1|NOT COMPLETED|Overall Study||5
7664808|NCT02036515|18875332|P3|COMPLETED|Overall Study||139
7664809|NCT02036515|18875333|P2|COMPLETED|Overall Study||143
7664810|NCT02036515|18875334|P1|COMPLETED|Overall Study||151
7664811|NCT02036515|18875332|P3|Treated|Overall Study||153
7664812|NCT02036515|18875333|P2|Treated|Overall Study||153
7664813|NCT02036515|18875334|P1|Treated|Overall Study||156
7664814|NCT02036515|18875332|P3|STARTED|Overall Study||153
7664815|NCT02036515|18875333|P2|STARTED|Overall Study||155
7664816|NCT02036515|18875334|P1|STARTED|Overall Study||156
7664817|NCT02036424|18875413|P2|NOT COMPLETED|Overall Study||0
7664818|NCT02036424|18875414|P1|NOT COMPLETED|Overall Study||0
7664819|NCT02036424|18875413|P2|COMPLETED|Overall Study|27 study eyes, not number of subjects|27
7664820|NCT02036424|18875414|P1|COMPLETED|Overall Study|23 study eyes, not number of subjects|23
7664821|NCT02036424|18875413|P2|STARTED|Overall Study|27 study eyes, not number of subjects|27
7664822|NCT02036424|18875414|P1|STARTED|Overall Study|23 study eyes, not number of subjects|23
7664823|NCT02036320|18875422|P2|NOT COMPLETED|Period 2||0
7664824|NCT02036320|18875423|P1|NOT COMPLETED|Period 2||0
7664825|NCT02036320|18875422|P2|COMPLETED|Period 2||95
7664826|NCT02036320|18875423|P1|COMPLETED|Period 2||95
7664827|NCT02036320|18875422|P2|STARTED|Period 2||95
7664828|NCT02036320|18875423|P1|STARTED|Period 2||95
7664829|NCT02036320|18875422|P2|NOT COMPLETED|Period 1||0
7664830|NCT02036320|18875423|P1|NOT COMPLETED|Period 1||0
7664831|NCT02036320|18875422|P2|COMPLETED|Period 1||95
7664832|NCT02036320|18875423|P1|COMPLETED|Period 1||95
7664833|NCT02036320|18875422|P2|STARTED|Period 1||95
7664834|NCT02036320|18875423|P1|STARTED|Period 1||95
7664835|NCT02036294|18875435|P2|NOT COMPLETED|Overall Study||11
7664836|NCT02036294|18875436|P1|NOT COMPLETED|Overall Study||9
7664837|NCT02036294|18875435|P2|COMPLETED|Overall Study||109
7664838|NCT02036294|18875436|P1|COMPLETED|Overall Study||111
7664839|NCT02036294|18875435|P2|STARTED|Overall Study||120
7664840|NCT02036294|18875436|P1|STARTED|Overall Study||120
7664841|NCT02035748|18875452|P1|NOT COMPLETED|Overall Study||20
7664842|NCT02035748|18875452|P1|COMPLETED|Overall Study||448
7664843|NCT02035748|18875452|P1|STARTED|Overall Study||468
7664844|NCT02035696|18875466|P4|NOT COMPLETED|Overall Study||3
7664845|NCT02035696|18875467|P3|NOT COMPLETED|Overall Study||3
7664846|NCT02035696|18875468|P2|NOT COMPLETED|Overall Study||3
7664847|NCT02035696|18875469|P1|NOT COMPLETED|Overall Study||3
7664848|NCT02035696|18875466|P4|COMPLETED|Overall Study||161
7664849|NCT02035696|18875467|P3|COMPLETED|Overall Study||164
7664850|NCT02035696|18875468|P2|COMPLETED|Overall Study||163
7664851|NCT02035696|18875469|P1|COMPLETED|Overall Study||171
7664852|NCT02035696|18875466|P4|STARTED|Overall Study||164
7664853|NCT02035696|18875467|P3|STARTED|Overall Study||167
7664854|NCT02035696|18875468|P2|STARTED|Overall Study||166
7664855|NCT02035696|18875469|P1|STARTED|Overall Study||174
7664856|NCT02035553|18875525|P2|NOT COMPLETED|Overall Study||23
7664857|NCT02035553|18875526|P1|NOT COMPLETED|Overall Study||18
7664858|NCT02035553|18875525|P2|COMPLETED|Overall Study||67
7664859|NCT02035553|18875526|P1|COMPLETED|Overall Study||73
7664860|NCT02035553|18875525|P2|STARTED|Overall Study||90
7664861|NCT02035553|18875526|P1|STARTED|Overall Study||91
7664862|NCT02035475|18875532|P1|NOT COMPLETED|Overall Study||6
7664863|NCT02035475|18875532|P1|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114
7664864|NCT02035475|18875532|P1|STARTED|Overall Study|120 subjects were consented for participation in the study.|120
7664865|NCT02035345|18875538|P1|NOT COMPLETED|Overall Study||0
7664866|NCT02035345|18875538|P1|COMPLETED|Overall Study||15
7664867|NCT02035345|18875538|P1|STARTED|Overall Study||15
7664868|NCT02035332|18875543|P1|NOT COMPLETED|Overall Study||1
7664869|NCT02035332|18875543|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|20
7664870|NCT02035332|18875543|P1|Treated|Overall Study|Treatment Completed|20
7664871|NCT02035332|18875543|P1|STARTED|Overall Study|Treatment Attempted|21
7664872|NCT02035267|18875553|P4|NOT COMPLETED|Overall Study||1
7664873|NCT02035267|18875554|P3|NOT COMPLETED|Overall Study||2
7664874|NCT02035267|18875555|P2|NOT COMPLETED|Overall Study||1
7664875|NCT02035267|18875556|P1|NOT COMPLETED|Overall Study||0
7664876|NCT02035267|18875553|P4|COMPLETED|Overall Study||15
7664877|NCT02035267|18875554|P3|COMPLETED|Overall Study||28
7664878|NCT02035267|18875555|P2|COMPLETED|Overall Study||15
7664879|NCT02035267|18875556|P1|COMPLETED|Overall Study||31
7664880|NCT02035267|18875553|P4|STARTED|Overall Study||16
7664881|NCT02035267|18875554|P3|STARTED|Overall Study||30
7664882|NCT02035267|18875555|P2|STARTED|Overall Study||16
7664883|NCT02035267|18875556|P1|STARTED|Overall Study||31
7664884|NCT02035202|18875587|P3|NOT COMPLETED|Overall Study||2
7664885|NCT02035202|18875588|P2|NOT COMPLETED|Overall Study||16
7664886|NCT02035202|18875589|P1|NOT COMPLETED|Overall Study||8
7664887|NCT02035202|18875587|P3|COMPLETED|Overall Study||83
7664888|NCT02035202|18875588|P2|COMPLETED|Overall Study||69
7664889|NCT02035202|18875589|P1|COMPLETED|Overall Study||77
7664890|NCT02035202|18875587|P3|STARTED|Overall Study||85
7664891|NCT02035202|18875588|P2|STARTED|Overall Study||85
7664892|NCT02035202|18875589|P1|STARTED|Overall Study||85
7664893|NCT02034916|18875605|P2|NOT COMPLETED|Overall Study||35
7664894|NCT02034916|18875606|P1|NOT COMPLETED|Overall Study||49
7664895|NCT02034916|18875605|P2|COMPLETED|Overall Study||0
7664896|NCT02034916|18875606|P1|COMPLETED|Overall Study||0
7664897|NCT02034916|18875605|P2|Treated|Overall Study||35
7664898|NCT02034916|18875606|P1|Treated|Overall Study||48
7664899|NCT02034916|18875605|P2|STARTED|Overall Study||35
7664900|NCT02034916|18875606|P1|STARTED|Overall Study||49
7664901|NCT02034877|18875643|P2|NOT COMPLETED|Overall Study||6
7664902|NCT02034877|18875644|P1|NOT COMPLETED|Overall Study||0
7664903|NCT02034877|18875643|P2|COMPLETED|Overall Study||993
7664904|NCT02034877|18875644|P1|COMPLETED|Overall Study||200
7664905|NCT02034877|18875643|P2|STARTED|Overall Study||999
7664906|NCT02034877|18875644|P1|STARTED|Overall Study||200
7664907|NCT02034799|18875662|P2|NOT COMPLETED|Overall Study||4
7664908|NCT02034799|18875663|P1|NOT COMPLETED|Overall Study||2
7664909|NCT02034799|18875662|P2|COMPLETED|Overall Study||123
7664910|NCT02034799|18875663|P1|COMPLETED|Overall Study||127
7664911|NCT02034799|18875662|P2|STARTED|Overall Study||127
7664912|NCT02034799|18875663|P1|STARTED|Overall Study||129
7664913|NCT02034708|18875677|P2|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
7664914|NCT02034708|18875678|P1|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
7664915|NCT02034708|18875677|P2|COMPLETED|Second Contrast Agent Injection (1 Day)||120
7664916|NCT02034708|18875678|P1|COMPLETED|Second Contrast Agent Injection (1 Day)||129
7664917|NCT02034708|18875677|P2|STARTED|Second Contrast Agent Injection (1 Day)||120
7664918|NCT02034708|18875678|P1|STARTED|Second Contrast Agent Injection (1 Day)||129
7664919|NCT02034708|18875677|P2|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10
7664920|NCT02034708|18875678|P1|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9
7664921|NCT02034708|18875677|P2|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120
7664922|NCT02034708|18875678|P1|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129
7664923|NCT02034708|18875677|P2|STARTED|Wash-out (From 2 Days up to 14 Days)||130
7664924|NCT02034708|18875678|P1|STARTED|Wash-out (From 2 Days up to 14 Days)||138
7664925|NCT02034708|18875677|P2|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
7664926|NCT02034708|18875678|P1|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
7664927|NCT02034708|18875677|P2|COMPLETED|First Contrast Agent Injection (1 Day)||130
7664928|NCT02034708|18875678|P1|COMPLETED|First Contrast Agent Injection (1 Day)||138
7664929|NCT02034708|18875677|P2|STARTED|First Contrast Agent Injection (1 Day)||130
7664930|NCT02034708|18875678|P1|STARTED|First Contrast Agent Injection (1 Day)||138
7664931|NCT02034591|18875689|P6|NOT COMPLETED|Overall Study||0
7664932|NCT02034591|18875690|P5|NOT COMPLETED|Overall Study||1
7664933|NCT02034591|18875691|P4|NOT COMPLETED|Overall Study||0
7664934|NCT02034591|18875692|P3|NOT COMPLETED|Overall Study||0
7664935|NCT02034591|18875693|P2|NOT COMPLETED|Overall Study||0
7664936|NCT02034591|18875694|P1|NOT COMPLETED|Overall Study||0
7664937|NCT02034591|18875689|P6|COMPLETED|Overall Study||3
7664938|NCT02034591|18875690|P5|COMPLETED|Overall Study||3
7664939|NCT02034591|18875691|P4|COMPLETED|Overall Study||3
7664940|NCT02034591|18875692|P3|COMPLETED|Overall Study||4
7664941|NCT02034591|18875693|P2|COMPLETED|Overall Study||3
7664942|NCT02034591|18875694|P1|COMPLETED|Overall Study||4
7664943|NCT02034591|18875689|P6|STARTED|Overall Study||3
7664944|NCT02034591|18875690|P5|STARTED|Overall Study||4
7664945|NCT02034591|18875691|P4|STARTED|Overall Study||3
7664946|NCT02034591|18875692|P3|STARTED|Overall Study||4
7664947|NCT02034591|18875693|P2|STARTED|Overall Study||3
7664948|NCT02034591|18875694|P1|STARTED|Overall Study||4
7664949|NCT02034578|18875717|P6|NOT COMPLETED|Overall Study||0
7664950|NCT02034578|18875718|P5|NOT COMPLETED|Overall Study||0
7664951|NCT02034578|18875719|P4|NOT COMPLETED|Overall Study||0
7664952|NCT02034578|18875720|P3|NOT COMPLETED|Overall Study||0
7664953|NCT02034578|18875721|P2|NOT COMPLETED|Overall Study||0
7664954|NCT02034578|18875722|P1|NOT COMPLETED|Overall Study||0
7664955|NCT02034578|18875717|P6|COMPLETED|Overall Study||3
7664956|NCT02034578|18875718|P5|COMPLETED|Overall Study||4
7664957|NCT02034578|18875719|P4|COMPLETED|Overall Study||3
7664958|NCT02034578|18875720|P3|COMPLETED|Overall Study||4
7664959|NCT02034578|18875721|P2|COMPLETED|Overall Study||3
7664960|NCT02034578|18875722|P1|COMPLETED|Overall Study||4
7664961|NCT02034578|18875717|P6|STARTED|Overall Study||3
7664962|NCT02034578|18875718|P5|STARTED|Overall Study||4
7664963|NCT02034578|18875719|P4|STARTED|Overall Study||3
7664964|NCT02034578|18875720|P3|STARTED|Overall Study||4
7664965|NCT02034578|18875721|P2|STARTED|Overall Study||3
7664966|NCT02034578|18875722|P1|STARTED|Overall Study||4
7664967|NCT02034565|18875749|P2|NOT COMPLETED|Overall Study||0
7664968|NCT02034565|18875750|P1|NOT COMPLETED|Overall Study||1
7664969|NCT02034565|18875749|P2|COMPLETED|Overall Study||7
7664970|NCT02034565|18875750|P1|COMPLETED|Overall Study||6
7664971|NCT02034565|18875749|P2|STARTED|Overall Study||7
7664972|NCT02034565|18875750|P1|STARTED|Overall Study||7
7664973|NCT02034552|18875767|P3|NOT COMPLETED|Overall Study||17
7664974|NCT02034552|18875768|P2|NOT COMPLETED|Overall Study||20
7664975|NCT02034552|18875769|P1|NOT COMPLETED|Overall Study||14
7664976|NCT02034552|18875767|P3|COMPLETED|Overall Study||5
7664977|NCT02034552|18875768|P2|COMPLETED|Overall Study||4
7664978|NCT02034552|18875769|P1|COMPLETED|Overall Study||8
7664979|NCT02034552|18875767|P3|Received Treatment|Overall Study||22
7664980|NCT02034552|18875768|P2|Received Treatment|Overall Study||22
7664981|NCT02034552|18875769|P1|Received Treatment|Overall Study||19
7664982|NCT02034552|18875767|P3|STARTED|Overall Study||22
7664983|NCT02034552|18875768|P2|STARTED|Overall Study||24
7664984|NCT02034552|18875769|P1|STARTED|Overall Study||22
7664985|NCT02034513|18875800|P2|NOT COMPLETED|Overall Study||57
7664986|NCT02034513|18875801|P1|NOT COMPLETED|Overall Study||49
7664987|NCT02034513|18875800|P2|COMPLETED|Overall Study||195
7664988|NCT02034513|18875801|P1|COMPLETED|Overall Study||200
7664989|NCT02034513|18875800|P2|Exposed|Overall Study||251
7664990|NCT02034513|18875801|P1|Exposed|Overall Study||249
7664991|NCT02034513|18875800|P2|STARTED|Overall Study||252
7664992|NCT02034513|18875801|P1|STARTED|Overall Study||249
7664993|NCT02034474|18875819|P2|NOT COMPLETED|Overall Study||4
7664994|NCT02034474|18875820|P1|NOT COMPLETED|Overall Study||4
7664995|NCT02034474|18875819|P2|COMPLETED|Overall Study||13
7664996|NCT02034474|18875820|P1|COMPLETED|Overall Study||15
7664997|NCT02034474|18875819|P2|3 Doses|Overall Study||13
7664998|NCT02034474|18875820|P1|3 Doses|Overall Study||15
7664999|NCT02034474|18875819|P2|2 Doses|Overall Study||0
7665000|NCT02034474|18875820|P1|2 Doses|Overall Study||2
7665001|NCT02034474|18875819|P2|1 Dose|Overall Study||4
7665002|NCT02034474|18875820|P1|1 Dose|Overall Study||2
7665003|NCT02034474|18875819|P2|STARTED|Overall Study||17
7665004|NCT02034474|18875820|P1|STARTED|Overall Study||19
7665005|NCT02034435|18875832|P4|NOT COMPLETED|Overall Study||1
7665006|NCT02034435|18875833|P3|NOT COMPLETED|Overall Study||0
7665007|NCT02034435|18875834|P2|NOT COMPLETED|Overall Study||2
7665008|NCT02034435|18875835|P1|NOT COMPLETED|Overall Study||2
7665009|NCT02034435|18875832|P4|COMPLETED|Overall Study||8
7665010|NCT02034435|18875833|P3|COMPLETED|Overall Study||7
7665011|NCT02034435|18875834|P2|COMPLETED|Overall Study||13
7665012|NCT02034435|18875835|P1|COMPLETED|Overall Study||11
7665013|NCT02034435|18875832|P4|Aim 2|Overall Study||9
7665014|NCT02034435|18875833|P3|Aim 2|Overall Study||7
7665015|NCT02034435|18875834|P2|Aim 2|Overall Study||0
7665016|NCT02034435|18875835|P1|Aim 2|Overall Study||0
7665017|NCT02034435|18875832|P4|Aim 1|Overall Study||0
7665018|NCT02034435|18875833|P3|Aim 1|Overall Study||0
7665019|NCT02034435|18875834|P2|Aim 1|Overall Study||15
7665020|NCT02034435|18875835|P1|Aim 1|Overall Study||13
7665021|NCT02034435|18875832|P4|STARTED|Overall Study||9
7665022|NCT02034435|18875833|P3|STARTED|Overall Study||7
7665023|NCT02034435|18875834|P2|STARTED|Overall Study||15
7665024|NCT02034435|18875835|P1|STARTED|Overall Study||13
7665025|NCT02034175|18875849|P1|NOT COMPLETED|Overall Study||0
7665026|NCT02034175|18875849|P1|COMPLETED|Overall Study||190
7665027|NCT02034175|18875849|P1|STARTED|Overall Study||190
7665028|NCT02034162|18875855|P3|NOT COMPLETED|Open-label||0
7665029|NCT02034162|18875856|P2|NOT COMPLETED|Open-label||0
7665030|NCT02034162|18875857|P1|NOT COMPLETED|Open-label||0
7665031|NCT02034162|18875855|P3|COMPLETED|Open-label||278
7665032|NCT02034162|18875856|P2|COMPLETED|Open-label||0
7665033|NCT02034162|18875857|P1|COMPLETED|Open-label||0
7665034|NCT02034162|18875855|P3|STARTED|Open-label||278
7665035|NCT02034162|18875856|P2|STARTED|Open-label||0
7665036|NCT02034162|18875857|P1|STARTED|Open-label||0
7665037|NCT02034162|18875855|P3|NOT COMPLETED|Double-blind||0
7665038|NCT02034162|18875856|P2|NOT COMPLETED|Double-blind||8
7665039|NCT02034162|18875857|P1|NOT COMPLETED|Double-blind||9
7665040|NCT02034162|18875855|P3|COMPLETED|Double-blind||0
7665041|NCT02034162|18875856|P2|COMPLETED|Double-blind||141
7665042|NCT02034162|18875857|P1|COMPLETED|Double-blind||137
7665043|NCT02034162|18875855|P3|STARTED|Double-blind||0
7665044|NCT02034162|18875856|P2|STARTED|Double-blind||149
7665045|NCT02034162|18875857|P1|STARTED|Double-blind||146
7665046|NCT02034123|18875903|P18|NOT COMPLETED|Part2(Up to 2 Years)||0
7665047|NCT02034123|18875904|P17|NOT COMPLETED|Part2(Up to 2 Years)||0
7665048|NCT02034123|18875905|P16|NOT COMPLETED|Part2(Up to 2 Years)||0
7665049|NCT02034123|18875906|P15|NOT COMPLETED|Part2(Up to 2 Years)||0
7665050|NCT02034123|18875907|P14|NOT COMPLETED|Part2(Up to 2 Years)||0
7665051|NCT02034123|18875908|P13|NOT COMPLETED|Part2(Up to 2 Years)||0
7665052|NCT02034123|18875909|P12|NOT COMPLETED|Part2(Up to 2 Years)||0
7665053|NCT02034123|18875910|P11|NOT COMPLETED|Part2(Up to 2 Years)||0
7665054|NCT02034123|18875911|P10|NOT COMPLETED|Part2(Up to 2 Years)||0
7665055|NCT02034123|18875912|P9|NOT COMPLETED|Part2(Up to 2 Years)||0
7665056|NCT02034123|18875913|P8|NOT COMPLETED|Part2(Up to 2 Years)||0
7665057|NCT02034123|18875914|P7|NOT COMPLETED|Part2(Up to 2 Years)||0
7665058|NCT02034123|18875915|P6|NOT COMPLETED|Part2(Up to 2 Years)||0
7665059|NCT02034123|18875916|P5|NOT COMPLETED|Part2(Up to 2 Years)||0
7665060|NCT02034123|18875917|P4|NOT COMPLETED|Part2(Up to 2 Years)||0
7665061|NCT02034123|18875918|P3|NOT COMPLETED|Part2(Up to 2 Years)||0
7665062|NCT02034123|18875919|P2|NOT COMPLETED|Part2(Up to 2 Years)||0
7665063|NCT02034123|18875920|P1|NOT COMPLETED|Part2(Up to 2 Years)||0
7665064|NCT02034123|18875903|P18|COMPLETED|Part2(Up to 2 Years)||0
7665065|NCT02034123|18875904|P17|COMPLETED|Part2(Up to 2 Years)||0
7665066|NCT02034123|18875905|P16|COMPLETED|Part2(Up to 2 Years)||0
7665067|NCT02034123|18875906|P15|COMPLETED|Part2(Up to 2 Years)||0
7665068|NCT02034123|18875907|P14|COMPLETED|Part2(Up to 2 Years)||0
7665069|NCT02034123|18875908|P13|COMPLETED|Part2(Up to 2 Years)||0
7665070|NCT02034123|18875909|P12|COMPLETED|Part2(Up to 2 Years)||0
7665071|NCT02034123|18875910|P11|COMPLETED|Part2(Up to 2 Years)||0
7665072|NCT02034123|18875911|P10|COMPLETED|Part2(Up to 2 Years)||0
7665073|NCT02034123|18875912|P9|COMPLETED|Part2(Up to 2 Years)||0
7665074|NCT02034123|18875913|P8|COMPLETED|Part2(Up to 2 Years)||0
7665075|NCT02034123|18875914|P7|COMPLETED|Part2(Up to 2 Years)||0
7665076|NCT02034123|18875915|P6|COMPLETED|Part2(Up to 2 Years)||0
7665077|NCT02034123|18875916|P5|COMPLETED|Part2(Up to 2 Years)||0
7665078|NCT02034123|18875917|P4|COMPLETED|Part2(Up to 2 Years)||0
7665079|NCT02034123|18875918|P3|COMPLETED|Part2(Up to 2 Years)||0
7665080|NCT02034123|18875919|P2|COMPLETED|Part2(Up to 2 Years)||0
7665081|NCT02034123|18875920|P1|COMPLETED|Part2(Up to 2 Years)||0
7665082|NCT02034123|18875903|P18|STARTED|Part2(Up to 2 Years)||0
7665083|NCT02034123|18875904|P17|STARTED|Part2(Up to 2 Years)||0
7665084|NCT02034123|18875905|P16|STARTED|Part2(Up to 2 Years)||0
7665085|NCT02034123|18875906|P15|STARTED|Part2(Up to 2 Years)||0
7665086|NCT02034123|18875907|P14|STARTED|Part2(Up to 2 Years)||0
7665087|NCT02034123|18875908|P13|STARTED|Part2(Up to 2 Years)||0
7665088|NCT02034123|18875909|P12|STARTED|Part2(Up to 2 Years)||0
7665089|NCT02034123|18875910|P11|STARTED|Part2(Up to 2 Years)||0
7665090|NCT02034123|18875911|P10|STARTED|Part2(Up to 2 Years)||0
7665091|NCT02034123|18875912|P9|STARTED|Part2(Up to 2 Years)||0
7665092|NCT02034123|18875913|P8|STARTED|Part2(Up to 2 Years)||0
7665093|NCT02034123|18875914|P7|STARTED|Part2(Up to 2 Years)||0
7665094|NCT02034123|18875915|P6|STARTED|Part2(Up to 2 Years)||0
7665095|NCT02034123|18875916|P5|STARTED|Part2(Up to 2 Years)||0
7665096|NCT02034123|18875917|P4|STARTED|Part2(Up to 2 Years)||0
7665097|NCT02034123|18875918|P3|STARTED|Part2(Up to 2 Years)||0
7665098|NCT02034123|18875919|P2|STARTED|Part2(Up to 2 Years)||0
7665099|NCT02034123|18875920|P1|STARTED|Part2(Up to 2 Years)||0
7665100|NCT02034123|18875903|P18|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665101|NCT02034123|18875904|P17|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665102|NCT02034123|18875905|P16|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665103|NCT02034123|18875906|P15|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665104|NCT02034123|18875907|P14|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665105|NCT02034123|18875908|P13|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665106|NCT02034123|18875909|P12|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665107|NCT02034123|18875910|P11|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665108|NCT02034123|18875911|P10|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665109|NCT02034123|18875912|P9|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
7665110|NCT02034123|18875913|P8|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
7665111|NCT02034123|18875914|P7|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665112|NCT02034123|18875915|P6|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665113|NCT02034123|18875916|P5|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
7665114|NCT02034123|18875917|P4|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
7665115|NCT02034123|18875918|P3|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665116|NCT02034123|18875919|P2|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665117|NCT02034123|18875920|P1|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665118|NCT02034123|18875903|P18|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665119|NCT02034123|18875904|P17|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665120|NCT02034123|18875905|P16|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665121|NCT02034123|18875906|P15|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665122|NCT02034123|18875907|P14|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665123|NCT02034123|18875908|P13|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665124|NCT02034123|18875909|P12|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665125|NCT02034123|18875910|P11|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665126|NCT02034123|18875911|P10|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665127|NCT02034123|18875912|P9|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
7665128|NCT02034123|18875913|P8|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||4
7665129|NCT02034123|18875914|P7|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
7665130|NCT02034123|18875915|P6|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||3
7665131|NCT02034123|18875916|P5|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
7665132|NCT02034123|18875917|P4|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
7665133|NCT02034123|18875918|P3|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
7665134|NCT02034123|18875919|P2|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
7665225|NCT02033213|18876595|P1|COMPLETED|Overall Study||8
7665135|NCT02034123|18875920|P1|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
7665136|NCT02034123|18875903|P18|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
7665137|NCT02034123|18875904|P17|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
7665138|NCT02034123|18875905|P16|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
7665139|NCT02034123|18875906|P15|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
7665140|NCT02034123|18875907|P14|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
7665141|NCT02034123|18875908|P13|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
7665142|NCT02034123|18875909|P12|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
7665143|NCT02034123|18875910|P11|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
7665144|NCT02034123|18875911|P10|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
7665145|NCT02034123|18875912|P9|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
7665146|NCT02034123|18875913|P8|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
7665147|NCT02034123|18875914|P7|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
7665148|NCT02034123|18875915|P6|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
7665149|NCT02034123|18875916|P5|STARTED|Part1(Median of 7.286 Weeks of Exposure)||7
7665150|NCT02034123|18875917|P4|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
7665151|NCT02034123|18875918|P3|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
7665152|NCT02034123|18875919|P2|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
7665153|NCT02034123|18875920|P1|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
7665154|NCT02034058|18876239|P1|NOT COMPLETED|Overall Study||3
7665155|NCT02034058|18876239|P1|COMPLETED|Overall Study||149
7665156|NCT02034058|18876239|P1|STARTED|Overall Study|Study stopped early per pre-defined criteria for interim analysis.|152
7665157|NCT02034019|18876249|P2|NOT COMPLETED|Overall Study||2
7665158|NCT02034019|18876250|P1|NOT COMPLETED|Overall Study||1
7665159|NCT02034019|18876249|P2|COMPLETED|Overall Study||81
7665160|NCT02034019|18876250|P1|COMPLETED|Overall Study||163
7665161|NCT02034019|18876249|P2|STARTED|Overall Study||83
7665162|NCT02034019|18876250|P1|STARTED|Overall Study||164
7665163|NCT02034006|18876260|P1|NOT COMPLETED|Overall Study||14
7665164|NCT02034006|18876260|P1|COMPLETED|Overall Study||186
7665165|NCT02034006|18876260|P1|Re-treated Patients|Overall Study||130
7665166|NCT02034006|18876260|P1|Once Treated Patients|Overall Study||70
7665167|NCT02034006|18876260|P1|STARTED|Overall Study||200
7665168|NCT02033993|18876293|P2|NOT COMPLETED|Overall Study||9
7665169|NCT02033993|18876294|P1|NOT COMPLETED|Overall Study||3
7665170|NCT02033993|18876293|P2|COMPLETED|Overall Study||91
7665171|NCT02033993|18876294|P1|COMPLETED|Overall Study||96
7665172|NCT02033993|18876293|P2|STARTED|Overall Study||100
7665173|NCT02033993|18876294|P1|STARTED|Overall Study||99
7665174|NCT02033889|18876311|P3|NOT COMPLETED|Overall Study||25
7665175|NCT02033889|18876312|P2|NOT COMPLETED|Overall Study||20
7665176|NCT02033889|18876313|P1|NOT COMPLETED|Overall Study||34
7665177|NCT02033889|18876311|P3|COMPLETED|Overall Study||180
7665178|NCT02033889|18876312|P2|COMPLETED|Overall Study||187
7665179|NCT02033889|18876313|P1|COMPLETED|Overall Study||175
7665180|NCT02033889|18876311|P3|STARTED|Overall Study||205
7665181|NCT02033889|18876312|P2|STARTED|Overall Study||207
7665182|NCT02033889|18876313|P1|STARTED|Overall Study||209
7665183|NCT02033876|18876467|P2|NOT COMPLETED|Overall Study||0
7665184|NCT02033876|18876468|P1|NOT COMPLETED|Overall Study||0
7665185|NCT02033876|18876467|P2|COMPLETED|Overall Study||12
7665186|NCT02033876|18876468|P1|COMPLETED|Overall Study||12
7665187|NCT02033876|18876467|P2|STARTED|Overall Study||12
7665188|NCT02033876|18876468|P1|STARTED|Overall Study||12
7665189|NCT02033850|18876490|P2|NOT COMPLETED|Overall Study||1
7665190|NCT02033850|18876491|P1|NOT COMPLETED|Overall Study||2
7665191|NCT02033850|18876490|P2|COMPLETED|Overall Study||22
7665192|NCT02033850|18876491|P1|COMPLETED|Overall Study||21
7665193|NCT02033850|18876490|P2|STARTED|Overall Study||23
7665194|NCT02033850|18876491|P1|STARTED|Overall Study||23
7665195|NCT02033759|18876515|P2|NOT COMPLETED|Overall Study||2
7665196|NCT02033759|18876516|P1|NOT COMPLETED|Overall Study||3
7665197|NCT02033759|18876515|P2|COMPLETED|Overall Study||19
7665198|NCT02033759|18876516|P1|COMPLETED|Overall Study||19
7665199|NCT02033759|18876515|P2|STARTED|Overall Study||21
7665200|NCT02033759|18876516|P1|STARTED|Overall Study||22
7665201|NCT02033694|18876526|P1|NOT COMPLETED|Overall Study||0
7665202|NCT02033694|18876526|P1|COMPLETED|Overall Study||1271
7665203|NCT02033694|18876526|P1|STARTED|Overall Study||1271
7665204|NCT02033499|18876534|P3|NOT COMPLETED|Overall Study||9
7665205|NCT02033499|18876535|P2|NOT COMPLETED|Overall Study||8
7665206|NCT02033499|18876536|P1|NOT COMPLETED|Overall Study||5
7665207|NCT02033499|18876534|P3|COMPLETED|Overall Study||139
7665208|NCT02033499|18876535|P2|COMPLETED|Overall Study||142
7665209|NCT02033499|18876536|P1|COMPLETED|Overall Study||147
7665210|NCT02033499|18876534|P3|STARTED|Overall Study||148
7665211|NCT02033499|18876535|P2|STARTED|Overall Study||150
7665212|NCT02033499|18876536|P1|STARTED|Overall Study||152
7665213|NCT02033369|18876576|P2|NOT COMPLETED|Overall Study||5
7665214|NCT02033369|18876577|P1|NOT COMPLETED|Overall Study||5
7665215|NCT02033369|18876576|P2|COMPLETED|Overall Study||21
7665216|NCT02033369|18876577|P1|COMPLETED|Overall Study||21
7665217|NCT02033369|18876576|P2|STARTED|Overall Study||26
7665218|NCT02033369|18876577|P1|STARTED|Overall Study||26
7665219|NCT02033317|18876587|P1|NOT COMPLETED|Overall Study||0
7665220|NCT02033317|18876587|P1|COMPLETED|Overall Study||6
7665221|NCT02033317|18876587|P1|STARTED|Overall Study||6
7665222|NCT02033213|18876594|P2|NOT COMPLETED|Overall Study||0
7665223|NCT02033213|18876595|P1|NOT COMPLETED|Overall Study||0
7665224|NCT02033213|18876594|P2|COMPLETED|Overall Study||8
7665226|NCT02033213|18876594|P2|STARTED|Overall Study||8
7665227|NCT02033213|18876595|P1|STARTED|Overall Study||8
7665228|NCT02033200|18876613|P2|NOT COMPLETED|Overall Study||0
7665229|NCT02033200|18876614|P1|NOT COMPLETED|Overall Study||0
7665230|NCT02033200|18876613|P2|COMPLETED|Overall Study||40
7665231|NCT02033200|18876614|P1|COMPLETED|Overall Study||40
7665232|NCT02033200|18876613|P2|STARTED|Overall Study||40
7665233|NCT02033200|18876614|P1|STARTED|Overall Study||40
7665234|NCT02033174|18876634|P2|NOT COMPLETED|Second Intervention||0
7665235|NCT02033174|18876635|P1|NOT COMPLETED|Second Intervention||0
7665236|NCT02033174|18876634|P2|COMPLETED|Second Intervention||8
7665237|NCT02033174|18876635|P1|COMPLETED|Second Intervention||8
7665238|NCT02033174|18876634|P2|STARTED|Second Intervention||8
7665239|NCT02033174|18876635|P1|STARTED|Second Intervention||8
7665240|NCT02033174|18876634|P2|NOT COMPLETED|Washout (1 Week)||0
7665241|NCT02033174|18876635|P1|NOT COMPLETED|Washout (1 Week)||0
7665242|NCT02033174|18876634|P2|COMPLETED|Washout (1 Week)||8
7665243|NCT02033174|18876635|P1|COMPLETED|Washout (1 Week)||8
7665244|NCT02033174|18876634|P2|STARTED|Washout (1 Week)||8
7665245|NCT02033174|18876635|P1|STARTED|Washout (1 Week)||8
7665246|NCT02033174|18876634|P2|NOT COMPLETED|First Intervention||0
7665247|NCT02033174|18876635|P1|NOT COMPLETED|First Intervention||0
7665248|NCT02033174|18876634|P2|COMPLETED|First Intervention||8
7665249|NCT02033174|18876635|P1|COMPLETED|First Intervention||8
7665250|NCT02033174|18876634|P2|STARTED|First Intervention||8
7665251|NCT02033174|18876635|P1|STARTED|First Intervention||8
7665252|NCT02033083|18876643|P2|NOT COMPLETED|Overall Study||1
7665253|NCT02033083|18876644|P1|NOT COMPLETED|Overall Study||1
7665254|NCT02033083|18876643|P2|COMPLETED|Overall Study||88
7665255|NCT02033083|18876644|P1|COMPLETED|Overall Study||88
7665256|NCT02033083|18876643|P2|STARTED|Overall Study||89
7665257|NCT02033083|18876644|P1|STARTED|Overall Study||89
7665258|NCT02033005|18876653|P3|NOT COMPLETED|Overall Study||10
7665259|NCT02033005|18876654|P2|NOT COMPLETED|Overall Study||0
7665260|NCT02033005|18876655|P1|NOT COMPLETED|Overall Study||44
7665261|NCT02033005|18876653|P3|COMPLETED|Overall Study||25
7665262|NCT02033005|18876654|P2|COMPLETED|Overall Study||9
7665263|NCT02033005|18876655|P1|COMPLETED|Overall Study||36
7665264|NCT02033005|18876653|P3|STARTED|Overall Study||35
7665265|NCT02033005|18876654|P2|STARTED|Overall Study||9
7665266|NCT02033005|18876655|P1|STARTED|Overall Study||80
7665267|NCT02032901|18876671|P2|NOT COMPLETED|Follow-Up Period (24 Weeks)||1
7665268|NCT02032901|18876672|P1|NOT COMPLETED|Follow-Up Period (24 Weeks)||0
7665269|NCT02032901|18876671|P2|COMPLETED|Follow-Up Period (24 Weeks)||50
7665270|NCT02032901|18876672|P1|COMPLETED|Follow-Up Period (24 Weeks)||101
7665271|NCT02032901|18876671|P2|STARTED|Follow-Up Period (24 Weeks)||51
7665272|NCT02032901|18876672|P1|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101
7665273|NCT02032901|18876671|P2|NOT COMPLETED|Treatment Period (12 Weeks)||0
7665274|NCT02032901|18876672|P1|NOT COMPLETED|Treatment Period (12 Weeks)||1
7665275|NCT02032901|18876671|P2|COMPLETED|Treatment Period (12 Weeks)||51
7665276|NCT02032901|18876672|P1|COMPLETED|Treatment Period (12 Weeks)||100
7665277|NCT02032901|18876671|P2|STARTED|Treatment Period (12 Weeks)||51
7665278|NCT02032901|18876672|P1|STARTED|Treatment Period (12 Weeks)||101
7665279|NCT02032888|18876696|P3|NOT COMPLETED|Follow-up Period||0
7665280|NCT02032888|18876697|P2|NOT COMPLETED|Follow-up Period||2
7665281|NCT02032888|18876698|P1|NOT COMPLETED|Follow-up Period||3
7665282|NCT02032888|18876696|P3|COMPLETED|Follow-up Period||52
7665283|NCT02032888|18876697|P2|COMPLETED|Follow-up Period||47
7665284|NCT02032888|18876698|P1|COMPLETED|Follow-up Period||97
7665285|NCT02032888|18876696|P3|STARTED|Follow-up Period||52
7665286|NCT02032888|18876697|P2|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49
7665287|NCT02032888|18876698|P1|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100
7665288|NCT02032888|18876696|P3|NOT COMPLETED|Treatment Period||0
7665289|NCT02032888|18876697|P2|NOT COMPLETED|Treatment Period||2
7665290|NCT02032888|18876698|P1|NOT COMPLETED|Treatment Period||2
7665291|NCT02032888|18876696|P3|COMPLETED|Treatment Period||52
7665292|NCT02032888|18876697|P2|COMPLETED|Treatment Period||48
7665293|NCT02032888|18876698|P1|COMPLETED|Treatment Period||99
7665294|NCT02032888|18876696|P3|STARTED|Treatment Period||52
7665295|NCT02032888|18876697|P2|STARTED|Treatment Period||50
7665296|NCT02032888|18876698|P1|STARTED|Treatment Period||101
7665297|NCT02032875|18876729|P2|NOT COMPLETED|Follow-up Period||11
7665298|NCT02032875|18876730|P1|NOT COMPLETED|Follow-up Period||3
7665299|NCT02032875|18876729|P2|COMPLETED|Follow-up Period||46
7665300|NCT02032875|18876730|P1|COMPLETED|Follow-up Period||50
7665301|NCT02032875|18876729|P2|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57
7665302|NCT02032875|18876730|P1|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53
7665303|NCT02032875|18876729|P2|NOT COMPLETED|Treatment Period||4
7665304|NCT02032875|18876730|P1|NOT COMPLETED|Treatment Period||1
7665305|NCT02032875|18876729|P2|COMPLETED|Treatment Period||56
7665306|NCT02032875|18876730|P1|COMPLETED|Treatment Period||52
7665307|NCT02032875|18876729|P2|STARTED|Treatment Period||60
7665308|NCT02032875|18876730|P1|STARTED|Treatment Period||53
7665309|NCT02032810|18876750|P2|NOT COMPLETED|Overall Study||0
7665310|NCT02032810|18876751|P1|NOT COMPLETED|Overall Study||0
7665311|NCT02032810|18876750|P2|COMPLETED|Overall Study||11
7665312|NCT02032810|18876751|P1|COMPLETED|Overall Study||6
7665313|NCT02032810|18876750|P2|STARTED|Overall Study||11
7665314|NCT02032810|18876751|P1|STARTED|Overall Study||6
7665315|NCT02032758|18876764|P2|NOT COMPLETED|Overall Study||0
7665316|NCT02032758|18876765|P1|NOT COMPLETED|Overall Study||0
7665317|NCT02032758|18876764|P2|COMPLETED|Overall Study||11
7665318|NCT02032758|18876765|P1|COMPLETED|Overall Study||27
7665319|NCT02032758|18876764|P2|STARTED|Overall Study||11
7665320|NCT02032758|18876765|P1|STARTED|Overall Study||27
7665321|NCT02032706|18876773|P1|NOT COMPLETED|Overall Study||6
7665322|NCT02032706|18876773|P1|COMPLETED|Overall Study||30
7665323|NCT02032706|18876773|P1|STARTED|Overall Study||36
7665324|NCT02032680|18876788|P2|NOT COMPLETED|Overall Study||1
7665325|NCT02032680|18876789|P1|NOT COMPLETED|Overall Study||6
7665326|NCT02032680|18876788|P2|COMPLETED|Overall Study||7
7665327|NCT02032680|18876789|P1|COMPLETED|Overall Study||16
7665328|NCT02032680|18876788|P2|STARTED|Overall Study||8
7665329|NCT02032680|18876789|P1|STARTED|Overall Study||22
7665330|NCT02032641|18876795|P1|NOT COMPLETED|Overall Study||1
7665331|NCT02032641|18876795|P1|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8
7665332|NCT02032641|18876795|P1|STARTED|Overall Study|18 Brows enrolled for evaluation|9
7665333|NCT02032550|18876807|P2|NOT COMPLETED|Overall Study||22
7665334|NCT02032550|18876808|P1|NOT COMPLETED|Overall Study||28
7665335|NCT02032550|18876807|P2|COMPLETED|Overall Study||350
7665336|NCT02032550|18876808|P1|COMPLETED|Overall Study||343
7665337|NCT02032550|18876807|P2|STARTED|Overall Study||372
7665338|NCT02032550|18876808|P1|STARTED|Overall Study||371
7665339|NCT02032433|18876820|P2|NOT COMPLETED|Overall Study||62
7665340|NCT02032433|18876821|P1|NOT COMPLETED|Overall Study||78
7665341|NCT02032433|18876820|P2|COMPLETED|Overall Study||225
7665342|NCT02032433|18876821|P1|COMPLETED|Overall Study||205
7665343|NCT02032433|18876820|P2|STARTED|Overall Study||287
7665344|NCT02032433|18876821|P1|STARTED|Overall Study||283
7665345|NCT02032420|18876943|P2|NOT COMPLETED|Overall Study||0
7665346|NCT02032420|18876944|P1|NOT COMPLETED|Overall Study||0
7665347|NCT02032420|18876943|P2|COMPLETED|Overall Study||17
7665348|NCT02032420|18876944|P1|COMPLETED|Overall Study||18
7665349|NCT02032420|18876943|P2|STARTED|Overall Study||17
7665350|NCT02032420|18876944|P1|STARTED|Overall Study||18
7665351|NCT02032407|18876956|P1|NOT COMPLETED|Overall Study||5
7665352|NCT02032407|18876956|P1|COMPLETED|Overall Study||63
7665353|NCT02032407|18876956|P1|STARTED|Overall Study||68
7665354|NCT02032238|18876969|P2|NOT COMPLETED|Overall Study||0
7665355|NCT02032238|18876970|P1|NOT COMPLETED|Overall Study||2
7665356|NCT02032238|18876969|P2|COMPLETED|Overall Study||0
7665357|NCT02032238|18876970|P1|COMPLETED|Overall Study||10
7665358|NCT02032238|18876969|P2|STARTED|Overall Study|Study Terminated due to slow enrollment, no subjects enrolled in this study arm|0
7665359|NCT02032238|18876970|P1|STARTED|Overall Study||12
7665360|NCT02032212|18876980|P4|NOT COMPLETED|Overall Study||0
7665361|NCT02032212|18876981|P3|NOT COMPLETED|Overall Study||0
7665362|NCT02032212|18876982|P2|NOT COMPLETED|Overall Study||0
7665363|NCT02032212|18876983|P1|NOT COMPLETED|Overall Study||0
7665364|NCT02032212|18876980|P4|COMPLETED|Overall Study||3
7665365|NCT02032212|18876981|P3|COMPLETED|Overall Study||3
7665366|NCT02032212|18876982|P2|COMPLETED|Overall Study||3
7665367|NCT02032212|18876983|P1|COMPLETED|Overall Study||3
7665368|NCT02032212|18876980|P4|STARTED|Overall Study||3
7665369|NCT02032212|18876981|P3|STARTED|Overall Study||3
7665370|NCT02032212|18876982|P2|STARTED|Overall Study||3
7665371|NCT02032212|18876983|P1|STARTED|Overall Study||3
7665372|NCT02032173|18877009|P1|NOT COMPLETED|Overall Study||31
7665373|NCT02032173|18877009|P1|COMPLETED|Overall Study||0
7665374|NCT02032173|18877009|P1|Rescue Group|Overall Study|1 participant moved to Rescue Group at M6 and trial discontinued before any data was collected.|1
7665375|NCT02032173|18877009|P1|Included Population - Main Group|Overall Study||31
7665376|NCT02032173|18877009|P1|STARTED|Overall Study||31
7665377|NCT02031770|18877022|P2|NOT COMPLETED|Overall Study||1
7665378|NCT02031770|18877023|P1|NOT COMPLETED|Overall Study||1
7665379|NCT02031770|18877022|P2|COMPLETED|Overall Study||9
7665380|NCT02031770|18877023|P1|COMPLETED|Overall Study||9
7665381|NCT02031770|18877022|P2|STARTED|Overall Study||10
7665382|NCT02031770|18877023|P1|STARTED|Overall Study||10
7665383|NCT02031679|18877031|P2|NOT COMPLETED|Overall Study||2
7665384|NCT02031679|18877032|P1|NOT COMPLETED|Overall Study||0
7665385|NCT02031679|18877031|P2|COMPLETED|Overall Study||12
7665386|NCT02031679|18877032|P1|COMPLETED|Overall Study||14
7665387|NCT02031679|18877031|P2|STARTED|Overall Study||14
7665388|NCT02031679|18877032|P1|STARTED|Overall Study||14
7665389|NCT02031640|18877047|P6|NOT COMPLETED|Double-blind Treatment Period||3
7665390|NCT02031640|18877048|P5|NOT COMPLETED|Double-blind Treatment Period||11
7665391|NCT02031640|18877049|P4|NOT COMPLETED|Double-blind Treatment Period||7
7665392|NCT02031640|18877050|P3|NOT COMPLETED|Double-blind Treatment Period||6
7665393|NCT02031640|18877051|P2|NOT COMPLETED|Double-blind Treatment Period||22
7665394|NCT02031640|18877052|P1|NOT COMPLETED|Double-blind Treatment Period||0
7665395|NCT02031640|18877047|P6|COMPLETED|Double-blind Treatment Period||104
7665396|NCT02031640|18877048|P5|COMPLETED|Double-blind Treatment Period||96
7665397|NCT02031640|18877049|P4|COMPLETED|Double-blind Treatment Period||99
7665398|NCT02031640|18877050|P3|COMPLETED|Double-blind Treatment Period||100
7665399|NCT02031640|18877051|P2|COMPLETED|Double-blind Treatment Period||84
7665400|NCT02031640|18877052|P1|COMPLETED|Double-blind Treatment Period||0
7665401|NCT02031640|18877047|P6|Full Analysis Set|Double-blind Treatment Period||107
7665402|NCT02031640|18877048|P5|Full Analysis Set|Double-blind Treatment Period||106
7665403|NCT02031640|18877049|P4|Full Analysis Set|Double-blind Treatment Period||106
7665404|NCT02031640|18877050|P3|Full Analysis Set|Double-blind Treatment Period||104
7665405|NCT02031640|18877051|P2|Full Analysis Set|Double-blind Treatment Period||106
7665406|NCT02031640|18877052|P1|Full Analysis Set|Double-blind Treatment Period||0
7665407|NCT02031640|18877047|P6|STARTED|Double-blind Treatment Period||107
7665408|NCT02031640|18877048|P5|STARTED|Double-blind Treatment Period||107
7665409|NCT02031640|18877049|P4|STARTED|Double-blind Treatment Period||106
7665410|NCT02031640|18877050|P3|STARTED|Double-blind Treatment Period||106
7665411|NCT02031640|18877051|P2|STARTED|Double-blind Treatment Period||106
7665412|NCT02031640|18877052|P1|STARTED|Double-blind Treatment Period||0
7665413|NCT02031640|18877047|P6|NOT COMPLETED|Run-In Period||0
7665414|NCT02031640|18877048|P5|NOT COMPLETED|Run-In Period||0
7665415|NCT02031640|18877049|P4|NOT COMPLETED|Run-In Period||0
7665416|NCT02031640|18877050|P3|NOT COMPLETED|Run-In Period||0
7665417|NCT02031640|18877051|P2|NOT COMPLETED|Run-In Period||0
7665418|NCT02031640|18877052|P1|NOT COMPLETED|Run-In Period||169
7665419|NCT02031640|18877047|P6|COMPLETED|Run-In Period||0
7665420|NCT02031640|18877048|P5|COMPLETED|Run-In Period||0
7665421|NCT02031640|18877049|P4|COMPLETED|Run-In Period||0
7665422|NCT02031640|18877050|P3|COMPLETED|Run-In Period||0
7665423|NCT02031640|18877051|P2|COMPLETED|Run-In Period||0
7665424|NCT02031640|18877052|P1|COMPLETED|Run-In Period||532
7665425|NCT02031640|18877047|P6|STARTED|Run-In Period||0
7665426|NCT02031640|18877048|P5|STARTED|Run-In Period||0
7665427|NCT02031640|18877049|P4|STARTED|Run-In Period||0
7665428|NCT02031640|18877050|P3|STARTED|Run-In Period||0
7665429|NCT02031640|18877051|P2|STARTED|Run-In Period||0
7665430|NCT02031640|18877052|P1|STARTED|Run-In Period||701
7665431|NCT02031640|18877047|P6|NOT COMPLETED|Screening Period||0
7665432|NCT02031640|18877048|P5|NOT COMPLETED|Screening Period||0
7665433|NCT02031640|18877049|P4|NOT COMPLETED|Screening Period||0
7665434|NCT02031640|18877050|P3|NOT COMPLETED|Screening Period||0
7665435|NCT02031640|18877051|P2|NOT COMPLETED|Screening Period||0
7665436|NCT02031640|18877052|P1|NOT COMPLETED|Screening Period||412
7665437|NCT02031640|18877047|P6|COMPLETED|Screening Period||0
7665438|NCT02031640|18877048|P5|COMPLETED|Screening Period||0
7665439|NCT02031640|18877049|P4|COMPLETED|Screening Period||0
7665440|NCT02031640|18877050|P3|COMPLETED|Screening Period||0
7665441|NCT02031640|18877051|P2|COMPLETED|Screening Period||0
7665442|NCT02031640|18877052|P1|COMPLETED|Screening Period||701
7665443|NCT02031640|18877047|P6|STARTED|Screening Period||0
7665444|NCT02031640|18877048|P5|STARTED|Screening Period||0
7665445|NCT02031640|18877049|P4|STARTED|Screening Period||0
7665446|NCT02031640|18877050|P3|STARTED|Screening Period||0
7665447|NCT02031640|18877051|P2|STARTED|Screening Period||0
7665448|NCT02031640|18877052|P1|STARTED|Screening Period|Consented|1113
7665449|NCT02031536|18877097|P2|NOT COMPLETED|Overall Study||0
7665450|NCT02031536|18877098|P1|NOT COMPLETED|Overall Study||1
7665451|NCT02031536|18877097|P2|COMPLETED|Overall Study||0
7665452|NCT02031536|18877098|P1|COMPLETED|Overall Study||1
7665453|NCT02031536|18877097|P2|STARTED|Overall Study||0
7665454|NCT02031536|18877098|P1|STARTED|Overall Study||2
7665455|NCT02031471|18877106|P1|NOT COMPLETED|Long Term Extension (LTE) Period||2
7665456|NCT02031471|18877106|P1|COMPLETED|Long Term Extension (LTE) Period||37
7665457|NCT02031471|18877106|P1|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39
7665458|NCT02031471|18877106|P1|NOT COMPLETED|24 Week Treatment Period||11
7665459|NCT02031471|18877106|P1|COMPLETED|24 Week Treatment Period||46
7665460|NCT02031471|18877106|P1|STARTED|24 Week Treatment Period||57
7665461|NCT02031458|18877139|P3|NOT COMPLETED|Baseline to May 8, 2015||253
7665462|NCT02031458|18877140|P2|NOT COMPLETED|Baseline to May 8, 2015||267
7665463|NCT02031458|18877141|P1|NOT COMPLETED|Baseline to May 8, 2015||139
7665464|NCT02031458|18877139|P3|COMPLETED|Baseline to May 8, 2015||0
7665465|NCT02031458|18877140|P2|COMPLETED|Baseline to May 8, 2015||0
7665466|NCT02031458|18877141|P1|COMPLETED|Baseline to May 8, 2015||0
7665467|NCT02031458|18877139|P3|STARTED|Baseline to May 8, 2015||253
7665468|NCT02031458|18877140|P2|STARTED|Baseline to May 8, 2015||267
7665469|NCT02031458|18877141|P1|STARTED|Baseline to May 8, 2015||139
7665470|NCT02031458|18877139|P3|NOT COMPLETED|May 8, 2015 to January 11, 2019||252
7665471|NCT02031458|18877140|P2|NOT COMPLETED|May 8, 2015 to January 11, 2019||269
7665472|NCT02031458|18877141|P1|NOT COMPLETED|May 8, 2015 to January 11, 2019||138
7665473|NCT02031458|18877139|P3|COMPLETED|May 8, 2015 to January 11, 2019||0
7665474|NCT02031458|18877140|P2|COMPLETED|May 8, 2015 to January 11, 2019||0
7665475|NCT02031458|18877141|P1|COMPLETED|May 8, 2015 to January 11, 2019||0
7665476|NCT02031458|18877139|P3|STARTED|May 8, 2015 to January 11, 2019||252
7665477|NCT02031458|18877140|P2|STARTED|May 8, 2015 to January 11, 2019||269
7665478|NCT02031458|18877141|P1|STARTED|May 8, 2015 to January 11, 2019||138
7665479|NCT02031432|18877235|P1|NOT COMPLETED|Overall Study||38
7665480|NCT02031432|18877235|P1|COMPLETED|Overall Study||38
7665481|NCT02031432|18877235|P1|Completing the Treatment|Overall Study||39
7665482|NCT02031432|18877235|P1|Completing the Titration Phase|Overall Study||67
7665483|NCT02031432|18877235|P1|STARTED|Overall Study||76
7665484|NCT02031302|18877262|P2|NOT COMPLETED|Overall Study||0
7665485|NCT02031302|18877263|P1|NOT COMPLETED|Overall Study||164
7665486|NCT02031302|18877262|P2|COMPLETED|Overall Study||50
7665487|NCT02031302|18877263|P1|COMPLETED|Overall Study||850
7665488|NCT02031302|18877262|P2|STARTED|Overall Study||50
7665489|NCT02031302|18877263|P1|STARTED|Overall Study||1014
7665490|NCT02031276|18877284|P3|NOT COMPLETED|Period 3 Open-label Risankizumab SC||2
7665491|NCT02031276|18877285|P2|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
7665492|NCT02031276|18877286|P1|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
7665493|NCT02031276|18877284|P3|COMPLETED|Period 3 Open-label Risankizumab SC||19
7665494|NCT02031276|18877285|P2|COMPLETED|Period 3 Open-label Risankizumab SC||19
7665495|NCT02031276|18877286|P1|COMPLETED|Period 3 Open-label Risankizumab SC||16
7665496|NCT02031276|18877284|P3|STARTED|Period 3 Open-label Risankizumab SC|17 participants did not enter period 3 (not in clinical remission)|21
7665497|NCT02031276|18877285|P2|STARTED|Period 3 Open-label Risankizumab SC|11 participants did not enter period 3 (not in clinical remission)|22
7665498|NCT02031276|18877286|P1|STARTED|Period 3 Open-label Risankizumab SC|10 participants did not enter period 3 (not in clinical remission)|19
7665499|NCT02031276|18877284|P3|NOT COMPLETED|Period 2 Open-label Risankizumab IV||1
7665500|NCT02031276|18877285|P2|NOT COMPLETED|Period 2 Open-label Risankizumab IV||2
7665501|NCT02031276|18877286|P1|NOT COMPLETED|Period 2 Open-label Risankizumab IV||4
7665502|NCT02031276|18877284|P3|COMPLETED|Period 2 Open-label Risankizumab IV||38
7665503|NCT02031276|18877285|P2|COMPLETED|Period 2 Open-label Risankizumab IV||33
7665504|NCT02031276|18877286|P1|COMPLETED|Period 2 Open-label Risankizumab IV||29
7665505|NCT02031276|18877284|P3|STARTED|Period 2 Open-label Risankizumab IV|1 participant did not enter Period 2 (declined open-label treatment in Period 2)|39
7665506|NCT02031276|18877285|P2|STARTED|Period 2 Open-label Risankizumab IV||35
7665507|NCT02031276|18877286|P1|STARTED|Period 2 Open-label Risankizumab IV||33
7665508|NCT02031276|18877284|P3|NOT COMPLETED|Period 1 Double-blind IV||1
7665509|NCT02031276|18877285|P2|NOT COMPLETED|Period 1 Double-blind IV||6
7665510|NCT02031276|18877286|P1|NOT COMPLETED|Period 1 Double-blind IV||6
7665511|NCT02031276|18877284|P3|COMPLETED|Period 1 Double-blind IV||40
7665512|NCT02031276|18877285|P2|COMPLETED|Period 1 Double-blind IV||35
7665513|NCT02031276|18877286|P1|COMPLETED|Period 1 Double-blind IV||33
7665514|NCT02031276|18877284|P3|STARTED|Period 1 Double-blind IV||41
7665515|NCT02031276|18877285|P2|STARTED|Period 1 Double-blind IV||41
7665516|NCT02031276|18877286|P1|STARTED|Period 1 Double-blind IV||39
7665517|NCT02031237|18877320|P3|NOT COMPLETED|Overall Study||3
7665518|NCT02031237|18877321|P2|NOT COMPLETED|Overall Study||14
7665519|NCT02031237|18877322|P1|NOT COMPLETED|Overall Study||5
7665520|NCT02031237|18877320|P3|COMPLETED|Overall Study||0
7665521|NCT02031237|18877321|P2|COMPLETED|Overall Study||21
7665522|NCT02031237|18877322|P1|COMPLETED|Overall Study||9
7665523|NCT02031237|18877320|P3|STARTED|Overall Study||3
7665524|NCT02031237|18877321|P2|STARTED|Overall Study||35
7665525|NCT02031237|18877322|P1|STARTED|Overall Study||14
7665526|NCT02030886|18877331|P2|NOT COMPLETED|Overall Study||0
7665527|NCT02030886|18877332|P1|NOT COMPLETED|Overall Study||0
7665528|NCT02030886|18877331|P2|COMPLETED|Overall Study||6
7665529|NCT02030886|18877332|P1|COMPLETED|Overall Study||14
7665530|NCT02030886|18877331|P2|STARTED|Overall Study||6
7665531|NCT02030886|18877332|P1|STARTED|Overall Study||14
7665532|NCT02030847|18877342|P1|NOT COMPLETED|Overall Study||37
7665533|NCT02030847|18877342|P1|COMPLETED|Overall Study||5
7665534|NCT02030847|18877342|P1|STARTED|Overall Study||42
7665535|NCT02030834|18877350|P3|NOT COMPLETED|Overall Study||3
7665536|NCT02030834|18877351|P2|NOT COMPLETED|Overall Study||0
7665537|NCT02030834|18877352|P1|NOT COMPLETED|Overall Study||11
7665538|NCT02030834|18877350|P3|COMPLETED|Overall Study||7
7665539|NCT02030834|18877351|P2|COMPLETED|Overall Study||3
7665540|NCT02030834|18877352|P1|COMPLETED|Overall Study||39
7665541|NCT02030834|18877350|P3|STARTED|Overall Study||10
7665542|NCT02030834|18877351|P2|STARTED|Overall Study||3
7665543|NCT02030834|18877352|P1|STARTED|Overall Study||50
7665544|NCT02030821|18877364|P4|NOT COMPLETED|Overall Study||2
7665545|NCT02030821|18877365|P3|NOT COMPLETED|Overall Study||5
7665546|NCT02030821|18877366|P2|NOT COMPLETED|Overall Study||2
7665547|NCT02030821|18877367|P1|NOT COMPLETED|Overall Study||2
7665548|NCT02030821|18877364|P4|COMPLETED|Overall Study||72
7665549|NCT02030821|18877365|P3|COMPLETED|Overall Study||73
7665550|NCT02030821|18877366|P2|COMPLETED|Overall Study||44
7665551|NCT02030821|18877367|P1|COMPLETED|Overall Study||46
7665552|NCT02030821|18877364|P4|STARTED|Overall Study||74
7665553|NCT02030821|18877365|P3|STARTED|Overall Study||78
7665554|NCT02030821|18877366|P2|STARTED|Overall Study||46
7665555|NCT02030821|18877367|P1|STARTED|Overall Study||48
7665556|NCT02030600|18877395|P2|NOT COMPLETED|Treatment Period 2||18
7665557|NCT02030600|18877396|P1|NOT COMPLETED|Treatment Period 2||25
7665558|NCT02030600|18877395|P2|COMPLETED|Treatment Period 2||297
7665559|NCT02030600|18877396|P1|COMPLETED|Treatment Period 2||283
7665560|NCT02030600|18877395|P2|STARTED|Treatment Period 2||315
7665561|NCT02030600|18877396|P1|STARTED|Treatment Period 2||308
7665562|NCT02030600|18877395|P2|NOT COMPLETED|Treatment Period 1||45
7665563|NCT02030600|18877396|P1|NOT COMPLETED|Treatment Period 1||53
7665564|NCT02030600|18877395|P2|COMPLETED|Treatment Period 1||315
7665565|NCT02030600|18877396|P1|COMPLETED|Treatment Period 1||308
7665566|NCT02030600|18877395|P2|Exposed|Treatment Period 1||357
7665567|NCT02030600|18877396|P1|Exposed|Treatment Period 1||356
7665568|NCT02030600|18877395|P2|STARTED|Treatment Period 1||360
7665569|NCT02030600|18877396|P1|STARTED|Treatment Period 1||361
7665570|NCT02030574|18877412|P1|NOT COMPLETED|Overall Study||0
7665571|NCT02030574|18877412|P1|COMPLETED|Overall Study||2
7665572|NCT02030574|18877412|P1|STARTED|Overall Study||2
7665573|NCT02030535|18877417|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7665574|NCT02030535|18877417|P1|COMPLETED|Treatment Period 3 (1 Day)||52
7665575|NCT02030535|18877417|P1|STARTED|Treatment Period 3 (1 Day)||52
7665576|NCT02030535|18877417|P1|NOT COMPLETED|Washout Period 2 (21 Days)||0
7665577|NCT02030535|18877417|P1|COMPLETED|Washout Period 2 (21 Days)||52
7665578|NCT02030535|18877417|P1|STARTED|Washout Period 2 (21 Days)||52
7665579|NCT02030535|18877417|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7665580|NCT02030535|18877417|P1|COMPLETED|Treatment Period 2 (1 Day)||52
7665581|NCT02030535|18877417|P1|STARTED|Treatment Period 2 (1 Day)||52
7665582|NCT02030535|18877417|P1|NOT COMPLETED|Washout Period 1 (21 Days)||1
7665583|NCT02030535|18877417|P1|COMPLETED|Washout Period 1 (21 Days)||52
7665584|NCT02030535|18877417|P1|STARTED|Washout Period 1 (21 Days)||53
7665585|NCT02030535|18877417|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7665586|NCT02030535|18877417|P1|COMPLETED|Treatment Period 1 (1 Day)||53
7665587|NCT02030535|18877417|P1|STARTED|Treatment Period 1 (1 Day)||53
7665588|NCT02030405|18877485|P1|NOT COMPLETED|Overall Study||2
7665589|NCT02030405|18877485|P1|COMPLETED|Overall Study||2
7665590|NCT02030405|18877485|P1|STARTED|Overall Study||4
7665591|NCT02030288|18877494|P2|NOT COMPLETED|Overall Study||0
7665592|NCT02030288|18877495|P1|NOT COMPLETED|Overall Study||0
7665593|NCT02030288|18877494|P2|COMPLETED|Overall Study||89
7665594|NCT02030288|18877495|P1|COMPLETED|Overall Study||89
7665595|NCT02030288|18877494|P2|STARTED|Overall Study||89
7665596|NCT02030288|18877495|P1|STARTED|Overall Study||89
7665597|NCT02030119|18877511|P4|NOT COMPLETED|Overall Study||3
7665598|NCT02030119|18877512|P3|NOT COMPLETED|Overall Study||6
7665599|NCT02030119|18877513|P2|NOT COMPLETED|Overall Study||2
7665600|NCT02030119|18877514|P1|NOT COMPLETED|Overall Study||3
7665601|NCT02030119|18877511|P4|COMPLETED|Overall Study||67
7665602|NCT02030119|18877512|P3|COMPLETED|Overall Study||65
7665603|NCT02030119|18877513|P2|COMPLETED|Overall Study||68
7665604|NCT02030119|18877514|P1|COMPLETED|Overall Study||67
7665605|NCT02030119|18877511|P4|STARTED|Overall Study||70
7665606|NCT02030119|18877512|P3|STARTED|Overall Study||71
7665607|NCT02030119|18877513|P2|STARTED|Overall Study||70
7665608|NCT02030119|18877514|P1|STARTED|Overall Study||70
7665609|NCT02030080|18877532|P4|NOT COMPLETED|Overall Study||2
7665610|NCT02030080|18877533|P3|NOT COMPLETED|Overall Study||0
7665611|NCT02030080|18877534|P2|NOT COMPLETED|Overall Study||0
7665612|NCT02030080|18877535|P1|NOT COMPLETED|Overall Study||0
7665613|NCT02030080|18877532|P4|COMPLETED|Overall Study||42
7665614|NCT02030080|18877533|P3|COMPLETED|Overall Study||80
7665615|NCT02030080|18877534|P2|COMPLETED|Overall Study||64
7665616|NCT02030080|18877535|P1|COMPLETED|Overall Study||100
7665617|NCT02030080|18877532|P4|STARTED|Overall Study|11 teams|44
7665618|NCT02030080|18877533|P3|STARTED|Overall Study|20 teams|80
7665619|NCT02030080|18877534|P2|STARTED|Overall Study|16 teams|64
7665620|NCT02030080|18877535|P1|STARTED|Overall Study|25 teams|100
7665621|NCT02030041|18877552|P3|NOT COMPLETED|Overall Study||1
7665622|NCT02030041|18877553|P2|NOT COMPLETED|Overall Study||2
7665623|NCT02030041|18877554|P1|NOT COMPLETED|Overall Study||2
7665624|NCT02030041|18877552|P3|COMPLETED|Overall Study||10
7665625|NCT02030041|18877553|P2|COMPLETED|Overall Study||9
7665626|NCT02030041|18877554|P1|COMPLETED|Overall Study||9
7665627|NCT02030041|18877552|P3|STARTED|Overall Study||11
7665628|NCT02030041|18877553|P2|STARTED|Overall Study||11
7665629|NCT02030041|18877554|P1|STARTED|Overall Study||11
7665630|NCT02029989|18877567|P2|NOT COMPLETED|Overall Study||11
7665631|NCT02029989|18877568|P1|NOT COMPLETED|Overall Study||16
7665632|NCT02029989|18877567|P2|COMPLETED|Overall Study||49
7665633|NCT02029989|18877568|P1|COMPLETED|Overall Study||45
7665634|NCT02029989|18877567|P2|STARTED|Overall Study||60
7665635|NCT02029989|18877568|P1|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61
7665636|NCT02029976|18877576|P2|NOT COMPLETED|YR-2 Follow Up vs Baseline||8
7665637|NCT02029976|18877577|P1|NOT COMPLETED|YR-2 Follow Up vs Baseline||10
7665638|NCT02029976|18877576|P2|COMPLETED|YR-2 Follow Up vs Baseline||124
7665639|NCT02029976|18877577|P1|COMPLETED|YR-2 Follow Up vs Baseline||122
7665640|NCT02029976|18877576|P2|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
7665641|NCT02029976|18877577|P1|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
7665642|NCT02029976|18877576|P2|NOT COMPLETED|YR-1 Post Intervention vs Baseline||8
7665643|NCT02029976|18877577|P1|NOT COMPLETED|YR-1 Post Intervention vs Baseline||12
7665644|NCT02029976|18877576|P2|COMPLETED|YR-1 Post Intervention vs Baseline||124
7665645|NCT02029976|18877577|P1|COMPLETED|YR-1 Post Intervention vs Baseline||120
7665646|NCT02029976|18877576|P2|STARTED|YR-1 Post Intervention vs Baseline||132
7665647|NCT02029976|18877577|P1|STARTED|YR-1 Post Intervention vs Baseline||132
7665648|NCT02029911|18877589|P1|NOT COMPLETED|Overall Study||0
7665649|NCT02029911|18877589|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|60
7665650|NCT02029911|18877589|P1|Treated|Overall Study|Treatment Completed|60
7665651|NCT02029911|18877589|P1|STARTED|Overall Study|Treatment Attempted|60
7665652|NCT02029872|18877597|P2|NOT COMPLETED|Overall Study||3
7665653|NCT02029872|18877598|P1|NOT COMPLETED|Overall Study||2
7665654|NCT02029872|18877597|P2|COMPLETED|Overall Study||6
7665655|NCT02029872|18877598|P1|COMPLETED|Overall Study||7
7665656|NCT02029872|18877597|P2|STARTED|Overall Study||9
7665657|NCT02029872|18877598|P1|STARTED|Overall Study||9
7665658|NCT02029846|18877606|P2|NOT COMPLETED|Overall Study||1
7665659|NCT02029846|18877607|P1|NOT COMPLETED|Overall Study||1
7665660|NCT02029846|18877606|P2|COMPLETED|Overall Study||0
7665661|NCT02029846|18877607|P1|COMPLETED|Overall Study||0
7665662|NCT02029846|18877606|P2|STARTED|Overall Study||1
7665663|NCT02029846|18877607|P1|STARTED|Overall Study||1
7665664|NCT02029755|18877620|P3|NOT COMPLETED|Overall Study||0
7665665|NCT02029755|18877621|P2|NOT COMPLETED|Overall Study||0
7665666|NCT02029755|18877622|P1|NOT COMPLETED|Overall Study||0
7665667|NCT02029755|18877620|P3|COMPLETED|Overall Study||36
7665668|NCT02029755|18877621|P2|COMPLETED|Overall Study||36
7665669|NCT02029755|18877622|P1|COMPLETED|Overall Study||36
7665670|NCT02029755|18877620|P3|STARTED|Overall Study||36
7665671|NCT02029755|18877621|P2|STARTED|Overall Study||36
7665672|NCT02029755|18877622|P1|STARTED|Overall Study||36
7665673|NCT02029703|18877635|P2|NOT COMPLETED|Overall Study||0
7665674|NCT02029703|18877636|P1|NOT COMPLETED|Overall Study||0
7665675|NCT02029703|18877635|P2|COMPLETED|Overall Study||22
7665676|NCT02029703|18877636|P1|COMPLETED|Overall Study||20
7665677|NCT02029703|18877635|P2|STARTED|Overall Study||22
7665678|NCT02029703|18877636|P1|STARTED|Overall Study||20
7665679|NCT02029638|18877645|P3|NOT COMPLETED|Overall Study||1
7665680|NCT02029638|18877646|P2|NOT COMPLETED|Overall Study||0
7665681|NCT02029638|18877647|P1|NOT COMPLETED|Overall Study||2
7665682|NCT02029638|18877645|P3|COMPLETED|Overall Study||0
7665683|NCT02029638|18877646|P2|COMPLETED|Overall Study||1
7665684|NCT02029638|18877647|P1|COMPLETED|Overall Study||0
7665685|NCT02029638|18877645|P3|STARTED|Overall Study||1
7665686|NCT02029638|18877646|P2|STARTED|Overall Study||1
7665687|NCT02029638|18877647|P1|STARTED|Overall Study||2
7665688|NCT02029521|18877676|P2|NOT COMPLETED|Overall Study||1
7665689|NCT02029521|18877677|P1|NOT COMPLETED|Overall Study||2
7665690|NCT02029521|18877676|P2|COMPLETED|Overall Study||22
7665691|NCT02029521|18877677|P1|COMPLETED|Overall Study||22
7665692|NCT02029521|18877676|P2|STARTED|Overall Study||23
7665693|NCT02029521|18877677|P1|STARTED|Overall Study||24
7665694|NCT02029495|18877762|P3|NOT COMPLETED|Overall Study||2
7665695|NCT02029495|18877763|P2|NOT COMPLETED|Overall Study||0
7665696|NCT02029495|18877764|P1|NOT COMPLETED|Overall Study||1
7665697|NCT02029495|18877762|P3|COMPLETED|Overall Study||159
7665698|NCT02029495|18877763|P2|COMPLETED|Overall Study||158
7665699|NCT02029495|18877764|P1|COMPLETED|Overall Study||158
7665700|NCT02029495|18877762|P3|STARTED|Overall Study||161
7665701|NCT02029495|18877763|P2|STARTED|Overall Study||158
7665702|NCT02029495|18877764|P1|STARTED|Overall Study||159
7665703|NCT02029417|18877775|P1|NOT COMPLETED|Overall Study||2
7665704|NCT02029417|18877775|P1|COMPLETED|Overall Study||0
7665705|NCT02029417|18877775|P1|STARTED|Overall Study||2
7665706|NCT02029274|18877784|P4|NOT COMPLETED|Overall Study||2
7665707|NCT02029274|18877785|P3|NOT COMPLETED|Overall Study||2
7665708|NCT02029274|18877786|P2|NOT COMPLETED|Overall Study||0
7665709|NCT02029274|18877787|P1|NOT COMPLETED|Overall Study||1
7665710|NCT02029274|18877784|P4|COMPLETED|Overall Study||2
7665711|NCT02029274|18877785|P3|COMPLETED|Overall Study||2
7665712|NCT02029274|18877786|P2|COMPLETED|Overall Study||4
7665713|NCT02029274|18877787|P1|COMPLETED|Overall Study||4
7665714|NCT02029274|18877784|P4|Fixed Dose Period 2|Overall Study||4
7665715|NCT02029274|18877785|P3|Fixed Dose Period 2|Overall Study||4
7665716|NCT02029274|18877786|P2|Fixed Dose Period 2|Overall Study||4
7665717|NCT02029274|18877787|P1|Fixed Dose Period 2|Overall Study||5
7665718|NCT02029274|18877784|P4|STARTED|Overall Study||4
7665719|NCT02029274|18877785|P3|STARTED|Overall Study||4
7665720|NCT02029274|18877786|P2|STARTED|Overall Study||4
7665721|NCT02029274|18877787|P1|STARTED|Overall Study||5
7665722|NCT02029235|18877819|P2|NOT COMPLETED|Overall Study||1
7665723|NCT02029235|18877820|P1|NOT COMPLETED|Overall Study||4
7665724|NCT02029235|18877819|P2|COMPLETED|Overall Study||30
7665725|NCT02029235|18877820|P1|COMPLETED|Overall Study||30
7665726|NCT02029235|18877819|P2|STARTED|Overall Study||31
7665727|NCT02029235|18877820|P1|STARTED|Overall Study||34
7665728|NCT02029196|18877830|P2|NOT COMPLETED|Overall Study||1
7665729|NCT02029196|18877831|P1|NOT COMPLETED|Overall Study||20
7665730|NCT02029196|18877830|P2|COMPLETED|Overall Study||101
7665731|NCT02029196|18877831|P1|COMPLETED|Overall Study||286
7665732|NCT02029196|18877830|P2|STARTED|Overall Study||102
7665733|NCT02029196|18877831|P1|STARTED|Overall Study||306
7665734|NCT02029040|18877841|P2|NOT COMPLETED|Overall Study||0
7665735|NCT02029040|18877842|P1|NOT COMPLETED|Overall Study||0
7665736|NCT02029040|18877841|P2|COMPLETED|Overall Study||25
7665737|NCT02029040|18877842|P1|COMPLETED|Overall Study||27
7665738|NCT02029040|18877841|P2|STARTED|Overall Study||25
7665739|NCT02029040|18877842|P1|STARTED|Overall Study||27
7665740|NCT02028884|18877852|P2|NOT COMPLETED|Open-label Extension Period||18
7665741|NCT02028884|18877853|P1|NOT COMPLETED|Open-label Extension Period||24
7665742|NCT02028884|18877852|P2|COMPLETED|Open-label Extension Period||0
7665743|NCT02028884|18877853|P1|COMPLETED|Open-label Extension Period||0
7665744|NCT02028884|18877852|P2|STARTED|Open-label Extension Period||18
7665745|NCT02028884|18877853|P1|STARTED|Open-label Extension Period||24
7665746|NCT02028884|18877852|P2|NOT COMPLETED|Double-blind Period||23
7665747|NCT02028884|18877853|P1|NOT COMPLETED|Double-blind Period||18
7665748|NCT02028884|18877852|P2|COMPLETED|Double-blind Period||18
7665749|NCT02028884|18877853|P1|COMPLETED|Double-blind Period||24
7665750|NCT02028884|18877852|P2|STARTED|Double-blind Period||41
7665751|NCT02028884|18877853|P1|STARTED|Double-blind Period||42
7665752|NCT02028871|18877923|P2|NOT COMPLETED|Overall Study||3
7665753|NCT02028871|18877924|P1|NOT COMPLETED|Overall Study||4
7665754|NCT02028871|18877923|P2|COMPLETED|Overall Study||9
7665755|NCT02028871|18877924|P1|COMPLETED|Overall Study||10
7665756|NCT02028871|18877923|P2|STARTED|Overall Study||12
7665757|NCT02028871|18877924|P1|STARTED|Overall Study||14
7665758|NCT02028780|18877945|P12|NOT COMPLETED|Follow up Phase||0
7665759|NCT02028780|18877946|P11|NOT COMPLETED|Follow up Phase||0
7665760|NCT02028780|18877947|P10|NOT COMPLETED|Follow up Phase||0
7665761|NCT02028780|18877948|P9|NOT COMPLETED|Follow up Phase||0
7665762|NCT02028780|18877949|P8|NOT COMPLETED|Follow up Phase||0
7665763|NCT02028780|18877950|P7|NOT COMPLETED|Follow up Phase||0
7665764|NCT02028780|18877951|P6|NOT COMPLETED|Follow up Phase||0
7665765|NCT02028780|18877952|P5|NOT COMPLETED|Follow up Phase||0
7665766|NCT02028780|18877953|P4|NOT COMPLETED|Follow up Phase||0
7665767|NCT02028780|18877954|P3|NOT COMPLETED|Follow up Phase||0
7665768|NCT02028780|18877955|P2|NOT COMPLETED|Follow up Phase||0
7665769|NCT02028780|18877956|P1|NOT COMPLETED|Follow up Phase||0
7665770|NCT02028780|18877945|P12|COMPLETED|Follow up Phase||9
7665771|NCT02028780|18877946|P11|COMPLETED|Follow up Phase||9
7665772|NCT02028780|18877947|P10|COMPLETED|Follow up Phase||9
7665773|NCT02028780|18877948|P9|COMPLETED|Follow up Phase||9
7665774|NCT02028780|18877949|P8|COMPLETED|Follow up Phase||3
7665775|NCT02028780|18877950|P7|COMPLETED|Follow up Phase||9
7665776|NCT02028780|18877951|P6|COMPLETED|Follow up Phase||6
7665777|NCT02028780|18877952|P5|COMPLETED|Follow up Phase||6
7665778|NCT02028780|18877953|P4|COMPLETED|Follow up Phase||6
7665779|NCT02028780|18877954|P3|COMPLETED|Follow up Phase||6
7665780|NCT02028780|18877955|P2|COMPLETED|Follow up Phase||2
7665781|NCT02028780|18877956|P1|COMPLETED|Follow up Phase||6
7665782|NCT02028780|18877945|P12|STARTED|Follow up Phase||9
7665783|NCT02028780|18877946|P11|STARTED|Follow up Phase||9
7665784|NCT02028780|18877947|P10|STARTED|Follow up Phase||9
7665785|NCT02028780|18877948|P9|STARTED|Follow up Phase||9
7665786|NCT02028780|18877949|P8|STARTED|Follow up Phase||3
7665787|NCT02028780|18877950|P7|STARTED|Follow up Phase||9
7665788|NCT02028780|18877951|P6|STARTED|Follow up Phase||6
7665789|NCT02028780|18877952|P5|STARTED|Follow up Phase||6
7665790|NCT02028780|18877953|P4|STARTED|Follow up Phase||6
7665791|NCT02028780|18877954|P3|STARTED|Follow up Phase||6
7665792|NCT02028780|18877955|P2|STARTED|Follow up Phase||2
7665793|NCT02028780|18877956|P1|STARTED|Follow up Phase||6
7665794|NCT02028780|18877945|P12|NOT COMPLETED|Observation Phase||0
7665795|NCT02028780|18877946|P11|NOT COMPLETED|Observation Phase||0
7665796|NCT02028780|18877947|P10|NOT COMPLETED|Observation Phase||0
7665797|NCT02028780|18877948|P9|NOT COMPLETED|Observation Phase||0
7665798|NCT02028780|18877949|P8|NOT COMPLETED|Observation Phase||0
7665799|NCT02028780|18877950|P7|NOT COMPLETED|Observation Phase||0
7665800|NCT02028780|18877951|P6|NOT COMPLETED|Observation Phase||0
7665801|NCT02028780|18877952|P5|NOT COMPLETED|Observation Phase||0
7665802|NCT02028780|18877953|P4|NOT COMPLETED|Observation Phase||0
7665803|NCT02028780|18877954|P3|NOT COMPLETED|Observation Phase||0
7665804|NCT02028780|18877955|P2|NOT COMPLETED|Observation Phase||0
7665805|NCT02028780|18877956|P1|NOT COMPLETED|Observation Phase||0
7665806|NCT02028780|18877945|P12|COMPLETED|Observation Phase||9
7665807|NCT02028780|18877946|P11|COMPLETED|Observation Phase||9
7665808|NCT02028780|18877947|P10|COMPLETED|Observation Phase||9
7665809|NCT02028780|18877948|P9|COMPLETED|Observation Phase||9
7665810|NCT02028780|18877949|P8|COMPLETED|Observation Phase||3
7665811|NCT02028780|18877950|P7|COMPLETED|Observation Phase||9
7665812|NCT02028780|18877951|P6|COMPLETED|Observation Phase||6
7665813|NCT02028780|18877952|P5|COMPLETED|Observation Phase||6
7665814|NCT02028780|18877953|P4|COMPLETED|Observation Phase||6
7665815|NCT02028780|18877954|P3|COMPLETED|Observation Phase||6
7665816|NCT02028780|18877955|P2|COMPLETED|Observation Phase||2
7665817|NCT02028780|18877956|P1|COMPLETED|Observation Phase||6
7665818|NCT02028780|18877945|P12|STARTED|Observation Phase||9
7665819|NCT02028780|18877946|P11|STARTED|Observation Phase||9
7665820|NCT02028780|18877947|P10|STARTED|Observation Phase||9
7665821|NCT02028780|18877948|P9|STARTED|Observation Phase||9
7665822|NCT02028780|18877949|P8|STARTED|Observation Phase||3
7665823|NCT02028780|18877950|P7|STARTED|Observation Phase||9
7665824|NCT02028780|18877951|P6|STARTED|Observation Phase||6
7665825|NCT02028780|18877952|P5|STARTED|Observation Phase||6
7665826|NCT02028780|18877953|P4|STARTED|Observation Phase||6
7665827|NCT02028780|18877954|P3|STARTED|Observation Phase||6
7665828|NCT02028780|18877955|P2|STARTED|Observation Phase||2
7665829|NCT02028780|18877956|P1|STARTED|Observation Phase||6
7665830|NCT02028767|18878021|P2|NOT COMPLETED|Treatment Period 2||0
7665831|NCT02028767|18878022|P1|NOT COMPLETED|Treatment Period 2||2
7665832|NCT02028767|18878021|P2|COMPLETED|Treatment Period 2||16
7665833|NCT02028767|18878022|P1|COMPLETED|Treatment Period 2||14
7665834|NCT02028767|18878021|P2|STARTED|Treatment Period 2||16
7665835|NCT02028767|18878022|P1|STARTED|Treatment Period 2||16
7665836|NCT02028767|18878021|P2|NOT COMPLETED|Treatment Period 1||0
7665837|NCT02028767|18878022|P1|NOT COMPLETED|Treatment Period 1||0
7665838|NCT02028767|18878021|P2|COMPLETED|Treatment Period 1||16
7665839|NCT02028767|18878022|P1|COMPLETED|Treatment Period 1||16
7665840|NCT02028767|18878021|P2|STARTED|Treatment Period 1||16
7665841|NCT02028767|18878022|P1|STARTED|Treatment Period 1||16
7665842|NCT02028754|18878034|P2|NOT COMPLETED|Overall Study||8
7665843|NCT02028754|18878035|P1|NOT COMPLETED|Overall Study||7
7665844|NCT02028754|18878034|P2|COMPLETED|Overall Study||82
7665845|NCT02028754|18878035|P1|COMPLETED|Overall Study||83
7665846|NCT02028754|18878034|P2|STARTED|Overall Study||90
7665847|NCT02028754|18878035|P1|STARTED|Overall Study||90
7665848|NCT02028715|18878055|P2|NOT COMPLETED|Overall Study||4
7665849|NCT02028715|18878056|P1|NOT COMPLETED|Overall Study||5
7665850|NCT02028715|18878055|P2|COMPLETED|Overall Study||30
7665851|NCT02028715|18878056|P1|COMPLETED|Overall Study||29
7665852|NCT02028715|18878055|P2|STARTED|Overall Study||34
7665853|NCT02028715|18878056|P1|STARTED|Overall Study||34
7665854|NCT02028676|18878083|P9|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
7665855|NCT02028676|18878084|P8|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
7665856|NCT02028676|18878085|P7|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
7665857|NCT02028676|18878086|P6|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
7665858|NCT02028676|18878087|P5|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
7665859|NCT02028676|18878088|P4|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
7665860|NCT02028676|18878089|P3|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
7665861|NCT02028676|18878090|P2|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
7665862|NCT02028676|18878091|P1|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
7665863|NCT02028676|18878083|P9|COMPLETED|Subsequent Cotrimoxazole Randomization||382
7665864|NCT02028676|18878084|P8|COMPLETED|Subsequent Cotrimoxazole Randomization||376
7665865|NCT02028676|18878085|P7|COMPLETED|Subsequent Cotrimoxazole Randomization||0
7665866|NCT02028676|18878086|P6|COMPLETED|Subsequent Cotrimoxazole Randomization||0
7665867|NCT02028676|18878087|P5|COMPLETED|Subsequent Cotrimoxazole Randomization||0
7665868|NCT02028676|18878088|P4|COMPLETED|Subsequent Cotrimoxazole Randomization||0
7665869|NCT02028676|18878089|P3|COMPLETED|Subsequent Cotrimoxazole Randomization||0
7665870|NCT02028676|18878090|P2|COMPLETED|Subsequent Cotrimoxazole Randomization||0
7665871|NCT02028676|18878091|P1|COMPLETED|Subsequent Cotrimoxazole Randomization||0
7665872|NCT02028676|18878083|P9|STARTED|Subsequent Cotrimoxazole Randomization||382
7665873|NCT02028676|18878084|P8|STARTED|Subsequent Cotrimoxazole Randomization||376
7665874|NCT02028676|18878085|P7|STARTED|Subsequent Cotrimoxazole Randomization||0
7665875|NCT02028676|18878086|P6|STARTED|Subsequent Cotrimoxazole Randomization||0
7665876|NCT02028676|18878087|P5|STARTED|Subsequent Cotrimoxazole Randomization||0
7665877|NCT02028676|18878088|P4|STARTED|Subsequent Cotrimoxazole Randomization||0
7665878|NCT02028676|18878089|P3|STARTED|Subsequent Cotrimoxazole Randomization||0
7665879|NCT02028676|18878090|P2|STARTED|Subsequent Cotrimoxazole Randomization||0
7665880|NCT02028676|18878091|P1|STARTED|Subsequent Cotrimoxazole Randomization||0
7665881|NCT02028676|18878083|P9|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
7665882|NCT02028676|18878084|P8|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
7665883|NCT02028676|18878085|P7|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
7665884|NCT02028676|18878086|P6|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
7665885|NCT02028676|18878087|P5|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
7665886|NCT02028676|18878088|P4|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
7665887|NCT02028676|18878089|P3|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
7665888|NCT02028676|18878090|P2|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
7665889|NCT02028676|18878091|P1|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
7665890|NCT02028676|18878083|P9|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
7665891|NCT02028676|18878084|P8|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
7665892|NCT02028676|18878085|P7|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333
7665893|NCT02028676|18878086|P6|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336
7665894|NCT02028676|18878087|P5|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
7665895|NCT02028676|18878088|P4|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
7665896|NCT02028676|18878089|P3|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
7665897|NCT02028676|18878090|P2|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
7665898|NCT02028676|18878091|P1|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
7665899|NCT02028676|18878083|P9|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
7665900|NCT02028676|18878084|P8|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
7665901|NCT02028676|18878085|P7|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333
7665902|NCT02028676|18878086|P6|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336
7665903|NCT02028676|18878087|P5|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
7665904|NCT02028676|18878088|P4|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
7665905|NCT02028676|18878089|P3|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
7665906|NCT02028676|18878090|P2|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
7665907|NCT02028676|18878091|P1|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
7665908|NCT02028676|18878083|P9|NOT COMPLETED|Initial Enrolment: Induction ART||0
7665909|NCT02028676|18878084|P8|NOT COMPLETED|Initial Enrolment: Induction ART||0
7665910|NCT02028676|18878085|P7|NOT COMPLETED|Initial Enrolment: Induction ART||0
7665911|NCT02028676|18878086|P6|NOT COMPLETED|Initial Enrolment: Induction ART||0
7665912|NCT02028676|18878087|P5|NOT COMPLETED|Initial Enrolment: Induction ART||0
7665913|NCT02028676|18878088|P4|NOT COMPLETED|Initial Enrolment: Induction ART||0
7665914|NCT02028676|18878089|P3|NOT COMPLETED|Initial Enrolment: Induction ART||0
7665915|NCT02028676|18878090|P2|NOT COMPLETED|Initial Enrolment: Induction ART||0
7665916|NCT02028676|18878091|P1|NOT COMPLETED|Initial Enrolment: Induction ART||0
7665917|NCT02028676|18878083|P9|COMPLETED|Initial Enrolment: Induction ART||0
7665918|NCT02028676|18878084|P8|COMPLETED|Initial Enrolment: Induction ART||0
7665919|NCT02028676|18878085|P7|COMPLETED|Initial Enrolment: Induction ART||0
7665920|NCT02028676|18878086|P6|COMPLETED|Initial Enrolment: Induction ART||0
7665921|NCT02028676|18878087|P5|COMPLETED|Initial Enrolment: Induction ART||405
7665922|NCT02028676|18878088|P4|COMPLETED|Initial Enrolment: Induction ART||404
7665923|NCT02028676|18878089|P3|COMPLETED|Initial Enrolment: Induction ART||397
7665924|NCT02028676|18878090|P2|COMPLETED|Initial Enrolment: Induction ART||0
7665925|NCT02028676|18878091|P1|COMPLETED|Initial Enrolment: Induction ART||0
7665926|NCT02028676|18878083|P9|STARTED|Initial Enrolment: Induction ART||0
7665927|NCT02028676|18878084|P8|STARTED|Initial Enrolment: Induction ART||0
7665928|NCT02028676|18878085|P7|STARTED|Initial Enrolment: Induction ART||0
7665929|NCT02028676|18878086|P6|STARTED|Initial Enrolment: Induction ART||0
7665930|NCT02028676|18878087|P5|STARTED|Initial Enrolment: Induction ART||405
7665931|NCT02028676|18878088|P4|STARTED|Initial Enrolment: Induction ART||404
7665932|NCT02028676|18878089|P3|STARTED|Initial Enrolment: Induction ART||397
7665933|NCT02028676|18878090|P2|STARTED|Initial Enrolment: Induction ART||0
7665934|NCT02028676|18878091|P1|STARTED|Initial Enrolment: Induction ART||0
7665935|NCT02028676|18878083|P9|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
7665936|NCT02028676|18878084|P8|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
7665937|NCT02028676|18878085|P7|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
7665938|NCT02028676|18878086|P6|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
7665939|NCT02028676|18878087|P5|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
7665940|NCT02028676|18878088|P4|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
7665941|NCT02028676|18878089|P3|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
7665942|NCT02028676|18878090|P2|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
7665943|NCT02028676|18878091|P1|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
7665944|NCT02028676|18878083|P9|COMPLETED|Initial Enrolment: CDM vs LCM||0
7665945|NCT02028676|18878084|P8|COMPLETED|Initial Enrolment: CDM vs LCM||0
7665946|NCT02028676|18878085|P7|COMPLETED|Initial Enrolment: CDM vs LCM||0
7665947|NCT02028676|18878086|P6|COMPLETED|Initial Enrolment: CDM vs LCM||0
7665948|NCT02028676|18878087|P5|COMPLETED|Initial Enrolment: CDM vs LCM||0
7665949|NCT02028676|18878088|P4|COMPLETED|Initial Enrolment: CDM vs LCM||0
7665950|NCT02028676|18878089|P3|COMPLETED|Initial Enrolment: CDM vs LCM||0
7665951|NCT02028676|18878090|P2|COMPLETED|Initial Enrolment: CDM vs LCM||600
7665952|NCT02028676|18878091|P1|COMPLETED|Initial Enrolment: CDM vs LCM||606
7665953|NCT02028676|18878083|P9|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
7665954|NCT02028676|18878084|P8|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
7665955|NCT02028676|18878085|P7|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
7665956|NCT02028676|18878086|P6|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
7665957|NCT02028676|18878087|P5|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
7665958|NCT02028676|18878088|P4|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
7665959|NCT02028676|18878089|P3|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
7665960|NCT02028676|18878090|P2|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600
7665961|NCT02028676|18878091|P1|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606
7665962|NCT02028325|18878264|P1|NOT COMPLETED|Overall Study||10
7665963|NCT02028325|18878264|P1|COMPLETED|Overall Study||126
7665964|NCT02028325|18878264|P1|STARTED|Overall Study||136
7665965|NCT02028208|18878271|P3|NOT COMPLETED|Overall Study||1
7665966|NCT02028208|18878272|P2|NOT COMPLETED|Overall Study||0
7665967|NCT02028208|18878273|P1|NOT COMPLETED|Overall Study||0
7665968|NCT02028208|18878271|P3|COMPLETED|Overall Study||21
7665969|NCT02028208|18878272|P2|COMPLETED|Overall Study||13
7665970|NCT02028208|18878273|P1|COMPLETED|Overall Study||21
7665971|NCT02028208|18878271|P3|STARTED|Overall Study||22
7665972|NCT02028208|18878272|P2|STARTED|Overall Study||13
7665973|NCT02028208|18878273|P1|STARTED|Overall Study||21
7665974|NCT02028182|18878284|P1|NOT COMPLETED|Overall Study||2
7665975|NCT02028182|18878284|P1|COMPLETED|Overall Study||20
7665976|NCT02028182|18878284|P1|STARTED|Overall Study||22
7665977|NCT02028169|18878290|P1|NOT COMPLETED|Overall Study||28
7665978|NCT02028169|18878290|P1|COMPLETED|Overall Study||92
7665979|NCT02028169|18878290|P1|STARTED|Overall Study||120
7665980|NCT02028065|18878316|P3|NOT COMPLETED|Treatment Through Study Completion||14
7665981|NCT02028065|18878317|P2|NOT COMPLETED|Treatment Through Study Completion||15
7665982|NCT02028065|18878318|P1|NOT COMPLETED|Treatment Through Study Completion||12
7665983|NCT02028065|18878316|P3|COMPLETED|Treatment Through Study Completion||134
7665984|NCT02028065|18878317|P2|COMPLETED|Treatment Through Study Completion||136
7665985|NCT02028065|18878318|P1|COMPLETED|Treatment Through Study Completion||64
7665986|NCT02028065|18878316|P3|Received Third Dose|Treatment Through Study Completion||134
7665987|NCT02028065|18878317|P2|Received Third Dose|Treatment Through Study Completion||136
7665988|NCT02028065|18878318|P1|Received Third Dose|Treatment Through Study Completion||64
7665989|NCT02028065|18878316|P3|Received Second Dose|Treatment Through Study Completion||138
7665990|NCT02028065|18878317|P2|Received Second Dose|Treatment Through Study Completion||140
7665991|NCT02028065|18878318|P1|Received Second Dose|Treatment Through Study Completion||69
7665992|NCT02028065|18878316|P3|Received First Dose|Treatment Through Study Completion||148
7665993|NCT02028065|18878317|P2|Received First Dose|Treatment Through Study Completion||151
7665994|NCT02028065|18878318|P1|Received First Dose|Treatment Through Study Completion||76
7665995|NCT02028065|18878316|P3|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148
7665996|NCT02028065|18878317|P2|STARTED|Treatment Through Study Completion||151
7665997|NCT02028065|18878318|P1|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76
7665998|NCT02028065|18878316|P3|NOT COMPLETED|Randomization Through Start Treatment||3
7665999|NCT02028065|18878317|P2|NOT COMPLETED|Randomization Through Start Treatment||3
7666000|NCT02028065|18878318|P1|NOT COMPLETED|Randomization Through Start Treatment||1
7666001|NCT02028065|18878316|P3|COMPLETED|Randomization Through Start Treatment||149
7666002|NCT02028065|18878317|P2|COMPLETED|Randomization Through Start Treatment||151
7666003|NCT02028065|18878318|P1|COMPLETED|Randomization Through Start Treatment||75
7666004|NCT02028065|18878316|P3|STARTED|Randomization Through Start Treatment|Randomized|152
7666005|NCT02028065|18878317|P2|STARTED|Randomization Through Start Treatment|Randomized|154
7666006|NCT02028065|18878318|P1|STARTED|Randomization Through Start Treatment|Randomized|76
7666007|NCT02027883|18878331|P2|NOT COMPLETED|Overall Study||0
7666008|NCT02027883|18878332|P1|NOT COMPLETED|Overall Study||0
7666009|NCT02027883|18878331|P2|COMPLETED|Overall Study||50
7666010|NCT02027883|18878332|P1|COMPLETED|Overall Study||50
7666011|NCT02027883|18878331|P2|STARTED|Overall Study||50
7666012|NCT02027883|18878332|P1|STARTED|Overall Study||50
7666013|NCT02027844|18878345|P3|NOT COMPLETED|Overall Study||2
7666014|NCT02027844|18878346|P2|NOT COMPLETED|Overall Study||6
7666015|NCT02027844|18878347|P1|NOT COMPLETED|Overall Study||5
7666016|NCT02027844|18878345|P3|COMPLETED|Overall Study||37
7666017|NCT02027844|18878346|P2|COMPLETED|Overall Study||33
7666018|NCT02027844|18878347|P1|COMPLETED|Overall Study||34
7666019|NCT02027844|18878345|P3|STARTED|Overall Study||39
7666020|NCT02027844|18878346|P2|STARTED|Overall Study||39
7666021|NCT02027844|18878347|P1|STARTED|Overall Study||39
7666022|NCT02027701|18878364|P1|NOT COMPLETED|Overall Study||16
7666023|NCT02027701|18878364|P1|COMPLETED|Overall Study||66
7666024|NCT02027701|18878364|P1|STARTED|Overall Study||82
7666025|NCT02027623|18878382|P2|NOT COMPLETED|Overall Study||12
7666026|NCT02027623|18878383|P1|NOT COMPLETED|Overall Study||9
7666027|NCT02027623|18878382|P2|COMPLETED|Overall Study||65
7666028|NCT02027623|18878383|P1|COMPLETED|Overall Study||68
7666029|NCT02027623|18878382|P2|STARTED|Overall Study||77
7666030|NCT02027623|18878383|P1|STARTED|Overall Study||77
7666031|NCT02027558|18878479|P2|NOT COMPLETED|Overall Study||2
7666032|NCT02027558|18878480|P1|NOT COMPLETED|Overall Study||9
7666033|NCT02027558|18878479|P2|COMPLETED|Overall Study||61
7666034|NCT02027558|18878480|P1|COMPLETED|Overall Study||53
7666035|NCT02027558|18878479|P2|6-month Follow-up|Overall Study||61
7666036|NCT02027558|18878480|P1|6-month Follow-up|Overall Study||53
7666037|NCT02027558|18878479|P2|3-month Follow-up|Overall Study||58
7666038|NCT02027558|18878480|P1|3-month Follow-up|Overall Study||53
7666039|NCT02027558|18878479|P2|Post-treatment|Overall Study||60
7666040|NCT02027558|18878480|P1|Post-treatment|Overall Study||49
7666041|NCT02027558|18878479|P2|STARTED|Overall Study||63
7666042|NCT02027558|18878480|P1|STARTED|Overall Study||62
7666043|NCT02027545|18878498|P2|NOT COMPLETED|Overall Study||2
7666044|NCT02027545|18878499|P1|NOT COMPLETED|Overall Study||2
7666045|NCT02027545|18878498|P2|COMPLETED|Overall Study||173
7666046|NCT02027545|18878499|P1|COMPLETED|Overall Study||259
7666047|NCT02027545|18878498|P2|STARTED|Overall Study||175
7666048|NCT02027545|18878499|P1|STARTED|Overall Study||261
7666049|NCT02027428|18878511|P3|NOT COMPLETED|Survival Follow-up||46
7666050|NCT02027428|18878512|P2|NOT COMPLETED|Survival Follow-up||79
7666051|NCT02027428|18878513|P1|NOT COMPLETED|Survival Follow-up||0
7666052|NCT02027428|18878511|P3|COMPLETED|Survival Follow-up||9
7666053|NCT02027428|18878512|P2|COMPLETED|Survival Follow-up||38
7666054|NCT02027428|18878513|P1|COMPLETED|Survival Follow-up||0
7666055|NCT02027428|18878511|P3|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|55
7666056|NCT02027428|18878512|P2|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|117
7666057|NCT02027428|18878513|P1|STARTED|Survival Follow-up||0
7666058|NCT02027428|18878511|P3|NOT COMPLETED|Maintenance||60
7666059|NCT02027428|18878512|P2|NOT COMPLETED|Maintenance||124
7666060|NCT02027428|18878513|P1|NOT COMPLETED|Maintenance||0
7666061|NCT02027428|18878511|P3|COMPLETED|Maintenance||6
7666062|NCT02027428|18878512|P2|COMPLETED|Maintenance||12
7666063|NCT02027428|18878513|P1|COMPLETED|Maintenance||0
7666064|NCT02027428|18878511|P3|STARTED|Maintenance||66
7666065|NCT02027428|18878512|P2|STARTED|Maintenance||136
7666066|NCT02027428|18878513|P1|STARTED|Maintenance||0
7666067|NCT02027428|18878511|P3|NOT COMPLETED|Induction||0
7666068|NCT02027428|18878512|P2|NOT COMPLETED|Induction||0
7666069|NCT02027428|18878513|P1|NOT COMPLETED|Induction||225
7666070|NCT02027428|18878511|P3|COMPLETED|Induction||0
7666071|NCT02027428|18878512|P2|COMPLETED|Induction||0
7666072|NCT02027428|18878513|P1|COMPLETED|Induction|If radiologically CR, PR or SD after 4 cycles of treatment, participants continue on to Maintenance.|202
7666073|NCT02027428|18878511|P3|Received Study Drug|Induction||0
7666074|NCT02027428|18878512|P2|Received Study Drug|Induction||0
7666075|NCT02027428|18878513|P1|Received Study Drug|Induction||420
7666076|NCT02027428|18878511|P3|STARTED|Induction||0
7666077|NCT02027428|18878512|P2|STARTED|Induction||0
7666078|NCT02027428|18878513|P1|STARTED|Induction||427
7666079|NCT02027402|18878551|P2|NOT COMPLETED|Overall Study||1
7666080|NCT02027402|18878552|P1|NOT COMPLETED|Overall Study||4
7666081|NCT02027402|18878551|P2|COMPLETED|Overall Study||99
7666082|NCT02027402|18878552|P1|COMPLETED|Overall Study||94
7666083|NCT02027402|18878551|P2|STARTED|Overall Study||100
7666084|NCT02027402|18878552|P1|STARTED|Overall Study||98
7666085|NCT02027376|18878564|P3|NOT COMPLETED|Overall Study||0
7666086|NCT02027376|18878565|P2|NOT COMPLETED|Overall Study||0
7666087|NCT02027376|18878566|P1|NOT COMPLETED|Overall Study||1
7666088|NCT02027376|18878564|P3|COMPLETED|Overall Study||3
7666089|NCT02027376|18878565|P2|COMPLETED|Overall Study||4
7666090|NCT02027376|18878566|P1|COMPLETED|Overall Study||4
7666091|NCT02027376|18878564|P3|STARTED|Overall Study||3
7666092|NCT02027376|18878565|P2|STARTED|Overall Study||4
7666093|NCT02027376|18878566|P1|STARTED|Overall Study||5
7666094|NCT02027311|18878592|P2|NOT COMPLETED|Overall Study||2
7666095|NCT02027311|18878593|P1|NOT COMPLETED|Overall Study||3
7666096|NCT02027311|18878592|P2|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33
7666097|NCT02027311|18878593|P1|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30
7666098|NCT02027311|18878592|P2|STARTED|Overall Study||35
7666099|NCT02027311|18878593|P1|STARTED|Overall Study||33
7666100|NCT02027272|18878603|P2|NOT COMPLETED|Overall Study||1
7666101|NCT02027272|18878604|P1|NOT COMPLETED|Overall Study||0
7666102|NCT02027272|18878603|P2|COMPLETED|Overall Study||0
7666103|NCT02027272|18878604|P1|COMPLETED|Overall Study||0
7666104|NCT02027272|18878603|P2|STARTED|Overall Study||1
7666105|NCT02027272|18878604|P1|STARTED|Overall Study||0
7666106|NCT02027025|18878613|P3|NOT COMPLETED|Overall Study||1
7666107|NCT02027025|18878614|P2|NOT COMPLETED|Overall Study||5
7666108|NCT02027025|18878615|P1|NOT COMPLETED|Overall Study||1
7666109|NCT02027025|18878613|P3|COMPLETED|Overall Study||46
7666110|NCT02027025|18878614|P2|COMPLETED|Overall Study||42
7666111|NCT02027025|18878615|P1|COMPLETED|Overall Study||47
7666112|NCT02027025|18878613|P3|STARTED|Overall Study||47
7666113|NCT02027025|18878614|P2|STARTED|Overall Study||47
7666114|NCT02027025|18878615|P1|STARTED|Overall Study||48
7666115|NCT02026687|18878636|P2|NOT COMPLETED|Overall Study||2
7666116|NCT02026687|18878637|P1|NOT COMPLETED|Overall Study||1
7666117|NCT02026687|18878636|P2|COMPLETED|Overall Study||38
7666118|NCT02026687|18878637|P1|COMPLETED|Overall Study||39
7666119|NCT02026687|18878636|P2|STARTED|Overall Study||40
7666120|NCT02026687|18878637|P1|STARTED|Overall Study||40
7666121|NCT02026453|18878650|P3|NOT COMPLETED|Overall Study||13
7666122|NCT02026453|18878651|P2|NOT COMPLETED|Overall Study||9
7666123|NCT02026453|18878652|P1|NOT COMPLETED|Overall Study||6
7666124|NCT02026453|18878650|P3|COMPLETED|Overall Study||89
7666125|NCT02026453|18878651|P2|COMPLETED|Overall Study||94
7666126|NCT02026453|18878652|P1|COMPLETED|Overall Study||95
7666127|NCT02026453|18878650|P3|STARTED|Overall Study||102
7666128|NCT02026453|18878651|P2|STARTED|Overall Study||103
7666129|NCT02026453|18878652|P1|STARTED|Overall Study||101
7666130|NCT02026297|18878665|P2|NOT COMPLETED|Overall Study||0
7666131|NCT02026297|18878666|P1|NOT COMPLETED|Overall Study||0
7666132|NCT02026297|18878665|P2|COMPLETED|Overall Study||13
7666133|NCT02026297|18878666|P1|COMPLETED|Overall Study||7
7666134|NCT02026297|18878665|P2|STARTED|Overall Study||13
7666135|NCT02026297|18878666|P1|STARTED|Overall Study||7
7666136|NCT02026258|18878678|P2|NOT COMPLETED|Recieved Allocated Intervention||2
7666137|NCT02026258|18878679|P1|NOT COMPLETED|Recieved Allocated Intervention||1
7666138|NCT02026258|18878678|P2|COMPLETED|Recieved Allocated Intervention||17
7666139|NCT02026258|18878679|P1|COMPLETED|Recieved Allocated Intervention||15
7666140|NCT02026258|18878678|P2|STARTED|Recieved Allocated Intervention||19
7666141|NCT02026258|18878679|P1|STARTED|Recieved Allocated Intervention||16
7666142|NCT02026258|18878678|P2|NOT COMPLETED|Randomized||2
7666143|NCT02026258|18878679|P1|NOT COMPLETED|Randomized||4
7666144|NCT02026258|18878678|P2|COMPLETED|Randomized||19
7666145|NCT02026258|18878679|P1|COMPLETED|Randomized||16
7666146|NCT02026258|18878678|P2|STARTED|Randomized||21
7666147|NCT02026258|18878679|P1|STARTED|Randomized||20
7666148|NCT02026206|18878693|P2|NOT COMPLETED|Overall Study||8
7666149|NCT02026206|18878694|P1|NOT COMPLETED|Overall Study||4
7666150|NCT02026206|18878693|P2|COMPLETED|Overall Study||36
7666151|NCT02026206|18878694|P1|COMPLETED|Overall Study||40
7666152|NCT02026206|18878693|P2|STARTED|Overall Study||44
7666153|NCT02026206|18878694|P1|STARTED|Overall Study||44
7666154|NCT02026193|18878704|P2|NOT COMPLETED|Overall Study||0
7666155|NCT02026193|18878705|P1|NOT COMPLETED|Overall Study||0
7666156|NCT02026193|18878704|P2|COMPLETED|Overall Study||8
7666157|NCT02026193|18878705|P1|COMPLETED|Overall Study||3
7666158|NCT02026193|18878704|P2|STARTED|Overall Study||8
7666159|NCT02026193|18878705|P1|STARTED|Overall Study||3
7666160|NCT02026141|18878713|P2|NOT COMPLETED|Overall Study||1
7666161|NCT02026141|18878714|P1|NOT COMPLETED|Overall Study||0
7666162|NCT02026141|18878713|P2|COMPLETED|Overall Study||19
7666163|NCT02026141|18878714|P1|COMPLETED|Overall Study||20
7666164|NCT02026141|18878713|P2|STARTED|Overall Study||20
7666165|NCT02026141|18878714|P1|STARTED|Overall Study||20
7666166|NCT02026063|18878722|P2|NOT COMPLETED|Overall Study||49
7666167|NCT02026063|18878723|P1|NOT COMPLETED|Overall Study||9
7666168|NCT02026063|18878722|P2|COMPLETED|Overall Study||53
7666169|NCT02026063|18878723|P1|COMPLETED|Overall Study||13
7666170|NCT02026063|18878722|P2|STARTED|Overall Study||102
7666171|NCT02026063|18878723|P1|STARTED|Overall Study||22
7666172|NCT02026011|18878735|P2|NOT COMPLETED|Allocation 2 (Second Set of Medication)||2
7666173|NCT02026011|18878736|P1|NOT COMPLETED|Allocation 2 (Second Set of Medication)||1
7666174|NCT02026011|18878735|P2|COMPLETED|Allocation 2 (Second Set of Medication)||35
7666175|NCT02026011|18878736|P1|COMPLETED|Allocation 2 (Second Set of Medication)||37
7666176|NCT02026011|18878735|P2|STARTED|Allocation 2 (Second Set of Medication)||37
7666177|NCT02026011|18878736|P1|STARTED|Allocation 2 (Second Set of Medication)||38
7666178|NCT02026011|18878735|P2|NOT COMPLETED|Allocation 1 (First Set of Medication)||2
7666179|NCT02026011|18878736|P1|NOT COMPLETED|Allocation 1 (First Set of Medication)||8
7666180|NCT02026011|18878735|P2|COMPLETED|Allocation 1 (First Set of Medication)||39
7666181|NCT02026011|18878736|P1|COMPLETED|Allocation 1 (First Set of Medication)||38
7666182|NCT02026011|18878735|P2|STARTED|Allocation 1 (First Set of Medication)||41
7666183|NCT02026011|18878736|P1|STARTED|Allocation 1 (First Set of Medication)||46
7666184|NCT02025907|18878762|P2|NOT COMPLETED|Overall Study||12
7666185|NCT02025907|18878763|P1|NOT COMPLETED|Overall Study||27
7666186|NCT02025907|18878762|P2|COMPLETED|Overall Study||96
7666187|NCT02025907|18878763|P1|COMPLETED|Overall Study||81
7666188|NCT02025907|18878762|P2|STARTED|Overall Study|Participant flow is presented for safety population.|108
7666189|NCT02025907|18878763|P1|STARTED|Overall Study|Participant flow is presented for safety population.|108
7666190|NCT02025829|18878779|P2|NOT COMPLETED|Overall Study||0
7666191|NCT02025829|18878780|P1|NOT COMPLETED|Overall Study||0
7666192|NCT02025829|18878779|P2|COMPLETED|Overall Study||11
7666193|NCT02025829|18878780|P1|COMPLETED|Overall Study||3
7666194|NCT02025829|18878779|P2|STARTED|Overall Study||11
7666195|NCT02025829|18878780|P1|STARTED|Overall Study||3
7666196|NCT02025751|18878791|P2|NOT COMPLETED|Overall Study||3
7666197|NCT02025751|18878792|P1|NOT COMPLETED|Overall Study||1
7666198|NCT02025751|18878791|P2|COMPLETED|Overall Study||24
7666199|NCT02025751|18878792|P1|COMPLETED|Overall Study||25
7666200|NCT02025751|18878791|P2|STARTED|Overall Study||27
7666201|NCT02025751|18878792|P1|STARTED|Overall Study||26
7666202|NCT02025725|18878800|P2|NOT COMPLETED|Overall Study||4
7666203|NCT02025725|18878801|P1|NOT COMPLETED|Overall Study||11
7666204|NCT02025725|18878800|P2|COMPLETED|Overall Study||99
7666205|NCT02025725|18878801|P1|COMPLETED|Overall Study||91
7666206|NCT02025725|18878800|P2|STARTED|Overall Study||103
7666207|NCT02025725|18878801|P1|STARTED|Overall Study||102
7666208|NCT02025647|18878809|P1|NOT COMPLETED|Overall Study||0
7666209|NCT02025647|18878809|P1|COMPLETED|Overall Study||139
7666210|NCT02025647|18878809|P1|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS
~36 lost to follow up"|76
7666211|NCT02025647|18878809|P1|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues
~3 administered wrong session"|117
7666212|NCT02025647|18878809|P1|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS
~15 technology issues or administered wrong session"|97
7666213|NCT02025647|18878809|P1|Session 1 (Narrative Module)|Overall Study||139
7666214|NCT02025647|18878809|P1|STARTED|Overall Study||139
7666215|NCT02025634|18878840|P2|NOT COMPLETED|Overall Study||0
7666216|NCT02025634|18878841|P1|NOT COMPLETED|Overall Study||0
7666217|NCT02025634|18878840|P2|COMPLETED|Overall Study||54
7666218|NCT02025634|18878841|P1|COMPLETED|Overall Study||65
7666219|NCT02025634|18878840|P2|STARTED|Overall Study||54
7666220|NCT02025634|18878841|P1|STARTED|Overall Study||65
7666221|NCT02025621|18878853|P2|NOT COMPLETED|Overall Study||19
7666222|NCT02025621|18878854|P1|NOT COMPLETED|Overall Study||14
7666223|NCT02025621|18878853|P2|COMPLETED|Overall Study||421
7666224|NCT02025621|18878854|P1|COMPLETED|Overall Study||428
7666225|NCT02025621|18878853|P2|STARTED|Overall Study||440
7666226|NCT02025621|18878854|P1|STARTED|Overall Study||442
7666227|NCT02025530|18878874|P2|NOT COMPLETED|Overall Study||1
7666228|NCT02025530|18878875|P1|NOT COMPLETED|Overall Study||5
7666229|NCT02025530|18878874|P2|COMPLETED|Overall Study||733
7666230|NCT02025530|18878875|P1|COMPLETED|Overall Study||291
7666231|NCT02025530|18878874|P2|STARTED|Overall Study||734
7666232|NCT02025530|18878875|P1|STARTED|Overall Study||296
7666233|NCT02025439|18878887|P2|NOT COMPLETED|Overall Study||0
7666234|NCT02025439|18878888|P1|NOT COMPLETED|Overall Study||0
7666235|NCT02025439|18878887|P2|COMPLETED|Overall Study||2
7666236|NCT02025439|18878888|P1|COMPLETED|Overall Study||2
7666237|NCT02025439|18878887|P2|STARTED|Overall Study||2
7666238|NCT02025439|18878888|P1|STARTED|Overall Study||2
7666239|NCT02025426|18878898|P2|NOT COMPLETED|Overall Study||0
7666240|NCT02025426|18878899|P1|NOT COMPLETED|Overall Study||0
7666241|NCT02025426|18878898|P2|COMPLETED|Overall Study||4
7666242|NCT02025426|18878899|P1|COMPLETED|Overall Study||9
7666243|NCT02025426|18878898|P2|STARTED|Overall Study||4
7666244|NCT02025426|18878899|P1|STARTED|Overall Study||9
7666245|NCT02025205|18878921|P2|NOT COMPLETED|Overall Study||3
7666246|NCT02025205|18878922|P1|NOT COMPLETED|Overall Study||3
7666247|NCT02025205|18878921|P2|COMPLETED|Overall Study||47
7666248|NCT02025205|18878922|P1|COMPLETED|Overall Study||40
7666249|NCT02025205|18878921|P2|STARTED|Overall Study||50
7666250|NCT02025205|18878922|P1|STARTED|Overall Study||43
7666251|NCT02025179|18878966|P3|NOT COMPLETED|Overall Study||1
7666252|NCT02025179|18878967|P2|NOT COMPLETED|Overall Study||0
7666253|NCT02025179|18878968|P1|NOT COMPLETED|Overall Study||0
7666254|NCT02025179|18878966|P3|COMPLETED|Overall Study||7
7666255|NCT02025179|18878967|P2|COMPLETED|Overall Study||9
7666256|NCT02025179|18878968|P1|COMPLETED|Overall Study||8
7666257|NCT02025179|18878966|P3|STARTED|Overall Study||8
7666258|NCT02025179|18878967|P2|STARTED|Overall Study||9
7666259|NCT02025179|18878968|P1|STARTED|Overall Study||8
7666260|NCT02025075|18878993|P2|NOT COMPLETED|Overall Study||2
7666261|NCT02025075|18878994|P1|NOT COMPLETED|Overall Study||0
7666262|NCT02025075|18878993|P2|COMPLETED|Overall Study||19
7666263|NCT02025075|18878994|P1|COMPLETED|Overall Study||16
7666264|NCT02025075|18878993|P2|STARTED|Overall Study||21
7666265|NCT02025075|18878994|P1|STARTED|Overall Study||16
7666266|NCT02024971|18879018|P1|NOT COMPLETED|Overall Study||36
7666267|NCT02024971|18879018|P1|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067
7666268|NCT02024971|18879018|P1|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067
7666269|NCT02024971|18879018|P1|STARTED|Overall Study||1103
7666270|NCT02024932|18879031|P6|NOT COMPLETED|Overall Study||0
7666271|NCT02024932|18879032|P5|NOT COMPLETED|Overall Study||2
7666272|NCT02024932|18879033|P4|NOT COMPLETED|Overall Study||2
7666273|NCT02024932|18879034|P3|NOT COMPLETED|Overall Study||0
7666274|NCT02024932|18879035|P2|NOT COMPLETED|Overall Study||3
7666275|NCT02024932|18879036|P1|NOT COMPLETED|Overall Study||2
7666276|NCT02024932|18879031|P6|COMPLETED|Overall Study||9
7666277|NCT02024932|18879032|P5|COMPLETED|Overall Study||16
7666278|NCT02024932|18879033|P4|COMPLETED|Overall Study||0
7666279|NCT02024932|18879034|P3|COMPLETED|Overall Study||2
7666280|NCT02024932|18879035|P2|COMPLETED|Overall Study||1
7666281|NCT02024932|18879036|P1|COMPLETED|Overall Study||0
7666282|NCT02024932|18879031|P6|Pharmacodynamic (PD) Analysis Set|Overall Study||9
7666283|NCT02024932|18879032|P5|Pharmacodynamic (PD) Analysis Set|Overall Study||18
7666284|NCT02024932|18879033|P4|Pharmacodynamic (PD) Analysis Set|Overall Study||2
7666285|NCT02024932|18879034|P3|Pharmacodynamic (PD) Analysis Set|Overall Study||2
7666286|NCT02024932|18879035|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||4
7666287|NCT02024932|18879036|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||2
7666288|NCT02024932|18879031|P6|Pharmacokinetic (PK) Analysis Set|Overall Study||0
7666289|NCT02024932|18879032|P5|Pharmacokinetic (PK) Analysis Set|Overall Study||18
7666290|NCT02024932|18879033|P4|Pharmacokinetic (PK) Analysis Set|Overall Study||2
7666291|NCT02024932|18879034|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
7666292|NCT02024932|18879035|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||4
7666293|NCT02024932|18879036|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||2
7666294|NCT02024932|18879031|P6|Safety Analysis Set|Overall Study||9
7666295|NCT02024932|18879032|P5|Safety Analysis Set|Overall Study||18
7666296|NCT02024932|18879033|P4|Safety Analysis Set|Overall Study||2
7666297|NCT02024932|18879034|P3|Safety Analysis Set|Overall Study||2
7666298|NCT02024932|18879035|P2|Safety Analysis Set|Overall Study||4
7666299|NCT02024932|18879036|P1|Safety Analysis Set|Overall Study||2
7666300|NCT02024932|18879031|P6|STARTED|Overall Study||9
7666301|NCT02024932|18879032|P5|STARTED|Overall Study||18
7666302|NCT02024932|18879033|P4|STARTED|Overall Study||2
7666303|NCT02024932|18879034|P3|STARTED|Overall Study||2
7666304|NCT02024932|18879035|P2|STARTED|Overall Study||4
7666305|NCT02024932|18879036|P1|STARTED|Overall Study||2
7666306|NCT02024867|18879095|P2|NOT COMPLETED|Overall Study||7
7666307|NCT02024867|18879096|P1|NOT COMPLETED|Overall Study||9
7666308|NCT02024867|18879095|P2|COMPLETED|Overall Study||124
7666309|NCT02024867|18879096|P1|COMPLETED|Overall Study||125
7666310|NCT02024867|18879095|P2|STARTED|Overall Study||131
7666311|NCT02024867|18879096|P1|STARTED|Overall Study||134
7666312|NCT02024750|18879114|P2|NOT COMPLETED|Overall Study||1
7666313|NCT02024750|18879115|P1|NOT COMPLETED|Overall Study||2
7666314|NCT02024750|18879114|P2|COMPLETED|Overall Study||107
7666315|NCT02024750|18879115|P1|COMPLETED|Overall Study||104
7666316|NCT02024750|18879114|P2|STARTED|Overall Study||108
7666317|NCT02024750|18879115|P1|STARTED|Overall Study||106
7666318|NCT02024724|18879129|P2|NOT COMPLETED|Overall Study||0
7666319|NCT02024724|18879130|P1|NOT COMPLETED|Overall Study||1
7666320|NCT02024724|18879129|P2|COMPLETED|Overall Study||30
7666321|NCT02024724|18879130|P1|COMPLETED|Overall Study||29
7666322|NCT02024724|18879129|P2|STARTED|Overall Study||30
7666323|NCT02024724|18879130|P1|STARTED|Overall Study||30
7666324|NCT02024711|18879138|P2|NOT COMPLETED|Overall Study||4
7666325|NCT02024711|18879139|P1|NOT COMPLETED|Overall Study||1
7666326|NCT02024711|18879138|P2|COMPLETED|Overall Study||128
7666327|NCT02024711|18879139|P1|COMPLETED|Overall Study||129
7666328|NCT02024711|18879138|P2|STARTED|Overall Study||132
7666329|NCT02024711|18879139|P1|STARTED|Overall Study||130
7666330|NCT02024698|18879151|P2|NOT COMPLETED|Second Intervention (7 Days)||0
7666331|NCT02024698|18879152|P1|NOT COMPLETED|Second Intervention (7 Days)||0
7666332|NCT02024698|18879151|P2|COMPLETED|Second Intervention (7 Days)||26
7666333|NCT02024698|18879152|P1|COMPLETED|Second Intervention (7 Days)||16
7666334|NCT02024698|18879151|P2|Received Etafilcon A Twice|Second Intervention (7 Days)||0
7666335|NCT02024698|18879152|P1|Received Etafilcon A Twice|Second Intervention (7 Days)||1
7666336|NCT02024698|18879151|P2|STARTED|Second Intervention (7 Days)||26
7666337|NCT02024698|18879152|P1|STARTED|Second Intervention (7 Days)||16
7666338|NCT02024698|18879151|P2|NOT COMPLETED|First Intervention (7 Days)||1
7666339|NCT02024698|18879152|P1|NOT COMPLETED|First Intervention (7 Days)||0
7666340|NCT02024698|18879151|P2|COMPLETED|First Intervention (7 Days)||26
7666341|NCT02024698|18879152|P1|COMPLETED|First Intervention (7 Days)||16
7666342|NCT02024698|18879151|P2|STARTED|First Intervention (7 Days)||27
7666343|NCT02024698|18879152|P1|STARTED|First Intervention (7 Days)||16
7666344|NCT02024646|18879181|P3|NOT COMPLETED|Overall Study||28
7666345|NCT02024646|18879182|P2|NOT COMPLETED|Overall Study||25
7666346|NCT02024646|18879183|P1|NOT COMPLETED|Overall Study||32
7666347|NCT02024646|18879181|P3|COMPLETED|Overall Study||133
7666348|NCT02024646|18879182|P2|COMPLETED|Overall Study||135
7666349|NCT02024646|18879183|P1|COMPLETED|Overall Study||131
7666350|NCT02024646|18879181|P3|STARTED|Overall Study||161
7666351|NCT02024646|18879182|P2|STARTED|Overall Study||160
7666352|NCT02024646|18879183|P1|STARTED|Overall Study||163
7666353|NCT02024555|18879193|P2|NOT COMPLETED|Overall Study||2
7666354|NCT02024555|18879194|P1|NOT COMPLETED|Overall Study||6
7666355|NCT02024555|18879193|P2|COMPLETED|Overall Study||46
7666356|NCT02024555|18879194|P1|COMPLETED|Overall Study||43
7666357|NCT02024555|18879193|P2|STARTED|Overall Study||48
7666358|NCT02024555|18879194|P1|STARTED|Overall Study||49
7666359|NCT02024477|18879224|P2|NOT COMPLETED|Overall Study||0
7666360|NCT02024477|18879225|P1|NOT COMPLETED|Overall Study||0
7666361|NCT02024477|18879224|P2|COMPLETED|Overall Study||21
7666362|NCT02024477|18879225|P1|COMPLETED|Overall Study||21
7666363|NCT02024477|18879224|P2|STARTED|Overall Study||21
7666364|NCT02024477|18879225|P1|STARTED|Overall Study||21
7666365|NCT02024386|18879246|P3|NOT COMPLETED|Overall Study||0
7666366|NCT02024386|18879247|P2|NOT COMPLETED|Overall Study||0
7666367|NCT02024386|18879248|P1|NOT COMPLETED|Overall Study||0
7666368|NCT02024386|18879246|P3|COMPLETED|Overall Study||5
7666369|NCT02024386|18879247|P2|COMPLETED|Overall Study||11
7666370|NCT02024386|18879248|P1|COMPLETED|Overall Study||6
7666371|NCT02024386|18879246|P3|STARTED|Overall Study||5
7666372|NCT02024386|18879247|P2|STARTED|Overall Study||11
7666373|NCT02024386|18879248|P1|STARTED|Overall Study||6
7666374|NCT02024165|18879271|P1|NOT COMPLETED|Overall Study||0
7666375|NCT02024165|18879271|P1|COMPLETED|Overall Study||71
7666376|NCT02024165|18879271|P1|STARTED|Overall Study||71
7666377|NCT02024087|18879278|P2|NOT COMPLETED|Overall Study||0
7666378|NCT02024087|18879279|P1|NOT COMPLETED|Overall Study||0
7666379|NCT02024087|18879278|P2|COMPLETED|Overall Study||16
7666380|NCT02024087|18879279|P1|COMPLETED|Overall Study||5
7666381|NCT02024087|18879278|P2|STARTED|Overall Study|Dose change to 0.4 mg/kg and cohort expanded to 16 participants in total at this dose level|16
7666382|NCT02024087|18879279|P1|STARTED|Overall Study||5
7666383|NCT02023983|18879293|P2|NOT COMPLETED|Overall Study||0
7666384|NCT02023983|18879294|P1|NOT COMPLETED|Overall Study||0
7666385|NCT02023983|18879293|P2|COMPLETED|Overall Study||75
7666386|NCT02023983|18879294|P1|COMPLETED|Overall Study||76
7666387|NCT02023983|18879293|P2|STARTED|Overall Study||75
7666388|NCT02023983|18879294|P1|STARTED|Overall Study||76
7666389|NCT02023944|18879304|P2|NOT COMPLETED|Overall Study||1
7666390|NCT02023944|18879305|P1|NOT COMPLETED|Overall Study||0
7666391|NCT02023944|18879304|P2|COMPLETED|Overall Study||24
7666392|NCT02023944|18879305|P1|COMPLETED|Overall Study||25
7666393|NCT02023944|18879304|P2|STARTED|Overall Study||25
7666394|NCT02023944|18879305|P1|STARTED|Overall Study||25
7666395|NCT02023918|18879313|P1|NOT COMPLETED|Overall Study||0
7666396|NCT02023918|18879313|P1|COMPLETED|Overall Study||6
7666397|NCT02023918|18879313|P1|STARTED|Overall Study||6
7666398|NCT02023879|18879321|P3|NOT COMPLETED|Extension Open Label Treatment||5
7666399|NCT02023879|18879322|P2|NOT COMPLETED|Extension Open Label Treatment||17
7666400|NCT02023879|18879323|P1|NOT COMPLETED|Extension Open Label Treatment||5
7666401|NCT02023879|18879321|P3|COMPLETED|Extension Open Label Treatment||43
7666402|NCT02023879|18879322|P2|COMPLETED|Extension Open Label Treatment||89
7666403|NCT02023879|18879323|P1|COMPLETED|Extension Open Label Treatment||46
7666404|NCT02023879|18879321|P3|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|48
7666405|NCT02023879|18879322|P2|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|106
7666406|NCT02023879|18879323|P1|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|51
7666407|NCT02023879|18879321|P3|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
7666408|NCT02023879|18879322|P2|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
7666409|NCT02023879|18879323|P1|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||4
7666410|NCT02023879|18879321|P3|COMPLETED|Period 1: 24-Week Double-blind Treatment||50
7666411|NCT02023879|18879322|P2|COMPLETED|Period 1: 24-Week Double-blind Treatment||107
7666412|NCT02023879|18879323|P1|COMPLETED|Period 1: 24-Week Double-blind Treatment||54
7666413|NCT02023879|18879321|P3|Treated|Period 1: 24-Week Double-blind Treatment||58
7666414|NCT02023879|18879322|P2|Treated|Period 1: 24-Week Double-blind Treatment||115
7666415|NCT02023879|18879323|P1|Treated|Period 1: 24-Week Double-blind Treatment||58
7666416|NCT02023879|18879321|P3|STARTED|Period 1: 24-Week Double-blind Treatment||59
7666417|NCT02023879|18879322|P2|STARTED|Period 1: 24-Week Double-blind Treatment||116
7666418|NCT02023879|18879323|P1|STARTED|Period 1: 24-Week Double-blind Treatment||58
7666419|NCT02023866|18879412|P1|NOT COMPLETED|Overall Study||6
7666420|NCT02023866|18879412|P1|COMPLETED|Overall Study||30
7666421|NCT02023866|18879412|P1|STARTED|Overall Study||36
7666422|NCT02023801|18879425|P1|NOT COMPLETED|Overall Study||0
7666423|NCT02023801|18879425|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|24
7666424|NCT02023801|18879425|P1|Treated|Overall Study|Treatment Completed|24
7666425|NCT02023801|18879425|P1|STARTED|Overall Study|Treatment Attempted|24
7666426|NCT02023697|18879434|P3|NOT COMPLETED|Long-term Follow-up Period||17
7666427|NCT02023697|18879435|P2|NOT COMPLETED|Long-term Follow-up Period||21
7666428|NCT02023697|18879436|P1|NOT COMPLETED|Long-term Follow-up Period||28
7666429|NCT02023697|18879434|P3|COMPLETED|Long-term Follow-up Period||0
7666430|NCT02023697|18879435|P2|COMPLETED|Long-term Follow-up Period||0
7666431|NCT02023697|18879436|P1|COMPLETED|Long-term Follow-up Period||0
7666432|NCT02023697|18879434|P3|STARTED|Long-term Follow-up Period||17
7666433|NCT02023697|18879435|P2|STARTED|Long-term Follow-up Period||21
7666434|NCT02023697|18879436|P1|STARTED|Long-term Follow-up Period||28
7666435|NCT02023697|18879434|P3|NOT COMPLETED|Active Follow-up Period||99
7666436|NCT02023697|18879435|P2|NOT COMPLETED|Active Follow-up Period||99
7666437|NCT02023697|18879436|P1|NOT COMPLETED|Active Follow-up Period||92
7666438|NCT02023697|18879434|P3|COMPLETED|Active Follow-up Period||17
7666439|NCT02023697|18879435|P2|COMPLETED|Active Follow-up Period||21
7666440|NCT02023697|18879436|P1|COMPLETED|Active Follow-up Period||28
7666441|NCT02023697|18879434|P3|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|116
7666442|NCT02023697|18879435|P2|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
7666443|NCT02023697|18879436|P1|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
7666444|NCT02023697|18879434|P3|NOT COMPLETED|Treatment Period||102
7666445|NCT02023697|18879435|P2|NOT COMPLETED|Treatment Period||63
7666446|NCT02023697|18879436|P1|NOT COMPLETED|Treatment Period||46
7666447|NCT02023697|18879434|P3|COMPLETED|Treatment Period||29
7666448|NCT02023697|18879435|P2|COMPLETED|Treatment Period||67
7666449|NCT02023697|18879436|P1|COMPLETED|Treatment Period||84
7666450|NCT02023697|18879434|P3|Received Treatment|Treatment Period||121
7666451|NCT02023697|18879435|P2|Received Treatment|Treatment Period||124
7666452|NCT02023697|18879436|P1|Received Treatment|Treatment Period||125
7666453|NCT02023697|18879434|P3|STARTED|Treatment Period||131
7666454|NCT02023697|18879435|P2|STARTED|Treatment Period||130
7666455|NCT02023697|18879436|P1|STARTED|Treatment Period||130
7666456|NCT02023515|18879538|P2|NOT COMPLETED|Overall Study||3
7666457|NCT02023515|18879539|P1|NOT COMPLETED|Overall Study||1
7666458|NCT02023515|18879538|P2|COMPLETED|Overall Study||22
7666459|NCT02023515|18879539|P1|COMPLETED|Overall Study||23
7666460|NCT02023515|18879538|P2|STARTED|Overall Study||25
7666461|NCT02023515|18879539|P1|STARTED|Overall Study||24
7666462|NCT02023411|18879549|P2|NOT COMPLETED|Overall Study||0
7666463|NCT02023411|18879550|P1|NOT COMPLETED|Overall Study||0
7666464|NCT02023411|18879549|P2|COMPLETED|Overall Study||10
7666465|NCT02023411|18879550|P1|COMPLETED|Overall Study||10
7666466|NCT02023411|18879549|P2|STARTED|Overall Study||10
7666467|NCT02023411|18879550|P1|STARTED|Overall Study||10
7666468|NCT02023268|18879560|P2|NOT COMPLETED|Overall Study||4
7666469|NCT02023268|18879561|P1|NOT COMPLETED|Overall Study||0
7666470|NCT02023268|18879560|P2|COMPLETED|Overall Study||49
7666471|NCT02023268|18879561|P1|COMPLETED|Overall Study||52
7666472|NCT02023268|18879560|P2|STARTED|Overall Study||53
7666473|NCT02023268|18879561|P1|STARTED|Overall Study||52
7666474|NCT02023242|18879569|P2|NOT COMPLETED|Overall Study||2
7666475|NCT02023242|18879570|P1|NOT COMPLETED|Overall Study||3
7666476|NCT02023242|18879569|P2|COMPLETED|Overall Study||75
7666477|NCT02023242|18879570|P1|COMPLETED|Overall Study||72
7666478|NCT02023242|18879569|P2|STARTED|Overall Study||77
7666479|NCT02023242|18879570|P1|STARTED|Overall Study||75
7666480|NCT02023151|18879584|P1|NOT COMPLETED|Overall Study||4
7666481|NCT02023151|18879584|P1|COMPLETED|Overall Study||13
7666482|NCT02023151|18879584|P1|STARTED|Overall Study||17
7666483|NCT02023125|18879591|P3|NOT COMPLETED|Period 2||0
7666484|NCT02023125|18879592|P2|NOT COMPLETED|Period 2||0
7666485|NCT02023125|18879593|P1|NOT COMPLETED|Period 2||0
7666486|NCT02023125|18879591|P3|COMPLETED|Period 2||24
7666487|NCT02023125|18879592|P2|COMPLETED|Period 2||9
7666488|NCT02023125|18879593|P1|COMPLETED|Period 2||9
7666489|NCT02023125|18879591|P3|STARTED|Period 2||24
7666490|NCT02023125|18879592|P2|STARTED|Period 2||9
7666491|NCT02023125|18879593|P1|STARTED|Period 2||9
7666492|NCT02023125|18879591|P3|NOT COMPLETED|Washout Period||0
7666493|NCT02023125|18879592|P2|NOT COMPLETED|Washout Period||0
7666494|NCT02023125|18879593|P1|NOT COMPLETED|Washout Period||0
7666495|NCT02023125|18879591|P3|COMPLETED|Washout Period||24
7666496|NCT02023125|18879592|P2|COMPLETED|Washout Period||9
7666497|NCT02023125|18879593|P1|COMPLETED|Washout Period||9
7666498|NCT02023125|18879591|P3|STARTED|Washout Period||24
7666499|NCT02023125|18879592|P2|STARTED|Washout Period||9
7666500|NCT02023125|18879593|P1|STARTED|Washout Period||9
7666501|NCT02023125|18879591|P3|NOT COMPLETED|Period 1||0
7666502|NCT02023125|18879592|P2|NOT COMPLETED|Period 1||0
7666503|NCT02023125|18879593|P1|NOT COMPLETED|Period 1||0
7666504|NCT02023125|18879591|P3|COMPLETED|Period 1||24
7666505|NCT02023125|18879592|P2|COMPLETED|Period 1||9
7666506|NCT02023125|18879593|P1|COMPLETED|Period 1||9
7666507|NCT02023125|18879591|P3|STARTED|Period 1||24
7666508|NCT02023125|18879592|P2|STARTED|Period 1||9
7666509|NCT02023125|18879593|P1|STARTED|Period 1||9
7666510|NCT02023112|18879654|P2|NOT COMPLETED|Overall Study||1
7666511|NCT02023112|18879655|P1|NOT COMPLETED|Overall Study||2
7666512|NCT02023112|18879654|P2|COMPLETED|Overall Study||85
7666513|NCT02023112|18879655|P1|COMPLETED|Overall Study||83
7666514|NCT02023112|18879654|P2|STARTED|Overall Study||86
7666515|NCT02023112|18879655|P1|STARTED|Overall Study||85
7666516|NCT02023099|18879676|P3|NOT COMPLETED|Overall Study||3
7666517|NCT02023099|18879677|P2|NOT COMPLETED|Overall Study||0
7666518|NCT02023099|18879678|P1|NOT COMPLETED|Overall Study||3
7666519|NCT02023099|18879676|P3|COMPLETED|Overall Study||39
7666520|NCT02023099|18879677|P2|COMPLETED|Overall Study||106
7666521|NCT02023099|18879678|P1|COMPLETED|Overall Study||212
7666522|NCT02023099|18879676|P3|STARTED|Overall Study||42
7666523|NCT02023099|18879677|P2|STARTED|Overall Study||106
7666524|NCT02023099|18879678|P1|STARTED|Overall Study||215
7666525|NCT02022826|18879694|P1|NOT COMPLETED|Overall Study||28
7666526|NCT02022826|18879694|P1|COMPLETED|Overall Study||139
7666527|NCT02022826|18879694|P1|STARTED|Overall Study||167
7666528|NCT02022748|18879701|P3|NOT COMPLETED|Overall Study||0
7666529|NCT02022748|18879702|P2|NOT COMPLETED|Overall Study||2
7666530|NCT02022748|18879703|P1|NOT COMPLETED|Overall Study||1
7666531|NCT02022748|18879701|P3|COMPLETED|Overall Study||13
7666532|NCT02022748|18879702|P2|COMPLETED|Overall Study||4
7666533|NCT02022748|18879703|P1|COMPLETED|Overall Study||7
7666534|NCT02022748|18879701|P3|Subjects Who Completed Treatment|Overall Study||13
7666535|NCT02022748|18879702|P2|Subjects Who Completed Treatment|Overall Study||4
7666536|NCT02022748|18879703|P1|Subjects Who Completed Treatment|Overall Study||7
7666537|NCT02022748|18879701|P3|Subject Who Started Treatment|Overall Study||13
7666538|NCT02022748|18879702|P2|Subject Who Started Treatment|Overall Study||6
7666539|NCT02022748|18879703|P1|Subject Who Started Treatment|Overall Study||8
7666540|NCT02022748|18879701|P3|STARTED|Overall Study||13
7666541|NCT02022748|18879702|P2|STARTED|Overall Study||6
7666542|NCT02022748|18879703|P1|STARTED|Overall Study||8
7666543|NCT02022670|18879729|P3|NOT COMPLETED|Overall Study||1
7666544|NCT02022670|18879730|P2|NOT COMPLETED|Overall Study||0
7666545|NCT02022670|18879731|P1|NOT COMPLETED|Overall Study||1
7666546|NCT02022670|18879729|P3|COMPLETED|Overall Study||11
7666547|NCT02022670|18879730|P2|COMPLETED|Overall Study||10
7666548|NCT02022670|18879731|P1|COMPLETED|Overall Study||10
7666549|NCT02022670|18879729|P3|STARTED|Overall Study||12
7666550|NCT02022670|18879730|P2|STARTED|Overall Study||10
7666551|NCT02022670|18879731|P1|STARTED|Overall Study||11
7666552|NCT02022657|18879745|P6|NOT COMPLETED|Overall Study||1
7666553|NCT02022657|18879746|P5|NOT COMPLETED|Overall Study||0
7666554|NCT02022657|18879747|P4|NOT COMPLETED|Overall Study||0
7666555|NCT02022657|18879748|P3|NOT COMPLETED|Overall Study||1
7666556|NCT02022657|18879749|P2|NOT COMPLETED|Overall Study||0
7666557|NCT02022657|18879750|P1|NOT COMPLETED|Overall Study||2
7666558|NCT02022657|18879745|P6|COMPLETED|Overall Study||8
7666559|NCT02022657|18879746|P5|COMPLETED|Overall Study||8
7666560|NCT02022657|18879747|P4|COMPLETED|Overall Study||8
7666561|NCT02022657|18879748|P3|COMPLETED|Overall Study||8
7666562|NCT02022657|18879749|P2|COMPLETED|Overall Study||8
7666563|NCT02022657|18879750|P1|COMPLETED|Overall Study||8
7666564|NCT02022657|18879745|P6|STARTED|Overall Study||9
7666565|NCT02022657|18879746|P5|STARTED|Overall Study||8
7666566|NCT02022657|18879747|P4|STARTED|Overall Study||8
7666567|NCT02022657|18879748|P3|STARTED|Overall Study||9
7666568|NCT02022657|18879749|P2|STARTED|Overall Study||8
7666569|NCT02022657|18879750|P1|STARTED|Overall Study||10
7666570|NCT02022111|18879758|P2|NOT COMPLETED|Overall Study||15
7666571|NCT02022111|18879759|P1|NOT COMPLETED|Overall Study||10
7666572|NCT02022111|18879758|P2|COMPLETED|Overall Study||193
7666573|NCT02022111|18879759|P1|COMPLETED|Overall Study||186
7666574|NCT02022111|18879758|P2|STARTED|Overall Study||208
7666575|NCT02022111|18879759|P1|STARTED|Overall Study||196
7666576|NCT02022085|18879765|P1|NOT COMPLETED|Overall Study||1
7666577|NCT02022085|18879765|P1|COMPLETED|Overall Study||53
7666578|NCT02022085|18879765|P1|STARTED|Overall Study||54
7666579|NCT02022020|18879791|P1|NOT COMPLETED|Overall Study||0
7666580|NCT02022020|18879791|P1|COMPLETED|Overall Study||220
7666581|NCT02022020|18879791|P1|STARTED|Overall Study||220
7666582|NCT02022007|18879800|P3|NOT COMPLETED|Overall Study||2
7666583|NCT02022007|18879801|P2|NOT COMPLETED|Overall Study||1
7666584|NCT02022007|18879802|P1|NOT COMPLETED|Overall Study||1
7666585|NCT02022007|18879800|P3|COMPLETED|Overall Study||11
7666586|NCT02022007|18879801|P2|COMPLETED|Overall Study||11
7666587|NCT02022007|18879802|P1|COMPLETED|Overall Study||12
7666588|NCT02022007|18879800|P3|STARTED|Overall Study||13
7666589|NCT02022007|18879801|P2|STARTED|Overall Study||12
7666590|NCT02022007|18879802|P1|STARTED|Overall Study||13
7666591|NCT02021942|18879843|P1|NOT COMPLETED|Overall Study||0
7666592|NCT02021942|18879843|P1|COMPLETED|Overall Study||16
7666593|NCT02021942|18879843|P1|STARTED|Overall Study||16
7666594|NCT02021929|18879855|P2|NOT COMPLETED|Overall Study||1
7666595|NCT02021929|18879856|P1|NOT COMPLETED|Overall Study||2
7666596|NCT02021929|18879855|P2|COMPLETED|Overall Study||11
7666597|NCT02021929|18879856|P1|COMPLETED|Overall Study||14
7666598|NCT02021929|18879855|P2|STARTED|Overall Study||12
7666599|NCT02021929|18879856|P1|STARTED|Overall Study||16
7666600|NCT02021812|18879866|P1|NOT COMPLETED|Overall Study||21
7666601|NCT02021812|18879866|P1|COMPLETED|Overall Study||10
7666602|NCT02021812|18879866|P1|STARTED|Overall Study||31
7666603|NCT02021669|18879876|P2|NOT COMPLETED|Overall Study||3
7666604|NCT02021669|18879877|P1|NOT COMPLETED|Overall Study||7
7666605|NCT02021669|18879876|P2|COMPLETED|Overall Study||70
7666606|NCT02021669|18879877|P1|COMPLETED|Overall Study||64
7666607|NCT02021669|18879876|P2|STARTED|Overall Study||73
7666608|NCT02021669|18879877|P1|STARTED|Overall Study||71
7666609|NCT02021656|18879885|P1|NOT COMPLETED|Overall Study||6
7666610|NCT02021656|18879885|P1|COMPLETED|Overall Study||378
7666611|NCT02021656|18879885|P1|STARTED|Overall Study||384
7666612|NCT02021643|18879905|P4|NOT COMPLETED|Overall Study||12
7666613|NCT02021643|18879906|P3|NOT COMPLETED|Overall Study||0
7666614|NCT02021643|18879907|P2|NOT COMPLETED|Overall Study||10
7666615|NCT02021643|18879908|P1|NOT COMPLETED|Overall Study||9
7666616|NCT02021643|18879905|P4|COMPLETED|Overall Study||218
7666617|NCT02021643|18879906|P3|COMPLETED|Overall Study||11
7666618|NCT02021643|18879907|P2|COMPLETED|Overall Study||280
7666619|NCT02021643|18879908|P1|COMPLETED|Overall Study||147
7666620|NCT02021643|18879905|P4|STARTED|Overall Study||230
7666621|NCT02021643|18879906|P3|STARTED|Overall Study||11
7666622|NCT02021643|18879907|P2|STARTED|Overall Study||290
7666623|NCT02021643|18879908|P1|STARTED|Overall Study||156
7666624|NCT02021565|18879950|P2|NOT COMPLETED|3-month Follow-up||2
7666625|NCT02021565|18879951|P1|NOT COMPLETED|3-month Follow-up||10
7666626|NCT02021565|18879950|P2|COMPLETED|3-month Follow-up||34
7666627|NCT02021565|18879951|P1|COMPLETED|3-month Follow-up||50
7666628|NCT02021565|18879950|P2|Care Recipients|3-month Follow-up||18
7666629|NCT02021565|18879951|P1|Care Recipients|3-month Follow-up||30
7666630|NCT02021565|18879950|P2|Caregivers|3-month Follow-up||18
7666631|NCT02021565|18879951|P1|Caregivers|3-month Follow-up||30
7666632|NCT02021565|18879950|P2|STARTED|3-month Follow-up||36
7666633|NCT02021565|18879951|P1|STARTED|3-month Follow-up||60
7666634|NCT02021565|18879950|P2|NOT COMPLETED|Baseline Through Intervention||18
7666635|NCT02021565|18879951|P1|NOT COMPLETED|Baseline Through Intervention||12
7666636|NCT02021565|18879950|P2|COMPLETED|Baseline Through Intervention||36
7666637|NCT02021565|18879951|P1|COMPLETED|Baseline Through Intervention||60
7666638|NCT02021565|18879950|P2|Care Recipients|Baseline Through Intervention||27
7666639|NCT02021565|18879951|P1|Care Recipients|Baseline Through Intervention||36
7666640|NCT02021565|18879950|P2|Caregivers|Baseline Through Intervention||27
7666641|NCT02021565|18879951|P1|Caregivers|Baseline Through Intervention||36
7666642|NCT02021565|18879950|P2|STARTED|Baseline Through Intervention||54
7666643|NCT02021565|18879951|P1|STARTED|Baseline Through Intervention||72
7666644|NCT02021461|18879963|P1|NOT COMPLETED|Overall Study||0
7666645|NCT02021461|18879963|P1|COMPLETED|Overall Study||38
7666646|NCT02021461|18879963|P1|STARTED|Overall Study||38
7666647|NCT02021331|18879971|P2|NOT COMPLETED|Overall Study||2
7666648|NCT02021331|18879972|P1|NOT COMPLETED|Overall Study||0
7666649|NCT02021331|18879971|P2|COMPLETED|Overall Study||1
7666650|NCT02021331|18879972|P1|COMPLETED|Overall Study||2
7666651|NCT02021331|18879971|P2|STARTED|Overall Study||3
7666652|NCT02021331|18879972|P1|STARTED|Overall Study||2
7666653|NCT02021292|18879984|P2|NOT COMPLETED|Overall Study||3
7666654|NCT02021292|18879985|P1|NOT COMPLETED|Overall Study||0
7666655|NCT02021292|18879984|P2|COMPLETED|Overall Study||37
7666656|NCT02021292|18879985|P1|COMPLETED|Overall Study||40
7666657|NCT02021292|18879984|P2|STARTED|Overall Study||40
7666658|NCT02021292|18879985|P1|STARTED|Overall Study||40
7666659|NCT02021071|18880007|P2|NOT COMPLETED|Overall Study||0
7666660|NCT02021071|18880008|P1|NOT COMPLETED|Overall Study||0
7666661|NCT02021071|18880007|P2|COMPLETED|Overall Study||12
7666662|NCT02021071|18880008|P1|COMPLETED|Overall Study||12
7666663|NCT02021071|18880007|P2|STARTED|Overall Study||12
7666664|NCT02021071|18880008|P1|STARTED|Overall Study||12
7666665|NCT02020941|18880015|P1|NOT COMPLETED|Overall Study||8
7666666|NCT02020941|18880015|P1|COMPLETED|Overall Study||2
7666667|NCT02020941|18880015|P1|STARTED|Overall Study||10
7666668|NCT02020889|18880026|P2|NOT COMPLETED|Overall Study||3
7666669|NCT02020889|18880027|P1|NOT COMPLETED|Overall Study||7
7666670|NCT02020889|18880026|P2|COMPLETED|Overall Study||65
7666671|NCT02020889|18880027|P1|COMPLETED|Overall Study||61
7666672|NCT02020889|18880026|P2|STARTED|Overall Study||68
7666673|NCT02020889|18880027|P1|STARTED|Overall Study||68
7666674|NCT02020863|18880081|P1|NOT COMPLETED|Overall Study||5
7666675|NCT02020863|18880081|P1|COMPLETED|Overall Study||35
7666676|NCT02020863|18880081|P1|STARTED|Overall Study||40
7666677|NCT02020837|18880085|P1|NOT COMPLETED|Overall Study||0
7666678|NCT02020837|18880085|P1|COMPLETED|Overall Study||2
7666679|NCT02020837|18880085|P1|STARTED|Overall Study||2
7666680|NCT02020785|18880091|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
7666681|NCT02020785|18880092|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
7666682|NCT02020785|18880091|P2|COMPLETED|Second Intervention (3 Weeks)||16
7666683|NCT02020785|18880092|P1|COMPLETED|Second Intervention (3 Weeks)||15
7666684|NCT02020785|18880091|P2|STARTED|Second Intervention (3 Weeks)||16
7666685|NCT02020785|18880092|P1|STARTED|Second Intervention (3 Weeks)||15
7666686|NCT02020785|18880091|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
7666687|NCT02020785|18880092|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
7666688|NCT02020785|18880091|P2|COMPLETED|First Intervention (3 Weeks)||16
7666689|NCT02020785|18880092|P1|COMPLETED|First Intervention (3 Weeks)||15
7666690|NCT02020785|18880091|P2|STARTED|First Intervention (3 Weeks)||16
7666691|NCT02020785|18880092|P1|STARTED|First Intervention (3 Weeks)||15
7666692|NCT02020616|18880111|P7|NOT COMPLETED|Overall Study||4
7666693|NCT02020616|18880112|P6|NOT COMPLETED|Overall Study||5
7666694|NCT02020616|18880113|P5|NOT COMPLETED|Overall Study||2
7666695|NCT02020616|18880114|P4|NOT COMPLETED|Overall Study||2
7666696|NCT02020616|18880115|P3|NOT COMPLETED|Overall Study||2
7666697|NCT02020616|18880116|P2|NOT COMPLETED|Overall Study||1
7666698|NCT02020616|18880117|P1|NOT COMPLETED|Overall Study||0
7666699|NCT02020616|18880111|P7|COMPLETED|Overall Study||6
7666700|NCT02020616|18880112|P6|COMPLETED|Overall Study||3
7666701|NCT02020616|18880113|P5|COMPLETED|Overall Study||6
7666702|NCT02020616|18880114|P4|COMPLETED|Overall Study||6
7666703|NCT02020616|18880115|P3|COMPLETED|Overall Study||6
7666704|NCT02020616|18880116|P2|COMPLETED|Overall Study||7
7666705|NCT02020616|18880117|P1|COMPLETED|Overall Study||10
7666706|NCT02020616|18880111|P7|Received at Least One Dose of Study Drug|Overall Study||10
7666707|NCT02020616|18880112|P6|Received at Least One Dose of Study Drug|Overall Study||8
7666708|NCT02020616|18880113|P5|Received at Least One Dose of Study Drug|Overall Study||8
7666709|NCT02020616|18880114|P4|Received at Least One Dose of Study Drug|Overall Study||7
7666710|NCT02020616|18880115|P3|Received at Least One Dose of Study Drug|Overall Study||8
7666711|NCT02020616|18880116|P2|Received at Least One Dose of Study Drug|Overall Study||8
7666712|NCT02020616|18880117|P1|Received at Least One Dose of Study Drug|Overall Study||10
7666713|NCT02020616|18880111|P7|STARTED|Overall Study||10
7666714|NCT02020616|18880112|P6|STARTED|Overall Study||8
7666715|NCT02020616|18880113|P5|STARTED|Overall Study||8
7666716|NCT02020616|18880114|P4|STARTED|Overall Study||8
7666717|NCT02020616|18880115|P3|STARTED|Overall Study||8
7666718|NCT02020616|18880116|P2|STARTED|Overall Study||8
7666719|NCT02020616|18880117|P1|STARTED|Overall Study||10
7666720|NCT02020577|18880210|P2|NOT COMPLETED|Overall Study||55
7666721|NCT02020577|18880211|P1|NOT COMPLETED|Overall Study||3
7666722|NCT02020577|18880210|P2|COMPLETED|Overall Study||0
7666723|NCT02020577|18880211|P1|COMPLETED|Overall Study||0
7666724|NCT02020577|18880210|P2|STARTED|Overall Study||55
7666725|NCT02020577|18880211|P1|STARTED|Overall Study||3
7666726|NCT02020512|18880238|P1|NOT COMPLETED|Overall Study||8
7666727|NCT02020512|18880238|P1|COMPLETED|Overall Study||79
7666728|NCT02020512|18880238|P1|STARTED|Overall Study||87
7666729|NCT02020408|18880242|P1|NOT COMPLETED|Overall Study||3
7666730|NCT02020408|18880242|P1|COMPLETED|Overall Study||85
7666731|NCT02020408|18880242|P1|STARTED|Overall Study||88
7666732|NCT02020369|18880254|P2|NOT COMPLETED|Overall Study||2
7666733|NCT02020369|18880255|P1|NOT COMPLETED|Overall Study||3
7666734|NCT02020369|18880254|P2|COMPLETED|Overall Study||11
7666735|NCT02020369|18880255|P1|COMPLETED|Overall Study||11
7666736|NCT02020369|18880254|P2|STARTED|Overall Study||13
7666737|NCT02020369|18880255|P1|STARTED|Overall Study||14
7666738|NCT02020304|18880271|P2|NOT COMPLETED|Overall Study||2
7666739|NCT02020304|18880272|P1|NOT COMPLETED|Overall Study||3
7666740|NCT02020304|18880271|P2|COMPLETED|Overall Study||26
7666741|NCT02020304|18880272|P1|COMPLETED|Overall Study||27
7666742|NCT02020304|18880271|P2|STARTED|Overall Study||28
7666743|NCT02020304|18880272|P1|STARTED|Overall Study||30
7666744|NCT02020278|18880286|P1|NOT COMPLETED|Optional Tolvaptan Treatment Component||0
7666745|NCT02020278|18880286|P1|COMPLETED|Optional Tolvaptan Treatment Component||0
7666746|NCT02020278|18880286|P1|STARTED|Optional Tolvaptan Treatment Component||0
7666747|NCT02020278|18880286|P1|NOT COMPLETED|Core Safety Follow-up Component||0
7666748|NCT02020278|18880286|P1|COMPLETED|Core Safety Follow-up Component||3
7666749|NCT02020278|18880286|P1|STARTED|Core Safety Follow-up Component||3
7666750|NCT02020135|18880305|P1|NOT COMPLETED|Overall Study||9
7666751|NCT02020135|18880305|P1|COMPLETED|Overall Study||0
7666752|NCT02020135|18880305|P1|STARTED|Overall Study||9
7666753|NCT02020031|18880317|P2|NOT COMPLETED|Overall Study||1
7666754|NCT02020031|18880318|P1|NOT COMPLETED|Overall Study||1
7666755|NCT02020031|18880317|P2|COMPLETED|Overall Study||10
7666756|NCT02020031|18880318|P1|COMPLETED|Overall Study||10
7666757|NCT02020031|18880317|P2|STARTED|Overall Study||11
7666758|NCT02020031|18880318|P1|STARTED|Overall Study||11
7666759|NCT02020018|18880328|P2|NOT COMPLETED|Overall Study||0
7666760|NCT02020018|18880329|P1|NOT COMPLETED|Overall Study||0
7666761|NCT02020018|18880328|P2|COMPLETED|Overall Study||1597
7666762|NCT02020018|18880329|P1|COMPLETED|Overall Study||272
7666763|NCT02020018|18880328|P2|STARTED|Overall Study||1597
7666764|NCT02020018|18880329|P1|STARTED|Overall Study||272
7666765|NCT02019979|18880339|P1|NOT COMPLETED|Overall Study||14
7666766|NCT02019979|18880339|P1|COMPLETED|Overall Study||0
7666767|NCT02019979|18880339|P1|STARTED|Overall Study||14
7666768|NCT02019940|18880345|P1|NOT COMPLETED|Overall Study||10
7666769|NCT02019940|18880345|P1|COMPLETED|Overall Study||8
7666770|NCT02019940|18880345|P1|STARTED|Overall Study||18
7666771|NCT02019927|18880355|P6|NOT COMPLETED|Overall Study||1
7666772|NCT02019927|18880356|P5|NOT COMPLETED|Overall Study||3
7666773|NCT02019927|18880357|P4|NOT COMPLETED|Overall Study||2
7666774|NCT02019927|18880358|P3|NOT COMPLETED|Overall Study||1
7666775|NCT02019927|18880359|P2|NOT COMPLETED|Overall Study||4
7666776|NCT02019927|18880360|P1|NOT COMPLETED|Overall Study||2
7666777|NCT02019927|18880355|P6|COMPLETED|Overall Study||3
7666778|NCT02019927|18880356|P5|COMPLETED|Overall Study||7
7666779|NCT02019927|18880357|P4|COMPLETED|Overall Study||3
7666780|NCT02019927|18880358|P3|COMPLETED|Overall Study||8
7666781|NCT02019927|18880359|P2|COMPLETED|Overall Study||19
7666782|NCT02019927|18880360|P1|COMPLETED|Overall Study||44
7666783|NCT02019927|18880355|P6|STARTED|Overall Study||4
7666784|NCT02019927|18880356|P5|STARTED|Overall Study||10
7666785|NCT02019927|18880357|P4|STARTED|Overall Study||5
7666786|NCT02019927|18880358|P3|STARTED|Overall Study||9
7666787|NCT02019927|18880359|P2|STARTED|Overall Study||23
7666788|NCT02019927|18880360|P1|STARTED|Overall Study||46
7666789|NCT02019758|18880430|P2|NOT COMPLETED|Overall Study||9
7666790|NCT02019758|18880431|P1|NOT COMPLETED|Overall Study||9
7666791|NCT02019758|18880430|P2|COMPLETED|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|55
7666792|NCT02019758|18880431|P1|COMPLETED|Overall Study||56
7666793|NCT02019758|18880430|P2|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
7666794|NCT02019758|18880431|P1|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
7666795|NCT02019758|18880430|P2|Did Not Receive Intervention|Overall Study||1
7666796|NCT02019758|18880431|P1|Did Not Receive Intervention|Overall Study||1
7666797|NCT02019758|18880430|P2|Received Intervention|Overall Study||63
7666798|NCT02019758|18880431|P1|Received Intervention|Overall Study||64
7666799|NCT02019758|18880430|P2|STARTED|Overall Study|63 received intervention; 1 did not receive intervention|64
7666800|NCT02019758|18880431|P1|STARTED|Overall Study|64 received intervention; 1 did not receive intervention|65
7666801|NCT02019719|18880460|P5|NOT COMPLETED|Overall Study||2
7666802|NCT02019719|18880461|P4|NOT COMPLETED|Overall Study||2
7666803|NCT02019719|18880462|P3|NOT COMPLETED|Overall Study||0
7666804|NCT02019719|18880463|P2|NOT COMPLETED|Overall Study||1
7666805|NCT02019719|18880464|P1|NOT COMPLETED|Overall Study||6
7666806|NCT02019719|18880460|P5|COMPLETED|Overall Study||18
7666807|NCT02019719|18880461|P4|COMPLETED|Overall Study||17
7666808|NCT02019719|18880462|P3|COMPLETED|Overall Study||20
7666809|NCT02019719|18880463|P2|COMPLETED|Overall Study||18
7666810|NCT02019719|18880464|P1|COMPLETED|Overall Study||13
7666811|NCT02019719|18880460|P5|STARTED|Overall Study||20
7666812|NCT02019719|18880461|P4|STARTED|Overall Study||19
7666813|NCT02019719|18880462|P3|STARTED|Overall Study||20
7666814|NCT02019719|18880463|P2|STARTED|Overall Study||19
7666815|NCT02019719|18880464|P1|STARTED|Overall Study||19
7666816|NCT02019667|18880561|P2|NOT COMPLETED|Washout Period (9 Weeks)||0
7666817|NCT02019667|18880562|P1|NOT COMPLETED|Washout Period (9 Weeks)||0
7666818|NCT02019667|18880561|P2|COMPLETED|Washout Period (9 Weeks)||6
7666819|NCT02019667|18880562|P1|COMPLETED|Washout Period (9 Weeks)||10
7666820|NCT02019667|18880561|P2|STARTED|Washout Period (9 Weeks)||6
7666821|NCT02019667|18880562|P1|STARTED|Washout Period (9 Weeks)||10
7666822|NCT02019667|18880561|P2|NOT COMPLETED|2nd Intervention (6 Months)||2
7666823|NCT02019667|18880562|P1|NOT COMPLETED|2nd Intervention (6 Months)||0
7666824|NCT02019667|18880561|P2|COMPLETED|2nd Intervention (6 Months)||6
7666825|NCT02019667|18880562|P1|COMPLETED|2nd Intervention (6 Months)||10
7666826|NCT02019667|18880561|P2|STARTED|2nd Intervention (6 Months)||8
7666827|NCT02019667|18880562|P1|STARTED|2nd Intervention (6 Months)||10
7666828|NCT02019667|18880561|P2|NOT COMPLETED|Washout Period (9 Weeks)||0
7666829|NCT02019667|18880562|P1|NOT COMPLETED|Washout Period (9 Weeks)||0
7666830|NCT02019667|18880561|P2|COMPLETED|Washout Period (9 Weeks)||8
7666831|NCT02019667|18880562|P1|COMPLETED|Washout Period (9 Weeks)||10
7666832|NCT02019667|18880561|P2|STARTED|Washout Period (9 Weeks)||8
7666833|NCT02019667|18880562|P1|STARTED|Washout Period (9 Weeks)||10
7666834|NCT02019667|18880561|P2|NOT COMPLETED|First Intervention (6 Months)||1
7666835|NCT02019667|18880562|P1|NOT COMPLETED|First Intervention (6 Months)||0
7666836|NCT02019667|18880561|P2|COMPLETED|First Intervention (6 Months)||8
7666837|NCT02019667|18880562|P1|COMPLETED|First Intervention (6 Months)||10
7666838|NCT02019667|18880561|P2|STARTED|First Intervention (6 Months)||9
7666839|NCT02019667|18880562|P1|STARTED|First Intervention (6 Months)||10
7666840|NCT02019602|18880582|P2|NOT COMPLETED|Sampling Period||0
7666841|NCT02019602|18880583|P1|NOT COMPLETED|Sampling Period||0
7666842|NCT02019602|18880582|P2|COMPLETED|Sampling Period||16
7666843|NCT02019602|18880583|P1|COMPLETED|Sampling Period||16
7666844|NCT02019602|18880582|P2|STARTED|Sampling Period||16
7666845|NCT02019602|18880583|P1|STARTED|Sampling Period||16
7666846|NCT02019602|18880582|P2|NOT COMPLETED|Screening Period||0
7666847|NCT02019602|18880583|P1|NOT COMPLETED|Screening Period||5
7666848|NCT02019602|18880582|P2|COMPLETED|Screening Period||16
7666849|NCT02019602|18880583|P1|COMPLETED|Screening Period||16
7666850|NCT02019602|18880582|P2|STARTED|Screening Period||16
7666851|NCT02019602|18880583|P1|STARTED|Screening Period||21
7666852|NCT02019563|18880595|P2|NOT COMPLETED|Overall Study||0
7666853|NCT02019563|18880596|P1|NOT COMPLETED|Overall Study||0
7666854|NCT02019563|18880595|P2|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30
7666855|NCT02019563|18880596|P1|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
7666856|NCT02019563|18880595|P2|STARTED|Overall Study|72 incisors were treated in the RCT group|30
7666857|NCT02019563|18880596|P1|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
7666858|NCT02019550|18880612|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
7666859|NCT02019550|18880613|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
7666860|NCT02019550|18880612|P2|COMPLETED|Treatment Period 2 (4 Weeks)||50
7666861|NCT02019550|18880613|P1|COMPLETED|Treatment Period 2 (4 Weeks)||46
7666862|NCT02019550|18880612|P2|STARTED|Treatment Period 2 (4 Weeks)||50
7666863|NCT02019550|18880613|P1|STARTED|Treatment Period 2 (4 Weeks)||46
7666864|NCT02019550|18880612|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
7666865|NCT02019550|18880613|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
7666866|NCT02019550|18880612|P2|COMPLETED|Treatment Period 1 (4 Weeks)||50
7666867|NCT02019550|18880613|P1|COMPLETED|Treatment Period 1 (4 Weeks)||46
7666868|NCT02019550|18880612|P2|STARTED|Treatment Period 1 (4 Weeks)||51
7666869|NCT02019550|18880613|P1|STARTED|Treatment Period 1 (4 Weeks)||46
7666870|NCT02019472|18880654|P3|NOT COMPLETED|Overall Study||42
7666871|NCT02019472|18880655|P2|NOT COMPLETED|Overall Study||52
7666872|NCT02019472|18880656|P1|NOT COMPLETED|Overall Study||37
7666873|NCT02019472|18880654|P3|COMPLETED|Overall Study||145
7666874|NCT02019472|18880655|P2|COMPLETED|Overall Study||134
7666875|NCT02019472|18880656|P1|COMPLETED|Overall Study||149
7666876|NCT02019472|18880654|P3|STARTED|Overall Study||187
7666877|NCT02019472|18880655|P2|STARTED|Overall Study||186
7666878|NCT02019472|18880656|P1|STARTED|Overall Study||186
7666879|NCT02019420|18880679|P2|NOT COMPLETED|Overall Study||106
7666880|NCT02019420|18880680|P1|NOT COMPLETED|Overall Study||108
7666881|NCT02019420|18880679|P2|COMPLETED|Overall Study||254
7666882|NCT02019420|18880680|P1|COMPLETED|Overall Study||258
7666883|NCT02019420|18880679|P2|Treated|Overall Study||357
7666884|NCT02019420|18880680|P1|Treated|Overall Study||361
7666885|NCT02019420|18880679|P2|STARTED|Overall Study||360
7666886|NCT02019420|18880680|P1|STARTED|Overall Study||366
7666887|NCT02019277|18880708|P1|NOT COMPLETED|Overall Study||12
7666888|NCT02019277|18880708|P1|COMPLETED|Overall Study||38
7666889|NCT02019277|18880708|P1|STARTED|Overall Study||50
7666890|NCT02019264|18880727|P2|NOT COMPLETED|Overall Study||207
7666891|NCT02019264|18880728|P1|NOT COMPLETED|Overall Study||248
7666892|NCT02019264|18880727|P2|COMPLETED|Overall Study||5793
7666893|NCT02019264|18880728|P1|COMPLETED|Overall Study||5752
7666894|NCT02019264|18880727|P2|Safety Analysis Set|Overall Study||5995
7666895|NCT02019264|18880728|P1|Safety Analysis Set|Overall Study||5992
7666896|NCT02019264|18880727|P2|STARTED|Overall Study||6000
7666897|NCT02019264|18880728|P1|STARTED|Overall Study||6000
7666898|NCT02019108|18880764|P2|NOT COMPLETED|Overall Study||7
7666899|NCT02019108|18880765|P1|NOT COMPLETED|Overall Study||5
7666900|NCT02019108|18880764|P2|COMPLETED|Overall Study||32
7666901|NCT02019108|18880765|P1|COMPLETED|Overall Study||35
7666902|NCT02019108|18880764|P2|Retention (Week 21)|Overall Study||32
7666903|NCT02019108|18880765|P1|Retention (Week 21)|Overall Study||35
7666904|NCT02019108|18880764|P2|Follow-up (Week 17)|Overall Study||36
7666905|NCT02019108|18880765|P1|Follow-up (Week 17)|Overall Study||38
7666906|NCT02019108|18880764|P2|Baseline (Week 0)|Overall Study||39
7666907|NCT02019108|18880765|P1|Baseline (Week 0)|Overall Study||40
7666908|NCT02019108|18880764|P2|STARTED|Overall Study||39
7666909|NCT02019108|18880765|P1|STARTED|Overall Study||40
7666910|NCT02019069|18880787|P1|NOT COMPLETED|Overall Study||0
7666911|NCT02019069|18880787|P1|COMPLETED|Overall Study||11
7666912|NCT02019069|18880787|P1|STARTED|Overall Study||11
7666913|NCT02018887|18880807|P11|NOT COMPLETED|Part C: Cohort 8 Overall||1
7666914|NCT02018887|18880808|P10|NOT COMPLETED|Part C: Cohort 8 Overall||3
7666915|NCT02018887|18880809|P9|NOT COMPLETED|Part C: Cohort 8 Overall||3
7666916|NCT02018887|18880810|P8|NOT COMPLETED|Part C: Cohort 8 Overall||0
7666917|NCT02018887|18880811|P7|NOT COMPLETED|Part C: Cohort 8 Overall||0
7666918|NCT02018887|18880812|P6|NOT COMPLETED|Part C: Cohort 8 Overall||0
7666919|NCT02018887|18880813|P5|NOT COMPLETED|Part C: Cohort 8 Overall||0
7666920|NCT02018887|18880814|P4|NOT COMPLETED|Part C: Cohort 8 Overall||0
7666921|NCT02018887|18880815|P3|NOT COMPLETED|Part C: Cohort 8 Overall||0
7666922|NCT02018887|18880816|P2|NOT COMPLETED|Part C: Cohort 8 Overall||0
7666923|NCT02018887|18880817|P1|NOT COMPLETED|Part C: Cohort 8 Overall||0
7666924|NCT02018887|18880807|P11|COMPLETED|Part C: Cohort 8 Overall||6
7666925|NCT02018887|18880808|P10|COMPLETED|Part C: Cohort 8 Overall||1
7666926|NCT02018887|18880809|P9|COMPLETED|Part C: Cohort 8 Overall||7
7666927|NCT02018887|18880810|P8|COMPLETED|Part C: Cohort 8 Overall||0
7666928|NCT02018887|18880811|P7|COMPLETED|Part C: Cohort 8 Overall||0
7666929|NCT02018887|18880812|P6|COMPLETED|Part C: Cohort 8 Overall||0
7666930|NCT02018887|18880813|P5|COMPLETED|Part C: Cohort 8 Overall||0
7666931|NCT02018887|18880814|P4|COMPLETED|Part C: Cohort 8 Overall||0
7666932|NCT02018887|18880815|P3|COMPLETED|Part C: Cohort 8 Overall||0
7666933|NCT02018887|18880816|P2|COMPLETED|Part C: Cohort 8 Overall||0
7666934|NCT02018887|18880817|P1|COMPLETED|Part C: Cohort 8 Overall||0
7666935|NCT02018887|18880807|P11|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||7
7666936|NCT02018887|18880808|P10|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||4
7666937|NCT02018887|18880809|P9|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||10
7666938|NCT02018887|18880810|P8|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
7666939|NCT02018887|18880811|P7|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
7666940|NCT02018887|18880812|P6|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
7666941|NCT02018887|18880813|P5|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
7666942|NCT02018887|18880814|P4|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
7666943|NCT02018887|18880815|P3|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
7666944|NCT02018887|18880816|P2|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
7666945|NCT02018887|18880817|P1|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
7666946|NCT02018887|18880807|P11|STARTED|Part C: Cohort 8 Overall||7
7666947|NCT02018887|18880808|P10|STARTED|Part C: Cohort 8 Overall||4
7666948|NCT02018887|18880809|P9|STARTED|Part C: Cohort 8 Overall||10
7666949|NCT02018887|18880810|P8|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
7666950|NCT02018887|18880811|P7|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
7666951|NCT02018887|18880812|P6|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
7666952|NCT02018887|18880813|P5|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
7666953|NCT02018887|18880814|P4|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
7666954|NCT02018887|18880815|P3|STARTED|Part C: Cohort 8 Overall|Placebo was not administered in this period.|0
7666955|NCT02018887|18880816|P2|STARTED|Part C: Cohort 8 Overall||0
7666956|NCT02018887|18880817|P1|STARTED|Part C: Cohort 8 Overall||0
7666957|NCT02018887|18880807|P11|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
7666958|NCT02018887|18880808|P10|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
7666959|NCT02018887|18880809|P9|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
7666960|NCT02018887|18880810|P8|NOT COMPLETED|Part B: Cohorts 3-7 Overall||4
7666961|NCT02018887|18880811|P7|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
7666962|NCT02018887|18880812|P6|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
7666963|NCT02018887|18880813|P5|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
7666964|NCT02018887|18880814|P4|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
7666965|NCT02018887|18880815|P3|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
7666966|NCT02018887|18880816|P2|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
7666967|NCT02018887|18880817|P1|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
7666968|NCT02018887|18880807|P11|COMPLETED|Part B: Cohorts 3-7 Overall||0
7666969|NCT02018887|18880808|P10|COMPLETED|Part B: Cohorts 3-7 Overall||0
7666970|NCT02018887|18880809|P9|COMPLETED|Part B: Cohorts 3-7 Overall||0
7666971|NCT02018887|18880810|P8|COMPLETED|Part B: Cohorts 3-7 Overall||5
7666972|NCT02018887|18880811|P7|COMPLETED|Part B: Cohorts 3-7 Overall||8
7666973|NCT02018887|18880812|P6|COMPLETED|Part B: Cohorts 3-7 Overall||9
7666974|NCT02018887|18880813|P5|COMPLETED|Part B: Cohorts 3-7 Overall||8
7666975|NCT02018887|18880814|P4|COMPLETED|Part B: Cohorts 3-7 Overall||9
7666976|NCT02018887|18880815|P3|COMPLETED|Part B: Cohorts 3-7 Overall||15
7666977|NCT02018887|18880816|P2|COMPLETED|Part B: Cohorts 3-7 Overall||0
7666978|NCT02018887|18880817|P1|COMPLETED|Part B: Cohorts 3-7 Overall||0
7666979|NCT02018887|18880807|P11|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
7666980|NCT02018887|18880808|P10|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
7666981|NCT02018887|18880809|P9|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
7666982|NCT02018887|18880810|P8|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
7666983|NCT02018887|18880811|P7|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
7666984|NCT02018887|18880812|P6|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
7666985|NCT02018887|18880813|P5|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
7666986|NCT02018887|18880814|P4|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
7666987|NCT02018887|18880815|P3|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||15
7666988|NCT02018887|18880816|P2|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
7666989|NCT02018887|18880817|P1|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
7666990|NCT02018887|18880807|P11|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
7666991|NCT02018887|18880808|P10|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
7666992|NCT02018887|18880809|P9|STARTED|Part B: Cohorts 3-7 Overall|Placebo was not administered in this period.|0
7666993|NCT02018887|18880810|P8|STARTED|Part B: Cohorts 3-7 Overall||9
7666994|NCT02018887|18880811|P7|STARTED|Part B: Cohorts 3-7 Overall||9
7666995|NCT02018887|18880812|P6|STARTED|Part B: Cohorts 3-7 Overall||9
7666996|NCT02018887|18880813|P5|STARTED|Part B: Cohorts 3-7 Overall||9
7666997|NCT02018887|18880814|P4|STARTED|Part B: Cohorts 3-7 Overall||9
7666998|NCT02018887|18880815|P3|STARTED|Part B: Cohorts 3-7 Overall||15
7666999|NCT02018887|18880816|P2|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
7667000|NCT02018887|18880817|P1|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
7667001|NCT02018887|18880807|P11|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
7667002|NCT02018887|18880808|P10|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
7667003|NCT02018887|18880809|P9|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
7667004|NCT02018887|18880810|P8|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
7667005|NCT02018887|18880811|P7|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
7667006|NCT02018887|18880812|P6|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
7667007|NCT02018887|18880813|P5|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
7667008|NCT02018887|18880814|P4|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
7667009|NCT02018887|18880815|P3|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
7667010|NCT02018887|18880816|P2|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
7667011|NCT02018887|18880817|P1|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||1
7667012|NCT02018887|18880807|P11|COMPLETED|Part A: Cohorts 1-2: Period 3||0
7667013|NCT02018887|18880808|P10|COMPLETED|Part A: Cohorts 1-2: Period 3||0
7667014|NCT02018887|18880809|P9|COMPLETED|Part A: Cohorts 1-2: Period 3||0
7667015|NCT02018887|18880810|P8|COMPLETED|Part A: Cohorts 1-2: Period 3||0
7667016|NCT02018887|18880811|P7|COMPLETED|Part A: Cohorts 1-2: Period 3||0
7667017|NCT02018887|18880812|P6|COMPLETED|Part A: Cohorts 1-2: Period 3||0
7667018|NCT02018887|18880813|P5|COMPLETED|Part A: Cohorts 1-2: Period 3||0
7667019|NCT02018887|18880814|P4|COMPLETED|Part A: Cohorts 1-2: Period 3||0
7667020|NCT02018887|18880815|P3|COMPLETED|Part A: Cohorts 1-2: Period 3||0
7667021|NCT02018887|18880816|P2|COMPLETED|Part A: Cohorts 1-2: Period 3||9
7667022|NCT02018887|18880817|P1|COMPLETED|Part A: Cohorts 1-2: Period 3||8
7667023|NCT02018887|18880807|P11|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
7667024|NCT02018887|18880808|P10|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
7667025|NCT02018887|18880809|P9|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
7667026|NCT02018887|18880810|P8|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
7667027|NCT02018887|18880811|P7|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
7667028|NCT02018887|18880812|P6|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
7667029|NCT02018887|18880813|P5|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
7667030|NCT02018887|18880814|P4|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
7667031|NCT02018887|18880815|P3|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
7667032|NCT02018887|18880816|P2|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||9
7667033|NCT02018887|18880817|P1|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||8
7667034|NCT02018887|18880807|P11|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
7667035|NCT02018887|18880808|P10|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
7667036|NCT02018887|18880809|P9|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
7667037|NCT02018887|18880810|P8|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
7667038|NCT02018887|18880811|P7|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
7667039|NCT02018887|18880812|P6|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
7667040|NCT02018887|18880813|P5|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
7667041|NCT02018887|18880814|P4|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
7667042|NCT02018887|18880815|P3|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
7667043|NCT02018887|18880816|P2|STARTED|Part A: Cohorts 1-2: Period 3||9
7667044|NCT02018887|18880817|P1|STARTED|Part A: Cohorts 1-2: Period 3||9
7667045|NCT02018887|18880807|P11|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
7667046|NCT02018887|18880808|P10|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
7667047|NCT02018887|18880809|P9|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
7667048|NCT02018887|18880810|P8|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
7667049|NCT02018887|18880811|P7|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
7667050|NCT02018887|18880812|P6|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
7667051|NCT02018887|18880813|P5|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
7667052|NCT02018887|18880814|P4|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
7667053|NCT02018887|18880815|P3|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
7667054|NCT02018887|18880816|P2|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
7667055|NCT02018887|18880817|P1|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
7667056|NCT02018887|18880807|P11|COMPLETED|Part A: Cohorts 1-2: Period 2||0
7667057|NCT02018887|18880808|P10|COMPLETED|Part A: Cohorts 1-2: Period 2||0
7667058|NCT02018887|18880809|P9|COMPLETED|Part A: Cohorts 1-2: Period 2||0
7667059|NCT02018887|18880810|P8|COMPLETED|Part A: Cohorts 1-2: Period 2||0
7667060|NCT02018887|18880811|P7|COMPLETED|Part A: Cohorts 1-2: Period 2||0
7667061|NCT02018887|18880812|P6|COMPLETED|Part A: Cohorts 1-2: Period 2||0
7667062|NCT02018887|18880813|P5|COMPLETED|Part A: Cohorts 1-2: Period 2||0
7667063|NCT02018887|18880814|P4|COMPLETED|Part A: Cohorts 1-2: Period 2||0
7667064|NCT02018887|18880815|P3|COMPLETED|Part A: Cohorts 1-2: Period 2||0
7667065|NCT02018887|18880816|P2|COMPLETED|Part A: Cohorts 1-2: Period 2||9
7667066|NCT02018887|18880817|P1|COMPLETED|Part A: Cohorts 1-2: Period 2||9
7667067|NCT02018887|18880807|P11|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
7667068|NCT02018887|18880808|P10|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
7667069|NCT02018887|18880809|P9|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
7667070|NCT02018887|18880810|P8|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
7667071|NCT02018887|18880811|P7|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
7667072|NCT02018887|18880812|P6|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
7667073|NCT02018887|18880813|P5|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
7667074|NCT02018887|18880814|P4|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
7667075|NCT02018887|18880815|P3|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
7667076|NCT02018887|18880816|P2|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
7667077|NCT02018887|18880817|P1|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
7667078|NCT02018887|18880807|P11|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
7667079|NCT02018887|18880808|P10|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
7667080|NCT02018887|18880809|P9|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
7667081|NCT02018887|18880810|P8|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
7667082|NCT02018887|18880811|P7|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
7667083|NCT02018887|18880812|P6|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
7667084|NCT02018887|18880813|P5|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
7667085|NCT02018887|18880814|P4|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
7667086|NCT02018887|18880815|P3|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
7667087|NCT02018887|18880816|P2|STARTED|Part A: Cohorts 1-2: Period 2||9
7667088|NCT02018887|18880817|P1|STARTED|Part A: Cohorts 1-2: Period 2||9
7667089|NCT02018887|18880807|P11|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
7667090|NCT02018887|18880808|P10|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
7667091|NCT02018887|18880809|P9|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
7667092|NCT02018887|18880810|P8|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
7667093|NCT02018887|18880811|P7|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
7667094|NCT02018887|18880812|P6|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
7667095|NCT02018887|18880813|P5|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
7667096|NCT02018887|18880814|P4|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
7667097|NCT02018887|18880815|P3|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
7667098|NCT02018887|18880816|P2|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
7667099|NCT02018887|18880817|P1|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
7667100|NCT02018887|18880807|P11|COMPLETED|Part A: Cohorts 1-2: Period 1||0
7667101|NCT02018887|18880808|P10|COMPLETED|Part A: Cohorts 1-2: Period 1||0
7667102|NCT02018887|18880809|P9|COMPLETED|Part A: Cohorts 1-2: Period 1||0
7667103|NCT02018887|18880810|P8|COMPLETED|Part A: Cohorts 1-2: Period 1||0
7667104|NCT02018887|18880811|P7|COMPLETED|Part A: Cohorts 1-2: Period 1||0
7667105|NCT02018887|18880812|P6|COMPLETED|Part A: Cohorts 1-2: Period 1||0
7667106|NCT02018887|18880813|P5|COMPLETED|Part A: Cohorts 1-2: Period 1||0
7667107|NCT02018887|18880814|P4|COMPLETED|Part A: Cohorts 1-2: Period 1||0
7667108|NCT02018887|18880815|P3|COMPLETED|Part A: Cohorts 1-2: Period 1||0
7667109|NCT02018887|18880816|P2|COMPLETED|Part A: Cohorts 1-2: Period 1||9
7667110|NCT02018887|18880817|P1|COMPLETED|Part A: Cohorts 1-2: Period 1||9
7667111|NCT02018887|18880807|P11|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
7667112|NCT02018887|18880808|P10|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
7667113|NCT02018887|18880809|P9|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
7667114|NCT02018887|18880810|P8|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
7667115|NCT02018887|18880811|P7|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
7667116|NCT02018887|18880812|P6|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
7667117|NCT02018887|18880813|P5|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
7667118|NCT02018887|18880814|P4|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
7667119|NCT02018887|18880815|P3|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
7667120|NCT02018887|18880816|P2|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
7667121|NCT02018887|18880817|P1|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
7667122|NCT02018887|18880807|P11|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
7667123|NCT02018887|18880808|P10|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
7667124|NCT02018887|18880809|P9|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
7667125|NCT02018887|18880810|P8|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
7667126|NCT02018887|18880811|P7|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
7667127|NCT02018887|18880812|P6|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
7667128|NCT02018887|18880813|P5|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
7667129|NCT02018887|18880814|P4|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
7667130|NCT02018887|18880815|P3|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
7667131|NCT02018887|18880816|P2|STARTED|Part A: Cohorts 1-2: Period 1||9
7667132|NCT02018887|18880817|P1|STARTED|Part A: Cohorts 1-2: Period 1||9
7667133|NCT02018822|18880906|P3|NOT COMPLETED|Overall Study||6
7667134|NCT02018822|18880907|P2|NOT COMPLETED|Overall Study||8
7667135|NCT02018822|18880908|P1|NOT COMPLETED|Overall Study||6
7667136|NCT02018822|18880906|P3|COMPLETED|Overall Study||29
7667137|NCT02018822|18880907|P2|COMPLETED|Overall Study||42
7667138|NCT02018822|18880908|P1|COMPLETED|Overall Study||44
7667139|NCT02018822|18880906|P3|STARTED|Overall Study||35
7667140|NCT02018822|18880907|P2|STARTED|Overall Study||50
7667141|NCT02018822|18880908|P1|STARTED|Overall Study||50
7667142|NCT02018809|18880935|P4|NOT COMPLETED|Overall Study||0
7667143|NCT02018809|18880936|P3|NOT COMPLETED|Overall Study||0
7667144|NCT02018809|18880937|P2|NOT COMPLETED|Overall Study||0
7667145|NCT02018809|18880938|P1|NOT COMPLETED|Overall Study||0
7667146|NCT02018809|18880935|P4|COMPLETED|Overall Study||50
7667147|NCT02018809|18880936|P3|COMPLETED|Overall Study||50
7667148|NCT02018809|18880937|P2|COMPLETED|Overall Study||50
7667149|NCT02018809|18880938|P1|COMPLETED|Overall Study||50
7667150|NCT02018809|18880935|P4|STARTED|Overall Study||50
7667151|NCT02018809|18880936|P3|STARTED|Overall Study||50
7667152|NCT02018809|18880937|P2|STARTED|Overall Study||50
7667153|NCT02018809|18880938|P1|STARTED|Overall Study||50
7667154|NCT02018653|18880954|P2|NOT COMPLETED|Overall Study||1
7667155|NCT02018653|18880955|P1|NOT COMPLETED|Overall Study||0
7667156|NCT02018653|18880954|P2|COMPLETED|Overall Study||0
7667157|NCT02018653|18880955|P1|COMPLETED|Overall Study||1
7667158|NCT02018653|18880954|P2|STARTED|Overall Study||1
7667159|NCT02018653|18880955|P1|STARTED|Overall Study||1
7667160|NCT02018627|18880963|P2|NOT COMPLETED|Overall Study||0
7667161|NCT02018627|18880964|P1|NOT COMPLETED|Overall Study||0
7667162|NCT02018627|18880963|P2|COMPLETED|Overall Study||6
7667163|NCT02018627|18880964|P1|COMPLETED|Overall Study||7
7667164|NCT02018627|18880963|P2|STARTED|Overall Study||6
7667165|NCT02018627|18880964|P1|STARTED|Overall Study||7
7667166|NCT02018562|18880988|P2|NOT COMPLETED|Overall Study||0
7667167|NCT02018562|18880989|P1|NOT COMPLETED|Overall Study||3
7667168|NCT02018562|18880988|P2|COMPLETED|Overall Study||25
7667169|NCT02018562|18880989|P1|COMPLETED|Overall Study||22
7667170|NCT02018562|18880988|P2|STARTED|Overall Study||25
7667171|NCT02018562|18880989|P1|STARTED|Overall Study||25
7667172|NCT02018458|18881007|P1|NOT COMPLETED|Overall Study||4
7667173|NCT02018458|18881007|P1|COMPLETED|Overall Study||6
7667174|NCT02018458|18881007|P1|STARTED|Overall Study||10
7667175|NCT02018445|18881013|P1|NOT COMPLETED|Overall Study||7
7667176|NCT02018445|18881013|P1|COMPLETED|Overall Study||29
7667177|NCT02018445|18881013|P1|STARTED|Overall Study||36
7667178|NCT02018315|18881024|P1|NOT COMPLETED|Overall Study||0
7667179|NCT02018315|18881024|P1|COMPLETED|Overall Study||14
7667180|NCT02018315|18881024|P1|STARTED|Overall Study||14
7667181|NCT02018107|18881029|P1|NOT COMPLETED|Overall Study||0
7667182|NCT02018107|18881029|P1|COMPLETED|Overall Study||27
7667183|NCT02018107|18881029|P1|STARTED|Overall Study||27
7667184|NCT02018042|18881034|P1|NOT COMPLETED|Overall Study||1
7667185|NCT02018042|18881034|P1|COMPLETED|Overall Study||14
7667186|NCT02018042|18881034|P1|STARTED|Overall Study||15
7667187|NCT02017964|18881040|P1|NOT COMPLETED|Overall Study||1
7667188|NCT02017964|18881040|P1|COMPLETED|Overall Study||25
7667189|NCT02017964|18881040|P1|STARTED|Overall Study||26
7667190|NCT02017899|18881054|P6|NOT COMPLETED|Overall Study||0
7667191|NCT02017899|18881055|P5|NOT COMPLETED|Overall Study||1
7667192|NCT02017899|18881056|P4|NOT COMPLETED|Overall Study||1
7667193|NCT02017899|18881057|P3|NOT COMPLETED|Overall Study||0
7667194|NCT02017899|18881058|P2|NOT COMPLETED|Overall Study||0
7667195|NCT02017899|18881059|P1|NOT COMPLETED|Overall Study||0
7667196|NCT02017899|18881054|P6|COMPLETED|Overall Study||8
7667197|NCT02017899|18881055|P5|COMPLETED|Overall Study||8
7667198|NCT02017899|18881056|P4|COMPLETED|Overall Study||7
7667199|NCT02017899|18881057|P3|COMPLETED|Overall Study||8
7667200|NCT02017899|18881058|P2|COMPLETED|Overall Study||9
7667201|NCT02017899|18881059|P1|COMPLETED|Overall Study||8
7667202|NCT02017899|18881054|P6|STARTED|Overall Study||8
7667203|NCT02017899|18881055|P5|STARTED|Overall Study||9
7667204|NCT02017899|18881056|P4|STARTED|Overall Study||8
7667205|NCT02017899|18881057|P3|STARTED|Overall Study||8
7667206|NCT02017899|18881058|P2|STARTED|Overall Study||9
7667207|NCT02017899|18881059|P1|STARTED|Overall Study||8
7667208|NCT02017860|18881133|P1|NOT COMPLETED|Overall Study||2
7667209|NCT02017860|18881133|P1|COMPLETED|Overall Study||2
7667210|NCT02017860|18881133|P1|STARTED|Overall Study||4
7667211|NCT02017574|18881139|P2|NOT COMPLETED|Overall Study||0
7667212|NCT02017574|18881140|P1|NOT COMPLETED|Overall Study||0
7667213|NCT02017574|18881139|P2|COMPLETED|Overall Study||12
7667214|NCT02017574|18881140|P1|COMPLETED|Overall Study||12
7667215|NCT02017574|18881139|P2|STARTED|Overall Study||12
7667216|NCT02017574|18881140|P1|STARTED|Overall Study||12
7667217|NCT02017535|18881152|P4|NOT COMPLETED|Overall Study||0
7667218|NCT02017535|18881153|P3|NOT COMPLETED|Overall Study||0
7667219|NCT02017535|18881154|P2|NOT COMPLETED|Overall Study||0
7667220|NCT02017535|18881155|P1|NOT COMPLETED|Overall Study||1
7667221|NCT02017535|18881152|P4|COMPLETED|Overall Study||1
7667222|NCT02017535|18881153|P3|COMPLETED|Overall Study||2
7667223|NCT02017535|18881154|P2|COMPLETED|Overall Study||3
7667224|NCT02017535|18881155|P1|COMPLETED|Overall Study||8
7667225|NCT02017535|18881152|P4|STARTED|Overall Study||1
7667226|NCT02017535|18881153|P3|STARTED|Overall Study||2
7667227|NCT02017535|18881154|P2|STARTED|Overall Study||3
7667228|NCT02017535|18881155|P1|STARTED|Overall Study||9
7667229|NCT02017522|18881177|P1|NOT COMPLETED|Overall Study||1
7667230|NCT02017522|18881177|P1|COMPLETED|Overall Study||2
7667231|NCT02017522|18881177|P1|Scan|Overall Study||2
7667232|NCT02017522|18881177|P1|STARTED|Overall Study||3
7667233|NCT02017327|18881185|P3|NOT COMPLETED|Overall Study||15
7667234|NCT02017327|18881186|P2|NOT COMPLETED|Overall Study||12
7667235|NCT02017327|18881187|P1|NOT COMPLETED|Overall Study||16
7667236|NCT02017327|18881185|P3|COMPLETED|Overall Study||117
7667237|NCT02017327|18881186|P2|COMPLETED|Overall Study||113
7667238|NCT02017327|18881187|P1|COMPLETED|Overall Study||106
7667239|NCT02017327|18881185|P3|STARTED|Overall Study||132
7667240|NCT02017327|18881186|P2|STARTED|Overall Study||125
7667241|NCT02017327|18881187|P1|STARTED|Overall Study||122
7667242|NCT02017223|18881195|P1|NOT COMPLETED|Overall Study||2
7667243|NCT02017223|18881195|P1|COMPLETED|Overall Study||10
7667244|NCT02017223|18881195|P1|STARTED|Overall Study||12
7667245|NCT02017210|18881202|P3|NOT COMPLETED|Overall Study||0
7667246|NCT02017210|18881203|P2|NOT COMPLETED|Overall Study||0
7667247|NCT02017210|18881204|P1|NOT COMPLETED|Overall Study||0
7667248|NCT02017210|18881202|P3|COMPLETED|Overall Study||20
7667249|NCT02017210|18881203|P2|COMPLETED|Overall Study||20
7667250|NCT02017210|18881204|P1|COMPLETED|Overall Study||17
7667251|NCT02017210|18881202|P3|STARTED|Overall Study||20
7667252|NCT02017210|18881203|P2|STARTED|Overall Study||20
7667253|NCT02017210|18881204|P1|STARTED|Overall Study||17
7667254|NCT02017171|18881241|P2|NOT COMPLETED|Overall Study||46
7667255|NCT02017171|18881242|P1|NOT COMPLETED|Overall Study||62
7667256|NCT02017171|18881241|P2|COMPLETED|Overall Study||217
7667257|NCT02017171|18881242|P1|COMPLETED|Overall Study||205
7667258|NCT02017171|18881241|P2|STARTED|Overall Study||263
7667259|NCT02017171|18881242|P1|STARTED|Overall Study||267
7667260|NCT02017093|18881266|P2|NOT COMPLETED|Overall Study||0
7667261|NCT02017093|18881267|P1|NOT COMPLETED|Overall Study||0
7667262|NCT02017093|18881266|P2|COMPLETED|Overall Study||3
7667263|NCT02017093|18881267|P1|COMPLETED|Overall Study||4
7667264|NCT02017093|18881266|P2|STARTED|Overall Study||3
7667265|NCT02017093|18881267|P1|STARTED|Overall Study||4
7667266|NCT02017015|18881275|P1|NOT COMPLETED|Overall Study||69
7667267|NCT02017015|18881275|P1|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14
7667268|NCT02017015|18881275|P1|Safety Population|Overall Study||83
7667269|NCT02017015|18881275|P1|STARTED|Overall Study||83
7667270|NCT02016963|18881282|P1|NOT COMPLETED|Overall Study||0
7667271|NCT02016963|18881282|P1|COMPLETED|Overall Study||20
7667272|NCT02016963|18881282|P1|STARTED|Overall Study||20
7667273|NCT02016898|18881300|P2|NOT COMPLETED|Overall Study||5
7667274|NCT02016898|18881301|P1|NOT COMPLETED|Overall Study||5
7667275|NCT02016898|18881300|P2|COMPLETED|Overall Study||40
7667276|NCT02016898|18881301|P1|COMPLETED|Overall Study||45
7667277|NCT02016898|18881300|P2|STARTED|Overall Study||45
7667278|NCT02016898|18881301|P1|STARTED|Overall Study||50
7667279|NCT02016885|18881314|P5|NOT COMPLETED|Overall Study||1
7667280|NCT02016885|18881315|P4|NOT COMPLETED|Overall Study||10
7667281|NCT02016885|18881316|P3|NOT COMPLETED|Overall Study||1
7667282|NCT02016885|18881317|P2|NOT COMPLETED|Overall Study||4
7667283|NCT02016885|18881318|P1|NOT COMPLETED|Overall Study||4
7667284|NCT02016885|18881314|P5|COMPLETED|Overall Study||39
7667285|NCT02016885|18881315|P4|COMPLETED|Overall Study||30
7667286|NCT02016885|18881316|P3|COMPLETED|Overall Study||39
7667287|NCT02016885|18881317|P2|COMPLETED|Overall Study||36
7667288|NCT02016885|18881318|P1|COMPLETED|Overall Study||34
7667289|NCT02016885|18881314|P5|STARTED|Overall Study||40
7667290|NCT02016885|18881315|P4|STARTED|Overall Study||40
7667291|NCT02016885|18881316|P3|STARTED|Overall Study||40
7667292|NCT02016885|18881317|P2|STARTED|Overall Study||40
7667293|NCT02016885|18881318|P1|STARTED|Overall Study||38
7667294|NCT02016716|18881358|P3|NOT COMPLETED|Overall Study||6
7667295|NCT02016716|18881359|P2|NOT COMPLETED|Overall Study||8
7667296|NCT02016716|18881360|P1|NOT COMPLETED|Overall Study||6
7667297|NCT02016716|18881358|P3|COMPLETED|Overall Study||117
7667298|NCT02016716|18881359|P2|COMPLETED|Overall Study||110
7667299|NCT02016716|18881360|P1|COMPLETED|Overall Study||47
7667300|NCT02016716|18881358|P3|Received Study Treatment|Overall Study||123
7667301|NCT02016716|18881359|P2|Received Study Treatment|Overall Study||118
7667302|NCT02016716|18881360|P1|Received Study Treatment|Overall Study||53
7667303|NCT02016716|18881358|P3|STARTED|Overall Study||123
7667304|NCT02016716|18881359|P2|STARTED|Overall Study||118
7667305|NCT02016716|18881360|P1|STARTED|Overall Study||53
7667306|NCT02016690|18881381|P1|NOT COMPLETED|Overall Study||24
7667307|NCT02016690|18881381|P1|COMPLETED|Overall Study|(Effectiveness analysis set)|288
7667308|NCT02016690|18881381|P1|Safety Analysis Set (SAS)|Overall Study||304
7667309|NCT02016690|18881381|P1|Treated|Overall Study||312
7667310|NCT02016690|18881381|P1|STARTED|Overall Study||312
7667311|NCT02016625|18881394|P2|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0
7667312|NCT02016625|18881395|P1|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3
7667313|NCT02016625|18881394|P2|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
7667314|NCT02016625|18881395|P1|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13
7667315|NCT02016625|18881394|P2|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
7667316|NCT02016625|18881395|P1|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16
7667317|NCT02016625|18881394|P2|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1
7667318|NCT02016625|18881395|P1|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0
7667319|NCT02016625|18881394|P2|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15
7667320|NCT02016625|18881395|P1|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16
7667321|NCT02016625|18881394|P2|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
7667322|NCT02016625|18881395|P1|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
7667323|NCT02016612|18881431|P4|NOT COMPLETED|Overall Study||0
7667324|NCT02016612|18881432|P3|NOT COMPLETED|Overall Study||0
7667325|NCT02016612|18881433|P2|NOT COMPLETED|Overall Study||0
7667326|NCT02016612|18881434|P1|NOT COMPLETED|Overall Study||0
7667327|NCT02016612|18881431|P4|COMPLETED|Overall Study||61
7667328|NCT02016612|18881432|P3|COMPLETED|Overall Study||26
7667329|NCT02016612|18881433|P2|COMPLETED|Overall Study||25
7667330|NCT02016612|18881434|P1|COMPLETED|Overall Study||25
7667331|NCT02016612|18881431|P4|STARTED|Overall Study||61
7667332|NCT02016612|18881432|P3|STARTED|Overall Study||26
7667333|NCT02016612|18881433|P2|STARTED|Overall Study||25
7667334|NCT02016612|18881434|P1|STARTED|Overall Study||25
7667335|NCT02016560|18881454|P6|NOT COMPLETED|Confirmatory Phase||27
7667336|NCT02016560|18881455|P5|NOT COMPLETED|Confirmatory Phase||22
7667337|NCT02016560|18881456|P4|NOT COMPLETED|Confirmatory Phase||0
7667338|NCT02016560|18881457|P3|NOT COMPLETED|Confirmatory Phase||0
7667339|NCT02016560|18881458|P2|NOT COMPLETED|Confirmatory Phase||0
7667340|NCT02016560|18881459|P1|NOT COMPLETED|Confirmatory Phase||0
7667341|NCT02016560|18881454|P6|COMPLETED|Confirmatory Phase||35
7667342|NCT02016560|18881455|P5|COMPLETED|Confirmatory Phase||76
7667343|NCT02016560|18881456|P4|COMPLETED|Confirmatory Phase||0
7667344|NCT02016560|18881457|P3|COMPLETED|Confirmatory Phase||0
7667345|NCT02016560|18881458|P2|COMPLETED|Confirmatory Phase||0
7667346|NCT02016560|18881459|P1|COMPLETED|Confirmatory Phase||0
7667347|NCT02016560|18881454|P6|STARTED|Confirmatory Phase||62
7667348|NCT02016560|18881455|P5|STARTED|Confirmatory Phase||98
7667349|NCT02016560|18881456|P4|STARTED|Confirmatory Phase||0
7667350|NCT02016560|18881457|P3|STARTED|Confirmatory Phase||0
7667351|NCT02016560|18881458|P2|STARTED|Confirmatory Phase||0
7667352|NCT02016560|18881459|P1|STARTED|Confirmatory Phase||0
7667353|NCT02016560|18881454|P6|NOT COMPLETED|Exploratory Phase||0
7667354|NCT02016560|18881455|P5|NOT COMPLETED|Exploratory Phase||0
7667355|NCT02016560|18881456|P4|NOT COMPLETED|Exploratory Phase||16
7667356|NCT02016560|18881457|P3|NOT COMPLETED|Exploratory Phase||36
7667357|NCT02016560|18881458|P2|NOT COMPLETED|Exploratory Phase||4
7667358|NCT02016560|18881459|P1|NOT COMPLETED|Exploratory Phase||0
7667359|NCT02016560|18881454|P6|COMPLETED|Exploratory Phase||0
7667360|NCT02016560|18881455|P5|COMPLETED|Exploratory Phase||0
7667361|NCT02016560|18881456|P4|COMPLETED|Exploratory Phase||35
7667362|NCT02016560|18881457|P3|COMPLETED|Exploratory Phase||62
7667363|NCT02016560|18881458|P2|COMPLETED|Exploratory Phase||54
7667364|NCT02016560|18881459|P1|COMPLETED|Exploratory Phase||16
7667365|NCT02016560|18881454|P6|STARTED|Exploratory Phase||0
7667366|NCT02016560|18881455|P5|STARTED|Exploratory Phase||0
7667367|NCT02016560|18881456|P4|STARTED|Exploratory Phase||51
7667368|NCT02016560|18881457|P3|STARTED|Exploratory Phase||98
7667369|NCT02016560|18881458|P2|STARTED|Exploratory Phase||58
7667370|NCT02016560|18881459|P1|STARTED|Exploratory Phase||16
7667371|NCT02016482|18881483|P2|NOT COMPLETED|Period B||7
7667372|NCT02016482|18881484|P1|NOT COMPLETED|Period B||13
7667373|NCT02016482|18881483|P2|COMPLETED|Period B||87
7667374|NCT02016482|18881484|P1|COMPLETED|Period B||81
7667375|NCT02016482|18881483|P2|STARTED|Period B||94
7667376|NCT02016482|18881484|P1|STARTED|Period B||94
7667377|NCT02016482|18881483|P2|NOT COMPLETED|Period A||15
7667378|NCT02016482|18881484|P1|NOT COMPLETED|Period A||14
7667379|NCT02016482|18881483|P2|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94
7667380|NCT02016482|18881484|P1|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94
7667381|NCT02016482|18881483|P2|STARTED|Period A||109
7667382|NCT02016482|18881484|P1|STARTED|Period A||108
7667383|NCT02016300|18881574|P2|NOT COMPLETED|Overall Study||3
7667384|NCT02016300|18881575|P1|NOT COMPLETED|Overall Study||0
7667385|NCT02016300|18881574|P2|COMPLETED|Overall Study||9
7667386|NCT02016300|18881575|P1|COMPLETED|Overall Study||12
7667387|NCT02016300|18881574|P2|STARTED|Overall Study||12
7667388|NCT02016300|18881575|P1|STARTED|Overall Study||12
7667389|NCT02016235|18881596|P3|NOT COMPLETED|Overall Study||0
7667390|NCT02016235|18881597|P2|NOT COMPLETED|Overall Study||0
7667391|NCT02016235|18881598|P1|NOT COMPLETED|Overall Study||0
7667392|NCT02016235|18881596|P3|COMPLETED|Overall Study||10
7667393|NCT02016235|18881597|P2|COMPLETED|Overall Study||10
7667394|NCT02016235|18881598|P1|COMPLETED|Overall Study||10
7667395|NCT02016235|18881596|P3|STARTED|Overall Study||10
7667396|NCT02016235|18881597|P2|STARTED|Overall Study||10
7667397|NCT02016235|18881598|P1|STARTED|Overall Study||10
7667398|NCT02016183|18881606|P1|NOT COMPLETED|Overall Study||65
7667399|NCT02016183|18881606|P1|COMPLETED|Overall Study||3157
7667400|NCT02016183|18881606|P1|STARTED|Overall Study||3222
7667401|NCT02016170|18881616|P3|NOT COMPLETED|Overall Study||0
7667402|NCT02016170|18881617|P2|NOT COMPLETED|Overall Study||1
7667403|NCT02016170|18881618|P1|NOT COMPLETED|Overall Study||2
7667404|NCT02016170|18881616|P3|COMPLETED|Overall Study||27
7667405|NCT02016170|18881617|P2|COMPLETED|Overall Study||27
7667406|NCT02016170|18881618|P1|COMPLETED|Overall Study||25
7667407|NCT02016170|18881616|P3|STARTED|Overall Study||27
7667408|NCT02016170|18881617|P2|STARTED|Overall Study||28
7667409|NCT02016170|18881618|P1|STARTED|Overall Study||27
7667410|NCT02016105|18881629|P6|NOT COMPLETED|EXTENSION PERIOD||6
7667411|NCT02016105|18881630|P5|NOT COMPLETED|EXTENSION PERIOD||6
7667412|NCT02016105|18881631|P4|NOT COMPLETED|EXTENSION PERIOD||5
7667413|NCT02016105|18881632|P3|NOT COMPLETED|EXTENSION PERIOD||5
7667414|NCT02016105|18881633|P2|NOT COMPLETED|EXTENSION PERIOD||0
7667415|NCT02016105|18881634|P1|NOT COMPLETED|EXTENSION PERIOD||0
7667416|NCT02016105|18881629|P6|COMPLETED|EXTENSION PERIOD||100
7667417|NCT02016105|18881630|P5|COMPLETED|EXTENSION PERIOD||50
7667418|NCT02016105|18881631|P4|COMPLETED|EXTENSION PERIOD||104
7667419|NCT02016105|18881632|P3|COMPLETED|EXTENSION PERIOD||47
7667420|NCT02016105|18881633|P2|COMPLETED|EXTENSION PERIOD||0
7667421|NCT02016105|18881634|P1|COMPLETED|EXTENSION PERIOD||0
7667422|NCT02016105|18881629|P6|STARTED|EXTENSION PERIOD|6 patients did not proceed from Treatment Period 2 into Extension Period|106
7667423|NCT02016105|18881630|P5|STARTED|EXTENSION PERIOD|3 patients did not proceed from Treatment Period 2 into Extension Period|56
7667424|NCT02016105|18881631|P4|STARTED|EXTENSION PERIOD|7 patients did not proceed from Treatment Period 2 into Extension Period|109
7667425|NCT02016105|18881632|P3|STARTED|EXTENSION PERIOD|5 patients did not proceed from Treatment Period 2 into Extension Period|52
7667426|NCT02016105|18881633|P2|STARTED|EXTENSION PERIOD||0
7667427|NCT02016105|18881634|P1|STARTED|EXTENSION PERIOD||0
7667428|NCT02016105|18881629|P6|NOT COMPLETED|TREATMENT PERIOD 2||14
7667429|NCT02016105|18881630|P5|NOT COMPLETED|TREATMENT PERIOD 2||4
7667430|NCT02016105|18881631|P4|NOT COMPLETED|TREATMENT PERIOD 2||11
7667431|NCT02016105|18881632|P3|NOT COMPLETED|TREATMENT PERIOD 2||6
7667432|NCT02016105|18881633|P2|NOT COMPLETED|TREATMENT PERIOD 2||0
7667433|NCT02016105|18881634|P1|NOT COMPLETED|TREATMENT PERIOD 2||0
7667434|NCT02016105|18881629|P6|COMPLETED|TREATMENT PERIOD 2||112
7667435|NCT02016105|18881630|P5|COMPLETED|TREATMENT PERIOD 2||59
7667436|NCT02016105|18881631|P4|COMPLETED|TREATMENT PERIOD 2||116
7667437|NCT02016105|18881632|P3|COMPLETED|TREATMENT PERIOD 2||57
7667438|NCT02016105|18881633|P2|COMPLETED|TREATMENT PERIOD 2||0
7667439|NCT02016105|18881634|P1|COMPLETED|TREATMENT PERIOD 2||0
7667440|NCT02016105|18881629|P6|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|126
7667441|NCT02016105|18881630|P5|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|63
7667442|NCT02016105|18881631|P4|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|127
7667443|NCT02016105|18881632|P3|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|63
7667444|NCT02016105|18881633|P2|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
7667445|NCT02016105|18881634|P1|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
7667446|NCT02016105|18881629|P6|NOT COMPLETED|TREATMENT PERIOD 1||0
7667447|NCT02016105|18881630|P5|NOT COMPLETED|TREATMENT PERIOD 1||0
7667448|NCT02016105|18881631|P4|NOT COMPLETED|TREATMENT PERIOD 1||0
7667449|NCT02016105|18881632|P3|NOT COMPLETED|TREATMENT PERIOD 1||0
7667450|NCT02016105|18881633|P2|NOT COMPLETED|TREATMENT PERIOD 1||33
7667451|NCT02016105|18881634|P1|NOT COMPLETED|TREATMENT PERIOD 1||30
7667452|NCT02016105|18881629|P6|COMPLETED|TREATMENT PERIOD 1||0
7667453|NCT02016105|18881630|P5|COMPLETED|TREATMENT PERIOD 1||0
7667454|NCT02016105|18881631|P4|COMPLETED|TREATMENT PERIOD 1||0
7667455|NCT02016105|18881632|P3|COMPLETED|TREATMENT PERIOD 1||0
7667456|NCT02016105|18881633|P2|COMPLETED|TREATMENT PERIOD 1|11 patients did not proceed into Treatment Period 2|201
7667457|NCT02016105|18881634|P1|COMPLETED|TREATMENT PERIOD 1|12 patients did not proceed into Treatment Period 2|201
7667458|NCT02016105|18881629|P6|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
7667459|NCT02016105|18881630|P5|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
7667460|NCT02016105|18881631|P4|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
7667461|NCT02016105|18881632|P3|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
7667462|NCT02016105|18881633|P2|STARTED|TREATMENT PERIOD 1||234
7667463|NCT02016105|18881634|P1|STARTED|TREATMENT PERIOD 1||231
7667464|NCT02015910|18881684|P2|NOT COMPLETED|Overall Study||0
7667465|NCT02015910|18881685|P1|NOT COMPLETED|Overall Study||0
7667466|NCT02015910|18881684|P2|COMPLETED|Overall Study||1
7667467|NCT02015910|18881685|P1|COMPLETED|Overall Study||0
7667468|NCT02015910|18881684|P2|STARTED|Overall Study||1
7667469|NCT02015910|18881685|P1|STARTED|Overall Study||0
7667470|NCT02015793|18881693|P2|NOT COMPLETED|Overall Study||4
7667471|NCT02015793|18881694|P1|NOT COMPLETED|Overall Study||4
7667472|NCT02015793|18881693|P2|COMPLETED|Overall Study||11
7667473|NCT02015793|18881694|P1|COMPLETED|Overall Study||11
7667474|NCT02015793|18881693|P2|Entered Open-label Extension Period|Overall Study||14
7667475|NCT02015793|18881694|P1|Entered Open-label Extension Period|Overall Study||13
7667476|NCT02015793|18881693|P2|Completed Double-Blind Period|Overall Study||14
7667477|NCT02015793|18881694|P1|Completed Double-Blind Period|Overall Study||14
7667478|NCT02015793|18881693|P2|STARTED|Overall Study||15
7667479|NCT02015793|18881694|P1|STARTED|Overall Study||15
7667480|NCT02015754|18881724|P1|NOT COMPLETED|Overall Study||11
7667481|NCT02015754|18881724|P1|COMPLETED|Overall Study||3
7667482|NCT02015754|18881724|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to follow-up|13
7667483|NCT02015754|18881724|P1|Completed First TACE|Overall Study||14
7667484|NCT02015754|18881724|P1|STARTED|Overall Study|17 participants were consented, but 3 participants were screened out prior to treatment|14
7667485|NCT02015676|18881744|P3|NOT COMPLETED|Overall Study||3
7667486|NCT02015676|18881745|P2|NOT COMPLETED|Overall Study||34
7667487|NCT02015676|18881746|P1|NOT COMPLETED|Overall Study||9
7667488|NCT02015676|18881744|P3|COMPLETED|Overall Study||3
7667489|NCT02015676|18881745|P2|COMPLETED|Overall Study||14
7667490|NCT02015676|18881746|P1|COMPLETED|Overall Study||6
7667491|NCT02015676|18881744|P3|STARTED|Overall Study||6
7667492|NCT02015676|18881745|P2|STARTED|Overall Study||48
7667493|NCT02015676|18881746|P1|STARTED|Overall Study||15
7667494|NCT02015663|18881762|P2|NOT COMPLETED|Overall Study||12
7667495|NCT02015663|18881763|P1|NOT COMPLETED|Overall Study||15
7667496|NCT02015663|18881762|P2|COMPLETED|Overall Study||4
7667497|NCT02015663|18881763|P1|COMPLETED|Overall Study||1
7667498|NCT02015663|18881762|P2|STARTED|Overall Study||16
7667499|NCT02015663|18881763|P1|STARTED|Overall Study||16
7667500|NCT02015637|18881794|P2|NOT COMPLETED|Overall Study||5
7667501|NCT02015637|18881795|P1|NOT COMPLETED|Overall Study||8
7667502|NCT02015637|18881794|P2|COMPLETED|Overall Study||149
7667503|NCT02015637|18881795|P1|COMPLETED|Overall Study||298
7667504|NCT02015637|18881794|P2|STARTED|Overall Study||154
7667505|NCT02015637|18881795|P1|STARTED|Overall Study||306
7667506|NCT02015546|18881806|P3|NOT COMPLETED|Overall Study||4
7667507|NCT02015546|18881807|P2|NOT COMPLETED|Overall Study||2
7667508|NCT02015546|18881808|P1|NOT COMPLETED|Overall Study||3
7667509|NCT02015546|18881806|P3|COMPLETED|Overall Study||22
7667510|NCT02015546|18881807|P2|COMPLETED|Overall Study||19
7667511|NCT02015546|18881808|P1|COMPLETED|Overall Study||20
7667512|NCT02015546|18881806|P3|STARTED|Overall Study||26
7667513|NCT02015546|18881807|P2|STARTED|Overall Study||21
7667514|NCT02015546|18881808|P1|STARTED|Overall Study||23
7667515|NCT02015481|18881840|P1|NOT COMPLETED|Overall Study||1
7667516|NCT02015481|18881840|P1|COMPLETED|Overall Study||24
7667517|NCT02015481|18881840|P1|STARTED|Overall Study||25
7667518|NCT02015442|18881847|P2|NOT COMPLETED|Second Intervention (7 Days)||0
7667519|NCT02015442|18881848|P1|NOT COMPLETED|Second Intervention (7 Days)||0
7667520|NCT02015442|18881847|P2|COMPLETED|Second Intervention (7 Days)||4
7667521|NCT02015442|18881848|P1|COMPLETED|Second Intervention (7 Days)||5
7667522|NCT02015442|18881847|P2|STARTED|Second Intervention (7 Days)||4
7667523|NCT02015442|18881848|P1|STARTED|Second Intervention (7 Days)||5
7667524|NCT02015442|18881847|P2|NOT COMPLETED|Wash-out (4 Weeks)||0
7667525|NCT02015442|18881848|P1|NOT COMPLETED|Wash-out (4 Weeks)||0
7667526|NCT02015442|18881847|P2|COMPLETED|Wash-out (4 Weeks)||4
7667527|NCT02015442|18881848|P1|COMPLETED|Wash-out (4 Weeks)||5
7667528|NCT02015442|18881847|P2|STARTED|Wash-out (4 Weeks)||4
7667529|NCT02015442|18881848|P1|STARTED|Wash-out (4 Weeks)||5
7667530|NCT02015442|18881847|P2|NOT COMPLETED|First Intervention (7 Days)||0
7667531|NCT02015442|18881848|P1|NOT COMPLETED|First Intervention (7 Days)||0
7667532|NCT02015442|18881847|P2|COMPLETED|First Intervention (7 Days)||4
7667533|NCT02015442|18881848|P1|COMPLETED|First Intervention (7 Days)||5
7667534|NCT02015442|18881847|P2|STARTED|First Intervention (7 Days)||4
7667535|NCT02015442|18881848|P1|STARTED|First Intervention (7 Days)||5
7667536|NCT02015234|18881858|P2|NOT COMPLETED|Overall Study||25
7667537|NCT02015234|18881859|P1|NOT COMPLETED|Overall Study||36
7667538|NCT02015234|18881858|P2|COMPLETED|Overall Study||54
7667539|NCT02015234|18881859|P1|COMPLETED|Overall Study||43
7667540|NCT02015234|18881858|P2|STARTED|Overall Study||79
7667541|NCT02015234|18881859|P1|STARTED|Overall Study||79
7667542|NCT02015221|18881873|P2|NOT COMPLETED|Overall Study||6
7667543|NCT02015221|18881874|P1|NOT COMPLETED|Overall Study||9
7667544|NCT02015221|18881873|P2|COMPLETED|Overall Study||34
7667545|NCT02015221|18881874|P1|COMPLETED|Overall Study||32
7667546|NCT02015221|18881873|P2|STARTED|Overall Study||40
7667547|NCT02015221|18881874|P1|STARTED|Overall Study||41
7667548|NCT02015195|18881887|P7|NOT COMPLETED|Overall Study||0
7667549|NCT02015195|18881888|P6|NOT COMPLETED|Overall Study||0
7667550|NCT02015195|18881889|P5|NOT COMPLETED|Overall Study||0
7667551|NCT02015195|18881890|P4|NOT COMPLETED|Overall Study||1
7667552|NCT02015195|18881891|P3|NOT COMPLETED|Overall Study||0
7667553|NCT02015195|18881892|P2|NOT COMPLETED|Overall Study||0
7667554|NCT02015195|18881893|P1|NOT COMPLETED|Overall Study||0
7667555|NCT02015195|18881887|P7|COMPLETED|Overall Study||16
7667556|NCT02015195|18881888|P6|COMPLETED|Overall Study||16
7667557|NCT02015195|18881889|P5|COMPLETED|Overall Study||16
7667558|NCT02015195|18881890|P4|COMPLETED|Overall Study||0
7667559|NCT02015195|18881891|P3|COMPLETED|Overall Study||16
7667560|NCT02015195|18881892|P2|COMPLETED|Overall Study||16
7667561|NCT02015195|18881893|P1|COMPLETED|Overall Study||16
7667562|NCT02015195|18881887|P7|STARTED|Overall Study||16
7667563|NCT02015195|18881888|P6|STARTED|Overall Study||16
7667564|NCT02015195|18881889|P5|STARTED|Overall Study||16
7667565|NCT02015195|18881890|P4|STARTED|Overall Study||1
7667566|NCT02015195|18881891|P3|STARTED|Overall Study||16
7667567|NCT02015195|18881892|P2|STARTED|Overall Study||16
7667568|NCT02015195|18881893|P1|STARTED|Overall Study||16
7667569|NCT02015104|18881916|P2|NOT COMPLETED|Overall Study||1
7667570|NCT02015104|18881917|P1|NOT COMPLETED|Overall Study||1
7667571|NCT02015104|18881916|P2|COMPLETED|Overall Study||15
7667572|NCT02015104|18881917|P1|COMPLETED|Overall Study||15
7667573|NCT02015104|18881916|P2|STARTED|Overall Study||16
7667574|NCT02015104|18881917|P1|STARTED|Overall Study||16
7667575|NCT02015065|18881934|P3|NOT COMPLETED|Overall Study||1
7667576|NCT02015065|18881935|P2|NOT COMPLETED|Overall Study||2
7667577|NCT02015065|18881936|P1|NOT COMPLETED|Overall Study||1
7667578|NCT02015065|18881934|P3|COMPLETED|Overall Study||1
7667579|NCT02015065|18881935|P2|COMPLETED|Overall Study||3
7667580|NCT02015065|18881936|P1|COMPLETED|Overall Study||1
7667581|NCT02015065|18881934|P3|STARTED|Overall Study||2
7667582|NCT02015065|18881935|P2|STARTED|Overall Study||5
7667583|NCT02015065|18881936|P1|STARTED|Overall Study||2
7667584|NCT02015039|18881958|P2|NOT COMPLETED|Overall Study||1
7667585|NCT02015039|18881959|P1|NOT COMPLETED|Overall Study||0
7667586|NCT02015039|18881958|P2|COMPLETED|Overall Study||6
7667587|NCT02015039|18881959|P1|COMPLETED|Overall Study||6
7667588|NCT02015039|18881958|P2|STARTED|Overall Study||7
7667589|NCT02015039|18881959|P1|STARTED|Overall Study||6
7667590|NCT02014740|18881979|P2|NOT COMPLETED|Overall Study||5
7667591|NCT02014740|18881980|P1|NOT COMPLETED|Overall Study||6
7667592|NCT02014740|18881979|P2|COMPLETED|Overall Study||40
7667593|NCT02014740|18881980|P1|COMPLETED|Overall Study||49
7667594|NCT02014740|18881979|P2|STARTED|Overall Study||45
7667595|NCT02014740|18881980|P1|STARTED|Overall Study||55
7667596|NCT02014597|18881988|P2|NOT COMPLETED|Overall Study||1
7667597|NCT02014597|18881989|P1|NOT COMPLETED|Overall Study||2
7667598|NCT02014597|18881988|P2|COMPLETED|Overall Study||10
7667599|NCT02014597|18881989|P1|COMPLETED|Overall Study||10
7667600|NCT02014597|18881988|P2|STARTED|Overall Study||11
7667601|NCT02014597|18881989|P1|STARTED|Overall Study||12
7667602|NCT02014584|18882005|P6|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
7667603|NCT02014584|18882006|P5|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1
7667604|NCT02014584|18882007|P4|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
7667605|NCT02014584|18882008|P3|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
7667606|NCT02014584|18882009|P2|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
7667607|NCT02014584|18882010|P1|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
7667608|NCT02014584|18882005|P6|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
7667609|NCT02014584|18882006|P5|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
7667610|NCT02014584|18882007|P4|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
7667611|NCT02014584|18882008|P3|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
7667612|NCT02014584|18882009|P2|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
7667613|NCT02014584|18882010|P1|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
7667614|NCT02014584|18882005|P6|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2
7667615|NCT02014584|18882006|P5|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3
7667616|NCT02014584|18882007|P4|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
7667617|NCT02014584|18882008|P3|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
7667618|NCT02014584|18882009|P2|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
7667619|NCT02014584|18882010|P1|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
7667620|NCT02014584|18882005|P6|NOT COMPLETED|Open-Label Period (24 Weeks)||0
7667621|NCT02014584|18882006|P5|NOT COMPLETED|Open-Label Period (24 Weeks)||0
7667622|NCT02014584|18882007|P4|NOT COMPLETED|Open-Label Period (24 Weeks)||1
7667623|NCT02014584|18882008|P3|NOT COMPLETED|Open-Label Period (24 Weeks)||5
7667624|NCT02014584|18882009|P2|NOT COMPLETED|Open-Label Period (24 Weeks)||0
7667625|NCT02014584|18882010|P1|NOT COMPLETED|Open-Label Period (24 Weeks)||0
7667626|NCT02014584|18882005|P6|COMPLETED|Open-Label Period (24 Weeks)||0
7667627|NCT02014584|18882006|P5|COMPLETED|Open-Label Period (24 Weeks)||0
7667628|NCT02014584|18882007|P4|COMPLETED|Open-Label Period (24 Weeks)||47
7667629|NCT02014584|18882008|P3|COMPLETED|Open-Label Period (24 Weeks)||44
7667630|NCT02014584|18882009|P2|COMPLETED|Open-Label Period (24 Weeks)||0
7667631|NCT02014584|18882010|P1|COMPLETED|Open-Label Period (24 Weeks)||0
7667632|NCT02014584|18882005|P6|STARTED|Open-Label Period (24 Weeks)||0
7667633|NCT02014584|18882006|P5|STARTED|Open-Label Period (24 Weeks)||0
7667634|NCT02014584|18882007|P4|STARTED|Open-Label Period (24 Weeks)||48
7667635|NCT02014584|18882008|P3|STARTED|Open-Label Period (24 Weeks)||49
7667636|NCT02014584|18882009|P2|STARTED|Open-Label Period (24 Weeks)||0
7667637|NCT02014584|18882010|P1|STARTED|Open-Label Period (24 Weeks)||0
7667638|NCT02014584|18882005|P6|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
7667639|NCT02014584|18882006|P5|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
7667640|NCT02014584|18882007|P4|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
7667641|NCT02014584|18882008|P3|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
7667642|NCT02014584|18882009|P2|NOT COMPLETED|Double-Blind Period (24 Weeks)||6
7667643|NCT02014584|18882010|P1|NOT COMPLETED|Double-Blind Period (24 Weeks)||2
7667644|NCT02014584|18882005|P6|COMPLETED|Double-Blind Period (24 Weeks)||0
7667645|NCT02014584|18882006|P5|COMPLETED|Double-Blind Period (24 Weeks)||0
7667646|NCT02014584|18882007|P4|COMPLETED|Double-Blind Period (24 Weeks)||0
7667647|NCT02014584|18882008|P3|COMPLETED|Double-Blind Period (24 Weeks)||0
7667648|NCT02014584|18882009|P2|COMPLETED|Double-Blind Period (24 Weeks)||52
7667649|NCT02014584|18882010|P1|COMPLETED|Double-Blind Period (24 Weeks)||57
7667650|NCT02014584|18882005|P6|STARTED|Double-Blind Period (24 Weeks)||0
7667651|NCT02014584|18882006|P5|STARTED|Double-Blind Period (24 Weeks)||0
7667652|NCT02014584|18882007|P4|STARTED|Double-Blind Period (24 Weeks)||0
7667653|NCT02014584|18882008|P3|STARTED|Double-Blind Period (24 Weeks)||0
7667654|NCT02014584|18882009|P2|STARTED|Double-Blind Period (24 Weeks)||58
7667655|NCT02014584|18882010|P1|STARTED|Double-Blind Period (24 Weeks)||59
7667656|NCT02014558|18882140|P13|NOT COMPLETED|Overall Study||17
7667657|NCT02014558|18882141|P12|NOT COMPLETED|Overall Study||102
7667658|NCT02014558|18882142|P11|NOT COMPLETED|Overall Study||69
7667659|NCT02014558|18882143|P10|NOT COMPLETED|Overall Study||21
7667660|NCT02014558|18882144|P9|NOT COMPLETED|Overall Study||15
7667661|NCT02014558|18882145|P8|NOT COMPLETED|Overall Study||11
7667662|NCT02014558|18882146|P7|NOT COMPLETED|Overall Study||4
7667663|NCT02014558|18882147|P6|NOT COMPLETED|Overall Study||3
7667664|NCT02014558|18882148|P5|NOT COMPLETED|Overall Study||4
7667665|NCT02014558|18882149|P4|NOT COMPLETED|Overall Study||3
7667666|NCT02014558|18882150|P3|NOT COMPLETED|Overall Study||3
7667667|NCT02014558|18882151|P2|NOT COMPLETED|Overall Study||3
7667668|NCT02014558|18882152|P1|NOT COMPLETED|Overall Study||5
7667669|NCT02014558|18882140|P13|COMPLETED|Overall Study||0
7667670|NCT02014558|18882141|P12|COMPLETED|Overall Study||0
7667671|NCT02014558|18882142|P11|COMPLETED|Overall Study||0
7667672|NCT02014558|18882143|P10|COMPLETED|Overall Study||0
7667673|NCT02014558|18882144|P9|COMPLETED|Overall Study||0
7667674|NCT02014558|18882145|P8|COMPLETED|Overall Study||0
7667675|NCT02014558|18882146|P7|COMPLETED|Overall Study||0
7667676|NCT02014558|18882147|P6|COMPLETED|Overall Study||0
7667677|NCT02014558|18882148|P5|COMPLETED|Overall Study||0
7667678|NCT02014558|18882149|P4|COMPLETED|Overall Study||0
7667679|NCT02014558|18882150|P3|COMPLETED|Overall Study||0
7667680|NCT02014558|18882151|P2|COMPLETED|Overall Study||0
7667681|NCT02014558|18882152|P1|COMPLETED|Overall Study||0
7667682|NCT02014558|18882140|P13|Treated|Overall Study||17
7667683|NCT02014558|18882141|P12|Treated|Overall Study||100
7667684|NCT02014558|18882142|P11|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|66
7667685|NCT02014558|18882143|P10|Treated|Overall Study||21
7667686|NCT02014558|18882144|P9|Treated|Overall Study||13
7667687|NCT02014558|18882145|P8|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|12
7667688|NCT02014558|18882146|P7|Treated|Overall Study||3
7667689|NCT02014558|18882147|P6|Treated|Overall Study||3
7667690|NCT02014558|18882148|P5|Treated|Overall Study||3
7667691|NCT02014558|18882149|P4|Treated|Overall Study||3
7667692|NCT02014558|18882150|P3|Treated|Overall Study||3
7667693|NCT02014558|18882151|P2|Treated|Overall Study||3
7667694|NCT02014558|18882152|P1|Treated|Overall Study||5
7667695|NCT02014558|18882140|P13|STARTED|Overall Study||17
7667696|NCT02014558|18882141|P12|STARTED|Overall Study||102
7667697|NCT02014558|18882142|P11|STARTED|Overall Study||69
7667698|NCT02014558|18882143|P10|STARTED|Overall Study||21
7667699|NCT02014558|18882144|P9|STARTED|Overall Study||15
7667700|NCT02014558|18882145|P8|STARTED|Overall Study||11
7667701|NCT02014558|18882146|P7|STARTED|Overall Study||4
7667702|NCT02014558|18882147|P6|STARTED|Overall Study||3
7667703|NCT02014558|18882148|P5|STARTED|Overall Study||4
7667704|NCT02014558|18882149|P4|STARTED|Overall Study||3
7667705|NCT02014558|18882150|P3|STARTED|Overall Study||3
7667706|NCT02014558|18882151|P2|STARTED|Overall Study||3
7667707|NCT02014558|18882152|P1|STARTED|Overall Study||5
7667708|NCT02014519|18882460|P1|NOT COMPLETED|Overall Study||0
7667709|NCT02014519|18882460|P1|COMPLETED|Overall Study||2000
7667710|NCT02014519|18882460|P1|STARTED|Overall Study||2000
7667711|NCT02014480|18882517|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
7667712|NCT02014480|18882518|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
7667713|NCT02014480|18882519|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
7667714|NCT02014480|18882520|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
7667715|NCT02014480|18882521|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
7667716|NCT02014480|18882522|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
7667717|NCT02014480|18882517|P6|COMPLETED|Treatment Period 3 (14 Days)||32
7667718|NCT02014480|18882518|P5|COMPLETED|Treatment Period 3 (14 Days)||34
7667719|NCT02014480|18882519|P4|COMPLETED|Treatment Period 3 (14 Days)||31
7667720|NCT02014480|18882520|P3|COMPLETED|Treatment Period 3 (14 Days)||29
7667721|NCT02014480|18882521|P2|COMPLETED|Treatment Period 3 (14 Days)||32
7667722|NCT02014480|18882522|P1|COMPLETED|Treatment Period 3 (14 Days)||34
7667723|NCT02014480|18882517|P6|STARTED|Treatment Period 3 (14 Days)||34
7667724|NCT02014480|18882518|P5|STARTED|Treatment Period 3 (14 Days)||34
7667725|NCT02014480|18882519|P4|STARTED|Treatment Period 3 (14 Days)||31
7667726|NCT02014480|18882520|P3|STARTED|Treatment Period 3 (14 Days)||30
7667727|NCT02014480|18882521|P2|STARTED|Treatment Period 3 (14 Days)||33
7667728|NCT02014480|18882522|P1|STARTED|Treatment Period 3 (14 Days)||34
7667729|NCT02014480|18882517|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
7667730|NCT02014480|18882518|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
7667731|NCT02014480|18882519|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
7667732|NCT02014480|18882520|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
7667733|NCT02014480|18882521|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
7667734|NCT02014480|18882522|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
7667735|NCT02014480|18882517|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||34
7667736|NCT02014480|18882518|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||34
7667737|NCT02014480|18882519|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||31
7667738|NCT02014480|18882520|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||30
7667739|NCT02014480|18882521|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||33
7667740|NCT02014480|18882522|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||34
7667741|NCT02014480|18882517|P6|STARTED|Washout Period 2 (10 to 14 Days)||34
7667742|NCT02014480|18882518|P5|STARTED|Washout Period 2 (10 to 14 Days)||34
7667743|NCT02014480|18882519|P4|STARTED|Washout Period 2 (10 to 14 Days)||31
7667744|NCT02014480|18882520|P3|STARTED|Washout Period 2 (10 to 14 Days)||30
7667745|NCT02014480|18882521|P2|STARTED|Washout Period 2 (10 to 14 Days)||33
7667746|NCT02014480|18882522|P1|STARTED|Washout Period 2 (10 to 14 Days)||34
7667747|NCT02014480|18882517|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
7667748|NCT02014480|18882518|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
7667749|NCT02014480|18882519|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
7667750|NCT02014480|18882520|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
7667751|NCT02014480|18882521|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
7667752|NCT02014480|18882522|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
7667753|NCT02014480|18882517|P6|COMPLETED|Treatment Period 2 (14 Days)||34
7667754|NCT02014480|18882518|P5|COMPLETED|Treatment Period 2 (14 Days)||34
7667755|NCT02014480|18882519|P4|COMPLETED|Treatment Period 2 (14 Days)||31
7667756|NCT02014480|18882520|P3|COMPLETED|Treatment Period 2 (14 Days)||30
7667757|NCT02014480|18882521|P2|COMPLETED|Treatment Period 2 (14 Days)||33
7667758|NCT02014480|18882522|P1|COMPLETED|Treatment Period 2 (14 Days)||34
7667759|NCT02014480|18882517|P6|STARTED|Treatment Period 2 (14 Days)||34
7667760|NCT02014480|18882518|P5|STARTED|Treatment Period 2 (14 Days)||34
7667761|NCT02014480|18882519|P4|STARTED|Treatment Period 2 (14 Days)||32
7667762|NCT02014480|18882520|P3|STARTED|Treatment Period 2 (14 Days)||32
7667763|NCT02014480|18882521|P2|STARTED|Treatment Period 2 (14 Days)||34
7667764|NCT02014480|18882522|P1|STARTED|Treatment Period 2 (14 Days)||35
7667765|NCT02014480|18882517|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
7667766|NCT02014480|18882518|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
7667767|NCT02014480|18882519|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
7667768|NCT02014480|18882520|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
7667769|NCT02014480|18882521|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
7667770|NCT02014480|18882522|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
7667771|NCT02014480|18882517|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||34
7667772|NCT02014480|18882518|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||34
7667773|NCT02014480|18882519|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||32
7667774|NCT02014480|18882520|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||32
7667775|NCT02014480|18882521|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||34
7667776|NCT02014480|18882522|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||35
7667777|NCT02014480|18882517|P6|STARTED|Washout Period 1 (10 to 14 Days)||34
7667778|NCT02014480|18882518|P5|STARTED|Washout Period 1 (10 to 14 Days)||34
7667779|NCT02014480|18882519|P4|STARTED|Washout Period 1 (10 to 14 Days)||32
7667780|NCT02014480|18882520|P3|STARTED|Washout Period 1 (10 to 14 Days)||33
7667781|NCT02014480|18882521|P2|STARTED|Washout Period 1 (10 to 14 Days)||34
7667782|NCT02014480|18882522|P1|STARTED|Washout Period 1 (10 to 14 Days)||35
7667783|NCT02014480|18882517|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||0
7667784|NCT02014480|18882518|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||1
7667785|NCT02014480|18882519|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
7667786|NCT02014480|18882520|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
7667787|NCT02014480|18882521|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
7667788|NCT02014480|18882522|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
7667789|NCT02014480|18882517|P6|COMPLETED|Treatment Period 1 (14 Days)||34
7667790|NCT02014480|18882518|P5|COMPLETED|Treatment Period 1 (14 Days)||34
7667791|NCT02014480|18882519|P4|COMPLETED|Treatment Period 1 (14 Days)||32
7667792|NCT02014480|18882520|P3|COMPLETED|Treatment Period 1 (14 Days)||33
7667793|NCT02014480|18882521|P2|COMPLETED|Treatment Period 1 (14 Days)||34
7667794|NCT02014480|18882522|P1|COMPLETED|Treatment Period 1 (14 Days)||35
7667795|NCT02014480|18882517|P6|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34
7667796|NCT02014480|18882518|P5|STARTED|Treatment Period 1 (14 Days)||35
7667797|NCT02014480|18882519|P4|STARTED|Treatment Period 1 (14 Days)||34
7667798|NCT02014480|18882520|P3|STARTED|Treatment Period 1 (14 Days)||34
7667799|NCT02014480|18882521|P2|STARTED|Treatment Period 1 (14 Days)||35
7667800|NCT02014480|18882522|P1|STARTED|Treatment Period 1 (14 Days)||35
7667801|NCT02014467|18882541|P2|NOT COMPLETED|Overall Study||7
7667802|NCT02014467|18882542|P1|NOT COMPLETED|Overall Study||25
7667803|NCT02014467|18882541|P2|COMPLETED|Overall Study||112
7667804|NCT02014467|18882542|P1|COMPLETED|Overall Study||340
7667805|NCT02014467|18882541|P2|STARTED|Overall Study||119
7667806|NCT02014467|18882542|P1|STARTED|Overall Study||365
7667807|NCT02014441|18882602|P1|NOT COMPLETED|Overall Study||12
7667808|NCT02014441|18882602|P1|COMPLETED|Overall Study||49
7667809|NCT02014441|18882602|P1|Received Treatment|Overall Study||60
7667810|NCT02014441|18882602|P1|STARTED|Overall Study||61
7667811|NCT02014402|18882698|P4|NOT COMPLETED|Overall Study||3
7667812|NCT02014402|18882699|P3|NOT COMPLETED|Overall Study||3
7667813|NCT02014402|18882700|P2|NOT COMPLETED|Overall Study||3
7667814|NCT02014402|18882701|P1|NOT COMPLETED|Overall Study||2
7667815|NCT02014402|18882698|P4|COMPLETED|Overall Study||82
7667816|NCT02014402|18882699|P3|COMPLETED|Overall Study||32
7667817|NCT02014402|18882700|P2|COMPLETED|Overall Study||27
7667818|NCT02014402|18882701|P1|COMPLETED|Overall Study||29
7667819|NCT02014402|18882698|P4|Bovine Thrombin|Overall Study||28
7667820|NCT02014402|18882699|P3|Bovine Thrombin|Overall Study||12
7667821|NCT02014402|18882700|P2|Bovine Thrombin|Overall Study||10
7667822|NCT02014402|18882701|P1|Bovine Thrombin|Overall Study||11
7667823|NCT02014402|18882698|P4|Human Thrombin|Overall Study||57
7667824|NCT02014402|18882699|P3|Human Thrombin|Overall Study||23
7667825|NCT02014402|18882700|P2|Human Thrombin|Overall Study||20
7667826|NCT02014402|18882701|P1|Human Thrombin|Overall Study||20
7667827|NCT02014402|18882698|P4|STARTED|Overall Study||85
7667828|NCT02014402|18882699|P3|STARTED|Overall Study||35
7667829|NCT02014402|18882700|P2|STARTED|Overall Study||30
7667830|NCT02014402|18882701|P1|STARTED|Overall Study||31
7667831|NCT02014376|18882731|P3|NOT COMPLETED|Overall Study||0
7667832|NCT02014376|18882732|P2|NOT COMPLETED|Overall Study||1
7667833|NCT02014376|18882733|P1|NOT COMPLETED|Overall Study||3
7667834|NCT02014376|18882731|P3|COMPLETED|Overall Study||17
7667835|NCT02014376|18882732|P2|COMPLETED|Overall Study||15
7667836|NCT02014376|18882733|P1|COMPLETED|Overall Study||12
7667837|NCT02014376|18882731|P3|Received at Least 1 Dose of Study Drug|Overall Study||17
7667838|NCT02014376|18882732|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
7667839|NCT02014376|18882733|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
7667840|NCT02014376|18882731|P3|STARTED|Overall Study||17
7667841|NCT02014376|18882732|P2|STARTED|Overall Study||16
7667842|NCT02014376|18882733|P1|STARTED|Overall Study||15
7667843|NCT02014363|18882759|P3|NOT COMPLETED|Overall Study||24
7667844|NCT02014363|18882760|P2|NOT COMPLETED|Overall Study||19
7667845|NCT02014363|18882761|P1|NOT COMPLETED|Overall Study||17
7667846|NCT02014363|18882759|P3|COMPLETED|Overall Study||31
7667847|NCT02014363|18882760|P2|COMPLETED|Overall Study||35
7667848|NCT02014363|18882761|P1|COMPLETED|Overall Study||38
7667849|NCT02014363|18882759|P3|STARTED|Overall Study||55
7667850|NCT02014363|18882760|P2|STARTED|Overall Study||54
7667851|NCT02014363|18882761|P1|STARTED|Overall Study||55
7667852|NCT02014272|18882769|P2|NOT COMPLETED|Intervention Period 2||0
7667853|NCT02014272|18882770|P1|NOT COMPLETED|Intervention Period 2||0
7667854|NCT02014272|18882769|P2|COMPLETED|Intervention Period 2||13
7667855|NCT02014272|18882770|P1|COMPLETED|Intervention Period 2||13
7667856|NCT02014272|18882769|P2|STARTED|Intervention Period 2||13
7667857|NCT02014272|18882770|P1|STARTED|Intervention Period 2||13
7667858|NCT02014272|18882769|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
7667859|NCT02014272|18882770|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
7667860|NCT02014272|18882769|P2|COMPLETED|Washout Period 1 (7 Days)||13
7667861|NCT02014272|18882770|P1|COMPLETED|Washout Period 1 (7 Days)||13
7667862|NCT02014272|18882769|P2|STARTED|Washout Period 1 (7 Days)||13
7667863|NCT02014272|18882770|P1|STARTED|Washout Period 1 (7 Days)||13
7667864|NCT02014272|18882769|P2|NOT COMPLETED|Intervention Period 1||1
7667865|NCT02014272|18882770|P1|NOT COMPLETED|Intervention Period 1||1
7667866|NCT02014272|18882769|P2|COMPLETED|Intervention Period 1||13
7667867|NCT02014272|18882770|P1|COMPLETED|Intervention Period 1||13
7667868|NCT02014272|18882769|P2|STARTED|Intervention Period 1||14
7667869|NCT02014272|18882770|P1|STARTED|Intervention Period 1||14
7667870|NCT02014129|18882791|P3|NOT COMPLETED|Overall Study||0
7667871|NCT02014129|18882792|P2|NOT COMPLETED|Overall Study||0
7667872|NCT02014129|18882793|P1|NOT COMPLETED|Overall Study||0
7667873|NCT02014129|18882791|P3|COMPLETED|Overall Study||6
7667874|NCT02014129|18882792|P2|COMPLETED|Overall Study||3
7667875|NCT02014129|18882793|P1|COMPLETED|Overall Study||3
7667876|NCT02014129|18882791|P3|Received at Least One Dose of Study Drug|Overall Study||6
7667877|NCT02014129|18882792|P2|Received at Least One Dose of Study Drug|Overall Study||3
7667878|NCT02014129|18882793|P1|Received at Least One Dose of Study Drug|Overall Study||3
7667879|NCT02014129|18882791|P3|STARTED|Overall Study||6
7667880|NCT02014129|18882792|P2|STARTED|Overall Study||3
7667881|NCT02014129|18882793|P1|STARTED|Overall Study||3
7667882|NCT02014116|18882819|P9|NOT COMPLETED|Overall Study||10
7667883|NCT02014116|18882820|P8|NOT COMPLETED|Overall Study||5
7667884|NCT02014116|18882821|P7|NOT COMPLETED|Overall Study||1
7667885|NCT02014116|18882822|P6|NOT COMPLETED|Overall Study||16
7667886|NCT02014116|18882823|P5|NOT COMPLETED|Overall Study||2
7667887|NCT02014116|18882824|P4|NOT COMPLETED|Overall Study||7
7667888|NCT02014116|18882825|P3|NOT COMPLETED|Overall Study||3
7667889|NCT02014116|18882826|P2|NOT COMPLETED|Overall Study||4
7667890|NCT02014116|18882827|P1|NOT COMPLETED|Overall Study||3
7667891|NCT02014116|18882819|P9|COMPLETED|Overall Study||0
7667892|NCT02014116|18882820|P8|COMPLETED|Overall Study||0
7667893|NCT02014116|18882821|P7|COMPLETED|Overall Study||0
7667894|NCT02014116|18882822|P6|COMPLETED|Overall Study||0
7667895|NCT02014116|18882823|P5|COMPLETED|Overall Study||0
7667896|NCT02014116|18882824|P4|COMPLETED|Overall Study||0
7667897|NCT02014116|18882825|P3|COMPLETED|Overall Study||0
7667898|NCT02014116|18882826|P2|COMPLETED|Overall Study||0
7667899|NCT02014116|18882827|P1|COMPLETED|Overall Study||0
7667900|NCT02014116|18882819|P9|Received at Least One Dose of Study Drug|Overall Study||10
7667901|NCT02014116|18882820|P8|Received at Least One Dose of Study Drug|Overall Study||5
7667902|NCT02014116|18882821|P7|Received at Least One Dose of Study Drug|Overall Study||1
7667903|NCT02014116|18882822|P6|Received at Least One Dose of Study Drug|Overall Study||16
7667904|NCT02014116|18882823|P5|Received at Least One Dose of Study Drug|Overall Study||2
7667905|NCT02014116|18882824|P4|Received at Least One Dose of Study Drug|Overall Study||7
7667906|NCT02014116|18882825|P3|Received at Least One Dose of Study Drug|Overall Study||3
7667907|NCT02014116|18882826|P2|Received at Least One Dose of Study Drug|Overall Study||4
7667908|NCT02014116|18882827|P1|Received at Least One Dose of Study Drug|Overall Study||3
7667909|NCT02014116|18882819|P9|STARTED|Overall Study||10
7667910|NCT02014116|18882820|P8|STARTED|Overall Study||5
7667911|NCT02014116|18882821|P7|STARTED|Overall Study||1
7667912|NCT02014116|18882822|P6|STARTED|Overall Study||16
7667913|NCT02014116|18882823|P5|STARTED|Overall Study||2
7667914|NCT02014116|18882824|P4|STARTED|Overall Study||7
7667915|NCT02014116|18882825|P3|STARTED|Overall Study||3
7667916|NCT02014116|18882826|P2|STARTED|Overall Study||4
7667917|NCT02014116|18882827|P1|STARTED|Overall Study||3
7667918|NCT02014051|18882878|P2|NOT COMPLETED|Overall Study||1
7667919|NCT02014051|18882879|P1|NOT COMPLETED|Overall Study||1
7667920|NCT02014051|18882878|P2|COMPLETED|Overall Study||5
7667921|NCT02014051|18882879|P1|COMPLETED|Overall Study||2
7667922|NCT02014051|18882878|P2|STARTED|Overall Study||6
7667923|NCT02014051|18882879|P1|STARTED|Overall Study||3
7667924|NCT02013830|18882892|P1|NOT COMPLETED|Overall Study||30
7667925|NCT02013830|18882892|P1|COMPLETED|Overall Study||15
7667926|NCT02013830|18882892|P1|STARTED|Overall Study||45
7667927|NCT02013817|18882903|P1|NOT COMPLETED|Overall Study||27
7667928|NCT02013817|18882903|P1|COMPLETED|Overall Study||16
7667929|NCT02013817|18882903|P1|STARTED|Overall Study||43
7667930|NCT02013791|18882921|P9|NOT COMPLETED|Period 2||0
7667931|NCT02013791|18882922|P8|NOT COMPLETED|Period 2||0
7667932|NCT02013791|18882923|P7|NOT COMPLETED|Period 2||0
7667933|NCT02013791|18882924|P6|NOT COMPLETED|Period 2||0
7667934|NCT02013791|18882925|P5|NOT COMPLETED|Period 2||0
7667935|NCT02013791|18882926|P4|NOT COMPLETED|Period 2||0
7667936|NCT02013791|18882927|P3|NOT COMPLETED|Period 2||0
7667937|NCT02013791|18882928|P2|NOT COMPLETED|Period 2||0
7667938|NCT02013791|18882929|P1|NOT COMPLETED|Period 2||0
7667939|NCT02013791|18882921|P9|COMPLETED|Period 2||0
7667940|NCT02013791|18882922|P8|COMPLETED|Period 2||0
7667941|NCT02013791|18882923|P7|COMPLETED|Period 2||3
7667942|NCT02013791|18882924|P6|COMPLETED|Period 2||0
7667943|NCT02013791|18882925|P5|COMPLETED|Period 2||0
7667944|NCT02013791|18882926|P4|COMPLETED|Period 2||0
7667945|NCT02013791|18882927|P3|COMPLETED|Period 2||2
7667946|NCT02013791|18882928|P2|COMPLETED|Period 2||0
7667947|NCT02013791|18882929|P1|COMPLETED|Period 2||0
7667948|NCT02013791|18882921|P9|STARTED|Period 2||0
7667949|NCT02013791|18882922|P8|STARTED|Period 2||0
7667950|NCT02013791|18882923|P7|STARTED|Period 2||3
7667951|NCT02013791|18882924|P6|STARTED|Period 2||0
7667952|NCT02013791|18882925|P5|STARTED|Period 2||0
7667953|NCT02013791|18882926|P4|STARTED|Period 2||0
7667954|NCT02013791|18882927|P3|STARTED|Period 2||2
7667955|NCT02013791|18882928|P2|STARTED|Period 2||0
7667956|NCT02013791|18882929|P1|STARTED|Period 2||0
7667957|NCT02013791|18882921|P9|NOT COMPLETED|Period 1||0
7667958|NCT02013791|18882922|P8|NOT COMPLETED|Period 1||1
7667959|NCT02013791|18882923|P7|NOT COMPLETED|Period 1||1
7667960|NCT02013791|18882924|P6|NOT COMPLETED|Period 1||0
7667961|NCT02013791|18882925|P5|NOT COMPLETED|Period 1||0
7667962|NCT02013791|18882926|P4|NOT COMPLETED|Period 1||1
7667963|NCT02013791|18882927|P3|NOT COMPLETED|Period 1||0
7667964|NCT02013791|18882928|P2|NOT COMPLETED|Period 1||2
7667965|NCT02013791|18882929|P1|NOT COMPLETED|Period 1||0
7667966|NCT02013791|18882921|P9|COMPLETED|Period 1||3
7667967|NCT02013791|18882922|P8|COMPLETED|Period 1||7
7667968|NCT02013791|18882923|P7|COMPLETED|Period 1||3
7667969|NCT02013791|18882924|P6|COMPLETED|Period 1||8
7667970|NCT02013791|18882925|P5|COMPLETED|Period 1||4
7667971|NCT02013791|18882926|P4|COMPLETED|Period 1||7
7667972|NCT02013791|18882927|P3|COMPLETED|Period 1||4
7667973|NCT02013791|18882928|P2|COMPLETED|Period 1||6
7667974|NCT02013791|18882929|P1|COMPLETED|Period 1||8
7667975|NCT02013791|18882921|P9|STARTED|Period 1||3
7667976|NCT02013791|18882922|P8|STARTED|Period 1||8
7667977|NCT02013791|18882923|P7|STARTED|Period 1||4
7667978|NCT02013791|18882924|P6|STARTED|Period 1||8
7667979|NCT02013791|18882925|P5|STARTED|Period 1||4
7667980|NCT02013791|18882926|P4|STARTED|Period 1||8
7667981|NCT02013791|18882927|P3|STARTED|Period 1||4
7667982|NCT02013791|18882928|P2|STARTED|Period 1||8
7667983|NCT02013791|18882929|P1|STARTED|Period 1||8
7667984|NCT02013778|18882950|P1|NOT COMPLETED|Overall Study||7
7667985|NCT02013778|18882950|P1|COMPLETED|Overall Study||1
7667986|NCT02013778|18882950|P1|STARTED|Overall Study||8
7667987|NCT02013765|18882954|P1|NOT COMPLETED|Overall Study||1
7667988|NCT02013765|18882954|P1|COMPLETED|Overall Study||4
7667989|NCT02013765|18882954|P1|STARTED|Overall Study||5
7667990|NCT02013687|18882968|P4|NOT COMPLETED|Overall Study||2
7667991|NCT02013687|18882969|P3|NOT COMPLETED|Overall Study||2
7667992|NCT02013687|18882970|P2|NOT COMPLETED|Overall Study||0
7667993|NCT02013687|18882971|P1|NOT COMPLETED|Overall Study||0
7667994|NCT02013687|18882968|P4|COMPLETED|Overall Study||14
7667995|NCT02013687|18882969|P3|COMPLETED|Overall Study||14
7667996|NCT02013687|18882970|P2|COMPLETED|Overall Study||6
7667997|NCT02013687|18882971|P1|COMPLETED|Overall Study||6
7667998|NCT02013687|18882968|P4|STARTED|Overall Study||16
7667999|NCT02013687|18882969|P3|STARTED|Overall Study||16
7668000|NCT02013687|18882970|P2|STARTED|Overall Study||6
7668001|NCT02013687|18882971|P1|STARTED|Overall Study||6
7668002|NCT02013674|18883003|P2|NOT COMPLETED|Overall Study||1
7668003|NCT02013674|18883004|P1|NOT COMPLETED|Overall Study||1
7668004|NCT02013674|18883003|P2|COMPLETED|Overall Study||14
7668005|NCT02013674|18883004|P1|COMPLETED|Overall Study||14
7668006|NCT02013674|18883003|P2|STARTED|Overall Study||15
7668007|NCT02013674|18883004|P1|STARTED|Overall Study||15
7668008|NCT02013622|18883054|P1|NOT COMPLETED|Overall Study||24
7668009|NCT02013622|18883054|P1|COMPLETED|Overall Study||25
7668010|NCT02013622|18883054|P1|STARTED|Overall Study||49
7668011|NCT02013609|18883074|P1|NOT COMPLETED|Overall Study||18
7668012|NCT02013609|18883074|P1|COMPLETED|Overall Study||29
7668105|NCT02012959|18883340|P3|NOT COMPLETED|Treatment Phase B||0
7668013|NCT02013609|18883074|P1|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47
7668014|NCT02013544|18883099|P2|NOT COMPLETED|Overall Study||20
7668015|NCT02013544|18883100|P1|NOT COMPLETED|Overall Study||11
7668016|NCT02013544|18883099|P2|COMPLETED|Overall Study||356
7668017|NCT02013544|18883100|P1|COMPLETED|Overall Study||171
7668018|NCT02013544|18883099|P2|ITT Population|Overall Study||325
7668019|NCT02013544|18883100|P1|ITT Population|Overall Study||157
7668020|NCT02013544|18883099|P2|Safety Population|Overall Study||374
7668021|NCT02013544|18883100|P1|Safety Population|Overall Study||180
7668022|NCT02013544|18883099|P2|STARTED|Overall Study||376
7668023|NCT02013544|18883100|P1|STARTED|Overall Study||182
7668024|NCT02013531|18883122|P1|NOT COMPLETED|Overall Study||5
7668025|NCT02013531|18883122|P1|COMPLETED|Overall Study||32
7668026|NCT02013531|18883122|P1|STARTED|Overall Study||37
7668027|NCT02013414|18883144|P1|NOT COMPLETED|Overall Study||0
7668028|NCT02013414|18883144|P1|COMPLETED|Overall Study||9
7668029|NCT02013414|18883144|P1|STARTED|Overall Study||9
7668030|NCT02013388|18883158|P8|NOT COMPLETED|Overall Study||0
7668031|NCT02013388|18883159|P7|NOT COMPLETED|Overall Study||0
7668032|NCT02013388|18883160|P6|NOT COMPLETED|Overall Study||0
7668033|NCT02013388|18883161|P5|NOT COMPLETED|Overall Study||1
7668034|NCT02013388|18883162|P4|NOT COMPLETED|Overall Study||0
7668035|NCT02013388|18883163|P3|NOT COMPLETED|Overall Study||0
7668036|NCT02013388|18883164|P2|NOT COMPLETED|Overall Study||0
7668037|NCT02013388|18883165|P1|NOT COMPLETED|Overall Study||1
7668038|NCT02013388|18883158|P8|COMPLETED|Overall Study||4
7668039|NCT02013388|18883159|P7|COMPLETED|Overall Study||6
7668040|NCT02013388|18883160|P6|COMPLETED|Overall Study||6
7668041|NCT02013388|18883161|P5|COMPLETED|Overall Study||5
7668042|NCT02013388|18883162|P4|COMPLETED|Overall Study||6
7668043|NCT02013388|18883163|P3|COMPLETED|Overall Study||6
7668044|NCT02013388|18883164|P2|COMPLETED|Overall Study||6
7668045|NCT02013388|18883165|P1|COMPLETED|Overall Study||8
7668046|NCT02013388|18883158|P8|STARTED|Overall Study||4
7668047|NCT02013388|18883159|P7|STARTED|Overall Study||6
7668048|NCT02013388|18883160|P6|STARTED|Overall Study||6
7668049|NCT02013388|18883161|P5|STARTED|Overall Study||6
7668050|NCT02013388|18883162|P4|STARTED|Overall Study||6
7668051|NCT02013388|18883163|P3|STARTED|Overall Study||6
7668052|NCT02013388|18883164|P2|STARTED|Overall Study||6
7668053|NCT02013388|18883165|P1|STARTED|Overall Study||9
7668054|NCT02013375|18883199|P1|NOT COMPLETED|Overall Study||2
7668055|NCT02013375|18883199|P1|COMPLETED|Overall Study||0
7668056|NCT02013375|18883199|P1|STARTED|Overall Study||2
7668057|NCT02013245|18883210|P4|NOT COMPLETED|Overall Study||0
7668058|NCT02013245|18883211|P3|NOT COMPLETED|Overall Study||0
7668059|NCT02013245|18883212|P2|NOT COMPLETED|Overall Study||1
7668060|NCT02013245|18883213|P1|NOT COMPLETED|Overall Study||0
7668061|NCT02013245|18883210|P4|COMPLETED|Overall Study||9
7668062|NCT02013245|18883211|P3|COMPLETED|Overall Study||9
7668063|NCT02013245|18883212|P2|COMPLETED|Overall Study||8
7668064|NCT02013245|18883213|P1|COMPLETED|Overall Study||9
7668065|NCT02013245|18883210|P4|STARTED|Overall Study||9
7668066|NCT02013245|18883211|P3|STARTED|Overall Study||9
7668067|NCT02013245|18883212|P2|STARTED|Overall Study||9
7668068|NCT02013245|18883213|P1|STARTED|Overall Study||9
7668069|NCT02013206|18883229|P2|NOT COMPLETED|Overall Study||22
7668070|NCT02013206|18883230|P1|NOT COMPLETED|Overall Study||27
7668071|NCT02013206|18883229|P2|COMPLETED|Overall Study||1
7668072|NCT02013206|18883230|P1|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2
7668073|NCT02013206|18883229|P2|Received Study Drug|Overall Study||23
7668074|NCT02013206|18883230|P1|Received Study Drug|Overall Study||26
7668075|NCT02013206|18883229|P2|STARTED|Overall Study||23
7668076|NCT02013206|18883230|P1|STARTED|Overall Study||29
7668077|NCT02013180|18883252|P2|NOT COMPLETED|Overall Study||0
7668078|NCT02013180|18883253|P1|NOT COMPLETED|Overall Study||0
7668079|NCT02013180|18883252|P2|COMPLETED|Overall Study||361
7668080|NCT02013180|18883253|P1|COMPLETED|Overall Study||119
7668081|NCT02013180|18883252|P2|STARTED|Overall Study||361
7668082|NCT02013180|18883253|P1|STARTED|Overall Study||119
7668083|NCT02013167|18883261|P2|NOT COMPLETED|Overall Study||178
7668084|NCT02013167|18883262|P1|NOT COMPLETED|Overall Study||101
7668085|NCT02013167|18883261|P2|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off; 22 were receiving treatment|93
7668086|NCT02013167|18883262|P1|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off|33
7668087|NCT02013167|18883261|P2|Received Treatment|Overall Study||267
7668088|NCT02013167|18883262|P1|Received Treatment|Overall Study||109
7668089|NCT02013167|18883261|P2|STARTED|Overall Study||271
7668090|NCT02013167|18883262|P1|STARTED|Overall Study||134
7668091|NCT02013050|18883293|P4|NOT COMPLETED|Overall Study||4
7668092|NCT02013050|18883294|P3|NOT COMPLETED|Overall Study||0
7668093|NCT02013050|18883295|P2|NOT COMPLETED|Overall Study||5
7668094|NCT02013050|18883296|P1|NOT COMPLETED|Overall Study||4
7668095|NCT02013050|18883293|P4|COMPLETED|Overall Study||19
7668096|NCT02013050|18883294|P3|COMPLETED|Overall Study||3
7668097|NCT02013050|18883295|P2|COMPLETED|Overall Study||36
7668098|NCT02013050|18883296|P1|COMPLETED|Overall Study||38
7668099|NCT02013050|18883293|P4|STARTED|Overall Study||23
7668100|NCT02013050|18883294|P3|STARTED|Overall Study||3
7668101|NCT02013050|18883295|P2|STARTED|Overall Study||41
7668102|NCT02013050|18883296|P1|STARTED|Overall Study||42
7668103|NCT02012959|18883338|P5|NOT COMPLETED|Treatment Phase B||0
7668104|NCT02012959|18883339|P4|NOT COMPLETED|Treatment Phase B||0
7668106|NCT02012959|18883341|P2|NOT COMPLETED|Treatment Phase B||0
7668107|NCT02012959|18883342|P1|NOT COMPLETED|Treatment Phase B||0
7668108|NCT02012959|18883338|P5|COMPLETED|Treatment Phase B||1
7668109|NCT02012959|18883339|P4|COMPLETED|Treatment Phase B||1
7668110|NCT02012959|18883340|P3|COMPLETED|Treatment Phase B||3
7668111|NCT02012959|18883341|P2|COMPLETED|Treatment Phase B||2
7668112|NCT02012959|18883342|P1|COMPLETED|Treatment Phase B||0
7668113|NCT02012959|18883338|P5|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
7668114|NCT02012959|18883339|P4|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
7668115|NCT02012959|18883340|P3|Received At Least 1 Dose of Study Drug|Treatment Phase B||3
7668116|NCT02012959|18883341|P2|Received At Least 1 Dose of Study Drug|Treatment Phase B||2
7668117|NCT02012959|18883342|P1|Received At Least 1 Dose of Study Drug|Treatment Phase B||0
7668118|NCT02012959|18883338|P5|STARTED|Treatment Phase B|Participants in this group could receive the investigator's preferred standard of care|1
7668119|NCT02012959|18883339|P4|STARTED|Treatment Phase B|Participants in this group could continue study drug treatment, per the investigator's discretion|1
7668120|NCT02012959|18883340|P3|STARTED|Treatment Phase B|Participants in this group did not receive additional study drug after Phase A|3
7668121|NCT02012959|18883341|P2|STARTED|Treatment Phase B|Participants in this group continued treatment with the study drug|2
7668122|NCT02012959|18883342|P1|STARTED|Treatment Phase B|Zero participants noted because participants had completed Phase A|0
7668123|NCT02012959|18883338|P5|NOT COMPLETED|Treatment Phase A||0
7668124|NCT02012959|18883339|P4|NOT COMPLETED|Treatment Phase A||0
7668125|NCT02012959|18883340|P3|NOT COMPLETED|Treatment Phase A||0
7668126|NCT02012959|18883341|P2|NOT COMPLETED|Treatment Phase A||0
7668127|NCT02012959|18883342|P1|NOT COMPLETED|Treatment Phase A||2
7668128|NCT02012959|18883338|P5|COMPLETED|Treatment Phase A||0
7668129|NCT02012959|18883339|P4|COMPLETED|Treatment Phase A||0
7668130|NCT02012959|18883340|P3|COMPLETED|Treatment Phase A||0
7668131|NCT02012959|18883341|P2|COMPLETED|Treatment Phase A||0
7668132|NCT02012959|18883342|P1|COMPLETED|Treatment Phase A||7
7668133|NCT02012959|18883338|P5|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
7668134|NCT02012959|18883339|P4|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
7668135|NCT02012959|18883340|P3|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
7668136|NCT02012959|18883341|P2|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
7668137|NCT02012959|18883342|P1|Received At Least 1 Dose of Study Drug|Treatment Phase A||9
7668138|NCT02012959|18883338|P5|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
7668139|NCT02012959|18883339|P4|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
7668140|NCT02012959|18883340|P3|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
7668141|NCT02012959|18883341|P2|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
7668142|NCT02012959|18883342|P1|STARTED|Treatment Phase A||9
7668143|NCT02012686|18883355|P2|NOT COMPLETED|Overall Study||2
7668144|NCT02012686|18883356|P1|NOT COMPLETED|Overall Study||0
7668145|NCT02012686|18883355|P2|COMPLETED|Overall Study||48
7668146|NCT02012686|18883356|P1|COMPLETED|Overall Study||50
7668147|NCT02012686|18883355|P2|STARTED|Overall Study||50
7668148|NCT02012686|18883356|P1|STARTED|Overall Study||50
7668149|NCT02012621|18883368|P1|NOT COMPLETED|Overall Study||0
7668150|NCT02012621|18883368|P1|COMPLETED|Overall Study||807
7668151|NCT02012621|18883368|P1|Visit 3 Completed|Overall Study||444
7668152|NCT02012621|18883368|P1|Visit 2 Completed|Overall Study||688
7668153|NCT02012621|18883368|P1|Visit 1 Completed|Overall Study||807
7668154|NCT02012621|18883368|P1|STARTED|Overall Study||807
7668155|NCT02012608|18883376|P2|NOT COMPLETED|Overall Study||0
7668156|NCT02012608|18883377|P1|NOT COMPLETED|Overall Study||3
7668157|NCT02012608|18883376|P2|COMPLETED|Overall Study||7
7668158|NCT02012608|18883377|P1|COMPLETED|Overall Study||4
7668159|NCT02012608|18883376|P2|STARTED|Overall Study||7
7668160|NCT02012608|18883377|P1|STARTED|Overall Study||7
7668161|NCT02012582|18883387|P4|NOT COMPLETED|Overall Study||1
7668162|NCT02012582|18883388|P3|NOT COMPLETED|Overall Study||0
7668163|NCT02012582|18883389|P2|NOT COMPLETED|Overall Study||0
7668164|NCT02012582|18883390|P1|NOT COMPLETED|Overall Study||0
7668165|NCT02012582|18883387|P4|COMPLETED|Overall Study||7
7668166|NCT02012582|18883388|P3|COMPLETED|Overall Study||8
7668167|NCT02012582|18883389|P2|COMPLETED|Overall Study||8
7668168|NCT02012582|18883390|P1|COMPLETED|Overall Study||8
7668169|NCT02012582|18883387|P4|STARTED|Overall Study||8
7668170|NCT02012582|18883388|P3|STARTED|Overall Study||8
7668171|NCT02012582|18883389|P2|STARTED|Overall Study||8
7668172|NCT02012582|18883390|P1|STARTED|Overall Study||8
7668173|NCT02012491|18883418|P2|NOT COMPLETED|Overall Study||1
7668174|NCT02012491|18883419|P1|NOT COMPLETED|Overall Study||2
7668175|NCT02012491|18883418|P2|COMPLETED|Overall Study||148
7668176|NCT02012491|18883419|P1|COMPLETED|Overall Study||149
7668177|NCT02012491|18883418|P2|STARTED|Overall Study||149
7668178|NCT02012491|18883419|P1|STARTED|Overall Study||151
7668179|NCT02012452|18883437|P2|NOT COMPLETED|Overall Study||1
7668180|NCT02012452|18883438|P1|NOT COMPLETED|Overall Study||6
7668181|NCT02012452|18883437|P2|COMPLETED|Overall Study||1
7668182|NCT02012452|18883438|P1|COMPLETED|Overall Study||1
7668183|NCT02012452|18883437|P2|STARTED|Overall Study||2
7668184|NCT02012452|18883438|P1|STARTED|Overall Study||7
7668185|NCT02012348|18883449|P3|NOT COMPLETED|Overall Study||0
7668186|NCT02012348|18883450|P2|NOT COMPLETED|Overall Study||0
7668187|NCT02012348|18883451|P1|NOT COMPLETED|Overall Study||0
7668188|NCT02012348|18883449|P3|COMPLETED|Overall Study||10
7668189|NCT02012348|18883450|P2|COMPLETED|Overall Study||10
7668190|NCT02012348|18883451|P1|COMPLETED|Overall Study||10
7668191|NCT02012348|18883449|P3|STARTED|Overall Study||10
7668192|NCT02012348|18883450|P2|STARTED|Overall Study||10
7668193|NCT02012348|18883451|P1|STARTED|Overall Study||10
7668194|NCT02012283|18883464|P2|NOT COMPLETED|Third Intervention||0
7668195|NCT02012283|18883465|P1|NOT COMPLETED|Third Intervention||0
7668196|NCT02012283|18883464|P2|COMPLETED|Third Intervention||10
7668197|NCT02012283|18883465|P1|COMPLETED|Third Intervention||10
7668198|NCT02012283|18883464|P2|STARTED|Third Intervention||10
7668199|NCT02012283|18883465|P1|STARTED|Third Intervention||10
7668200|NCT02012283|18883464|P2|NOT COMPLETED|Second Intervention||0
7668201|NCT02012283|18883465|P1|NOT COMPLETED|Second Intervention||0
7668202|NCT02012283|18883464|P2|COMPLETED|Second Intervention||10
7668203|NCT02012283|18883465|P1|COMPLETED|Second Intervention||10
7668204|NCT02012283|18883464|P2|STARTED|Second Intervention||10
7668205|NCT02012283|18883465|P1|STARTED|Second Intervention||10
7668206|NCT02012283|18883464|P2|NOT COMPLETED|First Intervention||0
7668207|NCT02012283|18883465|P1|NOT COMPLETED|First Intervention||0
7668208|NCT02012283|18883464|P2|COMPLETED|First Intervention||10
7668209|NCT02012283|18883465|P1|COMPLETED|First Intervention||10
7668210|NCT02012283|18883464|P2|STARTED|First Intervention||10
7668211|NCT02012283|18883465|P1|STARTED|First Intervention||10
7668212|NCT02012218|18883481|P5|NOT COMPLETED|Overall Study||1
7668213|NCT02012218|18883482|P4|NOT COMPLETED|Overall Study||2
7668214|NCT02012218|18883483|P3|NOT COMPLETED|Overall Study||2
7668215|NCT02012218|18883484|P2|NOT COMPLETED|Overall Study||1
7668216|NCT02012218|18883485|P1|NOT COMPLETED|Overall Study||4
7668217|NCT02012218|18883481|P5|COMPLETED|Overall Study||5
7668218|NCT02012218|18883482|P4|COMPLETED|Overall Study||17
7668219|NCT02012218|18883483|P3|COMPLETED|Overall Study||11
7668220|NCT02012218|18883484|P2|COMPLETED|Overall Study||10
7668221|NCT02012218|18883485|P1|COMPLETED|Overall Study||8
7668222|NCT02012218|18883481|P5|STARTED|Overall Study||6
7668223|NCT02012218|18883482|P4|STARTED|Overall Study||19
7668224|NCT02012218|18883483|P3|STARTED|Overall Study||13
7668225|NCT02012218|18883484|P2|STARTED|Overall Study||11
7668226|NCT02012218|18883485|P1|STARTED|Overall Study||12
7668227|NCT02012192|18883499|P2|NOT COMPLETED|Overall Study||0
7668228|NCT02012192|18883500|P1|NOT COMPLETED|Overall Study||27
7668229|NCT02012192|18883499|P2|COMPLETED|Overall Study||43
7668230|NCT02012192|18883500|P1|COMPLETED|Overall Study||63
7668231|NCT02012192|18883499|P2|STARTED|Overall Study||43
7668232|NCT02012192|18883500|P1|STARTED|Overall Study||90
7668233|NCT02011945|18883509|P3|NOT COMPLETED|Overall Study||10
7668234|NCT02011945|18883510|P2|NOT COMPLETED|Overall Study||10
7668235|NCT02011945|18883511|P1|NOT COMPLETED|Overall Study||2
7668236|NCT02011945|18883509|P3|COMPLETED|Overall Study||6
7668237|NCT02011945|18883510|P2|COMPLETED|Overall Study||3
7668238|NCT02011945|18883511|P1|COMPLETED|Overall Study||0
7668239|NCT02011945|18883509|P3|STARTED|Overall Study||16
7668240|NCT02011945|18883510|P2|STARTED|Overall Study||13
7668241|NCT02011945|18883511|P1|STARTED|Overall Study||2
7668242|NCT02011893|18883588|P3|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1
7668243|NCT02011893|18883589|P2|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
7668244|NCT02011893|18883590|P1|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
7668245|NCT02011893|18883588|P3|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51
7668246|NCT02011893|18883589|P2|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45
7668247|NCT02011893|18883590|P1|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
7668248|NCT02011893|18883588|P3|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
7668249|NCT02011893|18883589|P2|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45
7668250|NCT02011893|18883590|P1|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
7668251|NCT02011893|18883588|P3|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
7668252|NCT02011893|18883589|P2|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44
7668253|NCT02011893|18883590|P1|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
7668254|NCT02011893|18883588|P3|STARTED|Period 2 (12 Weeks to 24 Weeks)||52
7668255|NCT02011893|18883589|P2|STARTED|Period 2 (12 Weeks to 24 Weeks)||45
7668256|NCT02011893|18883590|P1|STARTED|Period 2 (12 Weeks to 24 Weeks)||0
7668257|NCT02011893|18883588|P3|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3
7668258|NCT02011893|18883589|P2|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
7668259|NCT02011893|18883590|P1|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
7668260|NCT02011893|18883588|P3|COMPLETED|Period 1 (Randomization to 12 Weeks)||52
7668261|NCT02011893|18883589|P2|COMPLETED|Period 1 (Randomization to 12 Weeks)||45
7668262|NCT02011893|18883590|P1|COMPLETED|Period 1 (Randomization to 12 Weeks)||0
7668263|NCT02011893|18883588|P3|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
7668264|NCT02011893|18883589|P2|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
7668265|NCT02011893|18883590|P1|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
7668266|NCT02011893|18883588|P3|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
7668267|NCT02011893|18883589|P2|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
7668268|NCT02011893|18883590|P1|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
7668269|NCT02011893|18883588|P3|STARTED|Period 1 (Randomization to 12 Weeks)||55
7668270|NCT02011893|18883589|P2|STARTED|Period 1 (Randomization to 12 Weeks)||45
7668271|NCT02011893|18883590|P1|STARTED|Period 1 (Randomization to 12 Weeks)||0
7668272|NCT02011893|18883588|P3|NOT COMPLETED|Enrollment to Randomization||0
7668273|NCT02011893|18883589|P2|NOT COMPLETED|Enrollment to Randomization||0
7668274|NCT02011893|18883590|P1|NOT COMPLETED|Enrollment to Randomization||73
7668275|NCT02011893|18883588|P3|COMPLETED|Enrollment to Randomization||0
7668276|NCT02011893|18883589|P2|COMPLETED|Enrollment to Randomization||0
7668277|NCT02011893|18883590|P1|COMPLETED|Enrollment to Randomization||100
7668278|NCT02011893|18883588|P3|Randomization|Enrollment to Randomization||0
7668279|NCT02011893|18883589|P2|Randomization|Enrollment to Randomization||0
7668280|NCT02011893|18883590|P1|Randomization|Enrollment to Randomization||100
7668281|NCT02011893|18883588|P3|Permanent Stimulation Implant|Enrollment to Randomization||0
7668282|NCT02011893|18883589|P2|Permanent Stimulation Implant|Enrollment to Randomization||0
7668283|NCT02011893|18883590|P1|Permanent Stimulation Implant|Enrollment to Randomization||101
7668284|NCT02011893|18883588|P3|Trial Stimulation Implant|Enrollment to Randomization||0
7668285|NCT02011893|18883589|P2|Trial Stimulation Implant|Enrollment to Randomization||0
7668286|NCT02011893|18883590|P1|Trial Stimulation Implant|Enrollment to Randomization||121
7668287|NCT02011893|18883588|P3|Baseline|Enrollment to Randomization||0
7668288|NCT02011893|18883589|P2|Baseline|Enrollment to Randomization||0
7668289|NCT02011893|18883590|P1|Baseline|Enrollment to Randomization||141
7668290|NCT02011893|18883588|P3|STARTED|Enrollment to Randomization||0
7668291|NCT02011893|18883589|P2|STARTED|Enrollment to Randomization||0
7668292|NCT02011893|18883590|P1|STARTED|Enrollment to Randomization||173
7668293|NCT02011542|18883601|P1|NOT COMPLETED|Overall Study||1
7668294|NCT02011542|18883601|P1|COMPLETED|Overall Study||29
7668295|NCT02011542|18883601|P1|STARTED|Overall Study||30
7668296|NCT02011516|18883608|P2|NOT COMPLETED|Overall Study||2
7668297|NCT02011516|18883609|P1|NOT COMPLETED|Overall Study||4
7668298|NCT02011516|18883608|P2|COMPLETED|Overall Study||6
7668299|NCT02011516|18883609|P1|COMPLETED|Overall Study||4
7668300|NCT02011516|18883608|P2|STARTED|Overall Study||8
7668301|NCT02011516|18883609|P1|STARTED|Overall Study||8
7668302|NCT02011490|18883618|P6|NOT COMPLETED|Part 2||0
7668303|NCT02011490|18883619|P5|NOT COMPLETED|Part 2||0
7668304|NCT02011490|18883620|P4|NOT COMPLETED|Part 2||0
7668305|NCT02011490|18883621|P3|NOT COMPLETED|Part 2||0
7668306|NCT02011490|18883622|P2|NOT COMPLETED|Part 2||0
7668307|NCT02011490|18883623|P1|NOT COMPLETED|Part 2||0
7668308|NCT02011490|18883618|P6|COMPLETED|Part 2||6
7668309|NCT02011490|18883619|P5|COMPLETED|Part 2||6
7668310|NCT02011490|18883620|P4|COMPLETED|Part 2||6
7668311|NCT02011490|18883621|P3|COMPLETED|Part 2||0
7668312|NCT02011490|18883622|P2|COMPLETED|Part 2||0
7668313|NCT02011490|18883623|P1|COMPLETED|Part 2||0
7668314|NCT02011490|18883618|P6|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6
7668315|NCT02011490|18883619|P5|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6
7668316|NCT02011490|18883620|P4|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6
7668317|NCT02011490|18883621|P3|STARTED|Part 2||0
7668318|NCT02011490|18883622|P2|STARTED|Part 2||0
7668319|NCT02011490|18883623|P1|STARTED|Part 2||0
7668320|NCT02011490|18883618|P6|NOT COMPLETED|Part 1||0
7668321|NCT02011490|18883619|P5|NOT COMPLETED|Part 1||0
7668322|NCT02011490|18883620|P4|NOT COMPLETED|Part 1||0
7668323|NCT02011490|18883621|P3|NOT COMPLETED|Part 1||0
7668324|NCT02011490|18883622|P2|NOT COMPLETED|Part 1||0
7668325|NCT02011490|18883623|P1|NOT COMPLETED|Part 1||0
7668326|NCT02011490|18883618|P6|COMPLETED|Part 1||0
7668327|NCT02011490|18883619|P5|COMPLETED|Part 1||0
7668328|NCT02011490|18883620|P4|COMPLETED|Part 1||0
7668329|NCT02011490|18883621|P3|COMPLETED|Part 1||8
7668330|NCT02011490|18883622|P2|COMPLETED|Part 1||8
7668331|NCT02011490|18883623|P1|COMPLETED|Part 1||8
7668332|NCT02011490|18883618|P6|STARTED|Part 1||0
7668333|NCT02011490|18883619|P5|STARTED|Part 1||0
7668334|NCT02011490|18883620|P4|STARTED|Part 1||0
7668335|NCT02011490|18883621|P3|STARTED|Part 1||8
7668336|NCT02011490|18883622|P2|STARTED|Part 1||8
7668337|NCT02011490|18883623|P1|STARTED|Part 1||8
7668338|NCT02011464|18883711|P2|NOT COMPLETED|Overall Study||0
7668339|NCT02011464|18883712|P1|NOT COMPLETED|Overall Study||0
7668340|NCT02011464|18883711|P2|COMPLETED|Overall Study||10
7668341|NCT02011464|18883712|P1|COMPLETED|Overall Study||10
7668342|NCT02011464|18883711|P2|STARTED|Overall Study||10
7668343|NCT02011464|18883712|P1|STARTED|Overall Study||10
7668344|NCT02011386|18883732|P1|NOT COMPLETED|Overall Study||5
7668345|NCT02011386|18883732|P1|COMPLETED|Overall Study||48
7668346|NCT02011386|18883732|P1|STARTED|Overall Study||53
7668347|NCT02011113|18883746|P1|NOT COMPLETED|Overall Study||36
7668348|NCT02011113|18883746|P1|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0
7668349|NCT02011113|18883746|P1|STARTED|Overall Study||36
7668350|NCT02010996|18883762|P2|NOT COMPLETED|Overall Study||0
7668351|NCT02010996|18883763|P1|NOT COMPLETED|Overall Study||0
7668352|NCT02010996|18883762|P2|COMPLETED|Overall Study||36
7668353|NCT02010996|18883763|P1|COMPLETED|Overall Study||36
7668354|NCT02010996|18883762|P2|STARTED|Overall Study||36
7668355|NCT02010996|18883763|P1|STARTED|Overall Study||36
7668356|NCT02010775|18883778|P5|NOT COMPLETED|Overall Study||6
7668357|NCT02010775|18883779|P4|NOT COMPLETED|Overall Study||3
7668358|NCT02010775|18883780|P3|NOT COMPLETED|Overall Study||3
7668359|NCT02010775|18883781|P2|NOT COMPLETED|Overall Study||3
7668360|NCT02010775|18883782|P1|NOT COMPLETED|Overall Study||5
7668361|NCT02010775|18883778|P5|COMPLETED|Overall Study||31
7668362|NCT02010775|18883779|P4|COMPLETED|Overall Study||34
7668363|NCT02010775|18883780|P3|COMPLETED|Overall Study||34
7668364|NCT02010775|18883781|P2|COMPLETED|Overall Study||35
7668365|NCT02010775|18883782|P1|COMPLETED|Overall Study||33
7668366|NCT02010775|18883778|P5|STARTED|Overall Study||37
7668367|NCT02010775|18883779|P4|STARTED|Overall Study||37
7668368|NCT02010775|18883780|P3|STARTED|Overall Study||37
7668369|NCT02010775|18883781|P2|STARTED|Overall Study||38
7668370|NCT02010775|18883782|P1|STARTED|Overall Study||38
7668371|NCT02010697|18883802|P3|NOT COMPLETED|Overall Study||0
7668372|NCT02010697|18883803|P2|NOT COMPLETED|Overall Study||0
7668373|NCT02010697|18883804|P1|NOT COMPLETED|Overall Study||0
7668374|NCT02010697|18883802|P3|COMPLETED|Overall Study||1043
7668375|NCT02010697|18883803|P2|COMPLETED|Overall Study||1038
7668376|NCT02010697|18883804|P1|COMPLETED|Overall Study||1044
7668377|NCT02010697|18883802|P3|STARTED|Overall Study||1043
7668378|NCT02010697|18883803|P2|STARTED|Overall Study||1038
7668379|NCT02010697|18883804|P1|STARTED|Overall Study||1044
7668380|NCT02010684|18883823|P2|NOT COMPLETED|Overall Study||23
7668381|NCT02010684|18883824|P1|NOT COMPLETED|Overall Study||12
7668382|NCT02010684|18883823|P2|COMPLETED|Overall Study||59
7668383|NCT02010684|18883824|P1|COMPLETED|Overall Study||27
7668384|NCT02010684|18883823|P2|STARTED|Overall Study||82
7668385|NCT02010684|18883824|P1|STARTED|Overall Study||39
7668386|NCT02010645|18883842|P1|NOT COMPLETED|Overall Study||0
7668387|NCT02010645|18883842|P1|COMPLETED|Overall Study||6
7668388|NCT02010645|18883842|P1|STARTED|Overall Study||6
7668389|NCT02010632|18883846|P2|NOT COMPLETED|Second Intervention (7 Days)||0
7668390|NCT02010632|18883847|P1|NOT COMPLETED|Second Intervention (7 Days)||1
7668391|NCT02010632|18883846|P2|COMPLETED|Second Intervention (7 Days)||16
7668392|NCT02010632|18883847|P1|COMPLETED|Second Intervention (7 Days)||15
7668393|NCT02010632|18883846|P2|STARTED|Second Intervention (7 Days)||16
7668394|NCT02010632|18883847|P1|STARTED|Second Intervention (7 Days)||16
7668395|NCT02010632|18883846|P2|NOT COMPLETED|Wash Out Period (14 Days)||0
7668396|NCT02010632|18883847|P1|NOT COMPLETED|Wash Out Period (14 Days)||0
7668397|NCT02010632|18883846|P2|COMPLETED|Wash Out Period (14 Days)||16
7668398|NCT02010632|18883847|P1|COMPLETED|Wash Out Period (14 Days)||16
7668399|NCT02010632|18883846|P2|STARTED|Wash Out Period (14 Days)||16
7668400|NCT02010632|18883847|P1|STARTED|Wash Out Period (14 Days)||16
7668401|NCT02010632|18883846|P2|NOT COMPLETED|First Intervention (7 Days)||0
7668402|NCT02010632|18883847|P1|NOT COMPLETED|First Intervention (7 Days)||0
7668403|NCT02010632|18883846|P2|COMPLETED|First Intervention (7 Days)||16
7668404|NCT02010632|18883847|P1|COMPLETED|First Intervention (7 Days)||16
7668405|NCT02010632|18883846|P2|STARTED|First Intervention (7 Days)||16
7668406|NCT02010632|18883847|P1|STARTED|First Intervention (7 Days)||16
7668407|NCT02010567|18883858|P5|NOT COMPLETED|Overall Study||1
7668408|NCT02010567|18883859|P4|NOT COMPLETED|Overall Study||0
7668409|NCT02010567|18883860|P3|NOT COMPLETED|Overall Study||1
7668410|NCT02010567|18883861|P2|NOT COMPLETED|Overall Study||0
7668411|NCT02010567|18883862|P1|NOT COMPLETED|Overall Study||0
7668412|NCT02010567|18883858|P5|COMPLETED|Overall Study||5
7668413|NCT02010567|18883859|P4|COMPLETED|Overall Study||3
7668414|NCT02010567|18883860|P3|COMPLETED|Overall Study||13
7668415|NCT02010567|18883861|P2|COMPLETED|Overall Study||6
7668416|NCT02010567|18883862|P1|COMPLETED|Overall Study||3
7668417|NCT02010567|18883858|P5|STARTED|Overall Study||6
7668418|NCT02010567|18883859|P4|STARTED|Overall Study||3
7668419|NCT02010567|18883860|P3|STARTED|Overall Study||14
7668420|NCT02010567|18883861|P2|STARTED|Overall Study||6
7668421|NCT02010567|18883862|P1|STARTED|Overall Study||3
7668422|NCT02010359|18883879|P2|NOT COMPLETED|Overall Study||2
7668423|NCT02010359|18883880|P1|NOT COMPLETED|Overall Study||2
7668424|NCT02010359|18883879|P2|COMPLETED|Overall Study||12
7668425|NCT02010359|18883880|P1|COMPLETED|Overall Study||13
7668426|NCT02010359|18883879|P2|STARTED|Overall Study||14
7668427|NCT02010359|18883880|P1|STARTED|Overall Study||15
7668428|NCT02010255|18883918|P14|NOT COMPLETED|Overall Study||1
7668429|NCT02010255|18883919|P13|NOT COMPLETED|Overall Study||0
7668430|NCT02010255|18883920|P12|NOT COMPLETED|Overall Study||1
7668431|NCT02010255|18883921|P11|NOT COMPLETED|Overall Study||2
7668432|NCT02010255|18883922|P10|NOT COMPLETED|Overall Study||0
7668433|NCT02010255|18883923|P9|NOT COMPLETED|Overall Study||1
7668434|NCT02010255|18883924|P8|NOT COMPLETED|Overall Study||1
7668435|NCT02010255|18883925|P7|NOT COMPLETED|Overall Study||1
7668436|NCT02010255|18883926|P6|NOT COMPLETED|Overall Study||0
7668437|NCT02010255|18883927|P5|NOT COMPLETED|Overall Study||4
7668438|NCT02010255|18883928|P4|NOT COMPLETED|Overall Study||6
7668439|NCT02010255|18883929|P3|NOT COMPLETED|Overall Study||7
7668440|NCT02010255|18883930|P2|NOT COMPLETED|Overall Study||2
7668441|NCT02010255|18883931|P1|NOT COMPLETED|Overall Study||6
7668442|NCT02010255|18883918|P14|COMPLETED|Overall Study||2
7668443|NCT02010255|18883919|P13|COMPLETED|Overall Study||3
7668444|NCT02010255|18883920|P12|COMPLETED|Overall Study||4
7668445|NCT02010255|18883921|P11|COMPLETED|Overall Study||1
7668446|NCT02010255|18883922|P10|COMPLETED|Overall Study||23
7668447|NCT02010255|18883923|P9|COMPLETED|Overall Study||21
7668448|NCT02010255|18883924|P8|COMPLETED|Overall Study||32
7668449|NCT02010255|18883925|P7|COMPLETED|Overall Study||33
7668450|NCT02010255|18883926|P6|COMPLETED|Overall Study||49
7668451|NCT02010255|18883927|P5|COMPLETED|Overall Study||48
7668452|NCT02010255|18883928|P4|COMPLETED|Overall Study||20
7668453|NCT02010255|18883929|P3|COMPLETED|Overall Study||18
7668454|NCT02010255|18883930|P2|COMPLETED|Overall Study||26
7668455|NCT02010255|18883931|P1|COMPLETED|Overall Study||22
7668456|NCT02010255|18883918|P14|STARTED|Overall Study||3
7668457|NCT02010255|18883919|P13|STARTED|Overall Study||3
7668458|NCT02010255|18883920|P12|STARTED|Overall Study||5
7668459|NCT02010255|18883921|P11|STARTED|Overall Study||3
7668460|NCT02010255|18883922|P10|STARTED|Overall Study||23
7668461|NCT02010255|18883923|P9|STARTED|Overall Study||22
7668462|NCT02010255|18883924|P8|STARTED|Overall Study||33
7668463|NCT02010255|18883925|P7|STARTED|Overall Study||34
7668464|NCT02010255|18883926|P6|STARTED|Overall Study||49
7668465|NCT02010255|18883927|P5|STARTED|Overall Study||52
7668466|NCT02010255|18883928|P4|STARTED|Overall Study||26
7668467|NCT02010255|18883929|P3|STARTED|Overall Study||25
7668468|NCT02010255|18883930|P2|STARTED|Overall Study||28
7668469|NCT02010255|18883931|P1|STARTED|Overall Study||28
7668470|NCT02010216|18884255|P1|NOT COMPLETED|Overall Study||0
7668471|NCT02010216|18884255|P1|COMPLETED|Overall Study||23
7668472|NCT02010216|18884255|P1|STARTED|Overall Study||23
7668473|NCT02010203|18884266|P5|NOT COMPLETED|Overall Study||13
7668474|NCT02010203|18884267|P4|NOT COMPLETED|Overall Study||3
7668475|NCT02010203|18884268|P3|NOT COMPLETED|Overall Study||10
7668476|NCT02010203|18884269|P2|NOT COMPLETED|Overall Study||9
7668477|NCT02010203|18884270|P1|NOT COMPLETED|Overall Study||0
7668478|NCT02010203|18884266|P5|COMPLETED|Overall Study||3
7668479|NCT02010203|18884267|P4|COMPLETED|Overall Study||23
7668480|NCT02010203|18884268|P3|COMPLETED|Overall Study||16
7668481|NCT02010203|18884269|P2|COMPLETED|Overall Study||17
7668482|NCT02010203|18884270|P1|COMPLETED|Overall Study||10
7668483|NCT02010203|18884266|P5|STARTED|Overall Study||16
7668484|NCT02010203|18884267|P4|STARTED|Overall Study||26
7668485|NCT02010203|18884268|P3|STARTED|Overall Study||26
7668486|NCT02010203|18884269|P2|STARTED|Overall Study||26
7668487|NCT02010203|18884270|P1|STARTED|Overall Study||10
7668488|NCT02010151|18884343|P2|NOT COMPLETED|Overall Study||0
7668489|NCT02010151|18884344|P1|NOT COMPLETED|Overall Study||0
7668490|NCT02010151|18884343|P2|COMPLETED|Overall Study|TM sent: 598|1696
7668491|NCT02010151|18884344|P1|COMPLETED|Overall Study|Text message (TM) sent: 0|1498
7668492|NCT02010151|18884343|P2|STARTED|Overall Study|January 2013 to December 2017|1696
7668493|NCT02010151|18884344|P1|STARTED|Overall Study|January 2013 to December 2017|1498
7668494|NCT02010021|18884356|P2|NOT COMPLETED|Overall Study||0
7668495|NCT02010021|18884357|P1|NOT COMPLETED|Overall Study||0
7668496|NCT02010021|18884356|P2|COMPLETED|Overall Study||7
7668497|NCT02010021|18884357|P1|COMPLETED|Overall Study||10
7668498|NCT02010021|18884356|P2|STARTED|Overall Study||7
7668499|NCT02010021|18884357|P1|STARTED|Overall Study||10
7668500|NCT02009982|18884367|P2|NOT COMPLETED|Overall Study||0
7668501|NCT02009982|18884368|P1|NOT COMPLETED|Overall Study||0
7668502|NCT02009982|18884367|P2|COMPLETED|Overall Study||2
7668503|NCT02009982|18884368|P1|COMPLETED|Overall Study||1
7668504|NCT02009982|18884367|P2|STARTED|Overall Study||2
7668505|NCT02009982|18884368|P1|STARTED|Overall Study||1
7668506|NCT02009930|18884376|P1|NOT COMPLETED|Overall Study||5
7668507|NCT02009930|18884376|P1|COMPLETED|Overall Study||107
7668508|NCT02009930|18884376|P1|STARTED|Overall Study|5 withdrawn|112
7668509|NCT02009878|18884401|P3|NOT COMPLETED|Overall Study||0
7668510|NCT02009878|18884402|P2|NOT COMPLETED|Overall Study||1
7668511|NCT02009878|18884403|P1|NOT COMPLETED|Overall Study||0
7668512|NCT02009878|18884401|P3|COMPLETED|Overall Study||9
7668513|NCT02009878|18884402|P2|COMPLETED|Overall Study||10
7668514|NCT02009878|18884403|P1|COMPLETED|Overall Study||10
7668515|NCT02009878|18884401|P3|STARTED|Overall Study||9
7668516|NCT02009878|18884402|P2|STARTED|Overall Study||11
7668517|NCT02009878|18884403|P1|STARTED|Overall Study||10
7668518|NCT02009865|18884437|P2|NOT COMPLETED|Overall Study||5
7668519|NCT02009865|18884438|P1|NOT COMPLETED|Overall Study||1
7668520|NCT02009865|18884437|P2|COMPLETED|Overall Study||76
7668521|NCT02009865|18884438|P1|COMPLETED|Overall Study||80
7668522|NCT02009865|18884437|P2|STARTED|Overall Study||81
7668523|NCT02009865|18884438|P1|STARTED|Overall Study||81
7668524|NCT02009722|18884454|P2|NOT COMPLETED|Overall Study||3
7668525|NCT02009722|18884455|P1|NOT COMPLETED|Overall Study||1
7668526|NCT02009722|18884454|P2|COMPLETED|Overall Study||40
7668527|NCT02009722|18884455|P1|COMPLETED|Overall Study||40
7668528|NCT02009722|18884454|P2|Received Intervention|Overall Study||42
7668529|NCT02009722|18884455|P1|Received Intervention|Overall Study||41
7668530|NCT02009722|18884454|P2|STARTED|Overall Study||43
7668531|NCT02009722|18884455|P1|STARTED|Overall Study||41
7668532|NCT02009696|18884479|P1|NOT COMPLETED|Overall Study||2
7668533|NCT02009696|18884479|P1|COMPLETED|Overall Study||219
7668534|NCT02009696|18884479|P1|STARTED|Overall Study||221
7668535|NCT02009501|18884489|P2|NOT COMPLETED|Overall Study||0
7668536|NCT02009501|18884490|P1|NOT COMPLETED|Overall Study||0
7668537|NCT02009501|18884489|P2|COMPLETED|Overall Study||11
7668538|NCT02009501|18884490|P1|COMPLETED|Overall Study||9
7668539|NCT02009501|18884489|P2|STARTED|Overall Study||11
7668540|NCT02009501|18884490|P1|STARTED|Overall Study||9
7668541|NCT02009163|18884496|P3|NOT COMPLETED|Randomized-withdrawal Period||35
7668542|NCT02009163|18884497|P2|NOT COMPLETED|Randomized-withdrawal Period||88
7668543|NCT02009163|18884498|P1|NOT COMPLETED|Randomized-withdrawal Period||0
7668544|NCT02009163|18884496|P3|COMPLETED|Randomized-withdrawal Period||102
7668545|NCT02009163|18884497|P2|COMPLETED|Randomized-withdrawal Period||50
7668546|NCT02009163|18884498|P1|COMPLETED|Randomized-withdrawal Period||0
7668547|NCT02009163|18884496|P3|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137
7668548|NCT02009163|18884497|P2|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138
7668549|NCT02009163|18884498|P1|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0
7668550|NCT02009163|18884496|P3|NOT COMPLETED|Open-label Period (Non-randomized)||0
7668551|NCT02009163|18884497|P2|NOT COMPLETED|Open-label Period (Non-randomized)||0
7668552|NCT02009163|18884498|P1|NOT COMPLETED|Open-label Period (Non-randomized)||143
7668553|NCT02009163|18884496|P3|COMPLETED|Open-label Period (Non-randomized)||0
7668554|NCT02009163|18884497|P2|COMPLETED|Open-label Period (Non-randomized)||0
7668555|NCT02009163|18884498|P1|COMPLETED|Open-label Period (Non-randomized)||275
7668556|NCT02009163|18884496|P3|STARTED|Open-label Period (Non-randomized)||0
7668557|NCT02009163|18884497|P2|STARTED|Open-label Period (Non-randomized)||0
7668558|NCT02009163|18884498|P1|STARTED|Open-label Period (Non-randomized)||418
7668559|NCT02009046|18884533|P2|NOT COMPLETED|Overall Study||206
7668560|NCT02009046|18884534|P1|NOT COMPLETED|Overall Study||256
7668561|NCT02009046|18884533|P2|COMPLETED|Overall Study||678
7668562|NCT02009046|18884534|P1|COMPLETED|Overall Study||769
7668563|NCT02009046|18884533|P2|Ctrl Curriculm +1 SchoolWide Component|Overall Study||428
7668564|NCT02009046|18884534|P1|Ctrl Curriculm +1 SchoolWide Component|Overall Study||0
7668565|NCT02009046|18884533|P2|Ctrl Curriculum Only|Overall Study||456
7668566|NCT02009046|18884534|P1|Ctrl Curriculum Only|Overall Study||0
7668567|NCT02009046|18884533|P2|SEI Curriculum + 3 SchoolWide Components|Overall Study||0
7668568|NCT02009046|18884534|P1|SEI Curriculum + 3 SchoolWide Components|Overall Study||544
7668569|NCT02009046|18884533|P2|SEI Curriculum Only|Overall Study||0
7668570|NCT02009046|18884534|P1|SEI Curriculum Only|Overall Study||461
7668571|NCT02009046|18884533|P2|STARTED|Overall Study||884
7668572|NCT02009046|18884534|P1|STARTED|Overall Study||1025
7668573|NCT02008942|18884584|P2|NOT COMPLETED|Second Intervention||0
7668574|NCT02008942|18884585|P1|NOT COMPLETED|Second Intervention||1
7668575|NCT02008942|18884584|P2|COMPLETED|Second Intervention||30
7668576|NCT02008942|18884585|P1|COMPLETED|Second Intervention||25
7668577|NCT02008942|18884584|P2|STARTED|Second Intervention||30
7668578|NCT02008942|18884585|P1|STARTED|Second Intervention||26
7668579|NCT02008942|18884584|P2|NOT COMPLETED|First Intervention||0
7668580|NCT02008942|18884585|P1|NOT COMPLETED|First Intervention||0
7668581|NCT02008942|18884584|P2|COMPLETED|First Intervention||30
7668582|NCT02008942|18884585|P1|COMPLETED|First Intervention||27
7668583|NCT02008942|18884584|P2|STARTED|First Intervention||30
7668584|NCT02008942|18884585|P1|STARTED|First Intervention||27
7668585|NCT02008916|18884594|P3|NOT COMPLETED|Week 16 - 156||10
7668586|NCT02008916|18884595|P2|NOT COMPLETED|Week 16 - 156||13
7668587|NCT02008916|18884596|P1|NOT COMPLETED|Week 16 - 156||19
7668588|NCT02008916|18884594|P3|COMPLETED|Week 16 - 156||63
7668589|NCT02008916|18884595|P2|COMPLETED|Week 16 - 156||62
7668590|NCT02008916|18884596|P1|COMPLETED|Week 16 - 156||55
7668591|NCT02008916|18884594|P3|STARTED|Week 16 - 156||73
7668592|NCT02008916|18884595|P2|STARTED|Week 16 - 156||75
7668593|NCT02008916|18884596|P1|STARTED|Week 16 - 156||74
7668594|NCT02008916|18884594|P3|NOT COMPLETED|Primary Assessment (up to Week 16)||3
7668595|NCT02008916|18884595|P2|NOT COMPLETED|Primary Assessment (up to Week 16)||1
7668596|NCT02008916|18884596|P1|NOT COMPLETED|Primary Assessment (up to Week 16)||0
7668597|NCT02008916|18884594|P3|COMPLETED|Primary Assessment (up to Week 16)||73
7668598|NCT02008916|18884595|P2|COMPLETED|Primary Assessment (up to Week 16)||75
7668599|NCT02008916|18884596|P1|COMPLETED|Primary Assessment (up to Week 16)||74
7668600|NCT02008916|18884594|P3|Safety Set|Primary Assessment (up to Week 16)||75
7668601|NCT02008916|18884595|P2|Safety Set|Primary Assessment (up to Week 16)||76
7668602|NCT02008916|18884596|P1|Safety Set|Primary Assessment (up to Week 16)||74
7668603|NCT02008916|18884594|P3|FAS|Primary Assessment (up to Week 16)||76
7668604|NCT02008916|18884595|P2|FAS|Primary Assessment (up to Week 16)||76
7668605|NCT02008916|18884596|P1|FAS|Primary Assessment (up to Week 16)||74
7668606|NCT02008916|18884594|P3|STARTED|Primary Assessment (up to Week 16)||76
7668607|NCT02008916|18884595|P2|STARTED|Primary Assessment (up to Week 16)||76
7668608|NCT02008916|18884596|P1|STARTED|Primary Assessment (up to Week 16)||74
7668609|NCT02008890|18884632|P5|NOT COMPLETED|Extension Period||4
7668610|NCT02008890|18884633|P4|NOT COMPLETED|Extension Period||4
7668611|NCT02008890|18884634|P3|NOT COMPLETED|Extension Period||0
7668612|NCT02008890|18884635|P2|NOT COMPLETED|Extension Period||5
7668613|NCT02008890|18884636|P1|NOT COMPLETED|Extension Period||5
7668614|NCT02008890|18884632|P5|COMPLETED|Extension Period||13
7668615|NCT02008890|18884633|P4|COMPLETED|Extension Period||6
7668616|NCT02008890|18884634|P3|COMPLETED|Extension Period||0
7668617|NCT02008890|18884635|P2|COMPLETED|Extension Period||31
7668618|NCT02008890|18884636|P1|COMPLETED|Extension Period||26
7668619|NCT02008890|18884632|P5|STARTED|Extension Period||17
7668620|NCT02008890|18884633|P4|STARTED|Extension Period||10
7668621|NCT02008890|18884634|P3|STARTED|Extension Period||0
7668622|NCT02008890|18884635|P2|STARTED|Extension Period||36
7668623|NCT02008890|18884636|P1|STARTED|Extension Period||31
7668624|NCT02008890|18884632|P5|NOT COMPLETED|Period 2||8
7668625|NCT02008890|18884633|P4|NOT COMPLETED|Period 2||14
7668626|NCT02008890|18884634|P3|NOT COMPLETED|Period 2||1
7668627|NCT02008890|18884635|P2|NOT COMPLETED|Period 2||15
7668628|NCT02008890|18884636|P1|NOT COMPLETED|Period 2||27
7668629|NCT02008890|18884632|P5|COMPLETED|Period 2||20
7668630|NCT02008890|18884633|P4|COMPLETED|Period 2||13
7668631|NCT02008890|18884634|P3|COMPLETED|Period 2||9
7668632|NCT02008890|18884635|P2|COMPLETED|Period 2||49
7668633|NCT02008890|18884636|P1|COMPLETED|Period 2||38
7668634|NCT02008890|18884632|P5|STARTED|Period 2||28
7668635|NCT02008890|18884633|P4|STARTED|Period 2||27
7668636|NCT02008890|18884634|P3|STARTED|Period 2||10
7668637|NCT02008890|18884635|P2|STARTED|Period 2||64
7668638|NCT02008890|18884636|P1|STARTED|Period 2||65
7668639|NCT02008890|18884632|P5|NOT COMPLETED|Period 1||0
7668640|NCT02008890|18884633|P4|NOT COMPLETED|Period 1||0
7668641|NCT02008890|18884634|P3|NOT COMPLETED|Period 1||12
7668642|NCT02008890|18884635|P2|NOT COMPLETED|Period 1||15
7668643|NCT02008890|18884636|P1|NOT COMPLETED|Period 1||15
7668644|NCT02008890|18884632|P5|COMPLETED|Period 1||0
7668645|NCT02008890|18884633|P4|COMPLETED|Period 1||0
7668646|NCT02008890|18884634|P3|COMPLETED|Period 1||66
7668647|NCT02008890|18884635|P2|COMPLETED|Period 1||64
7668648|NCT02008890|18884636|P1|COMPLETED|Period 1||65
7668649|NCT02008890|18884632|P5|STARTED|Period 1||0
7668650|NCT02008890|18884633|P4|STARTED|Period 1||0
7668651|NCT02008890|18884634|P3|STARTED|Period 1||78
7668652|NCT02008890|18884635|P2|STARTED|Period 1||79
7668653|NCT02008890|18884636|P1|STARTED|Period 1||80
7668654|NCT02008877|18884672|P3|NOT COMPLETED|Overall Study||0
7668655|NCT02008877|18884673|P2|NOT COMPLETED|Overall Study||1
7668656|NCT02008877|18884674|P1|NOT COMPLETED|Overall Study||0
7668657|NCT02008877|18884672|P3|COMPLETED|Overall Study||10
7668658|NCT02008877|18884673|P2|COMPLETED|Overall Study||6
7668659|NCT02008877|18884674|P1|COMPLETED|Overall Study||3
7668660|NCT02008877|18884672|P3|STARTED|Overall Study||10
7668661|NCT02008877|18884673|P2|STARTED|Overall Study||7
7668662|NCT02008877|18884674|P1|STARTED|Overall Study||3
7668663|NCT02008773|18884693|P4|NOT COMPLETED|Overall Study||12
7668664|NCT02008773|18884694|P3|NOT COMPLETED|Overall Study||14
7668665|NCT02008773|18884695|P2|NOT COMPLETED|Overall Study||9
7668666|NCT02008773|18884696|P1|NOT COMPLETED|Overall Study||13
7668667|NCT02008773|18884693|P4|COMPLETED|Overall Study||38
7668668|NCT02008773|18884694|P3|COMPLETED|Overall Study||32
7668669|NCT02008773|18884695|P2|COMPLETED|Overall Study||25
7668670|NCT02008773|18884696|P1|COMPLETED|Overall Study||27
7668671|NCT02008773|18884693|P4|STARTED|Overall Study||50
7668672|NCT02008773|18884694|P3|STARTED|Overall Study||46
7668673|NCT02008773|18884695|P2|STARTED|Overall Study||34
7668674|NCT02008773|18884696|P1|STARTED|Overall Study||40
7668675|NCT02008682|18884726|P2|NOT COMPLETED|Overall Study||14
7668676|NCT02008682|18884727|P1|NOT COMPLETED|Overall Study||27
7668677|NCT02008682|18884726|P2|COMPLETED|Overall Study|Completed without discontinuation of trial product|170
7668678|NCT02008682|18884727|P1|COMPLETED|Overall Study|Completed without discontinuation of trial product|157
7668679|NCT02008682|18884726|P2|Exposed|Overall Study||184
7668680|NCT02008682|18884727|P1|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183
7668681|NCT02008682|18884726|P2|STARTED|Overall Study||184
7668682|NCT02008682|18884727|P1|STARTED|Overall Study||184
7668683|NCT02008617|18884745|P2|NOT COMPLETED|Overall Study||0
7668684|NCT02008617|18884746|P1|NOT COMPLETED|Overall Study||0
7668685|NCT02008617|18884745|P2|COMPLETED|Overall Study||10
7668686|NCT02008617|18884746|P1|COMPLETED|Overall Study||8
7668687|NCT02008617|18884745|P2|STARTED|Overall Study||10
7668688|NCT02008617|18884746|P1|STARTED|Overall Study||8
7668689|NCT02008565|18884762|P4|NOT COMPLETED|Overall Study||0
7668690|NCT02008565|18884763|P3|NOT COMPLETED|Overall Study||2
7668691|NCT02008565|18884764|P2|NOT COMPLETED|Overall Study||1
7668692|NCT02008565|18884765|P1|NOT COMPLETED|Overall Study||1
7668693|NCT02008565|18884762|P4|COMPLETED|Overall Study||42
7668694|NCT02008565|18884763|P3|COMPLETED|Overall Study||86
7668695|NCT02008565|18884764|P2|COMPLETED|Overall Study||83
7668696|NCT02008565|18884765|P1|COMPLETED|Overall Study||85
7668697|NCT02008565|18884762|P4|STARTED|Overall Study||42
7668698|NCT02008565|18884763|P3|STARTED|Overall Study||88
7668699|NCT02008565|18884764|P2|STARTED|Overall Study||84
7668700|NCT02008565|18884765|P1|STARTED|Overall Study||86
7668701|NCT02008526|18884826|P3|NOT COMPLETED|Overall Study||9
7668702|NCT02008526|18884827|P2|NOT COMPLETED|Overall Study||14
7668703|NCT02008526|18884828|P1|NOT COMPLETED|Overall Study||8
7668704|NCT02008526|18884826|P3|COMPLETED|Overall Study||84
7668705|NCT02008526|18884827|P2|COMPLETED|Overall Study||85
7668706|NCT02008526|18884828|P1|COMPLETED|Overall Study||86
7668707|NCT02008526|18884826|P3|STARTED|Overall Study||93
7668708|NCT02008526|18884827|P2|STARTED|Overall Study||99
7668709|NCT02008526|18884828|P1|STARTED|Overall Study||94
7668710|NCT02008396|18884841|P2|NOT COMPLETED|Overall Study||1
7668711|NCT02008396|18884842|P1|NOT COMPLETED|Overall Study||0
7668712|NCT02008396|18884841|P2|COMPLETED|Overall Study||7
7668713|NCT02008396|18884842|P1|COMPLETED|Overall Study||4
7668714|NCT02008396|18884841|P2|STARTED|Overall Study||8
7668715|NCT02008396|18884842|P1|STARTED|Overall Study||4
7668716|NCT02008370|18884852|P1|NOT COMPLETED|Overall Study||7
7668717|NCT02008370|18884852|P1|COMPLETED|Overall Study||0
7668718|NCT02008370|18884852|P1|STARTED|Overall Study||7
7668719|NCT02008318|18884860|P2|NOT COMPLETED|Overall Study||1
7668720|NCT02008318|18884861|P1|NOT COMPLETED|Overall Study||12
7668721|NCT02008318|18884860|P2|COMPLETED|Overall Study||1
7668722|NCT02008318|18884861|P1|COMPLETED|Overall Study||29
7668723|NCT02008318|18884860|P2|Received At Least 1 Dose of Study Drug|Overall Study||2
7668724|NCT02008318|18884861|P1|Received At Least 1 Dose of Study Drug|Overall Study||41
7668725|NCT02008318|18884860|P2|STARTED|Overall Study||2
7668726|NCT02008318|18884861|P1|STARTED|Overall Study||41
7668727|NCT02008227|18884882|P2|NOT COMPLETED|Overall Study||613
7668728|NCT02008227|18884883|P1|NOT COMPLETED|Overall Study||612
7668729|NCT02008227|18884882|P2|COMPLETED|Overall Study||0
7668730|NCT02008227|18884883|P1|COMPLETED|Overall Study||0
7668731|NCT02008227|18884882|P2|Treated|Overall Study||608
7668732|NCT02008227|18884883|P1|Treated|Overall Study||579
7668733|NCT02008227|18884882|P2|STARTED|Overall Study||613
7668734|NCT02008227|18884883|P1|STARTED|Overall Study||612
7668735|NCT02008149|18884961|P3|NOT COMPLETED|Overall Study||0
7668736|NCT02008149|18884962|P2|NOT COMPLETED|Overall Study||1
7668737|NCT02008149|18884963|P1|NOT COMPLETED|Overall Study||3
7668738|NCT02008149|18884961|P3|COMPLETED|Overall Study||1
7668739|NCT02008149|18884962|P2|COMPLETED|Overall Study||0
7668740|NCT02008149|18884963|P1|COMPLETED|Overall Study||4
7668741|NCT02008149|18884961|P3|STARTED|Overall Study||1
7668742|NCT02008149|18884962|P2|STARTED|Overall Study||1
7668743|NCT02008149|18884963|P1|STARTED|Overall Study||7
7668744|NCT02007954|18884971|P1|NOT COMPLETED|Overall Study||7
7668745|NCT02007954|18884971|P1|COMPLETED|Overall Study||17
7668746|NCT02007954|18884971|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to first imaging follow-up due to unrelated serious adverse event and death|23
7668747|NCT02007954|18884971|P1|Completed First TACE|Overall Study||24
7668748|NCT02007954|18884971|P1|STARTED|Overall Study|A total of 32 participants were consented, with 8 patients screened out prior to treatment.|24
7668749|NCT02007863|18884984|P1|NOT COMPLETED|Overall Study||0
7668750|NCT02007863|18884984|P1|COMPLETED|Overall Study||2
7668751|NCT02007863|18884984|P1|STARTED|Overall Study||2
7668752|NCT02007720|18884990|P2|NOT COMPLETED|Overall Study||72
7668753|NCT02007720|18884991|P1|NOT COMPLETED|Overall Study||82
7668754|NCT02007720|18884990|P2|COMPLETED|Overall Study||368
7668755|NCT02007720|18884991|P1|COMPLETED|Overall Study||354
7668756|NCT02007720|18884990|P2|Safety Set|Overall Study||432
7668757|NCT02007720|18884991|P1|Safety Set|Overall Study||426
7668758|NCT02007720|18884990|P2|Full Analysis Set|Overall Study||437
7668759|NCT02007720|18884991|P1|Full Analysis Set|Overall Study||433
7668760|NCT02007720|18884990|P2|STARTED|Overall Study||440
7668761|NCT02007720|18884991|P1|STARTED|Overall Study||436
7668762|NCT02007577|18885026|P2|NOT COMPLETED|Overall Study||1
7668763|NCT02007577|18885027|P1|NOT COMPLETED|Overall Study||1
7668764|NCT02007577|18885026|P2|COMPLETED|Overall Study||13
7668765|NCT02007577|18885027|P1|COMPLETED|Overall Study||26
7668766|NCT02007577|18885026|P2|STARTED|Overall Study||14
7668767|NCT02007577|18885027|P1|STARTED|Overall Study||27
7668768|NCT02007512|18885039|P4|NOT COMPLETED|Open Label Treatment Period||12
7668769|NCT02007512|18885040|P3|NOT COMPLETED|Open Label Treatment Period||0
7668770|NCT02007512|18885041|P2|NOT COMPLETED|Open Label Treatment Period||21
7668771|NCT02007512|18885042|P1|NOT COMPLETED|Open Label Treatment Period||0
7668772|NCT02007512|18885039|P4|COMPLETED|Open Label Treatment Period||0
7668773|NCT02007512|18885040|P3|COMPLETED|Open Label Treatment Period||0
7668774|NCT02007512|18885041|P2|COMPLETED|Open Label Treatment Period||0
7668775|NCT02007512|18885042|P1|COMPLETED|Open Label Treatment Period||0
7668776|NCT02007512|18885039|P4|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 12 entered open label period.|12
7668777|NCT02007512|18885040|P3|STARTED|Open Label Treatment Period||0
7668778|NCT02007512|18885041|P2|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 21 entered open label period.|21
7668779|NCT02007512|18885042|P1|STARTED|Open Label Treatment Period||0
7668780|NCT02007512|18885039|P4|NOT COMPLETED|Double Blind Treatment Period||60
7668781|NCT02007512|18885040|P3|NOT COMPLETED|Double Blind Treatment Period||60
7668782|NCT02007512|18885041|P2|NOT COMPLETED|Double Blind Treatment Period||64
7668783|NCT02007512|18885042|P1|NOT COMPLETED|Double Blind Treatment Period||63
7668784|NCT02007512|18885039|P4|COMPLETED|Double Blind Treatment Period||0
7668785|NCT02007512|18885040|P3|COMPLETED|Double Blind Treatment Period||0
7668786|NCT02007512|18885041|P2|COMPLETED|Double Blind Treatment Period||0
7668787|NCT02007512|18885042|P1|COMPLETED|Double Blind Treatment Period||0
7668788|NCT02007512|18885039|P4|Treated|Double Blind Treatment Period||60
7668789|NCT02007512|18885040|P3|Treated|Double Blind Treatment Period||60
7668790|NCT02007512|18885041|P2|Treated|Double Blind Treatment Period||63
7668791|NCT02007512|18885042|P1|Treated|Double Blind Treatment Period||62
7668792|NCT02007512|18885039|P4|STARTED|Double Blind Treatment Period||60
7668793|NCT02007512|18885040|P3|STARTED|Double Blind Treatment Period||60
7668794|NCT02007512|18885041|P2|STARTED|Double Blind Treatment Period||64
7668795|NCT02007512|18885042|P1|STARTED|Double Blind Treatment Period||63
7668796|NCT02007434|18885120|P8|NOT COMPLETED|Overall Study||0
7668797|NCT02007434|18885121|P7|NOT COMPLETED|Overall Study||0
7668798|NCT02007434|18885122|P6|NOT COMPLETED|Overall Study||0
7668799|NCT02007434|18885123|P5|NOT COMPLETED|Overall Study||0
7668800|NCT02007434|18885124|P4|NOT COMPLETED|Overall Study||0
7668801|NCT02007434|18885125|P3|NOT COMPLETED|Overall Study||1
7668802|NCT02007434|18885126|P2|NOT COMPLETED|Overall Study||1
7668803|NCT02007434|18885127|P1|NOT COMPLETED|Overall Study||1
7668804|NCT02007434|18885120|P8|COMPLETED|Overall Study||4
7668805|NCT02007434|18885121|P7|COMPLETED|Overall Study||18
7668806|NCT02007434|18885122|P6|COMPLETED|Overall Study||4
7668807|NCT02007434|18885123|P5|COMPLETED|Overall Study||16
7668808|NCT02007434|18885124|P4|COMPLETED|Overall Study||4
7668809|NCT02007434|18885125|P3|COMPLETED|Overall Study||16
7668810|NCT02007434|18885126|P2|COMPLETED|Overall Study||3
7668811|NCT02007434|18885127|P1|COMPLETED|Overall Study||16
7668812|NCT02007434|18885120|P8|Received Treatment|Overall Study||4
7668813|NCT02007434|18885121|P7|Received Treatment|Overall Study||18
7668814|NCT02007434|18885122|P6|Received Treatment|Overall Study||4
7668815|NCT02007434|18885123|P5|Received Treatment|Overall Study||16
7668816|NCT02007434|18885124|P4|Received Treatment|Overall Study||4
7668817|NCT02007434|18885125|P3|Received Treatment|Overall Study||17
7668818|NCT02007434|18885126|P2|Received Treatment|Overall Study||3
7668819|NCT02007434|18885127|P1|Received Treatment|Overall Study||17
7668820|NCT02007434|18885120|P8|STARTED|Overall Study||4
7668821|NCT02007434|18885121|P7|STARTED|Overall Study||18
7668822|NCT02007434|18885122|P6|STARTED|Overall Study||4
7668823|NCT02007434|18885123|P5|STARTED|Overall Study||16
7668824|NCT02007434|18885124|P4|STARTED|Overall Study||4
7668825|NCT02007434|18885125|P3|STARTED|Overall Study||17
7668826|NCT02007434|18885126|P2|STARTED|Overall Study||4
7668827|NCT02007434|18885127|P1|STARTED|Overall Study||17
7668828|NCT02007369|18885228|P3|NOT COMPLETED|Overall Study||0
7668829|NCT02007369|18885229|P2|NOT COMPLETED|Overall Study||0
7668830|NCT02007369|18885230|P1|NOT COMPLETED|Overall Study||0
7668831|NCT02007369|18885228|P3|COMPLETED|Overall Study||54
7668832|NCT02007369|18885229|P2|COMPLETED|Overall Study||40
7668833|NCT02007369|18885230|P1|COMPLETED|Overall Study||42
7668834|NCT02007369|18885228|P3|STARTED|Overall Study||54
7668835|NCT02007369|18885229|P2|STARTED|Overall Study||40
7668836|NCT02007369|18885230|P1|STARTED|Overall Study||42
7668837|NCT02007291|18885247|P2|NOT COMPLETED|Overall Study||0
7668838|NCT02007291|18885248|P1|NOT COMPLETED|Overall Study||0
7668839|NCT02007291|18885247|P2|COMPLETED|Overall Study||23
7668840|NCT02007291|18885248|P1|COMPLETED|Overall Study||48
7668841|NCT02007291|18885247|P2|STARTED|Overall Study||23
7668842|NCT02007291|18885248|P1|STARTED|Overall Study||48
7668843|NCT02007278|18885258|P2|NOT COMPLETED|Overall Study||3
7668844|NCT02007278|18885259|P1|NOT COMPLETED|Overall Study||2
7668845|NCT02007278|18885258|P2|COMPLETED|Overall Study||17
7668846|NCT02007278|18885259|P1|COMPLETED|Overall Study||18
7668847|NCT02007278|18885258|P2|STARTED|Overall Study||20
7668848|NCT02007278|18885259|P1|STARTED|Overall Study||20
7668849|NCT02007252|18885281|P2|NOT COMPLETED|Overall Study||11
7668850|NCT02007252|18885282|P1|NOT COMPLETED|Overall Study||11
7668851|NCT02007252|18885281|P2|COMPLETED|Overall Study||22
7668852|NCT02007252|18885282|P1|COMPLETED|Overall Study||20
7668853|NCT02007252|18885281|P2|Pharmacodynamic Analysis Set|Overall Study||33
7668854|NCT02007252|18885282|P1|Pharmacodynamic Analysis Set|Overall Study||31
7668855|NCT02007252|18885281|P2|Safety Analysis Set|Overall Study||33
7668856|NCT02007252|18885282|P1|Safety Analysis Set|Overall Study||31
7668857|NCT02007252|18885281|P2|STARTED|Overall Study||33
7668858|NCT02007252|18885282|P1|STARTED|Overall Study||31
7668859|NCT02007200|18885288|P1|NOT COMPLETED|Overall Study||0
7668860|NCT02007200|18885288|P1|COMPLETED|Overall Study||55
7668861|NCT02007200|18885288|P1|STARTED|Overall Study||55
7668862|NCT02007109|18885295|P1|NOT COMPLETED|Overall Study||111
7668863|NCT02007109|18885295|P1|COMPLETED|Overall Study||82
7668864|NCT02007109|18885295|P1|PACU Analysis|Overall Study||184
7668865|NCT02007109|18885295|P1|STARTED|Overall Study||193
7668866|NCT02007096|18885304|P2|NOT COMPLETED|Overall Study||16
7668867|NCT02007096|18885305|P1|NOT COMPLETED|Overall Study||11
7668868|NCT02007096|18885304|P2|COMPLETED|Overall Study||48
7668869|NCT02007096|18885305|P1|COMPLETED|Overall Study||52
7668870|NCT02007096|18885304|P2|STARTED|Overall Study||64
7668871|NCT02007096|18885305|P1|STARTED|Overall Study||63
7668872|NCT02007070|18885317|P1|NOT COMPLETED|Overall Study||33
7668873|NCT02007070|18885317|P1|COMPLETED|Overall Study|Completed 2 years of treatment.|5
7668874|NCT02007070|18885317|P1|STARTED|Overall Study||38
7668875|NCT02006979|18885338|P2|NOT COMPLETED|Overall Study||2
7668876|NCT02006979|18885339|P1|NOT COMPLETED|Overall Study||1
7668877|NCT02006979|18885338|P2|COMPLETED|Overall Study||11
7668878|NCT02006979|18885339|P1|COMPLETED|Overall Study||13
7668879|NCT02006979|18885338|P2|STARTED|Overall Study||13
7668880|NCT02006979|18885339|P1|STARTED|Overall Study||14
7668881|NCT02006927|18885351|P1|NOT COMPLETED|Overall Study||3
7668882|NCT02006927|18885351|P1|COMPLETED|Overall Study||0
7668883|NCT02006927|18885351|P1|STARTED|Overall Study||3
7668884|NCT02006888|18885359|P3|NOT COMPLETED|Overall Study||22
7668885|NCT02006888|18885360|P2|NOT COMPLETED|Overall Study||34
7668886|NCT02006888|18885361|P1|NOT COMPLETED|Overall Study||36
7668887|NCT02006888|18885359|P3|COMPLETED|Overall Study||58
7668888|NCT02006888|18885360|P2|COMPLETED|Overall Study||122
7668889|NCT02006888|18885361|P1|COMPLETED|Overall Study||122
7668890|NCT02006888|18885359|P3|STARTED|Overall Study||80
7668891|NCT02006888|18885360|P2|STARTED|Overall Study||156
7668892|NCT02006888|18885361|P1|STARTED|Overall Study||158
7668893|NCT02006836|18885372|P3|NOT COMPLETED|Self-control Period: Month 7-month 12||0
7668894|NCT02006836|18885373|P2|NOT COMPLETED|Self-control Period: Month 7-month 12||0
7668895|NCT02006836|18885374|P1|NOT COMPLETED|Self-control Period: Month 7-month 12||0
7668896|NCT02006836|18885372|P3|COMPLETED|Self-control Period: Month 7-month 12||19
7668897|NCT02006836|18885373|P2|COMPLETED|Self-control Period: Month 7-month 12||0
7668898|NCT02006836|18885374|P1|COMPLETED|Self-control Period: Month 7-month 12||0
7668899|NCT02006836|18885372|P3|STARTED|Self-control Period: Month 7-month 12||19
7668900|NCT02006836|18885373|P2|STARTED|Self-control Period: Month 7-month 12||0
7668901|NCT02006836|18885374|P1|STARTED|Self-control Period: Month 7-month 12||0
7668902|NCT02006836|18885372|P3|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
7668903|NCT02006836|18885373|P2|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
7668904|NCT02006836|18885374|P1|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
7668905|NCT02006836|18885372|P3|COMPLETED|Case-control Period: Month 1- Month 6||0
7668906|NCT02006836|18885373|P2|COMPLETED|Case-control Period: Month 1- Month 6||20
7668907|NCT02006836|18885374|P1|COMPLETED|Case-control Period: Month 1- Month 6||20
7668908|NCT02006836|18885372|P3|STARTED|Case-control Period: Month 1- Month 6||0
7668909|NCT02006836|18885373|P2|STARTED|Case-control Period: Month 1- Month 6||20
7668910|NCT02006836|18885374|P1|STARTED|Case-control Period: Month 1- Month 6||20
7668911|NCT02006758|18885390|P1|NOT COMPLETED|Overall Study||13
7668912|NCT02006758|18885390|P1|COMPLETED|Overall Study||55
7668913|NCT02006758|18885390|P1|12-month Follow up|Overall Study|12-month follow up completed|55
7668914|NCT02006758|18885390|P1|6-month Follow up|Overall Study|6-month follow up completed|60
7668915|NCT02006758|18885390|P1|1-month Follow up|Overall Study|1-month follow up completed|66
7668916|NCT02006758|18885390|P1|Underwent Renal Denervation|Overall Study|Underwent renal denervation|67
7668917|NCT02006758|18885390|P1|STARTED|Overall Study|Total number of enrolled participants|68
7668918|NCT02006732|18885421|P4|NOT COMPLETED|Overall Study||4
7668919|NCT02006732|18885422|P3|NOT COMPLETED|Overall Study||9
7668920|NCT02006732|18885423|P2|NOT COMPLETED|Overall Study||12
7668921|NCT02006732|18885424|P1|NOT COMPLETED|Overall Study||20
7668922|NCT02006732|18885421|P4|COMPLETED|Overall Study||198
7668923|NCT02006732|18885422|P3|COMPLETED|Overall Study||193
7668924|NCT02006732|18885423|P2|COMPLETED|Overall Study||191
7668925|NCT02006732|18885424|P1|COMPLETED|Overall Study||182
7668926|NCT02006732|18885421|P4|STARTED|Overall Study||202
7668927|NCT02006732|18885422|P3|STARTED|Overall Study||202
7668928|NCT02006732|18885423|P2|STARTED|Overall Study||203
7668929|NCT02006732|18885424|P1|STARTED|Overall Study||202
7668930|NCT02006719|18885464|P2|NOT COMPLETED|Overall Study||5
7668931|NCT02006719|18885465|P1|NOT COMPLETED|Overall Study||18
7668932|NCT02006719|18885464|P2|COMPLETED|Overall Study||80
7668933|NCT02006719|18885465|P1|COMPLETED|Overall Study||219
7668934|NCT02006719|18885464|P2|STARTED|Overall Study||85
7668935|NCT02006719|18885465|P1|STARTED|Overall Study||237
7668936|NCT02006706|18885495|P1|NOT COMPLETED|Overall Study||1
7668937|NCT02006706|18885495|P1|COMPLETED|Overall Study||14
7668938|NCT02006706|18885495|P1|STARTED|Overall Study||15
7668939|NCT02006693|18885502|P2|NOT COMPLETED|Overall Study||13
7668940|NCT02006693|18885503|P1|NOT COMPLETED|Overall Study||28
7668941|NCT02006693|18885502|P2|COMPLETED|Overall Study||74
7668942|NCT02006693|18885503|P1|COMPLETED|Overall Study||84
7668943|NCT02006693|18885502|P2|STARTED|Overall Study||87
7668944|NCT02006693|18885503|P1|STARTED|Overall Study||112
7668945|NCT02006667|18885515|P1|NOT COMPLETED|Overall Study||6
7668946|NCT02006667|18885515|P1|COMPLETED|Overall Study||7
7668947|NCT02006667|18885515|P1|STARTED|Overall Study||13
7668948|NCT02006654|18885527|P2|NOT COMPLETED|Overall Study||44
7668949|NCT02006654|18885528|P1|NOT COMPLETED|Overall Study||45
7668950|NCT02006654|18885527|P2|COMPLETED|Overall Study||321
7668951|NCT02006654|18885528|P1|COMPLETED|Overall Study||324
7668952|NCT02006654|18885527|P2|Treated|Overall Study||363
7668953|NCT02006654|18885528|P1|Treated|Overall Study||365
7668954|NCT02006654|18885527|P2|STARTED|Overall Study||365
7668955|NCT02006654|18885528|P1|STARTED|Overall Study||369
7668956|NCT02006641|18885557|P3|NOT COMPLETED|Overall Study||36
7668957|NCT02006641|18885558|P2|NOT COMPLETED|Overall Study||33
7668958|NCT02006641|18885559|P1|NOT COMPLETED|Overall Study||26
7668959|NCT02006641|18885557|P3|COMPLETED|Overall Study||248
7668960|NCT02006641|18885558|P2|COMPLETED|Overall Study||257
7668961|NCT02006641|18885559|P1|COMPLETED|Overall Study||258
7668962|NCT02006641|18885557|P3|Treated|Overall Study||281
7668963|NCT02006641|18885558|P2|Treated|Overall Study||285
7668964|NCT02006641|18885559|P1|Treated|Overall Study||282
7668965|NCT02006641|18885557|P3|STARTED|Overall Study||284
7668966|NCT02006641|18885558|P2|STARTED|Overall Study||290
7668967|NCT02006641|18885559|P1|STARTED|Overall Study||284
7668968|NCT02006628|18885599|P2|NOT COMPLETED|Overall Study||2
7668969|NCT02006628|18885600|P1|NOT COMPLETED|Overall Study||3
7668970|NCT02006628|18885599|P2|COMPLETED|Overall Study||43
7668971|NCT02006628|18885600|P1|COMPLETED|Overall Study||40
7668972|NCT02006628|18885599|P2|Intention to Treat (ITT) Analysis Set|Overall Study||44
7668973|NCT02006628|18885600|P1|Intention to Treat (ITT) Analysis Set|Overall Study||42
7668974|NCT02006628|18885599|P2|Received at Least 1 Dose of Study Drug|Overall Study||45
7668975|NCT02006628|18885600|P1|Received at Least 1 Dose of Study Drug|Overall Study||43
7668976|NCT02006628|18885599|P2|STARTED|Overall Study||45
7668977|NCT02006628|18885600|P1|STARTED|Overall Study||43
7668978|NCT02006576|18885625|P3|NOT COMPLETED|Overall Study||17
7668979|NCT02006576|18885626|P2|NOT COMPLETED|Overall Study||7
7668980|NCT02006576|18885627|P1|NOT COMPLETED|Overall Study||18
7668981|NCT02006576|18885625|P3|COMPLETED|Overall Study||15
7668982|NCT02006576|18885626|P2|COMPLETED|Overall Study||44
7668983|NCT02006576|18885627|P1|COMPLETED|Overall Study||17
7668984|NCT02006576|18885625|P3|STARTED|Overall Study||32
7668985|NCT02006576|18885626|P2|STARTED|Overall Study||51
7668986|NCT02006576|18885627|P1|STARTED|Overall Study||35
7668987|NCT02006420|18885640|P2|NOT COMPLETED|Overall Study||0
7668988|NCT02006420|18885641|P1|NOT COMPLETED|Overall Study||0
7668989|NCT02006420|18885640|P2|COMPLETED|Overall Study||21
7668990|NCT02006420|18885641|P1|COMPLETED|Overall Study||24
7668991|NCT02006420|18885640|P2|STARTED|Overall Study||21
7668992|NCT02006420|18885641|P1|STARTED|Overall Study||24
7668993|NCT02006407|18885655|P1|NOT COMPLETED|Overall Study||0
7668994|NCT02006407|18885655|P1|COMPLETED|Overall Study||5
7668995|NCT02006407|18885655|P1|STARTED|Overall Study||5
7668996|NCT02006342|18885663|P2|NOT COMPLETED|Overall Study||0
7668997|NCT02006342|18885664|P1|NOT COMPLETED|Overall Study||1
7668998|NCT02006342|18885663|P2|COMPLETED|Overall Study||20
7668999|NCT02006342|18885664|P1|COMPLETED|Overall Study||19
7669000|NCT02006342|18885663|P2|STARTED|Overall Study||20
7669001|NCT02006342|18885664|P1|STARTED|Overall Study||20
7669002|NCT02006264|18885680|P2|NOT COMPLETED|Overall Study||0
7669003|NCT02006264|18885681|P1|NOT COMPLETED|Overall Study||1
7669004|NCT02006264|18885680|P2|COMPLETED|Overall Study||15
7669005|NCT02006264|18885681|P1|COMPLETED|Overall Study||14
7669006|NCT02006264|18885680|P2|STARTED|Overall Study||15
7669007|NCT02006264|18885681|P1|STARTED|Overall Study||15
7669008|NCT02006160|18885701|P2|NOT COMPLETED|Overall Study||0
7669009|NCT02006160|18885702|P1|NOT COMPLETED|Overall Study||4
7669010|NCT02006160|18885701|P2|COMPLETED|Overall Study||16
7669011|NCT02006160|18885702|P1|COMPLETED|Overall Study||41
7669012|NCT02006160|18885701|P2|STARTED|Overall Study||16
7669013|NCT02006160|18885702|P1|STARTED|Overall Study||45
7669014|NCT02006121|18885710|P2|NOT COMPLETED|Open Label Phase||0
7669015|NCT02006121|18885711|P1|NOT COMPLETED|Open Label Phase||25
7669016|NCT02006121|18885710|P2|COMPLETED|Open Label Phase||0
7669017|NCT02006121|18885711|P1|COMPLETED|Open Label Phase|30 who continued on apomorphine from blinded phase, 29 who switched to apomorphine from placebo|59
7669018|NCT02006121|18885710|P2|STARTED|Open Label Phase|No patients received placebo in the open label phase|0
7669019|NCT02006121|18885711|P1|STARTED|Open Label Phase|From Apo: 38 completers and 2 early switched; From Placebo: 28 completers and 16 early switched|84
7669020|NCT02006121|18885710|P2|NOT COMPLETED|Double Blind Phase||24
7669021|NCT02006121|18885711|P1|NOT COMPLETED|Double Blind Phase||12
7669022|NCT02006121|18885710|P2|COMPLETED|Double Blind Phase|16 placebo-treated patients early switched to open label phase due to lack of efficacy|29
7669023|NCT02006121|18885711|P1|COMPLETED|Double Blind Phase|Early switching to open label: 1 for lack of efficacy, 1 could not tolerate 3 mg/hour minimum rate|42
7669024|NCT02006121|18885710|P2|STARTED|Double Blind Phase||53
7669025|NCT02006121|18885711|P1|STARTED|Double Blind Phase||54
7669026|NCT02006108|18885725|P1|NOT COMPLETED|Overall Study||2
7669027|NCT02006108|18885725|P1|COMPLETED|Overall Study||19
7669028|NCT02006108|18885725|P1|MR Imaging|Overall Study||19
7669029|NCT02006108|18885725|P1|STARTED|Overall Study||21
7669030|NCT02006056|18885732|P2|NOT COMPLETED|Overall Study||0
7669031|NCT02006056|18885733|P1|NOT COMPLETED|Overall Study||0
7669032|NCT02006056|18885732|P2|COMPLETED|Overall Study||4
7669033|NCT02006056|18885733|P1|COMPLETED|Overall Study||26
7669034|NCT02006056|18885732|P2|STARTED|Overall Study||4
7669035|NCT02006056|18885733|P1|STARTED|Overall Study||26
7669036|NCT02005887|18885744|P2|NOT COMPLETED|Overall Study||2
7669037|NCT02005887|18885745|P1|NOT COMPLETED|Overall Study||0
7669038|NCT02005887|18885744|P2|COMPLETED|Overall Study||23
7669039|NCT02005887|18885745|P1|COMPLETED|Overall Study||26
7669040|NCT02005887|18885744|P2|STARTED|Overall Study||25
7669041|NCT02005887|18885745|P1|STARTED|Overall Study||26
7669042|NCT02005692|18885763|P1|NOT COMPLETED|Overall Study||7
7669043|NCT02005692|18885763|P1|COMPLETED|Overall Study||63
7669044|NCT02005692|18885763|P1|STARTED|Overall Study||70
7669045|NCT02005666|18885771|P3|NOT COMPLETED|Overall Study||9
7669046|NCT02005666|18885772|P2|NOT COMPLETED|Overall Study||44
7669047|NCT02005666|18885773|P1|NOT COMPLETED|Overall Study||27
7669048|NCT02005666|18885771|P3|COMPLETED|Overall Study||160
7669049|NCT02005666|18885772|P2|COMPLETED|Overall Study||299
7669050|NCT02005666|18885773|P1|COMPLETED|Overall Study||311
7669051|NCT02005666|18885771|P3|STARTED|Overall Study||169
7669052|NCT02005666|18885772|P2|STARTED|Overall Study||343
7669053|NCT02005666|18885773|P1|STARTED|Overall Study||338
7669054|NCT02005627|18885789|P2|NOT COMPLETED|Overall Study||4
7669055|NCT02005627|18885790|P1|NOT COMPLETED|Overall Study||2
7669056|NCT02005627|18885789|P2|COMPLETED|Overall Study||19
7669057|NCT02005627|18885790|P1|COMPLETED|Overall Study||21
7669058|NCT02005627|18885789|P2|STARTED|Overall Study||23
7669059|NCT02005627|18885790|P1|STARTED|Overall Study||23
7669060|NCT02005601|18885806|P2|NOT COMPLETED|Overall Study||0
7669061|NCT02005601|18885807|P1|NOT COMPLETED|Overall Study||0
7669062|NCT02005601|18885806|P2|COMPLETED|Overall Study||53
7669063|NCT02005601|18885807|P1|COMPLETED|Overall Study||53
7669064|NCT02005601|18885806|P2|STARTED|Overall Study||53
7669065|NCT02005601|18885807|P1|STARTED|Overall Study||53
7669066|NCT02005562|18885819|P2|NOT COMPLETED|Overall Study||15
7669067|NCT02005562|18885820|P1|NOT COMPLETED|Overall Study||12
7669068|NCT02005562|18885819|P2|COMPLETED|Overall Study||110
7669069|NCT02005562|18885820|P1|COMPLETED|Overall Study||115
7669070|NCT02005562|18885819|P2|Transplanted|Overall Study||121
7669071|NCT02005562|18885820|P1|Transplanted|Overall Study||126
7669072|NCT02005562|18885819|P2|STARTED|Overall Study||125
7669073|NCT02005562|18885820|P1|STARTED|Overall Study||127
7669074|NCT02005549|18885848|P1|NOT COMPLETED|Overall Study||0
7669075|NCT02005549|18885848|P1|COMPLETED|Overall Study||18
7669076|NCT02005549|18885848|P1|STARTED|Overall Study||18
7669077|NCT02005536|18885854|P1|NOT COMPLETED|Overall Study||0
7669078|NCT02005536|18885854|P1|COMPLETED|Overall Study||60
7669079|NCT02005536|18885854|P1|STARTED|Overall Study||60
7669080|NCT02005510|18885864|P2|NOT COMPLETED|Rerandomized (Round 3)||0
7669081|NCT02005510|18885865|P1|NOT COMPLETED|Rerandomized (Round 3)||0
7669082|NCT02005510|18885864|P2|COMPLETED|Rerandomized (Round 3)||195
7669083|NCT02005510|18885865|P1|COMPLETED|Rerandomized (Round 3)||209
7669084|NCT02005510|18885864|P2|STARTED|Rerandomized (Round 3)||195
7669085|NCT02005510|18885865|P1|STARTED|Rerandomized (Round 3)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|209
7669086|NCT02005510|18885864|P2|NOT COMPLETED|Rerandomized (Round 2)||0
7669087|NCT02005510|18885865|P1|NOT COMPLETED|Rerandomized (Round 2)||0
7669088|NCT02005510|18885864|P2|COMPLETED|Rerandomized (Round 2)||1585
7669089|NCT02005510|18885865|P1|COMPLETED|Rerandomized (Round 2)||1631
7669090|NCT02005510|18885864|P2|STARTED|Rerandomized (Round 2)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|1585
7669174|NCT02005211|18886006|P7|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
7669091|NCT02005510|18885865|P1|STARTED|Rerandomized (Round 2)|Excludes 10 determined to be ineligible post-randomization due to delays in data warehouse update.|1631
7669092|NCT02005510|18885864|P2|NOT COMPLETED|Randomized (Round 1)||0
7669093|NCT02005510|18885865|P1|NOT COMPLETED|Randomized (Round 1)||0
7669094|NCT02005510|18885864|P2|COMPLETED|Randomized (Round 1)||8111
7669095|NCT02005510|18885865|P1|COMPLETED|Randomized (Round 1)||8120
7669096|NCT02005510|18885864|P2|STARTED|Randomized (Round 1)|Excludes 196 determined to be ineligible post-randomization due to delays in data warehouse update.|8111
7669097|NCT02005510|18885865|P1|STARTED|Randomized (Round 1)|Excludes 163 determined to be ineligible post-randomization due to delays in data warehouse update.|8120
7669098|NCT02005484|18885881|P1|NOT COMPLETED|Overall Study||4
7669099|NCT02005484|18885881|P1|COMPLETED|Overall Study||2
7669100|NCT02005484|18885881|P1|STARTED|Overall Study||6
7669101|NCT02005471|18885893|P2|NOT COMPLETED|Overall Study||194
7669102|NCT02005471|18885894|P1|NOT COMPLETED|Overall Study||195
7669103|NCT02005471|18885893|P2|COMPLETED|Overall Study||0
7669104|NCT02005471|18885894|P1|COMPLETED|Overall Study||0
7669105|NCT02005471|18885893|P2|Treated|Overall Study||194
7669106|NCT02005471|18885894|P1|Treated|Overall Study||188
7669107|NCT02005471|18885893|P2|STARTED|Overall Study||194
7669108|NCT02005471|18885894|P1|STARTED|Overall Study||195
7669109|NCT02005445|18885949|P2|NOT COMPLETED|Overall Study||1
7669110|NCT02005445|18885950|P1|NOT COMPLETED|Overall Study||0
7669111|NCT02005445|18885949|P2|COMPLETED|Overall Study||1
7669112|NCT02005445|18885950|P1|COMPLETED|Overall Study||2
7669113|NCT02005445|18885949|P2|STARTED|Overall Study||2
7669114|NCT02005445|18885950|P1|STARTED|Overall Study||2
7669115|NCT02005393|18885956|P1|NOT COMPLETED|Overall Study||0
7669116|NCT02005393|18885956|P1|COMPLETED|Overall Study||20
7669117|NCT02005393|18885956|P1|STARTED|Overall Study||20
7669118|NCT02005354|18885962|P2|NOT COMPLETED|Overall Study||0
7669119|NCT02005354|18885963|P1|NOT COMPLETED|Overall Study||0
7669120|NCT02005354|18885962|P2|COMPLETED|Overall Study||35
7669121|NCT02005354|18885963|P1|COMPLETED|Overall Study||35
7669122|NCT02005354|18885962|P2|STARTED|Overall Study||35
7669123|NCT02005354|18885963|P1|STARTED|Overall Study||35
7669124|NCT02005276|18885973|P4|NOT COMPLETED|Overall Study||3
7669125|NCT02005276|18885974|P3|NOT COMPLETED|Overall Study||3
7669126|NCT02005276|18885975|P2|NOT COMPLETED|Overall Study||2
7669127|NCT02005276|18885976|P1|NOT COMPLETED|Overall Study||5
7669128|NCT02005276|18885973|P4|COMPLETED|Overall Study||41
7669129|NCT02005276|18885974|P3|COMPLETED|Overall Study||56
7669130|NCT02005276|18885975|P2|COMPLETED|Overall Study||39
7669131|NCT02005276|18885976|P1|COMPLETED|Overall Study||60
7669132|NCT02005276|18885973|P4|Completed Intervention|Overall Study||42
7669133|NCT02005276|18885974|P3|Completed Intervention|Overall Study||56
7669134|NCT02005276|18885975|P2|Completed Intervention|Overall Study||39
7669135|NCT02005276|18885976|P1|Completed Intervention|Overall Study||61
7669136|NCT02005276|18885973|P4|STARTED|Overall Study||44
7669137|NCT02005276|18885974|P3|STARTED|Overall Study||59
7669138|NCT02005276|18885975|P2|STARTED|Overall Study||41
7669139|NCT02005276|18885976|P1|STARTED|Overall Study||65
7669140|NCT02005250|18885992|P2|NOT COMPLETED|Overall Study||5
7669141|NCT02005250|18885993|P1|NOT COMPLETED|Overall Study||15
7669142|NCT02005250|18885992|P2|COMPLETED|Overall Study||27
7669143|NCT02005250|18885993|P1|COMPLETED|Overall Study||46
7669144|NCT02005250|18885992|P2|STARTED|Overall Study||32
7669145|NCT02005250|18885993|P1|STARTED|Overall Study||61
7669146|NCT02005211|18886006|P7|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
7669147|NCT02005211|18886007|P6|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
7669148|NCT02005211|18886008|P5|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1
7669149|NCT02005211|18886009|P4|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
7669150|NCT02005211|18886010|P3|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
7669151|NCT02005211|18886011|P2|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
7669152|NCT02005211|18886012|P1|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
7669153|NCT02005211|18886006|P7|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
7669154|NCT02005211|18886007|P6|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
7669155|NCT02005211|18886008|P5|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5
7669156|NCT02005211|18886009|P4|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
7669157|NCT02005211|18886010|P3|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
7669158|NCT02005211|18886011|P2|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
7669159|NCT02005211|18886012|P1|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
7669160|NCT02005211|18886006|P7|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
7669161|NCT02005211|18886007|P6|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
7669162|NCT02005211|18886008|P5|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
7669163|NCT02005211|18886009|P4|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
7669164|NCT02005211|18886010|P3|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
7669165|NCT02005211|18886011|P2|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
7669166|NCT02005211|18886012|P1|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
7669167|NCT02005211|18886006|P7|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
7669168|NCT02005211|18886007|P6|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
7669169|NCT02005211|18886008|P5|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
7669170|NCT02005211|18886009|P4|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
7669171|NCT02005211|18886010|P3|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
7669172|NCT02005211|18886011|P2|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
7669173|NCT02005211|18886012|P1|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
7669175|NCT02005211|18886007|P6|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
7669176|NCT02005211|18886008|P5|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
7669177|NCT02005211|18886009|P4|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
7669178|NCT02005211|18886010|P3|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
7669179|NCT02005211|18886011|P2|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
7669180|NCT02005211|18886012|P1|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
7669181|NCT02005211|18886006|P7|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
7669182|NCT02005211|18886007|P6|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
7669183|NCT02005211|18886008|P5|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
7669184|NCT02005211|18886009|P4|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
7669185|NCT02005211|18886010|P3|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
7669186|NCT02005211|18886011|P2|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
7669187|NCT02005211|18886012|P1|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
7669188|NCT02005029|18886047|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7669189|NCT02005029|18886048|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7669190|NCT02005029|18886047|P2|COMPLETED|Second Intervention (1 Day)||5
7669191|NCT02005029|18886048|P1|COMPLETED|Second Intervention (1 Day)||4
7669192|NCT02005029|18886047|P2|STARTED|Second Intervention (1 Day)||5
7669193|NCT02005029|18886048|P1|STARTED|Second Intervention (1 Day)||4
7669194|NCT02005029|18886047|P2|NOT COMPLETED|Washout (2 Weeks)||0
7669195|NCT02005029|18886048|P1|NOT COMPLETED|Washout (2 Weeks)||0
7669196|NCT02005029|18886047|P2|COMPLETED|Washout (2 Weeks)||5
7669197|NCT02005029|18886048|P1|COMPLETED|Washout (2 Weeks)||4
7669198|NCT02005029|18886047|P2|STARTED|Washout (2 Weeks)||5
7669199|NCT02005029|18886048|P1|STARTED|Washout (2 Weeks)||4
7669200|NCT02005029|18886047|P2|NOT COMPLETED|First Intervention (1 Day)||0
7669201|NCT02005029|18886048|P1|NOT COMPLETED|First Intervention (1 Day)||1
7669202|NCT02005029|18886047|P2|COMPLETED|First Intervention (1 Day)||5
7669203|NCT02005029|18886048|P1|COMPLETED|First Intervention (1 Day)||4
7669204|NCT02005029|18886047|P2|STARTED|First Intervention (1 Day)||5
7669205|NCT02005029|18886048|P1|STARTED|First Intervention (1 Day)||5
7669206|NCT02005016|18886074|P1|NOT COMPLETED|Overall Study||2
7669207|NCT02005016|18886074|P1|COMPLETED|Overall Study||44
7669208|NCT02005016|18886074|P1|STARTED|Overall Study||46
7669209|NCT02004990|18886079|P1|NOT COMPLETED|Overall Study||0
7669210|NCT02004990|18886079|P1|COMPLETED|Overall Study||12
7669211|NCT02004990|18886079|P1|STARTED|Overall Study||12
7669212|NCT02004977|18886086|P2|NOT COMPLETED|Overall Study||5
7669213|NCT02004977|18886087|P1|NOT COMPLETED|Overall Study||54
7669214|NCT02004977|18886086|P2|COMPLETED|Overall Study||436
7669215|NCT02004977|18886087|P1|COMPLETED|Overall Study||409
7669216|NCT02004977|18886086|P2|STARTED|Overall Study||441
7669217|NCT02004977|18886087|P1|STARTED|Overall Study||463
7669218|NCT02004886|18886105|P4|NOT COMPLETED|Overall Study||0
7669219|NCT02004886|18886106|P3|NOT COMPLETED|Overall Study||0
7669220|NCT02004886|18886107|P2|NOT COMPLETED|Overall Study||1
7669221|NCT02004886|18886108|P1|NOT COMPLETED|Overall Study||1
7669222|NCT02004886|18886105|P4|COMPLETED|Overall Study||19
7669223|NCT02004886|18886106|P3|COMPLETED|Overall Study||18
7669224|NCT02004886|18886107|P2|COMPLETED|Overall Study||17
7669225|NCT02004886|18886108|P1|COMPLETED|Overall Study||18
7669226|NCT02004886|18886105|P4|STARTED|Overall Study||19
7669227|NCT02004886|18886106|P3|STARTED|Overall Study||18
7669228|NCT02004886|18886107|P2|STARTED|Overall Study||18
7669229|NCT02004886|18886108|P1|STARTED|Overall Study||19
7669230|NCT02004873|18886158|P1|NOT COMPLETED|Overall Study||424
7669231|NCT02004873|18886158|P1|COMPLETED|Overall Study|6-Month Follow-up|301
7669232|NCT02004873|18886158|P1|Micra Implant Success|Overall Study||719
7669233|NCT02004873|18886158|P1|STARTED|Overall Study|Micra Implant Attempt|725
7669234|NCT02004847|18886167|P2|NOT COMPLETED|Overall Study||1
7669235|NCT02004847|18886168|P1|NOT COMPLETED|Overall Study||1
7669236|NCT02004847|18886167|P2|COMPLETED|Overall Study||22
7669237|NCT02004847|18886168|P1|COMPLETED|Overall Study||23
7669238|NCT02004847|18886167|P2|STARTED|Overall Study||23
7669239|NCT02004847|18886168|P1|STARTED|Overall Study||24
7669240|NCT02004522|18886214|P2|NOT COMPLETED|Overall Study||159
7669241|NCT02004522|18886215|P1|NOT COMPLETED|Overall Study||126
7669242|NCT02004522|18886214|P2|COMPLETED|Overall Study|Completed defined here as still on treatment.|0
7669243|NCT02004522|18886215|P1|COMPLETED|Overall Study|Completed defined here as still on treatment.|34
7669244|NCT02004522|18886214|P2|Number of Subjects Treated|Overall Study||155
7669245|NCT02004522|18886215|P1|Number of Subjects Treated|Overall Study||158
7669246|NCT02004522|18886214|P2|STARTED|Overall Study||159
7669247|NCT02004522|18886215|P1|STARTED|Overall Study||160
7669248|NCT02004366|18886239|P5|NOT COMPLETED|On Discharge||0
7669249|NCT02004366|18886240|P4|NOT COMPLETED|On Discharge||0
7669250|NCT02004366|18886241|P3|NOT COMPLETED|On Discharge||0
7669251|NCT02004366|18886242|P2|NOT COMPLETED|On Discharge||0
7669252|NCT02004366|18886243|P1|NOT COMPLETED|On Discharge||0
7669253|NCT02004366|18886239|P5|COMPLETED|On Discharge||39
7669254|NCT02004366|18886240|P4|COMPLETED|On Discharge||93
7669255|NCT02004366|18886241|P3|COMPLETED|On Discharge||92
7669256|NCT02004366|18886242|P2|COMPLETED|On Discharge||0
7669257|NCT02004366|18886243|P1|COMPLETED|On Discharge||0
7669258|NCT02004366|18886239|P5|STARTED|On Discharge||39
7669259|NCT02004366|18886240|P4|STARTED|On Discharge||93
7669260|NCT02004366|18886241|P3|STARTED|On Discharge||92
7669261|NCT02004366|18886242|P2|STARTED|On Discharge||0
7669262|NCT02004366|18886243|P1|STARTED|On Discharge||0
7669263|NCT02004366|18886239|P5|NOT COMPLETED|In-hospital||0
7669264|NCT02004366|18886240|P4|NOT COMPLETED|In-hospital||0
7669265|NCT02004366|18886241|P3|NOT COMPLETED|In-hospital||0
7669266|NCT02004366|18886242|P2|NOT COMPLETED|In-hospital||0
7669267|NCT02004366|18886243|P1|NOT COMPLETED|In-hospital||0
7669268|NCT02004366|18886239|P5|COMPLETED|In-hospital||0
7669269|NCT02004366|18886240|P4|COMPLETED|In-hospital||0
7669270|NCT02004366|18886241|P3|COMPLETED|In-hospital||0
7669271|NCT02004366|18886242|P2|COMPLETED|In-hospital||122
7669272|NCT02004366|18886243|P1|COMPLETED|In-hospital||128
7669273|NCT02004366|18886239|P5|STARTED|In-hospital||0
7669274|NCT02004366|18886240|P4|STARTED|In-hospital||0
7669275|NCT02004366|18886241|P3|STARTED|In-hospital||0
7669276|NCT02004366|18886242|P2|STARTED|In-hospital||122
7669277|NCT02004366|18886243|P1|STARTED|In-hospital||128
7669278|NCT02004262|18886336|P6|NOT COMPLETED|Overall Study||30
7669279|NCT02004262|18886337|P5|NOT COMPLETED|Overall Study||31
7669280|NCT02004262|18886338|P4|NOT COMPLETED|Overall Study||29
7669281|NCT02004262|18886339|P3|NOT COMPLETED|Overall Study||72
7669282|NCT02004262|18886340|P2|NOT COMPLETED|Overall Study||68
7669283|NCT02004262|18886341|P1|NOT COMPLETED|Overall Study||73
7669284|NCT02004262|18886336|P6|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
7669285|NCT02004262|18886337|P5|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
7669286|NCT02004262|18886338|P4|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
7669287|NCT02004262|18886339|P3|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
7669288|NCT02004262|18886340|P2|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
7669289|NCT02004262|18886341|P1|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
7669290|NCT02004262|18886336|P6|Treated|Overall Study||11
7669291|NCT02004262|18886337|P5|Treated|Overall Study||29
7669292|NCT02004262|18886338|P4|Treated|Overall Study||26
7669293|NCT02004262|18886339|P3|Treated|Overall Study||43
7669294|NCT02004262|18886340|P2|Treated|Overall Study||58
7669295|NCT02004262|18886341|P1|Treated|Overall Study||68
7669296|NCT02004262|18886336|P6|STARTED|Overall Study||30
7669297|NCT02004262|18886337|P5|STARTED|Overall Study||31
7669298|NCT02004262|18886338|P4|STARTED|Overall Study||29
7669299|NCT02004262|18886339|P3|STARTED|Overall Study||72
7669300|NCT02004262|18886340|P2|STARTED|Overall Study||68
7669301|NCT02004262|18886341|P1|STARTED|Overall Study||73
7669302|NCT02004236|18886361|P3|NOT COMPLETED|Overall Study||16
7669303|NCT02004236|18886362|P2|NOT COMPLETED|Overall Study||0
7669304|NCT02004236|18886363|P1|NOT COMPLETED|Overall Study||0
7669305|NCT02004236|18886361|P3|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59
7669306|NCT02004236|18886362|P2|COMPLETED|Overall Study||75
7669307|NCT02004236|18886363|P1|COMPLETED|Overall Study||75
7669308|NCT02004236|18886361|P3|STARTED|Overall Study||75
7669309|NCT02004236|18886362|P2|STARTED|Overall Study||75
7669310|NCT02004236|18886363|P1|STARTED|Overall Study||75
7669311|NCT02004158|18886407|P1|NOT COMPLETED|Overall Study||3
7669312|NCT02004158|18886407|P1|COMPLETED|Overall Study||20
7669313|NCT02004158|18886407|P1|STARTED|Overall Study||23
7669314|NCT02004132|18886415|P1|NOT COMPLETED|Overall Study||0
7669315|NCT02004132|18886415|P1|COMPLETED|Overall Study||12
7669316|NCT02004132|18886415|P1|Received Study Drug|Overall Study||12
7669317|NCT02004132|18886415|P1|STARTED|Overall Study||12
7669318|NCT02004093|18886423|P2|NOT COMPLETED|Overall Study||73
7669319|NCT02004093|18886424|P1|NOT COMPLETED|Overall Study||74
7669320|NCT02004093|18886423|P2|COMPLETED|Overall Study||1
7669321|NCT02004093|18886424|P1|COMPLETED|Overall Study||1
7669322|NCT02004093|18886423|P2|STARTED|Overall Study||74
7669323|NCT02004093|18886424|P1|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75
7669324|NCT02003963|18886456|P2|NOT COMPLETED|Overall Study||1
7669325|NCT02003963|18886457|P1|NOT COMPLETED|Overall Study||2
7669326|NCT02003963|18886456|P2|COMPLETED|Overall Study|1 participant was removed from analysis for completing final visit outside of visit window.|18
7669327|NCT02003963|18886457|P1|COMPLETED|Overall Study|2 participants dropped out: 1 due to lack of interest and 1 due to a mental health hospitalization.|20
7669328|NCT02003963|18886456|P2|STARTED|Overall Study||19
7669329|NCT02003963|18886457|P1|STARTED|Overall Study||22
7669330|NCT02003924|18886479|P3|NOT COMPLETED|Long-term Follow-up Phase||7
7669331|NCT02003924|18886480|P2|NOT COMPLETED|Long-term Follow-up Phase||237
7669332|NCT02003924|18886481|P1|NOT COMPLETED|Long-term Follow-up Phase||367
7669333|NCT02003924|18886479|P3|COMPLETED|Long-term Follow-up Phase||80
7669334|NCT02003924|18886480|P2|COMPLETED|Long-term Follow-up Phase||144
7669335|NCT02003924|18886481|P1|COMPLETED|Long-term Follow-up Phase||566
7669336|NCT02003924|18886479|P3|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in open label phase.|87
7669337|NCT02003924|18886480|P2|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in double blind phase.|381
7669338|NCT02003924|18886481|P1|STARTED|Long-term Follow-up Phase|Participants followed up after discontinuing study drug in either double blind or open label phase.|933
7669339|NCT02003924|18886479|P3|NOT COMPLETED|Open-label Phase||17
7669340|NCT02003924|18886480|P2|NOT COMPLETED|Open-label Phase||0
7669341|NCT02003924|18886481|P1|NOT COMPLETED|Open-label Phase||100
7669342|NCT02003924|18886479|P3|COMPLETED|Open-label Phase||70
7669343|NCT02003924|18886480|P2|COMPLETED|Open-label Phase||0
7669344|NCT02003924|18886481|P1|COMPLETED|Open-label Phase||378
7669345|NCT02003924|18886479|P3|Treated|Open-label Phase||87
7669346|NCT02003924|18886480|P2|Treated|Open-label Phase||0
7669347|NCT02003924|18886481|P1|Treated|Open-label Phase||478
7669348|NCT02003924|18886479|P3|STARTED|Open-label Phase|Participants previously treated with placebo, switched to receive open label Enzalutamide.|87
7669349|NCT02003924|18886480|P2|STARTED|Open-label Phase|Participants were offered to switch from double blind placebo to open label Enzalutamide.|0
7669350|NCT02003924|18886481|P1|STARTED|Open-label Phase||478
7669351|NCT02003924|18886479|P3|NOT COMPLETED|Double-blind Phase||0
7669352|NCT02003924|18886480|P2|NOT COMPLETED|Double-blind Phase||381
7669353|NCT02003924|18886481|P1|NOT COMPLETED|Double-blind Phase||455
7669354|NCT02003924|18886479|P3|COMPLETED|Double-blind Phase||0
7669355|NCT02003924|18886480|P2|COMPLETED|Double-blind Phase||87
7669356|NCT02003924|18886481|P1|COMPLETED|Double-blind Phase||478
7669357|NCT02003924|18886479|P3|Treated|Double-blind Phase||0
7669358|NCT02003924|18886480|P2|Treated|Double-blind Phase||465
7669359|NCT02003924|18886481|P1|Treated|Double-blind Phase||930
7669360|NCT02003924|18886479|P3|STARTED|Double-blind Phase||0
7669361|NCT02003924|18886480|P2|STARTED|Double-blind Phase||468
7669362|NCT02003924|18886481|P1|STARTED|Double-blind Phase||933
7669363|NCT02003911|18886582|P2|NOT COMPLETED|Overall Study||7
7669364|NCT02003911|18886583|P1|NOT COMPLETED|Overall Study||2
7669365|NCT02003911|18886582|P2|COMPLETED|Overall Study||72
7669366|NCT02003911|18886583|P1|COMPLETED|Overall Study||78
7669367|NCT02003911|18886582|P2|STARTED|Overall Study||79
7669368|NCT02003911|18886583|P1|STARTED|Overall Study||80
7669369|NCT02003898|18886603|P1|NOT COMPLETED|Overall Study||67
7669370|NCT02003898|18886603|P1|COMPLETED|Overall Study||305
7669371|NCT02003898|18886603|P1|STARTED|Overall Study||372
7669372|NCT02003638|18886612|P2|NOT COMPLETED|Overall Study||0
7669373|NCT02003638|18886613|P1|NOT COMPLETED|Overall Study||1
7669374|NCT02003638|18886612|P2|COMPLETED|Overall Study||3
7669375|NCT02003638|18886613|P1|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5
7669376|NCT02003638|18886612|P2|STARTED|Overall Study||3
7669377|NCT02003638|18886613|P1|STARTED|Overall Study||6
7669378|NCT02003625|18886621|P2|NOT COMPLETED|Overall Study||3
7669379|NCT02003625|18886622|P1|NOT COMPLETED|Overall Study||1
7669380|NCT02003625|18886621|P2|COMPLETED|Overall Study||12
7669381|NCT02003625|18886622|P1|COMPLETED|Overall Study||14
7669382|NCT02003625|18886621|P2|Received Transplant|Overall Study||12
7669383|NCT02003625|18886622|P1|Received Transplant|Overall Study||14
7669384|NCT02003625|18886621|P2|STARTED|Overall Study||15
7669385|NCT02003625|18886622|P1|STARTED|Overall Study||15
7669386|NCT02003573|18886643|P3|NOT COMPLETED|Overall Study||6
7669387|NCT02003573|18886644|P2|NOT COMPLETED|Overall Study||4
7669388|NCT02003573|18886645|P1|NOT COMPLETED|Overall Study||3
7669389|NCT02003573|18886643|P3|COMPLETED|Overall Study||0
7669390|NCT02003573|18886644|P2|COMPLETED|Overall Study||0
7669391|NCT02003573|18886645|P1|COMPLETED|Overall Study||0
7669392|NCT02003573|18886643|P3|STARTED|Overall Study|Started are treated patients|6
7669393|NCT02003573|18886644|P2|STARTED|Overall Study|Started are treated patients|4
7669394|NCT02003573|18886645|P1|STARTED|Overall Study|Started are treated patients|3
7669395|NCT02003534|18886655|P1|NOT COMPLETED|Overall Study||47
7669396|NCT02003534|18886655|P1|COMPLETED|Overall Study||329
7669397|NCT02003534|18886655|P1|STARTED|Overall Study||376
7669398|NCT02003508|18886661|P2|NOT COMPLETED|Overall Study||0
7669399|NCT02003508|18886662|P1|NOT COMPLETED|Overall Study||0
7669400|NCT02003508|18886661|P2|COMPLETED|Overall Study||166
7669401|NCT02003508|18886662|P1|COMPLETED|Overall Study||179
7669402|NCT02003508|18886661|P2|STARTED|Overall Study||166
7669403|NCT02003508|18886662|P1|STARTED|Overall Study||179
7669404|NCT02003404|18886668|P1|NOT COMPLETED|Overall Study||0
7669405|NCT02003404|18886668|P1|COMPLETED|Overall Study||17
7669406|NCT02003404|18886668|P1|STARTED|Overall Study||17
7669407|NCT02003391|18886676|P2|NOT COMPLETED|Overall Study||2
7669408|NCT02003391|18886677|P1|NOT COMPLETED|Overall Study||3
7669409|NCT02003391|18886676|P2|COMPLETED|Overall Study||73
7669410|NCT02003391|18886677|P1|COMPLETED|Overall Study||78
7669411|NCT02003391|18886676|P2|Intent to Treat Population|Overall Study||73
7669412|NCT02003391|18886677|P1|Intent to Treat Population|Overall Study||78
7669413|NCT02003391|18886676|P2|Safety Population|Overall Study||75
7669414|NCT02003391|18886677|P1|Safety Population|Overall Study||81
7669415|NCT02003391|18886676|P2|STARTED|Overall Study||75
7669416|NCT02003391|18886677|P1|STARTED|Overall Study||81
7669417|NCT02003365|18886690|P3|NOT COMPLETED|Overall Study||1
7669418|NCT02003365|18886691|P2|NOT COMPLETED|Overall Study||0
7669419|NCT02003365|18886692|P1|NOT COMPLETED|Overall Study||0
7669420|NCT02003365|18886690|P3|COMPLETED|Overall Study||9
7669421|NCT02003365|18886691|P2|COMPLETED|Overall Study||30
7669422|NCT02003365|18886692|P1|COMPLETED|Overall Study||10
7669423|NCT02003365|18886690|P3|STARTED|Overall Study||10
7669424|NCT02003365|18886691|P2|STARTED|Overall Study||30
7669425|NCT02003365|18886692|P1|STARTED|Overall Study||10
7669426|NCT02003352|18886703|P1|NOT COMPLETED|Overall Study||0
7669427|NCT02003352|18886703|P1|COMPLETED|Overall Study||98
7669428|NCT02003352|18886703|P1|STARTED|Overall Study||98
7669429|NCT02003183|18886709|P2|NOT COMPLETED|Overall Study||2
7669430|NCT02003183|18886710|P1|NOT COMPLETED|Overall Study||0
7669431|NCT02003183|18886709|P2|COMPLETED|Overall Study||15
7669432|NCT02003183|18886710|P1|COMPLETED|Overall Study||7
7669433|NCT02003183|18886709|P2|STARTED|Overall Study||17
7669434|NCT02003183|18886710|P1|STARTED|Overall Study||7
7669435|NCT02003053|18886718|P2|NOT COMPLETED|Overall Study||0
7669436|NCT02003053|18886719|P1|NOT COMPLETED|Overall Study||0
7669437|NCT02003053|18886718|P2|COMPLETED|Overall Study||3
7669438|NCT02003053|18886719|P1|COMPLETED|Overall Study||4
7669439|NCT02003053|18886718|P2|STARTED|Overall Study||3
7669440|NCT02003053|18886719|P1|STARTED|Overall Study||4
7669441|NCT02003014|18886725|P1|NOT COMPLETED|Overall Study||19
7669442|NCT02003014|18886725|P1|COMPLETED|Overall Study||880
7669443|NCT02003014|18886725|P1|STARTED|Overall Study||899
7669444|NCT02002975|18886735|P1|NOT COMPLETED|Overall Study||572
7669445|NCT02002975|18886735|P1|COMPLETED|Overall Study||17651
7669446|NCT02002975|18886735|P1|STARTED|Overall Study||18223
7669447|NCT02002936|18886751|P1|NOT COMPLETED|Overall Study||0
7669448|NCT02002936|18886751|P1|COMPLETED|Overall Study||1
7669449|NCT02002936|18886751|P1|STARTED|Overall Study||1
7669450|NCT02002884|18886763|P4|NOT COMPLETED|Open-Label Extension Period (OLEX)||50
7669451|NCT02002884|18886764|P3|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
7669452|NCT02002884|18886765|P2|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
7669453|NCT02002884|18886766|P1|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
7669454|NCT02002884|18886763|P4|COMPLETED|Open-Label Extension Period (OLEX)||281
7669455|NCT02002884|18886764|P3|COMPLETED|Open-Label Extension Period (OLEX)||0
7669456|NCT02002884|18886765|P2|COMPLETED|Open-Label Extension Period (OLEX)||0
7669457|NCT02002884|18886766|P1|COMPLETED|Open-Label Extension Period (OLEX)||0
7669458|NCT02002884|18886763|P4|STARTED|Open-Label Extension Period (OLEX)||331
7669459|NCT02002884|18886764|P3|STARTED|Open-Label Extension Period (OLEX)||0
7669460|NCT02002884|18886765|P2|STARTED|Open-Label Extension Period (OLEX)||0
7669461|NCT02002884|18886766|P1|STARTED|Open-Label Extension Period (OLEX)||0
7669462|NCT02002884|18886763|P4|NOT COMPLETED|Main Period (MP)||0
7669463|NCT02002884|18886764|P3|NOT COMPLETED|Main Period (MP)||8
7669464|NCT02002884|18886765|P2|NOT COMPLETED|Main Period (MP)||6
7669465|NCT02002884|18886766|P1|NOT COMPLETED|Main Period (MP)||6
7669466|NCT02002884|18886763|P4|COMPLETED|Main Period (MP)||0
7669467|NCT02002884|18886764|P3|COMPLETED|Main Period (MP)||168
7669468|NCT02002884|18886765|P2|COMPLETED|Main Period (MP)||82
7669469|NCT02002884|18886766|P1|COMPLETED|Main Period (MP)||81
7669470|NCT02002884|18886763|P4|Treated|Main Period (MP)||0
7669471|NCT02002884|18886764|P3|Treated|Main Period (MP)||176
7669472|NCT02002884|18886765|P2|Treated|Main Period (MP)||87
7669473|NCT02002884|18886766|P1|Treated|Main Period (MP)||87
7669474|NCT02002884|18886763|P4|STARTED|Main Period (MP)||0
7669475|NCT02002884|18886764|P3|STARTED|Main Period (MP)||176
7669476|NCT02002884|18886765|P2|STARTED|Main Period (MP)||88
7669477|NCT02002884|18886766|P1|STARTED|Main Period (MP)||87
7669478|NCT02002871|18886825|P1|NOT COMPLETED|Overall Study||1
7669479|NCT02002871|18886825|P1|COMPLETED|Overall Study||20
7669480|NCT02002871|18886825|P1|STARTED|Overall Study||21
7669481|NCT02002832|18886853|P2|NOT COMPLETED|Overall Study||26
7669482|NCT02002832|18886854|P1|NOT COMPLETED|Overall Study||28
7669483|NCT02002832|18886853|P2|COMPLETED|Overall Study||168
7669484|NCT02002832|18886854|P1|COMPLETED|Overall Study||166
7669485|NCT02002832|18886853|P2|STARTED|Overall Study||194
7669486|NCT02002832|18886854|P1|STARTED|Overall Study||194
7669487|NCT02002767|18886864|P2|NOT COMPLETED|Overall Study||0
7669488|NCT02002767|18886865|P1|NOT COMPLETED|Overall Study||0
7669489|NCT02002767|18886864|P2|COMPLETED|Overall Study||10
7669490|NCT02002767|18886865|P1|COMPLETED|Overall Study||9
7669491|NCT02002767|18886864|P2|STARTED|Overall Study||10
7669492|NCT02002767|18886865|P1|STARTED|Overall Study||9
7669493|NCT02002702|18886884|P3|NOT COMPLETED|Overall Study||0
7669494|NCT02002702|18886885|P2|NOT COMPLETED|Overall Study||0
7669495|NCT02002702|18886886|P1|NOT COMPLETED|Overall Study||0
7669496|NCT02002702|18886884|P3|COMPLETED|Overall Study||15
7669497|NCT02002702|18886885|P2|COMPLETED|Overall Study||15
7669498|NCT02002702|18886886|P1|COMPLETED|Overall Study||16
7669499|NCT02002702|18886884|P3|STARTED|Overall Study||15
7669500|NCT02002702|18886885|P2|STARTED|Overall Study||15
7669501|NCT02002702|18886886|P1|STARTED|Overall Study||16
7669502|NCT02002689|18886918|P1|NOT COMPLETED|Overall Study||10
7669503|NCT02002689|18886918|P1|COMPLETED|Overall Study||0
7669504|NCT02002689|18886918|P1|STARTED|Overall Study||10
7669505|NCT02002650|18886926|P2|NOT COMPLETED|Overall Study||0
7669506|NCT02002650|18886927|P1|NOT COMPLETED|Overall Study||0
7669507|NCT02002650|18886926|P2|COMPLETED|Overall Study||1303
7669508|NCT02002650|18886927|P1|COMPLETED|Overall Study||1297
7669509|NCT02002650|18886926|P2|STARTED|Overall Study||1303
7669510|NCT02002650|18886927|P1|STARTED|Overall Study||1297
7669511|NCT02002533|18886937|P2|NOT COMPLETED|Overall Study||18
7669512|NCT02002533|18886938|P1|NOT COMPLETED|Overall Study||6
7669513|NCT02002533|18886937|P2|COMPLETED|Overall Study||19
7669514|NCT02002533|18886938|P1|COMPLETED|Overall Study||28
7669515|NCT02002533|18886937|P2|STARTED|Overall Study||37
7669516|NCT02002533|18886938|P1|STARTED|Overall Study||34
7669517|NCT02002494|18886961|P1|NOT COMPLETED|Overall Study||0
7669518|NCT02002494|18886961|P1|COMPLETED|Overall Study||27
7669519|NCT02002494|18886961|P1|STARTED|Overall Study||27
7669520|NCT02002221|18886978|P2|NOT COMPLETED|Overall Study||3
7669521|NCT02002221|18886979|P1|NOT COMPLETED|Overall Study||2
7669522|NCT02002221|18886978|P2|COMPLETED|Overall Study||75
7669523|NCT02002221|18886979|P1|COMPLETED|Overall Study||76
7669524|NCT02002221|18886978|P2|STARTED|Overall Study||78
7669525|NCT02002221|18886979|P1|STARTED|Overall Study||78
7669526|NCT02002208|18886995|P2|NOT COMPLETED|Overall Study||40
7669527|NCT02002208|18886996|P1|NOT COMPLETED|Overall Study||37
7669528|NCT02002208|18886995|P2|COMPLETED|Overall Study||30
7669529|NCT02002208|18886996|P1|COMPLETED|Overall Study||32
7669530|NCT02002208|18886995|P2|STARTED|Overall Study||70
7669531|NCT02002208|18886996|P1|STARTED|Overall Study||69
7669532|NCT02002182|18887006|P2|NOT COMPLETED|Overall Study||1
7669533|NCT02002182|18887007|P1|NOT COMPLETED|Overall Study||5
7669534|NCT02002182|18887006|P2|COMPLETED|Overall Study||5
7669535|NCT02002182|18887007|P1|COMPLETED|Overall Study||4
7669536|NCT02002182|18887006|P2|STARTED|Overall Study||6
7669537|NCT02002182|18887007|P1|STARTED|Overall Study||9
7669538|NCT02002091|18887019|P2|NOT COMPLETED|One Year Follow up||0
7669539|NCT02002091|18887020|P1|NOT COMPLETED|One Year Follow up||0
7669540|NCT02002091|18887019|P2|COMPLETED|One Year Follow up||191
7669541|NCT02002091|18887020|P1|COMPLETED|One Year Follow up||109
7669542|NCT02002091|18887019|P2|STARTED|One Year Follow up||191
7669543|NCT02002091|18887020|P1|STARTED|One Year Follow up||109
7669544|NCT02002091|18887019|P2|NOT COMPLETED|Screening||14
7669545|NCT02002091|18887020|P1|NOT COMPLETED|Screening||13
7669546|NCT02002091|18887019|P2|COMPLETED|Screening||191
7669547|NCT02002091|18887020|P1|COMPLETED|Screening||109
7669548|NCT02002091|18887019|P2|STARTED|Screening||205
7669549|NCT02002091|18887020|P1|STARTED|Screening||122
7669550|NCT02001987|18887055|P1|NOT COMPLETED|LTE Period (52 Weeks)||9
7669551|NCT02001987|18887055|P1|COMPLETED|LTE Period (52 Weeks)||107
7669552|NCT02001987|18887055|P1|STARTED|LTE Period (52 Weeks)||116
7669553|NCT02001987|18887055|P1|NOT COMPLETED|Core Study Period (24 Weeks)||23
7669554|NCT02001987|18887055|P1|COMPLETED|Core Study Period (24 Weeks)||116
7669555|NCT02001987|18887055|P1|STARTED|Core Study Period (24 Weeks)||139
7669556|NCT02001714|18887131|P2|NOT COMPLETED|Overall Study||12
7669557|NCT02001714|18887132|P1|NOT COMPLETED|Overall Study||22
7669558|NCT02001714|18887131|P2|COMPLETED|Overall Study||219
7669559|NCT02001714|18887132|P1|COMPLETED|Overall Study||210
7669560|NCT02001714|18887131|P2|STARTED|Overall Study||231
7669561|NCT02001714|18887132|P1|STARTED|Overall Study||232
7669562|NCT02001688|18887141|P3|NOT COMPLETED|Overall Study||1
7669563|NCT02001688|18887142|P2|NOT COMPLETED|Overall Study||1
7669564|NCT02001688|18887143|P1|NOT COMPLETED|Overall Study||0
7669565|NCT02001688|18887141|P3|COMPLETED|Overall Study||11
7669566|NCT02001688|18887142|P2|COMPLETED|Overall Study||11
7669567|NCT02001688|18887143|P1|COMPLETED|Overall Study||12
7669568|NCT02001688|18887141|P3|STARTED|Overall Study||12
7669569|NCT02001688|18887142|P2|STARTED|Overall Study||12
7669570|NCT02001688|18887143|P1|STARTED|Overall Study||12
7669571|NCT02001558|18887162|P2|NOT COMPLETED|Overall Study||14
7669572|NCT02001558|18887163|P1|NOT COMPLETED|Overall Study||8
7669573|NCT02001558|18887162|P2|COMPLETED|Overall Study||19
7669574|NCT02001558|18887163|P1|COMPLETED|Overall Study||24
7669575|NCT02001558|18887162|P2|STARTED|Overall Study||33
7669576|NCT02001558|18887163|P1|STARTED|Overall Study||32
7669577|NCT02001194|18887199|P4|NOT COMPLETED|Follow-Up Period (13 Weeks)||0
7669578|NCT02001194|18887200|P3|NOT COMPLETED|Follow-Up Period (13 Weeks)||1
7669579|NCT02001194|18887201|P2|NOT COMPLETED|Follow-Up Period (13 Weeks)||2
7669580|NCT02001194|18887202|P1|NOT COMPLETED|Follow-Up Period (13 Weeks)||3
7669581|NCT02001194|18887199|P4|COMPLETED|Follow-Up Period (13 Weeks)||78
7669582|NCT02001194|18887200|P3|COMPLETED|Follow-Up Period (13 Weeks)||73
7669583|NCT02001194|18887201|P2|COMPLETED|Follow-Up Period (13 Weeks)||78
7669584|NCT02001194|18887202|P1|COMPLETED|Follow-Up Period (13 Weeks)||64
7669585|NCT02001194|18887199|P4|STARTED|Follow-Up Period (13 Weeks)||78
7669586|NCT02001194|18887200|P3|STARTED|Follow-Up Period (13 Weeks)||74
7669587|NCT02001194|18887201|P2|STARTED|Follow-Up Period (13 Weeks)||80
7669588|NCT02001194|18887202|P1|STARTED|Follow-Up Period (13 Weeks)||67
7669589|NCT02001194|18887199|P4|NOT COMPLETED|Intervention Period (13 Weeks)||2
7669590|NCT02001194|18887200|P3|NOT COMPLETED|Intervention Period (13 Weeks)||2
7669591|NCT02001194|18887201|P2|NOT COMPLETED|Intervention Period (13 Weeks)||0
7669592|NCT02001194|18887202|P1|NOT COMPLETED|Intervention Period (13 Weeks)||1
7669593|NCT02001194|18887199|P4|COMPLETED|Intervention Period (13 Weeks)|20 teams|78
7669594|NCT02001194|18887200|P3|COMPLETED|Intervention Period (13 Weeks)|19 teams|74
7669595|NCT02001194|18887201|P2|COMPLETED|Intervention Period (13 Weeks)|20 teams|80
7669596|NCT02001194|18887202|P1|COMPLETED|Intervention Period (13 Weeks)|16 teams|67
7669597|NCT02001194|18887199|P4|STARTED|Intervention Period (13 Weeks)|20 teams|80
7669598|NCT02001194|18887200|P3|STARTED|Intervention Period (13 Weeks)|19 teams|76
7669599|NCT02001194|18887201|P2|STARTED|Intervention Period (13 Weeks)|20 teams|80
7669600|NCT02001194|18887202|P1|STARTED|Intervention Period (13 Weeks)|17 teams|68
7669601|NCT02001181|18887218|P2|NOT COMPLETED|Overall Study||3
7669602|NCT02001181|18887219|P1|NOT COMPLETED|Overall Study||1
7669603|NCT02001181|18887218|P2|COMPLETED|Overall Study||31
7669604|NCT02001181|18887219|P1|COMPLETED|Overall Study||34
7669605|NCT02001181|18887218|P2|STARTED|Overall Study||34
7669606|NCT02001181|18887219|P1|STARTED|Overall Study||35
7669607|NCT02001051|18887235|P2|NOT COMPLETED|Overall Study||1
7669608|NCT02001051|18887236|P1|NOT COMPLETED|Overall Study||0
7669609|NCT02001051|18887235|P2|COMPLETED|Overall Study||1
7669610|NCT02001051|18887236|P1|COMPLETED|Overall Study||2
7669611|NCT02001051|18887235|P2|STARTED|Overall Study||2
7669612|NCT02001051|18887236|P1|STARTED|Overall Study||2
7669613|NCT02000973|18887260|P4|NOT COMPLETED|Overall Study||0
7669614|NCT02000973|18887261|P3|NOT COMPLETED|Overall Study||0
7669615|NCT02000973|18887262|P2|NOT COMPLETED|Overall Study||0
7669616|NCT02000973|18887263|P1|NOT COMPLETED|Overall Study||0
7669617|NCT02000973|18887260|P4|COMPLETED|Overall Study||20
7669618|NCT02000973|18887261|P3|COMPLETED|Overall Study||20
7669619|NCT02000973|18887262|P2|COMPLETED|Overall Study||20
7669620|NCT02000973|18887263|P1|COMPLETED|Overall Study||20
7669621|NCT02000973|18887260|P4|STARTED|Overall Study||20
7669622|NCT02000973|18887261|P3|STARTED|Overall Study||20
7669623|NCT02000973|18887262|P2|STARTED|Overall Study||20
7669624|NCT02000973|18887263|P1|STARTED|Overall Study||20
7669625|NCT02000921|18887288|P3|NOT COMPLETED|Overall Study||10
7669626|NCT02000921|18887289|P2|NOT COMPLETED|Overall Study||16
7669627|NCT02000921|18887290|P1|NOT COMPLETED|Overall Study||5
7669628|NCT02000921|18887288|P3|COMPLETED|Overall Study||46
7669629|NCT02000921|18887289|P2|COMPLETED|Overall Study||37
7669630|NCT02000921|18887290|P1|COMPLETED|Overall Study||22
7669631|NCT02000921|18887288|P3|STARTED|Overall Study||56
7669632|NCT02000921|18887289|P2|STARTED|Overall Study||53
7669633|NCT02000921|18887290|P1|STARTED|Overall Study||27
7669634|NCT02000908|18887309|P2|NOT COMPLETED|Overall Study||4
7669635|NCT02000908|18887310|P1|NOT COMPLETED|Overall Study||2
7669636|NCT02000908|18887309|P2|COMPLETED|Overall Study||36
7669637|NCT02000908|18887310|P1|COMPLETED|Overall Study||28
7669638|NCT02000908|18887309|P2|STARTED|Overall Study||40
7669639|NCT02000908|18887310|P1|STARTED|Overall Study||30
7669640|NCT02000817|18887320|P4|NOT COMPLETED|Overall Study||0
7669641|NCT02000817|18887321|P3|NOT COMPLETED|Overall Study||1
7669642|NCT02000817|18887322|P2|NOT COMPLETED|Overall Study||1
7669643|NCT02000817|18887323|P1|NOT COMPLETED|Overall Study||2
7669644|NCT02000817|18887320|P4|COMPLETED|Overall Study||7
7669645|NCT02000817|18887321|P3|COMPLETED|Overall Study||7
7669646|NCT02000817|18887322|P2|COMPLETED|Overall Study||8
7669647|NCT02000817|18887323|P1|COMPLETED|Overall Study||4
7669648|NCT02000817|18887320|P4|STARTED|Overall Study||7
7669649|NCT02000817|18887321|P3|STARTED|Overall Study||8
7669650|NCT02000817|18887322|P2|STARTED|Overall Study||9
7669651|NCT02000817|18887323|P1|STARTED|Overall Study||6
7669652|NCT02000752|18887418|P2|NOT COMPLETED|Overall Study||13
7669653|NCT02000752|18887419|P1|NOT COMPLETED|Overall Study||31
7669654|NCT02000752|18887418|P2|COMPLETED|Overall Study||47
7669655|NCT02000752|18887419|P1|COMPLETED|Overall Study||29
7669656|NCT02000752|18887418|P2|STARTED|Overall Study||60
7669657|NCT02000752|18887419|P1|STARTED|Overall Study||60
7669658|NCT02000622|18887433|P2|NOT COMPLETED|Overall Study||80
7669659|NCT02000622|18887434|P1|NOT COMPLETED|Overall Study||169
7669660|NCT02000622|18887433|P2|COMPLETED|Overall Study||17
7669661|NCT02000622|18887434|P1|COMPLETED|Overall Study||36
7669662|NCT02000622|18887433|P2|STARTED|Overall Study||97
7669663|NCT02000622|18887434|P1|STARTED|Overall Study||205
7669664|NCT02000583|18887464|P2|NOT COMPLETED|Overall Study||5
7669665|NCT02000583|18887465|P1|NOT COMPLETED|Overall Study||3
7669666|NCT02000583|18887464|P2|COMPLETED|Overall Study||34
7669667|NCT02000583|18887465|P1|COMPLETED|Overall Study||75
7669668|NCT02000583|18887464|P2|STARTED|Overall Study||39
7669669|NCT02000583|18887465|P1|STARTED|Overall Study||78
7669670|NCT02000531|18887477|P2|NOT COMPLETED|Overall Study||8
7669671|NCT02000531|18887478|P1|NOT COMPLETED|Overall Study||4
7669672|NCT02000531|18887477|P2|COMPLETED|Overall Study||16
7669673|NCT02000531|18887478|P1|COMPLETED|Overall Study||17
7669674|NCT02000531|18887477|P2|Safety Population|Overall Study||24
7669675|NCT02000531|18887478|P1|Safety Population|Overall Study||21
7669676|NCT02000531|18887477|P2|STARTED|Overall Study||24
7669677|NCT02000531|18887478|P1|STARTED|Overall Study||21
7669678|NCT02000440|18887486|P1|NOT COMPLETED|Overall Study||4
7669679|NCT02000440|18887486|P1|COMPLETED|Overall Study||13
7669680|NCT02000440|18887486|P1|STARTED|Overall Study||17
7669681|NCT02000427|18887506|P1|NOT COMPLETED|Overall Study||22
7669682|NCT02000427|18887506|P1|COMPLETED|Overall Study|Indicates participants ongoing in study as of the data cut-off date of 20 May 2015.|23
7669683|NCT02000427|18887506|P1|STARTED|Overall Study||45
7669684|NCT02000180|18887523|P2|NOT COMPLETED|Overall Study||0
7669685|NCT02000180|18887524|P1|NOT COMPLETED|Overall Study||0
7669686|NCT02000180|18887523|P2|COMPLETED|Overall Study||19
7669687|NCT02000180|18887524|P1|COMPLETED|Overall Study||18
7669688|NCT02000180|18887523|P2|STARTED|Overall Study||19
7669689|NCT02000180|18887524|P1|STARTED|Overall Study||18
7669690|NCT02000154|18887536|P1|NOT COMPLETED|Overall Study||0
7669691|NCT02000154|18887536|P1|COMPLETED|Overall Study||1
7669692|NCT02000154|18887536|P1|STARTED|Overall Study||1
7669693|NCT01999985|18887544|P3|NOT COMPLETED|Overall Study||0
7669694|NCT01999985|18887545|P2|NOT COMPLETED|Overall Study||0
7669695|NCT01999985|18887546|P1|NOT COMPLETED|Overall Study||0
7669696|NCT01999985|18887544|P3|COMPLETED|Overall Study||14
7669697|NCT01999985|18887545|P2|COMPLETED|Overall Study||3
7669698|NCT01999985|18887546|P1|COMPLETED|Overall Study||8
7669699|NCT01999985|18887544|P3|STARTED|Overall Study||14
7669700|NCT01999985|18887545|P2|STARTED|Overall Study||3
7669701|NCT01999985|18887546|P1|STARTED|Overall Study||8
7669702|NCT01999972|18887560|P6|NOT COMPLETED|Dose Expansion Part||7
7669703|NCT01999972|18887561|P5|NOT COMPLETED|Dose Expansion Part||21
7669704|NCT01999972|18887562|P4|NOT COMPLETED|Dose Expansion Part||0
7669705|NCT01999972|18887563|P3|NOT COMPLETED|Dose Expansion Part||0
7669706|NCT01999972|18887564|P2|NOT COMPLETED|Dose Expansion Part||0
7669707|NCT01999972|18887565|P1|NOT COMPLETED|Dose Expansion Part||0
7669708|NCT01999972|18887560|P6|COMPLETED|Dose Expansion Part||0
7669709|NCT01999972|18887561|P5|COMPLETED|Dose Expansion Part||0
7669710|NCT01999972|18887562|P4|COMPLETED|Dose Expansion Part||0
7669711|NCT01999972|18887563|P3|COMPLETED|Dose Expansion Part||0
7669712|NCT01999972|18887564|P2|COMPLETED|Dose Expansion Part||0
7669713|NCT01999972|18887565|P1|COMPLETED|Dose Expansion Part||0
7669714|NCT01999972|18887560|P6|Treated|Dose Expansion Part||7
7669715|NCT01999972|18887561|P5|Treated|Dose Expansion Part||21
7669716|NCT01999972|18887562|P4|Treated|Dose Expansion Part||0
7669717|NCT01999972|18887563|P3|Treated|Dose Expansion Part||0
7669718|NCT01999972|18887564|P2|Treated|Dose Expansion Part||0
7669719|NCT01999972|18887565|P1|Treated|Dose Expansion Part||0
7669720|NCT01999972|18887560|P6|STARTED|Dose Expansion Part||7
7669721|NCT01999972|18887561|P5|STARTED|Dose Expansion Part||21
7669722|NCT01999972|18887562|P4|STARTED|Dose Expansion Part||0
7669723|NCT01999972|18887563|P3|STARTED|Dose Expansion Part||0
7669724|NCT01999972|18887564|P2|STARTED|Dose Expansion Part||0
7669725|NCT01999972|18887565|P1|STARTED|Dose Expansion Part||0
7669726|NCT01999972|18887560|P6|NOT COMPLETED|Dose Escalation Part||0
7669727|NCT01999972|18887561|P5|NOT COMPLETED|Dose Escalation Part||0
7669728|NCT01999972|18887562|P4|NOT COMPLETED|Dose Escalation Part||11
7669729|NCT01999972|18887563|P3|NOT COMPLETED|Dose Escalation Part||5
7669730|NCT01999972|18887564|P2|NOT COMPLETED|Dose Escalation Part||3
7669731|NCT01999972|18887565|P1|NOT COMPLETED|Dose Escalation Part||5
7669732|NCT01999972|18887560|P6|COMPLETED|Dose Escalation Part||0
7669733|NCT01999972|18887561|P5|COMPLETED|Dose Escalation Part||0
7669734|NCT01999972|18887562|P4|COMPLETED|Dose Escalation Part||0
7669735|NCT01999972|18887563|P3|COMPLETED|Dose Escalation Part||0
7669736|NCT01999972|18887564|P2|COMPLETED|Dose Escalation Part||0
7669737|NCT01999972|18887565|P1|COMPLETED|Dose Escalation Part||0
7669738|NCT01999972|18887560|P6|Treated|Dose Escalation Part||0
7669739|NCT01999972|18887561|P5|Treated|Dose Escalation Part||0
7669740|NCT01999972|18887562|P4|Treated|Dose Escalation Part||10
7669741|NCT01999972|18887563|P3|Treated|Dose Escalation Part||4
7669742|NCT01999972|18887564|P2|Treated|Dose Escalation Part||3
7669743|NCT01999972|18887565|P1|Treated|Dose Escalation Part||5
7669744|NCT01999972|18887560|P6|STARTED|Dose Escalation Part||0
7669745|NCT01999972|18887561|P5|STARTED|Dose Escalation Part||0
7669746|NCT01999972|18887562|P4|STARTED|Dose Escalation Part||11
7669747|NCT01999972|18887563|P3|STARTED|Dose Escalation Part||5
7669748|NCT01999972|18887564|P2|STARTED|Dose Escalation Part||3
7669749|NCT01999972|18887565|P1|STARTED|Dose Escalation Part||5
7669750|NCT01999946|18887680|P3|NOT COMPLETED|Overall Study||79
7669751|NCT01999946|18887681|P2|NOT COMPLETED|Overall Study||2
7669752|NCT01999946|18887682|P1|NOT COMPLETED|Overall Study||2
7669753|NCT01999946|18887680|P3|COMPLETED|Overall Study||0
7669754|NCT01999946|18887681|P2|COMPLETED|Overall Study||56
7669755|NCT01999946|18887682|P1|COMPLETED|Overall Study||59
7669756|NCT01999946|18887680|P3|STARTED|Overall Study||79
7669757|NCT01999946|18887681|P2|STARTED|Overall Study||58
7669758|NCT01999946|18887682|P1|STARTED|Overall Study||61
7669759|NCT01999920|18887691|P2|NOT COMPLETED|Overall Study||2
7669760|NCT01999920|18887692|P1|NOT COMPLETED|Overall Study||6
7669761|NCT01999920|18887691|P2|COMPLETED|Overall Study||9
7669762|NCT01999920|18887692|P1|COMPLETED|Overall Study||7
7669763|NCT01999920|18887691|P2|STARTED|Overall Study||11
7669764|NCT01999920|18887692|P1|STARTED|Overall Study||13
7669765|NCT01999894|18887708|P1|NOT COMPLETED|Overall Study||36
7669766|NCT01999894|18887708|P1|COMPLETED|Overall Study||66
7669767|NCT01999894|18887708|P1|STARTED|Overall Study||102
7669768|NCT01999868|18887716|P3|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
7669769|NCT01999868|18887717|P2|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||29
7669770|NCT01999868|18887718|P1|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||23
7669771|NCT01999868|18887716|P3|COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
7669772|NCT01999868|18887717|P2|COMPLETED|Blinded Observation Phase (Week 40 - 88)||6
7669773|NCT01999868|18887718|P1|COMPLETED|Blinded Observation Phase (Week 40 - 88)||4
7669774|NCT01999868|18887716|P3|STARTED|Blinded Observation Phase (Week 40 - 88)||0
7669775|NCT01999868|18887717|P2|STARTED|Blinded Observation Phase (Week 40 - 88)||35
7669776|NCT01999868|18887718|P1|STARTED|Blinded Observation Phase (Week 40 - 88)||27
7669777|NCT01999868|18887716|P3|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
7669778|NCT01999868|18887717|P2|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||11
7669779|NCT01999868|18887718|P1|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||18
7669780|NCT01999868|18887716|P3|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
7669781|NCT01999868|18887717|P2|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||35
7669782|NCT01999868|18887718|P1|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||27
7669783|NCT01999868|18887716|P3|STARTED|Blinded Treatment Phase (Week 12 - 40)|Participants didn't meet eligibility requirements for randomization or withdrew prior to Week 12.|0
7669784|NCT01999868|18887717|P2|STARTED|Blinded Treatment Phase (Week 12 - 40)||46
7669785|NCT01999868|18887718|P1|STARTED|Blinded Treatment Phase (Week 12 - 40)||45
7669786|NCT01999868|18887716|P3|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||5
7669787|NCT01999868|18887717|P2|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
7669788|NCT01999868|18887718|P1|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
7669789|NCT01999868|18887716|P3|COMPLETED|Lead-in Phase (Week 0 - 12)||12
7669790|NCT01999868|18887717|P2|COMPLETED|Lead-in Phase (Week 0 - 12)||46
7669791|NCT01999868|18887718|P1|COMPLETED|Lead-in Phase (Week 0 - 12)||45
7669792|NCT01999868|18887716|P3|STARTED|Lead-in Phase (Week 0 - 12)||17
7669793|NCT01999868|18887717|P2|STARTED|Lead-in Phase (Week 0 - 12)||46
7669794|NCT01999868|18887718|P1|STARTED|Lead-in Phase (Week 0 - 12)||45
7669795|NCT01999777|18887745|P2|NOT COMPLETED|Overall Study||0
7669796|NCT01999777|18887746|P1|NOT COMPLETED|Overall Study||0
7669797|NCT01999777|18887745|P2|COMPLETED|Overall Study||31
7669798|NCT01999777|18887746|P1|COMPLETED|Overall Study||31
7669799|NCT01999777|18887745|P2|STARTED|Overall Study||31
7669800|NCT01999777|18887746|P1|STARTED|Overall Study||31
7669801|NCT01999530|18887754|P1|NOT COMPLETED|Overall Study||13
7669802|NCT01999530|18887754|P1|COMPLETED|Overall Study||7
7669803|NCT01999530|18887754|P1|STARTED|Overall Study||20
7669804|NCT01999517|18887760|P2|NOT COMPLETED|Overall Study||0
7669805|NCT01999517|18887761|P1|NOT COMPLETED|Overall Study||0
7669806|NCT01999517|18887760|P2|COMPLETED|Overall Study||54
7669807|NCT01999517|18887761|P1|COMPLETED|Overall Study||68
7669808|NCT01999517|18887760|P2|STARTED|Overall Study||54
7669809|NCT01999517|18887761|P1|STARTED|Overall Study||68
7669810|NCT01999465|18887769|P2|NOT COMPLETED|Overall Study||3
7669811|NCT01999465|18887770|P1|NOT COMPLETED|Overall Study||0
7669812|NCT01999465|18887769|P2|COMPLETED|Overall Study||7
7669813|NCT01999465|18887770|P1|COMPLETED|Overall Study||10
7669814|NCT01999465|18887769|P2|STARTED|Overall Study||10
7669815|NCT01999465|18887770|P1|STARTED|Overall Study||10
7669816|NCT01999400|18887778|P6|NOT COMPLETED|Fourth Intervention (1 Day)||0
7669817|NCT01999400|18887779|P5|NOT COMPLETED|Fourth Intervention (1 Day)||0
7669818|NCT01999400|18887780|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
7669819|NCT01999400|18887781|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
7669820|NCT01999400|18887782|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
7669821|NCT01999400|18887783|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
7669822|NCT01999400|18887778|P6|COMPLETED|Fourth Intervention (1 Day)||0
7669823|NCT01999400|18887779|P5|COMPLETED|Fourth Intervention (1 Day)||0
7669824|NCT01999400|18887780|P4|COMPLETED|Fourth Intervention (1 Day)||0
7669825|NCT01999400|18887781|P3|COMPLETED|Fourth Intervention (1 Day)||1
7669826|NCT01999400|18887782|P2|COMPLETED|Fourth Intervention (1 Day)||0
7669827|NCT01999400|18887783|P1|COMPLETED|Fourth Intervention (1 Day)||1
7669828|NCT01999400|18887778|P6|STARTED|Fourth Intervention (1 Day)||0
7669829|NCT01999400|18887779|P5|STARTED|Fourth Intervention (1 Day)||0
7669830|NCT01999400|18887780|P4|STARTED|Fourth Intervention (1 Day)||0
7669831|NCT01999400|18887781|P3|STARTED|Fourth Intervention (1 Day)||1
7669832|NCT01999400|18887782|P2|STARTED|Fourth Intervention (1 Day)||0
7669833|NCT01999400|18887783|P1|STARTED|Fourth Intervention (1 Day)||1
7669834|NCT01999400|18887778|P6|NOT COMPLETED|Washout (10 Days)||0
7669835|NCT01999400|18887779|P5|NOT COMPLETED|Washout (10 Days)||0
7669836|NCT01999400|18887780|P4|NOT COMPLETED|Washout (10 Days)||0
7669837|NCT01999400|18887781|P3|NOT COMPLETED|Washout (10 Days)||0
7669838|NCT01999400|18887782|P2|NOT COMPLETED|Washout (10 Days)||0
7669839|NCT01999400|18887783|P1|NOT COMPLETED|Washout (10 Days)||0
7669840|NCT01999400|18887778|P6|COMPLETED|Washout (10 Days)||0
7669841|NCT01999400|18887779|P5|COMPLETED|Washout (10 Days)||0
7669842|NCT01999400|18887780|P4|COMPLETED|Washout (10 Days)||0
7669843|NCT01999400|18887781|P3|COMPLETED|Washout (10 Days)||1
7669844|NCT01999400|18887782|P2|COMPLETED|Washout (10 Days)||0
7669845|NCT01999400|18887783|P1|COMPLETED|Washout (10 Days)||1
7669846|NCT01999400|18887778|P6|STARTED|Washout (10 Days)||0
7669847|NCT01999400|18887779|P5|STARTED|Washout (10 Days)||0
7669848|NCT01999400|18887780|P4|STARTED|Washout (10 Days)||0
7669849|NCT01999400|18887781|P3|STARTED|Washout (10 Days)||1
7669850|NCT01999400|18887782|P2|STARTED|Washout (10 Days)||0
7669851|NCT01999400|18887783|P1|STARTED|Washout (10 Days)||1
7669852|NCT01999400|18887778|P6|NOT COMPLETED|Third Intervention (1 Day)||1
7669853|NCT01999400|18887779|P5|NOT COMPLETED|Third Intervention (1 Day)||0
7669854|NCT01999400|18887780|P4|NOT COMPLETED|Third Intervention (1 Day)||0
7669855|NCT01999400|18887781|P3|NOT COMPLETED|Third Intervention (1 Day)||0
7669856|NCT01999400|18887782|P2|NOT COMPLETED|Third Intervention (1 Day)||0
7669857|NCT01999400|18887783|P1|NOT COMPLETED|Third Intervention (1 Day)||0
7669858|NCT01999400|18887778|P6|COMPLETED|Third Intervention (1 Day)||0
7669859|NCT01999400|18887779|P5|COMPLETED|Third Intervention (1 Day)||1
7669860|NCT01999400|18887780|P4|COMPLETED|Third Intervention (1 Day)||1
7669861|NCT01999400|18887781|P3|COMPLETED|Third Intervention (1 Day)||1
7669862|NCT01999400|18887782|P2|COMPLETED|Third Intervention (1 Day)||0
7669863|NCT01999400|18887783|P1|COMPLETED|Third Intervention (1 Day)||2
7669864|NCT01999400|18887778|P6|STARTED|Third Intervention (1 Day)||1
7669865|NCT01999400|18887779|P5|STARTED|Third Intervention (1 Day)||1
7669866|NCT01999400|18887780|P4|STARTED|Third Intervention (1 Day)||1
7669867|NCT01999400|18887781|P3|STARTED|Third Intervention (1 Day)||1
7669868|NCT01999400|18887782|P2|STARTED|Third Intervention (1 Day)||0
7669869|NCT01999400|18887783|P1|STARTED|Third Intervention (1 Day)||2
7669870|NCT01999400|18887778|P6|NOT COMPLETED|Washout (10 Days)||0
7669871|NCT01999400|18887779|P5|NOT COMPLETED|Washout (10 Days)||0
7669872|NCT01999400|18887780|P4|NOT COMPLETED|Washout (10 Days)||0
7669873|NCT01999400|18887781|P3|NOT COMPLETED|Washout (10 Days)||0
7669874|NCT01999400|18887782|P2|NOT COMPLETED|Washout (10 Days)||0
7669875|NCT01999400|18887783|P1|NOT COMPLETED|Washout (10 Days)||0
7669876|NCT01999400|18887778|P6|COMPLETED|Washout (10 Days)||1
7669877|NCT01999400|18887779|P5|COMPLETED|Washout (10 Days)||1
7669878|NCT01999400|18887780|P4|COMPLETED|Washout (10 Days)||1
7669879|NCT01999400|18887781|P3|COMPLETED|Washout (10 Days)||1
7669880|NCT01999400|18887782|P2|COMPLETED|Washout (10 Days)||0
7669881|NCT01999400|18887783|P1|COMPLETED|Washout (10 Days)||2
7669882|NCT01999400|18887778|P6|STARTED|Washout (10 Days)||1
7669883|NCT01999400|18887779|P5|STARTED|Washout (10 Days)||1
7669884|NCT01999400|18887780|P4|STARTED|Washout (10 Days)||1
7669885|NCT01999400|18887781|P3|STARTED|Washout (10 Days)||1
7669886|NCT01999400|18887782|P2|STARTED|Washout (10 Days)||0
7669887|NCT01999400|18887783|P1|STARTED|Washout (10 Days)||2
7669888|NCT01999400|18887778|P6|NOT COMPLETED|Second Intervention (1 Day)||0
7669889|NCT01999400|18887779|P5|NOT COMPLETED|Second Intervention (1 Day)||0
7669890|NCT01999400|18887780|P4|NOT COMPLETED|Second Intervention (1 Day)||0
7669891|NCT01999400|18887781|P3|NOT COMPLETED|Second Intervention (1 Day)||0
7669892|NCT01999400|18887782|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7669893|NCT01999400|18887783|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7669894|NCT01999400|18887778|P6|COMPLETED|Second Intervention (1 Day)||3
7669895|NCT01999400|18887779|P5|COMPLETED|Second Intervention (1 Day)||3
7669896|NCT01999400|18887780|P4|COMPLETED|Second Intervention (1 Day)||2
7669897|NCT01999400|18887781|P3|COMPLETED|Second Intervention (1 Day)||3
7669898|NCT01999400|18887782|P2|COMPLETED|Second Intervention (1 Day)||4
7669899|NCT01999400|18887783|P1|COMPLETED|Second Intervention (1 Day)||5
7669900|NCT01999400|18887778|P6|STARTED|Second Intervention (1 Day)||3
7669901|NCT01999400|18887779|P5|STARTED|Second Intervention (1 Day)||3
7669902|NCT01999400|18887780|P4|STARTED|Second Intervention (1 Day)||2
7669903|NCT01999400|18887781|P3|STARTED|Second Intervention (1 Day)||3
7669904|NCT01999400|18887782|P2|STARTED|Second Intervention (1 Day)||4
7669905|NCT01999400|18887783|P1|STARTED|Second Intervention (1 Day)||5
7669906|NCT01999400|18887778|P6|NOT COMPLETED|Washout (10 Days)||0
7669907|NCT01999400|18887779|P5|NOT COMPLETED|Washout (10 Days)||0
7669908|NCT01999400|18887780|P4|NOT COMPLETED|Washout (10 Days)||0
7669909|NCT01999400|18887781|P3|NOT COMPLETED|Washout (10 Days)||0
7669910|NCT01999400|18887782|P2|NOT COMPLETED|Washout (10 Days)||0
7669911|NCT01999400|18887783|P1|NOT COMPLETED|Washout (10 Days)||0
7669912|NCT01999400|18887778|P6|COMPLETED|Washout (10 Days)||3
7669913|NCT01999400|18887779|P5|COMPLETED|Washout (10 Days)||3
7669914|NCT01999400|18887780|P4|COMPLETED|Washout (10 Days)||2
7669915|NCT01999400|18887781|P3|COMPLETED|Washout (10 Days)||3
7669916|NCT01999400|18887782|P2|COMPLETED|Washout (10 Days)||4
7669917|NCT01999400|18887783|P1|COMPLETED|Washout (10 Days)||5
7669918|NCT01999400|18887778|P6|STARTED|Washout (10 Days)||3
7669919|NCT01999400|18887779|P5|STARTED|Washout (10 Days)||3
7669920|NCT01999400|18887780|P4|STARTED|Washout (10 Days)||2
7669921|NCT01999400|18887781|P3|STARTED|Washout (10 Days)||3
7669922|NCT01999400|18887782|P2|STARTED|Washout (10 Days)||4
7669923|NCT01999400|18887783|P1|STARTED|Washout (10 Days)||5
7669924|NCT01999400|18887778|P6|NOT COMPLETED|First Intervention (1 Day)||1
7669925|NCT01999400|18887779|P5|NOT COMPLETED|First Intervention (1 Day)||0
7669926|NCT01999400|18887780|P4|NOT COMPLETED|First Intervention (1 Day)||3
7669927|NCT01999400|18887781|P3|NOT COMPLETED|First Intervention (1 Day)||2
7669928|NCT01999400|18887782|P2|NOT COMPLETED|First Intervention (1 Day)||2
7669929|NCT01999400|18887783|P1|NOT COMPLETED|First Intervention (1 Day)||2
7669930|NCT01999400|18887778|P6|COMPLETED|First Intervention (1 Day)||3
7669931|NCT01999400|18887779|P5|COMPLETED|First Intervention (1 Day)||4
7669932|NCT01999400|18887780|P4|COMPLETED|First Intervention (1 Day)||2
7669933|NCT01999400|18887781|P3|COMPLETED|First Intervention (1 Day)||3
7669934|NCT01999400|18887782|P2|COMPLETED|First Intervention (1 Day)||4
7669935|NCT01999400|18887783|P1|COMPLETED|First Intervention (1 Day)||4
7669936|NCT01999400|18887778|P6|STARTED|First Intervention (1 Day)||4
7669937|NCT01999400|18887779|P5|STARTED|First Intervention (1 Day)||4
7669938|NCT01999400|18887780|P4|STARTED|First Intervention (1 Day)||5
7669939|NCT01999400|18887781|P3|STARTED|First Intervention (1 Day)||5
7669940|NCT01999400|18887782|P2|STARTED|First Intervention (1 Day)||6
7669941|NCT01999400|18887783|P1|STARTED|First Intervention (1 Day)||6
7669942|NCT01999348|18887803|P1|NOT COMPLETED|Overall Study||120
7669943|NCT01999348|18887803|P1|COMPLETED|Overall Study||1433
7669944|NCT01999348|18887803|P1|STARTED|Overall Study||1553
7669945|NCT01999322|18887815|P2|NOT COMPLETED|Overall Study||0
7669946|NCT01999322|18887816|P1|NOT COMPLETED|Overall Study||1
7669947|NCT01999322|18887815|P2|COMPLETED|Overall Study||12
7669948|NCT01999322|18887816|P1|COMPLETED|Overall Study||24
7669949|NCT01999322|18887815|P2|STARTED|Overall Study||12
7669950|NCT01999322|18887816|P1|STARTED|Overall Study||25
7669951|NCT01999231|18887832|P4|NOT COMPLETED|Overall Study||0
7669952|NCT01999231|18887833|P3|NOT COMPLETED|Overall Study||0
7669953|NCT01999231|18887834|P2|NOT COMPLETED|Overall Study||0
7669954|NCT01999231|18887835|P1|NOT COMPLETED|Overall Study||0
7669955|NCT01999231|18887832|P4|COMPLETED|Overall Study||6
7669956|NCT01999231|18887833|P3|COMPLETED|Overall Study||6
7669957|NCT01999231|18887834|P2|COMPLETED|Overall Study||6
7669958|NCT01999231|18887835|P1|COMPLETED|Overall Study||6
7669959|NCT01999231|18887832|P4|STARTED|Overall Study||6
7669960|NCT01999231|18887833|P3|STARTED|Overall Study||6
7669961|NCT01999231|18887834|P2|STARTED|Overall Study||6
7669962|NCT01999231|18887835|P1|STARTED|Overall Study||6
7669963|NCT01999218|18887868|P3|NOT COMPLETED|Overall Study||110
7669964|NCT01999218|18887869|P2|NOT COMPLETED|Overall Study||101
7669965|NCT01999218|18887870|P1|NOT COMPLETED|Overall Study||109
7669966|NCT01999218|18887868|P3|COMPLETED|Overall Study||327
7669967|NCT01999218|18887869|P2|COMPLETED|Overall Study||340
7669968|NCT01999218|18887870|P1|COMPLETED|Overall Study||339
7669969|NCT01999218|18887868|P3|Site Issue|Overall Study||435
7669970|NCT01999218|18887869|P2|Site Issue|Overall Study||435
7669971|NCT01999218|18887870|P1|Site Issue|Overall Study||445
7669972|NCT01999218|18887868|P3|Treated|Overall Study||437
7669973|NCT01999218|18887869|P2|Treated|Overall Study||440
7669974|NCT01999218|18887870|P1|Treated|Overall Study||448
7669975|NCT01999218|18887868|P3|STARTED|Overall Study||437
7669976|NCT01999218|18887869|P2|STARTED|Overall Study||441
7669977|NCT01999218|18887870|P1|STARTED|Overall Study||448
7669978|NCT01999192|18887897|P4|NOT COMPLETED|Extension Phase||0
7669979|NCT01999192|18887898|P3|NOT COMPLETED|Extension Phase||24
7669980|NCT01999192|18887899|P2|NOT COMPLETED|Extension Phase||18
7669981|NCT01999192|18887900|P1|NOT COMPLETED|Extension Phase||13
7669982|NCT01999192|18887897|P4|COMPLETED|Extension Phase||0
7669983|NCT01999192|18887898|P3|COMPLETED|Extension Phase||44
7669984|NCT01999192|18887899|P2|COMPLETED|Extension Phase||38
7669985|NCT01999192|18887900|P1|COMPLETED|Extension Phase||41
7669986|NCT01999192|18887897|P4|STARTED|Extension Phase|No Placebo arm for Extension Phase, all patients terminated or were switched to tregalizumab Groups.|0
7669987|NCT01999192|18887898|P3|STARTED|Extension Phase|Some patients terminated after Main Phase 2.|68
7669988|NCT01999192|18887899|P2|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|56
7669989|NCT01999192|18887900|P1|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|54
7669990|NCT01999192|18887897|P4|NOT COMPLETED|Main Phase II||1
7669991|NCT01999192|18887898|P3|NOT COMPLETED|Main Phase II||22
7669992|NCT01999192|18887899|P2|NOT COMPLETED|Main Phase II||9
7669993|NCT01999192|18887900|P1|NOT COMPLETED|Main Phase II||9
7669994|NCT01999192|18887897|P4|COMPLETED|Main Phase II||43
7669995|NCT01999192|18887898|P3|COMPLETED|Main Phase II||76
7669996|NCT01999192|18887899|P2|COMPLETED|Main Phase II||66
7669997|NCT01999192|18887900|P1|COMPLETED|Main Phase II||55
7669998|NCT01999192|18887897|P4|STARTED|Main Phase II|non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched|44
7669999|NCT01999192|18887898|P3|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|98
7670000|NCT01999192|18887899|P2|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|75
7670001|NCT01999192|18887900|P1|STARTED|Main Phase II|Non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched.|64
7670002|NCT01999192|18887897|P4|NOT COMPLETED|Main Phase I||8
7670003|NCT01999192|18887898|P3|NOT COMPLETED|Main Phase I||8
7670004|NCT01999192|18887899|P2|NOT COMPLETED|Main Phase I||10
7670005|NCT01999192|18887900|P1|NOT COMPLETED|Main Phase I||11
7670006|NCT01999192|18887897|P4|COMPLETED|Main Phase I||72
7670007|NCT01999192|18887898|P3|COMPLETED|Main Phase I||70
7670008|NCT01999192|18887899|P2|COMPLETED|Main Phase I||70
7670009|NCT01999192|18887900|P1|COMPLETED|Main Phase I||72
7670010|NCT01999192|18887897|P4|STARTED|Main Phase I||80
7670011|NCT01999192|18887898|P3|STARTED|Main Phase I||78
7670012|NCT01999192|18887899|P2|STARTED|Main Phase I||80
7670013|NCT01999192|18887900|P1|STARTED|Main Phase I||83
7670014|NCT01999114|18887915|P5|NOT COMPLETED|Overall Study||4
7670015|NCT01999114|18887916|P4|NOT COMPLETED|Overall Study||3
7670016|NCT01999114|18887917|P3|NOT COMPLETED|Overall Study||5
7670017|NCT01999114|18887918|P2|NOT COMPLETED|Overall Study||7
7670018|NCT01999114|18887919|P1|NOT COMPLETED|Overall Study||8
7670019|NCT01999114|18887915|P5|COMPLETED|Overall Study||61
7670020|NCT01999114|18887916|P4|COMPLETED|Overall Study||62
7670021|NCT01999114|18887917|P3|COMPLETED|Overall Study||61
7670022|NCT01999114|18887918|P2|COMPLETED|Overall Study||59
7670023|NCT01999114|18887919|P1|COMPLETED|Overall Study||58
7670024|NCT01999114|18887915|P5|STARTED|Overall Study||65
7670025|NCT01999114|18887916|P4|STARTED|Overall Study||65
7670026|NCT01999114|18887917|P3|STARTED|Overall Study||66
7670027|NCT01999114|18887918|P2|STARTED|Overall Study||66
7670028|NCT01999114|18887919|P1|STARTED|Overall Study||66
7670029|NCT01998984|18887987|P4|NOT COMPLETED|Overall Study||3
7670030|NCT01998984|18887988|P3|NOT COMPLETED|Overall Study||1
7670031|NCT01998984|18887989|P2|NOT COMPLETED|Overall Study||1
7670032|NCT01998984|18887990|P1|NOT COMPLETED|Overall Study||0
7670033|NCT01998984|18887987|P4|COMPLETED|Overall Study||58
7670034|NCT01998984|18887988|P3|COMPLETED|Overall Study||48
7670035|NCT01998984|18887989|P2|COMPLETED|Overall Study||58
7670036|NCT01998984|18887990|P1|COMPLETED|Overall Study||55
7670037|NCT01998984|18887987|P4|STARTED|Overall Study||61
7670038|NCT01998984|18887988|P3|STARTED|Overall Study||49
7670039|NCT01998984|18887989|P2|STARTED|Overall Study||59
7670040|NCT01998984|18887990|P1|STARTED|Overall Study||55
7670041|NCT01998958|18888015|P32|NOT COMPLETED|Follow-up Phase||0
7670042|NCT01998958|18888016|P31|NOT COMPLETED|Follow-up Phase||0
7670043|NCT01998958|18888017|P30|NOT COMPLETED|Follow-up Phase||0
7670044|NCT01998958|18888018|P29|NOT COMPLETED|Follow-up Phase||0
7670045|NCT01998958|18888019|P28|NOT COMPLETED|Follow-up Phase||0
7670046|NCT01998958|18888020|P27|NOT COMPLETED|Follow-up Phase||0
7670047|NCT01998958|18888021|P26|NOT COMPLETED|Follow-up Phase||0
7670048|NCT01998958|18888022|P25|NOT COMPLETED|Follow-up Phase||0
7670049|NCT01998958|18888023|P24|NOT COMPLETED|Follow-up Phase||0
7670050|NCT01998958|18888024|P23|NOT COMPLETED|Follow-up Phase||0
7670051|NCT01998958|18888025|P22|NOT COMPLETED|Follow-up Phase||0
7670052|NCT01998958|18888026|P21|NOT COMPLETED|Follow-up Phase||0
7670053|NCT01998958|18888027|P20|NOT COMPLETED|Follow-up Phase||0
7670054|NCT01998958|18888028|P19|NOT COMPLETED|Follow-up Phase||0
7670055|NCT01998958|18888029|P18|NOT COMPLETED|Follow-up Phase||0
7670056|NCT01998958|18888030|P17|NOT COMPLETED|Follow-up Phase||0
7670057|NCT01998958|18888031|P16|NOT COMPLETED|Follow-up Phase||0
7670058|NCT01998958|18888032|P15|NOT COMPLETED|Follow-up Phase||0
7670059|NCT01998958|18888033|P14|NOT COMPLETED|Follow-up Phase||0
7670060|NCT01998958|18888034|P13|NOT COMPLETED|Follow-up Phase||0
7670061|NCT01998958|18888035|P12|NOT COMPLETED|Follow-up Phase||0
7670062|NCT01998958|18888036|P11|NOT COMPLETED|Follow-up Phase||0
7670063|NCT01998958|18888037|P10|NOT COMPLETED|Follow-up Phase||0
7670064|NCT01998958|18888038|P9|NOT COMPLETED|Follow-up Phase||0
7670065|NCT01998958|18888039|P8|NOT COMPLETED|Follow-up Phase||0
7670066|NCT01998958|18888040|P7|NOT COMPLETED|Follow-up Phase||0
7670067|NCT01998958|18888041|P6|NOT COMPLETED|Follow-up Phase||0
7670068|NCT01998958|18888042|P5|NOT COMPLETED|Follow-up Phase||0
7670069|NCT01998958|18888043|P4|NOT COMPLETED|Follow-up Phase||0
7670070|NCT01998958|18888044|P3|NOT COMPLETED|Follow-up Phase||0
7670071|NCT01998958|18888045|P2|NOT COMPLETED|Follow-up Phase||0
7670072|NCT01998958|18888046|P1|NOT COMPLETED|Follow-up Phase||0
7670073|NCT01998958|18888015|P32|COMPLETED|Follow-up Phase||42
7670074|NCT01998958|18888016|P31|COMPLETED|Follow-up Phase||39
7670075|NCT01998958|18888017|P30|COMPLETED|Follow-up Phase||12
7670076|NCT01998958|18888018|P29|COMPLETED|Follow-up Phase||4
7670077|NCT01998958|18888019|P28|COMPLETED|Follow-up Phase||1
7670078|NCT01998958|18888020|P27|COMPLETED|Follow-up Phase||0
7670079|NCT01998958|18888021|P26|COMPLETED|Follow-up Phase||0
7670080|NCT01998958|18888022|P25|COMPLETED|Follow-up Phase||0
7670081|NCT01998958|18888023|P24|COMPLETED|Follow-up Phase||0
7670082|NCT01998958|18888024|P23|COMPLETED|Follow-up Phase||0
7670083|NCT01998958|18888025|P22|COMPLETED|Follow-up Phase||0
7670084|NCT01998958|18888026|P21|COMPLETED|Follow-up Phase||0
7670085|NCT01998958|18888027|P20|COMPLETED|Follow-up Phase||0
7670086|NCT01998958|18888028|P19|COMPLETED|Follow-up Phase||0
7670087|NCT01998958|18888029|P18|COMPLETED|Follow-up Phase||0
7670088|NCT01998958|18888030|P17|COMPLETED|Follow-up Phase||0
7670089|NCT01998958|18888031|P16|COMPLETED|Follow-up Phase||0
7670090|NCT01998958|18888032|P15|COMPLETED|Follow-up Phase||0
7670091|NCT01998958|18888033|P14|COMPLETED|Follow-up Phase||0
7670092|NCT01998958|18888034|P13|COMPLETED|Follow-up Phase||0
7670093|NCT01998958|18888035|P12|COMPLETED|Follow-up Phase||0
7670094|NCT01998958|18888036|P11|COMPLETED|Follow-up Phase||0
7670095|NCT01998958|18888037|P10|COMPLETED|Follow-up Phase||0
7670096|NCT01998958|18888038|P9|COMPLETED|Follow-up Phase||0
7670097|NCT01998958|18888039|P8|COMPLETED|Follow-up Phase||0
7670098|NCT01998958|18888040|P7|COMPLETED|Follow-up Phase||0
7670099|NCT01998958|18888041|P6|COMPLETED|Follow-up Phase||0
7670100|NCT01998958|18888042|P5|COMPLETED|Follow-up Phase||0
7670101|NCT01998958|18888043|P4|COMPLETED|Follow-up Phase||0
7670102|NCT01998958|18888044|P3|COMPLETED|Follow-up Phase||0
7670103|NCT01998958|18888045|P2|COMPLETED|Follow-up Phase||0
7670104|NCT01998958|18888046|P1|COMPLETED|Follow-up Phase||0
7670105|NCT01998958|18888015|P32|STARTED|Follow-up Phase||42
7670106|NCT01998958|18888016|P31|STARTED|Follow-up Phase||39
7670107|NCT01998958|18888017|P30|STARTED|Follow-up Phase||12
7670108|NCT01998958|18888018|P29|STARTED|Follow-up Phase||4
7670109|NCT01998958|18888019|P28|STARTED|Follow-up Phase||1
7670110|NCT01998958|18888020|P27|STARTED|Follow-up Phase||0
7670111|NCT01998958|18888021|P26|STARTED|Follow-up Phase||0
7670112|NCT01998958|18888022|P25|STARTED|Follow-up Phase||0
7670113|NCT01998958|18888023|P24|STARTED|Follow-up Phase||0
7670114|NCT01998958|18888024|P23|STARTED|Follow-up Phase||0
7670115|NCT01998958|18888025|P22|STARTED|Follow-up Phase||0
7670116|NCT01998958|18888026|P21|STARTED|Follow-up Phase||0
7670117|NCT01998958|18888027|P20|STARTED|Follow-up Phase||0
7670118|NCT01998958|18888028|P19|STARTED|Follow-up Phase||0
7670119|NCT01998958|18888029|P18|STARTED|Follow-up Phase||0
7670120|NCT01998958|18888030|P17|STARTED|Follow-up Phase||0
7670121|NCT01998958|18888031|P16|STARTED|Follow-up Phase||0
7670122|NCT01998958|18888032|P15|STARTED|Follow-up Phase||0
7670123|NCT01998958|18888033|P14|STARTED|Follow-up Phase||0
7670124|NCT01998958|18888034|P13|STARTED|Follow-up Phase||0
7670125|NCT01998958|18888035|P12|STARTED|Follow-up Phase||0
7670126|NCT01998958|18888036|P11|STARTED|Follow-up Phase||0
7670127|NCT01998958|18888037|P10|STARTED|Follow-up Phase||0
7670128|NCT01998958|18888038|P9|STARTED|Follow-up Phase||0
7670129|NCT01998958|18888039|P8|STARTED|Follow-up Phase||0
7670130|NCT01998958|18888040|P7|STARTED|Follow-up Phase||0
7670131|NCT01998958|18888041|P6|STARTED|Follow-up Phase||0
7670132|NCT01998958|18888042|P5|STARTED|Follow-up Phase||0
7670133|NCT01998958|18888043|P4|STARTED|Follow-up Phase||0
7670134|NCT01998958|18888044|P3|STARTED|Follow-up Phase||0
7670135|NCT01998958|18888045|P2|STARTED|Follow-up Phase||0
7670136|NCT01998958|18888046|P1|STARTED|Follow-up Phase||0
7670137|NCT01998958|18888015|P32|NOT COMPLETED|Open Label Phase (Optional)||0
7670138|NCT01998958|18888016|P31|NOT COMPLETED|Open Label Phase (Optional)||0
7670139|NCT01998958|18888017|P30|NOT COMPLETED|Open Label Phase (Optional)||0
7670140|NCT01998958|18888018|P29|NOT COMPLETED|Open Label Phase (Optional)||0
7670141|NCT01998958|18888019|P28|NOT COMPLETED|Open Label Phase (Optional)||0
7670142|NCT01998958|18888020|P27|NOT COMPLETED|Open Label Phase (Optional)||0
7670143|NCT01998958|18888021|P26|NOT COMPLETED|Open Label Phase (Optional)||0
7670144|NCT01998958|18888022|P25|NOT COMPLETED|Open Label Phase (Optional)||0
7670145|NCT01998958|18888023|P24|NOT COMPLETED|Open Label Phase (Optional)||4
7670146|NCT01998958|18888024|P23|NOT COMPLETED|Open Label Phase (Optional)||9
7670147|NCT01998958|18888025|P22|NOT COMPLETED|Open Label Phase (Optional)||3
7670148|NCT01998958|18888026|P21|NOT COMPLETED|Open Label Phase (Optional)||0
7670149|NCT01998958|18888027|P20|NOT COMPLETED|Open Label Phase (Optional)||0
7670150|NCT01998958|18888028|P19|NOT COMPLETED|Open Label Phase (Optional)||0
7670151|NCT01998958|18888029|P18|NOT COMPLETED|Open Label Phase (Optional)||0
7670152|NCT01998958|18888030|P17|NOT COMPLETED|Open Label Phase (Optional)||0
7670153|NCT01998958|18888031|P16|NOT COMPLETED|Open Label Phase (Optional)||0
7670154|NCT01998958|18888032|P15|NOT COMPLETED|Open Label Phase (Optional)||0
7670155|NCT01998958|18888033|P14|NOT COMPLETED|Open Label Phase (Optional)||0
7670156|NCT01998958|18888034|P13|NOT COMPLETED|Open Label Phase (Optional)||0
7670157|NCT01998958|18888035|P12|NOT COMPLETED|Open Label Phase (Optional)||0
7670158|NCT01998958|18888036|P11|NOT COMPLETED|Open Label Phase (Optional)||0
7670159|NCT01998958|18888037|P10|NOT COMPLETED|Open Label Phase (Optional)||0
7670160|NCT01998958|18888038|P9|NOT COMPLETED|Open Label Phase (Optional)||0
7670161|NCT01998958|18888039|P8|NOT COMPLETED|Open Label Phase (Optional)||0
7670162|NCT01998958|18888040|P7|NOT COMPLETED|Open Label Phase (Optional)||0
7670163|NCT01998958|18888041|P6|NOT COMPLETED|Open Label Phase (Optional)||0
7670164|NCT01998958|18888042|P5|NOT COMPLETED|Open Label Phase (Optional)||0
7670165|NCT01998958|18888043|P4|NOT COMPLETED|Open Label Phase (Optional)||0
7670166|NCT01998958|18888044|P3|NOT COMPLETED|Open Label Phase (Optional)||0
7670167|NCT01998958|18888045|P2|NOT COMPLETED|Open Label Phase (Optional)||0
7670168|NCT01998958|18888046|P1|NOT COMPLETED|Open Label Phase (Optional)||0
7670169|NCT01998958|18888015|P32|COMPLETED|Open Label Phase (Optional)||0
7670170|NCT01998958|18888016|P31|COMPLETED|Open Label Phase (Optional)||0
7670171|NCT01998958|18888017|P30|COMPLETED|Open Label Phase (Optional)||0
7670172|NCT01998958|18888018|P29|COMPLETED|Open Label Phase (Optional)||0
7670173|NCT01998958|18888019|P28|COMPLETED|Open Label Phase (Optional)||0
7670174|NCT01998958|18888020|P27|COMPLETED|Open Label Phase (Optional)||19
7670175|NCT01998958|18888021|P26|COMPLETED|Open Label Phase (Optional)||7
7670176|NCT01998958|18888022|P25|COMPLETED|Open Label Phase (Optional)||13
7670177|NCT01998958|18888023|P24|COMPLETED|Open Label Phase (Optional)||23
7670178|NCT01998958|18888024|P23|COMPLETED|Open Label Phase (Optional)||11
7670179|NCT01998958|18888025|P22|COMPLETED|Open Label Phase (Optional)||7
7670180|NCT01998958|18888026|P21|COMPLETED|Open Label Phase (Optional)||0
7670181|NCT01998958|18888027|P20|COMPLETED|Open Label Phase (Optional)||0
7670182|NCT01998958|18888028|P19|COMPLETED|Open Label Phase (Optional)||0
7670183|NCT01998958|18888029|P18|COMPLETED|Open Label Phase (Optional)||0
7670184|NCT01998958|18888030|P17|COMPLETED|Open Label Phase (Optional)||0
7670185|NCT01998958|18888031|P16|COMPLETED|Open Label Phase (Optional)||0
7670186|NCT01998958|18888032|P15|COMPLETED|Open Label Phase (Optional)||0
7670187|NCT01998958|18888033|P14|COMPLETED|Open Label Phase (Optional)||0
7670188|NCT01998958|18888034|P13|COMPLETED|Open Label Phase (Optional)||0
7670189|NCT01998958|18888035|P12|COMPLETED|Open Label Phase (Optional)||0
7670190|NCT01998958|18888036|P11|COMPLETED|Open Label Phase (Optional)||0
7670191|NCT01998958|18888037|P10|COMPLETED|Open Label Phase (Optional)||0
7670192|NCT01998958|18888038|P9|COMPLETED|Open Label Phase (Optional)||0
7670193|NCT01998958|18888039|P8|COMPLETED|Open Label Phase (Optional)||0
7670194|NCT01998958|18888040|P7|COMPLETED|Open Label Phase (Optional)||0
7670195|NCT01998958|18888041|P6|COMPLETED|Open Label Phase (Optional)||0
7670196|NCT01998958|18888042|P5|COMPLETED|Open Label Phase (Optional)||0
7670197|NCT01998958|18888043|P4|COMPLETED|Open Label Phase (Optional)||0
7670198|NCT01998958|18888044|P3|COMPLETED|Open Label Phase (Optional)||0
7670199|NCT01998958|18888045|P2|COMPLETED|Open Label Phase (Optional)||0
7670200|NCT01998958|18888046|P1|COMPLETED|Open Label Phase (Optional)||0
7670201|NCT01998958|18888015|P32|STARTED|Open Label Phase (Optional)||0
7670202|NCT01998958|18888016|P31|STARTED|Open Label Phase (Optional)||0
7670203|NCT01998958|18888017|P30|STARTED|Open Label Phase (Optional)||0
7670204|NCT01998958|18888018|P29|STARTED|Open Label Phase (Optional)||0
7670205|NCT01998958|18888019|P28|STARTED|Open Label Phase (Optional)||0
7670206|NCT01998958|18888020|P27|STARTED|Open Label Phase (Optional)||19
7670207|NCT01998958|18888021|P26|STARTED|Open Label Phase (Optional)||7
7670208|NCT01998958|18888022|P25|STARTED|Open Label Phase (Optional)||13
7670209|NCT01998958|18888023|P24|STARTED|Open Label Phase (Optional)||27
7670210|NCT01998958|18888024|P23|STARTED|Open Label Phase (Optional)||20
7670211|NCT01998958|18888025|P22|STARTED|Open Label Phase (Optional)||10
7670212|NCT01998958|18888026|P21|STARTED|Open Label Phase (Optional)||0
7670213|NCT01998958|18888027|P20|STARTED|Open Label Phase (Optional)||0
7670214|NCT01998958|18888028|P19|STARTED|Open Label Phase (Optional)||0
7670215|NCT01998958|18888029|P18|STARTED|Open Label Phase (Optional)||0
7670216|NCT01998958|18888030|P17|STARTED|Open Label Phase (Optional)||0
7670217|NCT01998958|18888031|P16|STARTED|Open Label Phase (Optional)||0
7670218|NCT01998958|18888032|P15|STARTED|Open Label Phase (Optional)||0
7670219|NCT01998958|18888033|P14|STARTED|Open Label Phase (Optional)||0
7670220|NCT01998958|18888034|P13|STARTED|Open Label Phase (Optional)||0
7670221|NCT01998958|18888035|P12|STARTED|Open Label Phase (Optional)||0
7670222|NCT01998958|18888036|P11|STARTED|Open Label Phase (Optional)||0
7670223|NCT01998958|18888037|P10|STARTED|Open Label Phase (Optional)||0
7670224|NCT01998958|18888038|P9|STARTED|Open Label Phase (Optional)||0
7670225|NCT01998958|18888039|P8|STARTED|Open Label Phase (Optional)||0
7670226|NCT01998958|18888040|P7|STARTED|Open Label Phase (Optional)||0
7670227|NCT01998958|18888041|P6|STARTED|Open Label Phase (Optional)||0
7670228|NCT01998958|18888042|P5|STARTED|Open Label Phase (Optional)||0
7670229|NCT01998958|18888043|P4|STARTED|Open Label Phase (Optional)||0
7670230|NCT01998958|18888044|P3|STARTED|Open Label Phase (Optional)||0
7670231|NCT01998958|18888045|P2|STARTED|Open Label Phase (Optional)||0
7670232|NCT01998958|18888046|P1|STARTED|Open Label Phase (Optional)||0
7670233|NCT01998958|18888015|P32|NOT COMPLETED|Period 2 (Panel A and B)||0
7670234|NCT01998958|18888016|P31|NOT COMPLETED|Period 2 (Panel A and B)||0
7670235|NCT01998958|18888017|P30|NOT COMPLETED|Period 2 (Panel A and B)||0
7670236|NCT01998958|18888018|P29|NOT COMPLETED|Period 2 (Panel A and B)||0
7670237|NCT01998958|18888019|P28|NOT COMPLETED|Period 2 (Panel A and B)||0
7670238|NCT01998958|18888020|P27|NOT COMPLETED|Period 2 (Panel A and B)||0
7670239|NCT01998958|18888021|P26|NOT COMPLETED|Period 2 (Panel A and B)||0
7670240|NCT01998958|18888022|P25|NOT COMPLETED|Period 2 (Panel A and B)||0
7670241|NCT01998958|18888023|P24|NOT COMPLETED|Period 2 (Panel A and B)||0
7670242|NCT01998958|18888024|P23|NOT COMPLETED|Period 2 (Panel A and B)||0
7670243|NCT01998958|18888025|P22|NOT COMPLETED|Period 2 (Panel A and B)||0
7670244|NCT01998958|18888026|P21|NOT COMPLETED|Period 2 (Panel A and B)||0
7670245|NCT01998958|18888027|P20|NOT COMPLETED|Period 2 (Panel A and B)||0
7670246|NCT01998958|18888028|P19|NOT COMPLETED|Period 2 (Panel A and B)||1
7670247|NCT01998958|18888029|P18|NOT COMPLETED|Period 2 (Panel A and B)||0
7670248|NCT01998958|18888030|P17|NOT COMPLETED|Period 2 (Panel A and B)||0
7670249|NCT01998958|18888031|P16|NOT COMPLETED|Period 2 (Panel A and B)||0
7670250|NCT01998958|18888032|P15|NOT COMPLETED|Period 2 (Panel A and B)||2
7670251|NCT01998958|18888033|P14|NOT COMPLETED|Period 2 (Panel A and B)||0
7670252|NCT01998958|18888034|P13|NOT COMPLETED|Period 2 (Panel A and B)||0
7670253|NCT01998958|18888035|P12|NOT COMPLETED|Period 2 (Panel A and B)||0
7670254|NCT01998958|18888036|P11|NOT COMPLETED|Period 2 (Panel A and B)||1
7670255|NCT01998958|18888037|P10|NOT COMPLETED|Period 2 (Panel A and B)||0
7670256|NCT01998958|18888038|P9|NOT COMPLETED|Period 2 (Panel A and B)||0
7670257|NCT01998958|18888039|P8|NOT COMPLETED|Period 2 (Panel A and B)||0
7670258|NCT01998958|18888040|P7|NOT COMPLETED|Period 2 (Panel A and B)||0
7670259|NCT01998958|18888041|P6|NOT COMPLETED|Period 2 (Panel A and B)||0
7670260|NCT01998958|18888042|P5|NOT COMPLETED|Period 2 (Panel A and B)||0
7670261|NCT01998958|18888043|P4|NOT COMPLETED|Period 2 (Panel A and B)||0
7670262|NCT01998958|18888044|P3|NOT COMPLETED|Period 2 (Panel A and B)||0
7670263|NCT01998958|18888045|P2|NOT COMPLETED|Period 2 (Panel A and B)||0
7670264|NCT01998958|18888046|P1|NOT COMPLETED|Period 2 (Panel A and B)||0
7670265|NCT01998958|18888015|P32|COMPLETED|Period 2 (Panel A and B)||0
7670266|NCT01998958|18888016|P31|COMPLETED|Period 2 (Panel A and B)||0
7670267|NCT01998958|18888017|P30|COMPLETED|Period 2 (Panel A and B)||0
7670268|NCT01998958|18888018|P29|COMPLETED|Period 2 (Panel A and B)||0
7670269|NCT01998958|18888019|P28|COMPLETED|Period 2 (Panel A and B)||0
7670270|NCT01998958|18888020|P27|COMPLETED|Period 2 (Panel A and B)||0
7670271|NCT01998958|18888021|P26|COMPLETED|Period 2 (Panel A and B)||0
7670272|NCT01998958|18888022|P25|COMPLETED|Period 2 (Panel A and B)||0
7670273|NCT01998958|18888023|P24|COMPLETED|Period 2 (Panel A and B)||0
7670274|NCT01998958|18888024|P23|COMPLETED|Period 2 (Panel A and B)||0
7670275|NCT01998958|18888025|P22|COMPLETED|Period 2 (Panel A and B)||0
7670276|NCT01998958|18888026|P21|COMPLETED|Period 2 (Panel A and B)||9
7670277|NCT01998958|18888027|P20|COMPLETED|Period 2 (Panel A and B)||11
7670278|NCT01998958|18888028|P19|COMPLETED|Period 2 (Panel A and B)||2
7670279|NCT01998958|18888029|P18|COMPLETED|Period 2 (Panel A and B)||5
7670280|NCT01998958|18888030|P17|COMPLETED|Period 2 (Panel A and B)||8
7670281|NCT01998958|18888031|P16|COMPLETED|Period 2 (Panel A and B)||5
7670282|NCT01998958|18888032|P15|COMPLETED|Period 2 (Panel A and B)||10
7670283|NCT01998958|18888033|P14|COMPLETED|Period 2 (Panel A and B)||11
7670284|NCT01998958|18888034|P13|COMPLETED|Period 2 (Panel A and B)||8
7670285|NCT01998958|18888035|P12|COMPLETED|Period 2 (Panel A and B)||5
7670286|NCT01998958|18888036|P11|COMPLETED|Period 2 (Panel A and B)||8
7670287|NCT01998958|18888037|P10|COMPLETED|Period 2 (Panel A and B)||8
7670288|NCT01998958|18888038|P9|COMPLETED|Period 2 (Panel A and B)||4
7670289|NCT01998958|18888039|P8|COMPLETED|Period 2 (Panel A and B)||6
7670290|NCT01998958|18888040|P7|COMPLETED|Period 2 (Panel A and B)||0
7670291|NCT01998958|18888041|P6|COMPLETED|Period 2 (Panel A and B)||0
7670292|NCT01998958|18888042|P5|COMPLETED|Period 2 (Panel A and B)||0
7670293|NCT01998958|18888043|P4|COMPLETED|Period 2 (Panel A and B)||0
7670294|NCT01998958|18888044|P3|COMPLETED|Period 2 (Panel A and B)||0
7670295|NCT01998958|18888045|P2|COMPLETED|Period 2 (Panel A and B)||0
7670296|NCT01998958|18888046|P1|COMPLETED|Period 2 (Panel A and B)||0
7670297|NCT01998958|18888015|P32|STARTED|Period 2 (Panel A and B)||0
7670298|NCT01998958|18888016|P31|STARTED|Period 2 (Panel A and B)||0
7670299|NCT01998958|18888017|P30|STARTED|Period 2 (Panel A and B)||0
7670300|NCT01998958|18888018|P29|STARTED|Period 2 (Panel A and B)||0
7670301|NCT01998958|18888019|P28|STARTED|Period 2 (Panel A and B)||0
7670302|NCT01998958|18888020|P27|STARTED|Period 2 (Panel A and B)||0
7670303|NCT01998958|18888021|P26|STARTED|Period 2 (Panel A and B)||0
7670304|NCT01998958|18888022|P25|STARTED|Period 2 (Panel A and B)||0
7670305|NCT01998958|18888023|P24|STARTED|Period 2 (Panel A and B)||0
7670306|NCT01998958|18888024|P23|STARTED|Period 2 (Panel A and B)||0
7670307|NCT01998958|18888025|P22|STARTED|Period 2 (Panel A and B)||0
7670308|NCT01998958|18888026|P21|STARTED|Period 2 (Panel A and B)||9
7670309|NCT01998958|18888027|P20|STARTED|Period 2 (Panel A and B)||11
7670310|NCT01998958|18888028|P19|STARTED|Period 2 (Panel A and B)||3
7670311|NCT01998958|18888029|P18|STARTED|Period 2 (Panel A and B)||5
7670312|NCT01998958|18888030|P17|STARTED|Period 2 (Panel A and B)||8
7670313|NCT01998958|18888031|P16|STARTED|Period 2 (Panel A and B)||5
7670314|NCT01998958|18888032|P15|STARTED|Period 2 (Panel A and B)||12
7670315|NCT01998958|18888033|P14|STARTED|Period 2 (Panel A and B)||11
7670316|NCT01998958|18888034|P13|STARTED|Period 2 (Panel A and B)||8
7670317|NCT01998958|18888035|P12|STARTED|Period 2 (Panel A and B)||5
7670318|NCT01998958|18888036|P11|STARTED|Period 2 (Panel A and B)||9
7670319|NCT01998958|18888037|P10|STARTED|Period 2 (Panel A and B)||8
7670320|NCT01998958|18888038|P9|STARTED|Period 2 (Panel A and B)||4
7670321|NCT01998958|18888039|P8|STARTED|Period 2 (Panel A and B)||6
7670322|NCT01998958|18888040|P7|STARTED|Period 2 (Panel A and B)||0
7670323|NCT01998958|18888041|P6|STARTED|Period 2 (Panel A and B)||0
7670324|NCT01998958|18888042|P5|STARTED|Period 2 (Panel A and B)||0
7670325|NCT01998958|18888043|P4|STARTED|Period 2 (Panel A and B)||0
7670326|NCT01998958|18888044|P3|STARTED|Period 2 (Panel A and B)||0
7670327|NCT01998958|18888045|P2|STARTED|Period 2 (Panel A and B)||0
7670328|NCT01998958|18888046|P1|STARTED|Period 2 (Panel A and B)||0
7670329|NCT01998958|18888015|P32|NOT COMPLETED|Period 1 (Panel A and B)||0
7670330|NCT01998958|18888016|P31|NOT COMPLETED|Period 1 (Panel A and B)||0
7670331|NCT01998958|18888017|P30|NOT COMPLETED|Period 1 (Panel A and B)||0
7670332|NCT01998958|18888018|P29|NOT COMPLETED|Period 1 (Panel A and B)||0
7670333|NCT01998958|18888019|P28|NOT COMPLETED|Period 1 (Panel A and B)||0
7670334|NCT01998958|18888020|P27|NOT COMPLETED|Period 1 (Panel A and B)||0
7670335|NCT01998958|18888021|P26|NOT COMPLETED|Period 1 (Panel A and B)||0
7670336|NCT01998958|18888022|P25|NOT COMPLETED|Period 1 (Panel A and B)||0
7670337|NCT01998958|18888023|P24|NOT COMPLETED|Period 1 (Panel A and B)||0
7670338|NCT01998958|18888024|P23|NOT COMPLETED|Period 1 (Panel A and B)||0
7670339|NCT01998958|18888025|P22|NOT COMPLETED|Period 1 (Panel A and B)||0
7670340|NCT01998958|18888026|P21|NOT COMPLETED|Period 1 (Panel A and B)||0
7670341|NCT01998958|18888027|P20|NOT COMPLETED|Period 1 (Panel A and B)||0
7670342|NCT01998958|18888028|P19|NOT COMPLETED|Period 1 (Panel A and B)||0
7670343|NCT01998958|18888029|P18|NOT COMPLETED|Period 1 (Panel A and B)||0
7670344|NCT01998958|18888030|P17|NOT COMPLETED|Period 1 (Panel A and B)||0
7670345|NCT01998958|18888031|P16|NOT COMPLETED|Period 1 (Panel A and B)||0
7670346|NCT01998958|18888032|P15|NOT COMPLETED|Period 1 (Panel A and B)||0
7670347|NCT01998958|18888033|P14|NOT COMPLETED|Period 1 (Panel A and B)||0
7670348|NCT01998958|18888034|P13|NOT COMPLETED|Period 1 (Panel A and B)||0
7670349|NCT01998958|18888035|P12|NOT COMPLETED|Period 1 (Panel A and B)||0
7670350|NCT01998958|18888036|P11|NOT COMPLETED|Period 1 (Panel A and B)||0
7670351|NCT01998958|18888037|P10|NOT COMPLETED|Period 1 (Panel A and B)||0
7670352|NCT01998958|18888038|P9|NOT COMPLETED|Period 1 (Panel A and B)||0
7670353|NCT01998958|18888039|P8|NOT COMPLETED|Period 1 (Panel A and B)||0
7670354|NCT01998958|18888040|P7|NOT COMPLETED|Period 1 (Panel A and B)||0
7670355|NCT01998958|18888041|P6|NOT COMPLETED|Period 1 (Panel A and B)||0
7670356|NCT01998958|18888042|P5|NOT COMPLETED|Period 1 (Panel A and B)||0
7670357|NCT01998958|18888043|P4|NOT COMPLETED|Period 1 (Panel A and B)||0
7670358|NCT01998958|18888044|P3|NOT COMPLETED|Period 1 (Panel A and B)||0
7670359|NCT01998958|18888045|P2|NOT COMPLETED|Period 1 (Panel A and B)||3
7670360|NCT01998958|18888046|P1|NOT COMPLETED|Period 1 (Panel A and B)||1
7670361|NCT01998958|18888015|P32|COMPLETED|Period 1 (Panel A and B)||0
7670362|NCT01998958|18888016|P31|COMPLETED|Period 1 (Panel A and B)||0
7670363|NCT01998958|18888017|P30|COMPLETED|Period 1 (Panel A and B)||0
7670364|NCT01998958|18888018|P29|COMPLETED|Period 1 (Panel A and B)||0
7670365|NCT01998958|18888019|P28|COMPLETED|Period 1 (Panel A and B)||0
7670366|NCT01998958|18888020|P27|COMPLETED|Period 1 (Panel A and B)||0
7670367|NCT01998958|18888021|P26|COMPLETED|Period 1 (Panel A and B)||0
7670368|NCT01998958|18888022|P25|COMPLETED|Period 1 (Panel A and B)||0
7670369|NCT01998958|18888023|P24|COMPLETED|Period 1 (Panel A and B)||0
7670370|NCT01998958|18888024|P23|COMPLETED|Period 1 (Panel A and B)||0
7670371|NCT01998958|18888025|P22|COMPLETED|Period 1 (Panel A and B)||0
7670372|NCT01998958|18888026|P21|COMPLETED|Period 1 (Panel A and B)||0
7670373|NCT01998958|18888027|P20|COMPLETED|Period 1 (Panel A and B)||0
7670374|NCT01998958|18888028|P19|COMPLETED|Period 1 (Panel A and B)||0
7670375|NCT01998958|18888029|P18|COMPLETED|Period 1 (Panel A and B)||0
7670376|NCT01998958|18888030|P17|COMPLETED|Period 1 (Panel A and B)||0
7670377|NCT01998958|18888031|P16|COMPLETED|Period 1 (Panel A and B)||0
7670378|NCT01998958|18888032|P15|COMPLETED|Period 1 (Panel A and B)||0
7670379|NCT01998958|18888033|P14|COMPLETED|Period 1 (Panel A and B)||0
7670380|NCT01998958|18888034|P13|COMPLETED|Period 1 (Panel A and B)||0
7670381|NCT01998958|18888035|P12|COMPLETED|Period 1 (Panel A and B)||0
7670382|NCT01998958|18888036|P11|COMPLETED|Period 1 (Panel A and B)||0
7670383|NCT01998958|18888037|P10|COMPLETED|Period 1 (Panel A and B)||0
7670384|NCT01998958|18888038|P9|COMPLETED|Period 1 (Panel A and B)||0
7670385|NCT01998958|18888039|P8|COMPLETED|Period 1 (Panel A and B)||0
7670386|NCT01998958|18888040|P7|COMPLETED|Period 1 (Panel A and B)||9
7670387|NCT01998958|18888041|P6|COMPLETED|Period 1 (Panel A and B)||11
7670388|NCT01998958|18888042|P5|COMPLETED|Period 1 (Panel A and B)||21
7670389|NCT01998958|18888043|P4|COMPLETED|Period 1 (Panel A and B)||12
7670390|NCT01998958|18888044|P3|COMPLETED|Period 1 (Panel A and B)||11
7670391|NCT01998958|18888045|P2|COMPLETED|Period 1 (Panel A and B)||8
7670392|NCT01998958|18888046|P1|COMPLETED|Period 1 (Panel A and B)||32
7670393|NCT01998958|18888015|P32|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670394|NCT01998958|18888016|P31|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670395|NCT01998958|18888017|P30|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670396|NCT01998958|18888018|P29|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670397|NCT01998958|18888019|P28|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670398|NCT01998958|18888020|P27|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670399|NCT01998958|18888021|P26|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670400|NCT01998958|18888022|P25|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670401|NCT01998958|18888023|P24|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670402|NCT01998958|18888024|P23|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670403|NCT01998958|18888025|P22|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670404|NCT01998958|18888026|P21|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670405|NCT01998958|18888027|P20|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670406|NCT01998958|18888028|P19|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670407|NCT01998958|18888029|P18|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670563|NCT01998581|18888329|P2|COMPLETED|Overall Study||44
7670408|NCT01998958|18888030|P17|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670409|NCT01998958|18888031|P16|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670410|NCT01998958|18888032|P15|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670411|NCT01998958|18888033|P14|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670412|NCT01998958|18888034|P13|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670413|NCT01998958|18888035|P12|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670414|NCT01998958|18888036|P11|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670415|NCT01998958|18888037|P10|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670416|NCT01998958|18888038|P9|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670417|NCT01998958|18888039|P8|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670418|NCT01998958|18888040|P7|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670419|NCT01998958|18888041|P6|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670420|NCT01998958|18888042|P5|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670421|NCT01998958|18888043|P4|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670422|NCT01998958|18888044|P3|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670423|NCT01998958|18888045|P2|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
7670424|NCT01998958|18888046|P1|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||5
7670425|NCT01998958|18888015|P32|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670426|NCT01998958|18888016|P31|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670427|NCT01998958|18888017|P30|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670428|NCT01998958|18888018|P29|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670429|NCT01998958|18888019|P28|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670430|NCT01998958|18888020|P27|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670431|NCT01998958|18888021|P26|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670432|NCT01998958|18888022|P25|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670433|NCT01998958|18888023|P24|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670434|NCT01998958|18888024|P23|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670435|NCT01998958|18888025|P22|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670436|NCT01998958|18888026|P21|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670437|NCT01998958|18888027|P20|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670438|NCT01998958|18888028|P19|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670439|NCT01998958|18888029|P18|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670440|NCT01998958|18888030|P17|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670441|NCT01998958|18888031|P16|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670442|NCT01998958|18888032|P15|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670443|NCT01998958|18888033|P14|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670444|NCT01998958|18888034|P13|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670445|NCT01998958|18888035|P12|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670446|NCT01998958|18888036|P11|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670447|NCT01998958|18888037|P10|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670448|NCT01998958|18888038|P9|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670449|NCT01998958|18888039|P8|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670450|NCT01998958|18888040|P7|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670451|NCT01998958|18888041|P6|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670452|NCT01998958|18888042|P5|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670453|NCT01998958|18888043|P4|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670454|NCT01998958|18888044|P3|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670455|NCT01998958|18888045|P2|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
7670456|NCT01998958|18888046|P1|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||8
7670457|NCT01998958|18888015|P32|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670458|NCT01998958|18888016|P31|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670459|NCT01998958|18888017|P30|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670460|NCT01998958|18888018|P29|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670461|NCT01998958|18888019|P28|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670462|NCT01998958|18888020|P27|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670463|NCT01998958|18888021|P26|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670464|NCT01998958|18888022|P25|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670465|NCT01998958|18888023|P24|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670466|NCT01998958|18888024|P23|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670467|NCT01998958|18888025|P22|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670468|NCT01998958|18888026|P21|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670469|NCT01998958|18888027|P20|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670470|NCT01998958|18888028|P19|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670471|NCT01998958|18888029|P18|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670472|NCT01998958|18888030|P17|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670473|NCT01998958|18888031|P16|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670474|NCT01998958|18888032|P15|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670475|NCT01998958|18888033|P14|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670476|NCT01998958|18888034|P13|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670477|NCT01998958|18888035|P12|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670478|NCT01998958|18888036|P11|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670479|NCT01998958|18888037|P10|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670480|NCT01998958|18888038|P9|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670481|NCT01998958|18888039|P8|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670482|NCT01998958|18888040|P7|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670483|NCT01998958|18888041|P6|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670484|NCT01998958|18888042|P5|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670485|NCT01998958|18888043|P4|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670486|NCT01998958|18888044|P3|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670487|NCT01998958|18888045|P2|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
7670488|NCT01998958|18888046|P1|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||9
7670489|NCT01998958|18888015|P32|STARTED|Period 1 (Panel A and B)||0
7670490|NCT01998958|18888016|P31|STARTED|Period 1 (Panel A and B)||0
7670491|NCT01998958|18888017|P30|STARTED|Period 1 (Panel A and B)||0
7670492|NCT01998958|18888018|P29|STARTED|Period 1 (Panel A and B)||0
7670493|NCT01998958|18888019|P28|STARTED|Period 1 (Panel A and B)||0
7670494|NCT01998958|18888020|P27|STARTED|Period 1 (Panel A and B)||0
7670495|NCT01998958|18888021|P26|STARTED|Period 1 (Panel A and B)||0
7670496|NCT01998958|18888022|P25|STARTED|Period 1 (Panel A and B)||0
7670497|NCT01998958|18888023|P24|STARTED|Period 1 (Panel A and B)||0
7670498|NCT01998958|18888024|P23|STARTED|Period 1 (Panel A and B)||0
7670499|NCT01998958|18888025|P22|STARTED|Period 1 (Panel A and B)||0
7670500|NCT01998958|18888026|P21|STARTED|Period 1 (Panel A and B)||0
7670501|NCT01998958|18888027|P20|STARTED|Period 1 (Panel A and B)||0
7670502|NCT01998958|18888028|P19|STARTED|Period 1 (Panel A and B)||0
7670503|NCT01998958|18888029|P18|STARTED|Period 1 (Panel A and B)||0
7670504|NCT01998958|18888030|P17|STARTED|Period 1 (Panel A and B)||0
7670505|NCT01998958|18888031|P16|STARTED|Period 1 (Panel A and B)||0
7670506|NCT01998958|18888032|P15|STARTED|Period 1 (Panel A and B)||0
7670507|NCT01998958|18888033|P14|STARTED|Period 1 (Panel A and B)||0
7670508|NCT01998958|18888034|P13|STARTED|Period 1 (Panel A and B)||0
7670509|NCT01998958|18888035|P12|STARTED|Period 1 (Panel A and B)||0
7670510|NCT01998958|18888036|P11|STARTED|Period 1 (Panel A and B)||0
7670511|NCT01998958|18888037|P10|STARTED|Period 1 (Panel A and B)||0
7670512|NCT01998958|18888038|P9|STARTED|Period 1 (Panel A and B)||0
7670513|NCT01998958|18888039|P8|STARTED|Period 1 (Panel A and B)||0
7670514|NCT01998958|18888040|P7|STARTED|Period 1 (Panel A and B)||9
7670515|NCT01998958|18888041|P6|STARTED|Period 1 (Panel A and B)||11
7670516|NCT01998958|18888042|P5|STARTED|Period 1 (Panel A and B)||21
7670517|NCT01998958|18888043|P4|STARTED|Period 1 (Panel A and B)||12
7670518|NCT01998958|18888044|P3|STARTED|Period 1 (Panel A and B)||11
7670519|NCT01998958|18888045|P2|STARTED|Period 1 (Panel A and B)||11
7670520|NCT01998958|18888046|P1|STARTED|Period 1 (Panel A and B)||33
7670521|NCT01998919|18888185|P2|NOT COMPLETED|Overall Study||35
7670522|NCT01998919|18888186|P1|NOT COMPLETED|Overall Study||42
7670523|NCT01998919|18888185|P2|COMPLETED|Overall Study||39
7670524|NCT01998919|18888186|P1|COMPLETED|Overall Study||37
7670525|NCT01998919|18888185|P2|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76
7670526|NCT01998919|18888186|P1|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78
7670527|NCT01998919|18888185|P2|STARTED|Overall Study||74
7670528|NCT01998919|18888186|P1|STARTED|Overall Study||79
7670529|NCT01998906|18888207|P3|NOT COMPLETED|Overall Study||98
7670530|NCT01998906|18888208|P2|NOT COMPLETED|Overall Study||114
7670531|NCT01998906|18888209|P1|NOT COMPLETED|Overall Study||114
7670532|NCT01998906|18888207|P3|COMPLETED|Overall Study||1
7670533|NCT01998906|18888208|P2|COMPLETED|Overall Study||2
7670534|NCT01998906|18888209|P1|COMPLETED|Overall Study||1
7670535|NCT01998906|18888207|P3|STARTED|Overall Study||99
7670536|NCT01998906|18888208|P2|STARTED|Overall Study||116
7670537|NCT01998906|18888209|P1|STARTED|Overall Study||115
7670538|NCT01998893|18888253|P1|NOT COMPLETED|Overall Study||17
7670539|NCT01998893|18888253|P1|COMPLETED|Overall Study||21
7670540|NCT01998893|18888253|P1|2nd Treatment Cycle Completed Until PD|Overall Study||3
7670541|NCT01998893|18888253|P1|2nd Treatment Cycle Started|Overall Study||5
7670542|NCT01998893|18888253|P1|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30
7670543|NCT01998893|18888253|P1|STARTED|Overall Study||38
7670544|NCT01998880|18888265|P2|NOT COMPLETED|Overall Study||40
7670545|NCT01998880|18888266|P1|NOT COMPLETED|Overall Study||28
7670546|NCT01998880|18888265|P2|COMPLETED|Overall Study||78
7670547|NCT01998880|18888266|P1|COMPLETED|Overall Study|Completed=Completed treatment.|205
7670548|NCT01998880|18888265|P2|Received Study Drug|Overall Study||116
7670549|NCT01998880|18888266|P1|Received Study Drug|Overall Study||230
7670550|NCT01998880|18888265|P2|STARTED|Overall Study||118
7670551|NCT01998880|18888266|P1|STARTED|Overall Study||233
7670552|NCT01998737|18888298|P2|NOT COMPLETED|Overall Study||0
7670553|NCT01998737|18888299|P1|NOT COMPLETED|Overall Study||23
7670554|NCT01998737|18888298|P2|COMPLETED|Overall Study||100
7670555|NCT01998737|18888299|P1|COMPLETED|Overall Study||888
7670556|NCT01998737|18888298|P2|STARTED|Overall Study||100
7670557|NCT01998737|18888299|P1|STARTED|Overall Study||911
7670558|NCT01998633|18888311|P1|NOT COMPLETED|Overall Study||1
7670559|NCT01998633|18888311|P1|COMPLETED|Overall Study||46
7670560|NCT01998633|18888311|P1|STARTED|Overall Study||47
7670561|NCT01998581|18888329|P2|NOT COMPLETED|Overall Study||12
7670562|NCT01998581|18888330|P1|NOT COMPLETED|Overall Study||46
7670564|NCT01998581|18888330|P1|COMPLETED|Overall Study||123
7670565|NCT01998581|18888329|P2|STARTED|Overall Study||56
7670566|NCT01998581|18888330|P1|STARTED|Overall Study||169
7670567|NCT01998477|18888343|P2|NOT COMPLETED|Overall Study||5
7670568|NCT01998477|18888344|P1|NOT COMPLETED|Overall Study||10
7670569|NCT01998477|18888343|P2|COMPLETED|Overall Study||143
7670570|NCT01998477|18888344|P1|COMPLETED|Overall Study||272
7670571|NCT01998477|18888343|P2|STARTED|Overall Study||148
7670572|NCT01998477|18888344|P1|STARTED|Overall Study||282
7670573|NCT01998438|18888378|P3|NOT COMPLETED|Overall Study||0
7670574|NCT01998438|18888379|P2|NOT COMPLETED|Overall Study||0
7670575|NCT01998438|18888380|P1|NOT COMPLETED|Overall Study||0
7670576|NCT01998438|18888378|P3|COMPLETED|Overall Study||318
7670577|NCT01998438|18888379|P2|COMPLETED|Overall Study||318
7670578|NCT01998438|18888380|P1|COMPLETED|Overall Study||319
7670579|NCT01998438|18888378|P3|STARTED|Overall Study||318
7670580|NCT01998438|18888379|P2|STARTED|Overall Study||318
7670581|NCT01998438|18888380|P1|STARTED|Overall Study||319
7670582|NCT01998399|18888390|P2|NOT COMPLETED|Overall Study||9
7670583|NCT01998399|18888391|P1|NOT COMPLETED|Overall Study||8
7670584|NCT01998399|18888390|P2|COMPLETED|Overall Study||4
7670585|NCT01998399|18888391|P1|COMPLETED|Overall Study||4
7670586|NCT01998399|18888390|P2|STARTED|Overall Study||13
7670587|NCT01998399|18888391|P1|STARTED|Overall Study||12
7670588|NCT01998360|18888425|P2|NOT COMPLETED|Overall Study||0
7670589|NCT01998360|18888426|P1|NOT COMPLETED|Overall Study||0
7670590|NCT01998360|18888425|P2|COMPLETED|Overall Study||50
7670591|NCT01998360|18888426|P1|COMPLETED|Overall Study||50
7670592|NCT01998360|18888425|P2|STARTED|Overall Study||50
7670593|NCT01998360|18888426|P1|STARTED|Overall Study||50
7670594|NCT01998269|18888440|P1|NOT COMPLETED|Overall Study||0
7670595|NCT01998269|18888440|P1|COMPLETED|Overall Study||193
7670596|NCT01998269|18888440|P1|STARTED|Overall Study||193
7670597|NCT01998243|18888446|P2|NOT COMPLETED|Overall Study||7
7670598|NCT01998243|18888447|P1|NOT COMPLETED|Overall Study||8
7670599|NCT01998243|18888446|P2|COMPLETED|Overall Study||32
7670600|NCT01998243|18888447|P1|COMPLETED|Overall Study||34
7670601|NCT01998243|18888446|P2|STARTED|Overall Study||39
7670602|NCT01998243|18888447|P1|STARTED|Overall Study||42
7670603|NCT01997905|18888461|P1|NOT COMPLETED|Overall Study||3
7670604|NCT01997905|18888461|P1|COMPLETED|Overall Study||10
7670605|NCT01997905|18888461|P1|Baseline Completed|Overall Study||11
7670606|NCT01997905|18888461|P1|STARTED|Overall Study||13
7670607|NCT01997892|18888470|P1|NOT COMPLETED|Overall Study||68
7670608|NCT01997892|18888470|P1|COMPLETED|Overall Study||959
7670609|NCT01997892|18888470|P1|Received Darbepoetin Alfa|Overall Study||987
7670610|NCT01997892|18888470|P1|STARTED|Overall Study||1027
7670611|NCT01997723|18888482|P1|NOT COMPLETED|Overall Study||0
7670612|NCT01997723|18888482|P1|COMPLETED|Overall Study||75
7670613|NCT01997723|18888482|P1|STARTED|Overall Study||75
7670614|NCT01997567|18888490|P2|NOT COMPLETED|Overall Study||0
7670615|NCT01997567|18888491|P1|NOT COMPLETED|Overall Study||0
7670616|NCT01997567|18888490|P2|COMPLETED|Overall Study||0
7670617|NCT01997567|18888491|P1|COMPLETED|Overall Study||0
7670618|NCT01997567|18888490|P2|STARTED|Overall Study||0
7670619|NCT01997567|18888491|P1|STARTED|Overall Study||0
7670620|NCT01997515|18888511|P2|NOT COMPLETED|Overall Study||5
7670621|NCT01997515|18888512|P1|NOT COMPLETED|Overall Study||4
7670622|NCT01997515|18888511|P2|COMPLETED|Overall Study||35
7670623|NCT01997515|18888512|P1|COMPLETED|Overall Study||36
7670624|NCT01997515|18888511|P2|STARTED|Overall Study||40
7670625|NCT01997515|18888512|P1|STARTED|Overall Study||40
7670626|NCT01997437|18888524|P1|NOT COMPLETED|Overall Study||0
7670627|NCT01997437|18888524|P1|COMPLETED|Overall Study||6
7670628|NCT01997437|18888524|P1|STARTED|Overall Study||6
7670629|NCT01997411|18888536|P8|NOT COMPLETED|Overall Study||0
7670630|NCT01997411|18888537|P7|NOT COMPLETED|Overall Study||0
7670631|NCT01997411|18888538|P6|NOT COMPLETED|Overall Study||1
7670632|NCT01997411|18888539|P5|NOT COMPLETED|Overall Study||0
7670633|NCT01997411|18888540|P4|NOT COMPLETED|Overall Study||0
7670634|NCT01997411|18888541|P3|NOT COMPLETED|Overall Study||0
7670635|NCT01997411|18888542|P2|NOT COMPLETED|Overall Study||0
7670636|NCT01997411|18888543|P1|NOT COMPLETED|Overall Study||0
7670637|NCT01997411|18888536|P8|COMPLETED|Overall Study||6
7670638|NCT01997411|18888537|P7|COMPLETED|Overall Study||6
7670639|NCT01997411|18888538|P6|COMPLETED|Overall Study||5
7670640|NCT01997411|18888539|P5|COMPLETED|Overall Study||6
7670641|NCT01997411|18888540|P4|COMPLETED|Overall Study||6
7670642|NCT01997411|18888541|P3|COMPLETED|Overall Study||6
7670643|NCT01997411|18888542|P2|COMPLETED|Overall Study||6
7670644|NCT01997411|18888543|P1|COMPLETED|Overall Study||6
7670645|NCT01997411|18888536|P8|STARTED|Overall Study||6
7670646|NCT01997411|18888537|P7|STARTED|Overall Study||6
7670647|NCT01997411|18888538|P6|STARTED|Overall Study||6
7670648|NCT01997411|18888539|P5|STARTED|Overall Study||6
7670649|NCT01997411|18888540|P4|STARTED|Overall Study||6
7670650|NCT01997411|18888541|P3|STARTED|Overall Study||6
7670651|NCT01997411|18888542|P2|STARTED|Overall Study||6
7670652|NCT01997411|18888543|P1|STARTED|Overall Study||6
7670653|NCT01997398|18888633|P1|NOT COMPLETED|Overall Study||1
7670654|NCT01997398|18888633|P1|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34
7670655|NCT01997398|18888633|P1|STARTED|Overall Study||35
7670656|NCT01997333|18888644|P2|NOT COMPLETED|Survival Follow up||14
7670657|NCT01997333|18888645|P1|NOT COMPLETED|Survival Follow up||16
7670658|NCT01997333|18888644|P2|COMPLETED|Survival Follow up||199
7670659|NCT01997333|18888645|P1|COMPLETED|Survival Follow up||76
7670660|NCT01997333|18888644|P2|STARTED|Survival Follow up||213
7670661|NCT01997333|18888645|P1|STARTED|Survival Follow up||92
7670662|NCT01997333|18888644|P2|NOT COMPLETED|Randomization and Treatment||203
7670663|NCT01997333|18888645|P1|NOT COMPLETED|Randomization and Treatment||103
7670664|NCT01997333|18888644|P2|COMPLETED|Randomization and Treatment||15
7670665|NCT01997333|18888645|P1|COMPLETED|Randomization and Treatment||6
7670666|NCT01997333|18888644|P2|STARTED|Randomization and Treatment||218
7670667|NCT01997333|18888645|P1|STARTED|Randomization and Treatment||109
7670668|NCT01997281|18888662|P2|NOT COMPLETED|Overall Study||0
7670669|NCT01997281|18888663|P1|NOT COMPLETED|Overall Study||1
7670670|NCT01997281|18888662|P2|COMPLETED|Overall Study||7
7670671|NCT01997281|18888663|P1|COMPLETED|Overall Study||6
7670672|NCT01997281|18888662|P2|Withdrawal|Overall Study||0
7670673|NCT01997281|18888663|P1|Withdrawal|Overall Study||1
7670674|NCT01997281|18888662|P2|STARTED|Overall Study||7
7670675|NCT01997281|18888663|P1|STARTED|Overall Study||7
7670676|NCT01997229|18888671|P2|NOT COMPLETED|Overall Study||2
7670677|NCT01997229|18888672|P1|NOT COMPLETED|Overall Study||5
7670678|NCT01997229|18888671|P2|COMPLETED|Overall Study||61
7670679|NCT01997229|18888672|P1|COMPLETED|Overall Study||57
7670680|NCT01997229|18888671|P2|STARTED|Overall Study||63
7670681|NCT01997229|18888672|P1|STARTED|Overall Study||62
7670682|NCT01997216|18888678|P2|NOT COMPLETED|Second 9 Hours||0
7670683|NCT01997216|18888679|P1|NOT COMPLETED|Second 9 Hours||0
7670684|NCT01997216|18888678|P2|COMPLETED|Second 9 Hours||21
7670685|NCT01997216|18888679|P1|COMPLETED|Second 9 Hours||19
7670686|NCT01997216|18888678|P2|STARTED|Second 9 Hours||21
7670687|NCT01997216|18888679|P1|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19
7670688|NCT01997216|18888678|P2|NOT COMPLETED|First 9 Hours||0
7670689|NCT01997216|18888679|P1|NOT COMPLETED|First 9 Hours||0
7670690|NCT01997216|18888678|P2|COMPLETED|First 9 Hours||21
7670691|NCT01997216|18888679|P1|COMPLETED|First 9 Hours||18
7670692|NCT01997216|18888678|P2|STARTED|First 9 Hours||21
7670693|NCT01997216|18888679|P1|STARTED|First 9 Hours||18
7670694|NCT01996982|18888689|P1|NOT COMPLETED|Overall Study||7
7670695|NCT01996982|18888689|P1|COMPLETED|Overall Study||0
7670696|NCT01996982|18888689|P1|STARTED|Overall Study||7
7670697|NCT01996917|18888694|P1|NOT COMPLETED|Overall Study||0
7670698|NCT01996917|18888694|P1|COMPLETED|Overall Study||21
7670699|NCT01996917|18888694|P1|STARTED|Overall Study||21
7670700|NCT01996904|18888705|P2|NOT COMPLETED|Overall Study||27
7670701|NCT01996904|18888706|P1|NOT COMPLETED|Overall Study||38
7670702|NCT01996904|18888705|P2|COMPLETED|Overall Study||90
7670703|NCT01996904|18888706|P1|COMPLETED|Overall Study||101
7670704|NCT01996904|18888705|P2|STARTED|Overall Study||117
7670705|NCT01996904|18888706|P1|STARTED|Overall Study||139
7670706|NCT01996852|18888715|P3|NOT COMPLETED|Overall Study||0
7670707|NCT01996852|18888716|P2|NOT COMPLETED|Overall Study||0
7670708|NCT01996852|18888717|P1|NOT COMPLETED|Overall Study||0
7670709|NCT01996852|18888715|P3|COMPLETED|Overall Study||0
7670710|NCT01996852|18888716|P2|COMPLETED|Overall Study||0
7670711|NCT01996852|18888717|P1|COMPLETED|Overall Study||0
7670712|NCT01996852|18888715|P3|STARTED|Overall Study||0
7670713|NCT01996852|18888716|P2|STARTED|Overall Study||0
7670714|NCT01996852|18888717|P1|STARTED|Overall Study||0
7670715|NCT01996839|18888764|P3|NOT COMPLETED|Overall Study||32
7670716|NCT01996839|18888765|P2|NOT COMPLETED|Overall Study||38
7670717|NCT01996839|18888766|P1|NOT COMPLETED|Overall Study||92
7670718|NCT01996839|18888764|P3|COMPLETED|Overall Study||139
7670719|NCT01996839|18888765|P2|COMPLETED|Overall Study||133
7670720|NCT01996839|18888766|P1|COMPLETED|Overall Study||80
7670721|NCT01996839|18888764|P3|STARTED|Overall Study||171
7670722|NCT01996839|18888765|P2|STARTED|Overall Study||171
7670723|NCT01996839|18888766|P1|STARTED|Overall Study||172
7670724|NCT01996826|18888791|P2|NOT COMPLETED|Overall Study||3
7670725|NCT01996826|18888792|P1|NOT COMPLETED|Overall Study||7
7670726|NCT01996826|18888791|P2|COMPLETED|Overall Study||33
7670727|NCT01996826|18888792|P1|COMPLETED|Overall Study||32
7670728|NCT01996826|18888791|P2|STARTED|Overall Study||36
7670729|NCT01996826|18888792|P1|STARTED|Overall Study||39
7670730|NCT01996813|18888804|P2|NOT COMPLETED|Overall Study||0
7670731|NCT01996813|18888805|P1|NOT COMPLETED|Overall Study||0
7670732|NCT01996813|18888804|P2|COMPLETED|Overall Study||24
7670733|NCT01996813|18888805|P1|COMPLETED|Overall Study||23
7670734|NCT01996813|18888804|P2|STARTED|Overall Study||24
7670735|NCT01996813|18888805|P1|STARTED|Overall Study||23
7670736|NCT01996748|18888815|P2|NOT COMPLETED|Overall Study||6
7670737|NCT01996748|18888816|P1|NOT COMPLETED|Overall Study||8
7670738|NCT01996748|18888815|P2|COMPLETED|Overall Study||63
7670739|NCT01996748|18888816|P1|COMPLETED|Overall Study||58
7670740|NCT01996748|18888815|P2|STARTED|Overall Study||69
7670741|NCT01996748|18888816|P1|STARTED|Overall Study||66
7670742|NCT01996709|18888830|P2|NOT COMPLETED|Overall Study||1
7670743|NCT01996709|18888831|P1|NOT COMPLETED|Overall Study||5
7670744|NCT01996709|18888830|P2|COMPLETED|Overall Study||67
7670745|NCT01996709|18888831|P1|COMPLETED|Overall Study||61
7670746|NCT01996709|18888830|P2|STARTED|Overall Study||68
7670747|NCT01996709|18888831|P1|STARTED|Overall Study||66
7670748|NCT01996657|18888848|P3|NOT COMPLETED|Overall Study||14
7670749|NCT01996657|18888849|P2|NOT COMPLETED|Overall Study||11
7670750|NCT01996657|18888850|P1|NOT COMPLETED|Overall Study||13
7670751|NCT01996657|18888848|P3|COMPLETED|Overall Study||234
7670752|NCT01996657|18888849|P2|COMPLETED|Overall Study||239
7670753|NCT01996657|18888850|P1|COMPLETED|Overall Study||237
7670754|NCT01996657|18888848|P3|STARTED|Overall Study||248
7670755|NCT01996657|18888849|P2|STARTED|Overall Study||250
7670756|NCT01996657|18888850|P1|STARTED|Overall Study||250
7670757|NCT01996644|18888866|P2|NOT COMPLETED|Overall Study||0
7670758|NCT01996644|18888867|P1|NOT COMPLETED|Overall Study||0
7670759|NCT01996644|18888866|P2|COMPLETED|Overall Study||16
7670760|NCT01996644|18888867|P1|COMPLETED|Overall Study||20
7670761|NCT01996644|18888866|P2|STARTED|Overall Study||16
7670762|NCT01996644|18888867|P1|STARTED|Overall Study||20
7670763|NCT01996592|18888878|P1|NOT COMPLETED|Overall Study||45
7670764|NCT01996592|18888878|P1|COMPLETED|Overall Study||530
7670765|NCT01996592|18888878|P1|STARTED|Overall Study||575
7670766|NCT01996410|18888895|P8|NOT COMPLETED|Overall Study||0
7670767|NCT01996410|18888896|P7|NOT COMPLETED|Overall Study||0
7670768|NCT01996410|18888897|P6|NOT COMPLETED|Overall Study||0
7670769|NCT01996410|18888898|P5|NOT COMPLETED|Overall Study||0
7670770|NCT01996410|18888899|P4|NOT COMPLETED|Overall Study||0
7670771|NCT01996410|18888900|P3|NOT COMPLETED|Overall Study||0
7670772|NCT01996410|18888901|P2|NOT COMPLETED|Overall Study||0
7670773|NCT01996410|18888902|P1|NOT COMPLETED|Overall Study||0
7670774|NCT01996410|18888895|P8|COMPLETED|Overall Study||0
7670775|NCT01996410|18888896|P7|COMPLETED|Overall Study||0
7670776|NCT01996410|18888897|P6|COMPLETED|Overall Study||2
7670777|NCT01996410|18888898|P5|COMPLETED|Overall Study||2
7670778|NCT01996410|18888899|P4|COMPLETED|Overall Study||0
7670779|NCT01996410|18888900|P3|COMPLETED|Overall Study||0
7670780|NCT01996410|18888901|P2|COMPLETED|Overall Study||3
7670781|NCT01996410|18888902|P1|COMPLETED|Overall Study||3
7670782|NCT01996410|18888895|P8|STARTED|Overall Study||0
7670783|NCT01996410|18888896|P7|STARTED|Overall Study||0
7670784|NCT01996410|18888897|P6|STARTED|Overall Study||2
7670785|NCT01996410|18888898|P5|STARTED|Overall Study||2
7670786|NCT01996410|18888899|P4|STARTED|Overall Study||0
7670787|NCT01996410|18888900|P3|STARTED|Overall Study||0
7670788|NCT01996410|18888901|P2|STARTED|Overall Study||3
7670789|NCT01996410|18888902|P1|STARTED|Overall Study||3
7670790|NCT01996332|18888914|P1|NOT COMPLETED|Overall Study||1805
7670791|NCT01996332|18888914|P1|COMPLETED|Overall Study||0
7670792|NCT01996332|18888914|P1|STARTED|Overall Study||1805
7670793|NCT01996319|18888922|P2|NOT COMPLETED|Overall Study||3
7670794|NCT01996319|18888923|P1|NOT COMPLETED|Overall Study||8
7670795|NCT01996319|18888922|P2|COMPLETED|Overall Study||95
7670796|NCT01996319|18888923|P1|COMPLETED|Overall Study||88
7670797|NCT01996319|18888922|P2|STARTED|Overall Study||98
7670798|NCT01996319|18888923|P1|STARTED|Overall Study||96
7670799|NCT01996254|18888945|P3|NOT COMPLETED|Overall Study||8
7670800|NCT01996254|18888946|P2|NOT COMPLETED|Overall Study||5
7670801|NCT01996254|18888947|P1|NOT COMPLETED|Overall Study||1
7670802|NCT01996254|18888945|P3|COMPLETED|Overall Study||6
7670803|NCT01996254|18888946|P2|COMPLETED|Overall Study||9
7670804|NCT01996254|18888947|P1|COMPLETED|Overall Study||4
7670805|NCT01996254|18888945|P3|Per Protocol Set|Overall Study||13
7670806|NCT01996254|18888946|P2|Per Protocol Set|Overall Study||10
7670807|NCT01996254|18888947|P1|Per Protocol Set|Overall Study||0
7670808|NCT01996254|18888945|P3|Long Term Analysis Set|Overall Study||14
7670809|NCT01996254|18888946|P2|Long Term Analysis Set|Overall Study||12
7670810|NCT01996254|18888947|P1|Long Term Analysis Set|Overall Study||0
7670811|NCT01996254|18888945|P3|Full Analysis Set|Overall Study||14
7670812|NCT01996254|18888946|P2|Full Analysis Set|Overall Study||12
7670813|NCT01996254|18888947|P1|Full Analysis Set|Overall Study||0
7670814|NCT01996254|18888945|P3|Safety Set|Overall Study||14
7670815|NCT01996254|18888946|P2|Safety Set|Overall Study||14
7670816|NCT01996254|18888947|P1|Safety Set|Overall Study||5
7670817|NCT01996254|18888945|P3|STARTED|Overall Study||14
7670818|NCT01996254|18888946|P2|STARTED|Overall Study||14
7670819|NCT01996254|18888947|P1|STARTED|Overall Study||5
7670820|NCT01996241|18888975|P2|NOT COMPLETED|Overall Study||235
7670821|NCT01996241|18888976|P1|NOT COMPLETED|Overall Study||252
7670822|NCT01996241|18888975|P2|COMPLETED|Overall Study||876
7670823|NCT01996241|18888976|P1|COMPLETED|Overall Study||912
7670824|NCT01996241|18888975|P2|STARTED|Overall Study||1111
7670825|NCT01996241|18888976|P1|STARTED|Overall Study||1164
7670826|NCT01996033|18888992|P1|NOT COMPLETED|Overall Study||9
7670827|NCT01996033|18888992|P1|COMPLETED|Overall Study||16
7670828|NCT01996033|18888992|P1|STARTED|Overall Study||25
7670829|NCT01995838|18889012|P7|NOT COMPLETED|Overall Study||5
7670830|NCT01995838|18889013|P6|NOT COMPLETED|Overall Study||2
7670831|NCT01995838|18889014|P5|NOT COMPLETED|Overall Study||2
7670832|NCT01995838|18889015|P4|NOT COMPLETED|Overall Study||2
7670833|NCT01995838|18889016|P3|NOT COMPLETED|Overall Study||0
7670834|NCT01995838|18889017|P2|NOT COMPLETED|Overall Study||2
7670835|NCT01995838|18889018|P1|NOT COMPLETED|Overall Study||5
7670836|NCT01995838|18889012|P7|COMPLETED|Overall Study||45
7670837|NCT01995838|18889013|P6|COMPLETED|Overall Study||54
7670838|NCT01995838|18889014|P5|COMPLETED|Overall Study||30
7670839|NCT01995838|18889015|P4|COMPLETED|Overall Study||36
7670840|NCT01995838|18889016|P3|COMPLETED|Overall Study||27
7670841|NCT01995838|18889017|P2|COMPLETED|Overall Study||30
7670842|NCT01995838|18889018|P1|COMPLETED|Overall Study||51
7670843|NCT01995838|18889012|P7|STARTED|Overall Study||50
7670844|NCT01995838|18889013|P6|STARTED|Overall Study||56
7670845|NCT01995838|18889014|P5|STARTED|Overall Study||32
7670846|NCT01995838|18889015|P4|STARTED|Overall Study||38
7670847|NCT01995838|18889016|P3|STARTED|Overall Study||27
7670848|NCT01995838|18889017|P2|STARTED|Overall Study||32
7670849|NCT01995838|18889018|P1|STARTED|Overall Study||56
7670850|NCT01995825|18889119|P2|NOT COMPLETED|Overall Study||0
7670851|NCT01995825|18889120|P1|NOT COMPLETED|Overall Study||1
7670852|NCT01995825|18889119|P2|COMPLETED|Overall Study||17
7670853|NCT01995825|18889120|P1|COMPLETED|Overall Study||17
7670854|NCT01995825|18889119|P2|STARTED|Overall Study||17
7670855|NCT01995825|18889120|P1|STARTED|Overall Study||18
7670856|NCT01995552|18889128|P1|NOT COMPLETED|Overall Study||17
7670857|NCT01995552|18889128|P1|COMPLETED|Overall Study|There were 233 patients who were eligible for primary objective analysis|233
7670858|NCT01995552|18889128|P1|STARTED|Overall Study|There were 249 patients were included for Baseline cohort and 233 in analysis cohort|250
7670859|NCT01995539|18889134|P1|NOT COMPLETED|Overall Study||33
7670860|NCT01995539|18889134|P1|COMPLETED|Overall Study||148
7670861|NCT01995539|18889134|P1|STARTED|Overall Study||181
7670862|NCT01995526|18889139|P1|NOT COMPLETED|Overall Study||1
7670863|NCT01995526|18889139|P1|COMPLETED|Overall Study||10
7670864|NCT01995526|18889139|P1|Received One Dose of Study Drug|Overall Study||11
7670865|NCT01995526|18889139|P1|STARTED|Overall Study||11
7670866|NCT01995513|18889147|P3|NOT COMPLETED|Double Blind Treatment Period||125
7670867|NCT01995513|18889148|P2|NOT COMPLETED|Double Blind Treatment Period||126
7670868|NCT01995513|18889149|P1|NOT COMPLETED|Double Blind Treatment Period||0
7670869|NCT01995513|18889147|P3|COMPLETED|Double Blind Treatment Period||0
7670870|NCT01995513|18889148|P2|COMPLETED|Double Blind Treatment Period||0
7670871|NCT01995513|18889149|P1|COMPLETED|Double Blind Treatment Period||0
7670872|NCT01995513|18889147|P3|Treated|Double Blind Treatment Period||124
7670873|NCT01995513|18889148|P2|Treated|Double Blind Treatment Period||125
7670874|NCT01995513|18889149|P1|Treated|Double Blind Treatment Period||0
7670875|NCT01995513|18889147|P3|STARTED|Double Blind Treatment Period||125
7670876|NCT01995513|18889148|P2|STARTED|Double Blind Treatment Period||126
7670877|NCT01995513|18889149|P1|STARTED|Double Blind Treatment Period||0
7670878|NCT01995513|18889147|P3|NOT COMPLETED|Open Label Treatment Period||0
7670879|NCT01995513|18889148|P2|NOT COMPLETED|Open Label Treatment Period||0
7670880|NCT01995513|18889149|P1|NOT COMPLETED|Open Label Treatment Period||258
7670881|NCT01995513|18889147|P3|COMPLETED|Open Label Treatment Period||0
7670882|NCT01995513|18889148|P2|COMPLETED|Open Label Treatment Period||0
7670883|NCT01995513|18889149|P1|COMPLETED|Open Label Treatment Period||251
7670884|NCT01995513|18889147|P3|STARTED|Open Label Treatment Period||0
7670885|NCT01995513|18889148|P2|STARTED|Open Label Treatment Period||0
7670886|NCT01995513|18889149|P1|STARTED|Open Label Treatment Period||509
7670887|NCT01995461|18889192|P1|NOT COMPLETED|Overall Study||5
7670888|NCT01995461|18889192|P1|COMPLETED|Overall Study||21
7670889|NCT01995461|18889192|P1|STARTED|Overall Study||26
7670890|NCT01995357|18889198|P6|NOT COMPLETED|Period 5||0
7670891|NCT01995357|18889199|P5|NOT COMPLETED|Period 5||0
7670892|NCT01995357|18889200|P4|NOT COMPLETED|Period 5||0
7670893|NCT01995357|18889201|P3|NOT COMPLETED|Period 5||1
7670894|NCT01995357|18889202|P2|NOT COMPLETED|Period 5||0
7670895|NCT01995357|18889203|P1|NOT COMPLETED|Period 5||2
7670896|NCT01995357|18889198|P6|COMPLETED|Period 5||4
7670897|NCT01995357|18889199|P5|COMPLETED|Period 5||4
7670898|NCT01995357|18889200|P4|COMPLETED|Period 5||3
7670899|NCT01995357|18889201|P3|COMPLETED|Period 5||3
7670900|NCT01995357|18889202|P2|COMPLETED|Period 5||3
7670901|NCT01995357|18889203|P1|COMPLETED|Period 5||2
7670902|NCT01995357|18889198|P6|STARTED|Period 5||4
7670903|NCT01995357|18889199|P5|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4
7670904|NCT01995357|18889200|P4|STARTED|Period 5||3
7670905|NCT01995357|18889201|P3|STARTED|Period 5||4
7670906|NCT01995357|18889202|P2|STARTED|Period 5||3
7670907|NCT01995357|18889203|P1|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4
7670908|NCT01995357|18889198|P6|NOT COMPLETED|Period 4||0
7670909|NCT01995357|18889199|P5|NOT COMPLETED|Period 4||0
7670910|NCT01995357|18889200|P4|NOT COMPLETED|Period 4||0
7670911|NCT01995357|18889201|P3|NOT COMPLETED|Period 4||0
7670912|NCT01995357|18889202|P2|NOT COMPLETED|Period 4||0
7670913|NCT01995357|18889203|P1|NOT COMPLETED|Period 4||0
7670914|NCT01995357|18889198|P6|COMPLETED|Period 4||4
7670915|NCT01995357|18889199|P5|COMPLETED|Period 4||4
7670916|NCT01995357|18889200|P4|COMPLETED|Period 4||3
7670917|NCT01995357|18889201|P3|COMPLETED|Period 4||4
7670918|NCT01995357|18889202|P2|COMPLETED|Period 4||3
7670919|NCT01995357|18889203|P1|COMPLETED|Period 4||4
7670920|NCT01995357|18889198|P6|STARTED|Period 4||4
7670921|NCT01995357|18889199|P5|STARTED|Period 4||4
7670922|NCT01995357|18889200|P4|STARTED|Period 4||3
7670923|NCT01995357|18889201|P3|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4
7670924|NCT01995357|18889202|P2|STARTED|Period 4||3
7670925|NCT01995357|18889203|P1|STARTED|Period 4||4
7670926|NCT01995357|18889198|P6|NOT COMPLETED|Period 3||0
7670927|NCT01995357|18889199|P5|NOT COMPLETED|Period 3||0
7670928|NCT01995357|18889200|P4|NOT COMPLETED|Period 3||0
7670929|NCT01995357|18889201|P3|NOT COMPLETED|Period 3||0
7670930|NCT01995357|18889202|P2|NOT COMPLETED|Period 3||0
7670931|NCT01995357|18889203|P1|NOT COMPLETED|Period 3||0
7670932|NCT01995357|18889198|P6|COMPLETED|Period 3||4
7670933|NCT01995357|18889199|P5|COMPLETED|Period 3||4
7670934|NCT01995357|18889200|P4|COMPLETED|Period 3||3
7670935|NCT01995357|18889201|P3|COMPLETED|Period 3||4
7670936|NCT01995357|18889202|P2|COMPLETED|Period 3||3
7670937|NCT01995357|18889203|P1|COMPLETED|Period 3||4
7670938|NCT01995357|18889198|P6|STARTED|Period 3||4
7670939|NCT01995357|18889199|P5|STARTED|Period 3||4
7670940|NCT01995357|18889200|P4|STARTED|Period 3||3
7670941|NCT01995357|18889201|P3|STARTED|Period 3||4
7670942|NCT01995357|18889202|P2|STARTED|Period 3||3
7670943|NCT01995357|18889203|P1|STARTED|Period 3||4
7670944|NCT01995357|18889198|P6|NOT COMPLETED|Period 2||0
7670945|NCT01995357|18889199|P5|NOT COMPLETED|Period 2||0
7670946|NCT01995357|18889200|P4|NOT COMPLETED|Period 2||0
7670947|NCT01995357|18889201|P3|NOT COMPLETED|Period 2||0
7670948|NCT01995357|18889202|P2|NOT COMPLETED|Period 2||0
7670949|NCT01995357|18889203|P1|NOT COMPLETED|Period 2||0
7670950|NCT01995357|18889198|P6|COMPLETED|Period 2||4
7670951|NCT01995357|18889199|P5|COMPLETED|Period 2||4
7670952|NCT01995357|18889200|P4|COMPLETED|Period 2||3
7670953|NCT01995357|18889201|P3|COMPLETED|Period 2||4
7670954|NCT01995357|18889202|P2|COMPLETED|Period 2||3
7670955|NCT01995357|18889203|P1|COMPLETED|Period 2||4
7670956|NCT01995357|18889198|P6|STARTED|Period 2||4
7670957|NCT01995357|18889199|P5|STARTED|Period 2||4
7670958|NCT01995357|18889200|P4|STARTED|Period 2||3
7670959|NCT01995357|18889201|P3|STARTED|Period 2||4
7670960|NCT01995357|18889202|P2|STARTED|Period 2||3
7670961|NCT01995357|18889203|P1|STARTED|Period 2||4
7670962|NCT01995357|18889198|P6|NOT COMPLETED|Period 1||0
7670963|NCT01995357|18889199|P5|NOT COMPLETED|Period 1||0
7670964|NCT01995357|18889200|P4|NOT COMPLETED|Period 1||0
7670965|NCT01995357|18889201|P3|NOT COMPLETED|Period 1||0
7670966|NCT01995357|18889202|P2|NOT COMPLETED|Period 1||0
7670967|NCT01995357|18889203|P1|NOT COMPLETED|Period 1||0
7670968|NCT01995357|18889198|P6|COMPLETED|Period 1||4
7670969|NCT01995357|18889199|P5|COMPLETED|Period 1||4
7670970|NCT01995357|18889200|P4|COMPLETED|Period 1||3
7670971|NCT01995357|18889201|P3|COMPLETED|Period 1||4
7670972|NCT01995357|18889202|P2|COMPLETED|Period 1||3
7670973|NCT01995357|18889203|P1|COMPLETED|Period 1||4
7670974|NCT01995357|18889198|P6|STARTED|Period 1||4
7670975|NCT01995357|18889199|P5|STARTED|Period 1||4
7670976|NCT01995357|18889200|P4|STARTED|Period 1||3
7670977|NCT01995357|18889201|P3|STARTED|Period 1||4
7670978|NCT01995357|18889202|P2|STARTED|Period 1||3
7670979|NCT01995357|18889203|P1|STARTED|Period 1||4
7670980|NCT01995266|18889219|P1|NOT COMPLETED|Overall Study||9
7670981|NCT01995266|18889219|P1|COMPLETED|Overall Study||150
7670982|NCT01995266|18889219|P1|STARTED|Overall Study||159
7670983|NCT01995201|18889234|P7|NOT COMPLETED|From Week 24 Until Week 48||2
7670984|NCT01995201|18889235|P6|NOT COMPLETED|From Week 24 Until Week 48||8
7670985|NCT01995201|18889236|P5|NOT COMPLETED|From Week 24 Until Week 48||6
7670986|NCT01995201|18889237|P4|NOT COMPLETED|From Week 24 Until Week 48||1
7670987|NCT01995201|18889238|P3|NOT COMPLETED|From Week 24 Until Week 48||5
7670988|NCT01995201|18889239|P2|NOT COMPLETED|From Week 24 Until Week 48||0
7670989|NCT01995201|18889240|P1|NOT COMPLETED|From Week 24 Until Week 48||0
7670990|NCT01995201|18889234|P7|COMPLETED|From Week 24 Until Week 48||0
7670991|NCT01995201|18889235|P6|COMPLETED|From Week 24 Until Week 48||59
7670992|NCT01995201|18889236|P5|COMPLETED|From Week 24 Until Week 48||89
7670993|NCT01995201|18889237|P4|COMPLETED|From Week 24 Until Week 48||89
7670994|NCT01995201|18889238|P3|COMPLETED|From Week 24 Until Week 48||84
7670995|NCT01995201|18889239|P2|COMPLETED|From Week 24 Until Week 48||0
7670996|NCT01995201|18889240|P1|COMPLETED|From Week 24 Until Week 48||0
7670997|NCT01995201|18889234|P7|STARTED|From Week 24 Until Week 48||2
7670998|NCT01995201|18889235|P6|STARTED|From Week 24 Until Week 48||67
7670999|NCT01995201|18889236|P5|STARTED|From Week 24 Until Week 48||95
7671000|NCT01995201|18889237|P4|STARTED|From Week 24 Until Week 48||90
7671001|NCT01995201|18889238|P3|STARTED|From Week 24 Until Week 48||89
7671002|NCT01995201|18889239|P2|STARTED|From Week 24 Until Week 48||0
7671003|NCT01995201|18889240|P1|STARTED|From Week 24 Until Week 48||0
7671004|NCT01995201|18889234|P7|NOT COMPLETED|From Baseline Until Week 24||0
7671005|NCT01995201|18889235|P6|NOT COMPLETED|From Baseline Until Week 24||0
7671006|NCT01995201|18889236|P5|NOT COMPLETED|From Baseline Until Week 24||0
7671007|NCT01995201|18889237|P4|NOT COMPLETED|From Baseline Until Week 24||0
7671008|NCT01995201|18889238|P3|NOT COMPLETED|From Baseline Until Week 24||0
7671009|NCT01995201|18889239|P2|NOT COMPLETED|From Baseline Until Week 24||46
7671010|NCT01995201|18889240|P1|NOT COMPLETED|From Baseline Until Week 24||10
7671011|NCT01995201|18889234|P7|COMPLETED|From Baseline Until Week 24||0
7671012|NCT01995201|18889235|P6|COMPLETED|From Baseline Until Week 24||0
7671013|NCT01995201|18889236|P5|COMPLETED|From Baseline Until Week 24||0
7671014|NCT01995201|18889237|P4|COMPLETED|From Baseline Until Week 24||0
7671015|NCT01995201|18889238|P3|COMPLETED|From Baseline Until Week 24||0
7671016|NCT01995201|18889239|P2|COMPLETED|From Baseline Until Week 24||281
7671017|NCT01995201|18889240|P1|COMPLETED|From Baseline Until Week 24||64
7671018|NCT01995201|18889234|P7|STARTED|From Baseline Until Week 24||0
7671019|NCT01995201|18889235|P6|STARTED|From Baseline Until Week 24||0
7671020|NCT01995201|18889236|P5|STARTED|From Baseline Until Week 24||0
7671021|NCT01995201|18889237|P4|STARTED|From Baseline Until Week 24||0
7671022|NCT01995201|18889238|P3|STARTED|From Baseline Until Week 24||0
7671023|NCT01995201|18889239|P2|STARTED|From Baseline Until Week 24||327
7671024|NCT01995201|18889240|P1|STARTED|From Baseline Until Week 24||74
7671025|NCT01995175|18889349|P1|NOT COMPLETED|Overall Study||253
7671026|NCT01995175|18889349|P1|COMPLETED|Overall Study||2148
7671027|NCT01995175|18889349|P1|STARTED|Overall Study||2401
7671028|NCT01995136|18889364|P1|NOT COMPLETED|Overall Study||1
7671029|NCT01995136|18889364|P1|COMPLETED|Overall Study||31
7671030|NCT01995136|18889364|P1|STARTED|Overall Study||32
7671031|NCT01995123|18889370|P2|NOT COMPLETED|Overall Study||15
7671032|NCT01995123|18889371|P1|NOT COMPLETED|Overall Study||18
7671033|NCT01995123|18889370|P2|COMPLETED|Overall Study||46
7671034|NCT01995123|18889371|P1|COMPLETED|Overall Study||45
7671035|NCT01995123|18889370|P2|STARTED|Overall Study||61
7671036|NCT01995123|18889371|P1|STARTED|Overall Study||63
7671037|NCT01995071|18889393|P12|NOT COMPLETED|Overall Study||0
7671038|NCT01995071|18889394|P11|NOT COMPLETED|Overall Study||1
7671039|NCT01995071|18889395|P10|NOT COMPLETED|Overall Study||0
7671040|NCT01995071|18889396|P9|NOT COMPLETED|Overall Study||1
7671041|NCT01995071|18889397|P8|NOT COMPLETED|Overall Study||2
7671042|NCT01995071|18889398|P7|NOT COMPLETED|Overall Study||1
7671043|NCT01995071|18889399|P6|NOT COMPLETED|Overall Study||0
7671044|NCT01995071|18889400|P5|NOT COMPLETED|Overall Study||1
7671045|NCT01995071|18889401|P4|NOT COMPLETED|Overall Study||0
7671046|NCT01995071|18889402|P3|NOT COMPLETED|Overall Study||1
7671047|NCT01995071|18889403|P2|NOT COMPLETED|Overall Study||0
7671048|NCT01995071|18889404|P1|NOT COMPLETED|Overall Study||1
7671049|NCT01995071|18889393|P12|COMPLETED|Overall Study||0
7671050|NCT01995071|18889394|P11|COMPLETED|Overall Study||7
7671051|NCT01995071|18889395|P10|COMPLETED|Overall Study||8
7671052|NCT01995071|18889396|P9|COMPLETED|Overall Study||7
7671053|NCT01995071|18889397|P8|COMPLETED|Overall Study||6
7671054|NCT01995071|18889398|P7|COMPLETED|Overall Study||7
7671055|NCT01995071|18889399|P6|COMPLETED|Overall Study||8
7671056|NCT01995071|18889400|P5|COMPLETED|Overall Study||7
7671057|NCT01995071|18889401|P4|COMPLETED|Overall Study||8
7671058|NCT01995071|18889402|P3|COMPLETED|Overall Study||8
7671059|NCT01995071|18889403|P2|COMPLETED|Overall Study||8
7671060|NCT01995071|18889404|P1|COMPLETED|Overall Study||7
7671061|NCT01995071|18889393|P12|STARTED|Overall Study||0
7671062|NCT01995071|18889394|P11|STARTED|Overall Study||8
7671063|NCT01995071|18889395|P10|STARTED|Overall Study||8
7671064|NCT01995071|18889396|P9|STARTED|Overall Study||8
7671065|NCT01995071|18889397|P8|STARTED|Overall Study||8
7671066|NCT01995071|18889398|P7|STARTED|Overall Study||8
7671067|NCT01995071|18889399|P6|STARTED|Overall Study||8
7671068|NCT01995071|18889400|P5|STARTED|Overall Study||8
7671069|NCT01995071|18889401|P4|STARTED|Overall Study||8
7671070|NCT01995071|18889402|P3|STARTED|Overall Study||9
7671071|NCT01995071|18889403|P2|STARTED|Overall Study||8
7671072|NCT01995071|18889404|P1|STARTED|Overall Study||8
7671073|NCT01995045|18889465|P2|NOT COMPLETED|Overall Study||0
7671074|NCT01995045|18889466|P1|NOT COMPLETED|Overall Study||0
7671075|NCT01995045|18889465|P2|COMPLETED|Overall Study||28
7671076|NCT01995045|18889466|P1|COMPLETED|Overall Study||29
7671077|NCT01995045|18889465|P2|STARTED|Overall Study||28
7671078|NCT01995045|18889466|P1|STARTED|Overall Study||29
7671079|NCT01994993|18889483|P5|NOT COMPLETED|Overall Study||2
7671080|NCT01994993|18889484|P4|NOT COMPLETED|Overall Study||46
7671081|NCT01994993|18889485|P3|NOT COMPLETED|Overall Study||47
7671082|NCT01994993|18889486|P2|NOT COMPLETED|Overall Study||35
7671083|NCT01994993|18889487|P1|NOT COMPLETED|Overall Study||35
7671084|NCT01994993|18889483|P5|COMPLETED|Overall Study||22
7671085|NCT01994993|18889484|P4|COMPLETED|Overall Study||9
7671086|NCT01994993|18889485|P3|COMPLETED|Overall Study||23
7671087|NCT01994993|18889486|P2|COMPLETED|Overall Study||12
7671088|NCT01994993|18889487|P1|COMPLETED|Overall Study||28
7671089|NCT01994993|18889483|P5|STARTED|Overall Study||24
7671090|NCT01994993|18889484|P4|STARTED|Overall Study||55
7671091|NCT01994993|18889485|P3|STARTED|Overall Study||70
7671092|NCT01994993|18889486|P2|STARTED|Overall Study||47
7671093|NCT01994993|18889487|P1|STARTED|Overall Study||63
7671094|NCT01994954|18889541|P2|NOT COMPLETED|Overall Study||30
7671095|NCT01994954|18889542|P1|NOT COMPLETED|Overall Study||25
7671096|NCT01994954|18889541|P2|COMPLETED|Overall Study||67
7671097|NCT01994954|18889542|P1|COMPLETED|Overall Study||74
7671098|NCT01994954|18889541|P2|STARTED|Overall Study||97
7671099|NCT01994954|18889542|P1|STARTED|Overall Study||99
7671100|NCT01994902|18889560|P2|NOT COMPLETED|Test Period 2||6
7671101|NCT01994902|18889561|P1|NOT COMPLETED|Test Period 2||0
7671102|NCT01994902|18889560|P2|COMPLETED|Test Period 2||55
7671103|NCT01994902|18889561|P1|COMPLETED|Test Period 2||57
7671104|NCT01994902|18889560|P2|STARTED|Test Period 2||61
7671105|NCT01994902|18889561|P1|STARTED|Test Period 2||57
7671106|NCT01994902|18889560|P2|NOT COMPLETED|Test Period 1||3
7671107|NCT01994902|18889561|P1|NOT COMPLETED|Test Period 1||6
7671108|NCT01994902|18889560|P2|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61
7671109|NCT01994902|18889561|P1|COMPLETED|Test Period 1||57
7671110|NCT01994902|18889560|P2|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64
7671111|NCT01994902|18889561|P1|STARTED|Test Period 1||63
7671112|NCT01994889|18889570|P3|NOT COMPLETED|Overall Study||92
7671113|NCT01994889|18889571|P2|NOT COMPLETED|Overall Study||63
7671114|NCT01994889|18889572|P1|NOT COMPLETED|Overall Study||28
7671115|NCT01994889|18889570|P3|COMPLETED|Overall Study||85
7671116|NCT01994889|18889571|P2|COMPLETED|Overall Study||113
7671117|NCT01994889|18889572|P1|COMPLETED|Overall Study||60
7671118|NCT01994889|18889570|P3|STARTED|Overall Study||177
7671119|NCT01994889|18889571|P2|STARTED|Overall Study||176
7671120|NCT01994889|18889572|P1|STARTED|Overall Study||88
7671121|NCT01994876|18889591|P2|NOT COMPLETED|Test Period 2||1
7671122|NCT01994876|18889592|P1|NOT COMPLETED|Test Period 2||1
7671123|NCT01994876|18889591|P2|COMPLETED|Test Period 2||6
7671124|NCT01994876|18889592|P1|COMPLETED|Test Period 2||8
7671125|NCT01994876|18889591|P2|STARTED|Test Period 2||7
7671126|NCT01994876|18889592|P1|STARTED|Test Period 2||9
7671127|NCT01994876|18889591|P2|NOT COMPLETED|Test Period 1||2
7671128|NCT01994876|18889592|P1|NOT COMPLETED|Test Period 1||0
7671129|NCT01994876|18889591|P2|COMPLETED|Test Period 1||7
7671130|NCT01994876|18889592|P1|COMPLETED|Test Period 1||9
7671131|NCT01994876|18889591|P2|STARTED|Test Period 1||9
7671132|NCT01994876|18889592|P1|STARTED|Test Period 1||9
7671133|NCT01994876|18889591|P2|NOT COMPLETED|Baseline - Own Product||0
7671134|NCT01994876|18889592|P1|NOT COMPLETED|Baseline - Own Product||0
7671135|NCT01994876|18889591|P2|COMPLETED|Baseline - Own Product||9
7671136|NCT01994876|18889592|P1|COMPLETED|Baseline - Own Product||9
7671137|NCT01994876|18889591|P2|STARTED|Baseline - Own Product||9
7671138|NCT01994876|18889592|P1|STARTED|Baseline - Own Product||9
7671139|NCT01994863|18889600|P2|NOT COMPLETED|Period 2||4
7671140|NCT01994863|18889601|P1|NOT COMPLETED|Period 2||1
7671141|NCT01994863|18889600|P2|COMPLETED|Period 2||5
7671142|NCT01994863|18889601|P1|COMPLETED|Period 2||7
7671143|NCT01994863|18889600|P2|STARTED|Period 2||9
7671144|NCT01994863|18889601|P1|STARTED|Period 2||8
7671145|NCT01994863|18889600|P2|NOT COMPLETED|Period 1||3
7671146|NCT01994863|18889601|P1|NOT COMPLETED|Period 1||7
7671147|NCT01994863|18889600|P2|COMPLETED|Period 1||9
7671148|NCT01994863|18889601|P1|COMPLETED|Period 1||4
7671149|NCT01994863|18889600|P2|STARTED|Period 1||12
7671150|NCT01994863|18889601|P1|STARTED|Period 1||11
7671151|NCT01994850|18889607|P1|NOT COMPLETED|Overall Study||2
7671152|NCT01994850|18889607|P1|COMPLETED|Overall Study||30
7671153|NCT01994850|18889607|P1|STARTED|Overall Study||32
7671154|NCT01994837|18889612|P1|NOT COMPLETED|Overall Study||32
7671155|NCT01994837|18889612|P1|COMPLETED|Overall Study||0
7671156|NCT01994837|18889612|P1|Treated|Overall Study||32
7671157|NCT01994837|18889612|P1|STARTED|Overall Study||32
7671158|NCT01994785|18889629|P4|NOT COMPLETED|Overall Study||3
7671159|NCT01994785|18889630|P3|NOT COMPLETED|Overall Study||0
7671160|NCT01994785|18889631|P2|NOT COMPLETED|Overall Study||1
7671161|NCT01994785|18889632|P1|NOT COMPLETED|Overall Study||8
7671162|NCT01994785|18889629|P4|COMPLETED|Overall Study||114
7671163|NCT01994785|18889630|P3|COMPLETED|Overall Study||117
7671164|NCT01994785|18889631|P2|COMPLETED|Overall Study||108
7671165|NCT01994785|18889632|P1|COMPLETED|Overall Study||101
7671166|NCT01994785|18889629|P4|STARTED|Overall Study||117
7671167|NCT01994785|18889630|P3|STARTED|Overall Study||117
7671168|NCT01994785|18889631|P2|STARTED|Overall Study||109
7671169|NCT01994785|18889632|P1|STARTED|Overall Study||109
7671170|NCT01994746|18889642|P2|NOT COMPLETED|Second Visit||0
7671171|NCT01994746|18889643|P1|NOT COMPLETED|Second Visit||0
7671172|NCT01994746|18889642|P2|COMPLETED|Second Visit||38
7671173|NCT01994746|18889643|P1|COMPLETED|Second Visit||38
7671174|NCT01994746|18889642|P2|Completed Both Dosing Visits|Second Visit||38
7671175|NCT01994746|18889643|P1|Completed Both Dosing Visits|Second Visit||38
7671176|NCT01994746|18889642|P2|STARTED|Second Visit||38
7671177|NCT01994746|18889643|P1|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38
7671178|NCT01994746|18889642|P2|NOT COMPLETED|First Visit||0
7671179|NCT01994746|18889643|P1|NOT COMPLETED|First Visit||0
7671180|NCT01994746|18889642|P2|COMPLETED|First Visit||38
7671181|NCT01994746|18889643|P1|COMPLETED|First Visit||39
7671182|NCT01994746|18889642|P2|Received At Least 1 Dose|First Visit||38
7671183|NCT01994746|18889643|P1|Received At Least 1 Dose|First Visit||39
7671184|NCT01994746|18889642|P2|STARTED|First Visit||38
7671185|NCT01994746|18889643|P1|STARTED|First Visit||39
7671186|NCT01994720|18889669|P2|NOT COMPLETED|Overall Study||56
7671187|NCT01994720|18889670|P1|NOT COMPLETED|Overall Study||46
7671188|NCT01994720|18889669|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6554
7671189|NCT01994720|18889670|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6543
7671190|NCT01994720|18889669|P2|STARTED|Overall Study||6610
7671191|NCT01994720|18889670|P1|STARTED|Overall Study||6589
7671192|NCT01994629|18889712|P2|NOT COMPLETED|Overall Study||3
7671193|NCT01994629|18889713|P1|NOT COMPLETED|Overall Study||1
7671194|NCT01994629|18889712|P2|COMPLETED|Overall Study||99
7671195|NCT01994629|18889713|P1|COMPLETED|Overall Study||99
7671196|NCT01994629|18889712|P2|STARTED|Overall Study||102
7671197|NCT01994629|18889713|P1|STARTED|Overall Study||100
7671198|NCT01994590|18889737|P1|NOT COMPLETED|Overall Study||2
7671199|NCT01994590|18889737|P1|COMPLETED|Overall Study||2
7671200|NCT01994590|18889737|P1|STARTED|Overall Study||4
7671201|NCT01994538|18889743|P2|NOT COMPLETED|Overall Study||0
7671202|NCT01994538|18889744|P1|NOT COMPLETED|Overall Study||0
7671203|NCT01994538|18889743|P2|COMPLETED|Overall Study||136
7671204|NCT01994538|18889744|P1|COMPLETED|Overall Study||136
7671205|NCT01994538|18889743|P2|STARTED|Overall Study||136
7671206|NCT01994538|18889744|P1|STARTED|Overall Study||136
7671207|NCT01994486|18889754|P1|NOT COMPLETED|Overall Study||0
7671208|NCT01994486|18889754|P1|COMPLETED|Overall Study||20
7671209|NCT01994486|18889754|P1|STARTED|Overall Study||20
7671210|NCT01994395|18889765|P2|NOT COMPLETED|Overall Study||2
7671211|NCT01994395|18889766|P1|NOT COMPLETED|Overall Study||1
7671212|NCT01994395|18889765|P2|COMPLETED|Overall Study||25
7671213|NCT01994395|18889766|P1|COMPLETED|Overall Study||25
7671214|NCT01994395|18889765|P2|STARTED|Overall Study||27
7671215|NCT01994395|18889766|P1|STARTED|Overall Study||26
7671216|NCT01994291|18889791|P3|NOT COMPLETED|Overall Study||9
7671217|NCT01994291|18889792|P2|NOT COMPLETED|Overall Study||7
7671218|NCT01994291|18889793|P1|NOT COMPLETED|Overall Study||15
7671219|NCT01994291|18889791|P3|COMPLETED|Overall Study||47
7671220|NCT01994291|18889792|P2|COMPLETED|Overall Study||36
7671221|NCT01994291|18889793|P1|COMPLETED|Overall Study||84
7671222|NCT01994291|18889791|P3|Received Treatment|Overall Study||56
7671223|NCT01994291|18889792|P2|Received Treatment|Overall Study||43
7671224|NCT01994291|18889793|P1|Received Treatment|Overall Study||99
7671225|NCT01994291|18889791|P3|STARTED|Overall Study||56
7671226|NCT01994291|18889792|P2|STARTED|Overall Study||43
7671227|NCT01994291|18889793|P1|STARTED|Overall Study||99
7671228|NCT01994226|18889849|P2|NOT COMPLETED|Overall Study||21
7671229|NCT01994226|18889850|P1|NOT COMPLETED|Overall Study||19
7671230|NCT01994226|18889849|P2|COMPLETED|Overall Study||179
7671231|NCT01994226|18889850|P1|COMPLETED|Overall Study||180
7671232|NCT01994226|18889849|P2|STARTED|Overall Study||200
7671233|NCT01994226|18889850|P1|STARTED|Overall Study||199
7671234|NCT01994109|18889859|P4|NOT COMPLETED|Open-label Phase (Part B)||42
7671235|NCT01994109|18889860|P3|NOT COMPLETED|Open-label Phase (Part B)||0
7671236|NCT01994109|18889861|P2|NOT COMPLETED|Open-label Phase (Part B)||0
7671237|NCT01994109|18889862|P1|NOT COMPLETED|Open-label Phase (Part B)||0
7671238|NCT01994109|18889859|P4|COMPLETED|Open-label Phase (Part B)||128
7671239|NCT01994109|18889860|P3|COMPLETED|Open-label Phase (Part B)|No placebo group in Part B.|0
7671240|NCT01994109|18889861|P2|COMPLETED|Open-label Phase (Part B)||0
7671241|NCT01994109|18889862|P1|COMPLETED|Open-label Phase (Part B)||0
7671242|NCT01994109|18889859|P4|STARTED|Open-label Phase (Part B)|61 from 2500 U group, 57 from 3500 U group, 52 from Placebo group continued to Part B|170
7671243|NCT01994109|18889860|P3|STARTED|Open-label Phase (Part B)|No placebo group in Part B.|0
7671244|NCT01994109|18889861|P2|STARTED|Open-label Phase (Part B)||0
7671245|NCT01994109|18889862|P1|STARTED|Open-label Phase (Part B)||0
7671246|NCT01994109|18889859|P4|NOT COMPLETED|Double-blind Phase (Part A)||0
7671247|NCT01994109|18889860|P3|NOT COMPLETED|Double-blind Phase (Part A)||7
7671248|NCT01994109|18889861|P2|NOT COMPLETED|Double-blind Phase (Part A)||3
7671249|NCT01994109|18889862|P1|NOT COMPLETED|Double-blind Phase (Part A)||1
7671250|NCT01994109|18889859|P4|COMPLETED|Double-blind Phase (Part A)||0
7671251|NCT01994109|18889860|P3|COMPLETED|Double-blind Phase (Part A)||53
7671252|NCT01994109|18889861|P2|COMPLETED|Double-blind Phase (Part A)||61
7671253|NCT01994109|18889862|P1|COMPLETED|Double-blind Phase (Part A)||62
7671254|NCT01994109|18889859|P4|STARTED|Double-blind Phase (Part A)||0
7671255|NCT01994109|18889860|P3|STARTED|Double-blind Phase (Part A)||60
7671256|NCT01994109|18889861|P2|STARTED|Double-blind Phase (Part A)||64
7671257|NCT01994109|18889862|P1|STARTED|Double-blind Phase (Part A)||63
7671258|NCT01993940|18889876|P2|NOT COMPLETED|Overall Study||44
7671259|NCT01993940|18889877|P1|NOT COMPLETED|Overall Study||40
7671260|NCT01993940|18889876|P2|COMPLETED|Overall Study||232
7671261|NCT01993940|18889877|P1|COMPLETED|Overall Study||237
7671262|NCT01993940|18889876|P2|Received Treatment|Overall Study||276
7671263|NCT01993940|18889877|P1|Received Treatment|Overall Study||272
7671264|NCT01993940|18889876|P2|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|276
7671265|NCT01993940|18889877|P1|STARTED|Overall Study|Includes one participant who enrolled at two different sites|277
7671266|NCT01993927|18889891|P1|NOT COMPLETED|Overall Study||29
7671267|NCT01993927|18889891|P1|COMPLETED|Overall Study||713
7671268|NCT01993927|18889891|P1|STARTED|Overall Study||742
7671269|NCT01993888|18889899|P2|NOT COMPLETED|Overall Study||3
7671270|NCT01993888|18889900|P1|NOT COMPLETED|Overall Study||2
7671271|NCT01993888|18889899|P2|COMPLETED|Overall Study||49
7671272|NCT01993888|18889900|P1|COMPLETED|Overall Study||48
7671273|NCT01993888|18889899|P2|STARTED|Overall Study||52
7671274|NCT01993888|18889900|P1|STARTED|Overall Study||50
7671275|NCT01993875|18889918|P2|NOT COMPLETED|Overall Study||6
7671276|NCT01993875|18889919|P1|NOT COMPLETED|Overall Study||7
7671277|NCT01993875|18889918|P2|COMPLETED|Overall Study||76
7671278|NCT01993875|18889919|P1|COMPLETED|Overall Study||75
7671279|NCT01993875|18889918|P2|STARTED|Overall Study||82
7671280|NCT01993875|18889919|P1|STARTED|Overall Study||82
7671281|NCT01993849|18889937|P2|NOT COMPLETED|Overall Study||2
7671282|NCT01993849|18889938|P1|NOT COMPLETED|Overall Study||3
7671283|NCT01993849|18889937|P2|COMPLETED|Overall Study||9
7671284|NCT01993849|18889938|P1|COMPLETED|Overall Study||9
7671285|NCT01993849|18889937|P2|STARTED|Overall Study||11
7671286|NCT01993849|18889938|P1|STARTED|Overall Study||12
7671287|NCT01993836|18889949|P3|NOT COMPLETED|Overall Study||5
7671288|NCT01993836|18889950|P2|NOT COMPLETED|Overall Study||13
7671289|NCT01993836|18889951|P1|NOT COMPLETED|Overall Study||17
7671290|NCT01993836|18889949|P3|COMPLETED|Overall Study||46
7671291|NCT01993836|18889950|P2|COMPLETED|Overall Study||55
7671292|NCT01993836|18889951|P1|COMPLETED|Overall Study||55
7671293|NCT01993836|18889949|P3|STARTED|Overall Study||51
7671294|NCT01993836|18889950|P2|STARTED|Overall Study||68
7671295|NCT01993836|18889951|P1|STARTED|Overall Study|This represents the number of enrolled patients who completed baseline cognitive testing|72
7671296|NCT01993823|18889967|P2|NOT COMPLETED|Overall Study||16
7671297|NCT01993823|18889968|P1|NOT COMPLETED|Overall Study||7
7671298|NCT01993823|18889967|P2|COMPLETED|Overall Study||79
7671299|NCT01993823|18889968|P1|COMPLETED|Overall Study||88
7671300|NCT01993823|18889967|P2|STARTED|Overall Study||95
7671301|NCT01993823|18889968|P1|STARTED|Overall Study||95
7671302|NCT01993667|18889978|P2|NOT COMPLETED|Overall Study||19
7671303|NCT01993667|18889979|P1|NOT COMPLETED|Overall Study||21
7671304|NCT01993667|18889978|P2|COMPLETED|Overall Study||47
7671305|NCT01993667|18889979|P1|COMPLETED|Overall Study||43
7671306|NCT01993667|18889978|P2|STARTED|Overall Study||66
7671307|NCT01993667|18889979|P1|STARTED|Overall Study||64
7671308|NCT01993615|18889989|P2|NOT COMPLETED|Overall Study||0
7671309|NCT01993615|18889990|P1|NOT COMPLETED|Overall Study||1
7671310|NCT01993615|18889989|P2|COMPLETED|Overall Study||40
7671311|NCT01993615|18889990|P1|COMPLETED|Overall Study||39
7671312|NCT01993615|18889989|P2|STARTED|Overall Study||40
7671313|NCT01993615|18889990|P1|STARTED|Overall Study||40
7671314|NCT01993238|18890002|P1|NOT COMPLETED|Overall Study||0
7671315|NCT01993238|18890002|P1|COMPLETED|Overall Study||11
7671316|NCT01993238|18890002|P1|STARTED|Overall Study||11
7671317|NCT01993186|18890009|P2|NOT COMPLETED|Open-Label Extension Period||6
7671318|NCT01993186|18890010|P1|NOT COMPLETED|Open-Label Extension Period||7
7671319|NCT01993186|18890009|P2|COMPLETED|Open-Label Extension Period||5
7671320|NCT01993186|18890010|P1|COMPLETED|Open-Label Extension Period||16
7671321|NCT01993186|18890009|P2|STARTED|Open-Label Extension Period||11
7671322|NCT01993186|18890010|P1|STARTED|Open-Label Extension Period||23
7671323|NCT01993186|18890009|P2|NOT COMPLETED|Double-Blind Placebo-Controlled Period||0
7671324|NCT01993186|18890010|P1|NOT COMPLETED|Double-Blind Placebo-Controlled Period||2
7671325|NCT01993186|18890009|P2|COMPLETED|Double-Blind Placebo-Controlled Period||11
7671326|NCT01993186|18890010|P1|COMPLETED|Double-Blind Placebo-Controlled Period||23
7671327|NCT01993186|18890009|P2|STARTED|Double-Blind Placebo-Controlled Period||11
7671328|NCT01993186|18890010|P1|STARTED|Double-Blind Placebo-Controlled Period||25
7671329|NCT01993108|18890055|P2|NOT COMPLETED|Overall Study||0
7671330|NCT01993108|18890056|P1|NOT COMPLETED|Overall Study||0
7671331|NCT01993108|18890055|P2|COMPLETED|Overall Study||12
7671332|NCT01993108|18890056|P1|COMPLETED|Overall Study||11
7671333|NCT01993108|18890055|P2|STARTED|Overall Study||12
7671334|NCT01993108|18890056|P1|STARTED|Overall Study||11
7671335|NCT01993030|18890087|P2|NOT COMPLETED|Overall Study||4
7671336|NCT01993030|18890088|P1|NOT COMPLETED|Overall Study||0
7671337|NCT01993030|18890087|P2|COMPLETED|Overall Study||31
7671338|NCT01993030|18890088|P1|COMPLETED|Overall Study||36
7671339|NCT01993030|18890087|P2|STARTED|Overall Study||35
7671340|NCT01993030|18890088|P1|STARTED|Overall Study||36
7671341|NCT01993017|18890105|P3|NOT COMPLETED|Overall Study||79
7671342|NCT01993017|18890106|P2|NOT COMPLETED|Overall Study||90
7671343|NCT01993017|18890107|P1|NOT COMPLETED|Overall Study||106
7671344|NCT01993017|18890105|P3|COMPLETED|Overall Study||421
7671345|NCT01993017|18890106|P2|COMPLETED|Overall Study||411
7671346|NCT01993017|18890107|P1|COMPLETED|Overall Study||393
7671347|NCT01993017|18890105|P3|STARTED|Overall Study||500
7671348|NCT01993017|18890106|P2|STARTED|Overall Study||501
7671349|NCT01993017|18890107|P1|STARTED|Overall Study||499
7671350|NCT01992874|18890118|P3|NOT COMPLETED|Part B||0
7671351|NCT01992874|18890119|P2|NOT COMPLETED|Part B||0
7671352|NCT01992874|18890120|P1|NOT COMPLETED|Part B||0
7671353|NCT01992874|18890118|P3|COMPLETED|Part B||38
7671354|NCT01992874|18890119|P2|COMPLETED|Part B||0
7671355|NCT01992874|18890120|P1|COMPLETED|Part B||0
7671356|NCT01992874|18890118|P3|STARTED|Part B||38
7671357|NCT01992874|18890119|P2|STARTED|Part B||0
7671358|NCT01992874|18890120|P1|STARTED|Part B||0
7671359|NCT01992874|18890118|P3|NOT COMPLETED|Part A||0
7671360|NCT01992874|18890119|P2|NOT COMPLETED|Part A||0
7671361|NCT01992874|18890120|P1|NOT COMPLETED|Part A||0
7671362|NCT01992874|18890118|P3|COMPLETED|Part A||0
7671363|NCT01992874|18890119|P2|COMPLETED|Part A||17
7671364|NCT01992874|18890120|P1|COMPLETED|Part A||21
7671365|NCT01992874|18890118|P3|STARTED|Part A||0
7671366|NCT01992874|18890119|P2|STARTED|Part A||17
7671367|NCT01992874|18890120|P1|STARTED|Part A||21
7671368|NCT01992757|18890148|P1|NOT COMPLETED|Overall Study||2
7671369|NCT01992757|18890148|P1|COMPLETED|Overall Study||49
7671370|NCT01992757|18890148|P1|STARTED|Overall Study||51
7671371|NCT01992653|18890161|P8|NOT COMPLETED|Overall Study||4
7671372|NCT01992653|18890162|P7|NOT COMPLETED|Overall Study||8
7671373|NCT01992653|18890163|P6|NOT COMPLETED|Overall Study||0
7671374|NCT01992653|18890164|P5|NOT COMPLETED|Overall Study||1
7671375|NCT01992653|18890165|P4|NOT COMPLETED|Overall Study||0
7671376|NCT01992653|18890166|P3|NOT COMPLETED|Overall Study||1
7671377|NCT01992653|18890167|P2|NOT COMPLETED|Overall Study||0
7671378|NCT01992653|18890168|P1|NOT COMPLETED|Overall Study||0
7671379|NCT01992653|18890161|P8|COMPLETED|Overall Study||13
7671380|NCT01992653|18890162|P7|COMPLETED|Overall Study||32
7671381|NCT01992653|18890163|P6|COMPLETED|Overall Study||6
7671382|NCT01992653|18890164|P5|COMPLETED|Overall Study||5
7671383|NCT01992653|18890165|P4|COMPLETED|Overall Study||1
7671384|NCT01992653|18890166|P3|COMPLETED|Overall Study||5
7671385|NCT01992653|18890167|P2|COMPLETED|Overall Study||3
7671386|NCT01992653|18890168|P1|COMPLETED|Overall Study||3
7671387|NCT01992653|18890161|P8|STARTED|Overall Study||17
7671388|NCT01992653|18890162|P7|STARTED|Overall Study||40
7671389|NCT01992653|18890163|P6|STARTED|Overall Study||6
7671390|NCT01992653|18890164|P5|STARTED|Overall Study||6
7671391|NCT01992653|18890165|P4|STARTED|Overall Study||1
7671392|NCT01992653|18890166|P3|STARTED|Overall Study||6
7671393|NCT01992653|18890167|P2|STARTED|Overall Study||3
7671394|NCT01992653|18890168|P1|STARTED|Overall Study||3
7671395|NCT01992549|18890394|P1|NOT COMPLETED|Overall Study||4
7671396|NCT01992549|18890394|P1|COMPLETED|Overall Study||44
7671397|NCT01992549|18890394|P1|SURG Population|Overall Study||3
7671398|NCT01992549|18890394|P1|BLEED Population|Overall Study||29
7671399|NCT01992549|18890394|P1|PROPH Population|Overall Study||47
7671400|NCT01992549|18890394|P1|ITT Population|Overall Study||47
7671401|NCT01992549|18890394|P1|SAF Population|Overall Study||48
7671402|NCT01992549|18890394|P1|STARTED|Overall Study||48
7671403|NCT01992536|18890414|P10|NOT COMPLETED|Overall Study||1
7671404|NCT01992536|18890415|P9|NOT COMPLETED|Overall Study||1
7671405|NCT01992536|18890416|P8|NOT COMPLETED|Overall Study||0
7671406|NCT01992536|18890417|P7|NOT COMPLETED|Overall Study||7
7671407|NCT01992536|18890418|P6|NOT COMPLETED|Overall Study||1
7671408|NCT01992536|18890419|P5|NOT COMPLETED|Overall Study||0
7671409|NCT01992536|18890420|P4|NOT COMPLETED|Overall Study||2
7671410|NCT01992536|18890421|P3|NOT COMPLETED|Overall Study||1
7671411|NCT01992536|18890422|P2|NOT COMPLETED|Overall Study||3
7671412|NCT01992536|18890423|P1|NOT COMPLETED|Overall Study||4
7671413|NCT01992536|18890414|P10|COMPLETED|Overall Study||18
7671414|NCT01992536|18890415|P9|COMPLETED|Overall Study||18
7671415|NCT01992536|18890416|P8|COMPLETED|Overall Study||21
7671416|NCT01992536|18890417|P7|COMPLETED|Overall Study||0
7671417|NCT01992536|18890418|P6|COMPLETED|Overall Study||20
7671418|NCT01992536|18890419|P5|COMPLETED|Overall Study||11
7671419|NCT01992536|18890420|P4|COMPLETED|Overall Study||22
7671420|NCT01992536|18890421|P3|COMPLETED|Overall Study||16
7671421|NCT01992536|18890422|P2|COMPLETED|Overall Study||22
7671422|NCT01992536|18890423|P1|COMPLETED|Overall Study||22
7671423|NCT01992536|18890414|P10|STARTED|Overall Study||19
7671424|NCT01992536|18890415|P9|STARTED|Overall Study||19
7671425|NCT01992536|18890416|P8|STARTED|Overall Study||21
7671426|NCT01992536|18890417|P7|STARTED|Overall Study||7
7671427|NCT01992536|18890418|P6|STARTED|Overall Study||21
7671428|NCT01992536|18890419|P5|STARTED|Overall Study||11
7671429|NCT01992536|18890420|P4|STARTED|Overall Study||24
7671430|NCT01992536|18890421|P3|STARTED|Overall Study||17
7671431|NCT01992536|18890422|P2|STARTED|Overall Study||25
7671432|NCT01992536|18890423|P1|STARTED|Overall Study||26
7671433|NCT01992523|18890640|P2|NOT COMPLETED|Overall Study||0
7671434|NCT01992523|18890641|P1|NOT COMPLETED|Overall Study||0
7671435|NCT01992523|18890640|P2|COMPLETED|Overall Study||41
7671436|NCT01992523|18890641|P1|COMPLETED|Overall Study||41
7671437|NCT01992523|18890640|P2|STARTED|Overall Study||41
7671438|NCT01992523|18890641|P1|STARTED|Overall Study||41
7671439|NCT01992380|18890656|P3|NOT COMPLETED|Overall Study||0
7671440|NCT01992380|18890657|P2|NOT COMPLETED|Overall Study||0
7671441|NCT01992380|18890658|P1|NOT COMPLETED|Overall Study||0
7671442|NCT01992380|18890656|P3|COMPLETED|Overall Study||10
7671443|NCT01992380|18890657|P2|COMPLETED|Overall Study||8
7671444|NCT01992380|18890658|P1|COMPLETED|Overall Study||6
7671445|NCT01992380|18890656|P3|STARTED|Overall Study||10
7671446|NCT01992380|18890657|P2|STARTED|Overall Study||8
7671447|NCT01992380|18890658|P1|STARTED|Overall Study||6
7671448|NCT01992354|18890665|P1|NOT COMPLETED|Overall Study||0
7671449|NCT01992354|18890665|P1|COMPLETED|Overall Study||4
7671450|NCT01992354|18890665|P1|STARTED|Overall Study||4
7671451|NCT01992185|18890672|P2|NOT COMPLETED|Overall Study||0
7671452|NCT01992185|18890673|P1|NOT COMPLETED|Overall Study||0
7671453|NCT01992185|18890672|P2|COMPLETED|Overall Study||8
7671454|NCT01992185|18890673|P1|COMPLETED|Overall Study||7
7671455|NCT01992185|18890672|P2|STARTED|Overall Study||8
7671456|NCT01992185|18890673|P1|STARTED|Overall Study||7
7671457|NCT01992172|18890681|P2|NOT COMPLETED|Overall Study||0
7671458|NCT01992172|18890682|P1|NOT COMPLETED|Overall Study||0
7671459|NCT01992172|18890681|P2|COMPLETED|Overall Study||0
7671460|NCT01992172|18890682|P1|COMPLETED|Overall Study||7
7671461|NCT01992172|18890681|P2|STARTED|Overall Study||0
7671462|NCT01992172|18890682|P1|STARTED|Overall Study||7
7671463|NCT01992159|18890692|P4|NOT COMPLETED|Overall Study||4
7671464|NCT01992159|18890693|P3|NOT COMPLETED|Overall Study||1
7671465|NCT01992159|18890694|P2|NOT COMPLETED|Overall Study||8
7671466|NCT01992159|18890695|P1|NOT COMPLETED|Overall Study||4
7671467|NCT01992159|18890692|P4|COMPLETED|Overall Study||59
7671468|NCT01992159|18890693|P3|COMPLETED|Overall Study||62
7671469|NCT01992159|18890694|P2|COMPLETED|Overall Study||55
7671470|NCT01992159|18890695|P1|COMPLETED|Overall Study||59
7671471|NCT01992159|18890692|P4|Completed First 12 Months of Study|Overall Study||59
7671472|NCT01992159|18890693|P3|Completed First 12 Months of Study|Overall Study||63
7671473|NCT01992159|18890694|P2|Completed First 12 Months of Study|Overall Study||56
7671474|NCT01992159|18890695|P1|Completed First 12 Months of Study|Overall Study||59
7671475|NCT01992159|18890692|P4|Received Treatment|Overall Study||63
7671476|NCT01992159|18890693|P3|Received Treatment|Overall Study||63
7671477|NCT01992159|18890694|P2|Received Treatment|Overall Study||63
7671478|NCT01992159|18890695|P1|Received Treatment|Overall Study||63
7671479|NCT01992159|18890692|P4|STARTED|Overall Study||63
7671480|NCT01992159|18890693|P3|STARTED|Overall Study||63
7671481|NCT01992159|18890694|P2|STARTED|Overall Study||63
7671482|NCT01992159|18890695|P1|STARTED|Overall Study||63
7671483|NCT01992107|18890748|P3|NOT COMPLETED|Overall Study||36
7671484|NCT01992107|18890749|P2|NOT COMPLETED|Overall Study||33
7671485|NCT01992107|18890750|P1|NOT COMPLETED|Overall Study||68
7671486|NCT01992107|18890748|P3|COMPLETED|Overall Study||545
7671487|NCT01992107|18890749|P2|COMPLETED|Overall Study||560
7671488|NCT01992107|18890750|P1|COMPLETED|Overall Study||1091
7671489|NCT01992107|18890748|P3|STARTED|Overall Study||581
7671490|NCT01992107|18890749|P2|STARTED|Overall Study||593
7671491|NCT01992107|18890750|P1|STARTED|Overall Study||1159
7671492|NCT01992094|18890806|P3|NOT COMPLETED|Overall Study||21
7671493|NCT01992094|18890807|P2|NOT COMPLETED|Overall Study||24
7671494|NCT01992094|18890808|P1|NOT COMPLETED|Overall Study||50
7671495|NCT01992094|18890806|P3|COMPLETED|Overall Study||648
7671496|NCT01992094|18890807|P2|COMPLETED|Overall Study||652
7671497|NCT01992094|18890808|P1|COMPLETED|Overall Study||1285
7671498|NCT01992094|18890806|P3|STARTED|Overall Study||669
7671499|NCT01992094|18890807|P2|STARTED|Overall Study||676
7671500|NCT01992094|18890808|P1|STARTED|Overall Study||1335
7671501|NCT01992016|18890866|P2|NOT COMPLETED|Overall Study||0
7671502|NCT01992016|18890867|P1|NOT COMPLETED|Overall Study||0
7671503|NCT01992016|18890866|P2|COMPLETED|Overall Study||7
7671504|NCT01992016|18890867|P1|COMPLETED|Overall Study||4
7671505|NCT01992016|18890866|P2|STARTED|Overall Study||7
7671506|NCT01992016|18890867|P1|STARTED|Overall Study||4
7671507|NCT01991990|18890875|P2|NOT COMPLETED|Overall Study||0
7671508|NCT01991990|18890876|P1|NOT COMPLETED|Overall Study||0
7671509|NCT01991990|18890875|P2|COMPLETED|Overall Study||12
7671510|NCT01991990|18890876|P1|COMPLETED|Overall Study||6
7671511|NCT01991990|18890875|P2|STARTED|Overall Study||12
7671512|NCT01991990|18890876|P1|STARTED|Overall Study||6
7671513|NCT01991977|18890916|P1|NOT COMPLETED|Overall Study||12
7671514|NCT01991977|18890916|P1|COMPLETED|Overall Study||79
7671515|NCT01991977|18890916|P1|Evaluable for the Primary Outcome|Overall Study||39
7671516|NCT01991977|18890916|P1|Received IMRT Treatment|Overall Study||79
7671517|NCT01991977|18890916|P1|Received PET Tracer|Overall Study||84
7671518|NCT01991977|18890916|P1|STARTED|Overall Study||91
7671519|NCT01991860|18890922|P2|NOT COMPLETED|Overall Study||2
7671520|NCT01991860|18890923|P1|NOT COMPLETED|Overall Study||4
7671521|NCT01991860|18890922|P2|COMPLETED|Overall Study||164
7671522|NCT01991860|18890923|P1|COMPLETED|Overall Study||172
7671523|NCT01991860|18890922|P2|STARTED|Overall Study||166
7671524|NCT01991860|18890923|P1|STARTED|Overall Study||176
7671525|NCT01991821|18890943|P2|NOT COMPLETED|Overall Study||167
7671526|NCT01991821|18890944|P1|NOT COMPLETED|Overall Study||163
7671527|NCT01991821|18890943|P2|COMPLETED|Overall Study||11
7671528|NCT01991821|18890944|P1|COMPLETED|Overall Study||6
7671529|NCT01991821|18890943|P2|STARTED|Overall Study||178
7671530|NCT01991821|18890944|P1|STARTED|Overall Study||169
7671531|NCT01991808|18890962|P1|NOT COMPLETED|Overall Study||0
7671532|NCT01991808|18890962|P1|COMPLETED|Overall Study||16
7671533|NCT01991808|18890962|P1|STARTED|Overall Study||16
7671534|NCT01991795|18890968|P2|NOT COMPLETED|Overall Study||123
7671535|NCT01991795|18890969|P1|NOT COMPLETED|Overall Study||149
7671536|NCT01991795|18890968|P2|COMPLETED|Overall Study||9503
7671537|NCT01991795|18890969|P1|COMPLETED|Overall Study||9496
7671538|NCT01991795|18890968|P2|STARTED|Overall Study||9626
7671539|NCT01991795|18890969|P1|STARTED|Overall Study||9645
7671540|NCT01991743|18890995|P4|NOT COMPLETED|Overall Study||0
7671541|NCT01991743|18890996|P3|NOT COMPLETED|Overall Study||1
7671542|NCT01991743|18890997|P2|NOT COMPLETED|Overall Study||0
7671543|NCT01991743|18890998|P1|NOT COMPLETED|Overall Study||0
7671544|NCT01991743|18890995|P4|COMPLETED|Overall Study||60
7671545|NCT01991743|18890996|P3|COMPLETED|Overall Study||59
7671546|NCT01991743|18890997|P2|COMPLETED|Overall Study||60
7671547|NCT01991743|18890998|P1|COMPLETED|Overall Study||60
7671548|NCT01991743|18890995|P4|STARTED|Overall Study||60
7671549|NCT01991743|18890996|P3|STARTED|Overall Study||60
7671550|NCT01991743|18890997|P2|STARTED|Overall Study||60
7671551|NCT01991743|18890998|P1|STARTED|Overall Study||60
7671552|NCT01991548|18891024|P1|NOT COMPLETED|Overall Study||1
7671553|NCT01991548|18891024|P1|COMPLETED|Overall Study||39
7671554|NCT01991548|18891024|P1|STARTED|Overall Study||40
7671555|NCT01991522|18891030|P2|NOT COMPLETED|Overall Study||0
7671556|NCT01991522|18891031|P1|NOT COMPLETED|Overall Study||0
7671557|NCT01991522|18891030|P2|COMPLETED|Overall Study||17
7671558|NCT01991522|18891031|P1|COMPLETED|Overall Study||16
7671559|NCT01991522|18891030|P2|STARTED|Overall Study||17
7671560|NCT01991522|18891031|P1|STARTED|Overall Study||16
7671561|NCT01991483|18891043|P4|NOT COMPLETED|Dose Level 1000 mg||1
7671562|NCT01991483|18891044|P3|NOT COMPLETED|Dose Level 1000 mg||0
7671563|NCT01991483|18891045|P2|NOT COMPLETED|Dose Level 1000 mg||0
7671564|NCT01991483|18891046|P1|NOT COMPLETED|Dose Level 1000 mg||0
7671565|NCT01991483|18891043|P4|COMPLETED|Dose Level 1000 mg||3
7671566|NCT01991483|18891044|P3|COMPLETED|Dose Level 1000 mg||0
7671567|NCT01991483|18891045|P2|COMPLETED|Dose Level 1000 mg||0
7671568|NCT01991483|18891046|P1|COMPLETED|Dose Level 1000 mg||0
7671569|NCT01991483|18891043|P4|Received at Least One Dose of Study Drug|Dose Level 1000 mg||4
7671570|NCT01991483|18891044|P3|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
7671571|NCT01991483|18891045|P2|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
7671572|NCT01991483|18891046|P1|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
7671573|NCT01991483|18891043|P4|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|4
7671574|NCT01991483|18891044|P3|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|0
7671575|NCT01991483|18891045|P2|STARTED|Dose Level 1000 mg||0
7671576|NCT01991483|18891046|P1|STARTED|Dose Level 1000 mg||0
7671577|NCT01991483|18891043|P4|NOT COMPLETED|Dose Level 600 mg||0
7671578|NCT01991483|18891044|P3|NOT COMPLETED|Dose Level 600 mg||2
7671579|NCT01991483|18891045|P2|NOT COMPLETED|Dose Level 600 mg||0
7671580|NCT01991483|18891046|P1|NOT COMPLETED|Dose Level 600 mg||0
7671581|NCT01991483|18891043|P4|COMPLETED|Dose Level 600 mg||0
7671582|NCT01991483|18891044|P3|COMPLETED|Dose Level 600 mg||9
7671583|NCT01991483|18891045|P2|COMPLETED|Dose Level 600 mg||0
7671584|NCT01991483|18891046|P1|COMPLETED|Dose Level 600 mg||0
7671585|NCT01991483|18891043|P4|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
7671586|NCT01991483|18891044|P3|Receive at Least One Dose of Study Drug|Dose Level 600 mg||11
7671587|NCT01991483|18891045|P2|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
7671588|NCT01991483|18891046|P1|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
7671589|NCT01991483|18891043|P4|STARTED|Dose Level 600 mg||0
7671590|NCT01991483|18891044|P3|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|11
7671591|NCT01991483|18891045|P2|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|0
7671592|NCT01991483|18891046|P1|STARTED|Dose Level 600 mg||0
7671593|NCT01991483|18891043|P4|NOT COMPLETED|Dose Level 300 mg||0
7671594|NCT01991483|18891044|P3|NOT COMPLETED|Dose Level 300 mg||0
7671595|NCT01991483|18891045|P2|NOT COMPLETED|Dose Level 300 mg||0
7671596|NCT01991483|18891046|P1|NOT COMPLETED|Dose Level 300 mg||0
7671597|NCT01991483|18891043|P4|COMPLETED|Dose Level 300 mg||0
7671598|NCT01991483|18891044|P3|COMPLETED|Dose Level 300 mg||0
7671599|NCT01991483|18891045|P2|COMPLETED|Dose Level 300 mg||6
7671600|NCT01991483|18891046|P1|COMPLETED|Dose Level 300 mg||0
7671601|NCT01991483|18891043|P4|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
7671602|NCT01991483|18891044|P3|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
7671603|NCT01991483|18891045|P2|Received at Least One Dose of Study Drug|Dose Level 300 mg||6
7671604|NCT01991483|18891046|P1|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
7671605|NCT01991483|18891043|P4|STARTED|Dose Level 300 mg||0
7671606|NCT01991483|18891044|P3|STARTED|Dose Level 300 mg||0
7671607|NCT01991483|18891045|P2|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|6
7671608|NCT01991483|18891046|P1|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|0
7671609|NCT01991483|18891043|P4|NOT COMPLETED|Dose Level: Placebo||0
7671610|NCT01991483|18891044|P3|NOT COMPLETED|Dose Level: Placebo||0
7671611|NCT01991483|18891045|P2|NOT COMPLETED|Dose Level: Placebo||0
7671612|NCT01991483|18891046|P1|NOT COMPLETED|Dose Level: Placebo||0
7671613|NCT01991483|18891043|P4|COMPLETED|Dose Level: Placebo||0
7671614|NCT01991483|18891044|P3|COMPLETED|Dose Level: Placebo||0
7671615|NCT01991483|18891045|P2|COMPLETED|Dose Level: Placebo||0
7671616|NCT01991483|18891046|P1|COMPLETED|Dose Level: Placebo||7
7671617|NCT01991483|18891043|P4|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
7671618|NCT01991483|18891044|P3|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
7671619|NCT01991483|18891045|P2|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
7671620|NCT01991483|18891046|P1|Received at Least One Dose of Study Drug|Dose Level: Placebo||7
7671621|NCT01991483|18891043|P4|STARTED|Dose Level: Placebo||0
7671622|NCT01991483|18891044|P3|STARTED|Dose Level: Placebo||0
7671623|NCT01991483|18891045|P2|STARTED|Dose Level: Placebo||0
7671624|NCT01991483|18891046|P1|STARTED|Dose Level: Placebo||7
7671625|NCT01991470|18891112|P1|NOT COMPLETED|Enlite 3 Period||12
7671626|NCT01991470|18891112|P1|COMPLETED|Enlite 3 Period||146
7671627|NCT01991470|18891112|P1|STARTED|Enlite 3 Period|Additional 25 subjects who participated only Enlite 3 phase|158
7671628|NCT01991470|18891112|P1|NOT COMPLETED|Enlite 1 Period||20
7671629|NCT01991470|18891112|P1|COMPLETED|Enlite 1 Period||141
7671630|NCT01991470|18891112|P1|STARTED|Enlite 1 Period||161
7671631|NCT01991314|18891126|P2|NOT COMPLETED|Overall Study||11
7671632|NCT01991314|18891127|P1|NOT COMPLETED|Overall Study||11
7671633|NCT01991314|18891126|P2|COMPLETED|Overall Study||32
7671634|NCT01991314|18891127|P1|COMPLETED|Overall Study||34
7671635|NCT01991314|18891126|P2|STARTED|Overall Study||43
7671636|NCT01991314|18891127|P1|STARTED|Overall Study||45
7671637|NCT01991197|18891147|P2|NOT COMPLETED|Overall Study||3
7671638|NCT01991197|18891148|P1|NOT COMPLETED|Overall Study||3
7671639|NCT01991197|18891147|P2|COMPLETED|Overall Study||8
7671640|NCT01991197|18891148|P1|COMPLETED|Overall Study||6
7671641|NCT01991197|18891147|P2|STARTED|Overall Study||11
7671642|NCT01991197|18891148|P1|STARTED|Overall Study||9
7671643|NCT01991067|18891186|P2|NOT COMPLETED|Overall Study||5
7671644|NCT01991067|18891187|P1|NOT COMPLETED|Overall Study||6
7671645|NCT01991067|18891186|P2|COMPLETED|Overall Study||10
7671646|NCT01991067|18891187|P1|COMPLETED|Overall Study||13
7671647|NCT01991067|18891186|P2|STARTED|Overall Study||15
7671648|NCT01991067|18891187|P1|STARTED|Overall Study||19
7671649|NCT01990898|18891197|P1|NOT COMPLETED|Overall Study||4
7671650|NCT01990898|18891197|P1|COMPLETED|Overall Study||22
7671651|NCT01990898|18891197|P1|3 Months|Overall Study||22
7671652|NCT01990898|18891197|P1|STARTED|Overall Study||26
7671653|NCT01990859|18891201|P1|NOT COMPLETED|90 Day Follow Up for All Participants||0
7671654|NCT01990859|18891201|P1|COMPLETED|90 Day Follow Up for All Participants||20
7671655|NCT01990859|18891201|P1|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20
7671656|NCT01990859|18891201|P1|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17
7671657|NCT01990859|18891201|P1|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3
7671658|NCT01990859|18891201|P1|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20
7671659|NCT01990859|18891201|P1|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5
7671660|NCT01990859|18891201|P1|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15
7671661|NCT01990859|18891201|P1|STARTED|Treatment (4 Doses Over 12 Weeks)||20
7671662|NCT01990820|18891214|P2|NOT COMPLETED|Overall Study||0
7671663|NCT01990820|18891215|P1|NOT COMPLETED|Overall Study||0
7671664|NCT01990820|18891214|P2|COMPLETED|Overall Study||12
7671665|NCT01990820|18891215|P1|COMPLETED|Overall Study||13
7671666|NCT01990820|18891214|P2|STARTED|Overall Study||12
7671667|NCT01990820|18891215|P1|STARTED|Overall Study||13
7671668|NCT01990794|18891221|P1|NOT COMPLETED|Overall Study||3
7671669|NCT01990794|18891221|P1|COMPLETED|Overall Study||10
7671670|NCT01990794|18891221|P1|One Month Into Study|Overall Study||10
7671671|NCT01990794|18891221|P1|STARTED|Overall Study||13
7671672|NCT01990768|18891336|P3|NOT COMPLETED|6-Month Follow-up||58
7671673|NCT01990768|18891337|P2|NOT COMPLETED|6-Month Follow-up||51
7671674|NCT01990768|18891338|P1|NOT COMPLETED|6-Month Follow-up||39
7671675|NCT01990768|18891336|P3|COMPLETED|6-Month Follow-up||288
7671676|NCT01990768|18891337|P2|COMPLETED|6-Month Follow-up||261
7671677|NCT01990768|18891338|P1|COMPLETED|6-Month Follow-up||270
7671678|NCT01990768|18891336|P3|STARTED|6-Month Follow-up||346
7671679|NCT01990768|18891337|P2|STARTED|6-Month Follow-up||312
7671680|NCT01990768|18891338|P1|STARTED|6-Month Follow-up||309
7671681|NCT01990768|18891336|P3|NOT COMPLETED|In-Hospital Study Drug Infusion||80
7671682|NCT01990768|18891337|P2|NOT COMPLETED|In-Hospital Study Drug Infusion||83
7671683|NCT01990768|18891338|P1|NOT COMPLETED|In-Hospital Study Drug Infusion||95
7671684|NCT01990768|18891336|P3|COMPLETED|In-Hospital Study Drug Infusion||266
7671685|NCT01990768|18891337|P2|COMPLETED|In-Hospital Study Drug Infusion||229
7671686|NCT01990768|18891338|P1|COMPLETED|In-Hospital Study Drug Infusion||214
7671687|NCT01990768|18891336|P3|STARTED|In-Hospital Study Drug Infusion||346
7671688|NCT01990768|18891337|P2|STARTED|In-Hospital Study Drug Infusion||312
7671689|NCT01990768|18891338|P1|STARTED|In-Hospital Study Drug Infusion||309
7671690|NCT01990768|18891336|P3|NOT COMPLETED|Prehospital Study Drug Infusion||19
7671691|NCT01990768|18891337|P2|NOT COMPLETED|Prehospital Study Drug Infusion||27
7671692|NCT01990768|18891338|P1|NOT COMPLETED|Prehospital Study Drug Infusion||19
7671693|NCT01990768|18891336|P3|COMPLETED|Prehospital Study Drug Infusion||327
7671694|NCT01990768|18891337|P2|COMPLETED|Prehospital Study Drug Infusion||285
7671695|NCT01990768|18891338|P1|COMPLETED|Prehospital Study Drug Infusion||290
7671696|NCT01990768|18891336|P3|STARTED|Prehospital Study Drug Infusion||346
7671697|NCT01990768|18891337|P2|STARTED|Prehospital Study Drug Infusion||312
7671698|NCT01990768|18891338|P1|STARTED|Prehospital Study Drug Infusion||309
7671699|NCT01990768|18891336|P3|NOT COMPLETED|Intervention Started||27
7671700|NCT01990768|18891337|P2|NOT COMPLETED|Intervention Started||33
7671701|NCT01990768|18891338|P1|NOT COMPLETED|Intervention Started||36
7671702|NCT01990768|18891336|P3|COMPLETED|Intervention Started||346
7671703|NCT01990768|18891337|P2|COMPLETED|Intervention Started||312
7671704|NCT01990768|18891338|P1|COMPLETED|Intervention Started||309
7671705|NCT01990768|18891336|P3|STARTED|Intervention Started||373
7671706|NCT01990768|18891337|P2|STARTED|Intervention Started||345
7671707|NCT01990768|18891338|P1|STARTED|Intervention Started||345
7671708|NCT01990742|18891403|P2|NOT COMPLETED|Overall Study||1353
7671709|NCT01990742|18891404|P1|NOT COMPLETED|Overall Study||407
7671710|NCT01990742|18891403|P2|COMPLETED|Overall Study|Eleven nursing homes completed the control group /usual care allocation.|2978
7671711|NCT01990742|18891404|P1|COMPLETED|Overall Study|Fourteen facilities completed the intervention.|2852
7671712|NCT01990742|18891403|P2|STARTED|Overall Study|This is a facility-level control , access to individual participants occurred only via MDS records.|4331
7671713|NCT01990742|18891404|P1|STARTED|Overall Study|This is a facility-level intervention, access to individual level records occurred via MDS data only|3259
7671714|NCT01990703|18891416|P2|NOT COMPLETED|Overall Study||45
7671715|NCT01990703|18891417|P1|NOT COMPLETED|Overall Study||39
7671716|NCT01990703|18891416|P2|COMPLETED|Overall Study||93
7671717|NCT01990703|18891417|P1|COMPLETED|Overall Study||108
7671718|NCT01990703|18891416|P2|STARTED|Overall Study||138
7671719|NCT01990703|18891417|P1|STARTED|Overall Study||147
7671720|NCT01990677|18891427|P2|NOT COMPLETED|Overall Study||1
7671721|NCT01990677|18891428|P1|NOT COMPLETED|Overall Study||2
7671722|NCT01990677|18891427|P2|COMPLETED|Overall Study||5
7671723|NCT01990677|18891428|P1|COMPLETED|Overall Study||10
7671724|NCT01990677|18891427|P2|STARTED|Overall Study||6
7671725|NCT01990677|18891428|P1|STARTED|Overall Study||12
7671726|NCT01990664|18891440|P2|NOT COMPLETED|Overall Study||11
7671727|NCT01990664|18891441|P1|NOT COMPLETED|Overall Study||7
7671728|NCT01990664|18891440|P2|COMPLETED|Overall Study||79
7671729|NCT01990664|18891441|P1|COMPLETED|Overall Study||95
7671730|NCT01990664|18891440|P2|STARTED|Overall Study||90
7671731|NCT01990664|18891441|P1|STARTED|Overall Study||102
7671732|NCT01990612|18891449|P2|NOT COMPLETED|Overall Study||3
7671733|NCT01990612|18891450|P1|NOT COMPLETED|Overall Study||7
7671734|NCT01990612|18891449|P2|COMPLETED|Overall Study||3059
7671735|NCT01990612|18891450|P1|COMPLETED|Overall Study||3037
7671736|NCT01990612|18891449|P2|STARTED|Overall Study||3062
7671737|NCT01990612|18891450|P1|STARTED|Overall Study||3044
7671738|NCT01990573|18891531|P3|NOT COMPLETED|Overall Study||1
7671739|NCT01990573|18891532|P2|NOT COMPLETED|Overall Study||0
7671740|NCT01990573|18891533|P1|NOT COMPLETED|Overall Study||0
7671741|NCT01990573|18891531|P3|COMPLETED|Overall Study||16
7671742|NCT01990573|18891532|P2|COMPLETED|Overall Study||14
7671743|NCT01990573|18891533|P1|COMPLETED|Overall Study||20
7671744|NCT01990573|18891531|P3|STARTED|Overall Study||17
7671745|NCT01990573|18891532|P2|STARTED|Overall Study||14
7671746|NCT01990573|18891533|P1|STARTED|Overall Study||20
7671747|NCT01990560|18891546|P1|NOT COMPLETED|Overall Study||1
7671748|NCT01990560|18891546|P1|COMPLETED|Overall Study||7
7671749|NCT01990560|18891546|P1|STARTED|Overall Study||8
7671750|NCT01990534|18891560|P1|NOT COMPLETED|Overall Study||60
7671751|NCT01990534|18891560|P1|COMPLETED|Overall Study||0
7671752|NCT01990534|18891560|P1|Ongoing|Overall Study||36
7671753|NCT01990534|18891560|P1|STARTED|Overall Study||60
7671754|NCT01990339|18891576|P1|NOT COMPLETED|Overall Study||2312
7671755|NCT01990339|18891576|P1|COMPLETED|Overall Study||12653
7671756|NCT01990339|18891576|P1|STARTED|Overall Study||14965
7671757|NCT01990313|18891581|P1|NOT COMPLETED|Overall Study||1
7671758|NCT01990313|18891581|P1|COMPLETED|Overall Study||14
7671759|NCT01990313|18891581|P1|STARTED|Overall Study||15
7671760|NCT01990300|18891586|P1|NOT COMPLETED|Overall Study||142
7671761|NCT01990300|18891586|P1|COMPLETED|Overall Study||3139
7671762|NCT01990300|18891586|P1|STARTED|Overall Study||3281
7671763|NCT01990261|18891592|P1|NOT COMPLETED|Overall Study||25
7671764|NCT01990261|18891592|P1|COMPLETED|Overall Study||8
7671765|NCT01990261|18891592|P1|Treated|Overall Study||29
7671766|NCT01990261|18891592|P1|STARTED|Overall Study||33
7671767|NCT01989975|18891602|P1|NOT COMPLETED|Overall Study||0
7671768|NCT01989975|18891602|P1|COMPLETED|Overall Study||40
7671769|NCT01989975|18891602|P1|STARTED|Overall Study||40
7671770|NCT01989910|18891611|P2|NOT COMPLETED|Overall Study||0
7671771|NCT01989910|18891612|P1|NOT COMPLETED|Overall Study||2
7671772|NCT01989910|18891611|P2|COMPLETED|Overall Study||54
7671773|NCT01989910|18891612|P1|COMPLETED|Overall Study||51
7671774|NCT01989910|18891611|P2|STARTED|Overall Study||54
7671775|NCT01989910|18891612|P1|STARTED|Overall Study||53
7671776|NCT01989793|18891624|P2|NOT COMPLETED|Overall Study||4
7671777|NCT01989793|18891625|P1|NOT COMPLETED|Overall Study||8
7671778|NCT01989793|18891624|P2|COMPLETED|Overall Study||15
7671779|NCT01989793|18891625|P1|COMPLETED|Overall Study||10
7671780|NCT01989793|18891624|P2|STARTED|Overall Study||19
7671781|NCT01989793|18891625|P1|STARTED|Overall Study||18
7671782|NCT01989754|18891649|P2|NOT COMPLETED|Overall Study||35
7671783|NCT01989754|18891650|P1|NOT COMPLETED|Overall Study||39
7671784|NCT01989754|18891649|P2|COMPLETED|Overall Study|Participants who died are included in this category.|2872
7671785|NCT01989754|18891650|P1|COMPLETED|Overall Study|Participants who died are included in this category.|2866
7671786|NCT01989754|18891649|P2|Treated|Overall Study||2904
7671787|NCT01989754|18891650|P1|Treated|Overall Study||2903
7671788|NCT01989754|18891649|P2|STARTED|Overall Study||2907
7671789|NCT01989754|18891650|P1|STARTED|Overall Study||2905
7671790|NCT01989689|18891662|P2|NOT COMPLETED|Treatment Period ( 3 Months)||0
7671791|NCT01989689|18891663|P1|NOT COMPLETED|Treatment Period ( 3 Months)||0
7671792|NCT01989689|18891662|P2|COMPLETED|Treatment Period ( 3 Months)||10
7671793|NCT01989689|18891663|P1|COMPLETED|Treatment Period ( 3 Months)||11
7671794|NCT01989689|18891662|P2|STARTED|Treatment Period ( 3 Months)||10
7671795|NCT01989689|18891663|P1|STARTED|Treatment Period ( 3 Months)||11
7671796|NCT01989689|18891662|P2|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3
7671797|NCT01989689|18891663|P1|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0
7671798|NCT01989689|18891662|P2|COMPLETED|Treatment Period 1 ( 3 Months)||10
7671799|NCT01989689|18891663|P1|COMPLETED|Treatment Period 1 ( 3 Months)||11
7671800|NCT01989689|18891662|P2|STARTED|Treatment Period 1 ( 3 Months)||13
7671801|NCT01989689|18891663|P1|STARTED|Treatment Period 1 ( 3 Months)||11
7671802|NCT01989689|18891662|P2|NOT COMPLETED|Baseline||0
7671803|NCT01989689|18891663|P1|NOT COMPLETED|Baseline||0
7671804|NCT01989689|18891662|P2|COMPLETED|Baseline||13
7671805|NCT01989689|18891663|P1|COMPLETED|Baseline||11
7671806|NCT01989689|18891662|P2|STARTED|Baseline||13
7671807|NCT01989689|18891663|P1|STARTED|Baseline||11
7671808|NCT01989676|18891675|P2|NOT COMPLETED|Overall Study||347
7671809|NCT01989676|18891676|P1|NOT COMPLETED|Overall Study||338
7671810|NCT01989676|18891675|P2|COMPLETED|Overall Study||6
7671811|NCT01989676|18891676|P1|COMPLETED|Overall Study||11
7671812|NCT01989676|18891675|P2|STARTED|Overall Study|Treated (355 randomized)|353
7671813|NCT01989676|18891676|P1|STARTED|Overall Study|Treated (352 randomized)|349
7671814|NCT01989572|18891702|P6|NOT COMPLETED|Overall Study||110
7671815|NCT01989572|18891703|P5|NOT COMPLETED|Overall Study||98
7671816|NCT01989572|18891704|P4|NOT COMPLETED|Overall Study||51
7671817|NCT01989572|18891705|P3|NOT COMPLETED|Overall Study||62
7671818|NCT01989572|18891706|P2|NOT COMPLETED|Overall Study||58
7671819|NCT01989572|18891707|P1|NOT COMPLETED|Overall Study||55
7671820|NCT01989572|18891702|P6|COMPLETED|Overall Study||79
7671821|NCT01989572|18891703|P5|COMPLETED|Overall Study||92
7671822|NCT01989572|18891704|P4|COMPLETED|Overall Study||56
7671823|NCT01989572|18891705|P3|COMPLETED|Overall Study||47
7671824|NCT01989572|18891706|P2|COMPLETED|Overall Study||53
7671825|NCT01989572|18891707|P1|COMPLETED|Overall Study||54
7671826|NCT01989572|18891702|P6|Treated|Overall Study||171
7671827|NCT01989572|18891703|P5|Treated|Overall Study||186
7671828|NCT01989572|18891704|P4|Treated|Overall Study||104
7671829|NCT01989572|18891705|P3|Treated|Overall Study||107
7671830|NCT01989572|18891706|P2|Treated|Overall Study||110
7671831|NCT01989572|18891707|P1|Treated|Overall Study||104
7671832|NCT01989572|18891702|P6|STARTED|Overall Study||189
7671833|NCT01989572|18891703|P5|STARTED|Overall Study||190
7671834|NCT01989572|18891704|P4|STARTED|Overall Study||107
7671835|NCT01989572|18891705|P3|STARTED|Overall Study||109
7671836|NCT01989572|18891706|P2|STARTED|Overall Study||111
7671837|NCT01989572|18891707|P1|STARTED|Overall Study||109
7671838|NCT01989468|18891738|P5|NOT COMPLETED|Overall Study||8
7671839|NCT01989468|18891739|P4|NOT COMPLETED|Overall Study||16
7671840|NCT01989468|18891740|P3|NOT COMPLETED|Overall Study||19
7671841|NCT01989468|18891741|P2|NOT COMPLETED|Overall Study||37
7671842|NCT01989468|18891742|P1|NOT COMPLETED|Overall Study||47
7671843|NCT01989468|18891738|P5|COMPLETED|Overall Study||0
7671844|NCT01989468|18891739|P4|COMPLETED|Overall Study||49
7671845|NCT01989468|18891740|P3|COMPLETED|Overall Study||45
7671846|NCT01989468|18891741|P2|COMPLETED|Overall Study||102
7671847|NCT01989468|18891742|P1|COMPLETED|Overall Study||91
7671848|NCT01989468|18891738|P5|STARTED|Overall Study||8
7671849|NCT01989468|18891739|P4|STARTED|Overall Study||65
7671850|NCT01989468|18891740|P3|STARTED|Overall Study||64
7671851|NCT01989468|18891741|P2|STARTED|Overall Study||139
7671852|NCT01989468|18891742|P1|STARTED|Overall Study||138
7671853|NCT01989455|18891784|P5|NOT COMPLETED|Overall Study||1
7671854|NCT01989455|18891785|P4|NOT COMPLETED|Overall Study||0
7671855|NCT01989455|18891786|P3|NOT COMPLETED|Overall Study||1
7671856|NCT01989455|18891787|P2|NOT COMPLETED|Overall Study||2
7671857|NCT01989455|18891788|P1|NOT COMPLETED|Overall Study||0
7671858|NCT01989455|18891784|P5|COMPLETED|Overall Study||7
7671859|NCT01989455|18891785|P4|COMPLETED|Overall Study||14
7671860|NCT01989455|18891786|P3|COMPLETED|Overall Study||13
7671861|NCT01989455|18891787|P2|COMPLETED|Overall Study||12
7671862|NCT01989455|18891788|P1|COMPLETED|Overall Study||14
7671863|NCT01989455|18891784|P5|STARTED|Overall Study||8
7671864|NCT01989455|18891785|P4|STARTED|Overall Study||14
7671865|NCT01989455|18891786|P3|STARTED|Overall Study||14
7671866|NCT01989455|18891787|P2|STARTED|Overall Study||14
7671867|NCT01989455|18891788|P1|STARTED|Overall Study||14
7671868|NCT01989208|18891824|P2|NOT COMPLETED|800 mg (7 Days)||0
7671869|NCT01989208|18891825|P1|NOT COMPLETED|800 mg (7 Days)||0
7671870|NCT01989208|18891824|P2|COMPLETED|800 mg (7 Days)||11
7671871|NCT01989208|18891825|P1|COMPLETED|800 mg (7 Days)||4
7671872|NCT01989208|18891824|P2|STARTED|800 mg (7 Days)||11
7671873|NCT01989208|18891825|P1|STARTED|800 mg (7 Days)||4
7671874|NCT01989208|18891824|P2|NOT COMPLETED|400 mg (7 Days)||0
7671875|NCT01989208|18891825|P1|NOT COMPLETED|400 mg (7 Days)||0
7671876|NCT01989208|18891824|P2|COMPLETED|400 mg (7 Days)||11
7671877|NCT01989208|18891825|P1|COMPLETED|400 mg (7 Days)||4
7671878|NCT01989208|18891824|P2|STARTED|400 mg (7 Days)||11
7671879|NCT01989208|18891825|P1|STARTED|400 mg (7 Days)||4
7671880|NCT01989208|18891824|P2|NOT COMPLETED|200 mg (7 Days)||1
7671881|NCT01989208|18891825|P1|NOT COMPLETED|200 mg (7 Days)||0
7671882|NCT01989208|18891824|P2|COMPLETED|200 mg (7 Days)||11
7671883|NCT01989208|18891825|P1|COMPLETED|200 mg (7 Days)||4
7671884|NCT01989208|18891824|P2|STARTED|200 mg (7 Days)||12
7671885|NCT01989208|18891825|P1|STARTED|200 mg (7 Days)||4
7671886|NCT01989195|18891843|P1|NOT COMPLETED|Overall Study||0
7671887|NCT01989195|18891843|P1|COMPLETED|Overall Study||6
7671888|NCT01989195|18891843|P1|STARTED|Overall Study||6
7671889|NCT01989169|18891853|P2|NOT COMPLETED|Period 2||1
7671890|NCT01989169|18891854|P1|NOT COMPLETED|Period 2||0
7671891|NCT01989169|18891853|P2|COMPLETED|Period 2||14
7671892|NCT01989169|18891854|P1|COMPLETED|Period 2||15
7671893|NCT01989169|18891853|P2|STARTED|Period 2||15
7671894|NCT01989169|18891854|P1|STARTED|Period 2||15
7671895|NCT01989169|18891853|P2|NOT COMPLETED|Period 1||0
7671896|NCT01989169|18891854|P1|NOT COMPLETED|Period 1||0
7671897|NCT01989169|18891853|P2|COMPLETED|Period 1||15
7671898|NCT01989169|18891854|P1|COMPLETED|Period 1||15
7671899|NCT01989169|18891853|P2|STARTED|Period 1||15
7671900|NCT01989169|18891854|P1|STARTED|Period 1||15
7671901|NCT01989156|18891867|P3|NOT COMPLETED|End of Study (Population at Day 90)||3
7671902|NCT01989156|18891868|P2|NOT COMPLETED|End of Study (Population at Day 90)||5
7671903|NCT01989156|18891869|P1|NOT COMPLETED|End of Study (Population at Day 90)||7
7671904|NCT01989156|18891867|P3|COMPLETED|End of Study (Population at Day 90)||31
7671905|NCT01989156|18891868|P2|COMPLETED|End of Study (Population at Day 90)||35
7671906|NCT01989156|18891869|P1|COMPLETED|End of Study (Population at Day 90)||73
7671907|NCT01989156|18891867|P3|STARTED|End of Study (Population at Day 90)||34
7671908|NCT01989156|18891868|P2|STARTED|End of Study (Population at Day 90)||40
7671909|NCT01989156|18891869|P1|STARTED|End of Study (Population at Day 90)||80
7671910|NCT01989156|18891867|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||5
7671911|NCT01989156|18891868|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
7671912|NCT01989156|18891869|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||0
7671913|NCT01989156|18891867|P3|COMPLETED|Confinement Period (Population at Day 5)||34
7671914|NCT01989156|18891868|P2|COMPLETED|Confinement Period (Population at Day 5)||40
7671915|NCT01989156|18891869|P1|COMPLETED|Confinement Period (Population at Day 5)||80
7671916|NCT01989156|18891867|P3|STARTED|Confinement Period (Population at Day 5)||39
7671917|NCT01989156|18891868|P2|STARTED|Confinement Period (Population at Day 5)||41
7671918|NCT01989156|18891869|P1|STARTED|Confinement Period (Population at Day 5)||80
7671919|NCT01989130|18891891|P2|NOT COMPLETED|Overall Study||0
7671920|NCT01989130|18891892|P1|NOT COMPLETED|Overall Study||0
7671921|NCT01989130|18891891|P2|COMPLETED|Overall Study||27
7671922|NCT01989130|18891892|P1|COMPLETED|Overall Study||43
7671923|NCT01989130|18891891|P2|STARTED|Overall Study||27
7671924|NCT01989130|18891892|P1|STARTED|Overall Study||43
7671925|NCT01988922|18891907|P3|NOT COMPLETED|Overall Study||0
7671926|NCT01988922|18891908|P2|NOT COMPLETED|Overall Study||0
7671927|NCT01988922|18891909|P1|NOT COMPLETED|Overall Study||0
7671928|NCT01988922|18891907|P3|COMPLETED|Overall Study||10
7671929|NCT01988922|18891908|P2|COMPLETED|Overall Study||10
7671930|NCT01988922|18891909|P1|COMPLETED|Overall Study||10
7671931|NCT01988922|18891907|P3|STARTED|Overall Study||10
7671932|NCT01988922|18891908|P2|STARTED|Overall Study||10
7671933|NCT01988922|18891909|P1|STARTED|Overall Study||10
7671934|NCT01988857|18891920|P1|NOT COMPLETED|Overall Study||0
7671935|NCT01988857|18891920|P1|COMPLETED|Overall Study||300
7671936|NCT01988857|18891920|P1|STARTED|Overall Study||300
7671937|NCT01988779|18891929|P2|NOT COMPLETED|Overall Study||2
7671938|NCT01988779|18891930|P1|NOT COMPLETED|Overall Study||3
7671939|NCT01988779|18891929|P2|COMPLETED|Overall Study||11
7671940|NCT01988779|18891930|P1|COMPLETED|Overall Study||9
7671941|NCT01988779|18891929|P2|STARTED|Overall Study||13
7671942|NCT01988779|18891930|P1|STARTED|Overall Study||12
7671943|NCT01988662|18891946|P2|NOT COMPLETED|Overall Study||2
7671944|NCT01988662|18891947|P1|NOT COMPLETED|Overall Study||4
7671945|NCT01988662|18891946|P2|COMPLETED|Overall Study||99
7671946|NCT01988662|18891947|P1|COMPLETED|Overall Study||100
7671947|NCT01988662|18891946|P2|STARTED|Overall Study||101
7671948|NCT01988662|18891947|P1|STARTED|Overall Study||104
7671949|NCT01988493|18891969|P5|NOT COMPLETED|Overall Study||1
7671950|NCT01988493|18891970|P4|NOT COMPLETED|Overall Study||2
7671951|NCT01988493|18891971|P3|NOT COMPLETED|Overall Study||0
7671952|NCT01988493|18891972|P2|NOT COMPLETED|Overall Study||0
7671953|NCT01988493|18891973|P1|NOT COMPLETED|Overall Study||0
7671954|NCT01988493|18891969|P5|COMPLETED|Overall Study||44
7671955|NCT01988493|18891970|P4|COMPLETED|Overall Study||43
7671956|NCT01988493|18891971|P3|COMPLETED|Overall Study||6
7671957|NCT01988493|18891972|P2|COMPLETED|Overall Study||14
7671958|NCT01988493|18891973|P1|COMPLETED|Overall Study||7
7671959|NCT01988493|18891969|P5|Safety Population|Overall Study||44
7671960|NCT01988493|18891970|P4|Safety Population|Overall Study||45
7671961|NCT01988493|18891971|P3|Safety Population|Overall Study||6
7671962|NCT01988493|18891972|P2|Safety Population|Overall Study||14
7671963|NCT01988493|18891973|P1|Safety Population|Overall Study||7
7671964|NCT01988493|18891969|P5|Treated|Overall Study||44
7671965|NCT01988493|18891970|P4|Treated|Overall Study||45
7671966|NCT01988493|18891971|P3|Treated|Overall Study||6
7671967|NCT01988493|18891972|P2|Treated|Overall Study||14
7671968|NCT01988493|18891973|P1|Treated|Overall Study||7
7671969|NCT01988493|18891969|P5|STARTED|Overall Study||45
7671970|NCT01988493|18891970|P4|STARTED|Overall Study||45
7671971|NCT01988493|18891971|P3|STARTED|Overall Study||6
7671972|NCT01988493|18891972|P2|STARTED|Overall Study||14
7671973|NCT01988493|18891973|P1|STARTED|Overall Study||7
7671974|NCT01988415|18892042|P1|NOT COMPLETED|Overall Study||0
7671975|NCT01988415|18892042|P1|COMPLETED|Overall Study||26
7671976|NCT01988415|18892042|P1|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26
7671977|NCT01988402|18892052|P2|NOT COMPLETED|Overall Study||2
7671978|NCT01988402|18892053|P1|NOT COMPLETED|Overall Study||2
7671979|NCT01988402|18892052|P2|COMPLETED|Overall Study||17
7671980|NCT01988402|18892053|P1|COMPLETED|Overall Study||14
7671981|NCT01988402|18892052|P2|STARTED|Overall Study||19
7671982|NCT01988402|18892053|P1|STARTED|Overall Study||16
7671983|NCT01988376|18892067|P2|NOT COMPLETED|Overall Study||0
7671984|NCT01988376|18892068|P1|NOT COMPLETED|Overall Study||0
7671985|NCT01988376|18892067|P2|COMPLETED|Overall Study||129
7671986|NCT01988376|18892068|P1|COMPLETED|Overall Study||129
7671987|NCT01988376|18892067|P2|STARTED|Overall Study||129
7671988|NCT01988376|18892068|P1|STARTED|Overall Study||129
7671989|NCT01988246|18892076|P2|NOT COMPLETED|Overall Study||0
7671990|NCT01988246|18892077|P1|NOT COMPLETED|Overall Study||1
7671991|NCT01988246|18892076|P2|COMPLETED|Overall Study||15
7671992|NCT01988246|18892077|P1|COMPLETED|Overall Study||14
7671993|NCT01988246|18892076|P2|STARTED|Overall Study||15
7671994|NCT01988246|18892077|P1|STARTED|Overall Study||15
7671995|NCT01988129|18892089|P2|NOT COMPLETED|Overall Study||0
7671996|NCT01988129|18892090|P1|NOT COMPLETED|Overall Study||0
7671997|NCT01988129|18892089|P2|COMPLETED|Overall Study||588
7671998|NCT01988129|18892090|P1|COMPLETED|Overall Study||601
7671999|NCT01988129|18892089|P2|Completed 1-year Follow-up Survey|Overall Study||4
7672000|NCT01988129|18892090|P1|Completed 1-year Follow-up Survey|Overall Study||100
7672001|NCT01988129|18892089|P2|Screened for Sleep Disorders|Overall Study||15
7672002|NCT01988129|18892090|P1|Screened for Sleep Disorders|Overall Study||416
7672003|NCT01988129|18892089|P2|Attended Education Session|Overall Study||18
7672004|NCT01988129|18892090|P1|Attended Education Session|Overall Study||542
7672005|NCT01988129|18892089|P2|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588
7672006|NCT01988129|18892090|P1|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601
7672007|NCT01988103|18892120|P5|NOT COMPLETED|Observational Follow-up Phase||0
7672008|NCT01988103|18892121|P4|NOT COMPLETED|Observational Follow-up Phase||0
7672009|NCT01988103|18892122|P3|NOT COMPLETED|Observational Follow-up Phase||1
7672010|NCT01988103|18892123|P2|NOT COMPLETED|Observational Follow-up Phase||3
7672011|NCT01988103|18892124|P1|NOT COMPLETED|Observational Follow-up Phase||0
7672012|NCT01988103|18892120|P5|COMPLETED|Observational Follow-up Phase||33
7672013|NCT01988103|18892121|P4|COMPLETED|Observational Follow-up Phase||36
7672014|NCT01988103|18892122|P3|COMPLETED|Observational Follow-up Phase||82
7672015|NCT01988103|18892123|P2|COMPLETED|Observational Follow-up Phase||79
7672016|NCT01988103|18892124|P1|COMPLETED|Observational Follow-up Phase||12
7672017|NCT01988103|18892120|P5|STARTED|Observational Follow-up Phase||33
7672018|NCT01988103|18892121|P4|STARTED|Observational Follow-up Phase||36
7672019|NCT01988103|18892122|P3|STARTED|Observational Follow-up Phase||83
7672020|NCT01988103|18892123|P2|STARTED|Observational Follow-up Phase||82
7672021|NCT01988103|18892124|P1|STARTED|Observational Follow-up Phase||12
7672022|NCT01988103|18892120|P5|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||5
7672023|NCT01988103|18892121|P4|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||3
7672024|NCT01988103|18892122|P3|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||11
7672025|NCT01988103|18892123|P2|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||13
7672026|NCT01988103|18892124|P1|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||0
7672027|NCT01988103|18892120|P5|COMPLETED|Active Treatment Phase (Weeks 16-68)||30
7672028|NCT01988103|18892121|P4|COMPLETED|Active Treatment Phase (Weeks 16-68)||33
7672029|NCT01988103|18892122|P3|COMPLETED|Active Treatment Phase (Weeks 16-68)||65
7672030|NCT01988103|18892123|P2|COMPLETED|Active Treatment Phase (Weeks 16-68)||56
7672031|NCT01988103|18892124|P1|COMPLETED|Active Treatment Phase (Weeks 16-68)||0
7672032|NCT01988103|18892120|P5|STARTED|Active Treatment Phase (Weeks 16-68)||35
7672033|NCT01988103|18892121|P4|STARTED|Active Treatment Phase (Weeks 16-68)||36
7672034|NCT01988103|18892122|P3|STARTED|Active Treatment Phase (Weeks 16-68)||76
7672035|NCT01988103|18892123|P2|STARTED|Active Treatment Phase (Weeks 16-68)||69
7672036|NCT01988103|18892124|P1|STARTED|Active Treatment Phase (Weeks 16-68)||0
7672037|NCT01988103|18892120|P5|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
7672038|NCT01988103|18892121|P4|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
7672039|NCT01988103|18892122|P3|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||9
7672040|NCT01988103|18892123|P2|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||16
7672041|NCT01988103|18892124|P1|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||12
7672042|NCT01988103|18892120|P5|COMPLETED|Placebo-Controlled Phase Week 0-16||0
7672043|NCT01988103|18892121|P4|COMPLETED|Placebo-Controlled Phase Week 0-16||0
7672044|NCT01988103|18892122|P3|COMPLETED|Placebo-Controlled Phase Week 0-16||76
7672045|NCT01988103|18892123|P2|COMPLETED|Placebo-Controlled Phase Week 0-16||69
7672046|NCT01988103|18892124|P1|COMPLETED|Placebo-Controlled Phase Week 0-16||72
7672047|NCT01988103|18892120|P5|STARTED|Placebo-Controlled Phase Week 0-16||0
7672048|NCT01988103|18892121|P4|STARTED|Placebo-Controlled Phase Week 0-16||0
7672049|NCT01988103|18892122|P3|STARTED|Placebo-Controlled Phase Week 0-16||85
7672050|NCT01988103|18892123|P2|STARTED|Placebo-Controlled Phase Week 0-16||85
7672051|NCT01988103|18892124|P1|STARTED|Placebo-Controlled Phase Week 0-16||84
7672052|NCT01988090|18892171|P2|NOT COMPLETED|Complete Study After Start||1
7672053|NCT01988090|18892172|P1|NOT COMPLETED|Complete Study After Start||3
7672054|NCT01988090|18892171|P2|COMPLETED|Complete Study After Start||42
7672055|NCT01988090|18892172|P1|COMPLETED|Complete Study After Start||41
7672056|NCT01988090|18892171|P2|STARTED|Complete Study After Start||43
7672057|NCT01988090|18892172|P1|STARTED|Complete Study After Start||44
7672058|NCT01988090|18892171|P2|NOT COMPLETED|Start Treament After Randomization||4
7672059|NCT01988090|18892172|P1|NOT COMPLETED|Start Treament After Randomization||2
7672060|NCT01988090|18892171|P2|COMPLETED|Start Treament After Randomization||43
7672061|NCT01988090|18892172|P1|COMPLETED|Start Treament After Randomization||44
7672062|NCT01988090|18892171|P2|STARTED|Start Treament After Randomization||47
7672063|NCT01988090|18892172|P1|STARTED|Start Treament After Randomization||46
7672064|NCT01988012|18892182|P1|NOT COMPLETED|Overall Study||15
7672065|NCT01988012|18892182|P1|COMPLETED|Overall Study||85
7672066|NCT01988012|18892182|P1|STARTED|Overall Study||100
7672067|NCT01987986|18892208|P4|NOT COMPLETED|Overall Study||0
7672068|NCT01987986|18892209|P3|NOT COMPLETED|Overall Study||2
7672069|NCT01987986|18892210|P2|NOT COMPLETED|Overall Study||0
7672070|NCT01987986|18892211|P1|NOT COMPLETED|Overall Study||2
7672071|NCT01987986|18892208|P4|COMPLETED|Overall Study||24
7672072|NCT01987986|18892209|P3|COMPLETED|Overall Study||38
7672073|NCT01987986|18892210|P2|COMPLETED|Overall Study||43
7672074|NCT01987986|18892211|P1|COMPLETED|Overall Study||41
7672075|NCT01987986|18892208|P4|STARTED|Overall Study||24
7672076|NCT01987986|18892209|P3|STARTED|Overall Study||40
7672077|NCT01987986|18892210|P2|STARTED|Overall Study||43
7672078|NCT01987986|18892211|P1|STARTED|Overall Study||43
7672079|NCT01987960|18892251|P4|NOT COMPLETED|Period 3||71
7672080|NCT01987960|18892252|P3|NOT COMPLETED|Period 3||0
7672081|NCT01987960|18892253|P2|NOT COMPLETED|Period 3||0
7672082|NCT01987960|18892254|P1|NOT COMPLETED|Period 3||0
7672083|NCT01987960|18892251|P4|COMPLETED|Period 3||119
7672084|NCT01987960|18892252|P3|COMPLETED|Period 3||0
7672085|NCT01987960|18892253|P2|COMPLETED|Period 3||0
7672086|NCT01987960|18892254|P1|COMPLETED|Period 3||0
7672087|NCT01987960|18892251|P4|STARTED|Period 3||190
7672088|NCT01987960|18892252|P3|STARTED|Period 3||0
7672089|NCT01987960|18892253|P2|STARTED|Period 3||0
7672090|NCT01987960|18892254|P1|STARTED|Period 3||0
7672091|NCT01987960|18892251|P4|NOT COMPLETED|Period 2||0
7672092|NCT01987960|18892252|P3|NOT COMPLETED|Period 2||9
7672093|NCT01987960|18892253|P2|NOT COMPLETED|Period 2||5
7672094|NCT01987960|18892254|P1|NOT COMPLETED|Period 2||0
7672095|NCT01987960|18892251|P4|COMPLETED|Period 2||0
7672096|NCT01987960|18892252|P3|COMPLETED|Period 2||14
7672097|NCT01987960|18892253|P2|COMPLETED|Period 2||12
7672098|NCT01987960|18892254|P1|COMPLETED|Period 2||0
7672099|NCT01987960|18892251|P4|STARTED|Period 2||0
7672100|NCT01987960|18892252|P3|STARTED|Period 2||23
7672101|NCT01987960|18892253|P2|STARTED|Period 2||17
7672102|NCT01987960|18892254|P1|STARTED|Period 2||0
7672103|NCT01987960|18892251|P4|NOT COMPLETED|Period 1||0
7672104|NCT01987960|18892252|P3|NOT COMPLETED|Period 1||0
7672105|NCT01987960|18892253|P2|NOT COMPLETED|Period 1||0
7672106|NCT01987960|18892254|P1|NOT COMPLETED|Period 1||186
7672107|NCT01987960|18892251|P4|COMPLETED|Period 1||0
7672108|NCT01987960|18892252|P3|COMPLETED|Period 1||0
7672109|NCT01987960|18892253|P2|COMPLETED|Period 1||0
7672110|NCT01987960|18892254|P1|COMPLETED|Period 1||231
7672111|NCT01987960|18892251|P4|STARTED|Period 1||0
7672112|NCT01987960|18892252|P3|STARTED|Period 1||0
7672113|NCT01987960|18892253|P2|STARTED|Period 1||0
7672114|NCT01987960|18892254|P1|STARTED|Period 1||417
7672115|NCT01987908|18892266|P3|NOT COMPLETED|Post-Treatment Observation Period||0
7672116|NCT01987908|18892267|P2|NOT COMPLETED|Post-Treatment Observation Period||3
7672117|NCT01987908|18892268|P1|NOT COMPLETED|Post-Treatment Observation Period||0
7672118|NCT01987908|18892266|P3|COMPLETED|Post-Treatment Observation Period||2
7672119|NCT01987908|18892267|P2|COMPLETED|Post-Treatment Observation Period||7
7672120|NCT01987908|18892268|P1|COMPLETED|Post-Treatment Observation Period||0
7672121|NCT01987908|18892266|P3|STARTED|Post-Treatment Observation Period||2
7672122|NCT01987908|18892267|P2|STARTED|Post-Treatment Observation Period||10
7672123|NCT01987908|18892268|P1|STARTED|Post-Treatment Observation Period||0
7672124|NCT01987908|18892266|P3|NOT COMPLETED|Treatment Period||1
7672125|NCT01987908|18892267|P2|NOT COMPLETED|Treatment Period||1
7672126|NCT01987908|18892268|P1|NOT COMPLETED|Treatment Period||0
7672127|NCT01987908|18892266|P3|COMPLETED|Treatment Period||2
7672128|NCT01987908|18892267|P2|COMPLETED|Treatment Period||10
7672129|NCT01987908|18892268|P1|COMPLETED|Treatment Period||0
7672130|NCT01987908|18892266|P3|STARTED|Treatment Period||3
7672131|NCT01987908|18892267|P2|STARTED|Treatment Period||11
7672132|NCT01987908|18892268|P1|STARTED|Treatment Period||0
7672133|NCT01987908|18892266|P3|NOT COMPLETED|Placebo Lead-in Period||0
7672134|NCT01987908|18892267|P2|NOT COMPLETED|Placebo Lead-in Period||0
7672135|NCT01987908|18892268|P1|NOT COMPLETED|Placebo Lead-in Period||9
7672136|NCT01987908|18892266|P3|COMPLETED|Placebo Lead-in Period||0
7672137|NCT01987908|18892267|P2|COMPLETED|Placebo Lead-in Period||0
7672138|NCT01987908|18892268|P1|COMPLETED|Placebo Lead-in Period||14
7672139|NCT01987908|18892266|P3|STARTED|Placebo Lead-in Period||0
7672140|NCT01987908|18892267|P2|STARTED|Placebo Lead-in Period||0
7672141|NCT01987908|18892268|P1|STARTED|Placebo Lead-in Period||23
7672142|NCT01987895|18892351|P2|NOT COMPLETED|Overall Study||30
7672143|NCT01987895|18892352|P1|NOT COMPLETED|Overall Study||30
7672144|NCT01987895|18892351|P2|COMPLETED|Overall Study||296
7672145|NCT01987895|18892352|P1|COMPLETED|Overall Study||276
7672146|NCT01987895|18892351|P2|STARTED|Overall Study||326
7672147|NCT01987895|18892352|P1|STARTED|Overall Study||306
7672148|NCT01987830|18892376|P1|NOT COMPLETED|Overall Study||1
7672149|NCT01987830|18892376|P1|COMPLETED|Overall Study||12
7672150|NCT01987830|18892376|P1|STARTED|Overall Study||13
7672151|NCT01987765|18892380|P1|NOT COMPLETED|Overall Study||102
7672152|NCT01987765|18892380|P1|COMPLETED|Overall Study||745
7672153|NCT01987765|18892380|P1|STARTED|Overall Study||847
7672154|NCT01987752|18892385|P1|NOT COMPLETED|Overall Study||0
7672155|NCT01987752|18892385|P1|COMPLETED|Overall Study||732
7672156|NCT01987752|18892385|P1|STARTED|Overall Study||732
7672157|NCT01987609|18892390|P1|NOT COMPLETED|Overall Study||1
7672158|NCT01987609|18892390|P1|COMPLETED|Overall Study||6
7672159|NCT01987609|18892390|P1|Normal Saline Injected in Arm|Overall Study||6
7672160|NCT01987609|18892390|P1|Hylenex Injected in Arm|Overall Study||6
7672161|NCT01987609|18892390|P1|STARTED|Overall Study|one arm on one patient|7
7672162|NCT01987596|18892423|P2|NOT COMPLETED|Overall Study||1
7672163|NCT01987596|18892424|P1|NOT COMPLETED|Overall Study||1
7672164|NCT01987596|18892423|P2|COMPLETED|Overall Study||10
7672165|NCT01987596|18892424|P1|COMPLETED|Overall Study||11
7672166|NCT01987596|18892423|P2|STARTED|Overall Study||11
7672167|NCT01987596|18892424|P1|STARTED|Overall Study||12
7672168|NCT01987583|18892438|P2|NOT COMPLETED|Overall Study||2
7672169|NCT01987583|18892439|P1|NOT COMPLETED|Overall Study||3
7672170|NCT01987583|18892438|P2|COMPLETED|Overall Study||38
7672171|NCT01987583|18892439|P1|COMPLETED|Overall Study||37
7672172|NCT01987583|18892438|P2|STARTED|Overall Study||40
7672173|NCT01987583|18892439|P1|STARTED|Overall Study||40
7672174|NCT01987557|18892450|P3|NOT COMPLETED|Overall Study||3
7672175|NCT01987557|18892451|P2|NOT COMPLETED|Overall Study||3
7672176|NCT01987557|18892452|P1|NOT COMPLETED|Overall Study||3
7672177|NCT01987557|18892450|P3|COMPLETED|Overall Study||13
7672178|NCT01987557|18892451|P2|COMPLETED|Overall Study||13
7672179|NCT01987557|18892452|P1|COMPLETED|Overall Study||13
7672180|NCT01987557|18892450|P3|STARTED|Overall Study||16
7672181|NCT01987557|18892451|P2|STARTED|Overall Study||16
7672182|NCT01987557|18892452|P1|STARTED|Overall Study||16
7672183|NCT01987505|18892462|P1|NOT COMPLETED|Overall Study||34
7672184|NCT01987505|18892462|P1|COMPLETED|Overall Study||106
7672185|NCT01987505|18892462|P1|STARTED|Overall Study||140
7672186|NCT01987479|18892492|P1|NOT COMPLETED|Overall Study||17
7672187|NCT01987479|18892492|P1|COMPLETED|Overall Study||133
7672188|NCT01987479|18892492|P1|STARTED|Overall Study||150
7672189|NCT01987453|18892520|P3|NOT COMPLETED|Overall Study||1
7672190|NCT01987453|18892521|P2|NOT COMPLETED|Overall Study||12
7672191|NCT01987453|18892522|P1|NOT COMPLETED|Overall Study||1
7672192|NCT01987453|18892520|P3|COMPLETED|Overall Study||7
7672193|NCT01987453|18892521|P2|COMPLETED|Overall Study||29
7672194|NCT01987453|18892522|P1|COMPLETED|Overall Study||50
7672195|NCT01987453|18892520|P3|STARTED|Overall Study||8
7672196|NCT01987453|18892521|P2|STARTED|Overall Study||41
7672197|NCT01987453|18892522|P1|STARTED|Overall Study||51
7672198|NCT01987427|18892548|P3|NOT COMPLETED|Overall Study||20
7672199|NCT01987427|18892549|P2|NOT COMPLETED|Overall Study||10
7672200|NCT01987427|18892550|P1|NOT COMPLETED|Overall Study||14
7672201|NCT01987427|18892548|P3|COMPLETED|Overall Study||59
7672202|NCT01987427|18892549|P2|COMPLETED|Overall Study||68
7672203|NCT01987427|18892550|P1|COMPLETED|Overall Study||64
7672204|NCT01987427|18892548|P3|STARTED|Overall Study||79
7672205|NCT01987427|18892549|P2|STARTED|Overall Study||78
7672206|NCT01987427|18892550|P1|STARTED|Overall Study||78
7672207|NCT01987414|18892581|P2|NOT COMPLETED|Overall Study||2
7672208|NCT01987414|18892582|P1|NOT COMPLETED|Overall Study||2
7672209|NCT01987414|18892581|P2|COMPLETED|Overall Study||6
7672210|NCT01987414|18892582|P1|COMPLETED|Overall Study||8
7672211|NCT01987414|18892581|P2|STARTED|Overall Study||8
7672212|NCT01987414|18892582|P1|STARTED|Overall Study||10
7672213|NCT01987401|18892631|P3|NOT COMPLETED|Overall Study||44
7672214|NCT01987401|18892632|P2|NOT COMPLETED|Overall Study||470
7672215|NCT01987401|18892633|P1|NOT COMPLETED|Overall Study||454
7672216|NCT01987401|18892631|P3|COMPLETED|Overall Study||16
7672217|NCT01987401|18892632|P2|COMPLETED|Overall Study||121
7672218|NCT01987401|18892633|P1|COMPLETED|Overall Study||137
7672219|NCT01987401|18892631|P3|STARTED|Overall Study||60
7672220|NCT01987401|18892632|P2|STARTED|Overall Study||591
7672221|NCT01987401|18892633|P1|STARTED|Overall Study||591
7672222|NCT01987349|18892649|P8|NOT COMPLETED|Overall Study||1
7672223|NCT01987349|18892650|P7|NOT COMPLETED|Overall Study||0
7672224|NCT01987349|18892651|P6|NOT COMPLETED|Overall Study||0
7672225|NCT01987349|18892652|P5|NOT COMPLETED|Overall Study||0
7672226|NCT01987349|18892653|P4|NOT COMPLETED|Overall Study||0
7672227|NCT01987349|18892654|P3|NOT COMPLETED|Overall Study||0
7672228|NCT01987349|18892655|P2|NOT COMPLETED|Overall Study||0
7672229|NCT01987349|18892656|P1|NOT COMPLETED|Overall Study||0
7672230|NCT01987349|18892649|P8|COMPLETED|Overall Study||24
7672231|NCT01987349|18892650|P7|COMPLETED|Overall Study||10
7672232|NCT01987349|18892651|P6|COMPLETED|Overall Study||6
7672233|NCT01987349|18892652|P5|COMPLETED|Overall Study||6
7672234|NCT01987349|18892653|P4|COMPLETED|Overall Study||6
7672235|NCT01987349|18892654|P3|COMPLETED|Overall Study||8
7672236|NCT01987349|18892655|P2|COMPLETED|Overall Study||6
7672237|NCT01987349|18892656|P1|COMPLETED|Overall Study||6
7672238|NCT01987349|18892649|P8|STARTED|Overall Study||25
7672239|NCT01987349|18892650|P7|STARTED|Overall Study||10
7672240|NCT01987349|18892651|P6|STARTED|Overall Study||6
7672241|NCT01987349|18892652|P5|STARTED|Overall Study||6
7672242|NCT01987349|18892653|P4|STARTED|Overall Study||6
7672243|NCT01987349|18892654|P3|STARTED|Overall Study||8
7672244|NCT01987349|18892655|P2|STARTED|Overall Study||6
7672245|NCT01987349|18892656|P1|STARTED|Overall Study||6
7672246|NCT01987232|18892687|P5|NOT COMPLETED|Overall Study||0
7672247|NCT01987232|18892688|P4|NOT COMPLETED|Overall Study||1
7672248|NCT01987232|18892689|P3|NOT COMPLETED|Overall Study||0
7672249|NCT01987232|18892690|P2|NOT COMPLETED|Overall Study||0
7672250|NCT01987232|18892691|P1|NOT COMPLETED|Overall Study||0
7672251|NCT01987232|18892687|P5|COMPLETED|Overall Study||6
7672252|NCT01987232|18892688|P4|COMPLETED|Overall Study||14
7672253|NCT01987232|18892689|P3|COMPLETED|Overall Study||3
7672254|NCT01987232|18892690|P2|COMPLETED|Overall Study||3
7672255|NCT01987232|18892691|P1|COMPLETED|Overall Study||5
7672256|NCT01987232|18892687|P5|STARTED|Overall Study||6
7672257|NCT01987232|18892688|P4|STARTED|Overall Study||15
7672258|NCT01987232|18892689|P3|STARTED|Overall Study||3
7672259|NCT01987232|18892690|P2|STARTED|Overall Study||3
7672260|NCT01987232|18892691|P1|STARTED|Overall Study||5
7672261|NCT01987219|18892756|P6|NOT COMPLETED|Overall Study||0
7672262|NCT01987219|18892757|P5|NOT COMPLETED|Overall Study||0
7672263|NCT01987219|18892758|P4|NOT COMPLETED|Overall Study||0
7672264|NCT01987219|18892759|P3|NOT COMPLETED|Overall Study||1
7672265|NCT01987219|18892760|P2|NOT COMPLETED|Overall Study||0
7672266|NCT01987219|18892761|P1|NOT COMPLETED|Overall Study||0
7672267|NCT01987219|18892756|P6|COMPLETED|Overall Study||1
7672268|NCT01987219|18892757|P5|COMPLETED|Overall Study||1
7672269|NCT01987219|18892758|P4|COMPLETED|Overall Study||2
7672270|NCT01987219|18892759|P3|COMPLETED|Overall Study||6
7672271|NCT01987219|18892760|P2|COMPLETED|Overall Study||2
7672272|NCT01987219|18892761|P1|COMPLETED|Overall Study||2
7672273|NCT01987219|18892756|P6|STARTED|Overall Study||1
7672274|NCT01987219|18892757|P5|STARTED|Overall Study||1
7672275|NCT01987219|18892758|P4|STARTED|Overall Study||2
7672276|NCT01987219|18892759|P3|STARTED|Overall Study||7
7672277|NCT01987219|18892760|P2|STARTED|Overall Study||2
7672278|NCT01987219|18892761|P1|STARTED|Overall Study||2
7672279|NCT01987102|18892780|P2|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||1
7672280|NCT01987102|18892781|P1|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||0
7672281|NCT01987102|18892780|P2|COMPLETED|2 Courses of HDMTX With MOD Rescue||3
7672282|NCT01987102|18892781|P1|COMPLETED|2 Courses of HDMTX With MOD Rescue||4
7672283|NCT01987102|18892780|P2|STARTED|2 Courses of HDMTX With MOD Rescue||4
7672284|NCT01987102|18892781|P1|STARTED|2 Courses of HDMTX With MOD Rescue||4
7672285|NCT01987102|18892780|P2|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||6
7672286|NCT01987102|18892781|P1|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||4
7672287|NCT01987102|18892780|P2|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
7672288|NCT01987102|18892781|P1|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
7672289|NCT01987102|18892780|P2|STARTED|2 Courses of HDMTX With SOC Rescue||10
7672290|NCT01987102|18892781|P1|STARTED|2 Courses of HDMTX With SOC Rescue||8
7672291|NCT01987089|18892815|P2|NOT COMPLETED|Overall Study||4
7672292|NCT01987089|18892816|P1|NOT COMPLETED|Overall Study||1
7672293|NCT01987089|18892815|P2|COMPLETED|Overall Study||28
7672294|NCT01987089|18892816|P1|COMPLETED|Overall Study||30
7672295|NCT01987089|18892815|P2|STARTED|Overall Study||32
7672296|NCT01987089|18892816|P1|STARTED|Overall Study||31
7672297|NCT01986985|18892828|P1|NOT COMPLETED|Overall Study||7
7672298|NCT01986985|18892828|P1|COMPLETED|Overall Study||51
7672299|NCT01986985|18892828|P1|STARTED|Overall Study||58
7672300|NCT01986946|18892834|P2|NOT COMPLETED|Overall Study||0
7672301|NCT01986946|18892835|P1|NOT COMPLETED|Overall Study||0
7672302|NCT01986946|18892834|P2|COMPLETED|Overall Study||9
7672303|NCT01986946|18892835|P1|COMPLETED|Overall Study||5
7672304|NCT01986946|18892834|P2|STARTED|Overall Study||9
7672305|NCT01986946|18892835|P1|STARTED|Overall Study||5
7672306|NCT01986920|18892865|P4|NOT COMPLETED|Placebo||1
7672307|NCT01986920|18892866|P3|NOT COMPLETED|Placebo||0
7672308|NCT01986920|18892867|P2|NOT COMPLETED|Placebo||0
7672309|NCT01986920|18892868|P1|NOT COMPLETED|Placebo||0
7672310|NCT01986920|18892865|P4|COMPLETED|Placebo||34
7672311|NCT01986920|18892866|P3|COMPLETED|Placebo||0
7672312|NCT01986920|18892867|P2|COMPLETED|Placebo||0
7672313|NCT01986920|18892868|P1|COMPLETED|Placebo||0
7672314|NCT01986920|18892865|P4|STARTED|Placebo||35
7672315|NCT01986920|18892866|P3|STARTED|Placebo||0
7672316|NCT01986920|18892867|P2|STARTED|Placebo||0
7672317|NCT01986920|18892868|P1|STARTED|Placebo||0
7672318|NCT01986920|18892865|P4|NOT COMPLETED|A-101 40%||0
7672319|NCT01986920|18892866|P3|NOT COMPLETED|A-101 40%||1
7672320|NCT01986920|18892867|P2|NOT COMPLETED|A-101 40%||0
7672321|NCT01986920|18892868|P1|NOT COMPLETED|A-101 40%||0
7672322|NCT01986920|18892865|P4|COMPLETED|A-101 40%||0
7672323|NCT01986920|18892866|P3|COMPLETED|A-101 40%||34
7672324|NCT01986920|18892867|P2|COMPLETED|A-101 40%||0
7672325|NCT01986920|18892868|P1|COMPLETED|A-101 40%||0
7672326|NCT01986920|18892865|P4|STARTED|A-101 40%||0
7672327|NCT01986920|18892866|P3|STARTED|A-101 40%||35
7672328|NCT01986920|18892867|P2|STARTED|A-101 40%||0
7672329|NCT01986920|18892868|P1|STARTED|A-101 40%||0
7672330|NCT01986920|18892865|P4|NOT COMPLETED|A-101 32.5%||0
7672331|NCT01986920|18892866|P3|NOT COMPLETED|A-101 32.5%||0
7672332|NCT01986920|18892867|P2|NOT COMPLETED|A-101 32.5%||1
7672333|NCT01986920|18892868|P1|NOT COMPLETED|A-101 32.5%||0
7672334|NCT01986920|18892865|P4|COMPLETED|A-101 32.5%||0
7672335|NCT01986920|18892866|P3|COMPLETED|A-101 32.5%||0
7672336|NCT01986920|18892867|P2|COMPLETED|A-101 32.5%||34
7672337|NCT01986920|18892868|P1|COMPLETED|A-101 32.5%||0
7672338|NCT01986920|18892865|P4|STARTED|A-101 32.5%||0
7672339|NCT01986920|18892866|P3|STARTED|A-101 32.5%||0
7672340|NCT01986920|18892867|P2|STARTED|A-101 32.5%||35
7672341|NCT01986920|18892868|P1|STARTED|A-101 32.5%||0
7672342|NCT01986920|18892865|P4|NOT COMPLETED|A- 101 25%||0
7672343|NCT01986920|18892866|P3|NOT COMPLETED|A- 101 25%||0
7672344|NCT01986920|18892867|P2|NOT COMPLETED|A- 101 25%||0
7672345|NCT01986920|18892868|P1|NOT COMPLETED|A- 101 25%||1
7672346|NCT01986920|18892865|P4|COMPLETED|A- 101 25%||0
7672347|NCT01986920|18892866|P3|COMPLETED|A- 101 25%||0
7672348|NCT01986920|18892867|P2|COMPLETED|A- 101 25%||0
7672349|NCT01986920|18892868|P1|COMPLETED|A- 101 25%||34
7672350|NCT01986920|18892865|P4|STARTED|A- 101 25%||0
7672351|NCT01986920|18892866|P3|STARTED|A- 101 25%||0
7672352|NCT01986920|18892867|P2|STARTED|A- 101 25%||0
7672353|NCT01986920|18892868|P1|STARTED|A- 101 25%||35
7672354|NCT01986907|18892882|P1|NOT COMPLETED|Overall Study||162
7672355|NCT01986907|18892882|P1|COMPLETED|Overall Study||774
7672356|NCT01986907|18892882|P1|STARTED|Overall Study||936
7672357|NCT01986855|18892895|P3|NOT COMPLETED|Overall Study||11
7672358|NCT01986855|18892896|P2|NOT COMPLETED|Overall Study||14
7672359|NCT01986855|18892897|P1|NOT COMPLETED|Overall Study||13
7672360|NCT01986855|18892895|P3|COMPLETED|Overall Study||143
7672361|NCT01986855|18892896|P2|COMPLETED|Overall Study||142
7672362|NCT01986855|18892897|P1|COMPLETED|Overall Study||145
7672363|NCT01986855|18892895|P3|Treated|Overall Study||154
7672364|NCT01986855|18892896|P2|Treated|Overall Study||155
7672365|NCT01986855|18892897|P1|Treated|Overall Study||158
7672366|NCT01986855|18892895|P3|STARTED|Overall Study||154
7672367|NCT01986855|18892896|P2|STARTED|Overall Study||156
7672368|NCT01986855|18892897|P1|STARTED|Overall Study||158
7672369|NCT01986829|18892926|P1|NOT COMPLETED|Overall Study||1
7672370|NCT01986829|18892926|P1|COMPLETED|Overall Study||8
7672371|NCT01986829|18892926|P1|STARTED|Overall Study||9
7672372|NCT01986790|18892956|P3|NOT COMPLETED|Overall Study||0
7672373|NCT01986790|18892957|P2|NOT COMPLETED|Overall Study||0
7672374|NCT01986790|18892958|P1|NOT COMPLETED|Overall Study||0
7672375|NCT01986790|18892956|P3|COMPLETED|Overall Study||98
7672376|NCT01986790|18892957|P2|COMPLETED|Overall Study||154
7672377|NCT01986790|18892958|P1|COMPLETED|Overall Study||91
7672378|NCT01986790|18892956|P3|STARTED|Overall Study||98
7672379|NCT01986790|18892957|P2|STARTED|Overall Study||154
7672380|NCT01986790|18892958|P1|STARTED|Overall Study||91
7672381|NCT01986751|18892974|P2|NOT COMPLETED|Overall Study||2
7672382|NCT01986751|18892975|P1|NOT COMPLETED|Overall Study||10
7672383|NCT01986751|18892974|P2|COMPLETED|Overall Study||2
7672384|NCT01986751|18892975|P1|COMPLETED|Overall Study||0
7672385|NCT01986751|18892974|P2|STARTED|Overall Study||4
7672386|NCT01986751|18892975|P1|STARTED|Overall Study||10
7672387|NCT01986686|18892997|P2|NOT COMPLETED|Overall Study||0
7672388|NCT01986686|18892998|P1|NOT COMPLETED|Overall Study||0
7672389|NCT01986686|18892997|P2|COMPLETED|Overall Study||26
7672390|NCT01986686|18892998|P1|COMPLETED|Overall Study||81
7672391|NCT01986686|18892997|P2|STARTED|Overall Study||26
7672392|NCT01986686|18892998|P1|STARTED|Overall Study||81
7672393|NCT01986647|18893008|P4|NOT COMPLETED|Overall Study||11
7672394|NCT01986647|18893009|P3|NOT COMPLETED|Overall Study||12
7672395|NCT01986647|18893010|P2|NOT COMPLETED|Overall Study||7
7672396|NCT01986647|18893011|P1|NOT COMPLETED|Overall Study||10
7672397|NCT01986647|18893008|P4|COMPLETED|Overall Study||66
7672398|NCT01986647|18893009|P3|COMPLETED|Overall Study||37
7672399|NCT01986647|18893010|P2|COMPLETED|Overall Study||139
7672400|NCT01986647|18893011|P1|COMPLETED|Overall Study||142
7672401|NCT01986647|18893008|P4|STARTED|Overall Study||77
7672402|NCT01986647|18893009|P3|STARTED|Overall Study||49
7672403|NCT01986647|18893010|P2|STARTED|Overall Study||146
7672404|NCT01986647|18893011|P1|STARTED|Overall Study||152
7672405|NCT01986361|18893083|P2|NOT COMPLETED|Overall Study||0
7672406|NCT01986361|18893084|P1|NOT COMPLETED|Overall Study||0
7672407|NCT01986361|18893083|P2|COMPLETED|Overall Study||21
7672408|NCT01986361|18893084|P1|COMPLETED|Overall Study||101
7672409|NCT01986361|18893083|P2|STARTED|Overall Study||21
7672410|NCT01986361|18893084|P1|STARTED|Overall Study||101
7672411|NCT01986231|18893106|P1|NOT COMPLETED|Overall Study||1
7672412|NCT01986231|18893106|P1|COMPLETED|Overall Study||11
7672413|NCT01986231|18893106|P1|STARTED|Overall Study||12
7672414|NCT01986140|18893113|P2|NOT COMPLETED|Overall Study||28
7672415|NCT01986140|18893114|P1|NOT COMPLETED|Overall Study||35
7672416|NCT01986140|18893113|P2|COMPLETED|Overall Study||51
7672417|NCT01986140|18893114|P1|COMPLETED|Overall Study||122
7672418|NCT01986140|18893113|P2|STARTED|Overall Study||79
7672419|NCT01986140|18893114|P1|STARTED|Overall Study||157
7672420|NCT01986114|18893120|P1|NOT COMPLETED|Overall Study||156
7672421|NCT01986114|18893120|P1|COMPLETED|Overall Study||339
7672422|NCT01986114|18893120|P1|STARTED|Overall Study||495
7672423|NCT01986101|18893135|P3|NOT COMPLETED|Overall Study||32
7672424|NCT01986101|18893136|P2|NOT COMPLETED|Overall Study||27
7672425|NCT01986101|18893137|P1|NOT COMPLETED|Overall Study||33
7672426|NCT01986101|18893135|P3|COMPLETED|Overall Study||137
7672427|NCT01986101|18893136|P2|COMPLETED|Overall Study||157
7672428|NCT01986101|18893137|P1|COMPLETED|Overall Study||139
7672429|NCT01986101|18893135|P3|Safety Population|Overall Study||169
7672430|NCT01986101|18893136|P2|Safety Population|Overall Study||184
7672431|NCT01986101|18893137|P1|Safety Population|Overall Study||172
7672432|NCT01986101|18893135|P3|Intent-to-Treat Population|Overall Study||169
7672433|NCT01986101|18893136|P2|Intent-to-Treat Population|Overall Study||182
7672434|NCT01986101|18893137|P1|Intent-to-Treat Population|Overall Study||171
7672435|NCT01986101|18893135|P3|STARTED|Overall Study||169
7672436|NCT01986101|18893136|P2|STARTED|Overall Study||184
7672437|NCT01986101|18893137|P1|STARTED|Overall Study||172
7672438|NCT01986062|18893159|P2|NOT COMPLETED|Overall Study||1
7672439|NCT01986062|18893160|P1|NOT COMPLETED|Overall Study||1
7672440|NCT01986062|18893159|P2|COMPLETED|Overall Study||49
7672441|NCT01986062|18893160|P1|COMPLETED|Overall Study||46
7672442|NCT01986062|18893159|P2|STARTED|Overall Study||50
7672443|NCT01986062|18893160|P1|STARTED|Overall Study||47
7672444|NCT01985971|18893176|P1|NOT COMPLETED|Overall Study||1
7672445|NCT01985971|18893176|P1|COMPLETED|Overall Study||1
7672446|NCT01985971|18893176|P1|STARTED|Overall Study||2
7672447|NCT01985958|18893180|P1|NOT COMPLETED|Overall Study||1
7672448|NCT01985958|18893180|P1|COMPLETED|Overall Study||3
7672449|NCT01985958|18893180|P1|STARTED|Overall Study||4
7672450|NCT01985932|18893184|P1|NOT COMPLETED|Overall Study||0
7672451|NCT01985932|18893184|P1|COMPLETED|Overall Study||15
7672452|NCT01985932|18893184|P1|STARTED|Overall Study||15
7672453|NCT01985763|18893188|P1|NOT COMPLETED|Overall Study||0
7672454|NCT01985763|18893188|P1|COMPLETED|Overall Study||13
7672455|NCT01985763|18893188|P1|STARTED|Overall Study||13
7672456|NCT01985685|18893203|P2|NOT COMPLETED|Overall Study||0
7672457|NCT01985685|18893204|P1|NOT COMPLETED|Overall Study||0
7672458|NCT01985685|18893203|P2|COMPLETED|Overall Study||29
7672459|NCT01985685|18893204|P1|COMPLETED|Overall Study||27
7672460|NCT01985685|18893203|P2|STARTED|Overall Study||29
7672461|NCT01985685|18893204|P1|STARTED|Overall Study||27
7672462|NCT01985581|18893216|P2|NOT COMPLETED|Second Intervention||4
7672463|NCT01985581|18893217|P1|NOT COMPLETED|Second Intervention||2
7672464|NCT01985581|18893216|P2|COMPLETED|Second Intervention||19
7672465|NCT01985581|18893217|P1|COMPLETED|Second Intervention||20
7672466|NCT01985581|18893216|P2|STARTED|Second Intervention||23
7672467|NCT01985581|18893217|P1|STARTED|Second Intervention||22
7672468|NCT01985581|18893216|P2|NOT COMPLETED|First Intervention||2
7672469|NCT01985581|18893217|P1|NOT COMPLETED|First Intervention||3
7672470|NCT01985581|18893216|P2|COMPLETED|First Intervention||23
7672471|NCT01985581|18893217|P1|COMPLETED|First Intervention||22
7672472|NCT01985581|18893216|P2|STARTED|First Intervention||25
7672473|NCT01985581|18893217|P1|STARTED|First Intervention||25
7672474|NCT01985425|18893237|P2|NOT COMPLETED|Overall Study||0
7672475|NCT01985425|18893238|P1|NOT COMPLETED|Overall Study||0
7672476|NCT01985425|18893237|P2|COMPLETED|Overall Study||51
7672477|NCT01985425|18893238|P1|COMPLETED|Overall Study||49
7672478|NCT01985425|18893237|P2|STARTED|Overall Study||51
7672479|NCT01985425|18893238|P1|STARTED|Overall Study||49
7672480|NCT01985360|18893258|P2|NOT COMPLETED|Overall Study||3
7672481|NCT01985360|18893259|P1|NOT COMPLETED|Overall Study||9
7672482|NCT01985360|18893258|P2|COMPLETED|Overall Study||386
7672483|NCT01985360|18893259|P1|COMPLETED|Overall Study||379
7672484|NCT01985360|18893258|P2|STARTED|Overall Study||389
7672485|NCT01985360|18893259|P1|STARTED|Overall Study||388
7672486|NCT01985334|18893275|P8|NOT COMPLETED|Overall Study||121
7672487|NCT01985334|18893276|P7|NOT COMPLETED|Overall Study||37
7672488|NCT01985334|18893277|P6|NOT COMPLETED|Overall Study||156
7672489|NCT01985334|18893278|P5|NOT COMPLETED|Overall Study||40
7672490|NCT01985334|18893279|P4|NOT COMPLETED|Overall Study||229
7672491|NCT01985334|18893280|P3|NOT COMPLETED|Overall Study||53
7672492|NCT01985334|18893281|P2|NOT COMPLETED|Overall Study||84
7672493|NCT01985334|18893282|P1|NOT COMPLETED|Overall Study||23
7672494|NCT01985334|18893275|P8|COMPLETED|Overall Study||699
7672495|NCT01985334|18893276|P7|COMPLETED|Overall Study||237
7672496|NCT01985334|18893277|P6|COMPLETED|Overall Study||666
7672497|NCT01985334|18893278|P5|COMPLETED|Overall Study||234
7672498|NCT01985334|18893279|P4|COMPLETED|Overall Study||1033
7672499|NCT01985334|18893280|P3|COMPLETED|Overall Study||367
7672500|NCT01985334|18893281|P2|COMPLETED|Overall Study||303
7672501|NCT01985334|18893282|P1|COMPLETED|Overall Study||107
7672502|NCT01985334|18893275|P8|The Intention-to-treat (ITT) Population|Overall Study||811
7672503|NCT01985334|18893276|P7|The Intention-to-treat (ITT) Population|Overall Study||268
7672504|NCT01985334|18893277|P6|The Intention-to-treat (ITT) Population|Overall Study||811
7672505|NCT01985334|18893278|P5|The Intention-to-treat (ITT) Population|Overall Study||269
7672506|NCT01985334|18893279|P4|The Intention-to-treat (ITT) Population|Overall Study||1254
7672507|NCT01985334|18893280|P3|The Intention-to-treat (ITT) Population|Overall Study||420
7672508|NCT01985334|18893281|P2|The Intention-to-treat (ITT) Population|Overall Study||369
7672509|NCT01985334|18893282|P1|The Intention-to-treat (ITT) Population|Overall Study||122
7672510|NCT01985334|18893275|P8|STARTED|Overall Study||820
7672511|NCT01985334|18893276|P7|STARTED|Overall Study||274
7672512|NCT01985334|18893277|P6|STARTED|Overall Study||822
7672513|NCT01985334|18893278|P5|STARTED|Overall Study||274
7672514|NCT01985334|18893279|P4|STARTED|Overall Study||1262
7672515|NCT01985334|18893280|P3|STARTED|Overall Study||420
7672516|NCT01985334|18893281|P2|STARTED|Overall Study||387
7672517|NCT01985334|18893282|P1|STARTED|Overall Study||130
7672518|NCT01985321|18893350|P2|NOT COMPLETED|Overall Study||5
7672519|NCT01985321|18893351|P1|NOT COMPLETED|Overall Study||11
7672520|NCT01985321|18893350|P2|COMPLETED|Overall Study||78
7672521|NCT01985321|18893351|P1|COMPLETED|Overall Study||79
7672522|NCT01985321|18893350|P2|STARTED|Overall Study|This is treatment eligible subjects only|83
7672523|NCT01985321|18893351|P1|STARTED|Overall Study|This is Treatment Eligible Subjects only|90
7672524|NCT01985126|18893361|P2|NOT COMPLETED|Overall Study||106
7672525|NCT01985126|18893362|P1|NOT COMPLETED|Overall Study||18
7672526|NCT01985126|18893361|P2|COMPLETED|Overall Study||0
7672527|NCT01985126|18893362|P1|COMPLETED|Overall Study||0
7672528|NCT01985126|18893361|P2|STARTED|Overall Study||106
7672529|NCT01985126|18893362|P1|STARTED|Overall Study||18
7672530|NCT01984892|18893380|P1|NOT COMPLETED|Overall Study||7
7672531|NCT01984892|18893380|P1|COMPLETED|Overall Study|1 completed all study visits up until the termination of the study, last study visit not done.|1
7672532|NCT01984892|18893380|P1|STARTED|Overall Study||8
7672533|NCT01984697|18893391|P5|NOT COMPLETED|Overall Study||35
7672534|NCT01984697|18893392|P4|NOT COMPLETED|Overall Study||21
7672535|NCT01984697|18893393|P3|NOT COMPLETED|Overall Study||29
7672536|NCT01984697|18893394|P2|NOT COMPLETED|Overall Study||31
7672537|NCT01984697|18893395|P1|NOT COMPLETED|Overall Study||43
7672538|NCT01984697|18893391|P5|COMPLETED|Overall Study||279
7672539|NCT01984697|18893392|P4|COMPLETED|Overall Study||280
7672540|NCT01984697|18893393|P3|COMPLETED|Overall Study||272
7672541|NCT01984697|18893394|P2|COMPLETED|Overall Study||270
7672542|NCT01984697|18893395|P1|COMPLETED|Overall Study||258
7672543|NCT01984697|18893391|P5|Month 36 Vaccination|Overall Study||31
7672544|NCT01984697|18893392|P4|Month 36 Vaccination|Overall Study||9
7672545|NCT01984697|18893393|P3|Month 36 Vaccination|Overall Study||280
7672546|NCT01984697|18893394|P2|Month 36 Vaccination|Overall Study||281
7672547|NCT01984697|18893395|P1|Month 36 Vaccination|Overall Study||270
7672548|NCT01984697|18893391|P5|Vaccination 3|Overall Study||311
7672549|NCT01984697|18893392|P4|Vaccination 3|Overall Study||293
7672550|NCT01984697|18893393|P3|Vaccination 3|Overall Study||0
7672551|NCT01984697|18893394|P2|Vaccination 3|Overall Study||0
7672552|NCT01984697|18893395|P1|Vaccination 3|Overall Study||0
7672553|NCT01984697|18893391|P5|Vaccination 2|Overall Study||313
7672554|NCT01984697|18893392|P4|Vaccination 2|Overall Study||298
7672555|NCT01984697|18893393|P3|Vaccination 2|Overall Study||291
7672556|NCT01984697|18893394|P2|Vaccination 2|Overall Study||296
7672557|NCT01984697|18893395|P1|Vaccination 2|Overall Study||293
7672558|NCT01984697|18893391|P5|Vaccination 1|Overall Study||314
7672559|NCT01984697|18893392|P4|Vaccination 1|Overall Study||300
7672560|NCT01984697|18893393|P3|Vaccination 1|Overall Study||300
7672561|NCT01984697|18893394|P2|Vaccination 1|Overall Study||301
7672562|NCT01984697|18893395|P1|Vaccination 1|Overall Study||301
7672563|NCT01984697|18893391|P5|STARTED|Overall Study||314
7672564|NCT01984697|18893392|P4|STARTED|Overall Study||301
7672565|NCT01984697|18893393|P3|STARTED|Overall Study||301
7672566|NCT01984697|18893394|P2|STARTED|Overall Study||301
7672567|NCT01984697|18893395|P1|STARTED|Overall Study||301
7672568|NCT01984684|18893514|P2|NOT COMPLETED|Overall Study||59
7672569|NCT01984684|18893515|P1|NOT COMPLETED|Overall Study||57
7672570|NCT01984684|18893514|P2|COMPLETED|Overall Study||368
7672571|NCT01984684|18893515|P1|COMPLETED|Overall Study||366
7672572|NCT01984684|18893514|P2|STARTED|Overall Study||427
7672573|NCT01984684|18893515|P1|STARTED|Overall Study||423
7672574|NCT01984515|18893525|P1|NOT COMPLETED|Overall Study||19
7672575|NCT01984515|18893525|P1|COMPLETED|Overall Study||40
7672576|NCT01984515|18893525|P1|Received CBT Session|Overall Study||40
7672577|NCT01984515|18893525|P1|STARTED|Overall Study||59
7672578|NCT01984424|18893533|P2|NOT COMPLETED|Overall Study||7
7672579|NCT01984424|18893534|P1|NOT COMPLETED|Overall Study||3
7672580|NCT01984424|18893533|P2|COMPLETED|Overall Study||138
7672581|NCT01984424|18893534|P1|COMPLETED|Overall Study||70
7672582|NCT01984424|18893533|P2|STARTED|Overall Study||145
7672583|NCT01984424|18893534|P1|STARTED|Overall Study||73
7672584|NCT01984398|18893588|P4|NOT COMPLETED|Treatment Period 2||0
7672585|NCT01984398|18893589|P3|NOT COMPLETED|Treatment Period 2||0
7672586|NCT01984398|18893590|P2|NOT COMPLETED|Treatment Period 2||0
7672587|NCT01984398|18893591|P1|NOT COMPLETED|Treatment Period 2||0
7672588|NCT01984398|18893588|P4|COMPLETED|Treatment Period 2||4
7672589|NCT01984398|18893589|P3|COMPLETED|Treatment Period 2||4
7672590|NCT01984398|18893590|P2|COMPLETED|Treatment Period 2||4
7672591|NCT01984398|18893591|P1|COMPLETED|Treatment Period 2||4
7672592|NCT01984398|18893588|P4|STARTED|Treatment Period 2||4
7672593|NCT01984398|18893589|P3|STARTED|Treatment Period 2||4
7672594|NCT01984398|18893590|P2|STARTED|Treatment Period 2||4
7672595|NCT01984398|18893591|P1|STARTED|Treatment Period 2||4
7672596|NCT01984398|18893588|P4|NOT COMPLETED|Washout Period of 5 to 7 Days||0
7672597|NCT01984398|18893589|P3|NOT COMPLETED|Washout Period of 5 to 7 Days||0
7672598|NCT01984398|18893590|P2|NOT COMPLETED|Washout Period of 5 to 7 Days||0
7672599|NCT01984398|18893591|P1|NOT COMPLETED|Washout Period of 5 to 7 Days||0
7672600|NCT01984398|18893588|P4|COMPLETED|Washout Period of 5 to 7 Days||4
7672601|NCT01984398|18893589|P3|COMPLETED|Washout Period of 5 to 7 Days||4
7672602|NCT01984398|18893590|P2|COMPLETED|Washout Period of 5 to 7 Days||4
7672603|NCT01984398|18893591|P1|COMPLETED|Washout Period of 5 to 7 Days||4
7672604|NCT01984398|18893588|P4|STARTED|Washout Period of 5 to 7 Days||4
7672605|NCT01984398|18893589|P3|STARTED|Washout Period of 5 to 7 Days||4
7672606|NCT01984398|18893590|P2|STARTED|Washout Period of 5 to 7 Days||4
7672607|NCT01984398|18893591|P1|STARTED|Washout Period of 5 to 7 Days||4
7672608|NCT01984398|18893588|P4|NOT COMPLETED|Treatment Period 1||0
7672609|NCT01984398|18893589|P3|NOT COMPLETED|Treatment Period 1||0
7672610|NCT01984398|18893590|P2|NOT COMPLETED|Treatment Period 1||0
7672611|NCT01984398|18893591|P1|NOT COMPLETED|Treatment Period 1||0
7672612|NCT01984398|18893588|P4|COMPLETED|Treatment Period 1||4
7672613|NCT01984398|18893589|P3|COMPLETED|Treatment Period 1||4
7672614|NCT01984398|18893590|P2|COMPLETED|Treatment Period 1||4
7672615|NCT01984398|18893591|P1|COMPLETED|Treatment Period 1||4
7672616|NCT01984398|18893588|P4|STARTED|Treatment Period 1||4
7672617|NCT01984398|18893589|P3|STARTED|Treatment Period 1||4
7672618|NCT01984398|18893590|P2|STARTED|Treatment Period 1||4
7672619|NCT01984398|18893591|P1|STARTED|Treatment Period 1||4
7672620|NCT01984294|18893604|P3|NOT COMPLETED|Overall Study||7
7672621|NCT01984294|18893605|P2|NOT COMPLETED|Overall Study||3
7672622|NCT01984294|18893606|P1|NOT COMPLETED|Overall Study||4
7672623|NCT01984294|18893604|P3|COMPLETED|Overall Study||27
7672624|NCT01984294|18893605|P2|COMPLETED|Overall Study||29
7672625|NCT01984294|18893606|P1|COMPLETED|Overall Study||31
7672626|NCT01984294|18893604|P3|STARTED|Overall Study||34
7672627|NCT01984294|18893605|P2|STARTED|Overall Study||32
7672628|NCT01984294|18893606|P1|STARTED|Overall Study||35
7672629|NCT01984242|18893629|P3|NOT COMPLETED|Overall Study||101
7672630|NCT01984242|18893630|P2|NOT COMPLETED|Overall Study||103
7672631|NCT01984242|18893631|P1|NOT COMPLETED|Overall Study||101
7672632|NCT01984242|18893629|P3|COMPLETED|Overall Study||0
7672633|NCT01984242|18893630|P2|COMPLETED|Overall Study||0
7672634|NCT01984242|18893631|P1|COMPLETED|Overall Study||0
7672635|NCT01984242|18893629|P3|Treated|Overall Study||100
7672636|NCT01984242|18893630|P2|Treated|Overall Study||103
7672637|NCT01984242|18893631|P1|Treated|Overall Study||101
7672638|NCT01984242|18893629|P3|STARTED|Overall Study||101
7672639|NCT01984242|18893630|P2|STARTED|Overall Study||103
7672640|NCT01984242|18893631|P1|STARTED|Overall Study||101
7672641|NCT01984229|18893781|P2|NOT COMPLETED|Safety Follow-up Period||1
7672642|NCT01984229|18893782|P1|NOT COMPLETED|Safety Follow-up Period||2
7672643|NCT01984229|18893781|P2|COMPLETED|Safety Follow-up Period||16
7672644|NCT01984229|18893782|P1|COMPLETED|Safety Follow-up Period||4
7672645|NCT01984229|18893781|P2|STARTED|Safety Follow-up Period||17
7672646|NCT01984229|18893782|P1|STARTED|Safety Follow-up Period||6
7672647|NCT01984229|18893781|P2|NOT COMPLETED|Period 3||0
7672648|NCT01984229|18893782|P1|NOT COMPLETED|Period 3||0
7672649|NCT01984229|18893781|P2|COMPLETED|Period 3||17
7672650|NCT01984229|18893782|P1|COMPLETED|Period 3||6
7672651|NCT01984229|18893781|P2|STARTED|Period 3||17
7672652|NCT01984229|18893782|P1|STARTED|Period 3||6
7672653|NCT01984229|18893781|P2|NOT COMPLETED|Period 2||0
7672654|NCT01984229|18893782|P1|NOT COMPLETED|Period 2||0
7672655|NCT01984229|18893781|P2|COMPLETED|Period 2||17
7672656|NCT01984229|18893782|P1|COMPLETED|Period 2||6
7672657|NCT01984229|18893781|P2|STARTED|Period 2||17
7672658|NCT01984229|18893782|P1|STARTED|Period 2||6
7672659|NCT01984229|18893781|P2|NOT COMPLETED|Period 1||0
7672660|NCT01984229|18893782|P1|NOT COMPLETED|Period 1||0
7672661|NCT01984229|18893781|P2|COMPLETED|Period 1||17
7672662|NCT01984229|18893782|P1|COMPLETED|Period 1||6
7672663|NCT01984229|18893781|P2|STARTED|Period 1||17
7672664|NCT01984229|18893782|P1|STARTED|Period 1||6
7672665|NCT01983969|18893835|P3|NOT COMPLETED|Overall Study||0
7672666|NCT01983969|18893836|P2|NOT COMPLETED|Overall Study||1
7672667|NCT01983969|18893837|P1|NOT COMPLETED|Overall Study||0
7672668|NCT01983969|18893835|P3|COMPLETED|Overall Study||5
7672669|NCT01983969|18893836|P2|COMPLETED|Overall Study||18
7672670|NCT01983969|18893837|P1|COMPLETED|Overall Study||37
7672671|NCT01983969|18893835|P3|STARTED|Overall Study||5
7672672|NCT01983969|18893836|P2|STARTED|Overall Study||19
7672673|NCT01983969|18893837|P1|STARTED|Overall Study||37
7672674|NCT01983930|18893851|P2|NOT COMPLETED|Overall Study||9
7672675|NCT01983930|18893852|P1|NOT COMPLETED|Overall Study||9
7672676|NCT01983930|18893851|P2|COMPLETED|Overall Study||29
7672677|NCT01983930|18893852|P1|COMPLETED|Overall Study||32
7672678|NCT01983930|18893851|P2|STARTED|Overall Study||38
7672679|NCT01983930|18893852|P1|STARTED|Overall Study||41
7672680|NCT01983878|18893864|P1|NOT COMPLETED|Overall Study||0
7672681|NCT01983878|18893864|P1|COMPLETED|Overall Study||36
7672682|NCT01983878|18893864|P1|Received At Least One Dose of Study Drug|Overall Study||36
7672683|NCT01983878|18893864|P1|STARTED|Overall Study||36
7672684|NCT01983839|18893875|P1|NOT COMPLETED|Overall Study||0
7672685|NCT01983839|18893875|P1|COMPLETED|Overall Study||18
7672686|NCT01983839|18893875|P1|STARTED|Overall Study||18
7672687|NCT01983826|18893882|P2|NOT COMPLETED|Overall Study||0
7672688|NCT01983826|18893883|P1|NOT COMPLETED|Overall Study||0
7672689|NCT01983826|18893882|P2|COMPLETED|Overall Study||8
7672690|NCT01983826|18893883|P1|COMPLETED|Overall Study||13
7672691|NCT01983826|18893882|P2|STARTED|Overall Study||8
7672692|NCT01983826|18893883|P1|STARTED|Overall Study||13
7672693|NCT01983787|18893901|P1|NOT COMPLETED|Overall Study||0
7672694|NCT01983787|18893901|P1|COMPLETED|Overall Study||10
7672695|NCT01983787|18893901|P1|STARTED|Overall Study||10
7672696|NCT01983683|18893926|P2|NOT COMPLETED|Overall Study||51
7672697|NCT01983683|18893927|P1|NOT COMPLETED|Overall Study||38
7672698|NCT01983683|18893926|P2|COMPLETED|Overall Study||260
7672699|NCT01983683|18893927|P1|COMPLETED|Overall Study||260
7672700|NCT01983683|18893926|P2|STARTED|Overall Study||311
7672701|NCT01983683|18893927|P1|STARTED|Overall Study||298
7672702|NCT01983566|18893955|P4|NOT COMPLETED|Test Period 4||0
7672703|NCT01983566|18893956|P3|NOT COMPLETED|Test Period 4||0
7672704|NCT01983566|18893957|P2|NOT COMPLETED|Test Period 4||0
7672705|NCT01983566|18893958|P1|NOT COMPLETED|Test Period 4||0
7672706|NCT01983566|18893955|P4|COMPLETED|Test Period 4||0
7672707|NCT01983566|18893956|P3|COMPLETED|Test Period 4||0
7672708|NCT01983566|18893957|P2|COMPLETED|Test Period 4||0
7672709|NCT01983566|18893958|P1|COMPLETED|Test Period 4||0
7672710|NCT01983566|18893955|P4|STARTED|Test Period 4||0
7672711|NCT01983566|18893956|P3|STARTED|Test Period 4||0
7672712|NCT01983566|18893957|P2|STARTED|Test Period 4||0
7672713|NCT01983566|18893958|P1|STARTED|Test Period 4||0
7672714|NCT01983566|18893955|P4|NOT COMPLETED|Wash-Out 3||0
7672715|NCT01983566|18893956|P3|NOT COMPLETED|Wash-Out 3||0
7672716|NCT01983566|18893957|P2|NOT COMPLETED|Wash-Out 3||0
7672717|NCT01983566|18893958|P1|NOT COMPLETED|Wash-Out 3||0
7672718|NCT01983566|18893955|P4|COMPLETED|Wash-Out 3||0
7672719|NCT01983566|18893956|P3|COMPLETED|Wash-Out 3||0
7672720|NCT01983566|18893957|P2|COMPLETED|Wash-Out 3||0
7672721|NCT01983566|18893958|P1|COMPLETED|Wash-Out 3||0
7672722|NCT01983566|18893955|P4|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
7672723|NCT01983566|18893956|P3|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
7672724|NCT01983566|18893957|P2|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
7672725|NCT01983566|18893958|P1|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
7672726|NCT01983566|18893955|P4|NOT COMPLETED|Test Period 3||0
7672727|NCT01983566|18893956|P3|NOT COMPLETED|Test Period 3||0
7672728|NCT01983566|18893957|P2|NOT COMPLETED|Test Period 3||0
7672729|NCT01983566|18893958|P1|NOT COMPLETED|Test Period 3||0
7672730|NCT01983566|18893955|P4|COMPLETED|Test Period 3||4
7672731|NCT01983566|18893956|P3|COMPLETED|Test Period 3||2
7672732|NCT01983566|18893957|P2|COMPLETED|Test Period 3||3
7672733|NCT01983566|18893958|P1|COMPLETED|Test Period 3||2
7672734|NCT01983566|18893955|P4|STARTED|Test Period 3||4
7672735|NCT01983566|18893956|P3|STARTED|Test Period 3||2
7672736|NCT01983566|18893957|P2|STARTED|Test Period 3||3
7672737|NCT01983566|18893958|P1|STARTED|Test Period 3||2
7672738|NCT01983566|18893955|P4|NOT COMPLETED|Wash-Out 2||0
7672739|NCT01983566|18893956|P3|NOT COMPLETED|Wash-Out 2||0
7672740|NCT01983566|18893957|P2|NOT COMPLETED|Wash-Out 2||0
7672741|NCT01983566|18893958|P1|NOT COMPLETED|Wash-Out 2||0
7672742|NCT01983566|18893955|P4|COMPLETED|Wash-Out 2||4
7672743|NCT01983566|18893956|P3|COMPLETED|Wash-Out 2||2
7672744|NCT01983566|18893957|P2|COMPLETED|Wash-Out 2||3
7672745|NCT01983566|18893958|P1|COMPLETED|Wash-Out 2||2
7672746|NCT01983566|18893955|P4|STARTED|Wash-Out 2||4
7672747|NCT01983566|18893956|P3|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
7672748|NCT01983566|18893957|P2|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3
7672749|NCT01983566|18893958|P1|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
7672750|NCT01983566|18893955|P4|NOT COMPLETED|Test Period 2||0
7672751|NCT01983566|18893956|P3|NOT COMPLETED|Test Period 2||0
7672752|NCT01983566|18893957|P2|NOT COMPLETED|Test Period 2||0
7672753|NCT01983566|18893958|P1|NOT COMPLETED|Test Period 2||0
7672754|NCT01983566|18893955|P4|COMPLETED|Test Period 2||4
7672755|NCT01983566|18893956|P3|COMPLETED|Test Period 2||4
7672756|NCT01983566|18893957|P2|COMPLETED|Test Period 2||4
7672757|NCT01983566|18893958|P1|COMPLETED|Test Period 2||4
7672758|NCT01983566|18893955|P4|STARTED|Test Period 2||4
7672759|NCT01983566|18893956|P3|STARTED|Test Period 2||4
7672760|NCT01983566|18893957|P2|STARTED|Test Period 2||4
7672761|NCT01983566|18893958|P1|STARTED|Test Period 2||4
7672762|NCT01983566|18893955|P4|NOT COMPLETED|Wash-Out 1||0
7672763|NCT01983566|18893956|P3|NOT COMPLETED|Wash-Out 1||0
7672764|NCT01983566|18893957|P2|NOT COMPLETED|Wash-Out 1||0
7672765|NCT01983566|18893958|P1|NOT COMPLETED|Wash-Out 1||0
7672766|NCT01983566|18893955|P4|COMPLETED|Wash-Out 1||4
7672767|NCT01983566|18893956|P3|COMPLETED|Wash-Out 1||4
7672768|NCT01983566|18893957|P2|COMPLETED|Wash-Out 1||4
7672769|NCT01983566|18893958|P1|COMPLETED|Wash-Out 1||4
7672770|NCT01983566|18893955|P4|STARTED|Wash-Out 1||4
7672771|NCT01983566|18893956|P3|STARTED|Wash-Out 1||4
7672772|NCT01983566|18893957|P2|STARTED|Wash-Out 1||4
7672773|NCT01983566|18893958|P1|STARTED|Wash-Out 1||4
7672774|NCT01983566|18893955|P4|NOT COMPLETED|Test Period 1||0
7672775|NCT01983566|18893956|P3|NOT COMPLETED|Test Period 1||0
7672776|NCT01983566|18893957|P2|NOT COMPLETED|Test Period 1||0
7672777|NCT01983566|18893958|P1|NOT COMPLETED|Test Period 1||0
7672778|NCT01983566|18893955|P4|COMPLETED|Test Period 1||4
7672779|NCT01983566|18893956|P3|COMPLETED|Test Period 1||4
7672780|NCT01983566|18893957|P2|COMPLETED|Test Period 1||4
7672781|NCT01983566|18893958|P1|COMPLETED|Test Period 1||4
7672782|NCT01983566|18893955|P4|STARTED|Test Period 1||4
7672783|NCT01983566|18893956|P3|STARTED|Test Period 1||4
7672784|NCT01983566|18893957|P2|STARTED|Test Period 1||4
7672785|NCT01983566|18893958|P1|STARTED|Test Period 1||4
7672786|NCT01983553|18893979|P2|NOT COMPLETED|Overall Study||0
7672787|NCT01983553|18893980|P1|NOT COMPLETED|Overall Study||0
7672788|NCT01983553|18893979|P2|COMPLETED|Overall Study||1072
7672789|NCT01983553|18893980|P1|COMPLETED|Overall Study||2131
7672790|NCT01983553|18893979|P2|STARTED|Overall Study||1072
7672791|NCT01983553|18893980|P1|STARTED|Overall Study||2131
7672792|NCT01983293|18894014|P2|NOT COMPLETED|Overall Study||19
7672793|NCT01983293|18894015|P1|NOT COMPLETED|Overall Study||33
7672794|NCT01983293|18894014|P2|COMPLETED|Overall Study||62
7672795|NCT01983293|18894015|P1|COMPLETED|Overall Study||128
7672796|NCT01983293|18894014|P2|STARTED|Overall Study||81
7672797|NCT01983293|18894015|P1|STARTED|Overall Study||161
7672798|NCT01983254|18894023|P2|NOT COMPLETED|Overall Study||30
7672799|NCT01983254|18894024|P1|NOT COMPLETED|Overall Study||34
7672800|NCT01983254|18894023|P2|COMPLETED|Overall Study|69 patients, 37 caregivers|106
7672801|NCT01983254|18894024|P1|COMPLETED|Overall Study|62 patients, 29 caregivers|91
7672802|NCT01983254|18894023|P2|Interview 3|Overall Study|69 patients, 37 caregivers|106
7672803|NCT01983254|18894024|P1|Interview 3|Overall Study|62 patients, 29 caregivers|91
7672804|NCT01983254|18894023|P2|Interview 2|Overall Study|71 patients, 39 caregivers|110
7672805|NCT01983254|18894024|P1|Interview 2|Overall Study|65 patients, 30 caregivers|95
7672806|NCT01983254|18894023|P2|Interview 1|Overall Study|89 patients, 47 caregivers|136
7672807|NCT01983254|18894024|P1|Interview 1|Overall Study|86 patients, 39 caregivers|125
7672808|NCT01983254|18894023|P2|STARTED|Overall Study|89 patients, 47 caregivers|136
7672809|NCT01983254|18894024|P1|STARTED|Overall Study|86 patients, 39 caregivers|125
7672810|NCT01983111|18894036|P2|NOT COMPLETED|Overall Study||7
7672811|NCT01983111|18894037|P1|NOT COMPLETED|Overall Study||12
7672812|NCT01983111|18894036|P2|COMPLETED|Overall Study||59
7672813|NCT01983111|18894037|P1|COMPLETED|Overall Study||58
7672814|NCT01983111|18894036|P2|STARTED|Overall Study||66
7672815|NCT01983111|18894037|P1|STARTED|Overall Study||70
7672816|NCT01983020|18894057|P4|NOT COMPLETED|Overall Study||0
7672817|NCT01983020|18894058|P3|NOT COMPLETED|Overall Study||0
7672818|NCT01983020|18894059|P2|NOT COMPLETED|Overall Study||0
7672819|NCT01983020|18894060|P1|NOT COMPLETED|Overall Study||0
7672820|NCT01983020|18894057|P4|COMPLETED|Overall Study||11
7672821|NCT01983020|18894058|P3|COMPLETED|Overall Study||12
7672822|NCT01983020|18894059|P2|COMPLETED|Overall Study||11
7672823|NCT01983020|18894060|P1|COMPLETED|Overall Study||12
7672824|NCT01983020|18894057|P4|STARTED|Overall Study||11
7672825|NCT01983020|18894058|P3|STARTED|Overall Study||12
7672826|NCT01983020|18894059|P2|STARTED|Overall Study||11
7672827|NCT01983020|18894060|P1|STARTED|Overall Study||12
7672828|NCT01982955|18894075|P5|NOT COMPLETED|Overall Study||0
7672829|NCT01982955|18894076|P4|NOT COMPLETED|Overall Study||1
7672830|NCT01982955|18894077|P3|NOT COMPLETED|Overall Study||4
7672831|NCT01982955|18894078|P2|NOT COMPLETED|Overall Study||0
7672832|NCT01982955|18894079|P1|NOT COMPLETED|Overall Study||0
7672833|NCT01982955|18894075|P5|COMPLETED|Overall Study||15
7672834|NCT01982955|18894076|P4|COMPLETED|Overall Study||23
7672835|NCT01982955|18894077|P3|COMPLETED|Overall Study||27
7672836|NCT01982955|18894078|P2|COMPLETED|Overall Study||12
7672837|NCT01982955|18894079|P1|COMPLETED|Overall Study||6
7672838|NCT01982955|18894075|P5|Treated|Overall Study||15
7672839|NCT01982955|18894076|P4|Treated|Overall Study||23
7672840|NCT01982955|18894077|P3|Treated|Overall Study||31
7672841|NCT01982955|18894078|P2|Treated|Overall Study||12
7672842|NCT01982955|18894079|P1|Treated|Overall Study||6
7672843|NCT01982955|18894075|P5|STARTED|Overall Study||15
7672844|NCT01982955|18894076|P4|STARTED|Overall Study||24
7672845|NCT01982955|18894077|P3|STARTED|Overall Study||31
7672846|NCT01982955|18894078|P2|STARTED|Overall Study||12
7672847|NCT01982955|18894079|P1|STARTED|Overall Study||6
7672848|NCT01982942|18894181|P2|NOT COMPLETED|Overall Study||14
7672849|NCT01982942|18894182|P1|NOT COMPLETED|Overall Study||21
7672850|NCT01982942|18894181|P2|COMPLETED|Overall Study||112
7672851|NCT01982942|18894182|P1|COMPLETED|Overall Study||108
7672852|NCT01982942|18894181|P2|STARTED|Overall Study||126
7672853|NCT01982942|18894182|P1|STARTED|Overall Study||129
7672854|NCT01982812|18894200|P2|NOT COMPLETED|Overall Study||10
7672855|NCT01982812|18894201|P1|NOT COMPLETED|Overall Study||1
7672856|NCT01982812|18894200|P2|COMPLETED|Overall Study||11
7672857|NCT01982812|18894201|P1|COMPLETED|Overall Study||22
7672858|NCT01982812|18894200|P2|STARTED|Overall Study||21
7672859|NCT01982812|18894201|P1|STARTED|Overall Study||23
7672860|NCT01982786|18894215|P2|NOT COMPLETED|Overall Study||0
7672861|NCT01982786|18894216|P1|NOT COMPLETED|Overall Study||0
7672862|NCT01982786|18894215|P2|COMPLETED|Overall Study||28
7672863|NCT01982786|18894216|P1|COMPLETED|Overall Study||29
7672864|NCT01982786|18894215|P2|STARTED|Overall Study||28
7672865|NCT01982786|18894216|P1|STARTED|Overall Study||29
7672866|NCT01982773|18894230|P2|NOT COMPLETED|Overall Study||4
7672867|NCT01982773|18894231|P1|NOT COMPLETED|Overall Study||8
7672868|NCT01982773|18894230|P2|COMPLETED|Overall Study||56
7672869|NCT01982773|18894231|P1|COMPLETED|Overall Study||50
7672870|NCT01982773|18894230|P2|STARTED|Overall Study||60
7672871|NCT01982773|18894231|P1|STARTED|Overall Study||58
7672872|NCT01982695|18894245|P2|NOT COMPLETED|Overall Study||1
7672873|NCT01982695|18894246|P1|NOT COMPLETED|Overall Study||0
7672874|NCT01982695|18894245|P2|COMPLETED|Overall Study||10
7672875|NCT01982695|18894246|P1|COMPLETED|Overall Study||12
7672876|NCT01982695|18894245|P2|STARTED|Overall Study||11
7672877|NCT01982695|18894246|P1|STARTED|Overall Study||12
7672878|NCT01982682|18894252|P1|NOT COMPLETED|Overall Study||1
7672879|NCT01982682|18894252|P1|COMPLETED|Overall Study||40
7672880|NCT01982682|18894252|P1|STARTED|Overall Study||41
7672881|NCT01982643|18894260|P1|NOT COMPLETED|Overall Study||12
7672882|NCT01982643|18894260|P1|COMPLETED|Overall Study||37
7672883|NCT01982643|18894260|P1|STARTED|Overall Study||49
7672884|NCT01982539|18894264|P1|NOT COMPLETED|Overall Study||0
7672885|NCT01982539|18894264|P1|COMPLETED|Overall Study||25
7672886|NCT01982539|18894264|P1|STARTED|Overall Study||25
7672887|NCT01982435|18894272|P2|NOT COMPLETED|Overall Study||0
7672888|NCT01982435|18894273|P1|NOT COMPLETED|Overall Study||1
7672889|NCT01982435|18894272|P2|COMPLETED|Overall Study||12
7672890|NCT01982435|18894273|P1|COMPLETED|Overall Study||14
7672891|NCT01982435|18894272|P2|STARTED|Overall Study||12
7672892|NCT01982435|18894273|P1|STARTED|Overall Study||15
7672893|NCT01982383|18894303|P2|NOT COMPLETED|Overall Study||0
7672894|NCT01982383|18894304|P1|NOT COMPLETED|Overall Study||0
7672895|NCT01982383|18894303|P2|COMPLETED|Overall Study||0
7672896|NCT01982383|18894304|P1|COMPLETED|Overall Study||2
7672897|NCT01982383|18894303|P2|STARTED|Overall Study||0
7672898|NCT01982383|18894304|P1|STARTED|Overall Study||2
7672899|NCT01982331|18894312|P2|NOT COMPLETED|Completed Study (Day 112)||0
7672900|NCT01982331|18894313|P1|NOT COMPLETED|Completed Study (Day 112)||2
7672901|NCT01982331|18894312|P2|COMPLETED|Completed Study (Day 112)||7
7672902|NCT01982331|18894313|P1|COMPLETED|Completed Study (Day 112)||25
7672903|NCT01982331|18894312|P2|STARTED|Completed Study (Day 112)||7
7672904|NCT01982331|18894313|P1|STARTED|Completed Study (Day 112)||27
7672905|NCT01982331|18894312|P2|NOT COMPLETED|Received Vaccination 2||3
7672906|NCT01982331|18894313|P1|NOT COMPLETED|Received Vaccination 2||1
7672907|NCT01982331|18894312|P2|COMPLETED|Received Vaccination 2||7
7672908|NCT01982331|18894313|P1|COMPLETED|Received Vaccination 2||27
7672909|NCT01982331|18894312|P2|STARTED|Received Vaccination 2||10
7672910|NCT01982331|18894313|P1|STARTED|Received Vaccination 2||28
7672911|NCT01982331|18894312|P2|NOT COMPLETED|Received Vaccination 1||0
7672912|NCT01982331|18894313|P1|NOT COMPLETED|Received Vaccination 1||0
7672913|NCT01982331|18894312|P2|COMPLETED|Received Vaccination 1||10
7672914|NCT01982331|18894313|P1|COMPLETED|Received Vaccination 1||28
7672915|NCT01982331|18894312|P2|STARTED|Received Vaccination 1||10
7672916|NCT01982331|18894313|P1|STARTED|Received Vaccination 1||28
7672917|NCT01982292|18894349|P2|NOT COMPLETED|Overall Study||1
7672918|NCT01982292|18894350|P1|NOT COMPLETED|Overall Study||12
7672919|NCT01982292|18894349|P2|COMPLETED|Overall Study||107
7672920|NCT01982292|18894350|P1|COMPLETED|Overall Study||203
7672921|NCT01982292|18894349|P2|Safety Set|Overall Study||108
7672922|NCT01982292|18894350|P1|Safety Set|Overall Study||212
7672923|NCT01982292|18894349|P2|Full Analaysis Set (FAS)|Overall Study||108
7672924|NCT01982292|18894350|P1|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213
7672925|NCT01982292|18894349|P2|STARTED|Overall Study||108
7672926|NCT01982292|18894350|P1|STARTED|Overall Study|"Started indicates Randomized set"|215
7672927|NCT01982253|18894371|P3|NOT COMPLETED|Overall Study||4
7672928|NCT01982253|18894372|P2|NOT COMPLETED|Overall Study||4
7672929|NCT01982253|18894373|P1|NOT COMPLETED|Overall Study||2
7672930|NCT01982253|18894371|P3|COMPLETED|Overall Study||0
7672931|NCT01982253|18894372|P2|COMPLETED|Overall Study||0
7672932|NCT01982253|18894373|P1|COMPLETED|Overall Study||0
7672933|NCT01982253|18894371|P3|STARTED|Overall Study||4
7672934|NCT01982253|18894372|P2|STARTED|Overall Study||4
7672935|NCT01982253|18894373|P1|STARTED|Overall Study||2
7672936|NCT01982240|18894387|P3|NOT COMPLETED|Overall Study||70
7672937|NCT01982240|18894388|P2|NOT COMPLETED|Overall Study||69
7672938|NCT01982240|18894389|P1|NOT COMPLETED|Overall Study||67
7672939|NCT01982240|18894387|P3|COMPLETED|Overall Study||371
7672940|NCT01982240|18894388|P2|COMPLETED|Overall Study||384
7672941|NCT01982240|18894389|P1|COMPLETED|Overall Study||385
7672942|NCT01982240|18894387|P3|STARTED|Overall Study||441
7672943|NCT01982240|18894388|P2|STARTED|Overall Study||453
7672944|NCT01982240|18894389|P1|STARTED|Overall Study||452
7672945|NCT01982123|18894409|P1|NOT COMPLETED|Overall Study||0
7672946|NCT01982123|18894409|P1|COMPLETED|Overall Study||12
7672947|NCT01982123|18894409|P1|STARTED|Overall Study||12
7672948|NCT01981967|18894416|P2|NOT COMPLETED|Overall Study||0
7672949|NCT01981967|18894417|P1|NOT COMPLETED|Overall Study||0
7672950|NCT01981967|18894416|P2|COMPLETED|Overall Study||3149
7672951|NCT01981967|18894417|P1|COMPLETED|Overall Study||6851
7672952|NCT01981967|18894416|P2|STARTED|Overall Study||3149
7672953|NCT01981967|18894417|P1|STARTED|Overall Study||6851
7672954|NCT01981954|18894427|P1|NOT COMPLETED|Fixed-Dose Assessment Period||1
7672955|NCT01981954|18894427|P1|COMPLETED|Fixed-Dose Assessment Period||21
7672956|NCT01981954|18894427|P1|Treated|Fixed-Dose Assessment Period||22
7672957|NCT01981954|18894427|P1|STARTED|Fixed-Dose Assessment Period||22
7672958|NCT01981954|18894427|P1|NOT COMPLETED|Titration Period||1
7672959|NCT01981954|18894427|P1|COMPLETED|Titration Period||22
7672960|NCT01981954|18894427|P1|Treated|Titration Period||23
7672961|NCT01981954|18894427|P1|STARTED|Titration Period||23
7672962|NCT01981863|18894474|P2|NOT COMPLETED|Overall Study||0
7672963|NCT01981863|18894475|P1|NOT COMPLETED|Overall Study||0
7672964|NCT01981863|18894474|P2|COMPLETED|Overall Study||20
7672965|NCT01981863|18894475|P1|COMPLETED|Overall Study||20
7672966|NCT01981863|18894474|P2|STARTED|Overall Study||20
7672967|NCT01981863|18894475|P1|STARTED|Overall Study||20
7672968|NCT01981772|18894487|P2|NOT COMPLETED|Overall Study||0
7672969|NCT01981772|18894488|P1|NOT COMPLETED|Overall Study||0
7672970|NCT01981772|18894487|P2|COMPLETED|Overall Study||43
7672971|NCT01981772|18894488|P1|COMPLETED|Overall Study||45
7672972|NCT01981772|18894487|P2|STARTED|Overall Study||43
7672973|NCT01981772|18894488|P1|STARTED|Overall Study||45
7672974|NCT01981759|18894498|P2|NOT COMPLETED|Overall Study||11
7672975|NCT01981759|18894499|P1|NOT COMPLETED|Overall Study||7
7672976|NCT01981759|18894498|P2|COMPLETED|Overall Study||19
7672977|NCT01981759|18894499|P1|COMPLETED|Overall Study||21
7672978|NCT01981759|18894498|P2|Completed Week 12|Overall Study||22
7672979|NCT01981759|18894499|P1|Completed Week 12|Overall Study||22
7672980|NCT01981759|18894498|P2|Randomization (Week 3)|Overall Study||30
7672981|NCT01981759|18894499|P1|Randomization (Week 3)|Overall Study||28
7672982|NCT01981759|18894498|P2|Baseline (Week 1)|Overall Study||30
7672983|NCT01981759|18894499|P1|Baseline (Week 1)|Overall Study||28
7672984|NCT01981759|18894498|P2|STARTED|Overall Study||30
7672985|NCT01981759|18894499|P1|STARTED|Overall Study||28
7672986|NCT01981616|18894511|P2|NOT COMPLETED|Overall Study||1
7672987|NCT01981616|18894512|P1|NOT COMPLETED|Overall Study||1
7672988|NCT01981616|18894511|P2|COMPLETED|Overall Study||62
7672989|NCT01981616|18894512|P1|COMPLETED|Overall Study||63
7672990|NCT01981616|18894511|P2|STARTED|Overall Study||63
7672991|NCT01981616|18894512|P1|STARTED|Overall Study||64
7672992|NCT01981590|18894524|P1|NOT COMPLETED|Overall Study||0
7672993|NCT01981590|18894524|P1|COMPLETED|Overall Study||15
7672994|NCT01981590|18894524|P1|STARTED|Overall Study||15
7672995|NCT01981564|18894533|P2|NOT COMPLETED|Overall Study||9
7672996|NCT01981564|18894534|P1|NOT COMPLETED|Overall Study||9
7672997|NCT01981564|18894533|P2|COMPLETED|Overall Study||106
7672998|NCT01981564|18894534|P1|COMPLETED|Overall Study||98
7672999|NCT01981564|18894533|P2|STARTED|Overall Study||115
7673000|NCT01981564|18894534|P1|STARTED|Overall Study||107
7673001|NCT01981551|18894542|P1|NOT COMPLETED|Overall Study||9
7673002|NCT01981551|18894542|P1|COMPLETED|Overall Study||8
7673003|NCT01981551|18894542|P1|STARTED|Overall Study||17
7673004|NCT01981473|18894552|P3|NOT COMPLETED|Overall Study||8
7673005|NCT01981473|18894553|P2|NOT COMPLETED|Overall Study||0
7673006|NCT01981473|18894554|P1|NOT COMPLETED|Overall Study||2
7673007|NCT01981473|18894552|P3|COMPLETED|Overall Study||196
7673008|NCT01981473|18894553|P2|COMPLETED|Overall Study||199
7673009|NCT01981473|18894554|P1|COMPLETED|Overall Study||200
7673010|NCT01981473|18894552|P3|STARTED|Overall Study||204
7673011|NCT01981473|18894553|P2|STARTED|Overall Study||199
7673012|NCT01981473|18894554|P1|STARTED|Overall Study||202
7673013|NCT01981356|18894595|P2|NOT COMPLETED|Overall Study||2
7673014|NCT01981356|18894596|P1|NOT COMPLETED|Overall Study||7
7673015|NCT01981356|18894595|P2|COMPLETED|Overall Study||4
7673016|NCT01981356|18894596|P1|COMPLETED|Overall Study||5
7673017|NCT01981356|18894595|P2|STARTED|Overall Study||6
7673018|NCT01981356|18894596|P1|STARTED|Overall Study||12
7673019|NCT01981122|18894623|P2|NOT COMPLETED|Overall Study||20
7673020|NCT01981122|18894624|P1|NOT COMPLETED|Overall Study||14
7673021|NCT01981122|18894623|P2|COMPLETED|Overall Study||7
7673022|NCT01981122|18894624|P1|COMPLETED|Overall Study||11
7673023|NCT01981122|18894623|P2|STARTED|Overall Study||27
7673024|NCT01981122|18894624|P1|STARTED|Overall Study||25
7673025|NCT01981109|18894630|P1|NOT COMPLETED|Overall Study||224
7673026|NCT01981109|18894630|P1|COMPLETED|Overall Study||1
7673027|NCT01981109|18894630|P1|STARTED|Overall Study||225
7673028|NCT01981096|18894637|P2|NOT COMPLETED|Overall Study||1
7673029|NCT01981096|18894638|P1|NOT COMPLETED|Overall Study||3
7673030|NCT01981096|18894637|P2|COMPLETED|Overall Study||19
7673031|NCT01981096|18894638|P1|COMPLETED|Overall Study||17
7673032|NCT01981096|18894637|P2|Post-treatment|Overall Study||19
7673033|NCT01981096|18894638|P1|Post-treatment|Overall Study||17
7673034|NCT01981096|18894637|P2|STARTED|Overall Study||20
7673035|NCT01981096|18894638|P1|STARTED|Overall Study||20
7673036|NCT01981057|18894650|P2|NOT COMPLETED|Overall Study||0
7673037|NCT01981057|18894651|P1|NOT COMPLETED|Overall Study||0
7673038|NCT01981057|18894650|P2|COMPLETED|Overall Study||50
7673039|NCT01981057|18894651|P1|COMPLETED|Overall Study||50
7673040|NCT01981057|18894650|P2|STARTED|Overall Study||50
7673041|NCT01981057|18894651|P1|STARTED|Overall Study||50
7673042|NCT01980992|18894659|P2|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1
7673043|NCT01980992|18894660|P1|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3
7673044|NCT01980992|18894659|P2|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
7673045|NCT01980992|18894660|P1|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
7673046|NCT01980992|18894659|P2|STARTED|52 Weeks Open Label Active Wheat OIT||19
7673047|NCT01980992|18894660|P1|STARTED|52 Weeks Open Label Active Wheat OIT||21
7673048|NCT01980992|18894659|P2|NOT COMPLETED|52 Weeks Blinded Study Treatment||4
7673049|NCT01980992|18894660|P1|NOT COMPLETED|52 Weeks Blinded Study Treatment||2
7673050|NCT01980992|18894659|P2|COMPLETED|52 Weeks Blinded Study Treatment||19
7673051|NCT01980992|18894660|P1|COMPLETED|52 Weeks Blinded Study Treatment||21
7673052|NCT01980992|18894659|P2|STARTED|52 Weeks Blinded Study Treatment||23
7673053|NCT01980992|18894660|P1|STARTED|52 Weeks Blinded Study Treatment||23
7673054|NCT01980940|18894685|P8|NOT COMPLETED|Overall Study||0
7673055|NCT01980940|18894686|P7|NOT COMPLETED|Overall Study||0
7673056|NCT01980940|18894687|P6|NOT COMPLETED|Overall Study||2
7673057|NCT01980940|18894688|P5|NOT COMPLETED|Overall Study||0
7673058|NCT01980940|18894689|P4|NOT COMPLETED|Overall Study||0
7673059|NCT01980940|18894690|P3|NOT COMPLETED|Overall Study||0
7673060|NCT01980940|18894691|P2|NOT COMPLETED|Overall Study||0
7673061|NCT01980940|18894692|P1|NOT COMPLETED|Overall Study||0
7673062|NCT01980940|18894685|P8|COMPLETED|Overall Study||24
7673063|NCT01980940|18894686|P7|COMPLETED|Overall Study||24
7673064|NCT01980940|18894687|P6|COMPLETED|Overall Study||0
7673065|NCT01980940|18894688|P5|COMPLETED|Overall Study||2
7673066|NCT01980940|18894689|P4|COMPLETED|Overall Study||3
7673067|NCT01980940|18894690|P3|COMPLETED|Overall Study||5
7673068|NCT01980940|18894691|P2|COMPLETED|Overall Study||5
7673069|NCT01980940|18894692|P1|COMPLETED|Overall Study||5
7673070|NCT01980940|18894685|P8|Treated|Overall Study||24
7673071|NCT01980940|18894686|P7|Treated|Overall Study||24
7673072|NCT01980940|18894687|P6|Treated|Overall Study||2
7673073|NCT01980940|18894688|P5|Treated|Overall Study||2
7673074|NCT01980940|18894689|P4|Treated|Overall Study||3
7673075|NCT01980940|18894690|P3|Treated|Overall Study||5
7673076|NCT01980940|18894691|P2|Treated|Overall Study||5
7673077|NCT01980940|18894692|P1|Treated|Overall Study||5
7673078|NCT01980940|18894685|P8|STARTED|Overall Study||24
7673079|NCT01980940|18894686|P7|STARTED|Overall Study||24
7673080|NCT01980940|18894687|P6|STARTED|Overall Study||2
7673081|NCT01980940|18894688|P5|STARTED|Overall Study||2
7673082|NCT01980940|18894689|P4|STARTED|Overall Study||3
7673083|NCT01980940|18894690|P3|STARTED|Overall Study||5
7673084|NCT01980940|18894691|P2|STARTED|Overall Study||5
7673085|NCT01980940|18894692|P1|STARTED|Overall Study||5
7673086|NCT01980914|18894744|P1|NOT COMPLETED|Overall Study||0
7673087|NCT01980914|18894744|P1|COMPLETED|Overall Study||11
7673088|NCT01980914|18894744|P1|STARTED|Overall Study||11
7673089|NCT01980888|18894751|P2|NOT COMPLETED|Overall Study||133
7673090|NCT01980888|18894752|P1|NOT COMPLETED|Overall Study||144
7673091|NCT01980888|18894751|P2|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|21
7673092|NCT01980888|18894752|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|13
7673093|NCT01980888|18894751|P2|STARTED|Overall Study||154
7673094|NCT01980888|18894752|P1|STARTED|Overall Study||157
7673095|NCT01980875|18894771|P3|NOT COMPLETED|Overall Study||24
7673096|NCT01980875|18894772|P2|NOT COMPLETED|Overall Study||25
7673097|NCT01980875|18894773|P1|NOT COMPLETED|Overall Study||8
7673098|NCT01980875|18894771|P3|COMPLETED|Overall Study||0
7673099|NCT01980875|18894772|P2|COMPLETED|Overall Study||0
7673100|NCT01980875|18894773|P1|COMPLETED|Overall Study||0
7673101|NCT01980875|18894771|P3|STARTED|Overall Study||24
7673102|NCT01980875|18894772|P2|STARTED|Overall Study||25
7673103|NCT01980875|18894773|P1|STARTED|Overall Study||8
7673104|NCT01980771|18894798|P2|NOT COMPLETED|Overall Study||119
7673105|NCT01980771|18894799|P1|NOT COMPLETED|Overall Study||84
7673106|NCT01980771|18894798|P2|COMPLETED|Overall Study||305
7673107|NCT01980771|18894799|P1|COMPLETED|Overall Study||352
7673108|NCT01980771|18894798|P2|STARTED|Overall Study||424
7673109|NCT01980771|18894799|P1|STARTED|Overall Study||436
7673110|NCT01980706|18894808|P3|NOT COMPLETED|Overall Study||13
7673111|NCT01980706|18894809|P2|NOT COMPLETED|Overall Study||17
7673112|NCT01980706|18894810|P1|NOT COMPLETED|Overall Study||17
7673113|NCT01980706|18894808|P3|COMPLETED|Overall Study||24
7673114|NCT01980706|18894809|P2|COMPLETED|Overall Study||26
7673115|NCT01980706|18894810|P1|COMPLETED|Overall Study||23
7673116|NCT01980706|18894808|P3|STARTED|Overall Study||37
7673117|NCT01980706|18894809|P2|STARTED|Overall Study||43
7673118|NCT01980706|18894810|P1|STARTED|Overall Study||40
7673119|NCT01980654|18894835|P2|NOT COMPLETED|Overall Study||0
7673120|NCT01980654|18894836|P1|NOT COMPLETED|Overall Study||0
7673121|NCT01980654|18894835|P2|COMPLETED|Overall Study||20
7673122|NCT01980654|18894836|P1|COMPLETED|Overall Study||60
7673123|NCT01980654|18894835|P2|STARTED|Overall Study||20
7673124|NCT01980654|18894836|P1|STARTED|Overall Study||60
7673125|NCT01980628|18894850|P1|NOT COMPLETED|Overall Study||63
7673126|NCT01980628|18894850|P1|COMPLETED|Overall Study|Participants who remain on treatment at Final Analysis.|0
7673127|NCT01980628|18894850|P1|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63
7673128|NCT01980589|18894858|P3|NOT COMPLETED|Overall Study||0
7673129|NCT01980589|18894859|P2|NOT COMPLETED|Overall Study||0
7673130|NCT01980589|18894860|P1|NOT COMPLETED|Overall Study||0
7673131|NCT01980589|18894858|P3|COMPLETED|Overall Study||16
7673132|NCT01980589|18894859|P2|COMPLETED|Overall Study||3
7673133|NCT01980589|18894860|P1|COMPLETED|Overall Study||3
7673134|NCT01980589|18894858|P3|STARTED|Overall Study||16
7673135|NCT01980589|18894859|P2|STARTED|Overall Study||3
7673136|NCT01980589|18894860|P1|STARTED|Overall Study||3
7673137|NCT01980524|18894877|P2|NOT COMPLETED|Study Day 2||0
7673138|NCT01980524|18894878|P1|NOT COMPLETED|Study Day 2||0
7673139|NCT01980524|18894877|P2|COMPLETED|Study Day 2||4
7673140|NCT01980524|18894878|P1|COMPLETED|Study Day 2||4
7673141|NCT01980524|18894877|P2|STARTED|Study Day 2||4
7673142|NCT01980524|18894878|P1|STARTED|Study Day 2||4
7673143|NCT01980524|18894877|P2|NOT COMPLETED|Washout (at Least 2 Weeks)||0
7673144|NCT01980524|18894878|P1|NOT COMPLETED|Washout (at Least 2 Weeks)||0
7673145|NCT01980524|18894877|P2|COMPLETED|Washout (at Least 2 Weeks)||4
7673146|NCT01980524|18894878|P1|COMPLETED|Washout (at Least 2 Weeks)||4
7673147|NCT01980524|18894877|P2|STARTED|Washout (at Least 2 Weeks)||4
7673148|NCT01980524|18894878|P1|STARTED|Washout (at Least 2 Weeks)||4
7673149|NCT01980524|18894877|P2|NOT COMPLETED|Study Day 1||0
7673150|NCT01980524|18894878|P1|NOT COMPLETED|Study Day 1||0
7673151|NCT01980524|18894877|P2|COMPLETED|Study Day 1||4
7673152|NCT01980524|18894878|P1|COMPLETED|Study Day 1||4
7673153|NCT01980524|18894877|P2|STARTED|Study Day 1||4
7673154|NCT01980524|18894878|P1|STARTED|Study Day 1||4
7673155|NCT01980485|18894890|P2|NOT COMPLETED|Overall Study||25
7673156|NCT01980485|18894891|P1|NOT COMPLETED|Overall Study||36
7673157|NCT01980485|18894890|P2|COMPLETED|Overall Study||80
7673158|NCT01980485|18894891|P1|COMPLETED|Overall Study||84
7673159|NCT01980485|18894890|P2|STARTED|Overall Study||105
7673160|NCT01980485|18894891|P1|STARTED|Overall Study||120
7673161|NCT01980342|18894899|P1|NOT COMPLETED|Overall Study||1
7673162|NCT01980342|18894899|P1|COMPLETED|Overall Study||0
7673163|NCT01980342|18894899|P1|STARTED|Overall Study||1
7673164|NCT01980095|18894909|P2|NOT COMPLETED|Overall Study||11
7673165|NCT01980095|18894910|P1|NOT COMPLETED|Overall Study||15
7673166|NCT01980095|18894909|P2|COMPLETED|Overall Study||30
7673167|NCT01980095|18894910|P1|COMPLETED|Overall Study||63
7673168|NCT01980095|18894909|P2|Treated|Overall Study||41
7673169|NCT01980095|18894910|P1|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77
7673170|NCT01980095|18894909|P2|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41
7673171|NCT01980095|18894910|P1|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|78
7673172|NCT01980056|18894921|P3|NOT COMPLETED|Overall Study||0
7673173|NCT01980056|18894922|P2|NOT COMPLETED|Overall Study||1
7673174|NCT01980056|18894923|P1|NOT COMPLETED|Overall Study||1
7673175|NCT01980056|18894921|P3|COMPLETED|Overall Study||2
7673176|NCT01980056|18894922|P2|COMPLETED|Overall Study||3
7673177|NCT01980056|18894923|P1|COMPLETED|Overall Study||3
7673178|NCT01980056|18894921|P3|STARTED|Overall Study||2
7673179|NCT01980056|18894922|P2|STARTED|Overall Study||4
7673180|NCT01980056|18894923|P1|STARTED|Overall Study||4
7673181|NCT01979952|18894937|P2|NOT COMPLETED|Overall Study||6
7673182|NCT01979952|18894938|P1|NOT COMPLETED|Overall Study||8
7673183|NCT01979952|18894937|P2|COMPLETED|Overall Study||51
7673184|NCT01979952|18894938|P1|COMPLETED|Overall Study||48
7673185|NCT01979952|18894937|P2|STARTED|Overall Study||57
7673186|NCT01979952|18894938|P1|STARTED|Overall Study||56
7673187|NCT01979835|18894966|P1|NOT COMPLETED|Follow-up||32
7673188|NCT01979835|18894966|P1|COMPLETED|Follow-up||980
7673189|NCT01979835|18894966|P1|STARTED|Follow-up||1012
7673190|NCT01979835|18894966|P1|NOT COMPLETED|Primary Outcome SA Measurment||18
7673191|NCT01979835|18894966|P1|COMPLETED|Primary Outcome SA Measurment||1012
7673192|NCT01979835|18894966|P1|STARTED|Primary Outcome SA Measurment||1030
7673193|NCT01979614|18894973|P2|NOT COMPLETED|Overall Study||1
7673194|NCT01979614|18894974|P1|NOT COMPLETED|Overall Study||1
7673195|NCT01979614|18894973|P2|COMPLETED|Overall Study||27
7673196|NCT01979614|18894974|P1|COMPLETED|Overall Study||29
7673197|NCT01979614|18894973|P2|PD Analysis Set|Overall Study||26
7673198|NCT01979614|18894974|P1|PD Analysis Set|Overall Study||25
7673199|NCT01979614|18894973|P2|PK Analysis Set|Overall Study||0
7673200|NCT01979614|18894974|P1|PK Analysis Set|Overall Study||30
7673201|NCT01979614|18894973|P2|Safety Analysis Set|Overall Study||28
7673202|NCT01979614|18894974|P1|Safety Analysis Set|Overall Study||30
7673203|NCT01979614|18894973|P2|STARTED|Overall Study||28
7673204|NCT01979614|18894974|P1|STARTED|Overall Study||30
7673205|NCT01979523|18894996|P2|NOT COMPLETED|Overall Study||0
7673206|NCT01979523|18894997|P1|NOT COMPLETED|Overall Study||1
7673207|NCT01979523|18894996|P2|COMPLETED|Overall Study||21
7673208|NCT01979523|18894997|P1|COMPLETED|Overall Study||20
7673209|NCT01979523|18894996|P2|STARTED|Overall Study||21
7673210|NCT01979523|18894997|P1|STARTED|Overall Study||21
7673211|NCT01979445|18895020|P4|NOT COMPLETED|Overall Study||0
7673212|NCT01979445|18895021|P3|NOT COMPLETED|Overall Study||0
7673213|NCT01979445|18895022|P2|NOT COMPLETED|Overall Study||0
7673214|NCT01979445|18895023|P1|NOT COMPLETED|Overall Study||0
7673215|NCT01979445|18895020|P4|COMPLETED|Overall Study||3
7673216|NCT01979445|18895021|P3|COMPLETED|Overall Study||6
7673217|NCT01979445|18895022|P2|COMPLETED|Overall Study||3
7673218|NCT01979445|18895023|P1|COMPLETED|Overall Study||3
7673219|NCT01979445|18895020|P4|ITT Population|Overall Study||3
7673220|NCT01979445|18895021|P3|ITT Population|Overall Study||6
7673221|NCT01979445|18895022|P2|ITT Population|Overall Study||3
7673222|NCT01979445|18895023|P1|ITT Population|Overall Study||3
7673223|NCT01979445|18895020|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
7673224|NCT01979445|18895021|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
7673225|NCT01979445|18895022|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
7673226|NCT01979445|18895023|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
7673227|NCT01979445|18895020|P4|STARTED|Overall Study||3
7673228|NCT01979445|18895021|P3|STARTED|Overall Study||6
7673229|NCT01979445|18895022|P2|STARTED|Overall Study||3
7673230|NCT01979445|18895023|P1|STARTED|Overall Study||3
7673231|NCT01979276|18895049|P1|NOT COMPLETED|Overall Study||0
7673232|NCT01979276|18895049|P1|COMPLETED|Overall Study||2
7673233|NCT01979276|18895049|P1|STARTED|Overall Study||2
7673234|NCT01979185|18895057|P2|NOT COMPLETED|Period 2||1
7673235|NCT01979185|18895058|P1|NOT COMPLETED|Period 2||0
7673236|NCT01979185|18895057|P2|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14
7673237|NCT01979185|18895058|P1|COMPLETED|Period 2||15
7673238|NCT01979185|18895057|P2|STARTED|Period 2||15
7673239|NCT01979185|18895058|P1|STARTED|Period 2||15
7673240|NCT01979185|18895057|P2|NOT COMPLETED|Period 1||0
7673241|NCT01979185|18895058|P1|NOT COMPLETED|Period 1||0
7673242|NCT01979185|18895057|P2|COMPLETED|Period 1||15
7673243|NCT01979185|18895058|P1|COMPLETED|Period 1||15
7673244|NCT01979185|18895057|P2|STARTED|Period 1||15
7673245|NCT01979185|18895058|P1|STARTED|Period 1||15
7673246|NCT01979159|18895068|P1|NOT COMPLETED|Overall Study||0
7673247|NCT01979159|18895068|P1|COMPLETED|Overall Study||4
7673248|NCT01979159|18895068|P1|STARTED|Overall Study||4
7673249|NCT01979133|18895074|P1|NOT COMPLETED|Overall Study||3
7673250|NCT01979133|18895074|P1|COMPLETED|Overall Study||7
7673251|NCT01979133|18895074|P1|STARTED|Overall Study||10
7673252|NCT01979029|18895093|P2|NOT COMPLETED|Overall Study||0
7673253|NCT01979029|18895094|P1|NOT COMPLETED|Overall Study||0
7673254|NCT01979029|18895093|P2|COMPLETED|Overall Study||28
7673255|NCT01979029|18895094|P1|COMPLETED|Overall Study||29
7673256|NCT01979029|18895093|P2|STARTED|Overall Study||28
7673257|NCT01979029|18895094|P1|STARTED|Overall Study||29
7673258|NCT01979016|18895106|P2|NOT COMPLETED|Overall Study||1
7673259|NCT01979016|18895107|P1|NOT COMPLETED|Overall Study||2
7673260|NCT01979016|18895106|P2|COMPLETED|Overall Study||26
7673261|NCT01979016|18895107|P1|COMPLETED|Overall Study||25
7673262|NCT01979016|18895106|P2|STARTED|Overall Study||27
7673263|NCT01979016|18895107|P1|STARTED|Overall Study||27
7673264|NCT01978938|18895141|P2|NOT COMPLETED|Overall Study||14
7673265|NCT01978938|18895142|P1|NOT COMPLETED|Overall Study||23
7673266|NCT01978938|18895141|P2|COMPLETED|Overall Study||439
7673267|NCT01978938|18895142|P1|COMPLETED|Overall Study||432
7673268|NCT01978938|18895141|P2|Received at Least 1 Dose of Study Drug|Overall Study||451
7673269|NCT01978938|18895142|P1|Received at Least 1 Dose of Study Drug|Overall Study||454
7673270|NCT01978938|18895141|P2|STARTED|Overall Study||453
7673271|NCT01978938|18895142|P1|STARTED|Overall Study||455
7673272|NCT01978912|18895156|P4|NOT COMPLETED|Overall Study||3
7673273|NCT01978912|18895157|P3|NOT COMPLETED|Overall Study||3
7673274|NCT01978912|18895158|P2|NOT COMPLETED|Overall Study||3
7673275|NCT01978912|18895159|P1|NOT COMPLETED|Overall Study||3
7673276|NCT01978912|18895156|P4|COMPLETED|Overall Study||3
7673277|NCT01978912|18895157|P3|COMPLETED|Overall Study||3
7673278|NCT01978912|18895158|P2|COMPLETED|Overall Study||3
7673279|NCT01978912|18895159|P1|COMPLETED|Overall Study||3
7673280|NCT01978912|18895156|P4|STARTED|Overall Study||6
7673281|NCT01978912|18895157|P3|STARTED|Overall Study||6
7673282|NCT01978912|18895158|P2|STARTED|Overall Study||6
7673283|NCT01978912|18895159|P1|STARTED|Overall Study||6
7673284|NCT01978743|18895205|P1|NOT COMPLETED|Overall Study||0
7673285|NCT01978743|18895205|P1|COMPLETED|Overall Study||10
7673286|NCT01978743|18895205|P1|STARTED|Overall Study||10
7673287|NCT01978600|18895219|P2|NOT COMPLETED|Overall Study||0
7673288|NCT01978600|18895220|P1|NOT COMPLETED|Overall Study||0
7673289|NCT01978600|18895219|P2|COMPLETED|Overall Study||42
7673290|NCT01978600|18895220|P1|COMPLETED|Overall Study||44
7673291|NCT01978600|18895219|P2|STARTED|Overall Study||42
7673292|NCT01978600|18895220|P1|STARTED|Overall Study||44
7673293|NCT01978535|18895232|P2|NOT COMPLETED|Overall Study||0
7673294|NCT01978535|18895233|P1|NOT COMPLETED|Overall Study||0
7673295|NCT01978535|18895232|P2|COMPLETED|Overall Study||2
7673296|NCT01978535|18895233|P1|COMPLETED|Overall Study||1
7673297|NCT01978535|18895232|P2|STARTED|Overall Study||2
7673298|NCT01978535|18895233|P1|STARTED|Overall Study||1
7673299|NCT01978509|18895242|P3|NOT COMPLETED|Overall Study||0
7673300|NCT01978509|18895243|P2|NOT COMPLETED|Overall Study||5
7673301|NCT01978509|18895244|P1|NOT COMPLETED|Overall Study||2
7673302|NCT01978509|18895242|P3|COMPLETED|Overall Study||9
7673303|NCT01978509|18895243|P2|COMPLETED|Overall Study||8
7673304|NCT01978509|18895244|P1|COMPLETED|Overall Study||8
7673305|NCT01978509|18895242|P3|STARTED|Overall Study||9
7673306|NCT01978509|18895243|P2|STARTED|Overall Study||13
7673307|NCT01978509|18895244|P1|STARTED|Overall Study||10
7673308|NCT01978314|18895266|P5|NOT COMPLETED|Overall Study||0
7673309|NCT01978314|18895267|P4|NOT COMPLETED|Overall Study||0
7673310|NCT01978314|18895268|P3|NOT COMPLETED|Overall Study||0
7673311|NCT01978314|18895269|P2|NOT COMPLETED|Overall Study||0
7673312|NCT01978314|18895270|P1|NOT COMPLETED|Overall Study||0
7673313|NCT01978314|18895266|P5|COMPLETED|Overall Study||8
7673314|NCT01978314|18895267|P4|COMPLETED|Overall Study||1
7673315|NCT01978314|18895268|P3|COMPLETED|Overall Study||8
7673316|NCT01978314|18895269|P2|COMPLETED|Overall Study||8
7673317|NCT01978314|18895270|P1|COMPLETED|Overall Study||8
7673318|NCT01978314|18895266|P5|STARTED|Overall Study||8
7673319|NCT01978314|18895267|P4|STARTED|Overall Study||1
7673320|NCT01978314|18895268|P3|STARTED|Overall Study||8
7673321|NCT01978314|18895269|P2|STARTED|Overall Study||8
7673322|NCT01978314|18895270|P1|STARTED|Overall Study||8
7673323|NCT01978262|18895352|P1|NOT COMPLETED|Overall Study||11
7673324|NCT01978262|18895352|P1|COMPLETED|Overall Study||92
7673325|NCT01978262|18895352|P1|STARTED|Overall Study||103
7673326|NCT01978236|18895357|P1|NOT COMPLETED|Overall Study||2
7673327|NCT01978236|18895357|P1|COMPLETED|Overall Study||4
7673328|NCT01978236|18895357|P1|STARTED|Overall Study||6
7673329|NCT01978184|18895378|P2|NOT COMPLETED|Overall Study||20
7673330|NCT01978184|18895379|P1|NOT COMPLETED|Overall Study||13
7673331|NCT01978184|18895378|P2|COMPLETED|Overall Study||41
7673332|NCT01978184|18895379|P1|COMPLETED|Overall Study||30
7673333|NCT01978184|18895378|P2|STARTED|Overall Study||61
7673334|NCT01978184|18895379|P1|STARTED|Overall Study||43
7673335|NCT01978145|18895405|P2|NOT COMPLETED|Treatment Period 2||14
7673336|NCT01978145|18895406|P1|NOT COMPLETED|Treatment Period 2||19
7673337|NCT01978145|18895405|P2|COMPLETED|Treatment Period 2||179
7673338|NCT01978145|18895406|P1|COMPLETED|Treatment Period 2||185
7673339|NCT01978145|18895405|P2|STARTED|Treatment Period 2||193
7673340|NCT01978145|18895406|P1|STARTED|Treatment Period 2||204
7673341|NCT01978145|18895405|P2|NOT COMPLETED|Washout Period 1||3
7673342|NCT01978145|18895406|P1|NOT COMPLETED|Washout Period 1||1
7673343|NCT01978145|18895405|P2|COMPLETED|Washout Period 1||193
7673344|NCT01978145|18895406|P1|COMPLETED|Washout Period 1||204
7673345|NCT01978145|18895405|P2|STARTED|Washout Period 1||196
7673346|NCT01978145|18895406|P1|STARTED|Washout Period 1||205
7673347|NCT01978145|18895405|P2|NOT COMPLETED|Treatment Period 1||16
7673348|NCT01978145|18895406|P1|NOT COMPLETED|Treatment Period 1||9
7673349|NCT01978145|18895405|P2|COMPLETED|Treatment Period 1||196
7673350|NCT01978145|18895406|P1|COMPLETED|Treatment Period 1||205
7673351|NCT01978145|18895405|P2|STARTED|Treatment Period 1||212
7673352|NCT01978145|18895406|P1|STARTED|Treatment Period 1||214
7673353|NCT01978119|18895422|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2
7673354|NCT01978119|18895423|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0
7673355|NCT01978119|18895422|P2|COMPLETED|Treatment Period 2 (12 Weeks)||40
7673356|NCT01978119|18895423|P1|COMPLETED|Treatment Period 2 (12 Weeks)||38
7673357|NCT01978119|18895422|P2|STARTED|Treatment Period 2 (12 Weeks)||42
7673358|NCT01978119|18895423|P1|STARTED|Treatment Period 2 (12 Weeks)||38
7673359|NCT01978119|18895422|P2|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
7673360|NCT01978119|18895423|P1|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
7673361|NCT01978119|18895422|P2|COMPLETED|Washout Period 1 (3 Weeks)||42
7673362|NCT01978119|18895423|P1|COMPLETED|Washout Period 1 (3 Weeks)||38
7673363|NCT01978119|18895422|P2|STARTED|Washout Period 1 (3 Weeks)||42
7673364|NCT01978119|18895423|P1|STARTED|Washout Period 1 (3 Weeks)||38
7673365|NCT01978119|18895422|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0
7673366|NCT01978119|18895423|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
7673367|NCT01978119|18895422|P2|COMPLETED|Treatment Period 1 (12 Weeks)||42
7673368|NCT01978119|18895423|P1|COMPLETED|Treatment Period 1 (12 Weeks)||38
7673369|NCT01978119|18895422|P2|STARTED|Treatment Period 1 (12 Weeks)||42
7673370|NCT01978119|18895423|P1|STARTED|Treatment Period 1 (12 Weeks)||40
7673371|NCT01978093|18895449|P2|NOT COMPLETED|Overall Study||73
7673372|NCT01978093|18895450|P1|NOT COMPLETED|Overall Study||65
7673373|NCT01978093|18895449|P2|COMPLETED|Overall Study||230
7673374|NCT01978093|18895450|P1|COMPLETED|Overall Study||232
7673375|NCT01978093|18895449|P2|STARTED|Overall Study||303
7673376|NCT01978093|18895450|P1|STARTED|Overall Study||297
7673377|NCT01977937|18895494|P2|NOT COMPLETED|Overall Study||2
7673378|NCT01977937|18895495|P1|NOT COMPLETED|Overall Study||3
7673379|NCT01977937|18895494|P2|COMPLETED|Overall Study||26
7673380|NCT01977937|18895495|P1|COMPLETED|Overall Study||24
7673381|NCT01977937|18895494|P2|STARTED|Overall Study||28
7673382|NCT01977937|18895495|P1|STARTED|Overall Study||27
7673383|NCT01977846|18895505|P2|NOT COMPLETED|Total Study - Prospective||29
7673384|NCT01977846|18895506|P1|NOT COMPLETED|Total Study - Prospective||0
7673385|NCT01977846|18895505|P2|COMPLETED|Total Study - Prospective||230
7673386|NCT01977846|18895506|P1|COMPLETED|Total Study - Prospective||0
7673387|NCT01977846|18895505|P2|STARTED|Total Study - Prospective||259
7673388|NCT01977846|18895506|P1|STARTED|Total Study - Prospective||0
7673389|NCT01977846|18895505|P2|NOT COMPLETED|Total Study - Retrospective||0
7673390|NCT01977846|18895506|P1|NOT COMPLETED|Total Study - Retrospective||0
7673391|NCT01977846|18895505|P2|COMPLETED|Total Study - Retrospective||0
7673392|NCT01977846|18895506|P1|COMPLETED|Total Study - Retrospective||251
7673393|NCT01977846|18895505|P2|STARTED|Total Study - Retrospective||0
7673394|NCT01977846|18895506|P1|STARTED|Total Study - Retrospective||251
7673395|NCT01977820|18895524|P2|NOT COMPLETED|Overall Study||1
7673396|NCT01977820|18895525|P1|NOT COMPLETED|Overall Study||1
7673397|NCT01977820|18895524|P2|COMPLETED|Overall Study||0
7673398|NCT01977820|18895525|P1|COMPLETED|Overall Study||0
7673399|NCT01977820|18895524|P2|STARTED|Overall Study||1
7673400|NCT01977820|18895525|P1|STARTED|Overall Study||1
7673401|NCT01977794|18895533|P2|NOT COMPLETED|Overall Study||6
7673402|NCT01977794|18895534|P1|NOT COMPLETED|Overall Study||8
7673403|NCT01977794|18895533|P2|COMPLETED|Overall Study||94
7673404|NCT01977794|18895534|P1|COMPLETED|Overall Study||92
7673405|NCT01977794|18895533|P2|STARTED|Overall Study||100
7673406|NCT01977794|18895534|P1|STARTED|Overall Study||100
7673407|NCT01977781|18895550|P2|NOT COMPLETED|Overall Study||1
7673408|NCT01977781|18895551|P1|NOT COMPLETED|Overall Study||6
7673409|NCT01977781|18895550|P2|COMPLETED|Overall Study||15
7673410|NCT01977781|18895551|P1|COMPLETED|Overall Study||18
7673411|NCT01977781|18895550|P2|STARTED|Overall Study||16
7673412|NCT01977781|18895551|P1|STARTED|Overall Study||24
7673413|NCT01977729|18895569|P1|NOT COMPLETED|Overall Study||1
7673414|NCT01977729|18895569|P1|COMPLETED|Overall Study||0
7673415|NCT01977729|18895569|P1|STARTED|Overall Study||1
7673416|NCT01977690|18895581|P2|NOT COMPLETED|Overall Study||4
7673417|NCT01977690|18895582|P1|NOT COMPLETED|Overall Study||0
7673418|NCT01977690|18895581|P2|COMPLETED|Overall Study||11
7673419|NCT01977690|18895582|P1|COMPLETED|Overall Study||15
7673420|NCT01977690|18895581|P2|STARTED|Overall Study||15
7673421|NCT01977690|18895582|P1|STARTED|Overall Study||15
7673422|NCT01977677|18895591|P3|NOT COMPLETED|Overall Study||1
7673423|NCT01977677|18895592|P2|NOT COMPLETED|Overall Study||0
7673424|NCT01977677|18895593|P1|NOT COMPLETED|Overall Study||0
7673425|NCT01977677|18895591|P3|COMPLETED|Overall Study||20
7673426|NCT01977677|18895592|P2|COMPLETED|Overall Study||6
7673427|NCT01977677|18895593|P1|COMPLETED|Overall Study||3
7673428|NCT01977677|18895591|P3|STARTED|Overall Study||21
7673429|NCT01977677|18895592|P2|STARTED|Overall Study||6
7673430|NCT01977677|18895593|P1|STARTED|Overall Study||3
7673431|NCT01977651|18895604|P1|NOT COMPLETED|Post 1 Year Extension Period||144
7673432|NCT01977651|18895604|P1|COMPLETED|Post 1 Year Extension Period||1
7673433|NCT01977651|18895604|P1|STARTED|Post 1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the post 1 year extension period|145
7673434|NCT01977651|18895604|P1|NOT COMPLETED|1 Year Extension Period||130
7673435|NCT01977651|18895604|P1|COMPLETED|1 Year Extension Period||157
7673436|NCT01977651|18895604|P1|STARTED|1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the 1 year extension period|287
7673437|NCT01977651|18895604|P1|NOT COMPLETED|4 Month Treatment Period||101
7673438|NCT01977651|18895604|P1|COMPLETED|4 Month Treatment Period||322
7673439|NCT01977651|18895604|P1|STARTED|4 Month Treatment Period||423
7673440|NCT01977625|18895608|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
7673441|NCT01977625|18895609|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
7673442|NCT01977625|18895608|P2|COMPLETED|Second Intervention (4 Weeks)||7
7673443|NCT01977625|18895609|P1|COMPLETED|Second Intervention (4 Weeks)||7
7673444|NCT01977625|18895608|P2|STARTED|Second Intervention (4 Weeks)||7
7673445|NCT01977625|18895609|P1|STARTED|Second Intervention (4 Weeks)||8
7673446|NCT01977625|18895608|P2|NOT COMPLETED|Washout (2 Weeks)||0
7673447|NCT01977625|18895609|P1|NOT COMPLETED|Washout (2 Weeks)||0
7673448|NCT01977625|18895608|P2|COMPLETED|Washout (2 Weeks)||7
7673449|NCT01977625|18895609|P1|COMPLETED|Washout (2 Weeks)||8
7673450|NCT01977625|18895608|P2|STARTED|Washout (2 Weeks)||7
7673451|NCT01977625|18895609|P1|STARTED|Washout (2 Weeks)||8
7673452|NCT01977625|18895608|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
7673453|NCT01977625|18895609|P1|NOT COMPLETED|First Intervention (4 Weeks)||3
7673454|NCT01977625|18895608|P2|COMPLETED|First Intervention (4 Weeks)||7
7673455|NCT01977625|18895609|P1|COMPLETED|First Intervention (4 Weeks)||8
7673456|NCT01977625|18895608|P2|STARTED|First Intervention (4 Weeks)||7
7673457|NCT01977625|18895609|P1|STARTED|First Intervention (4 Weeks)||11
7673458|NCT01977612|18895619|P2|NOT COMPLETED|Overall Study||1
7673459|NCT01977612|18895620|P1|NOT COMPLETED|Overall Study||1
7673460|NCT01977612|18895619|P2|COMPLETED|Overall Study||79
7673461|NCT01977612|18895620|P1|COMPLETED|Overall Study||84
7673462|NCT01977612|18895619|P2|STARTED|Overall Study||80
7673463|NCT01977612|18895620|P1|STARTED|Overall Study||85
7673464|NCT01977573|18895642|P4|NOT COMPLETED|Overall Study||3
7673465|NCT01977573|18895643|P3|NOT COMPLETED|Overall Study||4
7673466|NCT01977573|18895644|P2|NOT COMPLETED|Overall Study||3
7673467|NCT01977573|18895645|P1|NOT COMPLETED|Overall Study||20
7673468|NCT01977573|18895642|P4|COMPLETED|Overall Study||33
7673469|NCT01977573|18895643|P3|COMPLETED|Overall Study||32
7673470|NCT01977573|18895644|P2|COMPLETED|Overall Study||41
7673471|NCT01977573|18895645|P1|COMPLETED|Overall Study||116
7673472|NCT01977573|18895642|P4|STARTED|Overall Study||36
7673473|NCT01977573|18895643|P3|STARTED|Overall Study||36
7673474|NCT01977573|18895644|P2|STARTED|Overall Study||44
7673475|NCT01977573|18895645|P1|STARTED|Overall Study||136
7673476|NCT01977482|18895759|P6|NOT COMPLETED|Overall Study||5
7673477|NCT01977482|18895760|P5|NOT COMPLETED|Overall Study||3
7673478|NCT01977482|18895761|P4|NOT COMPLETED|Overall Study||4
7673479|NCT01977482|18895762|P3|NOT COMPLETED|Overall Study||5
7673480|NCT01977482|18895763|P2|NOT COMPLETED|Overall Study||9
7673481|NCT01977482|18895764|P1|NOT COMPLETED|Overall Study||3
7673482|NCT01977482|18895759|P6|COMPLETED|Overall Study||14
7673483|NCT01977482|18895760|P5|COMPLETED|Overall Study||37
7673484|NCT01977482|18895761|P4|COMPLETED|Overall Study||35
7673485|NCT01977482|18895762|P3|COMPLETED|Overall Study||35
7673486|NCT01977482|18895763|P2|COMPLETED|Overall Study||30
7673487|NCT01977482|18895764|P1|COMPLETED|Overall Study||36
7673488|NCT01977482|18895759|P6|STARTED|Overall Study||19
7673489|NCT01977482|18895760|P5|STARTED|Overall Study||40
7673490|NCT01977482|18895761|P4|STARTED|Overall Study||39
7673491|NCT01977482|18895762|P3|STARTED|Overall Study||40
7673492|NCT01977482|18895763|P2|STARTED|Overall Study||39
7673493|NCT01977482|18895764|P1|STARTED|Overall Study||39
7673494|NCT01977456|18895879|P1|NOT COMPLETED|Overall Study||5
7673495|NCT01977456|18895879|P1|COMPLETED|Overall Study||22
7673496|NCT01977456|18895879|P1|STARTED|Overall Study||27
7673497|NCT01977352|18895888|P2|NOT COMPLETED|Overall Study||2
7673498|NCT01977352|18895889|P1|NOT COMPLETED|Overall Study||1
7673499|NCT01977352|18895888|P2|COMPLETED|Overall Study||19
7673500|NCT01977352|18895889|P1|COMPLETED|Overall Study||20
7673501|NCT01977352|18895888|P2|STARTED|Overall Study||21
7673502|NCT01977352|18895889|P1|STARTED|Overall Study||21
7673503|NCT01977222|18895907|P1|NOT COMPLETED|Overall Study||1
7673504|NCT01977222|18895907|P1|COMPLETED|Overall Study||11
7673505|NCT01977222|18895907|P1|STARTED|Overall Study||12
7673506|NCT01977092|18895920|P2|NOT COMPLETED|Overall Study||30
7673507|NCT01977092|18895921|P1|NOT COMPLETED|Overall Study||31
7673508|NCT01977092|18895920|P2|COMPLETED|Overall Study||151
7673509|NCT01977092|18895921|P1|COMPLETED|Overall Study||118
7673510|NCT01977092|18895920|P2|STARTED|Overall Study||181
7673511|NCT01977092|18895921|P1|STARTED|Overall Study||149
7673512|NCT01977040|18895931|P1|NOT COMPLETED|Overall Study||2
7673513|NCT01977040|18895931|P1|COMPLETED|Overall Study||66
7673514|NCT01977040|18895931|P1|STARTED|Overall Study||68
7673515|NCT01976988|18895943|P2|NOT COMPLETED|Overall Study||18
7673516|NCT01976988|18895944|P1|NOT COMPLETED|Overall Study||16
7673517|NCT01976988|18895943|P2|COMPLETED|Overall Study||184
7673518|NCT01976988|18895944|P1|COMPLETED|Overall Study||192
7673519|NCT01976988|18895943|P2|STARTED|Overall Study||202
7673520|NCT01976988|18895944|P1|STARTED|Overall Study||208
7673521|NCT01976975|18895962|P2|NOT COMPLETED|Overall Study||12
7673522|NCT01976975|18895963|P1|NOT COMPLETED|Overall Study||147
7673523|NCT01976975|18895962|P2|COMPLETED|Overall Study||32
7673524|NCT01976975|18895963|P1|COMPLETED|Overall Study||79
7673525|NCT01976975|18895962|P2|STARTED|Overall Study||44
7673526|NCT01976975|18895963|P1|STARTED|Overall Study||226
7673527|NCT01976871|18895973|P1|NOT COMPLETED|Overall Study||1
7673528|NCT01976871|18895973|P1|COMPLETED|Overall Study||20
7673529|NCT01976871|18895973|P1|STARTED|Overall Study||21
7673530|NCT01976845|18895985|P3|NOT COMPLETED|Overall Study||3
7673531|NCT01976845|18895986|P2|NOT COMPLETED|Overall Study||8
7673532|NCT01976845|18895987|P1|NOT COMPLETED|Overall Study||8
7673533|NCT01976845|18895985|P3|COMPLETED|Overall Study||40
7673534|NCT01976845|18895986|P2|COMPLETED|Overall Study||40
7673535|NCT01976845|18895987|P1|COMPLETED|Overall Study||40
7673536|NCT01976845|18895985|P3|STARTED|Overall Study||43
7673537|NCT01976845|18895986|P2|STARTED|Overall Study||48
7673538|NCT01976845|18895987|P1|STARTED|Overall Study||48
7673539|NCT01976819|18896001|P1|NOT COMPLETED|Overall Study||5
7673540|NCT01976819|18896001|P1|COMPLETED|Overall Study||11
7673541|NCT01976819|18896001|P1|STARTED|Overall Study||16
7673542|NCT01976806|18896012|P2|NOT COMPLETED|Overall Study||6
7673543|NCT01976806|18896013|P1|NOT COMPLETED|Overall Study||3
7673544|NCT01976806|18896012|P2|COMPLETED|Overall Study||22
7673545|NCT01976806|18896013|P1|COMPLETED|Overall Study||24
7673546|NCT01976806|18896012|P2|STARTED|Overall Study||28
7673547|NCT01976806|18896013|P1|STARTED|Overall Study||27
7673548|NCT01976741|18896051|P10|NOT COMPLETED|Overall Study||4
7673549|NCT01976741|18896052|P9|NOT COMPLETED|Overall Study||1
7673550|NCT01976741|18896053|P8|NOT COMPLETED|Overall Study||12
7673551|NCT01976741|18896054|P7|NOT COMPLETED|Overall Study||4
7673552|NCT01976741|18896055|P6|NOT COMPLETED|Overall Study||0
7673553|NCT01976741|18896056|P5|NOT COMPLETED|Overall Study||0
7673554|NCT01976741|18896057|P4|NOT COMPLETED|Overall Study||1
7673555|NCT01976741|18896058|P3|NOT COMPLETED|Overall Study||3
7673556|NCT01976741|18896059|P2|NOT COMPLETED|Overall Study||0
7673557|NCT01976741|18896060|P1|NOT COMPLETED|Overall Study||1
7673558|NCT01976741|18896051|P10|COMPLETED|Overall Study||36
7673559|NCT01976741|18896052|P9|COMPLETED|Overall Study||7
7673560|NCT01976741|18896053|P8|COMPLETED|Overall Study||62
7673561|NCT01976741|18896054|P7|COMPLETED|Overall Study||19
7673562|NCT01976741|18896055|P6|COMPLETED|Overall Study||4
7673563|NCT01976741|18896056|P5|COMPLETED|Overall Study||4
7673564|NCT01976741|18896057|P4|COMPLETED|Overall Study||2
7673565|NCT01976741|18896058|P3|COMPLETED|Overall Study||1
7673566|NCT01976741|18896059|P2|COMPLETED|Overall Study||4
7673567|NCT01976741|18896060|P1|COMPLETED|Overall Study||3
7673568|NCT01976741|18896051|P10|STARTED|Overall Study||40
7673569|NCT01976741|18896052|P9|STARTED|Overall Study||8
7673570|NCT01976741|18896053|P8|STARTED|Overall Study||74
7673571|NCT01976741|18896054|P7|STARTED|Overall Study||23
7673572|NCT01976741|18896055|P6|STARTED|Overall Study||4
7673573|NCT01976741|18896056|P5|STARTED|Overall Study||4
7673574|NCT01976741|18896057|P4|STARTED|Overall Study||3
7673575|NCT01976741|18896058|P3|STARTED|Overall Study||4
7673576|NCT01976741|18896059|P2|STARTED|Overall Study||4
7673577|NCT01976741|18896060|P1|STARTED|Overall Study||4
7673578|NCT01976663|18896298|P1|NOT COMPLETED|Overall Study||42
7673579|NCT01976663|18896298|P1|COMPLETED|Overall Study||84
7673580|NCT01976663|18896298|P1|Received Repeat Treatment|Overall Study||85
7673581|NCT01976663|18896298|P1|Received Asymmetry Correction|Overall Study||45
7673582|NCT01976663|18896298|P1|Received Touch-up Treatment|Overall Study||63
7673583|NCT01976663|18896298|P1|STARTED|Overall Study||126
7673584|NCT01976650|18896312|P1|NOT COMPLETED|Overall Study||6
7673585|NCT01976650|18896312|P1|COMPLETED|Overall Study||718
7673586|NCT01976650|18896312|P1|STARTED|Overall Study||724
7673587|NCT01976624|18896317|P1|NOT COMPLETED|Overall Study||14
7673588|NCT01976624|18896317|P1|COMPLETED|Overall Study||742
7673589|NCT01976624|18896317|P1|STARTED|Overall Study||756
7673590|NCT01976572|18896322|P3|NOT COMPLETED|Overall Study||0
7673591|NCT01976572|18896323|P2|NOT COMPLETED|Overall Study||0
7673592|NCT01976572|18896324|P1|NOT COMPLETED|Overall Study||0
7673593|NCT01976572|18896322|P3|COMPLETED|Overall Study||6
7673594|NCT01976572|18896323|P2|COMPLETED|Overall Study||6
7673595|NCT01976572|18896324|P1|COMPLETED|Overall Study||6
7673596|NCT01976572|18896322|P3|STARTED|Overall Study||6
7673597|NCT01976572|18896323|P2|STARTED|Overall Study||6
7673598|NCT01976572|18896324|P1|STARTED|Overall Study||6
7673599|NCT01976507|18896345|P1|NOT COMPLETED|Overall Study||7
7673600|NCT01976507|18896345|P1|COMPLETED|Overall Study||94
7673601|NCT01976507|18896345|P1|Received Initial Dose of Dabigatran|Overall Study||100
7673602|NCT01976507|18896345|P1|STARTED|Overall Study||101
7673603|NCT01976442|18896354|P2|NOT COMPLETED|Overall Study||0
7673604|NCT01976442|18896355|P1|NOT COMPLETED|Overall Study||0
7673605|NCT01976442|18896354|P2|COMPLETED|Overall Study||31
7673606|NCT01976442|18896355|P1|COMPLETED|Overall Study||69
7673607|NCT01976442|18896354|P2|STARTED|Overall Study||31
7673608|NCT01976442|18896355|P1|STARTED|Overall Study||69
7673609|NCT01976416|18896369|P2|NOT COMPLETED|Overall Study||2
7673610|NCT01976416|18896370|P1|NOT COMPLETED|Overall Study||2
7673611|NCT01976416|18896369|P2|COMPLETED|Overall Study||102
7673612|NCT01976416|18896370|P1|COMPLETED|Overall Study||102
7673613|NCT01976416|18896369|P2|STARTED|Overall Study||104
7673614|NCT01976416|18896370|P1|STARTED|Overall Study||104
7673615|NCT01976364|18896376|P3|NOT COMPLETED|Sub-study (12 Months)||5
7673616|NCT01976364|18896377|P2|NOT COMPLETED|Sub-study (12 Months)||6
7673617|NCT01976364|18896378|P1|NOT COMPLETED|Sub-study (12 Months)||0
7673618|NCT01976364|18896376|P3|COMPLETED|Sub-study (12 Months)||85
7673619|NCT01976364|18896377|P2|COMPLETED|Sub-study (12 Months)||83
7673620|NCT01976364|18896378|P1|COMPLETED|Sub-study (12 Months)||0
7673621|NCT01976364|18896376|P3|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|90
7673622|NCT01976364|18896377|P2|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|89
7673623|NCT01976364|18896378|P1|STARTED|Sub-study (12 Months)||0
7673624|NCT01976364|18896376|P3|NOT COMPLETED|Main Study (36 Months)||0
7673625|NCT01976364|18896377|P2|NOT COMPLETED|Main Study (36 Months)||0
7673626|NCT01976364|18896378|P1|NOT COMPLETED|Main Study (36 Months)||221
7673627|NCT01976364|18896376|P3|COMPLETED|Main Study (36 Months)||0
7673628|NCT01976364|18896377|P2|COMPLETED|Main Study (36 Months)||0
7673629|NCT01976364|18896378|P1|COMPLETED|Main Study (36 Months)||465
7673630|NCT01976364|18896376|P3|STARTED|Main Study (36 Months)||0
7673631|NCT01976364|18896377|P2|STARTED|Main Study (36 Months)||0
7673632|NCT01976364|18896378|P1|STARTED|Main Study (36 Months)||686
7673633|NCT01976338|18896498|P2|NOT COMPLETED|Overall Study||4
7673634|NCT01976338|18896499|P1|NOT COMPLETED|Overall Study||13
7673635|NCT01976338|18896498|P2|COMPLETED|Overall Study|12 months|89
7673636|NCT01976338|18896499|P1|COMPLETED|Overall Study|12 months|177
7673637|NCT01976338|18896498|P2|Discontinued Study Prior to 6 Months|Overall Study||2
7673638|NCT01976338|18896499|P1|Discontinued Study Prior to 6 Months|Overall Study||5
7673639|NCT01976338|18896498|P2|Completed 6 Months|Overall Study||91
7673640|NCT01976338|18896499|P1|Completed 6 Months|Overall Study||185
7673641|NCT01976338|18896498|P2|STARTED|Overall Study||93
7673642|NCT01976338|18896499|P1|STARTED|Overall Study||190
7673643|NCT01976312|18896526|P2|NOT COMPLETED|Overall Study||9
7673644|NCT01976312|18896527|P1|NOT COMPLETED|Overall Study||17
7673645|NCT01976312|18896526|P2|COMPLETED|Overall Study|Completed study at 12 months|53
7673646|NCT01976312|18896527|P1|COMPLETED|Overall Study|Completed study at 12 months|173
7673647|NCT01976312|18896526|P2|Discontinued Study Prior to 3 Months|Overall Study||2
7673648|NCT01976312|18896527|P1|Discontinued Study Prior to 3 Months|Overall Study||4
7673649|NCT01976312|18896526|P2|Completed 3 Months|Overall Study||60
7673650|NCT01976312|18896527|P1|Completed 3 Months|Overall Study||186
7673651|NCT01976312|18896526|P2|STARTED|Overall Study||62
7673652|NCT01976312|18896527|P1|STARTED|Overall Study||190
7673653|NCT01976299|18896548|P2|NOT COMPLETED|Overall Study||6
7673654|NCT01976299|18896549|P1|NOT COMPLETED|Overall Study||23
7673655|NCT01976299|18896548|P2|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280
7673656|NCT01976299|18896549|P1|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269
7673657|NCT01976299|18896548|P2|Completed Procedure|Overall Study||284
7673658|NCT01976299|18896549|P1|Completed Procedure|Overall Study||283
7673659|NCT01976299|18896548|P2|STARTED|Overall Study||286
7673660|NCT01976299|18896549|P1|STARTED|Overall Study||292
7673661|NCT01976273|18896565|P2|NOT COMPLETED|Overall Study||1
7673662|NCT01976273|18896566|P1|NOT COMPLETED|Overall Study||1
7673663|NCT01976273|18896565|P2|COMPLETED|Overall Study||9
7673664|NCT01976273|18896566|P1|COMPLETED|Overall Study||9
7673665|NCT01976273|18896565|P2|STARTED|Overall Study||10
7673666|NCT01976273|18896566|P1|STARTED|Overall Study||10
7673667|NCT01976104|18896576|P4|NOT COMPLETED|Overall Study||3
7673668|NCT01976104|18896577|P3|NOT COMPLETED|Overall Study||2
7673669|NCT01976104|18896578|P2|NOT COMPLETED|Overall Study||2
7673670|NCT01976104|18896579|P1|NOT COMPLETED|Overall Study||6
7673671|NCT01976104|18896576|P4|COMPLETED|Overall Study||55
7673672|NCT01976104|18896577|P3|COMPLETED|Overall Study||31
7673673|NCT01976104|18896578|P2|COMPLETED|Overall Study||68
7673674|NCT01976104|18896579|P1|COMPLETED|Overall Study||37
7673675|NCT01976104|18896576|P4|STARTED|Overall Study||58
7673676|NCT01976104|18896577|P3|STARTED|Overall Study||33
7673677|NCT01976104|18896578|P2|STARTED|Overall Study||70
7673678|NCT01976104|18896579|P1|STARTED|Overall Study||43
7673679|NCT01975974|18896605|P1|NOT COMPLETED|Overall Study||0
7673680|NCT01975974|18896605|P1|COMPLETED|Overall Study||100
7673681|NCT01975974|18896605|P1|STARTED|Overall Study||100
7673682|NCT01975948|18896613|P4|NOT COMPLETED|Overall Study||6
7673683|NCT01975948|18896614|P3|NOT COMPLETED|Overall Study||7
7673684|NCT01975948|18896615|P2|NOT COMPLETED|Overall Study||21
7673685|NCT01975948|18896616|P1|NOT COMPLETED|Overall Study||17
7673686|NCT01975948|18896613|P4|COMPLETED|Overall Study||51
7673687|NCT01975948|18896614|P3|COMPLETED|Overall Study||65
7673688|NCT01975948|18896615|P2|COMPLETED|Overall Study||34
7673689|NCT01975948|18896616|P1|COMPLETED|Overall Study||39
7673690|NCT01975948|18896613|P4|STARTED|Overall Study||57
7673691|NCT01975948|18896614|P3|STARTED|Overall Study||72
7673692|NCT01975948|18896615|P2|STARTED|Overall Study||55
7673693|NCT01975948|18896616|P1|STARTED|Overall Study||56
7673694|NCT01975935|18896642|P2|NOT COMPLETED|Overall Study||1
7673695|NCT01975935|18896643|P1|NOT COMPLETED|Overall Study||3
7673696|NCT01975935|18896642|P2|COMPLETED|Overall Study||20
7673697|NCT01975935|18896643|P1|COMPLETED|Overall Study||18
7673698|NCT01975935|18896642|P2|STARTED|Overall Study||21
7673699|NCT01975935|18896643|P1|STARTED|Overall Study||21
7673700|NCT01975922|18896655|P2|NOT COMPLETED|Overall Study||9
7673701|NCT01975922|18896656|P1|NOT COMPLETED|Overall Study||0
7673702|NCT01975922|18896655|P2|COMPLETED|Overall Study||43
7673703|NCT01975922|18896656|P1|COMPLETED|Overall Study||45
7673704|NCT01975922|18896655|P2|STARTED|Overall Study||52
7673705|NCT01975922|18896656|P1|STARTED|Overall Study||45
7673706|NCT01975909|18896666|P2|NOT COMPLETED|Overall Study||0
7673707|NCT01975909|18896667|P1|NOT COMPLETED|Overall Study||0
7673708|NCT01975909|18896666|P2|COMPLETED|Overall Study||10
7673709|NCT01975909|18896667|P1|COMPLETED|Overall Study||10
7673710|NCT01975909|18896666|P2|STARTED|Overall Study||10
7673711|NCT01975909|18896667|P1|STARTED|Overall Study||10
7673712|NCT01975831|18896692|P9|NOT COMPLETED|Overall Study||12
7673713|NCT01975831|18896693|P8|NOT COMPLETED|Overall Study||15
7673714|NCT01975831|18896694|P7|NOT COMPLETED|Overall Study||16
7673715|NCT01975831|18896695|P6|NOT COMPLETED|Overall Study||14
7673716|NCT01975831|18896696|P5|NOT COMPLETED|Overall Study||18
7673717|NCT01975831|18896697|P4|NOT COMPLETED|Overall Study||4
7673718|NCT01975831|18896698|P3|NOT COMPLETED|Overall Study||4
7673719|NCT01975831|18896699|P2|NOT COMPLETED|Overall Study||9
7673720|NCT01975831|18896700|P1|NOT COMPLETED|Overall Study||3
7673721|NCT01975831|18896692|P9|COMPLETED|Overall Study||3
7673722|NCT01975831|18896693|P8|COMPLETED|Overall Study||1
7673723|NCT01975831|18896694|P7|COMPLETED|Overall Study||0
7673724|NCT01975831|18896695|P6|COMPLETED|Overall Study||2
7673725|NCT01975831|18896696|P5|COMPLETED|Overall Study||1
7673726|NCT01975831|18896697|P4|COMPLETED|Overall Study||0
7673727|NCT01975831|18896698|P3|COMPLETED|Overall Study||0
7673728|NCT01975831|18896699|P2|COMPLETED|Overall Study||2
7673729|NCT01975831|18896700|P1|COMPLETED|Overall Study||0
7673730|NCT01975831|18896692|P9|STARTED|Overall Study||15
7673731|NCT01975831|18896693|P8|STARTED|Overall Study||16
7673732|NCT01975831|18896694|P7|STARTED|Overall Study||16
7673733|NCT01975831|18896695|P6|STARTED|Overall Study||16
7673734|NCT01975831|18896696|P5|STARTED|Overall Study||19
7673735|NCT01975831|18896697|P4|STARTED|Overall Study||4
7673736|NCT01975831|18896698|P3|STARTED|Overall Study||4
7673737|NCT01975831|18896699|P2|STARTED|Overall Study||11
7673738|NCT01975831|18896700|P1|STARTED|Overall Study||3
7673739|NCT01975701|18896765|P1|NOT COMPLETED|Overall Study||25
7673740|NCT01975701|18896765|P1|COMPLETED|Overall Study||1
7673741|NCT01975701|18896765|P1|STARTED|Overall Study||26
7673742|NCT01975675|18896776|P4|NOT COMPLETED|Overall Study||0
7673743|NCT01975675|18896777|P3|NOT COMPLETED|Overall Study||0
7673744|NCT01975675|18896778|P2|NOT COMPLETED|Overall Study||1
7673745|NCT01975675|18896779|P1|NOT COMPLETED|Overall Study||0
7673746|NCT01975675|18896776|P4|COMPLETED|Overall Study||87
7673747|NCT01975675|18896777|P3|COMPLETED|Overall Study||88
7673748|NCT01975675|18896778|P2|COMPLETED|Overall Study||82
7673749|NCT01975675|18896779|P1|COMPLETED|Overall Study||83
7673750|NCT01975675|18896776|P4|STARTED|Overall Study||87
7673751|NCT01975675|18896777|P3|STARTED|Overall Study||88
7673752|NCT01975675|18896778|P2|STARTED|Overall Study||83
7673753|NCT01975675|18896779|P1|STARTED|Overall Study||83
7673754|NCT01975519|18896801|P2|NOT COMPLETED|Overall Study||0
7673755|NCT01975519|18896802|P1|NOT COMPLETED|Overall Study||0
7673756|NCT01975519|18896801|P2|COMPLETED|Overall Study||108
7673757|NCT01975519|18896802|P1|COMPLETED|Overall Study||3
7673758|NCT01975519|18896801|P2|Phase 2a Angiosarcoma Cohort|Overall Study||22
7673759|NCT01975519|18896802|P1|Phase 2a Angiosarcoma Cohort|Overall Study||0
7673760|NCT01975519|18896801|P2|Phase 2a Soft Tissue Sarcoma|Overall Study||63
7673761|NCT01975519|18896802|P1|Phase 2a Soft Tissue Sarcoma|Overall Study||0
7673762|NCT01975519|18896801|P2|Phase 1b|Overall Study||23
7673763|NCT01975519|18896802|P1|Phase 1b|Overall Study||3
7673764|NCT01975519|18896801|P2|STARTED|Overall Study||108
7673765|NCT01975519|18896802|P1|STARTED|Overall Study||3
7673766|NCT01975467|18896819|P2|NOT COMPLETED|Overall Study||0
7673767|NCT01975467|18896820|P1|NOT COMPLETED|Overall Study||0
7673768|NCT01975467|18896819|P2|COMPLETED|Overall Study||0
7673769|NCT01975467|18896820|P1|COMPLETED|Overall Study||0
7673770|NCT01975467|18896819|P2|STARTED|Overall Study|Study terminated before enrollment|0
7673771|NCT01975467|18896820|P1|STARTED|Overall Study|Study terminated before enrollment|0
7673772|NCT01975389|18896830|P2|NOT COMPLETED|Overall Study||236
7673773|NCT01975389|18896831|P1|NOT COMPLETED|Overall Study||252
7673774|NCT01975389|18896830|P2|COMPLETED|Overall Study||5045
7673775|NCT01975389|18896831|P1|COMPLETED|Overall Study||5031
7673776|NCT01975389|18896830|P2|Treated|Overall Study||5276
7673777|NCT01975389|18896831|P1|Treated|Overall Study||5279
7673778|NCT01975389|18896830|P2|STARTED|Overall Study||5281
7673779|NCT01975389|18896831|P1|STARTED|Overall Study||5283
7673780|NCT01975376|18896891|P2|NOT COMPLETED|Overall Study||217
7673781|NCT01975376|18896892|P1|NOT COMPLETED|Overall Study||226
7673782|NCT01975376|18896891|P2|COMPLETED|Overall Study||8177
7673783|NCT01975376|18896892|P1|COMPLETED|Overall Study||8164
7673784|NCT01975376|18896891|P2|Treated|Overall Study||8386
7673785|NCT01975376|18896892|P1|Treated|Overall Study||8374
7673786|NCT01975376|18896891|P2|STARTED|Overall Study||8394
7673787|NCT01975376|18896892|P1|STARTED|Overall Study||8390
7673788|NCT01975285|18896952|P2|NOT COMPLETED|Overall Study||2
7673789|NCT01975285|18896953|P1|NOT COMPLETED|Overall Study||2
7673790|NCT01975285|18896952|P2|COMPLETED|Overall Study||28
7673791|NCT01975285|18896953|P1|COMPLETED|Overall Study||28
7673792|NCT01975285|18896952|P2|STARTED|Overall Study||30
7673793|NCT01975285|18896953|P1|STARTED|Overall Study||30
7673794|NCT01975246|18896969|P2|NOT COMPLETED|Overall Study||2
7673795|NCT01975246|18896970|P1|NOT COMPLETED|Overall Study||4
7673796|NCT01975246|18896969|P2|COMPLETED|Overall Study||158
7673797|NCT01975246|18896970|P1|COMPLETED|Overall Study||145
7673798|NCT01975246|18896969|P2|STARTED|Overall Study||160
7673799|NCT01975246|18896970|P1|STARTED|Overall Study||149
7673800|NCT01975220|18896983|P6|NOT COMPLETED|Test Period 2||0
7673801|NCT01975220|18896984|P5|NOT COMPLETED|Test Period 2||0
7673802|NCT01975220|18896985|P4|NOT COMPLETED|Test Period 2||0
7673803|NCT01975220|18896986|P3|NOT COMPLETED|Test Period 2||0
7673804|NCT01975220|18896987|P2|NOT COMPLETED|Test Period 2||0
7673805|NCT01975220|18896988|P1|NOT COMPLETED|Test Period 2||0
7673806|NCT01975220|18896983|P6|COMPLETED|Test Period 2||12
7673807|NCT01975220|18896984|P5|COMPLETED|Test Period 2||12
7673808|NCT01975220|18896985|P4|COMPLETED|Test Period 2||12
7673809|NCT01975220|18896986|P3|COMPLETED|Test Period 2||12
7673810|NCT01975220|18896987|P2|COMPLETED|Test Period 2||11
7673811|NCT01975220|18896988|P1|COMPLETED|Test Period 2||12
7673812|NCT01975220|18896983|P6|STARTED|Test Period 2||12
7673813|NCT01975220|18896984|P5|STARTED|Test Period 2||12
7673814|NCT01975220|18896985|P4|STARTED|Test Period 2||12
7673815|NCT01975220|18896986|P3|STARTED|Test Period 2||12
7673816|NCT01975220|18896987|P2|STARTED|Test Period 2||11
7673817|NCT01975220|18896988|P1|STARTED|Test Period 2||12
7673818|NCT01975220|18896983|P6|NOT COMPLETED|Test Period 1||0
7673819|NCT01975220|18896984|P5|NOT COMPLETED|Test Period 1||0
7673820|NCT01975220|18896985|P4|NOT COMPLETED|Test Period 1||0
7673821|NCT01975220|18896986|P3|NOT COMPLETED|Test Period 1||0
7673822|NCT01975220|18896987|P2|NOT COMPLETED|Test Period 1||1
7673823|NCT01975220|18896988|P1|NOT COMPLETED|Test Period 1||0
7673824|NCT01975220|18896983|P6|COMPLETED|Test Period 1||12
7673825|NCT01975220|18896984|P5|COMPLETED|Test Period 1||12
7673826|NCT01975220|18896985|P4|COMPLETED|Test Period 1||12
7673827|NCT01975220|18896986|P3|COMPLETED|Test Period 1||12
7673828|NCT01975220|18896987|P2|COMPLETED|Test Period 1||11
7673829|NCT01975220|18896988|P1|COMPLETED|Test Period 1||12
7673830|NCT01975220|18896983|P6|STARTED|Test Period 1||12
7673831|NCT01975220|18896984|P5|STARTED|Test Period 1||12
7673832|NCT01975220|18896985|P4|STARTED|Test Period 1||12
7673833|NCT01975220|18896986|P3|STARTED|Test Period 1||12
7673834|NCT01975220|18896987|P2|STARTED|Test Period 1||12
7673835|NCT01975220|18896988|P1|STARTED|Test Period 1||12
7673836|NCT01975090|18897032|P1|NOT COMPLETED|Overall Study||12
7673837|NCT01975090|18897032|P1|COMPLETED|Overall Study||117
7673838|NCT01975090|18897032|P1|6-month Follow-up|Overall Study||117
7673839|NCT01975090|18897032|P1|STARTED|Overall Study||129
7673840|NCT01974895|18897044|P2|NOT COMPLETED|Overall Study||15
7673841|NCT01974895|18897045|P1|NOT COMPLETED|Overall Study||15
7673842|NCT01974895|18897044|P2|COMPLETED|Overall Study||141
7673843|NCT01974895|18897045|P1|COMPLETED|Overall Study||143
7673844|NCT01974895|18897044|P2|STARTED|Overall Study||156
7673845|NCT01974895|18897045|P1|STARTED|Overall Study||158
7673846|NCT01974817|18897075|P1|NOT COMPLETED|Overall Study||8
7673847|NCT01974817|18897075|P1|COMPLETED|Overall Study||17
7673848|NCT01974817|18897075|P1|STARTED|Overall Study||25
7673849|NCT01974752|18897081|P2|NOT COMPLETED|Overall Study||15
7673850|NCT01974752|18897082|P1|NOT COMPLETED|Overall Study||37
7673851|NCT01974752|18897081|P2|COMPLETED|Overall Study||17
7673852|NCT01974752|18897082|P1|COMPLETED|Overall Study||60
7673853|NCT01974752|18897081|P2|STARTED|Overall Study||32
7673854|NCT01974752|18897082|P1|STARTED|Overall Study||97
7673855|NCT01974700|18897096|P2|NOT COMPLETED|Overall Study||0
7673856|NCT01974700|18897097|P1|NOT COMPLETED|Overall Study||0
7673857|NCT01974700|18897096|P2|COMPLETED|Overall Study||3
7673858|NCT01974700|18897097|P1|COMPLETED|Overall Study||5
7673859|NCT01974700|18897096|P2|STARTED|Overall Study||3
7673860|NCT01974700|18897097|P1|STARTED|Overall Study||5
7673861|NCT01974687|18897132|P25|NOT COMPLETED|Overall Study||0
7673862|NCT01974687|18897133|P24|NOT COMPLETED|Overall Study||0
7673863|NCT01974687|18897134|P23|NOT COMPLETED|Overall Study||0
7673864|NCT01974687|18897135|P22|NOT COMPLETED|Overall Study||0
7673865|NCT01974687|18897136|P21|NOT COMPLETED|Overall Study||0
7673866|NCT01974687|18897137|P20|NOT COMPLETED|Overall Study||0
7673867|NCT01974687|18897138|P19|NOT COMPLETED|Overall Study||0
7673868|NCT01974687|18897139|P18|NOT COMPLETED|Overall Study||3
7673869|NCT01974687|18897140|P17|NOT COMPLETED|Overall Study||1
7673870|NCT01974687|18897141|P16|NOT COMPLETED|Overall Study||1
7673871|NCT01974687|18897142|P15|NOT COMPLETED|Overall Study||1
7673872|NCT01974687|18897143|P14|NOT COMPLETED|Overall Study||2
7673873|NCT01974687|18897144|P13|NOT COMPLETED|Overall Study||3
7673874|NCT01974687|18897145|P12|NOT COMPLETED|Overall Study||2
7673875|NCT01974687|18897146|P11|NOT COMPLETED|Overall Study||0
7673876|NCT01974687|18897147|P10|NOT COMPLETED|Overall Study||0
7673877|NCT01974687|18897148|P9|NOT COMPLETED|Overall Study||0
7673878|NCT01974687|18897149|P8|NOT COMPLETED|Overall Study||0
7673879|NCT01974687|18897150|P7|NOT COMPLETED|Overall Study||0
7673880|NCT01974687|18897151|P6|NOT COMPLETED|Overall Study||0
7673881|NCT01974687|18897152|P5|NOT COMPLETED|Overall Study||0
7673882|NCT01974687|18897153|P4|NOT COMPLETED|Overall Study||0
7673883|NCT01974687|18897154|P3|NOT COMPLETED|Overall Study||0
7673884|NCT01974687|18897155|P2|NOT COMPLETED|Overall Study||0
7673885|NCT01974687|18897156|P1|NOT COMPLETED|Overall Study||0
7673886|NCT01974687|18897132|P25|COMPLETED|Overall Study||10
7673887|NCT01974687|18897133|P24|COMPLETED|Overall Study||6
7673888|NCT01974687|18897134|P23|COMPLETED|Overall Study||8
7673889|NCT01974687|18897135|P22|COMPLETED|Overall Study||8
7673890|NCT01974687|18897136|P21|COMPLETED|Overall Study||3
7673891|NCT01974687|18897137|P20|COMPLETED|Overall Study||3
7673892|NCT01974687|18897138|P19|COMPLETED|Overall Study||9
7673893|NCT01974687|18897139|P18|COMPLETED|Overall Study||8
7673894|NCT01974687|18897140|P17|COMPLETED|Overall Study||8
7673895|NCT01974687|18897141|P16|COMPLETED|Overall Study||8
7673896|NCT01974687|18897142|P15|COMPLETED|Overall Study||18
7673897|NCT01974687|18897143|P14|COMPLETED|Overall Study||8
7673898|NCT01974687|18897144|P13|COMPLETED|Overall Study||10
7673899|NCT01974687|18897145|P12|COMPLETED|Overall Study||11
7673900|NCT01974687|18897146|P11|COMPLETED|Overall Study||3
7673901|NCT01974687|18897147|P10|COMPLETED|Overall Study||3
7673902|NCT01974687|18897148|P9|COMPLETED|Overall Study||3
7673903|NCT01974687|18897149|P8|COMPLETED|Overall Study||3
7673904|NCT01974687|18897150|P7|COMPLETED|Overall Study||3
7673905|NCT01974687|18897151|P6|COMPLETED|Overall Study||6
7673906|NCT01974687|18897152|P5|COMPLETED|Overall Study||2
7673907|NCT01974687|18897153|P4|COMPLETED|Overall Study||6
7673908|NCT01974687|18897154|P3|COMPLETED|Overall Study||6
7673909|NCT01974687|18897155|P2|COMPLETED|Overall Study||6
7673910|NCT01974687|18897156|P1|COMPLETED|Overall Study||6
7673911|NCT01974687|18897132|P25|Treated|Overall Study||10
7673912|NCT01974687|18897133|P24|Treated|Overall Study||6
7673913|NCT01974687|18897134|P23|Treated|Overall Study||8
7673914|NCT01974687|18897135|P22|Treated|Overall Study||8
7673915|NCT01974687|18897136|P21|Treated|Overall Study||3
7673916|NCT01974687|18897137|P20|Treated|Overall Study||3
7673917|NCT01974687|18897138|P19|Treated|Overall Study||9
7673918|NCT01974687|18897139|P18|Treated|Overall Study|3 participants discontinued prior to receiving study drug|8
7673919|NCT01974687|18897140|P17|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
7673920|NCT01974687|18897141|P16|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
7673921|NCT01974687|18897142|P15|Treated|Overall Study|1 participant discontinued prior to receiving study drug|18
7673922|NCT01974687|18897143|P14|Treated|Overall Study|2 participants discontinued prior to receiving study drug|8
7673923|NCT01974687|18897144|P13|Treated|Overall Study|3 participants discontinued prior to receiving study drug|10
7673924|NCT01974687|18897145|P12|Treated|Overall Study|2 participants discontinued prior to receiving study drug|11
7673925|NCT01974687|18897146|P11|Treated|Overall Study||3
7673926|NCT01974687|18897147|P10|Treated|Overall Study||3
7673927|NCT01974687|18897148|P9|Treated|Overall Study||3
7673928|NCT01974687|18897149|P8|Treated|Overall Study||3
7673929|NCT01974687|18897150|P7|Treated|Overall Study||3
7673930|NCT01974687|18897151|P6|Treated|Overall Study||6
7673931|NCT01974687|18897152|P5|Treated|Overall Study||2
7673932|NCT01974687|18897153|P4|Treated|Overall Study||6
7673933|NCT01974687|18897154|P3|Treated|Overall Study||6
7673934|NCT01974687|18897155|P2|Treated|Overall Study||6
7673935|NCT01974687|18897156|P1|Treated|Overall Study||6
7673936|NCT01974687|18897132|P25|STARTED|Overall Study||10
7673937|NCT01974687|18897133|P24|STARTED|Overall Study||6
7673938|NCT01974687|18897134|P23|STARTED|Overall Study||8
7673939|NCT01974687|18897135|P22|STARTED|Overall Study||8
7673940|NCT01974687|18897136|P21|STARTED|Overall Study||3
7673941|NCT01974687|18897137|P20|STARTED|Overall Study||3
7673942|NCT01974687|18897138|P19|STARTED|Overall Study||9
7673943|NCT01974687|18897139|P18|STARTED|Overall Study||11
7673944|NCT01974687|18897140|P17|STARTED|Overall Study||9
7673945|NCT01974687|18897141|P16|STARTED|Overall Study||9
7673946|NCT01974687|18897142|P15|STARTED|Overall Study||19
7673947|NCT01974687|18897143|P14|STARTED|Overall Study||10
7673948|NCT01974687|18897144|P13|STARTED|Overall Study||13
7673949|NCT01974687|18897145|P12|STARTED|Overall Study||13
7673950|NCT01974687|18897146|P11|STARTED|Overall Study||3
7673951|NCT01974687|18897147|P10|STARTED|Overall Study||3
7673952|NCT01974687|18897148|P9|STARTED|Overall Study||3
7673953|NCT01974687|18897149|P8|STARTED|Overall Study||3
7673954|NCT01974687|18897150|P7|STARTED|Overall Study||3
7673955|NCT01974687|18897151|P6|STARTED|Overall Study||6
7673956|NCT01974687|18897152|P5|STARTED|Overall Study||2
7673957|NCT01974687|18897153|P4|STARTED|Overall Study||6
7673958|NCT01974687|18897154|P3|STARTED|Overall Study||6
7673959|NCT01974687|18897155|P2|STARTED|Overall Study||6
7673960|NCT01974687|18897156|P1|STARTED|Overall Study||6
7673961|NCT01974635|18897503|P1|NOT COMPLETED|Overall Study||0
7673962|NCT01974635|18897503|P1|COMPLETED|Overall Study||2
7673963|NCT01974635|18897503|P1|STARTED|Overall Study||2
7673964|NCT01974323|18897510|P2|NOT COMPLETED|Overall Study||93
7673965|NCT01974323|18897511|P1|NOT COMPLETED|Overall Study||92
7673966|NCT01974323|18897510|P2|COMPLETED|Overall Study||1027
7673967|NCT01974323|18897511|P1|COMPLETED|Overall Study||1026
7673968|NCT01974323|18897510|P2|STARTED|Overall Study||1120
7673969|NCT01974323|18897511|P1|STARTED|Overall Study||1118
7673970|NCT01974284|18897533|P1|NOT COMPLETED|Overall Study||7
7673971|NCT01974284|18897533|P1|COMPLETED|Overall Study||0
7673972|NCT01974284|18897533|P1|STARTED|Overall Study||7
7673973|NCT01974245|18897542|P2|NOT COMPLETED|Overall Study||8
7673974|NCT01974245|18897543|P1|NOT COMPLETED|Overall Study||9
7673975|NCT01974245|18897542|P2|COMPLETED|Overall Study||20
7673976|NCT01974245|18897543|P1|COMPLETED|Overall Study||18
7673977|NCT01974245|18897542|P2|STARTED|Overall Study||28
7673978|NCT01974245|18897543|P1|STARTED|Overall Study||27
7673979|NCT01974141|18897551|P2|NOT COMPLETED|Overall Study||82
7673980|NCT01974141|18897552|P1|NOT COMPLETED|Overall Study||96
7673981|NCT01974141|18897551|P2|COMPLETED|Overall Study||976
7673982|NCT01974141|18897552|P1|COMPLETED|Overall Study||948
7673983|NCT01974141|18897551|P2|STARTED|Overall Study||1058
7673984|NCT01974141|18897552|P1|STARTED|Overall Study||1044
7673985|NCT01974089|18897576|P2|NOT COMPLETED|Overall Study||0
7673986|NCT01974089|18897577|P1|NOT COMPLETED|Overall Study||0
7673987|NCT01974089|18897576|P2|COMPLETED|Overall Study||101
7673988|NCT01974089|18897577|P1|COMPLETED|Overall Study||53
7673989|NCT01974089|18897576|P2|STARTED|Overall Study||101
7673990|NCT01974089|18897577|P1|STARTED|Overall Study||53
7673991|NCT01974050|18897587|P1|NOT COMPLETED|Overall Study||25
7673992|NCT01974050|18897587|P1|COMPLETED|Overall Study||141
7673993|NCT01974050|18897587|P1|STARTED|Overall Study||166
7673994|NCT01973998|18897596|P2|NOT COMPLETED|Overall Study||2
7673995|NCT01973998|18897597|P1|NOT COMPLETED|Overall Study||2
7673996|NCT01973998|18897596|P2|COMPLETED|Overall Study||33
7673997|NCT01973998|18897597|P1|COMPLETED|Overall Study||31
7673998|NCT01973998|18897596|P2|STARTED|Overall Study||35
7673999|NCT01973998|18897597|P1|STARTED|Overall Study||33
7674000|NCT01973972|18897609|P2|NOT COMPLETED|Overall Study||19
7674001|NCT01973972|18897610|P1|NOT COMPLETED|Overall Study||18
7674002|NCT01973972|18897609|P2|COMPLETED|Overall Study||117
7674003|NCT01973972|18897610|P1|COMPLETED|Overall Study||109
7674004|NCT01973972|18897609|P2|STARTED|Overall Study||136
7674005|NCT01973972|18897610|P1|STARTED|Overall Study||127
7674006|NCT01973777|18897624|P1|NOT COMPLETED|Overall Study||7
7674007|NCT01973777|18897624|P1|COMPLETED|Overall Study||44
7674008|NCT01973777|18897624|P1|One Year Follow-up|Overall Study||44
7674009|NCT01973777|18897624|P1|STARTED|Overall Study|January 2014|51
7674010|NCT01973608|18897634|P4|NOT COMPLETED|Overall Study||0
7674011|NCT01973608|18897635|P3|NOT COMPLETED|Overall Study||0
7674012|NCT01973608|18897636|P2|NOT COMPLETED|Overall Study||0
7674013|NCT01973608|18897637|P1|NOT COMPLETED|Overall Study||0
7674014|NCT01973608|18897634|P4|COMPLETED|Overall Study||2
7674015|NCT01973608|18897635|P3|COMPLETED|Overall Study||6
7674016|NCT01973608|18897636|P2|COMPLETED|Overall Study||2
7674017|NCT01973608|18897637|P1|COMPLETED|Overall Study||2
7674018|NCT01973608|18897634|P4|STARTED|Overall Study||2
7674019|NCT01973608|18897635|P3|STARTED|Overall Study||6
7674020|NCT01973608|18897636|P2|STARTED|Overall Study||2
7674021|NCT01973608|18897637|P1|STARTED|Overall Study||2
7674022|NCT01973595|18897659|P4|NOT COMPLETED|Intervention Phase 2||0
7674023|NCT01973595|18897660|P3|NOT COMPLETED|Intervention Phase 2||0
7674024|NCT01973595|18897661|P2|NOT COMPLETED|Intervention Phase 2||0
7674025|NCT01973595|18897662|P1|NOT COMPLETED|Intervention Phase 2||0
7674026|NCT01973595|18897659|P4|COMPLETED|Intervention Phase 2||14
7674027|NCT01973595|18897660|P3|COMPLETED|Intervention Phase 2||14
7674028|NCT01973595|18897661|P2|COMPLETED|Intervention Phase 2||14
7674029|NCT01973595|18897662|P1|COMPLETED|Intervention Phase 2||14
7674030|NCT01973595|18897659|P4|STARTED|Intervention Phase 2||14
7674031|NCT01973595|18897660|P3|STARTED|Intervention Phase 2||14
7674032|NCT01973595|18897661|P2|STARTED|Intervention Phase 2||14
7674033|NCT01973595|18897662|P1|STARTED|Intervention Phase 2||14
7674034|NCT01973595|18897659|P4|NOT COMPLETED|Washout||0
7674035|NCT01973595|18897660|P3|NOT COMPLETED|Washout||1
7674036|NCT01973595|18897661|P2|NOT COMPLETED|Washout||0
7674037|NCT01973595|18897662|P1|NOT COMPLETED|Washout||1
7674038|NCT01973595|18897659|P4|COMPLETED|Washout||14
7674039|NCT01973595|18897660|P3|COMPLETED|Washout||14
7674040|NCT01973595|18897661|P2|COMPLETED|Washout||14
7674041|NCT01973595|18897662|P1|COMPLETED|Washout||14
7674042|NCT01973595|18897659|P4|STARTED|Washout||14
7674043|NCT01973595|18897660|P3|STARTED|Washout||15
7674044|NCT01973595|18897661|P2|STARTED|Washout||14
7674045|NCT01973595|18897662|P1|STARTED|Washout||15
7674046|NCT01973595|18897659|P4|NOT COMPLETED|Intervention Phase 1||0
7674047|NCT01973595|18897660|P3|NOT COMPLETED|Intervention Phase 1||0
7674048|NCT01973595|18897661|P2|NOT COMPLETED|Intervention Phase 1||0
7674049|NCT01973595|18897662|P1|NOT COMPLETED|Intervention Phase 1||0
7674050|NCT01973595|18897659|P4|COMPLETED|Intervention Phase 1||14
7674051|NCT01973595|18897660|P3|COMPLETED|Intervention Phase 1||15
7674052|NCT01973595|18897661|P2|COMPLETED|Intervention Phase 1||14
7674053|NCT01973595|18897662|P1|COMPLETED|Intervention Phase 1||15
7674054|NCT01973595|18897659|P4|STARTED|Intervention Phase 1||14
7674055|NCT01973595|18897660|P3|STARTED|Intervention Phase 1||15
7674056|NCT01973595|18897661|P2|STARTED|Intervention Phase 1||14
7674057|NCT01973595|18897662|P1|STARTED|Intervention Phase 1||15
7674058|NCT01973569|18897679|P3|NOT COMPLETED|Overall Study||18
7674059|NCT01973569|18897680|P2|NOT COMPLETED|Overall Study||25
7674060|NCT01973569|18897681|P1|NOT COMPLETED|Overall Study||29
7674061|NCT01973569|18897679|P3|COMPLETED|Overall Study||208
7674062|NCT01973569|18897680|P2|COMPLETED|Overall Study||200
7674063|NCT01973569|18897681|P1|COMPLETED|Overall Study||199
7674064|NCT01973569|18897679|P3|Discontinued Study|Overall Study||15
7674065|NCT01973569|18897680|P2|Discontinued Study|Overall Study||22
7674066|NCT01973569|18897681|P1|Discontinued Study|Overall Study||23
7674067|NCT01973569|18897679|P3|Discontinued Study Treatment|Overall Study||15
7674068|NCT01973569|18897680|P2|Discontinued Study Treatment|Overall Study||22
7674069|NCT01973569|18897681|P1|Discontinued Study Treatment|Overall Study||23
7674070|NCT01973569|18897679|P3|Did Not Receive Study Drug|Overall Study||3
7674071|NCT01973569|18897680|P2|Did Not Receive Study Drug|Overall Study||3
7674072|NCT01973569|18897681|P1|Did Not Receive Study Drug|Overall Study||6
7674073|NCT01973569|18897679|P3|Received Study Drug|Overall Study||223
7674074|NCT01973569|18897680|P2|Received Study Drug|Overall Study||222
7674075|NCT01973569|18897681|P1|Received Study Drug|Overall Study||222
7674076|NCT01973569|18897679|P3|STARTED|Overall Study||226
7674077|NCT01973569|18897680|P2|STARTED|Overall Study||225
7674078|NCT01973569|18897681|P1|STARTED|Overall Study||228
7674079|NCT01973491|18897707|P1|NOT COMPLETED|Treatment Period (16 Weeks)||1
7674080|NCT01973491|18897707|P1|COMPLETED|Treatment Period (16 Weeks)||18
7674081|NCT01973491|18897707|P1|STARTED|Treatment Period (16 Weeks)||19
7674082|NCT01973491|18897707|P1|NOT COMPLETED|Titration Period(4 Weeks)||0
7674083|NCT01973491|18897707|P1|COMPLETED|Titration Period(4 Weeks)||19
7674084|NCT01973491|18897707|P1|STARTED|Titration Period(4 Weeks)||19
7674085|NCT01973491|18897707|P1|NOT COMPLETED|Baseline Control Period (8 Weeks)||18
7674086|NCT01973491|18897707|P1|COMPLETED|Baseline Control Period (8 Weeks)||19
7674087|NCT01973491|18897707|P1|STARTED|Baseline Control Period (8 Weeks)||37
7674088|NCT01973439|18897723|P1|NOT COMPLETED|Overall Study||5
7674089|NCT01973439|18897723|P1|COMPLETED|Overall Study||18
7674090|NCT01973439|18897723|P1|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5
7674091|NCT01973439|18897723|P1|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18
7674092|NCT01973439|18897723|P1|STARTED|Overall Study||23
7674093|NCT01973413|18897732|P2|NOT COMPLETED|Overall Study||0
7674094|NCT01973413|18897733|P1|NOT COMPLETED|Overall Study||1
7674095|NCT01973413|18897732|P2|COMPLETED|Overall Study||20
7674096|NCT01973413|18897733|P1|COMPLETED|Overall Study||11
7674097|NCT01973413|18897732|P2|STARTED|Overall Study||20
7674098|NCT01973413|18897733|P1|STARTED|Overall Study||12
7674099|NCT01973387|18897745|P2|NOT COMPLETED|Overall Study||18
7674100|NCT01973387|18897746|P1|NOT COMPLETED|Overall Study||106
7674101|NCT01973387|18897745|P2|COMPLETED|Overall Study||36
7674102|NCT01973387|18897746|P1|COMPLETED|Overall Study||0
7674103|NCT01973387|18897745|P2|Treated|Overall Study||52
7674104|NCT01973387|18897746|P1|Treated|Overall Study||104
7674105|NCT01973387|18897745|P2|STARTED|Overall Study||54
7674106|NCT01973387|18897746|P1|STARTED|Overall Study||106
7674107|NCT01973348|18897764|P4|NOT COMPLETED|Overall Study||0
7674108|NCT01973348|18897765|P3|NOT COMPLETED|Overall Study||0
7674109|NCT01973348|18897766|P2|NOT COMPLETED|Overall Study||3
7674110|NCT01973348|18897767|P1|NOT COMPLETED|Overall Study||8
7674111|NCT01973348|18897764|P4|COMPLETED|Overall Study||0
7674112|NCT01973348|18897765|P3|COMPLETED|Overall Study||0
7674113|NCT01973348|18897766|P2|COMPLETED|Overall Study||15
7674114|NCT01973348|18897767|P1|COMPLETED|Overall Study||19
7674115|NCT01973348|18897764|P4|STARTED|Overall Study||0
7674116|NCT01973348|18897765|P3|STARTED|Overall Study||0
7674117|NCT01973348|18897766|P2|STARTED|Overall Study||18
7674118|NCT01973348|18897767|P1|STARTED|Overall Study||27
7674119|NCT01973335|18897789|P4|NOT COMPLETED|Overall Study||0
7674120|NCT01973335|18897790|P3|NOT COMPLETED|Overall Study||0
7674121|NCT01973335|18897791|P2|NOT COMPLETED|Overall Study||0
7674122|NCT01973335|18897792|P1|NOT COMPLETED|Overall Study||0
7674123|NCT01973335|18897789|P4|COMPLETED|Overall Study||9
7674124|NCT01973335|18897790|P3|COMPLETED|Overall Study||9
7674125|NCT01973335|18897791|P2|COMPLETED|Overall Study||7
7674126|NCT01973335|18897792|P1|COMPLETED|Overall Study||9
7674127|NCT01973335|18897789|P4|STARTED|Overall Study||9
7674128|NCT01973335|18897790|P3|STARTED|Overall Study||9
7674129|NCT01973335|18897791|P2|STARTED|Overall Study||7
7674130|NCT01973335|18897792|P1|STARTED|Overall Study||9
7674131|NCT01973231|18897828|P2|NOT COMPLETED|Overall Study||12
7674132|NCT01973231|18897829|P1|NOT COMPLETED|Overall Study||11
7674133|NCT01973231|18897828|P2|COMPLETED|Overall Study||190
7674134|NCT01973231|18897829|P1|COMPLETED|Overall Study||191
7674135|NCT01973231|18897828|P2|STARTED|Overall Study||202
7674136|NCT01973231|18897829|P1|STARTED|Overall Study||202
7674137|NCT01973218|18897849|P2|NOT COMPLETED|Overall Study||0
7674138|NCT01973218|18897850|P1|NOT COMPLETED|Overall Study||2
7674139|NCT01973218|18897849|P2|COMPLETED|Overall Study||88
7674140|NCT01973218|18897850|P1|COMPLETED|Overall Study||174
7674141|NCT01973218|18897849|P2|STARTED|Overall Study||88
7674142|NCT01973218|18897850|P1|STARTED|Overall Study||176
7674143|NCT01973205|18897873|P2|NOT COMPLETED|Overall Study||22
7674144|NCT01973205|18897874|P1|NOT COMPLETED|Overall Study||30
7674145|NCT01973205|18897873|P2|COMPLETED|Overall Study||425
7674146|NCT01973205|18897874|P1|COMPLETED|Overall Study||423
7674147|NCT01973205|18897873|P2|STARTED|Overall Study||447
7674148|NCT01973205|18897874|P1|STARTED|Overall Study||453
7674149|NCT01973062|18897886|P1|NOT COMPLETED|Overall Study||0
7674150|NCT01973062|18897886|P1|COMPLETED|Overall Study||1
7674151|NCT01973062|18897886|P1|STARTED|Overall Study||1
7674152|NCT01973036|18897896|P2|NOT COMPLETED|Overall Study||0
7674153|NCT01973036|18897897|P1|NOT COMPLETED|Overall Study||0
7674154|NCT01973036|18897896|P2|COMPLETED|Overall Study||93
7674155|NCT01973036|18897897|P1|COMPLETED|Overall Study||108
7674156|NCT01973036|18897896|P2|Received Assigned Intervention|Overall Study||88
7674157|NCT01973036|18897897|P1|Received Assigned Intervention|Overall Study||113
7674158|NCT01973036|18897896|P2|STARTED|Overall Study||93
7674159|NCT01973036|18897897|P1|STARTED|Overall Study||108
7674160|NCT01972841|18897943|P6|NOT COMPLETED|Overall Study||85
7674161|NCT01972841|18897944|P5|NOT COMPLETED|Overall Study||83
7674162|NCT01972841|18897945|P4|NOT COMPLETED|Overall Study||37
7674163|NCT01972841|18897946|P3|NOT COMPLETED|Overall Study||50
7674164|NCT01972841|18897947|P2|NOT COMPLETED|Overall Study||44
7674165|NCT01972841|18897948|P1|NOT COMPLETED|Overall Study||43
7674166|NCT01972841|18897943|P6|COMPLETED|Overall Study||798
7674167|NCT01972841|18897944|P5|COMPLETED|Overall Study||802
7674168|NCT01972841|18897945|P4|COMPLETED|Overall Study||397
7674169|NCT01972841|18897946|P3|COMPLETED|Overall Study||387
7674170|NCT01972841|18897947|P2|COMPLETED|Overall Study||397
7674171|NCT01972841|18897948|P1|COMPLETED|Overall Study||404
7674172|NCT01972841|18897943|P6|STARTED|Overall Study||883
7674173|NCT01972841|18897944|P5|STARTED|Overall Study||885
7674174|NCT01972841|18897945|P4|STARTED|Overall Study||434
7674175|NCT01972841|18897946|P3|STARTED|Overall Study||437
7674176|NCT01972841|18897947|P2|STARTED|Overall Study||441
7674177|NCT01972841|18897948|P1|STARTED|Overall Study||447
7674178|NCT01972789|18898378|P2|NOT COMPLETED|Overall Study||30
7674179|NCT01972789|18898379|P1|NOT COMPLETED|Overall Study||40
7674180|NCT01972789|18898378|P2|COMPLETED|Overall Study||145
7674181|NCT01972789|18898379|P1|COMPLETED|Overall Study||134
7674182|NCT01972789|18898378|P2|STARTED|Overall Study||175
7674183|NCT01972789|18898379|P1|STARTED|Overall Study||174
7674184|NCT01972776|18898413|P6|NOT COMPLETED|Part 2||7
7674185|NCT01972776|18898414|P5|NOT COMPLETED|Part 2||13
7674186|NCT01972776|18898415|P4|NOT COMPLETED|Part 2||0
7674187|NCT01972776|18898416|P3|NOT COMPLETED|Part 2||0
7674188|NCT01972776|18898417|P2|NOT COMPLETED|Part 2||0
7674189|NCT01972776|18898418|P1|NOT COMPLETED|Part 2||0
7674190|NCT01972776|18898413|P6|COMPLETED|Part 2||0
7674191|NCT01972776|18898414|P5|COMPLETED|Part 2||1
7674192|NCT01972776|18898415|P4|COMPLETED|Part 2||0
7674193|NCT01972776|18898416|P3|COMPLETED|Part 2||0
7674194|NCT01972776|18898417|P2|COMPLETED|Part 2||0
7674195|NCT01972776|18898418|P1|COMPLETED|Part 2||0
7674196|NCT01972776|18898413|P6|STARTED|Part 2||7
7674197|NCT01972776|18898414|P5|STARTED|Part 2||14
7674198|NCT01972776|18898415|P4|STARTED|Part 2||0
7674199|NCT01972776|18898416|P3|STARTED|Part 2||0
7674200|NCT01972776|18898417|P2|STARTED|Part 2||0
7674201|NCT01972776|18898418|P1|STARTED|Part 2||0
7674202|NCT01972776|18898413|P6|NOT COMPLETED|Part 1||0
7674203|NCT01972776|18898414|P5|NOT COMPLETED|Part 1||0
7674204|NCT01972776|18898415|P4|NOT COMPLETED|Part 1||1
7674205|NCT01972776|18898416|P3|NOT COMPLETED|Part 1||2
7674206|NCT01972776|18898417|P2|NOT COMPLETED|Part 1||0
7674207|NCT01972776|18898418|P1|NOT COMPLETED|Part 1||0
7674208|NCT01972776|18898413|P6|COMPLETED|Part 1||0
7674209|NCT01972776|18898414|P5|COMPLETED|Part 1||0
7674210|NCT01972776|18898415|P4|COMPLETED|Part 1||6
7674211|NCT01972776|18898416|P3|COMPLETED|Part 1||6
7674212|NCT01972776|18898417|P2|COMPLETED|Part 1||6
7674213|NCT01972776|18898418|P1|COMPLETED|Part 1||6
7674214|NCT01972776|18898413|P6|STARTED|Part 1||0
7674215|NCT01972776|18898414|P5|STARTED|Part 1||0
7674216|NCT01972776|18898415|P4|STARTED|Part 1||7
7674217|NCT01972776|18898416|P3|STARTED|Part 1||8
7674218|NCT01972776|18898417|P2|STARTED|Part 1||6
7674219|NCT01972776|18898418|P1|STARTED|Part 1||6
7674220|NCT01972724|18898489|P3|NOT COMPLETED|Open-Label||5
7674221|NCT01972724|18898490|P2|NOT COMPLETED|Open-Label||0
7674222|NCT01972724|18898491|P1|NOT COMPLETED|Open-Label||0
7674223|NCT01972724|18898489|P3|COMPLETED|Open-Label||72
7674224|NCT01972724|18898490|P2|COMPLETED|Open-Label||0
7674225|NCT01972724|18898491|P1|COMPLETED|Open-Label||0
7674226|NCT01972724|18898489|P3|STARTED|Open-Label||77
7674227|NCT01972724|18898490|P2|STARTED|Open-Label||0
7674228|NCT01972724|18898491|P1|STARTED|Open-Label||0
7674229|NCT01972724|18898489|P3|NOT COMPLETED|Double-Blind||0
7674230|NCT01972724|18898490|P2|NOT COMPLETED|Double-Blind||9
7674231|NCT01972724|18898491|P1|NOT COMPLETED|Double-Blind||9
7674232|NCT01972724|18898489|P3|COMPLETED|Double-Blind||0
7674233|NCT01972724|18898490|P2|COMPLETED|Double-Blind||9
7674234|NCT01972724|18898491|P1|COMPLETED|Double-Blind||10
7674235|NCT01972724|18898489|P3|Intent-to-treat:Received Study Drug|Double-Blind||0
7674236|NCT01972724|18898490|P2|Intent-to-treat:Received Study Drug|Double-Blind||17
7674237|NCT01972724|18898491|P1|Intent-to-treat:Received Study Drug|Double-Blind||17
7674238|NCT01972724|18898489|P3|STARTED|Double-Blind||0
7674239|NCT01972724|18898490|P2|STARTED|Double-Blind||18
7674240|NCT01972724|18898491|P1|STARTED|Double-Blind||19
7674241|NCT01972659|18898504|P2|NOT COMPLETED|Overall Study||3
7674242|NCT01972659|18898505|P1|NOT COMPLETED|Overall Study||4
7674243|NCT01972659|18898504|P2|COMPLETED|Overall Study||37
7674244|NCT01972659|18898505|P1|COMPLETED|Overall Study||36
7674245|NCT01972659|18898504|P2|STARTED|Overall Study||40
7674246|NCT01972659|18898505|P1|STARTED|Overall Study||40
7674247|NCT01972568|18898514|P3|NOT COMPLETED|Overall Study||16
7674248|NCT01972568|18898515|P2|NOT COMPLETED|Overall Study||12
7674249|NCT01972568|18898516|P1|NOT COMPLETED|Overall Study||16
7674250|NCT01972568|18898514|P3|COMPLETED|Overall Study||84
7674251|NCT01972568|18898515|P2|COMPLETED|Overall Study||92
7674252|NCT01972568|18898516|P1|COMPLETED|Overall Study||86
7674253|NCT01972568|18898514|P3|STARTED|Overall Study||100
7674254|NCT01972568|18898515|P2|STARTED|Overall Study||104
7674255|NCT01972568|18898516|P1|STARTED|Overall Study||102
7674256|NCT01972529|18898555|P4|NOT COMPLETED|Overall Study||4
7674257|NCT01972529|18898556|P3|NOT COMPLETED|Overall Study||2
7674258|NCT01972529|18898557|P2|NOT COMPLETED|Overall Study||5
7674259|NCT01972529|18898558|P1|NOT COMPLETED|Overall Study||2
7674260|NCT01972529|18898555|P4|COMPLETED|Overall Study||55
7674261|NCT01972529|18898556|P3|COMPLETED|Overall Study||32
7674262|NCT01972529|18898557|P2|COMPLETED|Overall Study||85
7674263|NCT01972529|18898558|P1|COMPLETED|Overall Study||46
7674264|NCT01972529|18898555|P4|STARTED|Overall Study||59
7674265|NCT01972529|18898556|P3|STARTED|Overall Study||34
7674266|NCT01972529|18898557|P2|STARTED|Overall Study||90
7674267|NCT01972529|18898558|P1|STARTED|Overall Study||48
7674268|NCT01972516|18898586|P2|NOT COMPLETED|Overall Study||0
7674269|NCT01972516|18898587|P1|NOT COMPLETED|Overall Study||0
7674270|NCT01972516|18898586|P2|COMPLETED|Overall Study||1
7674271|NCT01972516|18898587|P1|COMPLETED|Overall Study||3
7674272|NCT01972516|18898586|P2|STARTED|Overall Study||1
7674273|NCT01972516|18898587|P1|STARTED|Overall Study||3
7674274|NCT01972464|18898603|P2|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
7674275|NCT01972464|18898604|P1|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
7674276|NCT01972464|18898603|P2|COMPLETED|3-Month Follow-Up (Week 20)||17
7674277|NCT01972464|18898604|P1|COMPLETED|3-Month Follow-Up (Week 20)||15
7674278|NCT01972464|18898603|P2|STARTED|3-Month Follow-Up (Week 20)||18
7674279|NCT01972464|18898604|P1|STARTED|3-Month Follow-Up (Week 20)||16
7674280|NCT01972464|18898603|P2|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||4
7674281|NCT01972464|18898604|P1|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||3
7674282|NCT01972464|18898603|P2|COMPLETED|Treatment Period (Week 1 Through Week 8)||18
7674283|NCT01972464|18898604|P1|COMPLETED|Treatment Period (Week 1 Through Week 8)||16
7674284|NCT01972464|18898603|P2|STARTED|Treatment Period (Week 1 Through Week 8)||22
7674285|NCT01972464|18898604|P1|STARTED|Treatment Period (Week 1 Through Week 8)||19
7674286|NCT01972438|18898620|P2|NOT COMPLETED|Post Month 12 Study Period||4
7674287|NCT01972438|18898621|P1|NOT COMPLETED|Post Month 12 Study Period||3
7674288|NCT01972438|18898620|P2|COMPLETED|Post Month 12 Study Period||0
7674289|NCT01972438|18898621|P1|COMPLETED|Post Month 12 Study Period||0
7674290|NCT01972438|18898620|P2|STARTED|Post Month 12 Study Period||4
7674291|NCT01972438|18898621|P1|STARTED|Post Month 12 Study Period||3
7674292|NCT01972438|18898620|P2|NOT COMPLETED|Months 6-12 Study Period||2
7674293|NCT01972438|18898621|P1|NOT COMPLETED|Months 6-12 Study Period||3
7674294|NCT01972438|18898620|P2|COMPLETED|Months 6-12 Study Period||4
7674295|NCT01972438|18898621|P1|COMPLETED|Months 6-12 Study Period||3
7674296|NCT01972438|18898620|P2|STARTED|Months 6-12 Study Period||6
7674297|NCT01972438|18898621|P1|STARTED|Months 6-12 Study Period||6
7674298|NCT01972438|18898620|P2|NOT COMPLETED|Months 3-6 Crossover Period||1
7674299|NCT01972438|18898621|P1|NOT COMPLETED|Months 3-6 Crossover Period||0
7674300|NCT01972438|18898620|P2|COMPLETED|Months 3-6 Crossover Period||6
7674301|NCT01972438|18898621|P1|COMPLETED|Months 3-6 Crossover Period||6
7674302|NCT01972438|18898620|P2|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7
7674303|NCT01972438|18898621|P1|STARTED|Months 3-6 Crossover Period||6
7674304|NCT01972438|18898620|P2|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
7674305|NCT01972438|18898621|P1|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
7674306|NCT01972438|18898620|P2|COMPLETED|Baseline-Month 3 Crossover Period||6
7674307|NCT01972438|18898621|P1|COMPLETED|Baseline-Month 3 Crossover Period||6
7674308|NCT01972438|18898620|P2|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9
7674309|NCT01972438|18898621|P1|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9
7674310|NCT01972308|18898675|P2|NOT COMPLETED|Overall Study||8
7674311|NCT01972308|18898676|P1|NOT COMPLETED|Overall Study||8
7674312|NCT01972308|18898675|P2|COMPLETED|Overall Study||148
7674313|NCT01972308|18898676|P1|COMPLETED|Overall Study||148
7674314|NCT01972308|18898675|P2|STARTED|Overall Study||156
7674315|NCT01972308|18898676|P1|STARTED|Overall Study||156
7674316|NCT01972282|18898692|P1|NOT COMPLETED|Overall Study||15
7674317|NCT01972282|18898692|P1|COMPLETED|Overall Study||1005
7674318|NCT01972282|18898692|P1|STARTED|Overall Study||1020
7674319|NCT01972217|18898702|P4|NOT COMPLETED|Part B Double-blind, Randomised Period||47
7674320|NCT01972217|18898703|P3|NOT COMPLETED|Part B Double-blind, Randomised Period||46
7674321|NCT01972217|18898704|P2|NOT COMPLETED|Part B Double-blind, Randomised Period||0
7674322|NCT01972217|18898705|P1|NOT COMPLETED|Part B Double-blind, Randomised Period||0
7674323|NCT01972217|18898702|P4|COMPLETED|Part B Double-blind, Randomised Period||24
7674324|NCT01972217|18898703|P3|COMPLETED|Part B Double-blind, Randomised Period||25
7674325|NCT01972217|18898704|P2|COMPLETED|Part B Double-blind, Randomised Period||0
7674326|NCT01972217|18898705|P1|COMPLETED|Part B Double-blind, Randomised Period||0
7674327|NCT01972217|18898702|P4|Received Abiraterone|Part B Double-blind, Randomised Period||71
7674328|NCT01972217|18898703|P3|Received Abiraterone|Part B Double-blind, Randomised Period||71
7674329|NCT01972217|18898704|P2|Received Abiraterone|Part B Double-blind, Randomised Period||0
7674330|NCT01972217|18898705|P1|Received Abiraterone|Part B Double-blind, Randomised Period||0
7674331|NCT01972217|18898702|P4|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
7674332|NCT01972217|18898703|P3|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
7674333|NCT01972217|18898704|P2|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
7674334|NCT01972217|18898705|P1|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
7674335|NCT01972217|18898702|P4|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
7674336|NCT01972217|18898703|P3|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
7674337|NCT01972217|18898704|P2|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
7674338|NCT01972217|18898705|P1|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
7674339|NCT01972217|18898702|P4|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
7674340|NCT01972217|18898703|P3|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
7674341|NCT01972217|18898704|P2|NOT COMPLETED|Part A: Open-label Safety Run-in Period||12
7674342|NCT01972217|18898705|P1|NOT COMPLETED|Part A: Open-label Safety Run-in Period||1
7674343|NCT01972217|18898702|P4|COMPLETED|Part A: Open-label Safety Run-in Period||0
7674344|NCT01972217|18898703|P3|COMPLETED|Part A: Open-label Safety Run-in Period||0
7674345|NCT01972217|18898704|P2|COMPLETED|Part A: Open-label Safety Run-in Period||1
7674346|NCT01972217|18898705|P1|COMPLETED|Part A: Open-label Safety Run-in Period||2
7674347|NCT01972217|18898702|P4|STARTED|Part A: Open-label Safety Run-in Period||0
7674348|NCT01972217|18898703|P3|STARTED|Part A: Open-label Safety Run-in Period||0
7674349|NCT01972217|18898704|P2|STARTED|Part A: Open-label Safety Run-in Period||13
7674350|NCT01972217|18898705|P1|STARTED|Part A: Open-label Safety Run-in Period||3
7674351|NCT01972204|18898753|P2|NOT COMPLETED|Overall Study||4
7674352|NCT01972204|18898754|P1|NOT COMPLETED|Overall Study||4
7674353|NCT01972204|18898753|P2|COMPLETED|Overall Study||59
7674354|NCT01972204|18898754|P1|COMPLETED|Overall Study||58
7674355|NCT01972204|18898753|P2|STARTED|Overall Study||63
7674356|NCT01972204|18898754|P1|STARTED|Overall Study||62
7674357|NCT01972152|18898766|P6|NOT COMPLETED|Third Treatment Visit||0
7674358|NCT01972152|18898767|P5|NOT COMPLETED|Third Treatment Visit||0
7674359|NCT01972152|18898768|P4|NOT COMPLETED|Third Treatment Visit||0
7674360|NCT01972152|18898769|P3|NOT COMPLETED|Third Treatment Visit||0
7674361|NCT01972152|18898770|P2|NOT COMPLETED|Third Treatment Visit||0
7674362|NCT01972152|18898771|P1|NOT COMPLETED|Third Treatment Visit||0
7674363|NCT01972152|18898766|P6|COMPLETED|Third Treatment Visit||5
7674364|NCT01972152|18898767|P5|COMPLETED|Third Treatment Visit||5
7674365|NCT01972152|18898768|P4|COMPLETED|Third Treatment Visit||5
7674366|NCT01972152|18898769|P3|COMPLETED|Third Treatment Visit||5
7674367|NCT01972152|18898770|P2|COMPLETED|Third Treatment Visit||3
7674368|NCT01972152|18898771|P1|COMPLETED|Third Treatment Visit||5
7674369|NCT01972152|18898766|P6|STARTED|Third Treatment Visit||5
7674370|NCT01972152|18898767|P5|STARTED|Third Treatment Visit||5
7674371|NCT01972152|18898768|P4|STARTED|Third Treatment Visit||5
7674372|NCT01972152|18898769|P3|STARTED|Third Treatment Visit||5
7674373|NCT01972152|18898770|P2|STARTED|Third Treatment Visit||3
7674374|NCT01972152|18898771|P1|STARTED|Third Treatment Visit||5
7674375|NCT01972152|18898766|P6|NOT COMPLETED|Second Treatment Visit||0
7674376|NCT01972152|18898767|P5|NOT COMPLETED|Second Treatment Visit||0
7674377|NCT01972152|18898768|P4|NOT COMPLETED|Second Treatment Visit||0
7674378|NCT01972152|18898769|P3|NOT COMPLETED|Second Treatment Visit||0
7674379|NCT01972152|18898770|P2|NOT COMPLETED|Second Treatment Visit||1
7674380|NCT01972152|18898771|P1|NOT COMPLETED|Second Treatment Visit||0
7674381|NCT01972152|18898766|P6|COMPLETED|Second Treatment Visit||5
7674382|NCT01972152|18898767|P5|COMPLETED|Second Treatment Visit||5
7674383|NCT01972152|18898768|P4|COMPLETED|Second Treatment Visit||5
7674384|NCT01972152|18898769|P3|COMPLETED|Second Treatment Visit||5
7674385|NCT01972152|18898770|P2|COMPLETED|Second Treatment Visit||3
7674386|NCT01972152|18898771|P1|COMPLETED|Second Treatment Visit||5
7674387|NCT01972152|18898766|P6|STARTED|Second Treatment Visit||5
7674388|NCT01972152|18898767|P5|STARTED|Second Treatment Visit||5
7674389|NCT01972152|18898768|P4|STARTED|Second Treatment Visit||5
7674390|NCT01972152|18898769|P3|STARTED|Second Treatment Visit||5
7674391|NCT01972152|18898770|P2|STARTED|Second Treatment Visit||4
7674392|NCT01972152|18898771|P1|STARTED|Second Treatment Visit||5
7674393|NCT01972152|18898766|P6|NOT COMPLETED|First Treatment Visit||0
7674394|NCT01972152|18898767|P5|NOT COMPLETED|First Treatment Visit||0
7674395|NCT01972152|18898768|P4|NOT COMPLETED|First Treatment Visit||0
7674396|NCT01972152|18898769|P3|NOT COMPLETED|First Treatment Visit||0
7674397|NCT01972152|18898770|P2|NOT COMPLETED|First Treatment Visit||1
7674398|NCT01972152|18898771|P1|NOT COMPLETED|First Treatment Visit||0
7674399|NCT01972152|18898766|P6|COMPLETED|First Treatment Visit||5
7674400|NCT01972152|18898767|P5|COMPLETED|First Treatment Visit||5
7674401|NCT01972152|18898768|P4|COMPLETED|First Treatment Visit||5
7674402|NCT01972152|18898769|P3|COMPLETED|First Treatment Visit||5
7674403|NCT01972152|18898770|P2|COMPLETED|First Treatment Visit||4
7674404|NCT01972152|18898771|P1|COMPLETED|First Treatment Visit||5
7674405|NCT01972152|18898766|P6|STARTED|First Treatment Visit||5
7674406|NCT01972152|18898767|P5|STARTED|First Treatment Visit||5
7674407|NCT01972152|18898768|P4|STARTED|First Treatment Visit||5
7674408|NCT01972152|18898769|P3|STARTED|First Treatment Visit||5
7674409|NCT01972152|18898770|P2|STARTED|First Treatment Visit||5
7674410|NCT01972152|18898771|P1|STARTED|First Treatment Visit||5
7674411|NCT01972074|18898809|P3|NOT COMPLETED|Overall Study||3
7674412|NCT01972074|18898810|P2|NOT COMPLETED|Overall Study||4
7674413|NCT01972074|18898811|P1|NOT COMPLETED|Overall Study||6
7674414|NCT01972074|18898809|P3|COMPLETED|Overall Study||15
7674415|NCT01972074|18898810|P2|COMPLETED|Overall Study||17
7674416|NCT01972074|18898811|P1|COMPLETED|Overall Study||16
7674417|NCT01972074|18898809|P3|STARTED|Overall Study||18
7674418|NCT01972074|18898810|P2|STARTED|Overall Study||21
7674419|NCT01972074|18898811|P1|STARTED|Overall Study||22
7674420|NCT01972061|18898821|P3|NOT COMPLETED|Overall Study||0
7674421|NCT01972061|18898822|P2|NOT COMPLETED|Overall Study||0
7674422|NCT01972061|18898823|P1|NOT COMPLETED|Overall Study||0
7674423|NCT01972061|18898821|P3|COMPLETED|Overall Study||20
7674424|NCT01972061|18898822|P2|COMPLETED|Overall Study||23
7674425|NCT01972061|18898823|P1|COMPLETED|Overall Study||1
7674426|NCT01972061|18898821|P3|STARTED|Overall Study||20
7674427|NCT01972061|18898822|P2|STARTED|Overall Study||23
7674428|NCT01972061|18898823|P1|STARTED|Overall Study||1
7674429|NCT01971723|18898837|P2|NOT COMPLETED|Overall Study||3
7674430|NCT01971723|18898838|P1|NOT COMPLETED|Overall Study||2
7674431|NCT01971723|18898837|P2|COMPLETED|Overall Study||13
7674432|NCT01971723|18898838|P1|COMPLETED|Overall Study||14
7674433|NCT01971723|18898837|P2|STARTED|Overall Study||16
7674434|NCT01971723|18898838|P1|STARTED|Overall Study||16
7674435|NCT01971645|18898871|P3|NOT COMPLETED|Overall Study||2
7674436|NCT01971645|18898872|P2|NOT COMPLETED|Overall Study||0
7674437|NCT01971645|18898873|P1|NOT COMPLETED|Overall Study||2
7674438|NCT01971645|18898871|P3|COMPLETED|Overall Study||23
7674439|NCT01971645|18898872|P2|COMPLETED|Overall Study||27
7674440|NCT01971645|18898873|P1|COMPLETED|Overall Study||23
7674441|NCT01971645|18898871|P3|STARTED|Overall Study||25
7674442|NCT01971645|18898872|P2|STARTED|Overall Study||27
7674443|NCT01971645|18898873|P1|STARTED|Overall Study||25
7674444|NCT01971593|18898884|P2|NOT COMPLETED|Overall Study||4
7674445|NCT01971593|18898885|P1|NOT COMPLETED|Overall Study||5
7674446|NCT01971593|18898884|P2|COMPLETED|Overall Study||8
7674447|NCT01971593|18898885|P1|COMPLETED|Overall Study||9
7674448|NCT01971593|18898884|P2|STARTED|Overall Study||12
7674449|NCT01971593|18898885|P1|STARTED|Overall Study||14
7674450|NCT01971580|18898896|P2|NOT COMPLETED|Overall Study||5
7674451|NCT01971580|18898897|P1|NOT COMPLETED|Overall Study||4
7674452|NCT01971580|18898896|P2|COMPLETED|Overall Study||9
7674453|NCT01971580|18898897|P1|COMPLETED|Overall Study||10
7674454|NCT01971580|18898896|P2|STARTED|Overall Study||14
7674455|NCT01971580|18898897|P1|STARTED|Overall Study||14
7674456|NCT01971567|18898907|P2|NOT COMPLETED|Overall Study||2
7674457|NCT01971567|18898908|P1|NOT COMPLETED|Overall Study||4
7674458|NCT01971567|18898907|P2|COMPLETED|Overall Study||49
7674459|NCT01971567|18898908|P1|COMPLETED|Overall Study||52
7674460|NCT01971567|18898907|P2|STARTED|Overall Study||51
7674461|NCT01971567|18898908|P1|STARTED|Overall Study||56
7674462|NCT01971554|18898934|P4|NOT COMPLETED|Overall Study||0
7674463|NCT01971554|18898935|P3|NOT COMPLETED|Overall Study||0
7674464|NCT01971554|18898936|P2|NOT COMPLETED|Overall Study||0
7674465|NCT01971554|18898937|P1|NOT COMPLETED|Overall Study||1
7674466|NCT01971554|18898934|P4|COMPLETED|Overall Study||18
7674467|NCT01971554|18898935|P3|COMPLETED|Overall Study||18
7674468|NCT01971554|18898936|P2|COMPLETED|Overall Study||18
7674469|NCT01971554|18898937|P1|COMPLETED|Overall Study||8
7674470|NCT01971554|18898934|P4|STARTED|Overall Study||18
7674471|NCT01971554|18898935|P3|STARTED|Overall Study||18
7674472|NCT01971554|18898936|P2|STARTED|Overall Study||18
7674473|NCT01971554|18898937|P1|STARTED|Overall Study||9
7674474|NCT01971476|18898974|P3|NOT COMPLETED|Cohort 2: 12 to <18 Years||0
7674475|NCT01971476|18898975|P2|NOT COMPLETED|Cohort 2: 12 to <18 Years||4
7674476|NCT01971476|18898976|P1|NOT COMPLETED|Cohort 2: 12 to <18 Years||6
7674477|NCT01971476|18898974|P3|COMPLETED|Cohort 2: 12 to <18 Years||0
7674478|NCT01971476|18898975|P2|COMPLETED|Cohort 2: 12 to <18 Years||0
7674479|NCT01971476|18898976|P1|COMPLETED|Cohort 2: 12 to <18 Years||0
7674480|NCT01971476|18898974|P3|STARTED|Cohort 2: 12 to <18 Years||0
7674481|NCT01971476|18898975|P2|STARTED|Cohort 2: 12 to <18 Years||4
7674482|NCT01971476|18898976|P1|STARTED|Cohort 2: 12 to <18 Years||6
7674483|NCT01971476|18898974|P3|NOT COMPLETED|Cohort 1: 2 to <12 Years||6
7674484|NCT01971476|18898975|P2|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
7674485|NCT01971476|18898976|P1|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
7674486|NCT01971476|18898974|P3|COMPLETED|Cohort 1: 2 to <12 Years||0
7674487|NCT01971476|18898975|P2|COMPLETED|Cohort 1: 2 to <12 Years||0
7674488|NCT01971476|18898976|P1|COMPLETED|Cohort 1: 2 to <12 Years||0
7674489|NCT01971476|18898974|P3|STARTED|Cohort 1: 2 to <12 Years||6
7674490|NCT01971476|18898975|P2|STARTED|Cohort 1: 2 to <12 Years||3
7674491|NCT01971476|18898976|P1|STARTED|Cohort 1: 2 to <12 Years||3
7674492|NCT01971463|18899053|P1|NOT COMPLETED|Overall Study||0
7674493|NCT01971463|18899053|P1|COMPLETED|Overall Study||81
7674494|NCT01971463|18899053|P1|STARTED|Overall Study||81
7674495|NCT01971385|18899061|P3|NOT COMPLETED|Overall Study||4
7674496|NCT01971385|18899062|P2|NOT COMPLETED|Overall Study||5
7674497|NCT01971385|18899063|P1|NOT COMPLETED|Overall Study||3
7674498|NCT01971385|18899061|P3|COMPLETED|Overall Study||15
7674499|NCT01971385|18899062|P2|COMPLETED|Overall Study||13
7674500|NCT01971385|18899063|P1|COMPLETED|Overall Study||14
7674501|NCT01971385|18899061|P3|STARTED|Overall Study||19
7674502|NCT01971385|18899062|P2|STARTED|Overall Study||18
7674503|NCT01971385|18899063|P1|STARTED|Overall Study||17
7674504|NCT01971346|18899070|P1|NOT COMPLETED|Overall Study||8
7674505|NCT01971346|18899070|P1|COMPLETED|Overall Study||42
7674506|NCT01971346|18899070|P1|STARTED|Overall Study|Four subjects signed the informed consent and terminated the study before beginning.|50
7674507|NCT01971255|18899084|P2|NOT COMPLETED|Overall Study||2
7674508|NCT01971255|18899085|P1|NOT COMPLETED|Overall Study||1
7674509|NCT01971255|18899084|P2|COMPLETED|Overall Study||40
7674510|NCT01971255|18899085|P1|COMPLETED|Overall Study||31
7674511|NCT01971255|18899084|P2|STARTED|Overall Study||42
7674512|NCT01971255|18899085|P1|STARTED|Overall Study||32
7674513|NCT01971203|18899103|P2|NOT COMPLETED|Overall Study||8
7674514|NCT01971203|18899104|P1|NOT COMPLETED|Overall Study||9
7674515|NCT01971203|18899103|P2|COMPLETED|Overall Study||21
7674516|NCT01971203|18899104|P1|COMPLETED|Overall Study||17
7674517|NCT01971203|18899103|P2|STARTED|Overall Study||29
7674518|NCT01971203|18899104|P1|STARTED|Overall Study||26
7674519|NCT01971086|18899116|P1|NOT COMPLETED|Overall Study||0
7674520|NCT01971086|18899116|P1|COMPLETED|Overall Study||300
7674521|NCT01971086|18899116|P1|STARTED|Overall Study||300
7674522|NCT01970995|18899131|P3|NOT COMPLETED|End of Study (Population at Day 90)||1
7674523|NCT01970995|18899132|P2|NOT COMPLETED|End of Study (Population at Day 90)||0
7674524|NCT01970995|18899133|P1|NOT COMPLETED|End of Study (Population at Day 90)||1
7674525|NCT01970995|18899131|P3|COMPLETED|End of Study (Population at Day 90)||38
7674526|NCT01970995|18899132|P2|COMPLETED|End of Study (Population at Day 90)||41
7674527|NCT01970995|18899133|P1|COMPLETED|End of Study (Population at Day 90)||76
7674528|NCT01970995|18899131|P3|STARTED|End of Study (Population at Day 90)||39
7674529|NCT01970995|18899132|P2|STARTED|End of Study (Population at Day 90)||41
7674530|NCT01970995|18899133|P1|STARTED|End of Study (Population at Day 90)||77
7674531|NCT01970995|18899131|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||1
7674532|NCT01970995|18899132|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
7674533|NCT01970995|18899133|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||1
7674534|NCT01970995|18899131|P3|COMPLETED|Confinement Period (Population at Day 5)||39
7674535|NCT01970995|18899132|P2|COMPLETED|Confinement Period (Population at Day 5)||41
7674536|NCT01970995|18899133|P1|COMPLETED|Confinement Period (Population at Day 5)||77
7674537|NCT01970995|18899131|P3|STARTED|Confinement Period (Population at Day 5)||40
7674538|NCT01970995|18899132|P2|STARTED|Confinement Period (Population at Day 5)||42
7674539|NCT01970995|18899133|P1|STARTED|Confinement Period (Population at Day 5)||78
7674540|NCT01970982|18899156|P3|NOT COMPLETED|Overall Study||2
7674541|NCT01970982|18899157|P2|NOT COMPLETED|Overall Study||0
7674542|NCT01970982|18899158|P1|NOT COMPLETED|Overall Study||0
7674543|NCT01970982|18899156|P3|COMPLETED|Overall Study||38
7674544|NCT01970982|18899157|P2|COMPLETED|Overall Study||40
7674545|NCT01970982|18899158|P1|COMPLETED|Overall Study||80
7674546|NCT01970982|18899156|P3|STARTED|Overall Study||40
7674547|NCT01970982|18899157|P2|STARTED|Overall Study||40
7674548|NCT01970982|18899158|P1|STARTED|Overall Study||80
7674549|NCT01970943|18899176|P2|NOT COMPLETED|Overall Study||1
7674550|NCT01970943|18899177|P1|NOT COMPLETED|Overall Study||3
7674551|NCT01970943|18899176|P2|COMPLETED|Overall Study||11
7674552|NCT01970943|18899177|P1|COMPLETED|Overall Study||8
7674553|NCT01970943|18899176|P2|STARTED|Overall Study||12
7674554|NCT01970943|18899177|P1|STARTED|Overall Study||11
7674555|NCT01970878|18899193|P4|NOT COMPLETED|Overall Study||24
7674556|NCT01970878|18899194|P3|NOT COMPLETED|Overall Study||26
7674557|NCT01970878|18899195|P2|NOT COMPLETED|Overall Study||27
7674558|NCT01970878|18899196|P1|NOT COMPLETED|Overall Study||37
7674559|NCT01970878|18899193|P4|COMPLETED|Overall Study||147
7674560|NCT01970878|18899194|P3|COMPLETED|Overall Study||187
7674561|NCT01970878|18899195|P2|COMPLETED|Overall Study||191
7674562|NCT01970878|18899196|P1|COMPLETED|Overall Study||253
7674563|NCT01970878|18899193|P4|STARTED|Overall Study||171
7674564|NCT01970878|18899194|P3|STARTED|Overall Study||213
7674565|NCT01970878|18899195|P2|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218
7674566|NCT01970878|18899196|P1|STARTED|Overall Study||290
7674567|NCT01970865|18899239|P17|NOT COMPLETED|Overall Study||3
7674568|NCT01970865|18899240|P16|NOT COMPLETED|Overall Study||47
7674569|NCT01970865|18899241|P15|NOT COMPLETED|Overall Study||46
7674570|NCT01970865|18899242|P14|NOT COMPLETED|Overall Study||66
7674571|NCT01970865|18899243|P13|NOT COMPLETED|Overall Study||60
7674572|NCT01970865|18899244|P12|NOT COMPLETED|Overall Study||27
7674573|NCT01970865|18899245|P11|NOT COMPLETED|Overall Study||30
7674574|NCT01970865|18899246|P10|NOT COMPLETED|Overall Study||4
7674575|NCT01970865|18899247|P9|NOT COMPLETED|Overall Study||3
7674576|NCT01970865|18899248|P8|NOT COMPLETED|Overall Study||3
7674577|NCT01970865|18899249|P7|NOT COMPLETED|Overall Study||3
7674578|NCT01970865|18899250|P6|NOT COMPLETED|Overall Study||3
7674579|NCT01970865|18899251|P5|NOT COMPLETED|Overall Study||17
7674580|NCT01970865|18899252|P4|NOT COMPLETED|Overall Study||13
7674581|NCT01970865|18899253|P3|NOT COMPLETED|Overall Study||3
7674582|NCT01970865|18899254|P2|NOT COMPLETED|Overall Study||3
7674583|NCT01970865|18899255|P1|NOT COMPLETED|Overall Study||3
7674584|NCT01970865|18899239|P17|COMPLETED|Overall Study||0
7674585|NCT01970865|18899240|P16|COMPLETED|Overall Study||0
7674586|NCT01970865|18899241|P15|COMPLETED|Overall Study||0
7674587|NCT01970865|18899242|P14|COMPLETED|Overall Study||0
7674588|NCT01970865|18899243|P13|COMPLETED|Overall Study||0
7674589|NCT01970865|18899244|P12|COMPLETED|Overall Study||0
7674590|NCT01970865|18899245|P11|COMPLETED|Overall Study||0
7674591|NCT01970865|18899246|P10|COMPLETED|Overall Study||0
7674592|NCT01970865|18899247|P9|COMPLETED|Overall Study||0
7674593|NCT01970865|18899248|P8|COMPLETED|Overall Study||0
7674594|NCT01970865|18899249|P7|COMPLETED|Overall Study||0
7674595|NCT01970865|18899250|P6|COMPLETED|Overall Study||0
7674596|NCT01970865|18899251|P5|COMPLETED|Overall Study||0
7674597|NCT01970865|18899252|P4|COMPLETED|Overall Study||0
7674598|NCT01970865|18899253|P3|COMPLETED|Overall Study||0
7674599|NCT01970865|18899254|P2|COMPLETED|Overall Study||0
7674600|NCT01970865|18899255|P1|COMPLETED|Overall Study||0
7674601|NCT01970865|18899239|P17|Received Treatment|Overall Study||3
7674602|NCT01970865|18899240|P16|Received Treatment|Overall Study||47
7674603|NCT01970865|18899241|P15|Received Treatment|Overall Study||46
7674604|NCT01970865|18899242|P14|Received Treatment|Overall Study||65
7674605|NCT01970865|18899243|P13|Received Treatment|Overall Study||60
7674606|NCT01970865|18899244|P12|Received Treatment|Overall Study||27
7674607|NCT01970865|18899245|P11|Received Treatment|Overall Study||30
7674608|NCT01970865|18899246|P10|Received Treatment|Overall Study||4
7674609|NCT01970865|18899247|P9|Received Treatment|Overall Study||3
7674610|NCT01970865|18899248|P8|Received Treatment|Overall Study||3
7674611|NCT01970865|18899249|P7|Received Treatment|Overall Study||3
7674612|NCT01970865|18899250|P6|Received Treatment|Overall Study||3
7674613|NCT01970865|18899251|P5|Received Treatment|Overall Study||17
7674614|NCT01970865|18899252|P4|Received Treatment|Overall Study||12
7674615|NCT01970865|18899253|P3|Received Treatment|Overall Study||3
7674616|NCT01970865|18899254|P2|Received Treatment|Overall Study||3
7674617|NCT01970865|18899255|P1|Received Treatment|Overall Study||3
7674618|NCT01970865|18899239|P17|STARTED|Overall Study||3
7674619|NCT01970865|18899240|P16|STARTED|Overall Study||47
7674620|NCT01970865|18899241|P15|STARTED|Overall Study||46
7674621|NCT01970865|18899242|P14|STARTED|Overall Study||66
7674622|NCT01970865|18899243|P13|STARTED|Overall Study||60
7674623|NCT01970865|18899244|P12|STARTED|Overall Study||27
7674624|NCT01970865|18899245|P11|STARTED|Overall Study||30
7674625|NCT01970865|18899246|P10|STARTED|Overall Study||4
7674626|NCT01970865|18899247|P9|STARTED|Overall Study||3
7674627|NCT01970865|18899248|P8|STARTED|Overall Study||3
7674628|NCT01970865|18899249|P7|STARTED|Overall Study||3
7674629|NCT01970865|18899250|P6|STARTED|Overall Study||3
7674630|NCT01970865|18899251|P5|STARTED|Overall Study||17
7674631|NCT01970865|18899252|P4|STARTED|Overall Study||13
7674632|NCT01970865|18899253|P3|STARTED|Overall Study||3
7674633|NCT01970865|18899254|P2|STARTED|Overall Study||3
7674634|NCT01970865|18899255|P1|STARTED|Overall Study||3
7674635|NCT01970787|18899679|P1|NOT COMPLETED|Overall Study||1
7674636|NCT01970787|18899679|P1|COMPLETED|Overall Study||21
7674637|NCT01970787|18899679|P1|STARTED|Overall Study||22
7674638|NCT01970592|18899687|P1|NOT COMPLETED|Overall Study||6
7674639|NCT01970592|18899687|P1|COMPLETED|Overall Study||50
7674640|NCT01970592|18899687|P1|STARTED|Overall Study|Completed all training sessions|56
7674641|NCT01970540|18899695|P3|NOT COMPLETED|Overall Study||19
7674642|NCT01970540|18899696|P2|NOT COMPLETED|Overall Study||28
7674643|NCT01970540|18899697|P1|NOT COMPLETED|Overall Study||73
7674644|NCT01970540|18899695|P3|COMPLETED|Overall Study||0
7674645|NCT01970540|18899696|P2|COMPLETED|Overall Study||0
7674646|NCT01970540|18899697|P1|COMPLETED|Overall Study||0
7674647|NCT01970540|18899695|P3|STARTED|Overall Study||19
7674648|NCT01970540|18899696|P2|STARTED|Overall Study||28
7674649|NCT01970540|18899697|P1|STARTED|Overall Study||73
7674650|NCT01970527|18899728|P2|NOT COMPLETED|Follow-up Clinic Visit||3
7674651|NCT01970527|18899729|P1|NOT COMPLETED|Follow-up Clinic Visit||1
7674652|NCT01970527|18899728|P2|COMPLETED|Follow-up Clinic Visit||8
7674653|NCT01970527|18899729|P1|COMPLETED|Follow-up Clinic Visit||7
7674654|NCT01970527|18899728|P2|STARTED|Follow-up Clinic Visit||11
7674655|NCT01970527|18899729|P1|STARTED|Follow-up Clinic Visit||8
7674656|NCT01970527|18899728|P2|NOT COMPLETED|Treatment||3
7674657|NCT01970527|18899729|P1|NOT COMPLETED|Treatment||0
7674658|NCT01970527|18899728|P2|COMPLETED|Treatment||11
7674659|NCT01970527|18899729|P1|COMPLETED|Treatment||8
7674660|NCT01970527|18899728|P2|STARTED|Treatment||14
7674661|NCT01970527|18899729|P1|STARTED|Treatment||8
7674662|NCT01970527|18899728|P2|NOT COMPLETED|Pre-treatment/Baseline||0
7674663|NCT01970527|18899729|P1|NOT COMPLETED|Pre-treatment/Baseline||1
7674664|NCT01970527|18899728|P2|COMPLETED|Pre-treatment/Baseline||14
7674665|NCT01970527|18899729|P1|COMPLETED|Pre-treatment/Baseline||8
7674666|NCT01970527|18899728|P2|STARTED|Pre-treatment/Baseline||14
7674667|NCT01970527|18899729|P1|STARTED|Pre-treatment/Baseline||9
7674668|NCT01970488|18899742|P5|NOT COMPLETED|Part 2: Post Week 16||8
7674669|NCT01970488|18899743|P4|NOT COMPLETED|Part 2: Post Week 16||8
7674670|NCT01970488|18899744|P3|NOT COMPLETED|Part 2: Post Week 16||17
7674671|NCT01970488|18899745|P2|NOT COMPLETED|Part 2: Post Week 16||0
7674672|NCT01970488|18899746|P1|NOT COMPLETED|Part 2: Post Week 16||0
7674673|NCT01970488|18899742|P5|COMPLETED|Part 2: Post Week 16||69
7674674|NCT01970488|18899743|P4|COMPLETED|Part 2: Post Week 16||71
7674675|NCT01970488|18899744|P3|COMPLETED|Part 2: Post Week 16||135
7674676|NCT01970488|18899745|P2|COMPLETED|Part 2: Post Week 16||0
7674677|NCT01970488|18899746|P1|COMPLETED|Part 2: Post Week 16||0
7674678|NCT01970488|18899742|P5|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77
7674679|NCT01970488|18899743|P4|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79
7674680|NCT01970488|18899744|P3|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152
7674681|NCT01970488|18899745|P2|STARTED|Part 2: Post Week 16||0
7674682|NCT01970488|18899746|P1|STARTED|Part 2: Post Week 16||0
7674683|NCT01970488|18899742|P5|NOT COMPLETED|Part 1: Through Week 16||0
7674684|NCT01970488|18899743|P4|NOT COMPLETED|Part 1: Through Week 16||0
7674685|NCT01970488|18899744|P3|NOT COMPLETED|Part 1: Through Week 16||0
7674686|NCT01970488|18899745|P2|NOT COMPLETED|Part 1: Through Week 16||13
7674687|NCT01970488|18899746|P1|NOT COMPLETED|Part 1: Through Week 16||11
7674688|NCT01970488|18899742|P5|COMPLETED|Part 1: Through Week 16||0
7674689|NCT01970488|18899743|P4|COMPLETED|Part 1: Through Week 16||0
7674690|NCT01970488|18899744|P3|COMPLETED|Part 1: Through Week 16||0
7674691|NCT01970488|18899745|P2|COMPLETED|Part 1: Through Week 16||162
7674692|NCT01970488|18899746|P1|COMPLETED|Part 1: Through Week 16||164
7674693|NCT01970488|18899742|P5|Received Treatment|Part 1: Through Week 16||0
7674694|NCT01970488|18899743|P4|Received Treatment|Part 1: Through Week 16||0
7674695|NCT01970488|18899744|P3|Received Treatment|Part 1: Through Week 16||0
7674696|NCT01970488|18899745|P2|Received Treatment|Part 1: Through Week 16||173
7674697|NCT01970488|18899746|P1|Received Treatment|Part 1: Through Week 16||174
7674698|NCT01970488|18899742|P5|STARTED|Part 1: Through Week 16||0
7674699|NCT01970488|18899743|P4|STARTED|Part 1: Through Week 16||0
7674700|NCT01970488|18899744|P3|STARTED|Part 1: Through Week 16||0
7674701|NCT01970488|18899745|P2|STARTED|Part 1: Through Week 16||175
7674702|NCT01970488|18899746|P1|STARTED|Part 1: Through Week 16||175
7674703|NCT01970475|18899813|P2|NOT COMPLETED|Overall Study||11
7674704|NCT01970475|18899814|P1|NOT COMPLETED|Overall Study||21
7674705|NCT01970475|18899813|P2|COMPLETED|Overall Study||251
7674706|NCT01970475|18899814|P1|COMPLETED|Overall Study||243
7674707|NCT01970475|18899813|P2|STARTED|Overall Study||262
7674708|NCT01970475|18899814|P1|STARTED|Overall Study||264
7674709|NCT01970462|18899834|P2|NOT COMPLETED|Overall Study||2
7674710|NCT01970462|18899835|P1|NOT COMPLETED|Overall Study||0
7674711|NCT01970462|18899834|P2|COMPLETED|Overall Study||2
7674712|NCT01970462|18899835|P1|COMPLETED|Overall Study||1
7674713|NCT01970462|18899834|P2|STARTED|Overall Study||4
7674714|NCT01970462|18899835|P1|STARTED|Overall Study||1
7674715|NCT01970397|18899849|P2|NOT COMPLETED|Overall Study||5
7674716|NCT01970397|18899850|P1|NOT COMPLETED|Overall Study||2
7674717|NCT01970397|18899849|P2|COMPLETED|Overall Study||64
7674718|NCT01970397|18899850|P1|COMPLETED|Overall Study||67
7674719|NCT01970397|18899849|P2|STARTED|Overall Study||69
7674720|NCT01970397|18899850|P1|STARTED|Overall Study||69
7674721|NCT01970371|18899863|P3|NOT COMPLETED|Overall Study||13
7674722|NCT01970371|18899864|P2|NOT COMPLETED|Overall Study||13
7674723|NCT01970371|18899865|P1|NOT COMPLETED|Overall Study||8
7674724|NCT01970371|18899863|P3|COMPLETED|Overall Study||17
7674725|NCT01970371|18899864|P2|COMPLETED|Overall Study||8
7674726|NCT01970371|18899865|P1|COMPLETED|Overall Study||10
7674727|NCT01970371|18899863|P3|STARTED|Overall Study||30
7674728|NCT01970371|18899864|P2|STARTED|Overall Study||21
7674729|NCT01970371|18899865|P1|STARTED|Overall Study||18
7674730|NCT01970241|18899890|P2|NOT COMPLETED|Overall Study||8
7674731|NCT01970241|18899891|P1|NOT COMPLETED|Overall Study||17
7674732|NCT01970241|18899890|P2|COMPLETED|Overall Study||31
7674733|NCT01970241|18899891|P1|COMPLETED|Overall Study||29
7674734|NCT01970241|18899890|P2|STARTED|Overall Study||39
7674735|NCT01970241|18899891|P1|STARTED|Overall Study||46
7674736|NCT01970176|18899933|P2|NOT COMPLETED|Overall Study||0
7674737|NCT01970176|18899934|P1|NOT COMPLETED|Overall Study||0
7674738|NCT01970176|18899933|P2|COMPLETED|Overall Study||6
7674739|NCT01970176|18899934|P1|COMPLETED|Overall Study||14
7674740|NCT01970176|18899933|P2|STARTED|Overall Study||6
7674741|NCT01970176|18899934|P1|STARTED|Overall Study||14
7674742|NCT01969916|18899944|P1|NOT COMPLETED|Overall Study||45
7674743|NCT01969916|18899944|P1|COMPLETED|Overall Study||105
7674744|NCT01969916|18899944|P1|STARTED|Overall Study||150
7674745|NCT01969851|18899951|P3|NOT COMPLETED|Overall Study||7
7674746|NCT01969851|18899952|P2|NOT COMPLETED|Overall Study||3
7674747|NCT01969851|18899953|P1|NOT COMPLETED|Overall Study||1
7674748|NCT01969851|18899951|P3|COMPLETED|Overall Study||14
7674749|NCT01969851|18899952|P2|COMPLETED|Overall Study||21
7674750|NCT01969851|18899953|P1|COMPLETED|Overall Study||9
7674751|NCT01969851|18899951|P3|STARTED|Overall Study||21
7674752|NCT01969851|18899952|P2|STARTED|Overall Study||24
7674753|NCT01969851|18899953|P1|STARTED|Overall Study||10
7674754|NCT01969799|18899975|P2|NOT COMPLETED|Overall Study||14
7674755|NCT01969799|18899976|P1|NOT COMPLETED|Overall Study||17
7674756|NCT01969799|18899975|P2|COMPLETED|Overall Study||58
7674757|NCT01969799|18899976|P1|COMPLETED|Overall Study||54
7674758|NCT01969799|18899975|P2|STARTED|Overall Study||72
7674759|NCT01969799|18899976|P1|STARTED|Overall Study||71
7674760|NCT01969747|18900000|P4|NOT COMPLETED|Overall Study||0
7674761|NCT01969747|18900001|P3|NOT COMPLETED|Overall Study||0
7674762|NCT01969747|18900002|P2|NOT COMPLETED|Overall Study||0
7674763|NCT01969747|18900003|P1|NOT COMPLETED|Overall Study||0
7674764|NCT01969747|18900000|P4|COMPLETED|Overall Study||18
7674765|NCT01969747|18900001|P3|COMPLETED|Overall Study||19
7674766|NCT01969747|18900002|P2|COMPLETED|Overall Study||19
7674767|NCT01969747|18900003|P1|COMPLETED|Overall Study||19
7674768|NCT01969747|18900000|P4|STARTED|Overall Study||18
7674769|NCT01969747|18900001|P3|STARTED|Overall Study||19
7674770|NCT01969747|18900002|P2|STARTED|Overall Study||19
7674771|NCT01969747|18900003|P1|STARTED|Overall Study||19
7674772|NCT01969721|18900013|P4|NOT COMPLETED|Overall Study||6
7674773|NCT01969721|18900014|P3|NOT COMPLETED|Overall Study||5
7674774|NCT01969721|18900015|P2|NOT COMPLETED|Overall Study||12
7674775|NCT01969721|18900016|P1|NOT COMPLETED|Overall Study||4
7674776|NCT01969721|18900013|P4|COMPLETED|Overall Study||46
7674777|NCT01969721|18900014|P3|COMPLETED|Overall Study||45
7674778|NCT01969721|18900015|P2|COMPLETED|Overall Study||57
7674779|NCT01969721|18900016|P1|COMPLETED|Overall Study||54
7674780|NCT01969721|18900013|P4|STARTED|Overall Study||52
7674781|NCT01969721|18900014|P3|STARTED|Overall Study||50
7674782|NCT01969721|18900015|P2|STARTED|Overall Study||69
7674783|NCT01969721|18900016|P1|STARTED|Overall Study||58
7674784|NCT01969708|18900044|P2|NOT COMPLETED|Overall Study||9
7674785|NCT01969708|18900045|P1|NOT COMPLETED|Overall Study||5
7674786|NCT01969708|18900044|P2|COMPLETED|Overall Study||173
7674787|NCT01969708|18900045|P1|COMPLETED|Overall Study||175
7674788|NCT01969708|18900044|P2|STARTED|Overall Study||182
7674789|NCT01969708|18900045|P1|STARTED|Overall Study||180
7674790|NCT01969565|18900061|P1|NOT COMPLETED|Overall Study||1
7674791|NCT01969565|18900061|P1|COMPLETED|Overall Study||0
7674792|NCT01969565|18900061|P1|STARTED|Overall Study||1
7674793|NCT01969539|18900067|P1|NOT COMPLETED|Overall Study||0
7674794|NCT01969539|18900067|P1|COMPLETED|Overall Study||11
7674795|NCT01969539|18900067|P1|STARTED|Overall Study||11
7674796|NCT01969500|18900075|P2|NOT COMPLETED|Overall Study||2
7674797|NCT01969500|18900076|P1|NOT COMPLETED|Overall Study||1
7674798|NCT01969500|18900075|P2|COMPLETED|Overall Study||24
7674799|NCT01969500|18900076|P1|COMPLETED|Overall Study||24
7674800|NCT01969500|18900075|P2|STARTED|Overall Study||26
7674801|NCT01969500|18900076|P1|STARTED|Overall Study||25
7674802|NCT01969448|18900091|P3|NOT COMPLETED|Overall Study||0
7674803|NCT01969448|18900092|P2|NOT COMPLETED|Overall Study||0
7674804|NCT01969448|18900093|P1|NOT COMPLETED|Overall Study||0
7674805|NCT01969448|18900091|P3|COMPLETED|Overall Study||0
7674806|NCT01969448|18900092|P2|COMPLETED|Overall Study||24
7674807|NCT01969448|18900093|P1|COMPLETED|Overall Study||55
7674808|NCT01969448|18900091|P3|STARTED|Overall Study||0
7674809|NCT01969448|18900092|P2|STARTED|Overall Study||24
7674810|NCT01969448|18900093|P1|STARTED|Overall Study||55
7674811|NCT01969435|18900116|P1|NOT COMPLETED|Overall Study||0
7674812|NCT01969435|18900116|P1|COMPLETED|Overall Study||50
7674813|NCT01969435|18900116|P1|STARTED|Overall Study||50
7674814|NCT01969240|18900132|P2|NOT COMPLETED|Overall Study||0
7674815|NCT01969240|18900133|P1|NOT COMPLETED|Overall Study||0
7674816|NCT01969240|18900132|P2|COMPLETED|Overall Study||447
7674817|NCT01969240|18900133|P1|COMPLETED|Overall Study||451
7674818|NCT01969240|18900132|P2|STARTED|Overall Study||447
7674819|NCT01969240|18900133|P1|STARTED|Overall Study||451
7674820|NCT01969214|18900151|P1|NOT COMPLETED|Overall Study||15
7674821|NCT01969214|18900151|P1|COMPLETED|Overall Study||86
7674822|NCT01969214|18900151|P1|STARTED|Overall Study||101
7674823|NCT01969201|18900170|P2|NOT COMPLETED|Overall Study||45
7674824|NCT01969201|18900171|P1|NOT COMPLETED|Overall Study||45
7674825|NCT01969201|18900170|P2|COMPLETED|Overall Study||313
7674826|NCT01969201|18900171|P1|COMPLETED|Overall Study||307
7674827|NCT01969201|18900170|P2|STARTED|Overall Study||358
7674828|NCT01969201|18900171|P1|STARTED|Overall Study||352
7674829|NCT01969162|18900191|P1|NOT COMPLETED|Overall Study||0
7674830|NCT01969162|18900191|P1|COMPLETED|Overall Study||35
7674831|NCT01969162|18900191|P1|STARTED|Overall Study||35
7674832|NCT01969084|18900197|P2|NOT COMPLETED|Overall Study||1
7674833|NCT01969084|18900198|P1|NOT COMPLETED|Overall Study||0
7674834|NCT01969084|18900197|P2|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21
7674835|NCT01969084|18900198|P1|COMPLETED|Overall Study||19
7674836|NCT01969084|18900197|P2|STARTED|Overall Study||22
7674837|NCT01969084|18900198|P1|STARTED|Overall Study||19
7674838|NCT01969058|18900214|P2|NOT COMPLETED|Overall Study||0
7674839|NCT01969058|18900215|P1|NOT COMPLETED|Overall Study||3
7674840|NCT01969058|18900214|P2|COMPLETED|Overall Study||26
7674841|NCT01969058|18900215|P1|COMPLETED|Overall Study||47
7674842|NCT01969058|18900214|P2|STARTED|Overall Study||26
7674843|NCT01969058|18900215|P1|STARTED|Overall Study||50
7674844|NCT01968980|18900259|P2|NOT COMPLETED|Overall Study||14
7674845|NCT01968980|18900260|P1|NOT COMPLETED|Overall Study||16
7674846|NCT01968980|18900259|P2|COMPLETED|Overall Study||171
7674847|NCT01968980|18900260|P1|COMPLETED|Overall Study||169
7674848|NCT01968980|18900259|P2|STARTED|Overall Study||185
7674849|NCT01968980|18900260|P1|STARTED|Overall Study||185
7674850|NCT01968967|18900322|P5|NOT COMPLETED|Extension Period||5
7674851|NCT01968967|18900323|P4|NOT COMPLETED|Extension Period||0
7674852|NCT01968967|18900324|P3|NOT COMPLETED|Extension Period||2
7674853|NCT01968967|18900325|P2|NOT COMPLETED|Extension Period||0
7674854|NCT01968967|18900326|P1|NOT COMPLETED|Extension Period||0
7674855|NCT01968967|18900322|P5|COMPLETED|Extension Period||34
7674856|NCT01968967|18900323|P4|COMPLETED|Extension Period||19
7674857|NCT01968967|18900324|P3|COMPLETED|Extension Period||45
7674858|NCT01968967|18900325|P2|COMPLETED|Extension Period||0
7674859|NCT01968967|18900326|P1|COMPLETED|Extension Period||0
7674860|NCT01968967|18900322|P5|STARTED|Extension Period||39
7674861|NCT01968967|18900323|P4|STARTED|Extension Period||19
7674862|NCT01968967|18900324|P3|STARTED|Extension Period||47
7674863|NCT01968967|18900325|P2|STARTED|Extension Period||0
7674864|NCT01968967|18900326|P1|STARTED|Extension Period||0
7674865|NCT01968967|18900322|P5|NOT COMPLETED|Treatment Period||0
7674866|NCT01968967|18900323|P4|NOT COMPLETED|Treatment Period||0
7674867|NCT01968967|18900324|P3|NOT COMPLETED|Treatment Period||0
7674868|NCT01968967|18900325|P2|NOT COMPLETED|Treatment Period||134
7674869|NCT01968967|18900326|P1|NOT COMPLETED|Treatment Period||146
7674870|NCT01968967|18900322|P5|COMPLETED|Treatment Period||0
7674871|NCT01968967|18900323|P4|COMPLETED|Treatment Period||0
7674872|NCT01968967|18900324|P3|COMPLETED|Treatment Period||0
7674873|NCT01968967|18900325|P2|COMPLETED|Treatment Period||934
7674874|NCT01968967|18900326|P1|COMPLETED|Treatment Period||925
7674875|NCT01968967|18900322|P5|Treated|Treatment Period||0
7674876|NCT01968967|18900323|P4|Treated|Treatment Period||0
7674877|NCT01968967|18900324|P3|Treated|Treatment Period||0
7674878|NCT01968967|18900325|P2|Treated|Treatment Period||1063
7674879|NCT01968967|18900326|P1|Treated|Treatment Period||1065
7674880|NCT01968967|18900322|P5|STARTED|Treatment Period||0
7674881|NCT01968967|18900323|P4|STARTED|Treatment Period||0
7674882|NCT01968967|18900324|P3|STARTED|Treatment Period||0
7674883|NCT01968967|18900325|P2|STARTED|Treatment Period||1068
7674884|NCT01968967|18900326|P1|STARTED|Treatment Period||1071
7674885|NCT01968954|18900395|P2|NOT COMPLETED|Overall Study||43
7674886|NCT01968954|18900396|P1|NOT COMPLETED|Overall Study||40
7674887|NCT01968954|18900395|P2|COMPLETED|Overall Study||314
7674888|NCT01968954|18900396|P1|COMPLETED|Overall Study||314
7674889|NCT01968954|18900395|P2|Treated|Overall Study||356
7674890|NCT01968954|18900396|P1|Treated|Overall Study||353
7674891|NCT01968954|18900395|P2|STARTED|Overall Study||357
7674892|NCT01968954|18900396|P1|STARTED|Overall Study||354
7674893|NCT01968811|18900460|P1|NOT COMPLETED|Overall Study||5
7674894|NCT01968811|18900460|P1|COMPLETED|Overall Study||5
7674895|NCT01968811|18900460|P1|STARTED|Overall Study||10
7674896|NCT01968694|18900467|P2|NOT COMPLETED|Visit 2 (1 Day)||0
7674897|NCT01968694|18900468|P1|NOT COMPLETED|Visit 2 (1 Day)||0
7674898|NCT01968694|18900467|P2|COMPLETED|Visit 2 (1 Day)||8
7674899|NCT01968694|18900468|P1|COMPLETED|Visit 2 (1 Day)||10
7674900|NCT01968694|18900467|P2|STARTED|Visit 2 (1 Day)||8
7674901|NCT01968694|18900468|P1|STARTED|Visit 2 (1 Day)||10
7674902|NCT01968694|18900467|P2|NOT COMPLETED|Washout (1 Month)||1
7674903|NCT01968694|18900468|P1|NOT COMPLETED|Washout (1 Month)||0
7674904|NCT01968694|18900467|P2|COMPLETED|Washout (1 Month)||8
7674905|NCT01968694|18900468|P1|COMPLETED|Washout (1 Month)||10
7674906|NCT01968694|18900467|P2|STARTED|Washout (1 Month)||9
7674907|NCT01968694|18900468|P1|STARTED|Washout (1 Month)||10
7674908|NCT01968694|18900467|P2|NOT COMPLETED|Visit 1 (1 Day)||0
7674909|NCT01968694|18900468|P1|NOT COMPLETED|Visit 1 (1 Day)||0
7674910|NCT01968694|18900467|P2|COMPLETED|Visit 1 (1 Day)||9
7674911|NCT01968694|18900468|P1|COMPLETED|Visit 1 (1 Day)||10
7674912|NCT01968694|18900467|P2|STARTED|Visit 1 (1 Day)||9
7674913|NCT01968694|18900468|P1|STARTED|Visit 1 (1 Day)||10
7674914|NCT01968551|18900485|P3|NOT COMPLETED|Extension Phase||4
7674915|NCT01968551|18900486|P2|NOT COMPLETED|Extension Phase||1
7674916|NCT01968551|18900487|P1|NOT COMPLETED|Extension Phase||1
7674917|NCT01968551|18900485|P3|COMPLETED|Extension Phase||30
7674918|NCT01968551|18900486|P2|COMPLETED|Extension Phase||86
7674919|NCT01968551|18900487|P1|COMPLETED|Extension Phase||19
7674920|NCT01968551|18900485|P3|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34
7674921|NCT01968551|18900486|P2|STARTED|Extension Phase||87
7674922|NCT01968551|18900487|P1|STARTED|Extension Phase||20
7674923|NCT01968551|18900485|P3|NOT COMPLETED|Open Label Phase (48 Weeks)||5
7674924|NCT01968551|18900486|P2|NOT COMPLETED|Open Label Phase (48 Weeks)||3
7674925|NCT01968551|18900487|P1|NOT COMPLETED|Open Label Phase (48 Weeks)||2
7674926|NCT01968551|18900485|P3|COMPLETED|Open Label Phase (48 Weeks)||41
7674927|NCT01968551|18900486|P2|COMPLETED|Open Label Phase (48 Weeks)||87
7674928|NCT01968551|18900487|P1|COMPLETED|Open Label Phase (48 Weeks)||20
7674929|NCT01968551|18900485|P3|STARTED|Open Label Phase (48 Weeks)||46
7674930|NCT01968551|18900486|P2|STARTED|Open Label Phase (48 Weeks)||90
7674931|NCT01968551|18900487|P1|STARTED|Open Label Phase (48 Weeks)||22
7674932|NCT01968447|18900503|P2|NOT COMPLETED|Overall Study||0
7674933|NCT01968447|18900504|P1|NOT COMPLETED|Overall Study||0
7674934|NCT01968447|18900503|P2|COMPLETED|Overall Study||20
7674935|NCT01968447|18900504|P1|COMPLETED|Overall Study||20
7674936|NCT01968447|18900503|P2|STARTED|Overall Study||20
7674937|NCT01968447|18900504|P1|STARTED|Overall Study||20
7674938|NCT01968434|18900524|P2|NOT COMPLETED|Overall Study||6
7674939|NCT01968434|18900525|P1|NOT COMPLETED|Overall Study||3
7674940|NCT01968434|18900524|P2|COMPLETED|Overall Study||66
7674941|NCT01968434|18900525|P1|COMPLETED|Overall Study||75
7674942|NCT01968434|18900524|P2|STARTED|Overall Study||72
7674943|NCT01968434|18900525|P1|STARTED|Overall Study||78
7674944|NCT01968421|18900537|P2|NOT COMPLETED|Overall Study||0
7674945|NCT01968421|18900538|P1|NOT COMPLETED|Overall Study||0
7674946|NCT01968421|18900537|P2|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|97
7674947|NCT01968421|18900538|P1|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|99
7674948|NCT01968421|18900537|P2|Starting Trial|Overall Study||97
7674949|NCT01968421|18900538|P1|Starting Trial|Overall Study||99
7674950|NCT01968421|18900537|P2|STARTED|Overall Study|March 1, 2015 was the date for recruiting controls|97
7674951|NCT01968421|18900538|P1|STARTED|Overall Study|March 1, 2015 was the date for recruiting patients|99
7674952|NCT01968382|18900547|P3|NOT COMPLETED|Overall Study||0
7674953|NCT01968382|18900548|P2|NOT COMPLETED|Overall Study||0
7674954|NCT01968382|18900549|P1|NOT COMPLETED|Overall Study||0
7674955|NCT01968382|18900547|P3|COMPLETED|Overall Study||20
7674956|NCT01968382|18900548|P2|COMPLETED|Overall Study||19
7674957|NCT01968382|18900549|P1|COMPLETED|Overall Study||18
7674958|NCT01968382|18900547|P3|STARTED|Overall Study||20
7674959|NCT01968382|18900548|P2|STARTED|Overall Study||19
7674960|NCT01968382|18900549|P1|STARTED|Overall Study||18
7674961|NCT01968226|18900593|P1|NOT COMPLETED|Overall Study||2
7674962|NCT01968226|18900593|P1|COMPLETED|Overall Study||1
7674963|NCT01968226|18900593|P1|STARTED|Overall Study||3
7674964|NCT01968213|18900599|P2|NOT COMPLETED|Overall Study||9
7674965|NCT01968213|18900600|P1|NOT COMPLETED|Overall Study||90
7674966|NCT01968213|18900599|P2|COMPLETED|Overall Study||180
7674967|NCT01968213|18900600|P1|COMPLETED|Overall Study||285
7674968|NCT01968213|18900599|P2|STARTED|Overall Study||189
7674969|NCT01968213|18900600|P1|STARTED|Overall Study||375
7674970|NCT01968135|18900611|P2|NOT COMPLETED|Overall Study||0
7674971|NCT01968135|18900612|P1|NOT COMPLETED|Overall Study||0
7674972|NCT01968135|18900611|P2|COMPLETED|Overall Study||16
7674973|NCT01968135|18900612|P1|COMPLETED|Overall Study||16
7674974|NCT01968135|18900611|P2|STARTED|Overall Study||16
7674975|NCT01968135|18900612|P1|STARTED|Overall Study||16
7674976|NCT01968070|18900642|P18|NOT COMPLETED|Period 3||0
7674977|NCT01968070|18900643|P17|NOT COMPLETED|Period 3||0
7674978|NCT01968070|18900644|P16|NOT COMPLETED|Period 3||0
7674979|NCT01968070|18900645|P15|NOT COMPLETED|Period 3||0
7674980|NCT01968070|18900646|P14|NOT COMPLETED|Period 3||0
7674981|NCT01968070|18900647|P13|NOT COMPLETED|Period 3||0
7674982|NCT01968070|18900648|P12|NOT COMPLETED|Period 3||0
7674983|NCT01968070|18900649|P11|NOT COMPLETED|Period 3||0
7674984|NCT01968070|18900650|P10|NOT COMPLETED|Period 3||0
7674985|NCT01968070|18900651|P9|NOT COMPLETED|Period 3||0
7674986|NCT01968070|18900652|P8|NOT COMPLETED|Period 3||0
7674987|NCT01968070|18900653|P7|NOT COMPLETED|Period 3||0
7674988|NCT01968070|18900654|P6|NOT COMPLETED|Period 3||0
7674989|NCT01968070|18900655|P5|NOT COMPLETED|Period 3||0
7674990|NCT01968070|18900656|P4|NOT COMPLETED|Period 3||0
7674991|NCT01968070|18900657|P3|NOT COMPLETED|Period 3||0
7674992|NCT01968070|18900658|P2|NOT COMPLETED|Period 3||0
7674993|NCT01968070|18900659|P1|NOT COMPLETED|Period 3||0
7674994|NCT01968070|18900642|P18|COMPLETED|Period 3||0
7674995|NCT01968070|18900643|P17|COMPLETED|Period 3||0
7674996|NCT01968070|18900644|P16|COMPLETED|Period 3||0
7674997|NCT01968070|18900645|P15|COMPLETED|Period 3||0
7674998|NCT01968070|18900646|P14|COMPLETED|Period 3||0
7674999|NCT01968070|18900647|P13|COMPLETED|Period 3||0
7675000|NCT01968070|18900648|P12|COMPLETED|Period 3||0
7675001|NCT01968070|18900649|P11|COMPLETED|Period 3||0
7675002|NCT01968070|18900650|P10|COMPLETED|Period 3||0
7675003|NCT01968070|18900651|P9|COMPLETED|Period 3||0
7675004|NCT01968070|18900652|P8|COMPLETED|Period 3||0
7675005|NCT01968070|18900653|P7|COMPLETED|Period 3||0
7675006|NCT01968070|18900654|P6|COMPLETED|Period 3||4
7675007|NCT01968070|18900655|P5|COMPLETED|Period 3||3
7675008|NCT01968070|18900656|P4|COMPLETED|Period 3||4
7675009|NCT01968070|18900657|P3|COMPLETED|Period 3||4
7675010|NCT01968070|18900658|P2|COMPLETED|Period 3||4
7675011|NCT01968070|18900659|P1|COMPLETED|Period 3||4
7675012|NCT01968070|18900642|P18|STARTED|Period 3||0
7675013|NCT01968070|18900643|P17|STARTED|Period 3||0
7675014|NCT01968070|18900644|P16|STARTED|Period 3||0
7675015|NCT01968070|18900645|P15|STARTED|Period 3||0
7675016|NCT01968070|18900646|P14|STARTED|Period 3||0
7675017|NCT01968070|18900647|P13|STARTED|Period 3||0
7675018|NCT01968070|18900648|P12|STARTED|Period 3||0
7675019|NCT01968070|18900649|P11|STARTED|Period 3||0
7675020|NCT01968070|18900650|P10|STARTED|Period 3||0
7675021|NCT01968070|18900651|P9|STARTED|Period 3||0
7675022|NCT01968070|18900652|P8|STARTED|Period 3||0
7675023|NCT01968070|18900653|P7|STARTED|Period 3||0
7675024|NCT01968070|18900654|P6|STARTED|Period 3||4
7675025|NCT01968070|18900655|P5|STARTED|Period 3||3
7675026|NCT01968070|18900656|P4|STARTED|Period 3||4
7675027|NCT01968070|18900657|P3|STARTED|Period 3||4
7675028|NCT01968070|18900658|P2|STARTED|Period 3||4
7675029|NCT01968070|18900659|P1|STARTED|Period 3||4
7675030|NCT01968070|18900642|P18|NOT COMPLETED|Period 2||0
7675031|NCT01968070|18900643|P17|NOT COMPLETED|Period 2||0
7675032|NCT01968070|18900644|P16|NOT COMPLETED|Period 2||0
7675033|NCT01968070|18900645|P15|NOT COMPLETED|Period 2||0
7675034|NCT01968070|18900646|P14|NOT COMPLETED|Period 2||0
7675035|NCT01968070|18900647|P13|NOT COMPLETED|Period 2||0
7675036|NCT01968070|18900648|P12|NOT COMPLETED|Period 2||0
7675037|NCT01968070|18900649|P11|NOT COMPLETED|Period 2||0
7675038|NCT01968070|18900650|P10|NOT COMPLETED|Period 2||0
7675039|NCT01968070|18900651|P9|NOT COMPLETED|Period 2||0
7675040|NCT01968070|18900652|P8|NOT COMPLETED|Period 2||0
7675041|NCT01968070|18900653|P7|NOT COMPLETED|Period 2||0
7675042|NCT01968070|18900654|P6|NOT COMPLETED|Period 2||0
7675043|NCT01968070|18900655|P5|NOT COMPLETED|Period 2||1
7675044|NCT01968070|18900656|P4|NOT COMPLETED|Period 2||0
7675045|NCT01968070|18900657|P3|NOT COMPLETED|Period 2||0
7675046|NCT01968070|18900658|P2|NOT COMPLETED|Period 2||0
7675047|NCT01968070|18900659|P1|NOT COMPLETED|Period 2||0
7675048|NCT01968070|18900642|P18|COMPLETED|Period 2||0
7675049|NCT01968070|18900643|P17|COMPLETED|Period 2||0
7675050|NCT01968070|18900644|P16|COMPLETED|Period 2||0
7675051|NCT01968070|18900645|P15|COMPLETED|Period 2||0
7675052|NCT01968070|18900646|P14|COMPLETED|Period 2||0
7675053|NCT01968070|18900647|P13|COMPLETED|Period 2||0
7675054|NCT01968070|18900648|P12|COMPLETED|Period 2||0
7675055|NCT01968070|18900649|P11|COMPLETED|Period 2||0
7675056|NCT01968070|18900650|P10|COMPLETED|Period 2||0
7675057|NCT01968070|18900651|P9|COMPLETED|Period 2||0
7675058|NCT01968070|18900652|P8|COMPLETED|Period 2||0
7675059|NCT01968070|18900653|P7|COMPLETED|Period 2||0
7675060|NCT01968070|18900654|P6|COMPLETED|Period 2||4
7675061|NCT01968070|18900655|P5|COMPLETED|Period 2||2
7675062|NCT01968070|18900656|P4|COMPLETED|Period 2||4
7675063|NCT01968070|18900657|P3|COMPLETED|Period 2||4
7675064|NCT01968070|18900658|P2|COMPLETED|Period 2||4
7675065|NCT01968070|18900659|P1|COMPLETED|Period 2||4
7675066|NCT01968070|18900642|P18|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
7675067|NCT01968070|18900643|P17|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
7675068|NCT01968070|18900644|P16|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
7675069|NCT01968070|18900645|P15|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
7675070|NCT01968070|18900646|P14|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
7675071|NCT01968070|18900647|P13|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
7675072|NCT01968070|18900648|P12|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
7675073|NCT01968070|18900649|P11|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
7675074|NCT01968070|18900650|P10|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
7675075|NCT01968070|18900651|P9|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
7675076|NCT01968070|18900652|P8|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
7675077|NCT01968070|18900653|P7|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
7675078|NCT01968070|18900654|P6|STARTED|Period 2||4
7675079|NCT01968070|18900655|P5|STARTED|Period 2||3
7675258|NCT01967719|18900916|P1|COMPLETED|Second Intervention (Day 3)||22
7675080|NCT01968070|18900656|P4|STARTED|Period 2|2 participants were added to replace the 2 participants who discontinued the period 1.|4
7675081|NCT01968070|18900657|P3|STARTED|Period 2||4
7675082|NCT01968070|18900658|P2|STARTED|Period 2|1 participant was added to replace the participant who discontinued the period 1.|4
7675083|NCT01968070|18900659|P1|STARTED|Period 2||4
7675084|NCT01968070|18900642|P18|NOT COMPLETED|Period 1||0
7675085|NCT01968070|18900643|P17|NOT COMPLETED|Period 1||0
7675086|NCT01968070|18900644|P16|NOT COMPLETED|Period 1||1
7675087|NCT01968070|18900645|P15|NOT COMPLETED|Period 1||0
7675088|NCT01968070|18900646|P14|NOT COMPLETED|Period 1||0
7675089|NCT01968070|18900647|P13|NOT COMPLETED|Period 1||0
7675090|NCT01968070|18900648|P12|NOT COMPLETED|Period 1||1
7675091|NCT01968070|18900649|P11|NOT COMPLETED|Period 1||0
7675092|NCT01968070|18900650|P10|NOT COMPLETED|Period 1||0
7675093|NCT01968070|18900651|P9|NOT COMPLETED|Period 1||0
7675094|NCT01968070|18900652|P8|NOT COMPLETED|Period 1||0
7675095|NCT01968070|18900653|P7|NOT COMPLETED|Period 1||2
7675096|NCT01968070|18900654|P6|NOT COMPLETED|Period 1||0
7675097|NCT01968070|18900655|P5|NOT COMPLETED|Period 1||1
7675098|NCT01968070|18900656|P4|NOT COMPLETED|Period 1||2
7675099|NCT01968070|18900657|P3|NOT COMPLETED|Period 1||0
7675100|NCT01968070|18900658|P2|NOT COMPLETED|Period 1||1
7675101|NCT01968070|18900659|P1|NOT COMPLETED|Period 1||0
7675102|NCT01968070|18900642|P18|COMPLETED|Period 1||2
7675103|NCT01968070|18900643|P17|COMPLETED|Period 1||2
7675104|NCT01968070|18900644|P16|COMPLETED|Period 1||8
7675105|NCT01968070|18900645|P15|COMPLETED|Period 1||2
7675106|NCT01968070|18900646|P14|COMPLETED|Period 1||2
7675107|NCT01968070|18900647|P13|COMPLETED|Period 1||9
7675108|NCT01968070|18900648|P12|COMPLETED|Period 1||1
7675109|NCT01968070|18900649|P11|COMPLETED|Period 1||2
7675110|NCT01968070|18900650|P10|COMPLETED|Period 1||9
7675111|NCT01968070|18900651|P9|COMPLETED|Period 1||2
7675112|NCT01968070|18900652|P8|COMPLETED|Period 1||2
7675113|NCT01968070|18900653|P7|COMPLETED|Period 1||8
7675114|NCT01968070|18900654|P6|COMPLETED|Period 1||4
7675115|NCT01968070|18900655|P5|COMPLETED|Period 1||3
7675116|NCT01968070|18900656|P4|COMPLETED|Period 1||2
7675117|NCT01968070|18900657|P3|COMPLETED|Period 1||4
7675118|NCT01968070|18900658|P2|COMPLETED|Period 1||3
7675119|NCT01968070|18900659|P1|COMPLETED|Period 1||4
7675120|NCT01968070|18900642|P18|STARTED|Period 1||2
7675121|NCT01968070|18900643|P17|STARTED|Period 1||2
7675122|NCT01968070|18900644|P16|STARTED|Period 1||9
7675123|NCT01968070|18900645|P15|STARTED|Period 1||2
7675124|NCT01968070|18900646|P14|STARTED|Period 1||2
7675125|NCT01968070|18900647|P13|STARTED|Period 1||9
7675126|NCT01968070|18900648|P12|STARTED|Period 1||2
7675127|NCT01968070|18900649|P11|STARTED|Period 1||2
7675128|NCT01968070|18900650|P10|STARTED|Period 1||9
7675129|NCT01968070|18900651|P9|STARTED|Period 1||2
7675130|NCT01968070|18900652|P8|STARTED|Period 1||2
7675131|NCT01968070|18900653|P7|STARTED|Period 1||10
7675132|NCT01968070|18900654|P6|STARTED|Period 1||4
7675133|NCT01968070|18900655|P5|STARTED|Period 1||4
7675134|NCT01968070|18900656|P4|STARTED|Period 1||4
7675135|NCT01968070|18900657|P3|STARTED|Period 1||4
7675136|NCT01968070|18900658|P2|STARTED|Period 1||4
7675137|NCT01968070|18900659|P1|STARTED|Period 1||4
7675138|NCT01968057|18900717|P1|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0
7675139|NCT01968057|18900717|P1|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18
7675140|NCT01968057|18900717|P1|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18
7675141|NCT01968057|18900717|P1|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18
7675142|NCT01968057|18900717|P1|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0
7675143|NCT01968057|18900717|P1|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18
7675144|NCT01968057|18900717|P1|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18
7675145|NCT01968057|18900717|P1|STARTED|Period 1 (Day 1 to Predosing Day 4)||18
7675146|NCT01968031|18900730|P3|NOT COMPLETED|Overall Study||29
7675147|NCT01968031|18900731|P2|NOT COMPLETED|Overall Study||20
7675148|NCT01968031|18900732|P1|NOT COMPLETED|Overall Study||18
7675149|NCT01968031|18900730|P3|COMPLETED|Overall Study||178
7675150|NCT01968031|18900731|P2|COMPLETED|Overall Study||182
7675151|NCT01968031|18900732|P1|COMPLETED|Overall Study||186
7675152|NCT01968031|18900730|P3|Completed Week 10|Overall Study||181
7675153|NCT01968031|18900731|P2|Completed Week 10|Overall Study||181
7675154|NCT01968031|18900732|P1|Completed Week 10|Overall Study||187
7675155|NCT01968031|18900730|P3|Completed Week 6|Overall Study||187
7675156|NCT01968031|18900731|P2|Completed Week 6|Overall Study||183
7675157|NCT01968031|18900732|P1|Completed Week 6|Overall Study||191
7675158|NCT01968031|18900730|P3|Completed Week 2|Overall Study||199
7675159|NCT01968031|18900731|P2|Completed Week 2|Overall Study||190
7675160|NCT01968031|18900732|P1|Completed Week 2|Overall Study||197
7675161|NCT01968031|18900730|P3|STARTED|Overall Study||207
7675162|NCT01968031|18900731|P2|STARTED|Overall Study||202
7675163|NCT01968031|18900732|P1|STARTED|Overall Study||204
7675164|NCT01967940|18900776|P4|NOT COMPLETED|Part 2||3
7675165|NCT01967940|18900777|P3|NOT COMPLETED|Part 2||0
7675166|NCT01967940|18900778|P2|NOT COMPLETED|Part 2||0
7675167|NCT01967940|18900779|P1|NOT COMPLETED|Part 2||0
7675168|NCT01967940|18900776|P4|COMPLETED|Part 2||35
7675169|NCT01967940|18900777|P3|COMPLETED|Part 2||0
7675170|NCT01967940|18900778|P2|COMPLETED|Part 2||0
7675171|NCT01967940|18900779|P1|COMPLETED|Part 2||0
7675172|NCT01967940|18900776|P4|STARTED|Part 2|38 participants from the Part 1 groups moved to this Part 2 E/C/F/TAF + ATV group|38
7675173|NCT01967940|18900777|P3|STARTED|Part 2|1 participant completed Part 1 and did not enter Part 2; 14 participants moved to the Part 2 group|0
7675174|NCT01967940|18900778|P2|STARTED|Part 2|12 participants completed Part 1 and did not enter Part 2; 16 participants moved to the Part 2 group|0
7675175|NCT01967940|18900779|P1|STARTED|Part 2|4 participants completed Part 1 and did not enter Part 2; 8 participants moved to the Part 2 group|0
7675176|NCT01967940|18900776|P4|NOT COMPLETED|Part 1||0
7675177|NCT01967940|18900777|P3|NOT COMPLETED|Part 1||0
7675178|NCT01967940|18900778|P2|NOT COMPLETED|Part 1||0
7675179|NCT01967940|18900779|P1|NOT COMPLETED|Part 1||0
7675180|NCT01967940|18900776|P4|COMPLETED|Part 1||0
7675181|NCT01967940|18900777|P3|COMPLETED|Part 1||15
7675182|NCT01967940|18900778|P2|COMPLETED|Part 1||28
7675183|NCT01967940|18900779|P1|COMPLETED|Part 1||12
7675184|NCT01967940|18900776|P4|STARTED|Part 1||0
7675185|NCT01967940|18900777|P3|STARTED|Part 1||15
7675186|NCT01967940|18900778|P2|STARTED|Part 1||28
7675187|NCT01967940|18900779|P1|STARTED|Part 1||12
7675188|NCT01967888|18900807|P2|NOT COMPLETED|Overall Study||7
7675189|NCT01967888|18900808|P1|NOT COMPLETED|Overall Study||10
7675190|NCT01967888|18900807|P2|COMPLETED|Overall Study||45
7675191|NCT01967888|18900808|P1|COMPLETED|Overall Study||42
7675192|NCT01967888|18900807|P2|STARTED|Overall Study||52
7675193|NCT01967888|18900808|P1|STARTED|Overall Study||52
7675194|NCT01967862|18900876|P1|NOT COMPLETED|Overall Study||0
7675195|NCT01967862|18900876|P1|COMPLETED|Overall Study||54
7675196|NCT01967862|18900876|P1|STARTED|Overall Study||54
7675197|NCT01967836|18900880|P1|NOT COMPLETED|Overall Study||9
7675198|NCT01967836|18900880|P1|COMPLETED|Overall Study||11
7675199|NCT01967836|18900880|P1|STARTED|Overall Study||20
7675200|NCT01967784|18900886|P1|NOT COMPLETED|Overall Study||0
7675201|NCT01967784|18900886|P1|COMPLETED|Overall Study||100
7675202|NCT01967784|18900886|P1|STARTED|Overall Study||100
7675203|NCT01967732|18900896|P4|NOT COMPLETED|Second Intervention (Day 3)||0
7675204|NCT01967732|18900897|P3|NOT COMPLETED|Second Intervention (Day 3)||0
7675205|NCT01967732|18900898|P2|NOT COMPLETED|Second Intervention (Day 3)||0
7675206|NCT01967732|18900899|P1|NOT COMPLETED|Second Intervention (Day 3)||0
7675207|NCT01967732|18900896|P4|COMPLETED|Second Intervention (Day 3)||9
7675208|NCT01967732|18900897|P3|COMPLETED|Second Intervention (Day 3)||9
7675209|NCT01967732|18900898|P2|COMPLETED|Second Intervention (Day 3)||20
7675210|NCT01967732|18900899|P1|COMPLETED|Second Intervention (Day 3)||22
7675211|NCT01967732|18900896|P4|STARTED|Second Intervention (Day 3)||9
7675212|NCT01967732|18900897|P3|STARTED|Second Intervention (Day 3)||9
7675213|NCT01967732|18900898|P2|STARTED|Second Intervention (Day 3)||20
7675214|NCT01967732|18900899|P1|STARTED|Second Intervention (Day 3)||22
7675215|NCT01967732|18900896|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
7675216|NCT01967732|18900897|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
7675217|NCT01967732|18900898|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
7675218|NCT01967732|18900899|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
7675219|NCT01967732|18900896|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
7675220|NCT01967732|18900897|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
7675221|NCT01967732|18900898|P2|COMPLETED|Washout Period of 1 Day (Day 2)||20
7675222|NCT01967732|18900899|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
7675223|NCT01967732|18900896|P4|STARTED|Washout Period of 1 Day (Day 2)||9
7675224|NCT01967732|18900897|P3|STARTED|Washout Period of 1 Day (Day 2)||9
7675225|NCT01967732|18900898|P2|STARTED|Washout Period of 1 Day (Day 2)||20
7675226|NCT01967732|18900899|P1|STARTED|Washout Period of 1 Day (Day 2)||22
7675227|NCT01967732|18900896|P4|NOT COMPLETED|First Intervention (Day 1)||0
7675228|NCT01967732|18900897|P3|NOT COMPLETED|First Intervention (Day 1)||0
7675229|NCT01967732|18900898|P2|NOT COMPLETED|First Intervention (Day 1)||1
7675230|NCT01967732|18900899|P1|NOT COMPLETED|First Intervention (Day 1)||0
7675231|NCT01967732|18900896|P4|COMPLETED|First Intervention (Day 1)||9
7675232|NCT01967732|18900897|P3|COMPLETED|First Intervention (Day 1)||9
7675233|NCT01967732|18900898|P2|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20
7675234|NCT01967732|18900899|P1|COMPLETED|First Intervention (Day 1)||22
7675235|NCT01967732|18900896|P4|STARTED|First Intervention (Day 1)||9
7675236|NCT01967732|18900897|P3|STARTED|First Intervention (Day 1)||9
7675237|NCT01967732|18900898|P2|STARTED|First Intervention (Day 1)||21
7675238|NCT01967732|18900899|P1|STARTED|First Intervention (Day 1)||22
7675239|NCT01967732|18900896|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
7675240|NCT01967732|18900897|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
7675241|NCT01967732|18900898|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1
7675242|NCT01967732|18900899|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
7675243|NCT01967732|18900896|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
7675244|NCT01967732|18900897|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
7675245|NCT01967732|18900898|P2|COMPLETED|Washout Period of 1 Day (Day 0)||21
7675246|NCT01967732|18900899|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
7675247|NCT01967732|18900896|P4|STARTED|Washout Period of 1 Day (Day 0)||9
7675248|NCT01967732|18900897|P3|STARTED|Washout Period of 1 Day (Day 0)||9
7675249|NCT01967732|18900898|P2|STARTED|Washout Period of 1 Day (Day 0)||22
7675250|NCT01967732|18900899|P1|STARTED|Washout Period of 1 Day (Day 0)||22
7675251|NCT01967719|18900913|P4|NOT COMPLETED|Second Intervention (Day 3)||0
7675252|NCT01967719|18900914|P3|NOT COMPLETED|Second Intervention (Day 3)||0
7675253|NCT01967719|18900915|P2|NOT COMPLETED|Second Intervention (Day 3)||1
7675254|NCT01967719|18900916|P1|NOT COMPLETED|Second Intervention (Day 3)||0
7675255|NCT01967719|18900913|P4|COMPLETED|Second Intervention (Day 3)||8
7675256|NCT01967719|18900914|P3|COMPLETED|Second Intervention (Day 3)||9
7675257|NCT01967719|18900915|P2|COMPLETED|Second Intervention (Day 3)||20
7675259|NCT01967719|18900913|P4|STARTED|Second Intervention (Day 3)||8
7675260|NCT01967719|18900914|P3|STARTED|Second Intervention (Day 3)||9
7675261|NCT01967719|18900915|P2|STARTED|Second Intervention (Day 3)||21
7675262|NCT01967719|18900916|P1|STARTED|Second Intervention (Day 3)||22
7675263|NCT01967719|18900913|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
7675264|NCT01967719|18900914|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
7675265|NCT01967719|18900915|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
7675266|NCT01967719|18900916|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
7675267|NCT01967719|18900913|P4|COMPLETED|Washout Period of 1 Day (Day 2)||8
7675268|NCT01967719|18900914|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
7675269|NCT01967719|18900915|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
7675270|NCT01967719|18900916|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
7675271|NCT01967719|18900913|P4|STARTED|Washout Period of 1 Day (Day 2)||8
7675272|NCT01967719|18900914|P3|STARTED|Washout Period of 1 Day (Day 2)||9
7675273|NCT01967719|18900915|P2|STARTED|Washout Period of 1 Day (Day 2)||21
7675274|NCT01967719|18900916|P1|STARTED|Washout Period of 1 Day (Day 2)||22
7675275|NCT01967719|18900913|P4|NOT COMPLETED|First Intervention (Day 1)||1
7675276|NCT01967719|18900914|P3|NOT COMPLETED|First Intervention (Day 1)||0
7675277|NCT01967719|18900915|P2|NOT COMPLETED|First Intervention (Day 1)||1
7675278|NCT01967719|18900916|P1|NOT COMPLETED|First Intervention (Day 1)||0
7675279|NCT01967719|18900913|P4|COMPLETED|First Intervention (Day 1)||8
7675280|NCT01967719|18900914|P3|COMPLETED|First Intervention (Day 1)||9
7675281|NCT01967719|18900915|P2|COMPLETED|First Intervention (Day 1)||21
7675282|NCT01967719|18900916|P1|COMPLETED|First Intervention (Day 1)||22
7675283|NCT01967719|18900913|P4|STARTED|First Intervention (Day 1)||9
7675284|NCT01967719|18900914|P3|STARTED|First Intervention (Day 1)||9
7675285|NCT01967719|18900915|P2|STARTED|First Intervention (Day 1)||22
7675286|NCT01967719|18900916|P1|STARTED|First Intervention (Day 1)||22
7675287|NCT01967719|18900913|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
7675288|NCT01967719|18900914|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
7675289|NCT01967719|18900915|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
7675290|NCT01967719|18900916|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
7675291|NCT01967719|18900913|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
7675292|NCT01967719|18900914|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
7675293|NCT01967719|18900915|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
7675294|NCT01967719|18900916|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
7675295|NCT01967719|18900913|P4|STARTED|Washout Period of 1 Day (Day 0)||9
7675296|NCT01967719|18900914|P3|STARTED|Washout Period of 1 Day (Day 0)||9
7675297|NCT01967719|18900915|P2|STARTED|Washout Period of 1 Day (Day 0)||22
7675298|NCT01967719|18900916|P1|STARTED|Washout Period of 1 Day (Day 0)||22
7675299|NCT01967706|18900931|P4|NOT COMPLETED|Second Intervention (Day 3)||0
7675300|NCT01967706|18900932|P3|NOT COMPLETED|Second Intervention (Day 3)||0
7675301|NCT01967706|18900933|P2|NOT COMPLETED|Second Intervention (Day 3)||0
7675302|NCT01967706|18900934|P1|NOT COMPLETED|Second Intervention (Day 3)||0
7675303|NCT01967706|18900931|P4|COMPLETED|Second Intervention (Day 3)||9
7675304|NCT01967706|18900932|P3|COMPLETED|Second Intervention (Day 3)||9
7675305|NCT01967706|18900933|P2|COMPLETED|Second Intervention (Day 3)||22
7675306|NCT01967706|18900934|P1|COMPLETED|Second Intervention (Day 3)||21
7675307|NCT01967706|18900931|P4|STARTED|Second Intervention (Day 3)||9
7675308|NCT01967706|18900932|P3|STARTED|Second Intervention (Day 3)||9
7675309|NCT01967706|18900933|P2|STARTED|Second Intervention (Day 3)||22
7675310|NCT01967706|18900934|P1|STARTED|Second Intervention (Day 3)||21
7675311|NCT01967706|18900931|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
7675312|NCT01967706|18900932|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
7675313|NCT01967706|18900933|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
7675314|NCT01967706|18900934|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
7675315|NCT01967706|18900931|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
7675316|NCT01967706|18900932|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
7675317|NCT01967706|18900933|P2|COMPLETED|Washout Period of 1 Day (Day 2)||22
7675318|NCT01967706|18900934|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
7675319|NCT01967706|18900931|P4|STARTED|Washout Period of 1 Day (Day 2)||9
7675320|NCT01967706|18900932|P3|STARTED|Washout Period of 1 Day (Day 2)||9
7675321|NCT01967706|18900933|P2|STARTED|Washout Period of 1 Day (Day 2)||22
7675322|NCT01967706|18900934|P1|STARTED|Washout Period of 1 Day (Day 2)||21
7675323|NCT01967706|18900931|P4|NOT COMPLETED|First Intervention (Day 1)||0
7675324|NCT01967706|18900932|P3|NOT COMPLETED|First Intervention (Day 1)||0
7675325|NCT01967706|18900933|P2|NOT COMPLETED|First Intervention (Day 1)||0
7675326|NCT01967706|18900934|P1|NOT COMPLETED|First Intervention (Day 1)||1
7675327|NCT01967706|18900931|P4|COMPLETED|First Intervention (Day 1)||9
7675328|NCT01967706|18900932|P3|COMPLETED|First Intervention (Day 1)||9
7675329|NCT01967706|18900933|P2|COMPLETED|First Intervention (Day 1)||22
7675330|NCT01967706|18900934|P1|COMPLETED|First Intervention (Day 1)||21
7675331|NCT01967706|18900931|P4|STARTED|First Intervention (Day 1)||9
7675332|NCT01967706|18900932|P3|STARTED|First Intervention (Day 1)||9
7675333|NCT01967706|18900933|P2|STARTED|First Intervention (Day 1)||22
7675334|NCT01967706|18900934|P1|STARTED|First Intervention (Day 1)||22
7675335|NCT01967706|18900931|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
7675336|NCT01967706|18900932|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
7675337|NCT01967706|18900933|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
7675338|NCT01967706|18900934|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
7675339|NCT01967706|18900931|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
7675340|NCT01967706|18900932|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
7675341|NCT01967706|18900933|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
7675342|NCT01967706|18900934|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
7675343|NCT01967706|18900931|P4|STARTED|Washout Period of 1 Day (Day 0)||9
7675344|NCT01967706|18900932|P3|STARTED|Washout Period of 1 Day (Day 0)||9
7675345|NCT01967706|18900933|P2|STARTED|Washout Period of 1 Day (Day 0)||22
7675346|NCT01967706|18900934|P1|STARTED|Washout Period of 1 Day (Day 0)||22
7675347|NCT01967641|18900947|P1|NOT COMPLETED|12-week Outpatient Phase||13
7675348|NCT01967641|18900947|P1|COMPLETED|12-week Outpatient Phase|Completed week 12 of outpatient phase|18
7675349|NCT01967641|18900947|P1|STARTED|12-week Outpatient Phase||31
7675350|NCT01967641|18900947|P1|NOT COMPLETED|Admission to Inpatient Phase||12
7675351|NCT01967641|18900947|P1|COMPLETED|Admission to Inpatient Phase|Completed 7 week inpatient phase|31
7675352|NCT01967641|18900947|P1|STARTED|Admission to Inpatient Phase||43
7675353|NCT01967641|18900947|P1|NOT COMPLETED|Randomized||8
7675354|NCT01967641|18900947|P1|COMPLETED|Randomized|Completed week 12|43
7675355|NCT01967641|18900947|P1|STARTED|Randomized||51
7675356|NCT01967628|18900955|P2|NOT COMPLETED|Overall Study||31
7675357|NCT01967628|18900956|P1|NOT COMPLETED|Overall Study||27
7675358|NCT01967628|18900955|P2|COMPLETED|Overall Study||19
7675359|NCT01967628|18900956|P1|COMPLETED|Overall Study||21
7675360|NCT01967628|18900955|P2|STARTED|Overall Study||50
7675361|NCT01967628|18900956|P1|STARTED|Overall Study||48
7675362|NCT01967576|18900962|P1|NOT COMPLETED|Overall Study||7
7675363|NCT01967576|18900962|P1|COMPLETED|Overall Study||7
7675364|NCT01967576|18900962|P1|STARTED|Overall Study||14
7675365|NCT01967550|18900973|P2|NOT COMPLETED|Overall Study||2
7675366|NCT01967550|18900974|P1|NOT COMPLETED|Overall Study||5
7675367|NCT01967550|18900973|P2|COMPLETED|Overall Study||149
7675368|NCT01967550|18900974|P1|COMPLETED|Overall Study||148
7675369|NCT01967550|18900973|P2|STARTED|Overall Study||151
7675370|NCT01967550|18900974|P1|STARTED|Overall Study||153
7675371|NCT01967537|18900980|P1|NOT COMPLETED|Overall Study||60
7675372|NCT01967537|18900980|P1|COMPLETED|Overall Study||281
7675373|NCT01967537|18900980|P1|STARTED|Overall Study||341
7675374|NCT01967433|18900991|P2|NOT COMPLETED|Overall Study||1
7675375|NCT01967433|18900992|P1|NOT COMPLETED|Overall Study||0
7675376|NCT01967433|18900991|P2|COMPLETED|Overall Study||58
7675377|NCT01967433|18900992|P1|COMPLETED|Overall Study||61
7675378|NCT01967433|18900991|P2|STARTED|Overall Study||59
7675379|NCT01967433|18900992|P1|STARTED|Overall Study||61
7675380|NCT01967342|18901013|P3|NOT COMPLETED|Overall Study||29
7675381|NCT01967342|18901014|P2|NOT COMPLETED|Overall Study||25
7675382|NCT01967342|18901015|P1|NOT COMPLETED|Overall Study||27
7675383|NCT01967342|18901013|P3|COMPLETED|Overall Study||68
7675384|NCT01967342|18901014|P2|COMPLETED|Overall Study||70
7675385|NCT01967342|18901015|P1|COMPLETED|Overall Study||71
7675386|NCT01967342|18901013|P3|10-week Follow-up|Overall Study||80
7675387|NCT01967342|18901014|P2|10-week Follow-up|Overall Study||83
7675388|NCT01967342|18901015|P1|10-week Follow-up|Overall Study||78
7675389|NCT01967342|18901013|P3|5-week Follow-up|Overall Study||76
7675390|NCT01967342|18901014|P2|5-week Follow-up|Overall Study||78
7675391|NCT01967342|18901015|P1|5-week Follow-up|Overall Study||83
7675392|NCT01967342|18901013|P3|STARTED|Overall Study||97
7675393|NCT01967342|18901014|P2|STARTED|Overall Study||95
7675394|NCT01967342|18901015|P1|STARTED|Overall Study||98
7675395|NCT01967277|18901034|P2|NOT COMPLETED|Overall Study||3
7675396|NCT01967277|18901035|P1|NOT COMPLETED|Overall Study||1
7675397|NCT01967277|18901034|P2|COMPLETED|Overall Study||19
7675398|NCT01967277|18901035|P1|COMPLETED|Overall Study||21
7675399|NCT01967277|18901034|P2|STARTED|Overall Study||22
7675400|NCT01967277|18901035|P1|STARTED|Overall Study||22
7675401|NCT01967225|18901047|P2|NOT COMPLETED|Overall Study||3
7675402|NCT01967225|18901048|P1|NOT COMPLETED|Overall Study||12
7675403|NCT01967225|18901047|P2|COMPLETED|Overall Study||38
7675404|NCT01967225|18901048|P1|COMPLETED|Overall Study||72
7675405|NCT01967225|18901047|P2|Participants Received Treatment|Overall Study||41
7675406|NCT01967225|18901048|P1|Participants Received Treatment|Overall Study||83
7675407|NCT01967225|18901047|P2|STARTED|Overall Study||41
7675408|NCT01967225|18901048|P1|STARTED|Overall Study||84
7675409|NCT01967173|18901080|P8|NOT COMPLETED|Overall Study||24
7675410|NCT01967173|18901081|P7|NOT COMPLETED|Overall Study||18
7675411|NCT01967173|18901082|P6|NOT COMPLETED|Overall Study||23
7675412|NCT01967173|18901083|P5|NOT COMPLETED|Overall Study||17
7675413|NCT01967173|18901084|P4|NOT COMPLETED|Overall Study||14
7675414|NCT01967173|18901085|P3|NOT COMPLETED|Overall Study||16
7675415|NCT01967173|18901086|P2|NOT COMPLETED|Overall Study||17
7675416|NCT01967173|18901087|P1|NOT COMPLETED|Overall Study||24
7675417|NCT01967173|18901080|P8|COMPLETED|Overall Study||50
7675418|NCT01967173|18901081|P7|COMPLETED|Overall Study||57
7675419|NCT01967173|18901082|P6|COMPLETED|Overall Study||49
7675420|NCT01967173|18901083|P5|COMPLETED|Overall Study||56
7675421|NCT01967173|18901084|P4|COMPLETED|Overall Study||57
7675422|NCT01967173|18901085|P3|COMPLETED|Overall Study||55
7675423|NCT01967173|18901086|P2|COMPLETED|Overall Study||52
7675424|NCT01967173|18901087|P1|COMPLETED|Overall Study||45
7675425|NCT01967173|18901080|P8|Completed 4th Period|Overall Study||50
7675426|NCT01967173|18901081|P7|Completed 4th Period|Overall Study||57
7675427|NCT01967173|18901082|P6|Completed 4th Period|Overall Study||49
7675428|NCT01967173|18901083|P5|Completed 4th Period|Overall Study||56
7675429|NCT01967173|18901084|P4|Completed 4th Period|Overall Study||57
7675430|NCT01967173|18901085|P3|Completed 4th Period|Overall Study||55
7675431|NCT01967173|18901086|P2|Completed 4th Period|Overall Study||52
7675432|NCT01967173|18901087|P1|Completed 4th Period|Overall Study||45
7675433|NCT01967173|18901080|P8|Completed 3rd Period|Overall Study||56
7675434|NCT01967173|18901081|P7|Completed 3rd Period|Overall Study||59
7675435|NCT01967173|18901082|P6|Completed 3rd Period|Overall Study||56
7675436|NCT01967173|18901083|P5|Completed 3rd Period|Overall Study||59
7675437|NCT01967173|18901084|P4|Completed 3rd Period|Overall Study||61
7675438|NCT01967173|18901085|P3|Completed 3rd Period|Overall Study||60
7675439|NCT01967173|18901086|P2|Completed 3rd Period|Overall Study||54
7675440|NCT01967173|18901087|P1|Completed 3rd Period|Overall Study||48
7675441|NCT01967173|18901080|P8|Completed 2nd Period|Overall Study||61
7675442|NCT01967173|18901081|P7|Completed 2nd Period|Overall Study||63
7675443|NCT01967173|18901082|P6|Completed 2nd Period|Overall Study||57
7675444|NCT01967173|18901083|P5|Completed 2nd Period|Overall Study||63
7675445|NCT01967173|18901084|P4|Completed 2nd Period|Overall Study||62
7675446|NCT01967173|18901085|P3|Completed 2nd Period|Overall Study||63
7675447|NCT01967173|18901086|P2|Completed 2nd Period|Overall Study||58
7675448|NCT01967173|18901087|P1|Completed 2nd Period|Overall Study||52
7675449|NCT01967173|18901080|P8|Completed 1st Period|Overall Study||69
7675450|NCT01967173|18901081|P7|Completed 1st Period|Overall Study||67
7675451|NCT01967173|18901082|P6|Completed 1st Period|Overall Study||62
7675452|NCT01967173|18901083|P5|Completed 1st Period|Overall Study||64
7675453|NCT01967173|18901084|P4|Completed 1st Period|Overall Study||65
7675454|NCT01967173|18901085|P3|Completed 1st Period|Overall Study||67
7675455|NCT01967173|18901086|P2|Completed 1st Period|Overall Study||60
7675456|NCT01967173|18901087|P1|Completed 1st Period|Overall Study||58
7675457|NCT01967173|18901080|P8|STARTED|Overall Study||74
7675458|NCT01967173|18901081|P7|STARTED|Overall Study||75
7675459|NCT01967173|18901082|P6|STARTED|Overall Study||72
7675460|NCT01967173|18901083|P5|STARTED|Overall Study||73
7675461|NCT01967173|18901084|P4|STARTED|Overall Study||71
7675462|NCT01967173|18901085|P3|STARTED|Overall Study||71
7675463|NCT01967173|18901086|P2|STARTED|Overall Study||69
7675464|NCT01967173|18901087|P1|STARTED|Overall Study||69
7675465|NCT01967147|18901101|P2|NOT COMPLETED|Overall Study||20
7675466|NCT01967147|18901102|P1|NOT COMPLETED|Overall Study||13
7675467|NCT01967147|18901101|P2|COMPLETED|Overall Study||82
7675468|NCT01967147|18901102|P1|COMPLETED|Overall Study||99
7675469|NCT01967147|18901101|P2|STARTED|Overall Study||102
7675470|NCT01967147|18901102|P1|STARTED|Overall Study||112
7675471|NCT01967134|18901120|P3|NOT COMPLETED|Overall Study||0
7675472|NCT01967134|18901121|P2|NOT COMPLETED|Overall Study||1
7675473|NCT01967134|18901122|P1|NOT COMPLETED|Overall Study||0
7675474|NCT01967134|18901120|P3|COMPLETED|Overall Study||9
7675475|NCT01967134|18901121|P2|COMPLETED|Overall Study||7
7675476|NCT01967134|18901122|P1|COMPLETED|Overall Study||8
7675477|NCT01967134|18901120|P3|STARTED|Overall Study||9
7675478|NCT01967134|18901121|P2|STARTED|Overall Study||8
7675479|NCT01967134|18901122|P1|STARTED|Overall Study||8
7675480|NCT01967121|18901145|P3|NOT COMPLETED|Overall Study||0
7675481|NCT01967121|18901146|P2|NOT COMPLETED|Overall Study||0
7675482|NCT01967121|18901147|P1|NOT COMPLETED|Overall Study||0
7675483|NCT01967121|18901145|P3|COMPLETED|Overall Study||25
7675484|NCT01967121|18901146|P2|COMPLETED|Overall Study||25
7675485|NCT01967121|18901147|P1|COMPLETED|Overall Study||25
7675486|NCT01967121|18901145|P3|STARTED|Overall Study||25
7675487|NCT01967121|18901146|P2|STARTED|Overall Study||25
7675488|NCT01967121|18901147|P1|STARTED|Overall Study||25
7675489|NCT01967069|18901157|P2|NOT COMPLETED|Overall Study||8
7675490|NCT01967069|18901158|P1|NOT COMPLETED|Overall Study||8
7675491|NCT01967069|18901157|P2|COMPLETED|Overall Study||87
7675492|NCT01967069|18901158|P1|COMPLETED|Overall Study||174
7675493|NCT01967069|18901157|P2|STARTED|Overall Study||95
7675494|NCT01967069|18901158|P1|STARTED|Overall Study||182
7675495|NCT01966978|18901166|P2|NOT COMPLETED|Overall Study||13
7675496|NCT01966978|18901167|P1|NOT COMPLETED|Overall Study||17
7675497|NCT01966978|18901166|P2|COMPLETED|Overall Study||46
7675498|NCT01966978|18901167|P1|COMPLETED|Overall Study||44
7675499|NCT01966978|18901166|P2|STARTED|Overall Study||59
7675500|NCT01966978|18901167|P1|STARTED|Overall Study||61
7675501|NCT01966926|18901189|P2|NOT COMPLETED|Overall Study||0
7675502|NCT01966926|18901190|P1|NOT COMPLETED|Overall Study||0
7675503|NCT01966926|18901189|P2|COMPLETED|Overall Study||15
7675504|NCT01966926|18901190|P1|COMPLETED|Overall Study||15
7675505|NCT01966926|18901189|P2|STARTED|Overall Study||15
7675506|NCT01966926|18901190|P1|STARTED|Overall Study||15
7675507|NCT01966900|18901208|P2|NOT COMPLETED|Overall Study||0
7675508|NCT01966900|18901209|P1|NOT COMPLETED|Overall Study||2
7675509|NCT01966900|18901208|P2|COMPLETED|Overall Study||6
7675510|NCT01966900|18901209|P1|COMPLETED|Overall Study||6
7675511|NCT01966900|18901208|P2|STARTED|Overall Study||6
7675512|NCT01966900|18901209|P1|STARTED|Overall Study||8
7675513|NCT01966809|18901219|P1|NOT COMPLETED|Overall Study||0
7675514|NCT01966809|18901219|P1|COMPLETED|Overall Study||1
7675515|NCT01966809|18901219|P1|STARTED|Overall Study||1
7675516|NCT01966796|18901230|P4|NOT COMPLETED|Overall Study||0
7675517|NCT01966796|18901231|P3|NOT COMPLETED|Overall Study||0
7675518|NCT01966796|18901232|P2|NOT COMPLETED|Overall Study||0
7675519|NCT01966796|18901233|P1|NOT COMPLETED|Overall Study||0
7675520|NCT01966796|18901230|P4|COMPLETED|Overall Study||269
7675521|NCT01966796|18901231|P3|COMPLETED|Overall Study||195
7675522|NCT01966796|18901232|P2|COMPLETED|Overall Study||51
7675523|NCT01966796|18901233|P1|COMPLETED|Overall Study||15
7675524|NCT01966796|18901230|P4|STARTED|Overall Study||269
7675525|NCT01966796|18901231|P3|STARTED|Overall Study||195
7675526|NCT01966796|18901232|P2|STARTED|Overall Study||51
7675527|NCT01966796|18901233|P1|STARTED|Overall Study||15
7675528|NCT01966770|18901247|P1|NOT COMPLETED|Overall Study||0
7675529|NCT01966770|18901247|P1|COMPLETED|Overall Study||20
7675530|NCT01966770|18901247|P1|STARTED|Overall Study||20
7675531|NCT01966731|18901356|P1|NOT COMPLETED|Overall Study||635
7675532|NCT01966731|18901356|P1|COMPLETED|Overall Study||0
7675533|NCT01966731|18901356|P1|Completed Study|Overall Study||0
7675534|NCT01966731|18901356|P1|Completed 3 Months of Treatment|Overall Study||600
7675535|NCT01966731|18901356|P1|Initiated Hydroxyurea|Overall Study||606
7675536|NCT01966731|18901356|P1|STARTED|Overall Study||635
7675537|NCT01966718|18901360|P1|NOT COMPLETED|Overall Study||0
7675538|NCT01966718|18901360|P1|COMPLETED|Overall Study||8
7675539|NCT01966718|18901360|P1|STARTED|Overall Study||8
7675540|NCT01966458|18901370|P2|NOT COMPLETED|Overall Study||2
7675541|NCT01966458|18901371|P1|NOT COMPLETED|Overall Study||4
7675542|NCT01966458|18901370|P2|COMPLETED|Overall Study||155
7675543|NCT01966458|18901371|P1|COMPLETED|Overall Study||304
7675544|NCT01966458|18901370|P2|STARTED|Overall Study||157
7675545|NCT01966458|18901371|P1|STARTED|Overall Study||308
7675546|NCT01966445|18901386|P7|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||5
7675547|NCT01966445|18901387|P6|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
7675548|NCT01966445|18901388|P5|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
7675549|NCT01966445|18901389|P4|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
7675550|NCT01966445|18901390|P3|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
7675551|NCT01966445|18901391|P2|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
7675552|NCT01966445|18901392|P1|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
7675553|NCT01966445|18901386|P7|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||4
7675554|NCT01966445|18901387|P6|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
7675555|NCT01966445|18901388|P5|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
7675556|NCT01966445|18901389|P4|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
7675557|NCT01966445|18901390|P3|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
7675558|NCT01966445|18901391|P2|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
7675559|NCT01966445|18901392|P1|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
7675560|NCT01966445|18901386|P7|STARTED|Part2 (Median Exposure of 7.143 Weeks)||9
7675561|NCT01966445|18901387|P6|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
7675562|NCT01966445|18901388|P5|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
7675563|NCT01966445|18901389|P4|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
7675564|NCT01966445|18901390|P3|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
7675565|NCT01966445|18901391|P2|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
7675566|NCT01966445|18901392|P1|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
7675567|NCT01966445|18901386|P7|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
7675568|NCT01966445|18901387|P6|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
7675569|NCT01966445|18901388|P5|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
7675570|NCT01966445|18901389|P4|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
7675571|NCT01966445|18901390|P3|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
7675572|NCT01966445|18901391|P2|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
7675573|NCT01966445|18901392|P1|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
7675574|NCT01966445|18901386|P7|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
7675575|NCT01966445|18901387|P6|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||4
7675576|NCT01966445|18901388|P5|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
7675577|NCT01966445|18901389|P4|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
7675578|NCT01966445|18901390|P3|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
7675579|NCT01966445|18901391|P2|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
7675580|NCT01966445|18901392|P1|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
7675581|NCT01966445|18901386|P7|STARTED|Part1 (Median Exposure of 6.143 Weeks)||0
7675582|NCT01966445|18901387|P6|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
7675583|NCT01966445|18901388|P5|STARTED|Part1 (Median Exposure of 6.143 Weeks)||4
7675584|NCT01966445|18901389|P4|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
7675585|NCT01966445|18901390|P3|STARTED|Part1 (Median Exposure of 6.143 Weeks)||2
7675586|NCT01966445|18901391|P2|STARTED|Part1 (Median Exposure of 6.143 Weeks)||3
7675587|NCT01966445|18901392|P1|STARTED|Part1 (Median Exposure of 6.143 Weeks)||1
7675588|NCT01966432|18901502|P3|NOT COMPLETED|Overall Study||26
7675589|NCT01966432|18901503|P2|NOT COMPLETED|Overall Study||13
7675590|NCT01966432|18901504|P1|NOT COMPLETED|Overall Study||5
7675591|NCT01966432|18901502|P3|COMPLETED|Overall Study||28
7675592|NCT01966432|18901503|P2|COMPLETED|Overall Study||21
7675593|NCT01966432|18901504|P1|COMPLETED|Overall Study||5
7675594|NCT01966432|18901502|P3|STARTED|Overall Study||54
7675595|NCT01966432|18901503|P2|STARTED|Overall Study||34
7675596|NCT01966432|18901504|P1|STARTED|Overall Study||10
7675597|NCT01966380|18901524|P2|NOT COMPLETED|Overall Study||1
7675598|NCT01966380|18901525|P1|NOT COMPLETED|Overall Study||0
7675599|NCT01966380|18901524|P2|COMPLETED|Overall Study||2
7675600|NCT01966380|18901525|P1|COMPLETED|Overall Study||3
7675601|NCT01966380|18901524|P2|STARTED|Overall Study||3
7675602|NCT01966380|18901525|P1|STARTED|Overall Study||3
7675603|NCT01966354|18901534|P3|NOT COMPLETED|Overall Study||0
7675604|NCT01966354|18901535|P2|NOT COMPLETED|Overall Study||0
7675605|NCT01966354|18901536|P1|NOT COMPLETED|Overall Study||0
7675606|NCT01966354|18901534|P3|COMPLETED|Overall Study||72
7675607|NCT01966354|18901535|P2|COMPLETED|Overall Study||73
7675608|NCT01966354|18901536|P1|COMPLETED|Overall Study||75
7675609|NCT01966354|18901534|P3|STARTED|Overall Study||72
7675610|NCT01966354|18901535|P2|STARTED|Overall Study||73
7675611|NCT01966354|18901536|P1|STARTED|Overall Study||75
7675612|NCT01966159|18901561|P2|NOT COMPLETED|Overall Study||0
7675613|NCT01966159|18901562|P1|NOT COMPLETED|Overall Study||0
7675614|NCT01966159|18901561|P2|COMPLETED|Overall Study||207
7675615|NCT01966159|18901562|P1|COMPLETED|Overall Study||205
7675616|NCT01966159|18901561|P2|STARTED|Overall Study||207
7675617|NCT01966159|18901562|P1|STARTED|Overall Study||205
7675618|NCT01966120|18901574|P2|NOT COMPLETED|Overall Study||6
7675619|NCT01966120|18901575|P1|NOT COMPLETED|Overall Study||1
7675620|NCT01966120|18901574|P2|COMPLETED|Overall Study||26
7675621|NCT01966120|18901575|P1|COMPLETED|Overall Study||54
7675622|NCT01966120|18901574|P2|STARTED|Overall Study||32
7675623|NCT01966120|18901575|P1|STARTED|Overall Study||55
7675624|NCT01966107|18901599|P2|NOT COMPLETED|Overall Study||881
7675625|NCT01966107|18901600|P1|NOT COMPLETED|Overall Study||802
7675626|NCT01966107|18901599|P2|COMPLETED|Overall Study||937
7675627|NCT01966107|18901600|P1|COMPLETED|Overall Study||1010
7675628|NCT01966107|18901599|P2|Full Analysis Set|Overall Study||1798
7675629|NCT01966107|18901600|P1|Full Analysis Set|Overall Study||1791
7675630|NCT01966107|18901599|P2|STARTED|Overall Study||1818
7675631|NCT01966107|18901600|P1|STARTED|Overall Study||1812
7675632|NCT01966068|18901614|P1|NOT COMPLETED|Overall Study||138
7675633|NCT01966068|18901614|P1|COMPLETED|Overall Study||156
7675634|NCT01966068|18901614|P1|Use the MyAsthma Portal More Than Once|Overall Study||156
7675635|NCT01966068|18901614|P1|Used the MyAsthma Portal at Least Once|Overall Study||237
7675636|NCT01966068|18901614|P1|STARTED|Overall Study||294
7675637|NCT01966042|18901619|P1|NOT COMPLETED|Overall Study||2
7675638|NCT01966042|18901619|P1|COMPLETED|Overall Study||11
7675639|NCT01966042|18901619|P1|STARTED|Overall Study||13
7675640|NCT01966003|18901628|P2|NOT COMPLETED|Overall Study||270
7675641|NCT01966003|18901629|P1|NOT COMPLETED|Overall Study||270
7675642|NCT01966003|18901628|P2|COMPLETED|Overall Study||44
7675643|NCT01966003|18901629|P1|COMPLETED|Overall Study||58
7675644|NCT01966003|18901628|P2|Received Study Drug|Overall Study||309
7675645|NCT01966003|18901629|P1|Received Study Drug|Overall Study||324
7675646|NCT01966003|18901628|P2|STARTED|Overall Study||314
7675647|NCT01966003|18901629|P1|STARTED|Overall Study||328
7675648|NCT01965938|18901647|P2|NOT COMPLETED|Overall Study||0
7675649|NCT01965938|18901648|P1|NOT COMPLETED|Overall Study||1
7675650|NCT01965938|18901647|P2|COMPLETED|Overall Study||20
7675651|NCT01965938|18901648|P1|COMPLETED|Overall Study||20
7675652|NCT01965938|18901647|P2|STARTED|Overall Study||20
7675653|NCT01965938|18901648|P1|STARTED|Overall Study||21
7675654|NCT01965899|18901668|P1|NOT COMPLETED|Overall Study||6
7675655|NCT01965899|18901668|P1|COMPLETED|Overall Study||145
7675656|NCT01965899|18901668|P1|STARTED|Overall Study||151
7675657|NCT01965834|18901679|P1|NOT COMPLETED|Overall Study||4
7675658|NCT01965834|18901679|P1|COMPLETED|Overall Study||2
7675659|NCT01965834|18901679|P1|STARTED|Overall Study||6
7675660|NCT01965782|18901685|P1|NOT COMPLETED|Overall Study||0
7675661|NCT01965782|18901685|P1|COMPLETED|Overall Study||0
7675662|NCT01965782|18901685|P1|STARTED|Overall Study||0
7675663|NCT01965756|18901697|P2|NOT COMPLETED|Overall Study||0
7675664|NCT01965756|18901698|P1|NOT COMPLETED|Overall Study||0
7675665|NCT01965756|18901697|P2|COMPLETED|Overall Study||10
7675666|NCT01965756|18901698|P1|COMPLETED|Overall Study||10
7675667|NCT01965756|18901697|P2|STARTED|Overall Study||10
7675668|NCT01965756|18901698|P1|STARTED|Overall Study||10
7675669|NCT01965665|18901712|P1|NOT COMPLETED|Overall Study||1
7675670|NCT01965665|18901712|P1|COMPLETED|Overall Study||19
7675671|NCT01965665|18901712|P1|STARTED|Overall Study||20
7675672|NCT01965652|18901720|P2|NOT COMPLETED|Overall Study||210
7675673|NCT01965652|18901721|P1|NOT COMPLETED|Overall Study||210
7675674|NCT01965652|18901720|P2|COMPLETED|Overall Study||413
7675675|NCT01965652|18901721|P1|COMPLETED|Overall Study||413
7675676|NCT01965652|18901720|P2|Received Treatment|Overall Study||623
7675677|NCT01965652|18901721|P1|Received Treatment|Overall Study||622
7675678|NCT01965652|18901720|P2|STARTED|Overall Study|Includes three participants who each enrolled at two different sites|623
7675679|NCT01965652|18901721|P1|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|623
7675680|NCT01965600|18901751|P4|NOT COMPLETED|Second Intervention||2
7675681|NCT01965600|18901752|P3|NOT COMPLETED|Second Intervention||2
7675682|NCT01965600|18901753|P2|NOT COMPLETED|Second Intervention||0
7675683|NCT01965600|18901754|P1|NOT COMPLETED|Second Intervention||0
7675684|NCT01965600|18901751|P4|COMPLETED|Second Intervention||0
7675685|NCT01965600|18901752|P3|COMPLETED|Second Intervention||1
7675686|NCT01965600|18901753|P2|COMPLETED|Second Intervention||4
7675687|NCT01965600|18901754|P1|COMPLETED|Second Intervention||4
7675688|NCT01965600|18901751|P4|STARTED|Second Intervention||2
7675689|NCT01965600|18901752|P3|STARTED|Second Intervention||3
7675690|NCT01965600|18901753|P2|STARTED|Second Intervention||4
7675691|NCT01965600|18901754|P1|STARTED|Second Intervention||4
7675692|NCT01965600|18901751|P4|NOT COMPLETED|Washout Period of Approximately 15 Days||2
7675693|NCT01965600|18901752|P3|NOT COMPLETED|Washout Period of Approximately 15 Days||2
7675694|NCT01965600|18901753|P2|NOT COMPLETED|Washout Period of Approximately 15 Days||4
7675695|NCT01965600|18901754|P1|NOT COMPLETED|Washout Period of Approximately 15 Days||2
7675696|NCT01965600|18901751|P4|COMPLETED|Washout Period of Approximately 15 Days||2
7675697|NCT01965600|18901752|P3|COMPLETED|Washout Period of Approximately 15 Days||3
7675698|NCT01965600|18901753|P2|COMPLETED|Washout Period of Approximately 15 Days||4
7675787|NCT01965067|18902152|P1|STARTED|Overall Study||30
7675699|NCT01965600|18901754|P1|COMPLETED|Washout Period of Approximately 15 Days||4
7675700|NCT01965600|18901751|P4|STARTED|Washout Period of Approximately 15 Days||4
7675701|NCT01965600|18901752|P3|STARTED|Washout Period of Approximately 15 Days||5
7675702|NCT01965600|18901753|P2|STARTED|Washout Period of Approximately 15 Days||8
7675703|NCT01965600|18901754|P1|STARTED|Washout Period of Approximately 15 Days||6
7675704|NCT01965600|18901751|P4|NOT COMPLETED|First Intervention||0
7675705|NCT01965600|18901752|P3|NOT COMPLETED|First Intervention||0
7675706|NCT01965600|18901753|P2|NOT COMPLETED|First Intervention||0
7675707|NCT01965600|18901754|P1|NOT COMPLETED|First Intervention||0
7675708|NCT01965600|18901751|P4|COMPLETED|First Intervention||4
7675709|NCT01965600|18901752|P3|COMPLETED|First Intervention||5
7675710|NCT01965600|18901753|P2|COMPLETED|First Intervention||8
7675711|NCT01965600|18901754|P1|COMPLETED|First Intervention||6
7675712|NCT01965600|18901751|P4|Received at Least One Dose of Drug|First Intervention||4
7675713|NCT01965600|18901752|P3|Received at Least One Dose of Drug|First Intervention||5
7675714|NCT01965600|18901753|P2|Received at Least One Dose of Drug|First Intervention||8
7675715|NCT01965600|18901754|P1|Received at Least One Dose of Drug|First Intervention||6
7675716|NCT01965600|18901751|P4|STARTED|First Intervention||4
7675717|NCT01965600|18901752|P3|STARTED|First Intervention||5
7675718|NCT01965600|18901753|P2|STARTED|First Intervention||8
7675719|NCT01965600|18901754|P1|STARTED|First Intervention||6
7675720|NCT01965561|18901798|P1|NOT COMPLETED|Overall Study||0
7675721|NCT01965561|18901798|P1|COMPLETED|Overall Study||10
7675722|NCT01965561|18901798|P1|STARTED|Overall Study||10
7675723|NCT01965535|18901811|P2|NOT COMPLETED|Overall Study||1
7675724|NCT01965535|18901812|P1|NOT COMPLETED|Overall Study||2
7675725|NCT01965535|18901811|P2|COMPLETED|Overall Study||76
7675726|NCT01965535|18901812|P1|COMPLETED|Overall Study||76
7675727|NCT01965535|18901811|P2|STARTED|Overall Study||77
7675728|NCT01965535|18901812|P1|STARTED|Overall Study||78
7675729|NCT01965431|18901826|P6|NOT COMPLETED|Overall Study||6
7675730|NCT01965431|18901827|P5|NOT COMPLETED|Overall Study||6
7675731|NCT01965431|18901828|P4|NOT COMPLETED|Overall Study||6
7675732|NCT01965431|18901829|P3|NOT COMPLETED|Overall Study||6
7675733|NCT01965431|18901830|P2|NOT COMPLETED|Overall Study||6
7675734|NCT01965431|18901831|P1|NOT COMPLETED|Overall Study||6
7675735|NCT01965431|18901826|P6|COMPLETED|Overall Study||2
7675736|NCT01965431|18901827|P5|COMPLETED|Overall Study||2
7675737|NCT01965431|18901828|P4|COMPLETED|Overall Study||2
7675738|NCT01965431|18901829|P3|COMPLETED|Overall Study||2
7675739|NCT01965431|18901830|P2|COMPLETED|Overall Study||2
7675740|NCT01965431|18901831|P1|COMPLETED|Overall Study||2
7675741|NCT01965431|18901826|P6|STARTED|Overall Study||8
7675742|NCT01965431|18901827|P5|STARTED|Overall Study||8
7675743|NCT01965431|18901828|P4|STARTED|Overall Study||8
7675744|NCT01965431|18901829|P3|STARTED|Overall Study||8
7675745|NCT01965431|18901830|P2|STARTED|Overall Study||8
7675746|NCT01965431|18901831|P1|STARTED|Overall Study|Started are actually Treated subjects|8
7675747|NCT01965366|18901846|P2|NOT COMPLETED|Overall Study||5
7675748|NCT01965366|18901847|P1|NOT COMPLETED|Overall Study||10
7675749|NCT01965366|18901846|P2|COMPLETED|Overall Study||9
7675750|NCT01965366|18901847|P1|COMPLETED|Overall Study||3
7675751|NCT01965366|18901846|P2|STARTED|Overall Study||14
7675752|NCT01965366|18901847|P1|STARTED|Overall Study||13
7675753|NCT01965327|18901855|P1|NOT COMPLETED|Overall Study||2
7675754|NCT01965327|18901855|P1|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10
7675755|NCT01965327|18901855|P1|STARTED|Overall Study||12
7675756|NCT01965288|18901862|P2|NOT COMPLETED|Overall Study||0
7675757|NCT01965288|18901863|P1|NOT COMPLETED|Overall Study||0
7675758|NCT01965288|18901862|P2|COMPLETED|Overall Study||30
7675759|NCT01965288|18901863|P1|COMPLETED|Overall Study||30
7675760|NCT01965288|18901862|P2|STARTED|Overall Study||30
7675761|NCT01965288|18901863|P1|STARTED|Overall Study||30
7675762|NCT01965262|18902069|P2|NOT COMPLETED|Second Intervention (7 Days)||10
7675763|NCT01965262|18902070|P1|NOT COMPLETED|Second Intervention (7 Days)||1
7675764|NCT01965262|18902069|P2|COMPLETED|Second Intervention (7 Days)||5
7675765|NCT01965262|18902070|P1|COMPLETED|Second Intervention (7 Days)||14
7675766|NCT01965262|18902069|P2|STARTED|Second Intervention (7 Days)||15
7675767|NCT01965262|18902070|P1|STARTED|Second Intervention (7 Days)||15
7675768|NCT01965262|18902069|P2|NOT COMPLETED|First Intervention (7 Days)||0
7675769|NCT01965262|18902070|P1|NOT COMPLETED|First Intervention (7 Days)||0
7675770|NCT01965262|18902069|P2|COMPLETED|First Intervention (7 Days)||15
7675771|NCT01965262|18902070|P1|COMPLETED|First Intervention (7 Days)||15
7675772|NCT01965262|18902069|P2|STARTED|First Intervention (7 Days)||15
7675773|NCT01965262|18902070|P1|STARTED|First Intervention (7 Days)||15
7675774|NCT01965158|18902134|P2|NOT COMPLETED|Overall Study||35
7675775|NCT01965158|18902135|P1|NOT COMPLETED|Overall Study||41
7675776|NCT01965158|18902134|P2|COMPLETED|Overall Study||238
7675777|NCT01965158|18902135|P1|COMPLETED|Overall Study||233
7675778|NCT01965158|18902134|P2|Received Treatment|Overall Study||273
7675779|NCT01965158|18902135|P1|Received Treatment|Overall Study||272
7675780|NCT01965158|18902134|P2|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|273
7675781|NCT01965158|18902135|P1|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|274
7675782|NCT01965067|18902151|P2|NOT COMPLETED|Overall Study||0
7675783|NCT01965067|18902152|P1|NOT COMPLETED|Overall Study||0
7675784|NCT01965067|18902151|P2|COMPLETED|Overall Study||30
7675785|NCT01965067|18902152|P1|COMPLETED|Overall Study||30
7675786|NCT01965067|18902151|P2|STARTED|Overall Study||30
7675788|NCT01965002|18902168|P1|NOT COMPLETED|Overall Study||0
7675789|NCT01965002|18902168|P1|COMPLETED|Overall Study||5
7675790|NCT01965002|18902168|P1|STARTED|Overall Study||5
7675791|NCT01964976|18902176|P1|NOT COMPLETED|Overall Study||31
7675792|NCT01964976|18902176|P1|COMPLETED|Overall Study||1065
7675793|NCT01964976|18902176|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1096
7675794|NCT01964963|18902188|P1|NOT COMPLETED|Overall Study||943
7675795|NCT01964963|18902188|P1|COMPLETED|Overall Study||18249
7675796|NCT01964963|18902188|P1|STARTED|Overall Study||19192
7675797|NCT01964950|18902196|P1|NOT COMPLETED|Overall Study||25
7675798|NCT01964950|18902196|P1|COMPLETED|Overall Study||1076
7675799|NCT01964950|18902196|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1101
7675800|NCT01964924|18902208|P2|NOT COMPLETED|Trametinib + GSK2141||0
7675801|NCT01964924|18902209|P1|NOT COMPLETED|Trametinib + GSK2141||0
7675802|NCT01964924|18902208|P2|COMPLETED|Trametinib + GSK2141||19
7675803|NCT01964924|18902209|P1|COMPLETED|Trametinib + GSK2141||0
7675804|NCT01964924|18902208|P2|STARTED|Trametinib + GSK2141|Progressed in Part 1 and therefore initiated combination treatment in Part 2|19
7675805|NCT01964924|18902209|P1|STARTED|Trametinib + GSK2141||0
7675806|NCT01964924|18902208|P2|NOT COMPLETED|Trametinib Monotherapy||0
7675807|NCT01964924|18902209|P1|NOT COMPLETED|Trametinib Monotherapy||19
7675808|NCT01964924|18902208|P2|COMPLETED|Trametinib Monotherapy||0
7675809|NCT01964924|18902209|P1|COMPLETED|Trametinib Monotherapy||18
7675810|NCT01964924|18902208|P2|STARTED|Trametinib Monotherapy||0
7675811|NCT01964924|18902209|P1|STARTED|Trametinib Monotherapy||37
7675812|NCT01964898|18902233|P2|NOT COMPLETED|Overall Study||7
7675813|NCT01964898|18902234|P1|NOT COMPLETED|Overall Study||7
7675814|NCT01964898|18902233|P2|COMPLETED|Overall Study||26
7675815|NCT01964898|18902234|P1|COMPLETED|Overall Study||24
7675816|NCT01964898|18902233|P2|12 Week Assessment|Overall Study||30
7675817|NCT01964898|18902234|P1|12 Week Assessment|Overall Study||25
7675818|NCT01964898|18902233|P2|STARTED|Overall Study||33
7675819|NCT01964898|18902234|P1|STARTED|Overall Study||31
7675820|NCT01964755|18902254|P1|NOT COMPLETED|Overall Study||2
7675821|NCT01964755|18902254|P1|COMPLETED|Overall Study||4
7675822|NCT01964755|18902254|P1|Cycle 5|Overall Study||4
7675823|NCT01964755|18902254|P1|Cycle 4|Overall Study||4
7675824|NCT01964755|18902254|P1|Cycle 3|Overall Study||4
7675825|NCT01964755|18902254|P1|Cycle 2|Overall Study||5
7675826|NCT01964755|18902254|P1|STARTED|Overall Study||6
7675827|NCT01964716|18902269|P2|NOT COMPLETED|Overall Study||6
7675828|NCT01964716|18902270|P1|NOT COMPLETED|Overall Study||5
7675829|NCT01964716|18902269|P2|COMPLETED|Overall Study||244
7675830|NCT01964716|18902270|P1|COMPLETED|Overall Study||245
7675831|NCT01964716|18902269|P2|Vaccinated Dose 3|Overall Study||244
7675832|NCT01964716|18902270|P1|Vaccinated Dose 3|Overall Study||247
7675833|NCT01964716|18902269|P2|Vaccinated Dose 2|Overall Study||248
7675834|NCT01964716|18902270|P1|Vaccinated Dose 2|Overall Study||249
7675835|NCT01964716|18902269|P2|Vaccinated Dose 1|Overall Study||250
7675836|NCT01964716|18902270|P1|Vaccinated Dose 1|Overall Study||250
7675837|NCT01964716|18902269|P2|STARTED|Overall Study||250
7675838|NCT01964716|18902270|P1|STARTED|Overall Study||250
7675839|NCT01964547|18902308|P2|NOT COMPLETED|Overall Study||11
7675840|NCT01964547|18902309|P1|NOT COMPLETED|Overall Study||12
7675841|NCT01964547|18902308|P2|COMPLETED|Overall Study||48
7675842|NCT01964547|18902309|P1|COMPLETED|Overall Study||50
7675843|NCT01964547|18902308|P2|STARTED|Overall Study||59
7675844|NCT01964547|18902309|P1|STARTED|Overall Study||62
7675845|NCT01964521|18902333|P1|NOT COMPLETED|Overall Study||4
7675846|NCT01964521|18902333|P1|COMPLETED|Overall Study||20
7675847|NCT01964521|18902333|P1|STARTED|Overall Study||24
7675848|NCT01964430|18902340|P2|NOT COMPLETED|Overall Study||124
7675849|NCT01964430|18902341|P1|NOT COMPLETED|Overall Study||145
7675850|NCT01964430|18902340|P2|COMPLETED|Overall Study||310
7675851|NCT01964430|18902341|P1|COMPLETED|Overall Study||287
7675852|NCT01964430|18902340|P2|Treated Population|Overall Study||423
7675853|NCT01964430|18902341|P1|Treated Population|Overall Study||429
7675854|NCT01964430|18902340|P2|STARTED|Overall Study||434
7675855|NCT01964430|18902341|P1|STARTED|Overall Study||432
7675856|NCT01964378|18902353|P2|NOT COMPLETED|Overall Study||21
7675857|NCT01964378|18902354|P1|NOT COMPLETED|Overall Study||25
7675858|NCT01964378|18902353|P2|COMPLETED|Overall Study||45
7675859|NCT01964378|18902354|P1|COMPLETED|Overall Study||41
7675860|NCT01964378|18902353|P2|Participants Treated (Safety Set)|Overall Study|"4 Participants died during treatment, hereof 2 with withdrawal... as primary reason for discont."|61
7675861|NCT01964378|18902354|P1|Participants Treated (Safety Set)|Overall Study||65
7675862|NCT01964378|18902353|P2|STARTED|Overall Study||66
7675863|NCT01964378|18902354|P1|STARTED|Overall Study||66
7675864|NCT01964352|18902390|P4|NOT COMPLETED|Overall Study||8
7675865|NCT01964352|18902391|P3|NOT COMPLETED|Overall Study||6
7675866|NCT01964352|18902392|P2|NOT COMPLETED|Overall Study||11
7675867|NCT01964352|18902393|P1|NOT COMPLETED|Overall Study||26
7675868|NCT01964352|18902390|P4|COMPLETED|Overall Study||195
7675869|NCT01964352|18902391|P3|COMPLETED|Overall Study||196
7675870|NCT01964352|18902392|P2|COMPLETED|Overall Study||192
7675871|NCT01964352|18902393|P1|COMPLETED|Overall Study||178
7675872|NCT01964352|18902390|P4|STARTED|Overall Study||203
7675873|NCT01964352|18902391|P3|STARTED|Overall Study||202
7675874|NCT01964352|18902392|P2|STARTED|Overall Study||203
7675875|NCT01964352|18902393|P1|STARTED|Overall Study||204
7675876|NCT01964326|18902423|P1|NOT COMPLETED|Overall Study||297
7675877|NCT01964326|18902423|P1|COMPLETED|Overall Study||1014
7675878|NCT01964326|18902423|P1|STARTED|Overall Study||1311
7675879|NCT01964300|18902432|P2|NOT COMPLETED|Overall Study||11
7675880|NCT01964300|18902433|P1|NOT COMPLETED|Overall Study||6
7675881|NCT01964300|18902432|P2|COMPLETED|Overall Study||1
7675882|NCT01964300|18902433|P1|COMPLETED|Overall Study||1
7675883|NCT01964300|18902432|P2|STARTED|Overall Study||12
7675884|NCT01964300|18902433|P1|STARTED|Overall Study||7
7675885|NCT01964222|18902447|P2|NOT COMPLETED|Overall Study||11
7675886|NCT01964222|18902448|P1|NOT COMPLETED|Overall Study||15
7675887|NCT01964222|18902447|P2|COMPLETED|Overall Study||89
7675888|NCT01964222|18902448|P1|COMPLETED|Overall Study||86
7675889|NCT01964222|18902447|P2|STARTED|Overall Study||100
7675890|NCT01964222|18902448|P1|STARTED|Overall Study||101
7675891|NCT01964105|18902465|P3|NOT COMPLETED|Overall Study||0
7675892|NCT01964105|18902466|P2|NOT COMPLETED|Overall Study||13
7675893|NCT01964105|18902467|P1|NOT COMPLETED|Overall Study||2
7675894|NCT01964105|18902465|P3|COMPLETED|Overall Study||10
7675895|NCT01964105|18902466|P2|COMPLETED|Overall Study||62
7675896|NCT01964105|18902467|P1|COMPLETED|Overall Study||13
7675897|NCT01964105|18902465|P3|STARTED|Overall Study||10
7675898|NCT01964105|18902466|P2|STARTED|Overall Study||75
7675899|NCT01964105|18902467|P1|STARTED|Overall Study||15
7675900|NCT01964092|18902477|P2|NOT COMPLETED|Overall Study||0
7675901|NCT01964092|18902478|P1|NOT COMPLETED|Overall Study||2
7675902|NCT01964092|18902477|P2|COMPLETED|Overall Study||181
7675903|NCT01964092|18902478|P1|COMPLETED|Overall Study||227
7675904|NCT01964092|18902477|P2|STARTED|Overall Study||181
7675905|NCT01964092|18902478|P1|STARTED|Overall Study||229
7675906|NCT01963923|18902486|P2|NOT COMPLETED|3 Months Post-surgery||1
7675907|NCT01963923|18902487|P1|NOT COMPLETED|3 Months Post-surgery||2
7675908|NCT01963923|18902486|P2|COMPLETED|3 Months Post-surgery||9
7675909|NCT01963923|18902487|P1|COMPLETED|3 Months Post-surgery||10
7675910|NCT01963923|18902486|P2|STARTED|3 Months Post-surgery||10
7675911|NCT01963923|18902487|P1|STARTED|3 Months Post-surgery||12
7675912|NCT01963923|18902486|P2|NOT COMPLETED|3 Weeks Post-surgery||10
7675913|NCT01963923|18902487|P1|NOT COMPLETED|3 Weeks Post-surgery||8
7675914|NCT01963923|18902486|P2|COMPLETED|3 Weeks Post-surgery||10
7675915|NCT01963923|18902487|P1|COMPLETED|3 Weeks Post-surgery||12
7675916|NCT01963923|18902486|P2|STARTED|3 Weeks Post-surgery||20
7675917|NCT01963923|18902487|P1|STARTED|3 Weeks Post-surgery||20
7675918|NCT01963845|18902509|P2|NOT COMPLETED|Overall Study||0
7675919|NCT01963845|18902510|P1|NOT COMPLETED|Overall Study||0
7675920|NCT01963845|18902509|P2|COMPLETED|Overall Study||25
7675921|NCT01963845|18902510|P1|COMPLETED|Overall Study||25
7675922|NCT01963845|18902509|P2|STARTED|Overall Study||25
7675923|NCT01963845|18902510|P1|STARTED|Overall Study||25
7675924|NCT01963767|18902526|P2|NOT COMPLETED|Overall Study||2
7675925|NCT01963767|18902527|P1|NOT COMPLETED|Overall Study||6
7675926|NCT01963767|18902526|P2|COMPLETED|Overall Study||53
7675927|NCT01963767|18902527|P1|COMPLETED|Overall Study||52
7675928|NCT01963767|18902526|P2|STARTED|Overall Study||55
7675929|NCT01963767|18902527|P1|STARTED|Overall Study||58
7675930|NCT01963676|18902537|P2|NOT COMPLETED|Overall Study||0
7675931|NCT01963676|18902538|P1|NOT COMPLETED|Overall Study||1
7675932|NCT01963676|18902537|P2|COMPLETED|Overall Study||13
7675933|NCT01963676|18902538|P1|COMPLETED|Overall Study||13
7675934|NCT01963676|18902537|P2|STARTED|Overall Study||13
7675935|NCT01963676|18902538|P1|STARTED|Overall Study||14
7675936|NCT01963611|18902551|P5|NOT COMPLETED|Overall Study||51
7675937|NCT01963611|18902552|P4|NOT COMPLETED|Overall Study||52
7675938|NCT01963611|18902553|P3|NOT COMPLETED|Overall Study||52
7675939|NCT01963611|18902554|P2|NOT COMPLETED|Overall Study||49
7675940|NCT01963611|18902555|P1|NOT COMPLETED|Overall Study||51
7675941|NCT01963611|18902551|P5|COMPLETED|Overall Study||0
7675942|NCT01963611|18902552|P4|COMPLETED|Overall Study||0
7675943|NCT01963611|18902553|P3|COMPLETED|Overall Study||0
7675944|NCT01963611|18902554|P2|COMPLETED|Overall Study||0
7675945|NCT01963611|18902555|P1|COMPLETED|Overall Study||0
7675946|NCT01963611|18902551|P5|Safety Analysis Set|Overall Study||50
7675947|NCT01963611|18902552|P4|Safety Analysis Set|Overall Study||52
7675948|NCT01963611|18902553|P3|Safety Analysis Set|Overall Study||52
7675949|NCT01963611|18902554|P2|Safety Analysis Set|Overall Study||49
7675950|NCT01963611|18902555|P1|Safety Analysis Set|Overall Study||51
7675951|NCT01963611|18902551|P5|STARTED|Overall Study||51
7675952|NCT01963611|18902552|P4|STARTED|Overall Study||52
7675953|NCT01963611|18902553|P3|STARTED|Overall Study||52
7675954|NCT01963611|18902554|P2|STARTED|Overall Study||49
7675955|NCT01963611|18902555|P1|STARTED|Overall Study||51
7675956|NCT01963481|18902612|P1|NOT COMPLETED|Overall Study||0
7675957|NCT01963481|18902612|P1|COMPLETED|Overall Study||23
7675958|NCT01963481|18902612|P1|STARTED|Overall Study||23
7675959|NCT01963403|18902620|P2|NOT COMPLETED|Overall Study||4
7675960|NCT01963403|18902621|P1|NOT COMPLETED|Overall Study||2
7675961|NCT01963403|18902620|P2|COMPLETED|Overall Study|Follow-up over three months|9
7675962|NCT01963403|18902621|P1|COMPLETED|Overall Study|Follow-up over three months|11
7675963|NCT01963403|18902620|P2|STARTED|Overall Study||13
7675964|NCT01963403|18902621|P1|STARTED|Overall Study||13
7675965|NCT01963260|18902643|P10|NOT COMPLETED|Overall Study||0
7675966|NCT01963260|18902644|P9|NOT COMPLETED|Overall Study||0
7675967|NCT01963260|18902645|P8|NOT COMPLETED|Overall Study||0
7675968|NCT01963260|18902646|P7|NOT COMPLETED|Overall Study||0
7675969|NCT01963260|18902647|P6|NOT COMPLETED|Overall Study||0
7675970|NCT01963260|18902648|P5|NOT COMPLETED|Overall Study||2
7675971|NCT01963260|18902649|P4|NOT COMPLETED|Overall Study||1
7675972|NCT01963260|18902650|P3|NOT COMPLETED|Overall Study||0
7675973|NCT01963260|18902651|P2|NOT COMPLETED|Overall Study||0
7675974|NCT01963260|18902652|P1|NOT COMPLETED|Overall Study||2
7675975|NCT01963260|18902643|P10|COMPLETED|Overall Study||4
7675976|NCT01963260|18902644|P9|COMPLETED|Overall Study||1
7675977|NCT01963260|18902645|P8|COMPLETED|Overall Study||2
7675978|NCT01963260|18902646|P7|COMPLETED|Overall Study||3
7675979|NCT01963260|18902647|P6|COMPLETED|Overall Study||10
7675980|NCT01963260|18902648|P5|COMPLETED|Overall Study||4
7675981|NCT01963260|18902649|P4|COMPLETED|Overall Study||5
7675982|NCT01963260|18902650|P3|COMPLETED|Overall Study||6
7675983|NCT01963260|18902651|P2|COMPLETED|Overall Study||6
7675984|NCT01963260|18902652|P1|COMPLETED|Overall Study||4
7675985|NCT01963260|18902643|P10|Treated|Overall Study||4
7675986|NCT01963260|18902644|P9|Treated|Overall Study||1
7675987|NCT01963260|18902645|P8|Treated|Overall Study||2
7675988|NCT01963260|18902646|P7|Treated|Overall Study||3
7675989|NCT01963260|18902647|P6|Treated|Overall Study||10
7675990|NCT01963260|18902648|P5|Treated|Overall Study||6
7675991|NCT01963260|18902649|P4|Treated|Overall Study||6
7675992|NCT01963260|18902650|P3|Treated|Overall Study||6
7675993|NCT01963260|18902651|P2|Treated|Overall Study||6
7675994|NCT01963260|18902652|P1|Treated|Overall Study||6
7675995|NCT01963260|18902643|P10|STARTED|Overall Study||4
7675996|NCT01963260|18902644|P9|STARTED|Overall Study||1
7675997|NCT01963260|18902645|P8|STARTED|Overall Study||2
7675998|NCT01963260|18902646|P7|STARTED|Overall Study||3
7675999|NCT01963260|18902647|P6|STARTED|Overall Study||10
7676000|NCT01963260|18902648|P5|STARTED|Overall Study||6
7676001|NCT01963260|18902649|P4|STARTED|Overall Study||6
7676002|NCT01963260|18902650|P3|STARTED|Overall Study||6
7676003|NCT01963260|18902651|P2|STARTED|Overall Study||6
7676004|NCT01963260|18902652|P1|STARTED|Overall Study||6
7676005|NCT01963234|18902707|P2|NOT COMPLETED|Overall Study||0
7676006|NCT01963234|18902708|P1|NOT COMPLETED|Overall Study||61
7676007|NCT01963234|18902707|P2|COMPLETED|Overall Study||171
7676008|NCT01963234|18902708|P1|COMPLETED|Overall Study||207
7676009|NCT01963234|18902707|P2|STARTED|Overall Study||171
7676010|NCT01963234|18902708|P1|STARTED|Overall Study||268
7676011|NCT01963169|18902735|P3|NOT COMPLETED|Overall Study||26
7676012|NCT01963169|18902736|P2|NOT COMPLETED|Overall Study||82
7676013|NCT01963169|18902737|P1|NOT COMPLETED|Overall Study||59
7676014|NCT01963169|18902735|P3|COMPLETED|Overall Study||237
7676015|NCT01963169|18902736|P2|COMPLETED|Overall Study||220
7676016|NCT01963169|18902737|P1|COMPLETED|Overall Study||242
7676017|NCT01963169|18902735|P3|STARTED|Overall Study||263
7676018|NCT01963169|18902736|P2|STARTED|Overall Study||302
7676019|NCT01963169|18902737|P1|STARTED|Overall Study||301
7676020|NCT01963143|18902754|P3|NOT COMPLETED|Overall Study||1
7676021|NCT01963143|18902755|P2|NOT COMPLETED|Overall Study||1
7676022|NCT01963143|18902756|P1|NOT COMPLETED|Overall Study||0
7676023|NCT01963143|18902754|P3|COMPLETED|Overall Study||14
7676024|NCT01963143|18902755|P2|COMPLETED|Overall Study||18
7676025|NCT01963143|18902756|P1|COMPLETED|Overall Study||14
7676026|NCT01963143|18902754|P3|STARTED|Overall Study||15
7676027|NCT01963143|18902755|P2|STARTED|Overall Study||19
7676028|NCT01963143|18902756|P1|STARTED|Overall Study||14
7676029|NCT01963117|18902766|P1|NOT COMPLETED|Overall Study||1
7676030|NCT01963117|18902766|P1|COMPLETED|Overall Study||10
7676031|NCT01963117|18902766|P1|STARTED|Overall Study||11
7676032|NCT01963091|18902777|P2|NOT COMPLETED|Overall Study||0
7676033|NCT01963091|18902778|P1|NOT COMPLETED|Overall Study||0
7676034|NCT01963091|18902777|P2|COMPLETED|Overall Study||16
7676035|NCT01963091|18902778|P1|COMPLETED|Overall Study||17
7676036|NCT01963091|18902777|P2|STARTED|Overall Study||16
7676037|NCT01963091|18902778|P1|STARTED|Overall Study||17
7676038|NCT01963078|18902792|P4|NOT COMPLETED|Overall Study||2
7676039|NCT01963078|18902793|P3|NOT COMPLETED|Overall Study||1
7676040|NCT01963078|18902794|P2|NOT COMPLETED|Overall Study||1
7676041|NCT01963078|18902795|P1|NOT COMPLETED|Overall Study||1
7676042|NCT01963078|18902792|P4|COMPLETED|Overall Study||7
7676043|NCT01963078|18902793|P3|COMPLETED|Overall Study||9
7676044|NCT01963078|18902794|P2|COMPLETED|Overall Study||9
7676045|NCT01963078|18902795|P1|COMPLETED|Overall Study||8
7676046|NCT01963078|18902792|P4|STARTED|Overall Study||9
7676047|NCT01963078|18902793|P3|STARTED|Overall Study||10
7676048|NCT01963078|18902794|P2|STARTED|Overall Study||10
7676049|NCT01963078|18902795|P1|STARTED|Overall Study||9
7676050|NCT01962987|18902808|P3|NOT COMPLETED|Overall Study||12
7676051|NCT01962987|18902809|P2|NOT COMPLETED|Overall Study||28
7676052|NCT01962987|18902810|P1|NOT COMPLETED|Overall Study||30
7676053|NCT01962987|18902808|P3|COMPLETED|Overall Study||83
7676054|NCT01962987|18902809|P2|COMPLETED|Overall Study||163
7676055|NCT01962987|18902810|P1|COMPLETED|Overall Study||160
7676056|NCT01962987|18902808|P3|STARTED|Overall Study||95
7676057|NCT01962987|18902809|P2|STARTED|Overall Study||191
7676058|NCT01962987|18902810|P1|STARTED|Overall Study||190
7676059|NCT01962974|18902818|P1|NOT COMPLETED|Overall Study||7
7676060|NCT01962974|18902818|P1|COMPLETED|Overall Study||0
7676061|NCT01962974|18902818|P1|STARTED|Overall Study||7
7676062|NCT01962961|18902827|P3|NOT COMPLETED|Overall Study||1
7676063|NCT01962961|18902828|P2|NOT COMPLETED|Overall Study||1
7676064|NCT01962961|18902829|P1|NOT COMPLETED|Overall Study||0
7676065|NCT01962961|18902827|P3|COMPLETED|Overall Study||6
7676066|NCT01962961|18902828|P2|COMPLETED|Overall Study||7
7676067|NCT01962961|18902829|P1|COMPLETED|Overall Study||9
7676068|NCT01962961|18902827|P3|STARTED|Overall Study||7
7676069|NCT01962961|18902828|P2|STARTED|Overall Study||8
7676070|NCT01962961|18902829|P1|STARTED|Overall Study||9
7676071|NCT01962922|18902845|P2|NOT COMPLETED|Extendion Portion (up to Month 6)||3
7676072|NCT01962922|18902846|P1|NOT COMPLETED|Extendion Portion (up to Month 6)||5
7676073|NCT01962922|18902845|P2|COMPLETED|Extendion Portion (up to Month 6)||20
7676074|NCT01962922|18902846|P1|COMPLETED|Extendion Portion (up to Month 6)||18
7676075|NCT01962922|18902845|P2|STARTED|Extendion Portion (up to Month 6)||23
7676076|NCT01962922|18902846|P1|STARTED|Extendion Portion (up to Month 6)||23
7676077|NCT01962922|18902845|P2|NOT COMPLETED|PK Portion Day 21||0
7676078|NCT01962922|18902846|P1|NOT COMPLETED|PK Portion Day 21||0
7676079|NCT01962922|18902845|P2|COMPLETED|PK Portion Day 21||23
7676080|NCT01962922|18902846|P1|COMPLETED|PK Portion Day 21||23
7676081|NCT01962922|18902845|P2|STARTED|PK Portion Day 21||23
7676082|NCT01962922|18902846|P1|STARTED|PK Portion Day 21||23
7676083|NCT01962922|18902845|P2|NOT COMPLETED|PK Portion Day 14||0
7676084|NCT01962922|18902846|P1|NOT COMPLETED|PK Portion Day 14||0
7676085|NCT01962922|18902845|P2|COMPLETED|PK Portion Day 14||23
7676086|NCT01962922|18902846|P1|COMPLETED|PK Portion Day 14||23
7676087|NCT01962922|18902845|P2|STARTED|PK Portion Day 14||23
7676088|NCT01962922|18902846|P1|STARTED|PK Portion Day 14||23
7676089|NCT01962922|18902845|P2|NOT COMPLETED|PK Portion Day 7||0
7676090|NCT01962922|18902846|P1|NOT COMPLETED|PK Portion Day 7||4
7676091|NCT01962922|18902845|P2|COMPLETED|PK Portion Day 7||23
7676092|NCT01962922|18902846|P1|COMPLETED|PK Portion Day 7||23
7676093|NCT01962922|18902845|P2|STARTED|PK Portion Day 7||23
7676094|NCT01962922|18902846|P1|STARTED|PK Portion Day 7||27
7676095|NCT01962896|18902868|P1|NOT COMPLETED|Overall Study||4
7676096|NCT01962896|18902868|P1|COMPLETED|Overall Study||0
7676097|NCT01962896|18902868|P1|STARTED|Overall Study||4
7676098|NCT01962870|18902877|P2|NOT COMPLETED|Overall Study||0
7676099|NCT01962870|18902878|P1|NOT COMPLETED|Overall Study||0
7676100|NCT01962870|18902877|P2|COMPLETED|Overall Study||17
7676101|NCT01962870|18902878|P1|COMPLETED|Overall Study||13
7676102|NCT01962870|18902877|P2|STARTED|Overall Study||17
7676103|NCT01962870|18902878|P1|STARTED|Overall Study||13
7676104|NCT01962714|18902926|P2|NOT COMPLETED|Overall Study||33
7676105|NCT01962714|18902927|P1|NOT COMPLETED|Overall Study||30
7676106|NCT01962714|18902926|P2|COMPLETED|Overall Study||60
7676107|NCT01962714|18902927|P1|COMPLETED|Overall Study||61
7676108|NCT01962714|18902926|P2|3-month Follow-up|Overall Study||56
7676109|NCT01962714|18902927|P1|3-month Follow-up|Overall Study||58
7676110|NCT01962714|18902926|P2|Immediate Post-treatment Assessment|Overall Study||57
7676111|NCT01962714|18902927|P1|Immediate Post-treatment Assessment|Overall Study||63
7676112|NCT01962714|18902926|P2|STARTED|Overall Study||93
7676113|NCT01962714|18902927|P1|STARTED|Overall Study||91
7676114|NCT01962688|18902937|P2|NOT COMPLETED|Overall Study||0
7676115|NCT01962688|18902938|P1|NOT COMPLETED|Overall Study||0
7676116|NCT01962688|18902937|P2|COMPLETED|Overall Study||18
7676117|NCT01962688|18902938|P1|COMPLETED|Overall Study||19
7676118|NCT01962688|18902937|P2|STARTED|Overall Study||18
7676119|NCT01962688|18902938|P1|STARTED|Overall Study||19
7676120|NCT01962675|18902956|P2|NOT COMPLETED|Overall Study||0
7676121|NCT01962675|18902957|P1|NOT COMPLETED|Overall Study||0
7676122|NCT01962675|18902956|P2|COMPLETED|Overall Study||7
7676123|NCT01962675|18902957|P1|COMPLETED|Overall Study||7
7676124|NCT01962675|18902956|P2|STARTED|Overall Study||7
7676125|NCT01962675|18902957|P1|STARTED|Overall Study||7
7676126|NCT01962558|18902971|P2|NOT COMPLETED|Overall Study||0
7676127|NCT01962558|18902972|P1|NOT COMPLETED|Overall Study||0
7676128|NCT01962558|18902971|P2|COMPLETED|Overall Study||14
7676129|NCT01962558|18902972|P1|COMPLETED|Overall Study||16
7676130|NCT01962558|18902971|P2|12-Weeks|Overall Study||14
7676131|NCT01962558|18902972|P1|12-Weeks|Overall Study||16
7676132|NCT01962558|18902971|P2|Acute Study|Overall Study||14
7676133|NCT01962558|18902972|P1|Acute Study|Overall Study||16
7676134|NCT01962558|18902971|P2|STARTED|Overall Study||14
7676135|NCT01962558|18902972|P1|STARTED|Overall Study||16
7676136|NCT01962493|18902990|P2|NOT COMPLETED|Overall Study||5
7676137|NCT01962493|18902991|P1|NOT COMPLETED|Overall Study||5
7676138|NCT01962493|18902990|P2|COMPLETED|Overall Study||77
7676139|NCT01962493|18902991|P1|COMPLETED|Overall Study||73
7676140|NCT01962493|18902990|P2|STARTED|Overall Study||82
7676141|NCT01962493|18902991|P1|STARTED|Overall Study||78
7676142|NCT01962441|18903014|P3|NOT COMPLETED|Retreatment Substudy||0
7676143|NCT01962441|18903015|P2|NOT COMPLETED|Retreatment Substudy||0
7676144|NCT01962441|18903016|P1|NOT COMPLETED|Retreatment Substudy||2
7676145|NCT01962441|18903014|P3|COMPLETED|Retreatment Substudy||0
7676146|NCT01962441|18903015|P2|COMPLETED|Retreatment Substudy||10
7676147|NCT01962441|18903016|P1|COMPLETED|Retreatment Substudy||18
7676148|NCT01962441|18903014|P3|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0
7676149|NCT01962441|18903015|P2|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10
7676150|NCT01962441|18903016|P1|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20
7676151|NCT01962441|18903014|P3|NOT COMPLETED|Randomized Period||11
7676152|NCT01962441|18903015|P2|NOT COMPLETED|Randomized Period||11
7676153|NCT01962441|18903016|P1|NOT COMPLETED|Randomized Period||10
7676154|NCT01962441|18903014|P3|COMPLETED|Randomized Period||189
7676155|NCT01962441|18903015|P2|COMPLETED|Randomized Period||190
7676156|NCT01962441|18903016|P1|COMPLETED|Randomized Period||190
7676157|NCT01962441|18903014|P3|STARTED|Randomized Period||200
7676158|NCT01962441|18903015|P2|STARTED|Randomized Period||201
7676159|NCT01962441|18903016|P1|STARTED|Randomized Period||200
7676160|NCT01962428|18903048|P2|NOT COMPLETED|Overall Study||6
7676161|NCT01962428|18903049|P1|NOT COMPLETED|Overall Study||10
7676162|NCT01962428|18903048|P2|COMPLETED|Overall Study||133
7676163|NCT01962428|18903049|P1|COMPLETED|Overall Study||129
7676164|NCT01962428|18903048|P2|STARTED|Overall Study||139
7676165|NCT01962428|18903049|P1|STARTED|Overall Study||139
7676166|NCT01962298|18903060|P5|NOT COMPLETED|Overall Study||6
7676167|NCT01962298|18903061|P4|NOT COMPLETED|Overall Study||2
7676168|NCT01962298|18903062|P3|NOT COMPLETED|Overall Study||5
7676169|NCT01962298|18903063|P2|NOT COMPLETED|Overall Study||4
7676170|NCT01962298|18903064|P1|NOT COMPLETED|Overall Study||3
7676171|NCT01962298|18903060|P5|COMPLETED|Overall Study||9
7676172|NCT01962298|18903061|P4|COMPLETED|Overall Study||13
7676173|NCT01962298|18903062|P3|COMPLETED|Overall Study||10
7676174|NCT01962298|18903063|P2|COMPLETED|Overall Study||11
7676175|NCT01962298|18903064|P1|COMPLETED|Overall Study||12
7676176|NCT01962298|18903060|P5|Received Intervention|Overall Study||15
7676177|NCT01962298|18903061|P4|Received Intervention|Overall Study||15
7676178|NCT01962298|18903062|P3|Received Intervention|Overall Study||15
7676179|NCT01962298|18903063|P2|Received Intervention|Overall Study||15
7676180|NCT01962298|18903064|P1|Received Intervention|Overall Study|1 subject did not receive the planned intervention and received a different one for clinical reasons|14
7676181|NCT01962298|18903060|P5|STARTED|Overall Study||15
7676182|NCT01962298|18903061|P4|STARTED|Overall Study||15
7676183|NCT01962298|18903062|P3|STARTED|Overall Study||15
7676184|NCT01962298|18903063|P2|STARTED|Overall Study||15
7676185|NCT01962298|18903064|P1|STARTED|Overall Study||15
7676186|NCT01962207|18903085|P4|NOT COMPLETED|Booster Phase (6 Months)||0
7676187|NCT01962207|18903086|P3|NOT COMPLETED|Booster Phase (6 Months)||0
7676188|NCT01962207|18903087|P2|NOT COMPLETED|Booster Phase (6 Months)||0
7676189|NCT01962207|18903088|P1|NOT COMPLETED|Booster Phase (6 Months)||0
7676190|NCT01962207|18903085|P4|COMPLETED|Booster Phase (6 Months)||21
7676191|NCT01962207|18903086|P3|COMPLETED|Booster Phase (6 Months)||77
7676192|NCT01962207|18903087|P2|COMPLETED|Booster Phase (6 Months)||16
7676193|NCT01962207|18903088|P1|COMPLETED|Booster Phase (6 Months)||67
7676194|NCT01962207|18903085|P4|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|21
7676195|NCT01962207|18903086|P3|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|77
7676196|NCT01962207|18903087|P2|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|16
7676197|NCT01962207|18903088|P1|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|67
7676198|NCT01962207|18903085|P4|NOT COMPLETED|Persistence Phase (5 Years)||12
7676199|NCT01962207|18903086|P3|NOT COMPLETED|Persistence Phase (5 Years)||44
7676200|NCT01962207|18903087|P2|NOT COMPLETED|Persistence Phase (5 Years)||13
7676201|NCT01962207|18903088|P1|NOT COMPLETED|Persistence Phase (5 Years)||29
7676202|NCT01962207|18903085|P4|COMPLETED|Persistence Phase (5 Years)||17
7676203|NCT01962207|18903086|P3|COMPLETED|Persistence Phase (5 Years)||71
7676204|NCT01962207|18903087|P2|COMPLETED|Persistence Phase (5 Years)||10
7676205|NCT01962207|18903088|P1|COMPLETED|Persistence Phase (5 Years)||47
7676206|NCT01962207|18903085|P4|STARTED|Persistence Phase (5 Years)||29
7676207|NCT01962207|18903086|P3|STARTED|Persistence Phase (5 Years)||115
7676208|NCT01962207|18903087|P2|STARTED|Persistence Phase (5 Years)||23
7676209|NCT01962207|18903088|P1|STARTED|Persistence Phase (5 Years)||76
7676210|NCT01962103|18903199|P9|NOT COMPLETED|Phase 2||14
7676211|NCT01962103|18903200|P8|NOT COMPLETED|Phase 2||14
7676212|NCT01962103|18903201|P7|NOT COMPLETED|Phase 2||14
7676213|NCT01962103|18903202|P6|NOT COMPLETED|Phase 2||0
7676214|NCT01962103|18903203|P5|NOT COMPLETED|Phase 2||0
7676215|NCT01962103|18903204|P4|NOT COMPLETED|Phase 2||0
7676216|NCT01962103|18903205|P3|NOT COMPLETED|Phase 2||0
7676217|NCT01962103|18903206|P2|NOT COMPLETED|Phase 2||0
7676218|NCT01962103|18903207|P1|NOT COMPLETED|Phase 2||0
7676219|NCT01962103|18903199|P9|COMPLETED|Phase 2|completed treatment|0
7676220|NCT01962103|18903200|P8|COMPLETED|Phase 2|completed treatment|0
7676221|NCT01962103|18903201|P7|COMPLETED|Phase 2|completed treatment|0
7676222|NCT01962103|18903202|P6|COMPLETED|Phase 2||0
7676223|NCT01962103|18903203|P5|COMPLETED|Phase 2||0
7676224|NCT01962103|18903204|P4|COMPLETED|Phase 2||0
7676225|NCT01962103|18903205|P3|COMPLETED|Phase 2||0
7676226|NCT01962103|18903206|P2|COMPLETED|Phase 2||0
7676227|NCT01962103|18903207|P1|COMPLETED|Phase 2||0
7676228|NCT01962103|18903199|P9|STARTED|Phase 2||14
7676229|NCT01962103|18903200|P8|STARTED|Phase 2||14
7676230|NCT01962103|18903201|P7|STARTED|Phase 2||14
7676231|NCT01962103|18903202|P6|STARTED|Phase 2||0
7676232|NCT01962103|18903203|P5|STARTED|Phase 2||0
7676233|NCT01962103|18903204|P4|STARTED|Phase 2||0
7676234|NCT01962103|18903205|P3|STARTED|Phase 2||0
7676235|NCT01962103|18903206|P2|STARTED|Phase 2||0
7676236|NCT01962103|18903207|P1|STARTED|Phase 2||0
7676237|NCT01962103|18903199|P9|NOT COMPLETED|Phase 1||0
7676238|NCT01962103|18903200|P8|NOT COMPLETED|Phase 1||0
7676239|NCT01962103|18903201|P7|NOT COMPLETED|Phase 1||0
7676240|NCT01962103|18903202|P6|NOT COMPLETED|Phase 1||7
7676241|NCT01962103|18903203|P5|NOT COMPLETED|Phase 1||8
7676242|NCT01962103|18903204|P4|NOT COMPLETED|Phase 1||11
7676243|NCT01962103|18903205|P3|NOT COMPLETED|Phase 1||14
7676244|NCT01962103|18903206|P2|NOT COMPLETED|Phase 1||8
7676245|NCT01962103|18903207|P1|NOT COMPLETED|Phase 1||16
7676246|NCT01962103|18903199|P9|COMPLETED|Phase 1||0
7676247|NCT01962103|18903200|P8|COMPLETED|Phase 1||0
7676248|NCT01962103|18903201|P7|COMPLETED|Phase 1||0
7676249|NCT01962103|18903202|P6|COMPLETED|Phase 1||0
7676250|NCT01962103|18903203|P5|COMPLETED|Phase 1||0
7676251|NCT01962103|18903204|P4|COMPLETED|Phase 1||0
7676252|NCT01962103|18903205|P3|COMPLETED|Phase 1||0
7676253|NCT01962103|18903206|P2|COMPLETED|Phase 1||0
7676254|NCT01962103|18903207|P1|COMPLETED|Phase 1||0
7676255|NCT01962103|18903199|P9|STARTED|Phase 1||0
7676256|NCT01962103|18903200|P8|STARTED|Phase 1||0
7676257|NCT01962103|18903201|P7|STARTED|Phase 1||0
7676258|NCT01962103|18903202|P6|STARTED|Phase 1||7
7676259|NCT01962103|18903203|P5|STARTED|Phase 1||8
7676260|NCT01962103|18903204|P4|STARTED|Phase 1||11
7676261|NCT01962103|18903205|P3|STARTED|Phase 1||14
7676262|NCT01962103|18903206|P2|STARTED|Phase 1||8
7676263|NCT01962103|18903207|P1|STARTED|Phase 1||16
7676264|NCT01962025|18903309|P2|NOT COMPLETED|Overall Study||0
7676265|NCT01962025|18903310|P1|NOT COMPLETED|Overall Study||0
7676266|NCT01962025|18903309|P2|COMPLETED|Overall Study||6
7676267|NCT01962025|18903310|P1|COMPLETED|Overall Study||8
7676268|NCT01962025|18903309|P2|STARTED|Overall Study||6
7676269|NCT01962025|18903310|P1|STARTED|Overall Study||8
7676270|NCT01961921|18903324|P1|NOT COMPLETED|Overall Study||2
7676271|NCT01961921|18903324|P1|COMPLETED|Overall Study||25
7676272|NCT01961921|18903324|P1|STARTED|Overall Study||27
7676273|NCT01961609|18903336|P4|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||7
7676274|NCT01961609|18903337|P3|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||4
7676275|NCT01961609|18903338|P2|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||6
7676276|NCT01961609|18903339|P1|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
7676277|NCT01961609|18903336|P4|COMPLETED|Maintanence 2 (Weeks 49 - 72)||17
7676278|NCT01961609|18903337|P3|COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
7676279|NCT01961609|18903338|P2|COMPLETED|Maintanence 2 (Weeks 49 - 72)||25
7676280|NCT01961609|18903339|P1|COMPLETED|Maintanence 2 (Weeks 49 - 72)||71
7676281|NCT01961609|18903336|P4|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||24
7676282|NCT01961609|18903337|P3|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||16
7676283|NCT01961609|18903338|P2|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||31
7676284|NCT01961609|18903339|P1|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||83
7676285|NCT01961609|18903336|P4|Safety Set|Maintanence 2 (Weeks 49 - 72)||24
7676286|NCT01961609|18903337|P3|Safety Set|Maintanence 2 (Weeks 49 - 72)||16
7676287|NCT01961609|18903338|P2|Safety Set|Maintanence 2 (Weeks 49 - 72)||31
7676288|NCT01961609|18903339|P1|Safety Set|Maintanence 2 (Weeks 49 - 72)||83
7676289|NCT01961609|18903336|P4|STARTED|Maintanence 2 (Weeks 49 - 72)||24
7676290|NCT01961609|18903337|P3|STARTED|Maintanence 2 (Weeks 49 - 72)||16
7676291|NCT01961609|18903338|P2|STARTED|Maintanence 2 (Weeks 49 - 72)||31
7676292|NCT01961609|18903339|P1|STARTED|Maintanence 2 (Weeks 49 - 72)||83
7676293|NCT01961609|18903336|P4|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
7676294|NCT01961609|18903337|P3|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||19
7676295|NCT01961609|18903338|P2|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||11
7676296|NCT01961609|18903339|P1|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||23
7676297|NCT01961609|18903336|P4|COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
7676298|NCT01961609|18903337|P3|COMPLETED|Maintenance 1 (Weeks 17 - 48)||18
7676299|NCT01961609|18903338|P2|COMPLETED|Maintenance 1 (Weeks 17 - 48)||55
7676300|NCT01961609|18903339|P1|COMPLETED|Maintenance 1 (Weeks 17 - 48)||84
7676301|NCT01961609|18903336|P4|Safety Set|Maintenance 1 (Weeks 17 - 48)||0
7676302|NCT01961609|18903337|P3|Safety Set|Maintenance 1 (Weeks 17 - 48)||37
7676303|NCT01961609|18903338|P2|Safety Set|Maintenance 1 (Weeks 17 - 48)||66
7676304|NCT01961609|18903339|P1|Safety Set|Maintenance 1 (Weeks 17 - 48)||107
7676305|NCT01961609|18903336|P4|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||0
7676306|NCT01961609|18903337|P3|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||37
7676307|NCT01961609|18903338|P2|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||66
7676308|NCT01961609|18903339|P1|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||107
7676309|NCT01961609|18903336|P4|STARTED|Maintenance 1 (Weeks 17 - 48)||0
7676310|NCT01961609|18903337|P3|STARTED|Maintenance 1 (Weeks 17 - 48)||37
7676311|NCT01961609|18903338|P2|STARTED|Maintenance 1 (Weeks 17 - 48)||66
7676312|NCT01961609|18903339|P1|STARTED|Maintenance 1 (Weeks 17 - 48)||107
7676313|NCT01961609|18903336|P4|NOT COMPLETED|Initiation||0
7676314|NCT01961609|18903337|P3|NOT COMPLETED|Initiation||0
7676315|NCT01961609|18903338|P2|NOT COMPLETED|Initiation||13
7676316|NCT01961609|18903339|P1|NOT COMPLETED|Initiation||12
7676317|NCT01961609|18903336|P4|COMPLETED|Initiation||0
7676318|NCT01961609|18903337|P3|COMPLETED|Initiation||0
7676319|NCT01961609|18903338|P2|COMPLETED|Initiation||103
7676320|NCT01961609|18903339|P1|COMPLETED|Initiation||107
7676321|NCT01961609|18903336|P4|Full Analysis Set|Initiation||0
7676322|NCT01961609|18903337|P3|Full Analysis Set|Initiation||0
7676323|NCT01961609|18903338|P2|Full Analysis Set|Initiation||115
7676324|NCT01961609|18903339|P1|Full Analysis Set|Initiation||118
7676325|NCT01961609|18903336|P4|Safety Set|Initiation||0
7676326|NCT01961609|18903337|P3|Safety Set|Initiation||0
7676327|NCT01961609|18903338|P2|Safety Set|Initiation||115
7676328|NCT01961609|18903339|P1|Safety Set|Initiation||118
7676329|NCT01961609|18903336|P4|STARTED|Initiation||0
7676330|NCT01961609|18903337|P3|STARTED|Initiation||0
7676331|NCT01961609|18903338|P2|STARTED|Initiation||116
7676332|NCT01961609|18903339|P1|STARTED|Initiation||119
7676333|NCT01961544|18903391|P1|NOT COMPLETED|Overall Study||13
7676334|NCT01961544|18903391|P1|COMPLETED|Overall Study||88
7676335|NCT01961544|18903391|P1|STARTED|Overall Study||101
7676336|NCT01961531|18903396|P1|NOT COMPLETED|Overall Study||0
7676337|NCT01961531|18903396|P1|COMPLETED|Overall Study||40
7676338|NCT01961531|18903396|P1|STARTED|Overall Study||40
7676339|NCT01961362|18903401|P1|NOT COMPLETED|Overall Study||0
7676340|NCT01961362|18903401|P1|COMPLETED|Overall Study||19
7676341|NCT01961362|18903401|P1|STARTED|Overall Study||19
7676342|NCT01961349|18903410|P3|NOT COMPLETED|Overall Study||2
7676343|NCT01961349|18903411|P2|NOT COMPLETED|Overall Study||6
7676344|NCT01961349|18903412|P1|NOT COMPLETED|Overall Study||3
7676345|NCT01961349|18903410|P3|COMPLETED|Overall Study||109
7676346|NCT01961349|18903411|P2|COMPLETED|Overall Study||101
7676347|NCT01961349|18903412|P1|COMPLETED|Overall Study||51
7676348|NCT01961349|18903410|P3|STARTED|Overall Study||111
7676349|NCT01961349|18903411|P2|STARTED|Overall Study||107
7676350|NCT01961349|18903412|P1|STARTED|Overall Study||54
7676351|NCT01961323|18903423|P1|NOT COMPLETED|Overall Study||49
7676352|NCT01961323|18903423|P1|COMPLETED|Overall Study||21
7676353|NCT01961323|18903423|P1|STARTED|Overall Study||70
7676354|NCT01961297|18903431|P2|NOT COMPLETED|Overall Study||1
7676355|NCT01961297|18903432|P1|NOT COMPLETED|Overall Study||2
7676356|NCT01961297|18903431|P2|COMPLETED|Overall Study||22
7676357|NCT01961297|18903432|P1|COMPLETED|Overall Study||28
7676358|NCT01961297|18903431|P2|STARTED|Overall Study||23
7676359|NCT01961297|18903432|P1|STARTED|Overall Study||30
7676360|NCT01961271|18903446|P1|NOT COMPLETED|Overall Study||50
7676361|NCT01961271|18903446|P1|COMPLETED|Overall Study||64
7676362|NCT01961271|18903446|P1|STARTED|Overall Study||114
7676363|NCT01961167|18903455|P1|NOT COMPLETED|Overall Study||0
7676364|NCT01961167|18903455|P1|COMPLETED|Overall Study||27
7676365|NCT01961167|18903455|P1|STARTED|Overall Study||27
7676366|NCT01961115|18903496|P3|NOT COMPLETED|Overall Study||4
7676367|NCT01961115|18903497|P2|NOT COMPLETED|Overall Study||0
7676368|NCT01961115|18903498|P1|NOT COMPLETED|Overall Study||2
7676369|NCT01961115|18903496|P3|COMPLETED|Overall Study||5
7676370|NCT01961115|18903497|P2|COMPLETED|Overall Study||0
7676371|NCT01961115|18903498|P1|COMPLETED|Overall Study||0
7676372|NCT01961115|18903496|P3|STARTED|Overall Study||9
7676373|NCT01961115|18903497|P2|STARTED|Overall Study||0
7676374|NCT01961115|18903498|P1|STARTED|Overall Study||2
7676375|NCT01961089|18903533|P1|NOT COMPLETED|Overall Study||0
7676376|NCT01961089|18903533|P1|COMPLETED|Overall Study||40
7676377|NCT01961089|18903533|P1|STARTED|Overall Study||40
7676378|NCT01960907|18903541|P2|NOT COMPLETED|Overall Study||45
7676379|NCT01960907|18903542|P1|NOT COMPLETED|Overall Study||36
7676380|NCT01960907|18903541|P2|COMPLETED|Overall Study||109
7676381|NCT01960907|18903542|P1|COMPLETED|Overall Study||122
7676382|NCT01960907|18903541|P2|STARTED|Overall Study||154
7676383|NCT01960907|18903542|P1|STARTED|Overall Study||158
7676384|NCT01960855|18903557|P5|NOT COMPLETED|Overall Study||5
7676385|NCT01960855|18903558|P4|NOT COMPLETED|Overall Study||4
7676386|NCT01960855|18903559|P3|NOT COMPLETED|Overall Study||9
7676387|NCT01960855|18903560|P2|NOT COMPLETED|Overall Study||4
7676388|NCT01960855|18903561|P1|NOT COMPLETED|Overall Study||11
7676389|NCT01960855|18903557|P5|COMPLETED|Overall Study||50
7676390|NCT01960855|18903558|P4|COMPLETED|Overall Study||51
7676391|NCT01960855|18903559|P3|COMPLETED|Overall Study||46
7676392|NCT01960855|18903560|P2|COMPLETED|Overall Study||51
7676393|NCT01960855|18903561|P1|COMPLETED|Overall Study||45
7676394|NCT01960855|18903557|P5|STARTED|Overall Study||55
7676395|NCT01960855|18903558|P4|STARTED|Overall Study||55
7676396|NCT01960855|18903559|P3|STARTED|Overall Study||55
7676397|NCT01960855|18903560|P2|STARTED|Overall Study||55
7676398|NCT01960855|18903561|P1|STARTED|Overall Study||56
7676399|NCT01960842|18903593|P1|NOT COMPLETED|Overall Study||3
7676400|NCT01960842|18903593|P1|COMPLETED|Overall Study||28
7676401|NCT01960842|18903593|P1|STARTED|Overall Study||31
7676402|NCT01960816|18903616|P1|NOT COMPLETED|Overall Study||1
7676403|NCT01960816|18903616|P1|COMPLETED|Overall Study||32
7676404|NCT01960816|18903616|P1|STARTED|Overall Study||33
7676405|NCT01960790|18903622|P1|NOT COMPLETED|Overall Study||11
7676406|NCT01960790|18903622|P1|COMPLETED|Overall Study||462
7676407|NCT01960790|18903622|P1|STARTED|Overall Study||473
7676408|NCT01960725|18903634|P2|NOT COMPLETED|Overall Study||5
7676409|NCT01960725|18903635|P1|NOT COMPLETED|Overall Study||6
7676410|NCT01960725|18903634|P2|COMPLETED|Overall Study||28
7676411|NCT01960725|18903635|P1|COMPLETED|Overall Study||27
7676412|NCT01960725|18903634|P2|Received Third Vaccine|Overall Study||32
7676413|NCT01960725|18903635|P1|Received Third Vaccine|Overall Study||32
7676414|NCT01960725|18903634|P2|Recieved Second Vaccine|Overall Study||33
7676415|NCT01960725|18903635|P1|Recieved Second Vaccine|Overall Study||33
7676416|NCT01960725|18903634|P2|Received First Vaccine|Overall Study||33
7676417|NCT01960725|18903635|P1|Received First Vaccine|Overall Study||33
7676418|NCT01960725|18903634|P2|STARTED|Overall Study||33
7676419|NCT01960725|18903635|P1|STARTED|Overall Study||33
7676420|NCT01960530|18903657|P1|NOT COMPLETED|Overall Study||0
7676421|NCT01960530|18903657|P1|COMPLETED|Overall Study||14
7676422|NCT01960530|18903657|P1|STARTED|Overall Study||14
7676423|NCT01960465|18903692|P2|NOT COMPLETED|Overall Study||9
7676424|NCT01960465|18903693|P1|NOT COMPLETED|Overall Study||20
7676425|NCT01960465|18903692|P2|COMPLETED|Overall Study||73
7676426|NCT01960465|18903693|P1|COMPLETED|Overall Study||118
7676427|NCT01960465|18903692|P2|STARTED|Overall Study||82
7676428|NCT01960465|18903693|P1|STARTED|Overall Study||138
7676429|NCT01960413|18903705|P2|NOT COMPLETED|Overall Study||1
7676430|NCT01960413|18903706|P1|NOT COMPLETED|Overall Study||4
7676431|NCT01960413|18903705|P2|COMPLETED|Overall Study||21
7676432|NCT01960413|18903706|P1|COMPLETED|Overall Study||20
7676433|NCT01960413|18903705|P2|STARTED|Overall Study||22
7676434|NCT01960413|18903706|P1|STARTED|Overall Study||24
7676435|NCT01960400|18903714|P2|NOT COMPLETED|Overall Study||0
7676436|NCT01960400|18903715|P1|NOT COMPLETED|Overall Study||0
7676437|NCT01960400|18903714|P2|COMPLETED|Overall Study||11
7676438|NCT01960400|18903715|P1|COMPLETED|Overall Study||11
7676439|NCT01960400|18903714|P2|STARTED|Overall Study||11
7676440|NCT01960400|18903715|P1|STARTED|Overall Study||11
7676441|NCT01960387|18903727|P1|NOT COMPLETED|Overall Study||0
7676442|NCT01960387|18903727|P1|COMPLETED|Overall Study||2
7676443|NCT01960387|18903727|P1|STARTED|Overall Study||2
7676444|NCT01960348|18903736|P2|NOT COMPLETED|Overall Study||22
7676445|NCT01960348|18903737|P1|NOT COMPLETED|Overall Study||10
7676446|NCT01960348|18903736|P2|COMPLETED|Overall Study||55
7676447|NCT01960348|18903737|P1|COMPLETED|Overall Study||138
7676448|NCT01960348|18903736|P2|STARTED|Overall Study||77
7676449|NCT01960348|18903737|P1|STARTED|Overall Study||148
7676450|NCT01960296|18903757|P2|NOT COMPLETED|Overall Study||3
7676451|NCT01960296|18903758|P1|NOT COMPLETED|Overall Study||2
7676452|NCT01960296|18903757|P2|COMPLETED|Overall Study||22
7676453|NCT01960296|18903758|P1|COMPLETED|Overall Study||21
7676454|NCT01960296|18903757|P2|STARTED|Overall Study||25
7676455|NCT01960296|18903758|P1|STARTED|Overall Study||23
7676456|NCT01960140|18903778|P1|NOT COMPLETED|Period 2 (Days 3-18)||2
7676457|NCT01960140|18903778|P1|COMPLETED|Period 2 (Days 3-18)||38
7676458|NCT01960140|18903778|P1|Received Simvastatin|Period 2 (Days 3-18)||38
7676459|NCT01960140|18903778|P1|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40
7676460|NCT01960140|18903778|P1|STARTED|Period 2 (Days 3-18)||40
7676461|NCT01960140|18903778|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
7676462|NCT01960140|18903778|P1|COMPLETED|Period 1 (Days 1-2)||40
7676463|NCT01960140|18903778|P1|Received Simvastatin|Period 1 (Days 1-2)||40
7676464|NCT01960140|18903778|P1|STARTED|Period 1 (Days 1-2)||40
7676465|NCT01960114|18903789|P2|NOT COMPLETED|Overall Study||1
7676466|NCT01960114|18903790|P1|NOT COMPLETED|Overall Study||1
7676467|NCT01960114|18903789|P2|COMPLETED|Overall Study||268
7676468|NCT01960114|18903790|P1|COMPLETED|Overall Study||133
7676469|NCT01960114|18903789|P2|STARTED|Overall Study||269
7676470|NCT01960114|18903790|P1|STARTED|Overall Study||134
7676471|NCT01960075|18903807|P3|NOT COMPLETED|Overall Study||7
7676472|NCT01960075|18903808|P2|NOT COMPLETED|Overall Study||3
7676473|NCT01960075|18903809|P1|NOT COMPLETED|Overall Study||8
7676474|NCT01960075|18903807|P3|COMPLETED|Overall Study||173
7676475|NCT01960075|18903808|P2|COMPLETED|Overall Study||146
7676476|NCT01960075|18903809|P1|COMPLETED|Overall Study||141
7676477|NCT01960075|18903807|P3|STARTED|Overall Study||180
7676478|NCT01960075|18903808|P2|STARTED|Overall Study||149
7676479|NCT01960075|18903809|P1|STARTED|Overall Study||149
7676480|NCT01959945|18903869|P4|NOT COMPLETED|Overall Study||16
7676481|NCT01959945|18903870|P3|NOT COMPLETED|Overall Study||19
7676482|NCT01959945|18903871|P2|NOT COMPLETED|Overall Study||3
7676483|NCT01959945|18903872|P1|NOT COMPLETED|Overall Study||4
7676484|NCT01959945|18903869|P4|COMPLETED|Overall Study||15
7676485|NCT01959945|18903870|P3|COMPLETED|Overall Study||9
7676486|NCT01959945|18903871|P2|COMPLETED|Overall Study||75
7676487|NCT01959945|18903872|P1|COMPLETED|Overall Study||76
7676488|NCT01959945|18903869|P4|STARTED|Overall Study||31
7676489|NCT01959945|18903870|P3|STARTED|Overall Study||28
7676490|NCT01959945|18903871|P2|STARTED|Overall Study||78
7676491|NCT01959945|18903872|P1|STARTED|Overall Study||80
7676492|NCT01959932|18903897|P3|NOT COMPLETED|Overall Study||0
7676493|NCT01959932|18903898|P2|NOT COMPLETED|Overall Study||0
7676494|NCT01959932|18903899|P1|NOT COMPLETED|Overall Study||1
7676495|NCT01959932|18903897|P3|COMPLETED|Overall Study||39
7676496|NCT01959932|18903898|P2|COMPLETED|Overall Study||41
7676497|NCT01959932|18903899|P1|COMPLETED|Overall Study||79
7676498|NCT01959932|18903897|P3|STARTED|Overall Study||39
7676499|NCT01959932|18903898|P2|STARTED|Overall Study||41
7676500|NCT01959932|18903899|P1|STARTED|Overall Study||80
7676501|NCT01959919|18903917|P1|NOT COMPLETED|Overall Study||2
7676502|NCT01959919|18903917|P1|COMPLETED|Overall Study||84
7676503|NCT01959919|18903917|P1|STARTED|Overall Study||86
7676504|NCT01959880|18903931|P4|NOT COMPLETED|Overall Study||181
7676505|NCT01959880|18903932|P3|NOT COMPLETED|Overall Study||208
7676506|NCT01959880|18903933|P2|NOT COMPLETED|Overall Study||369
7676507|NCT01959880|18903934|P1|NOT COMPLETED|Overall Study||1132
7676508|NCT01959880|18903931|P4|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
7676509|NCT01959880|18903932|P3|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1
7676510|NCT01959880|18903933|P2|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
7676511|NCT01959880|18903934|P1|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
7676512|NCT01959880|18903931|P4|STARTED|Overall Study||181
7676513|NCT01959880|18903932|P3|STARTED|Overall Study||209
7676514|NCT01959880|18903933|P2|STARTED|Overall Study||369
7676515|NCT01959880|18903934|P1|STARTED|Overall Study||1132
7676516|NCT01959841|18903959|P3|NOT COMPLETED|Overall Study||43
7676517|NCT01959841|18903960|P2|NOT COMPLETED|Overall Study||57
7676518|NCT01959841|18903961|P1|NOT COMPLETED|Overall Study||43
7676519|NCT01959841|18903959|P3|COMPLETED|Overall Study||206
7676520|NCT01959841|18903960|P2|COMPLETED|Overall Study||193
7676521|NCT01959841|18903961|P1|COMPLETED|Overall Study||209
7676522|NCT01959841|18903959|P3|Reason FAS Excluding 3|Overall Study||0
7676523|NCT01959841|18903960|P2|Reason FAS Excluding 3|Overall Study||1
7676524|NCT01959841|18903961|P1|Reason FAS Excluding 3|Overall Study||0
7676525|NCT01959841|18903959|P3|Reason FAS Excluding 2|Overall Study||0
7676526|NCT01959841|18903960|P2|Reason FAS Excluding 2|Overall Study||1
7676527|NCT01959841|18903961|P1|Reason FAS Excluding 2|Overall Study||0
7676528|NCT01959841|18903959|P3|Reason FAS Excluding 1|Overall Study||4
7676529|NCT01959841|18903960|P2|Reason FAS Excluding 1|Overall Study||5
7676530|NCT01959841|18903961|P1|Reason FAS Excluding 1|Overall Study||5
7676531|NCT01959841|18903959|P3|Full Analysis Set Excluded|Overall Study||4
7676532|NCT01959841|18903960|P2|Full Analysis Set Excluded|Overall Study||7
7676533|NCT01959841|18903961|P1|Full Analysis Set Excluded|Overall Study||5
7676534|NCT01959841|18903959|P3|Full Analysis Set Included|Overall Study||245
7676535|NCT01959841|18903960|P2|Full Analysis Set Included|Overall Study||243
7676536|NCT01959841|18903961|P1|Full Analysis Set Included|Overall Study||247
7676537|NCT01959841|18903959|P3|STARTED|Overall Study||249
7676538|NCT01959841|18903960|P2|STARTED|Overall Study||250
7676539|NCT01959841|18903961|P1|STARTED|Overall Study||252
7676540|NCT01959685|18903984|P1|NOT COMPLETED|Overall Study||0
7676541|NCT01959685|18903984|P1|COMPLETED|Overall Study||9
7676542|NCT01959685|18903984|P1|STARTED|Overall Study||9
7676543|NCT01959672|18903989|P1|NOT COMPLETED|Overall Study||1
7676544|NCT01959672|18903989|P1|COMPLETED|Overall Study||10
7676545|NCT01959672|18903989|P1|STARTED|Overall Study||11
7676546|NCT01959607|18904000|P4|NOT COMPLETED|Second Intervention (Day 3)||0
7676547|NCT01959607|18904001|P3|NOT COMPLETED|Second Intervention (Day 3)||0
7676548|NCT01959607|18904002|P2|NOT COMPLETED|Second Intervention (Day 3)||0
7676549|NCT01959607|18904003|P1|NOT COMPLETED|Second Intervention (Day 3)||0
7676550|NCT01959607|18904000|P4|COMPLETED|Second Intervention (Day 3)||9
7676551|NCT01959607|18904001|P3|COMPLETED|Second Intervention (Day 3)||9
7676552|NCT01959607|18904002|P2|COMPLETED|Second Intervention (Day 3)||21
7676553|NCT01959607|18904003|P1|COMPLETED|Second Intervention (Day 3)||21
7676554|NCT01959607|18904000|P4|STARTED|Second Intervention (Day 3)||9
7676555|NCT01959607|18904001|P3|STARTED|Second Intervention (Day 3)||9
7676556|NCT01959607|18904002|P2|STARTED|Second Intervention (Day 3)||21
7676557|NCT01959607|18904003|P1|STARTED|Second Intervention (Day 3)||21
7676558|NCT01959607|18904000|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
7676559|NCT01959607|18904001|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
7676560|NCT01959607|18904002|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
7676561|NCT01959607|18904003|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
7676562|NCT01959607|18904000|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
7676563|NCT01959607|18904001|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
7676564|NCT01959607|18904002|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
7676565|NCT01959607|18904003|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
7676566|NCT01959607|18904000|P4|STARTED|Washout Period of 1 Day (Day 2)||9
7676567|NCT01959607|18904001|P3|STARTED|Washout Period of 1 Day (Day 2)||9
7676568|NCT01959607|18904002|P2|STARTED|Washout Period of 1 Day (Day 2)||21
7676569|NCT01959607|18904003|P1|STARTED|Washout Period of 1 Day (Day 2)||21
7676570|NCT01959607|18904000|P4|NOT COMPLETED|First Intervention (Day 1)||0
7676571|NCT01959607|18904001|P3|NOT COMPLETED|First Intervention (Day 1)||0
7676572|NCT01959607|18904002|P2|NOT COMPLETED|First Intervention (Day 1)||1
7676573|NCT01959607|18904003|P1|NOT COMPLETED|First Intervention (Day 1)||1
7676574|NCT01959607|18904000|P4|COMPLETED|First Intervention (Day 1)||9
7676575|NCT01959607|18904001|P3|COMPLETED|First Intervention (Day 1)||9
7676576|NCT01959607|18904002|P2|COMPLETED|First Intervention (Day 1)||21
7676577|NCT01959607|18904003|P1|COMPLETED|First Intervention (Day 1)||21
7676578|NCT01959607|18904000|P4|STARTED|First Intervention (Day 1)||9
7676579|NCT01959607|18904001|P3|STARTED|First Intervention (Day 1)||9
7676580|NCT01959607|18904002|P2|STARTED|First Intervention (Day 1)||22
7676581|NCT01959607|18904003|P1|STARTED|First Intervention (Day 1)||22
7676582|NCT01959607|18904000|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
7676583|NCT01959607|18904001|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
7676584|NCT01959607|18904002|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
7676585|NCT01959607|18904003|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
7676586|NCT01959607|18904000|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
7676587|NCT01959607|18904001|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
7676588|NCT01959607|18904002|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
7676589|NCT01959607|18904003|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
7676590|NCT01959607|18904000|P4|STARTED|Washout Period of 1 Day (Day 0)||9
7676591|NCT01959607|18904001|P3|STARTED|Washout Period of 1 Day (Day 0)||9
7676592|NCT01959607|18904002|P2|STARTED|Washout Period of 1 Day (Day 0)||22
7676593|NCT01959607|18904003|P1|STARTED|Washout Period of 1 Day (Day 0)||22
7676594|NCT01959581|18904016|P1|NOT COMPLETED|Overall Study||5
7676595|NCT01959581|18904016|P1|COMPLETED|Overall Study||25
7676596|NCT01959581|18904016|P1|STARTED|Overall Study||30
7676597|NCT01959542|18904020|P1|NOT COMPLETED|Overall Study||3
7676598|NCT01959542|18904020|P1|COMPLETED|Overall Study||12
7676599|NCT01959542|18904020|P1|Evaluable at Visit 2|Overall Study||12
7676600|NCT01959542|18904020|P1|Evaluable at Visit 1|Overall Study||12
7676601|NCT01959542|18904020|P1|STARTED|Overall Study||15
7676602|NCT01959529|18904027|P2|NOT COMPLETED|Overall Study||72
7676603|NCT01959529|18904028|P1|NOT COMPLETED|Overall Study||76
7676604|NCT01959529|18904027|P2|COMPLETED|Overall Study||3747
7676605|NCT01959529|18904028|P1|COMPLETED|Overall Study||3742
7676606|NCT01959529|18904027|P2|Exposed|Overall Study||3806
7676607|NCT01959529|18904028|P1|Exposed|Overall Study||3809
7676608|NCT01959529|18904027|P2|STARTED|Overall Study||3819
7676609|NCT01959529|18904028|P1|STARTED|Overall Study||3818
7676610|NCT01959516|18904040|P2|NOT COMPLETED|Epoch 2||1
7676611|NCT01959516|18904041|P1|NOT COMPLETED|Epoch 2||2
7676612|NCT01959516|18904040|P2|COMPLETED|Epoch 2||62
7676613|NCT01959516|18904041|P1|COMPLETED|Epoch 2||61
7676614|NCT01959516|18904040|P2|STARTED|Epoch 2||63
7676615|NCT01959516|18904041|P1|STARTED|Epoch 2||63
7676616|NCT01959516|18904040|P2|NOT COMPLETED|Epoch 1||5
7676617|NCT01959516|18904041|P1|NOT COMPLETED|Epoch 1||10
7676618|NCT01959516|18904040|P2|COMPLETED|Epoch 1||58
7676619|NCT01959516|18904041|P1|COMPLETED|Epoch 1||53
7676620|NCT01959516|18904040|P2|ITT Population|Epoch 1||62
7676621|NCT01959516|18904041|P1|ITT Population|Epoch 1||62
7676622|NCT01959516|18904040|P2|Safety Population|Epoch 1||62
7676623|NCT01959516|18904041|P1|Safety Population|Epoch 1||62
7676624|NCT01959516|18904040|P2|STARTED|Epoch 1||63
7676625|NCT01959516|18904041|P1|STARTED|Epoch 1||63
7676626|NCT01959503|18904051|P2|NOT COMPLETED|Overall Study||2
7676627|NCT01959503|18904052|P1|NOT COMPLETED|Overall Study||3
7676628|NCT01959503|18904051|P2|COMPLETED|Overall Study||49
7676629|NCT01959503|18904052|P1|COMPLETED|Overall Study||104
7676630|NCT01959503|18904051|P2|STARTED|Overall Study||51
7676631|NCT01959503|18904052|P1|STARTED|Overall Study||107
7676632|NCT01959490|18904075|P3|NOT COMPLETED|Overall Study||0
7676633|NCT01959490|18904076|P2|NOT COMPLETED|Overall Study||0
7676634|NCT01959490|18904077|P1|NOT COMPLETED|Overall Study||0
7676635|NCT01959490|18904075|P3|COMPLETED|Overall Study||5
7676636|NCT01959490|18904076|P2|COMPLETED|Overall Study||6
7676637|NCT01959490|18904077|P1|COMPLETED|Overall Study||5
7676638|NCT01959490|18904075|P3|STARTED|Overall Study||5
7676639|NCT01959490|18904076|P2|STARTED|Overall Study||6
7676640|NCT01959490|18904077|P1|STARTED|Overall Study||5
7676641|NCT01959425|18904105|P2|NOT COMPLETED|Overall Study||8
7676642|NCT01959425|18904106|P1|NOT COMPLETED|Overall Study||12
7676643|NCT01959425|18904105|P2|COMPLETED|Overall Study||23
7676644|NCT01959425|18904106|P1|COMPLETED|Overall Study||20
7676645|NCT01959425|18904105|P2|STARTED|Overall Study||31
7676646|NCT01959425|18904106|P1|STARTED|Overall Study||32
7676647|NCT01959412|18904126|P6|NOT COMPLETED|Overall Study||0
7676648|NCT01959412|18904127|P5|NOT COMPLETED|Overall Study||3
7676649|NCT01959412|18904128|P4|NOT COMPLETED|Overall Study||2
7676650|NCT01959412|18904129|P3|NOT COMPLETED|Overall Study||0
7676651|NCT01959412|18904130|P2|NOT COMPLETED|Overall Study||1
7676652|NCT01959412|18904131|P1|NOT COMPLETED|Overall Study||1
7676653|NCT01959412|18904126|P6|COMPLETED|Overall Study||15
7676654|NCT01959412|18904127|P5|COMPLETED|Overall Study||13
7676655|NCT01959412|18904128|P4|COMPLETED|Overall Study||13
7676656|NCT01959412|18904129|P3|COMPLETED|Overall Study||15
7676657|NCT01959412|18904130|P2|COMPLETED|Overall Study||14
7676658|NCT01959412|18904131|P1|COMPLETED|Overall Study||14
7676659|NCT01959412|18904126|P6|STARTED|Overall Study||15
7676660|NCT01959412|18904127|P5|STARTED|Overall Study||16
7676661|NCT01959412|18904128|P4|STARTED|Overall Study||15
7676662|NCT01959412|18904129|P3|STARTED|Overall Study||15
7676663|NCT01959412|18904130|P2|STARTED|Overall Study||15
7676664|NCT01959412|18904131|P1|STARTED|Overall Study||15
7676665|NCT01959347|18904171|P2|NOT COMPLETED|Overall Study||7
7676666|NCT01959347|18904172|P1|NOT COMPLETED|Overall Study||9
7676667|NCT01959347|18904171|P2|COMPLETED|Overall Study||235
7676668|NCT01959347|18904172|P1|COMPLETED|Overall Study||229
7676669|NCT01959347|18904171|P2|STARTED|Overall Study||242
7676670|NCT01959347|18904172|P1|STARTED|Overall Study||238
7676671|NCT01959334|18904278|P2|NOT COMPLETED|Third Dose||1
7676672|NCT01959334|18904279|P1|NOT COMPLETED|Third Dose||0
7676673|NCT01959334|18904278|P2|COMPLETED|Third Dose||48
7676674|NCT01959334|18904279|P1|COMPLETED|Third Dose||25
7676675|NCT01959334|18904278|P2|STARTED|Third Dose||49
7676676|NCT01959334|18904279|P1|STARTED|Third Dose||25
7676677|NCT01959334|18904278|P2|NOT COMPLETED|Second Dose||0
7676678|NCT01959334|18904279|P1|NOT COMPLETED|Second Dose||1
7676679|NCT01959334|18904278|P2|COMPLETED|Second Dose||49
7676680|NCT01959334|18904279|P1|COMPLETED|Second Dose||25
7676681|NCT01959334|18904278|P2|STARTED|Second Dose||49
7676682|NCT01959334|18904279|P1|STARTED|Second Dose||26
7676683|NCT01959334|18904278|P2|NOT COMPLETED|First Dose||0
7676684|NCT01959334|18904279|P1|NOT COMPLETED|First Dose||0
7676685|NCT01959334|18904278|P2|COMPLETED|First Dose|Each Dosing Period is separated by at least 7 calendar days.|49
7676686|NCT01959334|18904279|P1|COMPLETED|First Dose|Each Dosing Period separated by at least 7 calendar days.|26
7676687|NCT01959334|18904278|P2|STARTED|First Dose||49
7676688|NCT01959334|18904279|P1|STARTED|First Dose||26
7676689|NCT01959243|18904291|P2|NOT COMPLETED|Overall Study||4
7676690|NCT01959243|18904292|P1|NOT COMPLETED|Overall Study||13
7676691|NCT01959243|18904291|P2|COMPLETED|Overall Study||166
7676692|NCT01959243|18904292|P1|COMPLETED|Overall Study||324
7676693|NCT01959243|18904291|P2|Received at Least 1 Dose of Study Drug|Overall Study||170
7676694|NCT01959243|18904292|P1|Received at Least 1 Dose of Study Drug|Overall Study||337
7676695|NCT01959243|18904291|P2|STARTED|Overall Study||170
7676696|NCT01959243|18904292|P1|STARTED|Overall Study||337
7676697|NCT01959230|18904304|P2|NOT COMPLETED|Overall Study||1
7676698|NCT01959230|18904305|P1|NOT COMPLETED|Overall Study||4
7676699|NCT01959230|18904304|P2|COMPLETED|Overall Study||19
7676700|NCT01959230|18904305|P1|COMPLETED|Overall Study||36
7676701|NCT01959230|18904304|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
7676702|NCT01959230|18904305|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
7676703|NCT01959230|18904304|P2|STARTED|Overall Study||20
7676704|NCT01959230|18904305|P1|STARTED|Overall Study||40
7676705|NCT01959178|18904315|P2|NOT COMPLETED|Overall Study||2
7676706|NCT01959178|18904316|P1|NOT COMPLETED|Overall Study||2
7676707|NCT01959178|18904315|P2|COMPLETED|Overall Study||71
7676708|NCT01959178|18904316|P1|COMPLETED|Overall Study||71
7676709|NCT01959178|18904315|P2|STARTED|Overall Study||73
7676710|NCT01959178|18904316|P1|STARTED|Overall Study||73
7676711|NCT01959165|18904328|P4|NOT COMPLETED|Overall Study||2
7676712|NCT01959165|18904329|P3|NOT COMPLETED|Overall Study||0
7676713|NCT01959165|18904330|P2|NOT COMPLETED|Overall Study||1
7676714|NCT01959165|18904331|P1|NOT COMPLETED|Overall Study||1
7676715|NCT01959165|18904328|P4|COMPLETED|Overall Study||7
7676716|NCT01959165|18904329|P3|COMPLETED|Overall Study||12
7676717|NCT01959165|18904330|P2|COMPLETED|Overall Study||10
7676718|NCT01959165|18904331|P1|COMPLETED|Overall Study||12
7676719|NCT01959165|18904328|P4|STARTED|Overall Study||9
7676720|NCT01959165|18904329|P3|STARTED|Overall Study||12
7676721|NCT01959165|18904330|P2|STARTED|Overall Study|1 patient discontinued the study without any treatment out of 11 patients.|11
7676722|NCT01959165|18904331|P1|STARTED|Overall Study||13
7676723|NCT01959139|18904357|P4|NOT COMPLETED|Phase II||55
7676724|NCT01959139|18904358|P3|NOT COMPLETED|Phase II||56
7676725|NCT01959139|18904359|P2|NOT COMPLETED|Phase II||0
7676726|NCT01959139|18904360|P1|NOT COMPLETED|Phase II||0
7676727|NCT01959139|18904357|P4|COMPLETED|Phase II||0
7676728|NCT01959139|18904358|P3|COMPLETED|Phase II||0
7676729|NCT01959139|18904359|P2|COMPLETED|Phase II||0
7676730|NCT01959139|18904360|P1|COMPLETED|Phase II||0
7676731|NCT01959139|18904357|P4|Assessed for AEs|Phase II||51
7676732|NCT01959139|18904358|P3|Assessed for AEs|Phase II||54
7676733|NCT01959139|18904359|P2|Assessed for AEs|Phase II||0
7676734|NCT01959139|18904360|P1|Assessed for AEs|Phase II||0
7676735|NCT01959139|18904357|P4|STARTED|Phase II||55
7676736|NCT01959139|18904358|P3|STARTED|Phase II||56
7676737|NCT01959139|18904359|P2|STARTED|Phase II||0
7676738|NCT01959139|18904360|P1|STARTED|Phase II||0
7676739|NCT01959139|18904357|P4|NOT COMPLETED|Phase I: Cohort 2||0
7676740|NCT01959139|18904358|P3|NOT COMPLETED|Phase I: Cohort 2||0
7676741|NCT01959139|18904359|P2|NOT COMPLETED|Phase I: Cohort 2||0
7676742|NCT01959139|18904360|P1|NOT COMPLETED|Phase I: Cohort 2||0
7676743|NCT01959139|18904357|P4|COMPLETED|Phase I: Cohort 2||0
7676744|NCT01959139|18904358|P3|COMPLETED|Phase I: Cohort 2||0
7676745|NCT01959139|18904359|P2|COMPLETED|Phase I: Cohort 2||6
7676746|NCT01959139|18904360|P1|COMPLETED|Phase I: Cohort 2||0
7676747|NCT01959139|18904357|P4|STARTED|Phase I: Cohort 2||0
7676748|NCT01959139|18904358|P3|STARTED|Phase I: Cohort 2||0
7676749|NCT01959139|18904359|P2|STARTED|Phase I: Cohort 2||6
7676750|NCT01959139|18904360|P1|STARTED|Phase I: Cohort 2||0
7676751|NCT01959139|18904357|P4|NOT COMPLETED|Phase I: Cohort 1||0
7676752|NCT01959139|18904358|P3|NOT COMPLETED|Phase I: Cohort 1||0
7676753|NCT01959139|18904359|P2|NOT COMPLETED|Phase I: Cohort 1||0
7676754|NCT01959139|18904360|P1|NOT COMPLETED|Phase I: Cohort 1||0
7676755|NCT01959139|18904357|P4|COMPLETED|Phase I: Cohort 1||0
7676756|NCT01959139|18904358|P3|COMPLETED|Phase I: Cohort 1||0
7676757|NCT01959139|18904359|P2|COMPLETED|Phase I: Cohort 1||0
7676758|NCT01959139|18904360|P1|COMPLETED|Phase I: Cohort 1||5
7676759|NCT01959139|18904357|P4|STARTED|Phase I: Cohort 1||0
7676760|NCT01959139|18904358|P3|STARTED|Phase I: Cohort 1||0
7676761|NCT01959139|18904359|P2|STARTED|Phase I: Cohort 1||0
7676762|NCT01959139|18904360|P1|STARTED|Phase I: Cohort 1||5
7676763|NCT01959113|18904379|P1|NOT COMPLETED|Overall Study||0
7676764|NCT01959113|18904379|P1|COMPLETED|Overall Study||5
7676765|NCT01959113|18904379|P1|STARTED|Overall Study||5
7676766|NCT01959048|18904385|P1|NOT COMPLETED|Overall Study||0
7676767|NCT01959048|18904385|P1|COMPLETED|Overall Study||3
7676768|NCT01959048|18904385|P1|STARTED|Overall Study||3
7676769|NCT01959035|18904393|P1|NOT COMPLETED|Overall Study||11
7676770|NCT01959035|18904393|P1|COMPLETED|Overall Study||77
7676771|NCT01959035|18904393|P1|STARTED|Overall Study||88
7676772|NCT01958918|18904421|P2|NOT COMPLETED|Overall Study||42
7676773|NCT01958918|18904422|P1|NOT COMPLETED|Overall Study||43
7676774|NCT01958918|18904421|P2|COMPLETED|Overall Study||314
7676775|NCT01958918|18904422|P1|COMPLETED|Overall Study||313
7676776|NCT01958918|18904421|P2|Full Analysis Set|Overall Study||354
7676777|NCT01958918|18904422|P1|Full Analysis Set|Overall Study||353
7676778|NCT01958918|18904421|P2|STARTED|Overall Study||356
7676779|NCT01958918|18904422|P1|STARTED|Overall Study||356
7676780|NCT01958827|18904436|P1|NOT COMPLETED|Overall Study||10
7676781|NCT01958827|18904436|P1|COMPLETED|Overall Study||18
7676782|NCT01958827|18904436|P1|STARTED|Overall Study||28
7676783|NCT01958788|18904454|P1|NOT COMPLETED|Overall Study||0
7676784|NCT01958788|18904454|P1|COMPLETED|Overall Study||7
7676785|NCT01958788|18904454|P1|STARTED|Overall Study||7
7676786|NCT01958671|18904467|P3|NOT COMPLETED|Overall Study||32
7676787|NCT01958671|18904468|P2|NOT COMPLETED|Overall Study||24
7676788|NCT01958671|18904469|P1|NOT COMPLETED|Overall Study||19
7676789|NCT01958671|18904467|P3|COMPLETED|Overall Study||121
7676790|NCT01958671|18904468|P2|COMPLETED|Overall Study||128
7676791|NCT01958671|18904469|P1|COMPLETED|Overall Study||137
7676792|NCT01958671|18904467|P3|STARTED|Overall Study||153
7676793|NCT01958671|18904468|P2|STARTED|Overall Study||152
7676794|NCT01958671|18904469|P1|STARTED|Overall Study||156
7676795|NCT01958645|18904513|P3|NOT COMPLETED|Overall Study||0
7676796|NCT01958645|18904514|P2|NOT COMPLETED|Overall Study||0
7676797|NCT01958645|18904515|P1|NOT COMPLETED|Overall Study||0
7676798|NCT01958645|18904513|P3|COMPLETED|Overall Study||4
7676799|NCT01958645|18904514|P2|COMPLETED|Overall Study||4
7676800|NCT01958645|18904515|P1|COMPLETED|Overall Study||4
7676801|NCT01958645|18904513|P3|STARTED|Overall Study||4
7676802|NCT01958645|18904514|P2|STARTED|Overall Study||4
7676803|NCT01958645|18904515|P1|STARTED|Overall Study||4
7676804|NCT01958619|18904543|P4|NOT COMPLETED|Overall Study||0
7676805|NCT01958619|18904544|P3|NOT COMPLETED|Overall Study||1
7676806|NCT01958619|18904545|P2|NOT COMPLETED|Overall Study||0
7676807|NCT01958619|18904546|P1|NOT COMPLETED|Overall Study||2
7676808|NCT01958619|18904543|P4|COMPLETED|Overall Study||12
7676809|NCT01958619|18904544|P3|COMPLETED|Overall Study||13
7676810|NCT01958619|18904545|P2|COMPLETED|Overall Study||14
7676811|NCT01958619|18904546|P1|COMPLETED|Overall Study||13
7676812|NCT01958619|18904543|P4|STARTED|Overall Study||12
7676813|NCT01958619|18904544|P3|STARTED|Overall Study||14
7676814|NCT01958619|18904545|P2|STARTED|Overall Study||14
7676815|NCT01958619|18904546|P1|STARTED|Overall Study||15
7676816|NCT01958606|18904568|P2|NOT COMPLETED|Overall Study||0
7676817|NCT01958606|18904569|P1|NOT COMPLETED|Overall Study||2
7676818|NCT01958606|18904568|P2|COMPLETED|Overall Study||5
7676819|NCT01958606|18904569|P1|COMPLETED|Overall Study||11
7676820|NCT01958606|18904568|P2|STARTED|Overall Study||5
7676821|NCT01958606|18904569|P1|STARTED|Overall Study||13
7676822|NCT01958489|18904607|P2|NOT COMPLETED|Period 2||1
7676823|NCT01958489|18904608|P1|NOT COMPLETED|Period 2||0
7676824|NCT01958489|18904607|P2|COMPLETED|Period 2||23
7676825|NCT01958489|18904608|P1|COMPLETED|Period 2||0
7676826|NCT01958489|18904607|P2|Received at Least 1 Dose of Study Drug|Period 2||24
7676827|NCT01958489|18904608|P1|Received at Least 1 Dose of Study Drug|Period 2||0
7676828|NCT01958489|18904607|P2|STARTED|Period 2|Participants who started Period 2 treatment crossed over from Period 1 treatment|24
7676829|NCT01958489|18904608|P1|STARTED|Period 2|Participants who completed Period 1 treatment crossed over to Period 2 treatment|0
7676830|NCT01958489|18904607|P2|NOT COMPLETED|Period 1||0
7676831|NCT01958489|18904608|P1|NOT COMPLETED|Period 1||0
7676832|NCT01958489|18904607|P2|COMPLETED|Period 1||0
7676833|NCT01958489|18904608|P1|COMPLETED|Period 1||24
7676834|NCT01958489|18904607|P2|Received at Least 1 Dose of Study Drug|Period 1||0
7676835|NCT01958489|18904608|P1|Received at Least 1 Dose of Study Drug|Period 1||24
7676836|NCT01958489|18904607|P2|STARTED|Period 1||0
7676837|NCT01958489|18904608|P1|STARTED|Period 1||24
7676838|NCT01958476|18904624|P2|NOT COMPLETED|Overall Study||0
7676839|NCT01958476|18904625|P1|NOT COMPLETED|Overall Study||1
7676840|NCT01958476|18904624|P2|COMPLETED|Overall Study||58
7676841|NCT01958476|18904625|P1|COMPLETED|Overall Study||58
7676842|NCT01958476|18904624|P2|STARTED|Overall Study||58
7676843|NCT01958476|18904625|P1|STARTED|Overall Study||59
7676844|NCT01958437|18904655|P4|NOT COMPLETED|Overall Study||1
7676845|NCT01958437|18904656|P3|NOT COMPLETED|Overall Study||1
7676846|NCT01958437|18904657|P2|NOT COMPLETED|Overall Study||0
7676847|NCT01958437|18904658|P1|NOT COMPLETED|Overall Study||0
7676848|NCT01958437|18904655|P4|COMPLETED|Overall Study||10
7676849|NCT01958437|18904656|P3|COMPLETED|Overall Study||10
7676850|NCT01958437|18904657|P2|COMPLETED|Overall Study||11
7676851|NCT01958437|18904658|P1|COMPLETED|Overall Study||11
7676852|NCT01958437|18904655|P4|STARTED|Overall Study||11
7676853|NCT01958437|18904656|P3|STARTED|Overall Study||11
7676854|NCT01958437|18904657|P2|STARTED|Overall Study||11
7676855|NCT01958437|18904658|P1|STARTED|Overall Study||11
7676856|NCT01958346|18904682|P2|NOT COMPLETED|Overall Study||0
7676857|NCT01958346|18904683|P1|NOT COMPLETED|Overall Study||0
7676858|NCT01958346|18904682|P2|COMPLETED|Overall Study||39
7676859|NCT01958346|18904683|P1|COMPLETED|Overall Study||39
7676860|NCT01958346|18904682|P2|STARTED|Overall Study||39
7676861|NCT01958346|18904683|P1|STARTED|Overall Study||39
7676862|NCT01958320|18904693|P2|NOT COMPLETED|Overall Study||0
7676863|NCT01958320|18904694|P1|NOT COMPLETED|Overall Study||0
7676864|NCT01958320|18904693|P2|COMPLETED|Overall Study||98
7676865|NCT01958320|18904694|P1|COMPLETED|Overall Study||104
7676866|NCT01958320|18904693|P2|STARTED|Overall Study||98
7676867|NCT01958320|18904694|P1|STARTED|Overall Study||104
7676868|NCT01958294|18904722|P1|NOT COMPLETED|Overall Study||2
7676869|NCT01958294|18904722|P1|COMPLETED|Overall Study||10
7676870|NCT01958294|18904722|P1|STARTED|Overall Study||12
7676871|NCT01958281|18904731|P3|NOT COMPLETED|Overall Study||0
7676872|NCT01958281|18904732|P2|NOT COMPLETED|Overall Study||4
7676873|NCT01958281|18904733|P1|NOT COMPLETED|Overall Study||6
7676874|NCT01958281|18904731|P3|COMPLETED|Overall Study||18
7676875|NCT01958281|18904732|P2|COMPLETED|Overall Study||6
7676876|NCT01958281|18904733|P1|COMPLETED|Overall Study||4
7676877|NCT01958281|18904731|P3|STARTED|Overall Study||18
7676878|NCT01958281|18904732|P2|STARTED|Overall Study||10
7676879|NCT01958281|18904733|P1|STARTED|Overall Study||10
7676880|NCT01958164|18904809|P2|NOT COMPLETED|Overall Study||5
7676881|NCT01958164|18904810|P1|NOT COMPLETED|Overall Study||2
7676882|NCT01958164|18904809|P2|COMPLETED|Overall Study||5
7676883|NCT01958164|18904810|P1|COMPLETED|Overall Study||4
7676884|NCT01958164|18904809|P2|STARTED|Overall Study|Randomised and treated|10
7676885|NCT01958164|18904810|P1|STARTED|Overall Study|Randomised and treated|6
7676886|NCT01958125|18904825|P2|NOT COMPLETED|Overall Study||8
7676887|NCT01958125|18904826|P1|NOT COMPLETED|Overall Study||2
7676888|NCT01958125|18904825|P2|COMPLETED|Overall Study||44
7676889|NCT01958125|18904826|P1|COMPLETED|Overall Study||48
7676890|NCT01958125|18904825|P2|STARTED|Overall Study||52
7676891|NCT01958125|18904826|P1|STARTED|Overall Study||50
7676892|NCT01958112|18904840|P1|NOT COMPLETED|Overall Study||0
7676893|NCT01958112|18904840|P1|COMPLETED|Overall Study||14
7676894|NCT01958112|18904840|P1|STARTED|Overall Study||14
7676895|NCT01958073|18904850|P5|NOT COMPLETED|Open Label Period||0
7676896|NCT01958073|18904851|P4|NOT COMPLETED|Open Label Period||0
7676897|NCT01958073|18904852|P3|NOT COMPLETED|Open Label Period||0
7676898|NCT01958073|18904853|P2|NOT COMPLETED|Open Label Period||0
7676899|NCT01958073|18904854|P1|NOT COMPLETED|Open Label Period||0
7676900|NCT01958073|18904850|P5|COMPLETED|Open Label Period||17
7676901|NCT01958073|18904851|P4|COMPLETED|Open Label Period||5
7676902|NCT01958073|18904852|P3|COMPLETED|Open Label Period||0
7676903|NCT01958073|18904853|P2|COMPLETED|Open Label Period||0
7676904|NCT01958073|18904854|P1|COMPLETED|Open Label Period||0
7676905|NCT01958073|18904850|P5|STARTED|Open Label Period||17
7676906|NCT01958073|18904851|P4|STARTED|Open Label Period||5
7676907|NCT01958073|18904852|P3|STARTED|Open Label Period||0
7676908|NCT01958073|18904853|P2|STARTED|Open Label Period||0
7676909|NCT01958073|18904854|P1|STARTED|Open Label Period||0
7676910|NCT01958073|18904850|P5|NOT COMPLETED|Randomized Period||0
7676911|NCT01958073|18904851|P4|NOT COMPLETED|Randomized Period||0
7676912|NCT01958073|18904852|P3|NOT COMPLETED|Randomized Period||6
7676913|NCT01958073|18904853|P2|NOT COMPLETED|Randomized Period||1
7676914|NCT01958073|18904854|P1|NOT COMPLETED|Randomized Period||2
7676915|NCT01958073|18904850|P5|COMPLETED|Randomized Period||0
7676916|NCT01958073|18904851|P4|COMPLETED|Randomized Period||0
7676917|NCT01958073|18904852|P3|COMPLETED|Randomized Period||11
7676918|NCT01958073|18904853|P2|COMPLETED|Randomized Period||8
7676919|NCT01958073|18904854|P1|COMPLETED|Randomized Period||7
7676920|NCT01958073|18904850|P5|STARTED|Randomized Period||0
7676921|NCT01958073|18904851|P4|STARTED|Randomized Period||0
7676922|NCT01958073|18904852|P3|STARTED|Randomized Period||17
7676923|NCT01958073|18904853|P2|STARTED|Randomized Period||9
7676924|NCT01958073|18904854|P1|STARTED|Randomized Period||9
7676925|NCT01958060|18904889|P6|NOT COMPLETED|Overall Study||0
7676926|NCT01958060|18904890|P5|NOT COMPLETED|Overall Study||1
7676927|NCT01958060|18904891|P4|NOT COMPLETED|Overall Study||0
7676928|NCT01958060|18904892|P3|NOT COMPLETED|Overall Study||0
7676929|NCT01958060|18904893|P2|NOT COMPLETED|Overall Study||0
7676930|NCT01958060|18904894|P1|NOT COMPLETED|Overall Study||2
7676931|NCT01958060|18904889|P6|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1
7676932|NCT01958060|18904890|P5|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6
7676933|NCT01958060|18904891|P4|COMPLETED|Overall Study||5
7676934|NCT01958060|18904892|P3|COMPLETED|Overall Study||6
7676935|NCT01958060|18904893|P2|COMPLETED|Overall Study||6
7676936|NCT01958060|18904894|P1|COMPLETED|Overall Study||8
7676937|NCT01958060|18904889|P6|STARTED|Overall Study||1
7676938|NCT01958060|18904890|P5|STARTED|Overall Study||7
7676939|NCT01958060|18904891|P4|STARTED|Overall Study||5
7676940|NCT01958060|18904892|P3|STARTED|Overall Study||6
7676941|NCT01958060|18904893|P2|STARTED|Overall Study||6
7676942|NCT01958060|18904894|P1|STARTED|Overall Study||10
7676943|NCT01958021|18904919|P2|NOT COMPLETED|Overall Study||180
7676944|NCT01958021|18904920|P1|NOT COMPLETED|Overall Study||139
7676945|NCT01958021|18904919|P2|COMPLETED|Overall Study|Completed = Treatment ongoing|154
7676946|NCT01958021|18904920|P1|COMPLETED|Overall Study|Completed = Treatment ongoing|195
7676947|NCT01958021|18904919|P2|Patients Treated|Overall Study||330
7676948|NCT01958021|18904920|P1|Patients Treated|Overall Study||334
7676949|NCT01958021|18904919|P2|Patients Untreated|Overall Study||4
7676950|NCT01958021|18904920|P1|Patients Untreated|Overall Study||0
7676951|NCT01958021|18904919|P2|STARTED|Overall Study||334
7676952|NCT01958021|18904920|P1|STARTED|Overall Study||334
7676953|NCT01958008|18904932|P4|NOT COMPLETED|Overall Study||0
7676954|NCT01958008|18904933|P3|NOT COMPLETED|Overall Study||1
7676955|NCT01958008|18904934|P2|NOT COMPLETED|Overall Study||0
7676956|NCT01958008|18904935|P1|NOT COMPLETED|Overall Study||1
7676957|NCT01958008|18904932|P4|COMPLETED|Overall Study||21
7676958|NCT01958008|18904933|P3|COMPLETED|Overall Study||20
7676959|NCT01958008|18904934|P2|COMPLETED|Overall Study||21
7676960|NCT01958008|18904935|P1|COMPLETED|Overall Study||20
7676961|NCT01958008|18904932|P4|STARTED|Overall Study||21
7676962|NCT01958008|18904933|P3|STARTED|Overall Study||21
7676963|NCT01958008|18904934|P2|STARTED|Overall Study||21
7676964|NCT01958008|18904935|P1|STARTED|Overall Study||21
7676965|NCT01957930|18904966|P3|NOT COMPLETED|Overall Study||0
7676966|NCT01957930|18904967|P2|NOT COMPLETED|Overall Study||0
7676967|NCT01957930|18904968|P1|NOT COMPLETED|Overall Study||0
7676968|NCT01957930|18904966|P3|COMPLETED|Overall Study||19
7676969|NCT01957930|18904967|P2|COMPLETED|Overall Study||37
7676970|NCT01957930|18904968|P1|COMPLETED|Overall Study||35
7676971|NCT01957930|18904966|P3|STARTED|Overall Study||19
7676972|NCT01957930|18904967|P2|STARTED|Overall Study||37
7676973|NCT01957930|18904968|P1|STARTED|Overall Study||35
7676974|NCT01957865|18904978|P3|NOT COMPLETED|Overall Study||3
7676975|NCT01957865|18904979|P2|NOT COMPLETED|Overall Study||2
7676976|NCT01957865|18904980|P1|NOT COMPLETED|Overall Study||0
7676977|NCT01957865|18904978|P3|COMPLETED|Overall Study||19
7676978|NCT01957865|18904979|P2|COMPLETED|Overall Study||18
7676979|NCT01957865|18904980|P1|COMPLETED|Overall Study||21
7676980|NCT01957865|18904978|P3|STARTED|Overall Study||22
7676981|NCT01957865|18904979|P2|STARTED|Overall Study||20
7676982|NCT01957865|18904980|P1|STARTED|Overall Study||21
7676983|NCT01957787|18904991|P1|NOT COMPLETED|Overall Study||36
7676984|NCT01957787|18904991|P1|COMPLETED|Overall Study||95
7676985|NCT01957787|18904991|P1|Modified ITT (mITT) Population|Overall Study||128
7676986|NCT01957787|18904991|P1|Intent-to-Treat (ITT) Population|Overall Study||130
7676987|NCT01957787|18904991|P1|STARTED|Overall Study|Participant who was withdrawn prior to study treatment was not included in Number of Index Tumors.|131
7676988|NCT01957761|18905006|P1|NOT COMPLETED|Overall Study||0
7676989|NCT01957761|18905006|P1|COMPLETED|Overall Study||189
7676990|NCT01957761|18905006|P1|STARTED|Overall Study||189
7676991|NCT01957709|18905010|P1|NOT COMPLETED|Overall Study||1
7676992|NCT01957709|18905010|P1|COMPLETED|Overall Study||7
7676993|NCT01957709|18905010|P1|STARTED|Overall Study||8
7676994|NCT01957657|18905016|P1|NOT COMPLETED|Overall Study||0
7676995|NCT01957657|18905016|P1|COMPLETED|Overall Study||4
7676996|NCT01957657|18905016|P1|STARTED|Overall Study||4
7676997|NCT01957644|18905035|P5|NOT COMPLETED|Overall Study||1
7676998|NCT01957644|18905036|P4|NOT COMPLETED|Overall Study||2
7676999|NCT01957644|18905037|P3|NOT COMPLETED|Overall Study||1
7677000|NCT01957644|18905038|P2|NOT COMPLETED|Overall Study||6
7677001|NCT01957644|18905039|P1|NOT COMPLETED|Overall Study||6
7677002|NCT01957644|18905035|P5|COMPLETED|Overall Study||0
7677003|NCT01957644|18905036|P4|COMPLETED|Overall Study||0
7677004|NCT01957644|18905037|P3|COMPLETED|Overall Study||0
7677005|NCT01957644|18905038|P2|COMPLETED|Overall Study||0
7677006|NCT01957644|18905039|P1|COMPLETED|Overall Study||0
7677007|NCT01957644|18905035|P5|STARTED|Overall Study||1
7677008|NCT01957644|18905036|P4|STARTED|Overall Study||2
7677009|NCT01957644|18905037|P3|STARTED|Overall Study||1
7677010|NCT01957644|18905038|P2|STARTED|Overall Study||6
7677011|NCT01957644|18905039|P1|STARTED|Overall Study||6
7677012|NCT01957579|18905063|P4|NOT COMPLETED|Overall Study||0
7677013|NCT01957579|18905064|P3|NOT COMPLETED|Overall Study||2
7677014|NCT01957579|18905065|P2|NOT COMPLETED|Overall Study||1
7677015|NCT01957579|18905066|P1|NOT COMPLETED|Overall Study||0
7677016|NCT01957579|18905063|P4|COMPLETED|Overall Study||6
7677017|NCT01957579|18905064|P3|COMPLETED|Overall Study||2
7677018|NCT01957579|18905065|P2|COMPLETED|Overall Study||6
7677019|NCT01957579|18905066|P1|COMPLETED|Overall Study||3
7677020|NCT01957579|18905063|P4|STARTED|Overall Study||6
7677021|NCT01957579|18905064|P3|STARTED|Overall Study||4
7677022|NCT01957579|18905065|P2|STARTED|Overall Study||7
7677023|NCT01957579|18905066|P1|STARTED|Overall Study||3
7677024|NCT01957553|18905133|P2|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7
7677025|NCT01957553|18905134|P1|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3
7677026|NCT01957553|18905133|P2|COMPLETED|Test Period 2 (21 +- 1 Days)||56
7677027|NCT01957553|18905134|P1|COMPLETED|Test Period 2 (21 +- 1 Days)||51
7677028|NCT01957553|18905133|P2|STARTED|Test Period 2 (21 +- 1 Days)||63
7677029|NCT01957553|18905134|P1|STARTED|Test Period 2 (21 +- 1 Days)||54
7677030|NCT01957553|18905133|P2|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3
7677031|NCT01957553|18905134|P1|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7
7677032|NCT01957553|18905133|P2|COMPLETED|Test Period 1 (21 +- 1 Days)||63
7677033|NCT01957553|18905134|P1|COMPLETED|Test Period 1 (21 +- 1 Days)||54
7677034|NCT01957553|18905133|P2|STARTED|Test Period 1 (21 +- 1 Days)||66
7677035|NCT01957553|18905134|P1|STARTED|Test Period 1 (21 +- 1 Days)||61
7677036|NCT01957488|18905140|P6|NOT COMPLETED|Test Period 3 (2 Weeks)||0
7677037|NCT01957488|18905141|P5|NOT COMPLETED|Test Period 3 (2 Weeks)||0
7677038|NCT01957488|18905142|P4|NOT COMPLETED|Test Period 3 (2 Weeks)||0
7677039|NCT01957488|18905143|P3|NOT COMPLETED|Test Period 3 (2 Weeks)||0
7677040|NCT01957488|18905144|P2|NOT COMPLETED|Test Period 3 (2 Weeks)||1
7677041|NCT01957488|18905145|P1|NOT COMPLETED|Test Period 3 (2 Weeks)||1
7677042|NCT01957488|18905140|P6|COMPLETED|Test Period 3 (2 Weeks)||23
7677043|NCT01957488|18905141|P5|COMPLETED|Test Period 3 (2 Weeks)||25
7677044|NCT01957488|18905142|P4|COMPLETED|Test Period 3 (2 Weeks)||28
7677045|NCT01957488|18905143|P3|COMPLETED|Test Period 3 (2 Weeks)||25
7677046|NCT01957488|18905144|P2|COMPLETED|Test Period 3 (2 Weeks)||26
7677047|NCT01957488|18905145|P1|COMPLETED|Test Period 3 (2 Weeks)||23
7677048|NCT01957488|18905140|P6|STARTED|Test Period 3 (2 Weeks)||23
7677049|NCT01957488|18905141|P5|STARTED|Test Period 3 (2 Weeks)||25
7677050|NCT01957488|18905142|P4|STARTED|Test Period 3 (2 Weeks)||28
7677051|NCT01957488|18905143|P3|STARTED|Test Period 3 (2 Weeks)||25
7677052|NCT01957488|18905144|P2|STARTED|Test Period 3 (2 Weeks)||27
7677053|NCT01957488|18905145|P1|STARTED|Test Period 3 (2 Weeks)||24
7677054|NCT01957488|18905140|P6|NOT COMPLETED|Test Period 2 (2 Weeks)||1
7677055|NCT01957488|18905141|P5|NOT COMPLETED|Test Period 2 (2 Weeks)||2
7677056|NCT01957488|18905142|P4|NOT COMPLETED|Test Period 2 (2 Weeks)||1
7677057|NCT01957488|18905143|P3|NOT COMPLETED|Test Period 2 (2 Weeks)||1
7677058|NCT01957488|18905144|P2|NOT COMPLETED|Test Period 2 (2 Weeks)||1
7677059|NCT01957488|18905145|P1|NOT COMPLETED|Test Period 2 (2 Weeks)||3
7677060|NCT01957488|18905140|P6|COMPLETED|Test Period 2 (2 Weeks)||23
7677061|NCT01957488|18905141|P5|COMPLETED|Test Period 2 (2 Weeks)||25
7677062|NCT01957488|18905142|P4|COMPLETED|Test Period 2 (2 Weeks)||28
7677063|NCT01957488|18905143|P3|COMPLETED|Test Period 2 (2 Weeks)||25
7677064|NCT01957488|18905144|P2|COMPLETED|Test Period 2 (2 Weeks)||27
7677065|NCT01957488|18905145|P1|COMPLETED|Test Period 2 (2 Weeks)||24
7677066|NCT01957488|18905140|P6|STARTED|Test Period 2 (2 Weeks)||24
7677067|NCT01957488|18905141|P5|STARTED|Test Period 2 (2 Weeks)||27
7677068|NCT01957488|18905142|P4|STARTED|Test Period 2 (2 Weeks)||29
7677069|NCT01957488|18905143|P3|STARTED|Test Period 2 (2 Weeks)||26
7677070|NCT01957488|18905144|P2|STARTED|Test Period 2 (2 Weeks)||28
7677071|NCT01957488|18905145|P1|STARTED|Test Period 2 (2 Weeks)||27
7677072|NCT01957488|18905140|P6|NOT COMPLETED|Test Period 1 (2 Weeks)||6
7677073|NCT01957488|18905141|P5|NOT COMPLETED|Test Period 1 (2 Weeks)||3
7677074|NCT01957488|18905142|P4|NOT COMPLETED|Test Period 1 (2 Weeks)||3
7677075|NCT01957488|18905143|P3|NOT COMPLETED|Test Period 1 (2 Weeks)||4
7677076|NCT01957488|18905144|P2|NOT COMPLETED|Test Period 1 (2 Weeks)||3
7677077|NCT01957488|18905145|P1|NOT COMPLETED|Test Period 1 (2 Weeks)||3
7677078|NCT01957488|18905140|P6|COMPLETED|Test Period 1 (2 Weeks)||24
7677079|NCT01957488|18905141|P5|COMPLETED|Test Period 1 (2 Weeks)||27
7677080|NCT01957488|18905142|P4|COMPLETED|Test Period 1 (2 Weeks)||29
7677081|NCT01957488|18905143|P3|COMPLETED|Test Period 1 (2 Weeks)||26
7677082|NCT01957488|18905144|P2|COMPLETED|Test Period 1 (2 Weeks)||28
7677083|NCT01957488|18905145|P1|COMPLETED|Test Period 1 (2 Weeks)||27
7677084|NCT01957488|18905140|P6|STARTED|Test Period 1 (2 Weeks)||30
7677085|NCT01957488|18905141|P5|STARTED|Test Period 1 (2 Weeks)||30
7677086|NCT01957488|18905142|P4|STARTED|Test Period 1 (2 Weeks)||32
7677087|NCT01957488|18905143|P3|STARTED|Test Period 1 (2 Weeks)||30
7677088|NCT01957488|18905144|P2|STARTED|Test Period 1 (2 Weeks)||31
7677089|NCT01957488|18905145|P1|STARTED|Test Period 1 (2 Weeks)||30
7677090|NCT01957475|18905153|P2|NOT COMPLETED|Test Period 2||0
7677091|NCT01957475|18905154|P1|NOT COMPLETED|Test Period 2||1
7677092|NCT01957475|18905153|P2|COMPLETED|Test Period 2||8
7677093|NCT01957475|18905154|P1|COMPLETED|Test Period 2||8
7677094|NCT01957475|18905153|P2|STARTED|Test Period 2||8
7677095|NCT01957475|18905154|P1|STARTED|Test Period 2||9
7677096|NCT01957475|18905153|P2|NOT COMPLETED|Test Period 1||1
7677097|NCT01957475|18905154|P1|NOT COMPLETED|Test Period 1||2
7677098|NCT01957475|18905153|P2|COMPLETED|Test Period 1||9
7677099|NCT01957475|18905154|P1|COMPLETED|Test Period 1||8
7677100|NCT01957475|18905153|P2|STARTED|Test Period 1||10
7677101|NCT01957475|18905154|P1|STARTED|Test Period 1||10
7677102|NCT01957462|18905160|P2|NOT COMPLETED|Test Period 2||0
7677103|NCT01957462|18905161|P1|NOT COMPLETED|Test Period 2||0
7677104|NCT01957462|18905160|P2|COMPLETED|Test Period 2||15
7677105|NCT01957462|18905161|P1|COMPLETED|Test Period 2||14
7677106|NCT01957462|18905160|P2|STARTED|Test Period 2||15
7677107|NCT01957462|18905161|P1|STARTED|Test Period 2||14
7677108|NCT01957462|18905160|P2|NOT COMPLETED|Test Period 1||0
7677109|NCT01957462|18905161|P1|NOT COMPLETED|Test Period 1||2
7677110|NCT01957462|18905160|P2|COMPLETED|Test Period 1||15
7677111|NCT01957462|18905161|P1|COMPLETED|Test Period 1||14
7677112|NCT01957462|18905160|P2|STARTED|Test Period 1||15
7677113|NCT01957462|18905161|P1|STARTED|Test Period 1||16
7677114|NCT01957410|18905167|P1|NOT COMPLETED|Optional Open Label||0
7677115|NCT01957410|18905167|P1|COMPLETED|Optional Open Label||13
7677116|NCT01957410|18905167|P1|STARTED|Optional Open Label||13
7677117|NCT01957410|18905167|P1|NOT COMPLETED|Open Label||0
7677118|NCT01957410|18905167|P1|COMPLETED|Open Label||13
7677119|NCT01957410|18905167|P1|STARTED|Open Label||13
7677120|NCT01957397|18905172|P2|NOT COMPLETED|Test Period 3||2
7677121|NCT01957397|18905173|P1|NOT COMPLETED|Test Period 3||2
7677122|NCT01957397|18905172|P2|COMPLETED|Test Period 3||9
7677123|NCT01957397|18905173|P1|COMPLETED|Test Period 3||9
7677124|NCT01957397|18905172|P2|STARTED|Test Period 3||11
7677125|NCT01957397|18905173|P1|STARTED|Test Period 3||11
7677126|NCT01957397|18905172|P2|NOT COMPLETED|Test Period 2||1
7677127|NCT01957397|18905173|P1|NOT COMPLETED|Test Period 2||0
7677128|NCT01957397|18905172|P2|COMPLETED|Test Period 2||11
7677129|NCT01957397|18905173|P1|COMPLETED|Test Period 2||11
7677130|NCT01957397|18905172|P2|STARTED|Test Period 2||12
7677131|NCT01957397|18905173|P1|STARTED|Test Period 2||11
7677132|NCT01957397|18905172|P2|NOT COMPLETED|Test Period 1||1
7677133|NCT01957397|18905173|P1|NOT COMPLETED|Test Period 1||2
7677134|NCT01957397|18905172|P2|COMPLETED|Test Period 1||12
7677135|NCT01957397|18905173|P1|COMPLETED|Test Period 1||11
7677136|NCT01957397|18905172|P2|STARTED|Test Period 1||13
7677137|NCT01957397|18905173|P1|STARTED|Test Period 1||13
7677138|NCT01957397|18905172|P2|NOT COMPLETED|Baseline Own Product||0
7677139|NCT01957397|18905173|P1|NOT COMPLETED|Baseline Own Product||0
7677140|NCT01957397|18905172|P2|COMPLETED|Baseline Own Product||13
7677141|NCT01957397|18905173|P1|COMPLETED|Baseline Own Product||13
7677142|NCT01957397|18905172|P2|STARTED|Baseline Own Product||13
7677143|NCT01957397|18905173|P1|STARTED|Baseline Own Product||13
7677144|NCT01957384|18905183|P6|NOT COMPLETED|Test Period 3 (14 Days)||0
7677145|NCT01957384|18905184|P5|NOT COMPLETED|Test Period 3 (14 Days)||0
7677146|NCT01957384|18905185|P4|NOT COMPLETED|Test Period 3 (14 Days)||0
7677147|NCT01957384|18905186|P3|NOT COMPLETED|Test Period 3 (14 Days)||0
7677148|NCT01957384|18905187|P2|NOT COMPLETED|Test Period 3 (14 Days)||0
7677149|NCT01957384|18905188|P1|NOT COMPLETED|Test Period 3 (14 Days)||0
7677150|NCT01957384|18905183|P6|COMPLETED|Test Period 3 (14 Days)||3
7677151|NCT01957384|18905184|P5|COMPLETED|Test Period 3 (14 Days)||3
7677152|NCT01957384|18905185|P4|COMPLETED|Test Period 3 (14 Days)||4
7677153|NCT01957384|18905186|P3|COMPLETED|Test Period 3 (14 Days)||4
7677154|NCT01957384|18905187|P2|COMPLETED|Test Period 3 (14 Days)||4
7677155|NCT01957384|18905188|P1|COMPLETED|Test Period 3 (14 Days)||4
7677156|NCT01957384|18905183|P6|STARTED|Test Period 3 (14 Days)||3
7677157|NCT01957384|18905184|P5|STARTED|Test Period 3 (14 Days)||3
7677158|NCT01957384|18905185|P4|STARTED|Test Period 3 (14 Days)||4
7677159|NCT01957384|18905186|P3|STARTED|Test Period 3 (14 Days)||4
7677160|NCT01957384|18905187|P2|STARTED|Test Period 3 (14 Days)||4
7677161|NCT01957384|18905188|P1|STARTED|Test Period 3 (14 Days)||4
7677162|NCT01957384|18905183|P6|NOT COMPLETED|Test Period 2 (14 Days)||0
7677163|NCT01957384|18905184|P5|NOT COMPLETED|Test Period 2 (14 Days)||0
7677164|NCT01957384|18905185|P4|NOT COMPLETED|Test Period 2 (14 Days)||0
7677165|NCT01957384|18905186|P3|NOT COMPLETED|Test Period 2 (14 Days)||0
7677166|NCT01957384|18905187|P2|NOT COMPLETED|Test Period 2 (14 Days)||0
7677167|NCT01957384|18905188|P1|NOT COMPLETED|Test Period 2 (14 Days)||0
7677168|NCT01957384|18905183|P6|COMPLETED|Test Period 2 (14 Days)||3
7677169|NCT01957384|18905184|P5|COMPLETED|Test Period 2 (14 Days)||3
7677170|NCT01957384|18905185|P4|COMPLETED|Test Period 2 (14 Days)||4
7677171|NCT01957384|18905186|P3|COMPLETED|Test Period 2 (14 Days)||4
7677172|NCT01957384|18905187|P2|COMPLETED|Test Period 2 (14 Days)||4
7677173|NCT01957384|18905188|P1|COMPLETED|Test Period 2 (14 Days)||4
7677174|NCT01957384|18905183|P6|STARTED|Test Period 2 (14 Days)||3
7677175|NCT01957384|18905184|P5|STARTED|Test Period 2 (14 Days)||3
7677176|NCT01957384|18905185|P4|STARTED|Test Period 2 (14 Days)||4
7677177|NCT01957384|18905186|P3|STARTED|Test Period 2 (14 Days)||4
7677178|NCT01957384|18905187|P2|STARTED|Test Period 2 (14 Days)||4
7677179|NCT01957384|18905188|P1|STARTED|Test Period 2 (14 Days)||4
7677180|NCT01957384|18905183|P6|NOT COMPLETED|Test Period 1 (14 Days)||0
7677181|NCT01957384|18905184|P5|NOT COMPLETED|Test Period 1 (14 Days)||0
7677182|NCT01957384|18905185|P4|NOT COMPLETED|Test Period 1 (14 Days)||0
7677183|NCT01957384|18905186|P3|NOT COMPLETED|Test Period 1 (14 Days)||0
7677184|NCT01957384|18905187|P2|NOT COMPLETED|Test Period 1 (14 Days)||0
7677185|NCT01957384|18905188|P1|NOT COMPLETED|Test Period 1 (14 Days)||0
7677186|NCT01957384|18905183|P6|COMPLETED|Test Period 1 (14 Days)||3
7677187|NCT01957384|18905184|P5|COMPLETED|Test Period 1 (14 Days)||3
7677188|NCT01957384|18905185|P4|COMPLETED|Test Period 1 (14 Days)||4
7677189|NCT01957384|18905186|P3|COMPLETED|Test Period 1 (14 Days)||4
7677190|NCT01957384|18905187|P2|COMPLETED|Test Period 1 (14 Days)||4
7677191|NCT01957384|18905188|P1|COMPLETED|Test Period 1 (14 Days)||4
7677192|NCT01957384|18905183|P6|STARTED|Test Period 1 (14 Days)||3
7677193|NCT01957384|18905184|P5|STARTED|Test Period 1 (14 Days)||3
7677194|NCT01957384|18905185|P4|STARTED|Test Period 1 (14 Days)||4
7677195|NCT01957384|18905186|P3|STARTED|Test Period 1 (14 Days)||4
7677196|NCT01957384|18905187|P2|STARTED|Test Period 1 (14 Days)||4
7677197|NCT01957384|18905188|P1|STARTED|Test Period 1 (14 Days)||4
7677198|NCT01957215|18905198|P2|NOT COMPLETED|Overall Study||12
7677199|NCT01957215|18905199|P1|NOT COMPLETED|Overall Study||13
7677200|NCT01957215|18905198|P2|COMPLETED|Overall Study||123
7677201|NCT01957215|18905199|P1|COMPLETED|Overall Study||122
7677202|NCT01957215|18905198|P2|STARTED|Overall Study||135
7677203|NCT01957215|18905199|P1|STARTED|Overall Study||135
7677204|NCT01957202|18905227|P18|NOT COMPLETED|Treatment Period 3 (8 Days)||0
7677205|NCT01957202|18905228|P17|NOT COMPLETED|Treatment Period 3 (8 Days)||1
7677206|NCT01957202|18905229|P16|NOT COMPLETED|Treatment Period 3 (8 Days)||0
7677207|NCT01957202|18905230|P15|NOT COMPLETED|Treatment Period 3 (8 Days)||0
7677208|NCT01957202|18905231|P14|NOT COMPLETED|Treatment Period 3 (8 Days)||0
7677209|NCT01957202|18905232|P13|NOT COMPLETED|Treatment Period 3 (8 Days)||0
7677210|NCT01957202|18905233|P12|NOT COMPLETED|Treatment Period 3 (8 Days)||0
7677211|NCT01957202|18905234|P11|NOT COMPLETED|Treatment Period 3 (8 Days)||0
7677212|NCT01957202|18905235|P10|NOT COMPLETED|Treatment Period 3 (8 Days)||0
7677213|NCT01957202|18905236|P9|NOT COMPLETED|Treatment Period 3 (8 Days)||0
7677214|NCT01957202|18905237|P8|NOT COMPLETED|Treatment Period 3 (8 Days)||0
7677215|NCT01957202|18905238|P7|NOT COMPLETED|Treatment Period 3 (8 Days)||0
7677216|NCT01957202|18905239|P6|NOT COMPLETED|Treatment Period 3 (8 Days)||0
7677217|NCT01957202|18905240|P5|NOT COMPLETED|Treatment Period 3 (8 Days)||0
7677218|NCT01957202|18905241|P4|NOT COMPLETED|Treatment Period 3 (8 Days)||0
7677219|NCT01957202|18905242|P3|NOT COMPLETED|Treatment Period 3 (8 Days)||0
7677220|NCT01957202|18905243|P2|NOT COMPLETED|Treatment Period 3 (8 Days)||0
7677221|NCT01957202|18905244|P1|NOT COMPLETED|Treatment Period 3 (8 Days)||0
7677222|NCT01957202|18905227|P18|COMPLETED|Treatment Period 3 (8 Days)||3
7677223|NCT01957202|18905228|P17|COMPLETED|Treatment Period 3 (8 Days)||4
7677224|NCT01957202|18905229|P16|COMPLETED|Treatment Period 3 (8 Days)||3
7677225|NCT01957202|18905230|P15|COMPLETED|Treatment Period 3 (8 Days)||6
7677226|NCT01957202|18905231|P14|COMPLETED|Treatment Period 3 (8 Days)||3
7677227|NCT01957202|18905232|P13|COMPLETED|Treatment Period 3 (8 Days)||3
7677228|NCT01957202|18905233|P12|COMPLETED|Treatment Period 3 (8 Days)||6
7677229|NCT01957202|18905234|P11|COMPLETED|Treatment Period 3 (8 Days)||3
7677230|NCT01957202|18905235|P10|COMPLETED|Treatment Period 3 (8 Days)||6
7677231|NCT01957202|18905236|P9|COMPLETED|Treatment Period 3 (8 Days)||3
7677232|NCT01957202|18905237|P8|COMPLETED|Treatment Period 3 (8 Days)||3
7677233|NCT01957202|18905238|P7|COMPLETED|Treatment Period 3 (8 Days)||3
7677234|NCT01957202|18905239|P6|COMPLETED|Treatment Period 3 (8 Days)||2
7677235|NCT01957202|18905240|P5|COMPLETED|Treatment Period 3 (8 Days)||3
7677236|NCT01957202|18905241|P4|COMPLETED|Treatment Period 3 (8 Days)||3
7677237|NCT01957202|18905242|P3|COMPLETED|Treatment Period 3 (8 Days)||6
7677238|NCT01957202|18905243|P2|COMPLETED|Treatment Period 3 (8 Days)||5
7677239|NCT01957202|18905244|P1|COMPLETED|Treatment Period 3 (8 Days)||3
7677240|NCT01957202|18905227|P18|STARTED|Treatment Period 3 (8 Days)||3
7677241|NCT01957202|18905228|P17|STARTED|Treatment Period 3 (8 Days)||5
7677242|NCT01957202|18905229|P16|STARTED|Treatment Period 3 (8 Days)||3
7677243|NCT01957202|18905230|P15|STARTED|Treatment Period 3 (8 Days)||6
7677244|NCT01957202|18905231|P14|STARTED|Treatment Period 3 (8 Days)||3
7677245|NCT01957202|18905232|P13|STARTED|Treatment Period 3 (8 Days)||3
7677246|NCT01957202|18905233|P12|STARTED|Treatment Period 3 (8 Days)||6
7677247|NCT01957202|18905234|P11|STARTED|Treatment Period 3 (8 Days)||3
7677248|NCT01957202|18905235|P10|STARTED|Treatment Period 3 (8 Days)||6
7677249|NCT01957202|18905236|P9|STARTED|Treatment Period 3 (8 Days)||3
7677250|NCT01957202|18905237|P8|STARTED|Treatment Period 3 (8 Days)||3
7677251|NCT01957202|18905238|P7|STARTED|Treatment Period 3 (8 Days)||3
7677252|NCT01957202|18905239|P6|STARTED|Treatment Period 3 (8 Days)||2
7677253|NCT01957202|18905240|P5|STARTED|Treatment Period 3 (8 Days)||3
7677254|NCT01957202|18905241|P4|STARTED|Treatment Period 3 (8 Days)||3
7677255|NCT01957202|18905242|P3|STARTED|Treatment Period 3 (8 Days)||6
7677256|NCT01957202|18905243|P2|STARTED|Treatment Period 3 (8 Days)||5
7677257|NCT01957202|18905244|P1|STARTED|Treatment Period 3 (8 Days)||3
7677258|NCT01957202|18905227|P18|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
7677259|NCT01957202|18905228|P17|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
7677260|NCT01957202|18905229|P16|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
7677261|NCT01957202|18905230|P15|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
7677262|NCT01957202|18905231|P14|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
7677263|NCT01957202|18905232|P13|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
7677264|NCT01957202|18905233|P12|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
7677265|NCT01957202|18905234|P11|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
7677266|NCT01957202|18905235|P10|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
7677267|NCT01957202|18905236|P9|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
7677268|NCT01957202|18905237|P8|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
7677269|NCT01957202|18905238|P7|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
7677270|NCT01957202|18905239|P6|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
7677271|NCT01957202|18905240|P5|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
7677272|NCT01957202|18905241|P4|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
7677273|NCT01957202|18905242|P3|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
7677274|NCT01957202|18905243|P2|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
7677275|NCT01957202|18905244|P1|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
7677276|NCT01957202|18905227|P18|COMPLETED|Washout Period 2 (14 to 28 Days)||3
7677277|NCT01957202|18905228|P17|COMPLETED|Washout Period 2 (14 to 28 Days)||5
7677278|NCT01957202|18905229|P16|COMPLETED|Washout Period 2 (14 to 28 Days)||3
7677279|NCT01957202|18905230|P15|COMPLETED|Washout Period 2 (14 to 28 Days)||6
7677280|NCT01957202|18905231|P14|COMPLETED|Washout Period 2 (14 to 28 Days)||3
7677281|NCT01957202|18905232|P13|COMPLETED|Washout Period 2 (14 to 28 Days)||3
7677282|NCT01957202|18905233|P12|COMPLETED|Washout Period 2 (14 to 28 Days)||6
7677283|NCT01957202|18905234|P11|COMPLETED|Washout Period 2 (14 to 28 Days)||3
7677284|NCT01957202|18905235|P10|COMPLETED|Washout Period 2 (14 to 28 Days)||6
7677285|NCT01957202|18905236|P9|COMPLETED|Washout Period 2 (14 to 28 Days)||3
7677286|NCT01957202|18905237|P8|COMPLETED|Washout Period 2 (14 to 28 Days)||3
7677287|NCT01957202|18905238|P7|COMPLETED|Washout Period 2 (14 to 28 Days)||3
7677288|NCT01957202|18905239|P6|COMPLETED|Washout Period 2 (14 to 28 Days)||2
7677289|NCT01957202|18905240|P5|COMPLETED|Washout Period 2 (14 to 28 Days)||3
7677290|NCT01957202|18905241|P4|COMPLETED|Washout Period 2 (14 to 28 Days)||3
7677291|NCT01957202|18905242|P3|COMPLETED|Washout Period 2 (14 to 28 Days)||6
7677292|NCT01957202|18905243|P2|COMPLETED|Washout Period 2 (14 to 28 Days)||5
7677293|NCT01957202|18905244|P1|COMPLETED|Washout Period 2 (14 to 28 Days)||3
7677294|NCT01957202|18905227|P18|STARTED|Washout Period 2 (14 to 28 Days)||3
7677295|NCT01957202|18905228|P17|STARTED|Washout Period 2 (14 to 28 Days)||5
7677296|NCT01957202|18905229|P16|STARTED|Washout Period 2 (14 to 28 Days)||3
7677297|NCT01957202|18905230|P15|STARTED|Washout Period 2 (14 to 28 Days)||6
7677298|NCT01957202|18905231|P14|STARTED|Washout Period 2 (14 to 28 Days)||3
7677299|NCT01957202|18905232|P13|STARTED|Washout Period 2 (14 to 28 Days)||3
7677300|NCT01957202|18905233|P12|STARTED|Washout Period 2 (14 to 28 Days)||6
7677301|NCT01957202|18905234|P11|STARTED|Washout Period 2 (14 to 28 Days)||3
7677302|NCT01957202|18905235|P10|STARTED|Washout Period 2 (14 to 28 Days)||6
7677303|NCT01957202|18905236|P9|STARTED|Washout Period 2 (14 to 28 Days)||3
7677304|NCT01957202|18905237|P8|STARTED|Washout Period 2 (14 to 28 Days)||3
7677305|NCT01957202|18905238|P7|STARTED|Washout Period 2 (14 to 28 Days)||3
7677306|NCT01957202|18905239|P6|STARTED|Washout Period 2 (14 to 28 Days)||2
7677307|NCT01957202|18905240|P5|STARTED|Washout Period 2 (14 to 28 Days)||3
7677308|NCT01957202|18905241|P4|STARTED|Washout Period 2 (14 to 28 Days)||3
7677309|NCT01957202|18905242|P3|STARTED|Washout Period 2 (14 to 28 Days)||6
7677310|NCT01957202|18905243|P2|STARTED|Washout Period 2 (14 to 28 Days)||5
7677311|NCT01957202|18905244|P1|STARTED|Washout Period 2 (14 to 28 Days)||3
7677312|NCT01957202|18905227|P18|NOT COMPLETED|Treatment Period 2 (8 Days)||0
7677313|NCT01957202|18905228|P17|NOT COMPLETED|Treatment Period 2 (8 Days)||1
7677314|NCT01957202|18905229|P16|NOT COMPLETED|Treatment Period 2 (8 Days)||0
7677315|NCT01957202|18905230|P15|NOT COMPLETED|Treatment Period 2 (8 Days)||0
7677316|NCT01957202|18905231|P14|NOT COMPLETED|Treatment Period 2 (8 Days)||0
7677317|NCT01957202|18905232|P13|NOT COMPLETED|Treatment Period 2 (8 Days)||0
7677318|NCT01957202|18905233|P12|NOT COMPLETED|Treatment Period 2 (8 Days)||0
7677319|NCT01957202|18905234|P11|NOT COMPLETED|Treatment Period 2 (8 Days)||0
7677320|NCT01957202|18905235|P10|NOT COMPLETED|Treatment Period 2 (8 Days)||0
7677321|NCT01957202|18905236|P9|NOT COMPLETED|Treatment Period 2 (8 Days)||0
7677322|NCT01957202|18905237|P8|NOT COMPLETED|Treatment Period 2 (8 Days)||0
7677323|NCT01957202|18905238|P7|NOT COMPLETED|Treatment Period 2 (8 Days)||0
7677324|NCT01957202|18905239|P6|NOT COMPLETED|Treatment Period 2 (8 Days)||0
7677325|NCT01957202|18905240|P5|NOT COMPLETED|Treatment Period 2 (8 Days)||0
7677326|NCT01957202|18905241|P4|NOT COMPLETED|Treatment Period 2 (8 Days)||0
7677327|NCT01957202|18905242|P3|NOT COMPLETED|Treatment Period 2 (8 Days)||0
7677328|NCT01957202|18905243|P2|NOT COMPLETED|Treatment Period 2 (8 Days)||1
7677329|NCT01957202|18905244|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
7677330|NCT01957202|18905227|P18|COMPLETED|Treatment Period 2 (8 Days)||3
7677331|NCT01957202|18905228|P17|COMPLETED|Treatment Period 2 (8 Days)||5
7677332|NCT01957202|18905229|P16|COMPLETED|Treatment Period 2 (8 Days)||3
7677333|NCT01957202|18905230|P15|COMPLETED|Treatment Period 2 (8 Days)||6
7677334|NCT01957202|18905231|P14|COMPLETED|Treatment Period 2 (8 Days)||3
7677335|NCT01957202|18905232|P13|COMPLETED|Treatment Period 2 (8 Days)||3
7677336|NCT01957202|18905233|P12|COMPLETED|Treatment Period 2 (8 Days)||6
7677337|NCT01957202|18905234|P11|COMPLETED|Treatment Period 2 (8 Days)||3
7677338|NCT01957202|18905235|P10|COMPLETED|Treatment Period 2 (8 Days)||6
7677339|NCT01957202|18905236|P9|COMPLETED|Treatment Period 2 (8 Days)||3
7677340|NCT01957202|18905237|P8|COMPLETED|Treatment Period 2 (8 Days)||3
7677341|NCT01957202|18905238|P7|COMPLETED|Treatment Period 2 (8 Days)||3
7677342|NCT01957202|18905239|P6|COMPLETED|Treatment Period 2 (8 Days)||2
7677343|NCT01957202|18905240|P5|COMPLETED|Treatment Period 2 (8 Days)||3
7677344|NCT01957202|18905241|P4|COMPLETED|Treatment Period 2 (8 Days)||3
7677345|NCT01957202|18905242|P3|COMPLETED|Treatment Period 2 (8 Days)||6
7677346|NCT01957202|18905243|P2|COMPLETED|Treatment Period 2 (8 Days)||5
7677347|NCT01957202|18905244|P1|COMPLETED|Treatment Period 2 (8 Days)||3
7677348|NCT01957202|18905227|P18|STARTED|Treatment Period 2 (8 Days)||3
7677349|NCT01957202|18905228|P17|STARTED|Treatment Period 2 (8 Days)||6
7677350|NCT01957202|18905229|P16|STARTED|Treatment Period 2 (8 Days)||3
7677351|NCT01957202|18905230|P15|STARTED|Treatment Period 2 (8 Days)||6
7677352|NCT01957202|18905231|P14|STARTED|Treatment Period 2 (8 Days)||3
7677353|NCT01957202|18905232|P13|STARTED|Treatment Period 2 (8 Days)||3
7677354|NCT01957202|18905233|P12|STARTED|Treatment Period 2 (8 Days)||6
7677355|NCT01957202|18905234|P11|STARTED|Treatment Period 2 (8 Days)||3
7677356|NCT01957202|18905235|P10|STARTED|Treatment Period 2 (8 Days)||6
7677357|NCT01957202|18905236|P9|STARTED|Treatment Period 2 (8 Days)||3
7677358|NCT01957202|18905237|P8|STARTED|Treatment Period 2 (8 Days)||3
7677359|NCT01957202|18905238|P7|STARTED|Treatment Period 2 (8 Days)||3
7677360|NCT01957202|18905239|P6|STARTED|Treatment Period 2 (8 Days)||2
7677361|NCT01957202|18905240|P5|STARTED|Treatment Period 2 (8 Days)||3
7677362|NCT01957202|18905241|P4|STARTED|Treatment Period 2 (8 Days)||3
7677363|NCT01957202|18905242|P3|STARTED|Treatment Period 2 (8 Days)||6
7677364|NCT01957202|18905243|P2|STARTED|Treatment Period 2 (8 Days)||6
7677365|NCT01957202|18905244|P1|STARTED|Treatment Period 2 (8 Days)||3
7677366|NCT01957202|18905227|P18|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
7677367|NCT01957202|18905228|P17|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
7677368|NCT01957202|18905229|P16|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
7677369|NCT01957202|18905230|P15|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
7677370|NCT01957202|18905231|P14|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
7677371|NCT01957202|18905232|P13|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
7677372|NCT01957202|18905233|P12|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
7677373|NCT01957202|18905234|P11|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
7677374|NCT01957202|18905235|P10|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
7677375|NCT01957202|18905236|P9|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
7677376|NCT01957202|18905237|P8|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
7677377|NCT01957202|18905238|P7|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
7677378|NCT01957202|18905239|P6|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
7677379|NCT01957202|18905240|P5|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
7677380|NCT01957202|18905241|P4|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
7677381|NCT01957202|18905242|P3|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
7677382|NCT01957202|18905243|P2|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
7677383|NCT01957202|18905244|P1|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
7677384|NCT01957202|18905227|P18|COMPLETED|Washout Period 1 (14 to 28 Days)||3
7677385|NCT01957202|18905228|P17|COMPLETED|Washout Period 1 (14 to 28 Days)||6
7677386|NCT01957202|18905229|P16|COMPLETED|Washout Period 1 (14 to 28 Days)||3
7677387|NCT01957202|18905230|P15|COMPLETED|Washout Period 1 (14 to 28 Days)||6
7677388|NCT01957202|18905231|P14|COMPLETED|Washout Period 1 (14 to 28 Days)||3
7677389|NCT01957202|18905232|P13|COMPLETED|Washout Period 1 (14 to 28 Days)||3
7677390|NCT01957202|18905233|P12|COMPLETED|Washout Period 1 (14 to 28 Days)||6
7677391|NCT01957202|18905234|P11|COMPLETED|Washout Period 1 (14 to 28 Days)||3
7677392|NCT01957202|18905235|P10|COMPLETED|Washout Period 1 (14 to 28 Days)||6
7677393|NCT01957202|18905236|P9|COMPLETED|Washout Period 1 (14 to 28 Days)||3
7677394|NCT01957202|18905237|P8|COMPLETED|Washout Period 1 (14 to 28 Days)||3
7677395|NCT01957202|18905238|P7|COMPLETED|Washout Period 1 (14 to 28 Days)||3
7677396|NCT01957202|18905239|P6|COMPLETED|Washout Period 1 (14 to 28 Days)||2
7677397|NCT01957202|18905240|P5|COMPLETED|Washout Period 1 (14 to 28 Days)||3
7677398|NCT01957202|18905241|P4|COMPLETED|Washout Period 1 (14 to 28 Days)||3
7677399|NCT01957202|18905242|P3|COMPLETED|Washout Period 1 (14 to 28 Days)||6
7677400|NCT01957202|18905243|P2|COMPLETED|Washout Period 1 (14 to 28 Days)||6
7677401|NCT01957202|18905244|P1|COMPLETED|Washout Period 1 (14 to 28 Days)||3
7677402|NCT01957202|18905227|P18|STARTED|Washout Period 1 (14 to 28 Days)||3
7677403|NCT01957202|18905228|P17|STARTED|Washout Period 1 (14 to 28 Days)||6
7677404|NCT01957202|18905229|P16|STARTED|Washout Period 1 (14 to 28 Days)||3
7677405|NCT01957202|18905230|P15|STARTED|Washout Period 1 (14 to 28 Days)||6
7677406|NCT01957202|18905231|P14|STARTED|Washout Period 1 (14 to 28 Days)||3
7677407|NCT01957202|18905232|P13|STARTED|Washout Period 1 (14 to 28 Days)||3
7677408|NCT01957202|18905233|P12|STARTED|Washout Period 1 (14 to 28 Days)||6
7677409|NCT01957202|18905234|P11|STARTED|Washout Period 1 (14 to 28 Days)||3
7677410|NCT01957202|18905235|P10|STARTED|Washout Period 1 (14 to 28 Days)||6
7677411|NCT01957202|18905236|P9|STARTED|Washout Period 1 (14 to 28 Days)||3
7677412|NCT01957202|18905237|P8|STARTED|Washout Period 1 (14 to 28 Days)||3
7677413|NCT01957202|18905238|P7|STARTED|Washout Period 1 (14 to 28 Days)||3
7677414|NCT01957202|18905239|P6|STARTED|Washout Period 1 (14 to 28 Days)||2
7677415|NCT01957202|18905240|P5|STARTED|Washout Period 1 (14 to 28 Days)||3
7677416|NCT01957202|18905241|P4|STARTED|Washout Period 1 (14 to 28 Days)||3
7677417|NCT01957202|18905242|P3|STARTED|Washout Period 1 (14 to 28 Days)||6
7677418|NCT01957202|18905243|P2|STARTED|Washout Period 1 (14 to 28 Days)||6
7677419|NCT01957202|18905244|P1|STARTED|Washout Period 1 (14 to 28 Days)||3
7677420|NCT01957202|18905227|P18|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7677421|NCT01957202|18905228|P17|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7677422|NCT01957202|18905229|P16|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7677423|NCT01957202|18905230|P15|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7677424|NCT01957202|18905231|P14|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7677425|NCT01957202|18905232|P13|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7677426|NCT01957202|18905233|P12|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7677427|NCT01957202|18905234|P11|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7677428|NCT01957202|18905235|P10|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7677429|NCT01957202|18905236|P9|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7677430|NCT01957202|18905237|P8|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7677431|NCT01957202|18905238|P7|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7677432|NCT01957202|18905239|P6|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7677433|NCT01957202|18905240|P5|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7677434|NCT01957202|18905241|P4|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7677435|NCT01957202|18905242|P3|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7677436|NCT01957202|18905243|P2|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7677437|NCT01957202|18905244|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
7677438|NCT01957202|18905227|P18|COMPLETED|Treatment Period 1 (8 Days)||3
7677439|NCT01957202|18905228|P17|COMPLETED|Treatment Period 1 (8 Days)||6
7677440|NCT01957202|18905229|P16|COMPLETED|Treatment Period 1 (8 Days)||3
7677441|NCT01957202|18905230|P15|COMPLETED|Treatment Period 1 (8 Days)||6
7677442|NCT01957202|18905231|P14|COMPLETED|Treatment Period 1 (8 Days)||3
7677443|NCT01957202|18905232|P13|COMPLETED|Treatment Period 1 (8 Days)||3
7677444|NCT01957202|18905233|P12|COMPLETED|Treatment Period 1 (8 Days)||6
7677445|NCT01957202|18905234|P11|COMPLETED|Treatment Period 1 (8 Days)||3
7677446|NCT01957202|18905235|P10|COMPLETED|Treatment Period 1 (8 Days)||6
7677447|NCT01957202|18905236|P9|COMPLETED|Treatment Period 1 (8 Days)||3
7677448|NCT01957202|18905237|P8|COMPLETED|Treatment Period 1 (8 Days)||3
7677449|NCT01957202|18905238|P7|COMPLETED|Treatment Period 1 (8 Days)||3
7677450|NCT01957202|18905239|P6|COMPLETED|Treatment Period 1 (8 Days)||2
7677451|NCT01957202|18905240|P5|COMPLETED|Treatment Period 1 (8 Days)||3
7677452|NCT01957202|18905241|P4|COMPLETED|Treatment Period 1 (8 Days)||3
7677453|NCT01957202|18905242|P3|COMPLETED|Treatment Period 1 (8 Days)||6
7677454|NCT01957202|18905243|P2|COMPLETED|Treatment Period 1 (8 Days)||6
7677455|NCT01957202|18905244|P1|COMPLETED|Treatment Period 1 (8 Days)||3
7677456|NCT01957202|18905227|P18|STARTED|Treatment Period 1 (8 Days)||3
7677457|NCT01957202|18905228|P17|STARTED|Treatment Period 1 (8 Days)||6
7677458|NCT01957202|18905229|P16|STARTED|Treatment Period 1 (8 Days)||3
7677459|NCT01957202|18905230|P15|STARTED|Treatment Period 1 (8 Days)||6
7677460|NCT01957202|18905231|P14|STARTED|Treatment Period 1 (8 Days)||3
7677461|NCT01957202|18905232|P13|STARTED|Treatment Period 1 (8 Days)||3
7677462|NCT01957202|18905233|P12|STARTED|Treatment Period 1 (8 Days)||6
7677463|NCT01957202|18905234|P11|STARTED|Treatment Period 1 (8 Days)||3
7677464|NCT01957202|18905235|P10|STARTED|Treatment Period 1 (8 Days)||6
7677465|NCT01957202|18905236|P9|STARTED|Treatment Period 1 (8 Days)||3
7677466|NCT01957202|18905237|P8|STARTED|Treatment Period 1 (8 Days)||3
7677467|NCT01957202|18905238|P7|STARTED|Treatment Period 1 (8 Days)||3
7677468|NCT01957202|18905239|P6|STARTED|Treatment Period 1 (8 Days)||2
7677469|NCT01957202|18905240|P5|STARTED|Treatment Period 1 (8 Days)||3
7677470|NCT01957202|18905241|P4|STARTED|Treatment Period 1 (8 Days)||3
7677471|NCT01957202|18905242|P3|STARTED|Treatment Period 1 (8 Days)||6
7677472|NCT01957202|18905243|P2|STARTED|Treatment Period 1 (8 Days)||6
7677473|NCT01957202|18905244|P1|STARTED|Treatment Period 1 (8 Days)||3
7677474|NCT01957163|18905269|P3|NOT COMPLETED|Overall Study||18
7677475|NCT01957163|18905270|P2|NOT COMPLETED|Overall Study||11
7677476|NCT01957163|18905271|P1|NOT COMPLETED|Overall Study||15
7677477|NCT01957163|18905269|P3|COMPLETED|Overall Study||189
7677478|NCT01957163|18905270|P2|COMPLETED|Overall Study||195
7677479|NCT01957163|18905271|P1|COMPLETED|Overall Study||191
7677480|NCT01957163|18905269|P3|STARTED|Overall Study||207
7677481|NCT01957163|18905270|P2|STARTED|Overall Study||206
7677482|NCT01957163|18905271|P1|STARTED|Overall Study||206
7677483|NCT01957150|18905284|P2|NOT COMPLETED|Overall Study||58
7677484|NCT01957150|18905285|P1|NOT COMPLETED|Overall Study||55
7677485|NCT01957150|18905284|P2|COMPLETED|Overall Study||83
7677486|NCT01957150|18905285|P1|COMPLETED|Overall Study||87
7677487|NCT01957150|18905284|P2|STARTED|Overall Study||141
7677488|NCT01957150|18905285|P1|STARTED|Overall Study||142
7677489|NCT01957137|18905301|P1|NOT COMPLETED|No Stimulation||0
7677490|NCT01957137|18905301|P1|COMPLETED|No Stimulation||28
7677491|NCT01957137|18905301|P1|STARTED|No Stimulation|Following randomized portion, all subjects went through no stimulation for approximately 4 weeks.|28
7677492|NCT01957137|18905301|P1|NOT COMPLETED|Randomized Portion||2
7677493|NCT01957137|18905301|P1|COMPLETED|Randomized Portion||28
7677494|NCT01957137|18905301|P1|Cycling Parameter #3|Randomized Portion|Subjects received Cycling Parameter #3 for approximately 4 weeks.|28
7677495|NCT01957137|18905301|P1|Cycling Parameter #2|Randomized Portion|Subjects received Cycling Parameter #2 for approximately 4 weeks.|28
7677496|NCT01957137|18905301|P1|Cycling Parameter #1|Randomized Portion|Subjects received Cycling Parameter #1 for approximately 4 weeks.|30
7677497|NCT01957137|18905301|P1|Continuous Stimulation|Randomized Portion|Subjects received continuous stimulation for approximately 4 weeks.|29
7677498|NCT01957137|18905301|P1|STARTED|Randomized Portion||30
7677499|NCT01957111|18905331|P2|NOT COMPLETED|Overall Study||1
7677500|NCT01957111|18905332|P1|NOT COMPLETED|Overall Study||1
7677501|NCT01957111|18905331|P2|COMPLETED|Overall Study||15
7677502|NCT01957111|18905332|P1|COMPLETED|Overall Study||15
7677503|NCT01957111|18905331|P2|STARTED|Overall Study||16
7677504|NCT01957111|18905332|P1|STARTED|Overall Study||16
7677505|NCT01957085|18905340|P1|NOT COMPLETED|Overall Study||0
7677506|NCT01957085|18905340|P1|COMPLETED|Overall Study|Per Institutional Review Board, exact dates are not to be reported|366
7677507|NCT01957085|18905340|P1|STARTED|Overall Study|Per Institutional Review Board requirements, exact dates are not to be reported|366
7677508|NCT01956773|18905351|P2|NOT COMPLETED|Overall Study||1
7677509|NCT01956773|18905352|P1|NOT COMPLETED|Overall Study||628
7677510|NCT01956773|18905351|P2|COMPLETED|Overall Study||99
7677511|NCT01956773|18905352|P1|COMPLETED|Overall Study||1892
7677512|NCT01956773|18905351|P2|STARTED|Overall Study||100
7677513|NCT01956773|18905352|P1|STARTED|Overall Study||2520
7677514|NCT01956669|18905370|P7|NOT COMPLETED|Overall Study||6
7677515|NCT01956669|18905371|P6|NOT COMPLETED|Overall Study||4
7677516|NCT01956669|18905372|P5|NOT COMPLETED|Overall Study||4
7677517|NCT01956669|18905373|P4|NOT COMPLETED|Overall Study||10
7677518|NCT01956669|18905374|P3|NOT COMPLETED|Overall Study||10
7677519|NCT01956669|18905375|P2|NOT COMPLETED|Overall Study||11
7677520|NCT01956669|18905376|P1|NOT COMPLETED|Overall Study||12
7677521|NCT01956669|18905370|P7|COMPLETED|Overall Study||0
7677522|NCT01956669|18905371|P6|COMPLETED|Overall Study||0
7677523|NCT01956669|18905372|P5|COMPLETED|Overall Study||0
7677524|NCT01956669|18905373|P4|COMPLETED|Overall Study||0
7677525|NCT01956669|18905374|P3|COMPLETED|Overall Study||0
7677526|NCT01956669|18905375|P2|COMPLETED|Overall Study||0
7677527|NCT01956669|18905376|P1|COMPLETED|Overall Study||0
7677528|NCT01956669|18905370|P7|Per Protocol Set (PP Set)|Overall Study||5
7677529|NCT01956669|18905371|P6|Per Protocol Set (PP Set)|Overall Study||4
7677530|NCT01956669|18905372|P5|Per Protocol Set (PP Set)|Overall Study||4
7677531|NCT01956669|18905373|P4|Per Protocol Set (PP Set)|Overall Study||9
7677532|NCT01956669|18905374|P3|Per Protocol Set (PP Set)|Overall Study||6
7677533|NCT01956669|18905375|P2|Per Protocol Set (PP Set)|Overall Study||10
7677534|NCT01956669|18905376|P1|Per Protocol Set (PP Set)|Overall Study||9
7677535|NCT01956669|18905370|P7|Biomarker Set|Overall Study||3
7677536|NCT01956669|18905371|P6|Biomarker Set|Overall Study||4
7677537|NCT01956669|18905372|P5|Biomarker Set|Overall Study||3
7677538|NCT01956669|18905373|P4|Biomarker Set|Overall Study||9
7677539|NCT01956669|18905374|P3|Biomarker Set|Overall Study||9
7677540|NCT01956669|18905375|P2|Biomarker Set|Overall Study||11
7677541|NCT01956669|18905376|P1|Biomarker Set|Overall Study||12
7677542|NCT01956669|18905370|P7|PKES Set|Overall Study||5
7677543|NCT01956669|18905371|P6|PKES Set|Overall Study||1
7677544|NCT01956669|18905372|P5|PKES Set|Overall Study||1
7677545|NCT01956669|18905373|P4|PKES Set|Overall Study||0
7677546|NCT01956669|18905374|P3|PKES Set|Overall Study||3
7677547|NCT01956669|18905375|P2|PKES Set|Overall Study||0
7677548|NCT01956669|18905376|P1|PKES Set|Overall Study||4
7677549|NCT01956669|18905370|P7|PK Set|Overall Study||6
7677550|NCT01956669|18905371|P6|PK Set|Overall Study||4
7677551|NCT01956669|18905372|P5|PK Set|Overall Study||4
7677552|NCT01956669|18905373|P4|PK Set|Overall Study||10
7677553|NCT01956669|18905374|P3|PK Set|Overall Study||10
7677554|NCT01956669|18905375|P2|PK Set|Overall Study||11
7677555|NCT01956669|18905376|P1|PK Set|Overall Study||11
7677556|NCT01956669|18905370|P7|STARTED|Overall Study||6
7677557|NCT01956669|18905371|P6|STARTED|Overall Study||4
7677558|NCT01956669|18905372|P5|STARTED|Overall Study||4
7677559|NCT01956669|18905373|P4|STARTED|Overall Study||10
7677560|NCT01956669|18905374|P3|STARTED|Overall Study||10
7677561|NCT01956669|18905375|P2|STARTED|Overall Study||11
7677562|NCT01956669|18905376|P1|STARTED|Overall Study||12
7677563|NCT01956435|18905471|P2|NOT COMPLETED|Overall Study||0
7677564|NCT01956435|18905472|P1|NOT COMPLETED|Overall Study||0
7677565|NCT01956435|18905471|P2|COMPLETED|Overall Study||3
7677566|NCT01956435|18905472|P1|COMPLETED|Overall Study||3
7677567|NCT01956435|18905471|P2|STARTED|Overall Study||3
7677568|NCT01956435|18905472|P1|STARTED|Overall Study||3
7677569|NCT01956279|18905481|P2|NOT COMPLETED|Overall Study||14
7677570|NCT01956279|18905482|P1|NOT COMPLETED|Overall Study||14
7677571|NCT01956279|18905481|P2|COMPLETED|Overall Study||74
7677572|NCT01956279|18905482|P1|COMPLETED|Overall Study||68
7677573|NCT01956279|18905481|P2|STARTED|Overall Study||88
7677574|NCT01956279|18905482|P1|STARTED|Overall Study||82
7677575|NCT01956240|18905498|P2|NOT COMPLETED|Overall Study||24
7677576|NCT01956240|18905499|P1|NOT COMPLETED|Overall Study||23
7677577|NCT01956240|18905498|P2|COMPLETED|Overall Study||25
7677578|NCT01956240|18905499|P1|COMPLETED|Overall Study||25
7677579|NCT01956240|18905498|P2|STARTED|Overall Study||49
7677580|NCT01956240|18905499|P1|STARTED|Overall Study||48
7677581|NCT01956123|18905509|P4|NOT COMPLETED|COS Cycle 3||2
7677582|NCT01956123|18905510|P3|NOT COMPLETED|COS Cycle 3||6
7677583|NCT01956123|18905511|P2|NOT COMPLETED|COS Cycle 3||0
7677584|NCT01956123|18905512|P1|NOT COMPLETED|COS Cycle 3||0
7677585|NCT01956123|18905509|P4|COMPLETED|COS Cycle 3||91
7677586|NCT01956123|18905510|P3|COMPLETED|COS Cycle 3||89
7677587|NCT01956123|18905511|P2|COMPLETED|COS Cycle 3||0
7677588|NCT01956123|18905512|P1|COMPLETED|COS Cycle 3||0
7677589|NCT01956123|18905509|P4|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|93
7677590|NCT01956123|18905510|P3|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|95
7677591|NCT01956123|18905511|P2|STARTED|COS Cycle 3||0
7677592|NCT01956123|18905512|P1|STARTED|COS Cycle 3||0
7677593|NCT01956123|18905509|P4|NOT COMPLETED|COS Cycle 2||0
7677594|NCT01956123|18905510|P3|NOT COMPLETED|COS Cycle 2||0
7677595|NCT01956123|18905511|P2|NOT COMPLETED|COS Cycle 2||7
7677596|NCT01956123|18905512|P1|NOT COMPLETED|COS Cycle 2||14
7677597|NCT01956123|18905509|P4|COMPLETED|COS Cycle 2||0
7677598|NCT01956123|18905510|P3|COMPLETED|COS Cycle 2||0
7677599|NCT01956123|18905511|P2|COMPLETED|COS Cycle 2||254
7677600|NCT01956123|18905512|P1|COMPLETED|COS Cycle 2||238
7677601|NCT01956123|18905509|P4|STARTED|COS Cycle 2||0
7677602|NCT01956123|18905510|P3|STARTED|COS Cycle 2||0
7677603|NCT01956123|18905511|P2|STARTED|COS Cycle 2||261
7677604|NCT01956123|18905512|P1|STARTED|COS Cycle 2||252
7677605|NCT01956110|18905564|P2|NOT COMPLETED|Overall Study||22
7677606|NCT01956110|18905565|P1|NOT COMPLETED|Overall Study||35
7677607|NCT01956110|18905564|P2|COMPLETED|Overall Study||639
7677608|NCT01956110|18905565|P1|COMPLETED|Overall Study||630
7677609|NCT01956110|18905564|P2|STARTED|Overall Study||661
7677610|NCT01956110|18905565|P1|STARTED|Overall Study||665
7677611|NCT01956097|18905618|P3|NOT COMPLETED|Overall Study||0
7677612|NCT01956097|18905619|P2|NOT COMPLETED|Overall Study||2
7677613|NCT01956097|18905620|P1|NOT COMPLETED|Overall Study||6
7677614|NCT01956097|18905618|P3|COMPLETED|Overall Study||15
7677615|NCT01956097|18905619|P2|COMPLETED|Overall Study||28
7677616|NCT01956097|18905620|P1|COMPLETED|Overall Study||24
7677617|NCT01956097|18905618|P3|STARTED|Overall Study||15
7677618|NCT01956097|18905619|P2|STARTED|Overall Study||30
7677619|NCT01956097|18905620|P1|STARTED|Overall Study||30
7677620|NCT01956071|18905637|P1|NOT COMPLETED|Overall Study||0
7677621|NCT01956071|18905637|P1|COMPLETED|Overall Study||44
7677622|NCT01956071|18905637|P1|STARTED|Overall Study||44
7677623|NCT01956032|18905641|P1|NOT COMPLETED|Overall Study||0
7677624|NCT01956032|18905641|P1|COMPLETED|Overall Study||15
7677625|NCT01956032|18905641|P1|STARTED|Overall Study||15
7677626|NCT01955954|18905688|P1|NOT COMPLETED|Overall Study||36
7677627|NCT01955954|18905688|P1|COMPLETED|Overall Study|12-months|33
7677628|NCT01955954|18905688|P1|Completed 6-month Assessement|Overall Study||42
7677629|NCT01955954|18905688|P1|Completed 2-month Assessment|Overall Study|Primary endpoint|46
7677630|NCT01955954|18905688|P1|Completed Post-treatment Assessement|Overall Study||48
7677631|NCT01955954|18905688|P1|Completed Treatment|Overall Study||53
7677632|NCT01955954|18905688|P1|Received Treatment|Overall Study||66
7677633|NCT01955954|18905688|P1|STARTED|Overall Study||69
7677634|NCT01955837|18905699|P2|NOT COMPLETED|Overall Study||0
7677635|NCT01955837|18905700|P1|NOT COMPLETED|Overall Study||0
7677636|NCT01955837|18905699|P2|COMPLETED|Overall Study||135
7677637|NCT01955837|18905700|P1|COMPLETED|Overall Study||271
7677638|NCT01955837|18905699|P2|STARTED|Overall Study||135
7677639|NCT01955837|18905700|P1|STARTED|Overall Study||271
7677640|NCT01955733|18905731|P3|NOT COMPLETED|Period 2||21
7677641|NCT01955733|18905732|P2|NOT COMPLETED|Period 2||19
7677642|NCT01955733|18905733|P1|NOT COMPLETED|Period 2||12
7677643|NCT01955733|18905731|P3|COMPLETED|Period 2||8
7677644|NCT01955733|18905732|P2|COMPLETED|Period 2||10
7677645|NCT01955733|18905733|P1|COMPLETED|Period 2||20
7677646|NCT01955733|18905731|P3|STARTED|Period 2||29
7677647|NCT01955733|18905732|P2|STARTED|Period 2||29
7677648|NCT01955733|18905733|P1|STARTED|Period 2||32
7677649|NCT01955733|18905731|P3|NOT COMPLETED|Period 1||0
7677650|NCT01955733|18905732|P2|NOT COMPLETED|Period 1||0
7677651|NCT01955733|18905733|P1|NOT COMPLETED|Period 1||1
7677652|NCT01955733|18905731|P3|COMPLETED|Period 1||29
7677653|NCT01955733|18905732|P2|COMPLETED|Period 1||29
7677654|NCT01955733|18905733|P1|COMPLETED|Period 1||32
7677655|NCT01955733|18905731|P3|STARTED|Period 1||29
7677656|NCT01955733|18905732|P2|STARTED|Period 1||29
7677657|NCT01955733|18905733|P1|STARTED|Period 1||33
7677658|NCT01955720|18905753|P6|NOT COMPLETED|Overall Study||0
7677659|NCT01955720|18905754|P5|NOT COMPLETED|Overall Study||0
7677660|NCT01955720|18905755|P4|NOT COMPLETED|Overall Study||0
7677661|NCT01955720|18905756|P3|NOT COMPLETED|Overall Study||0
7677662|NCT01955720|18905757|P2|NOT COMPLETED|Overall Study||0
7677663|NCT01955720|18905758|P1|NOT COMPLETED|Overall Study||0
7677664|NCT01955720|18905753|P6|COMPLETED|Overall Study||7
7677665|NCT01955720|18905754|P5|COMPLETED|Overall Study||7
7677666|NCT01955720|18905755|P4|COMPLETED|Overall Study||3
7677667|NCT01955720|18905756|P3|COMPLETED|Overall Study||3
7677668|NCT01955720|18905757|P2|COMPLETED|Overall Study||13
7677669|NCT01955720|18905758|P1|COMPLETED|Overall Study||13
7677670|NCT01955720|18905753|P6|Subjects With Moderate Renal Impairment|Overall Study||0
7677671|NCT01955720|18905754|P5|Subjects With Moderate Renal Impairment|Overall Study||0
7677672|NCT01955720|18905755|P4|Subjects With Moderate Renal Impairment|Overall Study||0
7677673|NCT01955720|18905756|P3|Subjects With Moderate Renal Impairment|Overall Study||0
7677674|NCT01955720|18905757|P2|Subjects With Moderate Renal Impairment|Overall Study||3
7677675|NCT01955720|18905758|P1|Subjects With Moderate Renal Impairment|Overall Study||3
7677676|NCT01955720|18905753|P6|Subjects With Mild Renal Impairment|Overall Study||3
7677677|NCT01955720|18905754|P5|Subjects With Mild Renal Impairment|Overall Study||3
7677678|NCT01955720|18905755|P4|Subjects With Mild Renal Impairment|Overall Study||0
7677679|NCT01955720|18905756|P3|Subjects With Mild Renal Impairment|Overall Study||0
7677680|NCT01955720|18905757|P2|Subjects With Mild Renal Impairment|Overall Study||3
7677681|NCT01955720|18905758|P1|Subjects With Mild Renal Impairment|Overall Study||3
7677682|NCT01955720|18905753|P6|Healthy Subjects Aged 65-80|Overall Study||4
7677683|NCT01955720|18905754|P5|Healthy Subjects Aged 65-80|Overall Study||4
7677684|NCT01955720|18905755|P4|Healthy Subjects Aged 65-80|Overall Study||0
7677685|NCT01955720|18905756|P3|Healthy Subjects Aged 65-80|Overall Study||0
7677686|NCT01955720|18905757|P2|Healthy Subjects Aged 65-80|Overall Study||4
7677687|NCT01955720|18905758|P1|Healthy Subjects Aged 65-80|Overall Study||4
7677688|NCT01955720|18905753|P6|Healthy Subjects Aged 45-64|Overall Study||0
7677689|NCT01955720|18905754|P5|Healthy Subjects Aged 45-64|Overall Study||0
7677690|NCT01955720|18905755|P4|Healthy Subjects Aged 45-64|Overall Study||3
7677691|NCT01955720|18905756|P3|Healthy Subjects Aged 45-64|Overall Study||3
7677692|NCT01955720|18905757|P2|Healthy Subjects Aged 45-64|Overall Study||3
7677693|NCT01955720|18905758|P1|Healthy Subjects Aged 45-64|Overall Study||3
7677694|NCT01955720|18905753|P6|STARTED|Overall Study||7
7677695|NCT01955720|18905754|P5|STARTED|Overall Study||7
7677696|NCT01955720|18905755|P4|STARTED|Overall Study||3
7677697|NCT01955720|18905756|P3|STARTED|Overall Study||3
7677698|NCT01955720|18905757|P2|STARTED|Overall Study||13
7677699|NCT01955720|18905758|P1|STARTED|Overall Study||13
7677700|NCT01955707|18905826|P2|NOT COMPLETED|Overall Study||22
7677701|NCT01955707|18905827|P1|NOT COMPLETED|Overall Study||20
7677702|NCT01955707|18905826|P2|COMPLETED|Overall Study||57
7677703|NCT01955707|18905827|P1|COMPLETED|Overall Study||62
7677704|NCT01955707|18905826|P2|Received Total Volume of Study Drug|Overall Study||77
7677705|NCT01955707|18905827|P1|Received Total Volume of Study Drug|Overall Study||82
7677706|NCT01955707|18905826|P2|Dosed|Overall Study||78
7677707|NCT01955707|18905827|P1|Dosed|Overall Study||82
7677708|NCT01955707|18905826|P2|Withdrew Prior to Dosing|Overall Study||1
7677709|NCT01955707|18905827|P1|Withdrew Prior to Dosing|Overall Study||0
7677710|NCT01955707|18905826|P2|STARTED|Overall Study||79
7677711|NCT01955707|18905827|P1|STARTED|Overall Study||82
7677712|NCT01955629|18905851|P1|NOT COMPLETED|Overall Study||0
7677713|NCT01955629|18905851|P1|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4
7677714|NCT01955629|18905851|P1|STARTED|Overall Study||4
7677715|NCT01955564|18905870|P7|NOT COMPLETED|Overall Study||0
7677716|NCT01955564|18905871|P6|NOT COMPLETED|Overall Study||0
7677717|NCT01955564|18905872|P5|NOT COMPLETED|Overall Study||0
7677718|NCT01955564|18905873|P4|NOT COMPLETED|Overall Study||0
7677719|NCT01955564|18905874|P3|NOT COMPLETED|Overall Study||0
7677720|NCT01955564|18905875|P2|NOT COMPLETED|Overall Study||0
7677721|NCT01955564|18905876|P1|NOT COMPLETED|Overall Study||0
7677722|NCT01955564|18905870|P7|COMPLETED|Overall Study||6
7677723|NCT01955564|18905871|P6|COMPLETED|Overall Study||6
7677724|NCT01955564|18905872|P5|COMPLETED|Overall Study||6
7677725|NCT01955564|18905873|P4|COMPLETED|Overall Study||6
7677726|NCT01955564|18905874|P3|COMPLETED|Overall Study||6
7677727|NCT01955564|18905875|P2|COMPLETED|Overall Study||6
7677728|NCT01955564|18905876|P1|COMPLETED|Overall Study||18
7677729|NCT01955564|18905870|P7|STARTED|Overall Study||6
7677730|NCT01955564|18905871|P6|STARTED|Overall Study||6
7677731|NCT01955564|18905872|P5|STARTED|Overall Study||6
7677732|NCT01955564|18905873|P4|STARTED|Overall Study||6
7677733|NCT01955564|18905874|P3|STARTED|Overall Study||6
7677734|NCT01955564|18905875|P2|STARTED|Overall Study||6
7677735|NCT01955564|18905876|P1|STARTED|Overall Study||18
7677736|NCT01955473|18905909|P5|NOT COMPLETED|Overall Study||0
7677737|NCT01955473|18905910|P4|NOT COMPLETED|Overall Study||0
7677738|NCT01955473|18905911|P3|NOT COMPLETED|Overall Study||0
7677739|NCT01955473|18905912|P2|NOT COMPLETED|Overall Study||0
7677740|NCT01955473|18905913|P1|NOT COMPLETED|Overall Study||0
7677741|NCT01955473|18905909|P5|COMPLETED|Overall Study||30
7677742|NCT01955473|18905910|P4|COMPLETED|Overall Study||6
7677743|NCT01955473|18905911|P3|COMPLETED|Overall Study||6
7677744|NCT01955473|18905912|P2|COMPLETED|Overall Study||6
7677745|NCT01955473|18905913|P1|COMPLETED|Overall Study||3
7677746|NCT01955473|18905909|P5|STARTED|Overall Study||30
7677747|NCT01955473|18905910|P4|STARTED|Overall Study||6
7677748|NCT01955473|18905911|P3|STARTED|Overall Study||6
7677749|NCT01955473|18905912|P2|STARTED|Overall Study||6
7677750|NCT01955473|18905913|P1|STARTED|Overall Study||3
7677751|NCT01955434|18906067|P1|NOT COMPLETED|Overall Study||0
7677752|NCT01955434|18906067|P1|COMPLETED|Overall Study||25
7677753|NCT01955434|18906067|P1|STARTED|Overall Study||25
7677754|NCT01955382|18906077|P2|NOT COMPLETED|Overall Study||0
7677755|NCT01955382|18906078|P1|NOT COMPLETED|Overall Study||0
7677756|NCT01955382|18906077|P2|COMPLETED|Overall Study||35
7677757|NCT01955382|18906078|P1|COMPLETED|Overall Study||35
7677758|NCT01955382|18906077|P2|STARTED|Overall Study||35
7677759|NCT01955382|18906078|P1|STARTED|Overall Study||35
7677760|NCT01955369|18906086|P1|NOT COMPLETED|Overall Study||0
7677761|NCT01955369|18906086|P1|COMPLETED|Overall Study||200
7677762|NCT01955369|18906086|P1|STARTED|Overall Study||200
7677763|NCT01955161|18906095|P3|NOT COMPLETED|Overall Study||35
7677764|NCT01955161|18906096|P2|NOT COMPLETED|Overall Study||25
7677765|NCT01955161|18906097|P1|NOT COMPLETED|Overall Study||27
7677766|NCT01955161|18906095|P3|COMPLETED|Overall Study||275
7677767|NCT01955161|18906096|P2|COMPLETED|Overall Study||288
7677768|NCT01955161|18906097|P1|COMPLETED|Overall Study||283
7677769|NCT01955161|18906095|P3|Treated|Overall Study||309
7677770|NCT01955161|18906096|P2|Treated|Overall Study||313
7677771|NCT01955161|18906097|P1|Treated|Overall Study||308
7677772|NCT01955161|18906095|P3|STARTED|Overall Study||310
7677773|NCT01955161|18906096|P2|STARTED|Overall Study||313
7677774|NCT01955161|18906097|P1|STARTED|Overall Study||310
7677775|NCT01955122|18906137|P2|NOT COMPLETED|Overall Study||5
7677776|NCT01955122|18906138|P1|NOT COMPLETED|Overall Study||5
7677777|NCT01955122|18906137|P2|COMPLETED|Overall Study||57
7677778|NCT01955122|18906138|P1|COMPLETED|Overall Study||59
7677779|NCT01955122|18906137|P2|No. Patients Completed Double Procedure|Overall Study||57
7677780|NCT01955122|18906138|P1|No. Patients Completed Double Procedure|Overall Study||59
7677781|NCT01955122|18906137|P2|No.Patients Enrolled|Overall Study||62
7677782|NCT01955122|18906138|P1|No.Patients Enrolled|Overall Study||64
7677783|NCT01955122|18906137|P2|STARTED|Overall Study|"Excluded (n = 5)
~Included in analysis (n = 57)"|62
7677784|NCT01955122|18906138|P1|STARTED|Overall Study|"Excluded (n = 5)
~Included in analysis (n = 59)"|64
7677785|NCT01955083|18906158|P2|NOT COMPLETED|Overall Study||1
7677786|NCT01955083|18906159|P1|NOT COMPLETED|Overall Study||1
7677787|NCT01955083|18906158|P2|COMPLETED|Overall Study||14
7677788|NCT01955083|18906159|P1|COMPLETED|Overall Study||14
7677789|NCT01955083|18906158|P2|STARTED|Overall Study||15
7677790|NCT01955083|18906159|P1|STARTED|Overall Study||15
7677791|NCT01955044|18906192|P3|NOT COMPLETED|Overall Study||0
7677792|NCT01955044|18906193|P2|NOT COMPLETED|Overall Study||1
7677793|NCT01955044|18906194|P1|NOT COMPLETED|Overall Study||1
7677794|NCT01955044|18906192|P3|COMPLETED|Overall Study||10
7677795|NCT01955044|18906193|P2|COMPLETED|Overall Study||9
7677796|NCT01955044|18906194|P1|COMPLETED|Overall Study||9
7677797|NCT01955044|18906192|P3|STARTED|Overall Study||10
7677798|NCT01955044|18906193|P2|STARTED|Overall Study||10
7677799|NCT01955044|18906194|P1|STARTED|Overall Study||10
7677800|NCT01955005|18906207|P2|NOT COMPLETED|Overall Study||5
7677801|NCT01955005|18906208|P1|NOT COMPLETED|Overall Study||3
7677802|NCT01955005|18906207|P2|COMPLETED|Overall Study||25
7677803|NCT01955005|18906208|P1|COMPLETED|Overall Study||27
7677804|NCT01955005|18906207|P2|STARTED|Overall Study||30
7677805|NCT01955005|18906208|P1|STARTED|Overall Study||30
7677806|NCT01954927|18906220|P2|NOT COMPLETED|Overall Study||1
7677807|NCT01954927|18906221|P1|NOT COMPLETED|Overall Study||3
7677808|NCT01954927|18906220|P2|COMPLETED|Overall Study||44
7677809|NCT01954927|18906221|P1|COMPLETED|Overall Study||42
7677810|NCT01954927|18906220|P2|STARTED|Overall Study||45
7677811|NCT01954927|18906221|P1|STARTED|Overall Study||45
7677812|NCT01954771|18906242|P3|NOT COMPLETED|Overall Study||3
7677813|NCT01954771|18906243|P2|NOT COMPLETED|Overall Study||3
7677814|NCT01954771|18906244|P1|NOT COMPLETED|Overall Study||7
7677815|NCT01954771|18906242|P3|COMPLETED|Overall Study||25
7677816|NCT01954771|18906243|P2|COMPLETED|Overall Study||29
7677817|NCT01954771|18906244|P1|COMPLETED|Overall Study||22
7677818|NCT01954771|18906242|P3|STARTED|Overall Study||28
7677819|NCT01954771|18906243|P2|STARTED|Overall Study||32
7677820|NCT01954771|18906244|P1|STARTED|Overall Study||29
7677821|NCT01954745|18906261|P1|NOT COMPLETED|Overall Study||19
7677822|NCT01954745|18906261|P1|COMPLETED|Overall Study||0
7677823|NCT01954745|18906261|P1|STARTED|Overall Study||19
7677824|NCT01954628|18906270|P2|NOT COMPLETED|Overall Study||27
7677825|NCT01954628|18906271|P1|NOT COMPLETED|Overall Study||31
7677826|NCT01954628|18906270|P2|COMPLETED|Overall Study||173
7677827|NCT01954628|18906271|P1|COMPLETED|Overall Study||169
7677828|NCT01954628|18906270|P2|US 6 Month Ophthalmology Safety Visit|Overall Study||32
7677829|NCT01954628|18906271|P1|US 6 Month Ophthalmology Safety Visit|Overall Study||37
7677830|NCT01954628|18906270|P2|Pharmacokinetic Population|Overall Study||0
7677831|NCT01954628|18906271|P1|Pharmacokinetic Population|Overall Study||181
7677832|NCT01954628|18906270|P2|Safety Set|Overall Study||200
7677833|NCT01954628|18906271|P1|Safety Set|Overall Study||200
7677834|NCT01954628|18906270|P2|Full Analysis Set (FAS)|Overall Study||198
7677835|NCT01954628|18906271|P1|Full Analysis Set (FAS)|Overall Study||200
7677836|NCT01954628|18906270|P2|STARTED|Overall Study||200
7677837|NCT01954628|18906271|P1|STARTED|Overall Study||200
7677838|NCT01954394|18906292|P2|NOT COMPLETED|Overall Study||57
7677839|NCT01954394|18906293|P1|NOT COMPLETED|Overall Study||30
7677840|NCT01954394|18906292|P2|COMPLETED|Overall Study||598
7677841|NCT01954394|18906293|P1|COMPLETED|Overall Study||301
7677842|NCT01954394|18906292|P2|Treated|Overall Study|Safety population|655
7677843|NCT01954394|18906293|P1|Treated|Overall Study|Safety population|330
7677844|NCT01954394|18906292|P2|STARTED|Overall Study|Enrolled|655
7677845|NCT01954394|18906293|P1|STARTED|Overall Study|Enrolled|331
7677846|NCT01954342|18906347|P4|NOT COMPLETED|Overall Study||18
7677847|NCT01954342|18906348|P3|NOT COMPLETED|Overall Study||0
7677848|NCT01954342|18906349|P2|NOT COMPLETED|Overall Study||0
7677849|NCT01954342|18906350|P1|NOT COMPLETED|Overall Study||0
7677850|NCT01954342|18906347|P4|COMPLETED|Overall Study||0
7677851|NCT01954342|18906348|P3|COMPLETED|Overall Study||10
7677852|NCT01954342|18906349|P2|COMPLETED|Overall Study||8
7677853|NCT01954342|18906350|P1|COMPLETED|Overall Study||36
7677854|NCT01954342|18906347|P4|STARTED|Overall Study||18
7677855|NCT01954342|18906348|P3|STARTED|Overall Study||10
7677856|NCT01954342|18906349|P2|STARTED|Overall Study||8
7677857|NCT01954342|18906350|P1|STARTED|Overall Study||36
7677858|NCT01954264|18906400|P1|NOT COMPLETED|Overall Study||0
7677859|NCT01954264|18906400|P1|COMPLETED|Overall Study||2421
7677860|NCT01954264|18906400|P1|STARTED|Overall Study||2421
7677861|NCT01954251|18906452|P2|NOT COMPLETED|Overall Study||19
7677862|NCT01954251|18906453|P1|NOT COMPLETED|Overall Study||13
7677863|NCT01954251|18906452|P2|COMPLETED|Overall Study||396
7677864|NCT01954251|18906453|P1|COMPLETED|Overall Study||400
7677865|NCT01954251|18906452|P2|STARTED|Overall Study||415
7677866|NCT01954251|18906453|P1|STARTED|Overall Study||413
7677867|NCT01954160|18906489|P2|NOT COMPLETED|Overall Study||0
7677868|NCT01954160|18906490|P1|NOT COMPLETED|Overall Study||5
7677869|NCT01954160|18906489|P2|COMPLETED|Overall Study||0
7677870|NCT01954160|18906490|P1|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0
7677871|NCT01954160|18906489|P2|STARTED|Overall Study|Not started|0
7677872|NCT01954160|18906490|P1|STARTED|Overall Study||5
7677873|NCT01954121|18906550|P2|NOT COMPLETED|Overall Study||91
7677874|NCT01954121|18906551|P1|NOT COMPLETED|Overall Study||127
7677875|NCT01954121|18906550|P2|COMPLETED|Overall Study||125
7677876|NCT01954121|18906551|P1|COMPLETED|Overall Study||93
7677877|NCT01954121|18906550|P2|STARTED|Overall Study||216
7677878|NCT01954121|18906551|P1|STARTED|Overall Study||220
7677879|NCT01954082|18906567|P2|NOT COMPLETED|Overall Study||57
7677880|NCT01954082|18906568|P1|NOT COMPLETED|Overall Study||68
7677881|NCT01954082|18906567|P2|COMPLETED|Overall Study|There were 27 infants that received more doses than intended per protocol.|264
7677882|NCT01954082|18906568|P1|COMPLETED|Overall Study|There were 22 infants that received more doses than intended per protocol.|249
7677883|NCT01954082|18906567|P2|Treated|Overall Study|The 2 participants who were not treated died before treatment start.|319
7677884|NCT01954082|18906568|P1|Treated|Overall Study|The 4 participants who were not treated either died (3) or withdrew before treatment start (1).|313
7677885|NCT01954082|18906567|P2|STARTED|Overall Study||321
7677886|NCT01954082|18906568|P1|STARTED|Overall Study||317
7677887|NCT01954056|18906588|P2|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||0
7677888|NCT01954056|18906589|P1|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||1
7677889|NCT01954056|18906588|P2|COMPLETED|Birth to 22-26 Mos. Corrected GA||6
7677890|NCT01954056|18906589|P1|COMPLETED|Birth to 22-26 Mos. Corrected GA||5
7677891|NCT01954056|18906588|P2|STARTED|Birth to 22-26 Mos. Corrected GA||6
7677892|NCT01954056|18906589|P1|STARTED|Birth to 22-26 Mos. Corrected GA||6
7677893|NCT01954056|18906588|P2|NOT COMPLETED|Birth to 60 Days of Life||0
7677894|NCT01954056|18906589|P1|NOT COMPLETED|Birth to 60 Days of Life||0
7677895|NCT01954056|18906588|P2|COMPLETED|Birth to 60 Days of Life||6
7677896|NCT01954056|18906589|P1|COMPLETED|Birth to 60 Days of Life||6
7677897|NCT01954056|18906588|P2|STARTED|Birth to 60 Days of Life||6
7677898|NCT01954056|18906589|P1|STARTED|Birth to 60 Days of Life||6
7677899|NCT01954017|18906634|P3|NOT COMPLETED|Overall Study||13
7677900|NCT01954017|18906635|P2|NOT COMPLETED|Overall Study||8
7677901|NCT01954017|18906636|P1|NOT COMPLETED|Overall Study||5
7677902|NCT01954017|18906634|P3|COMPLETED|Overall Study||21
7677903|NCT01954017|18906635|P2|COMPLETED|Overall Study||25
7677904|NCT01954017|18906636|P1|COMPLETED|Overall Study||31
7677905|NCT01954017|18906634|P3|STARTED|Overall Study||34
7677906|NCT01954017|18906635|P2|STARTED|Overall Study||33
7677907|NCT01954017|18906636|P1|STARTED|Overall Study||36
7677908|NCT01953913|18906862|P1|NOT COMPLETED|Overall Study||542
7677909|NCT01953913|18906862|P1|COMPLETED|Overall Study||0
7677910|NCT01953913|18906862|P1|Treated|Overall Study||541
7677911|NCT01953913|18906862|P1|STARTED|Overall Study||542
7677912|NCT01953874|18906870|P2|NOT COMPLETED|Overall Study||0
7677913|NCT01953874|18906871|P1|NOT COMPLETED|Overall Study||0
7677914|NCT01953874|18906870|P2|COMPLETED|Overall Study||61
7677915|NCT01953874|18906871|P1|COMPLETED|Overall Study||65
7677916|NCT01953874|18906870|P2|STARTED|Overall Study||61
7677917|NCT01953874|18906871|P1|STARTED|Overall Study||65
7677918|NCT01953783|18906914|P1|NOT COMPLETED|Overall Study||2
7677919|NCT01953783|18906914|P1|COMPLETED|Overall Study||5
7677920|NCT01953783|18906914|P1|STARTED|Overall Study||7
7677921|NCT01953601|18906939|P3|NOT COMPLETED|Part 2 (Extension Study)||204
7677922|NCT01953601|18906940|P2|NOT COMPLETED|Part 2 (Extension Study)||191
7677923|NCT01953601|18906941|P1|NOT COMPLETED|Part 2 (Extension Study)||198
7677924|NCT01953601|18906939|P3|COMPLETED|Part 2 (Extension Study)||0
7677925|NCT01953601|18906940|P2|COMPLETED|Part 2 (Extension Study)||0
7677926|NCT01953601|18906941|P1|COMPLETED|Part 2 (Extension Study)||0
7677927|NCT01953601|18906939|P3|Treated|Part 2 (Extension Study)||204
7677928|NCT01953601|18906940|P2|Treated|Part 2 (Extension Study)||191
7677929|NCT01953601|18906941|P1|Treated|Part 2 (Extension Study)||197
7677930|NCT01953601|18906939|P3|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|204
7677931|NCT01953601|18906940|P2|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|191
7677932|NCT01953601|18906941|P1|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|198
7677933|NCT01953601|18906939|P3|NOT COMPLETED|Part 1 (Base Study)||246
7677934|NCT01953601|18906940|P2|NOT COMPLETED|Part 1 (Base Study)||253
7677935|NCT01953601|18906941|P1|NOT COMPLETED|Part 1 (Base Study)||251
7677936|NCT01953601|18906939|P3|COMPLETED|Part 1 (Base Study)||239
7677937|NCT01953601|18906940|P2|COMPLETED|Part 1 (Base Study)||231
7677938|NCT01953601|18906941|P1|COMPLETED|Part 1 (Base Study)||234
7677939|NCT01953601|18906939|P3|Treated|Part 1 (Base Study)||484
7677940|NCT01953601|18906940|P2|Treated|Part 1 (Base Study)||484
7677941|NCT01953601|18906941|P1|Treated|Part 1 (Base Study)||483
7677942|NCT01953601|18906939|P3|STARTED|Part 1 (Base Study)||485
7677943|NCT01953601|18906940|P2|STARTED|Part 1 (Base Study)||484
7677944|NCT01953601|18906941|P1|STARTED|Part 1 (Base Study)||485
7677945|NCT01953575|18906991|P3|NOT COMPLETED|Overall Study||0
7677946|NCT01953575|18906992|P2|NOT COMPLETED|Overall Study||0
7677947|NCT01953575|18906993|P1|NOT COMPLETED|Overall Study||0
7677948|NCT01953575|18906991|P3|COMPLETED|Overall Study||10
7677949|NCT01953575|18906992|P2|COMPLETED|Overall Study||10
7677950|NCT01953575|18906993|P1|COMPLETED|Overall Study||10
7677951|NCT01953575|18906991|P3|STARTED|Overall Study||10
7677952|NCT01953575|18906992|P2|STARTED|Overall Study||10
7677953|NCT01953575|18906993|P1|STARTED|Overall Study||10
7677954|NCT01953432|18907003|P2|NOT COMPLETED|Overall Study||15
7677955|NCT01953432|18907004|P1|NOT COMPLETED|Overall Study||14
7677956|NCT01953432|18907003|P2|COMPLETED|Overall Study||6
7677957|NCT01953432|18907004|P1|COMPLETED|Overall Study||8
7677958|NCT01953432|18907003|P2|STARTED|Overall Study||21
7677959|NCT01953432|18907004|P1|STARTED|Overall Study||22
7677960|NCT01953354|18907012|P2|NOT COMPLETED|Overall Study||2
7677961|NCT01953354|18907013|P1|NOT COMPLETED|Overall Study||1
7677962|NCT01953354|18907012|P2|COMPLETED|Overall Study||5
7677963|NCT01953354|18907013|P1|COMPLETED|Overall Study||8
7677964|NCT01953354|18907012|P2|STARTED|Overall Study||7
7677965|NCT01953354|18907013|P1|STARTED|Overall Study||9
7677966|NCT01953328|18907041|P8|NOT COMPLETED|Overall Study||0
7677967|NCT01953328|18907042|P7|NOT COMPLETED|Overall Study||0
7677968|NCT01953328|18907043|P6|NOT COMPLETED|Overall Study||0
7677969|NCT01953328|18907044|P5|NOT COMPLETED|Overall Study||2
7677970|NCT01953328|18907045|P4|NOT COMPLETED|Overall Study||0
7677971|NCT01953328|18907046|P3|NOT COMPLETED|Overall Study||0
7677972|NCT01953328|18907047|P2|NOT COMPLETED|Overall Study||0
7677973|NCT01953328|18907048|P1|NOT COMPLETED|Overall Study||0
7677974|NCT01953328|18907041|P8|COMPLETED|Overall Study||51
7677975|NCT01953328|18907042|P7|COMPLETED|Overall Study||51
7677976|NCT01953328|18907043|P6|COMPLETED|Overall Study||51
7677977|NCT01953328|18907044|P5|COMPLETED|Overall Study||50
7677978|NCT01953328|18907045|P4|COMPLETED|Overall Study||50
7677979|NCT01953328|18907046|P3|COMPLETED|Overall Study||50
7677980|NCT01953328|18907047|P2|COMPLETED|Overall Study||50
7677981|NCT01953328|18907048|P1|COMPLETED|Overall Study||49
7677982|NCT01953328|18907041|P8|Received Treatment|Overall Study||51
7677983|NCT01953328|18907042|P7|Received Treatment|Overall Study||51
7677984|NCT01953328|18907043|P6|Received Treatment|Overall Study||51
7677985|NCT01953328|18907044|P5|Received Treatment|Overall Study||52
7677986|NCT01953328|18907045|P4|Received Treatment|Overall Study||50
7677987|NCT01953328|18907046|P3|Received Treatment|Overall Study||50
7677988|NCT01953328|18907047|P2|Received Treatment|Overall Study||50
7677989|NCT01953328|18907048|P1|Received Treatment|Overall Study||49
7677990|NCT01953328|18907041|P8|STARTED|Overall Study||51
7677991|NCT01953328|18907042|P7|STARTED|Overall Study||51
7677992|NCT01953328|18907043|P6|STARTED|Overall Study||51
7677993|NCT01953328|18907044|P5|STARTED|Overall Study||52
7677994|NCT01953328|18907045|P4|STARTED|Overall Study||50
7677995|NCT01953328|18907046|P3|STARTED|Overall Study||50
7677996|NCT01953328|18907047|P2|STARTED|Overall Study||50
7677997|NCT01953328|18907048|P1|STARTED|Overall Study||49
7677998|NCT01953237|18907252|P2|NOT COMPLETED|Overall Study||0
7677999|NCT01953237|18907253|P1|NOT COMPLETED|Overall Study||0
7678000|NCT01953237|18907252|P2|COMPLETED|Overall Study||21
7678001|NCT01953237|18907253|P1|COMPLETED|Overall Study||10
7678002|NCT01953237|18907252|P2|STARTED|Overall Study||21
7678003|NCT01953237|18907253|P1|STARTED|Overall Study||10
7678004|NCT01953224|18907261|P2|NOT COMPLETED|Overall Study||3
7678005|NCT01953224|18907262|P1|NOT COMPLETED|Overall Study||2
7678006|NCT01953224|18907261|P2|COMPLETED|Overall Study||17
7678007|NCT01953224|18907262|P1|COMPLETED|Overall Study||18
7678008|NCT01953224|18907261|P2|STARTED|Overall Study||20
7678009|NCT01953224|18907262|P1|STARTED|Overall Study||20
7678010|NCT01953211|18907278|P1|NOT COMPLETED|Overall Study||0
7678011|NCT01953211|18907278|P1|COMPLETED|Overall Study|completed prior to clinical trials submission|64
7678012|NCT01953211|18907278|P1|STARTED|Overall Study|completed prior to clinical trials submission|64
7678013|NCT01953081|18907286|P2|NOT COMPLETED|Overall Study||3
7678014|NCT01953081|18907287|P1|NOT COMPLETED|Overall Study||2
7678015|NCT01953081|18907286|P2|COMPLETED|Overall Study||3
7678016|NCT01953081|18907287|P1|COMPLETED|Overall Study||5
7678017|NCT01953081|18907286|P2|STARTED|Overall Study||6
7678018|NCT01953081|18907287|P1|STARTED|Overall Study||7
7678019|NCT01953003|18907311|P2|NOT COMPLETED|Overall Study||55
7678020|NCT01953003|18907312|P1|NOT COMPLETED|Overall Study||56
7678021|NCT01953003|18907311|P2|COMPLETED|Overall Study||1
7678022|NCT01953003|18907312|P1|COMPLETED|Overall Study||0
7678023|NCT01953003|18907311|P2|STARTED|Overall Study||56
7678024|NCT01953003|18907312|P1|STARTED|Overall Study||56
7678025|NCT01952834|18907318|P1|NOT COMPLETED|Overall Study||1
7678026|NCT01952834|18907318|P1|COMPLETED|Overall Study||20
7678027|NCT01952834|18907318|P1|STARTED|Overall Study||21
7678028|NCT01952691|18907325|P1|NOT COMPLETED|Overall Study||2
7678029|NCT01952691|18907325|P1|COMPLETED|Overall Study||20
7678030|NCT01952691|18907325|P1|STARTED|Overall Study||22
7678031|NCT01952678|18907333|P2|NOT COMPLETED|Overall Study||0
7678032|NCT01952678|18907334|P1|NOT COMPLETED|Overall Study||0
7678033|NCT01952678|18907333|P2|COMPLETED|Overall Study||102
7678034|NCT01952678|18907334|P1|COMPLETED|Overall Study||102
7678035|NCT01952678|18907333|P2|STARTED|Overall Study||102
7678036|NCT01952678|18907334|P1|STARTED|Overall Study||102
7678037|NCT01952665|18907352|P2|NOT COMPLETED|Overall Study||6
7678038|NCT01952665|18907353|P1|NOT COMPLETED|Overall Study||6
7678039|NCT01952665|18907352|P2|COMPLETED|Overall Study||20
7678040|NCT01952665|18907353|P1|COMPLETED|Overall Study||31
7678041|NCT01952665|18907352|P2|STARTED|Overall Study||26
7678042|NCT01952665|18907353|P1|STARTED|Overall Study||37
7678043|NCT01952600|18907494|P3|NOT COMPLETED|Overall Study||7
7678044|NCT01952600|18907495|P2|NOT COMPLETED|Overall Study||13
7678045|NCT01952600|18907496|P1|NOT COMPLETED|Overall Study||15
7678046|NCT01952600|18907494|P3|COMPLETED|Overall Study||38
7678047|NCT01952600|18907495|P2|COMPLETED|Overall Study||77
7678048|NCT01952600|18907496|P1|COMPLETED|Overall Study||65
7678049|NCT01952600|18907494|P3|STARTED|Overall Study||45
7678050|NCT01952600|18907495|P2|STARTED|Overall Study||90
7678051|NCT01952600|18907496|P1|STARTED|Overall Study||80
7678052|NCT01952574|18907508|P7|NOT COMPLETED|Clinical Home Use Substudy||1
7678053|NCT01952574|18907509|P6|NOT COMPLETED|Clinical Home Use Substudy||3
7678054|NCT01952574|18907510|P5|NOT COMPLETED|Clinical Home Use Substudy||0
7678055|NCT01952574|18907511|P4|NOT COMPLETED|Clinical Home Use Substudy||0
7678056|NCT01952574|18907512|P3|NOT COMPLETED|Clinical Home Use Substudy||0
7678057|NCT01952574|18907513|P2|NOT COMPLETED|Clinical Home Use Substudy||0
7678058|NCT01952574|18907514|P1|NOT COMPLETED|Clinical Home Use Substudy||0
7678059|NCT01952574|18907508|P7|COMPLETED|Clinical Home Use Substudy||40
7678060|NCT01952574|18907509|P6|COMPLETED|Clinical Home Use Substudy||39
7678061|NCT01952574|18907510|P5|COMPLETED|Clinical Home Use Substudy||0
7678062|NCT01952574|18907511|P4|COMPLETED|Clinical Home Use Substudy||0
7678063|NCT01952574|18907512|P3|COMPLETED|Clinical Home Use Substudy||0
7678064|NCT01952574|18907513|P2|COMPLETED|Clinical Home Use Substudy||0
7678065|NCT01952574|18907514|P1|COMPLETED|Clinical Home Use Substudy||0
7678066|NCT01952574|18907508|P7|STARTED|Clinical Home Use Substudy||41
7678067|NCT01952574|18907509|P6|STARTED|Clinical Home Use Substudy||42
7678068|NCT01952574|18907510|P5|STARTED|Clinical Home Use Substudy||0
7678069|NCT01952574|18907511|P4|STARTED|Clinical Home Use Substudy||0
7678070|NCT01952574|18907512|P3|STARTED|Clinical Home Use Substudy||0
7678071|NCT01952574|18907513|P2|STARTED|Clinical Home Use Substudy||0
7678072|NCT01952574|18907514|P1|STARTED|Clinical Home Use Substudy||0
7678073|NCT01952574|18907508|P7|NOT COMPLETED|Open-label Treatment Phase||0
7678074|NCT01952574|18907509|P6|NOT COMPLETED|Open-label Treatment Phase||0
7678075|NCT01952574|18907510|P5|NOT COMPLETED|Open-label Treatment Phase||162
7678076|NCT01952574|18907511|P4|NOT COMPLETED|Open-label Treatment Phase||0
7678077|NCT01952574|18907512|P3|NOT COMPLETED|Open-label Treatment Phase||0
7678078|NCT01952574|18907513|P2|NOT COMPLETED|Open-label Treatment Phase||0
7678079|NCT01952574|18907514|P1|NOT COMPLETED|Open-label Treatment Phase||0
7678080|NCT01952574|18907508|P7|COMPLETED|Open-label Treatment Phase||0
7678081|NCT01952574|18907509|P6|COMPLETED|Open-label Treatment Phase||0
7678082|NCT01952574|18907510|P5|COMPLETED|Open-label Treatment Phase||221
7678083|NCT01952574|18907511|P4|COMPLETED|Open-label Treatment Phase||0
7678084|NCT01952574|18907512|P3|COMPLETED|Open-label Treatment Phase||0
7678085|NCT01952574|18907513|P2|COMPLETED|Open-label Treatment Phase||0
7678086|NCT01952574|18907514|P1|COMPLETED|Open-label Treatment Phase||0
7678087|NCT01952574|18907508|P7|Received 140 mg Erenumab|Open-label Treatment Phase||0
7678088|NCT01952574|18907509|P6|Received 140 mg Erenumab|Open-label Treatment Phase||0
7678089|NCT01952574|18907510|P5|Received 140 mg Erenumab|Open-label Treatment Phase||250
7678090|NCT01952574|18907511|P4|Received 140 mg Erenumab|Open-label Treatment Phase||0
7678091|NCT01952574|18907512|P3|Received 140 mg Erenumab|Open-label Treatment Phase||0
7678092|NCT01952574|18907513|P2|Received 140 mg Erenumab|Open-label Treatment Phase||0
7678093|NCT01952574|18907514|P1|Received 140 mg Erenumab|Open-label Treatment Phase||0
7678094|NCT01952574|18907508|P7|Received 70 mg Erenumab|Open-label Treatment Phase||0
7678095|NCT01952574|18907509|P6|Received 70 mg Erenumab|Open-label Treatment Phase||0
7678096|NCT01952574|18907510|P5|Received 70 mg Erenumab|Open-label Treatment Phase||383
7678097|NCT01952574|18907511|P4|Received 70 mg Erenumab|Open-label Treatment Phase||0
7678098|NCT01952574|18907512|P3|Received 70 mg Erenumab|Open-label Treatment Phase||0
7678099|NCT01952574|18907513|P2|Received 70 mg Erenumab|Open-label Treatment Phase||0
7678100|NCT01952574|18907514|P1|Received 70 mg Erenumab|Open-label Treatment Phase||0
7678101|NCT01952574|18907508|P7|STARTED|Open-label Treatment Phase||0
7678102|NCT01952574|18907509|P6|STARTED|Open-label Treatment Phase||0
7678103|NCT01952574|18907510|P5|STARTED|Open-label Treatment Phase||383
7678104|NCT01952574|18907511|P4|STARTED|Open-label Treatment Phase||0
7678105|NCT01952574|18907512|P3|STARTED|Open-label Treatment Phase||0
7678106|NCT01952574|18907513|P2|STARTED|Open-label Treatment Phase||0
7678107|NCT01952574|18907514|P1|STARTED|Open-label Treatment Phase||0
7678108|NCT01952574|18907508|P7|NOT COMPLETED|Double-blind Treatment Phase||0
7678109|NCT01952574|18907509|P6|NOT COMPLETED|Double-blind Treatment Phase||0
7678110|NCT01952574|18907510|P5|NOT COMPLETED|Double-blind Treatment Phase||0
7678111|NCT01952574|18907511|P4|NOT COMPLETED|Double-blind Treatment Phase||6
7678112|NCT01952574|18907512|P3|NOT COMPLETED|Double-blind Treatment Phase||9
7678113|NCT01952574|18907513|P2|NOT COMPLETED|Double-blind Treatment Phase||3
7678114|NCT01952574|18907514|P1|NOT COMPLETED|Double-blind Treatment Phase||17
7678115|NCT01952574|18907508|P7|COMPLETED|Double-blind Treatment Phase||0
7678116|NCT01952574|18907509|P6|COMPLETED|Double-blind Treatment Phase||0
7678117|NCT01952574|18907510|P5|COMPLETED|Double-blind Treatment Phase||0
7678118|NCT01952574|18907511|P4|COMPLETED|Double-blind Treatment Phase||101
7678119|NCT01952574|18907512|P3|COMPLETED|Double-blind Treatment Phase||99
7678120|NCT01952574|18907513|P2|COMPLETED|Double-blind Treatment Phase||105
7678121|NCT01952574|18907514|P1|COMPLETED|Double-blind Treatment Phase||143
7678122|NCT01952574|18907508|P7|Received Study Drug|Double-blind Treatment Phase||0
7678123|NCT01952574|18907509|P6|Received Study Drug|Double-blind Treatment Phase||0
7678124|NCT01952574|18907510|P5|Received Study Drug|Double-blind Treatment Phase||0
7678125|NCT01952574|18907511|P4|Received Study Drug|Double-blind Treatment Phase||106
7678126|NCT01952574|18907512|P3|Received Study Drug|Double-blind Treatment Phase||105
7678127|NCT01952574|18907513|P2|Received Study Drug|Double-blind Treatment Phase||108
7678128|NCT01952574|18907514|P1|Received Study Drug|Double-blind Treatment Phase||153
7678129|NCT01952574|18907508|P7|STARTED|Double-blind Treatment Phase||0
7678130|NCT01952574|18907509|P6|STARTED|Double-blind Treatment Phase||0
7678131|NCT01952574|18907510|P5|STARTED|Double-blind Treatment Phase||0
7678132|NCT01952574|18907511|P4|STARTED|Double-blind Treatment Phase||107
7678133|NCT01952574|18907512|P3|STARTED|Double-blind Treatment Phase||108
7678134|NCT01952574|18907513|P2|STARTED|Double-blind Treatment Phase||108
7678135|NCT01952574|18907514|P1|STARTED|Double-blind Treatment Phase||160
7678136|NCT01952470|18907559|P2|NOT COMPLETED|Overall Study||3
7678137|NCT01952470|18907560|P1|NOT COMPLETED|Overall Study||3
7678138|NCT01952470|18907559|P2|COMPLETED|Overall Study||13
7678139|NCT01952470|18907560|P1|COMPLETED|Overall Study||13
7678140|NCT01952470|18907559|P2|Missing 3 Month LCI 2% Data.|Overall Study||0
7678141|NCT01952470|18907560|P1|Missing 3 Month LCI 2% Data.|Overall Study||1
7678142|NCT01952470|18907559|P2|Missing 1+3 Month LCI 2% Data.|Overall Study||1
7678143|NCT01952470|18907560|P1|Missing 1+3 Month LCI 2% Data.|Overall Study||2
7678144|NCT01952470|18907559|P2|Missing Baseline LCI 2% Data.|Overall Study||2
7678145|NCT01952470|18907560|P1|Missing Baseline LCI 2% Data.|Overall Study||0
7678146|NCT01952470|18907559|P2|Death|Overall Study||1
7678147|NCT01952470|18907560|P1|Death|Overall Study||1
7678148|NCT01952470|18907559|P2|Discontinued Intervention|Overall Study||1
7678149|NCT01952470|18907560|P1|Discontinued Intervention|Overall Study||2
7678150|NCT01952470|18907559|P2|ITT Analysis|Overall Study||16
7678151|NCT01952470|18907560|P1|ITT Analysis|Overall Study||16
7678152|NCT01952470|18907559|P2|STARTED|Overall Study||16
7678153|NCT01952470|18907560|P1|STARTED|Overall Study||16
7678154|NCT01952444|18907598|P2|NOT COMPLETED|Overall Study||1
7678155|NCT01952444|18907599|P1|NOT COMPLETED|Overall Study||0
7678156|NCT01952444|18907598|P2|COMPLETED|Overall Study||19
7678157|NCT01952444|18907599|P1|COMPLETED|Overall Study||20
7678158|NCT01952444|18907598|P2|STARTED|Overall Study||20
7678159|NCT01952444|18907599|P1|STARTED|Overall Study||20
7678160|NCT01952418|18907625|P2|NOT COMPLETED|Overall Study||0
7678161|NCT01952418|18907626|P1|NOT COMPLETED|Overall Study||0
7678162|NCT01952418|18907625|P2|COMPLETED|Overall Study||895
7678163|NCT01952418|18907626|P1|COMPLETED|Overall Study||910
7678164|NCT01952418|18907625|P2|STARTED|Overall Study||895
7678165|NCT01952418|18907626|P1|STARTED|Overall Study||910
7678166|NCT01952366|18907638|P1|NOT COMPLETED|Overall Study||31
7678167|NCT01952366|18907638|P1|COMPLETED|Overall Study||138
7678168|NCT01952366|18907638|P1|STARTED|Overall Study||169
7678169|NCT01952301|18907645|P1|NOT COMPLETED|Overall Study||0
7678170|NCT01952301|18907645|P1|COMPLETED|Overall Study||30
7678171|NCT01952301|18907645|P1|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30
7678172|NCT01952145|18907653|P2|NOT COMPLETED|Overall Study||14
7678173|NCT01952145|18907654|P1|NOT COMPLETED|Overall Study||28
7678174|NCT01952145|18907653|P2|COMPLETED|Overall Study||265
7678175|NCT01952145|18907654|P1|COMPLETED|Overall Study||250
7678176|NCT01952145|18907653|P2|STARTED|Overall Study||279
7678177|NCT01952145|18907654|P1|STARTED|Overall Study||278
7678178|NCT01952080|18907668|P4|NOT COMPLETED|Overall Study||1
7678179|NCT01952080|18907669|P3|NOT COMPLETED|Overall Study||0
7678180|NCT01952080|18907670|P2|NOT COMPLETED|Overall Study||1
7678181|NCT01952080|18907671|P1|NOT COMPLETED|Overall Study||0
7678182|NCT01952080|18907668|P4|COMPLETED|Overall Study||14
7678183|NCT01952080|18907669|P3|COMPLETED|Overall Study||14
7678184|NCT01952080|18907670|P2|COMPLETED|Overall Study||7
7678185|NCT01952080|18907671|P1|COMPLETED|Overall Study||5
7678186|NCT01952080|18907668|P4|Treated|Overall Study||15
7678187|NCT01952080|18907669|P3|Treated|Overall Study||14
7678188|NCT01952080|18907670|P2|Treated|Overall Study||8
7678189|NCT01952080|18907671|P1|Treated|Overall Study||5
7678190|NCT01952080|18907668|P4|STARTED|Overall Study||15
7678191|NCT01952080|18907669|P3|STARTED|Overall Study||14
7678192|NCT01952080|18907670|P2|STARTED|Overall Study||8
7678193|NCT01952080|18907671|P1|STARTED|Overall Study||5
7678194|NCT01952054|18907717|P1|NOT COMPLETED|Overall Study||1
7678195|NCT01952054|18907717|P1|COMPLETED|Overall Study||5
7678196|NCT01952054|18907717|P1|STARTED|Overall Study||6
7678197|NCT01952041|18907725|P2|NOT COMPLETED|Overall Study||21
7678198|NCT01952041|18907726|P1|NOT COMPLETED|Overall Study||17
7678199|NCT01952041|18907725|P2|COMPLETED|Overall Study||43
7678200|NCT01952041|18907726|P1|COMPLETED|Overall Study||45
7678201|NCT01952041|18907725|P2|STARTED|Overall Study||64
7678202|NCT01952041|18907726|P1|STARTED|Overall Study||62
7678203|NCT01952015|18907740|P1|NOT COMPLETED|Treatment Period 3||9
7678204|NCT01952015|18907740|P1|COMPLETED|Treatment Period 3||0
7678205|NCT01952015|18907740|P1|STARTED|Treatment Period 3||9
7678206|NCT01952015|18907740|P1|NOT COMPLETED|Maintenance||2
7678207|NCT01952015|18907740|P1|COMPLETED|Maintenance||9
7678208|NCT01952015|18907740|P1|STARTED|Maintenance||11
7678209|NCT01952015|18907740|P1|NOT COMPLETED|Induction||1
7678210|NCT01952015|18907740|P1|COMPLETED|Induction||11
7678211|NCT01952015|18907740|P1|STARTED|Induction||12
7678212|NCT01951963|18907763|P2|NOT COMPLETED|Overall Study||0
7678213|NCT01951963|18907764|P1|NOT COMPLETED|Overall Study||0
7678214|NCT01951963|18907763|P2|COMPLETED|Overall Study||32
7678215|NCT01951963|18907764|P1|COMPLETED|Overall Study||31
7678216|NCT01951963|18907763|P2|STARTED|Overall Study||32
7678217|NCT01951963|18907764|P1|STARTED|Overall Study||31
7678218|NCT01951950|18907776|P2|NOT COMPLETED|Overall Study||6
7678219|NCT01951950|18907777|P1|NOT COMPLETED|Overall Study||6
7678220|NCT01951950|18907776|P2|COMPLETED|Overall Study||20
7678221|NCT01951950|18907777|P1|COMPLETED|Overall Study||20
7678222|NCT01951950|18907776|P2|STARTED|Overall Study||26
7678223|NCT01951950|18907777|P1|STARTED|Overall Study||26
7678224|NCT01951820|18907785|P2|NOT COMPLETED|Overall Study||0
7678225|NCT01951820|18907786|P1|NOT COMPLETED|Overall Study||0
7678226|NCT01951820|18907785|P2|COMPLETED|Overall Study||30
7678227|NCT01951820|18907786|P1|COMPLETED|Overall Study||34
7678228|NCT01951820|18907785|P2|STARTED|Overall Study||30
7678229|NCT01951820|18907786|P1|STARTED|Overall Study||34
7678230|NCT01951768|18907794|P2|NOT COMPLETED|Overall Study||0
7678231|NCT01951768|18907795|P1|NOT COMPLETED|Overall Study||0
7678232|NCT01951768|18907794|P2|COMPLETED|Overall Study|45 patients|45
7678233|NCT01951768|18907795|P1|COMPLETED|Overall Study|43 patients|43
7678234|NCT01951768|18907794|P2|STARTED|Overall Study||45
7678235|NCT01951768|18907795|P1|STARTED|Overall Study||43
7678236|NCT01951703|18907807|P2|NOT COMPLETED|Second Intervention||2
7678237|NCT01951703|18907808|P1|NOT COMPLETED|Second Intervention||0
7678238|NCT01951703|18907807|P2|COMPLETED|Second Intervention||60
7678239|NCT01951703|18907808|P1|COMPLETED|Second Intervention||61
7678240|NCT01951703|18907807|P2|STARTED|Second Intervention||62
7678241|NCT01951703|18907808|P1|STARTED|Second Intervention||61
7678242|NCT01951703|18907807|P2|NOT COMPLETED|First Intervention||1
7678243|NCT01951703|18907808|P1|NOT COMPLETED|First Intervention||3
7678244|NCT01951703|18907807|P2|COMPLETED|First Intervention||62
7678245|NCT01951703|18907808|P1|COMPLETED|First Intervention||61
7678246|NCT01951703|18907807|P2|STARTED|First Intervention||63
7678247|NCT01951703|18907808|P1|STARTED|First Intervention||64
7678248|NCT01951651|18907818|P2|NOT COMPLETED|Overall Study||2
7678249|NCT01951651|18907819|P1|NOT COMPLETED|Overall Study||4
7678250|NCT01951651|18907818|P2|COMPLETED|Overall Study||10
7678251|NCT01951651|18907819|P1|COMPLETED|Overall Study||8
7678252|NCT01951651|18907818|P2|STARTED|Overall Study||12
7678253|NCT01951651|18907819|P1|STARTED|Overall Study||12
7678254|NCT01951586|18907833|P2|NOT COMPLETED|Overall Study||148
7678255|NCT01951586|18907834|P1|NOT COMPLETED|Overall Study||78
7678256|NCT01951586|18907833|P2|COMPLETED|Overall Study||0
7678257|NCT01951586|18907834|P1|COMPLETED|Overall Study||0
7678258|NCT01951586|18907833|P2|Received Study Drug|Overall Study||145
7678259|NCT01951586|18907834|P1|Received Study Drug|Overall Study||76
7678260|NCT01951586|18907833|P2|STARTED|Overall Study||148
7678261|NCT01951586|18907834|P1|STARTED|Overall Study||78
7678262|NCT01951573|18907858|P2|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
7678263|NCT01951573|18907859|P1|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
7678264|NCT01951573|18907858|P2|COMPLETED|Period 2, Second 9 Hours of Wear||16
7678265|NCT01951573|18907859|P1|COMPLETED|Period 2, Second 9 Hours of Wear||17
7678266|NCT01951573|18907858|P2|STARTED|Period 2, Second 9 Hours of Wear||16
7678267|NCT01951573|18907859|P1|STARTED|Period 2, Second 9 Hours of Wear||17
7678268|NCT01951573|18907858|P2|NOT COMPLETED|Washout Period||1
7678269|NCT01951573|18907859|P1|NOT COMPLETED|Washout Period||0
7678270|NCT01951573|18907858|P2|COMPLETED|Washout Period||16
7678271|NCT01951573|18907859|P1|COMPLETED|Washout Period||17
7678272|NCT01951573|18907858|P2|STARTED|Washout Period||17
7678273|NCT01951573|18907859|P1|STARTED|Washout Period||17
7678274|NCT01951573|18907858|P2|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
7678275|NCT01951573|18907859|P1|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
7678276|NCT01951573|18907858|P2|COMPLETED|Period 1, First 9 Hours of Wear||17
7678277|NCT01951573|18907859|P1|COMPLETED|Period 1, First 9 Hours of Wear||17
7678278|NCT01951573|18907858|P2|STARTED|Period 1, First 9 Hours of Wear||17
7678279|NCT01951573|18907859|P1|STARTED|Period 1, First 9 Hours of Wear||17
7678280|NCT01951417|18907869|P1|NOT COMPLETED|Overall Study||9
7678281|NCT01951417|18907869|P1|COMPLETED|Overall Study||72
7678282|NCT01951417|18907869|P1|STARTED|Overall Study||81
7678283|NCT01951391|18907894|P2|NOT COMPLETED|Overall Study||0
7678284|NCT01951391|18907895|P1|NOT COMPLETED|Overall Study||0
7678285|NCT01951391|18907894|P2|COMPLETED|Overall Study||5
7678286|NCT01951391|18907895|P1|COMPLETED|Overall Study||5
7678287|NCT01951391|18907894|P2|STARTED|Overall Study||5
7678288|NCT01951391|18907895|P1|STARTED|Overall Study||5
7678289|NCT01951378|18907905|P2|NOT COMPLETED|Overall Study||17
7678290|NCT01951378|18907906|P1|NOT COMPLETED|Overall Study||23
7678291|NCT01951378|18907905|P2|COMPLETED|Overall Study||0
7678292|NCT01951378|18907906|P1|COMPLETED|Overall Study||0
7678293|NCT01951378|18907905|P2|STARTED|Overall Study||17
7678294|NCT01951378|18907906|P1|STARTED|Overall Study||23
7678295|NCT01951352|18907914|P1|NOT COMPLETED|Overall Study||0
7678296|NCT01951352|18907914|P1|COMPLETED|Overall Study||10
7678297|NCT01951352|18907914|P1|STARTED|Overall Study||10
7678298|NCT01951339|18907923|P2|NOT COMPLETED|Overall Study||1
7678299|NCT01951339|18907924|P1|NOT COMPLETED|Overall Study||2
7678300|NCT01951339|18907923|P2|COMPLETED|Overall Study||14
7678301|NCT01951339|18907924|P1|COMPLETED|Overall Study||13
7678302|NCT01951339|18907923|P2|STARTED|Overall Study||15
7678303|NCT01951339|18907924|P1|STARTED|Overall Study||15
7678304|NCT01951326|18907948|P2|NOT COMPLETED|Overall Study||78
7678305|NCT01951326|18907949|P1|NOT COMPLETED|Overall Study||79
7678306|NCT01951326|18907948|P2|COMPLETED|Overall Study||87
7678307|NCT01951326|18907949|P1|COMPLETED|Overall Study||87
7678308|NCT01951326|18907948|P2|STARTED|Overall Study||165
7678309|NCT01951326|18907949|P1|STARTED|Overall Study||166
7678310|NCT01951261|18907983|P2|NOT COMPLETED|Overall Study||6
7678311|NCT01951261|18907984|P1|NOT COMPLETED|Overall Study||9
7678312|NCT01951261|18907983|P2|COMPLETED|Overall Study||52
7678313|NCT01951261|18907984|P1|COMPLETED|Overall Study||49
7678314|NCT01951261|18907983|P2|Discontinued|Overall Study|"2-readmission when was at home
~1-new home hospitalitation 3-missing"|6
7678315|NCT01951261|18907984|P1|Discontinued|Overall Study|"2-readmission when was at home
~1-monitor failure
~1-new home hospitalitation 4-missing
~1-death"|9
7678316|NCT01951261|18907983|P2|STARTED|Overall Study||58
7678317|NCT01951261|18907984|P1|STARTED|Overall Study||58
7678318|NCT01951170|18908002|P1|NOT COMPLETED|Overall Study||1
7678319|NCT01951170|18908002|P1|COMPLETED|Overall Study||51
7678320|NCT01951170|18908002|P1|STARTED|Overall Study||52
7678321|NCT01951157|18908028|P3|NOT COMPLETED|Overall Study||25
7678322|NCT01951157|18908029|P2|NOT COMPLETED|Overall Study||22
7678323|NCT01951157|18908030|P1|NOT COMPLETED|Overall Study||22
7678324|NCT01951157|18908028|P3|COMPLETED|Overall Study||0
7678325|NCT01951157|18908029|P2|COMPLETED|Overall Study||0
7678326|NCT01951157|18908030|P1|COMPLETED|Overall Study||0
7678327|NCT01951157|18908028|P3|STARTED|Overall Study||25
7678328|NCT01951157|18908029|P2|STARTED|Overall Study||22
7678329|NCT01951157|18908030|P1|STARTED|Overall Study||22
7678330|NCT01951118|18908059|P1|NOT COMPLETED|Overall Study||27
7678331|NCT01951118|18908059|P1|COMPLETED|Overall Study||94
7678332|NCT01951118|18908059|P1|STARTED|Overall Study||121
7678333|NCT01951105|18908081|P3|NOT COMPLETED|Overall Study||2
7678334|NCT01951105|18908082|P2|NOT COMPLETED|Overall Study||10
7678335|NCT01951105|18908083|P1|NOT COMPLETED|Overall Study||1
7678336|NCT01951105|18908081|P3|COMPLETED|Overall Study||28
7678337|NCT01951105|18908082|P2|COMPLETED|Overall Study||21
7678338|NCT01951105|18908083|P1|COMPLETED|Overall Study||10
7678339|NCT01951105|18908081|P3|Completed 12 Weeks Treatment|Overall Study||28
7678340|NCT01951105|18908082|P2|Completed 12 Weeks Treatment|Overall Study||24
7678341|NCT01951105|18908083|P1|Completed 12 Weeks Treatment|Overall Study||10
7678342|NCT01951105|18908081|P3|STARTED|Overall Study||30
7678343|NCT01951105|18908082|P2|STARTED|Overall Study||31
7678344|NCT01951105|18908083|P1|STARTED|Overall Study||11
7678345|NCT01951092|18908097|P1|NOT COMPLETED|Overall Study||12
7678346|NCT01951092|18908097|P1|COMPLETED|Overall Study||20
7678347|NCT01951092|18908097|P1|STARTED|Overall Study||32
7678348|NCT01951066|18908102|P2|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
7678349|NCT01951066|18908103|P1|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
7678350|NCT01951066|18908102|P2|COMPLETED|Second Intervention (Week 16 to Week 32)||10
7678351|NCT01951066|18908103|P1|COMPLETED|Second Intervention (Week 16 to Week 32)||10
7678352|NCT01951066|18908102|P2|STARTED|Second Intervention (Week 16 to Week 32)||10
7678353|NCT01951066|18908103|P1|STARTED|Second Intervention (Week 16 to Week 32)||10
7678354|NCT01951066|18908102|P2|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
7678355|NCT01951066|18908103|P1|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
7678356|NCT01951066|18908102|P2|COMPLETED|First Intervention (Baseline to Week 16)||10
7678357|NCT01951066|18908103|P1|COMPLETED|First Intervention (Baseline to Week 16)||10
7678358|NCT01951066|18908102|P2|STARTED|First Intervention (Baseline to Week 16)||10
7678359|NCT01951066|18908103|P1|STARTED|First Intervention (Baseline to Week 16)||10
7678360|NCT01950819|18908110|P2|NOT COMPLETED|Overall Study||134
7678361|NCT01950819|18908111|P1|NOT COMPLETED|Overall Study||129
7678362|NCT01950819|18908110|P2|COMPLETED|Overall Study||881
7678363|NCT01950819|18908111|P1|COMPLETED|Overall Study||893
7678364|NCT01950819|18908110|P2|STARTED|Overall Study||1015
7678365|NCT01950819|18908111|P1|STARTED|Overall Study||1022
7678366|NCT01950780|18908159|P1|NOT COMPLETED|Overall Study||0
7678367|NCT01950780|18908159|P1|COMPLETED|Overall Study||12
7678368|NCT01950780|18908159|P1|STARTED|Overall Study||12
7678369|NCT01950741|18908164|P1|NOT COMPLETED|Overall Study||3
7678370|NCT01950741|18908164|P1|COMPLETED|Overall Study||45
7678371|NCT01950741|18908164|P1|STARTED|Overall Study||48
7678372|NCT01950663|18908173|P1|NOT COMPLETED|Overall Study||1
7678373|NCT01950663|18908173|P1|COMPLETED|Overall Study||467
7678374|NCT01950663|18908173|P1|STARTED|Overall Study||468
7678375|NCT01950364|18908179|P2|NOT COMPLETED|Overall Study||10
7678376|NCT01950364|18908180|P1|NOT COMPLETED|Overall Study||10
7678377|NCT01950364|18908179|P2|COMPLETED|Overall Study||0
7678378|NCT01950364|18908180|P1|COMPLETED|Overall Study||0
7678379|NCT01950364|18908179|P2|STARTED|Overall Study||10
7678380|NCT01950364|18908180|P1|STARTED|Overall Study||10
7678381|NCT01950299|18908281|P3|NOT COMPLETED|Overall Study||7
7678382|NCT01950299|18908282|P2|NOT COMPLETED|Overall Study||4
7678383|NCT01950299|18908283|P1|NOT COMPLETED|Overall Study||11
7678384|NCT01950299|18908281|P3|COMPLETED|Overall Study||28
7678385|NCT01950299|18908282|P2|COMPLETED|Overall Study||27
7678386|NCT01950299|18908283|P1|COMPLETED|Overall Study||22
7678387|NCT01950299|18908281|P3|STARTED|Overall Study||35
7678388|NCT01950299|18908282|P2|STARTED|Overall Study||31
7678389|NCT01950299|18908283|P1|STARTED|Overall Study||33
7678390|NCT01950273|18908302|P2|NOT COMPLETED|Overall Study||0
7678391|NCT01950273|18908303|P1|NOT COMPLETED|Overall Study||4
7678392|NCT01950273|18908302|P2|COMPLETED|Overall Study||46
7678393|NCT01950273|18908303|P1|COMPLETED|Overall Study||45
7678394|NCT01950273|18908302|P2|STARTED|Overall Study||46
7678395|NCT01950273|18908303|P1|STARTED|Overall Study||49
7678396|NCT01950260|18908325|P2|NOT COMPLETED|Overall Study||0
7678397|NCT01950260|18908326|P1|NOT COMPLETED|Overall Study||0
7678398|NCT01950260|18908325|P2|COMPLETED|Overall Study||31
7678399|NCT01950260|18908326|P1|COMPLETED|Overall Study||30
7678400|NCT01950260|18908325|P2|STARTED|Overall Study||31
7678401|NCT01950260|18908326|P1|STARTED|Overall Study||30
7678402|NCT01950078|18908338|P2|NOT COMPLETED|Overall Study||12
7678403|NCT01950078|18908339|P1|NOT COMPLETED|Overall Study||20
7678404|NCT01950078|18908338|P2|COMPLETED|Overall Study||496
7678405|NCT01950078|18908339|P1|COMPLETED|Overall Study||1005
7678406|NCT01950078|18908338|P2|STARTED|Overall Study||508
7678407|NCT01950078|18908339|P1|STARTED|Overall Study||1025
7678408|NCT01950013|18908350|P3|NOT COMPLETED|Overall Study||0
7678409|NCT01950013|18908351|P2|NOT COMPLETED|Overall Study||2
7678410|NCT01950013|18908352|P1|NOT COMPLETED|Overall Study||0
7678411|NCT01950013|18908350|P3|COMPLETED|Overall Study||15
7678412|NCT01950013|18908351|P2|COMPLETED|Overall Study||13
7678413|NCT01950013|18908352|P1|COMPLETED|Overall Study||15
7678414|NCT01950013|18908350|P3|STARTED|Overall Study||15
7678415|NCT01950013|18908351|P2|STARTED|Overall Study||15
7678416|NCT01950013|18908352|P1|STARTED|Overall Study||15
7678417|NCT01949870|18908363|P1|NOT COMPLETED|Overall Study||6
7678418|NCT01949870|18908363|P1|COMPLETED|Overall Study||0
7678419|NCT01949870|18908363|P1|Received Treatment|Overall Study||4
7678420|NCT01949870|18908363|P1|STARTED|Overall Study||6
7678421|NCT01949844|18908367|P1|NOT COMPLETED|Overall Study||0
7678422|NCT01949844|18908367|P1|COMPLETED|Overall Study||44
7678423|NCT01949844|18908367|P1|STARTED|Overall Study||44
7678424|NCT01949779|18908371|P1|NOT COMPLETED|Overall Study||2
7678425|NCT01949779|18908371|P1|COMPLETED|Overall Study||79
7678426|NCT01949779|18908371|P1|STARTED|Overall Study||81
7678427|NCT01949662|18908379|P2|NOT COMPLETED|Overall Study||14
7678428|NCT01949662|18908380|P1|NOT COMPLETED|Overall Study||18
7678429|NCT01949662|18908379|P2|COMPLETED|Overall Study||29
7678430|NCT01949662|18908380|P1|COMPLETED|Overall Study||29
7678431|NCT01949662|18908379|P2|STARTED|Overall Study||43
7678432|NCT01949662|18908380|P1|STARTED|Overall Study||47
7678433|NCT01949545|18908396|P4|NOT COMPLETED|Overall Study||0
7678434|NCT01949545|18908397|P3|NOT COMPLETED|Overall Study||0
7678435|NCT01949545|18908398|P2|NOT COMPLETED|Overall Study||0
7678436|NCT01949545|18908399|P1|NOT COMPLETED|Overall Study||0
7678437|NCT01949545|18908396|P4|COMPLETED|Overall Study||4
7678438|NCT01949545|18908397|P3|COMPLETED|Overall Study||14
7678439|NCT01949545|18908398|P2|COMPLETED|Overall Study||17
7678440|NCT01949545|18908399|P1|COMPLETED|Overall Study||11
7678441|NCT01949545|18908396|P4|STARTED|Overall Study||4
7678442|NCT01949545|18908397|P3|STARTED|Overall Study||14
7678443|NCT01949545|18908398|P2|STARTED|Overall Study||17
7678444|NCT01949545|18908399|P1|STARTED|Overall Study||11
7678445|NCT01949532|18908547|P2|NOT COMPLETED|Overall Study||3
7678446|NCT01949532|18908548|P1|NOT COMPLETED|Overall Study||3
7678447|NCT01949532|18908547|P2|COMPLETED|Overall Study||8
7678448|NCT01949532|18908548|P1|COMPLETED|Overall Study||12
7678449|NCT01949532|18908547|P2|STARTED|Overall Study||11
7678450|NCT01949532|18908548|P1|STARTED|Overall Study||15
7678451|NCT01949480|18908618|P2|NOT COMPLETED|Overall Study||8
7678452|NCT01949480|18908619|P1|NOT COMPLETED|Overall Study||5
7678453|NCT01949480|18908618|P2|COMPLETED|Overall Study||14
7678454|NCT01949480|18908619|P1|COMPLETED|Overall Study||15
7678455|NCT01949480|18908618|P2|STARTED|Overall Study||22
7678456|NCT01949480|18908619|P1|STARTED|Overall Study||20
7678457|NCT01949389|18908647|P1|NOT COMPLETED|Overall Study||0
7678458|NCT01949389|18908647|P1|COMPLETED|Overall Study||51
7678459|NCT01949389|18908647|P1|STARTED|Overall Study||51
7678460|NCT01949337|18908654|P2|NOT COMPLETED|Overall Study||0
7678461|NCT01949337|18908655|P1|NOT COMPLETED|Overall Study||0
7678462|NCT01949337|18908654|P2|COMPLETED|Overall Study||654
7678463|NCT01949337|18908655|P1|COMPLETED|Overall Study||657
7678464|NCT01949337|18908654|P2|STARTED|Overall Study||654
7678465|NCT01949337|18908655|P1|STARTED|Overall Study||657
7678466|NCT01949155|18908665|P2|NOT COMPLETED|Overall Study||0
7678467|NCT01949155|18908666|P1|NOT COMPLETED|Overall Study||2
7678468|NCT01949155|18908665|P2|COMPLETED|Overall Study||88
7678469|NCT01949155|18908666|P1|COMPLETED|Overall Study||176
7678470|NCT01949155|18908665|P2|STARTED|Overall Study||88
7678471|NCT01949155|18908666|P1|STARTED|Overall Study||178
7678472|NCT01949142|18908678|P2|NOT COMPLETED|Overall Study||1
7678473|NCT01949142|18908679|P1|NOT COMPLETED|Overall Study||3
7678474|NCT01949142|18908678|P2|COMPLETED|Overall Study||86
7678475|NCT01949142|18908679|P1|COMPLETED|Overall Study||176
7678476|NCT01949142|18908678|P2|STARTED|Overall Study||87
7678477|NCT01949142|18908679|P1|STARTED|Overall Study||179
7678478|NCT01949116|18908691|P2|NOT COMPLETED|Overall Study||6
7678479|NCT01949116|18908692|P1|NOT COMPLETED|Overall Study||8
7678480|NCT01949116|18908691|P2|COMPLETED|Overall Study||84
7678481|NCT01949116|18908692|P1|COMPLETED|Overall Study||78
7678482|NCT01949116|18908691|P2|STARTED|Overall Study||90
7678483|NCT01949116|18908692|P1|STARTED|Overall Study||86
7678484|NCT01949090|18908729|P5|NOT COMPLETED|Overall Study||4
7678485|NCT01949090|18908730|P4|NOT COMPLETED|Overall Study||1
7678486|NCT01949090|18908731|P3|NOT COMPLETED|Overall Study||2
7678487|NCT01949090|18908732|P2|NOT COMPLETED|Overall Study||2
7678488|NCT01949090|18908733|P1|NOT COMPLETED|Overall Study||4
7678489|NCT01949090|18908729|P5|COMPLETED|Overall Study||116
7678490|NCT01949090|18908730|P4|COMPLETED|Overall Study||59
7678491|NCT01949090|18908731|P3|COMPLETED|Overall Study||58
7678492|NCT01949090|18908732|P2|COMPLETED|Overall Study||58
7678493|NCT01949090|18908733|P1|COMPLETED|Overall Study||56
7678494|NCT01949090|18908729|P5|STARTED|Overall Study||120
7678495|NCT01949090|18908730|P4|STARTED|Overall Study||60
7678496|NCT01949090|18908731|P3|STARTED|Overall Study||60
7678497|NCT01949090|18908732|P2|STARTED|Overall Study||60
7678498|NCT01949090|18908733|P1|STARTED|Overall Study||60
7678499|NCT01949051|18908910|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||0
7678500|NCT01949051|18908911|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
7678501|NCT01949051|18908912|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
7678502|NCT01949051|18908913|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||0
7678503|NCT01949051|18908914|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
7678504|NCT01949051|18908915|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
7678505|NCT01949051|18908910|P6|COMPLETED|Treatment Period 3 (7 Days)||12
7678506|NCT01949051|18908911|P5|COMPLETED|Treatment Period 3 (7 Days)||13
7678507|NCT01949051|18908912|P4|COMPLETED|Treatment Period 3 (7 Days)||12
7678508|NCT01949051|18908913|P3|COMPLETED|Treatment Period 3 (7 Days)||12
7678509|NCT01949051|18908914|P2|COMPLETED|Treatment Period 3 (7 Days)||12
7678510|NCT01949051|18908915|P1|COMPLETED|Treatment Period 3 (7 Days)||11
7678511|NCT01949051|18908910|P6|STARTED|Treatment Period 3 (7 Days)||12
7678512|NCT01949051|18908911|P5|STARTED|Treatment Period 3 (7 Days)||13
7678513|NCT01949051|18908912|P4|STARTED|Treatment Period 3 (7 Days)||12
7678514|NCT01949051|18908913|P3|STARTED|Treatment Period 3 (7 Days)||12
7678515|NCT01949051|18908914|P2|STARTED|Treatment Period 3 (7 Days)||12
7678516|NCT01949051|18908915|P1|STARTED|Treatment Period 3 (7 Days)||11
7678517|NCT01949051|18908910|P6|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
7678518|NCT01949051|18908911|P5|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
7678519|NCT01949051|18908912|P4|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
7678520|NCT01949051|18908913|P3|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
7678521|NCT01949051|18908914|P2|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
7678522|NCT01949051|18908915|P1|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
7678523|NCT01949051|18908910|P6|COMPLETED|Washout Period 2 (14 to 20 Days)||12
7678524|NCT01949051|18908911|P5|COMPLETED|Washout Period 2 (14 to 20 Days)||13
7678525|NCT01949051|18908912|P4|COMPLETED|Washout Period 2 (14 to 20 Days)||12
7678526|NCT01949051|18908913|P3|COMPLETED|Washout Period 2 (14 to 20 Days)||12
7678527|NCT01949051|18908914|P2|COMPLETED|Washout Period 2 (14 to 20 Days)||12
7678528|NCT01949051|18908915|P1|COMPLETED|Washout Period 2 (14 to 20 Days)||11
7678529|NCT01949051|18908910|P6|STARTED|Washout Period 2 (14 to 20 Days)||12
7678530|NCT01949051|18908911|P5|STARTED|Washout Period 2 (14 to 20 Days)||13
7678531|NCT01949051|18908912|P4|STARTED|Washout Period 2 (14 to 20 Days)||12
7678532|NCT01949051|18908913|P3|STARTED|Washout Period 2 (14 to 20 Days)||12
7678533|NCT01949051|18908914|P2|STARTED|Washout Period 2 (14 to 20 Days)||12
7678534|NCT01949051|18908915|P1|STARTED|Washout Period 2 (14 to 20 Days)||11
7678535|NCT01949051|18908910|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||1
7678536|NCT01949051|18908911|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
7678537|NCT01949051|18908912|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
7678538|NCT01949051|18908913|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||1
7678539|NCT01949051|18908914|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||1
7678540|NCT01949051|18908915|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
7678541|NCT01949051|18908910|P6|COMPLETED|Treatment Period 2 (7 Days)||12
7678542|NCT01949051|18908911|P5|COMPLETED|Treatment Period 2 (7 Days)||13
7678543|NCT01949051|18908912|P4|COMPLETED|Treatment Period 2 (7 Days)||12
7678544|NCT01949051|18908913|P3|COMPLETED|Treatment Period 2 (7 Days)||12
7678545|NCT01949051|18908914|P2|COMPLETED|Treatment Period 2 (7 Days)||12
7678546|NCT01949051|18908915|P1|COMPLETED|Treatment Period 2 (7 Days)||11
7678547|NCT01949051|18908910|P6|STARTED|Treatment Period 2 (7 Days)||13
7678548|NCT01949051|18908911|P5|STARTED|Treatment Period 2 (7 Days)||13
7678549|NCT01949051|18908912|P4|STARTED|Treatment Period 2 (7 Days)||12
7678550|NCT01949051|18908913|P3|STARTED|Treatment Period 2 (7 Days)||13
7678551|NCT01949051|18908914|P2|STARTED|Treatment Period 2 (7 Days)||13
7678552|NCT01949051|18908915|P1|STARTED|Treatment Period 2 (7 Days)||11
7678553|NCT01949051|18908910|P6|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
7678554|NCT01949051|18908911|P5|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
7678555|NCT01949051|18908912|P4|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
7678556|NCT01949051|18908913|P3|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
7678557|NCT01949051|18908914|P2|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
7678558|NCT01949051|18908915|P1|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
7678559|NCT01949051|18908910|P6|COMPLETED|Washout Period 1 (14 to 20 Days)||13
7678560|NCT01949051|18908911|P5|COMPLETED|Washout Period 1 (14 to 20 Days)||13
7678561|NCT01949051|18908912|P4|COMPLETED|Washout Period 1 (14 to 20 Days)||12
7678562|NCT01949051|18908913|P3|COMPLETED|Washout Period 1 (14 to 20 Days)||13
7678563|NCT01949051|18908914|P2|COMPLETED|Washout Period 1 (14 to 20 Days)||13
7678564|NCT01949051|18908915|P1|COMPLETED|Washout Period 1 (14 to 20 Days)||11
7678565|NCT01949051|18908910|P6|STARTED|Washout Period 1 (14 to 20 Days)||13
7678566|NCT01949051|18908911|P5|STARTED|Washout Period 1 (14 to 20 Days)||13
7678567|NCT01949051|18908912|P4|STARTED|Washout Period 1 (14 to 20 Days)||12
7678568|NCT01949051|18908913|P3|STARTED|Washout Period 1 (14 to 20 Days)||13
7678569|NCT01949051|18908914|P2|STARTED|Washout Period 1 (14 to 20 Days)||13
7678570|NCT01949051|18908915|P1|STARTED|Washout Period 1 (14 to 20 Days)||11
7678571|NCT01949051|18908910|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
7678572|NCT01949051|18908911|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||0
7678573|NCT01949051|18908912|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||1
7678574|NCT01949051|18908913|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
7678575|NCT01949051|18908914|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||0
7678576|NCT01949051|18908915|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||2
7678577|NCT01949051|18908910|P6|COMPLETED|Treatment Period 1 (7 Days)||13
7678578|NCT01949051|18908911|P5|COMPLETED|Treatment Period 1 (7 Days)||13
7678579|NCT01949051|18908912|P4|COMPLETED|Treatment Period 1 (7 Days)||12
7678580|NCT01949051|18908913|P3|COMPLETED|Treatment Period 1 (7 Days)||13
7678581|NCT01949051|18908914|P2|COMPLETED|Treatment Period 1 (7 Days)||13
7678582|NCT01949051|18908915|P1|COMPLETED|Treatment Period 1 (7 Days)||11
7678583|NCT01949051|18908910|P6|STARTED|Treatment Period 1 (7 Days)||13
7678584|NCT01949051|18908911|P5|STARTED|Treatment Period 1 (7 Days)||13
7678585|NCT01949051|18908912|P4|STARTED|Treatment Period 1 (7 Days)||13
7678586|NCT01949051|18908913|P3|STARTED|Treatment Period 1 (7 Days)||13
7678587|NCT01949051|18908914|P2|STARTED|Treatment Period 1 (7 Days)||13
7678588|NCT01949051|18908915|P1|STARTED|Treatment Period 1 (7 Days)||13
7678589|NCT01948986|18908931|P5|NOT COMPLETED|Overall Study||0
7678590|NCT01948986|18908932|P4|NOT COMPLETED|Overall Study||0
7678591|NCT01948986|18908933|P3|NOT COMPLETED|Overall Study||0
7678592|NCT01948986|18908934|P2|NOT COMPLETED|Overall Study||0
7678593|NCT01948986|18908935|P1|NOT COMPLETED|Overall Study||0
7678594|NCT01948986|18908931|P5|COMPLETED|Overall Study||8
7678595|NCT01948986|18908932|P4|COMPLETED|Overall Study||6
7678596|NCT01948986|18908933|P3|COMPLETED|Overall Study||8
7678597|NCT01948986|18908934|P2|COMPLETED|Overall Study||8
7678598|NCT01948986|18908935|P1|COMPLETED|Overall Study||6
7678599|NCT01948986|18908931|P5|STARTED|Overall Study||8
7678600|NCT01948986|18908932|P4|STARTED|Overall Study||6
7678601|NCT01948986|18908933|P3|STARTED|Overall Study||8
7678602|NCT01948986|18908934|P2|STARTED|Overall Study||8
7678603|NCT01948986|18908935|P1|STARTED|Overall Study||6
7678604|NCT01948947|18909094|P2|NOT COMPLETED|Overall Study||0
7678605|NCT01948947|18909095|P1|NOT COMPLETED|Overall Study||0
7678606|NCT01948947|18909094|P2|COMPLETED|Overall Study||15
7678607|NCT01948947|18909095|P1|COMPLETED|Overall Study||14
7678608|NCT01948947|18909094|P2|STARTED|Overall Study||15
7678609|NCT01948947|18909095|P1|STARTED|Overall Study||14
7678610|NCT01948908|18909110|P3|NOT COMPLETED|Overall Study||2
7678611|NCT01948908|18909111|P2|NOT COMPLETED|Overall Study||0
7678612|NCT01948908|18909112|P1|NOT COMPLETED|Overall Study||1
7678613|NCT01948908|18909110|P3|COMPLETED|Overall Study||31
7678614|NCT01948908|18909111|P2|COMPLETED|Overall Study||33
7678615|NCT01948908|18909112|P1|COMPLETED|Overall Study||32
7678616|NCT01948908|18909110|P3|STARTED|Overall Study||33
7678617|NCT01948908|18909111|P2|STARTED|Overall Study||33
7678618|NCT01948908|18909112|P1|STARTED|Overall Study||33
7678619|NCT01948830|18909128|P2|NOT COMPLETED|Overall Study||32
7678620|NCT01948830|18909129|P1|NOT COMPLETED|Overall Study||33
7678621|NCT01948830|18909128|P2|COMPLETED|Overall Study||295
7678622|NCT01948830|18909129|P1|COMPLETED|Overall Study||290
7678623|NCT01948830|18909128|P2|Safety Set|Overall Study||326
7678624|NCT01948830|18909129|P1|Safety Set|Overall Study||323
7678625|NCT01948830|18909128|P2|STARTED|Overall Study||327
7678626|NCT01948830|18909129|P1|STARTED|Overall Study||323
7678627|NCT01948791|18909161|P1|NOT COMPLETED|Overall Study||71
7678628|NCT01948791|18909161|P1|COMPLETED|Overall Study||151
7678629|NCT01948791|18909161|P1|STARTED|Overall Study||222
7678630|NCT01948518|18909169|P1|NOT COMPLETED|Overall Study||0
7678631|NCT01948518|18909169|P1|COMPLETED|Overall Study||15
7678632|NCT01948518|18909169|P1|STARTED|Overall Study||15
7678633|NCT01948388|18909176|P2|NOT COMPLETED|Overall Study||1
7678634|NCT01948388|18909177|P1|NOT COMPLETED|Overall Study||2
7678635|NCT01948388|18909176|P2|COMPLETED|Overall Study||9
7678636|NCT01948388|18909177|P1|COMPLETED|Overall Study||8
7678637|NCT01948388|18909176|P2|STARTED|Overall Study||10
7678638|NCT01948388|18909177|P1|STARTED|Overall Study||10
7678639|NCT01948375|18909193|P2|NOT COMPLETED|Overall Study||0
7678640|NCT01948375|18909194|P1|NOT COMPLETED|Overall Study||0
7678641|NCT01948375|18909193|P2|COMPLETED|Overall Study||30
7678642|NCT01948375|18909194|P1|COMPLETED|Overall Study||30
7678643|NCT01948375|18909193|P2|STARTED|Overall Study||30
7678644|NCT01948375|18909194|P1|STARTED|Overall Study||30
7678645|NCT01948310|18909210|P2|NOT COMPLETED|Overall Study||5
7678646|NCT01948310|18909211|P1|NOT COMPLETED|Overall Study||3
7678647|NCT01948310|18909210|P2|COMPLETED|Overall Study||13
7678648|NCT01948310|18909211|P1|COMPLETED|Overall Study||16
7678649|NCT01948310|18909210|P2|STARTED|Overall Study||18
7678650|NCT01948310|18909211|P1|STARTED|Overall Study||19
7678651|NCT01948258|18909221|P1|NOT COMPLETED|Overall Study||162
7678652|NCT01948258|18909221|P1|COMPLETED|Overall Study||233
7678653|NCT01948258|18909221|P1|STARTED|Overall Study||395
7678654|NCT01948193|18909227|P1|NOT COMPLETED|Overall Study||9
7678655|NCT01948193|18909227|P1|COMPLETED|Overall Study||168
7678656|NCT01948193|18909227|P1|STARTED|Overall Study||177
7678657|NCT01948141|18909236|P1|NOT COMPLETED|Overall Study||0
7678658|NCT01948141|18909236|P1|COMPLETED|Overall Study||6
7678659|NCT01948141|18909236|P1|STARTED|Overall Study||6
7678660|NCT01948076|18909249|P2|NOT COMPLETED|Overall Study||1
7678661|NCT01948076|18909250|P1|NOT COMPLETED|Overall Study||0
7678662|NCT01948076|18909249|P2|COMPLETED|Overall Study||19
7678663|NCT01948076|18909250|P1|COMPLETED|Overall Study||20
7678664|NCT01948076|18909249|P2|STARTED|Overall Study||20
7678665|NCT01948076|18909250|P1|STARTED|Overall Study||20
7678666|NCT01948063|18909260|P2|NOT COMPLETED|Overall Study||2
7678667|NCT01948063|18909261|P1|NOT COMPLETED|Overall Study||1
7678668|NCT01948063|18909260|P2|COMPLETED|Overall Study||19
7678669|NCT01948063|18909261|P1|COMPLETED|Overall Study||19
7678670|NCT01948063|18909260|P2|STARTED|Overall Study||21
7678671|NCT01948063|18909261|P1|STARTED|Overall Study||20
7678672|NCT01948050|18909269|P2|NOT COMPLETED|Overall Study||1
7678673|NCT01948050|18909270|P1|NOT COMPLETED|Overall Study||0
7678674|NCT01948050|18909269|P2|COMPLETED|Overall Study||7
7678675|NCT01948050|18909270|P1|COMPLETED|Overall Study||16
7678676|NCT01948050|18909269|P2|STARTED|Overall Study||8
7678677|NCT01948050|18909270|P1|STARTED|Overall Study||16
7678678|NCT01947946|18909279|P3|NOT COMPLETED|Overall Study||5
7678679|NCT01947946|18909280|P2|NOT COMPLETED|Overall Study||5
7678680|NCT01947946|18909281|P1|NOT COMPLETED|Overall Study||3
7678681|NCT01947946|18909279|P3|COMPLETED|Overall Study||0
7678682|NCT01947946|18909280|P2|COMPLETED|Overall Study||0
7678683|NCT01947946|18909281|P1|COMPLETED|Overall Study|Study Stopped|0
7678684|NCT01947946|18909279|P3|STARTED|Overall Study||5
7678685|NCT01947946|18909280|P2|STARTED|Overall Study||5
7678686|NCT01947946|18909281|P1|STARTED|Overall Study||3
7678687|NCT01947907|18909293|P4|NOT COMPLETED|Overall Study||0
7678688|NCT01947907|18909294|P3|NOT COMPLETED|Overall Study||0
7678689|NCT01947907|18909295|P2|NOT COMPLETED|Overall Study||0
7678690|NCT01947907|18909296|P1|NOT COMPLETED|Overall Study||0
7678691|NCT01947907|18909293|P4|COMPLETED|Overall Study||13
7678692|NCT01947907|18909294|P3|COMPLETED|Overall Study||14
7678693|NCT01947907|18909295|P2|COMPLETED|Overall Study||14
7678694|NCT01947907|18909296|P1|COMPLETED|Overall Study||12
7678695|NCT01947907|18909293|P4|STARTED|Overall Study||13
7678696|NCT01947907|18909294|P3|STARTED|Overall Study||14
7678697|NCT01947907|18909295|P2|STARTED|Overall Study||14
7678698|NCT01947907|18909296|P1|STARTED|Overall Study||12
7678699|NCT01947894|18909338|P3|NOT COMPLETED|Overall Study||27
7678700|NCT01947894|18909339|P2|NOT COMPLETED|Overall Study||18
7678701|NCT01947894|18909340|P1|NOT COMPLETED|Overall Study||87
7678702|NCT01947894|18909338|P3|COMPLETED|Overall Study||61
7678703|NCT01947894|18909339|P2|COMPLETED|Overall Study||24
7678704|NCT01947894|18909340|P1|COMPLETED|Overall Study||160
7678705|NCT01947894|18909338|P3|Treated|Overall Study||87
7678706|NCT01947894|18909339|P2|Treated|Overall Study||41
7678707|NCT01947894|18909340|P1|Treated|Overall Study||246
7678708|NCT01947894|18909338|P3|STARTED|Overall Study||88
7678709|NCT01947894|18909339|P2|STARTED|Overall Study||42
7678710|NCT01947894|18909340|P1|STARTED|Overall Study||247
7678711|NCT01947855|18909405|P3|NOT COMPLETED|Overall Study||0
7678712|NCT01947855|18909406|P2|NOT COMPLETED|Overall Study||0
7678713|NCT01947855|18909407|P1|NOT COMPLETED|Overall Study||1
7678714|NCT01947855|18909405|P3|COMPLETED|Overall Study||19
7678715|NCT01947855|18909406|P2|COMPLETED|Overall Study||20
7678716|NCT01947855|18909407|P1|COMPLETED|Overall Study||20
7678717|NCT01947855|18909405|P3|STARTED|Overall Study||19
7678718|NCT01947855|18909406|P2|STARTED|Overall Study||20
7678719|NCT01947855|18909407|P1|STARTED|Overall Study||21
7678720|NCT01947816|18909415|P1|NOT COMPLETED|Overall Study||70
7678721|NCT01947816|18909415|P1|COMPLETED|Overall Study||1523
7678722|NCT01947816|18909415|P1|STARTED|Overall Study||1593
7678723|NCT01947647|18909425|P2|NOT COMPLETED|6-month Followup Phase||8
7678724|NCT01947647|18909426|P1|NOT COMPLETED|6-month Followup Phase||9
7678725|NCT01947647|18909425|P2|COMPLETED|6-month Followup Phase||13
7678726|NCT01947647|18909426|P1|COMPLETED|6-month Followup Phase||20
7678727|NCT01947647|18909425|P2|STARTED|6-month Followup Phase||21
7678728|NCT01947647|18909426|P1|STARTED|6-month Followup Phase||29
7678729|NCT01947647|18909425|P2|NOT COMPLETED|Treatment Phase||26
7678730|NCT01947647|18909426|P1|NOT COMPLETED|Treatment Phase||17
7678731|NCT01947647|18909425|P2|COMPLETED|Treatment Phase||21
7678732|NCT01947647|18909426|P1|COMPLETED|Treatment Phase||29
7678733|NCT01947647|18909425|P2|STARTED|Treatment Phase||47
7678734|NCT01947647|18909426|P1|STARTED|Treatment Phase||46
7678735|NCT01947582|18909442|P1|NOT COMPLETED|Overall Study||1
7678736|NCT01947582|18909442|P1|COMPLETED|Overall Study||1
7678737|NCT01947582|18909442|P1|STARTED|Overall Study||2
7678738|NCT01947517|18909451|P2|NOT COMPLETED|Overall Study||1
7678739|NCT01947517|18909452|P1|NOT COMPLETED|Overall Study||1
7678740|NCT01947517|18909451|P2|COMPLETED|Overall Study||25
7678741|NCT01947517|18909452|P1|COMPLETED|Overall Study||25
7678742|NCT01947517|18909451|P2|STARTED|Overall Study||26
7678743|NCT01947517|18909452|P1|STARTED|Overall Study||26
7678744|NCT01947491|18909470|P4|NOT COMPLETED|Overall Study||5
7678745|NCT01947491|18909471|P3|NOT COMPLETED|Overall Study||2
7678746|NCT01947491|18909472|P2|NOT COMPLETED|Overall Study||6
7678747|NCT01947491|18909473|P1|NOT COMPLETED|Overall Study||8
7678748|NCT01947491|18909470|P4|COMPLETED|Overall Study||38
7678749|NCT01947491|18909471|P3|COMPLETED|Overall Study||88
7678750|NCT01947491|18909472|P2|COMPLETED|Overall Study||81
7678751|NCT01947491|18909473|P1|COMPLETED|Overall Study||166
7678752|NCT01947491|18909470|P4|STARTED|Overall Study||43
7678753|NCT01947491|18909471|P3|STARTED|Overall Study||90
7678754|NCT01947491|18909472|P2|STARTED|Overall Study||87
7678755|NCT01947491|18909473|P1|STARTED|Overall Study||174
7678756|NCT01947335|18909485|P2|NOT COMPLETED|Overall Study||0
7678757|NCT01947335|18909486|P1|NOT COMPLETED|Overall Study||0
7678758|NCT01947335|18909485|P2|COMPLETED|Overall Study||41
7678759|NCT01947335|18909486|P1|COMPLETED|Overall Study||42
7678760|NCT01947335|18909485|P2|STARTED|Overall Study||41
7678761|NCT01947335|18909486|P1|STARTED|Overall Study||42
7678762|NCT01947283|18909503|P7|NOT COMPLETED|Overall Study||8
7678763|NCT01947283|18909504|P6|NOT COMPLETED|Overall Study||7
7678764|NCT01947283|18909505|P5|NOT COMPLETED|Overall Study||0
7678765|NCT01947283|18909506|P4|NOT COMPLETED|Overall Study||17
7678766|NCT01947283|18909507|P3|NOT COMPLETED|Overall Study||21
7678767|NCT01947283|18909508|P2|NOT COMPLETED|Overall Study||23
7678768|NCT01947283|18909509|P1|NOT COMPLETED|Overall Study||29
7678769|NCT01947283|18909503|P7|COMPLETED|Overall Study||32
7678770|NCT01947283|18909504|P6|COMPLETED|Overall Study||27
7678771|NCT01947283|18909505|P5|COMPLETED|Overall Study||95
7678772|NCT01947283|18909506|P4|COMPLETED|Overall Study||55
7678773|NCT01947283|18909507|P3|COMPLETED|Overall Study||62
7678774|NCT01947283|18909508|P2|COMPLETED|Overall Study||45
7678775|NCT01947283|18909509|P1|COMPLETED|Overall Study||60
7678776|NCT01947283|18909503|P7|Completed NRCT Baseline Assessment|Overall Study||0
7678777|NCT01947283|18909504|P6|Completed NRCT Baseline Assessment|Overall Study||0
7678778|NCT01947283|18909505|P5|Completed NRCT Baseline Assessment|Overall Study||95
7678779|NCT01947283|18909506|P4|Completed NRCT Baseline Assessment|Overall Study||0
7678780|NCT01947283|18909507|P3|Completed NRCT Baseline Assessment|Overall Study||0
7678781|NCT01947283|18909508|P2|Completed NRCT Baseline Assessment|Overall Study||0
7678782|NCT01947283|18909509|P1|Completed NRCT Baseline Assessment|Overall Study||0
7678783|NCT01947283|18909503|P7|In Analysis|Overall Study||38
7678784|NCT01947283|18909504|P6|In Analysis|Overall Study||30
7678785|NCT01947283|18909505|P5|In Analysis|Overall Study||95
7678786|NCT01947283|18909506|P4|In Analysis|Overall Study||72
7678787|NCT01947283|18909507|P3|In Analysis|Overall Study||83
7678788|NCT01947283|18909508|P2|In Analysis|Overall Study||68
7678789|NCT01947283|18909509|P1|In Analysis|Overall Study||89
7678790|NCT01947283|18909503|P7|End-of-Intervention Assessment|Overall Study||33
7678791|NCT01947283|18909504|P6|End-of-Intervention Assessment|Overall Study||32
7678792|NCT01947283|18909505|P5|End-of-Intervention Assessment|Overall Study||0
7678793|NCT01947283|18909506|P4|End-of-Intervention Assessment|Overall Study||66
7678794|NCT01947283|18909507|P3|End-of-Intervention Assessment|Overall Study||73
7678795|NCT01947283|18909508|P2|End-of-Intervention Assessment|Overall Study||53
7678796|NCT01947283|18909509|P1|End-of-Intervention Assessment|Overall Study||74
7678797|NCT01947283|18909503|P7|Clinical Recording|Overall Study||0
7678798|NCT01947283|18909504|P6|Clinical Recording|Overall Study||0
7678799|NCT01947283|18909505|P5|Clinical Recording|Overall Study||0
7678800|NCT01947283|18909506|P4|Clinical Recording|Overall Study||57
7678801|NCT01947283|18909507|P3|Clinical Recording|Overall Study||68
7678802|NCT01947283|18909508|P2|Clinical Recording|Overall Study||54
7678803|NCT01947283|18909509|P1|Clinical Recording|Overall Study||65
7678804|NCT01947283|18909503|P7|Follow-up Assessment|Overall Study||36
7678805|NCT01947283|18909504|P6|Follow-up Assessment|Overall Study||27
7678806|NCT01947283|18909505|P5|Follow-up Assessment|Overall Study||0
7678807|NCT01947283|18909506|P4|Follow-up Assessment|Overall Study||59
7678808|NCT01947283|18909507|P3|Follow-up Assessment|Overall Study||65
7678809|NCT01947283|18909508|P2|Follow-up Assessment|Overall Study||51
7678810|NCT01947283|18909509|P1|Follow-up Assessment|Overall Study||64
7678811|NCT01947283|18909503|P7|Baseline Assessment|Overall Study||40
7678812|NCT01947283|18909504|P6|Baseline Assessment|Overall Study||34
7678813|NCT01947283|18909505|P5|Baseline Assessment|Overall Study||0
7678814|NCT01947283|18909506|P4|Baseline Assessment|Overall Study||72
7678815|NCT01947283|18909507|P3|Baseline Assessment|Overall Study||83
7678816|NCT01947283|18909508|P2|Baseline Assessment|Overall Study||68
7678817|NCT01947283|18909509|P1|Baseline Assessment|Overall Study||89
7678818|NCT01947283|18909503|P7|STARTED|Overall Study||40
7678819|NCT01947283|18909504|P6|STARTED|Overall Study||34
7678820|NCT01947283|18909505|P5|STARTED|Overall Study||95
7678821|NCT01947283|18909506|P4|STARTED|Overall Study||72
7678822|NCT01947283|18909507|P3|STARTED|Overall Study||83
7678823|NCT01947283|18909508|P2|STARTED|Overall Study||68
7678824|NCT01947283|18909509|P1|STARTED|Overall Study||89
7678825|NCT01947153|18909560|P2|NOT COMPLETED|Test Period 2||0
7678826|NCT01947153|18909561|P1|NOT COMPLETED|Test Period 2||0
7678827|NCT01947153|18909560|P2|COMPLETED|Test Period 2||18
7678828|NCT01947153|18909561|P1|COMPLETED|Test Period 2||18
7678829|NCT01947153|18909560|P2|STARTED|Test Period 2||18
7678830|NCT01947153|18909561|P1|STARTED|Test Period 2||18
7678831|NCT01947153|18909560|P2|NOT COMPLETED|Test Period 1||0
7678832|NCT01947153|18909561|P1|NOT COMPLETED|Test Period 1||0
7678833|NCT01947153|18909560|P2|COMPLETED|Test Period 1||18
7678834|NCT01947153|18909561|P1|COMPLETED|Test Period 1||18
7678835|NCT01947153|18909560|P2|STARTED|Test Period 1||18
7678836|NCT01947153|18909561|P1|STARTED|Test Period 1||18
7678837|NCT01947127|18909581|P2|NOT COMPLETED|Overall Study||43
7678838|NCT01947127|18909582|P1|NOT COMPLETED|Overall Study||23
7678839|NCT01947127|18909581|P2|COMPLETED|Overall Study||249
7678840|NCT01947127|18909582|P1|COMPLETED|Overall Study||143
7678841|NCT01947127|18909581|P2|STARTED|Overall Study||292
7678842|NCT01947127|18909582|P1|STARTED|Overall Study||166
7678843|NCT01946880|18909594|P2|NOT COMPLETED|Overall Study||3
7678844|NCT01946880|18909595|P1|NOT COMPLETED|Overall Study||7
7678845|NCT01946880|18909594|P2|COMPLETED|Overall Study||49
7678846|NCT01946880|18909595|P1|COMPLETED|Overall Study||43
7678847|NCT01946880|18909594|P2|STARTED|Overall Study||52
7678848|NCT01946880|18909595|P1|STARTED|Overall Study||50
7678849|NCT01946542|18909673|P2|NOT COMPLETED|Testing Visit 2||0
7678850|NCT01946542|18909674|P1|NOT COMPLETED|Testing Visit 2||0
7678851|NCT01946542|18909673|P2|COMPLETED|Testing Visit 2||1
7678852|NCT01946542|18909674|P1|COMPLETED|Testing Visit 2||1
7678853|NCT01946542|18909673|P2|STARTED|Testing Visit 2||1
7678854|NCT01946542|18909674|P1|STARTED|Testing Visit 2||1
7678855|NCT01946542|18909673|P2|NOT COMPLETED|Testing Visit 1||0
7678856|NCT01946542|18909674|P1|NOT COMPLETED|Testing Visit 1||0
7678857|NCT01946542|18909673|P2|COMPLETED|Testing Visit 1||1
7678858|NCT01946542|18909674|P1|COMPLETED|Testing Visit 1||1
7678859|NCT01946542|18909673|P2|STARTED|Testing Visit 1||1
7678860|NCT01946542|18909674|P1|STARTED|Testing Visit 1||1
7678861|NCT01946529|18909685|P3|NOT COMPLETED|Completion of All Therapy||6
7678862|NCT01946529|18909686|P2|NOT COMPLETED|Completion of All Therapy||16
7678863|NCT01946529|18909687|P1|NOT COMPLETED|Completion of All Therapy||1
7678864|NCT01946529|18909685|P3|COMPLETED|Completion of All Therapy||0
7678865|NCT01946529|18909686|P2|COMPLETED|Completion of All Therapy||0
7678866|NCT01946529|18909687|P1|COMPLETED|Completion of All Therapy||0
7678867|NCT01946529|18909685|P3|STARTED|Completion of All Therapy||6
7678868|NCT01946529|18909686|P2|STARTED|Completion of All Therapy||16
7678869|NCT01946529|18909687|P1|STARTED|Completion of All Therapy||1
7678870|NCT01946529|18909685|P3|NOT COMPLETED|End of Window Therapy (2 Courses)||0
7678871|NCT01946529|18909686|P2|NOT COMPLETED|End of Window Therapy (2 Courses)||1
7678872|NCT01946529|18909687|P1|NOT COMPLETED|End of Window Therapy (2 Courses)||0
7678873|NCT01946529|18909685|P3|COMPLETED|End of Window Therapy (2 Courses)||6
7678874|NCT01946529|18909686|P2|COMPLETED|End of Window Therapy (2 Courses)||16
7678875|NCT01946529|18909687|P1|COMPLETED|End of Window Therapy (2 Courses)||1
7678876|NCT01946529|18909685|P3|STARTED|End of Window Therapy (2 Courses)||6
7678877|NCT01946529|18909686|P2|STARTED|End of Window Therapy (2 Courses)||17
7678878|NCT01946529|18909687|P1|STARTED|End of Window Therapy (2 Courses)||1
7678879|NCT01946438|18909698|P4|NOT COMPLETED|Overall Study||1
7678880|NCT01946438|18909699|P3|NOT COMPLETED|Overall Study||1
7678881|NCT01946438|18909700|P2|NOT COMPLETED|Overall Study||0
7678882|NCT01946438|18909701|P1|NOT COMPLETED|Overall Study||2
7678883|NCT01946438|18909698|P4|COMPLETED|Overall Study||51
7678884|NCT01946438|18909699|P3|COMPLETED|Overall Study||51
7678885|NCT01946438|18909700|P2|COMPLETED|Overall Study||52
7678886|NCT01946438|18909701|P1|COMPLETED|Overall Study||50
7678887|NCT01946438|18909698|P4|STARTED|Overall Study||52
7678888|NCT01946438|18909699|P3|STARTED|Overall Study||52
7678889|NCT01946438|18909700|P2|STARTED|Overall Study||52
7678890|NCT01946438|18909701|P1|STARTED|Overall Study||52
7678891|NCT01946425|18909729|P2|NOT COMPLETED|Overall Study||0
7678892|NCT01946425|18909730|P1|NOT COMPLETED|Overall Study||2
7678893|NCT01946425|18909729|P2|COMPLETED|Overall Study||30
7678894|NCT01946425|18909730|P1|COMPLETED|Overall Study||28
7678895|NCT01946425|18909729|P2|STARTED|Overall Study||30
7678896|NCT01946425|18909730|P1|STARTED|Overall Study||30
7678897|NCT01946412|18909744|P1|NOT COMPLETED|Overall Study||5
7678898|NCT01946412|18909744|P1|COMPLETED|Overall Study||28
7678899|NCT01946412|18909744|P1|STARTED|Overall Study||33
7678900|NCT01946282|18909769|P3|NOT COMPLETED|Year 3||30
7678901|NCT01946282|18909770|P2|NOT COMPLETED|Year 3||43
7678902|NCT01946282|18909771|P1|NOT COMPLETED|Year 3||288
7678903|NCT01946282|18909769|P3|COMPLETED|Year 3||140
7678904|NCT01946282|18909770|P2|COMPLETED|Year 3||141
7678905|NCT01946282|18909771|P1|COMPLETED|Year 3||856
7678906|NCT01946282|18909769|P3|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|170
7678907|NCT01946282|18909770|P2|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|184
7678908|NCT01946282|18909771|P1|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|1144
7678909|NCT01946282|18909769|P3|NOT COMPLETED|Year 2||115
7678910|NCT01946282|18909770|P2|NOT COMPLETED|Year 2||131
7678911|NCT01946282|18909771|P1|NOT COMPLETED|Year 2||803
7678912|NCT01946282|18909769|P3|COMPLETED|Year 2||184
7678913|NCT01946282|18909770|P2|COMPLETED|Year 2||210
7678914|NCT01946282|18909771|P1|COMPLETED|Year 2||1248
7678915|NCT01946282|18909769|P3|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|299
7678916|NCT01946282|18909770|P2|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|341
7678917|NCT01946282|18909771|P1|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|2051
7678918|NCT01946282|18909769|P3|NOT COMPLETED|Year 1||654
7678919|NCT01946282|18909770|P2|NOT COMPLETED|Year 1||608
7678920|NCT01946282|18909771|P1|NOT COMPLETED|Year 1||4186
7678921|NCT01946282|18909769|P3|COMPLETED|Year 1||346
7678922|NCT01946282|18909770|P2|COMPLETED|Year 1||392
7678923|NCT01946282|18909771|P1|COMPLETED|Year 1||2379
7678924|NCT01946282|18909769|P3|STARTED|Year 1||1000
7678925|NCT01946282|18909770|P2|STARTED|Year 1||1000
7678926|NCT01946282|18909771|P1|STARTED|Year 1||6565
7678927|NCT01946243|18909781|P1|NOT COMPLETED|Overall Study||0
7678928|NCT01946243|18909781|P1|COMPLETED|Overall Study||96
7678929|NCT01946243|18909781|P1|STARTED|Overall Study||96
7678930|NCT01946204|18909804|P2|NOT COMPLETED|Overall Study||806
7678931|NCT01946204|18909805|P1|NOT COMPLETED|Overall Study||401
7678932|NCT01946204|18909804|P2|COMPLETED|Overall Study||0
7678933|NCT01946204|18909805|P1|COMPLETED|Overall Study||0
7678934|NCT01946204|18909804|P2|Treated|Overall Study||803
7678935|NCT01946204|18909805|P1|Treated|Overall Study||398
7678936|NCT01946204|18909804|P2|STARTED|Overall Study||806
7678937|NCT01946204|18909805|P1|STARTED|Overall Study||401
7678938|NCT01946191|18909823|P2|NOT COMPLETED|Primary Outcome Analysis||18
7678939|NCT01946191|18909824|P1|NOT COMPLETED|Primary Outcome Analysis||18
7678940|NCT01946191|18909823|P2|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|77
7678941|NCT01946191|18909824|P1|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|80
7678942|NCT01946191|18909823|P2|STARTED|Primary Outcome Analysis||95
7678943|NCT01946191|18909824|P1|STARTED|Primary Outcome Analysis||98
7678944|NCT01946191|18909823|P2|NOT COMPLETED|Follow-Up, 24-mo Endpoint||18
7678945|NCT01946191|18909824|P1|NOT COMPLETED|Follow-Up, 24-mo Endpoint||17
7678946|NCT01946191|18909823|P2|COMPLETED|Follow-Up, 24-mo Endpoint||77
7678947|NCT01946191|18909824|P1|COMPLETED|Follow-Up, 24-mo Endpoint||80
7678948|NCT01946191|18909823|P2|STARTED|Follow-Up, 24-mo Endpoint||95
7678949|NCT01946191|18909824|P1|STARTED|Follow-Up, 24-mo Endpoint||97
7678950|NCT01946191|18909823|P2|NOT COMPLETED|Allocation||1
7678951|NCT01946191|18909824|P1|NOT COMPLETED|Allocation||1
7678952|NCT01946191|18909823|P2|COMPLETED|Allocation||95
7678953|NCT01946191|18909824|P1|COMPLETED|Allocation||97
7678954|NCT01946191|18909823|P2|STARTED|Allocation||96
7678955|NCT01946191|18909824|P1|STARTED|Allocation||98
7678956|NCT01946178|18909850|P1|NOT COMPLETED|Overall Study||2
7678957|NCT01946178|18909850|P1|COMPLETED|Overall Study||71
7678958|NCT01946178|18909850|P1|STARTED|Overall Study||73
7678959|NCT01946165|18909860|P2|NOT COMPLETED|Overall Study||2
7678960|NCT01946165|18909861|P1|NOT COMPLETED|Overall Study||2
7678961|NCT01946165|18909860|P2|COMPLETED|Overall Study||21
7678962|NCT01946165|18909861|P1|COMPLETED|Overall Study||43
7678963|NCT01946165|18909860|P2|STARTED|Overall Study||23
7678964|NCT01946165|18909861|P1|STARTED|Overall Study||45
7678965|NCT01946126|18909871|P2|NOT COMPLETED|Overall Study||0
7678966|NCT01946126|18909872|P1|NOT COMPLETED|Overall Study||0
7678967|NCT01946126|18909871|P2|COMPLETED|Overall Study||275
7678968|NCT01946126|18909872|P1|COMPLETED|Overall Study||184
7678969|NCT01946126|18909871|P2|STARTED|Overall Study||275
7678970|NCT01946126|18909872|P1|STARTED|Overall Study||184
7678971|NCT01945996|18909888|P2|NOT COMPLETED|Overall Study||5
7678972|NCT01945996|18909889|P1|NOT COMPLETED|Overall Study||3
7678973|NCT01945996|18909888|P2|COMPLETED|Overall Study||17
7678974|NCT01945996|18909889|P1|COMPLETED|Overall Study||19
7678975|NCT01945996|18909888|P2|STARTED|Overall Study||22
7678976|NCT01945996|18909889|P1|STARTED|Overall Study||22
7678977|NCT01945970|18909921|P6|NOT COMPLETED|Overall Study||0
7678978|NCT01945970|18909922|P5|NOT COMPLETED|Overall Study||0
7678979|NCT01945970|18909923|P4|NOT COMPLETED|Overall Study||0
7678980|NCT01945970|18909924|P3|NOT COMPLETED|Overall Study||0
7678981|NCT01945970|18909925|P2|NOT COMPLETED|Overall Study||0
7678982|NCT01945970|18909926|P1|NOT COMPLETED|Overall Study||0
7678983|NCT01945970|18909921|P6|COMPLETED|Overall Study||5
7678984|NCT01945970|18909922|P5|COMPLETED|Overall Study||5
7678985|NCT01945970|18909923|P4|COMPLETED|Overall Study||5
7678986|NCT01945970|18909924|P3|COMPLETED|Overall Study||5
7678987|NCT01945970|18909925|P2|COMPLETED|Overall Study||5
7678988|NCT01945970|18909926|P1|COMPLETED|Overall Study||5
7678989|NCT01945970|18909921|P6|STARTED|Overall Study||5
7678990|NCT01945970|18909922|P5|STARTED|Overall Study||5
7678991|NCT01945970|18909923|P4|STARTED|Overall Study||5
7678992|NCT01945970|18909924|P3|STARTED|Overall Study||5
7678993|NCT01945970|18909925|P2|STARTED|Overall Study||5
7678994|NCT01945970|18909926|P1|STARTED|Overall Study||5
7678995|NCT01945944|18909965|P2|NOT COMPLETED|Overall Study||3
7678996|NCT01945944|18909966|P1|NOT COMPLETED|Overall Study||1
7678997|NCT01945944|18909965|P2|COMPLETED|Overall Study||6
7678998|NCT01945944|18909966|P1|COMPLETED|Overall Study||8
7678999|NCT01945944|18909965|P2|STARTED|Overall Study||9
7679000|NCT01945944|18909966|P1|STARTED|Overall Study||9
7679001|NCT01945866|18909990|P2|NOT COMPLETED|Overall Study||0
7679002|NCT01945866|18909991|P1|NOT COMPLETED|Overall Study||2
7679003|NCT01945866|18909990|P2|COMPLETED|Overall Study||64
7679004|NCT01945866|18909991|P1|COMPLETED|Overall Study||63
7679005|NCT01945866|18909990|P2|STARTED|Overall Study||64
7679006|NCT01945866|18909991|P1|STARTED|Overall Study||65
7679007|NCT01945775|18910012|P2|NOT COMPLETED|Overall Study||144
7679008|NCT01945775|18910013|P1|NOT COMPLETED|Overall Study||287
7679009|NCT01945775|18910012|P2|COMPLETED|Overall Study||0
7679010|NCT01945775|18910013|P1|COMPLETED|Overall Study||0
7679011|NCT01945775|18910012|P2|Treated|Overall Study||126
7679012|NCT01945775|18910013|P1|Treated|Overall Study||286
7679013|NCT01945775|18910012|P2|STARTED|Overall Study||144
7679014|NCT01945775|18910013|P1|STARTED|Overall Study||287
7679015|NCT01945710|18910049|P7|NOT COMPLETED|Overall Study||23
7679016|NCT01945710|18910050|P6|NOT COMPLETED|Overall Study||3
7679017|NCT01945710|18910051|P5|NOT COMPLETED|Overall Study||9
7679018|NCT01945710|18910052|P4|NOT COMPLETED|Overall Study||3
7679019|NCT01945710|18910053|P3|NOT COMPLETED|Overall Study||7
7679020|NCT01945710|18910054|P2|NOT COMPLETED|Overall Study||6
7679021|NCT01945710|18910055|P1|NOT COMPLETED|Overall Study||7
7679022|NCT01945710|18910049|P7|COMPLETED|Overall Study||0
7679023|NCT01945710|18910050|P6|COMPLETED|Overall Study||0
7679024|NCT01945710|18910051|P5|COMPLETED|Overall Study||0
7679025|NCT01945710|18910052|P4|COMPLETED|Overall Study||0
7679026|NCT01945710|18910053|P3|COMPLETED|Overall Study||0
7679027|NCT01945710|18910054|P2|COMPLETED|Overall Study||0
7679028|NCT01945710|18910055|P1|COMPLETED|Overall Study||0
7679029|NCT01945710|18910049|P7|STARTED|Overall Study||23
7679030|NCT01945710|18910050|P6|STARTED|Overall Study||3
7679031|NCT01945710|18910051|P5|STARTED|Overall Study||9
7679032|NCT01945710|18910052|P4|STARTED|Overall Study||3
7679033|NCT01945710|18910053|P3|STARTED|Overall Study||7
7679034|NCT01945710|18910054|P2|STARTED|Overall Study||6
7679035|NCT01945710|18910055|P1|STARTED|Overall Study||7
7679036|NCT01945593|18910174|P4|NOT COMPLETED|Overall Study||20
7679037|NCT01945593|18910175|P3|NOT COMPLETED|Overall Study||3
7679038|NCT01945593|18910176|P2|NOT COMPLETED|Overall Study||8
7679039|NCT01945593|18910177|P1|NOT COMPLETED|Overall Study||0
7679040|NCT01945593|18910174|P4|COMPLETED|Overall Study||105
7679041|NCT01945593|18910175|P3|COMPLETED|Overall Study||23
7679042|NCT01945593|18910176|P2|COMPLETED|Overall Study||56
7679043|NCT01945593|18910177|P1|COMPLETED|Overall Study||3
7679044|NCT01945593|18910174|P4|STARTED|Overall Study||125
7679045|NCT01945593|18910175|P3|STARTED|Overall Study||26
7679046|NCT01945593|18910176|P2|STARTED|Overall Study||64
7679047|NCT01945593|18910177|P1|STARTED|Overall Study||3
7679048|NCT01945489|18910259|P2|NOT COMPLETED|Cycle 2||1
7679049|NCT01945489|18910260|P1|NOT COMPLETED|Cycle 2||1
7679050|NCT01945489|18910259|P2|COMPLETED|Cycle 2||106
7679051|NCT01945489|18910260|P1|COMPLETED|Cycle 2||87
7679052|NCT01945489|18910259|P2|STARTED|Cycle 2||107
7679053|NCT01945489|18910260|P1|STARTED|Cycle 2|Not all participants participated in Cycle 2.|88
7679054|NCT01945489|18910259|P2|NOT COMPLETED|Cycle 1||4
7679055|NCT01945489|18910260|P1|NOT COMPLETED|Cycle 1||13
7679056|NCT01945489|18910259|P2|COMPLETED|Cycle 1||121
7679057|NCT01945489|18910260|P1|COMPLETED|Cycle 1||116
7679058|NCT01945489|18910259|P2|STARTED|Cycle 1||125
7679059|NCT01945489|18910260|P1|STARTED|Cycle 1||129
7679060|NCT01945294|18910280|P4|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6
7679061|NCT01945294|18910281|P3|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8
7679062|NCT01945294|18910282|P2|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5
7679063|NCT01945294|18910283|P1|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
7679064|NCT01945294|18910280|P4|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23
7679065|NCT01945294|18910281|P3|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
7679066|NCT01945294|18910282|P2|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
7679067|NCT01945294|18910283|P1|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
7679068|NCT01945294|18910280|P4|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29
7679069|NCT01945294|18910281|P3|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105
7679070|NCT01945294|18910282|P2|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102
7679071|NCT01945294|18910283|P1|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0
7679072|NCT01945294|18910280|P4|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
7679073|NCT01945294|18910281|P3|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
7679074|NCT01945294|18910282|P2|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
7679075|NCT01945294|18910283|P1|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21
7679076|NCT01945294|18910280|P4|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
7679077|NCT01945294|18910281|P3|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
7679078|NCT01945294|18910282|P2|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
7679079|NCT01945294|18910283|P1|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236
7679080|NCT01945294|18910280|P4|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
7679081|NCT01945294|18910281|P3|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
7679082|NCT01945294|18910282|P2|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
7679083|NCT01945294|18910283|P1|STARTED|Period 1: 12-Week PR + BOC Lead-In||257
7679084|NCT01945281|18910314|P2|NOT COMPLETED|Overall Study||4
7679085|NCT01945281|18910315|P1|NOT COMPLETED|Overall Study||6
7679086|NCT01945281|18910314|P2|COMPLETED|Overall Study||13
7679087|NCT01945281|18910315|P1|COMPLETED|Overall Study||28
7679088|NCT01945281|18910314|P2|Treated|Overall Study||16
7679089|NCT01945281|18910315|P1|Treated|Overall Study||33
7679090|NCT01945281|18910314|P2|STARTED|Overall Study||17
7679091|NCT01945281|18910315|P1|STARTED|Overall Study||34
7679092|NCT01945242|18910327|P2|NOT COMPLETED|Overall Study||3
7679093|NCT01945242|18910328|P1|NOT COMPLETED|Overall Study||3
7679094|NCT01945242|18910327|P2|COMPLETED|Overall Study||120
7679095|NCT01945242|18910328|P1|COMPLETED|Overall Study||1248
7679096|NCT01945242|18910327|P2|STARTED|Overall Study||123
7679097|NCT01945242|18910328|P1|STARTED|Overall Study||1251
7679098|NCT01945216|18910343|P1|NOT COMPLETED|Overall Study||99
7679099|NCT01945216|18910343|P1|COMPLETED|Overall Study||3218
7679100|NCT01945216|18910343|P1|STARTED|Overall Study||3317
7679101|NCT01945138|18910357|P2|NOT COMPLETED|Overall Study||0
7679102|NCT01945138|18910358|P1|NOT COMPLETED|Overall Study||0
7679103|NCT01945138|18910357|P2|COMPLETED|Overall Study||7
7679104|NCT01945138|18910358|P1|COMPLETED|Overall Study||7
7679105|NCT01945138|18910357|P2|STARTED|Overall Study||7
7679106|NCT01945138|18910358|P1|STARTED|Overall Study||7
7679107|NCT01945112|18910392|P2|NOT COMPLETED|Overall Study||0
7679108|NCT01945112|18910393|P1|NOT COMPLETED|Overall Study||0
7679109|NCT01945112|18910392|P2|COMPLETED|Overall Study||51
7679110|NCT01945112|18910393|P1|COMPLETED|Overall Study||77
7679111|NCT01945112|18910392|P2|STARTED|Overall Study|total number of sites where tape was applied|51
7679112|NCT01945112|18910393|P1|STARTED|Overall Study|total number of sites where tape was applied|77
7679113|NCT01945086|18910401|P3|NOT COMPLETED|Overall Study||2
7679114|NCT01945086|18910402|P2|NOT COMPLETED|Overall Study||0
7679115|NCT01945086|18910403|P1|NOT COMPLETED|Overall Study||1
7679116|NCT01945086|18910401|P3|COMPLETED|Overall Study||26
7679117|NCT01945086|18910402|P2|COMPLETED|Overall Study||24
7679118|NCT01945086|18910403|P1|COMPLETED|Overall Study||26
7679119|NCT01945086|18910401|P3|STARTED|Overall Study||28
7679120|NCT01945086|18910402|P2|STARTED|Overall Study||24
7679121|NCT01945086|18910403|P1|STARTED|Overall Study||27
7679122|NCT01945034|18910447|P3|NOT COMPLETED|Overall Study||7
7679123|NCT01945034|18910448|P2|NOT COMPLETED|Overall Study||5
7679124|NCT01945034|18910449|P1|NOT COMPLETED|Overall Study||1
7679125|NCT01945034|18910447|P3|COMPLETED|Overall Study||145
7679126|NCT01945034|18910448|P2|COMPLETED|Overall Study||80
7679127|NCT01945034|18910449|P1|COMPLETED|Overall Study||66
7679128|NCT01945034|18910447|P3|STARTED|Overall Study||152
7679129|NCT01945034|18910448|P2|STARTED|Overall Study||85
7679130|NCT01945034|18910449|P1|STARTED|Overall Study||67
7679131|NCT01945021|18910499|P1|NOT COMPLETED|Overall Study||47
7679132|NCT01945021|18910499|P1|COMPLETED|Overall Study|Completed is defined as patients who continued crizotinib at the time of final analysis (ongoing)|80
7679133|NCT01945021|18910499|P1|Patient Reported Outcome -Evaluable|Overall Study|All patients from the safety population who completed a baseline and >/= 1 post-baseline assessment.|123
7679134|NCT01945021|18910499|P1|Response Evaluable Population|Overall Study|All patients in the safety population who had an adequate baseline tumor assessment|127
7679135|NCT01945021|18910499|P1|Safety Population|Overall Study|All enrolled patients who received at least 1 dose of study medication.|127
7679136|NCT01945021|18910499|P1|STARTED|Overall Study|127 pts with ROS1+ & ALK negative tumors were consented and started study (2 more were screen fails)|127
7679137|NCT01944969|18910513|P1|NOT COMPLETED|Overall Study||26
7679138|NCT01944969|18910513|P1|COMPLETED|Overall Study||0
7679139|NCT01944969|18910513|P1|STARTED|Overall Study||26
7679140|NCT01944878|18910526|P2|NOT COMPLETED|Overall Study||0
7679141|NCT01944878|18910527|P1|NOT COMPLETED|Overall Study||0
7679142|NCT01944878|18910526|P2|COMPLETED|Overall Study||328
7679143|NCT01944878|18910527|P1|COMPLETED|Overall Study||127
7679144|NCT01944878|18910526|P2|STARTED|Overall Study||328
7679145|NCT01944878|18910527|P1|STARTED|Overall Study||127
7679146|NCT01944839|18910537|P2|NOT COMPLETED|Overall Study||28
7679147|NCT01944839|18910538|P1|NOT COMPLETED|Overall Study||22
7679148|NCT01944839|18910537|P2|COMPLETED|Overall Study||282
7679149|NCT01944839|18910538|P1|COMPLETED|Overall Study||287
7679150|NCT01944839|18910537|P2|STARTED|Overall Study||310
7679151|NCT01944839|18910538|P1|STARTED|Overall Study||309
7679152|NCT01944774|18910547|P3|NOT COMPLETED|Overall Study||8
7679153|NCT01944774|18910548|P2|NOT COMPLETED|Overall Study||8
7679154|NCT01944774|18910549|P1|NOT COMPLETED|Overall Study||6
7679155|NCT01944774|18910547|P3|COMPLETED|Overall Study||62
7679156|NCT01944774|18910548|P2|COMPLETED|Overall Study||60
7679157|NCT01944774|18910549|P1|COMPLETED|Overall Study||63
7679158|NCT01944774|18910547|P3|Received Treatment|Overall Study||70
7679159|NCT01944774|18910548|P2|Received Treatment|Overall Study||67
7679160|NCT01944774|18910549|P1|Received Treatment|Overall Study||68
7679161|NCT01944774|18910547|P3|STARTED|Overall Study||70
7679162|NCT01944774|18910548|P2|STARTED|Overall Study||68
7679163|NCT01944774|18910549|P1|STARTED|Overall Study||69
7679164|NCT01944722|18910592|P1|NOT COMPLETED|Overall Study||9515
7679165|NCT01944722|18910592|P1|COMPLETED|Overall Study||24343
7679166|NCT01944722|18910592|P1|STARTED|Overall Study||33858
7679167|NCT01944670|18910626|P1|NOT COMPLETED|Overall Study||2
7679168|NCT01944670|18910626|P1|COMPLETED|Overall Study||24
7679169|NCT01944670|18910626|P1|STARTED|Overall Study||26
7679170|NCT01944644|18910633|P2|NOT COMPLETED|Overall Study||0
7679171|NCT01944644|18910634|P1|NOT COMPLETED|Overall Study||0
7679172|NCT01944644|18910633|P2|COMPLETED|Overall Study||32
7679173|NCT01944644|18910634|P1|COMPLETED|Overall Study||34
7679174|NCT01944644|18910633|P2|STARTED|Overall Study||32
7679175|NCT01944644|18910634|P1|STARTED|Overall Study||34
7679176|NCT01944631|18910648|P2|NOT COMPLETED|Overall Study||2
7679177|NCT01944631|18910649|P1|NOT COMPLETED|Overall Study||4
7679178|NCT01944631|18910648|P2|COMPLETED|Overall Study||98
7679179|NCT01944631|18910649|P1|COMPLETED|Overall Study||96
7679180|NCT01944631|18910648|P2|STARTED|Overall Study||100
7679181|NCT01944631|18910649|P1|STARTED|Overall Study||100
7679182|NCT01944462|18910665|P1|NOT COMPLETED|Optional Vaccination||0
7679183|NCT01944462|18910665|P1|COMPLETED|Optional Vaccination||20
7679184|NCT01944462|18910665|P1|STARTED|Optional Vaccination||20
7679185|NCT01944462|18910665|P1|NOT COMPLETED|PPPP Educational Program||60
7679186|NCT01944462|18910665|P1|COMPLETED|PPPP Educational Program||143
7679187|NCT01944462|18910665|P1|3 Month Follow-Up|PPPP Educational Program||143
7679188|NCT01944462|18910665|P1|Post-Test|PPPP Educational Program||187
7679189|NCT01944462|18910665|P1|Baseline|PPPP Educational Program||203
7679190|NCT01944462|18910665|P1|STARTED|PPPP Educational Program||203
7679191|NCT01944371|18910677|P3|NOT COMPLETED|Overall Study||0
7679192|NCT01944371|18910678|P2|NOT COMPLETED|Overall Study||0
7679193|NCT01944371|18910679|P1|NOT COMPLETED|Overall Study||0
7679194|NCT01944371|18910677|P3|COMPLETED|Overall Study||10
7679195|NCT01944371|18910678|P2|COMPLETED|Overall Study||10
7679196|NCT01944371|18910679|P1|COMPLETED|Overall Study||10
7679197|NCT01944371|18910677|P3|STARTED|Overall Study||10
7679198|NCT01944371|18910678|P2|STARTED|Overall Study||10
7679199|NCT01944371|18910679|P1|STARTED|Overall Study||10
7679200|NCT01944345|18910696|P1|NOT COMPLETED|Overall Study||0
7679201|NCT01944345|18910696|P1|COMPLETED|Overall Study||69
7679202|NCT01944345|18910696|P1|STARTED|Overall Study||69
7679203|NCT01944319|18910704|P2|NOT COMPLETED|Overall Study||0
7679204|NCT01944319|18910705|P1|NOT COMPLETED|Overall Study||0
7679205|NCT01944319|18910704|P2|COMPLETED|Overall Study||39
7679206|NCT01944319|18910705|P1|COMPLETED|Overall Study||40
7679207|NCT01944319|18910704|P2|STARTED|Overall Study||39
7679208|NCT01944319|18910705|P1|STARTED|Overall Study||40
7679209|NCT01944293|18910717|P2|NOT COMPLETED|Overall Study||0
7679210|NCT01944293|18910718|P1|NOT COMPLETED|Overall Study||0
7679211|NCT01944293|18910717|P2|COMPLETED|Overall Study||9
7679212|NCT01944293|18910718|P1|COMPLETED|Overall Study||7
7679213|NCT01944293|18910717|P2|STARTED|Overall Study||9
7679214|NCT01944293|18910718|P1|STARTED|Overall Study||7
7679215|NCT01944098|18910728|P2|NOT COMPLETED|Overall Study||0
7679216|NCT01944098|18910729|P1|NOT COMPLETED|Overall Study||1
7679217|NCT01944098|18910728|P2|COMPLETED|Overall Study||10
7679218|NCT01944098|18910729|P1|COMPLETED|Overall Study||9
7679219|NCT01944098|18910728|P2|STARTED|Overall Study||10
7679220|NCT01944098|18910729|P1|STARTED|Overall Study||10
7679221|NCT01944059|18910741|P1|NOT COMPLETED|Overall Study||7
7679222|NCT01944059|18910741|P1|COMPLETED|Overall Study||24
7679223|NCT01944059|18910741|P1|STARTED|Overall Study||31
7679224|NCT01943864|18910750|P1|NOT COMPLETED|Overall Study||0
7679225|NCT01943864|18910750|P1|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20
7679226|NCT01943864|18910750|P1|STARTED|Overall Study||20
7679227|NCT01943825|18910782|P4|NOT COMPLETED|Overall Study||11
7679228|NCT01943825|18910783|P3|NOT COMPLETED|Overall Study||15
7679229|NCT01943825|18910784|P2|NOT COMPLETED|Overall Study||4
7679230|NCT01943825|18910785|P1|NOT COMPLETED|Overall Study||10
7679231|NCT01943825|18910782|P4|COMPLETED|Overall Study||14
7679232|NCT01943825|18910783|P3|COMPLETED|Overall Study||10
7679233|NCT01943825|18910784|P2|COMPLETED|Overall Study||11
7679234|NCT01943825|18910785|P1|COMPLETED|Overall Study||15
7679235|NCT01943825|18910782|P4|STARTED|Overall Study||25
7679236|NCT01943825|18910783|P3|STARTED|Overall Study||25
7679237|NCT01943825|18910784|P2|STARTED|Overall Study||15
7679238|NCT01943825|18910785|P1|STARTED|Overall Study||25
7679239|NCT01943799|18910827|P4|NOT COMPLETED|Overall Study||0
7679240|NCT01943799|18910828|P3|NOT COMPLETED|Overall Study||2
7679241|NCT01943799|18910829|P2|NOT COMPLETED|Overall Study||3
7679242|NCT01943799|18910830|P1|NOT COMPLETED|Overall Study||5
7679243|NCT01943799|18910827|P4|COMPLETED|Overall Study||50
7679244|NCT01943799|18910828|P3|COMPLETED|Overall Study||49
7679245|NCT01943799|18910829|P2|COMPLETED|Overall Study||47
7679246|NCT01943799|18910830|P1|COMPLETED|Overall Study||22
7679247|NCT01943799|18910827|P4|STARTED|Overall Study||50
7679248|NCT01943799|18910828|P3|STARTED|Overall Study|1 participant was randomized to OAV + GS-4774 2 YU but received OAV + GS-4774 10 YU.|51
7679249|NCT01943799|18910829|P2|STARTED|Overall Study||50
7679250|NCT01943799|18910830|P1|STARTED|Overall Study||27
7679251|NCT01943591|18910870|P2|NOT COMPLETED|Overall Study||11
7679252|NCT01943591|18910871|P1|NOT COMPLETED|Overall Study||5
7679253|NCT01943591|18910870|P2|COMPLETED|Overall Study||95
7679254|NCT01943591|18910871|P1|COMPLETED|Overall Study||99
7679255|NCT01943591|18910870|P2|STARTED|Overall Study||106
7679256|NCT01943591|18910871|P1|STARTED|Overall Study||104
7679257|NCT01943565|18910896|P3|NOT COMPLETED|Overall Study||0
7679258|NCT01943565|18910897|P2|NOT COMPLETED|Overall Study||0
7679259|NCT01943565|18910898|P1|NOT COMPLETED|Overall Study||0
7679260|NCT01943565|18910896|P3|COMPLETED|Overall Study||9
7679261|NCT01943565|18910897|P2|COMPLETED|Overall Study||9
7679262|NCT01943565|18910898|P1|COMPLETED|Overall Study||11
7679263|NCT01943565|18910896|P3|STARTED|Overall Study||9
7679264|NCT01943565|18910897|P2|STARTED|Overall Study||9
7679265|NCT01943565|18910898|P1|STARTED|Overall Study||11
7679266|NCT01943552|18910929|P2|NOT COMPLETED|Overall Study||25
7679267|NCT01943552|18910930|P1|NOT COMPLETED|Overall Study||25
7679268|NCT01943552|18910929|P2|COMPLETED|Overall Study||69
7679269|NCT01943552|18910930|P1|COMPLETED|Overall Study||71
7679270|NCT01943552|18910929|P2|STARTED|Overall Study||94
7679271|NCT01943552|18910930|P1|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96
7679272|NCT01943539|18910946|P2|NOT COMPLETED|Overall Study||0
7679273|NCT01943539|18910947|P1|NOT COMPLETED|Overall Study||4
7679274|NCT01943539|18910946|P2|COMPLETED|Overall Study||40
7679275|NCT01943539|18910947|P1|COMPLETED|Overall Study||40
7679276|NCT01943539|18910946|P2|STARTED|Overall Study||40
7679277|NCT01943539|18910947|P1|STARTED|Overall Study||44
7679278|NCT01943474|18910958|P2|NOT COMPLETED|Overall Study||0
7679279|NCT01943474|18910959|P1|NOT COMPLETED|Overall Study||0
7679280|NCT01943474|18910958|P2|COMPLETED|Overall Study||125
7679281|NCT01943474|18910959|P1|COMPLETED|Overall Study||123
7679282|NCT01943474|18910958|P2|STARTED|Overall Study||125
7679283|NCT01943474|18910959|P1|STARTED|Overall Study||123
7679284|NCT01943461|18910984|P4|NOT COMPLETED|Overall Study||0
7679285|NCT01943461|18910985|P3|NOT COMPLETED|Overall Study||0
7679286|NCT01943461|18910986|P2|NOT COMPLETED|Overall Study||0
7679287|NCT01943461|18910987|P1|NOT COMPLETED|Overall Study||0
7679288|NCT01943461|18910984|P4|COMPLETED|Overall Study||40
7679289|NCT01943461|18910985|P3|COMPLETED|Overall Study||6
7679290|NCT01943461|18910986|P2|COMPLETED|Overall Study||6
7679291|NCT01943461|18910987|P1|COMPLETED|Overall Study||5
7679292|NCT01943461|18910984|P4|STARTED|Overall Study||40
7679293|NCT01943461|18910985|P3|STARTED|Overall Study||6
7679294|NCT01943461|18910986|P2|STARTED|Overall Study||6
7679295|NCT01943461|18910987|P1|STARTED|Overall Study||5
7679296|NCT01943435|18911044|P3|NOT COMPLETED|6 Month Follow up||15
7679297|NCT01943435|18911045|P2|NOT COMPLETED|6 Month Follow up||7
7679298|NCT01943435|18911046|P1|NOT COMPLETED|6 Month Follow up||12
7679299|NCT01943435|18911044|P3|COMPLETED|6 Month Follow up||65
7679300|NCT01943435|18911045|P2|COMPLETED|6 Month Follow up||59
7679301|NCT01943435|18911046|P1|COMPLETED|6 Month Follow up||67
7679302|NCT01943435|18911044|P3|STARTED|6 Month Follow up||80
7679303|NCT01943435|18911045|P2|STARTED|6 Month Follow up||66
7679304|NCT01943435|18911046|P1|STARTED|6 Month Follow up||79
7679305|NCT01943435|18911044|P3|NOT COMPLETED|2 Month Follow up||0
7679306|NCT01943435|18911045|P2|NOT COMPLETED|2 Month Follow up||3
7679307|NCT01943435|18911046|P1|NOT COMPLETED|2 Month Follow up||2
7679308|NCT01943435|18911044|P3|COMPLETED|2 Month Follow up||80
7679309|NCT01943435|18911045|P2|COMPLETED|2 Month Follow up||66
7679310|NCT01943435|18911046|P1|COMPLETED|2 Month Follow up||79
7679311|NCT01943435|18911044|P3|STARTED|2 Month Follow up||80
7679312|NCT01943435|18911045|P2|STARTED|2 Month Follow up||69
7679313|NCT01943435|18911046|P1|STARTED|2 Month Follow up||81
7679314|NCT01943435|18911044|P3|NOT COMPLETED|Intervention Period||4
7679315|NCT01943435|18911045|P2|NOT COMPLETED|Intervention Period||3
7679316|NCT01943435|18911046|P1|NOT COMPLETED|Intervention Period||3
7679317|NCT01943435|18911044|P3|COMPLETED|Intervention Period||80
7679318|NCT01943435|18911045|P2|COMPLETED|Intervention Period||69
7679319|NCT01943435|18911046|P1|COMPLETED|Intervention Period||81
7679320|NCT01943435|18911044|P3|STARTED|Intervention Period||84
7679321|NCT01943435|18911045|P2|STARTED|Intervention Period||72
7679322|NCT01943435|18911046|P1|STARTED|Intervention Period||84
7679323|NCT01943435|18911044|P3|NOT COMPLETED|Baseline Eligibility and Randomization||3
7679324|NCT01943435|18911045|P2|NOT COMPLETED|Baseline Eligibility and Randomization||12
7679325|NCT01943435|18911046|P1|NOT COMPLETED|Baseline Eligibility and Randomization||4
7679326|NCT01943435|18911044|P3|COMPLETED|Baseline Eligibility and Randomization||84
7679327|NCT01943435|18911045|P2|COMPLETED|Baseline Eligibility and Randomization||72
7679328|NCT01943435|18911046|P1|COMPLETED|Baseline Eligibility and Randomization||84
7679329|NCT01943435|18911044|P3|STARTED|Baseline Eligibility and Randomization||87
7679330|NCT01943435|18911045|P2|STARTED|Baseline Eligibility and Randomization||84
7679331|NCT01943435|18911046|P1|STARTED|Baseline Eligibility and Randomization||88
7679332|NCT01943344|18911060|P1|NOT COMPLETED|Overall Study||3
7679333|NCT01943344|18911060|P1|COMPLETED|Overall Study||9
7679334|NCT01943344|18911060|P1|STARTED|Overall Study||12
7679335|NCT01943292|18911069|P3|NOT COMPLETED|Overall Study||0
7679336|NCT01943292|18911070|P2|NOT COMPLETED|Overall Study||0
7679337|NCT01943292|18911071|P1|NOT COMPLETED|Overall Study||1
7679338|NCT01943292|18911069|P3|COMPLETED|Overall Study||3
7679339|NCT01943292|18911070|P2|COMPLETED|Overall Study||3
7679340|NCT01943292|18911071|P1|COMPLETED|Overall Study||2
7679341|NCT01943292|18911069|P3|Completed Follow-Up|Overall Study||3
7679342|NCT01943292|18911070|P2|Completed Follow-Up|Overall Study||3
7679343|NCT01943292|18911071|P1|Completed Follow-Up|Overall Study||2
7679344|NCT01943292|18911069|P3|Completed Treatment|Overall Study||3
7679345|NCT01943292|18911070|P2|Completed Treatment|Overall Study||3
7679346|NCT01943292|18911071|P1|Completed Treatment|Overall Study||3
7679347|NCT01943292|18911069|P3|Completed Cycle 1|Overall Study||3
7679348|NCT01943292|18911070|P2|Completed Cycle 1|Overall Study||3
7679349|NCT01943292|18911071|P1|Completed Cycle 1|Overall Study||3
7679350|NCT01943292|18911069|P3|STARTED|Overall Study||3
7679351|NCT01943292|18911070|P2|STARTED|Overall Study||3
7679352|NCT01943292|18911071|P1|STARTED|Overall Study||3
7679353|NCT01943227|18911084|P2|NOT COMPLETED|Overall Study||0
7679354|NCT01943227|18911085|P1|NOT COMPLETED|Overall Study||0
7679355|NCT01943227|18911084|P2|COMPLETED|Overall Study||10
7679356|NCT01943227|18911085|P1|COMPLETED|Overall Study||10
7679357|NCT01943227|18911084|P2|STARTED|Overall Study||10
7679358|NCT01943227|18911085|P1|STARTED|Overall Study||10
7679359|NCT01943110|18911091|P1|NOT COMPLETED|Overall Study||0
7679360|NCT01943110|18911091|P1|COMPLETED|Overall Study||30
7679361|NCT01943110|18911091|P1|STARTED|Overall Study||30
7679362|NCT01942993|18911107|P1|NOT COMPLETED|Overall Study||2
7679363|NCT01942993|18911107|P1|COMPLETED|Overall Study||1
7679364|NCT01942993|18911107|P1|STARTED|Overall Study||3
7679365|NCT01942785|18911124|P1|NOT COMPLETED|Overall Study||4
7679366|NCT01942785|18911124|P1|COMPLETED|Overall Study||50
7679367|NCT01942785|18911124|P1|STARTED|Overall Study||54
7679368|NCT01942733|18911153|P1|NOT COMPLETED|Overall Study||3
7679369|NCT01942733|18911153|P1|COMPLETED|Overall Study||41
7679370|NCT01942733|18911153|P1|STARTED|Overall Study||44
7679371|NCT01942720|18911182|P1|NOT COMPLETED|Overall Study||21
7679372|NCT01942720|18911182|P1|COMPLETED|Overall Study||53
7679373|NCT01942720|18911182|P1|STARTED|Overall Study||74
7679374|NCT01942707|18911192|P2|NOT COMPLETED|Overall Study||0
7679375|NCT01942707|18911193|P1|NOT COMPLETED|Overall Study||0
7679376|NCT01942707|18911192|P2|COMPLETED|Overall Study||23
7679377|NCT01942707|18911193|P1|COMPLETED|Overall Study||23
7679378|NCT01942707|18911192|P2|STARTED|Overall Study||23
7679379|NCT01942707|18911193|P1|STARTED|Overall Study||23
7679380|NCT01942694|18911205|P2|NOT COMPLETED|Overall Study||0
7679381|NCT01942694|18911206|P1|NOT COMPLETED|Overall Study||1
7679382|NCT01942694|18911205|P2|COMPLETED|Overall Study||1211
7679383|NCT01942694|18911206|P1|COMPLETED|Overall Study||1211
7679384|NCT01942694|18911205|P2|STARTED|Overall Study||1211
7679385|NCT01942694|18911206|P1|STARTED|Overall Study||1212
7679386|NCT01942668|18911231|P5|NOT COMPLETED|Overall Study||59
7679387|NCT01942668|18911232|P4|NOT COMPLETED|Overall Study||146
7679388|NCT01942668|18911233|P3|NOT COMPLETED|Overall Study||110
7679389|NCT01942668|18911234|P2|NOT COMPLETED|Overall Study||121
7679390|NCT01942668|18911235|P1|NOT COMPLETED|Overall Study||134
7679391|NCT01942668|18911231|P5|COMPLETED|Overall Study||93
7679392|NCT01942668|18911232|P4|COMPLETED|Overall Study||281
7679393|NCT01942668|18911233|P3|COMPLETED|Overall Study||312
7679394|NCT01942668|18911234|P2|COMPLETED|Overall Study||305
7679395|NCT01942668|18911235|P1|COMPLETED|Overall Study||284
7679396|NCT01942668|18911231|P5|STARTED|Overall Study||152
7679397|NCT01942668|18911232|P4|STARTED|Overall Study||427
7679398|NCT01942668|18911233|P3|STARTED|Overall Study||422
7679399|NCT01942668|18911234|P2|STARTED|Overall Study||426
7679400|NCT01942668|18911235|P1|STARTED|Overall Study||418
7679401|NCT01942590|18912294|P2|NOT COMPLETED|Overall Study||1
7679402|NCT01942590|18912295|P1|NOT COMPLETED|Overall Study||1
7679403|NCT01942590|18912294|P2|COMPLETED|Overall Study||4
7679404|NCT01942590|18912295|P1|COMPLETED|Overall Study||7
7679405|NCT01942590|18912294|P2|STARTED|Overall Study||5
7679406|NCT01942590|18912295|P1|STARTED|Overall Study||8
7679407|NCT01942486|18912325|P1|NOT COMPLETED|Overall Study||27
7679408|NCT01942486|18912325|P1|COMPLETED|Overall Study||8
7679409|NCT01942486|18912325|P1|STARTED|Overall Study||35
7679410|NCT01942161|18912332|P3|NOT COMPLETED|Overall Study||6
7679411|NCT01942161|18912333|P2|NOT COMPLETED|Overall Study||6
7679412|NCT01942161|18912334|P1|NOT COMPLETED|Overall Study||8
7679413|NCT01942161|18912332|P3|COMPLETED|Overall Study||35
7679414|NCT01942161|18912333|P2|COMPLETED|Overall Study||24
7679415|NCT01942161|18912334|P1|COMPLETED|Overall Study||27
7679416|NCT01942161|18912332|P3|STARTED|Overall Study||41
7679417|NCT01942161|18912333|P2|STARTED|Overall Study||30
7679418|NCT01942161|18912334|P1|STARTED|Overall Study||35
7679419|NCT01942148|18912354|P1|NOT COMPLETED|Overall Study||27
7679420|NCT01942148|18912354|P1|COMPLETED|Overall Study||41
7679421|NCT01942148|18912354|P1|STARTED|Overall Study||68
7679422|NCT01942135|18912362|P2|NOT COMPLETED|Overall Study||174
7679423|NCT01942135|18912363|P1|NOT COMPLETED|Overall Study||347
7679424|NCT01942135|18912362|P2|COMPLETED|Overall Study||0
7679425|NCT01942135|18912363|P1|COMPLETED|Overall Study||0
7679426|NCT01942135|18912362|P2|STARTED|Overall Study||174
7679427|NCT01942135|18912363|P1|STARTED|Overall Study||347
7679428|NCT01941940|18912400|P1|NOT COMPLETED|Overall Study||33
7679429|NCT01941940|18912400|P1|COMPLETED|Overall Study||194
7679430|NCT01941940|18912400|P1|STARTED|Overall Study||227
7679431|NCT01941927|18912442|P2|NOT COMPLETED|Overall Study||0
7679432|NCT01941927|18912443|P1|NOT COMPLETED|Overall Study||0
7679433|NCT01941927|18912442|P2|COMPLETED|Overall Study||10
7679434|NCT01941927|18912443|P1|COMPLETED|Overall Study||10
7679435|NCT01941927|18912442|P2|STARTED|Overall Study||10
7679436|NCT01941927|18912443|P1|STARTED|Overall Study||10
7679437|NCT01941745|18912459|P4|NOT COMPLETED|Overall Study||0
7679438|NCT01941745|18912460|P3|NOT COMPLETED|Overall Study||0
7679439|NCT01941745|18912461|P2|NOT COMPLETED|Overall Study||0
7679440|NCT01941745|18912462|P1|NOT COMPLETED|Overall Study||0
7679441|NCT01941745|18912459|P4|COMPLETED|Overall Study||23
7679442|NCT01941745|18912460|P3|COMPLETED|Overall Study||21
7679443|NCT01941745|18912461|P2|COMPLETED|Overall Study||22
7679444|NCT01941745|18912462|P1|COMPLETED|Overall Study||22
7679445|NCT01941745|18912459|P4|STARTED|Overall Study||23
7679446|NCT01941745|18912460|P3|STARTED|Overall Study||21
7679447|NCT01941745|18912461|P2|STARTED|Overall Study||22
7679448|NCT01941745|18912462|P1|STARTED|Overall Study||22
7679449|NCT01941628|18912486|P2|NOT COMPLETED|Overall Study||0
7679450|NCT01941628|18912487|P1|NOT COMPLETED|Overall Study||1
7679451|NCT01941628|18912486|P2|COMPLETED|Overall Study||45
7679452|NCT01941628|18912487|P1|COMPLETED|Overall Study||45
7679453|NCT01941628|18912486|P2|STARTED|Overall Study||45
7679454|NCT01941628|18912487|P1|STARTED|Overall Study||46
7679455|NCT01941615|18912497|P1|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
7679456|NCT01941615|18912497|P1|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
7679457|NCT01941615|18912497|P1|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0
7679458|NCT01941615|18912497|P1|NOT COMPLETED|Reference Treatment: Microgynon®||0
7679459|NCT01941615|18912497|P1|COMPLETED|Reference Treatment: Microgynon®||0
7679460|NCT01941615|18912497|P1|STARTED|Reference Treatment: Microgynon®||0
7679461|NCT01941615|18912497|P1|NOT COMPLETED|Run in Treatment: Microgynon®||0
7679462|NCT01941615|18912497|P1|COMPLETED|Run in Treatment: Microgynon®||16
7679463|NCT01941615|18912497|P1|STARTED|Run in Treatment: Microgynon®||16
7679464|NCT01941537|18912508|P2|NOT COMPLETED|Overall Study||3
7679465|NCT01941537|18912509|P1|NOT COMPLETED|Overall Study||4
7679466|NCT01941537|18912508|P2|COMPLETED|Overall Study||17
7679467|NCT01941537|18912509|P1|COMPLETED|Overall Study||36
7679468|NCT01941537|18912508|P2|STARTED|Overall Study||20
7679469|NCT01941537|18912509|P1|STARTED|Overall Study||40
7679470|NCT01941498|18912521|P1|NOT COMPLETED|Overall Study||1
7679471|NCT01941498|18912521|P1|COMPLETED|Overall Study||96
7679472|NCT01941498|18912521|P1|STARTED|Overall Study||97
7679473|NCT01941485|18912567|P1|NOT COMPLETED|Overall Study||0
7679474|NCT01941485|18912567|P1|COMPLETED|Overall Study||59
7679475|NCT01941485|18912567|P1|STARTED|Overall Study||59
7679476|NCT01941472|18912633|P1|NOT COMPLETED|Overall Study||0
7679477|NCT01941472|18912633|P1|COMPLETED|Overall Study||40
7679478|NCT01941472|18912633|P1|STARTED|Overall Study||40
7679479|NCT01941186|18912639|P2|NOT COMPLETED|Follow-up||0
7679480|NCT01941186|18912640|P1|NOT COMPLETED|Follow-up||1
7679481|NCT01941186|18912639|P2|COMPLETED|Follow-up||33
7679482|NCT01941186|18912640|P1|COMPLETED|Follow-up||30
7679483|NCT01941186|18912639|P2|STARTED|Follow-up||33
7679484|NCT01941186|18912640|P1|STARTED|Follow-up||31
7679485|NCT01941186|18912639|P2|NOT COMPLETED|Randomization/Allocation to Study Group||0
7679486|NCT01941186|18912640|P1|NOT COMPLETED|Randomization/Allocation to Study Group||0
7679487|NCT01941186|18912639|P2|COMPLETED|Randomization/Allocation to Study Group||33
7679488|NCT01941186|18912640|P1|COMPLETED|Randomization/Allocation to Study Group||31
7679489|NCT01941186|18912639|P2|STARTED|Randomization/Allocation to Study Group||33
7679490|NCT01941186|18912640|P1|STARTED|Randomization/Allocation to Study Group||31
7679491|NCT01941095|18912666|P1|NOT COMPLETED|Overall Study||56
7679492|NCT01941095|18912666|P1|COMPLETED|Overall Study||41
7679493|NCT01941095|18912666|P1|STARTED|Overall Study||97
7679494|NCT01941030|18912691|P2|NOT COMPLETED|Overall Study||13
7679495|NCT01941030|18912692|P1|NOT COMPLETED|Overall Study||13
7679496|NCT01941030|18912691|P2|COMPLETED|Overall Study||13
7679497|NCT01941030|18912692|P1|COMPLETED|Overall Study||12
7679498|NCT01941030|18912691|P2|STARTED|Overall Study||26
7679499|NCT01941030|18912692|P1|STARTED|Overall Study||25
7679500|NCT01940939|18912714|P2|NOT COMPLETED|Overall Study||8
7679501|NCT01940939|18912715|P1|NOT COMPLETED|Overall Study||2
7679502|NCT01940939|18912714|P2|COMPLETED|Overall Study||27
7679503|NCT01940939|18912715|P1|COMPLETED|Overall Study||33
7679504|NCT01940939|18912714|P2|STARTED|Overall Study||35
7679505|NCT01940939|18912715|P1|STARTED|Overall Study||35
7679506|NCT01940900|18912727|P2|NOT COMPLETED|Overall Study||31
7679507|NCT01940900|18912728|P1|NOT COMPLETED|Overall Study||29
7679508|NCT01940900|18912727|P2|COMPLETED|Overall Study||284
7679509|NCT01940900|18912728|P1|COMPLETED|Overall Study||282
7679510|NCT01940900|18912727|P2|STARTED|Overall Study||315
7679511|NCT01940900|18912728|P1|STARTED|Overall Study||311
7679512|NCT01940887|18912736|P2|NOT COMPLETED|Year 2||222
7679513|NCT01940887|18912737|P1|NOT COMPLETED|Year 2||217
7679514|NCT01940887|18912736|P2|COMPLETED|Year 2||75
7679515|NCT01940887|18912737|P1|COMPLETED|Year 2||66
7679516|NCT01940887|18912736|P2|STARTED|Year 2||297
7679517|NCT01940887|18912737|P1|STARTED|Year 2||283
7679518|NCT01940887|18912736|P2|NOT COMPLETED|Year 1||23
7679519|NCT01940887|18912737|P1|NOT COMPLETED|Year 1||39
7679520|NCT01940887|18912736|P2|COMPLETED|Year 1||297
7679521|NCT01940887|18912737|P1|COMPLETED|Year 1||283
7679522|NCT01940887|18912736|P2|STARTED|Year 1||320
7679523|NCT01940887|18912737|P1|STARTED|Year 1||322
7679524|NCT01940705|18912747|P4|NOT COMPLETED|Overall Study||4
7679525|NCT01940705|18912748|P3|NOT COMPLETED|Overall Study||8
7679526|NCT01940705|18912749|P2|NOT COMPLETED|Overall Study||8
7679527|NCT01940705|18912750|P1|NOT COMPLETED|Overall Study||4
7679528|NCT01940705|18912747|P4|COMPLETED|Overall Study||63
7679529|NCT01940705|18912748|P3|COMPLETED|Overall Study||61
7679530|NCT01940705|18912749|P2|COMPLETED|Overall Study||59
7679531|NCT01940705|18912750|P1|COMPLETED|Overall Study||62
7679532|NCT01940705|18912747|P4|STARTED|Overall Study||67
7679533|NCT01940705|18912748|P3|STARTED|Overall Study||69
7679534|NCT01940705|18912749|P2|STARTED|Overall Study||67
7679535|NCT01940705|18912750|P1|STARTED|Overall Study||66
7679536|NCT01940523|18912770|P2|NOT COMPLETED|Overall Study||0
7679537|NCT01940523|18912771|P1|NOT COMPLETED|Overall Study||0
7679538|NCT01940523|18912770|P2|COMPLETED|Overall Study||320
7679539|NCT01940523|18912771|P1|COMPLETED|Overall Study||320
7679540|NCT01940523|18912770|P2|STARTED|Overall Study||320
7679541|NCT01940523|18912771|P1|STARTED|Overall Study||320
7679542|NCT01940510|18912781|P1|NOT COMPLETED|Overall Study||0
7679543|NCT01940510|18912781|P1|COMPLETED|Overall Study||24
7679544|NCT01940510|18912781|P1|STARTED|Overall Study||24
7679545|NCT01940497|18912814|P2|NOT COMPLETED|Overall Study||18
7679546|NCT01940497|18912815|P1|NOT COMPLETED|Overall Study||21
7679547|NCT01940497|18912814|P2|COMPLETED|Overall Study||101
7679548|NCT01940497|18912815|P1|COMPLETED|Overall Study||100
7679549|NCT01940497|18912814|P2|Treated: Neoadjuvant|Overall Study||21
7679550|NCT01940497|18912815|P1|Treated: Neoadjuvant|Overall Study||20
7679551|NCT01940497|18912814|P2|Treated: Adjuvant|Overall Study||92
7679552|NCT01940497|18912815|P1|Treated: Adjuvant|Overall Study||95
7679553|NCT01940497|18912814|P2|Treated|Overall Study||113
7679554|NCT01940497|18912815|P1|Treated|Overall Study||115
7679555|NCT01940497|18912814|P2|STARTED|Overall Study||119
7679556|NCT01940497|18912815|P1|STARTED|Overall Study||121
7679557|NCT01940484|18912856|P1|NOT COMPLETED|Overall Study||10
7679558|NCT01940484|18912856|P1|COMPLETED|Overall Study||88
7679559|NCT01940484|18912856|P1|STARTED|Overall Study||98
7679560|NCT01940471|18912876|P2|NOT COMPLETED|Open-Label Extension||8
7679561|NCT01940471|18912877|P1|NOT COMPLETED|Open-Label Extension||14
7679562|NCT01940471|18912876|P2|COMPLETED|Open-Label Extension||0
7679563|NCT01940471|18912877|P1|COMPLETED|Open-Label Extension||0
7679564|NCT01940471|18912876|P2|STARTED|Open-Label Extension||8
7679565|NCT01940471|18912877|P1|STARTED|Open-Label Extension||14
7679566|NCT01940471|18912876|P2|NOT COMPLETED|Double-Blind Phase||285
7679567|NCT01940471|18912877|P1|NOT COMPLETED|Double-Blind Phase||568
7679568|NCT01940471|18912876|P2|COMPLETED|Double-Blind Phase||8
7679569|NCT01940471|18912877|P1|COMPLETED|Double-Blind Phase||14
7679570|NCT01940471|18912876|P2|STARTED|Double-Blind Phase||293
7679571|NCT01940471|18912877|P1|STARTED|Double-Blind Phase||582
7679572|NCT01940354|18912895|P2|NOT COMPLETED|Overall Study||2
7679573|NCT01940354|18912896|P1|NOT COMPLETED|Overall Study||4
7679574|NCT01940354|18912895|P2|COMPLETED|Overall Study||108
7679575|NCT01940354|18912896|P1|COMPLETED|Overall Study||106
7679576|NCT01940354|18912895|P2|STARTED|Overall Study||110
7679577|NCT01940354|18912896|P1|STARTED|Overall Study||110
7679578|NCT01940341|18912908|P2|NOT COMPLETED|Open-label Extension Phase||1
7679579|NCT01940341|18912909|P1|NOT COMPLETED|Open-label Extension Phase||4
7679580|NCT01940341|18912908|P2|COMPLETED|Open-label Extension Phase||0
7679581|NCT01940341|18912909|P1|COMPLETED|Open-label Extension Phase||0
7679582|NCT01940341|18912908|P2|STARTED|Open-label Extension Phase||1
7679583|NCT01940341|18912909|P1|STARTED|Open-label Extension Phase||4
7679584|NCT01940341|18912908|P2|NOT COMPLETED|Double-Blind Phase||140
7679585|NCT01940341|18912909|P1|NOT COMPLETED|Double-Blind Phase||281
7679586|NCT01940341|18912908|P2|COMPLETED|Double-Blind Phase||1
7679587|NCT01940341|18912909|P1|COMPLETED|Double-Blind Phase||4
7679588|NCT01940341|18912908|P2|STARTED|Double-Blind Phase||141
7679589|NCT01940341|18912909|P1|STARTED|Double-Blind Phase||285
7679590|NCT01940276|18912925|P2|NOT COMPLETED|Overall Study||0
7679591|NCT01940276|18912926|P1|NOT COMPLETED|Overall Study||0
7679592|NCT01940276|18912925|P2|COMPLETED|Overall Study||50
7679593|NCT01940276|18912926|P1|COMPLETED|Overall Study||50
7679594|NCT01940276|18912925|P2|STARTED|Overall Study||50
7679595|NCT01940276|18912926|P1|STARTED|Overall Study||50
7679596|NCT01940146|18912946|P4|NOT COMPLETED|Overall Study||2
7679597|NCT01940146|18912947|P3|NOT COMPLETED|Overall Study||1
7679598|NCT01940146|18912948|P2|NOT COMPLETED|Overall Study||0
7679599|NCT01940146|18912949|P1|NOT COMPLETED|Overall Study||1
7679600|NCT01940146|18912946|P4|COMPLETED|Overall Study||53
7679601|NCT01940146|18912947|P3|COMPLETED|Overall Study||55
7679602|NCT01940146|18912948|P2|COMPLETED|Overall Study||55
7679603|NCT01940146|18912949|P1|COMPLETED|Overall Study||55
7679604|NCT01940146|18912946|P4|STARTED|Overall Study||55
7679605|NCT01940146|18912947|P3|STARTED|Overall Study||56
7679606|NCT01940146|18912948|P2|STARTED|Overall Study||55
7679607|NCT01940146|18912949|P1|STARTED|Overall Study||56
7679608|NCT01940120|18912959|P1|NOT COMPLETED|Overall Study||48
7679609|NCT01940120|18912959|P1|COMPLETED|Overall Study||30
7679610|NCT01940120|18912959|P1|STARTED|Overall Study||78
7679611|NCT01939977|18913115|P2|NOT COMPLETED|Overall Study||7
7679612|NCT01939977|18913116|P1|NOT COMPLETED|Overall Study||9
7679613|NCT01939977|18913115|P2|COMPLETED|Overall Study||41
7679614|NCT01939977|18913116|P1|COMPLETED|Overall Study||37
7679615|NCT01939977|18913115|P2|STARTED|Overall Study|48 patients randomized but 1 did not meet inclusion criteria. 47 patients analyzed.|48
7679616|NCT01939977|18913116|P1|STARTED|Overall Study||46
7679617|NCT01939938|18913152|P1|NOT COMPLETED|Overall Study||0
7679618|NCT01939938|18913152|P1|COMPLETED|Overall Study||10
7679619|NCT01939938|18913152|P1|STARTED|Overall Study||10
7679620|NCT01939899|18913163|P5|NOT COMPLETED|Phase 2||1
7679621|NCT01939899|18913164|P4|NOT COMPLETED|Phase 2||11
7679622|NCT01939899|18913165|P3|NOT COMPLETED|Phase 2||0
7679623|NCT01939899|18913166|P2|NOT COMPLETED|Phase 2||0
7679624|NCT01939899|18913167|P1|NOT COMPLETED|Phase 2||0
7679625|NCT01939899|18913163|P5|COMPLETED|Phase 2||0
7679626|NCT01939899|18913164|P4|COMPLETED|Phase 2||1
7679627|NCT01939899|18913165|P3|COMPLETED|Phase 2||0
7679628|NCT01939899|18913166|P2|COMPLETED|Phase 2||0
7679629|NCT01939899|18913167|P1|COMPLETED|Phase 2||0
7679630|NCT01939899|18913163|P5|STARTED|Phase 2||1
7679631|NCT01939899|18913164|P4|STARTED|Phase 2||12
7679632|NCT01939899|18913165|P3|STARTED|Phase 2||0
7679633|NCT01939899|18913166|P2|STARTED|Phase 2||0
7679634|NCT01939899|18913167|P1|STARTED|Phase 2||0
7679635|NCT01939899|18913163|P5|NOT COMPLETED|Lead-in Dose Finding Phase||0
7679636|NCT01939899|18913164|P4|NOT COMPLETED|Lead-in Dose Finding Phase||0
7679637|NCT01939899|18913165|P3|NOT COMPLETED|Lead-in Dose Finding Phase||5
7679638|NCT01939899|18913166|P2|NOT COMPLETED|Lead-in Dose Finding Phase||7
7679639|NCT01939899|18913167|P1|NOT COMPLETED|Lead-in Dose Finding Phase||2
7679640|NCT01939899|18913163|P5|COMPLETED|Lead-in Dose Finding Phase||0
7679641|NCT01939899|18913164|P4|COMPLETED|Lead-in Dose Finding Phase||0
7679642|NCT01939899|18913165|P3|COMPLETED|Lead-in Dose Finding Phase||1
7679643|NCT01939899|18913166|P2|COMPLETED|Lead-in Dose Finding Phase||0
7679644|NCT01939899|18913167|P1|COMPLETED|Lead-in Dose Finding Phase||1
7679645|NCT01939899|18913163|P5|STARTED|Lead-in Dose Finding Phase||0
7679646|NCT01939899|18913164|P4|STARTED|Lead-in Dose Finding Phase||0
7679647|NCT01939899|18913165|P3|STARTED|Lead-in Dose Finding Phase||6
7679648|NCT01939899|18913166|P2|STARTED|Lead-in Dose Finding Phase||7
7679649|NCT01939899|18913167|P1|STARTED|Lead-in Dose Finding Phase||3
7679650|NCT01939548|18913214|P3|NOT COMPLETED|Overall Study||30
7679651|NCT01939548|18913215|P2|NOT COMPLETED|Overall Study||49
7679652|NCT01939548|18913216|P1|NOT COMPLETED|Overall Study||37
7679653|NCT01939548|18913214|P3|COMPLETED|Overall Study||50
7679654|NCT01939548|18913215|P2|COMPLETED|Overall Study||33
7679655|NCT01939548|18913216|P1|COMPLETED|Overall Study||41
7679656|NCT01939548|18913214|P3|STARTED|Overall Study||80
7679657|NCT01939548|18913215|P2|STARTED|Overall Study||82
7679658|NCT01939548|18913216|P1|STARTED|Overall Study||78
7679659|NCT01939496|18913290|P3|NOT COMPLETED|Overall Study||2
7679660|NCT01939496|18913291|P2|NOT COMPLETED|Overall Study||3
7679661|NCT01939496|18913292|P1|NOT COMPLETED|Overall Study||9
7679662|NCT01939496|18913290|P3|COMPLETED|Overall Study||54
7679663|NCT01939496|18913291|P2|COMPLETED|Overall Study||54
7679664|NCT01939496|18913292|P1|COMPLETED|Overall Study||47
7679665|NCT01939496|18913290|P3|STARTED|Overall Study||56
7679666|NCT01939496|18913291|P2|STARTED|Overall Study||57
7679667|NCT01939496|18913292|P1|STARTED|Overall Study||56
7679668|NCT01939405|18913344|P2|NOT COMPLETED|Overall Study||2
7679669|NCT01939405|18913345|P1|NOT COMPLETED|Overall Study||3
7679670|NCT01939405|18913344|P2|COMPLETED|Overall Study||28
7679671|NCT01939405|18913345|P1|COMPLETED|Overall Study||27
7679672|NCT01939405|18913344|P2|STARTED|Overall Study||30
7679673|NCT01939405|18913345|P1|STARTED|Overall Study||30
7679674|NCT01939366|18913362|P5|NOT COMPLETED|Overall Study||18
7679675|NCT01939366|18913363|P4|NOT COMPLETED|Overall Study||17
7679676|NCT01939366|18913364|P3|NOT COMPLETED|Overall Study||38
7679677|NCT01939366|18913365|P2|NOT COMPLETED|Overall Study||23
7679678|NCT01939366|18913366|P1|NOT COMPLETED|Overall Study||14
7679679|NCT01939366|18913362|P5|COMPLETED|Overall Study||48
7679680|NCT01939366|18913363|P4|COMPLETED|Overall Study||51
7679681|NCT01939366|18913364|P3|COMPLETED|Overall Study||27
7679682|NCT01939366|18913365|P2|COMPLETED|Overall Study||41
7679683|NCT01939366|18913366|P1|COMPLETED|Overall Study||52
7679684|NCT01939366|18913362|P5|Per Protocol Set|Overall Study||49
7679685|NCT01939366|18913363|P4|Per Protocol Set|Overall Study||51
7679686|NCT01939366|18913364|P3|Per Protocol Set|Overall Study||50
7679687|NCT01939366|18913365|P2|Per Protocol Set|Overall Study||55
7679688|NCT01939366|18913366|P1|Per Protocol Set|Overall Study||58
7679689|NCT01939366|18913362|P5|Full Analysis Set|Overall Study||62
7679690|NCT01939366|18913363|P4|Full Analysis Set|Overall Study||65
7679691|NCT01939366|18913364|P3|Full Analysis Set|Overall Study||61
7679692|NCT01939366|18913365|P2|Full Analysis Set|Overall Study||60
7679693|NCT01939366|18913366|P1|Full Analysis Set|Overall Study||64
7679694|NCT01939366|18913362|P5|Safety Set|Overall Study||62
7679695|NCT01939366|18913363|P4|Safety Set|Overall Study||65
7679696|NCT01939366|18913364|P3|Safety Set|Overall Study||62
7679697|NCT01939366|18913365|P2|Safety Set|Overall Study||61
7679698|NCT01939366|18913366|P1|Safety Set|Overall Study||64
7679699|NCT01939366|18913362|P5|Allocated Set Excl. Non-compliant Sites|Overall Study||63
7679700|NCT01939366|18913363|P4|Allocated Set Excl. Non-compliant Sites|Overall Study||65
7679701|NCT01939366|18913364|P3|Allocated Set Excl. Non-compliant Sites|Overall Study||63
7679702|NCT01939366|18913365|P2|Allocated Set Excl. Non-compliant Sites|Overall Study||61
7679703|NCT01939366|18913366|P1|Allocated Set Excl. Non-compliant Sites|Overall Study||64
7679704|NCT01939366|18913362|P5|STARTED|Overall Study||66
7679705|NCT01939366|18913363|P4|STARTED|Overall Study||68
7679706|NCT01939366|18913364|P3|STARTED|Overall Study||65
7679707|NCT01939366|18913365|P2|STARTED|Overall Study||64
7679708|NCT01939366|18913366|P1|STARTED|Overall Study||66
7679709|NCT01939314|18913380|P2|NOT COMPLETED|Overall Study||8
7679710|NCT01939314|18913381|P1|NOT COMPLETED|Overall Study||9
7679711|NCT01939314|18913380|P2|COMPLETED|Overall Study||40
7679712|NCT01939314|18913381|P1|COMPLETED|Overall Study||36
7679713|NCT01939314|18913380|P2|24 Hour Endpoint|Overall Study||40
7679714|NCT01939314|18913381|P1|24 Hour Endpoint|Overall Study||36
7679715|NCT01939314|18913380|P2|15 Minute Endpoint|Overall Study||46
7679716|NCT01939314|18913381|P1|15 Minute Endpoint|Overall Study||41
7679717|NCT01939314|18913380|P2|STARTED|Overall Study||48
7679718|NCT01939314|18913381|P1|STARTED|Overall Study||45
7679719|NCT01939301|18913393|P2|NOT COMPLETED|Overall Study||1
7679720|NCT01939301|18913394|P1|NOT COMPLETED|Overall Study||1
7679721|NCT01939301|18913393|P2|COMPLETED|Overall Study||38
7679722|NCT01939301|18913394|P1|COMPLETED|Overall Study||38
7679723|NCT01939301|18913393|P2|STARTED|Overall Study||39
7679724|NCT01939301|18913394|P1|STARTED|Overall Study||39
7679725|NCT01939288|18913402|P2|NOT COMPLETED|Overall Study||0
7679726|NCT01939288|18913403|P1|NOT COMPLETED|Overall Study||0
7679727|NCT01939288|18913402|P2|COMPLETED|Overall Study||5
7679728|NCT01939288|18913403|P1|COMPLETED|Overall Study||5
7679729|NCT01939288|18913402|P2|STARTED|Overall Study||5
7679730|NCT01939288|18913403|P1|STARTED|Overall Study||5
7679731|NCT01939275|18913409|P1|NOT COMPLETED|Overall Study||0
7679732|NCT01939275|18913409|P1|COMPLETED|Overall Study||8
7679733|NCT01939275|18913409|P1|STARTED|Overall Study||8
7679734|NCT01939223|18913415|P2|NOT COMPLETED|Overall Study||11
7679735|NCT01939223|18913416|P1|NOT COMPLETED|Overall Study||13
7679736|NCT01939223|18913415|P2|COMPLETED|Overall Study||0
7679737|NCT01939223|18913416|P1|COMPLETED|Overall Study||1
7679738|NCT01939223|18913415|P2|Participants Received Treatment|Overall Study||11
7679739|NCT01939223|18913416|P1|Participants Received Treatment|Overall Study||14
7679740|NCT01939223|18913415|P2|STARTED|Overall Study||11
7679741|NCT01939223|18913416|P1|STARTED|Overall Study||14
7679742|NCT01939197|18913431|P7|NOT COMPLETED|Overall Study||2
7679743|NCT01939197|18913432|P6|NOT COMPLETED|Overall Study||1
7679744|NCT01939197|18913433|P5|NOT COMPLETED|Overall Study||4
7679745|NCT01939197|18913434|P4|NOT COMPLETED|Overall Study||1
7679746|NCT01939197|18913435|P3|NOT COMPLETED|Overall Study||0
7679747|NCT01939197|18913436|P2|NOT COMPLETED|Overall Study||1
7679748|NCT01939197|18913437|P1|NOT COMPLETED|Overall Study||1
7679749|NCT01939197|18913431|P7|COMPLETED|Overall Study||26
7679750|NCT01939197|18913432|P6|COMPLETED|Overall Study||4
7679751|NCT01939197|18913433|P5|COMPLETED|Overall Study||196
7679752|NCT01939197|18913434|P4|COMPLETED|Overall Study||11
7679753|NCT01939197|18913435|P3|COMPLETED|Overall Study||10
7679754|NCT01939197|18913436|P2|COMPLETED|Overall Study||31
7679755|NCT01939197|18913437|P1|COMPLETED|Overall Study||30
7679756|NCT01939197|18913431|P7|STARTED|Overall Study||28
7679757|NCT01939197|18913432|P6|STARTED|Overall Study||5
7679758|NCT01939197|18913433|P5|STARTED|Overall Study||200
7679759|NCT01939197|18913434|P4|STARTED|Overall Study||12
7679760|NCT01939197|18913435|P3|STARTED|Overall Study||10
7679761|NCT01939197|18913436|P2|STARTED|Overall Study||32
7679762|NCT01939197|18913437|P1|STARTED|Overall Study||31
7679763|NCT01939145|18913497|P2|NOT COMPLETED|Overall Study||7
7679764|NCT01939145|18913498|P1|NOT COMPLETED|Overall Study||2
7679765|NCT01939145|18913497|P2|COMPLETED|Overall Study||44
7679766|NCT01939145|18913498|P1|COMPLETED|Overall Study||47
7679767|NCT01939145|18913497|P2|STARTED|Overall Study||51
7679768|NCT01939145|18913498|P1|STARTED|Overall Study||49
7679769|NCT01939028|18913506|P1|NOT COMPLETED|Overall Study||12
7679770|NCT01939028|18913506|P1|COMPLETED|Overall Study||46
7679771|NCT01939028|18913506|P1|STARTED|Overall Study||58
7679772|NCT01939002|18913519|P2|NOT COMPLETED|Overall Study||18
7679773|NCT01939002|18913520|P1|NOT COMPLETED|Overall Study||19
7679774|NCT01939002|18913519|P2|COMPLETED|Overall Study||80
7679775|NCT01939002|18913520|P1|COMPLETED|Overall Study||84
7679776|NCT01939002|18913519|P2|STARTED|Overall Study||98
7679777|NCT01939002|18913520|P1|STARTED|Overall Study||103
7679778|NCT01938989|18913586|P2|NOT COMPLETED|Overall Study||0
7679779|NCT01938989|18913587|P1|NOT COMPLETED|Overall Study||0
7679780|NCT01938989|18913586|P2|COMPLETED|Overall Study||77
7679781|NCT01938989|18913587|P1|COMPLETED|Overall Study||77
7679782|NCT01938989|18913586|P2|STARTED|Overall Study||77
7679783|NCT01938989|18913587|P1|STARTED|Overall Study||77
7679784|NCT01938846|18913596|P3|NOT COMPLETED|Overall Study||24
7679785|NCT01938846|18913597|P2|NOT COMPLETED|Overall Study||25
7679786|NCT01938846|18913598|P1|NOT COMPLETED|Overall Study||41
7679787|NCT01938846|18913596|P3|COMPLETED|Overall Study||0
7679788|NCT01938846|18913597|P2|COMPLETED|Overall Study||0
7679789|NCT01938846|18913598|P1|COMPLETED|Overall Study||0
7679790|NCT01938846|18913596|P3|STARTED|Overall Study||24
7679791|NCT01938846|18913597|P2|STARTED|Overall Study||25
7679792|NCT01938846|18913598|P1|STARTED|Overall Study||41
7679793|NCT01938833|18913790|P1|NOT COMPLETED|Overall Study||0
7679794|NCT01938833|18913790|P1|COMPLETED|Overall Study||9
7679795|NCT01938833|18913790|P1|STARTED|Overall Study||9
7679796|NCT01938716|18913798|P1|NOT COMPLETED|Overall Study||4
7679797|NCT01938716|18913798|P1|COMPLETED|Overall Study||8
7679798|NCT01938716|18913798|P1|STARTED|Overall Study||12
7679799|NCT01938664|18913808|P2|NOT COMPLETED|Overall Study||10
7679800|NCT01938664|18913809|P1|NOT COMPLETED|Overall Study||15
7679801|NCT01938664|18913808|P2|COMPLETED|Overall Study||0
7679802|NCT01938664|18913809|P1|COMPLETED|Overall Study||5
7679803|NCT01938664|18913808|P2|STARTED|Overall Study||10
7679804|NCT01938664|18913809|P1|STARTED|Overall Study||20
7679805|NCT01938625|18913821|P2|NOT COMPLETED|Overall Study||2
7679806|NCT01938625|18913822|P1|NOT COMPLETED|Overall Study||0
7679807|NCT01938625|18913821|P2|COMPLETED|Overall Study||23
7679808|NCT01938625|18913822|P1|COMPLETED|Overall Study||10
7679809|NCT01938625|18913821|P2|STARTED|Overall Study||25
7679810|NCT01938625|18913822|P1|STARTED|Overall Study||10
7679811|NCT01938573|18913842|P2|NOT COMPLETED|Overall Study||0
7679812|NCT01938573|18913843|P1|NOT COMPLETED|Overall Study||2
7679813|NCT01938573|18913842|P2|COMPLETED|Overall Study||6
7679814|NCT01938573|18913843|P1|COMPLETED|Overall Study||13
7679815|NCT01938573|18913842|P2|STARTED|Overall Study||6
7679816|NCT01938573|18913843|P1|STARTED|Overall Study||15
7679817|NCT01938430|18913863|P14|NOT COMPLETED|Overall Study||1
7679818|NCT01938430|18913864|P13|NOT COMPLETED|Overall Study||0
7679819|NCT01938430|18913865|P12|NOT COMPLETED|Overall Study||1
7679820|NCT01938430|18913866|P11|NOT COMPLETED|Overall Study||3
7679821|NCT01938430|18913867|P10|NOT COMPLETED|Overall Study||3
7679822|NCT01938430|18913868|P9|NOT COMPLETED|Overall Study||4
7679823|NCT01938430|18913869|P8|NOT COMPLETED|Overall Study||1
7679824|NCT01938430|18913870|P7|NOT COMPLETED|Overall Study||2
7679825|NCT01938430|18913871|P6|NOT COMPLETED|Overall Study||1
7679826|NCT01938430|18913872|P5|NOT COMPLETED|Overall Study||0
7679827|NCT01938430|18913873|P4|NOT COMPLETED|Overall Study||2
7679828|NCT01938430|18913874|P3|NOT COMPLETED|Overall Study||5
7679829|NCT01938430|18913875|P2|NOT COMPLETED|Overall Study||3
7679830|NCT01938430|18913876|P1|NOT COMPLETED|Overall Study||4
7679831|NCT01938430|18913863|P14|COMPLETED|Overall Study||2
7679832|NCT01938430|18913864|P13|COMPLETED|Overall Study||4
7679833|NCT01938430|18913865|P12|COMPLETED|Overall Study||3
7679834|NCT01938430|18913866|P11|COMPLETED|Overall Study||3
7679835|NCT01938430|18913867|P10|COMPLETED|Overall Study||23
7679836|NCT01938430|18913868|P9|COMPLETED|Overall Study||22
7679837|NCT01938430|18913869|P8|COMPLETED|Overall Study||24
7679838|NCT01938430|18913870|P7|COMPLETED|Overall Study||24
7679839|NCT01938430|18913871|P6|COMPLETED|Overall Study||55
7679840|NCT01938430|18913872|P5|COMPLETED|Overall Study||55
7679841|NCT01938430|18913873|P4|COMPLETED|Overall Study||24
7679842|NCT01938430|18913874|P3|COMPLETED|Overall Study||18
7679843|NCT01938430|18913875|P2|COMPLETED|Overall Study||26
7679844|NCT01938430|18913876|P1|COMPLETED|Overall Study||26
7679845|NCT01938430|18913863|P14|STARTED|Overall Study||3
7679846|NCT01938430|18913864|P13|STARTED|Overall Study||4
7679847|NCT01938430|18913865|P12|STARTED|Overall Study||4
7679848|NCT01938430|18913866|P11|STARTED|Overall Study||6
7679849|NCT01938430|18913867|P10|STARTED|Overall Study||26
7679850|NCT01938430|18913868|P9|STARTED|Overall Study||26
7679851|NCT01938430|18913869|P8|STARTED|Overall Study||25
7679852|NCT01938430|18913870|P7|STARTED|Overall Study||26
7679853|NCT01938430|18913871|P6|STARTED|Overall Study||56
7679854|NCT01938430|18913872|P5|STARTED|Overall Study||55
7679855|NCT01938430|18913873|P4|STARTED|Overall Study||26
7679856|NCT01938430|18913874|P3|STARTED|Overall Study||23
7679857|NCT01938430|18913875|P2|STARTED|Overall Study||29
7679858|NCT01938430|18913876|P1|STARTED|Overall Study||30
7679859|NCT01938391|18914201|P1|NOT COMPLETED|12 Month Follow up||2
7679860|NCT01938391|18914201|P1|COMPLETED|12 Month Follow up||22
7679861|NCT01938391|18914201|P1|STARTED|12 Month Follow up||24
7679862|NCT01938391|18914201|P1|NOT COMPLETED|6 Month Follow up||1
7679863|NCT01938391|18914201|P1|COMPLETED|6 Month Follow up||24
7679864|NCT01938391|18914201|P1|STARTED|6 Month Follow up||25
7679865|NCT01938391|18914201|P1|NOT COMPLETED|2 Week Follow up||0
7679866|NCT01938391|18914201|P1|COMPLETED|2 Week Follow up||25
7679867|NCT01938391|18914201|P1|STARTED|2 Week Follow up||25
7679868|NCT01938391|18914201|P1|NOT COMPLETED|Baseline||0
7679869|NCT01938391|18914201|P1|COMPLETED|Baseline||25
7679870|NCT01938391|18914201|P1|STARTED|Baseline||25
7679871|NCT01938378|18914214|P1|NOT COMPLETED|Overall Study||0
7679872|NCT01938378|18914214|P1|COMPLETED|Overall Study||41
7679873|NCT01938378|18914214|P1|STARTED|Overall Study||41
7679874|NCT01938170|18914279|P1|NOT COMPLETED|Overall Study||0
7679875|NCT01938170|18914279|P1|COMPLETED|Overall Study||41
7679876|NCT01938170|18914279|P1|STARTED|Overall Study||41
7679877|NCT01938079|18914286|P2|NOT COMPLETED|Overall Study||0
7679878|NCT01938079|18914287|P1|NOT COMPLETED|Overall Study||0
7679879|NCT01938079|18914286|P2|COMPLETED|Overall Study||10
7679880|NCT01938079|18914287|P1|COMPLETED|Overall Study||10
7679881|NCT01938079|18914286|P2|STARTED|Overall Study||10
7679882|NCT01938079|18914287|P1|STARTED|Overall Study||10
7679883|NCT01938066|18914295|P2|NOT COMPLETED|Overall Study||2
7679884|NCT01938066|18914296|P1|NOT COMPLETED|Overall Study||1
7679885|NCT01938066|18914295|P2|COMPLETED|Overall Study||13
7679886|NCT01938066|18914296|P1|COMPLETED|Overall Study||14
7679887|NCT01938066|18914295|P2|STARTED|Overall Study||15
7679888|NCT01938066|18914296|P1|STARTED|Overall Study||15
7679889|NCT01938040|18914306|P2|NOT COMPLETED|Overall Study||0
7679890|NCT01938040|18914307|P1|NOT COMPLETED|Overall Study||0
7679891|NCT01938040|18914306|P2|COMPLETED|Overall Study||27
7679892|NCT01938040|18914307|P1|COMPLETED|Overall Study||28
7679893|NCT01938040|18914306|P2|Behavior Metrics|Overall Study||27
7679894|NCT01938040|18914307|P1|Behavior Metrics|Overall Study||28
7679895|NCT01938040|18914306|P2|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25
7679896|NCT01938040|18914307|P1|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24
7679897|NCT01938040|18914306|P2|STARTED|Overall Study||27
7679898|NCT01938040|18914307|P1|STARTED|Overall Study||28
7679899|NCT01938001|18914335|P2|NOT COMPLETED|Overall Study||47
7679900|NCT01938001|18914336|P1|NOT COMPLETED|Overall Study||43
7679901|NCT01938001|18914335|P2|COMPLETED|Overall Study||133
7679902|NCT01938001|18914336|P1|COMPLETED|Overall Study||135
7679903|NCT01938001|18914335|P2|Completed Treatment|Overall Study||110
7679904|NCT01938001|18914336|P1|Completed Treatment|Overall Study||124
7679905|NCT01938001|18914335|P2|Participants Received Treatment|Overall Study||180
7679906|NCT01938001|18914336|P1|Participants Received Treatment|Overall Study||176
7679907|NCT01938001|18914335|P2|STARTED|Overall Study||180
7679908|NCT01938001|18914336|P1|STARTED|Overall Study||178
7679909|NCT01937975|18914363|P3|NOT COMPLETED|Overall Study||0
7679910|NCT01937975|18914364|P2|NOT COMPLETED|Overall Study||0
7679911|NCT01937975|18914365|P1|NOT COMPLETED|Overall Study||0
7679912|NCT01937975|18914363|P3|COMPLETED|Overall Study||8
7679913|NCT01937975|18914364|P2|COMPLETED|Overall Study||8
7679914|NCT01937975|18914365|P1|COMPLETED|Overall Study||8
7679915|NCT01937975|18914363|P3|STARTED|Overall Study||8
7679916|NCT01937975|18914364|P2|STARTED|Overall Study||8
7679917|NCT01937975|18914365|P1|STARTED|Overall Study||8
7679918|NCT01937871|18914415|P3|NOT COMPLETED|Overall Study||11
7679919|NCT01937871|18914416|P2|NOT COMPLETED|Overall Study||17
7679920|NCT01937871|18914417|P1|NOT COMPLETED|Overall Study||24
7679921|NCT01937871|18914415|P3|COMPLETED|Overall Study||174
7679922|NCT01937871|18914416|P2|COMPLETED|Overall Study||346
7679923|NCT01937871|18914417|P1|COMPLETED|Overall Study||337
7679924|NCT01937871|18914415|P3|Received at Least One Dose of Study Drug|Overall Study||185
7679925|NCT01937871|18914416|P2|Received at Least One Dose of Study Drug|Overall Study||362
7679926|NCT01937871|18914417|P1|Received at Least One Dose of Study Drug|Overall Study||361
7679927|NCT01937871|18914415|P3|STARTED|Overall Study||185
7679928|NCT01937871|18914416|P2|STARTED|Overall Study||363
7679929|NCT01937871|18914417|P1|STARTED|Overall Study||361
7679930|NCT01937715|18914493|P5|NOT COMPLETED|Overall Study||2
7679931|NCT01937715|18914494|P4|NOT COMPLETED|Overall Study||4
7679932|NCT01937715|18914495|P3|NOT COMPLETED|Overall Study||0
7679933|NCT01937715|18914496|P2|NOT COMPLETED|Overall Study||1
7679934|NCT01937715|18914497|P1|NOT COMPLETED|Overall Study||0
7679935|NCT01937715|18914493|P5|COMPLETED|Overall Study||1
7679936|NCT01937715|18914494|P4|COMPLETED|Overall Study||1
7679937|NCT01937715|18914495|P3|COMPLETED|Overall Study||3
7679938|NCT01937715|18914496|P2|COMPLETED|Overall Study||3
7679939|NCT01937715|18914497|P1|COMPLETED|Overall Study||3
7679940|NCT01937715|18914493|P5|STARTED|Overall Study||3
7679941|NCT01937715|18914494|P4|STARTED|Overall Study||5
7679942|NCT01937715|18914495|P3|STARTED|Overall Study||3
7679943|NCT01937715|18914496|P2|STARTED|Overall Study||4
7679944|NCT01937715|18914497|P1|STARTED|Overall Study||3
7679945|NCT01937624|18914619|P1|NOT COMPLETED|Overall Study||0
7679946|NCT01937624|18914619|P1|COMPLETED|Overall Study||51
7679947|NCT01937624|18914619|P1|STARTED|Overall Study||51
7679948|NCT01937598|18914623|P2|NOT COMPLETED|Overall Study||0
7679949|NCT01937598|18914624|P1|NOT COMPLETED|Overall Study||0
7679950|NCT01937598|18914623|P2|COMPLETED|Overall Study||8
7679951|NCT01937598|18914624|P1|COMPLETED|Overall Study||8
7679952|NCT01937598|18914623|P2|STARTED|Overall Study||8
7679953|NCT01937598|18914624|P1|STARTED|Overall Study||8
7679954|NCT01937559|18914649|P3|NOT COMPLETED|Overall Study||0
7679955|NCT01937559|18914650|P2|NOT COMPLETED|Overall Study||11
7679956|NCT01937559|18914651|P1|NOT COMPLETED|Overall Study||11
7679957|NCT01937559|18914649|P3|COMPLETED|Overall Study||66
7679958|NCT01937559|18914650|P2|COMPLETED|Overall Study||50
7679959|NCT01937559|18914651|P1|COMPLETED|Overall Study||50
7679960|NCT01937559|18914649|P3|STARTED|Overall Study||66
7679961|NCT01937559|18914650|P2|STARTED|Overall Study||61
7679962|NCT01937559|18914651|P1|STARTED|Overall Study||61
7679963|NCT01937520|18914677|P2|NOT COMPLETED|Overall Study||0
7679964|NCT01937520|18914678|P1|NOT COMPLETED|Overall Study||0
7679965|NCT01937520|18914677|P2|COMPLETED|Overall Study||9
7679966|NCT01937520|18914678|P1|COMPLETED|Overall Study||11
7679967|NCT01937520|18914677|P2|STARTED|Overall Study||9
7679968|NCT01937520|18914678|P1|STARTED|Overall Study||11
7679969|NCT01937507|18914714|P1|NOT COMPLETED|Overall Study||2
7679970|NCT01937507|18914714|P1|COMPLETED|Overall Study||0
7679971|NCT01937507|18914714|P1|STARTED|Overall Study||2
7679972|NCT01937390|18914721|P1|NOT COMPLETED|Overall Study||35
7679973|NCT01937390|18914721|P1|COMPLETED|Overall Study||550
7679974|NCT01937390|18914721|P1|STARTED|Overall Study||585
7679975|NCT01937364|18914731|P2|NOT COMPLETED|Overall Study||1
7679976|NCT01937364|18914732|P1|NOT COMPLETED|Overall Study||2
7679977|NCT01937364|18914731|P2|COMPLETED|Overall Study||7
7679978|NCT01937364|18914732|P1|COMPLETED|Overall Study||7
7679979|NCT01937364|18914731|P2|STARTED|Overall Study||8
7679980|NCT01937364|18914732|P1|STARTED|Overall Study||9
7679981|NCT01937351|18914744|P2|NOT COMPLETED|Overall Study||2
7679982|NCT01937351|18914745|P1|NOT COMPLETED|Overall Study||9
7679983|NCT01937351|18914744|P2|COMPLETED|Overall Study||26
7679984|NCT01937351|18914745|P1|COMPLETED|Overall Study||125
7679985|NCT01937351|18914744|P2|6-Month Follow-up|Overall Study||26
7679986|NCT01937351|18914745|P1|6-Month Follow-up|Overall Study||125
7679987|NCT01937351|18914744|P2|30-Day Follow-up|Overall Study||27
7679988|NCT01937351|18914745|P1|30-Day Follow-up|Overall Study||128
7679989|NCT01937351|18914744|P2|Treated w Study Device|Overall Study||28
7679990|NCT01937351|18914745|P1|Treated w Study Device|Overall Study||130
7679991|NCT01937351|18914744|P2|STARTED|Overall Study||28
7679992|NCT01937351|18914745|P1|STARTED|Overall Study||134
7679993|NCT01937312|18914753|P2|NOT COMPLETED|Overall Study||3
7679994|NCT01937312|18914754|P1|NOT COMPLETED|Overall Study||11
7679995|NCT01937312|18914753|P2|COMPLETED|Overall Study||92
7679996|NCT01937312|18914754|P1|COMPLETED|Overall Study||83
7679997|NCT01937312|18914753|P2|Treated|Overall Study||95
7679998|NCT01937312|18914754|P1|Treated|Overall Study||93
7679999|NCT01937312|18914753|P2|STARTED|Overall Study||95
7680000|NCT01937312|18914754|P1|STARTED|Overall Study||94
7680001|NCT01937299|18914769|P2|NOT COMPLETED|Overall Study||4
7680002|NCT01937299|18914770|P1|NOT COMPLETED|Overall Study||14
7680003|NCT01937299|18914769|P2|COMPLETED|Overall Study||112
7680004|NCT01937299|18914770|P1|COMPLETED|Overall Study||103
7680005|NCT01937299|18914769|P2|STARTED|Overall Study||116
7680006|NCT01937299|18914770|P1|STARTED|Overall Study||117
7680007|NCT01937260|18914783|P2|NOT COMPLETED|Overall Study||0
7680008|NCT01937260|18914784|P1|NOT COMPLETED|Overall Study||1
7680009|NCT01937260|18914783|P2|COMPLETED|Overall Study||10
7680010|NCT01937260|18914784|P1|COMPLETED|Overall Study||20
7680011|NCT01937260|18914783|P2|STARTED|Overall Study||10
7680012|NCT01937260|18914784|P1|STARTED|Overall Study||21
7680013|NCT01937195|18914791|P1|NOT COMPLETED|Overall Study||0
7680014|NCT01937195|18914791|P1|COMPLETED|Overall Study||95
7680015|NCT01937195|18914791|P1|STARTED|Overall Study||95
7680016|NCT01937130|18914805|P4|NOT COMPLETED|Overall Study||2
7680017|NCT01937130|18914806|P3|NOT COMPLETED|Overall Study||3
7680018|NCT01937130|18914807|P2|NOT COMPLETED|Overall Study||4
7680019|NCT01937130|18914808|P1|NOT COMPLETED|Overall Study||5
7680020|NCT01937130|18914805|P4|COMPLETED|Overall Study||2
7680021|NCT01937130|18914806|P3|COMPLETED|Overall Study||2
7680022|NCT01937130|18914807|P2|COMPLETED|Overall Study||3
7680023|NCT01937130|18914808|P1|COMPLETED|Overall Study||0
7680024|NCT01937130|18914805|P4|STARTED|Overall Study||4
7680025|NCT01937130|18914806|P3|STARTED|Overall Study||5
7680026|NCT01937130|18914807|P2|STARTED|Overall Study||7
7680027|NCT01937130|18914808|P1|STARTED|Overall Study||5
7680028|NCT01937117|18914835|P1|NOT COMPLETED|Overall Study||13
7680029|NCT01937117|18914835|P1|COMPLETED|Overall Study||75
7680030|NCT01937117|18914835|P1|STARTED|Overall Study||88
7680031|NCT01937026|18914839|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0
7680032|NCT01937026|18914839|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18
7680033|NCT01937026|18914839|P1|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18
7680034|NCT01937026|18914839|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18
7680035|NCT01937026|18914839|P1|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18
7680036|NCT01937026|18914839|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
7680037|NCT01937026|18914839|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18
7680038|NCT01937026|18914839|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18
7680039|NCT01937026|18914839|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||18
7680040|NCT01936974|18914850|P2|NOT COMPLETED|Overall Study||5
7680041|NCT01936974|18914851|P1|NOT COMPLETED|Overall Study||2
7680042|NCT01936974|18914850|P2|COMPLETED|Overall Study||0
7680043|NCT01936974|18914851|P1|COMPLETED|Overall Study||0
7680044|NCT01936974|18914850|P2|STARTED|Overall Study||5
7680045|NCT01936974|18914851|P1|STARTED|Overall Study||2
7680046|NCT01936909|18914860|P3|NOT COMPLETED|Overall Study||6
7680047|NCT01936909|18914861|P2|NOT COMPLETED|Overall Study||8
7680048|NCT01936909|18914862|P1|NOT COMPLETED|Overall Study||10
7680049|NCT01936909|18914860|P3|COMPLETED|Overall Study||14
7680050|NCT01936909|18914861|P2|COMPLETED|Overall Study||12
7680051|NCT01936909|18914862|P1|COMPLETED|Overall Study||10
7680052|NCT01936909|18914860|P3|STARTED|Overall Study||20
7680053|NCT01936909|18914861|P2|STARTED|Overall Study||20
7680054|NCT01936909|18914862|P1|STARTED|Overall Study||20
7680055|NCT01936896|18914876|P1|NOT COMPLETED|Overall Study||0
7680056|NCT01936896|18914876|P1|COMPLETED|Overall Study||10
7680057|NCT01936896|18914876|P1|STARTED|Overall Study||10
7680058|NCT01936870|18914881|P1|NOT COMPLETED|Overall Study||189
7680059|NCT01936870|18914881|P1|COMPLETED|Overall Study||2303
7680060|NCT01936870|18914881|P1|STARTED|Overall Study||2492
7680061|NCT01936857|18914896|P2|NOT COMPLETED|Overall Study||25
7680062|NCT01936857|18914897|P1|NOT COMPLETED|Overall Study||34
7680063|NCT01936857|18914896|P2|COMPLETED|Overall Study||115
7680064|NCT01936857|18914897|P1|COMPLETED|Overall Study||107
7680065|NCT01936857|18914896|P2|STARTED|Overall Study||140
7680066|NCT01936857|18914897|P1|STARTED|Overall Study||141
7680067|NCT01936844|18914905|P2|NOT COMPLETED|Overall Study||7
7680068|NCT01936844|18914906|P1|NOT COMPLETED|Overall Study||6
7680069|NCT01936844|18914905|P2|COMPLETED|Overall Study||8
7680070|NCT01936844|18914906|P1|COMPLETED|Overall Study||9
7680071|NCT01936844|18914905|P2|STARTED|Overall Study||15
7680072|NCT01936844|18914906|P1|STARTED|Overall Study||15
7680073|NCT01936662|18914918|P2|NOT COMPLETED|Overall Study||0
7680074|NCT01936662|18914919|P1|NOT COMPLETED|Overall Study||0
7680075|NCT01936662|18914918|P2|COMPLETED|Overall Study||42
7680076|NCT01936662|18914919|P1|COMPLETED|Overall Study||42
7680077|NCT01936662|18914918|P2|STARTED|Overall Study||42
7680078|NCT01936662|18914919|P1|STARTED|Overall Study||42
7680079|NCT01936649|18914927|P1|NOT COMPLETED|Overall Study||13
7680080|NCT01936649|18914927|P1|COMPLETED|Overall Study||50
7680081|NCT01936649|18914927|P1|Treated|Overall Study||51
7680082|NCT01936649|18914927|P1|STARTED|Overall Study||63
7680083|NCT01936623|18914934|P2|NOT COMPLETED|Overall Study||5
7680084|NCT01936623|18914935|P1|NOT COMPLETED|Overall Study||0
7680085|NCT01936623|18914934|P2|COMPLETED|Overall Study||35
7680086|NCT01936623|18914935|P1|COMPLETED|Overall Study||40
7680087|NCT01936623|18914934|P2|STARTED|Overall Study||40
7680088|NCT01936623|18914935|P1|STARTED|Overall Study||40
7680089|NCT01936467|18914949|P2|NOT COMPLETED|Overall Study||0
7680090|NCT01936467|18914950|P1|NOT COMPLETED|Overall Study||0
7680091|NCT01936467|18914949|P2|COMPLETED|Overall Study||61
7680092|NCT01936467|18914950|P1|COMPLETED|Overall Study||60
7680093|NCT01936467|18914949|P2|STARTED|Overall Study||61
7680094|NCT01936467|18914950|P1|STARTED|Overall Study||60
7680095|NCT01936389|18914970|P2|NOT COMPLETED|Overall Study||0
7680096|NCT01936389|18914971|P1|NOT COMPLETED|Overall Study||1
7680097|NCT01936389|18914970|P2|COMPLETED|Overall Study||5
7680098|NCT01936389|18914971|P1|COMPLETED|Overall Study||4
7680099|NCT01936389|18914970|P2|STARTED|Overall Study||5
7680100|NCT01936389|18914971|P1|STARTED|Overall Study||5
7680101|NCT01936363|18914979|P2|NOT COMPLETED|Overall Study||0
7680102|NCT01936363|18914980|P1|NOT COMPLETED|Overall Study||0
7680103|NCT01936363|18914979|P2|COMPLETED|Overall Study||33
7680104|NCT01936363|18914980|P1|COMPLETED|Overall Study||32
7680105|NCT01936363|18914979|P2|STARTED|Overall Study||33
7680106|NCT01936363|18914980|P1|STARTED|Overall Study||32
7680107|NCT01936324|18915007|P3|NOT COMPLETED|Overall Study||5
7680108|NCT01936324|18915008|P2|NOT COMPLETED|Overall Study||6
7680109|NCT01936324|18915009|P1|NOT COMPLETED|Overall Study||0
7680110|NCT01936324|18915007|P3|COMPLETED|Overall Study||50
7680111|NCT01936324|18915008|P2|COMPLETED|Overall Study||47
7680112|NCT01936324|18915009|P1|COMPLETED|Overall Study||6
7680113|NCT01936324|18915007|P3|STARTED|Overall Study||55
7680114|NCT01936324|18915008|P2|STARTED|Overall Study||53
7680115|NCT01936324|18915009|P1|STARTED|Overall Study||6
7680116|NCT01936259|18915022|P2|NOT COMPLETED|Overall Study||20
7680117|NCT01936259|18915023|P1|NOT COMPLETED|Overall Study||12
7680118|NCT01936259|18915022|P2|COMPLETED|Overall Study||111
7680119|NCT01936259|18915023|P1|COMPLETED|Overall Study||118
7680120|NCT01936259|18915022|P2|STARTED|Overall Study||131
7680121|NCT01936259|18915023|P1|STARTED|Overall Study||130
7680122|NCT01936181|18915043|P4|NOT COMPLETED|Transition-extension||5
7680123|NCT01936181|18915044|P3|NOT COMPLETED|Transition-extension||6
7680124|NCT01936181|18915045|P2|NOT COMPLETED|Transition-extension||0
7680125|NCT01936181|18915046|P1|NOT COMPLETED|Transition-extension||15
7680126|NCT01936181|18915043|P4|COMPLETED|Transition-extension||96
7680127|NCT01936181|18915044|P3|COMPLETED|Transition-extension||88
7680128|NCT01936181|18915045|P2|COMPLETED|Transition-extension||0
7680129|NCT01936181|18915046|P1|COMPLETED|Transition-extension||186
7680130|NCT01936181|18915043|P4|STARTED|Transition-extension||101
7680131|NCT01936181|18915044|P3|STARTED|Transition-extension||94
7680132|NCT01936181|18915045|P2|STARTED|Transition-extension||0
7680133|NCT01936181|18915046|P1|STARTED|Transition-extension||201
7680134|NCT01936181|18915043|P4|NOT COMPLETED|Randomised, Double-blind||0
7680135|NCT01936181|18915044|P3|NOT COMPLETED|Randomised, Double-blind||0
7680136|NCT01936181|18915045|P2|NOT COMPLETED|Randomised, Double-blind||68
7680137|NCT01936181|18915046|P1|NOT COMPLETED|Randomised, Double-blind||64
7680138|NCT01936181|18915043|P4|COMPLETED|Randomised, Double-blind||0
7680139|NCT01936181|18915044|P3|COMPLETED|Randomised, Double-blind||0
7680140|NCT01936181|18915045|P2|COMPLETED|Randomised, Double-blind||225
7680141|NCT01936181|18915046|P1|COMPLETED|Randomised, Double-blind||227
7680142|NCT01936181|18915043|P4|STARTED|Randomised, Double-blind||0
7680143|NCT01936181|18915044|P3|STARTED|Randomised, Double-blind||0
7680144|NCT01936181|18915045|P2|STARTED|Randomised, Double-blind||293
7680145|NCT01936181|18915046|P1|STARTED|Randomised, Double-blind||291
7680146|NCT01935947|18915060|P3|NOT COMPLETED|Overall Study||2
7680147|NCT01935947|18915061|P2|NOT COMPLETED|Overall Study||4
7680148|NCT01935947|18915062|P1|NOT COMPLETED|Overall Study||3
7680149|NCT01935947|18915060|P3|COMPLETED|Overall Study||0
7680150|NCT01935947|18915061|P2|COMPLETED|Overall Study||0
7680151|NCT01935947|18915062|P1|COMPLETED|Overall Study||1
7680152|NCT01935947|18915060|P3|Cytotoxic Therapy|Overall Study||2
7680153|NCT01935947|18915061|P2|Cytotoxic Therapy|Overall Study||3
7680154|NCT01935947|18915062|P1|Cytotoxic Therapy|Overall Study||3
7680155|NCT01935947|18915060|P3|Epigenetic Therapy|Overall Study||0
7680156|NCT01935947|18915061|P2|Epigenetic Therapy|Overall Study||4
7680157|NCT01935947|18915062|P1|Epigenetic Therapy|Overall Study||4
7680158|NCT01935947|18915060|P3|STARTED|Overall Study||2
7680159|NCT01935947|18915061|P2|STARTED|Overall Study||4
7680160|NCT01935947|18915062|P1|STARTED|Overall Study||4
7680161|NCT01935934|18915087|P2|NOT COMPLETED|Overall Study||0
7680162|NCT01935934|18915088|P1|NOT COMPLETED|Overall Study||0
7680163|NCT01935934|18915087|P2|COMPLETED|Overall Study||32
7680164|NCT01935934|18915088|P1|COMPLETED|Overall Study||70
7680165|NCT01935934|18915087|P2|STARTED|Overall Study||32
7680166|NCT01935934|18915088|P1|STARTED|Overall Study||70
7680167|NCT01935700|18915097|P2|NOT COMPLETED|Overall Study||0
7680168|NCT01935700|18915098|P1|NOT COMPLETED|Overall Study||5
7680169|NCT01935700|18915097|P2|COMPLETED|Overall Study||86
7680170|NCT01935700|18915098|P1|COMPLETED|Overall Study||9
7680171|NCT01935700|18915097|P2|STARTED|Overall Study||86
7680172|NCT01935700|18915098|P1|STARTED|Overall Study||14
7680173|NCT01935622|18915109|P3|NOT COMPLETED|Overall Study||0
7680174|NCT01935622|18915110|P2|NOT COMPLETED|Overall Study||2
7680175|NCT01935622|18915111|P1|NOT COMPLETED|Overall Study||2
7680176|NCT01935622|18915109|P3|COMPLETED|Overall Study||4
7680177|NCT01935622|18915110|P2|COMPLETED|Overall Study||1
7680178|NCT01935622|18915111|P1|COMPLETED|Overall Study||1
7680179|NCT01935622|18915109|P3|STARTED|Overall Study||4
7680180|NCT01935622|18915110|P2|STARTED|Overall Study||3
7680181|NCT01935622|18915111|P1|STARTED|Overall Study||3
7680182|NCT01935180|18915121|P2|NOT COMPLETED|Overall Study||14
7680183|NCT01935180|18915122|P1|NOT COMPLETED|Overall Study||21
7680184|NCT01935180|18915121|P2|COMPLETED|Overall Study||561
7680185|NCT01935180|18915122|P1|COMPLETED|Overall Study||552
7680186|NCT01935180|18915121|P2|STARTED|Overall Study||575
7680187|NCT01935180|18915122|P1|STARTED|Overall Study||573
7680188|NCT01934972|18915142|P2|NOT COMPLETED|Overall Study||6
7680189|NCT01934972|18915143|P1|NOT COMPLETED|Overall Study||9
7680190|NCT01934972|18915142|P2|COMPLETED|Overall Study||5
7680191|NCT01934972|18915143|P1|COMPLETED|Overall Study||4
7680192|NCT01934972|18915142|P2|STARTED|Overall Study||11
7680193|NCT01934972|18915143|P1|STARTED|Overall Study||13
7680194|NCT01934894|18915173|P2|NOT COMPLETED|Overall Study||5
7680195|NCT01934894|18915174|P1|NOT COMPLETED|Overall Study||6
7680196|NCT01934894|18915173|P2|COMPLETED|Overall Study||0
7680197|NCT01934894|18915174|P1|COMPLETED|Overall Study||0
7680198|NCT01934894|18915173|P2|STARTED|Overall Study||5
7680199|NCT01934894|18915174|P1|STARTED|Overall Study||6
7680200|NCT01934790|18915189|P1|NOT COMPLETED|Long Term Follow up||0
7680201|NCT01934790|18915189|P1|COMPLETED|Long Term Follow up||12
7680202|NCT01934790|18915189|P1|STARTED|Long Term Follow up||12
7680203|NCT01934790|18915189|P1|NOT COMPLETED|Active Follow up||24
7680204|NCT01934790|18915189|P1|COMPLETED|Active Follow up||10
7680205|NCT01934790|18915189|P1|STARTED|Active Follow up||34
7680206|NCT01934790|18915189|P1|NOT COMPLETED|Treatment||16
7680207|NCT01934790|18915189|P1|COMPLETED|Treatment||29
7680208|NCT01934790|18915189|P1|Participants Received Study Treatment|Treatment||44
7680209|NCT01934790|18915189|P1|STARTED|Treatment|Eligible for treatment|45
7680210|NCT01934647|18915220|P3|NOT COMPLETED|Overall Study||0
7680211|NCT01934647|18915221|P2|NOT COMPLETED|Overall Study||0
7680212|NCT01934647|18915222|P1|NOT COMPLETED|Overall Study||0
7680213|NCT01934647|18915220|P3|COMPLETED|Overall Study||3
7680214|NCT01934647|18915221|P2|COMPLETED|Overall Study||2
7680215|NCT01934647|18915222|P1|COMPLETED|Overall Study||2
7680216|NCT01934647|18915220|P3|STARTED|Overall Study||3
7680217|NCT01934647|18915221|P2|STARTED|Overall Study||2
7680218|NCT01934647|18915222|P1|STARTED|Overall Study||2
7680219|NCT01934582|18915230|P1|NOT COMPLETED|Overall Study||0
7680220|NCT01934582|18915230|P1|COMPLETED|Overall Study||13
7680221|NCT01934582|18915230|P1|STARTED|Overall Study||13
7680222|NCT01934556|18915247|P3|NOT COMPLETED|Overall Study||10
7680223|NCT01934556|18915248|P2|NOT COMPLETED|Overall Study||16
7680224|NCT01934556|18915249|P1|NOT COMPLETED|Overall Study||5
7680225|NCT01934556|18915247|P3|COMPLETED|Overall Study||50
7680226|NCT01934556|18915248|P2|COMPLETED|Overall Study||44
7680227|NCT01934556|18915249|P1|COMPLETED|Overall Study||25
7680228|NCT01934556|18915247|P3|STARTED|Overall Study||60
7680229|NCT01934556|18915248|P2|STARTED|Overall Study||60
7680230|NCT01934556|18915249|P1|STARTED|Overall Study||30
7680231|NCT01934517|18915281|P1|NOT COMPLETED|Overall Study||0
7680232|NCT01934517|18915281|P1|COMPLETED|Overall Study||25
7680233|NCT01934517|18915281|P1|STARTED|Overall Study||25
7680234|NCT01934504|18915293|P4|NOT COMPLETED|Overall Study||7
7680235|NCT01934504|18915294|P3|NOT COMPLETED|Overall Study||5
7680236|NCT01934504|18915295|P2|NOT COMPLETED|Overall Study||0
7680237|NCT01934504|18915296|P1|NOT COMPLETED|Overall Study||1
7680238|NCT01934504|18915293|P4|COMPLETED|Overall Study||1
7680239|NCT01934504|18915294|P3|COMPLETED|Overall Study||11
7680240|NCT01934504|18915295|P2|COMPLETED|Overall Study||3
7680241|NCT01934504|18915296|P1|COMPLETED|Overall Study||5
7680242|NCT01934504|18915293|P4|STARTED|Overall Study||8
7680243|NCT01934504|18915294|P3|STARTED|Overall Study||16
7680244|NCT01934504|18915295|P2|STARTED|Overall Study||3
7680245|NCT01934504|18915296|P1|STARTED|Overall Study||6
7680246|NCT01934231|18915318|P1|NOT COMPLETED|Overall Study||0
7680247|NCT01934231|18915318|P1|COMPLETED|Overall Study||27
7680248|NCT01934231|18915318|P1|STARTED|Overall Study||27
7680249|NCT01934218|18915329|P2|NOT COMPLETED|Open-Label Phase||24
7680250|NCT01934218|18915330|P1|NOT COMPLETED|Open-Label Phase||26
7680251|NCT01934218|18915329|P2|COMPLETED|Open-Label Phase||304
7680252|NCT01934218|18915330|P1|COMPLETED|Open-Label Phase||290
7680253|NCT01934218|18915329|P2|STARTED|Open-Label Phase||328
7680254|NCT01934218|18915330|P1|STARTED|Open-Label Phase||316
7680255|NCT01934218|18915329|P2|NOT COMPLETED|Double-blind Phase||54
7680256|NCT01934218|18915330|P1|NOT COMPLETED|Double-blind Phase||48
7680257|NCT01934218|18915329|P2|COMPLETED|Double-blind Phase||356
7680258|NCT01934218|18915330|P1|COMPLETED|Double-blind Phase||356
7680259|NCT01934218|18915329|P2|Analyzed Participants|Double-blind Phase||407
7680260|NCT01934218|18915330|P1|Analyzed Participants|Double-blind Phase||402
7680261|NCT01934218|18915329|P2|STARTED|Double-blind Phase||410
7680262|NCT01934218|18915330|P1|STARTED|Double-blind Phase||404
7680263|NCT01934192|18915341|P4|NOT COMPLETED|Overall Study||1
7680264|NCT01934192|18915342|P3|NOT COMPLETED|Overall Study||1
7680265|NCT01934192|18915343|P2|NOT COMPLETED|Overall Study||7
7680266|NCT01934192|18915344|P1|NOT COMPLETED|Overall Study||9
7680267|NCT01934192|18915341|P4|COMPLETED|Overall Study||3
7680268|NCT01934192|18915342|P3|COMPLETED|Overall Study||3
7680269|NCT01934192|18915343|P2|COMPLETED|Overall Study||37
7680270|NCT01934192|18915344|P1|COMPLETED|Overall Study||31
7680271|NCT01934192|18915341|P4|STARTED|Overall Study||4
7680272|NCT01934192|18915342|P3|STARTED|Overall Study||4
7680273|NCT01934192|18915343|P2|STARTED|Overall Study||44
7680274|NCT01934192|18915344|P1|STARTED|Overall Study||40
7680275|NCT01934140|18915480|P2|NOT COMPLETED|Booster Phase (6 Months)||3
7680276|NCT01934140|18915481|P1|NOT COMPLETED|Booster Phase (6 Months)||5
7680277|NCT01934140|18915480|P2|COMPLETED|Booster Phase (6 Months)||53
7680278|NCT01934140|18915481|P1|COMPLETED|Booster Phase (6 Months)||159
7680279|NCT01934140|18915480|P2|Vaccinated|Booster Phase (6 Months)||56
7680280|NCT01934140|18915481|P1|Vaccinated|Booster Phase (6 Months)||164
7680281|NCT01934140|18915480|P2|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|56
7680282|NCT01934140|18915481|P1|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|164
7680283|NCT01934140|18915480|P2|NOT COMPLETED|Persistence Phase (Year 6-10)||25
7680284|NCT01934140|18915481|P1|NOT COMPLETED|Persistence Phase (Year 6-10)||83
7680285|NCT01934140|18915480|P2|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|51
7680286|NCT01934140|18915481|P1|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|152
7680287|NCT01934140|18915480|P2|STARTED|Persistence Phase (Year 6-10)||76
7680288|NCT01934140|18915481|P1|STARTED|Persistence Phase (Year 6-10)||235
7680289|NCT01934010|18915532|P3|NOT COMPLETED|Overall Study||2
7680290|NCT01934010|18915533|P2|NOT COMPLETED|Overall Study||11
7680291|NCT01934010|18915534|P1|NOT COMPLETED|Overall Study||23
7680292|NCT01934010|18915532|P3|COMPLETED|Overall Study||74
7680293|NCT01934010|18915533|P2|COMPLETED|Overall Study||56
7680294|NCT01934010|18915534|P1|COMPLETED|Overall Study||91
7680295|NCT01934010|18915532|P3|STARTED|Overall Study||76
7680296|NCT01934010|18915533|P2|STARTED|Overall Study||67
7680297|NCT01934010|18915534|P1|STARTED|Overall Study||114
7680298|NCT01933984|18915553|P2|NOT COMPLETED|Overall Study||0
7680299|NCT01933984|18915554|P1|NOT COMPLETED|Overall Study||0
7680300|NCT01933984|18915553|P2|COMPLETED|Overall Study||25
7680301|NCT01933984|18915554|P1|COMPLETED|Overall Study||26
7680302|NCT01933984|18915553|P2|STARTED|Overall Study||25
7680303|NCT01933984|18915554|P1|STARTED|Overall Study||26
7680304|NCT01933932|18915576|P2|NOT COMPLETED|Overall Study||178
7680305|NCT01933932|18915577|P1|NOT COMPLETED|Overall Study||184
7680306|NCT01933932|18915576|P2|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|78
7680307|NCT01933932|18915577|P1|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|70
7680308|NCT01933932|18915576|P2|STARTED|Overall Study||256
7680309|NCT01933932|18915577|P1|STARTED|Overall Study||254
7680310|NCT01933919|18915595|P2|NOT COMPLETED|Open-label Long-term Phase||6
7680311|NCT01933919|18915596|P1|NOT COMPLETED|Open-label Long-term Phase||7
7680312|NCT01933919|18915595|P2|COMPLETED|Open-label Long-term Phase||9
7680313|NCT01933919|18915596|P1|COMPLETED|Open-label Long-term Phase||12
7680314|NCT01933919|18915595|P2|STARTED|Open-label Long-term Phase||15
7680315|NCT01933919|18915596|P1|STARTED|Open-label Long-term Phase||19
7680316|NCT01933919|18915595|P2|NOT COMPLETED|Double-blind Placebo-controlled Phase||4
7680317|NCT01933919|18915596|P1|NOT COMPLETED|Double-blind Placebo-controlled Phase||0
7680318|NCT01933919|18915595|P2|COMPLETED|Double-blind Placebo-controlled Phase||15
7680319|NCT01933919|18915596|P1|COMPLETED|Double-blind Placebo-controlled Phase||19
7680320|NCT01933919|18915595|P2|Received Study Drug|Double-blind Placebo-controlled Phase||19
7680321|NCT01933919|18915596|P1|Received Study Drug|Double-blind Placebo-controlled Phase||19
7680322|NCT01933919|18915595|P2|STARTED|Double-blind Placebo-controlled Phase||19
7680323|NCT01933919|18915596|P1|STARTED|Double-blind Placebo-controlled Phase||19
7680324|NCT01933880|18915632|P2|NOT COMPLETED|Overall Study||1
7680325|NCT01933880|18915633|P1|NOT COMPLETED|Overall Study||30
7680326|NCT01933880|18915632|P2|COMPLETED|Overall Study||40
7680327|NCT01933880|18915633|P1|COMPLETED|Overall Study||123
7680328|NCT01933880|18915632|P2|STARTED|Overall Study||41
7680329|NCT01933880|18915633|P1|STARTED|Overall Study||153
7680330|NCT01933789|18915707|P9|NOT COMPLETED|Overall Study||0
7680331|NCT01933789|18915708|P8|NOT COMPLETED|Overall Study||14
7680332|NCT01933789|18915709|P7|NOT COMPLETED|Overall Study||15
7680333|NCT01933789|18915710|P6|NOT COMPLETED|Overall Study||67
7680334|NCT01933789|18915711|P5|NOT COMPLETED|Overall Study||59
7680335|NCT01933789|18915712|P4|NOT COMPLETED|Overall Study||1
7680336|NCT01933789|18915713|P3|NOT COMPLETED|Overall Study||0
7680337|NCT01933789|18915714|P2|NOT COMPLETED|Overall Study||1
7680338|NCT01933789|18915715|P1|NOT COMPLETED|Overall Study||6
7680339|NCT01933789|18915707|P9|COMPLETED|Overall Study||25
7680340|NCT01933789|18915708|P8|COMPLETED|Overall Study||47
7680341|NCT01933789|18915709|P7|COMPLETED|Overall Study||43
7680342|NCT01933789|18915710|P6|COMPLETED|Overall Study||221
7680343|NCT01933789|18915711|P5|COMPLETED|Overall Study||190
7680344|NCT01933789|18915712|P4|COMPLETED|Overall Study||1
7680345|NCT01933789|18915713|P3|COMPLETED|Overall Study||2
7680346|NCT01933789|18915714|P2|COMPLETED|Overall Study||66
7680347|NCT01933789|18915715|P1|COMPLETED|Overall Study||59
7680348|NCT01933789|18915707|P9|Qualitative Interviews|Overall Study||25
7680349|NCT01933789|18915708|P8|Qualitative Interviews|Overall Study||0
7680350|NCT01933789|18915709|P7|Qualitative Interviews|Overall Study||0
7680351|NCT01933789|18915710|P6|Qualitative Interviews|Overall Study||0
7680352|NCT01933789|18915711|P5|Qualitative Interviews|Overall Study||0
7680353|NCT01933789|18915712|P4|Qualitative Interviews|Overall Study||0
7680354|NCT01933789|18915713|P3|Qualitative Interviews|Overall Study||0
7680355|NCT01933789|18915714|P2|Qualitative Interviews|Overall Study||0
7680356|NCT01933789|18915715|P1|Qualitative Interviews|Overall Study||0
7680357|NCT01933789|18915707|P9|Completed 6-Month Survey|Overall Study||0
7680358|NCT01933789|18915708|P8|Completed 6-Month Survey|Overall Study||40
7680359|NCT01933789|18915709|P7|Completed 6-Month Survey|Overall Study||35
7680360|NCT01933789|18915710|P6|Completed 6-Month Survey|Overall Study||188
7680361|NCT01933789|18915711|P5|Completed 6-Month Survey|Overall Study||160
7680362|NCT01933789|18915712|P4|Completed 6-Month Survey|Overall Study||0
7680363|NCT01933789|18915713|P3|Completed 6-Month Survey|Overall Study||0
7680364|NCT01933789|18915714|P2|Completed 6-Month Survey|Overall Study||0
7680365|NCT01933789|18915715|P1|Completed 6-Month Survey|Overall Study||0
7680366|NCT01933789|18915707|P9|Completed 3-Month Survey|Overall Study||0
7680367|NCT01933789|18915708|P8|Completed 3-Month Survey|Overall Study||43
7680368|NCT01933789|18915709|P7|Completed 3-Month Survey|Overall Study||37
7680369|NCT01933789|18915710|P6|Completed 3-Month Survey|Overall Study||211
7680370|NCT01933789|18915711|P5|Completed 3-Month Survey|Overall Study||176
7680371|NCT01933789|18915712|P4|Completed 3-Month Survey|Overall Study||0
7680372|NCT01933789|18915713|P3|Completed 3-Month Survey|Overall Study||0
7680373|NCT01933789|18915714|P2|Completed 3-Month Survey|Overall Study||0
7680374|NCT01933789|18915715|P1|Completed 3-Month Survey|Overall Study||0
7680375|NCT01933789|18915707|P9|Completed 2-Week Survey|Overall Study||0
7680376|NCT01933789|18915708|P8|Completed 2-Week Survey|Overall Study||0
7680377|NCT01933789|18915709|P7|Completed 2-Week Survey|Overall Study||0
7680378|NCT01933789|18915710|P6|Completed 2-Week Survey|Overall Study||215
7680379|NCT01933789|18915711|P5|Completed 2-Week Survey|Overall Study||184
7680380|NCT01933789|18915712|P4|Completed 2-Week Survey|Overall Study||0
7680381|NCT01933789|18915713|P3|Completed 2-Week Survey|Overall Study||0
7680382|NCT01933789|18915714|P2|Completed 2-Week Survey|Overall Study||0
7680383|NCT01933789|18915715|P1|Completed 2-Week Survey|Overall Study||0
7680384|NCT01933789|18915707|P9|Completed After-visit Survey|Overall Study||0
7680385|NCT01933789|18915708|P8|Completed After-visit Survey|Overall Study||0
7680386|NCT01933789|18915709|P7|Completed After-visit Survey|Overall Study||0
7680387|NCT01933789|18915710|P6|Completed After-visit Survey|Overall Study||0
7680388|NCT01933789|18915711|P5|Completed After-visit Survey|Overall Study||0
7680389|NCT01933789|18915712|P4|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|1
7680390|NCT01933789|18915713|P3|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|2
7680391|NCT01933789|18915714|P2|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|64
7680392|NCT01933789|18915715|P1|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|57
7680393|NCT01933789|18915707|P9|Had Target Visit|Overall Study||0
7680394|NCT01933789|18915708|P8|Had Target Visit|Overall Study||0
7680395|NCT01933789|18915709|P7|Had Target Visit|Overall Study||0
7680396|NCT01933789|18915710|P6|Had Target Visit|Overall Study||266
7680397|NCT01933789|18915711|P5|Had Target Visit|Overall Study||228
7680398|NCT01933789|18915712|P4|Had Target Visit|Overall Study||2
7680399|NCT01933789|18915713|P3|Had Target Visit|Overall Study||2
7680400|NCT01933789|18915714|P2|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|65
7680401|NCT01933789|18915715|P1|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|61
7680402|NCT01933789|18915707|P9|STARTED|Overall Study||25
7680403|NCT01933789|18915708|P8|STARTED|Overall Study||61
7680404|NCT01933789|18915709|P7|STARTED|Overall Study||58
7680405|NCT01933789|18915710|P6|STARTED|Overall Study||288
7680406|NCT01933789|18915711|P5|STARTED|Overall Study||249
7680407|NCT01933789|18915712|P4|STARTED|Overall Study||2
7680408|NCT01933789|18915713|P3|STARTED|Overall Study||2
7680409|NCT01933789|18915714|P2|STARTED|Overall Study||67
7680410|NCT01933789|18915715|P1|STARTED|Overall Study||65
7680411|NCT01933776|18916016|P2|NOT COMPLETED|Overall Study||0
7680412|NCT01933776|18916017|P1|NOT COMPLETED|Overall Study||0
7680413|NCT01933776|18916016|P2|COMPLETED|Overall Study||20
7680414|NCT01933776|18916017|P1|COMPLETED|Overall Study||20
7680415|NCT01933776|18916016|P2|STARTED|Overall Study||20
7680416|NCT01933776|18916017|P1|STARTED|Overall Study||20
7680417|NCT01933672|18916025|P7|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
7680418|NCT01933672|18916026|P6|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
7680419|NCT01933672|18916027|P5|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
7680420|NCT01933672|18916028|P4|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
7680421|NCT01933672|18916029|P3|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
7680422|NCT01933672|18916030|P2|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
7680423|NCT01933672|18916031|P1|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
7680424|NCT01933672|18916025|P7|COMPLETED|Third Intervention Period (12-16 Days)||6
7680425|NCT01933672|18916026|P6|COMPLETED|Third Intervention Period (12-16 Days)||4
7680426|NCT01933672|18916027|P5|COMPLETED|Third Intervention Period (12-16 Days)||6
7680427|NCT01933672|18916028|P4|COMPLETED|Third Intervention Period (12-16 Days)||4
7680428|NCT01933672|18916029|P3|COMPLETED|Third Intervention Period (12-16 Days)||1
7680429|NCT01933672|18916030|P2|COMPLETED|Third Intervention Period (12-16 Days)||5
7680430|NCT01933672|18916031|P1|COMPLETED|Third Intervention Period (12-16 Days)||0
7680431|NCT01933672|18916025|P7|STARTED|Third Intervention Period (12-16 Days)||6
7680432|NCT01933672|18916026|P6|STARTED|Third Intervention Period (12-16 Days)||4
7680433|NCT01933672|18916027|P5|STARTED|Third Intervention Period (12-16 Days)||6
7680434|NCT01933672|18916028|P4|STARTED|Third Intervention Period (12-16 Days)||5
7680435|NCT01933672|18916029|P3|STARTED|Third Intervention Period (12-16 Days)||1
7680436|NCT01933672|18916030|P2|STARTED|Third Intervention Period (12-16 Days)||6
7680437|NCT01933672|18916031|P1|STARTED|Third Intervention Period (12-16 Days)||0
7680438|NCT01933672|18916025|P7|NOT COMPLETED|Second Washout Period (7-14 Days)||0
7680439|NCT01933672|18916026|P6|NOT COMPLETED|Second Washout Period (7-14 Days)||0
7680440|NCT01933672|18916027|P5|NOT COMPLETED|Second Washout Period (7-14 Days)||0
7680441|NCT01933672|18916028|P4|NOT COMPLETED|Second Washout Period (7-14 Days)||0
7680442|NCT01933672|18916029|P3|NOT COMPLETED|Second Washout Period (7-14 Days)||0
7680443|NCT01933672|18916030|P2|NOT COMPLETED|Second Washout Period (7-14 Days)||0
7680444|NCT01933672|18916031|P1|NOT COMPLETED|Second Washout Period (7-14 Days)||0
7680445|NCT01933672|18916025|P7|COMPLETED|Second Washout Period (7-14 Days)||6
7680446|NCT01933672|18916026|P6|COMPLETED|Second Washout Period (7-14 Days)||4
7680447|NCT01933672|18916027|P5|COMPLETED|Second Washout Period (7-14 Days)||6
7680448|NCT01933672|18916028|P4|COMPLETED|Second Washout Period (7-14 Days)||5
7680449|NCT01933672|18916029|P3|COMPLETED|Second Washout Period (7-14 Days)||1
7680450|NCT01933672|18916030|P2|COMPLETED|Second Washout Period (7-14 Days)||6
7680451|NCT01933672|18916031|P1|COMPLETED|Second Washout Period (7-14 Days)||0
7680452|NCT01933672|18916025|P7|STARTED|Second Washout Period (7-14 Days)||6
7680453|NCT01933672|18916026|P6|STARTED|Second Washout Period (7-14 Days)||4
7680454|NCT01933672|18916027|P5|STARTED|Second Washout Period (7-14 Days)||6
7680455|NCT01933672|18916028|P4|STARTED|Second Washout Period (7-14 Days)||5
7680456|NCT01933672|18916029|P3|STARTED|Second Washout Period (7-14 Days)||1
7680457|NCT01933672|18916030|P2|STARTED|Second Washout Period (7-14 Days)||6
7680458|NCT01933672|18916031|P1|STARTED|Second Washout Period (7-14 Days)||0
7680459|NCT01933672|18916025|P7|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
7680460|NCT01933672|18916026|P6|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
7680461|NCT01933672|18916027|P5|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
7680462|NCT01933672|18916028|P4|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
7680463|NCT01933672|18916029|P3|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
7680464|NCT01933672|18916030|P2|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
7680465|NCT01933672|18916031|P1|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
7680466|NCT01933672|18916025|P7|COMPLETED|Second Intervention Period (12-16 Days)||6
7680467|NCT01933672|18916026|P6|COMPLETED|Second Intervention Period (12-16 Days)||4
7680468|NCT01933672|18916027|P5|COMPLETED|Second Intervention Period (12-16 Days)||6
7680469|NCT01933672|18916028|P4|COMPLETED|Second Intervention Period (12-16 Days)||5
7680470|NCT01933672|18916029|P3|COMPLETED|Second Intervention Period (12-16 Days)||1
7680471|NCT01933672|18916030|P2|COMPLETED|Second Intervention Period (12-16 Days)||6
7680472|NCT01933672|18916031|P1|COMPLETED|Second Intervention Period (12-16 Days)||0
7680473|NCT01933672|18916025|P7|STARTED|Second Intervention Period (12-16 Days)||6
7680474|NCT01933672|18916026|P6|STARTED|Second Intervention Period (12-16 Days)||4
7680475|NCT01933672|18916027|P5|STARTED|Second Intervention Period (12-16 Days)||6
7680476|NCT01933672|18916028|P4|STARTED|Second Intervention Period (12-16 Days)||5
7680477|NCT01933672|18916029|P3|STARTED|Second Intervention Period (12-16 Days)||2
7680478|NCT01933672|18916030|P2|STARTED|Second Intervention Period (12-16 Days)||7
7680479|NCT01933672|18916031|P1|STARTED|Second Intervention Period (12-16 Days)||0
7680480|NCT01933672|18916025|P7|NOT COMPLETED|First Washout Period (7-14 Days)||0
7680481|NCT01933672|18916026|P6|NOT COMPLETED|First Washout Period (7-14 Days)||0
7680482|NCT01933672|18916027|P5|NOT COMPLETED|First Washout Period (7-14 Days)||0
7680483|NCT01933672|18916028|P4|NOT COMPLETED|First Washout Period (7-14 Days)||0
7680484|NCT01933672|18916029|P3|NOT COMPLETED|First Washout Period (7-14 Days)||0
7680485|NCT01933672|18916030|P2|NOT COMPLETED|First Washout Period (7-14 Days)||0
7680486|NCT01933672|18916031|P1|NOT COMPLETED|First Washout Period (7-14 Days)||0
7680487|NCT01933672|18916025|P7|COMPLETED|First Washout Period (7-14 Days)||6
7680488|NCT01933672|18916026|P6|COMPLETED|First Washout Period (7-14 Days)||4
7680489|NCT01933672|18916027|P5|COMPLETED|First Washout Period (7-14 Days)||6
7680490|NCT01933672|18916028|P4|COMPLETED|First Washout Period (7-14 Days)||5
7680491|NCT01933672|18916029|P3|COMPLETED|First Washout Period (7-14 Days)||2
7680492|NCT01933672|18916030|P2|COMPLETED|First Washout Period (7-14 Days)||7
7680493|NCT01933672|18916031|P1|COMPLETED|First Washout Period (7-14 Days)||0
7680494|NCT01933672|18916025|P7|STARTED|First Washout Period (7-14 Days)||6
7680495|NCT01933672|18916026|P6|STARTED|First Washout Period (7-14 Days)||4
7680496|NCT01933672|18916027|P5|STARTED|First Washout Period (7-14 Days)||6
7680497|NCT01933672|18916028|P4|STARTED|First Washout Period (7-14 Days)||5
7680498|NCT01933672|18916029|P3|STARTED|First Washout Period (7-14 Days)||2
7680499|NCT01933672|18916030|P2|STARTED|First Washout Period (7-14 Days)||7
7680500|NCT01933672|18916031|P1|STARTED|First Washout Period (7-14 Days)||0
7680501|NCT01933672|18916025|P7|NOT COMPLETED|First Intervention Period (12-16 Days)||0
7680502|NCT01933672|18916026|P6|NOT COMPLETED|First Intervention Period (12-16 Days)||1
7680503|NCT01933672|18916027|P5|NOT COMPLETED|First Intervention Period (12-16 Days)||1
7680504|NCT01933672|18916028|P4|NOT COMPLETED|First Intervention Period (12-16 Days)||0
7680505|NCT01933672|18916029|P3|NOT COMPLETED|First Intervention Period (12-16 Days)||1
7680506|NCT01933672|18916030|P2|NOT COMPLETED|First Intervention Period (12-16 Days)||0
7680507|NCT01933672|18916031|P1|NOT COMPLETED|First Intervention Period (12-16 Days)||0
7680508|NCT01933672|18916025|P7|COMPLETED|First Intervention Period (12-16 Days)||6
7680509|NCT01933672|18916026|P6|COMPLETED|First Intervention Period (12-16 Days)||4
7680510|NCT01933672|18916027|P5|COMPLETED|First Intervention Period (12-16 Days)||6
7680511|NCT01933672|18916028|P4|COMPLETED|First Intervention Period (12-16 Days)||5
7680512|NCT01933672|18916029|P3|COMPLETED|First Intervention Period (12-16 Days)||2
7680513|NCT01933672|18916030|P2|COMPLETED|First Intervention Period (12-16 Days)||7
7680514|NCT01933672|18916031|P1|COMPLETED|First Intervention Period (12-16 Days)||0
7680515|NCT01933672|18916025|P7|STARTED|First Intervention Period (12-16 Days)||6
7680516|NCT01933672|18916026|P6|STARTED|First Intervention Period (12-16 Days)||5
7680517|NCT01933672|18916027|P5|STARTED|First Intervention Period (12-16 Days)||7
7680518|NCT01933672|18916028|P4|STARTED|First Intervention Period (12-16 Days)||5
7680519|NCT01933672|18916029|P3|STARTED|First Intervention Period (12-16 Days)||3
7680520|NCT01933672|18916030|P2|STARTED|First Intervention Period (12-16 Days)||7
7680521|NCT01933672|18916031|P1|STARTED|First Intervention Period (12-16 Days)||0
7680522|NCT01933672|18916025|P7|NOT COMPLETED|Metformin Run-in Period||0
7680523|NCT01933672|18916026|P6|NOT COMPLETED|Metformin Run-in Period||0
7680524|NCT01933672|18916027|P5|NOT COMPLETED|Metformin Run-in Period||0
7680525|NCT01933672|18916028|P4|NOT COMPLETED|Metformin Run-in Period||0
7680526|NCT01933672|18916029|P3|NOT COMPLETED|Metformin Run-in Period||0
7680527|NCT01933672|18916030|P2|NOT COMPLETED|Metformin Run-in Period||0
7680528|NCT01933672|18916031|P1|NOT COMPLETED|Metformin Run-in Period||10
7680529|NCT01933672|18916025|P7|COMPLETED|Metformin Run-in Period||0
7680530|NCT01933672|18916026|P6|COMPLETED|Metformin Run-in Period||0
7680531|NCT01933672|18916027|P5|COMPLETED|Metformin Run-in Period||0
7680532|NCT01933672|18916028|P4|COMPLETED|Metformin Run-in Period||0
7680533|NCT01933672|18916029|P3|COMPLETED|Metformin Run-in Period||0
7680534|NCT01933672|18916030|P2|COMPLETED|Metformin Run-in Period||0
7680535|NCT01933672|18916031|P1|COMPLETED|Metformin Run-in Period||33
7680536|NCT01933672|18916025|P7|Received Treatment|Metformin Run-in Period||0
7680537|NCT01933672|18916026|P6|Received Treatment|Metformin Run-in Period||0
7680538|NCT01933672|18916027|P5|Received Treatment|Metformin Run-in Period||0
7680539|NCT01933672|18916028|P4|Received Treatment|Metformin Run-in Period||0
7680540|NCT01933672|18916029|P3|Received Treatment|Metformin Run-in Period||0
7680541|NCT01933672|18916030|P2|Received Treatment|Metformin Run-in Period||0
7680542|NCT01933672|18916031|P1|Received Treatment|Metformin Run-in Period||43
7680543|NCT01933672|18916025|P7|STARTED|Metformin Run-in Period||0
7680544|NCT01933672|18916026|P6|STARTED|Metformin Run-in Period||0
7680545|NCT01933672|18916027|P5|STARTED|Metformin Run-in Period||0
7680546|NCT01933672|18916028|P4|STARTED|Metformin Run-in Period||0
7680547|NCT01933672|18916029|P3|STARTED|Metformin Run-in Period||0
7680548|NCT01933672|18916030|P2|STARTED|Metformin Run-in Period||0
7680549|NCT01933672|18916031|P1|STARTED|Metformin Run-in Period||43
7680550|NCT01933594|18916083|P6|NOT COMPLETED|Overall Study||0
7680551|NCT01933594|18916084|P5|NOT COMPLETED|Overall Study||2
7680552|NCT01933594|18916085|P4|NOT COMPLETED|Overall Study||0
7680553|NCT01933594|18916086|P3|NOT COMPLETED|Overall Study||0
7680554|NCT01933594|18916087|P2|NOT COMPLETED|Overall Study||0
7680555|NCT01933594|18916088|P1|NOT COMPLETED|Overall Study||1
7680556|NCT01933594|18916083|P6|COMPLETED|Overall Study||3
7680557|NCT01933594|18916084|P5|COMPLETED|Overall Study||11
7680558|NCT01933594|18916085|P4|COMPLETED|Overall Study||7
7680559|NCT01933594|18916086|P3|COMPLETED|Overall Study||12
7680560|NCT01933594|18916087|P2|COMPLETED|Overall Study||12
7680561|NCT01933594|18916088|P1|COMPLETED|Overall Study||11
7680562|NCT01933594|18916083|P6|STARTED|Overall Study||3
7680563|NCT01933594|18916084|P5|STARTED|Overall Study||13
7680564|NCT01933594|18916085|P4|STARTED|Overall Study||7
7680565|NCT01933594|18916086|P3|STARTED|Overall Study||12
7680566|NCT01933594|18916087|P2|STARTED|Overall Study||12
7680567|NCT01933594|18916088|P1|STARTED|Overall Study||12
7680568|NCT01933464|18916180|P2|NOT COMPLETED|Overall Study||0
7680569|NCT01933464|18916181|P1|NOT COMPLETED|Overall Study||0
7680570|NCT01933464|18916180|P2|COMPLETED|Overall Study||5
7680571|NCT01933464|18916181|P1|COMPLETED|Overall Study||5
7680572|NCT01933464|18916180|P2|STARTED|Overall Study||5
7680573|NCT01933464|18916181|P1|STARTED|Overall Study||5
7680574|NCT01933425|18916193|P2|NOT COMPLETED|Overall Study||0
7680575|NCT01933425|18916194|P1|NOT COMPLETED|Overall Study||0
7680576|NCT01933425|18916193|P2|COMPLETED|Overall Study||7
7680577|NCT01933425|18916194|P1|COMPLETED|Overall Study||7
7680578|NCT01933425|18916193|P2|STARTED|Overall Study||7
7680579|NCT01933425|18916194|P1|STARTED|Overall Study||7
7680580|NCT01933399|18916207|P3|NOT COMPLETED|Overall Study||0
7680581|NCT01933399|18916208|P2|NOT COMPLETED|Overall Study||0
7680582|NCT01933399|18916209|P1|NOT COMPLETED|Overall Study||0
7680583|NCT01933399|18916207|P3|COMPLETED|Overall Study||37
7680584|NCT01933399|18916208|P2|COMPLETED|Overall Study||32
7680585|NCT01933399|18916209|P1|COMPLETED|Overall Study||29
7680586|NCT01933399|18916207|P3|STARTED|Overall Study||37
7680587|NCT01933399|18916208|P2|STARTED|Overall Study||32
7680588|NCT01933399|18916209|P1|STARTED|Overall Study||29
7680589|NCT01933334|18916222|P2|NOT COMPLETED|Overall Study||2
7680590|NCT01933334|18916223|P1|NOT COMPLETED|Overall Study||5
7680591|NCT01933334|18916222|P2|COMPLETED|Overall Study||29
7680592|NCT01933334|18916223|P1|COMPLETED|Overall Study||27
7680593|NCT01933334|18916222|P2|STARTED|Overall Study||31
7680594|NCT01933334|18916223|P1|STARTED|Overall Study||32
7680595|NCT01933243|18916235|P2|NOT COMPLETED|Overall Study||4
7680596|NCT01933243|18916236|P1|NOT COMPLETED|Overall Study||2
7680597|NCT01933243|18916235|P2|COMPLETED|Overall Study||8
7680598|NCT01933243|18916236|P1|COMPLETED|Overall Study||10
7680599|NCT01933243|18916235|P2|STARTED|Overall Study||12
7680600|NCT01933243|18916236|P1|STARTED|Overall Study||12
7680601|NCT01933230|18916246|P1|NOT COMPLETED|Overall Study||0
7680602|NCT01933230|18916246|P1|COMPLETED|Overall Study||2
7680603|NCT01933230|18916246|P1|STARTED|Overall Study||2
7680604|NCT01933217|18916252|P2|NOT COMPLETED|Crossover (4 Weeks)||0
7680605|NCT01933217|18916253|P1|NOT COMPLETED|Crossover (4 Weeks)||0
7680606|NCT01933217|18916252|P2|COMPLETED|Crossover (4 Weeks)||10
7680607|NCT01933217|18916253|P1|COMPLETED|Crossover (4 Weeks)||10
7680608|NCT01933217|18916252|P2|STARTED|Crossover (4 Weeks)||10
7680609|NCT01933217|18916253|P1|STARTED|Crossover (4 Weeks)||10
7680610|NCT01933217|18916252|P2|NOT COMPLETED|Randomization (4 Weeks)||4
7680611|NCT01933217|18916253|P1|NOT COMPLETED|Randomization (4 Weeks)||2
7680612|NCT01933217|18916252|P2|COMPLETED|Randomization (4 Weeks)||10
7680613|NCT01933217|18916253|P1|COMPLETED|Randomization (4 Weeks)||10
7680614|NCT01933217|18916252|P2|STARTED|Randomization (4 Weeks)||14
7680615|NCT01933217|18916253|P1|STARTED|Randomization (4 Weeks)||12
7680616|NCT01933113|18916265|P1|NOT COMPLETED|Overall Study||1
7680617|NCT01933113|18916265|P1|COMPLETED|Overall Study||2
7680618|NCT01933113|18916265|P1|STARTED|Overall Study||3
7680619|NCT01933048|18916271|P2|NOT COMPLETED|Overall Study||28
7680620|NCT01933048|18916272|P1|NOT COMPLETED|Overall Study||25
7680621|NCT01933048|18916271|P2|COMPLETED|Overall Study||501
7680622|NCT01933048|18916272|P1|COMPLETED|Overall Study||523
7680623|NCT01933048|18916271|P2|STARTED|Overall Study||529
7680624|NCT01933048|18916272|P1|STARTED|Overall Study||548
7680625|NCT01932996|18916287|P2|NOT COMPLETED|Overall Study||0
7680626|NCT01932996|18916288|P1|NOT COMPLETED|Overall Study||2
7680627|NCT01932996|18916287|P2|COMPLETED|Overall Study||180
7680628|NCT01932996|18916288|P1|COMPLETED|Overall Study||170
7680629|NCT01932996|18916287|P2|STARTED|Overall Study||180
7680630|NCT01932996|18916288|P1|STARTED|Overall Study||172
7680631|NCT01932970|18916298|P1|NOT COMPLETED|Overall Study||18
7680632|NCT01932970|18916298|P1|COMPLETED|Overall Study||140
7680633|NCT01932970|18916298|P1|Received Treatment|Overall Study|Includes participants who completed the washout period and received etelcalcetide|148
7680634|NCT01932970|18916298|P1|STARTED|Overall Study|Includes all participants who enrolled into the washout period.|158
7680635|NCT01932788|18916308|P2|NOT COMPLETED|Overall Study||51
7680636|NCT01932788|18916309|P1|NOT COMPLETED|Overall Study||38
7680637|NCT01932788|18916308|P2|COMPLETED|Overall Study||118
7680638|NCT01932788|18916309|P1|COMPLETED|Overall Study||135
7680639|NCT01932788|18916308|P2|STARTED|Overall Study||169
7680640|NCT01932788|18916309|P1|STARTED|Overall Study||173
7680641|NCT01932762|18916319|P4|NOT COMPLETED|Overall Study||1
7680642|NCT01932762|18916320|P3|NOT COMPLETED|Overall Study||0
7680643|NCT01932762|18916321|P2|NOT COMPLETED|Overall Study||2
7680644|NCT01932762|18916322|P1|NOT COMPLETED|Overall Study||6
7680645|NCT01932762|18916319|P4|COMPLETED|Overall Study||18
7680646|NCT01932762|18916320|P3|COMPLETED|Overall Study||19
7680647|NCT01932762|18916321|P2|COMPLETED|Overall Study||28
7680648|NCT01932762|18916322|P1|COMPLETED|Overall Study||24
7680649|NCT01932762|18916319|P4|STARTED|Overall Study||19
7680650|NCT01932762|18916320|P3|STARTED|Overall Study||19
7680651|NCT01932762|18916321|P2|STARTED|Overall Study||30
7680652|NCT01932762|18916322|P1|STARTED|Overall Study||30
7680653|NCT01932697|18916358|P2|NOT COMPLETED|Overall Study||0
7680654|NCT01932697|18916359|P1|NOT COMPLETED|Overall Study||2
7680655|NCT01932697|18916358|P2|COMPLETED|Overall Study||43
7680656|NCT01932697|18916359|P1|COMPLETED|Overall Study||36
7680657|NCT01932697|18916358|P2|STARTED|Overall Study||43
7680658|NCT01932697|18916359|P1|STARTED|Overall Study||38
7680659|NCT01932606|18916373|P2|NOT COMPLETED|Overall Study||0
7680660|NCT01932606|18916374|P1|NOT COMPLETED|Overall Study||0
7680661|NCT01932606|18916373|P2|COMPLETED|Overall Study||14
7680662|NCT01932606|18916374|P1|COMPLETED|Overall Study||14
7680663|NCT01932606|18916373|P2|STARTED|Overall Study||14
7680664|NCT01932606|18916374|P1|STARTED|Overall Study||14
7680665|NCT01932437|18916426|P6|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||1
7680666|NCT01932437|18916427|P5|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
7680667|NCT01932437|18916428|P4|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
7680668|NCT01932437|18916429|P3|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
7680669|NCT01932437|18916430|P2|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
7680670|NCT01932437|18916431|P1|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
7680671|NCT01932437|18916426|P6|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||5
7680672|NCT01932437|18916427|P5|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
7680673|NCT01932437|18916428|P4|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
7680674|NCT01932437|18916429|P3|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
7680675|NCT01932437|18916430|P2|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
7680676|NCT01932437|18916431|P1|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
7680677|NCT01932437|18916426|P6|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||6
7680678|NCT01932437|18916427|P5|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
7680679|NCT01932437|18916428|P4|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
7680680|NCT01932437|18916429|P3|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
7680681|NCT01932437|18916430|P2|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
7680682|NCT01932437|18916431|P1|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
7680683|NCT01932437|18916426|P6|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
7680684|NCT01932437|18916427|P5|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
7680685|NCT01932437|18916428|P4|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
7680686|NCT01932437|18916429|P3|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
7680687|NCT01932437|18916430|P2|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
7680688|NCT01932437|18916431|P1|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
7680689|NCT01932437|18916426|P6|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
7680690|NCT01932437|18916427|P5|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
7680691|NCT01932437|18916428|P4|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
7680692|NCT01932437|18916429|P3|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
7680693|NCT01932437|18916430|P2|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
7680694|NCT01932437|18916431|P1|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
7680695|NCT01932437|18916426|P6|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
7680696|NCT01932437|18916427|P5|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
7680697|NCT01932437|18916428|P4|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
7680698|NCT01932437|18916429|P3|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
7680699|NCT01932437|18916430|P2|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
7680700|NCT01932437|18916431|P1|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
7680701|NCT01932437|18916426|P6|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
7680702|NCT01932437|18916427|P5|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
7680703|NCT01932437|18916428|P4|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
7680704|NCT01932437|18916429|P3|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
7680705|NCT01932437|18916430|P2|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
7680706|NCT01932437|18916431|P1|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
7680707|NCT01932437|18916426|P6|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
7680708|NCT01932437|18916427|P5|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
7680709|NCT01932437|18916428|P4|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
7680710|NCT01932437|18916429|P3|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
7680711|NCT01932437|18916430|P2|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
7680712|NCT01932437|18916431|P1|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
7680713|NCT01932437|18916426|P6|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
7680714|NCT01932437|18916427|P5|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
7680715|NCT01932437|18916428|P4|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
7680716|NCT01932437|18916429|P3|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
7680717|NCT01932437|18916430|P2|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
7680718|NCT01932437|18916431|P1|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
7680719|NCT01932437|18916426|P6|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
7680720|NCT01932437|18916427|P5|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
7680721|NCT01932437|18916428|P4|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
7680722|NCT01932437|18916429|P3|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
7680723|NCT01932437|18916430|P2|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
7680724|NCT01932437|18916431|P1|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
7680725|NCT01932437|18916426|P6|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
7680726|NCT01932437|18916427|P5|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
7680727|NCT01932437|18916428|P4|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
7680728|NCT01932437|18916429|P3|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
7680729|NCT01932437|18916430|P2|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
7680730|NCT01932437|18916431|P1|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
7680731|NCT01932437|18916426|P6|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
7680732|NCT01932437|18916427|P5|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
7680733|NCT01932437|18916428|P4|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
7680734|NCT01932437|18916429|P3|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
7680735|NCT01932437|18916430|P2|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
7680736|NCT01932437|18916431|P1|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
7680737|NCT01932437|18916426|P6|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
7680738|NCT01932437|18916427|P5|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
7680739|NCT01932437|18916428|P4|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
7680740|NCT01932437|18916429|P3|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
7680741|NCT01932437|18916430|P2|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
7680742|NCT01932437|18916431|P1|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
7680743|NCT01932437|18916426|P6|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
7680744|NCT01932437|18916427|P5|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
7680745|NCT01932437|18916428|P4|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
7680746|NCT01932437|18916429|P3|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
7680747|NCT01932437|18916430|P2|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
7680748|NCT01932437|18916431|P1|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
7680749|NCT01932437|18916426|P6|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
7680750|NCT01932437|18916427|P5|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
7680751|NCT01932437|18916428|P4|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
7680752|NCT01932437|18916429|P3|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
7680753|NCT01932437|18916430|P2|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
7680754|NCT01932437|18916431|P1|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
7680755|NCT01932294|18916481|P1|NOT COMPLETED|Overall Study||99
7680756|NCT01932294|18916481|P1|COMPLETED|Overall Study||72
7680757|NCT01932294|18916481|P1|STARTED|Overall Study||171
7680758|NCT01932242|18916489|P2|NOT COMPLETED|Overall Study||5
7680759|NCT01932242|18916490|P1|NOT COMPLETED|Overall Study||5
7680760|NCT01932242|18916489|P2|COMPLETED|Overall Study||30
7680761|NCT01932242|18916490|P1|COMPLETED|Overall Study||30
7680762|NCT01932242|18916489|P2|STARTED|Overall Study||35
7680763|NCT01932242|18916490|P1|STARTED|Overall Study||35
7680764|NCT01932164|18916534|P1|NOT COMPLETED|Overall Study||0
7680765|NCT01932164|18916534|P1|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5
7680766|NCT01932164|18916534|P1|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5
7680767|NCT01932164|18916534|P1|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5
7680768|NCT01932164|18916534|P1|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5
7680769|NCT01932164|18916534|P1|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5
7680770|NCT01932164|18916534|P1|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5
7680771|NCT01932164|18916534|P1|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5
7680772|NCT01932112|18916539|P1|NOT COMPLETED|Overall Study||0
7680773|NCT01932112|18916539|P1|COMPLETED|Overall Study||378
7680774|NCT01932112|18916539|P1|STARTED|Overall Study||378
7680775|NCT01932060|18916545|P2|NOT COMPLETED|Overall Study||0
7680776|NCT01932060|18916546|P1|NOT COMPLETED|Overall Study||0
7680777|NCT01932060|18916545|P2|COMPLETED|Overall Study||24
7680778|NCT01932060|18916546|P1|COMPLETED|Overall Study||27
7680779|NCT01932060|18916545|P2|STARTED|Overall Study||24
7680780|NCT01932060|18916546|P1|STARTED|Overall Study||27
7680781|NCT01931956|18916558|P4|NOT COMPLETED|Overall Study||133
7680782|NCT01931956|18916559|P3|NOT COMPLETED|Overall Study||487
7680783|NCT01931956|18916560|P2|NOT COMPLETED|Overall Study||7
7680784|NCT01931956|18916561|P1|NOT COMPLETED|Overall Study||51
7680785|NCT01931956|18916558|P4|COMPLETED|Overall Study||138
7680786|NCT01931956|18916559|P3|COMPLETED|Overall Study||141
7680787|NCT01931956|18916560|P2|COMPLETED|Overall Study||0
7680788|NCT01931956|18916561|P1|COMPLETED|Overall Study||8
7680789|NCT01931956|18916558|P4|STARTED|Overall Study||271
7680790|NCT01931956|18916559|P3|STARTED|Overall Study||628
7680791|NCT01931956|18916560|P2|STARTED|Overall Study||7
7680792|NCT01931956|18916561|P1|STARTED|Overall Study||59
7680793|NCT01931878|18916917|P2|NOT COMPLETED|Second Intervention (After 3 Months)||2
7680794|NCT01931878|18916918|P1|NOT COMPLETED|Second Intervention (After 3 Months)||0
7680795|NCT01931878|18916917|P2|COMPLETED|Second Intervention (After 3 Months)||12
7680796|NCT01931878|18916918|P1|COMPLETED|Second Intervention (After 3 Months)||9
7680797|NCT01931878|18916917|P2|STARTED|Second Intervention (After 3 Months)||14
7680798|NCT01931878|18916918|P1|STARTED|Second Intervention (After 3 Months)||9
7680799|NCT01931878|18916917|P2|NOT COMPLETED|First Intervention||0
7680800|NCT01931878|18916918|P1|NOT COMPLETED|First Intervention||1
7680801|NCT01931878|18916917|P2|COMPLETED|First Intervention||14
7680802|NCT01931878|18916918|P1|COMPLETED|First Intervention||9
7680803|NCT01931878|18916917|P2|STARTED|First Intervention||14
7680804|NCT01931878|18916918|P1|STARTED|First Intervention||10
7680805|NCT01931865|18916928|P1|NOT COMPLETED|Overall Study||4
7680806|NCT01931865|18916928|P1|COMPLETED|Overall Study||8
7680807|NCT01931865|18916928|P1|STARTED|Overall Study||12
7680808|NCT01931839|18916941|P7|NOT COMPLETED|Overall Study||4
7680809|NCT01931839|18916942|P6|NOT COMPLETED|Overall Study||5
7680810|NCT01931839|18916943|P5|NOT COMPLETED|Overall Study||1
7680811|NCT01931839|18916944|P4|NOT COMPLETED|Overall Study||14
7680812|NCT01931839|18916945|P3|NOT COMPLETED|Overall Study||39
7680813|NCT01931839|18916946|P2|NOT COMPLETED|Overall Study||26
7680814|NCT01931839|18916947|P1|NOT COMPLETED|Overall Study||41
7680815|NCT01931839|18916941|P7|COMPLETED|Overall Study||56
7680816|NCT01931839|18916942|P6|COMPLETED|Overall Study||50
7680817|NCT01931839|18916943|P5|COMPLETED|Overall Study||18
7680818|NCT01931839|18916944|P4|COMPLETED|Overall Study||162
7680819|NCT01931839|18916945|P3|COMPLETED|Overall Study||301
7680820|NCT01931839|18916946|P2|COMPLETED|Overall Study||152
7680821|NCT01931839|18916947|P1|COMPLETED|Overall Study||294
7680822|NCT01931839|18916941|P7|Safety Analysis Set (As Dosed)|Overall Study||60
7680905|NCT01931566|18917174|P1|STARTED|Overall Study||433
7680823|NCT01931839|18916942|P6|Safety Analysis Set (As Dosed)|Overall Study||55
7680824|NCT01931839|18916943|P5|Safety Analysis Set (As Dosed)|Overall Study||19
7680825|NCT01931839|18916944|P4|Safety Analysis Set (As Dosed)|Overall Study||176
7680826|NCT01931839|18916945|P3|Safety Analysis Set (As Dosed)|Overall Study||340
7680827|NCT01931839|18916946|P2|Safety Analysis Set (As Dosed)|Overall Study||178
7680828|NCT01931839|18916947|P1|Safety Analysis Set (As Dosed)|Overall Study||335
7680829|NCT01931839|18916941|P7|Full Analysis Set (As Randomized)|Overall Study||60
7680830|NCT01931839|18916942|P6|Full Analysis Set (As Randomized)|Overall Study||55
7680831|NCT01931839|18916943|P5|Full Analysis Set (As Randomized)|Overall Study||19
7680832|NCT01931839|18916944|P4|Full Analysis Set (As Randomized)|Overall Study||176
7680833|NCT01931839|18916945|P3|Full Analysis Set (As Randomized)|Overall Study||340
7680834|NCT01931839|18916946|P2|Full Analysis Set (As Randomized)|Overall Study||179
7680835|NCT01931839|18916947|P1|Full Analysis Set (As Randomized)|Overall Study||334
7680836|NCT01931839|18916941|P7|STARTED|Overall Study||60
7680837|NCT01931839|18916942|P6|STARTED|Overall Study||55
7680838|NCT01931839|18916943|P5|STARTED|Overall Study||19
7680839|NCT01931839|18916944|P4|STARTED|Overall Study||176
7680840|NCT01931839|18916945|P3|STARTED|Overall Study||340
7680841|NCT01931839|18916946|P2|STARTED|Overall Study||178
7680842|NCT01931839|18916947|P1|STARTED|Overall Study||335
7680843|NCT01931735|18917019|P4|NOT COMPLETED|Observational Non-Randomized Phase||2
7680844|NCT01931735|18917020|P3|NOT COMPLETED|Observational Non-Randomized Phase||0
7680845|NCT01931735|18917021|P2|NOT COMPLETED|Observational Non-Randomized Phase||0
7680846|NCT01931735|18917022|P1|NOT COMPLETED|Observational Non-Randomized Phase||0
7680847|NCT01931735|18917019|P4|COMPLETED|Observational Non-Randomized Phase||9
7680848|NCT01931735|18917020|P3|COMPLETED|Observational Non-Randomized Phase||0
7680849|NCT01931735|18917021|P2|COMPLETED|Observational Non-Randomized Phase||1
7680850|NCT01931735|18917022|P1|COMPLETED|Observational Non-Randomized Phase||2
7680851|NCT01931735|18917019|P4|STARTED|Observational Non-Randomized Phase|Participants recruited post-amendment|11
7680852|NCT01931735|18917020|P3|STARTED|Observational Non-Randomized Phase||0
7680853|NCT01931735|18917021|P2|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|1
7680854|NCT01931735|18917022|P1|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|2
7680855|NCT01931735|18917019|P4|NOT COMPLETED|Randomized Phase||0
7680856|NCT01931735|18917020|P3|NOT COMPLETED|Randomized Phase||5
7680857|NCT01931735|18917021|P2|NOT COMPLETED|Randomized Phase||2
7680858|NCT01931735|18917022|P1|NOT COMPLETED|Randomized Phase||2
7680859|NCT01931735|18917019|P4|COMPLETED|Randomized Phase||0
7680860|NCT01931735|18917020|P3|COMPLETED|Randomized Phase||4
7680861|NCT01931735|18917021|P2|COMPLETED|Randomized Phase||1
7680862|NCT01931735|18917022|P1|COMPLETED|Randomized Phase||2
7680863|NCT01931735|18917019|P4|STARTED|Randomized Phase||0
7680864|NCT01931735|18917020|P3|STARTED|Randomized Phase||9
7680865|NCT01931735|18917021|P2|STARTED|Randomized Phase||3
7680866|NCT01931735|18917022|P1|STARTED|Randomized Phase||4
7680867|NCT01931709|18917056|P1|NOT COMPLETED|Overall Study||0
7680868|NCT01931709|18917056|P1|COMPLETED|Overall Study||35
7680869|NCT01931709|18917056|P1|STARTED|Overall Study||35
7680870|NCT01931670|18917069|P3|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||21
7680871|NCT01931670|18917070|P2|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||12
7680872|NCT01931670|18917071|P1|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||19
7680873|NCT01931670|18917069|P3|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||33
7680874|NCT01931670|18917070|P2|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||28
7680875|NCT01931670|18917071|P1|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||42
7680876|NCT01931670|18917069|P3|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||15
7680877|NCT01931670|18917070|P2|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||4
7680878|NCT01931670|18917071|P1|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||0
7680879|NCT01931670|18917069|P3|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||18
7680880|NCT01931670|18917070|P2|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||24
7680881|NCT01931670|18917071|P1|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||42
7680882|NCT01931670|18917069|P3|STARTED|Post-Treatment Follow-Up (PTFU) Period||54
7680883|NCT01931670|18917070|P2|STARTED|Post-Treatment Follow-Up (PTFU) Period||40
7680884|NCT01931670|18917071|P1|STARTED|Post-Treatment Follow-Up (PTFU) Period||61
7680885|NCT01931670|18917069|P3|NOT COMPLETED|Treatment Period||45
7680886|NCT01931670|18917070|P2|NOT COMPLETED|Treatment Period||48
7680887|NCT01931670|18917071|P1|NOT COMPLETED|Treatment Period||90
7680888|NCT01931670|18917069|P3|COMPLETED|Treatment Period||184
7680889|NCT01931670|18917070|P2|COMPLETED|Treatment Period||178
7680890|NCT01931670|18917071|P1|COMPLETED|Treatment Period||270
7680891|NCT01931670|18917069|P3|STARTED|Treatment Period||229
7680892|NCT01931670|18917070|P2|STARTED|Treatment Period||226
7680893|NCT01931670|18917071|P1|STARTED|Treatment Period||360
7680894|NCT01931566|18917172|P3|NOT COMPLETED|Overall Study||1506
7680895|NCT01931566|18917173|P2|NOT COMPLETED|Overall Study||1476
7680896|NCT01931566|18917174|P1|NOT COMPLETED|Overall Study||429
7680897|NCT01931566|18917172|P3|COMPLETED|Overall Study||39
7680898|NCT01931566|18917173|P2|COMPLETED|Overall Study||40
7680899|NCT01931566|18917174|P1|COMPLETED|Overall Study||4
7680900|NCT01931566|18917172|P3|Treated|Overall Study||1531
7680901|NCT01931566|18917173|P2|Treated|Overall Study||1507
7680902|NCT01931566|18917174|P1|Treated|Overall Study||427
7680903|NCT01931566|18917172|P3|STARTED|Overall Study||1545
7680904|NCT01931566|18917173|P2|STARTED|Overall Study||1516
7680906|NCT01931527|18917189|P2|NOT COMPLETED|Overall Study||0
7680907|NCT01931527|18917190|P1|NOT COMPLETED|Overall Study||0
7680908|NCT01931527|18917189|P2|COMPLETED|Overall Study||15
7680909|NCT01931527|18917190|P1|COMPLETED|Overall Study||16
7680910|NCT01931527|18917189|P2|STARTED|Overall Study||15
7680911|NCT01931527|18917190|P1|STARTED|Overall Study||16
7680912|NCT01931475|18917212|P2|NOT COMPLETED|Period 2: Extension Treatment Phase||19
7680913|NCT01931475|18917213|P1|NOT COMPLETED|Period 2: Extension Treatment Phase||4
7680914|NCT01931475|18917212|P2|COMPLETED|Period 2: Extension Treatment Phase||157
7680915|NCT01931475|18917213|P1|COMPLETED|Period 2: Extension Treatment Phase||162
7680916|NCT01931475|18917212|P2|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175
7680917|NCT01931475|18917213|P1|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166
7680918|NCT01931475|18917212|P2|STARTED|Period 2: Extension Treatment Phase||176
7680919|NCT01931475|18917213|P1|STARTED|Period 2: Extension Treatment Phase||166
7680920|NCT01931475|18917212|P2|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26
7680921|NCT01931475|18917213|P1|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39
7680922|NCT01931475|18917212|P2|COMPLETED|Period 1: Double-Blind Treatment Phase||176
7680923|NCT01931475|18917213|P1|COMPLETED|Period 1: Double-Blind Treatment Phase||166
7680924|NCT01931475|18917212|P2|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198
7680925|NCT01931475|18917213|P1|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199
7680926|NCT01931475|18917212|P2|STARTED|Period 1: Double-Blind Treatment Phase||202
7680927|NCT01931475|18917213|P1|STARTED|Period 1: Double-Blind Treatment Phase||205
7680928|NCT01931462|18917240|P1|NOT COMPLETED|Overall Study||1
7680929|NCT01931462|18917240|P1|COMPLETED|Overall Study||1
7680930|NCT01931462|18917240|P1|STARTED|Overall Study||2
7680931|NCT01931397|18917251|P1|NOT COMPLETED|Overall Study||11
7680932|NCT01931397|18917251|P1|COMPLETED|Overall Study||19
7680933|NCT01931397|18917251|P1|STARTED|Overall Study||30
7680934|NCT01931202|18917263|P3|NOT COMPLETED|Overall Study||4
7680935|NCT01931202|18917264|P2|NOT COMPLETED|Overall Study||5
7680936|NCT01931202|18917265|P1|NOT COMPLETED|Overall Study||0
7680937|NCT01931202|18917263|P3|COMPLETED|Overall Study||45
7680938|NCT01931202|18917264|P2|COMPLETED|Overall Study||46
7680939|NCT01931202|18917265|P1|COMPLETED|Overall Study||8
7680940|NCT01931202|18917263|P3|STARTED|Overall Study||49
7680941|NCT01931202|18917264|P2|STARTED|Overall Study||51
7680942|NCT01931202|18917265|P1|STARTED|Overall Study||8
7680943|NCT01931150|18917311|P2|NOT COMPLETED|Overall Study||2
7680944|NCT01931150|18917312|P1|NOT COMPLETED|Overall Study||1
7680945|NCT01931150|18917311|P2|COMPLETED|Overall Study||4
7680946|NCT01931150|18917312|P1|COMPLETED|Overall Study||4
7680947|NCT01931150|18917311|P2|STARTED|Overall Study||6
7680948|NCT01931150|18917312|P1|STARTED|Overall Study||5
7680949|NCT01931098|18917320|P2|NOT COMPLETED|Overall Study||4
7680950|NCT01931098|18917321|P1|NOT COMPLETED|Overall Study||0
7680951|NCT01931098|18917320|P2|COMPLETED|Overall Study||22
7680952|NCT01931098|18917321|P1|COMPLETED|Overall Study||9
7680953|NCT01931098|18917320|P2|STARTED|Overall Study||26
7680954|NCT01931098|18917321|P1|STARTED|Overall Study||9
7680955|NCT01931059|18917337|P2|NOT COMPLETED|Day3||0
7680956|NCT01931059|18917338|P1|NOT COMPLETED|Day3||1
7680957|NCT01931059|18917337|P2|COMPLETED|Day3||4
7680958|NCT01931059|18917338|P1|COMPLETED|Day3||5
7680959|NCT01931059|18917337|P2|STARTED|Day3||4
7680960|NCT01931059|18917338|P1|STARTED|Day3||6
7680961|NCT01931059|18917337|P2|NOT COMPLETED|Day2||0
7680962|NCT01931059|18917338|P1|NOT COMPLETED|Day2||0
7680963|NCT01931059|18917337|P2|COMPLETED|Day2||4
7680964|NCT01931059|18917338|P1|COMPLETED|Day2||6
7680965|NCT01931059|18917337|P2|STARTED|Day2||4
7680966|NCT01931059|18917338|P1|STARTED|Day2||6
7680967|NCT01931059|18917337|P2|NOT COMPLETED|Day 1||1
7680968|NCT01931059|18917338|P1|NOT COMPLETED|Day 1||0
7680969|NCT01931059|18917337|P2|COMPLETED|Day 1||4
7680970|NCT01931059|18917338|P1|COMPLETED|Day 1||6
7680971|NCT01931059|18917337|P2|STARTED|Day 1||5
7680972|NCT01931059|18917338|P1|STARTED|Day 1||6
7680973|NCT01930890|18917354|P4|NOT COMPLETED|Overall Study||27
7680974|NCT01930890|18917355|P3|NOT COMPLETED|Overall Study||13
7680975|NCT01930890|18917356|P2|NOT COMPLETED|Overall Study||33
7680976|NCT01930890|18917357|P1|NOT COMPLETED|Overall Study||14
7680977|NCT01930890|18917354|P4|COMPLETED|Overall Study||0
7680978|NCT01930890|18917355|P3|COMPLETED|Overall Study||0
7680979|NCT01930890|18917356|P2|COMPLETED|Overall Study||0
7680980|NCT01930890|18917357|P1|COMPLETED|Overall Study||0
7680981|NCT01930890|18917354|P4|STARTED|Overall Study||27
7680982|NCT01930890|18917355|P3|STARTED|Overall Study||13
7680983|NCT01930890|18917356|P2|STARTED|Overall Study||33
7680984|NCT01930890|18917357|P1|STARTED|Overall Study||14
7680985|NCT01930799|18917371|P1|NOT COMPLETED|Overall Study||8
7680986|NCT01930799|18917371|P1|COMPLETED|Overall Study||112
7680987|NCT01930799|18917371|P1|STARTED|Overall Study||120
7680988|NCT01930747|18917379|P3|NOT COMPLETED|Overall Study||0
7680989|NCT01930747|18917380|P2|NOT COMPLETED|Overall Study||0
7680990|NCT01930747|18917381|P1|NOT COMPLETED|Overall Study||0
7680991|NCT01930747|18917379|P3|COMPLETED|Overall Study||12
7680992|NCT01930747|18917380|P2|COMPLETED|Overall Study||14
7680993|NCT01930747|18917381|P1|COMPLETED|Overall Study||16
7680994|NCT01930747|18917379|P3|STARTED|Overall Study||12
7680995|NCT01930747|18917380|P2|STARTED|Overall Study||14
7680996|NCT01930747|18917381|P1|STARTED|Overall Study||16
7680997|NCT01930643|18917397|P2|NOT COMPLETED|Overall Study||0
7680998|NCT01930643|18917398|P1|NOT COMPLETED|Overall Study||0
7680999|NCT01930643|18917397|P2|COMPLETED|Overall Study||6
7681000|NCT01930643|18917398|P1|COMPLETED|Overall Study||7
7681001|NCT01930643|18917397|P2|STARTED|Overall Study||6
7681002|NCT01930643|18917398|P1|STARTED|Overall Study||7
7681003|NCT01930487|18917404|P2|NOT COMPLETED|Second Intervention (30 Days)||0
7681004|NCT01930487|18917405|P1|NOT COMPLETED|Second Intervention (30 Days)||0
7681005|NCT01930487|18917404|P2|COMPLETED|Second Intervention (30 Days)||23
7681006|NCT01930487|18917405|P1|COMPLETED|Second Intervention (30 Days)||19
7681007|NCT01930487|18917404|P2|STARTED|Second Intervention (30 Days)||23
7681008|NCT01930487|18917405|P1|STARTED|Second Intervention (30 Days)||19
7681009|NCT01930487|18917404|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
7681010|NCT01930487|18917405|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
7681011|NCT01930487|18917404|P2|COMPLETED|Washout Period (3 Weeks)||23
7681012|NCT01930487|18917405|P1|COMPLETED|Washout Period (3 Weeks)||19
7681013|NCT01930487|18917404|P2|STARTED|Washout Period (3 Weeks)||23
7681014|NCT01930487|18917405|P1|STARTED|Washout Period (3 Weeks)||19
7681015|NCT01930487|18917404|P2|NOT COMPLETED|First Intervention (30 Days)||2
7681016|NCT01930487|18917405|P1|NOT COMPLETED|First Intervention (30 Days)||2
7681017|NCT01930487|18917404|P2|COMPLETED|First Intervention (30 Days)||23
7681018|NCT01930487|18917405|P1|COMPLETED|First Intervention (30 Days)||19
7681019|NCT01930487|18917404|P2|STARTED|First Intervention (30 Days)||25
7681020|NCT01930487|18917405|P1|STARTED|First Intervention (30 Days)||21
7681021|NCT01930435|18917499|P1|NOT COMPLETED|Overall Study||0
7681022|NCT01930435|18917499|P1|COMPLETED|Overall Study||20
7681023|NCT01930435|18917499|P1|STARTED|Overall Study||20
7681024|NCT01930214|18917510|P3|NOT COMPLETED|Overall Study||25
7681025|NCT01930214|18917511|P2|NOT COMPLETED|Overall Study||21
7681026|NCT01930214|18917512|P1|NOT COMPLETED|Overall Study||20
7681027|NCT01930214|18917510|P3|COMPLETED|Overall Study||108
7681028|NCT01930214|18917511|P2|COMPLETED|Overall Study||96
7681029|NCT01930214|18917512|P1|COMPLETED|Overall Study||80
7681030|NCT01930214|18917510|P3|STARTED|Overall Study||133
7681031|NCT01930214|18917511|P2|STARTED|Overall Study||117
7681032|NCT01930214|18917512|P1|STARTED|Overall Study||100
7681033|NCT01930188|18917532|P3|NOT COMPLETED|Overall Study||19
7681034|NCT01930188|18917533|P2|NOT COMPLETED|Overall Study||21
7681035|NCT01930188|18917534|P1|NOT COMPLETED|Overall Study||22
7681036|NCT01930188|18917532|P3|COMPLETED|Overall Study||388
7681037|NCT01930188|18917533|P2|COMPLETED|Overall Study||388
7681038|NCT01930188|18917534|P1|COMPLETED|Overall Study||387
7681039|NCT01930188|18917532|P3|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|32
7681040|NCT01930188|18917533|P2|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|61
7681041|NCT01930188|18917534|P1|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|53
7681042|NCT01930188|18917532|P3|STARTED|Overall Study||407
7681043|NCT01930188|18917533|P2|STARTED|Overall Study||409
7681044|NCT01930188|18917534|P1|STARTED|Overall Study||409
7681045|NCT01930175|18917561|P3|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
7681046|NCT01930175|18917562|P2|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
7681047|NCT01930175|18917563|P1|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
7681048|NCT01930175|18917561|P3|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||3
7681049|NCT01930175|18917562|P2|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
7681050|NCT01930175|18917563|P1|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
7681051|NCT01930175|18917561|P3|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|3
7681052|NCT01930175|18917562|P2|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
7681053|NCT01930175|18917563|P1|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
7681054|NCT01930175|18917561|P3|NOT COMPLETED|Core Study||1
7681055|NCT01930175|18917562|P2|NOT COMPLETED|Core Study||1
7681056|NCT01930175|18917563|P1|NOT COMPLETED|Core Study||0
7681057|NCT01930175|18917561|P3|COMPLETED|Core Study||3
7681058|NCT01930175|18917562|P2|COMPLETED|Core Study||1
7681059|NCT01930175|18917563|P1|COMPLETED|Core Study||7
7681060|NCT01930175|18917561|P3|Pharmacokinetics (PK) Analysis Set|Core Study|Placebo patients were excluded from the PK analyses|0
7681061|NCT01930175|18917562|P2|Pharmacokinetics (PK) Analysis Set|Core Study||2
7681062|NCT01930175|18917563|P1|Pharmacokinetics (PK) Analysis Set|Core Study||7
7681063|NCT01930175|18917561|P3|Safety Analysis Set|Core Study||4
7681064|NCT01930175|18917562|P2|Safety Analysis Set|Core Study||2
7681065|NCT01930175|18917563|P1|Safety Analysis Set|Core Study||7
7681066|NCT01930175|18917561|P3|STARTED|Core Study||4
7681067|NCT01930175|18917562|P2|STARTED|Core Study||2
7681068|NCT01930175|18917563|P1|STARTED|Core Study||7
7681069|NCT01930162|18917593|P1|NOT COMPLETED|Overall Study||5
7681070|NCT01930162|18917593|P1|COMPLETED|Overall Study||4
7681071|NCT01930162|18917593|P1|STARTED|Overall Study||9
7681072|NCT01930058|18917605|P3|NOT COMPLETED|Overall Study||0
7681073|NCT01930058|18917606|P2|NOT COMPLETED|Overall Study||0
7681074|NCT01930058|18917607|P1|NOT COMPLETED|Overall Study||0
7681075|NCT01930058|18917605|P3|COMPLETED|Overall Study||3
7681076|NCT01930058|18917606|P2|COMPLETED|Overall Study||3
7681077|NCT01930058|18917607|P1|COMPLETED|Overall Study||3
7681078|NCT01930058|18917605|P3|STARTED|Overall Study||3
7681079|NCT01930058|18917606|P2|STARTED|Overall Study||3
7681080|NCT01930058|18917607|P1|STARTED|Overall Study||3
7681081|NCT01930045|18917629|P6|NOT COMPLETED|Part 2 - Period 5||0
7681082|NCT01930045|18917630|P5|NOT COMPLETED|Part 2 - Period 5||0
7681083|NCT01930045|18917631|P4|NOT COMPLETED|Part 2 - Period 5||0
7681084|NCT01930045|18917632|P3|NOT COMPLETED|Part 2 - Period 5||0
7681085|NCT01930045|18917633|P2|NOT COMPLETED|Part 2 - Period 5||0
7681086|NCT01930045|18917634|P1|NOT COMPLETED|Part 2 - Period 5||0
7681087|NCT01930045|18917629|P6|COMPLETED|Part 2 - Period 5||1
7681088|NCT01930045|18917630|P5|COMPLETED|Part 2 - Period 5||3
7681089|NCT01930045|18917631|P4|COMPLETED|Part 2 - Period 5||3
7681090|NCT01930045|18917632|P3|COMPLETED|Part 2 - Period 5||3
7681091|NCT01930045|18917633|P2|COMPLETED|Part 2 - Period 5||3
7681092|NCT01930045|18917634|P1|COMPLETED|Part 2 - Period 5||3
7681093|NCT01930045|18917629|P6|STARTED|Part 2 - Period 5||1
7681094|NCT01930045|18917630|P5|STARTED|Part 2 - Period 5||3
7681095|NCT01930045|18917631|P4|STARTED|Part 2 - Period 5||3
7681096|NCT01930045|18917632|P3|STARTED|Part 2 - Period 5||3
7681097|NCT01930045|18917633|P2|STARTED|Part 2 - Period 5||3
7681098|NCT01930045|18917634|P1|STARTED|Part 2 - Period 5||3
7681099|NCT01930045|18917629|P6|NOT COMPLETED|Part 2 - Period 4||0
7681100|NCT01930045|18917630|P5|NOT COMPLETED|Part 2 - Period 4||0
7681101|NCT01930045|18917631|P4|NOT COMPLETED|Part 2 - Period 4||0
7681102|NCT01930045|18917632|P3|NOT COMPLETED|Part 2 - Period 4||0
7681103|NCT01930045|18917633|P2|NOT COMPLETED|Part 2 - Period 4||0
7681104|NCT01930045|18917634|P1|NOT COMPLETED|Part 2 - Period 4||0
7681105|NCT01930045|18917629|P6|COMPLETED|Part 2 - Period 4||1
7681106|NCT01930045|18917630|P5|COMPLETED|Part 2 - Period 4||3
7681107|NCT01930045|18917631|P4|COMPLETED|Part 2 - Period 4||3
7681108|NCT01930045|18917632|P3|COMPLETED|Part 2 - Period 4||3
7681109|NCT01930045|18917633|P2|COMPLETED|Part 2 - Period 4||3
7681110|NCT01930045|18917634|P1|COMPLETED|Part 2 - Period 4||3
7681111|NCT01930045|18917629|P6|STARTED|Part 2 - Period 4||1
7681112|NCT01930045|18917630|P5|STARTED|Part 2 - Period 4||3
7681113|NCT01930045|18917631|P4|STARTED|Part 2 - Period 4||3
7681114|NCT01930045|18917632|P3|STARTED|Part 2 - Period 4||3
7681115|NCT01930045|18917633|P2|STARTED|Part 2 - Period 4||3
7681116|NCT01930045|18917634|P1|STARTED|Part 2 - Period 4||3
7681117|NCT01930045|18917629|P6|NOT COMPLETED|Pause (up to 37 Days)||2
7681118|NCT01930045|18917630|P5|NOT COMPLETED|Pause (up to 37 Days)||0
7681119|NCT01930045|18917631|P4|NOT COMPLETED|Pause (up to 37 Days)||0
7681120|NCT01930045|18917632|P3|NOT COMPLETED|Pause (up to 37 Days)||0
7681121|NCT01930045|18917633|P2|NOT COMPLETED|Pause (up to 37 Days)||0
7681122|NCT01930045|18917634|P1|NOT COMPLETED|Pause (up to 37 Days)||0
7681123|NCT01930045|18917629|P6|COMPLETED|Pause (up to 37 Days)||1
7681124|NCT01930045|18917630|P5|COMPLETED|Pause (up to 37 Days)||3
7681125|NCT01930045|18917631|P4|COMPLETED|Pause (up to 37 Days)||3
7681126|NCT01930045|18917632|P3|COMPLETED|Pause (up to 37 Days)||3
7681127|NCT01930045|18917633|P2|COMPLETED|Pause (up to 37 Days)||3
7681128|NCT01930045|18917634|P1|COMPLETED|Pause (up to 37 Days)||3
7681129|NCT01930045|18917629|P6|STARTED|Pause (up to 37 Days)||3
7681130|NCT01930045|18917630|P5|STARTED|Pause (up to 37 Days)||3
7681131|NCT01930045|18917631|P4|STARTED|Pause (up to 37 Days)||3
7681132|NCT01930045|18917632|P3|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3
7681133|NCT01930045|18917633|P2|STARTED|Pause (up to 37 Days)||3
7681134|NCT01930045|18917634|P1|STARTED|Pause (up to 37 Days)||3
7681135|NCT01930045|18917629|P6|NOT COMPLETED|Part 1 - Period 3||0
7681136|NCT01930045|18917630|P5|NOT COMPLETED|Part 1 - Period 3||0
7681137|NCT01930045|18917631|P4|NOT COMPLETED|Part 1 - Period 3||0
7681138|NCT01930045|18917632|P3|NOT COMPLETED|Part 1 - Period 3||0
7681139|NCT01930045|18917633|P2|NOT COMPLETED|Part 1 - Period 3||0
7681140|NCT01930045|18917634|P1|NOT COMPLETED|Part 1 - Period 3||0
7681141|NCT01930045|18917629|P6|COMPLETED|Part 1 - Period 3||3
7681142|NCT01930045|18917630|P5|COMPLETED|Part 1 - Period 3||3
7681143|NCT01930045|18917631|P4|COMPLETED|Part 1 - Period 3||3
7681144|NCT01930045|18917632|P3|COMPLETED|Part 1 - Period 3||2
7681145|NCT01930045|18917633|P2|COMPLETED|Part 1 - Period 3||3
7681146|NCT01930045|18917634|P1|COMPLETED|Part 1 - Period 3||3
7681147|NCT01930045|18917629|P6|STARTED|Part 1 - Period 3||3
7681148|NCT01930045|18917630|P5|STARTED|Part 1 - Period 3||3
7681149|NCT01930045|18917631|P4|STARTED|Part 1 - Period 3||3
7681150|NCT01930045|18917632|P3|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2
7681151|NCT01930045|18917633|P2|STARTED|Part 1 - Period 3||3
7681152|NCT01930045|18917634|P1|STARTED|Part 1 - Period 3||3
7681153|NCT01930045|18917629|P6|NOT COMPLETED|Part 1 - Period 2||0
7681154|NCT01930045|18917630|P5|NOT COMPLETED|Part 1 - Period 2||0
7681155|NCT01930045|18917631|P4|NOT COMPLETED|Part 1 - Period 2||0
7681156|NCT01930045|18917632|P3|NOT COMPLETED|Part 1 - Period 2||0
7681157|NCT01930045|18917633|P2|NOT COMPLETED|Part 1 - Period 2||0
7681158|NCT01930045|18917634|P1|NOT COMPLETED|Part 1 - Period 2||0
7681159|NCT01930045|18917629|P6|COMPLETED|Part 1 - Period 2||3
7681160|NCT01930045|18917630|P5|COMPLETED|Part 1 - Period 2||3
7681161|NCT01930045|18917631|P4|COMPLETED|Part 1 - Period 2||3
7681162|NCT01930045|18917632|P3|COMPLETED|Part 1 - Period 2||3
7681163|NCT01930045|18917633|P2|COMPLETED|Part 1 - Period 2||3
7681164|NCT01930045|18917634|P1|COMPLETED|Part 1 - Period 2||3
7681165|NCT01930045|18917629|P6|STARTED|Part 1 - Period 2||3
7681166|NCT01930045|18917630|P5|STARTED|Part 1 - Period 2||3
7681167|NCT01930045|18917631|P4|STARTED|Part 1 - Period 2||3
7681168|NCT01930045|18917632|P3|STARTED|Part 1 - Period 2||3
7681169|NCT01930045|18917633|P2|STARTED|Part 1 - Period 2||3
7681170|NCT01930045|18917634|P1|STARTED|Part 1 - Period 2||3
7681171|NCT01930045|18917629|P6|NOT COMPLETED|Part 1 - Period 1||0
7681172|NCT01930045|18917630|P5|NOT COMPLETED|Part 1 - Period 1||0
7681173|NCT01930045|18917631|P4|NOT COMPLETED|Part 1 - Period 1||0
7681174|NCT01930045|18917632|P3|NOT COMPLETED|Part 1 - Period 1||0
7681175|NCT01930045|18917633|P2|NOT COMPLETED|Part 1 - Period 1||0
7681176|NCT01930045|18917634|P1|NOT COMPLETED|Part 1 - Period 1||0
7681177|NCT01930045|18917629|P6|COMPLETED|Part 1 - Period 1||3
7681178|NCT01930045|18917630|P5|COMPLETED|Part 1 - Period 1||3
7681179|NCT01930045|18917631|P4|COMPLETED|Part 1 - Period 1||3
7681180|NCT01930045|18917632|P3|COMPLETED|Part 1 - Period 1||3
7681181|NCT01930045|18917633|P2|COMPLETED|Part 1 - Period 1||3
7681182|NCT01930045|18917634|P1|COMPLETED|Part 1 - Period 1||3
7681183|NCT01930045|18917629|P6|STARTED|Part 1 - Period 1||3
7681184|NCT01930045|18917630|P5|STARTED|Part 1 - Period 1||3
7681185|NCT01930045|18917631|P4|STARTED|Part 1 - Period 1||3
7681186|NCT01930045|18917632|P3|STARTED|Part 1 - Period 1||3
7681187|NCT01930045|18917633|P2|STARTED|Part 1 - Period 1||3
7681188|NCT01930045|18917634|P1|STARTED|Part 1 - Period 1||3
7681189|NCT01929993|18917661|P2|NOT COMPLETED|Overall Study||28
7681190|NCT01929993|18917662|P1|NOT COMPLETED|Overall Study||30
7681191|NCT01929993|18917661|P2|COMPLETED|Overall Study||54
7681192|NCT01929993|18917662|P1|COMPLETED|Overall Study||52
7681193|NCT01929993|18917661|P2|STARTED|Overall Study||82
7681194|NCT01929993|18917662|P1|STARTED|Overall Study||82
7681195|NCT01929980|18917668|P1|NOT COMPLETED|Overall Study||1
7681196|NCT01929980|18917668|P1|COMPLETED|Overall Study||3
7681197|NCT01929980|18917668|P1|STARTED|Overall Study||4
7681198|NCT01929889|18917672|P1|NOT COMPLETED|Overall Study||5
7681199|NCT01929889|18917672|P1|COMPLETED|Overall Study|3 subjects completed the study.|3
7681200|NCT01929889|18917672|P1|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8
7681201|NCT01929876|18917676|P1|NOT COMPLETED|Period 2||1
7681202|NCT01929876|18917676|P1|COMPLETED|Period 2||15
7681203|NCT01929876|18917676|P1|STARTED|Period 2||16
7681204|NCT01929876|18917676|P1|NOT COMPLETED|Period 1||0
7681205|NCT01929876|18917676|P1|COMPLETED|Period 1||16
7681206|NCT01929876|18917676|P1|STARTED|Period 1||16
7681207|NCT01929863|18917689|P2|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
7681208|NCT01929863|18917690|P1|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
7681209|NCT01929863|18917689|P2|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
7681210|NCT01929863|18917690|P1|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
7681211|NCT01929863|18917689|P2|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
7681212|NCT01929863|18917690|P1|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
7681213|NCT01929863|18917689|P2|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||1
7681214|NCT01929863|18917690|P1|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||0
7681215|NCT01929863|18917689|P2|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
7681216|NCT01929863|18917690|P1|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
7681217|NCT01929863|18917689|P2|STARTED|Period 3:Intervention Period 2 (7 Days)||7
7681218|NCT01929863|18917690|P1|STARTED|Period 3:Intervention Period 2 (7 Days)||6
7681219|NCT01929863|18917689|P2|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
7681220|NCT01929863|18917690|P1|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
7681221|NCT01929863|18917689|P2|COMPLETED|Period 2:Washout Period (13-15 Days)||7
7681222|NCT01929863|18917690|P1|COMPLETED|Period 2:Washout Period (13-15 Days)||6
7681223|NCT01929863|18917689|P2|STARTED|Period 2:Washout Period (13-15 Days)||7
7681224|NCT01929863|18917690|P1|STARTED|Period 2:Washout Period (13-15 Days)||6
7681225|NCT01929863|18917689|P2|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
7681226|NCT01929863|18917690|P1|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
7681227|NCT01929863|18917689|P2|COMPLETED|Period 1:Intervention Period 1 (7 Days)||7
7681228|NCT01929863|18917690|P1|COMPLETED|Period 1:Intervention Period 1 (7 Days)||6
7681229|NCT01929863|18917689|P2|STARTED|Period 1:Intervention Period 1 (7 Days)||8
7681230|NCT01929863|18917690|P1|STARTED|Period 1:Intervention Period 1 (7 Days)||7
7681231|NCT01929759|18917733|P1|NOT COMPLETED|Overall Study||0
7681232|NCT01929759|18917733|P1|COMPLETED|Overall Study||10
7681233|NCT01929759|18917733|P1|STARTED|Overall Study||10
7681234|NCT01929707|18917745|P8|NOT COMPLETED|Intervention Period 2||0
7681235|NCT01929707|18917746|P7|NOT COMPLETED|Intervention Period 2||0
7681236|NCT01929707|18917747|P6|NOT COMPLETED|Intervention Period 2||2
7681237|NCT01929707|18917748|P5|NOT COMPLETED|Intervention Period 2||0
7681238|NCT01929707|18917749|P4|NOT COMPLETED|Intervention Period 2||0
7681239|NCT01929707|18917750|P3|NOT COMPLETED|Intervention Period 2||0
7681240|NCT01929707|18917751|P2|NOT COMPLETED|Intervention Period 2||0
7681241|NCT01929707|18917752|P1|NOT COMPLETED|Intervention Period 2||0
7681242|NCT01929707|18917745|P8|COMPLETED|Intervention Period 2||4
7681243|NCT01929707|18917746|P7|COMPLETED|Intervention Period 2||12
7681244|NCT01929707|18917747|P6|COMPLETED|Intervention Period 2||6
7681245|NCT01929707|18917748|P5|COMPLETED|Intervention Period 2||6
7681246|NCT01929707|18917749|P4|COMPLETED|Intervention Period 2||5
7681247|NCT01929707|18917750|P3|COMPLETED|Intervention Period 2||0
7681248|NCT01929707|18917751|P2|COMPLETED|Intervention Period 2||0
7681249|NCT01929707|18917752|P1|COMPLETED|Intervention Period 2||0
7681250|NCT01929707|18917745|P8|STARTED|Intervention Period 2|Incomplete-crossover design|4
7681251|NCT01929707|18917746|P7|STARTED|Intervention Period 2|Incomplete-crossover design|12
7681252|NCT01929707|18917747|P6|STARTED|Intervention Period 2|Incomplete-crossover design|8
7681253|NCT01929707|18917748|P5|STARTED|Intervention Period 2|Incomplete-crossover design|6
7681254|NCT01929707|18917749|P4|STARTED|Intervention Period 2|Incomplete-crossover design|5
7681255|NCT01929707|18917750|P3|STARTED|Intervention Period 2|Incomplete-crossover design|0
7681256|NCT01929707|18917751|P2|STARTED|Intervention Period 2|Incomplete-crossover design|0
7681257|NCT01929707|18917752|P1|STARTED|Intervention Period 2|Incomplete-crossover design|0
7681258|NCT01929707|18917745|P8|NOT COMPLETED|Washout Period ≥7 Days||0
7681259|NCT01929707|18917746|P7|NOT COMPLETED|Washout Period ≥7 Days||0
7681260|NCT01929707|18917747|P6|NOT COMPLETED|Washout Period ≥7 Days||0
7681261|NCT01929707|18917748|P5|NOT COMPLETED|Washout Period ≥7 Days||0
7681262|NCT01929707|18917749|P4|NOT COMPLETED|Washout Period ≥7 Days||0
7681263|NCT01929707|18917750|P3|NOT COMPLETED|Washout Period ≥7 Days||0
7681264|NCT01929707|18917751|P2|NOT COMPLETED|Washout Period ≥7 Days||0
7681265|NCT01929707|18917752|P1|NOT COMPLETED|Washout Period ≥7 Days||0
7681266|NCT01929707|18917745|P8|COMPLETED|Washout Period ≥7 Days||0
7681267|NCT01929707|18917746|P7|COMPLETED|Washout Period ≥7 Days||0
7681268|NCT01929707|18917747|P6|COMPLETED|Washout Period ≥7 Days||0
7681269|NCT01929707|18917748|P5|COMPLETED|Washout Period ≥7 Days||0
7681270|NCT01929707|18917749|P4|COMPLETED|Washout Period ≥7 Days||7
7681271|NCT01929707|18917750|P3|COMPLETED|Washout Period ≥7 Days||12
7681272|NCT01929707|18917751|P2|COMPLETED|Washout Period ≥7 Days||8
7681273|NCT01929707|18917752|P1|COMPLETED|Washout Period ≥7 Days||6
7681274|NCT01929707|18917745|P8|STARTED|Washout Period ≥7 Days||0
7681275|NCT01929707|18917746|P7|STARTED|Washout Period ≥7 Days||0
7681276|NCT01929707|18917747|P6|STARTED|Washout Period ≥7 Days||0
7681277|NCT01929707|18917748|P5|STARTED|Washout Period ≥7 Days||0
7681278|NCT01929707|18917749|P4|STARTED|Washout Period ≥7 Days||7
7681279|NCT01929707|18917750|P3|STARTED|Washout Period ≥7 Days||12
7681280|NCT01929707|18917751|P2|STARTED|Washout Period ≥7 Days||8
7681281|NCT01929707|18917752|P1|STARTED|Washout Period ≥7 Days||6
7681282|NCT01929707|18917745|P8|NOT COMPLETED|Intervention Period 1||0
7681283|NCT01929707|18917746|P7|NOT COMPLETED|Intervention Period 1||0
7681284|NCT01929707|18917747|P6|NOT COMPLETED|Intervention Period 1||0
7681285|NCT01929707|18917748|P5|NOT COMPLETED|Intervention Period 1||0
7681286|NCT01929707|18917749|P4|NOT COMPLETED|Intervention Period 1||3
7681287|NCT01929707|18917750|P3|NOT COMPLETED|Intervention Period 1||0
7681288|NCT01929707|18917751|P2|NOT COMPLETED|Intervention Period 1||0
7681289|NCT01929707|18917752|P1|NOT COMPLETED|Intervention Period 1||0
7681290|NCT01929707|18917745|P8|COMPLETED|Intervention Period 1||0
7681291|NCT01929707|18917746|P7|COMPLETED|Intervention Period 1||0
7681292|NCT01929707|18917747|P6|COMPLETED|Intervention Period 1||0
7681293|NCT01929707|18917748|P5|COMPLETED|Intervention Period 1||0
7681294|NCT01929707|18917749|P4|COMPLETED|Intervention Period 1|Two discontinued participants were replaced in Period 2|7
7681295|NCT01929707|18917750|P3|COMPLETED|Intervention Period 1||12
7681296|NCT01929707|18917751|P2|COMPLETED|Intervention Period 1||8
7681297|NCT01929707|18917752|P1|COMPLETED|Intervention Period 1||6
7681298|NCT01929707|18917745|P8|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
7681299|NCT01929707|18917746|P7|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
7681300|NCT01929707|18917747|P6|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
7681301|NCT01929707|18917748|P5|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
7681302|NCT01929707|18917749|P4|Received at Least 1 Dose of Study Drug|Intervention Period 1||10
7681303|NCT01929707|18917750|P3|Received at Least 1 Dose of Study Drug|Intervention Period 1||12
7681304|NCT01929707|18917751|P2|Received at Least 1 Dose of Study Drug|Intervention Period 1||8
7681305|NCT01929707|18917752|P1|Received at Least 1 Dose of Study Drug|Intervention Period 1||6
7681306|NCT01929707|18917745|P8|STARTED|Intervention Period 1||0
7681307|NCT01929707|18917746|P7|STARTED|Intervention Period 1||0
7681308|NCT01929707|18917747|P6|STARTED|Intervention Period 1||0
7681309|NCT01929707|18917748|P5|STARTED|Intervention Period 1||0
7681310|NCT01929707|18917749|P4|STARTED|Intervention Period 1||10
7681311|NCT01929707|18917750|P3|STARTED|Intervention Period 1||12
7681312|NCT01929707|18917751|P2|STARTED|Intervention Period 1||8
7681313|NCT01929707|18917752|P1|STARTED|Intervention Period 1||6
7681314|NCT01929681|18917784|P2|NOT COMPLETED|Overall Study||1
7681315|NCT01929681|18917785|P1|NOT COMPLETED|Overall Study||2
7681316|NCT01929681|18917784|P2|COMPLETED|Overall Study||24
7681317|NCT01929681|18917785|P1|COMPLETED|Overall Study||26
7681318|NCT01929681|18917784|P2|STARTED|Overall Study||25
7681319|NCT01929681|18917785|P1|STARTED|Overall Study||28
7681320|NCT01929473|18917799|P1|NOT COMPLETED|Overall Study||587
7681321|NCT01929473|18917799|P1|COMPLETED|Overall Study||3243
7681322|NCT01929473|18917799|P1|365 Day|Overall Study||3589
7681323|NCT01929473|18917799|P1|STARTED|Overall Study|0 day|3830
7681324|NCT01929460|18917805|P2|NOT COMPLETED|Overall Study||0
7681325|NCT01929460|18917806|P1|NOT COMPLETED|Overall Study||0
7681326|NCT01929460|18917805|P2|COMPLETED|Overall Study||13
7681327|NCT01929460|18917806|P1|COMPLETED|Overall Study||13
7681328|NCT01929460|18917805|P2|STARTED|Overall Study||13
7681329|NCT01929460|18917806|P1|STARTED|Overall Study||13
7681330|NCT01929408|18917828|P1|NOT COMPLETED|Overall Study||8
7681331|NCT01929408|18917828|P1|COMPLETED|Overall Study||695
7681332|NCT01929408|18917828|P1|STARTED|Overall Study||703
7681333|NCT01929395|18917836|P3|NOT COMPLETED|Overall Study||1
7681334|NCT01929395|18917837|P2|NOT COMPLETED|Overall Study||1
7681335|NCT01929395|18917838|P1|NOT COMPLETED|Overall Study||1
7681336|NCT01929395|18917836|P3|COMPLETED|Overall Study||69
7681337|NCT01929395|18917837|P2|COMPLETED|Overall Study||69
7681338|NCT01929395|18917838|P1|COMPLETED|Overall Study||18
7681339|NCT01929395|18917836|P3|STARTED|Overall Study||70
7681340|NCT01929395|18917837|P2|STARTED|Overall Study||70
7681341|NCT01929395|18917838|P1|STARTED|Overall Study||19
7681342|NCT01929343|18917851|P3|NOT COMPLETED|Overall Study||0
7681343|NCT01929343|18917852|P2|NOT COMPLETED|Overall Study||2
7681344|NCT01929343|18917853|P1|NOT COMPLETED|Overall Study||1
7681345|NCT01929343|18917851|P3|COMPLETED|Overall Study||12
7681346|NCT01929343|18917852|P2|COMPLETED|Overall Study||7
7681347|NCT01929343|18917853|P1|COMPLETED|Overall Study||11
7681348|NCT01929343|18917851|P3|STARTED|Overall Study||12
7681349|NCT01929343|18917852|P2|STARTED|Overall Study||9
7681350|NCT01929343|18917853|P1|STARTED|Overall Study||12
7681351|NCT01929317|18917881|P2|NOT COMPLETED|Long-term Phase||4
7681352|NCT01929317|18917882|P1|NOT COMPLETED|Long-term Phase||19
7681353|NCT01929317|18917881|P2|COMPLETED|Long-term Phase||14
7681354|NCT01929317|18917882|P1|COMPLETED|Long-term Phase||25
7681355|NCT01929317|18917881|P2|STARTED|Long-term Phase||18
7681356|NCT01929317|18917882|P1|STARTED|Long-term Phase||44
7681357|NCT01929317|18917881|P2|NOT COMPLETED|Dose Increase Effect Verification Phase||1
7681358|NCT01929317|18917882|P1|NOT COMPLETED|Dose Increase Effect Verification Phase||9
7681359|NCT01929317|18917881|P2|COMPLETED|Dose Increase Effect Verification Phase||19
7681360|NCT01929317|18917882|P1|COMPLETED|Dose Increase Effect Verification Phase||52
7681361|NCT01929317|18917881|P2|STARTED|Dose Increase Effect Verification Phase||20
7681362|NCT01929317|18917882|P1|STARTED|Dose Increase Effect Verification Phase||61
7681363|NCT01929291|18917949|P1|NOT COMPLETED|Overall Study||0
7681364|NCT01929291|18917949|P1|COMPLETED|Overall Study||672
7681365|NCT01929291|18917949|P1|STARTED|Overall Study||672
7681366|NCT01929226|18917957|P2|NOT COMPLETED|Overall Study||1
7681367|NCT01929226|18917958|P1|NOT COMPLETED|Overall Study||5
7681368|NCT01929226|18917957|P2|COMPLETED|Overall Study||69
7681369|NCT01929226|18917958|P1|COMPLETED|Overall Study||205
7681370|NCT01929226|18917957|P2|STARTED|Overall Study||70
7681371|NCT01929226|18917958|P1|STARTED|Overall Study||210
7681372|NCT01929135|18917984|P2|NOT COMPLETED|Overall Study||1
7681373|NCT01929135|18917985|P1|NOT COMPLETED|Overall Study||1
7681374|NCT01929135|18917984|P2|COMPLETED|Overall Study||18
7681375|NCT01929135|18917985|P1|COMPLETED|Overall Study||18
7681376|NCT01929135|18917984|P2|STARTED|Overall Study||19
7681377|NCT01929135|18917985|P1|STARTED|Overall Study||19
7681378|NCT01929109|18918004|P5|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
7681379|NCT01929109|18918005|P4|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
7681380|NCT01929109|18918006|P3|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
7681381|NCT01929109|18918007|P2|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
7681382|NCT01929109|18918008|P1|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
7681383|NCT01929109|18918004|P5|COMPLETED|Period 2 (End Stage Renal Disease Only)||8
7681384|NCT01929109|18918005|P4|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
7681385|NCT01929109|18918006|P3|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
7681386|NCT01929109|18918007|P2|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
7681387|NCT01929109|18918008|P1|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
7681388|NCT01929109|18918004|P5|STARTED|Period 2 (End Stage Renal Disease Only)||8
7681389|NCT01929109|18918005|P4|STARTED|Period 2 (End Stage Renal Disease Only)||0
7681390|NCT01929109|18918006|P3|STARTED|Period 2 (End Stage Renal Disease Only)||0
7681391|NCT01929109|18918007|P2|STARTED|Period 2 (End Stage Renal Disease Only)||0
7681392|NCT01929109|18918008|P1|STARTED|Period 2 (End Stage Renal Disease Only)||0
7681393|NCT01929109|18918004|P5|NOT COMPLETED|Period 1 (All Groups)||0
7681394|NCT01929109|18918005|P4|NOT COMPLETED|Period 1 (All Groups)||0
7681395|NCT01929109|18918006|P3|NOT COMPLETED|Period 1 (All Groups)||1
7681396|NCT01929109|18918007|P2|NOT COMPLETED|Period 1 (All Groups)||0
7681397|NCT01929109|18918008|P1|NOT COMPLETED|Period 1 (All Groups)||0
7681398|NCT01929109|18918004|P5|COMPLETED|Period 1 (All Groups)||8
7681399|NCT01929109|18918005|P4|COMPLETED|Period 1 (All Groups)||8
7681400|NCT01929109|18918006|P3|COMPLETED|Period 1 (All Groups)||8
7681401|NCT01929109|18918007|P2|COMPLETED|Period 1 (All Groups)||8
7681402|NCT01929109|18918008|P1|COMPLETED|Period 1 (All Groups)||14
7681403|NCT01929109|18918004|P5|STARTED|Period 1 (All Groups)||8
7681404|NCT01929109|18918005|P4|STARTED|Period 1 (All Groups)||8
7681405|NCT01929109|18918006|P3|STARTED|Period 1 (All Groups)||9
7681406|NCT01929109|18918007|P2|STARTED|Period 1 (All Groups)||8
7681407|NCT01929109|18918008|P1|STARTED|Period 1 (All Groups)||14
7681408|NCT01929083|18918027|P2|NOT COMPLETED|Intervention 2||1
7681409|NCT01929083|18918028|P1|NOT COMPLETED|Intervention 2||0
7681410|NCT01929083|18918027|P2|COMPLETED|Intervention 2||8
7681411|NCT01929083|18918028|P1|COMPLETED|Intervention 2||7
7681412|NCT01929083|18918027|P2|Returned for 2nd Ibutilide Administratio|Intervention 2||8
7681413|NCT01929083|18918028|P1|Returned for 2nd Ibutilide Administratio|Intervention 2||7
7681414|NCT01929083|18918027|P2|STARTED|Intervention 2||9
7681415|NCT01929083|18918028|P1|STARTED|Intervention 2||7
7681416|NCT01929083|18918027|P2|NOT COMPLETED|Intervention 1||0
7681417|NCT01929083|18918028|P1|NOT COMPLETED|Intervention 1||3
7681418|NCT01929083|18918027|P2|COMPLETED|Intervention 1||9
7681419|NCT01929083|18918028|P1|COMPLETED|Intervention 1||7
7681420|NCT01929083|18918027|P2|Returned for 1st Ibutilide Administratio|Intervention 1||9
7681421|NCT01929083|18918028|P1|Returned for 1st Ibutilide Administratio|Intervention 1||7
7681422|NCT01929083|18918027|P2|STARTED|Intervention 1||9
7681423|NCT01929083|18918028|P1|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10
7681424|NCT01929057|18918054|P2|NOT COMPLETED|Overall Study||0
7681425|NCT01929057|18918055|P1|NOT COMPLETED|Overall Study||0
7681426|NCT01929057|18918054|P2|COMPLETED|Overall Study||3
7681427|NCT01929057|18918055|P1|COMPLETED|Overall Study||31
7681428|NCT01929057|18918054|P2|STARTED|Overall Study||3
7681429|NCT01929057|18918055|P1|STARTED|Overall Study||31
7681430|NCT01929044|18918065|P2|NOT COMPLETED|Overall Study||17
7681431|NCT01929044|18918066|P1|NOT COMPLETED|Overall Study||11
7681432|NCT01929044|18918065|P2|COMPLETED|Overall Study||129
7681433|NCT01929044|18918066|P1|COMPLETED|Overall Study||142
7681434|NCT01929044|18918065|P2|STARTED|Overall Study||146
7681435|NCT01929044|18918066|P1|STARTED|Overall Study||153
7681436|NCT01929031|18918088|P6|NOT COMPLETED|Overall Study||1
7681437|NCT01929031|18918089|P5|NOT COMPLETED|Overall Study||1
7681438|NCT01929031|18918090|P4|NOT COMPLETED|Overall Study||0
7681439|NCT01929031|18918091|P3|NOT COMPLETED|Overall Study||1
7681440|NCT01929031|18918092|P2|NOT COMPLETED|Overall Study||2
7681441|NCT01929031|18918093|P1|NOT COMPLETED|Overall Study||4
7681442|NCT01929031|18918088|P6|COMPLETED|Overall Study||35
7681443|NCT01929031|18918089|P5|COMPLETED|Overall Study||33
7681444|NCT01929031|18918090|P4|COMPLETED|Overall Study||35
7681445|NCT01929031|18918091|P3|COMPLETED|Overall Study||34
7681446|NCT01929031|18918092|P2|COMPLETED|Overall Study||207
7681447|NCT01929031|18918093|P1|COMPLETED|Overall Study||209
7681448|NCT01929031|18918088|P6|STARTED|Overall Study||36
7681449|NCT01929031|18918089|P5|STARTED|Overall Study||34
7681450|NCT01929031|18918090|P4|STARTED|Overall Study||35
7681451|NCT01929031|18918091|P3|STARTED|Overall Study||35
7681452|NCT01929031|18918092|P2|STARTED|Overall Study||209
7681453|NCT01929031|18918093|P1|STARTED|Overall Study||213
7681454|NCT01929018|18918117|P2|NOT COMPLETED|Overall Study||1
7681455|NCT01929018|18918118|P1|NOT COMPLETED|Overall Study||1
7681456|NCT01929018|18918117|P2|COMPLETED|Overall Study||18
7681457|NCT01929018|18918118|P1|COMPLETED|Overall Study||18
7681458|NCT01929018|18918117|P2|STARTED|Overall Study||19
7681459|NCT01929018|18918118|P1|STARTED|Overall Study||19
7681460|NCT01928940|18918142|P2|NOT COMPLETED|Overall Study||1
7681461|NCT01928940|18918143|P1|NOT COMPLETED|Overall Study||0
7681462|NCT01928940|18918142|P2|COMPLETED|Overall Study||5
7681463|NCT01928940|18918143|P1|COMPLETED|Overall Study||6
7681464|NCT01928940|18918142|P2|STARTED|Overall Study||6
7681465|NCT01928940|18918143|P1|STARTED|Overall Study||6
7681466|NCT01928927|18918186|P2|NOT COMPLETED|Overall Study||1
7681467|NCT01928927|18918187|P1|NOT COMPLETED|Overall Study||2
7681468|NCT01928927|18918186|P2|COMPLETED|Overall Study||14
7681469|NCT01928927|18918187|P1|COMPLETED|Overall Study||27
7681470|NCT01928927|18918186|P2|STARTED|Overall Study||15
7681471|NCT01928927|18918187|P1|STARTED|Overall Study||29
7681472|NCT01928862|18918328|P5|NOT COMPLETED|Overall Study||1
7681473|NCT01928862|18918329|P4|NOT COMPLETED|Overall Study||0
7681474|NCT01928862|18918330|P3|NOT COMPLETED|Overall Study||0
7681475|NCT01928862|18918331|P2|NOT COMPLETED|Overall Study||0
7681476|NCT01928862|18918332|P1|NOT COMPLETED|Overall Study||1
7681477|NCT01928862|18918328|P5|COMPLETED|Overall Study||13
7681478|NCT01928862|18918329|P4|COMPLETED|Overall Study||16
7681479|NCT01928862|18918330|P3|COMPLETED|Overall Study||16
7681480|NCT01928862|18918331|P2|COMPLETED|Overall Study||16
7681481|NCT01928862|18918332|P1|COMPLETED|Overall Study||15
7681482|NCT01928862|18918328|P5|STARTED|Overall Study||14
7681483|NCT01928862|18918329|P4|STARTED|Overall Study||16
7681484|NCT01928862|18918330|P3|STARTED|Overall Study||16
7681485|NCT01928862|18918331|P2|STARTED|Overall Study||16
7681486|NCT01928862|18918332|P1|STARTED|Overall Study||16
7681487|NCT01928849|18918371|P2|NOT COMPLETED|Overall Study||7
7681488|NCT01928849|18918372|P1|NOT COMPLETED|Overall Study||14
7681489|NCT01928849|18918371|P2|COMPLETED|Overall Study||55
7681490|NCT01928849|18918372|P1|COMPLETED|Overall Study||52
7681491|NCT01928849|18918371|P2|STARTED|Overall Study||62
7681492|NCT01928849|18918372|P1|STARTED|Overall Study||66
7681493|NCT01928797|18918392|P2|NOT COMPLETED|Overall Study||0
7681494|NCT01928797|18918393|P1|NOT COMPLETED|Overall Study||0
7681495|NCT01928797|18918392|P2|COMPLETED|Overall Study||30
7681496|NCT01928797|18918393|P1|COMPLETED|Overall Study||30
7681497|NCT01928797|18918392|P2|STARTED|Overall Study||30
7681498|NCT01928797|18918393|P1|STARTED|Overall Study||30
7681499|NCT01928771|18918406|P3|NOT COMPLETED|Overall Study||40
7681500|NCT01928771|18918407|P2|NOT COMPLETED|Overall Study||40
7681501|NCT01928771|18918408|P1|NOT COMPLETED|Overall Study||46
7681502|NCT01928771|18918406|P3|COMPLETED|Overall Study||367
7681503|NCT01928771|18918407|P2|COMPLETED|Overall Study||358
7681504|NCT01928771|18918408|P1|COMPLETED|Overall Study||354
7681505|NCT01928771|18918406|P3|Received Treatment|Overall Study||407
7681506|NCT01928771|18918407|P2|Received Treatment|Overall Study||398
7681507|NCT01928771|18918408|P1|Received Treatment|Overall Study||399
7681508|NCT01928771|18918406|P3|STARTED|Overall Study||407
7681509|NCT01928771|18918407|P2|STARTED|Overall Study||398
7681510|NCT01928771|18918408|P1|STARTED|Overall Study||400
7681511|NCT01928758|18918487|P2|NOT COMPLETED|Overall Study||20
7681512|NCT01928758|18918488|P1|NOT COMPLETED|Overall Study||25
7681513|NCT01928758|18918487|P2|COMPLETED|Overall Study||74
7681514|NCT01928758|18918488|P1|COMPLETED|Overall Study||69
7681515|NCT01928758|18918487|P2|STARTED|Overall Study||94
7681516|NCT01928758|18918488|P1|STARTED|Overall Study||94
7681517|NCT01928719|18918506|P2|NOT COMPLETED|Overall Study||19
7681518|NCT01928719|18918507|P1|NOT COMPLETED|Overall Study||52
7681519|NCT01928719|18918506|P2|COMPLETED|Overall Study||104
7681520|NCT01928719|18918507|P1|COMPLETED|Overall Study||70
7681521|NCT01928719|18918506|P2|STARTED|Overall Study||123
7681522|NCT01928719|18918507|P1|STARTED|Overall Study||122
7681523|NCT01928693|18918527|P3|NOT COMPLETED|Overall Study||0
7681524|NCT01928693|18918528|P2|NOT COMPLETED|Overall Study||0
7681525|NCT01928693|18918529|P1|NOT COMPLETED|Overall Study||0
7681526|NCT01928693|18918527|P3|COMPLETED|Overall Study||1
7681527|NCT01928693|18918528|P2|COMPLETED|Overall Study||1
7681528|NCT01928693|18918529|P1|COMPLETED|Overall Study||0
7681529|NCT01928693|18918527|P3|STARTED|Overall Study||1
7681530|NCT01928693|18918528|P2|STARTED|Overall Study||1
7681531|NCT01928693|18918529|P1|STARTED|Overall Study||0
7681532|NCT01928680|18918555|P1|NOT COMPLETED|Overall Study||0
7681533|NCT01928680|18918555|P1|COMPLETED|Overall Study||33
7681534|NCT01928680|18918555|P1|STARTED|Overall Study||33
7681535|NCT01928615|18918559|P1|NOT COMPLETED|Overall Study||2
7681536|NCT01928615|18918559|P1|COMPLETED|Overall Study||0
7681537|NCT01928615|18918559|P1|STARTED|Overall Study||2
7681538|NCT01928485|18918576|P2|NOT COMPLETED|Overall Study||1
7681539|NCT01928485|18918577|P1|NOT COMPLETED|Overall Study||0
7681540|NCT01928485|18918576|P2|COMPLETED|Overall Study||1
7681541|NCT01928485|18918577|P1|COMPLETED|Overall Study||4
7681542|NCT01928485|18918576|P2|STARTED|Overall Study||2
7681543|NCT01928485|18918577|P1|STARTED|Overall Study||4
7681544|NCT01928472|18918629|P4|NOT COMPLETED|Overall Study||2
7681545|NCT01928472|18918630|P3|NOT COMPLETED|Overall Study||7
7681546|NCT01928472|18918631|P2|NOT COMPLETED|Overall Study||8
7681547|NCT01928472|18918632|P1|NOT COMPLETED|Overall Study||8
7681548|NCT01928472|18918629|P4|COMPLETED|Overall Study||100
7681549|NCT01928472|18918630|P3|COMPLETED|Overall Study||91
7681550|NCT01928472|18918631|P2|COMPLETED|Overall Study||96
7681551|NCT01928472|18918632|P1|COMPLETED|Overall Study||90
7681552|NCT01928472|18918629|P4|STARTED|Overall Study||102
7681553|NCT01928472|18918630|P3|STARTED|Overall Study||98
7681554|NCT01928472|18918631|P2|STARTED|Overall Study||104
7681555|NCT01928472|18918632|P1|STARTED|Overall Study||98
7681556|NCT01928433|18918702|P3|NOT COMPLETED|Overall Study||28
7681557|NCT01928433|18918703|P2|NOT COMPLETED|Overall Study||21
7681558|NCT01928433|18918704|P1|NOT COMPLETED|Overall Study||20
7681559|NCT01928433|18918702|P3|COMPLETED|Overall Study||46
7681560|NCT01928433|18918703|P2|COMPLETED|Overall Study||54
7681561|NCT01928433|18918704|P1|COMPLETED|Overall Study||56
7681562|NCT01928433|18918702|P3|STARTED|Overall Study||74
7681563|NCT01928433|18918703|P2|STARTED|Overall Study||75
7681564|NCT01928433|18918704|P1|STARTED|Overall Study||76
7681565|NCT01928394|18918750|P23|NOT COMPLETED|Follow-up Period||6
7681566|NCT01928394|18918751|P22|NOT COMPLETED|Follow-up Period||9
7681567|NCT01928394|18918752|P21|NOT COMPLETED|Follow-up Period||9
7681568|NCT01928394|18918753|P20|NOT COMPLETED|Follow-up Period||21
7681569|NCT01928394|18918754|P19|NOT COMPLETED|Follow-up Period||16
7681570|NCT01928394|18918755|P18|NOT COMPLETED|Follow-up Period||8
7681571|NCT01928394|18918756|P17|NOT COMPLETED|Follow-up Period||14
7681572|NCT01928394|18918757|P16|NOT COMPLETED|Follow-up Period||0
7681573|NCT01928394|18918758|P15|NOT COMPLETED|Follow-up Period||30
7681574|NCT01928394|18918759|P14|NOT COMPLETED|Follow-up Period||38
7681575|NCT01928394|18918760|P13|NOT COMPLETED|Follow-up Period||14
7681576|NCT01928394|18918761|P12|NOT COMPLETED|Follow-up Period||22
7681577|NCT01928394|18918762|P11|NOT COMPLETED|Follow-up Period||11
7681578|NCT01928394|18918763|P10|NOT COMPLETED|Follow-up Period||2
7681579|NCT01928394|18918764|P9|NOT COMPLETED|Follow-up Period||1
7681580|NCT01928394|18918765|P8|NOT COMPLETED|Follow-up Period||6
7681581|NCT01928394|18918766|P7|NOT COMPLETED|Follow-up Period||12
7681582|NCT01928394|18918767|P6|NOT COMPLETED|Follow-up Period||8
7681583|NCT01928394|18918768|P5|NOT COMPLETED|Follow-up Period||0
7681584|NCT01928394|18918769|P4|NOT COMPLETED|Follow-up Period||10
7681585|NCT01928394|18918770|P3|NOT COMPLETED|Follow-up Period||3
7681586|NCT01928394|18918771|P2|NOT COMPLETED|Follow-up Period||0
7681587|NCT01928394|18918772|P1|NOT COMPLETED|Follow-up Period||3
7681588|NCT01928394|18918750|P23|COMPLETED|Follow-up Period||36
7681589|NCT01928394|18918751|P22|COMPLETED|Follow-up Period||34
7681590|NCT01928394|18918752|P21|COMPLETED|Follow-up Period||32
7681591|NCT01928394|18918753|P20|COMPLETED|Follow-up Period||83
7681592|NCT01928394|18918754|P19|COMPLETED|Follow-up Period||76
7681593|NCT01928394|18918755|P18|COMPLETED|Follow-up Period||50
7681594|NCT01928394|18918756|P17|COMPLETED|Follow-up Period||41
7681595|NCT01928394|18918757|P16|COMPLETED|Follow-up Period||3
7681596|NCT01928394|18918758|P15|COMPLETED|Follow-up Period||66
7681597|NCT01928394|18918759|P14|COMPLETED|Follow-up Period||107
7681598|NCT01928394|18918760|P13|COMPLETED|Follow-up Period||47
7681599|NCT01928394|18918761|P12|COMPLETED|Follow-up Period||59
7681600|NCT01928394|18918762|P11|COMPLETED|Follow-up Period||19
7681601|NCT01928394|18918763|P10|COMPLETED|Follow-up Period||16
7681602|NCT01928394|18918764|P9|COMPLETED|Follow-up Period||2
7681603|NCT01928394|18918765|P8|COMPLETED|Follow-up Period||10
7681604|NCT01928394|18918766|P7|COMPLETED|Follow-up Period||40
7681605|NCT01928394|18918767|P6|COMPLETED|Follow-up Period||41
7681606|NCT01928394|18918768|P5|COMPLETED|Follow-up Period||3
7681607|NCT01928394|18918769|P4|COMPLETED|Follow-up Period||40
7681608|NCT01928394|18918770|P3|COMPLETED|Follow-up Period||15
7681609|NCT01928394|18918771|P2|COMPLETED|Follow-up Period||3
7681610|NCT01928394|18918772|P1|COMPLETED|Follow-up Period||12
7681611|NCT01928394|18918750|P23|STARTED|Follow-up Period||42
7681612|NCT01928394|18918751|P22|STARTED|Follow-up Period||43
7681613|NCT01928394|18918752|P21|STARTED|Follow-up Period||41
7681614|NCT01928394|18918753|P20|STARTED|Follow-up Period||104
7681615|NCT01928394|18918754|P19|STARTED|Follow-up Period||92
7681616|NCT01928394|18918755|P18|STARTED|Follow-up Period||58
7681617|NCT01928394|18918756|P17|STARTED|Follow-up Period||55
7681618|NCT01928394|18918757|P16|STARTED|Follow-up Period||3
7681619|NCT01928394|18918758|P15|STARTED|Follow-up Period||96
7681620|NCT01928394|18918759|P14|STARTED|Follow-up Period||145
7681621|NCT01928394|18918760|P13|STARTED|Follow-up Period||61
7681622|NCT01928394|18918761|P12|STARTED|Follow-up Period||81
7681623|NCT01928394|18918762|P11|STARTED|Follow-up Period||30
7681624|NCT01928394|18918763|P10|STARTED|Follow-up Period||18
7681625|NCT01928394|18918764|P9|STARTED|Follow-up Period||3
7681626|NCT01928394|18918765|P8|STARTED|Follow-up Period||16
7681627|NCT01928394|18918766|P7|STARTED|Follow-up Period||52
7681628|NCT01928394|18918767|P6|STARTED|Follow-up Period||49
7681629|NCT01928394|18918768|P5|STARTED|Follow-up Period||3
7681630|NCT01928394|18918769|P4|STARTED|Follow-up Period||50
7681631|NCT01928394|18918770|P3|STARTED|Follow-up Period||18
7681632|NCT01928394|18918771|P2|STARTED|Follow-up Period||3
7681633|NCT01928394|18918772|P1|STARTED|Follow-up Period||15
7681634|NCT01928394|18918750|P23|NOT COMPLETED|Treatment Period||39
7681635|NCT01928394|18918751|P22|NOT COMPLETED|Treatment Period||42
7681636|NCT01928394|18918752|P21|NOT COMPLETED|Treatment Period||40
7681637|NCT01928394|18918753|P20|NOT COMPLETED|Treatment Period||96
7681638|NCT01928394|18918754|P19|NOT COMPLETED|Treatment Period||70
7681639|NCT01928394|18918755|P18|NOT COMPLETED|Treatment Period||71
7681640|NCT01928394|18918756|P17|NOT COMPLETED|Treatment Period||50
7681641|NCT01928394|18918757|P16|NOT COMPLETED|Treatment Period||2
7681642|NCT01928394|18918758|P15|NOT COMPLETED|Treatment Period||88
7681643|NCT01928394|18918759|P14|NOT COMPLETED|Treatment Period||139
7681644|NCT01928394|18918760|P13|NOT COMPLETED|Treatment Period||55
7681645|NCT01928394|18918761|P12|NOT COMPLETED|Treatment Period||93
7681646|NCT01928394|18918762|P11|NOT COMPLETED|Treatment Period||30
7681647|NCT01928394|18918763|P10|NOT COMPLETED|Treatment Period||18
7681648|NCT01928394|18918764|P9|NOT COMPLETED|Treatment Period||3
7681649|NCT01928394|18918765|P8|NOT COMPLETED|Treatment Period||18
7681650|NCT01928394|18918766|P7|NOT COMPLETED|Treatment Period||49
7681651|NCT01928394|18918767|P6|NOT COMPLETED|Treatment Period||43
7681652|NCT01928394|18918768|P5|NOT COMPLETED|Treatment Period||3
7681653|NCT01928394|18918769|P4|NOT COMPLETED|Treatment Period||56
7681654|NCT01928394|18918770|P3|NOT COMPLETED|Treatment Period||18
7681655|NCT01928394|18918771|P2|NOT COMPLETED|Treatment Period||3
7681656|NCT01928394|18918772|P1|NOT COMPLETED|Treatment Period||18
7681657|NCT01928394|18918750|P23|COMPLETED|Treatment Period||3
7681658|NCT01928394|18918751|P22|COMPLETED|Treatment Period||1
7681659|NCT01928394|18918752|P21|COMPLETED|Treatment Period||1
7681660|NCT01928394|18918753|P20|COMPLETED|Treatment Period||8
7681661|NCT01928394|18918754|P19|COMPLETED|Treatment Period||22
7681662|NCT01928394|18918755|P18|COMPLETED|Treatment Period||7
7681663|NCT01928394|18918756|P17|COMPLETED|Treatment Period||5
7681664|NCT01928394|18918757|P16|COMPLETED|Treatment Period||1
7681665|NCT01928394|18918758|P15|COMPLETED|Treatment Period||8
7681666|NCT01928394|18918759|P14|COMPLETED|Treatment Period||8
7681667|NCT01928394|18918760|P13|COMPLETED|Treatment Period||6
7681668|NCT01928394|18918761|P12|COMPLETED|Treatment Period||5
7681669|NCT01928394|18918762|P11|COMPLETED|Treatment Period||0
7681670|NCT01928394|18918763|P10|COMPLETED|Treatment Period||0
7681671|NCT01928394|18918764|P9|COMPLETED|Treatment Period||0
7681672|NCT01928394|18918765|P8|COMPLETED|Treatment Period||0
7681673|NCT01928394|18918766|P7|COMPLETED|Treatment Period||3
7681674|NCT01928394|18918767|P6|COMPLETED|Treatment Period||6
7681675|NCT01928394|18918768|P5|COMPLETED|Treatment Period||0
7681676|NCT01928394|18918769|P4|COMPLETED|Treatment Period||3
7681677|NCT01928394|18918770|P3|COMPLETED|Treatment Period||0
7681678|NCT01928394|18918771|P2|COMPLETED|Treatment Period||0
7681679|NCT01928394|18918772|P1|COMPLETED|Treatment Period||0
7681680|NCT01928394|18918750|P23|Transition- Continued|Treatment Period||0
7681681|NCT01928394|18918751|P22|Transition- Continued|Treatment Period||0
7681682|NCT01928394|18918752|P21|Transition- Continued|Treatment Period||0
7681683|NCT01928394|18918753|P20|Transition- Continued|Treatment Period||19
7681684|NCT01928394|18918754|P19|Transition- Continued|Treatment Period||1
7681685|NCT01928394|18918755|P18|Transition- Continued|Treatment Period||0
7681686|NCT01928394|18918756|P17|Transition- Continued|Treatment Period||0
7681687|NCT01928394|18918757|P16|Transition- Continued|Treatment Period||0
7681688|NCT01928394|18918758|P15|Transition- Continued|Treatment Period||2
7681689|NCT01928394|18918759|P14|Transition- Continued|Treatment Period||0
7681690|NCT01928394|18918760|P13|Transition- Continued|Treatment Period||17
7681691|NCT01928394|18918761|P12|Transition- Continued|Treatment Period||0
7681692|NCT01928394|18918762|P11|Transition- Continued|Treatment Period||0
7681693|NCT01928394|18918763|P10|Transition- Continued|Treatment Period||1
7681694|NCT01928394|18918764|P9|Transition- Continued|Treatment Period||1
7681695|NCT01928394|18918765|P8|Transition- Continued|Treatment Period||0
7681696|NCT01928394|18918766|P7|Transition- Continued|Treatment Period||6
7681697|NCT01928394|18918767|P6|Transition- Continued|Treatment Period||3
7681698|NCT01928394|18918768|P5|Transition- Continued|Treatment Period||0
7681699|NCT01928394|18918769|P4|Transition- Continued|Treatment Period||0
7681700|NCT01928394|18918770|P3|Transition- Continued|Treatment Period||3
7681701|NCT01928394|18918771|P2|Transition- Continued|Treatment Period||0
7681702|NCT01928394|18918772|P1|Transition- Continued|Treatment Period||0
7681703|NCT01928394|18918750|P23|Transition|Treatment Period||0
7681704|NCT01928394|18918751|P22|Transition|Treatment Period||0
7681705|NCT01928394|18918752|P21|Transition|Treatment Period||0
7681706|NCT01928394|18918753|P20|Transition|Treatment Period||0
7681707|NCT01928394|18918754|P19|Transition|Treatment Period||0
7681708|NCT01928394|18918755|P18|Transition|Treatment Period||20
7681709|NCT01928394|18918756|P17|Transition|Treatment Period||0
7681710|NCT01928394|18918757|P16|Transition|Treatment Period||0
7681711|NCT01928394|18918758|P15|Transition|Treatment Period||0
7681712|NCT01928394|18918759|P14|Transition|Treatment Period||2
7681713|NCT01928394|18918760|P13|Transition|Treatment Period||0
7681714|NCT01928394|18918761|P12|Transition|Treatment Period||17
7681715|NCT01928394|18918762|P11|Transition|Treatment Period||0
7681716|NCT01928394|18918763|P10|Transition|Treatment Period||0
7681717|NCT01928394|18918764|P9|Transition|Treatment Period||0
7681718|NCT01928394|18918765|P8|Transition|Treatment Period||2
7681719|NCT01928394|18918766|P7|Transition|Treatment Period||0
7681720|NCT01928394|18918767|P6|Transition|Treatment Period||0
7681721|NCT01928394|18918768|P5|Transition|Treatment Period||0
7681722|NCT01928394|18918769|P4|Transition|Treatment Period||9
7681723|NCT01928394|18918770|P3|Transition|Treatment Period||0
7681724|NCT01928394|18918771|P2|Transition|Treatment Period||0
7681725|NCT01928394|18918772|P1|Transition|Treatment Period||3
7681726|NCT01928394|18918750|P23|STARTED|Treatment Period||42
7681727|NCT01928394|18918751|P22|STARTED|Treatment Period||43
7681728|NCT01928394|18918752|P21|STARTED|Treatment Period||41
7681729|NCT01928394|18918753|P20|STARTED|Treatment Period||104
7681730|NCT01928394|18918754|P19|STARTED|Treatment Period||92
7681731|NCT01928394|18918755|P18|STARTED|Treatment Period||78
7681732|NCT01928394|18918756|P17|STARTED|Treatment Period||55
7681733|NCT01928394|18918757|P16|STARTED|Treatment Period||3
7681734|NCT01928394|18918758|P15|STARTED|Treatment Period||96
7681735|NCT01928394|18918759|P14|STARTED|Treatment Period||147
7681736|NCT01928394|18918760|P13|STARTED|Treatment Period||61
7681737|NCT01928394|18918761|P12|STARTED|Treatment Period||98
7681738|NCT01928394|18918762|P11|STARTED|Treatment Period||30
7681739|NCT01928394|18918763|P10|STARTED|Treatment Period||18
7681740|NCT01928394|18918764|P9|STARTED|Treatment Period||3
7681741|NCT01928394|18918765|P8|STARTED|Treatment Period||18
7681742|NCT01928394|18918766|P7|STARTED|Treatment Period||52
7681743|NCT01928394|18918767|P6|STARTED|Treatment Period||49
7681744|NCT01928394|18918768|P5|STARTED|Treatment Period||3
7681745|NCT01928394|18918769|P4|STARTED|Treatment Period||59
7681746|NCT01928394|18918770|P3|STARTED|Treatment Period||18
7681747|NCT01928394|18918771|P2|STARTED|Treatment Period||3
7681748|NCT01928394|18918772|P1|STARTED|Treatment Period||18
7681749|NCT01928381|18918820|P7|NOT COMPLETED|Part 2 - Post Third Intervention||0
7681750|NCT01928381|18918821|P6|NOT COMPLETED|Part 2 - Post Third Intervention||0
7681751|NCT01928381|18918822|P5|NOT COMPLETED|Part 2 - Post Third Intervention||0
7681752|NCT01928381|18918823|P4|NOT COMPLETED|Part 2 - Post Third Intervention||0
7681753|NCT01928381|18918824|P3|NOT COMPLETED|Part 2 - Post Third Intervention||1
7681754|NCT01928381|18918825|P2|NOT COMPLETED|Part 2 - Post Third Intervention||0
7681755|NCT01928381|18918826|P1|NOT COMPLETED|Part 2 - Post Third Intervention||0
7681756|NCT01928381|18918820|P7|COMPLETED|Part 2 - Post Third Intervention||5
7681757|NCT01928381|18918821|P6|COMPLETED|Part 2 - Post Third Intervention||5
7681758|NCT01928381|18918822|P5|COMPLETED|Part 2 - Post Third Intervention||3
7681759|NCT01928381|18918823|P4|COMPLETED|Part 2 - Post Third Intervention||4
7681760|NCT01928381|18918824|P3|COMPLETED|Part 2 - Post Third Intervention||3
7681761|NCT01928381|18918825|P2|COMPLETED|Part 2 - Post Third Intervention||5
7681762|NCT01928381|18918826|P1|COMPLETED|Part 2 - Post Third Intervention||0
7681763|NCT01928381|18918820|P7|STARTED|Part 2 - Post Third Intervention||5
7681764|NCT01928381|18918821|P6|STARTED|Part 2 - Post Third Intervention||5
7681765|NCT01928381|18918822|P5|STARTED|Part 2 - Post Third Intervention||3
7681766|NCT01928381|18918823|P4|STARTED|Part 2 - Post Third Intervention||4
7681767|NCT01928381|18918824|P3|STARTED|Part 2 - Post Third Intervention||4
7681768|NCT01928381|18918825|P2|STARTED|Part 2 - Post Third Intervention||5
7681769|NCT01928381|18918826|P1|STARTED|Part 2 - Post Third Intervention||0
7681770|NCT01928381|18918820|P7|NOT COMPLETED|Part 2 - Third Intervention||0
7681771|NCT01928381|18918821|P6|NOT COMPLETED|Part 2 - Third Intervention||0
7681772|NCT01928381|18918822|P5|NOT COMPLETED|Part 2 - Third Intervention||0
7681773|NCT01928381|18918823|P4|NOT COMPLETED|Part 2 - Third Intervention||0
7681774|NCT01928381|18918824|P3|NOT COMPLETED|Part 2 - Third Intervention||0
7681775|NCT01928381|18918825|P2|NOT COMPLETED|Part 2 - Third Intervention||0
7681776|NCT01928381|18918826|P1|NOT COMPLETED|Part 2 - Third Intervention||0
7681777|NCT01928381|18918820|P7|COMPLETED|Part 2 - Third Intervention||5
7681778|NCT01928381|18918821|P6|COMPLETED|Part 2 - Third Intervention||5
7681779|NCT01928381|18918822|P5|COMPLETED|Part 2 - Third Intervention||3
7681780|NCT01928381|18918823|P4|COMPLETED|Part 2 - Third Intervention||4
7681781|NCT01928381|18918824|P3|COMPLETED|Part 2 - Third Intervention||4
7681782|NCT01928381|18918825|P2|COMPLETED|Part 2 - Third Intervention||5
7681783|NCT01928381|18918826|P1|COMPLETED|Part 2 - Third Intervention||0
7681784|NCT01928381|18918820|P7|STARTED|Part 2 - Third Intervention||5
7681785|NCT01928381|18918821|P6|STARTED|Part 2 - Third Intervention||5
7681786|NCT01928381|18918822|P5|STARTED|Part 2 - Third Intervention||3
7681787|NCT01928381|18918823|P4|STARTED|Part 2 - Third Intervention||4
7681788|NCT01928381|18918824|P3|STARTED|Part 2 - Third Intervention||4
7681789|NCT01928381|18918825|P2|STARTED|Part 2 - Third Intervention||5
7681790|NCT01928381|18918826|P1|STARTED|Part 2 - Third Intervention||0
7681791|NCT01928381|18918820|P7|NOT COMPLETED|Washout Second Intervention||0
7681792|NCT01928381|18918821|P6|NOT COMPLETED|Washout Second Intervention||0
7681793|NCT01928381|18918822|P5|NOT COMPLETED|Washout Second Intervention||0
7681794|NCT01928381|18918823|P4|NOT COMPLETED|Washout Second Intervention||0
7681795|NCT01928381|18918824|P3|NOT COMPLETED|Washout Second Intervention||0
7681796|NCT01928381|18918825|P2|NOT COMPLETED|Washout Second Intervention||0
7681797|NCT01928381|18918826|P1|NOT COMPLETED|Washout Second Intervention||0
7681798|NCT01928381|18918820|P7|COMPLETED|Washout Second Intervention||5
7681799|NCT01928381|18918821|P6|COMPLETED|Washout Second Intervention||5
7681800|NCT01928381|18918822|P5|COMPLETED|Washout Second Intervention||3
7681801|NCT01928381|18918823|P4|COMPLETED|Washout Second Intervention||4
7681802|NCT01928381|18918824|P3|COMPLETED|Washout Second Intervention||4
7681803|NCT01928381|18918825|P2|COMPLETED|Washout Second Intervention||5
7681804|NCT01928381|18918826|P1|COMPLETED|Washout Second Intervention||0
7681805|NCT01928381|18918820|P7|STARTED|Washout Second Intervention||5
7681806|NCT01928381|18918821|P6|STARTED|Washout Second Intervention||5
7681807|NCT01928381|18918822|P5|STARTED|Washout Second Intervention||3
7681808|NCT01928381|18918823|P4|STARTED|Washout Second Intervention||4
7681809|NCT01928381|18918824|P3|STARTED|Washout Second Intervention||4
7681810|NCT01928381|18918825|P2|STARTED|Washout Second Intervention||5
7681811|NCT01928381|18918826|P1|STARTED|Washout Second Intervention||0
7681812|NCT01928381|18918820|P7|NOT COMPLETED|Part 2 - Second Intervention||0
7681813|NCT01928381|18918821|P6|NOT COMPLETED|Part 2 - Second Intervention||0
7681814|NCT01928381|18918822|P5|NOT COMPLETED|Part 2 - Second Intervention||0
7681815|NCT01928381|18918823|P4|NOT COMPLETED|Part 2 - Second Intervention||1
7681816|NCT01928381|18918824|P3|NOT COMPLETED|Part 2 - Second Intervention||0
7681817|NCT01928381|18918825|P2|NOT COMPLETED|Part 2 - Second Intervention||1
7681818|NCT01928381|18918826|P1|NOT COMPLETED|Part 2 - Second Intervention||0
7681819|NCT01928381|18918820|P7|COMPLETED|Part 2 - Second Intervention||5
7681820|NCT01928381|18918821|P6|COMPLETED|Part 2 - Second Intervention||5
7681821|NCT01928381|18918822|P5|COMPLETED|Part 2 - Second Intervention||3
7681822|NCT01928381|18918823|P4|COMPLETED|Part 2 - Second Intervention||4
7681823|NCT01928381|18918824|P3|COMPLETED|Part 2 - Second Intervention||4
7681824|NCT01928381|18918825|P2|COMPLETED|Part 2 - Second Intervention||5
7681825|NCT01928381|18918826|P1|COMPLETED|Part 2 - Second Intervention||0
7681826|NCT01928381|18918820|P7|STARTED|Part 2 - Second Intervention||5
7681827|NCT01928381|18918821|P6|STARTED|Part 2 - Second Intervention||5
7681828|NCT01928381|18918822|P5|STARTED|Part 2 - Second Intervention||3
7681829|NCT01928381|18918823|P4|STARTED|Part 2 - Second Intervention||5
7681830|NCT01928381|18918824|P3|STARTED|Part 2 - Second Intervention||4
7681831|NCT01928381|18918825|P2|STARTED|Part 2 - Second Intervention||6
7681832|NCT01928381|18918826|P1|STARTED|Part 2 - Second Intervention||0
7681833|NCT01928381|18918820|P7|NOT COMPLETED|Washout First Intervention||0
7681834|NCT01928381|18918821|P6|NOT COMPLETED|Washout First Intervention||0
7681835|NCT01928381|18918822|P5|NOT COMPLETED|Washout First Intervention||1
7681836|NCT01928381|18918823|P4|NOT COMPLETED|Washout First Intervention||0
7681837|NCT01928381|18918824|P3|NOT COMPLETED|Washout First Intervention||0
7681838|NCT01928381|18918825|P2|NOT COMPLETED|Washout First Intervention||0
7681839|NCT01928381|18918826|P1|NOT COMPLETED|Washout First Intervention||0
7681840|NCT01928381|18918820|P7|COMPLETED|Washout First Intervention||5
7681841|NCT01928381|18918821|P6|COMPLETED|Washout First Intervention||5
7681842|NCT01928381|18918822|P5|COMPLETED|Washout First Intervention||3
7681843|NCT01928381|18918823|P4|COMPLETED|Washout First Intervention||5
7681844|NCT01928381|18918824|P3|COMPLETED|Washout First Intervention||4
7681845|NCT01928381|18918825|P2|COMPLETED|Washout First Intervention||6
7681846|NCT01928381|18918826|P1|COMPLETED|Washout First Intervention||0
7681847|NCT01928381|18918820|P7|STARTED|Washout First Intervention||5
7681848|NCT01928381|18918821|P6|STARTED|Washout First Intervention||5
7681849|NCT01928381|18918822|P5|STARTED|Washout First Intervention||4
7681850|NCT01928381|18918823|P4|STARTED|Washout First Intervention||5
7681851|NCT01928381|18918824|P3|STARTED|Washout First Intervention||4
7681852|NCT01928381|18918825|P2|STARTED|Washout First Intervention||6
7681853|NCT01928381|18918826|P1|STARTED|Washout First Intervention||0
7681854|NCT01928381|18918820|P7|NOT COMPLETED|Part 2 - First Intervention||1
7681855|NCT01928381|18918821|P6|NOT COMPLETED|Part 2 - First Intervention||1
7681856|NCT01928381|18918822|P5|NOT COMPLETED|Part 2 - First Intervention||0
7681857|NCT01928381|18918823|P4|NOT COMPLETED|Part 2 - First Intervention||1
7681858|NCT01928381|18918824|P3|NOT COMPLETED|Part 2 - First Intervention||2
7681859|NCT01928381|18918825|P2|NOT COMPLETED|Part 2 - First Intervention||0
7681860|NCT01928381|18918826|P1|NOT COMPLETED|Part 2 - First Intervention||0
7681861|NCT01928381|18918820|P7|COMPLETED|Part 2 - First Intervention||5
7681862|NCT01928381|18918821|P6|COMPLETED|Part 2 - First Intervention||5
7681863|NCT01928381|18918822|P5|COMPLETED|Part 2 - First Intervention||4
7681864|NCT01928381|18918823|P4|COMPLETED|Part 2 - First Intervention||5
7681865|NCT01928381|18918824|P3|COMPLETED|Part 2 - First Intervention||4
7681866|NCT01928381|18918825|P2|COMPLETED|Part 2 - First Intervention||6
7681867|NCT01928381|18918826|P1|COMPLETED|Part 2 - First Intervention||0
7681868|NCT01928381|18918820|P7|STARTED|Part 2 - First Intervention||6
7681869|NCT01928381|18918821|P6|STARTED|Part 2 - First Intervention||6
7681870|NCT01928381|18918822|P5|STARTED|Part 2 - First Intervention||4
7681871|NCT01928381|18918823|P4|STARTED|Part 2 - First Intervention||6
7681872|NCT01928381|18918824|P3|STARTED|Part 2 - First Intervention||6
7681873|NCT01928381|18918825|P2|STARTED|Part 2 - First Intervention||6
7681874|NCT01928381|18918826|P1|STARTED|Part 2 - First Intervention||0
7681875|NCT01928381|18918820|P7|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
7681876|NCT01928381|18918821|P6|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
7681877|NCT01928381|18918822|P5|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
7681878|NCT01928381|18918823|P4|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
7681879|NCT01928381|18918824|P3|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
7681880|NCT01928381|18918825|P2|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
7681881|NCT01928381|18918826|P1|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14
7681882|NCT01928381|18918820|P7|COMPLETED|Placebo run-in & Part 2 Eligibility||0
7681883|NCT01928381|18918821|P6|COMPLETED|Placebo run-in & Part 2 Eligibility||0
7681884|NCT01928381|18918822|P5|COMPLETED|Placebo run-in & Part 2 Eligibility||0
7681885|NCT01928381|18918823|P4|COMPLETED|Placebo run-in & Part 2 Eligibility||0
7681886|NCT01928381|18918824|P3|COMPLETED|Placebo run-in & Part 2 Eligibility||0
7681887|NCT01928381|18918825|P2|COMPLETED|Placebo run-in & Part 2 Eligibility||0
7681888|NCT01928381|18918826|P1|COMPLETED|Placebo run-in & Part 2 Eligibility||34
7681889|NCT01928381|18918820|P7|STARTED|Placebo run-in & Part 2 Eligibility||0
7681890|NCT01928381|18918821|P6|STARTED|Placebo run-in & Part 2 Eligibility||0
7681891|NCT01928381|18918822|P5|STARTED|Placebo run-in & Part 2 Eligibility||0
7681892|NCT01928381|18918823|P4|STARTED|Placebo run-in & Part 2 Eligibility||0
7681893|NCT01928381|18918824|P3|STARTED|Placebo run-in & Part 2 Eligibility||0
7681894|NCT01928381|18918825|P2|STARTED|Placebo run-in & Part 2 Eligibility||0
7681895|NCT01928381|18918826|P1|STARTED|Placebo run-in & Part 2 Eligibility||48
7681896|NCT01928381|18918820|P7|NOT COMPLETED|Part 1 - Pain Training||0
7681897|NCT01928381|18918821|P6|NOT COMPLETED|Part 1 - Pain Training||0
7681898|NCT01928381|18918822|P5|NOT COMPLETED|Part 1 - Pain Training||0
7681899|NCT01928381|18918823|P4|NOT COMPLETED|Part 1 - Pain Training||0
7681900|NCT01928381|18918824|P3|NOT COMPLETED|Part 1 - Pain Training||0
7681901|NCT01928381|18918825|P2|NOT COMPLETED|Part 1 - Pain Training||0
7681902|NCT01928381|18918826|P1|NOT COMPLETED|Part 1 - Pain Training||35
7681903|NCT01928381|18918820|P7|COMPLETED|Part 1 - Pain Training||0
7681904|NCT01928381|18918821|P6|COMPLETED|Part 1 - Pain Training||0
7681905|NCT01928381|18918822|P5|COMPLETED|Part 1 - Pain Training||0
7681906|NCT01928381|18918823|P4|COMPLETED|Part 1 - Pain Training||0
7681907|NCT01928381|18918824|P3|COMPLETED|Part 1 - Pain Training||0
7681908|NCT01928381|18918825|P2|COMPLETED|Part 1 - Pain Training||0
7681909|NCT01928381|18918826|P1|COMPLETED|Part 1 - Pain Training||48
7681910|NCT01928381|18918820|P7|STARTED|Part 1 - Pain Training||0
7681911|NCT01928381|18918821|P6|STARTED|Part 1 - Pain Training||0
7681912|NCT01928381|18918822|P5|STARTED|Part 1 - Pain Training||0
7681913|NCT01928381|18918823|P4|STARTED|Part 1 - Pain Training||0
7681914|NCT01928381|18918824|P3|STARTED|Part 1 - Pain Training||0
7681915|NCT01928381|18918825|P2|STARTED|Part 1 - Pain Training||0
7681916|NCT01928381|18918826|P1|STARTED|Part 1 - Pain Training||83
7681917|NCT01928381|18918820|P7|NOT COMPLETED|Screening for Pain Training||0
7681918|NCT01928381|18918821|P6|NOT COMPLETED|Screening for Pain Training||0
7681919|NCT01928381|18918822|P5|NOT COMPLETED|Screening for Pain Training||0
7681920|NCT01928381|18918823|P4|NOT COMPLETED|Screening for Pain Training||0
7681921|NCT01928381|18918824|P3|NOT COMPLETED|Screening for Pain Training||0
7681922|NCT01928381|18918825|P2|NOT COMPLETED|Screening for Pain Training||0
7681923|NCT01928381|18918826|P1|NOT COMPLETED|Screening for Pain Training||60
7681924|NCT01928381|18918820|P7|COMPLETED|Screening for Pain Training||0
7681925|NCT01928381|18918821|P6|COMPLETED|Screening for Pain Training||0
7681926|NCT01928381|18918822|P5|COMPLETED|Screening for Pain Training||0
7681927|NCT01928381|18918823|P4|COMPLETED|Screening for Pain Training||0
7681928|NCT01928381|18918824|P3|COMPLETED|Screening for Pain Training||0
7681929|NCT01928381|18918825|P2|COMPLETED|Screening for Pain Training||0
7681930|NCT01928381|18918826|P1|COMPLETED|Screening for Pain Training||83
7681931|NCT01928381|18918820|P7|STARTED|Screening for Pain Training||0
7681932|NCT01928381|18918821|P6|STARTED|Screening for Pain Training||0
7681933|NCT01928381|18918822|P5|STARTED|Screening for Pain Training||0
7681934|NCT01928381|18918823|P4|STARTED|Screening for Pain Training||0
7681935|NCT01928381|18918824|P3|STARTED|Screening for Pain Training||0
7681936|NCT01928381|18918825|P2|STARTED|Screening for Pain Training||0
7681937|NCT01928381|18918826|P1|STARTED|Screening for Pain Training||143
7681938|NCT01928329|18918841|P2|NOT COMPLETED|Overall Study||14
7681939|NCT01928329|18918842|P1|NOT COMPLETED|Overall Study||12
7681940|NCT01928329|18918841|P2|COMPLETED|Overall Study||25
7681941|NCT01928329|18918842|P1|COMPLETED|Overall Study||28
7681942|NCT01928329|18918841|P2|STARTED|Overall Study||39
7681943|NCT01928329|18918842|P1|STARTED|Overall Study||40
7681944|NCT01928290|18918856|P2|NOT COMPLETED|Overall Study||0
7681945|NCT01928290|18918857|P1|NOT COMPLETED|Overall Study||0
7681946|NCT01928290|18918856|P2|COMPLETED|Overall Study||26
7681947|NCT01928290|18918857|P1|COMPLETED|Overall Study||41
7681948|NCT01928290|18918856|P2|STARTED|Overall Study||26
7681949|NCT01928290|18918857|P1|STARTED|Overall Study||41
7681950|NCT01928225|18918877|P2|NOT COMPLETED|Overall Study||3
7681951|NCT01928225|18918878|P1|NOT COMPLETED|Overall Study||3
7681952|NCT01928225|18918877|P2|COMPLETED|Overall Study||87
7681953|NCT01928225|18918878|P1|COMPLETED|Overall Study||87
7681954|NCT01928225|18918877|P2|STARTED|Overall Study||90
7681955|NCT01928225|18918878|P1|STARTED|Overall Study||90
7681956|NCT01928186|18918886|P1|NOT COMPLETED|Overall Study||0
7681957|NCT01928186|18918886|P1|COMPLETED|Overall Study||28
7681958|NCT01928186|18918886|P1|STARTED|Overall Study||28
7681959|NCT01928082|18918900|P1|NOT COMPLETED|Overall Study||1
7681960|NCT01928082|18918900|P1|COMPLETED|Overall Study||0
7681961|NCT01928082|18918900|P1|STARTED|Overall Study||1
7681962|NCT01928030|18918918|P3|NOT COMPLETED|Overall Study||0
7681963|NCT01928030|18918919|P2|NOT COMPLETED|Overall Study||0
7681964|NCT01928030|18918920|P1|NOT COMPLETED|Overall Study||0
7681965|NCT01928030|18918918|P3|COMPLETED|Overall Study||0
7681966|NCT01928030|18918919|P2|COMPLETED|Overall Study||0
7681967|NCT01928030|18918920|P1|COMPLETED|Overall Study||3
7681968|NCT01928030|18918918|P3|STARTED|Overall Study||0
7681969|NCT01928030|18918919|P2|STARTED|Overall Study||0
7681970|NCT01928030|18918920|P1|STARTED|Overall Study||3
7681971|NCT01927887|18918927|P1|NOT COMPLETED|Overall Study||0
7681972|NCT01927887|18918927|P1|COMPLETED|Overall Study||12
7681973|NCT01927887|18918927|P1|STARTED|Overall Study||12
7681974|NCT01927861|18918934|P2|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
7681975|NCT01927861|18918935|P1|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
7681976|NCT01927861|18918934|P2|COMPLETED|Extended Treatment Phase (26 Weeks)||14
7681977|NCT01927861|18918935|P1|COMPLETED|Extended Treatment Phase (26 Weeks)||15
7681978|NCT01927861|18918934|P2|STARTED|Extended Treatment Phase (26 Weeks)|14 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|14
7681979|NCT01927861|18918935|P1|STARTED|Extended Treatment Phase (26 Weeks)|15 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|15
7681980|NCT01927861|18918934|P2|NOT COMPLETED|Extension Phase (104 Weeks)||3
7681981|NCT01927861|18918935|P1|NOT COMPLETED|Extension Phase (104 Weeks)||0
7681982|NCT01927861|18918934|P2|COMPLETED|Extension Phase (104 Weeks)||23
7681983|NCT01927861|18918935|P1|COMPLETED|Extension Phase (104 Weeks)||25
7681984|NCT01927861|18918934|P2|STARTED|Extension Phase (104 Weeks)||26
7681985|NCT01927861|18918935|P1|STARTED|Extension Phase (104 Weeks)||25
7681986|NCT01927861|18918934|P2|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
7681987|NCT01927861|18918935|P1|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
7681988|NCT01927861|18918934|P2|COMPLETED|Pivotal Phase (104 Weeks)||26
7681989|NCT01927861|18918935|P1|COMPLETED|Pivotal Phase (104 Weeks)||25
7681990|NCT01927861|18918934|P2|STARTED|Pivotal Phase (104 Weeks)||26
7681991|NCT01927861|18918935|P1|STARTED|Pivotal Phase (104 Weeks)||25
7681992|NCT01927757|18919073|P1|NOT COMPLETED|Overall Study||23
7681993|NCT01927757|18919073|P1|COMPLETED|Overall Study||67
7681994|NCT01927757|18919073|P1|Received Etanercept|Overall Study||88
7681995|NCT01927757|18919073|P1|STARTED|Overall Study||90
7681996|NCT01927718|18919091|P1|NOT COMPLETED|Overall Study||0
7681997|NCT01927718|18919091|P1|COMPLETED|Overall Study||10
7681998|NCT01927718|18919091|P1|STARTED|Overall Study||10
7681999|NCT01927627|18919095|P1|NOT COMPLETED|Overall Study||5
7682000|NCT01927627|18919095|P1|COMPLETED|Overall Study||37
7682001|NCT01927627|18919095|P1|STARTED|Overall Study||42
7682002|NCT01927575|18919100|P1|NOT COMPLETED|Overall Study||0
7682003|NCT01927575|18919100|P1|COMPLETED|Overall Study||1
7682004|NCT01927575|18919100|P1|STARTED|Overall Study||1
7682005|NCT01927562|18919108|P1|NOT COMPLETED|Overall Study||38
7682006|NCT01927562|18919108|P1|COMPLETED|Overall Study|5 at M24, 2 at M30,12 at M36 due to two protocol changes moving followups from M24 to M30 to M36|19
7682007|NCT01927562|18919108|P1|STARTED|Overall Study||57
7682008|NCT01927419|18919114|P2|NOT COMPLETED|Overall Study||28
7682009|NCT01927419|18919115|P1|NOT COMPLETED|Overall Study||70
7682010|NCT01927419|18919114|P2|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|19
7682011|NCT01927419|18919115|P1|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|25
7682012|NCT01927419|18919114|P2|Received Treatment|Overall Study||46
7682013|NCT01927419|18919115|P1|Received Treatment|Overall Study||94
7682014|NCT01927419|18919114|P2|STARTED|Overall Study||47
7682015|NCT01927419|18919115|P1|STARTED|Overall Study||95
7682016|NCT01927367|18919133|P2|NOT COMPLETED|Overall Study||5
7682017|NCT01927367|18919134|P1|NOT COMPLETED|Overall Study||7
7682018|NCT01927367|18919133|P2|COMPLETED|Overall Study||543
7682019|NCT01927367|18919134|P1|COMPLETED|Overall Study||590
7682020|NCT01927367|18919133|P2|STARTED|Overall Study||548
7682021|NCT01927367|18919134|P1|STARTED|Overall Study||597
7682022|NCT01927120|18919148|P1|NOT COMPLETED|Overall Study||10
7682023|NCT01927120|18919148|P1|COMPLETED|Overall Study||10
7682024|NCT01927120|18919148|P1|STARTED|Overall Study||20
7682025|NCT01927055|18919166|P3|NOT COMPLETED|Double-Blind||13
7682026|NCT01927055|18919167|P2|NOT COMPLETED|Double-Blind||11
7682027|NCT01927055|18919168|P1|NOT COMPLETED|Double-Blind||0
7682028|NCT01927055|18919166|P3|COMPLETED|Double-Blind||10
7682029|NCT01927055|18919167|P2|COMPLETED|Double-Blind||11
7682030|NCT01927055|18919168|P1|COMPLETED|Double-Blind||0
7682031|NCT01927055|18919166|P3|STARTED|Double-Blind||23
7682032|NCT01927055|18919167|P2|STARTED|Double-Blind||22
7682033|NCT01927055|18919168|P1|STARTED|Double-Blind||0
7682034|NCT01927055|18919166|P3|NOT COMPLETED|Open-label||0
7682035|NCT01927055|18919167|P2|NOT COMPLETED|Open-label||0
7682036|NCT01927055|18919168|P1|NOT COMPLETED|Open-label||16
7682037|NCT01927055|18919166|P3|COMPLETED|Open-label||0
7682038|NCT01927055|18919167|P2|COMPLETED|Open-label||0
7682039|NCT01927055|18919168|P1|COMPLETED|Open-label||45
7682040|NCT01927055|18919166|P3|STARTED|Open-label||0
7682041|NCT01927055|18919167|P2|STARTED|Open-label||0
7682042|NCT01927055|18919168|P1|STARTED|Open-label||61
7682043|NCT01926977|18919177|P2|NOT COMPLETED|Overall Study||0
7682044|NCT01926977|18919178|P1|NOT COMPLETED|Overall Study||0
7682045|NCT01926977|18919177|P2|COMPLETED|Overall Study||53
7682046|NCT01926977|18919178|P1|COMPLETED|Overall Study||47
7682047|NCT01926977|18919177|P2|STARTED|Overall Study||53
7682048|NCT01926977|18919178|P1|STARTED|Overall Study||47
7682049|NCT01926886|18919186|P2|NOT COMPLETED|Overall Study||0
7682050|NCT01926886|18919187|P1|NOT COMPLETED|Overall Study||32
7682051|NCT01926886|18919186|P2|COMPLETED|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|21
7682052|NCT01926886|18919187|P1|COMPLETED|Overall Study||70
7682053|NCT01926886|18919186|P2|Received at Least 1 Dose of Study Drug|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|0
7682054|NCT01926886|18919187|P1|Received at Least 1 Dose of Study Drug|Overall Study||101
7682055|NCT01926886|18919186|P2|STARTED|Overall Study|HCPs were not enrolled in the study. No baseline data were collected for these participants.|21
7682056|NCT01926886|18919187|P1|STARTED|Overall Study||102
7682057|NCT01926782|18919206|P6|NOT COMPLETED|Overall Study||41
7682058|NCT01926782|18919207|P5|NOT COMPLETED|Overall Study||8
7682059|NCT01926782|18919208|P4|NOT COMPLETED|Overall Study||20
7682060|NCT01926782|18919209|P3|NOT COMPLETED|Overall Study||40
7682061|NCT01926782|18919210|P2|NOT COMPLETED|Overall Study||13
7682062|NCT01926782|18919211|P1|NOT COMPLETED|Overall Study||28
7682063|NCT01926782|18919206|P6|COMPLETED|Overall Study||105
7682064|NCT01926782|18919207|P5|COMPLETED|Overall Study||29
7682065|NCT01926782|18919208|P4|COMPLETED|Overall Study||53
7682066|NCT01926782|18919209|P3|COMPLETED|Overall Study||272
7682067|NCT01926782|18919210|P2|COMPLETED|Overall Study||65
7682068|NCT01926782|18919211|P1|COMPLETED|Overall Study||129
7682069|NCT01926782|18919206|P6|Completed 24 Weeks Treatment Period|Overall Study||120
7682070|NCT01926782|18919207|P5|Completed 24 Weeks Treatment Period|Overall Study||31
7682071|NCT01926782|18919208|P4|Completed 24 Weeks Treatment Period|Overall Study||58
7682072|NCT01926782|18919209|P3|Completed 24 Weeks Treatment Period|Overall Study||285
7682073|NCT01926782|18919210|P2|Completed 24 Weeks Treatment Period|Overall Study||68
7682074|NCT01926782|18919211|P1|Completed 24 Weeks Treatment Period|Overall Study||137
7682075|NCT01926782|18919206|P6|Treated|Overall Study||146
7682076|NCT01926782|18919207|P5|Treated|Overall Study||37
7682077|NCT01926782|18919208|P4|Treated|Overall Study||72
7682078|NCT01926782|18919209|P3|Treated|Overall Study||312
7682079|NCT01926782|18919210|P2|Treated|Overall Study||78
7682080|NCT01926782|18919211|P1|Treated|Overall Study||157
7682081|NCT01926782|18919206|P6|STARTED|Overall Study||146
7682082|NCT01926782|18919207|P5|STARTED|Overall Study||37
7682083|NCT01926782|18919208|P4|STARTED|Overall Study||73
7682084|NCT01926782|18919209|P3|STARTED|Overall Study||312
7682085|NCT01926782|18919210|P2|STARTED|Overall Study||78
7682086|NCT01926782|18919211|P1|STARTED|Overall Study||157
7682087|NCT01926626|18919360|P1|NOT COMPLETED|Overall Study||22
7682088|NCT01926626|18919360|P1|COMPLETED|Overall Study||16
7682089|NCT01926626|18919360|P1|Received Moclobemide|Overall Study||37
7682090|NCT01926626|18919360|P1|STARTED|Overall Study||38
7682091|NCT01926509|18919374|P4|NOT COMPLETED|Overall Study||0
7682092|NCT01926509|18919375|P3|NOT COMPLETED|Overall Study||0
7682093|NCT01926509|18919376|P2|NOT COMPLETED|Overall Study||0
7682094|NCT01926509|18919377|P1|NOT COMPLETED|Overall Study||1
7682095|NCT01926509|18919374|P4|COMPLETED|Overall Study||6
7682096|NCT01926509|18919375|P3|COMPLETED|Overall Study||5
7682097|NCT01926509|18919376|P2|COMPLETED|Overall Study||6
7682098|NCT01926509|18919377|P1|COMPLETED|Overall Study||5
7682099|NCT01926509|18919374|P4|STARTED|Overall Study||6
7682100|NCT01926509|18919375|P3|STARTED|Overall Study||5
7682101|NCT01926509|18919376|P2|STARTED|Overall Study||6
7682102|NCT01926509|18919377|P1|STARTED|Overall Study||6
7682103|NCT01926496|18919396|P2|NOT COMPLETED|Overall Study||48
7682104|NCT01926496|18919397|P1|NOT COMPLETED|Overall Study||37
7682105|NCT01926496|18919396|P2|COMPLETED|Overall Study||197
7682106|NCT01926496|18919397|P1|COMPLETED|Overall Study||203
7682107|NCT01926496|18919396|P2|STARTED|Overall Study||245
7682108|NCT01926496|18919397|P1|STARTED|Overall Study||240
7682109|NCT01926444|18919417|P4|NOT COMPLETED|Overall Study||2
7682110|NCT01926444|18919418|P3|NOT COMPLETED|Overall Study||4
7682111|NCT01926444|18919419|P2|NOT COMPLETED|Overall Study||0
7682112|NCT01926444|18919420|P1|NOT COMPLETED|Overall Study||0
7682113|NCT01926444|18919417|P4|COMPLETED|Overall Study||101
7682114|NCT01926444|18919418|P3|COMPLETED|Overall Study||53
7682115|NCT01926444|18919419|P2|COMPLETED|Overall Study||52
7682116|NCT01926444|18919420|P1|COMPLETED|Overall Study||56
7682117|NCT01926444|18919417|P4|STARTED|Overall Study||103
7682118|NCT01926444|18919418|P3|STARTED|Overall Study||57
7682119|NCT01926444|18919419|P2|STARTED|Overall Study||52
7682120|NCT01926444|18919420|P1|STARTED|Overall Study||56
7682121|NCT01926119|18919462|P1|NOT COMPLETED|Overall Study||1
7682122|NCT01926119|18919462|P1|COMPLETED|Overall Study||3
7682123|NCT01926119|18919462|P1|STARTED|Overall Study||4
7682124|NCT01926028|18919475|P3|NOT COMPLETED|Overall Study||2
7682125|NCT01926028|18919476|P2|NOT COMPLETED|Overall Study||22
7682126|NCT01926028|18919477|P1|NOT COMPLETED|Overall Study||21
7682127|NCT01926028|18919475|P3|COMPLETED|Overall Study||12
7682128|NCT01926028|18919476|P2|COMPLETED|Overall Study||67
7682129|NCT01926028|18919477|P1|COMPLETED|Overall Study||64
7682130|NCT01926028|18919475|P3|STARTED|Overall Study||14
7682131|NCT01926028|18919476|P2|STARTED|Overall Study||89
7682132|NCT01926028|18919477|P1|STARTED|Overall Study||85
7682133|NCT01926015|18919513|P2|NOT COMPLETED|Overall Study||1
7682134|NCT01926015|18919514|P1|NOT COMPLETED|Overall Study||2
7682135|NCT01926015|18919513|P2|COMPLETED|Overall Study||95
7682136|NCT01926015|18919514|P1|COMPLETED|Overall Study||94
7682137|NCT01926015|18919513|P2|Received >=1 Vaccination|Overall Study||96
7682138|NCT01926015|18919514|P1|Received >=1 Vaccination|Overall Study||94
7682139|NCT01926015|18919513|P2|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
7682140|NCT01926015|18919514|P1|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
7682141|NCT01925989|18919546|P3|NOT COMPLETED|Period 2||0
7682142|NCT01925989|18919547|P2|NOT COMPLETED|Period 2||0
7682143|NCT01925989|18919548|P1|NOT COMPLETED|Period 2||0
7682144|NCT01925989|18919546|P3|COMPLETED|Period 2||12
7682145|NCT01925989|18919547|P2|COMPLETED|Period 2||6
7682146|NCT01925989|18919548|P1|COMPLETED|Period 2||6
7682147|NCT01925989|18919546|P3|STARTED|Period 2||12
7682148|NCT01925989|18919547|P2|STARTED|Period 2||6
7682149|NCT01925989|18919548|P1|STARTED|Period 2||6
7682150|NCT01925989|18919546|P3|NOT COMPLETED|Period 1||0
7682151|NCT01925989|18919547|P2|NOT COMPLETED|Period 1||2
7682152|NCT01925989|18919548|P1|NOT COMPLETED|Period 1||1
7682153|NCT01925989|18919546|P3|COMPLETED|Period 1||12
7682154|NCT01925989|18919547|P2|COMPLETED|Period 1||6
7682155|NCT01925989|18919548|P1|COMPLETED|Period 1||6
7682156|NCT01925989|18919546|P3|Received at Least 1 Dose of Study Drug|Period 1||0
7682157|NCT01925989|18919547|P2|Received at Least 1 Dose of Study Drug|Period 1||8
7682158|NCT01925989|18919548|P1|Received at Least 1 Dose of Study Drug|Period 1||7
7682159|NCT01925989|18919546|P3|STARTED|Period 1||12
7682160|NCT01925989|18919547|P2|STARTED|Period 1||8
7682161|NCT01925989|18919548|P1|STARTED|Period 1||7
7682162|NCT01925950|18919568|P2|NOT COMPLETED|Part 2||0
7682163|NCT01925950|18919569|P1|NOT COMPLETED|Part 2||1
7682164|NCT01925950|18919568|P2|COMPLETED|Part 2||0
7682165|NCT01925950|18919569|P1|COMPLETED|Part 2||0
7682166|NCT01925950|18919568|P2|STARTED|Part 2|The 1 orBec subject completed Part 1 but did not meet the criteria of a CR to continue to Part 2|0
7682167|NCT01925950|18919569|P1|STARTED|Part 2||1
7682168|NCT01925950|18919568|P2|NOT COMPLETED|Part 1||0
7682169|NCT01925950|18919569|P1|NOT COMPLETED|Part 1||0
7682170|NCT01925950|18919568|P2|COMPLETED|Part 1||1
7682171|NCT01925950|18919569|P1|COMPLETED|Part 1||1
7682172|NCT01925950|18919568|P2|STARTED|Part 1||1
7682173|NCT01925950|18919569|P1|STARTED|Part 1||1
7682174|NCT01925781|18919577|P2|NOT COMPLETED|Overall Study||4
7682175|NCT01925781|18919578|P1|NOT COMPLETED|Overall Study||2
7682176|NCT01925781|18919577|P2|COMPLETED|Overall Study||1
7682177|NCT01925781|18919578|P1|COMPLETED|Overall Study||3
7682178|NCT01925781|18919577|P2|STARTED|Overall Study||5
7682179|NCT01925781|18919578|P1|STARTED|Overall Study||5
7682180|NCT01925768|18919588|P2|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||18
7682181|NCT01925768|18919589|P1|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||20
7682182|NCT01925768|18919588|P2|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)|Completed Apremilast treatment at Week 104|67
7682183|NCT01925768|18919589|P1|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||75
7682184|NCT01925768|18919588|P2|STARTED|ActiveTreatment/Extension (Weeks 24-104)||85
7682185|NCT01925768|18919589|P1|STARTED|ActiveTreatment/Extension (Weeks 24-104)||95
7682186|NCT01925768|18919588|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
7682187|NCT01925768|18919589|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||11
7682188|NCT01925768|18919588|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|2 participants who completed Week 24 did not enter the active treatment phase|87
7682189|NCT01925768|18919589|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|3 participants who completed Week 24 did not enter the active treatment phase|98
7682190|NCT01925768|18919588|P2|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||13
7682191|NCT01925768|18919589|P1|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||35
7682192|NCT01925768|18919588|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||91
7682193|NCT01925768|18919589|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||101
7682194|NCT01925768|18919588|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
7682195|NCT01925768|18919589|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
7682196|NCT01925768|18919588|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||110
7682197|NCT01925768|18919589|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||109
7682198|NCT01925703|18919637|P1|NOT COMPLETED|Overall Study||4
7682199|NCT01925703|18919637|P1|COMPLETED|Overall Study||9
7682200|NCT01925703|18919637|P1|Follow-up Completed|Overall Study||9
7682201|NCT01925703|18919637|P1|Full Iron Repletion Achieved|Overall Study||11
7682202|NCT01925703|18919637|P1|Dosing Regimen Completed|Overall Study||12
7682203|NCT01925703|18919637|P1|STARTED|Overall Study||13
7682204|NCT01925677|18919643|P1|NOT COMPLETED|Overall Study||0
7682205|NCT01925677|18919643|P1|COMPLETED|Overall Study||3
7682206|NCT01925677|18919643|P1|STARTED|Overall Study||3
7682207|NCT01925612|18919655|P5|NOT COMPLETED|Overall Study||2
7682208|NCT01925612|18919656|P4|NOT COMPLETED|Overall Study||1
7682209|NCT01925612|18919657|P3|NOT COMPLETED|Overall Study||1
7682210|NCT01925612|18919658|P2|NOT COMPLETED|Overall Study||4
7682211|NCT01925612|18919659|P1|NOT COMPLETED|Overall Study||4
7682212|NCT01925612|18919655|P5|COMPLETED|Overall Study||10
7682213|NCT01925612|18919656|P4|COMPLETED|Overall Study||10
7682214|NCT01925612|18919657|P3|COMPLETED|Overall Study||10
7682215|NCT01925612|18919658|P2|COMPLETED|Overall Study||18
7682216|NCT01925612|18919659|P1|COMPLETED|Overall Study||25
7682217|NCT01925612|18919655|P5|STARTED|Overall Study||12
7682218|NCT01925612|18919656|P4|STARTED|Overall Study||11
7682219|NCT01925612|18919657|P3|STARTED|Overall Study||11
7682220|NCT01925612|18919658|P2|STARTED|Overall Study||22
7682221|NCT01925612|18919659|P1|STARTED|Overall Study||29
7682222|NCT01925469|18919698|P2|NOT COMPLETED|Overall Study||0
7682223|NCT01925469|18919699|P1|NOT COMPLETED|Overall Study||1
7682224|NCT01925469|18919698|P2|COMPLETED|Overall Study||15
7682225|NCT01925469|18919699|P1|COMPLETED|Overall Study||14
7682226|NCT01925469|18919698|P2|STARTED|Overall Study||15
7682227|NCT01925469|18919699|P1|STARTED|Overall Study||15
7682228|NCT01925417|18919709|P1|NOT COMPLETED|Overall Study||3
7682229|NCT01925417|18919709|P1|COMPLETED|Overall Study||31
7682230|NCT01925417|18919709|P1|STARTED|Overall Study||34
7682231|NCT01925404|18919721|P4|NOT COMPLETED|Overall Study||0
7682232|NCT01925404|18919722|P3|NOT COMPLETED|Overall Study||0
7682233|NCT01925404|18919723|P2|NOT COMPLETED|Overall Study||0
7682234|NCT01925404|18919724|P1|NOT COMPLETED|Overall Study||0
7682235|NCT01925404|18919721|P4|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
7682236|NCT01925404|18919722|P3|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
7682237|NCT01925404|18919723|P2|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
7682238|NCT01925404|18919724|P1|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
7682239|NCT01925404|18919721|P4|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
7682240|NCT01925404|18919722|P3|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
7682241|NCT01925404|18919723|P2|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
7682242|NCT01925404|18919724|P1|STARTED|Overall Study|"The primary outcome of this study is at the level of a park.
~The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users"|0
7682243|NCT01925339|18919740|P2|NOT COMPLETED|Overall Study||0
7682244|NCT01925339|18919741|P1|NOT COMPLETED|Overall Study||2
7682245|NCT01925339|18919740|P2|COMPLETED|Overall Study||20
7682246|NCT01925339|18919741|P1|COMPLETED|Overall Study||18
7682247|NCT01925339|18919740|P2|STARTED|Overall Study||20
7682248|NCT01925339|18919741|P1|STARTED|Overall Study||20
7682249|NCT01925274|18919752|P3|NOT COMPLETED|Overall Study||6
7682250|NCT01925274|18919753|P2|NOT COMPLETED|Overall Study||6
7682251|NCT01925274|18919754|P1|NOT COMPLETED|Overall Study||7
7682252|NCT01925274|18919752|P3|COMPLETED|Overall Study||0
7682253|NCT01925274|18919753|P2|COMPLETED|Overall Study||0
7682254|NCT01925274|18919754|P1|COMPLETED|Overall Study||0
7682255|NCT01925274|18919752|P3|STARTED|Overall Study||6
7682256|NCT01925274|18919753|P2|STARTED|Overall Study||6
7682257|NCT01925274|18919754|P1|STARTED|Overall Study||7
7682258|NCT01925209|18919835|P4|NOT COMPLETED|Follow-up||4
7682259|NCT01925209|18919836|P3|NOT COMPLETED|Follow-up||1
7682260|NCT01925209|18919837|P2|NOT COMPLETED|Follow-up||6
7682261|NCT01925209|18919838|P1|NOT COMPLETED|Follow-up||1
7682262|NCT01925209|18919835|P4|COMPLETED|Follow-up||54
7682263|NCT01925209|18919836|P3|COMPLETED|Follow-up||55
7682264|NCT01925209|18919837|P2|COMPLETED|Follow-up||55
7682265|NCT01925209|18919838|P1|COMPLETED|Follow-up||56
7682266|NCT01925209|18919835|P4|STARTED|Follow-up||58
7682267|NCT01925209|18919836|P3|STARTED|Follow-up||56
7682268|NCT01925209|18919837|P2|STARTED|Follow-up||61
7682269|NCT01925209|18919838|P1|STARTED|Follow-up||57
7682270|NCT01925209|18919835|P4|NOT COMPLETED|Maintenance Treatment Epoch||2
7682271|NCT01925209|18919836|P3|NOT COMPLETED|Maintenance Treatment Epoch||2
7682272|NCT01925209|18919837|P2|NOT COMPLETED|Maintenance Treatment Epoch||1
7682273|NCT01925209|18919838|P1|NOT COMPLETED|Maintenance Treatment Epoch||0
7682274|NCT01925209|18919835|P4|COMPLETED|Maintenance Treatment Epoch||48
7682275|NCT01925209|18919836|P3|COMPLETED|Maintenance Treatment Epoch||50
7682276|NCT01925209|18919837|P2|COMPLETED|Maintenance Treatment Epoch||45
7682277|NCT01925209|18919838|P1|COMPLETED|Maintenance Treatment Epoch||49
7682278|NCT01925209|18919835|P4|STARTED|Maintenance Treatment Epoch||50
7682279|NCT01925209|18919836|P3|STARTED|Maintenance Treatment Epoch||52
7682280|NCT01925209|18919837|P2|STARTED|Maintenance Treatment Epoch||46
7682281|NCT01925209|18919838|P1|STARTED|Maintenance Treatment Epoch||49
7682282|NCT01925209|18919835|P4|NOT COMPLETED|Treatment Epoch||5
7682283|NCT01925209|18919836|P3|NOT COMPLETED|Treatment Epoch||7
7682284|NCT01925209|18919837|P2|NOT COMPLETED|Treatment Epoch||8
7682285|NCT01925209|18919838|P1|NOT COMPLETED|Treatment Epoch||9
7682286|NCT01925209|18919835|P4|COMPLETED|Treatment Epoch||57
7682287|NCT01925209|18919836|P3|COMPLETED|Treatment Epoch||56
7682288|NCT01925209|18919837|P2|COMPLETED|Treatment Epoch||55
7682289|NCT01925209|18919838|P1|COMPLETED|Treatment Epoch||54
7682290|NCT01925209|18919835|P4|Full Analysis Set|Treatment Epoch||62
7682291|NCT01925209|18919836|P3|Full Analysis Set|Treatment Epoch||63
7682292|NCT01925209|18919837|P2|Full Analysis Set|Treatment Epoch||63
7682293|NCT01925209|18919838|P1|Full Analysis Set|Treatment Epoch||63
7682294|NCT01925209|18919835|P4|STARTED|Treatment Epoch||62
7682295|NCT01925209|18919836|P3|STARTED|Treatment Epoch||63
7682296|NCT01925209|18919837|P2|STARTED|Treatment Epoch||63
7682297|NCT01925209|18919838|P1|STARTED|Treatment Epoch||63
7682298|NCT01925183|18919870|P2|NOT COMPLETED|Overall Study||0
7682299|NCT01925183|18919871|P1|NOT COMPLETED|Overall Study||1
7682300|NCT01925183|18919870|P2|COMPLETED|Overall Study||3
7682301|NCT01925183|18919871|P1|COMPLETED|Overall Study||2
7682302|NCT01925183|18919870|P2|STARTED|Overall Study||3
7682303|NCT01925183|18919871|P1|STARTED|Overall Study||3
7682304|NCT01925170|18919879|P1|NOT COMPLETED|Overall Study||53
7682305|NCT01925170|18919879|P1|COMPLETED|Overall Study||1585
7682306|NCT01925170|18919879|P1|STARTED|Overall Study||1638
7682307|NCT01925144|18919897|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0
7682308|NCT01925144|18919897|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30
7682309|NCT01925144|18919897|P1|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30
7682310|NCT01925144|18919897|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30
7682311|NCT01925144|18919897|P1|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30
7682312|NCT01925144|18919897|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
7682313|NCT01925144|18919897|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30
7682314|NCT01925144|18919897|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30
7682315|NCT01925144|18919897|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||30
7682316|NCT01925014|18919910|P2|NOT COMPLETED|Overall Study||19
7682317|NCT01925014|18919911|P1|NOT COMPLETED|Overall Study||9
7682318|NCT01925014|18919910|P2|COMPLETED|Overall Study||1520
7682319|NCT01925014|18919911|P1|COMPLETED|Overall Study||1526
7682320|NCT01925014|18919910|P2|STARTED|Overall Study||1539
7682321|NCT01925014|18919911|P1|STARTED|Overall Study||1535
7682322|NCT01924988|18919945|P1|NOT COMPLETED|Overall Study||0
7682323|NCT01924988|18919945|P1|COMPLETED|Overall Study||15
7682324|NCT01924988|18919945|P1|STARTED|Overall Study||15
7682325|NCT01924975|18919957|P2|NOT COMPLETED|Overall Study||0
7682326|NCT01924975|18919958|P1|NOT COMPLETED|Overall Study||0
7682327|NCT01924975|18919957|P2|COMPLETED|Overall Study||51
7682328|NCT01924975|18919958|P1|COMPLETED|Overall Study||51
7682329|NCT01924975|18919957|P2|STARTED|Overall Study||51
7682330|NCT01924975|18919958|P1|STARTED|Overall Study||51
7682331|NCT01924949|18919968|P1|NOT COMPLETED|Overall Study||0
7682332|NCT01924949|18919968|P1|COMPLETED|Overall Study||5
7682333|NCT01924949|18919968|P1|STARTED|Overall Study||5
7682334|NCT01924871|18919979|P2|NOT COMPLETED|Overall Study||2
7682335|NCT01924871|18919980|P1|NOT COMPLETED|Overall Study||6
7682336|NCT01924871|18919979|P2|COMPLETED|Overall Study||29
7682337|NCT01924871|18919980|P1|COMPLETED|Overall Study||25
7682338|NCT01924871|18919979|P2|STARTED|Overall Study||31
7682339|NCT01924871|18919980|P1|STARTED|Overall Study||31
7682340|NCT01924845|18919986|P1|NOT COMPLETED|Overall Study||6
7682341|NCT01924845|18919986|P1|COMPLETED|Overall Study||18
7682342|NCT01924845|18919986|P1|STARTED|Overall Study||24
7682343|NCT01924806|18919996|P2|NOT COMPLETED|Overall Study||1
7682344|NCT01924806|18919997|P1|NOT COMPLETED|Overall Study||2
7682345|NCT01924806|18919996|P2|COMPLETED|Overall Study||3
7682346|NCT01924806|18919997|P1|COMPLETED|Overall Study||3
7682347|NCT01924806|18919996|P2|STARTED|Overall Study||4
7682348|NCT01924806|18919997|P1|STARTED|Overall Study||5
7682349|NCT01924767|18920014|P5|NOT COMPLETED|Overall Study||0
7682350|NCT01924767|18920015|P4|NOT COMPLETED|Overall Study||0
7682351|NCT01924767|18920016|P3|NOT COMPLETED|Overall Study||1
7682352|NCT01924767|18920017|P2|NOT COMPLETED|Overall Study||0
7682353|NCT01924767|18920018|P1|NOT COMPLETED|Overall Study||1
7682354|NCT01924767|18920014|P5|COMPLETED|Overall Study||9
7682355|NCT01924767|18920015|P4|COMPLETED|Overall Study||9
7682356|NCT01924767|18920016|P3|COMPLETED|Overall Study||8
7682357|NCT01924767|18920017|P2|COMPLETED|Overall Study||9
7682358|NCT01924767|18920018|P1|COMPLETED|Overall Study||11
7682359|NCT01924767|18920014|P5|STARTED|Overall Study||9
7682360|NCT01924767|18920015|P4|STARTED|Overall Study||9
7682361|NCT01924767|18920016|P3|STARTED|Overall Study||9
7682362|NCT01924767|18920017|P2|STARTED|Overall Study||9
7682363|NCT01924767|18920018|P1|STARTED|Overall Study||12
7682364|NCT01924689|18920124|P6|NOT COMPLETED|Overall Study||2
7682365|NCT01924689|18920125|P5|NOT COMPLETED|Overall Study||6
7682366|NCT01924689|18920126|P4|NOT COMPLETED|Overall Study||6
7682367|NCT01924689|18920127|P3|NOT COMPLETED|Overall Study||4
7682368|NCT01924689|18920128|P2|NOT COMPLETED|Overall Study||3
7682369|NCT01924689|18920129|P1|NOT COMPLETED|Overall Study||3
7682370|NCT01924689|18920124|P6|COMPLETED|Overall Study||0
7682371|NCT01924689|18920125|P5|COMPLETED|Overall Study||0
7682372|NCT01924689|18920126|P4|COMPLETED|Overall Study||0
7682373|NCT01924689|18920127|P3|COMPLETED|Overall Study||0
7682374|NCT01924689|18920128|P2|COMPLETED|Overall Study||0
7682375|NCT01924689|18920129|P1|COMPLETED|Overall Study||0
7682376|NCT01924689|18920124|P6|STARTED|Overall Study||2
7682377|NCT01924689|18920125|P5|STARTED|Overall Study||6
7682378|NCT01924689|18920126|P4|STARTED|Overall Study||6
7682379|NCT01924689|18920127|P3|STARTED|Overall Study||4
7682380|NCT01924689|18920128|P2|STARTED|Overall Study||3
7682381|NCT01924689|18920129|P1|STARTED|Overall Study||3
7682382|NCT01924559|18920187|P1|NOT COMPLETED|Overall Study||0
7682383|NCT01924559|18920187|P1|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37
7682384|NCT01924559|18920187|P1|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37
7682385|NCT01924533|18920203|P2|NOT COMPLETED|Overall Study||205
7682386|NCT01924533|18920204|P1|NOT COMPLETED|Overall Study||189
7682387|NCT01924533|18920203|P2|COMPLETED|Overall Study||57
7682388|NCT01924533|18920204|P1|COMPLETED|Overall Study||74
7682389|NCT01924533|18920203|P2|STARTED|Overall Study||262
7682390|NCT01924533|18920204|P1|STARTED|Overall Study||263
7682391|NCT01924442|18920234|P2|NOT COMPLETED|Overall Study||137
7682392|NCT01924442|18920235|P1|NOT COMPLETED|Overall Study||40
7682393|NCT01924442|18920234|P2|COMPLETED|Overall Study||967
7682394|NCT01924442|18920235|P1|COMPLETED|Overall Study||1059
7682395|NCT01924442|18920234|P2|STARTED|Overall Study||1104
7682396|NCT01924442|18920235|P1|STARTED|Overall Study||1099
7682397|NCT01924429|18920245|P2|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
7682398|NCT01924429|18920246|P1|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
7682399|NCT01924429|18920245|P2|COMPLETED|Period 2 - Second Intervention (4 Weeks)||11
7682400|NCT01924429|18920246|P1|COMPLETED|Period 2 - Second Intervention (4 Weeks)||14
7682401|NCT01924429|18920245|P2|STARTED|Period 2 - Second Intervention (4 Weeks)||11
7682402|NCT01924429|18920246|P1|STARTED|Period 2 - Second Intervention (4 Weeks)||14
7682403|NCT01924429|18920245|P2|NOT COMPLETED|Washout Period (2 Weeks)||2
7682404|NCT01924429|18920246|P1|NOT COMPLETED|Washout Period (2 Weeks)||3
7682405|NCT01924429|18920245|P2|COMPLETED|Washout Period (2 Weeks)||11
7682406|NCT01924429|18920246|P1|COMPLETED|Washout Period (2 Weeks)||14
7682407|NCT01924429|18920245|P2|STARTED|Washout Period (2 Weeks)||13
7682408|NCT01924429|18920246|P1|STARTED|Washout Period (2 Weeks)||17
7682409|NCT01924429|18920245|P2|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
7682410|NCT01924429|18920246|P1|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
7682411|NCT01924429|18920245|P2|COMPLETED|Period 1 - First Intervention (4 Weeks)||13
7682412|NCT01924429|18920246|P1|COMPLETED|Period 1 - First Intervention (4 Weeks)||17
7682413|NCT01924429|18920245|P2|STARTED|Period 1 - First Intervention (4 Weeks)||13
7682414|NCT01924429|18920246|P1|STARTED|Period 1 - First Intervention (4 Weeks)||17
7682415|NCT01924390|18920278|P2|NOT COMPLETED|Overall Study||1
7682416|NCT01924390|18920279|P1|NOT COMPLETED|Overall Study||1
7682417|NCT01924390|18920278|P2|COMPLETED|Overall Study||21
7682418|NCT01924390|18920279|P1|COMPLETED|Overall Study||21
7682419|NCT01924390|18920278|P2|STARTED|Overall Study||22
7682420|NCT01924390|18920279|P1|STARTED|Overall Study||22
7682421|NCT01924364|18920289|P1|NOT COMPLETED|Overall Study||3
7682422|NCT01924364|18920289|P1|COMPLETED|Overall Study||4
7682423|NCT01924364|18920289|P1|STARTED|Overall Study||7
7682424|NCT01924299|18920306|P2|NOT COMPLETED|Period 2||1
7682425|NCT01924299|18920307|P1|NOT COMPLETED|Period 2||1
7682426|NCT01924299|18920306|P2|COMPLETED|Period 2||17
7682427|NCT01924299|18920307|P1|COMPLETED|Period 2||17
7682428|NCT01924299|18920306|P2|Received Baricitinib|Period 2||17
7682429|NCT01924299|18920307|P1|Received Baricitinib|Period 2||17
7682430|NCT01924299|18920306|P2|Received at Least 1 Dose of Study Drug|Period 2||18
7682431|NCT01924299|18920307|P1|Received at Least 1 Dose of Study Drug|Period 2||18
7682432|NCT01924299|18920306|P2|STARTED|Period 2||18
7682433|NCT01924299|18920307|P1|STARTED|Period 2||18
7682434|NCT01924299|18920306|P2|NOT COMPLETED|Period 1||0
7682435|NCT01924299|18920307|P1|NOT COMPLETED|Period 1||0
7682436|NCT01924299|18920306|P2|COMPLETED|Period 1||18
7682437|NCT01924299|18920307|P1|COMPLETED|Period 1||18
7682438|NCT01924299|18920306|P2|Received Baricitinib|Period 1||18
7682439|NCT01924299|18920307|P1|Received Baricitinib|Period 1||18
7682440|NCT01924299|18920306|P2|STARTED|Period 1||18
7682441|NCT01924299|18920307|P1|STARTED|Period 1||18
7682442|NCT01924182|18920329|P2|NOT COMPLETED|Overall Study||0
7682443|NCT01924182|18920330|P1|NOT COMPLETED|Overall Study||1
7682444|NCT01924182|18920329|P2|COMPLETED|Overall Study||0
7682445|NCT01924182|18920330|P1|COMPLETED|Overall Study||2
7682446|NCT01924182|18920329|P2|STARTED|Overall Study||0
7682447|NCT01924182|18920330|P1|STARTED|Overall Study||3
7682448|NCT01924169|18920342|P1|NOT COMPLETED|Overall Study||0
7682449|NCT01924169|18920342|P1|COMPLETED|Overall Study||3
7682450|NCT01924169|18920342|P1|STARTED|Overall Study||3
7682451|NCT01923961|18920350|P3|NOT COMPLETED|Third Intervention||0
7682452|NCT01923961|18920351|P2|NOT COMPLETED|Third Intervention||0
7682453|NCT01923961|18920352|P1|NOT COMPLETED|Third Intervention||0
7682454|NCT01923961|18920350|P3|COMPLETED|Third Intervention||2
7682455|NCT01923961|18920351|P2|COMPLETED|Third Intervention||3
7682456|NCT01923961|18920352|P1|COMPLETED|Third Intervention||3
7682457|NCT01923961|18920350|P3|STARTED|Third Intervention||2
7682458|NCT01923961|18920351|P2|STARTED|Third Intervention||3
7682459|NCT01923961|18920352|P1|STARTED|Third Intervention||3
7682460|NCT01923961|18920350|P3|NOT COMPLETED|Washout (1 Week)||0
7682461|NCT01923961|18920351|P2|NOT COMPLETED|Washout (1 Week)||0
7682462|NCT01923961|18920352|P1|NOT COMPLETED|Washout (1 Week)||0
7682463|NCT01923961|18920350|P3|COMPLETED|Washout (1 Week)||2
7682464|NCT01923961|18920351|P2|COMPLETED|Washout (1 Week)||3
7682465|NCT01923961|18920352|P1|COMPLETED|Washout (1 Week)||3
7682466|NCT01923961|18920350|P3|STARTED|Washout (1 Week)||2
7682467|NCT01923961|18920351|P2|STARTED|Washout (1 Week)||3
7682468|NCT01923961|18920352|P1|STARTED|Washout (1 Week)||3
7682469|NCT01923961|18920350|P3|NOT COMPLETED|Second Intervention||0
7682470|NCT01923961|18920351|P2|NOT COMPLETED|Second Intervention||0
7682471|NCT01923961|18920352|P1|NOT COMPLETED|Second Intervention||0
7682472|NCT01923961|18920350|P3|COMPLETED|Second Intervention||2
7682473|NCT01923961|18920351|P2|COMPLETED|Second Intervention||3
7682474|NCT01923961|18920352|P1|COMPLETED|Second Intervention||3
7682475|NCT01923961|18920350|P3|STARTED|Second Intervention||2
7682476|NCT01923961|18920351|P2|STARTED|Second Intervention||3
7682477|NCT01923961|18920352|P1|STARTED|Second Intervention||3
7682478|NCT01923961|18920350|P3|NOT COMPLETED|Washout (1 Week)||0
7682479|NCT01923961|18920351|P2|NOT COMPLETED|Washout (1 Week)||0
7682480|NCT01923961|18920352|P1|NOT COMPLETED|Washout (1 Week)||0
7682481|NCT01923961|18920350|P3|COMPLETED|Washout (1 Week)||2
7682482|NCT01923961|18920351|P2|COMPLETED|Washout (1 Week)||3
7682483|NCT01923961|18920352|P1|COMPLETED|Washout (1 Week)||3
7682484|NCT01923961|18920350|P3|STARTED|Washout (1 Week)||2
7682485|NCT01923961|18920351|P2|STARTED|Washout (1 Week)||3
7682486|NCT01923961|18920352|P1|STARTED|Washout (1 Week)||3
7682487|NCT01923961|18920350|P3|NOT COMPLETED|First Intervention||0
7682488|NCT01923961|18920351|P2|NOT COMPLETED|First Intervention||0
7682489|NCT01923961|18920352|P1|NOT COMPLETED|First Intervention||0
7682490|NCT01923961|18920350|P3|COMPLETED|First Intervention||2
7682491|NCT01923961|18920351|P2|COMPLETED|First Intervention||3
7682492|NCT01923961|18920352|P1|COMPLETED|First Intervention||3
7682493|NCT01923961|18920350|P3|STARTED|First Intervention||2
7682494|NCT01923961|18920351|P2|STARTED|First Intervention||3
7682495|NCT01923961|18920352|P1|STARTED|First Intervention||3
7682496|NCT01923896|18920371|P2|NOT COMPLETED|Overall Study||0
7682497|NCT01923896|18920372|P1|NOT COMPLETED|Overall Study||1
7682498|NCT01923896|18920371|P2|COMPLETED|Overall Study||8
7682499|NCT01923896|18920372|P1|COMPLETED|Overall Study||7
7682500|NCT01923896|18920371|P2|STARTED|Overall Study||8
7682501|NCT01923896|18920372|P1|STARTED|Overall Study||8
7682502|NCT01923805|18920386|P2|NOT COMPLETED|Overall Study||5
7682503|NCT01923805|18920387|P1|NOT COMPLETED|Overall Study||3
7682504|NCT01923805|18920386|P2|COMPLETED|Overall Study||0
7682505|NCT01923805|18920387|P1|COMPLETED|Overall Study||0
7682506|NCT01923805|18920386|P2|STARTED|Overall Study|early termination|5
7682507|NCT01923805|18920387|P1|STARTED|Overall Study|early termination|3
7682508|NCT01923740|18920395|P2|NOT COMPLETED|Overall Study||9
7682509|NCT01923740|18920396|P1|NOT COMPLETED|Overall Study||6
7682510|NCT01923740|18920395|P2|COMPLETED|Overall Study||223
7682511|NCT01923740|18920396|P1|COMPLETED|Overall Study||221
7682512|NCT01923740|18920395|P2|STARTED|Overall Study||232
7682513|NCT01923740|18920396|P1|STARTED|Overall Study||227
7682514|NCT01923480|18920661|P6|NOT COMPLETED|Period 2 (Hours 1-7)||0
7682515|NCT01923480|18920662|P5|NOT COMPLETED|Period 2 (Hours 1-7)||0
7682516|NCT01923480|18920663|P4|NOT COMPLETED|Period 2 (Hours 1-7)||0
7682517|NCT01923480|18920664|P3|NOT COMPLETED|Period 2 (Hours 1-7)||0
7682518|NCT01923480|18920665|P2|NOT COMPLETED|Period 2 (Hours 1-7)||0
7682519|NCT01923480|18920666|P1|NOT COMPLETED|Period 2 (Hours 1-7)||0
7682520|NCT01923480|18920661|P6|COMPLETED|Period 2 (Hours 1-7)||2
7682521|NCT01923480|18920662|P5|COMPLETED|Period 2 (Hours 1-7)||2
7682522|NCT01923480|18920663|P4|COMPLETED|Period 2 (Hours 1-7)||2
7682523|NCT01923480|18920664|P3|COMPLETED|Period 2 (Hours 1-7)||2
7682524|NCT01923480|18920665|P2|COMPLETED|Period 2 (Hours 1-7)||1
7682525|NCT01923480|18920666|P1|COMPLETED|Period 2 (Hours 1-7)||1
7682526|NCT01923480|18920661|P6|STARTED|Period 2 (Hours 1-7)||2
7682527|NCT01923480|18920662|P5|STARTED|Period 2 (Hours 1-7)||2
7682528|NCT01923480|18920663|P4|STARTED|Period 2 (Hours 1-7)||2
7682529|NCT01923480|18920664|P3|STARTED|Period 2 (Hours 1-7)||2
7682530|NCT01923480|18920665|P2|STARTED|Period 2 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|1
7682531|NCT01923480|18920666|P1|STARTED|Period 2 (Hours 1-7)||1
7682532|NCT01923480|18920661|P6|NOT COMPLETED|Period 1 (Hours 1-7)||0
7682533|NCT01923480|18920662|P5|NOT COMPLETED|Period 1 (Hours 1-7)||0
7682534|NCT01923480|18920663|P4|NOT COMPLETED|Period 1 (Hours 1-7)||0
7682535|NCT01923480|18920664|P3|NOT COMPLETED|Period 1 (Hours 1-7)||0
7682536|NCT01923480|18920665|P2|NOT COMPLETED|Period 1 (Hours 1-7)||0
7682537|NCT01923480|18920666|P1|NOT COMPLETED|Period 1 (Hours 1-7)||0
7682538|NCT01923480|18920661|P6|COMPLETED|Period 1 (Hours 1-7)||2
7682539|NCT01923480|18920662|P5|COMPLETED|Period 1 (Hours 1-7)||2
7682540|NCT01923480|18920663|P4|COMPLETED|Period 1 (Hours 1-7)||2
7682541|NCT01923480|18920664|P3|COMPLETED|Period 1 (Hours 1-7)||2
7682542|NCT01923480|18920665|P2|COMPLETED|Period 1 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|2
7682543|NCT01923480|18920666|P1|COMPLETED|Period 1 (Hours 1-7)||1
7682544|NCT01923480|18920661|P6|STARTED|Period 1 (Hours 1-7)||2
7682545|NCT01923480|18920662|P5|STARTED|Period 1 (Hours 1-7)||2
7682546|NCT01923480|18920663|P4|STARTED|Period 1 (Hours 1-7)||2
7682547|NCT01923480|18920664|P3|STARTED|Period 1 (Hours 1-7)||2
7682548|NCT01923480|18920665|P2|STARTED|Period 1 (Hours 1-7)||2
7682549|NCT01923480|18920666|P1|STARTED|Period 1 (Hours 1-7)||1
7682550|NCT01923467|18920821|P1|NOT COMPLETED|Overall Study||541
7682551|NCT01923467|18920821|P1|COMPLETED|Overall Study|Completed 3-month follow up survey|226
7682552|NCT01923467|18920821|P1|Baseline Completed, Enrolled|Overall Study||288
7682553|NCT01923467|18920821|P1|STARTED|Overall Study|Offered stop smoking program|767
7682554|NCT01923428|18920829|P4|NOT COMPLETED|Overall Study||10
7682555|NCT01923428|18920830|P3|NOT COMPLETED|Overall Study||11
7682556|NCT01923428|18920831|P2|NOT COMPLETED|Overall Study||12
7682557|NCT01923428|18920832|P1|NOT COMPLETED|Overall Study||19
7682558|NCT01923428|18920829|P4|COMPLETED|Overall Study||80
7682559|NCT01923428|18920830|P3|COMPLETED|Overall Study||78
7682560|NCT01923428|18920831|P2|COMPLETED|Overall Study||77
7682561|NCT01923428|18920832|P1|COMPLETED|Overall Study||69
7682562|NCT01923428|18920829|P4|STARTED|Overall Study||90
7682563|NCT01923428|18920830|P3|STARTED|Overall Study||89
7682564|NCT01923428|18920831|P2|STARTED|Overall Study||89
7682565|NCT01923428|18920832|P1|STARTED|Overall Study||88
7682566|NCT01923389|18920844|P2|NOT COMPLETED|Overall Study||0
7682567|NCT01923389|18920845|P1|NOT COMPLETED|Overall Study||1
7682568|NCT01923389|18920844|P2|COMPLETED|Overall Study||2
7682569|NCT01923389|18920845|P1|COMPLETED|Overall Study||1
7682570|NCT01923389|18920844|P2|STARTED|Overall Study||2
7682571|NCT01923389|18920845|P1|STARTED|Overall Study||2
7682572|NCT01923363|18920867|P1|NOT COMPLETED|Overall Study||1
7682573|NCT01923363|18920867|P1|COMPLETED|Overall Study||28
7682574|NCT01923363|18920867|P1|STARTED|Overall Study||29
7682575|NCT01923311|18920876|P2|NOT COMPLETED|Overall Study||1
7682576|NCT01923311|18920877|P1|NOT COMPLETED|Overall Study||17
7682577|NCT01923311|18920876|P2|COMPLETED|Overall Study||13
7682578|NCT01923311|18920877|P1|COMPLETED|Overall Study||0
7682579|NCT01923311|18920876|P2|STARTED|Overall Study||14
7682580|NCT01923311|18920877|P1|STARTED|Overall Study||17
7682581|NCT01923285|18920922|P2|NOT COMPLETED|Overall Study||6
7682582|NCT01923285|18920923|P1|NOT COMPLETED|Overall Study||7
7682583|NCT01923285|18920922|P2|COMPLETED|Overall Study||70
7682584|NCT01923285|18920923|P1|COMPLETED|Overall Study||69
7682585|NCT01923285|18920922|P2|Modified Intent-to-treat|Overall Study||73
7682586|NCT01923285|18920923|P1|Modified Intent-to-treat|Overall Study||73
7682587|NCT01923285|18920922|P2|STARTED|Overall Study||76
7682588|NCT01923285|18920923|P1|STARTED|Overall Study||76
7682589|NCT01923181|18920944|P9|NOT COMPLETED|Overall Study||3
7682590|NCT01923181|18920945|P8|NOT COMPLETED|Overall Study||8
7682591|NCT01923181|18920946|P7|NOT COMPLETED|Overall Study||8
7682592|NCT01923181|18920947|P6|NOT COMPLETED|Overall Study||4
7682593|NCT01923181|18920948|P5|NOT COMPLETED|Overall Study||8
7682594|NCT01923181|18920949|P4|NOT COMPLETED|Overall Study||5
7682595|NCT01923181|18920950|P3|NOT COMPLETED|Overall Study||2
7682596|NCT01923181|18920951|P2|NOT COMPLETED|Overall Study||6
7682597|NCT01923181|18920952|P1|NOT COMPLETED|Overall Study||3
7682598|NCT01923181|18920944|P9|COMPLETED|Overall Study||68
7682599|NCT01923181|18920945|P8|COMPLETED|Overall Study||61
7682600|NCT01923181|18920946|P7|COMPLETED|Overall Study||62
7682601|NCT01923181|18920947|P6|COMPLETED|Overall Study||66
7682602|NCT01923181|18920948|P5|COMPLETED|Overall Study||63
7682603|NCT01923181|18920949|P4|COMPLETED|Overall Study||65
7682604|NCT01923181|18920950|P3|COMPLETED|Overall Study||67
7682605|NCT01923181|18920951|P2|COMPLETED|Overall Study||64
7682606|NCT01923181|18920952|P1|COMPLETED|Overall Study||67
7682607|NCT01923181|18920944|P9|Safety Analysis Set (SAS)|Overall Study||71
7682608|NCT01923181|18920945|P8|Safety Analysis Set (SAS)|Overall Study||69
7682609|NCT01923181|18920946|P7|Safety Analysis Set (SAS)|Overall Study||70
7682610|NCT01923181|18920947|P6|Safety Analysis Set (SAS)|Overall Study||70
7682611|NCT01923181|18920948|P5|Safety Analysis Set (SAS)|Overall Study||71
7682612|NCT01923181|18920949|P4|Safety Analysis Set (SAS)|Overall Study||70
7682613|NCT01923181|18920950|P3|Safety Analysis Set (SAS)|Overall Study||69
7682614|NCT01923181|18920951|P2|Safety Analysis Set (SAS)|Overall Study||70
7682615|NCT01923181|18920952|P1|Safety Analysis Set (SAS)|Overall Study||70
7682616|NCT01923181|18920944|P9|Full Analysis Set (FAS)|Overall Study||71
7682617|NCT01923181|18920945|P8|Full Analysis Set (FAS)|Overall Study||69
7682618|NCT01923181|18920946|P7|Full Analysis Set (FAS)|Overall Study||70
7682619|NCT01923181|18920947|P6|Full Analysis Set (FAS)|Overall Study||70
7682620|NCT01923181|18920948|P5|Full Analysis Set (FAS)|Overall Study||71
7682621|NCT01923181|18920949|P4|Full Analysis Set (FAS)|Overall Study||70
7682622|NCT01923181|18920950|P3|Full Analysis Set (FAS)|Overall Study||69
7682623|NCT01923181|18920951|P2|Full Analysis Set (FAS)|Overall Study||70
7682624|NCT01923181|18920952|P1|Full Analysis Set (FAS)|Overall Study||70
7682625|NCT01923181|18920944|P9|STARTED|Overall Study||71
7682626|NCT01923181|18920945|P8|STARTED|Overall Study||69
7682627|NCT01923181|18920946|P7|STARTED|Overall Study||70
7682628|NCT01923181|18920947|P6|STARTED|Overall Study||70
7682629|NCT01923181|18920948|P5|STARTED|Overall Study||71
7682630|NCT01923181|18920949|P4|STARTED|Overall Study||70
7682631|NCT01923181|18920950|P3|STARTED|Overall Study||69
7682632|NCT01923181|18920951|P2|STARTED|Overall Study||70
7682633|NCT01923181|18920952|P1|STARTED|Overall Study||70
7682634|NCT01923168|18921030|P3|NOT COMPLETED|Overall Study||17
7682635|NCT01923168|18921031|P2|NOT COMPLETED|Overall Study||39
7682636|NCT01923168|18921032|P1|NOT COMPLETED|Overall Study||37
7682637|NCT01923168|18921030|P3|COMPLETED|Overall Study||109
7682638|NCT01923168|18921031|P2|COMPLETED|Overall Study||44
7682639|NCT01923168|18921032|P1|COMPLETED|Overall Study||94
7682640|NCT01923168|18921030|P3|STARTED|Overall Study||126
7682641|NCT01923168|18921031|P2|STARTED|Overall Study||83
7682642|NCT01923168|18921032|P1|STARTED|Overall Study||131
7682643|NCT01923129|18921091|P2|NOT COMPLETED|Overall Study||0
7682644|NCT01923129|18921092|P1|NOT COMPLETED|Overall Study||0
7682645|NCT01923129|18921091|P2|COMPLETED|Overall Study||71
7682646|NCT01923129|18921092|P1|COMPLETED|Overall Study||71
7682647|NCT01923129|18921091|P2|STARTED|Overall Study||71
7682648|NCT01923129|18921092|P1|STARTED|Overall Study||71
7682649|NCT01922986|18921102|P2|NOT COMPLETED|Overall Study||0
7682650|NCT01922986|18921103|P1|NOT COMPLETED|Overall Study||0
7682651|NCT01922986|18921102|P2|COMPLETED|Overall Study||2
7682652|NCT01922986|18921103|P1|COMPLETED|Overall Study||2
7682653|NCT01922986|18921102|P2|STARTED|Overall Study||2
7682654|NCT01922986|18921103|P1|STARTED|Overall Study||2
7682655|NCT01922934|18921115|P2|NOT COMPLETED|Visit 12 / Final Visits||290
7682656|NCT01922934|18921116|P1|NOT COMPLETED|Visit 12 / Final Visits||6
7682657|NCT01922934|18921115|P2|COMPLETED|Visit 12 / Final Visits|290 patients did not have a second weight recorded at one year (+/- 6months) of first weight|2640
7682658|NCT01922934|18921116|P1|COMPLETED|Visit 12 / Final Visits|6 patients did not return for final visit and weight measure|113
7682659|NCT01922934|18921115|P2|STARTED|Visit 12 / Final Visits||2930
7682660|NCT01922934|18921116|P1|STARTED|Visit 12 / Final Visits||119
7682661|NCT01922934|18921115|P2|NOT COMPLETED|Visit 1- Weight Measured||1284
7682662|NCT01922934|18921116|P1|NOT COMPLETED|Visit 1- Weight Measured||21
7682663|NCT01922934|18921115|P2|COMPLETED|Visit 1- Weight Measured|1284 patients did not have any weights recorded in EMR during study timeframe|2930
7682664|NCT01922934|18921116|P1|COMPLETED|Visit 1- Weight Measured|Patients first received tool and were weighed at Visit 1|119
7682665|NCT01922934|18921115|P2|STARTED|Visit 1- Weight Measured||4214
7682666|NCT01922934|18921116|P1|STARTED|Visit 1- Weight Measured|21 patients did not return for Visit 1 to receive tool or have weight measured.|140
7682667|NCT01922934|18921115|P2|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||0
7682668|NCT01922934|18921116|P1|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||235
7682669|NCT01922934|18921115|P2|COMPLETED|Visit 0 - Patient Contacted & Consented||4214
7682670|NCT01922934|18921116|P1|COMPLETED|Visit 0 - Patient Contacted & Consented|reflects number of patients that were contacted and agreed to attend Visit 0|140
7682671|NCT01922934|18921115|P2|STARTED|Visit 0 - Patient Contacted & Consented|Control group patients were not contacted or offered intervention|4214
7682672|NCT01922934|18921116|P1|STARTED|Visit 0 - Patient Contacted & Consented||375
7682673|NCT01922934|18921115|P2|NOT COMPLETED|Eligible Patients||88
7682674|NCT01922934|18921116|P1|NOT COMPLETED|Eligible Patients||53
7682675|NCT01922934|18921115|P2|COMPLETED|Eligible Patients|81 patients did not meet inclusion criteria as they were 80 years or older. 7 patients had died.|4214
7682676|NCT01922934|18921116|P1|COMPLETED|Eligible Patients|375 patients determined eligible after original random selection from DHHA data warehouse.|375
7682677|NCT01922934|18921115|P2|STARTED|Eligible Patients||4302
7682678|NCT01922934|18921116|P1|STARTED|Eligible Patients||428
7682679|NCT01922739|18921128|P1|NOT COMPLETED|Open-label Treatment Period||34
7682680|NCT01922739|18921128|P1|COMPLETED|Open-label Treatment Period||136
7682681|NCT01922739|18921128|P1|Treatment SAS and FAS|Open-label Treatment Period|SAS = safety analysis set FAS = full analysis set|170
7682682|NCT01922739|18921128|P1|STARTED|Open-label Treatment Period||170
7682683|NCT01922739|18921128|P1|NOT COMPLETED|Titration/Adjustment Period||12
7682684|NCT01922739|18921128|P1|COMPLETED|Titration/Adjustment Period||170
7682685|NCT01922739|18921128|P1|Safety Analysis Set|Titration/Adjustment Period||182
7682686|NCT01922739|18921128|P1|STARTED|Titration/Adjustment Period||182
7682687|NCT01922349|18921157|P4|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1
7682688|NCT01922349|18921158|P3|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
7682689|NCT01922349|18921159|P2|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
7682690|NCT01922349|18921160|P1|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
7682691|NCT01922349|18921157|P4|COMPLETED|Multiple Rising Dose (MRD) Period||26
7682692|NCT01922349|18921158|P3|COMPLETED|Multiple Rising Dose (MRD) Period||18
7682693|NCT01922349|18921159|P2|COMPLETED|Multiple Rising Dose (MRD) Period||27
7682694|NCT01922349|18921160|P1|COMPLETED|Multiple Rising Dose (MRD) Period||24
7682695|NCT01922349|18921157|P4|STARTED|Multiple Rising Dose (MRD) Period||27
7682696|NCT01922349|18921158|P3|STARTED|Multiple Rising Dose (MRD) Period||18
7682697|NCT01922349|18921159|P2|STARTED|Multiple Rising Dose (MRD) Period||27
7682698|NCT01922349|18921160|P1|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24
7682699|NCT01922349|18921157|P4|NOT COMPLETED|Single Rising Dose (SRD) Period||0
7682700|NCT01922349|18921158|P3|NOT COMPLETED|Single Rising Dose (SRD) Period||0
7682701|NCT01922349|18921159|P2|NOT COMPLETED|Single Rising Dose (SRD) Period||0
7682702|NCT01922349|18921160|P1|NOT COMPLETED|Single Rising Dose (SRD) Period||0
7682703|NCT01922349|18921157|P4|COMPLETED|Single Rising Dose (SRD) Period||27
7682704|NCT01922349|18921158|P3|COMPLETED|Single Rising Dose (SRD) Period||18
7682705|NCT01922349|18921159|P2|COMPLETED|Single Rising Dose (SRD) Period||27
7682706|NCT01922349|18921160|P1|COMPLETED|Single Rising Dose (SRD) Period||25
7682707|NCT01922349|18921157|P4|STARTED|Single Rising Dose (SRD) Period||27
7682708|NCT01922349|18921158|P3|STARTED|Single Rising Dose (SRD) Period||18
7682709|NCT01922349|18921159|P2|STARTED|Single Rising Dose (SRD) Period||27
7682710|NCT01922349|18921160|P1|STARTED|Single Rising Dose (SRD) Period||25
7682711|NCT01922336|18921268|P3|NOT COMPLETED|Overall Study||0
7682712|NCT01922336|18921269|P2|NOT COMPLETED|Overall Study||0
7682713|NCT01922336|18921270|P1|NOT COMPLETED|Overall Study||0
7682714|NCT01922336|18921268|P3|COMPLETED|Overall Study||53
7682715|NCT01922336|18921269|P2|COMPLETED|Overall Study||53
7682716|NCT01922336|18921270|P1|COMPLETED|Overall Study||53
7682717|NCT01922336|18921268|P3|STARTED|Overall Study||53
7682718|NCT01922336|18921269|P2|STARTED|Overall Study||53
7682719|NCT01922336|18921270|P1|STARTED|Overall Study||53
7682720|NCT01922271|18921289|P2|NOT COMPLETED|PERIOD 2||0
7682721|NCT01922271|18921290|P1|NOT COMPLETED|PERIOD 2||0
7682722|NCT01922271|18921289|P2|COMPLETED|PERIOD 2||76
7682723|NCT01922271|18921290|P1|COMPLETED|PERIOD 2||75
7682724|NCT01922271|18921289|P2|STARTED|PERIOD 2||76
7682725|NCT01922271|18921290|P1|STARTED|PERIOD 2||75
7682726|NCT01922271|18921289|P2|NOT COMPLETED|WASHOUT Period||0
7682727|NCT01922271|18921290|P1|NOT COMPLETED|WASHOUT Period||1
7682728|NCT01922271|18921289|P2|COMPLETED|WASHOUT Period||76
7682729|NCT01922271|18921290|P1|COMPLETED|WASHOUT Period||75
7682730|NCT01922271|18921289|P2|STARTED|WASHOUT Period||76
7682731|NCT01922271|18921290|P1|STARTED|WASHOUT Period||76
7682732|NCT01922271|18921289|P2|NOT COMPLETED|PERIOD 1||0
7682733|NCT01922271|18921290|P1|NOT COMPLETED|PERIOD 1||0
7682734|NCT01922271|18921289|P2|COMPLETED|PERIOD 1||76
7682735|NCT01922271|18921290|P1|COMPLETED|PERIOD 1||76
7682736|NCT01922271|18921289|P2|STARTED|PERIOD 1||76
7682737|NCT01922271|18921290|P1|STARTED|PERIOD 1||76
7682738|NCT01922258|18921310|P2|NOT COMPLETED|Overall Study||16
7682739|NCT01922258|18921311|P1|NOT COMPLETED|Overall Study||16
7682740|NCT01922258|18921310|P2|COMPLETED|Overall Study||121
7682741|NCT01922258|18921311|P1|COMPLETED|Overall Study||117
7682742|NCT01922258|18921310|P2|STARTED|Overall Study||137
7682743|NCT01922258|18921311|P1|STARTED|Overall Study||133
7682744|NCT01922219|18921319|P1|NOT COMPLETED|Overall Study||9
7682745|NCT01922219|18921319|P1|COMPLETED|Overall Study||28
7682746|NCT01922219|18921319|P1|STARTED|Overall Study||37
7682747|NCT01922115|18921327|P2|NOT COMPLETED|Overall Study||7
7682748|NCT01922115|18921328|P1|NOT COMPLETED|Overall Study||7
7682749|NCT01922115|18921327|P2|COMPLETED|Overall Study||24
7682750|NCT01922115|18921328|P1|COMPLETED|Overall Study||21
7682751|NCT01922115|18921327|P2|STARTED|Overall Study||31
7682752|NCT01922115|18921328|P1|STARTED|Overall Study||28
7682753|NCT01922102|18921343|P3|NOT COMPLETED|Overall Study||8
7682754|NCT01922102|18921344|P2|NOT COMPLETED|Overall Study||9
7682755|NCT01922102|18921345|P1|NOT COMPLETED|Overall Study||9
7682756|NCT01922102|18921343|P3|COMPLETED|Overall Study||83
7682757|NCT01922102|18921344|P2|COMPLETED|Overall Study||175
7682758|NCT01922102|18921345|P1|COMPLETED|Overall Study||173
7682759|NCT01922102|18921343|P3|STARTED|Overall Study||91
7682760|NCT01922102|18921344|P2|STARTED|Overall Study||184
7682761|NCT01922102|18921345|P1|STARTED|Overall Study||182
7682762|NCT01922089|18921381|P2|NOT COMPLETED|Overall Study||30
7682763|NCT01922089|18921382|P1|NOT COMPLETED|Overall Study||39
7682764|NCT01922089|18921381|P2|COMPLETED|Overall Study||221
7682765|NCT01922089|18921382|P1|COMPLETED|Overall Study||208
7682766|NCT01922089|18921381|P2|Safety Set|Overall Study||251
7682767|NCT01922089|18921382|P1|Safety Set|Overall Study||246
7682768|NCT01922089|18921381|P2|STARTED|Overall Study||251
7682769|NCT01922089|18921382|P1|STARTED|Overall Study||247
7682770|NCT01922050|18921406|P14|NOT COMPLETED|Part 2 Double-blind Phase||3
7682771|NCT01922050|18921407|P13|NOT COMPLETED|Part 2 Double-blind Phase||0
7682772|NCT01922050|18921408|P12|NOT COMPLETED|Part 2 Double-blind Phase||2
7682773|NCT01922050|18921409|P11|NOT COMPLETED|Part 2 Double-blind Phase||1
7682774|NCT01922050|18921410|P10|NOT COMPLETED|Part 2 Double-blind Phase||0
7682775|NCT01922050|18921411|P9|NOT COMPLETED|Part 2 Double-blind Phase||0
7682776|NCT01922050|18921412|P8|NOT COMPLETED|Part 2 Double-blind Phase||0
7682777|NCT01922050|18921413|P7|NOT COMPLETED|Part 2 Double-blind Phase||0
7682778|NCT01922050|18921414|P6|NOT COMPLETED|Part 2 Double-blind Phase||0
7682779|NCT01922050|18921415|P5|NOT COMPLETED|Part 2 Double-blind Phase||0
7682780|NCT01922050|18921416|P4|NOT COMPLETED|Part 2 Double-blind Phase||0
7682781|NCT01922050|18921417|P3|NOT COMPLETED|Part 2 Double-blind Phase||0
7682782|NCT01922050|18921418|P2|NOT COMPLETED|Part 2 Double-blind Phase||0
7682783|NCT01922050|18921419|P1|NOT COMPLETED|Part 2 Double-blind Phase||0
7682784|NCT01922050|18921406|P14|COMPLETED|Part 2 Double-blind Phase||56
7682785|NCT01922050|18921407|P13|COMPLETED|Part 2 Double-blind Phase||62
7682786|NCT01922050|18921408|P12|COMPLETED|Part 2 Double-blind Phase||58
7682787|NCT01922050|18921409|P11|COMPLETED|Part 2 Double-blind Phase||61
7682788|NCT01922050|18921410|P10|COMPLETED|Part 2 Double-blind Phase||0
7682789|NCT01922050|18921411|P9|COMPLETED|Part 2 Double-blind Phase||0
7682790|NCT01922050|18921412|P8|COMPLETED|Part 2 Double-blind Phase||0
7682791|NCT01922050|18921413|P7|COMPLETED|Part 2 Double-blind Phase||0
7682792|NCT01922050|18921414|P6|COMPLETED|Part 2 Double-blind Phase||0
7682793|NCT01922050|18921415|P5|COMPLETED|Part 2 Double-blind Phase||0
7682794|NCT01922050|18921416|P4|COMPLETED|Part 2 Double-blind Phase||0
7682795|NCT01922050|18921417|P3|COMPLETED|Part 2 Double-blind Phase||0
7682796|NCT01922050|18921418|P2|COMPLETED|Part 2 Double-blind Phase||0
7682797|NCT01922050|18921419|P1|COMPLETED|Part 2 Double-blind Phase||0
7682798|NCT01922050|18921406|P14|STARTED|Part 2 Double-blind Phase||59
7682799|NCT01922050|18921407|P13|STARTED|Part 2 Double-blind Phase||62
7682800|NCT01922050|18921408|P12|STARTED|Part 2 Double-blind Phase||60
7682801|NCT01922050|18921409|P11|STARTED|Part 2 Double-blind Phase||62
7682802|NCT01922050|18921410|P10|STARTED|Part 2 Double-blind Phase||0
7682803|NCT01922050|18921411|P9|STARTED|Part 2 Double-blind Phase||0
7682804|NCT01922050|18921412|P8|STARTED|Part 2 Double-blind Phase||0
7682805|NCT01922050|18921413|P7|STARTED|Part 2 Double-blind Phase||0
7682806|NCT01922050|18921414|P6|STARTED|Part 2 Double-blind Phase||0
7682807|NCT01922050|18921415|P5|STARTED|Part 2 Double-blind Phase||0
7682808|NCT01922050|18921416|P4|STARTED|Part 2 Double-blind Phase||0
7682809|NCT01922050|18921417|P3|STARTED|Part 2 Double-blind Phase||0
7682810|NCT01922050|18921418|P2|STARTED|Part 2 Double-blind Phase||0
7682811|NCT01922050|18921419|P1|STARTED|Part 2 Double-blind Phase||0
7682812|NCT01922050|18921406|P14|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7682813|NCT01922050|18921407|P13|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7682814|NCT01922050|18921408|P12|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7682815|NCT01922050|18921409|P11|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7682816|NCT01922050|18921410|P10|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7682817|NCT01922050|18921411|P9|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7682818|NCT01922050|18921412|P8|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7682819|NCT01922050|18921413|P7|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7682820|NCT01922050|18921414|P6|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7682821|NCT01922050|18921415|P5|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7682822|NCT01922050|18921416|P4|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7682823|NCT01922050|18921417|P3|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7682824|NCT01922050|18921418|P2|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7682825|NCT01922050|18921419|P1|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7682826|NCT01922050|18921406|P14|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7682827|NCT01922050|18921407|P13|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7682828|NCT01922050|18921408|P12|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7682829|NCT01922050|18921409|P11|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
7682830|NCT01922050|18921410|P10|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
7682831|NCT01922050|18921411|P9|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
7682832|NCT01922050|18921412|P8|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
7682833|NCT01922050|18921413|P7|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
7682834|NCT01922050|18921414|P6|COMPLETED|Part 1 Open-label, Dose-escalation Phase||18
7682835|NCT01922050|18921415|P5|COMPLETED|Part 1 Open-label, Dose-escalation Phase||17
7682836|NCT01922050|18921416|P4|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
7682837|NCT01922050|18921417|P3|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
7682838|NCT01922050|18921418|P2|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
7682839|NCT01922050|18921419|P1|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
7682840|NCT01922050|18921406|P14|STARTED|Part 1 Open-label, Dose-escalation Phase||0
7682841|NCT01922050|18921407|P13|STARTED|Part 1 Open-label, Dose-escalation Phase||0
7682842|NCT01922050|18921408|P12|STARTED|Part 1 Open-label, Dose-escalation Phase||0
7682843|NCT01922050|18921409|P11|STARTED|Part 1 Open-label, Dose-escalation Phase||0
7682844|NCT01922050|18921410|P10|STARTED|Part 1 Open-label, Dose-escalation Phase||12
7682845|NCT01922050|18921411|P9|STARTED|Part 1 Open-label, Dose-escalation Phase||6
7682846|NCT01922050|18921412|P8|STARTED|Part 1 Open-label, Dose-escalation Phase||3
7682847|NCT01922050|18921413|P7|STARTED|Part 1 Open-label, Dose-escalation Phase||3
7682848|NCT01922050|18921414|P6|STARTED|Part 1 Open-label, Dose-escalation Phase||18
7682849|NCT01922050|18921415|P5|STARTED|Part 1 Open-label, Dose-escalation Phase||17
7682850|NCT01922050|18921416|P4|STARTED|Part 1 Open-label, Dose-escalation Phase||6
7682851|NCT01922050|18921417|P3|STARTED|Part 1 Open-label, Dose-escalation Phase||6
7682852|NCT01922050|18921418|P2|STARTED|Part 1 Open-label, Dose-escalation Phase||3
7682853|NCT01922050|18921419|P1|STARTED|Part 1 Open-label, Dose-escalation Phase||3
7682854|NCT01922037|18921459|P2|NOT COMPLETED|Overall Study||174
7682855|NCT01922037|18921460|P1|NOT COMPLETED|Overall Study||10
7682856|NCT01922037|18921459|P2|COMPLETED|Overall Study||563
7682857|NCT01922037|18921460|P1|COMPLETED|Overall Study||59
7682858|NCT01922037|18921459|P2|Treated|Overall Study||732
7682859|NCT01922037|18921460|P1|Treated|Overall Study||69
7682860|NCT01922037|18921459|P2|STARTED|Overall Study||737
7682861|NCT01922037|18921460|P1|STARTED|Overall Study||69
7682862|NCT01922024|18921554|P2|NOT COMPLETED|Overall Study||0
7682863|NCT01922024|18921555|P1|NOT COMPLETED|Overall Study||0
7682864|NCT01922024|18921554|P2|COMPLETED|Overall Study||471
7682865|NCT01922024|18921555|P1|COMPLETED|Overall Study||1653
7682866|NCT01922024|18921554|P2|STARTED|Overall Study||471
7682867|NCT01922024|18921555|P1|STARTED|Overall Study||1653
7682868|NCT01922011|18921563|P2|NOT COMPLETED|Overall Study||5
7682869|NCT01922011|18921564|P1|NOT COMPLETED|Overall Study||6
7682870|NCT01922011|18921563|P2|COMPLETED|Overall Study||69
7682871|NCT01922011|18921564|P1|COMPLETED|Overall Study||69
7682872|NCT01922011|18921563|P2|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|72
7682873|NCT01922011|18921564|P1|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|74
7682874|NCT01922011|18921563|P2|Treated|Overall Study|Treated Participants|73
7682875|NCT01922011|18921564|P1|Treated|Overall Study|Treated Participants|73
7682876|NCT01922011|18921563|P2|STARTED|Overall Study|Randomized participants|74
7682877|NCT01922011|18921564|P1|STARTED|Overall Study|Randomized participants|75
7682878|NCT01921894|18921607|P3|NOT COMPLETED|Overall Study||0
7682879|NCT01921894|18921608|P2|NOT COMPLETED|Overall Study||0
7682880|NCT01921894|18921609|P1|NOT COMPLETED|Overall Study||0
7682881|NCT01921894|18921607|P3|COMPLETED|Overall Study||8
7682882|NCT01921894|18921608|P2|COMPLETED|Overall Study||8
7682883|NCT01921894|18921609|P1|COMPLETED|Overall Study||8
7682884|NCT01921894|18921607|P3|STARTED|Overall Study||8
7682885|NCT01921894|18921608|P2|STARTED|Overall Study||8
7682886|NCT01921894|18921609|P1|STARTED|Overall Study||8
7682887|NCT01921829|18921631|P2|NOT COMPLETED|Overall Study||1
7682888|NCT01921829|18921632|P1|NOT COMPLETED|Overall Study||0
7682889|NCT01921829|18921631|P2|COMPLETED|Overall Study||8
7682890|NCT01921829|18921632|P1|COMPLETED|Overall Study||10
7682891|NCT01921829|18921631|P2|STARTED|Overall Study||9
7682892|NCT01921829|18921632|P1|STARTED|Overall Study||10
7682893|NCT01921751|18921681|P3|NOT COMPLETED|Overall Study||0
7682894|NCT01921751|18921682|P2|NOT COMPLETED|Overall Study||0
7682895|NCT01921751|18921683|P1|NOT COMPLETED|Overall Study||0
7682896|NCT01921751|18921681|P3|COMPLETED|Overall Study|All randomized patients are reported here.|5
7682897|NCT01921751|18921682|P2|COMPLETED|Overall Study|All randomized patients are reported here.|4
7682898|NCT01921751|18921683|P1|COMPLETED|Overall Study|All randomized patients are reported here.|4
7682899|NCT01921751|18921681|P3|STARTED|Overall Study||5
7682900|NCT01921751|18921682|P2|STARTED|Overall Study||4
7682901|NCT01921751|18921683|P1|STARTED|Overall Study||4
7682902|NCT01921634|18921701|P1|NOT COMPLETED|Overall Study||0
7682903|NCT01921634|18921701|P1|COMPLETED|Overall Study||300
7682904|NCT01921634|18921701|P1|STARTED|Overall Study||300
7682905|NCT01921517|18921708|P2|NOT COMPLETED|Overall Study||9
7682906|NCT01921517|18921709|P1|NOT COMPLETED|Overall Study||15
7682907|NCT01921517|18921708|P2|COMPLETED|Overall Study||29
7682908|NCT01921517|18921709|P1|COMPLETED|Overall Study||27
7682909|NCT01921517|18921708|P2|STARTED|Overall Study||38
7682910|NCT01921517|18921709|P1|STARTED|Overall Study||42
7682911|NCT01921452|18921715|P1|NOT COMPLETED|Overall Study||0
7682912|NCT01921452|18921715|P1|COMPLETED|Overall Study||283
7682913|NCT01921452|18921715|P1|STARTED|Overall Study||283
7682914|NCT01921387|18921720|P1|NOT COMPLETED|Overall Study||1
7682915|NCT01921387|18921720|P1|COMPLETED|Overall Study||19
7682916|NCT01921387|18921720|P1|STARTED|Overall Study||20
7682917|NCT01921348|18921729|P2|NOT COMPLETED|Overall Study||2
7682918|NCT01921348|18921730|P1|NOT COMPLETED|Overall Study||1
7682919|NCT01921348|18921729|P2|COMPLETED|Overall Study||7
7682920|NCT01921348|18921730|P1|COMPLETED|Overall Study||8
7682921|NCT01921348|18921729|P2|STARTED|Overall Study||9
7682922|NCT01921348|18921730|P1|STARTED|Overall Study||9
7682923|NCT01921322|18921742|P2|NOT COMPLETED|Overall Study||17
7682924|NCT01921322|18921743|P1|NOT COMPLETED|Overall Study||15
7682925|NCT01921322|18921742|P2|COMPLETED|Overall Study||44
7682926|NCT01921322|18921743|P1|COMPLETED|Overall Study||42
7682927|NCT01921322|18921742|P2|STARTED|Overall Study||61
7682928|NCT01921322|18921743|P1|STARTED|Overall Study||57
7682929|NCT01921296|18921751|P1|NOT COMPLETED|Overall Study||0
7682930|NCT01921296|18921751|P1|COMPLETED|Overall Study||2
7682931|NCT01921296|18921751|P1|STARTED|Overall Study||2
7682932|NCT01921270|18921759|P1|NOT COMPLETED|Overall Study||1
7682933|NCT01921270|18921759|P1|COMPLETED|Overall Study||17
7682934|NCT01921270|18921759|P1|STARTED|Overall Study||18
7682935|NCT01921257|18921775|P1|NOT COMPLETED|Overall Study||3
7682936|NCT01921257|18921775|P1|COMPLETED|Overall Study||13
7682937|NCT01921257|18921775|P1|Active Treatment|Overall Study||13
7682938|NCT01921257|18921775|P1|Placebo run-in|Overall Study||16
7682939|NCT01921257|18921775|P1|STARTED|Overall Study||16
7682940|NCT01921205|18921782|P2|NOT COMPLETED|Overall Study||20
7682941|NCT01921205|18921783|P1|NOT COMPLETED|Overall Study||21
7682942|NCT01921205|18921782|P2|COMPLETED|Overall Study||151
7682943|NCT01921205|18921783|P1|COMPLETED|Overall Study||151
7682944|NCT01921205|18921782|P2|STARTED|Overall Study||171
7682945|NCT01921205|18921783|P1|STARTED|Overall Study||172
7682946|NCT01921179|18921813|P2|NOT COMPLETED|Long Term Follow-up After GOALS Training||0
7682947|NCT01921179|18921814|P1|NOT COMPLETED|Long Term Follow-up After GOALS Training||2
7682948|NCT01921179|18921813|P2|COMPLETED|Long Term Follow-up After GOALS Training||0
7682949|NCT01921179|18921814|P1|COMPLETED|Long Term Follow-up After GOALS Training||32
7682950|NCT01921179|18921813|P2|STARTED|Long Term Follow-up After GOALS Training|13 out of 19 participants who completed EDU, also completed GOALS training|0
7682951|NCT01921179|18921814|P1|STARTED|Long Term Follow-up After GOALS Training||34
7682952|NCT01921179|18921813|P2|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
7682953|NCT01921179|18921814|P1|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
7682954|NCT01921179|18921813|P2|COMPLETED|5 Week Randomized GOALS vs EDU Training||19
7682955|NCT01921179|18921814|P1|COMPLETED|5 Week Randomized GOALS vs EDU Training||21
7682956|NCT01921179|18921813|P2|STARTED|5 Week Randomized GOALS vs EDU Training||22
7682957|NCT01921179|18921814|P1|STARTED|5 Week Randomized GOALS vs EDU Training||24
7682958|NCT01921166|18921829|P2|NOT COMPLETED|Overall Study||0
7682959|NCT01921166|18921830|P1|NOT COMPLETED|Overall Study||0
7682960|NCT01921166|18921829|P2|COMPLETED|Overall Study||15
7682961|NCT01921166|18921830|P1|COMPLETED|Overall Study||8
7682962|NCT01921166|18921829|P2|STARTED|Overall Study||15
7682963|NCT01921166|18921830|P1|STARTED|Overall Study||8
7682964|NCT01921114|18921840|P2|NOT COMPLETED|Overall Study||0
7682965|NCT01921114|18921841|P1|NOT COMPLETED|Overall Study||0
7682966|NCT01921114|18921840|P2|COMPLETED|Overall Study||0
7682967|NCT01921114|18921841|P1|COMPLETED|Overall Study||0
7682968|NCT01921114|18921840|P2|STARTED|Overall Study||0
7682969|NCT01921114|18921841|P1|STARTED|Overall Study||0
7682970|NCT01921101|18921851|P2|NOT COMPLETED|Overall Study||6
7682971|NCT01921101|18921852|P1|NOT COMPLETED|Overall Study||16
7682972|NCT01921101|18921851|P2|COMPLETED|Overall Study||32
7682973|NCT01921101|18921852|P1|COMPLETED|Overall Study||24
7682974|NCT01921101|18921851|P2|STARTED|Overall Study||38
7682975|NCT01921101|18921852|P1|STARTED|Overall Study||40
7682976|NCT01920958|18921860|P1|NOT COMPLETED|Overall Study||5
7682977|NCT01920958|18921860|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228
7682978|NCT01920958|18921860|P1|STARTED|Overall Study||233
7682979|NCT01920893|18921878|P2|NOT COMPLETED|Overall Study||2
7682980|NCT01920893|18921879|P1|NOT COMPLETED|Overall Study||7
7682981|NCT01920893|18921878|P2|COMPLETED|Overall Study||28
7682982|NCT01920893|18921879|P1|COMPLETED|Overall Study||23
7682983|NCT01920893|18921878|P2|Treated (Safety Population)|Overall Study||30
7682984|NCT01920893|18921879|P1|Treated (Safety Population)|Overall Study||30
7682985|NCT01920893|18921878|P2|STARTED|Overall Study||30
7682986|NCT01920893|18921879|P1|STARTED|Overall Study||30
7682987|NCT01920854|18921912|P7|NOT COMPLETED|Overall Study||1
7682988|NCT01920854|18921913|P6|NOT COMPLETED|Overall Study||0
7682989|NCT01920854|18921914|P5|NOT COMPLETED|Overall Study||1
7682990|NCT01920854|18921915|P4|NOT COMPLETED|Overall Study||0
7682991|NCT01920854|18921916|P3|NOT COMPLETED|Overall Study||0
7682992|NCT01920854|18921917|P2|NOT COMPLETED|Overall Study||0
7682993|NCT01920854|18921918|P1|NOT COMPLETED|Overall Study||1
7682994|NCT01920854|18921912|P7|COMPLETED|Overall Study||5
7682995|NCT01920854|18921913|P6|COMPLETED|Overall Study||6
7682996|NCT01920854|18921914|P5|COMPLETED|Overall Study||5
7682997|NCT01920854|18921915|P4|COMPLETED|Overall Study||6
7682998|NCT01920854|18921916|P3|COMPLETED|Overall Study||6
7682999|NCT01920854|18921917|P2|COMPLETED|Overall Study||6
7683000|NCT01920854|18921918|P1|COMPLETED|Overall Study||11
7683001|NCT01920854|18921912|P7|STARTED|Overall Study||6
7683002|NCT01920854|18921913|P6|STARTED|Overall Study||6
7683003|NCT01920854|18921914|P5|STARTED|Overall Study||6
7683004|NCT01920854|18921915|P4|STARTED|Overall Study||6
7683005|NCT01920854|18921916|P3|STARTED|Overall Study||6
7683006|NCT01920854|18921917|P2|STARTED|Overall Study||6
7683007|NCT01920854|18921918|P1|STARTED|Overall Study||12
7683008|NCT01920802|18922045|P3|NOT COMPLETED|Overall Study||1
7683009|NCT01920802|18922046|P2|NOT COMPLETED|Overall Study||2
7683010|NCT01920802|18922047|P1|NOT COMPLETED|Overall Study||4
7683011|NCT01920802|18922045|P3|COMPLETED|Overall Study||10
7683012|NCT01920802|18922046|P2|COMPLETED|Overall Study||7
7683013|NCT01920802|18922047|P1|COMPLETED|Overall Study||7
7683014|NCT01920802|18922045|P3|STARTED|Overall Study||11
7683015|NCT01920802|18922046|P2|STARTED|Overall Study||9
7683016|NCT01920802|18922047|P1|STARTED|Overall Study||11
7683017|NCT01920711|18922078|P2|NOT COMPLETED|Overall Study||373
7683018|NCT01920711|18922079|P1|NOT COMPLETED|Overall Study||364
7683019|NCT01920711|18922078|P2|COMPLETED|Overall Study||2030
7683020|NCT01920711|18922079|P1|COMPLETED|Overall Study||2055
7683021|NCT01920711|18922078|P2|STARTED|Overall Study||2403
7683022|NCT01920711|18922079|P1|STARTED|Overall Study||2419
7683023|NCT01920594|18922096|P2|NOT COMPLETED|Overall Study||3
7683024|NCT01920594|18922097|P1|NOT COMPLETED|Overall Study||7
7683025|NCT01920594|18922096|P2|COMPLETED|Overall Study||25
7683026|NCT01920594|18922097|P1|COMPLETED|Overall Study||20
7683027|NCT01920594|18922096|P2|STARTED|Overall Study||28
7683028|NCT01920594|18922097|P1|STARTED|Overall Study||27
7683029|NCT01920568|18922147|P2|NOT COMPLETED|Overall Study||84
7683030|NCT01920568|18922148|P1|NOT COMPLETED|Overall Study||151
7683031|NCT01920568|18922147|P2|COMPLETED|Overall Study||75
7683032|NCT01920568|18922148|P1|COMPLETED|Overall Study||175
7683033|NCT01920568|18922147|P2|STARTED|Overall Study||159
7683034|NCT01920568|18922148|P1|STARTED|Overall Study||326
7683035|NCT01920555|18922174|P5|NOT COMPLETED|Overall Study||1
7683036|NCT01920555|18922175|P4|NOT COMPLETED|Overall Study||3
7683037|NCT01920555|18922176|P3|NOT COMPLETED|Overall Study||1
7683038|NCT01920555|18922177|P2|NOT COMPLETED|Overall Study||4
7683039|NCT01920555|18922178|P1|NOT COMPLETED|Overall Study||4
7683040|NCT01920555|18922174|P5|COMPLETED|Overall Study||18
7683041|NCT01920555|18922175|P4|COMPLETED|Overall Study||17
7683042|NCT01920555|18922176|P3|COMPLETED|Overall Study||21
7683043|NCT01920555|18922177|P2|COMPLETED|Overall Study||16
7683044|NCT01920555|18922178|P1|COMPLETED|Overall Study||14
7683045|NCT01920555|18922174|P5|STARTED|Overall Study||19
7683046|NCT01920555|18922175|P4|STARTED|Overall Study||20
7683047|NCT01920555|18922176|P3|STARTED|Overall Study||22
7683048|NCT01920555|18922177|P2|STARTED|Overall Study||20
7683049|NCT01920555|18922178|P1|STARTED|Overall Study||18
7683050|NCT01920477|18922237|P2|NOT COMPLETED|Overall Study||17
7683051|NCT01920477|18922238|P1|NOT COMPLETED|Overall Study||15
7683052|NCT01920477|18922237|P2|COMPLETED|Overall Study||1
7683053|NCT01920477|18922238|P1|COMPLETED|Overall Study||2
7683054|NCT01920477|18922237|P2|Requiried Individualized Follow-up|Overall Study||0
7683055|NCT01920477|18922238|P1|Requiried Individualized Follow-up|Overall Study||1
7683056|NCT01920477|18922237|P2|STARTED|Overall Study||18
7683057|NCT01920477|18922238|P1|STARTED|Overall Study||17
7683058|NCT01920282|18922272|P3|NOT COMPLETED|Overall Study||0
7683059|NCT01920282|18922273|P2|NOT COMPLETED|Overall Study||0
7683060|NCT01920282|18922274|P1|NOT COMPLETED|Overall Study||0
7683061|NCT01920282|18922272|P3|COMPLETED|Overall Study||15
7683062|NCT01920282|18922273|P2|COMPLETED|Overall Study||15
7683063|NCT01920282|18922274|P1|COMPLETED|Overall Study||15
7683064|NCT01920282|18922272|P3|STARTED|Overall Study||15
7683065|NCT01920282|18922273|P2|STARTED|Overall Study||15
7683066|NCT01920282|18922274|P1|STARTED|Overall Study||15
7683067|NCT01920178|18922287|P2|NOT COMPLETED|Overall Study||1
7683068|NCT01920178|18922288|P1|NOT COMPLETED|Overall Study||2
7683069|NCT01920178|18922287|P2|COMPLETED|Overall Study||1
7683070|NCT01920178|18922288|P1|COMPLETED|Overall Study||3
7683071|NCT01920178|18922287|P2|STARTED|Overall Study||2
7683072|NCT01920178|18922288|P1|STARTED|Overall Study||5
7683073|NCT01919996|18922298|P1|NOT COMPLETED|Overall Study||0
7683074|NCT01919996|18922298|P1|COMPLETED|Overall Study||8
7683075|NCT01919996|18922298|P1|STARTED|Overall Study||8
7683076|NCT01919970|18922306|P2|NOT COMPLETED|Overall Study||0
7683077|NCT01919970|18922307|P1|NOT COMPLETED|Overall Study||3
7683078|NCT01919970|18922306|P2|COMPLETED|Overall Study||18
7683079|NCT01919970|18922307|P1|COMPLETED|Overall Study||11
7683080|NCT01919970|18922306|P2|STARTED|Overall Study||18
7683081|NCT01919970|18922307|P1|STARTED|Overall Study||14
7683082|NCT01919814|18922315|P2|NOT COMPLETED|Overall Study||0
7683083|NCT01919814|18922316|P1|NOT COMPLETED|Overall Study||3
7683084|NCT01919814|18922315|P2|COMPLETED|Overall Study||30
7683085|NCT01919814|18922316|P1|COMPLETED|Overall Study||27
7683086|NCT01919814|18922315|P2|STARTED|Overall Study||30
7683087|NCT01919814|18922316|P1|STARTED|Overall Study||30
7683088|NCT01919801|18922328|P2|NOT COMPLETED|Overall Study||3
7683089|NCT01919801|18922329|P1|NOT COMPLETED|Overall Study||1
7683090|NCT01919801|18922328|P2|COMPLETED|Overall Study||57
7683091|NCT01919801|18922329|P1|COMPLETED|Overall Study||60
7683092|NCT01919801|18922328|P2|STARTED|Overall Study||60
7683093|NCT01919801|18922329|P1|STARTED|Overall Study||61
7683094|NCT01919723|18922354|P2|NOT COMPLETED|Overall Study||2
7683095|NCT01919723|18922355|P1|NOT COMPLETED|Overall Study||2
7683096|NCT01919723|18922354|P2|COMPLETED|Overall Study||33
7683097|NCT01919723|18922355|P1|COMPLETED|Overall Study||33
7683098|NCT01919723|18922354|P2|STARTED|Overall Study||35
7683099|NCT01919723|18922355|P1|STARTED|Overall Study||35
7683100|NCT01919697|18922369|P2|NOT COMPLETED|Overall Study||385
7683101|NCT01919697|18922370|P1|NOT COMPLETED|Overall Study||53
7683102|NCT01919697|18922369|P2|COMPLETED|Overall Study||1761
7683103|NCT01919697|18922370|P1|COMPLETED|Overall Study||171
7683104|NCT01919697|18922369|P2|STARTED|Overall Study||2146
7683105|NCT01919697|18922370|P1|STARTED|Overall Study||224
7683106|NCT01919606|18922400|P2|NOT COMPLETED|Overall Study||0
7683107|NCT01919606|18922401|P1|NOT COMPLETED|Overall Study||0
7683108|NCT01919606|18922400|P2|COMPLETED|Overall Study||0
7683109|NCT01919606|18922401|P1|COMPLETED|Overall Study||1
7683110|NCT01919606|18922400|P2|STARTED|Overall Study||0
7683111|NCT01919606|18922401|P1|STARTED|Overall Study||1
7683112|NCT01919450|18922413|P4|NOT COMPLETED|Overall Study||1
7683113|NCT01919450|18922414|P3|NOT COMPLETED|Overall Study||0
7683114|NCT01919450|18922415|P2|NOT COMPLETED|Overall Study||0
7683115|NCT01919450|18922416|P1|NOT COMPLETED|Overall Study||0
7683116|NCT01919450|18922413|P4|COMPLETED|Overall Study||19
7683117|NCT01919450|18922414|P3|COMPLETED|Overall Study||20
7683118|NCT01919450|18922415|P2|COMPLETED|Overall Study||20
7683119|NCT01919450|18922416|P1|COMPLETED|Overall Study||20
7683120|NCT01919450|18922413|P4|STARTED|Overall Study||20
7683121|NCT01919450|18922414|P3|STARTED|Overall Study||20
7683122|NCT01919450|18922415|P2|STARTED|Overall Study||20
7683123|NCT01919450|18922416|P1|STARTED|Overall Study||20
7683124|NCT01919411|18922428|P2|NOT COMPLETED|Overall Study||5
7683125|NCT01919411|18922429|P1|NOT COMPLETED|Overall Study||5
7683126|NCT01919411|18922428|P2|COMPLETED|Overall Study||41
7683127|NCT01919411|18922429|P1|COMPLETED|Overall Study||38
7683128|NCT01919411|18922428|P2|STARTED|Overall Study||46
7683129|NCT01919411|18922429|P1|STARTED|Overall Study||43
7683130|NCT01919398|18922448|P3|NOT COMPLETED|Overall Study||4
7683131|NCT01919398|18922449|P2|NOT COMPLETED|Overall Study||0
7683132|NCT01919398|18922450|P1|NOT COMPLETED|Overall Study||0
7683133|NCT01919398|18922448|P3|COMPLETED|Overall Study||9
7683134|NCT01919398|18922449|P2|COMPLETED|Overall Study||3
7683135|NCT01919398|18922450|P1|COMPLETED|Overall Study||3
7683136|NCT01919398|18922448|P3|Received at Least One Dose of Study Drug|Overall Study||13
7683137|NCT01919398|18922449|P2|Received at Least One Dose of Study Drug|Overall Study||3
7683138|NCT01919398|18922450|P1|Received at Least One Dose of Study Drug|Overall Study||3
7683139|NCT01919398|18922448|P3|STARTED|Overall Study||13
7683140|NCT01919398|18922449|P2|STARTED|Overall Study||3
7683141|NCT01919398|18922450|P1|STARTED|Overall Study||3
7683142|NCT01919307|18922470|P1|NOT COMPLETED|Overall Study||9
7683143|NCT01919307|18922470|P1|COMPLETED|Overall Study||20
7683144|NCT01919307|18922470|P1|STARTED|Overall Study||29
7683145|NCT01919229|18922480|P3|NOT COMPLETED|Overall Study||1
7683146|NCT01919229|18922481|P2|NOT COMPLETED|Overall Study||0
7683147|NCT01919229|18922482|P1|NOT COMPLETED|Overall Study||0
7683148|NCT01919229|18922480|P3|COMPLETED|Overall Study||3
7683149|NCT01919229|18922481|P2|COMPLETED|Overall Study||6
7683150|NCT01919229|18922482|P1|COMPLETED|Overall Study||4
7683151|NCT01919229|18922480|P3|STARTED|Overall Study||4
7683152|NCT01919229|18922481|P2|STARTED|Overall Study||6
7683153|NCT01919229|18922482|P1|STARTED|Overall Study||4
7683154|NCT01919216|18922514|P3|NOT COMPLETED|Overall Study||1
7683155|NCT01919216|18922515|P2|NOT COMPLETED|Overall Study||1
7683156|NCT01919216|18922516|P1|NOT COMPLETED|Overall Study||2
7683157|NCT01919216|18922514|P3|COMPLETED|Overall Study||4
7683158|NCT01919216|18922515|P2|COMPLETED|Overall Study||20
7683159|NCT01919216|18922516|P1|COMPLETED|Overall Study||26
7683160|NCT01919216|18922514|P3|STARTED|Overall Study||5
7683161|NCT01919216|18922515|P2|STARTED|Overall Study||21
7683162|NCT01919216|18922516|P1|STARTED|Overall Study||28
7683163|NCT01919164|18922529|P5|NOT COMPLETED|Overall Study||33
7683164|NCT01919164|18922530|P4|NOT COMPLETED|Overall Study||28
7683165|NCT01919164|18922531|P3|NOT COMPLETED|Overall Study||37
7683166|NCT01919164|18922532|P2|NOT COMPLETED|Overall Study||30
7683167|NCT01919164|18922533|P1|NOT COMPLETED|Overall Study||43
7683168|NCT01919164|18922529|P5|COMPLETED|Overall Study||77
7683169|NCT01919164|18922530|P4|COMPLETED|Overall Study||82
7683170|NCT01919164|18922531|P3|COMPLETED|Overall Study||74
7683171|NCT01919164|18922532|P2|COMPLETED|Overall Study||80
7683172|NCT01919164|18922533|P1|COMPLETED|Overall Study||65
7683173|NCT01919164|18922529|P5|Safety Analysis Set|Overall Study||109
7683174|NCT01919164|18922530|P4|Safety Analysis Set|Overall Study|1 participant in Sprifermin2 Cycles arm who inadvertently received 100 mcg was included in this arm.|111
7683175|NCT01919164|18922531|P3|Safety Analysis Set|Overall Study||111
7683176|NCT01919164|18922532|P2|Safety Analysis Set|Overall Study|1 participant assigned to Placebo arm who inadvertently received 30 mcg was included in this arm.|109
7683177|NCT01919164|18922533|P1|Safety Analysis Set|Overall Study||107
7683178|NCT01919164|18922529|P5|STARTED|Overall Study||110
7683179|NCT01919164|18922530|P4|STARTED|Overall Study||110
7683180|NCT01919164|18922531|P3|STARTED|Overall Study||111
7683181|NCT01919164|18922532|P2|STARTED|Overall Study||110
7683182|NCT01919164|18922533|P1|STARTED|Overall Study||108
7683183|NCT01919112|18922588|P3|NOT COMPLETED|Secondary Analysis-day 30||1
7683184|NCT01919112|18922589|P2|NOT COMPLETED|Secondary Analysis-day 30||1
7683185|NCT01919112|18922590|P1|NOT COMPLETED|Secondary Analysis-day 30||2
7683186|NCT01919112|18922588|P3|COMPLETED|Secondary Analysis-day 30||14
7683187|NCT01919112|18922589|P2|COMPLETED|Secondary Analysis-day 30||12
7683188|NCT01919112|18922590|P1|COMPLETED|Secondary Analysis-day 30||12
7683189|NCT01919112|18922588|P3|STARTED|Secondary Analysis-day 30||15
7683190|NCT01919112|18922589|P2|STARTED|Secondary Analysis-day 30||13
7683191|NCT01919112|18922590|P1|STARTED|Secondary Analysis-day 30||14
7683192|NCT01919112|18922588|P3|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
7683193|NCT01919112|18922589|P2|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
7683194|NCT01919112|18922590|P1|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
7683195|NCT01919112|18922588|P3|COMPLETED|Primary Analysis-day 5 of Intervention||15
7683196|NCT01919112|18922589|P2|COMPLETED|Primary Analysis-day 5 of Intervention||13
7683197|NCT01919112|18922590|P1|COMPLETED|Primary Analysis-day 5 of Intervention||14
7683198|NCT01919112|18922588|P3|STARTED|Primary Analysis-day 5 of Intervention||15
7683199|NCT01919112|18922589|P2|STARTED|Primary Analysis-day 5 of Intervention||13
7683200|NCT01919112|18922590|P1|STARTED|Primary Analysis-day 5 of Intervention||14
7683201|NCT01918800|18922630|P2|NOT COMPLETED|Overall Study||5
7683202|NCT01918800|18922631|P1|NOT COMPLETED|Overall Study||9
7683203|NCT01918800|18922630|P2|COMPLETED|Overall Study||104
7683204|NCT01918800|18922631|P1|COMPLETED|Overall Study||100
7683205|NCT01918800|18922630|P2|STARTED|Overall Study||109
7683206|NCT01918800|18922631|P1|STARTED|Overall Study||109
7683207|NCT01918774|18922649|P1|NOT COMPLETED|Overall Study||5
7683208|NCT01918774|18922649|P1|COMPLETED|Overall Study||52
7683209|NCT01918774|18922649|P1|STARTED|Overall Study||57
7683210|NCT01918761|18922664|P1|NOT COMPLETED|Overall Study||0
7683211|NCT01918761|18922664|P1|COMPLETED|Overall Study||5
7683212|NCT01918761|18922664|P1|STARTED|Overall Study||5
7683213|NCT01918371|18922673|P2|NOT COMPLETED|Overall Study||1
7683214|NCT01918371|18922674|P1|NOT COMPLETED|Overall Study||1
7683215|NCT01918371|18922673|P2|COMPLETED|Overall Study||156
7683216|NCT01918371|18922674|P1|COMPLETED|Overall Study||165
7683217|NCT01918371|18922673|P2|Participants With Complete Data|Overall Study||156
7683218|NCT01918371|18922674|P1|Participants With Complete Data|Overall Study||165
7683219|NCT01918371|18922673|P2|STARTED|Overall Study||157
7683220|NCT01918371|18922674|P1|STARTED|Overall Study||166
7683221|NCT01918332|18922752|P4|NOT COMPLETED|Overall Study||7
7683222|NCT01918332|18922753|P3|NOT COMPLETED|Overall Study||9
7683223|NCT01918332|18922754|P2|NOT COMPLETED|Overall Study||5
7683224|NCT01918332|18922755|P1|NOT COMPLETED|Overall Study||8
7683225|NCT01918332|18922752|P4|COMPLETED|Overall Study||38
7683226|NCT01918332|18922753|P3|COMPLETED|Overall Study||30
7683227|NCT01918332|18922754|P2|COMPLETED|Overall Study||36
7683228|NCT01918332|18922755|P1|COMPLETED|Overall Study||35
7683229|NCT01918332|18922752|P4|STARTED|Overall Study||45
7683230|NCT01918332|18922753|P3|STARTED|Overall Study||39
7683231|NCT01918332|18922754|P2|STARTED|Overall Study||41
7683232|NCT01918332|18922755|P1|STARTED|Overall Study||43
7683233|NCT01918306|18922767|P4|NOT COMPLETED|Overall Study||3
7683234|NCT01918306|18922768|P3|NOT COMPLETED|Overall Study||2
7683235|NCT01918306|18922769|P2|NOT COMPLETED|Overall Study||0
7683236|NCT01918306|18922770|P1|NOT COMPLETED|Overall Study||6
7683237|NCT01918306|18922767|P4|COMPLETED|Overall Study||0
7683238|NCT01918306|18922768|P3|COMPLETED|Overall Study||0
7683239|NCT01918306|18922769|P2|COMPLETED|Overall Study||0
7683240|NCT01918306|18922770|P1|COMPLETED|Overall Study||0
7683241|NCT01918306|18922767|P4|STARTED|Overall Study||3
7683242|NCT01918306|18922768|P3|STARTED|Overall Study|1 participant Crossed-over to ARM 2|2
7683243|NCT01918306|18922769|P2|STARTED|Overall Study|No patients enrolled|0
7683244|NCT01918306|18922770|P1|STARTED|Overall Study||6
7683245|NCT01918189|18922790|P1|NOT COMPLETED|Overall Study||18
7683246|NCT01918189|18922790|P1|COMPLETED|Overall Study||41
7683247|NCT01918189|18922790|P1|Completed Follow-up Assessment|Overall Study||41
7683248|NCT01918189|18922790|P1|Completed Baseline Assessment|Overall Study||58
7683249|NCT01918189|18922790|P1|STARTED|Overall Study||59
7683250|NCT01918085|18922801|P2|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
7683251|NCT01918085|18922802|P1|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
7683252|NCT01918085|18922801|P2|COMPLETED|Test Period 2: Hydrocolloid Strip||11
7683253|NCT01918085|18922802|P1|COMPLETED|Test Period 2: Hydrocolloid Strip||10
7683254|NCT01918085|18922801|P2|STARTED|Test Period 2: Hydrocolloid Strip||11
7683255|NCT01918085|18922802|P1|STARTED|Test Period 2: Hydrocolloid Strip||10
7683256|NCT01918085|18922801|P2|NOT COMPLETED|Test Period 2: Strata Strip||0
7683257|NCT01918085|18922802|P1|NOT COMPLETED|Test Period 2: Strata Strip||0
7683258|NCT01918085|18922801|P2|COMPLETED|Test Period 2: Strata Strip||11
7683259|NCT01918085|18922802|P1|COMPLETED|Test Period 2: Strata Strip||10
7683260|NCT01918085|18922801|P2|STARTED|Test Period 2: Strata Strip||11
7683261|NCT01918085|18922802|P1|STARTED|Test Period 2: Strata Strip||10
7683262|NCT01918085|18922801|P2|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
7683263|NCT01918085|18922802|P1|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
7683264|NCT01918085|18922801|P2|COMPLETED|Test Period 1: Hydrocolloid Strip||11
7683265|NCT01918085|18922802|P1|COMPLETED|Test Period 1: Hydrocolloid Strip||10
7683266|NCT01918085|18922801|P2|STARTED|Test Period 1: Hydrocolloid Strip||11
7683267|NCT01918085|18922802|P1|STARTED|Test Period 1: Hydrocolloid Strip||10
7683268|NCT01918085|18922801|P2|NOT COMPLETED|Test Period 1: Strata Strip||1
7683269|NCT01918085|18922802|P1|NOT COMPLETED|Test Period 1: Strata Strip||0
7683270|NCT01918085|18922801|P2|COMPLETED|Test Period 1: Strata Strip||11
7683271|NCT01918085|18922802|P1|COMPLETED|Test Period 1: Strata Strip||10
7683272|NCT01918085|18922801|P2|STARTED|Test Period 1: Strata Strip||12
7683273|NCT01918085|18922802|P1|STARTED|Test Period 1: Strata Strip||10
7683274|NCT01918072|18922810|P3|NOT COMPLETED|Quality Assessment Period||0
7683275|NCT01918072|18922811|P2|NOT COMPLETED|Quality Assessment Period||0
7683276|NCT01918072|18922812|P1|NOT COMPLETED|Quality Assessment Period||0
7683277|NCT01918072|18922810|P3|COMPLETED|Quality Assessment Period||202
7683278|NCT01918072|18922811|P2|COMPLETED|Quality Assessment Period||0
7683279|NCT01918072|18922812|P1|COMPLETED|Quality Assessment Period||0
7683280|NCT01918072|18922810|P3|STARTED|Quality Assessment Period||202
7683281|NCT01918072|18922811|P2|STARTED|Quality Assessment Period||0
7683282|NCT01918072|18922812|P1|STARTED|Quality Assessment Period||0
7683283|NCT01918072|18922810|P3|NOT COMPLETED|E-consult Assessment Period||0
7683284|NCT01918072|18922811|P2|NOT COMPLETED|E-consult Assessment Period||0
7683285|NCT01918072|18922812|P1|NOT COMPLETED|E-consult Assessment Period||0
7683286|NCT01918072|18922810|P3|COMPLETED|E-consult Assessment Period||0
7683287|NCT01918072|18922811|P2|COMPLETED|E-consult Assessment Period||42
7683288|NCT01918072|18922812|P1|COMPLETED|E-consult Assessment Period||0
7683289|NCT01918072|18922810|P3|STARTED|E-consult Assessment Period||0
7683290|NCT01918072|18922811|P2|STARTED|E-consult Assessment Period||42
7683291|NCT01918072|18922812|P1|STARTED|E-consult Assessment Period||0
7683292|NCT01918072|18922810|P3|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
7683293|NCT01918072|18922811|P2|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
7683294|NCT01918072|18922812|P1|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
7683295|NCT01918072|18922810|P3|COMPLETED|Controlled Trial Step Five - Four Months||0
7683296|NCT01918072|18922811|P2|COMPLETED|Controlled Trial Step Five - Four Months||0
7683297|NCT01918072|18922812|P1|COMPLETED|Controlled Trial Step Five - Four Months||11
7683298|NCT01918072|18922810|P3|Control|Controlled Trial Step Five - Four Months||0
7683299|NCT01918072|18922811|P2|Control|Controlled Trial Step Five - Four Months||0
7683300|NCT01918072|18922812|P1|Control|Controlled Trial Step Five - Four Months||0
7683301|NCT01918072|18922810|P3|Intervention|Controlled Trial Step Five - Four Months||0
7683302|NCT01918072|18922811|P2|Intervention|Controlled Trial Step Five - Four Months||0
7683303|NCT01918072|18922812|P1|Intervention|Controlled Trial Step Five - Four Months||11
7683304|NCT01918072|18922810|P3|STARTED|Controlled Trial Step Five - Four Months||0
7683305|NCT01918072|18922811|P2|STARTED|Controlled Trial Step Five - Four Months||0
7683306|NCT01918072|18922812|P1|STARTED|Controlled Trial Step Five - Four Months||11
7683307|NCT01918072|18922810|P3|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
7683308|NCT01918072|18922811|P2|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
7683309|NCT01918072|18922812|P1|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
7683310|NCT01918072|18922810|P3|COMPLETED|Controlled Trial Step Four - Six Months||0
7683311|NCT01918072|18922811|P2|COMPLETED|Controlled Trial Step Four - Six Months||0
7683312|NCT01918072|18922812|P1|COMPLETED|Controlled Trial Step Four - Six Months||11
7683313|NCT01918072|18922810|P3|Control|Controlled Trial Step Four - Six Months||0
7683314|NCT01918072|18922811|P2|Control|Controlled Trial Step Four - Six Months||0
7683315|NCT01918072|18922812|P1|Control|Controlled Trial Step Four - Six Months||0
7683316|NCT01918072|18922810|P3|Intervention|Controlled Trial Step Four - Six Months||0
7683317|NCT01918072|18922811|P2|Intervention|Controlled Trial Step Four - Six Months||0
7683318|NCT01918072|18922812|P1|Intervention|Controlled Trial Step Four - Six Months||11
7683319|NCT01918072|18922810|P3|STARTED|Controlled Trial Step Four - Six Months||0
7683320|NCT01918072|18922811|P2|STARTED|Controlled Trial Step Four - Six Months||0
7683321|NCT01918072|18922812|P1|STARTED|Controlled Trial Step Four - Six Months||11
7683322|NCT01918072|18922810|P3|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
7683323|NCT01918072|18922811|P2|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
7683324|NCT01918072|18922812|P1|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
7683325|NCT01918072|18922810|P3|COMPLETED|Controlled Trial Step Three - Six Months||0
7683326|NCT01918072|18922811|P2|COMPLETED|Controlled Trial Step Three - Six Months||0
7683327|NCT01918072|18922812|P1|COMPLETED|Controlled Trial Step Three - Six Months||11
7683328|NCT01918072|18922810|P3|Control|Controlled Trial Step Three - Six Months||0
7683329|NCT01918072|18922811|P2|Control|Controlled Trial Step Three - Six Months||0
7683330|NCT01918072|18922812|P1|Control|Controlled Trial Step Three - Six Months||2
7683331|NCT01918072|18922810|P3|Intervention|Controlled Trial Step Three - Six Months||0
7683332|NCT01918072|18922811|P2|Intervention|Controlled Trial Step Three - Six Months||0
7683333|NCT01918072|18922812|P1|Intervention|Controlled Trial Step Three - Six Months||9
7683334|NCT01918072|18922810|P3|STARTED|Controlled Trial Step Three - Six Months||0
7683335|NCT01918072|18922811|P2|STARTED|Controlled Trial Step Three - Six Months||0
7683336|NCT01918072|18922812|P1|STARTED|Controlled Trial Step Three - Six Months||11
7683337|NCT01918072|18922810|P3|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
7683338|NCT01918072|18922811|P2|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
7683339|NCT01918072|18922812|P1|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
7683340|NCT01918072|18922810|P3|COMPLETED|Controlled Trial Step Two - Six Months||0
7683341|NCT01918072|18922811|P2|COMPLETED|Controlled Trial Step Two - Six Months||0
7683342|NCT01918072|18922812|P1|COMPLETED|Controlled Trial Step Two - Six Months||11
7683343|NCT01918072|18922810|P3|Control|Controlled Trial Step Two - Six Months||0
7683344|NCT01918072|18922811|P2|Control|Controlled Trial Step Two - Six Months||0
7683345|NCT01918072|18922812|P1|Control|Controlled Trial Step Two - Six Months||4
7683346|NCT01918072|18922810|P3|Intervention|Controlled Trial Step Two - Six Months||0
7683347|NCT01918072|18922811|P2|Intervention|Controlled Trial Step Two - Six Months||0
7683348|NCT01918072|18922812|P1|Intervention|Controlled Trial Step Two - Six Months||7
7683349|NCT01918072|18922810|P3|STARTED|Controlled Trial Step Two - Six Months||0
7683350|NCT01918072|18922811|P2|STARTED|Controlled Trial Step Two - Six Months||0
7683351|NCT01918072|18922812|P1|STARTED|Controlled Trial Step Two - Six Months||11
7683352|NCT01918072|18922810|P3|NOT COMPLETED|Controlled Trial Step One - Six Months||0
7683353|NCT01918072|18922811|P2|NOT COMPLETED|Controlled Trial Step One - Six Months||0
7683354|NCT01918072|18922812|P1|NOT COMPLETED|Controlled Trial Step One - Six Months||0
7683355|NCT01918072|18922810|P3|COMPLETED|Controlled Trial Step One - Six Months||0
7683356|NCT01918072|18922811|P2|COMPLETED|Controlled Trial Step One - Six Months||0
7683357|NCT01918072|18922812|P1|COMPLETED|Controlled Trial Step One - Six Months||11
7683358|NCT01918072|18922810|P3|Control|Controlled Trial Step One - Six Months||0
7683359|NCT01918072|18922811|P2|Control|Controlled Trial Step One - Six Months||0
7683360|NCT01918072|18922812|P1|Control|Controlled Trial Step One - Six Months||10
7683361|NCT01918072|18922810|P3|Intervention|Controlled Trial Step One - Six Months||0
7683362|NCT01918072|18922811|P2|Intervention|Controlled Trial Step One - Six Months||0
7683363|NCT01918072|18922812|P1|Intervention|Controlled Trial Step One - Six Months||1
7683364|NCT01918072|18922810|P3|STARTED|Controlled Trial Step One - Six Months||0
7683365|NCT01918072|18922811|P2|STARTED|Controlled Trial Step One - Six Months||0
7683366|NCT01918072|18922812|P1|STARTED|Controlled Trial Step One - Six Months||11
7683367|NCT01918033|18922826|P3|NOT COMPLETED|Overall Study||3
7683368|NCT01918033|18922827|P2|NOT COMPLETED|Overall Study||2
7683369|NCT01918033|18922828|P1|NOT COMPLETED|Overall Study||5
7683370|NCT01918033|18922826|P3|COMPLETED|Overall Study||199
7683371|NCT01918033|18922827|P2|COMPLETED|Overall Study||201
7683372|NCT01918033|18922828|P1|COMPLETED|Overall Study||198
7683373|NCT01918033|18922826|P3|Treated|Overall Study|One randomized participant did not receive study drug.|201
7683374|NCT01918033|18922827|P2|Treated|Overall Study||203
7683375|NCT01918033|18922828|P1|Treated|Overall Study|One randomized participant did not receive study drug.|202
7683376|NCT01918033|18922826|P3|STARTED|Overall Study||202
7683377|NCT01918033|18922827|P2|STARTED|Overall Study||203
7683378|NCT01918033|18922828|P1|STARTED|Overall Study||203
7683379|NCT01917812|18922869|P3|NOT COMPLETED|Overall Study||0
7683380|NCT01917812|18922870|P2|NOT COMPLETED|Overall Study||0
7683381|NCT01917812|18922871|P1|NOT COMPLETED|Overall Study||1
7683382|NCT01917812|18922869|P3|COMPLETED|Overall Study||16
7683383|NCT01917812|18922870|P2|COMPLETED|Overall Study||16
7683384|NCT01917812|18922871|P1|COMPLETED|Overall Study||15
7683385|NCT01917812|18922869|P3|STARTED|Overall Study||16
7683386|NCT01917812|18922870|P2|STARTED|Overall Study||16
7683387|NCT01917812|18922871|P1|STARTED|Overall Study||16
7683388|NCT01917773|18922891|P1|NOT COMPLETED|Overall Study||0
7683389|NCT01917773|18922891|P1|COMPLETED|Overall Study||13
7683390|NCT01917773|18922891|P1|STARTED|Overall Study||13
7683391|NCT01917747|18922899|P2|NOT COMPLETED|Overall Study||11
7683392|NCT01917747|18922900|P1|NOT COMPLETED|Overall Study||19
7683393|NCT01917747|18922899|P2|COMPLETED|Overall Study||35
7683394|NCT01917747|18922900|P1|COMPLETED|Overall Study||41
7683395|NCT01917747|18922899|P2|STARTED|Overall Study||46
7683396|NCT01917747|18922900|P1|STARTED|Overall Study||60
7683397|NCT01917682|18922912|P1|NOT COMPLETED|Overall Study||0
7683398|NCT01917682|18922912|P1|COMPLETED|Overall Study||754
7683399|NCT01917682|18922912|P1|STARTED|Overall Study||754
7683400|NCT01917656|18922929|P2|NOT COMPLETED|Overall Study||24
7683401|NCT01917656|18922930|P1|NOT COMPLETED|Overall Study||26
7683402|NCT01917656|18922929|P2|COMPLETED|Overall Study||147
7683403|NCT01917656|18922930|P1|COMPLETED|Overall Study||146
7683404|NCT01917656|18922929|P2|Exposed During Ramadan (Fasting)|Overall Study||163
7683405|NCT01917656|18922930|P1|Exposed During Ramadan (Fasting)|Overall Study||152
7683406|NCT01917656|18922929|P2|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170
7683407|NCT01917656|18922930|P1|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171
7683408|NCT01917656|18922929|P2|STARTED|Overall Study||171
7683409|NCT01917656|18922930|P1|STARTED|Overall Study||172
7683410|NCT01917526|18922956|P2|NOT COMPLETED|Overall Study||1
7683411|NCT01917526|18922957|P1|NOT COMPLETED|Overall Study||1
7683412|NCT01917526|18922956|P2|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249
7683413|NCT01917526|18922957|P1|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249
7683414|NCT01917526|18922956|P2|STARTED|Overall Study||250
7683415|NCT01917526|18922957|P1|STARTED|Overall Study||250
7683416|NCT01917513|18922967|P2|NOT COMPLETED|Overall Study||102
7683417|NCT01917513|18922968|P1|NOT COMPLETED|Overall Study||95
7683418|NCT01917513|18922967|P2|COMPLETED|Overall Study||396
7683419|NCT01917513|18922968|P1|COMPLETED|Overall Study||407
7683420|NCT01917513|18922967|P2|STARTED|Overall Study||498
7683421|NCT01917513|18922968|P1|STARTED|Overall Study||502
7683422|NCT01917344|18922974|P1|NOT COMPLETED|Overall Study||1
7683423|NCT01917344|18922974|P1|COMPLETED|Overall Study||9
7683424|NCT01917344|18922974|P1|STARTED|Overall Study||10
7683425|NCT01917318|18922980|P2|NOT COMPLETED|Second Treatment||0
7683426|NCT01917318|18922981|P1|NOT COMPLETED|Second Treatment||0
7683427|NCT01917318|18922980|P2|COMPLETED|Second Treatment||0
7683428|NCT01917318|18922981|P1|COMPLETED|Second Treatment||0
7683429|NCT01917318|18922980|P2|STARTED|Second Treatment||0
7683430|NCT01917318|18922981|P1|STARTED|Second Treatment||0
7683431|NCT01917318|18922980|P2|NOT COMPLETED|First Treatment||1
7683432|NCT01917318|18922981|P1|NOT COMPLETED|First Treatment||0
7683433|NCT01917318|18922980|P2|COMPLETED|First Treatment||0
7683434|NCT01917318|18922981|P1|COMPLETED|First Treatment||0
7683435|NCT01917318|18922980|P2|STARTED|First Treatment||1
7683436|NCT01917318|18922981|P1|STARTED|First Treatment||0
7683437|NCT01917214|18923001|P1|NOT COMPLETED|Overall Study||0
7683438|NCT01917214|18923001|P1|COMPLETED|Overall Study||212
7683439|NCT01917214|18923001|P1|STARTED|Overall Study||212
7683440|NCT01917188|18923013|P3|NOT COMPLETED|Overall Study||9
7683441|NCT01917188|18923014|P2|NOT COMPLETED|Overall Study||6
7683442|NCT01917188|18923015|P1|NOT COMPLETED|Overall Study||12
7683443|NCT01917188|18923013|P3|COMPLETED|Overall Study||11
7683444|NCT01917188|18923014|P2|COMPLETED|Overall Study||17
7683445|NCT01917188|18923015|P1|COMPLETED|Overall Study||17
7683446|NCT01917188|18923013|P3|STARTED|Overall Study||20
7683447|NCT01917188|18923014|P2|STARTED|Overall Study||23
7683448|NCT01917188|18923015|P1|STARTED|Overall Study||29
7683449|NCT01917136|18923023|P1|NOT COMPLETED|Overall Study||0
7683450|NCT01917136|18923023|P1|COMPLETED|Overall Study||21
7683451|NCT01917136|18923023|P1|STARTED|Overall Study||21
7683452|NCT01917006|18923034|P8|NOT COMPLETED|Open-label Period||2
7683453|NCT01917006|18923035|P7|NOT COMPLETED|Open-label Period||0
7683454|NCT01917006|18923036|P6|NOT COMPLETED|Open-label Period||0
7683455|NCT01917006|18923037|P5|NOT COMPLETED|Open-label Period||0
7683456|NCT01917006|18923038|P4|NOT COMPLETED|Open-label Period||0
7683457|NCT01917006|18923039|P3|NOT COMPLETED|Open-label Period||0
7683458|NCT01917006|18923040|P2|NOT COMPLETED|Open-label Period||0
7683459|NCT01917006|18923041|P1|NOT COMPLETED|Open-label Period||0
7683460|NCT01917006|18923034|P8|COMPLETED|Open-label Period||6
7683461|NCT01917006|18923035|P7|COMPLETED|Open-label Period||0
7683462|NCT01917006|18923036|P6|COMPLETED|Open-label Period||0
7683463|NCT01917006|18923037|P5|COMPLETED|Open-label Period||0
7683464|NCT01917006|18923038|P4|COMPLETED|Open-label Period||0
7683465|NCT01917006|18923039|P3|COMPLETED|Open-label Period||0
7683466|NCT01917006|18923040|P2|COMPLETED|Open-label Period||0
7683467|NCT01917006|18923041|P1|COMPLETED|Open-label Period||0
7683468|NCT01917006|18923034|P8|STARTED|Open-label Period||8
7683469|NCT01917006|18923035|P7|STARTED|Open-label Period||0
7683470|NCT01917006|18923036|P6|STARTED|Open-label Period||0
7683471|NCT01917006|18923037|P5|STARTED|Open-label Period||0
7683472|NCT01917006|18923038|P4|STARTED|Open-label Period||0
7683473|NCT01917006|18923039|P3|STARTED|Open-label Period||0
7683474|NCT01917006|18923040|P2|STARTED|Open-label Period||0
7683475|NCT01917006|18923041|P1|STARTED|Open-label Period||0
7683476|NCT01917006|18923034|P8|NOT COMPLETED|Randomized-treatment Period||0
7683477|NCT01917006|18923035|P7|NOT COMPLETED|Randomized-treatment Period||1
7683478|NCT01917006|18923036|P6|NOT COMPLETED|Randomized-treatment Period||1
7683479|NCT01917006|18923037|P5|NOT COMPLETED|Randomized-treatment Period||0
7683480|NCT01917006|18923038|P4|NOT COMPLETED|Randomized-treatment Period||1
7683481|NCT01917006|18923039|P3|NOT COMPLETED|Randomized-treatment Period||0
7683482|NCT01917006|18923040|P2|NOT COMPLETED|Randomized-treatment Period||0
7683483|NCT01917006|18923041|P1|NOT COMPLETED|Randomized-treatment Period||2
7683484|NCT01917006|18923034|P8|COMPLETED|Randomized-treatment Period||0
7683485|NCT01917006|18923035|P7|COMPLETED|Randomized-treatment Period||14
7683486|NCT01917006|18923036|P6|COMPLETED|Randomized-treatment Period||7
7683487|NCT01917006|18923037|P5|COMPLETED|Randomized-treatment Period||8
7683488|NCT01917006|18923038|P4|COMPLETED|Randomized-treatment Period||7
7683489|NCT01917006|18923039|P3|COMPLETED|Randomized-treatment Period||8
7683490|NCT01917006|18923040|P2|COMPLETED|Randomized-treatment Period||7
7683491|NCT01917006|18923041|P1|COMPLETED|Randomized-treatment Period||3
7683492|NCT01917006|18923034|P8|STARTED|Randomized-treatment Period||0
7683493|NCT01917006|18923035|P7|STARTED|Randomized-treatment Period||15
7683494|NCT01917006|18923036|P6|STARTED|Randomized-treatment Period||8
7683495|NCT01917006|18923037|P5|STARTED|Randomized-treatment Period||8
7683496|NCT01917006|18923038|P4|STARTED|Randomized-treatment Period||8
7683497|NCT01917006|18923039|P3|STARTED|Randomized-treatment Period||8
7683498|NCT01917006|18923040|P2|STARTED|Randomized-treatment Period||7
7683499|NCT01917006|18923041|P1|STARTED|Randomized-treatment Period||5
7683500|NCT01916980|18923074|P2|NOT COMPLETED|Overall Study||4
7683501|NCT01916980|18923075|P1|NOT COMPLETED|Overall Study||7
7683502|NCT01916980|18923074|P2|COMPLETED|Overall Study||25
7683503|NCT01916980|18923075|P1|COMPLETED|Overall Study||58
7683504|NCT01916980|18923074|P2|STARTED|Overall Study||29
7683505|NCT01916980|18923075|P1|STARTED|Overall Study||65
7683506|NCT01916967|18923094|P3|NOT COMPLETED|Overall Study||9
7683507|NCT01916967|18923095|P2|NOT COMPLETED|Overall Study||1
7683508|NCT01916967|18923096|P1|NOT COMPLETED|Overall Study||0
7683509|NCT01916967|18923094|P3|COMPLETED|Overall Study||71
7683510|NCT01916967|18923095|P2|COMPLETED|Overall Study||78
7683511|NCT01916967|18923096|P1|COMPLETED|Overall Study||80
7683512|NCT01916967|18923094|P3|STARTED|Overall Study||80
7683513|NCT01916967|18923095|P2|STARTED|Overall Study||79
7683514|NCT01916967|18923096|P1|STARTED|Overall Study||80
7683515|NCT01916941|18923139|P2|NOT COMPLETED|Overall Study||4
7683516|NCT01916941|18923140|P1|NOT COMPLETED|Overall Study||5
7683517|NCT01916941|18923139|P2|COMPLETED|Overall Study||14
7683518|NCT01916941|18923140|P1|COMPLETED|Overall Study||13
7683519|NCT01916941|18923139|P2|STARTED|Overall Study||18
7683520|NCT01916941|18923140|P1|STARTED|Overall Study||18
7683521|NCT01916928|18923146|P1|NOT COMPLETED|Overall Study||0
7683522|NCT01916928|18923146|P1|COMPLETED|Overall Study||50
7683523|NCT01916928|18923146|P1|STARTED|Overall Study||50
7683524|NCT01916824|18923152|P2|NOT COMPLETED|Overall Study||9
7683525|NCT01916824|18923153|P1|NOT COMPLETED|Overall Study||7
7683526|NCT01916824|18923152|P2|COMPLETED|Overall Study||20
7683527|NCT01916824|18923153|P1|COMPLETED|Overall Study||17
7683528|NCT01916824|18923152|P2|STARTED|Overall Study||29
7683529|NCT01916824|18923153|P1|STARTED|Overall Study||24
7683530|NCT01916681|18923163|P4|NOT COMPLETED|Overall Study||0
7683531|NCT01916681|18923164|P3|NOT COMPLETED|Overall Study||0
7683532|NCT01916681|18923165|P2|NOT COMPLETED|Overall Study||0
7683533|NCT01916681|18923166|P1|NOT COMPLETED|Overall Study||0
7683534|NCT01916681|18923163|P4|COMPLETED|Overall Study||125
7683535|NCT01916681|18923164|P3|COMPLETED|Overall Study||123
7683536|NCT01916681|18923165|P2|COMPLETED|Overall Study||120
7683537|NCT01916681|18923166|P1|COMPLETED|Overall Study||123
7683538|NCT01916681|18923163|P4|STARTED|Overall Study||125
7683539|NCT01916681|18923164|P3|STARTED|Overall Study||123
7683540|NCT01916681|18923165|P2|STARTED|Overall Study||120
7683541|NCT01916681|18923166|P1|STARTED|Overall Study||123
7683542|NCT01916655|18923207|P3|NOT COMPLETED|Overall Study||29
7683543|NCT01916655|18923208|P2|NOT COMPLETED|Overall Study||20
7683544|NCT01916655|18923209|P1|NOT COMPLETED|Overall Study||15
7683545|NCT01916655|18923207|P3|COMPLETED|Overall Study||91
7683546|NCT01916655|18923208|P2|COMPLETED|Overall Study||89
7683547|NCT01916655|18923209|P1|COMPLETED|Overall Study||116
7683548|NCT01916655|18923207|P3|STARTED|Overall Study||120
7683549|NCT01916655|18923208|P2|STARTED|Overall Study||109
7683550|NCT01916655|18923209|P1|STARTED|Overall Study||131
7683551|NCT01916629|18923219|P2|NOT COMPLETED|Overall Study||0
7683552|NCT01916629|18923220|P1|NOT COMPLETED|Overall Study||0
7683553|NCT01916629|18923219|P2|COMPLETED|Overall Study||5
7683554|NCT01916629|18923220|P1|COMPLETED|Overall Study||7
7683555|NCT01916629|18923219|P2|STARTED|Overall Study||5
7683556|NCT01916629|18923220|P1|STARTED|Overall Study||7
7683557|NCT01916590|18923228|P2|NOT COMPLETED|Overall Study||0
7683558|NCT01916590|18923229|P1|NOT COMPLETED|Overall Study||0
7683559|NCT01916590|18923228|P2|COMPLETED|Overall Study||3
7683560|NCT01916590|18923229|P1|COMPLETED|Overall Study||4
7683561|NCT01916590|18923228|P2|STARTED|Overall Study||3
7683562|NCT01916590|18923229|P1|STARTED|Overall Study||4
7683563|NCT01916304|18923235|P1|NOT COMPLETED|Overall Study||17
7683564|NCT01916304|18923235|P1|COMPLETED|Overall Study||84
7683565|NCT01916304|18923235|P1|Intent-to-Treat Set|Overall Study||84
7683566|NCT01916304|18923235|P1|Safety Set|Overall Study||101
7683567|NCT01916304|18923235|P1|STARTED|Overall Study||101
7683568|NCT01916226|18923247|P4|NOT COMPLETED|Overall Study||4
7683569|NCT01916226|18923248|P3|NOT COMPLETED|Overall Study||3
7683570|NCT01916226|18923249|P2|NOT COMPLETED|Overall Study||1
7683571|NCT01916226|18923250|P1|NOT COMPLETED|Overall Study||1
7683572|NCT01916226|18923247|P4|COMPLETED|Overall Study||167
7683573|NCT01916226|18923248|P3|COMPLETED|Overall Study||168
7683574|NCT01916226|18923249|P2|COMPLETED|Overall Study||169
7683575|NCT01916226|18923250|P1|COMPLETED|Overall Study||169
7683576|NCT01916226|18923247|P4|STARTED|Overall Study||171
7683577|NCT01916226|18923248|P3|STARTED|Overall Study||171
7683578|NCT01916226|18923249|P2|STARTED|Overall Study||170
7683579|NCT01916226|18923250|P1|STARTED|Overall Study||170
7683580|NCT01916109|18923284|P1|NOT COMPLETED|Overall Study||1
7683581|NCT01916109|18923284|P1|COMPLETED|Overall Study||3
7683582|NCT01916109|18923284|P1|STARTED|Overall Study||4
7683583|NCT01915940|18923290|P3|NOT COMPLETED|Treatment Period||4
7683584|NCT01915940|18923291|P2|NOT COMPLETED|Treatment Period||11
7683585|NCT01915940|18923292|P1|NOT COMPLETED|Treatment Period||0
7683586|NCT01915940|18923290|P3|COMPLETED|Treatment Period||62
7683587|NCT01915940|18923291|P2|COMPLETED|Treatment Period||53
7683588|NCT01915940|18923292|P1|COMPLETED|Treatment Period||0
7683589|NCT01915940|18923290|P3|STARTED|Treatment Period||66
7683590|NCT01915940|18923291|P2|STARTED|Treatment Period||64
7683591|NCT01915940|18923292|P1|STARTED|Treatment Period||0
7683592|NCT01915940|18923290|P3|NOT COMPLETED|Pre-randomization Washout Period||0
7683593|NCT01915940|18923291|P2|NOT COMPLETED|Pre-randomization Washout Period||0
7683594|NCT01915940|18923292|P1|NOT COMPLETED|Pre-randomization Washout Period||39
7683595|NCT01915940|18923290|P3|COMPLETED|Pre-randomization Washout Period||0
7683596|NCT01915940|18923291|P2|COMPLETED|Pre-randomization Washout Period||0
7683597|NCT01915940|18923292|P1|COMPLETED|Pre-randomization Washout Period||130
7683598|NCT01915940|18923290|P3|STARTED|Pre-randomization Washout Period||0
7683599|NCT01915940|18923291|P2|STARTED|Pre-randomization Washout Period||0
7683600|NCT01915940|18923292|P1|STARTED|Pre-randomization Washout Period||169
7683601|NCT01915914|18923308|P4|NOT COMPLETED|Follow-up Phase||2
7683602|NCT01915914|18923309|P3|NOT COMPLETED|Follow-up Phase||0
7683603|NCT01915914|18923310|P2|NOT COMPLETED|Follow-up Phase||0
7683604|NCT01915914|18923311|P1|NOT COMPLETED|Follow-up Phase||0
7683605|NCT01915914|18923308|P4|COMPLETED|Follow-up Phase||64
7683606|NCT01915914|18923309|P3|COMPLETED|Follow-up Phase||0
7683607|NCT01915914|18923310|P2|COMPLETED|Follow-up Phase||0
7683608|NCT01915914|18923311|P1|COMPLETED|Follow-up Phase||0
7683609|NCT01915914|18923308|P4|STARTED|Follow-up Phase||66
7683610|NCT01915914|18923309|P3|STARTED|Follow-up Phase||0
7683611|NCT01915914|18923310|P2|STARTED|Follow-up Phase||0
7683612|NCT01915914|18923311|P1|STARTED|Follow-up Phase||0
7683613|NCT01915914|18923308|P4|NOT COMPLETED|Maintenance Phase||0
7683614|NCT01915914|18923309|P3|NOT COMPLETED|Maintenance Phase||2
7683615|NCT01915914|18923310|P2|NOT COMPLETED|Maintenance Phase||6
7683616|NCT01915914|18923311|P1|NOT COMPLETED|Maintenance Phase||0
7683617|NCT01915914|18923308|P4|COMPLETED|Maintenance Phase||0
7683618|NCT01915914|18923309|P3|COMPLETED|Maintenance Phase||51
7683619|NCT01915914|18923310|P2|COMPLETED|Maintenance Phase||48
7683620|NCT01915914|18923311|P1|COMPLETED|Maintenance Phase||0
7683621|NCT01915914|18923308|P4|STARTED|Maintenance Phase||0
7683622|NCT01915914|18923309|P3|STARTED|Maintenance Phase||53
7683623|NCT01915914|18923310|P2|STARTED|Maintenance Phase||54
7683624|NCT01915914|18923311|P1|STARTED|Maintenance Phase||0
7683625|NCT01915914|18923308|P4|NOT COMPLETED|Acute Phase||0
7683626|NCT01915914|18923309|P3|NOT COMPLETED|Acute Phase||0
7683627|NCT01915914|18923310|P2|NOT COMPLETED|Acute Phase||0
7683628|NCT01915914|18923311|P1|NOT COMPLETED|Acute Phase||12
7683629|NCT01915914|18923308|P4|COMPLETED|Acute Phase||0
7683630|NCT01915914|18923309|P3|COMPLETED|Acute Phase||0
7683631|NCT01915914|18923310|P2|COMPLETED|Acute Phase||0
7683632|NCT01915914|18923311|P1|COMPLETED|Acute Phase||111
7683633|NCT01915914|18923308|P4|Completed-Not Entered Maintenance Phase|Acute Phase||0
7683634|NCT01915914|18923309|P3|Completed-Not Entered Maintenance Phase|Acute Phase||0
7683635|NCT01915914|18923310|P2|Completed-Not Entered Maintenance Phase|Acute Phase||0
7683636|NCT01915914|18923311|P1|Completed-Not Entered Maintenance Phase|Acute Phase||4
7683637|NCT01915914|18923308|P4|STARTED|Acute Phase||0
7683638|NCT01915914|18923309|P3|STARTED|Acute Phase||0
7683639|NCT01915914|18923310|P2|STARTED|Acute Phase||0
7683640|NCT01915914|18923311|P1|STARTED|Acute Phase||123
7683641|NCT01915849|18923343|P4|NOT COMPLETED|Treatment Period 4 (4 Days)||0
7683642|NCT01915849|18923344|P3|NOT COMPLETED|Treatment Period 4 (4 Days)||0
7683643|NCT01915849|18923345|P2|NOT COMPLETED|Treatment Period 4 (4 Days)||0
7683644|NCT01915849|18923346|P1|NOT COMPLETED|Treatment Period 4 (4 Days)||0
7683645|NCT01915849|18923343|P4|COMPLETED|Treatment Period 4 (4 Days)||3
7683646|NCT01915849|18923344|P3|COMPLETED|Treatment Period 4 (4 Days)||3
7683647|NCT01915849|18923345|P2|COMPLETED|Treatment Period 4 (4 Days)||3
7683648|NCT01915849|18923346|P1|COMPLETED|Treatment Period 4 (4 Days)||3
7683649|NCT01915849|18923343|P4|STARTED|Treatment Period 4 (4 Days)||3
7683650|NCT01915849|18923344|P3|STARTED|Treatment Period 4 (4 Days)||3
7683651|NCT01915849|18923345|P2|STARTED|Treatment Period 4 (4 Days)||3
7683652|NCT01915849|18923346|P1|STARTED|Treatment Period 4 (4 Days)||3
7683653|NCT01915849|18923343|P4|NOT COMPLETED|Treatment Period 3 (4 Days)||0
7683654|NCT01915849|18923344|P3|NOT COMPLETED|Treatment Period 3 (4 Days)||0
7683655|NCT01915849|18923345|P2|NOT COMPLETED|Treatment Period 3 (4 Days)||0
7683656|NCT01915849|18923346|P1|NOT COMPLETED|Treatment Period 3 (4 Days)||0
7683657|NCT01915849|18923343|P4|COMPLETED|Treatment Period 3 (4 Days)||3
7683658|NCT01915849|18923344|P3|COMPLETED|Treatment Period 3 (4 Days)||3
7683659|NCT01915849|18923345|P2|COMPLETED|Treatment Period 3 (4 Days)||3
7683660|NCT01915849|18923346|P1|COMPLETED|Treatment Period 3 (4 Days)||3
7683661|NCT01915849|18923343|P4|STARTED|Treatment Period 3 (4 Days)||3
7683662|NCT01915849|18923344|P3|STARTED|Treatment Period 3 (4 Days)||3
7683663|NCT01915849|18923345|P2|STARTED|Treatment Period 3 (4 Days)||3
7683664|NCT01915849|18923346|P1|STARTED|Treatment Period 3 (4 Days)||3
7683665|NCT01915849|18923343|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7683666|NCT01915849|18923344|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7683667|NCT01915849|18923345|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7683668|NCT01915849|18923346|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
7683669|NCT01915849|18923343|P4|COMPLETED|Treatment Period 2 (4 Days)||3
7683670|NCT01915849|18923344|P3|COMPLETED|Treatment Period 2 (4 Days)||3
7683671|NCT01915849|18923345|P2|COMPLETED|Treatment Period 2 (4 Days)||3
7683672|NCT01915849|18923346|P1|COMPLETED|Treatment Period 2 (4 Days)||3
7683673|NCT01915849|18923343|P4|STARTED|Treatment Period 2 (4 Days)||3
7683674|NCT01915849|18923344|P3|STARTED|Treatment Period 2 (4 Days)||3
7683675|NCT01915849|18923345|P2|STARTED|Treatment Period 2 (4 Days)||3
7683676|NCT01915849|18923346|P1|STARTED|Treatment Period 2 (4 Days)||3
7683677|NCT01915849|18923343|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
7683678|NCT01915849|18923344|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
7683679|NCT01915849|18923345|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
7683680|NCT01915849|18923346|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||2
7683681|NCT01915849|18923343|P4|COMPLETED|Treatment Period 1 (4 Days)||3
7683682|NCT01915849|18923344|P3|COMPLETED|Treatment Period 1 (4 Days)||3
7683683|NCT01915849|18923345|P2|COMPLETED|Treatment Period 1 (4 Days)||3
7683684|NCT01915849|18923346|P1|COMPLETED|Treatment Period 1 (4 Days)||3
7683685|NCT01915849|18923343|P4|STARTED|Treatment Period 1 (4 Days)||3
7683686|NCT01915849|18923344|P3|STARTED|Treatment Period 1 (4 Days)||3
7683687|NCT01915849|18923345|P2|STARTED|Treatment Period 1 (4 Days)||3
7683688|NCT01915849|18923346|P1|STARTED|Treatment Period 1 (4 Days)||5
7683689|NCT01915823|18923358|P2|NOT COMPLETED|Overall Study||2
7683690|NCT01915823|18923359|P1|NOT COMPLETED|Overall Study||2
7683691|NCT01915823|18923358|P2|COMPLETED|Overall Study||173
7683692|NCT01915823|18923359|P1|COMPLETED|Overall Study||171
7683693|NCT01915823|18923358|P2|STARTED|Overall Study||175
7683694|NCT01915823|18923359|P1|STARTED|Overall Study||173
7683695|NCT01915771|18923369|P1|NOT COMPLETED|Day 15||1
7683696|NCT01915771|18923369|P1|COMPLETED|Day 15||13
7683697|NCT01915771|18923369|P1|STARTED|Day 15||14
7683698|NCT01915771|18923369|P1|NOT COMPLETED|Day 1||1
7683699|NCT01915771|18923369|P1|COMPLETED|Day 1||14
7683700|NCT01915771|18923369|P1|STARTED|Day 1||15
7683701|NCT01915732|18923393|P2|NOT COMPLETED|Overall Study||71
7683702|NCT01915732|18923394|P1|NOT COMPLETED|Overall Study||70
7683703|NCT01915732|18923393|P2|COMPLETED|Overall Study||445
7683704|NCT01915732|18923394|P1|COMPLETED|Overall Study||430
7683705|NCT01915732|18923393|P2|STARTED|Overall Study||516
7683706|NCT01915732|18923394|P1|STARTED|Overall Study||500
7683707|NCT01915563|18923420|P2|NOT COMPLETED|Overall Study||0
7683708|NCT01915563|18923421|P1|NOT COMPLETED|Overall Study||0
7683709|NCT01915563|18923420|P2|COMPLETED|Overall Study||227
7683710|NCT01915563|18923421|P1|COMPLETED|Overall Study||243
7683711|NCT01915563|18923420|P2|STARTED|Overall Study||227
7683712|NCT01915563|18923421|P1|STARTED|Overall Study||243
7683713|NCT01915498|18923447|P19|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||2
7683714|NCT01915498|18923448|P18|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683715|NCT01915498|18923449|P17|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683716|NCT01915498|18923450|P16|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683717|NCT01915498|18923451|P15|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683718|NCT01915498|18923452|P14|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683719|NCT01915498|18923453|P13|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683720|NCT01915498|18923454|P12|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683721|NCT01915498|18923455|P11|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683722|NCT01915498|18923456|P10|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683723|NCT01915498|18923457|P9|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683724|NCT01915498|18923458|P8|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683725|NCT01915498|18923459|P7|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683726|NCT01915498|18923460|P6|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683727|NCT01915498|18923461|P5|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683728|NCT01915498|18923462|P4|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683729|NCT01915498|18923463|P3|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683730|NCT01915498|18923464|P2|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683731|NCT01915498|18923465|P1|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683732|NCT01915498|18923447|P19|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||14
7683733|NCT01915498|18923448|P18|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683734|NCT01915498|18923449|P17|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683735|NCT01915498|18923450|P16|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683736|NCT01915498|18923451|P15|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683737|NCT01915498|18923452|P14|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683738|NCT01915498|18923453|P13|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683739|NCT01915498|18923454|P12|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683740|NCT01915498|18923455|P11|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683741|NCT01915498|18923456|P10|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683742|NCT01915498|18923457|P9|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683743|NCT01915498|18923458|P8|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683744|NCT01915498|18923459|P7|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683745|NCT01915498|18923460|P6|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683746|NCT01915498|18923461|P5|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683747|NCT01915498|18923462|P4|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683748|NCT01915498|18923463|P3|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683749|NCT01915498|18923464|P2|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683750|NCT01915498|18923465|P1|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
7683751|NCT01915498|18923447|P19|STARTED|Safety Follow-up (Sept 2017 to July 2019||16
7683752|NCT01915498|18923448|P18|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
7683753|NCT01915498|18923449|P17|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
7683754|NCT01915498|18923450|P16|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
7683755|NCT01915498|18923451|P15|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
7683756|NCT01915498|18923452|P14|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
7683757|NCT01915498|18923453|P13|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
7683758|NCT01915498|18923454|P12|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
7683759|NCT01915498|18923455|P11|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
7683760|NCT01915498|18923456|P10|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
7683761|NCT01915498|18923457|P9|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
7683762|NCT01915498|18923458|P8|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
7683763|NCT01915498|18923459|P7|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
7683764|NCT01915498|18923460|P6|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
7683765|NCT01915498|18923461|P5|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
7683766|NCT01915498|18923462|P4|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
7683767|NCT01915498|18923463|P3|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
7683768|NCT01915498|18923464|P2|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
7683769|NCT01915498|18923465|P1|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
7683770|NCT01915498|18923447|P19|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
7683771|NCT01915498|18923448|P18|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||100
7683772|NCT01915498|18923449|P17|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||24
7683773|NCT01915498|18923450|P16|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||23
7683774|NCT01915498|18923451|P15|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||25
7683775|NCT01915498|18923452|P14|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||46
7683776|NCT01915498|18923453|P13|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
7683777|NCT01915498|18923454|P12|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||4
7683778|NCT01915498|18923455|P11|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
7683779|NCT01915498|18923456|P10|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||14
7683780|NCT01915498|18923457|P9|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
7683781|NCT01915498|18923458|P8|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||21
7683782|NCT01915498|18923459|P7|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
7683783|NCT01915498|18923460|P6|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
7683784|NCT01915498|18923461|P5|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||5
7683785|NCT01915498|18923462|P4|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||8
7683786|NCT01915498|18923463|P3|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
7683787|NCT01915498|18923464|P2|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
7683788|NCT01915498|18923465|P1|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
7683789|NCT01915498|18923447|P19|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
7683790|NCT01915498|18923448|P18|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
7683791|NCT01915498|18923449|P17|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
7683792|NCT01915498|18923450|P16|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||2
7683793|NCT01915498|18923451|P15|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
7683794|NCT01915498|18923452|P14|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
7683795|NCT01915498|18923453|P13|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
7683796|NCT01915498|18923454|P12|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
7683797|NCT01915498|18923455|P11|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
7683798|NCT01915498|18923456|P10|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
7683799|NCT01915498|18923457|P9|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
7683800|NCT01915498|18923458|P8|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
7683801|NCT01915498|18923459|P7|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
7683802|NCT01915498|18923460|P6|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
7683803|NCT01915498|18923461|P5|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
7683804|NCT01915498|18923462|P4|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
7683805|NCT01915498|18923463|P3|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
7683806|NCT01915498|18923464|P2|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
7683807|NCT01915498|18923465|P1|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
7683808|NCT01915498|18923447|P19|STARTED|Main Analysis (Sept 2013 - Sept 2017)||0
7683809|NCT01915498|18923448|P18|STARTED|Main Analysis (Sept 2013 - Sept 2017)||106
7683810|NCT01915498|18923449|P17|STARTED|Main Analysis (Sept 2013 - Sept 2017)||27
7683811|NCT01915498|18923450|P16|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
7683812|NCT01915498|18923451|P15|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
7683813|NCT01915498|18923452|P14|STARTED|Main Analysis (Sept 2013 - Sept 2017)||49
7683814|NCT01915498|18923453|P13|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
7683815|NCT01915498|18923454|P12|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
7683816|NCT01915498|18923455|P11|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
7683817|NCT01915498|18923456|P10|STARTED|Main Analysis (Sept 2013 - Sept 2017)||14
7683818|NCT01915498|18923457|P9|STARTED|Main Analysis (Sept 2013 - Sept 2017)||6
7683819|NCT01915498|18923458|P8|STARTED|Main Analysis (Sept 2013 - Sept 2017)||22
7683820|NCT01915498|18923459|P7|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
7683821|NCT01915498|18923460|P6|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
7683822|NCT01915498|18923461|P5|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
7683823|NCT01915498|18923462|P4|STARTED|Main Analysis (Sept 2013 - Sept 2017)||8
7683824|NCT01915498|18923463|P3|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
7683825|NCT01915498|18923464|P2|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
7683826|NCT01915498|18923465|P1|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
7683827|NCT01915303|18923989|P1|NOT COMPLETED|Extension Phase||17
7683828|NCT01915303|18923989|P1|COMPLETED|Extension Phase||12
7683829|NCT01915303|18923989|P1|STARTED|Extension Phase||29
7683830|NCT01915303|18923989|P1|NOT COMPLETED|Core Phase||16
7683831|NCT01915303|18923989|P1|COMPLETED|Core Phase||52
7683832|NCT01915303|18923989|P1|STARTED|Core Phase||68
7683833|NCT01915173|18924018|P4|NOT COMPLETED|Overall Study||0
7683834|NCT01915173|18924019|P3|NOT COMPLETED|Overall Study||0
7683835|NCT01915173|18924020|P2|NOT COMPLETED|Overall Study||0
7683836|NCT01915173|18924021|P1|NOT COMPLETED|Overall Study||0
7683837|NCT01915173|18924018|P4|COMPLETED|Overall Study||6
7683838|NCT01915173|18924019|P3|COMPLETED|Overall Study||6
7683839|NCT01915173|18924020|P2|COMPLETED|Overall Study||6
7683840|NCT01915173|18924021|P1|COMPLETED|Overall Study||6
7683841|NCT01915173|18924018|P4|STARTED|Overall Study||6
7683842|NCT01915173|18924019|P3|STARTED|Overall Study||6
7683843|NCT01915173|18924020|P2|STARTED|Overall Study||6
7683844|NCT01915173|18924021|P1|STARTED|Overall Study||6
7683845|NCT01915108|18924043|P4|NOT COMPLETED|Overall Study||2
7683846|NCT01915108|18924044|P3|NOT COMPLETED|Overall Study||1
7683847|NCT01915108|18924045|P2|NOT COMPLETED|Overall Study||3
7683848|NCT01915108|18924046|P1|NOT COMPLETED|Overall Study||2
7683849|NCT01915108|18924043|P4|COMPLETED|Overall Study|two patients were excluded from the study|30
7683850|NCT01915108|18924044|P3|COMPLETED|Overall Study|one patients were excluded from the study|31
7683851|NCT01915108|18924045|P2|COMPLETED|Overall Study|three patients were excluded from the study|29
7683852|NCT01915108|18924046|P1|COMPLETED|Overall Study|two patients were excluded from the study|30
7683853|NCT01915108|18924043|P4|STARTED|Overall Study||32
7683854|NCT01915108|18924044|P3|STARTED|Overall Study||32
7683855|NCT01915108|18924045|P2|STARTED|Overall Study||32
7683856|NCT01915108|18924046|P1|STARTED|Overall Study||32
7683857|NCT01915095|18924063|P5|NOT COMPLETED|Overall Study||6
7683858|NCT01915095|18924064|P4|NOT COMPLETED|Overall Study||4
7683859|NCT01915095|18924065|P3|NOT COMPLETED|Overall Study||0
7683860|NCT01915095|18924066|P2|NOT COMPLETED|Overall Study||0
7683861|NCT01915095|18924067|P1|NOT COMPLETED|Overall Study||0
7683862|NCT01915095|18924063|P5|COMPLETED|Overall Study||3
7683863|NCT01915095|18924064|P4|COMPLETED|Overall Study||4
7683864|NCT01915095|18924065|P3|COMPLETED|Overall Study||5
7683865|NCT01915095|18924066|P2|COMPLETED|Overall Study||10
7683866|NCT01915095|18924067|P1|COMPLETED|Overall Study||10
7683867|NCT01915095|18924063|P5|Control|Overall Study||0
7683868|NCT01915095|18924064|P4|Control|Overall Study||0
7683869|NCT01915095|18924065|P3|Control|Overall Study||0
7683870|NCT01915095|18924066|P2|Control|Overall Study||5
7683871|NCT01915095|18924067|P1|Control|Overall Study||5
7683872|NCT01915095|18924063|P5|SCI|Overall Study||9
7683873|NCT01915095|18924064|P4|SCI|Overall Study||8
7683874|NCT01915095|18924065|P3|SCI|Overall Study||5
7683875|NCT01915095|18924066|P2|SCI|Overall Study||5
7683876|NCT01915095|18924067|P1|SCI|Overall Study||5
7683877|NCT01915095|18924063|P5|STARTED|Overall Study||9
7683878|NCT01915095|18924064|P4|STARTED|Overall Study||8
7683879|NCT01915095|18924065|P3|STARTED|Overall Study||5
7683880|NCT01915095|18924066|P2|STARTED|Overall Study||10
7683881|NCT01915095|18924067|P1|STARTED|Overall Study||10
7683882|NCT01914926|18924090|P2|NOT COMPLETED|Overall Study||1
7683883|NCT01914926|18924091|P1|NOT COMPLETED|Overall Study||1
7683884|NCT01914926|18924090|P2|COMPLETED|Overall Study||24
7683885|NCT01914926|18924091|P1|COMPLETED|Overall Study||28
7683886|NCT01914926|18924090|P2|STARTED|Overall Study||25
7683887|NCT01914926|18924091|P1|STARTED|Overall Study||29
7683888|NCT01914757|18924100|P3|NOT COMPLETED|Overall Study||38
7683889|NCT01914757|18924101|P2|NOT COMPLETED|Overall Study||51
7683890|NCT01914757|18924102|P1|NOT COMPLETED|Overall Study||36
7683891|NCT01914757|18924100|P3|COMPLETED|Overall Study||402
7683892|NCT01914757|18924101|P2|COMPLETED|Overall Study||390
7683893|NCT01914757|18924102|P1|COMPLETED|Overall Study||389
7683894|NCT01914757|18924100|P3|STARTED|Overall Study||440
7683895|NCT01914757|18924101|P2|STARTED|Overall Study||441
7683896|NCT01914757|18924102|P1|STARTED|Overall Study||425
7683897|NCT01914679|18924176|P1|NOT COMPLETED|Overall Study||5
7683898|NCT01914679|18924176|P1|COMPLETED|Overall Study||12
7683899|NCT01914679|18924176|P1|Began 12 Week Actual RINCE Treatment|Overall Study||17
7683900|NCT01914679|18924176|P1|STARTED|Overall Study||17
7683901|NCT01914666|18924183|P3|NOT COMPLETED|Tapering Period||0
7683902|NCT01914666|18924184|P2|NOT COMPLETED|Tapering Period||0
7683903|NCT01914666|18924185|P1|NOT COMPLETED|Tapering Period||0
7683904|NCT01914666|18924183|P3|COMPLETED|Tapering Period||40
7683905|NCT01914666|18924184|P2|COMPLETED|Tapering Period||39
7683906|NCT01914666|18924185|P1|COMPLETED|Tapering Period||59
7683907|NCT01914666|18924183|P3|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40
7683908|NCT01914666|18924184|P2|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39
7683909|NCT01914666|18924185|P1|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59
7683910|NCT01914666|18924183|P3|NOT COMPLETED|Treatment Period||8
7683911|NCT01914666|18924184|P2|NOT COMPLETED|Treatment Period||6
7683912|NCT01914666|18924185|P1|NOT COMPLETED|Treatment Period||13
7683913|NCT01914666|18924183|P3|COMPLETED|Treatment Period||33
7683914|NCT01914666|18924184|P2|COMPLETED|Treatment Period||36
7683915|NCT01914666|18924185|P1|COMPLETED|Treatment Period||55
7683916|NCT01914666|18924183|P3|Received at Least 1 Dose of Study Drug|Treatment Period||41
7683917|NCT01914666|18924184|P2|Received at Least 1 Dose of Study Drug|Treatment Period||42
7683918|NCT01914666|18924185|P1|Received at Least 1 Dose of Study Drug|Treatment Period||68
7683919|NCT01914666|18924183|P3|STARTED|Treatment Period||41
7683920|NCT01914666|18924184|P2|STARTED|Treatment Period||42
7683921|NCT01914666|18924185|P1|STARTED|Treatment Period||68
7683922|NCT01914510|18924218|P1|NOT COMPLETED|Overall Study||2
7683923|NCT01914510|18924218|P1|COMPLETED|Overall Study||38
7683924|NCT01914510|18924218|P1|STARTED|Overall Study||40
7683925|NCT01914393|18924228|P3|NOT COMPLETED|Overall Study||138
7683926|NCT01914393|18924229|P2|NOT COMPLETED|Overall Study||71
7683927|NCT01914393|18924230|P1|NOT COMPLETED|Overall Study||115
7683928|NCT01914393|18924228|P3|COMPLETED|Overall Study||168
7683929|NCT01914393|18924229|P2|COMPLETED|Overall Study||54
7683930|NCT01914393|18924230|P1|COMPLETED|Overall Study||156
7683931|NCT01914393|18924228|P3|STARTED|Overall Study||306
7683932|NCT01914393|18924229|P2|STARTED|Overall Study||125
7683933|NCT01914393|18924230|P1|STARTED|Overall Study||271
7683934|NCT01914159|18924262|P1|NOT COMPLETED|Overall Study||3
7683935|NCT01914159|18924262|P1|COMPLETED|Overall Study||21
7683936|NCT01914159|18924262|P1|STARTED|Overall Study||24
7683937|NCT01914003|18924270|P2|NOT COMPLETED|Overall Study||12
7683938|NCT01914003|18924271|P1|NOT COMPLETED|Overall Study||8
7683939|NCT01914003|18924270|P2|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14
7683940|NCT01914003|18924271|P1|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19
7683941|NCT01914003|18924270|P2|STARTED|Overall Study||26
7683942|NCT01914003|18924271|P1|STARTED|Overall Study||27
7683943|NCT01913795|18924281|P4|NOT COMPLETED|Overall Study||1
7683944|NCT01913795|18924282|P3|NOT COMPLETED|Overall Study||0
7683945|NCT01913795|18924283|P2|NOT COMPLETED|Overall Study||3
7683946|NCT01913795|18924284|P1|NOT COMPLETED|Overall Study||0
7683947|NCT01913795|18924281|P4|COMPLETED|Overall Study||5
7683948|NCT01913795|18924282|P3|COMPLETED|Overall Study||9
7683949|NCT01913795|18924283|P2|COMPLETED|Overall Study||7
7683950|NCT01913795|18924284|P1|COMPLETED|Overall Study||4
7683951|NCT01913795|18924281|P4|STARTED|Overall Study||6
7683952|NCT01913795|18924282|P3|STARTED|Overall Study||9
7683953|NCT01913795|18924283|P2|STARTED|Overall Study||10
7683954|NCT01913795|18924284|P1|STARTED|Overall Study||4
7683955|NCT01913639|18924298|P1|NOT COMPLETED|Overall Study||3
7683956|NCT01913639|18924298|P1|COMPLETED|Overall Study||36
7683957|NCT01913639|18924298|P1|STARTED|Overall Study||39
7683958|NCT01913600|18924305|P1|NOT COMPLETED|Overall Study||1
7683959|NCT01913600|18924305|P1|COMPLETED|Overall Study||55
7683960|NCT01913600|18924305|P1|STARTED|Overall Study||56
7683961|NCT01913535|18924327|P5|NOT COMPLETED|Phase 2 (Days 3-5)||0
7683962|NCT01913535|18924328|P4|NOT COMPLETED|Phase 2 (Days 3-5)||0
7683963|NCT01913535|18924329|P3|NOT COMPLETED|Phase 2 (Days 3-5)||0
7683964|NCT01913535|18924330|P2|NOT COMPLETED|Phase 2 (Days 3-5)||0
7683965|NCT01913535|18924331|P1|NOT COMPLETED|Phase 2 (Days 3-5)||0
7683966|NCT01913535|18924327|P5|COMPLETED|Phase 2 (Days 3-5)||1
7683967|NCT01913535|18924328|P4|COMPLETED|Phase 2 (Days 3-5)||2
7683968|NCT01913535|18924329|P3|COMPLETED|Phase 2 (Days 3-5)||1
7683969|NCT01913535|18924330|P2|COMPLETED|Phase 2 (Days 3-5)||2
7683970|NCT01913535|18924331|P1|COMPLETED|Phase 2 (Days 3-5)||2
7683971|NCT01913535|18924327|P5|STARTED|Phase 2 (Days 3-5)||1
7683972|NCT01913535|18924328|P4|STARTED|Phase 2 (Days 3-5)||2
7683973|NCT01913535|18924329|P3|STARTED|Phase 2 (Days 3-5)||1
7683974|NCT01913535|18924330|P2|STARTED|Phase 2 (Days 3-5)||2
7683975|NCT01913535|18924331|P1|STARTED|Phase 2 (Days 3-5)||2
7683976|NCT01913535|18924327|P5|NOT COMPLETED|Phase 1 (Days 0-2)||0
7683977|NCT01913535|18924328|P4|NOT COMPLETED|Phase 1 (Days 0-2)||0
7683978|NCT01913535|18924329|P3|NOT COMPLETED|Phase 1 (Days 0-2)||0
7683979|NCT01913535|18924330|P2|NOT COMPLETED|Phase 1 (Days 0-2)||0
7683980|NCT01913535|18924331|P1|NOT COMPLETED|Phase 1 (Days 0-2)||0
7683981|NCT01913535|18924327|P5|COMPLETED|Phase 1 (Days 0-2)||1
7683982|NCT01913535|18924328|P4|COMPLETED|Phase 1 (Days 0-2)||2
7683983|NCT01913535|18924329|P3|COMPLETED|Phase 1 (Days 0-2)||1
7683984|NCT01913535|18924330|P2|COMPLETED|Phase 1 (Days 0-2)||2
7683985|NCT01913535|18924331|P1|COMPLETED|Phase 1 (Days 0-2)||2
7683986|NCT01913535|18924327|P5|STARTED|Phase 1 (Days 0-2)||1
7683987|NCT01913535|18924328|P4|STARTED|Phase 1 (Days 0-2)||2
7683988|NCT01913535|18924329|P3|STARTED|Phase 1 (Days 0-2)||1
7683989|NCT01913535|18924330|P2|STARTED|Phase 1 (Days 0-2)||2
7683990|NCT01913535|18924331|P1|STARTED|Phase 1 (Days 0-2)||2
7683991|NCT01913483|18924364|P2|NOT COMPLETED|Overall Study||22
7683992|NCT01913483|18924365|P1|NOT COMPLETED|Overall Study||21
7683993|NCT01913483|18924364|P2|COMPLETED|Overall Study||343
7683994|NCT01913483|18924365|P1|COMPLETED|Overall Study||346
7683995|NCT01913483|18924364|P2|Received at Least 1 Dose of Study Drug|Overall Study||321
7683996|NCT01913483|18924365|P1|Received at Least 1 Dose of Study Drug|Overall Study||335
7683997|NCT01913483|18924364|P2|STARTED|Overall Study||365
7683998|NCT01913483|18924365|P1|STARTED|Overall Study||367
7683999|NCT01913470|18924377|P2|NOT COMPLETED|Overall Study||3
7684000|NCT01913470|18924378|P1|NOT COMPLETED|Overall Study||0
7684001|NCT01913470|18924377|P2|COMPLETED|Overall Study||4
7684002|NCT01913470|18924378|P1|COMPLETED|Overall Study||5
7684003|NCT01913470|18924377|P2|STARTED|Overall Study||7
7684004|NCT01913470|18924378|P1|STARTED|Overall Study||5
7684005|NCT01913405|18924396|P1|NOT COMPLETED|Overall Study||2
7684006|NCT01913405|18924396|P1|COMPLETED|Overall Study||20
7684007|NCT01913405|18924396|P1|STARTED|Overall Study||22
7684008|NCT01913353|18924452|P2|NOT COMPLETED|Overall Study||15
7684009|NCT01913353|18924453|P1|NOT COMPLETED|Overall Study||32
7684010|NCT01913353|18924452|P2|COMPLETED|Overall Study||204
7684011|NCT01913353|18924453|P1|COMPLETED|Overall Study||189
7684012|NCT01913353|18924452|P2|STARTED|Overall Study||219
7684013|NCT01913353|18924453|P1|STARTED|Overall Study||221
7684014|NCT01913340|18924523|P2|NOT COMPLETED|Overall Study||6
7684015|NCT01913340|18924524|P1|NOT COMPLETED|Overall Study||3
7684016|NCT01913340|18924523|P2|COMPLETED|Overall Study||20
7684017|NCT01913340|18924524|P1|COMPLETED|Overall Study||21
7684018|NCT01913340|18924523|P2|STARTED|Overall Study||26
7684019|NCT01913340|18924524|P1|STARTED|Overall Study|22 (92%) received all 5 doses, 1 (4%) received 4 doses, and 1 (4%) only received 1 dose.|24
7684020|NCT01913327|18924548|P2|NOT COMPLETED|Overall Study||1
7684021|NCT01913327|18924549|P1|NOT COMPLETED|Overall Study||0
7684022|NCT01913327|18924548|P2|COMPLETED|Overall Study||1
7684023|NCT01913327|18924549|P1|COMPLETED|Overall Study||1
7684024|NCT01913327|18924548|P2|STARTED|Overall Study||2
7684025|NCT01913327|18924549|P1|STARTED|Overall Study||1
7684026|NCT01913314|18924561|P1|NOT COMPLETED|Overall Study||0
7684027|NCT01913314|18924561|P1|COMPLETED|Overall Study||6
7684028|NCT01913314|18924561|P1|Received Study Drug|Overall Study||6
7684029|NCT01913314|18924561|P1|STARTED|Overall Study||6
7684030|NCT01913041|18924574|P1|NOT COMPLETED|Overall Study||39
7684031|NCT01913041|18924574|P1|COMPLETED|Overall Study||830
7684032|NCT01913041|18924574|P1|STARTED|Overall Study||869
7684033|NCT01912963|18924581|P3|NOT COMPLETED|Overall Study||7
7684034|NCT01912963|18924582|P2|NOT COMPLETED|Overall Study||19
7684035|NCT01912963|18924583|P1|NOT COMPLETED|Overall Study||6
7684036|NCT01912963|18924581|P3|COMPLETED|Overall Study||0
7684037|NCT01912963|18924582|P2|COMPLETED|Overall Study||0
7684038|NCT01912963|18924583|P1|COMPLETED|Overall Study||0
7684039|NCT01912963|18924581|P3|STARTED|Overall Study||7
7684040|NCT01912963|18924582|P2|STARTED|Overall Study||19
7684041|NCT01912963|18924583|P1|STARTED|Overall Study||6
7684042|NCT01912872|18924606|P4|NOT COMPLETED|Overall Study||12
7684043|NCT01912872|18924607|P3|NOT COMPLETED|Overall Study||10
7684044|NCT01912872|18924608|P2|NOT COMPLETED|Overall Study||4
7684045|NCT01912872|18924609|P1|NOT COMPLETED|Overall Study||5
7684046|NCT01912872|18924606|P4|COMPLETED|Overall Study||27
7684047|NCT01912872|18924607|P3|COMPLETED|Overall Study||30
7684048|NCT01912872|18924608|P2|COMPLETED|Overall Study||13
7684049|NCT01912872|18924609|P1|COMPLETED|Overall Study||11
7684050|NCT01912872|18924606|P4|Discontinued Treatment Prior to Month 12|Overall Study||11
7684051|NCT01912872|18924607|P3|Discontinued Treatment Prior to Month 12|Overall Study||10
7684052|NCT01912872|18924608|P2|Discontinued Treatment Prior to Month 12|Overall Study||4
7684053|NCT01912872|18924609|P1|Discontinued Treatment Prior to Month 12|Overall Study||5
7684054|NCT01912872|18924606|P4|Completed Study Treatment at Month 12|Overall Study||27
7684055|NCT01912872|18924607|P3|Completed Study Treatment at Month 12|Overall Study||30
7684056|NCT01912872|18924608|P2|Completed Study Treatment at Month 12|Overall Study||13
7684057|NCT01912872|18924609|P1|Completed Study Treatment at Month 12|Overall Study||11
7684058|NCT01912872|18924606|P4|STARTED|Overall Study||39
7684059|NCT01912872|18924607|P3|STARTED|Overall Study||40
7684060|NCT01912872|18924608|P2|STARTED|Overall Study||17
7684061|NCT01912872|18924609|P1|STARTED|Overall Study||16
7684062|NCT01912781|18924653|P2|NOT COMPLETED|Overall Study||0
7684063|NCT01912781|18924654|P1|NOT COMPLETED|Overall Study||2
7684064|NCT01912781|18924653|P2|COMPLETED|Overall Study||35
7684065|NCT01912781|18924654|P1|COMPLETED|Overall Study||69
7684066|NCT01912781|18924653|P2|STARTED|Overall Study||35
7684067|NCT01912781|18924654|P1|STARTED|Overall Study||71
7684068|NCT01912768|18924685|P2|NOT COMPLETED|Overall Study||4
7684069|NCT01912768|18924686|P1|NOT COMPLETED|Overall Study||10
7684070|NCT01912768|18924685|P2|COMPLETED|Overall Study||109
7684071|NCT01912768|18924686|P1|COMPLETED|Overall Study||229
7684072|NCT01912768|18924685|P2|STARTED|Overall Study||113
7684073|NCT01912768|18924686|P1|STARTED|Overall Study||239
7684074|NCT01912729|18924717|P2|NOT COMPLETED|Overall Study||1
7684075|NCT01912729|18924718|P1|NOT COMPLETED|Overall Study||0
7684076|NCT01912729|18924717|P2|COMPLETED|Overall Study||19
7684077|NCT01912729|18924718|P1|COMPLETED|Overall Study||20
7684078|NCT01912729|18924717|P2|STARTED|Overall Study||20
7684079|NCT01912729|18924718|P1|STARTED|Overall Study||20
7684080|NCT01912716|18924730|P2|NOT COMPLETED|Overall Study||0
7684081|NCT01912716|18924731|P1|NOT COMPLETED|Overall Study||0
7684082|NCT01912716|18924730|P2|COMPLETED|Overall Study||515
7684083|NCT01912716|18924731|P1|COMPLETED|Overall Study||522
7684084|NCT01912716|18924730|P2|3-day Follow-up|Overall Study||513
7684085|NCT01912716|18924731|P1|3-day Follow-up|Overall Study||521
7684086|NCT01912716|18924730|P2|5-day Follow-up|Overall Study||515
7684087|NCT01912716|18924731|P1|5-day Follow-up|Overall Study||522
7684088|NCT01912716|18924730|P2|Receipt of 2nd Dose|Overall Study||503
7684089|NCT01912716|18924731|P1|Receipt of 2nd Dose|Overall Study||511
7684090|NCT01912716|18924730|P2|STARTED|Overall Study||515
7684091|NCT01912716|18924731|P1|STARTED|Overall Study|receipt of 1st dose of indomethacin|522
7684092|NCT01912612|18924741|P3|NOT COMPLETED|Overall Study||3
7684093|NCT01912612|18924742|P2|NOT COMPLETED|Overall Study||0
7684094|NCT01912612|18924743|P1|NOT COMPLETED|Overall Study||5
7684095|NCT01912612|18924741|P3|COMPLETED|Overall Study||0
7684096|NCT01912612|18924742|P2|COMPLETED|Overall Study||40
7684097|NCT01912612|18924743|P1|COMPLETED|Overall Study||31
7684098|NCT01912612|18924741|P3|STARTED|Overall Study||3
7684099|NCT01912612|18924742|P2|STARTED|Overall Study||40
7684100|NCT01912612|18924743|P1|STARTED|Overall Study||36
7684101|NCT01912599|18924787|P2|NOT COMPLETED|Overall Study||1
7684102|NCT01912599|18924788|P1|NOT COMPLETED|Overall Study||0
7684103|NCT01912599|18924787|P2|COMPLETED|Overall Study||15
7684104|NCT01912599|18924788|P1|COMPLETED|Overall Study||20
7684105|NCT01912599|18924787|P2|STARTED|Overall Study||16
7684106|NCT01912599|18924788|P1|STARTED|Overall Study||20
7684107|NCT01912495|18924802|P1|NOT COMPLETED|Overall Study||0
7684108|NCT01912495|18924802|P1|COMPLETED|Overall Study||57
7684109|NCT01912495|18924802|P1|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57
7684110|NCT01912404|18924813|P2|NOT COMPLETED|Overall Study||0
7684111|NCT01912404|18924814|P1|NOT COMPLETED|Overall Study||1
7684112|NCT01912404|18924813|P2|COMPLETED|Overall Study||2
7684113|NCT01912404|18924814|P1|COMPLETED|Overall Study||2
7684114|NCT01912404|18924813|P2|STARTED|Overall Study||2
7684115|NCT01912404|18924814|P1|STARTED|Overall Study||3
7684116|NCT01912352|18924820|P1|NOT COMPLETED|Overall Study||5
7684117|NCT01912352|18924820|P1|COMPLETED|Overall Study||78
7684118|NCT01912352|18924820|P1|STARTED|Overall Study||83
7684119|NCT01912339|18924827|P3|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53
7684120|NCT01912339|18924828|P2|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
7684121|NCT01912339|18924829|P1|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133
7684122|NCT01912339|18924827|P3|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
7684123|NCT01912339|18924828|P2|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
7684124|NCT01912339|18924829|P1|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
7684125|NCT01912339|18924827|P3|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|Control subjects that have crossed over.|53
7684126|NCT01912339|18924828|P2|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|All subjects for the control group either completed study or crossed over.|0
7684127|NCT01912339|18924829|P1|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133
7684128|NCT01912339|18924827|P3|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
7684129|NCT01912339|18924828|P2|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
7684130|NCT01912339|18924829|P1|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1
7684131|NCT01912339|18924827|P3|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|0
7684132|NCT01912339|18924828|P2|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Of the 61 subjects, there were 53 crossover subjects and 8 that completed their study participation.|61
7684133|NCT01912339|18924829|P1|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|133
7684134|NCT01912339|18924827|P3|STARTED|Unblinded (3 to 6 Months/Crossover)||0
7684135|NCT01912339|18924828|P2|STARTED|Unblinded (3 to 6 Months/Crossover)||61
7684136|NCT01912339|18924829|P1|STARTED|Unblinded (3 to 6 Months/Crossover)||134
7684137|NCT01912339|18924827|P3|NOT COMPLETED|Blinded (0 to 3 Months)||0
7684138|NCT01912339|18924828|P2|NOT COMPLETED|Blinded (0 to 3 Months)||0
7684139|NCT01912339|18924829|P1|NOT COMPLETED|Blinded (0 to 3 Months)||2
7684140|NCT01912339|18924827|P3|COMPLETED|Blinded (0 to 3 Months)||0
7684141|NCT01912339|18924828|P2|COMPLETED|Blinded (0 to 3 Months)||61
7684142|NCT01912339|18924829|P1|COMPLETED|Blinded (0 to 3 Months)||134
7684143|NCT01912339|18924827|P3|STARTED|Blinded (0 to 3 Months)||0
7684144|NCT01912339|18924828|P2|STARTED|Blinded (0 to 3 Months)||61
7684145|NCT01912339|18924829|P1|STARTED|Blinded (0 to 3 Months)||136
7684146|NCT01912287|18924846|P3|NOT COMPLETED|Overall Study||15
7684147|NCT01912287|18924847|P2|NOT COMPLETED|Overall Study||23
7684148|NCT01912287|18924848|P1|NOT COMPLETED|Overall Study||33
7684149|NCT01912287|18924846|P3|COMPLETED|Overall Study||28
7684150|NCT01912287|18924847|P2|COMPLETED|Overall Study||67
7684151|NCT01912287|18924848|P1|COMPLETED|Overall Study||60
7684152|NCT01912287|18924846|P3|STARTED|Overall Study||43
7684153|NCT01912287|18924847|P2|STARTED|Overall Study||90
7684154|NCT01912287|18924848|P1|STARTED|Overall Study||93
7684155|NCT01912222|18924859|P3|NOT COMPLETED|Part B: Treatment Period||20
7684156|NCT01912222|18924860|P2|NOT COMPLETED|Part B: Treatment Period||15
7684157|NCT01912222|18924861|P1|NOT COMPLETED|Part B: Treatment Period||13
7684158|NCT01912222|18924859|P3|COMPLETED|Part B: Treatment Period||0
7684159|NCT01912222|18924860|P2|COMPLETED|Part B: Treatment Period||0
7684160|NCT01912222|18924861|P1|COMPLETED|Part B: Treatment Period||0
7684161|NCT01912222|18924859|P3|STARTED|Part B: Treatment Period||20
7684162|NCT01912222|18924860|P2|STARTED|Part B: Treatment Period||15
7684163|NCT01912222|18924861|P1|STARTED|Part B: Treatment Period||13
7684164|NCT01912222|18924859|P3|NOT COMPLETED|Part A: Pharmacokinetic Period||2
7684165|NCT01912222|18924860|P2|NOT COMPLETED|Part A: Pharmacokinetic Period||2
7684166|NCT01912222|18924861|P1|NOT COMPLETED|Part A: Pharmacokinetic Period||1
7684167|NCT01912222|18924859|P3|COMPLETED|Part A: Pharmacokinetic Period||18
7684168|NCT01912222|18924860|P2|COMPLETED|Part A: Pharmacokinetic Period||13
7684169|NCT01912222|18924861|P1|COMPLETED|Part A: Pharmacokinetic Period||12
7684170|NCT01912222|18924859|P3|STARTED|Part A: Pharmacokinetic Period||20
7684171|NCT01912222|18924860|P2|STARTED|Part A: Pharmacokinetic Period||15
7684172|NCT01912222|18924861|P1|STARTED|Part A: Pharmacokinetic Period||13
7684173|NCT01911910|18924886|P2|NOT COMPLETED|Overall Study||11
7684174|NCT01911910|18924887|P1|NOT COMPLETED|Overall Study||13
7684175|NCT01911910|18924886|P2|COMPLETED|Overall Study||194
7684176|NCT01911910|18924887|P1|COMPLETED|Overall Study||184
7684177|NCT01911910|18924886|P2|STARTED|Overall Study||205
7684178|NCT01911910|18924887|P1|STARTED|Overall Study||197
7684179|NCT01911845|18924919|P1|NOT COMPLETED|Overall Study||6
7684180|NCT01911845|18924919|P1|COMPLETED|Overall Study||32
7684181|NCT01911845|18924919|P1|Completed Study Drug|Overall Study||37
7684182|NCT01911845|18924919|P1|STARTED|Overall Study||38
7684183|NCT01911819|18924936|P3|NOT COMPLETED|Overall Study||0
7684184|NCT01911819|18924937|P2|NOT COMPLETED|Overall Study||2
7684185|NCT01911819|18924938|P1|NOT COMPLETED|Overall Study||1
7684186|NCT01911819|18924936|P3|COMPLETED|Overall Study||10
7684187|NCT01911819|18924937|P2|COMPLETED|Overall Study||9
7684188|NCT01911819|18924938|P1|COMPLETED|Overall Study||9
7684189|NCT01911819|18924936|P3|STARTED|Overall Study||10
7684190|NCT01911819|18924937|P2|STARTED|Overall Study|One of 10 sinuses was replaced to another sinus due to infection.|11
7684191|NCT01911819|18924938|P1|STARTED|Overall Study||10
7684192|NCT01911793|18924951|P2|NOT COMPLETED|Overall Study||5
7684193|NCT01911793|18924952|P1|NOT COMPLETED|Overall Study||1
7684194|NCT01911793|18924951|P2|COMPLETED|Overall Study||0
7684195|NCT01911793|18924952|P1|COMPLETED|Overall Study||0
7684196|NCT01911793|18924951|P2|STARTED|Overall Study||5
7684197|NCT01911793|18924952|P1|STARTED|Overall Study||1
7684198|NCT01911780|18924976|P2|NOT COMPLETED|Extension Period (52 Weeks)||3
7684199|NCT01911780|18924977|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
7684200|NCT01911780|18924976|P2|COMPLETED|Extension Period (52 Weeks)||58
7684201|NCT01911780|18924977|P1|COMPLETED|Extension Period (52 Weeks)||61
7684202|NCT01911780|18924976|P2|STARTED|Extension Period (52 Weeks)||61
7684203|NCT01911780|18924977|P1|STARTED|Extension Period (52 Weeks)||65
7684204|NCT01911780|18924976|P2|NOT COMPLETED|Double-blind Period (8 Weeks)||3
7684205|NCT01911780|18924977|P1|NOT COMPLETED|Double-blind Period (8 Weeks)||3
7684206|NCT01911780|18924976|P2|COMPLETED|Double-blind Period (8 Weeks)||61
7684207|NCT01911780|18924977|P1|COMPLETED|Double-blind Period (8 Weeks)||65
7684208|NCT01911780|18924976|P2|STARTED|Double-blind Period (8 Weeks)||64
7684209|NCT01911780|18924977|P1|STARTED|Double-blind Period (8 Weeks)||68
7684210|NCT01911689|18924997|P2|NOT COMPLETED|Overall Study||0
7684211|NCT01911689|18924998|P1|NOT COMPLETED|Overall Study||0
7684212|NCT01911689|18924997|P2|COMPLETED|Overall Study||51
7684213|NCT01911689|18924998|P1|COMPLETED|Overall Study||117
7684214|NCT01911689|18924997|P2|STARTED|Overall Study||51
7684215|NCT01911689|18924998|P1|STARTED|Overall Study||117
7684216|NCT01911546|18925011|P1|NOT COMPLETED|Overall Study||6
7684217|NCT01911546|18925011|P1|COMPLETED|Overall Study||14
7684218|NCT01911546|18925011|P1|STARTED|Overall Study||20
7684219|NCT01911442|18925021|P3|NOT COMPLETED|Overall Study||12
7684220|NCT01911442|18925022|P2|NOT COMPLETED|Overall Study||4
7684221|NCT01911442|18925023|P1|NOT COMPLETED|Overall Study||6
7684222|NCT01911442|18925021|P3|COMPLETED|Overall Study||38
7684223|NCT01911442|18925022|P2|COMPLETED|Overall Study||47
7684224|NCT01911442|18925023|P1|COMPLETED|Overall Study||43
7684225|NCT01911442|18925021|P3|STARTED|Overall Study||50
7684226|NCT01911442|18925022|P2|STARTED|Overall Study||51
7684227|NCT01911442|18925023|P1|STARTED|Overall Study||49
7684228|NCT01911429|18925052|P3|NOT COMPLETED|Overall Study||20
7684229|NCT01911429|18925053|P2|NOT COMPLETED|Overall Study||10
7684230|NCT01911429|18925054|P1|NOT COMPLETED|Overall Study||12
7684231|NCT01911429|18925052|P3|COMPLETED|Overall Study||93
7684232|NCT01911429|18925053|P2|COMPLETED|Overall Study||96
7684233|NCT01911429|18925054|P1|COMPLETED|Overall Study||96
7684234|NCT01911429|18925052|P3|STARTED|Overall Study|one subject randomized to Placebo group was never dosed for study medication, making the total 112|113
7684235|NCT01911429|18925053|P2|STARTED|Overall Study|Subjects received lurasidone 40/mg day from Days 1-3, and 80mg/day from days 4 to Week 6 visit|106
7684236|NCT01911429|18925054|P1|STARTED|Overall Study||108
7684237|NCT01911403|18925088|P2|NOT COMPLETED|Overall Study||3
7684238|NCT01911403|18925089|P1|NOT COMPLETED|Overall Study||9
7684239|NCT01911403|18925088|P2|COMPLETED|Overall Study||59
7684240|NCT01911403|18925089|P1|COMPLETED|Overall Study||52
7684241|NCT01911403|18925088|P2|STARTED|Overall Study||62
7684242|NCT01911403|18925089|P1|STARTED|Overall Study||61
7684243|NCT01911390|18925110|P4|NOT COMPLETED|Overall Study||1
7684244|NCT01911390|18925111|P3|NOT COMPLETED|Overall Study||1
7684245|NCT01911390|18925112|P2|NOT COMPLETED|Overall Study||0
7684246|NCT01911390|18925113|P1|NOT COMPLETED|Overall Study||1
7684247|NCT01911390|18925110|P4|COMPLETED|Overall Study||10
7684248|NCT01911390|18925111|P3|COMPLETED|Overall Study||9
7684249|NCT01911390|18925112|P2|COMPLETED|Overall Study||10
7684250|NCT01911390|18925113|P1|COMPLETED|Overall Study||9
7684251|NCT01911390|18925110|P4|STARTED|Overall Study||11
7684252|NCT01911390|18925111|P3|STARTED|Overall Study||10
7684253|NCT01911390|18925112|P2|STARTED|Overall Study||10
7684254|NCT01911390|18925113|P1|STARTED|Overall Study||10
7684255|NCT01911351|18925129|P2|NOT COMPLETED|Overall Study||0
7684256|NCT01911351|18925130|P1|NOT COMPLETED|Overall Study||0
7684257|NCT01911351|18925129|P2|COMPLETED|Overall Study||43
7684258|NCT01911351|18925130|P1|COMPLETED|Overall Study||39
7684259|NCT01911351|18925129|P2|STARTED|Overall Study||43
7684260|NCT01911351|18925130|P1|STARTED|Overall Study||39
7684261|NCT01911273|18925146|P2|NOT COMPLETED|Overall Study||2
7684262|NCT01911273|18925147|P1|NOT COMPLETED|Overall Study||1
7684263|NCT01911273|18925146|P2|COMPLETED|Overall Study||0
7684264|NCT01911273|18925147|P1|COMPLETED|Overall Study||0
7684265|NCT01911273|18925146|P2|STARTED|Overall Study||2
7684266|NCT01911273|18925147|P1|STARTED|Overall Study||1
7684267|NCT01911260|18925181|P4|NOT COMPLETED|Follow-up Period||12
7684268|NCT01911260|18925182|P3|NOT COMPLETED|Follow-up Period||15
7684269|NCT01911260|18925183|P2|NOT COMPLETED|Follow-up Period||20
7684270|NCT01911260|18925184|P1|NOT COMPLETED|Follow-up Period||13
7684271|NCT01911260|18925181|P4|COMPLETED|Follow-up Period||30
7684272|NCT01911260|18925182|P3|COMPLETED|Follow-up Period||24
7684273|NCT01911260|18925183|P2|COMPLETED|Follow-up Period||18
7684274|NCT01911260|18925184|P1|COMPLETED|Follow-up Period||27
7684275|NCT01911260|18925181|P4|STARTED|Follow-up Period||42
7684276|NCT01911260|18925182|P3|STARTED|Follow-up Period||39
7684277|NCT01911260|18925183|P2|STARTED|Follow-up Period||38
7684278|NCT01911260|18925184|P1|STARTED|Follow-up Period||40
7684279|NCT01911260|18925181|P4|NOT COMPLETED|Supplementation Period||8
7684280|NCT01911260|18925182|P3|NOT COMPLETED|Supplementation Period||10
7684281|NCT01911260|18925183|P2|NOT COMPLETED|Supplementation Period||12
7684282|NCT01911260|18925184|P1|NOT COMPLETED|Supplementation Period||10
7684283|NCT01911260|18925181|P4|COMPLETED|Supplementation Period||42
7684284|NCT01911260|18925182|P3|COMPLETED|Supplementation Period||39
7684285|NCT01911260|18925183|P2|COMPLETED|Supplementation Period||38
7684286|NCT01911260|18925184|P1|COMPLETED|Supplementation Period||40
7684287|NCT01911260|18925181|P4|STARTED|Supplementation Period||50
7684288|NCT01911260|18925182|P3|STARTED|Supplementation Period||49
7684289|NCT01911260|18925183|P2|STARTED|Supplementation Period||50
7684290|NCT01911260|18925184|P1|STARTED|Supplementation Period||50
7684291|NCT01911221|18925194|P1|NOT COMPLETED|Overall Study||0
7684292|NCT01911221|18925194|P1|COMPLETED|Overall Study||13
7684293|NCT01911221|18925194|P1|STARTED|Overall Study||13
7684294|NCT01911169|18925210|P2|NOT COMPLETED|Overall Study||0
7684295|NCT01911169|18925211|P1|NOT COMPLETED|Overall Study||0
7684296|NCT01911169|18925210|P2|COMPLETED|Overall Study||3
7684297|NCT01911169|18925211|P1|COMPLETED|Overall Study||6
7684298|NCT01911169|18925210|P2|STARTED|Overall Study||3
7684299|NCT01911169|18925211|P1|STARTED|Overall Study||6
7684300|NCT01911065|18925221|P2|NOT COMPLETED|Overall Study||0
7684301|NCT01911065|18925222|P1|NOT COMPLETED|Overall Study||0
7684302|NCT01911065|18925221|P2|COMPLETED|Overall Study||9
7684303|NCT01911065|18925222|P1|COMPLETED|Overall Study||45
7684304|NCT01911065|18925221|P2|STARTED|Overall Study||9
7684305|NCT01911065|18925222|P1|STARTED|Overall Study||45
7684306|NCT01910831|18925230|P1|NOT COMPLETED|Overall Study||1
7684307|NCT01910831|18925230|P1|COMPLETED|Overall Study||19
7684308|NCT01910831|18925230|P1|STARTED|Overall Study||20
7684309|NCT01910792|18925239|P2|NOT COMPLETED|Overall Study||0
7684310|NCT01910792|18925240|P1|NOT COMPLETED|Overall Study||0
7684311|NCT01910792|18925239|P2|COMPLETED|Overall Study||10
7684312|NCT01910792|18925240|P1|COMPLETED|Overall Study||9
7684313|NCT01910792|18925239|P2|STARTED|Overall Study||10
7684314|NCT01910792|18925240|P1|STARTED|Overall Study||9
7684315|NCT01910688|18925246|P1|NOT COMPLETED|Overall Study||5
7684316|NCT01910688|18925246|P1|COMPLETED|Overall Study||20
7684317|NCT01910688|18925246|P1|12months|Overall Study||22
7684318|NCT01910688|18925246|P1|3rd RFA Treatment|Overall Study||18
7684319|NCT01910688|18925246|P1|7.5months|Overall Study||24
7684320|NCT01910688|18925246|P1|2nd RFA Treatment|Overall Study||22
7684321|NCT01910688|18925246|P1|3.5month|Overall Study||25
7684322|NCT01910688|18925246|P1|STARTED|Overall Study||25
7684323|NCT01910636|18925255|P2|NOT COMPLETED|Overall Study||0
7684324|NCT01910636|18925256|P1|NOT COMPLETED|Overall Study||0
7684325|NCT01910636|18925255|P2|COMPLETED|Overall Study||63
7684326|NCT01910636|18925256|P1|COMPLETED|Overall Study||90
7684327|NCT01910636|18925255|P2|STARTED|Overall Study||63
7684328|NCT01910636|18925256|P1|STARTED|Overall Study||90
7684329|NCT01910519|18925270|P2|NOT COMPLETED|Overall Study||0
7684330|NCT01910519|18925271|P1|NOT COMPLETED|Overall Study||4
7684331|NCT01910519|18925270|P2|COMPLETED|Overall Study||15
7684332|NCT01910519|18925271|P1|COMPLETED|Overall Study||31
7684333|NCT01910519|18925270|P2|STARTED|Overall Study||15
7684334|NCT01910519|18925271|P1|STARTED|Overall Study||35
7684335|NCT01910441|18925297|P2|NOT COMPLETED|Overall Study||10
7684336|NCT01910441|18925298|P1|NOT COMPLETED|Overall Study||7
7684337|NCT01910441|18925297|P2|COMPLETED|Overall Study||37
7684338|NCT01910441|18925298|P1|COMPLETED|Overall Study||41
7684339|NCT01910441|18925297|P2|STARTED|Overall Study||47
7684340|NCT01910441|18925298|P1|STARTED|Overall Study||48
7684341|NCT01910402|18925306|P2|NOT COMPLETED|Continuation Phase||0
7684342|NCT01910402|18925307|P1|NOT COMPLETED|Continuation Phase||90
7684343|NCT01910402|18925306|P2|COMPLETED|Continuation Phase||0
7684344|NCT01910402|18925307|P1|COMPLETED|Continuation Phase||30
7684345|NCT01910402|18925306|P2|STARTED|Continuation Phase||0
7684346|NCT01910402|18925307|P1|STARTED|Continuation Phase||120
7684347|NCT01910402|18925306|P2|NOT COMPLETED|Randomized Phase||55
7684348|NCT01910402|18925307|P1|NOT COMPLETED|Randomized Phase||42
7684349|NCT01910402|18925306|P2|COMPLETED|Randomized Phase||192
7684350|NCT01910402|18925307|P1|COMPLETED|Randomized Phase||206
7684351|NCT01910402|18925306|P2|STARTED|Randomized Phase||247
7684352|NCT01910402|18925307|P1|STARTED|Randomized Phase||248
7684353|NCT01910389|18925377|P2|NOT COMPLETED|Overall Study||8
7684354|NCT01910389|18925378|P1|NOT COMPLETED|Overall Study||15
7684355|NCT01910389|18925377|P2|COMPLETED|Overall Study||0
7684356|NCT01910389|18925378|P1|COMPLETED|Overall Study||0
7684357|NCT01910389|18925377|P2|STARTED|Overall Study||8
7684358|NCT01910389|18925378|P1|STARTED|Overall Study||15
7684359|NCT01910311|18925408|P1|NOT COMPLETED|Period 2 (Days 3-32)||0
7684360|NCT01910311|18925408|P1|COMPLETED|Period 2 (Days 3-32)||18
7684361|NCT01910311|18925408|P1|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18
7684362|NCT01910311|18925408|P1|Received Baricitinib|Period 2 (Days 3-32)||18
7684363|NCT01910311|18925408|P1|STARTED|Period 2 (Days 3-32)||18
7684364|NCT01910311|18925408|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
7684365|NCT01910311|18925408|P1|COMPLETED|Period 1 (Days 1-2)||18
7684366|NCT01910311|18925408|P1|Received Baricitinib|Period 1 (Days 1-2)||18
7684367|NCT01910311|18925408|P1|STARTED|Period 1 (Days 1-2)||18
7684368|NCT01910298|18925421|P2|NOT COMPLETED|Overall Study||32
7684369|NCT01910298|18925422|P1|NOT COMPLETED|Overall Study||5
7684370|NCT01910298|18925421|P2|COMPLETED|Overall Study||23
7684371|NCT01910298|18925422|P1|COMPLETED|Overall Study||71
7684372|NCT01910298|18925421|P2|Safety Set|Overall Study|4 participants did not have first surgery date and were not included in Safety Set.|51
7684373|NCT01910298|18925422|P1|Safety Set|Overall Study||76
7684374|NCT01910298|18925421|P2|STARTED|Overall Study||55
7684375|NCT01910298|18925422|P1|STARTED|Overall Study||76
7684376|NCT01910181|18925440|P1|NOT COMPLETED|Overall Study||46
7684377|NCT01910181|18925440|P1|COMPLETED|Overall Study||0
7684378|NCT01910181|18925440|P1|Expansion Cohort|Overall Study||26
7684379|NCT01910181|18925440|P1|PK Cohort|Overall Study||20
7684380|NCT01910181|18925440|P1|STARTED|Overall Study||46
7684381|NCT01910129|18925467|P3|NOT COMPLETED|Randomized Phase 3||0
7684382|NCT01910129|18925468|P2|NOT COMPLETED|Randomized Phase 3||1
7684383|NCT01910129|18925469|P1|NOT COMPLETED|Randomized Phase 3||0
7684384|NCT01910129|18925467|P3|COMPLETED|Randomized Phase 3||0
7684385|NCT01910129|18925468|P2|COMPLETED|Randomized Phase 3||4
7684386|NCT01910129|18925469|P1|COMPLETED|Randomized Phase 3||5
7684387|NCT01910129|18925467|P3|STARTED|Randomized Phase 3||0
7684388|NCT01910129|18925468|P2|STARTED|Randomized Phase 3||5
7684389|NCT01910129|18925469|P1|STARTED|Randomized Phase 3||5
7684390|NCT01910129|18925467|P3|NOT COMPLETED|Randomized Phase 2||0
7684391|NCT01910129|18925468|P2|NOT COMPLETED|Randomized Phase 2||1
7684392|NCT01910129|18925469|P1|NOT COMPLETED|Randomized Phase 2||2
7684393|NCT01910129|18925467|P3|COMPLETED|Randomized Phase 2||0
7684394|NCT01910129|18925468|P2|COMPLETED|Randomized Phase 2||5
7684395|NCT01910129|18925469|P1|COMPLETED|Randomized Phase 2||5
7684396|NCT01910129|18925467|P3|STARTED|Randomized Phase 2||0
7684397|NCT01910129|18925468|P2|STARTED|Randomized Phase 2||6
7684398|NCT01910129|18925469|P1|STARTED|Randomized Phase 2||7
7684399|NCT01910129|18925467|P3|NOT COMPLETED|Run-in Period Phase 1||0
7684400|NCT01910129|18925468|P2|NOT COMPLETED|Run-in Period Phase 1||0
7684401|NCT01910129|18925469|P1|NOT COMPLETED|Run-in Period Phase 1||0
7684402|NCT01910129|18925467|P3|COMPLETED|Run-in Period Phase 1||13
7684403|NCT01910129|18925468|P2|COMPLETED|Run-in Period Phase 1||0
7684404|NCT01910129|18925469|P1|COMPLETED|Run-in Period Phase 1||0
7684405|NCT01910129|18925467|P3|STARTED|Run-in Period Phase 1||13
7684406|NCT01910129|18925468|P2|STARTED|Run-in Period Phase 1||0
7684407|NCT01910129|18925469|P1|STARTED|Run-in Period Phase 1||0
7684408|NCT01910116|18925493|P2|NOT COMPLETED|Overall Study||16
7684409|NCT01910116|18925494|P1|NOT COMPLETED|Overall Study||14
7684410|NCT01910116|18925493|P2|COMPLETED|Overall Study||94
7684411|NCT01910116|18925494|P1|COMPLETED|Overall Study||96
7684412|NCT01910116|18925493|P2|Week 16|Overall Study||94
7684413|NCT01910116|18925494|P1|Week 16|Overall Study||96
7684414|NCT01910116|18925493|P2|Week 12|Overall Study||96
7684415|NCT01910116|18925494|P1|Week 12|Overall Study||97
7684416|NCT01910116|18925493|P2|Week 8|Overall Study||99
7684417|NCT01910116|18925494|P1|Week 8|Overall Study||98
7684418|NCT01910116|18925493|P2|Week 4|Overall Study||102
7684419|NCT01910116|18925494|P1|Week 4|Overall Study||106
7684420|NCT01910116|18925493|P2|STARTED|Overall Study||110
7684421|NCT01910116|18925494|P1|STARTED|Overall Study||110
7684422|NCT01910064|18925570|P1|NOT COMPLETED|Overall Study||45
7684423|NCT01910064|18925570|P1|COMPLETED|Overall Study||391
7684424|NCT01910064|18925570|P1|STARTED|Overall Study||436
7684425|NCT01909973|18925581|P2|NOT COMPLETED|Overall Study||0
7684426|NCT01909973|18925582|P1|NOT COMPLETED|Overall Study||1
7684427|NCT01909973|18925581|P2|COMPLETED|Overall Study||7
7684428|NCT01909973|18925582|P1|COMPLETED|Overall Study||7
7684429|NCT01909973|18925581|P2|STARTED|Overall Study||7
7684430|NCT01909973|18925582|P1|STARTED|Overall Study||8
7684431|NCT01909804|18925602|P12|NOT COMPLETED|Overall Study||3
7684432|NCT01909804|18925603|P11|NOT COMPLETED|Overall Study||1
7684433|NCT01909804|18925604|P10|NOT COMPLETED|Overall Study||1
7684434|NCT01909804|18925605|P9|NOT COMPLETED|Overall Study||0
7684435|NCT01909804|18925606|P8|NOT COMPLETED|Overall Study||1
7684436|NCT01909804|18925607|P7|NOT COMPLETED|Overall Study||2
7684437|NCT01909804|18925608|P6|NOT COMPLETED|Overall Study||4
7684438|NCT01909804|18925609|P5|NOT COMPLETED|Overall Study||8
7684439|NCT01909804|18925610|P4|NOT COMPLETED|Overall Study||0
7684440|NCT01909804|18925611|P3|NOT COMPLETED|Overall Study||0
7684441|NCT01909804|18925612|P2|NOT COMPLETED|Overall Study||1
7684442|NCT01909804|18925613|P1|NOT COMPLETED|Overall Study||4
7684443|NCT01909804|18925602|P12|COMPLETED|Overall Study||26
7684444|NCT01909804|18925603|P11|COMPLETED|Overall Study||26
7684445|NCT01909804|18925604|P10|COMPLETED|Overall Study||28
7684446|NCT01909804|18925605|P9|COMPLETED|Overall Study||27
7684447|NCT01909804|18925606|P8|COMPLETED|Overall Study||25
7684448|NCT01909804|18925607|P7|COMPLETED|Overall Study||25
7684449|NCT01909804|18925608|P6|COMPLETED|Overall Study||21
7684450|NCT01909804|18925609|P5|COMPLETED|Overall Study||18
7684451|NCT01909804|18925610|P4|COMPLETED|Overall Study||26
7684452|NCT01909804|18925611|P3|COMPLETED|Overall Study||27
7684453|NCT01909804|18925612|P2|COMPLETED|Overall Study||27
7684454|NCT01909804|18925613|P1|COMPLETED|Overall Study||22
7684455|NCT01909804|18925602|P12|STARTED|Overall Study||29
7684456|NCT01909804|18925603|P11|STARTED|Overall Study||27
7684457|NCT01909804|18925604|P10|STARTED|Overall Study||29
7684458|NCT01909804|18925605|P9|STARTED|Overall Study||27
7684459|NCT01909804|18925606|P8|STARTED|Overall Study||26
7684460|NCT01909804|18925607|P7|STARTED|Overall Study||27
7684461|NCT01909804|18925608|P6|STARTED|Overall Study||25
7684462|NCT01909804|18925609|P5|STARTED|Overall Study||26
7684463|NCT01909804|18925610|P4|STARTED|Overall Study||26
7684464|NCT01909804|18925611|P3|STARTED|Overall Study||27
7684465|NCT01909804|18925612|P2|STARTED|Overall Study||28
7684466|NCT01909804|18925613|P1|STARTED|Overall Study||26
7684467|NCT01909791|18925662|P3|NOT COMPLETED|Overall Study||28
7684468|NCT01909791|18925663|P2|NOT COMPLETED|Overall Study||28
7684469|NCT01909791|18925664|P1|NOT COMPLETED|Overall Study||21
7684470|NCT01909791|18925662|P3|COMPLETED|Overall Study||208
7684471|NCT01909791|18925663|P2|COMPLETED|Overall Study||212
7684472|NCT01909791|18925664|P1|COMPLETED|Overall Study||205
7684473|NCT01909791|18925662|P3|STARTED|Overall Study||236
7684474|NCT01909791|18925663|P2|STARTED|Overall Study||240
7684475|NCT01909791|18925664|P1|STARTED|Overall Study||226
7684476|NCT01909778|18925722|P1|NOT COMPLETED|Overall Study||1
7684477|NCT01909778|18925722|P1|COMPLETED|Overall Study||1
7684478|NCT01909778|18925722|P1|STARTED|Overall Study||2
7684479|NCT01909713|18925746|P1|NOT COMPLETED|Overall Study||0
7684480|NCT01909713|18925746|P1|COMPLETED|Overall Study||35
7684481|NCT01909713|18925746|P1|STARTED|Overall Study||35
7684482|NCT01909674|18925801|P2|NOT COMPLETED|Overall Study||2
7684483|NCT01909674|18925802|P1|NOT COMPLETED|Overall Study||5
7684484|NCT01909674|18925801|P2|COMPLETED|Overall Study||7
7684485|NCT01909674|18925802|P1|COMPLETED|Overall Study||7
7684486|NCT01909674|18925801|P2|STARTED|Overall Study||9
7684487|NCT01909674|18925802|P1|STARTED|Overall Study||12
7684488|NCT01909570|18925810|P2|NOT COMPLETED|Overall Study||27
7684489|NCT01909570|18925811|P1|NOT COMPLETED|Overall Study||27
7684490|NCT01909570|18925810|P2|COMPLETED|Overall Study||64
7684491|NCT01909570|18925811|P1|COMPLETED|Overall Study||57
7684492|NCT01909570|18925810|P2|STARTED|Overall Study||91
7684493|NCT01909570|18925811|P1|STARTED|Overall Study||84
7684494|NCT01909466|18925821|P2|NOT COMPLETED|Overall Study||23
7684495|NCT01909466|18925822|P1|NOT COMPLETED|Overall Study||22
7684496|NCT01909466|18925821|P2|COMPLETED|Overall Study||50
7684497|NCT01909466|18925822|P1|COMPLETED|Overall Study||46
7684498|NCT01909466|18925821|P2|STARTED|Overall Study||73
7684499|NCT01909466|18925822|P1|STARTED|Overall Study||68
7684500|NCT01909336|18925845|P3|NOT COMPLETED|Overall Study||3
7684501|NCT01909336|18925846|P2|NOT COMPLETED|Overall Study||3
7684502|NCT01909336|18925847|P1|NOT COMPLETED|Overall Study||4
7684503|NCT01909336|18925845|P3|COMPLETED|Overall Study||52
7684504|NCT01909336|18925846|P2|COMPLETED|Overall Study||50
7684505|NCT01909336|18925847|P1|COMPLETED|Overall Study||49
7684506|NCT01909336|18925845|P3|STARTED|Overall Study||55
7684507|NCT01909336|18925846|P2|STARTED|Overall Study||53
7684508|NCT01909336|18925847|P1|STARTED|Overall Study||53
7684509|NCT01909180|18925861|P1|NOT COMPLETED|Overall Study||0
7684510|NCT01909180|18925861|P1|COMPLETED|Overall Study||49
7684511|NCT01909180|18925861|P1|STARTED|Overall Study||49
7684512|NCT01909154|18925867|P1|NOT COMPLETED|Overall Study||0
7684513|NCT01909154|18925867|P1|COMPLETED|Overall Study||12
7684514|NCT01909154|18925867|P1|STARTED|Overall Study||12
7684515|NCT01909141|18925878|P2|NOT COMPLETED|Overall Study||0
7684516|NCT01909141|18925879|P1|NOT COMPLETED|Overall Study||0
7684517|NCT01909141|18925878|P2|COMPLETED|Overall Study||50
7684518|NCT01909141|18925879|P1|COMPLETED|Overall Study||50
7684519|NCT01909141|18925878|P2|STARTED|Overall Study||50
7684520|NCT01909141|18925879|P1|STARTED|Overall Study||50
7684521|NCT01909011|18925895|P2|NOT COMPLETED|Overall Study||0
7684522|NCT01909011|18925896|P1|NOT COMPLETED|Overall Study||0
7684523|NCT01909011|18925895|P2|COMPLETED|Overall Study||9
7684524|NCT01909011|18925896|P1|COMPLETED|Overall Study||7
7684525|NCT01909011|18925895|P2|STARTED|Overall Study||9
7684526|NCT01909011|18925896|P1|STARTED|Overall Study||7
7684527|NCT01908972|18925908|P2|NOT COMPLETED|Overall Study||0
7684528|NCT01908972|18925909|P1|NOT COMPLETED|Overall Study||2
7684529|NCT01908972|18925908|P2|COMPLETED|Overall Study||17
7684530|NCT01908972|18925909|P1|COMPLETED|Overall Study||15
7684531|NCT01908972|18925908|P2|STARTED|Overall Study||17
7684532|NCT01908972|18925909|P1|STARTED|Overall Study||17
7684533|NCT01908907|18925945|P2|NOT COMPLETED|Overall Study||0
7684534|NCT01908907|18925946|P1|NOT COMPLETED|Overall Study||2
7684535|NCT01908907|18925945|P2|COMPLETED|Overall Study||29
7684536|NCT01908907|18925946|P1|COMPLETED|Overall Study||29
7684537|NCT01908907|18925945|P2|STARTED|Overall Study||29
7684538|NCT01908907|18925946|P1|STARTED|Overall Study||31
7684539|NCT01908842|18925968|P2|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17
7684540|NCT01908842|18925969|P1|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25
7684541|NCT01908842|18925968|P2|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
7684542|NCT01908842|18925969|P1|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
7684543|NCT01908842|18925968|P2|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279
7684544|NCT01908842|18925969|P1|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287
7684545|NCT01908842|18925968|P2|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65
7684546|NCT01908842|18925969|P1|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70
7684547|NCT01908842|18925968|P2|COMPLETED|Switch to Other BNX Formulation (Day 15)||279
7684548|NCT01908842|18925969|P1|COMPLETED|Switch to Other BNX Formulation (Day 15)||287
7684549|NCT01908842|18925968|P2|STARTED|Switch to Other BNX Formulation (Day 15)||344
7684550|NCT01908842|18925969|P1|STARTED|Switch to Other BNX Formulation (Day 15)||357
7684551|NCT01908842|18925968|P2|NOT COMPLETED|Induction||31
7684552|NCT01908842|18925969|P1|NOT COMPLETED|Induction||26
7684553|NCT01908842|18925968|P2|COMPLETED|Induction||344
7684554|NCT01908842|18925969|P1|COMPLETED|Induction||357
7684555|NCT01908842|18925968|P2|STARTED|Induction||375
7684556|NCT01908842|18925969|P1|STARTED|Induction||383
7684557|NCT01908829|18925990|P3|NOT COMPLETED|Overall Study||39
7684558|NCT01908829|18925991|P2|NOT COMPLETED|Overall Study||49
7684559|NCT01908829|18925992|P1|NOT COMPLETED|Overall Study||49
7684560|NCT01908829|18925990|P3|COMPLETED|Overall Study||680
7684561|NCT01908829|18925991|P2|COMPLETED|Overall Study||679
7684562|NCT01908829|18925992|P1|COMPLETED|Overall Study||678
7684563|NCT01908829|18925990|P3|Treated With Double-blind Drug|Overall Study||719
7684564|NCT01908829|18925991|P2|Treated With Double-blind Drug|Overall Study||728
7684565|NCT01908829|18925992|P1|Treated With Double-blind Drug|Overall Study||725
7684566|NCT01908829|18925990|P3|STARTED|Overall Study||719
7684567|NCT01908829|18925991|P2|STARTED|Overall Study||728
7684568|NCT01908829|18925992|P1|STARTED|Overall Study||727
7684569|NCT01908816|18926109|P4|NOT COMPLETED|Overall Study||35
7684570|NCT01908816|18926110|P3|NOT COMPLETED|Overall Study||58
7684571|NCT01908816|18926111|P2|NOT COMPLETED|Overall Study||84
7684572|NCT01908816|18926112|P1|NOT COMPLETED|Overall Study||93
7684573|NCT01908816|18926109|P4|COMPLETED|Overall Study||0
7684574|NCT01908816|18926110|P3|COMPLETED|Overall Study||0
7684575|NCT01908816|18926111|P2|COMPLETED|Overall Study||0
7684576|NCT01908816|18926112|P1|COMPLETED|Overall Study||0
7684577|NCT01908816|18926109|P4|STARTED|Overall Study||35
7684578|NCT01908816|18926110|P3|STARTED|Overall Study||58
7684579|NCT01908816|18926111|P2|STARTED|Overall Study||84
7684580|NCT01908816|18926112|P1|STARTED|Overall Study||93
7684581|NCT01908803|18926137|P2|NOT COMPLETED|Overall Study||1
7684582|NCT01908803|18926138|P1|NOT COMPLETED|Overall Study||4
7684583|NCT01908803|18926137|P2|COMPLETED|Overall Study||23
7684584|NCT01908803|18926138|P1|COMPLETED|Overall Study||42
7684585|NCT01908803|18926137|P2|Treated|Overall Study||24
7684586|NCT01908803|18926138|P1|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44
7684587|NCT01908803|18926137|P2|STARTED|Overall Study||24
7684588|NCT01908803|18926138|P1|STARTED|Overall Study||46
7684589|NCT01908751|18926153|P4|NOT COMPLETED|Overall Study||4
7684590|NCT01908751|18926154|P3|NOT COMPLETED|Overall Study||5
7684591|NCT01908751|18926155|P2|NOT COMPLETED|Overall Study||5
7684592|NCT01908751|18926156|P1|NOT COMPLETED|Overall Study||5
7684593|NCT01908751|18926153|P4|COMPLETED|Overall Study||16
7684594|NCT01908751|18926154|P3|COMPLETED|Overall Study||16
7684595|NCT01908751|18926155|P2|COMPLETED|Overall Study||18
7684596|NCT01908751|18926156|P1|COMPLETED|Overall Study||17
7684597|NCT01908751|18926153|P4|STARTED|Overall Study||20
7684598|NCT01908751|18926154|P3|STARTED|Overall Study||21
7684599|NCT01908751|18926155|P2|STARTED|Overall Study||23
7684600|NCT01908751|18926156|P1|STARTED|Overall Study||22
7684601|NCT01908699|18926192|P2|NOT COMPLETED|Overall Study||78
7684602|NCT01908699|18926193|P1|NOT COMPLETED|Overall Study||75
7684603|NCT01908699|18926192|P2|COMPLETED|Overall Study||58
7684604|NCT01908699|18926193|P1|COMPLETED|Overall Study||62
7684605|NCT01908699|18926192|P2|Received at Least 1 Dose of Study Drug|Overall Study||135
7684606|NCT01908699|18926193|P1|Received at Least 1 Dose of Study Drug|Overall Study||136
7684607|NCT01908699|18926192|P2|STARTED|Overall Study||136
7684608|NCT01908699|18926193|P1|STARTED|Overall Study||137
7684609|NCT01908582|18926209|P1|NOT COMPLETED|Period 2||2
7684610|NCT01908582|18926209|P1|COMPLETED|Period 2||24
7684611|NCT01908582|18926209|P1|STARTED|Period 2||26
7684612|NCT01908582|18926209|P1|NOT COMPLETED|Period 1||0
7684613|NCT01908582|18926209|P1|COMPLETED|Period 1||26
7684614|NCT01908582|18926209|P1|Received at Least One Dose of Study Drug|Period 1||26
7684615|NCT01908582|18926209|P1|STARTED|Period 1||26
7684616|NCT01908530|18926223|P3|NOT COMPLETED|Overall Study||0
7684617|NCT01908530|18926224|P2|NOT COMPLETED|Overall Study||0
7684618|NCT01908530|18926225|P1|NOT COMPLETED|Overall Study||0
7684619|NCT01908530|18926223|P3|COMPLETED|Overall Study||10
7684620|NCT01908530|18926224|P2|COMPLETED|Overall Study||8
7684621|NCT01908530|18926225|P1|COMPLETED|Overall Study||8
7684622|NCT01908530|18926223|P3|STARTED|Overall Study||10
7684623|NCT01908530|18926224|P2|STARTED|Overall Study||8
7684624|NCT01908530|18926225|P1|STARTED|Overall Study||8
7684625|NCT01908426|18926253|P2|NOT COMPLETED|Overall Study||211
7684626|NCT01908426|18926254|P1|NOT COMPLETED|Overall Study||397
7684627|NCT01908426|18926253|P2|COMPLETED|Overall Study||26
7684628|NCT01908426|18926254|P1|COMPLETED|Overall Study||73
7684629|NCT01908426|18926253|P2|STARTED|Overall Study||237
7684630|NCT01908426|18926254|P1|STARTED|Overall Study||470
7684631|NCT01908205|18926266|P2|NOT COMPLETED|Overall Study||1
7684632|NCT01908205|18926267|P1|NOT COMPLETED|Overall Study||5
7684633|NCT01908205|18926266|P2|COMPLETED|Overall Study||29
7684634|NCT01908205|18926267|P1|COMPLETED|Overall Study||25
7684635|NCT01908205|18926266|P2|STARTED|Overall Study||30
7684636|NCT01908205|18926267|P1|STARTED|Overall Study||30
7684637|NCT01908140|18926295|P2|NOT COMPLETED|Overall Study||79
7684638|NCT01908140|18926296|P1|NOT COMPLETED|Overall Study||66
7684639|NCT01908140|18926295|P2|COMPLETED|Overall Study||386
7684640|NCT01908140|18926296|P1|COMPLETED|Overall Study||402
7684641|NCT01908140|18926295|P2|STARTED|Overall Study||465
7684642|NCT01908140|18926296|P1|STARTED|Overall Study||468
7684643|NCT01908127|18926306|P2|NOT COMPLETED|Overall Study||0
7684644|NCT01908127|18926307|P1|NOT COMPLETED|Overall Study||1
7684645|NCT01908127|18926306|P2|COMPLETED|Overall Study||23
7684646|NCT01908127|18926307|P1|COMPLETED|Overall Study||22
7684647|NCT01908127|18926306|P2|STARTED|Overall Study||23
7684648|NCT01908127|18926307|P1|STARTED|Overall Study||23
7684649|NCT01908101|18926315|P1|NOT COMPLETED|Overall Study||9
7684650|NCT01908101|18926315|P1|COMPLETED|Overall Study||59
7684651|NCT01908101|18926315|P1|STARTED|Overall Study||68
7684652|NCT01908062|18926321|P2|NOT COMPLETED|Overall Study||3
7684653|NCT01908062|18926322|P1|NOT COMPLETED|Overall Study||2
7684654|NCT01908062|18926321|P2|COMPLETED|Overall Study||22
7684655|NCT01908062|18926322|P1|COMPLETED|Overall Study||24
7684656|NCT01908062|18926321|P2|STARTED|Overall Study||25
7684657|NCT01908062|18926322|P1|STARTED|Overall Study||26
7684658|NCT01907906|18926349|P2|NOT COMPLETED|Overall Study||1
7684659|NCT01907906|18926350|P1|NOT COMPLETED|Overall Study||4
7684660|NCT01907906|18926349|P2|COMPLETED|Overall Study||12
7684661|NCT01907906|18926350|P1|COMPLETED|Overall Study||12
7684662|NCT01907906|18926349|P2|STARTED|Overall Study||13
7684663|NCT01907906|18926350|P1|STARTED|Overall Study||16
7684664|NCT01907854|18926430|P2|NOT COMPLETED|Overall Study||13
7684665|NCT01907854|18926431|P1|NOT COMPLETED|Overall Study||16
7684666|NCT01907854|18926430|P2|COMPLETED|Overall Study||191
7684667|NCT01907854|18926431|P1|COMPLETED|Overall Study||187
7684668|NCT01907854|18926430|P2|Exposed|Overall Study||204
7684669|NCT01907854|18926431|P1|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202
7684670|NCT01907854|18926430|P2|STARTED|Overall Study||204
7684671|NCT01907854|18926431|P1|STARTED|Overall Study||203
7684672|NCT01907828|18926451|P2|NOT COMPLETED|Overall Study||6
7684673|NCT01907828|18926452|P1|NOT COMPLETED|Overall Study||7
7684674|NCT01907828|18926451|P2|COMPLETED|Overall Study||16
7684675|NCT01907828|18926452|P1|COMPLETED|Overall Study||32
7684676|NCT01907828|18926451|P2|24-month Follow-up|Overall Study||16
7684677|NCT01907828|18926452|P1|24-month Follow-up|Overall Study|2 participants terminated early|32
7684678|NCT01907828|18926451|P2|12-month Follow-up|Overall Study||16
7684679|NCT01907828|18926452|P1|12-month Follow-up|Overall Study|1 participant terminated early|34
7684680|NCT01907828|18926451|P2|6-month Follow-up|Overall Study||16
7684681|NCT01907828|18926452|P1|6-month Follow-up|Overall Study|1 participant terminated early|35
7684682|NCT01907828|18926451|P2|3-month Follow-up|Overall Study|1 participant terminated early|16
7684683|NCT01907828|18926452|P1|3-month Follow-up|Overall Study|1 participant terminated early|36
7684684|NCT01907828|18926451|P2|1-month Follow-up|Overall Study|3 participants terminated early|17
7684685|NCT01907828|18926452|P1|1-month Follow-up|Overall Study|2 participants terminated early|37
7684686|NCT01907828|18926451|P2|Underwent Procedure|Overall Study|2 participants terminated early|20
7684687|NCT01907828|18926452|P1|Underwent Procedure|Overall Study||39
7684688|NCT01907828|18926451|P2|STARTED|Overall Study||22
7684689|NCT01907828|18926452|P1|STARTED|Overall Study||39
7684690|NCT01907815|18926480|P2|NOT COMPLETED|Overall Study||0
7684691|NCT01907815|18926481|P1|NOT COMPLETED|Overall Study||1
7684692|NCT01907815|18926480|P2|COMPLETED|Overall Study||7
7684693|NCT01907815|18926481|P1|COMPLETED|Overall Study||16
7684694|NCT01907815|18926480|P2|STARTED|Overall Study||7
7684695|NCT01907815|18926481|P1|STARTED|Overall Study||17
7684696|NCT01907737|18926495|P1|NOT COMPLETED|Overall Study||1
7684697|NCT01907737|18926495|P1|COMPLETED|Overall Study||21
7684698|NCT01907737|18926495|P1|STARTED|Overall Study||22
7684699|NCT01907516|18926507|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
7684700|NCT01907516|18926508|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
7684701|NCT01907516|18926507|P2|COMPLETED|Second Intervention (3 Weeks)||34
7684702|NCT01907516|18926508|P1|COMPLETED|Second Intervention (3 Weeks)||40
7684703|NCT01907516|18926507|P2|STARTED|Second Intervention (3 Weeks)||34
7684704|NCT01907516|18926508|P1|STARTED|Second Intervention (3 Weeks)||40
7684705|NCT01907516|18926507|P2|NOT COMPLETED|First Intervention (3 Weeks)||16
7684706|NCT01907516|18926508|P1|NOT COMPLETED|First Intervention (3 Weeks)||10
7684707|NCT01907516|18926507|P2|COMPLETED|First Intervention (3 Weeks)||34
7684708|NCT01907516|18926508|P1|COMPLETED|First Intervention (3 Weeks)||40
7684709|NCT01907516|18926507|P2|STARTED|First Intervention (3 Weeks)||50
7684710|NCT01907516|18926508|P1|STARTED|First Intervention (3 Weeks)||50
7684711|NCT01907490|18926515|P1|NOT COMPLETED|Overall Study||0
7684712|NCT01907490|18926515|P1|COMPLETED|Overall Study||38
7684713|NCT01907490|18926515|P1|STARTED|Overall Study||38
7684714|NCT01907334|18926522|P2|NOT COMPLETED|Overall Study||0
7684715|NCT01907334|18926523|P1|NOT COMPLETED|Overall Study||0
7684716|NCT01907334|18926522|P2|COMPLETED|Overall Study||4
7684717|NCT01907334|18926523|P1|COMPLETED|Overall Study||6
7684718|NCT01907334|18926522|P2|STARTED|Overall Study||4
7684719|NCT01907334|18926523|P1|STARTED|Overall Study||6
7684720|NCT01907321|18926528|P1|NOT COMPLETED|Overall Study||2
7684721|NCT01907321|18926528|P1|COMPLETED|Overall Study||12
7684722|NCT01907321|18926528|P1|STARTED|Overall Study||14
7684723|NCT01907269|18926535|P2|NOT COMPLETED|18 Month Outcome Measures Post-intervent||280
7684724|NCT01907269|18926536|P1|NOT COMPLETED|18 Month Outcome Measures Post-intervent||319
7684725|NCT01907269|18926535|P2|COMPLETED|18 Month Outcome Measures Post-intervent||970
7684726|NCT01907269|18926536|P1|COMPLETED|18 Month Outcome Measures Post-intervent||859
7684727|NCT01907269|18926535|P2|STARTED|18 Month Outcome Measures Post-intervent||1250
7684728|NCT01907269|18926536|P1|STARTED|18 Month Outcome Measures Post-intervent||1178
7684729|NCT01907269|18926535|P2|NOT COMPLETED|6 Month Outcome Measures Post-interventi||289
7684730|NCT01907269|18926536|P1|NOT COMPLETED|6 Month Outcome Measures Post-interventi||389
7684731|NCT01907269|18926535|P2|COMPLETED|6 Month Outcome Measures Post-interventi||1053
7684732|NCT01907269|18926536|P1|COMPLETED|6 Month Outcome Measures Post-interventi||953
7684733|NCT01907269|18926535|P2|STARTED|6 Month Outcome Measures Post-interventi||1342
7684734|NCT01907269|18926536|P1|STARTED|6 Month Outcome Measures Post-interventi||1342
7684735|NCT01907217|18926552|P2|NOT COMPLETED|Overall Study||2
7684736|NCT01907217|18926553|P1|NOT COMPLETED|Overall Study||0
7684737|NCT01907217|18926552|P2|COMPLETED|Overall Study||67
7684738|NCT01907217|18926553|P1|COMPLETED|Overall Study||69
7684739|NCT01907217|18926552|P2|STARTED|Overall Study||69
7684740|NCT01907217|18926553|P1|STARTED|Overall Study||69
7684741|NCT01907113|18926570|P5|NOT COMPLETED|Overall Study||0
7684742|NCT01907113|18926571|P4|NOT COMPLETED|Overall Study||0
7684743|NCT01907113|18926572|P3|NOT COMPLETED|Overall Study||0
7684744|NCT01907113|18926573|P2|NOT COMPLETED|Overall Study||0
7684745|NCT01907113|18926574|P1|NOT COMPLETED|Overall Study||0
7684746|NCT01907113|18926570|P5|COMPLETED|Overall Study||8
7684747|NCT01907113|18926571|P4|COMPLETED|Overall Study||8
7684748|NCT01907113|18926572|P3|COMPLETED|Overall Study||7
7684749|NCT01907113|18926573|P2|COMPLETED|Overall Study||9
7684750|NCT01907113|18926574|P1|COMPLETED|Overall Study||8
7684751|NCT01907113|18926570|P5|STARTED|Overall Study||8
7684752|NCT01907113|18926571|P4|STARTED|Overall Study||8
7684753|NCT01907113|18926572|P3|STARTED|Overall Study||7
7684754|NCT01907113|18926573|P2|STARTED|Overall Study||9
7684755|NCT01907113|18926574|P1|STARTED|Overall Study||8
7684756|NCT01907100|18926665|P4|NOT COMPLETED|Overall Study||146
7684757|NCT01907100|18926666|P3|NOT COMPLETED|Overall Study||147
7684758|NCT01907100|18926667|P2|NOT COMPLETED|Overall Study||40
7684759|NCT01907100|18926668|P1|NOT COMPLETED|Overall Study||42
7684760|NCT01907100|18926665|P4|COMPLETED|Overall Study||83
7684761|NCT01907100|18926666|P3|COMPLETED|Overall Study||82
7684762|NCT01907100|18926667|P2|COMPLETED|Overall Study||4
7684763|NCT01907100|18926668|P1|COMPLETED|Overall Study||1
7684764|NCT01907100|18926665|P4|Treated Patients|Overall Study||227
7684765|NCT01907100|18926666|P3|Treated Patients|Overall Study||228
7684766|NCT01907100|18926667|P2|Treated Patients|Overall Study||44
7684767|NCT01907100|18926668|P1|Treated Patients|Overall Study||41
7684768|NCT01907100|18926665|P4|STARTED|Overall Study||229
7684769|NCT01907100|18926666|P3|STARTED|Overall Study||229
7684770|NCT01907100|18926667|P2|STARTED|Overall Study||44
7684771|NCT01907100|18926668|P1|STARTED|Overall Study||43
7684772|NCT01907087|18926682|P1|NOT COMPLETED|Overall Study||1
7684773|NCT01907087|18926682|P1|COMPLETED|Overall Study||23
7684774|NCT01907087|18926682|P1|STARTED|Overall Study||24
7684775|NCT01906866|18926693|P2|NOT COMPLETED|Overall Study||21
7684776|NCT01906866|18926694|P1|NOT COMPLETED|Overall Study||9
7684777|NCT01906866|18926693|P2|COMPLETED|Overall Study||44
7684778|NCT01906866|18926694|P1|COMPLETED|Overall Study||51
7684779|NCT01906866|18926693|P2|STARTED|Overall Study||65
7684780|NCT01906866|18926694|P1|STARTED|Overall Study||60
7684781|NCT01906658|18926707|P4|NOT COMPLETED|Overall Study||0
7684782|NCT01906658|18926708|P3|NOT COMPLETED|Overall Study||3
7684783|NCT01906658|18926709|P2|NOT COMPLETED|Overall Study||1
7684784|NCT01906658|18926710|P1|NOT COMPLETED|Overall Study||2
7684785|NCT01906658|18926707|P4|COMPLETED|Overall Study||11
7684786|NCT01906658|18926708|P3|COMPLETED|Overall Study||7
7684787|NCT01906658|18926709|P2|COMPLETED|Overall Study||10
7684788|NCT01906658|18926710|P1|COMPLETED|Overall Study||9
7684789|NCT01906658|18926707|P4|STARTED|Overall Study||11
7684790|NCT01906658|18926708|P3|STARTED|Overall Study||10
7684791|NCT01906658|18926709|P2|STARTED|Overall Study||11
7684792|NCT01906658|18926710|P1|STARTED|Overall Study||11
7684793|NCT01906515|18926734|P2|NOT COMPLETED|Overall Study||0
7684794|NCT01906515|18926735|P1|NOT COMPLETED|Overall Study||0
7684795|NCT01906515|18926734|P2|COMPLETED|Overall Study||61
7684796|NCT01906515|18926735|P1|COMPLETED|Overall Study||45
7684797|NCT01906515|18926734|P2|STARTED|Overall Study||61
7684798|NCT01906515|18926735|P1|STARTED|Overall Study||45
7684799|NCT01906476|18926745|P2|NOT COMPLETED|Overall Study||16
7684800|NCT01906476|18926746|P1|NOT COMPLETED|Overall Study||17
7684801|NCT01906476|18926745|P2|COMPLETED|Overall Study||139
7684802|NCT01906476|18926746|P1|COMPLETED|Overall Study||140
7684803|NCT01906476|18926745|P2|STARTED|Overall Study||155
7684804|NCT01906476|18926746|P1|STARTED|Overall Study||157
7684805|NCT01906372|18926754|P1|NOT COMPLETED|Overall Study||2
7684806|NCT01906372|18926754|P1|COMPLETED|Overall Study||10
7684807|NCT01906372|18926754|P1|Visit 10: Follow up Phase Completed|Overall Study||8
7684808|NCT01906372|18926754|P1|Visit 7: Treatment Phase Completed|Overall Study||10
7684809|NCT01906372|18926754|P1|STARTED|Overall Study||12
7684810|NCT01906346|18926759|P1|NOT COMPLETED|Overall Study||1
7684811|NCT01906346|18926759|P1|COMPLETED|Overall Study||8
7684812|NCT01906346|18926759|P1|STARTED|Overall Study||9
7684813|NCT01906008|18926767|P2|NOT COMPLETED|Overall Study||27
7684814|NCT01906008|18926768|P1|NOT COMPLETED|Overall Study||27
7684815|NCT01906008|18926767|P2|COMPLETED|Overall Study||34
7684816|NCT01906008|18926768|P1|COMPLETED|Overall Study||32
7684817|NCT01906008|18926767|P2|STARTED|Overall Study||61
7684818|NCT01906008|18926768|P1|STARTED|Overall Study||59
7684819|NCT01905956|18926778|P2|NOT COMPLETED|Overall Study||11
7684820|NCT01905956|18926779|P1|NOT COMPLETED|Overall Study||6
7684821|NCT01905956|18926778|P2|COMPLETED|Overall Study|Per-protocol population|48
7684822|NCT01905956|18926779|P1|COMPLETED|Overall Study|Per-protocol population|54
7684823|NCT01905956|18926778|P2|Intention-to-treat Population|Overall Study|Intention-to-treat population|54
7684824|NCT01905956|18926779|P1|Intention-to-treat Population|Overall Study|Intention-to-treat population|57
7684825|NCT01905956|18926778|P2|STARTED|Overall Study|Randomized|59
7684826|NCT01905956|18926779|P1|STARTED|Overall Study|Randomized|60
7684827|NCT01905943|18926801|P1|NOT COMPLETED|Overall Study||314
7684828|NCT01905943|18926801|P1|COMPLETED|Overall Study|All patients provide reason at final analysis|658
7684829|NCT01905943|18926801|P1|STARTED|Overall Study||972
7684830|NCT01905683|18926918|P1|NOT COMPLETED|Overall Study||51
7684831|NCT01905683|18926918|P1|COMPLETED|Overall Study||319
7684832|NCT01905683|18926918|P1|STARTED|Overall Study||370
7684833|NCT01905657|18926934|P3|NOT COMPLETED|Overall Study||328
7684834|NCT01905657|18926935|P2|NOT COMPLETED|Overall Study||346
7684835|NCT01905657|18926936|P1|NOT COMPLETED|Overall Study||345
7684836|NCT01905657|18926934|P3|COMPLETED|Overall Study||15
7684837|NCT01905657|18926935|P2|COMPLETED|Overall Study||0
7684838|NCT01905657|18926936|P1|COMPLETED|Overall Study||0
7684839|NCT01905657|18926934|P3|Treated|Overall Study||309
7684840|NCT01905657|18926935|P2|Treated|Overall Study||343
7684841|NCT01905657|18926936|P1|Treated|Overall Study||339
7684842|NCT01905657|18926934|P3|STARTED|Overall Study||343
7684843|NCT01905657|18926935|P2|STARTED|Overall Study||346
7684844|NCT01905657|18926936|P1|STARTED|Overall Study||345
7684845|NCT01905592|18926961|P2|NOT COMPLETED|Overall Study||135
7684846|NCT01905592|18926962|P1|NOT COMPLETED|Overall Study||71
7684847|NCT01905592|18926961|P2|COMPLETED|Overall Study||0
7684848|NCT01905592|18926962|P1|COMPLETED|Overall Study||0
7684849|NCT01905592|18926961|P2|STARTED|Overall Study||135
7684850|NCT01905592|18926962|P1|STARTED|Overall Study||71
7684851|NCT01905553|18926976|P2|NOT COMPLETED|Period 2||0
7684852|NCT01905553|18926977|P1|NOT COMPLETED|Period 2||1
7684853|NCT01905553|18926976|P2|COMPLETED|Period 2||4
7684854|NCT01905553|18926977|P1|COMPLETED|Period 2||4
7684855|NCT01905553|18926976|P2|STARTED|Period 2||4
7684856|NCT01905553|18926977|P1|STARTED|Period 2||5
7684857|NCT01905553|18926976|P2|NOT COMPLETED|Period 1||0
7684858|NCT01905553|18926977|P1|NOT COMPLETED|Period 1||0
7684859|NCT01905553|18926976|P2|COMPLETED|Period 1||4
7684860|NCT01905553|18926977|P1|COMPLETED|Period 1||5
7684861|NCT01905553|18926976|P2|STARTED|Period 1||4
7684862|NCT01905553|18926977|P1|STARTED|Period 1||5
7684863|NCT01905540|18926991|P4|NOT COMPLETED|Period 3||1
7684864|NCT01905540|18926992|P3|NOT COMPLETED|Period 3||1
7684865|NCT01905540|18926993|P2|NOT COMPLETED|Period 3||0
7684866|NCT01905540|18926994|P1|NOT COMPLETED|Period 3||1
7684867|NCT01905540|18926991|P4|COMPLETED|Period 3||6
7684868|NCT01905540|18926992|P3|COMPLETED|Period 3||6
7684869|NCT01905540|18926993|P2|COMPLETED|Period 3||7
7684870|NCT01905540|18926994|P1|COMPLETED|Period 3||6
7684871|NCT01905540|18926991|P4|STARTED|Period 3||7
7684872|NCT01905540|18926992|P3|STARTED|Period 3||7
7684873|NCT01905540|18926993|P2|STARTED|Period 3||7
7684874|NCT01905540|18926994|P1|STARTED|Period 3||7
7684875|NCT01905540|18926991|P4|NOT COMPLETED|Period 2||0
7684876|NCT01905540|18926992|P3|NOT COMPLETED|Period 2||0
7684877|NCT01905540|18926993|P2|NOT COMPLETED|Period 2||0
7684878|NCT01905540|18926994|P1|NOT COMPLETED|Period 2||0
7684879|NCT01905540|18926991|P4|COMPLETED|Period 2||7
7684880|NCT01905540|18926992|P3|COMPLETED|Period 2||7
7684881|NCT01905540|18926993|P2|COMPLETED|Period 2||7
7684882|NCT01905540|18926994|P1|COMPLETED|Period 2||7
7684883|NCT01905540|18926991|P4|STARTED|Period 2||7
7684884|NCT01905540|18926992|P3|STARTED|Period 2||7
7684885|NCT01905540|18926993|P2|STARTED|Period 2||7
7684886|NCT01905540|18926994|P1|STARTED|Period 2||7
7684887|NCT01905540|18926991|P4|NOT COMPLETED|Period 1||0
7684888|NCT01905540|18926992|P3|NOT COMPLETED|Period 1||0
7684889|NCT01905540|18926993|P2|NOT COMPLETED|Period 1||0
7684890|NCT01905540|18926994|P1|NOT COMPLETED|Period 1||0
7684891|NCT01905540|18926991|P4|COMPLETED|Period 1||7
7684892|NCT01905540|18926992|P3|COMPLETED|Period 1||7
7684893|NCT01905540|18926993|P2|COMPLETED|Period 1||7
7684894|NCT01905540|18926994|P1|COMPLETED|Period 1||7
7684895|NCT01905540|18926991|P4|STARTED|Period 1||7
7684896|NCT01905540|18926992|P3|STARTED|Period 1||7
7684897|NCT01905540|18926993|P2|STARTED|Period 1||7
7684898|NCT01905540|18926994|P1|STARTED|Period 1||7
7684899|NCT01905423|18927017|P5|NOT COMPLETED|Overall Study||0
7684900|NCT01905423|18927018|P4|NOT COMPLETED|Overall Study||0
7684901|NCT01905423|18927019|P3|NOT COMPLETED|Overall Study||0
7684902|NCT01905423|18927020|P2|NOT COMPLETED|Overall Study||0
7684903|NCT01905423|18927021|P1|NOT COMPLETED|Overall Study||0
7684904|NCT01905423|18927017|P5|COMPLETED|Overall Study||2487
7684905|NCT01905423|18927018|P4|COMPLETED|Overall Study||2757
7684906|NCT01905423|18927019|P3|COMPLETED|Overall Study||4111
7684907|NCT01905423|18927020|P2|COMPLETED|Overall Study||3297
7684908|NCT01905423|18927021|P1|COMPLETED|Overall Study||4456
7684909|NCT01905423|18927017|P5|Year 3 Follow-up|Overall Study||0
7684910|NCT01905423|18927018|P4|Year 3 Follow-up|Overall Study||0
7684911|NCT01905423|18927019|P3|Year 3 Follow-up|Overall Study||1028
7684912|NCT01905423|18927020|P2|Year 3 Follow-up|Overall Study||871
7684913|NCT01905423|18927021|P1|Year 3 Follow-up|Overall Study||905
7684914|NCT01905423|18927017|P5|Year 2 Follow-up|Overall Study||0
7684915|NCT01905423|18927018|P4|Year 2 Follow-up|Overall Study||0
7684916|NCT01905423|18927019|P3|Year 2 Follow-up|Overall Study||1043
7684917|NCT01905423|18927020|P2|Year 2 Follow-up|Overall Study||858
7684918|NCT01905423|18927021|P1|Year 2 Follow-up|Overall Study||1114
7684919|NCT01905423|18927017|P5|Year 1 Follow-up|Overall Study||1161
7684920|NCT01905423|18927018|P4|Year 1 Follow-up|Overall Study||1275
7684921|NCT01905423|18927019|P3|Year 1 Follow-up|Overall Study||1007
7684922|NCT01905423|18927020|P2|Year 1 Follow-up|Overall Study||846
7684923|NCT01905423|18927021|P1|Year 1 Follow-up|Overall Study||994
7684924|NCT01905423|18927017|P5|Baseline|Overall Study||1326
7684925|NCT01905423|18927018|P4|Baseline|Overall Study||1482
7684926|NCT01905423|18927019|P3|Baseline|Overall Study||1033
7684927|NCT01905423|18927020|P2|Baseline|Overall Study||722
7684928|NCT01905423|18927021|P1|Baseline|Overall Study||1443
7684929|NCT01905423|18927017|P5|STARTED|Overall Study||2487
7684930|NCT01905423|18927018|P4|STARTED|Overall Study||2757
7684931|NCT01905423|18927019|P3|STARTED|Overall Study||4111
7684932|NCT01905423|18927020|P2|STARTED|Overall Study||3297
7684933|NCT01905423|18927021|P1|STARTED|Overall Study||4456
7684934|NCT01905267|18927060|P2|NOT COMPLETED|Overall Study||2
7684935|NCT01905267|18927061|P1|NOT COMPLETED|Overall Study||2
7684936|NCT01905267|18927060|P2|COMPLETED|Overall Study||14
7684937|NCT01905267|18927061|P1|COMPLETED|Overall Study||15
7684938|NCT01905267|18927060|P2|STARTED|Overall Study||16
7684939|NCT01905267|18927061|P1|STARTED|Overall Study||17
7684940|NCT01905254|18927069|P1|NOT COMPLETED|Overall Study||0
7684941|NCT01905254|18927069|P1|COMPLETED|Overall Study||34
7684942|NCT01905254|18927069|P1|STARTED|Overall Study||34
7684943|NCT01904864|18927075|P2|NOT COMPLETED|Overall Study||12
7684944|NCT01904864|18927076|P1|NOT COMPLETED|Overall Study||9
7684945|NCT01904864|18927075|P2|COMPLETED|Overall Study||28
7684946|NCT01904864|18927076|P1|COMPLETED|Overall Study||31
7684947|NCT01904864|18927075|P2|STARTED|Overall Study||40
7684948|NCT01904864|18927076|P1|STARTED|Overall Study||40
7684949|NCT01904773|18927082|P9|NOT COMPLETED|Sixth Intervention||0
7684950|NCT01904773|18927083|P8|NOT COMPLETED|Sixth Intervention||0
7684951|NCT01904773|18927084|P7|NOT COMPLETED|Sixth Intervention||0
7684952|NCT01904773|18927085|P6|NOT COMPLETED|Sixth Intervention||0
7684953|NCT01904773|18927086|P5|NOT COMPLETED|Sixth Intervention||0
7684954|NCT01904773|18927087|P4|NOT COMPLETED|Sixth Intervention||0
7684955|NCT01904773|18927088|P3|NOT COMPLETED|Sixth Intervention||0
7684956|NCT01904773|18927089|P2|NOT COMPLETED|Sixth Intervention||0
7684957|NCT01904773|18927090|P1|NOT COMPLETED|Sixth Intervention||0
7684958|NCT01904773|18927082|P9|COMPLETED|Sixth Intervention||4
7684959|NCT01904773|18927083|P8|COMPLETED|Sixth Intervention||2
7684960|NCT01904773|18927084|P7|COMPLETED|Sixth Intervention||3
7684961|NCT01904773|18927085|P6|COMPLETED|Sixth Intervention||4
7684962|NCT01904773|18927086|P5|COMPLETED|Sixth Intervention||3
7684963|NCT01904773|18927087|P4|COMPLETED|Sixth Intervention||2
7684964|NCT01904773|18927088|P3|COMPLETED|Sixth Intervention||1
7684965|NCT01904773|18927089|P2|COMPLETED|Sixth Intervention||0
7684966|NCT01904773|18927090|P1|COMPLETED|Sixth Intervention||0
7684967|NCT01904773|18927082|P9|STARTED|Sixth Intervention||4
7684968|NCT01904773|18927083|P8|STARTED|Sixth Intervention||2
7684969|NCT01904773|18927084|P7|STARTED|Sixth Intervention||3
7684970|NCT01904773|18927085|P6|STARTED|Sixth Intervention||4
7684971|NCT01904773|18927086|P5|STARTED|Sixth Intervention||3
7684972|NCT01904773|18927087|P4|STARTED|Sixth Intervention||2
7684973|NCT01904773|18927088|P3|STARTED|Sixth Intervention||1
7684974|NCT01904773|18927089|P2|STARTED|Sixth Intervention||0
7684975|NCT01904773|18927090|P1|STARTED|Sixth Intervention||0
7684976|NCT01904773|18927082|P9|NOT COMPLETED|Placebo Washout Fifth Intervention||0
7684977|NCT01904773|18927083|P8|NOT COMPLETED|Placebo Washout Fifth Intervention||0
7684978|NCT01904773|18927084|P7|NOT COMPLETED|Placebo Washout Fifth Intervention||0
7684979|NCT01904773|18927085|P6|NOT COMPLETED|Placebo Washout Fifth Intervention||0
7684980|NCT01904773|18927086|P5|NOT COMPLETED|Placebo Washout Fifth Intervention||0
7684981|NCT01904773|18927087|P4|NOT COMPLETED|Placebo Washout Fifth Intervention||0
7684982|NCT01904773|18927088|P3|NOT COMPLETED|Placebo Washout Fifth Intervention||0
7684983|NCT01904773|18927089|P2|NOT COMPLETED|Placebo Washout Fifth Intervention||1
7684984|NCT01904773|18927090|P1|NOT COMPLETED|Placebo Washout Fifth Intervention||0
7684985|NCT01904773|18927082|P9|COMPLETED|Placebo Washout Fifth Intervention||4
7684986|NCT01904773|18927083|P8|COMPLETED|Placebo Washout Fifth Intervention||2
7684987|NCT01904773|18927084|P7|COMPLETED|Placebo Washout Fifth Intervention||3
7684988|NCT01904773|18927085|P6|COMPLETED|Placebo Washout Fifth Intervention||4
7684989|NCT01904773|18927086|P5|COMPLETED|Placebo Washout Fifth Intervention||3
7684990|NCT01904773|18927087|P4|COMPLETED|Placebo Washout Fifth Intervention||2
7684991|NCT01904773|18927088|P3|COMPLETED|Placebo Washout Fifth Intervention||1
7684992|NCT01904773|18927089|P2|COMPLETED|Placebo Washout Fifth Intervention||0
7684993|NCT01904773|18927090|P1|COMPLETED|Placebo Washout Fifth Intervention||0
7684994|NCT01904773|18927082|P9|STARTED|Placebo Washout Fifth Intervention||4
7684995|NCT01904773|18927083|P8|STARTED|Placebo Washout Fifth Intervention||2
7684996|NCT01904773|18927084|P7|STARTED|Placebo Washout Fifth Intervention||3
7684997|NCT01904773|18927085|P6|STARTED|Placebo Washout Fifth Intervention||4
7684998|NCT01904773|18927086|P5|STARTED|Placebo Washout Fifth Intervention||3
7684999|NCT01904773|18927087|P4|STARTED|Placebo Washout Fifth Intervention||2
7685000|NCT01904773|18927088|P3|STARTED|Placebo Washout Fifth Intervention||1
7685001|NCT01904773|18927089|P2|STARTED|Placebo Washout Fifth Intervention||1
7685002|NCT01904773|18927090|P1|STARTED|Placebo Washout Fifth Intervention||0
7685003|NCT01904773|18927082|P9|NOT COMPLETED|Fifth Intervention||0
7685004|NCT01904773|18927083|P8|NOT COMPLETED|Fifth Intervention||1
7685005|NCT01904773|18927084|P7|NOT COMPLETED|Fifth Intervention||0
7685006|NCT01904773|18927085|P6|NOT COMPLETED|Fifth Intervention||0
7685007|NCT01904773|18927086|P5|NOT COMPLETED|Fifth Intervention||0
7685008|NCT01904773|18927087|P4|NOT COMPLETED|Fifth Intervention||0
7685009|NCT01904773|18927088|P3|NOT COMPLETED|Fifth Intervention||0
7685010|NCT01904773|18927089|P2|NOT COMPLETED|Fifth Intervention||0
7685011|NCT01904773|18927090|P1|NOT COMPLETED|Fifth Intervention||0
7685012|NCT01904773|18927082|P9|COMPLETED|Fifth Intervention||4
7685013|NCT01904773|18927083|P8|COMPLETED|Fifth Intervention||2
7685014|NCT01904773|18927084|P7|COMPLETED|Fifth Intervention||3
7685015|NCT01904773|18927085|P6|COMPLETED|Fifth Intervention||4
7685016|NCT01904773|18927086|P5|COMPLETED|Fifth Intervention||3
7685017|NCT01904773|18927087|P4|COMPLETED|Fifth Intervention||2
7685018|NCT01904773|18927088|P3|COMPLETED|Fifth Intervention||1
7685019|NCT01904773|18927089|P2|COMPLETED|Fifth Intervention||1
7685020|NCT01904773|18927090|P1|COMPLETED|Fifth Intervention||0
7685021|NCT01904773|18927082|P9|STARTED|Fifth Intervention||4
7685022|NCT01904773|18927083|P8|STARTED|Fifth Intervention||3
7685023|NCT01904773|18927084|P7|STARTED|Fifth Intervention||3
7685024|NCT01904773|18927085|P6|STARTED|Fifth Intervention||4
7685025|NCT01904773|18927086|P5|STARTED|Fifth Intervention||3
7685026|NCT01904773|18927087|P4|STARTED|Fifth Intervention||2
7685027|NCT01904773|18927088|P3|STARTED|Fifth Intervention||1
7685028|NCT01904773|18927089|P2|STARTED|Fifth Intervention||1
7685029|NCT01904773|18927090|P1|STARTED|Fifth Intervention||0
7685030|NCT01904773|18927082|P9|NOT COMPLETED|Placebo Washout Fourth Intervention||0
7685031|NCT01904773|18927083|P8|NOT COMPLETED|Placebo Washout Fourth Intervention||0
7685032|NCT01904773|18927084|P7|NOT COMPLETED|Placebo Washout Fourth Intervention||0
7685033|NCT01904773|18927085|P6|NOT COMPLETED|Placebo Washout Fourth Intervention||0
7685034|NCT01904773|18927086|P5|NOT COMPLETED|Placebo Washout Fourth Intervention||0
7685035|NCT01904773|18927087|P4|NOT COMPLETED|Placebo Washout Fourth Intervention||0
7685036|NCT01904773|18927088|P3|NOT COMPLETED|Placebo Washout Fourth Intervention||0
7685037|NCT01904773|18927089|P2|NOT COMPLETED|Placebo Washout Fourth Intervention||0
7685038|NCT01904773|18927090|P1|NOT COMPLETED|Placebo Washout Fourth Intervention||0
7685039|NCT01904773|18927082|P9|COMPLETED|Placebo Washout Fourth Intervention||4
7685040|NCT01904773|18927083|P8|COMPLETED|Placebo Washout Fourth Intervention||3
7685041|NCT01904773|18927084|P7|COMPLETED|Placebo Washout Fourth Intervention||3
7685042|NCT01904773|18927085|P6|COMPLETED|Placebo Washout Fourth Intervention||4
7685043|NCT01904773|18927086|P5|COMPLETED|Placebo Washout Fourth Intervention||3
7685044|NCT01904773|18927087|P4|COMPLETED|Placebo Washout Fourth Intervention||2
7685045|NCT01904773|18927088|P3|COMPLETED|Placebo Washout Fourth Intervention||1
7685046|NCT01904773|18927089|P2|COMPLETED|Placebo Washout Fourth Intervention||1
7685047|NCT01904773|18927090|P1|COMPLETED|Placebo Washout Fourth Intervention||0
7685048|NCT01904773|18927082|P9|STARTED|Placebo Washout Fourth Intervention||4
7685049|NCT01904773|18927083|P8|STARTED|Placebo Washout Fourth Intervention||3
7685050|NCT01904773|18927084|P7|STARTED|Placebo Washout Fourth Intervention||3
7685051|NCT01904773|18927085|P6|STARTED|Placebo Washout Fourth Intervention||4
7685052|NCT01904773|18927086|P5|STARTED|Placebo Washout Fourth Intervention||3
7685053|NCT01904773|18927087|P4|STARTED|Placebo Washout Fourth Intervention||2
7685054|NCT01904773|18927088|P3|STARTED|Placebo Washout Fourth Intervention||1
7685055|NCT01904773|18927089|P2|STARTED|Placebo Washout Fourth Intervention||1
7685056|NCT01904773|18927090|P1|STARTED|Placebo Washout Fourth Intervention||0
7685057|NCT01904773|18927082|P9|NOT COMPLETED|Fourth Intervention||0
7685058|NCT01904773|18927083|P8|NOT COMPLETED|Fourth Intervention||0
7685059|NCT01904773|18927084|P7|NOT COMPLETED|Fourth Intervention||0
7685060|NCT01904773|18927085|P6|NOT COMPLETED|Fourth Intervention||0
7685061|NCT01904773|18927086|P5|NOT COMPLETED|Fourth Intervention||0
7685062|NCT01904773|18927087|P4|NOT COMPLETED|Fourth Intervention||0
7685063|NCT01904773|18927088|P3|NOT COMPLETED|Fourth Intervention||0
7685064|NCT01904773|18927089|P2|NOT COMPLETED|Fourth Intervention||0
7685065|NCT01904773|18927090|P1|NOT COMPLETED|Fourth Intervention||0
7685066|NCT01904773|18927082|P9|COMPLETED|Fourth Intervention||4
7685067|NCT01904773|18927083|P8|COMPLETED|Fourth Intervention||3
7685068|NCT01904773|18927084|P7|COMPLETED|Fourth Intervention||3
7685069|NCT01904773|18927085|P6|COMPLETED|Fourth Intervention||4
7685070|NCT01904773|18927086|P5|COMPLETED|Fourth Intervention||3
7685071|NCT01904773|18927087|P4|COMPLETED|Fourth Intervention||2
7685072|NCT01904773|18927088|P3|COMPLETED|Fourth Intervention||1
7685073|NCT01904773|18927089|P2|COMPLETED|Fourth Intervention||1
7685074|NCT01904773|18927090|P1|COMPLETED|Fourth Intervention||0
7685075|NCT01904773|18927082|P9|STARTED|Fourth Intervention||4
7685076|NCT01904773|18927083|P8|STARTED|Fourth Intervention||3
7685077|NCT01904773|18927084|P7|STARTED|Fourth Intervention||3
7685078|NCT01904773|18927085|P6|STARTED|Fourth Intervention||4
7685079|NCT01904773|18927086|P5|STARTED|Fourth Intervention||3
7685080|NCT01904773|18927087|P4|STARTED|Fourth Intervention||2
7685081|NCT01904773|18927088|P3|STARTED|Fourth Intervention||1
7685082|NCT01904773|18927089|P2|STARTED|Fourth Intervention||1
7685083|NCT01904773|18927090|P1|STARTED|Fourth Intervention||0
7685084|NCT01904773|18927082|P9|NOT COMPLETED|Placebo Washout Third Intervention||0
7685085|NCT01904773|18927083|P8|NOT COMPLETED|Placebo Washout Third Intervention||0
7685086|NCT01904773|18927084|P7|NOT COMPLETED|Placebo Washout Third Intervention||0
7685087|NCT01904773|18927085|P6|NOT COMPLETED|Placebo Washout Third Intervention||0
7685088|NCT01904773|18927086|P5|NOT COMPLETED|Placebo Washout Third Intervention||0
7685089|NCT01904773|18927087|P4|NOT COMPLETED|Placebo Washout Third Intervention||0
7685090|NCT01904773|18927088|P3|NOT COMPLETED|Placebo Washout Third Intervention||0
7685091|NCT01904773|18927089|P2|NOT COMPLETED|Placebo Washout Third Intervention||0
7685092|NCT01904773|18927090|P1|NOT COMPLETED|Placebo Washout Third Intervention||0
7685093|NCT01904773|18927082|P9|COMPLETED|Placebo Washout Third Intervention||4
7685094|NCT01904773|18927083|P8|COMPLETED|Placebo Washout Third Intervention||3
7685095|NCT01904773|18927084|P7|COMPLETED|Placebo Washout Third Intervention||3
7685096|NCT01904773|18927085|P6|COMPLETED|Placebo Washout Third Intervention||4
7685097|NCT01904773|18927086|P5|COMPLETED|Placebo Washout Third Intervention||3
7685098|NCT01904773|18927087|P4|COMPLETED|Placebo Washout Third Intervention||2
7685099|NCT01904773|18927088|P3|COMPLETED|Placebo Washout Third Intervention||1
7685100|NCT01904773|18927089|P2|COMPLETED|Placebo Washout Third Intervention||1
7685101|NCT01904773|18927090|P1|COMPLETED|Placebo Washout Third Intervention||0
7685102|NCT01904773|18927082|P9|STARTED|Placebo Washout Third Intervention||4
7685103|NCT01904773|18927083|P8|STARTED|Placebo Washout Third Intervention||3
7685104|NCT01904773|18927084|P7|STARTED|Placebo Washout Third Intervention||3
7685105|NCT01904773|18927085|P6|STARTED|Placebo Washout Third Intervention||4
7685106|NCT01904773|18927086|P5|STARTED|Placebo Washout Third Intervention||3
7685107|NCT01904773|18927087|P4|STARTED|Placebo Washout Third Intervention||2
7685108|NCT01904773|18927088|P3|STARTED|Placebo Washout Third Intervention||1
7685109|NCT01904773|18927089|P2|STARTED|Placebo Washout Third Intervention||1
7685110|NCT01904773|18927090|P1|STARTED|Placebo Washout Third Intervention||0
7685111|NCT01904773|18927082|P9|NOT COMPLETED|Third Intervention||0
7685112|NCT01904773|18927083|P8|NOT COMPLETED|Third Intervention||0
7685113|NCT01904773|18927084|P7|NOT COMPLETED|Third Intervention||0
7685114|NCT01904773|18927085|P6|NOT COMPLETED|Third Intervention||0
7685115|NCT01904773|18927086|P5|NOT COMPLETED|Third Intervention||0
7685116|NCT01904773|18927087|P4|NOT COMPLETED|Third Intervention||0
7685117|NCT01904773|18927088|P3|NOT COMPLETED|Third Intervention||0
7685118|NCT01904773|18927089|P2|NOT COMPLETED|Third Intervention||0
7685119|NCT01904773|18927090|P1|NOT COMPLETED|Third Intervention||0
7685120|NCT01904773|18927082|P9|COMPLETED|Third Intervention||4
7685121|NCT01904773|18927083|P8|COMPLETED|Third Intervention||3
7685122|NCT01904773|18927084|P7|COMPLETED|Third Intervention||3
7685123|NCT01904773|18927085|P6|COMPLETED|Third Intervention||4
7685124|NCT01904773|18927086|P5|COMPLETED|Third Intervention||3
7685125|NCT01904773|18927087|P4|COMPLETED|Third Intervention||2
7685126|NCT01904773|18927088|P3|COMPLETED|Third Intervention||1
7685127|NCT01904773|18927089|P2|COMPLETED|Third Intervention||1
7685128|NCT01904773|18927090|P1|COMPLETED|Third Intervention||0
7685129|NCT01904773|18927082|P9|STARTED|Third Intervention||4
7685130|NCT01904773|18927083|P8|STARTED|Third Intervention||3
7685131|NCT01904773|18927084|P7|STARTED|Third Intervention||3
7685132|NCT01904773|18927085|P6|STARTED|Third Intervention||4
7685133|NCT01904773|18927086|P5|STARTED|Third Intervention||3
7685134|NCT01904773|18927087|P4|STARTED|Third Intervention||2
7685135|NCT01904773|18927088|P3|STARTED|Third Intervention||1
7685136|NCT01904773|18927089|P2|STARTED|Third Intervention||1
7685137|NCT01904773|18927090|P1|STARTED|Third Intervention||0
7685138|NCT01904773|18927082|P9|NOT COMPLETED|Placebo Washout Second Intervention||0
7685139|NCT01904773|18927083|P8|NOT COMPLETED|Placebo Washout Second Intervention||0
7685140|NCT01904773|18927084|P7|NOT COMPLETED|Placebo Washout Second Intervention||0
7685141|NCT01904773|18927085|P6|NOT COMPLETED|Placebo Washout Second Intervention||0
7685142|NCT01904773|18927086|P5|NOT COMPLETED|Placebo Washout Second Intervention||0
7685143|NCT01904773|18927087|P4|NOT COMPLETED|Placebo Washout Second Intervention||0
7685144|NCT01904773|18927088|P3|NOT COMPLETED|Placebo Washout Second Intervention||0
7685145|NCT01904773|18927089|P2|NOT COMPLETED|Placebo Washout Second Intervention||0
7685146|NCT01904773|18927090|P1|NOT COMPLETED|Placebo Washout Second Intervention||0
7685147|NCT01904773|18927082|P9|COMPLETED|Placebo Washout Second Intervention||4
7685148|NCT01904773|18927083|P8|COMPLETED|Placebo Washout Second Intervention||3
7685149|NCT01904773|18927084|P7|COMPLETED|Placebo Washout Second Intervention||3
7685150|NCT01904773|18927085|P6|COMPLETED|Placebo Washout Second Intervention||4
7685151|NCT01904773|18927086|P5|COMPLETED|Placebo Washout Second Intervention||3
7685152|NCT01904773|18927087|P4|COMPLETED|Placebo Washout Second Intervention||2
7685153|NCT01904773|18927088|P3|COMPLETED|Placebo Washout Second Intervention||1
7685154|NCT01904773|18927089|P2|COMPLETED|Placebo Washout Second Intervention||1
7685155|NCT01904773|18927090|P1|COMPLETED|Placebo Washout Second Intervention||0
7685156|NCT01904773|18927082|P9|STARTED|Placebo Washout Second Intervention||4
7685157|NCT01904773|18927083|P8|STARTED|Placebo Washout Second Intervention||3
7685158|NCT01904773|18927084|P7|STARTED|Placebo Washout Second Intervention||3
7685159|NCT01904773|18927085|P6|STARTED|Placebo Washout Second Intervention||4
7685160|NCT01904773|18927086|P5|STARTED|Placebo Washout Second Intervention||3
7685161|NCT01904773|18927087|P4|STARTED|Placebo Washout Second Intervention||2
7685162|NCT01904773|18927088|P3|STARTED|Placebo Washout Second Intervention||1
7685163|NCT01904773|18927089|P2|STARTED|Placebo Washout Second Intervention||1
7685164|NCT01904773|18927090|P1|STARTED|Placebo Washout Second Intervention||0
7685165|NCT01904773|18927082|P9|NOT COMPLETED|Second Intervention||0
7685166|NCT01904773|18927083|P8|NOT COMPLETED|Second Intervention||0
7685167|NCT01904773|18927084|P7|NOT COMPLETED|Second Intervention||0
7685168|NCT01904773|18927085|P6|NOT COMPLETED|Second Intervention||0
7685169|NCT01904773|18927086|P5|NOT COMPLETED|Second Intervention||0
7685170|NCT01904773|18927087|P4|NOT COMPLETED|Second Intervention||0
7685171|NCT01904773|18927088|P3|NOT COMPLETED|Second Intervention||0
7685172|NCT01904773|18927089|P2|NOT COMPLETED|Second Intervention||0
7685173|NCT01904773|18927090|P1|NOT COMPLETED|Second Intervention||0
7685174|NCT01904773|18927082|P9|COMPLETED|Second Intervention||4
7685175|NCT01904773|18927083|P8|COMPLETED|Second Intervention||3
7685176|NCT01904773|18927084|P7|COMPLETED|Second Intervention||3
7685177|NCT01904773|18927085|P6|COMPLETED|Second Intervention||4
7685178|NCT01904773|18927086|P5|COMPLETED|Second Intervention||3
7685179|NCT01904773|18927087|P4|COMPLETED|Second Intervention||2
7685180|NCT01904773|18927088|P3|COMPLETED|Second Intervention||1
7685181|NCT01904773|18927089|P2|COMPLETED|Second Intervention||1
7685182|NCT01904773|18927090|P1|COMPLETED|Second Intervention||0
7685183|NCT01904773|18927082|P9|STARTED|Second Intervention||4
7685184|NCT01904773|18927083|P8|STARTED|Second Intervention||3
7685185|NCT01904773|18927084|P7|STARTED|Second Intervention||3
7685186|NCT01904773|18927085|P6|STARTED|Second Intervention||4
7685187|NCT01904773|18927086|P5|STARTED|Second Intervention||3
7685188|NCT01904773|18927087|P4|STARTED|Second Intervention||2
7685189|NCT01904773|18927088|P3|STARTED|Second Intervention||1
7685190|NCT01904773|18927089|P2|STARTED|Second Intervention||1
7685191|NCT01904773|18927090|P1|STARTED|Second Intervention||0
7685192|NCT01904773|18927082|P9|NOT COMPLETED|Placebo Washout First Intervention||0
7685193|NCT01904773|18927083|P8|NOT COMPLETED|Placebo Washout First Intervention||0
7685194|NCT01904773|18927084|P7|NOT COMPLETED|Placebo Washout First Intervention||0
7685195|NCT01904773|18927085|P6|NOT COMPLETED|Placebo Washout First Intervention||0
7685196|NCT01904773|18927086|P5|NOT COMPLETED|Placebo Washout First Intervention||0
7685197|NCT01904773|18927087|P4|NOT COMPLETED|Placebo Washout First Intervention||0
7685198|NCT01904773|18927088|P3|NOT COMPLETED|Placebo Washout First Intervention||0
7685199|NCT01904773|18927089|P2|NOT COMPLETED|Placebo Washout First Intervention||1
7685200|NCT01904773|18927090|P1|NOT COMPLETED|Placebo Washout First Intervention||0
7685201|NCT01904773|18927082|P9|COMPLETED|Placebo Washout First Intervention||4
7685202|NCT01904773|18927083|P8|COMPLETED|Placebo Washout First Intervention||3
7685203|NCT01904773|18927084|P7|COMPLETED|Placebo Washout First Intervention||3
7685204|NCT01904773|18927085|P6|COMPLETED|Placebo Washout First Intervention||4
7685205|NCT01904773|18927086|P5|COMPLETED|Placebo Washout First Intervention||3
7685206|NCT01904773|18927087|P4|COMPLETED|Placebo Washout First Intervention||2
7685207|NCT01904773|18927088|P3|COMPLETED|Placebo Washout First Intervention||1
7685208|NCT01904773|18927089|P2|COMPLETED|Placebo Washout First Intervention||1
7685209|NCT01904773|18927090|P1|COMPLETED|Placebo Washout First Intervention||0
7685210|NCT01904773|18927082|P9|STARTED|Placebo Washout First Intervention||4
7685211|NCT01904773|18927083|P8|STARTED|Placebo Washout First Intervention||3
7685212|NCT01904773|18927084|P7|STARTED|Placebo Washout First Intervention||3
7685213|NCT01904773|18927085|P6|STARTED|Placebo Washout First Intervention||4
7685214|NCT01904773|18927086|P5|STARTED|Placebo Washout First Intervention||3
7685215|NCT01904773|18927087|P4|STARTED|Placebo Washout First Intervention||2
7685216|NCT01904773|18927088|P3|STARTED|Placebo Washout First Intervention||1
7685217|NCT01904773|18927089|P2|STARTED|Placebo Washout First Intervention||2
7685218|NCT01904773|18927090|P1|STARTED|Placebo Washout First Intervention||0
7685219|NCT01904773|18927082|P9|NOT COMPLETED|First Intervention||0
7685220|NCT01904773|18927083|P8|NOT COMPLETED|First Intervention||0
7685221|NCT01904773|18927084|P7|NOT COMPLETED|First Intervention||1
7685222|NCT01904773|18927085|P6|NOT COMPLETED|First Intervention||0
7685223|NCT01904773|18927086|P5|NOT COMPLETED|First Intervention||0
7685224|NCT01904773|18927087|P4|NOT COMPLETED|First Intervention||0
7685225|NCT01904773|18927088|P3|NOT COMPLETED|First Intervention||0
7685226|NCT01904773|18927089|P2|NOT COMPLETED|First Intervention||0
7685227|NCT01904773|18927090|P1|NOT COMPLETED|First Intervention||0
7685228|NCT01904773|18927082|P9|COMPLETED|First Intervention||4
7685229|NCT01904773|18927083|P8|COMPLETED|First Intervention||3
7685230|NCT01904773|18927084|P7|COMPLETED|First Intervention||3
7685231|NCT01904773|18927085|P6|COMPLETED|First Intervention||4
7685232|NCT01904773|18927086|P5|COMPLETED|First Intervention||3
7685233|NCT01904773|18927087|P4|COMPLETED|First Intervention||2
7685234|NCT01904773|18927088|P3|COMPLETED|First Intervention||1
7685235|NCT01904773|18927089|P2|COMPLETED|First Intervention||2
7685236|NCT01904773|18927090|P1|COMPLETED|First Intervention||0
7685237|NCT01904773|18927082|P9|STARTED|First Intervention||4
7685238|NCT01904773|18927083|P8|STARTED|First Intervention||3
7685239|NCT01904773|18927084|P7|STARTED|First Intervention||4
7685240|NCT01904773|18927085|P6|STARTED|First Intervention||4
7685241|NCT01904773|18927086|P5|STARTED|First Intervention||3
7685242|NCT01904773|18927087|P4|STARTED|First Intervention||2
7685243|NCT01904773|18927088|P3|STARTED|First Intervention||1
7685244|NCT01904773|18927089|P2|STARTED|First Intervention||2
7685245|NCT01904773|18927090|P1|STARTED|First Intervention||0
7685246|NCT01904773|18927082|P9|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685247|NCT01904773|18927083|P8|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685248|NCT01904773|18927084|P7|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685249|NCT01904773|18927085|P6|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685250|NCT01904773|18927086|P5|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685251|NCT01904773|18927087|P4|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685252|NCT01904773|18927088|P3|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685253|NCT01904773|18927089|P2|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685254|NCT01904773|18927090|P1|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1
7685255|NCT01904773|18927082|P9|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685256|NCT01904773|18927083|P8|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685257|NCT01904773|18927084|P7|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685258|NCT01904773|18927085|P6|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685259|NCT01904773|18927086|P5|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685260|NCT01904773|18927087|P4|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685261|NCT01904773|18927088|P3|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685262|NCT01904773|18927089|P2|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685263|NCT01904773|18927090|P1|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23
7685264|NCT01904773|18927082|P9|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685265|NCT01904773|18927083|P8|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685266|NCT01904773|18927084|P7|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685267|NCT01904773|18927085|P6|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685268|NCT01904773|18927086|P5|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685269|NCT01904773|18927087|P4|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685270|NCT01904773|18927088|P3|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685271|NCT01904773|18927089|P2|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685272|NCT01904773|18927090|P1|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4
7685273|NCT01904773|18927082|P9|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685274|NCT01904773|18927083|P8|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685275|NCT01904773|18927084|P7|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685276|NCT01904773|18927085|P6|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685277|NCT01904773|18927086|P5|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685278|NCT01904773|18927087|P4|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685279|NCT01904773|18927088|P3|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685280|NCT01904773|18927089|P2|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685281|NCT01904773|18927090|P1|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20
7685282|NCT01904773|18927082|P9|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685283|NCT01904773|18927083|P8|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685284|NCT01904773|18927084|P7|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685285|NCT01904773|18927085|P6|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685286|NCT01904773|18927086|P5|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685287|NCT01904773|18927087|P4|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685288|NCT01904773|18927088|P3|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685289|NCT01904773|18927089|P2|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
7685290|NCT01904773|18927090|P1|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24
7685291|NCT01904773|18927082|P9|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685292|NCT01904773|18927083|P8|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685293|NCT01904773|18927084|P7|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685294|NCT01904773|18927085|P6|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685295|NCT01904773|18927086|P5|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685296|NCT01904773|18927087|P4|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685297|NCT01904773|18927088|P3|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685298|NCT01904773|18927089|P2|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685299|NCT01904773|18927090|P1|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685300|NCT01904773|18927082|P9|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685301|NCT01904773|18927083|P8|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685302|NCT01904773|18927084|P7|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685303|NCT01904773|18927085|P6|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685304|NCT01904773|18927086|P5|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685305|NCT01904773|18927087|P4|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685306|NCT01904773|18927088|P3|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685307|NCT01904773|18927089|P2|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685308|NCT01904773|18927090|P1|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24
7685309|NCT01904773|18927082|P9|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685310|NCT01904773|18927083|P8|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685311|NCT01904773|18927084|P7|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685312|NCT01904773|18927085|P6|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685313|NCT01904773|18927086|P5|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685314|NCT01904773|18927087|P4|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685315|NCT01904773|18927088|P3|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685316|NCT01904773|18927089|P2|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
7685317|NCT01904773|18927090|P1|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24
7685318|NCT01904773|18927082|P9|NOT COMPLETED|Screen||0
7685319|NCT01904773|18927083|P8|NOT COMPLETED|Screen||0
7685320|NCT01904773|18927084|P7|NOT COMPLETED|Screen||0
7685321|NCT01904773|18927085|P6|NOT COMPLETED|Screen||0
7685322|NCT01904773|18927086|P5|NOT COMPLETED|Screen||0
7685323|NCT01904773|18927087|P4|NOT COMPLETED|Screen||0
7685324|NCT01904773|18927088|P3|NOT COMPLETED|Screen||0
7685325|NCT01904773|18927089|P2|NOT COMPLETED|Screen||0
7685326|NCT01904773|18927090|P1|NOT COMPLETED|Screen||4
7685327|NCT01904773|18927082|P9|COMPLETED|Screen||0
7685328|NCT01904773|18927083|P8|COMPLETED|Screen||0
7685329|NCT01904773|18927084|P7|COMPLETED|Screen||0
7685330|NCT01904773|18927085|P6|COMPLETED|Screen||0
7685331|NCT01904773|18927086|P5|COMPLETED|Screen||0
7685332|NCT01904773|18927087|P4|COMPLETED|Screen||0
7685333|NCT01904773|18927088|P3|COMPLETED|Screen||0
7685334|NCT01904773|18927089|P2|COMPLETED|Screen||0
7685335|NCT01904773|18927090|P1|COMPLETED|Screen||24
7685336|NCT01904773|18927082|P9|STARTED|Screen||0
7685337|NCT01904773|18927083|P8|STARTED|Screen||0
7685338|NCT01904773|18927084|P7|STARTED|Screen||0
7685339|NCT01904773|18927085|P6|STARTED|Screen||0
7685340|NCT01904773|18927086|P5|STARTED|Screen||0
7685341|NCT01904773|18927087|P4|STARTED|Screen||0
7685342|NCT01904773|18927088|P3|STARTED|Screen||0
7685343|NCT01904773|18927089|P2|STARTED|Screen||0
7685344|NCT01904773|18927090|P1|STARTED|Screen||28
7685345|NCT01904760|18927107|P2|NOT COMPLETED|Overall Study||0
7685346|NCT01904760|18927108|P1|NOT COMPLETED|Overall Study||1
7685347|NCT01904760|18927107|P2|COMPLETED|Overall Study||40
7685348|NCT01904760|18927108|P1|COMPLETED|Overall Study||39
7685349|NCT01904760|18927107|P2|STARTED|Overall Study||40
7685350|NCT01904760|18927108|P1|STARTED|Overall Study||40
7685351|NCT01904721|18927123|P7|NOT COMPLETED|Overall Study||7
7685352|NCT01904721|18927124|P6|NOT COMPLETED|Overall Study||9
7685353|NCT01904721|18927125|P5|NOT COMPLETED|Overall Study||8
7685354|NCT01904721|18927126|P4|NOT COMPLETED|Overall Study||1
7685355|NCT01904721|18927127|P3|NOT COMPLETED|Overall Study||1
7685356|NCT01904721|18927128|P2|NOT COMPLETED|Overall Study||0
7685357|NCT01904721|18927129|P1|NOT COMPLETED|Overall Study||0
7685358|NCT01904721|18927123|P7|COMPLETED|Overall Study||57
7685359|NCT01904721|18927124|P6|COMPLETED|Overall Study||56
7685360|NCT01904721|18927125|P5|COMPLETED|Overall Study||57
7685361|NCT01904721|18927126|P4|COMPLETED|Overall Study||11
7685362|NCT01904721|18927127|P3|COMPLETED|Overall Study||11
7685363|NCT01904721|18927128|P2|COMPLETED|Overall Study||13
7685364|NCT01904721|18927129|P1|COMPLETED|Overall Study||13
7685365|NCT01904721|18927123|P7|STARTED|Overall Study||64
7685366|NCT01904721|18927124|P6|STARTED|Overall Study||65
7685367|NCT01904721|18927125|P5|STARTED|Overall Study||65
7685368|NCT01904721|18927126|P4|STARTED|Overall Study||12
7685369|NCT01904721|18927127|P3|STARTED|Overall Study||12
7685370|NCT01904721|18927128|P2|STARTED|Overall Study||13
7685371|NCT01904721|18927129|P1|STARTED|Overall Study||13
7685372|NCT01904604|18927159|P3|NOT COMPLETED|Overall Study||2
7685373|NCT01904604|18927160|P2|NOT COMPLETED|Overall Study||7
7685374|NCT01904604|18927161|P1|NOT COMPLETED|Overall Study||7
7685375|NCT01904604|18927159|P3|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|23
7685376|NCT01904604|18927160|P2|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
7685377|NCT01904604|18927161|P1|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
7685378|NCT01904604|18927159|P3|Completed Week 130 OFC|Overall Study||23
7685379|NCT01904604|18927160|P2|Completed Week 130 OFC|Overall Study||18
7685380|NCT01904604|18927161|P1|Completed Week 130 OFC|Overall Study||18
7685381|NCT01904604|18927159|P3|Began Crossover Treatment|Overall Study|Per protocol, this treatment group did not crossover.|0
7685382|NCT01904604|18927160|P2|Began Crossover Treatment|Overall Study||21
7685383|NCT01904604|18927161|P1|Began Crossover Treatment|Overall Study|2 participants who completed the Week 52 OFC did not crossover; 1 passed the OFC and 1 relocated.|20
7685384|NCT01904604|18927159|P3|Completed Week 52 OFC|Overall Study||25
7685385|NCT01904604|18927160|P2|Completed Week 52 OFC|Overall Study||21
7685386|NCT01904604|18927161|P1|Completed Week 52 OFC|Overall Study||22
7685387|NCT01904604|18927159|P3|STARTED|Overall Study||25
7685388|NCT01904604|18927160|P2|STARTED|Overall Study||25
7685389|NCT01904604|18927161|P1|STARTED|Overall Study||25
7685390|NCT01904526|18927190|P1|NOT COMPLETED|Overall Study||0
7685391|NCT01904526|18927190|P1|COMPLETED|Overall Study||5
7685392|NCT01904526|18927190|P1|STARTED|Overall Study||5
7685393|NCT01904448|18927204|P1|NOT COMPLETED|Overall Study||0
7685394|NCT01904448|18927204|P1|COMPLETED|Overall Study||5
7685395|NCT01904448|18927204|P1|STARTED|Overall Study||5
7685396|NCT01904383|18927226|P1|NOT COMPLETED|Overall Study||1774
7685397|NCT01904383|18927226|P1|COMPLETED|Overall Study||2283
7685398|NCT01904383|18927226|P1|Treated|Overall Study||3940
7685399|NCT01904383|18927226|P1|STARTED|Overall Study||4057
7685400|NCT01904279|18927233|P2|NOT COMPLETED|Overall Study||3
7685401|NCT01904279|18927234|P1|NOT COMPLETED|Overall Study||3
7685402|NCT01904279|18927233|P2|COMPLETED|Overall Study||22
7685403|NCT01904279|18927234|P1|COMPLETED|Overall Study||24
7685404|NCT01904279|18927233|P2|STARTED|Overall Study||25
7685405|NCT01904279|18927234|P1|STARTED|Overall Study||27
7685406|NCT01904149|18927260|P6|NOT COMPLETED|Overall Study||3
7685407|NCT01904149|18927261|P5|NOT COMPLETED|Overall Study||5
7685408|NCT01904149|18927262|P4|NOT COMPLETED|Overall Study||4
7685409|NCT01904149|18927263|P3|NOT COMPLETED|Overall Study||2
7685410|NCT01904149|18927264|P2|NOT COMPLETED|Overall Study||11
7685411|NCT01904149|18927265|P1|NOT COMPLETED|Overall Study||5
7685412|NCT01904149|18927260|P6|COMPLETED|Overall Study||48
7685413|NCT01904149|18927261|P5|COMPLETED|Overall Study||46
7685414|NCT01904149|18927262|P4|COMPLETED|Overall Study||47
7685415|NCT01904149|18927263|P3|COMPLETED|Overall Study||148
7685416|NCT01904149|18927264|P2|COMPLETED|Overall Study||140
7685417|NCT01904149|18927265|P1|COMPLETED|Overall Study||147
7685418|NCT01904149|18927260|P6|Multiple-dose Phase|Overall Study||49
7685419|NCT01904149|18927261|P5|Multiple-dose Phase|Overall Study||48
7685420|NCT01904149|18927262|P4|Multiple-dose Phase|Overall Study||48
7685421|NCT01904149|18927263|P3|Multiple-dose Phase|Overall Study||149
7685422|NCT01904149|18927264|P2|Multiple-dose Phase|Overall Study||146
7685423|NCT01904149|18927265|P1|Multiple-dose Phase|Overall Study||150
7685424|NCT01904149|18927260|P6|Single-dose Phase|Overall Study||51
7685425|NCT01904149|18927261|P5|Single-dose Phase|Overall Study||51
7685426|NCT01904149|18927262|P4|Single-dose Phase|Overall Study||51
7685427|NCT01904149|18927263|P3|Single-dose Phase|Overall Study||150
7685428|NCT01904149|18927264|P2|Single-dose Phase|Overall Study||151
7685429|NCT01904149|18927265|P1|Single-dose Phase|Overall Study||152
7685430|NCT01904149|18927260|P6|STARTED|Overall Study||51
7685431|NCT01904149|18927261|P5|STARTED|Overall Study||51
7685432|NCT01904149|18927262|P4|STARTED|Overall Study||51
7685433|NCT01904149|18927263|P3|STARTED|Overall Study||150
7685434|NCT01904149|18927264|P2|STARTED|Overall Study||151
7685435|NCT01904149|18927265|P1|STARTED|Overall Study||152
7685436|NCT01904071|18927290|P3|NOT COMPLETED|Overall Study||0
7685437|NCT01904071|18927291|P2|NOT COMPLETED|Overall Study||0
7685438|NCT01904071|18927292|P1|NOT COMPLETED|Overall Study||0
7685439|NCT01904071|18927290|P3|COMPLETED|Overall Study||20
7685440|NCT01904071|18927291|P2|COMPLETED|Overall Study||20
7685441|NCT01904071|18927292|P1|COMPLETED|Overall Study||24
7685442|NCT01904071|18927290|P3|STARTED|Overall Study||20
7685443|NCT01904071|18927291|P2|STARTED|Overall Study||20
7685444|NCT01904071|18927292|P1|STARTED|Overall Study||24
7685445|NCT01904058|18927316|P4|NOT COMPLETED|Overall Study||1
7685446|NCT01904058|18927317|P3|NOT COMPLETED|Overall Study||1
7685447|NCT01904058|18927318|P2|NOT COMPLETED|Overall Study||0
7685448|NCT01904058|18927319|P1|NOT COMPLETED|Overall Study||3
7685449|NCT01904058|18927316|P4|COMPLETED|Overall Study||12
7685450|NCT01904058|18927317|P3|COMPLETED|Overall Study||10
7685451|NCT01904058|18927318|P2|COMPLETED|Overall Study||21
7685452|NCT01904058|18927319|P1|COMPLETED|Overall Study||18
7685453|NCT01904058|18927316|P4|STARTED|Overall Study||13
7685454|NCT01904058|18927317|P3|STARTED|Overall Study||11
7685455|NCT01904058|18927318|P2|STARTED|Overall Study||21
7685456|NCT01904058|18927319|P1|STARTED|Overall Study||21
7685457|NCT01903993|18927359|P2|NOT COMPLETED|Overall Study||144
7685458|NCT01903993|18927360|P1|NOT COMPLETED|Overall Study||143
7685459|NCT01903993|18927359|P2|COMPLETED|Overall Study||0
7685460|NCT01903993|18927360|P1|COMPLETED|Overall Study||0
7685461|NCT01903993|18927359|P2|Received Treatment|Overall Study||142
7685462|NCT01903993|18927360|P1|Received Treatment|Overall Study||135
7685463|NCT01903993|18927359|P2|STARTED|Overall Study||144
7685464|NCT01903993|18927360|P1|STARTED|Overall Study||143
7685465|NCT01903876|18927377|P2|NOT COMPLETED|Six-Month Follow-up Period||145
7685466|NCT01903876|18927378|P1|NOT COMPLETED|Six-Month Follow-up Period||91
7685467|NCT01903876|18927377|P2|COMPLETED|Six-Month Follow-up Period||123
7685468|NCT01903876|18927378|P1|COMPLETED|Six-Month Follow-up Period||92
7685469|NCT01903876|18927377|P2|STARTED|Six-Month Follow-up Period||268
7685470|NCT01903876|18927378|P1|STARTED|Six-Month Follow-up Period||183
7685471|NCT01903876|18927377|P2|NOT COMPLETED|Baseline to Post-Intervention Period||108
7685472|NCT01903876|18927378|P1|NOT COMPLETED|Baseline to Post-Intervention Period||184
7685473|NCT01903876|18927377|P2|COMPLETED|Baseline to Post-Intervention Period||268
7685474|NCT01903876|18927378|P1|COMPLETED|Baseline to Post-Intervention Period||183
7685475|NCT01903876|18927377|P2|STARTED|Baseline to Post-Intervention Period||376
7685476|NCT01903876|18927378|P1|STARTED|Baseline to Post-Intervention Period||367
7685477|NCT01903863|18927388|P2|NOT COMPLETED|Overall Study||0
7685478|NCT01903863|18927389|P1|NOT COMPLETED|Overall Study||2
7685479|NCT01903863|18927388|P2|COMPLETED|Overall Study||16
7685480|NCT01903863|18927389|P1|COMPLETED|Overall Study||13
7685481|NCT01903863|18927388|P2|STARTED|Overall Study||16
7685482|NCT01903863|18927389|P1|STARTED|Overall Study||15
7685483|NCT01903811|18927411|P2|NOT COMPLETED|Overall Study||14
7685484|NCT01903811|18927412|P1|NOT COMPLETED|Overall Study||8
7685485|NCT01903811|18927411|P2|COMPLETED|Overall Study||57
7685486|NCT01903811|18927412|P1|COMPLETED|Overall Study||64
7685487|NCT01903811|18927411|P2|Crossover to Arm II|Overall Study||0
7685488|NCT01903811|18927412|P1|Crossover to Arm II|Overall Study|Following disease progression on Arm I. Note: these patients are also counted in 'Completed'.|16
7685489|NCT01903811|18927411|P2|STARTED|Overall Study||71
7685490|NCT01903811|18927412|P1|STARTED|Overall Study||72
7685491|NCT01903798|18927429|P4|NOT COMPLETED|Overall Study||0
7685492|NCT01903798|18927430|P3|NOT COMPLETED|Overall Study||0
7685493|NCT01903798|18927431|P2|NOT COMPLETED|Overall Study||0
7685494|NCT01903798|18927432|P1|NOT COMPLETED|Overall Study||0
7685495|NCT01903798|18927429|P4|COMPLETED|Overall Study||1
7685496|NCT01903798|18927430|P3|COMPLETED|Overall Study||1
7685497|NCT01903798|18927431|P2|COMPLETED|Overall Study||0
7685498|NCT01903798|18927432|P1|COMPLETED|Overall Study||2
7685499|NCT01903798|18927429|P4|STARTED|Overall Study||1
7685500|NCT01903798|18927430|P3|STARTED|Overall Study||1
7685501|NCT01903798|18927431|P2|STARTED|Overall Study||0
7685502|NCT01903798|18927432|P1|STARTED|Overall Study||2
7685503|NCT01903720|18927446|P1|NOT COMPLETED|Overall Study||12
7685504|NCT01903720|18927446|P1|COMPLETED|Overall Study||59
7685505|NCT01903720|18927446|P1|STARTED|Overall Study||71
7685506|NCT01903564|18927463|P2|NOT COMPLETED|Overall Study||0
7685507|NCT01903564|18927464|P1|NOT COMPLETED|Overall Study||0
7685508|NCT01903564|18927463|P2|COMPLETED|Overall Study||29
7685509|NCT01903564|18927464|P1|COMPLETED|Overall Study||10
7685510|NCT01903564|18927463|P2|STARTED|Overall Study||29
7685511|NCT01903564|18927464|P1|STARTED|Overall Study||10
7685512|NCT01903460|18927484|P4|NOT COMPLETED|Overall Study||1
7685513|NCT01903460|18927485|P3|NOT COMPLETED|Overall Study||0
7685514|NCT01903460|18927486|P2|NOT COMPLETED|Overall Study||0
7685515|NCT01903460|18927487|P1|NOT COMPLETED|Overall Study||0
7685516|NCT01903460|18927484|P4|COMPLETED|Overall Study||2
7685517|NCT01903460|18927485|P3|COMPLETED|Overall Study||3
7685518|NCT01903460|18927486|P2|COMPLETED|Overall Study||8
7685519|NCT01903460|18927487|P1|COMPLETED|Overall Study||6
7685520|NCT01903460|18927484|P4|STARTED|Overall Study||3
7685521|NCT01903460|18927485|P3|STARTED|Overall Study||3
7685522|NCT01903460|18927486|P2|STARTED|Overall Study||8
7685523|NCT01903460|18927487|P1|STARTED|Overall Study||6
7685524|NCT01903434|18927504|P2|NOT COMPLETED|Treatment Period 3||0
7685525|NCT01903434|18927505|P1|NOT COMPLETED|Treatment Period 3||0
7685526|NCT01903434|18927504|P2|COMPLETED|Treatment Period 3||28
7685527|NCT01903434|18927505|P1|COMPLETED|Treatment Period 3||29
7685528|NCT01903434|18927504|P2|Received at Least 1 Dose of Study Drug|Treatment Period 3||28
7685529|NCT01903434|18927505|P1|Received at Least 1 Dose of Study Drug|Treatment Period 3||29
7685530|NCT01903434|18927504|P2|STARTED|Treatment Period 3||28
7685531|NCT01903434|18927505|P1|STARTED|Treatment Period 3||29
7685532|NCT01903434|18927504|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
7685533|NCT01903434|18927505|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
7685534|NCT01903434|18927504|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||28
7685535|NCT01903434|18927505|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||29
7685536|NCT01903434|18927504|P2|STARTED|Washout Period 1 (at Least 14 Days)||28
7685537|NCT01903434|18927505|P1|STARTED|Washout Period 1 (at Least 14 Days)||29
7685538|NCT01903434|18927504|P2|NOT COMPLETED|Treatment Period 2||0
7685539|NCT01903434|18927505|P1|NOT COMPLETED|Treatment Period 2||0
7685540|NCT01903434|18927504|P2|COMPLETED|Treatment Period 2||28
7685541|NCT01903434|18927505|P1|COMPLETED|Treatment Period 2||29
7685542|NCT01903434|18927504|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||28
7685543|NCT01903434|18927505|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||29
7685544|NCT01903434|18927504|P2|STARTED|Treatment Period 2||28
7685545|NCT01903434|18927505|P1|STARTED|Treatment Period 2||29
7685546|NCT01903434|18927504|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||2
7685547|NCT01903434|18927505|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||1
7685548|NCT01903434|18927504|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||28
7685549|NCT01903434|18927505|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||29
7685550|NCT01903434|18927504|P2|STARTED|Washout Period 1 (at Least 14 Days)||30
7685551|NCT01903434|18927505|P1|STARTED|Washout Period 1 (at Least 14 Days)||30
7685552|NCT01903434|18927504|P2|NOT COMPLETED|Treatment Period 1||0
7685553|NCT01903434|18927505|P1|NOT COMPLETED|Treatment Period 1||0
7685554|NCT01903434|18927504|P2|COMPLETED|Treatment Period 1||30
7685555|NCT01903434|18927505|P1|COMPLETED|Treatment Period 1||30
7685556|NCT01903434|18927504|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
7685557|NCT01903434|18927505|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
7685558|NCT01903434|18927504|P2|STARTED|Treatment Period 1||30
7685559|NCT01903434|18927505|P1|STARTED|Treatment Period 1||30
7685560|NCT01903356|18927513|P1|NOT COMPLETED|Overall Study||15
7685561|NCT01903356|18927513|P1|COMPLETED|Overall Study||709
7685562|NCT01903356|18927513|P1|STARTED|Overall Study||724
7685563|NCT01903265|18927523|P2|NOT COMPLETED|Overall Study||17
7685564|NCT01903265|18927524|P1|NOT COMPLETED|Overall Study||14
7685565|NCT01903265|18927523|P2|COMPLETED|Overall Study||85
7685566|NCT01903265|18927524|P1|COMPLETED|Overall Study||89
7685567|NCT01903265|18927523|P2|STARTED|Overall Study||102
7685568|NCT01903265|18927524|P1|STARTED|Overall Study||103
7685569|NCT01903252|18927540|P6|NOT COMPLETED|Maintenance, Open-Label||18
7685570|NCT01903252|18927541|P5|NOT COMPLETED|Maintenance, Open-Label||21
7685571|NCT01903252|18927542|P4|NOT COMPLETED|Maintenance, Open-Label||6
7685572|NCT01903252|18927543|P3|NOT COMPLETED|Maintenance, Open-Label||0
7685573|NCT01903252|18927544|P2|NOT COMPLETED|Maintenance, Open-Label||0
7685574|NCT01903252|18927545|P1|NOT COMPLETED|Maintenance, Open-Label||0
7685575|NCT01903252|18927540|P6|COMPLETED|Maintenance, Open-Label||181
7685576|NCT01903252|18927541|P5|COMPLETED|Maintenance, Open-Label||253
7685577|NCT01903252|18927542|P4|COMPLETED|Maintenance, Open-Label||196
7685578|NCT01903252|18927543|P3|COMPLETED|Maintenance, Open-Label||0
7685579|NCT01903252|18927544|P2|COMPLETED|Maintenance, Open-Label||0
7685580|NCT01903252|18927545|P1|COMPLETED|Maintenance, Open-Label||0
7685581|NCT01903252|18927540|P6|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|199
7685582|NCT01903252|18927541|P5|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|274
7685583|NCT01903252|18927542|P4|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|202
7685584|NCT01903252|18927543|P3|STARTED|Maintenance, Open-Label|Period 2 (extended induction) is completed, subjects are newly allocated to Period 3, maintenance.|0
7685585|NCT01903252|18927544|P2|STARTED|Maintenance, Open-Label||0
7685586|NCT01903252|18927545|P1|STARTED|Maintenance, Open-Label||0
7685587|NCT01903252|18927540|P6|NOT COMPLETED|Extended Induction, Open-Label||0
7685588|NCT01903252|18927541|P5|NOT COMPLETED|Extended Induction, Open-Label||0
7685589|NCT01903252|18927542|P4|NOT COMPLETED|Extended Induction, Open-Label||0
7685590|NCT01903252|18927543|P3|NOT COMPLETED|Extended Induction, Open-Label||23
7685591|NCT01903252|18927544|P2|NOT COMPLETED|Extended Induction, Open-Label||0
7685592|NCT01903252|18927545|P1|NOT COMPLETED|Extended Induction, Open-Label||0
7685593|NCT01903252|18927540|P6|COMPLETED|Extended Induction, Open-Label||0
7685594|NCT01903252|18927541|P5|COMPLETED|Extended Induction, Open-Label||0
7685595|NCT01903252|18927542|P4|COMPLETED|Extended Induction, Open-Label||0
7685596|NCT01903252|18927543|P3|COMPLETED|Extended Induction, Open-Label||220
7685597|NCT01903252|18927544|P2|COMPLETED|Extended Induction, Open-Label||0
7685598|NCT01903252|18927545|P1|COMPLETED|Extended Induction, Open-Label||0
7685599|NCT01903252|18927540|P6|STARTED|Extended Induction, Open-Label||0
7685600|NCT01903252|18927541|P5|STARTED|Extended Induction, Open-Label||0
7685601|NCT01903252|18927542|P4|STARTED|Extended Induction, Open-Label||0
7685602|NCT01903252|18927543|P3|STARTED|Extended Induction, Open-Label|The subjects in this phase were non-responders at week 8 and discontinued the double-blind phase.|243
7685603|NCT01903252|18927544|P2|STARTED|Extended Induction, Open-Label|This treatment arm was only used in Period 1, double-blind induction phase.|0
7685604|NCT01903252|18927545|P1|STARTED|Extended Induction, Open-Label||0
7685605|NCT01903252|18927540|P6|NOT COMPLETED|Double-Blind Induction||0
7685606|NCT01903252|18927541|P5|NOT COMPLETED|Double-Blind Induction||0
7685607|NCT01903252|18927542|P4|NOT COMPLETED|Double-Blind Induction||0
7685608|NCT01903252|18927543|P3|NOT COMPLETED|Double-Blind Induction||0
7685609|NCT01903252|18927544|P2|NOT COMPLETED|Double-Blind Induction||41
7685610|NCT01903252|18927545|P1|NOT COMPLETED|Double-Blind Induction||39
7685611|NCT01903252|18927540|P6|COMPLETED|Double-Blind Induction||0
7685612|NCT01903252|18927541|P5|COMPLETED|Double-Blind Induction||0
7685613|NCT01903252|18927542|P4|COMPLETED|Double-Blind Induction||0
7685614|NCT01903252|18927543|P3|COMPLETED|Double-Blind Induction||0
7685615|NCT01903252|18927544|P2|COMPLETED|Double-Blind Induction||367
7685616|NCT01903252|18927545|P1|COMPLETED|Double-Blind Induction||370
7685617|NCT01903252|18927540|P6|STARTED|Double-Blind Induction||0
7685618|NCT01903252|18927541|P5|STARTED|Double-Blind Induction||0
7685619|NCT01903252|18927542|P4|STARTED|Double-Blind Induction||0
7685620|NCT01903252|18927543|P3|STARTED|Double-Blind Induction||0
7685621|NCT01903252|18927544|P2|STARTED|Double-Blind Induction||408
7685622|NCT01903252|18927545|P1|STARTED|Double-Blind Induction||409
7685623|NCT01903187|18927624|P2|NOT COMPLETED|12 Month||0
7685624|NCT01903187|18927625|P1|NOT COMPLETED|12 Month||0
7685625|NCT01903187|18927624|P2|COMPLETED|12 Month||0
7685626|NCT01903187|18927625|P1|COMPLETED|12 Month||2
7685627|NCT01903187|18927624|P2|STARTED|12 Month||0
7685628|NCT01903187|18927625|P1|STARTED|12 Month||2
7685629|NCT01903187|18927624|P2|NOT COMPLETED|6 Month||0
7685630|NCT01903187|18927625|P1|NOT COMPLETED|6 Month||0
7685631|NCT01903187|18927624|P2|COMPLETED|6 Month||0
7685632|NCT01903187|18927625|P1|COMPLETED|6 Month||2
7685633|NCT01903187|18927624|P2|STARTED|6 Month||0
7685634|NCT01903187|18927625|P1|STARTED|6 Month||2
7685635|NCT01903187|18927624|P2|NOT COMPLETED|3 Month||0
7685636|NCT01903187|18927625|P1|NOT COMPLETED|3 Month||0
7685637|NCT01903187|18927624|P2|COMPLETED|3 Month||0
7685638|NCT01903187|18927625|P1|COMPLETED|3 Month||2
7685639|NCT01903187|18927624|P2|STARTED|3 Month||0
7685640|NCT01903187|18927625|P1|STARTED|3 Month||2
7685641|NCT01903187|18927624|P2|NOT COMPLETED|1 Month||0
7685642|NCT01903187|18927625|P1|NOT COMPLETED|1 Month||0
7685643|NCT01903187|18927624|P2|COMPLETED|1 Month||2
7685644|NCT01903187|18927625|P1|COMPLETED|1 Month||2
7685645|NCT01903187|18927624|P2|STARTED|1 Month||2
7685646|NCT01903187|18927625|P1|STARTED|1 Month||2
7685647|NCT01903187|18927624|P2|NOT COMPLETED|Procedure||0
7685648|NCT01903187|18927625|P1|NOT COMPLETED|Procedure||0
7685649|NCT01903187|18927624|P2|COMPLETED|Procedure||2
7685650|NCT01903187|18927625|P1|COMPLETED|Procedure||2
7685651|NCT01903187|18927624|P2|STARTED|Procedure||2
7685652|NCT01903187|18927625|P1|STARTED|Procedure||2
7685653|NCT01903148|18927639|P1|NOT COMPLETED|Overall Study||0
7685654|NCT01903148|18927639|P1|COMPLETED|Overall Study||441
7685655|NCT01903148|18927639|P1|STARTED|Overall Study||441
7685656|NCT01903031|18927658|P3|NOT COMPLETED|Overall Study||5
7685657|NCT01903031|18927659|P2|NOT COMPLETED|Overall Study||3
7685658|NCT01903031|18927660|P1|NOT COMPLETED|Overall Study||2
7685659|NCT01903031|18927658|P3|COMPLETED|Overall Study||24
7685660|NCT01903031|18927659|P2|COMPLETED|Overall Study||25
7685661|NCT01903031|18927660|P1|COMPLETED|Overall Study||25
7685662|NCT01903031|18927658|P3|STARTED|Overall Study||29
7685663|NCT01903031|18927659|P2|STARTED|Overall Study||28
7685664|NCT01903031|18927660|P1|STARTED|Overall Study||27
7685665|NCT01903005|18927702|P1|NOT COMPLETED|Overall Study||373
7685666|NCT01903005|18927702|P1|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292
7685667|NCT01903005|18927702|P1|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665
7685668|NCT01902953|18927716|P1|NOT COMPLETED|Overall Study||0
7685669|NCT01902953|18927716|P1|COMPLETED|Overall Study||16
7685670|NCT01902953|18927716|P1|STARTED|Overall Study||16
7685671|NCT01902901|18927723|P2|NOT COMPLETED|Overall Study||2
7685672|NCT01902901|18927724|P1|NOT COMPLETED|Overall Study||0
7685673|NCT01902901|18927723|P2|COMPLETED|Overall Study||201
7685674|NCT01902901|18927724|P1|COMPLETED|Overall Study||180
7685675|NCT01902901|18927723|P2|STARTED|Overall Study||203
7685676|NCT01902901|18927724|P1|STARTED|Overall Study||180
7685677|NCT01902888|18927734|P1|NOT COMPLETED|Overall Study||3
7685678|NCT01902888|18927734|P1|COMPLETED|Overall Study||0
7685679|NCT01902888|18927734|P1|STARTED|Overall Study||3
7685680|NCT01902758|18927741|P2|NOT COMPLETED|Overall Study||0
7685681|NCT01902758|18927742|P1|NOT COMPLETED|Overall Study||0
7685682|NCT01902758|18927741|P2|COMPLETED|Overall Study||14
7685683|NCT01902758|18927742|P1|COMPLETED|Overall Study||14
7685684|NCT01902758|18927741|P2|STARTED|Overall Study||14
7685685|NCT01902758|18927742|P1|STARTED|Overall Study||14
7685686|NCT01902628|18927748|P1|NOT COMPLETED|Overall Study||83
7685687|NCT01902628|18927748|P1|COMPLETED|Overall Study||354
7685688|NCT01902628|18927748|P1|STARTED|Overall Study||437
7685689|NCT01902459|18927757|P2|NOT COMPLETED|Overall Study||0
7685690|NCT01902459|18927758|P1|NOT COMPLETED|Overall Study||0
7685691|NCT01902459|18927757|P2|COMPLETED|Overall Study||75
7685692|NCT01902459|18927758|P1|COMPLETED|Overall Study||75
7685693|NCT01902459|18927757|P2|STARTED|Overall Study||75
7685694|NCT01902459|18927758|P1|STARTED|Overall Study||75
7685695|NCT01902303|18927776|P2|NOT COMPLETED|Overall Study||24
7685696|NCT01902303|18927777|P1|NOT COMPLETED|Overall Study||23
7685697|NCT01902303|18927776|P2|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57
7685698|NCT01902303|18927777|P1|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54
7685699|NCT01902303|18927776|P2|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62
7685700|NCT01902303|18927777|P1|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56
7685701|NCT01902303|18927776|P2|STARTED|Overall Study|Allocated to active treatment|81
7685702|NCT01902303|18927777|P1|STARTED|Overall Study|Allocated to placebo|77
7685703|NCT01902173|18927791|P6|NOT COMPLETED|Phase II||0
7685704|NCT01902173|18927792|P5|NOT COMPLETED|Phase II||0
7685705|NCT01902173|18927793|P4|NOT COMPLETED|Phase II||0
7685706|NCT01902173|18927794|P3|NOT COMPLETED|Phase II||0
7685707|NCT01902173|18927795|P2|NOT COMPLETED|Phase II||0
7685708|NCT01902173|18927796|P1|NOT COMPLETED|Phase II||0
7685709|NCT01902173|18927791|P6|COMPLETED|Phase II||0
7685710|NCT01902173|18927792|P5|COMPLETED|Phase II||0
7685711|NCT01902173|18927793|P4|COMPLETED|Phase II||0
7685712|NCT01902173|18927794|P3|COMPLETED|Phase II||0
7685713|NCT01902173|18927795|P2|COMPLETED|Phase II||0
7685714|NCT01902173|18927796|P1|COMPLETED|Phase II||0
7685715|NCT01902173|18927791|P6|STARTED|Phase II||0
7685716|NCT01902173|18927792|P5|STARTED|Phase II||0
7685717|NCT01902173|18927793|P4|STARTED|Phase II||0
7685718|NCT01902173|18927794|P3|STARTED|Phase II||0
7685719|NCT01902173|18927795|P2|STARTED|Phase II||0
7685720|NCT01902173|18927796|P1|STARTED|Phase II||0
7685721|NCT01902173|18927791|P6|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||5
7685722|NCT01902173|18927792|P5|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
7685723|NCT01902173|18927793|P4|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
7685724|NCT01902173|18927794|P3|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
7685725|NCT01902173|18927795|P2|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
7685726|NCT01902173|18927796|P1|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
7685727|NCT01902173|18927791|P6|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
7685728|NCT01902173|18927792|P5|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
7685729|NCT01902173|18927793|P4|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
7685730|NCT01902173|18927794|P3|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
7685731|NCT01902173|18927795|P2|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
7685732|NCT01902173|18927796|P1|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
7685733|NCT01902173|18927791|P6|STARTED|Phase 1 Triplet Regimen Cohort 4||5
7685734|NCT01902173|18927792|P5|STARTED|Phase 1 Triplet Regimen Cohort 4||0
7685735|NCT01902173|18927793|P4|STARTED|Phase 1 Triplet Regimen Cohort 4||0
7685736|NCT01902173|18927794|P3|STARTED|Phase 1 Triplet Regimen Cohort 4||0
7685737|NCT01902173|18927795|P2|STARTED|Phase 1 Triplet Regimen Cohort 4||0
7685738|NCT01902173|18927796|P1|STARTED|Phase 1 Triplet Regimen Cohort 4||0
7685739|NCT01902173|18927791|P6|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
7685740|NCT01902173|18927792|P5|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||3
7685741|NCT01902173|18927793|P4|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
7685742|NCT01902173|18927794|P3|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
7685743|NCT01902173|18927795|P2|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
7685744|NCT01902173|18927796|P1|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
7685745|NCT01902173|18927791|P6|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
7685746|NCT01902173|18927792|P5|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
7685747|NCT01902173|18927793|P4|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
7685748|NCT01902173|18927794|P3|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
7685749|NCT01902173|18927795|P2|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
7685750|NCT01902173|18927796|P1|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
7685751|NCT01902173|18927791|P6|STARTED|Phase 1 Triplet Regimen Cohort 3||0
7685752|NCT01902173|18927792|P5|STARTED|Phase 1 Triplet Regimen Cohort 3||3
7685753|NCT01902173|18927793|P4|STARTED|Phase 1 Triplet Regimen Cohort 3||0
7685754|NCT01902173|18927794|P3|STARTED|Phase 1 Triplet Regimen Cohort 3||0
7685755|NCT01902173|18927795|P2|STARTED|Phase 1 Triplet Regimen Cohort 3||0
7685756|NCT01902173|18927796|P1|STARTED|Phase 1 Triplet Regimen Cohort 3||0
7685757|NCT01902173|18927791|P6|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
7685758|NCT01902173|18927792|P5|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
7685759|NCT01902173|18927793|P4|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||3
7685760|NCT01902173|18927794|P3|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
7685761|NCT01902173|18927795|P2|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
7685762|NCT01902173|18927796|P1|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
7685763|NCT01902173|18927791|P6|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
7685764|NCT01902173|18927792|P5|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
7685765|NCT01902173|18927793|P4|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
7685766|NCT01902173|18927794|P3|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
7685767|NCT01902173|18927795|P2|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
7685768|NCT01902173|18927796|P1|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
7685769|NCT01902173|18927791|P6|STARTED|Phase 1 Triplet Regimen Cohort 2||0
7685770|NCT01902173|18927792|P5|STARTED|Phase 1 Triplet Regimen Cohort 2||0
7685771|NCT01902173|18927793|P4|STARTED|Phase 1 Triplet Regimen Cohort 2||3
7685772|NCT01902173|18927794|P3|STARTED|Phase 1 Triplet Regimen Cohort 2||0
7685773|NCT01902173|18927795|P2|STARTED|Phase 1 Triplet Regimen Cohort 2||0
7685774|NCT01902173|18927796|P1|STARTED|Phase 1 Triplet Regimen Cohort 2||0
7685775|NCT01902173|18927791|P6|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
7685776|NCT01902173|18927792|P5|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
7685777|NCT01902173|18927793|P4|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
7685778|NCT01902173|18927794|P3|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||4
7685779|NCT01902173|18927795|P2|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
7685780|NCT01902173|18927796|P1|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
7685781|NCT01902173|18927791|P6|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
7685782|NCT01902173|18927792|P5|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
7685783|NCT01902173|18927793|P4|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
7685784|NCT01902173|18927794|P3|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
7685785|NCT01902173|18927795|P2|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
7685786|NCT01902173|18927796|P1|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
7685787|NCT01902173|18927791|P6|STARTED|Phase 1 Triplet Regimen Cohort 1||0
7685788|NCT01902173|18927792|P5|STARTED|Phase 1 Triplet Regimen Cohort 1||0
7685789|NCT01902173|18927793|P4|STARTED|Phase 1 Triplet Regimen Cohort 1||0
7685790|NCT01902173|18927794|P3|STARTED|Phase 1 Triplet Regimen Cohort 1||4
7685791|NCT01902173|18927795|P2|STARTED|Phase 1 Triplet Regimen Cohort 1||0
7685792|NCT01902173|18927796|P1|STARTED|Phase 1 Triplet Regimen Cohort 1||0
7685793|NCT01902173|18927791|P6|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
7685794|NCT01902173|18927792|P5|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
7685795|NCT01902173|18927793|P4|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
7685796|NCT01902173|18927794|P3|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
7685797|NCT01902173|18927795|P2|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||9
7685798|NCT01902173|18927796|P1|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
7685799|NCT01902173|18927791|P6|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
7685800|NCT01902173|18927792|P5|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
7685801|NCT01902173|18927793|P4|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
7685802|NCT01902173|18927794|P3|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
7685803|NCT01902173|18927795|P2|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
7685804|NCT01902173|18927796|P1|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
7685805|NCT01902173|18927791|P6|STARTED|Phase 1 Doublet Regimen Cohort 2||0
7685806|NCT01902173|18927792|P5|STARTED|Phase 1 Doublet Regimen Cohort 2||0
7685807|NCT01902173|18927793|P4|STARTED|Phase 1 Doublet Regimen Cohort 2||0
7685808|NCT01902173|18927794|P3|STARTED|Phase 1 Doublet Regimen Cohort 2||0
7685809|NCT01902173|18927795|P2|STARTED|Phase 1 Doublet Regimen Cohort 2||9
7685810|NCT01902173|18927796|P1|STARTED|Phase 1 Doublet Regimen Cohort 2||0
7685811|NCT01902173|18927791|P6|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
7685812|NCT01902173|18927792|P5|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
7685813|NCT01902173|18927793|P4|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
7685814|NCT01902173|18927794|P3|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
7685815|NCT01902173|18927795|P2|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
7685816|NCT01902173|18927796|P1|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||3
7685817|NCT01902173|18927791|P6|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
7685818|NCT01902173|18927792|P5|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
7685819|NCT01902173|18927793|P4|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
7685820|NCT01902173|18927794|P3|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
7685821|NCT01902173|18927795|P2|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
7685822|NCT01902173|18927796|P1|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
7685823|NCT01902173|18927791|P6|STARTED|Phase 1 Doublet Regimen Cohort 1||0
7685824|NCT01902173|18927792|P5|STARTED|Phase 1 Doublet Regimen Cohort 1||0
7685825|NCT01902173|18927793|P4|STARTED|Phase 1 Doublet Regimen Cohort 1||0
7685826|NCT01902173|18927794|P3|STARTED|Phase 1 Doublet Regimen Cohort 1||0
7685827|NCT01902173|18927795|P2|STARTED|Phase 1 Doublet Regimen Cohort 1||0
7685828|NCT01902173|18927796|P1|STARTED|Phase 1 Doublet Regimen Cohort 1||3
7685829|NCT01902134|18927819|P6|NOT COMPLETED|Overall Study||9
7685830|NCT01902134|18927820|P5|NOT COMPLETED|Overall Study||7
7685831|NCT01902134|18927821|P4|NOT COMPLETED|Overall Study||2
7685832|NCT01902134|18927822|P3|NOT COMPLETED|Overall Study||15
7685833|NCT01902134|18927823|P2|NOT COMPLETED|Overall Study||11
7685834|NCT01902134|18927824|P1|NOT COMPLETED|Overall Study||8
7685835|NCT01902134|18927819|P6|COMPLETED|Overall Study||45
7685836|NCT01902134|18927820|P5|COMPLETED|Overall Study||46
7685837|NCT01902134|18927821|P4|COMPLETED|Overall Study||52
7685838|NCT01902134|18927822|P3|COMPLETED|Overall Study||145
7685839|NCT01902134|18927823|P2|COMPLETED|Overall Study||150
7685840|NCT01902134|18927824|P1|COMPLETED|Overall Study||151
7685841|NCT01902134|18927819|P6|Multiple-dose Phase|Overall Study||52
7685842|NCT01902134|18927820|P5|Multiple-dose Phase|Overall Study||53
7685843|NCT01902134|18927821|P4|Multiple-dose Phase|Overall Study||54
7685844|NCT01902134|18927822|P3|Multiple-dose Phase|Overall Study||160
7685845|NCT01902134|18927823|P2|Multiple-dose Phase|Overall Study||160
7685846|NCT01902134|18927824|P1|Multiple-dose Phase|Overall Study||159
7685847|NCT01902134|18927819|P6|Single-dose Phase|Overall Study||54
7685848|NCT01902134|18927820|P5|Single-dose Phase|Overall Study||53
7685849|NCT01902134|18927821|P4|Single-dose Phase|Overall Study||54
7685850|NCT01902134|18927822|P3|Single-dose Phase|Overall Study||160
7685851|NCT01902134|18927823|P2|Single-dose Phase|Overall Study||161
7685852|NCT01902134|18927824|P1|Single-dose Phase|Overall Study||159
7685853|NCT01902134|18927819|P6|STARTED|Overall Study||54
7685854|NCT01902134|18927820|P5|STARTED|Overall Study||53
7685855|NCT01902134|18927821|P4|STARTED|Overall Study||54
7685856|NCT01902134|18927822|P3|STARTED|Overall Study||160
7685857|NCT01902134|18927823|P2|STARTED|Overall Study||161
7685858|NCT01902134|18927824|P1|STARTED|Overall Study||159
7685859|NCT01902004|18927848|P2|NOT COMPLETED|Overall Study||18
7685860|NCT01902004|18927849|P1|NOT COMPLETED|Overall Study||15
7685861|NCT01902004|18927848|P2|COMPLETED|Overall Study||29
7685862|NCT01902004|18927849|P1|COMPLETED|Overall Study||33
7685863|NCT01902004|18927848|P2|STARTED|Overall Study||47
7685864|NCT01902004|18927849|P1|STARTED|Overall Study||48
7685865|NCT01901874|18927861|P1|NOT COMPLETED|1-Year (365-Day) MAE Evaluation||20
7685866|NCT01901874|18927861|P1|COMPLETED|1-Year (365-Day) MAE Evaluation||244
7685867|NCT01901874|18927861|P1|STARTED|1-Year (365-Day) MAE Evaluation||264
7685868|NCT01901874|18927861|P1|NOT COMPLETED|30-Day MAE Evaluation||1
7685869|NCT01901874|18927861|P1|COMPLETED|30-Day MAE Evaluation||264
7685870|NCT01901874|18927861|P1|STARTED|30-Day MAE Evaluation||265
7685871|NCT01901874|18927861|P1|NOT COMPLETED|Screening Committee Retrospective Review||47
7685872|NCT01901874|18927861|P1|COMPLETED|Screening Committee Retrospective Review||265
7685873|NCT01901874|18927861|P1|STARTED|Screening Committee Retrospective Review||312
7685874|NCT01901874|18927861|P1|NOT COMPLETED|Procedure||0
7685875|NCT01901874|18927861|P1|COMPLETED|Procedure||312
7685876|NCT01901874|18927861|P1|STARTED|Procedure||312
7685877|NCT01901848|18927876|P2|NOT COMPLETED|Removed From Analyses||0
7685878|NCT01901848|18927877|P1|NOT COMPLETED|Removed From Analyses||10
7685879|NCT01901848|18927876|P2|COMPLETED|Removed From Analyses||19
7685880|NCT01901848|18927877|P1|COMPLETED|Removed From Analyses||12
7685881|NCT01901848|18927876|P2|STARTED|Removed From Analyses||19
7685882|NCT01901848|18927877|P1|STARTED|Removed From Analyses||22
7685883|NCT01901848|18927876|P2|NOT COMPLETED|Randomized and Treated||6
7685884|NCT01901848|18927877|P1|NOT COMPLETED|Randomized and Treated||3
7685885|NCT01901848|18927876|P2|COMPLETED|Randomized and Treated||19
7685886|NCT01901848|18927877|P1|COMPLETED|Randomized and Treated|Ten cases were practice cases used to establish fidelity to CPT, and were removed from analyses.|22
7685887|NCT01901848|18927876|P2|STARTED|Randomized and Treated||25
7685888|NCT01901848|18927877|P1|STARTED|Randomized and Treated||25
7685889|NCT01901809|18927889|P4|NOT COMPLETED|Overall Study||2
7685890|NCT01901809|18927890|P3|NOT COMPLETED|Overall Study||3
7685891|NCT01901809|18927891|P2|NOT COMPLETED|Overall Study||0
7685892|NCT01901809|18927892|P1|NOT COMPLETED|Overall Study||0
7685893|NCT01901809|18927889|P4|COMPLETED|Overall Study||22
7685894|NCT01901809|18927890|P3|COMPLETED|Overall Study||21
7685895|NCT01901809|18927891|P2|COMPLETED|Overall Study||23
7685896|NCT01901809|18927892|P1|COMPLETED|Overall Study||19
7685897|NCT01901809|18927889|P4|STARTED|Overall Study||24
7685898|NCT01901809|18927890|P3|STARTED|Overall Study||24
7685899|NCT01901809|18927891|P2|STARTED|Overall Study||23
7685900|NCT01901809|18927892|P1|STARTED|Overall Study||19
7685901|NCT01901653|18927919|P13|NOT COMPLETED|Overall Study||5
7685902|NCT01901653|18927920|P12|NOT COMPLETED|Overall Study||16
7685903|NCT01901653|18927921|P11|NOT COMPLETED|Overall Study||2
7685904|NCT01901653|18927922|P10|NOT COMPLETED|Overall Study||18
7685905|NCT01901653|18927923|P9|NOT COMPLETED|Overall Study||1
7685906|NCT01901653|18927924|P8|NOT COMPLETED|Overall Study||10
7685907|NCT01901653|18927925|P7|NOT COMPLETED|Overall Study||7
7685908|NCT01901653|18927926|P6|NOT COMPLETED|Overall Study||3
7685909|NCT01901653|18927927|P5|NOT COMPLETED|Overall Study||2
7685910|NCT01901653|18927928|P4|NOT COMPLETED|Overall Study||3
7685911|NCT01901653|18927929|P3|NOT COMPLETED|Overall Study||11
7685912|NCT01901653|18927930|P2|NOT COMPLETED|Overall Study||1
7685913|NCT01901653|18927931|P1|NOT COMPLETED|Overall Study||3
7685914|NCT01901653|18927919|P13|COMPLETED|Overall Study||0
7685915|NCT01901653|18927920|P12|COMPLETED|Overall Study||0
7685916|NCT01901653|18927921|P11|COMPLETED|Overall Study||0
7685917|NCT01901653|18927922|P10|COMPLETED|Overall Study||0
7685918|NCT01901653|18927923|P9|COMPLETED|Overall Study||0
7685919|NCT01901653|18927924|P8|COMPLETED|Overall Study||0
7685920|NCT01901653|18927925|P7|COMPLETED|Overall Study||0
7685921|NCT01901653|18927926|P6|COMPLETED|Overall Study||0
7685922|NCT01901653|18927927|P5|COMPLETED|Overall Study||0
7685923|NCT01901653|18927928|P4|COMPLETED|Overall Study||0
7685924|NCT01901653|18927929|P3|COMPLETED|Overall Study||0
7685925|NCT01901653|18927930|P2|COMPLETED|Overall Study||0
7685926|NCT01901653|18927931|P1|COMPLETED|Overall Study||0
7685927|NCT01901653|18927919|P13|STARTED|Overall Study||5
7685928|NCT01901653|18927920|P12|STARTED|Overall Study||16
7685929|NCT01901653|18927921|P11|STARTED|Overall Study||2
7685930|NCT01901653|18927922|P10|STARTED|Overall Study||18
7685931|NCT01901653|18927923|P9|STARTED|Overall Study||1
7685932|NCT01901653|18927924|P8|STARTED|Overall Study||10
7685933|NCT01901653|18927925|P7|STARTED|Overall Study||7
7685934|NCT01901653|18927926|P6|STARTED|Overall Study||3
7685935|NCT01901653|18927927|P5|STARTED|Overall Study||2
7685936|NCT01901653|18927928|P4|STARTED|Overall Study||3
7685937|NCT01901653|18927929|P3|STARTED|Overall Study||11
7685938|NCT01901653|18927930|P2|STARTED|Overall Study||1
7685939|NCT01901653|18927931|P1|STARTED|Overall Study||3
7685940|NCT01901614|18927975|P2|NOT COMPLETED|Overall Study||1
7685941|NCT01901614|18927976|P1|NOT COMPLETED|Overall Study||2
7685942|NCT01901614|18927975|P2|COMPLETED|Overall Study||1
7685943|NCT01901614|18927976|P1|COMPLETED|Overall Study||1
7685944|NCT01901614|18927975|P2|STARTED|Overall Study||2
7685945|NCT01901614|18927976|P1|STARTED|Overall Study||3
7685946|NCT01901588|18927984|P2|NOT COMPLETED|Overall Study||0
7685947|NCT01901588|18927985|P1|NOT COMPLETED|Overall Study||0
7685948|NCT01901588|18927984|P2|COMPLETED|Overall Study||31
7685949|NCT01901588|18927985|P1|COMPLETED|Overall Study||32
7685950|NCT01901588|18927984|P2|STARTED|Overall Study||31
7685951|NCT01901588|18927985|P1|STARTED|Overall Study||32
7685952|NCT01901575|18928001|P1|NOT COMPLETED|Overall Study||0
7685953|NCT01901575|18928001|P1|COMPLETED|Overall Study||16
7685954|NCT01901575|18928001|P1|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16
7685955|NCT01901432|18928011|P5|NOT COMPLETED|Overall Study||9
7685956|NCT01901432|18928012|P4|NOT COMPLETED|Overall Study||0
7685957|NCT01901432|18928013|P3|NOT COMPLETED|Overall Study||2
7685958|NCT01901432|18928014|P2|NOT COMPLETED|Overall Study||1
7685959|NCT01901432|18928015|P1|NOT COMPLETED|Overall Study||0
7685960|NCT01901432|18928011|P5|COMPLETED|Overall Study||27
7685961|NCT01901432|18928012|P4|COMPLETED|Overall Study||3
7685962|NCT01901432|18928013|P3|COMPLETED|Overall Study||1
7685963|NCT01901432|18928014|P2|COMPLETED|Overall Study||2
7685964|NCT01901432|18928015|P1|COMPLETED|Overall Study||3
7685965|NCT01901432|18928011|P5|Received Study Drug|Overall Study||35
7685966|NCT01901432|18928012|P4|Received Study Drug|Overall Study||3
7685967|NCT01901432|18928013|P3|Received Study Drug|Overall Study||3
7685968|NCT01901432|18928014|P2|Received Study Drug|Overall Study||3
7685969|NCT01901432|18928015|P1|Received Study Drug|Overall Study||3
7685970|NCT01901432|18928011|P5|STARTED|Overall Study||36
7685971|NCT01901432|18928012|P4|STARTED|Overall Study||3
7685972|NCT01901432|18928013|P3|STARTED|Overall Study||3
7685973|NCT01901432|18928014|P2|STARTED|Overall Study||3
7685974|NCT01901432|18928015|P1|STARTED|Overall Study||3
7685975|NCT01901419|18928067|P2|NOT COMPLETED|Overall Study||9
7685976|NCT01901419|18928068|P1|NOT COMPLETED|Overall Study||8
7685977|NCT01901419|18928067|P2|COMPLETED|Overall Study||31
7685978|NCT01901419|18928068|P1|COMPLETED|Overall Study||32
7685979|NCT01901419|18928067|P2|STARTED|Overall Study||40
7685980|NCT01901419|18928068|P1|STARTED|Overall Study||40
7685981|NCT01901393|18928134|P2|NOT COMPLETED|Overall Study||0
7685982|NCT01901393|18928135|P1|NOT COMPLETED|Overall Study||1
7685983|NCT01901393|18928134|P2|COMPLETED|Overall Study||49
7685984|NCT01901393|18928135|P1|COMPLETED|Overall Study||50
7685985|NCT01901393|18928134|P2|STARTED|Overall Study||49
7685986|NCT01901393|18928135|P1|STARTED|Overall Study||51
7685987|NCT01901341|18928153|P2|NOT COMPLETED|Overall Study||21
7685988|NCT01901341|18928154|P1|NOT COMPLETED|Overall Study||20
7685989|NCT01901341|18928153|P2|COMPLETED|Overall Study||1
7685990|NCT01901341|18928154|P1|COMPLETED|Overall Study||2
7685991|NCT01901341|18928153|P2|Received at Least 1 Dose of Study Drug|Overall Study||22
7685992|NCT01901341|18928154|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
7685993|NCT01901341|18928153|P2|STARTED|Overall Study||22
7685994|NCT01901341|18928154|P1|STARTED|Overall Study||22
7685995|NCT01901328|18928168|P2|NOT COMPLETED|Overall Study||21
7685996|NCT01901328|18928169|P1|NOT COMPLETED|Overall Study||22
7685997|NCT01901328|18928168|P2|COMPLETED|Overall Study||2
7685998|NCT01901328|18928169|P1|COMPLETED|Overall Study||4
7685999|NCT01901328|18928168|P2|Received at Least 1 Dose of Study Drug|Overall Study||23
7686000|NCT01901328|18928169|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
7686001|NCT01901328|18928168|P2|STARTED|Overall Study||23
7686002|NCT01901328|18928169|P1|STARTED|Overall Study||26
7686003|NCT01901302|18928183|P2|NOT COMPLETED|Overall Study||23
7686004|NCT01901302|18928184|P1|NOT COMPLETED|Overall Study||27
7686005|NCT01901302|18928183|P2|COMPLETED|Overall Study||7
7686006|NCT01901302|18928184|P1|COMPLETED|Overall Study||4
7686007|NCT01901302|18928183|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
7686008|NCT01901302|18928184|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
7686009|NCT01901302|18928183|P2|STARTED|Overall Study||30
7686010|NCT01901302|18928184|P1|STARTED|Overall Study||31
7686011|NCT01901289|18928196|P1|NOT COMPLETED|Overall Study||200
7686012|NCT01901289|18928196|P1|COMPLETED|Overall Study||0
7686013|NCT01901289|18928196|P1|12-Month Follow-up|Overall Study||175
7686014|NCT01901289|18928196|P1|STARTED|Overall Study||200
7686015|NCT01901250|18928202|P2|NOT COMPLETED|Overall Study||126
7686016|NCT01901250|18928203|P1|NOT COMPLETED|Overall Study||138
7686017|NCT01901250|18928202|P2|COMPLETED|Overall Study||139
7686018|NCT01901250|18928203|P1|COMPLETED|Overall Study||122
7686019|NCT01901250|18928202|P2|End of 1st Grade|Overall Study||151
7686020|NCT01901250|18928203|P1|End of 1st Grade|Overall Study||143
7686021|NCT01901250|18928202|P2|Start of 1st Grade|Overall Study||176
7686022|NCT01901250|18928203|P1|Start of 1st Grade|Overall Study||173
7686023|NCT01901250|18928202|P2|End of Kidergarten|Overall Study||212
7686024|NCT01901250|18928203|P1|End of Kidergarten|Overall Study||215
7686025|NCT01901250|18928202|P2|STARTED|Overall Study||265
7686026|NCT01901250|18928203|P1|STARTED|Overall Study||260
7686027|NCT01901224|18928209|P1|NOT COMPLETED|Overall Study||2
7686028|NCT01901224|18928209|P1|COMPLETED|Overall Study||0
7686029|NCT01901224|18928209|P1|STARTED|Overall Study||2
7686030|NCT01901211|18928220|P2|NOT COMPLETED|Second Ten-week Period||0
7686031|NCT01901211|18928221|P1|NOT COMPLETED|Second Ten-week Period||0
7686032|NCT01901211|18928220|P2|COMPLETED|Second Ten-week Period||5
7686033|NCT01901211|18928221|P1|COMPLETED|Second Ten-week Period||6
7686034|NCT01901211|18928220|P2|STARTED|Second Ten-week Period||5
7686035|NCT01901211|18928221|P1|STARTED|Second Ten-week Period||6
7686036|NCT01901211|18928220|P2|NOT COMPLETED|Washout (6 Weeks)||0
7686037|NCT01901211|18928221|P1|NOT COMPLETED|Washout (6 Weeks)||0
7686038|NCT01901211|18928220|P2|COMPLETED|Washout (6 Weeks)||5
7686039|NCT01901211|18928221|P1|COMPLETED|Washout (6 Weeks)||6
7686040|NCT01901211|18928220|P2|STARTED|Washout (6 Weeks)||5
7686041|NCT01901211|18928221|P1|STARTED|Washout (6 Weeks)||6
7686042|NCT01901211|18928220|P2|NOT COMPLETED|First Ten-week Period||0
7686043|NCT01901211|18928221|P1|NOT COMPLETED|First Ten-week Period||0
7686044|NCT01901211|18928220|P2|COMPLETED|First Ten-week Period||5
7686045|NCT01901211|18928221|P1|COMPLETED|First Ten-week Period||6
7686046|NCT01901211|18928220|P2|STARTED|First Ten-week Period||5
7686047|NCT01901211|18928221|P1|STARTED|First Ten-week Period||6
7686048|NCT01901185|18928244|P1|NOT COMPLETED|Overall Study||2
7686049|NCT01901185|18928244|P1|COMPLETED|Overall Study||75
7686050|NCT01901185|18928244|P1|Received Etanercept With Autoinjector A|Overall Study||75
7686051|NCT01901185|18928244|P1|STARTED|Overall Study||77
7686052|NCT01901146|18928253|P5|NOT COMPLETED|Adjuvant Phase||14
7686053|NCT01901146|18928254|P4|NOT COMPLETED|Adjuvant Phase||7
7686054|NCT01901146|18928255|P3|NOT COMPLETED|Adjuvant Phase||26
7686055|NCT01901146|18928256|P2|NOT COMPLETED|Adjuvant Phase||0
7686056|NCT01901146|18928257|P1|NOT COMPLETED|Adjuvant Phase||0
7686057|NCT01901146|18928253|P5|COMPLETED|Adjuvant Phase||157
7686058|NCT01901146|18928254|P4|COMPLETED|Adjuvant Phase||164
7686059|NCT01901146|18928255|P3|COMPLETED|Adjuvant Phase||323
7686060|NCT01901146|18928256|P2|COMPLETED|Adjuvant Phase||0
7686061|NCT01901146|18928257|P1|COMPLETED|Adjuvant Phase||0
7686062|NCT01901146|18928253|P5|STARTED|Adjuvant Phase|Three participants discontinued the study after surgery but before entering adjuvant phase.|171
7686063|NCT01901146|18928254|P4|STARTED|Adjuvant Phase|Two participants discontinued the study after surgery but before entering adjuvant phase.|171
7686064|NCT01901146|18928255|P3|STARTED|Adjuvant Phase|Nine participants discontinued the study after surgery but before entering adjuvant phase.|349
7686065|NCT01901146|18928256|P2|STARTED|Adjuvant Phase||0
7686066|NCT01901146|18928257|P1|STARTED|Adjuvant Phase||0
7686067|NCT01901146|18928253|P5|NOT COMPLETED|Neoadjuvant Phase||0
7686068|NCT01901146|18928254|P4|NOT COMPLETED|Neoadjuvant Phase||0
7686069|NCT01901146|18928255|P3|NOT COMPLETED|Neoadjuvant Phase||0
7686070|NCT01901146|18928256|P2|NOT COMPLETED|Neoadjuvant Phase||14
7686071|NCT01901146|18928257|P1|NOT COMPLETED|Neoadjuvant Phase||6
7686072|NCT01901146|18928253|P5|COMPLETED|Neoadjuvant Phase||0
7686073|NCT01901146|18928254|P4|COMPLETED|Neoadjuvant Phase||0
7686074|NCT01901146|18928255|P3|COMPLETED|Neoadjuvant Phase||0
7686075|NCT01901146|18928256|P2|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|347
7686076|NCT01901146|18928257|P1|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|358
7686077|NCT01901146|18928253|P5|STARTED|Neoadjuvant Phase||0
7686078|NCT01901146|18928254|P4|STARTED|Neoadjuvant Phase||0
7686079|NCT01901146|18928255|P3|STARTED|Neoadjuvant Phase||0
7686080|NCT01901146|18928256|P2|STARTED|Neoadjuvant Phase||361
7686081|NCT01901146|18928257|P1|STARTED|Neoadjuvant Phase||364
7686082|NCT01900899|18928272|P2|NOT COMPLETED|Overall Study||1
7686083|NCT01900899|18928273|P1|NOT COMPLETED|Overall Study||9
7686084|NCT01900899|18928272|P2|COMPLETED|Overall Study||24
7686085|NCT01900899|18928273|P1|COMPLETED|Overall Study||150
7686086|NCT01900899|18928272|P2|STARTED|Overall Study||25
7686087|NCT01900899|18928273|P1|STARTED|Overall Study||159
7686088|NCT01900730|18928299|P2|NOT COMPLETED|Overall Study||0
7686089|NCT01900730|18928300|P1|NOT COMPLETED|Overall Study||2
7686090|NCT01900730|18928299|P2|COMPLETED|Overall Study||0
7686091|NCT01900730|18928300|P1|COMPLETED|Overall Study||1
7686092|NCT01900730|18928299|P2|STARTED|Overall Study||0
7686093|NCT01900730|18928300|P1|STARTED|Overall Study||3
7686094|NCT01900704|18928309|P3|NOT COMPLETED|Overall Study||33
7686095|NCT01900704|18928310|P2|NOT COMPLETED|Overall Study||35
7686096|NCT01900704|18928311|P1|NOT COMPLETED|Overall Study||41
7686097|NCT01900704|18928309|P3|COMPLETED|Overall Study||237
7686098|NCT01900704|18928310|P2|COMPLETED|Overall Study||235
7686099|NCT01900704|18928311|P1|COMPLETED|Overall Study||229
7686100|NCT01900704|18928309|P3|STARTED|Overall Study||270
7686101|NCT01900704|18928310|P2|STARTED|Overall Study||270
7686102|NCT01900704|18928311|P1|STARTED|Overall Study||270
7686103|NCT01900665|18928324|P2|NOT COMPLETED|Open Label Period||859
7686104|NCT01900665|18928325|P1|NOT COMPLETED|Open Label Period||881
7686105|NCT01900665|18928324|P2|COMPLETED|Open Label Period||0
7686106|NCT01900665|18928325|P1|COMPLETED|Open Label Period||0
7686107|NCT01900665|18928324|P2|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|859
7686108|NCT01900665|18928325|P1|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|881
7686109|NCT01900665|18928324|P2|NOT COMPLETED|Placebo Controlled Period||164
7686110|NCT01900665|18928325|P1|NOT COMPLETED|Placebo Controlled Period||143
7686111|NCT01900665|18928324|P2|COMPLETED|Placebo Controlled Period||908
7686112|NCT01900665|18928325|P1|COMPLETED|Placebo Controlled Period||914
7686113|NCT01900665|18928324|P2|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1067
7686114|NCT01900665|18928325|P1|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1054
7686115|NCT01900665|18928324|P2|STARTED|Placebo Controlled Period||1072
7686116|NCT01900665|18928325|P1|STARTED|Placebo Controlled Period||1057
7686117|NCT01900652|18928368|P2|NOT COMPLETED|Overall Study||3
7686118|NCT01900652|18928369|P1|NOT COMPLETED|Overall Study||8
7686119|NCT01900652|18928368|P2|COMPLETED|Overall Study||25
7686120|NCT01900652|18928369|P1|COMPLETED|Overall Study||75
7686121|NCT01900652|18928368|P2|Post-Erlotinib Progression Tumor Sample|Overall Study||23
7686122|NCT01900652|18928369|P1|Post-Erlotinib Progression Tumor Sample|Overall Study||66
7686123|NCT01900652|18928368|P2|STARTED|Overall Study||28
7686124|NCT01900652|18928369|P1|STARTED|Overall Study||83
7686125|NCT01900626|18928405|P2|NOT COMPLETED|Overall Study||1
7686126|NCT01900626|18928406|P1|NOT COMPLETED|Overall Study||1
7686127|NCT01900626|18928405|P2|COMPLETED|Overall Study||0
7686128|NCT01900626|18928406|P1|COMPLETED|Overall Study||0
7686129|NCT01900626|18928405|P2|STARTED|Overall Study||1
7686130|NCT01900626|18928406|P1|STARTED|Overall Study||1
7686131|NCT01900561|18928424|P2|NOT COMPLETED|Overall Study||9
7686132|NCT01900561|18928425|P1|NOT COMPLETED|Overall Study||17
7686133|NCT01900561|18928424|P2|COMPLETED|Overall Study||269
7686134|NCT01900561|18928425|P1|COMPLETED|Overall Study||261
7686135|NCT01900561|18928424|P2|STARTED|Overall Study||278
7686136|NCT01900561|18928425|P1|STARTED|Overall Study||278
7686137|NCT01900444|18928485|P1|NOT COMPLETED|Overall Study||3
7686138|NCT01900444|18928485|P1|COMPLETED|Overall Study||116
7686139|NCT01900444|18928485|P1|STARTED|Overall Study||119
7686140|NCT01900431|18928498|P3|NOT COMPLETED|Open-Label Treatment Period (Part C)||8
7686141|NCT01900431|18928499|P2|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
7686142|NCT01900431|18928500|P1|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
7686143|NCT01900431|18928498|P3|COMPLETED|Open-Label Treatment Period (Part C)||13
7686144|NCT01900431|18928499|P2|COMPLETED|Open-Label Treatment Period (Part C)||0
7686145|NCT01900431|18928500|P1|COMPLETED|Open-Label Treatment Period (Part C)||0
7686146|NCT01900431|18928498|P3|STARTED|Open-Label Treatment Period (Part C)|10 non-responders (5 Placebo, 5 Sarilumab) & 11 non-completers (6 Placebo, 5 Sarilumab) from Part A.|21
7686147|NCT01900431|18928499|P2|STARTED|Open-Label Treatment Period (Part C)||0
7686148|NCT01900431|18928500|P1|STARTED|Open-Label Treatment Period (Part C)||0
7686149|NCT01900431|18928498|P3|NOT COMPLETED|Extended Treatment Period (Part B)||0
7686150|NCT01900431|18928499|P2|NOT COMPLETED|Extended Treatment Period (Part B)||10
7686151|NCT01900431|18928500|P1|NOT COMPLETED|Extended Treatment Period (Part B)||1
7686152|NCT01900431|18928498|P3|COMPLETED|Extended Treatment Period (Part B)||0
7686153|NCT01900431|18928499|P2|COMPLETED|Extended Treatment Period (Part B)||12
7686154|NCT01900431|18928500|P1|COMPLETED|Extended Treatment Period (Part B)||7
7686155|NCT01900431|18928498|P3|STARTED|Extended Treatment Period (Part B)||0
7686156|NCT01900431|18928499|P2|STARTED|Extended Treatment Period (Part B)||22
7686157|NCT01900431|18928500|P1|STARTED|Extended Treatment Period (Part B)||8
7686158|NCT01900431|18928498|P3|NOT COMPLETED|Principal Treatment Period (Part A)||0
7686159|NCT01900431|18928499|P2|NOT COMPLETED|Principal Treatment Period (Part A)||10
7686160|NCT01900431|18928500|P1|NOT COMPLETED|Principal Treatment Period (Part A)||7
7686161|NCT01900431|18928498|P3|COMPLETED|Principal Treatment Period (Part A)||0
7686162|NCT01900431|18928499|P2|COMPLETED|Principal Treatment Period (Part A)|22 responders entered Part B, 5 non-responders entered Part C, 1 discontinued the study.|28
7686163|NCT01900431|18928500|P1|COMPLETED|Principal Treatment Period (Part A)|8 responders entered Part B and 5 non-responders entered Part C.|13
7686164|NCT01900431|18928498|P3|STARTED|Principal Treatment Period (Part A)||0
7686165|NCT01900431|18928499|P2|STARTED|Principal Treatment Period (Part A)||38
7686166|NCT01900431|18928500|P1|STARTED|Principal Treatment Period (Part A)||20
7686167|NCT01900392|18928527|P3|NOT COMPLETED|Overall Study||0
7686168|NCT01900392|18928528|P2|NOT COMPLETED|Overall Study||1
7686169|NCT01900392|18928529|P1|NOT COMPLETED|Overall Study||1
7686170|NCT01900392|18928527|P3|COMPLETED|Overall Study||77
7686171|NCT01900392|18928528|P2|COMPLETED|Overall Study||74
7686172|NCT01900392|18928529|P1|COMPLETED|Overall Study||38
7686173|NCT01900392|18928527|P3|STARTED|Overall Study||77
7686174|NCT01900392|18928528|P2|STARTED|Overall Study||75
7686175|NCT01900392|18928529|P1|STARTED|Overall Study||39
7686176|NCT01900314|18928542|P2|NOT COMPLETED|Overall Study||4
7686177|NCT01900314|18928543|P1|NOT COMPLETED|Overall Study||4
7686178|NCT01900314|18928542|P2|COMPLETED|Overall Study|1 patient had 4 TMS Tx, but missed too many for protocol requirements,|16
7686179|NCT01900314|18928543|P1|COMPLETED|Overall Study|1 patient had MRI, then moved away after 5 TMS treatments|16
7686180|NCT01900314|18928542|P2|Completed MRI#1|Overall Study|2 withdrew consent, 1 patient was unable to tolerate MRI|17
7686181|NCT01900314|18928543|P1|Completed MRI#1|Overall Study|2 withdrew consent prior to MRI, 1 had MRI technical failure|17
7686182|NCT01900314|18928542|P2|STARTED|Overall Study||20
7686183|NCT01900314|18928543|P1|STARTED|Overall Study||20
7686184|NCT01900249|18928554|P3|NOT COMPLETED|Overall Study||4
7686185|NCT01900249|18928555|P2|NOT COMPLETED|Overall Study||5
7686186|NCT01900249|18928556|P1|NOT COMPLETED|Overall Study||3
7686187|NCT01900249|18928554|P3|COMPLETED|Overall Study||65
7686188|NCT01900249|18928555|P2|COMPLETED|Overall Study||63
7686189|NCT01900249|18928556|P1|COMPLETED|Overall Study||64
7686190|NCT01900249|18928554|P3|STARTED|Overall Study||69
7686191|NCT01900249|18928555|P2|STARTED|Overall Study||68
7686192|NCT01900249|18928556|P1|STARTED|Overall Study||67
7686193|NCT01900067|18928566|P2|NOT COMPLETED|Overall Study||13
7686194|NCT01900067|18928567|P1|NOT COMPLETED|Overall Study||12
7686195|NCT01900067|18928566|P2|COMPLETED|Overall Study||124
7686196|NCT01900067|18928567|P1|COMPLETED|Overall Study||122
7686197|NCT01900067|18928566|P2|STARTED|Overall Study||137
7686198|NCT01900067|18928567|P1|STARTED|Overall Study||134
7686199|NCT01900054|18928573|P1|NOT COMPLETED|Overall Study||2
7686200|NCT01900054|18928573|P1|COMPLETED|Overall Study||56
7686201|NCT01900054|18928573|P1|STARTED|Overall Study||58
7686202|NCT01899911|18928578|P1|NOT COMPLETED|Overall Study||0
7686203|NCT01899911|18928578|P1|COMPLETED|Overall Study||12
7686204|NCT01899911|18928578|P1|STARTED|Overall Study||12
7686205|NCT01899768|18928582|P1|NOT COMPLETED|Part C||0
7686206|NCT01899768|18928582|P1|COMPLETED|Part C||11
7686207|NCT01899768|18928582|P1|STARTED|Part C||11
7686208|NCT01899768|18928582|P1|NOT COMPLETED|Part B||2
7686209|NCT01899768|18928582|P1|COMPLETED|Part B||11
7686210|NCT01899768|18928582|P1|STARTED|Part B||13
7686211|NCT01899768|18928582|P1|NOT COMPLETED|Part A||3
7686212|NCT01899768|18928582|P1|COMPLETED|Part A||13
7686213|NCT01899768|18928582|P1|STARTED|Part A||16
7686214|NCT01899742|18928656|P2|NOT COMPLETED|Overall Study||16
7686215|NCT01899742|18928657|P1|NOT COMPLETED|Overall Study||17
7686216|NCT01899742|18928656|P2|COMPLETED|Overall Study||231
7686217|NCT01899742|18928657|P1|COMPLETED|Overall Study||230
7686218|NCT01899742|18928656|P2|STARTED|Overall Study||247
7686219|NCT01899742|18928657|P1|STARTED|Overall Study||247
7686220|NCT01899729|18928670|P5|NOT COMPLETED|Overall Study||2
7686221|NCT01899729|18928671|P4|NOT COMPLETED|Overall Study||0
7686222|NCT01899729|18928672|P3|NOT COMPLETED|Overall Study||2
7686223|NCT01899729|18928673|P2|NOT COMPLETED|Overall Study||2
7686224|NCT01899729|18928674|P1|NOT COMPLETED|Overall Study||2
7686225|NCT01899729|18928670|P5|COMPLETED|Overall Study||9
7686226|NCT01899729|18928671|P4|COMPLETED|Overall Study||9
7686227|NCT01899729|18928672|P3|COMPLETED|Overall Study||6
7686228|NCT01899729|18928673|P2|COMPLETED|Overall Study||7
7686229|NCT01899729|18928674|P1|COMPLETED|Overall Study||7
7686230|NCT01899729|18928670|P5|STARTED|Overall Study||11
7686231|NCT01899729|18928671|P4|STARTED|Overall Study||9
7686232|NCT01899729|18928672|P3|STARTED|Overall Study||8
7686233|NCT01899729|18928673|P2|STARTED|Overall Study||9
7686234|NCT01899729|18928674|P1|STARTED|Overall Study||9
7686235|NCT01899677|18928688|P2|NOT COMPLETED|Overall Study||7
7686236|NCT01899677|18928689|P1|NOT COMPLETED|Overall Study||10
7686237|NCT01899677|18928688|P2|COMPLETED|Overall Study||28
7686238|NCT01899677|18928689|P1|COMPLETED|Overall Study||25
7686239|NCT01899677|18928688|P2|STARTED|Overall Study||35
7686240|NCT01899677|18928689|P1|STARTED|Overall Study||35
7686241|NCT01899261|18928717|P1|NOT COMPLETED|Overall Study||0
7686242|NCT01899261|18928717|P1|COMPLETED|Overall Study||20
7686243|NCT01899261|18928717|P1|STARTED|Overall Study||20
7686244|NCT01899144|18928721|P1|NOT COMPLETED|Treatment Period 5||1
7686245|NCT01899144|18928721|P1|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57
7686246|NCT01899144|18928721|P1|STARTED|Treatment Period 5||58
7686247|NCT01899144|18928721|P1|NOT COMPLETED|Treatment Period 4||0
7686248|NCT01899144|18928721|P1|COMPLETED|Treatment Period 4||58
7686249|NCT01899144|18928721|P1|STARTED|Treatment Period 4||58
7686250|NCT01899144|18928721|P1|NOT COMPLETED|Treatment Period 3||2
7686251|NCT01899144|18928721|P1|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58
7686252|NCT01899144|18928721|P1|STARTED|Treatment Period 3||60
7686253|NCT01899144|18928721|P1|NOT COMPLETED|Treatment Period 2||1
7686254|NCT01899144|18928721|P1|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60
7686255|NCT01899144|18928721|P1|STARTED|Treatment Period 2||61
7686256|NCT01899144|18928721|P1|NOT COMPLETED|Treatment Period 1||0
7686257|NCT01899144|18928721|P1|COMPLETED|Treatment Period 1||61
7686258|NCT01899144|18928721|P1|STARTED|Treatment Period 1||61
7686259|NCT01899053|18928757|P14|NOT COMPLETED|Overall Study||20
7686260|NCT01899053|18928758|P13|NOT COMPLETED|Overall Study||14
7686261|NCT01899053|18928759|P12|NOT COMPLETED|Overall Study||7
7686262|NCT01899053|18928760|P11|NOT COMPLETED|Overall Study||16
7686263|NCT01899053|18928761|P10|NOT COMPLETED|Overall Study||3
7686264|NCT01899053|18928762|P9|NOT COMPLETED|Overall Study||6
7686265|NCT01899053|18928763|P8|NOT COMPLETED|Overall Study||3
7686266|NCT01899053|18928764|P7|NOT COMPLETED|Overall Study||3
7686267|NCT01899053|18928765|P6|NOT COMPLETED|Overall Study||3
7686268|NCT01899053|18928766|P5|NOT COMPLETED|Overall Study||6
7686269|NCT01899053|18928767|P4|NOT COMPLETED|Overall Study||3
7686270|NCT01899053|18928768|P3|NOT COMPLETED|Overall Study||7
7686271|NCT01899053|18928769|P2|NOT COMPLETED|Overall Study||3
7686272|NCT01899053|18928770|P1|NOT COMPLETED|Overall Study||7
7686273|NCT01899053|18928757|P14|COMPLETED|Overall Study||0
7686274|NCT01899053|18928758|P13|COMPLETED|Overall Study||0
7686275|NCT01899053|18928759|P12|COMPLETED|Overall Study||0
7686276|NCT01899053|18928760|P11|COMPLETED|Overall Study||0
7686277|NCT01899053|18928761|P10|COMPLETED|Overall Study||0
7686278|NCT01899053|18928762|P9|COMPLETED|Overall Study||0
7686279|NCT01899053|18928763|P8|COMPLETED|Overall Study||0
7686280|NCT01899053|18928764|P7|COMPLETED|Overall Study||0
7686281|NCT01899053|18928765|P6|COMPLETED|Overall Study||0
7686282|NCT01899053|18928766|P5|COMPLETED|Overall Study||0
7686283|NCT01899053|18928767|P4|COMPLETED|Overall Study||0
7686284|NCT01899053|18928768|P3|COMPLETED|Overall Study||0
7686285|NCT01899053|18928769|P2|COMPLETED|Overall Study||0
7686286|NCT01899053|18928770|P1|COMPLETED|Overall Study||0
7686287|NCT01899053|18928757|P14|STARTED|Overall Study||20
7686288|NCT01899053|18928758|P13|STARTED|Overall Study||14
7686289|NCT01899053|18928759|P12|STARTED|Overall Study||7
7686290|NCT01899053|18928760|P11|STARTED|Overall Study||16
7686291|NCT01899053|18928761|P10|STARTED|Overall Study||3
7686292|NCT01899053|18928762|P9|STARTED|Overall Study||6
7686293|NCT01899053|18928763|P8|STARTED|Overall Study||3
7686294|NCT01899053|18928764|P7|STARTED|Overall Study||3
7686295|NCT01899053|18928765|P6|STARTED|Overall Study||3
7686296|NCT01899053|18928766|P5|STARTED|Overall Study||6
7686297|NCT01899053|18928767|P4|STARTED|Overall Study||3
7686298|NCT01899053|18928768|P3|STARTED|Overall Study||7
7686299|NCT01899053|18928769|P2|STARTED|Overall Study||3
7686300|NCT01899053|18928770|P1|STARTED|Overall Study||7
7686301|NCT01898884|18929027|P9|NOT COMPLETED|Multiple Dose Period||1
7686302|NCT01898884|18929028|P8|NOT COMPLETED|Multiple Dose Period||0
7686303|NCT01898884|18929029|P7|NOT COMPLETED|Multiple Dose Period||1
7686304|NCT01898884|18929030|P6|NOT COMPLETED|Multiple Dose Period||0
7686305|NCT01898884|18929031|P5|NOT COMPLETED|Multiple Dose Period||0
7686306|NCT01898884|18929032|P4|NOT COMPLETED|Multiple Dose Period||0
7686307|NCT01898884|18929033|P3|NOT COMPLETED|Multiple Dose Period||0
7686308|NCT01898884|18929034|P2|NOT COMPLETED|Multiple Dose Period||0
7686309|NCT01898884|18929035|P1|NOT COMPLETED|Multiple Dose Period||0
7686310|NCT01898884|18929027|P9|COMPLETED|Multiple Dose Period||5
7686311|NCT01898884|18929028|P8|COMPLETED|Multiple Dose Period||6
7686312|NCT01898884|18929029|P7|COMPLETED|Multiple Dose Period||5
7686313|NCT01898884|18929030|P6|COMPLETED|Multiple Dose Period||6
7686314|NCT01898884|18929031|P5|COMPLETED|Multiple Dose Period||0
7686315|NCT01898884|18929032|P4|COMPLETED|Multiple Dose Period||0
7686316|NCT01898884|18929033|P3|COMPLETED|Multiple Dose Period||0
7686317|NCT01898884|18929034|P2|COMPLETED|Multiple Dose Period||0
7686318|NCT01898884|18929035|P1|COMPLETED|Multiple Dose Period||0
7686319|NCT01898884|18929027|P9|Treated|Multiple Dose Period||5
7686320|NCT01898884|18929028|P8|Treated|Multiple Dose Period||6
7686321|NCT01898884|18929029|P7|Treated|Multiple Dose Period||6
7686322|NCT01898884|18929030|P6|Treated|Multiple Dose Period||6
7686323|NCT01898884|18929031|P5|Treated|Multiple Dose Period||0
7686324|NCT01898884|18929032|P4|Treated|Multiple Dose Period||0
7686325|NCT01898884|18929033|P3|Treated|Multiple Dose Period||0
7686326|NCT01898884|18929034|P2|Treated|Multiple Dose Period||0
7686327|NCT01898884|18929035|P1|Treated|Multiple Dose Period||0
7686328|NCT01898884|18929027|P9|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
7686329|NCT01898884|18929028|P8|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
7686330|NCT01898884|18929029|P7|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
7686331|NCT01898884|18929030|P6|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
7686332|NCT01898884|18929031|P5|STARTED|Multiple Dose Period||0
7686333|NCT01898884|18929032|P4|STARTED|Multiple Dose Period||0
7686334|NCT01898884|18929033|P3|STARTED|Multiple Dose Period||0
7686335|NCT01898884|18929034|P2|STARTED|Multiple Dose Period||0
7686336|NCT01898884|18929035|P1|STARTED|Multiple Dose Period||0
7686337|NCT01898884|18929027|P9|NOT COMPLETED|Single Dose Period||0
7686338|NCT01898884|18929028|P8|NOT COMPLETED|Single Dose Period||0
7686339|NCT01898884|18929029|P7|NOT COMPLETED|Single Dose Period||0
7686340|NCT01898884|18929030|P6|NOT COMPLETED|Single Dose Period||0
7686341|NCT01898884|18929031|P5|NOT COMPLETED|Single Dose Period||0
7686342|NCT01898884|18929032|P4|NOT COMPLETED|Single Dose Period||0
7686343|NCT01898884|18929033|P3|NOT COMPLETED|Single Dose Period||0
7686344|NCT01898884|18929034|P2|NOT COMPLETED|Single Dose Period||0
7686345|NCT01898884|18929035|P1|NOT COMPLETED|Single Dose Period||0
7686346|NCT01898884|18929027|P9|COMPLETED|Single Dose Period||0
7686347|NCT01898884|18929028|P8|COMPLETED|Single Dose Period||0
7686348|NCT01898884|18929029|P7|COMPLETED|Single Dose Period||0
7686349|NCT01898884|18929030|P6|COMPLETED|Single Dose Period||0
7686350|NCT01898884|18929031|P5|COMPLETED|Single Dose Period||6
7686351|NCT01898884|18929032|P4|COMPLETED|Single Dose Period||6
7686352|NCT01898884|18929033|P3|COMPLETED|Single Dose Period||6
7686353|NCT01898884|18929034|P2|COMPLETED|Single Dose Period||6
7686354|NCT01898884|18929035|P1|COMPLETED|Single Dose Period||8
7686355|NCT01898884|18929027|P9|STARTED|Single Dose Period||0
7686356|NCT01898884|18929028|P8|STARTED|Single Dose Period||0
7686357|NCT01898884|18929029|P7|STARTED|Single Dose Period||0
7686358|NCT01898884|18929030|P6|STARTED|Single Dose Period||0
7686359|NCT01898884|18929031|P5|STARTED|Single Dose Period||6
7686360|NCT01898884|18929032|P4|STARTED|Single Dose Period||6
7686361|NCT01898884|18929033|P3|STARTED|Single Dose Period||6
7686362|NCT01898884|18929034|P2|STARTED|Single Dose Period||6
7686363|NCT01898884|18929035|P1|STARTED|Single Dose Period||8
7686364|NCT01898806|18929185|P1|NOT COMPLETED|Overall Study||3
7686365|NCT01898806|18929185|P1|COMPLETED|Overall Study||8
7686366|NCT01898806|18929185|P1|STARTED|Overall Study||11
7686367|NCT01898611|18929192|P2|NOT COMPLETED|Overall Study||1
7686368|NCT01898611|18929193|P1|NOT COMPLETED|Overall Study||0
7686369|NCT01898611|18929192|P2|COMPLETED|Overall Study||10
7686370|NCT01898611|18929193|P1|COMPLETED|Overall Study||5
7686371|NCT01898611|18929192|P2|STARTED|Overall Study||11
7686372|NCT01898611|18929193|P1|STARTED|Overall Study||5
7686373|NCT01898598|18929215|P2|NOT COMPLETED|Overall Study||2
7686374|NCT01898598|18929216|P1|NOT COMPLETED|Overall Study||4
7686375|NCT01898598|18929215|P2|COMPLETED|Overall Study||4
7686376|NCT01898598|18929216|P1|COMPLETED|Overall Study||8
7686377|NCT01898598|18929215|P2|Treated|Overall Study||5
7686378|NCT01898598|18929216|P1|Treated|Overall Study||11
7686379|NCT01898598|18929215|P2|STARTED|Overall Study||6
7686380|NCT01898598|18929216|P1|STARTED|Overall Study||12
7686381|NCT01898442|18929235|P3|NOT COMPLETED|Overall Study||3
7686382|NCT01898442|18929236|P2|NOT COMPLETED|Overall Study||2
7686383|NCT01898442|18929237|P1|NOT COMPLETED|Overall Study||1
7686384|NCT01898442|18929235|P3|COMPLETED|Overall Study||15
7686385|NCT01898442|18929236|P2|COMPLETED|Overall Study||15
7686386|NCT01898442|18929237|P1|COMPLETED|Overall Study||16
7686387|NCT01898442|18929235|P3|STARTED|Overall Study||18
7686388|NCT01898442|18929236|P2|STARTED|Overall Study||17
7686389|NCT01898442|18929237|P1|STARTED|Overall Study||17
7686390|NCT01898429|18929260|P3|NOT COMPLETED|Phase 3||0
7686391|NCT01898429|18929261|P2|NOT COMPLETED|Phase 3||0
7686392|NCT01898429|18929262|P1|NOT COMPLETED|Phase 3||0
7686393|NCT01898429|18929260|P3|COMPLETED|Phase 3||5
7686394|NCT01898429|18929261|P2|COMPLETED|Phase 3||0
7686395|NCT01898429|18929262|P1|COMPLETED|Phase 3||0
7686396|NCT01898429|18929260|P3|STARTED|Phase 3||5
7686397|NCT01898429|18929261|P2|STARTED|Phase 3||0
7686398|NCT01898429|18929262|P1|STARTED|Phase 3||0
7686399|NCT01898429|18929260|P3|NOT COMPLETED|Phase 2||0
7686400|NCT01898429|18929261|P2|NOT COMPLETED|Phase 2||0
7686401|NCT01898429|18929262|P1|NOT COMPLETED|Phase 2||0
7686402|NCT01898429|18929260|P3|COMPLETED|Phase 2||0
7686403|NCT01898429|18929261|P2|COMPLETED|Phase 2||5
7686404|NCT01898429|18929262|P1|COMPLETED|Phase 2||0
7686405|NCT01898429|18929260|P3|STARTED|Phase 2||0
7686406|NCT01898429|18929261|P2|STARTED|Phase 2||5
7686407|NCT01898429|18929262|P1|STARTED|Phase 2||0
7686408|NCT01898429|18929260|P3|NOT COMPLETED|Phase 1||0
7686409|NCT01898429|18929261|P2|NOT COMPLETED|Phase 1||0
7686410|NCT01898429|18929262|P1|NOT COMPLETED|Phase 1||0
7686411|NCT01898429|18929260|P3|COMPLETED|Phase 1||0
7686412|NCT01898429|18929261|P2|COMPLETED|Phase 1||0
7686413|NCT01898429|18929262|P1|COMPLETED|Phase 1||5
7686414|NCT01898429|18929260|P3|STARTED|Phase 1||0
7686415|NCT01898429|18929261|P2|STARTED|Phase 1||0
7686416|NCT01898429|18929262|P1|STARTED|Phase 1||5
7686417|NCT01898403|18929266|P1|NOT COMPLETED|Overall Study||0
7686418|NCT01898403|18929266|P1|COMPLETED|Overall Study||50
7686419|NCT01898403|18929266|P1|STARTED|Overall Study||50
7686420|NCT01898299|18929274|P2|NOT COMPLETED|Post Treatment (One Month)||4
7686421|NCT01898299|18929275|P1|NOT COMPLETED|Post Treatment (One Month)||3
7686422|NCT01898299|18929274|P2|COMPLETED|Post Treatment (One Month)||38
7686423|NCT01898299|18929275|P1|COMPLETED|Post Treatment (One Month)||44
7686424|NCT01898299|18929274|P2|STARTED|Post Treatment (One Month)||42
7686425|NCT01898299|18929275|P1|STARTED|Post Treatment (One Month)||47
7686426|NCT01898299|18929274|P2|NOT COMPLETED|Post Treatment (One Week)||0
7686427|NCT01898299|18929275|P1|NOT COMPLETED|Post Treatment (One Week)||0
7686428|NCT01898299|18929274|P2|COMPLETED|Post Treatment (One Week)||42
7686429|NCT01898299|18929275|P1|COMPLETED|Post Treatment (One Week)||47
7686430|NCT01898299|18929274|P2|STARTED|Post Treatment (One Week)||42
7686431|NCT01898299|18929275|P1|STARTED|Post Treatment (One Week)||47
7686432|NCT01898286|18929281|P1|NOT COMPLETED|Overall Study||3
7686433|NCT01898286|18929281|P1|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35
7686434|NCT01898286|18929281|P1|STARTED|Overall Study||38
7686435|NCT01898208|18929291|P3|NOT COMPLETED|Overall Study||37
7686436|NCT01898208|18929292|P2|NOT COMPLETED|Overall Study||49
7686437|NCT01898208|18929293|P1|NOT COMPLETED|Overall Study||40
7686438|NCT01898208|18929291|P3|COMPLETED|Overall Study||212
7686439|NCT01898208|18929292|P2|COMPLETED|Overall Study||198
7686440|NCT01898208|18929293|P1|COMPLETED|Overall Study||207
7686441|NCT01898208|18929291|P3|STARTED|Overall Study||249
7686442|NCT01898208|18929292|P2|STARTED|Overall Study||247
7686443|NCT01898208|18929293|P1|STARTED|Overall Study||247
7686444|NCT01898195|18929340|P3|NOT COMPLETED|Smoking Abstinence||36
7686445|NCT01898195|18929341|P2|NOT COMPLETED|Smoking Abstinence||38
7686446|NCT01898195|18929342|P1|NOT COMPLETED|Smoking Abstinence||35
7686447|NCT01898195|18929340|P3|COMPLETED|Smoking Abstinence||15
7686448|NCT01898195|18929341|P2|COMPLETED|Smoking Abstinence||16
7686449|NCT01898195|18929342|P1|COMPLETED|Smoking Abstinence||18
7686450|NCT01898195|18929340|P3|STARTED|Smoking Abstinence||51
7686451|NCT01898195|18929341|P2|STARTED|Smoking Abstinence||54
7686452|NCT01898195|18929342|P1|STARTED|Smoking Abstinence||53
7686453|NCT01898195|18929340|P3|NOT COMPLETED|Varenicline Adherence||36
7686454|NCT01898195|18929341|P2|NOT COMPLETED|Varenicline Adherence||38
7686455|NCT01898195|18929342|P1|NOT COMPLETED|Varenicline Adherence||35
7686456|NCT01898195|18929340|P3|COMPLETED|Varenicline Adherence||15
7686457|NCT01898195|18929341|P2|COMPLETED|Varenicline Adherence||16
7686458|NCT01898195|18929342|P1|COMPLETED|Varenicline Adherence||18
7686459|NCT01898195|18929340|P3|STARTED|Varenicline Adherence||51
7686460|NCT01898195|18929341|P2|STARTED|Varenicline Adherence||54
7686461|NCT01898195|18929342|P1|STARTED|Varenicline Adherence||53
7686462|NCT01898130|18929353|P1|NOT COMPLETED|Follow up Until PD or Death||1
7686463|NCT01898130|18929353|P1|COMPLETED|Follow up Until PD or Death||26
7686464|NCT01898130|18929353|P1|STARTED|Follow up Until PD or Death|All patients treated on study go into follow up period for survival data.|27
7686465|NCT01898130|18929353|P1|NOT COMPLETED|Treatment||6
7686466|NCT01898130|18929353|P1|COMPLETED|Treatment||21
7686467|NCT01898130|18929353|P1|Went on to Start Cycle 3|Treatment||21
7686468|NCT01898130|18929353|P1|Reached 1st Response/2 Cycles|Treatment||24
7686469|NCT01898130|18929353|P1|STARTED|Treatment||27
7686470|NCT01898091|18929368|P2|NOT COMPLETED|Overall Study||6
7686471|NCT01898091|18929369|P1|NOT COMPLETED|Overall Study||2
7686472|NCT01898091|18929368|P2|COMPLETED|Overall Study||19
7686473|NCT01898091|18929369|P1|COMPLETED|Overall Study||23
7686474|NCT01898091|18929368|P2|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
7686475|NCT01898091|18929369|P1|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
7686476|NCT01898078|18929377|P2|NOT COMPLETED|Overall Study||8
7686477|NCT01898078|18929378|P1|NOT COMPLETED|Overall Study||6
7686478|NCT01898078|18929377|P2|COMPLETED|Overall Study|Completed treatment|5
7686479|NCT01898078|18929378|P1|COMPLETED|Overall Study|Completed treatment|7
7686480|NCT01898078|18929377|P2|STARTED|Overall Study||13
7686481|NCT01898078|18929378|P1|STARTED|Overall Study||13
7686482|NCT01898013|18929396|P2|NOT COMPLETED|Visit 6||5
7686483|NCT01898013|18929397|P1|NOT COMPLETED|Visit 6||3
7686484|NCT01898013|18929396|P2|COMPLETED|Visit 6||42
7686485|NCT01898013|18929397|P1|COMPLETED|Visit 6||41
7686486|NCT01898013|18929396|P2|STARTED|Visit 6||47
7686487|NCT01898013|18929397|P1|STARTED|Visit 6||44
7686488|NCT01898013|18929396|P2|NOT COMPLETED|Visit 5||1
7686489|NCT01898013|18929397|P1|NOT COMPLETED|Visit 5||1
7686490|NCT01898013|18929396|P2|COMPLETED|Visit 5||47
7686491|NCT01898013|18929397|P1|COMPLETED|Visit 5||44
7686492|NCT01898013|18929396|P2|STARTED|Visit 5||48
7686493|NCT01898013|18929397|P1|STARTED|Visit 5||45
7686494|NCT01898013|18929396|P2|NOT COMPLETED|Visit 4||1
7686495|NCT01898013|18929397|P1|NOT COMPLETED|Visit 4||0
7686496|NCT01898013|18929396|P2|COMPLETED|Visit 4||48
7686497|NCT01898013|18929397|P1|COMPLETED|Visit 4||45
7686498|NCT01898013|18929396|P2|STARTED|Visit 4||49
7686499|NCT01898013|18929397|P1|STARTED|Visit 4||45
7686500|NCT01898013|18929396|P2|NOT COMPLETED|Visit 3 (Randomization Visit)||0
7686501|NCT01898013|18929397|P1|NOT COMPLETED|Visit 3 (Randomization Visit)||0
7686502|NCT01898013|18929396|P2|COMPLETED|Visit 3 (Randomization Visit)||49
7686503|NCT01898013|18929397|P1|COMPLETED|Visit 3 (Randomization Visit)||45
7686504|NCT01898013|18929396|P2|STARTED|Visit 3 (Randomization Visit)||49
7686505|NCT01898013|18929397|P1|STARTED|Visit 3 (Randomization Visit)||45
7686506|NCT01897896|18929415|P2|NOT COMPLETED|Overall Study||12
7686507|NCT01897896|18929416|P1|NOT COMPLETED|Overall Study||26
7686508|NCT01897896|18929415|P2|COMPLETED|Overall Study||25
7686509|NCT01897896|18929416|P1|COMPLETED|Overall Study||56
7686510|NCT01897896|18929415|P2|STARTED|Overall Study||37
7686511|NCT01897896|18929416|P1|STARTED|Overall Study||82
7686512|NCT01897792|18929498|P2|NOT COMPLETED|Overall Study||0
7686513|NCT01897792|18929499|P1|NOT COMPLETED|Overall Study||0
7686514|NCT01897792|18929498|P2|COMPLETED|Overall Study||5
7686515|NCT01897792|18929499|P1|COMPLETED|Overall Study||6
7686516|NCT01897792|18929498|P2|STARTED|Overall Study||5
7686517|NCT01897792|18929499|P1|STARTED|Overall Study||6
7686518|NCT01897766|18929523|P1|NOT COMPLETED|Overall Study||0
7686519|NCT01897766|18929523|P1|COMPLETED|Overall Study||482
7686520|NCT01897766|18929523|P1|STARTED|Overall Study||482
7686521|NCT01897727|18929548|P2|NOT COMPLETED|Overall Study||1
7686522|NCT01897727|18929549|P1|NOT COMPLETED|Overall Study||0
7686523|NCT01897727|18929548|P2|COMPLETED|Overall Study||8
7686524|NCT01897727|18929549|P1|COMPLETED|Overall Study||8
7686525|NCT01897727|18929548|P2|STARTED|Overall Study||9
7686526|NCT01897727|18929549|P1|STARTED|Overall Study||8
7686527|NCT01897714|18929561|P6|NOT COMPLETED|Phase II (MTD)||11
7686528|NCT01897714|18929562|P5|NOT COMPLETED|Phase II (MTD)||30
7686529|NCT01897714|18929563|P4|NOT COMPLETED|Phase II (MTD)||0
7686530|NCT01897714|18929564|P3|NOT COMPLETED|Phase II (MTD)||0
7686531|NCT01897714|18929565|P2|NOT COMPLETED|Phase II (MTD)||0
7686532|NCT01897714|18929566|P1|NOT COMPLETED|Phase II (MTD)||0
7686533|NCT01897714|18929561|P6|COMPLETED|Phase II (MTD)||2
7686534|NCT01897714|18929562|P5|COMPLETED|Phase II (MTD)||15
7686535|NCT01897714|18929563|P4|COMPLETED|Phase II (MTD)||0
7686536|NCT01897714|18929564|P3|COMPLETED|Phase II (MTD)||0
7686537|NCT01897714|18929565|P2|COMPLETED|Phase II (MTD)||0
7686538|NCT01897714|18929566|P1|COMPLETED|Phase II (MTD)||0
7686539|NCT01897714|18929561|P6|STARTED|Phase II (MTD)||13
7686625|NCT01896921|18929722|P1|NOT COMPLETED|Overall Study||2
7686540|NCT01897714|18929562|P5|STARTED|Phase II (MTD)|6 patients were entered from the Phase I: Melflufen 40 mg + Dexamethasone arm.|45
7686541|NCT01897714|18929563|P4|STARTED|Phase II (MTD)||0
7686542|NCT01897714|18929564|P3|STARTED|Phase II (MTD)||0
7686543|NCT01897714|18929565|P2|STARTED|Phase II (MTD)||0
7686544|NCT01897714|18929566|P1|STARTED|Phase II (MTD)||0
7686545|NCT01897714|18929561|P6|NOT COMPLETED|Phase I (Dose Escalation)||0
7686546|NCT01897714|18929562|P5|NOT COMPLETED|Phase I (Dose Escalation)||0
7686547|NCT01897714|18929563|P4|NOT COMPLETED|Phase I (Dose Escalation)||6
7686548|NCT01897714|18929564|P3|NOT COMPLETED|Phase I (Dose Escalation)||5
7686549|NCT01897714|18929565|P2|NOT COMPLETED|Phase I (Dose Escalation)||7
7686550|NCT01897714|18929566|P1|NOT COMPLETED|Phase I (Dose Escalation)||3
7686551|NCT01897714|18929561|P6|COMPLETED|Phase I (Dose Escalation)||0
7686552|NCT01897714|18929562|P5|COMPLETED|Phase I (Dose Escalation)||0
7686553|NCT01897714|18929563|P4|COMPLETED|Phase I (Dose Escalation)||0
7686554|NCT01897714|18929564|P3|COMPLETED|Phase I (Dose Escalation)||1
7686555|NCT01897714|18929565|P2|COMPLETED|Phase I (Dose Escalation)||0
7686556|NCT01897714|18929566|P1|COMPLETED|Phase I (Dose Escalation)||1
7686557|NCT01897714|18929561|P6|STARTED|Phase I (Dose Escalation)||0
7686558|NCT01897714|18929562|P5|STARTED|Phase I (Dose Escalation)||0
7686559|NCT01897714|18929563|P4|STARTED|Phase I (Dose Escalation)||6
7686560|NCT01897714|18929564|P3|STARTED|Phase I (Dose Escalation)||6
7686561|NCT01897714|18929565|P2|STARTED|Phase I (Dose Escalation)||7
7686562|NCT01897714|18929566|P1|STARTED|Phase I (Dose Escalation)||4
7686563|NCT01897532|18929612|P2|NOT COMPLETED|Discontinuation From Trial||41
7686564|NCT01897532|18929613|P1|NOT COMPLETED|Discontinuation From Trial||62
7686565|NCT01897532|18929612|P2|COMPLETED|Discontinuation From Trial||3458
7686566|NCT01897532|18929613|P1|COMPLETED|Discontinuation From Trial||3430
7686567|NCT01897532|18929612|P2|Treated|Discontinuation From Trial||3494
7686568|NCT01897532|18929613|P1|Treated|Discontinuation From Trial||3485
7686569|NCT01897532|18929612|P2|STARTED|Discontinuation From Trial||3499
7686570|NCT01897532|18929613|P1|STARTED|Discontinuation From Trial||3492
7686571|NCT01897532|18929612|P2|NOT COMPLETED|Discontinuation From Treatment||839
7686572|NCT01897532|18929613|P1|NOT COMPLETED|Discontinuation From Treatment||962
7686573|NCT01897532|18929612|P2|COMPLETED|Discontinuation From Treatment||2660
7686574|NCT01897532|18929613|P1|COMPLETED|Discontinuation From Treatment||2530
7686575|NCT01897532|18929612|P2|Treated|Discontinuation From Treatment||3494
7686576|NCT01897532|18929613|P1|Treated|Discontinuation From Treatment||3485
7686577|NCT01897532|18929612|P2|STARTED|Discontinuation From Treatment||3499
7686578|NCT01897532|18929613|P1|STARTED|Discontinuation From Treatment||3492
7686579|NCT01897493|18929621|P1|NOT COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||0
7686580|NCT01897493|18929621|P1|COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||15
7686581|NCT01897493|18929621|P1|Received at Least 1 Dose of Study Drug|Period 2 (Day 6 Postdose Through Day 20)||15
7686582|NCT01897493|18929621|P1|STARTED|Period 2 (Day 6 Postdose Through Day 20)||15
7686583|NCT01897493|18929621|P1|NOT COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||1
7686584|NCT01897493|18929621|P1|COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||15
7686585|NCT01897493|18929621|P1|Received at Least 1 Dose of Study Drug|Period 1 (Day 1 Through Day 6 Predose)||16
7686586|NCT01897493|18929621|P1|STARTED|Period 1 (Day 1 Through Day 6 Predose)||16
7686587|NCT01897402|18929636|P2|NOT COMPLETED|Overall Study||16
7686588|NCT01897402|18929637|P1|NOT COMPLETED|Overall Study||19
7686589|NCT01897402|18929636|P2|COMPLETED|Overall Study||244
7686590|NCT01897402|18929637|P1|COMPLETED|Overall Study||246
7686591|NCT01897402|18929636|P2|STARTED|Overall Study||260
7686592|NCT01897402|18929637|P1|STARTED|Overall Study||265
7686593|NCT01897285|18929649|P1|NOT COMPLETED|Overall Study||0
7686594|NCT01897285|18929649|P1|COMPLETED|Overall Study||20
7686595|NCT01897285|18929649|P1|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20
7686596|NCT01897233|18929657|P1|NOT COMPLETED|Part B (24 Weeks)||4
7686597|NCT01897233|18929657|P1|COMPLETED|Part B (24 Weeks)||54
7686598|NCT01897233|18929657|P1|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58
7686599|NCT01897233|18929657|P1|NOT COMPLETED|Part A (14 Days)||0
7686600|NCT01897233|18929657|P1|COMPLETED|Part A (14 Days)||10
7686601|NCT01897233|18929657|P1|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5
7686602|NCT01897233|18929657|P1|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5
7686603|NCT01897233|18929657|P1|STARTED|Part A (14 Days)||10
7686604|NCT01897077|18929681|P2|NOT COMPLETED|Overall Study||0
7686605|NCT01897077|18929682|P1|NOT COMPLETED|Overall Study||0
7686606|NCT01897077|18929681|P2|COMPLETED|Overall Study||5
7686607|NCT01897077|18929682|P1|COMPLETED|Overall Study||0
7686608|NCT01897077|18929681|P2|STARTED|Overall Study||5
7686609|NCT01897077|18929682|P1|STARTED|Overall Study||0
7686610|NCT01897025|18929700|P2|NOT COMPLETED|Overall Study||0
7686611|NCT01897025|18929701|P1|NOT COMPLETED|Overall Study||0
7686612|NCT01897025|18929700|P2|COMPLETED|Overall Study||9
7686613|NCT01897025|18929701|P1|COMPLETED|Overall Study||10
7686614|NCT01897025|18929700|P2|STARTED|Overall Study||9
7686615|NCT01897025|18929701|P1|STARTED|Overall Study||10
7686616|NCT01896986|18929709|P2|NOT COMPLETED|Overall Study||23
7686617|NCT01896986|18929710|P1|NOT COMPLETED|Overall Study||14
7686618|NCT01896986|18929709|P2|COMPLETED|Overall Study||0
7686619|NCT01896986|18929710|P1|COMPLETED|Overall Study||0
7686620|NCT01896986|18929709|P2|STARTED|Overall Study||23
7686621|NCT01896986|18929710|P1|STARTED|Overall Study||14
7686622|NCT01896934|18929716|P1|NOT COMPLETED|Overall Study||2
7686623|NCT01896934|18929716|P1|COMPLETED|Overall Study||19
7686624|NCT01896934|18929716|P1|STARTED|Overall Study||21
7686626|NCT01896921|18929722|P1|COMPLETED|Overall Study||5
7686627|NCT01896921|18929722|P1|STARTED|Overall Study||7
7686628|NCT01896895|18929729|P4|NOT COMPLETED|OLEX Period||0
7686629|NCT01896895|18929730|P3|NOT COMPLETED|OLEX Period||0
7686630|NCT01896895|18929731|P2|NOT COMPLETED|OLEX Period||0
7686631|NCT01896895|18929732|P1|NOT COMPLETED|OLEX Period||0
7686632|NCT01896895|18929729|P4|COMPLETED|OLEX Period||39
7686633|NCT01896895|18929730|P3|COMPLETED|OLEX Period||0
7686634|NCT01896895|18929731|P2|COMPLETED|OLEX Period||0
7686635|NCT01896895|18929732|P1|COMPLETED|OLEX Period||0
7686636|NCT01896895|18929729|P4|STARTED|OLEX Period|Not all participants who completed double-blind MP fulfilled the inclusion criteria for OLEX period.|39
7686637|NCT01896895|18929730|P3|STARTED|OLEX Period||0
7686638|NCT01896895|18929731|P2|STARTED|OLEX Period||0
7686639|NCT01896895|18929732|P1|STARTED|OLEX Period||0
7686640|NCT01896895|18929729|P4|NOT COMPLETED|Double-blind MP||0
7686641|NCT01896895|18929730|P3|NOT COMPLETED|Double-blind MP||3
7686642|NCT01896895|18929731|P2|NOT COMPLETED|Double-blind MP||2
7686643|NCT01896895|18929732|P1|NOT COMPLETED|Double-blind MP||1
7686644|NCT01896895|18929729|P4|COMPLETED|Double-blind MP||0
7686645|NCT01896895|18929730|P3|COMPLETED|Double-blind MP||16
7686646|NCT01896895|18929731|P2|COMPLETED|Double-blind MP||20
7686647|NCT01896895|18929732|P1|COMPLETED|Double-blind MP||19
7686648|NCT01896895|18929729|P4|STARTED|Double-blind MP||0
7686649|NCT01896895|18929730|P3|STARTED|Double-blind MP||19
7686650|NCT01896895|18929731|P2|STARTED|Double-blind MP||22
7686651|NCT01896895|18929732|P1|STARTED|Double-blind MP||20
7686652|NCT01896869|18929749|P2|NOT COMPLETED|Overall Study||6
7686653|NCT01896869|18929750|P1|NOT COMPLETED|Overall Study||1
7686654|NCT01896869|18929749|P2|COMPLETED|Overall Study||36
7686655|NCT01896869|18929750|P1|COMPLETED|Overall Study||40
7686656|NCT01896869|18929749|P2|STARTED|Overall Study||42
7686657|NCT01896869|18929750|P1|STARTED|Overall Study||41
7686658|NCT01896856|18929775|P6|NOT COMPLETED|Overall Study||0
7686659|NCT01896856|18929776|P5|NOT COMPLETED|Overall Study||0
7686660|NCT01896856|18929777|P4|NOT COMPLETED|Overall Study||0
7686661|NCT01896856|18929778|P3|NOT COMPLETED|Overall Study||1
7686662|NCT01896856|18929779|P2|NOT COMPLETED|Overall Study||0
7686663|NCT01896856|18929780|P1|NOT COMPLETED|Overall Study||0
7686664|NCT01896856|18929775|P6|COMPLETED|Overall Study||34
7686665|NCT01896856|18929776|P5|COMPLETED|Overall Study||62
7686666|NCT01896856|18929777|P4|COMPLETED|Overall Study||6
7686667|NCT01896856|18929778|P3|COMPLETED|Overall Study||6
7686668|NCT01896856|18929779|P2|COMPLETED|Overall Study||3
7686669|NCT01896856|18929780|P1|COMPLETED|Overall Study||6
7686670|NCT01896856|18929775|P6|STARTED|Overall Study||34
7686671|NCT01896856|18929776|P5|STARTED|Overall Study||62
7686672|NCT01896856|18929777|P4|STARTED|Overall Study||6
7686673|NCT01896856|18929778|P3|STARTED|Overall Study||7
7686674|NCT01896856|18929779|P2|STARTED|Overall Study||3
7686675|NCT01896856|18929780|P1|STARTED|Overall Study||6
7686676|NCT01896726|18929799|P1|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2
7686677|NCT01896726|18929799|P1|COMPLETED|Treatment Period 2 (Days 23-31)||18
7686678|NCT01896726|18929799|P1|Received Microgynon|Treatment Period 2 (Days 23-31)||18
7686679|NCT01896726|18929799|P1|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20
7686680|NCT01896726|18929799|P1|STARTED|Treatment Period 2 (Days 23-31)||20
7686681|NCT01896726|18929799|P1|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0
7686682|NCT01896726|18929799|P1|COMPLETED|Treatment Period 1 (Days 1-22)||20
7686683|NCT01896726|18929799|P1|Received Microgynon|Treatment Period 1 (Days 1-22)||20
7686684|NCT01896726|18929799|P1|STARTED|Treatment Period 1 (Days 1-22)||20
7686685|NCT01896700|18929814|P2|NOT COMPLETED|Overall Study||6
7686686|NCT01896700|18929815|P1|NOT COMPLETED|Overall Study||4
7686687|NCT01896700|18929814|P2|COMPLETED|Overall Study||6
7686688|NCT01896700|18929815|P1|COMPLETED|Overall Study||8
7686689|NCT01896700|18929814|P2|STARTED|Overall Study||12
7686690|NCT01896700|18929815|P1|STARTED|Overall Study||12
7686691|NCT01896687|18929837|P2|NOT COMPLETED|Overall Study||0
7686692|NCT01896687|18929838|P1|NOT COMPLETED|Overall Study||0
7686693|NCT01896687|18929837|P2|COMPLETED|Overall Study||15
7686694|NCT01896687|18929838|P1|COMPLETED|Overall Study||15
7686695|NCT01896687|18929837|P2|STARTED|Overall Study||15
7686696|NCT01896687|18929838|P1|STARTED|Overall Study||15
7686697|NCT01896557|18929846|P2|NOT COMPLETED|Clopidogrel + GI Protector||4
7686698|NCT01896557|18929847|P1|NOT COMPLETED|Clopidogrel + GI Protector||2
7686699|NCT01896557|18929846|P2|COMPLETED|Clopidogrel + GI Protector||44
7686700|NCT01896557|18929847|P1|COMPLETED|Clopidogrel + GI Protector||41
7686701|NCT01896557|18929846|P2|STARTED|Clopidogrel + GI Protector||48
7686702|NCT01896557|18929847|P1|STARTED|Clopidogrel + GI Protector||43
7686703|NCT01896557|18929846|P2|NOT COMPLETED|Clopidogrel Alone||0
7686704|NCT01896557|18929847|P1|NOT COMPLETED|Clopidogrel Alone||1
7686705|NCT01896557|18929846|P2|COMPLETED|Clopidogrel Alone||48
7686706|NCT01896557|18929847|P1|COMPLETED|Clopidogrel Alone||43
7686707|NCT01896557|18929846|P2|STARTED|Clopidogrel Alone||48
7686708|NCT01896557|18929847|P1|STARTED|Clopidogrel Alone||44
7686709|NCT01896544|18929862|P3|NOT COMPLETED|Overall Study||0
7686710|NCT01896544|18929863|P2|NOT COMPLETED|Overall Study||0
7686711|NCT01896544|18929864|P1|NOT COMPLETED|Overall Study||0
7686712|NCT01896544|18929862|P3|COMPLETED|Overall Study||10
7686713|NCT01896544|18929863|P2|COMPLETED|Overall Study||10
7686714|NCT01896544|18929864|P1|COMPLETED|Overall Study||10
7686715|NCT01896544|18929862|P3|STARTED|Overall Study||10
7686716|NCT01896544|18929863|P2|STARTED|Overall Study||10
7686717|NCT01896544|18929864|P1|STARTED|Overall Study||10
7686718|NCT01896297|18929884|P1|NOT COMPLETED|Overall Study||1
7686719|NCT01896297|18929884|P1|COMPLETED|Overall Study||59
7686720|NCT01896297|18929884|P1|STARTED|Overall Study||60
7686721|NCT01896232|18929891|P2|NOT COMPLETED|Overall Study||53
7686722|NCT01896232|18929892|P1|NOT COMPLETED|Overall Study||49
7686723|NCT01896232|18929891|P2|COMPLETED|Overall Study||287
7686724|NCT01896232|18929892|P1|COMPLETED|Overall Study||294
7686725|NCT01896232|18929891|P2|Received Treatment|Overall Study||338
7686726|NCT01896232|18929892|P1|Received Treatment|Overall Study||341
7686727|NCT01896232|18929891|P2|STARTED|Overall Study||340
7686728|NCT01896232|18929892|P1|STARTED|Overall Study||343
7686729|NCT01896206|18929912|P1|NOT COMPLETED|Overall Study||0
7686730|NCT01896206|18929912|P1|COMPLETED|Overall Study||21
7686731|NCT01896206|18929912|P1|STARTED|Overall Study||21
7686732|NCT01896193|18929920|P2|NOT COMPLETED|Overall Study||12
7686733|NCT01896193|18929921|P1|NOT COMPLETED|Overall Study||21
7686734|NCT01896193|18929920|P2|COMPLETED|Overall Study||53
7686735|NCT01896193|18929921|P1|COMPLETED|Overall Study||41
7686736|NCT01896193|18929920|P2|STARTED|Overall Study||65
7686737|NCT01896193|18929921|P1|STARTED|Overall Study||62
7686738|NCT01896128|18929947|P2|NOT COMPLETED|Overall Study||3
7686739|NCT01896128|18929948|P1|NOT COMPLETED|Overall Study||3
7686740|NCT01896128|18929947|P2|COMPLETED|Overall Study||8
7686741|NCT01896128|18929948|P1|COMPLETED|Overall Study||5
7686742|NCT01896128|18929947|P2|STARTED|Overall Study||11
7686743|NCT01896128|18929948|P1|STARTED|Overall Study||8
7686744|NCT01896115|18929964|P2|NOT COMPLETED|Overall Study||0
7686745|NCT01896115|18929965|P1|NOT COMPLETED|Overall Study||1
7686746|NCT01896115|18929964|P2|COMPLETED|Overall Study||24
7686747|NCT01896115|18929965|P1|COMPLETED|Overall Study||15
7686748|NCT01896115|18929964|P2|Phase 2 Steering|Overall Study||24
7686749|NCT01896115|18929965|P1|Phase 2 Steering|Overall Study||0
7686750|NCT01896115|18929964|P2|Phase 2 Single Contact|Overall Study||24
7686751|NCT01896115|18929965|P1|Phase 2 Single Contact|Overall Study||0
7686752|NCT01896115|18929964|P2|Phase 1 Ventral Steering|Overall Study||0
7686753|NCT01896115|18929965|P1|Phase 1 Ventral Steering|Overall Study||15
7686754|NCT01896115|18929964|P2|Phase 1 Dorsal Steering|Overall Study||0
7686755|NCT01896115|18929965|P1|Phase 1 Dorsal Steering|Overall Study||15
7686756|NCT01896115|18929964|P2|Phase 1 Conventional PW|Overall Study||0
7686757|NCT01896115|18929965|P1|Phase 1 Conventional PW|Overall Study||15
7686758|NCT01896115|18929964|P2|Phase 1 Short PW|Overall Study||0
7686759|NCT01896115|18929965|P1|Phase 1 Short PW|Overall Study||15
7686760|NCT01896115|18929964|P2|STARTED|Overall Study||24
7686761|NCT01896115|18929965|P1|STARTED|Overall Study||16
7686762|NCT01896050|18929990|P2|NOT COMPLETED|Overall Study||2
7686763|NCT01896050|18929991|P1|NOT COMPLETED|Overall Study||38
7686764|NCT01896050|18929990|P2|COMPLETED|Overall Study||20
7686765|NCT01896050|18929991|P1|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55
7686766|NCT01896050|18929990|P2|STARTED|Overall Study||22
7686767|NCT01896050|18929991|P1|STARTED|Overall Study||93
7686768|NCT01895972|18930001|P1|NOT COMPLETED|Overall Study||9
7686769|NCT01895972|18930001|P1|COMPLETED|Overall Study||121
7686770|NCT01895972|18930001|P1|STARTED|Overall Study||130
7686771|NCT01895959|18930006|P1|NOT COMPLETED|Overall Study||2
7686772|NCT01895959|18930006|P1|COMPLETED|Overall Study||10
7686773|NCT01895959|18930006|P1|STARTED|Overall Study||12
7686774|NCT01895946|18930014|P2|NOT COMPLETED|Overall Study||0
7686775|NCT01895946|18930015|P1|NOT COMPLETED|Overall Study||0
7686776|NCT01895946|18930014|P2|COMPLETED|Overall Study||12
7686777|NCT01895946|18930015|P1|COMPLETED|Overall Study||18
7686778|NCT01895946|18930014|P2|STARTED|Overall Study||12
7686779|NCT01895946|18930015|P1|STARTED|Overall Study||18
7686780|NCT01895777|18930035|P2|NOT COMPLETED|Overall Study||5
7686781|NCT01895777|18930036|P1|NOT COMPLETED|Overall Study||9
7686782|NCT01895777|18930035|P2|COMPLETED|Overall Study||85
7686783|NCT01895777|18930036|P1|COMPLETED|Overall Study||168
7686784|NCT01895777|18930035|P2|Treated|Overall Study||90
7686785|NCT01895777|18930036|P1|Treated|Overall Study||176
7686786|NCT01895777|18930035|P2|STARTED|Overall Study||90
7686787|NCT01895777|18930036|P1|STARTED|Overall Study||177
7686788|NCT01895647|18930064|P3|NOT COMPLETED|Overall Study||0
7686789|NCT01895647|18930065|P2|NOT COMPLETED|Overall Study||0
7686790|NCT01895647|18930066|P1|NOT COMPLETED|Overall Study||0
7686791|NCT01895647|18930064|P3|COMPLETED|Overall Study||7
7686792|NCT01895647|18930065|P2|COMPLETED|Overall Study||10
7686793|NCT01895647|18930066|P1|COMPLETED|Overall Study||8
7686794|NCT01895647|18930064|P3|STARTED|Overall Study||7
7686795|NCT01895647|18930065|P2|STARTED|Overall Study||10
7686796|NCT01895647|18930066|P1|STARTED|Overall Study||8
7686797|NCT01895634|18930080|P1|NOT COMPLETED|Overall Study||3
7686798|NCT01895634|18930080|P1|COMPLETED|Overall Study||46
7686799|NCT01895634|18930080|P1|STARTED|Overall Study||49
7686800|NCT01895608|18930092|P4|NOT COMPLETED|Overall Study||0
7686801|NCT01895608|18930093|P3|NOT COMPLETED|Overall Study||3
7686802|NCT01895608|18930094|P2|NOT COMPLETED|Overall Study||1
7686803|NCT01895608|18930095|P1|NOT COMPLETED|Overall Study||0
7686804|NCT01895608|18930092|P4|COMPLETED|Overall Study||6
7686805|NCT01895608|18930093|P3|COMPLETED|Overall Study||8
7686806|NCT01895608|18930094|P2|COMPLETED|Overall Study||6
7686807|NCT01895608|18930095|P1|COMPLETED|Overall Study||10
7686808|NCT01895608|18930092|P4|STARTED|Overall Study||6
7686809|NCT01895608|18930093|P3|STARTED|Overall Study||11
7686810|NCT01895608|18930094|P2|STARTED|Overall Study||7
7686811|NCT01895608|18930095|P1|STARTED|Overall Study||10
7686812|NCT01895543|18930125|P1|NOT COMPLETED|Overall Study||129
7686813|NCT01895543|18930125|P1|COMPLETED|Overall Study||282
7686814|NCT01895543|18930125|P1|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380
7686815|NCT01895543|18930125|P1|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409
7686816|NCT01895543|18930125|P1|STARTED|Overall Study||411
7686817|NCT01895452|18930141|P2|NOT COMPLETED|Overall Study||28
7686818|NCT01895452|18930142|P1|NOT COMPLETED|Overall Study||4
7686819|NCT01895452|18930141|P2|COMPLETED|Overall Study||198
7686820|NCT01895452|18930142|P1|COMPLETED|Overall Study||61
7686821|NCT01895452|18930141|P2|STARTED|Overall Study||226
7686822|NCT01895452|18930142|P1|STARTED|Overall Study||65
7686823|NCT01895361|18930155|P3|NOT COMPLETED|Overall Study||24
7686824|NCT01895361|18930156|P2|NOT COMPLETED|Overall Study||21
7686825|NCT01895361|18930157|P1|NOT COMPLETED|Overall Study||24
7686826|NCT01895361|18930155|P3|COMPLETED|Overall Study||41
7686827|NCT01895361|18930156|P2|COMPLETED|Overall Study||45
7686828|NCT01895361|18930157|P1|COMPLETED|Overall Study||43
7686829|NCT01895361|18930155|P3|STARTED|Overall Study||65
7686830|NCT01895361|18930156|P2|STARTED|Overall Study||66
7686831|NCT01895361|18930157|P1|STARTED|Overall Study||67
7686832|NCT01895335|18930186|P1|NOT COMPLETED|Overall Study||215
7686833|NCT01895335|18930186|P1|COMPLETED|Overall Study||786
7686834|NCT01895335|18930186|P1|Treated|Overall Study||1000
7686835|NCT01895335|18930186|P1|STARTED|Overall Study||1001
7686836|NCT01895322|18930203|P1|NOT COMPLETED|Overall Study||13
7686837|NCT01895322|18930203|P1|COMPLETED|Overall Study||7
7686838|NCT01895322|18930203|P1|STARTED|Overall Study||20
7686839|NCT01895309|18930212|P2|NOT COMPLETED|Overall Study||51
7686840|NCT01895309|18930213|P1|NOT COMPLETED|Overall Study||40
7686841|NCT01895309|18930212|P2|COMPLETED|Overall Study||246
7686842|NCT01895309|18930213|P1|COMPLETED|Overall Study||259
7686843|NCT01895309|18930212|P2|STARTED|Overall Study||297
7686844|NCT01895309|18930213|P1|STARTED|Overall Study||299
7686845|NCT01895270|18930227|P2|NOT COMPLETED|Isradipine Taper (W7-8)||2
7686846|NCT01895270|18930228|P1|NOT COMPLETED|Isradipine Taper (W7-8)||0
7686847|NCT01895270|18930227|P2|COMPLETED|Isradipine Taper (W7-8)||0
7686848|NCT01895270|18930228|P1|COMPLETED|Isradipine Taper (W7-8)||2
7686849|NCT01895270|18930227|P2|STARTED|Isradipine Taper (W7-8)||2
7686850|NCT01895270|18930228|P1|STARTED|Isradipine Taper (W7-8)||2
7686851|NCT01895270|18930227|P2|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5
7686852|NCT01895270|18930228|P1|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3
7686853|NCT01895270|18930227|P2|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
7686854|NCT01895270|18930228|P1|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
7686855|NCT01895270|18930227|P2|STARTED|Buprenorphine Taper (W5 to W6D3)|1 subject missed meds prior to bup taper so did not start this phase|7
7686856|NCT01895270|18930228|P1|STARTED|Buprenorphine Taper (W5 to W6D3)||5
7686857|NCT01895270|18930227|P2|NOT COMPLETED|Study Medications Induction (W1-4)||6
7686858|NCT01895270|18930228|P1|NOT COMPLETED|Study Medications Induction (W1-4)||6
7686859|NCT01895270|18930227|P2|COMPLETED|Study Medications Induction (W1-4)||8
7686860|NCT01895270|18930228|P1|COMPLETED|Study Medications Induction (W1-4)||5
7686861|NCT01895270|18930227|P2|STARTED|Study Medications Induction (W1-4)||14
7686862|NCT01895270|18930228|P1|STARTED|Study Medications Induction (W1-4)||11
7686863|NCT01895127|18930236|P2|NOT COMPLETED|Long Term Follow-up (Month 3-12)||3
7686864|NCT01895127|18930237|P1|NOT COMPLETED|Long Term Follow-up (Month 3-12)||2
7686865|NCT01895127|18930236|P2|COMPLETED|Long Term Follow-up (Month 3-12)||4
7686866|NCT01895127|18930237|P1|COMPLETED|Long Term Follow-up (Month 3-12)||1
7686867|NCT01895127|18930236|P2|STARTED|Long Term Follow-up (Month 3-12)||7
7686868|NCT01895127|18930237|P1|STARTED|Long Term Follow-up (Month 3-12)||3
7686869|NCT01895127|18930236|P2|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
7686870|NCT01895127|18930237|P1|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
7686871|NCT01895127|18930236|P2|COMPLETED|Month 3 Follow-up & Biopsy||7
7686872|NCT01895127|18930237|P1|COMPLETED|Month 3 Follow-up & Biopsy||3
7686873|NCT01895127|18930236|P2|STARTED|Month 3 Follow-up & Biopsy||7
7686874|NCT01895127|18930237|P1|STARTED|Month 3 Follow-up & Biopsy||3
7686875|NCT01895127|18930236|P2|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
7686876|NCT01895127|18930237|P1|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
7686877|NCT01895127|18930236|P2|COMPLETED|Treatment Period (Week 0-Month 3)||7
7686878|NCT01895127|18930237|P1|COMPLETED|Treatment Period (Week 0-Month 3)||3
7686879|NCT01895127|18930236|P2|STARTED|Treatment Period (Week 0-Month 3)||7
7686880|NCT01895127|18930237|P1|STARTED|Treatment Period (Week 0-Month 3)||3
7686881|NCT01895127|18930236|P2|NOT COMPLETED|Screening||0
7686882|NCT01895127|18930237|P1|NOT COMPLETED|Screening||0
7686883|NCT01895127|18930236|P2|COMPLETED|Screening||7
7686884|NCT01895127|18930237|P1|COMPLETED|Screening|One subject was found to be pregnant at screening so was withdrawn from the study prior to treatment|4
7686885|NCT01895127|18930236|P2|STARTED|Screening||7
7686886|NCT01895127|18930237|P1|STARTED|Screening||4
7686887|NCT01895101|18930247|P3|NOT COMPLETED|Overall Study||5
7686888|NCT01895101|18930248|P2|NOT COMPLETED|Overall Study||5
7686889|NCT01895101|18930249|P1|NOT COMPLETED|Overall Study||1
7686890|NCT01895101|18930247|P3|COMPLETED|Overall Study||245
7686891|NCT01895101|18930248|P2|COMPLETED|Overall Study||245
7686892|NCT01895101|18930249|P1|COMPLETED|Overall Study||249
7686893|NCT01895101|18930247|P3|STARTED|Overall Study||250
7686894|NCT01895101|18930248|P2|STARTED|Overall Study||250
7686895|NCT01895101|18930249|P1|STARTED|Overall Study||250
7686896|NCT01895088|18930263|P1|NOT COMPLETED|Overall Study||18
7686897|NCT01895088|18930263|P1|COMPLETED|Overall Study||253
7686898|NCT01895088|18930263|P1|STARTED|Overall Study|1 subject consented for monitoring after device removal (not included in cohort), per FDA request.|271
7686899|NCT01895062|18930269|P2|NOT COMPLETED|Overall Study||0
7686900|NCT01895062|18930270|P1|NOT COMPLETED|Overall Study||0
7686901|NCT01895062|18930269|P2|COMPLETED|Overall Study||24
7686902|NCT01895062|18930270|P1|COMPLETED|Overall Study||30
7686903|NCT01895062|18930269|P2|STARTED|Overall Study||24
7686904|NCT01895062|18930270|P1|STARTED|Overall Study||30
7686905|NCT01895036|18930278|P1|NOT COMPLETED|Overall Study||0
7686906|NCT01895036|18930278|P1|COMPLETED|Overall Study||6
7686907|NCT01895036|18930278|P1|STARTED|Overall Study||6
7686908|NCT01894984|18930284|P2|NOT COMPLETED|Overall Study||175
7686909|NCT01894984|18930285|P1|NOT COMPLETED|Overall Study||314
7686910|NCT01894984|18930284|P2|COMPLETED|Overall Study||69
7686911|NCT01894984|18930285|P1|COMPLETED|Overall Study||82
7686912|NCT01894984|18930284|P2|STARTED|Overall Study||244
7686913|NCT01894984|18930285|P1|STARTED|Overall Study||396
7686914|NCT01894919|18930314|P13|NOT COMPLETED|Overall Study||0
7686915|NCT01894919|18930315|P12|NOT COMPLETED|Overall Study||0
7686916|NCT01894919|18930316|P11|NOT COMPLETED|Overall Study||2
7686917|NCT01894919|18930317|P10|NOT COMPLETED|Overall Study||1
7686918|NCT01894919|18930318|P9|NOT COMPLETED|Overall Study||0
7686919|NCT01894919|18930319|P8|NOT COMPLETED|Overall Study||0
7686920|NCT01894919|18930320|P7|NOT COMPLETED|Overall Study||0
7686921|NCT01894919|18930321|P6|NOT COMPLETED|Overall Study||0
7686922|NCT01894919|18930322|P5|NOT COMPLETED|Overall Study||3
7686923|NCT01894919|18930323|P4|NOT COMPLETED|Overall Study||0
7686924|NCT01894919|18930324|P3|NOT COMPLETED|Overall Study||0
7686925|NCT01894919|18930325|P2|NOT COMPLETED|Overall Study||0
7686926|NCT01894919|18930326|P1|NOT COMPLETED|Overall Study||2
7686927|NCT01894919|18930314|P13|COMPLETED|Overall Study||50
7686928|NCT01894919|18930315|P12|COMPLETED|Overall Study||55
7686929|NCT01894919|18930316|P11|COMPLETED|Overall Study||98
7686930|NCT01894919|18930317|P10|COMPLETED|Overall Study||89
7686931|NCT01894919|18930318|P9|COMPLETED|Overall Study||91
7686932|NCT01894919|18930319|P8|COMPLETED|Overall Study||36
7686933|NCT01894919|18930320|P7|COMPLETED|Overall Study||32
7686934|NCT01894919|18930321|P6|COMPLETED|Overall Study||39
7686935|NCT01894919|18930322|P5|COMPLETED|Overall Study||78
7686936|NCT01894919|18930323|P4|COMPLETED|Overall Study||43
7686937|NCT01894919|18930324|P3|COMPLETED|Overall Study||89
7686938|NCT01894919|18930325|P2|COMPLETED|Overall Study||47
7686939|NCT01894919|18930326|P1|COMPLETED|Overall Study||96
7686940|NCT01894919|18930314|P13|STARTED|Overall Study||50
7686941|NCT01894919|18930315|P12|STARTED|Overall Study||55
7686942|NCT01894919|18930316|P11|STARTED|Overall Study||100
7686943|NCT01894919|18930317|P10|STARTED|Overall Study||90
7686944|NCT01894919|18930318|P9|STARTED|Overall Study||91
7686945|NCT01894919|18930319|P8|STARTED|Overall Study||36
7686946|NCT01894919|18930320|P7|STARTED|Overall Study||32
7686947|NCT01894919|18930321|P6|STARTED|Overall Study||39
7686948|NCT01894919|18930322|P5|STARTED|Overall Study||81
7686949|NCT01894919|18930323|P4|STARTED|Overall Study||43
7686950|NCT01894919|18930324|P3|STARTED|Overall Study||89
7686951|NCT01894919|18930325|P2|STARTED|Overall Study||47
7686952|NCT01894919|18930326|P1|STARTED|Overall Study||98
7686953|NCT01894906|18930448|P2|NOT COMPLETED|Overall Study||0
7686954|NCT01894906|18930449|P1|NOT COMPLETED|Overall Study||0
7686955|NCT01894906|18930448|P2|COMPLETED|Overall Study||6
7686956|NCT01894906|18930449|P1|COMPLETED|Overall Study||6
7686957|NCT01894906|18930448|P2|Treatment F|Overall Study||6
7686958|NCT01894906|18930449|P1|Treatment F|Overall Study||6
7686959|NCT01894906|18930448|P2|Treatment E|Overall Study||6
7686960|NCT01894906|18930449|P1|Treatment E|Overall Study||6
7686961|NCT01894906|18930448|P2|Treatment D|Overall Study||6
7686962|NCT01894906|18930449|P1|Treatment D|Overall Study||6
7686963|NCT01894906|18930448|P2|Treatment C|Overall Study||6
7686964|NCT01894906|18930449|P1|Treatment C|Overall Study||6
7686965|NCT01894906|18930448|P2|Treatment B|Overall Study||6
7686966|NCT01894906|18930449|P1|Treatment B|Overall Study||6
7686967|NCT01894906|18930448|P2|Treatment A|Overall Study||6
7686968|NCT01894906|18930449|P1|Treatment A|Overall Study||6
7686969|NCT01894906|18930448|P2|STARTED|Overall Study||6
7686970|NCT01894906|18930449|P1|STARTED|Overall Study||6
7686971|NCT01894841|18930481|P2|NOT COMPLETED|Overall Study||9
7686972|NCT01894841|18930482|P1|NOT COMPLETED|Overall Study||18
7686973|NCT01894841|18930481|P2|COMPLETED|Overall Study||44
7686974|NCT01894841|18930482|P1|COMPLETED|Overall Study||34
7686975|NCT01894841|18930481|P2|STARTED|Overall Study||53
7686976|NCT01894841|18930482|P1|STARTED|Overall Study||52
7686977|NCT01894776|18930498|P1|NOT COMPLETED|Overall Study||1
7686978|NCT01894776|18930498|P1|COMPLETED|Overall Study||14
7686979|NCT01894776|18930498|P1|STARTED|Overall Study||15
7686980|NCT01894672|18930504|P1|NOT COMPLETED|Overall Study||0
7686981|NCT01894672|18930504|P1|COMPLETED|Overall Study||7
7686982|NCT01894672|18930504|P1|STARTED|Overall Study||7
7686983|NCT01894620|18930512|P2|NOT COMPLETED|Overall Study||1
7686984|NCT01894620|18930513|P1|NOT COMPLETED|Overall Study||0
7686985|NCT01894620|18930512|P2|COMPLETED|Overall Study||4
7686986|NCT01894620|18930513|P1|COMPLETED|Overall Study||6
7686987|NCT01894620|18930512|P2|STARTED|Overall Study||5
7686988|NCT01894620|18930513|P1|STARTED|Overall Study||6
7686989|NCT01894607|18930521|P1|NOT COMPLETED|Overall Study||1
7686990|NCT01894607|18930521|P1|COMPLETED|Overall Study||10
7686991|NCT01894607|18930521|P1|STARTED|Overall Study||11
7686992|NCT01894581|18930528|P2|NOT COMPLETED|Overall Study||7
7686993|NCT01894581|18930529|P1|NOT COMPLETED|Overall Study||5
7686994|NCT01894581|18930528|P2|COMPLETED|Overall Study||12
7686995|NCT01894581|18930529|P1|COMPLETED|Overall Study||15
7686996|NCT01894581|18930528|P2|STARTED|Overall Study||19
7686997|NCT01894581|18930529|P1|STARTED|Overall Study||20
7686998|NCT01894568|18930537|P2|NOT COMPLETED|Overall Study||10
7686999|NCT01894568|18930538|P1|NOT COMPLETED|Overall Study||10
7687000|NCT01894568|18930537|P2|COMPLETED|Overall Study||186
7687001|NCT01894568|18930538|P1|COMPLETED|Overall Study||182
7687002|NCT01894568|18930537|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
7687003|NCT01894568|18930538|P1|Received at Least 1 Dose of Study Drug|Overall Study||192
7687004|NCT01894568|18930537|P2|STARTED|Overall Study||196
7687005|NCT01894568|18930538|P1|STARTED|Overall Study||192
7687006|NCT01894555|18930578|P1|NOT COMPLETED|Overall Study||0
7687007|NCT01894555|18930578|P1|COMPLETED|Overall Study||33
7687008|NCT01894555|18930578|P1|STARTED|Overall Study||33
7687009|NCT01894516|18930586|P4|NOT COMPLETED|Period 2 (Week 13 to Week 24)||1
7687010|NCT01894516|18930587|P3|NOT COMPLETED|Period 2 (Week 13 to Week 24)||5
7687011|NCT01894516|18930588|P2|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
7687012|NCT01894516|18930589|P1|NOT COMPLETED|Period 2 (Week 13 to Week 24)||0
7687013|NCT01894516|18930586|P4|COMPLETED|Period 2 (Week 13 to Week 24)||65
7687014|NCT01894516|18930587|P3|COMPLETED|Period 2 (Week 13 to Week 24)||142
7687015|NCT01894516|18930588|P2|COMPLETED|Period 2 (Week 13 to Week 24)||50
7687016|NCT01894516|18930589|P1|COMPLETED|Period 2 (Week 13 to Week 24)||0
7687017|NCT01894516|18930586|P4|STARTED|Period 2 (Week 13 to Week 24)||66
7687018|NCT01894516|18930587|P3|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(65 participants) and 50 mg QD (15 participants) moved to 100 mg QD group.|147
7687019|NCT01894516|18930588|P2|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (15 participants).|52
7687020|NCT01894516|18930589|P1|STARTED|Period 2 (Week 13 to Week 24)|All participants from Placebo moved to 100 mg QD (65 participants) group.|0
7687021|NCT01894516|18930586|P4|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
7687022|NCT01894516|18930587|P3|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
7687023|NCT01894516|18930588|P2|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5
7687024|NCT01894516|18930589|P1|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7
7687025|NCT01894516|18930586|P4|COMPLETED|Period 1 (Baseline up to Week 12)||66
7687026|NCT01894516|18930587|P3|COMPLETED|Period 1 (Baseline up to Week 12)||67
7687027|NCT01894516|18930588|P2|COMPLETED|Period 1 (Baseline up to Week 12)||67
7687028|NCT01894516|18930589|P1|COMPLETED|Period 1 (Baseline up to Week 12)||65
7687029|NCT01894516|18930586|P4|STARTED|Period 1 (Baseline up to Week 12)||69
7687030|NCT01894516|18930587|P3|STARTED|Period 1 (Baseline up to Week 12)||70
7687031|NCT01894516|18930588|P2|STARTED|Period 1 (Baseline up to Week 12)||72
7687032|NCT01894516|18930589|P1|STARTED|Period 1 (Baseline up to Week 12)||72
7687033|NCT01894503|18930638|P1|NOT COMPLETED|Overall Study||0
7687034|NCT01894503|18930638|P1|COMPLETED|Overall Study||5
7687035|NCT01894503|18930638|P1|STARTED|Overall Study||5
7687036|NCT01894477|18930645|P2|NOT COMPLETED|Overall Study||2
7687037|NCT01894477|18930646|P1|NOT COMPLETED|Overall Study||0
7687038|NCT01894477|18930645|P2|COMPLETED|Overall Study||65
7687039|NCT01894477|18930646|P1|COMPLETED|Overall Study||35
7687040|NCT01894477|18930645|P2|STARTED|Overall Study||67
7687041|NCT01894477|18930646|P1|STARTED|Overall Study||35
7687042|NCT01894256|18930657|P3|NOT COMPLETED|Part B||14
7687043|NCT01894256|18930658|P2|NOT COMPLETED|Part B||14
7687044|NCT01894256|18930659|P1|NOT COMPLETED|Part B||15
7687045|NCT01894256|18930657|P3|COMPLETED|Part B||0
7687046|NCT01894256|18930658|P2|COMPLETED|Part B||0
7687047|NCT01894256|18930659|P1|COMPLETED|Part B||0
7687048|NCT01894256|18930657|P3|STARTED|Part B||14
7687049|NCT01894256|18930658|P2|STARTED|Part B||14
7687050|NCT01894256|18930659|P1|STARTED|Part B||15
7687051|NCT01894256|18930657|P3|NOT COMPLETED|Part A||0
7687052|NCT01894256|18930658|P2|NOT COMPLETED|Part A||1
7687053|NCT01894256|18930659|P1|NOT COMPLETED|Part A||0
7687054|NCT01894256|18930657|P3|COMPLETED|Part A||14
7687055|NCT01894256|18930658|P2|COMPLETED|Part A||14
7687056|NCT01894256|18930659|P1|COMPLETED|Part A||15
7687057|NCT01894256|18930657|P3|STARTED|Part A||14
7687058|NCT01894256|18930658|P2|STARTED|Part A||15
7687059|NCT01894256|18930659|P1|STARTED|Part A||15
7687060|NCT01894243|18930706|P3|NOT COMPLETED|Overall Study||8
7687061|NCT01894243|18930707|P2|NOT COMPLETED|Overall Study||10
7687062|NCT01894243|18930708|P1|NOT COMPLETED|Overall Study||13
7687063|NCT01894243|18930706|P3|COMPLETED|Overall Study||0
7687064|NCT01894243|18930707|P2|COMPLETED|Overall Study||0
7687065|NCT01894243|18930708|P1|COMPLETED|Overall Study||0
7687066|NCT01894243|18930706|P3|Ongoing Into Part B|Overall Study||8
7687067|NCT01894243|18930707|P2|Ongoing Into Part B|Overall Study||10
7687068|NCT01894243|18930708|P1|Ongoing Into Part B|Overall Study||13
7687069|NCT01894243|18930706|P3|Completed Treatment in Part A|Overall Study||8
7687070|NCT01894243|18930707|P2|Completed Treatment in Part A|Overall Study||10
7687071|NCT01894243|18930708|P1|Completed Treatment in Part A|Overall Study||13
7687072|NCT01894243|18930706|P3|STARTED|Overall Study||8
7687073|NCT01894243|18930707|P2|STARTED|Overall Study||10
7687074|NCT01894243|18930708|P1|STARTED|Overall Study||13
7687075|NCT01894230|18930747|P2|NOT COMPLETED|Overall Study||7
7687076|NCT01894230|18930748|P1|NOT COMPLETED|Overall Study||7
7687077|NCT01894230|18930747|P2|COMPLETED|Overall Study||69
7687078|NCT01894230|18930748|P1|COMPLETED|Overall Study||76
7687079|NCT01894230|18930747|P2|STARTED|Overall Study||76
7687080|NCT01894230|18930748|P1|STARTED|Overall Study||83
7687081|NCT01894178|18930774|P2|NOT COMPLETED|Overall Study||0
7687082|NCT01894178|18930775|P1|NOT COMPLETED|Overall Study||0
7687083|NCT01894178|18930774|P2|COMPLETED|Overall Study||30
7687084|NCT01894178|18930775|P1|COMPLETED|Overall Study||30
7687085|NCT01894178|18930774|P2|STARTED|Overall Study||30
7687086|NCT01894178|18930775|P1|STARTED|Overall Study||30
7687087|NCT01894152|18930783|P1|NOT COMPLETED|Overall Study||151
7687088|NCT01894152|18930783|P1|COMPLETED|Overall Study||1851
7687089|NCT01894152|18930783|P1|STARTED|Overall Study||2002
7687090|NCT01894100|18930826|P2|NOT COMPLETED|Overall Study||1
7687091|NCT01894100|18930827|P1|NOT COMPLETED|Overall Study||3
7687092|NCT01894100|18930826|P2|COMPLETED|Overall Study||14
7687093|NCT01894100|18930827|P1|COMPLETED|Overall Study||12
7687094|NCT01894100|18930826|P2|STARTED|Overall Study||15
7687095|NCT01894100|18930827|P1|STARTED|Overall Study||15
7687096|NCT01894087|18930837|P2|NOT COMPLETED|Overall Study||0
7687097|NCT01894087|18930838|P1|NOT COMPLETED|Overall Study||6
7687098|NCT01894087|18930837|P2|COMPLETED|Overall Study||102
7687099|NCT01894087|18930838|P1|COMPLETED|Overall Study||96
7687100|NCT01894087|18930837|P2|STARTED|Overall Study||102
7687101|NCT01894087|18930838|P1|STARTED|Overall Study||102
7687102|NCT01894022|18930852|P2|NOT COMPLETED|Overall Study||10
7687103|NCT01894022|18930853|P1|NOT COMPLETED|Overall Study||9
7687104|NCT01894022|18930852|P2|COMPLETED|Overall Study||0
7687105|NCT01894022|18930853|P1|COMPLETED|Overall Study||0
7687106|NCT01894022|18930852|P2|STARTED|Overall Study||10
7687107|NCT01894022|18930853|P1|STARTED|Overall Study||9
7687108|NCT01893983|18930907|P2|NOT COMPLETED|Overall Study||6
7687109|NCT01893983|18930908|P1|NOT COMPLETED|Overall Study||10
7687110|NCT01893983|18930907|P2|COMPLETED|Overall Study||134
7687111|NCT01893983|18930908|P1|COMPLETED|Overall Study||130
7687112|NCT01893983|18930907|P2|STARTED|Overall Study||140
7687113|NCT01893983|18930908|P1|STARTED|Overall Study||140
7687114|NCT01893905|18930922|P2|NOT COMPLETED|Overall Study||14
7687115|NCT01893905|18930923|P1|NOT COMPLETED|Overall Study||25
7687116|NCT01893905|18930922|P2|COMPLETED|Overall Study||64
7687117|NCT01893905|18930923|P1|COMPLETED|Overall Study||55
7687118|NCT01893905|18930922|P2|STARTED|Overall Study||78
7687119|NCT01893905|18930923|P1|STARTED|Overall Study||80
7687120|NCT01893879|18930931|P2|NOT COMPLETED|Overall Study||3
7687121|NCT01893879|18930932|P1|NOT COMPLETED|Overall Study||2
7687122|NCT01893879|18930931|P2|COMPLETED|Overall Study||4
7687123|NCT01893879|18930932|P1|COMPLETED|Overall Study||5
7687124|NCT01893879|18930931|P2|STARTED|Overall Study||7
7687125|NCT01893879|18930932|P1|STARTED|Overall Study||7
7687126|NCT01893827|18930940|P2|NOT COMPLETED|Overall Study||26
7687127|NCT01893827|18930941|P1|NOT COMPLETED|Overall Study||19
7687128|NCT01893827|18930940|P2|COMPLETED|Overall Study||94
7687129|NCT01893827|18930941|P1|COMPLETED|Overall Study||98
7687130|NCT01893827|18930940|P2|STARTED|Overall Study||120
7687131|NCT01893827|18930941|P1|STARTED|Overall Study||117
7687132|NCT01893801|18930947|P1|NOT COMPLETED|Overall Study||0
7687133|NCT01893801|18930947|P1|COMPLETED|Overall Study||25
7687134|NCT01893801|18930947|P1|STARTED|Overall Study||25
7687135|NCT01893632|18930957|P2|NOT COMPLETED|Overall Study||0
7687136|NCT01893632|18930958|P1|NOT COMPLETED|Overall Study||0
7687137|NCT01893632|18930957|P2|COMPLETED|Overall Study||1
7687138|NCT01893632|18930958|P1|COMPLETED|Overall Study||1
7687139|NCT01893632|18930957|P2|STARTED|Overall Study||1
7687140|NCT01893632|18930958|P1|STARTED|Overall Study||1
7687141|NCT01893567|18930964|P1|NOT COMPLETED|Overall Study||0
7687142|NCT01893567|18930964|P1|COMPLETED|Overall Study||28
7687143|NCT01893567|18930964|P1|STARTED|Overall Study||28
7687144|NCT01893411|18930971|P3|NOT COMPLETED|Overall Study||9
7687145|NCT01893411|18930972|P2|NOT COMPLETED|Overall Study||7
7687146|NCT01893411|18930973|P1|NOT COMPLETED|Overall Study||17
7687147|NCT01893411|18930971|P3|COMPLETED|Overall Study||69
7687148|NCT01893411|18930972|P2|COMPLETED|Overall Study||70
7687149|NCT01893411|18930973|P1|COMPLETED|Overall Study||139
7687150|NCT01893411|18930971|P3|STARTED|Overall Study||78
7687151|NCT01893411|18930972|P2|STARTED|Overall Study||77
7687152|NCT01893411|18930973|P1|STARTED|Overall Study||156
7687153|NCT01893372|18931037|P2|NOT COMPLETED|Overall Study||0
7687154|NCT01893372|18931038|P1|NOT COMPLETED|Overall Study||0
7687155|NCT01893372|18931037|P2|COMPLETED|Overall Study||22
7687156|NCT01893372|18931038|P1|COMPLETED|Overall Study||7
7687157|NCT01893372|18931037|P2|STARTED|Overall Study||22
7687158|NCT01893372|18931038|P1|STARTED|Overall Study||7
7687159|NCT01893359|18931053|P3|NOT COMPLETED|Overall Study||0
7687160|NCT01893359|18931054|P2|NOT COMPLETED|Overall Study||0
7687161|NCT01893359|18931055|P1|NOT COMPLETED|Overall Study||0
7687162|NCT01893359|18931053|P3|COMPLETED|Overall Study||0
7687163|NCT01893359|18931054|P2|COMPLETED|Overall Study||2
7687164|NCT01893359|18931055|P1|COMPLETED|Overall Study||0
7687165|NCT01893359|18931053|P3|STARTED|Overall Study||0
7687166|NCT01893359|18931054|P2|STARTED|Overall Study||2
7687167|NCT01893359|18931055|P1|STARTED|Overall Study||0
7687168|NCT01893346|18931070|P4|NOT COMPLETED|Overall Study||0
7687169|NCT01893346|18931071|P3|NOT COMPLETED|Overall Study||0
7687170|NCT01893346|18931072|P2|NOT COMPLETED|Overall Study||1
7687171|NCT01893346|18931073|P1|NOT COMPLETED|Overall Study||3
7687172|NCT01893346|18931070|P4|COMPLETED|Overall Study||8
7687173|NCT01893346|18931071|P3|COMPLETED|Overall Study||8
7687174|NCT01893346|18931072|P2|COMPLETED|Overall Study||7
7687175|NCT01893346|18931073|P1|COMPLETED|Overall Study||8
7687266|NCT01892189|18931307|P8|COMPLETED|Third Intervention Period (1 Day)||3
7687176|NCT01893346|18931070|P4|Patients Who Received Full Infusion|Overall Study||8
7687177|NCT01893346|18931071|P3|Patients Who Received Full Infusion|Overall Study||8
7687178|NCT01893346|18931072|P2|Patients Who Received Full Infusion|Overall Study||8
7687179|NCT01893346|18931073|P1|Patients Who Received Full Infusion|Overall Study||8
7687180|NCT01893346|18931070|P4|STARTED|Overall Study||8
7687181|NCT01893346|18931071|P3|STARTED|Overall Study||8
7687182|NCT01893346|18931072|P2|STARTED|Overall Study||8
7687183|NCT01893346|18931073|P1|STARTED|Overall Study||11
7687184|NCT01893281|18931087|P1|NOT COMPLETED|Overall Study||3
7687185|NCT01893281|18931087|P1|COMPLETED|Overall Study||75
7687186|NCT01893281|18931087|P1|Received at Least 1 Dose of Study Drug|Overall Study||78
7687187|NCT01893281|18931087|P1|STARTED|Overall Study||78
7687188|NCT01893203|18931094|P1|NOT COMPLETED|Overall Study||1
7687189|NCT01893203|18931094|P1|COMPLETED|Overall Study||13
7687190|NCT01893203|18931094|P1|STARTED|Overall Study||14
7687191|NCT01892865|18931103|P2|NOT COMPLETED|Overall Study||0
7687192|NCT01892865|18931104|P1|NOT COMPLETED|Overall Study||0
7687193|NCT01892865|18931103|P2|COMPLETED|Overall Study||379
7687194|NCT01892865|18931104|P1|COMPLETED|Overall Study||356
7687195|NCT01892865|18931103|P2|STARTED|Overall Study|100 operative days scheduled with the Predictive Modeling System method were included|379
7687196|NCT01892865|18931104|P1|STARTED|Overall Study|107 operative days scheduled with the Historical Means method were included|356
7687197|NCT01892722|18931118|P2|NOT COMPLETED|Overall Study||20
7687198|NCT01892722|18931119|P1|NOT COMPLETED|Overall Study||7
7687199|NCT01892722|18931118|P2|COMPLETED|Overall Study||88
7687200|NCT01892722|18931119|P1|COMPLETED|Overall Study||100
7687201|NCT01892722|18931118|P2|Full Analysis Set|Overall Study||107
7687202|NCT01892722|18931119|P1|Full Analysis Set|Overall Study||107
7687203|NCT01892722|18931118|P2|STARTED|Overall Study||108
7687204|NCT01892722|18931119|P1|STARTED|Overall Study||107
7687205|NCT01892709|18931125|P1|NOT COMPLETED|Overall Study||0
7687206|NCT01892709|18931125|P1|COMPLETED|Overall Study||215
7687207|NCT01892709|18931125|P1|STARTED|Overall Study||215
7687208|NCT01892657|18931135|P1|NOT COMPLETED|Overall Study||18
7687209|NCT01892657|18931135|P1|COMPLETED|Overall Study||110
7687210|NCT01892657|18931135|P1|STARTED|Overall Study||128
7687211|NCT01892540|18931154|P3|NOT COMPLETED|Overall Study||3
7687212|NCT01892540|18931155|P2|NOT COMPLETED|Overall Study||0
7687213|NCT01892540|18931156|P1|NOT COMPLETED|Overall Study||0
7687214|NCT01892540|18931154|P3|COMPLETED|Overall Study||25
7687215|NCT01892540|18931155|P2|COMPLETED|Overall Study||0
7687216|NCT01892540|18931156|P1|COMPLETED|Overall Study||15
7687217|NCT01892540|18931154|P3|STARTED|Overall Study||28
7687218|NCT01892540|18931155|P2|STARTED|Overall Study||0
7687219|NCT01892540|18931156|P1|STARTED|Overall Study||15
7687220|NCT01892436|18931177|P4|NOT COMPLETED|Overall Study||14
7687221|NCT01892436|18931178|P3|NOT COMPLETED|Overall Study||11
7687222|NCT01892436|18931179|P2|NOT COMPLETED|Overall Study||29
7687223|NCT01892436|18931180|P1|NOT COMPLETED|Overall Study||23
7687224|NCT01892436|18931177|P4|COMPLETED|Overall Study||61
7687225|NCT01892436|18931178|P3|COMPLETED|Overall Study||63
7687226|NCT01892436|18931179|P2|COMPLETED|Overall Study||132
7687227|NCT01892436|18931180|P1|COMPLETED|Overall Study||124
7687228|NCT01892436|18931177|P4|STARTED|Overall Study||75
7687229|NCT01892436|18931178|P3|STARTED|Overall Study||74
7687230|NCT01892436|18931179|P2|STARTED|Overall Study||161
7687231|NCT01892436|18931180|P1|STARTED|Overall Study||147
7687232|NCT01892345|18931220|P2|NOT COMPLETED|Overall Study||3
7687233|NCT01892345|18931221|P1|NOT COMPLETED|Overall Study||16
7687234|NCT01892345|18931220|P2|COMPLETED|Overall Study||44
7687235|NCT01892345|18931221|P1|COMPLETED|Overall Study||80
7687236|NCT01892345|18931220|P2|Received At Least 1 Dose Of Study Drug|Overall Study||47
7687237|NCT01892345|18931221|P1|Received At Least 1 Dose Of Study Drug|Overall Study||96
7687238|NCT01892345|18931220|P2|STARTED|Overall Study||47
7687239|NCT01892345|18931221|P1|STARTED|Overall Study||96
7687240|NCT01892306|18931241|P2|NOT COMPLETED|Overall Study||6
7687241|NCT01892306|18931242|P1|NOT COMPLETED|Overall Study||5
7687242|NCT01892306|18931241|P2|COMPLETED|Overall Study||10
7687243|NCT01892306|18931242|P1|COMPLETED|Overall Study||8
7687244|NCT01892306|18931241|P2|STARTED|Overall Study||16
7687245|NCT01892306|18931242|P1|STARTED|Overall Study||13
7687246|NCT01892293|18931262|P1|NOT COMPLETED|Overall Study||4
7687247|NCT01892293|18931262|P1|COMPLETED|Overall Study||2
7687248|NCT01892293|18931262|P1|Received T-cell|Overall Study||2
7687249|NCT01892293|18931262|P1|STARTED|Overall Study||6
7687250|NCT01892267|18931270|P2|NOT COMPLETED|Overall Study||0
7687251|NCT01892267|18931271|P1|NOT COMPLETED|Overall Study||0
7687252|NCT01892267|18931270|P2|COMPLETED|Overall Study||10
7687253|NCT01892267|18931271|P1|COMPLETED|Overall Study||9
7687254|NCT01892267|18931270|P2|STARTED|Overall Study||10
7687255|NCT01892267|18931271|P1|STARTED|Overall Study||9
7687256|NCT01892189|18931306|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
7687257|NCT01892189|18931307|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
7687258|NCT01892189|18931308|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
7687259|NCT01892189|18931309|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
7687260|NCT01892189|18931310|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
7687261|NCT01892189|18931311|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
7687262|NCT01892189|18931312|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
7687263|NCT01892189|18931313|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
7687264|NCT01892189|18931314|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
7687265|NCT01892189|18931306|P9|COMPLETED|Third Intervention Period (1 Day)||1
7687267|NCT01892189|18931308|P7|COMPLETED|Third Intervention Period (1 Day)||2
7687268|NCT01892189|18931309|P6|COMPLETED|Third Intervention Period (1 Day)||2
7687269|NCT01892189|18931310|P5|COMPLETED|Third Intervention Period (1 Day)||3
7687270|NCT01892189|18931311|P4|COMPLETED|Third Intervention Period (1 Day)||2
7687271|NCT01892189|18931312|P3|COMPLETED|Third Intervention Period (1 Day)||1
7687272|NCT01892189|18931313|P2|COMPLETED|Third Intervention Period (1 Day)||3
7687273|NCT01892189|18931314|P1|COMPLETED|Third Intervention Period (1 Day)||3
7687274|NCT01892189|18931306|P9|STARTED|Third Intervention Period (1 Day)||1
7687275|NCT01892189|18931307|P8|STARTED|Third Intervention Period (1 Day)||3
7687276|NCT01892189|18931308|P7|STARTED|Third Intervention Period (1 Day)||2
7687277|NCT01892189|18931309|P6|STARTED|Third Intervention Period (1 Day)||2
7687278|NCT01892189|18931310|P5|STARTED|Third Intervention Period (1 Day)||3
7687279|NCT01892189|18931311|P4|STARTED|Third Intervention Period (1 Day)||2
7687280|NCT01892189|18931312|P3|STARTED|Third Intervention Period (1 Day)||1
7687281|NCT01892189|18931313|P2|STARTED|Third Intervention Period (1 Day)||3
7687282|NCT01892189|18931314|P1|STARTED|Third Intervention Period (1 Day)||3
7687283|NCT01892189|18931306|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
7687284|NCT01892189|18931307|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
7687285|NCT01892189|18931308|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
7687286|NCT01892189|18931309|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
7687287|NCT01892189|18931310|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
7687288|NCT01892189|18931311|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
7687289|NCT01892189|18931312|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
7687290|NCT01892189|18931313|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
7687291|NCT01892189|18931314|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
7687292|NCT01892189|18931306|P9|COMPLETED|Washout Period 2 (7 Days)||1
7687293|NCT01892189|18931307|P8|COMPLETED|Washout Period 2 (7 Days)||3
7687294|NCT01892189|18931308|P7|COMPLETED|Washout Period 2 (7 Days)||2
7687295|NCT01892189|18931309|P6|COMPLETED|Washout Period 2 (7 Days)||2
7687296|NCT01892189|18931310|P5|COMPLETED|Washout Period 2 (7 Days)||3
7687297|NCT01892189|18931311|P4|COMPLETED|Washout Period 2 (7 Days)||2
7687298|NCT01892189|18931312|P3|COMPLETED|Washout Period 2 (7 Days)||1
7687299|NCT01892189|18931313|P2|COMPLETED|Washout Period 2 (7 Days)||3
7687300|NCT01892189|18931314|P1|COMPLETED|Washout Period 2 (7 Days)||3
7687301|NCT01892189|18931306|P9|STARTED|Washout Period 2 (7 Days)||1
7687302|NCT01892189|18931307|P8|STARTED|Washout Period 2 (7 Days)||3
7687303|NCT01892189|18931308|P7|STARTED|Washout Period 2 (7 Days)||2
7687304|NCT01892189|18931309|P6|STARTED|Washout Period 2 (7 Days)||2
7687305|NCT01892189|18931310|P5|STARTED|Washout Period 2 (7 Days)||3
7687306|NCT01892189|18931311|P4|STARTED|Washout Period 2 (7 Days)||2
7687307|NCT01892189|18931312|P3|STARTED|Washout Period 2 (7 Days)||1
7687308|NCT01892189|18931313|P2|STARTED|Washout Period 2 (7 Days)||3
7687309|NCT01892189|18931314|P1|STARTED|Washout Period 2 (7 Days)||3
7687310|NCT01892189|18931306|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
7687311|NCT01892189|18931307|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
7687312|NCT01892189|18931308|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
7687313|NCT01892189|18931309|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
7687314|NCT01892189|18931310|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
7687315|NCT01892189|18931311|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
7687316|NCT01892189|18931312|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
7687317|NCT01892189|18931313|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
7687318|NCT01892189|18931314|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
7687319|NCT01892189|18931306|P9|COMPLETED|Second Intervention Period (1 Day)||1
7687320|NCT01892189|18931307|P8|COMPLETED|Second Intervention Period (1 Day)||3
7687321|NCT01892189|18931308|P7|COMPLETED|Second Intervention Period (1 Day)||2
7687322|NCT01892189|18931309|P6|COMPLETED|Second Intervention Period (1 Day)||2
7687323|NCT01892189|18931310|P5|COMPLETED|Second Intervention Period (1 Day)||3
7687324|NCT01892189|18931311|P4|COMPLETED|Second Intervention Period (1 Day)||2
7687325|NCT01892189|18931312|P3|COMPLETED|Second Intervention Period (1 Day)||1
7687326|NCT01892189|18931313|P2|COMPLETED|Second Intervention Period (1 Day)||3
7687327|NCT01892189|18931314|P1|COMPLETED|Second Intervention Period (1 Day)||3
7687328|NCT01892189|18931306|P9|STARTED|Second Intervention Period (1 Day)||1
7687329|NCT01892189|18931307|P8|STARTED|Second Intervention Period (1 Day)||3
7687330|NCT01892189|18931308|P7|STARTED|Second Intervention Period (1 Day)||2
7687331|NCT01892189|18931309|P6|STARTED|Second Intervention Period (1 Day)||2
7687332|NCT01892189|18931310|P5|STARTED|Second Intervention Period (1 Day)||3
7687333|NCT01892189|18931311|P4|STARTED|Second Intervention Period (1 Day)||2
7687334|NCT01892189|18931312|P3|STARTED|Second Intervention Period (1 Day)||1
7687335|NCT01892189|18931313|P2|STARTED|Second Intervention Period (1 Day)||3
7687336|NCT01892189|18931314|P1|STARTED|Second Intervention Period (1 Day)||3
7687337|NCT01892189|18931306|P9|NOT COMPLETED|Washout Period 1 (7 Days)||2
7687338|NCT01892189|18931307|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
7687339|NCT01892189|18931308|P7|NOT COMPLETED|Washout Period 1 (7 Days)||1
7687340|NCT01892189|18931309|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
7687341|NCT01892189|18931310|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
7687342|NCT01892189|18931311|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
7687343|NCT01892189|18931312|P3|NOT COMPLETED|Washout Period 1 (7 Days)||2
7687344|NCT01892189|18931313|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
7687345|NCT01892189|18931314|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
7687346|NCT01892189|18931306|P9|COMPLETED|Washout Period 1 (7 Days)||1
7687347|NCT01892189|18931307|P8|COMPLETED|Washout Period 1 (7 Days)||3
7687348|NCT01892189|18931308|P7|COMPLETED|Washout Period 1 (7 Days)||2
7687349|NCT01892189|18931309|P6|COMPLETED|Washout Period 1 (7 Days)||2
7687350|NCT01892189|18931310|P5|COMPLETED|Washout Period 1 (7 Days)||3
7687351|NCT01892189|18931311|P4|COMPLETED|Washout Period 1 (7 Days)||2
7687352|NCT01892189|18931312|P3|COMPLETED|Washout Period 1 (7 Days)||1
7687353|NCT01892189|18931313|P2|COMPLETED|Washout Period 1 (7 Days)||3
7687354|NCT01892189|18931314|P1|COMPLETED|Washout Period 1 (7 Days)||3
7687355|NCT01892189|18931306|P9|STARTED|Washout Period 1 (7 Days)||3
7687356|NCT01892189|18931307|P8|STARTED|Washout Period 1 (7 Days)||3
7687357|NCT01892189|18931308|P7|STARTED|Washout Period 1 (7 Days)||3
7687358|NCT01892189|18931309|P6|STARTED|Washout Period 1 (7 Days)||3
7687359|NCT01892189|18931310|P5|STARTED|Washout Period 1 (7 Days)||3
7687360|NCT01892189|18931311|P4|STARTED|Washout Period 1 (7 Days)||3
7687361|NCT01892189|18931312|P3|STARTED|Washout Period 1 (7 Days)||3
7687362|NCT01892189|18931313|P2|STARTED|Washout Period 1 (7 Days)||3
7687363|NCT01892189|18931314|P1|STARTED|Washout Period 1 (7 Days)||3
7687364|NCT01892189|18931306|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
7687365|NCT01892189|18931307|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
7687366|NCT01892189|18931308|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
7687367|NCT01892189|18931309|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
7687368|NCT01892189|18931310|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
7687369|NCT01892189|18931311|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
7687370|NCT01892189|18931312|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
7687371|NCT01892189|18931313|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
7687372|NCT01892189|18931314|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
7687373|NCT01892189|18931306|P9|COMPLETED|First Intervention Period (1 Day)||3
7687374|NCT01892189|18931307|P8|COMPLETED|First Intervention Period (1 Day)||3
7687375|NCT01892189|18931308|P7|COMPLETED|First Intervention Period (1 Day)||3
7687376|NCT01892189|18931309|P6|COMPLETED|First Intervention Period (1 Day)||3
7687377|NCT01892189|18931310|P5|COMPLETED|First Intervention Period (1 Day)||3
7687378|NCT01892189|18931311|P4|COMPLETED|First Intervention Period (1 Day)||3
7687379|NCT01892189|18931312|P3|COMPLETED|First Intervention Period (1 Day)||3
7687380|NCT01892189|18931313|P2|COMPLETED|First Intervention Period (1 Day)||3
7687381|NCT01892189|18931314|P1|COMPLETED|First Intervention Period (1 Day)||3
7687382|NCT01892189|18931306|P9|STARTED|First Intervention Period (1 Day)||3
7687383|NCT01892189|18931307|P8|STARTED|First Intervention Period (1 Day)||3
7687384|NCT01892189|18931308|P7|STARTED|First Intervention Period (1 Day)||3
7687385|NCT01892189|18931309|P6|STARTED|First Intervention Period (1 Day)||3
7687386|NCT01892189|18931310|P5|STARTED|First Intervention Period (1 Day)||3
7687387|NCT01892189|18931311|P4|STARTED|First Intervention Period (1 Day)||3
7687388|NCT01892189|18931312|P3|STARTED|First Intervention Period (1 Day)||3
7687389|NCT01892189|18931313|P2|STARTED|First Intervention Period (1 Day)||3
7687390|NCT01892189|18931314|P1|STARTED|First Intervention Period (1 Day)||3
7687391|NCT01892163|18931356|P2|NOT COMPLETED|Overall Study||1
7687392|NCT01892163|18931357|P1|NOT COMPLETED|Overall Study||2
7687393|NCT01892163|18931356|P2|COMPLETED|Overall Study||49
7687394|NCT01892163|18931357|P1|COMPLETED|Overall Study||48
7687395|NCT01892163|18931356|P2|STARTED|Overall Study||50
7687396|NCT01892163|18931357|P1|STARTED|Overall Study||50
7687397|NCT01892020|18931369|P2|NOT COMPLETED|Period 2||0
7687398|NCT01892020|18931370|P1|NOT COMPLETED|Period 2||1
7687399|NCT01892020|18931369|P2|COMPLETED|Period 2||74
7687400|NCT01892020|18931370|P1|COMPLETED|Period 2||77
7687401|NCT01892020|18931369|P2|STARTED|Period 2||74
7687402|NCT01892020|18931370|P1|STARTED|Period 2||78
7687403|NCT01892020|18931369|P2|NOT COMPLETED|Period 1||6
7687404|NCT01892020|18931370|P1|NOT COMPLETED|Period 1||3
7687405|NCT01892020|18931369|P2|COMPLETED|Period 1||74
7687406|NCT01892020|18931370|P1|COMPLETED|Period 1||78
7687407|NCT01892020|18931369|P2|STARTED|Period 1||80
7687408|NCT01892020|18931370|P1|STARTED|Period 1||81
7687409|NCT01892007|18931390|P2|NOT COMPLETED|Overall Study||0
7687410|NCT01892007|18931391|P1|NOT COMPLETED|Overall Study||0
7687411|NCT01892007|18931390|P2|COMPLETED|Overall Study||30
7687412|NCT01892007|18931391|P1|COMPLETED|Overall Study||27
7687413|NCT01892007|18931390|P2|STARTED|Overall Study||30
7687414|NCT01892007|18931391|P1|STARTED|Overall Study||27
7687415|NCT01891994|18931417|P1|NOT COMPLETED|Overall Study||0
7687416|NCT01891994|18931417|P1|COMPLETED|Overall Study||40
7687417|NCT01891994|18931417|P1|STARTED|Overall Study||40
7687418|NCT01891968|18931421|P1|NOT COMPLETED|Overall Study||0
7687419|NCT01891968|18931421|P1|COMPLETED|Overall Study||15
7687420|NCT01891968|18931421|P1|STARTED|Overall Study||15
7687421|NCT01891890|18931428|P3|NOT COMPLETED|Overall Study||7
7687422|NCT01891890|18931429|P2|NOT COMPLETED|Overall Study||3
7687423|NCT01891890|18931430|P1|NOT COMPLETED|Overall Study||7
7687424|NCT01891890|18931428|P3|COMPLETED|Overall Study||14
7687425|NCT01891890|18931429|P2|COMPLETED|Overall Study||24
7687426|NCT01891890|18931430|P1|COMPLETED|Overall Study||17
7687427|NCT01891890|18931428|P3|STARTED|Overall Study||21
7687428|NCT01891890|18931429|P2|STARTED|Overall Study||27
7687429|NCT01891890|18931430|P1|STARTED|Overall Study||24
7687430|NCT01891864|18931473|P6|NOT COMPLETED|Extension Period||0
7687431|NCT01891864|18931474|P5|NOT COMPLETED|Extension Period||7
7687432|NCT01891864|18931475|P4|NOT COMPLETED|Extension Period||5
7687433|NCT01891864|18931476|P3|NOT COMPLETED|Extension Period||8
7687434|NCT01891864|18931477|P2|NOT COMPLETED|Extension Period||0
7687435|NCT01891864|18931478|P1|NOT COMPLETED|Extension Period||0
7687436|NCT01891864|18931473|P6|COMPLETED|Extension Period||90
7687437|NCT01891864|18931474|P5|COMPLETED|Extension Period||88
7687438|NCT01891864|18931475|P4|COMPLETED|Extension Period||137
7687439|NCT01891864|18931476|P3|COMPLETED|Extension Period||132
7687440|NCT01891864|18931477|P2|COMPLETED|Extension Period||0
7687441|NCT01891864|18931478|P1|COMPLETED|Extension Period||0
7687442|NCT01891864|18931473|P6|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to an adverse event|90
7687443|NCT01891864|18931474|P5|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to lack of efficacy|95
7687444|NCT01891864|18931475|P4|STARTED|Extension Period||142
7687445|NCT01891864|18931476|P3|STARTED|Extension Period|2 patients withdrew consent 1 patient lost to FU between Treatment Period 2 and the Extension period|140
7687446|NCT01891864|18931477|P2|STARTED|Extension Period||0
7687447|NCT01891864|18931478|P1|STARTED|Extension Period||0
7687448|NCT01891864|18931473|P6|NOT COMPLETED|Treatment Period 2||5
7687449|NCT01891864|18931474|P5|NOT COMPLETED|Treatment Period 2||4
7687450|NCT01891864|18931475|P4|NOT COMPLETED|Treatment Period 2||9
7687451|NCT01891864|18931476|P3|NOT COMPLETED|Treatment Period 2||7
7687452|NCT01891864|18931477|P2|NOT COMPLETED|Treatment Period 2||0
7687453|NCT01891864|18931478|P1|NOT COMPLETED|Treatment Period 2||0
7687454|NCT01891864|18931473|P6|COMPLETED|Treatment Period 2||91
7687455|NCT01891864|18931474|P5|COMPLETED|Treatment Period 2||96
7687456|NCT01891864|18931475|P4|COMPLETED|Treatment Period 2||142
7687457|NCT01891864|18931476|P3|COMPLETED|Treatment Period 2||143
7687458|NCT01891864|18931477|P2|COMPLETED|Treatment Period 2||0
7687459|NCT01891864|18931478|P1|COMPLETED|Treatment Period 2||0
7687460|NCT01891864|18931473|P6|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|96
7687461|NCT01891864|18931474|P5|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|100
7687462|NCT01891864|18931475|P4|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|151
7687463|NCT01891864|18931476|P3|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|150
7687464|NCT01891864|18931477|P2|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
7687465|NCT01891864|18931478|P1|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
7687466|NCT01891864|18931473|P6|NOT COMPLETED|Treatment Period 1||0
7687467|NCT01891864|18931474|P5|NOT COMPLETED|Treatment Period 1||0
7687468|NCT01891864|18931475|P4|NOT COMPLETED|Treatment Period 1||0
7687469|NCT01891864|18931476|P3|NOT COMPLETED|Treatment Period 1||0
7687470|NCT01891864|18931477|P2|NOT COMPLETED|Treatment Period 1||12
7687471|NCT01891864|18931478|P1|NOT COMPLETED|Treatment Period 1||8
7687472|NCT01891864|18931473|P6|COMPLETED|Treatment Period 1||0
7687473|NCT01891864|18931474|P5|COMPLETED|Treatment Period 1||0
7687474|NCT01891864|18931475|P4|COMPLETED|Treatment Period 1||0
7687475|NCT01891864|18931476|P3|COMPLETED|Treatment Period 1||0
7687476|NCT01891864|18931477|P2|COMPLETED|Treatment Period 1|8 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|255
7687477|NCT01891864|18931478|P1|COMPLETED|Treatment Period 1|6 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|256
7687478|NCT01891864|18931473|P6|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
7687479|NCT01891864|18931474|P5|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
7687480|NCT01891864|18931475|P4|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
7687481|NCT01891864|18931476|P3|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
7687482|NCT01891864|18931477|P2|STARTED|Treatment Period 1||267
7687483|NCT01891864|18931478|P1|STARTED|Treatment Period 1||264
7687484|NCT01891734|18931500|P2|NOT COMPLETED|Overall Study||3
7687485|NCT01891734|18931501|P1|NOT COMPLETED|Overall Study||3
7687486|NCT01891734|18931500|P2|COMPLETED|Overall Study||13
7687487|NCT01891734|18931501|P1|COMPLETED|Overall Study||14
7687488|NCT01891734|18931500|P2|STARTED|Overall Study||16
7687489|NCT01891734|18931501|P1|STARTED|Overall Study||17
7687490|NCT01891721|18931514|P3|NOT COMPLETED|Overall Study||1
7687491|NCT01891721|18931515|P2|NOT COMPLETED|Overall Study||5
7687492|NCT01891721|18931516|P1|NOT COMPLETED|Overall Study||10
7687493|NCT01891721|18931514|P3|COMPLETED|Overall Study||19
7687494|NCT01891721|18931515|P2|COMPLETED|Overall Study||35
7687495|NCT01891721|18931516|P1|COMPLETED|Overall Study||29
7687496|NCT01891721|18931514|P3|STARTED|Overall Study||20
7687497|NCT01891721|18931515|P2|STARTED|Overall Study||40
7687498|NCT01891721|18931516|P1|STARTED|Overall Study||39
7687499|NCT01891669|18931540|P10|NOT COMPLETED|Overall Study||2
7687500|NCT01891669|18931541|P9|NOT COMPLETED|Overall Study||1
7687501|NCT01891669|18931542|P8|NOT COMPLETED|Overall Study||4
7687502|NCT01891669|18931543|P7|NOT COMPLETED|Overall Study||1
7687503|NCT01891669|18931544|P6|NOT COMPLETED|Overall Study||0
7687504|NCT01891669|18931545|P5|NOT COMPLETED|Overall Study||0
7687505|NCT01891669|18931546|P4|NOT COMPLETED|Overall Study||0
7687506|NCT01891669|18931547|P3|NOT COMPLETED|Overall Study||0
7687507|NCT01891669|18931548|P2|NOT COMPLETED|Overall Study||1
7687508|NCT01891669|18931549|P1|NOT COMPLETED|Overall Study||2
7687509|NCT01891669|18931540|P10|COMPLETED|Overall Study||1
7687510|NCT01891669|18931541|P9|COMPLETED|Overall Study||2
7687511|NCT01891669|18931542|P8|COMPLETED|Overall Study||2
7687512|NCT01891669|18931543|P7|COMPLETED|Overall Study||1
7687513|NCT01891669|18931544|P6|COMPLETED|Overall Study||2
7687514|NCT01891669|18931545|P5|COMPLETED|Overall Study||2
7687515|NCT01891669|18931546|P4|COMPLETED|Overall Study||2
7687516|NCT01891669|18931547|P3|COMPLETED|Overall Study||2
7687517|NCT01891669|18931548|P2|COMPLETED|Overall Study||1
7687518|NCT01891669|18931549|P1|COMPLETED|Overall Study||0
7687519|NCT01891669|18931540|P10|STARTED|Overall Study||3
7687520|NCT01891669|18931541|P9|STARTED|Overall Study||3
7687521|NCT01891669|18931542|P8|STARTED|Overall Study||6
7687522|NCT01891669|18931543|P7|STARTED|Overall Study||2
7687523|NCT01891669|18931544|P6|STARTED|Overall Study||2
7687524|NCT01891669|18931545|P5|STARTED|Overall Study||2
7687525|NCT01891669|18931546|P4|STARTED|Overall Study||2
7687526|NCT01891669|18931547|P3|STARTED|Overall Study||2
7687527|NCT01891669|18931548|P2|STARTED|Overall Study||2
7687528|NCT01891669|18931549|P1|STARTED|Overall Study||2
7687529|NCT01891357|18931700|P1|NOT COMPLETED|Overall Study||3
7687530|NCT01891357|18931700|P1|COMPLETED|Overall Study||61
7687531|NCT01891357|18931700|P1|STARTED|Overall Study||64
7687532|NCT01891331|18931711|P4|NOT COMPLETED|Overall Study||2
7687533|NCT01891331|18931712|P3|NOT COMPLETED|Overall Study||1
7687534|NCT01891331|18931713|P2|NOT COMPLETED|Overall Study||2
7687535|NCT01891331|18931714|P1|NOT COMPLETED|Overall Study||2
7687536|NCT01891331|18931711|P4|COMPLETED|Overall Study||13
7687537|NCT01891331|18931712|P3|COMPLETED|Overall Study||13
7687538|NCT01891331|18931713|P2|COMPLETED|Overall Study||10
7687539|NCT01891331|18931714|P1|COMPLETED|Overall Study||12
7687540|NCT01891331|18931711|P4|STARTED|Overall Study||15
7687541|NCT01891331|18931712|P3|STARTED|Overall Study||14
7687542|NCT01891331|18931713|P2|STARTED|Overall Study||12
7687543|NCT01891331|18931714|P1|STARTED|Overall Study||14
7687544|NCT01891305|18931728|P4|NOT COMPLETED|Overall Study||0
7687545|NCT01891305|18931729|P3|NOT COMPLETED|Overall Study||3
7687546|NCT01891305|18931730|P2|NOT COMPLETED|Overall Study||1
7687547|NCT01891305|18931731|P1|NOT COMPLETED|Overall Study||3
7687548|NCT01891305|18931728|P4|COMPLETED|Overall Study||12
7687549|NCT01891305|18931729|P3|COMPLETED|Overall Study||11
7687550|NCT01891305|18931730|P2|COMPLETED|Overall Study||11
7687551|NCT01891305|18931731|P1|COMPLETED|Overall Study||9
7687552|NCT01891305|18931728|P4|STARTED|Overall Study||12
7687553|NCT01891305|18931729|P3|STARTED|Overall Study||14
7687554|NCT01891305|18931730|P2|STARTED|Overall Study||12
7687555|NCT01891305|18931731|P1|STARTED|Overall Study||12
7687556|NCT01890967|18931747|P6|NOT COMPLETED|Overall Study||13
7687557|NCT01890967|18931748|P5|NOT COMPLETED|Overall Study||10
7687558|NCT01890967|18931749|P4|NOT COMPLETED|Overall Study||11
7687559|NCT01890967|18931750|P3|NOT COMPLETED|Overall Study||10
7687560|NCT01890967|18931751|P2|NOT COMPLETED|Overall Study||11
7687561|NCT01890967|18931752|P1|NOT COMPLETED|Overall Study||10
7687562|NCT01890967|18931747|P6|COMPLETED|Overall Study||75
7687563|NCT01890967|18931748|P5|COMPLETED|Overall Study||77
7687564|NCT01890967|18931749|P4|COMPLETED|Overall Study||77
7687565|NCT01890967|18931750|P3|COMPLETED|Overall Study||78
7687566|NCT01890967|18931751|P2|COMPLETED|Overall Study||77
7687567|NCT01890967|18931752|P1|COMPLETED|Overall Study||78
7687568|NCT01890967|18931747|P6|Received at Least One Dose of Study Drug|Overall Study||87
7687569|NCT01890967|18931748|P5|Received at Least One Dose of Study Drug|Overall Study||86
7687570|NCT01890967|18931749|P4|Received at Least One Dose of Study Drug|Overall Study||86
7687571|NCT01890967|18931750|P3|Received at Least One Dose of Study Drug|Overall Study||86
7687572|NCT01890967|18931751|P2|Received at Least One Dose of Study Drug|Overall Study||87
7687573|NCT01890967|18931752|P1|Received at Least One Dose of Study Drug|Overall Study||87
7687574|NCT01890967|18931747|P6|STARTED|Overall Study||88
7687575|NCT01890967|18931748|P5|STARTED|Overall Study||87
7687576|NCT01890967|18931749|P4|STARTED|Overall Study||88
7687577|NCT01890967|18931750|P3|STARTED|Overall Study||88
7687578|NCT01890967|18931751|P2|STARTED|Overall Study||88
7687579|NCT01890967|18931752|P1|STARTED|Overall Study||88
7687580|NCT01890954|18931821|P2|NOT COMPLETED|Overall Study||0
7687581|NCT01890954|18931822|P1|NOT COMPLETED|Overall Study||1
7687582|NCT01890954|18931821|P2|COMPLETED|Overall Study||8
7687583|NCT01890954|18931822|P1|COMPLETED|Overall Study||8
7687584|NCT01890954|18931821|P2|STARTED|Overall Study||8
7687585|NCT01890954|18931822|P1|STARTED|Overall Study||9
7687586|NCT01890915|18931830|P2|NOT COMPLETED|Overall Study||1
7687587|NCT01890915|18931831|P1|NOT COMPLETED|Overall Study||3
7687588|NCT01890915|18931830|P2|COMPLETED|Overall Study||9
7687589|NCT01890915|18931831|P1|COMPLETED|Overall Study||8
7687590|NCT01890915|18931830|P2|STARTED|Overall Study||10
7687591|NCT01890915|18931831|P1|STARTED|Overall Study||11
7687592|NCT01890785|18931847|P6|NOT COMPLETED|Third Intervention||0
7687593|NCT01890785|18931848|P5|NOT COMPLETED|Third Intervention||0
7687594|NCT01890785|18931849|P4|NOT COMPLETED|Third Intervention||0
7687595|NCT01890785|18931850|P3|NOT COMPLETED|Third Intervention||0
7687596|NCT01890785|18931851|P2|NOT COMPLETED|Third Intervention||1
7687597|NCT01890785|18931852|P1|NOT COMPLETED|Third Intervention||0
7687598|NCT01890785|18931847|P6|COMPLETED|Third Intervention||5
7687599|NCT01890785|18931848|P5|COMPLETED|Third Intervention||5
7687600|NCT01890785|18931849|P4|COMPLETED|Third Intervention||5
7687601|NCT01890785|18931850|P3|COMPLETED|Third Intervention||5
7687602|NCT01890785|18931851|P2|COMPLETED|Third Intervention||4
7687603|NCT01890785|18931852|P1|COMPLETED|Third Intervention||5
7687604|NCT01890785|18931847|P6|STARTED|Third Intervention||5
7687605|NCT01890785|18931848|P5|STARTED|Third Intervention||5
7687606|NCT01890785|18931849|P4|STARTED|Third Intervention||5
7687607|NCT01890785|18931850|P3|STARTED|Third Intervention||5
7687608|NCT01890785|18931851|P2|STARTED|Third Intervention||5
7687609|NCT01890785|18931852|P1|STARTED|Third Intervention||5
7687610|NCT01890785|18931847|P6|NOT COMPLETED|Second Intervention||0
7687611|NCT01890785|18931848|P5|NOT COMPLETED|Second Intervention||0
7687612|NCT01890785|18931849|P4|NOT COMPLETED|Second Intervention||0
7687613|NCT01890785|18931850|P3|NOT COMPLETED|Second Intervention||0
7687614|NCT01890785|18931851|P2|NOT COMPLETED|Second Intervention||0
7687615|NCT01890785|18931852|P1|NOT COMPLETED|Second Intervention||0
7687616|NCT01890785|18931847|P6|COMPLETED|Second Intervention||5
7687617|NCT01890785|18931848|P5|COMPLETED|Second Intervention||5
7687618|NCT01890785|18931849|P4|COMPLETED|Second Intervention||5
7687619|NCT01890785|18931850|P3|COMPLETED|Second Intervention||5
7687620|NCT01890785|18931851|P2|COMPLETED|Second Intervention||5
7687621|NCT01890785|18931852|P1|COMPLETED|Second Intervention||5
7687622|NCT01890785|18931847|P6|STARTED|Second Intervention||5
7687623|NCT01890785|18931848|P5|STARTED|Second Intervention||5
7687624|NCT01890785|18931849|P4|STARTED|Second Intervention||5
7687625|NCT01890785|18931850|P3|STARTED|Second Intervention||5
7687626|NCT01890785|18931851|P2|STARTED|Second Intervention||5
7687627|NCT01890785|18931852|P1|STARTED|Second Intervention||5
7687628|NCT01890785|18931847|P6|NOT COMPLETED|First Intervention||0
7687629|NCT01890785|18931848|P5|NOT COMPLETED|First Intervention||0
7687630|NCT01890785|18931849|P4|NOT COMPLETED|First Intervention||0
7687631|NCT01890785|18931850|P3|NOT COMPLETED|First Intervention||0
7687632|NCT01890785|18931851|P2|NOT COMPLETED|First Intervention||0
7687633|NCT01890785|18931852|P1|NOT COMPLETED|First Intervention||0
7687634|NCT01890785|18931847|P6|COMPLETED|First Intervention||5
7687635|NCT01890785|18931848|P5|COMPLETED|First Intervention||5
7687636|NCT01890785|18931849|P4|COMPLETED|First Intervention||5
7687637|NCT01890785|18931850|P3|COMPLETED|First Intervention||5
7687638|NCT01890785|18931851|P2|COMPLETED|First Intervention||5
7687639|NCT01890785|18931852|P1|COMPLETED|First Intervention||5
7687640|NCT01890785|18931847|P6|STARTED|First Intervention||5
7687641|NCT01890785|18931848|P5|STARTED|First Intervention||5
7687642|NCT01890785|18931849|P4|STARTED|First Intervention||5
7687643|NCT01890785|18931850|P3|STARTED|First Intervention||5
7687644|NCT01890785|18931851|P2|STARTED|First Intervention||5
7687645|NCT01890785|18931852|P1|STARTED|First Intervention||5
7687646|NCT01890759|18931871|P2|NOT COMPLETED|Overall Study||12
7687647|NCT01890759|18931872|P1|NOT COMPLETED|Overall Study||2
7687648|NCT01890759|18931871|P2|COMPLETED|Overall Study||188
7687649|NCT01890759|18931872|P1|COMPLETED|Overall Study||98
7687650|NCT01890759|18931871|P2|STARTED|Overall Study||200
7687651|NCT01890759|18931872|P1|STARTED|Overall Study||100
7687652|NCT01890746|18931906|P2|NOT COMPLETED|Overall Study||41
7687653|NCT01890746|18931907|P1|NOT COMPLETED|Overall Study||52
7687654|NCT01890746|18931906|P2|COMPLETED|Overall Study||33
7687655|NCT01890746|18931907|P1|COMPLETED|Overall Study||22
7687656|NCT01890746|18931906|P2|STARTED|Overall Study||74
7687657|NCT01890746|18931907|P1|STARTED|Overall Study||74
7687658|NCT01890707|18931993|P2|NOT COMPLETED|Overall Study||1
7687659|NCT01890707|18931994|P1|NOT COMPLETED|Overall Study||1
7687660|NCT01890707|18931993|P2|COMPLETED|Overall Study||7
7687661|NCT01890707|18931994|P1|COMPLETED|Overall Study||10
7687662|NCT01890707|18931993|P2|STARTED|Overall Study||8
7687663|NCT01890707|18931994|P1|STARTED|Overall Study||11
7687664|NCT01890694|18932002|P2|NOT COMPLETED|Overall Study||1
7687665|NCT01890694|18932003|P1|NOT COMPLETED|Overall Study||1
7687666|NCT01890694|18932002|P2|COMPLETED|Overall Study||0
7687667|NCT01890694|18932003|P1|COMPLETED|Overall Study||0
7687668|NCT01890694|18932002|P2|STARTED|Overall Study||1
7687669|NCT01890694|18932003|P1|STARTED|Overall Study||1
7687670|NCT01890642|18932038|P3|NOT COMPLETED|Overall Study||0
7687671|NCT01890642|18932039|P2|NOT COMPLETED|Overall Study||0
7687672|NCT01890642|18932040|P1|NOT COMPLETED|Overall Study||0
7687673|NCT01890642|18932038|P3|COMPLETED|Overall Study||96
7687674|NCT01890642|18932039|P2|COMPLETED|Overall Study||53
7687675|NCT01890642|18932040|P1|COMPLETED|Overall Study||56
7687676|NCT01890642|18932038|P3|STARTED|Overall Study||96
7687677|NCT01890642|18932039|P2|STARTED|Overall Study||53
7687678|NCT01890642|18932040|P1|STARTED|Overall Study||56
7687679|NCT01890577|18932060|P1|NOT COMPLETED|Overall Study||28
7687680|NCT01890577|18932060|P1|COMPLETED|Overall Study||0
7687681|NCT01890577|18932060|P1|STARTED|Overall Study||28
7687682|NCT01890512|18932073|P1|NOT COMPLETED|Overall Study||3
7687683|NCT01890512|18932073|P1|COMPLETED|Overall Study||17
7687684|NCT01890512|18932073|P1|STARTED|Overall Study||20
7687685|NCT01890473|18932079|P2|NOT COMPLETED|Overall Study||0
7687686|NCT01890473|18932080|P1|NOT COMPLETED|Overall Study||2
7687687|NCT01890473|18932079|P2|COMPLETED|Overall Study||113
7687688|NCT01890473|18932080|P1|COMPLETED|Overall Study||109
7687689|NCT01890473|18932079|P2|STARTED|Overall Study||113
7687690|NCT01890473|18932080|P1|STARTED|Overall Study||111
7687691|NCT01890434|18932106|P1|NOT COMPLETED|Overall Study||20
7687692|NCT01890434|18932106|P1|COMPLETED|Overall Study||458
7687693|NCT01890434|18932106|P1|Evaluated for Efficacy|Overall Study||389
7687694|NCT01890434|18932106|P1|STARTED|Overall Study||478
7687695|NCT01890421|18932136|P1|NOT COMPLETED|Overall Study||11
7687696|NCT01890421|18932136|P1|COMPLETED|Overall Study||415
7687697|NCT01890421|18932136|P1|STARTED|Overall Study||426
7687698|NCT01890343|18932162|P3|NOT COMPLETED|Overall Study||0
7687699|NCT01890343|18932163|P2|NOT COMPLETED|Overall Study||0
7687700|NCT01890343|18932164|P1|NOT COMPLETED|Overall Study||0
7687701|NCT01890343|18932162|P3|COMPLETED|Overall Study||10
7687702|NCT01890343|18932163|P2|COMPLETED|Overall Study||10
7687703|NCT01890343|18932164|P1|COMPLETED|Overall Study||8
7687704|NCT01890343|18932162|P3|STARTED|Overall Study||10
7687705|NCT01890343|18932163|P2|STARTED|Overall Study||10
7687706|NCT01890343|18932164|P1|STARTED|Overall Study||8
7687707|NCT01890265|18932181|P6|NOT COMPLETED|Overall Study||0
7687708|NCT01890265|18932182|P5|NOT COMPLETED|Overall Study||2
7687709|NCT01890265|18932183|P4|NOT COMPLETED|Overall Study||0
7687710|NCT01890265|18932184|P3|NOT COMPLETED|Overall Study||4
7687711|NCT01890265|18932185|P2|NOT COMPLETED|Overall Study||13
7687712|NCT01890265|18932186|P1|NOT COMPLETED|Overall Study||10
7687713|NCT01890265|18932181|P6|COMPLETED|Overall Study||6
7687714|NCT01890265|18932182|P5|COMPLETED|Overall Study||13
7687715|NCT01890265|18932183|P4|COMPLETED|Overall Study||12
7687716|NCT01890265|18932184|P3|COMPLETED|Overall Study||20
7687717|NCT01890265|18932185|P2|COMPLETED|Overall Study||40
7687718|NCT01890265|18932186|P1|COMPLETED|Overall Study||40
7687719|NCT01890265|18932181|P6|Intent-to-Treat (ITT) Population|Overall Study||6
7687720|NCT01890265|18932182|P5|Intent-to-Treat (ITT) Population|Overall Study||15
7687721|NCT01890265|18932183|P4|Intent-to-Treat (ITT) Population|Overall Study||12
7687722|NCT01890265|18932184|P3|Intent-to-Treat (ITT) Population|Overall Study||24
7687723|NCT01890265|18932185|P2|Intent-to-Treat (ITT) Population|Overall Study||51
7687724|NCT01890265|18932186|P1|Intent-to-Treat (ITT) Population|Overall Study||50
7687725|NCT01890265|18932181|P6|Safety Population|Overall Study||6
7687726|NCT01890265|18932182|P5|Safety Population|Overall Study||15
7687727|NCT01890265|18932183|P4|Safety Population|Overall Study||12
7687728|NCT01890265|18932184|P3|Safety Population|Overall Study||24
7687729|NCT01890265|18932185|P2|Safety Population|Overall Study||53
7687730|NCT01890265|18932186|P1|Safety Population|Overall Study||50
7687731|NCT01890265|18932181|P6|STARTED|Overall Study||6
7687732|NCT01890265|18932182|P5|STARTED|Overall Study||15
7687733|NCT01890265|18932183|P4|STARTED|Overall Study||12
7687734|NCT01890265|18932184|P3|STARTED|Overall Study||24
7687735|NCT01890265|18932185|P2|STARTED|Overall Study||53
7687736|NCT01890265|18932186|P1|STARTED|Overall Study||50
7687737|NCT01890226|18932210|P2|NOT COMPLETED|Overall Study||0
7687738|NCT01890226|18932211|P1|NOT COMPLETED|Overall Study||0
7687739|NCT01890226|18932210|P2|COMPLETED|Overall Study||156
7687740|NCT01890226|18932211|P1|COMPLETED|Overall Study||155
7687741|NCT01890226|18932210|P2|STARTED|Overall Study||156
7687742|NCT01890226|18932211|P1|STARTED|Overall Study||155
7687743|NCT01890148|18932223|P1|NOT COMPLETED|Overall Study||1
7687744|NCT01890148|18932223|P1|COMPLETED|Overall Study||4
7687745|NCT01890148|18932223|P1|STARTED|Overall Study||5
7687746|NCT01890122|18932243|P4|NOT COMPLETED|Overall Study||59
7687747|NCT01890122|18932244|P3|NOT COMPLETED|Overall Study||13
7687748|NCT01890122|18932245|P2|NOT COMPLETED|Overall Study||37
7687749|NCT01890122|18932246|P1|NOT COMPLETED|Overall Study||27
7687750|NCT01890122|18932243|P4|COMPLETED|Overall Study||104
7687751|NCT01890122|18932244|P3|COMPLETED|Overall Study||146
7687752|NCT01890122|18932245|P2|COMPLETED|Overall Study||126
7687753|NCT01890122|18932246|P1|COMPLETED|Overall Study||135
7687754|NCT01890122|18932243|P4|Treated|Overall Study||163
7687755|NCT01890122|18932244|P3|Treated|Overall Study||159
7687756|NCT01890122|18932245|P2|Treated|Overall Study||162
7687757|NCT01890122|18932246|P1|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161
7687758|NCT01890122|18932243|P4|STARTED|Overall Study||163
7687759|NCT01890122|18932244|P3|STARTED|Overall Study||159
7687760|NCT01890122|18932245|P2|STARTED|Overall Study||163
7687761|NCT01890122|18932246|P1|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162
7687762|NCT01890109|18932310|P2|NOT COMPLETED|Overall Study||5
7687763|NCT01890109|18932311|P1|NOT COMPLETED|Overall Study||1
7687764|NCT01890109|18932310|P2|COMPLETED|Overall Study||46
7687765|NCT01890109|18932311|P1|COMPLETED|Overall Study||51
7687766|NCT01890109|18932310|P2|Received Study Treatment|Overall Study||50
7687767|NCT01890109|18932311|P1|Received Study Treatment|Overall Study||52
7687768|NCT01890109|18932310|P2|STARTED|Overall Study||51
7687769|NCT01890109|18932311|P1|STARTED|Overall Study||52
7687770|NCT01890031|18932335|P5|NOT COMPLETED|Overall Study||0
7687771|NCT01890031|18932336|P4|NOT COMPLETED|Overall Study||0
7687772|NCT01890031|18932337|P3|NOT COMPLETED|Overall Study||0
7687773|NCT01890031|18932338|P2|NOT COMPLETED|Overall Study||0
7687774|NCT01890031|18932339|P1|NOT COMPLETED|Overall Study||0
7687775|NCT01890031|18932335|P5|COMPLETED|Overall Study||8
7687776|NCT01890031|18932336|P4|COMPLETED|Overall Study||11
7687777|NCT01890031|18932337|P3|COMPLETED|Overall Study||12
7687778|NCT01890031|18932338|P2|COMPLETED|Overall Study||50
7687779|NCT01890031|18932339|P1|COMPLETED|Overall Study||50
7687780|NCT01890031|18932335|P5|STARTED|Overall Study||8
7687781|NCT01890031|18932336|P4|STARTED|Overall Study||11
7687782|NCT01890031|18932337|P3|STARTED|Overall Study||12
7687783|NCT01890031|18932338|P2|STARTED|Overall Study||50
7687784|NCT01890031|18932339|P1|STARTED|Overall Study||50
7687785|NCT01889862|18932360|P4|NOT COMPLETED|Overall Study||0
7687786|NCT01889862|18932361|P3|NOT COMPLETED|Overall Study||1
7687787|NCT01889862|18932362|P2|NOT COMPLETED|Overall Study||0
7687788|NCT01889862|18932363|P1|NOT COMPLETED|Overall Study||0
7687789|NCT01889862|18932360|P4|COMPLETED|Overall Study||14
7687790|NCT01889862|18932361|P3|COMPLETED|Overall Study||31
7687791|NCT01889862|18932362|P2|COMPLETED|Overall Study||15
7687792|NCT01889862|18932363|P1|COMPLETED|Overall Study||34
7687793|NCT01889862|18932360|P4|STARTED|Overall Study||14
7687794|NCT01889862|18932361|P3|STARTED|Overall Study||32
7687795|NCT01889862|18932362|P2|STARTED|Overall Study||15
7687796|NCT01889862|18932363|P1|STARTED|Overall Study||34
7687797|NCT01889797|18932375|P2|NOT COMPLETED|Overall Study||0
7687798|NCT01889797|18932376|P1|NOT COMPLETED|Overall Study||0
7687799|NCT01889797|18932375|P2|COMPLETED|Overall Study||16
7687800|NCT01889797|18932376|P1|COMPLETED|Overall Study||16
7687801|NCT01889797|18932375|P2|STARTED|Overall Study||16
7687802|NCT01889797|18932376|P1|STARTED|Overall Study||16
7687803|NCT01889667|18932391|P3|NOT COMPLETED|Overall Study||0
7687804|NCT01889667|18932392|P2|NOT COMPLETED|Overall Study||0
7687805|NCT01889667|18932393|P1|NOT COMPLETED|Overall Study||0
7687806|NCT01889667|18932391|P3|COMPLETED|Overall Study||10
7687807|NCT01889667|18932392|P2|COMPLETED|Overall Study||10
7687808|NCT01889667|18932393|P1|COMPLETED|Overall Study||10
7687809|NCT01889667|18932391|P3|STARTED|Overall Study||10
7687810|NCT01889667|18932392|P2|STARTED|Overall Study||10
7687811|NCT01889667|18932393|P1|STARTED|Overall Study||10
7687812|NCT01889602|18932416|P3|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
7687813|NCT01889602|18932417|P2|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
7687814|NCT01889602|18932418|P1|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
7687815|NCT01889602|18932416|P3|COMPLETED|Third Washout Period of at Least 2 Weeks||16
7687816|NCT01889602|18932417|P2|COMPLETED|Third Washout Period of at Least 2 Weeks||15
7687817|NCT01889602|18932418|P1|COMPLETED|Third Washout Period of at Least 2 Weeks||15
7687818|NCT01889602|18932416|P3|STARTED|Third Washout Period of at Least 2 Weeks||16
7687819|NCT01889602|18932417|P2|STARTED|Third Washout Period of at Least 2 Weeks||15
7687820|NCT01889602|18932418|P1|STARTED|Third Washout Period of at Least 2 Weeks||15
7687821|NCT01889602|18932416|P3|NOT COMPLETED|Third Intervention||0
7687822|NCT01889602|18932417|P2|NOT COMPLETED|Third Intervention||2
7687823|NCT01889602|18932418|P1|NOT COMPLETED|Third Intervention||3
7687824|NCT01889602|18932416|P3|COMPLETED|Third Intervention||16
7687825|NCT01889602|18932417|P2|COMPLETED|Third Intervention||15
7687826|NCT01889602|18932418|P1|COMPLETED|Third Intervention||15
7687827|NCT01889602|18932416|P3|STARTED|Third Intervention||16
7687828|NCT01889602|18932417|P2|STARTED|Third Intervention||17
7687829|NCT01889602|18932418|P1|STARTED|Third Intervention||18
7687830|NCT01889602|18932416|P3|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
7687831|NCT01889602|18932417|P2|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
7687832|NCT01889602|18932418|P1|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
7687833|NCT01889602|18932416|P3|COMPLETED|Second Washout Period of at Least 2 Week||16
7687834|NCT01889602|18932417|P2|COMPLETED|Second Washout Period of at Least 2 Week||17
7687835|NCT01889602|18932418|P1|COMPLETED|Second Washout Period of at Least 2 Week||18
7687836|NCT01889602|18932416|P3|STARTED|Second Washout Period of at Least 2 Week||16
7687837|NCT01889602|18932417|P2|STARTED|Second Washout Period of at Least 2 Week||17
7687838|NCT01889602|18932418|P1|STARTED|Second Washout Period of at Least 2 Week||18
7687839|NCT01889602|18932416|P3|NOT COMPLETED|Second Intervention||2
7687840|NCT01889602|18932417|P2|NOT COMPLETED|Second Intervention||0
7687841|NCT01889602|18932418|P1|NOT COMPLETED|Second Intervention||1
7687842|NCT01889602|18932416|P3|COMPLETED|Second Intervention||16
7687843|NCT01889602|18932417|P2|COMPLETED|Second Intervention||17
7687844|NCT01889602|18932418|P1|COMPLETED|Second Intervention||18
7687845|NCT01889602|18932416|P3|STARTED|Second Intervention||18
7687846|NCT01889602|18932417|P2|STARTED|Second Intervention||17
7687847|NCT01889602|18932418|P1|STARTED|Second Intervention||19
7687848|NCT01889602|18932416|P3|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
7687849|NCT01889602|18932417|P2|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
7687850|NCT01889602|18932418|P1|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
7687851|NCT01889602|18932416|P3|COMPLETED|First Washout Period of at Least 2 Weeks||18
7687852|NCT01889602|18932417|P2|COMPLETED|First Washout Period of at Least 2 Weeks||17
7687853|NCT01889602|18932418|P1|COMPLETED|First Washout Period of at Least 2 Weeks||19
7687854|NCT01889602|18932416|P3|STARTED|First Washout Period of at Least 2 Weeks||18
7687855|NCT01889602|18932417|P2|STARTED|First Washout Period of at Least 2 Weeks||17
7687856|NCT01889602|18932418|P1|STARTED|First Washout Period of at Least 2 Weeks||19
7687857|NCT01889602|18932416|P3|NOT COMPLETED|First Intervention||2
7687858|NCT01889602|18932417|P2|NOT COMPLETED|First Intervention||3
7687859|NCT01889602|18932418|P1|NOT COMPLETED|First Intervention||1
7687860|NCT01889602|18932416|P3|COMPLETED|First Intervention||18
7687861|NCT01889602|18932417|P2|COMPLETED|First Intervention||17
7687862|NCT01889602|18932418|P1|COMPLETED|First Intervention||19
7687863|NCT01889602|18932416|P3|STARTED|First Intervention||20
7687864|NCT01889602|18932417|P2|STARTED|First Intervention||20
7687865|NCT01889602|18932418|P1|STARTED|First Intervention||20
7687866|NCT01889563|18932445|P2|NOT COMPLETED|Overall Study||5
7687867|NCT01889563|18932446|P1|NOT COMPLETED|Overall Study||7
7687868|NCT01889563|18932445|P2|COMPLETED|Overall Study||10
7687869|NCT01889563|18932446|P1|COMPLETED|Overall Study||10
7687870|NCT01889563|18932445|P2|STARTED|Overall Study||15
7687871|NCT01889563|18932446|P1|STARTED|Overall Study||17
7687872|NCT01889420|18932454|P1|NOT COMPLETED|Overall Study||0
7687873|NCT01889420|18932454|P1|COMPLETED|Overall Study||1
7687874|NCT01889420|18932454|P1|STARTED|Overall Study||1
7687875|NCT01889355|18932460|P1|NOT COMPLETED|Overall Study||2
7687876|NCT01889355|18932460|P1|COMPLETED|Overall Study||113
7687877|NCT01889355|18932460|P1|STARTED|Overall Study||115
7687878|NCT01889251|18932466|P2|NOT COMPLETED|Overall Study||0
7687879|NCT01889251|18932467|P1|NOT COMPLETED|Overall Study||1
7687880|NCT01889251|18932466|P2|COMPLETED|Overall Study||57
7687881|NCT01889251|18932467|P1|COMPLETED|Overall Study||114
7687882|NCT01889251|18932466|P2|STARTED|Overall Study||57
7687883|NCT01889251|18932467|P1|STARTED|Overall Study||115
7687884|NCT01889238|18932473|P1|NOT COMPLETED|Overall Study||9
7687885|NCT01889238|18932473|P1|COMPLETED|Overall Study|DP, AE, death, treatment withdrawal were considered completed (defined in protocol).|109
7687886|NCT01889238|18932473|P1|STARTED|Overall Study||118
7687887|NCT01889069|18932492|P1|NOT COMPLETED|Overall Study||45
7687888|NCT01889069|18932492|P1|COMPLETED|Overall Study||113
7687889|NCT01889069|18932492|P1|STARTED|Overall Study||158
7687890|NCT01888965|18932537|P1|NOT COMPLETED|Overall Study||9
7687891|NCT01888965|18932537|P1|COMPLETED|Overall Study||0
7687892|NCT01888965|18932537|P1|STARTED|Overall Study||9
7687893|NCT01888952|18932543|P1|NOT COMPLETED|Overall Study||0
7687894|NCT01888952|18932543|P1|COMPLETED|Overall Study||10
7687895|NCT01888952|18932543|P1|STARTED|Overall Study||10
7687896|NCT01888900|18932549|P2|NOT COMPLETED|Overall Study||2
7687897|NCT01888900|18932550|P1|NOT COMPLETED|Overall Study||0
7687898|NCT01888900|18932549|P2|COMPLETED|Overall Study||11
7687899|NCT01888900|18932550|P1|COMPLETED|Overall Study||22
7687900|NCT01888900|18932549|P2|STARTED|Overall Study||13
7687901|NCT01888900|18932550|P1|STARTED|Overall Study||22
7687902|NCT01888874|18932577|P7|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
7687903|NCT01888874|18932578|P6|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
7687904|NCT01888874|18932579|P5|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
7687905|NCT01888874|18932580|P4|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
7687906|NCT01888874|18932581|P3|NOT COMPLETED|Period 2 (Week 13 to Week 24)||8
7687907|NCT01888874|18932582|P2|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
7687908|NCT01888874|18932583|P1|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
7687909|NCT01888874|18932577|P7|COMPLETED|Period 2 (Week 13 to Week 24)||80
7687910|NCT01888874|18932578|P6|COMPLETED|Period 2 (Week 13 to Week 24)||109
7687911|NCT01888874|18932579|P5|COMPLETED|Period 2 (Week 13 to Week 24)||57
7687912|NCT01888874|18932580|P4|COMPLETED|Period 2 (Week 13 to Week 24)||78
7687913|NCT01888874|18932581|P3|COMPLETED|Period 2 (Week 13 to Week 24)||104
7687914|NCT01888874|18932582|P2|COMPLETED|Period 2 (Week 13 to Week 24)||55
7687915|NCT01888874|18932583|P1|COMPLETED|Period 2 (Week 13 to Week 24)||50
7687916|NCT01888874|18932577|P7|STARTED|Period 2 (Week 13 to Week 24)||83
7687917|NCT01888874|18932578|P6|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 25 mg BID(17 participants) moved to 50 mg BID group.|112
7687918|NCT01888874|18932579|P5|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 25 mg BID group moved to 50 mg BID group (17 participants).|60
7687919|NCT01888874|18932580|P4|STARTED|Period 2 (Week 13 to Week 24)||80
7687920|NCT01888874|18932581|P3|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 50 mg QD (19 participants) moved to 100 mg QD group.|112
7687921|NCT01888874|18932582|P2|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (19 participants).|57
7687922|NCT01888874|18932583|P1|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo group moved to 100 mg QD(15 participants) and 50 mg BID(15 participants).|53
7687923|NCT01888874|18932577|P7|NOT COMPLETED|Period 1 (Baseline up to Week 12)||1
7687924|NCT01888874|18932578|P6|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5
7687925|NCT01888874|18932579|P5|NOT COMPLETED|Period 1 (Baseline up to Week 12)||9
7687926|NCT01888874|18932580|P4|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6
7687927|NCT01888874|18932581|P3|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7
7687928|NCT01888874|18932582|P2|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6
7687929|NCT01888874|18932583|P1|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
7687930|NCT01888874|18932577|P7|COMPLETED|Period 1 (Baseline up to Week 12)||83
7687931|NCT01888874|18932578|P6|COMPLETED|Period 1 (Baseline up to Week 12)||80
7687932|NCT01888874|18932579|P5|COMPLETED|Period 1 (Baseline up to Week 12)||77
7687933|NCT01888874|18932580|P4|COMPLETED|Period 1 (Baseline up to Week 12)||80
7687934|NCT01888874|18932581|P3|COMPLETED|Period 1 (Baseline up to Week 12)||78
7687935|NCT01888874|18932582|P2|COMPLETED|Period 1 (Baseline up to Week 12)||76
7687936|NCT01888874|18932583|P1|COMPLETED|Period 1 (Baseline up to Week 12)||83
7687937|NCT01888874|18932577|P7|STARTED|Period 1 (Baseline up to Week 12)||84
7687938|NCT01888874|18932578|P6|STARTED|Period 1 (Baseline up to Week 12)||85
7687939|NCT01888874|18932579|P5|STARTED|Period 1 (Baseline up to Week 12)||86
7687940|NCT01888874|18932580|P4|STARTED|Period 1 (Baseline up to Week 12)||86
7687941|NCT01888874|18932581|P3|STARTED|Period 1 (Baseline up to Week 12)||85
7687942|NCT01888874|18932582|P2|STARTED|Period 1 (Baseline up to Week 12)||82
7687943|NCT01888874|18932583|P1|STARTED|Period 1 (Baseline up to Week 12)||86
7687944|NCT01888640|18932672|P3|NOT COMPLETED|Overall Study||5
7687945|NCT01888640|18932673|P2|NOT COMPLETED|Overall Study||31
7687946|NCT01888640|18932674|P1|NOT COMPLETED|Overall Study||27
7687947|NCT01888640|18932672|P3|COMPLETED|Overall Study||94
7687948|NCT01888640|18932673|P2|COMPLETED|Overall Study||68
7687949|NCT01888640|18932674|P1|COMPLETED|Overall Study||76
7687950|NCT01888640|18932672|P3|STARTED|Overall Study||99
7687951|NCT01888640|18932673|P2|STARTED|Overall Study||99
7687952|NCT01888640|18932674|P1|STARTED|Overall Study||103
7687953|NCT01888432|18932730|P2|NOT COMPLETED|36-month Analysis (Extension)||0
7687954|NCT01888432|18932731|P1|NOT COMPLETED|36-month Analysis (Extension)||1
7687955|NCT01888432|18932730|P2|COMPLETED|36-month Analysis (Extension)||5
7687956|NCT01888432|18932731|P1|COMPLETED|36-month Analysis (Extension)||12
7687957|NCT01888432|18932730|P2|STARTED|36-month Analysis (Extension)||5
7687958|NCT01888432|18932731|P1|STARTED|36-month Analysis (Extension)||13
7687959|NCT01888432|18932730|P2|NOT COMPLETED|24-month Analysis (FAS)||17
7687960|NCT01888432|18932731|P1|NOT COMPLETED|24-month Analysis (FAS)||17
7687961|NCT01888432|18932730|P2|COMPLETED|24-month Analysis (FAS)||125
7687962|NCT01888432|18932731|P1|COMPLETED|24-month Analysis (FAS)||125
7687963|NCT01888432|18932730|P2|STARTED|24-month Analysis (FAS)||142
7687964|NCT01888432|18932731|P1|STARTED|24-month Analysis (FAS)||142
7687965|NCT01888432|18932730|P2|NOT COMPLETED|12-month Analysis (FAS)||9
7687966|NCT01888432|18932731|P1|NOT COMPLETED|12-month Analysis (FAS)||11
7687967|NCT01888432|18932730|P2|COMPLETED|12-month Analysis (FAS)||133
7687968|NCT01888432|18932731|P1|COMPLETED|12-month Analysis (FAS)||131
7687969|NCT01888432|18932730|P2|STARTED|12-month Analysis (FAS)||142
7687970|NCT01888432|18932731|P1|STARTED|12-month Analysis (FAS)||142
7687971|NCT01888367|18932772|P3|NOT COMPLETED|Overall Study||5
7687972|NCT01888367|18932773|P2|NOT COMPLETED|Overall Study||5
7687973|NCT01888367|18932774|P1|NOT COMPLETED|Overall Study||8
7687974|NCT01888367|18932772|P3|COMPLETED|Overall Study||73
7687975|NCT01888367|18932773|P2|COMPLETED|Overall Study||66
7687976|NCT01888367|18932774|P1|COMPLETED|Overall Study||288
7687977|NCT01888367|18932772|P3|STARTED|Overall Study||78
7687978|NCT01888367|18932773|P2|STARTED|Overall Study||71
7687979|NCT01888367|18932774|P1|STARTED|Overall Study||296
7687980|NCT01888003|18932794|P3|NOT COMPLETED|Overall Study||40
7687981|NCT01888003|18932795|P2|NOT COMPLETED|Overall Study||6
7687982|NCT01888003|18932796|P1|NOT COMPLETED|Overall Study||5
7687983|NCT01888003|18932794|P3|COMPLETED|Overall Study||0
7687984|NCT01888003|18932795|P2|COMPLETED|Overall Study||0
7687985|NCT01888003|18932796|P1|COMPLETED|Overall Study||0
7687986|NCT01888003|18932794|P3|STARTED|Overall Study||40
7687987|NCT01888003|18932795|P2|STARTED|Overall Study||6
7687988|NCT01888003|18932796|P1|STARTED|Overall Study||5
7687989|NCT01887990|18932817|P4|NOT COMPLETED|Overall Study||0
7687990|NCT01887990|18932818|P3|NOT COMPLETED|Overall Study||0
7687991|NCT01887990|18932819|P2|NOT COMPLETED|Overall Study||0
7687992|NCT01887990|18932820|P1|NOT COMPLETED|Overall Study||0
7687993|NCT01887990|18932817|P4|COMPLETED|Overall Study||2
7687994|NCT01887990|18932818|P3|COMPLETED|Overall Study||2
7687995|NCT01887990|18932819|P2|COMPLETED|Overall Study||7
7687996|NCT01887990|18932820|P1|COMPLETED|Overall Study||7
7687997|NCT01887990|18932817|P4|STARTED|Overall Study||2
7687998|NCT01887990|18932818|P3|STARTED|Overall Study||2
7687999|NCT01887990|18932819|P2|STARTED|Overall Study||7
7688000|NCT01887990|18932820|P1|STARTED|Overall Study||7
7688001|NCT01887912|18932836|P2|NOT COMPLETED|Overall Study||731
7688002|NCT01887912|18932837|P1|NOT COMPLETED|Overall Study||1392
7688003|NCT01887912|18932836|P2|COMPLETED|Overall Study||2370
7688004|NCT01887912|18932837|P1|COMPLETED|Overall Study||4809
7688005|NCT01887912|18932836|P2|Safety Population|Overall Study||3057
7688006|NCT01887912|18932837|P1|Safety Population|Overall Study||6113
7688007|NCT01887912|18932836|P2|STARTED|Overall Study||3101
7688008|NCT01887912|18932837|P1|STARTED|Overall Study||6201
7688009|NCT01887717|18932865|P2|NOT COMPLETED|Overall Study||11
7688010|NCT01887717|18932866|P1|NOT COMPLETED|Overall Study||6
7688011|NCT01887717|18932865|P2|COMPLETED|Overall Study||8
7688012|NCT01887717|18932866|P1|COMPLETED|Overall Study||11
7688013|NCT01887717|18932865|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
7688014|NCT01887717|18932866|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
7688015|NCT01887717|18932865|P2|STARTED|Overall Study||19
7688016|NCT01887717|18932866|P1|STARTED|Overall Study||17
7688017|NCT01887678|18932888|P2|NOT COMPLETED|Overall Study||28
7688018|NCT01887678|18932889|P1|NOT COMPLETED|Overall Study||17
7688019|NCT01887678|18932888|P2|COMPLETED|Overall Study||85
7688020|NCT01887678|18932889|P1|COMPLETED|Overall Study||102
7688021|NCT01887678|18932888|P2|STARTED|Overall Study||113
7688022|NCT01887678|18932889|P1|STARTED|Overall Study||119
7688023|NCT01887600|18932933|P2|NOT COMPLETED|Overall Study||114
7688024|NCT01887600|18932934|P1|NOT COMPLETED|Overall Study||146
7688025|NCT01887600|18932933|P2|COMPLETED|Overall Study||89
7688026|NCT01887600|18932934|P1|COMPLETED|Overall Study||245
7688027|NCT01887600|18932933|P2|Treatment Received|Overall Study||203
7688028|NCT01887600|18932934|P1|Treatment Received|Overall Study||391
7688029|NCT01887600|18932933|P2|STARTED|Overall Study||203
7688030|NCT01887600|18932934|P1|STARTED|Overall Study||391
7688031|NCT01887587|18933044|P1|NOT COMPLETED|Overall Study||0
7688032|NCT01887587|18933044|P1|COMPLETED|Overall Study||5
7688033|NCT01887587|18933044|P1|STARTED|Overall Study||5
7688034|NCT01887470|18933053|P4|NOT COMPLETED|Overall Study||0
7688035|NCT01887470|18933054|P3|NOT COMPLETED|Overall Study||0
7688036|NCT01887470|18933055|P2|NOT COMPLETED|Overall Study||0
7688037|NCT01887470|18933056|P1|NOT COMPLETED|Overall Study||0
7688038|NCT01887470|18933053|P4|COMPLETED|Overall Study||10
7688039|NCT01887470|18933054|P3|COMPLETED|Overall Study||10
7688040|NCT01887470|18933055|P2|COMPLETED|Overall Study||10
7688041|NCT01887470|18933056|P1|COMPLETED|Overall Study||10
7688042|NCT01887470|18933053|P4|STARTED|Overall Study||10
7688043|NCT01887470|18933054|P3|STARTED|Overall Study||10
7688044|NCT01887470|18933055|P2|STARTED|Overall Study||10
7688045|NCT01887470|18933056|P1|STARTED|Overall Study||10
7688046|NCT01887418|18933075|P3|NOT COMPLETED|Overall Study||1
7688047|NCT01887418|18933076|P2|NOT COMPLETED|Overall Study||0
7688048|NCT01887418|18933077|P1|NOT COMPLETED|Overall Study||0
7688049|NCT01887418|18933075|P3|COMPLETED|Overall Study||9
7688050|NCT01887418|18933076|P2|COMPLETED|Overall Study||14
7688051|NCT01887418|18933077|P1|COMPLETED|Overall Study||15
7688052|NCT01887418|18933075|P3|STARTED|Overall Study||10
7688053|NCT01887418|18933076|P2|STARTED|Overall Study||14
7688054|NCT01887418|18933077|P1|STARTED|Overall Study||15
7688055|NCT01887353|18933096|P2|NOT COMPLETED|Overall Study||3
7688056|NCT01887353|18933097|P1|NOT COMPLETED|Overall Study||4
7688057|NCT01887353|18933096|P2|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1
7688058|NCT01887353|18933097|P1|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0
7688059|NCT01887353|18933096|P2|STARTED|Overall Study||4
7688060|NCT01887353|18933097|P1|STARTED|Overall Study||4
7688061|NCT01887327|18933106|P3|NOT COMPLETED|Overall Study||3
7688062|NCT01887327|18933107|P2|NOT COMPLETED|Overall Study||4
7688063|NCT01887327|18933108|P1|NOT COMPLETED|Overall Study||1
7688064|NCT01887327|18933106|P3|COMPLETED|Overall Study||27
7688065|NCT01887327|18933107|P2|COMPLETED|Overall Study||27
7688066|NCT01887327|18933108|P1|COMPLETED|Overall Study||29
7688067|NCT01887327|18933106|P3|STARTED|Overall Study||30
7688068|NCT01887327|18933107|P2|STARTED|Overall Study||31
7688069|NCT01887327|18933108|P1|STARTED|Overall Study||30
7688070|NCT01887288|18933125|P1|NOT COMPLETED|Overall Study||16
7688071|NCT01887288|18933125|P1|COMPLETED|Overall Study||0
7688072|NCT01887288|18933125|P1|STARTED|Overall Study||16
7688073|NCT01887210|18933132|P2|NOT COMPLETED|Overall Study||4
7688074|NCT01887210|18933133|P1|NOT COMPLETED|Overall Study||1
7688075|NCT01887210|18933132|P2|COMPLETED|Overall Study||29
7688076|NCT01887210|18933133|P1|COMPLETED|Overall Study||32
7688077|NCT01887210|18933132|P2|STARTED|Overall Study||33
7688078|NCT01887210|18933133|P1|STARTED|Overall Study||33
7688079|NCT01887171|18933147|P2|NOT COMPLETED|Overall Study||0
7688080|NCT01887171|18933148|P1|NOT COMPLETED|Overall Study||0
7688081|NCT01887171|18933147|P2|COMPLETED|Overall Study||43
7688082|NCT01887171|18933148|P1|COMPLETED|Overall Study||43
7688083|NCT01887171|18933147|P2|STARTED|Overall Study||43
7688084|NCT01887171|18933148|P1|STARTED|Overall Study||43
7688085|NCT01887132|18933154|P1|NOT COMPLETED|Overall Study||0
7688086|NCT01887132|18933154|P1|COMPLETED|Overall Study||4
7688087|NCT01887132|18933154|P1|STARTED|Overall Study||4
7688088|NCT01886963|18933161|P2|NOT COMPLETED|Overall Study||4
7688089|NCT01886963|18933162|P1|NOT COMPLETED|Overall Study||5
7688090|NCT01886963|18933161|P2|COMPLETED|Overall Study||49
7688091|NCT01886963|18933162|P1|COMPLETED|Overall Study||46
7688092|NCT01886963|18933161|P2|12 Week Follow Up|Overall Study||22
7688093|NCT01886963|18933162|P1|12 Week Follow Up|Overall Study||24
7688094|NCT01886963|18933161|P2|4 Week Follow Up|Overall Study||26
7688095|NCT01886963|18933162|P1|4 Week Follow Up|Overall Study||24
7688096|NCT01886963|18933161|P2|2 Week Follow Up|Overall Study||35
7688097|NCT01886963|18933162|P1|2 Week Follow Up|Overall Study||38
7688098|NCT01886963|18933161|P2|STARTED|Overall Study||53
7688099|NCT01886963|18933162|P1|STARTED|Overall Study||51
7688100|NCT01886937|18933170|P2|NOT COMPLETED|Overall Study||0
7688101|NCT01886937|18933171|P1|NOT COMPLETED|Overall Study||0
7688102|NCT01886937|18933170|P2|COMPLETED|Overall Study||6
7688103|NCT01886937|18933171|P1|COMPLETED|Overall Study||7
7688104|NCT01886937|18933170|P2|STARTED|Overall Study||6
7688105|NCT01886937|18933171|P1|STARTED|Overall Study||7
7688106|NCT01886872|18933180|P3|NOT COMPLETED|Overall Study||12
7688107|NCT01886872|18933181|P2|NOT COMPLETED|Overall Study||4
7688108|NCT01886872|18933182|P1|NOT COMPLETED|Overall Study||7
7688109|NCT01886872|18933180|P3|COMPLETED|Overall Study||170
7688110|NCT01886872|18933181|P2|COMPLETED|Overall Study||178
7688111|NCT01886872|18933182|P1|COMPLETED|Overall Study||176
7688112|NCT01886872|18933180|P3|Crossover Cohort|Overall Study||0
7688113|NCT01886872|18933181|P2|Crossover Cohort|Overall Study||0
7688114|NCT01886872|18933182|P1|Crossover Cohort|Overall Study||30
7688115|NCT01886872|18933180|P3|Evaluable for Adverse Events|Overall Study||181
7688116|NCT01886872|18933181|P2|Evaluable for Adverse Events|Overall Study||180
7688117|NCT01886872|18933182|P1|Evaluable for Adverse Events|Overall Study||176
7688118|NCT01886872|18933180|P3|Evaluable for Secondary Endpoints|Overall Study||182
7688119|NCT01886872|18933181|P2|Evaluable for Secondary Endpoints|Overall Study||182
7688120|NCT01886872|18933182|P1|Evaluable for Secondary Endpoints|Overall Study||183
7688121|NCT01886872|18933180|P3|STARTED|Overall Study||182
7688122|NCT01886872|18933181|P2|STARTED|Overall Study||182
7688123|NCT01886872|18933182|P1|STARTED|Overall Study||183
7688124|NCT01886833|18933215|P1|NOT COMPLETED|Overall Study||204
7688125|NCT01886833|18933215|P1|COMPLETED|Overall Study||216
7688126|NCT01886833|18933215|P1|STARTED|Overall Study||420
7688127|NCT01886807|18933226|P3|NOT COMPLETED|Overall Study||10
7688128|NCT01886807|18933227|P2|NOT COMPLETED|Overall Study||10
7688129|NCT01886807|18933228|P1|NOT COMPLETED|Overall Study||5
7688130|NCT01886807|18933226|P3|COMPLETED|Overall Study||153
7688131|NCT01886807|18933227|P2|COMPLETED|Overall Study||145
7688132|NCT01886807|18933228|P1|COMPLETED|Overall Study||159
7688133|NCT01886807|18933226|P3|STARTED|Overall Study||163
7688134|NCT01886807|18933227|P2|STARTED|Overall Study||155
7688135|NCT01886807|18933228|P1|STARTED|Overall Study||164
7688136|NCT01886781|18933247|P2|NOT COMPLETED|Overall Study||2
7688137|NCT01886781|18933248|P1|NOT COMPLETED|Overall Study||14
7688138|NCT01886781|18933247|P2|COMPLETED|Overall Study||25
7688139|NCT01886781|18933248|P1|COMPLETED|Overall Study||40
7688140|NCT01886781|18933247|P2|STARTED|Overall Study||27
7688141|NCT01886781|18933248|P1|STARTED|Overall Study||54
7688142|NCT01886716|18933258|P4|NOT COMPLETED|1-Month Post Follow-Up||0
7688143|NCT01886716|18933259|P3|NOT COMPLETED|1-Month Post Follow-Up||0
7688144|NCT01886716|18933260|P2|NOT COMPLETED|1-Month Post Follow-Up||0
7688145|NCT01886716|18933261|P1|NOT COMPLETED|1-Month Post Follow-Up||0
7688146|NCT01886716|18933258|P4|COMPLETED|1-Month Post Follow-Up||14
7688147|NCT01886716|18933259|P3|COMPLETED|1-Month Post Follow-Up||19
7688148|NCT01886716|18933260|P2|COMPLETED|1-Month Post Follow-Up||17
7688149|NCT01886716|18933261|P1|COMPLETED|1-Month Post Follow-Up||20
7688150|NCT01886716|18933258|P4|STARTED|1-Month Post Follow-Up||14
7688151|NCT01886716|18933259|P3|STARTED|1-Month Post Follow-Up||19
7688152|NCT01886716|18933260|P2|STARTED|1-Month Post Follow-Up||17
7688153|NCT01886716|18933261|P1|STARTED|1-Month Post Follow-Up||20
7688154|NCT01886716|18933258|P4|NOT COMPLETED|1-Week Post Follow-Up||0
7688155|NCT01886716|18933259|P3|NOT COMPLETED|1-Week Post Follow-Up||0
7688156|NCT01886716|18933260|P2|NOT COMPLETED|1-Week Post Follow-Up||0
7688157|NCT01886716|18933261|P1|NOT COMPLETED|1-Week Post Follow-Up||0
7688158|NCT01886716|18933258|P4|COMPLETED|1-Week Post Follow-Up||14
7688159|NCT01886716|18933259|P3|COMPLETED|1-Week Post Follow-Up||19
7688160|NCT01886716|18933260|P2|COMPLETED|1-Week Post Follow-Up||17
7688161|NCT01886716|18933261|P1|COMPLETED|1-Week Post Follow-Up||20
7688162|NCT01886716|18933258|P4|STARTED|1-Week Post Follow-Up||14
7688163|NCT01886716|18933259|P3|STARTED|1-Week Post Follow-Up||19
7688164|NCT01886716|18933260|P2|STARTED|1-Week Post Follow-Up||17
7688165|NCT01886716|18933261|P1|STARTED|1-Week Post Follow-Up||20
7688166|NCT01886716|18933258|P4|NOT COMPLETED|Week 4||0
7688167|NCT01886716|18933259|P3|NOT COMPLETED|Week 4||0
7688168|NCT01886716|18933260|P2|NOT COMPLETED|Week 4||0
7688169|NCT01886716|18933261|P1|NOT COMPLETED|Week 4||0
7688170|NCT01886716|18933258|P4|COMPLETED|Week 4||14
7688171|NCT01886716|18933259|P3|COMPLETED|Week 4||19
7688172|NCT01886716|18933260|P2|COMPLETED|Week 4||17
7688173|NCT01886716|18933261|P1|COMPLETED|Week 4||20
7688174|NCT01886716|18933258|P4|STARTED|Week 4||14
7688175|NCT01886716|18933259|P3|STARTED|Week 4||19
7688176|NCT01886716|18933260|P2|STARTED|Week 4||17
7688177|NCT01886716|18933261|P1|STARTED|Week 4||20
7688178|NCT01886716|18933258|P4|NOT COMPLETED|Week 3||1
7688179|NCT01886716|18933259|P3|NOT COMPLETED|Week 3||0
7688180|NCT01886716|18933260|P2|NOT COMPLETED|Week 3||1
7688181|NCT01886716|18933261|P1|NOT COMPLETED|Week 3||1
7688182|NCT01886716|18933258|P4|COMPLETED|Week 3||14
7688183|NCT01886716|18933259|P3|COMPLETED|Week 3||19
7688184|NCT01886716|18933260|P2|COMPLETED|Week 3||17
7688185|NCT01886716|18933261|P1|COMPLETED|Week 3||20
7688186|NCT01886716|18933258|P4|STARTED|Week 3||15
7688187|NCT01886716|18933259|P3|STARTED|Week 3||19
7688188|NCT01886716|18933260|P2|STARTED|Week 3||18
7688189|NCT01886716|18933261|P1|STARTED|Week 3||21
7688190|NCT01886716|18933258|P4|NOT COMPLETED|Week 2||3
7688191|NCT01886716|18933259|P3|NOT COMPLETED|Week 2||1
7688192|NCT01886716|18933260|P2|NOT COMPLETED|Week 2||2
7688193|NCT01886716|18933261|P1|NOT COMPLETED|Week 2||3
7688194|NCT01886716|18933258|P4|COMPLETED|Week 2||15
7688195|NCT01886716|18933259|P3|COMPLETED|Week 2||19
7688196|NCT01886716|18933260|P2|COMPLETED|Week 2||18
7688197|NCT01886716|18933261|P1|COMPLETED|Week 2||21
7688198|NCT01886716|18933258|P4|STARTED|Week 2||18
7688199|NCT01886716|18933259|P3|STARTED|Week 2||20
7688200|NCT01886716|18933260|P2|STARTED|Week 2||20
7688201|NCT01886716|18933261|P1|STARTED|Week 2||24
7688202|NCT01886716|18933258|P4|NOT COMPLETED|Week 1||2
7688203|NCT01886716|18933259|P3|NOT COMPLETED|Week 1||2
7688204|NCT01886716|18933260|P2|NOT COMPLETED|Week 1||0
7688205|NCT01886716|18933261|P1|NOT COMPLETED|Week 1||0
7688206|NCT01886716|18933258|P4|COMPLETED|Week 1||18
7688207|NCT01886716|18933259|P3|COMPLETED|Week 1||20
7688208|NCT01886716|18933260|P2|COMPLETED|Week 1||20
7688209|NCT01886716|18933261|P1|COMPLETED|Week 1||24
7688210|NCT01886716|18933258|P4|STARTED|Week 1||20
7688211|NCT01886716|18933259|P3|STARTED|Week 1||22
7688212|NCT01886716|18933260|P2|STARTED|Week 1||20
7688213|NCT01886716|18933261|P1|STARTED|Week 1||24
7688214|NCT01886690|18933277|P2|NOT COMPLETED|Overall Study||2
7688215|NCT01886690|18933278|P1|NOT COMPLETED|Overall Study||0
7688216|NCT01886690|18933277|P2|COMPLETED|Overall Study||71
7688217|NCT01886690|18933278|P1|COMPLETED|Overall Study||75
7688218|NCT01886690|18933277|P2|STARTED|Overall Study||73
7688219|NCT01886690|18933278|P1|STARTED|Overall Study||75
7688220|NCT01886313|18933294|P2|NOT COMPLETED|Overall Study||1
7688221|NCT01886313|18933295|P1|NOT COMPLETED|Overall Study||1
7688222|NCT01886313|18933294|P2|COMPLETED|Overall Study||4
7688223|NCT01886313|18933295|P1|COMPLETED|Overall Study||5
7688224|NCT01886313|18933294|P2|STARTED|Overall Study||5
7688225|NCT01886313|18933295|P1|STARTED|Overall Study||6
7688226|NCT01886300|18933301|P1|NOT COMPLETED|Overall Study||16
7688227|NCT01886300|18933301|P1|COMPLETED|Overall Study||0
7688228|NCT01886300|18933301|P1|STARTED|Overall Study||16
7688229|NCT01886287|18933312|P1|NOT COMPLETED|Overall Study||2
7688230|NCT01886287|18933312|P1|COMPLETED|Overall Study||0
7688231|NCT01886287|18933312|P1|STARTED|Overall Study||2
7688232|NCT01886235|18933317|P1|NOT COMPLETED|Overall Study||0
7688233|NCT01886235|18933317|P1|COMPLETED|Overall Study||10
7688234|NCT01886235|18933317|P1|STARTED|Overall Study||10
7688235|NCT01886105|18933328|P1|NOT COMPLETED|Overall Study||3
7688236|NCT01886105|18933328|P1|COMPLETED|Overall Study||1
7688237|NCT01886105|18933328|P1|STARTED|Overall Study||4
7688238|NCT01885936|18933335|P2|NOT COMPLETED|Overall Study||0
7688239|NCT01885936|18933336|P1|NOT COMPLETED|Overall Study||1
7688240|NCT01885936|18933335|P2|COMPLETED|Overall Study||5
7688241|NCT01885936|18933336|P1|COMPLETED|Overall Study||7
7688242|NCT01885936|18933335|P2|STARTED|Overall Study||5
7688243|NCT01885936|18933336|P1|STARTED|Overall Study||8
7688244|NCT01885910|18933346|P1|NOT COMPLETED|Overall Study||8
7688245|NCT01885910|18933346|P1|COMPLETED|Overall Study||24
7688246|NCT01885910|18933346|P1|STARTED|Overall Study||32
7688247|NCT01885897|18933366|P6|NOT COMPLETED|Overall Study||0
7688248|NCT01885897|18933367|P5|NOT COMPLETED|Overall Study||0
7688249|NCT01885897|18933368|P4|NOT COMPLETED|Overall Study||0
7688250|NCT01885897|18933369|P3|NOT COMPLETED|Overall Study||0
7688251|NCT01885897|18933370|P2|NOT COMPLETED|Overall Study||0
7688252|NCT01885897|18933371|P1|NOT COMPLETED|Overall Study||0
7688253|NCT01885897|18933366|P6|COMPLETED|Overall Study||9
7688254|NCT01885897|18933367|P5|COMPLETED|Overall Study||8
7688255|NCT01885897|18933368|P4|COMPLETED|Overall Study||3
7688256|NCT01885897|18933369|P3|COMPLETED|Overall Study||4
7688257|NCT01885897|18933370|P2|COMPLETED|Overall Study||3
7688258|NCT01885897|18933371|P1|COMPLETED|Overall Study||6
7688259|NCT01885897|18933366|P6|STARTED|Overall Study||9
7688260|NCT01885897|18933367|P5|STARTED|Overall Study||8
7688261|NCT01885897|18933368|P4|STARTED|Overall Study||3
7688262|NCT01885897|18933369|P3|STARTED|Overall Study||4
7688263|NCT01885897|18933370|P2|STARTED|Overall Study||3
7688264|NCT01885897|18933371|P1|STARTED|Overall Study||6
7688265|NCT01885871|18933409|P1|NOT COMPLETED|Overall Study||0
7688266|NCT01885871|18933409|P1|COMPLETED|Overall Study||20
7688267|NCT01885871|18933409|P1|STARTED|Overall Study||20
7688268|NCT01885559|18933419|P2|NOT COMPLETED|Overall Study||36
7688269|NCT01885559|18933420|P1|NOT COMPLETED|Overall Study||24
7688270|NCT01885559|18933419|P2|COMPLETED|Overall Study||208
7688271|NCT01885559|18933420|P1|COMPLETED|Overall Study||218
7688272|NCT01885559|18933419|P2|STARTED|Overall Study||244
7688273|NCT01885559|18933420|P1|STARTED|Overall Study||242
7688274|NCT01885208|18933442|P2|NOT COMPLETED|Overall Study||38
7688275|NCT01885208|18933443|P1|NOT COMPLETED|Overall Study||32
7688276|NCT01885208|18933442|P2|COMPLETED|Overall Study||369
7688277|NCT01885208|18933443|P1|COMPLETED|Overall Study||374
7688278|NCT01885208|18933442|P2|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|85
7688279|NCT01885208|18933443|P1|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|82
7688280|NCT01885208|18933442|P2|Exposed|Overall Study||405
7688281|NCT01885208|18933443|P1|Exposed|Overall Study||404
7688282|NCT01885208|18933442|P2|STARTED|Overall Study||407
7688283|NCT01885208|18933443|P1|STARTED|Overall Study||406
7688284|NCT01885182|18933461|P2|NOT COMPLETED|Overall Study||22
7688285|NCT01885182|18933462|P1|NOT COMPLETED|Overall Study||34
7688286|NCT01885182|18933461|P2|COMPLETED|Overall Study||93
7688287|NCT01885182|18933462|P1|COMPLETED|Overall Study||83
7688288|NCT01885182|18933461|P2|FAP Population|Overall Study||106
7688289|NCT01885182|18933462|P1|FAP Population|Overall Study||107
7688290|NCT01885182|18933461|P2|Safety Population|Overall Study||111
7688291|NCT01885182|18933462|P1|Safety Population|Overall Study||114
7688292|NCT01885182|18933461|P2|STARTED|Overall Study||115
7688293|NCT01885182|18933462|P1|STARTED|Overall Study||117
7688294|NCT01885117|18933486|P2|NOT COMPLETED|Overall Study||0
7688295|NCT01885117|18933487|P1|NOT COMPLETED|Overall Study||0
7688296|NCT01885117|18933486|P2|COMPLETED|Overall Study||64
7688297|NCT01885117|18933487|P1|COMPLETED|Overall Study||61
7688298|NCT01885117|18933486|P2|STARTED|Overall Study||64
7688299|NCT01885117|18933487|P1|STARTED|Overall Study||61
7688300|NCT01885104|18933509|P2|NOT COMPLETED|Overall Study||1
7688301|NCT01885104|18933510|P1|NOT COMPLETED|Overall Study||2
7688302|NCT01885104|18933509|P2|COMPLETED|Overall Study||33
7688303|NCT01885104|18933510|P1|COMPLETED|Overall Study||29
7688304|NCT01885104|18933509|P2|STARTED|Overall Study||34
7688305|NCT01885104|18933510|P1|STARTED|Overall Study||31
7688306|NCT01885000|18933520|P2|NOT COMPLETED|Overall Study||2
7688307|NCT01885000|18933521|P1|NOT COMPLETED|Overall Study||2
7688308|NCT01885000|18933520|P2|COMPLETED|Overall Study||42
7688309|NCT01885000|18933521|P1|COMPLETED|Overall Study||46
7688310|NCT01885000|18933520|P2|STARTED|Overall Study||44
7688311|NCT01885000|18933521|P1|STARTED|Overall Study||48
7688312|NCT01884844|18933535|P2|NOT COMPLETED|Overall Study||5
7688313|NCT01884844|18933536|P1|NOT COMPLETED|Overall Study||3
7688314|NCT01884844|18933535|P2|COMPLETED|Overall Study||12
7688315|NCT01884844|18933536|P1|COMPLETED|Overall Study||13
7688316|NCT01884844|18933535|P2|STARTED|Overall Study||17
7688317|NCT01884844|18933536|P1|STARTED|Overall Study||16
7688318|NCT01884688|18933542|P1|NOT COMPLETED|Overall Study||2
7688319|NCT01884688|18933542|P1|COMPLETED|Overall Study||1
7688320|NCT01884688|18933542|P1|STARTED|Overall Study||3
7688321|NCT01884675|18933548|P2|NOT COMPLETED|Overall Study||2
7688322|NCT01884675|18933549|P1|NOT COMPLETED|Overall Study||3
7688323|NCT01884675|18933548|P2|COMPLETED|Overall Study||15
7688324|NCT01884675|18933549|P1|COMPLETED|Overall Study||13
7688325|NCT01884675|18933548|P2|STARTED|Overall Study||17
7688326|NCT01884675|18933549|P1|STARTED|Overall Study||16
7688327|NCT01884597|18933592|P3|NOT COMPLETED|Overall Study||1
7688328|NCT01884597|18933593|P2|NOT COMPLETED|Overall Study||1
7688329|NCT01884597|18933594|P1|NOT COMPLETED|Overall Study||1
7688330|NCT01884597|18933592|P3|COMPLETED|Overall Study||15
7688331|NCT01884597|18933593|P2|COMPLETED|Overall Study||2
7688332|NCT01884597|18933594|P1|COMPLETED|Overall Study||4
7688333|NCT01884597|18933592|P3|STARTED|Overall Study||16
7688334|NCT01884597|18933593|P2|STARTED|Overall Study||3
7688335|NCT01884597|18933594|P1|STARTED|Overall Study||5
7688336|NCT01884571|18933623|P1|NOT COMPLETED|Overall Study||8
7688337|NCT01884571|18933623|P1|COMPLETED|Overall Study||23
7688338|NCT01884571|18933623|P1|STARTED|Overall Study||31
7688339|NCT01884545|18933638|P4|NOT COMPLETED|Overall Study||9
7688340|NCT01884545|18933639|P3|NOT COMPLETED|Overall Study||14
7688341|NCT01884545|18933640|P2|NOT COMPLETED|Overall Study||18
7688342|NCT01884545|18933641|P1|NOT COMPLETED|Overall Study||13
7688343|NCT01884545|18933638|P4|COMPLETED|Overall Study||43
7688344|NCT01884545|18933639|P3|COMPLETED|Overall Study||35
7688345|NCT01884545|18933640|P2|COMPLETED|Overall Study||31
7688346|NCT01884545|18933641|P1|COMPLETED|Overall Study||37
7688347|NCT01884545|18933638|P4|STARTED|Overall Study||52
7688348|NCT01884545|18933639|P3|STARTED|Overall Study||49
7688349|NCT01884545|18933640|P2|STARTED|Overall Study||49
7688350|NCT01884545|18933641|P1|STARTED|Overall Study||50
7688351|NCT01884519|18933749|P2|NOT COMPLETED|Overall Study||0
7688352|NCT01884519|18933750|P1|NOT COMPLETED|Overall Study||0
7688353|NCT01884519|18933749|P2|COMPLETED|Overall Study||60
7688354|NCT01884519|18933750|P1|COMPLETED|Overall Study||60
7688355|NCT01884519|18933749|P2|STARTED|Overall Study||60
7688356|NCT01884519|18933750|P1|STARTED|Overall Study||60
7688357|NCT01884350|18933794|P3|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||11
7688358|NCT01884350|18933795|P2|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||13
7688359|NCT01884350|18933796|P1|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||80
7688360|NCT01884350|18933794|P3|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
7688361|NCT01884350|18933795|P2|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
7688362|NCT01884350|18933796|P1|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||503
7688363|NCT01884350|18933794|P3|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||223
7688364|NCT01884350|18933795|P2|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||308
7688365|NCT01884350|18933796|P1|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||604
7688366|NCT01884350|18933794|P3|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|261
7688367|NCT01884350|18933795|P2|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|263
7688368|NCT01884350|18933796|P1|STARTED|Primary Efficacy Analysis Set (48 Weeks)||583
7688369|NCT01884350|18933794|P3|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
7688370|NCT01884350|18933795|P2|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
7688371|NCT01884350|18933796|P1|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
7688372|NCT01884350|18933794|P3|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
7688373|NCT01884350|18933795|P2|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||525
7688374|NCT01884350|18933796|P1|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||529
7688375|NCT01884350|18933794|P3|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||0
7688376|NCT01884350|18933795|P2|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||558
7688377|NCT01884350|18933796|P1|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||604
7688378|NCT01884350|18933794|P3|STARTED|Primary Efficacy Analysis Set (24 Weeks)|Participants were not randomized to this arm until after initial 24-week period|0
7688379|NCT01884350|18933795|P2|STARTED|Primary Efficacy Analysis Set (24 Weeks)||579
7688380|NCT01884350|18933796|P1|STARTED|Primary Efficacy Analysis Set (24 Weeks)||583
7688381|NCT01884337|18933819|P2|NOT COMPLETED|Follow-up Period||1
7688382|NCT01884337|18933820|P1|NOT COMPLETED|Follow-up Period||1
7688383|NCT01884337|18933819|P2|COMPLETED|Follow-up Period||170
7688384|NCT01884337|18933820|P1|COMPLETED|Follow-up Period||323
7688385|NCT01884337|18933819|P2|STARTED|Follow-up Period||171
7688386|NCT01884337|18933820|P1|STARTED|Follow-up Period||324
7688387|NCT01884337|18933819|P2|NOT COMPLETED|Treatment||2
7688388|NCT01884337|18933820|P1|NOT COMPLETED|Treatment||4
7688389|NCT01884337|18933819|P2|COMPLETED|Treatment||170
7688390|NCT01884337|18933820|P1|COMPLETED|Treatment||322
7688391|NCT01884337|18933819|P2|Continuing Into Follow-up Period|Treatment||171
7688392|NCT01884337|18933820|P1|Continuing Into Follow-up Period|Treatment||324
7688393|NCT01884337|18933819|P2|STARTED|Treatment||172
7688394|NCT01884337|18933820|P1|STARTED|Treatment||326
7688395|NCT01884311|18933828|P1|NOT COMPLETED|Overall Study||5
7688396|NCT01884311|18933828|P1|COMPLETED|Overall Study||33
7688397|NCT01884311|18933828|P1|STARTED|Overall Study||38
7688398|NCT01884077|18933838|P2|NOT COMPLETED|Overall Study||10
7688399|NCT01884077|18933839|P1|NOT COMPLETED|Overall Study||8
7688400|NCT01884077|18933838|P2|COMPLETED|Overall Study||1
7688401|NCT01884077|18933839|P1|COMPLETED|Overall Study||0
7688402|NCT01884077|18933838|P2|STARTED|Overall Study||11
7688403|NCT01884077|18933839|P1|STARTED|Overall Study||8
7688404|NCT01884064|18933851|P2|NOT COMPLETED|Overall Study||0
7688405|NCT01884064|18933852|P1|NOT COMPLETED|Overall Study||0
7688406|NCT01884064|18933851|P2|COMPLETED|Overall Study||5
7688407|NCT01884064|18933852|P1|COMPLETED|Overall Study||12
7688408|NCT01884064|18933851|P2|STARTED|Overall Study||5
7688409|NCT01884064|18933852|P1|STARTED|Overall Study||12
7688410|NCT01884025|18933860|P2|NOT COMPLETED|Overall Study||4
7688411|NCT01884025|18933861|P1|NOT COMPLETED|Overall Study||3
7688412|NCT01884025|18933860|P2|COMPLETED|Overall Study||10
7688413|NCT01884025|18933861|P1|COMPLETED|Overall Study||10
7688414|NCT01884025|18933860|P2|STARTED|Overall Study||14
7688415|NCT01884025|18933861|P1|STARTED|Overall Study||13
7688416|NCT01883999|18933889|P1|NOT COMPLETED|Overall Study||3
7688417|NCT01883999|18933889|P1|COMPLETED|Overall Study||61
7688418|NCT01883999|18933889|P1|STARTED|Overall Study||64
7688419|NCT01883986|18933897|P2|NOT COMPLETED|Overall Study||1
7688420|NCT01883986|18933898|P1|NOT COMPLETED|Overall Study||3
7688421|NCT01883986|18933897|P2|COMPLETED|Overall Study|Completed study|19
7688422|NCT01883986|18933898|P1|COMPLETED|Overall Study|Received allocated intervention|17
7688423|NCT01883986|18933897|P2|Did Not Complete Study|Overall Study|Did not completed study|1
7688424|NCT01883986|18933898|P1|Did Not Complete Study|Overall Study||3
7688425|NCT01883986|18933897|P2|STARTED|Overall Study|Allocated to usual care arm|20
7688426|NCT01883986|18933898|P1|STARTED|Overall Study|Allocated to intervention arm|20
7688427|NCT01883908|18933912|P2|NOT COMPLETED|Overall Study||0
7688428|NCT01883908|18933913|P1|NOT COMPLETED|Overall Study||0
7688429|NCT01883908|18933912|P2|COMPLETED|Overall Study||1
7688430|NCT01883908|18933913|P1|COMPLETED|Overall Study||3
7688431|NCT01883908|18933912|P2|STARTED|Overall Study||1
7688432|NCT01883908|18933913|P1|STARTED|Overall Study||3
7688433|NCT01883895|18933921|P1|NOT COMPLETED|Overall Study||2
7688434|NCT01883895|18933921|P1|COMPLETED|Overall Study||32
7688435|NCT01883895|18933921|P1|STARTED|Overall Study||34
7688436|NCT01883856|18933928|P2|NOT COMPLETED|Overall Study||0
7688437|NCT01883856|18933929|P1|NOT COMPLETED|Overall Study||0
7688438|NCT01883856|18933928|P2|COMPLETED|Overall Study||26
7688439|NCT01883856|18933929|P1|COMPLETED|Overall Study||26
7688440|NCT01883856|18933928|P2|STARTED|Overall Study||26
7688441|NCT01883856|18933929|P1|STARTED|Overall Study||26
7688442|NCT01883804|18933939|P1|NOT COMPLETED|Overall Study||5
7688443|NCT01883804|18933939|P1|COMPLETED|Overall Study||20
7688444|NCT01883804|18933939|P1|STARTED|Overall Study||25
7688445|NCT01883635|18933948|P2|NOT COMPLETED|Overall Study||0
7688446|NCT01883635|18933949|P1|NOT COMPLETED|Overall Study||4
7688447|NCT01883635|18933948|P2|COMPLETED|Overall Study||20
7688448|NCT01883635|18933949|P1|COMPLETED|Overall Study||20
7688449|NCT01883635|18933948|P2|STARTED|Overall Study||20
7688450|NCT01883635|18933949|P1|STARTED|Overall Study||24
7688451|NCT01883492|18933963|P2|NOT COMPLETED|Overall Study||11
7688452|NCT01883492|18933964|P1|NOT COMPLETED|Overall Study||13
7688453|NCT01883492|18933963|P2|COMPLETED|Overall Study||67
7688454|NCT01883492|18933964|P1|COMPLETED|Overall Study||62
7688455|NCT01883492|18933963|P2|STARTED|Overall Study||78
7688456|NCT01883492|18933964|P1|STARTED|Overall Study||75
7688457|NCT01883453|18933996|P2|NOT COMPLETED|Overall Study||23
7688458|NCT01883453|18933997|P1|NOT COMPLETED|Overall Study||25
7688459|NCT01883453|18933996|P2|COMPLETED|Overall Study||50
7688460|NCT01883453|18933997|P1|COMPLETED|Overall Study||48
7688461|NCT01883453|18933996|P2|STARTED|Overall Study||73
7688462|NCT01883453|18933997|P1|STARTED|Overall Study||73
7688463|NCT01883440|18934005|P2|NOT COMPLETED|Overall Study||0
7688464|NCT01883440|18934006|P1|NOT COMPLETED|Overall Study||3
7688465|NCT01883440|18934005|P2|COMPLETED|Overall Study||45
7688466|NCT01883440|18934006|P1|COMPLETED|Overall Study||42
7688467|NCT01883440|18934005|P2|STARTED|Overall Study||45
7688468|NCT01883440|18934006|P1|STARTED|Overall Study||45
7688469|NCT01883427|18934016|P2|NOT COMPLETED|Overall Study||0
7688470|NCT01883427|18934017|P1|NOT COMPLETED|Overall Study||0
7688471|NCT01883427|18934016|P2|COMPLETED|Overall Study||20
7688472|NCT01883427|18934017|P1|COMPLETED|Overall Study||20
7688473|NCT01883427|18934016|P2|STARTED|Overall Study||20
7688474|NCT01883427|18934017|P1|STARTED|Overall Study||20
7688475|NCT01883141|18934023|P1|NOT COMPLETED|Overall Study||0
7688476|NCT01883141|18934023|P1|COMPLETED|Overall Study|Exit form with exit reason available|31
7688477|NCT01883141|18934023|P1|Multivein|Overall Study||23
7688478|NCT01883141|18934023|P1|Biv Pacing-Posterior|Overall Study||22
7688479|NCT01883141|18934023|P1|BiV Pacing-Anterior|Overall Study||23
7688480|NCT01883141|18934023|P1|Multispot-pacing|Overall Study||24
7688481|NCT01883141|18934023|P1|BiV Pacing-Standard Therapy|Overall Study||26
7688482|NCT01883141|18934023|P1|BiV Pacing-Mid|Overall Study||25
7688483|NCT01883141|18934023|P1|BiV Pacing-Distal|Overall Study||24
7688484|NCT01883141|18934023|P1|Usable EP Data|Overall Study||26
7688485|NCT01883141|18934023|P1|EP Study Performed|Overall Study||30
7688486|NCT01883141|18934023|P1|Passing Eligibility|Overall Study||30
7688487|NCT01883141|18934023|P1|STARTED|Overall Study||31
7688488|NCT01882985|18934032|P1|NOT COMPLETED|Overall Study||2
7688489|NCT01882985|18934032|P1|COMPLETED|Overall Study||12
7688490|NCT01882985|18934032|P1|STARTED|Overall Study||14
7688491|NCT01882907|18934041|P2|NOT COMPLETED|Overall Study||28
7688492|NCT01882907|18934042|P1|NOT COMPLETED|Overall Study||14
7688493|NCT01882907|18934041|P2|COMPLETED|Overall Study||83
7688494|NCT01882907|18934042|P1|COMPLETED|Overall Study||103
7688495|NCT01882907|18934041|P2|STARTED|Overall Study||111
7688496|NCT01882907|18934042|P1|STARTED|Overall Study||117
7688497|NCT01882868|18934058|P1|NOT COMPLETED|Overall Study||0
7688498|NCT01882868|18934058|P1|COMPLETED|Overall Study||62
7688499|NCT01882868|18934058|P1|STARTED|Overall Study||62
7688500|NCT01882829|18934088|P1|NOT COMPLETED|Overall Study||6
7688501|NCT01882829|18934088|P1|COMPLETED|Overall Study||14
7688502|NCT01882829|18934088|P1|STARTED|Overall Study||20
7688503|NCT01882803|18934102|P1|NOT COMPLETED|Overall Study||94
7688504|NCT01882803|18934102|P1|COMPLETED|Overall Study|Subject received treatment in 28-day cycles until disease progression or unacceptable toxicity.|35
7688505|NCT01882803|18934102|P1|STARTED|Overall Study||129
7688506|NCT01882764|18934115|P2|NOT COMPLETED|Overall Study||18
7688507|NCT01882764|18934116|P1|NOT COMPLETED|Overall Study||47
7688508|NCT01882764|18934115|P2|COMPLETED|Overall Study||1
7688509|NCT01882764|18934116|P1|COMPLETED|Overall Study||0
7688510|NCT01882764|18934115|P2|STARTED|Overall Study||19
7688511|NCT01882764|18934116|P1|STARTED|Overall Study||47
7688512|NCT01882725|18934122|P1|NOT COMPLETED|Overall Study||0
7688513|NCT01882725|18934122|P1|COMPLETED|Overall Study||14
7688514|NCT01882725|18934122|P1|STARTED|Overall Study||14
7688515|NCT01882647|18934129|P2|NOT COMPLETED|Overall Study||6
7688516|NCT01882647|18934130|P1|NOT COMPLETED|Overall Study||2
7688517|NCT01882647|18934129|P2|COMPLETED|Overall Study||106
7688518|NCT01882647|18934130|P1|COMPLETED|Overall Study||108
7688519|NCT01882647|18934129|P2|STARTED|Overall Study||112
7688520|NCT01882647|18934130|P1|STARTED|Overall Study||110
7688521|NCT01882543|18934148|P2|NOT COMPLETED|Overall Study||3
7688522|NCT01882543|18934149|P1|NOT COMPLETED|Overall Study||4
7688523|NCT01882543|18934148|P2|COMPLETED|Overall Study||29
7688524|NCT01882543|18934149|P1|COMPLETED|Overall Study||33
7688525|NCT01882543|18934148|P2|STARTED|Overall Study||32
7688526|NCT01882543|18934149|P1|STARTED|Overall Study||37
7688527|NCT01882465|18934170|P7|NOT COMPLETED|Period 3||0
7688528|NCT01882465|18934171|P6|NOT COMPLETED|Period 3||0
7688529|NCT01882465|18934172|P5|NOT COMPLETED|Period 3||0
7688530|NCT01882465|18934173|P4|NOT COMPLETED|Period 3||0
7688531|NCT01882465|18934174|P3|NOT COMPLETED|Period 3||0
7688532|NCT01882465|18934175|P2|NOT COMPLETED|Period 3||0
7688533|NCT01882465|18934176|P1|NOT COMPLETED|Period 3||0
7688534|NCT01882465|18934170|P7|COMPLETED|Period 3||0
7688535|NCT01882465|18934171|P6|COMPLETED|Period 3||5
7688536|NCT01882465|18934172|P5|COMPLETED|Period 3||4
7688537|NCT01882465|18934173|P4|COMPLETED|Period 3||5
7688538|NCT01882465|18934174|P3|COMPLETED|Period 3||5
7688539|NCT01882465|18934175|P2|COMPLETED|Period 3||6
7688540|NCT01882465|18934176|P1|COMPLETED|Period 3||6
7688541|NCT01882465|18934170|P7|STARTED|Period 3||0
7688542|NCT01882465|18934171|P6|STARTED|Period 3||5
7688543|NCT01882465|18934172|P5|STARTED|Period 3||4
7688544|NCT01882465|18934173|P4|STARTED|Period 3||5
7688545|NCT01882465|18934174|P3|STARTED|Period 3||5
7688546|NCT01882465|18934175|P2|STARTED|Period 3||6
7688547|NCT01882465|18934176|P1|STARTED|Period 3||6
7688548|NCT01882465|18934170|P7|NOT COMPLETED|Period 2||0
7688549|NCT01882465|18934171|P6|NOT COMPLETED|Period 2||0
7688550|NCT01882465|18934172|P5|NOT COMPLETED|Period 2||1
7688551|NCT01882465|18934173|P4|NOT COMPLETED|Period 2||0
7688552|NCT01882465|18934174|P3|NOT COMPLETED|Period 2||0
7688553|NCT01882465|18934175|P2|NOT COMPLETED|Period 2||0
7688554|NCT01882465|18934176|P1|NOT COMPLETED|Period 2||0
7688555|NCT01882465|18934170|P7|COMPLETED|Period 2||0
7688556|NCT01882465|18934171|P6|COMPLETED|Period 2||5
7688557|NCT01882465|18934172|P5|COMPLETED|Period 2||4
7688558|NCT01882465|18934173|P4|COMPLETED|Period 2||5
7688559|NCT01882465|18934174|P3|COMPLETED|Period 2||5
7688560|NCT01882465|18934175|P2|COMPLETED|Period 2||6
7688561|NCT01882465|18934176|P1|COMPLETED|Period 2||6
7688562|NCT01882465|18934170|P7|STARTED|Period 2||0
7688563|NCT01882465|18934171|P6|STARTED|Period 2||5
7688564|NCT01882465|18934172|P5|STARTED|Period 2||5
7688565|NCT01882465|18934173|P4|STARTED|Period 2||5
7688566|NCT01882465|18934174|P3|STARTED|Period 2||5
7688567|NCT01882465|18934175|P2|STARTED|Period 2||6
7688568|NCT01882465|18934176|P1|STARTED|Period 2||6
7688569|NCT01882465|18934170|P7|NOT COMPLETED|Period 1||1
7688570|NCT01882465|18934171|P6|NOT COMPLETED|Period 1||0
7688571|NCT01882465|18934172|P5|NOT COMPLETED|Period 1||0
7688572|NCT01882465|18934173|P4|NOT COMPLETED|Period 1||1
7688573|NCT01882465|18934174|P3|NOT COMPLETED|Period 1||0
7688574|NCT01882465|18934175|P2|NOT COMPLETED|Period 1||0
7688575|NCT01882465|18934176|P1|NOT COMPLETED|Period 1||0
7688576|NCT01882465|18934170|P7|COMPLETED|Period 1||0
7688577|NCT01882465|18934171|P6|COMPLETED|Period 1||5
7688578|NCT01882465|18934172|P5|COMPLETED|Period 1||5
7688579|NCT01882465|18934173|P4|COMPLETED|Period 1||5
7688580|NCT01882465|18934174|P3|COMPLETED|Period 1||5
7688581|NCT01882465|18934175|P2|COMPLETED|Period 1||6
7688582|NCT01882465|18934176|P1|COMPLETED|Period 1||6
7688583|NCT01882465|18934170|P7|STARTED|Period 1||1
7688584|NCT01882465|18934171|P6|STARTED|Period 1||5
7688585|NCT01882465|18934172|P5|STARTED|Period 1||5
7688586|NCT01882465|18934173|P4|STARTED|Period 1||6
7688587|NCT01882465|18934174|P3|STARTED|Period 1||5
7688588|NCT01882465|18934175|P2|STARTED|Period 1||6
7688589|NCT01882465|18934176|P1|STARTED|Period 1||6
7688590|NCT01882439|18934188|P4|NOT COMPLETED|Overall Study||9
7688591|NCT01882439|18934189|P3|NOT COMPLETED|Overall Study||10
7688592|NCT01882439|18934190|P2|NOT COMPLETED|Overall Study||21
7688593|NCT01882439|18934191|P1|NOT COMPLETED|Overall Study||9
7688594|NCT01882439|18934188|P4|COMPLETED|Overall Study||56
7688595|NCT01882439|18934189|P3|COMPLETED|Overall Study||56
7688596|NCT01882439|18934190|P2|COMPLETED|Overall Study||111
7688597|NCT01882439|18934191|P1|COMPLETED|Overall Study||122
7688598|NCT01882439|18934188|P4|STARTED|Overall Study|Received treatment|65
7688599|NCT01882439|18934189|P3|STARTED|Overall Study|Received treatment|66
7688600|NCT01882439|18934190|P2|STARTED|Overall Study|Received treatment|132
7688601|NCT01882439|18934191|P1|STARTED|Overall Study|Received treatment|131
7688602|NCT01882413|18934371|P1|NOT COMPLETED|Overall Study||0
7688603|NCT01882413|18934371|P1|COMPLETED|Overall Study||204
7688604|NCT01882413|18934371|P1|STARTED|Overall Study||204
7688605|NCT01882257|18934388|P3|NOT COMPLETED|Therapy Portion of Study (12 Months)||4
7688606|NCT01882257|18934389|P2|NOT COMPLETED|Therapy Portion of Study (12 Months)||11
7688607|NCT01882257|18934390|P1|NOT COMPLETED|Therapy Portion of Study (12 Months)||0
7688608|NCT01882257|18934388|P3|COMPLETED|Therapy Portion of Study (12 Months)||18
7688609|NCT01882257|18934389|P2|COMPLETED|Therapy Portion of Study (12 Months)||27
7688610|NCT01882257|18934390|P1|COMPLETED|Therapy Portion of Study (12 Months)||11
7688611|NCT01882257|18934388|P3|STARTED|Therapy Portion of Study (12 Months)||22
7688612|NCT01882257|18934389|P2|STARTED|Therapy Portion of Study (12 Months)||38
7688613|NCT01882257|18934390|P1|STARTED|Therapy Portion of Study (12 Months)||11
7688614|NCT01882257|18934388|P3|NOT COMPLETED|Study Origination to Beginning Therapy||1
7688615|NCT01882257|18934389|P2|NOT COMPLETED|Study Origination to Beginning Therapy||2
7688616|NCT01882257|18934390|P1|NOT COMPLETED|Study Origination to Beginning Therapy||0
7688617|NCT01882257|18934388|P3|COMPLETED|Study Origination to Beginning Therapy||22
7688618|NCT01882257|18934389|P2|COMPLETED|Study Origination to Beginning Therapy||38
7688619|NCT01882257|18934390|P1|COMPLETED|Study Origination to Beginning Therapy||11
7688620|NCT01882257|18934388|P3|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22
7688621|NCT01882257|18934389|P2|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38
7688622|NCT01882257|18934390|P1|Started Therapy Using Device|Study Origination to Beginning Therapy||11
7688623|NCT01882257|18934388|P3|STARTED|Study Origination to Beginning Therapy||23
7688624|NCT01882257|18934389|P2|STARTED|Study Origination to Beginning Therapy||40
7688625|NCT01882257|18934390|P1|STARTED|Study Origination to Beginning Therapy||11
7688626|NCT01882088|18934397|P1|NOT COMPLETED|Overall Study||5
7688627|NCT01882088|18934397|P1|COMPLETED|Overall Study||30
7688628|NCT01882088|18934397|P1|STARTED|Overall Study|35 patients were provided with psyllium in 5.0 sachets, 3 sachets per day for 10 days|35
7688629|NCT01882062|18934410|P1|NOT COMPLETED|Overall Study||0
7688630|NCT01882062|18934410|P1|COMPLETED|Overall Study|18th of july 2013|10
7688631|NCT01882062|18934410|P1|STARTED|Overall Study|16th of may 2013|10
7688632|NCT01881984|18934414|P1|NOT COMPLETED|Overall Study||0
7688633|NCT01881984|18934414|P1|COMPLETED|Overall Study||4
7688634|NCT01881984|18934414|P1|STARTED|Overall Study||4
7688635|NCT01881932|18934422|P3|NOT COMPLETED|Overall Study||0
7688636|NCT01881932|18934423|P2|NOT COMPLETED|Overall Study||0
7688637|NCT01881932|18934424|P1|NOT COMPLETED|Overall Study||0
7688638|NCT01881932|18934422|P3|COMPLETED|Overall Study||13
7688639|NCT01881932|18934423|P2|COMPLETED|Overall Study||4
7688640|NCT01881932|18934424|P1|COMPLETED|Overall Study||2
7688641|NCT01881932|18934422|P3|STARTED|Overall Study||13
7688642|NCT01881932|18934423|P2|STARTED|Overall Study||4
7688643|NCT01881932|18934424|P1|STARTED|Overall Study||2
7688644|NCT01881867|18934434|P2|NOT COMPLETED|Overall Study||13
7688645|NCT01881867|18934435|P1|NOT COMPLETED|Overall Study||12
7688646|NCT01881867|18934434|P2|COMPLETED|Overall Study||15
7688647|NCT01881867|18934435|P1|COMPLETED|Overall Study||14
7688648|NCT01881867|18934434|P2|STARTED|Overall Study||28
7688649|NCT01881867|18934435|P1|STARTED|Overall Study||26
7688650|NCT01881828|18934455|P2|NOT COMPLETED|Overall Study||0
7688651|NCT01881828|18934456|P1|NOT COMPLETED|Overall Study||0
7688652|NCT01881828|18934455|P2|COMPLETED|Overall Study||69
7688653|NCT01881828|18934456|P1|COMPLETED|Overall Study||71
7688654|NCT01881828|18934455|P2|STARTED|Overall Study|23 excluded from randomization from enrollment|69
7688655|NCT01881828|18934456|P1|STARTED|Overall Study|23 excluded at randomization from enrollment|71
7688656|NCT01881776|18934479|P3|NOT COMPLETED|Overall Study||2
7688657|NCT01881776|18934480|P2|NOT COMPLETED|Overall Study||4
7688658|NCT01881776|18934481|P1|NOT COMPLETED|Overall Study||1
7688659|NCT01881776|18934479|P3|COMPLETED|Overall Study||20
7688660|NCT01881776|18934480|P2|COMPLETED|Overall Study||20
7688661|NCT01881776|18934481|P1|COMPLETED|Overall Study||23
7688662|NCT01881776|18934479|P3|STARTED|Overall Study||22
7688663|NCT01881776|18934480|P2|STARTED|Overall Study||24
7688664|NCT01881776|18934481|P1|STARTED|Overall Study||24
7688665|NCT01881750|18934509|P2|NOT COMPLETED|Overall Study||4
7688666|NCT01881750|18934510|P1|NOT COMPLETED|Overall Study||2
7688667|NCT01881750|18934509|P2|COMPLETED|Overall Study||22
7688668|NCT01881750|18934510|P1|COMPLETED|Overall Study||25
7688669|NCT01881750|18934509|P2|STARTED|Overall Study||26
7688670|NCT01881750|18934510|P1|STARTED|Overall Study||27
7688671|NCT01881737|18934528|P1|NOT COMPLETED|Overall Study||5
7688672|NCT01881737|18934528|P1|COMPLETED|Overall Study||10
7688673|NCT01881737|18934528|P1|Number Screened|Overall Study||15
7688674|NCT01881737|18934528|P1|STARTED|Overall Study|This is a pilot study|15
7688675|NCT01881620|18934537|P1|NOT COMPLETED|Overall Study||4
7688676|NCT01881620|18934537|P1|COMPLETED|Overall Study|Eligible patients with PET-CT scanner performed AND interpretation of 2 pairs of observors available|105
7688677|NCT01881620|18934537|P1|STARTED|Overall Study||109
7688678|NCT01881412|18934548|P2|NOT COMPLETED|Overall Study||2
7688679|NCT01881412|18934549|P1|NOT COMPLETED|Overall Study||10
7688680|NCT01881412|18934548|P2|COMPLETED|Overall Study||57
7688681|NCT01881412|18934549|P1|COMPLETED|Overall Study||49
7688682|NCT01881412|18934548|P2|STARTED|Overall Study||59
7688683|NCT01881412|18934549|P1|STARTED|Overall Study||59
7688684|NCT01881373|18934568|P3|NOT COMPLETED|24 Months||0
7688685|NCT01881373|18934569|P2|NOT COMPLETED|24 Months||0
7688686|NCT01881373|18934570|P1|NOT COMPLETED|24 Months||0
7688687|NCT01881373|18934568|P3|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
7688688|NCT01881373|18934569|P2|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
7688689|NCT01881373|18934570|P1|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
7688690|NCT01881373|18934568|P3|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
7688691|NCT01881373|18934569|P2|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
7688692|NCT01881373|18934570|P1|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
7688693|NCT01881373|18934568|P3|NOT COMPLETED|Baseline||0
7688694|NCT01881373|18934569|P2|NOT COMPLETED|Baseline||0
7688695|NCT01881373|18934570|P1|NOT COMPLETED|Baseline||0
7688696|NCT01881373|18934568|P3|COMPLETED|Baseline|Cross-sectional sample|1321
7688697|NCT01881373|18934569|P2|COMPLETED|Baseline|Cross-sectional sample|1491
7688698|NCT01881373|18934570|P1|COMPLETED|Baseline|Cross-sectional sample|1517
7688699|NCT01881373|18934568|P3|STARTED|Baseline|Cross-sectional sample|1321
7688700|NCT01881373|18934569|P2|STARTED|Baseline|Cross-sectional sample|1491
7688701|NCT01881373|18934570|P1|STARTED|Baseline|Cross-sectional sample|1517
7688702|NCT01881230|18934617|P3|NOT COMPLETED|Overall Study||66
7688703|NCT01881230|18934618|P2|NOT COMPLETED|Overall Study||64
7688704|NCT01881230|18934619|P1|NOT COMPLETED|Overall Study||61
7688705|NCT01881230|18934617|P3|COMPLETED|Overall Study|Not applicable according to the study design|0
7688706|NCT01881230|18934618|P2|COMPLETED|Overall Study|Not applicable according to the study design|0
7688707|NCT01881230|18934619|P1|COMPLETED|Overall Study|Not applicable according to the study design|0
7688708|NCT01881230|18934617|P3|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
7688709|NCT01881230|18934618|P2|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
7688710|NCT01881230|18934619|P1|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|60
7688711|NCT01881230|18934617|P3|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
7688712|NCT01881230|18934618|P2|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
7688713|NCT01881230|18934619|P1|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of Investigational Product (IP)|60
7688714|NCT01881230|18934617|P3|STARTED|Overall Study||66
7688715|NCT01881230|18934618|P2|STARTED|Overall Study||64
7688716|NCT01881230|18934619|P1|STARTED|Overall Study||61
7688717|NCT01881126|18934647|P2|NOT COMPLETED|Overall Study||2
7688718|NCT01881126|18934648|P1|NOT COMPLETED|Overall Study||1
7688719|NCT01881126|18934647|P2|COMPLETED|Overall Study||44
7688720|NCT01881126|18934648|P1|COMPLETED|Overall Study||46
7688721|NCT01881126|18934647|P2|STARTED|Overall Study||46
7688722|NCT01881126|18934648|P1|STARTED|Overall Study||47
7688723|NCT01881113|18934656|P2|NOT COMPLETED|Overall Study||6
7688724|NCT01881113|18934657|P1|NOT COMPLETED|Overall Study||8
7688725|NCT01881113|18934656|P2|COMPLETED|Overall Study||44
7688726|NCT01881113|18934657|P1|COMPLETED|Overall Study||43
7688727|NCT01881113|18934656|P2|STARTED|Overall Study||50
7688728|NCT01881113|18934657|P1|STARTED|Overall Study||51
7688729|NCT01881087|18934714|P3|NOT COMPLETED|Overall Study||2
7688730|NCT01881087|18934715|P2|NOT COMPLETED|Overall Study||0
7688731|NCT01881087|18934716|P1|NOT COMPLETED|Overall Study||1
7688732|NCT01881087|18934714|P3|COMPLETED|Overall Study||60
7688733|NCT01881087|18934715|P2|COMPLETED|Overall Study||61
7688734|NCT01881087|18934716|P1|COMPLETED|Overall Study||59
7688735|NCT01881087|18934714|P3|STARTED|Overall Study||62
7688736|NCT01881087|18934715|P2|STARTED|Overall Study||61
7688737|NCT01881087|18934716|P1|STARTED|Overall Study||60
7688738|NCT01881009|18934729|P2|NOT COMPLETED|Summer Camp Session (6 Days)||1
7688739|NCT01881009|18934730|P1|NOT COMPLETED|Summer Camp Session (6 Days)||0
7688740|NCT01881009|18934729|P2|COMPLETED|Summer Camp Session (6 Days)||21
7688741|NCT01881009|18934730|P1|COMPLETED|Summer Camp Session (6 Days)||0
7688742|NCT01881009|18934729|P2|STARTED|Summer Camp Session (6 Days)||22
7688743|NCT01881009|18934730|P1|STARTED|Summer Camp Session (6 Days)||0
7688744|NCT01881009|18934729|P2|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
7688745|NCT01881009|18934730|P1|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
7688746|NCT01881009|18934729|P2|COMPLETED|Inpatient Safety Testing (22 Hours)||0
7688747|NCT01881009|18934730|P1|COMPLETED|Inpatient Safety Testing (22 Hours)||16
7688748|NCT01881009|18934729|P2|STARTED|Inpatient Safety Testing (22 Hours)||0
7688749|NCT01881009|18934730|P1|STARTED|Inpatient Safety Testing (22 Hours)||16
7688750|NCT01880840|18934741|P2|NOT COMPLETED|Overall Study||5
7688751|NCT01880840|18934742|P1|NOT COMPLETED|Overall Study||8
7688752|NCT01880840|18934741|P2|COMPLETED|Overall Study||91
7688753|NCT01880840|18934742|P1|COMPLETED|Overall Study||87
7688754|NCT01880840|18934741|P2|STARTED|Overall Study||96
7688755|NCT01880840|18934742|P1|STARTED|Overall Study||95
7688756|NCT01880736|18934752|P4|NOT COMPLETED|Overall Study||6
7688757|NCT01880736|18934753|P3|NOT COMPLETED|Overall Study||1
7688758|NCT01880736|18934754|P2|NOT COMPLETED|Overall Study||2
7688759|NCT01880736|18934755|P1|NOT COMPLETED|Overall Study||1
7688760|NCT01880736|18934752|P4|COMPLETED|Overall Study||108
7688761|NCT01880736|18934753|P3|COMPLETED|Overall Study||114
7688762|NCT01880736|18934754|P2|COMPLETED|Overall Study||113
7688763|NCT01880736|18934755|P1|COMPLETED|Overall Study||113
7688764|NCT01880736|18934752|P4|STARTED|Overall Study||114
7688765|NCT01880736|18934753|P3|STARTED|Overall Study||115
7688766|NCT01880736|18934754|P2|STARTED|Overall Study||115
7688767|NCT01880736|18934755|P1|STARTED|Overall Study||114
7688768|NCT01880723|18934799|P2|NOT COMPLETED|Overall Study||0
7688769|NCT01880723|18934800|P1|NOT COMPLETED|Overall Study||0
7688770|NCT01880723|18934799|P2|COMPLETED|Overall Study||16
7688771|NCT01880723|18934800|P1|COMPLETED|Overall Study||16
7688772|NCT01880723|18934799|P2|STARTED|Overall Study||16
7688773|NCT01880723|18934800|P1|STARTED|Overall Study||16
7688774|NCT01880697|18934816|P2|NOT COMPLETED|Overall Study||1
7688775|NCT01880697|18934817|P1|NOT COMPLETED|Overall Study||0
7688776|NCT01880697|18934816|P2|COMPLETED|Overall Study||62
7688777|NCT01880697|18934817|P1|COMPLETED|Overall Study||63
7688778|NCT01880697|18934816|P2|STARTED|Overall Study||63
7688779|NCT01880697|18934817|P1|STARTED|Overall Study||63
7688780|NCT01880593|18934839|P2|NOT COMPLETED|Overall Study||6
7688781|NCT01880593|18934840|P1|NOT COMPLETED|Overall Study||8
7688782|NCT01880593|18934839|P2|COMPLETED|Overall Study||10
7688783|NCT01880593|18934840|P1|COMPLETED|Overall Study||10
7688784|NCT01880593|18934839|P2|STARTED|Overall Study||16
7688785|NCT01880593|18934840|P1|STARTED|Overall Study||18
7688786|NCT01880528|18934860|P2|NOT COMPLETED|Overall Study||1
7688787|NCT01880528|18934861|P1|NOT COMPLETED|Overall Study||1
7688788|NCT01880528|18934860|P2|COMPLETED|Overall Study||10
7688789|NCT01880528|18934861|P1|COMPLETED|Overall Study||11
7688790|NCT01880528|18934860|P2|STARTED|Overall Study||11
7688791|NCT01880528|18934861|P1|STARTED|Overall Study||12
7688792|NCT01880515|18934877|P2|NOT COMPLETED|Overall Study||9
7688793|NCT01880515|18934878|P1|NOT COMPLETED|Overall Study||8
7688794|NCT01880515|18934877|P2|COMPLETED|Overall Study||45
7688795|NCT01880515|18934878|P1|COMPLETED|Overall Study||45
7688796|NCT01880515|18934877|P2|STARTED|Overall Study||54
7688797|NCT01880515|18934878|P1|STARTED|Overall Study||53
7688798|NCT01880437|18934889|P3|NOT COMPLETED|Overall Study||19
7688799|NCT01880437|18934890|P2|NOT COMPLETED|Overall Study||4
7688800|NCT01880437|18934891|P1|NOT COMPLETED|Overall Study||15
7688801|NCT01880437|18934889|P3|COMPLETED|Overall Study||0
7688802|NCT01880437|18934890|P2|COMPLETED|Overall Study||0
7688803|NCT01880437|18934891|P1|COMPLETED|Overall Study||0
7688804|NCT01880437|18934889|P3|STARTED|Overall Study||19
7688805|NCT01880437|18934890|P2|STARTED|Overall Study||4
7688806|NCT01880437|18934891|P1|STARTED|Overall Study||15
7688807|NCT01880424|18934917|P2|NOT COMPLETED|Overall Study||55
7688808|NCT01880424|18934918|P1|NOT COMPLETED|Overall Study||33
7688809|NCT01880424|18934917|P2|COMPLETED|Overall Study||367
7688810|NCT01880424|18934918|P1|COMPLETED|Overall Study||384
7688811|NCT01880424|18934917|P2|STARTED|Overall Study||422
7688812|NCT01880424|18934918|P1|STARTED|Overall Study||417
7688813|NCT01880320|18934943|P3|NOT COMPLETED|Overall Study||8
7688814|NCT01880320|18934944|P2|NOT COMPLETED|Overall Study||25
7688815|NCT01880320|18934945|P1|NOT COMPLETED|Overall Study||20
7688816|NCT01880320|18934943|P3|COMPLETED|Overall Study||61
7688817|NCT01880320|18934944|P2|COMPLETED|Overall Study||192
7688818|NCT01880320|18934945|P1|COMPLETED|Overall Study||197
7688819|NCT01880320|18934943|P3|STARTED|Overall Study||69
7688820|NCT01880320|18934944|P2|STARTED|Overall Study||217
7688821|NCT01880320|18934945|P1|STARTED|Overall Study||217
7688822|NCT01880099|18934962|P3|NOT COMPLETED|Overall Study||7
7688823|NCT01880099|18934963|P2|NOT COMPLETED|Overall Study||10
7688824|NCT01880099|18934964|P1|NOT COMPLETED|Overall Study||8
7688825|NCT01880099|18934962|P3|COMPLETED|Overall Study||15
7688826|NCT01880099|18934963|P2|COMPLETED|Overall Study||11
7688827|NCT01880099|18934964|P1|COMPLETED|Overall Study||9
7688828|NCT01880099|18934962|P3|STARTED|Overall Study||22
7688829|NCT01880099|18934963|P2|STARTED|Overall Study||21
7688830|NCT01880099|18934964|P1|STARTED|Overall Study||17
7688831|NCT01880086|18934974|P2|NOT COMPLETED|Overall Study||1
7688832|NCT01880086|18934975|P1|NOT COMPLETED|Overall Study||1
7688833|NCT01880086|18934974|P2|COMPLETED|Overall Study||6
7688834|NCT01880086|18934975|P1|COMPLETED|Overall Study||5
7688835|NCT01880086|18934974|P2|STARTED|Overall Study||7
7688836|NCT01880086|18934975|P1|STARTED|Overall Study||6
7688837|NCT01880073|18934993|P1|NOT COMPLETED|Overall Study||0
7688838|NCT01880073|18934993|P1|COMPLETED|Overall Study||24
7688839|NCT01880073|18934993|P1|STARTED|Overall Study||24
7688840|NCT01880047|18935004|P4|NOT COMPLETED|Extension Phase - 18 Months||2
7688841|NCT01880047|18935005|P3|NOT COMPLETED|Extension Phase - 18 Months||1
7688842|NCT01880047|18935006|P2|NOT COMPLETED|Extension Phase - 18 Months||3
7688843|NCT01880047|18935007|P1|NOT COMPLETED|Extension Phase - 18 Months||9
7688844|NCT01880047|18935004|P4|COMPLETED|Extension Phase - 18 Months||0
7688845|NCT01880047|18935005|P3|COMPLETED|Extension Phase - 18 Months||3
7688846|NCT01880047|18935006|P2|COMPLETED|Extension Phase - 18 Months||3
7688847|NCT01880047|18935007|P1|COMPLETED|Extension Phase - 18 Months||6
7688848|NCT01880047|18935004|P4|STARTED|Extension Phase - 18 Months|2 subjects went into extension phase, were followed for variable periods of time|2
7688849|NCT01880047|18935005|P3|STARTED|Extension Phase - 18 Months|4 subjects went into extension phase, were followed for variable periods of time|4
7688850|NCT01880047|18935006|P2|STARTED|Extension Phase - 18 Months|6 subjects went into extension phase, were followed for variable periods of time|6
7688851|NCT01880047|18935007|P1|STARTED|Extension Phase - 18 Months|15 subjects went into extension phase, were followed for variable periods of time|15
7688852|NCT01880047|18935004|P4|NOT COMPLETED|Weeks 5-8||0
7688853|NCT01880047|18935005|P3|NOT COMPLETED|Weeks 5-8||0
7688854|NCT01880047|18935006|P2|NOT COMPLETED|Weeks 5-8||1
7688855|NCT01880047|18935007|P1|NOT COMPLETED|Weeks 5-8||2
7688856|NCT01880047|18935004|P4|COMPLETED|Weeks 5-8||2
7688857|NCT01880047|18935005|P3|COMPLETED|Weeks 5-8||4
7688858|NCT01880047|18935006|P2|COMPLETED|Weeks 5-8||6
7688859|NCT01880047|18935007|P1|COMPLETED|Weeks 5-8||15
7688860|NCT01880047|18935004|P4|STARTED|Weeks 5-8||2
7688861|NCT01880047|18935005|P3|STARTED|Weeks 5-8||4
7688862|NCT01880047|18935006|P2|STARTED|Weeks 5-8||7
7688863|NCT01880047|18935007|P1|STARTED|Weeks 5-8||17
7688864|NCT01880047|18935004|P4|NOT COMPLETED|Weeks 3-4||0
7688865|NCT01880047|18935005|P3|NOT COMPLETED|Weeks 3-4||0
7688866|NCT01880047|18935006|P2|NOT COMPLETED|Weeks 3-4||1
7688867|NCT01880047|18935007|P1|NOT COMPLETED|Weeks 3-4||0
7688868|NCT01880047|18935004|P4|COMPLETED|Weeks 3-4||2
7688869|NCT01880047|18935005|P3|COMPLETED|Weeks 3-4||4
7688870|NCT01880047|18935006|P2|COMPLETED|Weeks 3-4||7
7688871|NCT01880047|18935007|P1|COMPLETED|Weeks 3-4||17
7688872|NCT01880047|18935004|P4|STARTED|Weeks 3-4||2
7688873|NCT01880047|18935005|P3|STARTED|Weeks 3-4||4
7688874|NCT01880047|18935006|P2|STARTED|Weeks 3-4||8
7688875|NCT01880047|18935007|P1|STARTED|Weeks 3-4||17
7688876|NCT01880047|18935004|P4|NOT COMPLETED|Weeks 0-2||1
7688877|NCT01880047|18935005|P3|NOT COMPLETED|Weeks 0-2||1
7688878|NCT01880047|18935006|P2|NOT COMPLETED|Weeks 0-2||1
7688879|NCT01880047|18935007|P1|NOT COMPLETED|Weeks 0-2||0
7688880|NCT01880047|18935004|P4|COMPLETED|Weeks 0-2||2
7688881|NCT01880047|18935005|P3|COMPLETED|Weeks 0-2||4
7688882|NCT01880047|18935006|P2|COMPLETED|Weeks 0-2||8
7688883|NCT01880047|18935007|P1|COMPLETED|Weeks 0-2||17
7688884|NCT01880047|18935004|P4|STARTED|Weeks 0-2||3
7688885|NCT01880047|18935005|P3|STARTED|Weeks 0-2||5
7688886|NCT01880047|18935006|P2|STARTED|Weeks 0-2||9
7688887|NCT01880047|18935007|P1|STARTED|Weeks 0-2||17
7688888|NCT01879852|18935030|P2|NOT COMPLETED|Overall Study||0
7688889|NCT01879852|18935031|P1|NOT COMPLETED|Overall Study||2
7688890|NCT01879852|18935030|P2|COMPLETED|Overall Study||13
7688891|NCT01879852|18935031|P1|COMPLETED|Overall Study||12
7688892|NCT01879852|18935030|P2|STARTED|Overall Study||13
7688893|NCT01879852|18935031|P1|STARTED|Overall Study||14
7688894|NCT01879826|18935045|P2|NOT COMPLETED|Overall Study||0
7688895|NCT01879826|18935046|P1|NOT COMPLETED|Overall Study||0
7688896|NCT01879826|18935045|P2|COMPLETED|Overall Study||40
7688897|NCT01879826|18935046|P1|COMPLETED|Overall Study||41
7688898|NCT01879826|18935045|P2|STARTED|Overall Study||40
7688899|NCT01879826|18935046|P1|STARTED|Overall Study||41
7688900|NCT01879800|18935056|P2|NOT COMPLETED|Overall Study||4
7688901|NCT01879800|18935057|P1|NOT COMPLETED|Overall Study||0
7688902|NCT01879800|18935056|P2|COMPLETED|Overall Study||26
7688903|NCT01879800|18935057|P1|COMPLETED|Overall Study||14
7688904|NCT01879800|18935056|P2|STARTED|Overall Study||30
7688905|NCT01879800|18935057|P1|STARTED|Overall Study||14
7688906|NCT01879735|18935069|P2|NOT COMPLETED|Overall Study||0
7688907|NCT01879735|18935070|P1|NOT COMPLETED|Overall Study||0
7688908|NCT01879735|18935069|P2|COMPLETED|Overall Study||16
7688909|NCT01879735|18935070|P1|COMPLETED|Overall Study||6
7688910|NCT01879735|18935069|P2|STARTED|Overall Study||16
7688911|NCT01879735|18935070|P1|STARTED|Overall Study||6
7688912|NCT01879722|18935086|P10|NOT COMPLETED|Overall Study||0
7688913|NCT01879722|18935087|P9|NOT COMPLETED|Overall Study||2
7688914|NCT01879722|18935088|P8|NOT COMPLETED|Overall Study||1
7688915|NCT01879722|18935089|P7|NOT COMPLETED|Overall Study||0
7688916|NCT01879722|18935090|P6|NOT COMPLETED|Overall Study||0
7688917|NCT01879722|18935091|P5|NOT COMPLETED|Overall Study||1
7688918|NCT01879722|18935092|P4|NOT COMPLETED|Overall Study||1
7688919|NCT01879722|18935093|P3|NOT COMPLETED|Overall Study||0
7688920|NCT01879722|18935094|P2|NOT COMPLETED|Overall Study||1
7688921|NCT01879722|18935095|P1|NOT COMPLETED|Overall Study||0
7688922|NCT01879722|18935086|P10|COMPLETED|Overall Study||6
7688923|NCT01879722|18935087|P9|COMPLETED|Overall Study||6
7688924|NCT01879722|18935088|P8|COMPLETED|Overall Study||7
7688925|NCT01879722|18935089|P7|COMPLETED|Overall Study||8
7688926|NCT01879722|18935090|P6|COMPLETED|Overall Study||9
7688927|NCT01879722|18935091|P5|COMPLETED|Overall Study||7
7688928|NCT01879722|18935092|P4|COMPLETED|Overall Study||7
7688929|NCT01879722|18935093|P3|COMPLETED|Overall Study||7
7688930|NCT01879722|18935094|P2|COMPLETED|Overall Study||7
7688931|NCT01879722|18935095|P1|COMPLETED|Overall Study||7
7688932|NCT01879722|18935086|P10|STARTED|Overall Study||6
7688933|NCT01879722|18935087|P9|STARTED|Overall Study||8
7688934|NCT01879722|18935088|P8|STARTED|Overall Study||8
7688935|NCT01879722|18935089|P7|STARTED|Overall Study||8
7688936|NCT01879722|18935090|P6|STARTED|Overall Study||9
7688937|NCT01879722|18935091|P5|STARTED|Overall Study||8
7688938|NCT01879722|18935092|P4|STARTED|Overall Study||8
7688939|NCT01879722|18935093|P3|STARTED|Overall Study||7
7688940|NCT01879722|18935094|P2|STARTED|Overall Study||8
7688941|NCT01879722|18935095|P1|STARTED|Overall Study||7
7688942|NCT01879683|18935243|P1|NOT COMPLETED|Overall Study||1
7688943|NCT01879683|18935243|P1|COMPLETED|Overall Study||9
7688944|NCT01879683|18935243|P1|STARTED|Overall Study||10
7688945|NCT01879618|18935250|P1|NOT COMPLETED|Overall Study||21
7688946|NCT01879618|18935250|P1|COMPLETED|Overall Study||131
7688947|NCT01879618|18935250|P1|STARTED|Overall Study||152
7688948|NCT01879579|18935257|P2|NOT COMPLETED|Overall Study||2
7688949|NCT01879579|18935258|P1|NOT COMPLETED|Overall Study||5
7688950|NCT01879579|18935257|P2|COMPLETED|Overall Study||26
7688951|NCT01879579|18935258|P1|COMPLETED|Overall Study||28
7688952|NCT01879579|18935257|P2|STARTED|Overall Study||28
7688953|NCT01879579|18935258|P1|STARTED|Overall Study||33
7688954|NCT01879553|18935288|P2|NOT COMPLETED|Overall Study||0
7688955|NCT01879553|18935289|P1|NOT COMPLETED|Overall Study||1
7688956|NCT01879553|18935288|P2|COMPLETED|Overall Study||63
7688957|NCT01879553|18935289|P1|COMPLETED|Overall Study||62
7688958|NCT01879553|18935288|P2|STARTED|Overall Study||63
7688959|NCT01879553|18935289|P1|STARTED|Overall Study||63
7688960|NCT01879540|18935310|P1|NOT COMPLETED|Overall Study||0
7688961|NCT01879540|18935310|P1|COMPLETED|Overall Study||63
7688962|NCT01879540|18935310|P1|STARTED|Overall Study||63
7688963|NCT01879410|18935323|P2|NOT COMPLETED|Overall Study||38
7688964|NCT01879410|18935324|P1|NOT COMPLETED|Overall Study||24
7688965|NCT01879410|18935323|P2|COMPLETED|Overall Study||312
7688966|NCT01879410|18935324|P1|COMPLETED|Overall Study||326
7688967|NCT01879410|18935323|P2|Intent-to-Treat Population|Overall Study||348
7688968|NCT01879410|18935324|P1|Intent-to-Treat Population|Overall Study||349
7688969|NCT01879410|18935323|P2|STARTED|Overall Study||350
7688970|NCT01879410|18935324|P1|STARTED|Overall Study||350
7688971|NCT01879371|18935338|P6|NOT COMPLETED|Overall Study||0
7688972|NCT01879371|18935339|P5|NOT COMPLETED|Overall Study||0
7688973|NCT01879371|18935340|P4|NOT COMPLETED|Overall Study||0
7688974|NCT01879371|18935341|P3|NOT COMPLETED|Overall Study||0
7688975|NCT01879371|18935342|P2|NOT COMPLETED|Overall Study||0
7688976|NCT01879371|18935343|P1|NOT COMPLETED|Overall Study||0
7688977|NCT01879371|18935338|P6|COMPLETED|Overall Study||6
7688978|NCT01879371|18935339|P5|COMPLETED|Overall Study||6
7688979|NCT01879371|18935340|P4|COMPLETED|Overall Study||6
7688980|NCT01879371|18935341|P3|COMPLETED|Overall Study||6
7688981|NCT01879371|18935342|P2|COMPLETED|Overall Study||6
7688982|NCT01879371|18935343|P1|COMPLETED|Overall Study||6
7688983|NCT01879371|18935338|P6|STARTED|Overall Study||6
7688984|NCT01879371|18935339|P5|STARTED|Overall Study||6
7688985|NCT01879371|18935340|P4|STARTED|Overall Study||6
7688986|NCT01879371|18935341|P3|STARTED|Overall Study||6
7688987|NCT01879371|18935342|P2|STARTED|Overall Study||6
7688988|NCT01879371|18935343|P1|STARTED|Overall Study||6
7688989|NCT01879345|18935360|P3|NOT COMPLETED|7-day Multiple-dose Period||0
7688990|NCT01879345|18935361|P2|NOT COMPLETED|7-day Multiple-dose Period||0
7688991|NCT01879345|18935362|P1|NOT COMPLETED|7-day Multiple-dose Period||0
7688992|NCT01879345|18935360|P3|COMPLETED|7-day Multiple-dose Period||6
7688993|NCT01879345|18935361|P2|COMPLETED|7-day Multiple-dose Period||6
7688994|NCT01879345|18935362|P1|COMPLETED|7-day Multiple-dose Period||6
7688995|NCT01879345|18935360|P3|STARTED|7-day Multiple-dose Period||6
7688996|NCT01879345|18935361|P2|STARTED|7-day Multiple-dose Period||6
7688997|NCT01879345|18935362|P1|STARTED|7-day Multiple-dose Period||6
7688998|NCT01879345|18935360|P3|NOT COMPLETED|Single-dose Period||0
7688999|NCT01879345|18935361|P2|NOT COMPLETED|Single-dose Period||0
7689000|NCT01879345|18935362|P1|NOT COMPLETED|Single-dose Period||0
7689001|NCT01879345|18935360|P3|COMPLETED|Single-dose Period||6
7689002|NCT01879345|18935361|P2|COMPLETED|Single-dose Period||6
7689003|NCT01879345|18935362|P1|COMPLETED|Single-dose Period||6
7689004|NCT01879345|18935360|P3|STARTED|Single-dose Period||6
7689005|NCT01879345|18935361|P2|STARTED|Single-dose Period||6
7689006|NCT01879345|18935362|P1|STARTED|Single-dose Period||6
7689007|NCT01879332|18935379|P3|NOT COMPLETED|Overall Study||4
7689008|NCT01879332|18935380|P2|NOT COMPLETED|Overall Study||6
7689009|NCT01879332|18935381|P1|NOT COMPLETED|Overall Study||6
7689010|NCT01879332|18935379|P3|COMPLETED|Overall Study||0
7689011|NCT01879332|18935380|P2|COMPLETED|Overall Study||0
7689012|NCT01879332|18935381|P1|COMPLETED|Overall Study||0
7689013|NCT01879332|18935379|P3|STARTED|Overall Study||4
7689014|NCT01879332|18935380|P2|STARTED|Overall Study||6
7689015|NCT01879332|18935381|P1|STARTED|Overall Study||6
7689016|NCT01879319|18935391|P2|NOT COMPLETED|Overall Study||5
7689017|NCT01879319|18935392|P1|NOT COMPLETED|Overall Study||2
7689018|NCT01879319|18935391|P2|COMPLETED|Overall Study||77
7689019|NCT01879319|18935392|P1|COMPLETED|Overall Study||80
7689020|NCT01879319|18935391|P2|Received Treatment|Overall Study||82
7689021|NCT01879319|18935392|P1|Received Treatment|Overall Study||82
7689022|NCT01879319|18935391|P2|STARTED|Overall Study||82
7689023|NCT01879319|18935392|P1|STARTED|Overall Study||82
7689024|NCT01879176|18935402|P2|NOT COMPLETED|Overall Study||6
7689025|NCT01879176|18935403|P1|NOT COMPLETED|Overall Study||8
7689026|NCT01879176|18935402|P2|COMPLETED|Overall Study||16
7689027|NCT01879176|18935403|P1|COMPLETED|Overall Study||16
7689028|NCT01879176|18935402|P2|STARTED|Overall Study||22
7689029|NCT01879176|18935403|P1|STARTED|Overall Study||24
7689030|NCT01879072|18935409|P1|NOT COMPLETED|Overall Study||151
7689031|NCT01879072|18935409|P1|COMPLETED|Overall Study||1709
7689032|NCT01879072|18935409|P1|STARTED|Overall Study||1860
7689033|NCT01879059|18935413|P1|NOT COMPLETED|Overall Study||0
7689034|NCT01879059|18935413|P1|COMPLETED|Overall Study||13
7689035|NCT01879059|18935413|P1|STARTED|Overall Study||13
7689036|NCT01878825|18935419|P2|NOT COMPLETED|Overall Study||0
7689037|NCT01878825|18935420|P1|NOT COMPLETED|Overall Study||0
7689038|NCT01878825|18935419|P2|COMPLETED|Overall Study||60
7689039|NCT01878825|18935420|P1|COMPLETED|Overall Study||60
7689040|NCT01878825|18935419|P2|STARTED|Overall Study||60
7689041|NCT01878825|18935420|P1|STARTED|Overall Study||60
7689042|NCT01878812|18935458|P2|NOT COMPLETED|Overall Study||0
7689043|NCT01878812|18935459|P1|NOT COMPLETED|Overall Study||0
7689044|NCT01878812|18935458|P2|COMPLETED|Overall Study||57
7689045|NCT01878812|18935459|P1|COMPLETED|Overall Study||60
7689046|NCT01878812|18935458|P2|STARTED|Overall Study||57
7689047|NCT01878812|18935459|P1|STARTED|Overall Study||60
7689048|NCT01878799|18935495|P2|NOT COMPLETED|Overall Study||0
7689049|NCT01878799|18935496|P1|NOT COMPLETED|Overall Study||1
7689050|NCT01878799|18935495|P2|COMPLETED|Overall Study||13
7689051|NCT01878799|18935496|P1|COMPLETED|Overall Study||36
7689052|NCT01878799|18935495|P2|STARTED|Overall Study||13
7689053|NCT01878799|18935496|P1|STARTED|Overall Study||37
7689054|NCT01878786|18935505|P3|NOT COMPLETED|Overall Study||7
7689055|NCT01878786|18935506|P2|NOT COMPLETED|Overall Study||9
7689056|NCT01878786|18935507|P1|NOT COMPLETED|Overall Study||9
7689057|NCT01878786|18935505|P3|COMPLETED|Overall Study|Study closed prematurely; 1 patient was a screen fail|0
7689058|NCT01878786|18935506|P2|COMPLETED|Overall Study|Study closed prematurely|0
7689059|NCT01878786|18935507|P1|COMPLETED|Overall Study|Study closed prematurely|0
7689060|NCT01878786|18935505|P3|STARTED|Overall Study||7
7689061|NCT01878786|18935506|P2|STARTED|Overall Study||9
7689062|NCT01878786|18935507|P1|STARTED|Overall Study||9
7689063|NCT01878656|18935523|P2|NOT COMPLETED|Overall Study||0
7689064|NCT01878656|18935524|P1|NOT COMPLETED|Overall Study||0
7689065|NCT01878656|18935523|P2|COMPLETED|Overall Study||72
7689066|NCT01878656|18935524|P1|COMPLETED|Overall Study||72
7689067|NCT01878656|18935523|P2|STARTED|Overall Study||72
7689068|NCT01878656|18935524|P1|STARTED|Overall Study||72
7689069|NCT01878604|18935530|P1|NOT COMPLETED|Overall Study||0
7689070|NCT01878604|18935530|P1|COMPLETED|Overall Study||5
7689071|NCT01878604|18935530|P1|STARTED|Overall Study||5
7689072|NCT01878526|18935537|P2|NOT COMPLETED|Overall Study||2
7689073|NCT01878526|18935538|P1|NOT COMPLETED|Overall Study||3
7689074|NCT01878526|18935537|P2|COMPLETED|Overall Study||38
7689075|NCT01878526|18935538|P1|COMPLETED|Overall Study||37
7689076|NCT01878526|18935537|P2|STARTED|Overall Study||40
7689077|NCT01878526|18935538|P1|STARTED|Overall Study||40
7689078|NCT01878383|18935553|P2|NOT COMPLETED|Overall Study||1499
7689079|NCT01878383|18935554|P1|NOT COMPLETED|Overall Study||0
7689080|NCT01878383|18935553|P2|COMPLETED|Overall Study||11001
7689081|NCT01878383|18935554|P1|COMPLETED|Overall Study||50
7689082|NCT01878383|18935553|P2|STARTED|Overall Study||12500
7689083|NCT01878383|18935554|P1|STARTED|Overall Study||50
7689084|NCT01878292|18935564|P3|NOT COMPLETED|Double-blind Down-Taper Period||4
7689085|NCT01878292|18935565|P2|NOT COMPLETED|Double-blind Down-Taper Period||8
7689086|NCT01878292|18935566|P1|NOT COMPLETED|Double-blind Down-Taper Period||5
7689087|NCT01878292|18935564|P3|COMPLETED|Double-blind Down-Taper Period||142
7689088|NCT01878292|18935565|P2|COMPLETED|Double-blind Down-Taper Period||132
7689089|NCT01878292|18935566|P1|COMPLETED|Double-blind Down-Taper Period||122
7689090|NCT01878292|18935564|P3|STARTED|Double-blind Down-Taper Period||146
7689091|NCT01878292|18935565|P2|STARTED|Double-blind Down-Taper Period||140
7689092|NCT01878292|18935566|P1|STARTED|Double-blind Down-Taper Period||127
7689093|NCT01878292|18935564|P3|NOT COMPLETED|Double-blind Treatment Period||19
7689094|NCT01878292|18935565|P2|NOT COMPLETED|Double-blind Treatment Period||26
7689095|NCT01878292|18935566|P1|NOT COMPLETED|Double-blind Treatment Period||29
7689096|NCT01878292|18935564|P3|COMPLETED|Double-blind Treatment Period||161
7689097|NCT01878292|18935565|P2|COMPLETED|Double-blind Treatment Period||149
7689098|NCT01878292|18935566|P1|COMPLETED|Double-blind Treatment Period||142
7689099|NCT01878292|18935564|P3|STARTED|Double-blind Treatment Period||180
7689100|NCT01878292|18935565|P2|STARTED|Double-blind Treatment Period||175
7689101|NCT01878292|18935566|P1|STARTED|Double-blind Treatment Period||171
7689102|NCT01878292|18935564|P3|NOT COMPLETED|Randomized||0
7689103|NCT01878292|18935565|P2|NOT COMPLETED|Randomized||0
7689104|NCT01878292|18935566|P1|NOT COMPLETED|Randomized||3
7689105|NCT01878292|18935564|P3|COMPLETED|Randomized||180
7689106|NCT01878292|18935565|P2|COMPLETED|Randomized||175
7689107|NCT01878292|18935566|P1|COMPLETED|Randomized||171
7689108|NCT01878292|18935564|P3|STARTED|Randomized||180
7689109|NCT01878292|18935565|P2|STARTED|Randomized||175
7689110|NCT01878292|18935566|P1|STARTED|Randomized||174
7689111|NCT01878253|18935577|P1|NOT COMPLETED|Overall Study||9
7689112|NCT01878253|18935577|P1|COMPLETED|Overall Study||86
7689113|NCT01878253|18935577|P1|2 Year|Overall Study||86
7689114|NCT01878253|18935577|P1|1 Year|Overall Study||88
7689115|NCT01878253|18935577|P1|6 Months|Overall Study||90
7689116|NCT01878253|18935577|P1|6 Weeks|Overall Study||95
7689117|NCT01878253|18935577|P1|Pre-Operative|Overall Study||95
7689118|NCT01878253|18935577|P1|STARTED|Overall Study||95
7689119|NCT01878214|18935588|P2|NOT COMPLETED|Overall Study||44
7689120|NCT01878214|18935589|P1|NOT COMPLETED|Overall Study||53
7689121|NCT01878214|18935588|P2|COMPLETED|Overall Study||175
7689122|NCT01878214|18935589|P1|COMPLETED|Overall Study||170
7689123|NCT01878214|18935588|P2|STARTED|Overall Study||219
7689124|NCT01878214|18935589|P1|STARTED|Overall Study||223
7689125|NCT01878175|18935603|P1|NOT COMPLETED|Overall Study||2
7689126|NCT01878175|18935603|P1|COMPLETED|Overall Study||13
7689127|NCT01878175|18935603|P1|STARTED|Overall Study||15
7689128|NCT01878149|18935622|P2|NOT COMPLETED|Overall Study||2
7689129|NCT01878149|18935623|P1|NOT COMPLETED|Overall Study||2
7689130|NCT01878149|18935622|P2|COMPLETED|Overall Study||15
7689131|NCT01878149|18935623|P1|COMPLETED|Overall Study||19
7689132|NCT01878149|18935622|P2|STARTED|Overall Study||17
7689133|NCT01878149|18935623|P1|STARTED|Overall Study||21
7689134|NCT01878097|18935631|P2|NOT COMPLETED|Implementation Year 4||3007
7689135|NCT01878097|18935632|P1|NOT COMPLETED|Implementation Year 4||3604
7689136|NCT01878097|18935631|P2|COMPLETED|Implementation Year 4||6607
7689137|NCT01878097|18935632|P1|COMPLETED|Implementation Year 4||6981
7689138|NCT01878097|18935631|P2|STARTED|Implementation Year 4||9614
7689139|NCT01878097|18935632|P1|STARTED|Implementation Year 4||10585
7689140|NCT01878097|18935631|P2|NOT COMPLETED|Implementation Year 3||2980
7689141|NCT01878097|18935632|P1|NOT COMPLETED|Implementation Year 3||3494
7689142|NCT01878097|18935631|P2|COMPLETED|Implementation Year 3||6770
7689143|NCT01878097|18935632|P1|COMPLETED|Implementation Year 3||7046
7689144|NCT01878097|18935631|P2|STARTED|Implementation Year 3||9750
7689145|NCT01878097|18935632|P1|STARTED|Implementation Year 3||10540
7689146|NCT01878097|18935631|P2|NOT COMPLETED|Implementation Year 2||2841
7689147|NCT01878097|18935632|P1|NOT COMPLETED|Implementation Year 2||3281
7689148|NCT01878097|18935631|P2|COMPLETED|Implementation Year 2||6770
7689149|NCT01878097|18935632|P1|COMPLETED|Implementation Year 2||8286
7689150|NCT01878097|18935631|P2|STARTED|Implementation Year 2||9611
7689151|NCT01878097|18935632|P1|STARTED|Implementation Year 2||11567
7689152|NCT01878097|18935631|P2|NOT COMPLETED|Implementation Year 1||2549
7689153|NCT01878097|18935632|P1|NOT COMPLETED|Implementation Year 1||3202
7689154|NCT01878097|18935631|P2|COMPLETED|Implementation Year 1||7317
7689155|NCT01878097|18935632|P1|COMPLETED|Implementation Year 1||8540
7689156|NCT01878097|18935631|P2|STARTED|Implementation Year 1||9866
7689157|NCT01878097|18935632|P1|STARTED|Implementation Year 1||11742
7689158|NCT01878097|18935631|P2|NOT COMPLETED|Baseline||1800
7689159|NCT01878097|18935632|P1|NOT COMPLETED|Baseline||2497
7689160|NCT01878097|18935631|P2|COMPLETED|Baseline|Anonymous surveys; sum of all completed surveys.|8281
7689161|NCT01878097|18935632|P1|COMPLETED|Baseline|Anonymous surveys so only last year data provided as annual completed.|8228
7689162|NCT01878097|18935631|P2|STARTED|Baseline|number of students in 13 control schools completing anonymous surveys with non missing data|10081
7689163|NCT01878097|18935632|P1|STARTED|Baseline|number of students in 13 intervention schools completing anonymous surveys with non missing data|10725
7689164|NCT01878084|18935640|P1|NOT COMPLETED|Overall Study||2
7689165|NCT01878084|18935640|P1|COMPLETED|Overall Study||7
7689166|NCT01878084|18935640|P1|Control (Sockets Were Left Empty)|Overall Study||7
7689167|NCT01878084|18935640|P1|Test(Received TAMP Bioglass) s|Overall Study||7
7689168|NCT01878084|18935640|P1|STARTED|Overall Study||9
7689169|NCT01878006|18935645|P2|NOT COMPLETED|Study Session 2||0
7689170|NCT01878006|18935646|P1|NOT COMPLETED|Study Session 2||0
7689171|NCT01878006|18935645|P2|COMPLETED|Study Session 2||5
7689172|NCT01878006|18935646|P1|COMPLETED|Study Session 2||5
7689173|NCT01878006|18935645|P2|STARTED|Study Session 2||5
7689174|NCT01878006|18935646|P1|STARTED|Study Session 2||5
7689175|NCT01878006|18935645|P2|NOT COMPLETED|Study Session 1||0
7689176|NCT01878006|18935646|P1|NOT COMPLETED|Study Session 1||0
7689177|NCT01878006|18935645|P2|COMPLETED|Study Session 1||5
7689178|NCT01878006|18935646|P1|COMPLETED|Study Session 1||5
7689179|NCT01878006|18935645|P2|STARTED|Study Session 1||5
7689180|NCT01878006|18935646|P1|STARTED|Study Session 1||5
7689181|NCT01877941|18935666|P1|NOT COMPLETED|Overall Study||0
7689182|NCT01877941|18935666|P1|COMPLETED|Overall Study||39
7689183|NCT01877941|18935666|P1|STARTED|Overall Study||39
7689184|NCT01877915|18935674|P2|NOT COMPLETED|Overall Study||68
7689185|NCT01877915|18935675|P1|NOT COMPLETED|Overall Study||54
7689186|NCT01877915|18935674|P2|COMPLETED|Overall Study||2447
7689187|NCT01877915|18935675|P1|COMPLETED|Overall Study||2453
7689188|NCT01877915|18935674|P2|STARTED|Overall Study||2515
7689189|NCT01877915|18935675|P1|STARTED|Overall Study||2507
7689190|NCT01877720|18935697|P2|NOT COMPLETED|Overall Study||0
7689191|NCT01877720|18935698|P1|NOT COMPLETED|Overall Study||1
7689192|NCT01877720|18935697|P2|COMPLETED|Overall Study||8
7689193|NCT01877720|18935698|P1|COMPLETED|Overall Study||7
7689194|NCT01877720|18935697|P2|2nd Intervention|Overall Study||8
7689195|NCT01877720|18935698|P1|2nd Intervention|Overall Study||7
7689196|NCT01877720|18935697|P2|1st Intervention|Overall Study||8
7689197|NCT01877720|18935698|P1|1st Intervention|Overall Study||7
7689198|NCT01877720|18935697|P2|STARTED|Overall Study||8
7689199|NCT01877720|18935698|P1|STARTED|Overall Study||8
7689200|NCT01877668|18935727|P5|NOT COMPLETED|Overall Study||10
7689201|NCT01877668|18935728|P4|NOT COMPLETED|Overall Study||8
7689202|NCT01877668|18935729|P3|NOT COMPLETED|Overall Study||12
7689203|NCT01877668|18935730|P2|NOT COMPLETED|Overall Study||8
7689204|NCT01877668|18935731|P1|NOT COMPLETED|Overall Study||11
7689205|NCT01877668|18935727|P5|COMPLETED|Overall Study||43
7689206|NCT01877668|18935728|P4|COMPLETED|Overall Study||44
7689207|NCT01877668|18935729|P3|COMPLETED|Overall Study||94
7689208|NCT01877668|18935730|P2|COMPLETED|Overall Study||96
7689209|NCT01877668|18935731|P1|COMPLETED|Overall Study||96
7689210|NCT01877668|18935727|P5|STARTED|Overall Study|Received treatment|53
7689211|NCT01877668|18935728|P4|STARTED|Overall Study|Received treatment|52
7689212|NCT01877668|18935729|P3|STARTED|Overall Study|Received treatment|106
7689213|NCT01877668|18935730|P2|STARTED|Overall Study|Received treatment|104
7689214|NCT01877668|18935731|P1|STARTED|Overall Study|Received treatment|107
7689215|NCT01877655|18935962|P2|NOT COMPLETED|Overall Study||97
7689216|NCT01877655|18935963|P1|NOT COMPLETED|Overall Study||98
7689217|NCT01877655|18935962|P2|COMPLETED|Overall Study||154
7689218|NCT01877655|18935963|P1|COMPLETED|Overall Study||165
7689219|NCT01877655|18935962|P2|Received Treatment|Overall Study||246
7689220|NCT01877655|18935963|P1|Received Treatment|Overall Study||255
7689221|NCT01877655|18935962|P2|STARTED|Overall Study||251
7689222|NCT01877655|18935963|P1|STARTED|Overall Study||263
7689223|NCT01877642|18935981|P7|NOT COMPLETED|Overall Study||0
7689224|NCT01877642|18935982|P6|NOT COMPLETED|Overall Study||0
7689225|NCT01877642|18935983|P5|NOT COMPLETED|Overall Study||0
7689226|NCT01877642|18935984|P4|NOT COMPLETED|Overall Study||0
7689227|NCT01877642|18935985|P3|NOT COMPLETED|Overall Study||0
7689228|NCT01877642|18935986|P2|NOT COMPLETED|Overall Study||0
7689229|NCT01877642|18935987|P1|NOT COMPLETED|Overall Study||0
7689230|NCT01877642|18935981|P7|COMPLETED|Overall Study||3
7689231|NCT01877642|18935982|P6|COMPLETED|Overall Study||3
7689232|NCT01877642|18935983|P5|COMPLETED|Overall Study||3
7689233|NCT01877642|18935984|P4|COMPLETED|Overall Study||3
7689234|NCT01877642|18935985|P3|COMPLETED|Overall Study||3
7689235|NCT01877642|18935986|P2|COMPLETED|Overall Study||3
7689236|NCT01877642|18935987|P1|COMPLETED|Overall Study||4
7689237|NCT01877642|18935981|P7|STARTED|Overall Study||3
7689238|NCT01877642|18935982|P6|STARTED|Overall Study||3
7689239|NCT01877642|18935983|P5|STARTED|Overall Study||3
7689240|NCT01877642|18935984|P4|STARTED|Overall Study||3
7689241|NCT01877642|18935985|P3|STARTED|Overall Study||3
7689242|NCT01877642|18935986|P2|STARTED|Overall Study||3
7689243|NCT01877642|18935987|P1|STARTED|Overall Study||4
7689244|NCT01877564|18936010|P2|NOT COMPLETED|Overall Study||0
7689245|NCT01877564|18936011|P1|NOT COMPLETED|Overall Study||0
7689246|NCT01877564|18936010|P2|COMPLETED|Overall Study||4
7689247|NCT01877564|18936011|P1|COMPLETED|Overall Study||6
7689248|NCT01877564|18936010|P2|STARTED|Overall Study||4
7689249|NCT01877564|18936011|P1|STARTED|Overall Study||6
7689250|NCT01877551|18936019|P2|NOT COMPLETED|Overall Study||1
7689251|NCT01877551|18936020|P1|NOT COMPLETED|Overall Study||0
7689252|NCT01877551|18936019|P2|COMPLETED|Overall Study||13
7689253|NCT01877551|18936020|P1|COMPLETED|Overall Study||13
7689254|NCT01877551|18936019|P2|STARTED|Overall Study||14
7689255|NCT01877551|18936020|P1|STARTED|Overall Study||13
7689256|NCT01877538|18936032|P1|NOT COMPLETED|Overall Study||0
7689257|NCT01877538|18936032|P1|COMPLETED|Overall Study||7
7689258|NCT01877538|18936032|P1|STARTED|Overall Study||7
7689259|NCT01877421|18936069|P18|NOT COMPLETED|Phase 2||0
7689260|NCT01877421|18936070|P17|NOT COMPLETED|Phase 2||0
7689261|NCT01877421|18936071|P16|NOT COMPLETED|Phase 2||1
7689262|NCT01877421|18936072|P15|NOT COMPLETED|Phase 2||0
7689263|NCT01877421|18936073|P14|NOT COMPLETED|Phase 2||0
7689264|NCT01877421|18936074|P13|NOT COMPLETED|Phase 2||1
7689265|NCT01877421|18936075|P12|NOT COMPLETED|Phase 2||0
7689266|NCT01877421|18936076|P11|NOT COMPLETED|Phase 2||2
7689267|NCT01877421|18936077|P10|NOT COMPLETED|Phase 2||0
7689268|NCT01877421|18936078|P9|NOT COMPLETED|Phase 2||1
7689269|NCT01877421|18936079|P8|NOT COMPLETED|Phase 2||0
7689270|NCT01877421|18936080|P7|NOT COMPLETED|Phase 2||1
7689271|NCT01877421|18936081|P6|NOT COMPLETED|Phase 2||0
7689272|NCT01877421|18936082|P5|NOT COMPLETED|Phase 2||0
7689273|NCT01877421|18936083|P4|NOT COMPLETED|Phase 2||0
7689274|NCT01877421|18936084|P3|NOT COMPLETED|Phase 2||0
7689275|NCT01877421|18936085|P2|NOT COMPLETED|Phase 2||0
7689276|NCT01877421|18936086|P1|NOT COMPLETED|Phase 2||0
7689277|NCT01877421|18936069|P18|COMPLETED|Phase 2||0
7689278|NCT01877421|18936070|P17|COMPLETED|Phase 2||0
7689279|NCT01877421|18936071|P16|COMPLETED|Phase 2||2
7689280|NCT01877421|18936072|P15|COMPLETED|Phase 2||7
7689281|NCT01877421|18936073|P14|COMPLETED|Phase 2||3
7689282|NCT01877421|18936074|P13|COMPLETED|Phase 2||6
7689283|NCT01877421|18936075|P12|COMPLETED|Phase 2||3
7689284|NCT01877421|18936076|P11|COMPLETED|Phase 2||5
7689285|NCT01877421|18936077|P10|COMPLETED|Phase 2||3
7689286|NCT01877421|18936078|P9|COMPLETED|Phase 2||5
7689287|NCT01877421|18936079|P8|COMPLETED|Phase 2||2
7689288|NCT01877421|18936080|P7|COMPLETED|Phase 2||6
7689289|NCT01877421|18936081|P6|COMPLETED|Phase 2||3
7689290|NCT01877421|18936082|P5|COMPLETED|Phase 2||7
7689291|NCT01877421|18936083|P4|COMPLETED|Phase 2||2
7689292|NCT01877421|18936084|P3|COMPLETED|Phase 2||4
7689293|NCT01877421|18936085|P2|COMPLETED|Phase 2||0
7689294|NCT01877421|18936086|P1|COMPLETED|Phase 2||0
7689295|NCT01877421|18936069|P18|STARTED|Phase 2||0
7689296|NCT01877421|18936070|P17|STARTED|Phase 2||0
7689297|NCT01877421|18936071|P16|STARTED|Phase 2||3
7689298|NCT01877421|18936072|P15|STARTED|Phase 2||7
7689299|NCT01877421|18936073|P14|STARTED|Phase 2||3
7689300|NCT01877421|18936074|P13|STARTED|Phase 2||7
7689301|NCT01877421|18936075|P12|STARTED|Phase 2||3
7689302|NCT01877421|18936076|P11|STARTED|Phase 2||7
7689303|NCT01877421|18936077|P10|STARTED|Phase 2||3
7689304|NCT01877421|18936078|P9|STARTED|Phase 2||6
7689305|NCT01877421|18936079|P8|STARTED|Phase 2||2
7689306|NCT01877421|18936080|P7|STARTED|Phase 2||7
7689307|NCT01877421|18936081|P6|STARTED|Phase 2||3
7689308|NCT01877421|18936082|P5|STARTED|Phase 2||7
7689309|NCT01877421|18936083|P4|STARTED|Phase 2||2
7689310|NCT01877421|18936084|P3|STARTED|Phase 2||4
7689311|NCT01877421|18936085|P2|STARTED|Phase 2||0
7689312|NCT01877421|18936086|P1|STARTED|Phase 2||0
7689313|NCT01877421|18936069|P18|NOT COMPLETED|Phase 1||0
7689314|NCT01877421|18936070|P17|NOT COMPLETED|Phase 1||0
7689315|NCT01877421|18936071|P16|NOT COMPLETED|Phase 1||0
7689316|NCT01877421|18936072|P15|NOT COMPLETED|Phase 1||0
7689317|NCT01877421|18936073|P14|NOT COMPLETED|Phase 1||0
7689318|NCT01877421|18936074|P13|NOT COMPLETED|Phase 1||0
7689319|NCT01877421|18936075|P12|NOT COMPLETED|Phase 1||0
7689320|NCT01877421|18936076|P11|NOT COMPLETED|Phase 1||0
7689321|NCT01877421|18936077|P10|NOT COMPLETED|Phase 1||0
7689322|NCT01877421|18936078|P9|NOT COMPLETED|Phase 1||0
7689323|NCT01877421|18936079|P8|NOT COMPLETED|Phase 1||0
7689324|NCT01877421|18936080|P7|NOT COMPLETED|Phase 1||0
7689325|NCT01877421|18936081|P6|NOT COMPLETED|Phase 1||0
7689326|NCT01877421|18936082|P5|NOT COMPLETED|Phase 1||0
7689327|NCT01877421|18936083|P4|NOT COMPLETED|Phase 1||0
7689328|NCT01877421|18936084|P3|NOT COMPLETED|Phase 1||0
7689329|NCT01877421|18936085|P2|NOT COMPLETED|Phase 1||0
7689330|NCT01877421|18936086|P1|NOT COMPLETED|Phase 1||0
7689331|NCT01877421|18936069|P18|COMPLETED|Phase 1||3
7689332|NCT01877421|18936070|P17|COMPLETED|Phase 1||7
7689333|NCT01877421|18936071|P16|COMPLETED|Phase 1||3
7689334|NCT01877421|18936072|P15|COMPLETED|Phase 1||7
7689335|NCT01877421|18936073|P14|COMPLETED|Phase 1||3
7689336|NCT01877421|18936074|P13|COMPLETED|Phase 1||7
7689337|NCT01877421|18936075|P12|COMPLETED|Phase 1||3
7689338|NCT01877421|18936076|P11|COMPLETED|Phase 1||7
7689339|NCT01877421|18936077|P10|COMPLETED|Phase 1||3
7689340|NCT01877421|18936078|P9|COMPLETED|Phase 1||7
7689341|NCT01877421|18936079|P8|COMPLETED|Phase 1||2
7689342|NCT01877421|18936080|P7|COMPLETED|Phase 1||4
7689343|NCT01877421|18936081|P6|COMPLETED|Phase 1||2
7689344|NCT01877421|18936082|P5|COMPLETED|Phase 1||4
7689345|NCT01877421|18936083|P4|COMPLETED|Phase 1||2
7689346|NCT01877421|18936084|P3|COMPLETED|Phase 1||4
7689347|NCT01877421|18936085|P2|COMPLETED|Phase 1||1
7689348|NCT01877421|18936086|P1|COMPLETED|Phase 1||2
7689349|NCT01877421|18936069|P18|STARTED|Phase 1||3
7689350|NCT01877421|18936070|P17|STARTED|Phase 1||7
7689351|NCT01877421|18936071|P16|STARTED|Phase 1||3
7689352|NCT01877421|18936072|P15|STARTED|Phase 1||7
7689353|NCT01877421|18936073|P14|STARTED|Phase 1||3
7689354|NCT01877421|18936074|P13|STARTED|Phase 1||7
7689355|NCT01877421|18936075|P12|STARTED|Phase 1||3
7689356|NCT01877421|18936076|P11|STARTED|Phase 1||7
7689357|NCT01877421|18936077|P10|STARTED|Phase 1||3
7689358|NCT01877421|18936078|P9|STARTED|Phase 1||7
7689359|NCT01877421|18936079|P8|STARTED|Phase 1||2
7689360|NCT01877421|18936080|P7|STARTED|Phase 1||4
7689361|NCT01877421|18936081|P6|STARTED|Phase 1||2
7689362|NCT01877421|18936082|P5|STARTED|Phase 1||4
7689363|NCT01877421|18936083|P4|STARTED|Phase 1||2
7689364|NCT01877421|18936084|P3|STARTED|Phase 1||4
7689365|NCT01877421|18936085|P2|STARTED|Phase 1||1
7689366|NCT01877421|18936086|P1|STARTED|Phase 1||2
7689367|NCT01877408|18936196|P2|NOT COMPLETED|Overall Study||2
7689368|NCT01877408|18936197|P1|NOT COMPLETED|Overall Study||0
7689369|NCT01877408|18936196|P2|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98
7689370|NCT01877408|18936197|P1|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50
7689371|NCT01877408|18936196|P2|STARTED|Overall Study||100
7689372|NCT01877408|18936197|P1|STARTED|Overall Study||50
7689373|NCT01877343|18936217|P7|NOT COMPLETED|Overall Study||0
7689374|NCT01877343|18936218|P6|NOT COMPLETED|Overall Study||0
7689375|NCT01877343|18936219|P5|NOT COMPLETED|Overall Study||0
7689376|NCT01877343|18936220|P4|NOT COMPLETED|Overall Study||0
7689377|NCT01877343|18936221|P3|NOT COMPLETED|Overall Study||0
7689378|NCT01877343|18936222|P2|NOT COMPLETED|Overall Study||0
7689379|NCT01877343|18936223|P1|NOT COMPLETED|Overall Study||0
7689380|NCT01877343|18936217|P7|COMPLETED|Overall Study||0
7689381|NCT01877343|18936218|P6|COMPLETED|Overall Study||5
7689382|NCT01877343|18936219|P5|COMPLETED|Overall Study||0
7689383|NCT01877343|18936220|P4|COMPLETED|Overall Study||0
7689384|NCT01877343|18936221|P3|COMPLETED|Overall Study||0
7689385|NCT01877343|18936222|P2|COMPLETED|Overall Study||3
7689386|NCT01877343|18936223|P1|COMPLETED|Overall Study||2
7689387|NCT01877343|18936217|P7|STARTED|Overall Study||0
7689388|NCT01877343|18936218|P6|STARTED|Overall Study||5
7689389|NCT01877343|18936219|P5|STARTED|Overall Study||0
7689390|NCT01877343|18936220|P4|STARTED|Overall Study||0
7689391|NCT01877343|18936221|P3|STARTED|Overall Study||0
7689392|NCT01877343|18936222|P2|STARTED|Overall Study||3
7689393|NCT01877343|18936223|P1|STARTED|Overall Study||2
7689394|NCT01877278|18936230|P2|NOT COMPLETED|Overall Study||3
7689395|NCT01877278|18936231|P1|NOT COMPLETED|Overall Study||3
7689396|NCT01877278|18936230|P2|COMPLETED|Overall Study||30
7689397|NCT01877278|18936231|P1|COMPLETED|Overall Study||30
7689398|NCT01877278|18936230|P2|STARTED|Overall Study||33
7689399|NCT01877278|18936231|P1|STARTED|Overall Study||33
7689400|NCT01877265|18936239|P6|NOT COMPLETED|Treatment Period 3||0
7689401|NCT01877265|18936240|P5|NOT COMPLETED|Treatment Period 3||0
7689402|NCT01877265|18936241|P4|NOT COMPLETED|Treatment Period 3||0
7689403|NCT01877265|18936242|P3|NOT COMPLETED|Treatment Period 3||0
7689404|NCT01877265|18936243|P2|NOT COMPLETED|Treatment Period 3||0
7689405|NCT01877265|18936244|P1|NOT COMPLETED|Treatment Period 3||1
7689406|NCT01877265|18936239|P6|COMPLETED|Treatment Period 3||2
7689407|NCT01877265|18936240|P5|COMPLETED|Treatment Period 3||3
7689408|NCT01877265|18936241|P4|COMPLETED|Treatment Period 3||3
7689409|NCT01877265|18936242|P3|COMPLETED|Treatment Period 3||2
7689410|NCT01877265|18936243|P2|COMPLETED|Treatment Period 3||3
7689411|NCT01877265|18936244|P1|COMPLETED|Treatment Period 3||2
7689412|NCT01877265|18936239|P6|Received at Least One Dose of Study Drug|Treatment Period 3||2
7689413|NCT01877265|18936240|P5|Received at Least One Dose of Study Drug|Treatment Period 3||3
7689414|NCT01877265|18936241|P4|Received at Least One Dose of Study Drug|Treatment Period 3||3
7689415|NCT01877265|18936242|P3|Received at Least One Dose of Study Drug|Treatment Period 3||2
7689416|NCT01877265|18936243|P2|Received at Least One Dose of Study Drug|Treatment Period 3||3
7689417|NCT01877265|18936244|P1|Received at Least One Dose of Study Drug|Treatment Period 3||3
7689418|NCT01877265|18936239|P6|STARTED|Treatment Period 3||2
7689419|NCT01877265|18936240|P5|STARTED|Treatment Period 3||3
7689420|NCT01877265|18936241|P4|STARTED|Treatment Period 3||3
7689421|NCT01877265|18936242|P3|STARTED|Treatment Period 3||2
7689422|NCT01877265|18936243|P2|STARTED|Treatment Period 3||3
7689423|NCT01877265|18936244|P1|STARTED|Treatment Period 3||3
7689424|NCT01877265|18936239|P6|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||1
7689425|NCT01877265|18936240|P5|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
7689426|NCT01877265|18936241|P4|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
7689427|NCT01877265|18936242|P3|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
7689428|NCT01877265|18936243|P2|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
7689429|NCT01877265|18936244|P1|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
7689430|NCT01877265|18936239|P6|COMPLETED|Washout Period 2 (at Least 14 Days)||2
7689431|NCT01877265|18936240|P5|COMPLETED|Washout Period 2 (at Least 14 Days)||3
7689432|NCT01877265|18936241|P4|COMPLETED|Washout Period 2 (at Least 14 Days)||3
7689433|NCT01877265|18936242|P3|COMPLETED|Washout Period 2 (at Least 14 Days)||2
7689434|NCT01877265|18936243|P2|COMPLETED|Washout Period 2 (at Least 14 Days)||3
7689435|NCT01877265|18936244|P1|COMPLETED|Washout Period 2 (at Least 14 Days)||3
7689436|NCT01877265|18936239|P6|STARTED|Washout Period 2 (at Least 14 Days)||3
7689437|NCT01877265|18936240|P5|STARTED|Washout Period 2 (at Least 14 Days)||3
7689438|NCT01877265|18936241|P4|STARTED|Washout Period 2 (at Least 14 Days)||3
7689439|NCT01877265|18936242|P3|STARTED|Washout Period 2 (at Least 14 Days)||2
7689440|NCT01877265|18936243|P2|STARTED|Washout Period 2 (at Least 14 Days)||3
7689441|NCT01877265|18936244|P1|STARTED|Washout Period 2 (at Least 14 Days)||3
7689442|NCT01877265|18936239|P6|NOT COMPLETED|Treatment Period 2||0
7689443|NCT01877265|18936240|P5|NOT COMPLETED|Treatment Period 2||0
7689444|NCT01877265|18936241|P4|NOT COMPLETED|Treatment Period 2||0
7689445|NCT01877265|18936242|P3|NOT COMPLETED|Treatment Period 2||0
7689446|NCT01877265|18936243|P2|NOT COMPLETED|Treatment Period 2||0
7689447|NCT01877265|18936244|P1|NOT COMPLETED|Treatment Period 2||0
7689448|NCT01877265|18936239|P6|COMPLETED|Treatment Period 2||3
7689449|NCT01877265|18936240|P5|COMPLETED|Treatment Period 2||3
7689450|NCT01877265|18936241|P4|COMPLETED|Treatment Period 2||3
7689451|NCT01877265|18936242|P3|COMPLETED|Treatment Period 2||2
7689452|NCT01877265|18936243|P2|COMPLETED|Treatment Period 2||3
7689453|NCT01877265|18936244|P1|COMPLETED|Treatment Period 2||3
7689454|NCT01877265|18936239|P6|Received at Least One Dose of Study Drug|Treatment Period 2||3
7689455|NCT01877265|18936240|P5|Received at Least One Dose of Study Drug|Treatment Period 2||3
7689456|NCT01877265|18936241|P4|Received at Least One Dose of Study Drug|Treatment Period 2||3
7689457|NCT01877265|18936242|P3|Received at Least One Dose of Study Drug|Treatment Period 2||2
7689458|NCT01877265|18936243|P2|Received at Least One Dose of Study Drug|Treatment Period 2||3
7689459|NCT01877265|18936244|P1|Received at Least One Dose of Study Drug|Treatment Period 2||3
7689460|NCT01877265|18936239|P6|STARTED|Treatment Period 2||3
7689461|NCT01877265|18936240|P5|STARTED|Treatment Period 2||3
7689462|NCT01877265|18936241|P4|STARTED|Treatment Period 2||3
7689463|NCT01877265|18936242|P3|STARTED|Treatment Period 2||2
7689464|NCT01877265|18936243|P2|STARTED|Treatment Period 2||3
7689465|NCT01877265|18936244|P1|STARTED|Treatment Period 2||3
7689466|NCT01877265|18936239|P6|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
7689467|NCT01877265|18936240|P5|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
7689468|NCT01877265|18936241|P4|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
7689469|NCT01877265|18936242|P3|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
7689470|NCT01877265|18936243|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
7689471|NCT01877265|18936244|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
7689472|NCT01877265|18936239|P6|COMPLETED|Washout Period 1 (at Least 14 Days)||3
7689473|NCT01877265|18936240|P5|COMPLETED|Washout Period 1 (at Least 14 Days)||3
7689474|NCT01877265|18936241|P4|COMPLETED|Washout Period 1 (at Least 14 Days)||3
7689475|NCT01877265|18936242|P3|COMPLETED|Washout Period 1 (at Least 14 Days)||2
7689476|NCT01877265|18936243|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||3
7689477|NCT01877265|18936244|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||3
7689478|NCT01877265|18936239|P6|STARTED|Washout Period 1 (at Least 14 Days)||3
7689479|NCT01877265|18936240|P5|STARTED|Washout Period 1 (at Least 14 Days)||3
7689480|NCT01877265|18936241|P4|STARTED|Washout Period 1 (at Least 14 Days)||3
7689481|NCT01877265|18936242|P3|STARTED|Washout Period 1 (at Least 14 Days)||2
7689482|NCT01877265|18936243|P2|STARTED|Washout Period 1 (at Least 14 Days)||3
7689483|NCT01877265|18936244|P1|STARTED|Washout Period 1 (at Least 14 Days)||3
7689484|NCT01877265|18936239|P6|NOT COMPLETED|Treatment Period 1||0
7689485|NCT01877265|18936240|P5|NOT COMPLETED|Treatment Period 1||0
7689486|NCT01877265|18936241|P4|NOT COMPLETED|Treatment Period 1||0
7689487|NCT01877265|18936242|P3|NOT COMPLETED|Treatment Period 1||1
7689488|NCT01877265|18936243|P2|NOT COMPLETED|Treatment Period 1||0
7689489|NCT01877265|18936244|P1|NOT COMPLETED|Treatment Period 1||0
7689490|NCT01877265|18936239|P6|COMPLETED|Treatment Period 1||3
7689491|NCT01877265|18936240|P5|COMPLETED|Treatment Period 1||3
7689492|NCT01877265|18936241|P4|COMPLETED|Treatment Period 1||3
7689493|NCT01877265|18936242|P3|COMPLETED|Treatment Period 1||2
7689494|NCT01877265|18936243|P2|COMPLETED|Treatment Period 1||3
7689495|NCT01877265|18936244|P1|COMPLETED|Treatment Period 1||3
7689496|NCT01877265|18936239|P6|Received at Least One Dose of Study Drug|Treatment Period 1||3
7689497|NCT01877265|18936240|P5|Received at Least One Dose of Study Drug|Treatment Period 1||3
7689498|NCT01877265|18936241|P4|Received at Least One Dose of Study Drug|Treatment Period 1||3
7689499|NCT01877265|18936242|P3|Received at Least One Dose of Study Drug|Treatment Period 1||3
7689500|NCT01877265|18936243|P2|Received at Least One Dose of Study Drug|Treatment Period 1||3
7689501|NCT01877265|18936244|P1|Received at Least One Dose of Study Drug|Treatment Period 1||3
7689502|NCT01877265|18936239|P6|STARTED|Treatment Period 1||3
7689503|NCT01877265|18936240|P5|STARTED|Treatment Period 1||3
7689504|NCT01877265|18936241|P4|STARTED|Treatment Period 1||3
7689505|NCT01877265|18936242|P3|STARTED|Treatment Period 1||3
7689506|NCT01877265|18936243|P2|STARTED|Treatment Period 1||3
7689507|NCT01877265|18936244|P1|STARTED|Treatment Period 1||3
7689508|NCT01877239|18936261|P1|NOT COMPLETED|Overall Study||50
7689509|NCT01877239|18936261|P1|COMPLETED|Overall Study||61
7689510|NCT01877239|18936261|P1|Treated|Overall Study||76
7689511|NCT01877239|18936261|P1|STARTED|Overall Study||111
7689512|NCT01877187|18936267|P1|NOT COMPLETED|Overall Study||22
7689513|NCT01877187|18936267|P1|COMPLETED|Overall Study|10 HCC, 7 non-HCC|17
7689514|NCT01877187|18936267|P1|Completed 90 Day f/u|Overall Study|11 HCC, 9 non-HCC|20
7689515|NCT01877187|18936267|P1|Completed 30 Day f/u|Overall Study|18 HCC, 17 non-HCC|35
7689516|NCT01877187|18936267|P1|STARTED|Overall Study|21 HCC, 18 non-HCC|39
7689517|NCT01877161|18936296|P1|NOT COMPLETED|Third Session of Stimulation||0
7689518|NCT01877161|18936296|P1|COMPLETED|Third Session of Stimulation||12
7689519|NCT01877161|18936296|P1|STARTED|Third Session of Stimulation||12
7689520|NCT01877161|18936296|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
7689521|NCT01877161|18936296|P1|COMPLETED|Washout (at Least 3 Days)||12
7689522|NCT01877161|18936296|P1|STARTED|Washout (at Least 3 Days)||12
7689523|NCT01877161|18936296|P1|NOT COMPLETED|Second Session of Stimulation||0
7689524|NCT01877161|18936296|P1|COMPLETED|Second Session of Stimulation||12
7689525|NCT01877161|18936296|P1|STARTED|Second Session of Stimulation||12
7689526|NCT01877161|18936296|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
7689527|NCT01877161|18936296|P1|COMPLETED|Washout (at Least 3 Days)||12
7689528|NCT01877161|18936296|P1|STARTED|Washout (at Least 3 Days)||12
7689529|NCT01877161|18936296|P1|NOT COMPLETED|First Session of Stimulation||0
7689530|NCT01877161|18936296|P1|COMPLETED|First Session of Stimulation||12
7689531|NCT01877161|18936296|P1|STARTED|First Session of Stimulation||12
7689532|NCT01877148|18936306|P2|NOT COMPLETED|Overall Study||1
7689533|NCT01877148|18936307|P1|NOT COMPLETED|Overall Study||1
7689534|NCT01877148|18936306|P2|COMPLETED|Overall Study||5
7689535|NCT01877148|18936307|P1|COMPLETED|Overall Study||5
7689536|NCT01877148|18936306|P2|STARTED|Overall Study||6
7689537|NCT01877148|18936307|P1|STARTED|Overall Study||6
7689538|NCT01877083|18936319|P1|NOT COMPLETED|Extension Phase||5
7689539|NCT01877083|18936319|P1|COMPLETED|Extension Phase||0
7689540|NCT01877083|18936319|P1|STARTED|Extension Phase||5
7689541|NCT01877083|18936319|P1|NOT COMPLETED|Treatment Phase||20
7689542|NCT01877083|18936319|P1|COMPLETED|Treatment Phase||5
7689543|NCT01877083|18936319|P1|STARTED|Treatment Phase||25
7689544|NCT01876992|18936328|P2|NOT COMPLETED|Overall Study||0
7689545|NCT01876992|18936329|P1|NOT COMPLETED|Overall Study||0
7689546|NCT01876992|18936328|P2|COMPLETED|Overall Study||5
7689547|NCT01876992|18936329|P1|COMPLETED|Overall Study||5
7689548|NCT01876992|18936328|P2|STARTED|Overall Study||5
7689549|NCT01876992|18936329|P1|STARTED|Overall Study||5
7689550|NCT01876979|18936343|P2|NOT COMPLETED|Overall Study||3
7689551|NCT01876979|18936344|P1|NOT COMPLETED|Overall Study||2
7689552|NCT01876979|18936343|P2|COMPLETED|Overall Study||0
7689553|NCT01876979|18936344|P1|COMPLETED|Overall Study||0
7689554|NCT01876979|18936343|P2|STARTED|Overall Study||3
7689555|NCT01876979|18936344|P1|STARTED|Overall Study||2
7689556|NCT01876823|18936350|P1|NOT COMPLETED|Overall Study||9
7689557|NCT01876823|18936350|P1|COMPLETED|Overall Study||26
7689558|NCT01876823|18936350|P1|STARTED|Overall Study||35
7689559|NCT01876810|18936363|P2|NOT COMPLETED|Overall Study||1
7689560|NCT01876810|18936364|P1|NOT COMPLETED|Overall Study||0
7689561|NCT01876810|18936363|P2|COMPLETED|Overall Study||13
7689562|NCT01876810|18936364|P1|COMPLETED|Overall Study||14
7689563|NCT01876810|18936363|P2|STARTED|Overall Study||14
7689564|NCT01876810|18936364|P1|STARTED|Overall Study||14
7689565|NCT01876784|18936376|P2|NOT COMPLETED|Overall Study||119
7689566|NCT01876784|18936377|P1|NOT COMPLETED|Overall Study||119
7689567|NCT01876784|18936376|P2|COMPLETED|Overall Study||0
7689568|NCT01876784|18936377|P1|COMPLETED|Overall Study||0
7689569|NCT01876784|18936376|P2|Treated|Overall Study||118
7689570|NCT01876784|18936377|P1|Treated|Overall Study||117
7689571|NCT01876784|18936376|P2|STARTED|Overall Study||119
7689572|NCT01876784|18936377|P1|STARTED|Overall Study||119
7689573|NCT01876732|18936383|P1|NOT COMPLETED|Overall Study||75
7689574|NCT01876732|18936383|P1|COMPLETED|Overall Study||57
7689575|NCT01876732|18936383|P1|STARTED|Overall Study||132
7689576|NCT01876706|18936388|P1|NOT COMPLETED|Overall Study||25
7689577|NCT01876706|18936388|P1|COMPLETED|Overall Study||26
7689578|NCT01876706|18936388|P1|60 Months|Overall Study||26
7689579|NCT01876706|18936388|P1|48 Months|Overall Study||31
7689580|NCT01876706|18936388|P1|36 Months|Overall Study||32
7689581|NCT01876706|18936388|P1|24 Months|Overall Study||35
7689582|NCT01876706|18936388|P1|12 Months|Overall Study||42
7689583|NCT01876706|18936388|P1|6 Months|Overall Study||46
7689584|NCT01876706|18936388|P1|3 Months|Overall Study||51
7689585|NCT01876706|18936388|P1|1 Month|Overall Study||51
7689586|NCT01876706|18936388|P1|STARTED|Overall Study||51
7689587|NCT01876511|18936408|P3|NOT COMPLETED|Overall Study||31
7689588|NCT01876511|18936409|P2|NOT COMPLETED|Overall Study||25
7689589|NCT01876511|18936410|P1|NOT COMPLETED|Overall Study||23
7689590|NCT01876511|18936408|P3|COMPLETED|Overall Study||16
7689591|NCT01876511|18936409|P2|COMPLETED|Overall Study||0
7689592|NCT01876511|18936410|P1|COMPLETED|Overall Study||18
7689593|NCT01876511|18936408|P3|Stages 1 and 2|Overall Study||21
7689594|NCT01876511|18936409|P2|Stages 1 and 2|Overall Study||25
7689595|NCT01876511|18936410|P1|Stages 1 and 2|Overall Study||24
7689596|NCT01876511|18936408|P3|STARTED|Overall Study||47
7689597|NCT01876511|18936409|P2|STARTED|Overall Study||25
7689598|NCT01876511|18936410|P1|STARTED|Overall Study||41
7689599|NCT01876485|18936447|P2|NOT COMPLETED|Overall Study||26
7689600|NCT01876485|18936448|P1|NOT COMPLETED|Overall Study||24
7689601|NCT01876485|18936447|P2|COMPLETED|Overall Study||114
7689602|NCT01876485|18936448|P1|COMPLETED|Overall Study||116
7689603|NCT01876485|18936447|P2|Maintenance|Overall Study||114
7689604|NCT01876485|18936448|P1|Maintenance|Overall Study||116
7689605|NCT01876485|18936447|P2|Post-Intervention|Overall Study||129
7689606|NCT01876485|18936448|P1|Post-Intervention|Overall Study||125
7689607|NCT01876485|18936447|P2|STARTED|Overall Study||140
7689608|NCT01876485|18936448|P1|STARTED|Overall Study||140
7689609|NCT01876446|18936458|P2|NOT COMPLETED|Overall Study||6
7689610|NCT01876446|18936459|P1|NOT COMPLETED|Overall Study||2
7689611|NCT01876446|18936458|P2|COMPLETED|Overall Study||12
7689612|NCT01876446|18936459|P1|COMPLETED|Overall Study||18
7689613|NCT01876446|18936458|P2|STARTED|Overall Study||18
7689614|NCT01876446|18936459|P1|STARTED|Overall Study||20
7689615|NCT01876420|18936475|P1|NOT COMPLETED|Overall Study||1
7689616|NCT01876420|18936475|P1|COMPLETED|Overall Study||59
7689617|NCT01876420|18936475|P1|STARTED|Overall Study||60
7689618|NCT01876381|18936487|P1|NOT COMPLETED|Overall Study||7
7689619|NCT01876381|18936487|P1|COMPLETED|Overall Study||16
7689620|NCT01876381|18936487|P1|STARTED|Overall Study||23
7689621|NCT01876368|18936494|P2|NOT COMPLETED|Overall Study||13
7689622|NCT01876368|18936495|P1|NOT COMPLETED|Overall Study||9
7689623|NCT01876368|18936494|P2|COMPLETED|Overall Study||175
7689624|NCT01876368|18936495|P1|COMPLETED|Overall Study||179
7689625|NCT01876368|18936494|P2|Safety Set (SAF)|Overall Study||187
7689626|NCT01876368|18936495|P1|Safety Set (SAF)|Overall Study||188
7689627|NCT01876368|18936494|P2|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187
7689628|NCT01876368|18936495|P1|Full Analysis Set (FAS)|Overall Study||188
7689629|NCT01876368|18936494|P2|STARTED|Overall Study||188
7689630|NCT01876368|18936495|P1|STARTED|Overall Study||188
7689631|NCT01876329|18936524|P3|NOT COMPLETED|Overall Study||0
7689632|NCT01876329|18936525|P2|NOT COMPLETED|Overall Study||0
7689633|NCT01876329|18936526|P1|NOT COMPLETED|Overall Study||0
7689634|NCT01876329|18936524|P3|COMPLETED|Overall Study||44
7689635|NCT01876329|18936525|P2|COMPLETED|Overall Study||36
7689636|NCT01876329|18936526|P1|COMPLETED|Overall Study||45
7689637|NCT01876329|18936524|P3|STARTED|Overall Study||44
7689638|NCT01876329|18936525|P2|STARTED|Overall Study||36
7689639|NCT01876329|18936526|P1|STARTED|Overall Study||45
7689640|NCT01876251|18936540|P3|NOT COMPLETED|Overall Study||11
7689641|NCT01876251|18936541|P2|NOT COMPLETED|Overall Study||3
7689642|NCT01876251|18936542|P1|NOT COMPLETED|Overall Study||15
7689643|NCT01876251|18936540|P3|COMPLETED|Overall Study||0
7689644|NCT01876251|18936541|P2|COMPLETED|Overall Study||0
7689645|NCT01876251|18936542|P1|COMPLETED|Overall Study||0
7689646|NCT01876251|18936540|P3|STARTED|Overall Study||11
7689647|NCT01876251|18936541|P2|STARTED|Overall Study||3
7689648|NCT01876251|18936542|P1|STARTED|Overall Study||15
7689649|NCT01876212|18936601|P2|NOT COMPLETED|Overall Study||0
7689650|NCT01876212|18936602|P1|NOT COMPLETED|Overall Study||0
7689651|NCT01876212|18936601|P2|COMPLETED|Overall Study||6
7689652|NCT01876212|18936602|P1|COMPLETED|Overall Study||9
7689653|NCT01876212|18936601|P2|STARTED|Overall Study||6
7689654|NCT01876212|18936602|P1|STARTED|Overall Study||9
7689655|NCT01876043|18936646|P1|NOT COMPLETED|Overall Study||2
7689656|NCT01876043|18936646|P1|COMPLETED|Overall Study||22
7689657|NCT01876043|18936646|P1|Interim Analysis Population|Overall Study||17
7689658|NCT01876043|18936646|P1|STARTED|Overall Study||24
7689659|NCT01875991|18936658|P2|NOT COMPLETED|Overall Study||6
7689660|NCT01875991|18936659|P1|NOT COMPLETED|Overall Study||7
7689661|NCT01875991|18936658|P2|COMPLETED|Overall Study||103
7689662|NCT01875991|18936659|P1|COMPLETED|Overall Study||101
7689663|NCT01875991|18936658|P2|Received Etanercept in Period 2|Overall Study||103
7689664|NCT01875991|18936659|P1|Received Etanercept in Period 2|Overall Study||102
7689665|NCT01875991|18936658|P2|Received Etanercept in Period 1|Overall Study||108
7689666|NCT01875991|18936659|P1|Received Etanercept in Period 1|Overall Study||108
7689667|NCT01875991|18936658|P2|STARTED|Overall Study||109
7689668|NCT01875991|18936659|P1|STARTED|Overall Study||108
7689669|NCT01875978|18936682|P2|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
7689670|NCT01875978|18936683|P1|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
7689671|NCT01875978|18936682|P2|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
7689672|NCT01875978|18936683|P1|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
7689673|NCT01875978|18936682|P2|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
7689674|NCT01875978|18936683|P1|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
7689675|NCT01875978|18936682|P2|NOT COMPLETED|Study 4weeks||0
7689676|NCT01875978|18936683|P1|NOT COMPLETED|Study 4weeks||0
7689677|NCT01875978|18936682|P2|COMPLETED|Study 4weeks||20
7689678|NCT01875978|18936683|P1|COMPLETED|Study 4weeks||20
7689679|NCT01875978|18936682|P2|STARTED|Study 4weeks||20
7689680|NCT01875978|18936683|P1|STARTED|Study 4weeks||20
7689681|NCT01875874|18936695|P1|NOT COMPLETED|Overall Study||3
7689682|NCT01875874|18936695|P1|COMPLETED|Overall Study||5
7689683|NCT01875874|18936695|P1|STARTED|Overall Study||8
7689684|NCT01875861|18936702|P2|NOT COMPLETED|Sustainability||0
7689685|NCT01875861|18936703|P1|NOT COMPLETED|Sustainability||0
7689686|NCT01875861|18936702|P2|COMPLETED|Sustainability||3444
7689687|NCT01875861|18936703|P1|COMPLETED|Sustainability||4306
7689688|NCT01875861|18936702|P2|STARTED|Sustainability||3444
7689689|NCT01875861|18936703|P1|STARTED|Sustainability||4306
7689690|NCT01875861|18936702|P2|NOT COMPLETED|Implementation||0
7689691|NCT01875861|18936703|P1|NOT COMPLETED|Implementation||0
7689692|NCT01875861|18936702|P2|COMPLETED|Implementation||3444
7689693|NCT01875861|18936703|P1|COMPLETED|Implementation||4546
7689694|NCT01875861|18936702|P2|STARTED|Implementation||3444
7689695|NCT01875861|18936703|P1|STARTED|Implementation||4546
7689696|NCT01875861|18936702|P2|NOT COMPLETED|Pre-implementation||0
7689697|NCT01875861|18936703|P1|NOT COMPLETED|Pre-implementation||0
7689698|NCT01875861|18936702|P2|COMPLETED|Pre-implementation||3714
7689699|NCT01875861|18936703|P1|COMPLETED|Pre-implementation||4779
7689700|NCT01875861|18936702|P2|STARTED|Pre-implementation||3714
7689701|NCT01875861|18936703|P1|STARTED|Pre-implementation||4779
7689702|NCT01875848|18936715|P2|NOT COMPLETED|Overall Study||0
7689703|NCT01875848|18936716|P1|NOT COMPLETED|Overall Study||2
7689704|NCT01875848|18936715|P2|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4
7689705|NCT01875848|18936716|P1|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1
7689706|NCT01875848|18936715|P2|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4
7689707|NCT01875848|18936716|P1|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3
7689708|NCT01875783|18936724|P1|NOT COMPLETED|Overall Study||0
7689709|NCT01875783|18936724|P1|COMPLETED|Overall Study||385
7689710|NCT01875783|18936724|P1|STARTED|Overall Study||385
7689711|NCT01875731|18936733|P2|NOT COMPLETED|Overall Study||0
7689712|NCT01875731|18936734|P1|NOT COMPLETED|Overall Study||1
7689713|NCT01875731|18936733|P2|COMPLETED|Overall Study||32
7689714|NCT01875731|18936734|P1|COMPLETED|Overall Study||33
7689715|NCT01875731|18936733|P2|STARTED|Overall Study||32
7689716|NCT01875731|18936734|P1|STARTED|Overall Study||34
7689717|NCT01875510|18936744|P2|NOT COMPLETED|Overall Study||0
7689718|NCT01875510|18936745|P1|NOT COMPLETED|Overall Study||0
7689719|NCT01875510|18936744|P2|COMPLETED|Overall Study||40
7689720|NCT01875510|18936745|P1|COMPLETED|Overall Study||40
7689721|NCT01875510|18936744|P2|STARTED|Overall Study||40
7689722|NCT01875510|18936745|P1|STARTED|Overall Study||40
7689723|NCT01875471|18936753|P2|NOT COMPLETED|Overall Study||1
7689724|NCT01875471|18936754|P1|NOT COMPLETED|Overall Study||1
7689725|NCT01875471|18936753|P2|COMPLETED|Overall Study||137
7689726|NCT01875471|18936754|P1|COMPLETED|Overall Study||136
7689727|NCT01875471|18936753|P2|Completed Per Protocol|Overall Study||123
7689728|NCT01875471|18936754|P1|Completed Per Protocol|Overall Study||127
7689729|NCT01875471|18936753|P2|STARTED|Overall Study||138
7689730|NCT01875471|18936754|P1|STARTED|Overall Study||137
7689731|NCT01875445|18936762|P2|NOT COMPLETED|Overall Study||0
7689732|NCT01875445|18936763|P1|NOT COMPLETED|Overall Study||7
7689733|NCT01875445|18936762|P2|COMPLETED|Overall Study||19
7689734|NCT01875445|18936763|P1|COMPLETED|Overall Study||12
7689735|NCT01875445|18936762|P2|STARTED|Overall Study||19
7689736|NCT01875445|18936763|P1|STARTED|Overall Study||19
7689737|NCT01875250|18936773|P2|NOT COMPLETED|Overall Study||0
7689738|NCT01875250|18936774|P1|NOT COMPLETED|Overall Study||2
7689739|NCT01875250|18936773|P2|COMPLETED|Overall Study||19
7689740|NCT01875250|18936774|P1|COMPLETED|Overall Study||17
7689741|NCT01875250|18936773|P2|STARTED|Overall Study||19
7689742|NCT01875250|18936774|P1|STARTED|Overall Study||19
7689743|NCT01875237|18936789|P2|NOT COMPLETED|Overall Study||0
7689744|NCT01875237|18936790|P1|NOT COMPLETED|Overall Study||2
7689745|NCT01875237|18936789|P2|COMPLETED|Overall Study||1
7689746|NCT01875237|18936790|P1|COMPLETED|Overall Study||0
7689747|NCT01875237|18936789|P2|STARTED|Overall Study||1
7689748|NCT01875237|18936790|P1|STARTED|Overall Study||2
7689749|NCT01875185|18936816|P2|NOT COMPLETED|Overall Study||48
7689750|NCT01875185|18936817|P1|NOT COMPLETED|Overall Study||52
7689751|NCT01875185|18936816|P2|COMPLETED|Overall Study||0
7689752|NCT01875185|18936817|P1|COMPLETED|Overall Study||0
7689753|NCT01875185|18936816|P2|STARTED|Overall Study||48
7689754|NCT01875185|18936817|P1|STARTED|Overall Study||52
7689755|NCT01875159|18936831|P2|NOT COMPLETED|Overall Study||0
7689756|NCT01875159|18936832|P1|NOT COMPLETED|Overall Study||3
7689757|NCT01875159|18936831|P2|COMPLETED|Overall Study||53
7689758|NCT01875159|18936832|P1|COMPLETED|Overall Study||42
7689759|NCT01875159|18936831|P2|STARTED|Overall Study||53
7689760|NCT01875159|18936832|P1|STARTED|Overall Study||45
7689761|NCT01874951|18936842|P2|NOT COMPLETED|Overall Study||0
7689762|NCT01874951|18936843|P1|NOT COMPLETED|Overall Study||0
7689763|NCT01874951|18936842|P2|COMPLETED|Overall Study||6
7689764|NCT01874951|18936843|P1|COMPLETED|Overall Study||6
7689765|NCT01874951|18936842|P2|STARTED|Overall Study||6
7689766|NCT01874951|18936843|P1|STARTED|Overall Study||6
7689767|NCT01874756|18936867|P4|NOT COMPLETED|Overall Study||6
7689768|NCT01874756|18936868|P3|NOT COMPLETED|Overall Study||2
7689769|NCT01874756|18936869|P2|NOT COMPLETED|Overall Study||0
7689770|NCT01874756|18936870|P1|NOT COMPLETED|Overall Study||1
7689771|NCT01874756|18936867|P4|COMPLETED|Overall Study||21
7689772|NCT01874756|18936868|P3|COMPLETED|Overall Study||27
7689773|NCT01874756|18936869|P2|COMPLETED|Overall Study||10
7689774|NCT01874756|18936870|P1|COMPLETED|Overall Study||28
7689775|NCT01874756|18936867|P4|STARTED|Overall Study||27
7689776|NCT01874756|18936868|P3|STARTED|Overall Study||29
7689777|NCT01874756|18936869|P2|STARTED|Overall Study||10
7689778|NCT01874756|18936870|P1|STARTED|Overall Study||29
7689779|NCT01874665|18936902|P2|NOT COMPLETED|Overall Study||15
7689780|NCT01874665|18936903|P1|NOT COMPLETED|Overall Study||30
7689781|NCT01874665|18936902|P2|COMPLETED|Overall Study||0
7689782|NCT01874665|18936903|P1|COMPLETED|Overall Study||0
7689783|NCT01874665|18936902|P2|STARTED|Overall Study||15
7689784|NCT01874665|18936903|P1|STARTED|Overall Study||30
7689785|NCT01874535|18936931|P2|NOT COMPLETED|Overall Study||44
7689786|NCT01874535|18936932|P1|NOT COMPLETED|Overall Study||55
7689787|NCT01874535|18936931|P2|COMPLETED|Overall Study||157
7689788|NCT01874535|18936932|P1|COMPLETED|Overall Study||152
7689789|NCT01874535|18936931|P2|STARTED|Overall Study||201
7689790|NCT01874535|18936932|P1|STARTED|Overall Study||207
7689791|NCT01874353|18936940|P2|NOT COMPLETED|Overall Study||37
7689792|NCT01874353|18936941|P1|NOT COMPLETED|Overall Study||55
7689793|NCT01874353|18936940|P2|COMPLETED|Overall Study||62
7689794|NCT01874353|18936941|P1|COMPLETED|Overall Study||141
7689795|NCT01874353|18936940|P2|STARTED|Overall Study||99
7689796|NCT01874353|18936941|P1|STARTED|Overall Study||196
7689797|NCT01874340|18936968|P4|NOT COMPLETED|Overall Study||5
7689798|NCT01874340|18936969|P3|NOT COMPLETED|Overall Study||8
7689799|NCT01874340|18936970|P2|NOT COMPLETED|Overall Study||8
7689800|NCT01874340|18936971|P1|NOT COMPLETED|Overall Study||6
7689801|NCT01874340|18936968|P4|COMPLETED|Overall Study||1
7689802|NCT01874340|18936969|P3|COMPLETED|Overall Study||0
7689803|NCT01874340|18936970|P2|COMPLETED|Overall Study||0
7689804|NCT01874340|18936971|P1|COMPLETED|Overall Study||0
7689805|NCT01874340|18936968|P4|STARTED|Overall Study||6
7689806|NCT01874340|18936969|P3|STARTED|Overall Study||8
7689807|NCT01874340|18936970|P2|STARTED|Overall Study||8
7689808|NCT01874340|18936971|P1|STARTED|Overall Study||6
7689809|NCT01874288|18937002|P5|NOT COMPLETED|Overall Study||2
7689810|NCT01874288|18937003|P4|NOT COMPLETED|Overall Study||7
7689811|NCT01874288|18937004|P3|NOT COMPLETED|Overall Study||5
7689812|NCT01874288|18937005|P2|NOT COMPLETED|Overall Study||0
7689813|NCT01874288|18937006|P1|NOT COMPLETED|Overall Study||3
7689814|NCT01874288|18937002|P5|COMPLETED|Overall Study||0
7689815|NCT01874288|18937003|P4|COMPLETED|Overall Study||0
7689816|NCT01874288|18937004|P3|COMPLETED|Overall Study||4
7689817|NCT01874288|18937005|P2|COMPLETED|Overall Study||3
7689818|NCT01874288|18937006|P1|COMPLETED|Overall Study||0
7689819|NCT01874288|18937002|P5|Received at Least 1 Dose of Study Drug|Overall Study||2
7689820|NCT01874288|18937003|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
7689821|NCT01874288|18937004|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
7689822|NCT01874288|18937005|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
7689823|NCT01874288|18937006|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
7689824|NCT01874288|18937002|P5|STARTED|Overall Study||2
7689825|NCT01874288|18937003|P4|STARTED|Overall Study||7
7689826|NCT01874288|18937004|P3|STARTED|Overall Study||9
7689827|NCT01874288|18937005|P2|STARTED|Overall Study||3
7689828|NCT01874288|18937006|P1|STARTED|Overall Study||3
7689829|NCT01874275|18937041|P2|NOT COMPLETED|Overall Study||0
7689830|NCT01874275|18937042|P1|NOT COMPLETED|Overall Study||1
7689831|NCT01874275|18937041|P2|COMPLETED|Overall Study||2
7689832|NCT01874275|18937042|P1|COMPLETED|Overall Study||3
7689833|NCT01874275|18937041|P2|STARTED|Overall Study||2
7689834|NCT01874275|18937042|P1|STARTED|Overall Study||4
7689835|NCT01874262|18937056|P2|NOT COMPLETED|Overall Study||3
7689836|NCT01874262|18937057|P1|NOT COMPLETED|Overall Study||5
7689837|NCT01874262|18937056|P2|COMPLETED|Overall Study||80
7689838|NCT01874262|18937057|P1|COMPLETED|Overall Study||86
7689839|NCT01874262|18937056|P2|Not Included Due to Tehnical Issues|Overall Study||3
7689840|NCT01874262|18937057|P1|Not Included Due to Tehnical Issues|Overall Study||3
7689841|NCT01874262|18937056|P2|Not Correctly Randomised|Overall Study||0
7689842|NCT01874262|18937057|P1|Not Correctly Randomised|Overall Study||2
7689843|NCT01874262|18937056|P2|STARTED|Overall Study||83
7689844|NCT01874262|18937057|P1|STARTED|Overall Study||91
7689845|NCT01874145|18937065|P2|NOT COMPLETED|Extension Period||4
7689846|NCT01874145|18937066|P1|NOT COMPLETED|Extension Period||6
7689847|NCT01874145|18937065|P2|COMPLETED|Extension Period||97
7689848|NCT01874145|18937066|P1|COMPLETED|Extension Period||91
7689849|NCT01874145|18937065|P2|Full Analysis Set|Extension Period||101
7689850|NCT01874145|18937066|P1|Full Analysis Set|Extension Period||95
7689851|NCT01874145|18937065|P2|STARTED|Extension Period|Non-Switchers|101
7689852|NCT01874145|18937066|P1|STARTED|Extension Period|Switchers|97
7689853|NCT01874145|18937065|P2|NOT COMPLETED|Core Period||7
7689854|NCT01874145|18937066|P1|NOT COMPLETED|Core Period||3
7689855|NCT01874145|18937065|P2|COMPLETED|Core Period||101
7689856|NCT01874145|18937066|P1|COMPLETED|Core Period||98
7689857|NCT01874145|18937065|P2|Full Analysis Set|Core Period||108
7689858|NCT01874145|18937066|P1|Full Analysis Set|Core Period||100
7689859|NCT01874145|18937065|P2|STARTED|Core Period||108
7689860|NCT01874145|18937066|P1|STARTED|Core Period||101
7689861|NCT01874132|18937105|P3|NOT COMPLETED|Overall Study||3
7689862|NCT01874132|18937106|P2|NOT COMPLETED|Overall Study||4
7689863|NCT01874132|18937107|P1|NOT COMPLETED|Overall Study||4
7689864|NCT01874132|18937105|P3|COMPLETED|Overall Study||19
7689865|NCT01874132|18937106|P2|COMPLETED|Overall Study||18
7689866|NCT01874132|18937107|P1|COMPLETED|Overall Study||18
7689867|NCT01874132|18937105|P3|STARTED|Overall Study||22
7689868|NCT01874132|18937106|P2|STARTED|Overall Study||22
7689869|NCT01874132|18937107|P1|STARTED|Overall Study||22
7689870|NCT01874119|18937118|P2|NOT COMPLETED|Second Intervention (6 Days)||0
7689871|NCT01874119|18937119|P1|NOT COMPLETED|Second Intervention (6 Days)||0
7689872|NCT01874119|18937118|P2|COMPLETED|Second Intervention (6 Days)||3
7689873|NCT01874119|18937119|P1|COMPLETED|Second Intervention (6 Days)||4
7689874|NCT01874119|18937118|P2|STARTED|Second Intervention (6 Days)||3
7689875|NCT01874119|18937119|P1|STARTED|Second Intervention (6 Days)||4
7689876|NCT01874119|18937118|P2|NOT COMPLETED|Washout (7 Days)||2
7689877|NCT01874119|18937119|P1|NOT COMPLETED|Washout (7 Days)||3
7689878|NCT01874119|18937118|P2|COMPLETED|Washout (7 Days)||3
7689879|NCT01874119|18937119|P1|COMPLETED|Washout (7 Days)||4
7689880|NCT01874119|18937118|P2|STARTED|Washout (7 Days)||5
7689881|NCT01874119|18937119|P1|STARTED|Washout (7 Days)||7
7689882|NCT01874119|18937118|P2|NOT COMPLETED|First Intervention (6 Days)||0
7689883|NCT01874119|18937119|P1|NOT COMPLETED|First Intervention (6 Days)||1
7689884|NCT01874119|18937118|P2|COMPLETED|First Intervention (6 Days)||5
7689885|NCT01874119|18937119|P1|COMPLETED|First Intervention (6 Days)||7
7689886|NCT01874119|18937118|P2|STARTED|First Intervention (6 Days)||5
7689887|NCT01874119|18937119|P1|STARTED|First Intervention (6 Days)||8
7689888|NCT01874054|18937125|P1|NOT COMPLETED|Overall Study||55
7689889|NCT01874054|18937125|P1|COMPLETED|Overall Study||0
7689890|NCT01874054|18937125|P1|Completed 16 Cycles of BV Treatment|Overall Study||17
7689891|NCT01874054|18937125|P1|Completed ≥2 Cycles of Combo Treatment|Overall Study||53
7689892|NCT01874054|18937125|P1|STARTED|Overall Study||55
7689893|NCT01873989|18937136|P2|NOT COMPLETED|Overall Study||1
7689894|NCT01873989|18937137|P1|NOT COMPLETED|Overall Study||1
7689895|NCT01873989|18937136|P2|COMPLETED|Overall Study||6
7689896|NCT01873989|18937137|P1|COMPLETED|Overall Study||7
7689897|NCT01873989|18937136|P2|STARTED|Overall Study||7
7689898|NCT01873989|18937137|P1|STARTED|Overall Study||8
7689899|NCT01873950|18937147|P5|NOT COMPLETED|Period 5||0
7689900|NCT01873950|18937148|P4|NOT COMPLETED|Period 5||1
7689901|NCT01873950|18937149|P3|NOT COMPLETED|Period 5||0
7689902|NCT01873950|18937150|P2|NOT COMPLETED|Period 5||0
7689903|NCT01873950|18937151|P1|NOT COMPLETED|Period 5||0
7689904|NCT01873950|18937147|P5|COMPLETED|Period 5||4
7689905|NCT01873950|18937148|P4|COMPLETED|Period 5||3
7689906|NCT01873950|18937149|P3|COMPLETED|Period 5||4
7689907|NCT01873950|18937150|P2|COMPLETED|Period 5||5
7689908|NCT01873950|18937151|P1|COMPLETED|Period 5||4
7689909|NCT01873950|18937147|P5|STARTED|Period 5||4
7689910|NCT01873950|18937148|P4|STARTED|Period 5||4
7689911|NCT01873950|18937149|P3|STARTED|Period 5||4
7689912|NCT01873950|18937150|P2|STARTED|Period 5||5
7689913|NCT01873950|18937151|P1|STARTED|Period 5||4
7689914|NCT01873950|18937147|P5|NOT COMPLETED|Period 4||0
7689915|NCT01873950|18937148|P4|NOT COMPLETED|Period 4||0
7689916|NCT01873950|18937149|P3|NOT COMPLETED|Period 4||0
7689917|NCT01873950|18937150|P2|NOT COMPLETED|Period 4||0
7689918|NCT01873950|18937151|P1|NOT COMPLETED|Period 4||0
7689919|NCT01873950|18937147|P5|COMPLETED|Period 4||5
7689920|NCT01873950|18937148|P4|COMPLETED|Period 4||4
7689921|NCT01873950|18937149|P3|COMPLETED|Period 4||4
7689922|NCT01873950|18937150|P2|COMPLETED|Period 4||5
7689923|NCT01873950|18937151|P1|COMPLETED|Period 4||4
7689924|NCT01873950|18937147|P5|STARTED|Period 4||5
7689925|NCT01873950|18937148|P4|STARTED|Period 4||4
7689926|NCT01873950|18937149|P3|STARTED|Period 4||4
7689927|NCT01873950|18937150|P2|STARTED|Period 4||5
7689928|NCT01873950|18937151|P1|STARTED|Period 4||4
7689929|NCT01873950|18937147|P5|NOT COMPLETED|Period 3||0
7689930|NCT01873950|18937148|P4|NOT COMPLETED|Period 3||0
7689931|NCT01873950|18937149|P3|NOT COMPLETED|Period 3||0
7689932|NCT01873950|18937150|P2|NOT COMPLETED|Period 3||0
7689933|NCT01873950|18937151|P1|NOT COMPLETED|Period 3||0
7689934|NCT01873950|18937147|P5|COMPLETED|Period 3||4
7689935|NCT01873950|18937148|P4|COMPLETED|Period 3||5
7689936|NCT01873950|18937149|P3|COMPLETED|Period 3||5
7689937|NCT01873950|18937150|P2|COMPLETED|Period 3||4
7689938|NCT01873950|18937151|P1|COMPLETED|Period 3||4
7689939|NCT01873950|18937147|P5|STARTED|Period 3||4
7689940|NCT01873950|18937148|P4|STARTED|Period 3||5
7689941|NCT01873950|18937149|P3|STARTED|Period 3||5
7689942|NCT01873950|18937150|P2|STARTED|Period 3||4
7689943|NCT01873950|18937151|P1|STARTED|Period 3||4
7689944|NCT01873950|18937147|P5|NOT COMPLETED|Period 2||0
7689945|NCT01873950|18937148|P4|NOT COMPLETED|Period 2||0
7689946|NCT01873950|18937149|P3|NOT COMPLETED|Period 2||0
7689947|NCT01873950|18937150|P2|NOT COMPLETED|Period 2||0
7689948|NCT01873950|18937151|P1|NOT COMPLETED|Period 2||0
7689949|NCT01873950|18937147|P5|COMPLETED|Period 2||5
7689950|NCT01873950|18937148|P4|COMPLETED|Period 2||4
7689951|NCT01873950|18937149|P3|COMPLETED|Period 2||4
7689952|NCT01873950|18937150|P2|COMPLETED|Period 2||4
7689953|NCT01873950|18937151|P1|COMPLETED|Period 2||5
7689954|NCT01873950|18937147|P5|STARTED|Period 2||5
7689955|NCT01873950|18937148|P4|STARTED|Period 2||4
7689956|NCT01873950|18937149|P3|STARTED|Period 2||4
7689957|NCT01873950|18937150|P2|STARTED|Period 2||4
7689958|NCT01873950|18937151|P1|STARTED|Period 2||5
7689959|NCT01873950|18937147|P5|NOT COMPLETED|Period 1||0
7689960|NCT01873950|18937148|P4|NOT COMPLETED|Period 1||0
7689961|NCT01873950|18937149|P3|NOT COMPLETED|Period 1||0
7689962|NCT01873950|18937150|P2|NOT COMPLETED|Period 1||0
7689963|NCT01873950|18937151|P1|NOT COMPLETED|Period 1||0
7689964|NCT01873950|18937147|P5|COMPLETED|Period 1||4
7689965|NCT01873950|18937148|P4|COMPLETED|Period 1||4
7689966|NCT01873950|18937149|P3|COMPLETED|Period 1||5
7689967|NCT01873950|18937150|P2|COMPLETED|Period 1||4
7689968|NCT01873950|18937151|P1|COMPLETED|Period 1||5
7689969|NCT01873950|18937147|P5|STARTED|Period 1||4
7689970|NCT01873950|18937148|P4|STARTED|Period 1||4
7689971|NCT01873950|18937149|P3|STARTED|Period 1||5
7689972|NCT01873950|18937150|P2|STARTED|Period 1||4
7689973|NCT01873950|18937151|P1|STARTED|Period 1||5
7689974|NCT01873859|18937188|P2|NOT COMPLETED|Overall Study||4
7689975|NCT01873859|18937189|P1|NOT COMPLETED|Overall Study||0
7689976|NCT01873859|18937188|P2|COMPLETED|Overall Study||79
7689977|NCT01873859|18937189|P1|COMPLETED|Overall Study||83
7689978|NCT01873859|18937188|P2|STARTED|Overall Study||83
7689979|NCT01873859|18937189|P1|STARTED|Overall Study||83
7689980|NCT01873846|18937197|P1|NOT COMPLETED|Overall Study||12
7689981|NCT01873846|18937197|P1|COMPLETED|Overall Study||388
7689982|NCT01873846|18937197|P1|Eligble Participants Dispensed Lenses|Overall Study||396
7689983|NCT01873846|18937197|P1|STARTED|Overall Study||400
7689984|NCT01873742|18937207|P2|NOT COMPLETED|Overall Study||76
7689985|NCT01873742|18937208|P1|NOT COMPLETED|Overall Study||68
7689986|NCT01873742|18937207|P2|COMPLETED|Overall Study||87
7689987|NCT01873742|18937208|P1|COMPLETED|Overall Study||97
7689988|NCT01873742|18937207|P2|STARTED|Overall Study||163
7689989|NCT01873742|18937208|P1|STARTED|Overall Study||165
7689990|NCT01873729|18937214|P1|NOT COMPLETED|Overall Study||1
7689991|NCT01873729|18937214|P1|COMPLETED|Overall Study||2
7689992|NCT01873729|18937214|P1|STARTED|Overall Study||3
7689993|NCT01873586|18937219|P1|NOT COMPLETED|Overall Study||3
7689994|NCT01873586|18937219|P1|COMPLETED|Overall Study||26
7689995|NCT01873586|18937219|P1|STARTED|Overall Study||29
7689996|NCT01873495|18937232|P1|NOT COMPLETED|Overall Study||7
7689997|NCT01873495|18937232|P1|COMPLETED|Overall Study||0
7689998|NCT01873495|18937232|P1|STARTED|Overall Study||7
7689999|NCT01873417|18937240|P1|NOT COMPLETED|Overall Study||35
7690000|NCT01873417|18937240|P1|COMPLETED|Overall Study||202
7690001|NCT01873417|18937240|P1|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233
7690002|NCT01873417|18937240|P1|STARTED|Overall Study||237
7690003|NCT01873287|18937253|P2|NOT COMPLETED|Overall Study||174
7690004|NCT01873287|18937254|P1|NOT COMPLETED|Overall Study||305
7690005|NCT01873287|18937253|P2|COMPLETED|Overall Study||883
7690006|NCT01873287|18937254|P1|COMPLETED|Overall Study||1701
7690007|NCT01873287|18937253|P2|STARTED|Overall Study||1057
7690008|NCT01873287|18937254|P1|STARTED|Overall Study||2006
7690009|NCT01872910|18937268|P6|NOT COMPLETED|Overall Study||0
7690010|NCT01872910|18937269|P5|NOT COMPLETED|Overall Study||0
7690011|NCT01872910|18937270|P4|NOT COMPLETED|Overall Study||0
7690012|NCT01872910|18937271|P3|NOT COMPLETED|Overall Study||2
7690013|NCT01872910|18937272|P2|NOT COMPLETED|Overall Study||0
7690014|NCT01872910|18937273|P1|NOT COMPLETED|Overall Study||2
7690015|NCT01872910|18937268|P6|COMPLETED|Overall Study||3
7690016|NCT01872910|18937269|P5|COMPLETED|Overall Study||15
7690017|NCT01872910|18937270|P4|COMPLETED|Overall Study||15
7690018|NCT01872910|18937271|P3|COMPLETED|Overall Study||28
7690019|NCT01872910|18937272|P2|COMPLETED|Overall Study||31
7690020|NCT01872910|18937273|P1|COMPLETED|Overall Study||28
7690021|NCT01872910|18937268|P6|Received Any Study Drug|Overall Study||3
7690022|NCT01872910|18937269|P5|Received Any Study Drug|Overall Study||15
7690023|NCT01872910|18937270|P4|Received Any Study Drug|Overall Study||15
7690024|NCT01872910|18937271|P3|Received Any Study Drug|Overall Study||30
7690025|NCT01872910|18937272|P2|Received Any Study Drug|Overall Study||31
7690026|NCT01872910|18937273|P1|Received Any Study Drug|Overall Study||30
7690027|NCT01872910|18937268|P6|STARTED|Overall Study||3
7690028|NCT01872910|18937269|P5|STARTED|Overall Study||15
7690029|NCT01872910|18937270|P4|STARTED|Overall Study||15
7690030|NCT01872910|18937271|P3|STARTED|Overall Study||30
7690031|NCT01872910|18937272|P2|STARTED|Overall Study||31
7690032|NCT01872910|18937273|P1|STARTED|Overall Study||30
7690033|NCT01872819|18937313|P1|NOT COMPLETED|Overall Study||0
7690034|NCT01872819|18937313|P1|COMPLETED|Overall Study||14
7690035|NCT01872819|18937313|P1|STARTED|Overall Study||14
7690036|NCT01872715|18937318|P1|NOT COMPLETED|Overall Study||4
7690037|NCT01872715|18937318|P1|COMPLETED|Overall Study||20
7690038|NCT01872715|18937318|P1|STARTED|Overall Study||24
7690039|NCT01872689|18937337|P4|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
7690040|NCT01872689|18937338|P3|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
7690041|NCT01872689|18937339|P2|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||23
7690042|NCT01872689|18937340|P1|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||21
7690043|NCT01872689|18937337|P4|COMPLETED|Open-Label Period (Only For Monotherapy)||0
7690044|NCT01872689|18937338|P3|COMPLETED|Open-Label Period (Only For Monotherapy)||0
7690045|NCT01872689|18937339|P2|COMPLETED|Open-Label Period (Only For Monotherapy)||33
7690046|NCT01872689|18937340|P1|COMPLETED|Open-Label Period (Only For Monotherapy)||31
7690047|NCT01872689|18937337|P4|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
7690048|NCT01872689|18937338|P3|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
7690049|NCT01872689|18937339|P2|STARTED|Open-Label Period (Only For Monotherapy)|Of the 58 participants who completed Period 1, only 56 started Period 2.|56
7690050|NCT01872689|18937340|P1|STARTED|Open-Label Period (Only For Monotherapy)|Of the 56 participants who completed Period 1, only 52 started Period 2.|52
7690051|NCT01872689|18937337|P4|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||38
7690052|NCT01872689|18937338|P3|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||48
7690053|NCT01872689|18937339|P2|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
7690054|NCT01872689|18937340|P1|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
7690055|NCT01872689|18937337|P4|COMPLETED|Double-Blind/Placebo-Controlled Period||136
7690056|NCT01872689|18937338|P3|COMPLETED|Double-Blind/Placebo-Controlled Period||129
7690057|NCT01872689|18937339|P2|COMPLETED|Double-Blind/Placebo-Controlled Period||58
7690058|NCT01872689|18937340|P1|COMPLETED|Double-Blind/Placebo-Controlled Period||56
7690059|NCT01872689|18937337|P4|STARTED|Double-Blind/Placebo-Controlled Period||174
7690060|NCT01872689|18937338|P3|STARTED|Double-Blind/Placebo-Controlled Period||177
7690061|NCT01872689|18937339|P2|STARTED|Double-Blind/Placebo-Controlled Period||78
7690062|NCT01872689|18937340|P1|STARTED|Double-Blind/Placebo-Controlled Period||76
7690063|NCT01872611|18937416|P2|NOT COMPLETED|Overall Study||12
7690064|NCT01872611|18937417|P1|NOT COMPLETED|Overall Study||24
7690065|NCT01872611|18937416|P2|COMPLETED|Overall Study||292
7690066|NCT01872611|18937417|P1|COMPLETED|Overall Study||277
7690067|NCT01872611|18937416|P2|Full Analysis Set|Overall Study||293
7690068|NCT01872611|18937417|P1|Full Analysis Set|Overall Study||289
7690069|NCT01872611|18937416|P2|Treated (Safety Analysis Set)|Overall Study||295
7690070|NCT01872611|18937417|P1|Treated (Safety Analysis Set)|Overall Study||293
7690071|NCT01872611|18937416|P2|Randomized|Overall Study||304
7690072|NCT01872611|18937417|P1|Randomized|Overall Study||301
7690073|NCT01872611|18937416|P2|STARTED|Overall Study||304
7690074|NCT01872611|18937417|P1|STARTED|Overall Study||301
7690075|NCT01872338|18937437|P2|NOT COMPLETED|Overall Study||0
7690076|NCT01872338|18937438|P1|NOT COMPLETED|Overall Study||20
7690077|NCT01872338|18937437|P2|COMPLETED|Overall Study||69
7690078|NCT01872338|18937438|P1|COMPLETED|Overall Study||46
7690079|NCT01872338|18937437|P2|STARTED|Overall Study||69
7690080|NCT01872338|18937438|P1|STARTED|Overall Study||66
7690081|NCT01872325|18937452|P2|NOT COMPLETED|Overall Study||0
7690082|NCT01872325|18937453|P1|NOT COMPLETED|Overall Study||0
7690083|NCT01872325|18937452|P2|COMPLETED|Overall Study||387
7690084|NCT01872325|18937453|P1|COMPLETED|Overall Study||689
7690085|NCT01872325|18937452|P2|STARTED|Overall Study||387
7690086|NCT01872325|18937453|P1|STARTED|Overall Study||689
7690087|NCT01872078|18937469|P4|NOT COMPLETED|Overall Study||2
7690088|NCT01872078|18937470|P3|NOT COMPLETED|Overall Study||3
7690089|NCT01872078|18937471|P2|NOT COMPLETED|Overall Study||0
7690090|NCT01872078|18937472|P1|NOT COMPLETED|Overall Study||0
7690091|NCT01872078|18937469|P4|COMPLETED|Overall Study||15
7690092|NCT01872078|18937470|P3|COMPLETED|Overall Study||14
7690093|NCT01872078|18937471|P2|COMPLETED|Overall Study||15
7690094|NCT01872078|18937472|P1|COMPLETED|Overall Study||16
7690095|NCT01872078|18937469|P4|STARTED|Overall Study||17
7690096|NCT01872078|18937470|P3|STARTED|Overall Study||17
7690097|NCT01872078|18937471|P2|STARTED|Overall Study||15
7690098|NCT01872078|18937472|P1|STARTED|Overall Study||16
7690099|NCT01871870|18937482|P1|NOT COMPLETED|Overall Study||9
7690100|NCT01871870|18937482|P1|COMPLETED|Overall Study||11
7690101|NCT01871870|18937482|P1|STARTED|Overall Study||20
7690102|NCT01871805|18937493|P6|NOT COMPLETED|Phase II||87
7690103|NCT01871805|18937494|P5|NOT COMPLETED|Phase II||0
7690104|NCT01871805|18937495|P4|NOT COMPLETED|Phase II||0
7690105|NCT01871805|18937496|P3|NOT COMPLETED|Phase II||0
7690106|NCT01871805|18937497|P2|NOT COMPLETED|Phase II||0
7690107|NCT01871805|18937498|P1|NOT COMPLETED|Phase II||0
7690108|NCT01871805|18937493|P6|COMPLETED|Phase II||0
7690109|NCT01871805|18937494|P5|COMPLETED|Phase II||0
7690110|NCT01871805|18937495|P4|COMPLETED|Phase II||0
7690111|NCT01871805|18937496|P3|COMPLETED|Phase II||0
7690112|NCT01871805|18937497|P2|COMPLETED|Phase II||0
7690113|NCT01871805|18937498|P1|COMPLETED|Phase II||0
7690114|NCT01871805|18937493|P6|STARTED|Phase II||87
7690115|NCT01871805|18937494|P5|STARTED|Phase II||0
7690116|NCT01871805|18937495|P4|STARTED|Phase II||0
7690117|NCT01871805|18937496|P3|STARTED|Phase II||0
7690118|NCT01871805|18937497|P2|STARTED|Phase II||0
7690119|NCT01871805|18937498|P1|STARTED|Phase II||0
7690120|NCT01871805|18937493|P6|NOT COMPLETED|Phase I||0
7690121|NCT01871805|18937494|P5|NOT COMPLETED|Phase I||13
7690122|NCT01871805|18937495|P4|NOT COMPLETED|Phase I||7
7690123|NCT01871805|18937496|P3|NOT COMPLETED|Phase I||13
7690124|NCT01871805|18937497|P2|NOT COMPLETED|Phase I||7
7690125|NCT01871805|18937498|P1|NOT COMPLETED|Phase I||7
7690126|NCT01871805|18937493|P6|COMPLETED|Phase I||0
7690127|NCT01871805|18937494|P5|COMPLETED|Phase I||0
7690128|NCT01871805|18937495|P4|COMPLETED|Phase I||0
7690129|NCT01871805|18937496|P3|COMPLETED|Phase I||0
7690130|NCT01871805|18937497|P2|COMPLETED|Phase I||0
7690131|NCT01871805|18937498|P1|COMPLETED|Phase I||0
7690132|NCT01871805|18937493|P6|STARTED|Phase I||0
7690133|NCT01871805|18937494|P5|STARTED|Phase I||13
7690134|NCT01871805|18937495|P4|STARTED|Phase I||7
7690135|NCT01871805|18937496|P3|STARTED|Phase I||13
7690136|NCT01871805|18937497|P2|STARTED|Phase I||7
7690137|NCT01871805|18937498|P1|STARTED|Phase I||7
7690138|NCT01871558|18937570|P2|NOT COMPLETED|Overall Study||2
7690139|NCT01871558|18937571|P1|NOT COMPLETED|Overall Study||3
7690140|NCT01871558|18937570|P2|COMPLETED|Overall Study||19
7690141|NCT01871558|18937571|P1|COMPLETED|Overall Study||18
7690142|NCT01871558|18937570|P2|STARTED|Overall Study||21
7690143|NCT01871558|18937571|P1|STARTED|Overall Study||21
7690144|NCT01871545|18937591|P2|NOT COMPLETED|Overall Study||3
7690145|NCT01871545|18937592|P1|NOT COMPLETED|Overall Study||17
7690146|NCT01871545|18937591|P2|COMPLETED|Overall Study||8
7690147|NCT01871545|18937592|P1|COMPLETED|Overall Study||56
7690148|NCT01871545|18937591|P2|STARTED|Overall Study||11
7690149|NCT01871545|18937592|P1|STARTED|Overall Study||73
7690150|NCT01871532|18937633|P2|NOT COMPLETED|Overall Study||2
7690151|NCT01871532|18937634|P1|NOT COMPLETED|Overall Study||1
7690152|NCT01871532|18937633|P2|COMPLETED|Overall Study||10
7690153|NCT01871532|18937634|P1|COMPLETED|Overall Study||11
7690154|NCT01871532|18937633|P2|Subjects Received hCG Treatment|Overall Study||9
7690155|NCT01871532|18937634|P1|Subjects Received hCG Treatment|Overall Study||11
7690156|NCT01871532|18937633|P2|STARTED|Overall Study||12
7690157|NCT01871532|18937634|P1|STARTED|Overall Study||12
7690158|NCT01871519|18937668|P1|NOT COMPLETED|Overall Study||90
7690159|NCT01871519|18937668|P1|COMPLETED|Overall Study||260
7690160|NCT01871519|18937668|P1|STARTED|Overall Study||350
7690161|NCT01871506|18937691|P2|NOT COMPLETED|Overall Study||0
7690162|NCT01871506|18937692|P1|NOT COMPLETED|Overall Study||0
7690163|NCT01871506|18937691|P2|COMPLETED|Overall Study||153
7690164|NCT01871506|18937692|P1|COMPLETED|Overall Study||150
7690165|NCT01871506|18937691|P2|STARTED|Overall Study||153
7690166|NCT01871506|18937692|P1|STARTED|Overall Study||150
7690167|NCT01871441|18937716|P1|NOT COMPLETED|Overall Study||0
7690168|NCT01871441|18937716|P1|COMPLETED|Overall Study||4
7690169|NCT01871441|18937716|P1|STARTED|Overall Study||4
7690170|NCT01871402|18937725|P2|NOT COMPLETED|Overall Study||3
7690171|NCT01871402|18937726|P1|NOT COMPLETED|Overall Study||1
7690172|NCT01871402|18937725|P2|COMPLETED|Overall Study||108
7690173|NCT01871402|18937726|P1|COMPLETED|Overall Study||109
7690174|NCT01871402|18937725|P2|STARTED|Overall Study||111
7690175|NCT01871402|18937726|P1|STARTED|Overall Study||110
7690176|NCT01871285|18937744|P4|NOT COMPLETED|Second Intervention (1 Day)||0
7690177|NCT01871285|18937745|P3|NOT COMPLETED|Second Intervention (1 Day)||0
7690178|NCT01871285|18937746|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7690179|NCT01871285|18937747|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7690180|NCT01871285|18937744|P4|COMPLETED|Second Intervention (1 Day)||2
7690181|NCT01871285|18937745|P3|COMPLETED|Second Intervention (1 Day)||3
7690182|NCT01871285|18937746|P2|COMPLETED|Second Intervention (1 Day)||14
7690183|NCT01871285|18937747|P1|COMPLETED|Second Intervention (1 Day)||17
7690184|NCT01871285|18937744|P4|STARTED|Second Intervention (1 Day)||2
7690185|NCT01871285|18937745|P3|STARTED|Second Intervention (1 Day)||3
7690186|NCT01871285|18937746|P2|STARTED|Second Intervention (1 Day)||14
7690187|NCT01871285|18937747|P1|STARTED|Second Intervention (1 Day)||17
7690188|NCT01871285|18937744|P4|NOT COMPLETED|First Intervention (1 Day)||0
7690189|NCT01871285|18937745|P3|NOT COMPLETED|First Intervention (1 Day)||1
7690190|NCT01871285|18937746|P2|NOT COMPLETED|First Intervention (1 Day)||1
7690191|NCT01871285|18937747|P1|NOT COMPLETED|First Intervention (1 Day)||1
7690192|NCT01871285|18937744|P4|COMPLETED|First Intervention (1 Day)||2
7690193|NCT01871285|18937745|P3|COMPLETED|First Intervention (1 Day)||3
7690194|NCT01871285|18937746|P2|COMPLETED|First Intervention (1 Day)||14
7690195|NCT01871285|18937747|P1|COMPLETED|First Intervention (1 Day)||17
7690196|NCT01871285|18937744|P4|STARTED|First Intervention (1 Day)||2
7690197|NCT01871285|18937745|P3|STARTED|First Intervention (1 Day)||4
7690198|NCT01871285|18937746|P2|STARTED|First Intervention (1 Day)||15
7690199|NCT01871285|18937747|P1|STARTED|First Intervention (1 Day)||18
7690200|NCT01871142|18937773|P1|NOT COMPLETED|Overall Study||1
7690201|NCT01871142|18937773|P1|COMPLETED|Overall Study||11
7690202|NCT01871142|18937773|P1|Received 3000mg Aes-103 + Hypoxia|Overall Study||12
7690203|NCT01871142|18937773|P1|Received 1000mg Aes 103+ Hypoxia|Overall Study||11
7690204|NCT01871142|18937773|P1|Received Placebo + Hypoxia|Overall Study||12
7690205|NCT01871142|18937773|P1|Received Placebo + Normoixa|Overall Study||11
7690206|NCT01871142|18937773|P1|STARTED|Overall Study||12
7690207|NCT01871090|18937789|P2|NOT COMPLETED|Overall Study||23
7690208|NCT01871090|18937790|P1|NOT COMPLETED|Overall Study||2
7690209|NCT01871090|18937789|P2|COMPLETED|Overall Study||25
7690210|NCT01871090|18937790|P1|COMPLETED|Overall Study||33
7690211|NCT01871090|18937789|P2|STARTED|Overall Study||48
7690212|NCT01871090|18937790|P1|STARTED|Overall Study||35
7690213|NCT01871077|18937800|P1|NOT COMPLETED|Overall Study||0
7690214|NCT01871077|18937800|P1|COMPLETED|Overall Study||30
7690215|NCT01871077|18937800|P1|STARTED|Overall Study||30
7690216|NCT01870999|18937810|P3|NOT COMPLETED|Overall Study||7
7690217|NCT01870999|18937811|P2|NOT COMPLETED|Overall Study||8
7690218|NCT01870999|18937812|P1|NOT COMPLETED|Overall Study||4
7690219|NCT01870999|18937810|P3|COMPLETED|Overall Study||4
7690220|NCT01870999|18937811|P2|COMPLETED|Overall Study||8
7690221|NCT01870999|18937812|P1|COMPLETED|Overall Study||10
7690222|NCT01870999|18937810|P3|Safety Population; Received Study Drug|Overall Study||10
7690223|NCT01870999|18937811|P2|Safety Population; Received Study Drug|Overall Study||15
7690224|NCT01870999|18937812|P1|Safety Population; Received Study Drug|Overall Study||14
7690225|NCT01870999|18937810|P3|STARTED|Overall Study||11
7690226|NCT01870999|18937811|P2|STARTED|Overall Study||16
7690227|NCT01870999|18937812|P1|STARTED|Overall Study||14
7690228|NCT01870973|18937870|P2|NOT COMPLETED|Overall Study||3
7690229|NCT01870973|18937871|P1|NOT COMPLETED|Overall Study||10
7690230|NCT01870973|18937870|P2|COMPLETED|Overall Study||49
7690231|NCT01870973|18937871|P1|COMPLETED|Overall Study||46
7690232|NCT01870973|18937870|P2|STARTED|Overall Study||52
7690233|NCT01870973|18937871|P1|STARTED|Overall Study||56
7690234|NCT01870921|18937877|P1|NOT COMPLETED|Overall Study||90
7690235|NCT01870921|18937877|P1|COMPLETED|Overall Study||1914
7690236|NCT01870921|18937877|P1|STARTED|Overall Study||2004
7690237|NCT01870869|18937887|P4|NOT COMPLETED|Overall Study||30
7690238|NCT01870869|18937888|P3|NOT COMPLETED|Overall Study||130
7690239|NCT01870869|18937889|P2|NOT COMPLETED|Overall Study||14
7690240|NCT01870869|18937890|P1|NOT COMPLETED|Overall Study||28
7690241|NCT01870869|18937887|P4|COMPLETED|Overall Study||205
7690242|NCT01870869|18937888|P3|COMPLETED|Overall Study||1092
7690243|NCT01870869|18937889|P2|COMPLETED|Overall Study||192
7690244|NCT01870869|18937890|P1|COMPLETED|Overall Study||260
7690245|NCT01870869|18937887|P4|STARTED|Overall Study||235
7690246|NCT01870869|18937888|P3|STARTED|Overall Study||1222
7690247|NCT01870869|18937889|P2|STARTED|Overall Study||206
7690248|NCT01870869|18937890|P1|STARTED|Overall Study||288
7690249|NCT01870856|18937918|P2|NOT COMPLETED|Overall Study||0
7690250|NCT01870856|18937919|P1|NOT COMPLETED|Overall Study||0
7690251|NCT01870856|18937918|P2|COMPLETED|Overall Study||27
7690252|NCT01870856|18937919|P1|COMPLETED|Overall Study||25
7690253|NCT01870856|18937918|P2|STARTED|Overall Study||27
7690254|NCT01870856|18937919|P1|STARTED|Overall Study||25
7690255|NCT01870843|18937929|P1|NOT COMPLETED|Overall Study||53
7690256|NCT01870843|18937929|P1|COMPLETED|Overall Study||208
7690257|NCT01870843|18937929|P1|STARTED|Overall Study||261
7690258|NCT01870778|18937944|P2|NOT COMPLETED|Overall Study||9
7690259|NCT01870778|18937945|P1|NOT COMPLETED|Overall Study||8
7690260|NCT01870778|18937944|P2|COMPLETED|Overall Study||3262
7690261|NCT01870778|18937945|P1|COMPLETED|Overall Study||3266
7690262|NCT01870778|18937944|P2|Biomarker Analysis Set|Overall Study||510
7690263|NCT01870778|18937945|P1|Biomarker Analysis Set|Overall Study||521
7690264|NCT01870778|18937944|P2|Full Analysis Set|Overall Study||3271
7690265|NCT01870778|18937945|P1|Full Analysis Set|Overall Study||3274
7690266|NCT01870778|18937944|P2|Safety Set|Overall Study||3248
7690267|NCT01870778|18937945|P1|Safety Set|Overall Study||3257
7690268|NCT01870778|18937944|P2|STARTED|Overall Study||3271
7690269|NCT01870778|18937945|P1|STARTED|Overall Study||3274
7690270|NCT01870739|18937971|P2|NOT COMPLETED|Add-on Period (40 Weeks)||2
7690271|NCT01870739|18937972|P1|NOT COMPLETED|Add-on Period (40 Weeks)||3
7690272|NCT01870739|18937971|P2|COMPLETED|Add-on Period (40 Weeks)||51
7690273|NCT01870739|18937972|P1|COMPLETED|Add-on Period (40 Weeks)||51
7690274|NCT01870739|18937971|P2|STARTED|Add-on Period (40 Weeks)||53
7690275|NCT01870739|18937972|P1|STARTED|Add-on Period (40 Weeks)||54
7690276|NCT01870739|18937971|P2|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4
7690277|NCT01870739|18937972|P1|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3
7690278|NCT01870739|18937971|P2|COMPLETED|Single Drug Treatment (12 Weeks)||53
7690279|NCT01870739|18937972|P1|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54
7690280|NCT01870739|18937971|P2|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56
7690281|NCT01870739|18937972|P1|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57
7690282|NCT01870739|18937971|P2|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56
7690283|NCT01870739|18937972|P1|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57
7690284|NCT01870739|18937971|P2|STARTED|Single Drug Treatment (12 Weeks)||57
7690285|NCT01870739|18937972|P1|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57
7690286|NCT01870726|18938011|P7|NOT COMPLETED|Overall Study||10
7690287|NCT01870726|18938012|P6|NOT COMPLETED|Overall Study||5
7690288|NCT01870726|18938013|P5|NOT COMPLETED|Overall Study||7
7690289|NCT01870726|18938014|P4|NOT COMPLETED|Overall Study||6
7690290|NCT01870726|18938015|P3|NOT COMPLETED|Overall Study||4
7690291|NCT01870726|18938016|P2|NOT COMPLETED|Overall Study||6
7690292|NCT01870726|18938017|P1|NOT COMPLETED|Overall Study||5
7690293|NCT01870726|18938011|P7|COMPLETED|Overall Study||0
7690294|NCT01870726|18938012|P6|COMPLETED|Overall Study||0
7690295|NCT01870726|18938013|P5|COMPLETED|Overall Study||0
7690296|NCT01870726|18938014|P4|COMPLETED|Overall Study||0
7690297|NCT01870726|18938015|P3|COMPLETED|Overall Study||0
7690298|NCT01870726|18938016|P2|COMPLETED|Overall Study||0
7690299|NCT01870726|18938017|P1|COMPLETED|Overall Study||0
7690300|NCT01870726|18938011|P7|STARTED|Overall Study||10
7690301|NCT01870726|18938012|P6|STARTED|Overall Study||5
7690302|NCT01870726|18938013|P5|STARTED|Overall Study||7
7690303|NCT01870726|18938014|P4|STARTED|Overall Study||6
7690304|NCT01870726|18938015|P3|STARTED|Overall Study||4
7690305|NCT01870726|18938016|P2|STARTED|Overall Study||6
7690306|NCT01870726|18938017|P1|STARTED|Overall Study||5
7690307|NCT01870596|18938102|P2|NOT COMPLETED|Overall Study||0
7690308|NCT01870596|18938103|P1|NOT COMPLETED|Overall Study||0
7690309|NCT01870596|18938102|P2|COMPLETED|Overall Study||18
7690310|NCT01870596|18938103|P1|COMPLETED|Overall Study||14
7690311|NCT01870596|18938102|P2|STARTED|Overall Study||18
7690312|NCT01870596|18938103|P1|STARTED|Overall Study||14
7690313|NCT01870583|18938112|P3|NOT COMPLETED|Overall Study||8
7690314|NCT01870583|18938113|P2|NOT COMPLETED|Overall Study||18
7690315|NCT01870583|18938114|P1|NOT COMPLETED|Overall Study||11
7690316|NCT01870583|18938112|P3|COMPLETED|Overall Study||455
7690317|NCT01870583|18938113|P2|COMPLETED|Overall Study||456
7690318|NCT01870583|18938114|P1|COMPLETED|Overall Study||456
7690319|NCT01870583|18938112|P3|STARTED|Overall Study||463
7690320|NCT01870583|18938113|P2|STARTED|Overall Study||474
7690321|NCT01870583|18938114|P1|STARTED|Overall Study||467
7690322|NCT01870401|18938124|P2|NOT COMPLETED|Overall Study||96
7690323|NCT01870401|18938125|P1|NOT COMPLETED|Overall Study||150
7690324|NCT01870401|18938124|P2|COMPLETED|Overall Study||59
7690325|NCT01870401|18938125|P1|COMPLETED|Overall Study||137
7690326|NCT01870401|18938124|P2|STARTED|Overall Study||155
7690327|NCT01870401|18938125|P1|STARTED|Overall Study||287
7690328|NCT01870388|18938185|P2|NOT COMPLETED|Overall Study||0
7690329|NCT01870388|18938186|P1|NOT COMPLETED|Overall Study||0
7690330|NCT01870388|18938185|P2|COMPLETED|Overall Study||8
7690331|NCT01870388|18938186|P1|COMPLETED|Overall Study||8
7690332|NCT01870388|18938185|P2|Received 1 Dose of Study Drug|Overall Study||8
7690333|NCT01870388|18938186|P1|Received 1 Dose of Study Drug|Overall Study||8
7690334|NCT01870388|18938185|P2|STARTED|Overall Study||8
7690335|NCT01870388|18938186|P1|STARTED|Overall Study||8
7690336|NCT01870297|18938201|P7|NOT COMPLETED|Overall Study||2
7690337|NCT01870297|18938202|P6|NOT COMPLETED|Overall Study||1
7690338|NCT01870297|18938203|P5|NOT COMPLETED|Overall Study||3
7690339|NCT01870297|18938204|P4|NOT COMPLETED|Overall Study||0
7690340|NCT01870297|18938205|P3|NOT COMPLETED|Overall Study||1
7690341|NCT01870297|18938206|P2|NOT COMPLETED|Overall Study||7
7690342|NCT01870297|18938207|P1|NOT COMPLETED|Overall Study||0
7690343|NCT01870297|18938201|P7|COMPLETED|Overall Study||8
7690344|NCT01870297|18938202|P6|COMPLETED|Overall Study||8
7690345|NCT01870297|18938203|P5|COMPLETED|Overall Study||7
7690346|NCT01870297|18938204|P4|COMPLETED|Overall Study||9
7690347|NCT01870297|18938205|P3|COMPLETED|Overall Study||7
7690348|NCT01870297|18938206|P2|COMPLETED|Overall Study||8
7690349|NCT01870297|18938207|P1|COMPLETED|Overall Study||11
7690350|NCT01870297|18938201|P7|STARTED|Overall Study||10
7690351|NCT01870297|18938202|P6|STARTED|Overall Study||9
7690352|NCT01870297|18938203|P5|STARTED|Overall Study||10
7690353|NCT01870297|18938204|P4|STARTED|Overall Study||9
7690354|NCT01870297|18938205|P3|STARTED|Overall Study||8
7690355|NCT01870297|18938206|P2|STARTED|Overall Study||15
7690356|NCT01870297|18938207|P1|STARTED|Overall Study||11
7690357|NCT01870076|18938251|P4|NOT COMPLETED|Overall Study||0
7690358|NCT01870076|18938252|P3|NOT COMPLETED|Overall Study||1
7690359|NCT01870076|18938253|P2|NOT COMPLETED|Overall Study||0
7690360|NCT01870076|18938254|P1|NOT COMPLETED|Overall Study||1
7690361|NCT01870076|18938251|P4|COMPLETED|Overall Study||11
7690362|NCT01870076|18938252|P3|COMPLETED|Overall Study||7
7690363|NCT01870076|18938253|P2|COMPLETED|Overall Study||12
7690364|NCT01870076|18938254|P1|COMPLETED|Overall Study||9
7690365|NCT01870076|18938251|P4|STARTED|Overall Study||11
7690366|NCT01870076|18938252|P3|STARTED|Overall Study||8
7690367|NCT01870076|18938253|P2|STARTED|Overall Study||12
7690368|NCT01870076|18938254|P1|STARTED|Overall Study||10
7690369|NCT01869959|18938272|P5|NOT COMPLETED|Treatment Period||0
7690370|NCT01869959|18938273|P4|NOT COMPLETED|Treatment Period||2
7690371|NCT01869959|18938274|P3|NOT COMPLETED|Treatment Period||3
7690372|NCT01869959|18938275|P2|NOT COMPLETED|Treatment Period||2
7690373|NCT01869959|18938276|P1|NOT COMPLETED|Treatment Period||1
7690374|NCT01869959|18938272|P5|COMPLETED|Treatment Period||0
7690375|NCT01869959|18938273|P4|COMPLETED|Treatment Period||8
7690376|NCT01869959|18938274|P3|COMPLETED|Treatment Period||12
7690377|NCT01869959|18938275|P2|COMPLETED|Treatment Period||8
7690378|NCT01869959|18938276|P1|COMPLETED|Treatment Period||10
7690379|NCT01869959|18938272|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
7690380|NCT01869959|18938273|P4|Received at Least 1 Dose of Study Drug|Treatment Period||10
7690381|NCT01869959|18938274|P3|Received at Least 1 Dose of Study Drug|Treatment Period||15
7690382|NCT01869959|18938275|P2|Received at Least 1 Dose of Study Drug|Treatment Period||10
7690383|NCT01869959|18938276|P1|Received at Least 1 Dose of Study Drug|Treatment Period||11
7690384|NCT01869959|18938272|P5|STARTED|Treatment Period|Participants were randomized to treatment groups for the Treatment Period.|0
7690385|NCT01869959|18938273|P4|STARTED|Treatment Period||10
7690386|NCT01869959|18938274|P3|STARTED|Treatment Period||15
7690387|NCT01869959|18938275|P2|STARTED|Treatment Period||10
7690388|NCT01869959|18938276|P1|STARTED|Treatment Period||11
7690389|NCT01869959|18938272|P5|NOT COMPLETED|Randomization Period||1
7690390|NCT01869959|18938273|P4|NOT COMPLETED|Randomization Period||0
7690391|NCT01869959|18938274|P3|NOT COMPLETED|Randomization Period||0
7690392|NCT01869959|18938275|P2|NOT COMPLETED|Randomization Period||0
7690393|NCT01869959|18938276|P1|NOT COMPLETED|Randomization Period||0
7690394|NCT01869959|18938272|P5|COMPLETED|Randomization Period|One participant discontinued after randomization but did not receive study drug.|46
7690395|NCT01869959|18938273|P4|COMPLETED|Randomization Period||0
7690396|NCT01869959|18938274|P3|COMPLETED|Randomization Period||0
7690397|NCT01869959|18938275|P2|COMPLETED|Randomization Period||0
7690398|NCT01869959|18938276|P1|COMPLETED|Randomization Period||0
7690399|NCT01869959|18938272|P5|STARTED|Randomization Period||47
7690400|NCT01869959|18938273|P4|STARTED|Randomization Period||0
7690401|NCT01869959|18938274|P3|STARTED|Randomization Period||0
7690402|NCT01869959|18938275|P2|STARTED|Randomization Period||0
7690403|NCT01869959|18938276|P1|STARTED|Randomization Period||0
7690404|NCT01869777|18938344|P1|NOT COMPLETED|Overall Study||1
7690405|NCT01869777|18938344|P1|COMPLETED|Overall Study||101
7690406|NCT01869777|18938344|P1|STARTED|Overall Study||102
7690407|NCT01869764|18938357|P2|NOT COMPLETED|Overall Study||2
7690408|NCT01869764|18938358|P1|NOT COMPLETED|Overall Study||0
7690409|NCT01869764|18938357|P2|COMPLETED|Overall Study||27
7690410|NCT01869764|18938358|P1|COMPLETED|Overall Study||28
7690411|NCT01869764|18938357|P2|STARTED|Overall Study||29
7690412|NCT01869764|18938358|P1|STARTED|Overall Study||28
7690413|NCT01869699|18938376|P2|NOT COMPLETED|Overall Study||0
7690414|NCT01869699|18938377|P1|NOT COMPLETED|Overall Study||1
7690415|NCT01869699|18938376|P2|COMPLETED|Overall Study||20
7690416|NCT01869699|18938377|P1|COMPLETED|Overall Study||20
7690417|NCT01869699|18938376|P2|STARTED|Overall Study||20
7690418|NCT01869699|18938377|P1|STARTED|Overall Study||21
7690419|NCT01869686|18938395|P1|NOT COMPLETED|Overall Study||0
7690420|NCT01869686|18938395|P1|COMPLETED|Overall Study||12
7690421|NCT01869686|18938395|P1|STARTED|Overall Study||12
7690422|NCT01869647|18938410|P3|NOT COMPLETED|Overall Study||0
7690423|NCT01869647|18938411|P2|NOT COMPLETED|Overall Study||6
7690424|NCT01869647|18938412|P1|NOT COMPLETED|Overall Study||1
7690425|NCT01869647|18938410|P3|COMPLETED|Overall Study||62
7690426|NCT01869647|18938411|P2|COMPLETED|Overall Study||130
7690427|NCT01869647|18938412|P1|COMPLETED|Overall Study||65
7690428|NCT01869647|18938410|P3|STARTED|Overall Study||62
7690429|NCT01869647|18938411|P2|STARTED|Overall Study||136
7690430|NCT01869647|18938412|P1|STARTED|Overall Study||66
7690431|NCT01869634|18938425|P2|NOT COMPLETED|Overall Study||0
7690432|NCT01869634|18938426|P1|NOT COMPLETED|Overall Study||2
7690433|NCT01869634|18938425|P2|COMPLETED|Overall Study||17
7690434|NCT01869634|18938426|P1|COMPLETED|Overall Study||18
7690435|NCT01869634|18938425|P2|STARTED|Overall Study||17
7690436|NCT01869634|18938426|P1|STARTED|Overall Study||20
7690437|NCT01869478|18938438|P2|NOT COMPLETED|Overall Study||0
7690438|NCT01869478|18938439|P1|NOT COMPLETED|Overall Study||0
7690439|NCT01869478|18938438|P2|COMPLETED|Overall Study||1
7690440|NCT01869478|18938439|P1|COMPLETED|Overall Study||0
7690441|NCT01869478|18938438|P2|STARTED|Overall Study||1
7690442|NCT01869478|18938439|P1|STARTED|Overall Study||0
7690443|NCT01869439|18938447|P1|NOT COMPLETED|Overall Study||0
7690444|NCT01869439|18938447|P1|COMPLETED|Overall Study||40
7690445|NCT01869439|18938447|P1|STARTED|Overall Study||40
7690446|NCT01869374|18938453|P2|NOT COMPLETED|Overall Study||1
7690447|NCT01869374|18938454|P1|NOT COMPLETED|Overall Study||0
7690448|NCT01869374|18938453|P2|COMPLETED|Overall Study||8
7690449|NCT01869374|18938454|P1|COMPLETED|Overall Study||9
7690450|NCT01869374|18938453|P2|STARTED|Overall Study||9
7690451|NCT01869374|18938454|P1|STARTED|Overall Study||9
7690452|NCT01869348|18938462|P2|NOT COMPLETED|Overall Study||1
7690453|NCT01869348|18938463|P1|NOT COMPLETED|Overall Study||1
7690454|NCT01869348|18938462|P2|COMPLETED|Overall Study||19
7690455|NCT01869348|18938463|P1|COMPLETED|Overall Study||19
7690456|NCT01869348|18938462|P2|STARTED|Overall Study||20
7690457|NCT01869348|18938463|P1|STARTED|Overall Study||20
7690458|NCT01869192|18938471|P2|NOT COMPLETED|Postoperative Chemotherapy||2
7690459|NCT01869192|18938472|P1|NOT COMPLETED|Postoperative Chemotherapy||0
7690460|NCT01869192|18938471|P2|COMPLETED|Postoperative Chemotherapy||31
7690461|NCT01869192|18938472|P1|COMPLETED|Postoperative Chemotherapy||32
7690462|NCT01869192|18938471|P2|STARTED|Postoperative Chemotherapy||33
7690463|NCT01869192|18938472|P1|STARTED|Postoperative Chemotherapy|3 did not start postop chemotherapy|32
7690464|NCT01869192|18938471|P2|NOT COMPLETED|Preoperative Chemotherapy to Surgery||1
7690465|NCT01869192|18938472|P1|NOT COMPLETED|Preoperative Chemotherapy to Surgery||2
7690466|NCT01869192|18938471|P2|COMPLETED|Preoperative Chemotherapy to Surgery|one never got treatment on study|34
7690467|NCT01869192|18938472|P1|COMPLETED|Preoperative Chemotherapy to Surgery||35
7690468|NCT01869192|18938471|P2|STARTED|Preoperative Chemotherapy to Surgery||35
7690469|NCT01869192|18938472|P1|STARTED|Preoperative Chemotherapy to Surgery||37
7690470|NCT01869075|18938486|P6|NOT COMPLETED|Phase 2||0
7690471|NCT01869075|18938487|P5|NOT COMPLETED|Phase 2||0
7690472|NCT01869075|18938488|P4|NOT COMPLETED|Phase 2||0
7690473|NCT01869075|18938489|P3|NOT COMPLETED|Phase 2||0
7690474|NCT01869075|18938490|P2|NOT COMPLETED|Phase 2||0
7690475|NCT01869075|18938491|P1|NOT COMPLETED|Phase 2||0
7690476|NCT01869075|18938486|P6|COMPLETED|Phase 2||45
7690477|NCT01869075|18938487|P5|COMPLETED|Phase 2||75
7690478|NCT01869075|18938488|P4|COMPLETED|Phase 2||45
7690479|NCT01869075|18938489|P3|COMPLETED|Phase 2||75
7690480|NCT01869075|18938490|P2|COMPLETED|Phase 2||30
7690481|NCT01869075|18938491|P1|COMPLETED|Phase 2||90
7690482|NCT01869075|18938486|P6|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
7690483|NCT01869075|18938487|P5|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
7690484|NCT01869075|18938488|P4|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
7690485|NCT01869075|18938489|P3|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
7690486|NCT01869075|18938490|P2|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30
7690487|NCT01869075|18938491|P1|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90
7690488|NCT01869075|18938486|P6|NOT COMPLETED|Phase 1||0
7690489|NCT01869075|18938487|P5|NOT COMPLETED|Phase 1||0
7690490|NCT01869075|18938488|P4|NOT COMPLETED|Phase 1||0
7690491|NCT01869075|18938489|P3|NOT COMPLETED|Phase 1||0
7690492|NCT01869075|18938490|P2|NOT COMPLETED|Phase 1||0
7690493|NCT01869075|18938491|P1|NOT COMPLETED|Phase 1||0
7690494|NCT01869075|18938486|P6|COMPLETED|Phase 1||90
7690495|NCT01869075|18938487|P5|COMPLETED|Phase 1||30
7690496|NCT01869075|18938488|P4|COMPLETED|Phase 1||75
7690497|NCT01869075|18938489|P3|COMPLETED|Phase 1||45
7690498|NCT01869075|18938490|P2|COMPLETED|Phase 1||75
7690499|NCT01869075|18938491|P1|COMPLETED|Phase 1||45
7690500|NCT01869075|18938486|P6|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90
7690501|NCT01869075|18938487|P5|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30
7690502|NCT01869075|18938488|P4|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
7690503|NCT01869075|18938489|P3|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
7690504|NCT01869075|18938490|P2|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
7690505|NCT01869075|18938491|P1|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
7690506|NCT01869075|18938486|P6|NOT COMPLETED|Phase 0 (Baseline)||0
7690507|NCT01869075|18938487|P5|NOT COMPLETED|Phase 0 (Baseline)||0
7690508|NCT01869075|18938488|P4|NOT COMPLETED|Phase 0 (Baseline)||0
7690509|NCT01869075|18938489|P3|NOT COMPLETED|Phase 0 (Baseline)||0
7690510|NCT01869075|18938490|P2|NOT COMPLETED|Phase 0 (Baseline)||0
7690511|NCT01869075|18938491|P1|NOT COMPLETED|Phase 0 (Baseline)||0
7690512|NCT01869075|18938486|P6|COMPLETED|Phase 0 (Baseline)||341
7690513|NCT01869075|18938487|P5|COMPLETED|Phase 0 (Baseline)||0
7690514|NCT01869075|18938488|P4|COMPLETED|Phase 0 (Baseline)||416
7690515|NCT01869075|18938489|P3|COMPLETED|Phase 0 (Baseline)||0
7690516|NCT01869075|18938490|P2|COMPLETED|Phase 0 (Baseline)||418
7690517|NCT01869075|18938491|P1|COMPLETED|Phase 0 (Baseline)||0
7690518|NCT01869075|18938486|P6|STARTED|Phase 0 (Baseline)||341
7690519|NCT01869075|18938487|P5|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
7690520|NCT01869075|18938488|P4|STARTED|Phase 0 (Baseline)||416
7690521|NCT01869075|18938489|P3|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
7690522|NCT01869075|18938490|P2|STARTED|Phase 0 (Baseline)||418
7690523|NCT01869075|18938491|P1|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
7690524|NCT01868997|18938507|P2|NOT COMPLETED|Overall Study||6
7690525|NCT01868997|18938508|P1|NOT COMPLETED|Overall Study||7
7690526|NCT01868997|18938507|P2|COMPLETED|Overall Study||36
7690527|NCT01868997|18938508|P1|COMPLETED|Overall Study||38
7690528|NCT01868997|18938507|P2|STARTED|Overall Study|randomized and treated|42
7690529|NCT01868997|18938508|P1|STARTED|Overall Study|randomized and treated|45
7690530|NCT01868893|18938524|P1|NOT COMPLETED|Overall Study||20
7690531|NCT01868893|18938524|P1|COMPLETED|Overall Study||0
7690532|NCT01868893|18938524|P1|STARTED|Overall Study||20
7690533|NCT01868789|18938533|P2|NOT COMPLETED|Overall Study||2
7690534|NCT01868789|18938534|P1|NOT COMPLETED|Overall Study||2
7690535|NCT01868789|18938533|P2|COMPLETED|Overall Study||12
7690536|NCT01868789|18938534|P1|COMPLETED|Overall Study||7
7690537|NCT01868789|18938533|P2|STARTED|Overall Study||14
7690538|NCT01868789|18938534|P1|STARTED|Overall Study||9
7690539|NCT01868776|18938544|P2|NOT COMPLETED|Overall Study||0
7690540|NCT01868776|18938545|P1|NOT COMPLETED|Overall Study||0
7690541|NCT01868776|18938544|P2|COMPLETED|Overall Study||50
7690542|NCT01868776|18938545|P1|COMPLETED|Overall Study||50
7690543|NCT01868776|18938544|P2|STARTED|Overall Study||50
7690544|NCT01868776|18938545|P1|STARTED|Overall Study||50
7690545|NCT01868646|18938555|P2|NOT COMPLETED|Overall Study||5
7690546|NCT01868646|18938556|P1|NOT COMPLETED|Overall Study||3
7690547|NCT01868646|18938555|P2|COMPLETED|Overall Study||67
7690548|NCT01868646|18938556|P1|COMPLETED|Overall Study||73
7690549|NCT01868646|18938555|P2|STARTED|Overall Study||72
7690550|NCT01868646|18938556|P1|STARTED|Overall Study||76
7690551|NCT01868633|18938584|P2|NOT COMPLETED|Overall Study||0
7690552|NCT01868633|18938585|P1|NOT COMPLETED|Overall Study||0
7690553|NCT01868633|18938584|P2|COMPLETED|Overall Study||26
7690554|NCT01868633|18938585|P1|COMPLETED|Overall Study||26
7690555|NCT01868633|18938584|P2|STARTED|Overall Study||26
7690556|NCT01868633|18938585|P1|STARTED|Overall Study||26
7690557|NCT01868594|18938601|P2|NOT COMPLETED|Overall Study||3
7690558|NCT01868594|18938602|P1|NOT COMPLETED|Overall Study||4
7690559|NCT01868594|18938601|P2|COMPLETED|Overall Study||72
7690560|NCT01868594|18938602|P1|COMPLETED|Overall Study||72
7690561|NCT01868594|18938601|P2|STARTED|Overall Study||75
7690562|NCT01868594|18938602|P1|STARTED|Overall Study||76
7690563|NCT01868542|18938622|P2|NOT COMPLETED|Overall Study||2
7690564|NCT01868542|18938623|P1|NOT COMPLETED|Overall Study||0
7690565|NCT01868542|18938622|P2|COMPLETED|Overall Study||21
7690566|NCT01868542|18938623|P1|COMPLETED|Overall Study||23
7690567|NCT01868542|18938622|P2|STARTED|Overall Study||23
7690568|NCT01868542|18938623|P1|STARTED|Overall Study||23
7690569|NCT01868503|18938641|P1|NOT COMPLETED|Overall Study||2
7690570|NCT01868503|18938641|P1|COMPLETED|Overall Study||5
7690571|NCT01868503|18938641|P1|STARTED|Overall Study||7
7690572|NCT01868477|18938651|P2|NOT COMPLETED|Overall Study||5
7690573|NCT01868477|18938652|P1|NOT COMPLETED|Overall Study||4
7690574|NCT01868477|18938651|P2|COMPLETED|Overall Study||6
7690575|NCT01868477|18938652|P1|COMPLETED|Overall Study||8
7690576|NCT01868477|18938651|P2|Not Switched to EPO+DFX|Overall Study||0
7690577|NCT01868477|18938652|P1|Not Switched to EPO+DFX|Overall Study||7
7690578|NCT01868477|18938651|P2|Switched to EPO+DFX|Overall Study||0
7690579|NCT01868477|18938652|P1|Switched to EPO+DFX|Overall Study||5
7690580|NCT01868477|18938651|P2|STARTED|Overall Study||11
7690581|NCT01868477|18938652|P1|STARTED|Overall Study||12
7690582|NCT01868425|18938678|P2|NOT COMPLETED|Overall Study||0
7690583|NCT01868425|18938679|P1|NOT COMPLETED|Overall Study||0
7690584|NCT01868425|18938678|P2|COMPLETED|Overall Study||57
7690585|NCT01868425|18938679|P1|COMPLETED|Overall Study||55
7690586|NCT01868425|18938678|P2|STARTED|Overall Study||57
7690587|NCT01868425|18938679|P1|STARTED|Overall Study||55
7690588|NCT01868334|18938713|P4|NOT COMPLETED|Year 2 Pre-post Study||0
7690589|NCT01868334|18938714|P3|NOT COMPLETED|Year 2 Pre-post Study||0
7690590|NCT01868334|18938715|P2|NOT COMPLETED|Year 2 Pre-post Study||0
7690591|NCT01868334|18938716|P1|NOT COMPLETED|Year 2 Pre-post Study||0
7690592|NCT01868334|18938713|P4|COMPLETED|Year 2 Pre-post Study||19274
7690593|NCT01868334|18938714|P3|COMPLETED|Year 2 Pre-post Study||20904
7690594|NCT01868334|18938715|P2|COMPLETED|Year 2 Pre-post Study||8047
7690595|NCT01868334|18938716|P1|COMPLETED|Year 2 Pre-post Study||22324
7690596|NCT01868334|18938713|P4|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Intervention sites who chose not to actively engage Year 2|19274
7690597|NCT01868334|18938714|P3|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Control sites who became active in the intervention during Year 2|20904
7690598|NCT01868334|18938715|P2|STARTED|Year 2 Pre-post Study|Reflects: the six Year 1 Intervention sites who chose not to actively engage Year 2|8047
7690599|NCT01868334|18938716|P1|STARTED|Year 2 Pre-post Study|Reflects: control sites from Year 1 (N=8) and Year 1 Intervention sites who continued in Y2 (N=4)|22324
7690600|NCT01868334|18938713|P4|NOT COMPLETED|Year 1 RCCT Study||0
7690601|NCT01868334|18938714|P3|NOT COMPLETED|Year 1 RCCT Study||0
7690602|NCT01868334|18938715|P2|NOT COMPLETED|Year 1 RCCT Study||0
7690603|NCT01868334|18938716|P1|NOT COMPLETED|Year 1 RCCT Study||0
7690604|NCT01868334|18938713|P4|COMPLETED|Year 1 RCCT Study||20904
7690605|NCT01868334|18938714|P3|COMPLETED|Year 1 RCCT Study||19274
7690606|NCT01868334|18938715|P2|COMPLETED|Year 1 RCCT Study||17185
7690607|NCT01868334|18938716|P1|COMPLETED|Year 1 RCCT Study||13186
7690608|NCT01868334|18938713|P4|STARTED|Year 1 RCCT Study||20904
7690609|NCT01868334|18938714|P3|STARTED|Year 1 RCCT Study||19274
7690610|NCT01868334|18938715|P2|STARTED|Year 1 RCCT Study||17185
7690611|NCT01868334|18938716|P1|STARTED|Year 1 RCCT Study||13186
7690612|NCT01868243|18938756|P2|NOT COMPLETED|Overall Study||1
7690613|NCT01868243|18938757|P1|NOT COMPLETED|Overall Study||0
7690614|NCT01868243|18938756|P2|COMPLETED|Overall Study||11
7690615|NCT01868243|18938757|P1|COMPLETED|Overall Study||15
7690616|NCT01868243|18938756|P2|STARTED|Overall Study||12
7690617|NCT01868243|18938757|P1|STARTED|Overall Study||15
7690618|NCT01868165|18938765|P1|NOT COMPLETED|Overall Study||45
7690619|NCT01868165|18938765|P1|COMPLETED|Overall Study||292
7690620|NCT01868165|18938765|P1|STARTED|Overall Study||337
7690621|NCT01868139|18938769|P1|NOT COMPLETED|Overall Study||1
7690622|NCT01868139|18938769|P1|COMPLETED|Overall Study||0
7690623|NCT01868139|18938769|P1|STARTED|Overall Study||1
7690624|NCT01868074|18938781|P2|NOT COMPLETED|Overall Study||4
7690625|NCT01868074|18938782|P1|NOT COMPLETED|Overall Study||7
7690626|NCT01868074|18938781|P2|COMPLETED|Overall Study||32
7690627|NCT01868074|18938782|P1|COMPLETED|Overall Study||29
7690628|NCT01868074|18938781|P2|STARTED|Overall Study||36
7690629|NCT01868074|18938782|P1|STARTED|Overall Study||36
7690630|NCT01868035|18938792|P1|NOT COMPLETED|Overall Study||7
7690631|NCT01868035|18938792|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8
7690632|NCT01868035|18938792|P1|STARTED|Overall Study||15
7690633|NCT01868022|18938817|P9|NOT COMPLETED|Overall Study||2
7690634|NCT01868022|18938818|P8|NOT COMPLETED|Overall Study||9
7690635|NCT01868022|18938819|P7|NOT COMPLETED|Overall Study||0
7690636|NCT01868022|18938820|P6|NOT COMPLETED|Overall Study||1
7690637|NCT01868022|18938821|P5|NOT COMPLETED|Overall Study||2
7690638|NCT01868022|18938822|P4|NOT COMPLETED|Overall Study||1
7690639|NCT01868022|18938823|P3|NOT COMPLETED|Overall Study||1
7690640|NCT01868022|18938824|P2|NOT COMPLETED|Overall Study||0
7690641|NCT01868022|18938825|P1|NOT COMPLETED|Overall Study||0
7690642|NCT01868022|18938817|P9|COMPLETED|Overall Study||6
7690643|NCT01868022|18938818|P8|COMPLETED|Overall Study||16
7690644|NCT01868022|18938819|P7|COMPLETED|Overall Study||3
7690645|NCT01868022|18938820|P6|COMPLETED|Overall Study||2
7690646|NCT01868022|18938821|P5|COMPLETED|Overall Study||1
7690647|NCT01868022|18938822|P4|COMPLETED|Overall Study||2
7690648|NCT01868022|18938823|P3|COMPLETED|Overall Study||13
7690649|NCT01868022|18938824|P2|COMPLETED|Overall Study||3
7690650|NCT01868022|18938825|P1|COMPLETED|Overall Study||3
7690651|NCT01868022|18938817|P9|STARTED|Overall Study||8
7690652|NCT01868022|18938818|P8|STARTED|Overall Study||25
7690653|NCT01868022|18938819|P7|STARTED|Overall Study||3
7690654|NCT01868022|18938820|P6|STARTED|Overall Study||3
7690655|NCT01868022|18938821|P5|STARTED|Overall Study||3
7690656|NCT01868022|18938822|P4|STARTED|Overall Study||3
7690657|NCT01868022|18938823|P3|STARTED|Overall Study||14
7690658|NCT01868022|18938824|P2|STARTED|Overall Study||3
7690659|NCT01868022|18938825|P1|STARTED|Overall Study||3
7690660|NCT01868009|18939031|P2|NOT COMPLETED|Period 2 (5-9 Days)||0
7690661|NCT01868009|18939032|P1|NOT COMPLETED|Period 2 (5-9 Days)||2
7690662|NCT01868009|18939031|P2|COMPLETED|Period 2 (5-9 Days)||142
7690663|NCT01868009|18939032|P1|COMPLETED|Period 2 (5-9 Days)||141
7690664|NCT01868009|18939031|P2|STARTED|Period 2 (5-9 Days)||142
7690665|NCT01868009|18939032|P1|STARTED|Period 2 (5-9 Days)||143
7690666|NCT01868009|18939031|P2|NOT COMPLETED|Period 1 (5-9 Days)||2
7690667|NCT01868009|18939032|P1|NOT COMPLETED|Period 1 (5-9 Days)||0
7690668|NCT01868009|18939031|P2|COMPLETED|Period 1 (5-9 Days)||142
7690669|NCT01868009|18939032|P1|COMPLETED|Period 1 (5-9 Days)||143
7690670|NCT01868009|18939031|P2|STARTED|Period 1 (5-9 Days)||144
7690671|NCT01868009|18939032|P1|STARTED|Period 1 (5-9 Days)||143
7690672|NCT01867710|18939046|P4|NOT COMPLETED|Overall Study||42
7690673|NCT01867710|18939047|P3|NOT COMPLETED|Overall Study||40
7690674|NCT01867710|18939048|P2|NOT COMPLETED|Overall Study||41
7690675|NCT01867710|18939049|P1|NOT COMPLETED|Overall Study||41
7690676|NCT01867710|18939046|P4|COMPLETED|Overall Study||0
7690677|NCT01867710|18939047|P3|COMPLETED|Overall Study||0
7690678|NCT01867710|18939048|P2|COMPLETED|Overall Study||0
7690679|NCT01867710|18939049|P1|COMPLETED|Overall Study||0
7690680|NCT01867710|18939046|P4|Treated|Overall Study||42
7690681|NCT01867710|18939047|P3|Treated|Overall Study||39
7690682|NCT01867710|18939048|P2|Treated|Overall Study||41
7690683|NCT01867710|18939049|P1|Treated|Overall Study||41
7690684|NCT01867710|18939046|P4|STARTED|Overall Study||42
7690685|NCT01867710|18939047|P3|STARTED|Overall Study||40
7690686|NCT01867710|18939048|P2|STARTED|Overall Study||41
7690687|NCT01867710|18939049|P1|STARTED|Overall Study||41
7690688|NCT01867671|18939117|P2|NOT COMPLETED|Overall Study||28
7690689|NCT01867671|18939118|P1|NOT COMPLETED|Overall Study||29
7690690|NCT01867671|18939117|P2|COMPLETED|Overall Study||22
7690691|NCT01867671|18939118|P1|COMPLETED|Overall Study||67
7690692|NCT01867671|18939117|P2|STARTED|Overall Study||50
7690693|NCT01867671|18939118|P1|STARTED|Overall Study||96
7690694|NCT01867658|18939131|P1|NOT COMPLETED|Overall Study||9
7690695|NCT01867658|18939131|P1|COMPLETED|Overall Study||103
7690696|NCT01867658|18939131|P1|STARTED|Overall Study||112
7690697|NCT01867632|18939144|P2|NOT COMPLETED|Overall Study||0
7690698|NCT01867632|18939145|P1|NOT COMPLETED|Overall Study||0
7690699|NCT01867632|18939144|P2|COMPLETED|Overall Study||66
7690700|NCT01867632|18939145|P1|COMPLETED|Overall Study||65
7690701|NCT01867632|18939144|P2|STARTED|Overall Study||66
7690702|NCT01867632|18939145|P1|STARTED|Overall Study||65
7690703|NCT01867606|18939155|P2|NOT COMPLETED|Overall Study||15
7690704|NCT01867606|18939156|P1|NOT COMPLETED|Overall Study||10
7690705|NCT01867606|18939155|P2|COMPLETED|Overall Study||17
7690706|NCT01867606|18939156|P1|COMPLETED|Overall Study||16
7690707|NCT01867606|18939155|P2|STARTED|Overall Study||32
7690708|NCT01867606|18939156|P1|STARTED|Overall Study||26
7690709|NCT01867580|18939174|P2|NOT COMPLETED|Overall Study||24
7690710|NCT01867580|18939175|P1|NOT COMPLETED|Overall Study||28
7690711|NCT01867580|18939174|P2|COMPLETED|Overall Study||64
7690712|NCT01867580|18939175|P1|COMPLETED|Overall Study||65
7690713|NCT01867580|18939174|P2|STARTED|Overall Study||88
7690714|NCT01867580|18939175|P1|STARTED|Overall Study||93
7690715|NCT01867515|18939188|P3|NOT COMPLETED|Overall Study||11
7690716|NCT01867515|18939189|P2|NOT COMPLETED|Overall Study||1
7690717|NCT01867515|18939190|P1|NOT COMPLETED|Overall Study||0
7690718|NCT01867515|18939188|P3|COMPLETED|Overall Study||14
7690719|NCT01867515|18939189|P2|COMPLETED|Overall Study||11
7690720|NCT01867515|18939190|P1|COMPLETED|Overall Study||13
7690721|NCT01867515|18939188|P3|STARTED|Overall Study||25
7690722|NCT01867515|18939189|P2|STARTED|Overall Study||12
7690723|NCT01867515|18939190|P1|STARTED|Overall Study||13
7690724|NCT01867424|18939200|P2|NOT COMPLETED|Overall Study||1
7690725|NCT01867424|18939201|P1|NOT COMPLETED|Overall Study||2
7690726|NCT01867424|18939200|P2|COMPLETED|Overall Study||11
7690727|NCT01867424|18939201|P1|COMPLETED|Overall Study||10
7690728|NCT01867424|18939200|P2|STARTED|Overall Study||12
7690729|NCT01867424|18939201|P1|STARTED|Overall Study||12
7690730|NCT01867307|18939215|P2|NOT COMPLETED|Overall Study||3
7690731|NCT01867307|18939216|P1|NOT COMPLETED|Overall Study||3
7690732|NCT01867307|18939215|P2|COMPLETED|Overall Study||16
7690733|NCT01867307|18939216|P1|COMPLETED|Overall Study||15
7690734|NCT01867307|18939215|P2|STARTED|Overall Study|Started are the treated patients|19
7690735|NCT01867307|18939216|P1|STARTED|Overall Study|Started are the treated patients|18
7690736|NCT01867294|18939226|P4|NOT COMPLETED|Overall Study||0
7690737|NCT01867294|18939227|P3|NOT COMPLETED|Overall Study||0
7690738|NCT01867294|18939228|P2|NOT COMPLETED|Overall Study||1
7690739|NCT01867294|18939229|P1|NOT COMPLETED|Overall Study||1
7690740|NCT01867294|18939226|P4|COMPLETED|Overall Study||0
7690741|NCT01867294|18939227|P3|COMPLETED|Overall Study||0
7690742|NCT01867294|18939228|P2|COMPLETED|Overall Study||9
7690743|NCT01867294|18939229|P1|COMPLETED|Overall Study||8
7690744|NCT01867294|18939226|P4|STARTED|Overall Study||0
7690745|NCT01867294|18939227|P3|STARTED|Overall Study||0
7690746|NCT01867294|18939228|P2|STARTED|Overall Study||10
7690747|NCT01867294|18939229|P1|STARTED|Overall Study||9
7690748|NCT01867216|18939276|P7|NOT COMPLETED|Overall Study||1
7690749|NCT01867216|18939277|P6|NOT COMPLETED|Overall Study||0
7690750|NCT01867216|18939278|P5|NOT COMPLETED|Overall Study||1
7690751|NCT01867216|18939279|P4|NOT COMPLETED|Overall Study||0
7690752|NCT01867216|18939280|P3|NOT COMPLETED|Overall Study||0
7690753|NCT01867216|18939281|P2|NOT COMPLETED|Overall Study||0
7690754|NCT01867216|18939282|P1|NOT COMPLETED|Overall Study||4
7690755|NCT01867216|18939276|P7|COMPLETED|Overall Study||8
7690756|NCT01867216|18939277|P6|COMPLETED|Overall Study||8
7690757|NCT01867216|18939278|P5|COMPLETED|Overall Study||8
7690758|NCT01867216|18939279|P4|COMPLETED|Overall Study||8
7690759|NCT01867216|18939280|P3|COMPLETED|Overall Study||8
7690760|NCT01867216|18939281|P2|COMPLETED|Overall Study||8
7690761|NCT01867216|18939282|P1|COMPLETED|Overall Study||12
7690762|NCT01867216|18939276|P7|Received Study Drug|Overall Study||9
7690763|NCT01867216|18939277|P6|Received Study Drug|Overall Study||8
7690764|NCT01867216|18939278|P5|Received Study Drug|Overall Study||9
7690765|NCT01867216|18939279|P4|Received Study Drug|Overall Study||8
7690766|NCT01867216|18939280|P3|Received Study Drug|Overall Study||8
7690767|NCT01867216|18939281|P2|Received Study Drug|Overall Study||8
7690768|NCT01867216|18939282|P1|Received Study Drug|Overall Study||14
7690769|NCT01867216|18939276|P7|STARTED|Overall Study||9
7690770|NCT01867216|18939277|P6|STARTED|Overall Study||8
7690771|NCT01867216|18939278|P5|STARTED|Overall Study||9
7690772|NCT01867216|18939279|P4|STARTED|Overall Study||8
7690773|NCT01867216|18939280|P3|STARTED|Overall Study||8
7690774|NCT01867216|18939281|P2|STARTED|Overall Study||8
7690775|NCT01867216|18939282|P1|STARTED|Overall Study||16
7690776|NCT01867164|18939339|P2|NOT COMPLETED|Overall Study||0
7690777|NCT01867164|18939340|P1|NOT COMPLETED|Overall Study||0
7690778|NCT01867164|18939339|P2|COMPLETED|Overall Study||79
7690779|NCT01867164|18939340|P1|COMPLETED|Overall Study||81
7690780|NCT01867164|18939339|P2|STARTED|Overall Study||79
7690781|NCT01867164|18939340|P1|STARTED|Overall Study||81
7690782|NCT01867086|18939354|P1|NOT COMPLETED|Overall Study||1
7690783|NCT01867086|18939354|P1|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses."|0
7690784|NCT01867086|18939354|P1|STARTED|Overall Study||1
7690785|NCT01867047|18939363|P2|NOT COMPLETED|Overall Study||5
7690786|NCT01867047|18939364|P1|NOT COMPLETED|Overall Study||8
7690787|NCT01867047|18939363|P2|COMPLETED|Overall Study||23
7690788|NCT01867047|18939364|P1|COMPLETED|Overall Study||23
7690789|NCT01867047|18939363|P2|STARTED|Overall Study||28
7690790|NCT01867047|18939364|P1|STARTED|Overall Study||31
7690791|NCT01867021|18939384|P2|NOT COMPLETED|Overall Study||10
7690792|NCT01867021|18939385|P1|NOT COMPLETED|Overall Study||2
7690793|NCT01867021|18939384|P2|COMPLETED|Overall Study||1440
7690794|NCT01867021|18939385|P1|COMPLETED|Overall Study||1450
7690795|NCT01867021|18939384|P2|STARTED|Overall Study||1450
7690796|NCT01867021|18939385|P1|STARTED|Overall Study||1452
7690797|NCT01866943|18939404|P2|NOT COMPLETED|Overall Study||22
7690798|NCT01866943|18939405|P1|NOT COMPLETED|Overall Study||19
7690799|NCT01866943|18939404|P2|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
7690800|NCT01866943|18939405|P1|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
7690801|NCT01866943|18939404|P2|STARTED|Overall Study||22
7690802|NCT01866943|18939405|P1|STARTED|Overall Study||19
7690803|NCT01866917|18939416|P2|NOT COMPLETED|Overall Study||6
7690804|NCT01866917|18939417|P1|NOT COMPLETED|Overall Study||4
7690805|NCT01866917|18939416|P2|COMPLETED|Overall Study||12
7690806|NCT01866917|18939417|P1|COMPLETED|Overall Study||13
7690807|NCT01866917|18939416|P2|STARTED|Overall Study||18
7690808|NCT01866917|18939417|P1|STARTED|Overall Study||17
7690809|NCT01866839|18939425|P1|NOT COMPLETED|Overall Study||10
7690810|NCT01866839|18939425|P1|COMPLETED|Overall Study||30
7690811|NCT01866839|18939425|P1|STARTED|Overall Study||40
7690812|NCT01866826|18939441|P2|NOT COMPLETED|Second Intervention - 4 Weeks||0
7690813|NCT01866826|18939442|P1|NOT COMPLETED|Second Intervention - 4 Weeks||0
7690814|NCT01866826|18939441|P2|COMPLETED|Second Intervention - 4 Weeks||20
7690815|NCT01866826|18939442|P1|COMPLETED|Second Intervention - 4 Weeks||22
7690816|NCT01866826|18939441|P2|STARTED|Second Intervention - 4 Weeks||20
7690817|NCT01866826|18939442|P1|STARTED|Second Intervention - 4 Weeks||22
7690818|NCT01866826|18939441|P2|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||3
7690819|NCT01866826|18939442|P1|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||0
7690820|NCT01866826|18939441|P2|COMPLETED|Wash-Out Period - 4 -6 Weeks||20
7690821|NCT01866826|18939442|P1|COMPLETED|Wash-Out Period - 4 -6 Weeks||22
7690822|NCT01866826|18939441|P2|STARTED|Wash-Out Period - 4 -6 Weeks||23
7690823|NCT01866826|18939442|P1|STARTED|Wash-Out Period - 4 -6 Weeks||22
7690824|NCT01866826|18939441|P2|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||0
7690825|NCT01866826|18939442|P1|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||1
7690826|NCT01866826|18939441|P2|COMPLETED|Phase I -Initial Randomization - 4 Weeks||23
7690827|NCT01866826|18939442|P1|COMPLETED|Phase I -Initial Randomization - 4 Weeks||22
7690828|NCT01866826|18939441|P2|STARTED|Phase I -Initial Randomization - 4 Weeks||23
7690829|NCT01866826|18939442|P1|STARTED|Phase I -Initial Randomization - 4 Weeks||23
7690830|NCT01866709|18939458|P2|NOT COMPLETED|Overall Study||0
7690831|NCT01866709|18939459|P1|NOT COMPLETED|Overall Study||1
7690832|NCT01866709|18939458|P2|COMPLETED|Overall Study||17
7690833|NCT01866709|18939459|P1|COMPLETED|Overall Study||14
7690834|NCT01866709|18939458|P2|STARTED|Overall Study||17
7690835|NCT01866709|18939459|P1|STARTED|Overall Study||15
7690836|NCT01866592|18939467|P1|NOT COMPLETED|Overall Study||23
7690837|NCT01866592|18939467|P1|COMPLETED|Overall Study||58
7690838|NCT01866592|18939467|P1|STARTED|Overall Study||81
7690839|NCT01866423|18939500|P1|NOT COMPLETED|Overall Study||4
7690840|NCT01866423|18939500|P1|COMPLETED|Overall Study||0
7690841|NCT01866423|18939500|P1|STARTED|Overall Study||4
7690842|NCT01866410|18939510|P1|NOT COMPLETED|Overall Study||0
7690843|NCT01866410|18939510|P1|COMPLETED|Overall Study||37
7690844|NCT01866410|18939510|P1|STARTED|Overall Study||37
7690845|NCT01866319|18939528|P3|NOT COMPLETED|Overall Study||180
7690846|NCT01866319|18939529|P2|NOT COMPLETED|Overall Study||178
7690847|NCT01866319|18939530|P1|NOT COMPLETED|Overall Study||207
7690848|NCT01866319|18939528|P3|COMPLETED|Overall Study||97
7690849|NCT01866319|18939529|P2|COMPLETED|Overall Study||101
7690850|NCT01866319|18939530|P1|COMPLETED|Overall Study||71
7690851|NCT01866319|18939528|P3|Treated|Overall Study||277
7690852|NCT01866319|18939529|P2|Treated|Overall Study||278
7690853|NCT01866319|18939530|P1|Treated|Overall Study||256
7690854|NCT01866319|18939528|P3|STARTED|Overall Study||277
7690855|NCT01866319|18939529|P2|STARTED|Overall Study||279
7690856|NCT01866319|18939530|P1|STARTED|Overall Study||278
7690857|NCT01866306|18939551|P7|NOT COMPLETED|Overall Study||0
7690858|NCT01866306|18939552|P6|NOT COMPLETED|Overall Study||0
7690859|NCT01866306|18939553|P5|NOT COMPLETED|Overall Study||0
7690860|NCT01866306|18939554|P4|NOT COMPLETED|Overall Study||0
7690861|NCT01866306|18939555|P3|NOT COMPLETED|Overall Study||0
7690862|NCT01866306|18939556|P2|NOT COMPLETED|Overall Study||0
7690863|NCT01866306|18939557|P1|NOT COMPLETED|Overall Study||0
7690864|NCT01866306|18939551|P7|COMPLETED|Overall Study||23
7690865|NCT01866306|18939552|P6|COMPLETED|Overall Study||6
7690866|NCT01866306|18939553|P5|COMPLETED|Overall Study||6
7690867|NCT01866306|18939554|P4|COMPLETED|Overall Study||6
7690868|NCT01866306|18939555|P3|COMPLETED|Overall Study||6
7690869|NCT01866306|18939556|P2|COMPLETED|Overall Study||6
7690870|NCT01866306|18939557|P1|COMPLETED|Overall Study||6
7690871|NCT01866306|18939551|P7|STARTED|Overall Study||23
7690872|NCT01866306|18939552|P6|STARTED|Overall Study||6
7690873|NCT01866306|18939553|P5|STARTED|Overall Study||6
7690874|NCT01866306|18939554|P4|STARTED|Overall Study||6
7690875|NCT01866306|18939555|P3|STARTED|Overall Study||6
7690876|NCT01866306|18939556|P2|STARTED|Overall Study||6
7690877|NCT01866306|18939557|P1|STARTED|Overall Study||6
7690878|NCT01866293|18939629|P1|NOT COMPLETED|Overall Study||2
7690879|NCT01866293|18939629|P1|COMPLETED|Overall Study||9
7690880|NCT01866293|18939629|P1|STARTED|Overall Study||11
7690881|NCT01866163|18939639|P2|NOT COMPLETED|Overall Study||4
7690882|NCT01866163|18939640|P1|NOT COMPLETED|Overall Study||10
7690883|NCT01866163|18939639|P2|COMPLETED|Overall Study||99
7690884|NCT01866163|18939640|P1|COMPLETED|Overall Study||313
7690885|NCT01866163|18939639|P2|STARTED|Overall Study||103
7690886|NCT01866163|18939640|P1|STARTED|Overall Study||323
7690887|NCT01866150|18939650|P1|NOT COMPLETED|Overall Study||0
7690888|NCT01866150|18939650|P1|COMPLETED|Overall Study||450
7690889|NCT01866150|18939650|P1|STARTED|Overall Study||450
7690890|NCT01866098|18939674|P3|NOT COMPLETED|Overall Study||21
7690891|NCT01866098|18939675|P2|NOT COMPLETED|Overall Study||27
7690892|NCT01866098|18939676|P1|NOT COMPLETED|Overall Study||19
7690893|NCT01866098|18939674|P3|COMPLETED|Overall Study||25
7690894|NCT01866098|18939675|P2|COMPLETED|Overall Study||20
7690895|NCT01866098|18939676|P1|COMPLETED|Overall Study||32
7690896|NCT01866098|18939674|P3|STARTED|Overall Study||46
7690897|NCT01866098|18939675|P2|STARTED|Overall Study||47
7690898|NCT01866098|18939676|P1|STARTED|Overall Study||51
7690899|NCT01865812|18939705|P1|NOT COMPLETED|Overall Study||2
7690900|NCT01865812|18939705|P1|COMPLETED|Overall Study||24
7690901|NCT01865812|18939705|P1|STARTED|Overall Study||26
7690902|NCT01865747|18939713|P2|NOT COMPLETED|Primary Intent to Treat (PITT)||152
7690903|NCT01865747|18939714|P1|NOT COMPLETED|Primary Intent to Treat (PITT)||131
7690904|NCT01865747|18939713|P2|COMPLETED|Primary Intent to Treat (PITT)||36
7690905|NCT01865747|18939714|P1|COMPLETED|Primary Intent to Treat (PITT)||56
7690906|NCT01865747|18939713|P2|STARTED|Primary Intent to Treat (PITT)|Three subjects in the everolimus arm were randomized but not treated.|188
7690907|NCT01865747|18939714|P1|STARTED|Primary Intent to Treat (PITT)||187
7690908|NCT01865747|18939713|P2|NOT COMPLETED|Overall Study (ITT)||255
7690909|NCT01865747|18939714|P1|NOT COMPLETED|Overall Study (ITT)||198
7690910|NCT01865747|18939713|P2|COMPLETED|Overall Study (ITT)|Five subjects were randomized but not treated|73
7690911|NCT01865747|18939714|P1|COMPLETED|Overall Study (ITT)|One subject randomized to everolimus arm received cabozantinib discontd due to clin. deterioration|132
7690912|NCT01865747|18939713|P2|STARTED|Overall Study (ITT)||328
7690913|NCT01865747|18939714|P1|STARTED|Overall Study (ITT)||330
7690914|NCT01865708|18939724|P1|NOT COMPLETED|Overall Study||0
7690915|NCT01865708|18939724|P1|COMPLETED|Overall Study||10
7690916|NCT01865708|18939724|P1|STARTED|Overall Study||10
7690917|NCT01865552|18939735|P6|NOT COMPLETED|Period 2||0
7690918|NCT01865552|18939736|P5|NOT COMPLETED|Period 2||0
7690919|NCT01865552|18939737|P4|NOT COMPLETED|Period 2||0
7690920|NCT01865552|18939738|P3|NOT COMPLETED|Period 2||0
7690921|NCT01865552|18939739|P2|NOT COMPLETED|Period 2||0
7690922|NCT01865552|18939740|P1|NOT COMPLETED|Period 2||0
7690923|NCT01865552|18939735|P6|COMPLETED|Period 2||22
7690924|NCT01865552|18939736|P5|COMPLETED|Period 2||20
7690925|NCT01865552|18939737|P4|COMPLETED|Period 2||22
7690926|NCT01865552|18939738|P3|COMPLETED|Period 2||23
7690927|NCT01865552|18939739|P2|COMPLETED|Period 2||23
7690928|NCT01865552|18939740|P1|COMPLETED|Period 2||22
7690929|NCT01865552|18939735|P6|STARTED|Period 2||22
7690930|NCT01865552|18939736|P5|STARTED|Period 2||20
7690931|NCT01865552|18939737|P4|STARTED|Period 2||22
7690932|NCT01865552|18939738|P3|STARTED|Period 2||23
7690933|NCT01865552|18939739|P2|STARTED|Period 2||23
7690934|NCT01865552|18939740|P1|STARTED|Period 2||22
7690935|NCT01865552|18939735|P6|NOT COMPLETED|Period 1||1
7690936|NCT01865552|18939736|P5|NOT COMPLETED|Period 1||3
7690937|NCT01865552|18939737|P4|NOT COMPLETED|Period 1||1
7690938|NCT01865552|18939738|P3|NOT COMPLETED|Period 1||0
7690939|NCT01865552|18939739|P2|NOT COMPLETED|Period 1||0
7690940|NCT01865552|18939740|P1|NOT COMPLETED|Period 1||1
7690941|NCT01865552|18939735|P6|COMPLETED|Period 1||22
7690942|NCT01865552|18939736|P5|COMPLETED|Period 1||20
7690943|NCT01865552|18939737|P4|COMPLETED|Period 1||22
7690944|NCT01865552|18939738|P3|COMPLETED|Period 1||23
7690945|NCT01865552|18939739|P2|COMPLETED|Period 1||23
7690946|NCT01865552|18939740|P1|COMPLETED|Period 1||22
7690947|NCT01865552|18939735|P6|Discontinued From Period 1|Period 1||1
7690948|NCT01865552|18939736|P5|Discontinued From Period 1|Period 1||3
7690949|NCT01865552|18939737|P4|Discontinued From Period 1|Period 1||1
7690950|NCT01865552|18939738|P3|Discontinued From Period 1|Period 1||0
7690951|NCT01865552|18939739|P2|Discontinued From Period 1|Period 1||0
7690952|NCT01865552|18939740|P1|Discontinued From Period 1|Period 1||1
7690953|NCT01865552|18939735|P6|STARTED|Period 1||23
7690954|NCT01865552|18939736|P5|STARTED|Period 1||23
7690955|NCT01865552|18939737|P4|STARTED|Period 1||23
7690956|NCT01865552|18939738|P3|STARTED|Period 1||23
7690957|NCT01865552|18939739|P2|STARTED|Period 1||23
7690958|NCT01865552|18939740|P1|STARTED|Period 1||23
7690959|NCT01865487|18939778|P10|NOT COMPLETED|Overall Study||0
7690960|NCT01865487|18939779|P9|NOT COMPLETED|Overall Study||0
7690961|NCT01865487|18939780|P8|NOT COMPLETED|Overall Study||0
7690962|NCT01865487|18939781|P7|NOT COMPLETED|Overall Study||1
7690963|NCT01865487|18939782|P6|NOT COMPLETED|Overall Study||0
7690964|NCT01865487|18939783|P5|NOT COMPLETED|Overall Study||1
7690965|NCT01865487|18939784|P4|NOT COMPLETED|Overall Study||1
7690966|NCT01865487|18939785|P3|NOT COMPLETED|Overall Study||0
7690967|NCT01865487|18939786|P2|NOT COMPLETED|Overall Study||0
7690968|NCT01865487|18939787|P1|NOT COMPLETED|Overall Study||0
7690969|NCT01865487|18939778|P10|COMPLETED|Overall Study||4
7690970|NCT01865487|18939779|P9|COMPLETED|Overall Study||12
7690971|NCT01865487|18939780|P8|COMPLETED|Overall Study||4
7690972|NCT01865487|18939781|P7|COMPLETED|Overall Study||11
7690973|NCT01865487|18939782|P6|COMPLETED|Overall Study||4
7690974|NCT01865487|18939783|P5|COMPLETED|Overall Study||11
7690975|NCT01865487|18939784|P4|COMPLETED|Overall Study||4
7690976|NCT01865487|18939785|P3|COMPLETED|Overall Study||15
7690977|NCT01865487|18939786|P2|COMPLETED|Overall Study||15
7690978|NCT01865487|18939787|P1|COMPLETED|Overall Study||15
7690979|NCT01865487|18939778|P10|STARTED|Overall Study||4
7690980|NCT01865487|18939779|P9|STARTED|Overall Study||12
7690981|NCT01865487|18939780|P8|STARTED|Overall Study||4
7690982|NCT01865487|18939781|P7|STARTED|Overall Study||12
7690983|NCT01865487|18939782|P6|STARTED|Overall Study||4
7690984|NCT01865487|18939783|P5|STARTED|Overall Study||12
7690985|NCT01865487|18939784|P4|STARTED|Overall Study||5
7690986|NCT01865487|18939785|P3|STARTED|Overall Study||15
7690987|NCT01865487|18939786|P2|STARTED|Overall Study||15
7690988|NCT01865487|18939787|P1|STARTED|Overall Study||15
7690989|NCT01865448|18939826|P2|NOT COMPLETED|Overall Study||3
7690990|NCT01865448|18939827|P1|NOT COMPLETED|Overall Study||2
7690991|NCT01865448|18939826|P2|COMPLETED|Overall Study||14
7690992|NCT01865448|18939827|P1|COMPLETED|Overall Study||15
7690993|NCT01865448|18939826|P2|STARTED|Overall Study||17
7690994|NCT01865448|18939827|P1|STARTED|Overall Study||17
7690995|NCT01865084|18939938|P3|NOT COMPLETED|Open Label Extension (OLE) Period||7
7690996|NCT01865084|18939939|P2|NOT COMPLETED|Open Label Extension (OLE) Period||11
7690997|NCT01865084|18939940|P1|NOT COMPLETED|Open Label Extension (OLE) Period||0
7690998|NCT01865084|18939938|P3|COMPLETED|Open Label Extension (OLE) Period||158
7690999|NCT01865084|18939939|P2|COMPLETED|Open Label Extension (OLE) Period||139
7691000|NCT01865084|18939940|P1|COMPLETED|Open Label Extension (OLE) Period||0
7691001|NCT01865084|18939938|P3|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|165
7691002|NCT01865084|18939939|P2|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|150
7691003|NCT01865084|18939940|P1|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|0
7691004|NCT01865084|18939938|P3|NOT COMPLETED|Double Blind Period (DB)||6
7691005|NCT01865084|18939939|P2|NOT COMPLETED|Double Blind Period (DB)||4
7691006|NCT01865084|18939940|P1|NOT COMPLETED|Double Blind Period (DB)||5
7691007|NCT01865084|18939938|P3|COMPLETED|Double Blind Period (DB)||107
7691008|NCT01865084|18939939|P2|COMPLETED|Double Blind Period (DB)|One participant stopped therapy during the DB period but remained in the study for follow-up.|98
7691009|NCT01865084|18939940|P1|COMPLETED|Double Blind Period (DB)||111
7691010|NCT01865084|18939938|P3|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112
7691011|NCT01865084|18939939|P2|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102
7691012|NCT01865084|18939940|P1|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116
7691013|NCT01865084|18939938|P3|STARTED|Double Blind Period (DB)||113
7691014|NCT01865084|18939939|P2|STARTED|Double Blind Period (DB)||102
7691015|NCT01865084|18939940|P1|STARTED|Double Blind Period (DB)||116
7691016|NCT01864564|18939968|P2|NOT COMPLETED|Overall Study||95
7691017|NCT01864564|18939969|P1|NOT COMPLETED|Overall Study||37
7691018|NCT01864564|18939968|P2|COMPLETED|Overall Study||387
7691019|NCT01864564|18939969|P1|COMPLETED|Overall Study||443
7691020|NCT01864564|18939968|P2|STARTED|Overall Study||482
7691021|NCT01864564|18939969|P1|STARTED|Overall Study||480
7691022|NCT01864538|18939995|P1|NOT COMPLETED|Overall Study||11
7691023|NCT01864538|18939995|P1|COMPLETED|Overall Study||0
7691024|NCT01864538|18939995|P1|STARTED|Overall Study||11
7691025|NCT01864525|18940001|P2|NOT COMPLETED|Overall Study||0
7691026|NCT01864525|18940002|P1|NOT COMPLETED|Overall Study||1
7691027|NCT01864525|18940001|P2|COMPLETED|Overall Study||7
7691028|NCT01864525|18940002|P1|COMPLETED|Overall Study||9
7691029|NCT01864525|18940001|P2|STARTED|Overall Study||7
7691030|NCT01864525|18940002|P1|STARTED|Overall Study||10
7691031|NCT01864434|18940012|P2|NOT COMPLETED|Overall Study||0
7691032|NCT01864434|18940013|P1|NOT COMPLETED|Overall Study||0
7691033|NCT01864434|18940012|P2|COMPLETED|Overall Study||25
7691034|NCT01864434|18940013|P1|COMPLETED|Overall Study||25
7691035|NCT01864434|18940012|P2|STARTED|Overall Study||25
7691036|NCT01864434|18940013|P1|STARTED|Overall Study||25
7691037|NCT01864291|18940023|P1|NOT COMPLETED|Overall Study||2
7691038|NCT01864291|18940023|P1|COMPLETED|Overall Study|7/9 subjects had a minimum of one year followup since enrollment.|7
7691039|NCT01864291|18940023|P1|STARTED|Overall Study||9
7691040|NCT01864200|18940031|P2|NOT COMPLETED|Overall Study||3
7691041|NCT01864200|18940032|P1|NOT COMPLETED|Overall Study||2
7691042|NCT01864200|18940031|P2|COMPLETED|Overall Study||26
7691043|NCT01864200|18940032|P1|COMPLETED|Overall Study||43
7691044|NCT01864200|18940031|P2|STARTED|Overall Study||29
7691045|NCT01864200|18940032|P1|STARTED|Overall Study||45
7691046|NCT01864174|18940040|P2|NOT COMPLETED|Off Treatment Follow-Up||0
7691047|NCT01864174|18940041|P1|NOT COMPLETED|Off Treatment Follow-Up||3
7691048|NCT01864174|18940040|P2|COMPLETED|Off Treatment Follow-Up||1
7691049|NCT01864174|18940041|P1|COMPLETED|Off Treatment Follow-Up||6
7691050|NCT01864174|18940040|P2|STARTED|Off Treatment Follow-Up||1
7691051|NCT01864174|18940041|P1|STARTED|Off Treatment Follow-Up||9
7691052|NCT01864174|18940040|P2|NOT COMPLETED|Double Blind - Compliant Randomized||26
7691053|NCT01864174|18940041|P1|NOT COMPLETED|Double Blind - Compliant Randomized||23
7691054|NCT01864174|18940040|P2|COMPLETED|Double Blind - Compliant Randomized||245
7691055|NCT01864174|18940041|P1|COMPLETED|Double Blind - Compliant Randomized||245
7691056|NCT01864174|18940040|P2|STARTED|Double Blind - Compliant Randomized||271
7691057|NCT01864174|18940041|P1|STARTED|Double Blind - Compliant Randomized||268
7691058|NCT01864174|18940040|P2|NOT COMPLETED|Double Blind Treatment - All Treated||14
7691059|NCT01864174|18940041|P1|NOT COMPLETED|Double Blind Treatment - All Treated||15
7691060|NCT01864174|18940040|P2|COMPLETED|Double Blind Treatment - All Treated||271
7691061|NCT01864174|18940041|P1|COMPLETED|Double Blind Treatment - All Treated||268
7691062|NCT01864174|18940040|P2|STARTED|Double Blind Treatment - All Treated||285
7691063|NCT01864174|18940041|P1|STARTED|Double Blind Treatment - All Treated||283
7691064|NCT01864148|18940060|P5|NOT COMPLETED|Overall Study||23
7691065|NCT01864148|18940061|P4|NOT COMPLETED|Overall Study||26
7691066|NCT01864148|18940062|P3|NOT COMPLETED|Overall Study||11
7691067|NCT01864148|18940063|P2|NOT COMPLETED|Overall Study||5
7691068|NCT01864148|18940064|P1|NOT COMPLETED|Overall Study||20
7691069|NCT01864148|18940060|P5|COMPLETED|Overall Study||69
7691070|NCT01864148|18940061|P4|COMPLETED|Overall Study||68
7691071|NCT01864148|18940062|P3|COMPLETED|Overall Study||84
7691072|NCT01864148|18940063|P2|COMPLETED|Overall Study||40
7691073|NCT01864148|18940064|P1|COMPLETED|Overall Study||73
7691074|NCT01864148|18940060|P5|Randomized and Dosed|Overall Study||92
7691075|NCT01864148|18940061|P4|Randomized and Dosed|Overall Study||93
7691076|NCT01864148|18940062|P3|Randomized and Dosed|Overall Study||95
7691077|NCT01864148|18940063|P2|Randomized and Dosed|Overall Study||45
7691078|NCT01864148|18940064|P1|Randomized and Dosed|Overall Study||93
7691079|NCT01864148|18940060|P5|STARTED|Overall Study||92
7691080|NCT01864148|18940061|P4|STARTED|Overall Study||94
7691081|NCT01864148|18940062|P3|STARTED|Overall Study||95
7691082|NCT01864148|18940063|P2|STARTED|Overall Study||45
7691083|NCT01864148|18940064|P1|STARTED|Overall Study||93
7691084|NCT01864005|18940093|P2|NOT COMPLETED|Overall Study||6
7691085|NCT01864005|18940094|P1|NOT COMPLETED|Overall Study||3
7691086|NCT01864005|18940093|P2|COMPLETED|Overall Study||25
7691087|NCT01864005|18940094|P1|COMPLETED|Overall Study||26
7691088|NCT01864005|18940093|P2|STARTED|Overall Study||31
7691089|NCT01864005|18940094|P1|STARTED|Overall Study||29
7691090|NCT01863953|18940111|P3|NOT COMPLETED|Overall Study||1
7691091|NCT01863953|18940112|P2|NOT COMPLETED|Overall Study||0
7691092|NCT01863953|18940113|P1|NOT COMPLETED|Overall Study||0
7691093|NCT01863953|18940111|P3|COMPLETED|Overall Study||37
7691094|NCT01863953|18940112|P2|COMPLETED|Overall Study||36
7691095|NCT01863953|18940113|P1|COMPLETED|Overall Study||38
7691096|NCT01863953|18940111|P3|STARTED|Overall Study||38
7691097|NCT01863953|18940112|P2|STARTED|Overall Study||36
7691098|NCT01863953|18940113|P1|STARTED|Overall Study||38
7691099|NCT01863771|18940127|P4|NOT COMPLETED|Maintenance Phase||43
7691100|NCT01863771|18940128|P3|NOT COMPLETED|Maintenance Phase||12
7691101|NCT01863771|18940129|P2|NOT COMPLETED|Maintenance Phase||5
7691102|NCT01863771|18940130|P1|NOT COMPLETED|Maintenance Phase||0
7691103|NCT01863771|18940127|P4|COMPLETED|Maintenance Phase||17
7691104|NCT01863771|18940128|P3|COMPLETED|Maintenance Phase||19
7691105|NCT01863771|18940129|P2|COMPLETED|Maintenance Phase||27
7691106|NCT01863771|18940130|P1|COMPLETED|Maintenance Phase||0
7691107|NCT01863771|18940127|P4|STARTED|Maintenance Phase||60
7691108|NCT01863771|18940128|P3|STARTED|Maintenance Phase||31
7691109|NCT01863771|18940129|P2|STARTED|Maintenance Phase||32
7691110|NCT01863771|18940130|P1|STARTED|Maintenance Phase||0
7691111|NCT01863771|18940127|P4|NOT COMPLETED|Induction Phase||0
7691112|NCT01863771|18940128|P3|NOT COMPLETED|Induction Phase||0
7691113|NCT01863771|18940129|P2|NOT COMPLETED|Induction Phase||0
7691114|NCT01863771|18940130|P1|NOT COMPLETED|Induction Phase||21
7691115|NCT01863771|18940127|P4|COMPLETED|Induction Phase||0
7691116|NCT01863771|18940128|P3|COMPLETED|Induction Phase||0
7691117|NCT01863771|18940129|P2|COMPLETED|Induction Phase||0
7691118|NCT01863771|18940130|P1|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123
7691119|NCT01863771|18940127|P4|STARTED|Induction Phase||0
7691120|NCT01863771|18940128|P3|STARTED|Induction Phase||0
7691121|NCT01863771|18940129|P2|STARTED|Induction Phase||0
7691122|NCT01863771|18940130|P1|STARTED|Induction Phase||144
7691123|NCT01863758|18940142|P1|NOT COMPLETED|Prophylactic Treatment-Phase II||2
7691124|NCT01863758|18940142|P1|COMPLETED|Prophylactic Treatment-Phase II||64
7691125|NCT01863758|18940142|P1|STARTED|Prophylactic Treatment-Phase II||66
7691126|NCT01863758|18940142|P1|NOT COMPLETED|Prophylactic Treatment-Phase I||0
7691127|NCT01863758|18940142|P1|COMPLETED|Prophylactic Treatment-Phase I||66
7691128|NCT01863758|18940142|P1|STARTED|Prophylactic Treatment-Phase I||66
7691129|NCT01863758|18940142|P1|NOT COMPLETED|Pharmacokinetic Assessment||0
7691130|NCT01863758|18940142|P1|COMPLETED|Pharmacokinetic Assessment||66
7691131|NCT01863758|18940142|P1|STARTED|Pharmacokinetic Assessment||66
7691132|NCT01863732|18940154|P4|NOT COMPLETED|Overall Study||8
7691133|NCT01863732|18940155|P3|NOT COMPLETED|Overall Study||11
7691134|NCT01863732|18940156|P2|NOT COMPLETED|Overall Study||12
7691135|NCT01863732|18940157|P1|NOT COMPLETED|Overall Study||13
7691136|NCT01863732|18940154|P4|COMPLETED|Overall Study||33
7691137|NCT01863732|18940155|P3|COMPLETED|Overall Study||35
7691138|NCT01863732|18940156|P2|COMPLETED|Overall Study||75
7691139|NCT01863732|18940157|P1|COMPLETED|Overall Study||87
7691140|NCT01863732|18940154|P4|STARTED|Overall Study||41
7691141|NCT01863732|18940155|P3|STARTED|Overall Study||46
7691142|NCT01863732|18940156|P2|STARTED|Overall Study||87
7691143|NCT01863732|18940157|P1|STARTED|Overall Study||100
7691144|NCT01863680|18940170|P1|NOT COMPLETED|Overall Study||57
7691145|NCT01863680|18940170|P1|COMPLETED|Overall Study||121
7691146|NCT01863680|18940170|P1|Subjects Who Have Undergone IVF/ET|Overall Study||123
7691147|NCT01863680|18940170|P1|Subjects Received Study Drug|Overall Study||149
7691148|NCT01863680|18940170|P1|Subjects Received hCG Injection|Overall Study||162
7691149|NCT01863680|18940170|P1|Subjects Started COS Treatment|Overall Study||169
7691150|NCT01863680|18940170|P1|STARTED|Overall Study||178
7691151|NCT01863667|18940178|P2|NOT COMPLETED|Overall Study||32
7691152|NCT01863667|18940179|P1|NOT COMPLETED|Overall Study||33
7691153|NCT01863667|18940178|P2|COMPLETED|Overall Study||0
7691154|NCT01863667|18940179|P1|COMPLETED|Overall Study||0
7691155|NCT01863667|18940178|P2|STARTED|Overall Study||32
7691156|NCT01863667|18940179|P1|STARTED|Overall Study||33
7691157|NCT01863563|18940199|P1|NOT COMPLETED|Overall Study||0
7691158|NCT01863563|18940199|P1|COMPLETED|Overall Study||100
7691159|NCT01863563|18940199|P1|STARTED|Overall Study||100
7691160|NCT01863498|18940205|P2|NOT COMPLETED|Overall Study||0
7691161|NCT01863498|18940206|P1|NOT COMPLETED|Overall Study||0
7691162|NCT01863498|18940205|P2|COMPLETED|Overall Study||32
7691163|NCT01863498|18940206|P1|COMPLETED|Overall Study||33
7691164|NCT01863498|18940205|P2|STARTED|Overall Study||32
7691165|NCT01863498|18940206|P1|STARTED|Overall Study||33
7691166|NCT01863433|18940216|P1|NOT COMPLETED|Overall Study||1
7691167|NCT01863433|18940216|P1|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119
7691168|NCT01863433|18940216|P1|STARTED|Overall Study||120
7691169|NCT01863368|18940226|P2|NOT COMPLETED|Phase II, Day 35 to Day 90||0
7691170|NCT01863368|18940227|P1|NOT COMPLETED|Phase II, Day 35 to Day 90||2
7691171|NCT01863368|18940226|P2|COMPLETED|Phase II, Day 35 to Day 90||41
7691172|NCT01863368|18940227|P1|COMPLETED|Phase II, Day 35 to Day 90||41
7691173|NCT01863368|18940226|P2|STARTED|Phase II, Day 35 to Day 90||41
7691174|NCT01863368|18940227|P1|STARTED|Phase II, Day 35 to Day 90||43
7691175|NCT01863368|18940226|P2|NOT COMPLETED|Phase I, Day 0 to Day 35||7
7691176|NCT01863368|18940227|P1|NOT COMPLETED|Phase I, Day 0 to Day 35||3
7691177|NCT01863368|18940226|P2|COMPLETED|Phase I, Day 0 to Day 35||41
7691178|NCT01863368|18940227|P1|COMPLETED|Phase I, Day 0 to Day 35||43
7691179|NCT01863368|18940226|P2|Treated|Phase I, Day 0 to Day 35||47
7691180|NCT01863368|18940227|P1|Treated|Phase I, Day 0 to Day 35||46
7691181|NCT01863368|18940226|P2|STARTED|Phase I, Day 0 to Day 35||48
7691182|NCT01863368|18940227|P1|STARTED|Phase I, Day 0 to Day 35||46
7691183|NCT01863134|18940242|P2|NOT COMPLETED|Overall Study||0
7691184|NCT01863134|18940243|P1|NOT COMPLETED|Overall Study||0
7691185|NCT01863134|18940242|P2|COMPLETED|Overall Study||68
7691186|NCT01863134|18940243|P1|COMPLETED|Overall Study||72
7691187|NCT01863134|18940242|P2|STARTED|Overall Study||68
7691188|NCT01863134|18940243|P1|STARTED|Overall Study||72
7691189|NCT01863030|18940249|P1|NOT COMPLETED|Follow up||18
7691190|NCT01863030|18940249|P1|COMPLETED|Follow up||13
7691191|NCT01863030|18940249|P1|24 Months|Follow up||13
7691192|NCT01863030|18940249|P1|12 Months|Follow up||26
7691193|NCT01863030|18940249|P1|6 Months|Follow up||29
7691194|NCT01863030|18940249|P1|3 Months|Follow up||28
7691195|NCT01863030|18940249|P1|2 Weeks|Follow up||31
7691196|NCT01863030|18940249|P1|STARTED|Follow up||31
7691197|NCT01863030|18940249|P1|NOT COMPLETED|Baseline||0
7691198|NCT01863030|18940249|P1|COMPLETED|Baseline||31
7691199|NCT01863030|18940249|P1|STARTED|Baseline||31
7691200|NCT01863017|18940267|P2|NOT COMPLETED|Overall Study||0
7691201|NCT01863017|18940268|P1|NOT COMPLETED|Overall Study||0
7691202|NCT01863017|18940267|P2|COMPLETED|Overall Study||19
7691203|NCT01863017|18940268|P1|COMPLETED|Overall Study||12
7691204|NCT01863017|18940267|P2|Participants With PWS|Overall Study||7
7691205|NCT01863017|18940268|P1|Participants With PWS|Overall Study||3
7691206|NCT01863017|18940267|P2|Obese Participants|Overall Study||7
7691207|NCT01863017|18940268|P1|Obese Participants|Overall Study||4
7691208|NCT01863017|18940267|P2|Normal Weight Participants|Overall Study||5
7691209|NCT01863017|18940268|P1|Normal Weight Participants|Overall Study||5
7691210|NCT01863017|18940267|P2|STARTED|Overall Study||19
7691211|NCT01863017|18940268|P1|STARTED|Overall Study||12
7691212|NCT01862991|18940281|P3|NOT COMPLETED|Overall Study||1
7691213|NCT01862991|18940282|P2|NOT COMPLETED|Overall Study||1
7691214|NCT01862991|18940283|P1|NOT COMPLETED|Overall Study||3
7691215|NCT01862991|18940281|P3|COMPLETED|Overall Study||27
7691216|NCT01862991|18940282|P2|COMPLETED|Overall Study||27
7691217|NCT01862991|18940283|P1|COMPLETED|Overall Study||21
7691218|NCT01862991|18940281|P3|STARTED|Overall Study||28
7691219|NCT01862991|18940282|P2|STARTED|Overall Study||28
7691220|NCT01862991|18940283|P1|STARTED|Overall Study||24
7691221|NCT01862874|18940296|P2|NOT COMPLETED|Overall Study||77
7691222|NCT01862874|18940297|P1|NOT COMPLETED|Overall Study||79
7691223|NCT01862874|18940296|P2|COMPLETED|Overall Study||485
7691224|NCT01862874|18940297|P1|COMPLETED|Overall Study||483
7691225|NCT01862874|18940296|P2|Vaccination 3|Overall Study||532
7691226|NCT01862874|18940297|P1|Vaccination 3|Overall Study||530
7691227|NCT01862874|18940296|P2|Vaccination 2|Overall Study||542
7691228|NCT01862874|18940297|P1|Vaccination 2|Overall Study||539
7691229|NCT01862874|18940296|P2|Vaccination 1|Overall Study||562
7691230|NCT01862874|18940297|P1|Vaccination 1|Overall Study||561
7691231|NCT01862874|18940296|P2|STARTED|Overall Study|Randomized participants|562
7691232|NCT01862874|18940297|P1|STARTED|Overall Study|Randomized participants|562
7691233|NCT01862796|18940316|P3|NOT COMPLETED|Overall Study||1
7691234|NCT01862796|18940317|P2|NOT COMPLETED|Overall Study||0
7691235|NCT01862796|18940318|P1|NOT COMPLETED|Overall Study||0
7691236|NCT01862796|18940316|P3|COMPLETED|Overall Study||23
7691237|NCT01862796|18940317|P2|COMPLETED|Overall Study||18
7691238|NCT01862796|18940318|P1|COMPLETED|Overall Study||19
7691239|NCT01862796|18940316|P3|STARTED|Overall Study||24
7691240|NCT01862796|18940317|P2|STARTED|Overall Study||18
7691241|NCT01862796|18940318|P1|STARTED|Overall Study||19
7691242|NCT01862640|18940333|P4|NOT COMPLETED|Overall Study||15
7691243|NCT01862640|18940334|P3|NOT COMPLETED|Overall Study||18
7691244|NCT01862640|18940335|P2|NOT COMPLETED|Overall Study||16
7691245|NCT01862640|18940336|P1|NOT COMPLETED|Overall Study||7
7691246|NCT01862640|18940333|P4|COMPLETED|Overall Study||121
7691247|NCT01862640|18940334|P3|COMPLETED|Overall Study||122
7691248|NCT01862640|18940335|P2|COMPLETED|Overall Study||121
7691249|NCT01862640|18940336|P1|COMPLETED|Overall Study||13
7691250|NCT01862640|18940333|P4|STARTED|Overall Study||136
7691251|NCT01862640|18940334|P3|STARTED|Overall Study||140
7691252|NCT01862640|18940335|P2|STARTED|Overall Study||137
7691253|NCT01862640|18940336|P1|STARTED|Overall Study||20
7691254|NCT01862614|18940348|P2|NOT COMPLETED|Second Appointment.||0
7691255|NCT01862614|18940349|P1|NOT COMPLETED|Second Appointment.||0
7691256|NCT01862614|18940348|P2|COMPLETED|Second Appointment.||40
7691257|NCT01862614|18940349|P1|COMPLETED|Second Appointment.||40
7691258|NCT01862614|18940348|P2|STARTED|Second Appointment.|Received articaine at second appointment.|40
7691259|NCT01862614|18940349|P1|STARTED|Second Appointment.|Received buffered articaine at second appointment.|40
7691260|NCT01862614|18940348|P2|NOT COMPLETED|2 Week Washout Period.||0
7691261|NCT01862614|18940349|P1|NOT COMPLETED|2 Week Washout Period.||0
7691262|NCT01862614|18940348|P2|COMPLETED|2 Week Washout Period.||40
7691263|NCT01862614|18940349|P1|COMPLETED|2 Week Washout Period.||40
7691264|NCT01862614|18940348|P2|STARTED|2 Week Washout Period.||40
7691265|NCT01862614|18940349|P1|STARTED|2 Week Washout Period.||40
7691266|NCT01862614|18940348|P2|NOT COMPLETED|First Appointment.||0
7691267|NCT01862614|18940349|P1|NOT COMPLETED|First Appointment.||0
7691268|NCT01862614|18940348|P2|COMPLETED|First Appointment.||40
7691269|NCT01862614|18940349|P1|COMPLETED|First Appointment.||40
7691270|NCT01862614|18940348|P2|STARTED|First Appointment.|Received buffered articaine at first appointment.|40
7691271|NCT01862614|18940349|P1|STARTED|First Appointment.|Received articaine injection at first appointment.|40
7691272|NCT01862484|18940357|P2|NOT COMPLETED|Overall Study||8
7691273|NCT01862484|18940358|P1|NOT COMPLETED|Overall Study||2
7691274|NCT01862484|18940357|P2|COMPLETED|Overall Study||6
7691275|NCT01862484|18940358|P1|COMPLETED|Overall Study||13
7691276|NCT01862484|18940357|P2|STARTED|Overall Study||14
7691277|NCT01862484|18940358|P1|STARTED|Overall Study||15
7691278|NCT01862419|18940366|P2|NOT COMPLETED|Overall Study||0
7691279|NCT01862419|18940367|P1|NOT COMPLETED|Overall Study||0
7691280|NCT01862419|18940366|P2|COMPLETED|Overall Study||1192
7691281|NCT01862419|18940367|P1|COMPLETED|Overall Study||1201
7691282|NCT01862419|18940366|P2|STARTED|Overall Study||1192
7691283|NCT01862419|18940367|P1|STARTED|Overall Study||1201
7691284|NCT01862328|18940384|P7|NOT COMPLETED|Overall Study||10
7691285|NCT01862328|18940385|P6|NOT COMPLETED|Overall Study||7
7691286|NCT01862328|18940386|P5|NOT COMPLETED|Overall Study||12
7691287|NCT01862328|18940387|P4|NOT COMPLETED|Overall Study||7
7691288|NCT01862328|18940388|P3|NOT COMPLETED|Overall Study||6
7691289|NCT01862328|18940389|P2|NOT COMPLETED|Overall Study||18
7691290|NCT01862328|18940390|P1|NOT COMPLETED|Overall Study||4
7691291|NCT01862328|18940384|P7|COMPLETED|Overall Study||0
7691292|NCT01862328|18940385|P6|COMPLETED|Overall Study||0
7691293|NCT01862328|18940386|P5|COMPLETED|Overall Study||0
7691294|NCT01862328|18940387|P4|COMPLETED|Overall Study||0
7691295|NCT01862328|18940388|P3|COMPLETED|Overall Study||0
7691296|NCT01862328|18940389|P2|COMPLETED|Overall Study||0
7691297|NCT01862328|18940390|P1|COMPLETED|Overall Study||0
7691298|NCT01862328|18940384|P7|STARTED|Overall Study||10
7691299|NCT01862328|18940385|P6|STARTED|Overall Study||7
7691300|NCT01862328|18940386|P5|STARTED|Overall Study||12
7691301|NCT01862328|18940387|P4|STARTED|Overall Study||7
7691302|NCT01862328|18940388|P3|STARTED|Overall Study||6
7691303|NCT01862328|18940389|P2|STARTED|Overall Study||18
7691304|NCT01862328|18940390|P1|STARTED|Overall Study||4
7691305|NCT01862250|18940442|P1|NOT COMPLETED|Overall Study||4
7691306|NCT01862250|18940442|P1|COMPLETED|Overall Study||8
7691307|NCT01862250|18940442|P1|STARTED|Overall Study||12
7691308|NCT01862159|18940449|P1|NOT COMPLETED|Overall Study||0
7691309|NCT01862159|18940449|P1|COMPLETED|Overall Study||25038
7691310|NCT01862159|18940449|P1|STARTED|Overall Study||25038
7691311|NCT01862133|18940456|P2|NOT COMPLETED|Overall Study||0
7691312|NCT01862133|18940457|P1|NOT COMPLETED|Overall Study||0
7691313|NCT01862133|18940456|P2|COMPLETED|Overall Study||31
7691314|NCT01862133|18940457|P1|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105
7691315|NCT01862133|18940456|P2|Returned During 6 mo Study|Overall Study||31
7691316|NCT01862133|18940457|P1|Returned During 6 mo Study|Overall Study||92
7691317|NCT01862133|18940456|P2|STARTED|Overall Study||31
7691318|NCT01862133|18940457|P1|STARTED|Overall Study||105
7691319|NCT01862029|18940463|P1|NOT COMPLETED|Overall Study||1
7691320|NCT01862029|18940463|P1|COMPLETED|Overall Study||8
7691321|NCT01862029|18940463|P1|STARTED|Overall Study||9
7691322|NCT01861925|18940471|P3|NOT COMPLETED|Overall Study||0
7691323|NCT01861925|18940472|P2|NOT COMPLETED|Overall Study||0
7691324|NCT01861925|18940473|P1|NOT COMPLETED|Overall Study||0
7691325|NCT01861925|18940471|P3|COMPLETED|Overall Study||8
7691326|NCT01861925|18940472|P2|COMPLETED|Overall Study||8
7691327|NCT01861925|18940473|P1|COMPLETED|Overall Study||34
7691328|NCT01861925|18940471|P3|STARTED|Overall Study||8
7691329|NCT01861925|18940472|P2|STARTED|Overall Study||8
7691330|NCT01861925|18940473|P1|STARTED|Overall Study||34
7691331|NCT01861756|18940496|P2|NOT COMPLETED|Overall Study||18
7691332|NCT01861756|18940497|P1|NOT COMPLETED|Overall Study||13
7691333|NCT01861756|18940496|P2|COMPLETED|Overall Study||85
7691334|NCT01861756|18940497|P1|COMPLETED|Overall Study||88
7691335|NCT01861756|18940496|P2|STARTED|Overall Study||103
7691336|NCT01861756|18940497|P1|STARTED|Overall Study||101
7691337|NCT01861704|18940505|P2|NOT COMPLETED|Overall Study||3
7691338|NCT01861704|18940506|P1|NOT COMPLETED|Overall Study||3
7691339|NCT01861704|18940505|P2|COMPLETED|Overall Study||104
7691340|NCT01861704|18940506|P1|COMPLETED|Overall Study||67
7691341|NCT01861704|18940505|P2|STARTED|Overall Study||107
7691342|NCT01861704|18940506|P1|STARTED|Overall Study||70
7691343|NCT01861665|18940514|P2|NOT COMPLETED|Overall Study||0
7691344|NCT01861665|18940515|P1|NOT COMPLETED|Overall Study||0
7691345|NCT01861665|18940514|P2|COMPLETED|Overall Study||17
7691346|NCT01861665|18940515|P1|COMPLETED|Overall Study||10
7691347|NCT01861665|18940514|P2|STARTED|Overall Study||17
7691348|NCT01861665|18940515|P1|STARTED|Overall Study||10
7691349|NCT01861587|18940523|P2|NOT COMPLETED|Overall Study||0
7691350|NCT01861587|18940524|P1|NOT COMPLETED|Overall Study||0
7691351|NCT01861587|18940523|P2|COMPLETED|Overall Study||13
7691352|NCT01861587|18940524|P1|COMPLETED|Overall Study||14
7691353|NCT01861587|18940523|P2|STARTED|Overall Study||13
7691354|NCT01861587|18940524|P1|STARTED|Overall Study||14
7691355|NCT01861574|18940540|P4|NOT COMPLETED|Overall Study||0
7691356|NCT01861574|18940541|P3|NOT COMPLETED|Overall Study||0
7691357|NCT01861574|18940542|P2|NOT COMPLETED|Overall Study||0
7691358|NCT01861574|18940543|P1|NOT COMPLETED|Overall Study||0
7691359|NCT01861574|18940540|P4|COMPLETED|Overall Study||28
7691360|NCT01861574|18940541|P3|COMPLETED|Overall Study||27
7691361|NCT01861574|18940542|P2|COMPLETED|Overall Study||25
7691362|NCT01861574|18940543|P1|COMPLETED|Overall Study||28
7691363|NCT01861574|18940540|P4|STARTED|Overall Study||28
7691364|NCT01861574|18940541|P3|STARTED|Overall Study||27
7691365|NCT01861574|18940542|P2|STARTED|Overall Study||25
7691366|NCT01861574|18940543|P1|STARTED|Overall Study||28
7691367|NCT01861522|18940566|P2|NOT COMPLETED|Overall Study||0
7691368|NCT01861522|18940567|P1|NOT COMPLETED|Overall Study||3
7691369|NCT01861522|18940566|P2|COMPLETED|Overall Study||232
7691370|NCT01861522|18940567|P1|COMPLETED|Overall Study||237
7691371|NCT01861522|18940566|P2|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232
7691372|NCT01861522|18940567|P1|STARTED|Overall Study||240
7691373|NCT01861457|18940575|P2|NOT COMPLETED|Overall Study||0
7691374|NCT01861457|18940576|P1|NOT COMPLETED|Overall Study||0
7691375|NCT01861457|18940575|P2|COMPLETED|Overall Study||19
7691376|NCT01861457|18940576|P1|COMPLETED|Overall Study||20
7691377|NCT01861457|18940575|P2|STARTED|Overall Study||19
7691378|NCT01861457|18940576|P1|STARTED|Overall Study||20
7691379|NCT01861301|18940584|P1|NOT COMPLETED|Overall Study||0
7691380|NCT01861301|18940584|P1|COMPLETED|Overall Study||18
7691381|NCT01861301|18940584|P1|STARTED|Overall Study||18
7691382|NCT01861028|18940591|P1|NOT COMPLETED|Overall Study||0
7691383|NCT01861028|18940591|P1|COMPLETED|Overall Study||44
7691384|NCT01861028|18940591|P1|STARTED|Overall Study||44
7691385|NCT01860989|18940596|P1|NOT COMPLETED|Overall Study||5
7691386|NCT01860989|18940596|P1|COMPLETED|Overall Study||6
7691387|NCT01860989|18940596|P1|STARTED|Overall Study||11
7691388|NCT01860976|18940602|P2|NOT COMPLETED|Long Term Extension||107
7691389|NCT01860976|18940603|P1|NOT COMPLETED|Long Term Extension||113
7691390|NCT01860976|18940602|P2|COMPLETED|Long Term Extension||8
7691391|NCT01860976|18940603|P1|COMPLETED|Long Term Extension||0
7691392|NCT01860976|18940602|P2|STARTED|Long Term Extension||115
7691393|NCT01860976|18940603|P1|STARTED|Long Term Extension||113
7691394|NCT01860976|18940602|P2|NOT COMPLETED|Open-Label||64
7691395|NCT01860976|18940603|P1|NOT COMPLETED|Open-Label||74
7691396|NCT01860976|18940602|P2|COMPLETED|Open-Label||121
7691397|NCT01860976|18940603|P1|COMPLETED|Open-Label||123
7691398|NCT01860976|18940602|P2|STARTED|Open-Label||185
7691399|NCT01860976|18940603|P1|STARTED|Open-Label||197
7691400|NCT01860976|18940602|P2|NOT COMPLETED|Blinded Treatment||113
7691401|NCT01860976|18940603|P1|NOT COMPLETED|Blinded Treatment||88
7691402|NCT01860976|18940602|P2|COMPLETED|Blinded Treatment||98
7691403|NCT01860976|18940603|P1|COMPLETED|Blinded Treatment||125
7691404|NCT01860976|18940602|P2|STARTED|Blinded Treatment||211
7691405|NCT01860976|18940603|P1|STARTED|Blinded Treatment||213
7691406|NCT01860950|18940631|P6|NOT COMPLETED|Overall Study||0
7691407|NCT01860950|18940632|P5|NOT COMPLETED|Overall Study||0
7691408|NCT01860950|18940633|P4|NOT COMPLETED|Overall Study||0
7691409|NCT01860950|18940634|P3|NOT COMPLETED|Overall Study||0
7691410|NCT01860950|18940635|P2|NOT COMPLETED|Overall Study||0
7691411|NCT01860950|18940636|P1|NOT COMPLETED|Overall Study||0
7691412|NCT01860950|18940631|P6|COMPLETED|Overall Study||13
7691413|NCT01860950|18940632|P5|COMPLETED|Overall Study||14
7691414|NCT01860950|18940633|P4|COMPLETED|Overall Study||13
7691415|NCT01860950|18940634|P3|COMPLETED|Overall Study||10
7691416|NCT01860950|18940635|P2|COMPLETED|Overall Study||15
7691417|NCT01860950|18940636|P1|COMPLETED|Overall Study||14
7691418|NCT01860950|18940631|P6|STARTED|Overall Study||13
7691419|NCT01860950|18940632|P5|STARTED|Overall Study||14
7691420|NCT01860950|18940633|P4|STARTED|Overall Study||13
7691421|NCT01860950|18940634|P3|STARTED|Overall Study||10
7691422|NCT01860950|18940635|P2|STARTED|Overall Study||15
7691423|NCT01860950|18940636|P1|STARTED|Overall Study||14
7691424|NCT01860846|18940657|P1|NOT COMPLETED|Overall Study||33
7691425|NCT01860846|18940657|P1|COMPLETED|Overall Study||73
7691426|NCT01860846|18940657|P1|Month 12|Overall Study||73
7691427|NCT01860846|18940657|P1|Month 6|Overall Study||85
7691428|NCT01860846|18940657|P1|Month 4|Overall Study||82
7691429|NCT01860846|18940657|P1|Month 2|Overall Study||83
7691430|NCT01860846|18940657|P1|Month 1|Overall Study||97
7691431|NCT01860846|18940657|P1|STARTED|Overall Study||106
7691432|NCT01860807|18940670|P2|NOT COMPLETED|Overall Study||29
7691433|NCT01860807|18940671|P1|NOT COMPLETED|Overall Study||30
7691434|NCT01860807|18940670|P2|COMPLETED|Overall Study||32
7691435|NCT01860807|18940671|P1|COMPLETED|Overall Study||34
7691436|NCT01860807|18940670|P2|STARTED|Overall Study||61
7691437|NCT01860807|18940671|P1|STARTED|Overall Study||64
7691438|NCT01860703|18940677|P4|NOT COMPLETED|Overall Study||2
7691439|NCT01860703|18940678|P3|NOT COMPLETED|Overall Study||1
7691440|NCT01860703|18940679|P2|NOT COMPLETED|Overall Study||5
7691441|NCT01860703|18940680|P1|NOT COMPLETED|Overall Study||2
7691442|NCT01860703|18940677|P4|COMPLETED|Overall Study||10
7691443|NCT01860703|18940678|P3|COMPLETED|Overall Study||11
7691444|NCT01860703|18940679|P2|COMPLETED|Overall Study||8
7691445|NCT01860703|18940680|P1|COMPLETED|Overall Study||11
7691446|NCT01860703|18940677|P4|STARTED|Overall Study||12
7691447|NCT01860703|18940678|P3|STARTED|Overall Study||12
7691448|NCT01860703|18940679|P2|STARTED|Overall Study||13
7691449|NCT01860703|18940680|P1|STARTED|Overall Study||13
7691450|NCT01860677|18940712|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7691451|NCT01860677|18940713|P1|NOT COMPLETED|Second Intervention (1 Day)||7
7691452|NCT01860677|18940712|P2|COMPLETED|Second Intervention (1 Day)||0
7691453|NCT01860677|18940713|P1|COMPLETED|Second Intervention (1 Day)||1
7691454|NCT01860677|18940712|P2|STARTED|Second Intervention (1 Day)||0
7691455|NCT01860677|18940713|P1|STARTED|Second Intervention (1 Day)||8
7691456|NCT01860677|18940712|P2|NOT COMPLETED|First Intervention (1 Day)||0
7691457|NCT01860677|18940713|P1|NOT COMPLETED|First Intervention (1 Day)||0
7691458|NCT01860677|18940712|P2|COMPLETED|First Intervention (1 Day)||0
7691459|NCT01860677|18940713|P1|COMPLETED|First Intervention (1 Day)||8
7691460|NCT01860677|18940712|P2|STARTED|First Intervention (1 Day)||0
7691461|NCT01860677|18940713|P1|STARTED|First Intervention (1 Day)||8
7691462|NCT01860651|18940724|P2|NOT COMPLETED|Overall Study||8
7691463|NCT01860651|18940725|P1|NOT COMPLETED|Overall Study||25
7691464|NCT01860651|18940724|P2|COMPLETED|Overall Study||39
7691465|NCT01860651|18940725|P1|COMPLETED|Overall Study||31
7691466|NCT01860651|18940724|P2|STARTED|Overall Study||47
7691467|NCT01860651|18940725|P1|STARTED|Overall Study||56
7691468|NCT01860586|18940741|P1|NOT COMPLETED|Overall Study||0
7691469|NCT01860586|18940741|P1|COMPLETED|Overall Study||20
7691470|NCT01860586|18940741|P1|STARTED|Overall Study||20
7691471|NCT01860573|18940749|P2|NOT COMPLETED|Overall Study||0
7691472|NCT01860573|18940750|P1|NOT COMPLETED|Overall Study||0
7691473|NCT01860573|18940749|P2|COMPLETED|Overall Study||85
7691474|NCT01860573|18940750|P1|COMPLETED|Overall Study||83
7691475|NCT01860573|18940749|P2|STARTED|Overall Study||85
7691476|NCT01860573|18940750|P1|STARTED|Overall Study||83
7691477|NCT01860534|18940770|P2|NOT COMPLETED|ROP #2||0
7691478|NCT01860534|18940771|P1|NOT COMPLETED|ROP #2||1
7691479|NCT01860534|18940770|P2|COMPLETED|ROP #2||13
7691480|NCT01860534|18940771|P1|COMPLETED|ROP #2||13
7691481|NCT01860534|18940770|P2|STARTED|ROP #2||13
7691482|NCT01860534|18940771|P1|STARTED|ROP #2||14
7691483|NCT01860534|18940770|P2|NOT COMPLETED|ROP #1||1
7691484|NCT01860534|18940771|P1|NOT COMPLETED|ROP #1||0
7691485|NCT01860534|18940770|P2|COMPLETED|ROP #1||13
7691486|NCT01860534|18940771|P1|COMPLETED|ROP #1||14
7691487|NCT01860534|18940770|P2|STARTED|ROP #1||14
7691488|NCT01860534|18940771|P1|STARTED|ROP #1||14
7691489|NCT01860521|18940785|P2|NOT COMPLETED|Overall Study||0
7691490|NCT01860521|18940786|P1|NOT COMPLETED|Overall Study||0
7691491|NCT01860521|18940785|P2|COMPLETED|Overall Study|June 2013|52
7691492|NCT01860521|18940786|P1|COMPLETED|Overall Study|June 2013|52
7691493|NCT01860521|18940785|P2|STARTED|Overall Study|September 2011|52
7691494|NCT01860521|18940786|P1|STARTED|Overall Study|September 2011|52
7691495|NCT01860287|18940801|P3|NOT COMPLETED|Overall Study||0
7691496|NCT01860287|18940802|P2|NOT COMPLETED|Overall Study||0
7691497|NCT01860287|18940803|P1|NOT COMPLETED|Overall Study||0
7691498|NCT01860287|18940801|P3|COMPLETED|Overall Study||15
7691499|NCT01860287|18940802|P2|COMPLETED|Overall Study||15
7691500|NCT01860287|18940803|P1|COMPLETED|Overall Study||18
7691501|NCT01860287|18940801|P3|STARTED|Overall Study||15
7691502|NCT01860287|18940802|P2|STARTED|Overall Study||15
7691503|NCT01860287|18940803|P1|STARTED|Overall Study||18
7691504|NCT01860170|18940814|P3|NOT COMPLETED|Overall Study||0
7691505|NCT01860170|18940815|P2|NOT COMPLETED|Overall Study||0
7691506|NCT01860170|18940816|P1|NOT COMPLETED|Overall Study||0
7691507|NCT01860170|18940814|P3|COMPLETED|Overall Study||22
7691508|NCT01860170|18940815|P2|COMPLETED|Overall Study||3
7691509|NCT01860170|18940816|P1|COMPLETED|Overall Study||3
7691510|NCT01860170|18940814|P3|STARTED|Overall Study||22
7691511|NCT01860170|18940815|P2|STARTED|Overall Study||3
7691512|NCT01860170|18940816|P1|STARTED|Overall Study||3
7691513|NCT01860079|18940832|P2|NOT COMPLETED|Overall Study||22
7691514|NCT01860079|18940833|P1|NOT COMPLETED|Overall Study||14
7691515|NCT01860079|18940832|P2|COMPLETED|Overall Study||363
7691516|NCT01860079|18940833|P1|COMPLETED|Overall Study||370
7691517|NCT01860079|18940832|P2|STARTED|Overall Study||385
7691518|NCT01860079|18940833|P1|STARTED|Overall Study||384
7691519|NCT01860040|18940841|P2|NOT COMPLETED|Overall Study||0
7691520|NCT01860040|18940842|P1|NOT COMPLETED|Overall Study||1
7691521|NCT01860040|18940841|P2|COMPLETED|Overall Study|did not meet recruitment goal|0
7691522|NCT01860040|18940842|P1|COMPLETED|Overall Study|did not meet recruitment goal|0
7691523|NCT01860040|18940841|P2|STARTED|Overall Study|did not meet recruitment goal|0
7691524|NCT01860040|18940842|P1|STARTED|Overall Study|did not meet recruitment goal|1
7691525|NCT01859988|18940853|P6|NOT COMPLETED|Overall Study||19
7691526|NCT01859988|18940854|P5|NOT COMPLETED|Overall Study||23
7691527|NCT01859988|18940855|P4|NOT COMPLETED|Overall Study||10
7691528|NCT01859988|18940856|P3|NOT COMPLETED|Overall Study||28
7691529|NCT01859988|18940857|P2|NOT COMPLETED|Overall Study||12
7691530|NCT01859988|18940858|P1|NOT COMPLETED|Overall Study||11
7691531|NCT01859988|18940853|P6|COMPLETED|Overall Study||42
7691532|NCT01859988|18940854|P5|COMPLETED|Overall Study||42
7691533|NCT01859988|18940855|P4|COMPLETED|Overall Study||55
7691534|NCT01859988|18940856|P3|COMPLETED|Overall Study||34
7691535|NCT01859988|18940857|P2|COMPLETED|Overall Study||52
7691536|NCT01859988|18940858|P1|COMPLETED|Overall Study||52
7691537|NCT01859988|18940853|P6|Treated|Overall Study||61
7691538|NCT01859988|18940854|P5|Treated|Overall Study||65
7691539|NCT01859988|18940855|P4|Treated|Overall Study||65
7691540|NCT01859988|18940856|P3|Treated|Overall Study||61
7691541|NCT01859988|18940857|P2|Treated|Overall Study||64
7691542|NCT01859988|18940858|P1|Treated|Overall Study||63
7691543|NCT01859988|18940853|P6|STARTED|Overall Study||61
7691544|NCT01859988|18940854|P5|STARTED|Overall Study||65
7691545|NCT01859988|18940855|P4|STARTED|Overall Study||65
7691546|NCT01859988|18940856|P3|STARTED|Overall Study||62
7691547|NCT01859988|18940857|P2|STARTED|Overall Study||64
7691548|NCT01859988|18940858|P1|STARTED|Overall Study||63
7691549|NCT01859949|18940952|P2|NOT COMPLETED|Overall Study||17
7691550|NCT01859949|18940953|P1|NOT COMPLETED|Overall Study||14
7691551|NCT01859949|18940952|P2|COMPLETED|Overall Study||15
7691552|NCT01859949|18940953|P1|COMPLETED|Overall Study||15
7691553|NCT01859949|18940952|P2|STARTED|Overall Study|Treated participants|32
7691554|NCT01859949|18940953|P1|STARTED|Overall Study|Treated participants|29
7691555|NCT01859923|18940973|P4|NOT COMPLETED|Overall Study||1
7691556|NCT01859923|18940974|P3|NOT COMPLETED|Overall Study||1
7691557|NCT01859923|18940975|P2|NOT COMPLETED|Overall Study||0
7691558|NCT01859923|18940976|P1|NOT COMPLETED|Overall Study||0
7691559|NCT01859923|18940973|P4|COMPLETED|Overall Study||11
7691560|NCT01859923|18940974|P3|COMPLETED|Overall Study||11
7691561|NCT01859923|18940975|P2|COMPLETED|Overall Study||6
7691562|NCT01859923|18940976|P1|COMPLETED|Overall Study||7
7691563|NCT01859923|18940973|P4|STARTED|Overall Study||12
7691564|NCT01859923|18940974|P3|STARTED|Overall Study||12
7691565|NCT01859923|18940975|P2|STARTED|Overall Study||6
7691566|NCT01859923|18940976|P1|STARTED|Overall Study||7
7691567|NCT01859793|18941030|P2|NOT COMPLETED|2nd Intervention Period||0
7691568|NCT01859793|18941031|P1|NOT COMPLETED|2nd Intervention Period||0
7691569|NCT01859793|18941030|P2|COMPLETED|2nd Intervention Period||16
7691570|NCT01859793|18941031|P1|COMPLETED|2nd Intervention Period||14
7691571|NCT01859793|18941030|P2|STARTED|2nd Intervention Period||16
7691572|NCT01859793|18941031|P1|STARTED|2nd Intervention Period||14
7691573|NCT01859793|18941030|P2|NOT COMPLETED|Washout Period (4 Weeks)||1
7691574|NCT01859793|18941031|P1|NOT COMPLETED|Washout Period (4 Weeks)||1
7691575|NCT01859793|18941030|P2|COMPLETED|Washout Period (4 Weeks)||16
7691576|NCT01859793|18941031|P1|COMPLETED|Washout Period (4 Weeks)||14
7691577|NCT01859793|18941030|P2|STARTED|Washout Period (4 Weeks)||17
7691578|NCT01859793|18941031|P1|STARTED|Washout Period (4 Weeks)||15
7691579|NCT01859793|18941030|P2|NOT COMPLETED|First Intervention (8 Weeks)||1
7691580|NCT01859793|18941031|P1|NOT COMPLETED|First Intervention (8 Weeks)||5
7691581|NCT01859793|18941030|P2|COMPLETED|First Intervention (8 Weeks)||17
7691582|NCT01859793|18941031|P1|COMPLETED|First Intervention (8 Weeks)||15
7691583|NCT01859793|18941030|P2|STARTED|First Intervention (8 Weeks)||18
7691584|NCT01859793|18941031|P1|STARTED|First Intervention (8 Weeks)||20
7691585|NCT01859741|18941049|P8|NOT COMPLETED|Overall Study||70
7691586|NCT01859741|18941050|P7|NOT COMPLETED|Overall Study||70
7691587|NCT01859741|18941051|P6|NOT COMPLETED|Overall Study||6
7691588|NCT01859741|18941052|P5|NOT COMPLETED|Overall Study||6
7691589|NCT01859741|18941053|P4|NOT COMPLETED|Overall Study||3
7691590|NCT01859741|18941054|P3|NOT COMPLETED|Overall Study||6
7691591|NCT01859741|18941055|P2|NOT COMPLETED|Overall Study||3
7691592|NCT01859741|18941056|P1|NOT COMPLETED|Overall Study||3
7691593|NCT01859741|18941049|P8|COMPLETED|Overall Study||3
7691594|NCT01859741|18941050|P7|COMPLETED|Overall Study||2
7691595|NCT01859741|18941051|P6|COMPLETED|Overall Study||0
7691596|NCT01859741|18941052|P5|COMPLETED|Overall Study||0
7691597|NCT01859741|18941053|P4|COMPLETED|Overall Study||0
7691598|NCT01859741|18941054|P3|COMPLETED|Overall Study||0
7691599|NCT01859741|18941055|P2|COMPLETED|Overall Study||0
7691600|NCT01859741|18941056|P1|COMPLETED|Overall Study||0
7691601|NCT01859741|18941049|P8|STARTED|Overall Study||73
7691602|NCT01859741|18941050|P7|STARTED|Overall Study||72
7691603|NCT01859741|18941051|P6|STARTED|Overall Study||6
7691604|NCT01859741|18941052|P5|STARTED|Overall Study||6
7691605|NCT01859741|18941053|P4|STARTED|Overall Study||3
7691606|NCT01859741|18941054|P3|STARTED|Overall Study||6
7691607|NCT01859741|18941055|P2|STARTED|Overall Study||3
7691608|NCT01859741|18941056|P1|STARTED|Overall Study||3
7691609|NCT01859715|18941085|P3|NOT COMPLETED|Overall Study||23
7691610|NCT01859715|18941086|P2|NOT COMPLETED|Overall Study||8
7691611|NCT01859715|18941087|P1|NOT COMPLETED|Overall Study||16
7691612|NCT01859715|18941085|P3|COMPLETED|Overall Study||93
7691613|NCT01859715|18941086|P2|COMPLETED|Overall Study||83
7691614|NCT01859715|18941087|P1|COMPLETED|Overall Study||125
7691615|NCT01859715|18941085|P3|STARTED|Overall Study||116
7691616|NCT01859715|18941086|P2|STARTED|Overall Study||91
7691617|NCT01859715|18941087|P1|STARTED|Overall Study||141
7691618|NCT01859702|18941098|P1|NOT COMPLETED|Overall Study||5
7691619|NCT01859702|18941098|P1|COMPLETED|Overall Study||31
7691620|NCT01859702|18941098|P1|STARTED|Overall Study||36
7691621|NCT01859637|18941102|P1|NOT COMPLETED|Overall Study||0
7691622|NCT01859637|18941102|P1|COMPLETED|Overall Study||6
7691623|NCT01859637|18941102|P1|STARTED|Overall Study||6
7691624|NCT01859611|18941108|P1|NOT COMPLETED|Overall Study||8
7691625|NCT01859611|18941108|P1|COMPLETED|Overall Study||43
7691626|NCT01859611|18941108|P1|STARTED|Overall Study||51
7691627|NCT01859598|18941112|P1|NOT COMPLETED|Visit 3 at 6 Months||912
7691628|NCT01859598|18941112|P1|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341
7691629|NCT01859598|18941112|P1|STARTED|Visit 3 at 6 Months||17253
7691630|NCT01859598|18941112|P1|NOT COMPLETED|Visit 2 at 3 Months||1742
7691631|NCT01859598|18941112|P1|COMPLETED|Visit 2 at 3 Months||17253
7691632|NCT01859598|18941112|P1|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995
7691633|NCT01859507|18941120|P1|NOT COMPLETED|Overall Study||4
7691634|NCT01859507|18941120|P1|COMPLETED|Overall Study||28
7691635|NCT01859507|18941120|P1|STARTED|Overall Study||32
7691636|NCT01859494|18941125|P1|NOT COMPLETED|Overall Study||1
7691637|NCT01859494|18941125|P1|COMPLETED|Overall Study||218
7691638|NCT01859494|18941125|P1|STARTED|Overall Study||219
7691639|NCT01859390|18941136|P2|NOT COMPLETED|Overall Study||7
7691640|NCT01859390|18941137|P1|NOT COMPLETED|Overall Study||1
7691641|NCT01859390|18941136|P2|COMPLETED|Overall Study||30
7691642|NCT01859390|18941137|P1|COMPLETED|Overall Study||35
7691643|NCT01859390|18941136|P2|Withdrawals|Overall Study||2
7691644|NCT01859390|18941137|P1|Withdrawals|Overall Study||2
7691645|NCT01859390|18941136|P2|STARTED|Overall Study||37
7691646|NCT01859390|18941137|P1|STARTED|Overall Study||36
7691647|NCT01859325|18941161|P3|NOT COMPLETED|Overall Study||0
7691648|NCT01859325|18941162|P2|NOT COMPLETED|Overall Study||4
7691649|NCT01859325|18941163|P1|NOT COMPLETED|Overall Study||3
7691650|NCT01859325|18941161|P3|COMPLETED|Overall Study||2
7691651|NCT01859325|18941162|P2|COMPLETED|Overall Study||12
7691652|NCT01859325|18941163|P1|COMPLETED|Overall Study||12
7691653|NCT01859325|18941161|P3|STARTED|Overall Study||2
7691654|NCT01859325|18941162|P2|STARTED|Overall Study||16
7691655|NCT01859325|18941163|P1|STARTED|Overall Study||15
7691656|NCT01859312|18941171|P1|NOT COMPLETED|Overall Study||0
7691657|NCT01859312|18941171|P1|COMPLETED|Overall Study|Based on medication & supply accountability, one participant was found to be partially non-compliant|8
7691658|NCT01859312|18941171|P1|STARTED|Overall Study||8
7691659|NCT01859247|18941226|P8|NOT COMPLETED|Overall Study||0
7691660|NCT01859247|18941227|P7|NOT COMPLETED|Overall Study||0
7691661|NCT01859247|18941228|P6|NOT COMPLETED|Overall Study||0
7691662|NCT01859247|18941229|P5|NOT COMPLETED|Overall Study||0
7691663|NCT01859247|18941230|P4|NOT COMPLETED|Overall Study||0
7691664|NCT01859247|18941231|P3|NOT COMPLETED|Overall Study||0
7691665|NCT01859247|18941232|P2|NOT COMPLETED|Overall Study||0
7691666|NCT01859247|18941233|P1|NOT COMPLETED|Overall Study||0
7691667|NCT01859247|18941226|P8|COMPLETED|Overall Study||1
7691668|NCT01859247|18941227|P7|COMPLETED|Overall Study||1
7691669|NCT01859247|18941228|P6|COMPLETED|Overall Study||1
7691670|NCT01859247|18941229|P5|COMPLETED|Overall Study||1
7691671|NCT01859247|18941230|P4|COMPLETED|Overall Study||1
7691672|NCT01859247|18941231|P3|COMPLETED|Overall Study||1
7691673|NCT01859247|18941232|P2|COMPLETED|Overall Study||1
7691674|NCT01859247|18941233|P1|COMPLETED|Overall Study||1
7691675|NCT01859247|18941226|P8|STARTED|Overall Study||1
7691676|NCT01859247|18941227|P7|STARTED|Overall Study||1
7691677|NCT01859247|18941228|P6|STARTED|Overall Study||1
7691678|NCT01859247|18941229|P5|STARTED|Overall Study||1
7691679|NCT01859247|18941230|P4|STARTED|Overall Study||1
7691680|NCT01859247|18941231|P3|STARTED|Overall Study||1
7691681|NCT01859247|18941232|P2|STARTED|Overall Study||1
7691682|NCT01859247|18941233|P1|STARTED|Overall Study||1
7691683|NCT01859195|18941260|P2|NOT COMPLETED|Overall Study||0
7691684|NCT01859195|18941261|P1|NOT COMPLETED|Overall Study||0
7691685|NCT01859195|18941260|P2|COMPLETED|Overall Study||12
7691686|NCT01859195|18941261|P1|COMPLETED|Overall Study||24
7691687|NCT01859195|18941260|P2|STARTED|Overall Study||12
7691688|NCT01859195|18941261|P1|STARTED|Overall Study||24
7691689|NCT01859143|18941271|P2|NOT COMPLETED|Overall Study||0
7691690|NCT01859143|18941272|P1|NOT COMPLETED|Overall Study||2
7691691|NCT01859143|18941271|P2|COMPLETED|Overall Study||60
7691692|NCT01859143|18941272|P1|COMPLETED|Overall Study||238
7691693|NCT01859143|18941271|P2|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60
7691694|NCT01859143|18941272|P1|STARTED|Overall Study||240
7691695|NCT01859078|18941286|P1|NOT COMPLETED|Overall Study||0
7691696|NCT01859078|18941286|P1|COMPLETED|Overall Study||28
7691697|NCT01859078|18941286|P1|STARTED|Overall Study||28
7691698|NCT01859013|18941302|P2|NOT COMPLETED|Overall Study||5
7691699|NCT01859013|18941303|P1|NOT COMPLETED|Overall Study||4
7691700|NCT01859013|18941302|P2|COMPLETED|Overall Study||9
7691701|NCT01859013|18941303|P1|COMPLETED|Overall Study||12
7691702|NCT01859013|18941302|P2|STARTED|Overall Study||14
7691703|NCT01859013|18941303|P1|STARTED|Overall Study||16
7691704|NCT01858766|18941328|P19|NOT COMPLETED|Overall Study||4
7691705|NCT01858766|18941329|P18|NOT COMPLETED|Overall Study||4
7691706|NCT01858766|18941330|P17|NOT COMPLETED|Overall Study||3
7691707|NCT01858766|18941331|P16|NOT COMPLETED|Overall Study||6
7691708|NCT01858766|18941332|P15|NOT COMPLETED|Overall Study||8
7691709|NCT01858766|18941333|P14|NOT COMPLETED|Overall Study||3
7691710|NCT01858766|18941334|P13|NOT COMPLETED|Overall Study||5
7691711|NCT01858766|18941335|P12|NOT COMPLETED|Overall Study||5
7691712|NCT01858766|18941336|P11|NOT COMPLETED|Overall Study||0
7691713|NCT01858766|18941337|P10|NOT COMPLETED|Overall Study||0
7691714|NCT01858766|18941338|P9|NOT COMPLETED|Overall Study||0
7691715|NCT01858766|18941339|P8|NOT COMPLETED|Overall Study||2
7691716|NCT01858766|18941340|P7|NOT COMPLETED|Overall Study||0
7691717|NCT01858766|18941341|P6|NOT COMPLETED|Overall Study||4
7691718|NCT01858766|18941342|P5|NOT COMPLETED|Overall Study||1
7691719|NCT01858766|18941343|P4|NOT COMPLETED|Overall Study||0
7691720|NCT01858766|18941344|P3|NOT COMPLETED|Overall Study||1
7691721|NCT01858766|18941345|P2|NOT COMPLETED|Overall Study||0
7691722|NCT01858766|18941346|P1|NOT COMPLETED|Overall Study||1
7691723|NCT01858766|18941328|P19|COMPLETED|Overall Study||22
7691724|NCT01858766|18941329|P18|COMPLETED|Overall Study||23
7691725|NCT01858766|18941330|P17|COMPLETED|Overall Study||22
7691726|NCT01858766|18941331|P16|COMPLETED|Overall Study||20
7691727|NCT01858766|18941332|P15|COMPLETED|Overall Study||23
7691728|NCT01858766|18941333|P14|COMPLETED|Overall Study||26
7691729|NCT01858766|18941334|P13|COMPLETED|Overall Study||25
7691730|NCT01858766|18941335|P12|COMPLETED|Overall Study||25
7691731|NCT01858766|18941336|P11|COMPLETED|Overall Study||5
7691732|NCT01858766|18941337|P10|COMPLETED|Overall Study||4
7691733|NCT01858766|18941338|P9|COMPLETED|Overall Study||1
7691734|NCT01858766|18941339|P8|COMPLETED|Overall Study||5
7691735|NCT01858766|18941340|P7|COMPLETED|Overall Study||7
7691736|NCT01858766|18941341|P6|COMPLETED|Overall Study||24
7691737|NCT01858766|18941342|P5|COMPLETED|Overall Study||26
7691738|NCT01858766|18941343|P4|COMPLETED|Overall Study||10
7691739|NCT01858766|18941344|P3|COMPLETED|Overall Study||10
7691740|NCT01858766|18941345|P2|COMPLETED|Overall Study||28
7691741|NCT01858766|18941346|P1|COMPLETED|Overall Study||26
7691742|NCT01858766|18941328|P19|STARTED|Overall Study||26
7691743|NCT01858766|18941329|P18|STARTED|Overall Study||27
7691744|NCT01858766|18941330|P17|STARTED|Overall Study||25
7691745|NCT01858766|18941331|P16|STARTED|Overall Study||26
7691746|NCT01858766|18941332|P15|STARTED|Overall Study||31
7691747|NCT01858766|18941333|P14|STARTED|Overall Study||29
7691748|NCT01858766|18941334|P13|STARTED|Overall Study||30
7691749|NCT01858766|18941335|P12|STARTED|Overall Study||30
7691750|NCT01858766|18941336|P11|STARTED|Overall Study||5
7691751|NCT01858766|18941337|P10|STARTED|Overall Study||4
7691752|NCT01858766|18941338|P9|STARTED|Overall Study||1
7691753|NCT01858766|18941339|P8|STARTED|Overall Study||7
7691754|NCT01858766|18941340|P7|STARTED|Overall Study||7
7691755|NCT01858766|18941341|P6|STARTED|Overall Study||28
7691756|NCT01858766|18941342|P5|STARTED|Overall Study||27
7691757|NCT01858766|18941343|P4|STARTED|Overall Study||10
7691758|NCT01858766|18941344|P3|STARTED|Overall Study||11
7691759|NCT01858766|18941345|P2|STARTED|Overall Study||28
7691760|NCT01858766|18941346|P1|STARTED|Overall Study||27
7691761|NCT01858701|18941417|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
7691762|NCT01858701|18941418|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
7691763|NCT01858701|18941417|P2|COMPLETED|Period 2, Second 30 Days of Wear||16
7691764|NCT01858701|18941418|P1|COMPLETED|Period 2, Second 30 Days of Wear||18
7691765|NCT01858701|18941417|P2|STARTED|Period 2, Second 30 Days of Wear||17
7691766|NCT01858701|18941418|P1|STARTED|Period 2, Second 30 Days of Wear||18
7691767|NCT01858701|18941417|P2|NOT COMPLETED|Washout Period, 1-13 Days||2
7691768|NCT01858701|18941418|P1|NOT COMPLETED|Washout Period, 1-13 Days||2
7691769|NCT01858701|18941417|P2|COMPLETED|Washout Period, 1-13 Days||17
7691770|NCT01858701|18941418|P1|COMPLETED|Washout Period, 1-13 Days||18
7691771|NCT01858701|18941417|P2|STARTED|Washout Period, 1-13 Days||19
7691772|NCT01858701|18941418|P1|STARTED|Washout Period, 1-13 Days||20
7691773|NCT01858701|18941417|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
7691774|NCT01858701|18941418|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
7691775|NCT01858701|18941417|P2|COMPLETED|Period 1, First 30 Days of Wear||19
7691776|NCT01858701|18941418|P1|COMPLETED|Period 1, First 30 Days of Wear||20
7691777|NCT01858701|18941417|P2|STARTED|Period 1, First 30 Days of Wear||20
7691778|NCT01858701|18941418|P1|STARTED|Period 1, First 30 Days of Wear||20
7691779|NCT01858636|18941424|P1|NOT COMPLETED|Overall Study||28
7691780|NCT01858636|18941424|P1|COMPLETED|Overall Study||207
7691781|NCT01858636|18941424|P1|Device Deployment|Overall Study||211
7691782|NCT01858636|18941424|P1|STARTED|Overall Study|Subjects consented|235
7691783|NCT01858558|18941431|P2|NOT COMPLETED|Overall Study||2
7691784|NCT01858558|18941432|P1|NOT COMPLETED|Overall Study||9
7691785|NCT01858558|18941431|P2|COMPLETED|Overall Study||29
7691786|NCT01858558|18941432|P1|COMPLETED|Overall Study||61
7691787|NCT01858558|18941431|P2|STARTED|Overall Study||31
7691788|NCT01858558|18941432|P1|STARTED|Overall Study||70
7691789|NCT01858545|18941443|P2|NOT COMPLETED|Overall Study||6
7691790|NCT01858545|18941444|P1|NOT COMPLETED|Overall Study||4
7691791|NCT01858545|18941443|P2|COMPLETED|Overall Study||23
7691792|NCT01858545|18941444|P1|COMPLETED|Overall Study||23
7691793|NCT01858545|18941443|P2|STARTED|Overall Study||29
7691794|NCT01858545|18941444|P1|STARTED|Overall Study||27
7691795|NCT01858532|18941454|P4|NOT COMPLETED|Overall Study||93
7691796|NCT01858532|18941455|P3|NOT COMPLETED|Overall Study||98
7691797|NCT01858532|18941456|P2|NOT COMPLETED|Overall Study||192
7691798|NCT01858532|18941457|P1|NOT COMPLETED|Overall Study||181
7691799|NCT01858532|18941454|P4|COMPLETED|Overall Study||418
7691800|NCT01858532|18941455|P3|COMPLETED|Overall Study||411
7691801|NCT01858532|18941456|P2|COMPLETED|Overall Study||1131
7691802|NCT01858532|18941457|P1|COMPLETED|Overall Study||1144
7691803|NCT01858532|18941454|P4|STARTED|Overall Study||511
7691804|NCT01858532|18941455|P3|STARTED|Overall Study||509
7691805|NCT01858532|18941456|P2|STARTED|Overall Study||1323
7691806|NCT01858532|18941457|P1|STARTED|Overall Study||1325
7691807|NCT01858428|18941474|P2|NOT COMPLETED|Overall Study||10
7691808|NCT01858428|18941475|P1|NOT COMPLETED|Overall Study||1
7691809|NCT01858428|18941474|P2|COMPLETED|Overall Study||190
7691810|NCT01858428|18941475|P1|COMPLETED|Overall Study||99
7691811|NCT01858428|18941474|P2|STARTED|Overall Study||200
7691812|NCT01858428|18941475|P1|STARTED|Overall Study|EverCross™ Balloon Catheter now a product of Medtronic|100
7691813|NCT01858389|18941511|P2|NOT COMPLETED|Overall Study||25
7691814|NCT01858389|18941512|P1|NOT COMPLETED|Overall Study||16
7691815|NCT01858389|18941511|P2|COMPLETED|Overall Study||0
7691816|NCT01858389|18941512|P1|COMPLETED|Overall Study||0
7691817|NCT01858389|18941511|P2|Received Treatment|Overall Study||22
7691818|NCT01858389|18941512|P1|Received Treatment|Overall Study||16
7691819|NCT01858389|18941511|P2|STARTED|Overall Study|Enrolled|25
7691820|NCT01858389|18941512|P1|STARTED|Overall Study|Enrolled|16
7691821|NCT01858376|18941527|P1|NOT COMPLETED|Overall Study||4
7691822|NCT01858376|18941527|P1|COMPLETED|Overall Study||20
7691823|NCT01858376|18941527|P1|STARTED|Overall Study||24
7691824|NCT01858194|18941536|P2|NOT COMPLETED|Overall Study||2
7691825|NCT01858194|18941537|P1|NOT COMPLETED|Overall Study||0
7691826|NCT01858194|18941536|P2|COMPLETED|Overall Study||7
7691827|NCT01858194|18941537|P1|COMPLETED|Overall Study|All patients in Control arm completed.|8
7691828|NCT01858194|18941536|P2|STARTED|Overall Study||9
7691829|NCT01858194|18941537|P1|STARTED|Overall Study||8
7691830|NCT01857986|18941579|P2|NOT COMPLETED|Overall Study||7
7691831|NCT01857986|18941580|P1|NOT COMPLETED|Overall Study||5
7691832|NCT01857986|18941579|P2|COMPLETED|Overall Study||30
7691833|NCT01857986|18941580|P1|COMPLETED|Overall Study||34
7691834|NCT01857986|18941579|P2|STARTED|Overall Study||37
7691835|NCT01857986|18941580|P1|STARTED|Overall Study||39
7691836|NCT01857973|18941590|P1|NOT COMPLETED|Overall Study||5
7691837|NCT01857973|18941590|P1|COMPLETED|Overall Study||73
7691838|NCT01857973|18941590|P1|Phase 7|Overall Study||4
7691839|NCT01857973|18941590|P1|Phase 6|Overall Study||4
7691840|NCT01857973|18941590|P1|Phase 4|Overall Study||10
7691841|NCT01857973|18941590|P1|Phase 3|Overall Study||10
7691842|NCT01857973|18941590|P1|Phase 2|Overall Study||14
7691843|NCT01857973|18941590|P1|Phase 1|Overall Study||17
7691844|NCT01857973|18941590|P1|Xploratory B Phase|Overall Study||9
7691845|NCT01857973|18941590|P1|Exploratory A Phase|Overall Study||9
7691846|NCT01857973|18941590|P1|STARTED|Overall Study||78
7691847|NCT01857882|18941603|P2|NOT COMPLETED|Overall Study||0
7691848|NCT01857882|18941604|P1|NOT COMPLETED|Overall Study||0
7691849|NCT01857882|18941603|P2|COMPLETED|Overall Study||20
7691850|NCT01857882|18941604|P1|COMPLETED|Overall Study||21
7691851|NCT01857882|18941603|P2|STARTED|Overall Study||20
7691852|NCT01857882|18941604|P1|STARTED|Overall Study||21
7691853|NCT01857869|18941620|P10|NOT COMPLETED|Booster/Rechallenge Phase||0
7691854|NCT01857869|18941621|P9|NOT COMPLETED|Booster/Rechallenge Phase||0
7691855|NCT01857869|18941622|P8|NOT COMPLETED|Booster/Rechallenge Phase||0
7691856|NCT01857869|18941623|P7|NOT COMPLETED|Booster/Rechallenge Phase||0
7691857|NCT01857869|18941624|P6|NOT COMPLETED|Booster/Rechallenge Phase||0
7691858|NCT01857869|18941625|P5|NOT COMPLETED|Booster/Rechallenge Phase||0
7691859|NCT01857869|18941626|P4|NOT COMPLETED|Booster/Rechallenge Phase||2
7691860|NCT01857869|18941627|P3|NOT COMPLETED|Booster/Rechallenge Phase||0
7691861|NCT01857869|18941628|P2|NOT COMPLETED|Booster/Rechallenge Phase||0
7691862|NCT01857869|18941629|P1|NOT COMPLETED|Booster/Rechallenge Phase||0
7691863|NCT01857869|18941620|P10|COMPLETED|Booster/Rechallenge Phase||6
7691864|NCT01857869|18941621|P9|COMPLETED|Booster/Rechallenge Phase||3
7691865|NCT01857869|18941622|P8|COMPLETED|Booster/Rechallenge Phase||4
7691866|NCT01857869|18941623|P7|COMPLETED|Booster/Rechallenge Phase||5
7691867|NCT01857869|18941624|P6|COMPLETED|Booster/Rechallenge Phase||2
7691868|NCT01857869|18941625|P5|COMPLETED|Booster/Rechallenge Phase||10
7691869|NCT01857869|18941626|P4|COMPLETED|Booster/Rechallenge Phase||7
7691870|NCT01857869|18941627|P3|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
7691871|NCT01857869|18941628|P2|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
7691872|NCT01857869|18941629|P1|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
7691873|NCT01857869|18941620|P10|STARTED|Booster/Rechallenge Phase||6
7691874|NCT01857869|18941621|P9|STARTED|Booster/Rechallenge Phase||3
7691875|NCT01857869|18941622|P8|STARTED|Booster/Rechallenge Phase||4
7691876|NCT01857869|18941623|P7|STARTED|Booster/Rechallenge Phase||5
7691877|NCT01857869|18941624|P6|STARTED|Booster/Rechallenge Phase||2
7691878|NCT01857869|18941625|P5|STARTED|Booster/Rechallenge Phase||10
7691879|NCT01857869|18941626|P4|STARTED|Booster/Rechallenge Phase||9
7691880|NCT01857869|18941627|P3|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
7691881|NCT01857869|18941628|P2|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
7691882|NCT01857869|18941629|P1|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
7691883|NCT01857869|18941620|P10|NOT COMPLETED|Primary/Challenge Phase||0
7691884|NCT01857869|18941621|P9|NOT COMPLETED|Primary/Challenge Phase||0
7691885|NCT01857869|18941622|P8|NOT COMPLETED|Primary/Challenge Phase||0
7691886|NCT01857869|18941623|P7|NOT COMPLETED|Primary/Challenge Phase||0
7691887|NCT01857869|18941624|P6|NOT COMPLETED|Primary/Challenge Phase||0
7691888|NCT01857869|18941625|P5|NOT COMPLETED|Primary/Challenge Phase||0
7691889|NCT01857869|18941626|P4|NOT COMPLETED|Primary/Challenge Phase||0
7691890|NCT01857869|18941627|P3|NOT COMPLETED|Primary/Challenge Phase||0
7691891|NCT01857869|18941628|P2|NOT COMPLETED|Primary/Challenge Phase||1
7691892|NCT01857869|18941629|P1|NOT COMPLETED|Primary/Challenge Phase||5
7691893|NCT01857869|18941620|P10|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
7691894|NCT01857869|18941621|P9|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
7691968|NCT01857297|18941856|P2|COMPLETED|Overall Study||60
7691969|NCT01857297|18941857|P1|COMPLETED|Overall Study||60
7691895|NCT01857869|18941622|P8|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
7691896|NCT01857869|18941623|P7|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
7691897|NCT01857869|18941624|P6|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
7691898|NCT01857869|18941625|P5|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
7691899|NCT01857869|18941626|P4|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
7691900|NCT01857869|18941627|P3|COMPLETED|Primary/Challenge Phase||12
7691901|NCT01857869|18941628|P2|COMPLETED|Primary/Challenge Phase||16
7691902|NCT01857869|18941629|P1|COMPLETED|Primary/Challenge Phase||29
7691903|NCT01857869|18941620|P10|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
7691904|NCT01857869|18941621|P9|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
7691905|NCT01857869|18941622|P8|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
7691906|NCT01857869|18941623|P7|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
7691907|NCT01857869|18941624|P6|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
7691908|NCT01857869|18941625|P5|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
7691909|NCT01857869|18941626|P4|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
7691910|NCT01857869|18941627|P3|STARTED|Primary/Challenge Phase||12
7691911|NCT01857869|18941628|P2|STARTED|Primary/Challenge Phase||17
7691912|NCT01857869|18941629|P1|STARTED|Primary/Challenge Phase||34
7691913|NCT01857713|18941709|P1|NOT COMPLETED|Overall Study||6
7691914|NCT01857713|18941709|P1|COMPLETED|Overall Study||89
7691915|NCT01857713|18941709|P1|STARTED|Overall Study||95
7691916|NCT01857622|18941719|P3|NOT COMPLETED|Overall Study||2
7691917|NCT01857622|18941720|P2|NOT COMPLETED|Overall Study||1
7691918|NCT01857622|18941721|P1|NOT COMPLETED|Overall Study||11
7691919|NCT01857622|18941719|P3|COMPLETED|Overall Study||19
7691920|NCT01857622|18941720|P2|COMPLETED|Overall Study||21
7691921|NCT01857622|18941721|P1|COMPLETED|Overall Study||39
7691922|NCT01857622|18941719|P3|STARTED|Overall Study||21
7691923|NCT01857622|18941720|P2|STARTED|Overall Study||22
7691924|NCT01857622|18941721|P1|STARTED|Overall Study||50
7691925|NCT01857583|18941733|P4|NOT COMPLETED|Overall Study||4
7691926|NCT01857583|18941734|P3|NOT COMPLETED|Overall Study||3
7691927|NCT01857583|18941735|P2|NOT COMPLETED|Overall Study||1
7691928|NCT01857583|18941736|P1|NOT COMPLETED|Overall Study||1
7691929|NCT01857583|18941733|P4|COMPLETED|Overall Study||17
7691930|NCT01857583|18941734|P3|COMPLETED|Overall Study||19
7691931|NCT01857583|18941735|P2|COMPLETED|Overall Study||6
7691932|NCT01857583|18941736|P1|COMPLETED|Overall Study||29
7691933|NCT01857583|18941733|P4|Safety Analysis Population|Overall Study||20
7691934|NCT01857583|18941734|P3|Safety Analysis Population|Overall Study||22
7691935|NCT01857583|18941735|P2|Safety Analysis Population|Overall Study||7
7691936|NCT01857583|18941736|P1|Safety Analysis Population|Overall Study||30
7691937|NCT01857583|18941733|P4|STARTED|Overall Study||21
7691938|NCT01857583|18941734|P3|STARTED|Overall Study||22
7691939|NCT01857583|18941735|P2|STARTED|Overall Study||7
7691940|NCT01857583|18941736|P1|STARTED|Overall Study||30
7691941|NCT01857531|18941746|P1|NOT COMPLETED|Overall Study||4
7691942|NCT01857531|18941746|P1|COMPLETED|Overall Study||12
7691943|NCT01857531|18941746|P1|STARTED|Overall Study||16
7691944|NCT01857362|18941755|P2|NOT COMPLETED|Overall Study||0
7691945|NCT01857362|18941756|P1|NOT COMPLETED|Overall Study||0
7691946|NCT01857362|18941755|P2|COMPLETED|Overall Study||6
7691947|NCT01857362|18941756|P1|COMPLETED|Overall Study||6
7691948|NCT01857362|18941755|P2|STARTED|Overall Study||6
7691949|NCT01857362|18941756|P1|STARTED|Overall Study||6
7691950|NCT01857323|18941764|P1|NOT COMPLETED|Overall Study||64
7691951|NCT01857323|18941764|P1|COMPLETED|Overall Study||253
7691952|NCT01857323|18941764|P1|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316
7691953|NCT01857323|18941764|P1|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317
7691954|NCT01857310|18941775|P2|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||282
7691955|NCT01857310|18941776|P1|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||315
7691956|NCT01857310|18941775|P2|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|903
7691957|NCT01857310|18941776|P1|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|870
7691958|NCT01857310|18941775|P2|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185
7691959|NCT01857310|18941776|P1|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185
7691960|NCT01857310|18941775|P2|NOT COMPLETED|Primary Analysis: Live Birth||0
7691961|NCT01857310|18941776|P1|NOT COMPLETED|Primary Analysis: Live Birth||0
7691962|NCT01857310|18941775|P2|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185
7691963|NCT01857310|18941776|P1|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185
7691964|NCT01857310|18941775|P2|STARTED|Primary Analysis: Live Birth|Male partner|1185
7691965|NCT01857310|18941776|P1|STARTED|Primary Analysis: Live Birth|Male partner|1185
7691966|NCT01857297|18941856|P2|NOT COMPLETED|Overall Study||0
7691967|NCT01857297|18941857|P1|NOT COMPLETED|Overall Study||0
7691970|NCT01857297|18941856|P2|STARTED|Overall Study||60
7691971|NCT01857297|18941857|P1|STARTED|Overall Study||60
7691972|NCT01857271|18941871|P1|NOT COMPLETED|Overall Study||1
7691973|NCT01857271|18941871|P1|COMPLETED|Overall Study||2
7691974|NCT01857271|18941871|P1|STARTED|Overall Study||3
7691975|NCT01857258|18941875|P2|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
7691976|NCT01857258|18941876|P1|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
7691977|NCT01857258|18941875|P2|COMPLETED|Second Intervention (3 h Postprandially)||7
7691978|NCT01857258|18941876|P1|COMPLETED|Second Intervention (3 h Postprandially)||8
7691979|NCT01857258|18941875|P2|STARTED|Second Intervention (3 h Postprandially)||7
7691980|NCT01857258|18941876|P1|STARTED|Second Intervention (3 h Postprandially)||8
7691981|NCT01857258|18941875|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
7691982|NCT01857258|18941876|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
7691983|NCT01857258|18941875|P2|COMPLETED|Wash-out Period (7 Days)||7
7691984|NCT01857258|18941876|P1|COMPLETED|Wash-out Period (7 Days)||8
7691985|NCT01857258|18941875|P2|STARTED|Wash-out Period (7 Days)||7
7691986|NCT01857258|18941876|P1|STARTED|Wash-out Period (7 Days)||8
7691987|NCT01857258|18941875|P2|NOT COMPLETED|First Intervention (3 h Postprandially)||0
7691988|NCT01857258|18941876|P1|NOT COMPLETED|First Intervention (3 h Postprandially)||0
7691989|NCT01857258|18941875|P2|COMPLETED|First Intervention (3 h Postprandially)||7
7691990|NCT01857258|18941876|P1|COMPLETED|First Intervention (3 h Postprandially)||8
7691991|NCT01857258|18941875|P2|STARTED|First Intervention (3 h Postprandially)||7
7691992|NCT01857258|18941876|P1|STARTED|First Intervention (3 h Postprandially)||8
7691993|NCT01857232|18941901|P5|NOT COMPLETED|Overall Study||6
7691994|NCT01857232|18941902|P4|NOT COMPLETED|Overall Study||2
7691995|NCT01857232|18941903|P3|NOT COMPLETED|Overall Study||4
7691996|NCT01857232|18941904|P2|NOT COMPLETED|Overall Study||2
7691997|NCT01857232|18941905|P1|NOT COMPLETED|Overall Study||8
7691998|NCT01857232|18941901|P5|COMPLETED|Overall Study||63
7691999|NCT01857232|18941902|P4|COMPLETED|Overall Study||68
7692000|NCT01857232|18941903|P3|COMPLETED|Overall Study||63
7692001|NCT01857232|18941904|P2|COMPLETED|Overall Study||65
7692002|NCT01857232|18941905|P1|COMPLETED|Overall Study||61
7692003|NCT01857232|18941901|P5|Evaluable ITT|Overall Study||65
7692004|NCT01857232|18941902|P4|Evaluable ITT|Overall Study||68
7692005|NCT01857232|18941903|P3|Evaluable ITT|Overall Study||63
7692006|NCT01857232|18941904|P2|Evaluable ITT|Overall Study||66
7692007|NCT01857232|18941905|P1|Evaluable ITT|Overall Study||66
7692008|NCT01857232|18941901|P5|STARTED|Overall Study||69
7692009|NCT01857232|18941902|P4|STARTED|Overall Study||70
7692010|NCT01857232|18941903|P3|STARTED|Overall Study||67
7692011|NCT01857232|18941904|P2|STARTED|Overall Study||67
7692012|NCT01857232|18941905|P1|STARTED|Overall Study||69
7692013|NCT01857206|18941924|P2|NOT COMPLETED|Overall Study||10
7692014|NCT01857206|18941925|P1|NOT COMPLETED|Overall Study||13
7692015|NCT01857206|18941924|P2|COMPLETED|Overall Study||673
7692016|NCT01857206|18941925|P1|COMPLETED|Overall Study||1359
7692017|NCT01857206|18941924|P2|STARTED|Overall Study||683
7692018|NCT01857206|18941925|P1|STARTED|Overall Study||1372
7692019|NCT01857102|18941943|P2|NOT COMPLETED|Period 2||0
7692020|NCT01857102|18941944|P1|NOT COMPLETED|Period 2||2
7692021|NCT01857102|18941943|P2|COMPLETED|Period 2||51
7692022|NCT01857102|18941944|P1|COMPLETED|Period 2||53
7692023|NCT01857102|18941943|P2|Neophytes|Period 2||4
7692024|NCT01857102|18941944|P1|Neophytes|Period 2||7
7692025|NCT01857102|18941943|P2|Habitual Users|Period 2||47
7692026|NCT01857102|18941944|P1|Habitual Users|Period 2||48
7692027|NCT01857102|18941943|P2|STARTED|Period 2||51
7692028|NCT01857102|18941944|P1|STARTED|Period 2||55
7692029|NCT01857102|18941943|P2|NOT COMPLETED|Period 1||5
7692030|NCT01857102|18941944|P1|NOT COMPLETED|Period 1||3
7692031|NCT01857102|18941943|P2|COMPLETED|Period 1||51
7692032|NCT01857102|18941944|P1|COMPLETED|Period 1||55
7692033|NCT01857102|18941943|P2|Neophtyes|Period 1||4
7692034|NCT01857102|18941944|P1|Neophtyes|Period 1||7
7692035|NCT01857102|18941943|P2|Habitual Users|Period 1||52
7692036|NCT01857102|18941944|P1|Habitual Users|Period 1||51
7692037|NCT01857102|18941943|P2|STARTED|Period 1||56
7692038|NCT01857102|18941944|P1|STARTED|Period 1||58
7692039|NCT01857063|18941954|P2|NOT COMPLETED|Period 2 (7 Days)||2
7692040|NCT01857063|18941955|P1|NOT COMPLETED|Period 2 (7 Days)||4
7692041|NCT01857063|18941954|P2|COMPLETED|Period 2 (7 Days)||104
7692042|NCT01857063|18941955|P1|COMPLETED|Period 2 (7 Days)||104
7692043|NCT01857063|18941954|P2|STARTED|Period 2 (7 Days)||106
7692044|NCT01857063|18941955|P1|STARTED|Period 2 (7 Days)||108
7692045|NCT01857063|18941954|P2|NOT COMPLETED|Period 1 (7 Days)||4
7692046|NCT01857063|18941955|P1|NOT COMPLETED|Period 1 (7 Days)||2
7692047|NCT01857063|18941954|P2|COMPLETED|Period 1 (7 Days)||106
7692048|NCT01857063|18941955|P1|COMPLETED|Period 1 (7 Days)||108
7692049|NCT01857063|18941954|P2|STARTED|Period 1 (7 Days)||110
7692050|NCT01857063|18941955|P1|STARTED|Period 1 (7 Days)||110
7692051|NCT01856933|18941981|P1|NOT COMPLETED|Overall Study||0
7692052|NCT01856933|18941981|P1|COMPLETED|Overall Study||6
7692053|NCT01856933|18941981|P1|STARTED|Overall Study||6
7692054|NCT01856907|18941989|P3|NOT COMPLETED|Overall Study||0
7692055|NCT01856907|18941990|P2|NOT COMPLETED|Overall Study||3
7692056|NCT01856907|18941991|P1|NOT COMPLETED|Overall Study||0
7692057|NCT01856907|18941989|P3|COMPLETED|Overall Study||12
7692058|NCT01856907|18941990|P2|COMPLETED|Overall Study||9
7692059|NCT01856907|18941991|P1|COMPLETED|Overall Study||12
7692060|NCT01856907|18941989|P3|STARTED|Overall Study||12
7692061|NCT01856907|18941990|P2|STARTED|Overall Study||12
7692062|NCT01856907|18941991|P1|STARTED|Overall Study||12
7692063|NCT01856790|18942029|P1|NOT COMPLETED|Closed Loop Control + Liraglutide||2
7692064|NCT01856790|18942029|P1|COMPLETED|Closed Loop Control + Liraglutide||11
7692065|NCT01856790|18942029|P1|STARTED|Closed Loop Control + Liraglutide||13
7692066|NCT01856790|18942029|P1|NOT COMPLETED|Closed Loop Control||2
7692067|NCT01856790|18942029|P1|COMPLETED|Closed Loop Control||13
7692068|NCT01856790|18942029|P1|STARTED|Closed Loop Control||15
7692069|NCT01856764|18942055|P2|NOT COMPLETED|Overall Study||0
7692070|NCT01856764|18942056|P1|NOT COMPLETED|Overall Study||0
7692071|NCT01856764|18942055|P2|COMPLETED|Overall Study||20
7692072|NCT01856764|18942056|P1|COMPLETED|Overall Study||20
7692073|NCT01856764|18942055|P2|STARTED|Overall Study||20
7692074|NCT01856764|18942056|P1|STARTED|Overall Study||20
7692075|NCT01856712|18942068|P2|NOT COMPLETED|Overall Study||3
7692076|NCT01856712|18942069|P1|NOT COMPLETED|Overall Study||7
7692077|NCT01856712|18942068|P2|COMPLETED|Overall Study||19
7692078|NCT01856712|18942069|P1|COMPLETED|Overall Study||16
7692079|NCT01856712|18942068|P2|Lost to 45 Day Follow up|Overall Study||1
7692080|NCT01856712|18942069|P1|Lost to 45 Day Follow up|Overall Study||1
7692081|NCT01856712|18942068|P2|Lost to 14 Day Follow up|Overall Study||2
7692082|NCT01856712|18942069|P1|Lost to 14 Day Follow up|Overall Study||6
7692083|NCT01856712|18942068|P2|STARTED|Overall Study|1 received oral in error thus randomized.|22
7692084|NCT01856712|18942069|P1|STARTED|Overall Study||23
7692085|NCT01856686|18942083|P2|NOT COMPLETED|Overall Study||11
7692086|NCT01856686|18942084|P1|NOT COMPLETED|Overall Study||5
7692087|NCT01856686|18942083|P2|COMPLETED|Overall Study||22
7692088|NCT01856686|18942084|P1|COMPLETED|Overall Study||26
7692089|NCT01856686|18942083|P2|STARTED|Overall Study||33
7692090|NCT01856686|18942084|P1|STARTED|Overall Study||31
7692091|NCT01856673|18942127|P3|NOT COMPLETED|Overall Study||34
7692092|NCT01856673|18942128|P2|NOT COMPLETED|Overall Study||85
7692093|NCT01856673|18942129|P1|NOT COMPLETED|Overall Study||98
7692094|NCT01856673|18942127|P3|COMPLETED|Overall Study||137
7692095|NCT01856673|18942128|P2|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90
7692096|NCT01856673|18942129|P1|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|77
7692097|NCT01856673|18942127|P3|Quibdó Participants|Overall Study||83
7692098|NCT01856673|18942128|P2|Quibdó Participants|Overall Study||86
7692099|NCT01856673|18942129|P1|Quibdó Participants|Overall Study||83
7692100|NCT01856673|18942127|P3|Buenaventura Participants|Overall Study||88
7692101|NCT01856673|18942128|P2|Buenaventura Participants|Overall Study||89
7692102|NCT01856673|18942129|P1|Buenaventura Participants|Overall Study||92
7692103|NCT01856673|18942127|P3|STARTED|Overall Study||171
7692104|NCT01856673|18942128|P2|STARTED|Overall Study||175
7692105|NCT01856673|18942129|P1|STARTED|Overall Study||175
7692106|NCT01856595|18942149|P9|NOT COMPLETED|Overall Study||0
7692107|NCT01856595|18942150|P8|NOT COMPLETED|Overall Study||0
7692108|NCT01856595|18942151|P7|NOT COMPLETED|Overall Study||1
7692109|NCT01856595|18942152|P6|NOT COMPLETED|Overall Study||0
7692110|NCT01856595|18942153|P5|NOT COMPLETED|Overall Study||0
7692111|NCT01856595|18942154|P4|NOT COMPLETED|Overall Study||0
7692112|NCT01856595|18942155|P3|NOT COMPLETED|Overall Study||0
7692113|NCT01856595|18942156|P2|NOT COMPLETED|Overall Study||1
7692114|NCT01856595|18942157|P1|NOT COMPLETED|Overall Study||0
7692115|NCT01856595|18942149|P9|COMPLETED|Overall Study||14
7692116|NCT01856595|18942150|P8|COMPLETED|Overall Study||10
7692117|NCT01856595|18942151|P7|COMPLETED|Overall Study||12
7692118|NCT01856595|18942152|P6|COMPLETED|Overall Study||12
7692119|NCT01856595|18942153|P5|COMPLETED|Overall Study||14
7692120|NCT01856595|18942154|P4|COMPLETED|Overall Study||12
7692121|NCT01856595|18942155|P3|COMPLETED|Overall Study||12
7692122|NCT01856595|18942156|P2|COMPLETED|Overall Study||11
7692123|NCT01856595|18942157|P1|COMPLETED|Overall Study||18
7692124|NCT01856595|18942149|P9|STARTED|Overall Study||14
7692125|NCT01856595|18942150|P8|STARTED|Overall Study||10
7692126|NCT01856595|18942151|P7|STARTED|Overall Study||13
7692127|NCT01856595|18942152|P6|STARTED|Overall Study||12
7692128|NCT01856595|18942153|P5|STARTED|Overall Study||14
7692129|NCT01856595|18942154|P4|STARTED|Overall Study||12
7692130|NCT01856595|18942155|P3|STARTED|Overall Study||12
7692131|NCT01856595|18942156|P2|STARTED|Overall Study||12
7692132|NCT01856595|18942157|P1|STARTED|Overall Study||18
7692133|NCT01856582|18942390|P1|NOT COMPLETED|Overall Study||1
7692134|NCT01856582|18942390|P1|COMPLETED|Overall Study||22
7692135|NCT01856582|18942390|P1|STARTED|Overall Study||23
7692136|NCT01856569|18942394|P1|NOT COMPLETED|Overall Study||13
7692137|NCT01856569|18942394|P1|COMPLETED|Overall Study||139
7692138|NCT01856569|18942394|P1|Full Analysis Set|Overall Study||144
7692139|NCT01856569|18942394|P1|STARTED|Overall Study||152
7692140|NCT01856543|18942405|P2|NOT COMPLETED|Overall Study||6
7692141|NCT01856543|18942406|P1|NOT COMPLETED|Overall Study||13
7692142|NCT01856543|18942405|P2|COMPLETED|Overall Study||64
7692143|NCT01856543|18942406|P1|COMPLETED|Overall Study||60
7692144|NCT01856543|18942405|P2|STARTED|Overall Study||70
7692145|NCT01856543|18942406|P1|STARTED|Overall Study||73
7692146|NCT01856530|18942418|P2|NOT COMPLETED|Overall Study||0
7692147|NCT01856530|18942419|P1|NOT COMPLETED|Overall Study||0
7692148|NCT01856530|18942418|P2|COMPLETED|Overall Study||27
7692149|NCT01856530|18942419|P1|COMPLETED|Overall Study||27
7692150|NCT01856530|18942418|P2|STARTED|Overall Study||27
7692151|NCT01856530|18942419|P1|STARTED|Overall Study||27
7692152|NCT01856491|18942435|P1|NOT COMPLETED|Overall Study||15
7692153|NCT01856491|18942435|P1|COMPLETED|Overall Study||152
7692154|NCT01856491|18942435|P1|STARTED|Overall Study||167
7692155|NCT01856361|18942446|P2|NOT COMPLETED|Overall Study||0
7692156|NCT01856361|18942447|P1|NOT COMPLETED|Overall Study||0
7692157|NCT01856361|18942446|P2|COMPLETED|Overall Study||1
7692158|NCT01856361|18942447|P1|COMPLETED|Overall Study||1
7692159|NCT01856361|18942446|P2|STARTED|Overall Study||1
7692160|NCT01856361|18942447|P1|STARTED|Overall Study||1
7692161|NCT01856322|18942464|P3|NOT COMPLETED|Overall Study||3
7692162|NCT01856322|18942465|P2|NOT COMPLETED|Overall Study||0
7692163|NCT01856322|18942466|P1|NOT COMPLETED|Overall Study||0
7692164|NCT01856322|18942464|P3|COMPLETED|Overall Study||0
7692165|NCT01856322|18942465|P2|COMPLETED|Overall Study||0
7692166|NCT01856322|18942466|P1|COMPLETED|Overall Study||0
7692167|NCT01856322|18942464|P3|STARTED|Overall Study||3
7692168|NCT01856322|18942465|P2|STARTED|Overall Study||0
7692169|NCT01856322|18942466|P1|STARTED|Overall Study||0
7692170|NCT01856309|18942477|P4|NOT COMPLETED|Overall Study||609
7692171|NCT01856309|18942478|P3|NOT COMPLETED|Overall Study||595
7692172|NCT01856309|18942479|P2|NOT COMPLETED|Overall Study||288
7692173|NCT01856309|18942480|P1|NOT COMPLETED|Overall Study||299
7692174|NCT01856309|18942477|P4|COMPLETED|Overall Study||9
7692175|NCT01856309|18942478|P3|COMPLETED|Overall Study||11
7692176|NCT01856309|18942479|P2|COMPLETED|Overall Study||3
7692177|NCT01856309|18942480|P1|COMPLETED|Overall Study||6
7692178|NCT01856309|18942477|P4|Treated Partcipants|Overall Study||618
7692179|NCT01856309|18942478|P3|Treated Partcipants|Overall Study||605
7692180|NCT01856309|18942479|P2|Treated Partcipants|Overall Study||290
7692181|NCT01856309|18942480|P1|Treated Partcipants|Overall Study||305
7692182|NCT01856309|18942477|P4|Participants From Study CNTO136ARA3003|Overall Study||206
7692183|NCT01856309|18942478|P3|Participants From Study CNTO136ARA3003|Overall Study||201
7692184|NCT01856309|18942479|P2|Participants From Study CNTO136ARA3003|Overall Study||104
7692185|NCT01856309|18942480|P1|Participants From Study CNTO136ARA3003|Overall Study||108
7692186|NCT01856309|18942477|P4|Participants From Study CNTO136ARA3002|Overall Study||412
7692187|NCT01856309|18942478|P3|Participants From Study CNTO136ARA3002|Overall Study||405
7692188|NCT01856309|18942479|P2|Participants From Study CNTO136ARA3002|Overall Study||187
7692189|NCT01856309|18942480|P1|Participants From Study CNTO136ARA3002|Overall Study||197
7692190|NCT01856309|18942477|P4|STARTED|Overall Study||618
7692191|NCT01856309|18942478|P3|STARTED|Overall Study||606
7692192|NCT01856309|18942479|P2|STARTED|Overall Study||291
7692193|NCT01856309|18942480|P1|STARTED|Overall Study||305
7692194|NCT01856270|18942580|P2|NOT COMPLETED|Overall Study||12
7692195|NCT01856270|18942581|P1|NOT COMPLETED|Overall Study||11
7692196|NCT01856270|18942580|P2|COMPLETED|Overall Study||14
7692197|NCT01856270|18942581|P1|COMPLETED|Overall Study||13
7692198|NCT01856270|18942580|P2|STARTED|Overall Study||26
7692199|NCT01856270|18942581|P1|STARTED|Overall Study||24
7692200|NCT01856257|18942604|P4|NOT COMPLETED|Overall Study||2
7692201|NCT01856257|18942605|P3|NOT COMPLETED|Overall Study||0
7692202|NCT01856257|18942606|P2|NOT COMPLETED|Overall Study||1
7692203|NCT01856257|18942607|P1|NOT COMPLETED|Overall Study||3
7692204|NCT01856257|18942604|P4|COMPLETED|Overall Study||0
7692205|NCT01856257|18942605|P3|COMPLETED|Overall Study||11
7692206|NCT01856257|18942606|P2|COMPLETED|Overall Study||28
7692207|NCT01856257|18942607|P1|COMPLETED|Overall Study||26
7692208|NCT01856257|18942604|P4|STARTED|Overall Study||2
7692209|NCT01856257|18942605|P3|STARTED|Overall Study||11
7692210|NCT01856257|18942606|P2|STARTED|Overall Study||29
7692211|NCT01856257|18942607|P1|STARTED|Overall Study||29
7692212|NCT01856218|18942706|P1|NOT COMPLETED|Long-Term Extension Phase||0
7692213|NCT01856218|18942706|P1|COMPLETED|Long-Term Extension Phase||3
7692214|NCT01856218|18942706|P1|STARTED|Long-Term Extension Phase||3
7692215|NCT01856218|18942706|P1|NOT COMPLETED|First Phase||0
7692216|NCT01856218|18942706|P1|COMPLETED|First Phase||3
7692217|NCT01856218|18942706|P1|STARTED|First Phase||3
7692218|NCT01856114|18942722|P2|NOT COMPLETED|Overall Study||0
7692219|NCT01856114|18942723|P1|NOT COMPLETED|Overall Study||2
7692220|NCT01856114|18942722|P2|COMPLETED|Overall Study||11
7692221|NCT01856114|18942723|P1|COMPLETED|Overall Study||9
7692222|NCT01856114|18942722|P2|STARTED|Overall Study||11
7692223|NCT01856114|18942723|P1|STARTED|Overall Study||11
7692224|NCT01855997|18942733|P1|NOT COMPLETED|Overall Study||0
7692225|NCT01855997|18942733|P1|COMPLETED|Overall Study||1669
7692226|NCT01855997|18942733|P1|STARTED|Overall Study||1669
7692227|NCT01855958|18942788|P2|NOT COMPLETED|Overall Study||0
7692228|NCT01855958|18942789|P1|NOT COMPLETED|Overall Study||1
7692229|NCT01855958|18942788|P2|COMPLETED|Overall Study||13
7692230|NCT01855958|18942789|P1|COMPLETED|Overall Study||12
7692231|NCT01855958|18942788|P2|STARTED|Overall Study||13
7692232|NCT01855958|18942789|P1|STARTED|Overall Study||13
7692233|NCT01855945|18942819|P12|NOT COMPLETED|Overall Study||3
7692234|NCT01855945|18942820|P11|NOT COMPLETED|Overall Study||5
7692235|NCT01855945|18942821|P10|NOT COMPLETED|Overall Study||2
7692236|NCT01855945|18942822|P9|NOT COMPLETED|Overall Study||2
7692237|NCT01855945|18942823|P8|NOT COMPLETED|Overall Study||8
7692238|NCT01855945|18942824|P7|NOT COMPLETED|Overall Study||10
7692239|NCT01855945|18942825|P6|NOT COMPLETED|Overall Study||3
7692240|NCT01855945|18942826|P5|NOT COMPLETED|Overall Study||1
7692241|NCT01855945|18942827|P4|NOT COMPLETED|Overall Study||4
7692242|NCT01855945|18942828|P3|NOT COMPLETED|Overall Study||12
7692243|NCT01855945|18942829|P2|NOT COMPLETED|Overall Study||11
7692244|NCT01855945|18942830|P1|NOT COMPLETED|Overall Study||16
7692245|NCT01855945|18942819|P12|COMPLETED|Overall Study||49
7692246|NCT01855945|18942820|P11|COMPLETED|Overall Study||46
7692247|NCT01855945|18942821|P10|COMPLETED|Overall Study||49
7692248|NCT01855945|18942822|P9|COMPLETED|Overall Study||46
7692249|NCT01855945|18942823|P8|COMPLETED|Overall Study||47
7692250|NCT01855945|18942824|P7|COMPLETED|Overall Study||43
7692251|NCT01855945|18942825|P6|COMPLETED|Overall Study||50
7692252|NCT01855945|18942826|P5|COMPLETED|Overall Study||50
7692253|NCT01855945|18942827|P4|COMPLETED|Overall Study||49
7692254|NCT01855945|18942828|P3|COMPLETED|Overall Study||39
7692255|NCT01855945|18942829|P2|COMPLETED|Overall Study||44
7692256|NCT01855945|18942830|P1|COMPLETED|Overall Study||38
7692257|NCT01855945|18942819|P12|STARTED|Overall Study||52
7692258|NCT01855945|18942820|P11|STARTED|Overall Study||51
7692259|NCT01855945|18942821|P10|STARTED|Overall Study||51
7692260|NCT01855945|18942822|P9|STARTED|Overall Study||48
7692261|NCT01855945|18942823|P8|STARTED|Overall Study||55
7692262|NCT01855945|18942824|P7|STARTED|Overall Study||53
7692263|NCT01855945|18942825|P6|STARTED|Overall Study||53
7692264|NCT01855945|18942826|P5|STARTED|Overall Study||51
7692265|NCT01855945|18942827|P4|STARTED|Overall Study||53
7692266|NCT01855945|18942828|P3|STARTED|Overall Study||51
7692267|NCT01855945|18942829|P2|STARTED|Overall Study||55
7692268|NCT01855945|18942830|P1|STARTED|Overall Study||54
7692269|NCT01855919|18942966|P2|NOT COMPLETED|Overall Study||26
7692270|NCT01855919|18942967|P1|NOT COMPLETED|Overall Study||23
7692271|NCT01855919|18942966|P2|COMPLETED|Overall Study||200
7692272|NCT01855919|18942967|P1|COMPLETED|Overall Study||209
7692273|NCT01855919|18942966|P2|Received at Least 1 Dose of Study Drug|Overall Study||226
7692274|NCT01855919|18942967|P1|Received at Least 1 Dose of Study Drug|Overall Study||232
7692275|NCT01855919|18942966|P2|STARTED|Overall Study||226
7692276|NCT01855919|18942967|P1|STARTED|Overall Study||232
7692277|NCT01855828|18942999|P1|NOT COMPLETED|Overall Study||2
7692278|NCT01855828|18942999|P1|COMPLETED|Overall Study||48
7692279|NCT01855828|18942999|P1|STARTED|Overall Study||50
7692280|NCT01855789|18943009|P4|NOT COMPLETED|2) Week 24 up to End of Study||58
7692281|NCT01855789|18943010|P3|NOT COMPLETED|2) Week 24 up to End of Study||18
7692282|NCT01855789|18943011|P2|NOT COMPLETED|2) Week 24 up to End of Study||15
7692283|NCT01855789|18943012|P1|NOT COMPLETED|2) Week 24 up to End of Study||0
7692284|NCT01855789|18943009|P4|COMPLETED|2) Week 24 up to End of Study||250
7692285|NCT01855789|18943010|P3|COMPLETED|2) Week 24 up to End of Study||129
7692286|NCT01855789|18943011|P2|COMPLETED|2) Week 24 up to End of Study||132
7692287|NCT01855789|18943012|P1|COMPLETED|2) Week 24 up to End of Study||0
7692288|NCT01855789|18943009|P4|STARTED|2) Week 24 up to End of Study||308
7692289|NCT01855789|18943010|P3|STARTED|2) Week 24 up to End of Study||147
7692290|NCT01855789|18943011|P2|STARTED|2) Week 24 up to End of Study||147
7692291|NCT01855789|18943012|P1|STARTED|2) Week 24 up to End of Study||0
7692292|NCT01855789|18943009|P4|NOT COMPLETED|1) Baseline up to Week 24||0
7692293|NCT01855789|18943010|P3|NOT COMPLETED|1) Baseline up to Week 24||0
7692294|NCT01855789|18943011|P2|NOT COMPLETED|1) Baseline up to Week 24||0
7692295|NCT01855789|18943012|P1|NOT COMPLETED|1) Baseline up to Week 24||116
7692296|NCT01855789|18943009|P4|COMPLETED|1) Baseline up to Week 24||0
7692297|NCT01855789|18943010|P3|COMPLETED|1) Baseline up to Week 24||0
7692298|NCT01855789|18943011|P2|COMPLETED|1) Baseline up to Week 24||0
7692299|NCT01855789|18943012|P1|COMPLETED|1) Baseline up to Week 24||602
7692300|NCT01855789|18943009|P4|STARTED|1) Baseline up to Week 24||0
7692301|NCT01855789|18943010|P3|STARTED|1) Baseline up to Week 24||0
7692302|NCT01855789|18943011|P2|STARTED|1) Baseline up to Week 24||0
7692303|NCT01855789|18943012|P1|STARTED|1) Baseline up to Week 24||718
7692304|NCT01855750|18943036|P2|NOT COMPLETED|Overall Study||419
7692305|NCT01855750|18943037|P1|NOT COMPLETED|Overall Study||419
7692306|NCT01855750|18943036|P2|COMPLETED|Overall Study||0
7692307|NCT01855750|18943037|P1|COMPLETED|Overall Study||0
7692308|NCT01855750|18943036|P2|Treated|Overall Study|1 participant not treated: withdrew consent.|418
7692309|NCT01855750|18943037|P1|Treated|Overall Study|3 participants not treated:2 withdrew consent and 1 not treated per Sponsor/investigator's decision.|416
7692310|NCT01855750|18943036|P2|STARTED|Overall Study||419
7692311|NCT01855750|18943037|P1|STARTED|Overall Study||419
7692312|NCT01855425|18943053|P1|NOT COMPLETED|Overall Study||20
7692313|NCT01855425|18943053|P1|COMPLETED|Overall Study||76
7692314|NCT01855425|18943053|P1|STARTED|Overall Study||96
7692315|NCT01855399|18943059|P2|NOT COMPLETED|12 Month||11
7692316|NCT01855399|18943060|P1|NOT COMPLETED|12 Month||7
7692317|NCT01855399|18943059|P2|COMPLETED|12 Month||118
7692318|NCT01855399|18943060|P1|COMPLETED|12 Month||119
7692319|NCT01855399|18943059|P2|STARTED|12 Month||129
7692320|NCT01855399|18943060|P1|STARTED|12 Month||126
7692321|NCT01855399|18943059|P2|NOT COMPLETED|6 Month||15
7692322|NCT01855399|18943060|P1|NOT COMPLETED|6 Month||20
7692323|NCT01855399|18943059|P2|COMPLETED|6 Month||129
7692324|NCT01855399|18943060|P1|COMPLETED|6 Month||126
7692325|NCT01855399|18943059|P2|STARTED|6 Month||144
7692326|NCT01855399|18943060|P1|STARTED|6 Month||146
7692327|NCT01855360|18943066|P1|NOT COMPLETED|Overall Study||10
7692328|NCT01855360|18943066|P1|COMPLETED|Overall Study||30
7692329|NCT01855360|18943066|P1|STARTED|Overall Study||40
7692330|NCT01855243|18943074|P3|NOT COMPLETED|Overall Study||0
7692331|NCT01855243|18943075|P2|NOT COMPLETED|Overall Study||0
7692332|NCT01855243|18943076|P1|NOT COMPLETED|Overall Study||1
7692333|NCT01855243|18943074|P3|COMPLETED|Overall Study||22
7692334|NCT01855243|18943075|P2|COMPLETED|Overall Study||21
7692335|NCT01855243|18943076|P1|COMPLETED|Overall Study||19
7692336|NCT01855243|18943074|P3|STARTED|Overall Study||22
7692337|NCT01855243|18943075|P2|STARTED|Overall Study||21
7692338|NCT01855243|18943076|P1|STARTED|Overall Study||20
7692339|NCT01855126|18943098|P2|NOT COMPLETED|Second Intervention (8 Weeks)||2
7692340|NCT01855126|18943099|P1|NOT COMPLETED|Second Intervention (8 Weeks)||2
7692341|NCT01855126|18943098|P2|COMPLETED|Second Intervention (8 Weeks)||14
7692342|NCT01855126|18943099|P1|COMPLETED|Second Intervention (8 Weeks)||18
7692343|NCT01855126|18943098|P2|STARTED|Second Intervention (8 Weeks)||16
7692344|NCT01855126|18943099|P1|STARTED|Second Intervention (8 Weeks)||20
7692345|NCT01855126|18943098|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
7692346|NCT01855126|18943099|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
7692347|NCT01855126|18943098|P2|COMPLETED|Washout Period (2 Weeks)||16
7692348|NCT01855126|18943099|P1|COMPLETED|Washout Period (2 Weeks)||20
7692349|NCT01855126|18943098|P2|STARTED|Washout Period (2 Weeks)||16
7692350|NCT01855126|18943099|P1|STARTED|Washout Period (2 Weeks)||20
7692351|NCT01855126|18943098|P2|NOT COMPLETED|First Intervention (8 Weeks)||6
7692352|NCT01855126|18943099|P1|NOT COMPLETED|First Intervention (8 Weeks)||4
7692353|NCT01855126|18943098|P2|COMPLETED|First Intervention (8 Weeks)||16
7692354|NCT01855126|18943099|P1|COMPLETED|First Intervention (8 Weeks)||20
7692355|NCT01855126|18943098|P2|STARTED|First Intervention (8 Weeks)||22
7692356|NCT01855126|18943099|P1|STARTED|First Intervention (8 Weeks)||24
7692357|NCT01855074|18943111|P1|NOT COMPLETED|Overall Study||14
7692358|NCT01855074|18943111|P1|COMPLETED|Overall Study||66
7692359|NCT01855074|18943111|P1|Treated|Overall Study||79
7692360|NCT01855074|18943111|P1|STARTED|Overall Study||80
7692361|NCT01854944|18943123|P3|NOT COMPLETED|Overall Study||1
7692362|NCT01854944|18943124|P2|NOT COMPLETED|Overall Study||0
7692363|NCT01854944|18943125|P1|NOT COMPLETED|Overall Study||0
7692364|NCT01854944|18943123|P3|COMPLETED|Overall Study||3
7692365|NCT01854944|18943124|P2|COMPLETED|Overall Study||4
7692366|NCT01854944|18943125|P1|COMPLETED|Overall Study||4
7692367|NCT01854944|18943123|P3|STARTED|Overall Study||4
7692368|NCT01854944|18943124|P2|STARTED|Overall Study||4
7692369|NCT01854944|18943125|P1|STARTED|Overall Study||4
7692370|NCT01854918|18943177|P2|NOT COMPLETED|All-IP Period (Years 2 and 3)||195
7692371|NCT01854918|18943178|P1|NOT COMPLETED|All-IP Period (Years 2 and 3)||118
7692372|NCT01854918|18943177|P2|COMPLETED|All-IP Period (Years 2 and 3)||2196
7692373|NCT01854918|18943178|P1|COMPLETED|All-IP Period (Years 2 and 3)||1079
7692374|NCT01854918|18943177|P2|Received Evolocumab|All-IP Period (Years 2 and 3)||2291
7692375|NCT01854918|18943178|P1|Received Evolocumab|All-IP Period (Years 2 and 3)||1152
7692376|NCT01854918|18943177|P2|STARTED|All-IP Period (Years 2 and 3)||2391
7692377|NCT01854918|18943178|P1|STARTED|All-IP Period (Years 2 and 3)||1197
7692378|NCT01854918|18943177|P2|NOT COMPLETED|SOC-controlled Period (Year 1)||63
7692379|NCT01854918|18943178|P1|NOT COMPLETED|SOC-controlled Period (Year 1)||30
7692380|NCT01854918|18943177|P2|COMPLETED|SOC-controlled Period (Year 1)||2391
7692381|NCT01854918|18943178|P1|COMPLETED|SOC-controlled Period (Year 1)||1197
7692382|NCT01854918|18943177|P2|Received Evolocumab|SOC-controlled Period (Year 1)||2452
7692383|NCT01854918|18943178|P1|Received Evolocumab|SOC-controlled Period (Year 1)|5 participants received evolocumab in error|5
7692384|NCT01854918|18943177|P2|STARTED|SOC-controlled Period (Year 1)||2454
7692385|NCT01854918|18943178|P1|STARTED|SOC-controlled Period (Year 1)||1227
7692386|NCT01854905|18943193|P1|NOT COMPLETED|Overall Study||0
7692387|NCT01854905|18943193|P1|COMPLETED|Overall Study||400
7692388|NCT01854905|18943193|P1|STARTED|Overall Study||400
7692389|NCT01854879|18943197|P1|NOT COMPLETED|Overall Study||5
7692390|NCT01854879|18943197|P1|COMPLETED|Overall Study|92 had matched endpoint data|92
7692391|NCT01854879|18943197|P1|STARTED|Overall Study|97 consented|97
7692392|NCT01854827|18943201|P1|NOT COMPLETED|Overall Study||1
7692393|NCT01854827|18943201|P1|COMPLETED|Overall Study||29
7692394|NCT01854827|18943201|P1|STARTED|Overall Study||30
7692395|NCT01854710|18943213|P6|NOT COMPLETED|Overall Study||2
7692396|NCT01854710|18943214|P5|NOT COMPLETED|Overall Study||2
7692397|NCT01854710|18943215|P4|NOT COMPLETED|Overall Study||2
7692398|NCT01854710|18943216|P3|NOT COMPLETED|Overall Study||2
7692399|NCT01854710|18943217|P2|NOT COMPLETED|Overall Study||3
7692400|NCT01854710|18943218|P1|NOT COMPLETED|Overall Study||4
7692401|NCT01854710|18943213|P6|COMPLETED|Overall Study||8
7692402|NCT01854710|18943214|P5|COMPLETED|Overall Study||8
7692403|NCT01854710|18943215|P4|COMPLETED|Overall Study||8
7692404|NCT01854710|18943216|P3|COMPLETED|Overall Study||8
7692405|NCT01854710|18943217|P2|COMPLETED|Overall Study||7
7692406|NCT01854710|18943218|P1|COMPLETED|Overall Study||6
7692407|NCT01854710|18943213|P6|STARTED|Overall Study||10
7692408|NCT01854710|18943214|P5|STARTED|Overall Study||10
7692409|NCT01854710|18943215|P4|STARTED|Overall Study||10
7692410|NCT01854710|18943216|P3|STARTED|Overall Study||10
7692411|NCT01854710|18943217|P2|STARTED|Overall Study||10
7692412|NCT01854710|18943218|P1|STARTED|Overall Study||10
7692413|NCT01854697|18943239|P5|NOT COMPLETED|Overall Study||2
7692414|NCT01854697|18943240|P4|NOT COMPLETED|Overall Study||3
7692415|NCT01854697|18943241|P3|NOT COMPLETED|Overall Study||2
7692416|NCT01854697|18943242|P2|NOT COMPLETED|Overall Study||3
7692417|NCT01854697|18943243|P1|NOT COMPLETED|Overall Study||6
7692418|NCT01854697|18943239|P5|COMPLETED|Overall Study||39
7692419|NCT01854697|18943240|P4|COMPLETED|Overall Study||80
7692420|NCT01854697|18943241|P3|COMPLETED|Overall Study||82
7692421|NCT01854697|18943242|P2|COMPLETED|Overall Study||31
7692422|NCT01854697|18943243|P1|COMPLETED|Overall Study||63
7692423|NCT01854697|18943239|P5|STARTED|Overall Study||41
7692424|NCT01854697|18943240|P4|STARTED|Overall Study||83
7692425|NCT01854697|18943241|P3|STARTED|Overall Study||84
7692426|NCT01854697|18943242|P2|STARTED|Overall Study||34
7692427|NCT01854697|18943243|P1|STARTED|Overall Study||69
7692428|NCT01854658|18943287|P4|NOT COMPLETED|Overall Study||59
7692429|NCT01854658|18943288|P3|NOT COMPLETED|Overall Study||80
7692430|NCT01854658|18943289|P2|NOT COMPLETED|Overall Study||75
7692431|NCT01854658|18943290|P1|NOT COMPLETED|Overall Study||93
7692432|NCT01854658|18943287|P4|COMPLETED|Overall Study||165
7692433|NCT01854658|18943288|P3|COMPLETED|Overall Study||432
7692434|NCT01854658|18943289|P2|COMPLETED|Overall Study||365
7692435|NCT01854658|18943290|P1|COMPLETED|Overall Study||346
7692436|NCT01854658|18943287|P4|STARTED|Overall Study||224
7692437|NCT01854658|18943288|P3|STARTED|Overall Study||512
7692438|NCT01854658|18943289|P2|STARTED|Overall Study||440
7692439|NCT01854658|18943290|P1|STARTED|Overall Study||439
7692440|NCT01854645|18943325|P5|NOT COMPLETED|Overall Study||60
7692441|NCT01854645|18943326|P4|NOT COMPLETED|Overall Study||62
7692442|NCT01854645|18943327|P3|NOT COMPLETED|Overall Study||82
7692443|NCT01854645|18943328|P2|NOT COMPLETED|Overall Study||106
7692444|NCT01854645|18943329|P1|NOT COMPLETED|Overall Study||98
7692445|NCT01854645|18943325|P5|COMPLETED|Overall Study||160
7692446|NCT01854645|18943326|P4|COMPLETED|Overall Study||391
7692447|NCT01854645|18943327|P3|COMPLETED|Overall Study||370
7692448|NCT01854645|18943328|P2|COMPLETED|Overall Study||345
7692449|NCT01854645|18943329|P1|COMPLETED|Overall Study||429
7692450|NCT01854645|18943325|P5|STARTED|Overall Study||220
7692451|NCT01854645|18943326|P4|STARTED|Overall Study||453
7692452|NCT01854645|18943327|P3|STARTED|Overall Study||452
7692453|NCT01854645|18943328|P2|STARTED|Overall Study||451
7692454|NCT01854645|18943329|P1|STARTED|Overall Study||527
7692455|NCT01854632|18943368|P2|NOT COMPLETED|Overall Study||13
7692456|NCT01854632|18943369|P1|NOT COMPLETED|Overall Study||26
7692457|NCT01854632|18943368|P2|COMPLETED|Overall Study||574
7692458|NCT01854632|18943369|P1|COMPLETED|Overall Study||1148
7692459|NCT01854632|18943368|P2|STARTED|Overall Study||587
7692460|NCT01854632|18943369|P1|STARTED|Overall Study||1174
7692461|NCT01854593|18943377|P2|NOT COMPLETED|Overall Study||1
7692462|NCT01854593|18943378|P1|NOT COMPLETED|Overall Study||2
7692463|NCT01854593|18943377|P2|COMPLETED|Overall Study||34
7692464|NCT01854593|18943378|P1|COMPLETED|Overall Study||32
7692465|NCT01854593|18943377|P2|STARTED|Overall Study||35
7692466|NCT01854593|18943378|P1|STARTED|Overall Study||34
7692467|NCT01854528|18943410|P2|NOT COMPLETED|Overall Study||15
7692468|NCT01854528|18943411|P1|NOT COMPLETED|Overall Study||0
7692469|NCT01854528|18943410|P2|COMPLETED|Overall Study||32
7692470|NCT01854528|18943411|P1|COMPLETED|Overall Study||101
7692471|NCT01854528|18943410|P2|STARTED|Overall Study||47
7692472|NCT01854528|18943411|P1|STARTED|Overall Study||101
7692473|NCT01854281|18943431|P4|NOT COMPLETED|Overall Study||0
7692474|NCT01854281|18943432|P3|NOT COMPLETED|Overall Study||0
7692475|NCT01854281|18943433|P2|NOT COMPLETED|Overall Study||0
7692476|NCT01854281|18943434|P1|NOT COMPLETED|Overall Study||0
7692477|NCT01854281|18943431|P4|COMPLETED|Overall Study||8
7692478|NCT01854281|18943432|P3|COMPLETED|Overall Study||5
7692479|NCT01854281|18943433|P2|COMPLETED|Overall Study||19
7692480|NCT01854281|18943434|P1|COMPLETED|Overall Study||15
7692481|NCT01854281|18943431|P4|STARTED|Overall Study||8
7692482|NCT01854281|18943432|P3|STARTED|Overall Study||5
7692483|NCT01854281|18943433|P2|STARTED|Overall Study||19
7692484|NCT01854281|18943434|P1|STARTED|Overall Study||15
7692485|NCT01854268|18943444|P1|NOT COMPLETED|Overall Study||0
7692486|NCT01854268|18943444|P1|COMPLETED|Overall Study||25
7692487|NCT01854268|18943444|P1|STARTED|Overall Study||25
7692488|NCT01854242|18943450|P1|NOT COMPLETED|Overall Study||0
7692489|NCT01854242|18943450|P1|COMPLETED|Overall Study||50
7692490|NCT01854242|18943450|P1|STARTED|Overall Study||50
7692491|NCT01854177|18943454|P1|NOT COMPLETED|Overall Study||0
7692492|NCT01854177|18943454|P1|COMPLETED|Overall Study||10
7692493|NCT01854177|18943454|P1|STARTED|Overall Study||10
7692494|NCT01854138|18943464|P2|NOT COMPLETED|Overall Study||52
7692495|NCT01854138|18943465|P1|NOT COMPLETED|Overall Study||0
7692496|NCT01854138|18943464|P2|COMPLETED|Overall Study||196
7692497|NCT01854138|18943465|P1|COMPLETED|Overall Study||400
7692498|NCT01854138|18943464|P2|STARTED|Overall Study||248
7692499|NCT01854138|18943465|P1|STARTED|Overall Study|historical control with waiver of authorization; no informed consent signed|400
7692500|NCT01854047|18943482|P5|NOT COMPLETED|Overall Study||19
7692501|NCT01854047|18943483|P4|NOT COMPLETED|Overall Study||15
7692502|NCT01854047|18943484|P3|NOT COMPLETED|Overall Study||13
7692503|NCT01854047|18943485|P2|NOT COMPLETED|Overall Study||8
7692504|NCT01854047|18943486|P1|NOT COMPLETED|Overall Study||12
7692505|NCT01854047|18943482|P5|COMPLETED|Overall Study||135
7692506|NCT01854047|18943483|P4|COMPLETED|Overall Study||142
7692507|NCT01854047|18943484|P3|COMPLETED|Overall Study||137
7692508|NCT01854047|18943485|P2|COMPLETED|Overall Study||149
7692509|NCT01854047|18943486|P1|COMPLETED|Overall Study||146
7692510|NCT01854047|18943482|P5|Completed 12-week Study Treatment|Overall Study||143
7692511|NCT01854047|18943483|P4|Completed 12-week Study Treatment|Overall Study||146
7692512|NCT01854047|18943484|P3|Completed 12-week Study Treatment|Overall Study||141
7692513|NCT01854047|18943485|P2|Completed 12-week Study Treatment|Overall Study||149
7692514|NCT01854047|18943486|P1|Completed 12-week Study Treatment|Overall Study||153
7692515|NCT01854047|18943482|P5|Treated|Overall Study||150
7692516|NCT01854047|18943483|P4|Treated|Overall Study||157
7692517|NCT01854047|18943484|P3|Treated|Overall Study||148
7692518|NCT01854047|18943485|P2|Treated|Overall Study||156
7692519|NCT01854047|18943486|P1|Treated|Overall Study||158
7692520|NCT01854047|18943482|P5|STARTED|Overall Study||154
7692521|NCT01854047|18943483|P4|STARTED|Overall Study||157
7692522|NCT01854047|18943484|P3|STARTED|Overall Study||150
7692523|NCT01854047|18943485|P2|STARTED|Overall Study||157
7692524|NCT01854047|18943486|P1|STARTED|Overall Study||158
7692525|NCT01854034|18943608|P1|NOT COMPLETED|Overall Study||0
7692526|NCT01854034|18943608|P1|COMPLETED|Overall Study||29
7692527|NCT01854034|18943608|P1|STARTED|Overall Study||29
7692528|NCT01853982|18943617|P2|NOT COMPLETED|Overall Study||1
7692529|NCT01853982|18943618|P1|NOT COMPLETED|Overall Study||2
7692530|NCT01853982|18943617|P2|COMPLETED|Overall Study||1
7692531|NCT01853982|18943618|P1|COMPLETED|Overall Study||0
7692532|NCT01853982|18943617|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
7692533|NCT01853982|18943618|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
7692534|NCT01853982|18943617|P2|STARTED|Overall Study||2
7692535|NCT01853982|18943618|P1|STARTED|Overall Study||2
7692536|NCT01853930|18943626|P2|NOT COMPLETED|Overall Study||0
7692537|NCT01853930|18943627|P1|NOT COMPLETED|Overall Study||0
7692538|NCT01853930|18943626|P2|COMPLETED|Overall Study||8
7692539|NCT01853930|18943627|P1|COMPLETED|Overall Study||25
7692540|NCT01853930|18943626|P2|STARTED|Overall Study||8
7692541|NCT01853930|18943627|P1|STARTED|Overall Study||25
7692542|NCT01853878|18943635|P2|NOT COMPLETED|Overall Study||44
7692543|NCT01853878|18943636|P1|NOT COMPLETED|Overall Study||63
7692544|NCT01853878|18943635|P2|COMPLETED|Overall Study||3
7692545|NCT01853878|18943636|P1|COMPLETED|Overall Study||23
7692546|NCT01853878|18943635|P2|STARTED|Overall Study||47
7692547|NCT01853878|18943636|P1|STARTED|Overall Study||86
7692548|NCT01853839|18943660|P1|NOT COMPLETED|Overall Study||429
7692549|NCT01853839|18943660|P1|COMPLETED|Overall Study||1663
7692550|NCT01853839|18943660|P1|STARTED|Overall Study||2092
7692551|NCT01853774|18943682|P2|NOT COMPLETED|Overall Study||28
7692552|NCT01853774|18943683|P1|NOT COMPLETED|Overall Study||46
7692553|NCT01853774|18943682|P2|COMPLETED|Overall Study||134
7692554|NCT01853774|18943683|P1|COMPLETED|Overall Study||211
7692555|NCT01853774|18943682|P2|STARTED|Overall Study||162
7692556|NCT01853774|18943683|P1|STARTED|Overall Study||257
7692557|NCT01853696|18943693|P2|NOT COMPLETED|Overall Study||5
7692558|NCT01853696|18943694|P1|NOT COMPLETED|Overall Study||6
7692559|NCT01853696|18943693|P2|COMPLETED|Overall Study||78
7692560|NCT01853696|18943694|P1|COMPLETED|Overall Study||78
7692561|NCT01853696|18943693|P2|STARTED|Overall Study||83
7692562|NCT01853696|18943694|P1|STARTED|Overall Study||84
7692563|NCT01853644|18943702|P1|NOT COMPLETED|Follow up for 3 Years or Until Death||3
7692564|NCT01853644|18943702|P1|COMPLETED|Follow up for 3 Years or Until Death||26
7692565|NCT01853644|18943702|P1|STARTED|Follow up for 3 Years or Until Death|All patients that are treated on the study go into the follow up period|29
7692566|NCT01853644|18943702|P1|NOT COMPLETED|Continued Treatment After First Response||12
7692567|NCT01853644|18943702|P1|COMPLETED|Continued Treatment After First Response||12
7692568|NCT01853644|18943702|P1|STARTED|Continued Treatment After First Response||24
7692569|NCT01853644|18943702|P1|NOT COMPLETED|Reached First Response/Complete 2 Cycles||6
7692570|NCT01853644|18943702|P1|COMPLETED|Reached First Response/Complete 2 Cycles||24
7692571|NCT01853644|18943702|P1|STARTED|Reached First Response/Complete 2 Cycles||30
7692572|NCT01853644|18943702|P1|NOT COMPLETED|Registration and Treatment Start||1
7692573|NCT01853644|18943702|P1|COMPLETED|Registration and Treatment Start||30
7692574|NCT01853644|18943702|P1|Started Treatment|Registration and Treatment Start||30
7692575|NCT01853644|18943702|P1|Registered|Registration and Treatment Start||31
7692576|NCT01853644|18943702|P1|STARTED|Registration and Treatment Start||31
7692577|NCT01853618|18943716|P5|NOT COMPLETED|Overall Study||3
7692578|NCT01853618|18943717|P4|NOT COMPLETED|Overall Study||1
7692579|NCT01853618|18943718|P3|NOT COMPLETED|Overall Study||2
7692580|NCT01853618|18943719|P2|NOT COMPLETED|Overall Study||2
7692581|NCT01853618|18943720|P1|NOT COMPLETED|Overall Study||2
7692582|NCT01853618|18943716|P5|COMPLETED|Overall Study||17
7692583|NCT01853618|18943717|P4|COMPLETED|Overall Study||8
7692584|NCT01853618|18943718|P3|COMPLETED|Overall Study||10
7692585|NCT01853618|18943719|P2|COMPLETED|Overall Study||10
7692586|NCT01853618|18943720|P1|COMPLETED|Overall Study||6
7692587|NCT01853618|18943716|P5|STARTED|Overall Study||20
7692588|NCT01853618|18943717|P4|STARTED|Overall Study||9
7692589|NCT01853618|18943718|P3|STARTED|Overall Study||12
7692590|NCT01853618|18943719|P2|STARTED|Overall Study||12
7692591|NCT01853618|18943720|P1|STARTED|Overall Study||8
7692592|NCT01853605|18943751|P4|NOT COMPLETED|Overall Study||0
7692593|NCT01853605|18943752|P3|NOT COMPLETED|Overall Study||0
7692594|NCT01853605|18943753|P2|NOT COMPLETED|Overall Study||0
7692595|NCT01853605|18943754|P1|NOT COMPLETED|Overall Study||0
7692596|NCT01853605|18943751|P4|COMPLETED|Overall Study||428
7692597|NCT01853605|18943752|P3|COMPLETED|Overall Study||751
7692598|NCT01853605|18943753|P2|COMPLETED|Overall Study||693
7692599|NCT01853605|18943754|P1|COMPLETED|Overall Study||1939
7692600|NCT01853605|18943751|P4|STARTED|Overall Study||428
7692601|NCT01853605|18943752|P3|STARTED|Overall Study||751
7692602|NCT01853605|18943753|P2|STARTED|Overall Study||693
7692603|NCT01853605|18943754|P1|STARTED|Overall Study||1939
7692604|NCT01853553|18943774|P2|NOT COMPLETED|Overall Study||0
7692605|NCT01853553|18943775|P1|NOT COMPLETED|Overall Study||1
7692606|NCT01853553|18943774|P2|COMPLETED|Overall Study||32
7692607|NCT01853553|18943775|P1|COMPLETED|Overall Study||28
7692608|NCT01853553|18943774|P2|STARTED|Overall Study||32
7692609|NCT01853553|18943775|P1|STARTED|Overall Study||29
7692610|NCT01853475|18943786|P3|NOT COMPLETED|Overall Study||0
7692611|NCT01853475|18943787|P2|NOT COMPLETED|Overall Study||1
7692612|NCT01853475|18943788|P1|NOT COMPLETED|Overall Study||0
7692613|NCT01853475|18943786|P3|COMPLETED|Overall Study||8
7692614|NCT01853475|18943787|P2|COMPLETED|Overall Study||7
7692615|NCT01853475|18943788|P1|COMPLETED|Overall Study||8
7692616|NCT01853475|18943786|P3|STARTED|Overall Study||8
7692617|NCT01853475|18943787|P2|STARTED|Overall Study||8
7692618|NCT01853475|18943788|P1|STARTED|Overall Study||8
7692619|NCT01853462|18943807|P2|NOT COMPLETED|Overall Study||1
7692620|NCT01853462|18943808|P1|NOT COMPLETED|Overall Study||1
7692621|NCT01853462|18943807|P2|COMPLETED|Overall Study||10
7692622|NCT01853462|18943808|P1|COMPLETED|Overall Study||10
7692623|NCT01853462|18943807|P2|STARTED|Overall Study||11
7692624|NCT01853462|18943808|P1|STARTED|Overall Study||11
7692625|NCT01853397|18943878|P4|NOT COMPLETED|Overall Study||2
7692626|NCT01853397|18943879|P3|NOT COMPLETED|Overall Study||0
7692627|NCT01853397|18943880|P2|NOT COMPLETED|Overall Study||0
7692628|NCT01853397|18943881|P1|NOT COMPLETED|Overall Study||0
7692629|NCT01853397|18943878|P4|COMPLETED|Overall Study||15
7692630|NCT01853397|18943879|P3|COMPLETED|Overall Study||17
7692631|NCT01853397|18943880|P2|COMPLETED|Overall Study||20
7692632|NCT01853397|18943881|P1|COMPLETED|Overall Study||18
7692633|NCT01853397|18943878|P4|STARTED|Overall Study||17
7692634|NCT01853397|18943879|P3|STARTED|Overall Study||17
7692635|NCT01853397|18943880|P2|STARTED|Overall Study||20
7692636|NCT01853397|18943881|P1|STARTED|Overall Study||18
7692637|NCT01853384|18943909|P2|NOT COMPLETED|Completed Follow up Visit 2||3
7692638|NCT01853384|18943910|P1|NOT COMPLETED|Completed Follow up Visit 2||3
7692639|NCT01853384|18943909|P2|COMPLETED|Completed Follow up Visit 2||91
7692640|NCT01853384|18943910|P1|COMPLETED|Completed Follow up Visit 2||93
7692641|NCT01853384|18943909|P2|STARTED|Completed Follow up Visit 2||94
7692642|NCT01853384|18943910|P1|STARTED|Completed Follow up Visit 2||96
7692643|NCT01853384|18943909|P2|NOT COMPLETED|Completed Follow up Visit 1||9
7692644|NCT01853384|18943910|P1|NOT COMPLETED|Completed Follow up Visit 1||14
7692645|NCT01853384|18943909|P2|COMPLETED|Completed Follow up Visit 1||85
7692646|NCT01853384|18943910|P1|COMPLETED|Completed Follow up Visit 1||82
7692647|NCT01853384|18943909|P2|STARTED|Completed Follow up Visit 1||94
7692648|NCT01853384|18943910|P1|STARTED|Completed Follow up Visit 1||96
7692649|NCT01853384|18943909|P2|NOT COMPLETED|Enrolled in Follow up Period||0
7692650|NCT01853384|18943910|P1|NOT COMPLETED|Enrolled in Follow up Period||0
7692651|NCT01853384|18943909|P2|COMPLETED|Enrolled in Follow up Period||94
7692652|NCT01853384|18943910|P1|COMPLETED|Enrolled in Follow up Period||96
7692653|NCT01853384|18943909|P2|Not Enrolled in Follow-up|Enrolled in Follow up Period||27
7692654|NCT01853384|18943910|P1|Not Enrolled in Follow-up|Enrolled in Follow up Period||35
7692655|NCT01853384|18943909|P2|STARTED|Enrolled in Follow up Period||94
7692656|NCT01853384|18943910|P1|STARTED|Enrolled in Follow up Period||96
7692657|NCT01853384|18943909|P2|NOT COMPLETED|Randomized||46
7692658|NCT01853384|18943910|P1|NOT COMPLETED|Randomized||62
7692659|NCT01853384|18943909|P2|COMPLETED|Randomized||75
7692660|NCT01853384|18943910|P1|COMPLETED|Randomized||69
7692661|NCT01853384|18943909|P2|STARTED|Randomized||121
7692662|NCT01853384|18943910|P1|STARTED|Randomized||131
7692663|NCT01853371|18943930|P2|NOT COMPLETED|Overall Study||2
7692664|NCT01853371|18943931|P1|NOT COMPLETED|Overall Study||0
7692665|NCT01853371|18943930|P2|COMPLETED|Overall Study||8
7692666|NCT01853371|18943931|P1|COMPLETED|Overall Study||10
7692667|NCT01853371|18943930|P2|STARTED|Overall Study||10
7692668|NCT01853371|18943931|P1|STARTED|Overall Study||10
7692669|NCT01853332|18943939|P1|NOT COMPLETED|Overall Study||59
7692670|NCT01853332|18943939|P1|COMPLETED|Overall Study||151
7692671|NCT01853332|18943939|P1|STARTED|Overall Study||210
7692672|NCT01853280|18943950|P2|NOT COMPLETED|Overall Study||6
7692673|NCT01853280|18943951|P1|NOT COMPLETED|Overall Study||2
7692674|NCT01853280|18943950|P2|COMPLETED|Overall Study||16
7692675|NCT01853280|18943951|P1|COMPLETED|Overall Study||20
7692676|NCT01853280|18943950|P2|STARTED|Overall Study||22
7692677|NCT01853280|18943951|P1|STARTED|Overall Study||22
7692678|NCT01853254|18943957|P1|NOT COMPLETED|Overall Study||104
7692679|NCT01853254|18943957|P1|COMPLETED|Overall Study||168
7692680|NCT01853254|18943957|P1|STARTED|Overall Study||272
7692681|NCT01853228|18943961|P2|NOT COMPLETED|Phase 2||8
7692682|NCT01853228|18943962|P1|NOT COMPLETED|Phase 2||0
7692683|NCT01853228|18943961|P2|COMPLETED|Phase 2||0
7692684|NCT01853228|18943962|P1|COMPLETED|Phase 2||0
7692685|NCT01853228|18943961|P2|STARTED|Phase 2|1 additional participant was enrolled, making total of 8 participants evaluable in Phase 2.|8
7692686|NCT01853228|18943962|P1|STARTED|Phase 2||0
7692687|NCT01853228|18943961|P2|NOT COMPLETED|Phase 1||0
7692688|NCT01853228|18943962|P1|NOT COMPLETED|Phase 1||9
7692689|NCT01853228|18943961|P2|COMPLETED|Phase 1|Participants who completed Phase 1 moved to Phase 2.|7
7692690|NCT01853228|18943962|P1|COMPLETED|Phase 1||0
7692691|NCT01853228|18943961|P2|STARTED|Phase 1||7
7692692|NCT01853228|18943962|P1|STARTED|Phase 1||9
7692693|NCT01853215|18943979|P1|NOT COMPLETED|Overall Study||0
7692694|NCT01853215|18943979|P1|COMPLETED|Overall Study||24
7692695|NCT01853215|18943979|P1|STARTED|Overall Study||24
7692696|NCT01853176|18943992|P2|NOT COMPLETED|Overall Study||0
7692697|NCT01853176|18943993|P1|NOT COMPLETED|Overall Study||4
7692698|NCT01853176|18943992|P2|COMPLETED|Overall Study||0
7692699|NCT01853176|18943993|P1|COMPLETED|Overall Study||0
7692700|NCT01853176|18943992|P2|STARTED|Overall Study||0
7692701|NCT01853176|18943993|P1|STARTED|Overall Study||4
7692702|NCT01853137|18944001|P2|NOT COMPLETED|Overall Study||1
7692703|NCT01853137|18944002|P1|NOT COMPLETED|Overall Study||4
7692704|NCT01853137|18944001|P2|COMPLETED|Overall Study||17
7692705|NCT01853137|18944002|P1|COMPLETED|Overall Study||21
7692706|NCT01853137|18944001|P2|STARTED|Overall Study||18
7692707|NCT01853137|18944002|P1|STARTED|Overall Study||25
7692708|NCT01853085|18944010|P1|NOT COMPLETED|Overall Study||235
7692709|NCT01853085|18944010|P1|COMPLETED|Overall Study||1595
7692710|NCT01853085|18944010|P1|STARTED|Overall Study||1830
7692711|NCT01853072|18944023|P2|NOT COMPLETED|Overall Study||21
7692712|NCT01853072|18944024|P1|NOT COMPLETED|Overall Study||12
7692713|NCT01853072|18944023|P2|COMPLETED|Overall Study||286
7692714|NCT01853072|18944024|P1|COMPLETED|Overall Study||296
7692715|NCT01853072|18944023|P2|Full Analysis Set|Overall Study||300
7692716|NCT01853072|18944024|P1|Full Analysis Set|Overall Study||298
7692717|NCT01853072|18944023|P2|Treated (Safety Analysis Set)|Overall Study||302
7692718|NCT01853072|18944024|P1|Treated (Safety Analysis Set)|Overall Study||301
7692719|NCT01853072|18944023|P2|Randomized|Overall Study||307
7692720|NCT01853072|18944024|P1|Randomized|Overall Study||308
7692721|NCT01853072|18944023|P2|STARTED|Overall Study||307
7692722|NCT01853072|18944024|P1|STARTED|Overall Study||308
7692723|NCT01853046|18944044|P2|NOT COMPLETED|Overall Study||6
7692724|NCT01853046|18944045|P1|NOT COMPLETED|Overall Study||18
7692725|NCT01853046|18944044|P2|COMPLETED|Overall Study||0
7692726|NCT01853046|18944045|P1|COMPLETED|Overall Study||0
7692727|NCT01853046|18944044|P2|Received Treatment|Overall Study||6
7692728|NCT01853046|18944045|P1|Received Treatment|Overall Study||18
7692729|NCT01853046|18944044|P2|STARTED|Overall Study||6
7692730|NCT01853046|18944045|P1|STARTED|Overall Study||18
7692731|NCT01852955|18944099|P2|NOT COMPLETED|Overall Study||3
7692732|NCT01852955|18944100|P1|NOT COMPLETED|Overall Study||2
7692733|NCT01852955|18944099|P2|COMPLETED|Overall Study||32
7692734|NCT01852955|18944100|P1|COMPLETED|Overall Study||33
7692735|NCT01852955|18944099|P2|STARTED|Overall Study||35
7692736|NCT01852955|18944100|P1|STARTED|Overall Study||35
7692737|NCT01852942|18944112|P2|NOT COMPLETED|Overall Study||6
7692738|NCT01852942|18944113|P1|NOT COMPLETED|Overall Study||5
7692739|NCT01852942|18944112|P2|COMPLETED|Overall Study||21
7692740|NCT01852942|18944113|P1|COMPLETED|Overall Study||20
7692741|NCT01852942|18944112|P2|STARTED|Overall Study||27
7692742|NCT01852942|18944113|P1|STARTED|Overall Study||25
7692743|NCT01852825|18944208|P3|NOT COMPLETED|Overall Study||0
7692744|NCT01852825|18944209|P2|NOT COMPLETED|Overall Study||0
7692745|NCT01852825|18944210|P1|NOT COMPLETED|Overall Study||2
7692746|NCT01852825|18944208|P3|COMPLETED|Overall Study||3
7692747|NCT01852825|18944209|P2|COMPLETED|Overall Study||7
7692748|NCT01852825|18944210|P1|COMPLETED|Overall Study||14
7692749|NCT01852825|18944208|P3|STARTED|Overall Study||3
7692750|NCT01852825|18944209|P2|STARTED|Overall Study||7
7692751|NCT01852825|18944210|P1|STARTED|Overall Study||16
7692752|NCT01852812|18944236|P3|NOT COMPLETED|Overall Study||1
7692753|NCT01852812|18944237|P2|NOT COMPLETED|Overall Study||1
7692754|NCT01852812|18944238|P1|NOT COMPLETED|Overall Study||0
7692755|NCT01852812|18944236|P3|COMPLETED|Overall Study||17
7692756|NCT01852812|18944237|P2|COMPLETED|Overall Study||17
7692757|NCT01852812|18944238|P1|COMPLETED|Overall Study||51
7692758|NCT01852812|18944236|P3|STARTED|Overall Study||18
7692759|NCT01852812|18944237|P2|STARTED|Overall Study||18
7692760|NCT01852812|18944238|P1|STARTED|Overall Study||51
7692761|NCT01852799|18944258|P1|NOT COMPLETED|Overall Study||18
7692762|NCT01852799|18944258|P1|COMPLETED|Overall Study||0
7692763|NCT01852799|18944258|P1|STARTED|Overall Study||18
7692764|NCT01852669|18944269|P2|NOT COMPLETED|Overall Study||1
7692765|NCT01852669|18944270|P1|NOT COMPLETED|Overall Study||0
7692766|NCT01852669|18944269|P2|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68
7692767|NCT01852669|18944270|P1|COMPLETED|Overall Study||71
7692768|NCT01852669|18944269|P2|STARTED|Overall Study||69
7692769|NCT01852669|18944270|P1|STARTED|Overall Study||71
7692770|NCT01852591|18944276|P1|NOT COMPLETED|Overall Study||3
7692771|NCT01852591|18944276|P1|COMPLETED|Overall Study||5
7692772|NCT01852591|18944276|P1|STARTED|Overall Study||8
7692773|NCT01852513|18944285|P2|NOT COMPLETED|Overall Study||0
7692774|NCT01852513|18944286|P1|NOT COMPLETED|Overall Study||0
7692775|NCT01852513|18944285|P2|COMPLETED|Overall Study||19
7692776|NCT01852513|18944286|P1|COMPLETED|Overall Study||20
7692777|NCT01852513|18944285|P2|STARTED|Overall Study||19
7692778|NCT01852513|18944286|P1|STARTED|Overall Study||20
7692779|NCT01852383|18944296|P1|NOT COMPLETED|Overall Study||11
7692780|NCT01852383|18944296|P1|COMPLETED|Overall Study||19
7692781|NCT01852383|18944296|P1|STARTED|Overall Study||30
7692782|NCT01852344|18944307|P4|NOT COMPLETED|Overall Study||0
7692783|NCT01852344|18944308|P3|NOT COMPLETED|Overall Study||0
7692784|NCT01852344|18944309|P2|NOT COMPLETED|Overall Study||0
7692785|NCT01852344|18944310|P1|NOT COMPLETED|Overall Study||0
7692786|NCT01852344|18944307|P4|COMPLETED|Overall Study||27
7692787|NCT01852344|18944308|P3|COMPLETED|Overall Study||27
7692788|NCT01852344|18944309|P2|COMPLETED|Overall Study||27
7692789|NCT01852344|18944310|P1|COMPLETED|Overall Study||27
7692790|NCT01852344|18944307|P4|Actual Participation in First Assignment|Overall Study||27
7692791|NCT01852344|18944308|P3|Actual Participation in First Assignment|Overall Study||27
7692792|NCT01852344|18944309|P2|Actual Participation in First Assignment|Overall Study||27
7692793|NCT01852344|18944310|P1|Actual Participation in First Assignment|Overall Study||27
7692794|NCT01852344|18944307|P4|STARTED|Overall Study||27
7692795|NCT01852344|18944308|P3|STARTED|Overall Study||27
7692796|NCT01852344|18944309|P2|STARTED|Overall Study||27
7692797|NCT01852344|18944310|P1|STARTED|Overall Study||27
7692798|NCT01852292|18944330|P2|NOT COMPLETED|Overall Study||79
7692799|NCT01852292|18944331|P1|NOT COMPLETED|Overall Study||79
7692800|NCT01852292|18944330|P2|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
7692801|NCT01852292|18944331|P1|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
7692802|NCT01852292|18944330|P2|STARTED|Overall Study||79
7692803|NCT01852292|18944331|P1|STARTED|Overall Study||79
7692804|NCT01852214|18944355|P2|NOT COMPLETED|Period 2||0
7692805|NCT01852214|18944356|P1|NOT COMPLETED|Period 2||0
7692806|NCT01852214|18944355|P2|COMPLETED|Period 2||20
7692807|NCT01852214|18944356|P1|COMPLETED|Period 2||25
7692808|NCT01852214|18944355|P2|STARTED|Period 2||20
7692809|NCT01852214|18944356|P1|STARTED|Period 2||25
7692810|NCT01852214|18944355|P2|NOT COMPLETED|Washout Period||1
7692811|NCT01852214|18944356|P1|NOT COMPLETED|Washout Period||0
7692812|NCT01852214|18944355|P2|COMPLETED|Washout Period||20
7692813|NCT01852214|18944356|P1|COMPLETED|Washout Period||25
7692814|NCT01852214|18944355|P2|STARTED|Washout Period||21
7692815|NCT01852214|18944356|P1|STARTED|Washout Period||25
7692816|NCT01852214|18944355|P2|NOT COMPLETED|Period 1||3
7692817|NCT01852214|18944356|P1|NOT COMPLETED|Period 1||1
7692818|NCT01852214|18944355|P2|COMPLETED|Period 1||21
7692819|NCT01852214|18944356|P1|COMPLETED|Period 1||25
7692820|NCT01852214|18944355|P2|STARTED|Period 1||24
7692821|NCT01852214|18944356|P1|STARTED|Period 1||26
7692822|NCT01852201|18944370|P2|NOT COMPLETED|Overall Study||0
7692823|NCT01852201|18944371|P1|NOT COMPLETED|Overall Study||0
7692824|NCT01852201|18944370|P2|COMPLETED|Overall Study||12
7692825|NCT01852201|18944371|P1|COMPLETED|Overall Study||21
7692826|NCT01852201|18944370|P2|STARTED|Overall Study||12
7692827|NCT01852201|18944371|P1|STARTED|Overall Study||21
7692828|NCT01852175|18944395|P2|NOT COMPLETED|Overall Study||0
7692829|NCT01852175|18944396|P1|NOT COMPLETED|Overall Study||0
7692830|NCT01852175|18944395|P2|COMPLETED|Overall Study||55
7692831|NCT01852175|18944396|P1|COMPLETED|Overall Study||55
7692832|NCT01852175|18944395|P2|STARTED|Overall Study||55
7692833|NCT01852175|18944396|P1|STARTED|Overall Study||55
7692834|NCT01852162|18944408|P2|NOT COMPLETED|Overall Study||1
7692835|NCT01852162|18944409|P1|NOT COMPLETED|Overall Study||4
7692836|NCT01852162|18944408|P2|COMPLETED|Overall Study||16
7692837|NCT01852162|18944409|P1|COMPLETED|Overall Study||14
7692838|NCT01852162|18944408|P2|STARTED|Overall Study||17
7692839|NCT01852162|18944409|P1|STARTED|Overall Study||18
7692840|NCT01852110|18944425|P6|NOT COMPLETED|Overall Study||0
7692841|NCT01852110|18944426|P5|NOT COMPLETED|Overall Study||0
7692842|NCT01852110|18944427|P4|NOT COMPLETED|Overall Study||0
7692843|NCT01852110|18944428|P3|NOT COMPLETED|Overall Study||0
7692844|NCT01852110|18944429|P2|NOT COMPLETED|Overall Study||46
7692845|NCT01852110|18944430|P1|NOT COMPLETED|Overall Study||50
7692846|NCT01852110|18944425|P6|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
7692847|NCT01852110|18944426|P5|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
7692848|NCT01852110|18944427|P4|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
7692849|NCT01852110|18944428|P3|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
7692850|NCT01852110|18944429|P2|COMPLETED|Overall Study||74
7692851|NCT01852110|18944430|P1|COMPLETED|Overall Study||70
7692852|NCT01852110|18944425|P6|Treated|Overall Study||0
7692853|NCT01852110|18944426|P5|Treated|Overall Study||0
7692854|NCT01852110|18944427|P4|Treated|Overall Study||0
7692855|NCT01852110|18944428|P3|Treated|Overall Study||0
7692856|NCT01852110|18944429|P2|Treated|Overall Study||120
7692857|NCT01852110|18944430|P1|Treated|Overall Study||119
7692858|NCT01852110|18944425|P6|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
7692859|NCT01852110|18944426|P5|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
7692860|NCT01852110|18944427|P4|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
7692861|NCT01852110|18944428|P3|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
7692862|NCT01852110|18944429|P2|STARTED|Overall Study||120
7692863|NCT01852110|18944430|P1|STARTED|Overall Study||120
7692864|NCT01852084|18944462|P4|NOT COMPLETED|Overall Study||0
7692865|NCT01852084|18944463|P3|NOT COMPLETED|Overall Study||2
7692866|NCT01852084|18944464|P2|NOT COMPLETED|Overall Study||0
7692867|NCT01852084|18944465|P1|NOT COMPLETED|Overall Study||0
7692868|NCT01852084|18944462|P4|COMPLETED|Overall Study||12
7692869|NCT01852084|18944463|P3|COMPLETED|Overall Study||18
7692870|NCT01852084|18944464|P2|COMPLETED|Overall Study||80
7692871|NCT01852084|18944465|P1|COMPLETED|Overall Study||79
7692872|NCT01852084|18944462|P4|STARTED|Overall Study||12
7692873|NCT01852084|18944463|P3|STARTED|Overall Study||20
7692874|NCT01852084|18944464|P2|STARTED|Overall Study||80
7692875|NCT01852084|18944465|P1|STARTED|Overall Study||79
7692876|NCT01852058|18944494|P12|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
7692877|NCT01852058|18944495|P11|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
7692878|NCT01852058|18944496|P10|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
7692879|NCT01852058|18944497|P9|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
7692880|NCT01852058|18944498|P8|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
7692881|NCT01852058|18944499|P7|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
7692882|NCT01852058|18944500|P6|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
7692883|NCT01852058|18944501|P5|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
7692884|NCT01852058|18944502|P4|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
7692885|NCT01852058|18944503|P3|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
7692886|NCT01852058|18944504|P2|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
7692887|NCT01852058|18944505|P1|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
7692888|NCT01852058|18944494|P12|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
7692889|NCT01852058|18944495|P11|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
7692890|NCT01852058|18944496|P10|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||3
7692891|NCT01852058|18944497|P9|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
7692892|NCT01852058|18944498|P8|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
7692893|NCT01852058|18944499|P7|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
7692894|NCT01852058|18944500|P6|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
7692895|NCT01852058|18944501|P5|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
7692896|NCT01852058|18944502|P4|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
7692897|NCT01852058|18944503|P3|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
7692898|NCT01852058|18944504|P2|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
7692899|NCT01852058|18944505|P1|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
7692900|NCT01852058|18944494|P12|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
7692901|NCT01852058|18944495|P11|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
7692902|NCT01852058|18944496|P10|STARTED|Treatment Cycle4:Retreatment 3,Study 121||3
7692903|NCT01852058|18944497|P9|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
7692904|NCT01852058|18944498|P8|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
7692905|NCT01852058|18944499|P7|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
7692906|NCT01852058|18944500|P6|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
7692907|NCT01852058|18944501|P5|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
7692908|NCT01852058|18944502|P4|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
7692909|NCT01852058|18944503|P3|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
7692910|NCT01852058|18944504|P2|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
7692911|NCT01852058|18944505|P1|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
7692912|NCT01852058|18944494|P12|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
7692913|NCT01852058|18944495|P11|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
7692914|NCT01852058|18944496|P10|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
7692915|NCT01852058|18944497|P9|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
7692916|NCT01852058|18944498|P8|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
7692917|NCT01852058|18944499|P7|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
7692918|NCT01852058|18944500|P6|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
7692919|NCT01852058|18944501|P5|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
7692920|NCT01852058|18944502|P4|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
7692921|NCT01852058|18944503|P3|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
7692922|NCT01852058|18944504|P2|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
7692923|NCT01852058|18944505|P1|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
7692924|NCT01852058|18944494|P12|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
7692925|NCT01852058|18944495|P11|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
7692926|NCT01852058|18944496|P10|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
7692927|NCT01852058|18944497|P9|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||33
7692928|NCT01852058|18944498|P8|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||15
7692929|NCT01852058|18944499|P7|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||5
7692930|NCT01852058|18944500|P6|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
7692931|NCT01852058|18944501|P5|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
7692932|NCT01852058|18944502|P4|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
7692933|NCT01852058|18944503|P3|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
7692934|NCT01852058|18944504|P2|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
7692935|NCT01852058|18944505|P1|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
7692936|NCT01852058|18944494|P12|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
7692937|NCT01852058|18944495|P11|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
7692938|NCT01852058|18944496|P10|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
7692939|NCT01852058|18944497|P9|STARTED|Treatment Cycle3:Retreatment 2,Study 121||34
7692940|NCT01852058|18944498|P8|STARTED|Treatment Cycle3:Retreatment 2,Study 121||16
7692941|NCT01852058|18944499|P7|STARTED|Treatment Cycle3:Retreatment 2,Study 121||5
7692942|NCT01852058|18944500|P6|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
7692943|NCT01852058|18944501|P5|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
7692944|NCT01852058|18944502|P4|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
7692945|NCT01852058|18944503|P3|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
7692946|NCT01852058|18944504|P2|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
7692947|NCT01852058|18944505|P1|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
7692948|NCT01852058|18944494|P12|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
7692949|NCT01852058|18944495|P11|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
7692950|NCT01852058|18944496|P10|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
7692951|NCT01852058|18944497|P9|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
7692952|NCT01852058|18944498|P8|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
7692953|NCT01852058|18944499|P7|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
7692954|NCT01852058|18944500|P6|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||9
7692955|NCT01852058|18944501|P5|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||7
7692956|NCT01852058|18944502|P4|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||1
7692957|NCT01852058|18944503|P3|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
7692958|NCT01852058|18944504|P2|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
7692959|NCT01852058|18944505|P1|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
7692960|NCT01852058|18944494|P12|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
7692961|NCT01852058|18944495|P11|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
7692962|NCT01852058|18944496|P10|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
7692963|NCT01852058|18944497|P9|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
7692964|NCT01852058|18944498|P8|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
7692965|NCT01852058|18944499|P7|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
7692966|NCT01852058|18944500|P6|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||27
7692967|NCT01852058|18944501|P5|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||38
7692968|NCT01852058|18944502|P4|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||8
7692969|NCT01852058|18944503|P3|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
7692970|NCT01852058|18944504|P2|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
7692971|NCT01852058|18944505|P1|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
7692972|NCT01852058|18944494|P12|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
7692973|NCT01852058|18944495|P11|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
7692974|NCT01852058|18944496|P10|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
7692975|NCT01852058|18944497|P9|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
7692976|NCT01852058|18944498|P8|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
7692977|NCT01852058|18944499|P7|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
7692978|NCT01852058|18944500|P6|STARTED|Treatment Cycle2:Retreatment 1,Study 121||36
7692979|NCT01852058|18944501|P5|STARTED|Treatment Cycle2:Retreatment 1,Study 121||45
7692980|NCT01852058|18944502|P4|STARTED|Treatment Cycle2:Retreatment 1,Study 121||9
7692981|NCT01852058|18944503|P3|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
7692982|NCT01852058|18944504|P2|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
7692983|NCT01852058|18944505|P1|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
7692984|NCT01852058|18944494|P12|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
7692985|NCT01852058|18944495|P11|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
7692986|NCT01852058|18944496|P10|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
7692987|NCT01852058|18944497|P9|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
7692988|NCT01852058|18944498|P8|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
7692989|NCT01852058|18944499|P7|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
7692990|NCT01852058|18944500|P6|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
7692991|NCT01852058|18944501|P5|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
7692992|NCT01852058|18944502|P4|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
7692993|NCT01852058|18944503|P3|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
7692994|NCT01852058|18944504|P2|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
7692995|NCT01852058|18944505|P1|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||1
7692996|NCT01852058|18944494|P12|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
7692997|NCT01852058|18944495|P11|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
7692998|NCT01852058|18944496|P10|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
7692999|NCT01852058|18944497|P9|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
7693000|NCT01852058|18944498|P8|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
7693001|NCT01852058|18944499|P7|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
7693002|NCT01852058|18944500|P6|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
7693003|NCT01852058|18944501|P5|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
7693004|NCT01852058|18944502|P4|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
7693005|NCT01852058|18944503|P3|COMPLETED|Treatment Cycle 1, Occurred in Study 120||25
7693006|NCT01852058|18944504|P2|COMPLETED|Treatment Cycle 1, Occurred in Study 120||39
7693007|NCT01852058|18944505|P1|COMPLETED|Treatment Cycle 1, Occurred in Study 120||30
7693008|NCT01852058|18944494|P12|STARTED|Treatment Cycle 1, Occurred in Study 120||0
7693009|NCT01852058|18944495|P11|STARTED|Treatment Cycle 1, Occurred in Study 120||0
7693010|NCT01852058|18944496|P10|STARTED|Treatment Cycle 1, Occurred in Study 120||0
7693011|NCT01852058|18944497|P9|STARTED|Treatment Cycle 1, Occurred in Study 120||0
7693012|NCT01852058|18944498|P8|STARTED|Treatment Cycle 1, Occurred in Study 120||0
7693013|NCT01852058|18944499|P7|STARTED|Treatment Cycle 1, Occurred in Study 120||0
7693014|NCT01852058|18944500|P6|STARTED|Treatment Cycle 1, Occurred in Study 120||0
7693015|NCT01852058|18944501|P5|STARTED|Treatment Cycle 1, Occurred in Study 120||0
7693016|NCT01852058|18944502|P4|STARTED|Treatment Cycle 1, Occurred in Study 120||0
7693017|NCT01852058|18944503|P3|STARTED|Treatment Cycle 1, Occurred in Study 120||25
7693018|NCT01852058|18944504|P2|STARTED|Treatment Cycle 1, Occurred in Study 120||39
7693019|NCT01852058|18944505|P1|STARTED|Treatment Cycle 1, Occurred in Study 120||31
7693020|NCT01852045|18944585|P3|NOT COMPLETED|Overall Study||4
7693021|NCT01852045|18944586|P2|NOT COMPLETED|Overall Study||4
7693022|NCT01852045|18944587|P1|NOT COMPLETED|Overall Study||6
7693023|NCT01852045|18944585|P3|COMPLETED|Overall Study||26
7693024|NCT01852045|18944586|P2|COMPLETED|Overall Study||41
7693025|NCT01852045|18944587|P1|COMPLETED|Overall Study||33
7693026|NCT01852045|18944585|P3|Safety Population|Overall Study||30
7693027|NCT01852045|18944586|P2|Safety Population|Overall Study||45
7693028|NCT01852045|18944587|P1|Safety Population|Overall Study||38
7693029|NCT01852045|18944585|P3|mITT Population|Overall Study||30
7693030|NCT01852045|18944586|P2|mITT Population|Overall Study||45
7693031|NCT01852045|18944587|P1|mITT Population|Overall Study||38
7693032|NCT01852045|18944585|P3|STARTED|Overall Study||30
7693033|NCT01852045|18944586|P2|STARTED|Overall Study||45
7693034|NCT01852045|18944587|P1|STARTED|Overall Study||39
7693035|NCT01852032|18944625|P1|NOT COMPLETED|Overall Study||0
7693036|NCT01852032|18944625|P1|COMPLETED|Overall Study||23
7693037|NCT01852032|18944625|P1|STARTED|Overall Study||23
7693038|NCT01852019|18944635|P5|NOT COMPLETED|Day 8||0
7693039|NCT01852019|18944636|P4|NOT COMPLETED|Day 8||0
7693040|NCT01852019|18944637|P3|NOT COMPLETED|Day 8||0
7693041|NCT01852019|18944638|P2|NOT COMPLETED|Day 8||0
7693042|NCT01852019|18944639|P1|NOT COMPLETED|Day 8||0
7693043|NCT01852019|18944635|P5|COMPLETED|Day 8||6
7693044|NCT01852019|18944636|P4|COMPLETED|Day 8||6
7693045|NCT01852019|18944637|P3|COMPLETED|Day 8||0
7693046|NCT01852019|18944638|P2|COMPLETED|Day 8||0
7693047|NCT01852019|18944639|P1|COMPLETED|Day 8||0
7693048|NCT01852019|18944635|P5|STARTED|Day 8||6
7693049|NCT01852019|18944636|P4|STARTED|Day 8||6
7693050|NCT01852019|18944637|P3|STARTED|Day 8||0
7693051|NCT01852019|18944638|P2|STARTED|Day 8||0
7693052|NCT01852019|18944639|P1|STARTED|Day 8||0
7693053|NCT01852019|18944635|P5|NOT COMPLETED|Day 1||0
7693054|NCT01852019|18944636|P4|NOT COMPLETED|Day 1||0
7693055|NCT01852019|18944637|P3|NOT COMPLETED|Day 1||0
7693056|NCT01852019|18944638|P2|NOT COMPLETED|Day 1||0
7693057|NCT01852019|18944639|P1|NOT COMPLETED|Day 1||0
7693058|NCT01852019|18944635|P5|COMPLETED|Day 1||0
7693059|NCT01852019|18944636|P4|COMPLETED|Day 1||0
7693060|NCT01852019|18944637|P3|COMPLETED|Day 1||6
7693061|NCT01852019|18944638|P2|COMPLETED|Day 1||3
7693062|NCT01852019|18944639|P1|COMPLETED|Day 1||3
7693063|NCT01852019|18944635|P5|STARTED|Day 1||0
7693064|NCT01852019|18944636|P4|STARTED|Day 1||0
7693065|NCT01852019|18944637|P3|STARTED|Day 1||6
7693066|NCT01852019|18944638|P2|STARTED|Day 1||3
7693067|NCT01852019|18944639|P1|STARTED|Day 1||3
7693068|NCT01851876|18944660|P2|NOT COMPLETED|Overall Study||0
7693069|NCT01851876|18944661|P1|NOT COMPLETED|Overall Study||0
7693070|NCT01851876|18944660|P2|COMPLETED|Overall Study||62
7693071|NCT01851876|18944661|P1|COMPLETED|Overall Study||56
7693072|NCT01851876|18944660|P2|STARTED|Overall Study||62
7693073|NCT01851876|18944661|P1|STARTED|Overall Study||56
7693074|NCT01851863|18944671|P4|NOT COMPLETED|Overall Study||3
7693075|NCT01851863|18944672|P3|NOT COMPLETED|Overall Study||5
7693076|NCT01851863|18944673|P2|NOT COMPLETED|Overall Study||9
7693077|NCT01851863|18944674|P1|NOT COMPLETED|Overall Study||5
7693078|NCT01851863|18944671|P4|COMPLETED|Overall Study||63
7693079|NCT01851863|18944672|P3|COMPLETED|Overall Study||60
7693080|NCT01851863|18944673|P2|COMPLETED|Overall Study||57
7693081|NCT01851863|18944674|P1|COMPLETED|Overall Study||60
7693082|NCT01851863|18944671|P4|STARTED|Overall Study||66
7693083|NCT01851863|18944672|P3|STARTED|Overall Study||65
7693084|NCT01851863|18944673|P2|STARTED|Overall Study||66
7693085|NCT01851863|18944674|P1|STARTED|Overall Study||65
7693086|NCT01851772|18944695|P1|NOT COMPLETED|Overall Study||0
7693087|NCT01851772|18944695|P1|COMPLETED|Overall Study||3
7693088|NCT01851772|18944695|P1|STARTED|Overall Study||3
7693089|NCT01851720|18944703|P2|NOT COMPLETED|Overall Study||1
7693090|NCT01851720|18944704|P1|NOT COMPLETED|Overall Study||0
7693091|NCT01851720|18944703|P2|COMPLETED|Overall Study||0
7693092|NCT01851720|18944704|P1|COMPLETED|Overall Study||0
7693093|NCT01851720|18944703|P2|STARTED|Overall Study||1
7693094|NCT01851720|18944704|P1|STARTED|Overall Study||0
7693095|NCT01851655|18944712|P2|NOT COMPLETED|Overall Study||0
7693096|NCT01851655|18944713|P1|NOT COMPLETED|Overall Study||0
7693097|NCT01851655|18944712|P2|COMPLETED|Overall Study||12
7693098|NCT01851655|18944713|P1|COMPLETED|Overall Study||12
7693099|NCT01851655|18944712|P2|STARTED|Overall Study||12
7693100|NCT01851655|18944713|P1|STARTED|Overall Study||12
7693101|NCT01851590|18944734|P3|NOT COMPLETED|Overall Study||3
7693102|NCT01851590|18944735|P2|NOT COMPLETED|Overall Study||1
7693103|NCT01851590|18944736|P1|NOT COMPLETED|Overall Study||0
7693104|NCT01851590|18944734|P3|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22
7693105|NCT01851590|18944735|P2|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24
7693106|NCT01851590|18944736|P1|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23
7693107|NCT01851590|18944734|P3|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22
7693108|NCT01851590|18944735|P2|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24
7693109|NCT01851590|18944736|P1|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23
7693110|NCT01851590|18944734|P3|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22
7693111|NCT01851590|18944735|P2|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24
7693112|NCT01851590|18944736|P1|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23
7693113|NCT01851590|18944734|P3|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22
7693114|NCT01851590|18944735|P2|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24
7693115|NCT01851590|18944736|P1|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23
7693116|NCT01851590|18944734|P3|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22
7693117|NCT01851590|18944735|P2|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24
7693118|NCT01851590|18944736|P1|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23
7693119|NCT01851590|18944734|P3|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
7693120|NCT01851590|18944735|P2|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
7693121|NCT01851590|18944736|P1|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23
7693122|NCT01851330|18944759|P3|NOT COMPLETED|Overall Study||12
7693123|NCT01851330|18944760|P2|NOT COMPLETED|Overall Study||16
7693124|NCT01851330|18944761|P1|NOT COMPLETED|Overall Study||13
7693125|NCT01851330|18944759|P3|COMPLETED|Overall Study||204
7693126|NCT01851330|18944760|P2|COMPLETED|Overall Study||200
7693127|NCT01851330|18944761|P1|COMPLETED|Overall Study||202
7693128|NCT01851330|18944759|P3|STARTED|Overall Study||216
7693129|NCT01851330|18944760|P2|STARTED|Overall Study||216
7693130|NCT01851330|18944761|P1|STARTED|Overall Study||215
7693131|NCT01851174|18944796|P1|NOT COMPLETED|Overall Study||0
7693132|NCT01851174|18944796|P1|COMPLETED|Overall Study||15
7693133|NCT01851174|18944796|P1|STARTED|Overall Study||15
7693134|NCT01850823|18944804|P3|NOT COMPLETED|Overall Study||10
7693135|NCT01850823|18944805|P2|NOT COMPLETED|Overall Study||3
7693136|NCT01850823|18944806|P1|NOT COMPLETED|Overall Study||3
7693137|NCT01850823|18944804|P3|COMPLETED|Overall Study||345
7693138|NCT01850823|18944805|P2|COMPLETED|Overall Study||347
7693139|NCT01850823|18944806|P1|COMPLETED|Overall Study||172
7693140|NCT01850823|18944804|P3|STARTED|Overall Study||355
7693141|NCT01850823|18944805|P2|STARTED|Overall Study||350
7693142|NCT01850823|18944806|P1|STARTED|Overall Study||175
7693143|NCT01850745|18944819|P3|NOT COMPLETED|Overall Study||0
7693144|NCT01850745|18944820|P2|NOT COMPLETED|Overall Study||0
7693145|NCT01850745|18944821|P1|NOT COMPLETED|Overall Study||0
7693146|NCT01850745|18944819|P3|COMPLETED|Overall Study||131
7693147|NCT01850745|18944820|P2|COMPLETED|Overall Study||169
7693148|NCT01850745|18944821|P1|COMPLETED|Overall Study||147
7693149|NCT01850745|18944819|P3|STARTED|Overall Study||131
7693150|NCT01850745|18944820|P2|STARTED|Overall Study||169
7693151|NCT01850745|18944821|P1|STARTED|Overall Study||147
7693152|NCT01850641|18944829|P1|NOT COMPLETED|Overall Study||5
7693153|NCT01850641|18944829|P1|COMPLETED|Overall Study||30
7693154|NCT01850641|18944829|P1|STARTED|Overall Study||35
7693155|NCT01850615|18944843|P2|NOT COMPLETED|Overall Study||5
7693156|NCT01850615|18944844|P1|NOT COMPLETED|Overall Study||9
7693157|NCT01850615|18944843|P2|COMPLETED|Overall Study||115
7693158|NCT01850615|18944844|P1|COMPLETED|Overall Study||107
7693159|NCT01850615|18944843|P2|Exposed|Overall Study||120
7693160|NCT01850615|18944844|P1|Exposed|Overall Study||115
7693161|NCT01850615|18944843|P2|STARTED|Overall Study||120
7693162|NCT01850615|18944844|P1|STARTED|Overall Study||116
7693163|NCT01850602|18944862|P2|NOT COMPLETED|Overall Study||18
7693164|NCT01850602|18944863|P1|NOT COMPLETED|Overall Study||14
7693165|NCT01850602|18944862|P2|COMPLETED|Overall Study||87
7693166|NCT01850602|18944863|P1|COMPLETED|Overall Study||94
7693167|NCT01850602|18944862|P2|STARTED|Overall Study||105
7693168|NCT01850602|18944863|P1|STARTED|Overall Study||108
7693169|NCT01850589|18944877|P2|NOT COMPLETED|Overall Study||0
7693170|NCT01850589|18944878|P1|NOT COMPLETED|Overall Study||8
7693171|NCT01850589|18944877|P2|COMPLETED|Overall Study||22
7693172|NCT01850589|18944878|P1|COMPLETED|Overall Study||14
7693173|NCT01850589|18944877|P2|STARTED|Overall Study||22
7693174|NCT01850589|18944878|P1|STARTED|Overall Study||22
7693175|NCT01850550|18944886|P2|NOT COMPLETED|Overall Study||3
7693176|NCT01850550|18944887|P1|NOT COMPLETED|Overall Study||0
7693177|NCT01850550|18944886|P2|COMPLETED|Overall Study||37
7693178|NCT01850550|18944887|P1|COMPLETED|Overall Study||40
7693179|NCT01850550|18944886|P2|STARTED|Overall Study||40
7693180|NCT01850550|18944887|P1|STARTED|Overall Study||40
7693181|NCT01850485|18944897|P2|NOT COMPLETED|Overall Study||0
7693182|NCT01850485|18944898|P1|NOT COMPLETED|Overall Study||0
7693183|NCT01850485|18944897|P2|COMPLETED|Overall Study||13
7693184|NCT01850485|18944898|P1|COMPLETED|Overall Study||9
7693185|NCT01850485|18944897|P2|STARTED|Overall Study||13
7693186|NCT01850485|18944898|P1|STARTED|Overall Study||9
7693187|NCT01850446|18944918|P2|NOT COMPLETED|Overall Study||2
7693188|NCT01850446|18944919|P1|NOT COMPLETED|Overall Study||5
7693189|NCT01850446|18944918|P2|COMPLETED|Overall Study||90
7693190|NCT01850446|18944919|P1|COMPLETED|Overall Study||87
7693191|NCT01850446|18944918|P2|STARTED|Overall Study||92
7693192|NCT01850446|18944919|P1|STARTED|Overall Study||92
7693193|NCT01850394|18944954|P3|NOT COMPLETED|Overall Study||0
7693194|NCT01850394|18944955|P2|NOT COMPLETED|Overall Study||0
7693195|NCT01850394|18944956|P1|NOT COMPLETED|Overall Study||0
7693196|NCT01850394|18944954|P3|COMPLETED|Overall Study||45
7693197|NCT01850394|18944955|P2|COMPLETED|Overall Study||45
7693198|NCT01850394|18944956|P1|COMPLETED|Overall Study||45
7693199|NCT01850394|18944954|P3|STARTED|Overall Study||45
7693200|NCT01850394|18944955|P2|STARTED|Overall Study||45
7693201|NCT01850394|18944956|P1|STARTED|Overall Study||45
7693202|NCT01850030|18944978|P2|NOT COMPLETED|Overall Study||369
7693203|NCT01850030|18944979|P1|NOT COMPLETED|Overall Study||347
7693204|NCT01850030|18944978|P2|COMPLETED|Overall Study||142
7693205|NCT01850030|18944979|P1|COMPLETED|Overall Study||173
7693206|NCT01850030|18944978|P2|STARTED|Overall Study||511
7693207|NCT01850030|18944979|P1|STARTED|Overall Study||520
7693208|NCT01850004|18944991|P1|NOT COMPLETED|Overall Study||8
7693209|NCT01850004|18944991|P1|COMPLETED|Overall Study||76
7693210|NCT01850004|18944991|P1|STARTED|Overall Study||84
7693211|NCT01849848|18944998|P1|NOT COMPLETED|Overall Study||4
7693212|NCT01849848|18944998|P1|COMPLETED|Overall Study||13
7693213|NCT01849848|18944998|P1|STARTED|Overall Study||17
7693214|NCT01849770|18945015|P3|NOT COMPLETED|Overall Study||1
7693215|NCT01849770|18945016|P2|NOT COMPLETED|Overall Study||4
7693216|NCT01849770|18945017|P1|NOT COMPLETED|Overall Study||0
7693217|NCT01849770|18945015|P3|COMPLETED|Overall Study||19
7693218|NCT01849770|18945016|P2|COMPLETED|Overall Study||15
7693219|NCT01849770|18945017|P1|COMPLETED|Overall Study||20
7693220|NCT01849770|18945015|P3|STARTED|Overall Study||20
7693221|NCT01849770|18945016|P2|STARTED|Overall Study||19
7693222|NCT01849770|18945017|P1|STARTED|Overall Study||20
7693223|NCT01849692|18945060|P8|NOT COMPLETED|Overall Study||0
7693224|NCT01849692|18945061|P7|NOT COMPLETED|Overall Study||0
7693225|NCT01849692|18945062|P6|NOT COMPLETED|Overall Study||0
7693226|NCT01849692|18945063|P5|NOT COMPLETED|Overall Study||0
7693227|NCT01849692|18945064|P4|NOT COMPLETED|Overall Study||0
7693228|NCT01849692|18945065|P3|NOT COMPLETED|Overall Study||0
7693229|NCT01849692|18945066|P2|NOT COMPLETED|Overall Study||0
7693230|NCT01849692|18945067|P1|NOT COMPLETED|Overall Study||0
7693231|NCT01849692|18945060|P8|COMPLETED|Overall Study||3
7693232|NCT01849692|18945061|P7|COMPLETED|Overall Study||10
7693233|NCT01849692|18945062|P6|COMPLETED|Overall Study||3
7693234|NCT01849692|18945063|P5|COMPLETED|Overall Study||10
7693235|NCT01849692|18945064|P4|COMPLETED|Overall Study||3
7693236|NCT01849692|18945065|P3|COMPLETED|Overall Study||10
7693237|NCT01849692|18945066|P2|COMPLETED|Overall Study||3
7693238|NCT01849692|18945067|P1|COMPLETED|Overall Study||10
7693239|NCT01849692|18945060|P8|STARTED|Overall Study||3
7693240|NCT01849692|18945061|P7|STARTED|Overall Study||10
7693241|NCT01849692|18945062|P6|STARTED|Overall Study||3
7693242|NCT01849692|18945063|P5|STARTED|Overall Study||10
7693243|NCT01849692|18945064|P4|STARTED|Overall Study||3
7693244|NCT01849692|18945065|P3|STARTED|Overall Study||10
7693245|NCT01849692|18945066|P2|STARTED|Overall Study||3
7693246|NCT01849692|18945067|P1|STARTED|Overall Study||10
7693247|NCT01849588|18945096|P1|NOT COMPLETED|Overall Study||3
7693248|NCT01849588|18945096|P1|COMPLETED|Overall Study||0
7693249|NCT01849588|18945096|P1|STARTED|Overall Study||3
7693250|NCT01849575|18945105|P2|NOT COMPLETED|Overall Study||207
7693251|NCT01849575|18945106|P1|NOT COMPLETED|Overall Study||150
7693252|NCT01849575|18945105|P2|COMPLETED|Overall Study||1576
7693253|NCT01849575|18945106|P1|COMPLETED|Overall Study||1599
7693254|NCT01849575|18945105|P2|STARTED|Overall Study||1783
7693255|NCT01849575|18945106|P1|STARTED|Overall Study||1749
7693256|NCT01849562|18945115|P3|NOT COMPLETED|Overall Study||0
7693257|NCT01849562|18945116|P2|NOT COMPLETED|Overall Study||0
7693258|NCT01849562|18945117|P1|NOT COMPLETED|Overall Study||2
7693259|NCT01849562|18945115|P3|COMPLETED|Overall Study||10
7693260|NCT01849562|18945116|P2|COMPLETED|Overall Study||10
7693261|NCT01849562|18945117|P1|COMPLETED|Overall Study||8
7693262|NCT01849562|18945115|P3|STARTED|Overall Study||10
7693263|NCT01849562|18945116|P2|STARTED|Overall Study||10
7693264|NCT01849562|18945117|P1|STARTED|Overall Study||10
7693265|NCT01849497|18945130|P2|NOT COMPLETED|Overall Study||4
7693266|NCT01849497|18945131|P1|NOT COMPLETED|Overall Study||1
7693267|NCT01849497|18945130|P2|COMPLETED|Overall Study||70
7693268|NCT01849497|18945131|P1|COMPLETED|Overall Study||74
7693269|NCT01849497|18945130|P2|Received Treatment|Overall Study||74
7693270|NCT01849497|18945131|P1|Received Treatment|Overall Study||75
7693271|NCT01849497|18945130|P2|STARTED|Overall Study||74
7693272|NCT01849497|18945131|P1|STARTED|Overall Study||75
7693273|NCT01849458|18945139|P1|NOT COMPLETED|Overall Study||4
7693274|NCT01849458|18945139|P1|COMPLETED|Overall Study||46
7693275|NCT01849458|18945139|P1|6 Months Follow-up|Overall Study||50
7693276|NCT01849458|18945139|P1|STARTED|Overall Study||50
7693277|NCT01849419|18945149|P1|NOT COMPLETED|Overall Study||0
7693278|NCT01849419|18945149|P1|COMPLETED|Overall Study||65
7693279|NCT01849419|18945149|P1|STARTED|Overall Study||65
7693280|NCT01849289|18945178|P2|NOT COMPLETED|Overall Study||24
7693281|NCT01849289|18945179|P1|NOT COMPLETED|Overall Study||32
7693282|NCT01849289|18945178|P2|COMPLETED|Overall Study||254
7693283|NCT01849289|18945179|P1|COMPLETED|Overall Study||523
7693284|NCT01849289|18945178|P2|Exposed|Overall Study||278
7693285|NCT01849289|18945179|P1|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553
7693286|NCT01849289|18945178|P2|STARTED|Overall Study||278
7693287|NCT01849289|18945179|P1|STARTED|Overall Study||555
7693288|NCT01849276|18945195|P1|NOT COMPLETED|Followed for Survival for 5 Years||2
7693289|NCT01849276|18945195|P1|COMPLETED|Followed for Survival for 5 Years||0
7693290|NCT01849276|18945195|P1|STARTED|Followed for Survival for 5 Years||2
7693291|NCT01849276|18945195|P1|NOT COMPLETED|Completed Treatment||0
7693292|NCT01849276|18945195|P1|COMPLETED|Completed Treatment||2
7693293|NCT01849276|18945195|P1|STARTED|Completed Treatment||2
7693294|NCT01849276|18945195|P1|NOT COMPLETED|Registered to the Study||0
7693295|NCT01849276|18945195|P1|COMPLETED|Registered to the Study||2
7693296|NCT01849276|18945195|P1|STARTED|Registered to the Study||2
7693297|NCT01849263|18945207|P1|NOT COMPLETED|Overall Study||0
7693298|NCT01849263|18945207|P1|COMPLETED|Overall Study||40
7693299|NCT01849263|18945207|P1|STARTED|Overall Study||40
7693300|NCT01849172|18945219|P2|NOT COMPLETED|Overall Study||6
7693301|NCT01849172|18945220|P1|NOT COMPLETED|Overall Study||7
7693302|NCT01849172|18945219|P2|COMPLETED|Overall Study||174
7693303|NCT01849172|18945220|P1|COMPLETED|Overall Study||173
7693304|NCT01849172|18945219|P2|STARTED|Overall Study||180
7693305|NCT01849172|18945220|P1|STARTED|Overall Study||180
7693306|NCT01849068|18945258|P2|NOT COMPLETED|Overall Study||0
7693307|NCT01849068|18945259|P1|NOT COMPLETED|Overall Study||0
7693308|NCT01849068|18945258|P2|COMPLETED|Overall Study||10
7693309|NCT01849068|18945259|P1|COMPLETED|Overall Study||10
7693310|NCT01849068|18945258|P2|STARTED|Overall Study||10
7693311|NCT01849068|18945259|P1|STARTED|Overall Study||10
7693312|NCT01849055|18945277|P6|NOT COMPLETED|Overall Study||0
7693313|NCT01849055|18945278|P5|NOT COMPLETED|Overall Study||0
7693314|NCT01849055|18945279|P4|NOT COMPLETED|Overall Study||0
7693315|NCT01849055|18945280|P3|NOT COMPLETED|Overall Study||1
7693316|NCT01849055|18945281|P2|NOT COMPLETED|Overall Study||0
7693317|NCT01849055|18945282|P1|NOT COMPLETED|Overall Study||0
7693318|NCT01849055|18945277|P6|COMPLETED|Overall Study||8
7693319|NCT01849055|18945278|P5|COMPLETED|Overall Study||8
7693320|NCT01849055|18945279|P4|COMPLETED|Overall Study||8
7693321|NCT01849055|18945280|P3|COMPLETED|Overall Study||7
7693322|NCT01849055|18945281|P2|COMPLETED|Overall Study||8
7693323|NCT01849055|18945282|P1|COMPLETED|Overall Study||8
7693324|NCT01849055|18945277|P6|STARTED|Overall Study||8
7693325|NCT01849055|18945278|P5|STARTED|Overall Study||8
7693326|NCT01849055|18945279|P4|STARTED|Overall Study||8
7693327|NCT01849055|18945280|P3|STARTED|Overall Study||8
7693328|NCT01849055|18945281|P2|STARTED|Overall Study||8
7693329|NCT01849055|18945282|P1|STARTED|Overall Study||8
7693330|NCT01848990|18945317|P3|NOT COMPLETED|Overall Study||16
7693331|NCT01848990|18945318|P2|NOT COMPLETED|Overall Study||20
7693332|NCT01848990|18945319|P1|NOT COMPLETED|Overall Study||46
7693333|NCT01848990|18945317|P3|COMPLETED|Overall Study||98
7693334|NCT01848990|18945318|P2|COMPLETED|Overall Study||95
7693335|NCT01848990|18945319|P1|COMPLETED|Overall Study||181
7693336|NCT01848990|18945317|P3|Completed Month 6|Overall Study||103
7693337|NCT01848990|18945318|P2|Completed Month 6|Overall Study||106
7693338|NCT01848990|18945319|P1|Completed Month 6|Overall Study||194
7693339|NCT01848990|18945317|P3|Received at Least 1 Dose of Study Drug|Overall Study||113
7693340|NCT01848990|18945318|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
7693341|NCT01848990|18945319|P1|Received at Least 1 Dose of Study Drug|Overall Study||227
7693342|NCT01848990|18945317|P3|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114
7693343|NCT01848990|18945318|P2|STARTED|Overall Study||115
7693344|NCT01848990|18945319|P1|STARTED|Overall Study||227
7693345|NCT01848977|18945378|P1|NOT COMPLETED|Overall Study||0
7693346|NCT01848977|18945378|P1|COMPLETED|Overall Study||20
7693347|NCT01848977|18945378|P1|STARTED|Overall Study||20
7693348|NCT01848938|18945389|P2|NOT COMPLETED|Overall Study||1
7693349|NCT01848938|18945390|P1|NOT COMPLETED|Overall Study||1
7693350|NCT01848938|18945389|P2|COMPLETED|Overall Study||60
7693351|NCT01848938|18945390|P1|COMPLETED|Overall Study||61
7693352|NCT01848938|18945389|P2|STARTED|Overall Study||61
7693353|NCT01848938|18945390|P1|STARTED|Overall Study||62
7693354|NCT01848899|18945408|P2|NOT COMPLETED|Overall Study||0
7693355|NCT01848899|18945409|P1|NOT COMPLETED|Overall Study||0
7693356|NCT01848899|18945408|P2|COMPLETED|Overall Study||50
7693357|NCT01848899|18945409|P1|COMPLETED|Overall Study||50
7693358|NCT01848899|18945408|P2|STARTED|Overall Study||50
7693359|NCT01848899|18945409|P1|STARTED|Overall Study||50
7693360|NCT01848847|18945425|P2|NOT COMPLETED|Overall Study||3
7693361|NCT01848847|18945426|P1|NOT COMPLETED|Overall Study||2
7693362|NCT01848847|18945425|P2|COMPLETED|Overall Study||48
7693363|NCT01848847|18945426|P1|COMPLETED|Overall Study||49
7693364|NCT01848847|18945425|P2|STARTED|Overall Study||51
7693365|NCT01848847|18945426|P1|STARTED|Overall Study||51
7693366|NCT01848834|18945439|P5|NOT COMPLETED|Overall Study||132
7693367|NCT01848834|18945440|P4|NOT COMPLETED|Overall Study||37
7693368|NCT01848834|18945441|P3|NOT COMPLETED|Overall Study||32
7693369|NCT01848834|18945442|P2|NOT COMPLETED|Overall Study||60
7693370|NCT01848834|18945443|P1|NOT COMPLETED|Overall Study||30
7693371|NCT01848834|18945439|P5|COMPLETED|Overall Study|Completed means two-year treatment completed|0
7693372|NCT01848834|18945440|P4|COMPLETED|Overall Study|Completed means two-year treatment completed|2
7693373|NCT01848834|18945441|P3|COMPLETED|Overall Study|Completed means two-year treatment completed|1
7693374|NCT01848834|18945442|P2|COMPLETED|Overall Study|Completed means two-year treatment completed|1
7693375|NCT01848834|18945443|P1|COMPLETED|Overall Study|Completed means two-year treatment completed|2
7693376|NCT01848834|18945439|P5|Treated|Overall Study||132
7693377|NCT01848834|18945440|P4|Treated|Overall Study||39
7693378|NCT01848834|18945441|P3|Treated|Overall Study||33
7693379|NCT01848834|18945442|P2|Treated|Overall Study||60
7693380|NCT01848834|18945443|P1|Treated|Overall Study||32
7693381|NCT01848834|18945439|P5|STARTED|Overall Study||132
7693382|NCT01848834|18945440|P4|STARTED|Overall Study||39
7693383|NCT01848834|18945441|P3|STARTED|Overall Study||33
7693384|NCT01848834|18945442|P2|STARTED|Overall Study||61
7693385|NCT01848834|18945443|P1|STARTED|Overall Study||32
7693386|NCT01848821|18945480|P2|NOT COMPLETED|Overall Study||0
7693387|NCT01848821|18945481|P1|NOT COMPLETED|Overall Study||0
7693388|NCT01848821|18945480|P2|COMPLETED|Overall Study||7
7693389|NCT01848821|18945481|P1|COMPLETED|Overall Study||7
7693390|NCT01848821|18945480|P2|STARTED|Overall Study||7
7693391|NCT01848821|18945481|P1|STARTED|Overall Study||7
7693392|NCT01848756|18945491|P1|NOT COMPLETED|Overall Study||3
7693393|NCT01848756|18945491|P1|COMPLETED|Overall Study|Cycle 1|12
7693394|NCT01848756|18945491|P1|STARTED|Overall Study||15
7693395|NCT01848483|18945503|P2|NOT COMPLETED|Overall Study||11
7693396|NCT01848483|18945504|P1|NOT COMPLETED|Overall Study||11
7693397|NCT01848483|18945503|P2|COMPLETED|Overall Study||49
7693398|NCT01848483|18945504|P1|COMPLETED|Overall Study||50
7693399|NCT01848483|18945503|P2|STARTED|Overall Study||60
7693400|NCT01848483|18945504|P1|STARTED|Overall Study||61
7693401|NCT01848457|18945522|P4|NOT COMPLETED|Overall Study||0
7693402|NCT01848457|18945523|P3|NOT COMPLETED|Overall Study||0
7693403|NCT01848457|18945524|P2|NOT COMPLETED|Overall Study||0
7693404|NCT01848457|18945525|P1|NOT COMPLETED|Overall Study||1
7693405|NCT01848457|18945522|P4|COMPLETED|Overall Study||3
7693406|NCT01848457|18945523|P3|COMPLETED|Overall Study||3
7693407|NCT01848457|18945524|P2|COMPLETED|Overall Study||3
7693408|NCT01848457|18945525|P1|COMPLETED|Overall Study||3
7693409|NCT01848457|18945522|P4|Cycle 4|Overall Study||3
7693410|NCT01848457|18945523|P3|Cycle 4|Overall Study||3
7693411|NCT01848457|18945524|P2|Cycle 4|Overall Study||3
7693412|NCT01848457|18945525|P1|Cycle 4|Overall Study||3
7693413|NCT01848457|18945522|P4|Cycle 3|Overall Study||3
7693414|NCT01848457|18945523|P3|Cycle 3|Overall Study||3
7693415|NCT01848457|18945524|P2|Cycle 3|Overall Study||3
7693416|NCT01848457|18945525|P1|Cycle 3|Overall Study||3
7693417|NCT01848457|18945522|P4|Cycle 2|Overall Study||3
7693418|NCT01848457|18945523|P3|Cycle 2|Overall Study||3
7693419|NCT01848457|18945524|P2|Cycle 2|Overall Study||3
7693420|NCT01848457|18945525|P1|Cycle 2|Overall Study||3
7693421|NCT01848457|18945522|P4|Cycle 1|Overall Study||3
7693422|NCT01848457|18945523|P3|Cycle 1|Overall Study||3
7693423|NCT01848457|18945524|P2|Cycle 1|Overall Study||3
7693424|NCT01848457|18945525|P1|Cycle 1|Overall Study||4
7693425|NCT01848457|18945522|P4|Baseline|Overall Study||3
7693426|NCT01848457|18945523|P3|Baseline|Overall Study||3
7693427|NCT01848457|18945524|P2|Baseline|Overall Study||3
7693428|NCT01848457|18945525|P1|Baseline|Overall Study||4
7693429|NCT01848457|18945522|P4|STARTED|Overall Study||3
7693430|NCT01848457|18945523|P3|STARTED|Overall Study||3
7693431|NCT01848457|18945524|P2|STARTED|Overall Study||3
7693432|NCT01848457|18945525|P1|STARTED|Overall Study||4
7693433|NCT01848366|18945549|P1|NOT COMPLETED|Overall Study||0
7693434|NCT01848366|18945549|P1|COMPLETED|Overall Study||8
7693435|NCT01848366|18945549|P1|STARTED|Overall Study||8
7693436|NCT01848353|18945557|P4|NOT COMPLETED|Phase 3||0
7693437|NCT01848353|18945558|P3|NOT COMPLETED|Phase 3||0
7693438|NCT01848353|18945559|P2|NOT COMPLETED|Phase 3||1
7693439|NCT01848353|18945560|P1|NOT COMPLETED|Phase 3||1
7693440|NCT01848353|18945557|P4|COMPLETED|Phase 3||0
7693441|NCT01848353|18945558|P3|COMPLETED|Phase 3||0
7693442|NCT01848353|18945559|P2|COMPLETED|Phase 3||9
7693443|NCT01848353|18945560|P1|COMPLETED|Phase 3||4
7693444|NCT01848353|18945557|P4|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
7693445|NCT01848353|18945558|P3|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
7693446|NCT01848353|18945559|P2|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|10
7693447|NCT01848353|18945560|P1|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|5
7693448|NCT01848353|18945557|P4|NOT COMPLETED|Phase 2||0
7693449|NCT01848353|18945558|P3|NOT COMPLETED|Phase 2||0
7693450|NCT01848353|18945559|P2|NOT COMPLETED|Phase 2||2
7693451|NCT01848353|18945560|P1|NOT COMPLETED|Phase 2||3
7693452|NCT01848353|18945557|P4|COMPLETED|Phase 2||0
7693453|NCT01848353|18945558|P3|COMPLETED|Phase 2||0
7693454|NCT01848353|18945559|P2|COMPLETED|Phase 2||26
7693455|NCT01848353|18945560|P1|COMPLETED|Phase 2||20
7693456|NCT01848353|18945557|P4|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
7693457|NCT01848353|18945558|P3|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
7693458|NCT01848353|18945559|P2|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|28
7693459|NCT01848353|18945560|P1|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|23
7693460|NCT01848353|18945557|P4|NOT COMPLETED|Phase 1||0
7693461|NCT01848353|18945558|P3|NOT COMPLETED|Phase 1||0
7693462|NCT01848353|18945559|P2|NOT COMPLETED|Phase 1||1
7693463|NCT01848353|18945560|P1|NOT COMPLETED|Phase 1||3
7693464|NCT01848353|18945557|P4|COMPLETED|Phase 1||19
7693465|NCT01848353|18945558|P3|COMPLETED|Phase 1||20
7693466|NCT01848353|18945559|P2|COMPLETED|Phase 1||42
7693467|NCT01848353|18945560|P1|COMPLETED|Phase 1||35
7693468|NCT01848353|18945557|P4|STARTED|Phase 1||19
7693469|NCT01848353|18945558|P3|STARTED|Phase 1||20
7693470|NCT01848353|18945559|P2|STARTED|Phase 1||43
7693471|NCT01848353|18945560|P1|STARTED|Phase 1||38
7693472|NCT01848288|18945616|P1|NOT COMPLETED|Overall Study||3
7693473|NCT01848288|18945616|P1|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97
7693474|NCT01848288|18945616|P1|STARTED|Overall Study||100
7693475|NCT01848210|18945627|P2|NOT COMPLETED|Overall Study||78
7693476|NCT01848210|18945628|P1|NOT COMPLETED|Overall Study||88
7693477|NCT01848210|18945627|P2|COMPLETED|Overall Study||340
7693478|NCT01848210|18945628|P1|COMPLETED|Overall Study||323
7693479|NCT01848210|18945627|P2|Per Protocol Population|Overall Study||245
7693480|NCT01848210|18945628|P1|Per Protocol Population|Overall Study||222
7693481|NCT01848210|18945627|P2|Intent-to-Treat (ITT) Population|Overall Study||388
7693482|NCT01848210|18945628|P1|Intent-to-Treat (ITT) Population|Overall Study||383
7693483|NCT01848210|18945627|P2|Safety Population-Received Study Drug|Overall Study||398
7693484|NCT01848210|18945628|P1|Safety Population-Received Study Drug|Overall Study||394
7693485|NCT01848210|18945627|P2|STARTED|Overall Study||418
7693486|NCT01848210|18945628|P1|STARTED|Overall Study||411
7693487|NCT01848184|18945640|P1|NOT COMPLETED|Overall Study||26
7693488|NCT01848184|18945640|P1|COMPLETED|Overall Study||100
7693489|NCT01848184|18945640|P1|STARTED|Overall Study||126
7693490|NCT01848158|18945652|P2|NOT COMPLETED|Overall Study||0
7693491|NCT01848158|18945653|P1|NOT COMPLETED|Overall Study||0
7693492|NCT01848158|18945652|P2|COMPLETED|Overall Study||7
7693493|NCT01848158|18945653|P1|COMPLETED|Overall Study||10
7693494|NCT01848158|18945652|P2|STARTED|Overall Study||7
7693495|NCT01848158|18945653|P1|STARTED|Overall Study||10
7693496|NCT01848145|18945677|P1|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10
7693497|NCT01848145|18945677|P1|COMPLETED|Subsequent Infusions: Weeks 3-8||20
7693498|NCT01848145|18945677|P1|STARTED|Subsequent Infusions: Weeks 3-8||30
7693499|NCT01848145|18945677|P1|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1
7693500|NCT01848145|18945677|P1|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30
7693501|NCT01848145|18945677|P1|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26
7693502|NCT01848145|18945677|P1|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31
7693503|NCT01848145|18945677|P1|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2
7693504|NCT01848145|18945677|P1|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes|Includes participants that completed Infusion 2 and proceeded to the next infusion, Infusion 3.|31
7693505|NCT01848145|18945677|P1|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24
7693506|NCT01848145|18945677|P1|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33
7693507|NCT01848145|18945677|P1|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1
7693508|NCT01848145|18945677|P1|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes|Includes participants that completed Infusion 1 and proceeded to the next infusion, Infusion 2.|33
7693509|NCT01848145|18945677|P1|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes|Number of patients who completed within 15 minutes (min) of infusion time.|1
7693510|NCT01848145|18945677|P1|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34
7693511|NCT01848067|18945686|P1|NOT COMPLETED|Overall Study||0
7693512|NCT01848067|18945686|P1|COMPLETED|Overall Study||9
7693513|NCT01848067|18945686|P1|STARTED|Overall Study||9
7693514|NCT01848054|18945694|P2|NOT COMPLETED|Stabilization/Maintenance||40
7693515|NCT01848054|18945695|P1|NOT COMPLETED|Stabilization/Maintenance||40
7693516|NCT01848054|18945694|P2|COMPLETED|Stabilization/Maintenance||107
7693517|NCT01848054|18945695|P1|COMPLETED|Stabilization/Maintenance||92
7693518|NCT01848054|18945694|P2|STARTED|Stabilization/Maintenance||147
7693519|NCT01848054|18945695|P1|STARTED|Stabilization/Maintenance||132
7693520|NCT01848054|18945694|P2|NOT COMPLETED|Induction Phase||8
7693521|NCT01848054|18945695|P1|NOT COMPLETED|Induction Phase||23
7693522|NCT01848054|18945694|P2|COMPLETED|Induction Phase||147
7693523|NCT01848054|18945695|P1|COMPLETED|Induction Phase||132
7693524|NCT01848054|18945694|P2|STARTED|Induction Phase||155
7693525|NCT01848054|18945695|P1|STARTED|Induction Phase||155
7693526|NCT01847885|18945717|P3|NOT COMPLETED|Randomization||2
7693527|NCT01847885|18945718|P2|NOT COMPLETED|Randomization||4
7693528|NCT01847885|18945719|P1|NOT COMPLETED|Randomization||0
7693529|NCT01847885|18945717|P3|COMPLETED|Randomization||13
7693530|NCT01847885|18945718|P2|COMPLETED|Randomization||27
7693531|NCT01847885|18945719|P1|COMPLETED|Randomization||0
7693532|NCT01847885|18945717|P3|Per Protocol Set|Randomization||13
7693533|NCT01847885|18945718|P2|Per Protocol Set|Randomization||27
7693534|NCT01847885|18945719|P1|Per Protocol Set|Randomization||0
7693535|NCT01847885|18945717|P3|Safety Set|Randomization||13
7693536|NCT01847885|18945718|P2|Safety Set|Randomization||28
7693537|NCT01847885|18945719|P1|Safety Set|Randomization||0
7693538|NCT01847885|18945717|P3|Full Analysis Set|Randomization||15
7693539|NCT01847885|18945718|P2|Full Analysis Set|Randomization||28
7693540|NCT01847885|18945719|P1|Full Analysis Set|Randomization||0
7693541|NCT01847885|18945717|P3|STARTED|Randomization||15
7693542|NCT01847885|18945718|P2|STARTED|Randomization||31
7693543|NCT01847885|18945719|P1|STARTED|Randomization||0
7693544|NCT01847885|18945717|P3|NOT COMPLETED|Initial Enrollment (Consented)||0
7693545|NCT01847885|18945718|P2|NOT COMPLETED|Initial Enrollment (Consented)||0
7693546|NCT01847885|18945719|P1|NOT COMPLETED|Initial Enrollment (Consented)||48
7693547|NCT01847885|18945717|P3|COMPLETED|Initial Enrollment (Consented)||0
7693548|NCT01847885|18945718|P2|COMPLETED|Initial Enrollment (Consented)||0
7693549|NCT01847885|18945719|P1|COMPLETED|Initial Enrollment (Consented)||40
7693550|NCT01847885|18945717|P3|Per Protocol Set|Initial Enrollment (Consented)||0
7693551|NCT01847885|18945718|P2|Per Protocol Set|Initial Enrollment (Consented)||0
7693552|NCT01847885|18945719|P1|Per Protocol Set|Initial Enrollment (Consented)||40
7693553|NCT01847885|18945717|P3|Safety Set|Initial Enrollment (Consented)||0
7693554|NCT01847885|18945718|P2|Safety Set|Initial Enrollment (Consented)||0
7693555|NCT01847885|18945719|P1|Safety Set|Initial Enrollment (Consented)||41
7693556|NCT01847885|18945717|P3|Full Analysis Set|Initial Enrollment (Consented)||0
7693557|NCT01847885|18945718|P2|Full Analysis Set|Initial Enrollment (Consented)||0
7693558|NCT01847885|18945719|P1|Full Analysis Set|Initial Enrollment (Consented)||43
7693559|NCT01847885|18945717|P3|Randomized|Initial Enrollment (Consented)||0
7693560|NCT01847885|18945718|P2|Randomized|Initial Enrollment (Consented)||0
7693561|NCT01847885|18945719|P1|Randomized|Initial Enrollment (Consented)||46
7693562|NCT01847885|18945717|P3|STARTED|Initial Enrollment (Consented)||0
7693563|NCT01847885|18945718|P2|STARTED|Initial Enrollment (Consented)||0
7693564|NCT01847885|18945719|P1|STARTED|Initial Enrollment (Consented)||88
7693565|NCT01847638|18945753|P2|NOT COMPLETED|Overall Study||0
7693566|NCT01847638|18945754|P1|NOT COMPLETED|Overall Study||0
7693567|NCT01847638|18945753|P2|COMPLETED|Overall Study||25
7693568|NCT01847638|18945754|P1|COMPLETED|Overall Study||25
7693569|NCT01847638|18945753|P2|STARTED|Overall Study||25
7693570|NCT01847638|18945754|P1|STARTED|Overall Study||25
7693571|NCT01847560|18945774|P10|NOT COMPLETED|Overall Study||0
7693572|NCT01847560|18945775|P9|NOT COMPLETED|Overall Study||0
7693573|NCT01847560|18945776|P8|NOT COMPLETED|Overall Study||0
7693574|NCT01847560|18945777|P7|NOT COMPLETED|Overall Study||0
7693575|NCT01847560|18945778|P6|NOT COMPLETED|Overall Study||0
7693576|NCT01847560|18945779|P5|NOT COMPLETED|Overall Study||0
7693577|NCT01847560|18945780|P4|NOT COMPLETED|Overall Study||0
7693578|NCT01847560|18945781|P3|NOT COMPLETED|Overall Study||0
7693579|NCT01847560|18945782|P2|NOT COMPLETED|Overall Study||0
7693580|NCT01847560|18945783|P1|NOT COMPLETED|Overall Study||0
7693581|NCT01847560|18945774|P10|COMPLETED|Overall Study||39438
7693582|NCT01847560|18945775|P9|COMPLETED|Overall Study||77547
7693583|NCT01847560|18945776|P8|COMPLETED|Overall Study||19829
7693584|NCT01847560|18945777|P7|COMPLETED|Overall Study||40971
7693585|NCT01847560|18945778|P6|COMPLETED|Overall Study||28343
7693586|NCT01847560|18945779|P5|COMPLETED|Overall Study||27731
7693587|NCT01847560|18945780|P4|COMPLETED|Overall Study||56655
7693588|NCT01847560|18945781|P3|COMPLETED|Overall Study||9731
7693589|NCT01847560|18945782|P2|COMPLETED|Overall Study||19955
7693590|NCT01847560|18945783|P1|COMPLETED|Overall Study||13464
7693591|NCT01847560|18945774|P10|STARTED|Overall Study||39438
7693592|NCT01847560|18945775|P9|STARTED|Overall Study||77547
7693593|NCT01847560|18945776|P8|STARTED|Overall Study||19829
7693594|NCT01847560|18945777|P7|STARTED|Overall Study||40971
7693595|NCT01847560|18945778|P6|STARTED|Overall Study||28343
7693596|NCT01847560|18945779|P5|STARTED|Overall Study||27731
7693597|NCT01847560|18945780|P4|STARTED|Overall Study||56655
7693598|NCT01847560|18945781|P3|STARTED|Overall Study||9731
7693599|NCT01847560|18945782|P2|STARTED|Overall Study||19955
7693600|NCT01847560|18945783|P1|STARTED|Overall Study||13464
7693601|NCT01847547|18945827|P2|NOT COMPLETED|Overall Study||0
7693602|NCT01847547|18945828|P1|NOT COMPLETED|Overall Study||0
7693603|NCT01847547|18945827|P2|COMPLETED|Overall Study||2991
7693604|NCT01847547|18945828|P1|COMPLETED|Overall Study||2991
7693605|NCT01847547|18945827|P2|STARTED|Overall Study||2991
7693606|NCT01847547|18945828|P1|STARTED|Overall Study||2991
7693607|NCT01847469|18945872|P2|NOT COMPLETED|Overall Study||3
7693608|NCT01847469|18945873|P1|NOT COMPLETED|Overall Study||9
7693609|NCT01847469|18945872|P2|COMPLETED|Overall Study||3
7693610|NCT01847469|18945873|P1|COMPLETED|Overall Study||9
7693611|NCT01847469|18945872|P2|STARTED|Overall Study||6
7693612|NCT01847469|18945873|P1|STARTED|Overall Study||18
7693613|NCT01847443|18945883|P4|NOT COMPLETED|Study Period 4||0
7693614|NCT01847443|18945884|P3|NOT COMPLETED|Study Period 4||0
7693615|NCT01847443|18945885|P2|NOT COMPLETED|Study Period 4||0
7693616|NCT01847443|18945886|P1|NOT COMPLETED|Study Period 4||0
7693617|NCT01847443|18945883|P4|COMPLETED|Study Period 4||21
7693618|NCT01847443|18945884|P3|COMPLETED|Study Period 4||21
7693619|NCT01847443|18945885|P2|COMPLETED|Study Period 4||19
7693620|NCT01847443|18945886|P1|COMPLETED|Study Period 4||16
7693621|NCT01847443|18945883|P4|STARTED|Study Period 4||21
7693622|NCT01847443|18945884|P3|STARTED|Study Period 4||21
7693623|NCT01847443|18945885|P2|STARTED|Study Period 4||19
7693624|NCT01847443|18945886|P1|STARTED|Study Period 4||16
7693625|NCT01847443|18945883|P4|NOT COMPLETED|Washout Period Before Study Period 4||0
7693626|NCT01847443|18945884|P3|NOT COMPLETED|Washout Period Before Study Period 4||0
7693627|NCT01847443|18945885|P2|NOT COMPLETED|Washout Period Before Study Period 4||0
7693628|NCT01847443|18945886|P1|NOT COMPLETED|Washout Period Before Study Period 4||2
7693629|NCT01847443|18945883|P4|COMPLETED|Washout Period Before Study Period 4||21
7693630|NCT01847443|18945884|P3|COMPLETED|Washout Period Before Study Period 4||21
7693631|NCT01847443|18945885|P2|COMPLETED|Washout Period Before Study Period 4||19
7693632|NCT01847443|18945886|P1|COMPLETED|Washout Period Before Study Period 4||16
7693633|NCT01847443|18945883|P4|STARTED|Washout Period Before Study Period 4||21
7693634|NCT01847443|18945884|P3|STARTED|Washout Period Before Study Period 4||21
7693635|NCT01847443|18945885|P2|STARTED|Washout Period Before Study Period 4||19
7693636|NCT01847443|18945886|P1|STARTED|Washout Period Before Study Period 4||18
7693637|NCT01847443|18945883|P4|NOT COMPLETED|Study Period 3||0
7693638|NCT01847443|18945884|P3|NOT COMPLETED|Study Period 3||0
7693639|NCT01847443|18945885|P2|NOT COMPLETED|Study Period 3||0
7693640|NCT01847443|18945886|P1|NOT COMPLETED|Study Period 3||0
7693641|NCT01847443|18945883|P4|COMPLETED|Study Period 3||21
7693642|NCT01847443|18945884|P3|COMPLETED|Study Period 3||21
7693643|NCT01847443|18945885|P2|COMPLETED|Study Period 3||19
7693644|NCT01847443|18945886|P1|COMPLETED|Study Period 3||18
7693645|NCT01847443|18945883|P4|STARTED|Study Period 3||21
7693646|NCT01847443|18945884|P3|STARTED|Study Period 3||21
7693647|NCT01847443|18945885|P2|STARTED|Study Period 3||19
7693648|NCT01847443|18945886|P1|STARTED|Study Period 3||18
7693649|NCT01847443|18945883|P4|NOT COMPLETED|Washout Period Before Study Period 3||0
7693650|NCT01847443|18945884|P3|NOT COMPLETED|Washout Period Before Study Period 3||0
7693651|NCT01847443|18945885|P2|NOT COMPLETED|Washout Period Before Study Period 3||0
7693652|NCT01847443|18945886|P1|NOT COMPLETED|Washout Period Before Study Period 3||1
7693653|NCT01847443|18945883|P4|COMPLETED|Washout Period Before Study Period 3||21
7693654|NCT01847443|18945884|P3|COMPLETED|Washout Period Before Study Period 3||21
7693655|NCT01847443|18945885|P2|COMPLETED|Washout Period Before Study Period 3||19
7693656|NCT01847443|18945886|P1|COMPLETED|Washout Period Before Study Period 3||18
7693657|NCT01847443|18945883|P4|STARTED|Washout Period Before Study Period 3||21
7693658|NCT01847443|18945884|P3|STARTED|Washout Period Before Study Period 3||21
7693659|NCT01847443|18945885|P2|STARTED|Washout Period Before Study Period 3||19
7693660|NCT01847443|18945886|P1|STARTED|Washout Period Before Study Period 3||19
7693661|NCT01847443|18945883|P4|NOT COMPLETED|Study Period 2||0
7693662|NCT01847443|18945884|P3|NOT COMPLETED|Study Period 2||0
7693663|NCT01847443|18945885|P2|NOT COMPLETED|Study Period 2||0
7693664|NCT01847443|18945886|P1|NOT COMPLETED|Study Period 2||0
7693665|NCT01847443|18945883|P4|COMPLETED|Study Period 2||21
7693666|NCT01847443|18945884|P3|COMPLETED|Study Period 2||21
7693667|NCT01847443|18945885|P2|COMPLETED|Study Period 2||19
7693668|NCT01847443|18945886|P1|COMPLETED|Study Period 2||19
7693669|NCT01847443|18945883|P4|STARTED|Study Period 2||21
7693670|NCT01847443|18945884|P3|STARTED|Study Period 2||21
7693671|NCT01847443|18945885|P2|STARTED|Study Period 2||19
7693672|NCT01847443|18945886|P1|STARTED|Study Period 2||19
7693673|NCT01847443|18945883|P4|NOT COMPLETED|Washout Period Before Study Period 2||0
7693674|NCT01847443|18945884|P3|NOT COMPLETED|Washout Period Before Study Period 2||0
7693675|NCT01847443|18945885|P2|NOT COMPLETED|Washout Period Before Study Period 2||1
7693676|NCT01847443|18945886|P1|NOT COMPLETED|Washout Period Before Study Period 2||2
7693677|NCT01847443|18945883|P4|COMPLETED|Washout Period Before Study Period 2||21
7693678|NCT01847443|18945884|P3|COMPLETED|Washout Period Before Study Period 2||21
7693679|NCT01847443|18945885|P2|COMPLETED|Washout Period Before Study Period 2||19
7693680|NCT01847443|18945886|P1|COMPLETED|Washout Period Before Study Period 2||19
7693681|NCT01847443|18945883|P4|STARTED|Washout Period Before Study Period 2||21
7693682|NCT01847443|18945884|P3|STARTED|Washout Period Before Study Period 2||21
7693683|NCT01847443|18945885|P2|STARTED|Washout Period Before Study Period 2||20
7693684|NCT01847443|18945886|P1|STARTED|Washout Period Before Study Period 2||21
7693685|NCT01847443|18945883|P4|NOT COMPLETED|Study Period 1||0
7693686|NCT01847443|18945884|P3|NOT COMPLETED|Study Period 1||0
7693687|NCT01847443|18945885|P2|NOT COMPLETED|Study Period 1||1
7693688|NCT01847443|18945886|P1|NOT COMPLETED|Study Period 1||0
7693689|NCT01847443|18945883|P4|COMPLETED|Study Period 1||21
7693690|NCT01847443|18945884|P3|COMPLETED|Study Period 1||21
7693691|NCT01847443|18945885|P2|COMPLETED|Study Period 1||20
7693692|NCT01847443|18945886|P1|COMPLETED|Study Period 1||21
7693693|NCT01847443|18945883|P4|STARTED|Study Period 1||21
7693694|NCT01847443|18945884|P3|STARTED|Study Period 1||21
7693695|NCT01847443|18945885|P2|STARTED|Study Period 1||21
7693696|NCT01847443|18945886|P1|STARTED|Study Period 1||21
7693697|NCT01847430|18945916|P1|NOT COMPLETED|Overall Study||0
7693698|NCT01847430|18945916|P1|COMPLETED|Overall Study||302
7693699|NCT01847430|18945916|P1|STARTED|Overall Study||302
7693700|NCT01847313|18945929|P2|NOT COMPLETED|Overall Study||2
7693701|NCT01847313|18945930|P1|NOT COMPLETED|Overall Study||0
7693702|NCT01847313|18945929|P2|COMPLETED|Overall Study||8
7693703|NCT01847313|18945930|P1|COMPLETED|Overall Study||10
7693704|NCT01847313|18945929|P2|STARTED|Overall Study||10
7693705|NCT01847313|18945930|P1|STARTED|Overall Study||10
7693706|NCT01847274|18945946|P4|NOT COMPLETED|Overall Study||104
7693707|NCT01847274|18945947|P3|NOT COMPLETED|Overall Study||188
7693708|NCT01847274|18945948|P2|NOT COMPLETED|Overall Study||61
7693709|NCT01847274|18945949|P1|NOT COMPLETED|Overall Study||91
7693710|NCT01847274|18945946|P4|COMPLETED|Overall Study||12
7693711|NCT01847274|18945947|P3|COMPLETED|Overall Study||46
7693712|NCT01847274|18945948|P2|COMPLETED|Overall Study||4
7693713|NCT01847274|18945949|P1|COMPLETED|Overall Study||47
7693714|NCT01847274|18945946|P4|STARTED|Overall Study||116
7693715|NCT01847274|18945947|P3|STARTED|Overall Study||234
7693716|NCT01847274|18945948|P2|STARTED|Overall Study||65
7693717|NCT01847274|18945949|P1|STARTED|Overall Study||138
7693718|NCT01847209|18946003|P1|NOT COMPLETED|Overall Study||2
7693719|NCT01847209|18946003|P1|COMPLETED|Overall Study||23
7693720|NCT01847209|18946003|P1|STARTED|Overall Study||25
7693721|NCT01847196|18946008|P1|NOT COMPLETED|Overall Study||0
7693722|NCT01847196|18946008|P1|COMPLETED|Overall Study||5
7693723|NCT01847196|18946008|P1|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5
7693724|NCT01847131|18946015|P2|NOT COMPLETED|Overall Study||0
7693725|NCT01847131|18946016|P1|NOT COMPLETED|Overall Study||0
7693726|NCT01847131|18946015|P2|COMPLETED|Overall Study||25
7693727|NCT01847131|18946016|P1|COMPLETED|Overall Study||25
7693728|NCT01847131|18946015|P2|STARTED|Overall Study||25
7693729|NCT01847131|18946016|P1|STARTED|Overall Study||25
7693730|NCT01847092|18946026|P2|NOT COMPLETED|Overall Study||11
7693731|NCT01847092|18946027|P1|NOT COMPLETED|Overall Study||26
7693732|NCT01847092|18946026|P2|COMPLETED|Overall Study||66
7693733|NCT01847092|18946027|P1|COMPLETED|Overall Study||51
7693734|NCT01847092|18946026|P2|STARTED|Overall Study||77
7693735|NCT01847092|18946027|P1|STARTED|Overall Study||77
7693736|NCT01847027|18946037|P2|NOT COMPLETED|Overall Study||2
7693737|NCT01847027|18946038|P1|NOT COMPLETED|Overall Study||1
7693738|NCT01847027|18946037|P2|COMPLETED|Overall Study||10
7693739|NCT01847027|18946038|P1|COMPLETED|Overall Study||10
7693740|NCT01847027|18946037|P2|STARTED|Overall Study||12
7693741|NCT01847027|18946038|P1|STARTED|Overall Study||11
7693742|NCT01847014|18946048|P1|NOT COMPLETED|Completion of Extension Study||4
7693743|NCT01847014|18946048|P1|COMPLETED|Completion of Extension Study||0
7693744|NCT01847014|18946048|P1|STARTED|Completion of Extension Study||4
7693745|NCT01847014|18946048|P1|NOT COMPLETED|Baseline Extension Visit||0
7693746|NCT01847014|18946048|P1|COMPLETED|Baseline Extension Visit||4
7693747|NCT01847014|18946048|P1|STARTED|Baseline Extension Visit||4
7693748|NCT01847001|18946052|P1|NOT COMPLETED|Overall Study||0
7693749|NCT01847001|18946052|P1|COMPLETED|Overall Study||10
7693750|NCT01847001|18946052|P1|STARTED|Overall Study||10
7693751|NCT01846871|18946056|P1|NOT COMPLETED|Overall Study||0
7693752|NCT01846871|18946056|P1|COMPLETED|Overall Study||10
7693753|NCT01846871|18946056|P1|STARTED|Overall Study||10
7693754|NCT01846741|18946081|P1|NOT COMPLETED|Implantation to 18-Month/End of Study||0
7693755|NCT01846741|18946081|P1|COMPLETED|Implantation to 18-Month/End of Study||20
7693756|NCT01846741|18946081|P1|STARTED|Implantation to 18-Month/End of Study||20
7693757|NCT01846741|18946081|P1|NOT COMPLETED|Baseline Visit||2
7693758|NCT01846741|18946081|P1|COMPLETED|Baseline Visit||20
7693759|NCT01846741|18946081|P1|STARTED|Baseline Visit||22
7693760|NCT01846728|18946137|P1|NOT COMPLETED|Overall Study||0
7693761|NCT01846728|18946137|P1|COMPLETED|Overall Study||6
7693762|NCT01846728|18946137|P1|STARTED|Overall Study||6
7693763|NCT01846702|18946152|P7|NOT COMPLETED|Overall Study||0
7693764|NCT01846702|18946153|P6|NOT COMPLETED|Overall Study||0
7693765|NCT01846702|18946154|P5|NOT COMPLETED|Overall Study||0
7693766|NCT01846702|18946155|P4|NOT COMPLETED|Overall Study||0
7693767|NCT01846702|18946156|P3|NOT COMPLETED|Overall Study||1
7693768|NCT01846702|18946157|P2|NOT COMPLETED|Overall Study||0
7693769|NCT01846702|18946158|P1|NOT COMPLETED|Overall Study||0
7693770|NCT01846702|18946152|P7|COMPLETED|Overall Study||6
7693771|NCT01846702|18946153|P6|COMPLETED|Overall Study||6
7693772|NCT01846702|18946154|P5|COMPLETED|Overall Study||6
7693773|NCT01846702|18946155|P4|COMPLETED|Overall Study||6
7693774|NCT01846702|18946156|P3|COMPLETED|Overall Study||6
7693775|NCT01846702|18946157|P2|COMPLETED|Overall Study||6
7693776|NCT01846702|18946158|P1|COMPLETED|Overall Study||6
7693777|NCT01846702|18946152|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
7693778|NCT01846702|18946153|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
7693779|NCT01846702|18946154|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
7693780|NCT01846702|18946155|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
7693781|NCT01846702|18946156|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
7693782|NCT01846702|18946157|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
7693783|NCT01846702|18946158|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
7693784|NCT01846702|18946152|P7|STARTED|Overall Study||6
7693785|NCT01846702|18946153|P6|STARTED|Overall Study||6
7693786|NCT01846702|18946154|P5|STARTED|Overall Study||6
7693787|NCT01846702|18946155|P4|STARTED|Overall Study||6
7693788|NCT01846702|18946156|P3|STARTED|Overall Study||7
7693789|NCT01846702|18946157|P2|STARTED|Overall Study||6
7693790|NCT01846702|18946158|P1|STARTED|Overall Study||6
7693791|NCT01846624|18946237|P1|NOT COMPLETED|Overall Study||1
7693792|NCT01846624|18946237|P1|COMPLETED|Overall Study||12
7693793|NCT01846624|18946237|P1|STARTED|Overall Study||13
7693794|NCT01846611|18946247|P2|NOT COMPLETED|Overall Study||43
7693795|NCT01846611|18946248|P1|NOT COMPLETED|Overall Study||38
7693796|NCT01846611|18946247|P2|COMPLETED|Overall Study||244
7693797|NCT01846611|18946248|P1|COMPLETED|Overall Study||251
7693798|NCT01846611|18946247|P2|Treated|Overall Study||282
7693799|NCT01846611|18946248|P1|Treated|Overall Study||286
7693800|NCT01846611|18946247|P2|STARTED|Overall Study||287
7693801|NCT01846611|18946248|P1|STARTED|Overall Study||289
7693802|NCT01846507|18946258|P1|NOT COMPLETED|Overall Study||7
7693803|NCT01846507|18946258|P1|COMPLETED|Overall Study||25
7693804|NCT01846507|18946258|P1|STARTED|Overall Study||32
7693805|NCT01846494|18946277|P2|NOT COMPLETED|Overall Study||38
7693806|NCT01846494|18946278|P1|NOT COMPLETED|Overall Study||30
7693807|NCT01846494|18946277|P2|COMPLETED|Overall Study||25
7693808|NCT01846494|18946278|P1|COMPLETED|Overall Study||20
7693809|NCT01846494|18946277|P2|STARTED|Overall Study||63
7693810|NCT01846494|18946278|P1|STARTED|Overall Study||50
7693811|NCT01846455|18946291|P5|NOT COMPLETED|Overall Study||0
7693812|NCT01846455|18946292|P4|NOT COMPLETED|Overall Study||0
7693813|NCT01846455|18946293|P3|NOT COMPLETED|Overall Study||0
7693814|NCT01846455|18946294|P2|NOT COMPLETED|Overall Study||0
7693815|NCT01846455|18946295|P1|NOT COMPLETED|Overall Study||0
7693816|NCT01846455|18946291|P5|COMPLETED|Overall Study||8
7693817|NCT01846455|18946292|P4|COMPLETED|Overall Study||10
7693818|NCT01846455|18946293|P3|COMPLETED|Overall Study||8
7693819|NCT01846455|18946294|P2|COMPLETED|Overall Study||8
7693820|NCT01846455|18946295|P1|COMPLETED|Overall Study||9
7693821|NCT01846455|18946291|P5|PK Population|Overall Study||8
7693822|NCT01846455|18946292|P4|PK Population|Overall Study||6
7693823|NCT01846455|18946293|P3|PK Population|Overall Study||6
7693824|NCT01846455|18946294|P2|PK Population|Overall Study||7
7693825|NCT01846455|18946295|P1|PK Population|Overall Study||6
7693826|NCT01846455|18946291|P5|STARTED|Overall Study||8
7693827|NCT01846455|18946292|P4|STARTED|Overall Study||10
7693828|NCT01846455|18946293|P3|STARTED|Overall Study||8
7693829|NCT01846455|18946294|P2|STARTED|Overall Study||8
7693830|NCT01846455|18946295|P1|STARTED|Overall Study||9
7693831|NCT01846442|18946356|P4|NOT COMPLETED|Overall Study||3
7693832|NCT01846442|18946357|P3|NOT COMPLETED|Overall Study||4
7693833|NCT01846442|18946358|P2|NOT COMPLETED|Overall Study||6
7693834|NCT01846442|18946359|P1|NOT COMPLETED|Overall Study||6
7693835|NCT01846442|18946356|P4|COMPLETED|Overall Study||51
7693836|NCT01846442|18946357|P3|COMPLETED|Overall Study||52
7693837|NCT01846442|18946358|P2|COMPLETED|Overall Study||48
7693838|NCT01846442|18946359|P1|COMPLETED|Overall Study||48
7693839|NCT01846442|18946356|P4|ITT Population|Overall Study||54
7693840|NCT01846442|18946357|P3|ITT Population|Overall Study||56
7693841|NCT01846442|18946358|P2|ITT Population|Overall Study||53
7693842|NCT01846442|18946359|P1|ITT Population|Overall Study||53
7693843|NCT01846442|18946356|P4|Safety Population|Overall Study||54
7693844|NCT01846442|18946357|P3|Safety Population|Overall Study||56
7693845|NCT01846442|18946358|P2|Safety Population|Overall Study||53
7693846|NCT01846442|18946359|P1|Safety Population|Overall Study||54
7693847|NCT01846442|18946356|P4|STARTED|Overall Study||54
7693848|NCT01846442|18946357|P3|STARTED|Overall Study||56
7693849|NCT01846442|18946358|P2|STARTED|Overall Study||54
7693850|NCT01846442|18946359|P1|STARTED|Overall Study||54
7693851|NCT01846416|18946400|P3|NOT COMPLETED|Survival Follow-up||12
7693852|NCT01846416|18946401|P2|NOT COMPLETED|Survival Follow-up||80
7693853|NCT01846416|18946402|P1|NOT COMPLETED|Survival Follow-up||28
7693854|NCT01846416|18946400|P3|COMPLETED|Survival Follow-up||0
7693855|NCT01846416|18946401|P2|COMPLETED|Survival Follow-up||0
7693856|NCT01846416|18946402|P1|COMPLETED|Survival Follow-up||0
7693857|NCT01846416|18946400|P3|STARTED|Survival Follow-up||12
7693858|NCT01846416|18946401|P2|STARTED|Survival Follow-up||80
7693859|NCT01846416|18946402|P1|STARTED|Survival Follow-up||28
7693860|NCT01846416|18946400|P3|NOT COMPLETED|Treatment Phase||13
7693861|NCT01846416|18946401|P2|NOT COMPLETED|Treatment Phase||93
7693862|NCT01846416|18946402|P1|NOT COMPLETED|Treatment Phase||31
7693863|NCT01846416|18946400|P3|COMPLETED|Treatment Phase||0
7693864|NCT01846416|18946401|P2|COMPLETED|Treatment Phase||0
7693865|NCT01846416|18946402|P1|COMPLETED|Treatment Phase||0
7693866|NCT01846416|18946400|P3|STARTED|Treatment Phase||13
7693867|NCT01846416|18946401|P2|STARTED|Treatment Phase||93
7693868|NCT01846416|18946402|P1|STARTED|Treatment Phase||31
7693869|NCT01846299|18946447|P2|NOT COMPLETED|Overall Study||10
7693870|NCT01846299|18946448|P1|NOT COMPLETED|Overall Study||12
7693871|NCT01846299|18946447|P2|COMPLETED|Overall Study||50
7693872|NCT01846299|18946448|P1|COMPLETED|Overall Study||106
7693873|NCT01846299|18946447|P2|Safety Set|Overall Study||58
7693874|NCT01846299|18946448|P1|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119
7693875|NCT01846299|18946447|P2|Full Analysis Set|Overall Study||60
7693876|NCT01846299|18946448|P1|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117
7693877|NCT01846299|18946447|P2|STARTED|Overall Study||60
7693878|NCT01846299|18946448|P1|STARTED|Overall Study||118
7693879|NCT01846273|18946487|P3|NOT COMPLETED|Overall Study||0
7693880|NCT01846273|18946488|P2|NOT COMPLETED|Overall Study||26
7693881|NCT01846273|18946489|P1|NOT COMPLETED|Overall Study||22
7693882|NCT01846273|18946487|P3|COMPLETED|Overall Study||41
7693883|NCT01846273|18946488|P2|COMPLETED|Overall Study||87
7693884|NCT01846273|18946489|P1|COMPLETED|Overall Study||146
7693885|NCT01846273|18946487|P3|Safety Analysis Set|Overall Study||14
7693886|NCT01846273|18946488|P2|Safety Analysis Set|Overall Study||135
7693887|NCT01846273|18946489|P1|Safety Analysis Set|Overall Study||172
7693888|NCT01846273|18946487|P3|STARTED|Overall Study||41
7693889|NCT01846273|18946488|P2|STARTED|Overall Study||113
7693890|NCT01846273|18946489|P1|STARTED|Overall Study||168
7693891|NCT01846221|18946545|P2|NOT COMPLETED|Overall Study||0
7693892|NCT01846221|18946546|P1|NOT COMPLETED|Overall Study||3
7693893|NCT01846221|18946545|P2|COMPLETED|Overall Study||51
7693894|NCT01846221|18946546|P1|COMPLETED|Overall Study||47
7693895|NCT01846221|18946545|P2|STARTED|Overall Study||51
7693896|NCT01846221|18946546|P1|STARTED|Overall Study||50
7693897|NCT01846208|18946563|P3|NOT COMPLETED|Overall Study||8
7693898|NCT01846208|18946564|P2|NOT COMPLETED|Overall Study||4
7693899|NCT01846208|18946565|P1|NOT COMPLETED|Overall Study||9
7693900|NCT01846208|18946563|P3|COMPLETED|Overall Study||32
7693901|NCT01846208|18946564|P2|COMPLETED|Overall Study||20
7693902|NCT01846208|18946565|P1|COMPLETED|Overall Study||19
7693903|NCT01846208|18946563|P3|Year 2 Sustained Unresponsiveness OFC|Overall Study||21
7693904|NCT01846208|18946564|P2|Year 2 Sustained Unresponsiveness OFC|Overall Study||18
7693905|NCT01846208|18946565|P1|Year 2 Sustained Unresponsiveness OFC|Overall Study||4
7693906|NCT01846208|18946563|P3|Year 2 Desensitization OFC|Overall Study||33
7693907|NCT01846208|18946564|P2|Year 2 Desensitization OFC|Overall Study||20
7693908|NCT01846208|18946565|P1|Year 2 Desensitization OFC|Overall Study||19
7693909|NCT01846208|18946563|P3|Year 1 Desensitization OFC|Overall Study||34
7693910|NCT01846208|18946564|P2|Year 1 Desensitization OFC|Overall Study||20
7693911|NCT01846208|18946565|P1|Year 1 Desensitization OFC|Overall Study||23
7693912|NCT01846208|18946563|P3|Initiatiated Treatment|Overall Study||39
7693913|NCT01846208|18946564|P2|Initiatiated Treatment|Overall Study||23
7693914|NCT01846208|18946565|P1|Initiatiated Treatment|Overall Study||27
7693915|NCT01846208|18946563|P3|STARTED|Overall Study||40
7693916|NCT01846208|18946564|P2|STARTED|Overall Study||24
7693917|NCT01846208|18946565|P1|STARTED|Overall Study||28
7693918|NCT01846104|18946585|P1|NOT COMPLETED|Overall Study||1
7693919|NCT01846104|18946585|P1|COMPLETED|Overall Study||3
7693920|NCT01846104|18946585|P1|STARTED|Overall Study||4
7693921|NCT01846039|18946591|P1|NOT COMPLETED|Overall Study||2
7693922|NCT01846039|18946591|P1|COMPLETED|Overall Study||27
7693923|NCT01846039|18946591|P1|STARTED|Overall Study||29
7693924|NCT01845974|18946603|P2|NOT COMPLETED|Overall Study||0
7693925|NCT01845974|18946604|P1|NOT COMPLETED|Overall Study||1
7693926|NCT01845974|18946603|P2|COMPLETED|Overall Study||9
7693927|NCT01845974|18946604|P1|COMPLETED|Overall Study||3
7693928|NCT01845974|18946603|P2|STARTED|Overall Study||9
7693929|NCT01845974|18946604|P1|STARTED|Overall Study||4
7693930|NCT01845831|18946612|P5|NOT COMPLETED|Outpatient Phase||0
7693931|NCT01845831|18946613|P4|NOT COMPLETED|Outpatient Phase||0
7693932|NCT01845831|18946614|P3|NOT COMPLETED|Outpatient Phase||0
7693933|NCT01845831|18946615|P2|NOT COMPLETED|Outpatient Phase||0
7693934|NCT01845831|18946616|P1|NOT COMPLETED|Outpatient Phase||0
7693935|NCT01845831|18946612|P5|COMPLETED|Outpatient Phase||87
7693936|NCT01845831|18946613|P4|COMPLETED|Outpatient Phase||98
7693937|NCT01845831|18946614|P3|COMPLETED|Outpatient Phase||68
7693938|NCT01845831|18946615|P2|COMPLETED|Outpatient Phase||0
7693939|NCT01845831|18946616|P1|COMPLETED|Outpatient Phase||0
7693940|NCT01845831|18946612|P5|STARTED|Outpatient Phase||87
7693941|NCT01845831|18946613|P4|STARTED|Outpatient Phase||98
7693942|NCT01845831|18946614|P3|STARTED|Outpatient Phase||68
7693943|NCT01845831|18946615|P2|STARTED|Outpatient Phase||0
7693944|NCT01845831|18946616|P1|STARTED|Outpatient Phase||0
7693945|NCT01845831|18946612|P5|NOT COMPLETED|Inpatient Phase||0
7693946|NCT01845831|18946613|P4|NOT COMPLETED|Inpatient Phase||0
7693947|NCT01845831|18946614|P3|NOT COMPLETED|Inpatient Phase||0
7693948|NCT01845831|18946615|P2|NOT COMPLETED|Inpatient Phase||1
7693949|NCT01845831|18946616|P1|NOT COMPLETED|Inpatient Phase||1
7693950|NCT01845831|18946612|P5|COMPLETED|Inpatient Phase||0
7693951|NCT01845831|18946613|P4|COMPLETED|Inpatient Phase||0
7693952|NCT01845831|18946614|P3|COMPLETED|Inpatient Phase||0
7693953|NCT01845831|18946615|P2|COMPLETED|Inpatient Phase||138
7693954|NCT01845831|18946616|P1|COMPLETED|Inpatient Phase||139
7693955|NCT01845831|18946612|P5|STARTED|Inpatient Phase||0
7693956|NCT01845831|18946613|P4|STARTED|Inpatient Phase||0
7693957|NCT01845831|18946614|P3|STARTED|Inpatient Phase||0
7693958|NCT01845831|18946615|P2|STARTED|Inpatient Phase||139
7693959|NCT01845831|18946616|P1|STARTED|Inpatient Phase||140
7693960|NCT01845818|18946645|P2|NOT COMPLETED|Overall Study||17
7693961|NCT01845818|18946646|P1|NOT COMPLETED|Overall Study||45
7693962|NCT01845818|18946645|P2|COMPLETED|Overall Study||40
7693963|NCT01845818|18946646|P1|COMPLETED|Overall Study||81
7693964|NCT01845818|18946645|P2|STARTED|Overall Study||57
7693965|NCT01845818|18946646|P1|STARTED|Overall Study||126
7693966|NCT01845792|18946687|P2|NOT COMPLETED|Overall Study||0
7693967|NCT01845792|18946688|P1|NOT COMPLETED|Overall Study||0
7693968|NCT01845792|18946687|P2|COMPLETED|Overall Study||2
7693969|NCT01845792|18946688|P1|COMPLETED|Overall Study||5
7693970|NCT01845792|18946687|P2|STARTED|Overall Study||2
7693971|NCT01845792|18946688|P1|STARTED|Overall Study||5
7693972|NCT01845636|18946696|P1|NOT COMPLETED|Overall Study||4
7693973|NCT01845636|18946696|P1|COMPLETED|Overall Study||37
7693974|NCT01845636|18946696|P1|STARTED|Overall Study||41
7693975|NCT01845220|18946704|P2|NOT COMPLETED|Overall Study||0
7693976|NCT01845220|18946705|P1|NOT COMPLETED|Overall Study||0
7693977|NCT01845220|18946704|P2|COMPLETED|Overall Study||30
7693978|NCT01845220|18946705|P1|COMPLETED|Overall Study||30
7693979|NCT01845220|18946704|P2|STARTED|Overall Study||30
7693980|NCT01845220|18946705|P1|STARTED|Overall Study||30
7693981|NCT01845155|18946713|P2|NOT COMPLETED|Overall Study||0
7693982|NCT01845155|18946714|P1|NOT COMPLETED|Overall Study||1
7693983|NCT01845155|18946713|P2|COMPLETED|Overall Study||144
7693984|NCT01845155|18946714|P1|COMPLETED|Overall Study||145
7693985|NCT01845155|18946713|P2|STARTED|Overall Study||144
7693986|NCT01845155|18946714|P1|STARTED|Overall Study||146
7693987|NCT01845103|18946722|P1|NOT COMPLETED|Overall Study||0
7693988|NCT01845103|18946722|P1|COMPLETED|Overall Study||1
7693989|NCT01845103|18946722|P1|STARTED|Overall Study||1
7693990|NCT01845077|18946730|P6|NOT COMPLETED|Treatment Period 2||0
7693991|NCT01845077|18946731|P5|NOT COMPLETED|Treatment Period 2||0
7693992|NCT01845077|18946732|P4|NOT COMPLETED|Treatment Period 2||0
7693993|NCT01845077|18946733|P3|NOT COMPLETED|Treatment Period 2||0
7693994|NCT01845077|18946734|P2|NOT COMPLETED|Treatment Period 2||0
7693995|NCT01845077|18946735|P1|NOT COMPLETED|Treatment Period 2||0
7693996|NCT01845077|18946730|P6|COMPLETED|Treatment Period 2||11
7693997|NCT01845077|18946731|P5|COMPLETED|Treatment Period 2||11
7693998|NCT01845077|18946732|P4|COMPLETED|Treatment Period 2||10
7693999|NCT01845077|18946733|P3|COMPLETED|Treatment Period 2||11
7694000|NCT01845077|18946734|P2|COMPLETED|Treatment Period 2||11
7694001|NCT01845077|18946735|P1|COMPLETED|Treatment Period 2||11
7694002|NCT01845077|18946730|P6|STARTED|Treatment Period 2||11
7694003|NCT01845077|18946731|P5|STARTED|Treatment Period 2||11
7694004|NCT01845077|18946732|P4|STARTED|Treatment Period 2||10
7694005|NCT01845077|18946733|P3|STARTED|Treatment Period 2||11
7694006|NCT01845077|18946734|P2|STARTED|Treatment Period 2||11
7694007|NCT01845077|18946735|P1|STARTED|Treatment Period 2||11
7694008|NCT01845077|18946730|P6|NOT COMPLETED|Washout Period||1
7694009|NCT01845077|18946731|P5|NOT COMPLETED|Washout Period||1
7694010|NCT01845077|18946732|P4|NOT COMPLETED|Washout Period||2
7694011|NCT01845077|18946733|P3|NOT COMPLETED|Washout Period||1
7694012|NCT01845077|18946734|P2|NOT COMPLETED|Washout Period||1
7694013|NCT01845077|18946735|P1|NOT COMPLETED|Washout Period||1
7694014|NCT01845077|18946730|P6|COMPLETED|Washout Period||11
7694015|NCT01845077|18946731|P5|COMPLETED|Washout Period||11
7694016|NCT01845077|18946732|P4|COMPLETED|Washout Period||10
7694017|NCT01845077|18946733|P3|COMPLETED|Washout Period||11
7694018|NCT01845077|18946734|P2|COMPLETED|Washout Period||11
7694019|NCT01845077|18946735|P1|COMPLETED|Washout Period||11
7694020|NCT01845077|18946730|P6|STARTED|Washout Period||12
7694021|NCT01845077|18946731|P5|STARTED|Washout Period||12
7694022|NCT01845077|18946732|P4|STARTED|Washout Period||12
7694023|NCT01845077|18946733|P3|STARTED|Washout Period||12
7694024|NCT01845077|18946734|P2|STARTED|Washout Period||12
7694025|NCT01845077|18946735|P1|STARTED|Washout Period||12
7694026|NCT01845077|18946730|P6|NOT COMPLETED|Treatment Period 1||0
7694027|NCT01845077|18946731|P5|NOT COMPLETED|Treatment Period 1||0
7694028|NCT01845077|18946732|P4|NOT COMPLETED|Treatment Period 1||0
7694029|NCT01845077|18946733|P3|NOT COMPLETED|Treatment Period 1||0
7694030|NCT01845077|18946734|P2|NOT COMPLETED|Treatment Period 1||0
7694031|NCT01845077|18946735|P1|NOT COMPLETED|Treatment Period 1||0
7694032|NCT01845077|18946730|P6|COMPLETED|Treatment Period 1||12
7694033|NCT01845077|18946731|P5|COMPLETED|Treatment Period 1||12
7694034|NCT01845077|18946732|P4|COMPLETED|Treatment Period 1||12
7694035|NCT01845077|18946733|P3|COMPLETED|Treatment Period 1||12
7694036|NCT01845077|18946734|P2|COMPLETED|Treatment Period 1||12
7694037|NCT01845077|18946735|P1|COMPLETED|Treatment Period 1||12
7694038|NCT01845077|18946730|P6|STARTED|Treatment Period 1||12
7694039|NCT01845077|18946731|P5|STARTED|Treatment Period 1||12
7694040|NCT01845077|18946732|P4|STARTED|Treatment Period 1||12
7694041|NCT01845077|18946733|P3|STARTED|Treatment Period 1||12
7694042|NCT01845077|18946734|P2|STARTED|Treatment Period 1||12
7694043|NCT01845077|18946735|P1|STARTED|Treatment Period 1||12
7694044|NCT01845025|18946781|P2|NOT COMPLETED|Overall Study||77
7694045|NCT01845025|18946782|P1|NOT COMPLETED|Overall Study||85
7694046|NCT01845025|18946781|P2|COMPLETED|Overall Study||332
7694047|NCT01845025|18946782|P1|COMPLETED|Overall Study||326
7694048|NCT01845025|18946781|P2|STARTED|Overall Study||409
7694049|NCT01845025|18946782|P1|STARTED|Overall Study||411
7694050|NCT01844986|18946806|P2|NOT COMPLETED|Overall Study||40
7694051|NCT01844986|18946807|P1|NOT COMPLETED|Overall Study||77
7694052|NCT01844986|18946806|P2|COMPLETED|Overall Study||91
7694053|NCT01844986|18946807|P1|COMPLETED|Overall Study||183
7694054|NCT01844986|18946806|P2|STARTED|Overall Study||131
7694055|NCT01844986|18946807|P1|STARTED|Overall Study||260
7694056|NCT01844895|18946829|P1|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6
7694057|NCT01844895|18946829|P1|COMPLETED|Day 29 - Day113 - Autoinjector||111
7694058|NCT01844895|18946829|P1|STARTED|Day 29 - Day113 - Autoinjector||117
7694059|NCT01844895|18946829|P1|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3
7694060|NCT01844895|18946829|P1|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117
7694061|NCT01844895|18946829|P1|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120
7694062|NCT01844856|18946847|P2|NOT COMPLETED|Overall Study||16
7694063|NCT01844856|18946848|P1|NOT COMPLETED|Overall Study||24
7694064|NCT01844856|18946847|P2|COMPLETED|Overall Study||255
7694065|NCT01844856|18946848|P1|COMPLETED|Overall Study||246
7694066|NCT01844856|18946847|P2|Received at Least 1 Dose of Study Drug|Overall Study||268
7694067|NCT01844856|18946848|P1|Received at Least 1 Dose of Study Drug|Overall Study||270
7694068|NCT01844856|18946847|P2|STARTED|Overall Study||271
7694069|NCT01844856|18946848|P1|STARTED|Overall Study||270
7694070|NCT01844830|18946860|P2|NOT COMPLETED|Overall Study||0
7694071|NCT01844830|18946861|P1|NOT COMPLETED|Overall Study||1
7694072|NCT01844830|18946860|P2|COMPLETED|Overall Study||30
7694073|NCT01844830|18946861|P1|COMPLETED|Overall Study||59
7694074|NCT01844830|18946860|P2|400 µL Dose|Overall Study||10
7694075|NCT01844830|18946861|P1|400 µL Dose|Overall Study||20
7694076|NCT01844830|18946860|P2|200 µL Dose|Overall Study||12
7694077|NCT01844830|18946861|P1|200 µL Dose|Overall Study||24
7694078|NCT01844830|18946860|P2|100 µL Dose|Overall Study||8
7694079|NCT01844830|18946861|P1|100 µL Dose|Overall Study||16
7694080|NCT01844830|18946860|P2|STARTED|Overall Study||30
7694081|NCT01844830|18946861|P1|STARTED|Overall Study||60
7694082|NCT01844817|18946891|P2|NOT COMPLETED|Treatment||63
7694083|NCT01844817|18946892|P1|NOT COMPLETED|Treatment||64
7694084|NCT01844817|18946891|P2|COMPLETED|Treatment||0
7694085|NCT01844817|18946892|P1|COMPLETED|Treatment||0
7694086|NCT01844817|18946891|P2|STARTED|Treatment||63
7694087|NCT01844817|18946892|P1|STARTED|Treatment||64
7694088|NCT01844817|18946891|P2|NOT COMPLETED|Enrolled and Randomized||3
7694089|NCT01844817|18946892|P1|NOT COMPLETED|Enrolled and Randomized||2
7694090|NCT01844817|18946891|P2|COMPLETED|Enrolled and Randomized||63
7694091|NCT01844817|18946892|P1|COMPLETED|Enrolled and Randomized||64
7694092|NCT01844817|18946891|P2|STARTED|Enrolled and Randomized||66
7694093|NCT01844817|18946892|P1|STARTED|Enrolled and Randomized||66
7694094|NCT01844778|18946905|P3|NOT COMPLETED|Overall Study||4
7694095|NCT01844778|18946906|P2|NOT COMPLETED|Overall Study||3
7694096|NCT01844778|18946907|P1|NOT COMPLETED|Overall Study||2
7694097|NCT01844778|18946905|P3|COMPLETED|Overall Study||14
7694098|NCT01844778|18946906|P2|COMPLETED|Overall Study||25
7694099|NCT01844778|18946907|P1|COMPLETED|Overall Study||12
7694100|NCT01844778|18946905|P3|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15
7694101|NCT01844778|18946906|P2|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25
7694102|NCT01844778|18946907|P1|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12
7694103|NCT01844778|18946905|P3|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18
7694104|NCT01844778|18946906|P2|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28
7694105|NCT01844778|18946907|P1|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14
7694106|NCT01844778|18946905|P3|STARTED|Overall Study||18
7694107|NCT01844778|18946906|P2|STARTED|Overall Study||28
7694108|NCT01844778|18946907|P1|STARTED|Overall Study||14
7694109|NCT01844765|18946933|P2|NOT COMPLETED|Overall Study||6
7694110|NCT01844765|18946934|P1|NOT COMPLETED|Overall Study||9
7694111|NCT01844765|18946933|P2|COMPLETED|Overall Study|Completed = patients ongoing treatment at time of data cut-off|19
7694112|NCT01844765|18946934|P1|COMPLETED|Overall Study|Completed = patients ongoing treatment at time of data cut-off|25
7694113|NCT01844765|18946933|P2|Untreated|Overall Study||0
7694114|NCT01844765|18946934|P1|Untreated|Overall Study|Did not receive study drug due to adverse event (AE).|1
7694115|NCT01844765|18946933|P2|Treated|Overall Study||25
7694116|NCT01844765|18946934|P1|Treated|Overall Study||33
7694117|NCT01844765|18946933|P2|STARTED|Overall Study||25
7694118|NCT01844765|18946934|P1|STARTED|Overall Study||34
7694119|NCT01844700|18946954|P2|NOT COMPLETED|Overall Study||1
7694120|NCT01844700|18946955|P1|NOT COMPLETED|Overall Study||3
7694121|NCT01844700|18946954|P2|COMPLETED|Overall Study||2
7694122|NCT01844700|18946955|P1|COMPLETED|Overall Study||1
7694123|NCT01844700|18946954|P2|STARTED|Overall Study||3
7694124|NCT01844700|18946955|P1|STARTED|Overall Study||4
7694125|NCT01844687|18946967|P1|NOT COMPLETED|Visit 8||0
7694126|NCT01844687|18946967|P1|COMPLETED|Visit 8||31
7694127|NCT01844687|18946967|P1|STARTED|Visit 8||31
7694128|NCT01844687|18946967|P1|NOT COMPLETED|Visit 7||0
7694129|NCT01844687|18946967|P1|COMPLETED|Visit 7||31
7694130|NCT01844687|18946967|P1|STARTED|Visit 7||31
7694131|NCT01844687|18946967|P1|NOT COMPLETED|Visit 6||0
7694132|NCT01844687|18946967|P1|COMPLETED|Visit 6||31
7694133|NCT01844687|18946967|P1|STARTED|Visit 6||31
7694134|NCT01844687|18946967|P1|NOT COMPLETED|Visit 5||0
7694135|NCT01844687|18946967|P1|COMPLETED|Visit 5||31
7694136|NCT01844687|18946967|P1|STARTED|Visit 5||31
7694137|NCT01844687|18946967|P1|NOT COMPLETED|Visit 4||4
7694138|NCT01844687|18946967|P1|COMPLETED|Visit 4||31
7694139|NCT01844687|18946967|P1|STARTED|Visit 4||35
7694140|NCT01844687|18946967|P1|NOT COMPLETED|Visit 3||5
7694141|NCT01844687|18946967|P1|COMPLETED|Visit 3||35
7694142|NCT01844687|18946967|P1|STARTED|Visit 3||40
7694143|NCT01844687|18946967|P1|NOT COMPLETED|Visit 2||2
7694144|NCT01844687|18946967|P1|COMPLETED|Visit 2||40
7694145|NCT01844687|18946967|P1|STARTED|Visit 2||42
7694146|NCT01844687|18946967|P1|NOT COMPLETED|Visit 1||8
7694147|NCT01844687|18946967|P1|COMPLETED|Visit 1||42
7694148|NCT01844687|18946967|P1|STARTED|Visit 1||50
7694149|NCT01844583|18947028|P2|NOT COMPLETED|Overall Study||10
7694150|NCT01844583|18947029|P1|NOT COMPLETED|Overall Study||8
7694151|NCT01844583|18947028|P2|COMPLETED|Overall Study||19
7694152|NCT01844583|18947029|P1|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK/ECG assessment.|18
7694153|NCT01844583|18947028|P2|STARTED|Overall Study||29
7694154|NCT01844583|18947029|P1|STARTED|Overall Study||26
7694155|NCT01844531|18947061|P4|NOT COMPLETED|Overall Study||0
7694156|NCT01844531|18947062|P3|NOT COMPLETED|Overall Study||0
7694157|NCT01844531|18947063|P2|NOT COMPLETED|Overall Study||1
7694158|NCT01844531|18947064|P1|NOT COMPLETED|Overall Study||0
7694159|NCT01844531|18947061|P4|COMPLETED|Overall Study||6
7694160|NCT01844531|18947062|P3|COMPLETED|Overall Study||6
7694161|NCT01844531|18947063|P2|COMPLETED|Overall Study||5
7694162|NCT01844531|18947064|P1|COMPLETED|Overall Study||6
7694163|NCT01844531|18947061|P4|STARTED|Overall Study||6
7694164|NCT01844531|18947062|P3|STARTED|Overall Study||6
7694165|NCT01844531|18947063|P2|STARTED|Overall Study||6
7694166|NCT01844531|18947064|P1|STARTED|Overall Study||6
7694167|NCT01844518|18947094|P1|NOT COMPLETED|Long-Term Extension||157
7694168|NCT01844518|18947094|P1|COMPLETED|Long-Term Extension|Study is on-going|0
7694169|NCT01844518|18947094|P1|STARTED|Long-Term Extension|7 participants completed ST but did not continue in study.|157
7694170|NCT01844518|18947094|P1|NOT COMPLETED|Short-Term (ST) Period||9
7694171|NCT01844518|18947094|P1|COMPLETED|Short-Term (ST) Period||164
7694172|NCT01844518|18947094|P1|STARTED|Short-Term (ST) Period||173
7694173|NCT01844505|18947111|P3|NOT COMPLETED|Overall Study||295
7694174|NCT01844505|18947112|P2|NOT COMPLETED|Overall Study||269
7694175|NCT01844505|18947113|P1|NOT COMPLETED|Overall Study||249
7694176|NCT01844505|18947111|P3|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|16
7694177|NCT01844505|18947112|P2|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|44
7694178|NCT01844505|18947113|P1|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|64
7694179|NCT01844505|18947111|P3|STARTED|Overall Study||311
7694180|NCT01844505|18947112|P2|STARTED|Overall Study||313
7694181|NCT01844505|18947113|P1|STARTED|Overall Study||313
7694182|NCT01844479|18947163|P2|NOT COMPLETED|Second Intervention up to 30 Minutes||0
7694183|NCT01844479|18947164|P1|NOT COMPLETED|Second Intervention up to 30 Minutes||0
7694184|NCT01844479|18947163|P2|COMPLETED|Second Intervention up to 30 Minutes||13
7694185|NCT01844479|18947164|P1|COMPLETED|Second Intervention up to 30 Minutes||14
7694186|NCT01844479|18947163|P2|STARTED|Second Intervention up to 30 Minutes||13
7694187|NCT01844479|18947164|P1|STARTED|Second Intervention up to 30 Minutes||14
7694188|NCT01844479|18947163|P2|NOT COMPLETED|First Intervention up to 30 Minutes||0
7694189|NCT01844479|18947164|P1|NOT COMPLETED|First Intervention up to 30 Minutes||0
7694190|NCT01844479|18947163|P2|COMPLETED|First Intervention up to 30 Minutes||13
7694191|NCT01844479|18947164|P1|COMPLETED|First Intervention up to 30 Minutes||14
7694192|NCT01844479|18947163|P2|STARTED|First Intervention up to 30 Minutes||13
7694193|NCT01844479|18947164|P1|STARTED|First Intervention up to 30 Minutes||14
7694194|NCT01844388|18947194|P2|NOT COMPLETED|Overall Study||7
7694195|NCT01844388|18947195|P1|NOT COMPLETED|Overall Study||8
7694196|NCT01844388|18947194|P2|COMPLETED|Overall Study||114
7694197|NCT01844388|18947195|P1|COMPLETED|Overall Study||236
7694198|NCT01844388|18947194|P2|STARTED|Overall Study||121
7694199|NCT01844388|18947195|P1|STARTED|Overall Study||244
7694200|NCT01844375|18947207|P2|NOT COMPLETED|Overall Study||1
7694201|NCT01844375|18947208|P1|NOT COMPLETED|Overall Study||1
7694202|NCT01844375|18947207|P2|COMPLETED|Overall Study||34
7694203|NCT01844375|18947208|P1|COMPLETED|Overall Study||34
7694204|NCT01844375|18947207|P2|STARTED|Overall Study||35
7694205|NCT01844375|18947208|P1|STARTED|Overall Study||35
7694206|NCT01844284|18947220|P2|NOT COMPLETED|Overall Study||7
7694207|NCT01844284|18947221|P1|NOT COMPLETED|Overall Study||12
7694208|NCT01844284|18947220|P2|COMPLETED|Overall Study||127
7694209|NCT01844284|18947221|P1|COMPLETED|Overall Study||254
7694210|NCT01844284|18947220|P2|STARTED|Overall Study|Intent-to-treat (ITT) population|134
7694211|NCT01844284|18947221|P1|STARTED|Overall Study|Intent-to-treat (ITT) population|266
7694212|NCT01844206|18947431|P2|NOT COMPLETED|Overall Study||1
7694213|NCT01844206|18947432|P1|NOT COMPLETED|Overall Study||0
7694214|NCT01844206|18947431|P2|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2
7694215|NCT01844206|18947432|P1|COMPLETED|Overall Study||2
7694216|NCT01844206|18947431|P2|STARTED|Overall Study||3
7694217|NCT01844206|18947432|P1|STARTED|Overall Study||2
7694218|NCT01844115|18947440|P2|NOT COMPLETED|Overall Study||58
7694219|NCT01844115|18947441|P1|NOT COMPLETED|Overall Study||39
7694220|NCT01844115|18947440|P2|COMPLETED|Overall Study||144
7694221|NCT01844115|18947441|P1|COMPLETED|Overall Study||163
7694222|NCT01844115|18947440|P2|STARTED|Overall Study||202
7694223|NCT01844115|18947441|P1|STARTED|Overall Study||202
7694224|NCT01843972|18947459|P10|NOT COMPLETED|Overall Study||0
7694225|NCT01843972|18947460|P9|NOT COMPLETED|Overall Study||0
7694226|NCT01843972|18947461|P8|NOT COMPLETED|Overall Study||0
7694227|NCT01843972|18947462|P7|NOT COMPLETED|Overall Study||0
7694228|NCT01843972|18947463|P6|NOT COMPLETED|Overall Study||0
7694229|NCT01843972|18947464|P5|NOT COMPLETED|Overall Study||1
7694230|NCT01843972|18947465|P4|NOT COMPLETED|Overall Study||0
7694231|NCT01843972|18947466|P3|NOT COMPLETED|Overall Study||0
7694232|NCT01843972|18947467|P2|NOT COMPLETED|Overall Study||0
7694233|NCT01843972|18947468|P1|NOT COMPLETED|Overall Study||0
7694234|NCT01843972|18947459|P10|COMPLETED|Overall Study||12
7694235|NCT01843972|18947460|P9|COMPLETED|Overall Study||17
7694236|NCT01843972|18947461|P8|COMPLETED|Overall Study||5
7694237|NCT01843972|18947462|P7|COMPLETED|Overall Study||5
7694238|NCT01843972|18947463|P6|COMPLETED|Overall Study||6
7694239|NCT01843972|18947464|P5|COMPLETED|Overall Study||5
7694240|NCT01843972|18947465|P4|COMPLETED|Overall Study||6
7694241|NCT01843972|18947466|P3|COMPLETED|Overall Study||5
7694242|NCT01843972|18947467|P2|COMPLETED|Overall Study||6
7694243|NCT01843972|18947468|P1|COMPLETED|Overall Study||13
7694244|NCT01843972|18947459|P10|STARTED|Overall Study||12
7694245|NCT01843972|18947460|P9|STARTED|Overall Study||17
7694246|NCT01843972|18947461|P8|STARTED|Overall Study||5
7694247|NCT01843972|18947462|P7|STARTED|Overall Study||5
7694248|NCT01843972|18947463|P6|STARTED|Overall Study||6
7694249|NCT01843972|18947464|P5|STARTED|Overall Study||6
7694250|NCT01843972|18947465|P4|STARTED|Overall Study||6
7694251|NCT01843972|18947466|P3|STARTED|Overall Study||5
7694252|NCT01843972|18947467|P2|STARTED|Overall Study||6
7694253|NCT01843972|18947468|P1|STARTED|Overall Study||13
7694254|NCT01843933|18947538|P2|NOT COMPLETED|Overall Study||4
7694255|NCT01843933|18947539|P1|NOT COMPLETED|Overall Study||6
7694256|NCT01843933|18947538|P2|COMPLETED|Overall Study||103
7694257|NCT01843933|18947539|P1|COMPLETED|Overall Study||98
7694258|NCT01843933|18947538|P2|STARTED|Overall Study||107
7694259|NCT01843933|18947539|P1|STARTED|Overall Study||104
7694260|NCT01843920|18947547|P2|NOT COMPLETED|Overall Study||0
7694261|NCT01843920|18947548|P1|NOT COMPLETED|Overall Study||0
7694262|NCT01843920|18947547|P2|COMPLETED|Overall Study||9
7694263|NCT01843920|18947548|P1|COMPLETED|Overall Study||12
7694264|NCT01843920|18947547|P2|STARTED|Overall Study||9
7694265|NCT01843920|18947548|P1|STARTED|Overall Study||12
7694266|NCT01843842|18947558|P2|NOT COMPLETED|Overall Study||1
7694267|NCT01843842|18947559|P1|NOT COMPLETED|Overall Study||1
7694268|NCT01843842|18947558|P2|COMPLETED|Overall Study||151
7694269|NCT01843842|18947559|P1|COMPLETED|Overall Study||153
7694270|NCT01843842|18947558|P2|STARTED|Overall Study||152
7694271|NCT01843842|18947559|P1|STARTED|Overall Study||154
7694272|NCT01843803|18947581|P2|NOT COMPLETED|Overall Study||3
7694273|NCT01843803|18947582|P1|NOT COMPLETED|Overall Study||1
7694274|NCT01843803|18947581|P2|COMPLETED|Overall Study||136
7694275|NCT01843803|18947582|P1|COMPLETED|Overall Study||136
7694276|NCT01843803|18947581|P2|STARTED|Overall Study||139
7694277|NCT01843803|18947582|P1|STARTED|Overall Study||137
7694278|NCT01843777|18947596|P2|NOT COMPLETED|Overall Study||0
7694279|NCT01843777|18947597|P1|NOT COMPLETED|Overall Study||1
7694280|NCT01843777|18947596|P2|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10
7694281|NCT01843777|18947597|P1|COMPLETED|Overall Study|Final number of standard-of-care participants.|10
7694282|NCT01843777|18947596|P2|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9
7694283|NCT01843777|18947597|P1|Per Protocol Population|Overall Study||11
7694284|NCT01843777|18947596|P2|STARTED|Overall Study|Number of participants randomized to treatment.|10
7694285|NCT01843777|18947597|P1|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11
7694286|NCT01843751|18947607|P2|NOT COMPLETED|Overall Study||7
7694287|NCT01843751|18947608|P1|NOT COMPLETED|Overall Study||11
7694288|NCT01843751|18947607|P2|COMPLETED|Overall Study||3
7694289|NCT01843751|18947608|P1|COMPLETED|Overall Study||0
7694290|NCT01843751|18947607|P2|STARTED|Overall Study||10
7694291|NCT01843751|18947608|P1|STARTED|Overall Study||11
7694292|NCT01843673|18947622|P1|NOT COMPLETED|Overall Study||6
7694293|NCT01843673|18947622|P1|COMPLETED|Overall Study||10
7694294|NCT01843673|18947622|P1|STARTED|Overall Study||16
7694295|NCT01843660|18947634|P1|NOT COMPLETED|Overall Study||30
7694296|NCT01843660|18947634|P1|COMPLETED|Overall Study||1029
7694297|NCT01843660|18947634|P1|STARTED|Overall Study||1059
7694298|NCT01843621|18947652|P1|NOT COMPLETED|Overall Study||0
7694299|NCT01843621|18947652|P1|COMPLETED|Overall Study||7
7694300|NCT01843621|18947652|P1|STARTED|Overall Study||7
7694301|NCT01843465|18947669|P1|NOT COMPLETED|Overall Study||0
7694302|NCT01843465|18947669|P1|COMPLETED|Overall Study||34
7694303|NCT01843465|18947669|P1|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34
7694304|NCT01843374|18947675|P2|NOT COMPLETED|Overall Study||379
7694305|NCT01843374|18947676|P1|NOT COMPLETED|Overall Study||189
7694306|NCT01843374|18947675|P2|COMPLETED|Overall Study||3
7694307|NCT01843374|18947676|P1|COMPLETED|Overall Study||0
7694308|NCT01843374|18947675|P2|RANDOMIZED|Overall Study||382
7694309|NCT01843374|18947676|P1|RANDOMIZED|Overall Study||189
7694310|NCT01843374|18947675|P2|STARTED|Overall Study||382
7694311|NCT01843374|18947676|P1|STARTED|Overall Study||189
7694312|NCT01843348|18947703|P3|NOT COMPLETED|Overall Study||41
7694313|NCT01843348|18947704|P2|NOT COMPLETED|Overall Study||40
7694314|NCT01843348|18947705|P1|NOT COMPLETED|Overall Study||23
7694315|NCT01843348|18947703|P3|COMPLETED|Overall Study||158
7694316|NCT01843348|18947704|P2|COMPLETED|Overall Study||168
7694317|NCT01843348|18947705|P1|COMPLETED|Overall Study||182
7694318|NCT01843348|18947703|P3|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|80
7694319|NCT01843348|18947704|P2|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|111
7694320|NCT01843348|18947705|P1|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|147
7694321|NCT01843348|18947703|P3|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|199
7694322|NCT01843348|18947704|P2|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|208
7694323|NCT01843348|18947705|P1|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|205
7694324|NCT01843348|18947703|P3|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|198
7694325|NCT01843348|18947704|P2|Safety Analysis Set (SAS)|Overall Study|Two participants received TAC + Certican in other arms in errorr - analyzed with TAC + Certican arm|210
7694326|NCT01843348|18947705|P1|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|204
7694327|NCT01843348|18947703|P3|STARTED|Overall Study||199
7694328|NCT01843348|18947704|P2|STARTED|Overall Study||208
7694329|NCT01843348|18947705|P1|STARTED|Overall Study||205
7694330|NCT01843205|18947745|P2|NOT COMPLETED|Second Treatment (11 Days)||0
7694331|NCT01843205|18947746|P1|NOT COMPLETED|Second Treatment (11 Days)||0
7694332|NCT01843205|18947745|P2|COMPLETED|Second Treatment (11 Days)||4
7694333|NCT01843205|18947746|P1|COMPLETED|Second Treatment (11 Days)||4
7694334|NCT01843205|18947745|P2|STARTED|Second Treatment (11 Days)||4
7694335|NCT01843205|18947746|P1|STARTED|Second Treatment (11 Days)||4
7694336|NCT01843205|18947745|P2|NOT COMPLETED|First Treatment (11 Days)||0
7694337|NCT01843205|18947746|P1|NOT COMPLETED|First Treatment (11 Days)||1
7694338|NCT01843205|18947745|P2|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to placebo for Condition 2.|4
7694339|NCT01843205|18947746|P1|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to buspirone for Condition 2.|4
7694340|NCT01843205|18947745|P2|STARTED|First Treatment (11 Days)||4
7694341|NCT01843205|18947746|P1|STARTED|First Treatment (11 Days)||5
7694342|NCT01843192|18947807|P3|NOT COMPLETED|Overall Study||2
7694343|NCT01843192|18947808|P2|NOT COMPLETED|Overall Study||6
7694344|NCT01843192|18947809|P1|NOT COMPLETED|Overall Study||2
7694345|NCT01843192|18947807|P3|COMPLETED|Overall Study||9
7694346|NCT01843192|18947808|P2|COMPLETED|Overall Study||28
7694347|NCT01843192|18947809|P1|COMPLETED|Overall Study||24
7694348|NCT01843192|18947807|P3|STARTED|Overall Study||11
7694349|NCT01843192|18947808|P2|STARTED|Overall Study||34
7694350|NCT01843192|18947809|P1|STARTED|Overall Study||26
7694351|NCT01843062|18947840|P2|NOT COMPLETED|Overall Study||9
7694352|NCT01843062|18947841|P1|NOT COMPLETED|Overall Study||22
7694353|NCT01843062|18947840|P2|COMPLETED|Overall Study||69
7694354|NCT01843062|18947841|P1|COMPLETED|Overall Study||133
7694355|NCT01843062|18947840|P2|Ongoing at Primary Analysis Data Cut-off|Overall Study||71
7694356|NCT01843062|18947841|P1|Ongoing at Primary Analysis Data Cut-off|Overall Study||134
7694357|NCT01843062|18947840|P2|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||51
7694358|NCT01843062|18947841|P1|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||91
7694359|NCT01843062|18947840|P2|Safety Analysis Set|Overall Study||77
7694360|NCT01843062|18947841|P1|Safety Analysis Set|Overall Study||154
7694361|NCT01843062|18947840|P2|Intention to Treat (ITT) Analysis Set|Overall Study||78
7694362|NCT01843062|18947841|P1|Intention to Treat (ITT) Analysis Set|Overall Study||155
7694363|NCT01843062|18947840|P2|STARTED|Overall Study||78
7694364|NCT01843062|18947841|P1|STARTED|Overall Study||155
7694365|NCT01842958|18947855|P2|NOT COMPLETED|Overall Study||1
7694366|NCT01842958|18947856|P1|NOT COMPLETED|Overall Study||1
7694367|NCT01842958|18947855|P2|COMPLETED|Overall Study||24
7694368|NCT01842958|18947856|P1|COMPLETED|Overall Study||24
7694369|NCT01842958|18947855|P2|Randomized|Overall Study||25
7694370|NCT01842958|18947856|P1|Randomized|Overall Study|One subject was randomized to 3.3 mm implant, but received the 4.1 mm implant.|25
7694371|NCT01842958|18947855|P2|STARTED|Overall Study||25
7694372|NCT01842958|18947856|P1|STARTED|Overall Study||25
7694373|NCT01842906|18947876|P2|NOT COMPLETED|Overall Study||0
7694374|NCT01842906|18947877|P1|NOT COMPLETED|Overall Study||0
7694375|NCT01842906|18947876|P2|COMPLETED|Overall Study||104
7694376|NCT01842906|18947877|P1|COMPLETED|Overall Study||115
7694377|NCT01842906|18947876|P2|STARTED|Overall Study||104
7694378|NCT01842906|18947877|P1|STARTED|Overall Study||115
7694379|NCT01842841|18947889|P1|NOT COMPLETED|Overall Study||0
7694380|NCT01842841|18947889|P1|COMPLETED|Overall Study||5
7694381|NCT01842841|18947889|P1|STARTED|Overall Study||5
7694382|NCT01842789|18947910|P2|NOT COMPLETED|Overall Study||0
7694383|NCT01842789|18947911|P1|NOT COMPLETED|Overall Study||0
7694384|NCT01842789|18947910|P2|COMPLETED|Overall Study||8
7694385|NCT01842789|18947911|P1|COMPLETED|Overall Study||10
7694386|NCT01842789|18947910|P2|STARTED|Overall Study||8
7694387|NCT01842789|18947911|P1|STARTED|Overall Study||10
7694388|NCT01842646|18947920|P1|NOT COMPLETED|Overall Study||0
7694389|NCT01842646|18947920|P1|COMPLETED|Overall Study||35
7694390|NCT01842646|18947920|P1|STARTED|Overall Study||35
7694391|NCT01842633|18947931|P3|NOT COMPLETED|Overall Study||0
7694392|NCT01842633|18947932|P2|NOT COMPLETED|Overall Study||2
7694393|NCT01842633|18947933|P1|NOT COMPLETED|Overall Study||3
7694394|NCT01842633|18947931|P3|COMPLETED|Overall Study||34
7694395|NCT01842633|18947932|P2|COMPLETED|Overall Study||64
7694396|NCT01842633|18947933|P1|COMPLETED|Overall Study||62
7694397|NCT01842633|18947931|P3|STARTED|Overall Study||34
7694398|NCT01842633|18947932|P2|STARTED|Overall Study||66
7694399|NCT01842633|18947933|P1|STARTED|Overall Study||65
7694400|NCT01842620|18947980|P2|NOT COMPLETED|Period 2||0
7694401|NCT01842620|18947981|P1|NOT COMPLETED|Period 2||0
7694402|NCT01842620|18947980|P2|COMPLETED|Period 2||12
7694403|NCT01842620|18947981|P1|COMPLETED|Period 2||12
7694404|NCT01842620|18947980|P2|STARTED|Period 2||12
7694405|NCT01842620|18947981|P1|STARTED|Period 2||12
7694406|NCT01842620|18947980|P2|NOT COMPLETED|Washout Period||0
7694407|NCT01842620|18947981|P1|NOT COMPLETED|Washout Period||0
7694408|NCT01842620|18947980|P2|COMPLETED|Washout Period||12
7694409|NCT01842620|18947981|P1|COMPLETED|Washout Period||12
7694410|NCT01842620|18947980|P2|STARTED|Washout Period||12
7694411|NCT01842620|18947981|P1|STARTED|Washout Period||12
7694412|NCT01842620|18947980|P2|NOT COMPLETED|Period 1||0
7694413|NCT01842620|18947981|P1|NOT COMPLETED|Period 1||1
7694414|NCT01842620|18947980|P2|COMPLETED|Period 1||12
7694415|NCT01842620|18947981|P1|COMPLETED|Period 1||12
7694416|NCT01842620|18947980|P2|STARTED|Period 1||12
7694417|NCT01842620|18947981|P1|STARTED|Period 1||13
7694418|NCT01842607|18947997|P1|NOT COMPLETED|Overall Study||66
7694419|NCT01842607|18947997|P1|COMPLETED|Overall Study||585
7694420|NCT01842607|18947997|P1|STARTED|Overall Study||651
7694421|NCT01842594|18948016|P1|NOT COMPLETED|Overall Study||3
7694422|NCT01842594|18948016|P1|COMPLETED|Overall Study||10
7694423|NCT01842594|18948016|P1|STARTED|Overall Study||13
7694424|NCT01842581|18948023|P2|NOT COMPLETED|Overall Study||30
7694425|NCT01842581|18948024|P1|NOT COMPLETED|Overall Study||44
7694426|NCT01842581|18948023|P2|COMPLETED|Overall Study||79
7694427|NCT01842581|18948024|P1|COMPLETED|Overall Study||69
7694428|NCT01842581|18948023|P2|Received at Least 1 Dose of Study Drug|Overall Study||108
7694429|NCT01842581|18948024|P1|Received at Least 1 Dose of Study Drug|Overall Study||113
7694430|NCT01842581|18948023|P2|STARTED|Overall Study||109
7694431|NCT01842581|18948024|P1|STARTED|Overall Study||113
7694432|NCT01842464|18948040|P1|NOT COMPLETED|Overall Study||0
7694433|NCT01842464|18948040|P1|COMPLETED|Overall Study||44
7694434|NCT01842464|18948040|P1|STARTED|Overall Study||44
7694435|NCT01842438|18948048|P2|NOT COMPLETED|T2: 6month Follow-up||4
7694436|NCT01842438|18948049|P1|NOT COMPLETED|T2: 6month Follow-up||4
7694437|NCT01842438|18948048|P2|COMPLETED|T2: 6month Follow-up||32
7694438|NCT01842438|18948049|P1|COMPLETED|T2: 6month Follow-up||32
7694439|NCT01842438|18948048|P2|STARTED|T2: 6month Follow-up||36
7694440|NCT01842438|18948049|P1|STARTED|T2: 6month Follow-up||36
7694441|NCT01842438|18948048|P2|NOT COMPLETED|T1: Immediately After the Intervention||8
7694442|NCT01842438|18948049|P1|NOT COMPLETED|T1: Immediately After the Intervention||6
7694443|NCT01842438|18948048|P2|COMPLETED|T1: Immediately After the Intervention||36
7694444|NCT01842438|18948049|P1|COMPLETED|T1: Immediately After the Intervention||36
7694445|NCT01842438|18948048|P2|STARTED|T1: Immediately After the Intervention||44
7694446|NCT01842438|18948049|P1|STARTED|T1: Immediately After the Intervention||42
7694447|NCT01842334|18948063|P2|NOT COMPLETED|Overall Study||4
7694448|NCT01842334|18948064|P1|NOT COMPLETED|Overall Study||3
7694449|NCT01842334|18948063|P2|COMPLETED|Overall Study||3
7694450|NCT01842334|18948064|P1|COMPLETED|Overall Study||2
7694451|NCT01842334|18948063|P2|STARTED|Overall Study||7
7694452|NCT01842334|18948064|P1|STARTED|Overall Study||5
7694453|NCT01842308|18948075|P5|NOT COMPLETED|Overall Study||1
7694454|NCT01842308|18948076|P4|NOT COMPLETED|Overall Study||0
7694455|NCT01842308|18948077|P3|NOT COMPLETED|Overall Study||0
7694456|NCT01842308|18948078|P2|NOT COMPLETED|Overall Study||0
7694457|NCT01842308|18948079|P1|NOT COMPLETED|Overall Study||0
7694458|NCT01842308|18948075|P5|COMPLETED|Overall Study||35
7694459|NCT01842308|18948076|P4|COMPLETED|Overall Study||2
7694460|NCT01842308|18948077|P3|COMPLETED|Overall Study||3
7694461|NCT01842308|18948078|P2|COMPLETED|Overall Study||3
7694462|NCT01842308|18948079|P1|COMPLETED|Overall Study||6
7694463|NCT01842308|18948075|P5|STARTED|Overall Study||36
7694464|NCT01842308|18948076|P4|STARTED|Overall Study||2
7694465|NCT01842308|18948077|P3|STARTED|Overall Study||3
7694466|NCT01842308|18948078|P2|STARTED|Overall Study||3
7694467|NCT01842308|18948079|P1|STARTED|Overall Study||6
7694468|NCT01841970|18948098|P1|NOT COMPLETED|Overall Study||11
7694469|NCT01841970|18948098|P1|COMPLETED|Overall Study||9
7694470|NCT01841970|18948098|P1|STARTED|Overall Study||20
7694471|NCT01841931|18948114|P1|NOT COMPLETED|Overall Study||4
7694472|NCT01841931|18948114|P1|COMPLETED|Overall Study|As the PI left the institution the study was terminated|0
7694473|NCT01841931|18948114|P1|STARTED|Overall Study||4
7694474|NCT01841762|18948122|P1|NOT COMPLETED|Post-Treatment Safety Follow-Up Period||15
7694475|NCT01841762|18948122|P1|COMPLETED|Post-Treatment Safety Follow-Up Period||269
7694476|NCT01841762|18948122|P1|STARTED|Post-Treatment Safety Follow-Up Period||284
7694477|NCT01841762|18948122|P1|NOT COMPLETED|Treatment Period||32
7694478|NCT01841762|18948122|P1|COMPLETED|Treatment Period||252
7694479|NCT01841762|18948122|P1|STARTED|Treatment Period||284
7694480|NCT01841762|18948122|P1|NOT COMPLETED|Screening Period||51
7694481|NCT01841762|18948122|P1|COMPLETED|Screening Period||284
7694482|NCT01841762|18948122|P1|STARTED|Screening Period||335
7694483|NCT01841736|18948132|P2|NOT COMPLETED|Overall Study||0
7694484|NCT01841736|18948133|P1|NOT COMPLETED|Overall Study||0
7694485|NCT01841736|18948132|P2|COMPLETED|Overall Study||74
7694486|NCT01841736|18948133|P1|COMPLETED|Overall Study||97
7694487|NCT01841736|18948132|P2|Crossover|Overall Study||49
7694488|NCT01841736|18948133|P1|Crossover|Overall Study||0
7694489|NCT01841736|18948132|P2|STARTED|Overall Study||74
7694490|NCT01841736|18948133|P1|STARTED|Overall Study||97
7694491|NCT01841697|18948146|P2|NOT COMPLETED|Overall Study||18
7694492|NCT01841697|18948147|P1|NOT COMPLETED|Overall Study||20
7694493|NCT01841697|18948146|P2|COMPLETED|Overall Study||302
7694494|NCT01841697|18948147|P1|COMPLETED|Overall Study||302
7694495|NCT01841697|18948146|P2|STARTED|Overall Study||320
7694496|NCT01841697|18948147|P1|STARTED|Overall Study||322
7694497|NCT01841632|18948163|P1|NOT COMPLETED|Overall Study||0
7694498|NCT01841632|18948163|P1|COMPLETED|Overall Study||3
7694499|NCT01841632|18948163|P1|STARTED|Overall Study||3
7694500|NCT01841619|18948168|P1|NOT COMPLETED|Overall Study||0
7694501|NCT01841619|18948168|P1|COMPLETED|Overall Study||16
7694502|NCT01841619|18948168|P1|STARTED|Overall Study||16
7694503|NCT01841606|18948178|P2|NOT COMPLETED|Overall Study||0
7694504|NCT01841606|18948179|P1|NOT COMPLETED|Overall Study||0
7694505|NCT01841606|18948178|P2|COMPLETED|Overall Study||27
7694506|NCT01841606|18948179|P1|COMPLETED|Overall Study||25
7694507|NCT01841606|18948178|P2|STARTED|Overall Study||27
7694508|NCT01841606|18948179|P1|STARTED|Overall Study||25
7694509|NCT01841593|18948187|P2|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
7694510|NCT01841593|18948188|P1|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
7694511|NCT01841593|18948187|P2|COMPLETED|Third Intervention (Days 15 to 21)||6
7694512|NCT01841593|18948188|P1|COMPLETED|Third Intervention (Days 15 to 21)||11
7694513|NCT01841593|18948187|P2|STARTED|Third Intervention (Days 15 to 21)||6
7694514|NCT01841593|18948188|P1|STARTED|Third Intervention (Days 15 to 21)||11
7694515|NCT01841593|18948187|P2|NOT COMPLETED|Second Intervention (Days 8 to 14)||0
7694516|NCT01841593|18948188|P1|NOT COMPLETED|Second Intervention (Days 8 to 14)||1
7694517|NCT01841593|18948187|P2|COMPLETED|Second Intervention (Days 8 to 14)||6
7694518|NCT01841593|18948188|P1|COMPLETED|Second Intervention (Days 8 to 14)||11
7694519|NCT01841593|18948187|P2|STARTED|Second Intervention (Days 8 to 14)||6
7694520|NCT01841593|18948188|P1|STARTED|Second Intervention (Days 8 to 14)||12
7694521|NCT01841593|18948187|P2|NOT COMPLETED|First Intervention (Days 1 to 7)||1
7694522|NCT01841593|18948188|P1|NOT COMPLETED|First Intervention (Days 1 to 7)||0
7694523|NCT01841593|18948187|P2|COMPLETED|First Intervention (Days 1 to 7)||6
7694524|NCT01841593|18948188|P1|COMPLETED|First Intervention (Days 1 to 7)||12
7694525|NCT01841593|18948187|P2|STARTED|First Intervention (Days 1 to 7)||7
7694526|NCT01841593|18948188|P1|STARTED|First Intervention (Days 1 to 7)||12
7694527|NCT01841567|18948204|P1|NOT COMPLETED|Overall Study||3
7694528|NCT01841567|18948204|P1|COMPLETED|Overall Study||57
7694529|NCT01841567|18948204|P1|STARTED|Overall Study||60
7694530|NCT01841554|18948209|P1|NOT COMPLETED|Overall Study||19
7694531|NCT01841554|18948209|P1|COMPLETED|Overall Study||42
7694532|NCT01841554|18948209|P1|1 Year Follow Up|Overall Study||42
7694533|NCT01841554|18948209|P1|Implanted|Overall Study||60
7694534|NCT01841554|18948209|P1|STARTED|Overall Study||61
7694535|NCT01841281|18948222|P4|NOT COMPLETED|Second Intervention (12 Weeks)||0
7694536|NCT01841281|18948223|P3|NOT COMPLETED|Second Intervention (12 Weeks)||0
7694537|NCT01841281|18948224|P2|NOT COMPLETED|Second Intervention (12 Weeks)||3
7694538|NCT01841281|18948225|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
7694539|NCT01841281|18948222|P4|COMPLETED|Second Intervention (12 Weeks)||13
7694540|NCT01841281|18948223|P3|COMPLETED|Second Intervention (12 Weeks)||10
7694541|NCT01841281|18948224|P2|COMPLETED|Second Intervention (12 Weeks)||6
7694542|NCT01841281|18948225|P1|COMPLETED|Second Intervention (12 Weeks)||9
7694543|NCT01841281|18948222|P4|STARTED|Second Intervention (12 Weeks)||13
7694544|NCT01841281|18948223|P3|STARTED|Second Intervention (12 Weeks)||10
7694545|NCT01841281|18948224|P2|STARTED|Second Intervention (12 Weeks)||9
7694546|NCT01841281|18948225|P1|STARTED|Second Intervention (12 Weeks)||9
7694547|NCT01841281|18948222|P4|NOT COMPLETED|Washout (6 Weeks)||1
7694548|NCT01841281|18948223|P3|NOT COMPLETED|Washout (6 Weeks)||3
7694549|NCT01841281|18948224|P2|NOT COMPLETED|Washout (6 Weeks)||3
7694550|NCT01841281|18948225|P1|NOT COMPLETED|Washout (6 Weeks)||2
7694551|NCT01841281|18948222|P4|COMPLETED|Washout (6 Weeks)||13
7694552|NCT01841281|18948223|P3|COMPLETED|Washout (6 Weeks)||10
7694553|NCT01841281|18948224|P2|COMPLETED|Washout (6 Weeks)||9
7694554|NCT01841281|18948225|P1|COMPLETED|Washout (6 Weeks)||9
7694555|NCT01841281|18948222|P4|STARTED|Washout (6 Weeks)||14
7694556|NCT01841281|18948223|P3|STARTED|Washout (6 Weeks)||13
7694557|NCT01841281|18948224|P2|STARTED|Washout (6 Weeks)||12
7694558|NCT01841281|18948225|P1|STARTED|Washout (6 Weeks)||11
7694559|NCT01841281|18948222|P4|NOT COMPLETED|First Intervention (12 Weeks)||0
7694560|NCT01841281|18948223|P3|NOT COMPLETED|First Intervention (12 Weeks)||0
7694561|NCT01841281|18948224|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
7694562|NCT01841281|18948225|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
7694563|NCT01841281|18948222|P4|COMPLETED|First Intervention (12 Weeks)||14
7694564|NCT01841281|18948223|P3|COMPLETED|First Intervention (12 Weeks)||13
7694565|NCT01841281|18948224|P2|COMPLETED|First Intervention (12 Weeks)||12
7694566|NCT01841281|18948225|P1|COMPLETED|First Intervention (12 Weeks)||11
7694567|NCT01841281|18948222|P4|STARTED|First Intervention (12 Weeks)||14
7694568|NCT01841281|18948223|P3|STARTED|First Intervention (12 Weeks)||13
7694569|NCT01841281|18948224|P2|STARTED|First Intervention (12 Weeks)||12
7694570|NCT01841281|18948225|P1|STARTED|First Intervention (12 Weeks)||11
7694571|NCT01841216|18948247|P2|NOT COMPLETED|Overall Study||0
7694572|NCT01841216|18948248|P1|NOT COMPLETED|Overall Study||0
7694573|NCT01841216|18948247|P2|COMPLETED|Overall Study||15
7694574|NCT01841216|18948248|P1|COMPLETED|Overall Study||15
7694575|NCT01841216|18948247|P2|STARTED|Overall Study||15
7694576|NCT01841216|18948248|P1|STARTED|Overall Study||15
7694577|NCT01841073|18948258|P2|NOT COMPLETED|Overall Study||3
7694578|NCT01841073|18948259|P1|NOT COMPLETED|Overall Study||2
7694579|NCT01841073|18948258|P2|COMPLETED|Overall Study||19
7694580|NCT01841073|18948259|P1|COMPLETED|Overall Study||20
7694581|NCT01841073|18948258|P2|STARTED|Overall Study||22
7694582|NCT01841073|18948259|P1|STARTED|Overall Study||22
7694583|NCT01841021|18948269|P1|NOT COMPLETED|Overall Study||0
7694584|NCT01841021|18948269|P1|COMPLETED|Overall Study||1
7694585|NCT01841021|18948269|P1|STARTED|Overall Study||1
7694586|NCT01840943|18948281|P2|NOT COMPLETED|Overall Study||12
7694587|NCT01840943|18948282|P1|NOT COMPLETED|Overall Study||13
7694588|NCT01840943|18948281|P2|COMPLETED|Overall Study||0
7694589|NCT01840943|18948282|P1|COMPLETED|Overall Study||1
7694590|NCT01840943|18948281|P2|STARTED|Overall Study||12
7694591|NCT01840943|18948282|P1|STARTED|Overall Study||14
7694592|NCT01840722|18948318|P2|NOT COMPLETED|Overall Study||69
7694593|NCT01840722|18948319|P1|NOT COMPLETED|Overall Study||0
7694594|NCT01840722|18948318|P2|COMPLETED|Overall Study||130
7694595|NCT01840722|18948319|P1|COMPLETED|Overall Study||201
7694596|NCT01840722|18948318|P2|STARTED|Overall Study||199
7694597|NCT01840722|18948319|P1|STARTED|Overall Study||201
7694598|NCT01840605|18948331|P2|NOT COMPLETED|Overall Study||2
7694599|NCT01840605|18948332|P1|NOT COMPLETED|Overall Study||2
7694600|NCT01840605|18948331|P2|COMPLETED|Overall Study||150
7694601|NCT01840605|18948332|P1|COMPLETED|Overall Study||149
7694602|NCT01840605|18948331|P2|STARTED|Overall Study||152
7694603|NCT01840605|18948332|P1|STARTED|Overall Study||151
7694604|NCT01840410|18948346|P2|NOT COMPLETED|Overall Study||4
7694605|NCT01840410|18948347|P1|NOT COMPLETED|Overall Study||7
7694606|NCT01840410|18948346|P2|COMPLETED|Overall Study||55
7694607|NCT01840410|18948347|P1|COMPLETED|Overall Study||112
7694608|NCT01840410|18948346|P2|Full Analysis Set|Overall Study||59
7694609|NCT01840410|18948347|P1|Full Analysis Set|Overall Study||119
7694610|NCT01840410|18948346|P2|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59
7694611|NCT01840410|18948347|P1|Safety Set|Overall Study||119
7694612|NCT01840410|18948346|P2|STARTED|Overall Study||59
7694613|NCT01840410|18948347|P1|STARTED|Overall Study||119
7694614|NCT01840345|18948383|P1|NOT COMPLETED|Overall Study||1
7694615|NCT01840345|18948383|P1|COMPLETED|Overall Study||10
7694616|NCT01840345|18948383|P1|STARTED|Overall Study||11
7694617|NCT01840319|18948390|P1|NOT COMPLETED|Overall Study||0
7694618|NCT01840319|18948390|P1|COMPLETED|Overall Study||156
7694619|NCT01840319|18948390|P1|STARTED|Overall Study||156
7694620|NCT01840228|18948396|P2|NOT COMPLETED|Overall Study||1
7694621|NCT01840228|18948397|P1|NOT COMPLETED|Overall Study||1
7694622|NCT01840228|18948396|P2|COMPLETED|Overall Study||18
7694623|NCT01840228|18948397|P1|COMPLETED|Overall Study||18
7694624|NCT01840228|18948396|P2|STARTED|Overall Study||19
7694625|NCT01840228|18948397|P1|STARTED|Overall Study||19
7694626|NCT01840163|18948425|P2|NOT COMPLETED|Systemic Follow Up-secondary Outcome||75
7694627|NCT01840163|18948426|P1|NOT COMPLETED|Systemic Follow Up-secondary Outcome||91
7694628|NCT01840163|18948425|P2|COMPLETED|Systemic Follow Up-secondary Outcome||191
7694629|NCT01840163|18948426|P1|COMPLETED|Systemic Follow Up-secondary Outcome||174
7694630|NCT01840163|18948425|P2|STARTED|Systemic Follow Up-secondary Outcome|4 participants became unreachable and lost to follow up before sending 9 mo follow up|266
7694631|NCT01840163|18948426|P1|STARTED|Systemic Follow Up-secondary Outcome|From primary outcome to secondary outcome prd 1 participant withdrew and 1 became deceased|265
7694632|NCT01840163|18948425|P2|NOT COMPLETED|First Follow up -Primary Outcome||16
7694633|NCT01840163|18948426|P1|NOT COMPLETED|First Follow up -Primary Outcome||19
7694634|NCT01840163|18948425|P2|COMPLETED|First Follow up -Primary Outcome||254
7694635|NCT01840163|18948426|P1|COMPLETED|First Follow up -Primary Outcome||248
7694636|NCT01840163|18948425|P2|STARTED|First Follow up -Primary Outcome||270
7694637|NCT01840163|18948426|P1|STARTED|First Follow up -Primary Outcome||267
7694638|NCT01840072|18948448|P2|NOT COMPLETED|Overall Study||47
7694639|NCT01840072|18948449|P1|NOT COMPLETED|Overall Study||7
7694640|NCT01840072|18948448|P2|COMPLETED|Overall Study||1986
7694641|NCT01840072|18948449|P1|COMPLETED|Overall Study||2031
7694642|NCT01840072|18948448|P2|STARTED|Overall Study||2033
7694643|NCT01840072|18948449|P1|STARTED|Overall Study||2038
7694644|NCT01839916|18948471|P1|NOT COMPLETED|Overall Study||41
7694645|NCT01839916|18948471|P1|COMPLETED|Overall Study||36
7694646|NCT01839916|18948471|P1|STARTED|Overall Study||77
7694647|NCT01839708|18948482|P2|NOT COMPLETED|Overall Study||67
7694648|NCT01839708|18948483|P1|NOT COMPLETED|Overall Study||76
7694649|NCT01839708|18948482|P2|COMPLETED|Overall Study||115
7694650|NCT01839708|18948483|P1|COMPLETED|Overall Study||311
7694651|NCT01839708|18948482|P2|STARTED|Overall Study||182
7694652|NCT01839708|18948483|P1|STARTED|Overall Study||387
7694653|NCT01839695|18948515|P1|NOT COMPLETED|Overall Study||0
7694654|NCT01839695|18948515|P1|COMPLETED|Overall Study||9
7694655|NCT01839695|18948515|P1|STARTED|Overall Study||9
7694656|NCT01839656|18948522|P2|NOT COMPLETED|Overall Study||16
7694657|NCT01839656|18948523|P1|NOT COMPLETED|Overall Study||3
7694658|NCT01839656|18948522|P2|COMPLETED|Overall Study||0
7694659|NCT01839656|18948523|P1|COMPLETED|Overall Study||2
7694660|NCT01839656|18948522|P2|Completed Loading Dose Period|Overall Study||15
7694661|NCT01839656|18948523|P1|Completed Loading Dose Period|Overall Study||4
7694662|NCT01839656|18948522|P2|STARTED|Overall Study||16
7694663|NCT01839656|18948523|P1|STARTED|Overall Study||5
7694664|NCT01839604|18948550|P5|NOT COMPLETED|Overall Study||0
7694665|NCT01839604|18948551|P4|NOT COMPLETED|Overall Study||0
7694666|NCT01839604|18948552|P3|NOT COMPLETED|Overall Study||0
7694667|NCT01839604|18948553|P2|NOT COMPLETED|Overall Study||0
7694668|NCT01839604|18948554|P1|NOT COMPLETED|Overall Study||0
7694669|NCT01839604|18948550|P5|COMPLETED|Overall Study||15
7694670|NCT01839604|18948551|P4|COMPLETED|Overall Study||5
7694671|NCT01839604|18948552|P3|COMPLETED|Overall Study||7
7694672|NCT01839604|18948553|P2|COMPLETED|Overall Study||6
7694673|NCT01839604|18948554|P1|COMPLETED|Overall Study||6
7694674|NCT01839604|18948550|P5|STARTED|Overall Study||15
7694675|NCT01839604|18948551|P4|STARTED|Overall Study||5
7694676|NCT01839604|18948552|P3|STARTED|Overall Study||7
7694677|NCT01839604|18948553|P2|STARTED|Overall Study||6
7694678|NCT01839604|18948554|P1|STARTED|Overall Study||6
7694679|NCT01839487|18948583|P6|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||44
7694680|NCT01839487|18948584|P5|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||88
7694681|NCT01839487|18948585|P4|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||62
7694682|NCT01839487|18948586|P3|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||61
7694683|NCT01839487|18948587|P2|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
7694684|NCT01839487|18948588|P1|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
7694685|NCT01839487|18948583|P6|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
7694686|NCT01839487|18948584|P5|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||1
7694687|NCT01839487|18948585|P4|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
7694688|NCT01839487|18948586|P3|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
7694689|NCT01839487|18948587|P2|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
7694690|NCT01839487|18948588|P1|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
7694691|NCT01839487|18948583|P6|STARTED|Phase 2 (Maximum Exposure:935 Days)||44
7694692|NCT01839487|18948584|P5|STARTED|Phase 2 (Maximum Exposure:935 Days)||89
7694693|NCT01839487|18948585|P4|STARTED|Phase 2 (Maximum Exposure:935 Days)||62
7694694|NCT01839487|18948586|P3|STARTED|Phase 2 (Maximum Exposure:935 Days)||61
7694695|NCT01839487|18948587|P2|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
7694696|NCT01839487|18948588|P1|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
7694697|NCT01839487|18948583|P6|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
7694698|NCT01839487|18948584|P5|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
7694699|NCT01839487|18948585|P4|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
7694700|NCT01839487|18948586|P3|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
7694701|NCT01839487|18948587|P2|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||7
7694702|NCT01839487|18948588|P1|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||16
7694703|NCT01839487|18948583|P6|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
7694704|NCT01839487|18948584|P5|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
7694705|NCT01839487|18948585|P4|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
7694706|NCT01839487|18948586|P3|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
7694707|NCT01839487|18948587|P2|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
7694708|NCT01839487|18948588|P1|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
7694709|NCT01839487|18948583|P6|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
7694710|NCT01839487|18948584|P5|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
7694711|NCT01839487|18948585|P4|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
7694712|NCT01839487|18948586|P3|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
7694713|NCT01839487|18948587|P2|STARTED|Run-in Phase (Maximum Exposure:295 Days)||7
7694714|NCT01839487|18948588|P1|STARTED|Run-in Phase (Maximum Exposure:295 Days)||16
7694715|NCT01839396|18948611|P2|NOT COMPLETED|Overall Study||0
7694716|NCT01839396|18948612|P1|NOT COMPLETED|Overall Study||0
7694717|NCT01839396|18948611|P2|COMPLETED|Overall Study||39
7694718|NCT01839396|18948612|P1|COMPLETED|Overall Study||121
7694719|NCT01839396|18948611|P2|STARTED|Overall Study||39
7694720|NCT01839396|18948612|P1|STARTED|Overall Study||121
7694721|NCT01839318|18948620|P6|NOT COMPLETED|Period 3, Third Day of Wear||0
7694722|NCT01839318|18948621|P5|NOT COMPLETED|Period 3, Third Day of Wear||0
7694723|NCT01839318|18948622|P4|NOT COMPLETED|Period 3, Third Day of Wear||0
7694724|NCT01839318|18948623|P3|NOT COMPLETED|Period 3, Third Day of Wear||0
7694725|NCT01839318|18948624|P2|NOT COMPLETED|Period 3, Third Day of Wear||0
7694726|NCT01839318|18948625|P1|NOT COMPLETED|Period 3, Third Day of Wear||0
7694727|NCT01839318|18948620|P6|COMPLETED|Period 3, Third Day of Wear||2
7694728|NCT01839318|18948621|P5|COMPLETED|Period 3, Third Day of Wear||7
7694729|NCT01839318|18948622|P4|COMPLETED|Period 3, Third Day of Wear||6
7694730|NCT01839318|18948623|P3|COMPLETED|Period 3, Third Day of Wear||5
7694731|NCT01839318|18948624|P2|COMPLETED|Period 3, Third Day of Wear||4
7694732|NCT01839318|18948625|P1|COMPLETED|Period 3, Third Day of Wear||4
7694733|NCT01839318|18948620|P6|STARTED|Period 3, Third Day of Wear||2
7694734|NCT01839318|18948621|P5|STARTED|Period 3, Third Day of Wear||7
7694735|NCT01839318|18948622|P4|STARTED|Period 3, Third Day of Wear||6
7694736|NCT01839318|18948623|P3|STARTED|Period 3, Third Day of Wear||5
7694737|NCT01839318|18948624|P2|STARTED|Period 3, Third Day of Wear||4
7694738|NCT01839318|18948625|P1|STARTED|Period 3, Third Day of Wear||4
7694739|NCT01839318|18948620|P6|NOT COMPLETED|Period 2, Second Day of Wear||0
7694740|NCT01839318|18948621|P5|NOT COMPLETED|Period 2, Second Day of Wear||0
7694741|NCT01839318|18948622|P4|NOT COMPLETED|Period 2, Second Day of Wear||0
7694742|NCT01839318|18948623|P3|NOT COMPLETED|Period 2, Second Day of Wear||0
7694743|NCT01839318|18948624|P2|NOT COMPLETED|Period 2, Second Day of Wear||0
7694744|NCT01839318|18948625|P1|NOT COMPLETED|Period 2, Second Day of Wear||0
7694745|NCT01839318|18948620|P6|COMPLETED|Period 2, Second Day of Wear||2
7694746|NCT01839318|18948621|P5|COMPLETED|Period 2, Second Day of Wear||7
7694747|NCT01839318|18948622|P4|COMPLETED|Period 2, Second Day of Wear||6
7694748|NCT01839318|18948623|P3|COMPLETED|Period 2, Second Day of Wear||5
7694749|NCT01839318|18948624|P2|COMPLETED|Period 2, Second Day of Wear||4
7694750|NCT01839318|18948625|P1|COMPLETED|Period 2, Second Day of Wear||4
7694751|NCT01839318|18948620|P6|STARTED|Period 2, Second Day of Wear||2
7694752|NCT01839318|18948621|P5|STARTED|Period 2, Second Day of Wear||7
7694753|NCT01839318|18948622|P4|STARTED|Period 2, Second Day of Wear||6
7694754|NCT01839318|18948623|P3|STARTED|Period 2, Second Day of Wear||5
7694755|NCT01839318|18948624|P2|STARTED|Period 2, Second Day of Wear||4
7694756|NCT01839318|18948625|P1|STARTED|Period 2, Second Day of Wear||4
7694757|NCT01839318|18948620|P6|NOT COMPLETED|Period 1, First Day of Wear||0
7694758|NCT01839318|18948621|P5|NOT COMPLETED|Period 1, First Day of Wear||0
7694759|NCT01839318|18948622|P4|NOT COMPLETED|Period 1, First Day of Wear||0
7694760|NCT01839318|18948623|P3|NOT COMPLETED|Period 1, First Day of Wear||0
7694761|NCT01839318|18948624|P2|NOT COMPLETED|Period 1, First Day of Wear||0
7694762|NCT01839318|18948625|P1|NOT COMPLETED|Period 1, First Day of Wear||0
7694763|NCT01839318|18948620|P6|COMPLETED|Period 1, First Day of Wear||2
7694764|NCT01839318|18948621|P5|COMPLETED|Period 1, First Day of Wear||7
7694765|NCT01839318|18948622|P4|COMPLETED|Period 1, First Day of Wear||6
7694766|NCT01839318|18948623|P3|COMPLETED|Period 1, First Day of Wear||5
7694767|NCT01839318|18948624|P2|COMPLETED|Period 1, First Day of Wear||4
7694768|NCT01839318|18948625|P1|COMPLETED|Period 1, First Day of Wear||4
7694769|NCT01839318|18948620|P6|STARTED|Period 1, First Day of Wear||2
7694770|NCT01839318|18948621|P5|STARTED|Period 1, First Day of Wear||7
7694771|NCT01839318|18948622|P4|STARTED|Period 1, First Day of Wear||6
7694772|NCT01839318|18948623|P3|STARTED|Period 1, First Day of Wear||5
7694773|NCT01839318|18948624|P2|STARTED|Period 1, First Day of Wear||4
7694774|NCT01839318|18948625|P1|STARTED|Period 1, First Day of Wear||4
7694775|NCT01839279|18948639|P3|NOT COMPLETED|Overall Study||2
7694776|NCT01839279|18948640|P2|NOT COMPLETED|Overall Study||2
7694777|NCT01839279|18948641|P1|NOT COMPLETED|Overall Study||13
7694778|NCT01839279|18948639|P3|COMPLETED|Overall Study||30
7694779|NCT01839279|18948640|P2|COMPLETED|Overall Study||30
7694780|NCT01839279|18948641|P1|COMPLETED|Overall Study||59
7694781|NCT01839279|18948639|P3|PK/QTc Analysis Set|Overall Study||0
7694782|NCT01839279|18948640|P2|PK/QTc Analysis Set|Overall Study||0
7694783|NCT01839279|18948641|P1|PK/QTc Analysis Set|Overall Study||70
7694784|NCT01839279|18948639|P3|Moxifloxacin/Placebo Analysis Set|Overall Study||30
7694785|NCT01839279|18948640|P2|Moxifloxacin/Placebo Analysis Set|Overall Study||31
7694786|NCT01839279|18948641|P1|Moxifloxacin/Placebo Analysis Set|Overall Study||0
7694787|NCT01839279|18948639|P3|PK Analysis Set|Overall Study||0
7694788|NCT01839279|18948640|P2|PK Analysis Set|Overall Study||0
7694789|NCT01839279|18948641|P1|PK Analysis Set|Overall Study||70
7694790|NCT01839279|18948639|P3|QT/QTc Analysis Set|Overall Study||32
7694791|NCT01839279|18948640|P2|QT/QTc Analysis Set|Overall Study||32
7694792|NCT01839279|18948641|P1|QT/QTc Analysis Set|Overall Study||72
7694793|NCT01839279|18948639|P3|STARTED|Overall Study||32
7694794|NCT01839279|18948640|P2|STARTED|Overall Study||32
7694795|NCT01839279|18948641|P1|STARTED|Overall Study||72
7694796|NCT01839188|18948660|P1|NOT COMPLETED|Overall Study||1
7694797|NCT01839188|18948660|P1|COMPLETED|Overall Study|N=1 treated participant withdrew before receiving V3|384
7694798|NCT01839188|18948660|P1|Treated|Overall Study||385
7694799|NCT01839188|18948660|P1|STARTED|Overall Study||385
7694800|NCT01839110|18948703|P3|NOT COMPLETED|Overall Study||3
7694801|NCT01839110|18948704|P2|NOT COMPLETED|Overall Study||2
7694802|NCT01839110|18948705|P1|NOT COMPLETED|Overall Study||3
7694803|NCT01839110|18948703|P3|COMPLETED|Overall Study||6
7694804|NCT01839110|18948704|P2|COMPLETED|Overall Study||4
7694805|NCT01839110|18948705|P1|COMPLETED|Overall Study||4
7694806|NCT01839110|18948703|P3|STARTED|Overall Study||9
7694807|NCT01839110|18948704|P2|STARTED|Overall Study||6
7694808|NCT01839110|18948705|P1|STARTED|Overall Study||7
7694809|NCT01839058|18948715|P2|NOT COMPLETED|Overall Study||3
7694810|NCT01839058|18948716|P1|NOT COMPLETED|Overall Study||4
7694811|NCT01839058|18948715|P2|COMPLETED|Overall Study||16
7694812|NCT01839058|18948716|P1|COMPLETED|Overall Study||17
7694813|NCT01839058|18948715|P2|STARTED|Overall Study||19
7694814|NCT01839058|18948716|P1|STARTED|Overall Study||21
7694815|NCT01838980|18948728|P1|NOT COMPLETED|Overall Study||0
7694816|NCT01838980|18948728|P1|COMPLETED|Overall Study||15
7694817|NCT01838980|18948728|P1|STARTED|Overall Study||15
7694818|NCT01838941|18948732|P1|NOT COMPLETED|Overall Study||2
7694819|NCT01838941|18948732|P1|COMPLETED|Overall Study||10
7694820|NCT01838941|18948732|P1|STARTED|Overall Study||12
7694821|NCT01838876|18948737|P1|NOT COMPLETED|Overall Study||233
7694822|NCT01838876|18948737|P1|COMPLETED|Overall Study||209
7694823|NCT01838876|18948737|P1|Entered Safety Follow-up Period|Overall Study||287
7694824|NCT01838876|18948737|P1|Safety Population; Received Study Drug|Overall Study||345
7694825|NCT01838876|18948737|P1|STARTED|Overall Study||442
7694826|NCT01838863|18948752|P2|NOT COMPLETED|Overall Study||9
7694827|NCT01838863|18948753|P1|NOT COMPLETED|Overall Study||10
7694828|NCT01838863|18948752|P2|COMPLETED|Overall Study||60
7694829|NCT01838863|18948753|P1|COMPLETED|Overall Study||65
7694830|NCT01838863|18948752|P2|STARTED|Overall Study||69
7694831|NCT01838863|18948753|P1|STARTED|Overall Study||75
7694832|NCT01838785|18948839|P1|NOT COMPLETED|Overall Study||0
7694833|NCT01838785|18948839|P1|COMPLETED|Overall Study||25
7694834|NCT01838785|18948839|P1|STARTED|Overall Study||25
7694835|NCT01838694|18948846|P2|NOT COMPLETED|Overall Study||1
7694836|NCT01838694|18948847|P1|NOT COMPLETED|Overall Study||0
7694837|NCT01838694|18948846|P2|COMPLETED|Overall Study||21
7694838|NCT01838694|18948847|P1|COMPLETED|Overall Study||8
7694839|NCT01838694|18948846|P2|STARTED|Overall Study||22
7694840|NCT01838694|18948847|P1|STARTED|Overall Study||8
7694841|NCT01838681|18948856|P4|NOT COMPLETED|Period B/A+||117
7694842|NCT01838681|18948857|P3|NOT COMPLETED|Period B/A+||95
7694843|NCT01838681|18948858|P2|NOT COMPLETED|Period B/A+||62
7694844|NCT01838681|18948859|P1|NOT COMPLETED|Period B/A+||0
7694845|NCT01838681|18948856|P4|COMPLETED|Period B/A+||653
7694846|NCT01838681|18948857|P3|COMPLETED|Period B/A+||349
7694847|NCT01838681|18948858|P2|COMPLETED|Period B/A+||380
7694848|NCT01838681|18948859|P1|COMPLETED|Period B/A+||0
7694849|NCT01838681|18948856|P4|STARTED|Period B/A+||770
7694850|NCT01838681|18948857|P3|STARTED|Period B/A+||444
7694851|NCT01838681|18948858|P2|STARTED|Period B/A+||442
7694852|NCT01838681|18948859|P1|STARTED|Period B/A+||0
7694853|NCT01838681|18948856|P4|NOT COMPLETED|Period A||0
7694854|NCT01838681|18948857|P3|NOT COMPLETED|Period A||0
7694855|NCT01838681|18948858|P2|NOT COMPLETED|Period A||0
7694856|NCT01838681|18948859|P1|NOT COMPLETED|Period A||325
7694857|NCT01838681|18948856|P4|COMPLETED|Period A||0
7694858|NCT01838681|18948857|P3|COMPLETED|Period A||0
7694859|NCT01838681|18948858|P2|COMPLETED|Period A||0
7694860|NCT01838681|18948859|P1|COMPLETED|Period A||1661
7694861|NCT01838681|18948856|P4|STARTED|Period A||0
7694862|NCT01838681|18948857|P3|STARTED|Period A||0
7694863|NCT01838681|18948858|P2|STARTED|Period A||0
7694864|NCT01838681|18948859|P1|STARTED|Period A||1986
7694865|NCT01838655|18948899|P1|NOT COMPLETED|Overall Study||0
7694866|NCT01838655|18948899|P1|COMPLETED|Overall Study||5
7694867|NCT01838655|18948899|P1|STARTED|Overall Study||5
7694868|NCT01838642|18948967|P1|NOT COMPLETED|Overall Study||1
7694869|NCT01838642|18948967|P1|COMPLETED|Overall Study||2
7694870|NCT01838642|18948967|P1|STARTED|Overall Study||3
7694871|NCT01838616|18948980|P2|NOT COMPLETED|Pick-up Arm||0
7694872|NCT01838616|18948981|P1|NOT COMPLETED|Pick-up Arm||15
7694873|NCT01838616|18948980|P2|COMPLETED|Pick-up Arm||0
7694874|NCT01838616|18948981|P1|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35
7694875|NCT01838616|18948980|P2|Full Analysis Set|Pick-up Arm||0
7694876|NCT01838616|18948981|P1|Full Analysis Set|Pick-up Arm||49
7694877|NCT01838616|18948980|P2|STARTED|Pick-up Arm||0
7694878|NCT01838616|18948981|P1|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50
7694879|NCT01838616|18948980|P2|NOT COMPLETED|Continuation Period||14
7694880|NCT01838616|18948981|P1|NOT COMPLETED|Continuation Period||14
7694881|NCT01838616|18948980|P2|COMPLETED|Continuation Period||48
7694882|NCT01838616|18948981|P1|COMPLETED|Continuation Period||86
7694883|NCT01838616|18948980|P2|Switched to Pick-up Arm|Continuation Period||7
7694884|NCT01838616|18948981|P1|Switched to Pick-up Arm|Continuation Period||0
7694885|NCT01838616|18948980|P2|STARTED|Continuation Period||62
7694886|NCT01838616|18948981|P1|STARTED|Continuation Period||100
7694887|NCT01838616|18948980|P2|NOT COMPLETED|Titration Period||66
7694888|NCT01838616|18948981|P1|NOT COMPLETED|Titration Period||30
7694889|NCT01838616|18948980|P2|COMPLETED|Titration Period||62
7694890|NCT01838616|18948981|P1|COMPLETED|Titration Period||100
7694891|NCT01838616|18948980|P2|Per Protocol Set|Titration Period||112
7694892|NCT01838616|18948981|P1|Per Protocol Set|Titration Period||117
7694893|NCT01838616|18948980|P2|Full Analysis Set|Titration Period||128
7694894|NCT01838616|18948981|P1|Full Analysis Set|Titration Period||130
7694895|NCT01838616|18948980|P2|Switched to Pick-up Arm|Titration Period||43
7694896|NCT01838616|18948981|P1|Switched to Pick-up Arm|Titration Period||0
7694897|NCT01838616|18948980|P2|Major Protocol Deviations|Titration Period||16
7694898|NCT01838616|18948981|P1|Major Protocol Deviations|Titration Period||13
7694899|NCT01838616|18948980|P2|No Post Baseline Pain Intensity Values|Titration Period||2
7694900|NCT01838616|18948981|P1|No Post Baseline Pain Intensity Values|Titration Period||0
7694901|NCT01838616|18948980|P2|STARTED|Titration Period||128
7694902|NCT01838616|18948981|P1|STARTED|Titration Period||130
7694903|NCT01838590|18949052|P2|NOT COMPLETED|Overall Study||5
7694904|NCT01838590|18949053|P1|NOT COMPLETED|Overall Study||12
7694905|NCT01838590|18949052|P2|COMPLETED|Overall Study||46
7694906|NCT01838590|18949053|P1|COMPLETED|Overall Study||40
7694907|NCT01838590|18949052|P2|STARTED|Overall Study||51
7694908|NCT01838590|18949053|P1|STARTED|Overall Study||52
7694909|NCT01838499|18949077|P2|NOT COMPLETED|Overall Study||17
7694910|NCT01838499|18949078|P1|NOT COMPLETED|Overall Study||24
7694911|NCT01838499|18949077|P2|COMPLETED|Overall Study||37
7694912|NCT01838499|18949078|P1|COMPLETED|Overall Study||31
7694913|NCT01838499|18949077|P2|STARTED|Overall Study||54
7694914|NCT01838499|18949078|P1|STARTED|Overall Study||55
7694915|NCT01838447|18949090|P2|NOT COMPLETED|Overall Study||3
7694916|NCT01838447|18949091|P1|NOT COMPLETED|Overall Study||2
7694917|NCT01838447|18949090|P2|COMPLETED|Overall Study||21
7694918|NCT01838447|18949091|P1|COMPLETED|Overall Study||20
7694919|NCT01838447|18949090|P2|STARTED|Overall Study||24
7694920|NCT01838447|18949091|P1|STARTED|Overall Study||22
7694921|NCT01838304|18949111|P2|NOT COMPLETED|Overall Study||0
7694922|NCT01838304|18949112|P1|NOT COMPLETED|Overall Study||1
7694923|NCT01838304|18949111|P2|COMPLETED|Overall Study||20
7694924|NCT01838304|18949112|P1|COMPLETED|Overall Study||19
7694925|NCT01838304|18949111|P2|STARTED|Overall Study||20
7694926|NCT01838304|18949112|P1|STARTED|Overall Study||20
7694927|NCT01838226|18949126|P2|NOT COMPLETED|Overall Study||71
7694928|NCT01838226|18949127|P1|NOT COMPLETED|Overall Study||76
7694929|NCT01838226|18949126|P2|COMPLETED|Overall Study||128
7694930|NCT01838226|18949127|P1|COMPLETED|Overall Study||126
7694931|NCT01838226|18949126|P2|STARTED|Overall Study||199
7694932|NCT01838226|18949127|P1|STARTED|Overall Study||202
7694933|NCT01838213|18949139|P2|NOT COMPLETED|Overall Study||191
7694934|NCT01838213|18949140|P1|NOT COMPLETED|Overall Study||166
7694935|NCT01838213|18949139|P2|COMPLETED|Overall Study||262
7694936|NCT01838213|18949140|P1|COMPLETED|Overall Study||81
7694937|NCT01838213|18949139|P2|STARTED|Overall Study||453
7694938|NCT01838213|18949140|P1|STARTED|Overall Study||247
7694939|NCT01838200|18949148|P2|NOT COMPLETED|Overall Study||2
7694940|NCT01838200|18949149|P1|NOT COMPLETED|Overall Study||3
7694941|NCT01838200|18949148|P2|COMPLETED|Overall Study||0
7694942|NCT01838200|18949149|P1|COMPLETED|Overall Study||0
7694943|NCT01838200|18949148|P2|STARTED|Overall Study||2
7694944|NCT01838200|18949149|P1|STARTED|Overall Study||3
7694945|NCT01838044|18949161|P2|NOT COMPLETED|Overall Study||16
7694946|NCT01838044|18949162|P1|NOT COMPLETED|Overall Study||8
7694947|NCT01838044|18949161|P2|COMPLETED|Overall Study||75
7694948|NCT01838044|18949162|P1|COMPLETED|Overall Study||81
7694949|NCT01838044|18949161|P2|STARTED|Overall Study||91
7694950|NCT01838044|18949162|P1|STARTED|Overall Study||89
7694951|NCT01837966|18949195|P2|NOT COMPLETED|Overall Study||1
7694952|NCT01837966|18949196|P1|NOT COMPLETED|Overall Study||2
7694953|NCT01837966|18949195|P2|COMPLETED|Overall Study||45
7694954|NCT01837966|18949196|P1|COMPLETED|Overall Study||45
7694955|NCT01837966|18949195|P2|STARTED|Overall Study||46
7694956|NCT01837966|18949196|P1|STARTED|Overall Study||47
7694957|NCT01837823|18949202|P1|NOT COMPLETED|Overall Study||6
7694958|NCT01837823|18949202|P1|COMPLETED|Overall Study||85
7694959|NCT01837823|18949202|P1|STARTED|Overall Study||91
7694960|NCT01837797|18949233|P5|NOT COMPLETED|Period 3||23
7694961|NCT01837797|18949234|P4|NOT COMPLETED|Period 3||0
7694962|NCT01837797|18949235|P3|NOT COMPLETED|Period 3||0
7694963|NCT01837797|18949236|P2|NOT COMPLETED|Period 3||0
7694964|NCT01837797|18949237|P1|NOT COMPLETED|Period 3||0
7694965|NCT01837797|18949233|P5|COMPLETED|Period 3||24
7694966|NCT01837797|18949234|P4|COMPLETED|Period 3||0
7694967|NCT01837797|18949235|P3|COMPLETED|Period 3||0
7694968|NCT01837797|18949236|P2|COMPLETED|Period 3||0
7694969|NCT01837797|18949237|P1|COMPLETED|Period 3||0
7694970|NCT01837797|18949233|P5|STARTED|Period 3||47
7694971|NCT01837797|18949234|P4|STARTED|Period 3||0
7694972|NCT01837797|18949235|P3|STARTED|Period 3||0
7694973|NCT01837797|18949236|P2|STARTED|Period 3||0
7694974|NCT01837797|18949237|P1|STARTED|Period 3||0
7694975|NCT01837797|18949233|P5|NOT COMPLETED|Period 2||0
7694976|NCT01837797|18949234|P4|NOT COMPLETED|Period 2||5
7694977|NCT01837797|18949235|P3|NOT COMPLETED|Period 2||2
7694978|NCT01837797|18949236|P2|NOT COMPLETED|Period 2||5
7694979|NCT01837797|18949237|P1|NOT COMPLETED|Period 2||0
7694980|NCT01837797|18949233|P5|COMPLETED|Period 2||0
7694981|NCT01837797|18949234|P4|COMPLETED|Period 2||1
7694982|NCT01837797|18949235|P3|COMPLETED|Period 2||1
7694983|NCT01837797|18949236|P2|COMPLETED|Period 2||1
7694984|NCT01837797|18949237|P1|COMPLETED|Period 2||0
7694985|NCT01837797|18949233|P5|STARTED|Period 2||0
7694986|NCT01837797|18949234|P4|STARTED|Period 2||6
7694987|NCT01837797|18949235|P3|STARTED|Period 2||3
7694988|NCT01837797|18949236|P2|STARTED|Period 2||6
7694989|NCT01837797|18949237|P1|STARTED|Period 2||0
7694990|NCT01837797|18949233|P5|NOT COMPLETED|Period 1||0
7694991|NCT01837797|18949234|P4|NOT COMPLETED|Period 1||0
7694992|NCT01837797|18949235|P3|NOT COMPLETED|Period 1||0
7694993|NCT01837797|18949236|P2|NOT COMPLETED|Period 1||0
7694994|NCT01837797|18949237|P1|NOT COMPLETED|Period 1||102
7694995|NCT01837797|18949233|P5|COMPLETED|Period 1||0
7694996|NCT01837797|18949234|P4|COMPLETED|Period 1||0
7694997|NCT01837797|18949235|P3|COMPLETED|Period 1||0
7694998|NCT01837797|18949236|P2|COMPLETED|Period 1||0
7694999|NCT01837797|18949237|P1|COMPLETED|Period 1||27
7695000|NCT01837797|18949233|P5|STARTED|Period 1||0
7695001|NCT01837797|18949234|P4|STARTED|Period 1||0
7695002|NCT01837797|18949235|P3|STARTED|Period 1||0
7695003|NCT01837797|18949236|P2|STARTED|Period 1||0
7695004|NCT01837797|18949237|P1|STARTED|Period 1||129
7695005|NCT01837719|18949272|P1|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1
7695006|NCT01837719|18949272|P1|COMPLETED|Period 5: Days 29-31 (Treatment E)||30
7695007|NCT01837719|18949272|P1|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31
7695008|NCT01837719|18949272|P1|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0
7695009|NCT01837719|18949272|P1|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63
7695010|NCT01837719|18949272|P1|STARTED|Period 4: Days 22-28 (Treatment D or C)||63
7695011|NCT01837719|18949272|P1|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0
7695012|NCT01837719|18949272|P1|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63
7695013|NCT01837719|18949272|P1|STARTED|Period 3: Days 15-21 (Treatment C or D)||63
7695014|NCT01837719|18949272|P1|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1
7695015|NCT01837719|18949272|P1|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63
7695016|NCT01837719|18949272|P1|STARTED|Period 2: Days 8-14 (Treatment B or A)||64
7695017|NCT01837719|18949272|P1|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0
7695018|NCT01837719|18949272|P1|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64
7695019|NCT01837719|18949272|P1|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64
7695020|NCT01837680|18949341|P2|NOT COMPLETED|Overall Study||8
7695021|NCT01837680|18949342|P1|NOT COMPLETED|Overall Study||10
7695022|NCT01837680|18949341|P2|COMPLETED|Overall Study||45
7695023|NCT01837680|18949342|P1|COMPLETED|Overall Study||42
7695024|NCT01837680|18949341|P2|STARTED|Overall Study||53
7695025|NCT01837680|18949342|P1|STARTED|Overall Study||52
7695026|NCT01837654|18949380|P2|NOT COMPLETED|Overall Study||0
7695027|NCT01837654|18949381|P1|NOT COMPLETED|Overall Study||0
7695028|NCT01837654|18949380|P2|COMPLETED|Overall Study||11
7695029|NCT01837654|18949381|P1|COMPLETED|Overall Study||11
7695030|NCT01837654|18949380|P2|STARTED|Overall Study||11
7695031|NCT01837654|18949381|P1|STARTED|Overall Study||11
7695032|NCT01837550|18949391|P2|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
7695033|NCT01837550|18949392|P1|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
7695034|NCT01837550|18949391|P2|COMPLETED|T0-T2, 6 Months Follow-up||37
7695035|NCT01837550|18949392|P1|COMPLETED|T0-T2, 6 Months Follow-up||37
7695036|NCT01837550|18949391|P2|STARTED|T0-T2, 6 Months Follow-up||37
7695037|NCT01837550|18949392|P1|STARTED|T0-T2, 6 Months Follow-up||37
7695038|NCT01837550|18949391|P2|NOT COMPLETED|T0-T1, 5 Weeks||0
7695039|NCT01837550|18949392|P1|NOT COMPLETED|T0-T1, 5 Weeks||0
7695040|NCT01837550|18949391|P2|COMPLETED|T0-T1, 5 Weeks||37
7695041|NCT01837550|18949392|P1|COMPLETED|T0-T1, 5 Weeks||37
7695042|NCT01837550|18949391|P2|STARTED|T0-T1, 5 Weeks||37
7695043|NCT01837550|18949392|P1|STARTED|T0-T1, 5 Weeks||37
7695044|NCT01837537|18949404|P1|NOT COMPLETED|Overall Study||0
7695045|NCT01837537|18949404|P1|COMPLETED|Overall Study||90
7695046|NCT01837537|18949404|P1|STARTED|Overall Study||90
7695047|NCT01837524|18949411|P2|NOT COMPLETED|Overall Study||2
7695048|NCT01837524|18949412|P1|NOT COMPLETED|Overall Study||3
7695049|NCT01837524|18949411|P2|COMPLETED|Overall Study||25
7695050|NCT01837524|18949412|P1|COMPLETED|Overall Study||25
7695051|NCT01837524|18949411|P2|STARTED|Overall Study||27
7695052|NCT01837524|18949412|P1|STARTED|Overall Study||28
7695053|NCT01837069|18949420|P2|NOT COMPLETED|Overall Study||0
7695054|NCT01837069|18949421|P1|NOT COMPLETED|Overall Study||0
7695055|NCT01837069|18949420|P2|COMPLETED|Overall Study||95
7695056|NCT01837069|18949421|P1|COMPLETED|Overall Study||103
7695057|NCT01837069|18949420|P2|STARTED|Overall Study||95
7695058|NCT01837069|18949421|P1|STARTED|Overall Study||103
7695059|NCT01836809|18949437|P4|NOT COMPLETED|Overall Study||2
7695060|NCT01836809|18949438|P3|NOT COMPLETED|Overall Study||0
7695061|NCT01836809|18949439|P2|NOT COMPLETED|Overall Study||0
7695062|NCT01836809|18949440|P1|NOT COMPLETED|Overall Study||0
7695063|NCT01836809|18949437|P4|COMPLETED|Overall Study||0
7695064|NCT01836809|18949438|P3|COMPLETED|Overall Study||0
7695065|NCT01836809|18949439|P2|COMPLETED|Overall Study||0
7695066|NCT01836809|18949440|P1|COMPLETED|Overall Study||0
7695067|NCT01836809|18949437|P4|STARTED|Overall Study||2
7695068|NCT01836809|18949438|P3|STARTED|Overall Study||0
7695069|NCT01836809|18949439|P2|STARTED|Overall Study||0
7695070|NCT01836809|18949440|P1|STARTED|Overall Study||0
7695071|NCT01836549|18949476|P7|NOT COMPLETED|Overall Study||1
7695072|NCT01836549|18949477|P6|NOT COMPLETED|Overall Study||0
7695073|NCT01836549|18949478|P5|NOT COMPLETED|Overall Study||0
7695074|NCT01836549|18949479|P4|NOT COMPLETED|Overall Study||1
7695075|NCT01836549|18949480|P3|NOT COMPLETED|Overall Study||1
7695076|NCT01836549|18949481|P2|NOT COMPLETED|Overall Study||0
7695077|NCT01836549|18949482|P1|NOT COMPLETED|Overall Study||0
7695078|NCT01836549|18949476|P7|COMPLETED|Overall Study||8
7695079|NCT01836549|18949477|P6|COMPLETED|Overall Study||4
7695080|NCT01836549|18949478|P5|COMPLETED|Overall Study||18
7695081|NCT01836549|18949479|P4|COMPLETED|Overall Study||8
7695082|NCT01836549|18949480|P3|COMPLETED|Overall Study||0
7695083|NCT01836549|18949481|P2|COMPLETED|Overall Study||1
7695084|NCT01836549|18949482|P1|COMPLETED|Overall Study||1
7695085|NCT01836549|18949476|P7|STARTED|Overall Study||9
7695086|NCT01836549|18949477|P6|STARTED|Overall Study||4
7695087|NCT01836549|18949478|P5|STARTED|Overall Study||18
7695088|NCT01836549|18949479|P4|STARTED|Overall Study||9
7695089|NCT01836549|18949480|P3|STARTED|Overall Study||1
7695090|NCT01836549|18949481|P2|STARTED|Overall Study||1
7695091|NCT01836549|18949482|P1|STARTED|Overall Study||1
7695092|NCT01836523|18949506|P4|NOT COMPLETED|Overall Study||74
7695093|NCT01836523|18949507|P3|NOT COMPLETED|Overall Study||91
7695094|NCT01836523|18949508|P2|NOT COMPLETED|Overall Study||85
7695095|NCT01836523|18949509|P1|NOT COMPLETED|Overall Study||51
7695096|NCT01836523|18949506|P4|COMPLETED|Overall Study||274
7695097|NCT01836523|18949507|P3|COMPLETED|Overall Study||258
7695098|NCT01836523|18949508|P2|COMPLETED|Overall Study||265
7695099|NCT01836523|18949509|P1|COMPLETED|Overall Study||300
7695100|NCT01836523|18949506|P4|Exposed|Overall Study||348
7695101|NCT01836523|18949507|P3|Exposed|Overall Study||347
7695102|NCT01836523|18949508|P2|Exposed|Overall Study||348
7695103|NCT01836523|18949509|P1|Exposed|Overall Study||350
7695104|NCT01836523|18949506|P4|STARTED|Overall Study||348
7695105|NCT01836523|18949507|P3|STARTED|Overall Study||349
7695106|NCT01836523|18949508|P2|STARTED|Overall Study||350
7695107|NCT01836523|18949509|P1|STARTED|Overall Study||351
7695108|NCT01836471|18949536|P5|NOT COMPLETED|Overall Study||5
7695109|NCT01836471|18949537|P4|NOT COMPLETED|Overall Study||2
7695110|NCT01836471|18949538|P3|NOT COMPLETED|Overall Study||2
7695111|NCT01836471|18949539|P2|NOT COMPLETED|Overall Study||9
7695112|NCT01836471|18949540|P1|NOT COMPLETED|Overall Study||11
7695113|NCT01836471|18949536|P5|COMPLETED|Overall Study||49
7695114|NCT01836471|18949537|P4|COMPLETED|Overall Study||40
7695115|NCT01836471|18949538|P3|COMPLETED|Overall Study||49
7695116|NCT01836471|18949539|P2|COMPLETED|Overall Study||85
7695117|NCT01836471|18949540|P1|COMPLETED|Overall Study||82
7695118|NCT01836471|18949536|P5|STARTED|Overall Study||54
7695119|NCT01836471|18949537|P4|STARTED|Overall Study||42
7695120|NCT01836471|18949538|P3|STARTED|Overall Study||51
7695121|NCT01836471|18949539|P2|STARTED|Overall Study||94
7695122|NCT01836471|18949540|P1|STARTED|Overall Study||93
7695123|NCT01836458|18949569|P4|NOT COMPLETED|Overall Study||6
7695124|NCT01836458|18949570|P3|NOT COMPLETED|Overall Study||5
7695125|NCT01836458|18949571|P2|NOT COMPLETED|Overall Study||2
7695126|NCT01836458|18949572|P1|NOT COMPLETED|Overall Study||3
7695127|NCT01836458|18949569|P4|COMPLETED|Overall Study||1
7695128|NCT01836458|18949570|P3|COMPLETED|Overall Study||2
7695129|NCT01836458|18949571|P2|COMPLETED|Overall Study||2
7695130|NCT01836458|18949572|P1|COMPLETED|Overall Study||4
7695131|NCT01836458|18949569|P4|STARTED|Overall Study||7
7695132|NCT01836458|18949570|P3|STARTED|Overall Study||7
7695133|NCT01836458|18949571|P2|STARTED|Overall Study||4
7695134|NCT01836458|18949572|P1|STARTED|Overall Study||7
7695135|NCT01836445|18949596|P2|NOT COMPLETED|12 Month STI Testing||77
7695136|NCT01836445|18949597|P1|NOT COMPLETED|12 Month STI Testing||80
7695137|NCT01836445|18949596|P2|COMPLETED|12 Month STI Testing||378
7695138|NCT01836445|18949597|P1|COMPLETED|12 Month STI Testing||365
7695139|NCT01836445|18949596|P2|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
7695140|NCT01836445|18949597|P1|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
7695141|NCT01836445|18949596|P2|NOT COMPLETED|12 Month Follow-up Assessment||64
7695142|NCT01836445|18949597|P1|NOT COMPLETED|12 Month Follow-up Assessment||75
7695143|NCT01836445|18949596|P2|COMPLETED|12 Month Follow-up Assessment||391
7695144|NCT01836445|18949597|P1|COMPLETED|12 Month Follow-up Assessment||370
7695145|NCT01836445|18949596|P2|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
7695146|NCT01836445|18949597|P1|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
7695147|NCT01836445|18949596|P2|NOT COMPLETED|6 Month Follow-up Assessment||75
7695148|NCT01836445|18949597|P1|NOT COMPLETED|6 Month Follow-up Assessment||103
7695149|NCT01836445|18949596|P2|COMPLETED|6 Month Follow-up Assessment||380
7695150|NCT01836445|18949597|P1|COMPLETED|6 Month Follow-up Assessment||342
7695151|NCT01836445|18949596|P2|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
7695152|NCT01836445|18949597|P1|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
7695153|NCT01836445|18949596|P2|NOT COMPLETED|3 Month Follow-up Assessment||47
7695154|NCT01836445|18949597|P1|NOT COMPLETED|3 Month Follow-up Assessment||97
7695155|NCT01836445|18949596|P2|COMPLETED|3 Month Follow-up Assessment||409
7695156|NCT01836445|18949597|P1|COMPLETED|3 Month Follow-up Assessment||348
7695157|NCT01836445|18949596|P2|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|456
7695158|NCT01836445|18949597|P1|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
7695159|NCT01836445|18949596|P2|NOT COMPLETED|Intervention Modules||22
7695160|NCT01836445|18949597|P1|NOT COMPLETED|Intervention Modules||70
7695161|NCT01836445|18949596|P2|COMPLETED|Intervention Modules||434
7695162|NCT01836445|18949597|P1|COMPLETED|Intervention Modules||375
7695163|NCT01836445|18949596|P2|STARTED|Intervention Modules||456
7695164|NCT01836445|18949597|P1|STARTED|Intervention Modules||445
7695165|NCT01836276|18949657|P2|NOT COMPLETED|Overall Study||51
7695166|NCT01836276|18949658|P1|NOT COMPLETED|Overall Study||28
7695167|NCT01836276|18949657|P2|COMPLETED|Overall Study||174
7695168|NCT01836276|18949658|P1|COMPLETED|Overall Study||196
7695169|NCT01836276|18949657|P2|Week 12|Overall Study||165
7695170|NCT01836276|18949658|P1|Week 12|Overall Study||183
7695171|NCT01836276|18949657|P2|Week 4|Overall Study||186
7695172|NCT01836276|18949658|P1|Week 4|Overall Study||198
7695173|NCT01836276|18949657|P2|STARTED|Overall Study||225
7695174|NCT01836276|18949658|P1|STARTED|Overall Study||224
7695175|NCT01836198|18949666|P3|NOT COMPLETED|Part B||0
7695176|NCT01836198|18949667|P2|NOT COMPLETED|Part B||0
7695177|NCT01836198|18949668|P1|NOT COMPLETED|Part B||0
7695178|NCT01836198|18949666|P3|COMPLETED|Part B||12
7695179|NCT01836198|18949667|P2|COMPLETED|Part B||0
7695180|NCT01836198|18949668|P1|COMPLETED|Part B||0
7695181|NCT01836198|18949666|P3|Received at Least 1 Dose of Study Drug|Part B||12
7695182|NCT01836198|18949667|P2|Received at Least 1 Dose of Study Drug|Part B||0
7695183|NCT01836198|18949668|P1|Received at Least 1 Dose of Study Drug|Part B||0
7695184|NCT01836198|18949666|P3|STARTED|Part B||12
7695185|NCT01836198|18949667|P2|STARTED|Part B||0
7695186|NCT01836198|18949668|P1|STARTED|Part B||0
7695187|NCT01836198|18949666|P3|NOT COMPLETED|Part A, Period 2||0
7695188|NCT01836198|18949667|P2|NOT COMPLETED|Part A, Period 2||1
7695189|NCT01836198|18949668|P1|NOT COMPLETED|Part A, Period 2||0
7695190|NCT01836198|18949666|P3|COMPLETED|Part A, Period 2||0
7695191|NCT01836198|18949667|P2|COMPLETED|Part A, Period 2||14
7695192|NCT01836198|18949668|P1|COMPLETED|Part A, Period 2||15
7695193|NCT01836198|18949666|P3|Completed Part A, Entered Part B|Part A, Period 2||0
7695194|NCT01836198|18949667|P2|Completed Part A, Entered Part B|Part A, Period 2||6
7695195|NCT01836198|18949668|P1|Completed Part A, Entered Part B|Part A, Period 2||6
7695196|NCT01836198|18949666|P3|STARTED|Part A, Period 2||0
7695197|NCT01836198|18949667|P2|STARTED|Part A, Period 2||15
7695198|NCT01836198|18949668|P1|STARTED|Part A, Period 2||15
7695199|NCT01836198|18949666|P3|NOT COMPLETED|Part A, Period 1||0
7695200|NCT01836198|18949667|P2|NOT COMPLETED|Part A, Period 1||0
7695201|NCT01836198|18949668|P1|NOT COMPLETED|Part A, Period 1||0
7695202|NCT01836198|18949666|P3|COMPLETED|Part A, Period 1||0
7695203|NCT01836198|18949667|P2|COMPLETED|Part A, Period 1||15
7695204|NCT01836198|18949668|P1|COMPLETED|Part A, Period 1||15
7695205|NCT01836198|18949666|P3|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
7695206|NCT01836198|18949667|P2|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
7695207|NCT01836198|18949668|P1|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
7695208|NCT01836198|18949666|P3|STARTED|Part A, Period 1||0
7695209|NCT01836198|18949667|P2|STARTED|Part A, Period 1||15
7695210|NCT01836198|18949668|P1|STARTED|Part A, Period 1||15
7695211|NCT01836185|18949694|P4|NOT COMPLETED|Overall Study||0
7695212|NCT01836185|18949695|P3|NOT COMPLETED|Overall Study||0
7695213|NCT01836185|18949696|P2|NOT COMPLETED|Overall Study||0
7695214|NCT01836185|18949697|P1|NOT COMPLETED|Overall Study||0
7695215|NCT01836185|18949694|P4|COMPLETED|Overall Study||6
7695216|NCT01836185|18949695|P3|COMPLETED|Overall Study||8
7695217|NCT01836185|18949696|P2|COMPLETED|Overall Study||8
7695218|NCT01836185|18949697|P1|COMPLETED|Overall Study||10
7695219|NCT01836185|18949694|P4|Received Single Dose of Study Treatment|Overall Study||6
7695220|NCT01836185|18949695|P3|Received Single Dose of Study Treatment|Overall Study||8
7695221|NCT01836185|18949696|P2|Received Single Dose of Study Treatment|Overall Study||8
7695222|NCT01836185|18949697|P1|Received Single Dose of Study Treatment|Overall Study||10
7695223|NCT01836185|18949694|P4|STARTED|Overall Study||6
7695224|NCT01836185|18949695|P3|STARTED|Overall Study||8
7695225|NCT01836185|18949696|P2|STARTED|Overall Study||8
7695226|NCT01836185|18949697|P1|STARTED|Overall Study||10
7695227|NCT01836133|18949715|P1|NOT COMPLETED|Overall Study||0
7695228|NCT01836133|18949715|P1|COMPLETED|Overall Study||70
7695229|NCT01836133|18949715|P1|STARTED|Overall Study||70
7695230|NCT01836042|18949724|P3|NOT COMPLETED|Overall Study||0
7695231|NCT01836042|18949725|P2|NOT COMPLETED|Overall Study||0
7695232|NCT01836042|18949726|P1|NOT COMPLETED|Overall Study||0
7695233|NCT01836042|18949724|P3|COMPLETED|Overall Study||22
7695234|NCT01836042|18949725|P2|COMPLETED|Overall Study||35
7695235|NCT01836042|18949726|P1|COMPLETED|Overall Study||51
7695236|NCT01836042|18949724|P3|STARTED|Overall Study||22
7695237|NCT01836042|18949725|P2|STARTED|Overall Study||35
7695238|NCT01836042|18949726|P1|STARTED|Overall Study||51
7695239|NCT01836029|18949736|P2|NOT COMPLETED|Overall Study||0
7695240|NCT01836029|18949737|P1|NOT COMPLETED|Overall Study||0
7695241|NCT01836029|18949736|P2|COMPLETED|Overall Study||95
7695242|NCT01836029|18949737|P1|COMPLETED|Overall Study||100
7695243|NCT01836029|18949736|P2|STARTED|Overall Study||95
7695244|NCT01836029|18949737|P1|STARTED|Overall Study||100
7695245|NCT01835912|18949749|P1|NOT COMPLETED|Overall Study||0
7695246|NCT01835912|18949749|P1|COMPLETED|Overall Study||10
7695247|NCT01835912|18949749|P1|Chronic Placebo|Overall Study||10
7695248|NCT01835912|18949749|P1|Chronic|Overall Study||10
7695249|NCT01835912|18949749|P1|Acute Placebo|Overall Study||10
7695250|NCT01835912|18949749|P1|Acute|Overall Study||10
7695251|NCT01835912|18949749|P1|STARTED|Overall Study||10
7695252|NCT01835899|18949770|P3|NOT COMPLETED|Overall Study||1
7695253|NCT01835899|18949771|P2|NOT COMPLETED|Overall Study||1
7695254|NCT01835899|18949772|P1|NOT COMPLETED|Overall Study||0
7695255|NCT01835899|18949770|P3|COMPLETED|Overall Study||8
7695256|NCT01835899|18949771|P2|COMPLETED|Overall Study||8
7695257|NCT01835899|18949772|P1|COMPLETED|Overall Study||6
7695258|NCT01835899|18949770|P3|STARTED|Overall Study||9
7695259|NCT01835899|18949771|P2|STARTED|Overall Study||9
7695260|NCT01835899|18949772|P1|STARTED|Overall Study||6
7695261|NCT01835756|18949792|P2|NOT COMPLETED|Overall Study||0
7695262|NCT01835756|18949793|P1|NOT COMPLETED|Overall Study||0
7695263|NCT01835756|18949792|P2|COMPLETED|Overall Study||31
7695264|NCT01835756|18949793|P1|COMPLETED|Overall Study||31
7695265|NCT01835756|18949792|P2|STARTED|Overall Study||31
7695266|NCT01835756|18949793|P1|STARTED|Overall Study||31
7695267|NCT01835743|18949805|P2|NOT COMPLETED|Overall Study||0
7695268|NCT01835743|18949806|P1|NOT COMPLETED|Overall Study||0
7695269|NCT01835743|18949805|P2|COMPLETED|Overall Study||32
7695270|NCT01835743|18949806|P1|COMPLETED|Overall Study||37
7695271|NCT01835743|18949805|P2|STARTED|Overall Study||32
7695272|NCT01835743|18949806|P1|STARTED|Overall Study||37
7695273|NCT01835626|18949814|P1|NOT COMPLETED|Overall Study||0
7695274|NCT01835626|18949814|P1|COMPLETED|Overall Study||24
7695275|NCT01835626|18949814|P1|STARTED|Overall Study||24
7695276|NCT01835587|18949829|P4|NOT COMPLETED|Overall Study||9
7695277|NCT01835587|18949830|P3|NOT COMPLETED|Overall Study||2
7695278|NCT01835587|18949831|P2|NOT COMPLETED|Overall Study||4
7695279|NCT01835587|18949832|P1|NOT COMPLETED|Overall Study||2
7695280|NCT01835587|18949829|P4|COMPLETED|Overall Study||10
7695281|NCT01835587|18949830|P3|COMPLETED|Overall Study||2
7695282|NCT01835587|18949831|P2|COMPLETED|Overall Study||0
7695283|NCT01835587|18949832|P1|COMPLETED|Overall Study||1
7695284|NCT01835587|18949829|P4|STARTED|Overall Study||19
7695285|NCT01835587|18949830|P3|STARTED|Overall Study||4
7695286|NCT01835587|18949831|P2|STARTED|Overall Study||4
7695287|NCT01835587|18949832|P1|STARTED|Overall Study||3
7695288|NCT01835548|18949893|P3|NOT COMPLETED|Double-Blind Treatment Period||0
7695289|NCT01835548|18949894|P2|NOT COMPLETED|Double-Blind Treatment Period||2
7695290|NCT01835548|18949895|P1|NOT COMPLETED|Double-Blind Treatment Period||0
7695291|NCT01835548|18949893|P3|COMPLETED|Double-Blind Treatment Period||0
7695292|NCT01835548|18949894|P2|COMPLETED|Double-Blind Treatment Period||39
7695293|NCT01835548|18949895|P1|COMPLETED|Double-Blind Treatment Period||44
7695294|NCT01835548|18949893|P3|STARTED|Double-Blind Treatment Period||0
7695295|NCT01835548|18949894|P2|STARTED|Double-Blind Treatment Period||41
7695296|NCT01835548|18949895|P1|STARTED|Double-Blind Treatment Period||44
7695297|NCT01835548|18949893|P3|NOT COMPLETED|Dose Stabilization Period||0
7695298|NCT01835548|18949894|P2|NOT COMPLETED|Dose Stabilization Period||0
7695299|NCT01835548|18949895|P1|NOT COMPLETED|Dose Stabilization Period||0
7695300|NCT01835548|18949893|P3|COMPLETED|Dose Stabilization Period||85
7695301|NCT01835548|18949894|P2|COMPLETED|Dose Stabilization Period||0
7695302|NCT01835548|18949895|P1|COMPLETED|Dose Stabilization Period||0
7695303|NCT01835548|18949893|P3|STARTED|Dose Stabilization Period||85
7695304|NCT01835548|18949894|P2|STARTED|Dose Stabilization Period||0
7695305|NCT01835548|18949895|P1|STARTED|Dose Stabilization Period||0
7695306|NCT01835548|18949893|P3|NOT COMPLETED|Dose Optimization Period||2
7695307|NCT01835548|18949894|P2|NOT COMPLETED|Dose Optimization Period||0
7695308|NCT01835548|18949895|P1|NOT COMPLETED|Dose Optimization Period||0
7695309|NCT01835548|18949893|P3|COMPLETED|Dose Optimization Period||85
7695310|NCT01835548|18949894|P2|COMPLETED|Dose Optimization Period||0
7695311|NCT01835548|18949895|P1|COMPLETED|Dose Optimization Period||0
7695312|NCT01835548|18949893|P3|STARTED|Dose Optimization Period||87
7695313|NCT01835548|18949894|P2|STARTED|Dose Optimization Period||0
7695314|NCT01835548|18949895|P1|STARTED|Dose Optimization Period||0
7695315|NCT01835548|18949893|P3|NOT COMPLETED|Screening/Washout Period||0
7695316|NCT01835548|18949894|P2|NOT COMPLETED|Screening/Washout Period||0
7695317|NCT01835548|18949895|P1|NOT COMPLETED|Screening/Washout Period||0
7695318|NCT01835548|18949893|P3|COMPLETED|Screening/Washout Period||87
7695319|NCT01835548|18949894|P2|COMPLETED|Screening/Washout Period||0
7695320|NCT01835548|18949895|P1|COMPLETED|Screening/Washout Period||0
7695321|NCT01835548|18949893|P3|STARTED|Screening/Washout Period||87
7695322|NCT01835548|18949894|P2|STARTED|Screening/Washout Period||0
7695323|NCT01835548|18949895|P1|STARTED|Screening/Washout Period||0
7695324|NCT01835496|18949915|P1|NOT COMPLETED|Overall Study||0
7695325|NCT01835496|18949915|P1|COMPLETED|Overall Study||8
7695326|NCT01835496|18949915|P1|STARTED|Overall Study||8
7695327|NCT01835470|18949924|P1|NOT COMPLETED|Long Term Treatment Period||4
7695328|NCT01835470|18949924|P1|COMPLETED|Long Term Treatment Period|Completed LT period|16
7695329|NCT01835470|18949924|P1|STARTED|Long Term Treatment Period||20
7695330|NCT01835470|18949924|P1|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0
7695331|NCT01835470|18949924|P1|COMPLETED|Short Term Treatment Period (to Week 16)||20
7695332|NCT01835470|18949924|P1|STARTED|Short Term Treatment Period (to Week 16)||20
7695333|NCT01835431|18949936|P2|NOT COMPLETED|Overall Study||12
7695334|NCT01835431|18949937|P1|NOT COMPLETED|Overall Study||8
7695335|NCT01835431|18949936|P2|COMPLETED|Overall Study||168
7695336|NCT01835431|18949937|P1|COMPLETED|Overall Study||174
7695337|NCT01835431|18949936|P2|Exposed|Overall Study|One subject was withdrawn before exposure|179
7695338|NCT01835431|18949937|P1|Exposed|Overall Study|One subject was withdrawn before exposure.|181
7695339|NCT01835431|18949936|P2|STARTED|Overall Study||180
7695340|NCT01835431|18949937|P1|STARTED|Overall Study||182
7695341|NCT01835379|18949957|P2|NOT COMPLETED|Overall Study||0
7695342|NCT01835379|18949958|P1|NOT COMPLETED|Overall Study||0
7695343|NCT01835379|18949957|P2|COMPLETED|Overall Study||41
7695344|NCT01835379|18949958|P1|COMPLETED|Overall Study||41
7695345|NCT01835379|18949957|P2|STARTED|Overall Study||41
7695346|NCT01835379|18949958|P1|STARTED|Overall Study||41
7695347|NCT01835262|18949968|P2|NOT COMPLETED|Overall Study||0
7695348|NCT01835262|18949969|P1|NOT COMPLETED|Overall Study||0
7695349|NCT01835262|18949968|P2|COMPLETED|Overall Study||45
7695350|NCT01835262|18949969|P1|COMPLETED|Overall Study||45
7695351|NCT01835262|18949968|P2|STARTED|Overall Study||45
7695352|NCT01835262|18949969|P1|STARTED|Overall Study||45
7695353|NCT01835223|18949977|P2|NOT COMPLETED|Overall Study||1
7695354|NCT01835223|18949978|P1|NOT COMPLETED|Overall Study||9
7695355|NCT01835223|18949977|P2|COMPLETED|Overall Study||2
7695356|NCT01835223|18949978|P1|COMPLETED|Overall Study||21
7695357|NCT01835223|18949977|P2|STARTED|Overall Study||3
7695358|NCT01835223|18949978|P1|STARTED|Overall Study||30
7695359|NCT01835158|18949998|P2|NOT COMPLETED|Overall Study||6
7695360|NCT01835158|18949999|P1|NOT COMPLETED|Overall Study||1
7695361|NCT01835158|18949998|P2|COMPLETED|Overall Study||72
7695362|NCT01835158|18949999|P1|COMPLETED|Overall Study||78
7695363|NCT01835158|18949998|P2|STARTED|Overall Study||78
7695364|NCT01835158|18949999|P1|STARTED|Overall Study||79
7695365|NCT01835145|18950011|P2|NOT COMPLETED|Overall Study||0
7695366|NCT01835145|18950012|P1|NOT COMPLETED|Overall Study||1
7695367|NCT01835145|18950011|P2|COMPLETED|Overall Study||15
7695368|NCT01835145|18950012|P1|COMPLETED|Overall Study||31
7695369|NCT01835145|18950011|P2|STARTED|Overall Study||15
7695370|NCT01835145|18950012|P1|STARTED|Overall Study||32
7695371|NCT01835132|18950027|P1|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0
7695372|NCT01835132|18950027|P1|COMPLETED|2nd Extension Phase - As Needed (PRN)||3
7695373|NCT01835132|18950027|P1|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3
7695374|NCT01835132|18950027|P1|NOT COMPLETED|1st Extension Phase||0
7695375|NCT01835132|18950027|P1|COMPLETED|1st Extension Phase|Completed 52 Weeks|6
7695376|NCT01835132|18950027|P1|STARTED|1st Extension Phase||6
7695377|NCT01835132|18950027|P1|NOT COMPLETED|Initial Phase||2
7695378|NCT01835132|18950027|P1|COMPLETED|Initial Phase||6
7695379|NCT01835132|18950027|P1|STARTED|Initial Phase||8
7695380|NCT01835015|18950072|P5|NOT COMPLETED|Overall Study||0
7695381|NCT01835015|18950073|P4|NOT COMPLETED|Overall Study||0
7695382|NCT01835015|18950074|P3|NOT COMPLETED|Overall Study||1
7695383|NCT01835015|18950075|P2|NOT COMPLETED|Overall Study||0
7695384|NCT01835015|18950076|P1|NOT COMPLETED|Overall Study||0
7695385|NCT01835015|18950072|P5|COMPLETED|Overall Study||6
7695386|NCT01835015|18950073|P4|COMPLETED|Overall Study||6
7695387|NCT01835015|18950074|P3|COMPLETED|Overall Study||6
7695388|NCT01835015|18950075|P2|COMPLETED|Overall Study||6
7695389|NCT01835015|18950076|P1|COMPLETED|Overall Study||6
7695390|NCT01835015|18950072|P5|STARTED|Overall Study||6
7695391|NCT01835015|18950073|P4|STARTED|Overall Study||6
7695392|NCT01835015|18950074|P3|STARTED|Overall Study||7
7695393|NCT01835015|18950075|P2|STARTED|Overall Study||6
7695394|NCT01835015|18950076|P1|STARTED|Overall Study||6
7695395|NCT01834729|18950153|P4|NOT COMPLETED|Overall Study||2
7695396|NCT01834729|18950154|P3|NOT COMPLETED|Overall Study||3
7695397|NCT01834729|18950155|P2|NOT COMPLETED|Overall Study||1
7695398|NCT01834729|18950156|P1|NOT COMPLETED|Overall Study||1
7695399|NCT01834729|18950153|P4|COMPLETED|Overall Study||16
7695400|NCT01834729|18950154|P3|COMPLETED|Overall Study||15
7695401|NCT01834729|18950155|P2|COMPLETED|Overall Study||19
7695402|NCT01834729|18950156|P1|COMPLETED|Overall Study||17
7695403|NCT01834729|18950153|P4|STARTED|Overall Study||18
7695404|NCT01834729|18950154|P3|STARTED|Overall Study||18
7695405|NCT01834729|18950155|P2|STARTED|Overall Study||20
7695406|NCT01834729|18950156|P1|STARTED|Overall Study||18
7695407|NCT01834716|18950172|P2|NOT COMPLETED|Overall Study||1
7695408|NCT01834716|18950173|P1|NOT COMPLETED|Overall Study||0
7695409|NCT01834716|18950172|P2|COMPLETED|Overall Study||11
7695410|NCT01834716|18950173|P1|COMPLETED|Overall Study||4
7695411|NCT01834716|18950172|P2|STARTED|Overall Study||12
7695412|NCT01834716|18950173|P1|STARTED|Overall Study||4
7695413|NCT01834651|18950179|P1|NOT COMPLETED|Overall Study||1
7695414|NCT01834651|18950179|P1|COMPLETED|Overall Study|Evaluable for primary outcome assessment at 12 weeks|16
7695415|NCT01834651|18950179|P1|STARTED|Overall Study||17
7695416|NCT01834586|18950189|P1|NOT COMPLETED|Overall Study||1
7695417|NCT01834586|18950189|P1|COMPLETED|Overall Study||29
7695418|NCT01834586|18950189|P1|STARTED|Overall Study||30
7695419|NCT01834404|18950196|P2|NOT COMPLETED|Overall Study||0
7695420|NCT01834404|18950197|P1|NOT COMPLETED|Overall Study||0
7695421|NCT01834404|18950196|P2|COMPLETED|Overall Study||12
7695422|NCT01834404|18950197|P1|COMPLETED|Overall Study||12
7695423|NCT01834404|18950196|P2|STARTED|Overall Study||12
7695424|NCT01834404|18950197|P1|STARTED|Overall Study||12
7695425|NCT01834274|18950229|P2|NOT COMPLETED|Overall Study||41
7695426|NCT01834274|18950230|P1|NOT COMPLETED|Overall Study||47
7695427|NCT01834274|18950229|P2|COMPLETED|Overall Study||5
7695428|NCT01834274|18950230|P1|COMPLETED|Overall Study||3
7695429|NCT01834274|18950229|P2|STARTED|Overall Study||46
7695430|NCT01834274|18950230|P1|STARTED|Overall Study||50
7695431|NCT01834261|18950242|P2|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
7695432|NCT01834261|18950243|P1|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
7695433|NCT01834261|18950242|P2|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10
7695434|NCT01834261|18950243|P1|COMPLETED|MGH Rest + Nueroeconomic Task fMRI|Enrollment completed in May 2015.|10
7695435|NCT01834261|18950242|P2|STARTED|MGH Rest + Nueroeconomic Task fMRI||10
7695436|NCT01834261|18950243|P1|STARTED|MGH Rest + Nueroeconomic Task fMRI|Subjects who dropped out/were excluded (10), did so before they received either Oxytocin or Placebo.|10
7695437|NCT01834261|18950242|P2|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
7695438|NCT01834261|18950243|P1|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
7695439|NCT01834261|18950242|P2|COMPLETED|MIT fMRI and MEG Resting State Study||9
7695440|NCT01834261|18950243|P1|COMPLETED|MIT fMRI and MEG Resting State Study|Enrollment completed in March 2014.|10
7695441|NCT01834261|18950242|P2|STARTED|MIT fMRI and MEG Resting State Study||10
7695442|NCT01834261|18950243|P1|STARTED|MIT fMRI and MEG Resting State Study||11
7695443|NCT01834222|18950253|P1|NOT COMPLETED|Overall Study||1
7695444|NCT01834222|18950253|P1|COMPLETED|Overall Study||658
7695445|NCT01834222|18950253|P1|Treated|Overall Study||658
7695446|NCT01834222|18950253|P1|STARTED|Overall Study||659
7695447|NCT01834144|18950264|P2|NOT COMPLETED|Overall Study||1
7695448|NCT01834144|18950265|P1|NOT COMPLETED|Overall Study||0
7695449|NCT01834144|18950264|P2|COMPLETED|Overall Study||2
7695450|NCT01834144|18950265|P1|COMPLETED|Overall Study||1
7695451|NCT01834144|18950264|P2|STARTED|Overall Study||3
7695452|NCT01834144|18950265|P1|STARTED|Overall Study||1
7695453|NCT01834027|18950273|P2|NOT COMPLETED|Overall Study||0
7695454|NCT01834027|18950274|P1|NOT COMPLETED|Overall Study||0
7695455|NCT01834027|18950273|P2|COMPLETED|Overall Study||28
7695456|NCT01834027|18950274|P1|COMPLETED|Overall Study||28
7695457|NCT01834027|18950273|P2|STARTED|Overall Study||28
7695458|NCT01834027|18950274|P1|STARTED|Overall Study||28
7695459|NCT01833988|18950284|P2|NOT COMPLETED|Overall Study||0
7695460|NCT01833988|18950285|P1|NOT COMPLETED|Overall Study||0
7695461|NCT01833988|18950284|P2|COMPLETED|Overall Study||16
7695462|NCT01833988|18950285|P1|COMPLETED|Overall Study||16
7695463|NCT01833988|18950284|P2|STARTED|Overall Study||16
7695464|NCT01833988|18950285|P1|STARTED|Overall Study||16
7695465|NCT01833936|18950341|P2|NOT COMPLETED|Overall Study||2
7695466|NCT01833936|18950342|P1|NOT COMPLETED|Overall Study||4
7695467|NCT01833936|18950341|P2|COMPLETED|Overall Study||18
7695468|NCT01833936|18950342|P1|COMPLETED|Overall Study||16
7695469|NCT01833936|18950341|P2|STARTED|Overall Study||20
7695470|NCT01833936|18950342|P1|STARTED|Overall Study||20
7695471|NCT01833897|18950348|P1|NOT COMPLETED|Overall Study||1
7695472|NCT01833897|18950348|P1|COMPLETED|Overall Study||7
7695473|NCT01833897|18950348|P1|STARTED|Overall Study||8
7695474|NCT01833845|18950356|P1|NOT COMPLETED|Overall Study||0
7695475|NCT01833845|18950356|P1|COMPLETED|Overall Study||4
7695476|NCT01833845|18950356|P1|STARTED|Overall Study||4
7695477|NCT01833832|18950360|P1|NOT COMPLETED|Overall Study||1
7695478|NCT01833832|18950360|P1|COMPLETED|Overall Study||10
7695479|NCT01833832|18950360|P1|STARTED|Overall Study||11
7695480|NCT01833754|18950371|P3|NOT COMPLETED|Overall Study||0
7695481|NCT01833754|18950372|P2|NOT COMPLETED|Overall Study||0
7695482|NCT01833754|18950373|P1|NOT COMPLETED|Overall Study||0
7695483|NCT01833754|18950371|P3|COMPLETED|Overall Study||8
7695484|NCT01833754|18950372|P2|COMPLETED|Overall Study||8
7695485|NCT01833754|18950373|P1|COMPLETED|Overall Study||8
7695486|NCT01833754|18950371|P3|STARTED|Overall Study||8
7695487|NCT01833754|18950372|P2|STARTED|Overall Study||8
7695488|NCT01833754|18950373|P1|STARTED|Overall Study||8
7695489|NCT01833741|18950402|P1|NOT COMPLETED|Overall Study||140
7695490|NCT01833741|18950402|P1|COMPLETED|Overall Study||997
7695491|NCT01833741|18950402|P1|STARTED|Overall Study||1137
7695492|NCT01833546|18950419|P4|NOT COMPLETED|Overall Study||0
7695493|NCT01833546|18950420|P3|NOT COMPLETED|Overall Study||0
7695494|NCT01833546|18950421|P2|NOT COMPLETED|Overall Study||0
7695495|NCT01833546|18950422|P1|NOT COMPLETED|Overall Study||0
7695496|NCT01833546|18950419|P4|COMPLETED|Overall Study||6
7695497|NCT01833546|18950420|P3|COMPLETED|Overall Study||8
7695498|NCT01833546|18950421|P2|COMPLETED|Overall Study||3
7695499|NCT01833546|18950422|P1|COMPLETED|Overall Study||3
7695500|NCT01833546|18950419|P4|STARTED|Overall Study||6
7695501|NCT01833546|18950420|P3|STARTED|Overall Study||8
7695502|NCT01833546|18950421|P2|STARTED|Overall Study||3
7695503|NCT01833546|18950422|P1|STARTED|Overall Study||3
7695504|NCT01833533|18950515|P2|NOT COMPLETED|Overall Study||21
7695505|NCT01833533|18950516|P1|NOT COMPLETED|Overall Study||6
7695506|NCT01833533|18950515|P2|COMPLETED|Overall Study||184
7695507|NCT01833533|18950516|P1|COMPLETED|Overall Study||94
7695508|NCT01833533|18950515|P2|STARTED|Overall Study||205
7695509|NCT01833533|18950516|P1|STARTED|Overall Study||100
7695510|NCT01833494|18950530|P1|NOT COMPLETED|Overall Study||45
7695511|NCT01833494|18950530|P1|COMPLETED|Overall Study||116
7695512|NCT01833494|18950530|P1|STARTED|Overall Study||161
7695513|NCT01833481|18950540|P3|NOT COMPLETED|Overall Study||0
7695514|NCT01833481|18950541|P2|NOT COMPLETED|Overall Study||0
7695515|NCT01833481|18950542|P1|NOT COMPLETED|Overall Study||0
7695516|NCT01833481|18950540|P3|COMPLETED|Overall Study||10
7695517|NCT01833481|18950541|P2|COMPLETED|Overall Study||10
7695518|NCT01833481|18950542|P1|COMPLETED|Overall Study||10
7695519|NCT01833481|18950540|P3|STARTED|Overall Study||10
7695520|NCT01833481|18950541|P2|STARTED|Overall Study||10
7695521|NCT01833481|18950542|P1|STARTED|Overall Study||10
7695522|NCT01833455|18950558|P2|NOT COMPLETED|Overall Study||0
7695523|NCT01833455|18950559|P1|NOT COMPLETED|Overall Study||1
7695524|NCT01833455|18950558|P2|COMPLETED|Overall Study||4
7695525|NCT01833455|18950559|P1|COMPLETED|Overall Study||3
7695526|NCT01833455|18950558|P2|Completed 2nd Baseline (Washout)|Overall Study||4
7695527|NCT01833455|18950559|P1|Completed 2nd Baseline (Washout)|Overall Study||3
7695528|NCT01833455|18950558|P2|Completed 1st Intervention|Overall Study||4
7695529|NCT01833455|18950559|P1|Completed 1st Intervention|Overall Study||3
7695530|NCT01833455|18950558|P2|Completed 1st Baseline|Overall Study||4
7695531|NCT01833455|18950559|P1|Completed 1st Baseline|Overall Study||4
7695532|NCT01833455|18950558|P2|STARTED|Overall Study||4
7695533|NCT01833455|18950559|P1|STARTED|Overall Study||4
7695534|NCT01833403|18950577|P1|NOT COMPLETED|Overall Study||0
7695535|NCT01833403|18950577|P1|COMPLETED|Overall Study||4
7695536|NCT01833403|18950577|P1|STARTED|Overall Study||4
7695537|NCT01833247|18950582|P1|NOT COMPLETED|Overall Study||0
7695538|NCT01833247|18950582|P1|COMPLETED|Overall Study||12
7695539|NCT01833247|18950582|P1|STARTED|Overall Study||12
7695540|NCT01833169|18950588|P1|NOT COMPLETED|Overall Study||146
7695541|NCT01833169|18950588|P1|COMPLETED|Overall Study||0
7695542|NCT01833169|18950588|P1|Consented to be Followed for Survival|Overall Study||128
7695543|NCT01833169|18950588|P1|STARTED|Overall Study||146
7695544|NCT01833143|18950599|P1|NOT COMPLETED|Overall Study||1
7695545|NCT01833143|18950599|P1|COMPLETED|Overall Study||16
7695546|NCT01833143|18950599|P1|STARTED|Overall Study||17
7695547|NCT01833130|18950608|P2|NOT COMPLETED|Overall Study||19
7695548|NCT01833130|18950609|P1|NOT COMPLETED|Overall Study||10
7695549|NCT01833130|18950608|P2|COMPLETED|Overall Study||8
7695550|NCT01833130|18950609|P1|COMPLETED|Overall Study||15
7695551|NCT01833130|18950608|P2|STARTED|Overall Study||27
7695552|NCT01833130|18950609|P1|STARTED|Overall Study||25
7695553|NCT01833117|18950647|P2|NOT COMPLETED|Overall Study||0
7695554|NCT01833117|18950648|P1|NOT COMPLETED|Overall Study||0
7695555|NCT01833117|18950647|P2|COMPLETED|Overall Study||19
7695556|NCT01833117|18950648|P1|COMPLETED|Overall Study||43
7695557|NCT01833117|18950647|P2|STARTED|Overall Study||19
7695558|NCT01833117|18950648|P1|STARTED|Overall Study||43
7695559|NCT01833078|18950656|P1|NOT COMPLETED|Overall Study||0
7695560|NCT01833078|18950656|P1|COMPLETED|Overall Study||5
7695561|NCT01833078|18950656|P1|STARTED|Overall Study||5
7695562|NCT01833065|18950664|P5|NOT COMPLETED|Overall Study||36
7695563|NCT01833065|18950665|P4|NOT COMPLETED|Overall Study||9
7695564|NCT01833065|18950666|P3|NOT COMPLETED|Overall Study||12
7695565|NCT01833065|18950667|P2|NOT COMPLETED|Overall Study||13
7695566|NCT01833065|18950668|P1|NOT COMPLETED|Overall Study||24
7695567|NCT01833065|18950664|P5|COMPLETED|Overall Study||74
7695568|NCT01833065|18950665|P4|COMPLETED|Overall Study||41
7695569|NCT01833065|18950666|P3|COMPLETED|Overall Study||23
7695570|NCT01833065|18950667|P2|COMPLETED|Overall Study||40
7695571|NCT01833065|18950668|P1|COMPLETED|Overall Study||41
7695572|NCT01833065|18950664|P5|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111
7695573|NCT01833065|18950665|P4|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
7695574|NCT01833065|18950666|P3|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
7695575|NCT01833065|18950667|P2|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53
7695576|NCT01833065|18950668|P1|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
7695577|NCT01833065|18950664|P5|STARTED|Overall Study|Randomized patients - As treated|110
7695578|NCT01833065|18950665|P4|STARTED|Overall Study|Randomized patients - As treated|50
7695579|NCT01833065|18950666|P3|STARTED|Overall Study|Randomized patients - As treated|35
7695580|NCT01833065|18950667|P2|STARTED|Overall Study|Randomized patients - As treated|53
7695581|NCT01833065|18950668|P1|STARTED|Overall Study|Randomized patients - As treated|65
7695582|NCT01833026|18950701|P2|NOT COMPLETED|Overall Study||0
7695583|NCT01833026|18950702|P1|NOT COMPLETED|Overall Study||0
7695584|NCT01833026|18950701|P2|COMPLETED|Overall Study||34
7695585|NCT01833026|18950702|P1|COMPLETED|Overall Study||22
7695586|NCT01833026|18950701|P2|STARTED|Overall Study||34
7695587|NCT01833026|18950702|P1|STARTED|Overall Study||22
7695588|NCT01832961|18950708|P2|NOT COMPLETED|Third Intervention||0
7695589|NCT01832961|18950709|P1|NOT COMPLETED|Third Intervention||0
7695590|NCT01832961|18950708|P2|COMPLETED|Third Intervention||7
7695591|NCT01832961|18950709|P1|COMPLETED|Third Intervention||8
7695592|NCT01832961|18950708|P2|STARTED|Third Intervention||7
7695593|NCT01832961|18950709|P1|STARTED|Third Intervention||8
7695594|NCT01832961|18950708|P2|NOT COMPLETED|Second Intervention||0
7695595|NCT01832961|18950709|P1|NOT COMPLETED|Second Intervention||0
7695596|NCT01832961|18950708|P2|COMPLETED|Second Intervention||7
7695597|NCT01832961|18950709|P1|COMPLETED|Second Intervention||8
7695598|NCT01832961|18950708|P2|STARTED|Second Intervention||7
7695599|NCT01832961|18950709|P1|STARTED|Second Intervention||8
7695600|NCT01832961|18950708|P2|NOT COMPLETED|Washout||0
7695601|NCT01832961|18950709|P1|NOT COMPLETED|Washout||0
7695602|NCT01832961|18950708|P2|COMPLETED|Washout||7
7695603|NCT01832961|18950709|P1|COMPLETED|Washout||8
7695604|NCT01832961|18950708|P2|STARTED|Washout||7
7695605|NCT01832961|18950709|P1|STARTED|Washout||8
7695606|NCT01832961|18950708|P2|NOT COMPLETED|First Intervention||0
7695607|NCT01832961|18950709|P1|NOT COMPLETED|First Intervention||0
7695608|NCT01832961|18950708|P2|COMPLETED|First Intervention||7
7695609|NCT01832961|18950709|P1|COMPLETED|First Intervention||8
7695610|NCT01832961|18950708|P2|STARTED|First Intervention||7
7695611|NCT01832961|18950709|P1|STARTED|First Intervention||8
7695612|NCT01832818|18950737|P1|NOT COMPLETED|Overall Study||6
7695613|NCT01832818|18950737|P1|COMPLETED|Overall Study||8
7695614|NCT01832818|18950737|P1|STARTED|Overall Study||14
7695615|NCT01832766|18950746|P2|NOT COMPLETED|Second Intervention||0
7695616|NCT01832766|18950747|P1|NOT COMPLETED|Second Intervention||0
7695617|NCT01832766|18950746|P2|COMPLETED|Second Intervention||5
7695618|NCT01832766|18950747|P1|COMPLETED|Second Intervention||7
7695619|NCT01832766|18950746|P2|STARTED|Second Intervention||5
7695620|NCT01832766|18950747|P1|STARTED|Second Intervention||7
7695621|NCT01832766|18950746|P2|NOT COMPLETED|Washout||1
7695622|NCT01832766|18950747|P1|NOT COMPLETED|Washout||0
7695623|NCT01832766|18950746|P2|COMPLETED|Washout||5
7695624|NCT01832766|18950747|P1|COMPLETED|Washout||7
7695625|NCT01832766|18950746|P2|STARTED|Washout||6
7695626|NCT01832766|18950747|P1|STARTED|Washout||7
7695627|NCT01832766|18950746|P2|NOT COMPLETED|First Intervention||0
7695628|NCT01832766|18950747|P1|NOT COMPLETED|First Intervention||0
7695629|NCT01832766|18950746|P2|COMPLETED|First Intervention|one participant did not return for cross over visit|6
7695630|NCT01832766|18950747|P1|COMPLETED|First Intervention||7
7695631|NCT01832766|18950746|P2|STARTED|First Intervention||6
7695632|NCT01832766|18950747|P1|STARTED|First Intervention||7
7695809|NCT01831804|18951208|P1|NOT COMPLETED|Overall Study||1
7695633|NCT01832753|18950760|P3|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
7695634|NCT01832753|18950761|P2|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
7695635|NCT01832753|18950762|P1|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
7695636|NCT01832753|18950760|P3|COMPLETED|Open Label Dose Phase (Months 12-18)||0
7695637|NCT01832753|18950761|P2|COMPLETED|Open Label Dose Phase (Months 12-18)||3
7695638|NCT01832753|18950762|P1|COMPLETED|Open Label Dose Phase (Months 12-18)||3
7695639|NCT01832753|18950760|P3|STARTED|Open Label Dose Phase (Months 12-18)||0
7695640|NCT01832753|18950761|P2|STARTED|Open Label Dose Phase (Months 12-18)||3
7695641|NCT01832753|18950762|P1|STARTED|Open Label Dose Phase (Months 12-18)||3
7695642|NCT01832753|18950760|P3|NOT COMPLETED|Randomization Phase (Months 6-12)||0
7695643|NCT01832753|18950761|P2|NOT COMPLETED|Randomization Phase (Months 6-12)||1
7695644|NCT01832753|18950762|P1|NOT COMPLETED|Randomization Phase (Months 6-12)||1
7695645|NCT01832753|18950760|P3|COMPLETED|Randomization Phase (Months 6-12)||0
7695646|NCT01832753|18950761|P2|COMPLETED|Randomization Phase (Months 6-12)||3
7695647|NCT01832753|18950762|P1|COMPLETED|Randomization Phase (Months 6-12)||4
7695648|NCT01832753|18950760|P3|STARTED|Randomization Phase (Months 6-12)|1 subject was not randomized as they did not meet inclusion criteria at the end of observation phase|0
7695649|NCT01832753|18950761|P2|STARTED|Randomization Phase (Months 6-12)||4
7695650|NCT01832753|18950762|P1|STARTED|Randomization Phase (Months 6-12)||5
7695651|NCT01832753|18950760|P3|NOT COMPLETED|Observation Phase (Months 0-6)||2
7695652|NCT01832753|18950761|P2|NOT COMPLETED|Observation Phase (Months 0-6)||0
7695653|NCT01832753|18950762|P1|NOT COMPLETED|Observation Phase (Months 0-6)||0
7695654|NCT01832753|18950760|P3|COMPLETED|Observation Phase (Months 0-6)||1
7695655|NCT01832753|18950761|P2|COMPLETED|Observation Phase (Months 0-6)||4
7695656|NCT01832753|18950762|P1|COMPLETED|Observation Phase (Months 0-6)||5
7695657|NCT01832753|18950760|P3|STARTED|Observation Phase (Months 0-6)||3
7695658|NCT01832753|18950761|P2|STARTED|Observation Phase (Months 0-6)||4
7695659|NCT01832753|18950762|P1|STARTED|Observation Phase (Months 0-6)||5
7695660|NCT01832727|18950783|P9|NOT COMPLETED|Overall Study||18
7695661|NCT01832727|18950784|P8|NOT COMPLETED|Overall Study||6
7695662|NCT01832727|18950785|P7|NOT COMPLETED|Overall Study||8
7695663|NCT01832727|18950786|P6|NOT COMPLETED|Overall Study||6
7695664|NCT01832727|18950787|P5|NOT COMPLETED|Overall Study||4
7695665|NCT01832727|18950788|P4|NOT COMPLETED|Overall Study||4
7695666|NCT01832727|18950789|P3|NOT COMPLETED|Overall Study||3
7695667|NCT01832727|18950790|P2|NOT COMPLETED|Overall Study||7
7695668|NCT01832727|18950791|P1|NOT COMPLETED|Overall Study||9
7695669|NCT01832727|18950783|P9|COMPLETED|Overall Study||0
7695670|NCT01832727|18950784|P8|COMPLETED|Overall Study||0
7695671|NCT01832727|18950785|P7|COMPLETED|Overall Study||0
7695672|NCT01832727|18950786|P6|COMPLETED|Overall Study||0
7695673|NCT01832727|18950787|P5|COMPLETED|Overall Study||0
7695674|NCT01832727|18950788|P4|COMPLETED|Overall Study||0
7695675|NCT01832727|18950789|P3|COMPLETED|Overall Study||0
7695676|NCT01832727|18950790|P2|COMPLETED|Overall Study||0
7695677|NCT01832727|18950791|P1|COMPLETED|Overall Study||0
7695678|NCT01832727|18950783|P9|STARTED|Overall Study||18
7695679|NCT01832727|18950784|P8|STARTED|Overall Study||6
7695680|NCT01832727|18950785|P7|STARTED|Overall Study||8
7695681|NCT01832727|18950786|P6|STARTED|Overall Study||6
7695682|NCT01832727|18950787|P5|STARTED|Overall Study||4
7695683|NCT01832727|18950788|P4|STARTED|Overall Study||4
7695684|NCT01832727|18950789|P3|STARTED|Overall Study||3
7695685|NCT01832727|18950790|P2|STARTED|Overall Study||7
7695686|NCT01832727|18950791|P1|STARTED|Overall Study||9
7695687|NCT01832610|18950891|P1|NOT COMPLETED|Overall Study||4
7695688|NCT01832610|18950891|P1|COMPLETED|Overall Study||97
7695689|NCT01832610|18950891|P1|STARTED|Overall Study||101
7695690|NCT01832532|18950904|P2|NOT COMPLETED|Overall Study||2
7695691|NCT01832532|18950905|P1|NOT COMPLETED|Overall Study||5
7695692|NCT01832532|18950904|P2|COMPLETED|Overall Study||9
7695693|NCT01832532|18950905|P1|COMPLETED|Overall Study||18
7695694|NCT01832532|18950904|P2|STARTED|Overall Study||11
7695695|NCT01832532|18950905|P1|STARTED|Overall Study||23
7695696|NCT01832506|18950914|P3|NOT COMPLETED|Overall Study||0
7695697|NCT01832506|18950915|P2|NOT COMPLETED|Overall Study||0
7695698|NCT01832506|18950916|P1|NOT COMPLETED|Overall Study||0
7695699|NCT01832506|18950914|P3|COMPLETED|Overall Study||6
7695700|NCT01832506|18950915|P2|COMPLETED|Overall Study||3
7695701|NCT01832506|18950916|P1|COMPLETED|Overall Study||3
7695702|NCT01832506|18950914|P3|STARTED|Overall Study||6
7695703|NCT01832506|18950915|P2|STARTED|Overall Study||3
7695704|NCT01832506|18950916|P1|STARTED|Overall Study||3
7695705|NCT01832493|18950967|P1|NOT COMPLETED|Overall Study||8
7695706|NCT01832493|18950967|P1|COMPLETED|Overall Study||42
7695707|NCT01832493|18950967|P1|STARTED|Overall Study||50
7695708|NCT01832480|18950976|P2|NOT COMPLETED|Overall Study||42
7695709|NCT01832480|18950977|P1|NOT COMPLETED|Overall Study||41
7695710|NCT01832480|18950976|P2|COMPLETED|Overall Study||270
7695711|NCT01832480|18950977|P1|COMPLETED|Overall Study||270
7695712|NCT01832480|18950976|P2|STARTED|Overall Study||312
7695713|NCT01832480|18950977|P1|STARTED|Overall Study||311
7695714|NCT01832402|18950985|P2|NOT COMPLETED|Overall Study||4
7695715|NCT01832402|18950986|P1|NOT COMPLETED|Overall Study||7
7695716|NCT01832402|18950985|P2|COMPLETED|Overall Study||12
7695717|NCT01832402|18950986|P1|COMPLETED|Overall Study||12
7695718|NCT01832402|18950985|P2|Completed Study With Incorrect Dose|Overall Study||3
7695719|NCT01832402|18950986|P1|Completed Study With Incorrect Dose|Overall Study||2
7695720|NCT01832402|18950985|P2|Completed Study With Correct Dose|Overall Study||9
7695721|NCT01832402|18950986|P1|Completed Study With Correct Dose|Overall Study||10
7695722|NCT01832402|18950985|P2|Received Allocated Medication|Overall Study||12
7695723|NCT01832402|18950986|P1|Received Allocated Medication|Overall Study||12
7695724|NCT01832402|18950985|P2|STARTED|Overall Study||16
7695725|NCT01832402|18950986|P1|STARTED|Overall Study||19
7695726|NCT01832259|18951000|P2|NOT COMPLETED|Overall Study||0
7695727|NCT01832259|18951001|P1|NOT COMPLETED|Overall Study||0
7695728|NCT01832259|18951000|P2|COMPLETED|Overall Study||15
7695729|NCT01832259|18951001|P1|COMPLETED|Overall Study||15
7695730|NCT01832259|18951000|P2|STARTED|Overall Study||15
7695731|NCT01832259|18951001|P1|STARTED|Overall Study||15
7695732|NCT01832155|18951013|P2|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
7695733|NCT01832155|18951014|P1|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
7695734|NCT01832155|18951013|P2|COMPLETED|End of Study: 4 - 8 Weeks||18
7695735|NCT01832155|18951014|P1|COMPLETED|End of Study: 4 - 8 Weeks||16
7695736|NCT01832155|18951013|P2|STARTED|End of Study: 4 - 8 Weeks||18
7695737|NCT01832155|18951014|P1|STARTED|End of Study: 4 - 8 Weeks||16
7695738|NCT01832155|18951013|P2|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0
7695739|NCT01832155|18951014|P1|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1
7695740|NCT01832155|18951013|P2|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18
7695741|NCT01832155|18951014|P1|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16
7695742|NCT01832155|18951013|P2|STARTED|Mid-point of Study: 0 - 4 Weeks||18
7695743|NCT01832155|18951014|P1|STARTED|Mid-point of Study: 0 - 4 Weeks||17
7695744|NCT01832155|18951013|P2|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0
7695745|NCT01832155|18951014|P1|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1
7695746|NCT01832155|18951013|P2|COMPLETED|Beginning of Study: Baseline at 0 Week||18
7695747|NCT01832155|18951014|P1|COMPLETED|Beginning of Study: Baseline at 0 Week||17
7695748|NCT01832155|18951013|P2|STARTED|Beginning of Study: Baseline at 0 Week||18
7695749|NCT01832155|18951014|P1|STARTED|Beginning of Study: Baseline at 0 Week||18
7695750|NCT01832090|18951037|P2|NOT COMPLETED|Overall Study||1
7695751|NCT01832090|18951038|P1|NOT COMPLETED|Overall Study||6
7695752|NCT01832090|18951037|P2|COMPLETED|Overall Study||28
7695753|NCT01832090|18951038|P1|COMPLETED|Overall Study||83
7695754|NCT01832090|18951037|P2|STARTED|Overall Study||29
7695755|NCT01832090|18951038|P1|STARTED|Overall Study||89
7695756|NCT01832038|18951081|P1|NOT COMPLETED|Overall Study||235
7695757|NCT01832038|18951081|P1|COMPLETED|Overall Study||238
7695758|NCT01832038|18951081|P1|STARTED|Overall Study||473
7695759|NCT01831960|18951090|P2|NOT COMPLETED|Overall Study||0
7695760|NCT01831960|18951091|P1|NOT COMPLETED|Overall Study||0
7695761|NCT01831960|18951090|P2|COMPLETED|Overall Study||22
7695762|NCT01831960|18951091|P1|COMPLETED|Overall Study||20
7695763|NCT01831960|18951090|P2|STARTED|Overall Study||22
7695764|NCT01831960|18951091|P1|STARTED|Overall Study||20
7695765|NCT01831934|18951105|P2|NOT COMPLETED|Overall Study||0
7695766|NCT01831934|18951106|P1|NOT COMPLETED|Overall Study||1
7695767|NCT01831934|18951105|P2|COMPLETED|Overall Study||10
7695768|NCT01831934|18951106|P1|COMPLETED|Overall Study|Volunteer consented but not enrolled after reporting a prior bad reaction to influenza vaccine.|11
7695769|NCT01831934|18951105|P2|STARTED|Overall Study||10
7695770|NCT01831934|18951106|P1|STARTED|Overall Study||12
7695771|NCT01831921|18951114|P2|NOT COMPLETED|Overall Study||39
7695772|NCT01831921|18951115|P1|NOT COMPLETED|Overall Study||84
7695773|NCT01831921|18951114|P2|COMPLETED|Overall Study|Of 42 eligible for this visit.|36
7695774|NCT01831921|18951115|P1|COMPLETED|Overall Study|Of 85 eligible for this visit.|66
7695775|NCT01831921|18951114|P2|18 Months|Overall Study|Of 59 eligible for this visit.|49
7695776|NCT01831921|18951115|P1|18 Months|Overall Study|Of 118 eligible for this visit.|90
7695777|NCT01831921|18951114|P2|12 Months|Overall Study||62
7695778|NCT01831921|18951115|P1|12 Months|Overall Study|All participants were followed for 12 months to 24 months, depending on date of randomization.|120
7695779|NCT01831921|18951114|P2|6 Months|Overall Study||63
7695780|NCT01831921|18951115|P1|6 Months|Overall Study||122
7695781|NCT01831921|18951114|P2|STARTED|Overall Study||75
7695782|NCT01831921|18951115|P1|STARTED|Overall Study||150
7695783|NCT01831856|18951139|P2|NOT COMPLETED|Overall Study||37
7695784|NCT01831856|18951140|P1|NOT COMPLETED|Overall Study||34
7695785|NCT01831856|18951139|P2|COMPLETED|Overall Study||30
7695786|NCT01831856|18951140|P1|COMPLETED|Overall Study||33
7695787|NCT01831856|18951139|P2|STARTED|Overall Study||67
7695788|NCT01831856|18951140|P1|STARTED|Overall Study||67
7695789|NCT01831817|18951150|P4|NOT COMPLETED|Overall Study||0
7695790|NCT01831817|18951151|P3|NOT COMPLETED|Overall Study||0
7695791|NCT01831817|18951152|P2|NOT COMPLETED|Overall Study||0
7695792|NCT01831817|18951153|P1|NOT COMPLETED|Overall Study||4
7695793|NCT01831817|18951150|P4|COMPLETED|Overall Study||36
7695794|NCT01831817|18951151|P3|COMPLETED|Overall Study||35
7695795|NCT01831817|18951152|P2|COMPLETED|Overall Study||34
7695796|NCT01831817|18951153|P1|COMPLETED|Overall Study||31
7695797|NCT01831817|18951150|P4|STARTED|Overall Study||36
7695798|NCT01831817|18951151|P3|STARTED|Overall Study||35
7695799|NCT01831817|18951152|P2|STARTED|Overall Study||34
7695800|NCT01831817|18951153|P1|STARTED|Overall Study||35
7695801|NCT01831804|18951200|P9|NOT COMPLETED|Overall Study||2
7695802|NCT01831804|18951201|P8|NOT COMPLETED|Overall Study||3
7695803|NCT01831804|18951202|P7|NOT COMPLETED|Overall Study||1
7695804|NCT01831804|18951203|P6|NOT COMPLETED|Overall Study||0
7695805|NCT01831804|18951204|P5|NOT COMPLETED|Overall Study||2
7695806|NCT01831804|18951205|P4|NOT COMPLETED|Overall Study||0
7695807|NCT01831804|18951206|P3|NOT COMPLETED|Overall Study||6
7695808|NCT01831804|18951207|P2|NOT COMPLETED|Overall Study||2
7695810|NCT01831804|18951200|P9|COMPLETED|Overall Study||2
7695811|NCT01831804|18951201|P8|COMPLETED|Overall Study||23
7695812|NCT01831804|18951202|P7|COMPLETED|Overall Study||3
7695813|NCT01831804|18951203|P6|COMPLETED|Overall Study||3
7695814|NCT01831804|18951204|P5|COMPLETED|Overall Study||3
7695815|NCT01831804|18951205|P4|COMPLETED|Overall Study||5
7695816|NCT01831804|18951206|P3|COMPLETED|Overall Study||3
7695817|NCT01831804|18951207|P2|COMPLETED|Overall Study||1
7695818|NCT01831804|18951208|P1|COMPLETED|Overall Study||3
7695819|NCT01831804|18951200|P9|STARTED|Overall Study||4
7695820|NCT01831804|18951201|P8|STARTED|Overall Study||26
7695821|NCT01831804|18951202|P7|STARTED|Overall Study||4
7695822|NCT01831804|18951203|P6|STARTED|Overall Study||3
7695823|NCT01831804|18951204|P5|STARTED|Overall Study||5
7695824|NCT01831804|18951205|P4|STARTED|Overall Study||5
7695825|NCT01831804|18951206|P3|STARTED|Overall Study||9
7695826|NCT01831804|18951207|P2|STARTED|Overall Study||3
7695827|NCT01831804|18951208|P1|STARTED|Overall Study||4
7695828|NCT01831791|18951303|P1|NOT COMPLETED|Overall Study||10
7695829|NCT01831791|18951303|P1|COMPLETED|Overall Study||110
7695830|NCT01831791|18951303|P1|STARTED|Overall Study||120
7695831|NCT01831765|18951332|P3|NOT COMPLETED|Overall Study||42
7695832|NCT01831765|18951333|P2|NOT COMPLETED|Overall Study||27
7695833|NCT01831765|18951334|P1|NOT COMPLETED|Overall Study||44
7695834|NCT01831765|18951332|P3|COMPLETED|Overall Study||338
7695835|NCT01831765|18951333|P2|COMPLETED|Overall Study||355
7695836|NCT01831765|18951334|P1|COMPLETED|Overall Study||337
7695837|NCT01831765|18951332|P3|Completed 52 Weeks|Overall Study||338
7695838|NCT01831765|18951333|P2|Completed 52 Weeks|Overall Study|This arm did not continue in the trial after 26 weeks ( 26 to 52 weeks).|0
7695839|NCT01831765|18951334|P1|Completed 52 Weeks|Overall Study||337
7695840|NCT01831765|18951332|P3|Completed 26 Weeks|Overall Study||356
7695841|NCT01831765|18951333|P2|Completed 26 Weeks|Overall Study||355
7695842|NCT01831765|18951334|P1|Completed 26 Weeks|Overall Study||351
7695843|NCT01831765|18951332|P3|STARTED|Overall Study||380
7695844|NCT01831765|18951333|P2|STARTED|Overall Study||382
7695845|NCT01831765|18951334|P1|STARTED|Overall Study||381
7695846|NCT01831726|18951360|P1|NOT COMPLETED|Overall Study||80
7695847|NCT01831726|18951360|P1|COMPLETED|Overall Study||0
7695848|NCT01831726|18951360|P1|STARTED|Overall Study||80
7695849|NCT01831596|18951367|P1|NOT COMPLETED|Overall Study||8
7695850|NCT01831596|18951367|P1|COMPLETED|Overall Study||51
7695851|NCT01831596|18951367|P1|STARTED|Overall Study||59
7695852|NCT01831544|18951371|P1|NOT COMPLETED|Overall Study||3
7695853|NCT01831544|18951371|P1|COMPLETED|Overall Study||8
7695854|NCT01831544|18951371|P1|STARTED|Overall Study||11
7695855|NCT01831466|18951400|P12|NOT COMPLETED|Overall Study||4
7695856|NCT01831466|18951401|P11|NOT COMPLETED|Overall Study||2
7695857|NCT01831466|18951402|P10|NOT COMPLETED|Overall Study||5
7695858|NCT01831466|18951403|P9|NOT COMPLETED|Overall Study||3
7695859|NCT01831466|18951404|P8|NOT COMPLETED|Overall Study||2
7695860|NCT01831466|18951405|P7|NOT COMPLETED|Overall Study||1
7695861|NCT01831466|18951406|P6|NOT COMPLETED|Overall Study||26
7695862|NCT01831466|18951407|P5|NOT COMPLETED|Overall Study||17
7695863|NCT01831466|18951408|P4|NOT COMPLETED|Overall Study||19
7695864|NCT01831466|18951409|P3|NOT COMPLETED|Overall Study||23
7695865|NCT01831466|18951410|P2|NOT COMPLETED|Overall Study||18
7695866|NCT01831466|18951411|P1|NOT COMPLETED|Overall Study||16
7695867|NCT01831466|18951400|P12|COMPLETED|Overall Study||3
7695868|NCT01831466|18951401|P11|COMPLETED|Overall Study||4
7695869|NCT01831466|18951402|P10|COMPLETED|Overall Study||2
7695870|NCT01831466|18951403|P9|COMPLETED|Overall Study||4
7695871|NCT01831466|18951404|P8|COMPLETED|Overall Study||5
7695872|NCT01831466|18951405|P7|COMPLETED|Overall Study||6
7695873|NCT01831466|18951406|P6|COMPLETED|Overall Study||48
7695874|NCT01831466|18951407|P5|COMPLETED|Overall Study||57
7695875|NCT01831466|18951408|P4|COMPLETED|Overall Study||51
7695876|NCT01831466|18951409|P3|COMPLETED|Overall Study||48
7695877|NCT01831466|18951410|P2|COMPLETED|Overall Study||52
7695878|NCT01831466|18951411|P1|COMPLETED|Overall Study||55
7695879|NCT01831466|18951400|P12|STARTED|Overall Study|Treated|7
7695880|NCT01831466|18951401|P11|STARTED|Overall Study|Treated|6
7695881|NCT01831466|18951402|P10|STARTED|Overall Study|Treated|7
7695882|NCT01831466|18951403|P9|STARTED|Overall Study|Treated|7
7695883|NCT01831466|18951404|P8|STARTED|Overall Study|Treated|7
7695884|NCT01831466|18951405|P7|STARTED|Overall Study|Treated|7
7695885|NCT01831466|18951406|P6|STARTED|Overall Study|Treated|74
7695886|NCT01831466|18951407|P5|STARTED|Overall Study|Treated|74
7695887|NCT01831466|18951408|P4|STARTED|Overall Study|Treated|70
7695888|NCT01831466|18951409|P3|STARTED|Overall Study|Treated|71
7695889|NCT01831466|18951410|P2|STARTED|Overall Study|Treated|70
7695890|NCT01831466|18951411|P1|STARTED|Overall Study|Treated|71
7695891|NCT01831258|18951533|P2|NOT COMPLETED|Overall Study||3
7695892|NCT01831258|18951534|P1|NOT COMPLETED|Overall Study||5
7695893|NCT01831258|18951533|P2|COMPLETED|Overall Study||32
7695894|NCT01831258|18951534|P1|COMPLETED|Overall Study||30
7695895|NCT01831258|18951533|P2|STARTED|Overall Study||35
7695896|NCT01831258|18951534|P1|STARTED|Overall Study||35
7695897|NCT01831232|18951560|P1|NOT COMPLETED|Overall Study||0
7695898|NCT01831232|18951560|P1|COMPLETED|Overall Study||24
7695899|NCT01831232|18951560|P1|STARTED|Overall Study||24
7695900|NCT01831219|18951571|P2|NOT COMPLETED|Overall Study||24
7695901|NCT01831219|18951572|P1|NOT COMPLETED|Overall Study||33
7695902|NCT01831219|18951571|P2|COMPLETED|Overall Study||21
7695903|NCT01831219|18951572|P1|COMPLETED|Overall Study||40
7695904|NCT01831219|18951571|P2|STARTED|Overall Study||45
7695905|NCT01831219|18951572|P1|STARTED|Overall Study||73
7695906|NCT01831154|18951593|P3|NOT COMPLETED|Overall Study||0
7695907|NCT01831154|18951594|P2|NOT COMPLETED|Overall Study||0
7695908|NCT01831154|18951595|P1|NOT COMPLETED|Overall Study||0
7695909|NCT01831154|18951593|P3|COMPLETED|Overall Study||11
7695910|NCT01831154|18951594|P2|COMPLETED|Overall Study||11
7695911|NCT01831154|18951595|P1|COMPLETED|Overall Study||15
7695912|NCT01831154|18951593|P3|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
7695913|NCT01831154|18951594|P2|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
7695914|NCT01831154|18951595|P1|STARTED|Overall Study|Study Institutional Review Board (IRB) approval 11-11-2009, first subjects enrolled 6-7-2010|15
7695915|NCT01831089|18951624|P6|NOT COMPLETED|Cohort B: Arm B||14
7695916|NCT01831089|18951625|P5|NOT COMPLETED|Cohort B: Arm B||0
7695917|NCT01831089|18951626|P4|NOT COMPLETED|Cohort B: Arm B||0
7695918|NCT01831089|18951627|P3|NOT COMPLETED|Cohort B: Arm B||0
7695919|NCT01831089|18951628|P2|NOT COMPLETED|Cohort B: Arm B||0
7695920|NCT01831089|18951629|P1|NOT COMPLETED|Cohort B: Arm B||0
7695921|NCT01831089|18951624|P6|COMPLETED|Cohort B: Arm B||0
7695922|NCT01831089|18951625|P5|COMPLETED|Cohort B: Arm B||0
7695923|NCT01831089|18951626|P4|COMPLETED|Cohort B: Arm B||0
7695924|NCT01831089|18951627|P3|COMPLETED|Cohort B: Arm B||0
7695925|NCT01831089|18951628|P2|COMPLETED|Cohort B: Arm B||0
7695926|NCT01831089|18951629|P1|COMPLETED|Cohort B: Arm B||0
7695927|NCT01831089|18951624|P6|STARTED|Cohort B: Arm B||14
7695928|NCT01831089|18951625|P5|STARTED|Cohort B: Arm B||0
7695929|NCT01831089|18951626|P4|STARTED|Cohort B: Arm B||0
7695930|NCT01831089|18951627|P3|STARTED|Cohort B: Arm B||0
7695931|NCT01831089|18951628|P2|STARTED|Cohort B: Arm B||0
7695932|NCT01831089|18951629|P1|STARTED|Cohort B: Arm B||0
7695933|NCT01831089|18951624|P6|NOT COMPLETED|Cohort V: Dose Level 5||0
7695934|NCT01831089|18951625|P5|NOT COMPLETED|Cohort V: Dose Level 5||37
7695935|NCT01831089|18951626|P4|NOT COMPLETED|Cohort V: Dose Level 5||0
7695936|NCT01831089|18951627|P3|NOT COMPLETED|Cohort V: Dose Level 5||0
7695937|NCT01831089|18951628|P2|NOT COMPLETED|Cohort V: Dose Level 5||0
7695938|NCT01831089|18951629|P1|NOT COMPLETED|Cohort V: Dose Level 5||0
7695939|NCT01831089|18951624|P6|COMPLETED|Cohort V: Dose Level 5||0
7695940|NCT01831089|18951625|P5|COMPLETED|Cohort V: Dose Level 5||0
7695941|NCT01831089|18951626|P4|COMPLETED|Cohort V: Dose Level 5||0
7695942|NCT01831089|18951627|P3|COMPLETED|Cohort V: Dose Level 5||0
7695943|NCT01831089|18951628|P2|COMPLETED|Cohort V: Dose Level 5||0
7695944|NCT01831089|18951629|P1|COMPLETED|Cohort V: Dose Level 5||0
7695945|NCT01831089|18951624|P6|STARTED|Cohort V: Dose Level 5||0
7695946|NCT01831089|18951625|P5|STARTED|Cohort V: Dose Level 5||37
7695947|NCT01831089|18951626|P4|STARTED|Cohort V: Dose Level 5||0
7695948|NCT01831089|18951627|P3|STARTED|Cohort V: Dose Level 5||0
7695949|NCT01831089|18951628|P2|STARTED|Cohort V: Dose Level 5||0
7695950|NCT01831089|18951629|P1|STARTED|Cohort V: Dose Level 5||0
7695951|NCT01831089|18951624|P6|NOT COMPLETED|Cohort IV: Dose Level 4||0
7695952|NCT01831089|18951625|P5|NOT COMPLETED|Cohort IV: Dose Level 4||0
7695953|NCT01831089|18951626|P4|NOT COMPLETED|Cohort IV: Dose Level 4||6
7695954|NCT01831089|18951627|P3|NOT COMPLETED|Cohort IV: Dose Level 4||0
7695955|NCT01831089|18951628|P2|NOT COMPLETED|Cohort IV: Dose Level 4||0
7695956|NCT01831089|18951629|P1|NOT COMPLETED|Cohort IV: Dose Level 4||0
7695957|NCT01831089|18951624|P6|COMPLETED|Cohort IV: Dose Level 4||0
7695958|NCT01831089|18951625|P5|COMPLETED|Cohort IV: Dose Level 4||0
7695959|NCT01831089|18951626|P4|COMPLETED|Cohort IV: Dose Level 4||0
7695960|NCT01831089|18951627|P3|COMPLETED|Cohort IV: Dose Level 4||0
7695961|NCT01831089|18951628|P2|COMPLETED|Cohort IV: Dose Level 4||0
7695962|NCT01831089|18951629|P1|COMPLETED|Cohort IV: Dose Level 4||0
7695963|NCT01831089|18951624|P6|STARTED|Cohort IV: Dose Level 4||0
7695964|NCT01831089|18951625|P5|STARTED|Cohort IV: Dose Level 4||0
7695965|NCT01831089|18951626|P4|STARTED|Cohort IV: Dose Level 4||6
7695966|NCT01831089|18951627|P3|STARTED|Cohort IV: Dose Level 4||0
7695967|NCT01831089|18951628|P2|STARTED|Cohort IV: Dose Level 4||0
7695968|NCT01831089|18951629|P1|STARTED|Cohort IV: Dose Level 4||0
7695969|NCT01831089|18951624|P6|NOT COMPLETED|Cohort III: Dose Level 3||0
7695970|NCT01831089|18951625|P5|NOT COMPLETED|Cohort III: Dose Level 3||0
7695971|NCT01831089|18951626|P4|NOT COMPLETED|Cohort III: Dose Level 3||0
7695972|NCT01831089|18951627|P3|NOT COMPLETED|Cohort III: Dose Level 3||6
7695973|NCT01831089|18951628|P2|NOT COMPLETED|Cohort III: Dose Level 3||0
7695974|NCT01831089|18951629|P1|NOT COMPLETED|Cohort III: Dose Level 3||0
7695975|NCT01831089|18951624|P6|COMPLETED|Cohort III: Dose Level 3||0
7695976|NCT01831089|18951625|P5|COMPLETED|Cohort III: Dose Level 3||0
7695977|NCT01831089|18951626|P4|COMPLETED|Cohort III: Dose Level 3||0
7695978|NCT01831089|18951627|P3|COMPLETED|Cohort III: Dose Level 3||0
7695979|NCT01831089|18951628|P2|COMPLETED|Cohort III: Dose Level 3||0
7695980|NCT01831089|18951629|P1|COMPLETED|Cohort III: Dose Level 3||0
7695981|NCT01831089|18951624|P6|STARTED|Cohort III: Dose Level 3||0
7695982|NCT01831089|18951625|P5|STARTED|Cohort III: Dose Level 3||0
7695983|NCT01831089|18951626|P4|STARTED|Cohort III: Dose Level 3||0
7695984|NCT01831089|18951627|P3|STARTED|Cohort III: Dose Level 3||6
7695985|NCT01831089|18951628|P2|STARTED|Cohort III: Dose Level 3||0
7695986|NCT01831089|18951629|P1|STARTED|Cohort III: Dose Level 3||0
7695987|NCT01831089|18951624|P6|NOT COMPLETED|Cohort II: Dose Level 2||0
7695988|NCT01831089|18951625|P5|NOT COMPLETED|Cohort II: Dose Level 2||0
7695989|NCT01831089|18951626|P4|NOT COMPLETED|Cohort II: Dose Level 2||0
7695990|NCT01831089|18951627|P3|NOT COMPLETED|Cohort II: Dose Level 2||0
7695991|NCT01831089|18951628|P2|NOT COMPLETED|Cohort II: Dose Level 2||3
7695992|NCT01831089|18951629|P1|NOT COMPLETED|Cohort II: Dose Level 2||0
7695993|NCT01831089|18951624|P6|COMPLETED|Cohort II: Dose Level 2||0
7695994|NCT01831089|18951625|P5|COMPLETED|Cohort II: Dose Level 2||0
7695995|NCT01831089|18951626|P4|COMPLETED|Cohort II: Dose Level 2||0
7695996|NCT01831089|18951627|P3|COMPLETED|Cohort II: Dose Level 2||0
7695997|NCT01831089|18951628|P2|COMPLETED|Cohort II: Dose Level 2||0
7695998|NCT01831089|18951629|P1|COMPLETED|Cohort II: Dose Level 2||0
7695999|NCT01831089|18951624|P6|STARTED|Cohort II: Dose Level 2||0
7696000|NCT01831089|18951625|P5|STARTED|Cohort II: Dose Level 2||0
7696001|NCT01831089|18951626|P4|STARTED|Cohort II: Dose Level 2||0
7696002|NCT01831089|18951627|P3|STARTED|Cohort II: Dose Level 2||0
7696003|NCT01831089|18951628|P2|STARTED|Cohort II: Dose Level 2||3
7696004|NCT01831089|18951629|P1|STARTED|Cohort II: Dose Level 2||0
7696005|NCT01831089|18951624|P6|NOT COMPLETED|Cohort I: Dose Level 1||0
7696006|NCT01831089|18951625|P5|NOT COMPLETED|Cohort I: Dose Level 1||0
7696007|NCT01831089|18951626|P4|NOT COMPLETED|Cohort I: Dose Level 1||0
7696008|NCT01831089|18951627|P3|NOT COMPLETED|Cohort I: Dose Level 1||0
7696009|NCT01831089|18951628|P2|NOT COMPLETED|Cohort I: Dose Level 1||0
7696010|NCT01831089|18951629|P1|NOT COMPLETED|Cohort I: Dose Level 1||3
7696011|NCT01831089|18951624|P6|COMPLETED|Cohort I: Dose Level 1||0
7696012|NCT01831089|18951625|P5|COMPLETED|Cohort I: Dose Level 1||0
7696013|NCT01831089|18951626|P4|COMPLETED|Cohort I: Dose Level 1||0
7696014|NCT01831089|18951627|P3|COMPLETED|Cohort I: Dose Level 1||0
7696015|NCT01831089|18951628|P2|COMPLETED|Cohort I: Dose Level 1||0
7696016|NCT01831089|18951629|P1|COMPLETED|Cohort I: Dose Level 1||0
7696017|NCT01831089|18951624|P6|STARTED|Cohort I: Dose Level 1||0
7696018|NCT01831089|18951625|P5|STARTED|Cohort I: Dose Level 1||0
7696019|NCT01831089|18951626|P4|STARTED|Cohort I: Dose Level 1||0
7696020|NCT01831089|18951627|P3|STARTED|Cohort I: Dose Level 1||0
7696021|NCT01831089|18951628|P2|STARTED|Cohort I: Dose Level 1||0
7696022|NCT01831089|18951629|P1|STARTED|Cohort I: Dose Level 1||3
7696023|NCT01831076|18951671|P2|NOT COMPLETED|Overall Study||1
7696024|NCT01831076|18951672|P1|NOT COMPLETED|Overall Study||1
7696025|NCT01831076|18951671|P2|COMPLETED|Overall Study||4
7696026|NCT01831076|18951672|P1|COMPLETED|Overall Study||30
7696027|NCT01831076|18951671|P2|STARTED|Overall Study||5
7696028|NCT01831076|18951672|P1|STARTED|Overall Study||31
7696029|NCT01830972|18951680|P2|NOT COMPLETED|Part IV||1
7696030|NCT01830972|18951681|P1|NOT COMPLETED|Part IV||3
7696031|NCT01830972|18951680|P2|COMPLETED|Part IV||10
7696032|NCT01830972|18951681|P1|COMPLETED|Part IV||39
7696033|NCT01830972|18951680|P2|STARTED|Part IV||11
7696034|NCT01830972|18951681|P1|STARTED|Part IV||42
7696035|NCT01830972|18951680|P2|NOT COMPLETED|Part III||0
7696036|NCT01830972|18951681|P1|NOT COMPLETED|Part III||2
7696037|NCT01830972|18951680|P2|COMPLETED|Part III||11
7696038|NCT01830972|18951681|P1|COMPLETED|Part III||42
7696039|NCT01830972|18951680|P2|STARTED|Part III||11
7696040|NCT01830972|18951681|P1|STARTED|Part III|2 participants withdrew consent and did not enter Part 3|44
7696041|NCT01830972|18951680|P2|NOT COMPLETED|Part II||2
7696042|NCT01830972|18951681|P1|NOT COMPLETED|Part II||2
7696043|NCT01830972|18951680|P2|COMPLETED|Part II||11
7696044|NCT01830972|18951681|P1|COMPLETED|Part II||44
7696045|NCT01830972|18951680|P2|STARTED|Part II|Entered study at Part 2|13
7696046|NCT01830972|18951681|P1|STARTED|Part II||46
7696047|NCT01830972|18951680|P2|NOT COMPLETED|Part I||0
7696048|NCT01830972|18951681|P1|NOT COMPLETED|Part I||0
7696049|NCT01830972|18951680|P2|COMPLETED|Part I|Not applicable; participants in this arm entered during Part 2.|0
7696050|NCT01830972|18951681|P1|COMPLETED|Part I||46
7696051|NCT01830972|18951680|P2|STARTED|Part I|Not applicable; participants in this arm entered during Part 2.|0
7696052|NCT01830972|18951681|P1|STARTED|Part I||46
7696053|NCT01830933|18951707|P2|NOT COMPLETED|Overall Study||232
7696054|NCT01830933|18951708|P1|NOT COMPLETED|Overall Study||168
7696055|NCT01830933|18951707|P2|COMPLETED|Overall Study||580
7696056|NCT01830933|18951708|P1|COMPLETED|Overall Study||655
7696057|NCT01830933|18951707|P2|Completed Meet-up|Overall Study||603
7696058|NCT01830933|18951708|P1|Completed Meet-up|Overall Study||675
7696059|NCT01830933|18951707|P2|STARTED|Overall Study||812
7696060|NCT01830933|18951708|P1|STARTED|Overall Study||823
7696061|NCT01830920|18951725|P5|NOT COMPLETED|Overall Study||8
7696062|NCT01830920|18951726|P4|NOT COMPLETED|Overall Study||16
7696063|NCT01830920|18951727|P3|NOT COMPLETED|Overall Study||8
7696064|NCT01830920|18951728|P2|NOT COMPLETED|Overall Study||6
7696065|NCT01830920|18951729|P1|NOT COMPLETED|Overall Study||21
7696066|NCT01830920|18951725|P5|COMPLETED|Overall Study||99
7696067|NCT01830920|18951726|P4|COMPLETED|Overall Study||109
7696068|NCT01830920|18951727|P3|COMPLETED|Overall Study||40
7696069|NCT01830920|18951728|P2|COMPLETED|Overall Study||40
7696070|NCT01830920|18951729|P1|COMPLETED|Overall Study||105
7696071|NCT01830920|18951725|P5|Received Allocated Drug|Overall Study||105
7696072|NCT01830920|18951726|P4|Received Allocated Drug|Overall Study||119
7696073|NCT01830920|18951727|P3|Received Allocated Drug|Overall Study||47
7696074|NCT01830920|18951728|P2|Received Allocated Drug|Overall Study||45
7696075|NCT01830920|18951729|P1|Received Allocated Drug|Overall Study||115
7696076|NCT01830920|18951725|P5|STARTED|Overall Study||107
7696077|NCT01830920|18951726|P4|STARTED|Overall Study||125
7696078|NCT01830920|18951727|P3|STARTED|Overall Study||48
7696079|NCT01830920|18951728|P2|STARTED|Overall Study||46
7696080|NCT01830920|18951729|P1|STARTED|Overall Study||126
7696081|NCT01830881|18951768|P2|NOT COMPLETED|Overall Study||1
7696082|NCT01830881|18951769|P1|NOT COMPLETED|Overall Study||0
7696083|NCT01830881|18951768|P2|COMPLETED|Overall Study||61
7696084|NCT01830881|18951769|P1|COMPLETED|Overall Study||62
7696085|NCT01830881|18951768|P2|STARTED|Overall Study||62
7696086|NCT01830881|18951769|P1|STARTED|Overall Study||62
7696087|NCT01830855|18951817|P4|NOT COMPLETED|Overall Study||82
7696088|NCT01830855|18951818|P3|NOT COMPLETED|Overall Study||66
7696089|NCT01830855|18951819|P2|NOT COMPLETED|Overall Study||61
7696090|NCT01830855|18951820|P1|NOT COMPLETED|Overall Study||155
7696091|NCT01830855|18951817|P4|COMPLETED|Overall Study||815
7696092|NCT01830855|18951818|P3|COMPLETED|Overall Study||521
7696093|NCT01830855|18951819|P2|COMPLETED|Overall Study||537
7696094|NCT01830855|18951820|P1|COMPLETED|Overall Study||1353
7696095|NCT01830855|18951817|P4|STARTED|Overall Study||897
7696096|NCT01830855|18951818|P3|STARTED|Overall Study||587
7696097|NCT01830855|18951819|P2|STARTED|Overall Study||598
7696098|NCT01830855|18951820|P1|STARTED|Overall Study||1508
7696099|NCT01830842|18951926|P2|NOT COMPLETED|Overall Study||2
7696100|NCT01830842|18951927|P1|NOT COMPLETED|Overall Study||5
7696101|NCT01830842|18951926|P2|COMPLETED|Overall Study||22
7696102|NCT01830842|18951927|P1|COMPLETED|Overall Study||25
7696103|NCT01830842|18951926|P2|STARTED|Overall Study||24
7696104|NCT01830842|18951927|P1|STARTED|Overall Study||30
7696105|NCT01830816|18951936|P3|NOT COMPLETED|Overall Study||7
7696106|NCT01830816|18951937|P2|NOT COMPLETED|Overall Study||14
7696107|NCT01830816|18951938|P1|NOT COMPLETED|Overall Study||20
7696108|NCT01830816|18951936|P3|COMPLETED|Overall Study||0
7696109|NCT01830816|18951937|P2|COMPLETED|Overall Study||0
7696110|NCT01830816|18951938|P1|COMPLETED|Overall Study||0
7696111|NCT01830816|18951936|P3|Pharmacokinetic-Evaluable Population|Overall Study||6
7696112|NCT01830816|18951937|P2|Pharmacokinetic-Evaluable Population|Overall Study||14
7696113|NCT01830816|18951938|P1|Pharmacokinetic-Evaluable Population|Overall Study|Participants are considered to have completed study treatment if they are PK evaluable.|18
7696114|NCT01830816|18951936|P3|STARTED|Overall Study||7
7696115|NCT01830816|18951937|P2|STARTED|Overall Study||14
7696116|NCT01830816|18951938|P1|STARTED|Overall Study||20
7696117|NCT01830790|18951963|P2|NOT COMPLETED|Overall Study||0
7696118|NCT01830790|18951964|P1|NOT COMPLETED|Overall Study||0
7696119|NCT01830790|18951963|P2|COMPLETED|Overall Study||10
7696120|NCT01830790|18951964|P1|COMPLETED|Overall Study||0
7696121|NCT01830790|18951963|P2|STARTED|Overall Study||10
7696122|NCT01830790|18951964|P1|STARTED|Overall Study||0
7696123|NCT01830699|18951974|P2|NOT COMPLETED|Overall Study||0
7696124|NCT01830699|18951975|P1|NOT COMPLETED|Overall Study||0
7696125|NCT01830699|18951974|P2|COMPLETED|Overall Study||20
7696126|NCT01830699|18951975|P1|COMPLETED|Overall Study||13
7696127|NCT01830699|18951974|P2|STARTED|Overall Study||20
7696128|NCT01830699|18951975|P1|STARTED|Overall Study||13
7696129|NCT01830621|18951987|P2|NOT COMPLETED|Overall Study||0
7696130|NCT01830621|18951988|P1|NOT COMPLETED|Overall Study||0
7696131|NCT01830621|18951987|P2|COMPLETED|Overall Study||144
7696132|NCT01830621|18951988|P1|COMPLETED|Overall Study||138
7696133|NCT01830621|18951987|P2|STARTED|Overall Study||144
7696134|NCT01830621|18951988|P1|STARTED|Overall Study||138
7696135|NCT01830595|18952002|P2|NOT COMPLETED|Second Period||0
7696136|NCT01830595|18952003|P1|NOT COMPLETED|Second Period||0
7696137|NCT01830595|18952002|P2|COMPLETED|Second Period||23
7696138|NCT01830595|18952003|P1|COMPLETED|Second Period||23
7696139|NCT01830595|18952002|P2|STARTED|Second Period||23
7696140|NCT01830595|18952003|P1|STARTED|Second Period||23
7696141|NCT01830595|18952002|P2|NOT COMPLETED|Washout||2
7696142|NCT01830595|18952003|P1|NOT COMPLETED|Washout||2
7696143|NCT01830595|18952002|P2|COMPLETED|Washout||23
7696144|NCT01830595|18952003|P1|COMPLETED|Washout||23
7696145|NCT01830595|18952002|P2|STARTED|Washout||25
7696146|NCT01830595|18952003|P1|STARTED|Washout||25
7696147|NCT01830595|18952002|P2|NOT COMPLETED|First Period||3
7696148|NCT01830595|18952003|P1|NOT COMPLETED|First Period||1
7696149|NCT01830595|18952002|P2|COMPLETED|First Period||25
7696150|NCT01830595|18952003|P1|COMPLETED|First Period||25
7696151|NCT01830595|18952002|P2|Received at Least One Dose|First Period||28
7696152|NCT01830595|18952003|P1|Received at Least One Dose|First Period||26
7696153|NCT01830595|18952002|P2|STARTED|First Period||28
7696154|NCT01830595|18952003|P1|STARTED|First Period||26
7696155|NCT01830543|18952020|P3|NOT COMPLETED|Overall Study||214
7696156|NCT01830543|18952021|P2|NOT COMPLETED|Overall Study||152
7696157|NCT01830543|18952022|P1|NOT COMPLETED|Overall Study||159
7696158|NCT01830543|18952020|P3|COMPLETED|Overall Study||492
7696159|NCT01830543|18952021|P2|COMPLETED|Overall Study||557
7696160|NCT01830543|18952022|P1|COMPLETED|Overall Study||550
7696161|NCT01830543|18952020|P3|Treated|Overall Study||697
7696162|NCT01830543|18952021|P2|Treated|Overall Study||706
7696163|NCT01830543|18952022|P1|Treated|Overall Study||696
7696164|NCT01830543|18952020|P3|STARTED|Overall Study||706
7696165|NCT01830543|18952021|P2|STARTED|Overall Study||709
7696166|NCT01830543|18952022|P1|STARTED|Overall Study||709
7696167|NCT01830205|18952058|P4|NOT COMPLETED|Overall Study||0
7696168|NCT01830205|18952059|P3|NOT COMPLETED|Overall Study||0
7696169|NCT01830205|18952060|P2|NOT COMPLETED|Overall Study||0
7696170|NCT01830205|18952061|P1|NOT COMPLETED|Overall Study||0
7696171|NCT01830205|18952058|P4|COMPLETED|Overall Study||12
7696172|NCT01830205|18952059|P3|COMPLETED|Overall Study||6
7696173|NCT01830205|18952060|P2|COMPLETED|Overall Study||6
7696174|NCT01830205|18952061|P1|COMPLETED|Overall Study||12
7696175|NCT01830205|18952058|P4|STARTED|Overall Study||12
7696176|NCT01830205|18952059|P3|STARTED|Overall Study||6
7696177|NCT01830205|18952060|P2|STARTED|Overall Study||6
7696178|NCT01830205|18952061|P1|STARTED|Overall Study||12
7696179|NCT01830140|18952145|P2|NOT COMPLETED|Overall Study||4
7696180|NCT01830140|18952146|P1|NOT COMPLETED|Overall Study||7
7696181|NCT01830140|18952145|P2|COMPLETED|Overall Study||229
7696182|NCT01830140|18952146|P1|COMPLETED|Overall Study||226
7696183|NCT01830140|18952145|P2|STARTED|Overall Study||233
7696184|NCT01830140|18952146|P1|STARTED|Overall Study||233
7696185|NCT01830127|18952154|P2|NOT COMPLETED|Overall Study||9
7696186|NCT01830127|18952155|P1|NOT COMPLETED|Overall Study||5
7696187|NCT01830127|18952154|P2|COMPLETED|Overall Study||8
7696188|NCT01830127|18952155|P1|COMPLETED|Overall Study||13
7696189|NCT01830127|18952154|P2|STARTED|Overall Study||17
7696190|NCT01830127|18952155|P1|STARTED|Overall Study||18
7696191|NCT01829997|18952163|P1|NOT COMPLETED|Overall Study||6
7696192|NCT01829997|18952163|P1|COMPLETED|Overall Study||16
7696193|NCT01829997|18952163|P1|STARTED|Overall Study||22
7696194|NCT01829919|18952172|P1|NOT COMPLETED|Overall Study||0
7696195|NCT01829919|18952172|P1|COMPLETED|Overall Study||24
7696196|NCT01829919|18952172|P1|STARTED|Overall Study||24
7696197|NCT01829711|18952188|P1|NOT COMPLETED|Overall Study||43
7696198|NCT01829711|18952188|P1|COMPLETED|Overall Study||37
7696199|NCT01829711|18952188|P1|STARTED|Overall Study||80
7696200|NCT01829516|18952219|P2|NOT COMPLETED|2nd Intervention||0
7696201|NCT01829516|18952220|P1|NOT COMPLETED|2nd Intervention||0
7696202|NCT01829516|18952219|P2|COMPLETED|2nd Intervention||14
7696203|NCT01829516|18952220|P1|COMPLETED|2nd Intervention||18
7696204|NCT01829516|18952219|P2|STARTED|2nd Intervention||14
7696205|NCT01829516|18952220|P1|STARTED|2nd Intervention||18
7696206|NCT01829516|18952219|P2|NOT COMPLETED|Washout Period - 1 Week||0
7696207|NCT01829516|18952220|P1|NOT COMPLETED|Washout Period - 1 Week||0
7696208|NCT01829516|18952219|P2|COMPLETED|Washout Period - 1 Week||14
7696209|NCT01829516|18952220|P1|COMPLETED|Washout Period - 1 Week||18
7696210|NCT01829516|18952219|P2|STARTED|Washout Period - 1 Week||14
7696211|NCT01829516|18952220|P1|STARTED|Washout Period - 1 Week||18
7696212|NCT01829516|18952219|P2|NOT COMPLETED|First Intervention||0
7696213|NCT01829516|18952220|P1|NOT COMPLETED|First Intervention||0
7696214|NCT01829516|18952219|P2|COMPLETED|First Intervention||14
7696215|NCT01829516|18952220|P1|COMPLETED|First Intervention||18
7696216|NCT01829516|18952219|P2|STARTED|First Intervention||14
7696217|NCT01829516|18952220|P1|STARTED|First Intervention||18
7696218|NCT01829503|18952228|P1|NOT COMPLETED|Overall Study||0
7696219|NCT01829503|18952228|P1|COMPLETED|Overall Study||44
7696220|NCT01829503|18952228|P1|STARTED|Overall Study||44
7696221|NCT01829477|18952245|P2|NOT COMPLETED|Overall Study||15
7696222|NCT01829477|18952246|P1|NOT COMPLETED|Overall Study||16
7696223|NCT01829477|18952245|P2|COMPLETED|Overall Study||1
7696224|NCT01829477|18952246|P1|COMPLETED|Overall Study||1
7696225|NCT01829477|18952245|P2|STARTED|Overall Study||16
7696226|NCT01829477|18952246|P1|STARTED|Overall Study||17
7696227|NCT01829464|18952259|P3|NOT COMPLETED|Overall Study||26
7696228|NCT01829464|18952260|P2|NOT COMPLETED|Overall Study||29
7696229|NCT01829464|18952261|P1|NOT COMPLETED|Overall Study||28
7696230|NCT01829464|18952259|P3|COMPLETED|Overall Study||3
7696231|NCT01829464|18952260|P2|COMPLETED|Overall Study||2
7696232|NCT01829464|18952261|P1|COMPLETED|Overall Study||2
7696233|NCT01829464|18952259|P3|STARTED|Overall Study||29
7696234|NCT01829464|18952260|P2|STARTED|Overall Study||31
7696235|NCT01829464|18952261|P1|STARTED|Overall Study||30
7696236|NCT01829425|18952277|P2|NOT COMPLETED|Overall Study||4
7696237|NCT01829425|18952278|P1|NOT COMPLETED|Overall Study||6
7696238|NCT01829425|18952277|P2|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=70|70
7696239|NCT01829425|18952278|P1|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=72|72
7696240|NCT01829425|18952277|P2|STARTED|Overall Study||74
7696241|NCT01829425|18952278|P1|STARTED|Overall Study||78
7696242|NCT01829399|18952308|P2|NOT COMPLETED|Visit 2 (One Month Later)||0
7696243|NCT01829399|18952309|P1|NOT COMPLETED|Visit 2 (One Month Later)||0
7696244|NCT01829399|18952308|P2|COMPLETED|Visit 2 (One Month Later)||12
7696245|NCT01829399|18952309|P1|COMPLETED|Visit 2 (One Month Later)||12
7696246|NCT01829399|18952308|P2|STARTED|Visit 2 (One Month Later)||12
7696247|NCT01829399|18952309|P1|STARTED|Visit 2 (One Month Later)||12
7696248|NCT01829399|18952308|P2|NOT COMPLETED|Visit 1||0
7696249|NCT01829399|18952309|P1|NOT COMPLETED|Visit 1||0
7696250|NCT01829399|18952308|P2|COMPLETED|Visit 1||12
7696251|NCT01829399|18952309|P1|COMPLETED|Visit 1||12
7696252|NCT01829399|18952308|P2|STARTED|Visit 1||12
7696253|NCT01829399|18952309|P1|STARTED|Visit 1||12
7696254|NCT01829360|18952321|P4|NOT COMPLETED|Overall Study||0
7696255|NCT01829360|18952322|P3|NOT COMPLETED|Overall Study||1
7696256|NCT01829360|18952323|P2|NOT COMPLETED|Overall Study||0
7696257|NCT01829360|18952324|P1|NOT COMPLETED|Overall Study||0
7696258|NCT01829360|18952321|P4|COMPLETED|Overall Study||8
7696259|NCT01829360|18952322|P3|COMPLETED|Overall Study||9
7696260|NCT01829360|18952323|P2|COMPLETED|Overall Study||9
7696261|NCT01829360|18952324|P1|COMPLETED|Overall Study||8
7696262|NCT01829360|18952321|P4|STARTED|Overall Study||8
7696263|NCT01829360|18952322|P3|STARTED|Overall Study||10
7696264|NCT01829360|18952323|P2|STARTED|Overall Study||9
7696265|NCT01829360|18952324|P1|STARTED|Overall Study||8
7696266|NCT01829347|18952344|P2|NOT COMPLETED|VTI-210E||6
7696267|NCT01829347|18952345|P1|NOT COMPLETED|VTI-210E||3
7696268|NCT01829347|18952344|P2|COMPLETED|VTI-210E||0
7696269|NCT01829347|18952345|P1|COMPLETED|VTI-210E||0
7696270|NCT01829347|18952344|P2|STARTED|VTI-210E||6
7696271|NCT01829347|18952345|P1|STARTED|VTI-210E||3
7696272|NCT01829347|18952344|P2|NOT COMPLETED|VTI-210||3
7696273|NCT01829347|18952345|P1|NOT COMPLETED|VTI-210||6
7696274|NCT01829347|18952344|P2|COMPLETED|VTI-210||6
7696275|NCT01829347|18952345|P1|COMPLETED|VTI-210||3
7696276|NCT01829347|18952344|P2|STARTED|VTI-210||9
7696277|NCT01829347|18952345|P1|STARTED|VTI-210||9
7696278|NCT01829295|18952355|P4|NOT COMPLETED|6-12 Months||13
7696279|NCT01829295|18952356|P3|NOT COMPLETED|6-12 Months||12
7696280|NCT01829295|18952357|P2|NOT COMPLETED|6-12 Months||2
7696281|NCT01829295|18952358|P1|NOT COMPLETED|6-12 Months||4
7696282|NCT01829295|18952355|P4|COMPLETED|6-12 Months||29
7696283|NCT01829295|18952356|P3|COMPLETED|6-12 Months||20
7696284|NCT01829295|18952357|P2|COMPLETED|6-12 Months||54
7696285|NCT01829295|18952358|P1|COMPLETED|6-12 Months||60
7696286|NCT01829295|18952355|P4|STARTED|6-12 Months|42 patients failed on mycophenolate mofetil within the first 6 months|42
7696287|NCT01829295|18952356|P3|STARTED|6-12 Months|32 patients failed methotrexate within the first 6 months|32
7696288|NCT01829295|18952357|P2|STARTED|6-12 Months|56 patients were a treatment success on mycophenolate mofetil at 6 mo and had the option to continue|56
7696289|NCT01829295|18952358|P1|STARTED|6-12 Months|64 patients were a treatment success on methotrexate at 6 mo and had the option to continue|64
7696290|NCT01829295|18952355|P4|NOT COMPLETED|0-6 Months||0
7696291|NCT01829295|18952356|P3|NOT COMPLETED|0-6 Months||0
7696292|NCT01829295|18952357|P2|NOT COMPLETED|0-6 Months||11
7696293|NCT01829295|18952358|P1|NOT COMPLETED|0-6 Months||11
7696294|NCT01829295|18952355|P4|COMPLETED|0-6 Months||0
7696295|NCT01829295|18952356|P3|COMPLETED|0-6 Months||0
7696296|NCT01829295|18952357|P2|COMPLETED|0-6 Months||98
7696297|NCT01829295|18952358|P1|COMPLETED|0-6 Months||96
7696298|NCT01829295|18952355|P4|STARTED|0-6 Months||0
7696299|NCT01829295|18952356|P3|STARTED|0-6 Months||0
7696300|NCT01829295|18952357|P2|STARTED|0-6 Months||109
7696301|NCT01829295|18952358|P1|STARTED|0-6 Months||107
7696302|NCT01829243|18952368|P2|NOT COMPLETED|Second Intervention||0
7696303|NCT01829243|18952369|P1|NOT COMPLETED|Second Intervention||0
7696304|NCT01829243|18952368|P2|COMPLETED|Second Intervention||13
7696305|NCT01829243|18952369|P1|COMPLETED|Second Intervention||7
7696306|NCT01829243|18952368|P2|STARTED|Second Intervention||13
7696307|NCT01829243|18952369|P1|STARTED|Second Intervention||7
7696308|NCT01829243|18952368|P2|NOT COMPLETED|Washout Period of 1 Week||0
7696309|NCT01829243|18952369|P1|NOT COMPLETED|Washout Period of 1 Week||0
7696310|NCT01829243|18952368|P2|COMPLETED|Washout Period of 1 Week||13
7696311|NCT01829243|18952369|P1|COMPLETED|Washout Period of 1 Week||7
7696312|NCT01829243|18952368|P2|STARTED|Washout Period of 1 Week||13
7696313|NCT01829243|18952369|P1|STARTED|Washout Period of 1 Week||7
7696314|NCT01829243|18952368|P2|NOT COMPLETED|First Intervention||2
7696315|NCT01829243|18952369|P1|NOT COMPLETED|First Intervention||4
7696316|NCT01829243|18952368|P2|COMPLETED|First Intervention||13
7696317|NCT01829243|18952369|P1|COMPLETED|First Intervention||7
7696318|NCT01829243|18952368|P2|STARTED|First Intervention||15
7696319|NCT01829243|18952369|P1|STARTED|First Intervention||11
7696320|NCT01829230|18952383|P2|NOT COMPLETED|Overall Study||4
7696321|NCT01829230|18952384|P1|NOT COMPLETED|Overall Study||1
7696322|NCT01829230|18952383|P2|COMPLETED|Overall Study||38
7696323|NCT01829230|18952384|P1|COMPLETED|Overall Study||39
7696324|NCT01829230|18952383|P2|STARTED|Overall Study||42
7696325|NCT01829230|18952384|P1|STARTED|Overall Study||40
7696326|NCT01829217|18952392|P1|NOT COMPLETED|Overall Study||0
7696327|NCT01829217|18952392|P1|COMPLETED|Overall Study||13
7696328|NCT01829217|18952392|P1|STARTED|Overall Study||13
7696329|NCT01829191|18952398|P2|NOT COMPLETED|Overall Study||14
7696330|NCT01829191|18952399|P1|NOT COMPLETED|Overall Study||7
7696331|NCT01829191|18952398|P2|COMPLETED|Overall Study||50
7696332|NCT01829191|18952399|P1|COMPLETED|Overall Study||56
7696333|NCT01829191|18952398|P2|STARTED|Overall Study||64
7696334|NCT01829191|18952399|P1|STARTED|Overall Study||63
7696335|NCT01829165|18952408|P2|NOT COMPLETED|Overall Study||0
7696336|NCT01829165|18952409|P1|NOT COMPLETED|Overall Study||2
7696337|NCT01829165|18952408|P2|COMPLETED|Overall Study||13
7696338|NCT01829165|18952409|P1|COMPLETED|Overall Study||18
7696339|NCT01829165|18952408|P2|STARTED|Overall Study||13
7696340|NCT01829165|18952409|P1|STARTED|Overall Study||20
7696341|NCT01829113|18952417|P2|NOT COMPLETED|Overall Study||78
7696342|NCT01829113|18952418|P1|NOT COMPLETED|Overall Study||77
7696343|NCT01829113|18952417|P2|COMPLETED|Overall Study||0
7696344|NCT01829113|18952418|P1|COMPLETED|Overall Study||0
7696345|NCT01829113|18952417|P2|STARTED|Overall Study|Two patients were enrolled and randomized but never received treatment.|78
7696346|NCT01829113|18952418|P1|STARTED|Overall Study|Three patients were enrolled and randomized but never received treatment.|77
7696347|NCT01829048|18952435|P5|NOT COMPLETED|Overall Study||0
7696348|NCT01829048|18952436|P4|NOT COMPLETED|Overall Study||2
7696349|NCT01829048|18952437|P3|NOT COMPLETED|Overall Study||0
7696350|NCT01829048|18952438|P2|NOT COMPLETED|Overall Study||0
7696351|NCT01829048|18952439|P1|NOT COMPLETED|Overall Study||0
7696352|NCT01829048|18952435|P5|COMPLETED|Overall Study||2
7696353|NCT01829048|18952436|P4|COMPLETED|Overall Study||12
7696354|NCT01829048|18952437|P3|COMPLETED|Overall Study||7
7696355|NCT01829048|18952438|P2|COMPLETED|Overall Study||8
7696356|NCT01829048|18952439|P1|COMPLETED|Overall Study||6
7696357|NCT01829048|18952435|P5|STARTED|Overall Study||2
7696358|NCT01829048|18952436|P4|STARTED|Overall Study||14
7696359|NCT01829048|18952437|P3|STARTED|Overall Study||7
7696360|NCT01829048|18952438|P2|STARTED|Overall Study||8
7696361|NCT01829048|18952439|P1|STARTED|Overall Study||6
7696362|NCT01828983|18952513|P2|NOT COMPLETED|Overall Study||0
7696363|NCT01828983|18952514|P1|NOT COMPLETED|Overall Study||0
7696364|NCT01828983|18952513|P2|COMPLETED|Overall Study||81
7696365|NCT01828983|18952514|P1|COMPLETED|Overall Study||80
7696366|NCT01828983|18952513|P2|STARTED|Overall Study||81
7696367|NCT01828983|18952514|P1|STARTED|Overall Study||80
7696368|NCT01828593|18952527|P3|NOT COMPLETED|Placebo-Free Phase||6
7696369|NCT01828593|18952528|P2|NOT COMPLETED|Placebo-Free Phase||6
7696370|NCT01828593|18952529|P1|NOT COMPLETED|Placebo-Free Phase||0
7696371|NCT01828593|18952527|P3|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41
7696372|NCT01828593|18952528|P2|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49
7696373|NCT01828593|18952529|P1|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
7696374|NCT01828593|18952527|P3|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47
7696375|NCT01828593|18952528|P2|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55
7696376|NCT01828593|18952529|P1|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
7696377|NCT01828593|18952527|P3|NOT COMPLETED|Placebo-Controlled Phase||1
7696378|NCT01828593|18952528|P2|NOT COMPLETED|Placebo-Controlled Phase||0
7696379|NCT01828593|18952529|P1|NOT COMPLETED|Placebo-Controlled Phase||0
7696380|NCT01828593|18952527|P3|COMPLETED|Placebo-Controlled Phase||32
7696381|NCT01828593|18952528|P2|COMPLETED|Placebo-Controlled Phase||34
7696382|NCT01828593|18952529|P1|COMPLETED|Placebo-Controlled Phase||36
7696383|NCT01828593|18952527|P3|STARTED|Placebo-Controlled Phase||33
7696384|NCT01828593|18952528|P2|STARTED|Placebo-Controlled Phase||34
7696385|NCT01828593|18952529|P1|STARTED|Placebo-Controlled Phase||36
7696386|NCT01828567|18952552|P2|NOT COMPLETED|Overall Study||10
7696387|NCT01828567|18952553|P1|NOT COMPLETED|Overall Study||31
7696388|NCT01828567|18952552|P2|COMPLETED|Overall Study||199
7696389|NCT01828567|18952553|P1|COMPLETED|Overall Study||177
7696390|NCT01828567|18952552|P2|1 Month|Overall Study||192
7696391|NCT01828567|18952553|P1|1 Month|Overall Study||172
7696392|NCT01828567|18952552|P2|STARTED|Overall Study||209
7696393|NCT01828567|18952553|P1|STARTED|Overall Study||208
7696394|NCT01828554|18952569|P1|NOT COMPLETED|Overall Study||0
7696395|NCT01828554|18952569|P1|COMPLETED|Overall Study||8
7696396|NCT01828554|18952569|P1|STARTED|Overall Study||8
7696397|NCT01828515|18952576|P2|NOT COMPLETED|Second Intervention (19 Days)||3
7696398|NCT01828515|18952577|P1|NOT COMPLETED|Second Intervention (19 Days)||0
7696399|NCT01828515|18952576|P2|COMPLETED|Second Intervention (19 Days)||5
7696400|NCT01828515|18952577|P1|COMPLETED|Second Intervention (19 Days)||6
7696401|NCT01828515|18952576|P2|STARTED|Second Intervention (19 Days)||8
7696402|NCT01828515|18952577|P1|STARTED|Second Intervention (19 Days)||6
7696403|NCT01828515|18952576|P2|NOT COMPLETED|Washout (23 Days)||1
7696404|NCT01828515|18952577|P1|NOT COMPLETED|Washout (23 Days)||5
7696405|NCT01828515|18952576|P2|COMPLETED|Washout (23 Days)||8
7696406|NCT01828515|18952577|P1|COMPLETED|Washout (23 Days)||6
7696407|NCT01828515|18952576|P2|STARTED|Washout (23 Days)||9
7696408|NCT01828515|18952577|P1|STARTED|Washout (23 Days)||11
7696409|NCT01828515|18952576|P2|NOT COMPLETED|First Intervention (19 Days)||2
7696410|NCT01828515|18952577|P1|NOT COMPLETED|First Intervention (19 Days)||2
7696411|NCT01828515|18952576|P2|COMPLETED|First Intervention (19 Days)||9
7696412|NCT01828515|18952577|P1|COMPLETED|First Intervention (19 Days)||11
7696413|NCT01828515|18952576|P2|STARTED|First Intervention (19 Days)||11
7696414|NCT01828515|18952577|P1|STARTED|First Intervention (19 Days)||13
7696415|NCT01828476|18952585|P2|NOT COMPLETED|Overall Study||0
7696416|NCT01828476|18952586|P1|NOT COMPLETED|Overall Study||0
7696417|NCT01828476|18952585|P2|COMPLETED|Overall Study||0
7696418|NCT01828476|18952586|P1|COMPLETED|Overall Study||13
7696419|NCT01828476|18952585|P2|STARTED|Overall Study||0
7696420|NCT01828476|18952586|P1|STARTED|Overall Study||13
7696421|NCT01828281|18952608|P2|NOT COMPLETED|Overall Study||0
7696422|NCT01828281|18952609|P1|NOT COMPLETED|Overall Study||1
7696423|NCT01828281|18952608|P2|COMPLETED|Overall Study||45
7696424|NCT01828281|18952609|P1|COMPLETED|Overall Study||44
7696425|NCT01828281|18952608|P2|STARTED|Overall Study||45
7696426|NCT01828281|18952609|P1|STARTED|Overall Study||45
7696427|NCT01828255|18952621|P2|NOT COMPLETED|Overall Study||0
7696428|NCT01828255|18952622|P1|NOT COMPLETED|Overall Study||0
7696429|NCT01828255|18952621|P2|COMPLETED|Overall Study||20
7696430|NCT01828255|18952622|P1|COMPLETED|Overall Study||20
7696431|NCT01828255|18952621|P2|STARTED|Overall Study||20
7696432|NCT01828255|18952622|P1|STARTED|Overall Study||20
7696433|NCT01828216|18952638|P2|NOT COMPLETED|Overall Study||0
7696434|NCT01828216|18952639|P1|NOT COMPLETED|Overall Study||0
7696435|NCT01828216|18952638|P2|COMPLETED|Overall Study||157
7696436|NCT01828216|18952639|P1|COMPLETED|Overall Study||159
7696437|NCT01828216|18952638|P2|STARTED|Overall Study||157
7696438|NCT01828216|18952639|P1|STARTED|Overall Study||159
7696439|NCT01828164|18952647|P1|NOT COMPLETED|Overall Study||17
7696440|NCT01828164|18952647|P1|COMPLETED|Overall Study||32
7696441|NCT01828164|18952647|P1|STARTED|Overall Study|11 out of 60 subjects did not meet inclusion criteria after enrollment.|49
7696442|NCT01828112|18952659|P2|NOT COMPLETED|Overall Study||108
7696443|NCT01828112|18952660|P1|NOT COMPLETED|Overall Study||82
7696444|NCT01828112|18952659|P2|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|8
7696445|NCT01828112|18952660|P1|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|33
7696446|NCT01828112|18952659|P2|Treated|Overall Study||113
7696447|NCT01828112|18952660|P1|Treated|Overall Study||115
7696448|NCT01828112|18952659|P2|Untreated|Overall Study||3
7696449|NCT01828112|18952660|P1|Untreated|Overall Study||0
7696450|NCT01828112|18952659|P2|Untreated Patients|Overall Study|untreated = did not receive study drug|3
7696451|NCT01828112|18952660|P1|Untreated Patients|Overall Study||0
7696452|NCT01828112|18952659|P2|Discontinued From Study|Overall Study||10
7696453|NCT01828112|18952660|P1|Discontinued From Study|Overall Study||14
7696454|NCT01828112|18952659|P2|Entered Survival Follow-up Phase|Overall Study||19
7696455|NCT01828112|18952660|P1|Entered Survival Follow-up Phase|Overall Study||61
7696456|NCT01828112|18952659|P2|Entered Post-treatment Follow-up Phase|Overall Study||5
7696457|NCT01828112|18952660|P1|Entered Post-treatment Follow-up Phase|Overall Study||7
7696458|NCT01828112|18952659|P2|Entered Extension Treatment Phase|Overall Study||74
7696459|NCT01828112|18952660|P1|Entered Extension Treatment Phase|Overall Study||0
7696460|NCT01828112|18952659|P2|STARTED|Overall Study||116
7696461|NCT01828112|18952660|P1|STARTED|Overall Study||115
7696462|NCT01828099|18952668|P2|NOT COMPLETED|Overall Study||157
7696463|NCT01828099|18952669|P1|NOT COMPLETED|Overall Study||94
7696464|NCT01828099|18952668|P2|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|30
7696465|NCT01828099|18952669|P1|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|95
7696466|NCT01828099|18952668|P2|Discontinued From Study|Overall Study||29
7696467|NCT01828099|18952669|P1|Discontinued From Study|Overall Study||20
7696468|NCT01828099|18952668|P2|Entered Survival Follow-up Phase|Overall Study||31
7696469|NCT01828099|18952669|P1|Entered Survival Follow-up Phase|Overall Study||64
7696470|NCT01828099|18952668|P2|Entered Post-treatment Follow-up Phase|Overall Study||16
7696471|NCT01828099|18952669|P1|Entered Post-treatment Follow-up Phase|Overall Study||10
7696472|NCT01828099|18952668|P2|Entered Extension-treatment Phase|Overall Study||81
7696473|NCT01828099|18952669|P1|Entered Extension-treatment Phase|Overall Study||0
7696474|NCT01828099|18952668|P2|Discontinued From Treatment Phase|Overall Study||157
7696475|NCT01828099|18952669|P1|Discontinued From Treatment Phase|Overall Study||94
7696476|NCT01828099|18952668|P2|Treated|Overall Study||175
7696477|NCT01828099|18952669|P1|Treated|Overall Study|discontinued from treatment phase = Not completed|189
7696478|NCT01828099|18952668|P2|Untreated Patients|Overall Study||12
7696479|NCT01828099|18952669|P1|Untreated Patients|Overall Study||0
7696480|NCT01828099|18952668|P2|STARTED|Overall Study||187
7696481|NCT01828099|18952669|P1|STARTED|Overall Study||189
7696482|NCT01828073|18952677|P2|NOT COMPLETED|Overall Study||2
7696483|NCT01828073|18952678|P1|NOT COMPLETED|Overall Study||1
7696484|NCT01828073|18952677|P2|COMPLETED|Overall Study||16
7696485|NCT01828073|18952678|P1|COMPLETED|Overall Study||21
7696486|NCT01828073|18952677|P2|STARTED|Overall Study||18
7696487|NCT01828073|18952678|P1|STARTED|Overall Study||22
7696488|NCT01828034|18952702|P4|NOT COMPLETED|Overall Study||1
7696489|NCT01828034|18952703|P3|NOT COMPLETED|Overall Study||0
7696490|NCT01828034|18952704|P2|NOT COMPLETED|Overall Study||0
7696491|NCT01828034|18952705|P1|NOT COMPLETED|Overall Study||0
7696492|NCT01828034|18952702|P4|COMPLETED|Overall Study||29
7696493|NCT01828034|18952703|P3|COMPLETED|Overall Study||3
7696494|NCT01828034|18952704|P2|COMPLETED|Overall Study||6
7696495|NCT01828034|18952705|P1|COMPLETED|Overall Study||3
7696496|NCT01828034|18952702|P4|STARTED|Overall Study||30
7696497|NCT01828034|18952703|P3|STARTED|Overall Study||3
7696498|NCT01828034|18952704|P2|STARTED|Overall Study||6
7696499|NCT01828034|18952705|P1|STARTED|Overall Study||3
7696500|NCT01828021|18952717|P1|NOT COMPLETED|Overall Study||25
7696501|NCT01828021|18952717|P1|COMPLETED|Overall Study||0
7696502|NCT01828021|18952717|P1|STARTED|Overall Study||25
7696503|NCT01827930|18952725|P3|NOT COMPLETED|Overall Study||0
7696504|NCT01827930|18952726|P2|NOT COMPLETED|Overall Study||0
7696505|NCT01827930|18952727|P1|NOT COMPLETED|Overall Study||0
7696506|NCT01827930|18952725|P3|COMPLETED|Overall Study||19
7696507|NCT01827930|18952726|P2|COMPLETED|Overall Study||25
7696508|NCT01827930|18952727|P1|COMPLETED|Overall Study||24
7696509|NCT01827930|18952725|P3|STARTED|Overall Study||19
7696510|NCT01827930|18952726|P2|STARTED|Overall Study||25
7696511|NCT01827930|18952727|P1|STARTED|Overall Study||24
7696512|NCT01827839|18952756|P1|NOT COMPLETED|Overall Study||3
7696513|NCT01827839|18952756|P1|COMPLETED|Overall Study||93
7696514|NCT01827839|18952756|P1|STARTED|Overall Study||96
7696515|NCT01827787|18952780|P2|NOT COMPLETED|Overall Study||0
7696516|NCT01827787|18952781|P1|NOT COMPLETED|Overall Study||0
7696517|NCT01827787|18952780|P2|COMPLETED|Overall Study||38
7696518|NCT01827787|18952781|P1|COMPLETED|Overall Study||45
7696519|NCT01827787|18952780|P2|STARTED|Overall Study||38
7696520|NCT01827787|18952781|P1|STARTED|Overall Study||45
7696521|NCT01827670|18952801|P2|NOT COMPLETED|Overall Study||3
7696522|NCT01827670|18952802|P1|NOT COMPLETED|Overall Study||3
7696523|NCT01827670|18952801|P2|COMPLETED|Overall Study||56
7696524|NCT01827670|18952802|P1|COMPLETED|Overall Study||57
7696525|NCT01827670|18952801|P2|STARTED|Overall Study||59
7696526|NCT01827670|18952802|P1|STARTED|Overall Study||60
7696527|NCT01827592|18952821|P3|NOT COMPLETED|Overall Study||76
7696528|NCT01827592|18952822|P2|NOT COMPLETED|Overall Study||80
7696529|NCT01827592|18952823|P1|NOT COMPLETED|Overall Study||74
7696530|NCT01827592|18952821|P3|COMPLETED|Overall Study||48
7696531|NCT01827592|18952822|P2|COMPLETED|Overall Study||46
7696532|NCT01827592|18952823|P1|COMPLETED|Overall Study||52
7696533|NCT01827592|18952821|P3|Safety Analysis Set|Overall Study||124
7696534|NCT01827592|18952822|P2|Safety Analysis Set|Overall Study||126
7696535|NCT01827592|18952823|P1|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125
7696536|NCT01827592|18952821|P3|STARTED|Overall Study|Randomized patients.|124
7696537|NCT01827592|18952822|P2|STARTED|Overall Study|Randomized patients.|126
7696538|NCT01827592|18952823|P1|STARTED|Overall Study|Randomized patients.|126
7696539|NCT01827475|18952855|P3|NOT COMPLETED|Overall Study||0
7696540|NCT01827475|18952856|P2|NOT COMPLETED|Overall Study||0
7696541|NCT01827475|18952857|P1|NOT COMPLETED|Overall Study||0
7696542|NCT01827475|18952855|P3|COMPLETED|Overall Study||30
7696543|NCT01827475|18952856|P2|COMPLETED|Overall Study||30
7696544|NCT01827475|18952857|P1|COMPLETED|Overall Study||30
7696545|NCT01827475|18952855|P3|STARTED|Overall Study||30
7696546|NCT01827475|18952856|P2|STARTED|Overall Study||30
7696547|NCT01827475|18952857|P1|STARTED|Overall Study||30
7696548|NCT01827462|18952871|P3|NOT COMPLETED|Overall Study||28
7696549|NCT01827462|18952872|P2|NOT COMPLETED|Overall Study||18
7696550|NCT01827462|18952873|P1|NOT COMPLETED|Overall Study||41
7696551|NCT01827462|18952871|P3|COMPLETED|Overall Study||12
7696552|NCT01827462|18952872|P2|COMPLETED|Overall Study||19
7696553|NCT01827462|18952873|P1|COMPLETED|Overall Study||18
7696554|NCT01827462|18952871|P3|STARTED|Overall Study||40
7696555|NCT01827462|18952872|P2|STARTED|Overall Study||37
7696556|NCT01827462|18952873|P1|STARTED|Overall Study||59
7696557|NCT01827371|18952888|P4|NOT COMPLETED|Overall Study||23
7696558|NCT01827371|18952889|P3|NOT COMPLETED|Overall Study||11
7696559|NCT01827371|18952890|P2|NOT COMPLETED|Overall Study||7
7696560|NCT01827371|18952891|P1|NOT COMPLETED|Overall Study||13
7696561|NCT01827371|18952888|P4|COMPLETED|Overall Study||97
7696562|NCT01827371|18952889|P3|COMPLETED|Overall Study||93
7696563|NCT01827371|18952890|P2|COMPLETED|Overall Study||89
7696564|NCT01827371|18952891|P1|COMPLETED|Overall Study||102
7696565|NCT01827371|18952888|P4|STARTED|Overall Study||120
7696566|NCT01827371|18952889|P3|STARTED|Overall Study||104
7696567|NCT01827371|18952890|P2|STARTED|Overall Study||96
7696568|NCT01827371|18952891|P1|STARTED|Overall Study||115
7696569|NCT01827358|18952915|P2|NOT COMPLETED|Overall Study||31
7696570|NCT01827358|18952916|P1|NOT COMPLETED|Overall Study||35
7696571|NCT01827358|18952915|P2|COMPLETED|Overall Study||44
7696572|NCT01827358|18952916|P1|COMPLETED|Overall Study||45
7696573|NCT01827358|18952915|P2|STARTED|Overall Study||75
7696574|NCT01827358|18952916|P1|STARTED|Overall Study||80
7696575|NCT01827332|18952950|P2|NOT COMPLETED|Overall Study||1
7696576|NCT01827332|18952951|P1|NOT COMPLETED|Overall Study||2
7696577|NCT01827332|18952950|P2|COMPLETED|Overall Study||7
7696578|NCT01827332|18952951|P1|COMPLETED|Overall Study||6
7696579|NCT01827332|18952950|P2|STARTED|Overall Study||8
7696580|NCT01827332|18952951|P1|STARTED|Overall Study||8
7696581|NCT01827319|18952959|P1|NOT COMPLETED|Overall Study||3
7696582|NCT01827319|18952959|P1|COMPLETED|Overall Study||200
7696583|NCT01827319|18952959|P1|STARTED|Overall Study||203
7696584|NCT01827306|18952967|P2|NOT COMPLETED|Overall Study||5
7696585|NCT01827306|18952968|P1|NOT COMPLETED|Overall Study||11
7696586|NCT01827306|18952967|P2|COMPLETED|Overall Study||8
7696587|NCT01827306|18952968|P1|COMPLETED|Overall Study||10
7696588|NCT01827306|18952967|P2|STARTED|Overall Study||13
7696589|NCT01827306|18952968|P1|STARTED|Overall Study||21
7696590|NCT01827267|18952982|P2|NOT COMPLETED|Overall Study||12
7696591|NCT01827267|18952983|P1|NOT COMPLETED|Overall Study||5
7696592|NCT01827267|18952982|P2|COMPLETED|Overall Study||32
7696593|NCT01827267|18952983|P1|COMPLETED|Overall Study||13
7696594|NCT01827267|18952982|P2|Crossed Over to Neratinib + Temsirolimus|Overall Study||0
7696595|NCT01827267|18952983|P1|Crossed Over to Neratinib + Temsirolimus|Overall Study||11
7696596|NCT01827267|18952982|P2|Received Study Drug|Overall Study||43
7696597|NCT01827267|18952983|P1|Received Study Drug|Overall Study||17
7696598|NCT01827267|18952982|P2|STARTED|Overall Study|44 subjects were randomized; 43 subjects were treated.|44
7696599|NCT01827267|18952983|P1|STARTED|Overall Study|18 subjects were randomized but 17 received treatment.|18
7696600|NCT01827254|18952998|P1|NOT COMPLETED|Overall Study||59
7696601|NCT01827254|18952998|P1|COMPLETED|Overall Study||2
7696602|NCT01827254|18952998|P1|Evaluable Population|Overall Study||52
7696603|NCT01827254|18952998|P1|STARTED|Overall Study||61
7696604|NCT01827163|18953008|P1|NOT COMPLETED|Overall Study||11
7696605|NCT01827163|18953008|P1|COMPLETED|Overall Study||9
7696606|NCT01827163|18953008|P1|STARTED|Overall Study||20
7696607|NCT01827046|18953015|P2|NOT COMPLETED|Overall Study||9
7696608|NCT01827046|18953016|P1|NOT COMPLETED|Overall Study||1
7696609|NCT01827046|18953015|P2|COMPLETED|Overall Study||240
7696610|NCT01827046|18953016|P1|COMPLETED|Overall Study||249
7696611|NCT01827046|18953015|P2|STARTED|Overall Study||249
7696612|NCT01827046|18953016|P1|STARTED|Overall Study||250
7696613|NCT01826981|18953071|P15|NOT COMPLETED|Overall Study||0
7696614|NCT01826981|18953072|P14|NOT COMPLETED|Overall Study||5
7696615|NCT01826981|18953073|P13|NOT COMPLETED|Overall Study||1
7696616|NCT01826981|18953074|P12|NOT COMPLETED|Overall Study||2
7696617|NCT01826981|18953075|P11|NOT COMPLETED|Overall Study||2
7696618|NCT01826981|18953076|P10|NOT COMPLETED|Overall Study||1
7696619|NCT01826981|18953077|P9|NOT COMPLETED|Overall Study||7
7696620|NCT01826981|18953078|P8|NOT COMPLETED|Overall Study||11
7696621|NCT01826981|18953079|P7|NOT COMPLETED|Overall Study||1
7696622|NCT01826981|18953080|P6|NOT COMPLETED|Overall Study||1
7696623|NCT01826981|18953081|P5|NOT COMPLETED|Overall Study||7
7696624|NCT01826981|18953082|P4|NOT COMPLETED|Overall Study||0
7696625|NCT01826981|18953083|P3|NOT COMPLETED|Overall Study||0
7696626|NCT01826981|18953084|P2|NOT COMPLETED|Overall Study||1
7696627|NCT01826981|18953085|P1|NOT COMPLETED|Overall Study||0
7696628|NCT01826981|18953071|P15|COMPLETED|Overall Study||8
7696629|NCT01826981|18953072|P14|COMPLETED|Overall Study||15
7696630|NCT01826981|18953073|P13|COMPLETED|Overall Study||25
7696631|NCT01826981|18953074|P12|COMPLETED|Overall Study||25
7696632|NCT01826981|18953075|P11|COMPLETED|Overall Study||22
7696633|NCT01826981|18953076|P10|COMPLETED|Overall Study||26
7696634|NCT01826981|18953077|P9|COMPLETED|Overall Study||13
7696635|NCT01826981|18953078|P8|COMPLETED|Overall Study||40
7696636|NCT01826981|18953079|P7|COMPLETED|Overall Study||24
7696637|NCT01826981|18953080|P6|COMPLETED|Overall Study||25
7696638|NCT01826981|18953081|P5|COMPLETED|Overall Study||18
7696639|NCT01826981|18953082|P4|COMPLETED|Overall Study||26
7696640|NCT01826981|18953083|P3|COMPLETED|Overall Study||25
7696641|NCT01826981|18953084|P2|COMPLETED|Overall Study||9
7696642|NCT01826981|18953085|P1|COMPLETED|Overall Study||19
7696643|NCT01826981|18953071|P15|STARTED|Overall Study||8
7696644|NCT01826981|18953072|P14|STARTED|Overall Study||20
7696645|NCT01826981|18953073|P13|STARTED|Overall Study||26
7696646|NCT01826981|18953074|P12|STARTED|Overall Study||27
7696647|NCT01826981|18953075|P11|STARTED|Overall Study||24
7696648|NCT01826981|18953076|P10|STARTED|Overall Study||27
7696649|NCT01826981|18953077|P9|STARTED|Overall Study||20
7696650|NCT01826981|18953078|P8|STARTED|Overall Study||51
7696651|NCT01826981|18953079|P7|STARTED|Overall Study||25
7696652|NCT01826981|18953080|P6|STARTED|Overall Study||26
7696653|NCT01826981|18953081|P5|STARTED|Overall Study||25
7696654|NCT01826981|18953082|P4|STARTED|Overall Study||26
7696655|NCT01826981|18953083|P3|STARTED|Overall Study||25
7696656|NCT01826981|18953084|P2|STARTED|Overall Study||10
7696657|NCT01826981|18953085|P1|STARTED|Overall Study||19
7696658|NCT01826851|18953233|P2|NOT COMPLETED|Overall Study||0
7696659|NCT01826851|18953234|P1|NOT COMPLETED|Overall Study||0
7696660|NCT01826851|18953233|P2|COMPLETED|Overall Study||41
7696661|NCT01826851|18953234|P1|COMPLETED|Overall Study||38
7696662|NCT01826851|18953233|P2|STARTED|Overall Study||41
7696663|NCT01826851|18953234|P1|STARTED|Overall Study||38
7696664|NCT01826812|18953254|P2|NOT COMPLETED|Overall Study||1
7696665|NCT01826812|18953255|P1|NOT COMPLETED|Overall Study||0
7696666|NCT01826812|18953254|P2|COMPLETED|Overall Study||32
7696667|NCT01826812|18953255|P1|COMPLETED|Overall Study||167
7696668|NCT01826812|18953254|P2|STARTED|Overall Study||33
7696669|NCT01826812|18953255|P1|STARTED|Overall Study||167
7696670|NCT01826604|18953271|P2|NOT COMPLETED|Overall Study||9
7696671|NCT01826604|18953272|P1|NOT COMPLETED|Overall Study||8
7696672|NCT01826604|18953271|P2|COMPLETED|Overall Study||148
7696673|NCT01826604|18953272|P1|COMPLETED|Overall Study||136
7696674|NCT01826604|18953271|P2|STARTED|Overall Study||157
7696675|NCT01826604|18953272|P1|STARTED|Overall Study||144
7696676|NCT01826513|18953283|P3|NOT COMPLETED|Overall Study||0
7696677|NCT01826513|18953284|P2|NOT COMPLETED|Overall Study||0
7696678|NCT01826513|18953285|P1|NOT COMPLETED|Overall Study||0
7696679|NCT01826513|18953283|P3|COMPLETED|Overall Study||10
7696680|NCT01826513|18953284|P2|COMPLETED|Overall Study||10
7696681|NCT01826513|18953285|P1|COMPLETED|Overall Study||5
7696682|NCT01826513|18953283|P3|STARTED|Overall Study||10
7696683|NCT01826513|18953284|P2|STARTED|Overall Study||10
7696684|NCT01826513|18953285|P1|STARTED|Overall Study||5
7696685|NCT01826487|18953316|P2|NOT COMPLETED|Overall Study||5
7696686|NCT01826487|18953317|P1|NOT COMPLETED|Overall Study||4
7696687|NCT01826487|18953316|P2|COMPLETED|Overall Study||110
7696688|NCT01826487|18953317|P1|COMPLETED|Overall Study||111
7696689|NCT01826487|18953316|P2|ITT Population|Overall Study||114
7696690|NCT01826487|18953317|P1|ITT Population|Overall Study||114
7696691|NCT01826487|18953316|P2|As-treated Population|Overall Study||115
7696692|NCT01826487|18953317|P1|As-treated Population|Overall Study||115
7696693|NCT01826487|18953316|P2|STARTED|Overall Study||115
7696694|NCT01826487|18953317|P1|STARTED|Overall Study||115
7696695|NCT01826448|18953344|P2|NOT COMPLETED|Overall Study||9
7696696|NCT01826448|18953345|P1|NOT COMPLETED|Overall Study||4
7696697|NCT01826448|18953344|P2|COMPLETED|Overall Study||0
7696698|NCT01826448|18953345|P1|COMPLETED|Overall Study||0
7696699|NCT01826448|18953344|P2|STARTED|Overall Study||9
7696700|NCT01826448|18953345|P1|STARTED|Overall Study||4
7696701|NCT01826422|18953353|P2|NOT COMPLETED|Overall Study||3
7696702|NCT01826422|18953354|P1|NOT COMPLETED|Overall Study||1
7696703|NCT01826422|18953353|P2|COMPLETED|Overall Study||19
7696704|NCT01826422|18953354|P1|COMPLETED|Overall Study||17
7696705|NCT01826422|18953353|P2|STARTED|Overall Study||22
7696706|NCT01826422|18953354|P1|STARTED|Overall Study||18
7696707|NCT01826370|18953398|P1|NOT COMPLETED|Overall Study||20
7696708|NCT01826370|18953398|P1|COMPLETED|Overall Study||658
7696709|NCT01826370|18953398|P1|STARTED|Overall Study||678
7696710|NCT01826227|18953404|P1|NOT COMPLETED|Overall Study||0
7696711|NCT01826227|18953404|P1|COMPLETED|Overall Study||5
7696712|NCT01826227|18953404|P1|STARTED|Overall Study||5
7696713|NCT01826214|18953410|P2|NOT COMPLETED|Overall Study||34
7696714|NCT01826214|18953411|P1|NOT COMPLETED|Overall Study||35
7696715|NCT01826214|18953410|P2|COMPLETED|Overall Study||0
7696716|NCT01826214|18953411|P1|COMPLETED|Overall Study||0
7696717|NCT01826214|18953410|P2|Treated|Overall Study|Treated = received at least one dose of study drug|34
7696718|NCT01826214|18953411|P1|Treated|Overall Study|Treated = received at least one dose of study drug|35
7696719|NCT01826214|18953410|P2|Untreated|Overall Study|Untreated = did not receive study drug|1
7696720|NCT01826214|18953411|P1|Untreated|Overall Study|Untreated = did not receive study drug|0
7696814|NCT01825785|18953532|P3|NOT COMPLETED|Overall Study||0
7696721|NCT01826214|18953410|P2|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34
7696722|NCT01826214|18953411|P1|STARTED|Overall Study||35
7696723|NCT01826201|18953429|P1|NOT COMPLETED|Overall Study||4
7696724|NCT01826201|18953429|P1|COMPLETED|Overall Study||17
7696725|NCT01826201|18953429|P1|STARTED|Overall Study|Subjects in each arm are same|21
7696726|NCT01825941|18953437|P2|NOT COMPLETED|Overall Study||1
7696727|NCT01825941|18953438|P1|NOT COMPLETED|Overall Study||4
7696728|NCT01825941|18953437|P2|COMPLETED|Overall Study||103
7696729|NCT01825941|18953438|P1|COMPLETED|Overall Study||100
7696730|NCT01825941|18953437|P2|STARTED|Overall Study||104
7696731|NCT01825941|18953438|P1|STARTED|Overall Study||104
7696732|NCT01825889|18953446|P2|NOT COMPLETED|Overall Study||0
7696733|NCT01825889|18953447|P1|NOT COMPLETED|Overall Study||0
7696734|NCT01825889|18953446|P2|COMPLETED|Overall Study||10
7696735|NCT01825889|18953447|P1|COMPLETED|Overall Study||10
7696736|NCT01825889|18953446|P2|Received One Dose of Study Drug|Overall Study||10
7696737|NCT01825889|18953447|P1|Received One Dose of Study Drug|Overall Study||10
7696738|NCT01825889|18953446|P2|STARTED|Overall Study||10
7696739|NCT01825889|18953447|P1|STARTED|Overall Study||10
7696740|NCT01825876|18953457|P2|NOT COMPLETED|Period 2||1
7696741|NCT01825876|18953458|P1|NOT COMPLETED|Period 2||0
7696742|NCT01825876|18953457|P2|COMPLETED|Period 2||16
7696743|NCT01825876|18953458|P1|COMPLETED|Period 2||0
7696744|NCT01825876|18953457|P2|Received 1 Dose of Study Drug|Period 2||17
7696745|NCT01825876|18953458|P1|Received 1 Dose of Study Drug|Period 2||0
7696746|NCT01825876|18953457|P2|STARTED|Period 2|Participants received a different treatment in Period 1.|17
7696747|NCT01825876|18953458|P1|STARTED|Period 2|Participants received a different treatment in Period 2.|0
7696748|NCT01825876|18953457|P2|NOT COMPLETED|Period 1||0
7696749|NCT01825876|18953458|P1|NOT COMPLETED|Period 1||0
7696750|NCT01825876|18953457|P2|COMPLETED|Period 1||0
7696751|NCT01825876|18953458|P1|COMPLETED|Period 1||17
7696752|NCT01825876|18953457|P2|Received 1 Dose of Study Drug|Period 1||0
7696753|NCT01825876|18953458|P1|Received 1 Dose of Study Drug|Period 1||17
7696754|NCT01825876|18953457|P2|STARTED|Period 1||0
7696755|NCT01825876|18953458|P1|STARTED|Period 1||17
7696756|NCT01825837|18953479|P4|NOT COMPLETED|PART II||0
7696757|NCT01825837|18953480|P3|NOT COMPLETED|PART II||19
7696758|NCT01825837|18953481|P2|NOT COMPLETED|PART II||14
7696759|NCT01825837|18953482|P1|NOT COMPLETED|PART II||19
7696760|NCT01825837|18953479|P4|COMPLETED|PART II||0
7696761|NCT01825837|18953480|P3|COMPLETED|PART II||7
7696762|NCT01825837|18953481|P2|COMPLETED|PART II||12
7696763|NCT01825837|18953482|P1|COMPLETED|PART II||16
7696764|NCT01825837|18953479|P4|Per-Protocol Population|PART II||0
7696765|NCT01825837|18953480|P3|Per-Protocol Population|PART II||24
7696766|NCT01825837|18953481|P2|Per-Protocol Population|PART II||23
7696767|NCT01825837|18953482|P1|Per-Protocol Population|PART II||32
7696768|NCT01825837|18953479|P4|Intent-to-Treat Population|PART II||0
7696769|NCT01825837|18953480|P3|Intent-to-Treat Population|PART II||26
7696770|NCT01825837|18953481|P2|Intent-to-Treat Population|PART II||25
7696771|NCT01825837|18953482|P1|Intent-to-Treat Population|PART II||34
7696772|NCT01825837|18953479|P4|Safety Population (Double-Blind)|PART II||0
7696773|NCT01825837|18953480|P3|Safety Population (Double-Blind)|PART II||26
7696774|NCT01825837|18953481|P2|Safety Population (Double-Blind)|PART II||26
7696775|NCT01825837|18953482|P1|Safety Population (Double-Blind)|PART II||35
7696776|NCT01825837|18953479|P4|Randomized Patients|PART II||0
7696777|NCT01825837|18953480|P3|Randomized Patients|PART II||26
7696778|NCT01825837|18953481|P2|Randomized Patients|PART II||26
7696779|NCT01825837|18953482|P1|Randomized Patients|PART II||35
7696780|NCT01825837|18953479|P4|STARTED|PART II||0
7696781|NCT01825837|18953480|P3|STARTED|PART II||26
7696782|NCT01825837|18953481|P2|STARTED|PART II||26
7696783|NCT01825837|18953482|P1|STARTED|PART II||35
7696784|NCT01825837|18953479|P4|NOT COMPLETED|PART I||17
7696785|NCT01825837|18953480|P3|NOT COMPLETED|PART I||0
7696786|NCT01825837|18953481|P2|NOT COMPLETED|PART I||0
7696787|NCT01825837|18953482|P1|NOT COMPLETED|PART I||0
7696788|NCT01825837|18953479|P4|COMPLETED|PART I||87
7696789|NCT01825837|18953480|P3|COMPLETED|PART I||0
7696790|NCT01825837|18953481|P2|COMPLETED|PART I||0
7696791|NCT01825837|18953482|P1|COMPLETED|PART I||0
7696792|NCT01825837|18953479|P4|Safety Population (Open-Label)|PART I||104
7696793|NCT01825837|18953480|P3|Safety Population (Open-Label)|PART I||0
7696794|NCT01825837|18953481|P2|Safety Population (Open-Label)|PART I||0
7696795|NCT01825837|18953482|P1|Safety Population (Open-Label)|PART I||0
7696796|NCT01825837|18953479|P4|Enrolled|PART I||104
7696797|NCT01825837|18953480|P3|Enrolled|PART I||0
7696798|NCT01825837|18953481|P2|Enrolled|PART I||0
7696799|NCT01825837|18953482|P1|Enrolled|PART I||0
7696800|NCT01825837|18953479|P4|STARTED|PART I||104
7696801|NCT01825837|18953480|P3|STARTED|PART I||0
7696802|NCT01825837|18953481|P2|STARTED|PART I||0
7696803|NCT01825837|18953482|P1|STARTED|PART I||0
7696804|NCT01825798|18953492|P2|NOT COMPLETED|Overall Study||5
7696805|NCT01825798|18953493|P1|NOT COMPLETED|Overall Study||2
7696806|NCT01825798|18953492|P2|COMPLETED|Overall Study||23
7696807|NCT01825798|18953493|P1|COMPLETED|Overall Study||30
7696808|NCT01825798|18953492|P2|STARTED|Overall Study||28
7696809|NCT01825798|18953493|P1|STARTED|Overall Study||32
7696810|NCT01825785|18953528|P7|NOT COMPLETED|Overall Study||0
7696811|NCT01825785|18953529|P6|NOT COMPLETED|Overall Study||1
7696812|NCT01825785|18953530|P5|NOT COMPLETED|Overall Study||2
7696813|NCT01825785|18953531|P4|NOT COMPLETED|Overall Study||0
7696815|NCT01825785|18953533|P2|NOT COMPLETED|Overall Study||0
7696816|NCT01825785|18953534|P1|NOT COMPLETED|Overall Study||0
7696817|NCT01825785|18953528|P7|COMPLETED|Overall Study||6
7696818|NCT01825785|18953529|P6|COMPLETED|Overall Study||5
7696819|NCT01825785|18953530|P5|COMPLETED|Overall Study||4
7696820|NCT01825785|18953531|P4|COMPLETED|Overall Study||6
7696821|NCT01825785|18953532|P3|COMPLETED|Overall Study||6
7696822|NCT01825785|18953533|P2|COMPLETED|Overall Study||6
7696823|NCT01825785|18953534|P1|COMPLETED|Overall Study||12
7696824|NCT01825785|18953528|P7|STARTED|Overall Study||6
7696825|NCT01825785|18953529|P6|STARTED|Overall Study||6
7696826|NCT01825785|18953530|P5|STARTED|Overall Study||6
7696827|NCT01825785|18953531|P4|STARTED|Overall Study||6
7696828|NCT01825785|18953532|P3|STARTED|Overall Study||6
7696829|NCT01825785|18953533|P2|STARTED|Overall Study||6
7696830|NCT01825785|18953534|P1|STARTED|Overall Study||12
7696831|NCT01825655|18953680|P2|NOT COMPLETED|Overall Study||0
7696832|NCT01825655|18953681|P1|NOT COMPLETED|Overall Study||0
7696833|NCT01825655|18953680|P2|COMPLETED|Overall Study||2
7696834|NCT01825655|18953681|P1|COMPLETED|Overall Study||0
7696835|NCT01825655|18953680|P2|STARTED|Overall Study||2
7696836|NCT01825655|18953681|P1|STARTED|Overall Study||0
7696837|NCT01825577|18953687|P1|NOT COMPLETED|Overall Study||8
7696838|NCT01825577|18953687|P1|COMPLETED|Overall Study||6
7696839|NCT01825577|18953687|P1|STARTED|Overall Study||14
7696840|NCT01825408|18953696|P4|NOT COMPLETED|Overall Study||0
7696841|NCT01825408|18953697|P3|NOT COMPLETED|Overall Study||0
7696842|NCT01825408|18953698|P2|NOT COMPLETED|Overall Study||0
7696843|NCT01825408|18953699|P1|NOT COMPLETED|Overall Study||0
7696844|NCT01825408|18953696|P4|COMPLETED|Overall Study||12
7696845|NCT01825408|18953697|P3|COMPLETED|Overall Study||14
7696846|NCT01825408|18953698|P2|COMPLETED|Overall Study||7
7696847|NCT01825408|18953699|P1|COMPLETED|Overall Study||7
7696848|NCT01825408|18953696|P4|STARTED|Overall Study||12
7696849|NCT01825408|18953697|P3|STARTED|Overall Study||14
7696850|NCT01825408|18953698|P2|STARTED|Overall Study||7
7696851|NCT01825408|18953699|P1|STARTED|Overall Study||7
7696852|NCT01825200|18953711|P2|NOT COMPLETED|Overall Study||7
7696853|NCT01825200|18953712|P1|NOT COMPLETED|Overall Study||5
7696854|NCT01825200|18953711|P2|COMPLETED|Overall Study||1314
7696855|NCT01825200|18953712|P1|COMPLETED|Overall Study||1314
7696856|NCT01825200|18953711|P2|STARTED|Overall Study||1321
7696857|NCT01825200|18953712|P1|STARTED|Overall Study||1319
7696858|NCT01825122|18953726|P2|NOT COMPLETED|Overall Study||19
7696859|NCT01825122|18953727|P1|NOT COMPLETED|Overall Study||10
7696860|NCT01825122|18953726|P2|COMPLETED|Overall Study||59
7696861|NCT01825122|18953727|P1|COMPLETED|Overall Study||67
7696862|NCT01825122|18953726|P2|STARTED|Overall Study||78
7696863|NCT01825122|18953727|P1|STARTED|Overall Study||77
7696864|NCT01824979|18953735|P2|NOT COMPLETED|Overall Study||13
7696865|NCT01824979|18953736|P1|NOT COMPLETED|Overall Study||13
7696866|NCT01824979|18953735|P2|COMPLETED|Overall Study||37
7696867|NCT01824979|18953736|P1|COMPLETED|Overall Study||37
7696868|NCT01824979|18953735|P2|STARTED|Overall Study||50
7696869|NCT01824979|18953736|P1|STARTED|Overall Study||50
7696870|NCT01824901|18953744|P4|NOT COMPLETED|Overall Study||0
7696871|NCT01824901|18953745|P3|NOT COMPLETED|Overall Study||0
7696872|NCT01824901|18953746|P2|NOT COMPLETED|Overall Study||0
7696873|NCT01824901|18953747|P1|NOT COMPLETED|Overall Study||0
7696874|NCT01824901|18953744|P4|COMPLETED|Overall Study||0
7696875|NCT01824901|18953745|P3|COMPLETED|Overall Study||0
7696876|NCT01824901|18953746|P2|COMPLETED|Overall Study||0
7696877|NCT01824901|18953747|P1|COMPLETED|Overall Study||2
7696878|NCT01824901|18953744|P4|STARTED|Overall Study||0
7696879|NCT01824901|18953745|P3|STARTED|Overall Study||0
7696880|NCT01824901|18953746|P2|STARTED|Overall Study||0
7696881|NCT01824901|18953747|P1|STARTED|Overall Study||2
7696882|NCT01824823|18953753|P2|NOT COMPLETED|Overall Study||1
7696883|NCT01824823|18953754|P1|NOT COMPLETED|Overall Study||2
7696884|NCT01824823|18953753|P2|COMPLETED|Overall Study||0
7696885|NCT01824823|18953754|P1|COMPLETED|Overall Study||0
7696886|NCT01824823|18953753|P2|STARTED|Overall Study||1
7696887|NCT01824823|18953754|P1|STARTED|Overall Study||2
7696888|NCT01824693|18953763|P3|NOT COMPLETED|Overall Study||15
7696889|NCT01824693|18953764|P2|NOT COMPLETED|Overall Study||7
7696890|NCT01824693|18953765|P1|NOT COMPLETED|Overall Study||1
7696891|NCT01824693|18953763|P3|COMPLETED|Overall Study||0
7696892|NCT01824693|18953764|P2|COMPLETED|Overall Study||2
7696893|NCT01824693|18953765|P1|COMPLETED|Overall Study||5
7696894|NCT01824693|18953763|P3|STARTED|Overall Study||15
7696895|NCT01824693|18953764|P2|STARTED|Overall Study||9
7696896|NCT01824693|18953765|P1|STARTED|Overall Study||6
7696897|NCT01824602|18953782|P4|NOT COMPLETED|Overall Study||5
7696898|NCT01824602|18953783|P3|NOT COMPLETED|Overall Study||4
7696899|NCT01824602|18953784|P2|NOT COMPLETED|Overall Study||0
7696900|NCT01824602|18953785|P1|NOT COMPLETED|Overall Study||1
7696901|NCT01824602|18953782|P4|COMPLETED|Overall Study||5
7696902|NCT01824602|18953783|P3|COMPLETED|Overall Study||5
7696903|NCT01824602|18953784|P2|COMPLETED|Overall Study||8
7696904|NCT01824602|18953785|P1|COMPLETED|Overall Study||10
7696905|NCT01824602|18953782|P4|Intent-to-treat Population|Overall Study||9
7696906|NCT01824602|18953783|P3|Intent-to-treat Population|Overall Study||9
7696907|NCT01824602|18953784|P2|Intent-to-treat Population|Overall Study||8
7696908|NCT01824602|18953785|P1|Intent-to-treat Population|Overall Study||11
7696909|NCT01824602|18953782|P4|Safety Population|Overall Study||10
7696910|NCT01824602|18953783|P3|Safety Population|Overall Study||9
7696911|NCT01824602|18953784|P2|Safety Population|Overall Study||8
7696912|NCT01824602|18953785|P1|Safety Population|Overall Study||11
7696913|NCT01824602|18953782|P4|STARTED|Overall Study||10
7696914|NCT01824602|18953783|P3|STARTED|Overall Study||9
7696915|NCT01824602|18953784|P2|STARTED|Overall Study||8
7696916|NCT01824602|18953785|P1|STARTED|Overall Study||11
7696917|NCT01824589|18953799|P4|NOT COMPLETED|Overall Study||0
7696918|NCT01824589|18953800|P3|NOT COMPLETED|Overall Study||0
7696919|NCT01824589|18953801|P2|NOT COMPLETED|Overall Study||0
7696920|NCT01824589|18953802|P1|NOT COMPLETED|Overall Study||0
7696921|NCT01824589|18953799|P4|COMPLETED|Overall Study||0
7696922|NCT01824589|18953800|P3|COMPLETED|Overall Study||0
7696923|NCT01824589|18953801|P2|COMPLETED|Overall Study||0
7696924|NCT01824589|18953802|P1|COMPLETED|Overall Study||1
7696925|NCT01824589|18953799|P4|STARTED|Overall Study||0
7696926|NCT01824589|18953800|P3|STARTED|Overall Study||0
7696927|NCT01824589|18953801|P2|STARTED|Overall Study||0
7696928|NCT01824589|18953802|P1|STARTED|Overall Study||1
7696929|NCT01824576|18953824|P1|NOT COMPLETED|Overall Study||2
7696930|NCT01824576|18953824|P1|COMPLETED|Overall Study||7
7696931|NCT01824576|18953824|P1|STARTED|Overall Study||9
7696932|NCT01824498|18953842|P6|NOT COMPLETED|3rd Intervention (8 Weeks)||0
7696933|NCT01824498|18953843|P5|NOT COMPLETED|3rd Intervention (8 Weeks)||0
7696934|NCT01824498|18953844|P4|NOT COMPLETED|3rd Intervention (8 Weeks)||0
7696935|NCT01824498|18953845|P3|NOT COMPLETED|3rd Intervention (8 Weeks)||0
7696936|NCT01824498|18953846|P2|NOT COMPLETED|3rd Intervention (8 Weeks)||0
7696937|NCT01824498|18953847|P1|NOT COMPLETED|3rd Intervention (8 Weeks)||0
7696938|NCT01824498|18953842|P6|COMPLETED|3rd Intervention (8 Weeks)||4
7696939|NCT01824498|18953843|P5|COMPLETED|3rd Intervention (8 Weeks)||3
7696940|NCT01824498|18953844|P4|COMPLETED|3rd Intervention (8 Weeks)||2
7696941|NCT01824498|18953845|P3|COMPLETED|3rd Intervention (8 Weeks)||4
7696942|NCT01824498|18953846|P2|COMPLETED|3rd Intervention (8 Weeks)||2
7696943|NCT01824498|18953847|P1|COMPLETED|3rd Intervention (8 Weeks)||3
7696944|NCT01824498|18953842|P6|STARTED|3rd Intervention (8 Weeks)||4
7696945|NCT01824498|18953843|P5|STARTED|3rd Intervention (8 Weeks)||3
7696946|NCT01824498|18953844|P4|STARTED|3rd Intervention (8 Weeks)||2
7696947|NCT01824498|18953845|P3|STARTED|3rd Intervention (8 Weeks)||4
7696948|NCT01824498|18953846|P2|STARTED|3rd Intervention (8 Weeks)||2
7696949|NCT01824498|18953847|P1|STARTED|3rd Intervention (8 Weeks)||3
7696950|NCT01824498|18953842|P6|NOT COMPLETED|Washout (8 Weeks)||0
7696951|NCT01824498|18953843|P5|NOT COMPLETED|Washout (8 Weeks)||0
7696952|NCT01824498|18953844|P4|NOT COMPLETED|Washout (8 Weeks)||0
7696953|NCT01824498|18953845|P3|NOT COMPLETED|Washout (8 Weeks)||0
7696954|NCT01824498|18953846|P2|NOT COMPLETED|Washout (8 Weeks)||0
7696955|NCT01824498|18953847|P1|NOT COMPLETED|Washout (8 Weeks)||0
7696956|NCT01824498|18953842|P6|COMPLETED|Washout (8 Weeks)||4
7696957|NCT01824498|18953843|P5|COMPLETED|Washout (8 Weeks)||3
7696958|NCT01824498|18953844|P4|COMPLETED|Washout (8 Weeks)||2
7696959|NCT01824498|18953845|P3|COMPLETED|Washout (8 Weeks)||4
7696960|NCT01824498|18953846|P2|COMPLETED|Washout (8 Weeks)||2
7696961|NCT01824498|18953847|P1|COMPLETED|Washout (8 Weeks)||3
7696962|NCT01824498|18953842|P6|STARTED|Washout (8 Weeks)||4
7696963|NCT01824498|18953843|P5|STARTED|Washout (8 Weeks)||3
7696964|NCT01824498|18953844|P4|STARTED|Washout (8 Weeks)||2
7696965|NCT01824498|18953845|P3|STARTED|Washout (8 Weeks)||4
7696966|NCT01824498|18953846|P2|STARTED|Washout (8 Weeks)||2
7696967|NCT01824498|18953847|P1|STARTED|Washout (8 Weeks)||3
7696968|NCT01824498|18953842|P6|NOT COMPLETED|2nd Intervention (8 Weeks)||0
7696969|NCT01824498|18953843|P5|NOT COMPLETED|2nd Intervention (8 Weeks)||0
7696970|NCT01824498|18953844|P4|NOT COMPLETED|2nd Intervention (8 Weeks)||0
7696971|NCT01824498|18953845|P3|NOT COMPLETED|2nd Intervention (8 Weeks)||0
7696972|NCT01824498|18953846|P2|NOT COMPLETED|2nd Intervention (8 Weeks)||0
7696973|NCT01824498|18953847|P1|NOT COMPLETED|2nd Intervention (8 Weeks)||0
7696974|NCT01824498|18953842|P6|COMPLETED|2nd Intervention (8 Weeks)||4
7696975|NCT01824498|18953843|P5|COMPLETED|2nd Intervention (8 Weeks)||3
7696976|NCT01824498|18953844|P4|COMPLETED|2nd Intervention (8 Weeks)||2
7696977|NCT01824498|18953845|P3|COMPLETED|2nd Intervention (8 Weeks)||4
7696978|NCT01824498|18953846|P2|COMPLETED|2nd Intervention (8 Weeks)||2
7696979|NCT01824498|18953847|P1|COMPLETED|2nd Intervention (8 Weeks)||3
7696980|NCT01824498|18953842|P6|STARTED|2nd Intervention (8 Weeks)||4
7696981|NCT01824498|18953843|P5|STARTED|2nd Intervention (8 Weeks)||3
7696982|NCT01824498|18953844|P4|STARTED|2nd Intervention (8 Weeks)||2
7696983|NCT01824498|18953845|P3|STARTED|2nd Intervention (8 Weeks)||4
7696984|NCT01824498|18953846|P2|STARTED|2nd Intervention (8 Weeks)||2
7696985|NCT01824498|18953847|P1|STARTED|2nd Intervention (8 Weeks)||3
7696986|NCT01824498|18953842|P6|NOT COMPLETED|Washout (8 Weeks)||0
7696987|NCT01824498|18953843|P5|NOT COMPLETED|Washout (8 Weeks)||1
7696988|NCT01824498|18953844|P4|NOT COMPLETED|Washout (8 Weeks)||1
7696989|NCT01824498|18953845|P3|NOT COMPLETED|Washout (8 Weeks)||2
7696990|NCT01824498|18953846|P2|NOT COMPLETED|Washout (8 Weeks)||0
7696991|NCT01824498|18953847|P1|NOT COMPLETED|Washout (8 Weeks)||2
7696992|NCT01824498|18953842|P6|COMPLETED|Washout (8 Weeks)||4
7696993|NCT01824498|18953843|P5|COMPLETED|Washout (8 Weeks)||3
7696994|NCT01824498|18953844|P4|COMPLETED|Washout (8 Weeks)||2
7696995|NCT01824498|18953845|P3|COMPLETED|Washout (8 Weeks)||4
7696996|NCT01824498|18953846|P2|COMPLETED|Washout (8 Weeks)||2
7696997|NCT01824498|18953847|P1|COMPLETED|Washout (8 Weeks)||3
7696998|NCT01824498|18953842|P6|STARTED|Washout (8 Weeks)||4
7696999|NCT01824498|18953843|P5|STARTED|Washout (8 Weeks)|1 dropped out|4
7697000|NCT01824498|18953844|P4|STARTED|Washout (8 Weeks)|1 dropped out|3
7697001|NCT01824498|18953845|P3|STARTED|Washout (8 Weeks)|2 dropped out|6
7697002|NCT01824498|18953846|P2|STARTED|Washout (8 Weeks)||2
7697003|NCT01824498|18953847|P1|STARTED|Washout (8 Weeks)|2 dropped out|5
7697004|NCT01824498|18953842|P6|NOT COMPLETED|1st Intervention (8 Weeks)||0
7697005|NCT01824498|18953843|P5|NOT COMPLETED|1st Intervention (8 Weeks)||0
7697006|NCT01824498|18953844|P4|NOT COMPLETED|1st Intervention (8 Weeks)||0
7697007|NCT01824498|18953845|P3|NOT COMPLETED|1st Intervention (8 Weeks)||0
7697008|NCT01824498|18953846|P2|NOT COMPLETED|1st Intervention (8 Weeks)||0
7697009|NCT01824498|18953847|P1|NOT COMPLETED|1st Intervention (8 Weeks)||0
7697010|NCT01824498|18953842|P6|COMPLETED|1st Intervention (8 Weeks)||4
7697011|NCT01824498|18953843|P5|COMPLETED|1st Intervention (8 Weeks)||4
7697012|NCT01824498|18953844|P4|COMPLETED|1st Intervention (8 Weeks)||3
7697013|NCT01824498|18953845|P3|COMPLETED|1st Intervention (8 Weeks)||6
7697014|NCT01824498|18953846|P2|COMPLETED|1st Intervention (8 Weeks)||2
7697015|NCT01824498|18953847|P1|COMPLETED|1st Intervention (8 Weeks)||5
7697016|NCT01824498|18953842|P6|STARTED|1st Intervention (8 Weeks)||4
7697017|NCT01824498|18953843|P5|STARTED|1st Intervention (8 Weeks)||4
7697018|NCT01824498|18953844|P4|STARTED|1st Intervention (8 Weeks)||3
7697019|NCT01824498|18953845|P3|STARTED|1st Intervention (8 Weeks)||6
7697020|NCT01824498|18953846|P2|STARTED|1st Intervention (8 Weeks)||2
7697021|NCT01824498|18953847|P1|STARTED|1st Intervention (8 Weeks)||5
7697022|NCT01824472|18953858|P3|NOT COMPLETED|Overall Study||4
7697023|NCT01824472|18953859|P2|NOT COMPLETED|Overall Study||7
7697024|NCT01824472|18953860|P1|NOT COMPLETED|Overall Study||1
7697025|NCT01824472|18953858|P3|COMPLETED|Overall Study||11
7697026|NCT01824472|18953859|P2|COMPLETED|Overall Study||6
7697027|NCT01824472|18953860|P1|COMPLETED|Overall Study||16
7697028|NCT01824472|18953858|P3|STARTED|Overall Study||15
7697029|NCT01824472|18953859|P2|STARTED|Overall Study||13
7697030|NCT01824472|18953860|P1|STARTED|Overall Study||17
7697031|NCT01824446|18953868|P1|NOT COMPLETED|Overall Study||0
7697032|NCT01824446|18953868|P1|COMPLETED|Overall Study||6
7697033|NCT01824446|18953868|P1|STARTED|Overall Study||6
7697034|NCT01824394|18953894|P3|NOT COMPLETED|Overall Study||74
7697035|NCT01824394|18953895|P2|NOT COMPLETED|Overall Study||116
7697036|NCT01824394|18953896|P1|NOT COMPLETED|Overall Study||119
7697037|NCT01824394|18953894|P3|COMPLETED|Overall Study||51
7697038|NCT01824394|18953895|P2|COMPLETED|Overall Study||53
7697039|NCT01824394|18953896|P1|COMPLETED|Overall Study||55
7697040|NCT01824394|18953894|P3|Per-Protocol Population|Overall Study|Calibration Roll-in patients are not included in the per protocol population|0
7697041|NCT01824394|18953895|P2|Per-Protocol Population|Overall Study||148
7697042|NCT01824394|18953896|P1|Per-Protocol Population|Overall Study||150
7697043|NCT01824394|18953894|P3|Safety Population|Overall Study|Calibration Roll-in patients are included in the safety population|104
7697044|NCT01824394|18953895|P2|Safety Population|Overall Study||149
7697045|NCT01824394|18953896|P1|Safety Population|Overall Study||151
7697046|NCT01824394|18953894|P3|Intent to Treat Population|Overall Study|Calibration Roll-in patients are not included in the ITT|0
7697047|NCT01824394|18953895|P2|Intent to Treat Population|Overall Study||149
7697048|NCT01824394|18953896|P1|Intent to Treat Population|Overall Study||151
7697049|NCT01824394|18953894|P3|STARTED|Overall Study||125
7697050|NCT01824394|18953895|P2|STARTED|Overall Study||169
7697051|NCT01824394|18953896|P1|STARTED|Overall Study||174
7697052|NCT01824355|18953906|P1|NOT COMPLETED|Overall Study||3
7697053|NCT01824355|18953906|P1|COMPLETED|Overall Study||110
7697054|NCT01824355|18953906|P1|STARTED|Overall Study||113
7697055|NCT01824342|18953917|P2|NOT COMPLETED|Overall Study||5
7697056|NCT01824342|18953918|P1|NOT COMPLETED|Overall Study||9
7697057|NCT01824342|18953917|P2|COMPLETED|Overall Study||2
7697058|NCT01824342|18953918|P1|COMPLETED|Overall Study||2
7697059|NCT01824342|18953917|P2|STARTED|Overall Study||7
7697060|NCT01824342|18953918|P1|STARTED|Overall Study||11
7697061|NCT01824303|18953932|P2|NOT COMPLETED|Open Label Extension||0
7697062|NCT01824303|18953933|P1|NOT COMPLETED|Open Label Extension||0
7697063|NCT01824303|18953932|P2|COMPLETED|Open Label Extension||11
7697064|NCT01824303|18953933|P1|COMPLETED|Open Label Extension||12
7697065|NCT01824303|18953932|P2|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11
7697066|NCT01824303|18953933|P1|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12
7697067|NCT01824303|18953932|P2|NOT COMPLETED|Randomized Study||1
7697068|NCT01824303|18953933|P1|NOT COMPLETED|Randomized Study||2
7697069|NCT01824303|18953932|P2|COMPLETED|Randomized Study||13
7697070|NCT01824303|18953933|P1|COMPLETED|Randomized Study||14
7697071|NCT01824303|18953932|P2|STARTED|Randomized Study||14
7697072|NCT01824303|18953933|P1|STARTED|Randomized Study||16
7697073|NCT01824290|18953959|P2|NOT COMPLETED|Overall Study||2
7697074|NCT01824290|18953960|P1|NOT COMPLETED|Overall Study||3
7697075|NCT01824290|18953959|P2|COMPLETED|Overall Study||15
7697076|NCT01824290|18953960|P1|COMPLETED|Overall Study||15
7697077|NCT01824290|18953959|P2|Received 40 mg|Overall Study||13
7697078|NCT01824290|18953960|P1|Received 40 mg|Overall Study||0
7697079|NCT01824290|18953959|P2|Received 20 mg|Overall Study||4
7697080|NCT01824290|18953960|P1|Received 20 mg|Overall Study||0
7697081|NCT01824290|18953959|P2|Received at Least One Dose of Study Drug|Overall Study||17
7697082|NCT01824290|18953960|P1|Received at Least One Dose of Study Drug|Overall Study||18
7697083|NCT01824290|18953959|P2|STARTED|Overall Study||17
7697084|NCT01824290|18953960|P1|STARTED|Overall Study||18
7697085|NCT01824160|18953972|P1|NOT COMPLETED|Overall Study||0
7697086|NCT01824160|18953972|P1|COMPLETED|Overall Study||50
7697087|NCT01824160|18953972|P1|STARTED|Overall Study||50
7697088|NCT01823991|18953978|P2|NOT COMPLETED|Overall Study||5
7697089|NCT01823991|18953979|P1|NOT COMPLETED|Overall Study||8
7697090|NCT01823991|18953978|P2|COMPLETED|Overall Study||13
7697091|NCT01823991|18953979|P1|COMPLETED|Overall Study||10
7697092|NCT01823991|18953978|P2|STARTED|Overall Study||18
7697093|NCT01823991|18953979|P1|STARTED|Overall Study||18
7697094|NCT01823861|18954013|P2|NOT COMPLETED|12 Month Follow up||61
7697095|NCT01823861|18954014|P1|NOT COMPLETED|12 Month Follow up||42
7697096|NCT01823861|18954013|P2|COMPLETED|12 Month Follow up||159
7697097|NCT01823861|18954014|P1|COMPLETED|12 Month Follow up||169
7697098|NCT01823861|18954013|P2|STARTED|12 Month Follow up||220
7697099|NCT01823861|18954014|P1|STARTED|12 Month Follow up||211
7697100|NCT01823861|18954013|P2|NOT COMPLETED|4 Month Follow up||31
7697101|NCT01823861|18954014|P1|NOT COMPLETED|4 Month Follow up||38
7697102|NCT01823861|18954013|P2|COMPLETED|4 Month Follow up||220
7697103|NCT01823861|18954014|P1|COMPLETED|4 Month Follow up||211
7697104|NCT01823861|18954013|P2|STARTED|4 Month Follow up||251
7697105|NCT01823861|18954014|P1|STARTED|4 Month Follow up||249
7697106|NCT01823679|18954020|P1|NOT COMPLETED|Overall Study||1
7697107|NCT01823679|18954020|P1|COMPLETED|Overall Study||1
7697108|NCT01823679|18954020|P1|STARTED|Overall Study||2
7697109|NCT01823653|18954028|P1|NOT COMPLETED|Overall Study||0
7697110|NCT01823653|18954028|P1|COMPLETED|Overall Study||60
7697111|NCT01823653|18954028|P1|STARTED|Overall Study||60
7697112|NCT01823614|18954042|P6|NOT COMPLETED|Overall Study||0
7697113|NCT01823614|18954043|P5|NOT COMPLETED|Overall Study||0
7697114|NCT01823614|18954044|P4|NOT COMPLETED|Overall Study||0
7697115|NCT01823614|18954045|P3|NOT COMPLETED|Overall Study||0
7697116|NCT01823614|18954046|P2|NOT COMPLETED|Overall Study||0
7697117|NCT01823614|18954047|P1|NOT COMPLETED|Overall Study||0
7697118|NCT01823614|18954042|P6|COMPLETED|Overall Study||154
7697119|NCT01823614|18954043|P5|COMPLETED|Overall Study||172
7697120|NCT01823614|18954044|P4|COMPLETED|Overall Study||122
7697121|NCT01823614|18954045|P3|COMPLETED|Overall Study||176
7697122|NCT01823614|18954046|P2|COMPLETED|Overall Study||140
7697123|NCT01823614|18954047|P1|COMPLETED|Overall Study||179
7697124|NCT01823614|18954042|P6|STARTED|Overall Study||154
7697125|NCT01823614|18954043|P5|STARTED|Overall Study||172
7697126|NCT01823614|18954044|P4|STARTED|Overall Study||122
7697127|NCT01823614|18954045|P3|STARTED|Overall Study||176
7697128|NCT01823614|18954046|P2|STARTED|Overall Study||140
7697129|NCT01823614|18954047|P1|STARTED|Overall Study||179
7697130|NCT01823536|18954073|P6|NOT COMPLETED|Overall Study||0
7697131|NCT01823536|18954074|P5|NOT COMPLETED|Overall Study||2
7697132|NCT01823536|18954075|P4|NOT COMPLETED|Overall Study||2
7697133|NCT01823536|18954076|P3|NOT COMPLETED|Overall Study||1
7697134|NCT01823536|18954077|P2|NOT COMPLETED|Overall Study||2
7697135|NCT01823536|18954078|P1|NOT COMPLETED|Overall Study||2
7697136|NCT01823536|18954073|P6|COMPLETED|Overall Study||2
7697137|NCT01823536|18954074|P5|COMPLETED|Overall Study||99
7697138|NCT01823536|18954075|P4|COMPLETED|Overall Study||64
7697139|NCT01823536|18954076|P3|COMPLETED|Overall Study||119
7697140|NCT01823536|18954077|P2|COMPLETED|Overall Study||101
7697141|NCT01823536|18954078|P1|COMPLETED|Overall Study||71
7697142|NCT01823536|18954073|P6|STARTED|Overall Study||2
7697143|NCT01823536|18954074|P5|STARTED|Overall Study||101
7697144|NCT01823536|18954075|P4|STARTED|Overall Study||66
7697145|NCT01823536|18954076|P3|STARTED|Overall Study||120
7697146|NCT01823536|18954077|P2|STARTED|Overall Study||103
7697147|NCT01823536|18954078|P1|STARTED|Overall Study||73
7697148|NCT01823510|18954116|P2|NOT COMPLETED|Days 22-28||0
7697149|NCT01823510|18954117|P1|NOT COMPLETED|Days 22-28||0
7697150|NCT01823510|18954116|P2|COMPLETED|Days 22-28||10
7697151|NCT01823510|18954117|P1|COMPLETED|Days 22-28||10
7697152|NCT01823510|18954116|P2|STARTED|Days 22-28||10
7697153|NCT01823510|18954117|P1|STARTED|Days 22-28||10
7697154|NCT01823510|18954116|P2|NOT COMPLETED|Days 8-21||0
7697155|NCT01823510|18954117|P1|NOT COMPLETED|Days 8-21||0
7697156|NCT01823510|18954116|P2|COMPLETED|Days 8-21||10
7697157|NCT01823510|18954117|P1|COMPLETED|Days 8-21||10
7697158|NCT01823510|18954116|P2|STARTED|Days 8-21||10
7697159|NCT01823510|18954117|P1|STARTED|Days 8-21||10
7697160|NCT01823510|18954116|P2|NOT COMPLETED|Days 1-7||0
7697161|NCT01823510|18954117|P1|NOT COMPLETED|Days 1-7||0
7697162|NCT01823510|18954116|P2|COMPLETED|Days 1-7||10
7697163|NCT01823510|18954117|P1|COMPLETED|Days 1-7||10
7697164|NCT01823510|18954116|P2|STARTED|Days 1-7||10
7697165|NCT01823510|18954117|P1|STARTED|Days 1-7||10
7697166|NCT01823497|18954131|P2|NOT COMPLETED|Overall Study||8
7697167|NCT01823497|18954132|P1|NOT COMPLETED|Overall Study||3
7697168|NCT01823497|18954131|P2|COMPLETED|Overall Study||9
7697169|NCT01823497|18954132|P1|COMPLETED|Overall Study||16
7697170|NCT01823497|18954131|P2|STARTED|Overall Study||17
7697171|NCT01823497|18954132|P1|STARTED|Overall Study||19
7697172|NCT01823341|18954140|P1|NOT COMPLETED|Overall Study||15
7697173|NCT01823341|18954140|P1|COMPLETED|Overall Study||82
7697174|NCT01823341|18954140|P1|STARTED|Overall Study||97
7697175|NCT01823328|18954185|P2|NOT COMPLETED|Overall Study||6
7697176|NCT01823328|18954186|P1|NOT COMPLETED|Overall Study||8
7697177|NCT01823328|18954185|P2|COMPLETED|Overall Study||67
7697178|NCT01823328|18954186|P1|COMPLETED|Overall Study||62
7697179|NCT01823328|18954185|P2|STARTED|Overall Study||73
7697180|NCT01823328|18954186|P1|STARTED|Overall Study||70
7697181|NCT01823289|18954206|P1|NOT COMPLETED|Overall Study||24
7697182|NCT01823289|18954206|P1|COMPLETED|Overall Study||47
7697183|NCT01823289|18954206|P1|STARTED|Overall Study||71
7697184|NCT01823224|18954214|P2|NOT COMPLETED|Overall Study||11
7697185|NCT01823224|18954215|P1|NOT COMPLETED|Overall Study||6
7697186|NCT01823224|18954214|P2|COMPLETED|Overall Study||22
7697187|NCT01823224|18954215|P1|COMPLETED|Overall Study||28
7697188|NCT01823224|18954214|P2|STARTED|Overall Study||33
7697189|NCT01823224|18954215|P1|STARTED|Overall Study||34
7697190|NCT01823146|18954225|P2|NOT COMPLETED|Overall Study||2
7697191|NCT01823146|18954226|P1|NOT COMPLETED|Overall Study||2
7697192|NCT01823146|18954225|P2|COMPLETED|Overall Study||49
7697193|NCT01823146|18954226|P1|COMPLETED|Overall Study||53
7697194|NCT01823146|18954225|P2|STARTED|Overall Study||51
7697195|NCT01823146|18954226|P1|STARTED|Overall Study||55
7697196|NCT01823107|18954236|P1|NOT COMPLETED|Overall Study||1
7697197|NCT01823107|18954236|P1|COMPLETED|Overall Study||24
7697198|NCT01823107|18954236|P1|STARTED|Overall Study||25
7697199|NCT01822925|18954246|P4|NOT COMPLETED|Overall Study||5
7697200|NCT01822925|18954247|P3|NOT COMPLETED|Overall Study||3
7697201|NCT01822925|18954248|P2|NOT COMPLETED|Overall Study||2
7697202|NCT01822925|18954249|P1|NOT COMPLETED|Overall Study||6
7697203|NCT01822925|18954246|P4|COMPLETED|Overall Study||27
7697204|NCT01822925|18954247|P3|COMPLETED|Overall Study||29
7697205|NCT01822925|18954248|P2|COMPLETED|Overall Study||30
7697206|NCT01822925|18954249|P1|COMPLETED|Overall Study||26
7697207|NCT01822925|18954246|P4|STARTED|Overall Study||32
7697208|NCT01822925|18954247|P3|STARTED|Overall Study||32
7697209|NCT01822925|18954248|P2|STARTED|Overall Study||32
7697210|NCT01822925|18954249|P1|STARTED|Overall Study||32
7697211|NCT01822899|18954301|P2|NOT COMPLETED|Overall Study||18
7697212|NCT01822899|18954302|P1|NOT COMPLETED|Overall Study||24
7697213|NCT01822899|18954301|P2|COMPLETED|Overall Study||340
7697214|NCT01822899|18954302|P1|COMPLETED|Overall Study||334
7697215|NCT01822899|18954301|P2|STARTED|Overall Study||358
7697216|NCT01822899|18954302|P1|STARTED|Overall Study||358
7697217|NCT01822886|18954310|P1|NOT COMPLETED|Overall Study||15
7697218|NCT01822886|18954310|P1|COMPLETED|Overall Study||5
7697219|NCT01822886|18954310|P1|STARTED|Overall Study||20
7697220|NCT01822821|18954320|P2|NOT COMPLETED|Overall Study||1
7697221|NCT01822821|18954321|P1|NOT COMPLETED|Overall Study||2
7697222|NCT01822821|18954320|P2|COMPLETED|Overall Study||74
7697223|NCT01822821|18954321|P1|COMPLETED|Overall Study||73
7697224|NCT01822821|18954320|P2|STARTED|Overall Study||75
7697225|NCT01822821|18954321|P1|STARTED|Overall Study||75
7697226|NCT01822756|18954350|P5|NOT COMPLETED|Overall Study||7
7697227|NCT01822756|18954351|P4|NOT COMPLETED|Overall Study||4
7697228|NCT01822756|18954352|P3|NOT COMPLETED|Overall Study||10
7697229|NCT01822756|18954353|P2|NOT COMPLETED|Overall Study||4
7697230|NCT01822756|18954354|P1|NOT COMPLETED|Overall Study||16
7697231|NCT01822756|18954350|P5|COMPLETED|Overall Study||1
7697232|NCT01822756|18954351|P4|COMPLETED|Overall Study||0
7697233|NCT01822756|18954352|P3|COMPLETED|Overall Study||0
7697234|NCT01822756|18954353|P2|COMPLETED|Overall Study||0
7697235|NCT01822756|18954354|P1|COMPLETED|Overall Study||0
7697236|NCT01822756|18954350|P5|Discontinued From the Study|Overall Study||7
7697237|NCT01822756|18954351|P4|Discontinued From the Study|Overall Study||4
7697238|NCT01822756|18954352|P3|Discontinued From the Study|Overall Study||10
7697239|NCT01822756|18954353|P2|Discontinued From the Study|Overall Study||4
7697240|NCT01822756|18954354|P1|Discontinued From the Study|Overall Study||16
7697241|NCT01822756|18954350|P5|STARTED|Overall Study||8
7697242|NCT01822756|18954351|P4|STARTED|Overall Study||4
7697243|NCT01822756|18954352|P3|STARTED|Overall Study||10
7697244|NCT01822756|18954353|P2|STARTED|Overall Study||4
7697245|NCT01822756|18954354|P1|STARTED|Overall Study||16
7697246|NCT01822691|18954396|P1|NOT COMPLETED|Overall Study||2
7697247|NCT01822691|18954396|P1|COMPLETED|Overall Study||13
7697248|NCT01822691|18954396|P1|STARTED|Overall Study||15
7697249|NCT01822678|18954407|P3|NOT COMPLETED|Overall Study||11
7697250|NCT01822678|18954408|P2|NOT COMPLETED|Overall Study||15
7697251|NCT01822678|18954409|P1|NOT COMPLETED|Overall Study||12
7697252|NCT01822678|18954407|P3|COMPLETED|Overall Study||29
7697253|NCT01822678|18954408|P2|COMPLETED|Overall Study||49
7697254|NCT01822678|18954409|P1|COMPLETED|Overall Study||45
7697255|NCT01822678|18954407|P3|Per Protocol Population|Overall Study||34
7697256|NCT01822678|18954408|P2|Per Protocol Population|Overall Study||52
7697257|NCT01822678|18954409|P1|Per Protocol Population|Overall Study||45
7697258|NCT01822678|18954407|P3|Intention-to-Treat Population (ITT)|Overall Study||40
7697259|NCT01822678|18954408|P2|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63
7697260|NCT01822678|18954409|P1|Intention-to-Treat Population (ITT)|Overall Study||57
7697261|NCT01822678|18954407|P3|Safety Population|Overall Study||40
7697262|NCT01822678|18954408|P2|Safety Population|Overall Study||64
7697263|NCT01822678|18954409|P1|Safety Population|Overall Study||57
7697264|NCT01822678|18954407|P3|Treated|Overall Study||40
7697265|NCT01822678|18954408|P2|Treated|Overall Study||64
7697266|NCT01822678|18954409|P1|Treated|Overall Study||57
7697267|NCT01822678|18954407|P3|STARTED|Overall Study||40
7697268|NCT01822678|18954408|P2|STARTED|Overall Study||64
7697269|NCT01822678|18954409|P1|STARTED|Overall Study||57
7697270|NCT01822665|18954417|P1|NOT COMPLETED|Overall Study||8
7697271|NCT01822665|18954417|P1|COMPLETED|Overall Study||20
7697272|NCT01822665|18954417|P1|Received Paracetamol Tablet (1000 mg)|Overall Study||28
7697273|NCT01822665|18954417|P1|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24
7697274|NCT01822665|18954417|P1|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23
7697275|NCT01822665|18954417|P1|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23
7697276|NCT01822665|18954417|P1|STARTED|Overall Study||28
7697277|NCT01822587|18954444|P3|NOT COMPLETED|Overall Study||18
7697278|NCT01822587|18954445|P2|NOT COMPLETED|Overall Study||15
7697279|NCT01822587|18954446|P1|NOT COMPLETED|Overall Study||16
7697280|NCT01822587|18954444|P3|COMPLETED|Overall Study||44
7697281|NCT01822587|18954445|P2|COMPLETED|Overall Study||45
7697282|NCT01822587|18954446|P1|COMPLETED|Overall Study||43
7697283|NCT01822587|18954444|P3|STARTED|Overall Study||62
7697284|NCT01822587|18954445|P2|STARTED|Overall Study||60
7697285|NCT01822587|18954446|P1|STARTED|Overall Study||59
7697286|NCT01822574|18954469|P3|NOT COMPLETED|Overall Study||0
7697287|NCT01822574|18954470|P2|NOT COMPLETED|Overall Study||0
7697288|NCT01822574|18954471|P1|NOT COMPLETED|Overall Study||0
7697289|NCT01822574|18954469|P3|COMPLETED|Overall Study||30
7697290|NCT01822574|18954470|P2|COMPLETED|Overall Study||30
7697291|NCT01822574|18954471|P1|COMPLETED|Overall Study||30
7697292|NCT01822574|18954469|P3|STARTED|Overall Study||30
7697293|NCT01822574|18954470|P2|STARTED|Overall Study||30
7697294|NCT01822574|18954471|P1|STARTED|Overall Study||30
7697295|NCT01822561|18954485|P1|NOT COMPLETED|Overall Study||2
7697296|NCT01822561|18954485|P1|COMPLETED|Overall Study||13
7697297|NCT01822561|18954485|P1|STARTED|Overall Study||15
7697298|NCT01822548|18954495|P2|NOT COMPLETED|Overall Study||0
7697299|NCT01822548|18954496|P1|NOT COMPLETED|Overall Study||0
7697300|NCT01822548|18954495|P2|COMPLETED|Overall Study||24
7697301|NCT01822548|18954496|P1|COMPLETED|Overall Study||40
7697302|NCT01822548|18954495|P2|Discontinued Intervention|Overall Study||5
7697303|NCT01822548|18954496|P1|Discontinued Intervention|Overall Study||0
7697304|NCT01822548|18954495|P2|STARTED|Overall Study||24
7697305|NCT01822548|18954496|P1|STARTED|Overall Study|Received allocated intervention n=38 Did not receive allocated intervention (only metformin) n=2|40
7697306|NCT01822535|18954506|P2|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
7697307|NCT01822535|18954507|P1|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1
7697308|NCT01822535|18954506|P2|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
7697309|NCT01822535|18954507|P1|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10
7697310|NCT01822535|18954506|P2|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0
7697311|NCT01822535|18954507|P1|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11
7697312|NCT01822535|18954506|P2|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2
7697313|NCT01822535|18954507|P1|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6
7697314|NCT01822535|18954506|P2|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
7697315|NCT01822535|18954507|P1|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
7697316|NCT01822535|18954506|P2|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13
7697317|NCT01822535|18954507|P1|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17
7697318|NCT01822496|18954523|P4|NOT COMPLETED|Overall Study||4
7697319|NCT01822496|18954524|P3|NOT COMPLETED|Overall Study||0
7697320|NCT01822496|18954525|P2|NOT COMPLETED|Overall Study||2
7697321|NCT01822496|18954526|P1|NOT COMPLETED|Overall Study||2
7697322|NCT01822496|18954523|P4|COMPLETED|Overall Study||7
7697323|NCT01822496|18954524|P3|COMPLETED|Overall Study||9
7697324|NCT01822496|18954525|P2|COMPLETED|Overall Study||21
7697325|NCT01822496|18954526|P1|COMPLETED|Overall Study||14
7697326|NCT01822496|18954523|P4|Eligible and Started Study Treatment|Overall Study||7
7697327|NCT01822496|18954524|P3|Eligible and Started Study Treatment|Overall Study||9
7697328|NCT01822496|18954525|P2|Eligible and Started Study Treatment|Overall Study||20
7697329|NCT01822496|18954526|P1|Eligible and Started Study Treatment|Overall Study||14
7697330|NCT01822496|18954523|P4|Eligible With Disease Assessment|Overall Study||4
7697331|NCT01822496|18954524|P3|Eligible With Disease Assessment|Overall Study||6
7697332|NCT01822496|18954525|P2|Eligible With Disease Assessment|Overall Study||15
7697333|NCT01822496|18954526|P1|Eligible With Disease Assessment|Overall Study||10
7697334|NCT01822496|18954523|P4|Eligible|Overall Study||7
7697335|NCT01822496|18954524|P3|Eligible|Overall Study||9
7697336|NCT01822496|18954525|P2|Eligible|Overall Study||21
7697337|NCT01822496|18954526|P1|Eligible|Overall Study||14
7697338|NCT01822496|18954523|P4|STARTED|Overall Study||11
7697339|NCT01822496|18954524|P3|STARTED|Overall Study||9
7697340|NCT01822496|18954525|P2|STARTED|Overall Study||23
7697341|NCT01822496|18954526|P1|STARTED|Overall Study||16
7697342|NCT01822457|18954562|P2|NOT COMPLETED|Overall Study||5
7697343|NCT01822457|18954563|P1|NOT COMPLETED|Overall Study||4
7697344|NCT01822457|18954562|P2|COMPLETED|Overall Study||12
7697345|NCT01822457|18954563|P1|COMPLETED|Overall Study||16
7697346|NCT01822457|18954562|P2|STARTED|Overall Study||17
7697347|NCT01822457|18954563|P1|STARTED|Overall Study||20
7697348|NCT01822366|18954579|P4|NOT COMPLETED|Overall Study||22
7697349|NCT01822366|18954580|P3|NOT COMPLETED|Overall Study||5
7697350|NCT01822366|18954581|P2|NOT COMPLETED|Overall Study||22
7697351|NCT01822366|18954582|P1|NOT COMPLETED|Overall Study||5
7697352|NCT01822366|18954579|P4|COMPLETED|Overall Study||298
7697353|NCT01822366|18954580|P3|COMPLETED|Overall Study||315
7697354|NCT01822366|18954581|P2|COMPLETED|Overall Study||298
7697355|NCT01822366|18954582|P1|COMPLETED|Overall Study||315
7697356|NCT01822366|18954579|P4|STARTED|Overall Study||320
7697357|NCT01822366|18954580|P3|STARTED|Overall Study||320
7697358|NCT01822366|18954581|P2|STARTED|Overall Study||320
7697359|NCT01822366|18954582|P1|STARTED|Overall Study||320
7697360|NCT01822353|18954613|P3|NOT COMPLETED|Overall Study||1
7697361|NCT01822353|18954614|P2|NOT COMPLETED|Overall Study||5
7697362|NCT01822353|18954615|P1|NOT COMPLETED|Overall Study||4
7697363|NCT01822353|18954613|P3|COMPLETED|Overall Study||3
7697364|NCT01822353|18954614|P2|COMPLETED|Overall Study||4
7697365|NCT01822353|18954615|P1|COMPLETED|Overall Study||6
7697366|NCT01822353|18954613|P3|STARTED|Overall Study||4
7697367|NCT01822353|18954614|P2|STARTED|Overall Study||9
7697368|NCT01822353|18954615|P1|STARTED|Overall Study||10
7697369|NCT01822301|18954623|P1|NOT COMPLETED|Overall Study||0
7697370|NCT01822301|18954623|P1|COMPLETED|Overall Study||5
7697371|NCT01822301|18954623|P1|STARTED|Overall Study||5
7697372|NCT01822223|18954635|P2|NOT COMPLETED|Overall Study||1
7697373|NCT01822223|18954636|P1|NOT COMPLETED|Overall Study||0
7697374|NCT01822223|18954635|P2|COMPLETED|Overall Study||9
7697375|NCT01822223|18954636|P1|COMPLETED|Overall Study||10
7697376|NCT01822223|18954635|P2|STARTED|Overall Study||10
7697377|NCT01822223|18954636|P1|STARTED|Overall Study||10
7697378|NCT01822197|18954652|P1|NOT COMPLETED|Overall Study||0
7697379|NCT01822197|18954652|P1|COMPLETED|Overall Study||30
7697380|NCT01822197|18954652|P1|STARTED|Overall Study||30
7697381|NCT01822132|18954660|P2|NOT COMPLETED|Overall Study||2
7697382|NCT01822132|18954661|P1|NOT COMPLETED|Overall Study||4
7697383|NCT01822132|18954660|P2|COMPLETED|Overall Study||25
7697384|NCT01822132|18954661|P1|COMPLETED|Overall Study||21
7697385|NCT01822132|18954660|P2|STARTED|Overall Study||27
7697386|NCT01822132|18954661|P1|STARTED|Overall Study||25
7697387|NCT01822119|18954675|P1|NOT COMPLETED|Overall Study||0
7697388|NCT01822119|18954675|P1|COMPLETED|Overall Study||27
7697389|NCT01822119|18954675|P1|STARTED|Overall Study||27
7697390|NCT01821963|18954698|P1|NOT COMPLETED|Overall Study||1
7697391|NCT01821963|18954698|P1|COMPLETED|Overall Study||0
7697392|NCT01821963|18954698|P1|STARTED|Overall Study||1
7697393|NCT01821937|18954704|P2|NOT COMPLETED|Overall Study||3
7697394|NCT01821937|18954705|P1|NOT COMPLETED|Overall Study||0
7697395|NCT01821937|18954704|P2|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12
7697396|NCT01821937|18954705|P1|COMPLETED|Overall Study||10
7697397|NCT01821937|18954704|P2|STARTED|Overall Study||15
7697398|NCT01821937|18954705|P1|STARTED|Overall Study||10
7697399|NCT01821859|18954723|P1|NOT COMPLETED|Overall Study||5
7697400|NCT01821859|18954723|P1|COMPLETED|Overall Study||0
7697401|NCT01821859|18954723|P1|STARTED|Overall Study||5
7697402|NCT01821807|18954729|P2|NOT COMPLETED|Overall Study||1
7697403|NCT01821807|18954730|P1|NOT COMPLETED|Overall Study||3
7697404|NCT01821807|18954729|P2|COMPLETED|Overall Study||109
7697405|NCT01821807|18954730|P1|COMPLETED|Overall Study||147
7697406|NCT01821807|18954729|P2|STARTED|Overall Study||110
7697407|NCT01821807|18954730|P1|STARTED|Overall Study||150
7697408|NCT01821729|18954738|P1|NOT COMPLETED|Overall Study||1
7697409|NCT01821729|18954738|P1|COMPLETED|Overall Study||49
7697410|NCT01821729|18954738|P1|Underwent Attempted Surgery|Overall Study||42
7697411|NCT01821729|18954738|P1|Received Chemoradiotherapy|Overall Study||45
7697412|NCT01821729|18954738|P1|STARTED|Overall Study||50
7697413|NCT01821625|18954743|P1|NOT COMPLETED|Overall Study||6
7697414|NCT01821625|18954743|P1|COMPLETED|Overall Study||1
7697415|NCT01821625|18954743|P1|STARTED|Overall Study||7
7697416|NCT01821560|18954749|P2|NOT COMPLETED|Overall Study||7
7697417|NCT01821560|18954750|P1|NOT COMPLETED|Overall Study||6
7697418|NCT01821560|18954749|P2|COMPLETED|Overall Study||15
7697419|NCT01821560|18954750|P1|COMPLETED|Overall Study||16
7697420|NCT01821560|18954749|P2|STARTED|Overall Study||22
7697421|NCT01821560|18954750|P1|STARTED|Overall Study||22
7697422|NCT01821534|18954756|P1|NOT COMPLETED|Overall Study||0
7697423|NCT01821534|18954756|P1|COMPLETED|Overall Study||201
7697424|NCT01821534|18954756|P1|STARTED|Overall Study||201
7697425|NCT01821417|18954765|P2|NOT COMPLETED|Overall Study||0
7697426|NCT01821417|18954766|P1|NOT COMPLETED|Overall Study||0
7697427|NCT01821417|18954765|P2|COMPLETED|Overall Study||31
7697428|NCT01821417|18954766|P1|COMPLETED|Overall Study||37
7697429|NCT01821417|18954765|P2|STARTED|Overall Study||31
7697430|NCT01821417|18954766|P1|STARTED|Overall Study||37
7697431|NCT01821391|18954778|P2|NOT COMPLETED|Overall Study||0
7697432|NCT01821391|18954779|P1|NOT COMPLETED|Overall Study||1
7697433|NCT01821391|18954778|P2|COMPLETED|Overall Study||23
7697434|NCT01821391|18954779|P1|COMPLETED|Overall Study||107
7697435|NCT01821391|18954778|P2|STARTED|Overall Study||23
7697436|NCT01821391|18954779|P1|STARTED|Overall Study||108
7697437|NCT01821378|18954790|P3|NOT COMPLETED|Overall Study||42
7697438|NCT01821378|18954791|P2|NOT COMPLETED|Overall Study||54
7697439|NCT01821378|18954792|P1|NOT COMPLETED|Overall Study||27
7697440|NCT01821378|18954790|P3|COMPLETED|Overall Study||70
7697441|NCT01821378|18954791|P2|COMPLETED|Overall Study||145
7697442|NCT01821378|18954792|P1|COMPLETED|Overall Study||74
7697443|NCT01821378|18954790|P3|STARTED|Overall Study||112
7697444|NCT01821378|18954791|P2|STARTED|Overall Study||199
7697445|NCT01821378|18954792|P1|STARTED|Overall Study||101
7697446|NCT01821352|18954830|P2|NOT COMPLETED|Overall Study||0
7697447|NCT01821352|18954831|P1|NOT COMPLETED|Overall Study||0
7697448|NCT01821352|18954830|P2|COMPLETED|Overall Study||25
7697449|NCT01821352|18954831|P1|COMPLETED|Overall Study||28
7697450|NCT01821352|18954830|P2|STARTED|Overall Study||25
7697451|NCT01821352|18954831|P1|STARTED|Overall Study||28
7697452|NCT01821326|18954841|P1|NOT COMPLETED|Overall Study||0
7697453|NCT01821326|18954841|P1|COMPLETED|Overall Study||339
7697454|NCT01821326|18954841|P1|STARTED|Overall Study||339
7697455|NCT01821300|18954847|P2|NOT COMPLETED|Overall Study||0
7697456|NCT01821300|18954848|P1|NOT COMPLETED|Overall Study||0
7697457|NCT01821300|18954847|P2|COMPLETED|Overall Study||103
7697458|NCT01821300|18954848|P1|COMPLETED|Overall Study||154
7697459|NCT01821300|18954847|P2|STARTED|Overall Study||103
7697460|NCT01821300|18954848|P1|STARTED|Overall Study||154
7697461|NCT01821118|18954882|P2|NOT COMPLETED|Overall Study||1
7697462|NCT01821118|18954883|P1|NOT COMPLETED|Overall Study||0
7697463|NCT01821118|18954882|P2|COMPLETED|Overall Study||11
7697464|NCT01821118|18954883|P1|COMPLETED|Overall Study||24
7697465|NCT01821118|18954882|P2|STARTED|Overall Study||12
7697466|NCT01821118|18954883|P1|STARTED|Overall Study||24
7697467|NCT01821105|18954916|P1|NOT COMPLETED|Overall Study||0
7697468|NCT01821105|18954916|P1|COMPLETED|Overall Study||21
7697469|NCT01821105|18954916|P1|STARTED|Overall Study||21
7697470|NCT01820754|18954922|P1|NOT COMPLETED|Overall Study||0
7697471|NCT01820754|18954922|P1|COMPLETED|Overall Study||24
7697472|NCT01820754|18954922|P1|STARTED|Overall Study||24
7697473|NCT01820637|18954930|P1|NOT COMPLETED|Overall Study||3
7697474|NCT01820637|18954930|P1|COMPLETED|Overall Study||54
7697475|NCT01820637|18954930|P1|STARTED|Overall Study||57
7697476|NCT01820585|18954939|P4|NOT COMPLETED|Overall Study||49
7697477|NCT01820585|18954940|P3|NOT COMPLETED|Overall Study||34
7697478|NCT01820585|18954941|P2|NOT COMPLETED|Overall Study||32
7697479|NCT01820585|18954942|P1|NOT COMPLETED|Overall Study||27
7697480|NCT01820585|18954939|P4|COMPLETED|Overall Study||83
7697481|NCT01820585|18954940|P3|COMPLETED|Overall Study||101
7697482|NCT01820585|18954941|P2|COMPLETED|Overall Study||98
7697483|NCT01820585|18954942|P1|COMPLETED|Overall Study||104
7697484|NCT01820585|18954939|P4|Completed Maintenance Period|Overall Study||84
7697485|NCT01820585|18954940|P3|Completed Maintenance Period|Overall Study||101
7697486|NCT01820585|18954941|P2|Completed Maintenance Period|Overall Study||98
7697487|NCT01820585|18954942|P1|Completed Maintenance Period|Overall Study||105
7697488|NCT01820585|18954939|P4|Entered Maintenance Period|Overall Study||123
7697489|NCT01820585|18954940|P3|Entered Maintenance Period|Overall Study||131
7697490|NCT01820585|18954941|P2|Entered Maintenance Period|Overall Study||124
7697491|NCT01820585|18954942|P1|Entered Maintenance Period|Overall Study||128
7697492|NCT01820585|18954939|P4|Completed Titration Period|Overall Study||126
7697493|NCT01820585|18954940|P3|Completed Titration Period|Overall Study||131
7697494|NCT01820585|18954941|P2|Completed Titration Period|Overall Study||125
7697495|NCT01820585|18954942|P1|Completed Titration Period|Overall Study||128
7697496|NCT01820585|18954939|P4|Full Analysis Set|Overall Study||129
7697497|NCT01820585|18954940|P3|Full Analysis Set|Overall Study||135
7697498|NCT01820585|18954941|P2|Full Analysis Set|Overall Study||130
7697499|NCT01820585|18954942|P1|Full Analysis Set|Overall Study||131
7697500|NCT01820585|18954939|P4|Randomized and Treated|Overall Study||132
7697501|NCT01820585|18954940|P3|Randomized and Treated|Overall Study||135
7697502|NCT01820585|18954941|P2|Randomized and Treated|Overall Study||130
7697503|NCT01820585|18954942|P1|Randomized and Treated|Overall Study||131
7697504|NCT01820585|18954939|P4|STARTED|Overall Study||132
7697505|NCT01820585|18954940|P3|STARTED|Overall Study||135
7697506|NCT01820585|18954941|P2|STARTED|Overall Study||130
7697507|NCT01820585|18954942|P1|STARTED|Overall Study||131
7697508|NCT01820559|18954955|P3|NOT COMPLETED|Overall Study||29
7697509|NCT01820559|18954956|P2|NOT COMPLETED|Overall Study||13
7697510|NCT01820559|18954957|P1|NOT COMPLETED|Overall Study||14
7697511|NCT01820559|18954955|P3|COMPLETED|Overall Study||110
7697512|NCT01820559|18954956|P2|COMPLETED|Overall Study||122
7697513|NCT01820559|18954957|P1|COMPLETED|Overall Study||122
7697514|NCT01820559|18954955|P3|Completed Maintenance Period|Overall Study||110
7697515|NCT01820559|18954956|P2|Completed Maintenance Period|Overall Study||123
7697516|NCT01820559|18954957|P1|Completed Maintenance Period|Overall Study||122
7697517|NCT01820559|18954955|P3|Entered Maintenance Period|Overall Study||129
7697518|NCT01820559|18954956|P2|Entered Maintenance Period|Overall Study||133
7697519|NCT01820559|18954957|P1|Entered Maintenance Period|Overall Study||129
7697520|NCT01820559|18954955|P3|Completed Tutration Period|Overall Study||131
7697521|NCT01820559|18954956|P2|Completed Tutration Period|Overall Study||134
7697522|NCT01820559|18954957|P1|Completed Tutration Period|Overall Study||130
7697523|NCT01820559|18954955|P3|Randomized and Treated|Overall Study||139
7697524|NCT01820559|18954956|P2|Randomized and Treated|Overall Study||135
7697525|NCT01820559|18954957|P1|Randomized and Treated|Overall Study||136
7697526|NCT01820559|18954955|P3|STARTED|Overall Study||139
7697527|NCT01820559|18954956|P2|STARTED|Overall Study||135
7697528|NCT01820559|18954957|P1|STARTED|Overall Study||136
7697529|NCT01820416|18954968|P3|NOT COMPLETED|Overall Study||0
7697530|NCT01820416|18954969|P2|NOT COMPLETED|Overall Study||2
7697531|NCT01820416|18954970|P1|NOT COMPLETED|Overall Study||3
7697532|NCT01820416|18954968|P3|COMPLETED|Overall Study||11
7697533|NCT01820416|18954969|P2|COMPLETED|Overall Study||10
7697534|NCT01820416|18954970|P1|COMPLETED|Overall Study||9
7697535|NCT01820416|18954968|P3|STARTED|Overall Study||11
7697536|NCT01820416|18954969|P2|STARTED|Overall Study||12
7697537|NCT01820416|18954970|P1|STARTED|Overall Study||12
7697538|NCT01820364|18954978|P2|NOT COMPLETED|Part II: LGX818 + MEK162||1
7697539|NCT01820364|18954979|P1|NOT COMPLETED|Part II: LGX818 + MEK162||0
7697540|NCT01820364|18954978|P2|COMPLETED|Part II: LGX818 + MEK162||0
7697541|NCT01820364|18954979|P1|COMPLETED|Part II: LGX818 + MEK162||0
7697542|NCT01820364|18954978|P2|STARTED|Part II: LGX818 + MEK162||1
7697543|NCT01820364|18954979|P1|STARTED|Part II: LGX818 + MEK162||0
7697544|NCT01820364|18954978|P2|NOT COMPLETED|Part I: LGX818||0
7697545|NCT01820364|18954979|P1|NOT COMPLETED|Part I: LGX818||14
7697546|NCT01820364|18954978|P2|COMPLETED|Part I: LGX818||0
7697547|NCT01820364|18954979|P1|COMPLETED|Part I: LGX818||1
7697548|NCT01820364|18954978|P2|STARTED|Part I: LGX818||0
7697549|NCT01820364|18954979|P1|STARTED|Part I: LGX818||15
7697550|NCT01819935|18954993|P2|NOT COMPLETED|Overall Study||0
7697551|NCT01819935|18954994|P1|NOT COMPLETED|Overall Study||0
7697552|NCT01819935|18954993|P2|COMPLETED|Overall Study||4943
7697553|NCT01819935|18954994|P1|COMPLETED|Overall Study||328
7697554|NCT01819935|18954993|P2|STARTED|Overall Study||4943
7697555|NCT01819935|18954994|P1|STARTED|Overall Study||328
7697556|NCT01819922|18955014|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
7697557|NCT01819922|18955015|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
7697558|NCT01819922|18955014|P2|COMPLETED|Second Intervention Period (1 Day)||6
7697559|NCT01819922|18955015|P1|COMPLETED|Second Intervention Period (1 Day)||6
7697560|NCT01819922|18955014|P2|STARTED|Second Intervention Period (1 Day)||6
7697561|NCT01819922|18955015|P1|STARTED|Second Intervention Period (1 Day)||6
7697562|NCT01819922|18955014|P2|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
7697563|NCT01819922|18955015|P1|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
7697564|NCT01819922|18955014|P2|COMPLETED|Washout Period (at Least 7-10 Days)||6
7697565|NCT01819922|18955015|P1|COMPLETED|Washout Period (at Least 7-10 Days)||6
7697566|NCT01819922|18955014|P2|STARTED|Washout Period (at Least 7-10 Days)||6
7697567|NCT01819922|18955015|P1|STARTED|Washout Period (at Least 7-10 Days)||6
7697568|NCT01819922|18955014|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
7697569|NCT01819922|18955015|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
7697570|NCT01819922|18955014|P2|COMPLETED|First Intervention Period (1 Day)||6
7697571|NCT01819922|18955015|P1|COMPLETED|First Intervention Period (1 Day)||6
7697572|NCT01819922|18955014|P2|STARTED|First Intervention Period (1 Day)||6
7697573|NCT01819922|18955015|P1|STARTED|First Intervention Period (1 Day)||6
7697574|NCT01819883|18955101|P2|NOT COMPLETED|Overall Study||0
7697575|NCT01819883|18955102|P1|NOT COMPLETED|Overall Study||4
7697576|NCT01819883|18955101|P2|COMPLETED|Overall Study||20
7697577|NCT01819883|18955102|P1|COMPLETED|Overall Study||16
7697578|NCT01819883|18955101|P2|STARTED|Overall Study||20
7697579|NCT01819883|18955102|P1|STARTED|Overall Study||20
7697580|NCT01819844|18955108|P1|NOT COMPLETED|Overall Study||0
7697581|NCT01819844|18955108|P1|COMPLETED|Overall Study||12
7697582|NCT01819844|18955108|P1|STARTED|Overall Study||12
7697583|NCT01819727|18955123|P2|NOT COMPLETED|Overall Study||28
7697584|NCT01819727|18955124|P1|NOT COMPLETED|Overall Study||20
7697585|NCT01819727|18955123|P2|COMPLETED|Overall Study||102
7697586|NCT01819727|18955124|P1|COMPLETED|Overall Study||111
7697587|NCT01819727|18955123|P2|STARTED|Overall Study||130
7697588|NCT01819727|18955124|P1|STARTED|Overall Study||131
7697589|NCT01819597|18955134|P1|NOT COMPLETED|Overall Study||0
7697590|NCT01819597|18955134|P1|COMPLETED|Overall Study||52
7697591|NCT01819597|18955134|P1|STARTED|Overall Study||52
7697592|NCT01819506|18955146|P2|NOT COMPLETED|Overall Study||5
7697593|NCT01819506|18955147|P1|NOT COMPLETED|Overall Study||8
7697594|NCT01819506|18955146|P2|COMPLETED|Overall Study||47
7697595|NCT01819506|18955147|P1|COMPLETED|Overall Study||43
7697596|NCT01819506|18955146|P2|STARTED|Overall Study||52
7697597|NCT01819506|18955147|P1|STARTED|Overall Study||51
7697598|NCT01819415|18955161|P4|NOT COMPLETED|Overall Study||2
7697599|NCT01819415|18955162|P3|NOT COMPLETED|Overall Study||1
7697600|NCT01819415|18955163|P2|NOT COMPLETED|Overall Study||4
7697601|NCT01819415|18955164|P1|NOT COMPLETED|Overall Study||3
7697602|NCT01819415|18955161|P4|COMPLETED|Overall Study||8
7697603|NCT01819415|18955162|P3|COMPLETED|Overall Study||9
7697604|NCT01819415|18955163|P2|COMPLETED|Overall Study||6
7697605|NCT01819415|18955164|P1|COMPLETED|Overall Study||7
7697606|NCT01819415|18955161|P4|STARTED|Overall Study||10
7697607|NCT01819415|18955162|P3|STARTED|Overall Study||10
7697608|NCT01819415|18955163|P2|STARTED|Overall Study||10
7697609|NCT01819415|18955164|P1|STARTED|Overall Study||10
7697610|NCT01819311|18955176|P2|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
7697611|NCT01819311|18955177|P1|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
7697612|NCT01819311|18955176|P2|COMPLETED|Follow-up Phase (8 Weeks)||23
7697613|NCT01819311|18955177|P1|COMPLETED|Follow-up Phase (8 Weeks)||24
7697614|NCT01819311|18955176|P2|STARTED|Follow-up Phase (8 Weeks)||30
7697615|NCT01819311|18955177|P1|STARTED|Follow-up Phase (8 Weeks)||31
7697616|NCT01819311|18955176|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||1
7697617|NCT01819311|18955177|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||2
7697618|NCT01819311|18955176|P2|COMPLETED|Treatment Phase (4 Weeks)||30
7697619|NCT01819311|18955177|P1|COMPLETED|Treatment Phase (4 Weeks)||31
7697620|NCT01819311|18955176|P2|STARTED|Treatment Phase (4 Weeks)||31
7697621|NCT01819311|18955177|P1|STARTED|Treatment Phase (4 Weeks)||33
7697622|NCT01819272|18955199|P6|NOT COMPLETED|Overall Study||7
7697623|NCT01819272|18955200|P5|NOT COMPLETED|Overall Study||4
7697624|NCT01819272|18955201|P4|NOT COMPLETED|Overall Study||5
7697625|NCT01819272|18955202|P3|NOT COMPLETED|Overall Study||3
7697626|NCT01819272|18955203|P2|NOT COMPLETED|Overall Study||3
7697627|NCT01819272|18955204|P1|NOT COMPLETED|Overall Study||6
7697628|NCT01819272|18955199|P6|COMPLETED|Overall Study||33
7697629|NCT01819272|18955200|P5|COMPLETED|Overall Study||36
7697630|NCT01819272|18955201|P4|COMPLETED|Overall Study||35
7697631|NCT01819272|18955202|P3|COMPLETED|Overall Study||37
7697632|NCT01819272|18955203|P2|COMPLETED|Overall Study||36
7697633|NCT01819272|18955204|P1|COMPLETED|Overall Study||35
7697634|NCT01819272|18955199|P6|STARTED|Overall Study||40
7697635|NCT01819272|18955200|P5|STARTED|Overall Study||40
7697636|NCT01819272|18955201|P4|STARTED|Overall Study||40
7697637|NCT01819272|18955202|P3|STARTED|Overall Study||40
7697638|NCT01819272|18955203|P2|STARTED|Overall Study||39
7697639|NCT01819272|18955204|P1|STARTED|Overall Study||41
7697640|NCT01819233|18955230|P1|NOT COMPLETED|Overall Study||6
7697641|NCT01819233|18955230|P1|COMPLETED|Overall Study||32
7697642|NCT01819233|18955230|P1|STARTED|Overall Study||38
7697643|NCT01819194|18955242|P1|NOT COMPLETED|Overall Study||2
7697644|NCT01819194|18955242|P1|COMPLETED|Overall Study||60
7697645|NCT01819194|18955242|P1|STARTED|Overall Study||62
7697646|NCT01819129|18955249|P2|NOT COMPLETED|Overall Study||39
7697647|NCT01819129|18955250|P1|NOT COMPLETED|Overall Study||44
7697648|NCT01819129|18955249|P2|COMPLETED|Overall Study||305
7697649|NCT01819129|18955250|P1|COMPLETED|Overall Study||301
7697650|NCT01819129|18955249|P2|Exposed|Overall Study||341
7697651|NCT01819129|18955250|P1|Exposed|Overall Study||341
7697652|NCT01819129|18955249|P2|STARTED|Overall Study||344
7697653|NCT01819129|18955250|P1|STARTED|Overall Study||345
7697654|NCT01818804|18955264|P2|NOT COMPLETED|Overall Study||7
7697655|NCT01818804|18955265|P1|NOT COMPLETED|Overall Study||5
7697656|NCT01818804|18955264|P2|COMPLETED|Overall Study||65
7697657|NCT01818804|18955265|P1|COMPLETED|Overall Study||68
7697658|NCT01818804|18955264|P2|STARTED|Overall Study||72
7697659|NCT01818804|18955265|P1|STARTED|Overall Study||73
7697660|NCT01818765|18955275|P1|NOT COMPLETED|Overall Study||2
7697661|NCT01818765|18955275|P1|COMPLETED|Overall Study||18
7697662|NCT01818765|18955275|P1|STARTED|Overall Study||20
7697663|NCT01818752|18955288|P2|NOT COMPLETED|Overall Study||198
7697664|NCT01818752|18955289|P1|NOT COMPLETED|Overall Study||187
7697665|NCT01818752|18955288|P2|COMPLETED|Overall Study|Completed treatment|280
7697666|NCT01818752|18955289|P1|COMPLETED|Overall Study|Completed treatment|290
7697667|NCT01818752|18955288|P2|Received Treatment|Overall Study||474
7697668|NCT01818752|18955289|P1|Received Treatment|Overall Study||470
7697669|NCT01818752|18955288|P2|STARTED|Overall Study||478
7697670|NCT01818752|18955289|P1|STARTED|Overall Study||477
7697671|NCT01818726|18955309|P2|NOT COMPLETED|Overall Study||2
7697672|NCT01818726|18955310|P1|NOT COMPLETED|Overall Study||6
7697673|NCT01818726|18955309|P2|COMPLETED|Overall Study||3
7697674|NCT01818726|18955310|P1|COMPLETED|Overall Study||4
7697675|NCT01818726|18955309|P2|STARTED|Overall Study||5
7697676|NCT01818726|18955310|P1|STARTED|Overall Study||10
7697677|NCT01818700|18955320|P1|NOT COMPLETED|Overall Study||104
7697678|NCT01818700|18955320|P1|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141
7697679|NCT01818700|18955320|P1|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105
7697680|NCT01818700|18955320|P1|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210
7697681|NCT01818700|18955320|P1|Safety Set|Overall Study|4 subjects were not study drug administered.|241
7697682|NCT01818700|18955320|P1|STARTED|Overall Study|The No. of enrolled patients|245
7697683|NCT01818596|18955331|P2|NOT COMPLETED|Overall Study||0
7697684|NCT01818596|18955332|P1|NOT COMPLETED|Overall Study||31
7697685|NCT01818596|18955331|P2|COMPLETED|Overall Study||6
7697686|NCT01818596|18955332|P1|COMPLETED|Overall Study||215
7697687|NCT01818596|18955331|P2|STARTED|Overall Study||6
7697688|NCT01818596|18955332|P1|STARTED|Overall Study||246
7697689|NCT01818531|18955371|P2|NOT COMPLETED|Overall Study||2
7697690|NCT01818531|18955372|P1|NOT COMPLETED|Overall Study||1
7697691|NCT01818531|18955371|P2|COMPLETED|Overall Study||73
7697692|NCT01818531|18955372|P1|COMPLETED|Overall Study||74
7697693|NCT01818531|18955371|P2|STARTED|Overall Study||75
7697694|NCT01818531|18955372|P1|STARTED|Overall Study||75
7697695|NCT01818518|18955392|P6|NOT COMPLETED|Overall Study||0
7697696|NCT01818518|18955393|P5|NOT COMPLETED|Overall Study||0
7697697|NCT01818518|18955394|P4|NOT COMPLETED|Overall Study||0
7697698|NCT01818518|18955395|P3|NOT COMPLETED|Overall Study||0
7697699|NCT01818518|18955396|P2|NOT COMPLETED|Overall Study||0
7697700|NCT01818518|18955397|P1|NOT COMPLETED|Overall Study||0
7697701|NCT01818518|18955392|P6|COMPLETED|Overall Study||37
7697702|NCT01818518|18955393|P5|COMPLETED|Overall Study||38
7697703|NCT01818518|18955394|P4|COMPLETED|Overall Study||59
7697704|NCT01818518|18955395|P3|COMPLETED|Overall Study||288
7697705|NCT01818518|18955396|P2|COMPLETED|Overall Study||263
7697706|NCT01818518|18955397|P1|COMPLETED|Overall Study||310
7697707|NCT01818518|18955392|P6|STARTED|Overall Study||37
7697708|NCT01818518|18955393|P5|STARTED|Overall Study||38
7697709|NCT01818518|18955394|P4|STARTED|Overall Study||59
7697710|NCT01818518|18955395|P3|STARTED|Overall Study||288
7697711|NCT01818518|18955396|P2|STARTED|Overall Study||263
7697712|NCT01818518|18955397|P1|STARTED|Overall Study||310
7697713|NCT01818492|18955411|P1|NOT COMPLETED|Overall Study||10
7697714|NCT01818492|18955411|P1|COMPLETED|Overall Study||35
7697715|NCT01818492|18955411|P1|STARTED|Overall Study||45
7697716|NCT01818427|18955428|P2|NOT COMPLETED|Overall Study||13
7697717|NCT01818427|18955429|P1|NOT COMPLETED|Overall Study||9
7697718|NCT01818427|18955428|P2|COMPLETED|Overall Study||271
7697719|NCT01818427|18955429|P1|COMPLETED|Overall Study||230
7697720|NCT01818427|18955428|P2|STARTED|Overall Study||284
7697721|NCT01818427|18955429|P1|STARTED|Overall Study||239
7697722|NCT01818414|18955445|P2|NOT COMPLETED|Overall Study||0
7697723|NCT01818414|18955446|P1|NOT COMPLETED|Overall Study||0
7697724|NCT01818414|18955445|P2|COMPLETED|Overall Study||15
7697725|NCT01818414|18955446|P1|COMPLETED|Overall Study||14
7697726|NCT01818414|18955445|P2|STARTED|Overall Study||15
7697727|NCT01818414|18955446|P1|STARTED|Overall Study||14
7697728|NCT01818336|18955460|P2|NOT COMPLETED|Overall Study||12
7697729|NCT01818336|18955461|P1|NOT COMPLETED|Overall Study||0
7697730|NCT01818336|18955460|P2|COMPLETED|Overall Study||47
7697731|NCT01818336|18955461|P1|COMPLETED|Overall Study||391
7697732|NCT01818336|18955460|P2|STARTED|Overall Study||59
7697733|NCT01818336|18955461|P1|STARTED|Overall Study||391
7697734|NCT01818297|18955469|P2|NOT COMPLETED|Open Label Phase (3-12 Months)||10
7697735|NCT01818297|18955470|P1|NOT COMPLETED|Open Label Phase (3-12 Months)||18
7697736|NCT01818297|18955469|P2|COMPLETED|Open Label Phase (3-12 Months)||19
7697737|NCT01818297|18955470|P1|COMPLETED|Open Label Phase (3-12 Months)||14
7697738|NCT01818297|18955469|P2|STARTED|Open Label Phase (3-12 Months)||29
7697739|NCT01818297|18955470|P1|STARTED|Open Label Phase (3-12 Months)||32
7697740|NCT01818297|18955469|P2|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||1
7697741|NCT01818297|18955470|P1|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||0
7697742|NCT01818297|18955469|P2|COMPLETED|Blinded Phase (Randomization - 3 Months)||29
7697743|NCT01818297|18955470|P1|COMPLETED|Blinded Phase (Randomization - 3 Months)||32
7697744|NCT01818297|18955469|P2|Week 6|Blinded Phase (Randomization - 3 Months)||29
7697745|NCT01818297|18955470|P1|Week 6|Blinded Phase (Randomization - 3 Months)||32
7697746|NCT01818297|18955469|P2|Week 1|Blinded Phase (Randomization - 3 Months)||30
7697747|NCT01818297|18955470|P1|Week 1|Blinded Phase (Randomization - 3 Months)||32
7697748|NCT01818297|18955469|P2|STARTED|Blinded Phase (Randomization - 3 Months)||30
7697749|NCT01818297|18955470|P1|STARTED|Blinded Phase (Randomization - 3 Months)||32
7697750|NCT01818284|18955488|P2|NOT COMPLETED|Overall Study||6
7697751|NCT01818284|18955489|P1|NOT COMPLETED|Overall Study||4
7697752|NCT01818284|18955488|P2|COMPLETED|Overall Study||5
7697753|NCT01818284|18955489|P1|COMPLETED|Overall Study||7
7697754|NCT01818284|18955488|P2|STARTED|Overall Study||11
7697755|NCT01818284|18955489|P1|STARTED|Overall Study||11
7697756|NCT01818245|18955497|P2|NOT COMPLETED|Intervention C||0
7697757|NCT01818245|18955498|P1|NOT COMPLETED|Intervention C||0
7697758|NCT01818245|18955497|P2|COMPLETED|Intervention C||0
7697759|NCT01818245|18955498|P1|COMPLETED|Intervention C||30
7697760|NCT01818245|18955497|P2|STARTED|Intervention C||0
7697761|NCT01818245|18955498|P1|STARTED|Intervention C||30
7697762|NCT01818245|18955497|P2|NOT COMPLETED|Washout (16-28 Days)||0
7697763|NCT01818245|18955498|P1|NOT COMPLETED|Washout (16-28 Days)||0
7697764|NCT01818245|18955497|P2|COMPLETED|Washout (16-28 Days)||0
7697765|NCT01818245|18955498|P1|COMPLETED|Washout (16-28 Days)||30
7697766|NCT01818245|18955497|P2|STARTED|Washout (16-28 Days)||0
7697767|NCT01818245|18955498|P1|STARTED|Washout (16-28 Days)||30
7697768|NCT01818245|18955497|P2|NOT COMPLETED|Intervention B||0
7697769|NCT01818245|18955498|P1|NOT COMPLETED|Intervention B||0
7697770|NCT01818245|18955497|P2|COMPLETED|Intervention B||0
7697771|NCT01818245|18955498|P1|COMPLETED|Intervention B||30
7697772|NCT01818245|18955497|P2|STARTED|Intervention B||0
7697773|NCT01818245|18955498|P1|STARTED|Intervention B||30
7697774|NCT01818245|18955497|P2|NOT COMPLETED|Washout (16-28 Days)||0
7697775|NCT01818245|18955498|P1|NOT COMPLETED|Washout (16-28 Days)||0
7697776|NCT01818245|18955497|P2|COMPLETED|Washout (16-28 Days)||0
7697777|NCT01818245|18955498|P1|COMPLETED|Washout (16-28 Days)||30
7697778|NCT01818245|18955497|P2|STARTED|Washout (16-28 Days)||0
7697779|NCT01818245|18955498|P1|STARTED|Washout (16-28 Days)||30
7697780|NCT01818245|18955497|P2|NOT COMPLETED|Intervention A||0
7697781|NCT01818245|18955498|P1|NOT COMPLETED|Intervention A||0
7697782|NCT01818245|18955497|P2|COMPLETED|Intervention A||22
7697783|NCT01818245|18955498|P1|COMPLETED|Intervention A||30
7697784|NCT01818245|18955497|P2|Received One Dose of Study Drug|Intervention A||22
7697785|NCT01818245|18955498|P1|Received One Dose of Study Drug|Intervention A||30
7697786|NCT01818245|18955497|P2|STARTED|Intervention A|Participants didn't participate in separate interventions and received 1 dose of LY2605541 on Day 1.|22
7697787|NCT01818245|18955498|P1|STARTED|Intervention A||30
7697788|NCT01818141|18955522|P2|NOT COMPLETED|Overall Study||3
7697789|NCT01818141|18955523|P1|NOT COMPLETED|Overall Study||3
7697790|NCT01818141|18955522|P2|COMPLETED|Overall Study||13
7697791|NCT01818141|18955523|P1|COMPLETED|Overall Study||15
7697792|NCT01818141|18955522|P2|STARTED|Overall Study||16
7697793|NCT01818141|18955523|P1|STARTED|Overall Study||18
7697794|NCT01818063|18955533|P2|NOT COMPLETED|Overall Study||0
7697795|NCT01818063|18955534|P1|NOT COMPLETED|Overall Study||0
7697796|NCT01818063|18955533|P2|COMPLETED|Overall Study||4
7697797|NCT01818063|18955534|P1|COMPLETED|Overall Study||5
7697798|NCT01818063|18955533|P2|STARTED|Overall Study||4
7697799|NCT01818063|18955534|P1|STARTED|Overall Study||5
7697800|NCT01817959|18955546|P2|NOT COMPLETED|Overall Study||3
7697801|NCT01817959|18955547|P1|NOT COMPLETED|Overall Study||4
7697802|NCT01817959|18955546|P2|COMPLETED|Overall Study||16
7697803|NCT01817959|18955547|P1|COMPLETED|Overall Study||25
7697804|NCT01817959|18955546|P2|STARTED|Overall Study||19
7697805|NCT01817959|18955547|P1|STARTED|Overall Study||29
7697806|NCT01817907|18955593|P2|NOT COMPLETED|Second Intervention||0
7697807|NCT01817907|18955594|P1|NOT COMPLETED|Second Intervention||0
7697808|NCT01817907|18955593|P2|COMPLETED|Second Intervention||7
7697809|NCT01817907|18955594|P1|COMPLETED|Second Intervention||8
7697810|NCT01817907|18955593|P2|STARTED|Second Intervention||7
7697811|NCT01817907|18955594|P1|STARTED|Second Intervention||8
7697812|NCT01817907|18955593|P2|NOT COMPLETED|Washout Period||0
7697813|NCT01817907|18955594|P1|NOT COMPLETED|Washout Period||0
7697814|NCT01817907|18955593|P2|COMPLETED|Washout Period||7
7697815|NCT01817907|18955594|P1|COMPLETED|Washout Period||8
7697816|NCT01817907|18955593|P2|STARTED|Washout Period||7
7697817|NCT01817907|18955594|P1|STARTED|Washout Period||8
7697818|NCT01817907|18955593|P2|NOT COMPLETED|First Intervention||0
7697819|NCT01817907|18955594|P1|NOT COMPLETED|First Intervention||0
7697820|NCT01817907|18955593|P2|COMPLETED|First Intervention||7
7697821|NCT01817907|18955594|P1|COMPLETED|First Intervention||8
7697822|NCT01817907|18955593|P2|STARTED|First Intervention||7
7697823|NCT01817907|18955594|P1|STARTED|First Intervention||8
7697824|NCT01817855|18955606|P4|NOT COMPLETED|Overall Study||0
7697825|NCT01817855|18955607|P3|NOT COMPLETED|Overall Study||2
7697826|NCT01817855|18955608|P2|NOT COMPLETED|Overall Study||2
7697827|NCT01817855|18955609|P1|NOT COMPLETED|Overall Study||0
7697828|NCT01817855|18955606|P4|COMPLETED|Overall Study||5
7697829|NCT01817855|18955607|P3|COMPLETED|Overall Study||9
7697830|NCT01817855|18955608|P2|COMPLETED|Overall Study||6
7697831|NCT01817855|18955609|P1|COMPLETED|Overall Study||23
7697832|NCT01817855|18955606|P4|STARTED|Overall Study||5
7697833|NCT01817855|18955607|P3|STARTED|Overall Study||11
7697834|NCT01817855|18955608|P2|STARTED|Overall Study||8
7697835|NCT01817855|18955609|P1|STARTED|Overall Study||23
7697836|NCT01817790|18955639|P2|NOT COMPLETED|Overall Study||8
7697837|NCT01817790|18955640|P1|NOT COMPLETED|Overall Study||4
7697838|NCT01817790|18955639|P2|COMPLETED|Overall Study||304
7697839|NCT01817790|18955640|P1|COMPLETED|Overall Study||310
7697840|NCT01817790|18955639|P2|STARTED|Overall Study||312
7697841|NCT01817790|18955640|P1|STARTED|Overall Study||314
7697842|NCT01817777|18955684|P3|NOT COMPLETED|Interventional Phase (20 Weeks)||5
7697843|NCT01817777|18955685|P2|NOT COMPLETED|Interventional Phase (20 Weeks)||5
7697844|NCT01817777|18955686|P1|NOT COMPLETED|Interventional Phase (20 Weeks)||0
7697845|NCT01817777|18955684|P3|COMPLETED|Interventional Phase (20 Weeks)||10
7697846|NCT01817777|18955685|P2|COMPLETED|Interventional Phase (20 Weeks)||11
7697847|NCT01817777|18955686|P1|COMPLETED|Interventional Phase (20 Weeks)||0
7697848|NCT01817777|18955684|P3|STARTED|Interventional Phase (20 Weeks)||15
7697849|NCT01817777|18955685|P2|STARTED|Interventional Phase (20 Weeks)||16
7697850|NCT01817777|18955686|P1|STARTED|Interventional Phase (20 Weeks)||0
7697851|NCT01817777|18955684|P3|NOT COMPLETED|Observational Phase (8 Weeks)||0
7697852|NCT01817777|18955685|P2|NOT COMPLETED|Observational Phase (8 Weeks)||0
7697853|NCT01817777|18955686|P1|NOT COMPLETED|Observational Phase (8 Weeks)||5
7697854|NCT01817777|18955684|P3|COMPLETED|Observational Phase (8 Weeks)||0
7697855|NCT01817777|18955685|P2|COMPLETED|Observational Phase (8 Weeks)||0
7697856|NCT01817777|18955686|P1|COMPLETED|Observational Phase (8 Weeks)||31
7697857|NCT01817777|18955684|P3|STARTED|Observational Phase (8 Weeks)||0
7697858|NCT01817777|18955685|P2|STARTED|Observational Phase (8 Weeks)||0
7697859|NCT01817777|18955686|P1|STARTED|Observational Phase (8 Weeks)||36
7697860|NCT01817764|18955710|P2|NOT COMPLETED|Overall Study||38
7697861|NCT01817764|18955711|P1|NOT COMPLETED|Overall Study||34
7697862|NCT01817764|18955710|P2|COMPLETED|Overall Study||315
7697863|NCT01817764|18955711|P1|COMPLETED|Overall Study||319
7697864|NCT01817764|18955710|P2|STARTED|Overall Study||353
7697865|NCT01817764|18955711|P1|STARTED|Overall Study||353
7697866|NCT01817725|18955719|P1|NOT COMPLETED|Overall Study||1
7697867|NCT01817725|18955719|P1|COMPLETED|Overall Study||19
7697868|NCT01817725|18955719|P1|STARTED|Overall Study||20
7697869|NCT01817712|18955726|P2|NOT COMPLETED|Overall Study||30
7697870|NCT01817712|18955727|P1|NOT COMPLETED|Overall Study||21
7697871|NCT01817712|18955726|P2|COMPLETED|Overall Study|Primary Outcome assessed over 18 months|240
7697872|NCT01817712|18955727|P1|COMPLETED|Overall Study|Primary Outcome Assessed over 18 months|250
7697873|NCT01817712|18955726|P2|STARTED|Overall Study||270
7697874|NCT01817712|18955727|P1|STARTED|Overall Study||271
7697875|NCT01817582|18955740|P3|NOT COMPLETED|Overall Study||0
7697876|NCT01817582|18955741|P2|NOT COMPLETED|Overall Study||1
7697877|NCT01817582|18955742|P1|NOT COMPLETED|Overall Study||2
7697878|NCT01817582|18955740|P3|COMPLETED|Overall Study||33
7697879|NCT01817582|18955741|P2|COMPLETED|Overall Study||35
7697880|NCT01817582|18955742|P1|COMPLETED|Overall Study||31
7697881|NCT01817582|18955740|P3|Received at Least 1 Dose of Study Drug|Overall Study||33
7697882|NCT01817582|18955741|P2|Received at Least 1 Dose of Study Drug|Overall Study||36
7697883|NCT01817582|18955742|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
7697884|NCT01817582|18955740|P3|STARTED|Overall Study||33
7697885|NCT01817582|18955741|P2|STARTED|Overall Study||36
7697886|NCT01817582|18955742|P1|STARTED|Overall Study||33
7697887|NCT01817530|18955812|P8|NOT COMPLETED|Overall Study||24
7697888|NCT01817530|18955813|P7|NOT COMPLETED|Overall Study||23
7697889|NCT01817530|18955814|P6|NOT COMPLETED|Overall Study||19
7697890|NCT01817530|18955815|P5|NOT COMPLETED|Overall Study||11
7697891|NCT01817530|18955816|P4|NOT COMPLETED|Overall Study||13
7697892|NCT01817530|18955817|P3|NOT COMPLETED|Overall Study||11
7697893|NCT01817530|18955818|P2|NOT COMPLETED|Overall Study||13
7697894|NCT01817530|18955819|P1|NOT COMPLETED|Overall Study||15
7697895|NCT01817530|18955812|P8|COMPLETED|Overall Study||53
7697896|NCT01817530|18955813|P7|COMPLETED|Overall Study||53
7697897|NCT01817530|18955814|P6|COMPLETED|Overall Study||58
7697898|NCT01817530|18955815|P5|COMPLETED|Overall Study||67
7697899|NCT01817530|18955816|P4|COMPLETED|Overall Study||52
7697900|NCT01817530|18955817|P3|COMPLETED|Overall Study||53
7697901|NCT01817530|18955818|P2|COMPLETED|Overall Study||52
7697902|NCT01817530|18955819|P1|COMPLETED|Overall Study||50
7697903|NCT01817530|18955812|P8|STARTED|Overall Study||77
7697904|NCT01817530|18955813|P7|STARTED|Overall Study||76
7697905|NCT01817530|18955814|P6|STARTED|Overall Study||77
7697906|NCT01817530|18955815|P5|STARTED|Overall Study||78
7697907|NCT01817530|18955816|P4|STARTED|Overall Study||65
7697908|NCT01817530|18955817|P3|STARTED|Overall Study||64
7697909|NCT01817530|18955818|P2|STARTED|Overall Study||65
7697910|NCT01817530|18955819|P1|STARTED|Overall Study||65
7697911|NCT01817491|18955983|P2|NOT COMPLETED|Overall Study||0
7697912|NCT01817491|18955984|P1|NOT COMPLETED|Overall Study||4
7697913|NCT01817491|18955983|P2|COMPLETED|Overall Study||28
7697914|NCT01817491|18955984|P1|COMPLETED|Overall Study||28
7697915|NCT01817491|18955983|P2|STARTED|Overall Study||28
7697916|NCT01817491|18955984|P1|STARTED|Overall Study||32
7697917|NCT01817374|18956030|P1|NOT COMPLETED|Overall Study||0
7697918|NCT01817374|18956030|P1|COMPLETED|Overall Study||6
7697919|NCT01817374|18956030|P1|STARTED|Overall Study||6
7697920|NCT01817075|18956044|P2|NOT COMPLETED|Overall Study||35
7697921|NCT01817075|18956045|P1|NOT COMPLETED|Overall Study||47
7697922|NCT01817075|18956044|P2|COMPLETED|Overall Study||54
7697923|NCT01817075|18956045|P1|COMPLETED|Overall Study||41
7697924|NCT01817075|18956044|P2|STARTED|Overall Study||89
7697925|NCT01817075|18956045|P1|STARTED|Overall Study||88
7697926|NCT01816984|18956057|P1|NOT COMPLETED|Overall Study||1
7697927|NCT01816984|18956057|P1|COMPLETED|Overall Study||11
7697928|NCT01816984|18956057|P1|STARTED|Overall Study||12
7697929|NCT01816906|18956070|P2|NOT COMPLETED|12 Months||5
7697930|NCT01816906|18956071|P1|NOT COMPLETED|12 Months||4
7697931|NCT01816906|18956070|P2|COMPLETED|12 Months||14
7697932|NCT01816906|18956071|P1|COMPLETED|12 Months||16
7697933|NCT01816906|18956070|P2|STARTED|12 Months||19
7697934|NCT01816906|18956071|P1|STARTED|12 Months||20
7697935|NCT01816906|18956070|P2|NOT COMPLETED|Six Months||22
7697936|NCT01816906|18956071|P1|NOT COMPLETED|Six Months||21
7697937|NCT01816906|18956070|P2|COMPLETED|Six Months||19
7697938|NCT01816906|18956071|P1|COMPLETED|Six Months||20
7697939|NCT01816906|18956070|P2|STARTED|Six Months||41
7697940|NCT01816906|18956071|P1|STARTED|Six Months||41
7697941|NCT01816893|18956089|P2|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
7697942|NCT01816893|18956090|P1|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
7697943|NCT01816893|18956089|P2|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||11
7697944|NCT01816893|18956090|P1|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||9
7697945|NCT01816893|18956089|P2|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||11
7697946|NCT01816893|18956090|P1|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||9
7697947|NCT01816893|18956089|P2|NOT COMPLETED|Washout Period||0
7697948|NCT01816893|18956090|P1|NOT COMPLETED|Washout Period||2
7697949|NCT01816893|18956089|P2|COMPLETED|Washout Period||11
7697950|NCT01816893|18956090|P1|COMPLETED|Washout Period||9
7697951|NCT01816893|18956089|P2|STARTED|Washout Period||11
7697952|NCT01816893|18956090|P1|STARTED|Washout Period||11
7697953|NCT01816893|18956089|P2|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
7697954|NCT01816893|18956090|P1|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
7697955|NCT01816893|18956089|P2|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
7697956|NCT01816893|18956090|P1|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
7697957|NCT01816893|18956089|P2|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
7697958|NCT01816893|18956090|P1|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
7697959|NCT01816776|18956102|P2|NOT COMPLETED|Overall Study||8
7697960|NCT01816776|18956103|P1|NOT COMPLETED|Overall Study||13
7697961|NCT01816776|18956102|P2|COMPLETED|Overall Study||70
7697962|NCT01816776|18956103|P1|COMPLETED|Overall Study||60
7697963|NCT01816776|18956102|P2|6 Month Primary Effectiveness Assessed|Overall Study||73
7697964|NCT01816776|18956103|P1|6 Month Primary Effectiveness Assessed|Overall Study||68
7697965|NCT01816776|18956102|P2|STARTED|Overall Study||78
7697966|NCT01816776|18956103|P1|STARTED|Overall Study||73
7697967|NCT01816763|18956126|P3|NOT COMPLETED|Overall Study||11
7697968|NCT01816763|18956127|P2|NOT COMPLETED|Overall Study||15
7697969|NCT01816763|18956128|P1|NOT COMPLETED|Overall Study||4
7697970|NCT01816763|18956126|P3|COMPLETED|Overall Study||169
7697971|NCT01816763|18956127|P2|COMPLETED|Overall Study||179
7697972|NCT01816763|18956128|P1|COMPLETED|Overall Study||191
7697973|NCT01816763|18956126|P3|STARTED|Overall Study||180
7697974|NCT01816763|18956127|P2|STARTED|Overall Study||194
7697975|NCT01816763|18956128|P1|STARTED|Overall Study||195
7697976|NCT01816711|18956144|P2|NOT COMPLETED|Overall Study||0
7697977|NCT01816711|18956145|P1|NOT COMPLETED|Overall Study||0
7697978|NCT01816711|18956144|P2|COMPLETED|Overall Study||83
7697979|NCT01816711|18956145|P1|COMPLETED|Overall Study||121
7697980|NCT01816711|18956144|P2|STARTED|Overall Study||83
7697981|NCT01816711|18956145|P1|STARTED|Overall Study||121
7697982|NCT01816685|18956153|P2|NOT COMPLETED|Overall Study||11
7697983|NCT01816685|18956154|P1|NOT COMPLETED|Overall Study||10
7697984|NCT01816685|18956153|P2|COMPLETED|Overall Study||56
7697985|NCT01816685|18956154|P1|COMPLETED|Overall Study||58
7697986|NCT01816685|18956153|P2|STARTED|Overall Study||67
7697987|NCT01816685|18956154|P1|STARTED|Overall Study||68
7697988|NCT01816594|18956164|P2|NOT COMPLETED|Overall Study||2
7697989|NCT01816594|18956165|P1|NOT COMPLETED|Overall Study||11
7697990|NCT01816594|18956164|P2|COMPLETED|Overall Study||23
7697991|NCT01816594|18956165|P1|COMPLETED|Overall Study||14
7697992|NCT01816594|18956164|P2|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
7697993|NCT01816594|18956165|P1|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
7697994|NCT01816594|18956164|P2|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
7697995|NCT01816594|18956165|P1|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
7697996|NCT01816594|18956164|P2|STARTED|Overall Study||25
7697997|NCT01816594|18956165|P1|STARTED|Overall Study||25
7697998|NCT01816477|18956203|P2|NOT COMPLETED|Overall Study||1
7697999|NCT01816477|18956204|P1|NOT COMPLETED|Overall Study||16
7698000|NCT01816477|18956203|P2|COMPLETED|Overall Study||41
7698001|NCT01816477|18956204|P1|COMPLETED|Overall Study||27
7698002|NCT01816477|18956203|P2|STARTED|Overall Study||42
7698003|NCT01816477|18956204|P1|STARTED|Overall Study||43
7698004|NCT01816451|18956217|P3|NOT COMPLETED|Overall Study||0
7698005|NCT01816451|18956218|P2|NOT COMPLETED|Overall Study||0
7698006|NCT01816451|18956219|P1|NOT COMPLETED|Overall Study||0
7698007|NCT01816451|18956217|P3|COMPLETED|Overall Study||8
7698008|NCT01816451|18956218|P2|COMPLETED|Overall Study||11
7698009|NCT01816451|18956219|P1|COMPLETED|Overall Study||13
7698010|NCT01816451|18956217|P3|STARTED|Overall Study||8
7698011|NCT01816451|18956218|P2|STARTED|Overall Study||11
7698012|NCT01816451|18956219|P1|STARTED|Overall Study||13
7698013|NCT01816295|18956258|P2|NOT COMPLETED|OLE Phase||56
7698014|NCT01816295|18956259|P1|NOT COMPLETED|OLE Phase||53
7698015|NCT01816295|18956258|P2|COMPLETED|OLE Phase||227
7698016|NCT01816295|18956259|P1|COMPLETED|OLE Phase||222
7698017|NCT01816295|18956258|P2|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283
7698018|NCT01816295|18956259|P1|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275
7698019|NCT01816295|18956258|P2|NOT COMPLETED|Double Blind Phase||56
7698020|NCT01816295|18956259|P1|NOT COMPLETED|Double Blind Phase||63
7698021|NCT01816295|18956258|P2|COMPLETED|Double Blind Phase||302
7698022|NCT01816295|18956259|P1|COMPLETED|Double Blind Phase||294
7698023|NCT01816295|18956258|P2|Received Study Drug|Double Blind Phase||354
7698024|NCT01816295|18956259|P1|Received Study Drug|Double Blind Phase||356
7698025|NCT01816295|18956258|P2|STARTED|Double Blind Phase||358
7698026|NCT01816295|18956259|P1|STARTED|Double Blind Phase||357
7698027|NCT01816243|18956274|P1|NOT COMPLETED|Overall Study||12
7698028|NCT01816243|18956274|P1|COMPLETED|Overall Study||27
7698029|NCT01816243|18956274|P1|STARTED|Overall Study||39
7698030|NCT01816230|18956281|P1|NOT COMPLETED|Overall Study||0
7698031|NCT01816230|18956281|P1|COMPLETED|Overall Study||36
7698032|NCT01816230|18956281|P1|STARTED|Overall Study||36
7698033|NCT01816074|18956289|P4|NOT COMPLETED|Phase 2||1
7698034|NCT01816074|18956290|P3|NOT COMPLETED|Phase 2||0
7698035|NCT01816074|18956291|P2|NOT COMPLETED|Phase 2||2
7698036|NCT01816074|18956292|P1|NOT COMPLETED|Phase 2||2
7698037|NCT01816074|18956289|P4|COMPLETED|Phase 2||9
7698038|NCT01816074|18956290|P3|COMPLETED|Phase 2||10
7698039|NCT01816074|18956291|P2|COMPLETED|Phase 2||7
7698040|NCT01816074|18956292|P1|COMPLETED|Phase 2||9
7698041|NCT01816074|18956289|P4|STARTED|Phase 2||10
7698042|NCT01816074|18956290|P3|STARTED|Phase 2||10
7698043|NCT01816074|18956291|P2|STARTED|Phase 2||9
7698044|NCT01816074|18956292|P1|STARTED|Phase 2||11
7698045|NCT01816074|18956289|P4|NOT COMPLETED|Phase 1||0
7698046|NCT01816074|18956290|P3|NOT COMPLETED|Phase 1||1
7698047|NCT01816074|18956291|P2|NOT COMPLETED|Phase 1||0
7698048|NCT01816074|18956292|P1|NOT COMPLETED|Phase 1||0
7698049|NCT01816074|18956289|P4|COMPLETED|Phase 1||10
7698050|NCT01816074|18956290|P3|COMPLETED|Phase 1||10
7698051|NCT01816074|18956291|P2|COMPLETED|Phase 1||9
7698052|NCT01816074|18956292|P1|COMPLETED|Phase 1||11
7698053|NCT01816074|18956289|P4|STARTED|Phase 1||10
7698054|NCT01816074|18956290|P3|STARTED|Phase 1||11
7698055|NCT01816074|18956291|P2|STARTED|Phase 1||9
7698056|NCT01816074|18956292|P1|STARTED|Phase 1||11
7698057|NCT01816061|18956322|P2|NOT COMPLETED|Overall Study||24
7698058|NCT01816061|18956323|P1|NOT COMPLETED|Overall Study||13
7698059|NCT01816061|18956322|P2|COMPLETED|Overall Study||27
7698060|NCT01816061|18956323|P1|COMPLETED|Overall Study||27
7698061|NCT01816061|18956322|P2|STARTED|Overall Study||51
7698062|NCT01816061|18956323|P1|STARTED|Overall Study||40
7698063|NCT01816048|18956331|P1|NOT COMPLETED|Overall Study||6
7698064|NCT01816048|18956331|P1|COMPLETED|Overall Study||2
7698065|NCT01816048|18956331|P1|STARTED|Overall Study||8
7698066|NCT01815918|18956346|P2|NOT COMPLETED|Overall Study||19
7698067|NCT01815918|18956347|P1|NOT COMPLETED|Overall Study||18
7698068|NCT01815918|18956346|P2|COMPLETED|Overall Study||11
7698069|NCT01815918|18956347|P1|COMPLETED|Overall Study||12
7698070|NCT01815918|18956346|P2|STARTED|Overall Study||30
7698071|NCT01815918|18956347|P1|STARTED|Overall Study||30
7698072|NCT01815840|18956363|P2|NOT COMPLETED|Overall Study||63
7698073|NCT01815840|18956364|P1|NOT COMPLETED|Overall Study||59
7698074|NCT01815840|18956363|P2|COMPLETED|Overall Study||50
7698075|NCT01815840|18956364|P1|COMPLETED|Overall Study||57
7698076|NCT01815840|18956363|P2|STARTED|Overall Study||113
7698077|NCT01815840|18956364|P1|STARTED|Overall Study||116
7698078|NCT01815736|18956394|P2|NOT COMPLETED|Overall Study||478
7698079|NCT01815736|18956395|P1|NOT COMPLETED|Overall Study||961
7698080|NCT01815736|18956394|P2|COMPLETED|Overall Study||2
7698081|NCT01815736|18956395|P1|COMPLETED|Overall Study||2
7698082|NCT01815736|18956394|P2|STARTED|Overall Study||480
7698083|NCT01815736|18956395|P1|STARTED|Overall Study||963
7698084|NCT01815671|18956411|P2|NOT COMPLETED|Overall Study||0
7698085|NCT01815671|18956412|P1|NOT COMPLETED|Overall Study||0
7698086|NCT01815671|18956411|P2|COMPLETED|Overall Study||85
7698087|NCT01815671|18956412|P1|COMPLETED|Overall Study||88
7698088|NCT01815671|18956411|P2|STARTED|Overall Study||85
7698089|NCT01815671|18956412|P1|STARTED|Overall Study||88
7698090|NCT01815645|18956424|P2|NOT COMPLETED|Overall Study||0
7698091|NCT01815645|18956425|P1|NOT COMPLETED|Overall Study||0
7698092|NCT01815645|18956424|P2|COMPLETED|Overall Study||33
7698093|NCT01815645|18956425|P1|COMPLETED|Overall Study||32
7698094|NCT01815645|18956424|P2|STARTED|Overall Study||33
7698095|NCT01815645|18956425|P1|STARTED|Overall Study||32
7698096|NCT01815515|18956441|P1|NOT COMPLETED|Overall Study||0
7698097|NCT01815515|18956441|P1|COMPLETED|Overall Study||17
7698098|NCT01815515|18956441|P1|STARTED|Overall Study||17
7698099|NCT01815502|18956448|P2|NOT COMPLETED|Overall Study||0
7698100|NCT01815502|18956449|P1|NOT COMPLETED|Overall Study||0
7698101|NCT01815502|18956448|P2|COMPLETED|Overall Study||10
7698102|NCT01815502|18956449|P1|COMPLETED|Overall Study||10
7698103|NCT01815502|18956448|P2|STARTED|Overall Study||10
7698104|NCT01815502|18956449|P1|STARTED|Overall Study||10
7698105|NCT01815424|18956464|P5|NOT COMPLETED|Week 16 to 52||3
7698106|NCT01815424|18956465|P4|NOT COMPLETED|Week 16 to 52||3
7698107|NCT01815424|18956466|P3|NOT COMPLETED|Week 16 to 52||0
7698108|NCT01815424|18956467|P2|NOT COMPLETED|Week 16 to 52||5
7698109|NCT01815424|18956468|P1|NOT COMPLETED|Week 16 to 52||2
7698110|NCT01815424|18956464|P5|COMPLETED|Week 16 to 52||36
7698111|NCT01815424|18956465|P4|COMPLETED|Week 16 to 52||35
7698112|NCT01815424|18956466|P3|COMPLETED|Week 16 to 52||0
7698113|NCT01815424|18956467|P2|COMPLETED|Week 16 to 52||79
7698114|NCT01815424|18956468|P1|COMPLETED|Week 16 to 52||81
7698115|NCT01815424|18956464|P5|STARTED|Week 16 to 52||39
7698116|NCT01815424|18956465|P4|STARTED|Week 16 to 52||38
7698117|NCT01815424|18956466|P3|STARTED|Week 16 to 52||0
7698118|NCT01815424|18956467|P2|STARTED|Week 16 to 52||84
7698119|NCT01815424|18956468|P1|STARTED|Week 16 to 52||83
7698120|NCT01815424|18956464|P5|NOT COMPLETED|Week 0 to 16||0
7698121|NCT01815424|18956465|P4|NOT COMPLETED|Week 0 to 16||0
7698122|NCT01815424|18956466|P3|NOT COMPLETED|Week 0 to 16||11
7698123|NCT01815424|18956467|P2|NOT COMPLETED|Week 0 to 16||4
7698124|NCT01815424|18956468|P1|NOT COMPLETED|Week 0 to 16||7
7698125|NCT01815424|18956464|P5|COMPLETED|Week 0 to 16||0
7698126|NCT01815424|18956465|P4|COMPLETED|Week 0 to 16||0
7698127|NCT01815424|18956466|P3|COMPLETED|Week 0 to 16||77
7698128|NCT01815424|18956467|P2|COMPLETED|Week 0 to 16||84
7698129|NCT01815424|18956468|P1|COMPLETED|Week 0 to 16||83
7698130|NCT01815424|18956464|P5|STARTED|Week 0 to 16||0
7698131|NCT01815424|18956465|P4|STARTED|Week 0 to 16||0
7698132|NCT01815424|18956466|P3|STARTED|Week 0 to 16||88
7698133|NCT01815424|18956467|P2|STARTED|Week 0 to 16||88
7698134|NCT01815424|18956468|P1|STARTED|Week 0 to 16||90
7698135|NCT01815333|18956664|P1|NOT COMPLETED|Overall Study||0
7698136|NCT01815333|18956664|P1|COMPLETED|Overall Study||10
7698137|NCT01815333|18956664|P1|STARTED|Overall Study||10
7698138|NCT01815229|18956671|P3|NOT COMPLETED|Overall Study||51
7698139|NCT01815229|18956672|P2|NOT COMPLETED|Overall Study||0
7698140|NCT01815229|18956673|P1|NOT COMPLETED|Overall Study||0
7698141|NCT01815229|18956671|P3|COMPLETED|Overall Study||0
7698142|NCT01815229|18956672|P2|COMPLETED|Overall Study||18
7698143|NCT01815229|18956673|P1|COMPLETED|Overall Study||13
7698144|NCT01815229|18956671|P3|STARTED|Overall Study||51
7698145|NCT01815229|18956672|P2|STARTED|Overall Study||18
7698146|NCT01815229|18956673|P1|STARTED|Overall Study||13
7698147|NCT01815138|18956684|P2|NOT COMPLETED|Overall Study||6
7698148|NCT01815138|18956685|P1|NOT COMPLETED|Overall Study||8
7698149|NCT01815138|18956684|P2|COMPLETED|Overall Study||31
7698150|NCT01815138|18956685|P1|COMPLETED|Overall Study||26
7698151|NCT01815138|18956684|P2|STARTED|Overall Study||37
7698152|NCT01815138|18956685|P1|STARTED|Overall Study||34
7698153|NCT01815099|18956697|P1|NOT COMPLETED|Overall Study||2
7698154|NCT01815099|18956697|P1|COMPLETED|Overall Study||2
7698155|NCT01815099|18956697|P1|Began rTMS Treatment|Overall Study||3
7698156|NCT01815099|18956697|P1|STARTED|Overall Study||4
7698157|NCT01815008|18956702|P1|NOT COMPLETED|Overall Study||4
7698158|NCT01815008|18956702|P1|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15
7698159|NCT01815008|18956702|P1|STARTED|Overall Study|Had difficulty in completing enrollment|19
7698160|NCT01814878|18956711|P2|NOT COMPLETED|Overall Study||30
7698161|NCT01814878|18956712|P1|NOT COMPLETED|Overall Study||46
7698162|NCT01814878|18956711|P2|COMPLETED|Overall Study||128
7698163|NCT01814878|18956712|P1|COMPLETED|Overall Study||116
7698164|NCT01814878|18956711|P2|STARTED|Overall Study||158
7698165|NCT01814878|18956712|P1|STARTED|Overall Study||162
7698166|NCT01814826|18956735|P3|NOT COMPLETED|Overall Study||3
7698167|NCT01814826|18956736|P2|NOT COMPLETED|Overall Study||29
7698168|NCT01814826|18956737|P1|NOT COMPLETED|Overall Study||32
7698169|NCT01814826|18956735|P3|COMPLETED|Overall Study||0
7698170|NCT01814826|18956736|P2|COMPLETED|Overall Study||0
7698171|NCT01814826|18956737|P1|COMPLETED|Overall Study||0
7698172|NCT01814826|18956735|P3|STARTED|Overall Study|3 participants were enrolled into the dose escalation phase.|3
7698173|NCT01814826|18956736|P2|STARTED|Overall Study|29 participants were enrolled into the MTD expansion phase.|29
7698174|NCT01814826|18956737|P1|STARTED|Overall Study|6 participants were enrolled into the dose escalation phase and 26 in the MTD expansion phase.|32
7698175|NCT01814813|18956813|P3|NOT COMPLETED|Overall Study||0
7698176|NCT01814813|18956814|P2|NOT COMPLETED|Overall Study||0
7698177|NCT01814813|18956815|P1|NOT COMPLETED|Overall Study||0
7698178|NCT01814813|18956813|P3|COMPLETED|Overall Study||31
7698179|NCT01814813|18956814|P2|COMPLETED|Overall Study||30
7698180|NCT01814813|18956815|P1|COMPLETED|Overall Study||29
7698181|NCT01814813|18956813|P3|STARTED|Overall Study||31
7698182|NCT01814813|18956814|P2|STARTED|Overall Study||30
7698183|NCT01814813|18956815|P1|STARTED|Overall Study||29
7698184|NCT01814800|18956829|P1|NOT COMPLETED|Overall Study||5
7698185|NCT01814800|18956829|P1|COMPLETED|Overall Study||54
7698186|NCT01814800|18956829|P1|STARTED|Overall Study||59
7698187|NCT01814787|18956868|P2|NOT COMPLETED|Overall Study||0
7698188|NCT01814787|18956869|P1|NOT COMPLETED|Overall Study||0
7698189|NCT01814787|18956868|P2|COMPLETED|Overall Study||684
7698190|NCT01814787|18956869|P1|COMPLETED|Overall Study||685
7698191|NCT01814787|18956868|P2|STARTED|Overall Study||684
7698192|NCT01814787|18956869|P1|STARTED|Overall Study||685
7698193|NCT01814774|18956875|P1|NOT COMPLETED|Overall Study||0
7698194|NCT01814774|18956875|P1|COMPLETED|Overall Study||48
7698195|NCT01814774|18956875|P1|STARTED|Overall Study||48
7698196|NCT01814761|18956889|P2|NOT COMPLETED|Overall Study||30
7698197|NCT01814761|18956890|P1|NOT COMPLETED|Overall Study||8
7698198|NCT01814761|18956889|P2|COMPLETED|Overall Study||240
7698199|NCT01814761|18956890|P1|COMPLETED|Overall Study||34
7698200|NCT01814761|18956889|P2|STARTED|Overall Study||270
7698201|NCT01814761|18956890|P1|STARTED|Overall Study||42
7698202|NCT01814748|18956904|P2|NOT COMPLETED|Overall Study||7
7698203|NCT01814748|18956905|P1|NOT COMPLETED|Overall Study||8
7698204|NCT01814748|18956904|P2|COMPLETED|Overall Study||94
7698205|NCT01814748|18956905|P1|COMPLETED|Overall Study||94
7698206|NCT01814748|18956904|P2|STARTED|Overall Study||101
7698207|NCT01814748|18956905|P1|STARTED|Overall Study||102
7698208|NCT01814722|18956928|P3|NOT COMPLETED|Overall Study||0
7698209|NCT01814722|18956929|P2|NOT COMPLETED|Overall Study||0
7698210|NCT01814722|18956930|P1|NOT COMPLETED|Overall Study||0
7698211|NCT01814722|18956928|P3|COMPLETED|Overall Study||6
7698212|NCT01814722|18956929|P2|COMPLETED|Overall Study||21
7698213|NCT01814722|18956930|P1|COMPLETED|Overall Study||36
7698214|NCT01814722|18956928|P3|STARTED|Overall Study||6
7698215|NCT01814722|18956929|P2|STARTED|Overall Study||21
7698216|NCT01814722|18956930|P1|STARTED|Overall Study||36
7698217|NCT01814696|18956949|P2|NOT COMPLETED|Overall Study||0
7698218|NCT01814696|18956950|P1|NOT COMPLETED|Overall Study||2
7698219|NCT01814696|18956949|P2|COMPLETED|Overall Study||11
7698220|NCT01814696|18956950|P1|COMPLETED|Overall Study||13
7698221|NCT01814696|18956949|P2|STARTED|Overall Study||11
7698222|NCT01814696|18956950|P1|STARTED|Overall Study||15
7698223|NCT01814670|18956968|P1|NOT COMPLETED|Overall Study||12
7698224|NCT01814670|18956968|P1|COMPLETED|Overall Study||173
7698225|NCT01814670|18956968|P1|STARTED|Overall Study||185
7698226|NCT01814553|18956978|P2|NOT COMPLETED|Overall Study||22
7698227|NCT01814553|18956979|P1|NOT COMPLETED|Overall Study||18
7698228|NCT01814553|18956978|P2|COMPLETED|Overall Study||0
7698229|NCT01814553|18956979|P1|COMPLETED|Overall Study||0
7698230|NCT01814553|18956978|P2|STARTED|Overall Study||22
7698231|NCT01814553|18956979|P1|STARTED|Overall Study||18
7698232|NCT01814397|18956993|P1|NOT COMPLETED|Overall Study||14
7698233|NCT01814397|18956993|P1|COMPLETED|Overall Study||36
7698234|NCT01814397|18956993|P1|3 Month Evaluation|Overall Study||43
7698235|NCT01814397|18956993|P1|STARTED|Overall Study||50
7698236|NCT01814371|18957002|P2|NOT COMPLETED|Overall Study||27
7698237|NCT01814371|18957003|P1|NOT COMPLETED|Overall Study||30
7698238|NCT01814371|18957002|P2|COMPLETED|Overall Study||199
7698239|NCT01814371|18957003|P1|COMPLETED|Overall Study||218
7698240|NCT01814371|18957002|P2|STARTED|Overall Study||226
7698241|NCT01814371|18957003|P1|STARTED|Overall Study||248
7698242|NCT01814332|18957038|P2|NOT COMPLETED|Overall Study||16
7698243|NCT01814332|18957039|P1|NOT COMPLETED|Overall Study||16
7698244|NCT01814332|18957038|P2|COMPLETED|Overall Study||49
7698245|NCT01814332|18957039|P1|COMPLETED|Overall Study||47
7698246|NCT01814332|18957038|P2|STARTED|Overall Study||65
7698247|NCT01814332|18957039|P1|STARTED|Overall Study||63
7698248|NCT01814241|18957051|P1|NOT COMPLETED|Overall Study||4
7698249|NCT01814241|18957051|P1|COMPLETED|Overall Study||16
7698250|NCT01814241|18957051|P1|STARTED|Overall Study||20
7698251|NCT01814137|18957061|P2|NOT COMPLETED|Overall Study||5
7698252|NCT01814137|18957062|P1|NOT COMPLETED|Overall Study||5
7698253|NCT01814137|18957061|P2|COMPLETED|Overall Study||15
7698254|NCT01814137|18957062|P1|COMPLETED|Overall Study||15
7698255|NCT01814137|18957061|P2|STARTED|Overall Study||20
7698256|NCT01814137|18957062|P1|STARTED|Overall Study||20
7698257|NCT01814046|18957078|P3|NOT COMPLETED|Retreatment||0
7698258|NCT01814046|18957079|P2|NOT COMPLETED|Retreatment||0
7698259|NCT01814046|18957080|P1|NOT COMPLETED|Retreatment||0
7698260|NCT01814046|18957078|P3|COMPLETED|Retreatment||3
7698261|NCT01814046|18957079|P2|COMPLETED|Retreatment||0
7698262|NCT01814046|18957080|P1|COMPLETED|Retreatment||0
7698263|NCT01814046|18957078|P3|STARTED|Retreatment||3
7698264|NCT01814046|18957079|P2|STARTED|Retreatment||0
7698265|NCT01814046|18957080|P1|STARTED|Retreatment||0
7698266|NCT01814046|18957078|P3|NOT COMPLETED|Drug Administration||0
7698267|NCT01814046|18957079|P2|NOT COMPLETED|Drug Administration||0
7698268|NCT01814046|18957080|P1|NOT COMPLETED|Drug Administration||1
7698269|NCT01814046|18957078|P3|COMPLETED|Drug Administration||0
7698270|NCT01814046|18957079|P2|COMPLETED|Drug Administration||2
7698271|NCT01814046|18957080|P1|COMPLETED|Drug Administration||21
7698272|NCT01814046|18957078|P3|STARTED|Drug Administration||0
7698273|NCT01814046|18957079|P2|STARTED|Drug Administration||2
7698274|NCT01814046|18957080|P1|STARTED|Drug Administration||22
7698275|NCT01814007|18957091|P1|NOT COMPLETED|Overall Study||1
7698276|NCT01814007|18957091|P1|COMPLETED|Overall Study||34
7698277|NCT01814007|18957091|P1|STARTED|Overall Study||35
7698278|NCT01813890|18957104|P3|NOT COMPLETED|Overall Study||6
7698279|NCT01813890|18957105|P2|NOT COMPLETED|Overall Study||4
7698280|NCT01813890|18957106|P1|NOT COMPLETED|Overall Study||9
7698281|NCT01813890|18957104|P3|COMPLETED|Overall Study||13
7698282|NCT01813890|18957105|P2|COMPLETED|Overall Study||17
7698283|NCT01813890|18957106|P1|COMPLETED|Overall Study||11
7698284|NCT01813890|18957104|P3|STARTED|Overall Study||19
7698285|NCT01813890|18957105|P2|STARTED|Overall Study||21
7698286|NCT01813890|18957106|P1|STARTED|Overall Study||20
7698287|NCT01813734|18957135|P1|NOT COMPLETED|Overall Study||0
7698288|NCT01813734|18957135|P1|COMPLETED|Overall Study||9
7698289|NCT01813734|18957135|P1|STARTED|Overall Study||9
7698290|NCT01813721|18957143|P1|NOT COMPLETED|Overall Study||64
7698291|NCT01813721|18957143|P1|COMPLETED|Overall Study||943
7698292|NCT01813721|18957143|P1|STARTED|Overall Study|Indicates number of participants enrolled|1007
7698293|NCT01813474|18957198|P3|NOT COMPLETED|Overall Study||11
7698294|NCT01813474|18957199|P2|NOT COMPLETED|Overall Study||7
7698295|NCT01813474|18957200|P1|NOT COMPLETED|Overall Study||3
7698296|NCT01813474|18957198|P3|COMPLETED|Overall Study|ongoing study at final data cut off|1
7698297|NCT01813474|18957199|P2|COMPLETED|Overall Study||0
7698298|NCT01813474|18957200|P1|COMPLETED|Overall Study|ongoing study at final data cut off|1
7698299|NCT01813474|18957198|P3|STARTED|Overall Study||12
7698300|NCT01813474|18957199|P2|STARTED|Overall Study||7
7698301|NCT01813474|18957200|P1|STARTED|Overall Study||4
7698302|NCT01813435|18957224|P2|NOT COMPLETED|Overall Study||1007
7698303|NCT01813435|18957225|P1|NOT COMPLETED|Overall Study||2170
7698304|NCT01813435|18957224|P2|COMPLETED|Overall Study||6981
7698305|NCT01813435|18957225|P1|COMPLETED|Overall Study||5810
7698306|NCT01813435|18957224|P2|STARTED|Overall Study|11 participants withdrew consent or objected to use further use of data|7988
7698307|NCT01813435|18957225|P1|STARTED|Overall Study|12 participants withdrew consent or objected to use further use of data|7980
7698308|NCT01813422|18957249|P2|NOT COMPLETED|Overall Study||16
7698309|NCT01813422|18957250|P1|NOT COMPLETED|Overall Study||20
7698310|NCT01813422|18957249|P2|COMPLETED|Overall Study||468
7698311|NCT01813422|18957250|P1|COMPLETED|Overall Study||466
7698312|NCT01813422|18957249|P2|Received Treatment|Overall Study||484
7698313|NCT01813422|18957250|P1|Received Treatment|Overall Study||484
7698314|NCT01813422|18957249|P2|STARTED|Overall Study||484
7698315|NCT01813422|18957250|P1|STARTED|Overall Study||486
7698316|NCT01813357|18957264|P2|NOT COMPLETED|Overall Study||6
7698317|NCT01813357|18957265|P1|NOT COMPLETED|Overall Study||5
7698318|NCT01813357|18957264|P2|COMPLETED|Overall Study||38
7698319|NCT01813357|18957265|P1|COMPLETED|Overall Study||35
7698320|NCT01813357|18957264|P2|STARTED|Overall Study||44
7698321|NCT01813357|18957265|P1|STARTED|Overall Study||40
7698322|NCT01813214|18957275|P2|NOT COMPLETED|Overall Study||0
7698323|NCT01813214|18957276|P1|NOT COMPLETED|Overall Study||0
7698324|NCT01813214|18957275|P2|COMPLETED|Overall Study||2
7698325|NCT01813214|18957276|P1|COMPLETED|Overall Study||3
7698326|NCT01813214|18957275|P2|STARTED|Overall Study||2
7698327|NCT01813214|18957276|P1|STARTED|Overall Study||3
7698328|NCT01813110|18957286|P2|NOT COMPLETED|Overall Study||1
7698329|NCT01813110|18957287|P1|NOT COMPLETED|Overall Study||0
7698330|NCT01813110|18957286|P2|COMPLETED|Overall Study||10
7698331|NCT01813110|18957287|P1|COMPLETED|Overall Study||10
7698332|NCT01813110|18957286|P2|STARTED|Overall Study||11
7698333|NCT01813110|18957287|P1|STARTED|Overall Study||10
7698334|NCT01813071|18957306|P9|NOT COMPLETED|Overall Study||3
7698335|NCT01813071|18957307|P8|NOT COMPLETED|Overall Study||5
7698336|NCT01813071|18957308|P7|NOT COMPLETED|Overall Study||3
7698337|NCT01813071|18957309|P6|NOT COMPLETED|Overall Study||7
7698338|NCT01813071|18957310|P5|NOT COMPLETED|Overall Study||1
7698339|NCT01813071|18957311|P4|NOT COMPLETED|Overall Study||0
7698340|NCT01813071|18957312|P3|NOT COMPLETED|Overall Study||0
7698341|NCT01813071|18957313|P2|NOT COMPLETED|Overall Study||0
7698342|NCT01813071|18957314|P1|NOT COMPLETED|Overall Study||0
7698343|NCT01813071|18957306|P9|COMPLETED|Overall Study||13
7698344|NCT01813071|18957307|P8|COMPLETED|Overall Study||7
7698345|NCT01813071|18957308|P7|COMPLETED|Overall Study||9
7698346|NCT01813071|18957309|P6|COMPLETED|Overall Study||5
7698347|NCT01813071|18957310|P5|COMPLETED|Overall Study||11
7698348|NCT01813071|18957311|P4|COMPLETED|Overall Study||9
7698349|NCT01813071|18957312|P3|COMPLETED|Overall Study||10
7698350|NCT01813071|18957313|P2|COMPLETED|Overall Study||10
7698351|NCT01813071|18957314|P1|COMPLETED|Overall Study||10
7698352|NCT01813071|18957306|P9|STARTED|Overall Study||16
7698353|NCT01813071|18957307|P8|STARTED|Overall Study||12
7698354|NCT01813071|18957308|P7|STARTED|Overall Study||12
7698355|NCT01813071|18957309|P6|STARTED|Overall Study||12
7698356|NCT01813071|18957310|P5|STARTED|Overall Study||12
7698357|NCT01813071|18957311|P4|STARTED|Overall Study||9
7698358|NCT01813071|18957312|P3|STARTED|Overall Study||10
7698359|NCT01813071|18957313|P2|STARTED|Overall Study||10
7698360|NCT01813071|18957314|P1|STARTED|Overall Study||10
7698361|NCT01813058|18957781|P2|NOT COMPLETED|Overall Study||4
7698362|NCT01813058|18957782|P1|NOT COMPLETED|Overall Study||5
7698363|NCT01813058|18957781|P2|COMPLETED|Overall Study||56
7698364|NCT01813058|18957782|P1|COMPLETED|Overall Study||55
7698365|NCT01813058|18957781|P2|STARTED|Overall Study||60
7698366|NCT01813058|18957782|P1|STARTED|Overall Study||60
7698367|NCT01813019|18957790|P2|NOT COMPLETED|Overall Study||6
7698368|NCT01813019|18957791|P1|NOT COMPLETED|Overall Study||7
7698369|NCT01813019|18957790|P2|COMPLETED|Overall Study||20
7698370|NCT01813019|18957791|P1|COMPLETED|Overall Study||17
7698371|NCT01813019|18957790|P2|STARTED|Overall Study||26
7698372|NCT01813019|18957791|P1|STARTED|Overall Study||24
7698373|NCT01812837|18957802|P3|NOT COMPLETED|Overall Study||0
7698374|NCT01812837|18957803|P2|NOT COMPLETED|Overall Study||1
7698375|NCT01812837|18957804|P1|NOT COMPLETED|Overall Study||2
7698376|NCT01812837|18957802|P3|COMPLETED|Overall Study||17
7698377|NCT01812837|18957803|P2|COMPLETED|Overall Study||16
7698378|NCT01812837|18957804|P1|COMPLETED|Overall Study||15
7698379|NCT01812837|18957802|P3|STARTED|Overall Study||17
7698380|NCT01812837|18957803|P2|STARTED|Overall Study||17
7698381|NCT01812837|18957804|P1|STARTED|Overall Study||17
7698382|NCT01812759|18957815|P3|NOT COMPLETED|Overall Study||1
7698383|NCT01812759|18957816|P2|NOT COMPLETED|Overall Study||0
7698384|NCT01812759|18957817|P1|NOT COMPLETED|Overall Study||0
7698385|NCT01812759|18957815|P3|COMPLETED|Overall Study||0
7698386|NCT01812759|18957816|P2|COMPLETED|Overall Study||1
7698387|NCT01812759|18957817|P1|COMPLETED|Overall Study||1
7698388|NCT01812759|18957815|P3|STARTED|Overall Study||1
7698389|NCT01812759|18957816|P2|STARTED|Overall Study||1
7698390|NCT01812759|18957817|P1|STARTED|Overall Study||1
7698391|NCT01812707|18957829|P4|NOT COMPLETED|Overall Study||2
7698392|NCT01812707|18957830|P3|NOT COMPLETED|Overall Study||0
7698393|NCT01812707|18957831|P2|NOT COMPLETED|Overall Study||0
7698394|NCT01812707|18957832|P1|NOT COMPLETED|Overall Study||2
7698395|NCT01812707|18957829|P4|COMPLETED|Overall Study||23
7698396|NCT01812707|18957830|P3|COMPLETED|Overall Study||25
7698397|NCT01812707|18957831|P2|COMPLETED|Overall Study||25
7698398|NCT01812707|18957832|P1|COMPLETED|Overall Study||23
7698399|NCT01812707|18957829|P4|Treated|Overall Study||25
7698400|NCT01812707|18957830|P3|Treated|Overall Study||25
7698401|NCT01812707|18957831|P2|Treated|Overall Study||25
7698402|NCT01812707|18957832|P1|Treated|Overall Study||25
7698403|NCT01812707|18957829|P4|STARTED|Overall Study||25
7698404|NCT01812707|18957830|P3|STARTED|Overall Study||25
7698405|NCT01812707|18957831|P2|STARTED|Overall Study||25
7698406|NCT01812707|18957832|P1|STARTED|Overall Study||25
7698407|NCT01812681|18957868|P2|NOT COMPLETED|Overall Study||0
7698408|NCT01812681|18957869|P1|NOT COMPLETED|Overall Study||3
7698409|NCT01812681|18957868|P2|COMPLETED|Overall Study||24
7698410|NCT01812681|18957869|P1|COMPLETED|Overall Study||57
7698411|NCT01812681|18957868|P2|STARTED|Overall Study||24
7698412|NCT01812681|18957869|P1|STARTED|Overall Study||60
7698413|NCT01812655|18957880|P3|NOT COMPLETED|Overall Study||0
7698414|NCT01812655|18957881|P2|NOT COMPLETED|Overall Study||1
7698415|NCT01812655|18957882|P1|NOT COMPLETED|Overall Study||1
7698416|NCT01812655|18957880|P3|COMPLETED|Overall Study||10
7698417|NCT01812655|18957881|P2|COMPLETED|Overall Study||10
7698418|NCT01812655|18957882|P1|COMPLETED|Overall Study||8
7698419|NCT01812655|18957880|P3|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10
7698420|NCT01812655|18957881|P2|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11
7698421|NCT01812655|18957882|P1|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9
7698422|NCT01812473|18957898|P2|NOT COMPLETED|Overall Study||0
7698423|NCT01812473|18957899|P1|NOT COMPLETED|Overall Study||0
7698424|NCT01812473|18957898|P2|COMPLETED|Overall Study||13
7698425|NCT01812473|18957899|P1|COMPLETED|Overall Study||22
7698426|NCT01812473|18957898|P2|STARTED|Overall Study||13
7698427|NCT01812473|18957899|P1|STARTED|Overall Study||22
7698428|NCT01812057|18957907|P2|NOT COMPLETED|Overall Study||0
7698429|NCT01812057|18957908|P1|NOT COMPLETED|Overall Study||2
7698430|NCT01812057|18957907|P2|COMPLETED|Overall Study||24
7698431|NCT01812057|18957908|P1|COMPLETED|Overall Study||23
7698432|NCT01812057|18957907|P2|STARTED|Overall Study||24
7698433|NCT01812057|18957908|P1|STARTED|Overall Study||25
7698434|NCT01812044|18957949|P3|NOT COMPLETED|Overall Study||0
7698435|NCT01812044|18957950|P2|NOT COMPLETED|Overall Study||0
7698436|NCT01812044|18957951|P1|NOT COMPLETED|Overall Study||0
7698437|NCT01812044|18957949|P3|COMPLETED|Overall Study||16
7698438|NCT01812044|18957950|P2|COMPLETED|Overall Study||17
7698439|NCT01812044|18957951|P1|COMPLETED|Overall Study||17
7698440|NCT01812044|18957949|P3|STARTED|Overall Study||16
7698441|NCT01812044|18957950|P2|STARTED|Overall Study||17
7698442|NCT01812044|18957951|P1|STARTED|Overall Study||17
7698443|NCT01812005|18957982|P2|NOT COMPLETED|Overall Study||0
7698444|NCT01812005|18957983|P1|NOT COMPLETED|Overall Study||0
7698445|NCT01812005|18957982|P2|COMPLETED|Overall Study||13
7698446|NCT01812005|18957983|P1|COMPLETED|Overall Study||1
7698447|NCT01812005|18957982|P2|STARTED|Overall Study||13
7698448|NCT01812005|18957983|P1|STARTED|Overall Study||1
7698449|NCT01811953|18958011|P6|NOT COMPLETED|Overall Study||1
7698450|NCT01811953|18958012|P5|NOT COMPLETED|Overall Study||1
7698451|NCT01811953|18958013|P4|NOT COMPLETED|Overall Study||1
7698452|NCT01811953|18958014|P3|NOT COMPLETED|Overall Study||0
7698453|NCT01811953|18958015|P2|NOT COMPLETED|Overall Study||0
7698454|NCT01811953|18958016|P1|NOT COMPLETED|Overall Study||0
7698455|NCT01811953|18958011|P6|COMPLETED|Overall Study||11
7698456|NCT01811953|18958012|P5|COMPLETED|Overall Study||11
7698457|NCT01811953|18958013|P4|COMPLETED|Overall Study||5
7698458|NCT01811953|18958014|P3|COMPLETED|Overall Study||6
7698459|NCT01811953|18958015|P2|COMPLETED|Overall Study||6
7698460|NCT01811953|18958016|P1|COMPLETED|Overall Study||6
7698461|NCT01811953|18958011|P6|STARTED|Overall Study||12
7698462|NCT01811953|18958012|P5|STARTED|Overall Study||12
7698463|NCT01811953|18958013|P4|STARTED|Overall Study||6
7698464|NCT01811953|18958014|P3|STARTED|Overall Study||6
7698465|NCT01811953|18958015|P2|STARTED|Overall Study||6
7698466|NCT01811953|18958016|P1|STARTED|Overall Study||6
7698467|NCT01811940|18958062|P2|NOT COMPLETED|Overall Study||26
7698468|NCT01811940|18958063|P1|NOT COMPLETED|Overall Study||22
7698469|NCT01811940|18958062|P2|COMPLETED|Overall Study||37
7698470|NCT01811940|18958063|P1|COMPLETED|Overall Study||42
7698471|NCT01811940|18958062|P2|STARTED|Overall Study||63
7698472|NCT01811940|18958063|P1|STARTED|Overall Study||64
7698473|NCT01811732|18958073|P2|NOT COMPLETED|Overall Study||58
7698474|NCT01811732|18958074|P1|NOT COMPLETED|Overall Study||55
7698475|NCT01811732|18958073|P2|COMPLETED|Overall Study||271
7698476|NCT01811732|18958074|P1|COMPLETED|Overall Study||276
7698477|NCT01811732|18958073|P2|STARTED|Overall Study||329
7698478|NCT01811732|18958074|P1|STARTED|Overall Study||331
7698479|NCT01811706|18958084|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
7698480|NCT01811706|18958085|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
7698481|NCT01811706|18958084|P2|COMPLETED|Second Intervention (4 Weeks)||10
7698482|NCT01811706|18958085|P1|COMPLETED|Second Intervention (4 Weeks)||9
7698483|NCT01811706|18958084|P2|STARTED|Second Intervention (4 Weeks)||10
7698484|NCT01811706|18958085|P1|STARTED|Second Intervention (4 Weeks)||9
7698485|NCT01811706|18958084|P2|NOT COMPLETED|Washout ( 2 Weeks)||0
7698486|NCT01811706|18958085|P1|NOT COMPLETED|Washout ( 2 Weeks)||0
7698487|NCT01811706|18958084|P2|COMPLETED|Washout ( 2 Weeks)||10
7698488|NCT01811706|18958085|P1|COMPLETED|Washout ( 2 Weeks)||9
7698489|NCT01811706|18958084|P2|STARTED|Washout ( 2 Weeks)||10
7698490|NCT01811706|18958085|P1|STARTED|Washout ( 2 Weeks)||9
7698491|NCT01811706|18958084|P2|NOT COMPLETED|First Intervention ( 4 Weeks)||0
7698492|NCT01811706|18958085|P1|NOT COMPLETED|First Intervention ( 4 Weeks)||1
7698493|NCT01811706|18958084|P2|COMPLETED|First Intervention ( 4 Weeks)||10
7698494|NCT01811706|18958085|P1|COMPLETED|First Intervention ( 4 Weeks)||9
7698495|NCT01811706|18958084|P2|STARTED|First Intervention ( 4 Weeks)||10
7698496|NCT01811706|18958085|P1|STARTED|First Intervention ( 4 Weeks)||10
7698497|NCT01811693|18958098|P3|NOT COMPLETED|Overall Study||0
7698498|NCT01811693|18958099|P2|NOT COMPLETED|Overall Study||0
7698499|NCT01811693|18958100|P1|NOT COMPLETED|Overall Study||0
7698500|NCT01811693|18958098|P3|COMPLETED|Overall Study||0
7698501|NCT01811693|18958099|P2|COMPLETED|Overall Study||0
7698502|NCT01811693|18958100|P1|COMPLETED|Overall Study||4
7698503|NCT01811693|18958098|P3|STARTED|Overall Study||0
7698504|NCT01811693|18958099|P2|STARTED|Overall Study||0
7698505|NCT01811693|18958100|P1|STARTED|Overall Study||4
7698506|NCT01811680|18958107|P1|NOT COMPLETED|Overall Study||0
7698507|NCT01811680|18958107|P1|COMPLETED|Overall Study||10
7698508|NCT01811680|18958107|P1|STARTED|Overall Study||10
7698509|NCT01811654|18958114|P2|NOT COMPLETED|Overall Study||0
7698510|NCT01811654|18958115|P1|NOT COMPLETED|Overall Study||0
7698511|NCT01811654|18958114|P2|COMPLETED|Overall Study||16
7698512|NCT01811654|18958115|P1|COMPLETED|Overall Study||14
7698513|NCT01811654|18958114|P2|STARTED|Overall Study||16
7698514|NCT01811654|18958115|P1|STARTED|Overall Study||14
7698515|NCT01811563|18958125|P2|NOT COMPLETED|Overall Study||3
7698516|NCT01811563|18958126|P1|NOT COMPLETED|Overall Study||5
7698517|NCT01811563|18958125|P2|COMPLETED|Overall Study||20
7698518|NCT01811563|18958126|P1|COMPLETED|Overall Study||20
7698519|NCT01811563|18958125|P2|STARTED|Overall Study||23
7698520|NCT01811563|18958126|P1|STARTED|Overall Study||25
7698521|NCT01811485|18958155|P3|NOT COMPLETED|Overall Study||5
7698522|NCT01811485|18958156|P2|NOT COMPLETED|Overall Study||4
7698523|NCT01811485|18958157|P1|NOT COMPLETED|Overall Study||2
7698524|NCT01811485|18958155|P3|COMPLETED|Overall Study||51
7698525|NCT01811485|18958156|P2|COMPLETED|Overall Study||55
7698526|NCT01811485|18958157|P1|COMPLETED|Overall Study||54
7698527|NCT01811485|18958155|P3|STARTED|Overall Study||56
7698528|NCT01811485|18958156|P2|STARTED|Overall Study||59
7698529|NCT01811485|18958157|P1|STARTED|Overall Study|"Started indicates randomized patients"|56
7698530|NCT01811472|18958177|P3|NOT COMPLETED|Overall Study||5
7698531|NCT01811472|18958178|P2|NOT COMPLETED|Overall Study||0
7698532|NCT01811472|18958179|P1|NOT COMPLETED|Overall Study||2
7698533|NCT01811472|18958177|P3|COMPLETED|Overall Study||16
7698534|NCT01811472|18958178|P2|COMPLETED|Overall Study||11
7698535|NCT01811472|18958179|P1|COMPLETED|Overall Study||18
7698536|NCT01811472|18958177|P3|STARTED|Overall Study||21
7698537|NCT01811472|18958178|P2|STARTED|Overall Study||11
7698538|NCT01811472|18958179|P1|STARTED|Overall Study||20
7698539|NCT01811355|18958224|P2|NOT COMPLETED|Second Dose||0
7698540|NCT01811355|18958225|P1|NOT COMPLETED|Second Dose||0
7698541|NCT01811355|18958224|P2|COMPLETED|Second Dose||12
7698542|NCT01811355|18958225|P1|COMPLETED|Second Dose||9
7698543|NCT01811355|18958224|P2|STARTED|Second Dose||12
7698544|NCT01811355|18958225|P1|STARTED|Second Dose||9
7698545|NCT01811355|18958224|P2|NOT COMPLETED|Washout||0
7698546|NCT01811355|18958225|P1|NOT COMPLETED|Washout||0
7698547|NCT01811355|18958224|P2|COMPLETED|Washout||12
7698548|NCT01811355|18958225|P1|COMPLETED|Washout||9
7698549|NCT01811355|18958224|P2|STARTED|Washout||12
7698550|NCT01811355|18958225|P1|STARTED|Washout||9
7698551|NCT01811355|18958224|P2|NOT COMPLETED|First Dose||0
7698552|NCT01811355|18958225|P1|NOT COMPLETED|First Dose||2
7698553|NCT01811355|18958224|P2|COMPLETED|First Dose||12
7698554|NCT01811355|18958225|P1|COMPLETED|First Dose||9
7698555|NCT01811355|18958224|P2|STARTED|First Dose||12
7698556|NCT01811355|18958225|P1|STARTED|First Dose||11
7698557|NCT01811316|18958236|P3|NOT COMPLETED|Overall Study||0
7698558|NCT01811316|18958237|P2|NOT COMPLETED|Overall Study||0
7698559|NCT01811316|18958238|P1|NOT COMPLETED|Overall Study||3
7698560|NCT01811316|18958236|P3|COMPLETED|Overall Study||19
7698561|NCT01811316|18958237|P2|COMPLETED|Overall Study||22
7698562|NCT01811316|18958238|P1|COMPLETED|Overall Study||18
7698563|NCT01811316|18958236|P3|Visit 12 Weeks|Overall Study||19
7698564|NCT01811316|18958237|P2|Visit 12 Weeks|Overall Study||22
7698565|NCT01811316|18958238|P1|Visit 12 Weeks|Overall Study||18
7698566|NCT01811316|18958236|P3|Visit 4 Weeks|Overall Study||19
7698567|NCT01811316|18958237|P2|Visit 4 Weeks|Overall Study||22
7698568|NCT01811316|18958238|P1|Visit 4 Weeks|Overall Study||19
7698569|NCT01811316|18958236|P3|STARTED|Overall Study||19
7698570|NCT01811316|18958237|P2|STARTED|Overall Study||22
7698571|NCT01811316|18958238|P1|STARTED|Overall Study||21
7698572|NCT01811303|18958255|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
7698573|NCT01811303|18958256|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
7698574|NCT01811303|18958257|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
7698575|NCT01811303|18958258|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
7698576|NCT01811303|18958255|P4|COMPLETED|Fourth Intervention (1 Day)||2
7698577|NCT01811303|18958256|P3|COMPLETED|Fourth Intervention (1 Day)||4
7698578|NCT01811303|18958257|P2|COMPLETED|Fourth Intervention (1 Day)||4
7698579|NCT01811303|18958258|P1|COMPLETED|Fourth Intervention (1 Day)||4
7698580|NCT01811303|18958255|P4|STARTED|Fourth Intervention (1 Day)||2
7698581|NCT01811303|18958256|P3|STARTED|Fourth Intervention (1 Day)||4
7698582|NCT01811303|18958257|P2|STARTED|Fourth Intervention (1 Day)||4
7698583|NCT01811303|18958258|P1|STARTED|Fourth Intervention (1 Day)||4
7698584|NCT01811303|18958255|P4|NOT COMPLETED|Washout (2 Days or More)||0
7698585|NCT01811303|18958256|P3|NOT COMPLETED|Washout (2 Days or More)||0
7698586|NCT01811303|18958257|P2|NOT COMPLETED|Washout (2 Days or More)||0
7698587|NCT01811303|18958258|P1|NOT COMPLETED|Washout (2 Days or More)||0
7698588|NCT01811303|18958255|P4|COMPLETED|Washout (2 Days or More)||2
7698589|NCT01811303|18958256|P3|COMPLETED|Washout (2 Days or More)||4
7698590|NCT01811303|18958257|P2|COMPLETED|Washout (2 Days or More)||4
7698591|NCT01811303|18958258|P1|COMPLETED|Washout (2 Days or More)||4
7698592|NCT01811303|18958255|P4|STARTED|Washout (2 Days or More)||2
7698593|NCT01811303|18958256|P3|STARTED|Washout (2 Days or More)||4
7698594|NCT01811303|18958257|P2|STARTED|Washout (2 Days or More)||4
7698595|NCT01811303|18958258|P1|STARTED|Washout (2 Days or More)||4
7698596|NCT01811303|18958255|P4|NOT COMPLETED|Third Intervention (1 Day)||0
7698597|NCT01811303|18958256|P3|NOT COMPLETED|Third Intervention (1 Day)||0
7698598|NCT01811303|18958257|P2|NOT COMPLETED|Third Intervention (1 Day)||0
7698599|NCT01811303|18958258|P1|NOT COMPLETED|Third Intervention (1 Day)||0
7698600|NCT01811303|18958255|P4|COMPLETED|Third Intervention (1 Day)||2
7698601|NCT01811303|18958256|P3|COMPLETED|Third Intervention (1 Day)||4
7698602|NCT01811303|18958257|P2|COMPLETED|Third Intervention (1 Day)||4
7698603|NCT01811303|18958258|P1|COMPLETED|Third Intervention (1 Day)||4
7698604|NCT01811303|18958255|P4|STARTED|Third Intervention (1 Day)||2
7698605|NCT01811303|18958256|P3|STARTED|Third Intervention (1 Day)||4
7698606|NCT01811303|18958257|P2|STARTED|Third Intervention (1 Day)||4
7698607|NCT01811303|18958258|P1|STARTED|Third Intervention (1 Day)||4
7698608|NCT01811303|18958255|P4|NOT COMPLETED|Washout (2 Days or More)||0
7698609|NCT01811303|18958256|P3|NOT COMPLETED|Washout (2 Days or More)||0
7698610|NCT01811303|18958257|P2|NOT COMPLETED|Washout (2 Days or More)||0
7698611|NCT01811303|18958258|P1|NOT COMPLETED|Washout (2 Days or More)||0
7698612|NCT01811303|18958255|P4|COMPLETED|Washout (2 Days or More)||2
7698613|NCT01811303|18958256|P3|COMPLETED|Washout (2 Days or More)||4
7698614|NCT01811303|18958257|P2|COMPLETED|Washout (2 Days or More)||4
7698615|NCT01811303|18958258|P1|COMPLETED|Washout (2 Days or More)||4
7698616|NCT01811303|18958255|P4|STARTED|Washout (2 Days or More)||2
7698617|NCT01811303|18958256|P3|STARTED|Washout (2 Days or More)||4
7698618|NCT01811303|18958257|P2|STARTED|Washout (2 Days or More)||4
7698619|NCT01811303|18958258|P1|STARTED|Washout (2 Days or More)||4
7698620|NCT01811303|18958255|P4|NOT COMPLETED|Second Intervention (1 Day)||0
7698621|NCT01811303|18958256|P3|NOT COMPLETED|Second Intervention (1 Day)||0
7698622|NCT01811303|18958257|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7698623|NCT01811303|18958258|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7698624|NCT01811303|18958255|P4|COMPLETED|Second Intervention (1 Day)||2
7698625|NCT01811303|18958256|P3|COMPLETED|Second Intervention (1 Day)||4
7698626|NCT01811303|18958257|P2|COMPLETED|Second Intervention (1 Day)||4
7698627|NCT01811303|18958258|P1|COMPLETED|Second Intervention (1 Day)||4
7698628|NCT01811303|18958255|P4|STARTED|Second Intervention (1 Day)||2
7698629|NCT01811303|18958256|P3|STARTED|Second Intervention (1 Day)||4
7698630|NCT01811303|18958257|P2|STARTED|Second Intervention (1 Day)||4
7698631|NCT01811303|18958258|P1|STARTED|Second Intervention (1 Day)||4
7698632|NCT01811303|18958255|P4|NOT COMPLETED|Washout (2 Days or More)||0
7698633|NCT01811303|18958256|P3|NOT COMPLETED|Washout (2 Days or More)||0
7698634|NCT01811303|18958257|P2|NOT COMPLETED|Washout (2 Days or More)||0
7698635|NCT01811303|18958258|P1|NOT COMPLETED|Washout (2 Days or More)||0
7698636|NCT01811303|18958255|P4|COMPLETED|Washout (2 Days or More)||2
7698637|NCT01811303|18958256|P3|COMPLETED|Washout (2 Days or More)||4
7698638|NCT01811303|18958257|P2|COMPLETED|Washout (2 Days or More)||4
7698639|NCT01811303|18958258|P1|COMPLETED|Washout (2 Days or More)||4
7698640|NCT01811303|18958255|P4|STARTED|Washout (2 Days or More)||2
7698641|NCT01811303|18958256|P3|STARTED|Washout (2 Days or More)||4
7698642|NCT01811303|18958257|P2|STARTED|Washout (2 Days or More)||4
7698643|NCT01811303|18958258|P1|STARTED|Washout (2 Days or More)||4
7698644|NCT01811303|18958255|P4|NOT COMPLETED|First Intervention (1 Day)||0
7698645|NCT01811303|18958256|P3|NOT COMPLETED|First Intervention (1 Day)||0
7698646|NCT01811303|18958257|P2|NOT COMPLETED|First Intervention (1 Day)||0
7698647|NCT01811303|18958258|P1|NOT COMPLETED|First Intervention (1 Day)||0
7698648|NCT01811303|18958255|P4|COMPLETED|First Intervention (1 Day)||2
7698649|NCT01811303|18958256|P3|COMPLETED|First Intervention (1 Day)||4
7698650|NCT01811303|18958257|P2|COMPLETED|First Intervention (1 Day)||4
7698651|NCT01811303|18958258|P1|COMPLETED|First Intervention (1 Day)||4
7698652|NCT01811303|18958255|P4|STARTED|First Intervention (1 Day)||2
7698653|NCT01811303|18958256|P3|STARTED|First Intervention (1 Day)||4
7698654|NCT01811303|18958257|P2|STARTED|First Intervention (1 Day)||4
7698655|NCT01811303|18958258|P1|STARTED|First Intervention (1 Day)||4
7698656|NCT01811238|18958266|P1|NOT COMPLETED|Overall Study||81
7698657|NCT01811238|18958266|P1|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159
7698658|NCT01811238|18958266|P1|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120
7698659|NCT01811238|18958266|P1|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209
7698660|NCT01811238|18958266|P1|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220
7698661|NCT01811238|18958266|P1|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240
7698662|NCT01811225|18958275|P2|NOT COMPLETED|Treatment Period 2||6
7698663|NCT01811225|18958276|P1|NOT COMPLETED|Treatment Period 2||4
7698664|NCT01811225|18958275|P2|COMPLETED|Treatment Period 2||23
7698665|NCT01811225|18958276|P1|COMPLETED|Treatment Period 2||20
7698666|NCT01811225|18958275|P2|STARTED|Treatment Period 2||29
7698667|NCT01811225|18958276|P1|STARTED|Treatment Period 2||24
7698668|NCT01811225|18958275|P2|NOT COMPLETED|Treatment Period 1||17
7698669|NCT01811225|18958276|P1|NOT COMPLETED|Treatment Period 1||25
7698670|NCT01811225|18958275|P2|COMPLETED|Treatment Period 1||29
7698671|NCT01811225|18958276|P1|COMPLETED|Treatment Period 1|53 completed one arm of the cross-over and 43 completed two arms of the cross-over|24
7698672|NCT01811225|18958275|P2|STARTED|Treatment Period 1||46
7698673|NCT01811225|18958276|P1|STARTED|Treatment Period 1||49
7698674|NCT01811212|18958286|P1|NOT COMPLETED|Overall Study||0
7698675|NCT01811212|18958286|P1|COMPLETED|Overall Study||25
7698676|NCT01811212|18958286|P1|STARTED|Overall Study||25
7698677|NCT01811186|18958301|P2|NOT COMPLETED|Overall Study||62
7698678|NCT01811186|18958302|P1|NOT COMPLETED|Overall Study||71
7698679|NCT01811186|18958301|P2|COMPLETED|Overall Study||64
7698680|NCT01811186|18958302|P1|COMPLETED|Overall Study||61
7698681|NCT01811186|18958301|P2|STARTED|Overall Study||126
7698682|NCT01811186|18958302|P1|STARTED|Overall Study||132
7698683|NCT01811147|18958322|P4|NOT COMPLETED|Overall Study||29
7698684|NCT01811147|18958323|P3|NOT COMPLETED|Overall Study||43
7698685|NCT01811147|18958324|P2|NOT COMPLETED|Overall Study||45
7698686|NCT01811147|18958325|P1|NOT COMPLETED|Overall Study||36
7698687|NCT01811147|18958322|P4|COMPLETED|Overall Study||4
7698688|NCT01811147|18958323|P3|COMPLETED|Overall Study||6
7698689|NCT01811147|18958324|P2|COMPLETED|Overall Study||11
7698690|NCT01811147|18958325|P1|COMPLETED|Overall Study||15
7698691|NCT01811147|18958322|P4|STARTED|Overall Study||33
7698692|NCT01811147|18958323|P3|STARTED|Overall Study||49
7698693|NCT01811147|18958324|P2|STARTED|Overall Study||56
7698694|NCT01811147|18958325|P1|STARTED|Overall Study||51
7698695|NCT01811030|18958339|P1|NOT COMPLETED|Overall Study||13
7698696|NCT01811030|18958339|P1|COMPLETED|Overall Study||20
7698697|NCT01811030|18958339|P1|STARTED|Overall Study||33
7698698|NCT01810991|18958344|P1|NOT COMPLETED|Overall Study||2
7698699|NCT01810991|18958344|P1|COMPLETED|Overall Study||17
7698700|NCT01810991|18958344|P1|STARTED|Overall Study||19
7698701|NCT01810952|18958352|P2|NOT COMPLETED|Overall Study||0
7698702|NCT01810952|18958353|P1|NOT COMPLETED|Overall Study||0
7698703|NCT01810952|18958352|P2|COMPLETED|Overall Study||17
7698704|NCT01810952|18958353|P1|COMPLETED|Overall Study||20
7698705|NCT01810952|18958352|P2|STARTED|Overall Study||17
7698706|NCT01810952|18958353|P1|STARTED|Overall Study||20
7698707|NCT01810939|18958367|P3|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22
7698708|NCT01810939|18958368|P2|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10
7698709|NCT01810939|18958369|P1|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0
7698710|NCT01810939|18958367|P3|COMPLETED|Part B Placebo-Controlled Withdrawal||30
7698711|NCT01810939|18958368|P2|COMPLETED|Part B Placebo-Controlled Withdrawal||45
7698712|NCT01810939|18958369|P1|COMPLETED|Part B Placebo-Controlled Withdrawal||0
7698713|NCT01810939|18958367|P3|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52
7698714|NCT01810939|18958368|P2|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55
7698715|NCT01810939|18958369|P1|STARTED|Part B Placebo-Controlled Withdrawal||0
7698716|NCT01810939|18958367|P3|NOT COMPLETED|Part A Treatment Period||0
7698717|NCT01810939|18958368|P2|NOT COMPLETED|Part A Treatment Period||0
7698718|NCT01810939|18958369|P1|NOT COMPLETED|Part A Treatment Period||24
7698719|NCT01810939|18958367|P3|COMPLETED|Part A Treatment Period||0
7698720|NCT01810939|18958368|P2|COMPLETED|Part A Treatment Period||0
7698721|NCT01810939|18958369|P1|COMPLETED|Part A Treatment Period||219
7698722|NCT01810939|18958367|P3|STARTED|Part A Treatment Period||0
7698723|NCT01810939|18958368|P2|STARTED|Part A Treatment Period||0
7698724|NCT01810939|18958369|P1|STARTED|Part A Treatment Period||243
7698725|NCT01810783|18958382|P1|NOT COMPLETED|Overall Study||109
7698726|NCT01810783|18958382|P1|COMPLETED|Overall Study||101
7698727|NCT01810783|18958382|P1|STARTED|Overall Study||210
7698728|NCT01810692|18958388|P2|NOT COMPLETED|Overall Study||0
7698729|NCT01810692|18958389|P1|NOT COMPLETED|Overall Study||0
7698730|NCT01810692|18958388|P2|COMPLETED|Overall Study||77
7698731|NCT01810692|18958389|P1|COMPLETED|Overall Study||77
7698732|NCT01810692|18958388|P2|STARTED|Overall Study||77
7698733|NCT01810692|18958389|P1|STARTED|Overall Study||77
7698734|NCT01810666|18958401|P1|NOT COMPLETED|Overall Study||0
7698735|NCT01810666|18958401|P1|COMPLETED|Overall Study||30
7698736|NCT01810666|18958401|P1|STARTED|Overall Study||30
7698737|NCT01810432|18958407|P2|NOT COMPLETED|Period 2||2
7698738|NCT01810432|18958408|P1|NOT COMPLETED|Period 2||4
7698739|NCT01810432|18958407|P2|COMPLETED|Period 2||17
7698740|NCT01810432|18958408|P1|COMPLETED|Period 2||15
7698741|NCT01810432|18958407|P2|Received at Least 1 Dose of Study Drug|Period 2||19
7698742|NCT01810432|18958408|P1|Received at Least 1 Dose of Study Drug|Period 2||19
7698743|NCT01810432|18958407|P2|STARTED|Period 2||19
7698744|NCT01810432|18958408|P1|STARTED|Period 2||19
7698745|NCT01810432|18958407|P2|NOT COMPLETED|Washout||1
7698746|NCT01810432|18958408|P1|NOT COMPLETED|Washout||1
7698747|NCT01810432|18958407|P2|COMPLETED|Washout||19
7698748|NCT01810432|18958408|P1|COMPLETED|Washout||19
7698749|NCT01810432|18958407|P2|STARTED|Washout||20
7698750|NCT01810432|18958408|P1|STARTED|Washout||20
7698751|NCT01810432|18958407|P2|NOT COMPLETED|Period 1||0
7698752|NCT01810432|18958408|P1|NOT COMPLETED|Period 1||0
7698753|NCT01810432|18958407|P2|COMPLETED|Period 1||20
7698754|NCT01810432|18958408|P1|COMPLETED|Period 1||20
7698755|NCT01810432|18958407|P2|Received at Least 1 Dose of Study Drug|Period 1||20
7698756|NCT01810432|18958408|P1|Received at Least 1 Dose of Study Drug|Period 1||20
7698757|NCT01810432|18958407|P2|STARTED|Period 1||20
7698758|NCT01810432|18958408|P1|STARTED|Period 1||20
7698759|NCT01810380|18958421|P3|NOT COMPLETED|Overall Study||32
7698760|NCT01810380|18958422|P2|NOT COMPLETED|Overall Study||38
7698761|NCT01810380|18958423|P1|NOT COMPLETED|Overall Study||55
7698762|NCT01810380|18958421|P3|COMPLETED|Overall Study||122
7698763|NCT01810380|18958422|P2|COMPLETED|Overall Study||113
7698764|NCT01810380|18958423|P1|COMPLETED|Overall Study||108
7698765|NCT01810380|18958421|P3|Treated|Overall Study||153
7698766|NCT01810380|18958422|P2|Treated|Overall Study||150
7698767|NCT01810380|18958423|P1|Treated|Overall Study||161
7698768|NCT01810380|18958421|P3|STARTED|Overall Study||154
7698769|NCT01810380|18958422|P2|STARTED|Overall Study||151
7698770|NCT01810380|18958423|P1|STARTED|Overall Study||163
7698771|NCT01810302|18958484|P2|NOT COMPLETED|Overall Study||1
7698772|NCT01810302|18958485|P1|NOT COMPLETED|Overall Study||1
7698773|NCT01810302|18958484|P2|COMPLETED|Overall Study||0
7698774|NCT01810302|18958485|P1|COMPLETED|Overall Study||0
7698775|NCT01810302|18958484|P2|STARTED|Overall Study||1
7698776|NCT01810302|18958485|P1|STARTED|Overall Study||1
7698777|NCT01810289|18958495|P2|NOT COMPLETED|Overall Study||0
7698778|NCT01810289|18958496|P1|NOT COMPLETED|Overall Study||0
7698779|NCT01810289|18958495|P2|COMPLETED|Overall Study||4747
7698780|NCT01810289|18958496|P1|COMPLETED|Overall Study||7277
7698781|NCT01810289|18958495|P2|STARTED|Overall Study||4747
7698782|NCT01810289|18958496|P1|STARTED|Overall Study||7277
7698783|NCT01810263|18958512|P2|NOT COMPLETED|Overall Study||7
7698784|NCT01810263|18958513|P1|NOT COMPLETED|Overall Study||8
7698785|NCT01810263|18958512|P2|COMPLETED|Overall Study||11
7698786|NCT01810263|18958513|P1|COMPLETED|Overall Study|2014 July|8
7698787|NCT01810263|18958512|P2|STARTED|Overall Study||18
7698788|NCT01810263|18958513|P1|STARTED|Overall Study||16
7698789|NCT01810042|18958519|P1|NOT COMPLETED|Overall Study||10
7698790|NCT01810042|18958519|P1|COMPLETED|Overall Study||39
7698791|NCT01810042|18958519|P1|STARTED|Overall Study||49
7698792|NCT01810016|18958529|P3|NOT COMPLETED|Overall Study||1
7698793|NCT01810016|18958530|P2|NOT COMPLETED|Overall Study||1
7698794|NCT01810016|18958531|P1|NOT COMPLETED|Overall Study||1
7698795|NCT01810016|18958529|P3|COMPLETED|Overall Study||0
7698796|NCT01810016|18958530|P2|COMPLETED|Overall Study||1
7698797|NCT01810016|18958531|P1|COMPLETED|Overall Study||4
7698798|NCT01810016|18958529|P3|STARTED|Overall Study||1
7698799|NCT01810016|18958530|P2|STARTED|Overall Study||2
7698800|NCT01810016|18958531|P1|STARTED|Overall Study||5
7698801|NCT01809938|18958542|P2|NOT COMPLETED|Second Intervention (170 Minutes)||0
7698802|NCT01809938|18958543|P1|NOT COMPLETED|Second Intervention (170 Minutes)||0
7698803|NCT01809938|18958542|P2|COMPLETED|Second Intervention (170 Minutes)||5
7698804|NCT01809938|18958543|P1|COMPLETED|Second Intervention (170 Minutes)||5
7698805|NCT01809938|18958542|P2|STARTED|Second Intervention (170 Minutes)||5
7698806|NCT01809938|18958543|P1|STARTED|Second Intervention (170 Minutes)||5
7698807|NCT01809938|18958542|P2|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
7698808|NCT01809938|18958543|P1|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
7698809|NCT01809938|18958542|P2|COMPLETED|Washout (Not Less Than 24 Hours)||5
7698810|NCT01809938|18958543|P1|COMPLETED|Washout (Not Less Than 24 Hours)||5
7698811|NCT01809938|18958542|P2|STARTED|Washout (Not Less Than 24 Hours)||5
7698812|NCT01809938|18958543|P1|STARTED|Washout (Not Less Than 24 Hours)||5
7698813|NCT01809938|18958542|P2|NOT COMPLETED|First Intervention (170 Minutes)||0
7698814|NCT01809938|18958543|P1|NOT COMPLETED|First Intervention (170 Minutes)||0
7698815|NCT01809938|18958542|P2|COMPLETED|First Intervention (170 Minutes)||5
7698816|NCT01809938|18958543|P1|COMPLETED|First Intervention (170 Minutes)||5
7698817|NCT01809938|18958542|P2|STARTED|First Intervention (170 Minutes)||5
7698818|NCT01809938|18958543|P1|STARTED|First Intervention (170 Minutes)||5
7698819|NCT01809899|18958552|P2|NOT COMPLETED|Overall Study||0
7698820|NCT01809899|18958553|P1|NOT COMPLETED|Overall Study||0
7698821|NCT01809899|18958552|P2|COMPLETED|Overall Study||4
7698822|NCT01809899|18958553|P1|COMPLETED|Overall Study||8
7698823|NCT01809899|18958552|P2|STARTED|Overall Study||4
7698824|NCT01809899|18958553|P1|STARTED|Overall Study||8
7698825|NCT01809834|18958561|P1|NOT COMPLETED|Overall Study||0
7698826|NCT01809834|18958561|P1|COMPLETED|Overall Study||44
7698827|NCT01809834|18958561|P1|STARTED|Overall Study||44
7698828|NCT01809639|18958589|P2|NOT COMPLETED|Overall Study||0
7698829|NCT01809639|18958590|P1|NOT COMPLETED|Overall Study||0
7698830|NCT01809639|18958589|P2|COMPLETED|Overall Study||7
7698831|NCT01809639|18958590|P1|COMPLETED|Overall Study||18
7698832|NCT01809639|18958589|P2|STARTED|Overall Study||7
7698833|NCT01809639|18958590|P1|STARTED|Overall Study||18
7698834|NCT01809327|18958601|P5|NOT COMPLETED|Overall Study||25
7698835|NCT01809327|18958602|P4|NOT COMPLETED|Overall Study||12
7698836|NCT01809327|18958603|P3|NOT COMPLETED|Overall Study||22
7698837|NCT01809327|18958604|P2|NOT COMPLETED|Overall Study||26
7698838|NCT01809327|18958605|P1|NOT COMPLETED|Overall Study||32
7698839|NCT01809327|18958601|P5|COMPLETED|Overall Study||212
7698840|NCT01809327|18958602|P4|COMPLETED|Overall Study||225
7698841|NCT01809327|18958603|P3|COMPLETED|Overall Study||216
7698842|NCT01809327|18958604|P2|COMPLETED|Overall Study||211
7698843|NCT01809327|18958605|P1|COMPLETED|Overall Study||205
7698844|NCT01809327|18958601|P5|STARTED|Overall Study||237
7698845|NCT01809327|18958602|P4|STARTED|Overall Study||237
7698846|NCT01809327|18958603|P3|STARTED|Overall Study||238
7698847|NCT01809327|18958604|P2|STARTED|Overall Study||237
7698848|NCT01809327|18958605|P1|STARTED|Overall Study||237
7698849|NCT01809314|18958647|P1|NOT COMPLETED|Overall Study||745
7698850|NCT01809314|18958647|P1|COMPLETED|Overall Study||422
7698851|NCT01809314|18958647|P1|STARTED|Overall Study||1167
7698852|NCT01809262|18958653|P10|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
7698853|NCT01809262|18958654|P9|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
7698854|NCT01809262|18958655|P8|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
7698855|NCT01809262|18958656|P7|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
7698856|NCT01809262|18958657|P6|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
7698857|NCT01809262|18958658|P5|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
7698858|NCT01809262|18958659|P4|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
7698859|NCT01809262|18958660|P3|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
7698860|NCT01809262|18958661|P2|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
7698861|NCT01809262|18958662|P1|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
7698862|NCT01809262|18958653|P10|COMPLETED|Period 5 (Fifth Dose + Washout)||4
7698863|NCT01809262|18958654|P9|COMPLETED|Period 5 (Fifth Dose + Washout)||3
7698864|NCT01809262|18958655|P8|COMPLETED|Period 5 (Fifth Dose + Washout)||4
7698865|NCT01809262|18958656|P7|COMPLETED|Period 5 (Fifth Dose + Washout)||3
7698866|NCT01809262|18958657|P6|COMPLETED|Period 5 (Fifth Dose + Washout)||3
7698867|NCT01809262|18958658|P5|COMPLETED|Period 5 (Fifth Dose + Washout)||3
7698868|NCT01809262|18958659|P4|COMPLETED|Period 5 (Fifth Dose + Washout)||3
7698869|NCT01809262|18958660|P3|COMPLETED|Period 5 (Fifth Dose + Washout)||4
7698870|NCT01809262|18958661|P2|COMPLETED|Period 5 (Fifth Dose + Washout)||3
7698871|NCT01809262|18958662|P1|COMPLETED|Period 5 (Fifth Dose + Washout)||4
7698872|NCT01809262|18958653|P10|STARTED|Period 5 (Fifth Dose + Washout)||4
7698873|NCT01809262|18958654|P9|STARTED|Period 5 (Fifth Dose + Washout)||3
7698874|NCT01809262|18958655|P8|STARTED|Period 5 (Fifth Dose + Washout)||4
7698875|NCT01809262|18958656|P7|STARTED|Period 5 (Fifth Dose + Washout)||3
7698876|NCT01809262|18958657|P6|STARTED|Period 5 (Fifth Dose + Washout)||3
7698877|NCT01809262|18958658|P5|STARTED|Period 5 (Fifth Dose + Washout)||3
7698878|NCT01809262|18958659|P4|STARTED|Period 5 (Fifth Dose + Washout)||3
7698879|NCT01809262|18958660|P3|STARTED|Period 5 (Fifth Dose + Washout)||4
7698880|NCT01809262|18958661|P2|STARTED|Period 5 (Fifth Dose + Washout)||3
7698881|NCT01809262|18958662|P1|STARTED|Period 5 (Fifth Dose + Washout)||4
7698882|NCT01809262|18958653|P10|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
7698883|NCT01809262|18958654|P9|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
7698884|NCT01809262|18958655|P8|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
7698885|NCT01809262|18958656|P7|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
7698886|NCT01809262|18958657|P6|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
7698887|NCT01809262|18958658|P5|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
7698888|NCT01809262|18958659|P4|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
7698889|NCT01809262|18958660|P3|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
7698890|NCT01809262|18958661|P2|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
7698891|NCT01809262|18958662|P1|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
7698892|NCT01809262|18958653|P10|COMPLETED|Period 4 (Fourth Dose + Washout)||4
7698893|NCT01809262|18958654|P9|COMPLETED|Period 4 (Fourth Dose + Washout)||3
7698894|NCT01809262|18958655|P8|COMPLETED|Period 4 (Fourth Dose + Washout)||4
7698895|NCT01809262|18958656|P7|COMPLETED|Period 4 (Fourth Dose + Washout)||3
7698896|NCT01809262|18958657|P6|COMPLETED|Period 4 (Fourth Dose + Washout)||3
7698897|NCT01809262|18958658|P5|COMPLETED|Period 4 (Fourth Dose + Washout)||3
7698898|NCT01809262|18958659|P4|COMPLETED|Period 4 (Fourth Dose + Washout)||3
7698899|NCT01809262|18958660|P3|COMPLETED|Period 4 (Fourth Dose + Washout)||4
7698900|NCT01809262|18958661|P2|COMPLETED|Period 4 (Fourth Dose + Washout)||3
7698901|NCT01809262|18958662|P1|COMPLETED|Period 4 (Fourth Dose + Washout)||4
7698902|NCT01809262|18958653|P10|STARTED|Period 4 (Fourth Dose + Washout)||4
7698903|NCT01809262|18958654|P9|STARTED|Period 4 (Fourth Dose + Washout)||3
7698904|NCT01809262|18958655|P8|STARTED|Period 4 (Fourth Dose + Washout)||4
7698905|NCT01809262|18958656|P7|STARTED|Period 4 (Fourth Dose + Washout)||3
7698906|NCT01809262|18958657|P6|STARTED|Period 4 (Fourth Dose + Washout)||3
7698907|NCT01809262|18958658|P5|STARTED|Period 4 (Fourth Dose + Washout)||3
7698908|NCT01809262|18958659|P4|STARTED|Period 4 (Fourth Dose + Washout)||3
7698909|NCT01809262|18958660|P3|STARTED|Period 4 (Fourth Dose + Washout)||4
7698910|NCT01809262|18958661|P2|STARTED|Period 4 (Fourth Dose + Washout)||3
7698911|NCT01809262|18958662|P1|STARTED|Period 4 (Fourth Dose + Washout)||4
7698912|NCT01809262|18958653|P10|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
7698913|NCT01809262|18958654|P9|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
7698914|NCT01809262|18958655|P8|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
7698915|NCT01809262|18958656|P7|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
7698916|NCT01809262|18958657|P6|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
7698917|NCT01809262|18958658|P5|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
7698918|NCT01809262|18958659|P4|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
7698919|NCT01809262|18958660|P3|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
7698920|NCT01809262|18958661|P2|NOT COMPLETED|Period 3 (Third Dose + Washout)||1
7698921|NCT01809262|18958662|P1|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
7698922|NCT01809262|18958653|P10|COMPLETED|Period 3 (Third Dose + Washout)||4
7698923|NCT01809262|18958654|P9|COMPLETED|Period 3 (Third Dose + Washout)||3
7698924|NCT01809262|18958655|P8|COMPLETED|Period 3 (Third Dose + Washout)||4
7698925|NCT01809262|18958656|P7|COMPLETED|Period 3 (Third Dose + Washout)||3
7698926|NCT01809262|18958657|P6|COMPLETED|Period 3 (Third Dose + Washout)||3
7698927|NCT01809262|18958658|P5|COMPLETED|Period 3 (Third Dose + Washout)||3
7698928|NCT01809262|18958659|P4|COMPLETED|Period 3 (Third Dose + Washout)||3
7698929|NCT01809262|18958660|P3|COMPLETED|Period 3 (Third Dose + Washout)||4
7698930|NCT01809262|18958661|P2|COMPLETED|Period 3 (Third Dose + Washout)||3
7698931|NCT01809262|18958662|P1|COMPLETED|Period 3 (Third Dose + Washout)||4
7698932|NCT01809262|18958653|P10|STARTED|Period 3 (Third Dose + Washout)||4
7698933|NCT01809262|18958654|P9|STARTED|Period 3 (Third Dose + Washout)||3
7698934|NCT01809262|18958655|P8|STARTED|Period 3 (Third Dose + Washout)||4
7698935|NCT01809262|18958656|P7|STARTED|Period 3 (Third Dose + Washout)||3
7698936|NCT01809262|18958657|P6|STARTED|Period 3 (Third Dose + Washout)||3
7698937|NCT01809262|18958658|P5|STARTED|Period 3 (Third Dose + Washout)||3
7698938|NCT01809262|18958659|P4|STARTED|Period 3 (Third Dose + Washout)||3
7698939|NCT01809262|18958660|P3|STARTED|Period 3 (Third Dose + Washout)||4
7698940|NCT01809262|18958661|P2|STARTED|Period 3 (Third Dose + Washout)||4
7698941|NCT01809262|18958662|P1|STARTED|Period 3 (Third Dose + Washout)||4
7698942|NCT01809262|18958653|P10|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
7698943|NCT01809262|18958654|P9|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
7698944|NCT01809262|18958655|P8|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
7698945|NCT01809262|18958656|P7|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
7698946|NCT01809262|18958657|P6|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
7698947|NCT01809262|18958658|P5|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
7698948|NCT01809262|18958659|P4|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
7698949|NCT01809262|18958660|P3|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
7698950|NCT01809262|18958661|P2|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
7698951|NCT01809262|18958662|P1|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
7698952|NCT01809262|18958653|P10|COMPLETED|Period 2 (Second Dose + Washout)||4
7698953|NCT01809262|18958654|P9|COMPLETED|Period 2 (Second Dose + Washout)||3
7698954|NCT01809262|18958655|P8|COMPLETED|Period 2 (Second Dose + Washout)||4
7698955|NCT01809262|18958656|P7|COMPLETED|Period 2 (Second Dose + Washout)||3
7698956|NCT01809262|18958657|P6|COMPLETED|Period 2 (Second Dose + Washout)||3
7698957|NCT01809262|18958658|P5|COMPLETED|Period 2 (Second Dose + Washout)||3
7698958|NCT01809262|18958659|P4|COMPLETED|Period 2 (Second Dose + Washout)||3
7698959|NCT01809262|18958660|P3|COMPLETED|Period 2 (Second Dose + Washout)||4
7698960|NCT01809262|18958661|P2|COMPLETED|Period 2 (Second Dose + Washout)||4
7698961|NCT01809262|18958662|P1|COMPLETED|Period 2 (Second Dose + Washout)||4
7698962|NCT01809262|18958653|P10|STARTED|Period 2 (Second Dose + Washout)||4
7698963|NCT01809262|18958654|P9|STARTED|Period 2 (Second Dose + Washout)||3
7698964|NCT01809262|18958655|P8|STARTED|Period 2 (Second Dose + Washout)||4
7698965|NCT01809262|18958656|P7|STARTED|Period 2 (Second Dose + Washout)||3
7698966|NCT01809262|18958657|P6|STARTED|Period 2 (Second Dose + Washout)||3
7698967|NCT01809262|18958658|P5|STARTED|Period 2 (Second Dose + Washout)||3
7698968|NCT01809262|18958659|P4|STARTED|Period 2 (Second Dose + Washout)||3
7698969|NCT01809262|18958660|P3|STARTED|Period 2 (Second Dose + Washout)||4
7698970|NCT01809262|18958661|P2|STARTED|Period 2 (Second Dose + Washout)||4
7698971|NCT01809262|18958662|P1|STARTED|Period 2 (Second Dose + Washout)||4
7698972|NCT01809262|18958653|P10|NOT COMPLETED|Period 1 (First Dose + Washout)||0
7698973|NCT01809262|18958654|P9|NOT COMPLETED|Period 1 (First Dose + Washout)||0
7698974|NCT01809262|18958655|P8|NOT COMPLETED|Period 1 (First Dose + Washout)||0
7698975|NCT01809262|18958656|P7|NOT COMPLETED|Period 1 (First Dose + Washout)||0
7698976|NCT01809262|18958657|P6|NOT COMPLETED|Period 1 (First Dose + Washout)||0
7698977|NCT01809262|18958658|P5|NOT COMPLETED|Period 1 (First Dose + Washout)||1
7698978|NCT01809262|18958659|P4|NOT COMPLETED|Period 1 (First Dose + Washout)||0
7698979|NCT01809262|18958660|P3|NOT COMPLETED|Period 1 (First Dose + Washout)||0
7698980|NCT01809262|18958661|P2|NOT COMPLETED|Period 1 (First Dose + Washout)||0
7698981|NCT01809262|18958662|P1|NOT COMPLETED|Period 1 (First Dose + Washout)||0
7698982|NCT01809262|18958653|P10|COMPLETED|Period 1 (First Dose + Washout)||4
7698983|NCT01809262|18958654|P9|COMPLETED|Period 1 (First Dose + Washout)||3
7698984|NCT01809262|18958655|P8|COMPLETED|Period 1 (First Dose + Washout)||4
7698985|NCT01809262|18958656|P7|COMPLETED|Period 1 (First Dose + Washout)||3
7698986|NCT01809262|18958657|P6|COMPLETED|Period 1 (First Dose + Washout)||3
7698987|NCT01809262|18958658|P5|COMPLETED|Period 1 (First Dose + Washout)||3
7698988|NCT01809262|18958659|P4|COMPLETED|Period 1 (First Dose + Washout)||3
7698989|NCT01809262|18958660|P3|COMPLETED|Period 1 (First Dose + Washout)||4
7698990|NCT01809262|18958661|P2|COMPLETED|Period 1 (First Dose + Washout)||4
7698991|NCT01809262|18958662|P1|COMPLETED|Period 1 (First Dose + Washout)||4
7698992|NCT01809262|18958653|P10|STARTED|Period 1 (First Dose + Washout)||4
7698993|NCT01809262|18958654|P9|STARTED|Period 1 (First Dose + Washout)||3
7698994|NCT01809262|18958655|P8|STARTED|Period 1 (First Dose + Washout)||4
7698995|NCT01809262|18958656|P7|STARTED|Period 1 (First Dose + Washout)||3
7698996|NCT01809262|18958657|P6|STARTED|Period 1 (First Dose + Washout)||3
7698997|NCT01809262|18958658|P5|STARTED|Period 1 (First Dose + Washout)||4
7698998|NCT01809262|18958659|P4|STARTED|Period 1 (First Dose + Washout)||3
7698999|NCT01809262|18958660|P3|STARTED|Period 1 (First Dose + Washout)||4
7699000|NCT01809262|18958661|P2|STARTED|Period 1 (First Dose + Washout)||4
7699001|NCT01809262|18958662|P1|STARTED|Period 1 (First Dose + Washout)||4
7699002|NCT01809210|18958736|P7|NOT COMPLETED|Overall Study||5
7699003|NCT01809210|18958737|P6|NOT COMPLETED|Overall Study||3
7699004|NCT01809210|18958738|P5|NOT COMPLETED|Overall Study||2
7699005|NCT01809210|18958739|P4|NOT COMPLETED|Overall Study||1
7699006|NCT01809210|18958740|P3|NOT COMPLETED|Overall Study||3
7699007|NCT01809210|18958741|P2|NOT COMPLETED|Overall Study||1
7699008|NCT01809210|18958742|P1|NOT COMPLETED|Overall Study||1
7699009|NCT01809210|18958736|P7|COMPLETED|Overall Study||7
7699010|NCT01809210|18958737|P6|COMPLETED|Overall Study||12
7699011|NCT01809210|18958738|P5|COMPLETED|Overall Study||4
7699012|NCT01809210|18958739|P4|COMPLETED|Overall Study||2
7699013|NCT01809210|18958740|P3|COMPLETED|Overall Study||4
7699014|NCT01809210|18958741|P2|COMPLETED|Overall Study||8
7699015|NCT01809210|18958742|P1|COMPLETED|Overall Study||2
7699016|NCT01809210|18958736|P7|STARTED|Overall Study||12
7699017|NCT01809210|18958737|P6|STARTED|Overall Study||15
7699018|NCT01809210|18958738|P5|STARTED|Overall Study||6
7699019|NCT01809210|18958739|P4|STARTED|Overall Study||3
7699020|NCT01809210|18958740|P3|STARTED|Overall Study||7
7699021|NCT01809210|18958741|P2|STARTED|Overall Study||9
7699022|NCT01809210|18958742|P1|STARTED|Overall Study||3
7699023|NCT01809197|18958816|P2|NOT COMPLETED|Overall Study||8
7699024|NCT01809197|18958817|P1|NOT COMPLETED|Overall Study||10
7699025|NCT01809197|18958816|P2|COMPLETED|Overall Study||177
7699026|NCT01809197|18958817|P1|COMPLETED|Overall Study||177
7699027|NCT01809197|18958816|P2|STARTED|Overall Study||185
7699028|NCT01809197|18958817|P1|STARTED|Overall Study||187
7699029|NCT01809132|18958826|P3|NOT COMPLETED|Overall Study||1
7699030|NCT01809132|18958827|P2|NOT COMPLETED|Overall Study||0
7699031|NCT01809132|18958828|P1|NOT COMPLETED|Overall Study||0
7699032|NCT01809132|18958826|P3|COMPLETED|Overall Study||0
7699033|NCT01809132|18958827|P2|COMPLETED|Overall Study||50
7699034|NCT01809132|18958828|P1|COMPLETED|Overall Study||53
7699035|NCT01809132|18958826|P3|STARTED|Overall Study|Subject was consented but withdrew prior to randomization and initiation of treatment.|1
7699036|NCT01809132|18958827|P2|STARTED|Overall Study||50
7699037|NCT01809132|18958828|P1|STARTED|Overall Study||53
7699038|NCT01809106|18958849|P4|NOT COMPLETED|Overall Study||4
7699039|NCT01809106|18958850|P3|NOT COMPLETED|Overall Study||3
7699040|NCT01809106|18958851|P2|NOT COMPLETED|Overall Study||5
7699041|NCT01809106|18958852|P1|NOT COMPLETED|Overall Study||8
7699042|NCT01809106|18958849|P4|COMPLETED|Overall Study||124
7699043|NCT01809106|18958850|P3|COMPLETED|Overall Study||127
7699044|NCT01809106|18958851|P2|COMPLETED|Overall Study||125
7699045|NCT01809106|18958852|P1|COMPLETED|Overall Study||122
7699046|NCT01809106|18958849|P4|STARTED|Overall Study||128
7699047|NCT01809106|18958850|P3|STARTED|Overall Study||130
7699048|NCT01809106|18958851|P2|STARTED|Overall Study||130
7699049|NCT01809106|18958852|P1|STARTED|Overall Study||130
7699050|NCT01809054|18958872|P2|NOT COMPLETED|Overall Study||0
7699051|NCT01809054|18958873|P1|NOT COMPLETED|Overall Study||0
7699052|NCT01809054|18958872|P2|COMPLETED|Overall Study||22
7699053|NCT01809054|18958873|P1|COMPLETED|Overall Study||27
7699054|NCT01809054|18958872|P2|STARTED|Overall Study||22
7699055|NCT01809054|18958873|P1|STARTED|Overall Study||27
7699056|NCT01808963|18958881|P1|NOT COMPLETED|Overall Study||0
7699057|NCT01808963|18958881|P1|COMPLETED|Overall Study||13
7699058|NCT01808963|18958881|P1|STARTED|Overall Study||13
7699059|NCT01808950|18958888|P3|NOT COMPLETED|Overall Study||0
7699060|NCT01808950|18958889|P2|NOT COMPLETED|Overall Study||0
7699061|NCT01808950|18958890|P1|NOT COMPLETED|Overall Study||0
7699062|NCT01808950|18958888|P3|COMPLETED|Overall Study||0
7699063|NCT01808950|18958889|P2|COMPLETED|Overall Study||3
7699064|NCT01808950|18958890|P1|COMPLETED|Overall Study||1
7699065|NCT01808950|18958888|P3|STARTED|Overall Study||0
7699066|NCT01808950|18958889|P2|STARTED|Overall Study||3
7699067|NCT01808950|18958890|P1|STARTED|Overall Study||1
7699068|NCT01808794|18958903|P2|NOT COMPLETED|Overall Study||0
7699069|NCT01808794|18958904|P1|NOT COMPLETED|Overall Study||0
7699070|NCT01808794|18958903|P2|COMPLETED|Overall Study||0
7699071|NCT01808794|18958904|P1|COMPLETED|Overall Study||0
7699072|NCT01808794|18958903|P2|STARTED|Overall Study||0
7699073|NCT01808794|18958904|P1|STARTED|Overall Study||0
7699074|NCT01808755|18958912|P2|NOT COMPLETED|Overall Study||0
7699075|NCT01808755|18958913|P1|NOT COMPLETED|Overall Study||0
7699076|NCT01808755|18958912|P2|COMPLETED|Overall Study||30
7699077|NCT01808755|18958913|P1|COMPLETED|Overall Study||30
7699078|NCT01808755|18958912|P2|STARTED|Overall Study||30
7699079|NCT01808755|18958913|P1|STARTED|Overall Study||30
7699080|NCT01808690|18958920|P2|NOT COMPLETED|Overall Study||2
7699081|NCT01808690|18958921|P1|NOT COMPLETED|Overall Study||1
7699082|NCT01808690|18958920|P2|COMPLETED|Overall Study||21
7699083|NCT01808690|18958921|P1|COMPLETED|Overall Study||24
7699084|NCT01808690|18958920|P2|STARTED|Overall Study||23
7699085|NCT01808690|18958921|P1|STARTED|Overall Study||25
7699086|NCT01808651|18958940|P3|NOT COMPLETED|Study Period 2||0
7699087|NCT01808651|18958941|P2|NOT COMPLETED|Study Period 2||0
7699088|NCT01808651|18958942|P1|NOT COMPLETED|Study Period 2||0
7699089|NCT01808651|18958940|P3|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33
7699090|NCT01808651|18958941|P2|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52
7699091|NCT01808651|18958942|P1|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77
7699092|NCT01808651|18958940|P3|STARTED|Study Period 2||33
7699093|NCT01808651|18958941|P2|STARTED|Study Period 2||52
7699094|NCT01808651|18958942|P1|STARTED|Study Period 2||77
7699095|NCT01808651|18958940|P3|NOT COMPLETED|Study Period 1||5
7699096|NCT01808651|18958941|P2|NOT COMPLETED|Study Period 1||17
7699097|NCT01808651|18958942|P1|NOT COMPLETED|Study Period 1||26
7699098|NCT01808651|18958940|P3|COMPLETED|Study Period 1||31
7699099|NCT01808651|18958941|P2|COMPLETED|Study Period 1||48
7699100|NCT01808651|18958942|P1|COMPLETED|Study Period 1||73
7699101|NCT01808651|18958940|P3|Received at Least One Dose of Study Drug|Study Period 1||36
7699102|NCT01808651|18958941|P2|Received at Least One Dose of Study Drug|Study Period 1||65
7699103|NCT01808651|18958942|P1|Received at Least One Dose of Study Drug|Study Period 1||98
7699104|NCT01808651|18958940|P3|STARTED|Study Period 1||36
7699105|NCT01808651|18958941|P2|STARTED|Study Period 1||65
7699106|NCT01808651|18958942|P1|STARTED|Study Period 1||99
7699107|NCT01808612|18958977|P3|NOT COMPLETED|Discontinuation Period||0
7699108|NCT01808612|18958978|P2|NOT COMPLETED|Discontinuation Period||1
7699109|NCT01808612|18958979|P1|NOT COMPLETED|Discontinuation Period||2
7699110|NCT01808612|18958977|P3|COMPLETED|Discontinuation Period||145
7699111|NCT01808612|18958978|P2|COMPLETED|Discontinuation Period||37
7699112|NCT01808612|18958979|P1|COMPLETED|Discontinuation Period||85
7699113|NCT01808612|18958977|P3|STARTED|Discontinuation Period||145
7699114|NCT01808612|18958978|P2|STARTED|Discontinuation Period||38
7699115|NCT01808612|18958979|P1|STARTED|Discontinuation Period||87
7699116|NCT01808612|18958977|P3|NOT COMPLETED|Treatment Period||14
7699117|NCT01808612|18958978|P2|NOT COMPLETED|Treatment Period||7
7699118|NCT01808612|18958979|P1|NOT COMPLETED|Treatment Period||15
7699119|NCT01808612|18958977|P3|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246
7699120|NCT01808612|18958978|P2|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77
7699121|NCT01808612|18958979|P1|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154
7699122|NCT01808612|18958977|P3|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259
7699123|NCT01808612|18958978|P2|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83
7699124|NCT01808612|18958979|P1|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168
7699125|NCT01808612|18958977|P3|STARTED|Treatment Period||260
7699126|NCT01808612|18958978|P2|STARTED|Treatment Period||84
7699127|NCT01808612|18958979|P1|STARTED|Treatment Period||169
7699128|NCT01808573|18959010|P2|NOT COMPLETED|Overall Study||314
7699129|NCT01808573|18959011|P1|NOT COMPLETED|Overall Study||307
7699130|NCT01808573|18959010|P2|COMPLETED|Overall Study||0
7699131|NCT01808573|18959011|P1|COMPLETED|Overall Study||0
7699132|NCT01808573|18959010|P2|Received Treatment|Overall Study||311
7699133|NCT01808573|18959011|P1|Received Treatment|Overall Study||303
7699134|NCT01808573|18959010|P2|STARTED|Overall Study||314
7699135|NCT01808573|18959011|P1|STARTED|Overall Study||307
7699136|NCT01808560|18959032|P3|NOT COMPLETED|4-Month After Cataract Surgery||0
7699137|NCT01808560|18959033|P2|NOT COMPLETED|4-Month After Cataract Surgery||0
7699138|NCT01808560|18959034|P1|NOT COMPLETED|4-Month After Cataract Surgery||0
7699139|NCT01808560|18959032|P3|COMPLETED|4-Month After Cataract Surgery||13
7699140|NCT01808560|18959033|P2|COMPLETED|4-Month After Cataract Surgery||0
7699141|NCT01808560|18959034|P1|COMPLETED|4-Month After Cataract Surgery||0
7699142|NCT01808560|18959032|P3|STARTED|4-Month After Cataract Surgery||13
7699143|NCT01808560|18959033|P2|STARTED|4-Month After Cataract Surgery||0
7699144|NCT01808560|18959034|P1|STARTED|4-Month After Cataract Surgery||0
7699145|NCT01808560|18959032|P3|NOT COMPLETED|Crossover Treatment||0
7699146|NCT01808560|18959033|P2|NOT COMPLETED|Crossover Treatment||0
7699147|NCT01808560|18959034|P1|NOT COMPLETED|Crossover Treatment||0
7699148|NCT01808560|18959032|P3|COMPLETED|Crossover Treatment||13
7699149|NCT01808560|18959033|P2|COMPLETED|Crossover Treatment||0
7699150|NCT01808560|18959034|P1|COMPLETED|Crossover Treatment||0
7699151|NCT01808560|18959032|P3|STARTED|Crossover Treatment|Post-Treatment Group Received Crossover LipiFlow treatment 3 Months after cataract surgery|13
7699152|NCT01808560|18959033|P2|STARTED|Crossover Treatment||0
7699153|NCT01808560|18959034|P1|STARTED|Crossover Treatment||0
7699154|NCT01808560|18959032|P3|NOT COMPLETED|3-Month After Cataract Surgery||0
7699155|NCT01808560|18959033|P2|NOT COMPLETED|3-Month After Cataract Surgery||0
7699156|NCT01808560|18959034|P1|NOT COMPLETED|3-Month After Cataract Surgery||0
7699157|NCT01808560|18959032|P3|COMPLETED|3-Month After Cataract Surgery||0
7699158|NCT01808560|18959033|P2|COMPLETED|3-Month After Cataract Surgery||13
7699159|NCT01808560|18959034|P1|COMPLETED|3-Month After Cataract Surgery||17
7699160|NCT01808560|18959032|P3|STARTED|3-Month After Cataract Surgery||0
7699161|NCT01808560|18959033|P2|STARTED|3-Month After Cataract Surgery||13
7699162|NCT01808560|18959034|P1|STARTED|3-Month After Cataract Surgery||17
7699163|NCT01808560|18959032|P3|NOT COMPLETED|1-Month After Cataract Surgery||0
7699164|NCT01808560|18959033|P2|NOT COMPLETED|1-Month After Cataract Surgery||0
7699165|NCT01808560|18959034|P1|NOT COMPLETED|1-Month After Cataract Surgery||0
7699166|NCT01808560|18959032|P3|COMPLETED|1-Month After Cataract Surgery||0
7699167|NCT01808560|18959033|P2|COMPLETED|1-Month After Cataract Surgery||13
7699168|NCT01808560|18959034|P1|COMPLETED|1-Month After Cataract Surgery||16
7699169|NCT01808560|18959032|P3|STARTED|1-Month After Cataract Surgery||0
7699170|NCT01808560|18959033|P2|STARTED|1-Month After Cataract Surgery|ITT: 3 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|13
7699171|NCT01808560|18959034|P1|STARTED|1-Month After Cataract Surgery|ITT: 2 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|16
7699172|NCT01808560|18959032|P3|NOT COMPLETED|Randomization and Treatment Allocation||0
7699173|NCT01808560|18959033|P2|NOT COMPLETED|Randomization and Treatment Allocation||0
7699174|NCT01808560|18959034|P1|NOT COMPLETED|Randomization and Treatment Allocation||0
7699175|NCT01808560|18959032|P3|COMPLETED|Randomization and Treatment Allocation||0
7699176|NCT01808560|18959033|P2|COMPLETED|Randomization and Treatment Allocation||16
7699177|NCT01808560|18959034|P1|COMPLETED|Randomization and Treatment Allocation||18
7699178|NCT01808560|18959032|P3|STARTED|Randomization and Treatment Allocation||0
7699179|NCT01808560|18959033|P2|STARTED|Randomization and Treatment Allocation||16
7699180|NCT01808560|18959034|P1|STARTED|Randomization and Treatment Allocation||18
7699181|NCT01808547|18959059|P2|NOT COMPLETED|Overall Study||46
7699182|NCT01808547|18959060|P1|NOT COMPLETED|Overall Study||37
7699183|NCT01808547|18959059|P2|COMPLETED|Overall Study||48
7699184|NCT01808547|18959060|P1|COMPLETED|Overall Study||137
7699185|NCT01808547|18959059|P2|mITT Population|Overall Study||85
7699186|NCT01808547|18959060|P1|mITT Population|Overall Study||168
7699187|NCT01808547|18959059|P2|Safety Population|Overall Study||85
7699188|NCT01808547|18959060|P1|Safety Population|Overall Study||170
7699189|NCT01808547|18959059|P2|STARTED|Overall Study||94
7699190|NCT01808547|18959060|P1|STARTED|Overall Study||174
7699191|NCT01808534|18959066|P1|NOT COMPLETED|Overall Study||4
7699192|NCT01808534|18959066|P1|COMPLETED|Overall Study||1
7699193|NCT01808534|18959066|P1|STARTED|Overall Study||5
7699194|NCT01808508|18959077|P3|NOT COMPLETED|Overall Study||0
7699195|NCT01808508|18959078|P2|NOT COMPLETED|Overall Study||0
7699196|NCT01808508|18959079|P1|NOT COMPLETED|Overall Study||1
7699197|NCT01808508|18959077|P3|COMPLETED|Overall Study||3
7699198|NCT01808508|18959078|P2|COMPLETED|Overall Study||9
7699199|NCT01808508|18959079|P1|COMPLETED|Overall Study||10
7699200|NCT01808508|18959077|P3|STARTED|Overall Study||3
7699201|NCT01808508|18959078|P2|STARTED|Overall Study||9
7699202|NCT01808508|18959079|P1|STARTED|Overall Study||11
7699203|NCT01808339|18959096|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||0
7699204|NCT01808339|18959097|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
7699205|NCT01808339|18959098|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
7699206|NCT01808339|18959099|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
7699207|NCT01808339|18959100|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
7699208|NCT01808339|18959101|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
7699209|NCT01808339|18959096|P6|COMPLETED|Treatment Period 3 (14 Days)||5
7699210|NCT01808339|18959097|P5|COMPLETED|Treatment Period 3 (14 Days)||4
7699211|NCT01808339|18959098|P4|COMPLETED|Treatment Period 3 (14 Days)||2
7699212|NCT01808339|18959099|P3|COMPLETED|Treatment Period 3 (14 Days)||3
7699213|NCT01808339|18959100|P2|COMPLETED|Treatment Period 3 (14 Days)||3
7699214|NCT01808339|18959101|P1|COMPLETED|Treatment Period 3 (14 Days)||4
7699215|NCT01808339|18959096|P6|STARTED|Treatment Period 3 (14 Days)||5
7699216|NCT01808339|18959097|P5|STARTED|Treatment Period 3 (14 Days)||4
7699217|NCT01808339|18959098|P4|STARTED|Treatment Period 3 (14 Days)||2
7699218|NCT01808339|18959099|P3|STARTED|Treatment Period 3 (14 Days)||4
7699219|NCT01808339|18959100|P2|STARTED|Treatment Period 3 (14 Days)||3
7699220|NCT01808339|18959101|P1|STARTED|Treatment Period 3 (14 Days)||4
7699221|NCT01808339|18959096|P6|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
7699222|NCT01808339|18959097|P5|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
7699223|NCT01808339|18959098|P4|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
7699224|NCT01808339|18959099|P3|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
7699225|NCT01808339|18959100|P2|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
7699226|NCT01808339|18959101|P1|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
7699227|NCT01808339|18959096|P6|COMPLETED|Washout Period 2 (14-21 Days)||5
7699228|NCT01808339|18959097|P5|COMPLETED|Washout Period 2 (14-21 Days)||4
7699229|NCT01808339|18959098|P4|COMPLETED|Washout Period 2 (14-21 Days)||2
7699230|NCT01808339|18959099|P3|COMPLETED|Washout Period 2 (14-21 Days)||4
7699231|NCT01808339|18959100|P2|COMPLETED|Washout Period 2 (14-21 Days)||3
7699232|NCT01808339|18959101|P1|COMPLETED|Washout Period 2 (14-21 Days)||4
7699233|NCT01808339|18959096|P6|STARTED|Washout Period 2 (14-21 Days)||5
7699234|NCT01808339|18959097|P5|STARTED|Washout Period 2 (14-21 Days)||4
7699235|NCT01808339|18959098|P4|STARTED|Washout Period 2 (14-21 Days)||2
7699236|NCT01808339|18959099|P3|STARTED|Washout Period 2 (14-21 Days)||4
7699237|NCT01808339|18959100|P2|STARTED|Washout Period 2 (14-21 Days)||3
7699238|NCT01808339|18959101|P1|STARTED|Washout Period 2 (14-21 Days)||4
7699239|NCT01808339|18959096|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
7699240|NCT01808339|18959097|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
7699241|NCT01808339|18959098|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||0
7699242|NCT01808339|18959099|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
7699243|NCT01808339|18959100|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
7699244|NCT01808339|18959101|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
7699245|NCT01808339|18959096|P6|COMPLETED|Treatment Period 2 (14 Days)||5
7699246|NCT01808339|18959097|P5|COMPLETED|Treatment Period 2 (14 Days)||4
7699247|NCT01808339|18959098|P4|COMPLETED|Treatment Period 2 (14 Days)||2
7699248|NCT01808339|18959099|P3|COMPLETED|Treatment Period 2 (14 Days)||4
7699249|NCT01808339|18959100|P2|COMPLETED|Treatment Period 2 (14 Days)||3
7699250|NCT01808339|18959101|P1|COMPLETED|Treatment Period 2 (14 Days)||4
7699251|NCT01808339|18959096|P6|STARTED|Treatment Period 2 (14 Days)||5
7699252|NCT01808339|18959097|P5|STARTED|Treatment Period 2 (14 Days)||4
7699253|NCT01808339|18959098|P4|STARTED|Treatment Period 2 (14 Days)||2
7699254|NCT01808339|18959099|P3|STARTED|Treatment Period 2 (14 Days)||4
7699255|NCT01808339|18959100|P2|STARTED|Treatment Period 2 (14 Days)||3
7699256|NCT01808339|18959101|P1|STARTED|Treatment Period 2 (14 Days)||4
7699257|NCT01808339|18959096|P6|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
7699258|NCT01808339|18959097|P5|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
7699259|NCT01808339|18959098|P4|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
7699260|NCT01808339|18959099|P3|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
7699261|NCT01808339|18959100|P2|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
7699262|NCT01808339|18959101|P1|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
7699263|NCT01808339|18959096|P6|COMPLETED|Washout Period 1 (14-21 Days)||5
7699264|NCT01808339|18959097|P5|COMPLETED|Washout Period 1 (14-21 Days)||4
7699265|NCT01808339|18959098|P4|COMPLETED|Washout Period 1 (14-21 Days)||2
7699266|NCT01808339|18959099|P3|COMPLETED|Washout Period 1 (14-21 Days)||4
7699267|NCT01808339|18959100|P2|COMPLETED|Washout Period 1 (14-21 Days)||3
7699268|NCT01808339|18959101|P1|COMPLETED|Washout Period 1 (14-21 Days)||4
7699269|NCT01808339|18959096|P6|STARTED|Washout Period 1 (14-21 Days)||5
7699270|NCT01808339|18959097|P5|STARTED|Washout Period 1 (14-21 Days)||4
7699271|NCT01808339|18959098|P4|STARTED|Washout Period 1 (14-21 Days)||2
7699272|NCT01808339|18959099|P3|STARTED|Washout Period 1 (14-21 Days)||4
7699273|NCT01808339|18959100|P2|STARTED|Washout Period 1 (14-21 Days)||3
7699274|NCT01808339|18959101|P1|STARTED|Washout Period 1 (14-21 Days)||4
7699275|NCT01808339|18959096|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
7699276|NCT01808339|18959097|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||2
7699277|NCT01808339|18959098|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
7699278|NCT01808339|18959099|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||0
7699279|NCT01808339|18959100|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
7699280|NCT01808339|18959101|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
7699281|NCT01808339|18959096|P6|COMPLETED|Treatment Period 1 (14 Days)||5
7699282|NCT01808339|18959097|P5|COMPLETED|Treatment Period 1 (14 Days)||4
7699283|NCT01808339|18959098|P4|COMPLETED|Treatment Period 1 (14 Days)||2
7699284|NCT01808339|18959099|P3|COMPLETED|Treatment Period 1 (14 Days)||4
7699285|NCT01808339|18959100|P2|COMPLETED|Treatment Period 1 (14 Days)||3
7699286|NCT01808339|18959101|P1|COMPLETED|Treatment Period 1 (14 Days)||4
7699287|NCT01808339|18959096|P6|STARTED|Treatment Period 1 (14 Days)||6
7699288|NCT01808339|18959097|P5|STARTED|Treatment Period 1 (14 Days)||6
7699289|NCT01808339|18959098|P4|STARTED|Treatment Period 1 (14 Days)||4
7699290|NCT01808339|18959099|P3|STARTED|Treatment Period 1 (14 Days)||4
7699291|NCT01808339|18959100|P2|STARTED|Treatment Period 1 (14 Days)||4
7699292|NCT01808339|18959101|P1|STARTED|Treatment Period 1 (14 Days)||4
7699293|NCT01808326|18959118|P1|NOT COMPLETED|Overall Study||0
7699294|NCT01808326|18959118|P1|COMPLETED|Overall Study||5
7699295|NCT01808326|18959118|P1|STARTED|Overall Study||5
7699296|NCT01808313|18959145|P1|NOT COMPLETED|Overall Study||10
7699297|NCT01808313|18959145|P1|COMPLETED|Overall Study||123
7699298|NCT01808313|18959145|P1|STARTED|Overall Study||133
7699299|NCT01808261|18959175|P2|NOT COMPLETED|Overall Study||33
7699300|NCT01808261|18959176|P1|NOT COMPLETED|Overall Study||36
7699301|NCT01808261|18959175|P2|COMPLETED|Overall Study||32
7699302|NCT01808261|18959176|P1|COMPLETED|Overall Study||32
7699303|NCT01808261|18959175|P2|STARTED|Overall Study||65
7699304|NCT01808261|18959176|P1|STARTED|Overall Study||68
7699305|NCT01808248|18959232|P1|NOT COMPLETED|Overall Study||5
7699306|NCT01808248|18959232|P1|COMPLETED|Overall Study||42
7699307|NCT01808248|18959232|P1|Completed Posttreatment Week 12 Visit|Overall Study||45
7699308|NCT01808248|18959232|P1|STARTED|Overall Study||47
7699309|NCT01808222|18959244|P1|NOT COMPLETED|Overall Study||1
7699310|NCT01808222|18959244|P1|COMPLETED|Overall Study||24
7699311|NCT01808222|18959244|P1|Completed mpMR Scan|Overall Study||24
7699312|NCT01808222|18959244|P1|Completed Fluciclovine PET-CT Scan|Overall Study||25
7699313|NCT01808222|18959244|P1|STARTED|Overall Study||25
7699314|NCT01808209|18959251|P2|NOT COMPLETED|Overall Study||1
7699315|NCT01808209|18959252|P1|NOT COMPLETED|Overall Study||0
7699316|NCT01808209|18959251|P2|COMPLETED|Overall Study||26
7699317|NCT01808209|18959252|P1|COMPLETED|Overall Study||33
7699318|NCT01808209|18959251|P2|STARTED|Overall Study||27
7699319|NCT01808209|18959252|P1|STARTED|Overall Study||33
7699320|NCT01808196|18959294|P1|NOT COMPLETED|Overall Study||1
7699321|NCT01808196|18959294|P1|COMPLETED|Overall Study||5
7699322|NCT01808196|18959294|P1|STARTED|Overall Study||6
7699323|NCT01808144|18959302|P2|NOT COMPLETED|Overall Study||48
7699324|NCT01808144|18959303|P1|NOT COMPLETED|Overall Study||40
7699325|NCT01808144|18959302|P2|COMPLETED|Overall Study||51
7699326|NCT01808144|18959303|P1|COMPLETED|Overall Study||57
7699327|NCT01808144|18959302|P2|STARTED|Overall Study||99
7699328|NCT01808144|18959303|P1|STARTED|Overall Study||97
7699329|NCT01808118|18959311|P3|NOT COMPLETED|Period 2||8
7699330|NCT01808118|18959312|P2|NOT COMPLETED|Period 2||13
7699331|NCT01808118|18959313|P1|NOT COMPLETED|Period 2||0
7699332|NCT01808118|18959311|P3|COMPLETED|Period 2||144
7699333|NCT01808118|18959312|P2|COMPLETED|Period 2||140
7699334|NCT01808118|18959313|P1|COMPLETED|Period 2||0
7699335|NCT01808118|18959311|P3|STARTED|Period 2||152
7699336|NCT01808118|18959312|P2|STARTED|Period 2||153
7699337|NCT01808118|18959313|P1|STARTED|Period 2||0
7699338|NCT01808118|18959311|P3|NOT COMPLETED|Period 1||0
7699339|NCT01808118|18959312|P2|NOT COMPLETED|Period 1||0
7699340|NCT01808118|18959313|P1|NOT COMPLETED|Period 1||368
7699341|NCT01808118|18959311|P3|COMPLETED|Period 1||0
7699342|NCT01808118|18959312|P2|COMPLETED|Period 1||0
7699343|NCT01808118|18959313|P1|COMPLETED|Period 1||305
7699344|NCT01808118|18959311|P3|STARTED|Period 1||0
7699345|NCT01808118|18959312|P2|STARTED|Period 1||0
7699346|NCT01808118|18959313|P1|STARTED|Period 1||673
7699347|NCT01808092|18959376|P2|NOT COMPLETED|Overall Study||45
7699348|NCT01808092|18959377|P1|NOT COMPLETED|Overall Study||54
7699349|NCT01808092|18959376|P2|COMPLETED|Overall Study||363
7699350|NCT01808092|18959377|P1|COMPLETED|Overall Study||355
7699351|NCT01808092|18959376|P2|STARTED|Overall Study||408
7699352|NCT01808092|18959377|P1|STARTED|Overall Study||409
7699353|NCT01808066|18959479|P1|NOT COMPLETED|Overall Study||15
7699354|NCT01808066|18959479|P1|COMPLETED|Overall Study||6
7699355|NCT01808066|18959479|P1|STARTED|Overall Study||21
7699356|NCT01807949|18959490|P3|NOT COMPLETED|Overall Study||9
7699357|NCT01807949|18959491|P2|NOT COMPLETED|Overall Study||7
7699358|NCT01807949|18959492|P1|NOT COMPLETED|Overall Study||2
7699359|NCT01807949|18959490|P3|COMPLETED|Overall Study||180
7699360|NCT01807949|18959491|P2|COMPLETED|Overall Study||180
7699361|NCT01807949|18959492|P1|COMPLETED|Overall Study||185
7699362|NCT01807949|18959490|P3|STARTED|Overall Study||189
7699363|NCT01807949|18959491|P2|STARTED|Overall Study||187
7699364|NCT01807949|18959492|P1|STARTED|Overall Study||187
7699365|NCT01807923|18959544|P3|NOT COMPLETED|Overall Study||11
7699366|NCT01807923|18959545|P2|NOT COMPLETED|Overall Study||6
7699367|NCT01807923|18959546|P1|NOT COMPLETED|Overall Study||5
7699368|NCT01807923|18959544|P3|COMPLETED|Overall Study||176
7699369|NCT01807923|18959545|P2|COMPLETED|Overall Study||179
7699370|NCT01807923|18959546|P1|COMPLETED|Overall Study||182
7699371|NCT01807923|18959544|P3|STARTED|Overall Study||187
7699372|NCT01807923|18959545|P2|STARTED|Overall Study||185
7699373|NCT01807923|18959546|P1|STARTED|Overall Study||187
7699374|NCT01807871|18959597|P2|NOT COMPLETED|Overall Study||218
7699375|NCT01807871|18959598|P1|NOT COMPLETED|Overall Study||178
7699376|NCT01807871|18959597|P2|COMPLETED|Overall Study||127
7699377|NCT01807871|18959598|P1|COMPLETED|Overall Study||178
7699378|NCT01807871|18959597|P2|STARTED|Overall Study||345
7699379|NCT01807871|18959598|P1|STARTED|Overall Study||356
7699380|NCT01807650|18959608|P1|NOT COMPLETED|Overall Study||20
7699381|NCT01807650|18959608|P1|COMPLETED|Overall Study||92
7699382|NCT01807650|18959608|P1|STARTED|Overall Study||112
7699383|NCT01807637|18959661|P2|NOT COMPLETED|One Month||0
7699384|NCT01807637|18959662|P1|NOT COMPLETED|One Month||0
7699385|NCT01807637|18959661|P2|COMPLETED|One Month||2
7699386|NCT01807637|18959662|P1|COMPLETED|One Month||4
7699387|NCT01807637|18959661|P2|STARTED|One Month||2
7699388|NCT01807637|18959662|P1|STARTED|One Month||4
7699389|NCT01807637|18959661|P2|NOT COMPLETED|One Week||0
7699390|NCT01807637|18959662|P1|NOT COMPLETED|One Week||0
7699391|NCT01807637|18959661|P2|COMPLETED|One Week||2
7699392|NCT01807637|18959662|P1|COMPLETED|One Week||4
7699393|NCT01807637|18959661|P2|STARTED|One Week||2
7699394|NCT01807637|18959662|P1|STARTED|One Week||4
7699395|NCT01807637|18959661|P2|NOT COMPLETED|Baseline||0
7699396|NCT01807637|18959662|P1|NOT COMPLETED|Baseline||0
7699397|NCT01807637|18959661|P2|COMPLETED|Baseline||2
7699398|NCT01807637|18959662|P1|COMPLETED|Baseline||4
7699399|NCT01807637|18959661|P2|STARTED|Baseline||2
7699400|NCT01807637|18959662|P1|STARTED|Baseline||4
7699401|NCT01807624|18959678|P1|NOT COMPLETED|Overall Study||0
7699402|NCT01807624|18959678|P1|COMPLETED|Overall Study||24
7699403|NCT01807624|18959678|P1|STARTED|Overall Study||24
7699404|NCT01807598|18959694|P1|NOT COMPLETED|Overall Study||6
7699405|NCT01807598|18959694|P1|COMPLETED|Overall Study||4
7699406|NCT01807598|18959694|P1|STARTED|Overall Study||10
7699407|NCT01807585|18959708|P3|NOT COMPLETED|Overall Study||6
7699408|NCT01807585|18959709|P2|NOT COMPLETED|Overall Study||4
7699409|NCT01807585|18959710|P1|NOT COMPLETED|Overall Study||1
7699410|NCT01807585|18959708|P3|COMPLETED|Overall Study||108
7699411|NCT01807585|18959709|P2|COMPLETED|Overall Study||104
7699412|NCT01807585|18959710|P1|COMPLETED|Overall Study||19
7699413|NCT01807585|18959708|P3|3 Mos|Overall Study||113
7699414|NCT01807585|18959709|P2|3 Mos|Overall Study||108
7699415|NCT01807585|18959710|P1|3 Mos|Overall Study||20
7699416|NCT01807585|18959708|P3|STARTED|Overall Study||114
7699417|NCT01807585|18959709|P2|STARTED|Overall Study||108
7699418|NCT01807585|18959710|P1|STARTED|Overall Study||20
7699419|NCT01807520|18959726|P7|NOT COMPLETED|Follow-up Period (132-140 Weeks)||1
7699420|NCT01807520|18959727|P6|NOT COMPLETED|Follow-up Period (132-140 Weeks)||4
7699421|NCT01807520|18959728|P5|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
7699422|NCT01807520|18959729|P4|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
7699423|NCT01807520|18959730|P3|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
7699424|NCT01807520|18959731|P2|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
7699425|NCT01807520|18959732|P1|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
7699426|NCT01807520|18959726|P7|COMPLETED|Follow-up Period (132-140 Weeks)||75
7699427|NCT01807520|18959727|P6|COMPLETED|Follow-up Period (132-140 Weeks)||77
7699428|NCT01807520|18959728|P5|COMPLETED|Follow-up Period (132-140 Weeks)||0
7699429|NCT01807520|18959729|P4|COMPLETED|Follow-up Period (132-140 Weeks)||0
7699430|NCT01807520|18959730|P3|COMPLETED|Follow-up Period (132-140 Weeks)||2
7699431|NCT01807520|18959731|P2|COMPLETED|Follow-up Period (132-140 Weeks)||0
7699432|NCT01807520|18959732|P1|COMPLETED|Follow-up Period (132-140 Weeks)||0
7699433|NCT01807520|18959726|P7|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457 300mg during treatment period 1 and/or treatment period 2.|76
7699434|NCT01807520|18959727|P6|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457150mg during treatment period 1 and/or treatment period 2.|81
7699435|NCT01807520|18959728|P5|STARTED|Follow-up Period (132-140 Weeks)||0
7699436|NCT01807520|18959729|P4|STARTED|Follow-up Period (132-140 Weeks)||0
7699437|NCT01807520|18959730|P3|STARTED|Follow-up Period (132-140 Weeks)|These participants discontinued from Treatment Period 1.|2
7699438|NCT01807520|18959731|P2|STARTED|Follow-up Period (132-140 Weeks)||0
7699439|NCT01807520|18959732|P1|STARTED|Follow-up Period (132-140 Weeks)||0
7699440|NCT01807520|18959726|P7|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
7699441|NCT01807520|18959727|P6|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
7699442|NCT01807520|18959728|P5|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||5
7699443|NCT01807520|18959729|P4|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||7
7699444|NCT01807520|18959730|P3|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
7699445|NCT01807520|18959731|P2|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||18
7699446|NCT01807520|18959732|P1|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||25
7699447|NCT01807520|18959726|P7|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
7699448|NCT01807520|18959727|P6|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
7699449|NCT01807520|18959728|P5|COMPLETED|Treatment Period 2 (16-132 Weeks)||24
7699450|NCT01807520|18959729|P4|COMPLETED|Treatment Period 2 (16-132 Weeks)||22
7699451|NCT01807520|18959730|P3|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
7699452|NCT01807520|18959731|P2|COMPLETED|Treatment Period 2 (16-132 Weeks)||47
7699453|NCT01807520|18959732|P1|COMPLETED|Treatment Period 2 (16-132 Weeks)||38
7699454|NCT01807520|18959726|P7|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
7699455|NCT01807520|18959727|P6|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
7699456|NCT01807520|18959728|P5|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
7699457|NCT01807520|18959729|P4|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
7699458|NCT01807520|18959730|P3|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
7699459|NCT01807520|18959731|P2|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||66
7699460|NCT01807520|18959732|P1|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||67
7699461|NCT01807520|18959726|P7|Safety Set|Treatment Period 2 (16-132 Weeks)||0
7699462|NCT01807520|18959727|P6|Safety Set|Treatment Period 2 (16-132 Weeks)||0
7699463|NCT01807520|18959728|P5|Safety Set|Treatment Period 2 (16-132 Weeks)||29
7699464|NCT01807520|18959729|P4|Safety Set|Treatment Period 2 (16-132 Weeks)||29
7699465|NCT01807520|18959730|P3|Safety Set|Treatment Period 2 (16-132 Weeks)||0
7699466|NCT01807520|18959731|P2|Safety Set|Treatment Period 2 (16-132 Weeks)||65
7699467|NCT01807520|18959732|P1|Safety Set|Treatment Period 2 (16-132 Weeks)||63
7699468|NCT01807520|18959726|P7|STARTED|Treatment Period 2 (16-132 Weeks)||0
7699469|NCT01807520|18959727|P6|STARTED|Treatment Period 2 (16-132 Weeks)||0
7699470|NCT01807520|18959728|P5|STARTED|Treatment Period 2 (16-132 Weeks)||29
7699471|NCT01807520|18959729|P4|STARTED|Treatment Period 2 (16-132 Weeks)||29
7699472|NCT01807520|18959730|P3|STARTED|Treatment Period 2 (16-132 Weeks)||0
7699473|NCT01807520|18959731|P2|STARTED|Treatment Period 2 (16-132 Weeks)||65
7699474|NCT01807520|18959732|P1|STARTED|Treatment Period 2 (16-132 Weeks)||63
7699475|NCT01807520|18959726|P7|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
7699476|NCT01807520|18959727|P6|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
7699477|NCT01807520|18959728|P5|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
7699478|NCT01807520|18959729|P4|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
7699479|NCT01807520|18959730|P3|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||7
7699480|NCT01807520|18959731|P2|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||1
7699481|NCT01807520|18959732|P1|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||4
7699482|NCT01807520|18959726|P7|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
7699483|NCT01807520|18959727|P6|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
7699484|NCT01807520|18959728|P5|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
7699485|NCT01807520|18959729|P4|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
7699486|NCT01807520|18959730|P3|COMPLETED|Treatment Period 1 (0-16 Weeks)||58
7699487|NCT01807520|18959731|P2|COMPLETED|Treatment Period 1 (0-16 Weeks)||65
7699488|NCT01807520|18959732|P1|COMPLETED|Treatment Period 1 (0-16 Weeks)||63
7699489|NCT01807520|18959726|P7|Safety Set|Treatment Period 1 (0-16 Weeks)||0
7699490|NCT01807520|18959727|P6|Safety Set|Treatment Period 1 (0-16 Weeks)||0
7699491|NCT01807520|18959728|P5|Safety Set|Treatment Period 1 (0-16 Weeks)||0
7699492|NCT01807520|18959729|P4|Safety Set|Treatment Period 1 (0-16 Weeks)||0
7699493|NCT01807520|18959730|P3|Safety Set|Treatment Period 1 (0-16 Weeks)||65
7699494|NCT01807520|18959731|P2|Safety Set|Treatment Period 1 (0-16 Weeks)||65
7699495|NCT01807520|18959732|P1|Safety Set|Treatment Period 1 (0-16 Weeks)||67
7699496|NCT01807520|18959726|P7|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
7699497|NCT01807520|18959727|P6|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
7699498|NCT01807520|18959728|P5|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
7699499|NCT01807520|18959729|P4|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
7699500|NCT01807520|18959730|P3|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||65
7699501|NCT01807520|18959731|P2|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||66
7699502|NCT01807520|18959732|P1|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||67
7699503|NCT01807520|18959726|P7|STARTED|Treatment Period 1 (0-16 Weeks)||0
7699504|NCT01807520|18959727|P6|STARTED|Treatment Period 1 (0-16 Weeks)||0
7699505|NCT01807520|18959728|P5|STARTED|Treatment Period 1 (0-16 Weeks)||0
7699506|NCT01807520|18959729|P4|STARTED|Treatment Period 1 (0-16 Weeks)||0
7699507|NCT01807520|18959730|P3|STARTED|Treatment Period 1 (0-16 Weeks)||65
7699508|NCT01807520|18959731|P2|STARTED|Treatment Period 1 (0-16 Weeks)||66
7699509|NCT01807520|18959732|P1|STARTED|Treatment Period 1 (0-16 Weeks)||67
7699510|NCT01807455|18959751|P1|NOT COMPLETED|Overall Study||0
7699511|NCT01807455|18959751|P1|COMPLETED|Overall Study||12
7699512|NCT01807455|18959751|P1|STARTED|Overall Study||12
7699513|NCT01807299|18959763|P4|NOT COMPLETED|Overall Study||2
7699514|NCT01807299|18959764|P3|NOT COMPLETED|Overall Study||0
7699515|NCT01807299|18959765|P2|NOT COMPLETED|Overall Study||1
7699516|NCT01807299|18959766|P1|NOT COMPLETED|Overall Study||3
7699517|NCT01807299|18959763|P4|COMPLETED|Overall Study||11
7699518|NCT01807299|18959764|P3|COMPLETED|Overall Study||12
7699519|NCT01807299|18959765|P2|COMPLETED|Overall Study||13
7699520|NCT01807299|18959766|P1|COMPLETED|Overall Study||11
7699521|NCT01807299|18959763|P4|STARTED|Overall Study||13
7699522|NCT01807299|18959764|P3|STARTED|Overall Study||12
7699523|NCT01807299|18959765|P2|STARTED|Overall Study||14
7699524|NCT01807299|18959766|P1|STARTED|Overall Study||14
7699525|NCT01807234|18959782|P6|NOT COMPLETED|Overall Study||4
7699526|NCT01807234|18959783|P5|NOT COMPLETED|Overall Study||4
7699527|NCT01807234|18959784|P4|NOT COMPLETED|Overall Study||2
7699528|NCT01807234|18959785|P3|NOT COMPLETED|Overall Study||2
7699529|NCT01807234|18959786|P2|NOT COMPLETED|Overall Study||6
7699530|NCT01807234|18959787|P1|NOT COMPLETED|Overall Study||5
7699531|NCT01807234|18959782|P6|COMPLETED|Overall Study||8
7699532|NCT01807234|18959783|P5|COMPLETED|Overall Study||8
7699533|NCT01807234|18959784|P4|COMPLETED|Overall Study||10
7699534|NCT01807234|18959785|P3|COMPLETED|Overall Study||10
7699535|NCT01807234|18959786|P2|COMPLETED|Overall Study||6
7699536|NCT01807234|18959787|P1|COMPLETED|Overall Study||7
7699537|NCT01807234|18959782|P6|Completed Only 1 Attack|Overall Study||1
7699538|NCT01807234|18959783|P5|Completed Only 1 Attack|Overall Study||0
7699539|NCT01807234|18959784|P4|Completed Only 1 Attack|Overall Study||1
7699540|NCT01807234|18959785|P3|Completed Only 1 Attack|Overall Study||0
7699541|NCT01807234|18959786|P2|Completed Only 1 Attack|Overall Study||1
7699542|NCT01807234|18959787|P1|Completed Only 1 Attack|Overall Study||2
7699543|NCT01807234|18959782|P6|Randomized, But Did Not Take Drug|Overall Study||3
7699544|NCT01807234|18959783|P5|Randomized, But Did Not Take Drug|Overall Study||4
7699545|NCT01807234|18959784|P4|Randomized, But Did Not Take Drug|Overall Study||1
7699546|NCT01807234|18959785|P3|Randomized, But Did Not Take Drug|Overall Study||2
7699547|NCT01807234|18959786|P2|Randomized, But Did Not Take Drug|Overall Study||5
7699548|NCT01807234|18959787|P1|Randomized, But Did Not Take Drug|Overall Study||3
7699549|NCT01807234|18959782|P6|STARTED|Overall Study||12
7699550|NCT01807234|18959783|P5|STARTED|Overall Study||12
7699551|NCT01807234|18959784|P4|STARTED|Overall Study||12
7699552|NCT01807234|18959785|P3|STARTED|Overall Study||12
7699553|NCT01807234|18959786|P2|STARTED|Overall Study||12
7699554|NCT01807234|18959787|P1|STARTED|Overall Study||12
7699555|NCT01807156|18959822|P1|NOT COMPLETED|Overall Study||1
7699556|NCT01807156|18959822|P1|COMPLETED|Overall Study||6
7699557|NCT01807156|18959822|P1|STARTED|Overall Study||7
7699558|NCT01807104|18959829|P2|NOT COMPLETED|Overall Study||4
7699559|NCT01807104|18959830|P1|NOT COMPLETED|Overall Study||4
7699560|NCT01807104|18959829|P2|COMPLETED|Overall Study||40
7699561|NCT01807104|18959830|P1|COMPLETED|Overall Study||39
7699562|NCT01807104|18959829|P2|STARTED|Overall Study||44
7699563|NCT01807104|18959830|P1|STARTED|Overall Study||43
7699564|NCT01807065|18959838|P2|NOT COMPLETED|Overall Study||1
7699565|NCT01807065|18959839|P1|NOT COMPLETED|Overall Study||1
7699566|NCT01807065|18959838|P2|COMPLETED|Overall Study||25
7699567|NCT01807065|18959839|P1|COMPLETED|Overall Study||24
7699568|NCT01807065|18959838|P2|STARTED|Overall Study||26
7699569|NCT01807065|18959839|P1|STARTED|Overall Study||25
7699570|NCT01807026|18959853|P6|NOT COMPLETED|Overall Study||0
7699571|NCT01807026|18959854|P5|NOT COMPLETED|Overall Study||0
7699572|NCT01807026|18959855|P4|NOT COMPLETED|Overall Study||0
7699573|NCT01807026|18959856|P3|NOT COMPLETED|Overall Study||0
7699574|NCT01807026|18959857|P2|NOT COMPLETED|Overall Study||0
7699575|NCT01807026|18959858|P1|NOT COMPLETED|Overall Study||0
7699576|NCT01807026|18959853|P6|COMPLETED|Overall Study||3
7699577|NCT01807026|18959854|P5|COMPLETED|Overall Study||9
7699578|NCT01807026|18959855|P4|COMPLETED|Overall Study||2
7699579|NCT01807026|18959856|P3|COMPLETED|Overall Study||10
7699580|NCT01807026|18959857|P2|COMPLETED|Overall Study||2
7699581|NCT01807026|18959858|P1|COMPLETED|Overall Study||10
7699582|NCT01807026|18959853|P6|Received at Least One Dose of Study Drug|Overall Study||3
7699583|NCT01807026|18959854|P5|Received at Least One Dose of Study Drug|Overall Study||9
7699584|NCT01807026|18959855|P4|Received at Least One Dose of Study Drug|Overall Study||2
7699585|NCT01807026|18959856|P3|Received at Least One Dose of Study Drug|Overall Study||10
7699586|NCT01807026|18959857|P2|Received at Least One Dose of Study Drug|Overall Study||2
7699587|NCT01807026|18959858|P1|Received at Least One Dose of Study Drug|Overall Study||10
7699588|NCT01807026|18959853|P6|STARTED|Overall Study||3
7699589|NCT01807026|18959854|P5|STARTED|Overall Study||9
7699590|NCT01807026|18959855|P4|STARTED|Overall Study||2
7699591|NCT01807026|18959856|P3|STARTED|Overall Study||10
7699592|NCT01807026|18959857|P2|STARTED|Overall Study||2
7699593|NCT01807026|18959858|P1|STARTED|Overall Study||10
7699594|NCT01807000|18959886|P1|NOT COMPLETED|Overall Study||0
7699595|NCT01807000|18959886|P1|COMPLETED|Overall Study||6
7699596|NCT01807000|18959886|P1|STARTED|Overall Study||6
7699597|NCT01806961|18959905|P1|NOT COMPLETED|Overall Study||16
7699598|NCT01806961|18959905|P1|COMPLETED|Overall Study||0
7699599|NCT01806961|18959905|P1|STARTED|Overall Study||16
7699600|NCT01806896|18959911|P2|NOT COMPLETED|Overall Study||0
7699601|NCT01806896|18959912|P1|NOT COMPLETED|Overall Study||3
7699602|NCT01806896|18959911|P2|COMPLETED|Overall Study||17
7699603|NCT01806896|18959912|P1|COMPLETED|Overall Study||17
7699604|NCT01806896|18959911|P2|Received Treatment|Overall Study||17
7699605|NCT01806896|18959912|P1|Received Treatment|Overall Study||19
7699606|NCT01806896|18959911|P2|STARTED|Overall Study||17
7699607|NCT01806896|18959912|P1|STARTED|Overall Study||20
7699608|NCT01806857|18959940|P2|NOT COMPLETED|Overall Study||0
7699609|NCT01806857|18959941|P1|NOT COMPLETED|Overall Study||1
7699610|NCT01806857|18959940|P2|COMPLETED|Overall Study||29
7699611|NCT01806857|18959941|P1|COMPLETED|Overall Study||30
7699612|NCT01806857|18959940|P2|STARTED|Overall Study||29
7699613|NCT01806857|18959941|P1|STARTED|Overall Study||31
7699614|NCT01806779|18959979|P3|NOT COMPLETED|Overall Study||23
7699615|NCT01806779|18959980|P2|NOT COMPLETED|Overall Study||44
7699616|NCT01806779|18959981|P1|NOT COMPLETED|Overall Study||42
7699617|NCT01806779|18959979|P3|COMPLETED|Overall Study||0
7699618|NCT01806779|18959980|P2|COMPLETED|Overall Study||40
7699619|NCT01806779|18959981|P1|COMPLETED|Overall Study||48
7699620|NCT01806779|18959979|P3|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0
7699621|NCT01806779|18959980|P2|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83
7699622|NCT01806779|18959981|P1|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87
7699623|NCT01806779|18959979|P3|Randomized at Visit 2|Overall Study||0
7699624|NCT01806779|18959980|P2|Randomized at Visit 2|Overall Study||84
7699625|NCT01806779|18959981|P1|Randomized at Visit 2|Overall Study||90
7699626|NCT01806779|18959979|P3|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2
7699627|NCT01806779|18959980|P2|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84
7699628|NCT01806779|18959981|P1|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90
7699629|NCT01806779|18959979|P3|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23
7699630|NCT01806779|18959980|P2|STARTED|Overall Study||84
7699631|NCT01806779|18959981|P1|STARTED|Overall Study||90
7699632|NCT01806740|18959994|P1|NOT COMPLETED|Overall Study||6
7699633|NCT01806740|18959994|P1|COMPLETED|Overall Study||31
7699634|NCT01806740|18959994|P1|STARTED|Overall Study||37
7699635|NCT01806714|18960005|P2|NOT COMPLETED|Overall Study||170
7699636|NCT01806714|18960006|P1|NOT COMPLETED|Overall Study||200
7699637|NCT01806714|18960005|P2|COMPLETED|Overall Study||1919
7699638|NCT01806714|18960006|P1|COMPLETED|Overall Study||1893
7699639|NCT01806714|18960005|P2|STARTED|Overall Study||2089
7699640|NCT01806714|18960006|P1|STARTED|Overall Study||2093
7699641|NCT01806675|18960019|P3|NOT COMPLETED|Overall Study||0
7699642|NCT01806675|18960020|P2|NOT COMPLETED|Overall Study||0
7699643|NCT01806675|18960021|P1|NOT COMPLETED|Overall Study||0
7699644|NCT01806675|18960019|P3|COMPLETED|Overall Study||8
7699645|NCT01806675|18960020|P2|COMPLETED|Overall Study||6
7699646|NCT01806675|18960021|P1|COMPLETED|Overall Study||11
7699647|NCT01806675|18960019|P3|STARTED|Overall Study||8
7699648|NCT01806675|18960020|P2|STARTED|Overall Study||6
7699649|NCT01806675|18960021|P1|STARTED|Overall Study||11
7699650|NCT01806662|18960041|P2|NOT COMPLETED|Second Intervention (Weeks 16-32)||4
7699651|NCT01806662|18960042|P1|NOT COMPLETED|Second Intervention (Weeks 16-32)||2
7699652|NCT01806662|18960041|P2|COMPLETED|Second Intervention (Weeks 16-32)||11
7699653|NCT01806662|18960042|P1|COMPLETED|Second Intervention (Weeks 16-32)||10
7699654|NCT01806662|18960041|P2|STARTED|Second Intervention (Weeks 16-32)||15
7699655|NCT01806662|18960042|P1|STARTED|Second Intervention (Weeks 16-32)||12
7699656|NCT01806662|18960041|P2|NOT COMPLETED|First Intervention (Weeks 0-16)||1
7699657|NCT01806662|18960042|P1|NOT COMPLETED|First Intervention (Weeks 0-16)||4
7699658|NCT01806662|18960041|P2|COMPLETED|First Intervention (Weeks 0-16)||15
7699659|NCT01806662|18960042|P1|COMPLETED|First Intervention (Weeks 0-16)||12
7699660|NCT01806662|18960041|P2|Received Intervention|First Intervention (Weeks 0-16)||15
7699661|NCT01806662|18960042|P1|Received Intervention|First Intervention (Weeks 0-16)||12
7699662|NCT01806662|18960041|P2|STARTED|First Intervention (Weeks 0-16)||16
7699663|NCT01806662|18960042|P1|STARTED|First Intervention (Weeks 0-16)||16
7699664|NCT01806623|18960048|P1|NOT COMPLETED|Overall Study||58
7699665|NCT01806623|18960048|P1|COMPLETED|Overall Study||99
7699666|NCT01806623|18960048|P1|STARTED|Overall Study||157
7699667|NCT01806597|18960068|P6|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||12
7699668|NCT01806597|18960069|P5|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
7699669|NCT01806597|18960070|P4|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
7699670|NCT01806597|18960071|P3|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
7699671|NCT01806597|18960072|P2|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
7699672|NCT01806597|18960073|P1|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
7699673|NCT01806597|18960068|P6|COMPLETED|Follow-up Period (Week 132 to Week 140)||149
7699674|NCT01806597|18960069|P5|COMPLETED|Follow-up Period (Week 132 to Week 140)||3
7699675|NCT01806597|18960070|P4|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
7699676|NCT01806597|18960071|P3|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
7699677|NCT01806597|18960072|P2|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
7699678|NCT01806597|18960073|P1|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
7699679|NCT01806597|18960068|P6|STARTED|Follow-up Period (Week 132 to Week 140)||161
7699680|NCT01806597|18960069|P5|STARTED|Follow-up Period (Week 132 to Week 140)||3
7699681|NCT01806597|18960070|P4|STARTED|Follow-up Period (Week 132 to Week 140)||0
7699682|NCT01806597|18960071|P3|STARTED|Follow-up Period (Week 132 to Week 140)||0
7699683|NCT01806597|18960072|P2|STARTED|Follow-up Period (Week 132 to Week 140)||0
7699684|NCT01806597|18960073|P1|STARTED|Follow-up Period (Week 132 to Week 140)||0
7699685|NCT01806597|18960068|P6|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
7699686|NCT01806597|18960069|P5|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||1
7699687|NCT01806597|18960070|P4|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||11
7699688|NCT01806597|18960071|P3|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||14
7699689|NCT01806597|18960072|P2|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
7699690|NCT01806597|18960073|P1|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||39
7699691|NCT01806597|18960068|P6|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
7699692|NCT01806597|18960069|P5|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
7699693|NCT01806597|18960070|P4|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
7699694|NCT01806597|18960071|P3|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||17
7699695|NCT01806597|18960072|P2|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||44
7699696|NCT01806597|18960073|P1|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||24
7699697|NCT01806597|18960068|P6|STARTED|Treatment Period 2 (Week 16 to Week 132)||0
7699698|NCT01806597|18960069|P5|STARTED|Treatment Period 2 (Week 16 to Week 132)||1
7699699|NCT01806597|18960070|P4|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
7699700|NCT01806597|18960071|P3|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
7699701|NCT01806597|18960072|P2|STARTED|Treatment Period 2 (Week 16 to Week 132)||64
7699702|NCT01806597|18960073|P1|STARTED|Treatment Period 2 (Week 16 to Week 132)||63
7699703|NCT01806597|18960068|P6|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
7699704|NCT01806597|18960069|P5|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
7699705|NCT01806597|18960070|P4|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
7699706|NCT01806597|18960071|P3|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
7699707|NCT01806597|18960072|P2|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
7699708|NCT01806597|18960073|P1|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
7699709|NCT01806597|18960068|P6|COMPLETED|Period 1 (Baseline to Week 16)||0
7699710|NCT01806597|18960069|P5|COMPLETED|Period 1 (Baseline to Week 16)||63
7699711|NCT01806597|18960070|P4|COMPLETED|Period 1 (Baseline to Week 16)||0
7699712|NCT01806597|18960071|P3|COMPLETED|Period 1 (Baseline to Week 16)||0
7699713|NCT01806597|18960072|P2|COMPLETED|Period 1 (Baseline to Week 16)||64
7699714|NCT01806597|18960073|P1|COMPLETED|Period 1 (Baseline to Week 16)||63
7699715|NCT01806597|18960068|P6|STARTED|Period 1 (Baseline to Week 16)||0
7699716|NCT01806597|18960069|P5|STARTED|Period 1 (Baseline to Week 16)||68
7699717|NCT01806597|18960070|P4|STARTED|Period 1 (Baseline to Week 16)||0
7699718|NCT01806597|18960071|P3|STARTED|Period 1 (Baseline to Week 16)||0
7699719|NCT01806597|18960072|P2|STARTED|Period 1 (Baseline to Week 16)||69
7699720|NCT01806597|18960073|P1|STARTED|Period 1 (Baseline to Week 16)||68
7699721|NCT01806584|18960109|P2|NOT COMPLETED|Overall Study||18
7699722|NCT01806584|18960110|P1|NOT COMPLETED|Overall Study||14
7699723|NCT01806584|18960109|P2|COMPLETED|Overall Study||0
7699724|NCT01806584|18960110|P1|COMPLETED|Overall Study||0
7699725|NCT01806584|18960109|P2|STARTED|Overall Study||18
7699726|NCT01806584|18960110|P1|STARTED|Overall Study||14
7699727|NCT01806571|18960122|P1|NOT COMPLETED|Overall Study||0
7699728|NCT01806571|18960122|P1|COMPLETED|Overall Study||34
7699729|NCT01806571|18960122|P1|STARTED|Overall Study||34
7699730|NCT01806545|18960132|P2|NOT COMPLETED|Overall Study||5
7699731|NCT01806545|18960133|P1|NOT COMPLETED|Overall Study||6
7699732|NCT01806545|18960132|P2|COMPLETED|Overall Study||30
7699733|NCT01806545|18960133|P1|COMPLETED|Overall Study||23
7699734|NCT01806545|18960132|P2|STARTED|Overall Study||35
7699735|NCT01806545|18960133|P1|STARTED|Overall Study||29
7699736|NCT01806506|18960157|P2|NOT COMPLETED|Overall Study||1
7699737|NCT01806506|18960158|P1|NOT COMPLETED|Overall Study||2
7699738|NCT01806506|18960157|P2|COMPLETED|Overall Study||35
7699739|NCT01806506|18960158|P1|COMPLETED|Overall Study||34
7699740|NCT01806506|18960157|P2|9 Months|Overall Study|1 patient (reason - lost contact)|35
7699741|NCT01806506|18960158|P1|9 Months|Overall Study||34
7699742|NCT01806506|18960157|P2|6 Months|Overall Study||36
7699743|NCT01806506|18960158|P1|6 Months|Overall Study|1 patient (reason - lost contact)|34
7699744|NCT01806506|18960157|P2|3 Months|Overall Study||36
7699745|NCT01806506|18960158|P1|3 Months|Overall Study|1 patient (reason - lost contact)|35
7699746|NCT01806506|18960157|P2|1 Month|Overall Study||36
7699747|NCT01806506|18960158|P1|1 Month|Overall Study||36
7699748|NCT01806506|18960157|P2|STARTED|Overall Study||36
7699749|NCT01806506|18960158|P1|STARTED|Overall Study||36
7699750|NCT01806389|18960164|P1|NOT COMPLETED|Overall Study||4
7699751|NCT01806389|18960164|P1|COMPLETED|Overall Study||10
7699752|NCT01806389|18960164|P1|STARTED|Overall Study||14
7699753|NCT01806298|18960178|P1|NOT COMPLETED|Overall Study||10
7699754|NCT01806298|18960178|P1|COMPLETED|Overall Study||68
7699755|NCT01806298|18960178|P1|STARTED|Overall Study||78
7699756|NCT01806259|18960190|P2|NOT COMPLETED|Overall Study||0
7699757|NCT01806259|18960191|P1|NOT COMPLETED|Overall Study||0
7699758|NCT01806259|18960190|P2|COMPLETED|Overall Study||107
7699759|NCT01806259|18960191|P1|COMPLETED|Overall Study||96
7699760|NCT01806259|18960190|P2|STARTED|Overall Study||107
7699761|NCT01806259|18960191|P1|STARTED|Overall Study||96
7699762|NCT01806064|18960204|P5|NOT COMPLETED|Overall Study||2
7699763|NCT01806064|18960205|P4|NOT COMPLETED|Overall Study||1
7699764|NCT01806064|18960206|P3|NOT COMPLETED|Overall Study||0
7699765|NCT01806064|18960207|P2|NOT COMPLETED|Overall Study||0
7699766|NCT01806064|18960208|P1|NOT COMPLETED|Overall Study||0
7699767|NCT01806064|18960204|P5|COMPLETED|Overall Study||73
7699768|NCT01806064|18960205|P4|COMPLETED|Overall Study||74
7699769|NCT01806064|18960206|P3|COMPLETED|Overall Study||5
7699770|NCT01806064|18960207|P2|COMPLETED|Overall Study||15
7699771|NCT01806064|18960208|P1|COMPLETED|Overall Study||3
7699772|NCT01806064|18960204|P5|STARTED|Overall Study||75
7699773|NCT01806064|18960205|P4|STARTED|Overall Study||75
7699774|NCT01806064|18960206|P3|STARTED|Overall Study||5
7699775|NCT01806064|18960207|P2|STARTED|Overall Study||15
7699776|NCT01806064|18960208|P1|STARTED|Overall Study||3
7699777|NCT01806051|18960233|P1|NOT COMPLETED|Overall Study||6
7699778|NCT01806051|18960233|P1|COMPLETED|Overall Study||0
7699779|NCT01806051|18960233|P1|STARTED|Overall Study||6
7699780|NCT01805895|18960241|P2|NOT COMPLETED|Overall Study||0
7699781|NCT01805895|18960242|P1|NOT COMPLETED|Overall Study||0
7699782|NCT01805895|18960241|P2|COMPLETED|Overall Study||8
7699783|NCT01805895|18960242|P1|COMPLETED|Overall Study||8
7699784|NCT01805895|18960241|P2|STARTED|Overall Study||8
7699785|NCT01805895|18960242|P1|STARTED|Overall Study||8
7699786|NCT01805882|18960259|P9|NOT COMPLETED|Overall Study||1
7699787|NCT01805882|18960260|P8|NOT COMPLETED|Overall Study||0
7699788|NCT01805882|18960261|P7|NOT COMPLETED|Overall Study||2
7699789|NCT01805882|18960262|P6|NOT COMPLETED|Overall Study||1
7699790|NCT01805882|18960263|P5|NOT COMPLETED|Overall Study||0
7699791|NCT01805882|18960264|P4|NOT COMPLETED|Overall Study||2
7699792|NCT01805882|18960265|P3|NOT COMPLETED|Overall Study||1
7699793|NCT01805882|18960266|P2|NOT COMPLETED|Overall Study||0
7699794|NCT01805882|18960267|P1|NOT COMPLETED|Overall Study||0
7699795|NCT01805882|18960259|P9|COMPLETED|Overall Study||24
7699796|NCT01805882|18960260|P8|COMPLETED|Overall Study||25
7699797|NCT01805882|18960261|P7|COMPLETED|Overall Study||48
7699798|NCT01805882|18960262|P6|COMPLETED|Overall Study||20
7699799|NCT01805882|18960263|P5|COMPLETED|Overall Study||14
7699800|NCT01805882|18960264|P4|COMPLETED|Overall Study||32
7699801|NCT01805882|18960265|P3|COMPLETED|Overall Study||19
7699802|NCT01805882|18960266|P2|COMPLETED|Overall Study||20
7699803|NCT01805882|18960267|P1|COMPLETED|Overall Study||20
7699804|NCT01805882|18960259|P9|STARTED|Overall Study||25
7699805|NCT01805882|18960260|P8|STARTED|Overall Study||25
7699806|NCT01805882|18960261|P7|STARTED|Overall Study||50
7699807|NCT01805882|18960262|P6|STARTED|Overall Study||21
7699808|NCT01805882|18960263|P5|STARTED|Overall Study||14
7699809|NCT01805882|18960264|P4|STARTED|Overall Study||34
7699810|NCT01805882|18960265|P3|STARTED|Overall Study||20
7699811|NCT01805882|18960266|P2|STARTED|Overall Study||20
7699812|NCT01805882|18960267|P1|STARTED|Overall Study||20
7699813|NCT01805791|18960290|P3|NOT COMPLETED|Overall Study||20
7699814|NCT01805791|18960291|P2|NOT COMPLETED|Overall Study||17
7699815|NCT01805791|18960292|P1|NOT COMPLETED|Overall Study||22
7699816|NCT01805791|18960290|P3|COMPLETED|Overall Study||48
7699817|NCT01805791|18960291|P2|COMPLETED|Overall Study||50
7699818|NCT01805791|18960292|P1|COMPLETED|Overall Study||44
7699819|NCT01805791|18960290|P3|STARTED|Overall Study||68
7699820|NCT01805791|18960291|P2|STARTED|Overall Study||67
7699821|NCT01805791|18960292|P1|STARTED|Overall Study||66
7699822|NCT01805687|18960306|P1|NOT COMPLETED|Overall Study||0
7699823|NCT01805687|18960306|P1|COMPLETED|Overall Study||25
7699824|NCT01805687|18960306|P1|STARTED|Overall Study||25
7699825|NCT01805440|18960313|P3|NOT COMPLETED|Overall Study||0
7699826|NCT01805440|18960314|P2|NOT COMPLETED|Overall Study||0
7699827|NCT01805440|18960315|P1|NOT COMPLETED|Overall Study||1
7699828|NCT01805440|18960313|P3|COMPLETED|Overall Study||26
7699829|NCT01805440|18960314|P2|COMPLETED|Overall Study||17
7699830|NCT01805440|18960315|P1|COMPLETED|Overall Study||18
7699831|NCT01805440|18960313|P3|STARTED|Overall Study||26
7699832|NCT01805440|18960314|P2|STARTED|Overall Study||17
7699833|NCT01805440|18960315|P1|STARTED|Overall Study||19
7699834|NCT01805323|18960328|P1|NOT COMPLETED|Overall Study||0
7699835|NCT01805323|18960328|P1|COMPLETED|Overall Study||101
7699836|NCT01805323|18960328|P1|STARTED|Overall Study||101
7699837|NCT01805297|18960335|P2|NOT COMPLETED|Overall Study||3
7699838|NCT01805297|18960336|P1|NOT COMPLETED|Overall Study||2
7699839|NCT01805297|18960335|P2|COMPLETED|Overall Study||3
7699840|NCT01805297|18960336|P1|COMPLETED|Overall Study||4
7699841|NCT01805297|18960335|P2|STARTED|Overall Study||6
7699842|NCT01805297|18960336|P1|STARTED|Overall Study||6
7699843|NCT01805180|18960350|P3|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
7699844|NCT01805180|18960351|P2|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
7699845|NCT01805180|18960352|P1|NOT COMPLETED|Pivotal Randomization Through Study Exit||0
7699846|NCT01805180|18960350|P3|COMPLETED|Pivotal Randomization Through Study Exit||15
7699847|NCT01805180|18960351|P2|COMPLETED|Pivotal Randomization Through Study Exit||17
7699848|NCT01805180|18960352|P1|COMPLETED|Pivotal Randomization Through Study Exit||0
7699849|NCT01805180|18960350|P3|STARTED|Pivotal Randomization Through Study Exit||20
7699850|NCT01805180|18960351|P2|STARTED|Pivotal Randomization Through Study Exit||22
7699851|NCT01805180|18960352|P1|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0
7699852|NCT01805180|18960350|P3|NOT COMPLETED|Lead-in Donor Phase||0
7699853|NCT01805180|18960351|P2|NOT COMPLETED|Lead-in Donor Phase||0
7699854|NCT01805180|18960352|P1|NOT COMPLETED|Lead-in Donor Phase||1
7699855|NCT01805180|18960350|P3|COMPLETED|Lead-in Donor Phase||0
7699856|NCT01805180|18960351|P2|COMPLETED|Lead-in Donor Phase||0
7699857|NCT01805180|18960352|P1|COMPLETED|Lead-in Donor Phase||6
7699858|NCT01805180|18960350|P3|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
7699859|NCT01805180|18960351|P2|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
7699860|NCT01805180|18960352|P1|STARTED|Lead-in Donor Phase||7
7699861|NCT01805154|18960375|P1|NOT COMPLETED|Overall Study||354
7699862|NCT01805154|18960375|P1|COMPLETED|Overall Study||1175
7699863|NCT01805154|18960375|P1|STARTED|Overall Study||1529
7699864|NCT01805089|18960385|P2|NOT COMPLETED|Overall Study||4
7699865|NCT01805089|18960386|P1|NOT COMPLETED|Overall Study||5
7699866|NCT01805089|18960385|P2|COMPLETED|Overall Study||43
7699867|NCT01805089|18960386|P1|COMPLETED|Overall Study||43
7699868|NCT01805089|18960385|P2|STARTED|Overall Study||47
7699869|NCT01805089|18960386|P1|STARTED|Overall Study||48
7699870|NCT01805024|18960400|P4|NOT COMPLETED|Overall Study||0
7699871|NCT01805024|18960401|P3|NOT COMPLETED|Overall Study||0
7699872|NCT01805024|18960402|P2|NOT COMPLETED|Overall Study||0
7699873|NCT01805024|18960403|P1|NOT COMPLETED|Overall Study||0
7699874|NCT01805024|18960400|P4|COMPLETED|Overall Study||8
7699875|NCT01805024|18960401|P3|COMPLETED|Overall Study||4
7699876|NCT01805024|18960402|P2|COMPLETED|Overall Study||4
7699877|NCT01805024|18960403|P1|COMPLETED|Overall Study||4
7699878|NCT01805024|18960400|P4|STARTED|Overall Study||8
7699879|NCT01805024|18960401|P3|STARTED|Overall Study||4
7699880|NCT01805024|18960402|P2|STARTED|Overall Study||4
7699881|NCT01805024|18960403|P1|STARTED|Overall Study||4
7699882|NCT01804946|18960427|P2|NOT COMPLETED|Overall Study||4
7699883|NCT01804946|18960428|P1|NOT COMPLETED|Overall Study||2
7699884|NCT01804946|18960427|P2|COMPLETED|Overall Study||76
7699885|NCT01804946|18960428|P1|COMPLETED|Overall Study||79
7699886|NCT01804946|18960427|P2|STARTED|Overall Study||80
7699887|NCT01804946|18960428|P1|STARTED|Overall Study||81
7699888|NCT01804881|18960452|P2|NOT COMPLETED|Overall Study||4
7699889|NCT01804881|18960453|P1|NOT COMPLETED|Overall Study||5
7699890|NCT01804881|18960452|P2|COMPLETED|Overall Study||10
7699891|NCT01804881|18960453|P1|COMPLETED|Overall Study||11
7699892|NCT01804881|18960452|P2|STARTED|Overall Study||14
7699893|NCT01804881|18960453|P1|STARTED|Overall Study||16
7699894|NCT01804842|18960466|P3|NOT COMPLETED|Overall Study||1
7699895|NCT01804842|18960467|P2|NOT COMPLETED|Overall Study||2
7699896|NCT01804842|18960468|P1|NOT COMPLETED|Overall Study||3
7699897|NCT01804842|18960466|P3|COMPLETED|Overall Study||8
7699898|NCT01804842|18960467|P2|COMPLETED|Overall Study||6
7699899|NCT01804842|18960468|P1|COMPLETED|Overall Study||6
7699900|NCT01804842|18960466|P3|Completed Treatment C|Overall Study||9
7699901|NCT01804842|18960467|P2|Completed Treatment C|Overall Study||7
7699902|NCT01804842|18960468|P1|Completed Treatment C|Overall Study||7
7699903|NCT01804842|18960466|P3|Completed Treatment B|Overall Study||8
7699904|NCT01804842|18960467|P2|Completed Treatment B|Overall Study||8
7699905|NCT01804842|18960468|P1|Completed Treatment B|Overall Study||8
7699906|NCT01804842|18960466|P3|Completed Treatment A|Overall Study||8
7699907|NCT01804842|18960467|P2|Completed Treatment A|Overall Study||6
7699908|NCT01804842|18960468|P1|Completed Treatment A|Overall Study||9
7699909|NCT01804842|18960466|P3|STARTED|Overall Study||9
7699910|NCT01804842|18960467|P2|STARTED|Overall Study||8
7699911|NCT01804842|18960468|P1|STARTED|Overall Study||9
7699912|NCT01804816|18960485|P1|NOT COMPLETED|Acupuncture (Second 5 Weeks)||1
7699913|NCT01804816|18960485|P1|COMPLETED|Acupuncture (Second 5 Weeks)||10
7699914|NCT01804816|18960485|P1|STARTED|Acupuncture (Second 5 Weeks)||11
7699915|NCT01804816|18960485|P1|NOT COMPLETED|No Acupuncture (Initial 5 Weeks)||3
7699916|NCT01804816|18960485|P1|COMPLETED|No Acupuncture (Initial 5 Weeks)||11
7699917|NCT01804816|18960485|P1|STARTED|No Acupuncture (Initial 5 Weeks)||14
7699918|NCT01804673|18960497|P1|NOT COMPLETED|Overall Study||140
7699919|NCT01804673|18960497|P1|COMPLETED|Overall Study||34
7699920|NCT01804673|18960497|P1|Completed Hour 72|Overall Study||36
7699921|NCT01804673|18960497|P1|Completed Hour 48|Overall Study||79
7699922|NCT01804673|18960497|P1|Completed Hour 24|Overall Study||170
7699923|NCT01804673|18960497|P1|STARTED|Overall Study||174
7699924|NCT01804582|18960515|P2|NOT COMPLETED|Overall Study||56
7699925|NCT01804582|18960516|P1|NOT COMPLETED|Overall Study||49
7699926|NCT01804582|18960515|P2|COMPLETED|Overall Study||117
7699927|NCT01804582|18960516|P1|COMPLETED|Overall Study||128
7699928|NCT01804582|18960515|P2|STARTED|Overall Study||173
7699929|NCT01804582|18960516|P1|STARTED|Overall Study||177
7699930|NCT01804257|18960532|P1|NOT COMPLETED|Overall Study||1
7699931|NCT01804257|18960532|P1|COMPLETED|Overall Study||27
7699932|NCT01804257|18960532|P1|STARTED|Overall Study||28
7699933|NCT01804140|18960536|P1|NOT COMPLETED|Overall Study||114
7699934|NCT01804140|18960536|P1|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548
7699935|NCT01804140|18960536|P1|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662
7699936|NCT01804101|18960543|P2|NOT COMPLETED|Overall Study||0
7699937|NCT01804101|18960544|P1|NOT COMPLETED|Overall Study||0
7699938|NCT01804101|18960543|P2|COMPLETED|Overall Study||10
7699939|NCT01804101|18960544|P1|COMPLETED|Overall Study||38
7699940|NCT01804101|18960543|P2|STARTED|Overall Study||10
7699941|NCT01804101|18960544|P1|STARTED|Overall Study||38
7699942|NCT01804075|18960554|P2|NOT COMPLETED|Overall Study||0
7699943|NCT01804075|18960555|P1|NOT COMPLETED|Overall Study||0
7699944|NCT01804075|18960554|P2|COMPLETED|Overall Study||16
7699945|NCT01804075|18960555|P1|COMPLETED|Overall Study||15
7699946|NCT01804075|18960554|P2|STARTED|Overall Study||16
7699947|NCT01804075|18960555|P1|STARTED|Overall Study||15
7699948|NCT01804062|18960563|P1|NOT COMPLETED|Overall Study||0
7699949|NCT01804062|18960563|P1|COMPLETED|Overall Study||30
7699950|NCT01804062|18960563|P1|STARTED|Overall Study||30
7699951|NCT01804049|18960570|P2|NOT COMPLETED|Overall Study||32
7699952|NCT01804049|18960571|P1|NOT COMPLETED|Overall Study||11
7699953|NCT01804049|18960570|P2|COMPLETED|Overall Study||45
7699954|NCT01804049|18960571|P1|COMPLETED|Overall Study||32
7699955|NCT01804049|18960570|P2|STARTED|Overall Study||77
7699956|NCT01804049|18960571|P1|STARTED|Overall Study||43
7699957|NCT01804036|18960583|P2|NOT COMPLETED|Overall Study||20
7699958|NCT01804036|18960584|P1|NOT COMPLETED|Overall Study||13
7699959|NCT01804036|18960583|P2|COMPLETED|Overall Study||21
7699960|NCT01804036|18960584|P1|COMPLETED|Overall Study||18
7699961|NCT01804036|18960583|P2|STARTED|Overall Study||41
7699962|NCT01804036|18960584|P1|STARTED|Overall Study||31
7699963|NCT01803880|18960619|P3|NOT COMPLETED|Overall Study||15
7699964|NCT01803880|18960620|P2|NOT COMPLETED|Overall Study||10
7699965|NCT01803880|18960621|P1|NOT COMPLETED|Overall Study||6
7699966|NCT01803880|18960619|P3|COMPLETED|Overall Study||14
7699967|NCT01803880|18960620|P2|COMPLETED|Overall Study||18
7699968|NCT01803880|18960621|P1|COMPLETED|Overall Study||13
7699969|NCT01803880|18960619|P3|STARTED|Overall Study||29
7699970|NCT01803880|18960620|P2|STARTED|Overall Study||28
7699971|NCT01803880|18960621|P1|STARTED|Overall Study||19
7699972|NCT01803737|18960657|P2|NOT COMPLETED|Overall Study||3
7699973|NCT01803737|18960658|P1|NOT COMPLETED|Overall Study||1
7699974|NCT01803737|18960657|P2|COMPLETED|Overall Study||10
7699975|NCT01803737|18960658|P1|COMPLETED|Overall Study||12
7699976|NCT01803737|18960657|P2|STARTED|Overall Study||13
7699977|NCT01803737|18960658|P1|STARTED|Overall Study||13
7699978|NCT01803711|18960682|P2|NOT COMPLETED|Overall Study||1
7699979|NCT01803711|18960683|P1|NOT COMPLETED|Overall Study||1
7699980|NCT01803711|18960682|P2|COMPLETED|Overall Study||2
7699981|NCT01803711|18960683|P1|COMPLETED|Overall Study||1
7699982|NCT01803711|18960682|P2|STARTED|Overall Study||3
7699983|NCT01803711|18960683|P1|STARTED|Overall Study||2
7699984|NCT01803646|18960701|P2|NOT COMPLETED|Overall Study||10
7699985|NCT01803646|18960702|P1|NOT COMPLETED|Overall Study||17
7699986|NCT01803646|18960701|P2|COMPLETED|Overall Study||129
7699987|NCT01803646|18960702|P1|COMPLETED|Overall Study||187
7699988|NCT01803646|18960701|P2|STARTED|Overall Study||139
7699989|NCT01803646|18960702|P1|STARTED|Overall Study||204
7699990|NCT01803607|18960714|P2|NOT COMPLETED|Overall Study||67
7699991|NCT01803607|18960715|P1|NOT COMPLETED|Overall Study||68
7699992|NCT01803607|18960714|P2|COMPLETED|Overall Study||0
7699993|NCT01803607|18960715|P1|COMPLETED|Overall Study||0
7699994|NCT01803607|18960714|P2|STARTED|Overall Study||67
7699995|NCT01803607|18960715|P1|STARTED|Overall Study||68
7699996|NCT01803464|18960739|P4|NOT COMPLETED|Overall Study||0
7699997|NCT01803464|18960740|P3|NOT COMPLETED|Overall Study||4
7699998|NCT01803464|18960741|P2|NOT COMPLETED|Overall Study||0
7699999|NCT01803464|18960742|P1|NOT COMPLETED|Overall Study||1
7700000|NCT01803464|18960739|P4|COMPLETED|Overall Study||10
7700001|NCT01803464|18960740|P3|COMPLETED|Overall Study||6
7700002|NCT01803464|18960741|P2|COMPLETED|Overall Study||4
7700003|NCT01803464|18960742|P1|COMPLETED|Overall Study||4
7700004|NCT01803464|18960739|P4|STARTED|Overall Study||10
7700005|NCT01803464|18960740|P3|STARTED|Overall Study||10
7700006|NCT01803464|18960741|P2|STARTED|Overall Study||4
7700007|NCT01803464|18960742|P1|STARTED|Overall Study||5
7700008|NCT01803282|18960772|P12|NOT COMPLETED|Overall Study||15
7700009|NCT01803282|18960773|P11|NOT COMPLETED|Overall Study||8
7700010|NCT01803282|18960774|P10|NOT COMPLETED|Overall Study||45
7700011|NCT01803282|18960775|P9|NOT COMPLETED|Overall Study||11
7700012|NCT01803282|18960776|P8|NOT COMPLETED|Overall Study||46
7700013|NCT01803282|18960777|P7|NOT COMPLETED|Overall Study||41
7700014|NCT01803282|18960778|P6|NOT COMPLETED|Overall Study||10
7700015|NCT01803282|18960779|P5|NOT COMPLETED|Overall Study||11
7700016|NCT01803282|18960780|P4|NOT COMPLETED|Overall Study||36
7700017|NCT01803282|18960781|P3|NOT COMPLETED|Overall Study||6
7700018|NCT01803282|18960782|P2|NOT COMPLETED|Overall Study||3
7700019|NCT01803282|18960783|P1|NOT COMPLETED|Overall Study||4
7700020|NCT01803282|18960772|P12|COMPLETED|Overall Study||0
7700021|NCT01803282|18960773|P11|COMPLETED|Overall Study||0
7700022|NCT01803282|18960774|P10|COMPLETED|Overall Study||0
7700023|NCT01803282|18960775|P9|COMPLETED|Overall Study||0
7700024|NCT01803282|18960776|P8|COMPLETED|Overall Study||0
7700025|NCT01803282|18960777|P7|COMPLETED|Overall Study||0
7700026|NCT01803282|18960778|P6|COMPLETED|Overall Study||0
7700027|NCT01803282|18960779|P5|COMPLETED|Overall Study||0
7700028|NCT01803282|18960780|P4|COMPLETED|Overall Study||0
7700029|NCT01803282|18960781|P3|COMPLETED|Overall Study||0
7700030|NCT01803282|18960782|P2|COMPLETED|Overall Study||0
7700031|NCT01803282|18960783|P1|COMPLETED|Overall Study||0
7700032|NCT01803282|18960772|P12|STARTED|Overall Study||15
7700033|NCT01803282|18960773|P11|STARTED|Overall Study||8
7700034|NCT01803282|18960774|P10|STARTED|Overall Study||45
7700035|NCT01803282|18960775|P9|STARTED|Overall Study||11
7700036|NCT01803282|18960776|P8|STARTED|Overall Study||46
7700037|NCT01803282|18960777|P7|STARTED|Overall Study||41
7700038|NCT01803282|18960778|P6|STARTED|Overall Study||10
7700039|NCT01803282|18960779|P5|STARTED|Overall Study||11
7700040|NCT01803282|18960780|P4|STARTED|Overall Study||36
7700041|NCT01803282|18960781|P3|STARTED|Overall Study||6
7700042|NCT01803282|18960782|P2|STARTED|Overall Study||3
7700043|NCT01803282|18960783|P1|STARTED|Overall Study||4
7700044|NCT01803269|18960824|P3|NOT COMPLETED|Overall Study||0
7700045|NCT01803269|18960825|P2|NOT COMPLETED|Overall Study||0
7700046|NCT01803269|18960826|P1|NOT COMPLETED|Overall Study||3
7700047|NCT01803269|18960824|P3|COMPLETED|Overall Study||14
7700048|NCT01803269|18960825|P2|COMPLETED|Overall Study||8
7700049|NCT01803269|18960826|P1|COMPLETED|Overall Study||4
7700050|NCT01803269|18960824|P3|STARTED|Overall Study||14
7700051|NCT01803269|18960825|P2|STARTED|Overall Study||8
7700052|NCT01803269|18960826|P1|STARTED|Overall Study||7
7700053|NCT01803204|18960848|P2|NOT COMPLETED|Overall Study||0
7700054|NCT01803204|18960849|P1|NOT COMPLETED|Overall Study||0
7700055|NCT01803204|18960848|P2|COMPLETED|Overall Study||20
7700056|NCT01803204|18960849|P1|COMPLETED|Overall Study||20
7700057|NCT01803204|18960848|P2|STARTED|Overall Study||20
7700058|NCT01803204|18960849|P1|STARTED|Overall Study||20
7700059|NCT01803074|18960873|P14|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700060|NCT01803074|18960874|P13|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700061|NCT01803074|18960875|P12|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700062|NCT01803074|18960876|P11|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700063|NCT01803074|18960877|P10|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700064|NCT01803074|18960878|P9|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700065|NCT01803074|18960879|P8|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700066|NCT01803074|18960880|P7|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700067|NCT01803074|18960881|P6|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700068|NCT01803074|18960882|P5|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700069|NCT01803074|18960883|P4|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700070|NCT01803074|18960884|P3|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700071|NCT01803074|18960885|P2|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700072|NCT01803074|18960886|P1|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700073|NCT01803074|18960873|P14|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||4
7700074|NCT01803074|18960874|P13|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||7
7700075|NCT01803074|18960875|P12|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||8
7700076|NCT01803074|18960876|P11|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700077|NCT01803074|18960877|P10|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700078|NCT01803074|18960878|P9|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700079|NCT01803074|18960879|P8|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700080|NCT01803074|18960880|P7|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700081|NCT01803074|18960881|P6|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700082|NCT01803074|18960882|P5|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700083|NCT01803074|18960883|P4|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700084|NCT01803074|18960884|P3|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700085|NCT01803074|18960885|P2|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700086|NCT01803074|18960886|P1|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
7700087|NCT01803074|18960873|P14|STARTED|Period 3: Part C (HIV-1 Clade C Only)||4
7700088|NCT01803074|18960874|P13|STARTED|Period 3: Part C (HIV-1 Clade C Only)||7
7700089|NCT01803074|18960875|P12|STARTED|Period 3: Part C (HIV-1 Clade C Only)||8
7700090|NCT01803074|18960876|P11|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
7700091|NCT01803074|18960877|P10|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
7700092|NCT01803074|18960878|P9|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
7700093|NCT01803074|18960879|P8|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
7700094|NCT01803074|18960880|P7|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
7700095|NCT01803074|18960881|P6|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
7700096|NCT01803074|18960882|P5|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
7700097|NCT01803074|18960883|P4|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
7700098|NCT01803074|18960884|P3|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
7700099|NCT01803074|18960885|P2|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
7700100|NCT01803074|18960886|P1|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
7700101|NCT01803074|18960873|P14|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700102|NCT01803074|18960874|P13|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700103|NCT01803074|18960875|P12|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700104|NCT01803074|18960876|P11|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700105|NCT01803074|18960877|P10|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700106|NCT01803074|18960878|P9|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700107|NCT01803074|18960879|P8|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700108|NCT01803074|18960880|P7|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700109|NCT01803074|18960881|P6|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700110|NCT01803074|18960882|P5|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700111|NCT01803074|18960883|P4|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700112|NCT01803074|18960884|P3|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700113|NCT01803074|18960885|P2|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700114|NCT01803074|18960886|P1|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700115|NCT01803074|18960873|P14|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700116|NCT01803074|18960874|P13|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700117|NCT01803074|18960875|P12|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700118|NCT01803074|18960876|P11|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
7700119|NCT01803074|18960877|P10|COMPLETED|Period 2: Part B (HIV-1 Clade B)||4
7700120|NCT01803074|18960878|P9|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
7700121|NCT01803074|18960879|P8|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
7700122|NCT01803074|18960880|P7|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700123|NCT01803074|18960881|P6|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700124|NCT01803074|18960882|P5|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700125|NCT01803074|18960883|P4|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700126|NCT01803074|18960884|P3|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700127|NCT01803074|18960885|P2|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700128|NCT01803074|18960886|P1|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
7700129|NCT01803074|18960873|P14|STARTED|Period 2: Part B (HIV-1 Clade B)||0
7700130|NCT01803074|18960874|P13|STARTED|Period 2: Part B (HIV-1 Clade B)||0
7700131|NCT01803074|18960875|P12|STARTED|Period 2: Part B (HIV-1 Clade B)||0
7700132|NCT01803074|18960876|P11|STARTED|Period 2: Part B (HIV-1 Clade B)||8
7700133|NCT01803074|18960877|P10|STARTED|Period 2: Part B (HIV-1 Clade B)||4
7700134|NCT01803074|18960878|P9|STARTED|Period 2: Part B (HIV-1 Clade B)||8
7700135|NCT01803074|18960879|P8|STARTED|Period 2: Part B (HIV-1 Clade B)||8
7700136|NCT01803074|18960880|P7|STARTED|Period 2: Part B (HIV-1 Clade B)||0
7700137|NCT01803074|18960881|P6|STARTED|Period 2: Part B (HIV-1 Clade B)||0
7700138|NCT01803074|18960882|P5|STARTED|Period 2: Part B (HIV-1 Clade B)||0
7700139|NCT01803074|18960883|P4|STARTED|Period 2: Part B (HIV-1 Clade B)||0
7700140|NCT01803074|18960884|P3|STARTED|Period 2: Part B (HIV-1 Clade B)||0
7700141|NCT01803074|18960885|P2|STARTED|Period 2: Part B (HIV-1 Clade B)||0
7700142|NCT01803074|18960886|P1|STARTED|Period 2: Part B (HIV-1 Clade B)||0
7700143|NCT01803074|18960873|P14|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
7700144|NCT01803074|18960874|P13|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
7700145|NCT01803074|18960875|P12|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
7700146|NCT01803074|18960876|P11|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
7700147|NCT01803074|18960877|P10|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
7700148|NCT01803074|18960878|P9|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
7700149|NCT01803074|18960879|P8|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
7700150|NCT01803074|18960880|P7|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
7700151|NCT01803074|18960881|P6|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
7700152|NCT01803074|18960882|P5|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
7700153|NCT01803074|18960883|P4|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
7700154|NCT01803074|18960884|P3|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
7700155|NCT01803074|18960885|P2|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
7700156|NCT01803074|18960886|P1|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
7700157|NCT01803074|18960873|P14|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
7700158|NCT01803074|18960874|P13|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
7700159|NCT01803074|18960875|P12|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
7700160|NCT01803074|18960876|P11|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
7700161|NCT01803074|18960877|P10|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
7700162|NCT01803074|18960878|P9|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
7700163|NCT01803074|18960879|P8|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
7700164|NCT01803074|18960880|P7|COMPLETED|Period 1: Part A (HIV-1 Clade B)||12
7700165|NCT01803074|18960881|P6|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
7700166|NCT01803074|18960882|P5|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
7700167|NCT01803074|18960883|P4|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
7700168|NCT01803074|18960884|P3|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
7700169|NCT01803074|18960885|P2|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
7700170|NCT01803074|18960886|P1|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
7700171|NCT01803074|18960873|P14|STARTED|Period 1: Part A (HIV-1 Clade B)||0
7700172|NCT01803074|18960874|P13|STARTED|Period 1: Part A (HIV-1 Clade B)||0
7700173|NCT01803074|18960875|P12|STARTED|Period 1: Part A (HIV-1 Clade B)||0
7700174|NCT01803074|18960876|P11|STARTED|Period 1: Part A (HIV-1 Clade B)||0
7700175|NCT01803074|18960877|P10|STARTED|Period 1: Part A (HIV-1 Clade B)||0
7700176|NCT01803074|18960878|P9|STARTED|Period 1: Part A (HIV-1 Clade B)||0
7700177|NCT01803074|18960879|P8|STARTED|Period 1: Part A (HIV-1 Clade B)||0
7700178|NCT01803074|18960880|P7|STARTED|Period 1: Part A (HIV-1 Clade B)||12
7700179|NCT01803074|18960881|P6|STARTED|Period 1: Part A (HIV-1 Clade B)||8
7700180|NCT01803074|18960882|P5|STARTED|Period 1: Part A (HIV-1 Clade B)||8
7700181|NCT01803074|18960883|P4|STARTED|Period 1: Part A (HIV-1 Clade B)||8
7700182|NCT01803074|18960884|P3|STARTED|Period 1: Part A (HIV-1 Clade B)||8
7700183|NCT01803074|18960885|P2|STARTED|Period 1: Part A (HIV-1 Clade B)||8
7700184|NCT01803074|18960886|P1|STARTED|Period 1: Part A (HIV-1 Clade B)||8
7700185|NCT01802879|18961140|P1|NOT COMPLETED|Overall Study||8
7700186|NCT01802879|18961140|P1|COMPLETED|Overall Study||0
7700187|NCT01802879|18961140|P1|STARTED|Overall Study||8
7700188|NCT01802775|18961147|P2|NOT COMPLETED|Overall Study||12
7700189|NCT01802775|18961148|P1|NOT COMPLETED|Overall Study||6
7700190|NCT01802775|18961147|P2|COMPLETED|Overall Study||89
7700191|NCT01802775|18961148|P1|COMPLETED|Overall Study||96
7700192|NCT01802775|18961147|P2|Received Drug (Safety Analysis Set)|Overall Study||100
7700193|NCT01802775|18961148|P1|Received Drug (Safety Analysis Set)|Overall Study||101
7700194|NCT01802775|18961147|P2|STARTED|Overall Study||101
7700195|NCT01802775|18961148|P1|STARTED|Overall Study||102
7700196|NCT01802710|18961166|P2|NOT COMPLETED|From T1 to T2||2
7700197|NCT01802710|18961167|P1|NOT COMPLETED|From T1 to T2||2
7700198|NCT01802710|18961166|P2|COMPLETED|From T1 to T2||70
7700199|NCT01802710|18961167|P1|COMPLETED|From T1 to T2||58
7700200|NCT01802710|18961166|P2|STARTED|From T1 to T2||72
7700201|NCT01802710|18961167|P1|STARTED|From T1 to T2||60
7700202|NCT01802710|18961166|P2|NOT COMPLETED|From T0 to T1||10
7700203|NCT01802710|18961167|P1|NOT COMPLETED|From T0 to T1||16
7700204|NCT01802710|18961166|P2|COMPLETED|From T0 to T1||72
7700205|NCT01802710|18961167|P1|COMPLETED|From T0 to T1||60
7700206|NCT01802710|18961166|P2|STARTED|From T0 to T1||82
7700207|NCT01802710|18961167|P1|STARTED|From T0 to T1||76
7700208|NCT01802632|18961183|P6|NOT COMPLETED|Overall Study||28
7700209|NCT01802632|18961184|P5|NOT COMPLETED|Overall Study||12
7700210|NCT01802632|18961185|P4|NOT COMPLETED|Overall Study||60
7700211|NCT01802632|18961186|P3|NOT COMPLETED|Overall Study||271
7700212|NCT01802632|18961187|P2|NOT COMPLETED|Overall Study||31
7700213|NCT01802632|18961188|P1|NOT COMPLETED|Overall Study||201
7700214|NCT01802632|18961183|P6|COMPLETED|Overall Study||0
7700215|NCT01802632|18961184|P5|COMPLETED|Overall Study||0
7700216|NCT01802632|18961185|P4|COMPLETED|Overall Study||0
7700217|NCT01802632|18961186|P3|COMPLETED|Overall Study||0
7700218|NCT01802632|18961187|P2|COMPLETED|Overall Study||0
7700219|NCT01802632|18961188|P1|COMPLETED|Overall Study||0
7700220|NCT01802632|18961183|P6|STARTED|Overall Study||28
7700221|NCT01802632|18961184|P5|STARTED|Overall Study||12
7700222|NCT01802632|18961185|P4|STARTED|Overall Study||60
7700223|NCT01802632|18961186|P3|STARTED|Overall Study||271
7700224|NCT01802632|18961187|P2|STARTED|Overall Study||31
7700225|NCT01802632|18961188|P1|STARTED|Overall Study||201
7700226|NCT01802580|18961204|P2|NOT COMPLETED|Overall Study||11
7700227|NCT01802580|18961205|P1|NOT COMPLETED|Overall Study||9
7700228|NCT01802580|18961204|P2|COMPLETED|Overall Study||9
7700229|NCT01802580|18961205|P1|COMPLETED|Overall Study||11
7700230|NCT01802580|18961204|P2|STARTED|Overall Study||20
7700231|NCT01802580|18961205|P1|STARTED|Overall Study||20
7700232|NCT01802554|18961218|P2|NOT COMPLETED|Overall Study||6
7700233|NCT01802554|18961219|P1|NOT COMPLETED|Overall Study||8
7700234|NCT01802554|18961218|P2|COMPLETED|Overall Study||43
7700235|NCT01802554|18961219|P1|COMPLETED|Overall Study||43
7700236|NCT01802554|18961218|P2|STARTED|Overall Study||49
7700237|NCT01802554|18961219|P1|STARTED|Overall Study||51
7700238|NCT01802515|18961236|P3|NOT COMPLETED|Overall Study||0
7700239|NCT01802515|18961237|P2|NOT COMPLETED|Overall Study||0
7700240|NCT01802515|18961238|P1|NOT COMPLETED|Overall Study||3
7700241|NCT01802515|18961236|P3|COMPLETED|Overall Study||4
7700242|NCT01802515|18961237|P2|COMPLETED|Overall Study||5
7700243|NCT01802515|18961238|P1|COMPLETED|Overall Study||2
7700244|NCT01802515|18961236|P3|STARTED|Overall Study||4
7700245|NCT01802515|18961237|P2|STARTED|Overall Study||5
7700246|NCT01802515|18961238|P1|STARTED|Overall Study||5
7700247|NCT01802437|18961251|P2|NOT COMPLETED|Overall Study||4
7700248|NCT01802437|18961252|P1|NOT COMPLETED|Overall Study||4
7700249|NCT01802437|18961251|P2|COMPLETED|Overall Study||16
7700250|NCT01802437|18961252|P1|COMPLETED|Overall Study||16
7700251|NCT01802437|18961251|P2|STARTED|Overall Study||20
7700252|NCT01802437|18961252|P1|STARTED|Overall Study||20
7700253|NCT01802411|18961264|P2|NOT COMPLETED|Overall Study||21
7700254|NCT01802411|18961265|P1|NOT COMPLETED|Overall Study||14
7700255|NCT01802411|18961264|P2|COMPLETED|Overall Study||74
7700256|NCT01802411|18961265|P1|COMPLETED|Overall Study||82
7700257|NCT01802411|18961264|P2|STARTED|Overall Study||95
7700258|NCT01802411|18961265|P1|STARTED|Overall Study||96
7700259|NCT01802385|18961277|P2|NOT COMPLETED|Overall Study||120
7700260|NCT01802385|18961278|P1|NOT COMPLETED|Overall Study||106
7700261|NCT01802385|18961277|P2|COMPLETED|Overall Study||109
7700262|NCT01802385|18961278|P1|COMPLETED|Overall Study||125
7700263|NCT01802385|18961277|P2|STARTED|Overall Study||229
7700264|NCT01802385|18961278|P1|STARTED|Overall Study||231
7700265|NCT01802333|18961301|P3|NOT COMPLETED|Overall Study||63
7700266|NCT01802333|18961302|P2|NOT COMPLETED|Overall Study||61
7700267|NCT01802333|18961303|P1|NOT COMPLETED|Overall Study||49
7700268|NCT01802333|18961301|P3|COMPLETED|Overall Study||161
7700269|NCT01802333|18961302|P2|COMPLETED|Overall Study||206
7700270|NCT01802333|18961303|P1|COMPLETED|Overall Study||214
7700271|NCT01802333|18961301|P3|Known Cytogenetic Risk at Baseline|Overall Study||210
7700272|NCT01802333|18961302|P2|Known Cytogenetic Risk at Baseline|Overall Study||250
7700273|NCT01802333|18961303|P1|Known Cytogenetic Risk at Baseline|Overall Study||252
7700274|NCT01802333|18961301|P3|Known NPM1 Status at Baseline|Overall Study||142
7700275|NCT01802333|18961302|P2|Known NPM1 Status at Baseline|Overall Study||156
7700276|NCT01802333|18961303|P1|Known NPM1 Status at Baseline|Overall Study||169
7700277|NCT01802333|18961301|P3|High Risk Patients Achieved CR/CRi|Overall Study||29
7700278|NCT01802333|18961302|P2|High Risk Patients Achieved CR/CRi|Overall Study||40
7700279|NCT01802333|18961303|P1|High Risk Patients Achieved CR/CRi|Overall Study||38
7700280|NCT01802333|18961301|P3|High Risk Patients|Overall Study||38
7700281|NCT01802333|18961302|P2|High Risk Patients|Overall Study||61
7700282|NCT01802333|18961303|P1|High Risk Patients|Overall Study||60
7700283|NCT01802333|18961301|P3|STARTED|Overall Study||224
7700284|NCT01802333|18961302|P2|STARTED|Overall Study||267
7700285|NCT01802333|18961303|P1|STARTED|Overall Study||263
7700286|NCT01802320|18961330|P1|NOT COMPLETED|Overall Study||2
7700287|NCT01802320|18961330|P1|COMPLETED|Overall Study||16
7700288|NCT01802320|18961330|P1|STARTED|Overall Study||18
7700289|NCT01802216|18961340|P2|NOT COMPLETED|12 Month Visit||4
7700290|NCT01802216|18961341|P1|NOT COMPLETED|12 Month Visit||3
7700291|NCT01802216|18961340|P2|COMPLETED|12 Month Visit||30
7700292|NCT01802216|18961341|P1|COMPLETED|12 Month Visit||14
7700293|NCT01802216|18961340|P2|STARTED|12 Month Visit||34
7700294|NCT01802216|18961341|P1|STARTED|12 Month Visit||17
7700295|NCT01802216|18961340|P2|NOT COMPLETED|8 Month Visit||5
7700296|NCT01802216|18961341|P1|NOT COMPLETED|8 Month Visit||3
7700297|NCT01802216|18961340|P2|COMPLETED|8 Month Visit||29
7700298|NCT01802216|18961341|P1|COMPLETED|8 Month Visit||14
7700299|NCT01802216|18961340|P2|STARTED|8 Month Visit||34
7700300|NCT01802216|18961341|P1|STARTED|8 Month Visit||17
7700301|NCT01802216|18961340|P2|NOT COMPLETED|4 Month Visit||4
7700302|NCT01802216|18961341|P1|NOT COMPLETED|4 Month Visit||3
7700303|NCT01802216|18961340|P2|COMPLETED|4 Month Visit||30
7700304|NCT01802216|18961341|P1|COMPLETED|4 Month Visit||14
7700305|NCT01802216|18961340|P2|STARTED|4 Month Visit||34
7700306|NCT01802216|18961341|P1|STARTED|4 Month Visit||17
7700307|NCT01802216|18961340|P2|NOT COMPLETED|Baseline||0
7700308|NCT01802216|18961341|P1|NOT COMPLETED|Baseline||0
7700309|NCT01802216|18961340|P2|COMPLETED|Baseline||34
7700310|NCT01802216|18961341|P1|COMPLETED|Baseline||17
7700311|NCT01802216|18961340|P2|STARTED|Baseline||34
7700312|NCT01802216|18961341|P1|STARTED|Baseline||17
7700313|NCT01802151|18961353|P4|NOT COMPLETED|Overall Study||0
7700314|NCT01802151|18961354|P3|NOT COMPLETED|Overall Study||2
7700315|NCT01802151|18961355|P2|NOT COMPLETED|Overall Study||0
7700316|NCT01802151|18961356|P1|NOT COMPLETED|Overall Study||0
7700317|NCT01802151|18961353|P4|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
7700318|NCT01802151|18961354|P3|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
7700319|NCT01802151|18961355|P2|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21
7700320|NCT01802151|18961356|P1|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
7700321|NCT01802151|18961353|P4|STARTED|Overall Study||20
7700322|NCT01802151|18961354|P3|STARTED|Overall Study||22
7700323|NCT01802151|18961355|P2|STARTED|Overall Study||21
7700324|NCT01802151|18961356|P1|STARTED|Overall Study||20
7700325|NCT01802073|18961420|P2|NOT COMPLETED|Overall Study||11
7700326|NCT01802073|18961421|P1|NOT COMPLETED|Overall Study||5
7700327|NCT01802073|18961420|P2|COMPLETED|Overall Study||9
7700328|NCT01802073|18961421|P1|COMPLETED|Overall Study||9
7700329|NCT01802073|18961420|P2|STARTED|Overall Study||20
7700330|NCT01802073|18961421|P1|STARTED|Overall Study||14
7700331|NCT01801982|18961437|P1|NOT COMPLETED|Overall Study||1
7700332|NCT01801982|18961437|P1|COMPLETED|Overall Study||0
7700333|NCT01801982|18961437|P1|STARTED|Overall Study||1
7700334|NCT01801917|18961451|P4|NOT COMPLETED|Extension - All Active||0
7700335|NCT01801917|18961452|P3|NOT COMPLETED|Extension - All Active||0
7700336|NCT01801917|18961453|P2|NOT COMPLETED|Extension - All Active||0
7700337|NCT01801917|18961454|P1|NOT COMPLETED|Extension - All Active||0
7700338|NCT01801917|18961451|P4|COMPLETED|Extension - All Active||0
7700339|NCT01801917|18961452|P3|COMPLETED|Extension - All Active||3
7700340|NCT01801917|18961453|P2|COMPLETED|Extension - All Active||0
7700341|NCT01801917|18961454|P1|COMPLETED|Extension - All Active||6
7700342|NCT01801917|18961451|P4|STARTED|Extension - All Active||0
7700343|NCT01801917|18961452|P3|STARTED|Extension - All Active||3
7700344|NCT01801917|18961453|P2|STARTED|Extension - All Active||0
7700345|NCT01801917|18961454|P1|STARTED|Extension - All Active||6
7700346|NCT01801917|18961451|P4|NOT COMPLETED|Period 1 - Randomized||0
7700347|NCT01801917|18961452|P3|NOT COMPLETED|Period 1 - Randomized||1
7700348|NCT01801917|18961453|P2|NOT COMPLETED|Period 1 - Randomized||0
7700349|NCT01801917|18961454|P1|NOT COMPLETED|Period 1 - Randomized||1
7700350|NCT01801917|18961451|P4|COMPLETED|Period 1 - Randomized||1
7700351|NCT01801917|18961452|P3|COMPLETED|Period 1 - Randomized||3
7700352|NCT01801917|18961453|P2|COMPLETED|Period 1 - Randomized||2
7700353|NCT01801917|18961454|P1|COMPLETED|Period 1 - Randomized||6
7700354|NCT01801917|18961451|P4|STARTED|Period 1 - Randomized||1
7700355|NCT01801917|18961452|P3|STARTED|Period 1 - Randomized||4
7700356|NCT01801917|18961453|P2|STARTED|Period 1 - Randomized||2
7700357|NCT01801917|18961454|P1|STARTED|Period 1 - Randomized||7
7700358|NCT01801865|18961474|P1|NOT COMPLETED|Overall Study||42
7700359|NCT01801865|18961474|P1|COMPLETED|Overall Study||615
7700360|NCT01801865|18961474|P1|STARTED|Overall Study||657
7700361|NCT01801735|18961479|P1|NOT COMPLETED|Overall Study||210
7700362|NCT01801735|18961479|P1|COMPLETED|Overall Study||390
7700363|NCT01801735|18961479|P1|STARTED|Overall Study||600
7700364|NCT01801475|18961486|P5|NOT COMPLETED|Overall Study||1
7700365|NCT01801475|18961487|P4|NOT COMPLETED|Overall Study||0
7700366|NCT01801475|18961488|P3|NOT COMPLETED|Overall Study||0
7700367|NCT01801475|18961489|P2|NOT COMPLETED|Overall Study||0
7700368|NCT01801475|18961490|P1|NOT COMPLETED|Overall Study||0
7700369|NCT01801475|18961486|P5|COMPLETED|Overall Study||39
7700370|NCT01801475|18961487|P4|COMPLETED|Overall Study||10
7700371|NCT01801475|18961488|P3|COMPLETED|Overall Study||10
7700372|NCT01801475|18961489|P2|COMPLETED|Overall Study||30
7700373|NCT01801475|18961490|P1|COMPLETED|Overall Study||10
7700374|NCT01801475|18961486|P5|STARTED|Overall Study||40
7700375|NCT01801475|18961487|P4|STARTED|Overall Study||10
7700376|NCT01801475|18961488|P3|STARTED|Overall Study||10
7700377|NCT01801475|18961489|P2|STARTED|Overall Study||30
7700378|NCT01801475|18961490|P1|STARTED|Overall Study||10
7700379|NCT01801449|18961501|P1|NOT COMPLETED|Overall Study||0
7700380|NCT01801449|18961501|P1|COMPLETED|Overall Study||6
7700381|NCT01801449|18961501|P1|STARTED|Overall Study||6
7700382|NCT01801436|18961515|P1|NOT COMPLETED|Overall Study||9
7700383|NCT01801436|18961515|P1|COMPLETED|Overall Study||5
7700384|NCT01801436|18961515|P1|STARTED|Overall Study||14
7700385|NCT01801358|18961553|P6|NOT COMPLETED|Overall Study||8
7700386|NCT01801358|18961554|P5|NOT COMPLETED|Overall Study||6
7700387|NCT01801358|18961555|P4|NOT COMPLETED|Overall Study||6
7700388|NCT01801358|18961556|P3|NOT COMPLETED|Overall Study||6
7700389|NCT01801358|18961557|P2|NOT COMPLETED|Overall Study||6
7700390|NCT01801358|18961558|P1|NOT COMPLETED|Overall Study||6
7700391|NCT01801358|18961553|P6|COMPLETED|Overall Study||0
7700392|NCT01801358|18961554|P5|COMPLETED|Overall Study||0
7700393|NCT01801358|18961555|P4|COMPLETED|Overall Study||0
7700394|NCT01801358|18961556|P3|COMPLETED|Overall Study||0
7700395|NCT01801358|18961557|P2|COMPLETED|Overall Study||0
7700396|NCT01801358|18961558|P1|COMPLETED|Overall Study||0
7700397|NCT01801358|18961553|P6|STARTED|Overall Study||8
7700398|NCT01801358|18961554|P5|STARTED|Overall Study||6
7700399|NCT01801358|18961555|P4|STARTED|Overall Study||6
7700400|NCT01801358|18961556|P3|STARTED|Overall Study||6
7700401|NCT01801358|18961557|P2|STARTED|Overall Study||6
7700402|NCT01801358|18961558|P1|STARTED|Overall Study||6
7700403|NCT01801280|18961680|P4|NOT COMPLETED|Period 4||0
7700404|NCT01801280|18961681|P3|NOT COMPLETED|Period 4||1
7700405|NCT01801280|18961682|P2|NOT COMPLETED|Period 4||0
7700406|NCT01801280|18961683|P1|NOT COMPLETED|Period 4||0
7700407|NCT01801280|18961680|P4|COMPLETED|Period 4||5
7700408|NCT01801280|18961681|P3|COMPLETED|Period 4||4
7700409|NCT01801280|18961682|P2|COMPLETED|Period 4||4
7700410|NCT01801280|18961683|P1|COMPLETED|Period 4||4
7700411|NCT01801280|18961680|P4|STARTED|Period 4||5
7700412|NCT01801280|18961681|P3|STARTED|Period 4||5
7700413|NCT01801280|18961682|P2|STARTED|Period 4||4
7700414|NCT01801280|18961683|P1|STARTED|Period 4||4
7700415|NCT01801280|18961680|P4|NOT COMPLETED|Period 3||0
7700416|NCT01801280|18961681|P3|NOT COMPLETED|Period 3||0
7700417|NCT01801280|18961682|P2|NOT COMPLETED|Period 3||0
7700418|NCT01801280|18961683|P1|NOT COMPLETED|Period 3||0
7700419|NCT01801280|18961680|P4|COMPLETED|Period 3||5
7700420|NCT01801280|18961681|P3|COMPLETED|Period 3||5
7700421|NCT01801280|18961682|P2|COMPLETED|Period 3||4
7700422|NCT01801280|18961683|P1|COMPLETED|Period 3||4
7700423|NCT01801280|18961680|P4|STARTED|Period 3||5
7700424|NCT01801280|18961681|P3|STARTED|Period 3||5
7700425|NCT01801280|18961682|P2|STARTED|Period 3||4
7700426|NCT01801280|18961683|P1|STARTED|Period 3||4
7700427|NCT01801280|18961680|P4|NOT COMPLETED|Period 2||0
7700428|NCT01801280|18961681|P3|NOT COMPLETED|Period 2||0
7700429|NCT01801280|18961682|P2|NOT COMPLETED|Period 2||0
7700430|NCT01801280|18961683|P1|NOT COMPLETED|Period 2||1
7700431|NCT01801280|18961680|P4|COMPLETED|Period 2||5
7700432|NCT01801280|18961681|P3|COMPLETED|Period 2||5
7700433|NCT01801280|18961682|P2|COMPLETED|Period 2||4
7700434|NCT01801280|18961683|P1|COMPLETED|Period 2||4
7700435|NCT01801280|18961680|P4|STARTED|Period 2||5
7700436|NCT01801280|18961681|P3|STARTED|Period 2||5
7700437|NCT01801280|18961682|P2|STARTED|Period 2||4
7700438|NCT01801280|18961683|P1|STARTED|Period 2||5
7700439|NCT01801280|18961680|P4|NOT COMPLETED|Period 1||0
7700440|NCT01801280|18961681|P3|NOT COMPLETED|Period 1||0
7700441|NCT01801280|18961682|P2|NOT COMPLETED|Period 1||1
7700442|NCT01801280|18961683|P1|NOT COMPLETED|Period 1||0
7700443|NCT01801280|18961680|P4|COMPLETED|Period 1||5
7700444|NCT01801280|18961681|P3|COMPLETED|Period 1||5
7700445|NCT01801280|18961682|P2|COMPLETED|Period 1||4
7700446|NCT01801280|18961683|P1|COMPLETED|Period 1||5
7700447|NCT01801280|18961680|P4|STARTED|Period 1||5
7700448|NCT01801280|18961681|P3|STARTED|Period 1||5
7700449|NCT01801280|18961682|P2|STARTED|Period 1||5
7700450|NCT01801280|18961683|P1|STARTED|Period 1|Each period lasted 10-14 weeks|5
7700451|NCT01801124|18961693|P1|NOT COMPLETED|Overall Study||0
7700452|NCT01801124|18961693|P1|COMPLETED|Overall Study||13
7700453|NCT01801124|18961693|P1|STARTED|Overall Study||13
7700454|NCT01801111|18961698|P1|NOT COMPLETED|Overall Study||138
7700455|NCT01801111|18961698|P1|COMPLETED|Overall Study||0
7700456|NCT01801111|18961698|P1|STARTED|Overall Study||138
7700457|NCT01801007|18961737|P1|NOT COMPLETED|Overall Study||11
7700458|NCT01801007|18961737|P1|COMPLETED|Overall Study||134
7700459|NCT01801007|18961737|P1|STARTED|Overall Study||145
7700460|NCT01800968|18961750|P2|NOT COMPLETED|Overall Study||32
7700461|NCT01800968|18961751|P1|NOT COMPLETED|Overall Study||36
7700462|NCT01800968|18961750|P2|COMPLETED|Overall Study||114
7700463|NCT01800968|18961751|P1|COMPLETED|Overall Study||118
7700464|NCT01800968|18961750|P2|STARTED|Overall Study||146
7700465|NCT01800968|18961751|P1|STARTED|Overall Study||154
7700466|NCT01800916|18961793|P9|NOT COMPLETED|Test Period 3 (1 Week)||0
7700467|NCT01800916|18961794|P8|NOT COMPLETED|Test Period 3 (1 Week)||0
7700468|NCT01800916|18961795|P7|NOT COMPLETED|Test Period 3 (1 Week)||0
7700469|NCT01800916|18961796|P6|NOT COMPLETED|Test Period 3 (1 Week)||0
7700470|NCT01800916|18961797|P5|NOT COMPLETED|Test Period 3 (1 Week)||0
7700471|NCT01800916|18961798|P4|NOT COMPLETED|Test Period 3 (1 Week)||0
7700472|NCT01800916|18961799|P3|NOT COMPLETED|Test Period 3 (1 Week)||0
7700473|NCT01800916|18961800|P2|NOT COMPLETED|Test Period 3 (1 Week)||0
7700474|NCT01800916|18961801|P1|NOT COMPLETED|Test Period 3 (1 Week)||0
7700475|NCT01800916|18961793|P9|COMPLETED|Test Period 3 (1 Week)||7
7700476|NCT01800916|18961794|P8|COMPLETED|Test Period 3 (1 Week)||7
7700477|NCT01800916|18961795|P7|COMPLETED|Test Period 3 (1 Week)||7
7700478|NCT01800916|18961796|P6|COMPLETED|Test Period 3 (1 Week)||7
7700479|NCT01800916|18961797|P5|COMPLETED|Test Period 3 (1 Week)||7
7700480|NCT01800916|18961798|P4|COMPLETED|Test Period 3 (1 Week)||6
7700481|NCT01800916|18961799|P3|COMPLETED|Test Period 3 (1 Week)||7
7700482|NCT01800916|18961800|P2|COMPLETED|Test Period 3 (1 Week)||7
7700483|NCT01800916|18961801|P1|COMPLETED|Test Period 3 (1 Week)||7
7700484|NCT01800916|18961793|P9|STARTED|Test Period 3 (1 Week)||7
7700485|NCT01800916|18961794|P8|STARTED|Test Period 3 (1 Week)||7
7700486|NCT01800916|18961795|P7|STARTED|Test Period 3 (1 Week)||7
7700487|NCT01800916|18961796|P6|STARTED|Test Period 3 (1 Week)||7
7700488|NCT01800916|18961797|P5|STARTED|Test Period 3 (1 Week)||7
7700489|NCT01800916|18961798|P4|STARTED|Test Period 3 (1 Week)||6
7700490|NCT01800916|18961799|P3|STARTED|Test Period 3 (1 Week)||7
7700491|NCT01800916|18961800|P2|STARTED|Test Period 3 (1 Week)||7
7700492|NCT01800916|18961801|P1|STARTED|Test Period 3 (1 Week)||7
7700493|NCT01800916|18961793|P9|NOT COMPLETED|Test Period 2 (1 Week)||0
7700494|NCT01800916|18961794|P8|NOT COMPLETED|Test Period 2 (1 Week)||0
7700495|NCT01800916|18961795|P7|NOT COMPLETED|Test Period 2 (1 Week)||0
7700496|NCT01800916|18961796|P6|NOT COMPLETED|Test Period 2 (1 Week)||0
7700497|NCT01800916|18961797|P5|NOT COMPLETED|Test Period 2 (1 Week)||0
7700498|NCT01800916|18961798|P4|NOT COMPLETED|Test Period 2 (1 Week)||0
7700499|NCT01800916|18961799|P3|NOT COMPLETED|Test Period 2 (1 Week)||0
7700500|NCT01800916|18961800|P2|NOT COMPLETED|Test Period 2 (1 Week)||0
7700501|NCT01800916|18961801|P1|NOT COMPLETED|Test Period 2 (1 Week)||0
7700502|NCT01800916|18961793|P9|COMPLETED|Test Period 2 (1 Week)||7
7700503|NCT01800916|18961794|P8|COMPLETED|Test Period 2 (1 Week)||7
7700504|NCT01800916|18961795|P7|COMPLETED|Test Period 2 (1 Week)||7
7700505|NCT01800916|18961796|P6|COMPLETED|Test Period 2 (1 Week)||7
7700506|NCT01800916|18961797|P5|COMPLETED|Test Period 2 (1 Week)||7
7700507|NCT01800916|18961798|P4|COMPLETED|Test Period 2 (1 Week)||6
7700508|NCT01800916|18961799|P3|COMPLETED|Test Period 2 (1 Week)||7
7700509|NCT01800916|18961800|P2|COMPLETED|Test Period 2 (1 Week)||7
7700510|NCT01800916|18961801|P1|COMPLETED|Test Period 2 (1 Week)||7
7700511|NCT01800916|18961793|P9|STARTED|Test Period 2 (1 Week)||7
7700512|NCT01800916|18961794|P8|STARTED|Test Period 2 (1 Week)||7
7700513|NCT01800916|18961795|P7|STARTED|Test Period 2 (1 Week)||7
7700514|NCT01800916|18961796|P6|STARTED|Test Period 2 (1 Week)||7
7700515|NCT01800916|18961797|P5|STARTED|Test Period 2 (1 Week)||7
7700516|NCT01800916|18961798|P4|STARTED|Test Period 2 (1 Week)||6
7700517|NCT01800916|18961799|P3|STARTED|Test Period 2 (1 Week)||7
7700518|NCT01800916|18961800|P2|STARTED|Test Period 2 (1 Week)||7
7700519|NCT01800916|18961801|P1|STARTED|Test Period 2 (1 Week)||7
7700520|NCT01800916|18961793|P9|NOT COMPLETED|Test Period 1 (1 Week)||0
7700521|NCT01800916|18961794|P8|NOT COMPLETED|Test Period 1 (1 Week)||0
7700522|NCT01800916|18961795|P7|NOT COMPLETED|Test Period 1 (1 Week)||0
7700523|NCT01800916|18961796|P6|NOT COMPLETED|Test Period 1 (1 Week)||0
7700524|NCT01800916|18961797|P5|NOT COMPLETED|Test Period 1 (1 Week)||1
7700525|NCT01800916|18961798|P4|NOT COMPLETED|Test Period 1 (1 Week)||1
7700526|NCT01800916|18961799|P3|NOT COMPLETED|Test Period 1 (1 Week)||0
7700527|NCT01800916|18961800|P2|NOT COMPLETED|Test Period 1 (1 Week)||0
7700528|NCT01800916|18961801|P1|NOT COMPLETED|Test Period 1 (1 Week)||0
7700529|NCT01800916|18961793|P9|COMPLETED|Test Period 1 (1 Week)||7
7700530|NCT01800916|18961794|P8|COMPLETED|Test Period 1 (1 Week)||7
7700531|NCT01800916|18961795|P7|COMPLETED|Test Period 1 (1 Week)||7
7700532|NCT01800916|18961796|P6|COMPLETED|Test Period 1 (1 Week)||7
7700533|NCT01800916|18961797|P5|COMPLETED|Test Period 1 (1 Week)||7
7700534|NCT01800916|18961798|P4|COMPLETED|Test Period 1 (1 Week)||6
7700535|NCT01800916|18961799|P3|COMPLETED|Test Period 1 (1 Week)||7
7700536|NCT01800916|18961800|P2|COMPLETED|Test Period 1 (1 Week)||7
7700537|NCT01800916|18961801|P1|COMPLETED|Test Period 1 (1 Week)||7
7700538|NCT01800916|18961793|P9|STARTED|Test Period 1 (1 Week)||7
7700539|NCT01800916|18961794|P8|STARTED|Test Period 1 (1 Week)||7
7700540|NCT01800916|18961795|P7|STARTED|Test Period 1 (1 Week)||7
7700541|NCT01800916|18961796|P6|STARTED|Test Period 1 (1 Week)||7
7700542|NCT01800916|18961797|P5|STARTED|Test Period 1 (1 Week)||8
7700543|NCT01800916|18961798|P4|STARTED|Test Period 1 (1 Week)||7
7700544|NCT01800916|18961799|P3|STARTED|Test Period 1 (1 Week)||7
7700545|NCT01800916|18961800|P2|STARTED|Test Period 1 (1 Week)||7
7700546|NCT01800916|18961801|P1|STARTED|Test Period 1 (1 Week)||7
7700547|NCT01800903|18961811|P6|NOT COMPLETED|Third Test Period||0
7700548|NCT01800903|18961812|P5|NOT COMPLETED|Third Test Period||0
7700549|NCT01800903|18961813|P4|NOT COMPLETED|Third Test Period||0
7700550|NCT01800903|18961814|P3|NOT COMPLETED|Third Test Period||0
7700551|NCT01800903|18961815|P2|NOT COMPLETED|Third Test Period||0
7700552|NCT01800903|18961816|P1|NOT COMPLETED|Third Test Period||0
7700553|NCT01800903|18961811|P6|COMPLETED|Third Test Period||6
7700554|NCT01800903|18961812|P5|COMPLETED|Third Test Period||6
7700555|NCT01800903|18961813|P4|COMPLETED|Third Test Period||7
7700556|NCT01800903|18961814|P3|COMPLETED|Third Test Period||4
7700557|NCT01800903|18961815|P2|COMPLETED|Third Test Period||6
7700558|NCT01800903|18961816|P1|COMPLETED|Third Test Period||6
7700559|NCT01800903|18961811|P6|STARTED|Third Test Period||6
7700560|NCT01800903|18961812|P5|STARTED|Third Test Period||6
7700561|NCT01800903|18961813|P4|STARTED|Third Test Period||7
7700562|NCT01800903|18961814|P3|STARTED|Third Test Period||4
7700563|NCT01800903|18961815|P2|STARTED|Third Test Period||6
7700564|NCT01800903|18961816|P1|STARTED|Third Test Period||6
7700565|NCT01800903|18961811|P6|NOT COMPLETED|Second Test Period||0
7700566|NCT01800903|18961812|P5|NOT COMPLETED|Second Test Period||0
7700567|NCT01800903|18961813|P4|NOT COMPLETED|Second Test Period||0
7700568|NCT01800903|18961814|P3|NOT COMPLETED|Second Test Period||0
7700569|NCT01800903|18961815|P2|NOT COMPLETED|Second Test Period||0
7700570|NCT01800903|18961816|P1|NOT COMPLETED|Second Test Period||1
7700571|NCT01800903|18961811|P6|COMPLETED|Second Test Period||6
7700572|NCT01800903|18961812|P5|COMPLETED|Second Test Period||6
7700573|NCT01800903|18961813|P4|COMPLETED|Second Test Period||7
7700574|NCT01800903|18961814|P3|COMPLETED|Second Test Period||4
7700575|NCT01800903|18961815|P2|COMPLETED|Second Test Period||6
7700576|NCT01800903|18961816|P1|COMPLETED|Second Test Period||6
7700577|NCT01800903|18961811|P6|STARTED|Second Test Period||6
7700578|NCT01800903|18961812|P5|STARTED|Second Test Period||6
7700579|NCT01800903|18961813|P4|STARTED|Second Test Period||7
7700580|NCT01800903|18961814|P3|STARTED|Second Test Period||4
7700581|NCT01800903|18961815|P2|STARTED|Second Test Period||6
7700582|NCT01800903|18961816|P1|STARTED|Second Test Period||7
7700583|NCT01800903|18961811|P6|NOT COMPLETED|First Test Period||0
7700584|NCT01800903|18961812|P5|NOT COMPLETED|First Test Period||0
7700585|NCT01800903|18961813|P4|NOT COMPLETED|First Test Period||0
7700586|NCT01800903|18961814|P3|NOT COMPLETED|First Test Period||0
7700587|NCT01800903|18961815|P2|NOT COMPLETED|First Test Period||0
7700588|NCT01800903|18961816|P1|NOT COMPLETED|First Test Period||0
7700589|NCT01800903|18961811|P6|COMPLETED|First Test Period||6
7700590|NCT01800903|18961812|P5|COMPLETED|First Test Period||6
7700591|NCT01800903|18961813|P4|COMPLETED|First Test Period||7
7700592|NCT01800903|18961814|P3|COMPLETED|First Test Period||4
7700593|NCT01800903|18961815|P2|COMPLETED|First Test Period||6
7700594|NCT01800903|18961816|P1|COMPLETED|First Test Period||7
7700595|NCT01800903|18961811|P6|STARTED|First Test Period||6
7700596|NCT01800903|18961812|P5|STARTED|First Test Period||6
7700597|NCT01800903|18961813|P4|STARTED|First Test Period||7
7700598|NCT01800903|18961814|P3|STARTED|First Test Period||4
7700599|NCT01800903|18961815|P2|STARTED|First Test Period||6
7700600|NCT01800903|18961816|P1|STARTED|First Test Period||7
7700601|NCT01800890|18961822|P9|NOT COMPLETED|Test Period 3||0
7700602|NCT01800890|18961823|P8|NOT COMPLETED|Test Period 3||0
7700603|NCT01800890|18961824|P7|NOT COMPLETED|Test Period 3||0
7700604|NCT01800890|18961825|P6|NOT COMPLETED|Test Period 3||0
7700605|NCT01800890|18961826|P5|NOT COMPLETED|Test Period 3||0
7700606|NCT01800890|18961827|P4|NOT COMPLETED|Test Period 3||0
7700607|NCT01800890|18961828|P3|NOT COMPLETED|Test Period 3||0
7700608|NCT01800890|18961829|P2|NOT COMPLETED|Test Period 3||0
7700609|NCT01800890|18961830|P1|NOT COMPLETED|Test Period 3||0
7700610|NCT01800890|18961822|P9|COMPLETED|Test Period 3||3
7700611|NCT01800890|18961823|P8|COMPLETED|Test Period 3||3
7700612|NCT01800890|18961824|P7|COMPLETED|Test Period 3||3
7700613|NCT01800890|18961825|P6|COMPLETED|Test Period 3||4
7700614|NCT01800890|18961826|P5|COMPLETED|Test Period 3||4
7700615|NCT01800890|18961827|P4|COMPLETED|Test Period 3||2
7700616|NCT01800890|18961828|P3|COMPLETED|Test Period 3||3
7700617|NCT01800890|18961829|P2|COMPLETED|Test Period 3||3
7700618|NCT01800890|18961830|P1|COMPLETED|Test Period 3||3
7700619|NCT01800890|18961822|P9|STARTED|Test Period 3||3
7700620|NCT01800890|18961823|P8|STARTED|Test Period 3||3
7700621|NCT01800890|18961824|P7|STARTED|Test Period 3||3
7700622|NCT01800890|18961825|P6|STARTED|Test Period 3||4
7700623|NCT01800890|18961826|P5|STARTED|Test Period 3||4
7700624|NCT01800890|18961827|P4|STARTED|Test Period 3||2
7700625|NCT01800890|18961828|P3|STARTED|Test Period 3||3
7700626|NCT01800890|18961829|P2|STARTED|Test Period 3||3
7700627|NCT01800890|18961830|P1|STARTED|Test Period 3||3
7700628|NCT01800890|18961822|P9|NOT COMPLETED|Test Period 2||0
7700629|NCT01800890|18961823|P8|NOT COMPLETED|Test Period 2||0
7700630|NCT01800890|18961824|P7|NOT COMPLETED|Test Period 2||0
7700631|NCT01800890|18961825|P6|NOT COMPLETED|Test Period 2||0
7700632|NCT01800890|18961826|P5|NOT COMPLETED|Test Period 2||0
7700633|NCT01800890|18961827|P4|NOT COMPLETED|Test Period 2||0
7700634|NCT01800890|18961828|P3|NOT COMPLETED|Test Period 2||0
7700635|NCT01800890|18961829|P2|NOT COMPLETED|Test Period 2||0
7700636|NCT01800890|18961830|P1|NOT COMPLETED|Test Period 2||0
7700637|NCT01800890|18961822|P9|COMPLETED|Test Period 2||3
7700638|NCT01800890|18961823|P8|COMPLETED|Test Period 2||3
7700639|NCT01800890|18961824|P7|COMPLETED|Test Period 2||3
7700640|NCT01800890|18961825|P6|COMPLETED|Test Period 2||4
7700641|NCT01800890|18961826|P5|COMPLETED|Test Period 2||4
7700642|NCT01800890|18961827|P4|COMPLETED|Test Period 2||2
7700643|NCT01800890|18961828|P3|COMPLETED|Test Period 2||3
7700644|NCT01800890|18961829|P2|COMPLETED|Test Period 2||3
7700645|NCT01800890|18961830|P1|COMPLETED|Test Period 2||3
7700646|NCT01800890|18961822|P9|STARTED|Test Period 2||3
7700647|NCT01800890|18961823|P8|STARTED|Test Period 2||3
7700648|NCT01800890|18961824|P7|STARTED|Test Period 2||3
7700649|NCT01800890|18961825|P6|STARTED|Test Period 2||4
7700650|NCT01800890|18961826|P5|STARTED|Test Period 2||4
7700651|NCT01800890|18961827|P4|STARTED|Test Period 2||2
7700652|NCT01800890|18961828|P3|STARTED|Test Period 2||3
7700653|NCT01800890|18961829|P2|STARTED|Test Period 2||3
7700654|NCT01800890|18961830|P1|STARTED|Test Period 2||3
7700655|NCT01800890|18961822|P9|NOT COMPLETED|Test Period 1||0
7700656|NCT01800890|18961823|P8|NOT COMPLETED|Test Period 1||0
7700657|NCT01800890|18961824|P7|NOT COMPLETED|Test Period 1||0
7700658|NCT01800890|18961825|P6|NOT COMPLETED|Test Period 1||0
7700659|NCT01800890|18961826|P5|NOT COMPLETED|Test Period 1||0
7700660|NCT01800890|18961827|P4|NOT COMPLETED|Test Period 1||1
7700661|NCT01800890|18961828|P3|NOT COMPLETED|Test Period 1||0
7700662|NCT01800890|18961829|P2|NOT COMPLETED|Test Period 1||0
7700663|NCT01800890|18961830|P1|NOT COMPLETED|Test Period 1||0
7700664|NCT01800890|18961822|P9|COMPLETED|Test Period 1||3
7700665|NCT01800890|18961823|P8|COMPLETED|Test Period 1||3
7700666|NCT01800890|18961824|P7|COMPLETED|Test Period 1||3
7700667|NCT01800890|18961825|P6|COMPLETED|Test Period 1||4
7700668|NCT01800890|18961826|P5|COMPLETED|Test Period 1||4
7700669|NCT01800890|18961827|P4|COMPLETED|Test Period 1||2
7700670|NCT01800890|18961828|P3|COMPLETED|Test Period 1||3
7700671|NCT01800890|18961829|P2|COMPLETED|Test Period 1||3
7700672|NCT01800890|18961830|P1|COMPLETED|Test Period 1||3
7700673|NCT01800890|18961822|P9|STARTED|Test Period 1||3
7700674|NCT01800890|18961823|P8|STARTED|Test Period 1||3
7700675|NCT01800890|18961824|P7|STARTED|Test Period 1||3
7700676|NCT01800890|18961825|P6|STARTED|Test Period 1||4
7700677|NCT01800890|18961826|P5|STARTED|Test Period 1||4
7700678|NCT01800890|18961827|P4|STARTED|Test Period 1||3
7700679|NCT01800890|18961828|P3|STARTED|Test Period 1||3
7700680|NCT01800890|18961829|P2|STARTED|Test Period 1||3
7700681|NCT01800890|18961830|P1|STARTED|Test Period 1||3
7700682|NCT01800877|18961842|P2|NOT COMPLETED|Overall Study||0
7700683|NCT01800877|18961843|P1|NOT COMPLETED|Overall Study||2
7700684|NCT01800877|18961842|P2|COMPLETED|Overall Study||60
7700685|NCT01800877|18961843|P1|COMPLETED|Overall Study||58
7700686|NCT01800877|18961842|P2|STARTED|Overall Study||60
7700687|NCT01800877|18961843|P1|STARTED|Overall Study||60
7700688|NCT01800838|18961853|P4|NOT COMPLETED|Overall Study||0
7700689|NCT01800838|18961854|P3|NOT COMPLETED|Overall Study||0
7700690|NCT01800838|18961855|P2|NOT COMPLETED|Overall Study||0
7700691|NCT01800838|18961856|P1|NOT COMPLETED|Overall Study||0
7700692|NCT01800838|18961853|P4|COMPLETED|Overall Study||2
7700693|NCT01800838|18961854|P3|COMPLETED|Overall Study||7
7700694|NCT01800838|18961855|P2|COMPLETED|Overall Study||1
7700695|NCT01800838|18961856|P1|COMPLETED|Overall Study||1
7700696|NCT01800838|18961853|P4|STARTED|Overall Study||2
7700697|NCT01800838|18961854|P3|STARTED|Overall Study||7
7700698|NCT01800838|18961855|P2|STARTED|Overall Study||1
7700699|NCT01800838|18961856|P1|STARTED|Overall Study||1
7700700|NCT01800786|18961863|P2|NOT COMPLETED|Overall Study||1
7700701|NCT01800786|18961864|P1|NOT COMPLETED|Overall Study||2
7700702|NCT01800786|18961863|P2|COMPLETED|Overall Study||15
7700703|NCT01800786|18961864|P1|COMPLETED|Overall Study||15
7700704|NCT01800786|18961863|P2|STARTED|Overall Study||16
7700705|NCT01800786|18961864|P1|STARTED|Overall Study||17
7700706|NCT01800318|18961874|P4|NOT COMPLETED|Overall Study||1
7700707|NCT01800318|18961875|P3|NOT COMPLETED|Overall Study||1
7700708|NCT01800318|18961876|P2|NOT COMPLETED|Overall Study||5
7700709|NCT01800318|18961877|P1|NOT COMPLETED|Overall Study||2
7700710|NCT01800318|18961874|P4|COMPLETED|Overall Study||39
7700711|NCT01800318|18961875|P3|COMPLETED|Overall Study||40
7700712|NCT01800318|18961876|P2|COMPLETED|Overall Study||37
7700713|NCT01800318|18961877|P1|COMPLETED|Overall Study||37
7700714|NCT01800318|18961874|P4|STARTED|Overall Study||40
7700715|NCT01800318|18961875|P3|STARTED|Overall Study||41
7700716|NCT01800318|18961876|P2|STARTED|Overall Study||42
7700717|NCT01800318|18961877|P1|STARTED|Overall Study||39
7700718|NCT01800201|18961905|P2|NOT COMPLETED|Overall Study||3
7700719|NCT01800201|18961906|P1|NOT COMPLETED|Overall Study||3
7700720|NCT01800201|18961905|P2|COMPLETED|Overall Study||1000
7700721|NCT01800201|18961906|P1|COMPLETED|Overall Study||503
7700722|NCT01800201|18961905|P2|STARTED|Overall Study||1003
7700723|NCT01800201|18961906|P1|STARTED|Overall Study||506
7700724|NCT01800162|18961921|P3|NOT COMPLETED|Overall Study||0
7700725|NCT01800162|18961922|P2|NOT COMPLETED|Overall Study||0
7700726|NCT01800162|18961923|P1|NOT COMPLETED|Overall Study||0
7700727|NCT01800162|18961921|P3|COMPLETED|Overall Study||1
7700728|NCT01800162|18961922|P2|COMPLETED|Overall Study||0
7700729|NCT01800162|18961923|P1|COMPLETED|Overall Study||1
7700730|NCT01800162|18961921|P3|STARTED|Overall Study|1 subject randomized to expectant management on 11/1/2013.|1
7700731|NCT01800162|18961922|P2|STARTED|Overall Study||0
7700732|NCT01800162|18961923|P1|STARTED|Overall Study|1 subject was randomized to uterine evacuation on 6/26/2013.|1
7700733|NCT01800058|18961947|P1|NOT COMPLETED|Overall Study||1
7700734|NCT01800058|18961947|P1|COMPLETED|Overall Study||65
7700735|NCT01800058|18961947|P1|STARTED|Overall Study||66
7700736|NCT01799993|18961960|P2|NOT COMPLETED|Overall Study||128
7700737|NCT01799993|18961961|P1|NOT COMPLETED|Overall Study||133
7700738|NCT01799993|18961960|P2|COMPLETED|Overall Study||235
7700739|NCT01799993|18961961|P1|COMPLETED|Overall Study||229
7700740|NCT01799993|18961960|P2|mITT Population|Overall Study||253
7700741|NCT01799993|18961961|P1|mITT Population|Overall Study||255
7700742|NCT01799993|18961960|P2|ITT Population|Overall Study||358
7700743|NCT01799993|18961961|P1|ITT Population|Overall Study||354
7700744|NCT01799993|18961960|P2|STARTED|Overall Study||363
7700745|NCT01799993|18961961|P1|STARTED|Overall Study||362
7700746|NCT01799941|18961993|P1|NOT COMPLETED|Overall Study||96
7700747|NCT01799941|18961993|P1|COMPLETED|Overall Study||271
7700748|NCT01799941|18961993|P1|STARTED|Overall Study||367
7700749|NCT01799889|18962059|P12|NOT COMPLETED|Overall Study||3
7700750|NCT01799889|18962060|P11|NOT COMPLETED|Overall Study||7
7700751|NCT01799889|18962061|P10|NOT COMPLETED|Overall Study||8
7700752|NCT01799889|18962062|P9|NOT COMPLETED|Overall Study||33
7700753|NCT01799889|18962063|P8|NOT COMPLETED|Overall Study||20
7700754|NCT01799889|18962064|P7|NOT COMPLETED|Overall Study||21
7700755|NCT01799889|18962065|P6|NOT COMPLETED|Overall Study||20
7700756|NCT01799889|18962066|P5|NOT COMPLETED|Overall Study||49
7700757|NCT01799889|18962067|P4|NOT COMPLETED|Overall Study||39
7700758|NCT01799889|18962068|P3|NOT COMPLETED|Overall Study||44
7700759|NCT01799889|18962069|P2|NOT COMPLETED|Overall Study||41
7700760|NCT01799889|18962070|P1|NOT COMPLETED|Overall Study||41
7700761|NCT01799889|18962059|P12|COMPLETED|Overall Study||0
7700762|NCT01799889|18962060|P11|COMPLETED|Overall Study||0
7700763|NCT01799889|18962061|P10|COMPLETED|Overall Study||0
7700764|NCT01799889|18962062|P9|COMPLETED|Overall Study||0
7700765|NCT01799889|18962063|P8|COMPLETED|Overall Study||0
7700766|NCT01799889|18962064|P7|COMPLETED|Overall Study||0
7700767|NCT01799889|18962065|P6|COMPLETED|Overall Study||0
7700768|NCT01799889|18962066|P5|COMPLETED|Overall Study||0
7700769|NCT01799889|18962067|P4|COMPLETED|Overall Study||0
7700770|NCT01799889|18962068|P3|COMPLETED|Overall Study||0
7700771|NCT01799889|18962069|P2|COMPLETED|Overall Study||0
7700772|NCT01799889|18962070|P1|COMPLETED|Overall Study||0
7700773|NCT01799889|18962059|P12|STARTED|Overall Study||3
7700774|NCT01799889|18962060|P11|STARTED|Overall Study||7
7700775|NCT01799889|18962061|P10|STARTED|Overall Study||8
7700776|NCT01799889|18962062|P9|STARTED|Overall Study||33
7700777|NCT01799889|18962063|P8|STARTED|Overall Study||20
7700778|NCT01799889|18962064|P7|STARTED|Overall Study||21
7700779|NCT01799889|18962065|P6|STARTED|Overall Study||20
7700780|NCT01799889|18962066|P5|STARTED|Overall Study||49
7700781|NCT01799889|18962067|P4|STARTED|Overall Study||39
7700782|NCT01799889|18962068|P3|STARTED|Overall Study||44
7700783|NCT01799889|18962069|P2|STARTED|Overall Study||41
7700784|NCT01799889|18962070|P1|STARTED|Overall Study||41
7700785|NCT01799720|18962171|P3|NOT COMPLETED|Overall Study||1
7700786|NCT01799720|18962172|P2|NOT COMPLETED|Overall Study||1
7700787|NCT01799720|18962173|P1|NOT COMPLETED|Overall Study||3
7700788|NCT01799720|18962171|P3|COMPLETED|Overall Study||18
7700789|NCT01799720|18962172|P2|COMPLETED|Overall Study||17
7700790|NCT01799720|18962173|P1|COMPLETED|Overall Study||17
7700791|NCT01799720|18962171|P3|Began the Treatment and Finished it|Overall Study||18
7700792|NCT01799720|18962172|P2|Began the Treatment and Finished it|Overall Study||17
7700793|NCT01799720|18962173|P1|Began the Treatment and Finished it|Overall Study||17
7700794|NCT01799720|18962171|P3|Began the Treatment|Overall Study||19
7700795|NCT01799720|18962172|P2|Began the Treatment|Overall Study||18
7700796|NCT01799720|18962173|P1|Began the Treatment|Overall Study||20
7700797|NCT01799720|18962171|P3|STARTED|Overall Study||19
7700798|NCT01799720|18962172|P2|STARTED|Overall Study||18
7700799|NCT01799720|18962173|P1|STARTED|Overall Study||20
7700800|NCT01799590|18962211|P3|NOT COMPLETED|Overall Study||14
7700801|NCT01799590|18962212|P2|NOT COMPLETED|Overall Study||16
7700802|NCT01799590|18962213|P1|NOT COMPLETED|Overall Study||26
7700803|NCT01799590|18962211|P3|COMPLETED|Overall Study||77
7700804|NCT01799590|18962212|P2|COMPLETED|Overall Study||78
7700805|NCT01799590|18962213|P1|COMPLETED|Overall Study||85
7700806|NCT01799590|18962211|P3|STARTED|Overall Study||91
7700807|NCT01799590|18962212|P2|STARTED|Overall Study||94
7700808|NCT01799590|18962213|P1|STARTED|Overall Study||111
7700809|NCT01799278|18962248|P1|NOT COMPLETED|Overall Study||0
7700810|NCT01799278|18962248|P1|COMPLETED|Overall Study||60
7700811|NCT01799278|18962248|P1|STARTED|Overall Study||60
7700812|NCT01799239|18962256|P2|NOT COMPLETED|Period 2 (7 Days)||1
7700813|NCT01799239|18962257|P1|NOT COMPLETED|Period 2 (7 Days)||2
7700814|NCT01799239|18962256|P2|COMPLETED|Period 2 (7 Days)||14
7700815|NCT01799239|18962257|P1|COMPLETED|Period 2 (7 Days)||11
7700816|NCT01799239|18962256|P2|STARTED|Period 2 (7 Days)||15
7700817|NCT01799239|18962257|P1|STARTED|Period 2 (7 Days)||13
7700818|NCT01799239|18962256|P2|NOT COMPLETED|Period 1 (7 Days)||1
7700819|NCT01799239|18962257|P1|NOT COMPLETED|Period 1 (7 Days)||3
7700820|NCT01799239|18962256|P2|COMPLETED|Period 1 (7 Days)||15
7700821|NCT01799239|18962257|P1|COMPLETED|Period 1 (7 Days)||12
7700822|NCT01799239|18962256|P2|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16
7700823|NCT01799239|18962257|P1|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15
7700824|NCT01799226|18962265|P2|NOT COMPLETED|Overall Study||0
7700825|NCT01799226|18962266|P1|NOT COMPLETED|Overall Study||2
7700826|NCT01799226|18962265|P2|COMPLETED|Overall Study||16
7700827|NCT01799226|18962266|P1|COMPLETED|Overall Study||14
7700828|NCT01799226|18962265|P2|Left Stent Side|Overall Study||8
7700829|NCT01799226|18962266|P1|Left Stent Side|Overall Study||8
7700830|NCT01799226|18962265|P2|Right Stent Side|Overall Study||8
7700831|NCT01799226|18962266|P1|Right Stent Side|Overall Study||8
7700832|NCT01799226|18962265|P2|STARTED|Overall Study||16
7700833|NCT01799226|18962266|P1|STARTED|Overall Study||16
7700834|NCT01799213|18962276|P2|NOT COMPLETED|Overall Study||6
7700835|NCT01799213|18962277|P1|NOT COMPLETED|Overall Study||7
7700836|NCT01799213|18962276|P2|COMPLETED|Overall Study||178
7700837|NCT01799213|18962277|P1|COMPLETED|Overall Study||173
7700838|NCT01799213|18962276|P2|STARTED|Overall Study||184
7700839|NCT01799213|18962277|P1|STARTED|Overall Study||180
7700840|NCT01798992|18962297|P4|NOT COMPLETED|Overall Study||1
7700841|NCT01798992|18962298|P3|NOT COMPLETED|Overall Study||2
7700842|NCT01798992|18962299|P2|NOT COMPLETED|Overall Study||2
7700843|NCT01798992|18962300|P1|NOT COMPLETED|Overall Study||0
7700844|NCT01798992|18962297|P4|COMPLETED|Overall Study||16
7700845|NCT01798992|18962298|P3|COMPLETED|Overall Study||14
7700846|NCT01798992|18962299|P2|COMPLETED|Overall Study||17
7700847|NCT01798992|18962300|P1|COMPLETED|Overall Study||4
7700848|NCT01798992|18962297|P4|STARTED|Overall Study||17
7700849|NCT01798992|18962298|P3|STARTED|Overall Study||16
7700850|NCT01798992|18962299|P2|STARTED|Overall Study||19
7700851|NCT01798992|18962300|P1|STARTED|Overall Study||4
7700852|NCT01798966|18962314|P1|NOT COMPLETED|Overall Study||0
7700853|NCT01798966|18962314|P1|COMPLETED|Overall Study||10
7700854|NCT01798966|18962314|P1|STARTED|Overall Study||10
7700855|NCT01798927|18962320|P1|NOT COMPLETED|Overall Study||1
7700856|NCT01798927|18962320|P1|COMPLETED|Overall Study||3
7700857|NCT01798927|18962320|P1|STARTED|Overall Study||4
7700858|NCT01798849|18962329|P3|NOT COMPLETED|Overall Study||1
7700859|NCT01798849|18962330|P2|NOT COMPLETED|Overall Study||0
7700860|NCT01798849|18962331|P1|NOT COMPLETED|Overall Study||0
7700861|NCT01798849|18962329|P3|COMPLETED|Overall Study||8
7700862|NCT01798849|18962330|P2|COMPLETED|Overall Study||8
7700863|NCT01798849|18962331|P1|COMPLETED|Overall Study||8
7700864|NCT01798849|18962329|P3|STARTED|Overall Study|1 participant discontinued after Period 1 and was replaced for Periods 2-4|9
7700865|NCT01798849|18962330|P2|STARTED|Overall Study||8
7700866|NCT01798849|18962331|P1|STARTED|Overall Study||8
7700867|NCT01798706|18962521|P2|NOT COMPLETED|Overall Study||21
7700868|NCT01798706|18962522|P1|NOT COMPLETED|Overall Study||21
7700869|NCT01798706|18962521|P2|COMPLETED|Overall Study||153
7700870|NCT01798706|18962522|P1|COMPLETED|Overall Study||155
7700871|NCT01798706|18962521|P2|STARTED|Overall Study||174
7700872|NCT01798706|18962522|P1|STARTED|Overall Study||176
7700873|NCT01798641|18962550|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
7700874|NCT01798641|18962551|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
7700875|NCT01798641|18962550|P2|COMPLETED|Second Intervention (6 Weeks)||19
7700876|NCT01798641|18962551|P1|COMPLETED|Second Intervention (6 Weeks)||19
7700877|NCT01798641|18962550|P2|STARTED|Second Intervention (6 Weeks)||19
7700878|NCT01798641|18962551|P1|STARTED|Second Intervention (6 Weeks)||19
7700879|NCT01798641|18962550|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
7700880|NCT01798641|18962551|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
7700881|NCT01798641|18962550|P2|COMPLETED|First Intervention (6 Weeks)||19
7700882|NCT01798641|18962551|P1|COMPLETED|First Intervention (6 Weeks)||19
7700883|NCT01798641|18962550|P2|STARTED|First Intervention (6 Weeks)||19
7700884|NCT01798641|18962551|P1|STARTED|First Intervention (6 Weeks)||19
7700885|NCT01798589|18962565|P1|NOT COMPLETED|Overall Study||0
7700886|NCT01798589|18962565|P1|COMPLETED|Overall Study||16
7700887|NCT01798589|18962565|P1|STARTED|Overall Study||16
7700888|NCT01798550|18962576|P2|NOT COMPLETED|Overall Study||6
7700889|NCT01798550|18962577|P1|NOT COMPLETED|Overall Study||2
7700890|NCT01798550|18962576|P2|COMPLETED|Overall Study||26
7700891|NCT01798550|18962577|P1|COMPLETED|Overall Study||28
7700892|NCT01798550|18962576|P2|STARTED|Overall Study||32
7700893|NCT01798550|18962577|P1|STARTED|Overall Study||30
7700894|NCT01798485|18962593|P2|NOT COMPLETED|Overall Study||290
7700895|NCT01798485|18962594|P1|NOT COMPLETED|Overall Study||346
7700896|NCT01798485|18962593|P2|COMPLETED|Overall Study||59
7700897|NCT01798485|18962594|P1|COMPLETED|Overall Study||1
7700898|NCT01798485|18962593|P2|Randomized as of 19 October 2015|Overall Study||337
7700899|NCT01798485|18962594|P1|Randomized as of 19 October 2015|Overall Study||335
7700900|NCT01798485|18962593|P2|Safety Population as of 23 Dec 2015|Overall Study||342
7700901|NCT01798485|18962594|P1|Safety Population as of 23 Dec 2015|Overall Study||338
7700902|NCT01798485|18962593|P2|STARTED|Overall Study||349
7700903|NCT01798485|18962594|P1|STARTED|Overall Study||347
7700904|NCT01798394|18962630|P2|NOT COMPLETED|Overall Study||3
7700905|NCT01798394|18962631|P1|NOT COMPLETED|Overall Study||3
7700906|NCT01798394|18962630|P2|COMPLETED|Overall Study||19
7700907|NCT01798394|18962631|P1|COMPLETED|Overall Study||21
7700908|NCT01798394|18962630|P2|STARTED|Overall Study||22
7700909|NCT01798394|18962631|P1|STARTED|Overall Study||24
7700910|NCT01798316|18962651|P2|NOT COMPLETED|Overall Study||0
7700911|NCT01798316|18962652|P1|NOT COMPLETED|Overall Study||0
7700912|NCT01798316|18962651|P2|COMPLETED|Overall Study||53
7700913|NCT01798316|18962652|P1|COMPLETED|Overall Study||52
7700914|NCT01798316|18962651|P2|STARTED|Overall Study||53
7700915|NCT01798316|18962652|P1|STARTED|Overall Study||52
7700916|NCT01798264|18962674|P4|NOT COMPLETED|Overall Study||4
7700917|NCT01798264|18962675|P3|NOT COMPLETED|Overall Study||0
7700918|NCT01798264|18962676|P2|NOT COMPLETED|Overall Study||0
7700919|NCT01798264|18962677|P1|NOT COMPLETED|Overall Study||1
7700920|NCT01798264|18962674|P4|COMPLETED|Overall Study||7
7700921|NCT01798264|18962675|P3|COMPLETED|Overall Study||10
7700922|NCT01798264|18962676|P2|COMPLETED|Overall Study||11
7700923|NCT01798264|18962677|P1|COMPLETED|Overall Study||11
7700924|NCT01798264|18962674|P4|STARTED|Overall Study||11
7700925|NCT01798264|18962675|P3|STARTED|Overall Study||10
7700926|NCT01798264|18962676|P2|STARTED|Overall Study||11
7700927|NCT01798264|18962677|P1|STARTED|Overall Study||12
7700928|NCT01798225|18962701|P2|NOT COMPLETED|Overall Study||3
7700929|NCT01798225|18962702|P1|NOT COMPLETED|Overall Study||0
7700930|NCT01798225|18962701|P2|COMPLETED|Overall Study||53
7700931|NCT01798225|18962702|P1|COMPLETED|Overall Study||57
7700932|NCT01798225|18962701|P2|STARTED|Overall Study||56
7700933|NCT01798225|18962702|P1|STARTED|Overall Study||57
7700934|NCT01798186|18962714|P4|NOT COMPLETED|Overall Study||0
7700935|NCT01798186|18962715|P3|NOT COMPLETED|Overall Study||0
7700936|NCT01798186|18962716|P2|NOT COMPLETED|Overall Study||0
7700937|NCT01798186|18962717|P1|NOT COMPLETED|Overall Study||0
7700938|NCT01798186|18962714|P4|COMPLETED|Overall Study||8
7700939|NCT01798186|18962715|P3|COMPLETED|Overall Study||6
7700940|NCT01798186|18962716|P2|COMPLETED|Overall Study||6
7700941|NCT01798186|18962717|P1|COMPLETED|Overall Study||6
7700942|NCT01798186|18962714|P4|STARTED|Overall Study||8
7700943|NCT01798186|18962715|P3|STARTED|Overall Study||6
7700944|NCT01798186|18962716|P2|STARTED|Overall Study||6
7700945|NCT01798186|18962717|P1|STARTED|Overall Study||6
7700946|NCT01798134|18962731|P1|NOT COMPLETED|Overall Study||16
7700947|NCT01798134|18962731|P1|COMPLETED|Overall Study||9
7700948|NCT01798134|18962731|P1|STARTED|Overall Study||25
7700949|NCT01798056|18962740|P2|NOT COMPLETED|Overall Study||25
7700950|NCT01798056|18962741|P1|NOT COMPLETED|Overall Study||27
7700951|NCT01798056|18962740|P2|COMPLETED|Overall Study||90
7700952|NCT01798056|18962741|P1|COMPLETED|Overall Study||90
7700953|NCT01798056|18962740|P2|STARTED|Overall Study||115
7700954|NCT01798056|18962741|P1|STARTED|Overall Study||117
7700955|NCT01798004|18962775|P1|NOT COMPLETED|Overall Study||87
7700956|NCT01798004|18962775|P1|COMPLETED|Overall Study||63
7700957|NCT01798004|18962775|P1|STARTED|Overall Study||150
7700958|NCT01797965|18962783|P4|NOT COMPLETED|Overall Study||73
7700959|NCT01797965|18962784|P3|NOT COMPLETED|Overall Study||8
7700960|NCT01797965|18962785|P2|NOT COMPLETED|Overall Study||569
7700961|NCT01797965|18962786|P1|NOT COMPLETED|Overall Study||549
7700962|NCT01797965|18962783|P4|COMPLETED|Overall Study||154
7700963|NCT01797965|18962784|P3|COMPLETED|Overall Study||62
7700964|NCT01797965|18962785|P2|COMPLETED|Overall Study||38
7700965|NCT01797965|18962786|P1|COMPLETED|Overall Study||48
7700966|NCT01797965|18962783|P4|STARTED|Overall Study||227
7700967|NCT01797965|18962784|P3|STARTED|Overall Study||70
7700968|NCT01797965|18962785|P2|STARTED|Overall Study||607
7700969|NCT01797965|18962786|P1|STARTED|Overall Study||597
7700970|NCT01797835|18962920|P2|NOT COMPLETED|Overall Study||27
7700971|NCT01797835|18962921|P1|NOT COMPLETED|Overall Study||31
7700972|NCT01797835|18962920|P2|COMPLETED|Overall Study||114
7700973|NCT01797835|18962921|P1|COMPLETED|Overall Study||122
7700974|NCT01797835|18962920|P2|STARTED|Overall Study||141
7700975|NCT01797835|18962921|P1|STARTED|Overall Study||153
7700976|NCT01797822|18962929|P1|NOT COMPLETED|Overall Study||0
7700977|NCT01797822|18962929|P1|COMPLETED|Overall Study|The protocol is now closed.|20
7700978|NCT01797822|18962929|P1|STARTED|Overall Study||20
7700979|NCT01797783|18962937|P2|NOT COMPLETED|Overall Study||1
7700980|NCT01797783|18962938|P1|NOT COMPLETED|Overall Study||2
7700981|NCT01797783|18962937|P2|COMPLETED|Overall Study||26
7700982|NCT01797783|18962938|P1|COMPLETED|Overall Study||50
7700983|NCT01797783|18962937|P2|STARTED|Overall Study||27
7700984|NCT01797783|18962938|P1|STARTED|Overall Study||52
7700985|NCT01797731|18962962|P2|NOT COMPLETED|Overall Study||3
7700986|NCT01797731|18962963|P1|NOT COMPLETED|Overall Study||3
7700987|NCT01797731|18962962|P2|COMPLETED|Overall Study|3 excluded due to not having proper radiographs for adequate follow up|47
7700988|NCT01797731|18962963|P1|COMPLETED|Overall Study|3 were excluded due to not having proper radiographs for adequate follow up|47
7700989|NCT01797731|18962962|P2|STARTED|Overall Study||50
7700990|NCT01797731|18962963|P1|STARTED|Overall Study||50
7700991|NCT01797705|18962971|P1|NOT COMPLETED|Overall Study||5
7700992|NCT01797705|18962971|P1|COMPLETED|Overall Study||28
7700993|NCT01797705|18962971|P1|STARTED|Overall Study||33
7700994|NCT01797575|18962979|P4|NOT COMPLETED|Week 8 Re-Randomization||3
7700995|NCT01797575|18962980|P3|NOT COMPLETED|Week 8 Re-Randomization||1
7700996|NCT01797575|18962981|P2|NOT COMPLETED|Week 8 Re-Randomization||0
7700997|NCT01797575|18962982|P1|NOT COMPLETED|Week 8 Re-Randomization||0
7700998|NCT01797575|18962979|P4|COMPLETED|Week 8 Re-Randomization||7
7700999|NCT01797575|18962980|P3|COMPLETED|Week 8 Re-Randomization||4
7701000|NCT01797575|18962981|P2|COMPLETED|Week 8 Re-Randomization||5
7701001|NCT01797575|18962982|P1|COMPLETED|Week 8 Re-Randomization||4
7701002|NCT01797575|18962979|P4|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|10
7701003|NCT01797575|18962980|P3|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
7701004|NCT01797575|18962981|P2|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
7701005|NCT01797575|18962982|P1|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|4
7701006|NCT01797575|18962979|P4|NOT COMPLETED|Baseline Allocation||7
7701007|NCT01797575|18962980|P3|NOT COMPLETED|Baseline Allocation||5
7701008|NCT01797575|18962981|P2|NOT COMPLETED|Baseline Allocation||1
7701009|NCT01797575|18962982|P1|NOT COMPLETED|Baseline Allocation||1
7701010|NCT01797575|18962979|P4|COMPLETED|Baseline Allocation||8
7701011|NCT01797575|18962980|P3|COMPLETED|Baseline Allocation||4
7701012|NCT01797575|18962981|P2|COMPLETED|Baseline Allocation||8
7701013|NCT01797575|18962982|P1|COMPLETED|Baseline Allocation||4
7701014|NCT01797575|18962979|P4|STARTED|Baseline Allocation||15
7701015|NCT01797575|18962980|P3|STARTED|Baseline Allocation||9
7701016|NCT01797575|18962981|P2|STARTED|Baseline Allocation||9
7701017|NCT01797575|18962982|P1|STARTED|Baseline Allocation||5
7701018|NCT01797562|18963032|P1|NOT COMPLETED|Overall Study||5
7701019|NCT01797562|18963032|P1|COMPLETED|Overall Study||111
7701020|NCT01797562|18963032|P1|STARTED|Overall Study||116
7701021|NCT01797536|18963041|P4|NOT COMPLETED|Overall Study||0
7701022|NCT01797536|18963042|P3|NOT COMPLETED|Overall Study||0
7701023|NCT01797536|18963043|P2|NOT COMPLETED|Overall Study||1
7701024|NCT01797536|18963044|P1|NOT COMPLETED|Overall Study||0
7701025|NCT01797536|18963041|P4|COMPLETED|Overall Study||8
7701026|NCT01797536|18963042|P3|COMPLETED|Overall Study||7
7701027|NCT01797536|18963043|P2|COMPLETED|Overall Study||10
7701028|NCT01797536|18963044|P1|COMPLETED|Overall Study||8
7701029|NCT01797536|18963041|P4|STARTED|Overall Study||8
7701030|NCT01797536|18963042|P3|STARTED|Overall Study||7
7701031|NCT01797536|18963043|P2|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11
7701032|NCT01797536|18963044|P1|STARTED|Overall Study||8
7701033|NCT01797484|18963076|P2|NOT COMPLETED|Overall Study||0
7701034|NCT01797484|18963077|P1|NOT COMPLETED|Overall Study||0
7701035|NCT01797484|18963076|P2|COMPLETED|Overall Study||10
7701036|NCT01797484|18963077|P1|COMPLETED|Overall Study||10
7701037|NCT01797484|18963076|P2|STARTED|Overall Study||10
7701038|NCT01797484|18963077|P1|STARTED|Overall Study||10
7701039|NCT01797471|18963083|P1|NOT COMPLETED|Overall Study||0
7701040|NCT01797471|18963083|P1|COMPLETED|Overall Study||1
7701041|NCT01797471|18963083|P1|STARTED|Overall Study||1
7701042|NCT01797458|18963095|P3|NOT COMPLETED|Overall Study||7
7701043|NCT01797458|18963096|P2|NOT COMPLETED|Overall Study||9
7701044|NCT01797458|18963097|P1|NOT COMPLETED|Overall Study||12
7701045|NCT01797458|18963095|P3|COMPLETED|Overall Study||58
7701046|NCT01797458|18963096|P2|COMPLETED|Overall Study||43
7701047|NCT01797458|18963097|P1|COMPLETED|Overall Study||40
7701048|NCT01797458|18963095|P3|STARTED|Overall Study||65
7701049|NCT01797458|18963096|P2|STARTED|Overall Study||52
7701050|NCT01797458|18963097|P1|STARTED|Overall Study||52
7701051|NCT01797445|18963116|P2|NOT COMPLETED|Open-Label Extension Phase||0
7701052|NCT01797445|18963117|P1|NOT COMPLETED|Open-Label Extension Phase||1
7701053|NCT01797445|18963116|P2|COMPLETED|Open-Label Extension Phase||119
7701054|NCT01797445|18963117|P1|COMPLETED|Open-Label Extension Phase||140
7701055|NCT01797445|18963116|P2|STARTED|Open-Label Extension Phase|229 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|119
7701056|NCT01797445|18963117|P1|STARTED|Open-Label Extension Phase|207 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|141
7701057|NCT01797445|18963116|P2|NOT COMPLETED|Double-Blind Phase||89
7701058|NCT01797445|18963117|P1|NOT COMPLETED|Double-Blind Phase||87
7701059|NCT01797445|18963116|P2|COMPLETED|Double-Blind Phase||348
7701060|NCT01797445|18963117|P1|COMPLETED|Double-Blind Phase||348
7701061|NCT01797445|18963116|P2|STARTED|Double-Blind Phase||437
7701062|NCT01797445|18963117|P1|STARTED|Double-Blind Phase||435
7701063|NCT01797380|18963159|P2|NOT COMPLETED|Overall Study||2
7701064|NCT01797380|18963160|P1|NOT COMPLETED|Overall Study||3
7701065|NCT01797380|18963159|P2|COMPLETED|Overall Study||0
7701066|NCT01797380|18963160|P1|COMPLETED|Overall Study|Terminated due to lack of enrollment|0
7701067|NCT01797380|18963159|P2|STARTED|Overall Study||2
7701068|NCT01797380|18963160|P1|STARTED|Overall Study|Terminated due to lack of enrollment|3
7701069|NCT01797328|18963168|P2|NOT COMPLETED|Overall Study||0
7701070|NCT01797328|18963169|P1|NOT COMPLETED|Overall Study||2
7701071|NCT01797328|18963168|P2|COMPLETED|Overall Study||12
7701072|NCT01797328|18963169|P1|COMPLETED|Overall Study||14
7701073|NCT01797328|18963168|P2|STARTED|Overall Study||12
7701074|NCT01797328|18963169|P1|STARTED|Overall Study||16
7701075|NCT01797302|18963178|P3|NOT COMPLETED|Overall Study||26
7701076|NCT01797302|18963179|P2|NOT COMPLETED|Overall Study||26
7701077|NCT01797302|18963180|P1|NOT COMPLETED|Overall Study||17
7701078|NCT01797302|18963178|P3|COMPLETED|Overall Study||50
7701079|NCT01797302|18963179|P2|COMPLETED|Overall Study||48
7701080|NCT01797302|18963180|P1|COMPLETED|Overall Study||58
7701081|NCT01797302|18963178|P3|3 Month Visit|Overall Study||57
7701082|NCT01797302|18963179|P2|3 Month Visit|Overall Study||57
7701083|NCT01797302|18963180|P1|3 Month Visit|Overall Study||60
7701084|NCT01797302|18963178|P3|STARTED|Overall Study||76
7701085|NCT01797302|18963179|P2|STARTED|Overall Study||74
7701086|NCT01797302|18963180|P1|STARTED|Overall Study||75
7701087|NCT01797263|18963217|P2|NOT COMPLETED|Overall Study||40
7701088|NCT01797263|18963218|P1|NOT COMPLETED|Overall Study||37
7701089|NCT01797263|18963217|P2|COMPLETED|Overall Study||87
7701090|NCT01797263|18963218|P1|COMPLETED|Overall Study||92
7701091|NCT01797263|18963217|P2|9 Month|Overall Study||87
7701092|NCT01797263|18963218|P1|9 Month|Overall Study||92
7701093|NCT01797263|18963217|P2|6 Month|Overall Study||85
7701094|NCT01797263|18963218|P1|6 Month|Overall Study||90
7701095|NCT01797263|18963217|P2|3 Month|Overall Study||84
7701096|NCT01797263|18963218|P1|3 Month|Overall Study||87
7701097|NCT01797263|18963217|P2|1 Month|Overall Study||87
7701098|NCT01797263|18963218|P1|1 Month|Overall Study||96
7701099|NCT01797263|18963217|P2|STARTED|Overall Study||127
7701100|NCT01797263|18963218|P1|STARTED|Overall Study||129
7701101|NCT01797185|18963253|P3|NOT COMPLETED|Overall Study||12
7701102|NCT01797185|18963254|P2|NOT COMPLETED|Overall Study||38
7701103|NCT01797185|18963255|P1|NOT COMPLETED|Overall Study||28
7701104|NCT01797185|18963253|P3|COMPLETED|Overall Study||38
7701105|NCT01797185|18963254|P2|COMPLETED|Overall Study||125
7701106|NCT01797185|18963255|P1|COMPLETED|Overall Study||134
7701107|NCT01797185|18963253|P3|STARTED|Overall Study||50
7701108|NCT01797185|18963254|P2|STARTED|Overall Study||163
7701109|NCT01797185|18963255|P1|STARTED|Overall Study||162
7701110|NCT01797159|18963263|P1|NOT COMPLETED|Overall Study||0
7701111|NCT01797159|18963263|P1|COMPLETED|Overall Study||20
7701112|NCT01797159|18963263|P1|STARTED|Overall Study||20
7701113|NCT01797120|18963279|P2|NOT COMPLETED|Overall Study||65
7701114|NCT01797120|18963280|P1|NOT COMPLETED|Overall Study||66
7701115|NCT01797120|18963279|P2|COMPLETED|Overall Study||0
7701116|NCT01797120|18963280|P1|COMPLETED|Overall Study||0
7701117|NCT01797120|18963279|P2|STARTED|Overall Study||65
7701118|NCT01797120|18963280|P1|STARTED|Overall Study||66
7701119|NCT01797094|18963294|P2|NOT COMPLETED|Overall Study||2
7701120|NCT01797094|18963295|P1|NOT COMPLETED|Overall Study||6
7701121|NCT01797094|18963294|P2|COMPLETED|Overall Study||51
7701122|NCT01797094|18963295|P1|COMPLETED|Overall Study||42
7701123|NCT01797094|18963294|P2|STARTED|Overall Study||53
7701124|NCT01797094|18963295|P1|STARTED|Overall Study||48
7701125|NCT01797081|18963317|P4|NOT COMPLETED|Overall Study||9
7701126|NCT01797081|18963318|P3|NOT COMPLETED|Overall Study||5
7701127|NCT01797081|18963319|P2|NOT COMPLETED|Overall Study||4
7701128|NCT01797081|18963320|P1|NOT COMPLETED|Overall Study||14
7701129|NCT01797081|18963317|P4|COMPLETED|Overall Study||40
7701130|NCT01797081|18963318|P3|COMPLETED|Overall Study||43
7701131|NCT01797081|18963319|P2|COMPLETED|Overall Study||95
7701132|NCT01797081|18963320|P1|COMPLETED|Overall Study||90
7701133|NCT01797081|18963317|P4|STARTED|Overall Study||49
7701134|NCT01797081|18963318|P3|STARTED|Overall Study||48
7701135|NCT01797081|18963319|P2|STARTED|Overall Study||99
7701136|NCT01797081|18963320|P1|STARTED|Overall Study||104
7701137|NCT01797029|18963339|P2|NOT COMPLETED|Overall Study||61
7701138|NCT01797029|18963340|P1|NOT COMPLETED|Overall Study||159
7701139|NCT01797029|18963339|P2|COMPLETED|Overall Study||526
7701140|NCT01797029|18963340|P1|COMPLETED|Overall Study||1015
7701141|NCT01797029|18963339|P2|STARTED|Overall Study||587
7701142|NCT01797029|18963340|P1|STARTED|Overall Study||1174
7701143|NCT01796977|18963348|P1|NOT COMPLETED|Overall Study||0
7701144|NCT01796977|18963348|P1|COMPLETED|Overall Study||27
7701145|NCT01796977|18963348|P1|STARTED|Overall Study||27
7701146|NCT01796964|18963361|P2|NOT COMPLETED|Overall Study||3
7701147|NCT01796964|18963362|P1|NOT COMPLETED|Overall Study||3
7701148|NCT01796964|18963361|P2|COMPLETED|Overall Study||42
7701149|NCT01796964|18963362|P1|COMPLETED|Overall Study||41
7701150|NCT01796964|18963361|P2|STARTED|Overall Study||45
7701151|NCT01796964|18963362|P1|STARTED|Overall Study||44
7701152|NCT01796912|18963384|P2|NOT COMPLETED|Second Intervention||0
7701153|NCT01796912|18963385|P1|NOT COMPLETED|Second Intervention||0
7701154|NCT01796912|18963384|P2|COMPLETED|Second Intervention||10
7701155|NCT01796912|18963385|P1|COMPLETED|Second Intervention||10
7701156|NCT01796912|18963384|P2|STARTED|Second Intervention||10
7701157|NCT01796912|18963385|P1|STARTED|Second Intervention||10
7701158|NCT01796912|18963384|P2|NOT COMPLETED|Washout||0
7701159|NCT01796912|18963385|P1|NOT COMPLETED|Washout||0
7701160|NCT01796912|18963384|P2|COMPLETED|Washout||10
7701161|NCT01796912|18963385|P1|COMPLETED|Washout||10
7701162|NCT01796912|18963384|P2|STARTED|Washout||10
7701163|NCT01796912|18963385|P1|STARTED|Washout||10
7701164|NCT01796912|18963384|P2|NOT COMPLETED|First Intervention||0
7701165|NCT01796912|18963385|P1|NOT COMPLETED|First Intervention||0
7701166|NCT01796912|18963384|P2|COMPLETED|First Intervention||10
7701167|NCT01796912|18963385|P1|COMPLETED|First Intervention||10
7701168|NCT01796912|18963384|P2|STARTED|First Intervention||10
7701169|NCT01796912|18963385|P1|STARTED|First Intervention||10
7701170|NCT01796860|18963403|P1|NOT COMPLETED|Overall Study||3
7701171|NCT01796860|18963403|P1|COMPLETED|Overall Study||7
7701172|NCT01796860|18963403|P1|STARTED|Overall Study||10
7701173|NCT01796548|18963409|P1|NOT COMPLETED|Overall Study||3
7701174|NCT01796548|18963409|P1|COMPLETED|Overall Study||14
7701175|NCT01796548|18963409|P1|Treated|Overall Study||15
7701176|NCT01796548|18963409|P1|STARTED|Overall Study||17
7701177|NCT01796470|18963426|P5|NOT COMPLETED|Overall Study||8
7701178|NCT01796470|18963427|P4|NOT COMPLETED|Overall Study||3
7701179|NCT01796470|18963428|P3|NOT COMPLETED|Overall Study||6
7701180|NCT01796470|18963429|P2|NOT COMPLETED|Overall Study||14
7701181|NCT01796470|18963430|P1|NOT COMPLETED|Overall Study||35
7701182|NCT01796470|18963426|P5|COMPLETED|Overall Study||0
7701183|NCT01796470|18963427|P4|COMPLETED|Overall Study||0
7701184|NCT01796470|18963428|P3|COMPLETED|Overall Study||0
7701185|NCT01796470|18963429|P2|COMPLETED|Overall Study||0
7701186|NCT01796470|18963430|P1|COMPLETED|Overall Study||0
7701187|NCT01796470|18963426|P5|Entospletinib Monotherapy|Overall Study||0
7701188|NCT01796470|18963427|P4|Entospletinib Monotherapy|Overall Study||0
7701189|NCT01796470|18963428|P3|Entospletinib Monotherapy|Overall Study||0
7701190|NCT01796470|18963429|P2|Entospletinib Monotherapy|Overall Study||4
7701191|NCT01796470|18963430|P1|Entospletinib Monotherapy|Overall Study||4
7701192|NCT01796470|18963426|P5|STARTED|Overall Study||8
7701193|NCT01796470|18963427|P4|STARTED|Overall Study||3
7701194|NCT01796470|18963428|P3|STARTED|Overall Study||6
7701195|NCT01796470|18963429|P2|STARTED|Overall Study||14
7701196|NCT01796470|18963430|P1|STARTED|Overall Study||35
7701197|NCT01796392|18963474|P2|NOT COMPLETED|Overall Study||3
7701198|NCT01796392|18963475|P1|NOT COMPLETED|Overall Study||9
7701199|NCT01796392|18963474|P2|COMPLETED|Overall Study|59 active subjects at 12-months|59
7701200|NCT01796392|18963475|P1|COMPLETED|Overall Study|119 active subjects at 12-months|119
7701201|NCT01796392|18963474|P2|STARTED|Overall Study||62
7701202|NCT01796392|18963475|P1|STARTED|Overall Study||128
7701203|NCT01796301|18963489|P2|NOT COMPLETED|Overall Study||20
7701204|NCT01796301|18963490|P1|NOT COMPLETED|Overall Study||18
7701205|NCT01796301|18963489|P2|COMPLETED|Overall Study||198
7701206|NCT01796301|18963490|P1|COMPLETED|Overall Study||200
7701207|NCT01796301|18963489|P2|Received Treatment|Overall Study||218
7701208|NCT01796301|18963490|P1|Received Treatment|Overall Study||214
7701209|NCT01796301|18963489|P2|STARTED|Overall Study||218
7701210|NCT01796301|18963490|P1|STARTED|Overall Study||218
7701211|NCT01796236|18963526|P2|NOT COMPLETED|Overall Study||2
7701212|NCT01796236|18963527|P1|NOT COMPLETED|Overall Study||2
7701213|NCT01796236|18963526|P2|COMPLETED|Overall Study||50
7701214|NCT01796236|18963527|P1|COMPLETED|Overall Study||49
7701215|NCT01796236|18963526|P2|STARTED|Overall Study||52
7701216|NCT01796236|18963527|P1|STARTED|Overall Study||51
7701217|NCT01795937|18963576|P3|NOT COMPLETED|Overall Study||0
7701218|NCT01795937|18963577|P2|NOT COMPLETED|Overall Study||1
7701219|NCT01795937|18963578|P1|NOT COMPLETED|Overall Study||1
7701220|NCT01795937|18963576|P3|COMPLETED|Overall Study||17
7701221|NCT01795937|18963577|P2|COMPLETED|Overall Study||15
7701222|NCT01795937|18963578|P1|COMPLETED|Overall Study||17
7701223|NCT01795937|18963576|P3|STARTED|Overall Study||17
7701224|NCT01795937|18963577|P2|STARTED|Overall Study||16
7701225|NCT01795937|18963578|P1|STARTED|Overall Study||18
7701226|NCT01795898|18963607|P1|NOT COMPLETED|Overall Study||60
7701227|NCT01795898|18963607|P1|COMPLETED|Overall Study||177
7701228|NCT01795898|18963607|P1|STARTED|Overall Study||237
7701229|NCT01795859|18963617|P2|NOT COMPLETED|Overall Study||2
7701230|NCT01795859|18963618|P1|NOT COMPLETED|Overall Study||1
7701231|NCT01795859|18963617|P2|COMPLETED|Overall Study||43
7701232|NCT01795859|18963618|P1|COMPLETED|Overall Study||44
7701233|NCT01795859|18963617|P2|STARTED|Overall Study||45
7701234|NCT01795859|18963618|P1|STARTED|Overall Study||45
7701235|NCT01795833|18963636|P2|NOT COMPLETED|Overall Study||149
7701236|NCT01795833|18963637|P1|NOT COMPLETED|Overall Study||150
7701237|NCT01795833|18963636|P2|COMPLETED|Overall Study||882
7701238|NCT01795833|18963637|P1|COMPLETED|Overall Study||881
7701239|NCT01795833|18963636|P2|STARTED|Overall Study||1031
7701240|NCT01795833|18963637|P1|STARTED|Overall Study||1031
7701241|NCT01795716|18963657|P2|NOT COMPLETED|Second Intervention (13 Days)||0
7701242|NCT01795716|18963658|P1|NOT COMPLETED|Second Intervention (13 Days)||0
7701243|NCT01795716|18963657|P2|COMPLETED|Second Intervention (13 Days)||11
7701244|NCT01795716|18963658|P1|COMPLETED|Second Intervention (13 Days)||10
7701245|NCT01795716|18963657|P2|STARTED|Second Intervention (13 Days)||11
7701246|NCT01795716|18963658|P1|STARTED|Second Intervention (13 Days)||10
7701247|NCT01795716|18963657|P2|NOT COMPLETED|Washout (10 Days)||0
7701248|NCT01795716|18963658|P1|NOT COMPLETED|Washout (10 Days)||0
7701249|NCT01795716|18963657|P2|COMPLETED|Washout (10 Days)||11
7701250|NCT01795716|18963658|P1|COMPLETED|Washout (10 Days)||10
7701251|NCT01795716|18963657|P2|STARTED|Washout (10 Days)||11
7701252|NCT01795716|18963658|P1|STARTED|Washout (10 Days)||10
7701253|NCT01795716|18963657|P2|NOT COMPLETED|First Intervention (13 Days)||0
7701254|NCT01795716|18963658|P1|NOT COMPLETED|First Intervention (13 Days)||0
7701255|NCT01795716|18963657|P2|COMPLETED|First Intervention (13 Days)||11
7701256|NCT01795716|18963658|P1|COMPLETED|First Intervention (13 Days)||10
7701257|NCT01795716|18963657|P2|STARTED|First Intervention (13 Days)||11
7701258|NCT01795716|18963658|P1|STARTED|First Intervention (13 Days)||10
7701259|NCT01795638|18963666|P2|NOT COMPLETED|Overall Study||11
7701260|NCT01795638|18963667|P1|NOT COMPLETED|Overall Study||13
7701261|NCT01795638|18963666|P2|COMPLETED|Overall Study||15
7701262|NCT01795638|18963667|P1|COMPLETED|Overall Study||14
7701263|NCT01795638|18963666|P2|STARTED|Overall Study||26
7701264|NCT01795638|18963667|P1|STARTED|Overall Study||27
7701265|NCT01795547|18963693|P2|NOT COMPLETED|Overall Study||64
7701266|NCT01795547|18963694|P1|NOT COMPLETED|Overall Study||48
7701267|NCT01795547|18963693|P2|COMPLETED|Overall Study||83
7701268|NCT01795547|18963694|P1|COMPLETED|Overall Study||100
7701269|NCT01795547|18963693|P2|STARTED|Overall Study||147
7701270|NCT01795547|18963694|P1|STARTED|Overall Study||148
7701271|NCT01795534|18963716|P2|NOT COMPLETED|Second Intervention (Second Shot)||0
7701272|NCT01795534|18963717|P1|NOT COMPLETED|Second Intervention (Second Shot)||0
7701273|NCT01795534|18963716|P2|COMPLETED|Second Intervention (Second Shot)||5
7701274|NCT01795534|18963717|P1|COMPLETED|Second Intervention (Second Shot)||5
7701275|NCT01795534|18963716|P2|STARTED|Second Intervention (Second Shot)||5
7701276|NCT01795534|18963717|P1|STARTED|Second Intervention (Second Shot)||5
7701277|NCT01795534|18963716|P2|NOT COMPLETED|Wash Out Period (4 Days)||0
7701278|NCT01795534|18963717|P1|NOT COMPLETED|Wash Out Period (4 Days)||0
7701279|NCT01795534|18963716|P2|COMPLETED|Wash Out Period (4 Days)||5
7701280|NCT01795534|18963717|P1|COMPLETED|Wash Out Period (4 Days)||5
7701281|NCT01795534|18963716|P2|STARTED|Wash Out Period (4 Days)||5
7701282|NCT01795534|18963717|P1|STARTED|Wash Out Period (4 Days)||5
7701283|NCT01795534|18963716|P2|NOT COMPLETED|First Intervention (First Shot)||0
7701284|NCT01795534|18963717|P1|NOT COMPLETED|First Intervention (First Shot)||0
7701285|NCT01795534|18963716|P2|COMPLETED|First Intervention (First Shot)||5
7701286|NCT01795534|18963717|P1|COMPLETED|First Intervention (First Shot)||5
7701287|NCT01795534|18963716|P2|STARTED|First Intervention (First Shot)||5
7701288|NCT01795534|18963717|P1|STARTED|First Intervention (First Shot)||5
7701289|NCT01795495|18963726|P3|NOT COMPLETED|Overall Study||2
7701290|NCT01795495|18963727|P2|NOT COMPLETED|Overall Study||0
7701291|NCT01795495|18963728|P1|NOT COMPLETED|Overall Study||1
7701292|NCT01795495|18963726|P3|COMPLETED|Overall Study||19
7701293|NCT01795495|18963727|P2|COMPLETED|Overall Study||22
7701294|NCT01795495|18963728|P1|COMPLETED|Overall Study||19
7701295|NCT01795495|18963726|P3|STARTED|Overall Study||21
7701296|NCT01795495|18963727|P2|STARTED|Overall Study||22
7701297|NCT01795495|18963728|P1|STARTED|Overall Study||20
7701298|NCT01795105|18963739|P1|NOT COMPLETED|Overall Study||44
7701299|NCT01795105|18963739|P1|COMPLETED|Overall Study||648
7701300|NCT01795105|18963739|P1|STARTED|Overall Study||692
7701301|NCT01794949|18963748|P2|NOT COMPLETED|Overall Study||0
7701302|NCT01794949|18963749|P1|NOT COMPLETED|Overall Study||1
7701303|NCT01794949|18963748|P2|COMPLETED|Overall Study||1
7701304|NCT01794949|18963749|P1|COMPLETED|Overall Study||6
7701305|NCT01794949|18963748|P2|6 Month Follow-up|Overall Study||1
7701306|NCT01794949|18963749|P1|6 Month Follow-up|Overall Study||6
7701307|NCT01794949|18963748|P2|STARTED|Overall Study||1
7701308|NCT01794949|18963749|P1|STARTED|Overall Study||7
7701309|NCT01794936|18963755|P1|NOT COMPLETED|Overall Study||0
7701310|NCT01794936|18963755|P1|COMPLETED|Overall Study||9
7701311|NCT01794936|18963755|P1|STARTED|Overall Study||9
7701312|NCT01794845|18963760|P1|NOT COMPLETED|Overall Study||1
7701313|NCT01794845|18963760|P1|COMPLETED|Overall Study||4
7701314|NCT01794845|18963760|P1|STARTED|Overall Study||5
7701315|NCT01794806|18963769|P2|NOT COMPLETED|Overall Study||1
7701316|NCT01794806|18963770|P1|NOT COMPLETED|Overall Study||5
7701317|NCT01794806|18963769|P2|COMPLETED|Overall Study||27
7701318|NCT01794806|18963770|P1|COMPLETED|Overall Study||26
7701319|NCT01794806|18963769|P2|4 Weeks|Overall Study||27
7701320|NCT01794806|18963770|P1|4 Weeks|Overall Study||26
7701321|NCT01794806|18963769|P2|1 Week|Overall Study||28
7701322|NCT01794806|18963770|P1|1 Week|Overall Study||28
7701323|NCT01794806|18963769|P2|STARTED|Overall Study||28
7701324|NCT01794806|18963770|P1|STARTED|Overall Study||31
7701325|NCT01794780|18963788|P8|NOT COMPLETED|Overall Study||9
7701326|NCT01794780|18963789|P7|NOT COMPLETED|Overall Study||42
7701327|NCT01794780|18963790|P6|NOT COMPLETED|Overall Study||180
7701328|NCT01794780|18963791|P5|NOT COMPLETED|Overall Study||3
7701329|NCT01794780|18963792|P4|NOT COMPLETED|Overall Study||83
7701330|NCT01794780|18963793|P3|NOT COMPLETED|Overall Study||242
7701331|NCT01794780|18963794|P2|NOT COMPLETED|Overall Study||96
7701332|NCT01794780|18963795|P1|NOT COMPLETED|Overall Study||17
7701333|NCT01794780|18963788|P8|COMPLETED|Overall Study||21
7701334|NCT01794780|18963789|P7|COMPLETED|Overall Study||112
7701335|NCT01794780|18963790|P6|COMPLETED|Overall Study||452
7701336|NCT01794780|18963791|P5|COMPLETED|Overall Study||6
7701337|NCT01794780|18963792|P4|COMPLETED|Overall Study||200
7701338|NCT01794780|18963793|P3|COMPLETED|Overall Study||571
7701339|NCT01794780|18963794|P2|COMPLETED|Overall Study||180
7701340|NCT01794780|18963795|P1|COMPLETED|Overall Study||15
7701341|NCT01794780|18963788|P8|STARTED|Overall Study||30
7701342|NCT01794780|18963789|P7|STARTED|Overall Study||154
7701343|NCT01794780|18963790|P6|STARTED|Overall Study||632
7701344|NCT01794780|18963791|P5|STARTED|Overall Study||9
7701345|NCT01794780|18963792|P4|STARTED|Overall Study||283
7701346|NCT01794780|18963793|P3|STARTED|Overall Study||813
7701347|NCT01794780|18963794|P2|STARTED|Overall Study||276
7701348|NCT01794780|18963795|P1|STARTED|Overall Study||32
7701349|NCT01794741|18963845|P2|NOT COMPLETED|Overall Study||9
7701350|NCT01794741|18963846|P1|NOT COMPLETED|Overall Study||19
7701351|NCT01794741|18963845|P2|COMPLETED|Overall Study||92
7701352|NCT01794741|18963846|P1|COMPLETED|Overall Study||285
7701353|NCT01794741|18963845|P2|STARTED|Overall Study||101
7701354|NCT01794741|18963846|P1|STARTED|Overall Study||304
7701355|NCT01794702|18963855|P3|NOT COMPLETED|Overall Study||0
7701356|NCT01794702|18963856|P2|NOT COMPLETED|Overall Study||0
7701357|NCT01794702|18963857|P1|NOT COMPLETED|Overall Study||0
7701358|NCT01794702|18963855|P3|COMPLETED|Overall Study||47
7701359|NCT01794702|18963856|P2|COMPLETED|Overall Study||0
7701360|NCT01794702|18963857|P1|COMPLETED|Overall Study||18
7701361|NCT01794702|18963855|P3|STARTED|Overall Study||47
7701362|NCT01794702|18963856|P2|STARTED|Overall Study||0
7701363|NCT01794702|18963857|P1|STARTED|Overall Study||18
7701364|NCT01794689|18963871|P4|NOT COMPLETED|Intervention 2 (2 Nights)||0
7701365|NCT01794689|18963872|P3|NOT COMPLETED|Intervention 2 (2 Nights)||0
7701366|NCT01794689|18963873|P2|NOT COMPLETED|Intervention 2 (2 Nights)||0
7701367|NCT01794689|18963874|P1|NOT COMPLETED|Intervention 2 (2 Nights)||0
7701368|NCT01794689|18963871|P4|COMPLETED|Intervention 2 (2 Nights)||18
7701369|NCT01794689|18963872|P3|COMPLETED|Intervention 2 (2 Nights)||21
7701370|NCT01794689|18963873|P2|COMPLETED|Intervention 2 (2 Nights)||27
7701371|NCT01794689|18963874|P1|COMPLETED|Intervention 2 (2 Nights)||20
7701372|NCT01794689|18963871|P4|STARTED|Intervention 2 (2 Nights)||18
7701373|NCT01794689|18963872|P3|STARTED|Intervention 2 (2 Nights)||21
7701374|NCT01794689|18963873|P2|STARTED|Intervention 2 (2 Nights)||27
7701375|NCT01794689|18963874|P1|STARTED|Intervention 2 (2 Nights)||20
7701376|NCT01794689|18963871|P4|NOT COMPLETED|Washout (2 Weeks)||0
7701377|NCT01794689|18963872|P3|NOT COMPLETED|Washout (2 Weeks)||0
7701378|NCT01794689|18963873|P2|NOT COMPLETED|Washout (2 Weeks)||0
7701379|NCT01794689|18963874|P1|NOT COMPLETED|Washout (2 Weeks)||0
7701380|NCT01794689|18963871|P4|COMPLETED|Washout (2 Weeks)||18
7701381|NCT01794689|18963872|P3|COMPLETED|Washout (2 Weeks)||21
7701382|NCT01794689|18963873|P2|COMPLETED|Washout (2 Weeks)||27
7701383|NCT01794689|18963874|P1|COMPLETED|Washout (2 Weeks)||20
7701384|NCT01794689|18963871|P4|STARTED|Washout (2 Weeks)||18
7701385|NCT01794689|18963872|P3|STARTED|Washout (2 Weeks)||21
7701386|NCT01794689|18963873|P2|STARTED|Washout (2 Weeks)||27
7701387|NCT01794689|18963874|P1|STARTED|Washout (2 Weeks)||20
7701388|NCT01794689|18963871|P4|NOT COMPLETED|Intervention 1 (2 Nights)||4
7701389|NCT01794689|18963872|P3|NOT COMPLETED|Intervention 1 (2 Nights)||3
7701390|NCT01794689|18963873|P2|NOT COMPLETED|Intervention 1 (2 Nights)||2
7701391|NCT01794689|18963874|P1|NOT COMPLETED|Intervention 1 (2 Nights)||5
7701392|NCT01794689|18963871|P4|COMPLETED|Intervention 1 (2 Nights)||18
7701393|NCT01794689|18963872|P3|COMPLETED|Intervention 1 (2 Nights)||21
7701394|NCT01794689|18963873|P2|COMPLETED|Intervention 1 (2 Nights)||27
7701395|NCT01794689|18963874|P1|COMPLETED|Intervention 1 (2 Nights)||20
7701396|NCT01794689|18963871|P4|STARTED|Intervention 1 (2 Nights)||22
7701397|NCT01794689|18963872|P3|STARTED|Intervention 1 (2 Nights)||24
7701398|NCT01794689|18963873|P2|STARTED|Intervention 1 (2 Nights)||29
7701399|NCT01794689|18963874|P1|STARTED|Intervention 1 (2 Nights)||25
7701400|NCT01794455|18963898|P2|NOT COMPLETED|Overall Study||0
7701401|NCT01794455|18963899|P1|NOT COMPLETED|Overall Study||0
7701402|NCT01794455|18963898|P2|COMPLETED|Overall Study||1
7701403|NCT01794455|18963899|P1|COMPLETED|Overall Study||0
7701404|NCT01794455|18963898|P2|STARTED|Overall Study||1
7701405|NCT01794455|18963899|P1|STARTED|Overall Study||0
7701406|NCT01794312|18963917|P2|NOT COMPLETED|Overall Study||11
7701407|NCT01794312|18963918|P1|NOT COMPLETED|Overall Study||6
7701408|NCT01794312|18963917|P2|COMPLETED|Overall Study||67
7701409|NCT01794312|18963918|P1|COMPLETED|Overall Study||68
7701410|NCT01794312|18963917|P2|STARTED|Overall Study||78
7701411|NCT01794312|18963918|P1|STARTED|Overall Study||74
7701412|NCT01794039|18963930|P2|NOT COMPLETED|Overall Study||0
7701413|NCT01794039|18963931|P1|NOT COMPLETED|Overall Study||0
7701414|NCT01794039|18963930|P2|COMPLETED|Overall Study||4
7701415|NCT01794039|18963931|P1|COMPLETED|Overall Study||5
7701416|NCT01794039|18963930|P2|STARTED|Overall Study||4
7701417|NCT01794039|18963931|P1|STARTED|Overall Study||5
7701418|NCT01794000|18963943|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
7701419|NCT01794000|18963944|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||3
7701420|NCT01794000|18963943|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
7701421|NCT01794000|18963944|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
7701422|NCT01794000|18963943|P2|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0
7701423|NCT01794000|18963944|P1|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3
7701424|NCT01794000|18963943|P2|NOT COMPLETED|Double-Blind Phase (DBP)||166
7701425|NCT01794000|18963944|P1|NOT COMPLETED|Double-Blind Phase (DBP)||169
7701426|NCT01794000|18963943|P2|COMPLETED|Double-Blind Phase (DBP)||4
7701427|NCT01794000|18963944|P1|COMPLETED|Double-Blind Phase (DBP)||2
7701428|NCT01794000|18963943|P2|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166
7701429|NCT01794000|18963944|P1|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169
7701430|NCT01794000|18963943|P2|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
7701431|NCT01794000|18963944|P1|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
7701432|NCT01794000|18963943|P2|STARTED|Double-Blind Phase (DBP)||170
7701433|NCT01794000|18963944|P1|STARTED|Double-Blind Phase (DBP)||171
7701434|NCT01793935|18963977|P2|NOT COMPLETED|Overall Study||3
7701435|NCT01793935|18963978|P1|NOT COMPLETED|Overall Study||6
7701436|NCT01793935|18963977|P2|COMPLETED|Overall Study||31
7701437|NCT01793935|18963978|P1|COMPLETED|Overall Study||28
7701438|NCT01793935|18963977|P2|STARTED|Overall Study||34
7701439|NCT01793935|18963978|P1|STARTED|Overall Study||34
7701440|NCT01793909|18964014|P2|NOT COMPLETED|Overall Study||5
7701441|NCT01793909|18964015|P1|NOT COMPLETED|Overall Study||10
7701442|NCT01793909|18964014|P2|COMPLETED|Overall Study||20
7701443|NCT01793909|18964015|P1|COMPLETED|Overall Study||20
7701444|NCT01793909|18964014|P2|STARTED|Overall Study||25
7701445|NCT01793909|18964015|P1|STARTED|Overall Study||30
7701446|NCT01793883|18964024|P3|NOT COMPLETED|Overall Study||8
7701447|NCT01793883|18964025|P2|NOT COMPLETED|Overall Study||10
7701448|NCT01793883|18964026|P1|NOT COMPLETED|Overall Study||12
7701449|NCT01793883|18964024|P3|COMPLETED|Overall Study||204
7701450|NCT01793883|18964025|P2|COMPLETED|Overall Study||204
7701451|NCT01793883|18964026|P1|COMPLETED|Overall Study||201
7701452|NCT01793883|18964024|P3|STARTED|Overall Study||212
7701453|NCT01793883|18964025|P2|STARTED|Overall Study||214
7701454|NCT01793883|18964026|P1|STARTED|Overall Study||213
7701455|NCT01793792|18964034|P1|NOT COMPLETED|Overall Study||12
7701456|NCT01793792|18964034|P1|COMPLETED|Overall Study||141
7701457|NCT01793792|18964034|P1|Treated|Overall Study|153 Treated, 152 implanted with device, 1 attempted no device implanted|153
7701458|NCT01793792|18964034|P1|STARTED|Overall Study|153 treated: 1 attempted no device implanted, 152 device implanted.|153
7701459|NCT01793688|18964039|P1|NOT COMPLETED|Overall Study||2
7701460|NCT01793688|18964039|P1|COMPLETED|Overall Study||980
7701461|NCT01793688|18964039|P1|STARTED|Overall Study||982
7701462|NCT01793610|18964049|P3|NOT COMPLETED|Overall Study||1
7701463|NCT01793610|18964050|P2|NOT COMPLETED|Overall Study||0
7701464|NCT01793610|18964051|P1|NOT COMPLETED|Overall Study||1
7701465|NCT01793610|18964049|P3|COMPLETED|Overall Study||12
7701466|NCT01793610|18964050|P2|COMPLETED|Overall Study||9
7701467|NCT01793610|18964051|P1|COMPLETED|Overall Study||5
7701468|NCT01793610|18964049|P3|STARTED|Overall Study||13
7701469|NCT01793610|18964050|P2|STARTED|Overall Study||9
7701470|NCT01793610|18964051|P1|STARTED|Overall Study||6
7701471|NCT01793285|18964077|P1|NOT COMPLETED|Overall Study||0
7701472|NCT01793285|18964077|P1|COMPLETED|Overall Study||85
7701473|NCT01793285|18964077|P1|STARTED|Overall Study||85
7701474|NCT01793142|18964097|P1|NOT COMPLETED|Overall Study||7
7701475|NCT01793142|18964097|P1|COMPLETED|Overall Study||3423
7701476|NCT01793142|18964097|P1|Treated|Overall Study||3423
7701477|NCT01793142|18964097|P1|STARTED|Overall Study||3430
7701478|NCT01792986|18964108|P1|NOT COMPLETED|Overall Study||0
7701479|NCT01792986|18964108|P1|COMPLETED|Overall Study||12
7701480|NCT01792986|18964108|P1|STARTED|Overall Study||12
7701481|NCT01792830|18964127|P11|NOT COMPLETED|Overall Study||3
7701482|NCT01792830|18964128|P10|NOT COMPLETED|Overall Study||0
7701483|NCT01792830|18964129|P9|NOT COMPLETED|Overall Study||9
7701484|NCT01792830|18964130|P8|NOT COMPLETED|Overall Study||1
7701485|NCT01792830|18964131|P7|NOT COMPLETED|Overall Study||2
7701486|NCT01792830|18964132|P6|NOT COMPLETED|Overall Study||1
7701487|NCT01792830|18964133|P5|NOT COMPLETED|Overall Study||1
7701488|NCT01792830|18964134|P4|NOT COMPLETED|Overall Study||3
7701489|NCT01792830|18964135|P3|NOT COMPLETED|Overall Study||0
7701490|NCT01792830|18964136|P2|NOT COMPLETED|Overall Study||0
7701491|NCT01792830|18964137|P1|NOT COMPLETED|Overall Study||25
7701492|NCT01792830|18964127|P11|COMPLETED|Overall Study||9
7701493|NCT01792830|18964128|P10|COMPLETED|Overall Study||4
7701494|NCT01792830|18964129|P9|COMPLETED|Overall Study||11
7701495|NCT01792830|18964130|P8|COMPLETED|Overall Study||6
7701496|NCT01792830|18964131|P7|COMPLETED|Overall Study||12
7701497|NCT01792830|18964132|P6|COMPLETED|Overall Study||3
7701498|NCT01792830|18964133|P5|COMPLETED|Overall Study||1
7701499|NCT01792830|18964134|P4|COMPLETED|Overall Study||18
7701500|NCT01792830|18964135|P3|COMPLETED|Overall Study||4
7701501|NCT01792830|18964136|P2|COMPLETED|Overall Study||3
7701502|NCT01792830|18964137|P1|COMPLETED|Overall Study||59
7701503|NCT01792830|18964127|P11|STARTED|Overall Study||12
7701504|NCT01792830|18964128|P10|STARTED|Overall Study||4
7701505|NCT01792830|18964129|P9|STARTED|Overall Study||20
7701506|NCT01792830|18964130|P8|STARTED|Overall Study||7
7701507|NCT01792830|18964131|P7|STARTED|Overall Study||14
7701508|NCT01792830|18964132|P6|STARTED|Overall Study||4
7701509|NCT01792830|18964133|P5|STARTED|Overall Study||2
7701510|NCT01792830|18964134|P4|STARTED|Overall Study||21
7701511|NCT01792830|18964135|P3|STARTED|Overall Study||4
7701512|NCT01792830|18964136|P2|STARTED|Overall Study||3
7701513|NCT01792830|18964137|P1|STARTED|Overall Study||84
7701514|NCT01792817|18964206|P3|NOT COMPLETED|Phase 2 Open Label||26
7701515|NCT01792817|18964207|P2|NOT COMPLETED|Phase 2 Open Label||0
7701516|NCT01792817|18964208|P1|NOT COMPLETED|Phase 2 Open Label||0
7701517|NCT01792817|18964206|P3|COMPLETED|Phase 2 Open Label||74
7701518|NCT01792817|18964207|P2|COMPLETED|Phase 2 Open Label||0
7701519|NCT01792817|18964208|P1|COMPLETED|Phase 2 Open Label||0
7701520|NCT01792817|18964206|P3|STARTED|Phase 2 Open Label||100
7701521|NCT01792817|18964207|P2|STARTED|Phase 2 Open Label||0
7701522|NCT01792817|18964208|P1|STARTED|Phase 2 Open Label||0
7701523|NCT01792817|18964206|P3|NOT COMPLETED|Phase 1 Double Blind Period||0
7701524|NCT01792817|18964207|P2|NOT COMPLETED|Phase 1 Double Blind Period||31
7701525|NCT01792817|18964208|P1|NOT COMPLETED|Phase 1 Double Blind Period||19
7701526|NCT01792817|18964206|P3|COMPLETED|Phase 1 Double Blind Period||0
7701527|NCT01792817|18964207|P2|COMPLETED|Phase 1 Double Blind Period||42
7701528|NCT01792817|18964208|P1|COMPLETED|Phase 1 Double Blind Period||58
7701529|NCT01792817|18964206|P3|STARTED|Phase 1 Double Blind Period||0
7701530|NCT01792817|18964207|P2|STARTED|Phase 1 Double Blind Period||73
7701531|NCT01792817|18964208|P1|STARTED|Phase 1 Double Blind Period||77
7701532|NCT01792635|18964224|P3|NOT COMPLETED|Part B||4
7701533|NCT01792635|18964225|P2|NOT COMPLETED|Part B||4
7701534|NCT01792635|18964226|P1|NOT COMPLETED|Part B||0
7701535|NCT01792635|18964224|P3|COMPLETED|Part B||3
7701536|NCT01792635|18964225|P2|COMPLETED|Part B||2
7701537|NCT01792635|18964226|P1|COMPLETED|Part B||0
7701538|NCT01792635|18964224|P3|STARTED|Part B||7
7701539|NCT01792635|18964225|P2|STARTED|Part B||6
7701540|NCT01792635|18964226|P1|STARTED|Part B||0
7701541|NCT01792635|18964224|P3|NOT COMPLETED|Part A||0
7701542|NCT01792635|18964225|P2|NOT COMPLETED|Part A||0
7701543|NCT01792635|18964226|P1|NOT COMPLETED|Part A||0
7701544|NCT01792635|18964224|P3|COMPLETED|Part A||0
7701545|NCT01792635|18964225|P2|COMPLETED|Part A||0
7701546|NCT01792635|18964226|P1|COMPLETED|Part A||6
7701547|NCT01792635|18964224|P3|STARTED|Part A||0
7701548|NCT01792635|18964225|P2|STARTED|Part A||0
7701549|NCT01792635|18964226|P1|STARTED|Part A||6
7701550|NCT01792518|18964254|P2|NOT COMPLETED|Overall Study||7
7701551|NCT01792518|18964255|P1|NOT COMPLETED|Overall Study||8
7701552|NCT01792518|18964254|P2|COMPLETED|Overall Study||175
7701553|NCT01792518|18964255|P1|COMPLETED|Overall Study||170
7701554|NCT01792518|18964254|P2|STARTED|Overall Study||182
7701555|NCT01792518|18964255|P1|STARTED|Overall Study||178
7701556|NCT01792284|18964265|P3|NOT COMPLETED|Randomization Period 2||0
7701557|NCT01792284|18964266|P2|NOT COMPLETED|Randomization Period 2||3
7701558|NCT01792284|18964267|P1|NOT COMPLETED|Randomization Period 2||0
7701559|NCT01792284|18964265|P3|COMPLETED|Randomization Period 2||85
7701560|NCT01792284|18964266|P2|COMPLETED|Randomization Period 2||87
7701561|NCT01792284|18964267|P1|COMPLETED|Randomization Period 2||0
7701562|NCT01792284|18964265|P3|Received at Least 1 Dose of Study Drug|Randomization Period 2||85
7701563|NCT01792284|18964266|P2|Received at Least 1 Dose of Study Drug|Randomization Period 2||90
7701564|NCT01792284|18964267|P1|Received at Least 1 Dose of Study Drug|Randomization Period 2||0
7701565|NCT01792284|18964265|P3|STARTED|Randomization Period 2||85
7701566|NCT01792284|18964266|P2|STARTED|Randomization Period 2||90
7701567|NCT01792284|18964267|P1|STARTED|Randomization Period 2||0
7701568|NCT01792284|18964265|P3|NOT COMPLETED|Randomization Period 1||5
7701569|NCT01792284|18964266|P2|NOT COMPLETED|Randomization Period 1||2
7701570|NCT01792284|18964267|P1|NOT COMPLETED|Randomization Period 1||0
7701571|NCT01792284|18964265|P3|COMPLETED|Randomization Period 1||85
7701572|NCT01792284|18964266|P2|COMPLETED|Randomization Period 1||90
7701573|NCT01792284|18964267|P1|COMPLETED|Randomization Period 1||0
7701574|NCT01792284|18964265|P3|Received at Least 1 Dose of Study Drug|Randomization Period 1||90
7701575|NCT01792284|18964266|P2|Received at Least 1 Dose of Study Drug|Randomization Period 1||92
7701576|NCT01792284|18964267|P1|Received at Least 1 Dose of Study Drug|Randomization Period 1||0
7701577|NCT01792284|18964265|P3|STARTED|Randomization Period 1||90
7701578|NCT01792284|18964266|P2|STARTED|Randomization Period 1||92
7701579|NCT01792284|18964267|P1|STARTED|Randomization Period 1||0
7701580|NCT01792284|18964265|P3|NOT COMPLETED|Lead-in Period||0
7701581|NCT01792284|18964266|P2|NOT COMPLETED|Lead-in Period||0
7701582|NCT01792284|18964267|P1|NOT COMPLETED|Lead-in Period||30
7701583|NCT01792284|18964265|P3|COMPLETED|Lead-in Period||0
7701584|NCT01792284|18964266|P2|COMPLETED|Lead-in Period||0
7701585|NCT01792284|18964267|P1|COMPLETED|Lead-in Period|Participants that completed the Lead-in Period were randomized and entered Randomization Period 1.|182
7701586|NCT01792284|18964265|P3|STARTED|Lead-in Period||0
7701587|NCT01792284|18964266|P2|STARTED|Lead-in Period||0
7701588|NCT01792284|18964267|P1|STARTED|Lead-in Period||212
7701589|NCT01792115|18964308|P3|NOT COMPLETED|Overall Study||0
7701590|NCT01792115|18964309|P2|NOT COMPLETED|Overall Study||1
7701591|NCT01792115|18964310|P1|NOT COMPLETED|Overall Study||0
7701592|NCT01792115|18964308|P3|COMPLETED|Overall Study||8
7701593|NCT01792115|18964309|P2|COMPLETED|Overall Study||6
7701594|NCT01792115|18964310|P1|COMPLETED|Overall Study||7
7701595|NCT01792115|18964308|P3|STARTED|Overall Study||8
7701596|NCT01792115|18964309|P2|STARTED|Overall Study||7
7701597|NCT01792115|18964310|P1|STARTED|Overall Study||7
7701598|NCT01792024|18964339|P1|NOT COMPLETED|Overall Study||0
7701599|NCT01792024|18964339|P1|COMPLETED|Overall Study||27
7701600|NCT01792024|18964339|P1|STARTED|Overall Study||27
7701601|NCT01791972|18964349|P2|NOT COMPLETED|Overall Study||0
7701602|NCT01791972|18964350|P1|NOT COMPLETED|Overall Study||0
7701603|NCT01791972|18964349|P2|COMPLETED|Overall Study||19
7701604|NCT01791972|18964350|P1|COMPLETED|Overall Study||19
7701605|NCT01791972|18964349|P2|STARTED|Overall Study||19
7701606|NCT01791972|18964350|P1|STARTED|Overall Study||19
7701607|NCT01791894|18964360|P1|NOT COMPLETED|Overall Study||1
7701608|NCT01791894|18964360|P1|COMPLETED|Overall Study||4
7701609|NCT01791894|18964360|P1|STARTED|Overall Study||5
7701610|NCT01791803|18964371|P4|NOT COMPLETED|Overall Study||5
7701611|NCT01791803|18964372|P3|NOT COMPLETED|Overall Study||2
7701612|NCT01791803|18964373|P2|NOT COMPLETED|Overall Study||2
7701613|NCT01791803|18964374|P1|NOT COMPLETED|Overall Study||0
7701614|NCT01791803|18964371|P4|COMPLETED|Overall Study||37
7701615|NCT01791803|18964372|P3|COMPLETED|Overall Study||38
7701616|NCT01791803|18964373|P2|COMPLETED|Overall Study||39
7701617|NCT01791803|18964374|P1|COMPLETED|Overall Study||41
7701618|NCT01791803|18964371|P4|STARTED|Overall Study||42
7701619|NCT01791803|18964372|P3|STARTED|Overall Study||40
7701620|NCT01791803|18964373|P2|STARTED|Overall Study||41
7701621|NCT01791803|18964374|P1|STARTED|Overall Study||41
7701622|NCT01791725|18964392|P3|NOT COMPLETED|Overall Study||0
7701623|NCT01791725|18964393|P2|NOT COMPLETED|Overall Study||1
7701624|NCT01791725|18964394|P1|NOT COMPLETED|Overall Study||0
7701625|NCT01791725|18964392|P3|COMPLETED|Overall Study||6
7701626|NCT01791725|18964393|P2|COMPLETED|Overall Study||4
7701627|NCT01791725|18964394|P1|COMPLETED|Overall Study||12
7701628|NCT01791725|18964392|P3|STARTED|Overall Study||6
7701629|NCT01791725|18964393|P2|STARTED|Overall Study||5
7701630|NCT01791725|18964394|P1|STARTED|Overall Study||12
7701631|NCT01791517|18964417|P12|NOT COMPLETED|Phase II||1
7701632|NCT01791517|18964418|P11|NOT COMPLETED|Phase II||1
7701633|NCT01791517|18964419|P10|NOT COMPLETED|Phase II||3
7701634|NCT01791517|18964420|P9|NOT COMPLETED|Phase II||2
7701635|NCT01791517|18964421|P8|NOT COMPLETED|Phase II||3
7701636|NCT01791517|18964422|P7|NOT COMPLETED|Phase II||2
7701637|NCT01791517|18964423|P6|NOT COMPLETED|Phase II||4
7701638|NCT01791517|18964424|P5|NOT COMPLETED|Phase II||2
7701639|NCT01791517|18964425|P4|NOT COMPLETED|Phase II||0
7701640|NCT01791517|18964426|P3|NOT COMPLETED|Phase II||1
7701641|NCT01791517|18964427|P2|NOT COMPLETED|Phase II||0
7701642|NCT01791517|18964428|P1|NOT COMPLETED|Phase II||2
7701643|NCT01791517|18964417|P12|COMPLETED|Phase II||17
7701644|NCT01791517|18964418|P11|COMPLETED|Phase II||15
7701645|NCT01791517|18964419|P10|COMPLETED|Phase II||15
7701646|NCT01791517|18964420|P9|COMPLETED|Phase II||17
7701647|NCT01791517|18964421|P8|COMPLETED|Phase II||17
7701648|NCT01791517|18964422|P7|COMPLETED|Phase II||17
7701649|NCT01791517|18964423|P6|COMPLETED|Phase II||14
7701650|NCT01791517|18964424|P5|COMPLETED|Phase II||16
7701651|NCT01791517|18964425|P4|COMPLETED|Phase II||15
7701652|NCT01791517|18964426|P3|COMPLETED|Phase II||15
7701653|NCT01791517|18964427|P2|COMPLETED|Phase II||14
7701654|NCT01791517|18964428|P1|COMPLETED|Phase II||15
7701655|NCT01791517|18964417|P12|STARTED|Phase II||18
7701656|NCT01791517|18964418|P11|STARTED|Phase II||16
7701657|NCT01791517|18964419|P10|STARTED|Phase II||18
7701658|NCT01791517|18964420|P9|STARTED|Phase II||19
7701659|NCT01791517|18964421|P8|STARTED|Phase II||20
7701660|NCT01791517|18964422|P7|STARTED|Phase II||19
7701661|NCT01791517|18964423|P6|STARTED|Phase II||18
7701662|NCT01791517|18964424|P5|STARTED|Phase II||18
7701663|NCT01791517|18964425|P4|STARTED|Phase II||15
7701664|NCT01791517|18964426|P3|STARTED|Phase II||16
7701665|NCT01791517|18964427|P2|STARTED|Phase II||14
7701666|NCT01791517|18964428|P1|STARTED|Phase II||17
7701667|NCT01791517|18964417|P12|NOT COMPLETED|Phase I: Period 4||0
7701668|NCT01791517|18964418|P11|NOT COMPLETED|Phase I: Period 4||0
7701669|NCT01791517|18964419|P10|NOT COMPLETED|Phase I: Period 4||0
7701670|NCT01791517|18964420|P9|NOT COMPLETED|Phase I: Period 4||0
7701671|NCT01791517|18964421|P8|NOT COMPLETED|Phase I: Period 4||0
7701672|NCT01791517|18964422|P7|NOT COMPLETED|Phase I: Period 4||0
7701673|NCT01791517|18964423|P6|NOT COMPLETED|Phase I: Period 4||0
7701674|NCT01791517|18964424|P5|NOT COMPLETED|Phase I: Period 4||0
7701675|NCT01791517|18964425|P4|NOT COMPLETED|Phase I: Period 4||0
7701676|NCT01791517|18964426|P3|NOT COMPLETED|Phase I: Period 4||0
7701677|NCT01791517|18964427|P2|NOT COMPLETED|Phase I: Period 4||0
7701678|NCT01791517|18964428|P1|NOT COMPLETED|Phase I: Period 4||0
7701679|NCT01791517|18964417|P12|COMPLETED|Phase I: Period 4||18
7701680|NCT01791517|18964418|P11|COMPLETED|Phase I: Period 4||16
7701681|NCT01791517|18964419|P10|COMPLETED|Phase I: Period 4||18
7701682|NCT01791517|18964420|P9|COMPLETED|Phase I: Period 4||19
7701683|NCT01791517|18964421|P8|COMPLETED|Phase I: Period 4||20
7701684|NCT01791517|18964422|P7|COMPLETED|Phase I: Period 4||19
7701685|NCT01791517|18964423|P6|COMPLETED|Phase I: Period 4||18
7701686|NCT01791517|18964424|P5|COMPLETED|Phase I: Period 4||18
7701687|NCT01791517|18964425|P4|COMPLETED|Phase I: Period 4||15
7701688|NCT01791517|18964426|P3|COMPLETED|Phase I: Period 4||16
7701689|NCT01791517|18964427|P2|COMPLETED|Phase I: Period 4||14
7701690|NCT01791517|18964428|P1|COMPLETED|Phase I: Period 4||17
7701691|NCT01791517|18964417|P12|STARTED|Phase I: Period 4||18
7701692|NCT01791517|18964418|P11|STARTED|Phase I: Period 4||16
7701693|NCT01791517|18964419|P10|STARTED|Phase I: Period 4||18
7701694|NCT01791517|18964420|P9|STARTED|Phase I: Period 4||19
7701695|NCT01791517|18964421|P8|STARTED|Phase I: Period 4||20
7701696|NCT01791517|18964422|P7|STARTED|Phase I: Period 4||19
7701697|NCT01791517|18964423|P6|STARTED|Phase I: Period 4||18
7701698|NCT01791517|18964424|P5|STARTED|Phase I: Period 4||18
7701699|NCT01791517|18964425|P4|STARTED|Phase I: Period 4||15
7701700|NCT01791517|18964426|P3|STARTED|Phase I: Period 4||16
7701701|NCT01791517|18964427|P2|STARTED|Phase I: Period 4||14
7701702|NCT01791517|18964428|P1|STARTED|Phase I: Period 4||17
7701703|NCT01791517|18964417|P12|NOT COMPLETED|Phase I: Period 3||1
7701704|NCT01791517|18964418|P11|NOT COMPLETED|Phase I: Period 3||0
7701705|NCT01791517|18964419|P10|NOT COMPLETED|Phase I: Period 3||0
7701706|NCT01791517|18964420|P9|NOT COMPLETED|Phase I: Period 3||0
7701707|NCT01791517|18964421|P8|NOT COMPLETED|Phase I: Period 3||0
7701708|NCT01791517|18964422|P7|NOT COMPLETED|Phase I: Period 3||0
7701709|NCT01791517|18964423|P6|NOT COMPLETED|Phase I: Period 3||0
7701710|NCT01791517|18964424|P5|NOT COMPLETED|Phase I: Period 3||1
7701711|NCT01791517|18964425|P4|NOT COMPLETED|Phase I: Period 3||1
7701712|NCT01791517|18964426|P3|NOT COMPLETED|Phase I: Period 3||0
7701713|NCT01791517|18964427|P2|NOT COMPLETED|Phase I: Period 3||1
7701714|NCT01791517|18964428|P1|NOT COMPLETED|Phase I: Period 3||0
7701715|NCT01791517|18964417|P12|COMPLETED|Phase I: Period 3||18
7701716|NCT01791517|18964418|P11|COMPLETED|Phase I: Period 3||16
7701717|NCT01791517|18964419|P10|COMPLETED|Phase I: Period 3||18
7701718|NCT01791517|18964420|P9|COMPLETED|Phase I: Period 3||19
7701719|NCT01791517|18964421|P8|COMPLETED|Phase I: Period 3||20
7701720|NCT01791517|18964422|P7|COMPLETED|Phase I: Period 3||19
7701721|NCT01791517|18964423|P6|COMPLETED|Phase I: Period 3||18
7701722|NCT01791517|18964424|P5|COMPLETED|Phase I: Period 3||18
7701723|NCT01791517|18964425|P4|COMPLETED|Phase I: Period 3||15
7701724|NCT01791517|18964426|P3|COMPLETED|Phase I: Period 3||16
7701725|NCT01791517|18964427|P2|COMPLETED|Phase I: Period 3||14
7701726|NCT01791517|18964428|P1|COMPLETED|Phase I: Period 3||17
7701727|NCT01791517|18964417|P12|STARTED|Phase I: Period 3||19
7701728|NCT01791517|18964418|P11|STARTED|Phase I: Period 3||16
7701729|NCT01791517|18964419|P10|STARTED|Phase I: Period 3||18
7701730|NCT01791517|18964420|P9|STARTED|Phase I: Period 3||19
7701731|NCT01791517|18964421|P8|STARTED|Phase I: Period 3||20
7701732|NCT01791517|18964422|P7|STARTED|Phase I: Period 3||19
7701733|NCT01791517|18964423|P6|STARTED|Phase I: Period 3||18
7701734|NCT01791517|18964424|P5|STARTED|Phase I: Period 3||19
7701735|NCT01791517|18964425|P4|STARTED|Phase I: Period 3||16
7701736|NCT01791517|18964426|P3|STARTED|Phase I: Period 3||16
7701737|NCT01791517|18964427|P2|STARTED|Phase I: Period 3||15
7701738|NCT01791517|18964428|P1|STARTED|Phase I: Period 3||17
7701739|NCT01791517|18964417|P12|NOT COMPLETED|Phase I: Period 2||0
7701740|NCT01791517|18964418|P11|NOT COMPLETED|Phase I: Period 2||2
7701741|NCT01791517|18964419|P10|NOT COMPLETED|Phase I: Period 2||1
7701742|NCT01791517|18964420|P9|NOT COMPLETED|Phase I: Period 2||0
7701743|NCT01791517|18964421|P8|NOT COMPLETED|Phase I: Period 2||0
7701744|NCT01791517|18964422|P7|NOT COMPLETED|Phase I: Period 2||0
7701745|NCT01791517|18964423|P6|NOT COMPLETED|Phase I: Period 2||1
7701746|NCT01791517|18964424|P5|NOT COMPLETED|Phase I: Period 2||0
7701747|NCT01791517|18964425|P4|NOT COMPLETED|Phase I: Period 2||1
7701748|NCT01791517|18964426|P3|NOT COMPLETED|Phase I: Period 2||2
7701749|NCT01791517|18964427|P2|NOT COMPLETED|Phase I: Period 2||3
7701750|NCT01791517|18964428|P1|NOT COMPLETED|Phase I: Period 2||1
7701751|NCT01791517|18964417|P12|COMPLETED|Phase I: Period 2||19
7701752|NCT01791517|18964418|P11|COMPLETED|Phase I: Period 2||16
7701753|NCT01791517|18964419|P10|COMPLETED|Phase I: Period 2||18
7701754|NCT01791517|18964420|P9|COMPLETED|Phase I: Period 2||19
7701755|NCT01791517|18964421|P8|COMPLETED|Phase I: Period 2||20
7701756|NCT01791517|18964422|P7|COMPLETED|Phase I: Period 2||19
7701757|NCT01791517|18964423|P6|COMPLETED|Phase I: Period 2||18
7701758|NCT01791517|18964424|P5|COMPLETED|Phase I: Period 2||19
7701759|NCT01791517|18964425|P4|COMPLETED|Phase I: Period 2||16
7701760|NCT01791517|18964426|P3|COMPLETED|Phase I: Period 2||16
7701761|NCT01791517|18964427|P2|COMPLETED|Phase I: Period 2||15
7701762|NCT01791517|18964428|P1|COMPLETED|Phase I: Period 2||17
7701763|NCT01791517|18964417|P12|STARTED|Phase I: Period 2||19
7701764|NCT01791517|18964418|P11|STARTED|Phase I: Period 2||18
7701765|NCT01791517|18964419|P10|STARTED|Phase I: Period 2||19
7701766|NCT01791517|18964420|P9|STARTED|Phase I: Period 2||19
7701767|NCT01791517|18964421|P8|STARTED|Phase I: Period 2||20
7701768|NCT01791517|18964422|P7|STARTED|Phase I: Period 2||19
7701769|NCT01791517|18964423|P6|STARTED|Phase I: Period 2||19
7701770|NCT01791517|18964424|P5|STARTED|Phase I: Period 2||19
7701771|NCT01791517|18964425|P4|STARTED|Phase I: Period 2||17
7701772|NCT01791517|18964426|P3|STARTED|Phase I: Period 2||18
7701773|NCT01791517|18964427|P2|STARTED|Phase I: Period 2||18
7701774|NCT01791517|18964428|P1|STARTED|Phase I: Period 2||18
7701775|NCT01791517|18964417|P12|NOT COMPLETED|Phase I: Period 1||1
7701776|NCT01791517|18964418|P11|NOT COMPLETED|Phase I: Period 1||0
7701777|NCT01791517|18964419|P10|NOT COMPLETED|Phase I: Period 1||1
7701778|NCT01791517|18964420|P9|NOT COMPLETED|Phase I: Period 1||1
7701779|NCT01791517|18964421|P8|NOT COMPLETED|Phase I: Period 1||0
7701780|NCT01791517|18964422|P7|NOT COMPLETED|Phase I: Period 1||1
7701781|NCT01791517|18964423|P6|NOT COMPLETED|Phase I: Period 1||1
7701782|NCT01791517|18964424|P5|NOT COMPLETED|Phase I: Period 1||1
7701783|NCT01791517|18964425|P4|NOT COMPLETED|Phase I: Period 1||2
7701784|NCT01791517|18964426|P3|NOT COMPLETED|Phase I: Period 1||2
7701785|NCT01791517|18964427|P2|NOT COMPLETED|Phase I: Period 1||2
7701786|NCT01791517|18964428|P1|NOT COMPLETED|Phase I: Period 1||1
7701787|NCT01791517|18964417|P12|COMPLETED|Phase I: Period 1||19
7701788|NCT01791517|18964418|P11|COMPLETED|Phase I: Period 1||18
7701789|NCT01791517|18964419|P10|COMPLETED|Phase I: Period 1||19
7701790|NCT01791517|18964420|P9|COMPLETED|Phase I: Period 1||19
7701791|NCT01791517|18964421|P8|COMPLETED|Phase I: Period 1||20
7701792|NCT01791517|18964422|P7|COMPLETED|Phase I: Period 1||19
7701793|NCT01791517|18964423|P6|COMPLETED|Phase I: Period 1||19
7701794|NCT01791517|18964424|P5|COMPLETED|Phase I: Period 1||19
7701795|NCT01791517|18964425|P4|COMPLETED|Phase I: Period 1||17
7701796|NCT01791517|18964426|P3|COMPLETED|Phase I: Period 1||18
7701797|NCT01791517|18964427|P2|COMPLETED|Phase I: Period 1||18
7701798|NCT01791517|18964428|P1|COMPLETED|Phase I: Period 1||18
7701799|NCT01791517|18964417|P12|STARTED|Phase I: Period 1||20
7701800|NCT01791517|18964418|P11|STARTED|Phase I: Period 1||18
7701801|NCT01791517|18964419|P10|STARTED|Phase I: Period 1||20
7701802|NCT01791517|18964420|P9|STARTED|Phase I: Period 1||20
7701803|NCT01791517|18964421|P8|STARTED|Phase I: Period 1||20
7701804|NCT01791517|18964422|P7|STARTED|Phase I: Period 1||20
7701805|NCT01791517|18964423|P6|STARTED|Phase I: Period 1||20
7701806|NCT01791517|18964424|P5|STARTED|Phase I: Period 1||20
7701807|NCT01791517|18964425|P4|STARTED|Phase I: Period 1||19
7701808|NCT01791517|18964426|P3|STARTED|Phase I: Period 1||20
7701809|NCT01791517|18964427|P2|STARTED|Phase I: Period 1||20
7701810|NCT01791517|18964428|P1|STARTED|Phase I: Period 1||19
7701811|NCT01791491|18964454|P1|NOT COMPLETED|Overall Study||0
7701812|NCT01791491|18964454|P1|COMPLETED|Overall Study||9
7701813|NCT01791491|18964454|P1|STARTED|Overall Study|Reasons for enrollment and non-treatment: 1 withdrew consent and 6 no longer met study criteria.|9
7701814|NCT01791465|18964466|P1|NOT COMPLETED|Overall Study||0
7701815|NCT01791465|18964466|P1|COMPLETED|Overall Study||6
7701816|NCT01791465|18964466|P1|STARTED|Overall Study||6
7701817|NCT01791413|18964492|P2|NOT COMPLETED|Overall Study||1
7701818|NCT01791413|18964493|P1|NOT COMPLETED|Overall Study||5
7701819|NCT01791413|18964492|P2|COMPLETED|Overall Study||19
7701820|NCT01791413|18964493|P1|COMPLETED|Overall Study||15
7701821|NCT01791413|18964492|P2|STARTED|Overall Study||20
7701822|NCT01791413|18964493|P1|STARTED|Overall Study||20
7701823|NCT01791244|18964502|P2|NOT COMPLETED|Overall Study||18
7701824|NCT01791244|18964503|P1|NOT COMPLETED|Overall Study||15
7701825|NCT01791244|18964502|P2|COMPLETED|Overall Study||29
7701826|NCT01791244|18964503|P1|COMPLETED|Overall Study||31
7701827|NCT01791244|18964502|P2|Intent to Treat (ITT)|Overall Study||39
7701828|NCT01791244|18964503|P1|Intent to Treat (ITT)|Overall Study||38
7701829|NCT01791244|18964502|P2|STARTED|Overall Study||47
7701830|NCT01791244|18964503|P1|STARTED|Overall Study||46
7701831|NCT01791205|18964539|P2|NOT COMPLETED|Phase II||0
7701832|NCT01791205|18964540|P1|NOT COMPLETED|Phase II||12
7701833|NCT01791205|18964539|P2|COMPLETED|Phase II||0
7701834|NCT01791205|18964540|P1|COMPLETED|Phase II||92
7701835|NCT01791205|18964539|P2|STARTED|Phase II||0
7701836|NCT01791205|18964540|P1|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104
7701837|NCT01791205|18964539|P2|NOT COMPLETED|Phase I||0
7701838|NCT01791205|18964540|P1|NOT COMPLETED|Phase I||0
7701839|NCT01791205|18964539|P2|COMPLETED|Phase I||152
7701840|NCT01791205|18964540|P1|COMPLETED|Phase I||152
7701841|NCT01791205|18964539|P2|STARTED|Phase I||152
7701842|NCT01791205|18964540|P1|STARTED|Phase I||152
7701843|NCT01791153|18964624|P8|NOT COMPLETED|Part 2: Open-label Period||6
7701844|NCT01791153|18964625|P7|NOT COMPLETED|Part 2: Open-label Period||6
7701845|NCT01791153|18964626|P6|NOT COMPLETED|Part 2: Open-label Period||4
7701846|NCT01791153|18964627|P5|NOT COMPLETED|Part 2: Open-label Period||2
7701847|NCT01791153|18964628|P4|NOT COMPLETED|Part 2: Open-label Period||0
7701848|NCT01791153|18964629|P3|NOT COMPLETED|Part 2: Open-label Period||0
7701849|NCT01791153|18964630|P2|NOT COMPLETED|Part 2: Open-label Period||0
7701850|NCT01791153|18964631|P1|NOT COMPLETED|Part 2: Open-label Period||0
7701851|NCT01791153|18964624|P8|COMPLETED|Part 2: Open-label Period||61
7701852|NCT01791153|18964625|P7|COMPLETED|Part 2: Open-label Period||44
7701853|NCT01791153|18964626|P6|COMPLETED|Part 2: Open-label Period||54
7701854|NCT01791153|18964627|P5|COMPLETED|Part 2: Open-label Period||38
7701855|NCT01791153|18964628|P4|COMPLETED|Part 2: Open-label Period||0
7701856|NCT01791153|18964629|P3|COMPLETED|Part 2: Open-label Period||0
7701857|NCT01791153|18964630|P2|COMPLETED|Part 2: Open-label Period||0
7701858|NCT01791153|18964631|P1|COMPLETED|Part 2: Open-label Period||0
7701859|NCT01791153|18964624|P8|STARTED|Part 2: Open-label Period||67
7701860|NCT01791153|18964625|P7|STARTED|Part 2: Open-label Period||50
7701861|NCT01791153|18964626|P6|STARTED|Part 2: Open-label Period||58
7701862|NCT01791153|18964627|P5|STARTED|Part 2: Open-label Period||40
7701863|NCT01791153|18964628|P4|STARTED|Part 2: Open-label Period||0
7701864|NCT01791153|18964629|P3|STARTED|Part 2: Open-label Period||0
7701865|NCT01791153|18964630|P2|STARTED|Part 2: Open-label Period||0
7701866|NCT01791153|18964631|P1|STARTED|Part 2: Open-label Period||0
7701867|NCT01791153|18964624|P8|NOT COMPLETED|Part 1: Blinded Period||0
7701868|NCT01791153|18964625|P7|NOT COMPLETED|Part 1: Blinded Period||0
7701869|NCT01791153|18964626|P6|NOT COMPLETED|Part 1: Blinded Period||0
7701870|NCT01791153|18964627|P5|NOT COMPLETED|Part 1: Blinded Period||0
7701871|NCT01791153|18964628|P4|NOT COMPLETED|Part 1: Blinded Period||5
7701872|NCT01791153|18964629|P3|NOT COMPLETED|Part 1: Blinded Period||6
7701873|NCT01791153|18964630|P2|NOT COMPLETED|Part 1: Blinded Period||8
7701874|NCT01791153|18964631|P1|NOT COMPLETED|Part 1: Blinded Period||15
7701875|NCT01791153|18964624|P8|COMPLETED|Part 1: Blinded Period||0
7701876|NCT01791153|18964625|P7|COMPLETED|Part 1: Blinded Period||0
7701877|NCT01791153|18964626|P6|COMPLETED|Part 1: Blinded Period||0
7701878|NCT01791153|18964627|P5|COMPLETED|Part 1: Blinded Period||0
7701879|NCT01791153|18964628|P4|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|46
7701880|NCT01791153|18964629|P3|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|44
7701881|NCT01791153|18964630|P2|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|41
7701882|NCT01791153|18964631|P1|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|85
7701883|NCT01791153|18964624|P8|STARTED|Part 1: Blinded Period||0
7701884|NCT01791153|18964625|P7|STARTED|Part 1: Blinded Period||0
7701885|NCT01791153|18964626|P6|STARTED|Part 1: Blinded Period||0
7701886|NCT01791153|18964627|P5|STARTED|Part 1: Blinded Period||0
7701887|NCT01791153|18964628|P4|STARTED|Part 1: Blinded Period||51
7701888|NCT01791153|18964629|P3|STARTED|Part 1: Blinded Period||50
7701889|NCT01791153|18964630|P2|STARTED|Part 1: Blinded Period||49
7701890|NCT01791153|18964631|P1|STARTED|Part 1: Blinded Period||100
7701891|NCT01791127|18964691|P1|NOT COMPLETED|Overall Study||1472
7701892|NCT01791127|18964691|P1|COMPLETED|Overall Study||286
7701893|NCT01791127|18964691|P1|STARTED|Overall Study||1758
7701894|NCT01790932|18964715|P1|NOT COMPLETED|Overall Study||50
7701895|NCT01790932|18964715|P1|COMPLETED|Overall Study||0
7701896|NCT01790932|18964715|P1|STARTED|Overall Study||50
7701897|NCT01790828|18964721|P1|NOT COMPLETED|Overall Study||34
7701898|NCT01790828|18964721|P1|COMPLETED|Overall Study||8
7701899|NCT01790828|18964721|P1|STARTED|Overall Study||42
7701900|NCT01790750|18964744|P1|NOT COMPLETED|Overall Study||0
7701901|NCT01790750|18964744|P1|COMPLETED|Overall Study||50
7701902|NCT01790750|18964744|P1|STARTED|Overall Study||50
7701903|NCT01790685|18964751|P2|NOT COMPLETED|Overall Study||0
7701904|NCT01790685|18964752|P1|NOT COMPLETED|Overall Study||0
7701905|NCT01790685|18964751|P2|COMPLETED|Overall Study||17
7701906|NCT01790685|18964752|P1|COMPLETED|Overall Study||23
7701907|NCT01790685|18964751|P2|STARTED|Overall Study||17
7701908|NCT01790685|18964752|P1|STARTED|Overall Study||23
7701909|NCT01790659|18964760|P2|NOT COMPLETED|Overall Study||6
7701910|NCT01790659|18964761|P1|NOT COMPLETED|Overall Study||6
7701911|NCT01790659|18964760|P2|COMPLETED|Overall Study||192
7701912|NCT01790659|18964761|P1|COMPLETED|Overall Study||195
7701913|NCT01790659|18964760|P2|STARTED|Overall Study||198
7701914|NCT01790659|18964761|P1|STARTED|Overall Study||201
7701915|NCT01790633|18964779|P2|NOT COMPLETED|Overall Study||5
7701916|NCT01790633|18964780|P1|NOT COMPLETED|Overall Study||48
7701917|NCT01790633|18964779|P2|COMPLETED|Overall Study||159
7701918|NCT01790633|18964780|P1|COMPLETED|Overall Study||115
7701919|NCT01790633|18964779|P2|STARTED|Overall Study||164
7701920|NCT01790633|18964780|P1|STARTED|Overall Study||163
7701921|NCT01790594|18964793|P3|NOT COMPLETED|Overall Study||3
7701922|NCT01790594|18964794|P2|NOT COMPLETED|Overall Study||3
7701923|NCT01790594|18964795|P1|NOT COMPLETED|Overall Study||5
7701924|NCT01790594|18964793|P3|COMPLETED|Overall Study||0
7701925|NCT01790594|18964794|P2|COMPLETED|Overall Study||18
7701926|NCT01790594|18964795|P1|COMPLETED|Overall Study||17
7701927|NCT01790594|18964793|P3|STARTED|Overall Study||3
7701928|NCT01790594|18964794|P2|STARTED|Overall Study||21
7701929|NCT01790594|18964795|P1|STARTED|Overall Study||22
7701930|NCT01790581|18964863|P2|NOT COMPLETED|Overall Study||0
7701931|NCT01790581|18964864|P1|NOT COMPLETED|Overall Study||0
7701932|NCT01790581|18964863|P2|COMPLETED|Overall Study||12
7701933|NCT01790581|18964864|P1|COMPLETED|Overall Study||12
7701934|NCT01790581|18964863|P2|STARTED|Overall Study||12
7701935|NCT01790581|18964864|P1|STARTED|Overall Study||12
7701936|NCT01790568|18964872|P2|NOT COMPLETED|Overall Study||1
7701937|NCT01790568|18964873|P1|NOT COMPLETED|Overall Study||0
7701938|NCT01790568|18964872|P2|COMPLETED|Overall Study||25
7701939|NCT01790568|18964873|P1|COMPLETED|Overall Study||12
7701940|NCT01790568|18964872|P2|STARTED|Overall Study||26
7701941|NCT01790568|18964873|P1|STARTED|Overall Study||12
7701942|NCT01790516|18964881|P2|NOT COMPLETED|Overall Study||0
7701943|NCT01790516|18964882|P1|NOT COMPLETED|Overall Study||1
7701944|NCT01790516|18964881|P2|COMPLETED|Overall Study||1
7701945|NCT01790516|18964882|P1|COMPLETED|Overall Study||0
7701946|NCT01790516|18964881|P2|STARTED|Overall Study||1
7701947|NCT01790516|18964882|P1|STARTED|Overall Study||1
7701948|NCT01790503|18964899|P11|NOT COMPLETED|Overall Study||16
7701949|NCT01790503|18964900|P10|NOT COMPLETED|Overall Study||26
7701950|NCT01790503|18964901|P9|NOT COMPLETED|Overall Study||3
7701951|NCT01790503|18964902|P8|NOT COMPLETED|Overall Study||1
7701952|NCT01790503|18964903|P7|NOT COMPLETED|Overall Study||1
7701953|NCT01790503|18964904|P6|NOT COMPLETED|Overall Study||5
7701954|NCT01790503|18964905|P5|NOT COMPLETED|Overall Study||5
7701955|NCT01790503|18964906|P4|NOT COMPLETED|Overall Study||2
7701956|NCT01790503|18964907|P3|NOT COMPLETED|Overall Study||1
7701957|NCT01790503|18964908|P2|NOT COMPLETED|Overall Study||1
7701958|NCT01790503|18964909|P1|NOT COMPLETED|Overall Study||3
7701959|NCT01790503|18964899|P11|COMPLETED|Overall Study||0
7701960|NCT01790503|18964900|P10|COMPLETED|Overall Study||1
7701961|NCT01790503|18964901|P9|COMPLETED|Overall Study||0
7701962|NCT01790503|18964902|P8|COMPLETED|Overall Study||0
7701963|NCT01790503|18964903|P7|COMPLETED|Overall Study||0
7701964|NCT01790503|18964904|P6|COMPLETED|Overall Study||0
7701965|NCT01790503|18964905|P5|COMPLETED|Overall Study||0
7701966|NCT01790503|18964906|P4|COMPLETED|Overall Study||0
7701967|NCT01790503|18964907|P3|COMPLETED|Overall Study||0
7701968|NCT01790503|18964908|P2|COMPLETED|Overall Study||0
7701969|NCT01790503|18964909|P1|COMPLETED|Overall Study||0
7701970|NCT01790503|18964899|P11|STARTED|Overall Study||16
7701971|NCT01790503|18964900|P10|STARTED|Overall Study||27
7701972|NCT01790503|18964901|P9|STARTED|Overall Study||3
7701973|NCT01790503|18964902|P8|STARTED|Overall Study||1
7701974|NCT01790503|18964903|P7|STARTED|Overall Study||1
7701975|NCT01790503|18964904|P6|STARTED|Overall Study||5
7701976|NCT01790503|18964905|P5|STARTED|Overall Study||5
7701977|NCT01790503|18964906|P4|STARTED|Overall Study||2
7701978|NCT01790503|18964907|P3|STARTED|Overall Study||1
7701979|NCT01790503|18964908|P2|STARTED|Overall Study||1
7701980|NCT01790503|18964909|P1|STARTED|Overall Study||3
7701981|NCT01790490|18964964|P3|NOT COMPLETED|Overall Study||0
7701982|NCT01790490|18964965|P2|NOT COMPLETED|Overall Study||0
7701983|NCT01790490|18964966|P1|NOT COMPLETED|Overall Study||0
7701984|NCT01790490|18964964|P3|COMPLETED|Overall Study||2
7701985|NCT01790490|18964965|P2|COMPLETED|Overall Study||3
7701986|NCT01790490|18964966|P1|COMPLETED|Overall Study||3
7701987|NCT01790490|18964964|P3|STARTED|Overall Study||2
7701988|NCT01790490|18964965|P2|STARTED|Overall Study||3
7701989|NCT01790490|18964966|P1|STARTED|Overall Study||3
7701990|NCT01790438|18964979|P2|NOT COMPLETED|Overall Study||11
7701991|NCT01790438|18964980|P1|NOT COMPLETED|Overall Study||35
7701992|NCT01790438|18964979|P2|COMPLETED|Overall Study||202
7701993|NCT01790438|18964980|P1|COMPLETED|Overall Study||393
7701994|NCT01790438|18964979|P2|Received at Least One Dose of Study Drug|Overall Study||212
7701995|NCT01790438|18964980|P1|Received at Least One Dose of Study Drug|Overall Study||427
7701996|NCT01790438|18964979|P2|STARTED|Overall Study||213
7701997|NCT01790438|18964980|P1|STARTED|Overall Study||428
7701998|NCT01790295|18965030|P1|NOT COMPLETED|Overall Study||11
7701999|NCT01790295|18965030|P1|COMPLETED|Overall Study||10
7702000|NCT01790295|18965030|P1|STARTED|Overall Study||21
7702001|NCT01790243|18965055|P2|NOT COMPLETED|Overall Study||43
7702002|NCT01790243|18965056|P1|NOT COMPLETED|Overall Study||290
7702003|NCT01790243|18965055|P2|COMPLETED|Overall Study||117
7702004|NCT01790243|18965056|P1|COMPLETED|Overall Study||739
7702005|NCT01790243|18965055|P2|STARTED|Overall Study||160
7702006|NCT01790243|18965056|P1|STARTED|Overall Study||1029
7702007|NCT01790178|18965082|P2|NOT COMPLETED|Overall Study||0
7702008|NCT01790178|18965083|P1|NOT COMPLETED|Overall Study||0
7702009|NCT01790178|18965082|P2|COMPLETED|Overall Study||24
7702010|NCT01790178|18965083|P1|COMPLETED|Overall Study||16
7702011|NCT01790178|18965082|P2|STARTED|Overall Study||24
7702012|NCT01790178|18965083|P1|STARTED|Overall Study||16
7702013|NCT01790126|18965100|P3|NOT COMPLETED|Overall Study||31
7702014|NCT01790126|18965101|P2|NOT COMPLETED|Overall Study||29
7702015|NCT01790126|18965102|P1|NOT COMPLETED|Overall Study||30
7702016|NCT01790126|18965100|P3|COMPLETED|Overall Study||0
7702017|NCT01790126|18965101|P2|COMPLETED|Overall Study||0
7702018|NCT01790126|18965102|P1|COMPLETED|Overall Study||0
7702019|NCT01790126|18965100|P3|Treated|Overall Study||31
7702020|NCT01790126|18965101|P2|Treated|Overall Study||29
7702021|NCT01790126|18965102|P1|Treated|Overall Study||29
7702022|NCT01790126|18965100|P3|STARTED|Overall Study||31
7702023|NCT01790126|18965101|P2|STARTED|Overall Study||29
7702024|NCT01790126|18965102|P1|STARTED|Overall Study||30
7702025|NCT01790048|18965159|P2|NOT COMPLETED|Overall Study||17
7702026|NCT01790048|18965160|P1|NOT COMPLETED|Overall Study||12
7702027|NCT01790048|18965159|P2|COMPLETED|Overall Study||1086
7702028|NCT01790048|18965160|P1|COMPLETED|Overall Study||1144
7702029|NCT01790048|18965159|P2|STARTED|Overall Study||1103
7702030|NCT01790048|18965160|P1|STARTED|Overall Study||1156
7702031|NCT01789970|18965178|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44
7702032|NCT01789970|18965179|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50
7702033|NCT01789970|18965180|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
7702034|NCT01789970|18965178|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||147
7702035|NCT01789970|18965179|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||130
7702036|NCT01789970|18965180|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
7702037|NCT01789970|18965178|P3|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191
7702038|NCT01789970|18965179|P2|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)|One participant was randomized but not treated.|179
7702039|NCT01789970|18965180|P1|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0
7702040|NCT01789970|18965178|P3|STARTED|Double-blind Treatment Period (12 Weeks)||191
7702041|NCT01789970|18965179|P2|STARTED|Double-blind Treatment Period (12 Weeks)||180
7702042|NCT01789970|18965180|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
7702043|NCT01789970|18965178|P3|NOT COMPLETED|Open-label Titration Period||0
7702044|NCT01789970|18965179|P2|NOT COMPLETED|Open-label Titration Period||0
7702045|NCT01789970|18965180|P1|NOT COMPLETED|Open-label Titration Period||254
7702046|NCT01789970|18965178|P3|COMPLETED|Open-label Titration Period||0
7702047|NCT01789970|18965179|P2|COMPLETED|Open-label Titration Period||0
7702048|NCT01789970|18965180|P1|COMPLETED|Open-label Titration Period||371
7702049|NCT01789970|18965178|P3|Safety Analysis Set|Open-label Titration Period||0
7702050|NCT01789970|18965179|P2|Safety Analysis Set|Open-label Titration Period||0
7702051|NCT01789970|18965180|P1|Safety Analysis Set|Open-label Titration Period|Two enrolled patients were not treated|623
7702052|NCT01789970|18965178|P3|STARTED|Open-label Titration Period||0
7702053|NCT01789970|18965179|P2|STARTED|Open-label Titration Period||0
7702054|NCT01789970|18965180|P1|STARTED|Open-label Titration Period||625
7702055|NCT01789905|18965212|P1|NOT COMPLETED|Overall Study||0
7702056|NCT01789905|18965212|P1|COMPLETED|Overall Study||116
7702057|NCT01789905|18965212|P1|STARTED|Overall Study||116
7702058|NCT01789814|18965220|P2|NOT COMPLETED|Overall Study||0
7702059|NCT01789814|18965221|P1|NOT COMPLETED|Overall Study||0
7702060|NCT01789814|18965220|P2|COMPLETED|Overall Study||12
7702061|NCT01789814|18965221|P1|COMPLETED|Overall Study||12
7702062|NCT01789814|18965220|P2|STARTED|Overall Study||12
7702063|NCT01789814|18965221|P1|STARTED|Overall Study||12
7702064|NCT01789775|18965229|P2|NOT COMPLETED|Overall Study||7
7702065|NCT01789775|18965230|P1|NOT COMPLETED|Overall Study||2
7702066|NCT01789775|18965229|P2|COMPLETED|Overall Study||50
7702067|NCT01789775|18965230|P1|COMPLETED|Overall Study||53
7702068|NCT01789775|18965229|P2|STARTED|Overall Study||57
7702069|NCT01789775|18965230|P1|STARTED|Overall Study||55
7702070|NCT01789606|18965238|P2|NOT COMPLETED|Overall Study||450
7702071|NCT01789606|18965239|P1|NOT COMPLETED|Overall Study||23
7702072|NCT01789606|18965238|P2|COMPLETED|Overall Study||382
7702073|NCT01789606|18965239|P1|COMPLETED|Overall Study||228
7702074|NCT01789606|18965238|P2|STARTED|Overall Study||832
7702075|NCT01789606|18965239|P1|STARTED|Overall Study||251
7702076|NCT01789567|18965257|P1|NOT COMPLETED|Overall Study||6
7702077|NCT01789567|18965257|P1|COMPLETED|Overall Study||14
7702078|NCT01789567|18965257|P1|STARTED|Overall Study||20
7702079|NCT01789476|18965266|P2|NOT COMPLETED|Overall Study||2
7702080|NCT01789476|18965267|P1|NOT COMPLETED|Overall Study||8
7702081|NCT01789476|18965266|P2|COMPLETED|Overall Study||15
7702082|NCT01789476|18965267|P1|COMPLETED|Overall Study||26
7702083|NCT01789476|18965266|P2|STARTED|Overall Study||17
7702084|NCT01789476|18965267|P1|STARTED|Overall Study||34
7702085|NCT01789255|18965277|P1|NOT COMPLETED|Overall Study||0
7702086|NCT01789255|18965277|P1|COMPLETED|Overall Study||12
7702087|NCT01789255|18965277|P1|STARTED|Overall Study||12
7702088|NCT01789203|18965289|P2|NOT COMPLETED|Overall Study||4
7702089|NCT01789203|18965290|P1|NOT COMPLETED|Overall Study||9
7702090|NCT01789203|18965289|P2|COMPLETED|Overall Study||63
7702091|NCT01789203|18965290|P1|COMPLETED|Overall Study||124
7702092|NCT01789203|18965289|P2|STARTED|Overall Study||67
7702093|NCT01789203|18965290|P1|STARTED|Overall Study||133
7702094|NCT01789138|18965320|P2|NOT COMPLETED|Overall Study||52
7702095|NCT01789138|18965321|P1|NOT COMPLETED|Overall Study||41
7702096|NCT01789138|18965320|P2|COMPLETED|Overall Study||206
7702097|NCT01789138|18965321|P1|COMPLETED|Overall Study||213
7702098|NCT01789138|18965320|P2|STARTED|Overall Study||258
7702099|NCT01789138|18965321|P1|STARTED|Overall Study||254
7702100|NCT01789047|18965331|P2|NOT COMPLETED|Overall Study||4
7702101|NCT01789047|18965332|P1|NOT COMPLETED|Overall Study||4
7702102|NCT01789047|18965331|P2|COMPLETED|Overall Study||17
7702103|NCT01789047|18965332|P1|COMPLETED|Overall Study||17
7702104|NCT01789047|18965331|P2|STARTED|Overall Study||21
7702105|NCT01789047|18965332|P1|STARTED|Overall Study||21
7702106|NCT01788943|18965340|P2|NOT COMPLETED|Overall Study||0
7702107|NCT01788943|18965341|P1|NOT COMPLETED|Overall Study||1
7702108|NCT01788943|18965340|P2|COMPLETED|Overall Study||12
7702109|NCT01788943|18965341|P1|COMPLETED|Overall Study|2FA-PET Brain Image Analysis Completion Date|12
7702110|NCT01788943|18965340|P2|STARTED|Overall Study||12
7702111|NCT01788943|18965341|P1|STARTED|Overall Study|Recruitment for study began.|13
7702112|NCT01788631|18965351|P2|NOT COMPLETED|Overall Study||1
7702113|NCT01788631|18965352|P1|NOT COMPLETED|Overall Study||3
7702114|NCT01788631|18965351|P2|COMPLETED|Overall Study||43
7702115|NCT01788631|18965352|P1|COMPLETED|Overall Study||49
7702116|NCT01788631|18965351|P2|Randomized|Overall Study||47
7702117|NCT01788631|18965352|P1|Randomized|Overall Study||53
7702118|NCT01788631|18965351|P2|STARTED|Overall Study||44
7702119|NCT01788631|18965352|P1|STARTED|Overall Study||52
7702120|NCT01788566|18965370|P1|NOT COMPLETED|Overall Study||8
7702121|NCT01788566|18965370|P1|COMPLETED|Overall Study||53
7702122|NCT01788566|18965370|P1|STARTED|Overall Study||61
7702123|NCT01788475|18965383|P3|NOT COMPLETED|Overall Study||0
7702124|NCT01788475|18965384|P2|NOT COMPLETED|Overall Study||0
7702125|NCT01788475|18965385|P1|NOT COMPLETED|Overall Study||3
7702126|NCT01788475|18965383|P3|COMPLETED|Overall Study||0
7702127|NCT01788475|18965384|P2|COMPLETED|Overall Study||0
7702128|NCT01788475|18965385|P1|COMPLETED|Overall Study||0
7702129|NCT01788475|18965383|P3|STARTED|Overall Study||0
7702130|NCT01788475|18965384|P2|STARTED|Overall Study||0
7702131|NCT01788475|18965385|P1|STARTED|Overall Study||3
7702132|NCT01788423|18965408|P3|NOT COMPLETED|Overall Study||5
7702133|NCT01788423|18965409|P2|NOT COMPLETED|Overall Study||4
7702134|NCT01788423|18965410|P1|NOT COMPLETED|Overall Study||0
7702135|NCT01788423|18965408|P3|COMPLETED|Overall Study|Three people developed unrelated health problems and two were unable to fit/use hearing aids.|50
7702136|NCT01788423|18965409|P2|COMPLETED|Overall Study|Four participants were unable to self-select hearing aids.|51
7702137|NCT01788423|18965410|P1|COMPLETED|Overall Study||53
7702138|NCT01788423|18965408|P3|STARTED|Overall Study||55
7702139|NCT01788423|18965409|P2|STARTED|Overall Study||55
7702140|NCT01788423|18965410|P1|STARTED|Overall Study||53
7702141|NCT01788358|18965421|P1|NOT COMPLETED|Overall Study||98
7702142|NCT01788358|18965421|P1|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410
7702143|NCT01788358|18965421|P1|Completed Week 52|Overall Study||193
7702144|NCT01788358|18965421|P1|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200
7702145|NCT01788358|18965421|P1|Completed Week 28|Overall Study||417
7702146|NCT01788358|18965421|P1|Treated|Overall Study||508
7702147|NCT01788358|18965421|P1|STARTED|Overall Study||508
7702148|NCT01788228|18965435|P2|NOT COMPLETED|Overall Study||0
7702149|NCT01788228|18965436|P1|NOT COMPLETED|Overall Study||1
7702150|NCT01788228|18965435|P2|COMPLETED|Overall Study||1
7702151|NCT01788228|18965436|P1|COMPLETED|Overall Study||48
7702152|NCT01788228|18965435|P2|STARTED|Overall Study||1
7702153|NCT01788228|18965436|P1|STARTED|Overall Study||49
7702154|NCT01788215|18965469|P2|NOT COMPLETED|Overall Study||1
7702155|NCT01788215|18965470|P1|NOT COMPLETED|Overall Study||2
7702156|NCT01788215|18965469|P2|COMPLETED|Overall Study||4
7702157|NCT01788215|18965470|P1|COMPLETED|Overall Study||3
7702158|NCT01788215|18965469|P2|12 Weeks of Doxycycline or Placebo|Overall Study||5
7702159|NCT01788215|18965470|P1|12 Weeks of Doxycycline or Placebo|Overall Study||5
7702160|NCT01788215|18965469|P2|STARTED|Overall Study||5
7702161|NCT01788215|18965470|P1|STARTED|Overall Study||5
7702162|NCT01788163|18965499|P9|NOT COMPLETED|Overall Study||16
7702163|NCT01788163|18965500|P8|NOT COMPLETED|Overall Study||48
7702164|NCT01788163|18965501|P7|NOT COMPLETED|Overall Study||1
7702165|NCT01788163|18965502|P6|NOT COMPLETED|Overall Study||7
7702166|NCT01788163|18965503|P5|NOT COMPLETED|Overall Study||0
7702167|NCT01788163|18965504|P4|NOT COMPLETED|Overall Study||0
7702168|NCT01788163|18965505|P3|NOT COMPLETED|Overall Study||0
7702169|NCT01788163|18965506|P2|NOT COMPLETED|Overall Study||0
7702170|NCT01788163|18965507|P1|NOT COMPLETED|Overall Study||55
7702171|NCT01788163|18965499|P9|COMPLETED|Overall Study||956
7702172|NCT01788163|18965500|P8|COMPLETED|Overall Study||254
7702173|NCT01788163|18965501|P7|COMPLETED|Overall Study||49
7702174|NCT01788163|18965502|P6|COMPLETED|Overall Study||95
7702175|NCT01788163|18965503|P5|COMPLETED|Overall Study||94
7702176|NCT01788163|18965504|P4|COMPLETED|Overall Study||71
7702177|NCT01788163|18965505|P3|COMPLETED|Overall Study||62
7702178|NCT01788163|18965506|P2|COMPLETED|Overall Study||271
7702179|NCT01788163|18965507|P1|COMPLETED|Overall Study||1403
7702180|NCT01788163|18965499|P9|STARTED|Overall Study||972
7702181|NCT01788163|18965500|P8|STARTED|Overall Study||302
7702182|NCT01788163|18965501|P7|STARTED|Overall Study||50
7702183|NCT01788163|18965502|P6|STARTED|Overall Study||102
7702184|NCT01788163|18965503|P5|STARTED|Overall Study||94
7702185|NCT01788163|18965504|P4|STARTED|Overall Study||71
7702186|NCT01788163|18965505|P3|STARTED|Overall Study||62
7702187|NCT01788163|18965506|P2|STARTED|Overall Study||271
7702188|NCT01788163|18965507|P1|STARTED|Overall Study||1458
7702189|NCT01788046|18965670|P2|NOT COMPLETED|Overall Study||37
7702190|NCT01788046|18965671|P1|NOT COMPLETED|Overall Study||56
7702191|NCT01788046|18965670|P2|COMPLETED|Overall Study||218
7702192|NCT01788046|18965671|P1|COMPLETED|Overall Study||204
7702193|NCT01788046|18965670|P2|Received Treatment|Overall Study||252
7702194|NCT01788046|18965671|P1|Received Treatment|Overall Study||259
7702195|NCT01788046|18965670|P2|STARTED|Overall Study||255
7702196|NCT01788046|18965671|P1|STARTED|Overall Study||260
7702197|NCT01787916|18965687|P2|NOT COMPLETED|Second Intervention (24 Weeks)||0
7702198|NCT01787916|18965688|P1|NOT COMPLETED|Second Intervention (24 Weeks)||0
7702199|NCT01787916|18965687|P2|COMPLETED|Second Intervention (24 Weeks)||7
7702200|NCT01787916|18965688|P1|COMPLETED|Second Intervention (24 Weeks)||8
7702201|NCT01787916|18965687|P2|STARTED|Second Intervention (24 Weeks)||7
7702202|NCT01787916|18965688|P1|STARTED|Second Intervention (24 Weeks)||8
7702203|NCT01787916|18965687|P2|NOT COMPLETED|Washout (4 Weeks)||0
7702204|NCT01787916|18965688|P1|NOT COMPLETED|Washout (4 Weeks)||0
7702205|NCT01787916|18965687|P2|COMPLETED|Washout (4 Weeks)||7
7702206|NCT01787916|18965688|P1|COMPLETED|Washout (4 Weeks)||8
7702207|NCT01787916|18965687|P2|STARTED|Washout (4 Weeks)||7
7702208|NCT01787916|18965688|P1|STARTED|Washout (4 Weeks)||8
7702209|NCT01787916|18965687|P2|NOT COMPLETED|First Intervention (24 Weeks)||0
7702210|NCT01787916|18965688|P1|NOT COMPLETED|First Intervention (24 Weeks)||0
7702211|NCT01787916|18965687|P2|COMPLETED|First Intervention (24 Weeks)||7
7702212|NCT01787916|18965688|P1|COMPLETED|First Intervention (24 Weeks)||8
7702213|NCT01787916|18965687|P2|STARTED|First Intervention (24 Weeks)||7
7702214|NCT01787916|18965688|P1|STARTED|First Intervention (24 Weeks)||8
7702215|NCT01787838|18965694|P1|NOT COMPLETED|Overall Study||1413
7702216|NCT01787838|18965694|P1|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096
7702217|NCT01787838|18965694|P1|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509
7702218|NCT01787825|18965698|P2|NOT COMPLETED|Overall Study||1
7702219|NCT01787825|18965699|P1|NOT COMPLETED|Overall Study||6
7702220|NCT01787825|18965698|P2|COMPLETED|Overall Study||60
7702221|NCT01787825|18965699|P1|COMPLETED|Overall Study||54
7702222|NCT01787825|18965698|P2|STARTED|Overall Study||61
7702223|NCT01787825|18965699|P1|STARTED|Overall Study||60
7702224|NCT01787799|18965710|P1|NOT COMPLETED|Overall Study||0
7702225|NCT01787799|18965710|P1|COMPLETED|Overall Study||100
7702226|NCT01787799|18965710|P1|STARTED|Overall Study||100
7702227|NCT01787760|18965717|P3|NOT COMPLETED|Overall Study||5
7702228|NCT01787760|18965718|P2|NOT COMPLETED|Overall Study||16
7702229|NCT01787760|18965719|P1|NOT COMPLETED|Overall Study||26
7702230|NCT01787760|18965717|P3|COMPLETED|Overall Study||46
7702231|NCT01787760|18965718|P2|COMPLETED|Overall Study||34
7702232|NCT01787760|18965719|P1|COMPLETED|Overall Study||25
7702233|NCT01787760|18965717|P3|STARTED|Overall Study||51
7702234|NCT01787760|18965718|P2|STARTED|Overall Study||50
7702235|NCT01787760|18965719|P1|STARTED|Overall Study||51
7702236|NCT01787604|18965733|P2|NOT COMPLETED|Overall Study||4
7702237|NCT01787604|18965734|P1|NOT COMPLETED|Overall Study||4
7702238|NCT01787604|18965733|P2|COMPLETED|Overall Study||28
7702239|NCT01787604|18965734|P1|COMPLETED|Overall Study||28
7702240|NCT01787604|18965733|P2|STARTED|Overall Study||32
7702241|NCT01787604|18965734|P1|STARTED|Overall Study||32
7702242|NCT01787591|18965744|P4|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
7702243|NCT01787591|18965745|P3|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
7702244|NCT01787591|18965746|P2|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
7702245|NCT01787591|18965747|P1|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
7702246|NCT01787591|18965744|P4|COMPLETED|Period 4 (Cross-over Arm 4)||5
7702247|NCT01787591|18965745|P3|COMPLETED|Period 4 (Cross-over Arm 4)||5
7702248|NCT01787591|18965746|P2|COMPLETED|Period 4 (Cross-over Arm 4)||5
7702249|NCT01787591|18965747|P1|COMPLETED|Period 4 (Cross-over Arm 4)||5
7702250|NCT01787591|18965744|P4|STARTED|Period 4 (Cross-over Arm 4)||5
7702251|NCT01787591|18965745|P3|STARTED|Period 4 (Cross-over Arm 4)||5
7702252|NCT01787591|18965746|P2|STARTED|Period 4 (Cross-over Arm 4)||5
7702253|NCT01787591|18965747|P1|STARTED|Period 4 (Cross-over Arm 4)||5
7702254|NCT01787591|18965744|P4|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
7702255|NCT01787591|18965745|P3|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
7702256|NCT01787591|18965746|P2|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
7702257|NCT01787591|18965747|P1|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
7702258|NCT01787591|18965744|P4|COMPLETED|Period 3 (Cross-over Arm 3)||5
7702259|NCT01787591|18965745|P3|COMPLETED|Period 3 (Cross-over Arm 3)||5
7702260|NCT01787591|18965746|P2|COMPLETED|Period 3 (Cross-over Arm 3)||5
7702261|NCT01787591|18965747|P1|COMPLETED|Period 3 (Cross-over Arm 3)||5
7702262|NCT01787591|18965744|P4|STARTED|Period 3 (Cross-over Arm 3)||5
7702263|NCT01787591|18965745|P3|STARTED|Period 3 (Cross-over Arm 3)||5
7702264|NCT01787591|18965746|P2|STARTED|Period 3 (Cross-over Arm 3)||5
7702265|NCT01787591|18965747|P1|STARTED|Period 3 (Cross-over Arm 3)||5
7702266|NCT01787591|18965744|P4|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
7702267|NCT01787591|18965745|P3|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
7702268|NCT01787591|18965746|P2|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
7702269|NCT01787591|18965747|P1|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
7702270|NCT01787591|18965744|P4|COMPLETED|Period 2 (Cross-over Arm 2)||5
7702271|NCT01787591|18965745|P3|COMPLETED|Period 2 (Cross-over Arm 2)||5
7702272|NCT01787591|18965746|P2|COMPLETED|Period 2 (Cross-over Arm 2)||5
7702273|NCT01787591|18965747|P1|COMPLETED|Period 2 (Cross-over Arm 2)||5
7702274|NCT01787591|18965744|P4|STARTED|Period 2 (Cross-over Arm 2)||5
7702275|NCT01787591|18965745|P3|STARTED|Period 2 (Cross-over Arm 2)||5
7702276|NCT01787591|18965746|P2|STARTED|Period 2 (Cross-over Arm 2)||5
7702277|NCT01787591|18965747|P1|STARTED|Period 2 (Cross-over Arm 2)||5
7702278|NCT01787591|18965744|P4|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1
7702279|NCT01787591|18965745|P3|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
7702280|NCT01787591|18965746|P2|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
7702281|NCT01787591|18965747|P1|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
7702282|NCT01787591|18965744|P4|COMPLETED|Period 1 (Cross-over Arm 1)||5
7702283|NCT01787591|18965745|P3|COMPLETED|Period 1 (Cross-over Arm 1)||5
7702284|NCT01787591|18965746|P2|COMPLETED|Period 1 (Cross-over Arm 1)||5
7702285|NCT01787591|18965747|P1|COMPLETED|Period 1 (Cross-over Arm 1)||5
7702286|NCT01787591|18965744|P4|STARTED|Period 1 (Cross-over Arm 1)||6
7702287|NCT01787591|18965745|P3|STARTED|Period 1 (Cross-over Arm 1)||5
7702288|NCT01787591|18965746|P2|STARTED|Period 1 (Cross-over Arm 1)||5
7702289|NCT01787591|18965747|P1|STARTED|Period 1 (Cross-over Arm 1)||5
7702290|NCT01787552|18965777|P4|NOT COMPLETED|Overall Study||27
7702291|NCT01787552|18965778|P3|NOT COMPLETED|Overall Study||5
7702292|NCT01787552|18965779|P2|NOT COMPLETED|Overall Study||9
7702293|NCT01787552|18965780|P1|NOT COMPLETED|Overall Study||8
7702294|NCT01787552|18965777|P4|COMPLETED|Overall Study||0
7702295|NCT01787552|18965778|P3|COMPLETED|Overall Study||0
7702296|NCT01787552|18965779|P2|COMPLETED|Overall Study||1
7702297|NCT01787552|18965780|P1|COMPLETED|Overall Study||0
7702298|NCT01787552|18965777|P4|STARTED|Overall Study||27
7702299|NCT01787552|18965778|P3|STARTED|Overall Study||5
7702300|NCT01787552|18965779|P2|STARTED|Overall Study||10
7702301|NCT01787552|18965780|P1|STARTED|Overall Study||8
7702302|NCT01787461|18965850|P2|NOT COMPLETED|Overall Study||9
7702303|NCT01787461|18965851|P1|NOT COMPLETED|Overall Study||14
7702304|NCT01787461|18965850|P2|COMPLETED|Overall Study||89
7702305|NCT01787461|18965851|P1|COMPLETED|Overall Study||82
7702306|NCT01787461|18965850|P2|STARTED|Overall Study||98
7702307|NCT01787461|18965851|P1|STARTED|Overall Study||96
7702308|NCT01787383|18965879|P2|NOT COMPLETED|Overall Study||22
7702309|NCT01787383|18965880|P1|NOT COMPLETED|Overall Study||9
7702310|NCT01787383|18965879|P2|COMPLETED|Overall Study||76
7702311|NCT01787383|18965880|P1|COMPLETED|Overall Study||92
7702312|NCT01787383|18965879|P2|STARTED|Overall Study||98
7702313|NCT01787383|18965880|P1|STARTED|Overall Study||101
7702314|NCT01787331|18965900|P1|NOT COMPLETED|Overall Study||2
7702315|NCT01787331|18965900|P1|COMPLETED|Overall Study||19
7702316|NCT01787331|18965900|P1|STARTED|Overall Study||21
7702317|NCT01787292|18965912|P2|NOT COMPLETED|Home Based Exercise Program||1
7702318|NCT01787292|18965913|P1|NOT COMPLETED|Home Based Exercise Program||3
7702319|NCT01787292|18965912|P2|COMPLETED|Home Based Exercise Program||13
7702320|NCT01787292|18965913|P1|COMPLETED|Home Based Exercise Program||12
7702321|NCT01787292|18965912|P2|STARTED|Home Based Exercise Program||14
7702322|NCT01787292|18965913|P1|STARTED|Home Based Exercise Program||15
7702323|NCT01787292|18965912|P2|NOT COMPLETED|Crossover Exercise Interventions||2
7702324|NCT01787292|18965913|P1|NOT COMPLETED|Crossover Exercise Interventions||2
7702325|NCT01787292|18965912|P2|COMPLETED|Crossover Exercise Interventions|These participants completed the 12-week in-house program and cross-over into the balance program.|14
7702326|NCT01787292|18965913|P1|COMPLETED|Crossover Exercise Interventions|Participants completed the 12-week in-house program and cross-over into the balance program.|15
7702327|NCT01787292|18965912|P2|STARTED|Crossover Exercise Interventions|Participants in this group performed balance training prior to cross-over to aerobic training.|16
7702328|NCT01787292|18965913|P1|STARTED|Crossover Exercise Interventions|Participants in this group performed aerobic training prior to cross-over to balance training.|17
7702329|NCT01787279|18965930|P1|NOT COMPLETED|Overall Study||3
7702330|NCT01787279|18965930|P1|COMPLETED|Overall Study||56
7702331|NCT01787279|18965930|P1|STARTED|Overall Study||59
7702332|NCT01787240|18965941|P2|NOT COMPLETED|Overall Study||1
7702333|NCT01787240|18965942|P1|NOT COMPLETED|Overall Study||5
7702334|NCT01787240|18965941|P2|COMPLETED|Overall Study||4
7702335|NCT01787240|18965942|P1|COMPLETED|Overall Study||10
7702336|NCT01787240|18965941|P2|STARTED|Overall Study||5
7702337|NCT01787240|18965942|P1|STARTED|Overall Study||15
7702338|NCT01787188|18965956|P3|NOT COMPLETED|Overall Study||18
7702339|NCT01787188|18965957|P2|NOT COMPLETED|Overall Study||18
7702340|NCT01787188|18965958|P1|NOT COMPLETED|Overall Study||17
7702341|NCT01787188|18965956|P3|COMPLETED|Overall Study||116
7702342|NCT01787188|18965957|P2|COMPLETED|Overall Study||112
7702343|NCT01787188|18965958|P1|COMPLETED|Overall Study||122
7702344|NCT01787188|18965956|P3|STARTED|Overall Study||134
7702345|NCT01787188|18965957|P2|STARTED|Overall Study||130
7702346|NCT01787188|18965958|P1|STARTED|Overall Study||139
7702347|NCT01787175|18966013|P2|NOT COMPLETED|Overall Study||0
7702348|NCT01787175|18966014|P1|NOT COMPLETED|Overall Study||0
7702349|NCT01787175|18966013|P2|COMPLETED|Overall Study||28
7702350|NCT01787175|18966014|P1|COMPLETED|Overall Study||30
7702351|NCT01787175|18966013|P2|STARTED|Overall Study||28
7702352|NCT01787175|18966014|P1|STARTED|Overall Study||30
7702353|NCT01787097|18966024|P4|NOT COMPLETED|Overall Study||0
7702354|NCT01787097|18966025|P3|NOT COMPLETED|Overall Study||0
7702355|NCT01787097|18966026|P2|NOT COMPLETED|Overall Study||0
7702356|NCT01787097|18966027|P1|NOT COMPLETED|Overall Study||1
7702357|NCT01787097|18966024|P4|COMPLETED|Overall Study||9
7702358|NCT01787097|18966025|P3|COMPLETED|Overall Study||7
7702359|NCT01787097|18966026|P2|COMPLETED|Overall Study||7
7702360|NCT01787097|18966027|P1|COMPLETED|Overall Study|Study completed|7
7702361|NCT01787097|18966024|P4|STARTED|Overall Study||9
7702362|NCT01787097|18966025|P3|STARTED|Overall Study||7
7702363|NCT01787097|18966026|P2|STARTED|Overall Study||7
7702364|NCT01787097|18966027|P1|STARTED|Overall Study|Study started in 2012/2013|8
7702365|NCT01787032|18966059|P6|NOT COMPLETED|Overall Study||1
7702366|NCT01787032|18966060|P5|NOT COMPLETED|Overall Study||1
7702367|NCT01787032|18966061|P4|NOT COMPLETED|Overall Study||0
7702368|NCT01787032|18966062|P3|NOT COMPLETED|Overall Study||0
7702369|NCT01787032|18966063|P2|NOT COMPLETED|Overall Study||0
7702370|NCT01787032|18966064|P1|NOT COMPLETED|Overall Study||0
7702371|NCT01787032|18966059|P6|COMPLETED|Overall Study||3
7702372|NCT01787032|18966060|P5|COMPLETED|Overall Study||3
7702373|NCT01787032|18966061|P4|COMPLETED|Overall Study||3
7702374|NCT01787032|18966062|P3|COMPLETED|Overall Study||3
7702375|NCT01787032|18966063|P2|COMPLETED|Overall Study||3
7702376|NCT01787032|18966064|P1|COMPLETED|Overall Study||3
7702377|NCT01787032|18966059|P6|Received T2|Overall Study||4
7702378|NCT01787032|18966060|P5|Received T2|Overall Study||4
7702379|NCT01787032|18966061|P4|Received T2|Overall Study||3
7702380|NCT01787032|18966062|P3|Received T2|Overall Study||3
7702381|NCT01787032|18966063|P2|Received T2|Overall Study||3
7702382|NCT01787032|18966064|P1|Received T2|Overall Study||3
7702383|NCT01787032|18966059|P6|Received T1|Overall Study||4
7702384|NCT01787032|18966060|P5|Received T1|Overall Study||3
7702385|NCT01787032|18966061|P4|Received T1|Overall Study||3
7702386|NCT01787032|18966062|P3|Received T1|Overall Study||3
7702387|NCT01787032|18966063|P2|Received T1|Overall Study||3
7702388|NCT01787032|18966064|P1|Received T1|Overall Study||3
7702389|NCT01787032|18966059|P6|Received R|Overall Study||3
7702390|NCT01787032|18966060|P5|Received R|Overall Study||4
7702391|NCT01787032|18966061|P4|Received R|Overall Study||3
7702392|NCT01787032|18966062|P3|Received R|Overall Study||3
7702393|NCT01787032|18966063|P2|Received R|Overall Study||3
7702394|NCT01787032|18966064|P1|Received R|Overall Study||3
7702395|NCT01787032|18966059|P6|STARTED|Overall Study||4
7702396|NCT01787032|18966060|P5|STARTED|Overall Study||4
7702397|NCT01787032|18966061|P4|STARTED|Overall Study||3
7702398|NCT01787032|18966062|P3|STARTED|Overall Study||3
7702399|NCT01787032|18966063|P2|STARTED|Overall Study||3
7702400|NCT01787032|18966064|P1|STARTED|Overall Study||3
7702401|NCT01787006|18966088|P2|NOT COMPLETED|Overall Study||3
7702402|NCT01787006|18966089|P1|NOT COMPLETED|Overall Study||3
7702403|NCT01787006|18966088|P2|COMPLETED|Overall Study||36
7702404|NCT01787006|18966089|P1|COMPLETED|Overall Study||32
7702405|NCT01787006|18966088|P2|STARTED|Overall Study||39
7702406|NCT01787006|18966089|P1|STARTED|Overall Study||35
7702407|NCT01786993|18966117|P2|NOT COMPLETED|Overall Study||10
7702408|NCT01786993|18966118|P1|NOT COMPLETED|Overall Study||12
7702409|NCT01786993|18966117|P2|COMPLETED|Overall Study||170
7702410|NCT01786993|18966118|P1|COMPLETED|Overall Study||189
7702411|NCT01786993|18966117|P2|Per Protocol Population at 9 Months|Overall Study||170
7702412|NCT01786993|18966118|P1|Per Protocol Population at 9 Months|Overall Study||189
7702413|NCT01786993|18966117|P2|STARTED|Overall Study||180
7702414|NCT01786993|18966118|P1|STARTED|Overall Study||201
7702415|NCT01786967|18966125|P1|NOT COMPLETED|Overall Study||0
7702416|NCT01786967|18966125|P1|COMPLETED|Overall Study||61
7702417|NCT01786967|18966125|P1|Metabolizer Status Undetermined|Overall Study||3
7702418|NCT01786967|18966125|P1|Poor Metabolizers|Overall Study||4
7702419|NCT01786967|18966125|P1|Extensive Metabolizers|Overall Study||54
7702420|NCT01786967|18966125|P1|STARTED|Overall Study||61
7702421|NCT01786954|18966134|P2|NOT COMPLETED|Overall Study||0
7702422|NCT01786954|18966135|P1|NOT COMPLETED|Overall Study||0
7702423|NCT01786954|18966134|P2|COMPLETED|Overall Study||34
7702424|NCT01786954|18966135|P1|COMPLETED|Overall Study||34
7702425|NCT01786954|18966134|P2|STARTED|Overall Study||34
7702426|NCT01786954|18966135|P1|STARTED|Overall Study||34
7702427|NCT01786902|18966147|P2|NOT COMPLETED|Overall Study||3
7702428|NCT01786902|18966148|P1|NOT COMPLETED|Overall Study||4
7702429|NCT01786902|18966147|P2|COMPLETED|Overall Study||31
7702430|NCT01786902|18966148|P1|COMPLETED|Overall Study||32
7702431|NCT01786902|18966147|P2|STARTED|Overall Study||34
7702432|NCT01786902|18966148|P1|STARTED|Overall Study||36
7702433|NCT01786876|18966158|P1|NOT COMPLETED|Overall Study||0
7702434|NCT01786876|18966158|P1|COMPLETED|Overall Study||6
7702435|NCT01786876|18966158|P1|STARTED|Overall Study||6
7702436|NCT01786707|18966177|P2|NOT COMPLETED|Overall Study||1
7702437|NCT01786707|18966178|P1|NOT COMPLETED|Overall Study||1
7702438|NCT01786707|18966177|P2|COMPLETED|Overall Study||0
7702439|NCT01786707|18966178|P1|COMPLETED|Overall Study||0
7702440|NCT01786707|18966177|P2|STARTED|Overall Study||1
7702441|NCT01786707|18966178|P1|STARTED|Overall Study||1
7702442|NCT01786668|18966190|P4|NOT COMPLETED|Overall Study||4
7702443|NCT01786668|18966191|P3|NOT COMPLETED|Overall Study||5
7702444|NCT01786668|18966192|P2|NOT COMPLETED|Overall Study||1
7702445|NCT01786668|18966193|P1|NOT COMPLETED|Overall Study||1
7702446|NCT01786668|18966190|P4|COMPLETED|Overall Study||47
7702447|NCT01786668|18966191|P3|COMPLETED|Overall Study||47
7702448|NCT01786668|18966192|P2|COMPLETED|Overall Study||51
7702449|NCT01786668|18966193|P1|COMPLETED|Overall Study||51
7702450|NCT01786668|18966190|P4|STARTED|Overall Study||51
7702451|NCT01786668|18966191|P3|STARTED|Overall Study||52
7702452|NCT01786668|18966192|P2|STARTED|Overall Study||52
7702453|NCT01786668|18966193|P1|STARTED|Overall Study||52
7702454|NCT01786629|18966293|P2|NOT COMPLETED|Overall Study||5
7702455|NCT01786629|18966294|P1|NOT COMPLETED|Overall Study||0
7702456|NCT01786629|18966293|P2|COMPLETED|Overall Study||164
7702457|NCT01786629|18966294|P1|COMPLETED|Overall Study||169
7702458|NCT01786629|18966293|P2|STARTED|Overall Study||169
7702459|NCT01786629|18966294|P1|STARTED|Overall Study||169
7702460|NCT01786603|18966302|P2|NOT COMPLETED|Overall Study||12
7702461|NCT01786603|18966303|P1|NOT COMPLETED|Overall Study||18
7702462|NCT01786603|18966302|P2|COMPLETED|Overall Study||8
7702463|NCT01786603|18966303|P1|COMPLETED|Overall Study||42
7702464|NCT01786603|18966302|P2|STARTED|Overall Study||20
7702465|NCT01786603|18966303|P1|STARTED|Overall Study||60
7702466|NCT01786564|18966321|P1|NOT COMPLETED|Overall Study||64
7702467|NCT01786564|18966321|P1|COMPLETED|Overall Study||56
7702468|NCT01786564|18966321|P1|STARTED|Overall Study||120
7702469|NCT01786551|18966325|P1|NOT COMPLETED|Overall Study||2
7702470|NCT01786551|18966325|P1|COMPLETED|Overall Study||14
7702471|NCT01786551|18966325|P1|STARTED|Overall Study||16
7702472|NCT01786343|18966333|P2|NOT COMPLETED|Overall Study||0
7702473|NCT01786343|18966334|P1|NOT COMPLETED|Overall Study||0
7702474|NCT01786343|18966333|P2|COMPLETED|Overall Study||46
7702475|NCT01786343|18966334|P1|COMPLETED|Overall Study||28
7702476|NCT01786343|18966333|P2|STARTED|Overall Study||46
7702477|NCT01786343|18966334|P1|STARTED|Overall Study||28
7702478|NCT01786330|18966346|P2|NOT COMPLETED|Overall Study||3
7702479|NCT01786330|18966347|P1|NOT COMPLETED|Overall Study||1
7702480|NCT01786330|18966346|P2|COMPLETED|Overall Study||27
7702481|NCT01786330|18966347|P1|COMPLETED|Overall Study||29
7702482|NCT01786330|18966346|P2|STARTED|Overall Study||30
7702483|NCT01786330|18966347|P1|STARTED|Overall Study||30
7702484|NCT01786252|18966361|P2|NOT COMPLETED|Overall Study||0
7702485|NCT01786252|18966362|P1|NOT COMPLETED|Overall Study||0
7702486|NCT01786252|18966361|P2|COMPLETED|Overall Study||8
7702487|NCT01786252|18966362|P1|COMPLETED|Overall Study||7
7702488|NCT01786252|18966361|P2|STARTED|Overall Study||8
7702489|NCT01786252|18966362|P1|STARTED|Overall Study||7
7702490|NCT01786239|18966376|P2|NOT COMPLETED|Overall Study||11
7702491|NCT01786239|18966377|P1|NOT COMPLETED|Overall Study||11
7702492|NCT01786239|18966376|P2|COMPLETED|Overall Study||14
7702493|NCT01786239|18966377|P1|COMPLETED|Overall Study||14
7702494|NCT01786239|18966376|P2|STARTED|Overall Study||25
7702495|NCT01786239|18966377|P1|STARTED|Overall Study||25
7702496|NCT01786187|18966385|P2|NOT COMPLETED|Overall Study||10
7702497|NCT01786187|18966386|P1|NOT COMPLETED|Overall Study||5
7702498|NCT01786187|18966385|P2|COMPLETED|Overall Study||37
7702499|NCT01786187|18966386|P1|COMPLETED|Overall Study||35
7702500|NCT01786187|18966385|P2|STARTED|Overall Study||47
7702501|NCT01786187|18966386|P1|STARTED|Overall Study||40
7702502|NCT01786174|18966399|P2|NOT COMPLETED|Overall Study||0
7702503|NCT01786174|18966400|P1|NOT COMPLETED|Overall Study||2
7702504|NCT01786174|18966399|P2|COMPLETED|Overall Study||10
7702505|NCT01786174|18966400|P1|COMPLETED|Overall Study||16
7702506|NCT01786174|18966399|P2|Randomized|Overall Study||11
7702507|NCT01786174|18966400|P1|Randomized|Overall Study||19
7702508|NCT01786174|18966399|P2|STARTED|Overall Study||10
7702509|NCT01786174|18966400|P1|STARTED|Overall Study||18
7702510|NCT01786161|18966416|P2|NOT COMPLETED|Overall Study||0
7702511|NCT01786161|18966417|P1|NOT COMPLETED|Overall Study||0
7702512|NCT01786161|18966416|P2|COMPLETED|Overall Study||22
7702513|NCT01786161|18966417|P1|COMPLETED|Overall Study||22
7702514|NCT01786161|18966416|P2|STARTED|Overall Study||22
7702515|NCT01786161|18966417|P1|STARTED|Overall Study||22
7702516|NCT01786148|18966429|P2|NOT COMPLETED|Overall Study||22
7702517|NCT01786148|18966430|P1|NOT COMPLETED|Overall Study||22
7702518|NCT01786148|18966429|P2|COMPLETED|Overall Study||50
7702519|NCT01786148|18966430|P1|COMPLETED|Overall Study||55
7702520|NCT01786148|18966429|P2|STARTED|Overall Study||72
7702521|NCT01786148|18966430|P1|STARTED|Overall Study||77
7702522|NCT01786109|18966445|P3|NOT COMPLETED|Overall Study||2
7702523|NCT01786109|18966446|P2|NOT COMPLETED|Overall Study||0
7702524|NCT01786109|18966447|P1|NOT COMPLETED|Overall Study||1
7702525|NCT01786109|18966445|P3|COMPLETED|Overall Study||25
7702526|NCT01786109|18966446|P2|COMPLETED|Overall Study||24
7702527|NCT01786109|18966447|P1|COMPLETED|Overall Study||23
7702528|NCT01786109|18966445|P3|STARTED|Overall Study||27
7702529|NCT01786109|18966446|P2|STARTED|Overall Study||24
7702530|NCT01786109|18966447|P1|STARTED|Overall Study||24
7702531|NCT01785875|18966476|P3|NOT COMPLETED|Overall Study||107
7702532|NCT01785875|18966477|P2|NOT COMPLETED|Overall Study||289
7702533|NCT01785875|18966478|P1|NOT COMPLETED|Overall Study||294
7702534|NCT01785875|18966476|P3|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|16
7702535|NCT01785875|18966477|P2|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|95
7702536|NCT01785875|18966478|P1|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|90
7702537|NCT01785875|18966476|P3|Received Etelcalcetide|Overall Study||123
7702538|NCT01785875|18966477|P2|Received Etelcalcetide|Overall Study||384
7702539|NCT01785875|18966478|P1|Received Etelcalcetide|Overall Study||383
7702540|NCT01785875|18966476|P3|STARTED|Overall Study||123
7702541|NCT01785875|18966477|P2|STARTED|Overall Study||384
7702542|NCT01785875|18966478|P1|STARTED|Overall Study||384
7702543|NCT01785849|18966547|P2|NOT COMPLETED|Overall Study||34
7702544|NCT01785849|18966548|P1|NOT COMPLETED|Overall Study||61
7702545|NCT01785849|18966547|P2|COMPLETED|Overall Study||220
7702546|NCT01785849|18966548|P1|COMPLETED|Overall Study||193
7702547|NCT01785849|18966547|P2|Received Treatment|Overall Study||251
7702548|NCT01785849|18966548|P1|Received Treatment|Overall Study||254
7702549|NCT01785849|18966547|P2|STARTED|Overall Study||254
7702550|NCT01785849|18966548|P1|STARTED|Overall Study||254
7702551|NCT01785680|18966566|P2|NOT COMPLETED|Overall Study||0
7702552|NCT01785680|18966567|P1|NOT COMPLETED|Overall Study||0
7702553|NCT01785680|18966566|P2|COMPLETED|Overall Study||857
7702554|NCT01785680|18966567|P1|COMPLETED|Overall Study||1100
7702555|NCT01785680|18966566|P2|STARTED|Overall Study||857
7702556|NCT01785680|18966567|P1|STARTED|Overall Study||1100
7702557|NCT01785628|18966581|P2|NOT COMPLETED|Overall Study||3
7702558|NCT01785628|18966582|P1|NOT COMPLETED|Overall Study||2
7702559|NCT01785628|18966581|P2|COMPLETED|Overall Study||12
7702560|NCT01785628|18966582|P1|COMPLETED|Overall Study||13
7702561|NCT01785628|18966581|P2|STARTED|Overall Study||15
7702562|NCT01785628|18966582|P1|STARTED|Overall Study||15
7702563|NCT01785615|18966605|P4|NOT COMPLETED|Atorvastatin Phase||0
7702564|NCT01785615|18966606|P3|NOT COMPLETED|Atorvastatin Phase||0
7702565|NCT01785615|18966607|P2|NOT COMPLETED|Atorvastatin Phase||0
7702566|NCT01785615|18966608|P1|NOT COMPLETED|Atorvastatin Phase||0
7702567|NCT01785615|18966605|P4|COMPLETED|Atorvastatin Phase||0
7702568|NCT01785615|18966606|P3|COMPLETED|Atorvastatin Phase||0
7702569|NCT01785615|18966607|P2|COMPLETED|Atorvastatin Phase||44
7702570|NCT01785615|18966608|P1|COMPLETED|Atorvastatin Phase||44
7702571|NCT01785615|18966605|P4|STARTED|Atorvastatin Phase||0
7702572|NCT01785615|18966606|P3|STARTED|Atorvastatin Phase||0
7702573|NCT01785615|18966607|P2|STARTED|Atorvastatin Phase||44
7702574|NCT01785615|18966608|P1|STARTED|Atorvastatin Phase||44
7702575|NCT01785615|18966605|P4|NOT COMPLETED|Dietary Phase||24
7702576|NCT01785615|18966606|P3|NOT COMPLETED|Dietary Phase||0
7702577|NCT01785615|18966607|P2|NOT COMPLETED|Dietary Phase||0
7702578|NCT01785615|18966608|P1|NOT COMPLETED|Dietary Phase||0
7702579|NCT01785615|18966605|P4|COMPLETED|Dietary Phase||116
7702580|NCT01785615|18966606|P3|COMPLETED|Dietary Phase||35
7702581|NCT01785615|18966607|P2|COMPLETED|Dietary Phase||0
7702582|NCT01785615|18966608|P1|COMPLETED|Dietary Phase||0
7702583|NCT01785615|18966605|P4|STARTED|Dietary Phase||140
7702584|NCT01785615|18966606|P3|STARTED|Dietary Phase||35
7702585|NCT01785615|18966607|P2|STARTED|Dietary Phase||0
7702586|NCT01785615|18966608|P1|STARTED|Dietary Phase||0
7702587|NCT01785602|18966680|P2|NOT COMPLETED|Overall Study||9
7702588|NCT01785602|18966681|P1|NOT COMPLETED|Overall Study||13
7702589|NCT01785602|18966680|P2|COMPLETED|Overall Study||18
7702590|NCT01785602|18966681|P1|COMPLETED|Overall Study||63
7702591|NCT01785602|18966680|P2|STARTED|Overall Study||27
7702592|NCT01785602|18966681|P1|STARTED|Overall Study||76
7702593|NCT01785524|18966691|P2|NOT COMPLETED|Overall Study||2
7702594|NCT01785524|18966692|P1|NOT COMPLETED|Overall Study||2
7702595|NCT01785524|18966691|P2|COMPLETED|Overall Study||2
7702596|NCT01785524|18966692|P1|COMPLETED|Overall Study||5
7702597|NCT01785524|18966691|P2|STARTED|Overall Study||4
7702598|NCT01785524|18966692|P1|STARTED|Overall Study||7
7702599|NCT01785472|18966711|P3|NOT COMPLETED|Overall Study||22
7702600|NCT01785472|18966712|P2|NOT COMPLETED|Overall Study||19
7702601|NCT01785472|18966713|P1|NOT COMPLETED|Overall Study||24
7702602|NCT01785472|18966711|P3|COMPLETED|Overall Study||464
7702603|NCT01785472|18966712|P2|COMPLETED|Overall Study||454
7702604|NCT01785472|18966713|P1|COMPLETED|Overall Study||455
7702605|NCT01785472|18966711|P3|Safety Set (SAF)|Overall Study||484
7702606|NCT01785472|18966712|P2|Safety Set (SAF)|Overall Study||472
7702607|NCT01785472|18966713|P1|Safety Set (SAF)|Overall Study||478
7702608|NCT01785472|18966711|P3|Full Analysis Set (FAS)|Overall Study||484
7702609|NCT01785472|18966712|P2|Full Analysis Set (FAS)|Overall Study||472
7702610|NCT01785472|18966713|P1|Full Analysis Set (FAS)|Overall Study||479
7702611|NCT01785472|18966711|P3|STARTED|Overall Study||486
7702612|NCT01785472|18966712|P2|STARTED|Overall Study||473
7702613|NCT01785472|18966713|P1|STARTED|Overall Study||479
7702614|NCT01785459|18966757|P2|NOT COMPLETED|Overall Study||0
7702615|NCT01785459|18966758|P1|NOT COMPLETED|Overall Study||0
7702616|NCT01785459|18966757|P2|COMPLETED|Overall Study||12
7702617|NCT01785459|18966758|P1|COMPLETED|Overall Study||11
7702618|NCT01785459|18966757|P2|STARTED|Overall Study||12
7702619|NCT01785459|18966758|P1|STARTED|Overall Study||11
7702620|NCT01785186|18966773|P5|NOT COMPLETED|Overall Study||6
7702621|NCT01785186|18966774|P4|NOT COMPLETED|Overall Study||5
7702622|NCT01785186|18966775|P3|NOT COMPLETED|Overall Study||5
7702623|NCT01785186|18966776|P2|NOT COMPLETED|Overall Study||6
7702624|NCT01785186|18966777|P1|NOT COMPLETED|Overall Study||6
7702625|NCT01785186|18966773|P5|COMPLETED|Overall Study||117
7702626|NCT01785186|18966774|P4|COMPLETED|Overall Study||58
7702627|NCT01785186|18966775|P3|COMPLETED|Overall Study||52
7702628|NCT01785186|18966776|P2|COMPLETED|Overall Study||57
7702629|NCT01785186|18966777|P1|COMPLETED|Overall Study||53
7702630|NCT01785186|18966773|P5|STARTED|Overall Study||123
7702631|NCT01785186|18966774|P4|STARTED|Overall Study||63
7702632|NCT01785186|18966775|P3|STARTED|Overall Study||57
7702633|NCT01785186|18966776|P2|STARTED|Overall Study||63
7702634|NCT01785186|18966777|P1|STARTED|Overall Study||59
7702635|NCT01785160|18966799|P1|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0
7702636|NCT01785160|18966799|P1|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23
7702637|NCT01785160|18966799|P1|STARTED|Treatment Period 2: Raltegravir + Faldap||23
7702638|NCT01785160|18966799|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
7702639|NCT01785160|18966799|P1|COMPLETED|Washout Period of at Least 7 Days||23
7702640|NCT01785160|18966799|P1|STARTED|Washout Period of at Least 7 Days||24
7702641|NCT01785160|18966799|P1|NOT COMPLETED|Treatment Period 1: Raltegravir||1
7702642|NCT01785160|18966799|P1|COMPLETED|Treatment Period 1: Raltegravir||24
7702643|NCT01785160|18966799|P1|STARTED|Treatment Period 1: Raltegravir||25
7702644|NCT01785134|18966809|P2|NOT COMPLETED|Overall Study||7
7702645|NCT01785134|18966810|P1|NOT COMPLETED|Overall Study||12
7702646|NCT01785134|18966809|P2|COMPLETED|Overall Study||33
7702647|NCT01785134|18966810|P1|COMPLETED|Overall Study||29
7702648|NCT01785134|18966809|P2|STARTED|Overall Study||40
7702649|NCT01785134|18966810|P1|STARTED|Overall Study||41
7702650|NCT01785095|18966824|P1|NOT COMPLETED|Overall Study||3
7702651|NCT01785095|18966824|P1|COMPLETED|Overall Study||24
7702652|NCT01785095|18966824|P1|STARTED|Overall Study||27
7702653|NCT01785069|18966836|P4|NOT COMPLETED|Overall Study||14
7702654|NCT01785069|18966837|P3|NOT COMPLETED|Overall Study||13
7702655|NCT01785069|18966838|P2|NOT COMPLETED|Overall Study||12
7702656|NCT01785069|18966839|P1|NOT COMPLETED|Overall Study||12
7702657|NCT01785069|18966836|P4|COMPLETED|Overall Study||54
7702658|NCT01785069|18966837|P3|COMPLETED|Overall Study||91
7702659|NCT01785069|18966838|P2|COMPLETED|Overall Study||64
7702660|NCT01785069|18966839|P1|COMPLETED|Overall Study||95
7702661|NCT01785069|18966836|P4|STARTED|Overall Study||68
7702662|NCT01785069|18966837|P3|STARTED|Overall Study||104
7702663|NCT01785069|18966838|P2|STARTED|Overall Study||76
7702664|NCT01785069|18966839|P1|STARTED|Overall Study||107
7702665|NCT01784991|18966867|P2|NOT COMPLETED|Overall Study||0
7702666|NCT01784991|18966868|P1|NOT COMPLETED|Overall Study||0
7702667|NCT01784991|18966867|P2|COMPLETED|Overall Study||0
7702668|NCT01784991|18966868|P1|COMPLETED|Overall Study||0
7702669|NCT01784991|18966867|P2|STARTED|Overall Study||0
7702670|NCT01784991|18966868|P1|STARTED|Overall Study||0
7702671|NCT01784965|18966888|P2|NOT COMPLETED|Overall Study||11
7702672|NCT01784965|18966889|P1|NOT COMPLETED|Overall Study||6
7702673|NCT01784965|18966888|P2|COMPLETED|Overall Study||24
7702674|NCT01784965|18966889|P1|COMPLETED|Overall Study||27
7702675|NCT01784965|18966888|P2|STARTED|Overall Study||35
7702676|NCT01784965|18966889|P1|STARTED|Overall Study||33
7702677|NCT01784926|18966901|P2|NOT COMPLETED|Overall Study||8
7702678|NCT01784926|18966902|P1|NOT COMPLETED|Overall Study||11
7702679|NCT01784926|18966901|P2|COMPLETED|Overall Study||42
7702680|NCT01784926|18966902|P1|COMPLETED|Overall Study||43
7702681|NCT01784926|18966901|P2|STARTED|Overall Study||50
7702682|NCT01784926|18966902|P1|STARTED|Overall Study||54
7702683|NCT01784848|18966920|P2|NOT COMPLETED|Overall Study||3
7702684|NCT01784848|18966921|P1|NOT COMPLETED|Overall Study||1
7702685|NCT01784848|18966920|P2|COMPLETED|Overall Study||47
7702686|NCT01784848|18966921|P1|COMPLETED|Overall Study||49
7702687|NCT01784848|18966920|P2|STARTED|Overall Study||50
7702688|NCT01784848|18966921|P1|STARTED|Overall Study||50
7702689|NCT01784796|18966929|P2|NOT COMPLETED|Overall Study||23
7702690|NCT01784796|18966930|P1|NOT COMPLETED|Overall Study||35
7702691|NCT01784796|18966929|P2|COMPLETED|Overall Study||35
7702692|NCT01784796|18966930|P1|COMPLETED|Overall Study||39
7702693|NCT01784796|18966929|P2|8 wk Data Collection|Overall Study||39
7702694|NCT01784796|18966930|P1|8 wk Data Collection|Overall Study||56
7702695|NCT01784796|18966929|P2|4 Week Data Collection|Overall Study||43
7702696|NCT01784796|18966930|P1|4 Week Data Collection|Overall Study||47
7702697|NCT01784796|18966929|P2|Baseline Data Collected|Overall Study||58
7702698|NCT01784796|18966930|P1|Baseline Data Collected|Overall Study||68
7702699|NCT01784796|18966929|P2|STARTED|Overall Study|These are participants who provided informed consent|58
7702700|NCT01784796|18966930|P1|STARTED|Overall Study|These are participants who provided informed consent|74
7702701|NCT01784770|18966942|P1|NOT COMPLETED|Overall Study||0
7702702|NCT01784770|18966942|P1|COMPLETED|Overall Study||21
7702703|NCT01784770|18966942|P1|STARTED|Overall Study||21
7702704|NCT01784666|18966950|P3|NOT COMPLETED|Overall Study||0
7702705|NCT01784666|18966951|P2|NOT COMPLETED|Overall Study||0
7702706|NCT01784666|18966952|P1|NOT COMPLETED|Overall Study||0
7702707|NCT01784666|18966950|P3|COMPLETED|Overall Study||1
7702708|NCT01784666|18966951|P2|COMPLETED|Overall Study||0
7702709|NCT01784666|18966952|P1|COMPLETED|Overall Study||1
7702710|NCT01784666|18966950|P3|STARTED|Overall Study||1
7702711|NCT01784666|18966951|P2|STARTED|Overall Study||0
7702712|NCT01784666|18966952|P1|STARTED|Overall Study||1
7702713|NCT01784614|18966960|P8|NOT COMPLETED|Period 4||0
7702714|NCT01784614|18966961|P7|NOT COMPLETED|Period 4||0
7702715|NCT01784614|18966962|P6|NOT COMPLETED|Period 4||0
7702716|NCT01784614|18966963|P5|NOT COMPLETED|Period 4||0
7702717|NCT01784614|18966964|P4|NOT COMPLETED|Period 4||0
7702718|NCT01784614|18966965|P3|NOT COMPLETED|Period 4||0
7702719|NCT01784614|18966966|P2|NOT COMPLETED|Period 4||0
7702720|NCT01784614|18966967|P1|NOT COMPLETED|Period 4||0
7702721|NCT01784614|18966960|P8|COMPLETED|Period 4||2
7702722|NCT01784614|18966961|P7|COMPLETED|Period 4||3
7702723|NCT01784614|18966962|P6|COMPLETED|Period 4||3
7702724|NCT01784614|18966963|P5|COMPLETED|Period 4||3
7702725|NCT01784614|18966964|P4|COMPLETED|Period 4||3
7702726|NCT01784614|18966965|P3|COMPLETED|Period 4||3
7702727|NCT01784614|18966966|P2|COMPLETED|Period 4||2
7702728|NCT01784614|18966967|P1|COMPLETED|Period 4||3
7702729|NCT01784614|18966960|P8|STARTED|Period 4||2
7702730|NCT01784614|18966961|P7|STARTED|Period 4||3
7702731|NCT01784614|18966962|P6|STARTED|Period 4||3
7702732|NCT01784614|18966963|P5|STARTED|Period 4||3
7702733|NCT01784614|18966964|P4|STARTED|Period 4||3
7702734|NCT01784614|18966965|P3|STARTED|Period 4||3
7702735|NCT01784614|18966966|P2|STARTED|Period 4||2
7702736|NCT01784614|18966967|P1|STARTED|Period 4||3
7702737|NCT01784614|18966960|P8|NOT COMPLETED|Period 3||0
7702738|NCT01784614|18966961|P7|NOT COMPLETED|Period 3||0
7702739|NCT01784614|18966962|P6|NOT COMPLETED|Period 3||0
7702740|NCT01784614|18966963|P5|NOT COMPLETED|Period 3||0
7702741|NCT01784614|18966964|P4|NOT COMPLETED|Period 3||0
7702742|NCT01784614|18966965|P3|NOT COMPLETED|Period 3||0
7702743|NCT01784614|18966966|P2|NOT COMPLETED|Period 3||0
7702744|NCT01784614|18966967|P1|NOT COMPLETED|Period 3||0
7702745|NCT01784614|18966960|P8|COMPLETED|Period 3||2
7702746|NCT01784614|18966961|P7|COMPLETED|Period 3||3
7702747|NCT01784614|18966962|P6|COMPLETED|Period 3||3
7702748|NCT01784614|18966963|P5|COMPLETED|Period 3||3
7702749|NCT01784614|18966964|P4|COMPLETED|Period 3||3
7702750|NCT01784614|18966965|P3|COMPLETED|Period 3||3
7702751|NCT01784614|18966966|P2|COMPLETED|Period 3||2
7702752|NCT01784614|18966967|P1|COMPLETED|Period 3||3
7702753|NCT01784614|18966960|P8|STARTED|Period 3||2
7702754|NCT01784614|18966961|P7|STARTED|Period 3||3
7702755|NCT01784614|18966962|P6|STARTED|Period 3||3
7702756|NCT01784614|18966963|P5|STARTED|Period 3||3
7702757|NCT01784614|18966964|P4|STARTED|Period 3||3
7702758|NCT01784614|18966965|P3|STARTED|Period 3||3
7702759|NCT01784614|18966966|P2|STARTED|Period 3||2
7702760|NCT01784614|18966967|P1|STARTED|Period 3||3
7702761|NCT01784614|18966960|P8|NOT COMPLETED|Period 2||0
7702762|NCT01784614|18966961|P7|NOT COMPLETED|Period 2||0
7702763|NCT01784614|18966962|P6|NOT COMPLETED|Period 2||0
7702764|NCT01784614|18966963|P5|NOT COMPLETED|Period 2||0
7702765|NCT01784614|18966964|P4|NOT COMPLETED|Period 2||0
7702766|NCT01784614|18966965|P3|NOT COMPLETED|Period 2||0
7702767|NCT01784614|18966966|P2|NOT COMPLETED|Period 2||0
7702768|NCT01784614|18966967|P1|NOT COMPLETED|Period 2||0
7702769|NCT01784614|18966960|P8|COMPLETED|Period 2||2
7702770|NCT01784614|18966961|P7|COMPLETED|Period 2||3
7702771|NCT01784614|18966962|P6|COMPLETED|Period 2||3
7702772|NCT01784614|18966963|P5|COMPLETED|Period 2||3
7702773|NCT01784614|18966964|P4|COMPLETED|Period 2||3
7702774|NCT01784614|18966965|P3|COMPLETED|Period 2||3
7702775|NCT01784614|18966966|P2|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3
7702776|NCT01784614|18966967|P1|COMPLETED|Period 2||3
7702777|NCT01784614|18966960|P8|STARTED|Period 2||2
7702778|NCT01784614|18966961|P7|STARTED|Period 2||3
7702779|NCT01784614|18966962|P6|STARTED|Period 2||3
7702780|NCT01784614|18966963|P5|STARTED|Period 2||3
7702781|NCT01784614|18966964|P4|STARTED|Period 2||3
7702782|NCT01784614|18966965|P3|STARTED|Period 2||3
7702783|NCT01784614|18966966|P2|STARTED|Period 2||3
7702784|NCT01784614|18966967|P1|STARTED|Period 2||3
7702785|NCT01784614|18966960|P8|NOT COMPLETED|Period 1||0
7702786|NCT01784614|18966961|P7|NOT COMPLETED|Period 1||0
7702787|NCT01784614|18966962|P6|NOT COMPLETED|Period 1||0
7702788|NCT01784614|18966963|P5|NOT COMPLETED|Period 1||0
7702789|NCT01784614|18966964|P4|NOT COMPLETED|Period 1||0
7702790|NCT01784614|18966965|P3|NOT COMPLETED|Period 1||0
7702791|NCT01784614|18966966|P2|NOT COMPLETED|Period 1||0
7702792|NCT01784614|18966967|P1|NOT COMPLETED|Period 1||0
7702793|NCT01784614|18966960|P8|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3
7702794|NCT01784614|18966961|P7|COMPLETED|Period 1||3
7702795|NCT01784614|18966962|P6|COMPLETED|Period 1||3
7702796|NCT01784614|18966963|P5|COMPLETED|Period 1||3
7702797|NCT01784614|18966964|P4|COMPLETED|Period 1||3
7702798|NCT01784614|18966965|P3|COMPLETED|Period 1||3
7702799|NCT01784614|18966966|P2|COMPLETED|Period 1||3
7702800|NCT01784614|18966967|P1|COMPLETED|Period 1||3
7702801|NCT01784614|18966960|P8|Received at Least 1 Dose of Study Drug|Period 1||3
7702802|NCT01784614|18966961|P7|Received at Least 1 Dose of Study Drug|Period 1||3
7702803|NCT01784614|18966962|P6|Received at Least 1 Dose of Study Drug|Period 1||3
7702804|NCT01784614|18966963|P5|Received at Least 1 Dose of Study Drug|Period 1||3
7702805|NCT01784614|18966964|P4|Received at Least 1 Dose of Study Drug|Period 1||3
7702806|NCT01784614|18966965|P3|Received at Least 1 Dose of Study Drug|Period 1||3
7702807|NCT01784614|18966966|P2|Received at Least 1 Dose of Study Drug|Period 1||3
7702808|NCT01784614|18966967|P1|Received at Least 1 Dose of Study Drug|Period 1||3
7702809|NCT01784614|18966960|P8|STARTED|Period 1||3
7702810|NCT01784614|18966961|P7|STARTED|Period 1||3
7702811|NCT01784614|18966962|P6|STARTED|Period 1||3
7702812|NCT01784614|18966963|P5|STARTED|Period 1||3
7702813|NCT01784614|18966964|P4|STARTED|Period 1||3
7702814|NCT01784614|18966965|P3|STARTED|Period 1||3
7702815|NCT01784614|18966966|P2|STARTED|Period 1||3
7702816|NCT01784614|18966967|P1|STARTED|Period 1||3
7702817|NCT01784588|18967003|P2|NOT COMPLETED|Overall Study||32
7702818|NCT01784588|18967004|P1|NOT COMPLETED|Overall Study||37
7702819|NCT01784588|18967003|P2|COMPLETED|Overall Study||108
7702820|NCT01784588|18967004|P1|COMPLETED|Overall Study||104
7702821|NCT01784588|18967003|P2|STARTED|Overall Study||140
7702822|NCT01784588|18967004|P1|STARTED|Overall Study||141
7702823|NCT01784419|18967010|P1|NOT COMPLETED|Overall Study||3
7702824|NCT01784419|18967010|P1|COMPLETED|Overall Study||7
7702825|NCT01784419|18967010|P1|STARTED|Overall Study||10
7702826|NCT01784211|18967018|P6|NOT COMPLETED|Part B (Days 16-21)||0
7702827|NCT01784211|18967019|P5|NOT COMPLETED|Part B (Days 16-21)||0
7702828|NCT01784211|18967020|P4|NOT COMPLETED|Part B (Days 16-21)||0
7702829|NCT01784211|18967021|P3|NOT COMPLETED|Part B (Days 16-21)||0
7702830|NCT01784211|18967022|P2|NOT COMPLETED|Part B (Days 16-21)||0
7702831|NCT01784211|18967023|P1|NOT COMPLETED|Part B (Days 16-21)||0
7702832|NCT01784211|18967018|P6|COMPLETED|Part B (Days 16-21)||10
7702833|NCT01784211|18967019|P5|COMPLETED|Part B (Days 16-21)||11
7702834|NCT01784211|18967020|P4|COMPLETED|Part B (Days 16-21)||9
7702835|NCT01784211|18967021|P3|COMPLETED|Part B (Days 16-21)||10
7702836|NCT01784211|18967022|P2|COMPLETED|Part B (Days 16-21)||0
7702837|NCT01784211|18967023|P1|COMPLETED|Part B (Days 16-21)||0
7702838|NCT01784211|18967018|P6|STARTED|Part B (Days 16-21)||10
7702839|NCT01784211|18967019|P5|STARTED|Part B (Days 16-21)||11
7702840|NCT01784211|18967020|P4|STARTED|Part B (Days 16-21)||9
7702841|NCT01784211|18967021|P3|STARTED|Part B (Days 16-21)||10
7702842|NCT01784211|18967022|P2|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
7702843|NCT01784211|18967023|P1|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
7702844|NCT01784211|18967018|P6|NOT COMPLETED|Part A (Days 1-15)||0
7702845|NCT01784211|18967019|P5|NOT COMPLETED|Part A (Days 1-15)||0
7702846|NCT01784211|18967020|P4|NOT COMPLETED|Part A (Days 1-15)||0
7702847|NCT01784211|18967021|P3|NOT COMPLETED|Part A (Days 1-15)||0
7702848|NCT01784211|18967022|P2|NOT COMPLETED|Part A (Days 1-15)||2
7702849|NCT01784211|18967023|P1|NOT COMPLETED|Part A (Days 1-15)||3
7702850|NCT01784211|18967018|P6|COMPLETED|Part A (Days 1-15)||0
7702851|NCT01784211|18967019|P5|COMPLETED|Part A (Days 1-15)||0
7702852|NCT01784211|18967020|P4|COMPLETED|Part A (Days 1-15)||0
7702853|NCT01784211|18967021|P3|COMPLETED|Part A (Days 1-15)||0
7702854|NCT01784211|18967022|P2|COMPLETED|Part A (Days 1-15)||36
7702855|NCT01784211|18967023|P1|COMPLETED|Part A (Days 1-15)||35
7702856|NCT01784211|18967018|P6|Entered Part B|Part A (Days 1-15)||0
7702857|NCT01784211|18967019|P5|Entered Part B|Part A (Days 1-15)||0
7702858|NCT01784211|18967020|P4|Entered Part B|Part A (Days 1-15)||0
7702859|NCT01784211|18967021|P3|Entered Part B|Part A (Days 1-15)||0
7702860|NCT01784211|18967022|P2|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|21
7702861|NCT01784211|18967023|P1|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|19
7702862|NCT01784211|18967018|P6|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
7702863|NCT01784211|18967019|P5|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
7702864|NCT01784211|18967020|P4|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
7702865|NCT01784211|18967021|P3|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
7702866|NCT01784211|18967022|P2|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||38
7702867|NCT01784211|18967023|P1|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||37
7702868|NCT01784211|18967018|P6|STARTED|Part A (Days 1-15)||0
7702869|NCT01784211|18967019|P5|STARTED|Part A (Days 1-15)||0
7702870|NCT01784211|18967020|P4|STARTED|Part A (Days 1-15)||0
7702871|NCT01784211|18967021|P3|STARTED|Part A (Days 1-15)||0
7702872|NCT01784211|18967022|P2|STARTED|Part A (Days 1-15)||38
7702873|NCT01784211|18967023|P1|STARTED|Part A (Days 1-15)||38
7702874|NCT01784055|18967041|P1|NOT COMPLETED|Overall Study||26
7702875|NCT01784055|18967041|P1|COMPLETED|Overall Study||100
7702876|NCT01784055|18967041|P1|STARTED|Overall Study||126
7702877|NCT01784029|18967048|P3|NOT COMPLETED|Overall Study||22
7702878|NCT01784029|18967049|P2|NOT COMPLETED|Overall Study||20
7702879|NCT01784029|18967050|P1|NOT COMPLETED|Overall Study||19
7702880|NCT01784029|18967048|P3|COMPLETED|Overall Study||41
7702881|NCT01784029|18967049|P2|COMPLETED|Overall Study||39
7702882|NCT01784029|18967050|P1|COMPLETED|Overall Study||42
7702883|NCT01784029|18967048|P3|STARTED|Overall Study||63
7702884|NCT01784029|18967049|P2|STARTED|Overall Study||59
7702885|NCT01784029|18967050|P1|STARTED|Overall Study||61
7702886|NCT01783990|18967060|P2|NOT COMPLETED|Overall Study||2
7702887|NCT01783990|18967061|P1|NOT COMPLETED|Overall Study||5
7702888|NCT01783990|18967060|P2|COMPLETED|Overall Study||18
7702889|NCT01783990|18967061|P1|COMPLETED|Overall Study||125
7702890|NCT01783990|18967060|P2|STARTED|Overall Study||20
7702891|NCT01783990|18967061|P1|STARTED|Overall Study||130
7702892|NCT01783938|18967079|P2|NOT COMPLETED|Overall Study||53
7702893|NCT01783938|18967080|P1|NOT COMPLETED|Overall Study||47
7702894|NCT01783938|18967079|P2|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|17
7702895|NCT01783938|18967080|P1|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|21
7702896|NCT01783938|18967079|P2|STARTED|Overall Study||70
7702897|NCT01783938|18967080|P1|STARTED|Overall Study||68
7702898|NCT01783912|18967095|P3|NOT COMPLETED|Overall Study||23
7702899|NCT01783912|18967096|P2|NOT COMPLETED|Overall Study||46
7702900|NCT01783912|18967097|P1|NOT COMPLETED|Overall Study||30
7702901|NCT01783912|18967095|P3|COMPLETED|Overall Study||25
7702902|NCT01783912|18967096|P2|COMPLETED|Overall Study||58
7702903|NCT01783912|18967097|P1|COMPLETED|Overall Study||88
7702904|NCT01783912|18967095|P3|STARTED|Overall Study||48
7702905|NCT01783912|18967096|P2|STARTED|Overall Study||104
7702906|NCT01783912|18967097|P1|STARTED|Overall Study||118
7702907|NCT01783886|18967108|P3|NOT COMPLETED|Overall Study||10
7702908|NCT01783886|18967109|P2|NOT COMPLETED|Overall Study||11
7702909|NCT01783886|18967110|P1|NOT COMPLETED|Overall Study||5
7702910|NCT01783886|18967108|P3|COMPLETED|Overall Study||117
7702911|NCT01783886|18967109|P2|COMPLETED|Overall Study||116
7702912|NCT01783886|18967110|P1|COMPLETED|Overall Study||122
7702913|NCT01783886|18967108|P3|Participants Received Treatment|Overall Study||124
7702914|NCT01783886|18967109|P2|Participants Received Treatment|Overall Study||127
7702915|NCT01783886|18967110|P1|Participants Received Treatment|Overall Study||127
7702916|NCT01783886|18967108|P3|STARTED|Overall Study||127
7702917|NCT01783886|18967109|P2|STARTED|Overall Study||127
7702918|NCT01783886|18967110|P1|STARTED|Overall Study||127
7702919|NCT01783860|18967138|P2|NOT COMPLETED|Overall Study||0
7702920|NCT01783860|18967139|P1|NOT COMPLETED|Overall Study||0
7702921|NCT01783860|18967138|P2|COMPLETED|Overall Study||50
7702922|NCT01783860|18967139|P1|COMPLETED|Overall Study||50
7702923|NCT01783860|18967138|P2|STARTED|Overall Study||50
7702924|NCT01783860|18967139|P1|STARTED|Overall Study||50
7702925|NCT01783847|18967158|P3|NOT COMPLETED|Overall Study||0
7702926|NCT01783847|18967159|P2|NOT COMPLETED|Overall Study||1
7702927|NCT01783847|18967160|P1|NOT COMPLETED|Overall Study||16
7702928|NCT01783847|18967158|P3|COMPLETED|Overall Study||16
7702929|NCT01783847|18967159|P2|COMPLETED|Overall Study||15
7702930|NCT01783847|18967160|P1|COMPLETED|Overall Study||69
7702931|NCT01783847|18967158|P3|STARTED|Overall Study||16
7702932|NCT01783847|18967159|P2|STARTED|Overall Study||16
7702933|NCT01783847|18967160|P1|STARTED|Overall Study||85
7702934|NCT01783821|18967173|P2|NOT COMPLETED|Overall Study||1
7702935|NCT01783821|18967174|P1|NOT COMPLETED|Overall Study||1
7702936|NCT01783821|18967173|P2|COMPLETED|Overall Study||30
7702937|NCT01783821|18967174|P1|COMPLETED|Overall Study||29
7702938|NCT01783821|18967173|P2|STARTED|Overall Study||31
7702939|NCT01783821|18967174|P1|STARTED|Overall Study||30
7702940|NCT01783743|18967192|P2|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10920
7702941|NCT01783743|18967193|P1|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10896
7702942|NCT01783743|18967192|P2|COMPLETED|Rescreening of Subjects by Senior Grader||3044
7702943|NCT01783743|18967193|P1|COMPLETED|Rescreening of Subjects by Senior Grader||2613
7702944|NCT01783743|18967192|P2|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||849
7702945|NCT01783743|18967193|P1|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||846
7702946|NCT01783743|18967192|P2|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1786
7702947|NCT01783743|18967193|P1|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1721
7702948|NCT01783743|18967192|P2|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||409
7702949|NCT01783743|18967193|P1|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||46
7702950|NCT01783743|18967192|P2|STARTED|Rescreening of Subjects by Senior Grader||13964
7702951|NCT01783743|18967193|P1|STARTED|Rescreening of Subjects by Senior Grader||13509
7702952|NCT01783743|18967192|P2|NOT COMPLETED|Screening of Subjects by CTA During MDA||4439
7702953|NCT01783743|18967193|P1|NOT COMPLETED|Screening of Subjects by CTA During MDA||3427
7702954|NCT01783743|18967192|P2|COMPLETED|Screening of Subjects by CTA During MDA||9525
7702955|NCT01783743|18967193|P1|COMPLETED|Screening of Subjects by CTA During MDA||10082
7702956|NCT01783743|18967192|P2|STARTED|Screening of Subjects by CTA During MDA||13964
7702957|NCT01783743|18967193|P1|STARTED|Screening of Subjects by CTA During MDA||13509
7702958|NCT01783730|18967207|P1|NOT COMPLETED|Overall Study||6
7702959|NCT01783730|18967207|P1|COMPLETED|Overall Study||157
7702960|NCT01783730|18967207|P1|STARTED|Overall Study||163
7702961|NCT01783678|18967232|P6|NOT COMPLETED|Overall Study||5
7702962|NCT01783678|18967233|P5|NOT COMPLETED|Overall Study||7
7702963|NCT01783678|18967234|P4|NOT COMPLETED|Overall Study||8
7702964|NCT01783678|18967235|P3|NOT COMPLETED|Overall Study||1
7702965|NCT01783678|18967236|P2|NOT COMPLETED|Overall Study||18
7702966|NCT01783678|18967237|P1|NOT COMPLETED|Overall Study||2
7702967|NCT01783678|18967232|P6|COMPLETED|Overall Study||26
7702968|NCT01783678|18967233|P5|COMPLETED|Overall Study||42
7702969|NCT01783678|18967234|P4|COMPLETED|Overall Study||50
7702970|NCT01783678|18967235|P3|COMPLETED|Overall Study||5
7702971|NCT01783678|18967236|P2|COMPLETED|Overall Study||94
7702972|NCT01783678|18967237|P1|COMPLETED|Overall Study||17
7702973|NCT01783678|18967232|P6|STARTED|Overall Study||31
7702974|NCT01783678|18967233|P5|STARTED|Overall Study||49
7702975|NCT01783678|18967234|P4|STARTED|Overall Study||58
7702976|NCT01783678|18967235|P3|STARTED|Overall Study||6
7702977|NCT01783678|18967236|P2|STARTED|Overall Study||112
7702978|NCT01783678|18967237|P1|STARTED|Overall Study||19
7702979|NCT01783639|18967309|P1|NOT COMPLETED|Overall Study||0
7702980|NCT01783639|18967309|P1|COMPLETED|Overall Study||120
7702981|NCT01783639|18967309|P1|STARTED|Overall Study||120
7702982|NCT01783574|18967315|P2|NOT COMPLETED|Overall Study||9
7702983|NCT01783574|18967316|P1|NOT COMPLETED|Overall Study||5
7702984|NCT01783574|18967315|P2|COMPLETED|Overall Study||41
7702985|NCT01783574|18967316|P1|COMPLETED|Overall Study||46
7702986|NCT01783574|18967315|P2|STARTED|Overall Study||50
7702987|NCT01783574|18967316|P1|STARTED|Overall Study||51
7702988|NCT01783561|18967328|P2|NOT COMPLETED|Overall Study||0
7702989|NCT01783561|18967329|P1|NOT COMPLETED|Overall Study||0
7702990|NCT01783561|18967328|P2|COMPLETED|Overall Study||10
7702991|NCT01783561|18967329|P1|COMPLETED|Overall Study||11
7702992|NCT01783561|18967328|P2|STARTED|Overall Study||10
7702993|NCT01783561|18967329|P1|STARTED|Overall Study||11
7702994|NCT01783548|18967341|P2|NOT COMPLETED|Overall Study||18
7702995|NCT01783548|18967342|P1|NOT COMPLETED|Overall Study||34
7702996|NCT01783548|18967341|P2|COMPLETED|Overall Study||167
7702997|NCT01783548|18967342|P1|COMPLETED|Overall Study||328
7702998|NCT01783548|18967341|P2|Full Analysis Set (FAS)|Overall Study||184
7702999|NCT01783548|18967342|P1|Full Analysis Set (FAS)|Overall Study||358
7703000|NCT01783548|18967341|P2|STARTED|Overall Study|Randomized|185
7703001|NCT01783548|18967342|P1|STARTED|Overall Study|Randomized|362
7703002|NCT01783522|18967356|P2|NOT COMPLETED|Overall Study||0
7703003|NCT01783522|18967357|P1|NOT COMPLETED|Overall Study||0
7703004|NCT01783522|18967356|P2|COMPLETED|Overall Study||5
7703005|NCT01783522|18967357|P1|COMPLETED|Overall Study||4
7703006|NCT01783522|18967356|P2|STARTED|Overall Study||5
7703007|NCT01783522|18967357|P1|STARTED|Overall Study||4
7703008|NCT01783496|18967375|P6|NOT COMPLETED|Overall Study||1
7703009|NCT01783496|18967376|P5|NOT COMPLETED|Overall Study||0
7703010|NCT01783496|18967377|P4|NOT COMPLETED|Overall Study||2
7703011|NCT01783496|18967378|P3|NOT COMPLETED|Overall Study||0
7703012|NCT01783496|18967379|P2|NOT COMPLETED|Overall Study||0
7703013|NCT01783496|18967380|P1|NOT COMPLETED|Overall Study||1
7703014|NCT01783496|18967375|P6|COMPLETED|Overall Study||4
7703015|NCT01783496|18967376|P5|COMPLETED|Overall Study||5
7703016|NCT01783496|18967377|P4|COMPLETED|Overall Study||8
7703017|NCT01783496|18967378|P3|COMPLETED|Overall Study||10
7703018|NCT01783496|18967379|P2|COMPLETED|Overall Study||10
7703019|NCT01783496|18967380|P1|COMPLETED|Overall Study||9
7703020|NCT01783496|18967375|P6|STARTED|Overall Study||5
7703021|NCT01783496|18967376|P5|STARTED|Overall Study||5
7703022|NCT01783496|18967377|P4|STARTED|Overall Study||10
7703023|NCT01783496|18967378|P3|STARTED|Overall Study||10
7703024|NCT01783496|18967379|P2|STARTED|Overall Study||10
7703025|NCT01783496|18967380|P1|STARTED|Overall Study||10
7703026|NCT01783483|18967408|P2|NOT COMPLETED|Overall Study||15
7703027|NCT01783483|18967409|P1|NOT COMPLETED|Overall Study||20
7703028|NCT01783483|18967408|P2|COMPLETED|Overall Study||101
7703029|NCT01783483|18967409|P1|COMPLETED|Overall Study||100
7703030|NCT01783483|18967408|P2|STARTED|Overall Study||116
7703031|NCT01783483|18967409|P1|STARTED|Overall Study||120
7703032|NCT01783470|18967437|P2|NOT COMPLETED|Overall Study||0
7703033|NCT01783470|18967438|P1|NOT COMPLETED|Overall Study||0
7703034|NCT01783470|18967437|P2|COMPLETED|Overall Study||6
7703035|NCT01783470|18967438|P1|COMPLETED|Overall Study||6
7703036|NCT01783470|18967437|P2|STARTED|Overall Study|Single-dose|6
7703037|NCT01783470|18967438|P1|STARTED|Overall Study||6
7703038|NCT01783418|18967447|P2|NOT COMPLETED|Overall Study||0
7703039|NCT01783418|18967448|P1|NOT COMPLETED|Overall Study||1
7703040|NCT01783418|18967447|P2|COMPLETED|Overall Study||6
7703041|NCT01783418|18967448|P1|COMPLETED|Overall Study||7
7703042|NCT01783418|18967447|P2|STARTED|Overall Study||6
7703043|NCT01783418|18967448|P1|STARTED|Overall Study||8
7703044|NCT01783236|18967468|P2|NOT COMPLETED|Overall Study||0
7703045|NCT01783236|18967469|P1|NOT COMPLETED|Overall Study||2
7703046|NCT01783236|18967468|P2|COMPLETED|Overall Study||8
7703047|NCT01783236|18967469|P1|COMPLETED|Overall Study||6
7703048|NCT01783236|18967468|P2|STARTED|Overall Study||8
7703049|NCT01783236|18967469|P1|STARTED|Overall Study||8
7703050|NCT01783080|18967483|P1|NOT COMPLETED|Overall Study||0
7703051|NCT01783080|18967483|P1|COMPLETED|Overall Study||16
7703052|NCT01783080|18967483|P1|STARTED|Overall Study||16
7703053|NCT01783054|18967490|P1|NOT COMPLETED|Overall Study||0
7703054|NCT01783054|18967490|P1|COMPLETED|Overall Study||2
7703055|NCT01783054|18967490|P1|STARTED|Overall Study||2
7703056|NCT01783015|18967501|P3|NOT COMPLETED|Open Label Treatment||6
7703057|NCT01783015|18967502|P2|NOT COMPLETED|Open Label Treatment||0
7703058|NCT01783015|18967503|P1|NOT COMPLETED|Open Label Treatment||0
7703059|NCT01783015|18967501|P3|COMPLETED|Open Label Treatment||5
7703060|NCT01783015|18967502|P2|COMPLETED|Open Label Treatment||0
7703061|NCT01783015|18967503|P1|COMPLETED|Open Label Treatment||0
7703062|NCT01783015|18967501|P3|STARTED|Open Label Treatment||11
7703063|NCT01783015|18967502|P2|STARTED|Open Label Treatment||0
7703064|NCT01783015|18967503|P1|STARTED|Open Label Treatment||0
7703065|NCT01783015|18967501|P3|NOT COMPLETED|Blinded Treatment||0
7703066|NCT01783015|18967502|P2|NOT COMPLETED|Blinded Treatment||3
7703067|NCT01783015|18967503|P1|NOT COMPLETED|Blinded Treatment||2
7703068|NCT01783015|18967501|P3|COMPLETED|Blinded Treatment||0
7703069|NCT01783015|18967502|P2|COMPLETED|Blinded Treatment||2
7703070|NCT01783015|18967503|P1|COMPLETED|Blinded Treatment||9
7703071|NCT01783015|18967501|P3|Treated|Blinded Treatment||0
7703072|NCT01783015|18967502|P2|Treated|Blinded Treatment||5
7703073|NCT01783015|18967503|P1|Treated|Blinded Treatment||11
7703074|NCT01783015|18967501|P3|STARTED|Blinded Treatment||0
7703075|NCT01783015|18967502|P2|STARTED|Blinded Treatment||5
7703076|NCT01783015|18967503|P1|STARTED|Blinded Treatment||11
7703077|NCT01782963|18967588|P1|NOT COMPLETED|Overall Study||0
7703078|NCT01782963|18967588|P1|COMPLETED|Overall Study||50
7703079|NCT01782963|18967588|P1|STARTED|Overall Study||50
7703080|NCT01782898|18967603|P2|NOT COMPLETED|Overall Study||6
7703081|NCT01782898|18967604|P1|NOT COMPLETED|Overall Study||6
7703082|NCT01782898|18967603|P2|COMPLETED|Overall Study||29
7703083|NCT01782898|18967604|P1|COMPLETED|Overall Study||29
7703084|NCT01782898|18967603|P2|STARTED|Overall Study||35
7703085|NCT01782898|18967604|P1|STARTED|Overall Study||35
7703086|NCT01782885|18967616|P2|NOT COMPLETED|Overall Study||6
7703087|NCT01782885|18967617|P1|NOT COMPLETED|Overall Study||4
7703088|NCT01782885|18967616|P2|COMPLETED|Overall Study||33
7703089|NCT01782885|18967617|P1|COMPLETED|Overall Study||32
7703090|NCT01782885|18967616|P2|STARTED|Overall Study||39
7703091|NCT01782885|18967617|P1|STARTED|Overall Study||36
7703092|NCT01782872|18967643|P4|NOT COMPLETED|Overall Study||1
7703093|NCT01782872|18967644|P3|NOT COMPLETED|Overall Study||0
7703094|NCT01782872|18967645|P2|NOT COMPLETED|Overall Study||1
7703095|NCT01782872|18967646|P1|NOT COMPLETED|Overall Study||0
7703096|NCT01782872|18967643|P4|COMPLETED|Overall Study||19
7703097|NCT01782872|18967644|P3|COMPLETED|Overall Study||20
7703098|NCT01782872|18967645|P2|COMPLETED|Overall Study||19
7703099|NCT01782872|18967646|P1|COMPLETED|Overall Study||20
7703100|NCT01782872|18967643|P4|STARTED|Overall Study||20
7703101|NCT01782872|18967644|P3|STARTED|Overall Study||20
7703102|NCT01782872|18967645|P2|STARTED|Overall Study||20
7703103|NCT01782872|18967646|P1|STARTED|Overall Study||20
7703104|NCT01782859|18967670|P2|NOT COMPLETED|Overall Study||7
7703105|NCT01782859|18967671|P1|NOT COMPLETED|Overall Study||6
7703106|NCT01782859|18967670|P2|COMPLETED|Overall Study||13
7703107|NCT01782859|18967671|P1|COMPLETED|Overall Study||14
7703108|NCT01782859|18967670|P2|STARTED|Overall Study||20
7703109|NCT01782859|18967671|P1|STARTED|Overall Study||20
7703110|NCT01782833|18967685|P1|NOT COMPLETED|Overall Study||270
7703111|NCT01782833|18967685|P1|COMPLETED|Overall Study||3365
7703112|NCT01782833|18967685|P1|STARTED|Overall Study||3635
7703113|NCT01782742|18967693|P2|NOT COMPLETED|Open Label Phase||0
7703114|NCT01782742|18967694|P1|NOT COMPLETED|Open Label Phase||0
7703115|NCT01782742|18967693|P2|COMPLETED|Open Label Phase||0
7703116|NCT01782742|18967694|P1|COMPLETED|Open Label Phase||19
7703117|NCT01782742|18967693|P2|STARTED|Open Label Phase||0
7703118|NCT01782742|18967694|P1|STARTED|Open Label Phase||19
7703119|NCT01782742|18967693|P2|NOT COMPLETED|Double-blind Treatment Phase||0
7703120|NCT01782742|18967694|P1|NOT COMPLETED|Double-blind Treatment Phase||1
7703121|NCT01782742|18967693|P2|COMPLETED|Double-blind Treatment Phase||4
7703122|NCT01782742|18967694|P1|COMPLETED|Double-blind Treatment Phase||15
7703123|NCT01782742|18967693|P2|STARTED|Double-blind Treatment Phase||4
7703124|NCT01782742|18967694|P1|STARTED|Double-blind Treatment Phase||16
7703125|NCT01782690|18967727|P1|NOT COMPLETED|Overall Study||299
7703126|NCT01782690|18967727|P1|COMPLETED|Overall Study||39
7703127|NCT01782690|18967727|P1|STARTED|Overall Study||338
7703128|NCT01782664|18967749|P6|NOT COMPLETED|Overall Study||0
7703129|NCT01782664|18967750|P5|NOT COMPLETED|Overall Study||0
7703130|NCT01782664|18967751|P4|NOT COMPLETED|Overall Study||5
7703131|NCT01782664|18967752|P3|NOT COMPLETED|Overall Study||4
7703132|NCT01782664|18967753|P2|NOT COMPLETED|Overall Study||5
7703133|NCT01782664|18967754|P1|NOT COMPLETED|Overall Study||6
7703134|NCT01782664|18967749|P6|COMPLETED|Overall Study||2
7703135|NCT01782664|18967750|P5|COMPLETED|Overall Study||6
7703136|NCT01782664|18967751|P4|COMPLETED|Overall Study||9
7703137|NCT01782664|18967752|P3|COMPLETED|Overall Study||12
7703138|NCT01782664|18967753|P2|COMPLETED|Overall Study||10
7703139|NCT01782664|18967754|P1|COMPLETED|Overall Study||8
7703140|NCT01782664|18967749|P6|STARTED|Overall Study||2
7703141|NCT01782664|18967750|P5|STARTED|Overall Study||6
7703142|NCT01782664|18967751|P4|STARTED|Overall Study||14
7703143|NCT01782664|18967752|P3|STARTED|Overall Study||16
7703144|NCT01782664|18967753|P2|STARTED|Overall Study||15
7703145|NCT01782664|18967754|P1|STARTED|Overall Study||14
7703146|NCT01782495|18967911|P11|NOT COMPLETED|Overall Study||0
7703147|NCT01782495|18967912|P10|NOT COMPLETED|Overall Study||0
7703148|NCT01782495|18967913|P9|NOT COMPLETED|Overall Study||0
7703149|NCT01782495|18967914|P8|NOT COMPLETED|Overall Study||3
7703150|NCT01782495|18967915|P7|NOT COMPLETED|Overall Study||0
7703151|NCT01782495|18967916|P6|NOT COMPLETED|Overall Study||0
7703152|NCT01782495|18967917|P5|NOT COMPLETED|Overall Study||0
7703153|NCT01782495|18967918|P4|NOT COMPLETED|Overall Study||0
7703154|NCT01782495|18967919|P3|NOT COMPLETED|Overall Study||0
7703155|NCT01782495|18967920|P2|NOT COMPLETED|Overall Study||1
7703156|NCT01782495|18967921|P1|NOT COMPLETED|Overall Study||0
7703157|NCT01782495|18967911|P11|COMPLETED|Overall Study||1
7703158|NCT01782495|18967912|P10|COMPLETED|Overall Study||2
7703159|NCT01782495|18967913|P9|COMPLETED|Overall Study||3
7703160|NCT01782495|18967914|P8|COMPLETED|Overall Study||6
7703161|NCT01782495|18967915|P7|COMPLETED|Overall Study||12
7703162|NCT01782495|18967916|P6|COMPLETED|Overall Study||22
7703163|NCT01782495|18967917|P5|COMPLETED|Overall Study||2
7703164|NCT01782495|18967918|P4|COMPLETED|Overall Study||4
7703165|NCT01782495|18967919|P3|COMPLETED|Overall Study||13
7703166|NCT01782495|18967920|P2|COMPLETED|Overall Study||26
7703167|NCT01782495|18967921|P1|COMPLETED|Overall Study||34
7703168|NCT01782495|18967911|P11|STARTED|Overall Study||1
7703169|NCT01782495|18967912|P10|STARTED|Overall Study||2
7703170|NCT01782495|18967913|P9|STARTED|Overall Study||3
7703171|NCT01782495|18967914|P8|STARTED|Overall Study||9
7703172|NCT01782495|18967915|P7|STARTED|Overall Study||12
7703173|NCT01782495|18967916|P6|STARTED|Overall Study||22
7703174|NCT01782495|18967917|P5|STARTED|Overall Study||2
7703175|NCT01782495|18967918|P4|STARTED|Overall Study||4
7703176|NCT01782495|18967919|P3|STARTED|Overall Study||13
7703177|NCT01782495|18967920|P2|STARTED|Overall Study||27
7703178|NCT01782495|18967921|P1|STARTED|Overall Study||34
7703179|NCT01782482|18967980|P2|NOT COMPLETED|Overall Study||10
7703180|NCT01782482|18967981|P1|NOT COMPLETED|Overall Study||10
7703181|NCT01782482|18967980|P2|COMPLETED|Overall Study||270
7703182|NCT01782482|18967981|P1|COMPLETED|Overall Study||271
7703183|NCT01782482|18967980|P2|STARTED|Overall Study||280
7703184|NCT01782482|18967981|P1|STARTED|Overall Study||281
7703185|NCT01782469|18967989|P1|NOT COMPLETED|Overall Study||1
7703186|NCT01782469|18967989|P1|COMPLETED|Overall Study||15
7703187|NCT01782469|18967989|P1|STARTED|Overall Study||16
7703188|NCT01782378|18967999|P2|NOT COMPLETED|Second Series||32
7703189|NCT01782378|18968000|P1|NOT COMPLETED|Second Series||26
7703190|NCT01782378|18967999|P2|COMPLETED|Second Series||0
7703191|NCT01782378|18968000|P1|COMPLETED|Second Series||5
7703192|NCT01782378|18967999|P2|STARTED|Second Series||32
7703193|NCT01782378|18968000|P1|STARTED|Second Series||31
7703194|NCT01782378|18967999|P2|NOT COMPLETED|First Series||8
7703195|NCT01782378|18968000|P1|NOT COMPLETED|First Series||7
7703196|NCT01782378|18967999|P2|COMPLETED|First Series||23
7703197|NCT01782378|18968000|P1|COMPLETED|First Series||25
7703198|NCT01782378|18967999|P2|STARTED|First Series||31
7703199|NCT01782378|18968000|P1|STARTED|First Series||32
7703200|NCT01782326|18968066|P2|NOT COMPLETED|Double-blind Treatment||320
7703201|NCT01782326|18968067|P1|NOT COMPLETED|Double-blind Treatment||278
7703202|NCT01782326|18968066|P2|COMPLETED|Double-blind Treatment||1360
7703203|NCT01782326|18968067|P1|COMPLETED|Double-blind Treatment||1400
7703204|NCT01782326|18968066|P2|STARTED|Double-blind Treatment||1680
7703205|NCT01782326|18968067|P1|STARTED|Double-blind Treatment||1678
7703206|NCT01782326|18968066|P2|NOT COMPLETED|Planned Treatment Epoch||208
7703207|NCT01782326|18968067|P1|NOT COMPLETED|Planned Treatment Epoch||202
7703208|NCT01782326|18968066|P2|COMPLETED|Planned Treatment Epoch||1474
7703209|NCT01782326|18968067|P1|COMPLETED|Planned Treatment Epoch||1478
7703210|NCT01782326|18968066|P2|Urine Cortisol Set|Planned Treatment Epoch||269
7703211|NCT01782326|18968067|P1|Urine Cortisol Set|Planned Treatment Epoch||266
7703212|NCT01782326|18968066|P2|Safety Set (SAF)|Planned Treatment Epoch||1680
7703213|NCT01782326|18968067|P1|Safety Set (SAF)|Planned Treatment Epoch||1678
7703214|NCT01782326|18968066|P2|Serial Spirometry Set|Planned Treatment Epoch||279
7703215|NCT01782326|18968067|P1|Serial Spirometry Set|Planned Treatment Epoch||280
7703216|NCT01782326|18968066|P2|Per-protocol Set (PPS)|Planned Treatment Epoch||1556
7703217|NCT01782326|18968067|P1|Per-protocol Set (PPS)|Planned Treatment Epoch||1528
7703218|NCT01782326|18968066|P2|Full Analysis Set (FAS)|Planned Treatment Epoch||1679
7703219|NCT01782326|18968067|P1|Full Analysis Set (FAS)|Planned Treatment Epoch||1675
7703220|NCT01782326|18968066|P2|STARTED|Planned Treatment Epoch||1682
7703221|NCT01782326|18968067|P1|STARTED|Planned Treatment Epoch||1680
7703222|NCT01782313|18968127|P1|NOT COMPLETED|Survival Follow up||1
7703223|NCT01782313|18968127|P1|COMPLETED|Survival Follow up||57
7703224|NCT01782313|18968127|P1|STARTED|Survival Follow up||58
7703225|NCT01782313|18968127|P1|NOT COMPLETED|Continued Treatment After 16 Weeks||7
7703226|NCT01782313|18968127|P1|COMPLETED|Continued Treatment After 16 Weeks||18
7703227|NCT01782313|18968127|P1|STARTED|Continued Treatment After 16 Weeks||25
7703228|NCT01782313|18968127|P1|NOT COMPLETED|Treated Cycle 4/Reached 16 Week Response||6
7703229|NCT01782313|18968127|P1|COMPLETED|Treated Cycle 4/Reached 16 Week Response||25
7703230|NCT01782313|18968127|P1|STARTED|Treated Cycle 4/Reached 16 Week Response||31
7703231|NCT01782313|18968127|P1|NOT COMPLETED|Treated Cycle 3||21
7703232|NCT01782313|18968127|P1|COMPLETED|Treated Cycle 3||31
7703233|NCT01782313|18968127|P1|STARTED|Treated Cycle 3||52
7703234|NCT01782313|18968127|P1|NOT COMPLETED|Reached First Response/Completed 2 Cycle||6
7703235|NCT01782313|18968127|P1|COMPLETED|Reached First Response/Completed 2 Cycle||52
7703236|NCT01782313|18968127|P1|STARTED|Reached First Response/Completed 2 Cycle||58
7703237|NCT01782222|18968141|P3|NOT COMPLETED|Overall Study||4
7703238|NCT01782222|18968142|P2|NOT COMPLETED|Overall Study||11
7703239|NCT01782222|18968143|P1|NOT COMPLETED|Overall Study||8
7703240|NCT01782222|18968141|P3|COMPLETED|Overall Study||37
7703241|NCT01782222|18968142|P2|COMPLETED|Overall Study||30
7703242|NCT01782222|18968143|P1|COMPLETED|Overall Study||32
7703243|NCT01782222|18968141|P3|STARTED|Overall Study||41
7703244|NCT01782222|18968142|P2|STARTED|Overall Study||41
7703245|NCT01782222|18968143|P1|STARTED|Overall Study||40
7703246|NCT01782209|18968175|P1|NOT COMPLETED|Overall Study||110
7703247|NCT01782209|18968175|P1|COMPLETED|Overall Study||225
7703248|NCT01782209|18968175|P1|STARTED|Overall Study||335
7703249|NCT01782131|18968181|P2|NOT COMPLETED|Overall Study||115
7703250|NCT01782131|18968182|P1|NOT COMPLETED|Overall Study||109
7703251|NCT01782131|18968181|P2|COMPLETED|Overall Study||177
7703252|NCT01782131|18968182|P1|COMPLETED|Overall Study||184
7703253|NCT01782131|18968181|P2|Treated|Overall Study||287
7703254|NCT01782131|18968182|P1|Treated|Overall Study||288
7703255|NCT01782131|18968181|P2|STARTED|Overall Study||292
7703256|NCT01782131|18968182|P1|STARTED|Overall Study||293
7703257|NCT01781975|18968219|P2|NOT COMPLETED|Overall Study||1
7703258|NCT01781975|18968220|P1|NOT COMPLETED|Overall Study||2
7703259|NCT01781975|18968219|P2|COMPLETED|Overall Study||21
7703260|NCT01781975|18968220|P1|COMPLETED|Overall Study||43
7703261|NCT01781975|18968219|P2|Follow-Up Period|Overall Study||21
7703262|NCT01781975|18968220|P1|Follow-Up Period|Overall Study||43
7703263|NCT01781975|18968219|P2|Treatment Period|Overall Study||22
7703264|NCT01781975|18968220|P1|Treatment Period|Overall Study||44
7703265|NCT01781975|18968219|P2|STARTED|Overall Study||22
7703266|NCT01781975|18968220|P1|STARTED|Overall Study||45
7703267|NCT01781962|18968236|P1|NOT COMPLETED|Overall Study||5
7703268|NCT01781962|18968236|P1|COMPLETED|Overall Study||201
7703269|NCT01781962|18968236|P1|STARTED|Overall Study||206
7703270|NCT01781832|18968242|P1|NOT COMPLETED|Overall Study||1
7703271|NCT01781832|18968242|P1|COMPLETED|Overall Study||25
7703272|NCT01781832|18968242|P1|STARTED|Overall Study||26
7703273|NCT01781806|18968249|P2|NOT COMPLETED|Overall Study||3
7703274|NCT01781806|18968250|P1|NOT COMPLETED|Overall Study||79
7703275|NCT01781806|18968249|P2|COMPLETED|Overall Study||1
7703276|NCT01781806|18968250|P1|COMPLETED|Overall Study||218
7703277|NCT01781806|18968249|P2|Week 48|Overall Study||1
7703278|NCT01781806|18968250|P1|Week 48|Overall Study||222
7703279|NCT01781806|18968249|P2|Week 36|Overall Study||1
7703280|NCT01781806|18968250|P1|Week 36|Overall Study||247
7703281|NCT01781806|18968249|P2|Week 24|Overall Study||1
7703282|NCT01781806|18968250|P1|Week 24|Overall Study||260
7703283|NCT01781806|18968249|P2|Week 12|Overall Study||2
7703284|NCT01781806|18968250|P1|Week 12|Overall Study||272
7703285|NCT01781806|18968249|P2|Week 8|Overall Study||4
7703286|NCT01781806|18968250|P1|Week 8|Overall Study||278
7703287|NCT01781806|18968249|P2|Week 4|Overall Study||4
7703288|NCT01781806|18968250|P1|Week 4|Overall Study||284
7703289|NCT01781806|18968249|P2|Week 0|Overall Study||4
7703290|NCT01781806|18968250|P1|Week 0|Overall Study||297
7703291|NCT01781806|18968249|P2|STARTED|Overall Study||4
7703292|NCT01781806|18968250|P1|STARTED|Overall Study||297
7703293|NCT01781637|18968262|P2|NOT COMPLETED|Overall Study||6
7703294|NCT01781637|18968263|P1|NOT COMPLETED|Overall Study||4
7703295|NCT01781637|18968262|P2|COMPLETED|Overall Study||2
7703296|NCT01781637|18968263|P1|COMPLETED|Overall Study||24
7703297|NCT01781637|18968262|P2|STARTED|Overall Study||8
7703298|NCT01781637|18968263|P1|STARTED|Overall Study||28
7703299|NCT01781611|18968273|P2|NOT COMPLETED|Overall Study||0
7703300|NCT01781611|18968274|P1|NOT COMPLETED|Overall Study||4
7703301|NCT01781611|18968273|P2|COMPLETED|Overall Study||5
7703302|NCT01781611|18968274|P1|COMPLETED|Overall Study||9
7703303|NCT01781611|18968273|P2|STARTED|Overall Study||5
7703304|NCT01781611|18968274|P1|STARTED|Overall Study||13
7703305|NCT01781572|18968295|P3|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
7703306|NCT01781572|18968296|P2|NOT COMPLETED|MEK162 45mg LEE011 600mg||6
7703307|NCT01781572|18968297|P1|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
7703308|NCT01781572|18968295|P3|COMPLETED|MEK162 45mg LEE011 600mg||0
7703309|NCT01781572|18968296|P2|COMPLETED|MEK162 45mg LEE011 600mg||0
7703310|NCT01781572|18968297|P1|COMPLETED|MEK162 45mg LEE011 600mg||0
7703311|NCT01781572|18968295|P3|STARTED|MEK162 45mg LEE011 600mg||0
7703312|NCT01781572|18968296|P2|STARTED|MEK162 45mg LEE011 600mg||6
7703313|NCT01781572|18968297|P1|STARTED|MEK162 45mg LEE011 600mg||0
7703314|NCT01781572|18968295|P3|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
7703315|NCT01781572|18968296|P2|NOT COMPLETED|MEK162 45mg LEE011 450mg||9
7703316|NCT01781572|18968297|P1|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
7703317|NCT01781572|18968295|P3|COMPLETED|MEK162 45mg LEE011 450mg||0
7703318|NCT01781572|18968296|P2|COMPLETED|MEK162 45mg LEE011 450mg||0
7703319|NCT01781572|18968297|P1|COMPLETED|MEK162 45mg LEE011 450mg||0
7703320|NCT01781572|18968295|P3|STARTED|MEK162 45mg LEE011 450mg||0
7703321|NCT01781572|18968296|P2|STARTED|MEK162 45mg LEE011 450mg||9
7703322|NCT01781572|18968297|P1|STARTED|MEK162 45mg LEE011 450mg||0
7703323|NCT01781572|18968295|P3|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
7703324|NCT01781572|18968296|P2|NOT COMPLETED|MEK162 30mg LEE011 200mg||5
7703325|NCT01781572|18968297|P1|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
7703326|NCT01781572|18968295|P3|COMPLETED|MEK162 30mg LEE011 200mg||0
7703327|NCT01781572|18968296|P2|COMPLETED|MEK162 30mg LEE011 200mg||0
7703328|NCT01781572|18968297|P1|COMPLETED|MEK162 30mg LEE011 200mg||0
7703329|NCT01781572|18968295|P3|STARTED|MEK162 30mg LEE011 200mg||0
7703330|NCT01781572|18968296|P2|STARTED|MEK162 30mg LEE011 200mg||5
7703331|NCT01781572|18968297|P1|STARTED|MEK162 30mg LEE011 200mg||0
7703332|NCT01781572|18968295|P3|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||0
7703333|NCT01781572|18968296|P2|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||4
7703334|NCT01781572|18968297|P1|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||6
7703335|NCT01781572|18968295|P3|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
7703336|NCT01781572|18968296|P2|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
7703337|NCT01781572|18968297|P1|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
7703338|NCT01781572|18968295|P3|STARTED|MEK162 45mg BID+LEE011 300mg||0
7703339|NCT01781572|18968296|P2|STARTED|MEK162 45mg BID+LEE011 300mg||4
7703340|NCT01781572|18968297|P1|STARTED|MEK162 45mg BID+LEE011 300mg||6
7703341|NCT01781572|18968295|P3|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||0
7703342|NCT01781572|18968296|P2|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||2
7703343|NCT01781572|18968297|P1|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||4
7703344|NCT01781572|18968295|P3|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
7703345|NCT01781572|18968296|P2|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
7703346|NCT01781572|18968297|P1|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
7703347|NCT01781572|18968295|P3|STARTED|MEK162 30mg BID+LEE011 300mg||0
7703348|NCT01781572|18968296|P2|STARTED|MEK162 30mg BID+LEE011 300mg||2
7703349|NCT01781572|18968297|P1|STARTED|MEK162 30mg BID+LEE011 300mg||4
7703350|NCT01781572|18968295|P3|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
7703351|NCT01781572|18968296|P2|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
7703352|NCT01781572|18968297|P1|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||3
7703353|NCT01781572|18968295|P3|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
7703354|NCT01781572|18968296|P2|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
7703355|NCT01781572|18968297|P1|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
7703356|NCT01781572|18968295|P3|STARTED|MEK162 45mg BID+LEE011 250mg||0
7703357|NCT01781572|18968296|P2|STARTED|MEK162 45mg BID+LEE011 250mg||0
7703358|NCT01781572|18968297|P1|STARTED|MEK162 45mg BID+LEE011 250mg||3
7703359|NCT01781572|18968295|P3|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||41
7703360|NCT01781572|18968296|P2|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||6
7703361|NCT01781572|18968297|P1|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||16
7703362|NCT01781572|18968295|P3|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
7703363|NCT01781572|18968296|P2|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
7703364|NCT01781572|18968297|P1|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
7703365|NCT01781572|18968295|P3|STARTED|MEK162 45mg BID+LEE011 200mg||41
7703366|NCT01781572|18968296|P2|STARTED|MEK162 45mg BID+LEE011 200mg||6
7703367|NCT01781572|18968297|P1|STARTED|MEK162 45mg BID+LEE011 200mg||16
7703368|NCT01781481|18968539|P1|NOT COMPLETED|Overall Study||0
7703369|NCT01781481|18968539|P1|COMPLETED|Overall Study||148
7703370|NCT01781481|18968539|P1|STARTED|Overall Study||148
7703371|NCT01781468|18968601|P3|NOT COMPLETED|Overall Study||12
7703372|NCT01781468|18968602|P2|NOT COMPLETED|Overall Study||13
7703373|NCT01781468|18968603|P1|NOT COMPLETED|Overall Study||6
7703374|NCT01781468|18968601|P3|COMPLETED|Overall Study||97
7703375|NCT01781468|18968602|P2|COMPLETED|Overall Study||97
7703376|NCT01781468|18968603|P1|COMPLETED|Overall Study||103
7703377|NCT01781468|18968601|P3|STARTED|Overall Study||109
7703378|NCT01781468|18968602|P2|STARTED|Overall Study||110
7703379|NCT01781468|18968603|P1|STARTED|Overall Study||109
7703380|NCT01781429|18968638|P16|NOT COMPLETED|Overall Study||0
7703381|NCT01781429|18968639|P15|NOT COMPLETED|Overall Study||16
7703382|NCT01781429|18968640|P14|NOT COMPLETED|Overall Study||8
7703383|NCT01781429|18968641|P13|NOT COMPLETED|Overall Study||22
7703384|NCT01781429|18968642|P12|NOT COMPLETED|Overall Study||21
7703385|NCT01781429|18968643|P11|NOT COMPLETED|Overall Study||18
7703386|NCT01781429|18968644|P10|NOT COMPLETED|Overall Study||24
7703387|NCT01781429|18968645|P9|NOT COMPLETED|Overall Study||7
7703388|NCT01781429|18968646|P8|NOT COMPLETED|Overall Study||4
7703389|NCT01781429|18968647|P7|NOT COMPLETED|Overall Study||7
7703390|NCT01781429|18968648|P6|NOT COMPLETED|Overall Study||4
7703391|NCT01781429|18968649|P5|NOT COMPLETED|Overall Study||1
7703392|NCT01781429|18968650|P4|NOT COMPLETED|Overall Study||1
7703393|NCT01781429|18968651|P3|NOT COMPLETED|Overall Study||1
7703394|NCT01781429|18968652|P2|NOT COMPLETED|Overall Study||1
7703395|NCT01781429|18968653|P1|NOT COMPLETED|Overall Study||1
7703396|NCT01781429|18968638|P16|COMPLETED|Overall Study||0
7703397|NCT01781429|18968639|P15|COMPLETED|Overall Study||0
7703398|NCT01781429|18968640|P14|COMPLETED|Overall Study||0
7703399|NCT01781429|18968641|P13|COMPLETED|Overall Study||0
7703400|NCT01781429|18968642|P12|COMPLETED|Overall Study||0
7703401|NCT01781429|18968643|P11|COMPLETED|Overall Study||0
7703402|NCT01781429|18968644|P10|COMPLETED|Overall Study||0
7703403|NCT01781429|18968645|P9|COMPLETED|Overall Study||0
7703404|NCT01781429|18968646|P8|COMPLETED|Overall Study||0
7703405|NCT01781429|18968647|P7|COMPLETED|Overall Study||0
7703406|NCT01781429|18968648|P6|COMPLETED|Overall Study||0
7703407|NCT01781429|18968649|P5|COMPLETED|Overall Study||0
7703408|NCT01781429|18968650|P4|COMPLETED|Overall Study||0
7703409|NCT01781429|18968651|P3|COMPLETED|Overall Study||0
7703410|NCT01781429|18968652|P2|COMPLETED|Overall Study||0
7703411|NCT01781429|18968653|P1|COMPLETED|Overall Study||0
7703412|NCT01781429|18968638|P16|STARTED|Overall Study||0
7703413|NCT01781429|18968639|P15|STARTED|Overall Study||16
7703414|NCT01781429|18968640|P14|STARTED|Overall Study||8
7703415|NCT01781429|18968641|P13|STARTED|Overall Study||22
7703416|NCT01781429|18968642|P12|STARTED|Overall Study||21
7703417|NCT01781429|18968643|P11|STARTED|Overall Study||18
7703418|NCT01781429|18968644|P10|STARTED|Overall Study||24
7703419|NCT01781429|18968645|P9|STARTED|Overall Study||7
7703420|NCT01781429|18968646|P8|STARTED|Overall Study||4
7703421|NCT01781429|18968647|P7|STARTED|Overall Study||7
7703422|NCT01781429|18968648|P6|STARTED|Overall Study||4
7703423|NCT01781429|18968649|P5|STARTED|Overall Study||1
7703424|NCT01781429|18968650|P4|STARTED|Overall Study||1
7703425|NCT01781429|18968651|P3|STARTED|Overall Study||1
7703426|NCT01781429|18968652|P2|STARTED|Overall Study||1
7703427|NCT01781429|18968653|P1|STARTED|Overall Study||1
7703428|NCT01781403|18968710|P3|NOT COMPLETED|Overall Study||0
7703429|NCT01781403|18968711|P2|NOT COMPLETED|Overall Study||0
7703430|NCT01781403|18968712|P1|NOT COMPLETED|Overall Study||0
7703431|NCT01781403|18968710|P3|COMPLETED|Overall Study||18
7703432|NCT01781403|18968711|P2|COMPLETED|Overall Study||2
7703433|NCT01781403|18968712|P1|COMPLETED|Overall Study||2
7703434|NCT01781403|18968710|P3|STARTED|Overall Study||18
7703435|NCT01781403|18968711|P2|STARTED|Overall Study||2
7703436|NCT01781403|18968712|P1|STARTED|Overall Study||2
7703437|NCT01781299|18968730|P2|NOT COMPLETED|Overall Study||1
7703438|NCT01781299|18968731|P1|NOT COMPLETED|Overall Study||0
7703439|NCT01781299|18968730|P2|COMPLETED|Overall Study||4
7703440|NCT01781299|18968731|P1|COMPLETED|Overall Study||4
7703441|NCT01781299|18968730|P2|STARTED|Overall Study||5
7703442|NCT01781299|18968731|P1|STARTED|Overall Study||4
7703443|NCT01781286|18968739|P6|NOT COMPLETED|Overall Study||1
7703444|NCT01781286|18968740|P5|NOT COMPLETED|Overall Study||0
7703445|NCT01781286|18968741|P4|NOT COMPLETED|Overall Study||1
7703446|NCT01781286|18968742|P3|NOT COMPLETED|Overall Study||2
7703447|NCT01781286|18968743|P2|NOT COMPLETED|Overall Study||0
7703448|NCT01781286|18968744|P1|NOT COMPLETED|Overall Study||2
7703449|NCT01781286|18968739|P6|COMPLETED|Overall Study||2
7703450|NCT01781286|18968740|P5|COMPLETED|Overall Study||6
7703451|NCT01781286|18968741|P4|COMPLETED|Overall Study||7
7703452|NCT01781286|18968742|P3|COMPLETED|Overall Study||7
7703453|NCT01781286|18968743|P2|COMPLETED|Overall Study||4
7703454|NCT01781286|18968744|P1|COMPLETED|Overall Study||5
7703455|NCT01781286|18968739|P6|Started 3rd Intervention|Overall Study||2
7703456|NCT01781286|18968740|P5|Started 3rd Intervention|Overall Study||6
7703457|NCT01781286|18968741|P4|Started 3rd Intervention|Overall Study||7
7703458|NCT01781286|18968742|P3|Started 3rd Intervention|Overall Study||7
7703459|NCT01781286|18968743|P2|Started 3rd Intervention|Overall Study||4
7703460|NCT01781286|18968744|P1|Started 3rd Intervention|Overall Study||5
7703461|NCT01781286|18968739|P6|Started 2nd Intervention|Overall Study||2
7703462|NCT01781286|18968740|P5|Started 2nd Intervention|Overall Study||6
7703463|NCT01781286|18968741|P4|Started 2nd Intervention|Overall Study||8
7703464|NCT01781286|18968742|P3|Started 2nd Intervention|Overall Study||9
7703465|NCT01781286|18968743|P2|Started 2nd Intervention|Overall Study||4
7703466|NCT01781286|18968744|P1|Started 2nd Intervention|Overall Study||5
7703467|NCT01781286|18968739|P6|Started 1st Intervention|Overall Study||2
7703468|NCT01781286|18968740|P5|Started 1st Intervention|Overall Study||6
7703469|NCT01781286|18968741|P4|Started 1st Intervention|Overall Study||8
7703470|NCT01781286|18968742|P3|Started 1st Intervention|Overall Study||9
7703471|NCT01781286|18968743|P2|Started 1st Intervention|Overall Study||4
7703472|NCT01781286|18968744|P1|Started 1st Intervention|Overall Study||6
7703473|NCT01781286|18968739|P6|STARTED|Overall Study||3
7703474|NCT01781286|18968740|P5|STARTED|Overall Study||6
7703475|NCT01781286|18968741|P4|STARTED|Overall Study||8
7703476|NCT01781286|18968742|P3|STARTED|Overall Study||9
7703477|NCT01781286|18968743|P2|STARTED|Overall Study||4
7703478|NCT01781286|18968744|P1|STARTED|Overall Study||7
7703479|NCT01781234|18968769|P2|NOT COMPLETED|Overall Study||3
7703480|NCT01781234|18968770|P1|NOT COMPLETED|Overall Study||9
7703481|NCT01781234|18968769|P2|COMPLETED|Overall Study||21
7703482|NCT01781234|18968770|P1|COMPLETED|Overall Study||18
7703483|NCT01781234|18968769|P2|STARTED|Overall Study||24
7703484|NCT01781234|18968770|P1|STARTED|Overall Study||27
7703485|NCT01781208|18968780|P1|NOT COMPLETED|Overall Study||0
7703486|NCT01781208|18968780|P1|COMPLETED|Overall Study||62
7703487|NCT01781208|18968780|P1|Overall Study|Overall Study||62
7703488|NCT01781208|18968780|P1|STARTED|Overall Study||62
7703489|NCT01781169|18968787|P2|NOT COMPLETED|Overall Study||0
7703490|NCT01781169|18968788|P1|NOT COMPLETED|Overall Study||1
7703491|NCT01781169|18968787|P2|COMPLETED|Overall Study||21
7703492|NCT01781169|18968788|P1|COMPLETED|Overall Study||21
7703493|NCT01781169|18968787|P2|STARTED|Overall Study||21
7703494|NCT01781169|18968788|P1|STARTED|Overall Study||22
7703495|NCT01781078|18968796|P3|NOT COMPLETED|Overall Study||16
7703496|NCT01781078|18968797|P2|NOT COMPLETED|Overall Study||5
7703497|NCT01781078|18968798|P1|NOT COMPLETED|Overall Study||12
7703498|NCT01781078|18968796|P3|COMPLETED|Overall Study||0
7703499|NCT01781078|18968797|P2|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|113
7703500|NCT01781078|18968798|P1|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|217
7703501|NCT01781078|18968796|P3|STARTED|Overall Study||16
7703502|NCT01781078|18968797|P2|STARTED|Overall Study|Randomized post implantation|118
7703503|NCT01781078|18968798|P1|STARTED|Overall Study|Randomized post implantation|229
7703504|NCT01781026|18968808|P1|NOT COMPLETED|Overall Study||2
7703505|NCT01781026|18968808|P1|COMPLETED|Overall Study||0
7703506|NCT01781026|18968808|P1|STARTED|Overall Study||2
7703507|NCT01780987|18968814|P2|NOT COMPLETED|Overall Study||6
7703508|NCT01780987|18968815|P1|NOT COMPLETED|Overall Study||3
7703509|NCT01780987|18968814|P2|COMPLETED|Overall Study||34
7703510|NCT01780987|18968815|P1|COMPLETED|Overall Study||37
7703511|NCT01780987|18968814|P2|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40
7703512|NCT01780987|18968815|P1|STARTED|Overall Study||40
7703513|NCT01780974|18968833|P2|NOT COMPLETED|Overall Study||3
7703514|NCT01780974|18968834|P1|NOT COMPLETED|Overall Study||2
7703515|NCT01780974|18968833|P2|COMPLETED|Overall Study||18
7703516|NCT01780974|18968834|P1|COMPLETED|Overall Study||19
7703517|NCT01780974|18968833|P2|STARTED|Overall Study||21
7703518|NCT01780974|18968834|P1|STARTED|Overall Study||21
7703519|NCT01780935|18968844|P2|NOT COMPLETED|Overall Study||336
7703520|NCT01780935|18968845|P1|NOT COMPLETED|Overall Study||335
7703521|NCT01780935|18968844|P2|COMPLETED|Overall Study||0
7703522|NCT01780935|18968845|P1|COMPLETED|Overall Study||0
7703523|NCT01780935|18968844|P2|Safety Set|Overall Study||336
7703524|NCT01780935|18968845|P1|Safety Set|Overall Study||334
7703525|NCT01780935|18968844|P2|STARTED|Overall Study||336
7703526|NCT01780935|18968845|P1|STARTED|Overall Study||335
7703527|NCT01780922|18968875|P6|NOT COMPLETED|Third Intervention (1 Day)||0
7703528|NCT01780922|18968876|P5|NOT COMPLETED|Third Intervention (1 Day)||0
7703529|NCT01780922|18968877|P4|NOT COMPLETED|Third Intervention (1 Day)||0
7703530|NCT01780922|18968878|P3|NOT COMPLETED|Third Intervention (1 Day)||0
7703531|NCT01780922|18968879|P2|NOT COMPLETED|Third Intervention (1 Day)||0
7703532|NCT01780922|18968880|P1|NOT COMPLETED|Third Intervention (1 Day)||0
7703533|NCT01780922|18968875|P6|COMPLETED|Third Intervention (1 Day)||2
7703534|NCT01780922|18968876|P5|COMPLETED|Third Intervention (1 Day)||2
7703535|NCT01780922|18968877|P4|COMPLETED|Third Intervention (1 Day)||2
7703536|NCT01780922|18968878|P3|COMPLETED|Third Intervention (1 Day)||2
7703537|NCT01780922|18968879|P2|COMPLETED|Third Intervention (1 Day)||2
7703538|NCT01780922|18968880|P1|COMPLETED|Third Intervention (1 Day)||2
7703539|NCT01780922|18968875|P6|STARTED|Third Intervention (1 Day)||2
7703540|NCT01780922|18968876|P5|STARTED|Third Intervention (1 Day)||2
7703541|NCT01780922|18968877|P4|STARTED|Third Intervention (1 Day)||2
7703542|NCT01780922|18968878|P3|STARTED|Third Intervention (1 Day)||2
7703543|NCT01780922|18968879|P2|STARTED|Third Intervention (1 Day)||2
7703544|NCT01780922|18968880|P1|STARTED|Third Intervention (1 Day)||2
7703545|NCT01780922|18968875|P6|NOT COMPLETED|Washout (7 Days)||0
7703546|NCT01780922|18968876|P5|NOT COMPLETED|Washout (7 Days)||0
7703547|NCT01780922|18968877|P4|NOT COMPLETED|Washout (7 Days)||0
7703548|NCT01780922|18968878|P3|NOT COMPLETED|Washout (7 Days)||0
7703549|NCT01780922|18968879|P2|NOT COMPLETED|Washout (7 Days)||0
7703550|NCT01780922|18968880|P1|NOT COMPLETED|Washout (7 Days)||0
7703551|NCT01780922|18968875|P6|COMPLETED|Washout (7 Days)||2
7703552|NCT01780922|18968876|P5|COMPLETED|Washout (7 Days)||2
7703553|NCT01780922|18968877|P4|COMPLETED|Washout (7 Days)||2
7703554|NCT01780922|18968878|P3|COMPLETED|Washout (7 Days)||2
7703555|NCT01780922|18968879|P2|COMPLETED|Washout (7 Days)||2
7703556|NCT01780922|18968880|P1|COMPLETED|Washout (7 Days)||2
7703557|NCT01780922|18968875|P6|STARTED|Washout (7 Days)||2
7703558|NCT01780922|18968876|P5|STARTED|Washout (7 Days)||2
7703559|NCT01780922|18968877|P4|STARTED|Washout (7 Days)||2
7703560|NCT01780922|18968878|P3|STARTED|Washout (7 Days)||2
7703561|NCT01780922|18968879|P2|STARTED|Washout (7 Days)||2
7703562|NCT01780922|18968880|P1|STARTED|Washout (7 Days)||2
7703563|NCT01780922|18968875|P6|NOT COMPLETED|Second Intervention (1 Day)||0
7703564|NCT01780922|18968876|P5|NOT COMPLETED|Second Intervention (1 Day)||0
7703565|NCT01780922|18968877|P4|NOT COMPLETED|Second Intervention (1 Day)||0
7703566|NCT01780922|18968878|P3|NOT COMPLETED|Second Intervention (1 Day)||0
7703567|NCT01780922|18968879|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7703568|NCT01780922|18968880|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7703569|NCT01780922|18968875|P6|COMPLETED|Second Intervention (1 Day)||2
7703570|NCT01780922|18968876|P5|COMPLETED|Second Intervention (1 Day)||2
7703571|NCT01780922|18968877|P4|COMPLETED|Second Intervention (1 Day)||2
7703572|NCT01780922|18968878|P3|COMPLETED|Second Intervention (1 Day)||2
7703573|NCT01780922|18968879|P2|COMPLETED|Second Intervention (1 Day)||2
7703574|NCT01780922|18968880|P1|COMPLETED|Second Intervention (1 Day)||2
7703575|NCT01780922|18968875|P6|STARTED|Second Intervention (1 Day)||2
7703576|NCT01780922|18968876|P5|STARTED|Second Intervention (1 Day)||2
7703577|NCT01780922|18968877|P4|STARTED|Second Intervention (1 Day)||2
7703578|NCT01780922|18968878|P3|STARTED|Second Intervention (1 Day)||2
7703579|NCT01780922|18968879|P2|STARTED|Second Intervention (1 Day)||2
7703580|NCT01780922|18968880|P1|STARTED|Second Intervention (1 Day)||2
7703581|NCT01780922|18968875|P6|NOT COMPLETED|Washout (7 Days)||0
7703582|NCT01780922|18968876|P5|NOT COMPLETED|Washout (7 Days)||0
7703583|NCT01780922|18968877|P4|NOT COMPLETED|Washout (7 Days)||0
7703584|NCT01780922|18968878|P3|NOT COMPLETED|Washout (7 Days)||0
7703585|NCT01780922|18968879|P2|NOT COMPLETED|Washout (7 Days)||0
7703586|NCT01780922|18968880|P1|NOT COMPLETED|Washout (7 Days)||0
7703587|NCT01780922|18968875|P6|COMPLETED|Washout (7 Days)||2
7703588|NCT01780922|18968876|P5|COMPLETED|Washout (7 Days)||2
7703589|NCT01780922|18968877|P4|COMPLETED|Washout (7 Days)||2
7703590|NCT01780922|18968878|P3|COMPLETED|Washout (7 Days)||2
7703591|NCT01780922|18968879|P2|COMPLETED|Washout (7 Days)||2
7703592|NCT01780922|18968880|P1|COMPLETED|Washout (7 Days)||2
7703593|NCT01780922|18968875|P6|STARTED|Washout (7 Days)||2
7703594|NCT01780922|18968876|P5|STARTED|Washout (7 Days)||2
7703595|NCT01780922|18968877|P4|STARTED|Washout (7 Days)||2
7703596|NCT01780922|18968878|P3|STARTED|Washout (7 Days)||2
7703597|NCT01780922|18968879|P2|STARTED|Washout (7 Days)||2
7703598|NCT01780922|18968880|P1|STARTED|Washout (7 Days)||2
7703599|NCT01780922|18968875|P6|NOT COMPLETED|First Intervention (1 Day)||0
7703600|NCT01780922|18968876|P5|NOT COMPLETED|First Intervention (1 Day)||0
7703601|NCT01780922|18968877|P4|NOT COMPLETED|First Intervention (1 Day)||0
7703602|NCT01780922|18968878|P3|NOT COMPLETED|First Intervention (1 Day)||0
7703603|NCT01780922|18968879|P2|NOT COMPLETED|First Intervention (1 Day)||0
7703604|NCT01780922|18968880|P1|NOT COMPLETED|First Intervention (1 Day)||0
7703605|NCT01780922|18968875|P6|COMPLETED|First Intervention (1 Day)||2
7703606|NCT01780922|18968876|P5|COMPLETED|First Intervention (1 Day)||2
7703607|NCT01780922|18968877|P4|COMPLETED|First Intervention (1 Day)||2
7703608|NCT01780922|18968878|P3|COMPLETED|First Intervention (1 Day)||2
7703609|NCT01780922|18968879|P2|COMPLETED|First Intervention (1 Day)||2
7703610|NCT01780922|18968880|P1|COMPLETED|First Intervention (1 Day)||2
7703611|NCT01780922|18968875|P6|STARTED|First Intervention (1 Day)||2
7703612|NCT01780922|18968876|P5|STARTED|First Intervention (1 Day)||2
7703613|NCT01780922|18968877|P4|STARTED|First Intervention (1 Day)||2
7703614|NCT01780922|18968878|P3|STARTED|First Intervention (1 Day)||2
7703615|NCT01780922|18968879|P2|STARTED|First Intervention (1 Day)||2
7703616|NCT01780922|18968880|P1|STARTED|First Intervention (1 Day)||2
7703617|NCT01780870|18968935|P2|NOT COMPLETED|Overall Study||0
7703618|NCT01780870|18968936|P1|NOT COMPLETED|Overall Study||0
7703619|NCT01780870|18968935|P2|COMPLETED|Overall Study||5
7703620|NCT01780870|18968936|P1|COMPLETED|Overall Study||0
7703621|NCT01780870|18968935|P2|STARTED|Overall Study||5
7703622|NCT01780870|18968936|P1|STARTED|Overall Study||0
7703623|NCT01780831|18968950|P4|NOT COMPLETED|Overall Study||1
7703624|NCT01780831|18968951|P3|NOT COMPLETED|Overall Study||4
7703625|NCT01780831|18968952|P2|NOT COMPLETED|Overall Study||0
7703626|NCT01780831|18968953|P1|NOT COMPLETED|Overall Study||0
7703627|NCT01780831|18968950|P4|COMPLETED|Overall Study||9
7703628|NCT01780831|18968951|P3|COMPLETED|Overall Study||22
7703629|NCT01780831|18968952|P2|COMPLETED|Overall Study||6
7703630|NCT01780831|18968953|P1|COMPLETED|Overall Study||10
7703631|NCT01780831|18968950|P4|STARTED|Overall Study||10
7703632|NCT01780831|18968951|P3|STARTED|Overall Study||26
7703633|NCT01780831|18968952|P2|STARTED|Overall Study||6
7703634|NCT01780831|18968953|P1|STARTED|Overall Study||10
7703635|NCT01780662|18969021|P3|NOT COMPLETED|Overall Study||10
7703636|NCT01780662|18969022|P2|NOT COMPLETED|Overall Study||6
7703637|NCT01780662|18969023|P1|NOT COMPLETED|Overall Study||1
7703638|NCT01780662|18969021|P3|COMPLETED|Overall Study||20
7703639|NCT01780662|18969022|P2|COMPLETED|Overall Study||7
7703640|NCT01780662|18969023|P1|COMPLETED|Overall Study||2
7703641|NCT01780662|18969021|P3|STARTED|Overall Study||30
7703642|NCT01780662|18969022|P2|STARTED|Overall Study||13
7703643|NCT01780662|18969023|P1|STARTED|Overall Study||3
7703644|NCT01780584|18969040|P3|NOT COMPLETED|Overall Study||2
7703645|NCT01780584|18969041|P2|NOT COMPLETED|Overall Study||1
7703646|NCT01780584|18969042|P1|NOT COMPLETED|Overall Study||1
7703647|NCT01780584|18969040|P3|COMPLETED|Overall Study||13
7703648|NCT01780584|18969041|P2|COMPLETED|Overall Study||14
7703649|NCT01780584|18969042|P1|COMPLETED|Overall Study||14
7703650|NCT01780584|18969040|P3|STARTED|Overall Study||15
7703651|NCT01780584|18969041|P2|STARTED|Overall Study||15
7703652|NCT01780584|18969042|P1|STARTED|Overall Study||15
7703653|NCT01780545|18969064|P2|NOT COMPLETED|Overall Study||2
7703654|NCT01780545|18969065|P1|NOT COMPLETED|Overall Study||4
7703655|NCT01780545|18969064|P2|COMPLETED|Overall Study||99
7703656|NCT01780545|18969065|P1|COMPLETED|Overall Study||95
7703657|NCT01780545|18969064|P2|STARTED|Overall Study||101
7703658|NCT01780545|18969065|P1|STARTED|Overall Study||99
7703659|NCT01780506|18969083|P2|NOT COMPLETED|Open-Label Extension Phase||1
7703660|NCT01780506|18969084|P1|NOT COMPLETED|Open-Label Extension Phase||0
7703661|NCT01780506|18969083|P2|COMPLETED|Open-Label Extension Phase||94
7703662|NCT01780506|18969084|P1|COMPLETED|Open-Label Extension Phase||90
7703663|NCT01780506|18969083|P2|STARTED|Open-Label Extension Phase|261 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|95
7703664|NCT01780506|18969084|P1|STARTED|Open-Label Extension Phase|278 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|90
7703665|NCT01780506|18969083|P2|NOT COMPLETED|Double-Blind Phase||78
7703666|NCT01780506|18969084|P1|NOT COMPLETED|Double-Blind Phase||70
7703667|NCT01780506|18969083|P2|COMPLETED|Double-Blind Phase||356
7703668|NCT01780506|18969084|P1|COMPLETED|Double-Blind Phase||368
7703669|NCT01780506|18969083|P2|STARTED|Double-Blind Phase||434
7703670|NCT01780506|18969084|P1|STARTED|Double-Blind Phase||438
7703671|NCT01780454|18969138|P1|NOT COMPLETED|Overall Study||0
7703672|NCT01780454|18969138|P1|COMPLETED|Overall Study||2
7703673|NCT01780454|18969138|P1|STARTED|Overall Study||2
7703674|NCT01780389|18969142|P1|NOT COMPLETED|Overall Study||1
7703675|NCT01780389|18969142|P1|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4
7703676|NCT01780389|18969142|P1|STARTED|Overall Study||5
7703677|NCT01780350|18969153|P1|NOT COMPLETED|Overall Study||0
7703678|NCT01780350|18969153|P1|COMPLETED|Overall Study||200
7703679|NCT01780350|18969153|P1|STARTED|Overall Study||200
7703680|NCT01780337|18969160|P2|NOT COMPLETED|Overall Study||0
7703681|NCT01780337|18969161|P1|NOT COMPLETED|Overall Study||0
7703682|NCT01780337|18969160|P2|COMPLETED|Overall Study||6
7703683|NCT01780337|18969161|P1|COMPLETED|Overall Study||6
7703684|NCT01780337|18969160|P2|STARTED|Overall Study||6
7703685|NCT01780337|18969161|P1|STARTED|Overall Study||6
7703686|NCT01780324|18969173|P2|NOT COMPLETED|Overall Study||6
7703687|NCT01780324|18969174|P1|NOT COMPLETED|Overall Study||1
7703688|NCT01780324|18969173|P2|COMPLETED|Overall Study||33
7703689|NCT01780324|18969174|P1|COMPLETED|Overall Study||40
7703690|NCT01780324|18969173|P2|STARTED|Overall Study||39
7703691|NCT01780324|18969174|P1|STARTED|Overall Study||41
7703692|NCT01779869|18969180|P1|NOT COMPLETED|Overall Study||2
7703693|NCT01779869|18969180|P1|COMPLETED|Overall Study||14
7703694|NCT01779869|18969180|P1|STARTED|Overall Study||16
7703695|NCT01779700|18969186|P2|NOT COMPLETED|Overall Study||5
7703696|NCT01779700|18969187|P1|NOT COMPLETED|Overall Study||4
7703697|NCT01779700|18969186|P2|COMPLETED|Overall Study||17
7703698|NCT01779700|18969187|P1|COMPLETED|Overall Study||14
7703699|NCT01779700|18969186|P2|STARTED|Overall Study||22
7703700|NCT01779700|18969187|P1|STARTED|Overall Study||18
7703701|NCT01779648|18969227|P2|NOT COMPLETED|Overall Study||0
7703702|NCT01779648|18969228|P1|NOT COMPLETED|Overall Study||1
7703703|NCT01779648|18969227|P2|COMPLETED|Overall Study||27
7703704|NCT01779648|18969228|P1|COMPLETED|Overall Study||27
7703705|NCT01779648|18969227|P2|STARTED|Overall Study||27
7703706|NCT01779648|18969228|P1|STARTED|Overall Study||28
7703707|NCT01779440|18969258|P2|NOT COMPLETED|Overall Study||5
7703708|NCT01779440|18969259|P1|NOT COMPLETED|Overall Study||3
7703709|NCT01779440|18969258|P2|COMPLETED|Overall Study||23
7703710|NCT01779440|18969259|P1|COMPLETED|Overall Study||27
7703711|NCT01779440|18969258|P2|STARTED|Overall Study||28
7703712|NCT01779440|18969259|P1|STARTED|Overall Study||30
7703713|NCT01779375|18969269|P2|NOT COMPLETED|Overall Study||3
7703714|NCT01779375|18969270|P1|NOT COMPLETED|Overall Study||2
7703715|NCT01779375|18969269|P2|COMPLETED|Overall Study||41
7703716|NCT01779375|18969270|P1|COMPLETED|Overall Study||45
7703717|NCT01779375|18969269|P2|STARTED|Overall Study||44
7703718|NCT01779375|18969270|P1|STARTED|Overall Study||47
7703719|NCT01779219|18969286|P2|NOT COMPLETED|Overall Study||0
7703720|NCT01779219|18969287|P1|NOT COMPLETED|Overall Study||0
7703721|NCT01779219|18969286|P2|COMPLETED|Overall Study|First interim analysis|21
7703722|NCT01779219|18969287|P1|COMPLETED|Overall Study|First interim analysis|21
7703723|NCT01779219|18969286|P2|STARTED|Overall Study|First interim analysis|21
7703724|NCT01779219|18969287|P1|STARTED|Overall Study|First interim analysis|21
7703725|NCT01779167|18969299|P1|NOT COMPLETED|Overall Study||1
7703726|NCT01779167|18969299|P1|COMPLETED|Overall Study||3
7703727|NCT01779167|18969299|P1|STARTED|Overall Study||4
7703728|NCT01779141|18969308|P1|NOT COMPLETED|Overall Study||181
7703729|NCT01779141|18969308|P1|COMPLETED|Overall Study||300
7703730|NCT01779141|18969308|P1|STARTED|Overall Study||481
7703731|NCT01779024|18969315|P2|NOT COMPLETED|2nd Visit - Functional MRI||0
7703732|NCT01779024|18969316|P1|NOT COMPLETED|2nd Visit - Functional MRI||0
7703733|NCT01779024|18969315|P2|COMPLETED|2nd Visit - Functional MRI||6
7703734|NCT01779024|18969316|P1|COMPLETED|2nd Visit - Functional MRI||5
7703735|NCT01779024|18969315|P2|STARTED|2nd Visit - Functional MRI||6
7703736|NCT01779024|18969316|P1|STARTED|2nd Visit - Functional MRI||5
7703737|NCT01779024|18969315|P2|NOT COMPLETED|1st Visit - Functional MRI||2
7703738|NCT01779024|18969316|P1|NOT COMPLETED|1st Visit - Functional MRI||2
7703739|NCT01779024|18969315|P2|COMPLETED|1st Visit - Functional MRI||5
7703740|NCT01779024|18969316|P1|COMPLETED|1st Visit - Functional MRI||4
7703741|NCT01779024|18969315|P2|STARTED|1st Visit - Functional MRI||7
7703742|NCT01779024|18969316|P1|STARTED|1st Visit - Functional MRI||6
7703743|NCT01779024|18969315|P2|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||0
7703744|NCT01779024|18969316|P1|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||2
7703745|NCT01779024|18969315|P2|COMPLETED|2nd Visit - Alcohol Self-Administration||9
7703746|NCT01779024|18969316|P1|COMPLETED|2nd Visit - Alcohol Self-Administration||6
7703747|NCT01779024|18969315|P2|STARTED|2nd Visit - Alcohol Self-Administration||9
7703748|NCT01779024|18969316|P1|STARTED|2nd Visit - Alcohol Self-Administration||8
7703749|NCT01779024|18969315|P2|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
7703750|NCT01779024|18969316|P1|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
7703751|NCT01779024|18969315|P2|COMPLETED|1st Visit - Alcohol Self-Administration||9
7703752|NCT01779024|18969316|P1|COMPLETED|1st Visit - Alcohol Self-Administration||8
7703753|NCT01779024|18969315|P2|STARTED|1st Visit - Alcohol Self-Administration||9
7703754|NCT01779024|18969316|P1|STARTED|1st Visit - Alcohol Self-Administration||8
7703755|NCT01778985|18969324|P2|NOT COMPLETED|Overall Study||3
7703756|NCT01778985|18969325|P1|NOT COMPLETED|Overall Study||7
7703757|NCT01778985|18969324|P2|COMPLETED|Overall Study||12
7703758|NCT01778985|18969325|P1|COMPLETED|Overall Study||8
7703759|NCT01778985|18969324|P2|STARTED|Overall Study||15
7703760|NCT01778985|18969325|P1|STARTED|Overall Study||15
7703761|NCT01778855|18969371|P2|NOT COMPLETED|Overall Study||1
7703762|NCT01778855|18969372|P1|NOT COMPLETED|Overall Study||0
7703763|NCT01778855|18969371|P2|COMPLETED|Overall Study||3
7703764|NCT01778855|18969372|P1|COMPLETED|Overall Study||2
7703765|NCT01778855|18969371|P2|STARTED|Overall Study||4
7703766|NCT01778855|18969372|P1|STARTED|Overall Study||2
7703767|NCT01778751|18969380|P2|NOT COMPLETED|Overall Study||2
7703768|NCT01778751|18969381|P1|NOT COMPLETED|Overall Study||2
7703769|NCT01778751|18969380|P2|COMPLETED|Overall Study||23
7703770|NCT01778751|18969381|P1|COMPLETED|Overall Study||23
7703771|NCT01778751|18969380|P2|STARTED|Overall Study||25
7703772|NCT01778751|18969381|P1|STARTED|Overall Study||25
7703773|NCT01778634|18969395|P2|NOT COMPLETED|Overall Study||0
7703774|NCT01778634|18969396|P1|NOT COMPLETED|Overall Study||0
7703775|NCT01778634|18969395|P2|COMPLETED|Overall Study||60
7703776|NCT01778634|18969396|P1|COMPLETED|Overall Study||61
7703777|NCT01778634|18969395|P2|STARTED|Overall Study||60
7703778|NCT01778634|18969396|P1|STARTED|Overall Study||61
7703779|NCT01778556|18969438|P2|NOT COMPLETED|Long-term Follow-up||0
7703780|NCT01778556|18969439|P1|NOT COMPLETED|Long-term Follow-up||1
7703781|NCT01778556|18969438|P2|COMPLETED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
7703782|NCT01778556|18969439|P1|COMPLETED|Long-term Follow-up||14
7703783|NCT01778556|18969438|P2|STARTED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
7703784|NCT01778556|18969439|P1|STARTED|Long-term Follow-up||15
7703785|NCT01778556|18969438|P2|NOT COMPLETED|Intervention 2 (14 Days)||0
7703786|NCT01778556|18969439|P1|NOT COMPLETED|Intervention 2 (14 Days)||1
7703787|NCT01778556|18969438|P2|COMPLETED|Intervention 2 (14 Days)||8
7703788|NCT01778556|18969439|P1|COMPLETED|Intervention 2 (14 Days)||14
7703789|NCT01778556|18969438|P2|STARTED|Intervention 2 (14 Days)||8
7703790|NCT01778556|18969439|P1|STARTED|Intervention 2 (14 Days)||15
7703791|NCT01778556|18969438|P2|NOT COMPLETED|Intervention 1 (5 Days)||2
7703792|NCT01778556|18969439|P1|NOT COMPLETED|Intervention 1 (5 Days)||0
7703793|NCT01778556|18969438|P2|COMPLETED|Intervention 1 (5 Days)||8
7703794|NCT01778556|18969439|P1|COMPLETED|Intervention 1 (5 Days)||15
7703795|NCT01778556|18969438|P2|STARTED|Intervention 1 (5 Days)||10
7703796|NCT01778556|18969439|P1|STARTED|Intervention 1 (5 Days)||15
7703797|NCT01778530|18969452|P1|NOT COMPLETED|Overall Study||2
7703798|NCT01778530|18969452|P1|COMPLETED|Overall Study||0
7703799|NCT01778530|18969452|P1|STARTED|Overall Study||2
7703800|NCT01778426|18969459|P2|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
7703801|NCT01778426|18969460|P1|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
7703802|NCT01778426|18969459|P2|COMPLETED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
7703803|NCT01778426|18969460|P1|COMPLETED|Intention-To-Treat (ITT) - Completer||198
7703804|NCT01778426|18969459|P2|STARTED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
7703805|NCT01778426|18969460|P1|STARTED|Intention-To-Treat (ITT) - Completer||198
7703806|NCT01778426|18969459|P2|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||25
7703807|NCT01778426|18969460|P1|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||56
7703808|NCT01778426|18969459|P2|COMPLETED|Overall Study - Full Analysis Set (FAS)||113
7703809|NCT01778426|18969460|P1|COMPLETED|Overall Study - Full Analysis Set (FAS)||208
7703810|NCT01778426|18969459|P2|STARTED|Overall Study - Full Analysis Set (FAS)||138
7703811|NCT01778426|18969460|P1|STARTED|Overall Study - Full Analysis Set (FAS)||264
7703812|NCT01778296|18969476|P1|NOT COMPLETED|Overall Study||0
7703813|NCT01778296|18969476|P1|COMPLETED|Overall Study|No patient was lost to follow-up.|12
7703814|NCT01778296|18969476|P1|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12
7703815|NCT01778179|18969482|P2|NOT COMPLETED|Overall Study||3
7703816|NCT01778179|18969483|P1|NOT COMPLETED|Overall Study||2
7703817|NCT01778179|18969482|P2|COMPLETED|Overall Study||22
7703818|NCT01778179|18969483|P1|COMPLETED|Overall Study||23
7703819|NCT01778179|18969482|P2|STARTED|Overall Study||25
7703820|NCT01778179|18969483|P1|STARTED|Overall Study||25
7703821|NCT01778127|18969494|P3|NOT COMPLETED|Overall Study||6
7703822|NCT01778127|18969495|P2|NOT COMPLETED|Overall Study||2
7703823|NCT01778127|18969496|P1|NOT COMPLETED|Overall Study||8
7703824|NCT01778127|18969494|P3|COMPLETED|Overall Study||26
7703825|NCT01778127|18969495|P2|COMPLETED|Overall Study||31
7703826|NCT01778127|18969496|P1|COMPLETED|Overall Study||25
7703827|NCT01778127|18969494|P3|STARTED|Overall Study||32
7703828|NCT01778127|18969495|P2|STARTED|Overall Study||33
7703829|NCT01778127|18969496|P1|STARTED|Overall Study||33
7703830|NCT01778062|18969539|P2|NOT COMPLETED|Overall Study||11
7703831|NCT01778062|18969540|P1|NOT COMPLETED|Overall Study||6
7703832|NCT01778062|18969539|P2|COMPLETED|Overall Study||57
7703833|NCT01778062|18969540|P1|COMPLETED|Overall Study||62
7703834|NCT01778062|18969539|P2|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67
7703835|NCT01778062|18969540|P1|Intent to Treat (ITT)|Overall Study||68
7703836|NCT01778062|18969539|P2|Safety Set|Overall Study||68
7703837|NCT01778062|18969540|P1|Safety Set|Overall Study||68
7703838|NCT01778062|18969539|P2|STARTED|Overall Study||68
7703839|NCT01778062|18969540|P1|STARTED|Overall Study||68
7703840|NCT01778049|18969554|P6|NOT COMPLETED|Double Blind Treatment Period||7
7703841|NCT01778049|18969555|P5|NOT COMPLETED|Double Blind Treatment Period||12
7703842|NCT01778049|18969556|P4|NOT COMPLETED|Double Blind Treatment Period||12
7703843|NCT01778049|18969557|P3|NOT COMPLETED|Double Blind Treatment Period||15
7703844|NCT01778049|18969558|P2|NOT COMPLETED|Double Blind Treatment Period||0
7703845|NCT01778049|18969559|P1|NOT COMPLETED|Double Blind Treatment Period||0
7703846|NCT01778049|18969554|P6|COMPLETED|Double Blind Treatment Period||105
7703847|NCT01778049|18969555|P5|COMPLETED|Double Blind Treatment Period||102
7703848|NCT01778049|18969556|P4|COMPLETED|Double Blind Treatment Period||118
7703849|NCT01778049|18969557|P3|COMPLETED|Double Blind Treatment Period||111
7703850|NCT01778049|18969558|P2|COMPLETED|Double Blind Treatment Period||0
7703851|NCT01778049|18969559|P1|COMPLETED|Double Blind Treatment Period||0
7703852|NCT01778049|18969554|P6|STARTED|Double Blind Treatment Period||112
7703853|NCT01778049|18969555|P5|STARTED|Double Blind Treatment Period||114
7703854|NCT01778049|18969556|P4|STARTED|Double Blind Treatment Period||130
7703855|NCT01778049|18969557|P3|STARTED|Double Blind Treatment Period||126
7703856|NCT01778049|18969558|P2|STARTED|Double Blind Treatment Period||0
7703857|NCT01778049|18969559|P1|STARTED|Double Blind Treatment Period||0
7703858|NCT01778049|18969554|P6|NOT COMPLETED|Open Label Treatment Period||0
7703859|NCT01778049|18969555|P5|NOT COMPLETED|Open Label Treatment Period||0
7703860|NCT01778049|18969556|P4|NOT COMPLETED|Open Label Treatment Period||0
7703861|NCT01778049|18969557|P3|NOT COMPLETED|Open Label Treatment Period||0
7703862|NCT01778049|18969558|P2|NOT COMPLETED|Open Label Treatment Period||129
7703863|NCT01778049|18969559|P1|NOT COMPLETED|Open Label Treatment Period||98
7703864|NCT01778049|18969554|P6|COMPLETED|Open Label Treatment Period||0
7703865|NCT01778049|18969555|P5|COMPLETED|Open Label Treatment Period||0
7703866|NCT01778049|18969556|P4|COMPLETED|Open Label Treatment Period||0
7703867|NCT01778049|18969557|P3|COMPLETED|Open Label Treatment Period||0
7703868|NCT01778049|18969558|P2|COMPLETED|Open Label Treatment Period||226
7703869|NCT01778049|18969559|P1|COMPLETED|Open Label Treatment Period||256
7703870|NCT01778049|18969554|P6|STARTED|Open Label Treatment Period||0
7703871|NCT01778049|18969555|P5|STARTED|Open Label Treatment Period||0
7703872|NCT01778049|18969556|P4|STARTED|Open Label Treatment Period||0
7703873|NCT01778049|18969557|P3|STARTED|Open Label Treatment Period||0
7703874|NCT01778049|18969558|P2|STARTED|Open Label Treatment Period||355
7703875|NCT01778049|18969559|P1|STARTED|Open Label Treatment Period||354
7703876|NCT01778023|18969577|P2|NOT COMPLETED|Overall Study||3
7703877|NCT01778023|18969578|P1|NOT COMPLETED|Overall Study||0
7703878|NCT01778023|18969577|P2|COMPLETED|Overall Study||15
7703879|NCT01778023|18969578|P1|COMPLETED|Overall Study||36
7703880|NCT01778023|18969577|P2|Exposed|Overall Study||15
7703881|NCT01778023|18969578|P1|Exposed|Overall Study||36
7703882|NCT01778023|18969577|P2|STARTED|Overall Study||18
7703883|NCT01778023|18969578|P1|STARTED|Overall Study||36
7703884|NCT01778010|18969595|P1|NOT COMPLETED|Overall Study||5
7703885|NCT01778010|18969595|P1|COMPLETED|Overall Study||8
7703886|NCT01778010|18969595|P1|STARTED|Overall Study||13
7703887|NCT01777997|18969636|P1|NOT COMPLETED|Weeks 48 to 72/96 on ART||2
7703888|NCT01777997|18969636|P1|COMPLETED|Weeks 48 to 72/96 on ART||26
7703889|NCT01777997|18969636|P1|STARTED|Weeks 48 to 72/96 on ART||28
7703890|NCT01777997|18969636|P1|NOT COMPLETED|Weeks 0 to 24/48 on ART||1
7703891|NCT01777997|18969636|P1|COMPLETED|Weeks 0 to 24/48 on ART|7 of these participants opted not to continue ART into next period|35
7703892|NCT01777997|18969636|P1|STARTED|Weeks 0 to 24/48 on ART||36
7703893|NCT01777997|18969636|P1|NOT COMPLETED|12 Week lead-in of no ART||2
7703894|NCT01777997|18969636|P1|COMPLETED|12 Week lead-in of no ART||36
7703895|NCT01777997|18969636|P1|STARTED|12 Week lead-in of no ART||38
7703896|NCT01777945|18969648|P1|NOT COMPLETED|Overall Study||0
7703897|NCT01777945|18969648|P1|COMPLETED|Overall Study||46
7703898|NCT01777945|18969648|P1|Evaluable Participants|Overall Study||45
7703899|NCT01777945|18969648|P1|STARTED|Overall Study||46
7703900|NCT01777932|18969658|P1|NOT COMPLETED|Overall Study||205
7703901|NCT01777932|18969658|P1|COMPLETED|Overall Study||15
7703902|NCT01777932|18969658|P1|STARTED|Overall Study||220
7703903|NCT01777854|18969672|P2|NOT COMPLETED|Overall Study||3
7703904|NCT01777854|18969673|P1|NOT COMPLETED|Overall Study||3
7703905|NCT01777854|18969672|P2|COMPLETED|Overall Study||0
7703906|NCT01777854|18969673|P1|COMPLETED|Overall Study||0
7703907|NCT01777854|18969672|P2|STARTED|Overall Study||3
7703908|NCT01777854|18969673|P1|STARTED|Overall Study||3
7703909|NCT01777776|18969681|P4|NOT COMPLETED|Overall Study||4
7703910|NCT01777776|18969682|P3|NOT COMPLETED|Overall Study||6
7703911|NCT01777776|18969683|P2|NOT COMPLETED|Overall Study||12
7703912|NCT01777776|18969684|P1|NOT COMPLETED|Overall Study||6
7703913|NCT01777776|18969681|P4|COMPLETED|Overall Study||0
7703914|NCT01777776|18969682|P3|COMPLETED|Overall Study||0
7703915|NCT01777776|18969683|P2|COMPLETED|Overall Study||0
7703916|NCT01777776|18969684|P1|COMPLETED|Overall Study||0
7703917|NCT01777776|18969681|P4|STARTED|Overall Study||4
7703918|NCT01777776|18969682|P3|STARTED|Overall Study||6
7703919|NCT01777776|18969683|P2|STARTED|Overall Study||12
7703920|NCT01777776|18969684|P1|STARTED|Overall Study||6
7703921|NCT01777763|18969743|P2|NOT COMPLETED|Overall Study||47
7703922|NCT01777763|18969744|P1|NOT COMPLETED|Overall Study||4
7703923|NCT01777763|18969743|P2|COMPLETED|Overall Study||163
7703924|NCT01777763|18969744|P1|COMPLETED|Overall Study||16
7703925|NCT01777763|18969743|P2|STARTED|Overall Study||210
7703926|NCT01777763|18969744|P1|STARTED|Overall Study||20
7703927|NCT01777620|18969768|P2|NOT COMPLETED|Overall Study||0
7703928|NCT01777620|18969769|P1|NOT COMPLETED|Overall Study||1
7703929|NCT01777620|18969768|P2|COMPLETED|Overall Study||62
7703930|NCT01777620|18969769|P1|COMPLETED|Overall Study||62
7703931|NCT01777620|18969768|P2|STARTED|Overall Study||62
7703932|NCT01777620|18969769|P1|STARTED|Overall Study||63
7703933|NCT01777581|18969795|P2|NOT COMPLETED|Overall Study||2
7703934|NCT01777581|18969796|P1|NOT COMPLETED|Overall Study||3
7703935|NCT01777581|18969795|P2|COMPLETED|Overall Study||3
7703936|NCT01777581|18969796|P1|COMPLETED|Overall Study||5
7703937|NCT01777581|18969795|P2|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5
7703938|NCT01777581|18969796|P1|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8
7703939|NCT01777568|18969816|P2|NOT COMPLETED|Overall Study||0
7703940|NCT01777568|18969817|P1|NOT COMPLETED|Overall Study||0
7703941|NCT01777568|18969816|P2|COMPLETED|Overall Study||2896
7703942|NCT01777568|18969817|P1|COMPLETED|Overall Study||2853
7703943|NCT01777568|18969816|P2|STARTED|Overall Study||2896
7703944|NCT01777568|18969817|P1|STARTED|Overall Study||2853
7703945|NCT01777542|18969825|P2|NOT COMPLETED|Second Intervention (20 Weeks)||1
7703946|NCT01777542|18969826|P1|NOT COMPLETED|Second Intervention (20 Weeks)||0
7703947|NCT01777542|18969825|P2|COMPLETED|Second Intervention (20 Weeks)||14
7703948|NCT01777542|18969826|P1|COMPLETED|Second Intervention (20 Weeks)||15
7703949|NCT01777542|18969825|P2|STARTED|Second Intervention (20 Weeks)||15
7703950|NCT01777542|18969826|P1|STARTED|Second Intervention (20 Weeks)||15
7703951|NCT01777542|18969825|P2|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
7703952|NCT01777542|18969826|P1|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
7703953|NCT01777542|18969825|P2|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
7703954|NCT01777542|18969826|P1|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
7703955|NCT01777542|18969825|P2|STARTED|Washout Period (28 +/- 2 Weeks)||15
7703956|NCT01777542|18969826|P1|STARTED|Washout Period (28 +/- 2 Weeks)||15
7703957|NCT01777542|18969825|P2|NOT COMPLETED|First Intervention (20 Weeks)||0
7703958|NCT01777542|18969826|P1|NOT COMPLETED|First Intervention (20 Weeks)||0
7703959|NCT01777542|18969825|P2|COMPLETED|First Intervention (20 Weeks)||15
7703960|NCT01777542|18969826|P1|COMPLETED|First Intervention (20 Weeks)||15
7703961|NCT01777542|18969825|P2|STARTED|First Intervention (20 Weeks)||15
7703962|NCT01777542|18969826|P1|STARTED|First Intervention (20 Weeks)||15
7703963|NCT01777490|18969869|P4|NOT COMPLETED|Overall Study||1
7703964|NCT01777490|18969870|P3|NOT COMPLETED|Overall Study||1
7703965|NCT01777490|18969871|P2|NOT COMPLETED|Overall Study||0
7703966|NCT01777490|18969872|P1|NOT COMPLETED|Overall Study||0
7703967|NCT01777490|18969869|P4|COMPLETED|Overall Study||118
7703968|NCT01777490|18969870|P3|COMPLETED|Overall Study||118
7703969|NCT01777490|18969871|P2|COMPLETED|Overall Study||123
7703970|NCT01777490|18969872|P1|COMPLETED|Overall Study||123
7703971|NCT01777490|18969869|P4|STARTED|Overall Study||119
7703972|NCT01777490|18969870|P3|STARTED|Overall Study||119
7703973|NCT01777490|18969871|P2|STARTED|Overall Study||123
7703974|NCT01777490|18969872|P1|STARTED|Overall Study||123
7703975|NCT01777438|18969890|P2|NOT COMPLETED|Overall Study||0
7703976|NCT01777438|18969891|P1|NOT COMPLETED|Overall Study||0
7703977|NCT01777438|18969890|P2|COMPLETED|Overall Study||82
7703978|NCT01777438|18969891|P1|COMPLETED|Overall Study||352
7703979|NCT01777438|18969890|P2|STARTED|Overall Study||82
7703980|NCT01777438|18969891|P1|STARTED|Overall Study||352
7703981|NCT01777425|18969903|P1|NOT COMPLETED|Overall Study||0
7703982|NCT01777425|18969903|P1|COMPLETED|Overall Study||389
7703983|NCT01777425|18969903|P1|STARTED|Overall Study||389
7703984|NCT01777412|18969909|P1|NOT COMPLETED|Overall Study||0
7703985|NCT01777412|18969909|P1|COMPLETED|Overall Study||10
7703986|NCT01777412|18969909|P1|STARTED|Overall Study||10
7703987|NCT01777334|18969917|P2|NOT COMPLETED|Overall Study||63
7703988|NCT01777334|18969918|P1|NOT COMPLETED|Overall Study||53
7703989|NCT01777334|18969917|P2|COMPLETED|Overall Study||388
7703990|NCT01777334|18969918|P1|COMPLETED|Overall Study||401
7703991|NCT01777334|18969917|P2|STARTED|Overall Study||451
7703992|NCT01777334|18969918|P1|STARTED|Overall Study||454
7703993|NCT01777321|18969928|P2|NOT COMPLETED|Overall Study||1
7703994|NCT01777321|18969929|P1|NOT COMPLETED|Overall Study||0
7703995|NCT01777321|18969928|P2|COMPLETED|Overall Study||29
7703996|NCT01777321|18969929|P1|COMPLETED|Overall Study||30
7703997|NCT01777321|18969928|P2|STARTED|Overall Study||30
7703998|NCT01777321|18969929|P1|STARTED|Overall Study||30
7703999|NCT01777308|18969967|P2|NOT COMPLETED|Overall Study||3
7704000|NCT01777308|18969968|P1|NOT COMPLETED|Overall Study||14
7704001|NCT01777308|18969967|P2|COMPLETED|Overall Study||34
7704002|NCT01777308|18969968|P1|COMPLETED|Overall Study||105
7704003|NCT01777308|18969967|P2|Completed up to Month 73|Overall Study||37
7704004|NCT01777308|18969968|P1|Completed up to Month 73|Overall Study||118
7704005|NCT01777308|18969967|P2|STARTED|Overall Study||37
7704006|NCT01777308|18969968|P1|STARTED|Overall Study||119
7704007|NCT01777295|18970000|P2|NOT COMPLETED|Overall Study||3
7704008|NCT01777295|18970001|P1|NOT COMPLETED|Overall Study||4
7704009|NCT01777295|18970000|P2|COMPLETED|Overall Study||38
7704010|NCT01777295|18970001|P1|COMPLETED|Overall Study||36
7704011|NCT01777295|18970000|P2|STARTED|Overall Study||41
7704012|NCT01777295|18970001|P1|STARTED|Overall Study||40
7704013|NCT01777282|18970208|P5|NOT COMPLETED|Overall Study||7
7704014|NCT01777282|18970209|P4|NOT COMPLETED|Overall Study||2
7704015|NCT01777282|18970210|P3|NOT COMPLETED|Overall Study||6
7704016|NCT01777282|18970211|P2|NOT COMPLETED|Overall Study||4
7704017|NCT01777282|18970212|P1|NOT COMPLETED|Overall Study||11
7704018|NCT01777282|18970208|P5|COMPLETED|Overall Study||54
7704019|NCT01777282|18970209|P4|COMPLETED|Overall Study||59
7704020|NCT01777282|18970210|P3|COMPLETED|Overall Study||59
7704021|NCT01777282|18970211|P2|COMPLETED|Overall Study||63
7704022|NCT01777282|18970212|P1|COMPLETED|Overall Study||109
7704023|NCT01777282|18970208|P5|Completing Follow-up Period|Overall Study||54
7704024|NCT01777282|18970209|P4|Completing Follow-up Period|Overall Study||59
7704025|NCT01777282|18970210|P3|Completing Follow-up Period|Overall Study||59
7704026|NCT01777282|18970211|P2|Completing Follow-up Period|Overall Study||63
7704027|NCT01777282|18970212|P1|Completing Follow-up Period|Overall Study||109
7704028|NCT01777282|18970208|P5|Completing Treatment Period|Overall Study||54
7704029|NCT01777282|18970209|P4|Completing Treatment Period|Overall Study||59
7704030|NCT01777282|18970210|P3|Completing Treatment Period|Overall Study||59
7704031|NCT01777282|18970211|P2|Completing Treatment Period|Overall Study||63
7704032|NCT01777282|18970212|P1|Completing Treatment Period|Overall Study||109
7704033|NCT01777282|18970208|P5|STARTED|Overall Study||61
7704034|NCT01777282|18970209|P4|STARTED|Overall Study||61
7704035|NCT01777282|18970210|P3|STARTED|Overall Study||65
7704036|NCT01777282|18970211|P2|STARTED|Overall Study||67
7704037|NCT01777282|18970212|P1|STARTED|Overall Study||120
7704038|NCT01777269|18970256|P2|NOT COMPLETED|Overall Study||59
7704039|NCT01777269|18970257|P1|NOT COMPLETED|Overall Study||55
7704040|NCT01777269|18970256|P2|COMPLETED|Overall Study||184
7704041|NCT01777269|18970257|P1|COMPLETED|Overall Study||191
7704042|NCT01777269|18970256|P2|STARTED|Overall Study||243
7704043|NCT01777269|18970257|P1|STARTED|Overall Study||246
7704044|NCT01777217|18970285|P2|NOT COMPLETED|Overall Study||0
7704045|NCT01777217|18970286|P1|NOT COMPLETED|Overall Study||0
7704046|NCT01777217|18970285|P2|COMPLETED|Overall Study||4
7704047|NCT01777217|18970286|P1|COMPLETED|Overall Study||4
7704048|NCT01777217|18970285|P2|STARTED|Overall Study||4
7704049|NCT01777217|18970286|P1|STARTED|Overall Study||4
7704050|NCT01777191|18970294|P2|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13
7704051|NCT01777191|18970295|P1|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9
7704052|NCT01777191|18970294|P2|COMPLETED|Safety Extension Per (Week 12-Week 48)||78
7704053|NCT01777191|18970295|P1|COMPLETED|Safety Extension Per (Week 12-Week 48)||85
7704054|NCT01777191|18970294|P2|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91
7704055|NCT01777191|18970295|P1|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94
7704056|NCT01777191|18970294|P2|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8
7704057|NCT01777191|18970295|P1|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6
7704058|NCT01777191|18970294|P2|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94
7704059|NCT01777191|18970295|P1|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96
7704060|NCT01777191|18970294|P2|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
7704061|NCT01777191|18970295|P1|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
7704062|NCT01777152|18970325|P2|NOT COMPLETED|Overall Study||226
7704063|NCT01777152|18970326|P1|NOT COMPLETED|Overall Study||226
7704064|NCT01777152|18970325|P2|COMPLETED|Overall Study||0
7704065|NCT01777152|18970326|P1|COMPLETED|Overall Study||0
7704066|NCT01777152|18970325|P2|STARTED|Overall Study||226
7704067|NCT01777152|18970326|P1|STARTED|Overall Study||226
7704068|NCT01777139|18970342|P2|NOT COMPLETED|SFUCP (Up to 1.4 Years)||4
7704069|NCT01777139|18970343|P1|NOT COMPLETED|SFUCP (Up to 1.4 Years)||0
7704070|NCT01777139|18970342|P2|COMPLETED|SFUCP (Up to 1.4 Years)||0
7704071|NCT01777139|18970343|P1|COMPLETED|SFUCP (Up to 1.4 Years)||0
7704072|NCT01777139|18970342|P2|STARTED|SFUCP (Up to 1.4 Years)||4
7704073|NCT01777139|18970343|P1|STARTED|SFUCP (Up to 1.4 Years)||0
7704074|NCT01777139|18970342|P2|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
7704075|NCT01777139|18970343|P1|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||30
7704076|NCT01777139|18970342|P2|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
7704077|NCT01777139|18970343|P1|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
7704078|NCT01777139|18970342|P2|STARTED|Primary Reporting Phase (Up to 4 Years)||0
7704079|NCT01777139|18970343|P1|STARTED|Primary Reporting Phase (Up to 4 Years)||30
7704080|NCT01777126|18970384|P2|NOT COMPLETED|Overall Study||0
7704081|NCT01777126|18970385|P1|NOT COMPLETED|Overall Study||0
7704082|NCT01777126|18970384|P2|COMPLETED|Overall Study||46
7704083|NCT01777126|18970385|P1|COMPLETED|Overall Study||48
7704084|NCT01777126|18970384|P2|STARTED|Overall Study||46
7704085|NCT01777126|18970385|P1|STARTED|Overall Study||48
7704086|NCT01776723|18970411|P5|NOT COMPLETED|Overall Study||0
7704087|NCT01776723|18970412|P4|NOT COMPLETED|Overall Study||0
7704088|NCT01776723|18970413|P3|NOT COMPLETED|Overall Study||0
7704089|NCT01776723|18970414|P2|NOT COMPLETED|Overall Study||0
7704090|NCT01776723|18970415|P1|NOT COMPLETED|Overall Study||0
7704091|NCT01776723|18970411|P5|COMPLETED|Overall Study||30
7704092|NCT01776723|18970412|P4|COMPLETED|Overall Study||5
7704093|NCT01776723|18970413|P3|COMPLETED|Overall Study||5
7704094|NCT01776723|18970414|P2|COMPLETED|Overall Study||4
7704095|NCT01776723|18970415|P1|COMPLETED|Overall Study||6
7704096|NCT01776723|18970411|P5|STARTED|Overall Study||30
7704097|NCT01776723|18970412|P4|STARTED|Overall Study||5
7704098|NCT01776723|18970413|P3|STARTED|Overall Study||5
7704099|NCT01776723|18970414|P2|STARTED|Overall Study||4
7704100|NCT01776723|18970415|P1|STARTED|Overall Study||6
7704101|NCT01776645|18970433|P2|NOT COMPLETED|Overall Study||14
7704102|NCT01776645|18970434|P1|NOT COMPLETED|Overall Study||14
7704103|NCT01776645|18970433|P2|COMPLETED|Overall Study||14
7704104|NCT01776645|18970434|P1|COMPLETED|Overall Study||14
7704105|NCT01776645|18970433|P2|STARTED|Overall Study||28
7704106|NCT01776645|18970434|P1|STARTED|Overall Study||28
7704107|NCT01776632|18970442|P2|NOT COMPLETED|Overall Study||29
7704108|NCT01776632|18970443|P1|NOT COMPLETED|Overall Study||27
7704109|NCT01776632|18970442|P2|COMPLETED|Overall Study||190
7704110|NCT01776632|18970443|P1|COMPLETED|Overall Study||190
7704111|NCT01776632|18970442|P2|STARTED|Overall Study||219
7704112|NCT01776632|18970443|P1|STARTED|Overall Study||217
7704113|NCT01776554|18970457|P2|NOT COMPLETED|Overall Study||23
7704114|NCT01776554|18970458|P1|NOT COMPLETED|Overall Study||17
7704115|NCT01776554|18970457|P2|COMPLETED|Overall Study||307
7704116|NCT01776554|18970458|P1|COMPLETED|Overall Study||315
7704117|NCT01776554|18970457|P2|STARTED|Overall Study||330
7704118|NCT01776554|18970458|P1|STARTED|Overall Study||332
7704119|NCT01776541|18970501|P2|NOT COMPLETED|Overall Study||75
7704120|NCT01776541|18970502|P1|NOT COMPLETED|Overall Study||56
7704121|NCT01776541|18970501|P2|COMPLETED|Overall Study||416
7704122|NCT01776541|18970502|P1|COMPLETED|Overall Study||432
7704123|NCT01776541|18970501|P2|STARTED|Overall Study||491
7704124|NCT01776541|18970502|P1|STARTED|Overall Study||488
7704125|NCT01776424|18970524|P3|NOT COMPLETED|Overall Study||24
7704126|NCT01776424|18970525|P2|NOT COMPLETED|Overall Study||19
7704127|NCT01776424|18970526|P1|NOT COMPLETED|Overall Study||20
7704128|NCT01776424|18970524|P3|COMPLETED|Overall Study||9102
7704129|NCT01776424|18970525|P2|COMPLETED|Overall Study||9098
7704130|NCT01776424|18970526|P1|COMPLETED|Overall Study||9132
7704131|NCT01776424|18970524|P3|Treated|Overall Study||9107
7704132|NCT01776424|18970525|P2|Treated|Overall Study||9110
7704133|NCT01776424|18970526|P1|Treated|Overall Study||9134
7704134|NCT01776424|18970524|P3|STARTED|Overall Study||9126
7704135|NCT01776424|18970525|P2|STARTED|Overall Study||9117
7704136|NCT01776424|18970526|P1|STARTED|Overall Study||9152
7704137|NCT01776268|18970548|P2|NOT COMPLETED|Overall Study||0
7704138|NCT01776268|18970549|P1|NOT COMPLETED|Overall Study||0
7704139|NCT01776268|18970548|P2|COMPLETED|Overall Study||51
7704140|NCT01776268|18970549|P1|COMPLETED|Overall Study||48
7704141|NCT01776268|18970548|P2|STARTED|Overall Study||51
7704142|NCT01776268|18970549|P1|STARTED|Overall Study||48
7704143|NCT01776008|18970557|P1|NOT COMPLETED|Overall Study||2
7704144|NCT01776008|18970557|P1|COMPLETED|Overall Study||14
7704145|NCT01776008|18970557|P1|STARTED|Overall Study||16
7704146|NCT01775995|18970571|P2|NOT COMPLETED|Overall Study||1
7704147|NCT01775995|18970572|P1|NOT COMPLETED|Overall Study||1
7704148|NCT01775995|18970571|P2|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13
7704149|NCT01775995|18970572|P1|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20
7704150|NCT01775995|18970571|P2|STARTED|Overall Study||14
7704151|NCT01775995|18970572|P1|STARTED|Overall Study||21
7704152|NCT01775930|18970632|P1|NOT COMPLETED|Overall Study||1
7704153|NCT01775930|18970632|P1|COMPLETED|Overall Study||9
7704154|NCT01775930|18970632|P1|STARTED|Overall Study||10
7704155|NCT01775904|18970640|P1|NOT COMPLETED|LY2886721 ODT (Water, Fasting)||1
7704156|NCT01775904|18970640|P1|COMPLETED|LY2886721 ODT (Water, Fasting)||24
7704157|NCT01775904|18970640|P1|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fasting)|One participant was not dosed in this period due to an adverse event (AE).|24
7704158|NCT01775904|18970640|P1|STARTED|LY2886721 ODT (Water, Fasting)||25
7704159|NCT01775904|18970640|P1|NOT COMPLETED|Third Washout (7 Days)||0
7704160|NCT01775904|18970640|P1|COMPLETED|Third Washout (7 Days)||25
7704161|NCT01775904|18970640|P1|STARTED|Third Washout (7 Days)||25
7704162|NCT01775904|18970640|P1|NOT COMPLETED|LY2886721 ODT (Water, Fed)||0
7704163|NCT01775904|18970640|P1|COMPLETED|LY2886721 ODT (Water, Fed)||25
7704164|NCT01775904|18970640|P1|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fed)||25
7704165|NCT01775904|18970640|P1|STARTED|LY2886721 ODT (Water, Fed)||25
7704166|NCT01775904|18970640|P1|NOT COMPLETED|Second Washout (7 Days)||0
7704167|NCT01775904|18970640|P1|COMPLETED|Second Washout (7 Days)||25
7704168|NCT01775904|18970640|P1|STARTED|Second Washout (7 Days)||25
7704169|NCT01775904|18970640|P1|NOT COMPLETED|LY2886721 Capsule (Water, Fasting)||1
7704170|NCT01775904|18970640|P1|COMPLETED|LY2886721 Capsule (Water, Fasting)||25
7704171|NCT01775904|18970640|P1|Received at Least One Dose of Drug|LY2886721 Capsule (Water, Fasting)||26
7704172|NCT01775904|18970640|P1|STARTED|LY2886721 Capsule (Water, Fasting)||26
7704173|NCT01775904|18970640|P1|NOT COMPLETED|First Washout (7 Days)||0
7704174|NCT01775904|18970640|P1|COMPLETED|First Washout (7 Days)||26
7704175|NCT01775904|18970640|P1|STARTED|First Washout (7 Days)||26
7704176|NCT01775904|18970640|P1|NOT COMPLETED|LY2886721 ODT (no Water, Fasting)||0
7704177|NCT01775904|18970640|P1|COMPLETED|LY2886721 ODT (no Water, Fasting)||26
7704178|NCT01775904|18970640|P1|Received at Least One Dose of Drug|LY2886721 ODT (no Water, Fasting)||26
7704179|NCT01775904|18970640|P1|STARTED|LY2886721 ODT (no Water, Fasting)||26
7704180|NCT01775865|18970665|P3|NOT COMPLETED|Overall Study||0
7704181|NCT01775865|18970666|P2|NOT COMPLETED|Overall Study||1
7704182|NCT01775865|18970667|P1|NOT COMPLETED|Overall Study||3
7704183|NCT01775865|18970665|P3|COMPLETED|Overall Study||17
7704184|NCT01775865|18970666|P2|COMPLETED|Overall Study||13
7704185|NCT01775865|18970667|P1|COMPLETED|Overall Study||11
7704186|NCT01775865|18970665|P3|STARTED|Overall Study||17
7704187|NCT01775865|18970666|P2|STARTED|Overall Study||14
7704188|NCT01775865|18970667|P1|STARTED|Overall Study||14
7704189|NCT01775852|18970683|P2|NOT COMPLETED|Overall Study||1
7704190|NCT01775852|18970684|P1|NOT COMPLETED|Overall Study||0
7704191|NCT01775852|18970683|P2|COMPLETED|Overall Study||13
7704192|NCT01775852|18970684|P1|COMPLETED|Overall Study||31
7704193|NCT01775852|18970683|P2|STARTED|Overall Study||14
7704194|NCT01775852|18970684|P1|STARTED|Overall Study||31
7704195|NCT01775800|18970698|P2|NOT COMPLETED|Overall Study||0
7704196|NCT01775800|18970699|P1|NOT COMPLETED|Overall Study||0
7704197|NCT01775800|18970698|P2|COMPLETED|Overall Study||8
7704198|NCT01775800|18970699|P1|COMPLETED|Overall Study||8
7704199|NCT01775800|18970698|P2|STARTED|Overall Study||8
7704200|NCT01775800|18970699|P1|STARTED|Overall Study||8
7704201|NCT01775787|18970706|P2|NOT COMPLETED|Second 7-10 Days||2
7704202|NCT01775787|18970707|P1|NOT COMPLETED|Second 7-10 Days||0
7704203|NCT01775787|18970706|P2|COMPLETED|Second 7-10 Days||6
7704204|NCT01775787|18970707|P1|COMPLETED|Second 7-10 Days||12
7704205|NCT01775787|18970706|P2|STARTED|Second 7-10 Days||8
7704206|NCT01775787|18970707|P1|STARTED|Second 7-10 Days||12
7704207|NCT01775787|18970706|P2|NOT COMPLETED|First 7-10 Days||6
7704208|NCT01775787|18970707|P1|NOT COMPLETED|First 7-10 Days||1
7704209|NCT01775787|18970706|P2|COMPLETED|First 7-10 Days||8
7704210|NCT01775787|18970707|P1|COMPLETED|First 7-10 Days||12
7704211|NCT01775787|18970706|P2|STARTED|First 7-10 Days||14
7704212|NCT01775787|18970707|P1|STARTED|First 7-10 Days||13
7704213|NCT01775774|18970718|P3|NOT COMPLETED|Overall Study||0
7704214|NCT01775774|18970719|P2|NOT COMPLETED|Overall Study||0
7704215|NCT01775774|18970720|P1|NOT COMPLETED|Overall Study||0
7704216|NCT01775774|18970718|P3|COMPLETED|Overall Study||3
7704217|NCT01775774|18970719|P2|COMPLETED|Overall Study||3
7704218|NCT01775774|18970720|P1|COMPLETED|Overall Study||3
7704219|NCT01775774|18970718|P3|STARTED|Overall Study||3
7704220|NCT01775774|18970719|P2|STARTED|Overall Study||3
7704221|NCT01775774|18970720|P1|STARTED|Overall Study||3
7704222|NCT01775735|18970748|P2|NOT COMPLETED|Open Label (24 Months)||4
7704223|NCT01775735|18970749|P1|NOT COMPLETED|Open Label (24 Months)||1
7704224|NCT01775735|18970748|P2|COMPLETED|Open Label (24 Months)||3
7704225|NCT01775735|18970749|P1|COMPLETED|Open Label (24 Months)||7
7704226|NCT01775735|18970748|P2|STARTED|Open Label (24 Months)||7
7704227|NCT01775735|18970749|P1|STARTED|Open Label (24 Months)||8
7704228|NCT01775735|18970748|P2|NOT COMPLETED|Intervention (6 Months)||0
7704229|NCT01775735|18970749|P1|NOT COMPLETED|Intervention (6 Months)||0
7704230|NCT01775735|18970748|P2|COMPLETED|Intervention (6 Months)||7
7704231|NCT01775735|18970749|P1|COMPLETED|Intervention (6 Months)||8
7704232|NCT01775735|18970748|P2|STARTED|Intervention (6 Months)||7
7704233|NCT01775735|18970749|P1|STARTED|Intervention (6 Months)||8
7704234|NCT01775722|18970755|P1|NOT COMPLETED|Overall Study||2
7704235|NCT01775722|18970755|P1|COMPLETED|Overall Study||20
7704236|NCT01775722|18970755|P1|STARTED|Overall Study||22
7704237|NCT01775670|18970763|P2|NOT COMPLETED|Overall Study||1
7704238|NCT01775670|18970764|P1|NOT COMPLETED|Overall Study||1
7704239|NCT01775670|18970763|P2|COMPLETED|Overall Study||2
7704240|NCT01775670|18970764|P1|COMPLETED|Overall Study||0
7704241|NCT01775670|18970763|P2|STARTED|Overall Study||3
7704242|NCT01775670|18970764|P1|STARTED|Overall Study||1
7704243|NCT01775553|18970790|P1|NOT COMPLETED|Overall Study||13
7704244|NCT01775553|18970790|P1|COMPLETED|Overall Study||0
7704245|NCT01775553|18970790|P1|STARTED|Overall Study||13
7704246|NCT01775501|18970798|P1|NOT COMPLETED|Overall Study||1
7704247|NCT01775501|18970798|P1|COMPLETED|Overall Study||39
7704248|NCT01775501|18970798|P1|STARTED|Overall Study||40
7704249|NCT01775371|18970809|P2|NOT COMPLETED|Overall Study||0
7704250|NCT01775371|18970810|P1|NOT COMPLETED|Overall Study||0
7704251|NCT01775371|18970809|P2|COMPLETED|Overall Study||330
7704252|NCT01775371|18970810|P1|COMPLETED|Overall Study||306
7704253|NCT01775371|18970809|P2|STARTED|Overall Study||330
7704254|NCT01775371|18970810|P1|STARTED|Overall Study||306
7704255|NCT01775189|18970822|P7|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
7704256|NCT01775189|18970823|P6|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
7704257|NCT01775189|18970824|P5|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
7704258|NCT01775189|18970825|P4|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
7704259|NCT01775189|18970826|P3|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
7704260|NCT01775189|18970827|P2|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
7704261|NCT01775189|18970828|P1|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
7704262|NCT01775189|18970822|P7|COMPLETED|Treatment Phase: Fourth Intervention||7
7704263|NCT01775189|18970823|P6|COMPLETED|Treatment Phase: Fourth Intervention||7
7704264|NCT01775189|18970824|P5|COMPLETED|Treatment Phase: Fourth Intervention||8
7704265|NCT01775189|18970825|P4|COMPLETED|Treatment Phase: Fourth Intervention||6
7704266|NCT01775189|18970826|P3|COMPLETED|Treatment Phase: Fourth Intervention||0
7704267|NCT01775189|18970827|P2|COMPLETED|Treatment Phase: Fourth Intervention||0
7704268|NCT01775189|18970828|P1|COMPLETED|Treatment Phase: Fourth Intervention||0
7704269|NCT01775189|18970822|P7|STARTED|Treatment Phase: Fourth Intervention||7
7704270|NCT01775189|18970823|P6|STARTED|Treatment Phase: Fourth Intervention||7
7704271|NCT01775189|18970824|P5|STARTED|Treatment Phase: Fourth Intervention||8
7704272|NCT01775189|18970825|P4|STARTED|Treatment Phase: Fourth Intervention||6
7704273|NCT01775189|18970826|P3|STARTED|Treatment Phase: Fourth Intervention||0
7704274|NCT01775189|18970827|P2|STARTED|Treatment Phase: Fourth Intervention||0
7704275|NCT01775189|18970828|P1|STARTED|Treatment Phase: Fourth Intervention||0
7704276|NCT01775189|18970822|P7|NOT COMPLETED|Treatment Phase: Washout Period 3||1
7704277|NCT01775189|18970823|P6|NOT COMPLETED|Treatment Phase: Washout Period 3||0
7704278|NCT01775189|18970824|P5|NOT COMPLETED|Treatment Phase: Washout Period 3||0
7704279|NCT01775189|18970825|P4|NOT COMPLETED|Treatment Phase: Washout Period 3||1
7704280|NCT01775189|18970826|P3|NOT COMPLETED|Treatment Phase: Washout Period 3||0
7704281|NCT01775189|18970827|P2|NOT COMPLETED|Treatment Phase: Washout Period 3||0
7704282|NCT01775189|18970828|P1|NOT COMPLETED|Treatment Phase: Washout Period 3||0
7704283|NCT01775189|18970822|P7|COMPLETED|Treatment Phase: Washout Period 3||7
7704284|NCT01775189|18970823|P6|COMPLETED|Treatment Phase: Washout Period 3||7
7704285|NCT01775189|18970824|P5|COMPLETED|Treatment Phase: Washout Period 3||8
7704286|NCT01775189|18970825|P4|COMPLETED|Treatment Phase: Washout Period 3||6
7704287|NCT01775189|18970826|P3|COMPLETED|Treatment Phase: Washout Period 3||0
7704288|NCT01775189|18970827|P2|COMPLETED|Treatment Phase: Washout Period 3||0
7704289|NCT01775189|18970828|P1|COMPLETED|Treatment Phase: Washout Period 3||0
7704290|NCT01775189|18970822|P7|STARTED|Treatment Phase: Washout Period 3||8
7704291|NCT01775189|18970823|P6|STARTED|Treatment Phase: Washout Period 3||7
7704292|NCT01775189|18970824|P5|STARTED|Treatment Phase: Washout Period 3||8
7704293|NCT01775189|18970825|P4|STARTED|Treatment Phase: Washout Period 3||7
7704294|NCT01775189|18970826|P3|STARTED|Treatment Phase: Washout Period 3||0
7704295|NCT01775189|18970827|P2|STARTED|Treatment Phase: Washout Period 3||0
7704296|NCT01775189|18970828|P1|STARTED|Treatment Phase: Washout Period 3||0
7704297|NCT01775189|18970822|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
7704298|NCT01775189|18970823|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
7704299|NCT01775189|18970824|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
7704300|NCT01775189|18970825|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
7704301|NCT01775189|18970826|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
7704302|NCT01775189|18970827|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
7704303|NCT01775189|18970828|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
7704304|NCT01775189|18970822|P7|COMPLETED|Treatment Phase: Third Intervention||8
7704305|NCT01775189|18970823|P6|COMPLETED|Treatment Phase: Third Intervention||7
7704306|NCT01775189|18970824|P5|COMPLETED|Treatment Phase: Third Intervention||8
7704307|NCT01775189|18970825|P4|COMPLETED|Treatment Phase: Third Intervention||7
7704308|NCT01775189|18970826|P3|COMPLETED|Treatment Phase: Third Intervention||0
7704309|NCT01775189|18970827|P2|COMPLETED|Treatment Phase: Third Intervention||0
7704310|NCT01775189|18970828|P1|COMPLETED|Treatment Phase: Third Intervention||0
7704311|NCT01775189|18970822|P7|STARTED|Treatment Phase: Third Intervention||8
7704312|NCT01775189|18970823|P6|STARTED|Treatment Phase: Third Intervention||7
7704313|NCT01775189|18970824|P5|STARTED|Treatment Phase: Third Intervention||8
7704314|NCT01775189|18970825|P4|STARTED|Treatment Phase: Third Intervention||7
7704315|NCT01775189|18970826|P3|STARTED|Treatment Phase: Third Intervention||0
7704316|NCT01775189|18970827|P2|STARTED|Treatment Phase: Third Intervention||0
7704317|NCT01775189|18970828|P1|STARTED|Treatment Phase: Third Intervention||0
7704318|NCT01775189|18970822|P7|NOT COMPLETED|Treatment Phase: Washout Period 2||0
7704319|NCT01775189|18970823|P6|NOT COMPLETED|Treatment Phase: Washout Period 2||0
7704320|NCT01775189|18970824|P5|NOT COMPLETED|Treatment Phase: Washout Period 2||0
7704321|NCT01775189|18970825|P4|NOT COMPLETED|Treatment Phase: Washout Period 2||1
7704322|NCT01775189|18970826|P3|NOT COMPLETED|Treatment Phase: Washout Period 2||0
7704323|NCT01775189|18970827|P2|NOT COMPLETED|Treatment Phase: Washout Period 2||0
7704324|NCT01775189|18970828|P1|NOT COMPLETED|Treatment Phase: Washout Period 2||0
7704325|NCT01775189|18970822|P7|COMPLETED|Treatment Phase: Washout Period 2||8
7704326|NCT01775189|18970823|P6|COMPLETED|Treatment Phase: Washout Period 2||7
7704327|NCT01775189|18970824|P5|COMPLETED|Treatment Phase: Washout Period 2||8
7704328|NCT01775189|18970825|P4|COMPLETED|Treatment Phase: Washout Period 2||7
7704329|NCT01775189|18970826|P3|COMPLETED|Treatment Phase: Washout Period 2||0
7704330|NCT01775189|18970827|P2|COMPLETED|Treatment Phase: Washout Period 2||0
7704331|NCT01775189|18970828|P1|COMPLETED|Treatment Phase: Washout Period 2||0
7704332|NCT01775189|18970822|P7|STARTED|Treatment Phase: Washout Period 2||8
7704333|NCT01775189|18970823|P6|STARTED|Treatment Phase: Washout Period 2||7
7704334|NCT01775189|18970824|P5|STARTED|Treatment Phase: Washout Period 2||8
7704335|NCT01775189|18970825|P4|STARTED|Treatment Phase: Washout Period 2||8
7704336|NCT01775189|18970826|P3|STARTED|Treatment Phase: Washout Period 2||0
7704337|NCT01775189|18970827|P2|STARTED|Treatment Phase: Washout Period 2||0
7704338|NCT01775189|18970828|P1|STARTED|Treatment Phase: Washout Period 2||0
7704339|NCT01775189|18970822|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
7704340|NCT01775189|18970823|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
7704341|NCT01775189|18970824|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
7704342|NCT01775189|18970825|P4|NOT COMPLETED|Treatment Phase: Second Intervention||0
7704343|NCT01775189|18970826|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
7704344|NCT01775189|18970827|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
7704345|NCT01775189|18970828|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
7704346|NCT01775189|18970822|P7|COMPLETED|Treatment Phase: Second Intervention||8
7704347|NCT01775189|18970823|P6|COMPLETED|Treatment Phase: Second Intervention||7
7704348|NCT01775189|18970824|P5|COMPLETED|Treatment Phase: Second Intervention||8
7704349|NCT01775189|18970825|P4|COMPLETED|Treatment Phase: Second Intervention||8
7704350|NCT01775189|18970826|P3|COMPLETED|Treatment Phase: Second Intervention||0
7704351|NCT01775189|18970827|P2|COMPLETED|Treatment Phase: Second Intervention||0
7704352|NCT01775189|18970828|P1|COMPLETED|Treatment Phase: Second Intervention||0
7704353|NCT01775189|18970822|P7|STARTED|Treatment Phase: Second Intervention||8
7704354|NCT01775189|18970823|P6|STARTED|Treatment Phase: Second Intervention||7
7704355|NCT01775189|18970824|P5|STARTED|Treatment Phase: Second Intervention||8
7704356|NCT01775189|18970825|P4|STARTED|Treatment Phase: Second Intervention||8
7704357|NCT01775189|18970826|P3|STARTED|Treatment Phase: Second Intervention||0
7704358|NCT01775189|18970827|P2|STARTED|Treatment Phase: Second Intervention||0
7704359|NCT01775189|18970828|P1|STARTED|Treatment Phase: Second Intervention||0
7704360|NCT01775189|18970822|P7|NOT COMPLETED|Treatment Phase: Washout Period 1||0
7704361|NCT01775189|18970823|P6|NOT COMPLETED|Treatment Phase: Washout Period 1||1
7704362|NCT01775189|18970824|P5|NOT COMPLETED|Treatment Phase: Washout Period 1||0
7704363|NCT01775189|18970825|P4|NOT COMPLETED|Treatment Phase: Washout Period 1||0
7704364|NCT01775189|18970826|P3|NOT COMPLETED|Treatment Phase: Washout Period 1||0
7704365|NCT01775189|18970827|P2|NOT COMPLETED|Treatment Phase: Washout Period 1||0
7704366|NCT01775189|18970828|P1|NOT COMPLETED|Treatment Phase: Washout Period 1||0
7704367|NCT01775189|18970822|P7|COMPLETED|Treatment Phase: Washout Period 1||8
7704368|NCT01775189|18970823|P6|COMPLETED|Treatment Phase: Washout Period 1||7
7704369|NCT01775189|18970824|P5|COMPLETED|Treatment Phase: Washout Period 1||8
7704370|NCT01775189|18970825|P4|COMPLETED|Treatment Phase: Washout Period 1||8
7704371|NCT01775189|18970826|P3|COMPLETED|Treatment Phase: Washout Period 1||0
7704372|NCT01775189|18970827|P2|COMPLETED|Treatment Phase: Washout Period 1||0
7704373|NCT01775189|18970828|P1|COMPLETED|Treatment Phase: Washout Period 1||0
7704374|NCT01775189|18970822|P7|STARTED|Treatment Phase: Washout Period 1||8
7704375|NCT01775189|18970823|P6|STARTED|Treatment Phase: Washout Period 1||8
7704376|NCT01775189|18970824|P5|STARTED|Treatment Phase: Washout Period 1||8
7704377|NCT01775189|18970825|P4|STARTED|Treatment Phase: Washout Period 1||8
7704378|NCT01775189|18970826|P3|STARTED|Treatment Phase: Washout Period 1||0
7704379|NCT01775189|18970827|P2|STARTED|Treatment Phase: Washout Period 1||0
7704380|NCT01775189|18970828|P1|STARTED|Treatment Phase: Washout Period 1||0
7704381|NCT01775189|18970822|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
7704382|NCT01775189|18970823|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
7704383|NCT01775189|18970824|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
7704384|NCT01775189|18970825|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
7704385|NCT01775189|18970826|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
7704386|NCT01775189|18970827|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
7704387|NCT01775189|18970828|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
7704388|NCT01775189|18970822|P7|COMPLETED|Treatment Phase: First Intervention||8
7704389|NCT01775189|18970823|P6|COMPLETED|Treatment Phase: First Intervention||8
7704390|NCT01775189|18970824|P5|COMPLETED|Treatment Phase: First Intervention||8
7704391|NCT01775189|18970825|P4|COMPLETED|Treatment Phase: First Intervention||8
7704392|NCT01775189|18970826|P3|COMPLETED|Treatment Phase: First Intervention||0
7704393|NCT01775189|18970827|P2|COMPLETED|Treatment Phase: First Intervention||0
7704394|NCT01775189|18970828|P1|COMPLETED|Treatment Phase: First Intervention||0
7704395|NCT01775189|18970822|P7|STARTED|Treatment Phase: First Intervention||8
7704396|NCT01775189|18970823|P6|STARTED|Treatment Phase: First Intervention||8
7704397|NCT01775189|18970824|P5|STARTED|Treatment Phase: First Intervention||8
7704398|NCT01775189|18970825|P4|STARTED|Treatment Phase: First Intervention||8
7704399|NCT01775189|18970826|P3|STARTED|Treatment Phase: First Intervention||0
7704400|NCT01775189|18970827|P2|STARTED|Treatment Phase: First Intervention||0
7704401|NCT01775189|18970828|P1|STARTED|Treatment Phase: First Intervention||0
7704402|NCT01775189|18970822|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
7704403|NCT01775189|18970823|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
7704404|NCT01775189|18970824|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
7704405|NCT01775189|18970825|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
7704406|NCT01775189|18970826|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||7
7704407|NCT01775189|18970827|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||3
7704408|NCT01775189|18970828|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
7704409|NCT01775189|18970822|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
7704410|NCT01775189|18970823|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
7704411|NCT01775189|18970824|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
7704412|NCT01775189|18970825|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
7704413|NCT01775189|18970826|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
7704414|NCT01775189|18970827|P2|COMPLETED|Drug Discrimination Phase: Day 2||16
7704415|NCT01775189|18970828|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
7704416|NCT01775189|18970822|P7|STARTED|Drug Discrimination Phase: Day 2||0
7704417|NCT01775189|18970823|P6|STARTED|Drug Discrimination Phase: Day 2||0
7704418|NCT01775189|18970824|P5|STARTED|Drug Discrimination Phase: Day 2||0
7704419|NCT01775189|18970825|P4|STARTED|Drug Discrimination Phase: Day 2||0
7704420|NCT01775189|18970826|P3|STARTED|Drug Discrimination Phase: Day 2||23
7704421|NCT01775189|18970827|P2|STARTED|Drug Discrimination Phase: Day 2||19
7704422|NCT01775189|18970828|P1|STARTED|Drug Discrimination Phase: Day 2||0
7704423|NCT01775189|18970822|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7704424|NCT01775189|18970823|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7704425|NCT01775189|18970824|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7704426|NCT01775189|18970825|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7704427|NCT01775189|18970826|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7704428|NCT01775189|18970827|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
7704429|NCT01775189|18970828|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7704430|NCT01775189|18970822|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
7704431|NCT01775189|18970823|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
7704432|NCT01775189|18970824|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
7704433|NCT01775189|18970825|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
7704434|NCT01775189|18970826|P3|COMPLETED|Drug Discrimination Phase: Day 1||23
7704435|NCT01775189|18970827|P2|COMPLETED|Drug Discrimination Phase: Day 1||19
7704436|NCT01775189|18970828|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
7704437|NCT01775189|18970822|P7|STARTED|Drug Discrimination Phase: Day 1||0
7704438|NCT01775189|18970823|P6|STARTED|Drug Discrimination Phase: Day 1||0
7704439|NCT01775189|18970824|P5|STARTED|Drug Discrimination Phase: Day 1||0
7704440|NCT01775189|18970825|P4|STARTED|Drug Discrimination Phase: Day 1||0
7704441|NCT01775189|18970826|P3|STARTED|Drug Discrimination Phase: Day 1||23
7704442|NCT01775189|18970827|P2|STARTED|Drug Discrimination Phase: Day 1||22
7704443|NCT01775189|18970828|P1|STARTED|Drug Discrimination Phase: Day 1||0
7704444|NCT01775189|18970822|P7|NOT COMPLETED|Naloxone Challenge Phase||0
7704445|NCT01775189|18970823|P6|NOT COMPLETED|Naloxone Challenge Phase||0
7704446|NCT01775189|18970824|P5|NOT COMPLETED|Naloxone Challenge Phase||0
7704447|NCT01775189|18970825|P4|NOT COMPLETED|Naloxone Challenge Phase||0
7704448|NCT01775189|18970826|P3|NOT COMPLETED|Naloxone Challenge Phase||0
7704449|NCT01775189|18970827|P2|NOT COMPLETED|Naloxone Challenge Phase||0
7704450|NCT01775189|18970828|P1|NOT COMPLETED|Naloxone Challenge Phase||0
7704451|NCT01775189|18970822|P7|COMPLETED|Naloxone Challenge Phase||0
7704452|NCT01775189|18970823|P6|COMPLETED|Naloxone Challenge Phase||0
7704453|NCT01775189|18970824|P5|COMPLETED|Naloxone Challenge Phase||0
7704454|NCT01775189|18970825|P4|COMPLETED|Naloxone Challenge Phase||0
7704455|NCT01775189|18970826|P3|COMPLETED|Naloxone Challenge Phase||0
7704456|NCT01775189|18970827|P2|COMPLETED|Naloxone Challenge Phase||0
7704457|NCT01775189|18970828|P1|COMPLETED|Naloxone Challenge Phase||45
7704458|NCT01775189|18970822|P7|STARTED|Naloxone Challenge Phase||0
7704459|NCT01775189|18970823|P6|STARTED|Naloxone Challenge Phase||0
7704460|NCT01775189|18970824|P5|STARTED|Naloxone Challenge Phase||0
7704461|NCT01775189|18970825|P4|STARTED|Naloxone Challenge Phase||0
7704462|NCT01775189|18970826|P3|STARTED|Naloxone Challenge Phase||0
7704463|NCT01775189|18970827|P2|STARTED|Naloxone Challenge Phase||0
7704464|NCT01775189|18970828|P1|STARTED|Naloxone Challenge Phase||45
7704465|NCT01775137|18971047|P1|NOT COMPLETED|Overall Study||11
7704466|NCT01775137|18971047|P1|COMPLETED|Overall Study||34
7704467|NCT01775137|18971047|P1|STARTED|Overall Study||45
7704468|NCT01775124|18971074|P2|NOT COMPLETED|Extension Period||18
7704469|NCT01775124|18971075|P1|NOT COMPLETED|Extension Period||12
7704470|NCT01775124|18971074|P2|COMPLETED|Extension Period||138
7704471|NCT01775124|18971075|P1|COMPLETED|Extension Period||145
7704472|NCT01775124|18971074|P2|STARTED|Extension Period||156
7704473|NCT01775124|18971075|P1|STARTED|Extension Period||157
7704474|NCT01775124|18971074|P2|NOT COMPLETED|Core Period||10
7704475|NCT01775124|18971075|P1|NOT COMPLETED|Core Period||11
7704476|NCT01775124|18971074|P2|COMPLETED|Core Period||156
7704477|NCT01775124|18971075|P1|COMPLETED|Core Period||157
7704478|NCT01775124|18971074|P2|Safety Set|Core Period||166
7704479|NCT01775124|18971075|P1|Safety Set|Core Period|1 patient was mis-randomized & 1 patient discontinued due to AE. No treatment given|166
7704480|NCT01775124|18971074|P2|Per Protocol Set|Core Period||155
7704481|NCT01775124|18971075|P1|Per Protocol Set|Core Period||157
7704482|NCT01775124|18971074|P2|Full Analysis Set|Core Period||166
7704483|NCT01775124|18971075|P1|Full Analysis Set|Core Period||167
7704484|NCT01775124|18971074|P2|STARTED|Core Period||166
7704485|NCT01775124|18971075|P1|STARTED|Core Period||168
7704486|NCT01774981|18971110|P8|NOT COMPLETED|Overall Study||1
7704487|NCT01774981|18971111|P7|NOT COMPLETED|Overall Study||0
7704488|NCT01774981|18971112|P6|NOT COMPLETED|Overall Study||1
7704489|NCT01774981|18971113|P5|NOT COMPLETED|Overall Study||1
7704490|NCT01774981|18971114|P4|NOT COMPLETED|Overall Study||0
7704491|NCT01774981|18971115|P3|NOT COMPLETED|Overall Study||0
7704492|NCT01774981|18971116|P2|NOT COMPLETED|Overall Study||0
7704493|NCT01774981|18971117|P1|NOT COMPLETED|Overall Study||0
7704494|NCT01774981|18971110|P8|COMPLETED|Overall Study||11
7704495|NCT01774981|18971111|P7|COMPLETED|Overall Study||13
7704496|NCT01774981|18971112|P6|COMPLETED|Overall Study||13
7704497|NCT01774981|18971113|P5|COMPLETED|Overall Study||5
7704498|NCT01774981|18971114|P4|COMPLETED|Overall Study||4
7704499|NCT01774981|18971115|P3|COMPLETED|Overall Study||4
7704500|NCT01774981|18971116|P2|COMPLETED|Overall Study||4
7704501|NCT01774981|18971117|P1|COMPLETED|Overall Study||3
7704502|NCT01774981|18971110|P8|Received at Least 1 Dose of Study Drug|Overall Study||12
7704503|NCT01774981|18971111|P7|Received at Least 1 Dose of Study Drug|Overall Study||13
7704504|NCT01774981|18971112|P6|Received at Least 1 Dose of Study Drug|Overall Study||14
7704505|NCT01774981|18971113|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
7704506|NCT01774981|18971114|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
7704507|NCT01774981|18971115|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
7704508|NCT01774981|18971116|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
7704509|NCT01774981|18971117|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
7704510|NCT01774981|18971110|P8|STARTED|Overall Study||12
7704511|NCT01774981|18971111|P7|STARTED|Overall Study||13
7704512|NCT01774981|18971112|P6|STARTED|Overall Study||14
7704513|NCT01774981|18971113|P5|STARTED|Overall Study||6
7704514|NCT01774981|18971114|P4|STARTED|Overall Study||4
7704515|NCT01774981|18971115|P3|STARTED|Overall Study||4
7704516|NCT01774981|18971116|P2|STARTED|Overall Study||4
7704517|NCT01774981|18971117|P1|STARTED|Overall Study||3
7704518|NCT01774968|18971149|P2|NOT COMPLETED|Overall Study||35
7704519|NCT01774968|18971150|P1|NOT COMPLETED|Overall Study||30
7704520|NCT01774968|18971149|P2|COMPLETED|Overall Study||128
7704521|NCT01774968|18971150|P1|COMPLETED|Overall Study||132
7704522|NCT01774968|18971149|P2|Received at Least 1 Dose of Study Drug|Overall Study||161
7704523|NCT01774968|18971150|P1|Received at Least 1 Dose of Study Drug|Overall Study||162
7704524|NCT01774968|18971149|P2|STARTED|Overall Study||163
7704525|NCT01774968|18971150|P1|STARTED|Overall Study||162
7704526|NCT01774929|18971184|P1|NOT COMPLETED|Overall Study||3
7704527|NCT01774929|18971184|P1|COMPLETED|Overall Study||32
7704528|NCT01774929|18971184|P1|STARTED|Overall Study||35
7704529|NCT01774903|18971190|P1|NOT COMPLETED|Overall Study||11
7704530|NCT01774903|18971190|P1|COMPLETED|Overall Study||34
7704531|NCT01774903|18971190|P1|STARTED|Overall Study||45
7704532|NCT01774851|18971199|P2|NOT COMPLETED|Overall Study||0
7704533|NCT01774851|18971200|P1|NOT COMPLETED|Overall Study||0
7704534|NCT01774851|18971199|P2|COMPLETED|Overall Study||42
7704535|NCT01774851|18971200|P1|COMPLETED|Overall Study||42
7704536|NCT01774851|18971199|P2|STARTED|Overall Study||42
7704537|NCT01774851|18971200|P1|STARTED|Overall Study||42
7704538|NCT01774799|18971210|P4|NOT COMPLETED|Overall Study||0
7704539|NCT01774799|18971211|P3|NOT COMPLETED|Overall Study||0
7704540|NCT01774799|18971212|P2|NOT COMPLETED|Overall Study||1
7704541|NCT01774799|18971213|P1|NOT COMPLETED|Overall Study||1
7704542|NCT01774799|18971210|P4|COMPLETED|Overall Study||190
7704543|NCT01774799|18971211|P3|COMPLETED|Overall Study||212
7704544|NCT01774799|18971212|P2|COMPLETED|Overall Study||189
7704545|NCT01774799|18971213|P1|COMPLETED|Overall Study||211
7704546|NCT01774799|18971210|P4|STARTED|Overall Study||190
7704547|NCT01774799|18971211|P3|STARTED|Overall Study||212
7704548|NCT01774799|18971212|P2|STARTED|Overall Study||190
7704549|NCT01774799|18971213|P1|STARTED|Overall Study||212
7704550|NCT01774786|18971229|P2|NOT COMPLETED|Overall Study||346
7704551|NCT01774786|18971230|P1|NOT COMPLETED|Overall Study||328
7704552|NCT01774786|18971229|P2|COMPLETED|Overall Study||46
7704553|NCT01774786|18971230|P1|COMPLETED|Overall Study||60
7704554|NCT01774786|18971229|P2|Received Placebo (No Pertuzumab)|Overall Study||388
7704555|NCT01774786|18971230|P1|Received Placebo (No Pertuzumab)|Overall Study||0
7704556|NCT01774786|18971229|P2|Received at Least One Dose of Pertuzumab|Overall Study|One participant randomized to placebo arm received 1 dose of pertuzumab by error.|1
7704557|NCT01774786|18971230|P1|Received at Least One Dose of Pertuzumab|Overall Study||384
7704558|NCT01774786|18971229|P2|Did Not Receive Any Study Treatment|Overall Study|All 3 patients found ineligible for the study after enrollment and before treatment.|3
7704559|NCT01774786|18971230|P1|Did Not Receive Any Study Treatment|Overall Study|2 patients found ineligible after enrollment and 2 patients died before treatment.|4
7704560|NCT01774786|18971229|P2|STARTED|Overall Study||392
7704561|NCT01774786|18971230|P1|STARTED|Overall Study||388
7704562|NCT01774760|18971260|P1|NOT COMPLETED|Overall Study||0
7704563|NCT01774760|18971260|P1|COMPLETED|Overall Study||10
7704564|NCT01774760|18971260|P1|STARTED|Overall Study||10
7704565|NCT01774721|18971266|P2|NOT COMPLETED|Overall Study||225
7704566|NCT01774721|18971267|P1|NOT COMPLETED|Overall Study||227
7704567|NCT01774721|18971266|P2|COMPLETED|Overall Study||0
7704568|NCT01774721|18971267|P1|COMPLETED|Overall Study||0
7704569|NCT01774721|18971266|P2|Treated|Overall Study||224
7704570|NCT01774721|18971267|P1|Treated|Overall Study||227
7704571|NCT01774721|18971266|P2|STARTED|Overall Study||225
7704572|NCT01774721|18971267|P1|STARTED|Overall Study||227
7704573|NCT01774604|18971311|P2|NOT COMPLETED|Overall Study||0
7704574|NCT01774604|18971312|P1|NOT COMPLETED|Overall Study||0
7704575|NCT01774604|18971311|P2|COMPLETED|Overall Study||226
7704576|NCT01774604|18971312|P1|COMPLETED|Overall Study||223
7704577|NCT01774604|18971311|P2|STARTED|Overall Study||226
7704578|NCT01774604|18971312|P1|STARTED|Overall Study||223
7704579|NCT01774591|18971332|P2|NOT COMPLETED|Overall Study||4
7704580|NCT01774591|18971333|P1|NOT COMPLETED|Overall Study||1
7704581|NCT01774591|18971332|P2|COMPLETED|Overall Study||7
7704582|NCT01774591|18971333|P1|COMPLETED|Overall Study||9
7704583|NCT01774591|18971332|P2|STARTED|Overall Study||11
7704584|NCT01774591|18971333|P1|STARTED|Overall Study||10
7704585|NCT01774370|18971343|P1|NOT COMPLETED|Overall Study||129
7704586|NCT01774370|18971343|P1|COMPLETED|Overall Study||3053
7704587|NCT01774370|18971343|P1|STARTED|Overall Study||3182
7704588|NCT01774344|18971351|P2|NOT COMPLETED|Overall Study||121
7704589|NCT01774344|18971352|P1|NOT COMPLETED|Overall Study||62
7704590|NCT01774344|18971351|P2|COMPLETED|Overall Study||258
7704591|NCT01774344|18971352|P1|COMPLETED|Overall Study||132
7704592|NCT01774344|18971351|P2|Entered Survival FU|Overall Study||291
7704593|NCT01774344|18971352|P1|Entered Survival FU|Overall Study||145
7704594|NCT01774344|18971351|P2|Treated|Overall Study||374
7704595|NCT01774344|18971352|P1|Treated|Overall Study||193
7704596|NCT01774344|18971351|P2|STARTED|Overall Study||379
7704597|NCT01774344|18971352|P1|STARTED|Overall Study||194
7704598|NCT01774305|18971370|P2|NOT COMPLETED|Overall Study||0
7704599|NCT01774305|18971371|P1|NOT COMPLETED|Overall Study||1
7704600|NCT01774305|18971370|P2|COMPLETED|Overall Study||71
7704601|NCT01774305|18971371|P1|COMPLETED|Overall Study||70
7704602|NCT01774305|18971370|P2|STARTED|Overall Study||71
7704603|NCT01774305|18971371|P1|STARTED|Overall Study||71
7704604|NCT01774253|18971379|P1|NOT COMPLETED|Overall Study||9
7704605|NCT01774253|18971379|P1|COMPLETED|Overall Study||0
7704606|NCT01774253|18971379|P1|STARTED|Overall Study||9
7704607|NCT01774149|18971389|P2|NOT COMPLETED|Overall Study||3
7704608|NCT01774149|18971390|P1|NOT COMPLETED|Overall Study||1
7704609|NCT01774149|18971389|P2|COMPLETED|Overall Study||12
7704610|NCT01774149|18971390|P1|COMPLETED|Overall Study||14
7704611|NCT01774149|18971389|P2|STARTED|Overall Study||15
7704612|NCT01774149|18971390|P1|STARTED|Overall Study||15
7704613|NCT01774110|18971398|P1|NOT COMPLETED|Overall Study||7
7704614|NCT01774110|18971398|P1|COMPLETED|Overall Study||5
7704615|NCT01774110|18971398|P1|STARTED|Overall Study||12
7704616|NCT01774097|18971406|P2|NOT COMPLETED|Overall Study||2
7704617|NCT01774097|18971407|P1|NOT COMPLETED|Overall Study||2
7704618|NCT01774097|18971406|P2|COMPLETED|Overall Study||40
7704619|NCT01774097|18971407|P1|COMPLETED|Overall Study||38
7704620|NCT01774097|18971406|P2|STARTED|Overall Study||42
7704621|NCT01774097|18971407|P1|STARTED|Overall Study||40
7704622|NCT01774084|18971437|P2|NOT COMPLETED|Overall Study||0
7704623|NCT01774084|18971438|P1|NOT COMPLETED|Overall Study||1
7704624|NCT01774084|18971437|P2|COMPLETED|Overall Study||12
7704625|NCT01774084|18971438|P1|COMPLETED|Overall Study||10
7704626|NCT01774084|18971437|P2|STARTED|Overall Study||12
7704627|NCT01774084|18971438|P1|STARTED|Overall Study||11
7704628|NCT01774045|18971448|P2|NOT COMPLETED|Overall Study||0
7704629|NCT01774045|18971449|P1|NOT COMPLETED|Overall Study||0
7704630|NCT01774045|18971448|P2|COMPLETED|Overall Study||7
7704631|NCT01774045|18971449|P1|COMPLETED|Overall Study||23
7704632|NCT01774045|18971448|P2|STARTED|Overall Study||7
7704633|NCT01774045|18971449|P1|STARTED|Overall Study||23
7704634|NCT01773993|18971463|P1|NOT COMPLETED|Overall Study||35
7704635|NCT01773993|18971463|P1|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|499
7704636|NCT01773993|18971463|P1|STARTED|Overall Study||534
7704637|NCT01773967|18971482|P2|NOT COMPLETED|Overall Study||13
7704638|NCT01773967|18971483|P1|NOT COMPLETED|Overall Study||15
7704639|NCT01773967|18971482|P2|COMPLETED|Overall Study||475
7704640|NCT01773967|18971483|P1|COMPLETED|Overall Study||468
7704641|NCT01773967|18971482|P2|STARTED|Overall Study||488
7704642|NCT01773967|18971483|P1|STARTED|Overall Study||483
7704643|NCT01773954|18971493|P1|NOT COMPLETED|Overall Study||9
7704644|NCT01773954|18971493|P1|COMPLETED|Overall Study||31
7704645|NCT01773954|18971493|P1|STARTED|Overall Study||40
7704646|NCT01773889|18971498|P1|NOT COMPLETED|Overall Study||2
7704647|NCT01773889|18971498|P1|COMPLETED|Overall Study||0
7704648|NCT01773889|18971498|P1|STARTED|Overall Study||2
7704649|NCT01773473|18971504|P2|NOT COMPLETED|Overall Study||19
7704650|NCT01773473|18971505|P1|NOT COMPLETED|Overall Study||16
7704651|NCT01773473|18971504|P2|COMPLETED|Overall Study||177
7704652|NCT01773473|18971505|P1|COMPLETED|Overall Study||191
7704653|NCT01773473|18971504|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
7704654|NCT01773473|18971505|P1|Received at Least 1 Dose of Study Drug|Overall Study||207
7704655|NCT01773473|18971504|P2|STARTED|Overall Study||196
7704656|NCT01773473|18971505|P1|STARTED|Overall Study||207
7704657|NCT01773421|18971527|P7|NOT COMPLETED|Extension Phase||0
7704658|NCT01773421|18971528|P6|NOT COMPLETED|Extension Phase||2
7704659|NCT01773421|18971529|P5|NOT COMPLETED|Extension Phase||3
7704660|NCT01773421|18971530|P4|NOT COMPLETED|Extension Phase||0
7704661|NCT01773421|18971531|P3|NOT COMPLETED|Extension Phase||0
7704662|NCT01773421|18971532|P2|NOT COMPLETED|Extension Phase||0
7704663|NCT01773421|18971533|P1|NOT COMPLETED|Extension Phase||0
7704664|NCT01773421|18971527|P7|COMPLETED|Extension Phase||0
7704665|NCT01773421|18971528|P6|COMPLETED|Extension Phase||1
7704666|NCT01773421|18971529|P5|COMPLETED|Extension Phase||12
7704667|NCT01773421|18971530|P4|COMPLETED|Extension Phase||0
7704668|NCT01773421|18971531|P3|COMPLETED|Extension Phase||0
7704669|NCT01773421|18971532|P2|COMPLETED|Extension Phase||0
7704670|NCT01773421|18971533|P1|COMPLETED|Extension Phase||0
7704671|NCT01773421|18971527|P7|STARTED|Extension Phase||0
7704672|NCT01773421|18971528|P6|STARTED|Extension Phase||3
7704673|NCT01773421|18971529|P5|STARTED|Extension Phase||15
7704674|NCT01773421|18971530|P4|STARTED|Extension Phase||0
7704675|NCT01773421|18971531|P3|STARTED|Extension Phase||0
7704676|NCT01773421|18971532|P2|STARTED|Extension Phase||0
7704677|NCT01773421|18971533|P1|STARTED|Extension Phase||0
7704678|NCT01773421|18971527|P7|NOT COMPLETED|Treatment Phase||0
7704679|NCT01773421|18971528|P6|NOT COMPLETED|Treatment Phase||0
7704680|NCT01773421|18971529|P5|NOT COMPLETED|Treatment Phase||0
7704681|NCT01773421|18971530|P4|NOT COMPLETED|Treatment Phase||2
7704682|NCT01773421|18971531|P3|NOT COMPLETED|Treatment Phase||6
7704683|NCT01773421|18971532|P2|NOT COMPLETED|Treatment Phase||0
7704684|NCT01773421|18971533|P1|NOT COMPLETED|Treatment Phase||0
7704685|NCT01773421|18971527|P7|COMPLETED|Treatment Phase||0
7704686|NCT01773421|18971528|P6|COMPLETED|Treatment Phase||0
7704687|NCT01773421|18971529|P5|COMPLETED|Treatment Phase||0
7704688|NCT01773421|18971530|P4|COMPLETED|Treatment Phase||5
7704689|NCT01773421|18971531|P3|COMPLETED|Treatment Phase||13
7704690|NCT01773421|18971532|P2|COMPLETED|Treatment Phase||8
7704691|NCT01773421|18971533|P1|COMPLETED|Treatment Phase||7
7704692|NCT01773421|18971527|P7|STARTED|Treatment Phase||0
7704693|NCT01773421|18971528|P6|STARTED|Treatment Phase||0
7704694|NCT01773421|18971529|P5|STARTED|Treatment Phase||0
7704695|NCT01773421|18971530|P4|STARTED|Treatment Phase||7
7704696|NCT01773421|18971531|P3|STARTED|Treatment Phase||19
7704697|NCT01773421|18971532|P2|STARTED|Treatment Phase||8
7704698|NCT01773421|18971533|P1|STARTED|Treatment Phase||7
7704699|NCT01773291|18971564|P3|NOT COMPLETED|Overall Study||1
7704700|NCT01773291|18971565|P2|NOT COMPLETED|Overall Study||0
7704701|NCT01773291|18971566|P1|NOT COMPLETED|Overall Study||1
7704702|NCT01773291|18971564|P3|COMPLETED|Overall Study||6
7704703|NCT01773291|18971565|P2|COMPLETED|Overall Study||9
7704704|NCT01773291|18971566|P1|COMPLETED|Overall Study||7
7704705|NCT01773291|18971564|P3|STARTED|Overall Study||7
7704706|NCT01773291|18971565|P2|STARTED|Overall Study||9
7704707|NCT01773291|18971566|P1|STARTED|Overall Study||8
7704708|NCT01773226|18971577|P1|NOT COMPLETED|Overall Study||1
7704709|NCT01773226|18971577|P1|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10
7704710|NCT01773226|18971577|P1|STARTED|Overall Study||11
7704711|NCT01773187|18971587|P2|NOT COMPLETED|Overall Study||32
7704712|NCT01773187|18971588|P1|NOT COMPLETED|Overall Study||53
7704713|NCT01773187|18971587|P2|COMPLETED|Overall Study||75
7704714|NCT01773187|18971588|P1|COMPLETED|Overall Study||167
7704715|NCT01773187|18971587|P2|STARTED|Overall Study||107
7704716|NCT01773187|18971588|P1|STARTED|Overall Study||220
7704717|NCT01773135|18971598|P1|NOT COMPLETED|Overall Study||0
7704718|NCT01773135|18971598|P1|COMPLETED|Overall Study||262
7704719|NCT01773135|18971598|P1|STARTED|Overall Study||262
7704720|NCT01773122|18971607|P4|NOT COMPLETED|Overall Study||1
7704721|NCT01773122|18971608|P3|NOT COMPLETED|Overall Study||0
7704722|NCT01773122|18971609|P2|NOT COMPLETED|Overall Study||1
7704723|NCT01773122|18971610|P1|NOT COMPLETED|Overall Study||3
7704724|NCT01773122|18971607|P4|COMPLETED|Overall Study||18
7704725|NCT01773122|18971608|P3|COMPLETED|Overall Study||19
7704726|NCT01773122|18971609|P2|COMPLETED|Overall Study||18
7704727|NCT01773122|18971610|P1|COMPLETED|Overall Study||17
7704728|NCT01773122|18971607|P4|STARTED|Overall Study||19
7704729|NCT01773122|18971608|P3|STARTED|Overall Study||19
7704730|NCT01773122|18971609|P2|STARTED|Overall Study||19
7704731|NCT01773122|18971610|P1|STARTED|Overall Study||20
7704732|NCT01773109|18971624|P1|NOT COMPLETED|Overall Study||3
7704733|NCT01773109|18971624|P1|COMPLETED|Overall Study||37
7704734|NCT01773109|18971624|P1|STARTED|Overall Study||40
7704735|NCT01773070|18971628|P1|NOT COMPLETED|Overall Study||81
7704736|NCT01773070|18971628|P1|COMPLETED|Overall Study||397
7704737|NCT01773070|18971628|P1|STARTED|Overall Study||478
7704738|NCT01772823|18971638|P2|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||9
7704739|NCT01772823|18971639|P1|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||10
7704740|NCT01772823|18971638|P2|COMPLETED|Extension Phase (Visits 24,48wks Post tx||33
7704741|NCT01772823|18971639|P1|COMPLETED|Extension Phase (Visits 24,48wks Post tx||53
7704742|NCT01772823|18971638|P2|STARTED|Extension Phase (Visits 24,48wks Post tx|10 of the 52 subjects that completed the Treatment Phase were not eligible for the Extension Phase|42
7704743|NCT01772823|18971639|P1|STARTED|Extension Phase (Visits 24,48wks Post tx|25 of the 88 subjects that completed the Treatment Phase were not eligible for the Extension Phase|63
7704744|NCT01772823|18971638|P2|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||18
7704745|NCT01772823|18971639|P1|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||28
7704746|NCT01772823|18971638|P2|COMPLETED|Treatment Phase (Week 0- Week 48)||52
7704747|NCT01772823|18971639|P1|COMPLETED|Treatment Phase (Week 0- Week 48)||88
7704748|NCT01772823|18971638|P2|STARTED|Treatment Phase (Week 0- Week 48)||70
7704749|NCT01772823|18971639|P1|STARTED|Treatment Phase (Week 0- Week 48)||116
7704750|NCT01772823|18971638|P2|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||2
7704751|NCT01772823|18971639|P1|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||12
7704752|NCT01772823|18971638|P2|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||70
7704753|NCT01772823|18971639|P1|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||116
7704754|NCT01772823|18971638|P2|STARTED|Behavioral Intervention (BL -3MV or PCC)||72
7704755|NCT01772823|18971639|P1|STARTED|Behavioral Intervention (BL -3MV or PCC)||128
7704756|NCT01772758|18971739|P4|NOT COMPLETED|Overall Study||0
7704757|NCT01772758|18971740|P3|NOT COMPLETED|Overall Study||0
7704758|NCT01772758|18971741|P2|NOT COMPLETED|Overall Study||0
7704759|NCT01772758|18971742|P1|NOT COMPLETED|Overall Study||0
7704760|NCT01772758|18971739|P4|COMPLETED|Overall Study||17
7704761|NCT01772758|18971740|P3|COMPLETED|Overall Study||12
7704762|NCT01772758|18971741|P2|COMPLETED|Overall Study||17
7704763|NCT01772758|18971742|P1|COMPLETED|Overall Study||18
7704764|NCT01772758|18971739|P4|STARTED|Overall Study||17
7704765|NCT01772758|18971740|P3|STARTED|Overall Study||12
7704766|NCT01772758|18971741|P2|STARTED|Overall Study||17
7704767|NCT01772758|18971742|P1|STARTED|Overall Study||18
7704768|NCT01772719|18971752|P1|NOT COMPLETED|Overall Study||7
7704769|NCT01772719|18971752|P1|COMPLETED|Overall Study||0
7704770|NCT01772719|18971752|P1|STARTED|Overall Study||7
7704771|NCT01772693|18971765|P2|NOT COMPLETED|Overall Study||1
7704772|NCT01772693|18971766|P1|NOT COMPLETED|Overall Study||6
7704773|NCT01772693|18971765|P2|COMPLETED|Overall Study||6
7704774|NCT01772693|18971766|P1|COMPLETED|Overall Study||14
7704775|NCT01772693|18971765|P2|STARTED|Overall Study||7
7704776|NCT01772693|18971766|P1|STARTED|Overall Study||20
7704777|NCT01772654|18971780|P2|NOT COMPLETED|Overall Study||0
7704778|NCT01772654|18971781|P1|NOT COMPLETED|Overall Study||0
7704779|NCT01772654|18971780|P2|COMPLETED|Overall Study||15
7704780|NCT01772654|18971781|P1|COMPLETED|Overall Study||2
7704781|NCT01772654|18971780|P2|STARTED|Overall Study||15
7704782|NCT01772654|18971781|P1|STARTED|Overall Study||2
7704783|NCT01772576|18971787|P1|NOT COMPLETED|Overall Study||34
7704784|NCT01772576|18971787|P1|COMPLETED|Overall Study||133
7704785|NCT01772576|18971787|P1|STARTED|Overall Study||167
7704786|NCT01772550|18971799|P3|NOT COMPLETED|Overall Study||6
7704787|NCT01772550|18971800|P2|NOT COMPLETED|Overall Study||1
7704788|NCT01772550|18971801|P1|NOT COMPLETED|Overall Study||1
7704789|NCT01772550|18971799|P3|COMPLETED|Overall Study||27
7704790|NCT01772550|18971800|P2|COMPLETED|Overall Study||102
7704791|NCT01772550|18971801|P1|COMPLETED|Overall Study||101
7704792|NCT01772550|18971799|P3|CT Cardiac|Overall Study||1
7704793|NCT01772550|18971800|P2|CT Cardiac|Overall Study||7
7704794|NCT01772550|18971801|P1|CT Cardiac|Overall Study||7
7704795|NCT01772550|18971799|P3|CT Kidney|Overall Study||6
7704796|NCT01772550|18971800|P2|CT Kidney|Overall Study||19
7704797|NCT01772550|18971801|P1|CT Kidney|Overall Study||12
7704798|NCT01772550|18971799|P3|CT Liver|Overall Study||8
7704799|NCT01772550|18971800|P2|CT Liver|Overall Study||14
7704800|NCT01772550|18971801|P1|CT Liver|Overall Study||18
7704801|NCT01772550|18971799|P3|CT Angiogram|Overall Study||4
7704802|NCT01772550|18971800|P2|CT Angiogram|Overall Study||25
7704803|NCT01772550|18971801|P1|CT Angiogram|Overall Study||24
7704804|NCT01772550|18971799|P3|CT Pancreas|Overall Study||8
7704805|NCT01772550|18971800|P2|CT Pancreas|Overall Study||36
7704806|NCT01772550|18971801|P1|CT Pancreas|Overall Study||40
7704807|NCT01772550|18971799|P3|STARTED|Overall Study||33
7704808|NCT01772550|18971800|P2|STARTED|Overall Study||103
7704809|NCT01772550|18971801|P1|STARTED|Overall Study||102
7704810|NCT01772537|18971842|P3|NOT COMPLETED|Overall Study||0
7704811|NCT01772537|18971843|P2|NOT COMPLETED|Overall Study||0
7704812|NCT01772537|18971844|P1|NOT COMPLETED|Overall Study||1
7704813|NCT01772537|18971842|P3|COMPLETED|Overall Study||6
7704814|NCT01772537|18971843|P2|COMPLETED|Overall Study||3
7704815|NCT01772537|18971844|P1|COMPLETED|Overall Study||4
7704816|NCT01772537|18971842|P3|STARTED|Overall Study||6
7704817|NCT01772537|18971843|P2|STARTED|Overall Study||3
7704818|NCT01772537|18971844|P1|STARTED|Overall Study||5
7704819|NCT01772472|18971860|P2|NOT COMPLETED|Overall Study||743
7704820|NCT01772472|18971861|P1|NOT COMPLETED|Overall Study||743
7704821|NCT01772472|18971860|P2|COMPLETED|Overall Study||0
7704822|NCT01772472|18971861|P1|COMPLETED|Overall Study||0
7704823|NCT01772472|18971860|P2|STARTED|Overall Study||743
7704824|NCT01772472|18971861|P1|STARTED|Overall Study||743
7704825|NCT01772368|18971873|P1|NOT COMPLETED|Overall Study||7
7704826|NCT01772368|18971873|P1|COMPLETED|Overall Study||65
7704827|NCT01772368|18971873|P1|Received Advair Diskus 100/50 mcg|Overall Study||66
7704828|NCT01772368|18971873|P1|Received FS MDPI 100/50 mcg|Overall Study||68
7704829|NCT01772368|18971873|P1|Received FS MDPI 100/25 mcg|Overall Study||67
7704830|NCT01772368|18971873|P1|Received FS MDPI 100/12.5mcg|Overall Study||69
7704831|NCT01772368|18971873|P1|Received FS MDPI 100/6.25 mcg|Overall Study||68
7704832|NCT01772368|18971873|P1|Received Fp MDPI 100 mcg|Overall Study||67
7704833|NCT01772368|18971873|P1|STARTED|Overall Study||72
7704834|NCT01772316|18971919|P1|NOT COMPLETED|Overall Study||7
7704835|NCT01772316|18971919|P1|COMPLETED|Overall Study||40
7704836|NCT01772316|18971919|P1|STARTED|Overall Study||47
7704837|NCT01772160|18971937|P1|NOT COMPLETED|Overall Study||48
7704838|NCT01772160|18971937|P1|COMPLETED|Overall Study||346
7704839|NCT01772160|18971937|P1|STARTED|Overall Study||394
7704840|NCT01772147|18971960|P3|NOT COMPLETED|Overall Study||18
7704841|NCT01772147|18971961|P2|NOT COMPLETED|Overall Study||25
7704842|NCT01772147|18971962|P1|NOT COMPLETED|Overall Study||31
7704843|NCT01772147|18971960|P3|COMPLETED|Overall Study||184
7704844|NCT01772147|18971961|P2|COMPLETED|Overall Study||178
7704845|NCT01772147|18971962|P1|COMPLETED|Overall Study||170
7704846|NCT01772147|18971960|P3|STARTED|Overall Study||202
7704847|NCT01772147|18971961|P2|STARTED|Overall Study||203
7704848|NCT01772147|18971962|P1|STARTED|Overall Study||201
7704849|NCT01772134|18971982|P3|NOT COMPLETED|Overall Study||22
7704850|NCT01772134|18971983|P2|NOT COMPLETED|Overall Study||14
7704851|NCT01772134|18971984|P1|NOT COMPLETED|Overall Study||29
7704852|NCT01772134|18971982|P3|COMPLETED|Overall Study||184
7704853|NCT01772134|18971983|P2|COMPLETED|Overall Study||190
7704854|NCT01772134|18971984|P1|COMPLETED|Overall Study||178
7704855|NCT01772134|18971982|P3|Received Randomized Study Medication|Overall Study||205
7704856|NCT01772134|18971983|P2|Received Randomized Study Medication|Overall Study||204
7704857|NCT01772134|18971984|P1|Received Randomized Study Medication|Overall Study||205
7704858|NCT01772134|18971982|P3|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206
7704859|NCT01772134|18971983|P2|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204
7704860|NCT01772134|18971984|P1|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207
7704861|NCT01771991|18972003|P2|NOT COMPLETED|Overall Study||6
7704862|NCT01771991|18972004|P1|NOT COMPLETED|Overall Study||8
7704863|NCT01771991|18972003|P2|COMPLETED|Overall Study||30
7704864|NCT01771991|18972004|P1|COMPLETED|Overall Study||30
7704865|NCT01771991|18972003|P2|Started Treatment|Overall Study||34
7704866|NCT01771991|18972004|P1|Started Treatment|Overall Study||37
7704867|NCT01771991|18972003|P2|STARTED|Overall Study||36
7704868|NCT01771991|18972004|P1|STARTED|Overall Study||38
7704869|NCT01771965|18972018|P2|NOT COMPLETED|Overall Study||5
7704870|NCT01771965|18972019|P1|NOT COMPLETED|Overall Study||3
7704871|NCT01771965|18972018|P2|COMPLETED|Overall Study||4
7704872|NCT01771965|18972019|P1|COMPLETED|Overall Study||7
7704873|NCT01771965|18972018|P2|STARTED|Overall Study||9
7704874|NCT01771965|18972019|P1|STARTED|Overall Study||10
7704875|NCT01771952|18972027|P2|NOT COMPLETED|Overall Study||3
7704876|NCT01771952|18972028|P1|NOT COMPLETED|Overall Study||3
7704877|NCT01771952|18972027|P2|COMPLETED|Overall Study||38
7704878|NCT01771952|18972028|P1|COMPLETED|Overall Study||42
7704879|NCT01771952|18972027|P2|STARTED|Overall Study||41
7704880|NCT01771952|18972028|P1|STARTED|Overall Study||45
7704881|NCT01771913|18972040|P2|NOT COMPLETED|Overall Study||0
7704882|NCT01771913|18972041|P1|NOT COMPLETED|Overall Study||1
7704883|NCT01771913|18972040|P2|COMPLETED|Overall Study||11
7704884|NCT01771913|18972041|P1|COMPLETED|Overall Study||8
7704885|NCT01771913|18972040|P2|STARTED|Overall Study||11
7704886|NCT01771913|18972041|P1|STARTED|Overall Study||9
7704887|NCT01771809|18972053|P2|NOT COMPLETED|Overall Study||83
7704888|NCT01771809|18972054|P1|NOT COMPLETED|Overall Study||71
7704889|NCT01771809|18972053|P2|COMPLETED|Overall Study||83
7704890|NCT01771809|18972054|P1|COMPLETED|Overall Study||93
7704891|NCT01771809|18972053|P2|STARTED|Overall Study||166
7704892|NCT01771809|18972054|P1|STARTED|Overall Study||164
7704893|NCT01771731|18972070|P2|NOT COMPLETED|Overall Study||2
7704894|NCT01771731|18972071|P1|NOT COMPLETED|Overall Study||2
7704895|NCT01771731|18972070|P2|COMPLETED|Overall Study||12
7704896|NCT01771731|18972071|P1|COMPLETED|Overall Study||11
7704897|NCT01771731|18972070|P2|STARTED|Overall Study||14
7704898|NCT01771731|18972071|P1|STARTED|Overall Study||13
7704899|NCT01771666|18972077|P1|NOT COMPLETED|Overall Study||0
7704900|NCT01771666|18972077|P1|COMPLETED|Overall Study||23
7704901|NCT01771666|18972077|P1|STARTED|Overall Study||23
7704902|NCT01771627|18972084|P2|NOT COMPLETED|Overall Study||50
7704903|NCT01771627|18972085|P1|NOT COMPLETED|Overall Study||108
7704904|NCT01771627|18972084|P2|COMPLETED|Overall Study||50
7704905|NCT01771627|18972085|P1|COMPLETED|Overall Study||92
7704906|NCT01771627|18972084|P2|STARTED|Overall Study||100
7704907|NCT01771627|18972085|P1|STARTED|Overall Study||200
7704908|NCT01771250|18972091|P2|NOT COMPLETED|Period 2||0
7704909|NCT01771250|18972092|P1|NOT COMPLETED|Period 2||0
7704910|NCT01771250|18972091|P2|COMPLETED|Period 2||7
7704911|NCT01771250|18972092|P1|COMPLETED|Period 2||7
7704912|NCT01771250|18972091|P2|STARTED|Period 2||7
7704913|NCT01771250|18972092|P1|STARTED|Period 2||7
7704914|NCT01771250|18972091|P2|NOT COMPLETED|Period 1||0
7704915|NCT01771250|18972092|P1|NOT COMPLETED|Period 1||1
7704916|NCT01771250|18972091|P2|COMPLETED|Period 1||7
7704917|NCT01771250|18972092|P1|COMPLETED|Period 1||7
7704918|NCT01771250|18972091|P2|Received at Least One Dose of Study Drug|Period 1||7
7704919|NCT01771250|18972092|P1|Received at Least One Dose of Study Drug|Period 1||7
7704920|NCT01771250|18972091|P2|STARTED|Period 1||7
7704921|NCT01771250|18972092|P1|STARTED|Period 1||8
7704922|NCT01771172|18972104|P1|NOT COMPLETED|Overall Study||2
7704923|NCT01771172|18972104|P1|COMPLETED|Overall Study||46
7704924|NCT01771172|18972104|P1|STARTED|Overall Study||48
7704925|NCT01770912|18972110|P2|NOT COMPLETED|Overall Study||0
7704926|NCT01770912|18972111|P1|NOT COMPLETED|Overall Study||2
7704927|NCT01770912|18972110|P2|COMPLETED|Overall Study||12
7704928|NCT01770912|18972111|P1|COMPLETED|Overall Study||10
7704929|NCT01770912|18972110|P2|STARTED|Overall Study||12
7704930|NCT01770912|18972111|P1|STARTED|Overall Study||12
7704931|NCT01770860|18972145|P1|NOT COMPLETED|Overall Study||6
7704932|NCT01770860|18972145|P1|COMPLETED|Overall Study||40
7704933|NCT01770860|18972145|P1|Randomization|Overall Study|One participant withdrew before randomization|45
7704934|NCT01770860|18972145|P1|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46
7704935|NCT01770743|18972193|P5|NOT COMPLETED|Overall Study||2
7704936|NCT01770743|18972194|P4|NOT COMPLETED|Overall Study||2
7704937|NCT01770743|18972195|P3|NOT COMPLETED|Overall Study||1
7704938|NCT01770743|18972196|P2|NOT COMPLETED|Overall Study||3
7704939|NCT01770743|18972197|P1|NOT COMPLETED|Overall Study||2
7704940|NCT01770743|18972193|P5|COMPLETED|Overall Study||21
7704941|NCT01770743|18972194|P4|COMPLETED|Overall Study||42
7704942|NCT01770743|18972195|P3|COMPLETED|Overall Study||22
7704943|NCT01770743|18972196|P2|COMPLETED|Overall Study||31
7704944|NCT01770743|18972197|P1|COMPLETED|Overall Study||42
7704945|NCT01770743|18972193|P5|Treated|Overall Study||23
7704946|NCT01770743|18972194|P4|Treated|Overall Study||44
7704947|NCT01770743|18972195|P3|Treated|Overall Study||23
7704948|NCT01770743|18972196|P2|Treated|Overall Study||34
7704949|NCT01770743|18972197|P1|Treated|Overall Study||44
7704950|NCT01770743|18972193|P5|STARTED|Overall Study||23
7704951|NCT01770743|18972194|P4|STARTED|Overall Study||44
7704952|NCT01770743|18972195|P3|STARTED|Overall Study||23
7704953|NCT01770743|18972196|P2|STARTED|Overall Study||34
7704954|NCT01770743|18972197|P1|STARTED|Overall Study||44
7704955|NCT01770691|18972249|P1|NOT COMPLETED|Overall Study||0
7704956|NCT01770691|18972249|P1|COMPLETED|Overall Study||7
7704957|NCT01770691|18972249|P1|STARTED|Overall Study||7
7704958|NCT01770652|18972260|P4|NOT COMPLETED|Overall Study||0
7704959|NCT01770652|18972261|P3|NOT COMPLETED|Overall Study||0
7704960|NCT01770652|18972262|P2|NOT COMPLETED|Overall Study||0
7704961|NCT01770652|18972263|P1|NOT COMPLETED|Overall Study||0
7704962|NCT01770652|18972260|P4|COMPLETED|Overall Study||8
7704963|NCT01770652|18972261|P3|COMPLETED|Overall Study||8
7704964|NCT01770652|18972262|P2|COMPLETED|Overall Study||8
7704965|NCT01770652|18972263|P1|COMPLETED|Overall Study||8
7704966|NCT01770652|18972260|P4|STARTED|Overall Study||8
7704967|NCT01770652|18972261|P3|STARTED|Overall Study||8
7704968|NCT01770652|18972262|P2|STARTED|Overall Study||8
7704969|NCT01770652|18972263|P1|STARTED|Overall Study||8
7704970|NCT01770509|18972299|P2|NOT COMPLETED|Overall Study||3
7704971|NCT01770509|18972300|P1|NOT COMPLETED|Overall Study||1
7704972|NCT01770509|18972299|P2|COMPLETED|Overall Study||14
7704973|NCT01770509|18972300|P1|COMPLETED|Overall Study||11
7704974|NCT01770509|18972299|P2|STARTED|Overall Study||17
7704975|NCT01770509|18972300|P1|STARTED|Overall Study||12
7704976|NCT01770483|18972316|P2|NOT COMPLETED|Overall Study||0
7704977|NCT01770483|18972317|P1|NOT COMPLETED|Overall Study||0
7704978|NCT01770483|18972316|P2|COMPLETED|Overall Study||33
7704979|NCT01770483|18972317|P1|COMPLETED|Overall Study||33
7704980|NCT01770483|18972316|P2|STARTED|Overall Study||33
7704981|NCT01770483|18972317|P1|STARTED|Overall Study||33
7704982|NCT01770431|18972327|P2|NOT COMPLETED|Overall Study||32
7704983|NCT01770431|18972328|P1|NOT COMPLETED|Overall Study||10
7704984|NCT01770431|18972327|P2|COMPLETED|Overall Study||316
7704985|NCT01770431|18972328|P1|COMPLETED|Overall Study||686
7704986|NCT01770431|18972327|P2|STARTED|Overall Study||348
7704987|NCT01770431|18972328|P1|STARTED|Overall Study||696
7704988|NCT01770392|18972336|P1|NOT COMPLETED|Nintedanib+ Rifampicin||0
7704989|NCT01770392|18972336|P1|COMPLETED|Nintedanib+ Rifampicin||25
7704990|NCT01770392|18972336|P1|STARTED|Nintedanib+ Rifampicin||25
7704991|NCT01770392|18972336|P1|NOT COMPLETED|Washout Period of at Least 14 Days||1
7704992|NCT01770392|18972336|P1|COMPLETED|Washout Period of at Least 14 Days||25
7704993|NCT01770392|18972336|P1|STARTED|Washout Period of at Least 14 Days||26
7704994|NCT01770392|18972336|P1|NOT COMPLETED|Nintedanib||0
7704995|NCT01770392|18972336|P1|COMPLETED|Nintedanib||26
7704996|NCT01770392|18972336|P1|STARTED|Nintedanib||26
7704997|NCT01770379|18972351|P3|NOT COMPLETED|Overall Study||42
7704998|NCT01770379|18972352|P2|NOT COMPLETED|Overall Study||44
7704999|NCT01770379|18972353|P1|NOT COMPLETED|Overall Study||39
7705000|NCT01770379|18972351|P3|COMPLETED|Overall Study||39
7705001|NCT01770379|18972352|P2|COMPLETED|Overall Study||37
7705002|NCT01770379|18972353|P1|COMPLETED|Overall Study||41
7705003|NCT01770379|18972351|P3|STARTED|Overall Study||81
7705004|NCT01770379|18972352|P2|STARTED|Overall Study||81
7705005|NCT01770379|18972353|P1|STARTED|Overall Study||80
7705006|NCT01770366|18972372|P2|NOT COMPLETED|Overall Study||2
7705007|NCT01770366|18972373|P1|NOT COMPLETED|Overall Study||2
7705008|NCT01770366|18972372|P2|COMPLETED|Overall Study||4
7705009|NCT01770366|18972373|P1|COMPLETED|Overall Study||2
7705010|NCT01770366|18972372|P2|STARTED|Overall Study||6
7705011|NCT01770366|18972373|P1|STARTED|Overall Study||4
7705012|NCT01770353|18972381|P2|NOT COMPLETED|Overall Study||12
7705013|NCT01770353|18972382|P1|NOT COMPLETED|Overall Study||6
7705014|NCT01770353|18972381|P2|COMPLETED|Overall Study||18
7705015|NCT01770353|18972382|P1|COMPLETED|Overall Study||9
7705016|NCT01770353|18972381|P2|Received FMX and MM-398|Overall Study||29
7705017|NCT01770353|18972382|P1|Received FMX and MM-398|Overall Study||13
7705018|NCT01770353|18972381|P2|Received FMX|Overall Study|1 subject excluded from MM-398 safety population.|30
7705019|NCT01770353|18972382|P1|Received FMX|Overall Study|2 subjects excluded from MM-398 safety population.|15
7705020|NCT01770353|18972381|P2|STARTED|Overall Study||30
7705021|NCT01770353|18972382|P1|STARTED|Overall Study||15
7705022|NCT01770314|18972432|P2|NOT COMPLETED|Overall Study||0
7705023|NCT01770314|18972433|P1|NOT COMPLETED|Overall Study||0
7705024|NCT01770314|18972432|P2|COMPLETED|Overall Study||90
7705025|NCT01770314|18972433|P1|COMPLETED|Overall Study||86
7705026|NCT01770314|18972432|P2|Contributed Data to One-month Follow-up|Overall Study||66
7705027|NCT01770314|18972433|P1|Contributed Data to One-month Follow-up|Overall Study||61
7705028|NCT01770314|18972432|P2|Contributed Data to Post-test|Overall Study||67
7705029|NCT01770314|18972433|P1|Contributed Data to Post-test|Overall Study||65
7705030|NCT01770314|18972432|P2|Contributed Data to Baseline|Overall Study||72
7705031|NCT01770314|18972433|P1|Contributed Data to Baseline|Overall Study||68
7705032|NCT01770314|18972432|P2|STARTED|Overall Study||90
7705033|NCT01770314|18972433|P1|STARTED|Overall Study||86
7705034|NCT01770145|18972441|P1|NOT COMPLETED|Treatment||4
7705035|NCT01770145|18972441|P1|COMPLETED|Treatment||97
7705036|NCT01770145|18972441|P1|STARTED|Treatment||101
7705037|NCT01770145|18972441|P1|NOT COMPLETED|Baseline||26
7705038|NCT01770145|18972441|P1|COMPLETED|Baseline||101
7705039|NCT01770145|18972441|P1|STARTED|Baseline||127
7705040|NCT01769612|18972446|P1|NOT COMPLETED|Overall Study||0
7705041|NCT01769612|18972446|P1|COMPLETED|Overall Study||168
7705042|NCT01769612|18972446|P1|STARTED|Overall Study||168
7705043|NCT01769586|18972454|P2|NOT COMPLETED|Overall Study||0
7705044|NCT01769586|18972455|P1|NOT COMPLETED|Overall Study||0
7705045|NCT01769586|18972454|P2|COMPLETED|Overall Study||100
7705046|NCT01769586|18972455|P1|COMPLETED|Overall Study||100
7705047|NCT01769586|18972454|P2|STARTED|Overall Study||100
7705048|NCT01769586|18972455|P1|STARTED|Overall Study||100
7705049|NCT01769573|18972466|P5|NOT COMPLETED|Overall Study||0
7705050|NCT01769573|18972467|P4|NOT COMPLETED|Overall Study||0
7705051|NCT01769573|18972468|P3|NOT COMPLETED|Overall Study||0
7705052|NCT01769573|18972469|P2|NOT COMPLETED|Overall Study||0
7705053|NCT01769573|18972470|P1|NOT COMPLETED|Overall Study||0
7705054|NCT01769573|18972466|P5|COMPLETED|Overall Study||10
7705055|NCT01769573|18972467|P4|COMPLETED|Overall Study||0
7705056|NCT01769573|18972468|P3|COMPLETED|Overall Study||10
7705057|NCT01769573|18972469|P2|COMPLETED|Overall Study||6
7705058|NCT01769573|18972470|P1|COMPLETED|Overall Study||10
7705059|NCT01769573|18972466|P5|STARTED|Overall Study||10
7705060|NCT01769573|18972467|P4|STARTED|Overall Study||0
7705061|NCT01769573|18972468|P3|STARTED|Overall Study||10
7705062|NCT01769573|18972469|P2|STARTED|Overall Study||6
7705063|NCT01769573|18972470|P1|STARTED|Overall Study||10
7705064|NCT01769508|18972497|P1|NOT COMPLETED|Overall Study||6
7705065|NCT01769508|18972497|P1|COMPLETED|Overall Study||6
7705066|NCT01769508|18972497|P1|STARTED|Overall Study||12
7705067|NCT01769469|18972506|P1|NOT COMPLETED|Overall Study||35
7705068|NCT01769469|18972506|P1|COMPLETED|Overall Study||66
7705069|NCT01769469|18972506|P1|STARTED|Overall Study||101
7705070|NCT01769456|18972666|P1|NOT COMPLETED|Overall Study||37
7705071|NCT01769456|18972666|P1|COMPLETED|Overall Study||41
7705072|NCT01769456|18972666|P1|STARTED|Overall Study|1 subject inadvertently enrolled, discontin'd after baseline, re-enrolled later and completed study|78
7705073|NCT01769443|18972687|P2|NOT COMPLETED|Overall Study||0
7705074|NCT01769443|18972688|P1|NOT COMPLETED|Overall Study||1
7705075|NCT01769443|18972687|P2|COMPLETED|Overall Study||1
7705076|NCT01769443|18972688|P1|COMPLETED|Overall Study||0
7705077|NCT01769443|18972687|P2|STARTED|Overall Study||1
7705078|NCT01769443|18972688|P1|STARTED|Overall Study||1
7705079|NCT01769404|18972730|P2|NOT COMPLETED|Treatment Period 2||0
7705080|NCT01769404|18972731|P1|NOT COMPLETED|Treatment Period 2||7
7705081|NCT01769404|18972730|P2|COMPLETED|Treatment Period 2||13
7705082|NCT01769404|18972731|P1|COMPLETED|Treatment Period 2||0
7705083|NCT01769404|18972730|P2|STARTED|Treatment Period 2||13
7705084|NCT01769404|18972731|P1|STARTED|Treatment Period 2||7
7705085|NCT01769404|18972730|P2|NOT COMPLETED|Treatment Period 1||0
7705086|NCT01769404|18972731|P1|NOT COMPLETED|Treatment Period 1||5
7705087|NCT01769404|18972730|P2|COMPLETED|Treatment Period 1||13
7705088|NCT01769404|18972731|P1|COMPLETED|Treatment Period 1||7
7705089|NCT01769404|18972730|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||13
7705090|NCT01769404|18972731|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
7705091|NCT01769404|18972730|P2|STARTED|Treatment Period 1||13
7705092|NCT01769404|18972731|P1|STARTED|Treatment Period 1||12
7705093|NCT01769391|18972753|P2|NOT COMPLETED|Overall Study||9
7705094|NCT01769391|18972754|P1|NOT COMPLETED|Overall Study||17
7705095|NCT01769391|18972753|P2|COMPLETED|Overall Study||48
7705096|NCT01769391|18972754|P1|COMPLETED|Overall Study||93
7705097|NCT01769391|18972753|P2|Received at Least One Dose of Study Drug|Overall Study||55
7705098|NCT01769391|18972754|P1|Received at Least One Dose of Study Drug|Overall Study||106
7705099|NCT01769391|18972753|P2|STARTED|Overall Study||57
7705100|NCT01769391|18972754|P1|STARTED|Overall Study||110
7705101|NCT01769378|18972773|P2|NOT COMPLETED|Overall Study||4
7705102|NCT01769378|18972774|P1|NOT COMPLETED|Overall Study||25
7705103|NCT01769378|18972773|P2|COMPLETED|Overall Study|Completed the study on study treatment|56
7705104|NCT01769378|18972774|P1|COMPLETED|Overall Study|Completed the study on study treatment|215
7705105|NCT01769378|18972773|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
7705106|NCT01769378|18972774|P1|Received at Least 1 Dose of Study Drug|Overall Study||239
7705107|NCT01769378|18972773|P2|STARTED|Overall Study||60
7705108|NCT01769378|18972774|P1|STARTED|Overall Study||240
7705109|NCT01769365|18972812|P3|NOT COMPLETED|Overall Study||2
7705110|NCT01769365|18972813|P2|NOT COMPLETED|Overall Study||2
7705111|NCT01769365|18972814|P1|NOT COMPLETED|Overall Study||0
7705112|NCT01769365|18972812|P3|COMPLETED|Overall Study||101
7705113|NCT01769365|18972813|P2|COMPLETED|Overall Study||100
7705114|NCT01769365|18972814|P1|COMPLETED|Overall Study||102
7705115|NCT01769365|18972812|P3|STARTED|Overall Study||103
7705116|NCT01769365|18972813|P2|STARTED|Overall Study||102
7705117|NCT01769365|18972814|P1|STARTED|Overall Study||102
7705118|NCT01769352|18972826|P4|NOT COMPLETED|Overall Study||0
7705119|NCT01769352|18972827|P3|NOT COMPLETED|Overall Study||0
7705120|NCT01769352|18972828|P2|NOT COMPLETED|Overall Study||0
7705121|NCT01769352|18972829|P1|NOT COMPLETED|Overall Study||0
7705122|NCT01769352|18972826|P4|COMPLETED|Overall Study||8
7705123|NCT01769352|18972827|P3|COMPLETED|Overall Study||9
7705124|NCT01769352|18972828|P2|COMPLETED|Overall Study||12
7705125|NCT01769352|18972829|P1|COMPLETED|Overall Study||13
7705126|NCT01769352|18972826|P4|STARTED|Overall Study||8
7705127|NCT01769352|18972827|P3|STARTED|Overall Study||9
7705128|NCT01769352|18972828|P2|STARTED|Overall Study||12
7705129|NCT01769352|18972829|P1|STARTED|Overall Study||13
7705130|NCT01769339|18972854|P1|NOT COMPLETED|Overall Study||43
7705131|NCT01769339|18972854|P1|COMPLETED|Overall Study||72
7705132|NCT01769339|18972854|P1|STARTED|Overall Study||115
7705133|NCT01769326|18972865|P4|NOT COMPLETED|Overall Study||0
7705134|NCT01769326|18972866|P3|NOT COMPLETED|Overall Study||1
7705135|NCT01769326|18972867|P2|NOT COMPLETED|Overall Study||4
7705136|NCT01769326|18972868|P1|NOT COMPLETED|Overall Study||2
7705137|NCT01769326|18972865|P4|COMPLETED|Overall Study||8
7705138|NCT01769326|18972866|P3|COMPLETED|Overall Study||8
7705139|NCT01769326|18972867|P2|COMPLETED|Overall Study||8
7705140|NCT01769326|18972868|P1|COMPLETED|Overall Study||9
7705141|NCT01769326|18972865|P4|STARTED|Overall Study||8
7705142|NCT01769326|18972866|P3|STARTED|Overall Study||9
7705143|NCT01769326|18972867|P2|STARTED|Overall Study||12
7705144|NCT01769326|18972868|P1|STARTED|Overall Study||11
7705145|NCT01769274|18972878|P3|NOT COMPLETED|Part B:Treatment Session2-Period4||0
7705146|NCT01769274|18972879|P2|NOT COMPLETED|Part B:Treatment Session2-Period4||0
7705147|NCT01769274|18972880|P1|NOT COMPLETED|Part B:Treatment Session2-Period4||0
7705148|NCT01769274|18972878|P3|COMPLETED|Part B:Treatment Session2-Period4||3
7705149|NCT01769274|18972879|P2|COMPLETED|Part B:Treatment Session2-Period4||2
7705150|NCT01769274|18972880|P1|COMPLETED|Part B:Treatment Session2-Period4||0
7705151|NCT01769274|18972878|P3|STARTED|Part B:Treatment Session2-Period4||3
7705152|NCT01769274|18972879|P2|STARTED|Part B:Treatment Session2-Period4||2
7705153|NCT01769274|18972880|P1|STARTED|Part B:Treatment Session2-Period4||0
7705154|NCT01769274|18972878|P3|NOT COMPLETED|Washout Period||0
7705155|NCT01769274|18972879|P2|NOT COMPLETED|Washout Period||0
7705156|NCT01769274|18972880|P1|NOT COMPLETED|Washout Period||0
7705157|NCT01769274|18972878|P3|COMPLETED|Washout Period||3
7705158|NCT01769274|18972879|P2|COMPLETED|Washout Period||2
7705159|NCT01769274|18972880|P1|COMPLETED|Washout Period||0
7705160|NCT01769274|18972878|P3|STARTED|Washout Period||3
7705161|NCT01769274|18972879|P2|STARTED|Washout Period||2
7705162|NCT01769274|18972880|P1|STARTED|Washout Period||0
7705163|NCT01769274|18972878|P3|NOT COMPLETED|Part B:Treatment Session2-Period3||0
7705164|NCT01769274|18972879|P2|NOT COMPLETED|Part B:Treatment Session2-Period3||0
7705165|NCT01769274|18972880|P1|NOT COMPLETED|Part B:Treatment Session2-Period3||0
7705166|NCT01769274|18972878|P3|COMPLETED|Part B:Treatment Session2-Period3||3
7705167|NCT01769274|18972879|P2|COMPLETED|Part B:Treatment Session2-Period3||2
7705168|NCT01769274|18972880|P1|COMPLETED|Part B:Treatment Session2-Period3||0
7705169|NCT01769274|18972878|P3|STARTED|Part B:Treatment Session2-Period3||3
7705170|NCT01769274|18972879|P2|STARTED|Part B:Treatment Session2-Period3||2
7705171|NCT01769274|18972880|P1|STARTED|Part B:Treatment Session2-Period3||0
7705172|NCT01769274|18972878|P3|NOT COMPLETED|Washout Period||0
7705173|NCT01769274|18972879|P2|NOT COMPLETED|Washout Period||0
7705174|NCT01769274|18972880|P1|NOT COMPLETED|Washout Period||0
7705175|NCT01769274|18972878|P3|COMPLETED|Washout Period||3
7705176|NCT01769274|18972879|P2|COMPLETED|Washout Period||2
7705177|NCT01769274|18972880|P1|COMPLETED|Washout Period||0
7705178|NCT01769274|18972878|P3|STARTED|Washout Period||3
7705179|NCT01769274|18972879|P2|STARTED|Washout Period||2
7705180|NCT01769274|18972880|P1|STARTED|Washout Period||0
7705181|NCT01769274|18972878|P3|NOT COMPLETED|Part B:Treatment Session1-Period2||0
7705182|NCT01769274|18972879|P2|NOT COMPLETED|Part B:Treatment Session1-Period2||0
7705183|NCT01769274|18972880|P1|NOT COMPLETED|Part B:Treatment Session1-Period2||0
7705184|NCT01769274|18972878|P3|COMPLETED|Part B:Treatment Session1-Period2||3
7705185|NCT01769274|18972879|P2|COMPLETED|Part B:Treatment Session1-Period2||2
7705186|NCT01769274|18972880|P1|COMPLETED|Part B:Treatment Session1-Period2||0
7705187|NCT01769274|18972878|P3|STARTED|Part B:Treatment Session1-Period2||3
7705188|NCT01769274|18972879|P2|STARTED|Part B:Treatment Session1-Period2||2
7705189|NCT01769274|18972880|P1|STARTED|Part B:Treatment Session1-Period2||0
7705190|NCT01769274|18972878|P3|NOT COMPLETED|Washout Period||0
7705191|NCT01769274|18972879|P2|NOT COMPLETED|Washout Period||0
7705192|NCT01769274|18972880|P1|NOT COMPLETED|Washout Period||0
7705193|NCT01769274|18972878|P3|COMPLETED|Washout Period||3
7705194|NCT01769274|18972879|P2|COMPLETED|Washout Period||2
7705195|NCT01769274|18972880|P1|COMPLETED|Washout Period||0
7705196|NCT01769274|18972878|P3|STARTED|Washout Period||3
7705197|NCT01769274|18972879|P2|STARTED|Washout Period||2
7705198|NCT01769274|18972880|P1|STARTED|Washout Period||0
7705199|NCT01769274|18972878|P3|NOT COMPLETED|Part B:Treatment Session1-Period1||0
7705200|NCT01769274|18972879|P2|NOT COMPLETED|Part B:Treatment Session1-Period1||0
7705201|NCT01769274|18972880|P1|NOT COMPLETED|Part B:Treatment Session1-Period1||0
7705202|NCT01769274|18972878|P3|COMPLETED|Part B:Treatment Session1-Period1||3
7705203|NCT01769274|18972879|P2|COMPLETED|Part B:Treatment Session1-Period1||2
7705204|NCT01769274|18972880|P1|COMPLETED|Part B:Treatment Session1-Period1||0
7705205|NCT01769274|18972878|P3|STARTED|Part B:Treatment Session1-Period1||3
7705206|NCT01769274|18972879|P2|STARTED|Part B:Treatment Session1-Period1||2
7705207|NCT01769274|18972880|P1|STARTED|Part B:Treatment Session1-Period1||0
7705208|NCT01769274|18972878|P3|NOT COMPLETED|Part A||0
7705209|NCT01769274|18972879|P2|NOT COMPLETED|Part A||0
7705210|NCT01769274|18972880|P1|NOT COMPLETED|Part A||0
7705211|NCT01769274|18972878|P3|COMPLETED|Part A||0
7705212|NCT01769274|18972879|P2|COMPLETED|Part A||0
7705213|NCT01769274|18972880|P1|COMPLETED|Part A||5
7705214|NCT01769274|18972878|P3|STARTED|Part A||0
7705215|NCT01769274|18972879|P2|STARTED|Part A||0
7705216|NCT01769274|18972880|P1|STARTED|Part A||5
7705217|NCT01769248|18972972|P2|NOT COMPLETED|Overall Study||12
7705218|NCT01769248|18972973|P1|NOT COMPLETED|Overall Study||28
7705219|NCT01769248|18972972|P2|COMPLETED|Overall Study||58
7705220|NCT01769248|18972973|P1|COMPLETED|Overall Study||42
7705221|NCT01769248|18972972|P2|Participants Who Crossed-over|Overall Study||12
7705222|NCT01769248|18972973|P1|Participants Who Crossed-over|Overall Study||28
7705223|NCT01769248|18972972|P2|STARTED|Overall Study||70
7705224|NCT01769248|18972973|P1|STARTED|Overall Study||70
7705225|NCT01769222|18972985|P2|NOT COMPLETED|Overall Study||0
7705226|NCT01769222|18972986|P1|NOT COMPLETED|Overall Study||0
7705227|NCT01769222|18972985|P2|COMPLETED|Overall Study||0
7705228|NCT01769222|18972986|P1|COMPLETED|Overall Study||3
7705229|NCT01769222|18972985|P2|STARTED|Overall Study||0
7705230|NCT01769222|18972986|P1|STARTED|Overall Study||3
7705231|NCT01769209|18973000|P1|NOT COMPLETED|Overall Study||0
7705232|NCT01769209|18973000|P1|COMPLETED|Overall Study||18
7705233|NCT01769209|18973000|P1|STARTED|Overall Study||18
7705234|NCT01769196|18973013|P2|NOT COMPLETED|Overall Study||272
7705235|NCT01769196|18973014|P1|NOT COMPLETED|Overall Study||272
7705236|NCT01769196|18973013|P2|COMPLETED|Overall Study||0
7705237|NCT01769196|18973014|P1|COMPLETED|Overall Study||0
7705238|NCT01769196|18973013|P2|STARTED|Overall Study||272
7705239|NCT01769196|18973014|P1|STARTED|Overall Study||272
7705240|NCT01769105|18973044|P2|NOT COMPLETED|Cross-over||0
7705241|NCT01769105|18973045|P1|NOT COMPLETED|Cross-over||5
7705242|NCT01769105|18973044|P2|COMPLETED|Cross-over|Was not intended by the study protocol|0
7705243|NCT01769105|18973045|P1|COMPLETED|Cross-over||9
7705244|NCT01769105|18973044|P2|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0
7705245|NCT01769105|18973045|P1|STARTED|Cross-over||14
7705246|NCT01769105|18973044|P2|NOT COMPLETED|First Intervention||2
7705247|NCT01769105|18973045|P1|NOT COMPLETED|First Intervention||2
7705248|NCT01769105|18973044|P2|COMPLETED|First Intervention||17
7705249|NCT01769105|18973045|P1|COMPLETED|First Intervention||14
7705250|NCT01769105|18973044|P2|STARTED|First Intervention||19
7705251|NCT01769105|18973045|P1|STARTED|First Intervention||16
7705252|NCT01768858|18973064|P1|NOT COMPLETED|Overall Study||22
7705253|NCT01768858|18973064|P1|COMPLETED|Overall Study||74
7705254|NCT01768858|18973064|P1|STARTED|Overall Study||96
7705255|NCT01768832|18973079|P3|NOT COMPLETED|Overall Study||9
7705256|NCT01768832|18973080|P2|NOT COMPLETED|Overall Study||4
7705257|NCT01768832|18973081|P1|NOT COMPLETED|Overall Study||10
7705258|NCT01768832|18973079|P3|COMPLETED|Overall Study||26
7705259|NCT01768832|18973080|P2|COMPLETED|Overall Study||39
7705260|NCT01768832|18973081|P1|COMPLETED|Overall Study||31
7705261|NCT01768832|18973079|P3|STARTED|Overall Study||35
7705262|NCT01768832|18973080|P2|STARTED|Overall Study||43
7705263|NCT01768832|18973081|P1|STARTED|Overall Study||41
7705264|NCT01768676|18973115|P2|NOT COMPLETED|Overall Study||31
7705265|NCT01768676|18973116|P1|NOT COMPLETED|Overall Study||24
7705266|NCT01768676|18973115|P2|COMPLETED|Overall Study||60
7705267|NCT01768676|18973116|P1|COMPLETED|Overall Study||66
7705268|NCT01768676|18973115|P2|STARTED|Overall Study||91
7705269|NCT01768676|18973116|P1|STARTED|Overall Study||90
7705270|NCT01768637|18973132|P2|NOT COMPLETED|Overall Study||7
7705271|NCT01768637|18973133|P1|NOT COMPLETED|Overall Study||3
7705272|NCT01768637|18973132|P2|COMPLETED|Overall Study||12
7705273|NCT01768637|18973133|P1|COMPLETED|Overall Study||26
7705274|NCT01768637|18973132|P2|Completed Visit 2|Overall Study||13
7705275|NCT01768637|18973133|P1|Completed Visit 2|Overall Study||26
7705276|NCT01768637|18973132|P2|Completed Visit 1|Overall Study||16
7705277|NCT01768637|18973133|P1|Completed Visit 1|Overall Study||28
7705278|NCT01768637|18973132|P2|STARTED|Overall Study||19
7705279|NCT01768637|18973133|P1|STARTED|Overall Study||29
7705280|NCT01768572|18973146|P3|NOT COMPLETED|Overall Study||6
7705281|NCT01768572|18973147|P2|NOT COMPLETED|Overall Study||12
7705282|NCT01768572|18973148|P1|NOT COMPLETED|Overall Study||9
7705283|NCT01768572|18973146|P3|COMPLETED|Overall Study||96
7705284|NCT01768572|18973147|P2|COMPLETED|Overall Study||39
7705285|NCT01768572|18973148|P1|COMPLETED|Overall Study||40
7705286|NCT01768572|18973146|P3|STARTED|Overall Study||102
7705287|NCT01768572|18973147|P2|STARTED|Overall Study||51
7705288|NCT01768572|18973148|P1|STARTED|Overall Study||49
7705289|NCT01768559|18973159|P3|NOT COMPLETED|Overall Study||13
7705290|NCT01768559|18973160|P2|NOT COMPLETED|Overall Study||17
7705291|NCT01768559|18973161|P1|NOT COMPLETED|Overall Study||30
7705292|NCT01768559|18973159|P3|COMPLETED|Overall Study||285
7705293|NCT01768559|18973160|P2|COMPLETED|Overall Study||281
7705294|NCT01768559|18973161|P1|COMPLETED|Overall Study||268
7705295|NCT01768559|18973159|P3|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297
7705296|NCT01768559|18973160|P2|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298
7705297|NCT01768559|18973161|P1|Treated|Overall Study||298
7705298|NCT01768559|18973159|P3|STARTED|Overall Study||298
7705299|NCT01768559|18973160|P2|STARTED|Overall Study||298
7705300|NCT01768559|18973161|P1|STARTED|Overall Study||298
7705301|NCT01768520|18973212|P3|NOT COMPLETED|Overall Study||9
7705302|NCT01768520|18973213|P2|NOT COMPLETED|Overall Study||26
7705303|NCT01768520|18973214|P1|NOT COMPLETED|Overall Study||32
7705304|NCT01768520|18973212|P3|COMPLETED|Overall Study||30
7705305|NCT01768520|18973213|P2|COMPLETED|Overall Study||121
7705306|NCT01768520|18973214|P1|COMPLETED|Overall Study||120
7705307|NCT01768520|18973212|P3|STARTED|Overall Study||39
7705308|NCT01768520|18973213|P2|STARTED|Overall Study||147
7705309|NCT01768520|18973214|P1|STARTED|Overall Study||152
7705310|NCT01768325|18973227|P2|NOT COMPLETED|Overall Study||0
7705311|NCT01768325|18973228|P1|NOT COMPLETED|Overall Study||0
7705312|NCT01768325|18973227|P2|COMPLETED|Overall Study||41
7705313|NCT01768325|18973228|P1|COMPLETED|Overall Study||37
7705314|NCT01768325|18973227|P2|STARTED|Overall Study||41
7705315|NCT01768325|18973228|P1|STARTED|Overall Study||37
7705316|NCT01768286|18973242|P4|NOT COMPLETED|Overall Study||1
7705317|NCT01768286|18973243|P3|NOT COMPLETED|Overall Study||2
7705318|NCT01768286|18973244|P2|NOT COMPLETED|Overall Study||4
7705319|NCT01768286|18973245|P1|NOT COMPLETED|Overall Study||7
7705320|NCT01768286|18973242|P4|COMPLETED|Overall Study||110
7705321|NCT01768286|18973243|P3|COMPLETED|Overall Study||108
7705322|NCT01768286|18973244|P2|COMPLETED|Overall Study||107
7705323|NCT01768286|18973245|P1|COMPLETED|Overall Study||102
7705324|NCT01768286|18973242|P4|STARTED|Overall Study||111
7705325|NCT01768286|18973243|P3|STARTED|Overall Study||110
7705326|NCT01768286|18973244|P2|STARTED|Overall Study||111
7705327|NCT01768286|18973245|P1|STARTED|Overall Study||109
7705328|NCT01768117|18973307|P1|NOT COMPLETED|Overall Study||6
7705329|NCT01768117|18973307|P1|COMPLETED|Overall Study||7
7705330|NCT01768117|18973307|P1|STARTED|Overall Study||13
7705331|NCT01768013|18973315|P1|NOT COMPLETED|Overall Study||0
7705332|NCT01768013|18973315|P1|COMPLETED|Overall Study||13
7705333|NCT01768013|18973315|P1|STARTED|Overall Study||13
7705334|NCT01768000|18973348|P4|NOT COMPLETED|Overall Study||2
7705335|NCT01768000|18973349|P3|NOT COMPLETED|Overall Study||1
7705336|NCT01768000|18973350|P2|NOT COMPLETED|Overall Study||2
7705337|NCT01768000|18973351|P1|NOT COMPLETED|Overall Study||1
7705338|NCT01768000|18973348|P4|COMPLETED|Overall Study||8
7705339|NCT01768000|18973349|P3|COMPLETED|Overall Study||9
7705340|NCT01768000|18973350|P2|COMPLETED|Overall Study||8
7705341|NCT01768000|18973351|P1|COMPLETED|Overall Study||9
7705342|NCT01768000|18973348|P4|STARTED|Overall Study||10
7705343|NCT01768000|18973349|P3|STARTED|Overall Study||10
7705344|NCT01768000|18973350|P2|STARTED|Overall Study||10
7705345|NCT01768000|18973351|P1|STARTED|Overall Study||10
7705346|NCT01767987|18973371|P2|NOT COMPLETED|Overall Study||1
7705347|NCT01767987|18973372|P1|NOT COMPLETED|Overall Study||4
7705348|NCT01767987|18973371|P2|COMPLETED|Overall Study||1
7705349|NCT01767987|18973372|P1|COMPLETED|Overall Study||0
7705350|NCT01767987|18973371|P2|STARTED|Overall Study||2
7705351|NCT01767987|18973372|P1|STARTED|Overall Study||4
7705352|NCT01767935|18973394|P1|NOT COMPLETED|Overall Study||0
7705353|NCT01767935|18973394|P1|COMPLETED|Overall Study||1
7705354|NCT01767935|18973394|P1|STARTED|Overall Study||1
7705355|NCT01767909|18973404|P2|NOT COMPLETED|Overall Study||12
7705356|NCT01767909|18973405|P1|NOT COMPLETED|Overall Study||13
7705357|NCT01767909|18973404|P2|COMPLETED|Overall Study||107
7705358|NCT01767909|18973405|P1|COMPLETED|Overall Study||108
7705359|NCT01767909|18973404|P2|STARTED|Overall Study||119
7705360|NCT01767909|18973405|P1|STARTED|Overall Study||121
7705361|NCT01767792|18973421|P1|NOT COMPLETED|Overall Study||2
7705362|NCT01767792|18973421|P1|COMPLETED|Overall Study||20
7705363|NCT01767792|18973421|P1|STARTED|Overall Study||22
7705364|NCT01767701|18973431|P1|NOT COMPLETED|Overall Study||0
7705365|NCT01767701|18973431|P1|COMPLETED|Overall Study||20
7705366|NCT01767701|18973431|P1|STARTED|Overall Study|All 20 patients who entered the treatment phase completed the six months trial period.|20
7705367|NCT01767688|18973444|P2|NOT COMPLETED|Overall Study||0
7705368|NCT01767688|18973445|P1|NOT COMPLETED|Overall Study||0
7705369|NCT01767688|18973444|P2|COMPLETED|Overall Study||8
7705370|NCT01767688|18973445|P1|COMPLETED|Overall Study||8
7705371|NCT01767688|18973444|P2|STARTED|Overall Study||8
7705372|NCT01767688|18973445|P1|STARTED|Overall Study||8
7705373|NCT01767636|18973465|P1|NOT COMPLETED|Overall Study||3
7705374|NCT01767636|18973465|P1|COMPLETED|Overall Study||35
7705375|NCT01767636|18973465|P1|STARTED|Overall Study||38
7705376|NCT01767597|18973475|P2|NOT COMPLETED|Overall Study||1
7705377|NCT01767597|18973476|P1|NOT COMPLETED|Overall Study||4
7705378|NCT01767597|18973475|P2|COMPLETED|Overall Study||499
7705379|NCT01767597|18973476|P1|COMPLETED|Overall Study||496
7705380|NCT01767597|18973475|P2|STARTED|Overall Study||500
7705381|NCT01767597|18973476|P1|STARTED|Overall Study||500
7705382|NCT01767519|18973485|P3|NOT COMPLETED|Overall Study||5
7705383|NCT01767519|18973486|P2|NOT COMPLETED|Overall Study||13
7705384|NCT01767519|18973487|P1|NOT COMPLETED|Overall Study||14
7705385|NCT01767519|18973485|P3|COMPLETED|Overall Study||55
7705386|NCT01767519|18973486|P2|COMPLETED|Overall Study||138
7705387|NCT01767519|18973487|P1|COMPLETED|Overall Study||131
7705388|NCT01767519|18973485|P3|STARTED|Overall Study||60
7705389|NCT01767519|18973486|P2|STARTED|Overall Study||151
7705390|NCT01767519|18973487|P1|STARTED|Overall Study||145
7705391|NCT01767506|18973515|P2|NOT COMPLETED|Overall Study||0
7705392|NCT01767506|18973516|P1|NOT COMPLETED|Overall Study||0
7705393|NCT01767506|18973515|P2|COMPLETED|Overall Study|The study was conducted at the community level.|0
7705394|NCT01767506|18973516|P1|COMPLETED|Overall Study|The study was conducted at the community level.|0
7705395|NCT01767506|18973515|P2|STARTED|Overall Study|"26 communities were randomized to control group
~The study was conducted at the community level."|0
7705396|NCT01767506|18973516|P1|STARTED|Overall Study|"26 communities were randomized to intervention group
~The study was conducted at the community level."|0
7705397|NCT01767467|18973528|P2|NOT COMPLETED|End of Study Phase (up to Month 13)||63
7705398|NCT01767467|18973529|P1|NOT COMPLETED|End of Study Phase (up to Month 13)||47
7705399|NCT01767467|18973528|P2|COMPLETED|End of Study Phase (up to Month 13)||216
7705400|NCT01767467|18973529|P1|COMPLETED|End of Study Phase (up to Month 13)||236
7705401|NCT01767467|18973528|P2|STARTED|End of Study Phase (up to Month 13)||279
7705402|NCT01767467|18973529|P1|STARTED|End of Study Phase (up to Month 13)||283
7705403|NCT01767467|18973528|P2|NOT COMPLETED|Vaccination Phase (up to Month 2)||20
7705404|NCT01767467|18973529|P1|NOT COMPLETED|Vaccination Phase (up to Month 2)||17
7705405|NCT01767467|18973528|P2|COMPLETED|Vaccination Phase (up to Month 2)||259
7705406|NCT01767467|18973529|P1|COMPLETED|Vaccination Phase (up to Month 2)||266
7705407|NCT01767467|18973528|P2|STARTED|Vaccination Phase (up to Month 2)||279
7705408|NCT01767467|18973529|P1|STARTED|Vaccination Phase (up to Month 2)||283
7705409|NCT01767415|18973577|P1|NOT COMPLETED|Overall Study||0
7705410|NCT01767415|18973577|P1|COMPLETED|Overall Study||10
7705411|NCT01767415|18973577|P1|STARTED|Overall Study||10
7705412|NCT01767376|18973585|P3|NOT COMPLETED|Overall Study||0
7705413|NCT01767376|18973586|P2|NOT COMPLETED|Overall Study||3
7705414|NCT01767376|18973587|P1|NOT COMPLETED|Overall Study||4
7705415|NCT01767376|18973585|P3|COMPLETED|Overall Study||232
7705416|NCT01767376|18973586|P2|COMPLETED|Overall Study||225
7705417|NCT01767376|18973587|P1|COMPLETED|Overall Study||227
7705418|NCT01767376|18973585|P3|STARTED|Overall Study||232
7705419|NCT01767376|18973586|P2|STARTED|Overall Study||228
7705420|NCT01767376|18973587|P1|STARTED|Overall Study||231
7705421|NCT01767285|18973634|P2|NOT COMPLETED|Overall Study||6
7705422|NCT01767285|18973635|P1|NOT COMPLETED|Overall Study||7
7705423|NCT01767285|18973634|P2|COMPLETED|Overall Study||24
7705424|NCT01767285|18973635|P1|COMPLETED|Overall Study||22
7705425|NCT01767285|18973634|P2|STARTED|Overall Study||30
7705426|NCT01767285|18973635|P1|STARTED|Overall Study||29
7705427|NCT01767194|18973653|P2|NOT COMPLETED|Overall Study||43
7705428|NCT01767194|18973654|P1|NOT COMPLETED|Overall Study||18
7705429|NCT01767194|18973653|P2|COMPLETED|Overall Study||11
7705430|NCT01767194|18973654|P1|COMPLETED|Overall Study||1
7705431|NCT01767194|18973653|P2|STARTED|Overall Study||54
7705432|NCT01767194|18973654|P1|STARTED|Overall Study||19
7705433|NCT01767155|18973663|P2|NOT COMPLETED|Overall Study||15
7705434|NCT01767155|18973664|P1|NOT COMPLETED|Overall Study||13
7705435|NCT01767155|18973663|P2|COMPLETED|Overall Study||240
7705436|NCT01767155|18973664|P1|COMPLETED|Overall Study||243
7705437|NCT01767155|18973663|P2|Safety Population (SAF)|Overall Study||249
7705438|NCT01767155|18973664|P1|Safety Population (SAF)|Overall Study||252
7705439|NCT01767155|18973663|P2|Modified ITT (mITT)|Overall Study||249
7705440|NCT01767155|18973664|P1|Modified ITT (mITT)|Overall Study||252
7705441|NCT01767155|18973663|P2|STARTED|Overall Study|Patients allocated to doxorubicin|255
7705442|NCT01767155|18973664|P1|STARTED|Overall Study|Patients allocated to AEZS-108|256
7705443|NCT01767142|18973676|P1|NOT COMPLETED|Overall Study||3
7705444|NCT01767142|18973676|P1|COMPLETED|Overall Study||37
7705445|NCT01767142|18973676|P1|STARTED|Overall Study|Each subject was treated on a single thigh. therefore the number of units is 40.|40
7705446|NCT01767116|18973685|P2|NOT COMPLETED|Overall Study||2
7705447|NCT01767116|18973686|P1|NOT COMPLETED|Overall Study||2
7705448|NCT01767116|18973685|P2|COMPLETED|Overall Study||207
7705449|NCT01767116|18973686|P1|COMPLETED|Overall Study||208
7705450|NCT01767116|18973685|P2|STARTED|Overall Study||209
7705451|NCT01767116|18973686|P1|STARTED|Overall Study||210
7705452|NCT01767103|18973705|P3|NOT COMPLETED|Overall Study||0
7705453|NCT01767103|18973706|P2|NOT COMPLETED|Overall Study||0
7705454|NCT01767103|18973707|P1|NOT COMPLETED|Overall Study||0
7705455|NCT01767103|18973705|P3|COMPLETED|Overall Study||7
7705456|NCT01767103|18973706|P2|COMPLETED|Overall Study||7
7705457|NCT01767103|18973707|P1|COMPLETED|Overall Study||7
7705458|NCT01767103|18973705|P3|STARTED|Overall Study||7
7705459|NCT01767103|18973706|P2|STARTED|Overall Study||7
7705460|NCT01767103|18973707|P1|STARTED|Overall Study||7
7705461|NCT01767064|18973735|P2|NOT COMPLETED|Overall Study||0
7705462|NCT01767064|18973736|P1|NOT COMPLETED|Overall Study||0
7705463|NCT01767064|18973735|P2|COMPLETED|Overall Study||7
7705464|NCT01767064|18973736|P1|COMPLETED|Overall Study||7
7705465|NCT01767064|18973735|P2|STARTED|Overall Study||7
7705466|NCT01767064|18973736|P1|STARTED|Overall Study||7
7705467|NCT01766921|18973744|P2|NOT COMPLETED|Overall Study||17
7705468|NCT01766921|18973745|P1|NOT COMPLETED|Overall Study||24
7705469|NCT01766921|18973744|P2|COMPLETED|Overall Study||676
7705470|NCT01766921|18973745|P1|COMPLETED|Overall Study||676
7705471|NCT01766921|18973744|P2|STARTED|Overall Study||693
7705472|NCT01766921|18973745|P1|STARTED|Overall Study||700
7705473|NCT01766817|18973767|P3|NOT COMPLETED|Overall Study||13
7705474|NCT01766817|18973768|P2|NOT COMPLETED|Overall Study||11
7705475|NCT01766817|18973769|P1|NOT COMPLETED|Overall Study||11
7705476|NCT01766817|18973767|P3|COMPLETED|Overall Study||34
7705477|NCT01766817|18973768|P2|COMPLETED|Overall Study||37
7705478|NCT01766817|18973769|P1|COMPLETED|Overall Study||37
7705479|NCT01766817|18973767|P3|STARTED|Overall Study||47
7705480|NCT01766817|18973768|P2|STARTED|Overall Study||48
7705481|NCT01766817|18973769|P1|STARTED|Overall Study||48
7705482|NCT01766778|18973820|P2|NOT COMPLETED|Overall Study||4
7705483|NCT01766778|18973821|P1|NOT COMPLETED|Overall Study||5
7705484|NCT01766778|18973820|P2|COMPLETED|Overall Study||57
7705485|NCT01766778|18973821|P1|COMPLETED|Overall Study||51
7705486|NCT01766778|18973820|P2|STARTED|Overall Study||61
7705487|NCT01766778|18973821|P1|STARTED|Overall Study|Intent to treat population|56
7705488|NCT01766713|18973839|P2|NOT COMPLETED|Overall Study||3
7705489|NCT01766713|18973840|P1|NOT COMPLETED|Overall Study||2
7705490|NCT01766713|18973839|P2|COMPLETED|Overall Study||22
7705491|NCT01766713|18973840|P1|COMPLETED|Overall Study||23
7705492|NCT01766713|18973839|P2|STARTED|Overall Study||25
7705493|NCT01766713|18973840|P1|STARTED|Overall Study||25
7705494|NCT01766466|18973848|P4|NOT COMPLETED|Day 5||0
7705495|NCT01766466|18973849|P3|NOT COMPLETED|Day 5||0
7705496|NCT01766466|18973850|P2|NOT COMPLETED|Day 5||0
7705497|NCT01766466|18973851|P1|NOT COMPLETED|Day 5||0
7705498|NCT01766466|18973848|P4|COMPLETED|Day 5||6
7705499|NCT01766466|18973849|P3|COMPLETED|Day 5||0
7705500|NCT01766466|18973850|P2|COMPLETED|Day 5||6
7705501|NCT01766466|18973851|P1|COMPLETED|Day 5||0
7705502|NCT01766466|18973848|P4|STARTED|Day 5||6
7705503|NCT01766466|18973849|P3|STARTED|Day 5||0
7705504|NCT01766466|18973850|P2|STARTED|Day 5||6
7705505|NCT01766466|18973851|P1|STARTED|Day 5||0
7705506|NCT01766466|18973848|P4|NOT COMPLETED|Day 1||0
7705507|NCT01766466|18973849|P3|NOT COMPLETED|Day 1||0
7705508|NCT01766466|18973850|P2|NOT COMPLETED|Day 1||0
7705509|NCT01766466|18973851|P1|NOT COMPLETED|Day 1||0
7705510|NCT01766466|18973848|P4|COMPLETED|Day 1||0
7705511|NCT01766466|18973849|P3|COMPLETED|Day 1||6
7705512|NCT01766466|18973850|P2|COMPLETED|Day 1||0
7705513|NCT01766466|18973851|P1|COMPLETED|Day 1||6
7705514|NCT01766466|18973848|P4|STARTED|Day 1||0
7705515|NCT01766466|18973849|P3|STARTED|Day 1||6
7705516|NCT01766466|18973850|P2|STARTED|Day 1||0
7705517|NCT01766466|18973851|P1|STARTED|Day 1||6
7705518|NCT01766440|18973864|P1|NOT COMPLETED|Overall Study||1
7705519|NCT01766440|18973864|P1|COMPLETED|Overall Study||17
7705520|NCT01766440|18973864|P1|STARTED|Overall Study||18
7705521|NCT01766401|18973875|P2|NOT COMPLETED|Overall Study||56
7705522|NCT01766401|18973876|P1|NOT COMPLETED|Overall Study||37
7705523|NCT01766401|18973875|P2|COMPLETED|Overall Study||144
7705524|NCT01766401|18973876|P1|COMPLETED|Overall Study||161
7705525|NCT01766401|18973875|P2|STARTED|Overall Study||200
7705526|NCT01766401|18973876|P1|STARTED|Overall Study||198
7705527|NCT01766336|18973886|P2|NOT COMPLETED|Overall Study||75
7705528|NCT01766336|18973887|P1|NOT COMPLETED|Overall Study||90
7705529|NCT01766336|18973886|P2|COMPLETED|Overall Study||71
7705530|NCT01766336|18973887|P1|COMPLETED|Overall Study||60
7705531|NCT01766336|18973886|P2|STARTED|Overall Study||146
7705532|NCT01766336|18973887|P1|STARTED|Overall Study||150
7705533|NCT01766310|18973895|P2|NOT COMPLETED|Overall Study||3
7705534|NCT01766310|18973896|P1|NOT COMPLETED|Overall Study||1
7705535|NCT01766310|18973895|P2|COMPLETED|Overall Study||23
7705536|NCT01766310|18973896|P1|COMPLETED|Overall Study||23
7705537|NCT01766310|18973895|P2|STARTED|Overall Study||26
7705538|NCT01766310|18973896|P1|STARTED|Overall Study||24
7705539|NCT01766219|18973907|P3|NOT COMPLETED|Overall Study||0
7705540|NCT01766219|18973908|P2|NOT COMPLETED|Overall Study||0
7705541|NCT01766219|18973909|P1|NOT COMPLETED|Overall Study||0
7705542|NCT01766219|18973907|P3|COMPLETED|Overall Study||11
7705543|NCT01766219|18973908|P2|COMPLETED|Overall Study||2
7705544|NCT01766219|18973909|P1|COMPLETED|Overall Study||4
7705545|NCT01766219|18973907|P3|STARTED|Overall Study||11
7705546|NCT01766219|18973908|P2|STARTED|Overall Study||2
7705547|NCT01766219|18973909|P1|STARTED|Overall Study||4
7705548|NCT01766206|18973926|P1|NOT COMPLETED|Overall Study||51
7705549|NCT01766206|18973926|P1|COMPLETED|Overall Study||3888
7705550|NCT01766206|18973926|P1|STARTED|Overall Study||3939
7705551|NCT01766102|18973935|P2|NOT COMPLETED|Overall Study||0
7705552|NCT01766102|18973936|P1|NOT COMPLETED|Overall Study||0
7705553|NCT01766102|18973935|P2|COMPLETED|Overall Study||36
7705554|NCT01766102|18973936|P1|COMPLETED|Overall Study||36
7705555|NCT01766102|18973935|P2|STARTED|Overall Study||36
7705556|NCT01766102|18973936|P1|STARTED|Overall Study||36
7705557|NCT01766076|18973946|P2|NOT COMPLETED|Overall Study||0
7705558|NCT01766076|18973947|P1|NOT COMPLETED|Overall Study||0
7705559|NCT01766076|18973946|P2|COMPLETED|Overall Study||15
7705560|NCT01766076|18973947|P1|COMPLETED|Overall Study||15
7705561|NCT01766076|18973946|P2|STARTED|Overall Study||15
7705562|NCT01766076|18973947|P1|STARTED|Overall Study||15
7705563|NCT01766050|18973953|P1|NOT COMPLETED|Overall Study||4
7705564|NCT01766050|18973953|P1|COMPLETED|Overall Study||18
7705565|NCT01766050|18973953|P1|STARTED|Overall Study||22
7705566|NCT01766037|18974088|P2|NOT COMPLETED|Overall Study||29
7705567|NCT01766037|18974089|P1|NOT COMPLETED|Overall Study||29
7705568|NCT01766037|18974088|P2|COMPLETED|Overall Study||31
7705569|NCT01766037|18974089|P1|COMPLETED|Overall Study||82
7705570|NCT01766037|18974088|P2|STARTED|Overall Study||60
7705571|NCT01766037|18974089|P1|STARTED|Overall Study||111
7705572|NCT01766024|18974126|P2|NOT COMPLETED|Overall Study||0
7705573|NCT01766024|18974127|P1|NOT COMPLETED|Overall Study||0
7705574|NCT01766024|18974126|P2|COMPLETED|Overall Study||16
7705575|NCT01766024|18974127|P1|COMPLETED|Overall Study||16
7705576|NCT01766024|18974126|P2|STARTED|Overall Study||16
7705577|NCT01766024|18974127|P1|STARTED|Overall Study||16
7705578|NCT01765972|18974137|P4|NOT COMPLETED|Overall Study||0
7705579|NCT01765972|18974138|P3|NOT COMPLETED|Overall Study||0
7705580|NCT01765972|18974139|P2|NOT COMPLETED|Overall Study||0
7705581|NCT01765972|18974140|P1|NOT COMPLETED|Overall Study||0
7705582|NCT01765972|18974137|P4|COMPLETED|Overall Study||6
7705583|NCT01765972|18974138|P3|COMPLETED|Overall Study||6
7705584|NCT01765972|18974139|P2|COMPLETED|Overall Study||6
7705585|NCT01765972|18974140|P1|COMPLETED|Overall Study||6
7705586|NCT01765972|18974137|P4|STARTED|Overall Study||6
7705587|NCT01765972|18974138|P3|STARTED|Overall Study||6
7705588|NCT01765972|18974139|P2|STARTED|Overall Study||6
7705589|NCT01765972|18974140|P1|STARTED|Overall Study||6
7705590|NCT01765920|18974152|P2|NOT COMPLETED|Overall Study||6
7705591|NCT01765920|18974153|P1|NOT COMPLETED|Overall Study||2
7705592|NCT01765920|18974152|P2|COMPLETED|Overall Study||167
7705593|NCT01765920|18974153|P1|COMPLETED|Overall Study||167
7705594|NCT01765920|18974152|P2|STARTED|Overall Study||173
7705595|NCT01765920|18974153|P1|STARTED|Overall Study||169
7705596|NCT01765803|18974167|P1|NOT COMPLETED|Overall Study||0
7705597|NCT01765803|18974167|P1|COMPLETED|Overall Study||6
7705598|NCT01765803|18974167|P1|STARTED|Overall Study||6
7705599|NCT01765764|18974175|P3|NOT COMPLETED|Post-treatment Period||0
7705600|NCT01765764|18974176|P2|NOT COMPLETED|Post-treatment Period||0
7705601|NCT01765764|18974177|P1|NOT COMPLETED|Post-treatment Period||0
7705602|NCT01765764|18974175|P3|COMPLETED|Post-treatment Period||112
7705603|NCT01765764|18974176|P2|COMPLETED|Post-treatment Period||107
7705604|NCT01765764|18974177|P1|COMPLETED|Post-treatment Period||114
7705605|NCT01765764|18974175|P3|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112
7705606|NCT01765764|18974176|P2|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107
7705607|NCT01765764|18974177|P1|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114
7705608|NCT01765764|18974175|P3|NOT COMPLETED|Treatment Period||6
7705609|NCT01765764|18974176|P2|NOT COMPLETED|Treatment Period||9
7705610|NCT01765764|18974177|P1|NOT COMPLETED|Treatment Period||3
7705611|NCT01765764|18974175|P3|COMPLETED|Treatment Period||115
7705612|NCT01765764|18974176|P2|COMPLETED|Treatment Period||109
7705613|NCT01765764|18974177|P1|COMPLETED|Treatment Period||115
7705614|NCT01765764|18974175|P3|STARTED|Treatment Period||121
7705615|NCT01765764|18974176|P2|STARTED|Treatment Period||118
7705616|NCT01765764|18974177|P1|STARTED|Treatment Period||118
7705617|NCT01765751|18974197|P3|NOT COMPLETED|Overall Study||1
7705618|NCT01765751|18974198|P2|NOT COMPLETED|Overall Study||2
7705619|NCT01765751|18974199|P1|NOT COMPLETED|Overall Study||0
7705620|NCT01765751|18974197|P3|COMPLETED|Overall Study||15
7705621|NCT01765751|18974198|P2|COMPLETED|Overall Study||14
7705622|NCT01765751|18974199|P1|COMPLETED|Overall Study||16
7705623|NCT01765751|18974197|P3|STARTED|Overall Study||16
7705624|NCT01765751|18974198|P2|STARTED|Overall Study||16
7705625|NCT01765751|18974199|P1|STARTED|Overall Study||16
7705626|NCT01765673|18974231|P1|NOT COMPLETED|Overall Study||1
7705627|NCT01765673|18974231|P1|COMPLETED|Overall Study||11
7705628|NCT01765673|18974231|P1|STARTED|Overall Study||12
7705629|NCT01765647|18974254|P1|NOT COMPLETED|Overall Study||0
7705630|NCT01765647|18974254|P1|COMPLETED|Overall Study|10 entered the AGY treatment phase and all 10 completed treatment.|10
7705631|NCT01765647|18974254|P1|STARTED|Overall Study|One began the run-in period, but was withdrawn prior to beginning treatment with AGY|10
7705632|NCT01765582|18974264|P3|NOT COMPLETED|Overall Study||95
7705633|NCT01765582|18974265|P2|NOT COMPLETED|Overall Study||92
7705634|NCT01765582|18974266|P1|NOT COMPLETED|Overall Study||93
7705635|NCT01765582|18974264|P3|COMPLETED|Overall Study||0
7705636|NCT01765582|18974265|P2|COMPLETED|Overall Study||0
7705637|NCT01765582|18974266|P1|COMPLETED|Overall Study||0
7705638|NCT01765582|18974264|P3|STARTED|Overall Study||95
7705639|NCT01765582|18974265|P2|STARTED|Overall Study||92
7705640|NCT01765582|18974266|P1|STARTED|Overall Study||93
7705641|NCT01765569|18974299|P1|NOT COMPLETED|Period C||1
7705642|NCT01765569|18974299|P1|COMPLETED|Period C||27
7705643|NCT01765569|18974299|P1|STARTED|Period C||28
7705644|NCT01765569|18974299|P1|NOT COMPLETED|Period B||1
7705645|NCT01765569|18974299|P1|COMPLETED|Period B||28
7705646|NCT01765569|18974299|P1|STARTED|Period B||29
7705647|NCT01765569|18974299|P1|NOT COMPLETED|Period A||0
7705648|NCT01765569|18974299|P1|COMPLETED|Period A||29
7705649|NCT01765569|18974299|P1|STARTED|Period A||29
7705650|NCT01765543|18974320|P1|NOT COMPLETED|Overall Study||3
7705651|NCT01765543|18974320|P1|COMPLETED|Overall Study||24
7705652|NCT01765543|18974320|P1|STARTED|Overall Study||27
7705653|NCT01765530|18974344|P2|NOT COMPLETED|Overall Study||1
7705654|NCT01765530|18974345|P1|NOT COMPLETED|Overall Study||1
7705655|NCT01765530|18974344|P2|COMPLETED|Overall Study||36
7705656|NCT01765530|18974345|P1|COMPLETED|Overall Study||36
7705657|NCT01765530|18974344|P2|STARTED|Overall Study||37
7705658|NCT01765530|18974345|P1|STARTED|Overall Study||37
7705659|NCT01765465|18974355|P2|NOT COMPLETED|Overall Study||4
7705660|NCT01765465|18974356|P1|NOT COMPLETED|Overall Study||7
7705661|NCT01765465|18974355|P2|COMPLETED|Overall Study||63
7705662|NCT01765465|18974356|P1|COMPLETED|Overall Study||64
7705663|NCT01765465|18974355|P2|STARTED|Overall Study||67
7705664|NCT01765465|18974356|P1|STARTED|Overall Study||71
7705665|NCT01765426|18974372|P4|NOT COMPLETED|Overall Study||0
7705666|NCT01765426|18974373|P3|NOT COMPLETED|Overall Study||0
7705667|NCT01765426|18974374|P2|NOT COMPLETED|Overall Study||1
7705668|NCT01765426|18974375|P1|NOT COMPLETED|Overall Study||0
7705669|NCT01765426|18974372|P4|COMPLETED|Overall Study||15
7705670|NCT01765426|18974373|P3|COMPLETED|Overall Study||17
7705671|NCT01765426|18974374|P2|COMPLETED|Overall Study||16
7705672|NCT01765426|18974375|P1|COMPLETED|Overall Study||18
7705673|NCT01765426|18974372|P4|Completed All Vaccinations|Overall Study||15
7705674|NCT01765426|18974373|P3|Completed All Vaccinations|Overall Study||17
7705675|NCT01765426|18974374|P2|Completed All Vaccinations|Overall Study||16
7705676|NCT01765426|18974375|P1|Completed All Vaccinations|Overall Study||17
7705677|NCT01765426|18974372|P4|STARTED|Overall Study||15
7705678|NCT01765426|18974373|P3|STARTED|Overall Study||17
7705679|NCT01765426|18974374|P2|STARTED|Overall Study||17
7705680|NCT01765426|18974375|P1|STARTED|Overall Study||18
7705681|NCT01765270|18974431|P2|NOT COMPLETED|Overall Study||1
7705682|NCT01765270|18974432|P1|NOT COMPLETED|Overall Study||1
7705683|NCT01765270|18974431|P2|COMPLETED|Overall Study||6
7705684|NCT01765270|18974432|P1|COMPLETED|Overall Study||4
7705685|NCT01765270|18974431|P2|STARTED|Overall Study||7
7705686|NCT01765270|18974432|P1|STARTED|Overall Study||5
7705687|NCT01765192|18974454|P2|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1
7705688|NCT01765192|18974455|P1|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0
7705689|NCT01765192|18974454|P2|COMPLETED|End of Treatment Period 2 to Final Visit||27
7705690|NCT01765192|18974455|P1|COMPLETED|End of Treatment Period 2 to Final Visit||30
7705691|NCT01765192|18974454|P2|STARTED|End of Treatment Period 2 to Final Visit||28
7705692|NCT01765192|18974455|P1|STARTED|End of Treatment Period 2 to Final Visit||30
7705693|NCT01765192|18974454|P2|NOT COMPLETED|Treatment Period 2||2
7705694|NCT01765192|18974455|P1|NOT COMPLETED|Treatment Period 2||0
7705695|NCT01765192|18974454|P2|COMPLETED|Treatment Period 2||28
7705696|NCT01765192|18974455|P1|COMPLETED|Treatment Period 2||30
7705697|NCT01765192|18974454|P2|STARTED|Treatment Period 2||30
7705698|NCT01765192|18974455|P1|STARTED|Treatment Period 2||30
7705699|NCT01765192|18974454|P2|NOT COMPLETED|Washout Period||1
7705700|NCT01765192|18974455|P1|NOT COMPLETED|Washout Period||2
7705701|NCT01765192|18974454|P2|COMPLETED|Washout Period||30
7705702|NCT01765192|18974455|P1|COMPLETED|Washout Period||30
7705703|NCT01765192|18974454|P2|STARTED|Washout Period||31
7705704|NCT01765192|18974455|P1|STARTED|Washout Period||32
7705705|NCT01765192|18974454|P2|NOT COMPLETED|Treatment Period 1||1
7705706|NCT01765192|18974455|P1|NOT COMPLETED|Treatment Period 1||0
7705707|NCT01765192|18974454|P2|COMPLETED|Treatment Period 1||31
7705708|NCT01765192|18974455|P1|COMPLETED|Treatment Period 1||32
7705709|NCT01765192|18974454|P2|STARTED|Treatment Period 1||32
7705710|NCT01765192|18974455|P1|STARTED|Treatment Period 1||32
7705711|NCT01765179|18974473|P1|NOT COMPLETED|Overall Study||27
7705712|NCT01765179|18974473|P1|COMPLETED|Overall Study||117
7705713|NCT01765179|18974473|P1|STARTED|Overall Study||144
7705714|NCT01765153|18974480|P2|NOT COMPLETED|Rest Phase 2||1
7705715|NCT01765153|18974481|P1|NOT COMPLETED|Rest Phase 2||2
7705716|NCT01765153|18974480|P2|COMPLETED|Rest Phase 2||7
7705717|NCT01765153|18974481|P1|COMPLETED|Rest Phase 2||8
7705718|NCT01765153|18974480|P2|STARTED|Rest Phase 2||8
7705719|NCT01765153|18974481|P1|STARTED|Rest Phase 2||10
7705720|NCT01765153|18974480|P2|NOT COMPLETED|Training Phase 2||1
7705721|NCT01765153|18974481|P1|NOT COMPLETED|Training Phase 2||0
7705722|NCT01765153|18974480|P2|COMPLETED|Training Phase 2||8
7705723|NCT01765153|18974481|P1|COMPLETED|Training Phase 2||10
7705724|NCT01765153|18974480|P2|STARTED|Training Phase 2||9
7705725|NCT01765153|18974481|P1|STARTED|Training Phase 2|1st subject didn't use same training(phase 1) as subsequent participants Phase 1 and 2 data removed.|10
7705726|NCT01765153|18974480|P2|NOT COMPLETED|Rest Phase 1||1
7705727|NCT01765153|18974481|P1|NOT COMPLETED|Rest Phase 1||0
7705728|NCT01765153|18974480|P2|COMPLETED|Rest Phase 1||9
7705729|NCT01765153|18974481|P1|COMPLETED|Rest Phase 1||9
7705730|NCT01765153|18974480|P2|STARTED|Rest Phase 1||10
7705731|NCT01765153|18974481|P1|STARTED|Rest Phase 1||9
7705732|NCT01765153|18974480|P2|NOT COMPLETED|Training Phase 1||1
7705733|NCT01765153|18974481|P1|NOT COMPLETED|Training Phase 1||1
7705734|NCT01765153|18974480|P2|COMPLETED|Training Phase 1||10
7705735|NCT01765153|18974481|P1|COMPLETED|Training Phase 1||9
7705736|NCT01765153|18974480|P2|STARTED|Training Phase 1||11
7705737|NCT01765153|18974481|P1|STARTED|Training Phase 1||10
7705738|NCT01764997|18974588|P5|NOT COMPLETED|Study Drug Treatment Period||36
7705739|NCT01764997|18974589|P4|NOT COMPLETED|Study Drug Treatment Period||0
7705740|NCT01764997|18974590|P3|NOT COMPLETED|Study Drug Treatment Period||0
7705741|NCT01764997|18974591|P2|NOT COMPLETED|Study Drug Treatment Period||1
7705742|NCT01764997|18974592|P1|NOT COMPLETED|Study Drug Treatment Period||0
7705743|NCT01764997|18974588|P5|COMPLETED|Study Drug Treatment Period||286
7705744|NCT01764997|18974589|P4|COMPLETED|Study Drug Treatment Period||13
7705745|NCT01764997|18974590|P3|COMPLETED|Study Drug Treatment Period||13
7705746|NCT01764997|18974591|P2|COMPLETED|Study Drug Treatment Period||16
7705747|NCT01764997|18974592|P1|COMPLETED|Study Drug Treatment Period||0
7705748|NCT01764997|18974588|P5|STARTED|Study Drug Treatment Period||322
7705749|NCT01764997|18974589|P4|STARTED|Study Drug Treatment Period||13
7705750|NCT01764997|18974590|P3|STARTED|Study Drug Treatment Period||13
7705751|NCT01764997|18974591|P2|STARTED|Study Drug Treatment Period||17
7705752|NCT01764997|18974592|P1|STARTED|Study Drug Treatment Period||0
7705753|NCT01764997|18974588|P5|NOT COMPLETED|Run-in Period||0
7705754|NCT01764997|18974589|P4|NOT COMPLETED|Run-in Period||0
7705755|NCT01764997|18974590|P3|NOT COMPLETED|Run-in Period||0
7705756|NCT01764997|18974591|P2|NOT COMPLETED|Run-in Period||0
7705757|NCT01764997|18974592|P1|NOT COMPLETED|Run-in Period||38
7705758|NCT01764997|18974588|P5|COMPLETED|Run-in Period||0
7705759|NCT01764997|18974589|P4|COMPLETED|Run-in Period||0
7705760|NCT01764997|18974590|P3|COMPLETED|Run-in Period||0
7705761|NCT01764997|18974591|P2|COMPLETED|Run-in Period||0
7705762|NCT01764997|18974592|P1|COMPLETED|Run-in Period|43 participants proceeded to randomized treatment and 322 proceeded to open-label sub-study.|738
7705763|NCT01764997|18974588|P5|STARTED|Run-in Period||0
7705764|NCT01764997|18974589|P4|STARTED|Run-in Period||0
7705765|NCT01764997|18974590|P3|STARTED|Run-in Period||0
7705766|NCT01764997|18974591|P2|STARTED|Run-in Period||0
7705767|NCT01764997|18974592|P1|STARTED|Run-in Period||776
7705768|NCT01764945|18974619|P8|NOT COMPLETED|Overall Study||0
7705769|NCT01764945|18974620|P7|NOT COMPLETED|Overall Study||1
7705770|NCT01764945|18974621|P6|NOT COMPLETED|Overall Study||0
7705771|NCT01764945|18974622|P5|NOT COMPLETED|Overall Study||0
7705772|NCT01764945|18974623|P4|NOT COMPLETED|Overall Study||0
7705773|NCT01764945|18974624|P3|NOT COMPLETED|Overall Study||0
7705774|NCT01764945|18974625|P2|NOT COMPLETED|Overall Study||1
7705775|NCT01764945|18974626|P1|NOT COMPLETED|Overall Study||0
7705776|NCT01764945|18974619|P8|COMPLETED|Overall Study||9
7705777|NCT01764945|18974620|P7|COMPLETED|Overall Study||8
7705778|NCT01764945|18974621|P6|COMPLETED|Overall Study||8
7705779|NCT01764945|18974622|P5|COMPLETED|Overall Study||10
7705780|NCT01764945|18974623|P4|COMPLETED|Overall Study||5
7705781|NCT01764945|18974624|P3|COMPLETED|Overall Study||5
7705782|NCT01764945|18974625|P2|COMPLETED|Overall Study||4
7705783|NCT01764945|18974626|P1|COMPLETED|Overall Study||5
7705784|NCT01764945|18974619|P8|STARTED|Overall Study||9
7705785|NCT01764945|18974620|P7|STARTED|Overall Study||9
7705786|NCT01764945|18974621|P6|STARTED|Overall Study||8
7705787|NCT01764945|18974622|P5|STARTED|Overall Study||10
7705788|NCT01764945|18974623|P4|STARTED|Overall Study||5
7705789|NCT01764945|18974624|P3|STARTED|Overall Study||5
7705790|NCT01764945|18974625|P2|STARTED|Overall Study||5
7705791|NCT01764945|18974626|P1|STARTED|Overall Study||5
7705792|NCT01764919|18974660|P1|NOT COMPLETED|Overall Study||0
7705793|NCT01764919|18974660|P1|COMPLETED|Overall Study||4
7705794|NCT01764919|18974660|P1|STARTED|Overall Study||4
7705795|NCT01764854|18974672|P4|NOT COMPLETED|Overall Study||2
7705796|NCT01764854|18974673|P3|NOT COMPLETED|Overall Study||6
7705797|NCT01764854|18974674|P2|NOT COMPLETED|Overall Study||0
7705798|NCT01764854|18974675|P1|NOT COMPLETED|Overall Study||0
7705799|NCT01764854|18974672|P4|COMPLETED|Overall Study||33
7705800|NCT01764854|18974673|P3|COMPLETED|Overall Study||31
7705801|NCT01764854|18974674|P2|COMPLETED|Overall Study||8
7705802|NCT01764854|18974675|P1|COMPLETED|Overall Study||8
7705803|NCT01764854|18974672|P4|STARTED|Overall Study||35
7705804|NCT01764854|18974673|P3|STARTED|Overall Study||37
7705805|NCT01764854|18974674|P2|STARTED|Overall Study||8
7705806|NCT01764854|18974675|P1|STARTED|Overall Study||8
7705807|NCT01764841|18974689|P4|NOT COMPLETED|Overall Study||19
7705808|NCT01764841|18974690|P3|NOT COMPLETED|Overall Study||14
7705809|NCT01764841|18974691|P2|NOT COMPLETED|Overall Study||26
7705810|NCT01764841|18974692|P1|NOT COMPLETED|Overall Study||23
7705811|NCT01764841|18974689|P4|COMPLETED|Overall Study||49
7705812|NCT01764841|18974690|P3|COMPLETED|Overall Study||56
7705813|NCT01764841|18974691|P2|COMPLETED|Overall Study||111
7705814|NCT01764841|18974692|P1|COMPLETED|Overall Study||118
7705815|NCT01764841|18974689|P4|Participants Received Treatment|Overall Study|safety population|68
7705816|NCT01764841|18974690|P3|Participants Received Treatment|Overall Study|safety population|69
7705817|NCT01764841|18974691|P2|Participants Received Treatment|Overall Study|safety population|136
7705818|NCT01764841|18974692|P1|Participants Received Treatment|Overall Study|safety population|141
7705819|NCT01764841|18974689|P4|STARTED|Overall Study||68
7705820|NCT01764841|18974690|P3|STARTED|Overall Study||70
7705821|NCT01764841|18974691|P2|STARTED|Overall Study||137
7705822|NCT01764841|18974692|P1|STARTED|Overall Study||141
7705823|NCT01764685|18974726|P2|NOT COMPLETED|Overall Study||1
7705824|NCT01764685|18974727|P1|NOT COMPLETED|Overall Study||0
7705825|NCT01764685|18974726|P2|COMPLETED|Overall Study||3
7705826|NCT01764685|18974727|P1|COMPLETED|Overall Study||0
7705827|NCT01764685|18974726|P2|STARTED|Overall Study||4
7705828|NCT01764685|18974727|P1|STARTED|Overall Study||0
7705829|NCT01764659|18974733|P1|NOT COMPLETED|Overall Study||2
7705830|NCT01764659|18974733|P1|COMPLETED|Overall Study||12
7705831|NCT01764659|18974733|P1|STARTED|Overall Study||14
7705832|NCT01764633|18974747|P2|NOT COMPLETED|Overall Study||93
7705833|NCT01764633|18974748|P1|NOT COMPLETED|Overall Study||118
7705834|NCT01764633|18974747|P2|COMPLETED|Overall Study||13691
7705835|NCT01764633|18974748|P1|COMPLETED|Overall Study||13662
7705836|NCT01764633|18974747|P2|Received Treatment|Overall Study||13769
7705837|NCT01764633|18974748|P1|Received Treatment|Overall Study||13756
7705838|NCT01764633|18974747|P2|STARTED|Overall Study||13784
7705839|NCT01764633|18974748|P1|STARTED|Overall Study||13780
7705840|NCT01764607|18974770|P1|NOT COMPLETED|Overall Study||0
7705841|NCT01764607|18974770|P1|COMPLETED|Overall Study||1
7705842|NCT01764607|18974770|P1|STARTED|Overall Study||1
7705843|NCT01764464|18974777|P2|NOT COMPLETED|Second Intervention (Cross-over)||0
7705844|NCT01764464|18974778|P1|NOT COMPLETED|Second Intervention (Cross-over)||2
7705845|NCT01764464|18974777|P2|COMPLETED|Second Intervention (Cross-over)|Completed Gralise|13
7705846|NCT01764464|18974778|P1|COMPLETED|Second Intervention (Cross-over)|Completed Placebo|12
7705847|NCT01764464|18974777|P2|STARTED|Second Intervention (Cross-over)|Started Gralise|13
7705848|NCT01764464|18974778|P1|STARTED|Second Intervention (Cross-over)|Started Placebo|14
7705849|NCT01764464|18974777|P2|NOT COMPLETED|First Intervention||3
7705850|NCT01764464|18974778|P1|NOT COMPLETED|First Intervention||2
7705851|NCT01764464|18974777|P2|COMPLETED|First Intervention|Completed Placebo|13
7705852|NCT01764464|18974778|P1|COMPLETED|First Intervention|Completed Gralise|14
7705853|NCT01764464|18974777|P2|STARTED|First Intervention|Started Placebo|16
7705854|NCT01764464|18974778|P1|STARTED|First Intervention|Started Gralise|16
7705855|NCT01764386|18974796|P2|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53
7705856|NCT01764386|18974797|P1|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16
7705857|NCT01764386|18974796|P2|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28
7705858|NCT01764386|18974797|P1|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55
7705859|NCT01764386|18974796|P2|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35
7705860|NCT01764386|18974797|P1|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61
7705861|NCT01764386|18974796|P2|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81
7705862|NCT01764386|18974797|P1|STARTED|Uncontrolled Treatment Period (UTP)||71
7705863|NCT01764386|18974796|P2|NOT COMPLETED|Controlled Treatment Period (CTP)||7
7705864|NCT01764386|18974797|P1|NOT COMPLETED|Controlled Treatment Period (CTP)||82
7705865|NCT01764386|18974796|P2|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82
7705866|NCT01764386|18974797|P1|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71
7705867|NCT01764386|18974796|P2|STARTED|Controlled Treatment Period (CTP)||89
7705868|NCT01764386|18974797|P1|STARTED|Controlled Treatment Period (CTP)||153
7705869|NCT01764256|18974842|P4|NOT COMPLETED|Completed Study||1
7705870|NCT01764256|18974843|P3|NOT COMPLETED|Completed Study||0
7705871|NCT01764256|18974844|P2|NOT COMPLETED|Completed Study||0
7705872|NCT01764256|18974845|P1|NOT COMPLETED|Completed Study||0
7705873|NCT01764256|18974842|P4|COMPLETED|Completed Study||11
7705874|NCT01764256|18974843|P3|COMPLETED|Completed Study||11
7705875|NCT01764256|18974844|P2|COMPLETED|Completed Study||11
7705876|NCT01764256|18974845|P1|COMPLETED|Completed Study||10
7705877|NCT01764256|18974842|P4|STARTED|Completed Study||12
7705878|NCT01764256|18974843|P3|STARTED|Completed Study||11
7705879|NCT01764256|18974844|P2|STARTED|Completed Study||11
7705880|NCT01764256|18974845|P1|STARTED|Completed Study||10
7705881|NCT01764256|18974842|P4|NOT COMPLETED|Received All Vaccinations||0
7705882|NCT01764256|18974843|P3|NOT COMPLETED|Received All Vaccinations||1
7705883|NCT01764256|18974844|P2|NOT COMPLETED|Received All Vaccinations||1
7705884|NCT01764256|18974845|P1|NOT COMPLETED|Received All Vaccinations||2
7705885|NCT01764256|18974842|P4|COMPLETED|Received All Vaccinations||12
7705886|NCT01764256|18974843|P3|COMPLETED|Received All Vaccinations||11
7705887|NCT01764256|18974844|P2|COMPLETED|Received All Vaccinations||11
7705888|NCT01764256|18974845|P1|COMPLETED|Received All Vaccinations||10
7705889|NCT01764256|18974842|P4|STARTED|Received All Vaccinations||12
7705890|NCT01764256|18974843|P3|STARTED|Received All Vaccinations||12
7705891|NCT01764256|18974844|P2|STARTED|Received All Vaccinations||12
7705892|NCT01764256|18974845|P1|STARTED|Received All Vaccinations||12
7705893|NCT01764022|18974888|P2|NOT COMPLETED|Overall Study||14
7705894|NCT01764022|18974889|P1|NOT COMPLETED|Overall Study||8
7705895|NCT01764022|18974888|P2|COMPLETED|Overall Study||96
7705896|NCT01764022|18974889|P1|COMPLETED|Overall Study||107
7705897|NCT01764022|18974888|P2|Received at Least 1 Dose of Study Drug|Overall Study||110
7705898|NCT01764022|18974889|P1|Received at Least 1 Dose of Study Drug|Overall Study||113
7705899|NCT01764022|18974888|P2|STARTED|Overall Study||110
7705900|NCT01764022|18974889|P1|STARTED|Overall Study||115
7705901|NCT01763996|18974921|P2|NOT COMPLETED|Treatment Period 2||1
7705902|NCT01763996|18974922|P1|NOT COMPLETED|Treatment Period 2||0
7705903|NCT01763996|18974921|P2|COMPLETED|Treatment Period 2||14
7705904|NCT01763996|18974922|P1|COMPLETED|Treatment Period 2||15
7705905|NCT01763996|18974921|P2|STARTED|Treatment Period 2||15
7705906|NCT01763996|18974922|P1|STARTED|Treatment Period 2||15
7705907|NCT01763996|18974921|P2|NOT COMPLETED|Treatment Period 1||0
7705908|NCT01763996|18974922|P1|NOT COMPLETED|Treatment Period 1||0
7705909|NCT01763996|18974921|P2|COMPLETED|Treatment Period 1||15
7705910|NCT01763996|18974922|P1|COMPLETED|Treatment Period 1||15
7705911|NCT01763996|18974921|P2|STARTED|Treatment Period 1||15
7705912|NCT01763996|18974922|P1|STARTED|Treatment Period 1||15
7705913|NCT01763970|18974948|P1|NOT COMPLETED|Overall Study||0
7705914|NCT01763970|18974948|P1|COMPLETED|Overall Study||14
7705915|NCT01763970|18974948|P1|STARTED|Overall Study||14
7705916|NCT01763931|18974963|P2|NOT COMPLETED|Overall Study||1
7705917|NCT01763931|18974964|P1|NOT COMPLETED|Overall Study||0
7705918|NCT01763931|18974963|P2|COMPLETED|Overall Study||3
7705919|NCT01763931|18974964|P1|COMPLETED|Overall Study||2
7705920|NCT01763931|18974963|P2|STARTED|Overall Study||4
7705921|NCT01763931|18974964|P1|STARTED|Overall Study||2
7705922|NCT01763918|18974976|P4|NOT COMPLETED|Overall Study||2
7705923|NCT01763918|18974977|P3|NOT COMPLETED|Overall Study||10
7705924|NCT01763918|18974978|P2|NOT COMPLETED|Overall Study||1
7705925|NCT01763918|18974979|P1|NOT COMPLETED|Overall Study||6
7705926|NCT01763918|18974976|P4|COMPLETED|Overall Study||108
7705927|NCT01763918|18974977|P3|COMPLETED|Overall Study||101
7705928|NCT01763918|18974978|P2|COMPLETED|Overall Study||54
7705929|NCT01763918|18974979|P1|COMPLETED|Overall Study||49
7705930|NCT01763918|18974976|P4|Received Treatment|Overall Study||110
7705931|NCT01763918|18974977|P3|Received Treatment|Overall Study||110
7705932|NCT01763918|18974978|P2|Received Treatment|Overall Study||55
7705933|NCT01763918|18974979|P1|Received Treatment|Overall Study||54
7705934|NCT01763918|18974976|P4|STARTED|Overall Study||110
7705935|NCT01763918|18974977|P3|STARTED|Overall Study||111
7705936|NCT01763918|18974978|P2|STARTED|Overall Study||55
7705937|NCT01763918|18974979|P1|STARTED|Overall Study||55
7705938|NCT01763905|18975077|P4|NOT COMPLETED|Overall Study||1
7705939|NCT01763905|18975078|P3|NOT COMPLETED|Overall Study||9
7705940|NCT01763905|18975079|P2|NOT COMPLETED|Overall Study||1
7705941|NCT01763905|18975080|P1|NOT COMPLETED|Overall Study||6
7705942|NCT01763905|18975077|P4|COMPLETED|Overall Study||101
7705943|NCT01763905|18975078|P3|COMPLETED|Overall Study||94
7705944|NCT01763905|18975079|P2|COMPLETED|Overall Study||50
7705945|NCT01763905|18975080|P1|COMPLETED|Overall Study||45
7705946|NCT01763905|18975077|P4|STARTED|Overall Study||102
7705947|NCT01763905|18975078|P3|STARTED|Overall Study||103
7705948|NCT01763905|18975079|P2|STARTED|Overall Study||51
7705949|NCT01763905|18975080|P1|STARTED|Overall Study||51
7705950|NCT01763866|18975198|P24|NOT COMPLETED|Overall Study||2
7705951|NCT01763866|18975199|P23|NOT COMPLETED|Overall Study||3
7705952|NCT01763866|18975200|P22|NOT COMPLETED|Overall Study||1
7705953|NCT01763866|18975201|P21|NOT COMPLETED|Overall Study||4
7705954|NCT01763866|18975202|P20|NOT COMPLETED|Overall Study||2
7705955|NCT01763866|18975203|P19|NOT COMPLETED|Overall Study||6
7705956|NCT01763866|18975204|P18|NOT COMPLETED|Overall Study||1
7705957|NCT01763866|18975205|P17|NOT COMPLETED|Overall Study||1
7705958|NCT01763866|18975206|P16|NOT COMPLETED|Overall Study||3
7705959|NCT01763866|18975207|P15|NOT COMPLETED|Overall Study||12
7705960|NCT01763866|18975208|P14|NOT COMPLETED|Overall Study||0
7705961|NCT01763866|18975209|P13|NOT COMPLETED|Overall Study||4
7705962|NCT01763866|18975210|P12|NOT COMPLETED|Overall Study||2
7705963|NCT01763866|18975211|P11|NOT COMPLETED|Overall Study||8
7705964|NCT01763866|18975212|P10|NOT COMPLETED|Overall Study||1
7705965|NCT01763866|18975213|P9|NOT COMPLETED|Overall Study||3
7705966|NCT01763866|18975214|P8|NOT COMPLETED|Overall Study||0
7705967|NCT01763866|18975215|P7|NOT COMPLETED|Overall Study||7
7705968|NCT01763866|18975216|P6|NOT COMPLETED|Overall Study||3
7705969|NCT01763866|18975217|P5|NOT COMPLETED|Overall Study||2
7705970|NCT01763866|18975218|P4|NOT COMPLETED|Overall Study||0
7705971|NCT01763866|18975219|P3|NOT COMPLETED|Overall Study||5
7705972|NCT01763866|18975220|P2|NOT COMPLETED|Overall Study||1
7705973|NCT01763866|18975221|P1|NOT COMPLETED|Overall Study||2
7705974|NCT01763866|18975198|P24|COMPLETED|Overall Study||113
7705975|NCT01763866|18975199|P23|COMPLETED|Overall Study||109
7705976|NCT01763866|18975200|P22|COMPLETED|Overall Study||54
7705977|NCT01763866|18975201|P21|COMPLETED|Overall Study||52
7705978|NCT01763866|18975202|P20|COMPLETED|Overall Study||110
7705979|NCT01763866|18975203|P19|COMPLETED|Overall Study||105
7705980|NCT01763866|18975204|P18|COMPLETED|Overall Study||55
7705981|NCT01763866|18975205|P17|COMPLETED|Overall Study||55
7705982|NCT01763866|18975206|P16|COMPLETED|Overall Study||112
7705983|NCT01763866|18975207|P15|COMPLETED|Overall Study||102
7705984|NCT01763866|18975208|P14|COMPLETED|Overall Study||57
7705985|NCT01763866|18975209|P13|COMPLETED|Overall Study||54
7705986|NCT01763866|18975210|P12|COMPLETED|Overall Study||108
7705987|NCT01763866|18975211|P11|COMPLETED|Overall Study||102
7705988|NCT01763866|18975212|P10|COMPLETED|Overall Study||53
7705989|NCT01763866|18975213|P9|COMPLETED|Overall Study||53
7705990|NCT01763866|18975214|P8|COMPLETED|Overall Study||55
7705991|NCT01763866|18975215|P7|COMPLETED|Overall Study||48
7705992|NCT01763866|18975216|P6|COMPLETED|Overall Study||107
7705993|NCT01763866|18975217|P5|COMPLETED|Overall Study||108
7705994|NCT01763866|18975218|P4|COMPLETED|Overall Study||55
7705995|NCT01763866|18975219|P3|COMPLETED|Overall Study||51
7705996|NCT01763866|18975220|P2|COMPLETED|Overall Study||54
7705997|NCT01763866|18975221|P1|COMPLETED|Overall Study||54
7705998|NCT01763866|18975198|P24|Received Treatment|Overall Study||115
7705999|NCT01763866|18975199|P23|Received Treatment|Overall Study||112
7706000|NCT01763866|18975200|P22|Received Treatment|Overall Study||55
7706001|NCT01763866|18975201|P21|Received Treatment|Overall Study||56
7706002|NCT01763866|18975202|P20|Received Treatment|Overall Study||112
7706003|NCT01763866|18975203|P19|Received Treatment|Overall Study||111
7706004|NCT01763866|18975204|P18|Received Treatment|Overall Study||55
7706005|NCT01763866|18975205|P17|Received Treatment|Overall Study||56
7706006|NCT01763866|18975206|P16|Received Treatment|Overall Study||115
7706007|NCT01763866|18975207|P15|Received Treatment|Overall Study||113
7706008|NCT01763866|18975208|P14|Received Treatment|Overall Study||57
7706009|NCT01763866|18975209|P13|Received Treatment|Overall Study||58
7706010|NCT01763866|18975210|P12|Received Treatment|Overall Study||110
7706011|NCT01763866|18975211|P11|Received Treatment|Overall Study||109
7706012|NCT01763866|18975212|P10|Received Treatment|Overall Study||54
7706013|NCT01763866|18975213|P9|Received Treatment|Overall Study||56
7706014|NCT01763866|18975214|P8|Received Treatment|Overall Study||55
7706015|NCT01763866|18975215|P7|Received Treatment|Overall Study||55
7706016|NCT01763866|18975216|P6|Received Treatment|Overall Study||110
7706017|NCT01763866|18975217|P5|Received Treatment|Overall Study||110
7706018|NCT01763866|18975218|P4|Received Treatment|Overall Study||55
7706019|NCT01763866|18975219|P3|Received Treatment|Overall Study||56
7706020|NCT01763866|18975220|P2|Received Treatment|Overall Study||55
7706021|NCT01763866|18975221|P1|Received Treatment|Overall Study||56
7706022|NCT01763866|18975198|P24|STARTED|Overall Study||115
7706023|NCT01763866|18975199|P23|STARTED|Overall Study||112
7706024|NCT01763866|18975200|P22|STARTED|Overall Study||55
7706025|NCT01763866|18975201|P21|STARTED|Overall Study||56
7706026|NCT01763866|18975202|P20|STARTED|Overall Study||112
7706027|NCT01763866|18975203|P19|STARTED|Overall Study||111
7706028|NCT01763866|18975204|P18|STARTED|Overall Study||56
7706029|NCT01763866|18975205|P17|STARTED|Overall Study||56
7706030|NCT01763866|18975206|P16|STARTED|Overall Study||115
7706031|NCT01763866|18975207|P15|STARTED|Overall Study||114
7706032|NCT01763866|18975208|P14|STARTED|Overall Study||57
7706033|NCT01763866|18975209|P13|STARTED|Overall Study||58
7706034|NCT01763866|18975210|P12|STARTED|Overall Study||110
7706035|NCT01763866|18975211|P11|STARTED|Overall Study||110
7706036|NCT01763866|18975212|P10|STARTED|Overall Study||54
7706037|NCT01763866|18975213|P9|STARTED|Overall Study||56
7706038|NCT01763866|18975214|P8|STARTED|Overall Study||55
7706039|NCT01763866|18975215|P7|STARTED|Overall Study||55
7706040|NCT01763866|18975216|P6|STARTED|Overall Study||110
7706041|NCT01763866|18975217|P5|STARTED|Overall Study||110
7706042|NCT01763866|18975218|P4|STARTED|Overall Study||55
7706043|NCT01763866|18975219|P3|STARTED|Overall Study||56
7706044|NCT01763866|18975220|P2|STARTED|Overall Study||55
7706045|NCT01763866|18975221|P1|STARTED|Overall Study||56
7706046|NCT01763827|18975781|P6|NOT COMPLETED|Overall Study||2
7706047|NCT01763827|18975782|P5|NOT COMPLETED|Overall Study||6
7706048|NCT01763827|18975783|P4|NOT COMPLETED|Overall Study||1
7706049|NCT01763827|18975784|P3|NOT COMPLETED|Overall Study||4
7706050|NCT01763827|18975785|P2|NOT COMPLETED|Overall Study||1
7706051|NCT01763827|18975786|P1|NOT COMPLETED|Overall Study||3
7706052|NCT01763827|18975781|P6|COMPLETED|Overall Study||151
7706053|NCT01763827|18975782|P5|COMPLETED|Overall Study||147
7706054|NCT01763827|18975783|P4|COMPLETED|Overall Study||76
7706055|NCT01763827|18975784|P3|COMPLETED|Overall Study||73
7706056|NCT01763827|18975785|P2|COMPLETED|Overall Study||77
7706057|NCT01763827|18975786|P1|COMPLETED|Overall Study||74
7706058|NCT01763827|18975781|P6|Received at Least 1 Dose of Study Drug|Overall Study||153
7706059|NCT01763827|18975782|P5|Received at Least 1 Dose of Study Drug|Overall Study||153
7706060|NCT01763827|18975783|P4|Received at Least 1 Dose of Study Drug|Overall Study||77
7706061|NCT01763827|18975784|P3|Received at Least 1 Dose of Study Drug|Overall Study||77
7706062|NCT01763827|18975785|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
7706063|NCT01763827|18975786|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
7706064|NCT01763827|18975781|P6|STARTED|Overall Study||153
7706065|NCT01763827|18975782|P5|STARTED|Overall Study||153
7706066|NCT01763827|18975783|P4|STARTED|Overall Study||77
7706067|NCT01763827|18975784|P3|STARTED|Overall Study||77
7706068|NCT01763827|18975785|P2|STARTED|Overall Study||78
7706069|NCT01763827|18975786|P1|STARTED|Overall Study||77
7706070|NCT01763788|18975930|P4|NOT COMPLETED|Overall Study||0
7706071|NCT01763788|18975931|P3|NOT COMPLETED|Overall Study||1
7706072|NCT01763788|18975932|P2|NOT COMPLETED|Overall Study||0
7706073|NCT01763788|18975933|P1|NOT COMPLETED|Overall Study||0
7706074|NCT01763788|18975930|P4|COMPLETED|Overall Study||92
7706075|NCT01763788|18975931|P3|COMPLETED|Overall Study||90
7706076|NCT01763788|18975932|P2|COMPLETED|Overall Study||6
7706077|NCT01763788|18975933|P1|COMPLETED|Overall Study||3
7706078|NCT01763788|18975930|P4|Received at Least 1dose of Study Drug|Overall Study||91
7706079|NCT01763788|18975931|P3|Received at Least 1dose of Study Drug|Overall Study||90
7706080|NCT01763788|18975932|P2|Received at Least 1dose of Study Drug|Overall Study||6
7706081|NCT01763788|18975933|P1|Received at Least 1dose of Study Drug|Overall Study||3
7706082|NCT01763788|18975930|P4|STARTED|Overall Study||92
7706083|NCT01763788|18975931|P3|STARTED|Overall Study||91
7706084|NCT01763788|18975932|P2|STARTED|Overall Study||6
7706085|NCT01763788|18975933|P1|STARTED|Overall Study||3
7706086|NCT01763645|18975969|P2|NOT COMPLETED|Overall Study||24
7706087|NCT01763645|18975970|P1|NOT COMPLETED|Overall Study||26
7706088|NCT01763645|18975969|P2|COMPLETED|Overall Study|Completed the study according the protocol.|45
7706089|NCT01763645|18975970|P1|COMPLETED|Overall Study|Completed the study according the protocol.|43
7706090|NCT01763645|18975969|P2|Received at Least 1 Dose of Study Drug|Overall Study||66
7706091|NCT01763645|18975970|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
7706092|NCT01763645|18975969|P2|STARTED|Overall Study||69
7706093|NCT01763645|18975970|P1|STARTED|Overall Study||69
7706094|NCT01763606|18975990|P2|NOT COMPLETED|Overall Study||0
7706095|NCT01763606|18975991|P1|NOT COMPLETED|Overall Study||0
7706096|NCT01763606|18975990|P2|COMPLETED|Overall Study||10
7706097|NCT01763606|18975991|P1|COMPLETED|Overall Study||10
7706098|NCT01763606|18975990|P2|STARTED|Overall Study||10
7706099|NCT01763606|18975991|P1|STARTED|Overall Study||10
7706100|NCT01763567|18976000|P1|NOT COMPLETED|Overall Study||0
7706101|NCT01763567|18976000|P1|COMPLETED|Overall Study||19
7706102|NCT01763567|18976000|P1|STARTED|Overall Study||19
7706103|NCT01763346|18976010|P2|NOT COMPLETED|Overall Study||8
7706104|NCT01763346|18976011|P1|NOT COMPLETED|Overall Study||10
7706105|NCT01763346|18976010|P2|COMPLETED|Overall Study||36
7706106|NCT01763346|18976011|P1|COMPLETED|Overall Study||34
7706107|NCT01763346|18976010|P2|Received Intervention|Overall Study||38
7706108|NCT01763346|18976011|P1|Received Intervention|Overall Study||39
7706109|NCT01763346|18976010|P2|STARTED|Overall Study|"Six subjects randomized to gastric banding refused the banding surgery and, thus, did not start"|44
7706110|NCT01763346|18976011|P1|STARTED|Overall Study|"Five subjects who enrolled in the study refused to initiate metformin therapy, thus did not start"|44
7706111|NCT01763333|18976035|P14|NOT COMPLETED|Overall Study||0
7706112|NCT01763333|18976036|P13|NOT COMPLETED|Overall Study||0
7706113|NCT01763333|18976037|P12|NOT COMPLETED|Overall Study||0
7706114|NCT01763333|18976038|P11|NOT COMPLETED|Overall Study||0
7706115|NCT01763333|18976039|P10|NOT COMPLETED|Overall Study||0
7706116|NCT01763333|18976040|P9|NOT COMPLETED|Overall Study||0
7706117|NCT01763333|18976041|P8|NOT COMPLETED|Overall Study||0
7706118|NCT01763333|18976042|P7|NOT COMPLETED|Overall Study||0
7706119|NCT01763333|18976043|P6|NOT COMPLETED|Overall Study||0
7706120|NCT01763333|18976044|P5|NOT COMPLETED|Overall Study||0
7706121|NCT01763333|18976045|P4|NOT COMPLETED|Overall Study||0
7706122|NCT01763333|18976046|P3|NOT COMPLETED|Overall Study||0
7706123|NCT01763333|18976047|P2|NOT COMPLETED|Overall Study||0
7706124|NCT01763333|18976048|P1|NOT COMPLETED|Overall Study||0
7706125|NCT01763333|18976035|P14|COMPLETED|Overall Study||3
7706126|NCT01763333|18976036|P13|COMPLETED|Overall Study||3
7706127|NCT01763333|18976037|P12|COMPLETED|Overall Study||3
7706128|NCT01763333|18976038|P11|COMPLETED|Overall Study||3
7706129|NCT01763333|18976039|P10|COMPLETED|Overall Study||18
7706130|NCT01763333|18976040|P9|COMPLETED|Overall Study||5
7706131|NCT01763333|18976041|P8|COMPLETED|Overall Study||6
7706132|NCT01763333|18976042|P7|COMPLETED|Overall Study||5
7706133|NCT01763333|18976043|P6|COMPLETED|Overall Study||6
7706134|NCT01763333|18976044|P5|COMPLETED|Overall Study||4
7706135|NCT01763333|18976045|P4|COMPLETED|Overall Study||6
7706136|NCT01763333|18976046|P3|COMPLETED|Overall Study||6
7706137|NCT01763333|18976047|P2|COMPLETED|Overall Study||6
7706138|NCT01763333|18976048|P1|COMPLETED|Overall Study||6
7706139|NCT01763333|18976035|P14|STARTED|Overall Study||3
7706140|NCT01763333|18976036|P13|STARTED|Overall Study||3
7706141|NCT01763333|18976037|P12|STARTED|Overall Study||3
7706142|NCT01763333|18976038|P11|STARTED|Overall Study||3
7706143|NCT01763333|18976039|P10|STARTED|Overall Study||18
7706144|NCT01763333|18976040|P9|STARTED|Overall Study||5
7706145|NCT01763333|18976041|P8|STARTED|Overall Study||6
7706146|NCT01763333|18976042|P7|STARTED|Overall Study||5
7706147|NCT01763333|18976043|P6|STARTED|Overall Study||6
7706148|NCT01763333|18976044|P5|STARTED|Overall Study||4
7706149|NCT01763333|18976045|P4|STARTED|Overall Study||6
7706150|NCT01763333|18976046|P3|STARTED|Overall Study||6
7706151|NCT01763333|18976047|P2|STARTED|Overall Study||6
7706152|NCT01763333|18976048|P1|STARTED|Overall Study||6
7706153|NCT01763203|18976154|P2|NOT COMPLETED|Overall Study||42
7706154|NCT01763203|18976155|P1|NOT COMPLETED|Overall Study||33
7706155|NCT01763203|18976154|P2|COMPLETED|Overall Study||204
7706156|NCT01763203|18976155|P1|COMPLETED|Overall Study||208
7706157|NCT01763203|18976154|P2|STARTED|Overall Study||246
7706158|NCT01763203|18976155|P1|STARTED|Overall Study||241
7706159|NCT01763047|18976201|P2|NOT COMPLETED|Period 2||5
7706160|NCT01763047|18976202|P1|NOT COMPLETED|Period 2||4
7706161|NCT01763047|18976201|P2|COMPLETED|Period 2||121
7706162|NCT01763047|18976202|P1|COMPLETED|Period 2||126
7706163|NCT01763047|18976201|P2|Hyperopes|Period 2||54
7706164|NCT01763047|18976202|P1|Hyperopes|Period 2||56
7706165|NCT01763047|18976201|P2|Myopes|Period 2||72
7706166|NCT01763047|18976202|P1|Myopes|Period 2||74
7706167|NCT01763047|18976201|P2|STARTED|Period 2||126
7706168|NCT01763047|18976202|P1|STARTED|Period 2||130
7706169|NCT01763047|18976201|P2|NOT COMPLETED|Period 1||11
7706170|NCT01763047|18976202|P1|NOT COMPLETED|Period 1||9
7706171|NCT01763047|18976201|P2|COMPLETED|Period 1||126
7706172|NCT01763047|18976202|P1|COMPLETED|Period 1||130
7706173|NCT01763047|18976201|P2|Hyperopes|Period 1||61
7706174|NCT01763047|18976202|P1|Hyperopes|Period 1||62
7706175|NCT01763047|18976201|P2|Myopes|Period 1||76
7706176|NCT01763047|18976202|P1|Myopes|Period 1||77
7706177|NCT01763047|18976201|P2|STARTED|Period 1||137
7706178|NCT01763047|18976202|P1|STARTED|Period 1||139
7706179|NCT01762982|18976218|P1|NOT COMPLETED|Overall Study||0
7706180|NCT01762982|18976218|P1|COMPLETED|Overall Study||36
7706181|NCT01762982|18976218|P1|Received Empty Finn Chamber|Overall Study||36
7706182|NCT01762982|18976218|P1|Received SLS|Overall Study||36
7706183|NCT01762982|18976218|P1|Received Benzalkonium Chloride|Overall Study||36
7706184|NCT01762982|18976218|P1|Received Saline Water|Overall Study||36
7706185|NCT01762982|18976218|P1|STARTED|Overall Study||36
7706186|NCT01762943|18976241|P2|NOT COMPLETED|Overall Study||2
7706187|NCT01762943|18976242|P1|NOT COMPLETED|Overall Study||4
7706188|NCT01762943|18976241|P2|COMPLETED|Overall Study||15
7706189|NCT01762943|18976242|P1|COMPLETED|Overall Study||15
7706190|NCT01762943|18976241|P2|Withdrawal|Overall Study||15
7706191|NCT01762943|18976242|P1|Withdrawal|Overall Study||15
7706192|NCT01762943|18976241|P2|Addback|Overall Study||15
7706193|NCT01762943|18976242|P1|Addback|Overall Study||16
7706194|NCT01762943|18976241|P2|Hypogonadism|Overall Study||15
7706195|NCT01762943|18976242|P1|Hypogonadism|Overall Study||18
7706196|NCT01762943|18976241|P2|STARTED|Overall Study||17
7706197|NCT01762943|18976242|P1|STARTED|Overall Study||19
7706198|NCT01762904|18976250|P1|NOT COMPLETED|Overall Study||0
7706199|NCT01762904|18976250|P1|COMPLETED|Overall Study|October, 2013|135
7706200|NCT01762904|18976250|P1|STARTED|Overall Study|January, 2013|135
7706201|NCT01762800|18976259|P2|NOT COMPLETED|Overall Study||21
7706202|NCT01762800|18976260|P1|NOT COMPLETED|Overall Study||19
7706203|NCT01762800|18976259|P2|COMPLETED|Overall Study||183
7706204|NCT01762800|18976260|P1|COMPLETED|Overall Study||183
7706205|NCT01762800|18976259|P2|STARTED|Overall Study||204
7706206|NCT01762800|18976260|P1|STARTED|Overall Study||202
7706207|NCT01762761|18976334|P2|NOT COMPLETED|Overall Study||65
7706208|NCT01762761|18976335|P1|NOT COMPLETED|Overall Study||39
7706209|NCT01762761|18976334|P2|COMPLETED|Overall Study||39
7706210|NCT01762761|18976335|P1|COMPLETED|Overall Study||12
7706211|NCT01762761|18976334|P2|STARTED|Overall Study||104
7706212|NCT01762761|18976335|P1|STARTED|Overall Study||51
7706213|NCT01762722|18976391|P2|NOT COMPLETED|Overall Study||0
7706214|NCT01762722|18976392|P1|NOT COMPLETED|Overall Study||0
7706215|NCT01762722|18976391|P2|COMPLETED|Overall Study||11
7706216|NCT01762722|18976392|P1|COMPLETED|Overall Study||12
7706217|NCT01762722|18976391|P2|STARTED|Overall Study||11
7706218|NCT01762722|18976392|P1|STARTED|Overall Study||12
7706219|NCT01762631|18976400|P2|NOT COMPLETED|Overall Study||0
7706220|NCT01762631|18976401|P1|NOT COMPLETED|Overall Study||0
7706221|NCT01762631|18976400|P2|COMPLETED|Overall Study||22
7706222|NCT01762631|18976401|P1|COMPLETED|Overall Study||53
7706223|NCT01762631|18976400|P2|STARTED|Overall Study||22
7706224|NCT01762631|18976401|P1|STARTED|Overall Study||53
7706225|NCT01762501|18976419|P2|NOT COMPLETED|Overall Study||23
7706226|NCT01762501|18976420|P1|NOT COMPLETED|Overall Study||27
7706227|NCT01762501|18976419|P2|COMPLETED|Overall Study||336
7706228|NCT01762501|18976420|P1|COMPLETED|Overall Study||332
7706229|NCT01762501|18976419|P2|STARTED|Overall Study||359
7706230|NCT01762501|18976420|P1|STARTED|Overall Study||359
7706231|NCT01762345|18976434|P1|NOT COMPLETED|Overall Study||7
7706232|NCT01762345|18976434|P1|COMPLETED|Overall Study||76
7706233|NCT01762345|18976434|P1|STARTED|Overall Study||83
7706234|NCT01762059|18976444|P1|NOT COMPLETED|Overall Study||0
7706235|NCT01762059|18976444|P1|COMPLETED|Overall Study||20
7706236|NCT01762059|18976444|P1|STARTED|Overall Study||20
7706237|NCT01761747|18976471|P1|NOT COMPLETED|Overall Study||1
7706238|NCT01761747|18976471|P1|COMPLETED|Overall Study||2
7706239|NCT01761747|18976471|P1|STARTED|Overall Study||3
7706240|NCT01761643|18976484|P2|NOT COMPLETED|Overall Study||42
7706241|NCT01761643|18976485|P1|NOT COMPLETED|Overall Study||32
7706242|NCT01761643|18976484|P2|COMPLETED|Overall Study||158
7706243|NCT01761643|18976485|P1|COMPLETED|Overall Study||166
7706244|NCT01761643|18976484|P2|STARTED|Overall Study||200
7706245|NCT01761643|18976485|P1|STARTED|Overall Study||198
7706246|NCT01761565|18976495|P1|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1
7706247|NCT01761565|18976495|P1|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38
7706248|NCT01761565|18976495|P1|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39
7706249|NCT01761565|18976495|P1|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0
7706250|NCT01761565|18976495|P1|COMPLETED|Single Dose of SUF NT 15 mcg||40
7706251|NCT01761565|18976495|P1|STARTED|Single Dose of SUF NT 15 mcg||40
7706252|NCT01761292|18976507|P1|NOT COMPLETED|Extension 3||0
7706253|NCT01761292|18976507|P1|COMPLETED|Extension 3||18
7706254|NCT01761292|18976507|P1|STARTED|Extension 3||18
7706255|NCT01761292|18976507|P1|NOT COMPLETED|Extension 2||0
7706256|NCT01761292|18976507|P1|COMPLETED|Extension 2||18
7706257|NCT01761292|18976507|P1|STARTED|Extension 2||18
7706258|NCT01761292|18976507|P1|NOT COMPLETED|Extension 1||1
7706259|NCT01761292|18976507|P1|COMPLETED|Extension 1||18
7706260|NCT01761292|18976507|P1|STARTED|Extension 1||19
7706261|NCT01761292|18976507|P1|NOT COMPLETED|Part 2||0
7706262|NCT01761292|18976507|P1|COMPLETED|Part 2||19
7706263|NCT01761292|18976507|P1|STARTED|Part 2|1 pt was enrolled in Part 1 but started the treatment in Part 2. So 19 pts started Part 2.|19
7706264|NCT01761292|18976507|P1|NOT COMPLETED|Part 1||2
7706265|NCT01761292|18976507|P1|COMPLETED|Part 1||18
7706266|NCT01761292|18976507|P1|Patients Receiving Drug in Part 1|Part 1|One patient was enrolled in Part 1 and started treatment in Part 2.|19
7706267|NCT01761292|18976507|P1|STARTED|Part 1||20
7706268|NCT01761279|18976526|P1|NOT COMPLETED|Overall Study||0
7706269|NCT01761279|18976526|P1|COMPLETED|Overall Study||84
7706270|NCT01761279|18976526|P1|STARTED|Overall Study||84
7706271|NCT01761266|18976541|P2|NOT COMPLETED|Overall Study||476
7706272|NCT01761266|18976542|P1|NOT COMPLETED|Overall Study||478
7706273|NCT01761266|18976541|P2|COMPLETED|Overall Study||0
7706274|NCT01761266|18976542|P1|COMPLETED|Overall Study||0
7706275|NCT01761266|18976541|P2|Treated|Overall Study||475
7706276|NCT01761266|18976542|P1|Treated|Overall Study||476
7706277|NCT01761266|18976541|P2|STARTED|Overall Study||476
7706278|NCT01761266|18976542|P1|STARTED|Overall Study||478
7706279|NCT01761175|18976570|P2|NOT COMPLETED|Overall Study||0
7706280|NCT01761175|18976571|P1|NOT COMPLETED|Overall Study||0
7706281|NCT01761175|18976570|P2|COMPLETED|Overall Study||112
7706282|NCT01761175|18976571|P1|COMPLETED|Overall Study||112
7706283|NCT01761175|18976570|P2|STARTED|Overall Study||112
7706284|NCT01761175|18976571|P1|STARTED|Overall Study||112
7706285|NCT01761162|18976599|P1|NOT COMPLETED|Overall Study||3
7706286|NCT01761162|18976599|P1|COMPLETED|Overall Study||226
7706287|NCT01761162|18976599|P1|STARTED|Overall Study||229
7706288|NCT01761084|18976609|P2|NOT COMPLETED|Overall Study||6
7706289|NCT01761084|18976610|P1|NOT COMPLETED|Overall Study||5
7706290|NCT01761084|18976609|P2|COMPLETED|Overall Study||64
7706291|NCT01761084|18976610|P1|COMPLETED|Overall Study||66
7706292|NCT01761084|18976609|P2|STARTED|Overall Study||70
7706293|NCT01761084|18976610|P1|STARTED|Overall Study||71
7706294|NCT01761019|18976659|P1|NOT COMPLETED|Overall Study||0
7706295|NCT01761019|18976659|P1|COMPLETED|Overall Study||8
7706296|NCT01761019|18976659|P1|STARTED|Overall Study||8
7706297|NCT01760993|18976667|P1|NOT COMPLETED|Overall Study||0
7706298|NCT01760993|18976667|P1|COMPLETED|Overall Study||0
7706299|NCT01760993|18976667|P1|STARTED|Overall Study||0
7706300|NCT01760954|18976688|P4|NOT COMPLETED|Post-treatment Follow-up (12 Months)||20
7706301|NCT01760954|18976689|P3|NOT COMPLETED|Post-treatment Follow-up (12 Months)||21
7706302|NCT01760954|18976690|P2|NOT COMPLETED|Post-treatment Follow-up (12 Months)||35
7706303|NCT01760954|18976691|P1|NOT COMPLETED|Post-treatment Follow-up (12 Months)||30
7706304|NCT01760954|18976688|P4|COMPLETED|Post-treatment Follow-up (12 Months)||67
7706305|NCT01760954|18976689|P3|COMPLETED|Post-treatment Follow-up (12 Months)||65
7706306|NCT01760954|18976690|P2|COMPLETED|Post-treatment Follow-up (12 Months)||83
7706307|NCT01760954|18976691|P1|COMPLETED|Post-treatment Follow-up (12 Months)||96
7706308|NCT01760954|18976688|P4|STARTED|Post-treatment Follow-up (12 Months)||87
7706309|NCT01760954|18976689|P3|STARTED|Post-treatment Follow-up (12 Months)||86
7706310|NCT01760954|18976690|P2|STARTED|Post-treatment Follow-up (12 Months)||118
7706311|NCT01760954|18976691|P1|STARTED|Post-treatment Follow-up (12 Months)||126
7706312|NCT01760954|18976688|P4|NOT COMPLETED|Treatment Period (6 Months)||26
7706313|NCT01760954|18976689|P3|NOT COMPLETED|Treatment Period (6 Months)||21
7706314|NCT01760954|18976690|P2|NOT COMPLETED|Treatment Period (6 Months)||28
7706315|NCT01760954|18976691|P1|NOT COMPLETED|Treatment Period (6 Months)||33
7706316|NCT01760954|18976688|P4|COMPLETED|Treatment Period (6 Months)||83
7706317|NCT01760954|18976689|P3|COMPLETED|Treatment Period (6 Months)||87
7706318|NCT01760954|18976690|P2|COMPLETED|Treatment Period (6 Months)||110
7706319|NCT01760954|18976691|P1|COMPLETED|Treatment Period (6 Months)||116
7706320|NCT01760954|18976688|P4|STARTED|Treatment Period (6 Months)||109
7706321|NCT01760954|18976689|P3|STARTED|Treatment Period (6 Months)||108
7706322|NCT01760954|18976690|P2|STARTED|Treatment Period (6 Months)||138
7706323|NCT01760954|18976691|P1|STARTED|Treatment Period (6 Months)||149
7706324|NCT01760941|18976769|P1|NOT COMPLETED|Overall Study||0
7706325|NCT01760941|18976769|P1|COMPLETED|Overall Study||1
7706326|NCT01760941|18976769|P1|STARTED|Overall Study||1
7706327|NCT01760889|18976779|P3|NOT COMPLETED|Overall Study||0
7706328|NCT01760889|18976780|P2|NOT COMPLETED|Overall Study||0
7706329|NCT01760889|18976781|P1|NOT COMPLETED|Overall Study||0
7706330|NCT01760889|18976779|P3|COMPLETED|Overall Study||0
7706331|NCT01760889|18976780|P2|COMPLETED|Overall Study||0
7706332|NCT01760889|18976781|P1|COMPLETED|Overall Study||0
7706333|NCT01760889|18976779|P3|STARTED|Overall Study||0
7706334|NCT01760889|18976780|P2|STARTED|Overall Study||0
7706335|NCT01760889|18976781|P1|STARTED|Overall Study||0
7706336|NCT01760876|18976828|P1|NOT COMPLETED|Overall Study||6
7706337|NCT01760876|18976828|P1|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100
7706338|NCT01760876|18976828|P1|STARTED|Overall Study||106
7706339|NCT01760785|18976834|P2|NOT COMPLETED|Overall Study||0
7706340|NCT01760785|18976835|P1|NOT COMPLETED|Overall Study||0
7706341|NCT01760785|18976834|P2|COMPLETED|Overall Study||27
7706342|NCT01760785|18976835|P1|COMPLETED|Overall Study||23
7706343|NCT01760785|18976834|P2|STARTED|Overall Study||27
7706344|NCT01760785|18976835|P1|STARTED|Overall Study||23
7706345|NCT01760733|18976843|P1|NOT COMPLETED|Transplanted||217
7706346|NCT01760733|18976843|P1|COMPLETED|Transplanted||0
7706347|NCT01760733|18976843|P1|STARTED|Transplanted||217
7706348|NCT01760733|18976843|P1|NOT COMPLETED|Waiting List||72
7706349|NCT01760733|18976843|P1|COMPLETED|Waiting List|217 patients have been transplanted|217
7706350|NCT01760733|18976843|P1|STARTED|Waiting List|All patients included started in the waiting list group.|289
7706351|NCT01760473|18976848|P1|NOT COMPLETED|Overall Study||15
7706352|NCT01760473|18976848|P1|COMPLETED|Overall Study||12
7706353|NCT01760473|18976848|P1|STARTED|Overall Study||27
7706354|NCT01760447|18976873|P4|NOT COMPLETED|Weeks 20-54||4
7706355|NCT01760447|18976874|P3|NOT COMPLETED|Weeks 20-54||3
7706356|NCT01760447|18976875|P2|NOT COMPLETED|Weeks 20-54||2
7706357|NCT01760447|18976876|P1|NOT COMPLETED|Weeks 20-54||3
7706358|NCT01760447|18976873|P4|COMPLETED|Weeks 20-54||43
7706359|NCT01760447|18976874|P3|COMPLETED|Weeks 20-54||39
7706360|NCT01760447|18976875|P2|COMPLETED|Weeks 20-54||28
7706361|NCT01760447|18976876|P1|COMPLETED|Weeks 20-54||25
7706362|NCT01760447|18976873|P4|STARTED|Weeks 20-54||47
7706363|NCT01760447|18976874|P3|STARTED|Weeks 20-54||42
7706364|NCT01760447|18976875|P2|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|30
7706365|NCT01760447|18976876|P1|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|28
7706366|NCT01760447|18976873|P4|NOT COMPLETED|Weeks 0-20||4
7706367|NCT01760447|18976874|P3|NOT COMPLETED|Weeks 0-20||5
7706368|NCT01760447|18976875|P2|NOT COMPLETED|Weeks 0-20||0
7706369|NCT01760447|18976876|P1|NOT COMPLETED|Weeks 0-20||3
7706370|NCT01760447|18976873|P4|COMPLETED|Weeks 0-20||47
7706371|NCT01760447|18976874|P3|COMPLETED|Weeks 0-20||42
7706372|NCT01760447|18976875|P2|COMPLETED|Weeks 0-20||62
7706373|NCT01760447|18976876|P1|COMPLETED|Weeks 0-20||59
7706374|NCT01760447|18976873|P4|Treated|Weeks 0-20||51
7706375|NCT01760447|18976874|P3|Treated|Weeks 0-20||45
7706376|NCT01760447|18976875|P2|Treated|Weeks 0-20||62
7706377|NCT01760447|18976876|P1|Treated|Weeks 0-20||62
7706378|NCT01760447|18976873|P4|STARTED|Weeks 0-20||51
7706379|NCT01760447|18976874|P3|STARTED|Weeks 0-20||47
7706380|NCT01760447|18976875|P2|STARTED|Weeks 0-20||62
7706476|NCT01759251|18977382|P1|COMPLETED|30 Days Treatment Period||305
7706381|NCT01760447|18976876|P1|STARTED|Weeks 0-20|The first randomization for the participant who withdrew and re-randomized is not counted in the 62.|62
7706382|NCT01760304|18976936|P2|NOT COMPLETED|Overall Study||0
7706383|NCT01760304|18976937|P1|NOT COMPLETED|Overall Study||0
7706384|NCT01760304|18976936|P2|COMPLETED|Overall Study||3
7706385|NCT01760304|18976937|P1|COMPLETED|Overall Study||2
7706386|NCT01760304|18976936|P2|STARTED|Overall Study||3
7706387|NCT01760304|18976937|P1|STARTED|Overall Study||2
7706388|NCT01760239|18976949|P2|NOT COMPLETED|Overall Study||14316
7706389|NCT01760239|18976950|P1|NOT COMPLETED|Overall Study||16741
7706390|NCT01760239|18976949|P2|COMPLETED|Overall Study||226
7706391|NCT01760239|18976950|P1|COMPLETED|Overall Study||296
7706392|NCT01760239|18976949|P2|STARTED|Overall Study||14542
7706393|NCT01760239|18976950|P1|STARTED|Overall Study||17037
7706394|NCT01760187|18976970|P5|NOT COMPLETED|Overall Study||0
7706395|NCT01760187|18976971|P4|NOT COMPLETED|Overall Study||2
7706396|NCT01760187|18976972|P3|NOT COMPLETED|Overall Study||0
7706397|NCT01760187|18976973|P2|NOT COMPLETED|Overall Study||0
7706398|NCT01760187|18976974|P1|NOT COMPLETED|Overall Study||1
7706399|NCT01760187|18976970|P5|COMPLETED|Overall Study||16
7706400|NCT01760187|18976971|P4|COMPLETED|Overall Study||10
7706401|NCT01760187|18976972|P3|COMPLETED|Overall Study||12
7706402|NCT01760187|18976973|P2|COMPLETED|Overall Study||12
7706403|NCT01760187|18976974|P1|COMPLETED|Overall Study||19
7706404|NCT01760187|18976970|P5|STARTED|Overall Study||16
7706405|NCT01760187|18976971|P4|STARTED|Overall Study||12
7706406|NCT01760187|18976972|P3|STARTED|Overall Study||12
7706407|NCT01760187|18976973|P2|STARTED|Overall Study||12
7706408|NCT01760187|18976974|P1|STARTED|Overall Study||20
7706409|NCT01759862|18977204|P2|NOT COMPLETED|Overall Study||2
7706410|NCT01759862|18977205|P1|NOT COMPLETED|Overall Study||3
7706411|NCT01759862|18977204|P2|COMPLETED|Overall Study||25
7706412|NCT01759862|18977205|P1|COMPLETED|Overall Study||20
7706413|NCT01759862|18977204|P2|STARTED|Overall Study||27
7706414|NCT01759862|18977205|P1|STARTED|Overall Study||23
7706415|NCT01759602|18977215|P1|NOT COMPLETED|Overall Study||0
7706416|NCT01759602|18977215|P1|COMPLETED|Overall Study||10
7706417|NCT01759602|18977215|P1|STARTED|Overall Study||10
7706418|NCT01759511|18977223|P1|NOT COMPLETED|Overall Study||34
7706419|NCT01759511|18977223|P1|COMPLETED|Overall Study||0
7706420|NCT01759511|18977223|P1|STARTED|Overall Study||34
7706421|NCT01759446|18977236|P5|NOT COMPLETED|Overall Study||0
7706422|NCT01759446|18977237|P4|NOT COMPLETED|Overall Study||1
7706423|NCT01759446|18977238|P3|NOT COMPLETED|Overall Study||1
7706424|NCT01759446|18977239|P2|NOT COMPLETED|Overall Study||1
7706425|NCT01759446|18977240|P1|NOT COMPLETED|Overall Study||1
7706426|NCT01759446|18977236|P5|COMPLETED|Overall Study||8
7706427|NCT01759446|18977237|P4|COMPLETED|Overall Study||8
7706428|NCT01759446|18977238|P3|COMPLETED|Overall Study||8
7706429|NCT01759446|18977239|P2|COMPLETED|Overall Study||8
7706430|NCT01759446|18977240|P1|COMPLETED|Overall Study||8
7706431|NCT01759446|18977236|P5|STARTED|Overall Study||8
7706432|NCT01759446|18977237|P4|STARTED|Overall Study||9
7706433|NCT01759446|18977238|P3|STARTED|Overall Study||9
7706434|NCT01759446|18977239|P2|STARTED|Overall Study||9
7706435|NCT01759446|18977240|P1|STARTED|Overall Study||9
7706436|NCT01759420|18977252|P1|NOT COMPLETED|Overall Study||6
7706437|NCT01759420|18977252|P1|COMPLETED|Overall Study||22
7706438|NCT01759420|18977252|P1|STARTED|Overall Study||28
7706439|NCT01759407|18977259|P2|NOT COMPLETED|Overall Study||2
7706440|NCT01759407|18977260|P1|NOT COMPLETED|Overall Study||0
7706441|NCT01759407|18977259|P2|COMPLETED|Overall Study||7
7706442|NCT01759407|18977260|P1|COMPLETED|Overall Study||10
7706443|NCT01759407|18977259|P2|STARTED|Overall Study||9
7706444|NCT01759407|18977260|P1|STARTED|Overall Study||10
7706445|NCT01759381|18977272|P2|NOT COMPLETED|Overall Study||0
7706446|NCT01759381|18977273|P1|NOT COMPLETED|Overall Study||1
7706447|NCT01759381|18977272|P2|COMPLETED|Overall Study||11
7706448|NCT01759381|18977273|P1|COMPLETED|Overall Study||7
7706449|NCT01759381|18977272|P2|STARTED|Overall Study||11
7706450|NCT01759381|18977273|P1|STARTED|Overall Study||8
7706451|NCT01759368|18977281|P2|NOT COMPLETED|Overall Study||0
7706452|NCT01759368|18977282|P1|NOT COMPLETED|Overall Study||1
7706453|NCT01759368|18977281|P2|COMPLETED|Overall Study||47
7706454|NCT01759368|18977282|P1|COMPLETED|Overall Study||46
7706455|NCT01759368|18977281|P2|STARTED|Overall Study||47
7706456|NCT01759368|18977282|P1|STARTED|Overall Study||47
7706457|NCT01759290|18977300|P1|NOT COMPLETED|Overall Study||81
7706458|NCT01759290|18977300|P1|COMPLETED|Overall Study||1719
7706459|NCT01759290|18977300|P1|STARTED|Overall Study||1800
7706460|NCT01759277|18977362|P2|NOT COMPLETED|Overall Study||0
7706461|NCT01759277|18977363|P1|NOT COMPLETED|Overall Study||0
7706462|NCT01759277|18977362|P2|COMPLETED|Overall Study||39
7706463|NCT01759277|18977363|P1|COMPLETED|Overall Study||41
7706464|NCT01759277|18977362|P2|STARTED|Overall Study||39
7706465|NCT01759277|18977363|P1|STARTED|Overall Study||41
7706466|NCT01759264|18977369|P1|NOT COMPLETED|Overall Study||10
7706467|NCT01759264|18977369|P1|COMPLETED|Overall Study||91
7706468|NCT01759264|18977369|P1|STARTED|Overall Study||101
7706469|NCT01759251|18977382|P1|NOT COMPLETED|Follow-up Period||0
7706470|NCT01759251|18977382|P1|COMPLETED|Follow-up Period||305
7706471|NCT01759251|18977382|P1|STARTED|Follow-up Period||305
7706472|NCT01759251|18977382|P1|NOT COMPLETED|60 Days Treatment Period||0
7706473|NCT01759251|18977382|P1|COMPLETED|60 Days Treatment Period||305
7706474|NCT01759251|18977382|P1|STARTED|60 Days Treatment Period||305
7706475|NCT01759251|18977382|P1|NOT COMPLETED|30 Days Treatment Period||4
7706477|NCT01759251|18977382|P1|STARTED|30 Days Treatment Period||309
7706478|NCT01759160|18977388|P2|NOT COMPLETED|Overall Study||0
7706479|NCT01759160|18977389|P1|NOT COMPLETED|Overall Study||0
7706480|NCT01759160|18977388|P2|COMPLETED|Overall Study||30
7706481|NCT01759160|18977389|P1|COMPLETED|Overall Study||30
7706482|NCT01759160|18977388|P2|STARTED|Overall Study||30
7706483|NCT01759160|18977389|P1|STARTED|Overall Study||30
7706484|NCT01758900|18977397|P2|NOT COMPLETED|Overall Study||8
7706485|NCT01758900|18977398|P1|NOT COMPLETED|Overall Study||7
7706486|NCT01758900|18977397|P2|COMPLETED|Overall Study||100
7706487|NCT01758900|18977398|P1|COMPLETED|Overall Study||99
7706488|NCT01758900|18977397|P2|STARTED|Overall Study||108
7706489|NCT01758900|18977398|P1|STARTED|Overall Study||106
7706490|NCT01758731|18977416|P1|NOT COMPLETED|Overall Study||1
7706491|NCT01758731|18977416|P1|COMPLETED|Overall Study||16
7706492|NCT01758731|18977416|P1|STARTED|Overall Study||17
7706493|NCT01758588|18977422|P2|NOT COMPLETED|Overall Study||0
7706494|NCT01758588|18977423|P1|NOT COMPLETED|Overall Study||0
7706495|NCT01758588|18977422|P2|COMPLETED|Overall Study||3
7706496|NCT01758588|18977423|P1|COMPLETED|Overall Study||5
7706497|NCT01758588|18977422|P2|STARTED|Overall Study||3
7706498|NCT01758588|18977423|P1|STARTED|Overall Study||5
7706499|NCT01758523|18977435|P2|NOT COMPLETED|Overall Study||14
7706500|NCT01758523|18977436|P1|NOT COMPLETED|Overall Study||21
7706501|NCT01758523|18977435|P2|COMPLETED|Overall Study||54
7706502|NCT01758523|18977436|P1|COMPLETED|Overall Study||53
7706503|NCT01758523|18977435|P2|Attended >/= 1 Visit Post-randomization|Overall Study||67
7706504|NCT01758523|18977436|P1|Attended >/= 1 Visit Post-randomization|Overall Study||68
7706505|NCT01758523|18977435|P2|STARTED|Overall Study||68
7706506|NCT01758523|18977436|P1|STARTED|Overall Study||74
7706507|NCT01758432|18977461|P7|NOT COMPLETED|Overall Study||0
7706508|NCT01758432|18977462|P6|NOT COMPLETED|Overall Study||0
7706509|NCT01758432|18977463|P5|NOT COMPLETED|Overall Study||0
7706510|NCT01758432|18977464|P4|NOT COMPLETED|Overall Study||0
7706511|NCT01758432|18977465|P3|NOT COMPLETED|Overall Study||0
7706512|NCT01758432|18977466|P2|NOT COMPLETED|Overall Study||0
7706513|NCT01758432|18977467|P1|NOT COMPLETED|Overall Study||0
7706514|NCT01758432|18977461|P7|COMPLETED|Overall Study||6
7706515|NCT01758432|18977462|P6|COMPLETED|Overall Study||6
7706516|NCT01758432|18977463|P5|COMPLETED|Overall Study||6
7706517|NCT01758432|18977464|P4|COMPLETED|Overall Study||6
7706518|NCT01758432|18977465|P3|COMPLETED|Overall Study||6
7706519|NCT01758432|18977466|P2|COMPLETED|Overall Study||6
7706520|NCT01758432|18977467|P1|COMPLETED|Overall Study||18
7706521|NCT01758432|18977461|P7|STARTED|Overall Study||6
7706522|NCT01758432|18977462|P6|STARTED|Overall Study||6
7706523|NCT01758432|18977463|P5|STARTED|Overall Study||6
7706524|NCT01758432|18977464|P4|STARTED|Overall Study||6
7706525|NCT01758432|18977465|P3|STARTED|Overall Study||6
7706526|NCT01758432|18977466|P2|STARTED|Overall Study||6
7706527|NCT01758432|18977467|P1|STARTED|Overall Study||18
7706528|NCT01758289|18977539|P1|NOT COMPLETED|Overall Study||53
7706529|NCT01758289|18977539|P1|COMPLETED|Overall Study||52
7706530|NCT01758289|18977539|P1|STARTED|Overall Study||105
7706531|NCT01757964|18977558|P2|NOT COMPLETED|Overall Study||0
7706532|NCT01757964|18977559|P1|NOT COMPLETED|Overall Study||0
7706533|NCT01757964|18977558|P2|COMPLETED|Overall Study||4
7706534|NCT01757964|18977559|P1|COMPLETED|Overall Study||9
7706535|NCT01757964|18977558|P2|STARTED|Overall Study||4
7706536|NCT01757964|18977559|P1|STARTED|Overall Study||9
7706537|NCT01757847|18977565|P2|NOT COMPLETED|Overall Study||4
7706538|NCT01757847|18977566|P1|NOT COMPLETED|Overall Study||3
7706539|NCT01757847|18977565|P2|COMPLETED|Overall Study||42
7706540|NCT01757847|18977566|P1|COMPLETED|Overall Study||41
7706541|NCT01757847|18977565|P2|STARTED|Overall Study||46
7706542|NCT01757847|18977566|P1|STARTED|Overall Study||44
7706543|NCT01757821|18977574|P1|NOT COMPLETED|Overall Study||1
7706544|NCT01757821|18977574|P1|COMPLETED|Overall Study|10 subjects|10
7706545|NCT01757821|18977574|P1|STARTED|Overall Study|11 subjects|11
7706546|NCT01757717|18977582|P1|NOT COMPLETED|Overall Study||0
7706547|NCT01757717|18977582|P1|COMPLETED|Overall Study||3
7706548|NCT01757717|18977582|P1|STARTED|Overall Study||3
7706549|NCT01757704|18977589|P2|NOT COMPLETED|Overall Study||3
7706550|NCT01757704|18977590|P1|NOT COMPLETED|Overall Study||1
7706551|NCT01757704|18977589|P2|COMPLETED|Overall Study||10
7706552|NCT01757704|18977590|P1|COMPLETED|Overall Study||10
7706553|NCT01757704|18977589|P2|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13
7706554|NCT01757704|18977590|P1|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11
7706555|NCT01757691|18977608|P2|NOT COMPLETED|Overall Study||0
7706556|NCT01757691|18977609|P1|NOT COMPLETED|Overall Study||2
7706557|NCT01757691|18977608|P2|COMPLETED|Overall Study||0
7706558|NCT01757691|18977609|P1|COMPLETED|Overall Study||0
7706559|NCT01757691|18977608|P2|STARTED|Overall Study||0
7706560|NCT01757691|18977609|P1|STARTED|Overall Study||2
7706561|NCT01757678|18977622|P1|NOT COMPLETED|Overall Study||0
7706562|NCT01757678|18977622|P1|COMPLETED|Overall Study||276
7706563|NCT01757678|18977622|P1|STARTED|Overall Study||276
7706564|NCT01757665|18977636|P2|NOT COMPLETED|Overall Study||83
7706565|NCT01757665|18977637|P1|NOT COMPLETED|Overall Study||694
7706566|NCT01757665|18977636|P2|COMPLETED|Overall Study||0
7706567|NCT01757665|18977637|P1|COMPLETED|Overall Study||0
7706568|NCT01757665|18977636|P2|Implanted With Device|Overall Study||82
7706569|NCT01757665|18977637|P1|Implanted With Device|Overall Study||689
7706570|NCT01757665|18977636|P2|STARTED|Overall Study||83
7706571|NCT01757665|18977637|P1|STARTED|Overall Study||694
7706572|NCT01757561|18977790|P4|NOT COMPLETED|Overall Study||9
7706573|NCT01757561|18977791|P3|NOT COMPLETED|Overall Study||7
7706574|NCT01757561|18977792|P2|NOT COMPLETED|Overall Study||6
7706575|NCT01757561|18977793|P1|NOT COMPLETED|Overall Study||6
7706576|NCT01757561|18977790|P4|COMPLETED|Overall Study||25
7706577|NCT01757561|18977791|P3|COMPLETED|Overall Study||31
7706578|NCT01757561|18977792|P2|COMPLETED|Overall Study||28
7706579|NCT01757561|18977793|P1|COMPLETED|Overall Study||32
7706580|NCT01757561|18977790|P4|STARTED|Overall Study||34
7706581|NCT01757561|18977791|P3|STARTED|Overall Study||38
7706582|NCT01757561|18977792|P2|STARTED|Overall Study||34
7706583|NCT01757561|18977793|P1|STARTED|Overall Study||38
7706584|NCT01757535|18977809|P2|NOT COMPLETED|Overall Study||208
7706585|NCT01757535|18977810|P1|NOT COMPLETED|Overall Study||193
7706586|NCT01757535|18977809|P2|COMPLETED|Overall Study||26
7706587|NCT01757535|18977810|P1|COMPLETED|Overall Study||45
7706588|NCT01757535|18977809|P2|Received Treatment|Overall Study||233
7706589|NCT01757535|18977810|P1|Received Treatment|Overall Study||236
7706590|NCT01757535|18977809|P2|STARTED|Overall Study||234
7706591|NCT01757535|18977810|P1|STARTED|Overall Study||238
7706592|NCT01757405|18977842|P2|NOT COMPLETED|Overall Study||2
7706593|NCT01757405|18977843|P1|NOT COMPLETED|Overall Study||1
7706594|NCT01757405|18977842|P2|COMPLETED|Overall Study||18
7706595|NCT01757405|18977843|P1|COMPLETED|Overall Study||17
7706596|NCT01757405|18977842|P2|STARTED|Overall Study||20
7706597|NCT01757405|18977843|P1|STARTED|Overall Study||18
7706598|NCT01757301|18977861|P2|NOT COMPLETED|Overall Study||14
7706599|NCT01757301|18977862|P1|NOT COMPLETED|Overall Study||13
7706600|NCT01757301|18977861|P2|COMPLETED|Overall Study||133
7706601|NCT01757301|18977862|P1|COMPLETED|Overall Study||134
7706602|NCT01757301|18977861|P2|STARTED|Overall Study||147
7706603|NCT01757301|18977862|P1|STARTED|Overall Study||147
7706604|NCT01757275|18977878|P2|NOT COMPLETED|Overall Study||13
7706605|NCT01757275|18977879|P1|NOT COMPLETED|Overall Study||9
7706606|NCT01757275|18977878|P2|COMPLETED|Overall Study||98
7706607|NCT01757275|18977879|P1|COMPLETED|Overall Study||102
7706608|NCT01757275|18977878|P2|STARTED|Overall Study||111
7706609|NCT01757275|18977879|P1|STARTED|Overall Study||111
7706610|NCT01757197|18977901|P1|NOT COMPLETED|Overall Study||2
7706611|NCT01757197|18977901|P1|COMPLETED|Overall Study||0
7706612|NCT01757197|18977901|P1|STARTED|Overall Study||2
7706613|NCT01757184|18977910|P4|NOT COMPLETED|Open-label Period||3
7706614|NCT01757184|18977911|P3|NOT COMPLETED|Open-label Period||4
7706615|NCT01757184|18977912|P2|NOT COMPLETED|Open-label Period||0
7706616|NCT01757184|18977913|P1|NOT COMPLETED|Open-label Period||0
7706617|NCT01757184|18977910|P4|COMPLETED|Open-label Period||27
7706618|NCT01757184|18977911|P3|COMPLETED|Open-label Period||32
7706619|NCT01757184|18977912|P2|COMPLETED|Open-label Period||0
7706620|NCT01757184|18977913|P1|COMPLETED|Open-label Period||0
7706621|NCT01757184|18977910|P4|Received at Least 1 Dose of Study Drug|Open-label Period||30
7706622|NCT01757184|18977911|P3|Received at Least 1 Dose of Study Drug|Open-label Period||36
7706623|NCT01757184|18977912|P2|Received at Least 1 Dose of Study Drug|Open-label Period||0
7706624|NCT01757184|18977913|P1|Received at Least 1 Dose of Study Drug|Open-label Period||0
7706625|NCT01757184|18977910|P4|STARTED|Open-label Period||30
7706626|NCT01757184|18977911|P3|STARTED|Open-label Period|1 participant who did not complete Double-blind Period due to AE rechallenged for Open-label Period|36
7706627|NCT01757184|18977912|P2|STARTED|Open-label Period||0
7706628|NCT01757184|18977913|P1|STARTED|Open-label Period||0
7706629|NCT01757184|18977910|P4|NOT COMPLETED|Double-blind Period||0
7706630|NCT01757184|18977911|P3|NOT COMPLETED|Double-blind Period||0
7706631|NCT01757184|18977912|P2|NOT COMPLETED|Double-blind Period||0
7706632|NCT01757184|18977913|P1|NOT COMPLETED|Double-blind Period||1
7706633|NCT01757184|18977910|P4|COMPLETED|Double-blind Period||0
7706634|NCT01757184|18977911|P3|COMPLETED|Double-blind Period||0
7706635|NCT01757184|18977912|P2|COMPLETED|Double-blind Period||30
7706636|NCT01757184|18977913|P1|COMPLETED|Double-blind Period||35
7706637|NCT01757184|18977910|P4|Received at Least 1 Dose of Study Drug|Double-blind Period||0
7706638|NCT01757184|18977911|P3|Received at Least 1 Dose of Study Drug|Double-blind Period||0
7706639|NCT01757184|18977912|P2|Received at Least 1 Dose of Study Drug|Double-blind Period||30
7706640|NCT01757184|18977913|P1|Received at Least 1 Dose of Study Drug|Double-blind Period||36
7706641|NCT01757184|18977910|P4|STARTED|Double-blind Period||0
7706642|NCT01757184|18977911|P3|STARTED|Double-blind Period||0
7706643|NCT01757184|18977912|P2|STARTED|Double-blind Period||30
7706644|NCT01757184|18977913|P1|STARTED|Double-blind Period||36
7706645|NCT01757171|18977957|P2|NOT COMPLETED|Overall Study||1
7706646|NCT01757171|18977958|P1|NOT COMPLETED|Overall Study||8
7706647|NCT01757171|18977957|P2|COMPLETED|Overall Study||23
7706648|NCT01757171|18977958|P1|COMPLETED|Overall Study||53
7706649|NCT01757171|18977957|P2|STARTED|Overall Study||24
7706650|NCT01757171|18977958|P1|STARTED|Overall Study||61
7706651|NCT01756976|18977972|P2|NOT COMPLETED|Overall Study||0
7706652|NCT01756976|18977973|P1|NOT COMPLETED|Overall Study||3
7706653|NCT01756976|18977972|P2|COMPLETED|Overall Study||8
7706654|NCT01756976|18977973|P1|COMPLETED|Overall Study||73
7706655|NCT01756976|18977972|P2|STARTED|Overall Study||8
7706656|NCT01756976|18977973|P1|STARTED|Overall Study||76
7706657|NCT01756885|18977981|P2|NOT COMPLETED|Overall Study||26
7706658|NCT01756885|18977982|P1|NOT COMPLETED|Overall Study||23
7706659|NCT01756885|18977981|P2|COMPLETED|Overall Study||79
7706660|NCT01756885|18977982|P1|COMPLETED|Overall Study||79
7706661|NCT01756885|18977981|P2|STARTED|Overall Study||105
7706662|NCT01756885|18977982|P1|STARTED|Overall Study||102
7706663|NCT01756846|18977994|P2|NOT COMPLETED|Overall Study||12
7706664|NCT01756846|18977995|P1|NOT COMPLETED|Overall Study||6
7706665|NCT01756846|18977994|P2|COMPLETED|Overall Study||1821
7706666|NCT01756846|18977995|P1|COMPLETED|Overall Study||1827
7706667|NCT01756846|18977994|P2|STARTED|Overall Study||1833
7706668|NCT01756846|18977995|P1|STARTED|Overall Study||1833
7706669|NCT01756586|18978005|P2|NOT COMPLETED|Overall Study||2
7706670|NCT01756586|18978006|P1|NOT COMPLETED|Overall Study||2
7706671|NCT01756586|18978005|P2|COMPLETED|Overall Study||0
7706672|NCT01756586|18978006|P1|COMPLETED|Overall Study||0
7706673|NCT01756586|18978005|P2|STARTED|Overall Study||2
7706674|NCT01756586|18978006|P1|STARTED|Overall Study||2
7706675|NCT01756573|18978015|P3|NOT COMPLETED|Overall Study||0
7706676|NCT01756573|18978016|P2|NOT COMPLETED|Overall Study||0
7706677|NCT01756573|18978017|P1|NOT COMPLETED|Overall Study||0
7706678|NCT01756573|18978015|P3|COMPLETED|Overall Study||1
7706679|NCT01756573|18978016|P2|COMPLETED|Overall Study||1
7706680|NCT01756573|18978017|P1|COMPLETED|Overall Study||3
7706681|NCT01756573|18978015|P3|STARTED|Overall Study||1
7706682|NCT01756573|18978016|P2|STARTED|Overall Study||1
7706683|NCT01756573|18978017|P1|STARTED|Overall Study||3
7706684|NCT01756560|18978027|P2|NOT COMPLETED|Overall Study||0
7706685|NCT01756560|18978028|P1|NOT COMPLETED|Overall Study||2
7706686|NCT01756560|18978027|P2|COMPLETED|Overall Study||0
7706687|NCT01756560|18978028|P1|COMPLETED|Overall Study||0
7706688|NCT01756560|18978027|P2|STARTED|Overall Study||0
7706689|NCT01756560|18978028|P1|STARTED|Overall Study||2
7706690|NCT01756456|18978040|P6|NOT COMPLETED|Follow Up Period Phase I/II||33
7706691|NCT01756456|18978041|P5|NOT COMPLETED|Follow Up Period Phase I/II||26
7706692|NCT01756456|18978042|P4|NOT COMPLETED|Follow Up Period Phase I/II||33
7706693|NCT01756456|18978043|P3|NOT COMPLETED|Follow Up Period Phase I/II||1
7706694|NCT01756456|18978044|P2|NOT COMPLETED|Follow Up Period Phase I/II||1
7706695|NCT01756456|18978045|P1|NOT COMPLETED|Follow Up Period Phase I/II||1
7706696|NCT01756456|18978040|P6|COMPLETED|Follow Up Period Phase I/II||15
7706697|NCT01756456|18978041|P5|COMPLETED|Follow Up Period Phase I/II||13
7706698|NCT01756456|18978042|P4|COMPLETED|Follow Up Period Phase I/II||12
7706699|NCT01756456|18978043|P3|COMPLETED|Follow Up Period Phase I/II||1
7706700|NCT01756456|18978044|P2|COMPLETED|Follow Up Period Phase I/II||5
7706701|NCT01756456|18978045|P1|COMPLETED|Follow Up Period Phase I/II||5
7706702|NCT01756456|18978040|P6|STARTED|Follow Up Period Phase I/II||48
7706703|NCT01756456|18978041|P5|STARTED|Follow Up Period Phase I/II||39
7706704|NCT01756456|18978042|P4|STARTED|Follow Up Period Phase I/II||45
7706705|NCT01756456|18978043|P3|STARTED|Follow Up Period Phase I/II||2
7706706|NCT01756456|18978044|P2|STARTED|Follow Up Period Phase I/II||6
7706707|NCT01756456|18978045|P1|STARTED|Follow Up Period Phase I/II||6
7706708|NCT01756456|18978040|P6|NOT COMPLETED|Treatment Period: Phase I/II||4
7706709|NCT01756456|18978041|P5|NOT COMPLETED|Treatment Period: Phase I/II||13
7706710|NCT01756456|18978042|P4|NOT COMPLETED|Treatment Period: Phase I/II||7
7706711|NCT01756456|18978043|P3|NOT COMPLETED|Treatment Period: Phase I/II||2
7706712|NCT01756456|18978044|P2|NOT COMPLETED|Treatment Period: Phase I/II||1
7706713|NCT01756456|18978045|P1|NOT COMPLETED|Treatment Period: Phase I/II||1
7706714|NCT01756456|18978040|P6|COMPLETED|Treatment Period: Phase I/II||48
7706715|NCT01756456|18978041|P5|COMPLETED|Treatment Period: Phase I/II||39
7706716|NCT01756456|18978042|P4|COMPLETED|Treatment Period: Phase I/II||45
7706717|NCT01756456|18978043|P3|COMPLETED|Treatment Period: Phase I/II||2
7706718|NCT01756456|18978044|P2|COMPLETED|Treatment Period: Phase I/II||6
7706719|NCT01756456|18978045|P1|COMPLETED|Treatment Period: Phase I/II||6
7706720|NCT01756456|18978040|P6|STARTED|Treatment Period: Phase I/II||52
7706721|NCT01756456|18978041|P5|STARTED|Treatment Period: Phase I/II||52
7706722|NCT01756456|18978042|P4|STARTED|Treatment Period: Phase I/II||52
7706723|NCT01756456|18978043|P3|STARTED|Treatment Period: Phase I/II||4
7706724|NCT01756456|18978044|P2|STARTED|Treatment Period: Phase I/II||7
7706725|NCT01756456|18978045|P1|STARTED|Treatment Period: Phase I/II||7
7706726|NCT01756391|18978143|P1|NOT COMPLETED|Overall Study||32
7706727|NCT01756391|18978143|P1|COMPLETED|Overall Study||319
7706728|NCT01756391|18978143|P1|STARTED|Overall Study||351
7706729|NCT01756352|18978147|P1|NOT COMPLETED|Overall Study||1
7706730|NCT01756352|18978147|P1|COMPLETED|Overall Study||12
7706731|NCT01756352|18978147|P1|STARTED|Overall Study||13
7706732|NCT01756300|18978152|P1|NOT COMPLETED|Overall Study||2
7706733|NCT01756300|18978152|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33
7706734|NCT01756300|18978152|P1|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35
7706735|NCT01756274|18978174|P1|NOT COMPLETED|Overall Study||3
7706736|NCT01756274|18978174|P1|COMPLETED|Overall Study||159
7706737|NCT01756274|18978174|P1|STARTED|Overall Study||162
7706738|NCT01756235|18978181|P1|NOT COMPLETED|Overall Study||2
7706739|NCT01756235|18978181|P1|COMPLETED|Overall Study||460
7706740|NCT01756235|18978181|P1|STARTED|Overall Study||462
7706741|NCT01756209|18978206|P4|NOT COMPLETED|Overall Study||0
7706742|NCT01756209|18978207|P3|NOT COMPLETED|Overall Study||0
7706743|NCT01756209|18978208|P2|NOT COMPLETED|Overall Study||0
7706744|NCT01756209|18978209|P1|NOT COMPLETED|Overall Study||0
7706745|NCT01756209|18978206|P4|COMPLETED|Overall Study||40
7706746|NCT01756209|18978207|P3|COMPLETED|Overall Study||40
7706747|NCT01756209|18978208|P2|COMPLETED|Overall Study||40
7706748|NCT01756209|18978209|P1|COMPLETED|Overall Study||40
7706749|NCT01756209|18978206|P4|STARTED|Overall Study||40
7706750|NCT01756209|18978207|P3|STARTED|Overall Study||40
7706751|NCT01756209|18978208|P2|STARTED|Overall Study||40
7706752|NCT01756209|18978209|P1|STARTED|Overall Study||40
7706753|NCT01756157|18978219|P2|NOT COMPLETED|Second Intervention Period||0
7706754|NCT01756157|18978220|P1|NOT COMPLETED|Second Intervention Period||0
7706755|NCT01756157|18978219|P2|COMPLETED|Second Intervention Period||22
7706756|NCT01756157|18978220|P1|COMPLETED|Second Intervention Period||22
7706757|NCT01756157|18978219|P2|STARTED|Second Intervention Period||22
7706758|NCT01756157|18978220|P1|STARTED|Second Intervention Period||22
7706759|NCT01756157|18978219|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7706760|NCT01756157|18978220|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7706761|NCT01756157|18978219|P2|COMPLETED|Washout Period (at Least 7 Days)||22
7706762|NCT01756157|18978220|P1|COMPLETED|Washout Period (at Least 7 Days)||22
7706763|NCT01756157|18978219|P2|STARTED|Washout Period (at Least 7 Days)||22
7706764|NCT01756157|18978220|P1|STARTED|Washout Period (at Least 7 Days)||22
7706765|NCT01756157|18978219|P2|NOT COMPLETED|First Intervention Period||2
7706766|NCT01756157|18978220|P1|NOT COMPLETED|First Intervention Period||1
7706767|NCT01756157|18978219|P2|COMPLETED|First Intervention Period||22
7706768|NCT01756157|18978220|P1|COMPLETED|First Intervention Period||22
7706769|NCT01756157|18978219|P2|STARTED|First Intervention Period||24
7706770|NCT01756157|18978220|P1|STARTED|First Intervention Period||23
7706771|NCT01756079|18978234|P1|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35
7706772|NCT01756079|18978234|P1|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23
7706773|NCT01756079|18978234|P1|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54
7706774|NCT01756079|18978234|P1|STARTED|Treatment / Follow-up: Week 4 to Week 72||58
7706775|NCT01756079|18978234|P1|NOT COMPLETED|Lead-in: Day 0 to Week 4||0
7706776|NCT01756079|18978234|P1|COMPLETED|Lead-in: Day 0 to Week 4||58
7706777|NCT01756079|18978234|P1|STARTED|Lead-in: Day 0 to Week 4||58
7706778|NCT01756053|18978240|P2|NOT COMPLETED|Period 2 (10 Days)||2
7706779|NCT01756053|18978241|P1|NOT COMPLETED|Period 2 (10 Days)||0
7706780|NCT01756053|18978240|P2|COMPLETED|Period 2 (10 Days)||6
7706781|NCT01756053|18978241|P1|COMPLETED|Period 2 (10 Days)||7
7706782|NCT01756053|18978240|P2|STARTED|Period 2 (10 Days)||8
7706783|NCT01756053|18978241|P1|STARTED|Period 2 (10 Days)||7
7706784|NCT01756053|18978240|P2|NOT COMPLETED|Washout Period (~21 Days)||0
7706785|NCT01756053|18978241|P1|NOT COMPLETED|Washout Period (~21 Days)||0
7706786|NCT01756053|18978240|P2|COMPLETED|Washout Period (~21 Days)||8
7706787|NCT01756053|18978241|P1|COMPLETED|Washout Period (~21 Days)||7
7706788|NCT01756053|18978240|P2|STARTED|Washout Period (~21 Days)||8
7706789|NCT01756053|18978241|P1|STARTED|Washout Period (~21 Days)||7
7706790|NCT01756053|18978240|P2|NOT COMPLETED|Period 1 (10 Days)||1
7706791|NCT01756053|18978241|P1|NOT COMPLETED|Period 1 (10 Days)||1
7706792|NCT01756053|18978240|P2|COMPLETED|Period 1 (10 Days)||8
7706793|NCT01756053|18978241|P1|COMPLETED|Period 1 (10 Days)||7
7706794|NCT01756053|18978240|P2|STARTED|Period 1 (10 Days)||9
7706795|NCT01756053|18978241|P1|STARTED|Period 1 (10 Days)||8
7706796|NCT01755949|18978267|P6|NOT COMPLETED|Overall Study||0
7706797|NCT01755949|18978268|P5|NOT COMPLETED|Overall Study||0
7706798|NCT01755949|18978269|P4|NOT COMPLETED|Overall Study||0
7706799|NCT01755949|18978270|P3|NOT COMPLETED|Overall Study||0
7706800|NCT01755949|18978271|P2|NOT COMPLETED|Overall Study||0
7706801|NCT01755949|18978272|P1|NOT COMPLETED|Overall Study||0
7706802|NCT01755949|18978267|P6|COMPLETED|Overall Study||3
7706803|NCT01755949|18978268|P5|COMPLETED|Overall Study||4
7706804|NCT01755949|18978269|P4|COMPLETED|Overall Study||5
7706805|NCT01755949|18978270|P3|COMPLETED|Overall Study||4
7706806|NCT01755949|18978271|P2|COMPLETED|Overall Study||5
7706807|NCT01755949|18978272|P1|COMPLETED|Overall Study||5
7706808|NCT01755949|18978267|P6|STARTED|Overall Study||3
7706809|NCT01755949|18978268|P5|STARTED|Overall Study||4
7706810|NCT01755949|18978269|P4|STARTED|Overall Study||5
7706811|NCT01755949|18978270|P3|STARTED|Overall Study||4
7706812|NCT01755949|18978271|P2|STARTED|Overall Study||5
7706813|NCT01755949|18978272|P1|STARTED|Overall Study||5
7706814|NCT01755858|18978300|P2|NOT COMPLETED|Overall Study||1
7706815|NCT01755858|18978301|P1|NOT COMPLETED|Overall Study||1
7706816|NCT01755858|18978300|P2|COMPLETED|Overall Study||8
7706817|NCT01755858|18978301|P1|COMPLETED|Overall Study||6
7706818|NCT01755858|18978300|P2|STARTED|Overall Study||9
7706819|NCT01755858|18978301|P1|STARTED|Overall Study||7
7706820|NCT01755767|18978327|P4|NOT COMPLETED|Overall Study||114
7706821|NCT01755767|18978328|P3|NOT COMPLETED|Overall Study||226
7706822|NCT01755767|18978329|P2|NOT COMPLETED|Overall Study||15
7706823|NCT01755767|18978330|P1|NOT COMPLETED|Overall Study||28
7706824|NCT01755767|18978327|P4|COMPLETED|Overall Study||0
7706825|NCT01755767|18978328|P3|COMPLETED|Overall Study||0
7706826|NCT01755767|18978329|P2|COMPLETED|Overall Study||0
7706827|NCT01755767|18978330|P1|COMPLETED|Overall Study||0
7706828|NCT01755767|18978327|P4|STARTED|Overall Study||114
7706829|NCT01755767|18978328|P3|STARTED|Overall Study||226
7706830|NCT01755767|18978329|P2|STARTED|Overall Study||15
7706831|NCT01755767|18978330|P1|STARTED|Overall Study||28
7706832|NCT01755702|18978346|P1|NOT COMPLETED|Period III||0
7706833|NCT01755702|18978346|P1|COMPLETED|Period III||58
7706834|NCT01755702|18978346|P1|Received Ibuprofen|Period III||18
7706835|NCT01755702|18978346|P1|Received Paracetamol/Caffeine|Period III||10
7706836|NCT01755702|18978346|P1|Received Placebo|Period III||13
7706837|NCT01755702|18978346|P1|Received Paracetamol|Period III||17
7706838|NCT01755702|18978346|P1|STARTED|Period III||58
7706839|NCT01755702|18978346|P1|NOT COMPLETED|Washout Period II||5
7706840|NCT01755702|18978346|P1|COMPLETED|Washout Period II||58
7706841|NCT01755702|18978346|P1|STARTED|Washout Period II||63
7706842|NCT01755702|18978346|P1|NOT COMPLETED|Period II||0
7706843|NCT01755702|18978346|P1|COMPLETED|Period II||63
7706844|NCT01755702|18978346|P1|Received Paracetamol|Period II||17
7706845|NCT01755702|18978346|P1|Received Paracetamol/Caffeine|Period II||20
7706846|NCT01755702|18978346|P1|Received Placebo|Period II||15
7706847|NCT01755702|18978346|P1|Received Ibuprofen|Period II||11
7706848|NCT01755702|18978346|P1|STARTED|Period II||63
7706849|NCT01755702|18978346|P1|NOT COMPLETED|Wash Out Period I||3
7706850|NCT01755702|18978346|P1|COMPLETED|Wash Out Period I||63
7706851|NCT01755702|18978346|P1|STARTED|Wash Out Period I||66
7706852|NCT01755702|18978346|P1|NOT COMPLETED|Period I||0
7706853|NCT01755702|18978346|P1|COMPLETED|Period I||66
7706854|NCT01755702|18978346|P1|Received Paracetamol/Caffeine|Period I||17
7706855|NCT01755702|18978346|P1|Received Ibuprofen|Period I||16
7706856|NCT01755702|18978346|P1|Received Placebo|Period I||17
7706857|NCT01755702|18978346|P1|Received Paracetamol|Period I||16
7706858|NCT01755702|18978346|P1|STARTED|Period I||66
7706859|NCT01755689|18978393|P5|NOT COMPLETED|Overall Study||6
7706860|NCT01755689|18978394|P4|NOT COMPLETED|Overall Study||6
7706861|NCT01755689|18978395|P3|NOT COMPLETED|Overall Study||6
7706862|NCT01755689|18978396|P2|NOT COMPLETED|Overall Study||5
7706863|NCT01755689|18978397|P1|NOT COMPLETED|Overall Study||3
7706864|NCT01755689|18978393|P5|COMPLETED|Overall Study||255
7706865|NCT01755689|18978394|P4|COMPLETED|Overall Study||254
7706866|NCT01755689|18978395|P3|COMPLETED|Overall Study||255
7706867|NCT01755689|18978396|P2|COMPLETED|Overall Study||254
7706868|NCT01755689|18978397|P1|COMPLETED|Overall Study||256
7706869|NCT01755689|18978393|P5|STARTED|Overall Study||261
7706870|NCT01755689|18978394|P4|STARTED|Overall Study||260
7706871|NCT01755689|18978395|P3|STARTED|Overall Study||261
7706872|NCT01755689|18978396|P2|STARTED|Overall Study||259
7706873|NCT01755689|18978397|P1|STARTED|Overall Study||259
7706874|NCT01755637|18978472|P2|NOT COMPLETED|Period 2||0
7706875|NCT01755637|18978473|P1|NOT COMPLETED|Period 2||0
7706876|NCT01755637|18978472|P2|COMPLETED|Period 2||27
7706877|NCT01755637|18978473|P1|COMPLETED|Period 2||28
7706878|NCT01755637|18978472|P2|STARTED|Period 2||27
7706879|NCT01755637|18978473|P1|STARTED|Period 2||28
7706880|NCT01755637|18978472|P2|NOT COMPLETED|Period 1||1
7706881|NCT01755637|18978473|P1|NOT COMPLETED|Period 1||0
7706882|NCT01755637|18978472|P2|COMPLETED|Period 1||27
7706883|NCT01755637|18978473|P1|COMPLETED|Period 1||28
7706884|NCT01755637|18978472|P2|STARTED|Period 1||28
7706885|NCT01755637|18978473|P1|STARTED|Period 1||28
7706886|NCT01755598|18978493|P2|NOT COMPLETED|Overall Study||283
7706887|NCT01755598|18978494|P1|NOT COMPLETED|Overall Study||265
7706888|NCT01755598|18978493|P2|COMPLETED|Overall Study||1504
7706889|NCT01755598|18978494|P1|COMPLETED|Overall Study||1521
7706890|NCT01755598|18978493|P2|STARTED|Overall Study||1787
7706891|NCT01755598|18978494|P1|STARTED|Overall Study||1786
7706892|NCT01755546|18978528|P1|NOT COMPLETED|Long Term Treatment||121
7706893|NCT01755546|18978528|P1|COMPLETED|Long Term Treatment||103
7706894|NCT01755546|18978528|P1|STARTED|Long Term Treatment||224
7706895|NCT01755546|18978528|P1|NOT COMPLETED|Titration Phase||70
7706896|NCT01755546|18978528|P1|COMPLETED|Titration Phase||224
7706897|NCT01755546|18978528|P1|STARTED|Titration Phase||294
7706898|NCT01755546|18978528|P1|NOT COMPLETED|Screened and Taper (Rollover and DeNovo)||10
7706899|NCT01755546|18978528|P1|COMPLETED|Screened and Taper (Rollover and DeNovo)||294
7706900|NCT01755546|18978528|P1|STARTED|Screened and Taper (Rollover and DeNovo)||304
7706901|NCT01755455|18978532|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
7706902|NCT01755455|18978533|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
7706903|NCT01755455|18978532|P2|COMPLETED|Second Intervention (6 Weeks)||11
7706904|NCT01755455|18978533|P1|COMPLETED|Second Intervention (6 Weeks)||11
7706905|NCT01755455|18978532|P2|STARTED|Second Intervention (6 Weeks)||11
7706906|NCT01755455|18978533|P1|STARTED|Second Intervention (6 Weeks)||11
7706907|NCT01755455|18978532|P2|NOT COMPLETED|Washout (4 Weeks)||0
7706908|NCT01755455|18978533|P1|NOT COMPLETED|Washout (4 Weeks)||0
7706909|NCT01755455|18978532|P2|COMPLETED|Washout (4 Weeks)||11
7706910|NCT01755455|18978533|P1|COMPLETED|Washout (4 Weeks)||11
7706911|NCT01755455|18978532|P2|STARTED|Washout (4 Weeks)||11
7706912|NCT01755455|18978533|P1|STARTED|Washout (4 Weeks)||11
7706913|NCT01755455|18978532|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
7706914|NCT01755455|18978533|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
7706915|NCT01755455|18978532|P2|COMPLETED|First Intervention (6 Weeks)||11
7706916|NCT01755455|18978533|P1|COMPLETED|First Intervention (6 Weeks)||11
7706917|NCT01755455|18978532|P2|STARTED|First Intervention (6 Weeks)||11
7706918|NCT01755455|18978533|P1|STARTED|First Intervention (6 Weeks)||11
7706919|NCT01755416|18978545|P2|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
7706920|NCT01755416|18978546|P1|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
7706921|NCT01755416|18978545|P2|COMPLETED|Second Intervention (Upto 2 Days)||7
7706922|NCT01755416|18978546|P1|COMPLETED|Second Intervention (Upto 2 Days)||8
7706923|NCT01755416|18978545|P2|STARTED|Second Intervention (Upto 2 Days)||7
7706924|NCT01755416|18978546|P1|STARTED|Second Intervention (Upto 2 Days)||8
7706925|NCT01755416|18978545|P2|NOT COMPLETED|First Intervention ( Upto 2 Days)||2
7706926|NCT01755416|18978546|P1|NOT COMPLETED|First Intervention ( Upto 2 Days)||1
7706927|NCT01755416|18978545|P2|COMPLETED|First Intervention ( Upto 2 Days)||7
7706928|NCT01755416|18978546|P1|COMPLETED|First Intervention ( Upto 2 Days)||8
7706929|NCT01755416|18978545|P2|STARTED|First Intervention ( Upto 2 Days)||9
7706930|NCT01755416|18978546|P1|STARTED|First Intervention ( Upto 2 Days)||9
7706931|NCT01755234|18978554|P2|NOT COMPLETED|Overall Study||8
7706932|NCT01755234|18978555|P1|NOT COMPLETED|Overall Study||15
7706933|NCT01755234|18978554|P2|COMPLETED|Overall Study||37
7706934|NCT01755234|18978555|P1|COMPLETED|Overall Study||30
7706935|NCT01755234|18978554|P2|STARTED|Overall Study||45
7706936|NCT01755234|18978555|P1|STARTED|Overall Study||45
7706937|NCT01755169|18978571|P4|NOT COMPLETED|Overall Study||0
7706938|NCT01755169|18978572|P3|NOT COMPLETED|Overall Study||0
7706939|NCT01755169|18978573|P2|NOT COMPLETED|Overall Study||0
7706940|NCT01755169|18978574|P1|NOT COMPLETED|Overall Study||0
7706941|NCT01755169|18978571|P4|COMPLETED|Overall Study||1
7706942|NCT01755169|18978572|P3|COMPLETED|Overall Study||0
7706943|NCT01755169|18978573|P2|COMPLETED|Overall Study||1
7706944|NCT01755169|18978574|P1|COMPLETED|Overall Study||2
7706945|NCT01755169|18978571|P4|STARTED|Overall Study||1
7706946|NCT01755169|18978572|P3|STARTED|Overall Study||0
7706947|NCT01755169|18978573|P2|STARTED|Overall Study||1
7706948|NCT01755169|18978574|P1|STARTED|Overall Study||2
7706949|NCT01755156|18978586|P2|NOT COMPLETED|Phase B (Weeks 24-104)||36
7706950|NCT01755156|18978587|P1|NOT COMPLETED|Phase B (Weeks 24-104)||39
7706951|NCT01755156|18978586|P2|COMPLETED|Phase B (Weeks 24-104)||141
7706952|NCT01755156|18978587|P1|COMPLETED|Phase B (Weeks 24-104)||144
7706953|NCT01755156|18978586|P2|STARTED|Phase B (Weeks 24-104)||177
7706954|NCT01755156|18978587|P1|STARTED|Phase B (Weeks 24-104)|1 participant who completed Phase A did not continue to Phase B.|183
7706955|NCT01755156|18978586|P2|NOT COMPLETED|Phase A (Weeks 0-24)||24
7706956|NCT01755156|18978587|P1|NOT COMPLETED|Phase A (Weeks 0-24)||17
7706957|NCT01755156|18978586|P2|COMPLETED|Phase A (Weeks 0-24)||177
7706958|NCT01755156|18978587|P1|COMPLETED|Phase A (Weeks 0-24)||184
7706959|NCT01755156|18978586|P2|STARTED|Phase A (Weeks 0-24)||201
7706960|NCT01755156|18978587|P1|STARTED|Phase A (Weeks 0-24)||201
7706961|NCT01755143|18978633|P2|NOT COMPLETED|Overall Study||3
7706962|NCT01755143|18978634|P1|NOT COMPLETED|Overall Study||11
7706963|NCT01755143|18978633|P2|COMPLETED|Overall Study||86
7706964|NCT01755143|18978634|P1|COMPLETED|Overall Study||166
7706965|NCT01755143|18978633|P2|STARTED|Overall Study||89
7706966|NCT01755143|18978634|P1|STARTED|Overall Study||177
7706967|NCT01755091|18978651|P3|NOT COMPLETED|Overall Study||7
7706968|NCT01755091|18978652|P2|NOT COMPLETED|Overall Study||3
7706969|NCT01755091|18978653|P1|NOT COMPLETED|Overall Study||9
7706970|NCT01755091|18978651|P3|COMPLETED|Overall Study||20
7706971|NCT01755091|18978652|P2|COMPLETED|Overall Study||19
7706972|NCT01755091|18978653|P1|COMPLETED|Overall Study||17
7706973|NCT01755091|18978651|P3|STARTED|Overall Study||27
7706974|NCT01755091|18978652|P2|STARTED|Overall Study||22
7706975|NCT01755091|18978653|P1|STARTED|Overall Study||26
7706976|NCT01755026|18978678|P2|NOT COMPLETED|Overall Study||1
7706977|NCT01755026|18978679|P1|NOT COMPLETED|Overall Study||2
7706978|NCT01755026|18978678|P2|COMPLETED|Overall Study||11
7706979|NCT01755026|18978679|P1|COMPLETED|Overall Study||9
7706980|NCT01755026|18978678|P2|STARTED|Overall Study||12
7706981|NCT01755026|18978679|P1|STARTED|Overall Study||11
7706982|NCT01754987|18978687|P2|NOT COMPLETED|Overall Study||0
7706983|NCT01754987|18978688|P1|NOT COMPLETED|Overall Study||0
7706984|NCT01754987|18978687|P2|COMPLETED|Overall Study||0
7706985|NCT01754987|18978688|P1|COMPLETED|Overall Study||5
7706986|NCT01754987|18978687|P2|STARTED|Overall Study||0
7706987|NCT01754987|18978688|P1|STARTED|Overall Study||5
7706988|NCT01754922|18978702|P2|NOT COMPLETED|Overall Study||1
7706989|NCT01754922|18978703|P1|NOT COMPLETED|Overall Study||0
7706990|NCT01754922|18978702|P2|COMPLETED|Overall Study||17
7706991|NCT01754922|18978703|P1|COMPLETED|Overall Study||32
7706992|NCT01754922|18978702|P2|STARTED|Overall Study||18
7706993|NCT01754922|18978703|P1|STARTED|Overall Study||32
7706994|NCT01754909|18978715|P2|NOT COMPLETED|Overall Study||0
7706995|NCT01754909|18978716|P1|NOT COMPLETED|Overall Study||0
7706996|NCT01754909|18978715|P2|COMPLETED|Overall Study||23
7706997|NCT01754909|18978716|P1|COMPLETED|Overall Study||20
7706998|NCT01754909|18978715|P2|STARTED|Overall Study||23
7706999|NCT01754909|18978716|P1|STARTED|Overall Study||20
7707000|NCT01754766|18978729|P3|NOT COMPLETED|Overall Study||0
7707001|NCT01754766|18978730|P2|NOT COMPLETED|Overall Study||1
7707002|NCT01754766|18978731|P1|NOT COMPLETED|Overall Study||1
7707003|NCT01754766|18978729|P3|COMPLETED|Overall Study||30
7707004|NCT01754766|18978730|P2|COMPLETED|Overall Study||28
7707005|NCT01754766|18978731|P1|COMPLETED|Overall Study||30
7707006|NCT01754766|18978729|P3|STARTED|Overall Study||30
7707007|NCT01754766|18978730|P2|STARTED|Overall Study||29
7707008|NCT01754766|18978731|P1|STARTED|Overall Study||31
7707009|NCT01754727|18978745|P1|NOT COMPLETED|Overall Study||2
7707010|NCT01754727|18978745|P1|COMPLETED|Overall Study||450
7707011|NCT01754727|18978745|P1|STARTED|Overall Study||452
7707012|NCT01754714|18978763|P4|NOT COMPLETED|Overall Study||1
7707013|NCT01754714|18978764|P3|NOT COMPLETED|Overall Study||2
7707014|NCT01754714|18978765|P2|NOT COMPLETED|Overall Study||1
7707015|NCT01754714|18978766|P1|NOT COMPLETED|Overall Study||0
7707016|NCT01754714|18978763|P4|COMPLETED|Overall Study||27
7707017|NCT01754714|18978764|P3|COMPLETED|Overall Study||24
7707018|NCT01754714|18978765|P2|COMPLETED|Overall Study||26
7707019|NCT01754714|18978766|P1|COMPLETED|Overall Study||27
7707020|NCT01754714|18978763|P4|STARTED|Overall Study||28
7707021|NCT01754714|18978764|P3|STARTED|Overall Study||26
7707022|NCT01754714|18978765|P2|STARTED|Overall Study||27
7707023|NCT01754714|18978766|P1|STARTED|Overall Study||27
7707024|NCT01754688|18978856|P1|NOT COMPLETED|Overall Study||0
7707025|NCT01754688|18978856|P1|COMPLETED|Overall Study||624
7707026|NCT01754688|18978856|P1|STARTED|Overall Study||624
7707027|NCT01754623|18978861|P1|NOT COMPLETED|Overall Study||0
7707028|NCT01754623|18978861|P1|COMPLETED|Overall Study||9
7707029|NCT01754623|18978861|P1|STARTED|Overall Study||9
7707030|NCT01754519|18978868|P1|NOT COMPLETED|Overall Study||0
7707031|NCT01754519|18978868|P1|COMPLETED|Overall Study||1
7707032|NCT01754519|18978868|P1|STARTED|Overall Study||1
7707033|NCT01754493|18978877|P1|NOT COMPLETED|Overall Study||7
7707034|NCT01754493|18978877|P1|COMPLETED|Overall Study||10
7707035|NCT01754493|18978877|P1|STARTED|Overall Study||17
7707036|NCT01754480|18978887|P2|NOT COMPLETED|Primary Part II||11
7707037|NCT01754480|18978888|P1|NOT COMPLETED|Primary Part II||15
7707038|NCT01754480|18978887|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102
7707039|NCT01754480|18978888|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96
7707040|NCT01754480|18978887|P2|Completed Study up to Week 6|Primary Part II||108
7707041|NCT01754480|18978888|P1|Completed Study up to Week 6|Primary Part II||100
7707042|NCT01754480|18978887|P2|STARTED|Primary Part II||113
7707043|NCT01754480|18978888|P1|STARTED|Primary Part II||111
7707044|NCT01754480|18978887|P2|NOT COMPLETED|Part I + Part II (Overall Study)||23
7707045|NCT01754480|18978888|P1|NOT COMPLETED|Part I + Part II (Overall Study)||25
7707046|NCT01754480|18978887|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139
7707047|NCT01754480|18978888|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138
7707048|NCT01754480|18978887|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||153
7707049|NCT01754480|18978888|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||147
7707050|NCT01754480|18978887|P2|STARTED|Part I + Part II (Overall Study)||162
7707051|NCT01754480|18978888|P1|STARTED|Part I + Part II (Overall Study)||163
7707052|NCT01754467|18978902|P1|NOT COMPLETED|Overall Study||1
7707053|NCT01754467|18978902|P1|COMPLETED|Overall Study||8
7707054|NCT01754467|18978902|P1|STARTED|Overall Study||9
7707055|NCT01754402|18978912|P3|NOT COMPLETED|Overall Study||4
7707056|NCT01754402|18978913|P2|NOT COMPLETED|Overall Study||2
7707057|NCT01754402|18978914|P1|NOT COMPLETED|Overall Study||2
7707058|NCT01754402|18978912|P3|COMPLETED|Overall Study||26
7707059|NCT01754402|18978913|P2|COMPLETED|Overall Study||0
7707060|NCT01754402|18978914|P1|COMPLETED|Overall Study||4
7707061|NCT01754402|18978912|P3|STARTED|Overall Study||30
7707062|NCT01754402|18978913|P2|STARTED|Overall Study||2
7707063|NCT01754402|18978914|P1|STARTED|Overall Study||6
7707064|NCT01754389|18978926|P3|NOT COMPLETED|Overall Study||0
7707065|NCT01754389|18978927|P2|NOT COMPLETED|Overall Study||0
7707066|NCT01754389|18978928|P1|NOT COMPLETED|Overall Study||0
7707067|NCT01754389|18978926|P3|COMPLETED|Overall Study||47
7707068|NCT01754389|18978927|P2|COMPLETED|Overall Study||45
7707069|NCT01754389|18978928|P1|COMPLETED|Overall Study||46
7707070|NCT01754389|18978926|P3|STARTED|Overall Study||47
7707071|NCT01754389|18978927|P2|STARTED|Overall Study||45
7707072|NCT01754389|18978928|P1|STARTED|Overall Study||46
7707073|NCT01754376|18978948|P1|NOT COMPLETED|Overall Study||3
7707074|NCT01754376|18978948|P1|COMPLETED|Overall Study||3
7707075|NCT01754376|18978948|P1|Completed 2-week Lead in of Vemurafenib|Overall Study||6
7707076|NCT01754376|18978948|P1|STARTED|Overall Study||6
7707077|NCT01754259|18978959|P2|NOT COMPLETED|Overall Study||6
7707078|NCT01754259|18978960|P1|NOT COMPLETED|Overall Study||5
7707079|NCT01754259|18978959|P2|COMPLETED|Overall Study||18
7707080|NCT01754259|18978960|P1|COMPLETED|Overall Study||18
7707081|NCT01754259|18978959|P2|STARTED|Overall Study||24
7707082|NCT01754259|18978960|P1|STARTED|Overall Study||23
7707083|NCT01754207|18978968|P1|NOT COMPLETED|Overall Study||3
7707084|NCT01754207|18978968|P1|COMPLETED|Overall Study||17
7707085|NCT01754207|18978968|P1|STARTED|Overall Study||20
7707086|NCT01754194|18978974|P2|NOT COMPLETED|Overall Study||27
7707087|NCT01754194|18978975|P1|NOT COMPLETED|Overall Study||52
7707088|NCT01754194|18978974|P2|COMPLETED|Overall Study||97
7707089|NCT01754194|18978975|P1|COMPLETED|Overall Study||117
7707090|NCT01754194|18978974|P2|STARTED|Overall Study||124
7707091|NCT01754194|18978975|P1|STARTED|Overall Study||169
7707092|NCT01754129|18978995|P1|NOT COMPLETED|Overall Study||33
7707093|NCT01754129|18978995|P1|COMPLETED|Overall Study||115
7707094|NCT01754129|18978995|P1|Visit 3 (Year 2)|Overall Study||115
7707095|NCT01754129|18978995|P1|Visit 2 (Year 1)|Overall Study||129
7707096|NCT01754129|18978995|P1|Visit 1 (Enrollment Day)|Overall Study||145
7707097|NCT01754129|18978995|P1|STARTED|Overall Study||148
7707098|NCT01753999|18979018|P2|NOT COMPLETED|Period 2 -Cross to Alternate Arm||23
7707099|NCT01753999|18979019|P1|NOT COMPLETED|Period 2 -Cross to Alternate Arm||17
7707100|NCT01753999|18979018|P2|COMPLETED|Period 2 -Cross to Alternate Arm||89
7707101|NCT01753999|18979019|P1|COMPLETED|Period 2 -Cross to Alternate Arm||99
7707102|NCT01753999|18979018|P2|Received Intervention|Period 2 -Cross to Alternate Arm||95
7707103|NCT01753999|18979019|P1|Received Intervention|Period 2 -Cross to Alternate Arm||103
7707104|NCT01753999|18979018|P2|STARTED|Period 2 -Cross to Alternate Arm||112
7707105|NCT01753999|18979019|P1|STARTED|Period 2 -Cross to Alternate Arm||116
7707106|NCT01753999|18979018|P2|NOT COMPLETED|Period 1 - Initial Assignment||50
7707107|NCT01753999|18979019|P1|NOT COMPLETED|Period 1 - Initial Assignment||39
7707108|NCT01753999|18979018|P2|COMPLETED|Period 1 - Initial Assignment||112
7707109|NCT01753999|18979019|P1|COMPLETED|Period 1 - Initial Assignment||116
7707110|NCT01753999|18979018|P2|Received Intervention|Period 1 - Initial Assignment||146
7707111|NCT01753999|18979019|P1|Received Intervention|Period 1 - Initial Assignment||144
7707112|NCT01753999|18979018|P2|STARTED|Period 1 - Initial Assignment||162
7707113|NCT01753999|18979019|P1|STARTED|Period 1 - Initial Assignment||155
7707114|NCT01753856|18979037|P2|NOT COMPLETED|Overall Study||2
7707115|NCT01753856|18979038|P1|NOT COMPLETED|Overall Study||3
7707116|NCT01753856|18979037|P2|COMPLETED|Overall Study||34
7707117|NCT01753856|18979038|P1|COMPLETED|Overall Study||30
7707118|NCT01753856|18979037|P2|Completed 3-Month Bone Biopsy|Overall Study||35
7707119|NCT01753856|18979038|P1|Completed 3-Month Bone Biopsy|Overall Study||31
7707120|NCT01753856|18979037|P2|Received at Least 1 Dose of Study Drug|Overall Study||36
7707121|NCT01753856|18979038|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
7707122|NCT01753856|18979037|P2|STARTED|Overall Study||36
7707123|NCT01753856|18979038|P1|STARTED|Overall Study||33
7707124|NCT01753830|18979090|P2|NOT COMPLETED|Overall Study||3
7707125|NCT01753830|18979091|P1|NOT COMPLETED|Overall Study||7
7707126|NCT01753830|18979090|P2|COMPLETED|Overall Study||35
7707127|NCT01753830|18979091|P1|COMPLETED|Overall Study||30
7707128|NCT01753830|18979090|P2|STARTED|Overall Study||38
7707129|NCT01753830|18979091|P1|STARTED|Overall Study||37
7707130|NCT01753739|18979102|P5|NOT COMPLETED|Overall Study||3
7707131|NCT01753739|18979103|P4|NOT COMPLETED|Overall Study||7
7707132|NCT01753739|18979104|P3|NOT COMPLETED|Overall Study||5
7707133|NCT01753739|18979105|P2|NOT COMPLETED|Overall Study||5
7707134|NCT01753739|18979106|P1|NOT COMPLETED|Overall Study||4
7707135|NCT01753739|18979102|P5|COMPLETED|Overall Study||120
7707136|NCT01753739|18979103|P4|COMPLETED|Overall Study||117
7707137|NCT01753739|18979104|P3|COMPLETED|Overall Study||118
7707138|NCT01753739|18979105|P2|COMPLETED|Overall Study||118
7707139|NCT01753739|18979106|P1|COMPLETED|Overall Study||120
7707140|NCT01753739|18979102|P5|STARTED|Overall Study||123
7707141|NCT01753739|18979103|P4|STARTED|Overall Study||124
7707142|NCT01753739|18979104|P3|STARTED|Overall Study||123
7707143|NCT01753739|18979105|P2|STARTED|Overall Study||123
7707144|NCT01753739|18979106|P1|STARTED|Overall Study||124
7707145|NCT01753713|18979130|P2|NOT COMPLETED|Overall Study||0
7707146|NCT01753713|18979131|P1|NOT COMPLETED|Overall Study||0
7707147|NCT01753713|18979130|P2|COMPLETED|Overall Study||19
7707148|NCT01753713|18979131|P1|COMPLETED|Overall Study||14
7707149|NCT01753713|18979130|P2|STARTED|Overall Study||19
7707150|NCT01753713|18979131|P1|STARTED|Overall Study||14
7707151|NCT01753570|18979150|P3|NOT COMPLETED|Overall Study||1
7707152|NCT01753570|18979151|P2|NOT COMPLETED|Overall Study||5
7707153|NCT01753570|18979152|P1|NOT COMPLETED|Overall Study||2
7707154|NCT01753570|18979150|P3|COMPLETED|Overall Study||13
7707155|NCT01753570|18979151|P2|COMPLETED|Overall Study||25
7707156|NCT01753570|18979152|P1|COMPLETED|Overall Study||28
7707157|NCT01753570|18979150|P3|STARTED|Overall Study||14
7707158|NCT01753570|18979151|P2|STARTED|Overall Study||30
7707159|NCT01753570|18979152|P1|STARTED|Overall Study||30
7707160|NCT01753557|18979176|P2|NOT COMPLETED|Overall Study||0
7707161|NCT01753557|18979177|P1|NOT COMPLETED|Overall Study||0
7707162|NCT01753557|18979176|P2|COMPLETED|Overall Study||19
7707163|NCT01753557|18979177|P1|COMPLETED|Overall Study||35
7707164|NCT01753557|18979176|P2|STARTED|Overall Study||19
7707165|NCT01753557|18979177|P1|STARTED|Overall Study||35
7707166|NCT01753518|18979195|P2|NOT COMPLETED|Postpartum Follow-up||15
7707167|NCT01753518|18979196|P1|NOT COMPLETED|Postpartum Follow-up||22
7707168|NCT01753518|18979195|P2|COMPLETED|Postpartum Follow-up||88
7707169|NCT01753518|18979196|P1|COMPLETED|Postpartum Follow-up||81
7707170|NCT01753518|18979195|P2|STARTED|Postpartum Follow-up||103
7707171|NCT01753518|18979196|P1|STARTED|Postpartum Follow-up||103
7707172|NCT01753518|18979195|P2|NOT COMPLETED|Intention-to-Treat Analysis||7
7707173|NCT01753518|18979196|P1|NOT COMPLETED|Intention-to-Treat Analysis||7
7707174|NCT01753518|18979195|P2|COMPLETED|Intention-to-Treat Analysis||103
7707175|NCT01753518|18979196|P1|COMPLETED|Intention-to-Treat Analysis||103
7707176|NCT01753518|18979195|P2|STARTED|Intention-to-Treat Analysis||110
7707177|NCT01753518|18979196|P1|STARTED|Intention-to-Treat Analysis||110
7707178|NCT01753401|18979220|P4|NOT COMPLETED|Open Label Period (44 Weeks)||9
7707179|NCT01753401|18979221|P3|NOT COMPLETED|Open Label Period (44 Weeks)||4
7707180|NCT01753401|18979222|P2|NOT COMPLETED|Open Label Period (44 Weeks)||0
7707181|NCT01753401|18979223|P1|NOT COMPLETED|Open Label Period (44 Weeks)||0
7707182|NCT01753401|18979220|P4|COMPLETED|Open Label Period (44 Weeks)||13
7707183|NCT01753401|18979221|P3|COMPLETED|Open Label Period (44 Weeks)||7
7707184|NCT01753401|18979222|P2|COMPLETED|Open Label Period (44 Weeks)||0
7707185|NCT01753401|18979223|P1|COMPLETED|Open Label Period (44 Weeks)||0
7707186|NCT01753401|18979220|P4|Safety Analysis Set|Open Label Period (44 Weeks)||22
7707187|NCT01753401|18979221|P3|Safety Analysis Set|Open Label Period (44 Weeks)||11
7707188|NCT01753401|18979222|P2|Safety Analysis Set|Open Label Period (44 Weeks)||0
7707189|NCT01753401|18979223|P1|Safety Analysis Set|Open Label Period (44 Weeks)||0
7707190|NCT01753401|18979220|P4|mITT|Open Label Period (44 Weeks)||22
7707191|NCT01753401|18979221|P3|mITT|Open Label Period (44 Weeks)||11
7707192|NCT01753401|18979222|P2|mITT|Open Label Period (44 Weeks)||0
7707193|NCT01753401|18979223|P1|mITT|Open Label Period (44 Weeks)||0
7707194|NCT01753401|18979220|P4|STARTED|Open Label Period (44 Weeks)||22
7707195|NCT01753401|18979221|P3|STARTED|Open Label Period (44 Weeks)||11
7707196|NCT01753401|18979222|P2|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
7707197|NCT01753401|18979223|P1|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
7707198|NCT01753401|18979220|P4|NOT COMPLETED|Double-blind Period (8 Weeks)||0
7707199|NCT01753401|18979221|P3|NOT COMPLETED|Double-blind Period (8 Weeks)||0
7707200|NCT01753401|18979222|P2|NOT COMPLETED|Double-blind Period (8 Weeks)||4
7707201|NCT01753401|18979223|P1|NOT COMPLETED|Double-blind Period (8 Weeks)||1
7707202|NCT01753401|18979220|P4|COMPLETED|Double-blind Period (8 Weeks)||0
7707203|NCT01753401|18979221|P3|COMPLETED|Double-blind Period (8 Weeks)||0
7707204|NCT01753401|18979222|P2|COMPLETED|Double-blind Period (8 Weeks)||22
7707205|NCT01753401|18979223|P1|COMPLETED|Double-blind Period (8 Weeks)||11
7707206|NCT01753401|18979220|P4|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
7707207|NCT01753401|18979221|P3|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
7707208|NCT01753401|18979222|P2|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||25
7707209|NCT01753401|18979223|P1|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||11
7707210|NCT01753401|18979220|P4|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
7707211|NCT01753401|18979221|P3|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
7707212|NCT01753401|18979222|P2|STARTED|Double-blind Period (8 Weeks)||26
7707213|NCT01753401|18979223|P1|STARTED|Double-blind Period (8 Weeks)||12
7707214|NCT01753362|18979273|P2|NOT COMPLETED|Overall Study||8
7707215|NCT01753362|18979274|P1|NOT COMPLETED|Overall Study||10
7707216|NCT01753362|18979273|P2|COMPLETED|Overall Study||40
7707217|NCT01753362|18979274|P1|COMPLETED|Overall Study||26
7707218|NCT01753362|18979273|P2|STARTED|Overall Study||48
7707219|NCT01753362|18979274|P1|STARTED|Overall Study||36
7707220|NCT01753336|18979282|P1|NOT COMPLETED|Overall Study||20
7707221|NCT01753336|18979282|P1|COMPLETED|Overall Study||92
7707222|NCT01753336|18979282|P1|Cycle 3|Overall Study||93
7707223|NCT01753336|18979282|P1|Cycle 2|Overall Study||98
7707224|NCT01753336|18979282|P1|Cycle 1|Overall Study||112
7707225|NCT01753336|18979282|P1|STARTED|Overall Study||112
7707226|NCT01753323|18979294|P3|NOT COMPLETED|Overall Study||9
7707227|NCT01753323|18979295|P2|NOT COMPLETED|Overall Study||0
7707228|NCT01753323|18979296|P1|NOT COMPLETED|Overall Study||1
7707229|NCT01753323|18979294|P3|COMPLETED|Overall Study||13
7707230|NCT01753323|18979295|P2|COMPLETED|Overall Study||10
7707231|NCT01753323|18979296|P1|COMPLETED|Overall Study||10
7707232|NCT01753323|18979294|P3|Intent-to-treat Analysis Set|Overall Study||22
7707233|NCT01753323|18979295|P2|Intent-to-treat Analysis Set|Overall Study||10
7707234|NCT01753323|18979296|P1|Intent-to-treat Analysis Set|Overall Study||11
7707235|NCT01753323|18979294|P3|Safety Set|Overall Study||22
7707236|NCT01753323|18979295|P2|Safety Set|Overall Study||10
7707237|NCT01753323|18979296|P1|Safety Set|Overall Study||11
7707238|NCT01753323|18979294|P3|Pharmacokinetic(PK) Set|Overall Study||21
7707239|NCT01753323|18979295|P2|Pharmacokinetic(PK) Set|Overall Study||10
7707240|NCT01753323|18979296|P1|Pharmacokinetic(PK) Set|Overall Study||10
7707241|NCT01753323|18979294|P3|Pharmacodynamic (PD) Set|Overall Study||21
7707242|NCT01753323|18979295|P2|Pharmacodynamic (PD) Set|Overall Study||10
7707243|NCT01753323|18979296|P1|Pharmacodynamic (PD) Set|Overall Study||10
7707244|NCT01753323|18979294|P3|STARTED|Overall Study||22
7707245|NCT01753323|18979295|P2|STARTED|Overall Study||10
7707246|NCT01753323|18979296|P1|STARTED|Overall Study||11
7707247|NCT01753310|18979334|P2|NOT COMPLETED|Overall Study||24
7707248|NCT01753310|18979335|P1|NOT COMPLETED|Overall Study||32
7707249|NCT01753310|18979334|P2|COMPLETED|Overall Study||21
7707250|NCT01753310|18979335|P1|COMPLETED|Overall Study||57
7707251|NCT01753310|18979334|P2|STARTED|Overall Study||45
7707252|NCT01753310|18979335|P1|STARTED|Overall Study||89
7707253|NCT01753297|18979357|P2|NOT COMPLETED|Overall Study||36
7707254|NCT01753297|18979358|P1|NOT COMPLETED|Overall Study||41
7707255|NCT01753297|18979357|P2|COMPLETED|Overall Study||73
7707256|NCT01753297|18979358|P1|COMPLETED|Overall Study||76
7707257|NCT01753297|18979357|P2|Received Triptorelin Treatment|Overall Study||105
7707258|NCT01753297|18979358|P1|Received Triptorelin Treatment|Overall Study||0
7707259|NCT01753297|18979357|P2|STARTED|Overall Study||109
7707260|NCT01753297|18979358|P1|STARTED|Overall Study||117
7707261|NCT01753193|18979390|P1|NOT COMPLETED|Overall Study||46
7707262|NCT01753193|18979390|P1|COMPLETED|Overall Study||172
7707263|NCT01753193|18979390|P1|STARTED|Overall Study||218
7707264|NCT01753115|18979405|P3|NOT COMPLETED|Overall Study||14
7707265|NCT01753115|18979406|P2|NOT COMPLETED|Overall Study||15
7707266|NCT01753115|18979407|P1|NOT COMPLETED|Overall Study||12
7707267|NCT01753115|18979405|P3|COMPLETED|Overall Study||56
7707268|NCT01753115|18979406|P2|COMPLETED|Overall Study||25
7707269|NCT01753115|18979407|P1|COMPLETED|Overall Study||32
7707270|NCT01753115|18979405|P3|Treated|Overall Study||67
7707271|NCT01753115|18979406|P2|Treated|Overall Study||39
7707272|NCT01753115|18979407|P1|Treated|Overall Study||38
7707273|NCT01753115|18979405|P3|STARTED|Overall Study||70
7707274|NCT01753115|18979406|P2|STARTED|Overall Study||40
7707275|NCT01753115|18979407|P1|STARTED|Overall Study||44
7707276|NCT01753076|18979417|P2|NOT COMPLETED|Overall Study||46
7707277|NCT01753076|18979418|P1|NOT COMPLETED|Overall Study||41
7707278|NCT01753076|18979417|P2|COMPLETED|Overall Study||106
7707279|NCT01753076|18979418|P1|COMPLETED|Overall Study||110
7707280|NCT01753076|18979417|P2|STARTED|Overall Study||152
7707281|NCT01753076|18979418|P1|STARTED|Overall Study||151
7707282|NCT01752985|18979445|P3|NOT COMPLETED|Follow-up Period||0
7707283|NCT01752985|18979446|P2|NOT COMPLETED|Follow-up Period||0
7707284|NCT01752985|18979447|P1|NOT COMPLETED|Follow-up Period||0
7707285|NCT01752985|18979445|P3|COMPLETED|Follow-up Period||26
7707286|NCT01752985|18979446|P2|COMPLETED|Follow-up Period||27
7707287|NCT01752985|18979447|P1|COMPLETED|Follow-up Period||28
7707288|NCT01752985|18979445|P3|STARTED|Follow-up Period|Includes 24 participants in this period and 2 participants re-joined for follow-up|26
7707289|NCT01752985|18979446|P2|STARTED|Follow-up Period||27
7707290|NCT01752985|18979447|P1|STARTED|Follow-up Period|Includes 25 participants in this period and 3 participants re-joined for follow-up|28
7707291|NCT01752985|18979445|P3|NOT COMPLETED|Treatment Period||5
7707292|NCT01752985|18979446|P2|NOT COMPLETED|Treatment Period||3
7707293|NCT01752985|18979447|P1|NOT COMPLETED|Treatment Period||4
7707294|NCT01752985|18979445|P3|COMPLETED|Treatment Period||24
7707295|NCT01752985|18979446|P2|COMPLETED|Treatment Period||27
7707296|NCT01752985|18979447|P1|COMPLETED|Treatment Period||25
7707297|NCT01752985|18979445|P3|STARTED|Treatment Period||29
7707298|NCT01752985|18979446|P2|STARTED|Treatment Period||30
7707299|NCT01752985|18979447|P1|STARTED|Treatment Period||29
7707300|NCT01752933|18979475|P2|NOT COMPLETED|Overall Study and Follow-up||46
7707301|NCT01752933|18979476|P1|NOT COMPLETED|Overall Study and Follow-up||4
7707302|NCT01752933|18979475|P2|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
7707303|NCT01752933|18979476|P1|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
7707304|NCT01752933|18979475|P2|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|46
7707305|NCT01752933|18979476|P1|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|4
7707306|NCT01752933|18979475|P2|NOT COMPLETED|Treatment||46
7707307|NCT01752933|18979476|P1|NOT COMPLETED|Treatment||4
7707308|NCT01752933|18979475|P2|COMPLETED|Treatment|Completion not applicable for this survival study|0
7707309|NCT01752933|18979476|P1|COMPLETED|Treatment|Completion not applicable for this survival study|0
7707310|NCT01752933|18979475|P2|STARTED|Treatment|Includes all patients who received any treatment|46
7707311|NCT01752933|18979476|P1|STARTED|Treatment|Includes all patients who received any treatment|4
7707312|NCT01752907|18979494|P2|NOT COMPLETED|Overall Study||20
7707313|NCT01752907|18979495|P1|NOT COMPLETED|Overall Study||12
7707314|NCT01752907|18979494|P2|COMPLETED|Overall Study||133
7707315|NCT01752907|18979495|P1|COMPLETED|Overall Study||139
7707316|NCT01752907|18979494|P2|Received Pegfilgrastim|Overall Study||151
7707317|NCT01752907|18979495|P1|Received Pegfilgrastim|Overall Study||149
7707318|NCT01752907|18979494|P2|STARTED|Overall Study||153
7707319|NCT01752907|18979495|P1|STARTED|Overall Study||151
7707320|NCT01752855|18979515|P2|NOT COMPLETED|Overall Study||4
7707321|NCT01752855|18979516|P1|NOT COMPLETED|Overall Study||1
7707322|NCT01752855|18979515|P2|COMPLETED|Overall Study||40
7707323|NCT01752855|18979516|P1|COMPLETED|Overall Study||43
7707324|NCT01752855|18979515|P2|STARTED|Overall Study||44
7707325|NCT01752855|18979516|P1|STARTED|Overall Study||44
7707326|NCT01752842|18979532|P2|NOT COMPLETED|Overall Study||2
7707327|NCT01752842|18979533|P1|NOT COMPLETED|Overall Study||3
7707328|NCT01752842|18979532|P2|COMPLETED|Overall Study||34
7707329|NCT01752842|18979533|P1|COMPLETED|Overall Study||31
7707330|NCT01752842|18979532|P2|STARTED|Overall Study||36
7707331|NCT01752842|18979533|P1|STARTED|Overall Study||34
7707332|NCT01752712|18979545|P2|NOT COMPLETED|Overall Study||10
7707333|NCT01752712|18979546|P1|NOT COMPLETED|Overall Study||9
7707334|NCT01752712|18979545|P2|COMPLETED|Overall Study||21
7707335|NCT01752712|18979546|P1|COMPLETED|Overall Study||22
7707336|NCT01752712|18979545|P2|STARTED|Overall Study||31
7707337|NCT01752712|18979546|P1|STARTED|Overall Study||31
7707338|NCT01752634|18979568|P6|NOT COMPLETED|Week 24 to Week 260||0
7707339|NCT01752634|18979569|P5|NOT COMPLETED|Week 24 to Week 260||14
7707340|NCT01752634|18979570|P4|NOT COMPLETED|Week 24 to Week 260||14
7707341|NCT01752634|18979571|P3|NOT COMPLETED|Week 24 to Week 260||33
7707342|NCT01752634|18979572|P2|NOT COMPLETED|Week 24 to Week 260||30
7707343|NCT01752634|18979573|P1|NOT COMPLETED|Week 24 to Week 260||34
7707344|NCT01752634|18979568|P6|COMPLETED|Week 24 to Week 260||0
7707345|NCT01752634|18979569|P5|COMPLETED|Week 24 to Week 260||31
7707346|NCT01752634|18979570|P4|COMPLETED|Week 24 to Week 260||29
7707347|NCT01752634|18979571|P3|COMPLETED|Week 24 to Week 260||64
7707348|NCT01752634|18979572|P2|COMPLETED|Week 24 to Week 260||65
7707349|NCT01752634|18979573|P1|COMPLETED|Week 24 to Week 260||59
7707350|NCT01752634|18979568|P6|STARTED|Week 24 to Week 260||0
7707351|NCT01752634|18979569|P5|STARTED|Week 24 to Week 260||45
7707352|NCT01752634|18979570|P4|STARTED|Week 24 to Week 260||43
7707353|NCT01752634|18979571|P3|STARTED|Week 24 to Week 260||97
7707354|NCT01752634|18979572|P2|STARTED|Week 24 to Week 260||95
7707355|NCT01752634|18979573|P1|STARTED|Week 24 to Week 260||93
7707356|NCT01752634|18979568|P6|NOT COMPLETED|Up to Week 24 (Primary Analysis)||10
7707357|NCT01752634|18979569|P5|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
7707358|NCT01752634|18979570|P4|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
7707359|NCT01752634|18979571|P3|NOT COMPLETED|Up to Week 24 (Primary Analysis)||3
7707360|NCT01752634|18979572|P2|NOT COMPLETED|Up to Week 24 (Primary Analysis)||5
7707361|NCT01752634|18979573|P1|NOT COMPLETED|Up to Week 24 (Primary Analysis)||6
7707362|NCT01752634|18979568|P6|COMPLETED|Up to Week 24 (Primary Analysis)||0
7707363|NCT01752634|18979569|P5|COMPLETED|Up to Week 24 (Primary Analysis)||45
7707364|NCT01752634|18979570|P4|COMPLETED|Up to Week 24 (Primary Analysis)||43
7707365|NCT01752634|18979571|P3|COMPLETED|Up to Week 24 (Primary Analysis)||97
7707366|NCT01752634|18979572|P2|COMPLETED|Up to Week 24 (Primary Analysis)||95
7707367|NCT01752634|18979573|P1|COMPLETED|Up to Week 24 (Primary Analysis)||93
7707368|NCT01752634|18979568|P6|STARTED|Up to Week 24 (Primary Analysis)||10
7707369|NCT01752634|18979569|P5|STARTED|Up to Week 24 (Primary Analysis)||45
7707370|NCT01752634|18979570|P4|STARTED|Up to Week 24 (Primary Analysis)||43
7707371|NCT01752634|18979571|P3|STARTED|Up to Week 24 (Primary Analysis)||100
7707372|NCT01752634|18979572|P2|STARTED|Up to Week 24 (Primary Analysis)||100
7707373|NCT01752634|18979573|P1|STARTED|Up to Week 24 (Primary Analysis)||99
7707374|NCT01752426|18979615|P1|NOT COMPLETED|Overall Study||0
7707375|NCT01752426|18979615|P1|COMPLETED|Overall Study||30
7707376|NCT01752426|18979615|P1|STARTED|Overall Study||30
7707377|NCT01752400|18979620|P1|NOT COMPLETED|Overall Study||0
7707378|NCT01752400|18979620|P1|COMPLETED|Overall Study||6
7707379|NCT01752400|18979620|P1|STARTED|Overall Study||6
7707380|NCT01752036|18979631|P1|NOT COMPLETED|Overall Study||2
7707381|NCT01752036|18979631|P1|COMPLETED|Overall Study||31
7707382|NCT01752036|18979631|P1|STARTED|Overall Study||33
7707383|NCT01752023|18979644|P2|NOT COMPLETED|Overall Study||1
7707384|NCT01752023|18979645|P1|NOT COMPLETED|Overall Study||2
7707385|NCT01752023|18979644|P2|COMPLETED|Overall Study||0
7707386|NCT01752023|18979645|P1|COMPLETED|Overall Study||0
7707387|NCT01752023|18979644|P2|STARTED|Overall Study||1
7707388|NCT01752023|18979645|P1|STARTED|Overall Study||2
7707389|NCT01751971|18979663|P2|NOT COMPLETED|Overall Study||1
7707390|NCT01751971|18979664|P1|NOT COMPLETED|Overall Study||2
7707391|NCT01751971|18979663|P2|COMPLETED|Overall Study||24
7707392|NCT01751971|18979664|P1|COMPLETED|Overall Study||20
7707393|NCT01751971|18979663|P2|STARTED|Overall Study||25
7707394|NCT01751971|18979664|P1|STARTED|Overall Study||22
7707395|NCT01751906|18979681|P2|NOT COMPLETED|Overall Study||47
7707396|NCT01751906|18979682|P1|NOT COMPLETED|Overall Study||84
7707397|NCT01751906|18979681|P2|COMPLETED|Overall Study||639
7707398|NCT01751906|18979682|P1|COMPLETED|Overall Study||1238
7707399|NCT01751906|18979681|P2|STARTED|Overall Study||686
7707400|NCT01751906|18979682|P1|STARTED|Overall Study||1322
7707401|NCT01751867|18979886|P2|NOT COMPLETED|Overall Study||99
7707402|NCT01751867|18979887|P1|NOT COMPLETED|Overall Study||36
7707403|NCT01751867|18979886|P2|COMPLETED|Overall Study||0
7707404|NCT01751867|18979887|P1|COMPLETED|Overall Study||0
7707405|NCT01751867|18979886|P2|Treated|Overall Study||98
7707406|NCT01751867|18979887|P1|Treated|Overall Study||34
7707407|NCT01751867|18979886|P2|STARTED|Overall Study||99
7707408|NCT01751867|18979887|P1|STARTED|Overall Study||36
7707409|NCT01751802|18979907|P2|NOT COMPLETED|Overall Study||2
7707410|NCT01751802|18979908|P1|NOT COMPLETED|Overall Study||4
7707411|NCT01751802|18979907|P2|COMPLETED|Overall Study||2
7707412|NCT01751802|18979908|P1|COMPLETED|Overall Study||1
7707413|NCT01751802|18979907|P2|Completed Period 3|Overall Study||1
7707414|NCT01751802|18979908|P1|Completed Period 3|Overall Study||2
7707415|NCT01751802|18979907|P2|Completed Period 2|Overall Study||1
7707416|NCT01751802|18979908|P1|Completed Period 2|Overall Study||2
7707417|NCT01751802|18979907|P2|Completed Period 1|Overall Study||4
7707418|NCT01751802|18979908|P1|Completed Period 1|Overall Study||2
7707419|NCT01751802|18979907|P2|STARTED|Overall Study||4
7707420|NCT01751802|18979908|P1|STARTED|Overall Study||5
7707421|NCT01751724|18979922|P2|NOT COMPLETED|Overall Study||2
7707422|NCT01751724|18979923|P1|NOT COMPLETED|Overall Study||1
7707423|NCT01751724|18979922|P2|COMPLETED|Overall Study||42
7707424|NCT01751724|18979923|P1|COMPLETED|Overall Study||41
7707425|NCT01751724|18979922|P2|STARTED|Overall Study||44
7707426|NCT01751724|18979923|P1|STARTED|Overall Study||42
7707427|NCT01751646|18979951|P2|NOT COMPLETED|Overall Study||18
7707428|NCT01751646|18979952|P1|NOT COMPLETED|Overall Study||11
7707429|NCT01751646|18979951|P2|COMPLETED|Overall Study||87
7707430|NCT01751646|18979952|P1|COMPLETED|Overall Study||98
7707431|NCT01751646|18979951|P2|STARTED|Overall Study||105
7707432|NCT01751646|18979952|P1|STARTED|Overall Study||109
7707433|NCT01751568|18980103|P3|NOT COMPLETED|Overall Study||0
7707434|NCT01751568|18980104|P2|NOT COMPLETED|Overall Study||0
7707435|NCT01751568|18980105|P1|NOT COMPLETED|Overall Study||1
7707436|NCT01751568|18980103|P3|COMPLETED|Overall Study||13
7707437|NCT01751568|18980104|P2|COMPLETED|Overall Study||14
7707438|NCT01751568|18980105|P1|COMPLETED|Overall Study||12
7707439|NCT01751568|18980103|P3|STARTED|Overall Study||13
7707440|NCT01751568|18980104|P2|STARTED|Overall Study||14
7707441|NCT01751568|18980105|P1|STARTED|Overall Study||13
7707442|NCT01751412|18980134|P1|NOT COMPLETED|Overall Study||1
7707443|NCT01751412|18980134|P1|COMPLETED|Overall Study||11
7707444|NCT01751412|18980134|P1|STARTED|Overall Study||12
7707445|NCT01751399|18980148|P4|NOT COMPLETED|Overall Study||0
7707446|NCT01751399|18980149|P3|NOT COMPLETED|Overall Study||0
7707447|NCT01751399|18980150|P2|NOT COMPLETED|Overall Study||0
7707448|NCT01751399|18980151|P1|NOT COMPLETED|Overall Study||0
7707449|NCT01751399|18980148|P4|COMPLETED|Overall Study||7
7707450|NCT01751399|18980149|P3|COMPLETED|Overall Study||8
7707451|NCT01751399|18980150|P2|COMPLETED|Overall Study||8
7707452|NCT01751399|18980151|P1|COMPLETED|Overall Study||12
7707453|NCT01751399|18980148|P4|Received 1 Dose of Study Drug|Overall Study||7
7707454|NCT01751399|18980149|P3|Received 1 Dose of Study Drug|Overall Study||8
7707455|NCT01751399|18980150|P2|Received 1 Dose of Study Drug|Overall Study||8
7707456|NCT01751399|18980151|P1|Received 1 Dose of Study Drug|Overall Study||12
7707457|NCT01751399|18980148|P4|STARTED|Overall Study||7
7707458|NCT01751399|18980149|P3|STARTED|Overall Study||8
7707459|NCT01751399|18980150|P2|STARTED|Overall Study||8
7707460|NCT01751399|18980151|P1|STARTED|Overall Study||12
7707461|NCT01751386|18980167|P2|NOT COMPLETED|Overall Study||3
7707462|NCT01751386|18980168|P1|NOT COMPLETED|Overall Study||2
7707463|NCT01751386|18980167|P2|COMPLETED|Overall Study||16
7707464|NCT01751386|18980168|P1|COMPLETED|Overall Study||18
7707465|NCT01751386|18980167|P2|STARTED|Overall Study||19
7707466|NCT01751386|18980168|P1|STARTED|Overall Study||20
7707467|NCT01751308|18980179|P5|NOT COMPLETED|Phase 2||0
7707468|NCT01751308|18980180|P4|NOT COMPLETED|Phase 2||0
7707469|NCT01751308|18980181|P3|NOT COMPLETED|Phase 2||0
7707470|NCT01751308|18980182|P2|NOT COMPLETED|Phase 2||0
7707471|NCT01751308|18980183|P1|NOT COMPLETED|Phase 2||0
7707472|NCT01751308|18980179|P5|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16
7707473|NCT01751308|18980180|P4|COMPLETED|Phase 2||0
7707474|NCT01751308|18980181|P3|COMPLETED|Phase 2||0
7707475|NCT01751308|18980182|P2|COMPLETED|Phase 2||0
7707476|NCT01751308|18980183|P1|COMPLETED|Phase 2||0
7707477|NCT01751308|18980179|P5|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16
7707478|NCT01751308|18980180|P4|STARTED|Phase 2||0
7707479|NCT01751308|18980181|P3|STARTED|Phase 2||0
7707480|NCT01751308|18980182|P2|STARTED|Phase 2||0
7707481|NCT01751308|18980183|P1|STARTED|Phase 2||0
7707482|NCT01751308|18980179|P5|NOT COMPLETED|Phase 1||0
7707483|NCT01751308|18980180|P4|NOT COMPLETED|Phase 1||0
7707484|NCT01751308|18980181|P3|NOT COMPLETED|Phase 1||0
7707485|NCT01751308|18980182|P2|NOT COMPLETED|Phase 1||0
7707486|NCT01751308|18980183|P1|NOT COMPLETED|Phase 1||0
7707487|NCT01751308|18980179|P5|COMPLETED|Phase 1||0
7707488|NCT01751308|18980180|P4|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
7707489|NCT01751308|18980181|P3|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
7707490|NCT01751308|18980182|P2|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3
7707491|NCT01751308|18980183|P1|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6
7707492|NCT01751308|18980179|P5|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0
7707493|NCT01751308|18980180|P4|STARTED|Phase 1||7
7707494|NCT01751308|18980181|P3|STARTED|Phase 1||7
7707495|NCT01751308|18980182|P2|STARTED|Phase 1||3
7707496|NCT01751308|18980183|P1|STARTED|Phase 1||6
7707497|NCT01751230|18980222|P2|NOT COMPLETED|Overall Study||4
7707498|NCT01751230|18980223|P1|NOT COMPLETED|Overall Study||1
7707499|NCT01751230|18980222|P2|COMPLETED|Overall Study||16
7707500|NCT01751230|18980223|P1|COMPLETED|Overall Study||19
7707501|NCT01751230|18980222|P2|STARTED|Overall Study||20
7707502|NCT01751230|18980223|P1|STARTED|Overall Study||20
7707503|NCT01751178|18980244|P3|NOT COMPLETED|Overall Study||2
7707504|NCT01751178|18980245|P2|NOT COMPLETED|Overall Study||0
7707505|NCT01751178|18980246|P1|NOT COMPLETED|Overall Study||3
7707506|NCT01751178|18980244|P3|COMPLETED|Overall Study||105
7707507|NCT01751178|18980245|P2|COMPLETED|Overall Study||109
7707508|NCT01751178|18980246|P1|COMPLETED|Overall Study||105
7707509|NCT01751178|18980244|P3|STARTED|Overall Study||107
7707510|NCT01751178|18980245|P2|STARTED|Overall Study||109
7707511|NCT01751178|18980246|P1|STARTED|Overall Study||108
7707512|NCT01751165|18980266|P3|NOT COMPLETED|Overall Study||3
7707513|NCT01751165|18980267|P2|NOT COMPLETED|Overall Study||3
7707514|NCT01751165|18980268|P1|NOT COMPLETED|Overall Study||2
7707515|NCT01751165|18980266|P3|COMPLETED|Overall Study||113
7707516|NCT01751165|18980267|P2|COMPLETED|Overall Study||116
7707517|NCT01751165|18980268|P1|COMPLETED|Overall Study||117
7707518|NCT01751165|18980266|P3|STARTED|Overall Study||116
7707519|NCT01751165|18980267|P2|STARTED|Overall Study||119
7707520|NCT01751165|18980268|P1|STARTED|Overall Study||119
7707521|NCT01751139|18980308|P1|NOT COMPLETED|Overall Study||2267
7707522|NCT01751139|18980308|P1|COMPLETED|Overall Study||1033
7707523|NCT01751139|18980308|P1|STARTED|Overall Study||3300
7707524|NCT01751113|18980326|P6|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1
7707525|NCT01751113|18980327|P5|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
7707526|NCT01751113|18980328|P4|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
7707527|NCT01751113|18980329|P3|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
7707528|NCT01751113|18980330|P2|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
7707529|NCT01751113|18980331|P1|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
7707530|NCT01751113|18980326|P6|COMPLETED|Treatment Period 3 (4 Weeks)||9
7707531|NCT01751113|18980327|P5|COMPLETED|Treatment Period 3 (4 Weeks)||8
7707532|NCT01751113|18980328|P4|COMPLETED|Treatment Period 3 (4 Weeks)||8
7707533|NCT01751113|18980329|P3|COMPLETED|Treatment Period 3 (4 Weeks)||9
7707534|NCT01751113|18980330|P2|COMPLETED|Treatment Period 3 (4 Weeks)||8
7707535|NCT01751113|18980331|P1|COMPLETED|Treatment Period 3 (4 Weeks)||8
7707536|NCT01751113|18980326|P6|STARTED|Treatment Period 3 (4 Weeks)||10
7707537|NCT01751113|18980327|P5|STARTED|Treatment Period 3 (4 Weeks)||8
7707538|NCT01751113|18980328|P4|STARTED|Treatment Period 3 (4 Weeks)||8
7707539|NCT01751113|18980329|P3|STARTED|Treatment Period 3 (4 Weeks)||9
7707540|NCT01751113|18980330|P2|STARTED|Treatment Period 3 (4 Weeks)||8
7707541|NCT01751113|18980331|P1|STARTED|Treatment Period 3 (4 Weeks)||8
7707542|NCT01751113|18980326|P6|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
7707543|NCT01751113|18980327|P5|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
7707544|NCT01751113|18980328|P4|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
7707545|NCT01751113|18980329|P3|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
7707546|NCT01751113|18980330|P2|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
7707547|NCT01751113|18980331|P1|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
7707548|NCT01751113|18980326|P6|COMPLETED|Washout Period 2 (2 Weeks)||10
7707549|NCT01751113|18980327|P5|COMPLETED|Washout Period 2 (2 Weeks)||8
7707550|NCT01751113|18980328|P4|COMPLETED|Washout Period 2 (2 Weeks)||8
7707551|NCT01751113|18980329|P3|COMPLETED|Washout Period 2 (2 Weeks)||9
7707552|NCT01751113|18980330|P2|COMPLETED|Washout Period 2 (2 Weeks)||8
7707553|NCT01751113|18980331|P1|COMPLETED|Washout Period 2 (2 Weeks)||8
7707554|NCT01751113|18980326|P6|STARTED|Washout Period 2 (2 Weeks)||10
7707555|NCT01751113|18980327|P5|STARTED|Washout Period 2 (2 Weeks)||8
7707556|NCT01751113|18980328|P4|STARTED|Washout Period 2 (2 Weeks)||8
7707557|NCT01751113|18980329|P3|STARTED|Washout Period 2 (2 Weeks)||9
7707558|NCT01751113|18980330|P2|STARTED|Washout Period 2 (2 Weeks)||8
7707559|NCT01751113|18980331|P1|STARTED|Washout Period 2 (2 Weeks)||8
7707560|NCT01751113|18980326|P6|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
7707561|NCT01751113|18980327|P5|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
7707562|NCT01751113|18980328|P4|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
7707563|NCT01751113|18980329|P3|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
7707564|NCT01751113|18980330|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
7707565|NCT01751113|18980331|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
7707566|NCT01751113|18980326|P6|COMPLETED|Treatment Period 2 (4 Weeks)||10
7707567|NCT01751113|18980327|P5|COMPLETED|Treatment Period 2 (4 Weeks)||8
7707568|NCT01751113|18980328|P4|COMPLETED|Treatment Period 2 (4 Weeks)||8
7707569|NCT01751113|18980329|P3|COMPLETED|Treatment Period 2 (4 Weeks)||9
7707570|NCT01751113|18980330|P2|COMPLETED|Treatment Period 2 (4 Weeks)||8
7707571|NCT01751113|18980331|P1|COMPLETED|Treatment Period 2 (4 Weeks)||8
7707572|NCT01751113|18980326|P6|STARTED|Treatment Period 2 (4 Weeks)||10
7707573|NCT01751113|18980327|P5|STARTED|Treatment Period 2 (4 Weeks)||8
7707574|NCT01751113|18980328|P4|STARTED|Treatment Period 2 (4 Weeks)||8
7707575|NCT01751113|18980329|P3|STARTED|Treatment Period 2 (4 Weeks)||9
7707576|NCT01751113|18980330|P2|STARTED|Treatment Period 2 (4 Weeks)||8
7707577|NCT01751113|18980331|P1|STARTED|Treatment Period 2 (4 Weeks)||8
7707578|NCT01751113|18980326|P6|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
7707579|NCT01751113|18980327|P5|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
7707580|NCT01751113|18980328|P4|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
7707581|NCT01751113|18980329|P3|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
7707582|NCT01751113|18980330|P2|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
7707583|NCT01751113|18980331|P1|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
7707584|NCT01751113|18980326|P6|COMPLETED|Washout Period 1 (2 Weeks)||10
7707585|NCT01751113|18980327|P5|COMPLETED|Washout Period 1 (2 Weeks)||8
7707586|NCT01751113|18980328|P4|COMPLETED|Washout Period 1 (2 Weeks)||8
7707587|NCT01751113|18980329|P3|COMPLETED|Washout Period 1 (2 Weeks)||9
7707588|NCT01751113|18980330|P2|COMPLETED|Washout Period 1 (2 Weeks)||8
7707589|NCT01751113|18980331|P1|COMPLETED|Washout Period 1 (2 Weeks)||8
7707590|NCT01751113|18980326|P6|STARTED|Washout Period 1 (2 Weeks)||10
7707591|NCT01751113|18980327|P5|STARTED|Washout Period 1 (2 Weeks)||8
7707592|NCT01751113|18980328|P4|STARTED|Washout Period 1 (2 Weeks)||8
7707593|NCT01751113|18980329|P3|STARTED|Washout Period 1 (2 Weeks)||9
7707594|NCT01751113|18980330|P2|STARTED|Washout Period 1 (2 Weeks)||8
7707595|NCT01751113|18980331|P1|STARTED|Washout Period 1 (2 Weeks)||8
7707596|NCT01751113|18980326|P6|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
7707597|NCT01751113|18980327|P5|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
7707598|NCT01751113|18980328|P4|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
7707599|NCT01751113|18980329|P3|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
7707600|NCT01751113|18980330|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
7707601|NCT01751113|18980331|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
7707602|NCT01751113|18980326|P6|COMPLETED|Treatment Period 1 (4 Weeks)||10
7707603|NCT01751113|18980327|P5|COMPLETED|Treatment Period 1 (4 Weeks)||8
7707604|NCT01751113|18980328|P4|COMPLETED|Treatment Period 1 (4 Weeks)||8
7707605|NCT01751113|18980329|P3|COMPLETED|Treatment Period 1 (4 Weeks)||9
7707606|NCT01751113|18980330|P2|COMPLETED|Treatment Period 1 (4 Weeks)||8
7707607|NCT01751113|18980331|P1|COMPLETED|Treatment Period 1 (4 Weeks)||8
7707608|NCT01751113|18980326|P6|STARTED|Treatment Period 1 (4 Weeks)||10
7707609|NCT01751113|18980327|P5|STARTED|Treatment Period 1 (4 Weeks)||9
7707610|NCT01751113|18980328|P4|STARTED|Treatment Period 1 (4 Weeks)||9
7707611|NCT01751113|18980329|P3|STARTED|Treatment Period 1 (4 Weeks)||9
7707612|NCT01751113|18980330|P2|STARTED|Treatment Period 1 (4 Weeks)||8
7707613|NCT01751113|18980331|P1|STARTED|Treatment Period 1 (4 Weeks)||8
7707614|NCT01751087|18980372|P3|NOT COMPLETED|Overall Study||1
7707615|NCT01751087|18980373|P2|NOT COMPLETED|Overall Study||0
7707616|NCT01751087|18980374|P1|NOT COMPLETED|Overall Study||1
7707617|NCT01751087|18980372|P3|COMPLETED|Overall Study||99
7707618|NCT01751087|18980373|P2|COMPLETED|Overall Study||100
7707619|NCT01751087|18980374|P1|COMPLETED|Overall Study||99
7707620|NCT01751087|18980372|P3|STARTED|Overall Study||100
7707621|NCT01751087|18980373|P2|STARTED|Overall Study||100
7707622|NCT01751087|18980374|P1|STARTED|Overall Study||100
7707623|NCT01751061|18980408|P2|NOT COMPLETED|Overall Study||34
7707624|NCT01751061|18980409|P1|NOT COMPLETED|Overall Study||56
7707625|NCT01751061|18980408|P2|COMPLETED|Overall Study||172
7707626|NCT01751061|18980409|P1|COMPLETED|Overall Study||154
7707627|NCT01751061|18980408|P2|STARTED|Overall Study||206
7707628|NCT01751061|18980409|P1|STARTED|Overall Study||210
7707629|NCT01751022|18980430|P3|NOT COMPLETED|Overall Study||27
7707630|NCT01751022|18980431|P2|NOT COMPLETED|Overall Study||44
7707631|NCT01751022|18980432|P1|NOT COMPLETED|Overall Study||56
7707632|NCT01751022|18980430|P3|COMPLETED|Overall Study|6 month visit|273
7707633|NCT01751022|18980431|P2|COMPLETED|Overall Study|6 month visit|282
7707634|NCT01751022|18980432|P1|COMPLETED|Overall Study|6 month visit|443
7707635|NCT01751022|18980430|P3|STARTED|Overall Study||300
7707636|NCT01751022|18980431|P2|STARTED|Overall Study||326
7707637|NCT01751022|18980432|P1|STARTED|Overall Study||499
7707638|NCT01750931|18980464|P2|NOT COMPLETED|Period 2||0
7707639|NCT01750931|18980465|P1|NOT COMPLETED|Period 2||0
7707640|NCT01750931|18980464|P2|COMPLETED|Period 2||14
7707641|NCT01750931|18980465|P1|COMPLETED|Period 2||14
7707642|NCT01750931|18980464|P2|STARTED|Period 2||14
7707643|NCT01750931|18980465|P1|STARTED|Period 2||14
7707644|NCT01750931|18980464|P2|NOT COMPLETED|Wash Out||0
7707645|NCT01750931|18980465|P1|NOT COMPLETED|Wash Out||0
7707646|NCT01750931|18980464|P2|COMPLETED|Wash Out||14
7707647|NCT01750931|18980465|P1|COMPLETED|Wash Out||14
7707648|NCT01750931|18980464|P2|STARTED|Wash Out||14
7707649|NCT01750931|18980465|P1|STARTED|Wash Out||14
7707650|NCT01750931|18980464|P2|NOT COMPLETED|Period 1||0
7707651|NCT01750931|18980465|P1|NOT COMPLETED|Period 1||0
7707652|NCT01750931|18980464|P2|COMPLETED|Period 1||14
7707653|NCT01750931|18980465|P1|COMPLETED|Period 1||14
7707654|NCT01750931|18980464|P2|STARTED|Period 1||14
7707655|NCT01750931|18980465|P1|STARTED|Period 1||14
7707656|NCT01750840|18980483|P1|NOT COMPLETED|Overall Study||4
7707657|NCT01750840|18980483|P1|COMPLETED|Overall Study||4
7707658|NCT01750840|18980483|P1|STARTED|Overall Study||8
7707659|NCT01750697|18980488|P1|NOT COMPLETED|Overall Study||9
7707660|NCT01750697|18980488|P1|COMPLETED|Overall Study|Completed to CCO. 6 participants entered Extended Safety Follow-up, 10 participants completed Study.|16
7707661|NCT01750697|18980488|P1|Follow-up Phase|Overall Study|Completed required follow-up|24
7707662|NCT01750697|18980488|P1|Completed|Overall Study||25
7707663|NCT01750697|18980488|P1|STARTED|Overall Study||25
7707664|NCT01750684|18980500|P2|NOT COMPLETED|Overall Study||2
7707665|NCT01750684|18980501|P1|NOT COMPLETED|Overall Study||2
7707666|NCT01750684|18980500|P2|COMPLETED|Overall Study||5
7707667|NCT01750684|18980501|P1|COMPLETED|Overall Study||4
7707668|NCT01750684|18980500|P2|STARTED|Overall Study||7
7707669|NCT01750684|18980501|P1|STARTED|Overall Study||6
7707670|NCT01750502|18980511|P2|NOT COMPLETED|Overall Study||0
7707671|NCT01750502|18980512|P1|NOT COMPLETED|Overall Study||0
7707672|NCT01750502|18980511|P2|COMPLETED|Overall Study||186
7707673|NCT01750502|18980512|P1|COMPLETED|Overall Study||70
7707674|NCT01750502|18980511|P2|STARTED|Overall Study||186
7707675|NCT01750502|18980512|P1|STARTED|Overall Study||70
7707676|NCT01750398|18980525|P1|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3
7707677|NCT01750398|18980525|P1|COMPLETED|Bipolar Androgen Thearpy Phase||26
7707678|NCT01750398|18980525|P1|STARTED|Bipolar Androgen Thearpy Phase||29
7707679|NCT01750398|18980525|P1|NOT COMPLETED|ADT Lead In Phase||4
7707680|NCT01750398|18980525|P1|COMPLETED|ADT Lead In Phase||29
7707681|NCT01750398|18980525|P1|STARTED|ADT Lead In Phase||33
7707682|NCT01750346|18980538|P3|NOT COMPLETED|Overall Study||0
7707683|NCT01750346|18980539|P2|NOT COMPLETED|Overall Study||0
7707684|NCT01750346|18980540|P1|NOT COMPLETED|Overall Study||1
7707685|NCT01750346|18980538|P3|COMPLETED|Overall Study||3
7707686|NCT01750346|18980539|P2|COMPLETED|Overall Study||2
7707687|NCT01750346|18980540|P1|COMPLETED|Overall Study||2
7707688|NCT01750346|18980538|P3|STARTED|Overall Study||3
7707689|NCT01750346|18980539|P2|STARTED|Overall Study||2
7707690|NCT01750346|18980540|P1|STARTED|Overall Study||3
7707691|NCT01750294|18980566|P1|NOT COMPLETED|Overall Study||2
7707692|NCT01750294|18980566|P1|COMPLETED|Overall Study||12
7707693|NCT01750294|18980566|P1|STARTED|Overall Study||14
7707694|NCT01750281|18980573|P3|NOT COMPLETED|Overall Study||84
7707695|NCT01750281|18980574|P2|NOT COMPLETED|Overall Study||85
7707696|NCT01750281|18980575|P1|NOT COMPLETED|Overall Study||43
7707697|NCT01750281|18980573|P3|COMPLETED|Overall Study||0
7707698|NCT01750281|18980574|P2|COMPLETED|Overall Study||0
7707699|NCT01750281|18980575|P1|COMPLETED|Overall Study||0
7707700|NCT01750281|18980573|P3|Did Not Receive Treatment|Overall Study||0
7707701|NCT01750281|18980574|P2|Did Not Receive Treatment|Overall Study||1
7707702|NCT01750281|18980575|P1|Did Not Receive Treatment|Overall Study||0
7707703|NCT01750281|18980573|P3|Received Treatment|Overall Study||84
7707704|NCT01750281|18980574|P2|Received Treatment|Overall Study||84
7707705|NCT01750281|18980575|P1|Received Treatment|Overall Study||43
7707706|NCT01750281|18980573|P3|STARTED|Overall Study||84
7707707|NCT01750281|18980574|P2|STARTED|Overall Study||85
7707708|NCT01750281|18980575|P1|STARTED|Overall Study||43
7707709|NCT01750268|18980588|P2|NOT COMPLETED|Overall Study||5
7707710|NCT01750268|18980589|P1|NOT COMPLETED|Overall Study||2
7707711|NCT01750268|18980588|P2|COMPLETED|Overall Study||12
7707712|NCT01750268|18980589|P1|COMPLETED|Overall Study||13
7707713|NCT01750268|18980588|P2|STARTED|Overall Study||17
7707714|NCT01750268|18980589|P1|STARTED|Overall Study||15
7707715|NCT01750255|18980599|P2|NOT COMPLETED|Overall Study||5
7707716|NCT01750255|18980600|P1|NOT COMPLETED|Overall Study||6
7707717|NCT01750255|18980599|P2|COMPLETED|Overall Study||38
7707718|NCT01750255|18980600|P1|COMPLETED|Overall Study||43
7707719|NCT01750255|18980599|P2|STARTED|Overall Study||43
7707720|NCT01750255|18980600|P1|STARTED|Overall Study||49
7707721|NCT01750242|18980616|P1|NOT COMPLETED|Overall Study||3
7707722|NCT01750242|18980616|P1|COMPLETED|Overall Study||20
7707723|NCT01750242|18980616|P1|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20
7707724|NCT01750242|18980616|P1|STARTED|Overall Study||23
7707725|NCT01750229|18980621|P1|NOT COMPLETED|Long-term Follow-up Phase||3
7707726|NCT01750229|18980621|P1|COMPLETED|Long-term Follow-up Phase||25
7707727|NCT01750229|18980621|P1|STARTED|Long-term Follow-up Phase|Four subjects who had protocol violations continued to be followed in long-term follow-up phase.|28
7707728|NCT01750229|18980621|P1|NOT COMPLETED|Randomized Crossover Phase||2
7707729|NCT01750229|18980621|P1|COMPLETED|Randomized Crossover Phase||28
7707730|NCT01750229|18980621|P1|Protocol Violation|Randomized Crossover Phase||4
7707731|NCT01750229|18980621|P1|Subjects Received 5882 Hz|Randomized Crossover Phase||24
7707732|NCT01750229|18980621|P1|Subjects Received 3030 Hz|Randomized Crossover Phase||24
7707733|NCT01750229|18980621|P1|Subjects Received 1200 Hz|Randomized Crossover Phase||24
7707734|NCT01750229|18980621|P1|Subject Received Sham|Randomized Crossover Phase||24
7707735|NCT01750229|18980621|P1|STARTED|Randomized Crossover Phase||30
7707736|NCT01750086|18980633|P2|NOT COMPLETED|Overall Study||1
7707737|NCT01750086|18980634|P1|NOT COMPLETED|Overall Study||1
7707738|NCT01750086|18980633|P2|COMPLETED|Overall Study||13
7707739|NCT01750086|18980634|P1|COMPLETED|Overall Study||12
7707740|NCT01750086|18980633|P2|STARTED|Overall Study||14
7707741|NCT01750086|18980634|P1|STARTED|Overall Study||13
7707742|NCT01749995|18980640|P1|NOT COMPLETED|Overall Study||4
7707743|NCT01749995|18980640|P1|COMPLETED|Overall Study||196
7707744|NCT01749995|18980640|P1|STARTED|Overall Study||200
7707745|NCT01749982|18980648|P4|NOT COMPLETED|Overall Study||3
7707746|NCT01749982|18980649|P3|NOT COMPLETED|Overall Study||0
7707747|NCT01749982|18980650|P2|NOT COMPLETED|Overall Study||0
7707748|NCT01749982|18980651|P1|NOT COMPLETED|Overall Study||0
7707749|NCT01749982|18980648|P4|COMPLETED|Overall Study||12
7707750|NCT01749982|18980649|P3|COMPLETED|Overall Study||15
7707751|NCT01749982|18980650|P2|COMPLETED|Overall Study||15
7707752|NCT01749982|18980651|P1|COMPLETED|Overall Study||15
7707753|NCT01749982|18980648|P4|STARTED|Overall Study||15
7707754|NCT01749982|18980649|P3|STARTED|Overall Study||15
7707755|NCT01749982|18980650|P2|STARTED|Overall Study||15
7707756|NCT01749982|18980651|P1|STARTED|Overall Study||15
7707757|NCT01749956|18980669|P1|NOT COMPLETED|Overall Study||15
7707758|NCT01749956|18980669|P1|COMPLETED|Overall Study||24
7707759|NCT01749956|18980669|P1|STARTED|Overall Study||39
7707760|NCT01749930|18980681|P2|NOT COMPLETED|Overall Study||12
7707761|NCT01749930|18980682|P1|NOT COMPLETED|Overall Study||30
7707762|NCT01749930|18980681|P2|COMPLETED|Overall Study|randomized population|125
7707763|NCT01749930|18980682|P1|COMPLETED|Overall Study|randomized population|253
7707764|NCT01749930|18980681|P2|STARTED|Overall Study|randomized population|137
7707765|NCT01749930|18980682|P1|STARTED|Overall Study|randomized population|283
7707766|NCT01749904|18980698|P2|NOT COMPLETED|Overall Study||11
7707767|NCT01749904|18980699|P1|NOT COMPLETED|Overall Study||22
7707768|NCT01749904|18980698|P2|COMPLETED|Overall Study|randomized population|123
7707769|NCT01749904|18980699|P1|COMPLETED|Overall Study|randomized population|264
7707770|NCT01749904|18980698|P2|STARTED|Overall Study|randomized population|134
7707771|NCT01749904|18980699|P1|STARTED|Overall Study|randomized population|286
7707772|NCT01749826|18980715|P2|NOT COMPLETED|Overall Study||0
7707773|NCT01749826|18980716|P1|NOT COMPLETED|Overall Study||20
7707774|NCT01749826|18980715|P2|COMPLETED|Overall Study||0
7707775|NCT01749826|18980716|P1|COMPLETED|Overall Study||0
7707776|NCT01749826|18980715|P2|STARTED|Overall Study||0
7707777|NCT01749826|18980716|P1|STARTED|Overall Study||20
7707778|NCT01749800|18980731|P3|NOT COMPLETED|Overall Study||0
7707779|NCT01749800|18980732|P2|NOT COMPLETED|Overall Study||1
7707780|NCT01749800|18980733|P1|NOT COMPLETED|Overall Study||3
7707781|NCT01749800|18980731|P3|COMPLETED|Overall Study||0
7707782|NCT01749800|18980732|P2|COMPLETED|Overall Study||0
7707783|NCT01749800|18980733|P1|COMPLETED|Overall Study||3
7707784|NCT01749800|18980731|P3|STARTED|Overall Study||0
7707785|NCT01749800|18980732|P2|STARTED|Overall Study|1 subject showed significant motor impairments but decided to undergo therapy (exclusion criterion)|1
7707786|NCT01749800|18980733|P1|STARTED|Overall Study|3 subjects did not show significant attention span deficit (required inclusion criterion)|6
7707787|NCT01749735|18980743|P2|NOT COMPLETED|Overall Study||0
7707788|NCT01749735|18980744|P1|NOT COMPLETED|Overall Study||1
7707789|NCT01749735|18980743|P2|COMPLETED|Overall Study||0
7707790|NCT01749735|18980744|P1|COMPLETED|Overall Study||1
7707791|NCT01749735|18980743|P2|STARTED|Overall Study||0
7707792|NCT01749735|18980744|P1|STARTED|Overall Study||2
7707793|NCT01749631|18980752|P1|NOT COMPLETED|Overall Study||0
7707794|NCT01749631|18980752|P1|COMPLETED|Overall Study||97
7707795|NCT01749631|18980752|P1|STARTED|Overall Study||97
7707796|NCT01749605|18980764|P2|NOT COMPLETED|Overall Study||3
7707797|NCT01749605|18980765|P1|NOT COMPLETED|Overall Study||4
7707798|NCT01749605|18980764|P2|COMPLETED|Overall Study||14
7707799|NCT01749605|18980765|P1|COMPLETED|Overall Study||14
7707800|NCT01749605|18980764|P2|STARTED|Overall Study||17
7707801|NCT01749605|18980765|P1|STARTED|Overall Study||18
7707802|NCT01749501|18980773|P2|NOT COMPLETED|Overall Study||0
7707803|NCT01749501|18980774|P1|NOT COMPLETED|Overall Study||0
7707804|NCT01749501|18980773|P2|COMPLETED|Overall Study||23
7707805|NCT01749501|18980774|P1|COMPLETED|Overall Study||22
7707806|NCT01749501|18980773|P2|STARTED|Overall Study||23
7707807|NCT01749501|18980774|P1|STARTED|Overall Study||22
7707808|NCT01749410|18980782|P1|NOT COMPLETED|Overall Study||0
7707809|NCT01749410|18980782|P1|COMPLETED|Overall Study||33
7707810|NCT01749410|18980782|P1|STARTED|Overall Study||33
7707811|NCT01749293|18980786|P1|NOT COMPLETED|Overall Study||0
7707812|NCT01749293|18980786|P1|COMPLETED|Overall Study||3
7707813|NCT01749293|18980786|P1|STARTED|Overall Study||3
7707814|NCT01749033|18980795|P3|NOT COMPLETED|Overall Study||1
7707815|NCT01749033|18980796|P2|NOT COMPLETED|Overall Study||5
7707816|NCT01749033|18980797|P1|NOT COMPLETED|Overall Study||3
7707817|NCT01749033|18980795|P3|COMPLETED|Overall Study||149
7707818|NCT01749033|18980796|P2|COMPLETED|Overall Study||145
7707819|NCT01749033|18980797|P1|COMPLETED|Overall Study||147
7707820|NCT01749033|18980795|P3|STARTED|Overall Study||150
7707821|NCT01749033|18980796|P2|STARTED|Overall Study||150
7707822|NCT01749033|18980797|P1|STARTED|Overall Study||150
7707823|NCT01748955|18980822|P2|NOT COMPLETED|Overall Study||5
7707824|NCT01748955|18980823|P1|NOT COMPLETED|Overall Study||3
7707825|NCT01748955|18980822|P2|COMPLETED|Overall Study||4
7707826|NCT01748955|18980823|P1|COMPLETED|Overall Study||3
7707827|NCT01748955|18980822|P2|STARTED|Overall Study||9
7707828|NCT01748955|18980823|P1|STARTED|Overall Study||6
7707829|NCT01748942|18980833|P2|NOT COMPLETED|Overall Study||4
7707830|NCT01748942|18980834|P1|NOT COMPLETED|Overall Study||4
7707831|NCT01748942|18980833|P2|COMPLETED|Overall Study||33
7707832|NCT01748942|18980834|P1|COMPLETED|Overall Study||35
7707833|NCT01748942|18980833|P2|STARTED|Overall Study||37
7707834|NCT01748942|18980834|P1|STARTED|Overall Study||39
7707835|NCT01748916|18980854|P6|NOT COMPLETED|Overall Study||0
7707836|NCT01748916|18980855|P5|NOT COMPLETED|Overall Study||0
7707837|NCT01748916|18980856|P4|NOT COMPLETED|Overall Study||0
7707838|NCT01748916|18980857|P3|NOT COMPLETED|Overall Study||0
7707839|NCT01748916|18980858|P2|NOT COMPLETED|Overall Study||0
7707840|NCT01748916|18980859|P1|NOT COMPLETED|Overall Study||0
7707841|NCT01748916|18980854|P6|COMPLETED|Overall Study||3
7707842|NCT01748916|18980855|P5|COMPLETED|Overall Study||3
7707843|NCT01748916|18980856|P4|COMPLETED|Overall Study||3
7707844|NCT01748916|18980857|P3|COMPLETED|Overall Study||2
7707845|NCT01748916|18980858|P2|COMPLETED|Overall Study||3
7707846|NCT01748916|18980859|P1|COMPLETED|Overall Study||2
7707847|NCT01748916|18980854|P6|STARTED|Overall Study||3
7707848|NCT01748916|18980855|P5|STARTED|Overall Study||3
7707849|NCT01748916|18980856|P4|STARTED|Overall Study||3
7707850|NCT01748916|18980857|P3|STARTED|Overall Study||2
7707851|NCT01748916|18980858|P2|STARTED|Overall Study||3
7707852|NCT01748916|18980859|P1|STARTED|Overall Study||2
7707853|NCT01748890|18980867|P1|NOT COMPLETED|Overall Study||4
7707854|NCT01748890|18980867|P1|COMPLETED|Overall Study|Insufficient recruitment for analysis|0
7707855|NCT01748890|18980867|P1|STARTED|Overall Study||4
7707856|NCT01748799|18980879|P8|NOT COMPLETED|Overall Study||0
7707857|NCT01748799|18980880|P7|NOT COMPLETED|Overall Study||1
7707858|NCT01748799|18980881|P6|NOT COMPLETED|Overall Study||1
7707859|NCT01748799|18980882|P5|NOT COMPLETED|Overall Study||0
7707860|NCT01748799|18980883|P4|NOT COMPLETED|Overall Study||0
7707861|NCT01748799|18980884|P3|NOT COMPLETED|Overall Study||0
7707862|NCT01748799|18980885|P2|NOT COMPLETED|Overall Study||0
7707863|NCT01748799|18980886|P1|NOT COMPLETED|Overall Study||5
7707864|NCT01748799|18980879|P8|COMPLETED|Overall Study||1
7707865|NCT01748799|18980880|P7|COMPLETED|Overall Study||1
7707866|NCT01748799|18980881|P6|COMPLETED|Overall Study||1
7707867|NCT01748799|18980882|P5|COMPLETED|Overall Study||1
7707868|NCT01748799|18980883|P4|COMPLETED|Overall Study||2
7707869|NCT01748799|18980884|P3|COMPLETED|Overall Study||1
7707870|NCT01748799|18980885|P2|COMPLETED|Overall Study||1
7707871|NCT01748799|18980886|P1|COMPLETED|Overall Study||1
7707872|NCT01748799|18980879|P8|Completed Self-titrated Sativex|Overall Study||1
7707873|NCT01748799|18980880|P7|Completed Self-titrated Sativex|Overall Study||1
7707874|NCT01748799|18980881|P6|Completed Self-titrated Sativex|Overall Study||1
7707875|NCT01748799|18980882|P5|Completed Self-titrated Sativex|Overall Study||1
7707876|NCT01748799|18980883|P4|Completed Self-titrated Sativex|Overall Study||2
7707877|NCT01748799|18980884|P3|Completed Self-titrated Sativex|Overall Study||1
7707878|NCT01748799|18980885|P2|Completed Self-titrated Sativex|Overall Study||1
7707879|NCT01748799|18980886|P1|Completed Self-titrated Sativex|Overall Study||1
7707880|NCT01748799|18980879|P8|Completed SAU of Self-titrated Sativex|Overall Study||1
7707881|NCT01748799|18980880|P7|Completed SAU of Self-titrated Sativex|Overall Study||1
7707882|NCT01748799|18980881|P6|Completed SAU of Self-titrated Sativex|Overall Study||2
7707883|NCT01748799|18980882|P5|Completed SAU of Self-titrated Sativex|Overall Study||1
7707884|NCT01748799|18980883|P4|Completed SAU of Self-titrated Sativex|Overall Study||2
7707885|NCT01748799|18980884|P3|Completed SAU of Self-titrated Sativex|Overall Study||1
7707886|NCT01748799|18980885|P2|Completed SAU of Self-titrated Sativex|Overall Study||1
7707887|NCT01748799|18980886|P1|Completed SAU of Self-titrated Sativex|Overall Study||2
7707888|NCT01748799|18980879|P8|Completed Self-titrated Placebo|Overall Study||1
7707889|NCT01748799|18980880|P7|Completed Self-titrated Placebo|Overall Study||1
7707890|NCT01748799|18980881|P6|Completed Self-titrated Placebo|Overall Study||2
7707891|NCT01748799|18980882|P5|Completed Self-titrated Placebo|Overall Study||1
7707892|NCT01748799|18980883|P4|Completed Self-titrated Placebo|Overall Study||2
7707893|NCT01748799|18980884|P3|Completed Self-titrated Placebo|Overall Study||1
7707894|NCT01748799|18980885|P2|Completed Self-titrated Placebo|Overall Study||1
7707895|NCT01748799|18980886|P1|Completed Self-titrated Placebo|Overall Study||4
7707896|NCT01748799|18980879|P8|Completed SAU of Self-titrated Placebo|Overall Study||1
7707897|NCT01748799|18980880|P7|Completed SAU of Self-titrated Placebo|Overall Study||1
7707898|NCT01748799|18980881|P6|Completed SAU of Self-titrated Placebo|Overall Study||2
7707899|NCT01748799|18980882|P5|Completed SAU of Self-titrated Placebo|Overall Study||1
7707900|NCT01748799|18980883|P4|Completed SAU of Self-titrated Placebo|Overall Study||2
7707901|NCT01748799|18980884|P3|Completed SAU of Self-titrated Placebo|Overall Study||1
7707902|NCT01748799|18980885|P2|Completed SAU of Self-titrated Placebo|Overall Study||1
7707903|NCT01748799|18980886|P1|Completed SAU of Self-titrated Placebo|Overall Study||5
7707904|NCT01748799|18980879|P8|Completed Fixed Dose Sativex|Overall Study||1
7707905|NCT01748799|18980880|P7|Completed Fixed Dose Sativex|Overall Study||1
7707906|NCT01748799|18980881|P6|Completed Fixed Dose Sativex|Overall Study||1
7707907|NCT01748799|18980882|P5|Completed Fixed Dose Sativex|Overall Study||1
7707908|NCT01748799|18980883|P4|Completed Fixed Dose Sativex|Overall Study||2
7707909|NCT01748799|18980884|P3|Completed Fixed Dose Sativex|Overall Study||1
7707910|NCT01748799|18980885|P2|Completed Fixed Dose Sativex|Overall Study||1
7707911|NCT01748799|18980886|P1|Completed Fixed Dose Sativex|Overall Study||1
7707912|NCT01748799|18980879|P8|Completed SAU of Fixed Dose Sativex|Overall Study||1
7707913|NCT01748799|18980880|P7|Completed SAU of Fixed Dose Sativex|Overall Study||1
7707914|NCT01748799|18980881|P6|Completed SAU of Fixed Dose Sativex|Overall Study||1
7707915|NCT01748799|18980882|P5|Completed SAU of Fixed Dose Sativex|Overall Study||1
7707916|NCT01748799|18980883|P4|Completed SAU of Fixed Dose Sativex|Overall Study||2
7707917|NCT01748799|18980884|P3|Completed SAU of Fixed Dose Sativex|Overall Study||1
7707918|NCT01748799|18980885|P2|Completed SAU of Fixed Dose Sativex|Overall Study||1
7707919|NCT01748799|18980886|P1|Completed SAU of Fixed Dose Sativex|Overall Study||1
7707920|NCT01748799|18980879|P8|Completed Fixed Dose Placebo|Overall Study||1
7707921|NCT01748799|18980880|P7|Completed Fixed Dose Placebo|Overall Study||1
7707922|NCT01748799|18980881|P6|Completed Fixed Dose Placebo|Overall Study||1
7707923|NCT01748799|18980882|P5|Completed Fixed Dose Placebo|Overall Study||1
7707924|NCT01748799|18980883|P4|Completed Fixed Dose Placebo|Overall Study||2
7707925|NCT01748799|18980884|P3|Completed Fixed Dose Placebo|Overall Study||1
7707926|NCT01748799|18980885|P2|Completed Fixed Dose Placebo|Overall Study||1
7707927|NCT01748799|18980886|P1|Completed Fixed Dose Placebo|Overall Study||2
7707928|NCT01748799|18980879|P8|Completed SAU of Fixed Dose Placebo|Overall Study||1
7707929|NCT01748799|18980880|P7|Completed SAU of Fixed Dose Placebo|Overall Study||1
7707930|NCT01748799|18980881|P6|Completed SAU of Fixed Dose Placebo|Overall Study||1
7707931|NCT01748799|18980882|P5|Completed SAU of Fixed Dose Placebo|Overall Study||1
7707932|NCT01748799|18980883|P4|Completed SAU of Fixed Dose Placebo|Overall Study||2
7707933|NCT01748799|18980884|P3|Completed SAU of Fixed Dose Placebo|Overall Study||1
7707934|NCT01748799|18980885|P2|Completed SAU of Fixed Dose Placebo|Overall Study||1
7707935|NCT01748799|18980886|P1|Completed SAU of Fixed Dose Placebo|Overall Study||2
7707936|NCT01748799|18980879|P8|STARTED|Overall Study||1
7707937|NCT01748799|18980880|P7|STARTED|Overall Study||2
7707938|NCT01748799|18980881|P6|STARTED|Overall Study||2
7707939|NCT01748799|18980882|P5|STARTED|Overall Study||1
7707940|NCT01748799|18980883|P4|STARTED|Overall Study||2
7707941|NCT01748799|18980884|P3|STARTED|Overall Study||1
7707942|NCT01748799|18980885|P2|STARTED|Overall Study||1
7707943|NCT01748799|18980886|P1|STARTED|Overall Study||6
7707944|NCT01748760|18980922|P2|NOT COMPLETED|Overall Study||2
7707945|NCT01748760|18980923|P1|NOT COMPLETED|Overall Study||6
7707946|NCT01748760|18980922|P2|COMPLETED|Overall Study||23
7707947|NCT01748760|18980923|P1|COMPLETED|Overall Study||19
7707948|NCT01748760|18980922|P2|STARTED|Overall Study||25
7707949|NCT01748760|18980923|P1|STARTED|Overall Study||25
7707950|NCT01748695|18980929|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
7707951|NCT01748695|18980930|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
7707952|NCT01748695|18980929|P2|COMPLETED|Second Intervention (4 Weeks)||11
7707953|NCT01748695|18980930|P1|COMPLETED|Second Intervention (4 Weeks)||14
7707954|NCT01748695|18980929|P2|STARTED|Second Intervention (4 Weeks)||11
7707955|NCT01748695|18980930|P1|STARTED|Second Intervention (4 Weeks)||14
7707956|NCT01748695|18980929|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
7707957|NCT01748695|18980930|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
7707958|NCT01748695|18980929|P2|COMPLETED|First Intervention (4 Weeks)||11
7707959|NCT01748695|18980930|P1|COMPLETED|First Intervention (4 Weeks)||14
7707960|NCT01748695|18980929|P2|STARTED|First Intervention (4 Weeks)||11
7707961|NCT01748695|18980930|P1|STARTED|First Intervention (4 Weeks)||14
7707962|NCT01748643|18980940|P2|NOT COMPLETED|Overall Study||0
7707963|NCT01748643|18980941|P1|NOT COMPLETED|Overall Study||0
7707964|NCT01748643|18980940|P2|COMPLETED|Overall Study||30
7707965|NCT01748643|18980941|P1|COMPLETED|Overall Study||30
7707966|NCT01748643|18980940|P2|STARTED|Overall Study||30
7707967|NCT01748643|18980941|P1|STARTED|Overall Study||30
7707968|NCT01748552|18980969|P12|NOT COMPLETED|Intervention Period 3 and Washout||0
7707969|NCT01748552|18980970|P11|NOT COMPLETED|Intervention Period 3 and Washout||0
7707970|NCT01748552|18980971|P10|NOT COMPLETED|Intervention Period 3 and Washout||0
7707971|NCT01748552|18980972|P9|NOT COMPLETED|Intervention Period 3 and Washout||0
7707972|NCT01748552|18980973|P8|NOT COMPLETED|Intervention Period 3 and Washout||0
7707973|NCT01748552|18980974|P7|NOT COMPLETED|Intervention Period 3 and Washout||0
7707974|NCT01748552|18980975|P6|NOT COMPLETED|Intervention Period 3 and Washout||0
7707975|NCT01748552|18980976|P5|NOT COMPLETED|Intervention Period 3 and Washout||0
7707976|NCT01748552|18980977|P4|NOT COMPLETED|Intervention Period 3 and Washout||0
7707977|NCT01748552|18980978|P3|NOT COMPLETED|Intervention Period 3 and Washout||0
7707978|NCT01748552|18980979|P2|NOT COMPLETED|Intervention Period 3 and Washout||0
7707979|NCT01748552|18980980|P1|NOT COMPLETED|Intervention Period 3 and Washout||0
7707980|NCT01748552|18980969|P12|COMPLETED|Intervention Period 3 and Washout||3
7707981|NCT01748552|18980970|P11|COMPLETED|Intervention Period 3 and Washout||3
7707982|NCT01748552|18980971|P10|COMPLETED|Intervention Period 3 and Washout||3
7707983|NCT01748552|18980972|P9|COMPLETED|Intervention Period 3 and Washout||0
7707984|NCT01748552|18980973|P8|COMPLETED|Intervention Period 3 and Washout||0
7707985|NCT01748552|18980974|P7|COMPLETED|Intervention Period 3 and Washout||0
7707986|NCT01748552|18980975|P6|COMPLETED|Intervention Period 3 and Washout||3
7707987|NCT01748552|18980976|P5|COMPLETED|Intervention Period 3 and Washout||3
7707988|NCT01748552|18980977|P4|COMPLETED|Intervention Period 3 and Washout||3
7707989|NCT01748552|18980978|P3|COMPLETED|Intervention Period 3 and Washout||2
7707990|NCT01748552|18980979|P2|COMPLETED|Intervention Period 3 and Washout||3
7707991|NCT01748552|18980980|P1|COMPLETED|Intervention Period 3 and Washout||3
7707992|NCT01748552|18980969|P12|STARTED|Intervention Period 3 and Washout||3
7707993|NCT01748552|18980970|P11|STARTED|Intervention Period 3 and Washout||3
7707994|NCT01748552|18980971|P10|STARTED|Intervention Period 3 and Washout||3
7707995|NCT01748552|18980972|P9|STARTED|Intervention Period 3 and Washout||0
7707996|NCT01748552|18980973|P8|STARTED|Intervention Period 3 and Washout||0
7707997|NCT01748552|18980974|P7|STARTED|Intervention Period 3 and Washout||0
7707998|NCT01748552|18980975|P6|STARTED|Intervention Period 3 and Washout||3
7707999|NCT01748552|18980976|P5|STARTED|Intervention Period 3 and Washout||3
7708000|NCT01748552|18980977|P4|STARTED|Intervention Period 3 and Washout||3
7708001|NCT01748552|18980978|P3|STARTED|Intervention Period 3 and Washout||2
7708002|NCT01748552|18980979|P2|STARTED|Intervention Period 3 and Washout||3
7708003|NCT01748552|18980980|P1|STARTED|Intervention Period 3 and Washout||3
7708004|NCT01748552|18980969|P12|NOT COMPLETED|Intervention Period 2 and Washout||0
7708005|NCT01748552|18980970|P11|NOT COMPLETED|Intervention Period 2 and Washout||0
7708006|NCT01748552|18980971|P10|NOT COMPLETED|Intervention Period 2 and Washout||0
7708007|NCT01748552|18980972|P9|NOT COMPLETED|Intervention Period 2 and Washout||3
7708008|NCT01748552|18980973|P8|NOT COMPLETED|Intervention Period 2 and Washout||3
7708009|NCT01748552|18980974|P7|NOT COMPLETED|Intervention Period 2 and Washout||3
7708010|NCT01748552|18980975|P6|NOT COMPLETED|Intervention Period 2 and Washout||0
7708011|NCT01748552|18980976|P5|NOT COMPLETED|Intervention Period 2 and Washout||0
7708012|NCT01748552|18980977|P4|NOT COMPLETED|Intervention Period 2 and Washout||0
7708013|NCT01748552|18980978|P3|NOT COMPLETED|Intervention Period 2 and Washout||1
7708014|NCT01748552|18980979|P2|NOT COMPLETED|Intervention Period 2 and Washout||0
7708015|NCT01748552|18980980|P1|NOT COMPLETED|Intervention Period 2 and Washout||0
7708016|NCT01748552|18980969|P12|COMPLETED|Intervention Period 2 and Washout||3
7708017|NCT01748552|18980970|P11|COMPLETED|Intervention Period 2 and Washout||3
7708018|NCT01748552|18980971|P10|COMPLETED|Intervention Period 2 and Washout||3
7708019|NCT01748552|18980972|P9|COMPLETED|Intervention Period 2 and Washout||0
7708020|NCT01748552|18980973|P8|COMPLETED|Intervention Period 2 and Washout||0
7708021|NCT01748552|18980974|P7|COMPLETED|Intervention Period 2 and Washout||0
7708022|NCT01748552|18980975|P6|COMPLETED|Intervention Period 2 and Washout||3
7708023|NCT01748552|18980976|P5|COMPLETED|Intervention Period 2 and Washout||3
7708024|NCT01748552|18980977|P4|COMPLETED|Intervention Period 2 and Washout||3
7708025|NCT01748552|18980978|P3|COMPLETED|Intervention Period 2 and Washout||2
7708026|NCT01748552|18980979|P2|COMPLETED|Intervention Period 2 and Washout||3
7708027|NCT01748552|18980980|P1|COMPLETED|Intervention Period 2 and Washout||3
7708028|NCT01748552|18980969|P12|STARTED|Intervention Period 2 and Washout||3
7708029|NCT01748552|18980970|P11|STARTED|Intervention Period 2 and Washout||3
7708030|NCT01748552|18980971|P10|STARTED|Intervention Period 2 and Washout||3
7708031|NCT01748552|18980972|P9|STARTED|Intervention Period 2 and Washout||3
7708032|NCT01748552|18980973|P8|STARTED|Intervention Period 2 and Washout||3
7708033|NCT01748552|18980974|P7|STARTED|Intervention Period 2 and Washout||3
7708034|NCT01748552|18980975|P6|STARTED|Intervention Period 2 and Washout||3
7708035|NCT01748552|18980976|P5|STARTED|Intervention Period 2 and Washout||3
7708036|NCT01748552|18980977|P4|STARTED|Intervention Period 2 and Washout||3
7708037|NCT01748552|18980978|P3|STARTED|Intervention Period 2 and Washout||3
7708038|NCT01748552|18980979|P2|STARTED|Intervention Period 2 and Washout||3
7708039|NCT01748552|18980980|P1|STARTED|Intervention Period 2 and Washout||3
7708040|NCT01748552|18980969|P12|NOT COMPLETED|Intervention Period 1 and Washout||0
7708041|NCT01748552|18980970|P11|NOT COMPLETED|Intervention Period 1 and Washout||0
7708042|NCT01748552|18980971|P10|NOT COMPLETED|Intervention Period 1 and Washout||0
7708043|NCT01748552|18980972|P9|NOT COMPLETED|Intervention Period 1 and Washout||0
7708044|NCT01748552|18980973|P8|NOT COMPLETED|Intervention Period 1 and Washout||0
7708045|NCT01748552|18980974|P7|NOT COMPLETED|Intervention Period 1 and Washout||0
7708046|NCT01748552|18980975|P6|NOT COMPLETED|Intervention Period 1 and Washout||0
7708047|NCT01748552|18980976|P5|NOT COMPLETED|Intervention Period 1 and Washout||0
7708048|NCT01748552|18980977|P4|NOT COMPLETED|Intervention Period 1 and Washout||0
7708049|NCT01748552|18980978|P3|NOT COMPLETED|Intervention Period 1 and Washout||0
7708050|NCT01748552|18980979|P2|NOT COMPLETED|Intervention Period 1 and Washout||0
7708051|NCT01748552|18980980|P1|NOT COMPLETED|Intervention Period 1 and Washout||0
7708052|NCT01748552|18980969|P12|COMPLETED|Intervention Period 1 and Washout||3
7708053|NCT01748552|18980970|P11|COMPLETED|Intervention Period 1 and Washout||3
7708054|NCT01748552|18980971|P10|COMPLETED|Intervention Period 1 and Washout||3
7708055|NCT01748552|18980972|P9|COMPLETED|Intervention Period 1 and Washout||3
7708056|NCT01748552|18980973|P8|COMPLETED|Intervention Period 1 and Washout||3
7708057|NCT01748552|18980974|P7|COMPLETED|Intervention Period 1 and Washout||3
7708058|NCT01748552|18980975|P6|COMPLETED|Intervention Period 1 and Washout||3
7708059|NCT01748552|18980976|P5|COMPLETED|Intervention Period 1 and Washout||3
7708060|NCT01748552|18980977|P4|COMPLETED|Intervention Period 1 and Washout||3
7708061|NCT01748552|18980978|P3|COMPLETED|Intervention Period 1 and Washout||3
7708062|NCT01748552|18980979|P2|COMPLETED|Intervention Period 1 and Washout||3
7708063|NCT01748552|18980980|P1|COMPLETED|Intervention Period 1 and Washout||3
7708064|NCT01748552|18980969|P12|STARTED|Intervention Period 1 and Washout||3
7708065|NCT01748552|18980970|P11|STARTED|Intervention Period 1 and Washout||3
7708066|NCT01748552|18980971|P10|STARTED|Intervention Period 1 and Washout||3
7708067|NCT01748552|18980972|P9|STARTED|Intervention Period 1 and Washout||3
7708068|NCT01748552|18980973|P8|STARTED|Intervention Period 1 and Washout||3
7708069|NCT01748552|18980974|P7|STARTED|Intervention Period 1 and Washout||3
7708070|NCT01748552|18980975|P6|STARTED|Intervention Period 1 and Washout||3
7708071|NCT01748552|18980976|P5|STARTED|Intervention Period 1 and Washout||3
7708072|NCT01748552|18980977|P4|STARTED|Intervention Period 1 and Washout||3
7708073|NCT01748552|18980978|P3|STARTED|Intervention Period 1 and Washout||3
7708074|NCT01748552|18980979|P2|STARTED|Intervention Period 1 and Washout||3
7708075|NCT01748552|18980980|P1|STARTED|Intervention Period 1 and Washout||3
7708076|NCT01748292|18981050|P2|NOT COMPLETED|Overall Study||12
7708077|NCT01748292|18981051|P1|NOT COMPLETED|Overall Study||2
7708078|NCT01748292|18981050|P2|COMPLETED|Overall Study||28
7708079|NCT01748292|18981051|P1|COMPLETED|Overall Study||18
7708080|NCT01748292|18981050|P2|STARTED|Overall Study||40
7708081|NCT01748292|18981051|P1|STARTED|Overall Study||20
7708082|NCT01748240|18981071|P1|NOT COMPLETED|Overall Study||0
7708083|NCT01748240|18981071|P1|COMPLETED|Overall Study||21
7708084|NCT01748240|18981071|P1|STARTED|Overall Study||21
7708085|NCT01748227|18981075|P1|NOT COMPLETED|Overall Study||3
7708086|NCT01748227|18981075|P1|COMPLETED|Overall Study||17
7708087|NCT01748227|18981075|P1|STARTED|Overall Study||20
7708088|NCT01748162|18981085|P2|NOT COMPLETED|Overall Study||5
7708089|NCT01748162|18981086|P1|NOT COMPLETED|Overall Study||5
7708090|NCT01748162|18981085|P2|COMPLETED|Overall Study||0
7708091|NCT01748162|18981086|P1|COMPLETED|Overall Study||0
7708092|NCT01748162|18981085|P2|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
7708093|NCT01748162|18981086|P1|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
7708094|NCT01748162|18981085|P2|Completed 6 Month Initial Treatment|Overall Study||0
7708095|NCT01748162|18981086|P1|Completed 6 Month Initial Treatment|Overall Study||0
7708096|NCT01748162|18981085|P2|Started 6 Month Initial Treatment Plan|Overall Study||2
7708097|NCT01748162|18981086|P1|Started 6 Month Initial Treatment Plan|Overall Study||2
7708098|NCT01748162|18981085|P2|STARTED|Overall Study||5
7708099|NCT01748162|18981086|P1|STARTED|Overall Study||5
7708100|NCT01748071|18981097|P3|NOT COMPLETED|Overall Study||0
7708101|NCT01748071|18981098|P2|NOT COMPLETED|Overall Study||2
7708102|NCT01748071|18981099|P1|NOT COMPLETED|Overall Study||2
7708103|NCT01748071|18981097|P3|COMPLETED|Overall Study||40
7708104|NCT01748071|18981098|P2|COMPLETED|Overall Study||38
7708105|NCT01748071|18981099|P1|COMPLETED|Overall Study||38
7708106|NCT01748071|18981097|P3|STARTED|Overall Study||40
7708107|NCT01748071|18981098|P2|STARTED|Overall Study||40
7708108|NCT01748071|18981099|P1|STARTED|Overall Study||40
7708109|NCT01748045|18981121|P2|NOT COMPLETED|Overall Study||0
7708110|NCT01748045|18981122|P1|NOT COMPLETED|Overall Study||0
7708111|NCT01748045|18981121|P2|COMPLETED|Overall Study||1
7708112|NCT01748045|18981122|P1|COMPLETED|Overall Study||2
7708113|NCT01748045|18981121|P2|STARTED|Overall Study||1
7708114|NCT01748045|18981122|P1|STARTED|Overall Study||2
7708115|NCT01747928|18981148|P8|NOT COMPLETED|Overall Study||0
7708116|NCT01747928|18981149|P7|NOT COMPLETED|Overall Study||0
7708117|NCT01747928|18981150|P6|NOT COMPLETED|Overall Study||0
7708118|NCT01747928|18981151|P5|NOT COMPLETED|Overall Study||0
7708119|NCT01747928|18981152|P4|NOT COMPLETED|Overall Study||0
7708120|NCT01747928|18981153|P3|NOT COMPLETED|Overall Study||0
7708121|NCT01747928|18981154|P2|NOT COMPLETED|Overall Study||0
7708122|NCT01747928|18981155|P1|NOT COMPLETED|Overall Study||0
7708123|NCT01747928|18981148|P8|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
7708124|NCT01747928|18981149|P7|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
7708125|NCT01747928|18981150|P6|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
7708126|NCT01747928|18981151|P5|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
7708127|NCT01747928|18981152|P4|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
7708128|NCT01747928|18981153|P3|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
7708129|NCT01747928|18981154|P2|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
7708130|NCT01747928|18981155|P1|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
7708131|NCT01747928|18981148|P8|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
7708132|NCT01747928|18981149|P7|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
7708133|NCT01747928|18981150|P6|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
7708134|NCT01747928|18981151|P5|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
7708135|NCT01747928|18981152|P4|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
7708136|NCT01747928|18981153|P3|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
7708137|NCT01747928|18981154|P2|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
7708138|NCT01747928|18981155|P1|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
7708139|NCT01747915|18981362|P3|NOT COMPLETED|Overall Study||6
7708140|NCT01747915|18981363|P2|NOT COMPLETED|Overall Study||11
7708141|NCT01747915|18981364|P1|NOT COMPLETED|Overall Study||15
7708142|NCT01747915|18981362|P3|COMPLETED|Overall Study||66
7708143|NCT01747915|18981363|P2|COMPLETED|Overall Study||61
7708144|NCT01747915|18981364|P1|COMPLETED|Overall Study||60
7708145|NCT01747915|18981362|P3|STARTED|Overall Study||72
7708146|NCT01747915|18981363|P2|STARTED|Overall Study||72
7708147|NCT01747915|18981364|P1|STARTED|Overall Study||75
7708148|NCT01747876|18981378|P3|NOT COMPLETED|Overall Study||12
7708149|NCT01747876|18981379|P2|NOT COMPLETED|Overall Study||15
7708150|NCT01747876|18981380|P1|NOT COMPLETED|Overall Study||5
7708151|NCT01747876|18981378|P3|COMPLETED|Overall Study||0
7708152|NCT01747876|18981379|P2|COMPLETED|Overall Study||0
7708153|NCT01747876|18981380|P1|COMPLETED|Overall Study||0
7708154|NCT01747876|18981378|P3|STARTED|Overall Study||12
7708155|NCT01747876|18981379|P2|STARTED|Overall Study||15
7708156|NCT01747876|18981380|P1|STARTED|Overall Study||5
7708157|NCT01747850|18981409|P3|NOT COMPLETED|Overall Study||6
7708158|NCT01747850|18981410|P2|NOT COMPLETED|Overall Study||7
7708159|NCT01747850|18981411|P1|NOT COMPLETED|Overall Study||1
7708160|NCT01747850|18981409|P3|COMPLETED|Overall Study||14
7708161|NCT01747850|18981410|P2|COMPLETED|Overall Study||13
7708162|NCT01747850|18981411|P1|COMPLETED|Overall Study||4
7708163|NCT01747850|18981409|P3|STARTED|Overall Study||20
7708164|NCT01747850|18981410|P2|STARTED|Overall Study||20
7708165|NCT01747850|18981411|P1|STARTED|Overall Study||5
7708166|NCT01747837|18981433|P2|NOT COMPLETED|Overall Study||6
7708167|NCT01747837|18981434|P1|NOT COMPLETED|Overall Study||9
7708168|NCT01747837|18981433|P2|COMPLETED|Overall Study||17
7708169|NCT01747837|18981434|P1|COMPLETED|Overall Study||16
7708170|NCT01747837|18981433|P2|STARTED|Overall Study||23
7708171|NCT01747837|18981434|P1|STARTED|Overall Study||25
7708172|NCT01747811|18981464|P2|NOT COMPLETED|Overall Study||4
7708173|NCT01747811|18981465|P1|NOT COMPLETED|Overall Study||2
7708174|NCT01747811|18981464|P2|COMPLETED|Overall Study||12
7708175|NCT01747811|18981465|P1|COMPLETED|Overall Study||14
7708176|NCT01747811|18981464|P2|STARTED|Overall Study||16
7708177|NCT01747811|18981465|P1|STARTED|Overall Study||16
7708178|NCT01747772|18981481|P1|NOT COMPLETED|Overall Study||9
7708179|NCT01747772|18981481|P1|COMPLETED|Overall Study||171
7708180|NCT01747772|18981481|P1|Analysis Population|Overall Study|All participants who completed the study and had adequate SWE and liver biopsy data.|164
7708181|NCT01747772|18981481|P1|STARTED|Overall Study||180
7708182|NCT01747655|18981489|P2|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
7708183|NCT01747655|18981490|P1|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
7708184|NCT01747655|18981489|P2|COMPLETED|PEG-J Period (Continued Treatment)||15
7708185|NCT01747655|18981490|P1|COMPLETED|PEG-J Period (Continued Treatment)||41
7708186|NCT01747655|18981489|P2|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15
7708187|NCT01747655|18981490|P1|STARTED|PEG-J Period (Continued Treatment)||41
7708188|NCT01747655|18981489|P2|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0
7708189|NCT01747655|18981490|P1|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14
7708190|NCT01747655|18981489|P2|COMPLETED|PEG-J Period (Duodopa Treatment)||6
7708191|NCT01747655|18981490|P1|COMPLETED|PEG-J Period (Duodopa Treatment)||44
7708192|NCT01747655|18981489|P2|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6
7708193|NCT01747655|18981490|P1|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58
7708194|NCT01747655|18981489|P2|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
7708195|NCT01747655|18981490|P1|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
7708196|NCT01747655|18981489|P2|COMPLETED|Temporary Naso-jejunal Tube Period||0
7708197|NCT01747655|18981490|P1|COMPLETED|Temporary Naso-jejunal Tube Period||64
7708198|NCT01747655|18981489|P2|STARTED|Temporary Naso-jejunal Tube Period||0
7708199|NCT01747655|18981490|P1|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64
7708200|NCT01747629|18981520|P2|NOT COMPLETED|Overall Study||6
7708201|NCT01747629|18981521|P1|NOT COMPLETED|Overall Study||8
7708202|NCT01747629|18981520|P2|COMPLETED|Overall Study||69
7708203|NCT01747629|18981521|P1|COMPLETED|Overall Study||77
7708204|NCT01747629|18981520|P2|Treated|Overall Study|Safety set and full analysis set|75
7708205|NCT01747629|18981521|P1|Treated|Overall Study|Safety set and full analysis set|84
7708206|NCT01747629|18981520|P2|STARTED|Overall Study||75
7708207|NCT01747629|18981521|P1|STARTED|Overall Study||85
7708208|NCT01747551|18981555|P2|NOT COMPLETED|Overall Study||21
7708209|NCT01747551|18981556|P1|NOT COMPLETED|Overall Study||43
7708210|NCT01747551|18981555|P2|COMPLETED|Overall Study||0
7708211|NCT01747551|18981556|P1|COMPLETED|Overall Study||0
7708212|NCT01747551|18981555|P2|STARTED|Overall Study||21
7708213|NCT01747551|18981556|P1|STARTED|Overall Study||43
7708214|NCT01747499|18981573|P5|NOT COMPLETED|Overall Study||15
7708215|NCT01747499|18981574|P4|NOT COMPLETED|Overall Study||2
7708216|NCT01747499|18981575|P3|NOT COMPLETED|Overall Study||0
7708217|NCT01747499|18981576|P2|NOT COMPLETED|Overall Study||1
7708218|NCT01747499|18981577|P1|NOT COMPLETED|Overall Study||1
7708219|NCT01747499|18981573|P5|COMPLETED|Overall Study||24
7708220|NCT01747499|18981574|P4|COMPLETED|Overall Study||4
7708221|NCT01747499|18981575|P3|COMPLETED|Overall Study||3
7708222|NCT01747499|18981576|P2|COMPLETED|Overall Study||2
7708223|NCT01747499|18981577|P1|COMPLETED|Overall Study||2
7708224|NCT01747499|18981573|P5|STARTED|Overall Study||39
7708225|NCT01747499|18981574|P4|STARTED|Overall Study||6
7708226|NCT01747499|18981575|P3|STARTED|Overall Study||3
7708227|NCT01747499|18981576|P2|STARTED|Overall Study||3
7708228|NCT01747499|18981577|P1|STARTED|Overall Study||3
7708229|NCT01747486|18981613|P2|NOT COMPLETED|Stage 2||0
7708230|NCT01747486|18981614|P1|NOT COMPLETED|Stage 2||9
7708231|NCT01747486|18981613|P2|COMPLETED|Stage 2||0
7708232|NCT01747486|18981614|P1|COMPLETED|Stage 2||3
7708233|NCT01747486|18981613|P2|STARTED|Stage 2||0
7708234|NCT01747486|18981614|P1|STARTED|Stage 2||12
7708235|NCT01747486|18981613|P2|NOT COMPLETED|Stage 1||13
7708236|NCT01747486|18981614|P1|NOT COMPLETED|Stage 1||12
7708237|NCT01747486|18981613|P2|COMPLETED|Stage 1||2
7708238|NCT01747486|18981614|P1|COMPLETED|Stage 1||3
7708239|NCT01747486|18981613|P2|STARTED|Stage 1||15
7708240|NCT01747486|18981614|P1|STARTED|Stage 1||15
7708241|NCT01747343|18981620|P1|NOT COMPLETED|Underwear/Differential Reinforcement||0
7708242|NCT01747343|18981620|P1|COMPLETED|Underwear/Differential Reinforcement||4
7708243|NCT01747343|18981620|P1|STARTED|Underwear/Differential Reinforcement||4
7708244|NCT01747343|18981620|P1|NOT COMPLETED|Underwear||0
7708245|NCT01747343|18981620|P1|COMPLETED|Underwear||4
7708246|NCT01747343|18981620|P1|STARTED|Underwear||4
7708247|NCT01747343|18981620|P1|NOT COMPLETED|Baseline||0
7708248|NCT01747343|18981620|P1|COMPLETED|Baseline||4
7708249|NCT01747343|18981620|P1|STARTED|Baseline||4
7708250|NCT01747330|18981626|P1|NOT COMPLETED|Overall Study||0
7708251|NCT01747330|18981626|P1|COMPLETED|Overall Study||40
7708252|NCT01747330|18981626|P1|STARTED|Overall Study||40
7708253|NCT01746979|18981640|P2|NOT COMPLETED|Overall Study||347
7708254|NCT01746979|18981641|P1|NOT COMPLETED|Overall Study||346
7708255|NCT01746979|18981640|P2|COMPLETED|Overall Study||0
7708256|NCT01746979|18981641|P1|COMPLETED|Overall Study||0
7708257|NCT01746979|18981640|P2|STARTED|Overall Study||347
7708258|NCT01746979|18981641|P1|STARTED|Overall Study||346
7708259|NCT01746940|18981653|P4|NOT COMPLETED|Safety Second Phase||0
7708260|NCT01746940|18981654|P3|NOT COMPLETED|Safety Second Phase||0
7708261|NCT01746940|18981655|P2|NOT COMPLETED|Safety Second Phase||0
7708262|NCT01746940|18981656|P1|NOT COMPLETED|Safety Second Phase||0
7708263|NCT01746940|18981653|P4|COMPLETED|Safety Second Phase||0
7708264|NCT01746940|18981654|P3|COMPLETED|Safety Second Phase||0
7708265|NCT01746940|18981655|P2|COMPLETED|Safety Second Phase||18
7708266|NCT01746940|18981656|P1|COMPLETED|Safety Second Phase||18
7708267|NCT01746940|18981653|P4|STARTED|Safety Second Phase||0
7708268|NCT01746940|18981654|P3|STARTED|Safety Second Phase||0
7708269|NCT01746940|18981655|P2|STARTED|Safety Second Phase||18
7708270|NCT01746940|18981656|P1|STARTED|Safety Second Phase||18
7708271|NCT01746940|18981653|P4|NOT COMPLETED|Safety and Efficacy First Phase||3
7708272|NCT01746940|18981654|P3|NOT COMPLETED|Safety and Efficacy First Phase||0
7708273|NCT01746940|18981655|P2|NOT COMPLETED|Safety and Efficacy First Phase||0
7708274|NCT01746940|18981656|P1|NOT COMPLETED|Safety and Efficacy First Phase||0
7708275|NCT01746940|18981653|P4|COMPLETED|Safety and Efficacy First Phase||0
7708276|NCT01746940|18981654|P3|COMPLETED|Safety and Efficacy First Phase||40
7708277|NCT01746940|18981655|P2|COMPLETED|Safety and Efficacy First Phase||41
7708278|NCT01746940|18981656|P1|COMPLETED|Safety and Efficacy First Phase||39
7708279|NCT01746940|18981653|P4|STARTED|Safety and Efficacy First Phase||3
7708280|NCT01746940|18981654|P3|STARTED|Safety and Efficacy First Phase||40
7708281|NCT01746940|18981655|P2|STARTED|Safety and Efficacy First Phase||41
7708282|NCT01746940|18981656|P1|STARTED|Safety and Efficacy First Phase||39
7708283|NCT01746901|18981664|P9|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
7708284|NCT01746901|18981665|P8|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
7708285|NCT01746901|18981666|P7|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
7708286|NCT01746901|18981667|P6|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
7708287|NCT01746901|18981668|P5|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
7708288|NCT01746901|18981669|P4|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
7708289|NCT01746901|18981670|P3|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
7708290|NCT01746901|18981671|P2|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
7708291|NCT01746901|18981672|P1|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
7708292|NCT01746901|18981664|P9|COMPLETED|Treatment Phase: Sixth Intervention||5
7708293|NCT01746901|18981665|P8|COMPLETED|Treatment Phase: Sixth Intervention||6
7708294|NCT01746901|18981666|P7|COMPLETED|Treatment Phase: Sixth Intervention||5
7708295|NCT01746901|18981667|P6|COMPLETED|Treatment Phase: Sixth Intervention||5
7708296|NCT01746901|18981668|P5|COMPLETED|Treatment Phase: Sixth Intervention||6
7708297|NCT01746901|18981669|P4|COMPLETED|Treatment Phase: Sixth Intervention||5
7708298|NCT01746901|18981670|P3|COMPLETED|Treatment Phase: Sixth Intervention||0
7708299|NCT01746901|18981671|P2|COMPLETED|Treatment Phase: Sixth Intervention||0
7708300|NCT01746901|18981672|P1|COMPLETED|Treatment Phase: Sixth Intervention||0
7708301|NCT01746901|18981664|P9|STARTED|Treatment Phase: Sixth Intervention||5
7708302|NCT01746901|18981665|P8|STARTED|Treatment Phase: Sixth Intervention||6
7708303|NCT01746901|18981666|P7|STARTED|Treatment Phase: Sixth Intervention||5
7708304|NCT01746901|18981667|P6|STARTED|Treatment Phase: Sixth Intervention||5
7708305|NCT01746901|18981668|P5|STARTED|Treatment Phase: Sixth Intervention||6
7708306|NCT01746901|18981669|P4|STARTED|Treatment Phase: Sixth Intervention||5
7708307|NCT01746901|18981670|P3|STARTED|Treatment Phase: Sixth Intervention||0
7708308|NCT01746901|18981671|P2|STARTED|Treatment Phase: Sixth Intervention||0
7708309|NCT01746901|18981672|P1|STARTED|Treatment Phase: Sixth Intervention||0
7708310|NCT01746901|18981664|P9|NOT COMPLETED|Treatment Phase: Washout Period 5||0
7708311|NCT01746901|18981665|P8|NOT COMPLETED|Treatment Phase: Washout Period 5||0
7708312|NCT01746901|18981666|P7|NOT COMPLETED|Treatment Phase: Washout Period 5||0
7708313|NCT01746901|18981667|P6|NOT COMPLETED|Treatment Phase: Washout Period 5||0
7708314|NCT01746901|18981668|P5|NOT COMPLETED|Treatment Phase: Washout Period 5||0
7708315|NCT01746901|18981669|P4|NOT COMPLETED|Treatment Phase: Washout Period 5||0
7708316|NCT01746901|18981670|P3|NOT COMPLETED|Treatment Phase: Washout Period 5||0
7708317|NCT01746901|18981671|P2|NOT COMPLETED|Treatment Phase: Washout Period 5||0
7708318|NCT01746901|18981672|P1|NOT COMPLETED|Treatment Phase: Washout Period 5||0
7708319|NCT01746901|18981664|P9|COMPLETED|Treatment Phase: Washout Period 5||5
7708320|NCT01746901|18981665|P8|COMPLETED|Treatment Phase: Washout Period 5||6
7708321|NCT01746901|18981666|P7|COMPLETED|Treatment Phase: Washout Period 5||5
7708322|NCT01746901|18981667|P6|COMPLETED|Treatment Phase: Washout Period 5||5
7708323|NCT01746901|18981668|P5|COMPLETED|Treatment Phase: Washout Period 5||6
7708324|NCT01746901|18981669|P4|COMPLETED|Treatment Phase: Washout Period 5||5
7708325|NCT01746901|18981670|P3|COMPLETED|Treatment Phase: Washout Period 5||0
7708326|NCT01746901|18981671|P2|COMPLETED|Treatment Phase: Washout Period 5||0
7708327|NCT01746901|18981672|P1|COMPLETED|Treatment Phase: Washout Period 5||0
7708328|NCT01746901|18981664|P9|STARTED|Treatment Phase: Washout Period 5||5
7708329|NCT01746901|18981665|P8|STARTED|Treatment Phase: Washout Period 5||6
7708330|NCT01746901|18981666|P7|STARTED|Treatment Phase: Washout Period 5||5
7708331|NCT01746901|18981667|P6|STARTED|Treatment Phase: Washout Period 5||5
7708332|NCT01746901|18981668|P5|STARTED|Treatment Phase: Washout Period 5||6
7708333|NCT01746901|18981669|P4|STARTED|Treatment Phase: Washout Period 5||5
7708334|NCT01746901|18981670|P3|STARTED|Treatment Phase: Washout Period 5||0
7708335|NCT01746901|18981671|P2|STARTED|Treatment Phase: Washout Period 5||0
7708336|NCT01746901|18981672|P1|STARTED|Treatment Phase: Washout Period 5||0
7708337|NCT01746901|18981664|P9|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
7708338|NCT01746901|18981665|P8|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
7708339|NCT01746901|18981666|P7|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
7708340|NCT01746901|18981667|P6|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
7708341|NCT01746901|18981668|P5|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
7708342|NCT01746901|18981669|P4|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
7708343|NCT01746901|18981670|P3|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
7708344|NCT01746901|18981671|P2|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
7708345|NCT01746901|18981672|P1|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
7708346|NCT01746901|18981664|P9|COMPLETED|Treatment Phase: Fifth Intervention||5
7708347|NCT01746901|18981665|P8|COMPLETED|Treatment Phase: Fifth Intervention||6
7708348|NCT01746901|18981666|P7|COMPLETED|Treatment Phase: Fifth Intervention||5
7708349|NCT01746901|18981667|P6|COMPLETED|Treatment Phase: Fifth Intervention||5
7708350|NCT01746901|18981668|P5|COMPLETED|Treatment Phase: Fifth Intervention||6
7708351|NCT01746901|18981669|P4|COMPLETED|Treatment Phase: Fifth Intervention||5
7708352|NCT01746901|18981670|P3|COMPLETED|Treatment Phase: Fifth Intervention||0
7708353|NCT01746901|18981671|P2|COMPLETED|Treatment Phase: Fifth Intervention||0
7708354|NCT01746901|18981672|P1|COMPLETED|Treatment Phase: Fifth Intervention||0
7708355|NCT01746901|18981664|P9|STARTED|Treatment Phase: Fifth Intervention||5
7708356|NCT01746901|18981665|P8|STARTED|Treatment Phase: Fifth Intervention||6
7708357|NCT01746901|18981666|P7|STARTED|Treatment Phase: Fifth Intervention||5
7708358|NCT01746901|18981667|P6|STARTED|Treatment Phase: Fifth Intervention||5
7708359|NCT01746901|18981668|P5|STARTED|Treatment Phase: Fifth Intervention||6
7708360|NCT01746901|18981669|P4|STARTED|Treatment Phase: Fifth Intervention||5
7708361|NCT01746901|18981670|P3|STARTED|Treatment Phase: Fifth Intervention||0
7708362|NCT01746901|18981671|P2|STARTED|Treatment Phase: Fifth Intervention||0
7708363|NCT01746901|18981672|P1|STARTED|Treatment Phase: Fifth Intervention||0
7708364|NCT01746901|18981664|P9|NOT COMPLETED|Treatment Phase: Washout Period 4||0
7708365|NCT01746901|18981665|P8|NOT COMPLETED|Treatment Phase: Washout Period 4||0
7708366|NCT01746901|18981666|P7|NOT COMPLETED|Treatment Phase: Washout Period 4||0
7708367|NCT01746901|18981667|P6|NOT COMPLETED|Treatment Phase: Washout Period 4||0
7708368|NCT01746901|18981668|P5|NOT COMPLETED|Treatment Phase: Washout Period 4||0
7708369|NCT01746901|18981669|P4|NOT COMPLETED|Treatment Phase: Washout Period 4||0
7708370|NCT01746901|18981670|P3|NOT COMPLETED|Treatment Phase: Washout Period 4||0
7708371|NCT01746901|18981671|P2|NOT COMPLETED|Treatment Phase: Washout Period 4||0
7708372|NCT01746901|18981672|P1|NOT COMPLETED|Treatment Phase: Washout Period 4||0
7708373|NCT01746901|18981664|P9|COMPLETED|Treatment Phase: Washout Period 4||5
7708374|NCT01746901|18981665|P8|COMPLETED|Treatment Phase: Washout Period 4||6
7708375|NCT01746901|18981666|P7|COMPLETED|Treatment Phase: Washout Period 4||5
7708376|NCT01746901|18981667|P6|COMPLETED|Treatment Phase: Washout Period 4||5
7708377|NCT01746901|18981668|P5|COMPLETED|Treatment Phase: Washout Period 4||6
7708378|NCT01746901|18981669|P4|COMPLETED|Treatment Phase: Washout Period 4||5
7708379|NCT01746901|18981670|P3|COMPLETED|Treatment Phase: Washout Period 4||0
7708380|NCT01746901|18981671|P2|COMPLETED|Treatment Phase: Washout Period 4||0
7708381|NCT01746901|18981672|P1|COMPLETED|Treatment Phase: Washout Period 4||0
7708382|NCT01746901|18981664|P9|STARTED|Treatment Phase: Washout Period 4||5
7708383|NCT01746901|18981665|P8|STARTED|Treatment Phase: Washout Period 4||6
7708384|NCT01746901|18981666|P7|STARTED|Treatment Phase: Washout Period 4||5
7708385|NCT01746901|18981667|P6|STARTED|Treatment Phase: Washout Period 4||5
7708386|NCT01746901|18981668|P5|STARTED|Treatment Phase: Washout Period 4||6
7708387|NCT01746901|18981669|P4|STARTED|Treatment Phase: Washout Period 4||5
7708388|NCT01746901|18981670|P3|STARTED|Treatment Phase: Washout Period 4||0
7708389|NCT01746901|18981671|P2|STARTED|Treatment Phase: Washout Period 4||0
7708390|NCT01746901|18981672|P1|STARTED|Treatment Phase: Washout Period 4||0
7708391|NCT01746901|18981664|P9|NOT COMPLETED|Treatment Phase: Fourth Intervention||2
7708392|NCT01746901|18981665|P8|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
7708470|NCT01746901|18981671|P2|STARTED|Treatment Phase: Third Intervention||0
7708393|NCT01746901|18981666|P7|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
7708394|NCT01746901|18981667|P6|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
7708395|NCT01746901|18981668|P5|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
7708396|NCT01746901|18981669|P4|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
7708397|NCT01746901|18981670|P3|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
7708398|NCT01746901|18981671|P2|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
7708399|NCT01746901|18981672|P1|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
7708400|NCT01746901|18981664|P9|COMPLETED|Treatment Phase: Fourth Intervention||5
7708401|NCT01746901|18981665|P8|COMPLETED|Treatment Phase: Fourth Intervention||6
7708402|NCT01746901|18981666|P7|COMPLETED|Treatment Phase: Fourth Intervention||5
7708403|NCT01746901|18981667|P6|COMPLETED|Treatment Phase: Fourth Intervention||5
7708404|NCT01746901|18981668|P5|COMPLETED|Treatment Phase: Fourth Intervention||6
7708405|NCT01746901|18981669|P4|COMPLETED|Treatment Phase: Fourth Intervention||5
7708406|NCT01746901|18981670|P3|COMPLETED|Treatment Phase: Fourth Intervention||0
7708407|NCT01746901|18981671|P2|COMPLETED|Treatment Phase: Fourth Intervention||0
7708408|NCT01746901|18981672|P1|COMPLETED|Treatment Phase: Fourth Intervention||0
7708409|NCT01746901|18981664|P9|STARTED|Treatment Phase: Fourth Intervention||7
7708410|NCT01746901|18981665|P8|STARTED|Treatment Phase: Fourth Intervention||6
7708411|NCT01746901|18981666|P7|STARTED|Treatment Phase: Fourth Intervention||6
7708412|NCT01746901|18981667|P6|STARTED|Treatment Phase: Fourth Intervention||6
7708413|NCT01746901|18981668|P5|STARTED|Treatment Phase: Fourth Intervention||6
7708414|NCT01746901|18981669|P4|STARTED|Treatment Phase: Fourth Intervention||6
7708415|NCT01746901|18981670|P3|STARTED|Treatment Phase: Fourth Intervention||0
7708416|NCT01746901|18981671|P2|STARTED|Treatment Phase: Fourth Intervention||0
7708417|NCT01746901|18981672|P1|STARTED|Treatment Phase: Fourth Intervention||0
7708418|NCT01746901|18981664|P9|NOT COMPLETED|Treatment Phase: Washout Period 3||0
7708419|NCT01746901|18981665|P8|NOT COMPLETED|Treatment Phase: Washout Period 3||0
7708420|NCT01746901|18981666|P7|NOT COMPLETED|Treatment Phase: Washout Period 3||0
7708421|NCT01746901|18981667|P6|NOT COMPLETED|Treatment Phase: Washout Period 3||0
7708422|NCT01746901|18981668|P5|NOT COMPLETED|Treatment Phase: Washout Period 3||0
7708423|NCT01746901|18981669|P4|NOT COMPLETED|Treatment Phase: Washout Period 3||0
7708424|NCT01746901|18981670|P3|NOT COMPLETED|Treatment Phase: Washout Period 3||0
7708425|NCT01746901|18981671|P2|NOT COMPLETED|Treatment Phase: Washout Period 3||0
7708426|NCT01746901|18981672|P1|NOT COMPLETED|Treatment Phase: Washout Period 3||0
7708427|NCT01746901|18981664|P9|COMPLETED|Treatment Phase: Washout Period 3||7
7708428|NCT01746901|18981665|P8|COMPLETED|Treatment Phase: Washout Period 3||6
7708429|NCT01746901|18981666|P7|COMPLETED|Treatment Phase: Washout Period 3||6
7708430|NCT01746901|18981667|P6|COMPLETED|Treatment Phase: Washout Period 3||6
7708431|NCT01746901|18981668|P5|COMPLETED|Treatment Phase: Washout Period 3||6
7708432|NCT01746901|18981669|P4|COMPLETED|Treatment Phase: Washout Period 3||6
7708433|NCT01746901|18981670|P3|COMPLETED|Treatment Phase: Washout Period 3||0
7708434|NCT01746901|18981671|P2|COMPLETED|Treatment Phase: Washout Period 3||0
7708435|NCT01746901|18981672|P1|COMPLETED|Treatment Phase: Washout Period 3||0
7708436|NCT01746901|18981664|P9|STARTED|Treatment Phase: Washout Period 3||7
7708437|NCT01746901|18981665|P8|STARTED|Treatment Phase: Washout Period 3||6
7708438|NCT01746901|18981666|P7|STARTED|Treatment Phase: Washout Period 3||6
7708439|NCT01746901|18981667|P6|STARTED|Treatment Phase: Washout Period 3||6
7708440|NCT01746901|18981668|P5|STARTED|Treatment Phase: Washout Period 3||6
7708441|NCT01746901|18981669|P4|STARTED|Treatment Phase: Washout Period 3||6
7708442|NCT01746901|18981670|P3|STARTED|Treatment Phase: Washout Period 3||0
7708443|NCT01746901|18981671|P2|STARTED|Treatment Phase: Washout Period 3||0
7708444|NCT01746901|18981672|P1|STARTED|Treatment Phase: Washout Period 3||0
7708445|NCT01746901|18981664|P9|NOT COMPLETED|Treatment Phase: Third Intervention||0
7708446|NCT01746901|18981665|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
7708447|NCT01746901|18981666|P7|NOT COMPLETED|Treatment Phase: Third Intervention||1
7708448|NCT01746901|18981667|P6|NOT COMPLETED|Treatment Phase: Third Intervention||1
7708449|NCT01746901|18981668|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
7708450|NCT01746901|18981669|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
7708451|NCT01746901|18981670|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
7708452|NCT01746901|18981671|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
7708453|NCT01746901|18981672|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
7708454|NCT01746901|18981664|P9|COMPLETED|Treatment Phase: Third Intervention||7
7708455|NCT01746901|18981665|P8|COMPLETED|Treatment Phase: Third Intervention||6
7708456|NCT01746901|18981666|P7|COMPLETED|Treatment Phase: Third Intervention||6
7708457|NCT01746901|18981667|P6|COMPLETED|Treatment Phase: Third Intervention||6
7708458|NCT01746901|18981668|P5|COMPLETED|Treatment Phase: Third Intervention||6
7708459|NCT01746901|18981669|P4|COMPLETED|Treatment Phase: Third Intervention||6
7708460|NCT01746901|18981670|P3|COMPLETED|Treatment Phase: Third Intervention||0
7708461|NCT01746901|18981671|P2|COMPLETED|Treatment Phase: Third Intervention||0
7708462|NCT01746901|18981672|P1|COMPLETED|Treatment Phase: Third Intervention||0
7708463|NCT01746901|18981664|P9|STARTED|Treatment Phase: Third Intervention||7
7708464|NCT01746901|18981665|P8|STARTED|Treatment Phase: Third Intervention||6
7708465|NCT01746901|18981666|P7|STARTED|Treatment Phase: Third Intervention||7
7708466|NCT01746901|18981667|P6|STARTED|Treatment Phase: Third Intervention||7
7708467|NCT01746901|18981668|P5|STARTED|Treatment Phase: Third Intervention||6
7708468|NCT01746901|18981669|P4|STARTED|Treatment Phase: Third Intervention||6
7708469|NCT01746901|18981670|P3|STARTED|Treatment Phase: Third Intervention||0
7708471|NCT01746901|18981672|P1|STARTED|Treatment Phase: Third Intervention||0
7708472|NCT01746901|18981664|P9|NOT COMPLETED|Treatment Phase: Washout Period 2||0
7708473|NCT01746901|18981665|P8|NOT COMPLETED|Treatment Phase: Washout Period 2||0
7708474|NCT01746901|18981666|P7|NOT COMPLETED|Treatment Phase: Washout Period 2||0
7708475|NCT01746901|18981667|P6|NOT COMPLETED|Treatment Phase: Washout Period 2||0
7708476|NCT01746901|18981668|P5|NOT COMPLETED|Treatment Phase: Washout Period 2||0
7708477|NCT01746901|18981669|P4|NOT COMPLETED|Treatment Phase: Washout Period 2||0
7708478|NCT01746901|18981670|P3|NOT COMPLETED|Treatment Phase: Washout Period 2||0
7708479|NCT01746901|18981671|P2|NOT COMPLETED|Treatment Phase: Washout Period 2||0
7708480|NCT01746901|18981672|P1|NOT COMPLETED|Treatment Phase: Washout Period 2||0
7708481|NCT01746901|18981664|P9|COMPLETED|Treatment Phase: Washout Period 2||7
7708482|NCT01746901|18981665|P8|COMPLETED|Treatment Phase: Washout Period 2||6
7708483|NCT01746901|18981666|P7|COMPLETED|Treatment Phase: Washout Period 2||7
7708484|NCT01746901|18981667|P6|COMPLETED|Treatment Phase: Washout Period 2||7
7708485|NCT01746901|18981668|P5|COMPLETED|Treatment Phase: Washout Period 2||6
7708486|NCT01746901|18981669|P4|COMPLETED|Treatment Phase: Washout Period 2||6
7708487|NCT01746901|18981670|P3|COMPLETED|Treatment Phase: Washout Period 2||0
7708488|NCT01746901|18981671|P2|COMPLETED|Treatment Phase: Washout Period 2||0
7708489|NCT01746901|18981672|P1|COMPLETED|Treatment Phase: Washout Period 2||0
7708490|NCT01746901|18981664|P9|STARTED|Treatment Phase: Washout Period 2||7
7708491|NCT01746901|18981665|P8|STARTED|Treatment Phase: Washout Period 2||6
7708492|NCT01746901|18981666|P7|STARTED|Treatment Phase: Washout Period 2||7
7708493|NCT01746901|18981667|P6|STARTED|Treatment Phase: Washout Period 2||7
7708494|NCT01746901|18981668|P5|STARTED|Treatment Phase: Washout Period 2||6
7708495|NCT01746901|18981669|P4|STARTED|Treatment Phase: Washout Period 2||6
7708496|NCT01746901|18981670|P3|STARTED|Treatment Phase: Washout Period 2||0
7708497|NCT01746901|18981671|P2|STARTED|Treatment Phase: Washout Period 2||0
7708498|NCT01746901|18981672|P1|STARTED|Treatment Phase: Washout Period 2||0
7708499|NCT01746901|18981664|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
7708500|NCT01746901|18981665|P8|NOT COMPLETED|Treatment Phase: Second Intervention||1
7708501|NCT01746901|18981666|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
7708502|NCT01746901|18981667|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
7708503|NCT01746901|18981668|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
7708504|NCT01746901|18981669|P4|NOT COMPLETED|Treatment Phase: Second Intervention||0
7708505|NCT01746901|18981670|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
7708506|NCT01746901|18981671|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
7708507|NCT01746901|18981672|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
7708508|NCT01746901|18981664|P9|COMPLETED|Treatment Phase: Second Intervention||7
7708509|NCT01746901|18981665|P8|COMPLETED|Treatment Phase: Second Intervention||6
7708510|NCT01746901|18981666|P7|COMPLETED|Treatment Phase: Second Intervention||7
7708511|NCT01746901|18981667|P6|COMPLETED|Treatment Phase: Second Intervention||7
7708512|NCT01746901|18981668|P5|COMPLETED|Treatment Phase: Second Intervention||6
7708513|NCT01746901|18981669|P4|COMPLETED|Treatment Phase: Second Intervention||6
7708514|NCT01746901|18981670|P3|COMPLETED|Treatment Phase: Second Intervention||0
7708515|NCT01746901|18981671|P2|COMPLETED|Treatment Phase: Second Intervention||0
7708516|NCT01746901|18981672|P1|COMPLETED|Treatment Phase: Second Intervention||0
7708517|NCT01746901|18981664|P9|STARTED|Treatment Phase: Second Intervention||7
7708518|NCT01746901|18981665|P8|STARTED|Treatment Phase: Second Intervention||7
7708519|NCT01746901|18981666|P7|STARTED|Treatment Phase: Second Intervention||7
7708520|NCT01746901|18981667|P6|STARTED|Treatment Phase: Second Intervention||7
7708521|NCT01746901|18981668|P5|STARTED|Treatment Phase: Second Intervention||6
7708522|NCT01746901|18981669|P4|STARTED|Treatment Phase: Second Intervention||6
7708523|NCT01746901|18981670|P3|STARTED|Treatment Phase: Second Intervention||0
7708524|NCT01746901|18981671|P2|STARTED|Treatment Phase: Second Intervention||0
7708525|NCT01746901|18981672|P1|STARTED|Treatment Phase: Second Intervention||0
7708526|NCT01746901|18981664|P9|NOT COMPLETED|Treatment Phase: Washout Period 1||0
7708527|NCT01746901|18981665|P8|NOT COMPLETED|Treatment Phase: Washout Period 1||0
7708528|NCT01746901|18981666|P7|NOT COMPLETED|Treatment Phase: Washout Period 1||0
7708529|NCT01746901|18981667|P6|NOT COMPLETED|Treatment Phase: Washout Period 1||0
7708530|NCT01746901|18981668|P5|NOT COMPLETED|Treatment Phase: Washout Period 1||0
7708531|NCT01746901|18981669|P4|NOT COMPLETED|Treatment Phase: Washout Period 1||0
7708532|NCT01746901|18981670|P3|NOT COMPLETED|Treatment Phase: Washout Period 1||0
7708533|NCT01746901|18981671|P2|NOT COMPLETED|Treatment Phase: Washout Period 1||0
7708534|NCT01746901|18981672|P1|NOT COMPLETED|Treatment Phase: Washout Period 1||0
7708535|NCT01746901|18981664|P9|COMPLETED|Treatment Phase: Washout Period 1||7
7708536|NCT01746901|18981665|P8|COMPLETED|Treatment Phase: Washout Period 1||7
7708537|NCT01746901|18981666|P7|COMPLETED|Treatment Phase: Washout Period 1||7
7708538|NCT01746901|18981667|P6|COMPLETED|Treatment Phase: Washout Period 1||7
7708539|NCT01746901|18981668|P5|COMPLETED|Treatment Phase: Washout Period 1||6
7708540|NCT01746901|18981669|P4|COMPLETED|Treatment Phase: Washout Period 1||6
7708541|NCT01746901|18981670|P3|COMPLETED|Treatment Phase: Washout Period 1||0
7708542|NCT01746901|18981671|P2|COMPLETED|Treatment Phase: Washout Period 1||0
7708543|NCT01746901|18981672|P1|COMPLETED|Treatment Phase: Washout Period 1||0
7708544|NCT01746901|18981664|P9|STARTED|Treatment Phase: Washout Period 1||7
7708545|NCT01746901|18981665|P8|STARTED|Treatment Phase: Washout Period 1||7
7708546|NCT01746901|18981666|P7|STARTED|Treatment Phase: Washout Period 1||7
7708547|NCT01746901|18981667|P6|STARTED|Treatment Phase: Washout Period 1||7
7708548|NCT01746901|18981668|P5|STARTED|Treatment Phase: Washout Period 1||6
7708549|NCT01746901|18981669|P4|STARTED|Treatment Phase: Washout Period 1||6
7708550|NCT01746901|18981670|P3|STARTED|Treatment Phase: Washout Period 1||0
7708551|NCT01746901|18981671|P2|STARTED|Treatment Phase: Washout Period 1||0
7708552|NCT01746901|18981672|P1|STARTED|Treatment Phase: Washout Period 1||0
7708553|NCT01746901|18981664|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
7708554|NCT01746901|18981665|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
7708555|NCT01746901|18981666|P7|NOT COMPLETED|Treatment Phase: First Intervention||1
7708556|NCT01746901|18981667|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
7708557|NCT01746901|18981668|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
7708558|NCT01746901|18981669|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
7708559|NCT01746901|18981670|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
7708560|NCT01746901|18981671|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
7708561|NCT01746901|18981672|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
7708562|NCT01746901|18981664|P9|COMPLETED|Treatment Phase: First Intervention||7
7708563|NCT01746901|18981665|P8|COMPLETED|Treatment Phase: First Intervention||7
7708564|NCT01746901|18981666|P7|COMPLETED|Treatment Phase: First Intervention||7
7708565|NCT01746901|18981667|P6|COMPLETED|Treatment Phase: First Intervention||7
7708566|NCT01746901|18981668|P5|COMPLETED|Treatment Phase: First Intervention||6
7708567|NCT01746901|18981669|P4|COMPLETED|Treatment Phase: First Intervention||6
7708568|NCT01746901|18981670|P3|COMPLETED|Treatment Phase: First Intervention||0
7708569|NCT01746901|18981671|P2|COMPLETED|Treatment Phase: First Intervention||0
7708570|NCT01746901|18981672|P1|COMPLETED|Treatment Phase: First Intervention||0
7708571|NCT01746901|18981664|P9|STARTED|Treatment Phase: First Intervention||7
7708572|NCT01746901|18981665|P8|STARTED|Treatment Phase: First Intervention||7
7708573|NCT01746901|18981666|P7|STARTED|Treatment Phase: First Intervention||8
7708574|NCT01746901|18981667|P6|STARTED|Treatment Phase: First Intervention||7
7708575|NCT01746901|18981668|P5|STARTED|Treatment Phase: First Intervention||6
7708576|NCT01746901|18981669|P4|STARTED|Treatment Phase: First Intervention||6
7708577|NCT01746901|18981670|P3|STARTED|Treatment Phase: First Intervention||0
7708578|NCT01746901|18981671|P2|STARTED|Treatment Phase: First Intervention||0
7708579|NCT01746901|18981672|P1|STARTED|Treatment Phase: First Intervention||0
7708580|NCT01746901|18981664|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
7708581|NCT01746901|18981665|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
7708582|NCT01746901|18981666|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
7708583|NCT01746901|18981667|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
7708584|NCT01746901|18981668|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
7708585|NCT01746901|18981669|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
7708586|NCT01746901|18981670|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
7708587|NCT01746901|18981671|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
7708588|NCT01746901|18981672|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
7708589|NCT01746901|18981664|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
7708590|NCT01746901|18981665|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
7708591|NCT01746901|18981666|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
7708592|NCT01746901|18981667|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
7708593|NCT01746901|18981668|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
7708594|NCT01746901|18981669|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
7708595|NCT01746901|18981670|P3|COMPLETED|Drug Discrimination Phase: Day 2||22
7708596|NCT01746901|18981671|P2|COMPLETED|Drug Discrimination Phase: Day 2||19
7708597|NCT01746901|18981672|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
7708598|NCT01746901|18981664|P9|STARTED|Drug Discrimination Phase: Day 2||0
7708599|NCT01746901|18981665|P8|STARTED|Drug Discrimination Phase: Day 2||0
7708600|NCT01746901|18981666|P7|STARTED|Drug Discrimination Phase: Day 2||0
7708601|NCT01746901|18981667|P6|STARTED|Drug Discrimination Phase: Day 2||0
7708602|NCT01746901|18981668|P5|STARTED|Drug Discrimination Phase: Day 2||0
7708603|NCT01746901|18981669|P4|STARTED|Drug Discrimination Phase: Day 2||0
7708604|NCT01746901|18981670|P3|STARTED|Drug Discrimination Phase: Day 2||36
7708605|NCT01746901|18981671|P2|STARTED|Drug Discrimination Phase: Day 2||33
7708606|NCT01746901|18981672|P1|STARTED|Drug Discrimination Phase: Day 2||0
7708607|NCT01746901|18981664|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7708608|NCT01746901|18981665|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7708609|NCT01746901|18981666|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7708610|NCT01746901|18981667|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7708611|NCT01746901|18981668|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7708612|NCT01746901|18981669|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7708613|NCT01746901|18981670|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7708614|NCT01746901|18981671|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
7708615|NCT01746901|18981672|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7708616|NCT01746901|18981664|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
7708617|NCT01746901|18981665|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
7708618|NCT01746901|18981666|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
7708619|NCT01746901|18981667|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
7708620|NCT01746901|18981668|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
7708621|NCT01746901|18981669|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
7708622|NCT01746901|18981670|P3|COMPLETED|Drug Discrimination Phase: Day 1||36
7708623|NCT01746901|18981671|P2|COMPLETED|Drug Discrimination Phase: Day 1||33
7708624|NCT01746901|18981672|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
7708625|NCT01746901|18981664|P9|STARTED|Drug Discrimination Phase: Day 1||0
7708626|NCT01746901|18981665|P8|STARTED|Drug Discrimination Phase: Day 1||0
7708627|NCT01746901|18981666|P7|STARTED|Drug Discrimination Phase: Day 1||0
7708628|NCT01746901|18981667|P6|STARTED|Drug Discrimination Phase: Day 1||0
7708629|NCT01746901|18981668|P5|STARTED|Drug Discrimination Phase: Day 1||0
7708630|NCT01746901|18981669|P4|STARTED|Drug Discrimination Phase: Day 1||0
7708631|NCT01746901|18981670|P3|STARTED|Drug Discrimination Phase: Day 1||36
7708632|NCT01746901|18981671|P2|STARTED|Drug Discrimination Phase: Day 1||36
7708633|NCT01746901|18981672|P1|STARTED|Drug Discrimination Phase: Day 1||0
7708634|NCT01746901|18981664|P9|NOT COMPLETED|Naloxone Challenge Phase||0
7708635|NCT01746901|18981665|P8|NOT COMPLETED|Naloxone Challenge Phase||0
7708636|NCT01746901|18981666|P7|NOT COMPLETED|Naloxone Challenge Phase||0
7708637|NCT01746901|18981667|P6|NOT COMPLETED|Naloxone Challenge Phase||0
7708638|NCT01746901|18981668|P5|NOT COMPLETED|Naloxone Challenge Phase||0
7708639|NCT01746901|18981669|P4|NOT COMPLETED|Naloxone Challenge Phase||0
7708640|NCT01746901|18981670|P3|NOT COMPLETED|Naloxone Challenge Phase||0
7708641|NCT01746901|18981671|P2|NOT COMPLETED|Naloxone Challenge Phase||0
7708642|NCT01746901|18981672|P1|NOT COMPLETED|Naloxone Challenge Phase||3
7708643|NCT01746901|18981664|P9|COMPLETED|Naloxone Challenge Phase||0
7708644|NCT01746901|18981665|P8|COMPLETED|Naloxone Challenge Phase||0
7708645|NCT01746901|18981666|P7|COMPLETED|Naloxone Challenge Phase||0
7708646|NCT01746901|18981667|P6|COMPLETED|Naloxone Challenge Phase||0
7708647|NCT01746901|18981668|P5|COMPLETED|Naloxone Challenge Phase||0
7708648|NCT01746901|18981669|P4|COMPLETED|Naloxone Challenge Phase||0
7708649|NCT01746901|18981670|P3|COMPLETED|Naloxone Challenge Phase||0
7708650|NCT01746901|18981671|P2|COMPLETED|Naloxone Challenge Phase||0
7708651|NCT01746901|18981672|P1|COMPLETED|Naloxone Challenge Phase||72
7708652|NCT01746901|18981664|P9|STARTED|Naloxone Challenge Phase||0
7708653|NCT01746901|18981665|P8|STARTED|Naloxone Challenge Phase||0
7708654|NCT01746901|18981666|P7|STARTED|Naloxone Challenge Phase||0
7708655|NCT01746901|18981667|P6|STARTED|Naloxone Challenge Phase||0
7708656|NCT01746901|18981668|P5|STARTED|Naloxone Challenge Phase||0
7708657|NCT01746901|18981669|P4|STARTED|Naloxone Challenge Phase||0
7708658|NCT01746901|18981670|P3|STARTED|Naloxone Challenge Phase||0
7708659|NCT01746901|18981671|P2|STARTED|Naloxone Challenge Phase||0
7708660|NCT01746901|18981672|P1|STARTED|Naloxone Challenge Phase||75
7708661|NCT01746862|18981995|P2|NOT COMPLETED|Overall Study||3
7708662|NCT01746862|18981996|P1|NOT COMPLETED|Overall Study||8
7708663|NCT01746862|18981995|P2|COMPLETED|Overall Study||27
7708664|NCT01746862|18981996|P1|COMPLETED|Overall Study||52
7708665|NCT01746862|18981995|P2|Treated|Overall Study||30
7708666|NCT01746862|18981996|P1|Treated|Overall Study||59
7708667|NCT01746862|18981995|P2|STARTED|Overall Study||30
7708668|NCT01746862|18981996|P1|STARTED|Overall Study||60
7708669|NCT01746784|18982021|P5|NOT COMPLETED|Overall Study||0
7708670|NCT01746784|18982022|P4|NOT COMPLETED|Overall Study||0
7708671|NCT01746784|18982023|P3|NOT COMPLETED|Overall Study||0
7708672|NCT01746784|18982024|P2|NOT COMPLETED|Overall Study||0
7708673|NCT01746784|18982025|P1|NOT COMPLETED|Overall Study||0
7708674|NCT01746784|18982021|P5|COMPLETED|Overall Study||19
7708675|NCT01746784|18982022|P4|COMPLETED|Overall Study||9
7708676|NCT01746784|18982023|P3|COMPLETED|Overall Study||9
7708677|NCT01746784|18982024|P2|COMPLETED|Overall Study||10
7708678|NCT01746784|18982025|P1|COMPLETED|Overall Study||19
7708679|NCT01746784|18982021|P5|Enrolled|Overall Study||19
7708680|NCT01746784|18982022|P4|Enrolled|Overall Study||9
7708681|NCT01746784|18982023|P3|Enrolled|Overall Study||9
7708682|NCT01746784|18982024|P2|Enrolled|Overall Study||10
7708683|NCT01746784|18982025|P1|Enrolled|Overall Study||19
7708684|NCT01746784|18982021|P5|STARTED|Overall Study||19
7708685|NCT01746784|18982022|P4|STARTED|Overall Study||9
7708686|NCT01746784|18982023|P3|STARTED|Overall Study||9
7708687|NCT01746784|18982024|P2|STARTED|Overall Study||10
7708688|NCT01746784|18982025|P1|STARTED|Overall Study||19
7708689|NCT01746745|18982047|P1|NOT COMPLETED|Overall Study||0
7708690|NCT01746745|18982047|P1|COMPLETED|Overall Study||6
7708691|NCT01746745|18982047|P1|Received Study Drug|Overall Study||6
7708692|NCT01746745|18982047|P1|STARTED|Overall Study||6
7708693|NCT01746732|18982060|P3|NOT COMPLETED|Period 2||4
7708694|NCT01746732|18982061|P2|NOT COMPLETED|Period 2||0
7708695|NCT01746732|18982062|P1|NOT COMPLETED|Period 2||0
7708696|NCT01746732|18982060|P3|COMPLETED|Period 2||7
7708697|NCT01746732|18982061|P2|COMPLETED|Period 2||10
7708698|NCT01746732|18982062|P1|COMPLETED|Period 2||0
7708699|NCT01746732|18982060|P3|STARTED|Period 2||11
7708700|NCT01746732|18982061|P2|STARTED|Period 2||10
7708701|NCT01746732|18982062|P1|STARTED|Period 2||0
7708702|NCT01746732|18982060|P3|NOT COMPLETED|Period 1||0
7708703|NCT01746732|18982061|P2|NOT COMPLETED|Period 1||1
7708704|NCT01746732|18982062|P1|NOT COMPLETED|Period 1||0
7708705|NCT01746732|18982060|P3|COMPLETED|Period 1||11
7708706|NCT01746732|18982061|P2|COMPLETED|Period 1||10
7708707|NCT01746732|18982062|P1|COMPLETED|Period 1||0
7708708|NCT01746732|18982060|P3|STARTED|Period 1||11
7708709|NCT01746732|18982061|P2|STARTED|Period 1||11
7708710|NCT01746732|18982062|P1|STARTED|Period 1||0
7708711|NCT01746732|18982060|P3|NOT COMPLETED|Lead-In Period||0
7708712|NCT01746732|18982061|P2|NOT COMPLETED|Lead-In Period||0
7708713|NCT01746732|18982062|P1|NOT COMPLETED|Lead-In Period||1
7708714|NCT01746732|18982060|P3|COMPLETED|Lead-In Period||0
7708715|NCT01746732|18982061|P2|COMPLETED|Lead-In Period||0
7708716|NCT01746732|18982062|P1|COMPLETED|Lead-In Period||22
7708717|NCT01746732|18982060|P3|Participants Received at Least 1 Dose|Lead-In Period||0
7708718|NCT01746732|18982061|P2|Participants Received at Least 1 Dose|Lead-In Period||0
7708719|NCT01746732|18982062|P1|Participants Received at Least 1 Dose|Lead-In Period||22
7708720|NCT01746732|18982060|P3|STARTED|Lead-In Period||0
7708721|NCT01746732|18982061|P2|STARTED|Lead-In Period||0
7708722|NCT01746732|18982062|P1|STARTED|Lead-In Period||23
7708723|NCT01746511|18982085|P2|NOT COMPLETED|Overall Study||0
7708724|NCT01746511|18982086|P1|NOT COMPLETED|Overall Study||0
7708725|NCT01746511|18982085|P2|COMPLETED|Overall Study||39
7708726|NCT01746511|18982086|P1|COMPLETED|Overall Study||40
7708727|NCT01746511|18982085|P2|STARTED|Overall Study||39
7708728|NCT01746511|18982086|P1|STARTED|Overall Study||40
7708729|NCT01746420|18982105|P5|NOT COMPLETED|Overall Study||0
7708730|NCT01746420|18982106|P4|NOT COMPLETED|Overall Study||0
7708731|NCT01746420|18982107|P3|NOT COMPLETED|Overall Study||3
7708732|NCT01746420|18982108|P2|NOT COMPLETED|Overall Study||2
7708733|NCT01746420|18982109|P1|NOT COMPLETED|Overall Study||3
7708734|NCT01746420|18982105|P5|COMPLETED|Overall Study||20
7708735|NCT01746420|18982106|P4|COMPLETED|Overall Study||20
7708736|NCT01746420|18982107|P3|COMPLETED|Overall Study||17
7708737|NCT01746420|18982108|P2|COMPLETED|Overall Study||18
7708738|NCT01746420|18982109|P1|COMPLETED|Overall Study||17
7708739|NCT01746420|18982105|P5|STARTED|Overall Study||20
7708740|NCT01746420|18982106|P4|STARTED|Overall Study||20
7708741|NCT01746420|18982107|P3|STARTED|Overall Study||20
7708742|NCT01746420|18982108|P2|STARTED|Overall Study||20
7708743|NCT01746420|18982109|P1|STARTED|Overall Study||20
7708744|NCT01746368|18982143|P2|NOT COMPLETED|Overall Study||1
7708745|NCT01746368|18982144|P1|NOT COMPLETED|Overall Study||2
7708746|NCT01746368|18982143|P2|COMPLETED|Overall Study||16
7708747|NCT01746368|18982144|P1|COMPLETED|Overall Study||31
7708748|NCT01746368|18982143|P2|Analyzed for Satisfaction|Overall Study||16
7708749|NCT01746368|18982144|P1|Analyzed for Satisfaction|Overall Study||30
7708750|NCT01746368|18982143|P2|Analyzed for AD Completion Rate|Overall Study||17
7708751|NCT01746368|18982144|P1|Analyzed for AD Completion Rate|Overall Study||32
7708752|NCT01746368|18982143|P2|Assessment Completed|Overall Study||16
7708753|NCT01746368|18982144|P1|Assessment Completed|Overall Study||31
7708754|NCT01746368|18982143|P2|Recieved Allocated Intervention|Overall Study||8
7708755|NCT01746368|18982144|P1|Recieved Allocated Intervention|Overall Study||31
7708756|NCT01746368|18982143|P2|STARTED|Overall Study||17
7708757|NCT01746368|18982144|P1|STARTED|Overall Study||33
7708758|NCT01746264|18982152|P1|NOT COMPLETED|Overall Study||0
7708759|NCT01746264|18982152|P1|COMPLETED|Overall Study||19
7708760|NCT01746264|18982152|P1|STARTED|Overall Study||19
7708761|NCT01746225|18982174|P3|NOT COMPLETED|Overall Study||43
7708762|NCT01746225|18982175|P2|NOT COMPLETED|Overall Study||46
7708763|NCT01746225|18982176|P1|NOT COMPLETED|Overall Study||40
7708764|NCT01746225|18982174|P3|COMPLETED|Overall Study||43
7708765|NCT01746225|18982175|P2|COMPLETED|Overall Study||40
7708766|NCT01746225|18982176|P1|COMPLETED|Overall Study||43
7708767|NCT01746225|18982174|P3|STARTED|Overall Study||86
7708768|NCT01746225|18982175|P2|STARTED|Overall Study||86
7708769|NCT01746225|18982176|P1|STARTED|Overall Study||83
7708770|NCT01746173|18982199|P1|NOT COMPLETED|Overall Study||2
7708771|NCT01746173|18982199|P1|COMPLETED|Overall Study||3
7708772|NCT01746173|18982199|P1|STARTED|Overall Study||5
7708773|NCT01746108|18982207|P3|NOT COMPLETED|Overall Study||0
7708774|NCT01746108|18982208|P2|NOT COMPLETED|Overall Study||4
7708775|NCT01746108|18982209|P1|NOT COMPLETED|Overall Study||0
7708776|NCT01746108|18982207|P3|COMPLETED|Overall Study||6
7708777|NCT01746108|18982208|P2|COMPLETED|Overall Study||24
7708778|NCT01746108|18982209|P1|COMPLETED|Overall Study||18
7708779|NCT01746108|18982207|P3|STARTED|Overall Study||6
7708780|NCT01746108|18982208|P2|STARTED|Overall Study||28
7708781|NCT01746108|18982209|P1|STARTED|Overall Study||18
7708782|NCT01746095|18982249|P4|NOT COMPLETED|Overall Study||8
7708783|NCT01746095|18982250|P3|NOT COMPLETED|Overall Study||13
7708784|NCT01746095|18982251|P2|NOT COMPLETED|Overall Study||4
7708785|NCT01746095|18982252|P1|NOT COMPLETED|Overall Study||4
7708786|NCT01746095|18982249|P4|COMPLETED|Overall Study||15
7708787|NCT01746095|18982250|P3|COMPLETED|Overall Study||11
7708788|NCT01746095|18982251|P2|COMPLETED|Overall Study||16
7708789|NCT01746095|18982252|P1|COMPLETED|Overall Study||16
7708790|NCT01746095|18982249|P4|STARTED|Overall Study||23
7708791|NCT01746095|18982250|P3|STARTED|Overall Study||24
7708792|NCT01746095|18982251|P2|STARTED|Overall Study||20
7708793|NCT01746095|18982252|P1|STARTED|Overall Study||20
7708794|NCT01746043|18982302|P4|NOT COMPLETED|Overall Study||0
7708795|NCT01746043|18982303|P3|NOT COMPLETED|Overall Study||0
7708796|NCT01746043|18982304|P2|NOT COMPLETED|Overall Study||0
7708797|NCT01746043|18982305|P1|NOT COMPLETED|Overall Study||0
7708798|NCT01746043|18982302|P4|COMPLETED|Overall Study||5
7708799|NCT01746043|18982303|P3|COMPLETED|Overall Study||5
7708800|NCT01746043|18982304|P2|COMPLETED|Overall Study||4
7708801|NCT01746043|18982305|P1|COMPLETED|Overall Study||5
7708802|NCT01746043|18982302|P4|STARTED|Overall Study||5
7708803|NCT01746043|18982303|P3|STARTED|Overall Study||5
7708804|NCT01746043|18982304|P2|STARTED|Overall Study||4
7708805|NCT01746043|18982305|P1|STARTED|Overall Study||5
7708806|NCT01746017|18982326|P11|NOT COMPLETED|Period 4||0
7708807|NCT01746017|18982327|P10|NOT COMPLETED|Period 4||0
7708808|NCT01746017|18982328|P9|NOT COMPLETED|Period 4||0
7708809|NCT01746017|18982329|P8|NOT COMPLETED|Period 4||0
7708810|NCT01746017|18982330|P7|NOT COMPLETED|Period 4||0
7708811|NCT01746017|18982331|P6|NOT COMPLETED|Period 4||0
7708812|NCT01746017|18982332|P5|NOT COMPLETED|Period 4||0
7708813|NCT01746017|18982333|P4|NOT COMPLETED|Period 4||0
7708814|NCT01746017|18982334|P3|NOT COMPLETED|Period 4||0
7708815|NCT01746017|18982335|P2|NOT COMPLETED|Period 4||0
7708816|NCT01746017|18982336|P1|NOT COMPLETED|Period 4||0
7708817|NCT01746017|18982326|P11|COMPLETED|Period 4||0
7708818|NCT01746017|18982327|P10|COMPLETED|Period 4||0
7708819|NCT01746017|18982328|P9|COMPLETED|Period 4||0
7708820|NCT01746017|18982329|P8|COMPLETED|Period 4||2
7708821|NCT01746017|18982330|P7|COMPLETED|Period 4||2
7708822|NCT01746017|18982331|P6|COMPLETED|Period 4||1
7708823|NCT01746017|18982332|P5|COMPLETED|Period 4||2
7708824|NCT01746017|18982333|P4|COMPLETED|Period 4||2
7708825|NCT01746017|18982334|P3|COMPLETED|Period 4||2
7708826|NCT01746017|18982335|P2|COMPLETED|Period 4||2
7708827|NCT01746017|18982336|P1|COMPLETED|Period 4||2
7708828|NCT01746017|18982326|P11|STARTED|Period 4|Part B occurred only for 3 periods.|0
7708829|NCT01746017|18982327|P10|STARTED|Period 4|Part B occurred only for 3 periods.|0
7708830|NCT01746017|18982328|P9|STARTED|Period 4|Part B occurred only for 3 periods.|0
7708831|NCT01746017|18982329|P8|STARTED|Period 4||2
7708832|NCT01746017|18982330|P7|STARTED|Period 4||2
7708833|NCT01746017|18982331|P6|STARTED|Period 4||1
7708834|NCT01746017|18982332|P5|STARTED|Period 4||2
7708835|NCT01746017|18982333|P4|STARTED|Period 4||2
7708836|NCT01746017|18982334|P3|STARTED|Period 4||2
7708837|NCT01746017|18982335|P2|STARTED|Period 4||2
7708838|NCT01746017|18982336|P1|STARTED|Period 4||2
7708839|NCT01746017|18982326|P11|NOT COMPLETED|Period 3||0
7708840|NCT01746017|18982327|P10|NOT COMPLETED|Period 3||0
7708841|NCT01746017|18982328|P9|NOT COMPLETED|Period 3||0
7708842|NCT01746017|18982329|P8|NOT COMPLETED|Period 3||0
7708843|NCT01746017|18982330|P7|NOT COMPLETED|Period 3||0
7708844|NCT01746017|18982331|P6|NOT COMPLETED|Period 3||1
7708845|NCT01746017|18982332|P5|NOT COMPLETED|Period 3||0
7708846|NCT01746017|18982333|P4|NOT COMPLETED|Period 3||0
7708847|NCT01746017|18982334|P3|NOT COMPLETED|Period 3||0
7708848|NCT01746017|18982335|P2|NOT COMPLETED|Period 3||0
7708849|NCT01746017|18982336|P1|NOT COMPLETED|Period 3||0
7708850|NCT01746017|18982326|P11|COMPLETED|Period 3||3
7708851|NCT01746017|18982327|P10|COMPLETED|Period 3||3
7708852|NCT01746017|18982328|P9|COMPLETED|Period 3||3
7708853|NCT01746017|18982329|P8|COMPLETED|Period 3||2
7708854|NCT01746017|18982330|P7|COMPLETED|Period 3||2
7708855|NCT01746017|18982331|P6|COMPLETED|Period 3||1
7708856|NCT01746017|18982332|P5|COMPLETED|Period 3||2
7708857|NCT01746017|18982333|P4|COMPLETED|Period 3||2
7708858|NCT01746017|18982334|P3|COMPLETED|Period 3||2
7708859|NCT01746017|18982335|P2|COMPLETED|Period 3||2
7708860|NCT01746017|18982336|P1|COMPLETED|Period 3||2
7708861|NCT01746017|18982326|P11|STARTED|Period 3||3
7708862|NCT01746017|18982327|P10|STARTED|Period 3||3
7708863|NCT01746017|18982328|P9|STARTED|Period 3||3
7708864|NCT01746017|18982329|P8|STARTED|Period 3||2
7708865|NCT01746017|18982330|P7|STARTED|Period 3||2
7708866|NCT01746017|18982331|P6|STARTED|Period 3||2
7708867|NCT01746017|18982332|P5|STARTED|Period 3||2
7708868|NCT01746017|18982333|P4|STARTED|Period 3||2
7708869|NCT01746017|18982334|P3|STARTED|Period 3||2
7708870|NCT01746017|18982335|P2|STARTED|Period 3||2
7708871|NCT01746017|18982336|P1|STARTED|Period 3||2
7708872|NCT01746017|18982326|P11|NOT COMPLETED|Period 2||0
7708873|NCT01746017|18982327|P10|NOT COMPLETED|Period 2||0
7708874|NCT01746017|18982328|P9|NOT COMPLETED|Period 2||0
7708875|NCT01746017|18982329|P8|NOT COMPLETED|Period 2||0
7708876|NCT01746017|18982330|P7|NOT COMPLETED|Period 2||0
7708877|NCT01746017|18982331|P6|NOT COMPLETED|Period 2||0
7708878|NCT01746017|18982332|P5|NOT COMPLETED|Period 2||0
7708879|NCT01746017|18982333|P4|NOT COMPLETED|Period 2||0
7708880|NCT01746017|18982334|P3|NOT COMPLETED|Period 2||0
7708881|NCT01746017|18982335|P2|NOT COMPLETED|Period 2||0
7708882|NCT01746017|18982336|P1|NOT COMPLETED|Period 2||0
7708883|NCT01746017|18982326|P11|COMPLETED|Period 2||3
7708884|NCT01746017|18982327|P10|COMPLETED|Period 2||3
7708885|NCT01746017|18982328|P9|COMPLETED|Period 2||3
7708886|NCT01746017|18982329|P8|COMPLETED|Period 2||2
7708887|NCT01746017|18982330|P7|COMPLETED|Period 2||2
7708888|NCT01746017|18982331|P6|COMPLETED|Period 2||2
7708889|NCT01746017|18982332|P5|COMPLETED|Period 2||2
7708890|NCT01746017|18982333|P4|COMPLETED|Period 2||2
7708891|NCT01746017|18982334|P3|COMPLETED|Period 2||2
7708892|NCT01746017|18982335|P2|COMPLETED|Period 2||2
7708893|NCT01746017|18982336|P1|COMPLETED|Period 2||2
7708894|NCT01746017|18982326|P11|STARTED|Period 2||3
7708895|NCT01746017|18982327|P10|STARTED|Period 2||3
7708896|NCT01746017|18982328|P9|STARTED|Period 2||3
7708897|NCT01746017|18982329|P8|STARTED|Period 2||2
7708898|NCT01746017|18982330|P7|STARTED|Period 2||2
7708899|NCT01746017|18982331|P6|STARTED|Period 2||2
7708900|NCT01746017|18982332|P5|STARTED|Period 2||2
7708901|NCT01746017|18982333|P4|STARTED|Period 2||2
7708902|NCT01746017|18982334|P3|STARTED|Period 2||2
7708903|NCT01746017|18982335|P2|STARTED|Period 2||2
7708904|NCT01746017|18982336|P1|STARTED|Period 2||2
7708905|NCT01746017|18982326|P11|NOT COMPLETED|Period 1||0
7708906|NCT01746017|18982327|P10|NOT COMPLETED|Period 1||0
7708907|NCT01746017|18982328|P9|NOT COMPLETED|Period 1||0
7708908|NCT01746017|18982329|P8|NOT COMPLETED|Period 1||0
7708909|NCT01746017|18982330|P7|NOT COMPLETED|Period 1||1
7708910|NCT01746017|18982331|P6|NOT COMPLETED|Period 1||0
7708911|NCT01746017|18982332|P5|NOT COMPLETED|Period 1||0
7708912|NCT01746017|18982333|P4|NOT COMPLETED|Period 1||0
7708913|NCT01746017|18982334|P3|NOT COMPLETED|Period 1||0
7708914|NCT01746017|18982335|P2|NOT COMPLETED|Period 1||0
7708915|NCT01746017|18982336|P1|NOT COMPLETED|Period 1||0
7708916|NCT01746017|18982326|P11|COMPLETED|Period 1||3
7708917|NCT01746017|18982327|P10|COMPLETED|Period 1||3
7708918|NCT01746017|18982328|P9|COMPLETED|Period 1||3
7708919|NCT01746017|18982329|P8|COMPLETED|Period 1||2
7708920|NCT01746017|18982330|P7|COMPLETED|Period 1||2
7708921|NCT01746017|18982331|P6|COMPLETED|Period 1||2
7708922|NCT01746017|18982332|P5|COMPLETED|Period 1||2
7708923|NCT01746017|18982333|P4|COMPLETED|Period 1||2
7708924|NCT01746017|18982334|P3|COMPLETED|Period 1||2
7708925|NCT01746017|18982335|P2|COMPLETED|Period 1||2
7708926|NCT01746017|18982336|P1|COMPLETED|Period 1||2
7708927|NCT01746017|18982326|P11|Received at Least 1 Dose of Study Drug|Period 1||3
7708928|NCT01746017|18982327|P10|Received at Least 1 Dose of Study Drug|Period 1||3
7708929|NCT01746017|18982328|P9|Received at Least 1 Dose of Study Drug|Period 1||3
7708930|NCT01746017|18982329|P8|Received at Least 1 Dose of Study Drug|Period 1||2
7708931|NCT01746017|18982330|P7|Received at Least 1 Dose of Study Drug|Period 1||3
7708932|NCT01746017|18982331|P6|Received at Least 1 Dose of Study Drug|Period 1||2
7708933|NCT01746017|18982332|P5|Received at Least 1 Dose of Study Drug|Period 1||2
7708934|NCT01746017|18982333|P4|Received at Least 1 Dose of Study Drug|Period 1||2
7708935|NCT01746017|18982334|P3|Received at Least 1 Dose of Study Drug|Period 1||2
7708936|NCT01746017|18982335|P2|Received at Least 1 Dose of Study Drug|Period 1||2
7708937|NCT01746017|18982336|P1|Received at Least 1 Dose of Study Drug|Period 1||2
7708938|NCT01746017|18982326|P11|STARTED|Period 1||3
7708939|NCT01746017|18982327|P10|STARTED|Period 1||3
7708940|NCT01746017|18982328|P9|STARTED|Period 1||3
7708941|NCT01746017|18982329|P8|STARTED|Period 1||2
7708942|NCT01746017|18982330|P7|STARTED|Period 1||3
7708943|NCT01746017|18982331|P6|STARTED|Period 1||2
7708944|NCT01746017|18982332|P5|STARTED|Period 1||2
7708945|NCT01746017|18982333|P4|STARTED|Period 1||2
7708946|NCT01746017|18982334|P3|STARTED|Period 1||2
7708947|NCT01746017|18982335|P2|STARTED|Period 1||2
7708948|NCT01746017|18982336|P1|STARTED|Period 1||2
7708949|NCT01745952|18982412|P3|NOT COMPLETED|Overall Study||0
7708950|NCT01745952|18982413|P2|NOT COMPLETED|Overall Study||1
7708951|NCT01745952|18982414|P1|NOT COMPLETED|Overall Study||1
7708952|NCT01745952|18982412|P3|COMPLETED|Overall Study||3
7708953|NCT01745952|18982413|P2|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3
7708954|NCT01745952|18982414|P1|COMPLETED|Overall Study||3
7708955|NCT01745952|18982412|P3|STARTED|Overall Study||3
7708956|NCT01745952|18982413|P2|STARTED|Overall Study||4
7708957|NCT01745952|18982414|P1|STARTED|Overall Study||4
7708958|NCT01745913|18982440|P2|NOT COMPLETED|Overall Study||1
7708959|NCT01745913|18982441|P1|NOT COMPLETED|Overall Study||1
7708960|NCT01745913|18982440|P2|COMPLETED|Overall Study||0
7708961|NCT01745913|18982441|P1|COMPLETED|Overall Study||0
7708962|NCT01745913|18982440|P2|STARTED|Overall Study||1
7708963|NCT01745913|18982441|P1|STARTED|Overall Study||1
7708964|NCT01745848|18982457|P1|NOT COMPLETED|Overall Study||6
7708965|NCT01745848|18982457|P1|COMPLETED|Overall Study||20
7708966|NCT01745848|18982457|P1|STARTED|Overall Study||26
7708967|NCT01745627|18982462|P1|NOT COMPLETED|Overall Study||22
7708968|NCT01745627|18982462|P1|COMPLETED|Overall Study||20
7708969|NCT01745627|18982462|P1|STARTED|Overall Study||42
7708970|NCT01745393|18982469|P2|NOT COMPLETED|12-month Follow-up||5
7708971|NCT01745393|18982470|P1|NOT COMPLETED|12-month Follow-up||6
7708972|NCT01745393|18982469|P2|COMPLETED|12-month Follow-up||151
7708973|NCT01745393|18982470|P1|COMPLETED|12-month Follow-up||136
7708974|NCT01745393|18982469|P2|STARTED|12-month Follow-up||156
7708975|NCT01745393|18982470|P1|STARTED|12-month Follow-up||142
7708976|NCT01745393|18982469|P2|NOT COMPLETED|Treatment to End-of-treatment Assessment||8
7708977|NCT01745393|18982470|P1|NOT COMPLETED|Treatment to End-of-treatment Assessment||21
7708978|NCT01745393|18982469|P2|COMPLETED|Treatment to End-of-treatment Assessment||156
7708979|NCT01745393|18982470|P1|COMPLETED|Treatment to End-of-treatment Assessment||142
7708980|NCT01745393|18982469|P2|Received Treatment|Treatment to End-of-treatment Assessment|Attention control = nutrition education via telephone|144
7708981|NCT01745393|18982470|P1|Received Treatment|Treatment to End-of-treatment Assessment|Behavioral counseling = TSE-reduction and cessation counseling via telephone|147
7708982|NCT01745393|18982469|P2|STARTED|Treatment to End-of-treatment Assessment||164
7708983|NCT01745393|18982470|P1|STARTED|Treatment to End-of-treatment Assessment||163
7708984|NCT01745380|18982482|P2|NOT COMPLETED|Overall Study||1
7708985|NCT01745380|18982483|P1|NOT COMPLETED|Overall Study||1
7708986|NCT01745380|18982482|P2|COMPLETED|Overall Study||49
7708987|NCT01745380|18982483|P1|COMPLETED|Overall Study||99
7708988|NCT01745380|18982482|P2|STARTED|Overall Study||50
7708989|NCT01745380|18982483|P1|STARTED|Overall Study||100
7708990|NCT01745367|18982521|P2|NOT COMPLETED|Overall Study||22
7708991|NCT01745367|18982522|P1|NOT COMPLETED|Overall Study||8
7708992|NCT01745367|18982521|P2|COMPLETED|Overall Study||0
7708993|NCT01745367|18982522|P1|COMPLETED|Overall Study||0
7708994|NCT01745367|18982521|P2|Treated|Overall Study||21
7708995|NCT01745367|18982522|P1|Treated|Overall Study||8
7708996|NCT01745367|18982521|P2|STARTED|Overall Study||22
7708997|NCT01745367|18982522|P1|STARTED|Overall Study||8
7708998|NCT01745146|18982542|P2|NOT COMPLETED|Overall Study||3
7708999|NCT01745146|18982543|P1|NOT COMPLETED|Overall Study||3
7709000|NCT01745146|18982542|P2|COMPLETED|Overall Study||57
7709001|NCT01745146|18982543|P1|COMPLETED|Overall Study||27
7709002|NCT01745146|18982542|P2|Analysis|Overall Study||57
7709003|NCT01745146|18982543|P1|Analysis|Overall Study||27
7709004|NCT01745146|18982542|P2|Primary Outcome Assessment|Overall Study||57
7709005|NCT01745146|18982543|P1|Primary Outcome Assessment|Overall Study||27
7709006|NCT01745146|18982542|P2|Allocation to Intervention|Overall Study||60
7709007|NCT01745146|18982543|P1|Allocation to Intervention|Overall Study||30
7709008|NCT01745146|18982542|P2|STARTED|Overall Study||60
7709009|NCT01745146|18982543|P1|STARTED|Overall Study||30
7709010|NCT01745133|18982553|P3|NOT COMPLETED|Overall Study||4
7709011|NCT01745133|18982554|P2|NOT COMPLETED|Overall Study||4
7709012|NCT01745133|18982555|P1|NOT COMPLETED|Overall Study||6
7709013|NCT01745133|18982553|P3|COMPLETED|Overall Study||15
7709014|NCT01745133|18982554|P2|COMPLETED|Overall Study||16
7709015|NCT01745133|18982555|P1|COMPLETED|Overall Study||13
7709016|NCT01745133|18982553|P3|STARTED|Overall Study||19
7709017|NCT01745133|18982554|P2|STARTED|Overall Study||20
7709018|NCT01745133|18982555|P1|STARTED|Overall Study||19
7709019|NCT01745120|18982565|P2|NOT COMPLETED|Overall Study||0
7709020|NCT01745120|18982566|P1|NOT COMPLETED|Overall Study||1
7709021|NCT01745120|18982565|P2|COMPLETED|Overall Study||8
7709022|NCT01745120|18982566|P1|COMPLETED|Overall Study||10
7709023|NCT01745120|18982565|P2|STARTED|Overall Study||8
7709024|NCT01745120|18982566|P1|STARTED|Overall Study||11
7709025|NCT01745094|18982624|P4|NOT COMPLETED|Overall Study||3
7709026|NCT01745094|18982625|P3|NOT COMPLETED|Overall Study||12
7709027|NCT01745094|18982626|P2|NOT COMPLETED|Overall Study||0
7709028|NCT01745094|18982627|P1|NOT COMPLETED|Overall Study||5
7709029|NCT01745094|18982624|P4|COMPLETED|Overall Study||90
7709030|NCT01745094|18982625|P3|COMPLETED|Overall Study||46
7709031|NCT01745094|18982626|P2|COMPLETED|Overall Study||37
7709032|NCT01745094|18982627|P1|COMPLETED|Overall Study||30
7709033|NCT01745094|18982624|P4|STARTED|Overall Study||93
7709034|NCT01745094|18982625|P3|STARTED|Overall Study||58
7709035|NCT01745094|18982626|P2|STARTED|Overall Study||37
7709036|NCT01745094|18982627|P1|STARTED|Overall Study||35
7709037|NCT01745055|18982693|P1|NOT COMPLETED|Overall Study||0
7709038|NCT01745055|18982693|P1|COMPLETED|Overall Study||12
7709039|NCT01745055|18982693|P1|STARTED|Overall Study||12
7709040|NCT01744977|18982728|P2|NOT COMPLETED|Overall Study||5
7709041|NCT01744977|18982729|P1|NOT COMPLETED|Overall Study||11
7709042|NCT01744977|18982728|P2|COMPLETED|Overall Study||115
7709043|NCT01744977|18982729|P1|COMPLETED|Overall Study||109
7709044|NCT01744977|18982728|P2|6 Month Completed|Overall Study||115
7709045|NCT01744977|18982729|P1|6 Month Completed|Overall Study||113
7709046|NCT01744977|18982728|P2|STARTED|Overall Study||120
7709047|NCT01744977|18982729|P1|STARTED|Overall Study||120
7709048|NCT01744860|18982737|P1|NOT COMPLETED|Overall Study||0
7709049|NCT01744860|18982737|P1|COMPLETED|Overall Study||420
7709050|NCT01744860|18982737|P1|STARTED|Overall Study||420
7709051|NCT01744821|18982775|P4|NOT COMPLETED|Overall Study||0
7709052|NCT01744821|18982776|P3|NOT COMPLETED|Overall Study||0
7709053|NCT01744821|18982777|P2|NOT COMPLETED|Overall Study||0
7709054|NCT01744821|18982778|P1|NOT COMPLETED|Overall Study||0
7709055|NCT01744821|18982775|P4|COMPLETED|Overall Study||1
7709056|NCT01744821|18982776|P3|COMPLETED|Overall Study||2
7709057|NCT01744821|18982777|P2|COMPLETED|Overall Study||3
7709058|NCT01744821|18982778|P1|COMPLETED|Overall Study||1
7709059|NCT01744821|18982775|P4|STARTED|Overall Study||1
7709060|NCT01744821|18982776|P3|STARTED|Overall Study||2
7709061|NCT01744821|18982777|P2|STARTED|Overall Study||3
7709062|NCT01744821|18982778|P1|STARTED|Overall Study||1
7709063|NCT01744782|18982800|P1|NOT COMPLETED|Overall Study||1
7709064|NCT01744782|18982800|P1|COMPLETED|Overall Study||16
7709065|NCT01744782|18982800|P1|STARTED|Overall Study||17
7709066|NCT01744730|18982813|P5|NOT COMPLETED|Overall Study||0
7709067|NCT01744730|18982814|P4|NOT COMPLETED|Overall Study||0
7709068|NCT01744730|18982815|P3|NOT COMPLETED|Overall Study||0
7709069|NCT01744730|18982816|P2|NOT COMPLETED|Overall Study||0
7709070|NCT01744730|18982817|P1|NOT COMPLETED|Overall Study||0
7709071|NCT01744730|18982813|P5|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
7709072|NCT01744730|18982814|P4|COMPLETED|Overall Study||11
7709073|NCT01744730|18982815|P3|COMPLETED|Overall Study||4
7709074|NCT01744730|18982816|P2|COMPLETED|Overall Study||3
7709075|NCT01744730|18982817|P1|COMPLETED|Overall Study||4
7709076|NCT01744730|18982813|P5|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
7709077|NCT01744730|18982814|P4|STARTED|Overall Study||11
7709078|NCT01744730|18982815|P3|STARTED|Overall Study||4
7709079|NCT01744730|18982816|P2|STARTED|Overall Study||3
7709080|NCT01744730|18982817|P1|STARTED|Overall Study||4
7709081|NCT01744704|18982871|P12|NOT COMPLETED|Overall Study||0
7709082|NCT01744704|18982872|P11|NOT COMPLETED|Overall Study||0
7709083|NCT01744704|18982873|P10|NOT COMPLETED|Overall Study||0
7709084|NCT01744704|18982874|P9|NOT COMPLETED|Overall Study||0
7709085|NCT01744704|18982875|P8|NOT COMPLETED|Overall Study||0
7709086|NCT01744704|18982876|P7|NOT COMPLETED|Overall Study||0
7709087|NCT01744704|18982877|P6|NOT COMPLETED|Overall Study||0
7709088|NCT01744704|18982878|P5|NOT COMPLETED|Overall Study||0
7709089|NCT01744704|18982879|P4|NOT COMPLETED|Overall Study||0
7709090|NCT01744704|18982880|P3|NOT COMPLETED|Overall Study||0
7709091|NCT01744704|18982881|P2|NOT COMPLETED|Overall Study||0
7709092|NCT01744704|18982882|P1|NOT COMPLETED|Overall Study||0
7709093|NCT01744704|18982871|P12|COMPLETED|Overall Study||10
7709094|NCT01744704|18982872|P11|COMPLETED|Overall Study||9
7709095|NCT01744704|18982873|P10|COMPLETED|Overall Study||9
7709096|NCT01744704|18982874|P9|COMPLETED|Overall Study||3
7709097|NCT01744704|18982875|P8|COMPLETED|Overall Study||9
7709098|NCT01744704|18982876|P7|COMPLETED|Overall Study||6
7709099|NCT01744704|18982877|P6|COMPLETED|Overall Study||7
7709100|NCT01744704|18982878|P5|COMPLETED|Overall Study||6
7709101|NCT01744704|18982879|P4|COMPLETED|Overall Study||6
7709102|NCT01744704|18982880|P3|COMPLETED|Overall Study||3
7709103|NCT01744704|18982881|P2|COMPLETED|Overall Study||3
7709104|NCT01744704|18982882|P1|COMPLETED|Overall Study||3
7709105|NCT01744704|18982871|P12|STARTED|Overall Study||10
7709106|NCT01744704|18982872|P11|STARTED|Overall Study||9
7709107|NCT01744704|18982873|P10|STARTED|Overall Study||9
7709108|NCT01744704|18982874|P9|STARTED|Overall Study||3
7709109|NCT01744704|18982875|P8|STARTED|Overall Study||9
7709110|NCT01744704|18982876|P7|STARTED|Overall Study||6
7709111|NCT01744704|18982877|P6|STARTED|Overall Study||7
7709112|NCT01744704|18982878|P5|STARTED|Overall Study||6
7709113|NCT01744704|18982879|P4|STARTED|Overall Study||6
7709114|NCT01744704|18982880|P3|STARTED|Overall Study||3
7709115|NCT01744704|18982881|P2|STARTED|Overall Study||3
7709116|NCT01744704|18982882|P1|STARTED|Overall Study||3
7709117|NCT01744691|18982961|P1|NOT COMPLETED|Overall Study||43
7709118|NCT01744691|18982961|P1|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101
7709119|NCT01744691|18982961|P1|STARTED|Overall Study|Participants who received study treatment|144
7709120|NCT01744665|18982966|P1|NOT COMPLETED|Re-initiation Phase||13
7709121|NCT01744665|18982966|P1|COMPLETED|Re-initiation Phase||4
7709122|NCT01744665|18982966|P1|STARTED|Re-initiation Phase||17
7709123|NCT01744665|18982966|P1|NOT COMPLETED|Treatment Free Remission Phase||0
7709124|NCT01744665|18982966|P1|COMPLETED|Treatment Free Remission Phase||32
7709125|NCT01744665|18982966|P1|STARTED|Treatment Free Remission Phase||32
7709126|NCT01744665|18982966|P1|NOT COMPLETED|Consolidation Phase||19
7709127|NCT01744665|18982966|P1|COMPLETED|Consolidation Phase||22
7709128|NCT01744665|18982966|P1|STARTED|Consolidation Phase||41
7709129|NCT01744665|18982966|P1|NOT COMPLETED|Monitoring Phase||18
7709130|NCT01744665|18982966|P1|COMPLETED|Monitoring Phase||41
7709131|NCT01744665|18982966|P1|STARTED|Monitoring Phase||59
7709132|NCT01744574|18982997|P4|NOT COMPLETED|Overall Study||11
7709133|NCT01744574|18982998|P3|NOT COMPLETED|Overall Study||20
7709134|NCT01744574|18982999|P2|NOT COMPLETED|Overall Study||25
7709135|NCT01744574|18983000|P1|NOT COMPLETED|Overall Study||24
7709136|NCT01744574|18982997|P4|COMPLETED|Overall Study||40
7709137|NCT01744574|18982998|P3|COMPLETED|Overall Study||32
7709138|NCT01744574|18982999|P2|COMPLETED|Overall Study||31
7709139|NCT01744574|18983000|P1|COMPLETED|Overall Study||33
7709140|NCT01744574|18982997|P4|STARTED|Overall Study||51
7709141|NCT01744574|18982998|P3|STARTED|Overall Study||52
7709142|NCT01744574|18982999|P2|STARTED|Overall Study||56
7709143|NCT01744574|18983000|P1|STARTED|Overall Study||57
7709144|NCT01744496|18983036|P2|NOT COMPLETED|Maintenance Period||4
7709145|NCT01744496|18983037|P1|NOT COMPLETED|Maintenance Period||4
7709146|NCT01744496|18983036|P2|COMPLETED|Maintenance Period||29
7709147|NCT01744496|18983037|P1|COMPLETED|Maintenance Period||27
7709148|NCT01744496|18983036|P2|STARTED|Maintenance Period||33
7709149|NCT01744496|18983037|P1|STARTED|Maintenance Period||31
7709150|NCT01744496|18983036|P2|NOT COMPLETED|Titration Period||2
7709151|NCT01744496|18983037|P1|NOT COMPLETED|Titration Period||2
7709152|NCT01744496|18983036|P2|COMPLETED|Titration Period||33
7709153|NCT01744496|18983037|P1|COMPLETED|Titration Period||31
7709154|NCT01744496|18983036|P2|STARTED|Titration Period||35
7709155|NCT01744496|18983037|P1|STARTED|Titration Period||33
7709156|NCT01744483|18983058|P3|NOT COMPLETED|Overall Study||28
7709157|NCT01744483|18983059|P2|NOT COMPLETED|Overall Study||22
7709158|NCT01744483|18983060|P1|NOT COMPLETED|Overall Study||29
7709159|NCT01744483|18983058|P3|COMPLETED|Overall Study||10
7709160|NCT01744483|18983059|P2|COMPLETED|Overall Study||13
7709161|NCT01744483|18983060|P1|COMPLETED|Overall Study||15
7709162|NCT01744483|18983058|P3|STARTED|Overall Study||38
7709163|NCT01744483|18983059|P2|STARTED|Overall Study||35
7709164|NCT01744483|18983060|P1|STARTED|Overall Study||44
7709165|NCT01744392|18983068|P1|NOT COMPLETED|Overall Study||1
7709166|NCT01744392|18983068|P1|COMPLETED|Overall Study||22
7709167|NCT01744392|18983068|P1|STARTED|Overall Study||23
7709168|NCT01744353|18983084|P3|NOT COMPLETED|Overall Study||0
7709169|NCT01744353|18983085|P2|NOT COMPLETED|Overall Study||0
7709170|NCT01744353|18983086|P1|NOT COMPLETED|Overall Study||0
7709171|NCT01744353|18983084|P3|COMPLETED|Overall Study||3
7709172|NCT01744353|18983085|P2|COMPLETED|Overall Study||26
7709173|NCT01744353|18983086|P1|COMPLETED|Overall Study||6
7709174|NCT01744353|18983084|P3|STARTED|Overall Study||3
7709175|NCT01744353|18983085|P2|STARTED|Overall Study||26
7709176|NCT01744353|18983086|P1|STARTED|Overall Study||6
7709177|NCT01744340|18983097|P2|NOT COMPLETED|Overall Study||0
7709178|NCT01744340|18983098|P1|NOT COMPLETED|Overall Study||0
7709179|NCT01744340|18983097|P2|COMPLETED|Overall Study||15
7709180|NCT01744340|18983098|P1|COMPLETED|Overall Study||8
7709181|NCT01744340|18983097|P2|STARTED|Overall Study||15
7709182|NCT01744340|18983098|P1|STARTED|Overall Study||8
7709183|NCT01744197|18983108|P2|NOT COMPLETED|Overall Study||3
7709184|NCT01744197|18983109|P1|NOT COMPLETED|Overall Study||4
7709185|NCT01744197|18983108|P2|COMPLETED|Overall Study||26
7709186|NCT01744197|18983109|P1|COMPLETED|Overall Study||28
7709187|NCT01744197|18983108|P2|STARTED|Overall Study||29
7709188|NCT01744197|18983109|P1|STARTED|Overall Study||32
7709189|NCT01744093|18983121|P2|NOT COMPLETED|Overall Study||1
7709190|NCT01744093|18983122|P1|NOT COMPLETED|Overall Study||6
7709191|NCT01744093|18983121|P2|COMPLETED|Overall Study||8
7709192|NCT01744093|18983122|P1|COMPLETED|Overall Study||12
7709193|NCT01744093|18983121|P2|STARTED|Overall Study||9
7709194|NCT01744093|18983122|P1|STARTED|Overall Study||18
7709195|NCT01743976|18983132|P2|NOT COMPLETED|Overall Study||0
7709196|NCT01743976|18983133|P1|NOT COMPLETED|Overall Study||0
7709197|NCT01743976|18983132|P2|COMPLETED|Overall Study||3
7709198|NCT01743976|18983133|P1|COMPLETED|Overall Study||2
7709199|NCT01743976|18983132|P2|STARTED|Overall Study||3
7709200|NCT01743976|18983133|P1|STARTED|Overall Study||2
7709201|NCT01743963|18983145|P2|NOT COMPLETED|Overall Study||0
7709202|NCT01743963|18983146|P1|NOT COMPLETED|Overall Study||0
7709203|NCT01743963|18983145|P2|COMPLETED|Overall Study||17
7709204|NCT01743963|18983146|P1|COMPLETED|Overall Study||21
7709205|NCT01743963|18983145|P2|STARTED|Overall Study||17
7709206|NCT01743963|18983146|P1|STARTED|Overall Study||21
7709207|NCT01743859|18983152|P1|NOT COMPLETED|Overall Study||9
7709208|NCT01743859|18983152|P1|COMPLETED|Overall Study||28
7709209|NCT01743859|18983152|P1|STARTED|Overall Study||37
7709210|NCT01743729|18983164|P2|NOT COMPLETED|Overall Study||12
7709211|NCT01743729|18983165|P1|NOT COMPLETED|Overall Study||37
7709212|NCT01743729|18983164|P2|COMPLETED|Overall Study||348
7709213|NCT01743729|18983165|P1|COMPLETED|Overall Study||321
7709214|NCT01743729|18983164|P2|STARTED|Overall Study|One placebo participant was considered for Lifitegrast arm; Placebo safety analysis set (N= 359).|360
7709215|NCT01743729|18983165|P1|STARTED|Overall Study|One participant from placebo arm included in Lifitegrast arm for safety analysis set (N=359).|358
7709216|NCT01743677|18983173|P6|NOT COMPLETED|Third Intervention Period||0
7709217|NCT01743677|18983174|P5|NOT COMPLETED|Third Intervention Period||0
7709218|NCT01743677|18983175|P4|NOT COMPLETED|Third Intervention Period||0
7709219|NCT01743677|18983176|P3|NOT COMPLETED|Third Intervention Period||0
7709220|NCT01743677|18983177|P2|NOT COMPLETED|Third Intervention Period||0
7709221|NCT01743677|18983178|P1|NOT COMPLETED|Third Intervention Period||0
7709222|NCT01743677|18983173|P6|COMPLETED|Third Intervention Period||10
7709223|NCT01743677|18983174|P5|COMPLETED|Third Intervention Period||10
7709224|NCT01743677|18983175|P4|COMPLETED|Third Intervention Period||10
7709225|NCT01743677|18983176|P3|COMPLETED|Third Intervention Period||10
7709226|NCT01743677|18983177|P2|COMPLETED|Third Intervention Period||10
7709227|NCT01743677|18983178|P1|COMPLETED|Third Intervention Period||10
7709228|NCT01743677|18983173|P6|STARTED|Third Intervention Period||10
7709229|NCT01743677|18983174|P5|STARTED|Third Intervention Period||10
7709230|NCT01743677|18983175|P4|STARTED|Third Intervention Period||10
7709231|NCT01743677|18983176|P3|STARTED|Third Intervention Period||10
7709232|NCT01743677|18983177|P2|STARTED|Third Intervention Period||10
7709233|NCT01743677|18983178|P1|STARTED|Third Intervention Period||10
7709234|NCT01743677|18983173|P6|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
7709235|NCT01743677|18983174|P5|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
7709236|NCT01743677|18983175|P4|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
7709237|NCT01743677|18983176|P3|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
7709238|NCT01743677|18983177|P2|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
7709239|NCT01743677|18983178|P1|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
7709240|NCT01743677|18983173|P6|COMPLETED|Washout Period 2 (at Least 7 Days)||10
7709241|NCT01743677|18983174|P5|COMPLETED|Washout Period 2 (at Least 7 Days)||10
7709242|NCT01743677|18983175|P4|COMPLETED|Washout Period 2 (at Least 7 Days)||10
7709243|NCT01743677|18983176|P3|COMPLETED|Washout Period 2 (at Least 7 Days)||10
7709244|NCT01743677|18983177|P2|COMPLETED|Washout Period 2 (at Least 7 Days)||10
7709245|NCT01743677|18983178|P1|COMPLETED|Washout Period 2 (at Least 7 Days)||10
7709246|NCT01743677|18983173|P6|STARTED|Washout Period 2 (at Least 7 Days)||10
7709247|NCT01743677|18983174|P5|STARTED|Washout Period 2 (at Least 7 Days)||10
7709248|NCT01743677|18983175|P4|STARTED|Washout Period 2 (at Least 7 Days)||10
7709249|NCT01743677|18983176|P3|STARTED|Washout Period 2 (at Least 7 Days)||10
7709250|NCT01743677|18983177|P2|STARTED|Washout Period 2 (at Least 7 Days)||10
7709251|NCT01743677|18983178|P1|STARTED|Washout Period 2 (at Least 7 Days)||10
7709252|NCT01743677|18983173|P6|NOT COMPLETED|Second Intervention Period||0
7709253|NCT01743677|18983174|P5|NOT COMPLETED|Second Intervention Period||0
7709254|NCT01743677|18983175|P4|NOT COMPLETED|Second Intervention Period||0
7709255|NCT01743677|18983176|P3|NOT COMPLETED|Second Intervention Period||0
7709256|NCT01743677|18983177|P2|NOT COMPLETED|Second Intervention Period||0
7709257|NCT01743677|18983178|P1|NOT COMPLETED|Second Intervention Period||0
7709258|NCT01743677|18983173|P6|COMPLETED|Second Intervention Period||10
7709259|NCT01743677|18983174|P5|COMPLETED|Second Intervention Period||10
7709260|NCT01743677|18983175|P4|COMPLETED|Second Intervention Period||10
7709261|NCT01743677|18983176|P3|COMPLETED|Second Intervention Period||10
7709262|NCT01743677|18983177|P2|COMPLETED|Second Intervention Period||10
7709263|NCT01743677|18983178|P1|COMPLETED|Second Intervention Period||10
7709264|NCT01743677|18983173|P6|STARTED|Second Intervention Period||10
7709265|NCT01743677|18983174|P5|STARTED|Second Intervention Period||10
7709266|NCT01743677|18983175|P4|STARTED|Second Intervention Period||10
7709267|NCT01743677|18983176|P3|STARTED|Second Intervention Period||10
7709268|NCT01743677|18983177|P2|STARTED|Second Intervention Period||10
7709269|NCT01743677|18983178|P1|STARTED|Second Intervention Period||10
7709270|NCT01743677|18983173|P6|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
7709271|NCT01743677|18983174|P5|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
7709272|NCT01743677|18983175|P4|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
7709273|NCT01743677|18983176|P3|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
7709274|NCT01743677|18983177|P2|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
7709275|NCT01743677|18983178|P1|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
7709276|NCT01743677|18983173|P6|COMPLETED|Washout Period 1 (at Least 7 Days)||10
7709277|NCT01743677|18983174|P5|COMPLETED|Washout Period 1 (at Least 7 Days)||10
7709278|NCT01743677|18983175|P4|COMPLETED|Washout Period 1 (at Least 7 Days)||10
7709279|NCT01743677|18983176|P3|COMPLETED|Washout Period 1 (at Least 7 Days)||10
7709280|NCT01743677|18983177|P2|COMPLETED|Washout Period 1 (at Least 7 Days)||10
7709281|NCT01743677|18983178|P1|COMPLETED|Washout Period 1 (at Least 7 Days)||10
7709282|NCT01743677|18983173|P6|STARTED|Washout Period 1 (at Least 7 Days)||10
7709283|NCT01743677|18983174|P5|STARTED|Washout Period 1 (at Least 7 Days)||10
7709284|NCT01743677|18983175|P4|STARTED|Washout Period 1 (at Least 7 Days)||10
7709285|NCT01743677|18983176|P3|STARTED|Washout Period 1 (at Least 7 Days)||10
7709286|NCT01743677|18983177|P2|STARTED|Washout Period 1 (at Least 7 Days)||10
7709287|NCT01743677|18983178|P1|STARTED|Washout Period 1 (at Least 7 Days)||10
7709288|NCT01743677|18983173|P6|NOT COMPLETED|First Intervention Period||0
7709289|NCT01743677|18983174|P5|NOT COMPLETED|First Intervention Period||0
7709290|NCT01743677|18983175|P4|NOT COMPLETED|First Intervention Period||0
7709291|NCT01743677|18983176|P3|NOT COMPLETED|First Intervention Period||0
7709292|NCT01743677|18983177|P2|NOT COMPLETED|First Intervention Period||0
7709293|NCT01743677|18983178|P1|NOT COMPLETED|First Intervention Period||0
7709294|NCT01743677|18983173|P6|COMPLETED|First Intervention Period||10
7709295|NCT01743677|18983174|P5|COMPLETED|First Intervention Period||10
7709296|NCT01743677|18983175|P4|COMPLETED|First Intervention Period||10
7709297|NCT01743677|18983176|P3|COMPLETED|First Intervention Period||10
7709298|NCT01743677|18983177|P2|COMPLETED|First Intervention Period||10
7709299|NCT01743677|18983178|P1|COMPLETED|First Intervention Period||10
7709300|NCT01743677|18983173|P6|STARTED|First Intervention Period||10
7709301|NCT01743677|18983174|P5|STARTED|First Intervention Period||10
7709302|NCT01743677|18983175|P4|STARTED|First Intervention Period||10
7709303|NCT01743677|18983176|P3|STARTED|First Intervention Period||10
7709304|NCT01743677|18983177|P2|STARTED|First Intervention Period||10
7709305|NCT01743677|18983178|P1|STARTED|First Intervention Period||10
7709306|NCT01743560|18983215|P1|NOT COMPLETED|Overall Study||43
7709307|NCT01743560|18983215|P1|COMPLETED|Overall Study||9
7709308|NCT01743560|18983215|P1|Safety Analysis Set (SAF)|Overall Study|≥ 1 dose study drug +1 post baseline safety assessment|49
7709309|NCT01743560|18983215|P1|Full Analysis Set (FAS)|Overall Study|≥ 1 dose study drug|49
7709310|NCT01743560|18983215|P1|STARTED|Overall Study||52
7709311|NCT01743521|18983242|P4|NOT COMPLETED|Overall Study||0
7709312|NCT01743521|18983243|P3|NOT COMPLETED|Overall Study||0
7709313|NCT01743521|18983244|P2|NOT COMPLETED|Overall Study||0
7709314|NCT01743521|18983245|P1|NOT COMPLETED|Overall Study||0
7709315|NCT01743521|18983242|P4|COMPLETED|Overall Study||2
7709316|NCT01743521|18983243|P3|COMPLETED|Overall Study||2
7709317|NCT01743521|18983244|P2|COMPLETED|Overall Study||3
7709318|NCT01743521|18983245|P1|COMPLETED|Overall Study||7
7709319|NCT01743521|18983242|P4|STARTED|Overall Study||2
7709320|NCT01743521|18983243|P3|STARTED|Overall Study||2
7709321|NCT01743521|18983244|P2|STARTED|Overall Study||3
7709322|NCT01743521|18983245|P1|STARTED|Overall Study||7
7709323|NCT01743469|18983299|P4|NOT COMPLETED|Follow-up Period - Post-Treatment||16
7709324|NCT01743469|18983300|P3|NOT COMPLETED|Follow-up Period - Post-Treatment||23
7709325|NCT01743469|18983301|P2|NOT COMPLETED|Follow-up Period - Post-Treatment||48
7709326|NCT01743469|18983302|P1|NOT COMPLETED|Follow-up Period - Post-Treatment||45
7709327|NCT01743469|18983299|P4|COMPLETED|Follow-up Period - Post-Treatment||5
7709328|NCT01743469|18983300|P3|COMPLETED|Follow-up Period - Post-Treatment||14
7709329|NCT01743469|18983301|P2|COMPLETED|Follow-up Period - Post-Treatment||5
7709330|NCT01743469|18983302|P1|COMPLETED|Follow-up Period - Post-Treatment||6
7709331|NCT01743469|18983299|P4|STARTED|Follow-up Period - Post-Treatment||21
7709332|NCT01743469|18983300|P3|STARTED|Follow-up Period - Post-Treatment||37
7709333|NCT01743469|18983301|P2|STARTED|Follow-up Period - Post-Treatment||53
7709334|NCT01743469|18983302|P1|STARTED|Follow-up Period - Post-Treatment||51
7709335|NCT01743469|18983299|P4|NOT COMPLETED|Active Treatment Phase||21
7709336|NCT01743469|18983300|P3|NOT COMPLETED|Active Treatment Phase||38
7709337|NCT01743469|18983301|P2|NOT COMPLETED|Active Treatment Phase||55
7709338|NCT01743469|18983302|P1|NOT COMPLETED|Active Treatment Phase||53
7709339|NCT01743469|18983299|P4|COMPLETED|Active Treatment Phase||0
7709340|NCT01743469|18983300|P3|COMPLETED|Active Treatment Phase||0
7709341|NCT01743469|18983301|P2|COMPLETED|Active Treatment Phase||0
7709342|NCT01743469|18983302|P1|COMPLETED|Active Treatment Phase||0
7709343|NCT01743469|18983299|P4|STARTED|Active Treatment Phase||21
7709344|NCT01743469|18983300|P3|STARTED|Active Treatment Phase||38
7709345|NCT01743469|18983301|P2|STARTED|Active Treatment Phase||55
7709346|NCT01743469|18983302|P1|STARTED|Active Treatment Phase||53
7709347|NCT01743131|18983344|P5|NOT COMPLETED|Overall Study||0
7709348|NCT01743131|18983345|P4|NOT COMPLETED|Overall Study||0
7709349|NCT01743131|18983346|P3|NOT COMPLETED|Overall Study||0
7709350|NCT01743131|18983347|P2|NOT COMPLETED|Overall Study||0
7709351|NCT01743131|18983348|P1|NOT COMPLETED|Overall Study||0
7709352|NCT01743131|18983344|P5|COMPLETED|Overall Study||127
7709353|NCT01743131|18983345|P4|COMPLETED|Overall Study||1
7709354|NCT01743131|18983346|P3|COMPLETED|Overall Study||43
7709355|NCT01743131|18983347|P2|COMPLETED|Overall Study||69
7709356|NCT01743131|18983348|P1|COMPLETED|Overall Study||73
7709357|NCT01743131|18983344|P5|Not Included in Analysis|Overall Study||0
7709358|NCT01743131|18983345|P4|Not Included in Analysis|Overall Study||1
7709359|NCT01743131|18983346|P3|Not Included in Analysis|Overall Study||0
7709360|NCT01743131|18983347|P2|Not Included in Analysis|Overall Study||0
7709361|NCT01743131|18983348|P1|Not Included in Analysis|Overall Study||0
7709362|NCT01743131|18983344|P5|STARTED|Overall Study||127
7709363|NCT01743131|18983345|P4|STARTED|Overall Study||1
7709364|NCT01743131|18983346|P3|STARTED|Overall Study||43
7709365|NCT01743131|18983347|P2|STARTED|Overall Study||69
7709366|NCT01743131|18983348|P1|STARTED|Overall Study||73
7709367|NCT01743092|18983367|P2|NOT COMPLETED|Overall Study||15
7709368|NCT01743092|18983368|P1|NOT COMPLETED|Overall Study||14
7709369|NCT01743092|18983367|P2|COMPLETED|Overall Study||11
7709370|NCT01743092|18983368|P1|COMPLETED|Overall Study||19
7709371|NCT01743092|18983367|P2|STARTED|Overall Study||26
7709372|NCT01743092|18983368|P1|STARTED|Overall Study||33
7709373|NCT01743040|18983376|P1|NOT COMPLETED|Overall Study||229
7709374|NCT01743040|18983376|P1|COMPLETED|Overall Study||785
7709375|NCT01743040|18983376|P1|CT and/or Standard Angiogram|Overall Study||785
7709376|NCT01743040|18983376|P1|Nuclear Stress Test|Overall Study||992
7709377|NCT01743040|18983376|P1|CADence Testing|Overall Study||1013
7709378|NCT01743040|18983376|P1|STARTED|Overall Study||1014
7709379|NCT01743027|18983384|P4|NOT COMPLETED|Overall Study||1
7709380|NCT01743027|18983385|P3|NOT COMPLETED|Overall Study||9
7709381|NCT01743027|18983386|P2|NOT COMPLETED|Overall Study||5
7709382|NCT01743027|18983387|P1|NOT COMPLETED|Overall Study||5
7709383|NCT01743027|18983384|P4|COMPLETED|Overall Study||48
7709384|NCT01743027|18983385|P3|COMPLETED|Overall Study||90
7709385|NCT01743027|18983386|P2|COMPLETED|Overall Study||94
7709386|NCT01743027|18983387|P1|COMPLETED|Overall Study||93
7709387|NCT01743027|18983384|P4|STARTED|Overall Study||49
7709388|NCT01743027|18983385|P3|STARTED|Overall Study||99
7709389|NCT01743027|18983386|P2|STARTED|Overall Study||99
7709390|NCT01743027|18983387|P1|STARTED|Overall Study||98
7709391|NCT01743001|18983427|P2|NOT COMPLETED|Overall Study||0
7709392|NCT01743001|18983428|P1|NOT COMPLETED|Overall Study||3
7709393|NCT01743001|18983427|P2|COMPLETED|Overall Study||112
7709394|NCT01743001|18983428|P1|COMPLETED|Overall Study||111
7709395|NCT01743001|18983427|P2|STARTED|Overall Study||112
7709396|NCT01743001|18983428|P1|STARTED|Overall Study||114
7709397|NCT01742949|18983440|P2|NOT COMPLETED|Overall Study||0
7709398|NCT01742949|18983441|P1|NOT COMPLETED|Overall Study||0
7709399|NCT01742949|18983440|P2|COMPLETED|Overall Study||20
7709400|NCT01742949|18983441|P1|COMPLETED|Overall Study||20
7709401|NCT01742949|18983440|P2|STARTED|Overall Study||20
7709402|NCT01742949|18983441|P1|STARTED|Overall Study||20
7709403|NCT01742936|18983462|P2|NOT COMPLETED|Overall Study||0
7709404|NCT01742936|18983463|P1|NOT COMPLETED|Overall Study||0
7709405|NCT01742936|18983462|P2|COMPLETED|Overall Study||50
7709406|NCT01742936|18983463|P1|COMPLETED|Overall Study||50
7709407|NCT01742936|18983462|P2|STARTED|Overall Study||50
7709408|NCT01742936|18983463|P1|STARTED|Overall Study||50
7709409|NCT01742897|18983471|P1|NOT COMPLETED|Overall Study||5
7709410|NCT01742897|18983471|P1|COMPLETED|Overall Study||30
7709411|NCT01742897|18983471|P1|Treated|Overall Study||33
7709412|NCT01742897|18983471|P1|STARTED|Overall Study||35
7709413|NCT01742832|18983477|P2|NOT COMPLETED|Overall Study||5
7709414|NCT01742832|18983478|P1|NOT COMPLETED|Overall Study||1
7709415|NCT01742832|18983477|P2|COMPLETED|Overall Study||23
7709416|NCT01742832|18983478|P1|COMPLETED|Overall Study||19
7709417|NCT01742832|18983477|P2|STARTED|Overall Study||28
7709418|NCT01742832|18983478|P1|STARTED|Overall Study||20
7709419|NCT01742364|18983488|P4|NOT COMPLETED|Overall Study||0
7709420|NCT01742364|18983489|P3|NOT COMPLETED|Overall Study||0
7709421|NCT01742364|18983490|P2|NOT COMPLETED|Overall Study||0
7709422|NCT01742364|18983491|P1|NOT COMPLETED|Overall Study||0
7709423|NCT01742364|18983488|P4|COMPLETED|Overall Study||15
7709424|NCT01742364|18983489|P3|COMPLETED|Overall Study||15
7709425|NCT01742364|18983490|P2|COMPLETED|Overall Study||33
7709426|NCT01742364|18983491|P1|COMPLETED|Overall Study||33
7709427|NCT01742364|18983488|P4|STARTED|Overall Study||15
7709428|NCT01742364|18983489|P3|STARTED|Overall Study||15
7709429|NCT01742364|18983490|P2|STARTED|Overall Study||33
7709430|NCT01742364|18983491|P1|STARTED|Overall Study||33
7709431|NCT01742286|18983524|P7|NOT COMPLETED|Expansion Phase||36
7709432|NCT01742286|18983525|P6|NOT COMPLETED|Expansion Phase||0
7709433|NCT01742286|18983526|P5|NOT COMPLETED|Expansion Phase||0
7709434|NCT01742286|18983527|P4|NOT COMPLETED|Expansion Phase||0
7709435|NCT01742286|18983528|P3|NOT COMPLETED|Expansion Phase||7
7709436|NCT01742286|18983529|P2|NOT COMPLETED|Expansion Phase||0
7709437|NCT01742286|18983530|P1|NOT COMPLETED|Expansion Phase||0
7709438|NCT01742286|18983524|P7|COMPLETED|Expansion Phase||0
7709439|NCT01742286|18983525|P6|COMPLETED|Expansion Phase||0
7709440|NCT01742286|18983526|P5|COMPLETED|Expansion Phase||0
7709441|NCT01742286|18983527|P4|COMPLETED|Expansion Phase||0
7709442|NCT01742286|18983528|P3|COMPLETED|Expansion Phase||0
7709443|NCT01742286|18983529|P2|COMPLETED|Expansion Phase||0
7709444|NCT01742286|18983530|P1|COMPLETED|Expansion Phase||0
7709445|NCT01742286|18983524|P7|End of Treatment = Not Ccompleted|Expansion Phase||36
7709446|NCT01742286|18983525|P6|End of Treatment = Not Ccompleted|Expansion Phase||0
7709447|NCT01742286|18983526|P5|End of Treatment = Not Ccompleted|Expansion Phase||0
7709448|NCT01742286|18983527|P4|End of Treatment = Not Ccompleted|Expansion Phase||0
7709449|NCT01742286|18983528|P3|End of Treatment = Not Ccompleted|Expansion Phase||7
7709450|NCT01742286|18983529|P2|End of Treatment = Not Ccompleted|Expansion Phase||0
7709451|NCT01742286|18983530|P1|End of Treatment = Not Ccompleted|Expansion Phase||0
7709452|NCT01742286|18983524|P7|STARTED|Expansion Phase||36
7709453|NCT01742286|18983525|P6|STARTED|Expansion Phase||0
7709454|NCT01742286|18983526|P5|STARTED|Expansion Phase||0
7709455|NCT01742286|18983527|P4|STARTED|Expansion Phase||0
7709456|NCT01742286|18983528|P3|STARTED|Expansion Phase||7
7709457|NCT01742286|18983529|P2|STARTED|Expansion Phase||0
7709458|NCT01742286|18983530|P1|STARTED|Expansion Phase||0
7709459|NCT01742286|18983524|P7|NOT COMPLETED|Escalation Phase||6
7709460|NCT01742286|18983525|P6|NOT COMPLETED|Escalation Phase||5
7709461|NCT01742286|18983526|P5|NOT COMPLETED|Escalation Phase||4
7709462|NCT01742286|18983527|P4|NOT COMPLETED|Escalation Phase||2
7709463|NCT01742286|18983528|P3|NOT COMPLETED|Escalation Phase||6
7709464|NCT01742286|18983529|P2|NOT COMPLETED|Escalation Phase||12
7709465|NCT01742286|18983530|P1|NOT COMPLETED|Escalation Phase||5
7709466|NCT01742286|18983524|P7|COMPLETED|Escalation Phase||0
7709467|NCT01742286|18983525|P6|COMPLETED|Escalation Phase||0
7709468|NCT01742286|18983526|P5|COMPLETED|Escalation Phase||0
7709469|NCT01742286|18983527|P4|COMPLETED|Escalation Phase||0
7709470|NCT01742286|18983528|P3|COMPLETED|Escalation Phase||0
7709471|NCT01742286|18983529|P2|COMPLETED|Escalation Phase||0
7709472|NCT01742286|18983530|P1|COMPLETED|Escalation Phase||0
7709473|NCT01742286|18983524|P7|Ended Treatment = Not Completed)|Escalation Phase||6
7709474|NCT01742286|18983525|P6|Ended Treatment = Not Completed)|Escalation Phase||5
7709475|NCT01742286|18983526|P5|Ended Treatment = Not Completed)|Escalation Phase||4
7709476|NCT01742286|18983527|P4|Ended Treatment = Not Completed)|Escalation Phase||2
7709477|NCT01742286|18983528|P3|Ended Treatment = Not Completed)|Escalation Phase||6
7709478|NCT01742286|18983529|P2|Ended Treatment = Not Completed)|Escalation Phase||12
7709479|NCT01742286|18983530|P1|Ended Treatment = Not Completed)|Escalation Phase||5
7709480|NCT01742286|18983524|P7|STARTED|Escalation Phase||6
7709481|NCT01742286|18983525|P6|STARTED|Escalation Phase||5
7709482|NCT01742286|18983526|P5|STARTED|Escalation Phase||4
7709483|NCT01742286|18983527|P4|STARTED|Escalation Phase||2
7709484|NCT01742286|18983528|P3|STARTED|Escalation Phase||6
7709485|NCT01742286|18983529|P2|STARTED|Escalation Phase||12
7709486|NCT01742286|18983530|P1|STARTED|Escalation Phase||5
7709487|NCT01742208|18983631|P3|NOT COMPLETED|Overall Study||0
7709488|NCT01742208|18983632|P2|NOT COMPLETED|Overall Study||0
7709489|NCT01742208|18983633|P1|NOT COMPLETED|Overall Study||0
7709490|NCT01742208|18983631|P3|COMPLETED|Overall Study||16
7709491|NCT01742208|18983632|P2|COMPLETED|Overall Study||17
7709492|NCT01742208|18983633|P1|COMPLETED|Overall Study||3
7709493|NCT01742208|18983631|P3|STARTED|Overall Study||16
7709494|NCT01742208|18983632|P2|STARTED|Overall Study||17
7709495|NCT01742208|18983633|P1|STARTED|Overall Study||3
7709496|NCT01742091|18983663|P6|NOT COMPLETED|Overall Study||2
7709497|NCT01742091|18983664|P5|NOT COMPLETED|Overall Study||1
7709498|NCT01742091|18983665|P4|NOT COMPLETED|Overall Study||1
7709499|NCT01742091|18983666|P3|NOT COMPLETED|Overall Study||0
7709500|NCT01742091|18983667|P2|NOT COMPLETED|Overall Study||0
7709501|NCT01742091|18983668|P1|NOT COMPLETED|Overall Study||0
7709502|NCT01742091|18983663|P6|COMPLETED|Overall Study||10
7709503|NCT01742091|18983664|P5|COMPLETED|Overall Study||7
7709504|NCT01742091|18983665|P4|COMPLETED|Overall Study||8
7709505|NCT01742091|18983666|P3|COMPLETED|Overall Study||10
7709506|NCT01742091|18983667|P2|COMPLETED|Overall Study||11
7709507|NCT01742091|18983668|P1|COMPLETED|Overall Study||9
7709508|NCT01742091|18983663|P6|RECEIVED STUDY DRUG|Overall Study||12
7709509|NCT01742091|18983664|P5|RECEIVED STUDY DRUG|Overall Study||8
7709510|NCT01742091|18983665|P4|RECEIVED STUDY DRUG|Overall Study||9
7709511|NCT01742091|18983666|P3|RECEIVED STUDY DRUG|Overall Study||10
7709512|NCT01742091|18983667|P2|RECEIVED STUDY DRUG|Overall Study||11
7709513|NCT01742091|18983668|P1|RECEIVED STUDY DRUG|Overall Study||9
7709514|NCT01742091|18983663|P6|STARTED|Overall Study||12
7709515|NCT01742091|18983664|P5|STARTED|Overall Study||8
7709516|NCT01742091|18983665|P4|STARTED|Overall Study||9
7709517|NCT01742091|18983666|P3|STARTED|Overall Study||10
7709518|NCT01742091|18983667|P2|STARTED|Overall Study||11
7709519|NCT01742091|18983668|P1|STARTED|Overall Study||9
7709520|NCT01742078|18983714|P9|NOT COMPLETED|Overall Study||0
7709521|NCT01742078|18983715|P8|NOT COMPLETED|Overall Study||0
7709522|NCT01742078|18983716|P7|NOT COMPLETED|Overall Study||0
7709523|NCT01742078|18983717|P6|NOT COMPLETED|Overall Study||0
7709524|NCT01742078|18983718|P5|NOT COMPLETED|Overall Study||0
7709525|NCT01742078|18983719|P4|NOT COMPLETED|Overall Study||1
7709526|NCT01742078|18983720|P3|NOT COMPLETED|Overall Study||0
7709527|NCT01742078|18983721|P2|NOT COMPLETED|Overall Study||0
7709528|NCT01742078|18983722|P1|NOT COMPLETED|Overall Study||0
7709529|NCT01742078|18983714|P9|COMPLETED|Overall Study||12
7709530|NCT01742078|18983715|P8|COMPLETED|Overall Study||6
7709531|NCT01742078|18983716|P7|COMPLETED|Overall Study||6
7709532|NCT01742078|18983717|P6|COMPLETED|Overall Study||6
7709533|NCT01742078|18983718|P5|COMPLETED|Overall Study||6
7709534|NCT01742078|18983719|P4|COMPLETED|Overall Study||5
7709535|NCT01742078|18983720|P3|COMPLETED|Overall Study||6
7709536|NCT01742078|18983721|P2|COMPLETED|Overall Study||6
7709537|NCT01742078|18983722|P1|COMPLETED|Overall Study||6
7709538|NCT01742078|18983714|P9|RECEIVED STUDY DRUG|Overall Study||12
7709539|NCT01742078|18983715|P8|RECEIVED STUDY DRUG|Overall Study||6
7709540|NCT01742078|18983716|P7|RECEIVED STUDY DRUG|Overall Study||6
7709541|NCT01742078|18983717|P6|RECEIVED STUDY DRUG|Overall Study||6
7709542|NCT01742078|18983718|P5|RECEIVED STUDY DRUG|Overall Study||6
7709543|NCT01742078|18983719|P4|RECEIVED STUDY DRUG|Overall Study||6
7709544|NCT01742078|18983720|P3|RECEIVED STUDY DRUG|Overall Study||6
7709545|NCT01742078|18983721|P2|RECEIVED STUDY DRUG|Overall Study||6
7709546|NCT01742078|18983722|P1|RECEIVED STUDY DRUG|Overall Study||6
7709547|NCT01742078|18983714|P9|STARTED|Overall Study||12
7709548|NCT01742078|18983715|P8|STARTED|Overall Study||6
7709549|NCT01742078|18983716|P7|STARTED|Overall Study||6
7709550|NCT01742078|18983717|P6|STARTED|Overall Study||6
7709551|NCT01742078|18983718|P5|STARTED|Overall Study||6
7709552|NCT01742078|18983719|P4|STARTED|Overall Study||6
7709553|NCT01742078|18983720|P3|STARTED|Overall Study||6
7709554|NCT01742078|18983721|P2|STARTED|Overall Study||6
7709555|NCT01742078|18983722|P1|STARTED|Overall Study||6
7709556|NCT01742065|18983779|P2|NOT COMPLETED|Overall Study||0
7709557|NCT01742065|18983780|P1|NOT COMPLETED|Overall Study||0
7709558|NCT01742065|18983779|P2|COMPLETED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
7709559|NCT01742065|18983780|P1|COMPLETED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
7709560|NCT01742065|18983779|P2|STARTED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
7709561|NCT01742065|18983780|P1|STARTED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
7709562|NCT01741792|18983791|P3|NOT COMPLETED|Overall Study||12
7709563|NCT01741792|18983792|P2|NOT COMPLETED|Overall Study||1
7709564|NCT01741792|18983793|P1|NOT COMPLETED|Overall Study||6
7709565|NCT01741792|18983791|P3|COMPLETED|Overall Study||2
7709566|NCT01741792|18983792|P2|COMPLETED|Overall Study||1
7709567|NCT01741792|18983793|P1|COMPLETED|Overall Study||3
7709568|NCT01741792|18983791|P3|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13
7709569|NCT01741792|18983792|P2|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1
7709570|NCT01741792|18983793|P1|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7
7709571|NCT01741792|18983791|P3|STARTED|Overall Study||14
7709572|NCT01741792|18983792|P2|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2
7709573|NCT01741792|18983793|P1|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9
7709574|NCT01741701|18983860|P2|NOT COMPLETED|Overall Study||2
7709575|NCT01741701|18983861|P1|NOT COMPLETED|Overall Study||5
7709576|NCT01741701|18983860|P2|COMPLETED|Overall Study||13
7709577|NCT01741701|18983861|P1|COMPLETED|Overall Study||13
7709578|NCT01741701|18983860|P2|STARTED|Overall Study||15
7709579|NCT01741701|18983861|P1|STARTED|Overall Study||18
7709580|NCT01741688|18983877|P1|NOT COMPLETED|Overall Study||3
7709581|NCT01741688|18983877|P1|COMPLETED|Overall Study||13
7709582|NCT01741688|18983877|P1|STARTED|Overall Study||16
7709583|NCT01741545|18983896|P2|NOT COMPLETED|Follow-up Period (24 Weeks)||2
7709584|NCT01741545|18983897|P1|NOT COMPLETED|Follow-up Period (24 Weeks)||1
7709585|NCT01741545|18983896|P2|COMPLETED|Follow-up Period (24 Weeks)||37
7709586|NCT01741545|18983897|P1|COMPLETED|Follow-up Period (24 Weeks)||11
7709587|NCT01741545|18983896|P2|STARTED|Follow-up Period (24 Weeks)|4 participants re-joined Cohort B in follow-up period.|39
7709588|NCT01741545|18983897|P1|STARTED|Follow-up Period (24 Weeks)|1 participant re-joined Cohort A in follow-up period.|12
7709589|NCT01741545|18983896|P2|NOT COMPLETED|Treatment Period||4
7709590|NCT01741545|18983897|P1|NOT COMPLETED|Treatment Period||1
7709591|NCT01741545|18983896|P2|COMPLETED|Treatment Period||35
7709592|NCT01741545|18983897|P1|COMPLETED|Treatment Period||11
7709593|NCT01741545|18983896|P2|STARTED|Treatment Period||39
7709594|NCT01741545|18983897|P1|STARTED|Treatment Period||12
7709595|NCT01741532|18983921|P2|NOT COMPLETED|Overall Study||3
7709596|NCT01741532|18983922|P1|NOT COMPLETED|Overall Study||10
7709597|NCT01741532|18983921|P2|COMPLETED|Overall Study||27
7709598|NCT01741532|18983922|P1|COMPLETED|Overall Study||49
7709599|NCT01741532|18983921|P2|Provided Post-baseline Efficacy Data|Overall Study||28
7709600|NCT01741532|18983922|P1|Provided Post-baseline Efficacy Data|Overall Study||58
7709601|NCT01741532|18983921|P2|Exposed|Overall Study||30
7709602|NCT01741532|18983922|P1|Exposed|Overall Study||58
7709603|NCT01741532|18983921|P2|STARTED|Overall Study||30
7709604|NCT01741532|18983922|P1|STARTED|Overall Study||59
7709605|NCT01741480|18983944|P2|NOT COMPLETED|Overall Study||0
7709606|NCT01741480|18983945|P1|NOT COMPLETED|Overall Study||0
7709607|NCT01741480|18983944|P2|COMPLETED|Overall Study||286
7709608|NCT01741480|18983945|P1|COMPLETED|Overall Study||285
7709609|NCT01741480|18983944|P2|STARTED|Overall Study||286
7709610|NCT01741480|18983945|P1|STARTED|Overall Study||285
7709611|NCT01741454|18983955|P4|NOT COMPLETED|Overall Study||22
7709612|NCT01741454|18983956|P3|NOT COMPLETED|Overall Study||17
7709613|NCT01741454|18983957|P2|NOT COMPLETED|Overall Study||6
7709614|NCT01741454|18983958|P1|NOT COMPLETED|Overall Study||13
7709615|NCT01741454|18983955|P4|COMPLETED|Overall Study||21
7709616|NCT01741454|18983956|P3|COMPLETED|Overall Study||22
7709617|NCT01741454|18983957|P2|COMPLETED|Overall Study||44
7709618|NCT01741454|18983958|P1|COMPLETED|Overall Study||36
7709619|NCT01741454|18983955|P4|STARTED|Overall Study||43
7709620|NCT01741454|18983956|P3|STARTED|Overall Study||39
7709621|NCT01741454|18983957|P2|STARTED|Overall Study||50
7709622|NCT01741454|18983958|P1|STARTED|Overall Study||49
7709623|NCT01741350|18983982|P2|NOT COMPLETED|12-Month Follow-up Assessment||2
7709624|NCT01741350|18983983|P1|NOT COMPLETED|12-Month Follow-up Assessment||3
7709625|NCT01741350|18983982|P2|COMPLETED|12-Month Follow-up Assessment||109
7709626|NCT01741350|18983983|P1|COMPLETED|12-Month Follow-up Assessment||111
7709627|NCT01741350|18983982|P2|STARTED|12-Month Follow-up Assessment||111
7709628|NCT01741350|18983983|P1|STARTED|12-Month Follow-up Assessment||114
7709629|NCT01741350|18983982|P2|NOT COMPLETED|6-Month Follow-up Assessment||8
7709630|NCT01741350|18983983|P1|NOT COMPLETED|6-Month Follow-up Assessment||15
7709631|NCT01741350|18983982|P2|COMPLETED|6-Month Follow-up Assessment||111
7709632|NCT01741350|18983983|P1|COMPLETED|6-Month Follow-up Assessment||114
7709633|NCT01741350|18983982|P2|STARTED|6-Month Follow-up Assessment||119
7709634|NCT01741350|18983983|P1|STARTED|6-Month Follow-up Assessment||129
7709635|NCT01741350|18983982|P2|NOT COMPLETED|3-Month Follow-up Assessment||22
7709636|NCT01741350|18983983|P1|NOT COMPLETED|3-Month Follow-up Assessment||6
7709637|NCT01741350|18983982|P2|COMPLETED|3-Month Follow-up Assessment||119
7709638|NCT01741350|18983983|P1|COMPLETED|3-Month Follow-up Assessment||129
7709639|NCT01741350|18983982|P2|STARTED|3-Month Follow-up Assessment||141
7709640|NCT01741350|18983983|P1|STARTED|3-Month Follow-up Assessment||135
7709641|NCT01741350|18983982|P2|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
7709642|NCT01741350|18983983|P1|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
7709643|NCT01741350|18983982|P2|COMPLETED|Post Intervention Assessment (at Week 4)||141
7709644|NCT01741350|18983983|P1|COMPLETED|Post Intervention Assessment (at Week 4)||135
7709645|NCT01741350|18983982|P2|STARTED|Post Intervention Assessment (at Week 4)||155
7709646|NCT01741350|18983983|P1|STARTED|Post Intervention Assessment (at Week 4)||149
7709647|NCT01741350|18983982|P2|NOT COMPLETED|Study Intervention||0
7709648|NCT01741350|18983983|P1|NOT COMPLETED|Study Intervention||0
7709649|NCT01741350|18983982|P2|COMPLETED|Study Intervention||155
7709650|NCT01741350|18983983|P1|COMPLETED|Study Intervention||149
7709651|NCT01741350|18983982|P2|STARTED|Study Intervention||155
7709652|NCT01741350|18983983|P1|STARTED|Study Intervention||149
7709653|NCT01741272|18984119|P2|NOT COMPLETED|Overall Study||0
7709654|NCT01741272|18984120|P1|NOT COMPLETED|Overall Study||0
7709655|NCT01741272|18984119|P2|COMPLETED|Overall Study||97
7709656|NCT01741272|18984120|P1|COMPLETED|Overall Study||92
7709657|NCT01741272|18984119|P2|STARTED|Overall Study||97
7709658|NCT01741272|18984120|P1|STARTED|Overall Study||92
7709659|NCT01741259|18984136|P2|NOT COMPLETED|Overall Study||6
7709660|NCT01741259|18984137|P1|NOT COMPLETED|Overall Study||6
7709661|NCT01741259|18984136|P2|COMPLETED|Overall Study||129
7709662|NCT01741259|18984137|P1|COMPLETED|Overall Study||127
7709663|NCT01741259|18984136|P2|STARTED|Overall Study||135
7709664|NCT01741259|18984137|P1|STARTED|Overall Study||133
7709665|NCT01741012|18984191|P1|NOT COMPLETED|Overall Study||3
7709666|NCT01741012|18984191|P1|COMPLETED|Overall Study||34
7709667|NCT01741012|18984191|P1|STARTED|Overall Study||37
7709668|NCT01740817|18984198|P2|NOT COMPLETED|Second Intervention (48 h)||0
7709669|NCT01740817|18984199|P1|NOT COMPLETED|Second Intervention (48 h)||0
7709670|NCT01740817|18984198|P2|COMPLETED|Second Intervention (48 h)||4
7709671|NCT01740817|18984199|P1|COMPLETED|Second Intervention (48 h)||8
7709672|NCT01740817|18984198|P2|STARTED|Second Intervention (48 h)||4
7709673|NCT01740817|18984199|P1|STARTED|Second Intervention (48 h)||8
7709674|NCT01740817|18984198|P2|NOT COMPLETED|Washout (4-6 Weeks)||0
7709675|NCT01740817|18984199|P1|NOT COMPLETED|Washout (4-6 Weeks)||0
7709676|NCT01740817|18984198|P2|COMPLETED|Washout (4-6 Weeks)||4
7709677|NCT01740817|18984199|P1|COMPLETED|Washout (4-6 Weeks)||8
7709678|NCT01740817|18984198|P2|STARTED|Washout (4-6 Weeks)||4
7709679|NCT01740817|18984199|P1|STARTED|Washout (4-6 Weeks)||8
7709680|NCT01740817|18984198|P2|NOT COMPLETED|First Intervention (48 h)||0
7709681|NCT01740817|18984199|P1|NOT COMPLETED|First Intervention (48 h)||0
7709682|NCT01740817|18984198|P2|COMPLETED|First Intervention (48 h)||4
7709683|NCT01740817|18984199|P1|COMPLETED|First Intervention (48 h)||8
7709684|NCT01740817|18984198|P2|STARTED|First Intervention (48 h)||4
7709685|NCT01740817|18984199|P1|STARTED|First Intervention (48 h)||8
7709686|NCT01740791|18984215|P6|NOT COMPLETED|Overall Study||11
7709687|NCT01740791|18984216|P5|NOT COMPLETED|Overall Study||3
7709688|NCT01740791|18984217|P4|NOT COMPLETED|Overall Study||7
7709689|NCT01740791|18984218|P3|NOT COMPLETED|Overall Study||6
7709690|NCT01740791|18984219|P2|NOT COMPLETED|Overall Study||3
7709691|NCT01740791|18984220|P1|NOT COMPLETED|Overall Study||12
7709692|NCT01740791|18984215|P6|COMPLETED|Overall Study||23
7709693|NCT01740791|18984216|P5|COMPLETED|Overall Study||6
7709694|NCT01740791|18984217|P4|COMPLETED|Overall Study||7
7709695|NCT01740791|18984218|P3|COMPLETED|Overall Study||11
7709696|NCT01740791|18984219|P2|COMPLETED|Overall Study||4
7709697|NCT01740791|18984220|P1|COMPLETED|Overall Study||10
7709698|NCT01740791|18984215|P6|STARTED|Overall Study||34
7709699|NCT01740791|18984216|P5|STARTED|Overall Study||9
7709700|NCT01740791|18984217|P4|STARTED|Overall Study||14
7709701|NCT01740791|18984218|P3|STARTED|Overall Study||17
7709702|NCT01740791|18984219|P2|STARTED|Overall Study||7
7709703|NCT01740791|18984220|P1|STARTED|Overall Study||22
7709704|NCT01740726|18984351|P2|NOT COMPLETED|Overall Study||0
7709705|NCT01740726|18984352|P1|NOT COMPLETED|Overall Study||0
7709706|NCT01740726|18984351|P2|COMPLETED|Overall Study||1
7709707|NCT01740726|18984352|P1|COMPLETED|Overall Study||0
7709708|NCT01740726|18984351|P2|STARTED|Overall Study||1
7709709|NCT01740726|18984352|P1|STARTED|Overall Study||0
7709710|NCT01740713|18984377|P3|NOT COMPLETED|Overall Study||1
7709711|NCT01740713|18984378|P2|NOT COMPLETED|Overall Study||2
7709712|NCT01740713|18984379|P1|NOT COMPLETED|Overall Study||0
7709713|NCT01740713|18984377|P3|COMPLETED|Overall Study||6
7709714|NCT01740713|18984378|P2|COMPLETED|Overall Study||6
7709715|NCT01740713|18984379|P1|COMPLETED|Overall Study||6
7709716|NCT01740713|18984377|P3|STARTED|Overall Study||7
7709717|NCT01740713|18984378|P2|STARTED|Overall Study||8
7709718|NCT01740713|18984379|P1|STARTED|Overall Study||6
7709719|NCT01740440|18984403|P1|NOT COMPLETED|Overall Study||3
7709720|NCT01740440|18984403|P1|COMPLETED|Overall Study||27
7709721|NCT01740440|18984403|P1|STARTED|Overall Study||30
7709722|NCT01740427|18984411|P2|NOT COMPLETED|Overall Study||222
7709723|NCT01740427|18984412|P1|NOT COMPLETED|Overall Study||444
7709724|NCT01740427|18984411|P2|COMPLETED|Overall Study||0
7709725|NCT01740427|18984412|P1|COMPLETED|Overall Study||0
7709726|NCT01740427|18984411|P2|STARTED|Overall Study||222
7709727|NCT01740427|18984412|P1|STARTED|Overall Study||444
7709728|NCT01740414|18984441|P2|NOT COMPLETED|Overall Study||8
7709729|NCT01740414|18984442|P1|NOT COMPLETED|Overall Study||9
7709730|NCT01740414|18984441|P2|COMPLETED|Overall Study||8
7709731|NCT01740414|18984442|P1|COMPLETED|Overall Study||3
7709732|NCT01740414|18984441|P2|STARTED|Overall Study||16
7709733|NCT01740414|18984442|P1|STARTED|Overall Study||12
7709734|NCT01740401|18984464|P1|NOT COMPLETED|Overall Study||10
7709735|NCT01740401|18984464|P1|COMPLETED|Overall Study||0
7709736|NCT01740401|18984464|P1|STARTED|Overall Study||10
7709737|NCT01740388|18984473|P2|NOT COMPLETED|Overall Study||44
7709738|NCT01740388|18984474|P1|NOT COMPLETED|Overall Study||46
7709739|NCT01740388|18984473|P2|COMPLETED|Overall Study||28
7709740|NCT01740388|18984474|P1|COMPLETED|Overall Study||18
7709741|NCT01740388|18984473|P2|STARTED|Overall Study||72
7709742|NCT01740388|18984474|P1|STARTED|Overall Study||64
7709743|NCT01740362|18984494|P4|NOT COMPLETED|Overall Study||0
7709744|NCT01740362|18984495|P3|NOT COMPLETED|Overall Study||0
7709745|NCT01740362|18984496|P2|NOT COMPLETED|Overall Study||0
7709746|NCT01740362|18984497|P1|NOT COMPLETED|Overall Study||0
7709747|NCT01740362|18984494|P4|COMPLETED|Overall Study||6
7709748|NCT01740362|18984495|P3|COMPLETED|Overall Study||6
7709749|NCT01740362|18984496|P2|COMPLETED|Overall Study||6
7709750|NCT01740362|18984497|P1|COMPLETED|Overall Study||6
7709751|NCT01740362|18984494|P4|STARTED|Overall Study||6
7709752|NCT01740362|18984495|P3|STARTED|Overall Study||6
7709753|NCT01740362|18984496|P2|STARTED|Overall Study||6
7709754|NCT01740362|18984497|P1|STARTED|Overall Study||6
7709755|NCT01740323|18984525|P2|NOT COMPLETED|Overall Study||0
7709756|NCT01740323|18984526|P1|NOT COMPLETED|Overall Study||2
7709757|NCT01740323|18984525|P2|COMPLETED|Overall Study||15
7709758|NCT01740323|18984526|P1|COMPLETED|Overall Study||13
7709759|NCT01740323|18984525|P2|STARTED|Overall Study||15
7709760|NCT01740323|18984526|P1|STARTED|Overall Study||15
7709761|NCT01740297|18984547|P3|NOT COMPLETED|Overall Study||98
7709762|NCT01740297|18984548|P2|NOT COMPLETED|Overall Study||100
7709763|NCT01740297|18984549|P1|NOT COMPLETED|Overall Study||19
7709764|NCT01740297|18984547|P3|COMPLETED|Overall Study||0
7709765|NCT01740297|18984548|P2|COMPLETED|Overall Study||0
7709766|NCT01740297|18984549|P1|COMPLETED|Overall Study||0
7709767|NCT01740297|18984547|P3|Received Ipilimumab|Overall Study||92
7709768|NCT01740297|18984548|P2|Received Ipilimumab|Overall Study||95
7709769|NCT01740297|18984549|P1|Received Ipilimumab|Overall Study||18
7709770|NCT01740297|18984547|P3|Received Talimogene Laherparepvec|Overall Study||95
7709771|NCT01740297|18984548|P2|Received Talimogene Laherparepvec|Overall Study||0
7709772|NCT01740297|18984549|P1|Received Talimogene Laherparepvec|Overall Study||19
7709773|NCT01740297|18984547|P3|STARTED|Overall Study||98
7709774|NCT01740297|18984548|P2|STARTED|Overall Study||100
7709775|NCT01740297|18984549|P1|STARTED|Overall Study||19
7709776|NCT01740258|18984579|P1|NOT COMPLETED|Overall Study||0
7709777|NCT01740258|18984579|P1|COMPLETED|Overall Study||68
7709778|NCT01740258|18984579|P1|STARTED|Overall Study||68
7709779|NCT01740206|18984587|P2|NOT COMPLETED|Overall Study||0
7709780|NCT01740206|18984588|P1|NOT COMPLETED|Overall Study||0
7709781|NCT01740206|18984587|P2|COMPLETED|Overall Study||34
7709782|NCT01740206|18984588|P1|COMPLETED|Overall Study||14
7709783|NCT01740206|18984587|P2|STARTED|Overall Study||34
7709784|NCT01740206|18984588|P1|STARTED|Overall Study||14
7709785|NCT01740154|18984604|P1|NOT COMPLETED|Overall Study||1
7709786|NCT01740154|18984604|P1|COMPLETED|Overall Study||12
7709787|NCT01740154|18984604|P1|STARTED|Overall Study||13
7709788|NCT01740128|18984612|P2|NOT COMPLETED|Overall Study||7
7709789|NCT01740128|18984613|P1|NOT COMPLETED|Overall Study||6
7709790|NCT01740128|18984612|P2|COMPLETED|Overall Study||4
7709791|NCT01740128|18984613|P1|COMPLETED|Overall Study||4
7709792|NCT01740128|18984612|P2|STARTED|Overall Study||11
7709793|NCT01740128|18984613|P1|STARTED|Overall Study||10
7709794|NCT01740089|18984642|P3|NOT COMPLETED|After 12 Weeks||11
7709795|NCT01740089|18984643|P2|NOT COMPLETED|After 12 Weeks||3
7709796|NCT01740089|18984644|P1|NOT COMPLETED|After 12 Weeks||7
7709797|NCT01740089|18984642|P3|COMPLETED|After 12 Weeks|"Withdrawn due to:
~No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37
7709798|NCT01740089|18984643|P2|COMPLETED|After 12 Weeks|"Withdrawn due to:
~Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45
7709799|NCT01740089|18984644|P1|COMPLETED|After 12 Weeks|"Withdrawn due to:
~No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43
7709800|NCT01740089|18984642|P3|STARTED|After 12 Weeks||48
7709801|NCT01740089|18984643|P2|STARTED|After 12 Weeks||48
7709802|NCT01740089|18984644|P1|STARTED|After 12 Weeks||50
7709803|NCT01740089|18984642|P3|NOT COMPLETED|First 12 Weeks of Treatment||2
7709804|NCT01740089|18984643|P2|NOT COMPLETED|First 12 Weeks of Treatment||2
7709805|NCT01740089|18984644|P1|NOT COMPLETED|First 12 Weeks of Treatment||0
7709806|NCT01740089|18984642|P3|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:
~AE before W12 (n=2)"|48
7709807|NCT01740089|18984643|P2|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:
~AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48
7709808|NCT01740089|18984644|P1|COMPLETED|First 12 Weeks of Treatment||50
7709809|NCT01740089|18984642|P3|STARTED|First 12 Weeks of Treatment||50
7709810|NCT01740089|18984643|P2|STARTED|First 12 Weeks of Treatment||50
7709811|NCT01740089|18984644|P1|STARTED|First 12 Weeks of Treatment||50
7709812|NCT01739803|18984662|P2|NOT COMPLETED|Overall Study||6
7709813|NCT01739803|18984663|P1|NOT COMPLETED|Overall Study||9
7709814|NCT01739803|18984662|P2|COMPLETED|Overall Study||68
7709815|NCT01739803|18984663|P1|COMPLETED|Overall Study||67
7709816|NCT01739803|18984662|P2|STARTED|Overall Study||74
7709817|NCT01739803|18984663|P1|STARTED|Overall Study||76
7709818|NCT01739790|18984675|P2|NOT COMPLETED|Overall Study||4
7709819|NCT01739790|18984676|P1|NOT COMPLETED|Overall Study||2
7709820|NCT01739790|18984675|P2|COMPLETED|Overall Study||23
7709821|NCT01739790|18984676|P1|COMPLETED|Overall Study||22
7709822|NCT01739790|18984675|P2|STARTED|Overall Study||27
7709823|NCT01739790|18984676|P1|STARTED|Overall Study||24
7709824|NCT01739764|18984685|P3|NOT COMPLETED|Overall Study||126
7709825|NCT01739764|18984686|P2|NOT COMPLETED|Overall Study||36
7709826|NCT01739764|18984687|P1|NOT COMPLETED|Overall Study||26
7709827|NCT01739764|18984685|P3|COMPLETED|Overall Study||20
7709828|NCT01739764|18984686|P2|COMPLETED|Overall Study||4
7709829|NCT01739764|18984687|P1|COMPLETED|Overall Study||3
7709830|NCT01739764|18984685|P3|STARTED|Overall Study||146
7709831|NCT01739764|18984686|P2|STARTED|Overall Study||40
7709832|NCT01739764|18984687|P1|STARTED|Overall Study||29
7709833|NCT01739595|18984701|P3|NOT COMPLETED|Overall Study||2
7709834|NCT01739595|18984702|P2|NOT COMPLETED|Overall Study||1
7709835|NCT01739595|18984703|P1|NOT COMPLETED|Overall Study||13
7709836|NCT01739595|18984701|P3|COMPLETED|Overall Study||45
7709837|NCT01739595|18984702|P2|COMPLETED|Overall Study||21
7709838|NCT01739595|18984703|P1|COMPLETED|Overall Study||99
7709839|NCT01739595|18984701|P3|STARTED|Overall Study||47
7709840|NCT01739595|18984702|P2|STARTED|Overall Study||22
7709841|NCT01739595|18984703|P1|STARTED|Overall Study||112
7709842|NCT01739400|18984713|P2|NOT COMPLETED|Overall Study||9
7709843|NCT01739400|18984714|P1|NOT COMPLETED|Overall Study||17
7709844|NCT01739400|18984713|P2|COMPLETED|Overall Study||99
7709845|NCT01739400|18984714|P1|COMPLETED|Overall Study||92
7709846|NCT01739400|18984713|P2|Treated With 10 mg Macitentan|Overall Study||108
7709847|NCT01739400|18984714|P1|Treated With 10 mg Macitentan|Overall Study||109
7709848|NCT01739400|18984713|P2|STARTED|Overall Study||108
7709849|NCT01739400|18984714|P1|STARTED|Overall Study||109
7709850|NCT01739361|18984727|P2|NOT COMPLETED|Overall Study||1
7709851|NCT01739361|18984728|P1|NOT COMPLETED|Overall Study||3
7709852|NCT01739361|18984727|P2|COMPLETED|Overall Study||22
7709853|NCT01739361|18984728|P1|COMPLETED|Overall Study||18
7709854|NCT01739361|18984727|P2|STARTED|Overall Study||23
7709855|NCT01739361|18984728|P1|STARTED|Overall Study||21
7709856|NCT01739348|18984742|P4|NOT COMPLETED|Part II (Extension Study)||396
7709857|NCT01739348|18984743|P3|NOT COMPLETED|Part II (Extension Study)||61
7709858|NCT01739348|18984744|P2|NOT COMPLETED|Part II (Extension Study)||366
7709859|NCT01739348|18984745|P1|NOT COMPLETED|Part II (Extension Study)||379
7709860|NCT01739348|18984742|P4|COMPLETED|Part II (Extension Study)||0
7709861|NCT01739348|18984743|P3|COMPLETED|Part II (Extension Study)||0
7709862|NCT01739348|18984744|P2|COMPLETED|Part II (Extension Study)||0
7709863|NCT01739348|18984745|P1|COMPLETED|Part II (Extension Study)||0
7709864|NCT01739348|18984742|P4|Treated|Part II (Extension Study)||394
7709865|NCT01739348|18984743|P3|Treated|Part II (Extension Study)||61
7709866|NCT01739348|18984744|P2|Treated|Part II (Extension Study)||365
7709867|NCT01739348|18984745|P1|Treated|Part II (Extension Study)||379
7709868|NCT01739348|18984742|P4|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|396
7709869|NCT01739348|18984743|P3|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|61
7709870|NCT01739348|18984744|P2|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|366
7709871|NCT01739348|18984745|P1|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|379
7709872|NCT01739348|18984742|P4|NOT COMPLETED|Part I (Base Study)||189
7709873|NCT01739348|18984743|P3|NOT COMPLETED|Part I (Base Study)||26
7709874|NCT01739348|18984744|P2|NOT COMPLETED|Part I (Base Study)||203
7709875|NCT01739348|18984745|P1|NOT COMPLETED|Part I (Base Study)||202
7709876|NCT01739348|18984742|P4|COMPLETED|Part I (Base Study)||516
7709877|NCT01739348|18984743|P3|COMPLETED|Part I (Base Study)||77
7709878|NCT01739348|18984744|P2|COMPLETED|Part I (Base Study)||497
7709879|NCT01739348|18984745|P1|COMPLETED|Part I (Base Study)||501
7709880|NCT01739348|18984742|P4|Treated|Part I (Base Study)||705
7709881|NCT01739348|18984743|P3|Treated|Part I (Base Study)||103
7709882|NCT01739348|18984744|P2|Treated|Part I (Base Study)||700
7709883|NCT01739348|18984745|P1|Treated|Part I (Base Study)||702
7709884|NCT01739348|18984742|P4|STARTED|Part I (Base Study)||705
7709885|NCT01739348|18984743|P3|STARTED|Part I (Base Study)||103
7709886|NCT01739348|18984744|P2|STARTED|Part I (Base Study)||700
7709887|NCT01739348|18984745|P1|STARTED|Part I (Base Study)||703
7709888|NCT01739335|18984817|P2|NOT COMPLETED|Overall Study||5
7709889|NCT01739335|18984818|P1|NOT COMPLETED|Overall Study||7
7709890|NCT01739335|18984817|P2|COMPLETED|Overall Study||35
7709891|NCT01739335|18984818|P1|COMPLETED|Overall Study||34
7709892|NCT01739335|18984817|P2|STARTED|Overall Study||40
7709893|NCT01739335|18984818|P1|STARTED|Overall Study||41
7709894|NCT01739309|18984850|P1|NOT COMPLETED|Overall Study||3
7709895|NCT01739309|18984850|P1|COMPLETED|Overall Study||25
7709896|NCT01739309|18984850|P1|Alive and on Study, Off Treatment|Overall Study||8
7709897|NCT01739309|18984850|P1|Death Due to Any Cause|Overall Study||17
7709898|NCT01739309|18984850|P1|Received at Least One Dose of Study Drug|Overall Study||28
7709899|NCT01739309|18984850|P1|STARTED|Overall Study||28
7709900|NCT01739231|18984873|P4|NOT COMPLETED|Part B||2
7709901|NCT01739231|18984874|P3|NOT COMPLETED|Part B||2
7709902|NCT01739231|18984875|P2|NOT COMPLETED|Part B||5
7709903|NCT01739231|18984876|P1|NOT COMPLETED|Part B||7
7709904|NCT01739231|18984873|P4|COMPLETED|Part B||19
7709905|NCT01739231|18984874|P3|COMPLETED|Part B||10
7709906|NCT01739231|18984875|P2|COMPLETED|Part B||12
7709907|NCT01739231|18984876|P1|COMPLETED|Part B||13
7709908|NCT01739231|18984873|P4|Challenged|Part B||21
7709909|NCT01739231|18984874|P3|Challenged|Part B||10
7709910|NCT01739231|18984875|P2|Challenged|Part B||13
7709911|NCT01739231|18984876|P1|Challenged|Part B||13
7709912|NCT01739231|18984873|P4|STARTED|Part B||21
7709913|NCT01739231|18984874|P3|STARTED|Part B||12
7709914|NCT01739231|18984875|P2|STARTED|Part B||17
7709915|NCT01739231|18984876|P1|STARTED|Part B||20
7709916|NCT01739231|18984873|P4|NOT COMPLETED|Part A||0
7709917|NCT01739231|18984874|P3|NOT COMPLETED|Part A||0
7709918|NCT01739231|18984875|P2|NOT COMPLETED|Part A||7
7709919|NCT01739231|18984876|P1|NOT COMPLETED|Part A||4
7709920|NCT01739231|18984873|P4|COMPLETED|Part A||0
7709921|NCT01739231|18984874|P3|COMPLETED|Part A||12
7709922|NCT01739231|18984875|P2|COMPLETED|Part A||17
7709923|NCT01739231|18984876|P1|COMPLETED|Part A||20
7709924|NCT01739231|18984873|P4|Received All 3 Vaccinations|Part A||0
7709925|NCT01739231|18984874|P3|Received All 3 Vaccinations|Part A||12
7709926|NCT01739231|18984875|P2|Received All 3 Vaccinations|Part A||20
7709927|NCT01739231|18984876|P1|Received All 3 Vaccinations|Part A||21
7709928|NCT01739231|18984873|P4|STARTED|Part A||0
7709929|NCT01739231|18984874|P3|STARTED|Part A||12
7709930|NCT01739231|18984875|P2|STARTED|Part A||24
7709931|NCT01739231|18984876|P1|STARTED|Part A||24
7709932|NCT01738984|18985045|P2|NOT COMPLETED|Overall Study||39
7709933|NCT01738984|18985046|P1|NOT COMPLETED|Overall Study||64
7709934|NCT01738984|18985045|P2|COMPLETED|Overall Study||210
7709935|NCT01738984|18985046|P1|COMPLETED|Overall Study||186
7709936|NCT01738984|18985045|P2|STARTED|Overall Study||249
7709937|NCT01738984|18985046|P1|STARTED|Overall Study||250
7709938|NCT01738971|18985059|P3|NOT COMPLETED|Overall Study||17
7709939|NCT01738971|18985060|P2|NOT COMPLETED|Overall Study||30
7709940|NCT01738971|18985061|P1|NOT COMPLETED|Overall Study||19
7709941|NCT01738971|18985059|P3|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39
7709942|NCT01738971|18985060|P2|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28
7709943|NCT01738971|18985061|P1|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35
7709944|NCT01738971|18985059|P3|STARTED|Overall Study|56 participants recruited to this arm|56
7709945|NCT01738971|18985060|P2|STARTED|Overall Study|58 participants recruited to this arm|58
7709946|NCT01738971|18985061|P1|STARTED|Overall Study|54 participants recruited to this arm|54
7709947|NCT01738919|18985077|P2|NOT COMPLETED|Overall Study||3
7709948|NCT01738919|18985078|P1|NOT COMPLETED|Overall Study||1
7709949|NCT01738919|18985077|P2|COMPLETED|Overall Study||14
7709950|NCT01738919|18985078|P1|COMPLETED|Overall Study||14
7709951|NCT01738919|18985077|P2|STARTED|Overall Study||17
7709952|NCT01738919|18985078|P1|STARTED|Overall Study||15
7709953|NCT01738750|18985096|P2|NOT COMPLETED|Overall Study||0
7709954|NCT01738750|18985097|P1|NOT COMPLETED|Overall Study||0
7709955|NCT01738750|18985096|P2|COMPLETED|Overall Study||51
7709956|NCT01738750|18985097|P1|COMPLETED|Overall Study||49
7709957|NCT01738750|18985096|P2|STARTED|Overall Study||51
7709958|NCT01738750|18985097|P1|STARTED|Overall Study||49
7709959|NCT01738737|18985110|P5|NOT COMPLETED|Overall Study||4
7709960|NCT01738737|18985111|P4|NOT COMPLETED|Overall Study||4
7709961|NCT01738737|18985112|P3|NOT COMPLETED|Overall Study||4
7709962|NCT01738737|18985113|P2|NOT COMPLETED|Overall Study||4
7709963|NCT01738737|18985114|P1|NOT COMPLETED|Overall Study||4
7709964|NCT01738737|18985110|P5|COMPLETED|Overall Study||25
7709965|NCT01738737|18985111|P4|COMPLETED|Overall Study||25
7709966|NCT01738737|18985112|P3|COMPLETED|Overall Study||25
7709967|NCT01738737|18985113|P2|COMPLETED|Overall Study||25
7709968|NCT01738737|18985114|P1|COMPLETED|Overall Study||25
7709969|NCT01738737|18985110|P5|STARTED|Overall Study||29
7709970|NCT01738737|18985111|P4|STARTED|Overall Study||29
7709971|NCT01738737|18985112|P3|STARTED|Overall Study||29
7709972|NCT01738737|18985113|P2|STARTED|Overall Study||29
7709973|NCT01738737|18985114|P1|STARTED|Overall Study||29
7709974|NCT01738698|18985150|P4|NOT COMPLETED|Overall Study||0
7709975|NCT01738698|18985151|P3|NOT COMPLETED|Overall Study||0
7709976|NCT01738698|18985152|P2|NOT COMPLETED|Overall Study||0
7709977|NCT01738698|18985153|P1|NOT COMPLETED|Overall Study||0
7709978|NCT01738698|18985150|P4|COMPLETED|Overall Study||0
7709979|NCT01738698|18985151|P3|COMPLETED|Overall Study||0
7709980|NCT01738698|18985152|P2|COMPLETED|Overall Study||0
7709981|NCT01738698|18985153|P1|COMPLETED|Overall Study||0
7709982|NCT01738698|18985150|P4|STARTED|Overall Study||0
7709983|NCT01738698|18985151|P3|STARTED|Overall Study||0
7709984|NCT01738698|18985152|P2|STARTED|Overall Study||0
7709985|NCT01738698|18985153|P1|STARTED|Overall Study||0
7709986|NCT01738672|18985219|P1|NOT COMPLETED|Overall Study||5
7709987|NCT01738672|18985219|P1|COMPLETED|Overall Study||11
7709988|NCT01738672|18985219|P1|STARTED|Overall Study||16
7709989|NCT01738646|18985228|P1|NOT COMPLETED|Overall Study||2
7709990|NCT01738646|18985228|P1|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38
7709991|NCT01738646|18985228|P1|STARTED|Overall Study||40
7709992|NCT01738594|18985239|P8|NOT COMPLETED|Follow up for 1 Year||0
7709993|NCT01738594|18985240|P7|NOT COMPLETED|Follow up for 1 Year||0
7709994|NCT01738594|18985241|P6|NOT COMPLETED|Follow up for 1 Year||3
7709995|NCT01738594|18985242|P5|NOT COMPLETED|Follow up for 1 Year||0
7709996|NCT01738594|18985243|P4|NOT COMPLETED|Follow up for 1 Year||0
7709997|NCT01738594|18985244|P3|NOT COMPLETED|Follow up for 1 Year||0
7709998|NCT01738594|18985245|P2|NOT COMPLETED|Follow up for 1 Year||0
7709999|NCT01738594|18985246|P1|NOT COMPLETED|Follow up for 1 Year||0
7710000|NCT01738594|18985239|P8|COMPLETED|Follow up for 1 Year||0
7710001|NCT01738594|18985240|P7|COMPLETED|Follow up for 1 Year||0
7710002|NCT01738594|18985241|P6|COMPLETED|Follow up for 1 Year||0
7710003|NCT01738594|18985242|P5|COMPLETED|Follow up for 1 Year||1
7710004|NCT01738594|18985243|P4|COMPLETED|Follow up for 1 Year||0
7710005|NCT01738594|18985244|P3|COMPLETED|Follow up for 1 Year||0
7710006|NCT01738594|18985245|P2|COMPLETED|Follow up for 1 Year||2
7710007|NCT01738594|18985246|P1|COMPLETED|Follow up for 1 Year||0
7710008|NCT01738594|18985239|P8|STARTED|Follow up for 1 Year||0
7710009|NCT01738594|18985240|P7|STARTED|Follow up for 1 Year||0
7710010|NCT01738594|18985241|P6|STARTED|Follow up for 1 Year||3
7710011|NCT01738594|18985242|P5|STARTED|Follow up for 1 Year||1
7710012|NCT01738594|18985243|P4|STARTED|Follow up for 1 Year||0
7710013|NCT01738594|18985244|P3|STARTED|Follow up for 1 Year||0
7710014|NCT01738594|18985245|P2|STARTED|Follow up for 1 Year||2
7710015|NCT01738594|18985246|P1|STARTED|Follow up for 1 Year||0
7710016|NCT01738594|18985239|P8|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
7710017|NCT01738594|18985240|P7|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
7710018|NCT01738594|18985241|P6|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
7710019|NCT01738594|18985242|P5|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
7710020|NCT01738594|18985243|P4|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
7710021|NCT01738594|18985244|P3|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
7710022|NCT01738594|18985245|P2|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
7710023|NCT01738594|18985246|P1|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
7710024|NCT01738594|18985239|P8|COMPLETED|Went on to Continue Treatment Cycle 5||0
7710025|NCT01738594|18985240|P7|COMPLETED|Went on to Continue Treatment Cycle 5||0
7710026|NCT01738594|18985241|P6|COMPLETED|Went on to Continue Treatment Cycle 5||0
7710027|NCT01738594|18985242|P5|COMPLETED|Went on to Continue Treatment Cycle 5||0
7710028|NCT01738594|18985243|P4|COMPLETED|Went on to Continue Treatment Cycle 5||0
7710029|NCT01738594|18985244|P3|COMPLETED|Went on to Continue Treatment Cycle 5||0
7710030|NCT01738594|18985245|P2|COMPLETED|Went on to Continue Treatment Cycle 5||0
7710031|NCT01738594|18985246|P1|COMPLETED|Went on to Continue Treatment Cycle 5||0
7710032|NCT01738594|18985239|P8|STARTED|Went on to Continue Treatment Cycle 5||0
7710033|NCT01738594|18985240|P7|STARTED|Went on to Continue Treatment Cycle 5||0
7710034|NCT01738594|18985241|P6|STARTED|Went on to Continue Treatment Cycle 5||1
7710035|NCT01738594|18985242|P5|STARTED|Went on to Continue Treatment Cycle 5||1
7710036|NCT01738594|18985243|P4|STARTED|Went on to Continue Treatment Cycle 5||0
7710037|NCT01738594|18985244|P3|STARTED|Went on to Continue Treatment Cycle 5||0
7710038|NCT01738594|18985245|P2|STARTED|Went on to Continue Treatment Cycle 5||0
7710039|NCT01738594|18985246|P1|STARTED|Went on to Continue Treatment Cycle 5||0
7710040|NCT01738594|18985239|P8|NOT COMPLETED|Completed 4 Cycles of Treatment||0
7710041|NCT01738594|18985240|P7|NOT COMPLETED|Completed 4 Cycles of Treatment||0
7710042|NCT01738594|18985241|P6|NOT COMPLETED|Completed 4 Cycles of Treatment||1
7710043|NCT01738594|18985242|P5|NOT COMPLETED|Completed 4 Cycles of Treatment||0
7710044|NCT01738594|18985243|P4|NOT COMPLETED|Completed 4 Cycles of Treatment||0
7710045|NCT01738594|18985244|P3|NOT COMPLETED|Completed 4 Cycles of Treatment||0
7710046|NCT01738594|18985245|P2|NOT COMPLETED|Completed 4 Cycles of Treatment||2
7710047|NCT01738594|18985246|P1|NOT COMPLETED|Completed 4 Cycles of Treatment||0
7710048|NCT01738594|18985239|P8|COMPLETED|Completed 4 Cycles of Treatment||0
7710049|NCT01738594|18985240|P7|COMPLETED|Completed 4 Cycles of Treatment||0
7710050|NCT01738594|18985241|P6|COMPLETED|Completed 4 Cycles of Treatment||1
7710051|NCT01738594|18985242|P5|COMPLETED|Completed 4 Cycles of Treatment||1
7710052|NCT01738594|18985243|P4|COMPLETED|Completed 4 Cycles of Treatment||0
7710053|NCT01738594|18985244|P3|COMPLETED|Completed 4 Cycles of Treatment||0
7710054|NCT01738594|18985245|P2|COMPLETED|Completed 4 Cycles of Treatment||0
7710055|NCT01738594|18985246|P1|COMPLETED|Completed 4 Cycles of Treatment||0
7710056|NCT01738594|18985239|P8|STARTED|Completed 4 Cycles of Treatment||0
7710057|NCT01738594|18985240|P7|STARTED|Completed 4 Cycles of Treatment||0
7710058|NCT01738594|18985241|P6|STARTED|Completed 4 Cycles of Treatment||2
7710059|NCT01738594|18985242|P5|STARTED|Completed 4 Cycles of Treatment||1
7710060|NCT01738594|18985243|P4|STARTED|Completed 4 Cycles of Treatment||0
7710061|NCT01738594|18985244|P3|STARTED|Completed 4 Cycles of Treatment||0
7710062|NCT01738594|18985245|P2|STARTED|Completed 4 Cycles of Treatment||2
7710063|NCT01738594|18985246|P1|STARTED|Completed 4 Cycles of Treatment||0
7710064|NCT01738594|18985239|P8|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
7710065|NCT01738594|18985240|P7|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
7710066|NCT01738594|18985241|P6|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
7710067|NCT01738594|18985242|P5|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
7710068|NCT01738594|18985243|P4|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
7710069|NCT01738594|18985244|P3|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
7710070|NCT01738594|18985245|P2|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
7710071|NCT01738594|18985246|P1|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
7710072|NCT01738594|18985239|P8|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
7710073|NCT01738594|18985240|P7|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
7710074|NCT01738594|18985241|P6|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
7710075|NCT01738594|18985242|P5|COMPLETED|Completed 2 Cycles/Reached 1st Response||1
7710076|NCT01738594|18985243|P4|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
7710077|NCT01738594|18985244|P3|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
7710078|NCT01738594|18985245|P2|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
7710079|NCT01738594|18985246|P1|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
7710080|NCT01738594|18985239|P8|STARTED|Completed 2 Cycles/Reached 1st Response||0
7710081|NCT01738594|18985240|P7|STARTED|Completed 2 Cycles/Reached 1st Response||0
7710082|NCT01738594|18985241|P6|STARTED|Completed 2 Cycles/Reached 1st Response||3
7710083|NCT01738594|18985242|P5|STARTED|Completed 2 Cycles/Reached 1st Response||1
7710084|NCT01738594|18985243|P4|STARTED|Completed 2 Cycles/Reached 1st Response||0
7710085|NCT01738594|18985244|P3|STARTED|Completed 2 Cycles/Reached 1st Response||0
7710086|NCT01738594|18985245|P2|STARTED|Completed 2 Cycles/Reached 1st Response||2
7710087|NCT01738594|18985246|P1|STARTED|Completed 2 Cycles/Reached 1st Response||0
7710088|NCT01738594|18985239|P8|NOT COMPLETED|Registration and Treatment Start||0
7710089|NCT01738594|18985240|P7|NOT COMPLETED|Registration and Treatment Start||0
7710090|NCT01738594|18985241|P6|NOT COMPLETED|Registration and Treatment Start||0
7710091|NCT01738594|18985242|P5|NOT COMPLETED|Registration and Treatment Start||0
7710092|NCT01738594|18985243|P4|NOT COMPLETED|Registration and Treatment Start||0
7710093|NCT01738594|18985244|P3|NOT COMPLETED|Registration and Treatment Start||0
7710094|NCT01738594|18985245|P2|NOT COMPLETED|Registration and Treatment Start||1
7710095|NCT01738594|18985246|P1|NOT COMPLETED|Registration and Treatment Start||0
7710096|NCT01738594|18985239|P8|COMPLETED|Registration and Treatment Start||0
7710097|NCT01738594|18985240|P7|COMPLETED|Registration and Treatment Start||0
7710098|NCT01738594|18985241|P6|COMPLETED|Registration and Treatment Start||3
7710099|NCT01738594|18985242|P5|COMPLETED|Registration and Treatment Start||1
7710100|NCT01738594|18985243|P4|COMPLETED|Registration and Treatment Start||0
7710101|NCT01738594|18985244|P3|COMPLETED|Registration and Treatment Start||0
7710102|NCT01738594|18985245|P2|COMPLETED|Registration and Treatment Start||2
7710103|NCT01738594|18985246|P1|COMPLETED|Registration and Treatment Start||0
7710104|NCT01738594|18985239|P8|Treatment Started|Registration and Treatment Start||0
7710105|NCT01738594|18985240|P7|Treatment Started|Registration and Treatment Start||0
7710106|NCT01738594|18985241|P6|Treatment Started|Registration and Treatment Start||3
7710107|NCT01738594|18985242|P5|Treatment Started|Registration and Treatment Start||1
7710108|NCT01738594|18985243|P4|Treatment Started|Registration and Treatment Start||0
7710109|NCT01738594|18985244|P3|Treatment Started|Registration and Treatment Start||0
7710110|NCT01738594|18985245|P2|Treatment Started|Registration and Treatment Start||2
7710111|NCT01738594|18985246|P1|Treatment Started|Registration and Treatment Start||0
7710112|NCT01738594|18985239|P8|Registered to Study|Registration and Treatment Start||0
7710113|NCT01738594|18985240|P7|Registered to Study|Registration and Treatment Start||0
7710114|NCT01738594|18985241|P6|Registered to Study|Registration and Treatment Start||3
7710115|NCT01738594|18985242|P5|Registered to Study|Registration and Treatment Start||1
7710116|NCT01738594|18985243|P4|Registered to Study|Registration and Treatment Start||0
7710117|NCT01738594|18985244|P3|Registered to Study|Registration and Treatment Start||0
7710118|NCT01738594|18985245|P2|Registered to Study|Registration and Treatment Start||3
7710119|NCT01738594|18985246|P1|Registered to Study|Registration and Treatment Start||0
7710120|NCT01738594|18985239|P8|STARTED|Registration and Treatment Start||0
7710121|NCT01738594|18985240|P7|STARTED|Registration and Treatment Start||0
7710122|NCT01738594|18985241|P6|STARTED|Registration and Treatment Start||3
7710123|NCT01738594|18985242|P5|STARTED|Registration and Treatment Start||1
7710124|NCT01738594|18985243|P4|STARTED|Registration and Treatment Start||0
7710125|NCT01738594|18985244|P3|STARTED|Registration and Treatment Start||0
7710126|NCT01738594|18985245|P2|STARTED|Registration and Treatment Start||3
7710127|NCT01738594|18985246|P1|STARTED|Registration and Treatment Start||0
7710128|NCT01738581|18985264|P2|NOT COMPLETED|Overall Study||0
7710129|NCT01738581|18985265|P1|NOT COMPLETED|Overall Study||1
7710130|NCT01738581|18985264|P2|COMPLETED|Overall Study||4
7710131|NCT01738581|18985265|P1|COMPLETED|Overall Study||4
7710132|NCT01738581|18985264|P2|STARTED|Overall Study||4
7710133|NCT01738581|18985265|P1|STARTED|Overall Study||5
7710134|NCT01738503|18985289|P7|NOT COMPLETED|PET Imaging Sub-study||1
7710135|NCT01738503|18985290|P6|NOT COMPLETED|PET Imaging Sub-study||2
7710136|NCT01738503|18985291|P5|NOT COMPLETED|PET Imaging Sub-study||0
7710137|NCT01738503|18985292|P4|NOT COMPLETED|PET Imaging Sub-study||0
7710138|NCT01738503|18985293|P3|NOT COMPLETED|PET Imaging Sub-study||0
7710139|NCT01738503|18985294|P2|NOT COMPLETED|PET Imaging Sub-study||0
7710140|NCT01738503|18985295|P1|NOT COMPLETED|PET Imaging Sub-study||0
7710141|NCT01738503|18985289|P7|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 6 injections plus all PET images|1
7710142|NCT01738503|18985290|P6|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 12 injections plus all PET images|1
7710143|NCT01738503|18985291|P5|COMPLETED|PET Imaging Sub-study||0
7710144|NCT01738503|18985292|P4|COMPLETED|PET Imaging Sub-study||0
7710145|NCT01738503|18985293|P3|COMPLETED|PET Imaging Sub-study||0
7710146|NCT01738503|18985294|P2|COMPLETED|PET Imaging Sub-study||0
7710147|NCT01738503|18985295|P1|COMPLETED|PET Imaging Sub-study||0
7710148|NCT01738503|18985289|P7|STARTED|PET Imaging Sub-study||2
7710149|NCT01738503|18985290|P6|STARTED|PET Imaging Sub-study||3
7710150|NCT01738503|18985291|P5|STARTED|PET Imaging Sub-study||0
7710151|NCT01738503|18985292|P4|STARTED|PET Imaging Sub-study||0
7710152|NCT01738503|18985293|P3|STARTED|PET Imaging Sub-study||0
7710153|NCT01738503|18985294|P2|STARTED|PET Imaging Sub-study||0
7710154|NCT01738503|18985295|P1|STARTED|PET Imaging Sub-study||0
7710155|NCT01738503|18985289|P7|NOT COMPLETED|Treatment Period||8
7710156|NCT01738503|18985290|P6|NOT COMPLETED|Treatment Period||6
7710157|NCT01738503|18985291|P5|NOT COMPLETED|Treatment Period||8
7710158|NCT01738503|18985292|P4|NOT COMPLETED|Treatment Period||6
7710159|NCT01738503|18985293|P3|NOT COMPLETED|Treatment Period||5
7710160|NCT01738503|18985294|P2|NOT COMPLETED|Treatment Period||5
7710161|NCT01738503|18985295|P1|NOT COMPLETED|Treatment Period||0
7710162|NCT01738503|18985289|P7|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|6
7710163|NCT01738503|18985290|P6|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
7710164|NCT01738503|18985291|P5|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|7
7710165|NCT01738503|18985292|P4|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
7710166|NCT01738503|18985293|P3|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
7710167|NCT01738503|18985294|P2|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
7710168|NCT01738503|18985295|P1|COMPLETED|Treatment Period||0
7710169|NCT01738503|18985289|P7|STARTED|Treatment Period||14
7710170|NCT01738503|18985290|P6|STARTED|Treatment Period||15
7710171|NCT01738503|18985291|P5|STARTED|Treatment Period||15
7710172|NCT01738503|18985292|P4|STARTED|Treatment Period||15
7710173|NCT01738503|18985293|P3|STARTED|Treatment Period||15
7710174|NCT01738503|18985294|P2|STARTED|Treatment Period||15
7710175|NCT01738503|18985295|P1|STARTED|Treatment Period||0
7710176|NCT01738503|18985289|P7|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
7710177|NCT01738503|18985290|P6|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
7710178|NCT01738503|18985291|P5|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
7710179|NCT01738503|18985292|P4|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
7710180|NCT01738503|18985293|P3|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
7710181|NCT01738503|18985294|P2|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
7710182|NCT01738503|18985295|P1|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||35
7710183|NCT01738503|18985289|P7|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
7710184|NCT01738503|18985290|P6|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
7710185|NCT01738503|18985291|P5|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
7710186|NCT01738503|18985292|P4|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
7710187|NCT01738503|18985293|P3|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
7710188|NCT01738503|18985294|P2|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
7710189|NCT01738503|18985295|P1|COMPLETED|Induction/Stabilization (Days -14 to -1)||89
7710190|NCT01738503|18985289|P7|STARTED|Induction/Stabilization (Days -14 to -1)||0
7710191|NCT01738503|18985290|P6|STARTED|Induction/Stabilization (Days -14 to -1)||0
7710192|NCT01738503|18985291|P5|STARTED|Induction/Stabilization (Days -14 to -1)||0
7710193|NCT01738503|18985292|P4|STARTED|Induction/Stabilization (Days -14 to -1)||0
7710194|NCT01738503|18985293|P3|STARTED|Induction/Stabilization (Days -14 to -1)||0
7710195|NCT01738503|18985294|P2|STARTED|Induction/Stabilization (Days -14 to -1)||0
7710196|NCT01738503|18985295|P1|STARTED|Induction/Stabilization (Days -14 to -1)||124
7710197|NCT01738477|18985493|P2|NOT COMPLETED|Overall Study||4
7710198|NCT01738477|18985494|P1|NOT COMPLETED|Overall Study||1
7710199|NCT01738477|18985493|P2|COMPLETED|Overall Study||124
7710200|NCT01738477|18985494|P1|COMPLETED|Overall Study||36
7710201|NCT01738477|18985493|P2|STARTED|Overall Study||128
7710202|NCT01738477|18985494|P1|STARTED|Overall Study||37
7710203|NCT01738438|18985522|P1|NOT COMPLETED|Overall Study||35
7710204|NCT01738438|18985522|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
7710205|NCT01738438|18985522|P1|STARTED|Overall Study||35
7710206|NCT01738321|18985530|P2|NOT COMPLETED|Overall Study||0
7710207|NCT01738321|18985531|P1|NOT COMPLETED|Overall Study||0
7710208|NCT01738321|18985530|P2|COMPLETED|Overall Study||30
7710209|NCT01738321|18985531|P1|COMPLETED|Overall Study||33
7710210|NCT01738321|18985530|P2|STARTED|Overall Study||30
7710211|NCT01738321|18985531|P1|STARTED|Overall Study||33
7710212|NCT01738191|18985539|P2|NOT COMPLETED|Overall Study||1
7710213|NCT01738191|18985540|P1|NOT COMPLETED|Overall Study||4
7710214|NCT01738191|18985539|P2|COMPLETED|Overall Study||14
7710215|NCT01738191|18985540|P1|COMPLETED|Overall Study||11
7710216|NCT01738191|18985539|P2|STARTED|Overall Study||15
7710217|NCT01738191|18985540|P1|STARTED|Overall Study||15
7710218|NCT01737996|18985563|P3|NOT COMPLETED|Overall Study||2
7710219|NCT01737996|18985564|P2|NOT COMPLETED|Overall Study||1
7710220|NCT01737996|18985565|P1|NOT COMPLETED|Overall Study||0
7710221|NCT01737996|18985563|P3|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14
7710222|NCT01737996|18985564|P2|COMPLETED|Overall Study||7
7710223|NCT01737996|18985565|P1|COMPLETED|Overall Study||8
7710224|NCT01737996|18985563|P3|STARTED|Overall Study||16
7710225|NCT01737996|18985564|P2|STARTED|Overall Study||8
7710226|NCT01737996|18985565|P1|STARTED|Overall Study||8
7710227|NCT01737944|18985606|P4|NOT COMPLETED|Overall Study||0
7710228|NCT01737944|18985607|P3|NOT COMPLETED|Overall Study||0
7710229|NCT01737944|18985608|P2|NOT COMPLETED|Overall Study||0
7710230|NCT01737944|18985609|P1|NOT COMPLETED|Overall Study||0
7710231|NCT01737944|18985606|P4|COMPLETED|Overall Study||9
7710232|NCT01737944|18985607|P3|COMPLETED|Overall Study||9
7710233|NCT01737944|18985608|P2|COMPLETED|Overall Study||9
7710234|NCT01737944|18985609|P1|COMPLETED|Overall Study||9
7710235|NCT01737944|18985606|P4|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
7710236|NCT01737944|18985607|P3|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
7710237|NCT01737944|18985608|P2|STARTED|Overall Study||9
7710238|NCT01737944|18985609|P1|STARTED|Overall Study||9
7710239|NCT01737931|18985627|P3|NOT COMPLETED|Overall Study||1
7710240|NCT01737931|18985628|P2|NOT COMPLETED|Overall Study||2
7710241|NCT01737931|18985629|P1|NOT COMPLETED|Overall Study||0
7710242|NCT01737931|18985627|P3|COMPLETED|Overall Study||38
7710243|NCT01737931|18985628|P2|COMPLETED|Overall Study||38
7710244|NCT01737931|18985629|P1|COMPLETED|Overall Study||38
7710245|NCT01737931|18985627|P3|STARTED|Overall Study||39
7710246|NCT01737931|18985628|P2|STARTED|Overall Study||40
7710247|NCT01737931|18985629|P1|STARTED|Overall Study||38
7710248|NCT01737879|18985644|P1|NOT COMPLETED|Overall Study||41
7710249|NCT01737879|18985644|P1|COMPLETED|Overall Study||0
7710250|NCT01737879|18985644|P1|Transitioned to Epoetin Alfa|Overall Study||0
7710251|NCT01737879|18985644|P1|Received Peginesatide|Overall Study||34
7710252|NCT01737879|18985644|P1|STARTED|Overall Study||41
7710253|NCT01737840|18985653|P2|NOT COMPLETED|Overall Study||2
7710254|NCT01737840|18985654|P1|NOT COMPLETED|Overall Study||2
7710255|NCT01737840|18985653|P2|COMPLETED|Overall Study||33
7710256|NCT01737840|18985654|P1|COMPLETED|Overall Study||33
7710257|NCT01737840|18985653|P2|STARTED|Overall Study||35
7710258|NCT01737840|18985654|P1|STARTED|Overall Study||35
7710259|NCT01737762|18985664|P2|NOT COMPLETED|Overall Study||17
7710260|NCT01737762|18985665|P1|NOT COMPLETED|Overall Study||20
7710261|NCT01737762|18985664|P2|COMPLETED|Overall Study||61
7710262|NCT01737762|18985665|P1|COMPLETED|Overall Study||57
7710263|NCT01737762|18985664|P2|STARTED|Overall Study||78
7710264|NCT01737762|18985665|P1|STARTED|Overall Study||77
7710265|NCT01737710|18985678|P5|NOT COMPLETED|Overall Study||0
7710266|NCT01737710|18985679|P4|NOT COMPLETED|Overall Study||0
7710267|NCT01737710|18985680|P3|NOT COMPLETED|Overall Study||3
7710268|NCT01737710|18985681|P2|NOT COMPLETED|Overall Study||4
7710269|NCT01737710|18985682|P1|NOT COMPLETED|Overall Study||2
7710270|NCT01737710|18985678|P5|COMPLETED|Overall Study||21
7710271|NCT01737710|18985679|P4|COMPLETED|Overall Study||23
7710272|NCT01737710|18985680|P3|COMPLETED|Overall Study||102
7710273|NCT01737710|18985681|P2|COMPLETED|Overall Study||101
7710274|NCT01737710|18985682|P1|COMPLETED|Overall Study||112
7710275|NCT01737710|18985678|P5|STARTED|Overall Study||21
7710276|NCT01737710|18985679|P4|STARTED|Overall Study||23
7710277|NCT01737710|18985680|P3|STARTED|Overall Study||105
7710278|NCT01737710|18985681|P2|STARTED|Overall Study||105
7710279|NCT01737710|18985682|P1|STARTED|Overall Study||114
7710280|NCT01737697|18985724|P15|NOT COMPLETED|Subacute Phase||1
7710281|NCT01737697|18985725|P14|NOT COMPLETED|Subacute Phase||2
7710282|NCT01737697|18985726|P13|NOT COMPLETED|Subacute Phase||2
7710283|NCT01737697|18985727|P12|NOT COMPLETED|Subacute Phase||3
7710284|NCT01737697|18985728|P11|NOT COMPLETED|Subacute Phase||6
7710285|NCT01737697|18985729|P10|NOT COMPLETED|Subacute Phase||2
7710286|NCT01737697|18985730|P9|NOT COMPLETED|Subacute Phase||2
7710287|NCT01737697|18985731|P8|NOT COMPLETED|Subacute Phase||3
7710288|NCT01737697|18985732|P7|NOT COMPLETED|Subacute Phase||1
7710289|NCT01737697|18985733|P6|NOT COMPLETED|Subacute Phase||3
7710290|NCT01737697|18985734|P5|NOT COMPLETED|Subacute Phase||0
7710291|NCT01737697|18985735|P4|NOT COMPLETED|Subacute Phase||0
7710292|NCT01737697|18985736|P3|NOT COMPLETED|Subacute Phase||0
7710293|NCT01737697|18985737|P2|NOT COMPLETED|Subacute Phase||0
7710294|NCT01737697|18985738|P1|NOT COMPLETED|Subacute Phase||0
7710295|NCT01737697|18985724|P15|COMPLETED|Subacute Phase||49
7710296|NCT01737697|18985725|P14|COMPLETED|Subacute Phase||44
7710297|NCT01737697|18985726|P13|COMPLETED|Subacute Phase||61
7710298|NCT01737697|18985727|P12|COMPLETED|Subacute Phase||58
7710299|NCT01737697|18985728|P11|COMPLETED|Subacute Phase||59
7710300|NCT01737697|18985729|P10|COMPLETED|Subacute Phase||66
7710301|NCT01737697|18985730|P9|COMPLETED|Subacute Phase||52
7710302|NCT01737697|18985731|P8|COMPLETED|Subacute Phase||43
7710303|NCT01737697|18985732|P7|COMPLETED|Subacute Phase||48
7710304|NCT01737697|18985733|P6|COMPLETED|Subacute Phase||38
7710305|NCT01737697|18985734|P5|COMPLETED|Subacute Phase||0
7710306|NCT01737697|18985735|P4|COMPLETED|Subacute Phase||0
7710307|NCT01737697|18985736|P3|COMPLETED|Subacute Phase||0
7710308|NCT01737697|18985737|P2|COMPLETED|Subacute Phase||0
7710309|NCT01737697|18985738|P1|COMPLETED|Subacute Phase||0
7710310|NCT01737697|18985724|P15|STARTED|Subacute Phase||50
7710311|NCT01737697|18985725|P14|STARTED|Subacute Phase||46
7710312|NCT01737697|18985726|P13|STARTED|Subacute Phase||63
7710313|NCT01737697|18985727|P12|STARTED|Subacute Phase||61
7710314|NCT01737697|18985728|P11|STARTED|Subacute Phase||65
7710315|NCT01737697|18985729|P10|STARTED|Subacute Phase||68
7710316|NCT01737697|18985730|P9|STARTED|Subacute Phase||54
7710317|NCT01737697|18985731|P8|STARTED|Subacute Phase||46
7710318|NCT01737697|18985732|P7|STARTED|Subacute Phase||49
7710319|NCT01737697|18985733|P6|STARTED|Subacute Phase||41
7710320|NCT01737697|18985734|P5|STARTED|Subacute Phase||0
7710321|NCT01737697|18985735|P4|STARTED|Subacute Phase||0
7710322|NCT01737697|18985736|P3|STARTED|Subacute Phase||0
7710323|NCT01737697|18985737|P2|STARTED|Subacute Phase||0
7710324|NCT01737697|18985738|P1|STARTED|Subacute Phase||0
7710325|NCT01737697|18985724|P15|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
7710326|NCT01737697|18985725|P14|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
7710327|NCT01737697|18985726|P13|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
7710328|NCT01737697|18985727|P12|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
7710329|NCT01737697|18985728|P11|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
7710330|NCT01737697|18985729|P10|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
7710331|NCT01737697|18985730|P9|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
7710332|NCT01737697|18985731|P8|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
7710333|NCT01737697|18985732|P7|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
7710334|NCT01737697|18985733|P6|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
7710335|NCT01737697|18985734|P5|NOT COMPLETED|Acute Phase-Initial 48 Hours||3
7710336|NCT01737697|18985735|P4|NOT COMPLETED|Acute Phase-Initial 48 Hours||6
7710337|NCT01737697|18985736|P3|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
7710338|NCT01737697|18985737|P2|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
7710339|NCT01737697|18985738|P1|NOT COMPLETED|Acute Phase-Initial 48 Hours||1
7710340|NCT01737697|18985724|P15|COMPLETED|Acute Phase-Initial 48 Hours||0
7710341|NCT01737697|18985725|P14|COMPLETED|Acute Phase-Initial 48 Hours||0
7710342|NCT01737697|18985726|P13|COMPLETED|Acute Phase-Initial 48 Hours||0
7710343|NCT01737697|18985727|P12|COMPLETED|Acute Phase-Initial 48 Hours||0
7710344|NCT01737697|18985728|P11|COMPLETED|Acute Phase-Initial 48 Hours||0
7710345|NCT01737697|18985729|P10|COMPLETED|Acute Phase-Initial 48 Hours||0
7710346|NCT01737697|18985730|P9|COMPLETED|Acute Phase-Initial 48 Hours||0
7710347|NCT01737697|18985731|P8|COMPLETED|Acute Phase-Initial 48 Hours||0
7710348|NCT01737697|18985732|P7|COMPLETED|Acute Phase-Initial 48 Hours||0
7710349|NCT01737697|18985733|P6|COMPLETED|Acute Phase-Initial 48 Hours||0
7710350|NCT01737697|18985734|P5|COMPLETED|Acute Phase-Initial 48 Hours||140
7710351|NCT01737697|18985735|P4|COMPLETED|Acute Phase-Initial 48 Hours||152
7710352|NCT01737697|18985736|P3|COMPLETED|Acute Phase-Initial 48 Hours||137
7710353|NCT01737697|18985737|P2|COMPLETED|Acute Phase-Initial 48 Hours||150
7710354|NCT01737697|18985738|P1|COMPLETED|Acute Phase-Initial 48 Hours||157
7710355|NCT01737697|18985724|P15|STARTED|Acute Phase-Initial 48 Hours||0
7710356|NCT01737697|18985725|P14|STARTED|Acute Phase-Initial 48 Hours||0
7710357|NCT01737697|18985726|P13|STARTED|Acute Phase-Initial 48 Hours||0
7710358|NCT01737697|18985727|P12|STARTED|Acute Phase-Initial 48 Hours||0
7710359|NCT01737697|18985728|P11|STARTED|Acute Phase-Initial 48 Hours||0
7710360|NCT01737697|18985729|P10|STARTED|Acute Phase-Initial 48 Hours||0
7710361|NCT01737697|18985730|P9|STARTED|Acute Phase-Initial 48 Hours||0
7710362|NCT01737697|18985731|P8|STARTED|Acute Phase-Initial 48 Hours||0
7710363|NCT01737697|18985732|P7|STARTED|Acute Phase-Initial 48 Hours||0
7710364|NCT01737697|18985733|P6|STARTED|Acute Phase-Initial 48 Hours||0
7710365|NCT01737697|18985734|P5|STARTED|Acute Phase-Initial 48 Hours||143
7710366|NCT01737697|18985735|P4|STARTED|Acute Phase-Initial 48 Hours||158
7710367|NCT01737697|18985736|P3|STARTED|Acute Phase-Initial 48 Hours||141
7710368|NCT01737697|18985737|P2|STARTED|Acute Phase-Initial 48 Hours||154
7710369|NCT01737697|18985738|P1|STARTED|Acute Phase-Initial 48 Hours||158
7710370|NCT01737684|18985827|P3|NOT COMPLETED|Overall Study||0
7710371|NCT01737684|18985828|P2|NOT COMPLETED|Overall Study||0
7710372|NCT01737684|18985829|P1|NOT COMPLETED|Overall Study||0
7710373|NCT01737684|18985827|P3|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
7710374|NCT01737684|18985828|P2|COMPLETED|Overall Study||8
7710375|NCT01737684|18985829|P1|COMPLETED|Overall Study||8
7710376|NCT01737684|18985827|P3|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
7710377|NCT01737684|18985828|P2|STARTED|Overall Study||8
7710378|NCT01737684|18985829|P1|STARTED|Overall Study||8
7710379|NCT01737593|18985848|P3|NOT COMPLETED|Overall Study||0
7710380|NCT01737593|18985849|P2|NOT COMPLETED|Overall Study||0
7710381|NCT01737593|18985850|P1|NOT COMPLETED|Overall Study||0
7710382|NCT01737593|18985848|P3|COMPLETED|Overall Study||39
7710383|NCT01737593|18985849|P2|COMPLETED|Overall Study||32
7710384|NCT01737593|18985850|P1|COMPLETED|Overall Study||37
7710385|NCT01737593|18985848|P3|STARTED|Overall Study||39
7710386|NCT01737593|18985849|P2|STARTED|Overall Study||32
7710387|NCT01737593|18985850|P1|STARTED|Overall Study||37
7710388|NCT01737398|18985881|P2|NOT COMPLETED|Overall Study||8
7710389|NCT01737398|18985882|P1|NOT COMPLETED|Overall Study||26
7710390|NCT01737398|18985881|P2|COMPLETED|Overall Study||52
7710391|NCT01737398|18985882|P1|COMPLETED|Overall Study||87
7710392|NCT01737398|18985881|P2|Safety Set|Overall Study||60
7710393|NCT01737398|18985882|P1|Safety Set|Overall Study||112
7710394|NCT01737398|18985881|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
7710395|NCT01737398|18985882|P1|Received at Least 1 Dose of Study Drug|Overall Study||112
7710396|NCT01737398|18985881|P2|STARTED|Overall Study||60
7710397|NCT01737398|18985882|P1|STARTED|Overall Study||113
7710398|NCT01737281|18985926|P2|NOT COMPLETED|Overall Study||280
7710399|NCT01737281|18985927|P1|NOT COMPLETED|Overall Study||366
7710400|NCT01737281|18985926|P2|COMPLETED|Overall Study||689
7710401|NCT01737281|18985927|P1|COMPLETED|Overall Study||603
7710402|NCT01737281|18985926|P2|STARTED|Overall Study||969
7710403|NCT01737281|18985927|P1|STARTED|Overall Study||969
7710404|NCT01737268|18985935|P1|NOT COMPLETED|Overall Study||9
7710405|NCT01737268|18985935|P1|COMPLETED|Overall Study||11
7710406|NCT01737268|18985935|P1|Treated|Overall Study||20
7710407|NCT01737268|18985935|P1|STARTED|Overall Study||20
7710408|NCT01737021|18985949|P2|NOT COMPLETED|Overall Study||3
7710409|NCT01737021|18985950|P1|NOT COMPLETED|Overall Study||5
7710410|NCT01737021|18985949|P2|COMPLETED|Overall Study||6
7710411|NCT01737021|18985950|P1|COMPLETED|Overall Study||17
7710412|NCT01737021|18985949|P2|STARTED|Overall Study||9
7710413|NCT01737021|18985950|P1|STARTED|Overall Study||22
7710414|NCT01736930|18985956|P1|NOT COMPLETED|Overall Study||1
7710415|NCT01736930|18985956|P1|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19
7710510|NCT01736553|18986569|P1|COMPLETED|Overall Study||7
7710416|NCT01736930|18985956|P1|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20
7710417|NCT01736917|18985996|P1|NOT COMPLETED|Overall Study||11
7710418|NCT01736917|18985996|P1|COMPLETED|Overall Study||54
7710419|NCT01736917|18985996|P1|STARTED|Overall Study||65
7710420|NCT01736865|18986005|P2|NOT COMPLETED|Overall Study||0
7710421|NCT01736865|18986006|P1|NOT COMPLETED|Overall Study||0
7710422|NCT01736865|18986005|P2|COMPLETED|Overall Study||66
7710423|NCT01736865|18986006|P1|COMPLETED|Overall Study||61
7710424|NCT01736865|18986005|P2|STARTED|Overall Study||66
7710425|NCT01736865|18986006|P1|STARTED|Overall Study||61
7710426|NCT01736852|18986020|P2|NOT COMPLETED|Overall Study||3
7710427|NCT01736852|18986021|P1|NOT COMPLETED|Overall Study||2
7710428|NCT01736852|18986020|P2|COMPLETED|Overall Study||61
7710429|NCT01736852|18986021|P1|COMPLETED|Overall Study||63
7710430|NCT01736852|18986020|P2|STARTED|Overall Study||64
7710431|NCT01736852|18986021|P1|STARTED|Overall Study||65
7710432|NCT01736696|18986036|P7|NOT COMPLETED|Overall Study||0
7710433|NCT01736696|18986037|P6|NOT COMPLETED|Overall Study||0
7710434|NCT01736696|18986038|P5|NOT COMPLETED|Overall Study||0
7710435|NCT01736696|18986039|P4|NOT COMPLETED|Overall Study||0
7710436|NCT01736696|18986040|P3|NOT COMPLETED|Overall Study||1
7710437|NCT01736696|18986041|P2|NOT COMPLETED|Overall Study||0
7710438|NCT01736696|18986042|P1|NOT COMPLETED|Overall Study||0
7710439|NCT01736696|18986036|P7|COMPLETED|Overall Study||13
7710440|NCT01736696|18986037|P6|COMPLETED|Overall Study||8
7710441|NCT01736696|18986038|P5|COMPLETED|Overall Study||9
7710442|NCT01736696|18986039|P4|COMPLETED|Overall Study||9
7710443|NCT01736696|18986040|P3|COMPLETED|Overall Study||9
7710444|NCT01736696|18986041|P2|COMPLETED|Overall Study||5
7710445|NCT01736696|18986042|P1|COMPLETED|Overall Study||5
7710446|NCT01736696|18986036|P7|STARTED|Overall Study||13
7710447|NCT01736696|18986037|P6|STARTED|Overall Study||8
7710448|NCT01736696|18986038|P5|STARTED|Overall Study||9
7710449|NCT01736696|18986039|P4|STARTED|Overall Study||9
7710450|NCT01736696|18986040|P3|STARTED|Overall Study||10
7710451|NCT01736696|18986041|P2|STARTED|Overall Study||5
7710452|NCT01736696|18986042|P1|STARTED|Overall Study||5
7710453|NCT01736683|18986364|P5|NOT COMPLETED|Overall Study||5
7710454|NCT01736683|18986365|P4|NOT COMPLETED|Overall Study||35
7710455|NCT01736683|18986366|P3|NOT COMPLETED|Overall Study||21
7710456|NCT01736683|18986367|P2|NOT COMPLETED|Overall Study||6
7710457|NCT01736683|18986368|P1|NOT COMPLETED|Overall Study||7
7710458|NCT01736683|18986364|P5|COMPLETED|Overall Study|# who completed treatment|0
7710459|NCT01736683|18986365|P4|COMPLETED|Overall Study|# who completed treatment|0
7710460|NCT01736683|18986366|P3|COMPLETED|Overall Study|# who completed treatment|0
7710461|NCT01736683|18986367|P2|COMPLETED|Overall Study|# who completed treatment|0
7710462|NCT01736683|18986368|P1|COMPLETED|Overall Study|# who completed treatment|0
7710463|NCT01736683|18986364|P5|STARTED|Overall Study||5
7710464|NCT01736683|18986365|P4|STARTED|Overall Study||35
7710465|NCT01736683|18986366|P3|STARTED|Overall Study||21
7710466|NCT01736683|18986367|P2|STARTED|Overall Study||6
7710467|NCT01736683|18986368|P1|STARTED|Overall Study||7
7710468|NCT01736657|18986430|P1|NOT COMPLETED|Overall Study||1
7710469|NCT01736657|18986430|P1|COMPLETED|Overall Study||72
7710470|NCT01736657|18986430|P1|STARTED|Overall Study||73
7710471|NCT01736579|18986439|P2|NOT COMPLETED|Overall Study||2
7710472|NCT01736579|18986440|P1|NOT COMPLETED|Overall Study||2
7710473|NCT01736579|18986439|P2|COMPLETED|Overall Study||0
7710474|NCT01736579|18986440|P1|COMPLETED|Overall Study||0
7710475|NCT01736579|18986439|P2|STARTED|Overall Study||2
7710476|NCT01736579|18986440|P1|STARTED|Overall Study||2
7710477|NCT01736566|18986479|P5|NOT COMPLETED|Long Term Follow-up||1
7710478|NCT01736566|18986480|P4|NOT COMPLETED|Long Term Follow-up||0
7710479|NCT01736566|18986481|P3|NOT COMPLETED|Long Term Follow-up||49
7710480|NCT01736566|18986482|P2|NOT COMPLETED|Long Term Follow-up||0
7710481|NCT01736566|18986483|P1|NOT COMPLETED|Long Term Follow-up||42
7710482|NCT01736566|18986479|P5|COMPLETED|Long Term Follow-up||0
7710483|NCT01736566|18986480|P4|COMPLETED|Long Term Follow-up||0
7710484|NCT01736566|18986481|P3|COMPLETED|Long Term Follow-up||0
7710485|NCT01736566|18986482|P2|COMPLETED|Long Term Follow-up||0
7710486|NCT01736566|18986483|P1|COMPLETED|Long Term Follow-up||0
7710487|NCT01736566|18986479|P5|STARTED|Long Term Follow-up||1
7710488|NCT01736566|18986480|P4|STARTED|Long Term Follow-up||0
7710489|NCT01736566|18986481|P3|STARTED|Long Term Follow-up||49
7710490|NCT01736566|18986482|P2|STARTED|Long Term Follow-up||0
7710491|NCT01736566|18986483|P1|STARTED|Long Term Follow-up||42
7710492|NCT01736566|18986479|P5|NOT COMPLETED|Main Study||4
7710493|NCT01736566|18986480|P4|NOT COMPLETED|Main Study||1
7710494|NCT01736566|18986481|P3|NOT COMPLETED|Main Study||1
7710495|NCT01736566|18986482|P2|NOT COMPLETED|Main Study||0
7710496|NCT01736566|18986483|P1|NOT COMPLETED|Main Study||1
7710497|NCT01736566|18986479|P5|COMPLETED|Main Study||6
7710498|NCT01736566|18986480|P4|COMPLETED|Main Study||51
7710499|NCT01736566|18986481|P3|COMPLETED|Main Study||49
7710500|NCT01736566|18986482|P2|COMPLETED|Main Study||50
7710501|NCT01736566|18986483|P1|COMPLETED|Main Study||50
7710502|NCT01736566|18986479|P5|STARTED|Main Study||10
7710503|NCT01736566|18986480|P4|STARTED|Main Study||52
7710504|NCT01736566|18986481|P3|STARTED|Main Study||50
7710505|NCT01736566|18986482|P2|STARTED|Main Study||50
7710506|NCT01736566|18986483|P1|STARTED|Main Study||51
7710507|NCT01736553|18986568|P2|NOT COMPLETED|Overall Study||4
7710508|NCT01736553|18986569|P1|NOT COMPLETED|Overall Study||19
7710509|NCT01736553|18986568|P2|COMPLETED|Overall Study||23
7710511|NCT01736553|18986568|P2|STARTED|Overall Study||27
7710512|NCT01736553|18986569|P1|STARTED|Overall Study||26
7710513|NCT01736540|18986620|P1|NOT COMPLETED|Overall Study||15
7710514|NCT01736540|18986620|P1|COMPLETED|Overall Study||228
7710515|NCT01736540|18986620|P1|STARTED|Overall Study||243
7710516|NCT01736527|18986677|P1|NOT COMPLETED|Overall Study||0
7710517|NCT01736527|18986677|P1|COMPLETED|Overall Study||12
7710518|NCT01736527|18986677|P1|STARTED|Overall Study||12
7710519|NCT01736475|18986686|P2|NOT COMPLETED|Overall Study||0
7710520|NCT01736475|18986687|P1|NOT COMPLETED|Overall Study||12
7710521|NCT01736475|18986686|P2|COMPLETED|Overall Study||17
7710522|NCT01736475|18986687|P1|COMPLETED|Overall Study||109
7710523|NCT01736475|18986686|P2|STARTED|Overall Study||17
7710524|NCT01736475|18986687|P1|STARTED|Overall Study||121
7710525|NCT01736397|18986742|P2|NOT COMPLETED|Overall Study||24
7710526|NCT01736397|18986743|P1|NOT COMPLETED|Overall Study||14
7710527|NCT01736397|18986742|P2|COMPLETED|Overall Study||50
7710528|NCT01736397|18986743|P1|COMPLETED|Overall Study||61
7710529|NCT01736397|18986742|P2|STARTED|Overall Study||74
7710530|NCT01736397|18986743|P1|STARTED|Overall Study||75
7710531|NCT01736358|18986757|P2|NOT COMPLETED|Overall Study||2
7710532|NCT01736358|18986758|P1|NOT COMPLETED|Overall Study||5
7710533|NCT01736358|18986757|P2|COMPLETED|Overall Study||23
7710534|NCT01736358|18986758|P1|COMPLETED|Overall Study||20
7710535|NCT01736358|18986757|P2|STARTED|Overall Study||25
7710536|NCT01736358|18986758|P1|STARTED|Overall Study||25
7710537|NCT01736267|18986772|P1|NOT COMPLETED|Overall Study||0
7710538|NCT01736267|18986772|P1|COMPLETED|Overall Study||3
7710539|NCT01736267|18986772|P1|STARTED|Overall Study||3
7710540|NCT01736254|18986776|P1|NOT COMPLETED|Period 3 (Days 13 to 23)||1
7710541|NCT01736254|18986776|P1|COMPLETED|Period 3 (Days 13 to 23)||20
7710542|NCT01736254|18986776|P1|STARTED|Period 3 (Days 13 to 23)||21
7710543|NCT01736254|18986776|P1|NOT COMPLETED|Period 2 (Days 2 to 12)||3
7710544|NCT01736254|18986776|P1|COMPLETED|Period 2 (Days 2 to 12)||21
7710545|NCT01736254|18986776|P1|STARTED|Period 2 (Days 2 to 12)||24
7710546|NCT01736254|18986776|P1|NOT COMPLETED|Period 1 (Day 1)||0
7710547|NCT01736254|18986776|P1|COMPLETED|Period 1 (Day 1)||24
7710548|NCT01736254|18986776|P1|Received at Least One Dose of Study Drug|Period 1 (Day 1)||24
7710549|NCT01736254|18986776|P1|STARTED|Period 1 (Day 1)||24
7710550|NCT01736241|18986800|P7|NOT COMPLETED|Overall Study||0
7710551|NCT01736241|18986801|P6|NOT COMPLETED|Overall Study||0
7710552|NCT01736241|18986802|P5|NOT COMPLETED|Overall Study||0
7710553|NCT01736241|18986803|P4|NOT COMPLETED|Overall Study||0
7710554|NCT01736241|18986804|P3|NOT COMPLETED|Overall Study||0
7710555|NCT01736241|18986805|P2|NOT COMPLETED|Overall Study||0
7710556|NCT01736241|18986806|P1|NOT COMPLETED|Overall Study||0
7710557|NCT01736241|18986800|P7|COMPLETED|Overall Study||6
7710558|NCT01736241|18986801|P6|COMPLETED|Overall Study||6
7710559|NCT01736241|18986802|P5|COMPLETED|Overall Study||6
7710560|NCT01736241|18986803|P4|COMPLETED|Overall Study||5
7710561|NCT01736241|18986804|P3|COMPLETED|Overall Study||6
7710562|NCT01736241|18986805|P2|COMPLETED|Overall Study||6
7710563|NCT01736241|18986806|P1|COMPLETED|Overall Study||6
7710564|NCT01736241|18986800|P7|Received at Least One Dose of Study Drug|Overall Study||6
7710565|NCT01736241|18986801|P6|Received at Least One Dose of Study Drug|Overall Study||6
7710566|NCT01736241|18986802|P5|Received at Least One Dose of Study Drug|Overall Study||6
7710567|NCT01736241|18986803|P4|Received at Least One Dose of Study Drug|Overall Study||5
7710568|NCT01736241|18986804|P3|Received at Least One Dose of Study Drug|Overall Study||6
7710569|NCT01736241|18986805|P2|Received at Least One Dose of Study Drug|Overall Study||6
7710570|NCT01736241|18986806|P1|Received at Least One Dose of Study Drug|Overall Study||6
7710571|NCT01736241|18986800|P7|STARTED|Overall Study||6
7710572|NCT01736241|18986801|P6|STARTED|Overall Study||6
7710573|NCT01736241|18986802|P5|STARTED|Overall Study||6
7710574|NCT01736241|18986803|P4|STARTED|Overall Study||5
7710575|NCT01736241|18986804|P3|STARTED|Overall Study||6
7710576|NCT01736241|18986805|P2|STARTED|Overall Study||6
7710577|NCT01736241|18986806|P1|STARTED|Overall Study||6
7710578|NCT01736215|18986841|P1|NOT COMPLETED|Overall Study||14
7710579|NCT01736215|18986841|P1|COMPLETED|Overall Study||19
7710580|NCT01736215|18986841|P1|Treated|Overall Study||25
7710581|NCT01736215|18986841|P1|STARTED|Overall Study||33
7710582|NCT01736189|18986853|P1|NOT COMPLETED|Overall Study||46
7710583|NCT01736189|18986853|P1|COMPLETED|Overall Study||300
7710584|NCT01736189|18986853|P1|STARTED|Overall Study||346
7710585|NCT01736176|18986862|P1|NOT COMPLETED|Overall Study||11
7710586|NCT01736176|18986862|P1|COMPLETED|Overall Study||28
7710587|NCT01736176|18986862|P1|Received LCIG|Overall Study||38
7710588|NCT01736176|18986862|P1|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39
7710589|NCT01736085|18986912|P6|NOT COMPLETED|Overall Study||0
7710590|NCT01736085|18986913|P5|NOT COMPLETED|Overall Study||0
7710591|NCT01736085|18986914|P4|NOT COMPLETED|Overall Study||0
7710592|NCT01736085|18986915|P3|NOT COMPLETED|Overall Study||0
7710593|NCT01736085|18986916|P2|NOT COMPLETED|Overall Study||0
7710594|NCT01736085|18986917|P1|NOT COMPLETED|Overall Study||0
7710595|NCT01736085|18986912|P6|COMPLETED|Overall Study||794
7710596|NCT01736085|18986913|P5|COMPLETED|Overall Study||530
7710597|NCT01736085|18986914|P4|COMPLETED|Overall Study||530
7710598|NCT01736085|18986915|P3|COMPLETED|Overall Study||793
7710599|NCT01736085|18986916|P2|COMPLETED|Overall Study||530
7710600|NCT01736085|18986917|P1|COMPLETED|Overall Study||529
7710601|NCT01736085|18986912|P6|STARTED|Overall Study||794
7710602|NCT01736085|18986913|P5|STARTED|Overall Study||530
7710603|NCT01736085|18986914|P4|STARTED|Overall Study||530
7710604|NCT01736085|18986915|P3|STARTED|Overall Study||793
7710605|NCT01736085|18986916|P2|STARTED|Overall Study||530
7710606|NCT01736085|18986917|P1|STARTED|Overall Study||529
7710607|NCT01735994|18986933|P2|NOT COMPLETED|Overall Study||66
7710608|NCT01735994|18986934|P1|NOT COMPLETED|Overall Study||63
7710609|NCT01735994|18986933|P2|COMPLETED|Overall Study||152
7710610|NCT01735994|18986934|P1|COMPLETED|Overall Study||200
7710611|NCT01735994|18986933|P2|Follow-Up #2 (12 Months)|Overall Study||174
7710612|NCT01735994|18986934|P1|Follow-Up #2 (12 Months)|Overall Study||212
7710613|NCT01735994|18986933|P2|Follow-Up #1 (6 Months)|Overall Study||163
7710614|NCT01735994|18986934|P1|Follow-Up #1 (6 Months)|Overall Study||213
7710615|NCT01735994|18986933|P2|Post Intervention (3 Weeks)|Overall Study||198
7710616|NCT01735994|18986934|P1|Post Intervention (3 Weeks)|Overall Study||239
7710617|NCT01735994|18986933|P2|STARTED|Overall Study||218
7710618|NCT01735994|18986934|P1|STARTED|Overall Study||263
7710619|NCT01735916|18986949|P3|NOT COMPLETED|Overall Study||7
7710620|NCT01735916|18986950|P2|NOT COMPLETED|Overall Study||19
7710621|NCT01735916|18986951|P1|NOT COMPLETED|Overall Study||18
7710622|NCT01735916|18986949|P3|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
7710623|NCT01735916|18986950|P2|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
7710624|NCT01735916|18986951|P1|COMPLETED|Overall Study||0
7710625|NCT01735916|18986949|P3|STARTED|Overall Study||7
7710626|NCT01735916|18986950|P2|STARTED|Overall Study||19
7710627|NCT01735916|18986951|P1|STARTED|Overall Study||18
7710628|NCT01735877|18986972|P2|NOT COMPLETED|Overall Study||0
7710629|NCT01735877|18986973|P1|NOT COMPLETED|Overall Study||1
7710630|NCT01735877|18986972|P2|COMPLETED|Overall Study||21
7710631|NCT01735877|18986973|P1|COMPLETED|Overall Study||26
7710632|NCT01735877|18986972|P2|STARTED|Overall Study||21
7710633|NCT01735877|18986973|P1|STARTED|Overall Study||27
7710634|NCT01735630|18986989|P2|NOT COMPLETED|Overall Study||18
7710635|NCT01735630|18986990|P1|NOT COMPLETED|Overall Study||18
7710636|NCT01735630|18986989|P2|COMPLETED|Overall Study||157
7710637|NCT01735630|18986990|P1|COMPLETED|Overall Study||157
7710638|NCT01735630|18986989|P2|STARTED|Overall Study||175
7710639|NCT01735630|18986990|P1|STARTED|Overall Study||175
7710640|NCT01735617|18987004|P1|NOT COMPLETED|Overall Study||0
7710641|NCT01735617|18987004|P1|COMPLETED|Overall Study||16
7710642|NCT01735617|18987004|P1|STARTED|Overall Study||16
7710643|NCT01735396|18987017|P1|NOT COMPLETED|Overall Study||1
7710644|NCT01735396|18987017|P1|COMPLETED|Overall Study||10
7710645|NCT01735396|18987017|P1|STARTED|Overall Study||11
7710646|NCT01735279|18987028|P2|NOT COMPLETED|Overall Study||8
7710647|NCT01735279|18987029|P1|NOT COMPLETED|Overall Study||11
7710648|NCT01735279|18987028|P2|COMPLETED|Overall Study||21
7710649|NCT01735279|18987029|P1|COMPLETED|Overall Study||18
7710650|NCT01735279|18987028|P2|STARTED|Overall Study||29
7710651|NCT01735279|18987029|P1|STARTED|Overall Study||29
7710652|NCT01735214|18987041|P1|NOT COMPLETED|Overall Study||0
7710653|NCT01735214|18987041|P1|COMPLETED|Overall Study||358
7710654|NCT01735214|18987041|P1|STARTED|Overall Study||358
7710655|NCT01735201|18987061|P8|NOT COMPLETED|Overall Study||2
7710656|NCT01735201|18987062|P7|NOT COMPLETED|Overall Study||3
7710657|NCT01735201|18987063|P6|NOT COMPLETED|Overall Study||5
7710658|NCT01735201|18987064|P5|NOT COMPLETED|Overall Study||1
7710659|NCT01735201|18987065|P4|NOT COMPLETED|Overall Study||2
7710660|NCT01735201|18987066|P3|NOT COMPLETED|Overall Study||0
7710661|NCT01735201|18987067|P2|NOT COMPLETED|Overall Study||1
7710662|NCT01735201|18987068|P1|NOT COMPLETED|Overall Study||3
7710663|NCT01735201|18987061|P8|COMPLETED|Overall Study||42
7710664|NCT01735201|18987062|P7|COMPLETED|Overall Study||42
7710665|NCT01735201|18987063|P6|COMPLETED|Overall Study||40
7710666|NCT01735201|18987064|P5|COMPLETED|Overall Study||44
7710667|NCT01735201|18987065|P4|COMPLETED|Overall Study||42
7710668|NCT01735201|18987066|P3|COMPLETED|Overall Study||44
7710669|NCT01735201|18987067|P2|COMPLETED|Overall Study||43
7710670|NCT01735201|18987068|P1|COMPLETED|Overall Study||42
7710671|NCT01735201|18987061|P8|STARTED|Overall Study||44
7710672|NCT01735201|18987062|P7|STARTED|Overall Study||45
7710673|NCT01735201|18987063|P6|STARTED|Overall Study||45
7710674|NCT01735201|18987064|P5|STARTED|Overall Study||45
7710675|NCT01735201|18987065|P4|STARTED|Overall Study||44
7710676|NCT01735201|18987066|P3|STARTED|Overall Study||44
7710677|NCT01735201|18987067|P2|STARTED|Overall Study||44
7710678|NCT01735201|18987068|P1|STARTED|Overall Study||45
7710679|NCT01735175|18987104|P2|NOT COMPLETED|Overall Study||13
7710680|NCT01735175|18987105|P1|NOT COMPLETED|Overall Study||29
7710681|NCT01735175|18987104|P2|COMPLETED|Overall Study||144
7710682|NCT01735175|18987105|P1|COMPLETED|Overall Study||130
7710683|NCT01735175|18987104|P2|Completed the 6-month SFU Visit|Overall Study||138
7710684|NCT01735175|18987105|P1|Completed the 6-month SFU Visit|Overall Study||120
7710685|NCT01735175|18987104|P2|Completed All Treatments as Planned|Overall Study||150
7710686|NCT01735175|18987105|P1|Completed All Treatments as Planned|Overall Study||140
7710687|NCT01735175|18987104|P2|Completed All Cycles|Overall Study||150
7710688|NCT01735175|18987105|P1|Completed All Cycles|Overall Study||141
7710689|NCT01735175|18987104|P2|STARTED|Overall Study||157
7710690|NCT01735175|18987105|P1|STARTED|Overall Study||159
7710691|NCT01734993|18987125|P1|NOT COMPLETED|Overall Study||2
7710692|NCT01734993|18987125|P1|COMPLETED|Overall Study||9
7710693|NCT01734993|18987125|P1|STARTED|Overall Study||11
7710694|NCT01734902|18987153|P2|NOT COMPLETED|Overall Study||2
7710695|NCT01734902|18987154|P1|NOT COMPLETED|Overall Study||0
7710696|NCT01734902|18987153|P2|COMPLETED|Overall Study||14
7710697|NCT01734902|18987154|P1|COMPLETED|Overall Study||14
7710698|NCT01734902|18987153|P2|STARTED|Overall Study||16
7710699|NCT01734902|18987154|P1|STARTED|Overall Study||14
7710700|NCT01734889|18987164|P1|NOT COMPLETED|Overall Study||0
7710701|NCT01734889|18987164|P1|COMPLETED|Overall Study||18
7710702|NCT01734889|18987164|P1|STARTED|Overall Study||18
7710703|NCT01734850|18987175|P3|NOT COMPLETED|Overall Study||4
7710704|NCT01734850|18987176|P2|NOT COMPLETED|Overall Study||2
7710705|NCT01734850|18987177|P1|NOT COMPLETED|Overall Study||3
7710706|NCT01734850|18987175|P3|COMPLETED|Overall Study||1
7710707|NCT01734850|18987176|P2|COMPLETED|Overall Study||2
7710708|NCT01734850|18987177|P1|COMPLETED|Overall Study||1
7710709|NCT01734850|18987175|P3|STARTED|Overall Study||5
7710710|NCT01734850|18987176|P2|STARTED|Overall Study||4
7710711|NCT01734850|18987177|P1|STARTED|Overall Study||4
7710712|NCT01734811|18987234|P2|NOT COMPLETED|Overall Study||3
7710713|NCT01734811|18987235|P1|NOT COMPLETED|Overall Study||4
7710714|NCT01734811|18987234|P2|COMPLETED|Overall Study||59
7710715|NCT01734811|18987235|P1|COMPLETED|Overall Study||54
7710716|NCT01734811|18987234|P2|STARTED|Overall Study||62
7710717|NCT01734811|18987235|P1|STARTED|Overall Study||58
7710718|NCT01734785|18987262|P4|NOT COMPLETED|Double-Blind Period||0
7710719|NCT01734785|18987263|P3|NOT COMPLETED|Double-Blind Period||5
7710720|NCT01734785|18987264|P2|NOT COMPLETED|Double-Blind Period||9
7710721|NCT01734785|18987265|P1|NOT COMPLETED|Double-Blind Period||5
7710722|NCT01734785|18987262|P4|COMPLETED|Double-Blind Period||0
7710723|NCT01734785|18987263|P3|COMPLETED|Double-Blind Period||105
7710724|NCT01734785|18987264|P2|COMPLETED|Double-Blind Period||103
7710725|NCT01734785|18987265|P1|COMPLETED|Double-Blind Period||106
7710726|NCT01734785|18987262|P4|STARTED|Double-Blind Period||0
7710727|NCT01734785|18987263|P3|STARTED|Double-Blind Period||110
7710728|NCT01734785|18987264|P2|STARTED|Double-Blind Period||112
7710729|NCT01734785|18987265|P1|STARTED|Double-Blind Period||111
7710730|NCT01734785|18987262|P4|NOT COMPLETED|Open-Label Period||273
7710731|NCT01734785|18987263|P3|NOT COMPLETED|Open-Label Period||0
7710732|NCT01734785|18987264|P2|NOT COMPLETED|Open-Label Period||0
7710733|NCT01734785|18987265|P1|NOT COMPLETED|Open-Label Period||0
7710734|NCT01734785|18987262|P4|COMPLETED|Open-Label Period||333
7710735|NCT01734785|18987263|P3|COMPLETED|Open-Label Period||0
7710736|NCT01734785|18987264|P2|COMPLETED|Open-Label Period||0
7710737|NCT01734785|18987265|P1|COMPLETED|Open-Label Period||0
7710738|NCT01734785|18987262|P4|STARTED|Open-Label Period||606
7710739|NCT01734785|18987263|P3|STARTED|Open-Label Period||0
7710740|NCT01734785|18987264|P2|STARTED|Open-Label Period||0
7710741|NCT01734785|18987265|P1|STARTED|Open-Label Period||0
7710742|NCT01734772|18987282|P2|NOT COMPLETED|Overall Study||3
7710743|NCT01734772|18987283|P1|NOT COMPLETED|Overall Study||1
7710744|NCT01734772|18987282|P2|COMPLETED|Overall Study||21
7710745|NCT01734772|18987283|P1|COMPLETED|Overall Study||23
7710746|NCT01734772|18987282|P2|STARTED|Overall Study||24
7710747|NCT01734772|18987283|P1|STARTED|Overall Study||24
7710748|NCT01734746|18987300|P1|NOT COMPLETED|Overall Study||1
7710749|NCT01734746|18987300|P1|COMPLETED|Overall Study||21
7710750|NCT01734746|18987300|P1|STARTED|Overall Study||22
7710751|NCT01734655|18987306|P1|NOT COMPLETED|Overall Study||0
7710752|NCT01734655|18987306|P1|COMPLETED|Overall Study||40
7710753|NCT01734655|18987306|P1|STARTED|Overall Study||40
7710754|NCT01734551|18987317|P2|NOT COMPLETED|Overall Study||0
7710755|NCT01734551|18987318|P1|NOT COMPLETED|Overall Study||0
7710756|NCT01734551|18987317|P2|COMPLETED|Overall Study||16
7710757|NCT01734551|18987318|P1|COMPLETED|Overall Study||15
7710758|NCT01734551|18987317|P2|STARTED|Overall Study||16
7710759|NCT01734551|18987318|P1|STARTED|Overall Study||15
7710760|NCT01734525|18987330|P1|NOT COMPLETED|Overall Study||0
7710761|NCT01734525|18987330|P1|COMPLETED|Overall Study||85
7710762|NCT01734525|18987330|P1|STARTED|Overall Study||85
7710763|NCT01734434|18987338|P4|NOT COMPLETED|Overall Study||23
7710764|NCT01734434|18987339|P3|NOT COMPLETED|Overall Study||129
7710765|NCT01734434|18987340|P2|NOT COMPLETED|Overall Study||12
7710766|NCT01734434|18987341|P1|NOT COMPLETED|Overall Study||10
7710767|NCT01734434|18987338|P4|COMPLETED|Overall Study||228
7710768|NCT01734434|18987339|P3|COMPLETED|Overall Study||1863
7710769|NCT01734434|18987340|P2|COMPLETED|Overall Study||488
7710770|NCT01734434|18987341|P1|COMPLETED|Overall Study||490
7710771|NCT01734434|18987338|P4|STARTED|Overall Study||251
7710772|NCT01734434|18987339|P3|STARTED|Overall Study||1992
7710773|NCT01734434|18987340|P2|STARTED|Overall Study||500
7710774|NCT01734434|18987341|P1|STARTED|Overall Study||500
7710775|NCT01734395|18987363|P1|NOT COMPLETED|Overall Study||410
7710776|NCT01734395|18987363|P1|COMPLETED|Overall Study||1472
7710777|NCT01734395|18987363|P1|STARTED|Overall Study||1882
7710778|NCT01734382|18987372|P3|NOT COMPLETED|Part 2||7
7710779|NCT01734382|18987373|P2|NOT COMPLETED|Part 2||2
7710780|NCT01734382|18987374|P1|NOT COMPLETED|Part 2||0
7710781|NCT01734382|18987372|P3|COMPLETED|Part 2||8
7710782|NCT01734382|18987373|P2|COMPLETED|Part 2||5
7710783|NCT01734382|18987374|P1|COMPLETED|Part 2||0
7710784|NCT01734382|18987372|P3|STARTED|Part 2||15
7710785|NCT01734382|18987373|P2|STARTED|Part 2||7
7710786|NCT01734382|18987374|P1|STARTED|Part 2||0
7710787|NCT01734382|18987372|P3|NOT COMPLETED|Part 1||0
7710788|NCT01734382|18987373|P2|NOT COMPLETED|Part 1||0
7710789|NCT01734382|18987374|P1|NOT COMPLETED|Part 1||2
7710790|NCT01734382|18987372|P3|COMPLETED|Part 1||0
7710791|NCT01734382|18987373|P2|COMPLETED|Part 1||0
7710792|NCT01734382|18987374|P1|COMPLETED|Part 1||17
7710793|NCT01734382|18987372|P3|STARTED|Part 1||0
7710794|NCT01734382|18987373|P2|STARTED|Part 1||0
7710795|NCT01734382|18987374|P1|STARTED|Part 1||19
7710796|NCT01734317|18987434|P1|NOT COMPLETED|Overall Study||0
7710797|NCT01734317|18987434|P1|COMPLETED|Overall Study||10
7710798|NCT01734317|18987434|P1|STARTED|Overall Study||10
7710799|NCT01734239|18987441|P2|NOT COMPLETED|Overall Study||0
7710800|NCT01734239|18987442|P1|NOT COMPLETED|Overall Study||0
7710801|NCT01734239|18987441|P2|COMPLETED|Overall Study||50
7710802|NCT01734239|18987442|P1|COMPLETED|Overall Study||52
7710803|NCT01734239|18987441|P2|STARTED|Overall Study||50
7710804|NCT01734239|18987442|P1|STARTED|Overall Study||52
7710805|NCT01734161|18987457|P2|NOT COMPLETED|Overall Study||8
7710806|NCT01734161|18987458|P1|NOT COMPLETED|Overall Study||6
7710807|NCT01734161|18987457|P2|COMPLETED|Overall Study||53
7710808|NCT01734161|18987458|P1|COMPLETED|Overall Study||55
7710809|NCT01734161|18987457|P2|STARTED|Overall Study||61
7710810|NCT01734161|18987458|P1|STARTED|Overall Study||61
7710811|NCT01733953|18987466|P2|NOT COMPLETED|Overall Study||7
7710812|NCT01733953|18987467|P1|NOT COMPLETED|Overall Study||5
7710813|NCT01733953|18987466|P2|COMPLETED|Overall Study||6
7710814|NCT01733953|18987467|P1|COMPLETED|Overall Study||9
7710815|NCT01733953|18987466|P2|STARTED|Overall Study||13
7710816|NCT01733953|18987467|P1|STARTED|Overall Study||14
7710817|NCT01733758|18987487|P4|NOT COMPLETED|Overall Study||8
7710818|NCT01733758|18987488|P3|NOT COMPLETED|Overall Study||15
7710819|NCT01733758|18987489|P2|NOT COMPLETED|Overall Study||12
7710820|NCT01733758|18987490|P1|NOT COMPLETED|Overall Study||15
7710821|NCT01733758|18987487|P4|COMPLETED|Overall Study||95
7710822|NCT01733758|18987488|P3|COMPLETED|Overall Study||135
7710823|NCT01733758|18987489|P2|COMPLETED|Overall Study||148
7710824|NCT01733758|18987490|P1|COMPLETED|Overall Study||62
7710825|NCT01733758|18987487|P4|STARTED|Overall Study||103
7710826|NCT01733758|18987488|P3|STARTED|Overall Study||150
7710827|NCT01733758|18987489|P2|STARTED|Overall Study||160
7710828|NCT01733758|18987490|P1|STARTED|Overall Study||77
7710829|NCT01733745|18987543|P2|NOT COMPLETED|Overall Study||0
7710830|NCT01733745|18987544|P1|NOT COMPLETED|Overall Study||0
7710831|NCT01733745|18987543|P2|COMPLETED|Overall Study||13
7710832|NCT01733745|18987544|P1|COMPLETED|Overall Study||13
7710833|NCT01733745|18987543|P2|STARTED|Overall Study||13
7710834|NCT01733745|18987544|P1|STARTED|Overall Study||13
7710835|NCT01733732|18987556|P2|NOT COMPLETED|Overall Study||0
7710836|NCT01733732|18987557|P1|NOT COMPLETED|Overall Study||2
7710837|NCT01733732|18987556|P2|COMPLETED|Overall Study||27
7710838|NCT01733732|18987557|P1|COMPLETED|Overall Study||25
7710839|NCT01733732|18987556|P2|STARTED|Overall Study||27
7710840|NCT01733732|18987557|P1|STARTED|Overall Study||27
7710841|NCT01733680|18987593|P2|NOT COMPLETED|Overall Study||1
7710842|NCT01733680|18987594|P1|NOT COMPLETED|Overall Study||0
7710843|NCT01733680|18987593|P2|COMPLETED|Overall Study||0
7710844|NCT01733680|18987594|P1|COMPLETED|Overall Study||2
7710845|NCT01733680|18987593|P2|STARTED|Overall Study||1
7710846|NCT01733680|18987594|P1|STARTED|Overall Study||2
7710847|NCT01733628|18987604|P1|NOT COMPLETED|Overall Study||0
7710848|NCT01733628|18987604|P1|COMPLETED|Overall Study||143
7710849|NCT01733628|18987604|P1|STARTED|Overall Study||143
7710850|NCT01733472|18987613|P2|NOT COMPLETED|Overall Study||0
7710851|NCT01733472|18987614|P1|NOT COMPLETED|Overall Study||0
7710852|NCT01733472|18987613|P2|COMPLETED|Overall Study||60
7710853|NCT01733472|18987614|P1|COMPLETED|Overall Study||60
7710854|NCT01733472|18987613|P2|STARTED|Overall Study||60
7710855|NCT01733472|18987614|P1|STARTED|Overall Study||60
7710856|NCT01733407|18987626|P2|NOT COMPLETED|Overall Study||0
7710857|NCT01733407|18987627|P1|NOT COMPLETED|Overall Study||2
7710858|NCT01733407|18987626|P2|COMPLETED|Overall Study||9
7710859|NCT01733407|18987627|P1|COMPLETED|Overall Study||7
7710860|NCT01733407|18987626|P2|STARTED|Overall Study||9
7710861|NCT01733407|18987627|P1|STARTED|Overall Study||9
7710862|NCT01733368|18987643|P1|NOT COMPLETED|Overall Study||31
7710863|NCT01733368|18987643|P1|COMPLETED|Overall Study||167
7710864|NCT01733368|18987643|P1|STARTED|Overall Study||198
7710865|NCT01733329|18987653|P2|NOT COMPLETED|Overall Study||1
7710866|NCT01733329|18987654|P1|NOT COMPLETED|Overall Study||2
7710867|NCT01733329|18987653|P2|COMPLETED|Overall Study||60
7710868|NCT01733329|18987654|P1|COMPLETED|Overall Study||60
7710869|NCT01733329|18987653|P2|STARTED|Overall Study||61
7710870|NCT01733329|18987654|P1|STARTED|Overall Study||62
7710871|NCT01733316|18987666|P1|NOT COMPLETED|Long Term Extension Phase||5
7710872|NCT01733316|18987666|P1|COMPLETED|Long Term Extension Phase||33
7710873|NCT01733316|18987666|P1|STARTED|Long Term Extension Phase|Two participants did not enter the long term follow up period.|38
7710874|NCT01733316|18987666|P1|NOT COMPLETED|RP103 Phase||1
7710875|NCT01733316|18987666|P1|COMPLETED|RP103 Phase||40
7710876|NCT01733316|18987666|P1|STARTED|RP103 Phase||41
7710877|NCT01733316|18987666|P1|NOT COMPLETED|Cystagon® Phase||0
7710878|NCT01733316|18987666|P1|COMPLETED|Cystagon® Phase||41
7710879|NCT01733316|18987666|P1|STARTED|Cystagon® Phase||41
7710880|NCT01733277|18987682|P2|NOT COMPLETED|Overall Study||0
7710881|NCT01733277|18987683|P1|NOT COMPLETED|Overall Study||0
7710882|NCT01733277|18987682|P2|COMPLETED|Overall Study||25
7710883|NCT01733277|18987683|P1|COMPLETED|Overall Study||25
7710884|NCT01733277|18987682|P2|STARTED|Overall Study||25
7710885|NCT01733277|18987683|P1|STARTED|Overall Study||25
7710886|NCT01733238|18987693|P1|NOT COMPLETED|Overall Study||5
7710887|NCT01733238|18987693|P1|COMPLETED|Overall Study|8 subjects completed the Induction Phase and 7 subjects started Maintenance Phase|8
7710888|NCT01733238|18987693|P1|STARTED|Overall Study||13
7710889|NCT01733212|18987700|P2|NOT COMPLETED|Overall Study||0
7710890|NCT01733212|18987701|P1|NOT COMPLETED|Overall Study||0
7710891|NCT01733212|18987700|P2|COMPLETED|Overall Study||123
7710892|NCT01733212|18987701|P1|COMPLETED|Overall Study||116
7710893|NCT01733212|18987700|P2|STARTED|Overall Study||123
7710894|NCT01733212|18987701|P1|STARTED|Overall Study||116
7710895|NCT01733121|18987709|P2|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
7710896|NCT01733121|18987710|P1|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
7710897|NCT01733121|18987709|P2|COMPLETED|Follow-Up Period (Week 6 to 8)||46
7710898|NCT01733121|18987710|P1|COMPLETED|Follow-Up Period (Week 6 to 8)||44
7710899|NCT01733121|18987709|P2|STARTED|Follow-Up Period (Week 6 to 8)||46
7710900|NCT01733121|18987710|P1|STARTED|Follow-Up Period (Week 6 to 8)||44
7710901|NCT01733121|18987709|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||5
7710902|NCT01733121|18987710|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
7710903|NCT01733121|18987709|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||46
7710904|NCT01733121|18987710|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||44
7710905|NCT01733121|18987709|P2|STARTED|Double-Blind Period (Week 0 to 6)||51
7710906|NCT01733121|18987710|P1|STARTED|Double-Blind Period (Week 0 to 6)||51
7710907|NCT01733069|18987724|P2|NOT COMPLETED|Overall Study||0
7710908|NCT01733069|18987725|P1|NOT COMPLETED|Overall Study||0
7710909|NCT01733069|18987724|P2|COMPLETED|Overall Study||1598
7710910|NCT01733069|18987725|P1|COMPLETED|Overall Study||264
7710911|NCT01733069|18987724|P2|STARTED|Overall Study||1598
7710912|NCT01733069|18987725|P1|STARTED|Overall Study||264
7710913|NCT01733056|18987734|P3|NOT COMPLETED|Overall Study||0
7710914|NCT01733056|18987735|P2|NOT COMPLETED|Overall Study||0
7710915|NCT01733056|18987736|P1|NOT COMPLETED|Overall Study||0
7710916|NCT01733056|18987734|P3|COMPLETED|Overall Study||12
7710917|NCT01733056|18987735|P2|COMPLETED|Overall Study||10
7710918|NCT01733056|18987736|P1|COMPLETED|Overall Study||21
7710919|NCT01733056|18987734|P3|STARTED|Overall Study||12
7710920|NCT01733056|18987735|P2|STARTED|Overall Study||10
7710921|NCT01733056|18987736|P1|STARTED|Overall Study||21
7710922|NCT01732926|18987752|P2|NOT COMPLETED|Overall Study||110
7710923|NCT01732926|18987753|P1|NOT COMPLETED|Overall Study||267
7710924|NCT01732926|18987752|P2|COMPLETED|Overall Study||45
7710925|NCT01732926|18987753|P1|COMPLETED|Overall Study||53
7710926|NCT01732926|18987752|P2|STARTED|Overall Study||155
7710927|NCT01732926|18987753|P1|STARTED|Overall Study||320
7710928|NCT01732913|18987769|P2|NOT COMPLETED|Overall Study||69
7710929|NCT01732913|18987770|P1|NOT COMPLETED|Overall Study||156
7710930|NCT01732913|18987769|P2|COMPLETED|Overall Study||28
7710931|NCT01732913|18987770|P1|COMPLETED|Overall Study||42
7710932|NCT01732913|18987769|P2|STARTED|Overall Study||97
7710933|NCT01732913|18987770|P1|STARTED|Overall Study||198
7710934|NCT01732835|18987784|P1|NOT COMPLETED|2-year Extended Follow-up||5
7710935|NCT01732835|18987784|P1|COMPLETED|2-year Extended Follow-up||39
7710936|NCT01732835|18987784|P1|STARTED|2-year Extended Follow-up||44
7710937|NCT01732835|18987784|P1|NOT COMPLETED|6-month Primary Endpoint||24
7710938|NCT01732835|18987784|P1|COMPLETED|6-month Primary Endpoint||44
7710939|NCT01732835|18987784|P1|STARTED|6-month Primary Endpoint||68
7710940|NCT01732822|18987817|P2|NOT COMPLETED|Overall Study||113
7710941|NCT01732822|18987818|P1|NOT COMPLETED|Overall Study||123
7710942|NCT01732822|18987817|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6842
7710943|NCT01732822|18987818|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6807
7710944|NCT01732822|18987817|P2|STARTED|Overall Study||6955
7710945|NCT01732822|18987818|P1|STARTED|Overall Study||6930
7710946|NCT01732809|18987890|P2|NOT COMPLETED|Overall Study||1
7710947|NCT01732809|18987891|P1|NOT COMPLETED|Overall Study||0
7710948|NCT01732809|18987890|P2|COMPLETED|Overall Study||9
7710949|NCT01732809|18987891|P1|COMPLETED|Overall Study||9
7710950|NCT01732809|18987890|P2|STARTED|Overall Study||10
7710951|NCT01732809|18987891|P1|STARTED|Overall Study||9
7710952|NCT01732796|18987910|P3|NOT COMPLETED|Overall Study||13
7710953|NCT01732796|18987911|P2|NOT COMPLETED|Overall Study||42
7710954|NCT01732796|18987912|P1|NOT COMPLETED|Overall Study||46
7710955|NCT01732796|18987910|P3|COMPLETED|Overall Study||38
7710956|NCT01732796|18987911|P2|COMPLETED|Overall Study||169
7710957|NCT01732796|18987912|P1|COMPLETED|Overall Study||162
7710958|NCT01732796|18987910|P3|STARTED|Overall Study||51
7710959|NCT01732796|18987911|P2|STARTED|Overall Study||211
7710960|NCT01732796|18987912|P1|STARTED|Overall Study||208
7710961|NCT01732783|18987931|P3|NOT COMPLETED|Overall Study||10
7710962|NCT01732783|18987932|P2|NOT COMPLETED|Overall Study||32
7710963|NCT01732783|18987933|P1|NOT COMPLETED|Overall Study||135
7710964|NCT01732783|18987931|P3|COMPLETED|Overall Study|Completed 12-month observation period.|2
7710965|NCT01732783|18987932|P2|COMPLETED|Overall Study|Completed 12-month observation period.|5
7710966|NCT01732783|18987933|P1|COMPLETED|Overall Study|Completed 12-month observation period.|29
7710967|NCT01732783|18987931|P3|STARTED|Overall Study||12
7710968|NCT01732783|18987932|P2|STARTED|Overall Study||37
7710969|NCT01732783|18987933|P1|STARTED|Overall Study||164
7710970|NCT01732770|18987997|P2|NOT COMPLETED|Overall Study||8
7710971|NCT01732770|18987998|P1|NOT COMPLETED|Overall Study||10
7710972|NCT01732770|18987997|P2|COMPLETED|Overall Study||313
7710973|NCT01732770|18987998|P1|COMPLETED|Overall Study||312
7710974|NCT01732770|18987997|P2|Received Study Treatment|Overall Study||320
7710975|NCT01732770|18987998|P1|Received Study Treatment|Overall Study||320
7710976|NCT01732770|18987997|P2|STARTED|Overall Study||321
7710977|NCT01732770|18987998|P1|STARTED|Overall Study||322
7710978|NCT01732757|18988013|P3|NOT COMPLETED|Overall Study||0
7710979|NCT01732757|18988014|P2|NOT COMPLETED|Overall Study||0
7710980|NCT01732757|18988015|P1|NOT COMPLETED|Overall Study||1
7710981|NCT01732757|18988013|P3|COMPLETED|Overall Study||52
7710982|NCT01732757|18988014|P2|COMPLETED|Overall Study||52
7710983|NCT01732757|18988015|P1|COMPLETED|Overall Study||52
7710984|NCT01732757|18988013|P3|STARTED|Overall Study||52
7710985|NCT01732757|18988014|P2|STARTED|Overall Study||52
7710986|NCT01732757|18988015|P1|STARTED|Overall Study||53
7710987|NCT01732718|18988053|P2|NOT COMPLETED|Second Intervention||0
7710988|NCT01732718|18988054|P1|NOT COMPLETED|Second Intervention||0
7710989|NCT01732718|18988053|P2|COMPLETED|Second Intervention||6
7710990|NCT01732718|18988054|P1|COMPLETED|Second Intervention||7
7710991|NCT01732718|18988053|P2|STARTED|Second Intervention||6
7710992|NCT01732718|18988054|P1|STARTED|Second Intervention||7
7710993|NCT01732718|18988053|P2|NOT COMPLETED|Washout (4 Weeks)||0
7710994|NCT01732718|18988054|P1|NOT COMPLETED|Washout (4 Weeks)||0
7710995|NCT01732718|18988053|P2|COMPLETED|Washout (4 Weeks)||6
7710996|NCT01732718|18988054|P1|COMPLETED|Washout (4 Weeks)||7
7710997|NCT01732718|18988053|P2|STARTED|Washout (4 Weeks)||6
7710998|NCT01732718|18988054|P1|STARTED|Washout (4 Weeks)||7
7710999|NCT01732718|18988053|P2|NOT COMPLETED|First Intervention||0
7711000|NCT01732718|18988054|P1|NOT COMPLETED|First Intervention||0
7711001|NCT01732718|18988053|P2|COMPLETED|First Intervention||6
7711002|NCT01732718|18988054|P1|COMPLETED|First Intervention||7
7711003|NCT01732718|18988053|P2|STARTED|First Intervention||6
7711004|NCT01732718|18988054|P1|STARTED|First Intervention||7
7711005|NCT01732692|18988092|P2|NOT COMPLETED|Overall Study||1
7711006|NCT01732692|18988093|P1|NOT COMPLETED|Overall Study||0
7711007|NCT01732692|18988092|P2|COMPLETED|Overall Study||69
7711008|NCT01732692|18988093|P1|COMPLETED|Overall Study||70
7711009|NCT01732692|18988092|P2|STARTED|Overall Study||70
7711010|NCT01732692|18988093|P1|STARTED|Overall Study||70
7711011|NCT01732640|18988107|P2|NOT COMPLETED|Overall Study||2
7711012|NCT01732640|18988108|P1|NOT COMPLETED|Overall Study||0
7711013|NCT01732640|18988107|P2|COMPLETED|Overall Study||1
7711014|NCT01732640|18988108|P1|COMPLETED|Overall Study||6
7711015|NCT01732640|18988107|P2|STARTED|Overall Study||3
7711016|NCT01732640|18988108|P1|STARTED|Overall Study||6
7711017|NCT01732627|18988125|P2|NOT COMPLETED|Overall Study||0
7711018|NCT01732627|18988126|P1|NOT COMPLETED|Overall Study||1
7711019|NCT01732627|18988125|P2|COMPLETED|Overall Study||100
7711020|NCT01732627|18988126|P1|COMPLETED|Overall Study||200
7711021|NCT01732627|18988125|P2|Safety Analysis Set (SafAS)|Overall Study||100
7711022|NCT01732627|18988126|P1|Safety Analysis Set (SafAS)|Overall Study||199
7711023|NCT01732627|18988125|P2|STARTED|Overall Study||100
7711024|NCT01732627|18988126|P1|STARTED|Overall Study||201
7711025|NCT01732588|18988159|P3|NOT COMPLETED|Third Intervention (7 Days)||0
7711026|NCT01732588|18988160|P2|NOT COMPLETED|Third Intervention (7 Days)||0
7711027|NCT01732588|18988161|P1|NOT COMPLETED|Third Intervention (7 Days)||0
7711028|NCT01732588|18988159|P3|COMPLETED|Third Intervention (7 Days)||4
7711029|NCT01732588|18988160|P2|COMPLETED|Third Intervention (7 Days)||2
7711030|NCT01732588|18988161|P1|COMPLETED|Third Intervention (7 Days)||4
7711031|NCT01732588|18988159|P3|STARTED|Third Intervention (7 Days)||4
7711032|NCT01732588|18988160|P2|STARTED|Third Intervention (7 Days)||2
7711033|NCT01732588|18988161|P1|STARTED|Third Intervention (7 Days)||4
7711034|NCT01732588|18988159|P3|NOT COMPLETED|Second Intervention (7 Days)||0
7711035|NCT01732588|18988160|P2|NOT COMPLETED|Second Intervention (7 Days)||0
7711036|NCT01732588|18988161|P1|NOT COMPLETED|Second Intervention (7 Days)||0
7711037|NCT01732588|18988159|P3|COMPLETED|Second Intervention (7 Days)||4
7711038|NCT01732588|18988160|P2|COMPLETED|Second Intervention (7 Days)||2
7711039|NCT01732588|18988161|P1|COMPLETED|Second Intervention (7 Days)||4
7711040|NCT01732588|18988159|P3|STARTED|Second Intervention (7 Days)||4
7711041|NCT01732588|18988160|P2|STARTED|Second Intervention (7 Days)||2
7711042|NCT01732588|18988161|P1|STARTED|Second Intervention (7 Days)||4
7711043|NCT01732588|18988159|P3|NOT COMPLETED|First Intervention (7 Days)||0
7711044|NCT01732588|18988160|P2|NOT COMPLETED|First Intervention (7 Days)||1
7711045|NCT01732588|18988161|P1|NOT COMPLETED|First Intervention (7 Days)||0
7711046|NCT01732588|18988159|P3|COMPLETED|First Intervention (7 Days)||4
7711047|NCT01732588|18988160|P2|COMPLETED|First Intervention (7 Days)||2
7711048|NCT01732588|18988161|P1|COMPLETED|First Intervention (7 Days)||4
7711049|NCT01732588|18988159|P3|STARTED|First Intervention (7 Days)||4
7711050|NCT01732588|18988160|P2|STARTED|First Intervention (7 Days)||3
7711051|NCT01732588|18988161|P1|STARTED|First Intervention (7 Days)||4
7711052|NCT01732549|18988177|P2|NOT COMPLETED|Overall Study||73
7711053|NCT01732549|18988178|P1|NOT COMPLETED|Overall Study||71
7711054|NCT01732549|18988177|P2|COMPLETED|Overall Study||0
7711055|NCT01732549|18988178|P1|COMPLETED|Overall Study||0
7711056|NCT01732549|18988177|P2|Withdrawn During Treatment:Final Analysi|Overall Study||73
7711057|NCT01732549|18988178|P1|Withdrawn During Treatment:Final Analysi|Overall Study||71
7711058|NCT01732549|18988177|P2|Ongoing Treatment Period:Final Analysis|Overall Study||0
7711059|NCT01732549|18988178|P1|Ongoing Treatment Period:Final Analysis|Overall Study||0
7711060|NCT01732549|18988177|P2|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61
7711061|NCT01732549|18988178|P1|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59
7711062|NCT01732549|18988177|P2|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
7711063|NCT01732549|18988178|P1|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
7711064|NCT01732549|18988177|P2|STARTED|Overall Study||73
7711065|NCT01732549|18988178|P1|STARTED|Overall Study||71
7711066|NCT01732536|18988200|P2|NOT COMPLETED|Overall Study||1
7711067|NCT01732536|18988201|P1|NOT COMPLETED|Overall Study||1
7711068|NCT01732536|18988200|P2|COMPLETED|Overall Study||46
7711069|NCT01732536|18988201|P1|COMPLETED|Overall Study||52
7711070|NCT01732536|18988200|P2|STARTED|Overall Study||47
7711071|NCT01732536|18988201|P1|STARTED|Overall Study||53
7711072|NCT01732510|18988224|P7|NOT COMPLETED|Overall Study||8
7711073|NCT01732510|18988225|P6|NOT COMPLETED|Overall Study||13
7711074|NCT01732510|18988226|P5|NOT COMPLETED|Overall Study||5
7711075|NCT01732510|18988227|P4|NOT COMPLETED|Overall Study||5
7711076|NCT01732510|18988228|P3|NOT COMPLETED|Overall Study||4
7711077|NCT01732510|18988229|P2|NOT COMPLETED|Overall Study||5
7711078|NCT01732510|18988230|P1|NOT COMPLETED|Overall Study||1
7711079|NCT01732510|18988224|P7|COMPLETED|Overall Study||0
7711080|NCT01732510|18988225|P6|COMPLETED|Overall Study||0
7711081|NCT01732510|18988226|P5|COMPLETED|Overall Study||3
7711082|NCT01732510|18988227|P4|COMPLETED|Overall Study||5
7711083|NCT01732510|18988228|P3|COMPLETED|Overall Study||4
7711084|NCT01732510|18988229|P2|COMPLETED|Overall Study||4
7711085|NCT01732510|18988230|P1|COMPLETED|Overall Study||8
7711086|NCT01732510|18988224|P7|STARTED|Overall Study||8
7711087|NCT01732510|18988225|P6|STARTED|Overall Study||13
7711088|NCT01732510|18988226|P5|STARTED|Overall Study||8
7711089|NCT01732510|18988227|P4|STARTED|Overall Study||10
7711090|NCT01732510|18988228|P3|STARTED|Overall Study||8
7711091|NCT01732510|18988229|P2|STARTED|Overall Study||9
7711092|NCT01732510|18988230|P1|STARTED|Overall Study||9
7711093|NCT01732484|18988309|P1|NOT COMPLETED|Overall Study||26
7711094|NCT01732484|18988309|P1|COMPLETED|Overall Study||74
7711095|NCT01732484|18988309|P1|Allocation|Overall Study||100
7711096|NCT01732484|18988309|P1|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100
7711097|NCT01732484|18988309|P1|STARTED|Overall Study||100
7711098|NCT01732471|18988317|P1|NOT COMPLETED|Overall Study||1
7711099|NCT01732471|18988317|P1|COMPLETED|Overall Study||89
7711100|NCT01732471|18988317|P1|STARTED|Overall Study||90
7711101|NCT01732458|18988328|P4|NOT COMPLETED|Overall Study||2
7711102|NCT01732458|18988329|P3|NOT COMPLETED|Overall Study||3
7711103|NCT01732458|18988330|P2|NOT COMPLETED|Overall Study||5
7711104|NCT01732458|18988331|P1|NOT COMPLETED|Overall Study||3
7711105|NCT01732458|18988328|P4|COMPLETED|Overall Study||50
7711106|NCT01732458|18988329|P3|COMPLETED|Overall Study||55
7711107|NCT01732458|18988330|P2|COMPLETED|Overall Study||53
7711108|NCT01732458|18988331|P1|COMPLETED|Overall Study||57
7711109|NCT01732458|18988328|P4|Treated|Overall Study||52
7711110|NCT01732458|18988329|P3|Treated|Overall Study||56
7711111|NCT01732458|18988330|P2|Treated|Overall Study||55
7711112|NCT01732458|18988331|P1|Treated|Overall Study||57
7711113|NCT01732458|18988328|P4|STARTED|Overall Study||52
7711114|NCT01732458|18988329|P3|STARTED|Overall Study||58
7711115|NCT01732458|18988330|P2|STARTED|Overall Study||58
7711116|NCT01732458|18988331|P1|STARTED|Overall Study||60
7711117|NCT01732445|18988393|P1|NOT COMPLETED|Overall Study||0
7711118|NCT01732445|18988393|P1|COMPLETED|Overall Study||14
7711119|NCT01732445|18988393|P1|STARTED|Overall Study||14
7711120|NCT01732419|18988402|P2|NOT COMPLETED|Overall Study||4
7711121|NCT01732419|18988403|P1|NOT COMPLETED|Overall Study||8
7711122|NCT01732419|18988402|P2|COMPLETED|Overall Study||41
7711123|NCT01732419|18988403|P1|COMPLETED|Overall Study||37
7711124|NCT01732419|18988402|P2|STARTED|Overall Study||45
7711125|NCT01732419|18988403|P1|STARTED|Overall Study||45
7711126|NCT01732406|18988420|P3|NOT COMPLETED|Overall Study||0
7711127|NCT01732406|18988421|P2|NOT COMPLETED|Overall Study||0
7711128|NCT01732406|18988422|P1|NOT COMPLETED|Overall Study||0
7711129|NCT01732406|18988420|P3|COMPLETED|Overall Study||35
7711130|NCT01732406|18988421|P2|COMPLETED|Overall Study||60
7711131|NCT01732406|18988422|P1|COMPLETED|Overall Study||31
7711132|NCT01732406|18988420|P3|STARTED|Overall Study||35
7711133|NCT01732406|18988421|P2|STARTED|Overall Study||60
7711134|NCT01732406|18988422|P1|STARTED|Overall Study||31
7711135|NCT01732263|18988441|P2|NOT COMPLETED|Overall Study||0
7711136|NCT01732263|18988442|P1|NOT COMPLETED|Overall Study||0
7711137|NCT01732263|18988441|P2|COMPLETED|Overall Study||20
7711138|NCT01732263|18988442|P1|COMPLETED|Overall Study||23
7711139|NCT01732263|18988441|P2|STARTED|Overall Study||20
7711140|NCT01732263|18988442|P1|STARTED|Overall Study||23
7711141|NCT01732211|18988482|P1|NOT COMPLETED|Overall Study||0
7711142|NCT01732211|18988482|P1|COMPLETED|Overall Study||1
7711143|NCT01732211|18988482|P1|STARTED|Overall Study||1
7711144|NCT01732107|18988493|P1|NOT COMPLETED|Overall Study||13
7711145|NCT01732107|18988493|P1|COMPLETED|Overall Study||0
7711146|NCT01732107|18988493|P1|STARTED|Overall Study||13
7711147|NCT01731990|18988510|P2|NOT COMPLETED|Overall Study||8
7711148|NCT01731990|18988511|P1|NOT COMPLETED|Overall Study||4
7711149|NCT01731990|18988510|P2|COMPLETED|Overall Study||12
7711150|NCT01731990|18988511|P1|COMPLETED|Overall Study||14
7711151|NCT01731990|18988510|P2|STARTED|Overall Study||20
7711152|NCT01731990|18988511|P1|STARTED|Overall Study|"Started indicates Safety and Pharmacodynamics set ."|18
7711153|NCT01731938|18988527|P2|NOT COMPLETED|Primary Part II||13
7711154|NCT01731938|18988528|P1|NOT COMPLETED|Primary Part II||13
7711155|NCT01731938|18988527|P2|COMPLETED|Primary Part II||95
7711156|NCT01731938|18988528|P1|COMPLETED|Primary Part II||103
7711157|NCT01731938|18988527|P2|STARTED|Primary Part II|Subjects from Preliminary Part I were not carried over to Primary Part II to assess safety/efficacy.|108
7711158|NCT01731938|18988528|P1|STARTED|Primary Part II|Preliminary Part I was for study team familiarization with FS Grifols application.|116
7711159|NCT01731938|18988527|P2|NOT COMPLETED|Preliminary Part I||8
7711160|NCT01731938|18988528|P1|NOT COMPLETED|Preliminary Part I||3
7711161|NCT01731938|18988527|P2|COMPLETED|Preliminary Part I||44
7711162|NCT01731938|18988528|P1|COMPLETED|Preliminary Part I||48
7711163|NCT01731938|18988527|P2|STARTED|Preliminary Part I||52
7711164|NCT01731938|18988528|P1|STARTED|Preliminary Part I||51
7711165|NCT01731912|18988540|P1|NOT COMPLETED|Overall Study||2
7711166|NCT01731912|18988540|P1|COMPLETED|Overall Study||14
7711167|NCT01731912|18988540|P1|STARTED|Overall Study||16
7711168|NCT01731886|18988547|P2|NOT COMPLETED|Overall Study||1
7711169|NCT01731886|18988548|P1|NOT COMPLETED|Overall Study||2
7711170|NCT01731886|18988547|P2|COMPLETED|Overall Study||28
7711171|NCT01731886|18988548|P1|COMPLETED|Overall Study||29
7711172|NCT01731886|18988547|P2|STARTED|Overall Study||29
7711173|NCT01731886|18988548|P1|STARTED|Overall Study||31
7711174|NCT01731691|18988565|P3|NOT COMPLETED|Overall Study||0
7711175|NCT01731691|18988566|P2|NOT COMPLETED|Overall Study||0
7711176|NCT01731691|18988567|P1|NOT COMPLETED|Overall Study||0
7711177|NCT01731691|18988565|P3|COMPLETED|Overall Study||4
7711178|NCT01731691|18988566|P2|COMPLETED|Overall Study||5
7711179|NCT01731691|18988567|P1|COMPLETED|Overall Study||3
7711180|NCT01731691|18988565|P3|STARTED|Overall Study||4
7711181|NCT01731691|18988566|P2|STARTED|Overall Study||5
7711182|NCT01731691|18988567|P1|STARTED|Overall Study||3
7711183|NCT01731678|18988593|P1|NOT COMPLETED|Overall Study||7
7711184|NCT01731678|18988593|P1|COMPLETED|Overall Study||32
7711185|NCT01731678|18988593|P1|STARTED|Overall Study||39
7711186|NCT01731600|18988599|P2|NOT COMPLETED|Overall Study||0
7711187|NCT01731600|18988600|P1|NOT COMPLETED|Overall Study||6
7711188|NCT01731600|18988599|P2|COMPLETED|Overall Study||34
7711189|NCT01731600|18988600|P1|COMPLETED|Overall Study||28
7711190|NCT01731600|18988599|P2|STARTED|Overall Study||34
7711191|NCT01731600|18988600|P1|STARTED|Overall Study||34
7711192|NCT01731470|18988654|P1|NOT COMPLETED|Overall Study||2
7711193|NCT01731470|18988654|P1|COMPLETED|Overall Study|Number of patients enrolled in the study|14
7711194|NCT01731470|18988654|P1|STARTED|Overall Study|Number of patients consented to participate in the study|16
7711195|NCT01731171|18988661|P2|NOT COMPLETED|Overall Study||7
7711196|NCT01731171|18988662|P1|NOT COMPLETED|Overall Study||7
7711197|NCT01731171|18988661|P2|COMPLETED|Overall Study||26
7711198|NCT01731171|18988662|P1|COMPLETED|Overall Study||26
7711199|NCT01731171|18988661|P2|STARTED|Overall Study||33
7711200|NCT01731171|18988662|P1|STARTED|Overall Study||33
7711201|NCT01731119|18988674|P1|NOT COMPLETED|Overall Study||2
7711202|NCT01731119|18988674|P1|COMPLETED|Overall Study||7
7711203|NCT01731119|18988674|P1|STARTED|Overall Study||9
7711204|NCT01731041|18988684|P2|NOT COMPLETED|Overall Study||0
7711205|NCT01731041|18988685|P1|NOT COMPLETED|Overall Study||0
7711206|NCT01731041|18988684|P2|COMPLETED|Overall Study||30
7711207|NCT01731041|18988685|P1|COMPLETED|Overall Study||30
7711208|NCT01731041|18988684|P2|STARTED|Overall Study||30
7711209|NCT01731041|18988685|P1|STARTED|Overall Study||30
7711210|NCT01731002|18988696|P3|NOT COMPLETED|Overall Study||3
7711211|NCT01731002|18988697|P2|NOT COMPLETED|Overall Study||4
7711212|NCT01731002|18988698|P1|NOT COMPLETED|Overall Study||4
7711213|NCT01731002|18988696|P3|COMPLETED|Overall Study||74
7711214|NCT01731002|18988697|P2|COMPLETED|Overall Study||68
7711215|NCT01731002|18988698|P1|COMPLETED|Overall Study||71
7711216|NCT01731002|18988696|P3|STARTED|Overall Study||77
7711217|NCT01731002|18988697|P2|STARTED|Overall Study||72
7711218|NCT01731002|18988698|P1|STARTED|Overall Study||75
7711219|NCT01730950|18988711|P2|NOT COMPLETED|Overall Study||6
7711220|NCT01730950|18988712|P1|NOT COMPLETED|Overall Study||6
7711221|NCT01730950|18988711|P2|COMPLETED|Overall Study||86
7711222|NCT01730950|18988712|P1|COMPLETED|Overall Study||84
7711223|NCT01730950|18988711|P2|Delayed Toxicity Population|Overall Study||83
7711224|NCT01730950|18988712|P1|Delayed Toxicity Population|Overall Study||0
7711225|NCT01730950|18988711|P2|6-month Progression-free Analysis|Overall Study||81
7711226|NCT01730950|18988712|P1|6-month Progression-free Analysis|Overall Study||79
7711227|NCT01730950|18988711|P2|Response Population|Overall Study||77
7711228|NCT01730950|18988712|P1|Response Population|Overall Study||78
7711229|NCT01730950|18988711|P2|Adverse Event Population|Overall Study||83
7711230|NCT01730950|18988712|P1|Adverse Event Population|Overall Study||76
7711231|NCT01730950|18988711|P2|Eligible Population|Overall Study||86
7711232|NCT01730950|18988712|P1|Eligible Population|Overall Study||84
7711233|NCT01730950|18988711|P2|STARTED|Overall Study||92
7711234|NCT01730950|18988712|P1|STARTED|Overall Study||90
7711235|NCT01730872|18988729|P3|NOT COMPLETED|Overall Study||0
7711236|NCT01730872|18988730|P2|NOT COMPLETED|Overall Study||0
7711237|NCT01730872|18988731|P1|NOT COMPLETED|Overall Study||0
7711238|NCT01730872|18988729|P3|COMPLETED|Overall Study||3
7711239|NCT01730872|18988730|P2|COMPLETED|Overall Study||5
7711240|NCT01730872|18988731|P1|COMPLETED|Overall Study||8
7711241|NCT01730872|18988729|P3|Full Analysis Set|Overall Study||0
7711242|NCT01730872|18988730|P2|Full Analysis Set|Overall Study|1 subject did not complete the last post-CAE measurement on Day 6 and was excluded from the FAS|4
7711243|NCT01730872|18988731|P1|Full Analysis Set|Overall Study||8
7711244|NCT01730872|18988729|P3|STARTED|Overall Study||3
7711245|NCT01730872|18988730|P2|STARTED|Overall Study||5
7711246|NCT01730872|18988731|P1|STARTED|Overall Study||8
7711247|NCT01730846|18988745|P3|NOT COMPLETED|Overall Study||0
7711248|NCT01730846|18988746|P2|NOT COMPLETED|Overall Study||0
7711249|NCT01730846|18988747|P1|NOT COMPLETED|Overall Study||0
7711250|NCT01730846|18988745|P3|COMPLETED|Overall Study||13
7711251|NCT01730846|18988746|P2|COMPLETED|Overall Study||11
7711252|NCT01730846|18988747|P1|COMPLETED|Overall Study||11
7711253|NCT01730846|18988745|P3|STARTED|Overall Study||13
7711254|NCT01730846|18988746|P2|STARTED|Overall Study||11
7711255|NCT01730846|18988747|P1|STARTED|Overall Study||11
7711256|NCT01730729|18988758|P1|NOT COMPLETED|Overall Study||14
7711257|NCT01730729|18988758|P1|COMPLETED|Overall Study||6
7711258|NCT01730729|18988758|P1|Treated Cycle 3 and Beyond|Overall Study||6
7711259|NCT01730729|18988758|P1|Completed 2 Cycles/Reached 1st Response|Overall Study||18
7711260|NCT01730729|18988758|P1|STARTED|Overall Study||20
7711261|NCT01730586|18988772|P1|NOT COMPLETED|Overall Study||13
7711262|NCT01730586|18988772|P1|COMPLETED|Overall Study||21
7711263|NCT01730586|18988772|P1|STARTED|Overall Study||34
7711264|NCT01730534|18988781|P2|NOT COMPLETED|Overall Study||145
7711265|NCT01730534|18988782|P1|NOT COMPLETED|Overall Study||109
7711266|NCT01730534|18988781|P2|COMPLETED|Overall Study||8433
7711267|NCT01730534|18988782|P1|COMPLETED|Overall Study||8473
7711268|NCT01730534|18988781|P2|STARTED|Overall Study||8578
7711269|NCT01730534|18988782|P1|STARTED|Overall Study||8582
7711270|NCT01730378|18988796|P2|NOT COMPLETED|Overall Study||0
7711271|NCT01730378|18988797|P1|NOT COMPLETED|Overall Study||1
7711272|NCT01730378|18988796|P2|COMPLETED|Overall Study||47
7711273|NCT01730378|18988797|P1|COMPLETED|Overall Study||83
7711274|NCT01730378|18988796|P2|STARTED|Overall Study||47
7711275|NCT01730378|18988797|P1|STARTED|Overall Study||84
7711276|NCT01730339|18988828|P2|NOT COMPLETED|Overall Study||3
7711277|NCT01730339|18988829|P1|NOT COMPLETED|Overall Study||5
7711278|NCT01730339|18988828|P2|COMPLETED|Overall Study||52
7711279|NCT01730339|18988829|P1|COMPLETED|Overall Study||40
7711280|NCT01730339|18988828|P2|STARTED|Overall Study||55
7711281|NCT01730339|18988829|P1|STARTED|Overall Study||45
7711282|NCT01730053|18988869|P6|NOT COMPLETED|Overall Study||13
7711283|NCT01730053|18988870|P5|NOT COMPLETED|Overall Study||9
7711284|NCT01730053|18988871|P4|NOT COMPLETED|Overall Study||8
7711285|NCT01730053|18988872|P3|NOT COMPLETED|Overall Study||11
7711286|NCT01730053|18988873|P2|NOT COMPLETED|Overall Study||14
7711287|NCT01730053|18988874|P1|NOT COMPLETED|Overall Study||5
7711288|NCT01730053|18988869|P6|COMPLETED|Overall Study||41
7711289|NCT01730053|18988870|P5|COMPLETED|Overall Study||44
7711290|NCT01730053|18988871|P4|COMPLETED|Overall Study||45
7711291|NCT01730053|18988872|P3|COMPLETED|Overall Study||38
7711292|NCT01730053|18988873|P2|COMPLETED|Overall Study||34
7711293|NCT01730053|18988874|P1|COMPLETED|Overall Study||43
7711294|NCT01730053|18988869|P6|Treated|Overall Study||54
7711295|NCT01730053|18988870|P5|Treated|Overall Study||53
7711296|NCT01730053|18988871|P4|Treated|Overall Study||53
7711297|NCT01730053|18988872|P3|Treated|Overall Study||49
7711298|NCT01730053|18988873|P2|Treated|Overall Study||48
7711299|NCT01730053|18988874|P1|Treated|Overall Study||48
7711300|NCT01730053|18988869|P6|STARTED|Overall Study||54
7711301|NCT01730053|18988870|P5|STARTED|Overall Study||53
7711302|NCT01730053|18988871|P4|STARTED|Overall Study||53
7711303|NCT01730053|18988872|P3|STARTED|Overall Study||49
7711304|NCT01730053|18988873|P2|STARTED|Overall Study||48
7711305|NCT01730053|18988874|P1|STARTED|Overall Study||48
7711306|NCT01730040|18989033|P7|NOT COMPLETED|Overall Study||9
7711307|NCT01730040|18989034|P6|NOT COMPLETED|Overall Study||7
7711308|NCT01730040|18989035|P5|NOT COMPLETED|Overall Study||6
7711309|NCT01730040|18989036|P4|NOT COMPLETED|Overall Study||8
7711310|NCT01730040|18989037|P3|NOT COMPLETED|Overall Study||11
7711311|NCT01730040|18989038|P2|NOT COMPLETED|Overall Study||15
7711312|NCT01730040|18989039|P1|NOT COMPLETED|Overall Study||13
7711313|NCT01730040|18989033|P7|COMPLETED|Overall Study||38
7711314|NCT01730040|18989034|P6|COMPLETED|Overall Study||40
7711315|NCT01730040|18989035|P5|COMPLETED|Overall Study||39
7711316|NCT01730040|18989036|P4|COMPLETED|Overall Study||39
7711317|NCT01730040|18989037|P3|COMPLETED|Overall Study||46
7711318|NCT01730040|18989038|P2|COMPLETED|Overall Study||40
7711319|NCT01730040|18989039|P1|COMPLETED|Overall Study||44
7711320|NCT01730040|18989033|P7|Treated|Overall Study||47
7711321|NCT01730040|18989034|P6|Treated|Overall Study||46
7711322|NCT01730040|18989035|P5|Treated|Overall Study||45
7711323|NCT01730040|18989036|P4|Treated|Overall Study||47
7711324|NCT01730040|18989037|P3|Treated|Overall Study||57
7711325|NCT01730040|18989038|P2|Treated|Overall Study||55
7711326|NCT01730040|18989039|P1|Treated|Overall Study||57
7711327|NCT01730040|18989033|P7|STARTED|Overall Study||47
7711328|NCT01730040|18989034|P6|STARTED|Overall Study||47
7711329|NCT01730040|18989035|P5|STARTED|Overall Study||45
7711330|NCT01730040|18989036|P4|STARTED|Overall Study||47
7711331|NCT01730040|18989037|P3|STARTED|Overall Study||57
7711332|NCT01730040|18989038|P2|STARTED|Overall Study||55
7711333|NCT01730040|18989039|P1|STARTED|Overall Study||57
7711334|NCT01729923|18989216|P1|NOT COMPLETED|Overall Study||27
7711335|NCT01729923|18989216|P1|COMPLETED|Overall Study||0
7711336|NCT01729923|18989216|P1|STARTED|Overall Study||27
7711337|NCT01729871|18989228|P2|NOT COMPLETED|Overall Study||23
7711338|NCT01729871|18989229|P1|NOT COMPLETED|Overall Study||12
7711339|NCT01729871|18989228|P2|COMPLETED|Overall Study||101
7711340|NCT01729871|18989229|P1|COMPLETED|Overall Study||112
7711341|NCT01729871|18989228|P2|STARTED|Overall Study||124
7711342|NCT01729871|18989229|P1|STARTED|Overall Study||124
7711343|NCT01729845|18989248|P3|NOT COMPLETED|Efficacy of Dec/MEC||0
7711344|NCT01729845|18989249|P2|NOT COMPLETED|Efficacy of Dec/MEC||0
7711345|NCT01729845|18989250|P1|NOT COMPLETED|Efficacy of Dec/MEC||0
7711346|NCT01729845|18989248|P3|COMPLETED|Efficacy of Dec/MEC||0
7711347|NCT01729845|18989249|P2|COMPLETED|Efficacy of Dec/MEC||22
7711348|NCT01729845|18989250|P1|COMPLETED|Efficacy of Dec/MEC||0
7711349|NCT01729845|18989248|P3|STARTED|Efficacy of Dec/MEC||0
7711350|NCT01729845|18989249|P2|STARTED|Efficacy of Dec/MEC||22
7711351|NCT01729845|18989250|P1|STARTED|Efficacy of Dec/MEC||0
7711352|NCT01729845|18989248|P3|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
7711353|NCT01729845|18989249|P2|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
7711354|NCT01729845|18989250|P1|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
7711355|NCT01729845|18989248|P3|COMPLETED|Safety/Tolerability of Dec/MEC||12
7711356|NCT01729845|18989249|P2|COMPLETED|Safety/Tolerability of Dec/MEC||34
7711357|NCT01729845|18989250|P1|COMPLETED|Safety/Tolerability of Dec/MEC||6
7711358|NCT01729845|18989248|P3|STARTED|Safety/Tolerability of Dec/MEC||12
7711359|NCT01729845|18989249|P2|STARTED|Safety/Tolerability of Dec/MEC||34
7711360|NCT01729845|18989250|P1|STARTED|Safety/Tolerability of Dec/MEC||6
7711361|NCT01729819|18989263|P2|NOT COMPLETED|Overall Study||7
7711362|NCT01729819|18989264|P1|NOT COMPLETED|Overall Study||6
7711363|NCT01729819|18989263|P2|COMPLETED|Overall Study||50
7711364|NCT01729819|18989264|P1|COMPLETED|Overall Study||43
7711365|NCT01729819|18989263|P2|STARTED|Overall Study||57
7711366|NCT01729819|18989264|P1|STARTED|Overall Study||49
7711367|NCT01729754|18989283|P10|NOT COMPLETED|Part 3||7
7711368|NCT01729754|18989284|P9|NOT COMPLETED|Part 3||1
7711369|NCT01729754|18989285|P8|NOT COMPLETED|Part 3||3
7711370|NCT01729754|18989286|P7|NOT COMPLETED|Part 3||0
7711371|NCT01729754|18989287|P6|NOT COMPLETED|Part 3||13
7711372|NCT01729754|18989288|P5|NOT COMPLETED|Part 3||4
7711373|NCT01729754|18989289|P4|NOT COMPLETED|Part 3||0
7711374|NCT01729754|18989290|P3|NOT COMPLETED|Part 3||5
7711375|NCT01729754|18989291|P2|NOT COMPLETED|Part 3||5
7711376|NCT01729754|18989292|P1|NOT COMPLETED|Part 3||0
7711377|NCT01729754|18989283|P10|COMPLETED|Part 3||114
7711378|NCT01729754|18989284|P9|COMPLETED|Part 3||65
7711379|NCT01729754|18989285|P8|COMPLETED|Part 3||66
7711380|NCT01729754|18989286|P7|COMPLETED|Part 3||0
7711381|NCT01729754|18989287|P6|COMPLETED|Part 3||224
7711382|NCT01729754|18989288|P5|COMPLETED|Part 3||17
7711383|NCT01729754|18989289|P4|COMPLETED|Part 3||0
7711384|NCT01729754|18989290|P3|COMPLETED|Part 3||105
7711385|NCT01729754|18989291|P2|COMPLETED|Part 3||165
7711386|NCT01729754|18989292|P1|COMPLETED|Part 3||0
7711387|NCT01729754|18989283|P10|STARTED|Part 3|156 participants completed Part 2 but did not enter Part 3|121
7711388|NCT01729754|18989284|P9|STARTED|Part 3||66
7711389|NCT01729754|18989285|P8|STARTED|Part 3||69
7711390|NCT01729754|18989286|P7|STARTED|Part 3||0
7711391|NCT01729754|18989287|P6|STARTED|Part 3|31 participants completed Part 2 but did not enter Part 3|237
7711392|NCT01729754|18989288|P5|STARTED|Part 3||21
7711393|NCT01729754|18989289|P4|STARTED|Part 3||0
7711394|NCT01729754|18989290|P3|STARTED|Part 3||110
7711395|NCT01729754|18989291|P2|STARTED|Part 3|14 participants completed Part 2 but did not enter Part 3|170
7711396|NCT01729754|18989292|P1|STARTED|Part 3||0
7711397|NCT01729754|18989283|P10|NOT COMPLETED|Part 2||12
7711398|NCT01729754|18989284|P9|NOT COMPLETED|Part 2||4
7711399|NCT01729754|18989285|P8|NOT COMPLETED|Part 2||3
7711400|NCT01729754|18989286|P7|NOT COMPLETED|Part 2||0
7711401|NCT01729754|18989287|P6|NOT COMPLETED|Part 2||0
7711402|NCT01729754|18989288|P5|NOT COMPLETED|Part 2||0
7711403|NCT01729754|18989289|P4|NOT COMPLETED|Part 2||5
7711404|NCT01729754|18989290|P3|NOT COMPLETED|Part 2||0
7711405|NCT01729754|18989291|P2|NOT COMPLETED|Part 2||0
7711406|NCT01729754|18989292|P1|NOT COMPLETED|Part 2||6
7711407|NCT01729754|18989283|P10|COMPLETED|Part 2||277
7711408|NCT01729754|18989284|P9|COMPLETED|Part 2||66
7711409|NCT01729754|18989285|P8|COMPLETED|Part 2||69
7711410|NCT01729754|18989286|P7|COMPLETED|Part 2||0
7711411|NCT01729754|18989287|P6|COMPLETED|Part 2||268
7711412|NCT01729754|18989288|P5|COMPLETED|Part 2||21
7711413|NCT01729754|18989289|P4|COMPLETED|Part 2||0
7711414|NCT01729754|18989290|P3|COMPLETED|Part 2||110
7711415|NCT01729754|18989291|P2|COMPLETED|Part 2||184
7711416|NCT01729754|18989292|P1|COMPLETED|Part 2||0
7711417|NCT01729754|18989283|P10|STARTED|Part 2||289
7711418|NCT01729754|18989284|P9|STARTED|Part 2||70
7711419|NCT01729754|18989285|P8|STARTED|Part 2||72
7711420|NCT01729754|18989286|P7|STARTED|Part 2||0
7711421|NCT01729754|18989287|P6|STARTED|Part 2||268
7711422|NCT01729754|18989288|P5|STARTED|Part 2||21
7711423|NCT01729754|18989289|P4|STARTED|Part 2|1 participant completed Part 1 but did not enter Part 2|5
7711424|NCT01729754|18989290|P3|STARTED|Part 2||110
7711425|NCT01729754|18989291|P2|STARTED|Part 2||184
7711426|NCT01729754|18989292|P1|STARTED|Part 2||6
7711427|NCT01729754|18989283|P10|NOT COMPLETED|Part 1||24
7711428|NCT01729754|18989284|P9|NOT COMPLETED|Part 1||0
7711429|NCT01729754|18989285|P8|NOT COMPLETED|Part 1||0
7711430|NCT01729754|18989286|P7|NOT COMPLETED|Part 1||14
7711431|NCT01729754|18989287|P6|NOT COMPLETED|Part 1||0
7711432|NCT01729754|18989288|P5|NOT COMPLETED|Part 1||0
7711433|NCT01729754|18989289|P4|NOT COMPLETED|Part 1||12
7711434|NCT01729754|18989290|P3|NOT COMPLETED|Part 1||0
7711435|NCT01729754|18989291|P2|NOT COMPLETED|Part 1||0
7711436|NCT01729754|18989292|P1|NOT COMPLETED|Part 1||14
7711437|NCT01729754|18989283|P10|COMPLETED|Part 1||289
7711438|NCT01729754|18989284|P9|COMPLETED|Part 1||70
7711439|NCT01729754|18989285|P8|COMPLETED|Part 1||72
7711440|NCT01729754|18989286|P7|COMPLETED|Part 1||0
7711441|NCT01729754|18989287|P6|COMPLETED|Part 1||268
7711442|NCT01729754|18989288|P5|COMPLETED|Part 1||21
7711443|NCT01729754|18989289|P4|COMPLETED|Part 1||6
7711444|NCT01729754|18989290|P3|COMPLETED|Part 1||110
7711445|NCT01729754|18989291|P2|COMPLETED|Part 1||184
7711446|NCT01729754|18989292|P1|COMPLETED|Part 1||6
7711447|NCT01729754|18989283|P10|STARTED|Part 1||313
7711448|NCT01729754|18989284|P9|STARTED|Part 1||70
7711449|NCT01729754|18989285|P8|STARTED|Part 1||72
7711450|NCT01729754|18989286|P7|STARTED|Part 1||14
7711451|NCT01729754|18989287|P6|STARTED|Part 1||268
7711452|NCT01729754|18989288|P5|STARTED|Part 1||21
7711453|NCT01729754|18989289|P4|STARTED|Part 1||18
7711454|NCT01729754|18989290|P3|STARTED|Part 1||110
7711455|NCT01729754|18989291|P2|STARTED|Part 1||184
7711456|NCT01729754|18989292|P1|STARTED|Part 1||20
7711457|NCT01729728|18989499|P3|NOT COMPLETED|Overall Study||1
7711458|NCT01729728|18989500|P2|NOT COMPLETED|Overall Study||6
7711459|NCT01729728|18989501|P1|NOT COMPLETED|Overall Study||1
7711460|NCT01729728|18989499|P3|COMPLETED|Overall Study||16
7711461|NCT01729728|18989500|P2|COMPLETED|Overall Study||22
7711462|NCT01729728|18989501|P1|COMPLETED|Overall Study||20
7711463|NCT01729728|18989499|P3|STARTED|Overall Study||17
7711464|NCT01729728|18989500|P2|STARTED|Overall Study||28
7711465|NCT01729728|18989501|P1|STARTED|Overall Study||21
7711466|NCT01729598|18989634|P2|NOT COMPLETED|Overall Study||0
7711467|NCT01729598|18989635|P1|NOT COMPLETED|Overall Study||0
7711468|NCT01729598|18989634|P2|COMPLETED|Overall Study||4
7711469|NCT01729598|18989635|P1|COMPLETED|Overall Study||10
7711470|NCT01729598|18989634|P2|STARTED|Overall Study||4
7711471|NCT01729598|18989635|P1|STARTED|Overall Study||10
7711472|NCT01729559|18989651|P2|NOT COMPLETED|Overall Study||28
7711473|NCT01729559|18989652|P1|NOT COMPLETED|Overall Study||31
7711474|NCT01729559|18989651|P2|COMPLETED|Overall Study||216
7711475|NCT01729559|18989652|P1|COMPLETED|Overall Study||220
7711476|NCT01729559|18989651|P2|STARTED|Overall Study||244
7711477|NCT01729559|18989652|P1|STARTED|Overall Study||251
7711478|NCT01729338|18989664|P1|NOT COMPLETED|Overall Study||2
7711479|NCT01729338|18989664|P1|COMPLETED|Overall Study||14
7711480|NCT01729338|18989664|P1|STARTED|Overall Study||16
7711481|NCT01729247|18989679|P1|NOT COMPLETED|Overall Study||0
7711482|NCT01729247|18989679|P1|COMPLETED|Overall Study||50
7711483|NCT01729247|18989679|P1|STARTED|Overall Study||50
7711484|NCT01729208|18989695|P2|NOT COMPLETED|36 Months Follow-up||4
7711485|NCT01729208|18989696|P1|NOT COMPLETED|36 Months Follow-up||3
7711486|NCT01729208|18989695|P2|COMPLETED|36 Months Follow-up||56
7711487|NCT01729208|18989696|P1|COMPLETED|36 Months Follow-up||52
7711488|NCT01729208|18989695|P2|STARTED|36 Months Follow-up||60
7711489|NCT01729208|18989696|P1|STARTED|36 Months Follow-up||55
7711490|NCT01729208|18989695|P2|NOT COMPLETED|24 Months Follow-up||0
7711491|NCT01729208|18989696|P1|NOT COMPLETED|24 Months Follow-up||3
7711492|NCT01729208|18989695|P2|COMPLETED|24 Months Follow-up||60
7711493|NCT01729208|18989696|P1|COMPLETED|24 Months Follow-up||55
7711494|NCT01729208|18989695|P2|STARTED|24 Months Follow-up||60
7711495|NCT01729208|18989696|P1|STARTED|24 Months Follow-up||58
7711496|NCT01729208|18989695|P2|NOT COMPLETED|12 Months Follow-up||10
7711497|NCT01729208|18989696|P1|NOT COMPLETED|12 Months Follow-up||7
7711498|NCT01729208|18989695|P2|COMPLETED|12 Months Follow-up||60
7711499|NCT01729208|18989696|P1|COMPLETED|12 Months Follow-up||58
7711500|NCT01729208|18989695|P2|STARTED|12 Months Follow-up||70
7711501|NCT01729208|18989696|P1|STARTED|12 Months Follow-up||65
7711502|NCT01729208|18989695|P2|NOT COMPLETED|Baseline||4
7711503|NCT01729208|18989696|P1|NOT COMPLETED|Baseline||5
7711504|NCT01729208|18989695|P2|COMPLETED|Baseline||70
7711505|NCT01729208|18989696|P1|COMPLETED|Baseline||65
7711506|NCT01729208|18989695|P2|STARTED|Baseline||74
7711507|NCT01729208|18989696|P1|STARTED|Baseline||70
7711508|NCT01729156|18989729|P3|NOT COMPLETED|Overall Study||0
7711509|NCT01729156|18989730|P2|NOT COMPLETED|Overall Study||0
7711510|NCT01729156|18989731|P1|NOT COMPLETED|Overall Study||1
7711511|NCT01729156|18989729|P3|COMPLETED|Overall Study||12
7711512|NCT01729156|18989730|P2|COMPLETED|Overall Study||12
7711513|NCT01729156|18989731|P1|COMPLETED|Overall Study||11
7711514|NCT01729156|18989729|P3|STARTED|Overall Study||12
7711515|NCT01729156|18989730|P2|STARTED|Overall Study||12
7711516|NCT01729156|18989731|P1|STARTED|Overall Study||12
7711517|NCT01729039|18989759|P2|NOT COMPLETED|Overall Study||12
7711518|NCT01729039|18989760|P1|NOT COMPLETED|Overall Study||10
7711519|NCT01729039|18989759|P2|COMPLETED|Overall Study||14
7711520|NCT01729039|18989760|P1|COMPLETED|Overall Study||13
7711521|NCT01729039|18989759|P2|STARTED|Overall Study||26
7711522|NCT01729039|18989760|P1|STARTED|Overall Study||23
7711523|NCT01729026|18989776|P2|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2
7711524|NCT01729026|18989777|P1|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1
7711525|NCT01729026|18989776|P2|COMPLETED|3-month to 6-month (Final) Follow-up||6
7711526|NCT01729026|18989777|P1|COMPLETED|3-month to 6-month (Final) Follow-up||6
7711527|NCT01729026|18989776|P2|STARTED|3-month to 6-month (Final) Follow-up||8
7711528|NCT01729026|18989777|P1|STARTED|3-month to 6-month (Final) Follow-up||7
7711529|NCT01729026|18989776|P2|NOT COMPLETED|Randomization to 3-month Follow-up||2
7711530|NCT01729026|18989777|P1|NOT COMPLETED|Randomization to 3-month Follow-up||2
7711531|NCT01729026|18989776|P2|COMPLETED|Randomization to 3-month Follow-up||8
7711532|NCT01729026|18989777|P1|COMPLETED|Randomization to 3-month Follow-up||7
7711533|NCT01729026|18989776|P2|STARTED|Randomization to 3-month Follow-up||10
7711534|NCT01729026|18989777|P1|STARTED|Randomization to 3-month Follow-up||9
7711535|NCT01728844|18989809|P4|NOT COMPLETED|Overall Study||2
7711536|NCT01728844|18989810|P3|NOT COMPLETED|Overall Study||0
7711537|NCT01728844|18989811|P2|NOT COMPLETED|Overall Study||0
7711538|NCT01728844|18989812|P1|NOT COMPLETED|Overall Study||1
7711539|NCT01728844|18989809|P4|COMPLETED|Overall Study||21
7711540|NCT01728844|18989810|P3|COMPLETED|Overall Study||22
7711541|NCT01728844|18989811|P2|COMPLETED|Overall Study||21
7711542|NCT01728844|18989812|P1|COMPLETED|Overall Study||21
7711543|NCT01728844|18989809|P4|STARTED|Overall Study||23
7711544|NCT01728844|18989810|P3|STARTED|Overall Study||22
7711545|NCT01728844|18989811|P2|STARTED|Overall Study||21
7711546|NCT01728844|18989812|P1|STARTED|Overall Study||22
7711547|NCT01728805|18989860|P3|NOT COMPLETED|Crossover Period||0
7711548|NCT01728805|18989861|P2|NOT COMPLETED|Crossover Period||0
7711549|NCT01728805|18989862|P1|NOT COMPLETED|Crossover Period||0
7711550|NCT01728805|18989860|P3|COMPLETED|Crossover Period||136
7711551|NCT01728805|18989861|P2|COMPLETED|Crossover Period||0
7711552|NCT01728805|18989862|P1|COMPLETED|Crossover Period||0
7711553|NCT01728805|18989860|P3|STARTED|Crossover Period||136
7711554|NCT01728805|18989861|P2|STARTED|Crossover Period||0
7711555|NCT01728805|18989862|P1|STARTED|Crossover Period||0
7711556|NCT01728805|18989860|P3|NOT COMPLETED|Randomization Period||0
7711557|NCT01728805|18989861|P2|NOT COMPLETED|Randomization Period||0
7711558|NCT01728805|18989862|P1|NOT COMPLETED|Randomization Period||0
7711559|NCT01728805|18989860|P3|COMPLETED|Randomization Period||0
7711560|NCT01728805|18989861|P2|COMPLETED|Randomization Period||186
7711561|NCT01728805|18989862|P1|COMPLETED|Randomization Period||186
7711562|NCT01728805|18989860|P3|STARTED|Randomization Period||0
7711563|NCT01728805|18989861|P2|STARTED|Randomization Period||186
7711564|NCT01728805|18989862|P1|STARTED|Randomization Period||186
7711565|NCT01728792|18989880|P5|NOT COMPLETED|Overall Study||0
7711566|NCT01728792|18989881|P4|NOT COMPLETED|Overall Study||3
7711567|NCT01728792|18989882|P3|NOT COMPLETED|Overall Study||4
7711568|NCT01728792|18989883|P2|NOT COMPLETED|Overall Study||2
7711569|NCT01728792|18989884|P1|NOT COMPLETED|Overall Study||3
7711570|NCT01728792|18989880|P5|COMPLETED|Overall Study||16
7711571|NCT01728792|18989881|P4|COMPLETED|Overall Study||14
7711572|NCT01728792|18989882|P3|COMPLETED|Overall Study||13
7711573|NCT01728792|18989883|P2|COMPLETED|Overall Study||14
7711574|NCT01728792|18989884|P1|COMPLETED|Overall Study||11
7711575|NCT01728792|18989880|P5|STARTED|Overall Study||16
7711576|NCT01728792|18989881|P4|STARTED|Overall Study||17
7711577|NCT01728792|18989882|P3|STARTED|Overall Study||17
7711578|NCT01728792|18989883|P2|STARTED|Overall Study||16
7711579|NCT01728792|18989884|P1|STARTED|Overall Study||14
7711580|NCT01728623|18989934|P1|NOT COMPLETED|Overall Study||28
7711581|NCT01728623|18989934|P1|COMPLETED|Overall Study||23
7711582|NCT01728623|18989934|P1|ATC|Overall Study||17
7711583|NCT01728623|18989934|P1|MTC|Overall Study||9
7711584|NCT01728623|18989934|P1|DTC|Overall Study||25
7711585|NCT01728623|18989934|P1|STARTED|Overall Study||51
7711586|NCT01728584|18989960|P4|NOT COMPLETED|Overall Study||1
7711587|NCT01728584|18989961|P3|NOT COMPLETED|Overall Study||1
7711588|NCT01728584|18989962|P2|NOT COMPLETED|Overall Study||0
7711589|NCT01728584|18989963|P1|NOT COMPLETED|Overall Study||8
7711590|NCT01728584|18989960|P4|COMPLETED|Overall Study||29
7711591|NCT01728584|18989961|P3|COMPLETED|Overall Study||30
7711592|NCT01728584|18989962|P2|COMPLETED|Overall Study||30
7711593|NCT01728584|18989963|P1|COMPLETED|Overall Study||28
7711594|NCT01728584|18989960|P4|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30
7711595|NCT01728584|18989961|P3|STARTED|Overall Study|Randomized|31
7711596|NCT01728584|18989962|P2|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30
7711597|NCT01728584|18989963|P1|STARTED|Overall Study|Randomized|36
7711598|NCT01728454|18990018|P3|NOT COMPLETED|Stage 3||4
7711599|NCT01728454|18990019|P2|NOT COMPLETED|Stage 3||4
7711600|NCT01728454|18990020|P1|NOT COMPLETED|Stage 3||3
7711601|NCT01728454|18990018|P3|COMPLETED|Stage 3||7
7711602|NCT01728454|18990019|P2|COMPLETED|Stage 3||1
7711603|NCT01728454|18990020|P1|COMPLETED|Stage 3||3
7711604|NCT01728454|18990018|P3|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|11
7711605|NCT01728454|18990019|P2|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|5
7711606|NCT01728454|18990020|P1|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|6
7711607|NCT01728454|18990018|P3|NOT COMPLETED|Stage 1 and 2||4
7711608|NCT01728454|18990019|P2|NOT COMPLETED|Stage 1 and 2||4
7711609|NCT01728454|18990020|P1|NOT COMPLETED|Stage 1 and 2||5
7711610|NCT01728454|18990018|P3|COMPLETED|Stage 1 and 2||19
7711611|NCT01728454|18990019|P2|COMPLETED|Stage 1 and 2||16
7711612|NCT01728454|18990020|P1|COMPLETED|Stage 1 and 2||12
7711613|NCT01728454|18990018|P3|STARTED|Stage 1 and 2||23
7711614|NCT01728454|18990019|P2|STARTED|Stage 1 and 2||20
7711615|NCT01728454|18990020|P1|STARTED|Stage 1 and 2||17
7711616|NCT01728376|18990070|P6|NOT COMPLETED|Overall Study||2
7711617|NCT01728376|18990071|P5|NOT COMPLETED|Overall Study||2
7711618|NCT01728376|18990072|P4|NOT COMPLETED|Overall Study||2
7711619|NCT01728376|18990073|P3|NOT COMPLETED|Overall Study||2
7711620|NCT01728376|18990074|P2|NOT COMPLETED|Overall Study||2
7711621|NCT01728376|18990075|P1|NOT COMPLETED|Overall Study||4
7711622|NCT01728376|18990070|P6|COMPLETED|Overall Study||5
7711623|NCT01728376|18990071|P5|COMPLETED|Overall Study||12
7711624|NCT01728376|18990072|P4|COMPLETED|Overall Study||7
7711625|NCT01728376|18990073|P3|COMPLETED|Overall Study||17
7711626|NCT01728376|18990074|P2|COMPLETED|Overall Study||9
7711627|NCT01728376|18990075|P1|COMPLETED|Overall Study||18
7711628|NCT01728376|18990070|P6|Treated|Overall Study||7
7711629|NCT01728376|18990071|P5|Treated|Overall Study||14
7711630|NCT01728376|18990072|P4|Treated|Overall Study||9
7711631|NCT01728376|18990073|P3|Treated|Overall Study||19
7711632|NCT01728376|18990074|P2|Treated|Overall Study||10
7711633|NCT01728376|18990075|P1|Treated|Overall Study||22
7711634|NCT01728376|18990070|P6|STARTED|Overall Study||7
7711635|NCT01728376|18990071|P5|STARTED|Overall Study||14
7711636|NCT01728376|18990072|P4|STARTED|Overall Study||9
7711637|NCT01728376|18990073|P3|STARTED|Overall Study||19
7711638|NCT01728376|18990074|P2|STARTED|Overall Study||11
7711639|NCT01728376|18990075|P1|STARTED|Overall Study||22
7711640|NCT01728337|18990137|P1|NOT COMPLETED|Overall Study||0
7711641|NCT01728337|18990137|P1|COMPLETED|Overall Study||80
7711642|NCT01728337|18990137|P1|STARTED|Overall Study||80
7711643|NCT01728324|18990148|P3|NOT COMPLETED|Termination of RBV||15
7711644|NCT01728324|18990149|P2|NOT COMPLETED|Termination of RBV||37
7711645|NCT01728324|18990150|P1|NOT COMPLETED|Termination of RBV||39
7711646|NCT01728324|18990148|P3|COMPLETED|Termination of RBV||57
7711647|NCT01728324|18990149|P2|COMPLETED|Termination of RBV||176
7711648|NCT01728324|18990150|P1|COMPLETED|Termination of RBV||172
7711649|NCT01728324|18990148|P3|STARTED|Termination of RBV||72
7711650|NCT01728324|18990149|P2|STARTED|Termination of RBV||213
7711651|NCT01728324|18990150|P1|STARTED|Termination of RBV||211
7711652|NCT01728324|18990148|P3|NOT COMPLETED|Termination of FDV||14
7711653|NCT01728324|18990149|P2|NOT COMPLETED|Termination of FDV||36
7711654|NCT01728324|18990150|P1|NOT COMPLETED|Termination of FDV||38
7711655|NCT01728324|18990148|P3|COMPLETED|Termination of FDV||58
7711656|NCT01728324|18990149|P2|COMPLETED|Termination of FDV||177
7711657|NCT01728324|18990150|P1|COMPLETED|Termination of FDV||173
7711658|NCT01728324|18990148|P3|STARTED|Termination of FDV||72
7711659|NCT01728324|18990149|P2|STARTED|Termination of FDV||213
7711660|NCT01728324|18990150|P1|STARTED|Termination of FDV||211
7711661|NCT01728324|18990148|P3|NOT COMPLETED|Termination of DBV||14
7711662|NCT01728324|18990149|P2|NOT COMPLETED|Termination of DBV||36
7711663|NCT01728324|18990150|P1|NOT COMPLETED|Termination of DBV||38
7711664|NCT01728324|18990148|P3|COMPLETED|Termination of DBV||58
7711665|NCT01728324|18990149|P2|COMPLETED|Termination of DBV||177
7711666|NCT01728324|18990150|P1|COMPLETED|Termination of DBV||173
7711667|NCT01728324|18990148|P3|STARTED|Termination of DBV||72
7711668|NCT01728324|18990149|P2|STARTED|Termination of DBV||213
7711669|NCT01728324|18990150|P1|STARTED|Termination of DBV||211
7711670|NCT01728246|18990171|P2|NOT COMPLETED|Overall Study||36
7711671|NCT01728246|18990172|P1|NOT COMPLETED|Overall Study||36
7711672|NCT01728246|18990171|P2|COMPLETED|Overall Study||195
7711673|NCT01728246|18990172|P1|COMPLETED|Overall Study||206
7711674|NCT01728246|18990171|P2|STARTED|Overall Study||231
7711675|NCT01728246|18990172|P1|STARTED|Overall Study||242
7711676|NCT01728194|18990190|P2|NOT COMPLETED|Overall Study||6
7711677|NCT01728194|18990191|P1|NOT COMPLETED|Overall Study||20
7711678|NCT01728194|18990190|P2|COMPLETED|Overall Study||61
7711679|NCT01728194|18990191|P1|COMPLETED|Overall Study||34
7711680|NCT01728194|18990190|P2|STARTED|Overall Study||67
7711681|NCT01728194|18990191|P1|STARTED|Overall Study||54
7711682|NCT01728116|18990201|P2|NOT COMPLETED|Overall Study||47
7711683|NCT01728116|18990202|P1|NOT COMPLETED|Overall Study||161
7711684|NCT01728116|18990201|P2|COMPLETED|Overall Study|Completed to Week 52|60
7711685|NCT01728116|18990202|P1|COMPLETED|Overall Study|Completed to Week 78|52
7711686|NCT01728116|18990201|P2|STARTED|Overall Study|Sham mITT subjects|107
7711687|NCT01728116|18990202|P1|STARTED|Overall Study|EndoBarrier mITT Subjects|213
7711688|NCT01728077|18990227|P2|NOT COMPLETED|Overall Study||5
7711689|NCT01728077|18990228|P1|NOT COMPLETED|Overall Study||8
7711690|NCT01728077|18990227|P2|COMPLETED|Overall Study||2
7711691|NCT01728077|18990228|P1|COMPLETED|Overall Study||11
7711692|NCT01728077|18990227|P2|STARTED|Overall Study||7
7711693|NCT01728077|18990228|P1|STARTED|Overall Study||19
7711694|NCT01727895|18990243|P2|NOT COMPLETED|Overall Study||0
7711695|NCT01727895|18990244|P1|NOT COMPLETED|Overall Study||0
7711696|NCT01727895|18990243|P2|COMPLETED|Overall Study||5
7711697|NCT01727895|18990244|P1|COMPLETED|Overall Study||10
7711698|NCT01727895|18990243|P2|STARTED|Overall Study||5
7711699|NCT01727895|18990244|P1|STARTED|Overall Study||10
7711700|NCT01727791|18990250|P1|NOT COMPLETED|Overall Study||0
7711701|NCT01727791|18990250|P1|COMPLETED|Overall Study||10
7711702|NCT01727791|18990250|P1|STARTED|Overall Study||10
7711703|NCT01727765|18990282|P2|NOT COMPLETED|Overall Study||0
7711704|NCT01727765|18990283|P1|NOT COMPLETED|Overall Study||0
7711705|NCT01727765|18990282|P2|COMPLETED|Overall Study||8
7711706|NCT01727765|18990283|P1|COMPLETED|Overall Study||8
7711707|NCT01727765|18990282|P2|STARTED|Overall Study||8
7711708|NCT01727765|18990283|P1|STARTED|Overall Study||8
7711709|NCT01727726|18990292|P3|NOT COMPLETED|Overall Study||20
7711710|NCT01727726|18990293|P2|NOT COMPLETED|Overall Study||14
7711711|NCT01727726|18990294|P1|NOT COMPLETED|Overall Study||26
7711712|NCT01727726|18990292|P3|COMPLETED|Overall Study||186
7711713|NCT01727726|18990293|P2|COMPLETED|Overall Study||86
7711714|NCT01727726|18990294|P1|COMPLETED|Overall Study||171
7711715|NCT01727726|18990292|P3|STARTED|Overall Study||206
7711716|NCT01727726|18990293|P2|STARTED|Overall Study||100
7711717|NCT01727726|18990294|P1|STARTED|Overall Study||197
7711718|NCT01727713|18990326|P1|NOT COMPLETED|Overall Study||35
7711719|NCT01727713|18990326|P1|COMPLETED|Overall Study||75
7711720|NCT01727713|18990326|P1|STARTED|Overall Study||110
7711721|NCT01727700|18990353|P3|NOT COMPLETED|Overall Study||2
7711722|NCT01727700|18990354|P2|NOT COMPLETED|Overall Study||10
7711723|NCT01727700|18990355|P1|NOT COMPLETED|Overall Study||2
7711724|NCT01727700|18990353|P3|COMPLETED|Overall Study||42
7711725|NCT01727700|18990354|P2|COMPLETED|Overall Study||35
7711726|NCT01727700|18990355|P1|COMPLETED|Overall Study||42
7711727|NCT01727700|18990353|P3|STARTED|Overall Study||44
7711728|NCT01727700|18990354|P2|STARTED|Overall Study||45
7711729|NCT01727700|18990355|P1|STARTED|Overall Study||44
7711730|NCT01727505|18990378|P2|NOT COMPLETED|Second 24 Hours||1
7711731|NCT01727505|18990379|P1|NOT COMPLETED|Second 24 Hours||0
7711732|NCT01727505|18990378|P2|COMPLETED|Second 24 Hours||10
7711733|NCT01727505|18990379|P1|COMPLETED|Second 24 Hours||14
7711734|NCT01727505|18990378|P2|STARTED|Second 24 Hours||11
7711735|NCT01727505|18990379|P1|STARTED|Second 24 Hours||14
7711736|NCT01727505|18990378|P2|NOT COMPLETED|First 24 Hours||1
7711737|NCT01727505|18990379|P1|NOT COMPLETED|First 24 Hours||0
7711738|NCT01727505|18990378|P2|COMPLETED|First 24 Hours||11
7711739|NCT01727505|18990379|P1|COMPLETED|First 24 Hours||14
7711740|NCT01727505|18990378|P2|STARTED|First 24 Hours||12
7711741|NCT01727505|18990379|P1|STARTED|First 24 Hours||14
7711742|NCT01727414|18990397|P2|NOT COMPLETED|Overall Study||0
7711743|NCT01727414|18990398|P1|NOT COMPLETED|Overall Study||3
7711744|NCT01727414|18990397|P2|COMPLETED|Overall Study||45
7711745|NCT01727414|18990398|P1|COMPLETED|Overall Study||123
7711746|NCT01727414|18990397|P2|STARTED|Overall Study||45
7711747|NCT01727414|18990398|P1|STARTED|Overall Study||126
7711748|NCT01727297|18990404|P2|NOT COMPLETED|Overall Study||51
7711749|NCT01727297|18990405|P1|NOT COMPLETED|Overall Study||102
7711750|NCT01727297|18990404|P2|COMPLETED|Overall Study||0
7711751|NCT01727297|18990405|P1|COMPLETED|Overall Study||293
7711752|NCT01727297|18990404|P2|STARTED|Overall Study||51
7711753|NCT01727297|18990405|P1|STARTED|Overall Study||395
7711754|NCT01727258|18990421|P3|NOT COMPLETED|Overall Study||1
7711755|NCT01727258|18990422|P2|NOT COMPLETED|Overall Study||3
7711756|NCT01727258|18990423|P1|NOT COMPLETED|Overall Study||2
7711757|NCT01727258|18990421|P3|COMPLETED|Overall Study||50
7711758|NCT01727258|18990422|P2|COMPLETED|Overall Study||48
7711759|NCT01727258|18990423|P1|COMPLETED|Overall Study||49
7711760|NCT01727258|18990421|P3|STARTED|Overall Study||51
7711761|NCT01727258|18990422|P2|STARTED|Overall Study||51
7711762|NCT01727258|18990423|P1|STARTED|Overall Study||51
7711763|NCT01727180|18990446|P1|NOT COMPLETED|Overall Study||0
7711764|NCT01727180|18990446|P1|COMPLETED|Overall Study||108
7711765|NCT01727180|18990446|P1|STARTED|Overall Study||108
7711766|NCT01727167|18990452|P2|NOT COMPLETED|Overall Study||0
7711767|NCT01727167|18990453|P1|NOT COMPLETED|Overall Study||0
7711768|NCT01727167|18990452|P2|COMPLETED|Overall Study||0
7711769|NCT01727167|18990453|P1|COMPLETED|Overall Study||1
7711770|NCT01727167|18990452|P2|STARTED|Overall Study||0
7711771|NCT01727167|18990453|P1|STARTED|Overall Study||1
7711772|NCT01727154|18990461|P1|NOT COMPLETED|Overall Study||59
7711773|NCT01727154|18990461|P1|COMPLETED|Overall Study||80
7711774|NCT01727154|18990461|P1|STARTED|Overall Study||139
7711775|NCT01727141|18990469|P4|NOT COMPLETED|Overall Study||15
7711776|NCT01727141|18990470|P3|NOT COMPLETED|Overall Study||3
7711777|NCT01727141|18990471|P2|NOT COMPLETED|Overall Study||9
7711778|NCT01727141|18990472|P1|NOT COMPLETED|Overall Study||5
7711779|NCT01727141|18990469|P4|COMPLETED|Overall Study||246
7711780|NCT01727141|18990470|P3|COMPLETED|Overall Study||258
7711781|NCT01727141|18990471|P2|COMPLETED|Overall Study||251
7711782|NCT01727141|18990472|P1|COMPLETED|Overall Study||255
7711783|NCT01727141|18990469|P4|Full Analysis Set|Overall Study||261
7711784|NCT01727141|18990470|P3|Full Analysis Set|Overall Study||261
7711785|NCT01727141|18990471|P2|Full Analysis Set|Overall Study||260
7711786|NCT01727141|18990472|P1|Full Analysis Set|Overall Study||258
7711787|NCT01727141|18990469|P4|Safety Set|Overall Study||260
7711788|NCT01727141|18990470|P3|Safety Set|Overall Study||262
7711789|NCT01727141|18990471|P2|Safety Set|Overall Study||260
7711790|NCT01727141|18990472|P1|Safety Set|Overall Study||258
7711791|NCT01727141|18990469|P4|STARTED|Overall Study||261
7711792|NCT01727141|18990470|P3|STARTED|Overall Study||261
7711793|NCT01727141|18990471|P2|STARTED|Overall Study||260
7711794|NCT01727141|18990472|P1|STARTED|Overall Study||260
7711795|NCT01727089|18990524|P2|NOT COMPLETED|Overall Study||0
7711796|NCT01727089|18990525|P1|NOT COMPLETED|Overall Study||0
7711797|NCT01727089|18990524|P2|COMPLETED|Overall Study||30
7711798|NCT01727089|18990525|P1|COMPLETED|Overall Study||29
7711799|NCT01727089|18990524|P2|STARTED|Overall Study||30
7711800|NCT01727089|18990525|P1|STARTED|Overall Study||29
7711801|NCT01727024|18990537|P2|NOT COMPLETED|Period 2||0
7711802|NCT01727024|18990538|P1|NOT COMPLETED|Period 2||0
7711803|NCT01727024|18990537|P2|COMPLETED|Period 2||64
7711804|NCT01727024|18990538|P1|COMPLETED|Period 2||68
7711805|NCT01727024|18990537|P2|STARTED|Period 2||64
7711806|NCT01727024|18990538|P1|STARTED|Period 2||68
7711807|NCT01727024|18990537|P2|NOT COMPLETED|Period 1||4
7711808|NCT01727024|18990538|P1|NOT COMPLETED|Period 1||3
7711809|NCT01727024|18990537|P2|COMPLETED|Period 1||64
7711810|NCT01727024|18990538|P1|COMPLETED|Period 1||68
7711811|NCT01727024|18990537|P2|STARTED|Period 1||68
7711812|NCT01727024|18990538|P1|STARTED|Period 1||71
7711813|NCT01726803|18990553|P2|NOT COMPLETED|Overall Study||1
7711814|NCT01726803|18990554|P1|NOT COMPLETED|Overall Study||7
7711815|NCT01726803|18990553|P2|COMPLETED|Overall Study||107
7711816|NCT01726803|18990554|P1|COMPLETED|Overall Study||105
7711817|NCT01726803|18990553|P2|STARTED|Overall Study||108
7711818|NCT01726803|18990554|P1|STARTED|Overall Study||112
7711819|NCT01726738|18990574|P1|NOT COMPLETED|Overall Study||0
7711820|NCT01726738|18990574|P1|COMPLETED|Overall Study||17
7711821|NCT01726738|18990574|P1|STARTED|Overall Study||17
7711822|NCT01726673|18990586|P2|NOT COMPLETED|Overall Study||3
7711823|NCT01726673|18990587|P1|NOT COMPLETED|Overall Study||6
7711824|NCT01726673|18990586|P2|COMPLETED|Overall Study||21
7711825|NCT01726673|18990587|P1|COMPLETED|Overall Study||24
7711826|NCT01726673|18990586|P2|STARTED|Overall Study||24
7711827|NCT01726673|18990587|P1|STARTED|Overall Study||30
7711828|NCT01726621|18990597|P1|NOT COMPLETED|Overall Study||4
7711829|NCT01726621|18990597|P1|COMPLETED|Overall Study||51
7711830|NCT01726621|18990597|P1|STARTED|Overall Study||55
7711831|NCT01726517|18990606|P5|NOT COMPLETED|Overall Study||0
7711832|NCT01726517|18990607|P4|NOT COMPLETED|Overall Study||0
7711833|NCT01726517|18990608|P3|NOT COMPLETED|Overall Study||1
7711834|NCT01726517|18990609|P2|NOT COMPLETED|Overall Study||0
7711835|NCT01726517|18990610|P1|NOT COMPLETED|Overall Study||0
7711836|NCT01726517|18990606|P5|COMPLETED|Overall Study||21
7711837|NCT01726517|18990607|P4|COMPLETED|Overall Study||19
7711838|NCT01726517|18990608|P3|COMPLETED|Overall Study||18
7711839|NCT01726517|18990609|P2|COMPLETED|Overall Study||21
7711840|NCT01726517|18990610|P1|COMPLETED|Overall Study||20
7711841|NCT01726517|18990606|P5|STARTED|Overall Study||21
7711842|NCT01726517|18990607|P4|STARTED|Overall Study||19
7711843|NCT01726517|18990608|P3|STARTED|Overall Study||19
7711844|NCT01726517|18990609|P2|STARTED|Overall Study||21
7711845|NCT01726517|18990610|P1|STARTED|Overall Study||20
7711846|NCT01726504|18990639|P2|NOT COMPLETED|Overall Study||28
7711847|NCT01726504|18990640|P1|NOT COMPLETED|Overall Study||12
7711848|NCT01726504|18990639|P2|COMPLETED|Overall Study||511
7711849|NCT01726504|18990640|P1|COMPLETED|Overall Study||524
7711850|NCT01726504|18990639|P2|STARTED|Overall Study||539
7711851|NCT01726504|18990640|P1|STARTED|Overall Study||536
7711852|NCT01726335|18990666|P1|NOT COMPLETED|Overall Study||24
7711853|NCT01726335|18990666|P1|COMPLETED|Overall Study||29
7711854|NCT01726335|18990666|P1|STARTED|Overall Study||53
7711855|NCT01726270|18990682|P1|NOT COMPLETED|Part 2, Actual-Use Phase||39
7711856|NCT01726270|18990682|P1|COMPLETED|Part 2, Actual-Use Phase||330
7711857|NCT01726270|18990682|P1|STARTED|Part 2, Actual-Use Phase|20 subjects were eligible for Part 2 but did not enter Part 2|369
7711858|NCT01726270|18990682|P1|NOT COMPLETED|Eligibility for Part 2||20
7711859|NCT01726270|18990682|P1|COMPLETED|Eligibility for Part 2||369
7711860|NCT01726270|18990682|P1|STARTED|Eligibility for Part 2|No. of subjects potentially eligible for Part 2|389
7711861|NCT01726270|18990682|P1|NOT COMPLETED|Part 1, Self-Selection Phase||10
7711862|NCT01726270|18990682|P1|COMPLETED|Part 1, Self-Selection Phase||679
7711863|NCT01726270|18990682|P1|STARTED|Part 1, Self-Selection Phase||689
7711864|NCT01726049|18990695|P2|NOT COMPLETED|Overall Study||4
7711865|NCT01726049|18990696|P1|NOT COMPLETED|Overall Study||5
7711866|NCT01726049|18990695|P2|COMPLETED|Overall Study||22
7711867|NCT01726049|18990696|P1|COMPLETED|Overall Study||21
7711868|NCT01726049|18990695|P2|STARTED|Overall Study||26
7711869|NCT01726049|18990696|P1|STARTED|Overall Study||26
7711870|NCT01726036|18990710|P2|NOT COMPLETED|Overall Study||7
7711871|NCT01726036|18990711|P1|NOT COMPLETED|Overall Study||16
7711872|NCT01726036|18990710|P2|COMPLETED|Overall Study||130
7711873|NCT01726036|18990711|P1|COMPLETED|Overall Study||121
7711874|NCT01726036|18990710|P2|STARTED|Overall Study||137
7711875|NCT01726036|18990711|P1|STARTED|Overall Study||137
7711876|NCT01726023|18990721|P2|NOT COMPLETED|Overall Study||26
7711877|NCT01726023|18990722|P1|NOT COMPLETED|Overall Study||29
7711878|NCT01726023|18990721|P2|COMPLETED|Overall Study||196
7711879|NCT01726023|18990722|P1|COMPLETED|Overall Study||190
7711880|NCT01726023|18990721|P2|STARTED|Overall Study||222
7711881|NCT01726023|18990722|P1|STARTED|Overall Study||219
7711882|NCT01725984|18990814|P2|NOT COMPLETED|Overall Study||0
7711883|NCT01725984|18990815|P1|NOT COMPLETED|Overall Study||0
7711884|NCT01725984|18990814|P2|COMPLETED|Overall Study||41
7711885|NCT01725984|18990815|P1|COMPLETED|Overall Study||39
7711886|NCT01725984|18990814|P2|STARTED|Overall Study||41
7711887|NCT01725984|18990815|P1|STARTED|Overall Study||39
7711888|NCT01725815|18990841|P2|NOT COMPLETED|Overall Study||0
7711889|NCT01725815|18990842|P1|NOT COMPLETED|Overall Study||0
7711890|NCT01725815|18990841|P2|COMPLETED|Overall Study||202
7711891|NCT01725815|18990842|P1|COMPLETED|Overall Study||198
7711892|NCT01725815|18990841|P2|STARTED|Overall Study||202
7711893|NCT01725815|18990842|P1|STARTED|Overall Study||198
7711894|NCT01725750|18990856|P2|NOT COMPLETED|Overall Study||10
7711895|NCT01725750|18990857|P1|NOT COMPLETED|Overall Study||2
7711896|NCT01725750|18990856|P2|COMPLETED|Overall Study||34
7711897|NCT01725750|18990857|P1|COMPLETED|Overall Study||42
7711898|NCT01725750|18990856|P2|STARTED|Overall Study||44
7711899|NCT01725750|18990857|P1|STARTED|Overall Study||44
7711900|NCT01725529|18990890|P3|NOT COMPLETED|Overall Study||10
7711901|NCT01725529|18990891|P2|NOT COMPLETED|Overall Study||16
7711902|NCT01725529|18990892|P1|NOT COMPLETED|Overall Study||15
7711903|NCT01725529|18990890|P3|COMPLETED|Overall Study||142
7711904|NCT01725529|18990891|P2|COMPLETED|Overall Study||137
7711905|NCT01725529|18990892|P1|COMPLETED|Overall Study||137
7711906|NCT01725529|18990890|P3|STARTED|Overall Study||152
7711907|NCT01725529|18990891|P2|STARTED|Overall Study||153
7711908|NCT01725529|18990892|P1|STARTED|Overall Study||152
7711909|NCT01725451|18990918|P4|NOT COMPLETED|Period 6||0
7711910|NCT01725451|18990919|P3|NOT COMPLETED|Period 6||0
7711911|NCT01725451|18990920|P2|NOT COMPLETED|Period 6||0
7711912|NCT01725451|18990921|P1|NOT COMPLETED|Period 6||0
7711913|NCT01725451|18990918|P4|COMPLETED|Period 6||7
7711914|NCT01725451|18990919|P3|COMPLETED|Period 6||6
7711915|NCT01725451|18990920|P2|COMPLETED|Period 6||6
7711916|NCT01725451|18990921|P1|COMPLETED|Period 6||7
7711917|NCT01725451|18990918|P4|STARTED|Period 6||7
7711918|NCT01725451|18990919|P3|STARTED|Period 6||6
7711919|NCT01725451|18990920|P2|STARTED|Period 6||6
7711920|NCT01725451|18990921|P1|STARTED|Period 6||7
7711921|NCT01725451|18990918|P4|NOT COMPLETED|Washout From Period 5||0
7711922|NCT01725451|18990919|P3|NOT COMPLETED|Washout From Period 5||0
7711923|NCT01725451|18990920|P2|NOT COMPLETED|Washout From Period 5||0
7711924|NCT01725451|18990921|P1|NOT COMPLETED|Washout From Period 5||0
7711925|NCT01725451|18990918|P4|COMPLETED|Washout From Period 5||7
7711926|NCT01725451|18990919|P3|COMPLETED|Washout From Period 5||6
7711927|NCT01725451|18990920|P2|COMPLETED|Washout From Period 5||6
7711928|NCT01725451|18990921|P1|COMPLETED|Washout From Period 5||7
7711929|NCT01725451|18990918|P4|STARTED|Washout From Period 5||7
7711930|NCT01725451|18990919|P3|STARTED|Washout From Period 5||6
7711931|NCT01725451|18990920|P2|STARTED|Washout From Period 5||6
7711932|NCT01725451|18990921|P1|STARTED|Washout From Period 5||7
7711933|NCT01725451|18990918|P4|NOT COMPLETED|Period 5||0
7711934|NCT01725451|18990919|P3|NOT COMPLETED|Period 5||0
7711935|NCT01725451|18990920|P2|NOT COMPLETED|Period 5||0
7711936|NCT01725451|18990921|P1|NOT COMPLETED|Period 5||0
7711937|NCT01725451|18990918|P4|COMPLETED|Period 5||7
7711938|NCT01725451|18990919|P3|COMPLETED|Period 5||6
7711939|NCT01725451|18990920|P2|COMPLETED|Period 5||6
7711940|NCT01725451|18990921|P1|COMPLETED|Period 5||7
7711941|NCT01725451|18990918|P4|STARTED|Period 5||7
7711942|NCT01725451|18990919|P3|STARTED|Period 5||6
7711943|NCT01725451|18990920|P2|STARTED|Period 5||6
7711944|NCT01725451|18990921|P1|STARTED|Period 5||7
7711945|NCT01725451|18990918|P4|NOT COMPLETED|Washout From Period 4||0
7711946|NCT01725451|18990919|P3|NOT COMPLETED|Washout From Period 4||0
7711947|NCT01725451|18990920|P2|NOT COMPLETED|Washout From Period 4||0
7711948|NCT01725451|18990921|P1|NOT COMPLETED|Washout From Period 4||0
7711949|NCT01725451|18990918|P4|COMPLETED|Washout From Period 4||7
7711950|NCT01725451|18990919|P3|COMPLETED|Washout From Period 4||6
7711951|NCT01725451|18990920|P2|COMPLETED|Washout From Period 4||6
7711952|NCT01725451|18990921|P1|COMPLETED|Washout From Period 4||7
7711953|NCT01725451|18990918|P4|STARTED|Washout From Period 4||7
7711954|NCT01725451|18990919|P3|STARTED|Washout From Period 4||6
7711955|NCT01725451|18990920|P2|STARTED|Washout From Period 4||6
7711956|NCT01725451|18990921|P1|STARTED|Washout From Period 4||7
7711957|NCT01725451|18990918|P4|NOT COMPLETED|Period 4||0
7711958|NCT01725451|18990919|P3|NOT COMPLETED|Period 4||1
7711959|NCT01725451|18990920|P2|NOT COMPLETED|Period 4||0
7711960|NCT01725451|18990921|P1|NOT COMPLETED|Period 4||0
7711961|NCT01725451|18990918|P4|COMPLETED|Period 4||7
7711962|NCT01725451|18990919|P3|COMPLETED|Period 4||6
7711963|NCT01725451|18990920|P2|COMPLETED|Period 4||6
7711964|NCT01725451|18990921|P1|COMPLETED|Period 4||7
7711965|NCT01725451|18990918|P4|STARTED|Period 4||7
7711966|NCT01725451|18990919|P3|STARTED|Period 4||7
7711967|NCT01725451|18990920|P2|STARTED|Period 4||6
7711968|NCT01725451|18990921|P1|STARTED|Period 4||7
7711969|NCT01725451|18990918|P4|NOT COMPLETED|Washout From Period 3||0
7711970|NCT01725451|18990919|P3|NOT COMPLETED|Washout From Period 3||1
7711971|NCT01725451|18990920|P2|NOT COMPLETED|Washout From Period 3||1
7711972|NCT01725451|18990921|P1|NOT COMPLETED|Washout From Period 3||0
7711973|NCT01725451|18990918|P4|COMPLETED|Washout From Period 3||7
7711974|NCT01725451|18990919|P3|COMPLETED|Washout From Period 3||7
7711975|NCT01725451|18990920|P2|COMPLETED|Washout From Period 3||6
7711976|NCT01725451|18990921|P1|COMPLETED|Washout From Period 3||7
7711977|NCT01725451|18990918|P4|STARTED|Washout From Period 3||7
7711978|NCT01725451|18990919|P3|STARTED|Washout From Period 3||8
7711979|NCT01725451|18990920|P2|STARTED|Washout From Period 3||7
7711980|NCT01725451|18990921|P1|STARTED|Washout From Period 3||7
7711981|NCT01725451|18990918|P4|NOT COMPLETED|Period 3||0
7711982|NCT01725451|18990919|P3|NOT COMPLETED|Period 3||0
7711983|NCT01725451|18990920|P2|NOT COMPLETED|Period 3||0
7711984|NCT01725451|18990921|P1|NOT COMPLETED|Period 3||0
7711985|NCT01725451|18990918|P4|COMPLETED|Period 3||7
7711986|NCT01725451|18990919|P3|COMPLETED|Period 3||8
7711987|NCT01725451|18990920|P2|COMPLETED|Period 3||7
7711988|NCT01725451|18990921|P1|COMPLETED|Period 3||7
7711989|NCT01725451|18990918|P4|STARTED|Period 3||7
7711990|NCT01725451|18990919|P3|STARTED|Period 3||8
7711991|NCT01725451|18990920|P2|STARTED|Period 3||7
7711992|NCT01725451|18990921|P1|STARTED|Period 3||7
7711993|NCT01725451|18990918|P4|NOT COMPLETED|Washout From Period 2||0
7711994|NCT01725451|18990919|P3|NOT COMPLETED|Washout From Period 2||0
7711995|NCT01725451|18990920|P2|NOT COMPLETED|Washout From Period 2||0
7711996|NCT01725451|18990921|P1|NOT COMPLETED|Washout From Period 2||0
7711997|NCT01725451|18990918|P4|COMPLETED|Washout From Period 2||7
7711998|NCT01725451|18990919|P3|COMPLETED|Washout From Period 2||8
7711999|NCT01725451|18990920|P2|COMPLETED|Washout From Period 2||7
7712000|NCT01725451|18990921|P1|COMPLETED|Washout From Period 2||7
7712001|NCT01725451|18990918|P4|STARTED|Washout From Period 2||7
7712002|NCT01725451|18990919|P3|STARTED|Washout From Period 2||8
7712003|NCT01725451|18990920|P2|STARTED|Washout From Period 2||7
7712004|NCT01725451|18990921|P1|STARTED|Washout From Period 2||7
7712005|NCT01725451|18990918|P4|NOT COMPLETED|Period 2||0
7712006|NCT01725451|18990919|P3|NOT COMPLETED|Period 2||0
7712007|NCT01725451|18990920|P2|NOT COMPLETED|Period 2||0
7712008|NCT01725451|18990921|P1|NOT COMPLETED|Period 2||0
7712009|NCT01725451|18990918|P4|COMPLETED|Period 2||7
7712010|NCT01725451|18990919|P3|COMPLETED|Period 2||8
7712011|NCT01725451|18990920|P2|COMPLETED|Period 2||7
7712012|NCT01725451|18990921|P1|COMPLETED|Period 2||7
7712013|NCT01725451|18990918|P4|STARTED|Period 2||7
7712014|NCT01725451|18990919|P3|STARTED|Period 2||8
7712015|NCT01725451|18990920|P2|STARTED|Period 2||7
7712016|NCT01725451|18990921|P1|STARTED|Period 2||7
7712017|NCT01725451|18990918|P4|NOT COMPLETED|Washout From Period 1||0
7712018|NCT01725451|18990919|P3|NOT COMPLETED|Washout From Period 1||0
7712019|NCT01725451|18990920|P2|NOT COMPLETED|Washout From Period 1||0
7712020|NCT01725451|18990921|P1|NOT COMPLETED|Washout From Period 1||0
7712021|NCT01725451|18990918|P4|COMPLETED|Washout From Period 1||7
7712022|NCT01725451|18990919|P3|COMPLETED|Washout From Period 1||8
7712023|NCT01725451|18990920|P2|COMPLETED|Washout From Period 1||7
7712024|NCT01725451|18990921|P1|COMPLETED|Washout From Period 1||7
7712025|NCT01725451|18990918|P4|STARTED|Washout From Period 1||7
7712026|NCT01725451|18990919|P3|STARTED|Washout From Period 1||8
7712027|NCT01725451|18990920|P2|STARTED|Washout From Period 1||7
7712028|NCT01725451|18990921|P1|STARTED|Washout From Period 1||7
7712029|NCT01725451|18990918|P4|NOT COMPLETED|Period 1||0
7712030|NCT01725451|18990919|P3|NOT COMPLETED|Period 1||0
7712031|NCT01725451|18990920|P2|NOT COMPLETED|Period 1||0
7712032|NCT01725451|18990921|P1|NOT COMPLETED|Period 1||1
7712033|NCT01725451|18990918|P4|COMPLETED|Period 1||7
7712034|NCT01725451|18990919|P3|COMPLETED|Period 1||8
7712035|NCT01725451|18990920|P2|COMPLETED|Period 1||7
7712036|NCT01725451|18990921|P1|COMPLETED|Period 1||7
7712037|NCT01725451|18990918|P4|STARTED|Period 1||7
7712038|NCT01725451|18990919|P3|STARTED|Period 1||8
7712039|NCT01725451|18990920|P2|STARTED|Period 1||7
7712040|NCT01725451|18990921|P1|STARTED|Period 1||8
7712041|NCT01725386|18990943|P2|NOT COMPLETED|Overall Study||46
7712042|NCT01725386|18990944|P1|NOT COMPLETED|Overall Study||175
7712043|NCT01725386|18990943|P2|COMPLETED|Overall Study||17
7712044|NCT01725386|18990944|P1|COMPLETED|Overall Study||13
7712045|NCT01725386|18990943|P2|STARTED|Overall Study||63
7712046|NCT01725386|18990944|P1|STARTED|Overall Study||188
7712047|NCT01725308|18990963|P3|NOT COMPLETED|Treatment Period II||64
7712048|NCT01725308|18990964|P2|NOT COMPLETED|Treatment Period II||29
7712049|NCT01725308|18990965|P1|NOT COMPLETED|Treatment Period II||55
7712050|NCT01725308|18990963|P3|COMPLETED|Treatment Period II||74
7712051|NCT01725308|18990964|P2|COMPLETED|Treatment Period II||31
7712052|NCT01725308|18990965|P1|COMPLETED|Treatment Period II||79
7712053|NCT01725308|18990963|P3|Treated|Treatment Period II||130
7712054|NCT01725308|18990964|P2|Treated|Treatment Period II||53
7712055|NCT01725308|18990965|P1|Treated|Treatment Period II||120
7712056|NCT01725308|18990963|P3|STARTED|Treatment Period II||138
7712057|NCT01725308|18990964|P2|STARTED|Treatment Period II||60
7712058|NCT01725308|18990965|P1|STARTED|Treatment Period II||134
7712059|NCT01725308|18990963|P3|NOT COMPLETED|Treatment Period I||41
7712060|NCT01725308|18990964|P2|NOT COMPLETED|Treatment Period I||14
7712061|NCT01725308|18990965|P1|NOT COMPLETED|Treatment Period I||44
7712062|NCT01725308|18990963|P3|COMPLETED|Treatment Period I||138
7712063|NCT01725308|18990964|P2|COMPLETED|Treatment Period I||60
7712064|NCT01725308|18990965|P1|COMPLETED|Treatment Period I||134
7712065|NCT01725308|18990963|P3|Treated|Treatment Period I||179
7712066|NCT01725308|18990964|P2|Treated|Treatment Period I||74
7712067|NCT01725308|18990965|P1|Treated|Treatment Period I||177
7712068|NCT01725308|18990963|P3|STARTED|Treatment Period I||179
7712069|NCT01725308|18990964|P2|STARTED|Treatment Period I||74
7712070|NCT01725308|18990965|P1|STARTED|Treatment Period I||178
7712071|NCT01725282|18991112|P4|NOT COMPLETED|Overall Study||7
7712072|NCT01725282|18991113|P3|NOT COMPLETED|Overall Study||8
7712073|NCT01725282|18991114|P2|NOT COMPLETED|Overall Study||5
7712074|NCT01725282|18991115|P1|NOT COMPLETED|Overall Study||2
7712075|NCT01725282|18991112|P4|COMPLETED|Overall Study||36
7712076|NCT01725282|18991113|P3|COMPLETED|Overall Study||33
7712077|NCT01725282|18991114|P2|COMPLETED|Overall Study||39
7712078|NCT01725282|18991115|P1|COMPLETED|Overall Study||42
7712079|NCT01725282|18991112|P4|STARTED|Overall Study||43
7712080|NCT01725282|18991113|P3|STARTED|Overall Study||41
7712081|NCT01725282|18991114|P2|STARTED|Overall Study||44
7712082|NCT01725282|18991115|P1|STARTED|Overall Study||44
7712083|NCT01725217|18991148|P3|NOT COMPLETED|Overall Study||0
7712084|NCT01725217|18991149|P2|NOT COMPLETED|Overall Study||0
7712085|NCT01725217|18991150|P1|NOT COMPLETED|Overall Study||1
7712086|NCT01725217|18991148|P3|COMPLETED|Overall Study||66
7712087|NCT01725217|18991149|P2|COMPLETED|Overall Study||66
7712088|NCT01725217|18991150|P1|COMPLETED|Overall Study||65
7712089|NCT01725217|18991148|P3|STARTED|Overall Study||66
7712090|NCT01725217|18991149|P2|STARTED|Overall Study||66
7712091|NCT01725217|18991150|P1|STARTED|Overall Study||66
7712092|NCT01725126|18991184|P6|NOT COMPLETED|Overall Study||0
7712093|NCT01725126|18991185|P5|NOT COMPLETED|Overall Study||0
7712094|NCT01725126|18991186|P4|NOT COMPLETED|Overall Study||1
7712095|NCT01725126|18991187|P3|NOT COMPLETED|Overall Study||0
7712096|NCT01725126|18991188|P2|NOT COMPLETED|Overall Study||1
7712097|NCT01725126|18991189|P1|NOT COMPLETED|Overall Study||0
7712098|NCT01725126|18991184|P6|COMPLETED|Overall Study||12
7712099|NCT01725126|18991185|P5|COMPLETED|Overall Study||6
7712100|NCT01725126|18991186|P4|COMPLETED|Overall Study||13
7712101|NCT01725126|18991187|P3|COMPLETED|Overall Study||6
7712102|NCT01725126|18991188|P2|COMPLETED|Overall Study||10
7712103|NCT01725126|18991189|P1|COMPLETED|Overall Study||4
7712104|NCT01725126|18991184|P6|STARTED|Overall Study||12
7712105|NCT01725126|18991185|P5|STARTED|Overall Study||6
7712106|NCT01725126|18991186|P4|STARTED|Overall Study||14
7712107|NCT01725126|18991187|P3|STARTED|Overall Study||6
7712108|NCT01725126|18991188|P2|STARTED|Overall Study||11
7712109|NCT01725126|18991189|P1|STARTED|Overall Study||4
7712110|NCT01724528|18991387|P2|NOT COMPLETED|Overall Study||3
7712111|NCT01724528|18991388|P1|NOT COMPLETED|Overall Study||4
7712112|NCT01724528|18991387|P2|COMPLETED|Overall Study||170
7712113|NCT01724528|18991388|P1|COMPLETED|Overall Study||169
7712114|NCT01724528|18991387|P2|STARTED|Overall Study||173
7712115|NCT01724528|18991388|P1|STARTED|Overall Study||173
7712116|NCT01724489|18991404|P2|NOT COMPLETED|Overall Study||12
7712117|NCT01724489|18991405|P1|NOT COMPLETED|Overall Study||16
7712118|NCT01724489|18991404|P2|COMPLETED|Overall Study||26
7712119|NCT01724489|18991405|P1|COMPLETED|Overall Study||23
7712120|NCT01724489|18991404|P2|STARTED|Overall Study||38
7712121|NCT01724489|18991405|P1|STARTED|Overall Study||39
7712122|NCT01724359|18991411|P1|NOT COMPLETED|Overall Study||31
7712123|NCT01724359|18991411|P1|COMPLETED|Overall Study||64
7712124|NCT01724359|18991411|P1|STARTED|Overall Study||95
7712125|NCT01724216|18991424|P1|NOT COMPLETED|Overall Study||1
7712126|NCT01724216|18991424|P1|COMPLETED|Overall Study||10
7712127|NCT01724216|18991424|P1|STARTED|Overall Study||11
7712128|NCT01724177|18991428|P1|NOT COMPLETED|Overall Study||26
7712129|NCT01724177|18991428|P1|COMPLETED|Overall Study||0
7712130|NCT01724177|18991428|P1|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26
7712131|NCT01724177|18991428|P1|STARTED|Overall Study||26
7712132|NCT01724060|18991447|P8|NOT COMPLETED|Overall Study||0
7712133|NCT01724060|18991448|P7|NOT COMPLETED|Overall Study||0
7712134|NCT01724060|18991449|P6|NOT COMPLETED|Overall Study||0
7712135|NCT01724060|18991450|P5|NOT COMPLETED|Overall Study||0
7712136|NCT01724060|18991451|P4|NOT COMPLETED|Overall Study||0
7712137|NCT01724060|18991452|P3|NOT COMPLETED|Overall Study||0
7712138|NCT01724060|18991453|P2|NOT COMPLETED|Overall Study||0
7712139|NCT01724060|18991454|P1|NOT COMPLETED|Overall Study||0
7712140|NCT01724060|18991447|P8|COMPLETED|Overall Study||10
7712141|NCT01724060|18991448|P7|COMPLETED|Overall Study||10
7712142|NCT01724060|18991449|P6|COMPLETED|Overall Study||10
7712143|NCT01724060|18991450|P5|COMPLETED|Overall Study||10
7712144|NCT01724060|18991451|P4|COMPLETED|Overall Study||10
7712145|NCT01724060|18991452|P3|COMPLETED|Overall Study||10
7712146|NCT01724060|18991453|P2|COMPLETED|Overall Study||10
7712147|NCT01724060|18991454|P1|COMPLETED|Overall Study||10
7712148|NCT01724060|18991447|P8|STARTED|Overall Study||10
7712149|NCT01724060|18991448|P7|STARTED|Overall Study||10
7712150|NCT01724060|18991449|P6|STARTED|Overall Study||10
7712151|NCT01724060|18991450|P5|STARTED|Overall Study||10
7712152|NCT01724060|18991451|P4|STARTED|Overall Study||10
7712153|NCT01724060|18991452|P3|STARTED|Overall Study||10
7712154|NCT01724060|18991453|P2|STARTED|Overall Study||10
7712155|NCT01724060|18991454|P1|STARTED|Overall Study||10
7712156|NCT01724021|18991474|P2|NOT COMPLETED|Overall Study||133
7712157|NCT01724021|18991475|P1|NOT COMPLETED|Overall Study||127
7712158|NCT01724021|18991474|P2|COMPLETED|Overall Study||236
7712159|NCT01724021|18991475|P1|COMPLETED|Overall Study||244
7712160|NCT01724021|18991474|P2|STARTED|Overall Study||369
7712161|NCT01724021|18991475|P1|STARTED|Overall Study||371
7712162|NCT01723904|18991507|P1|NOT COMPLETED|Overall Study||11
7712163|NCT01723904|18991507|P1|COMPLETED|Overall Study||79
7712164|NCT01723904|18991507|P1|STARTED|Overall Study||90
7712165|NCT01723826|18991521|P4|NOT COMPLETED|Overall Study||90
7712166|NCT01723826|18991522|P3|NOT COMPLETED|Overall Study||57
7712167|NCT01723826|18991523|P2|NOT COMPLETED|Overall Study||36
7712168|NCT01723826|18991524|P1|NOT COMPLETED|Overall Study||27
7712169|NCT01723826|18991521|P4|COMPLETED|Overall Study||59
7712170|NCT01723826|18991522|P3|COMPLETED|Overall Study||44
7712171|NCT01723826|18991523|P2|COMPLETED|Overall Study||27
7712172|NCT01723826|18991524|P1|COMPLETED|Overall Study||20
7712173|NCT01723826|18991521|P4|STARTED|Overall Study||149
7712174|NCT01723826|18991522|P3|STARTED|Overall Study||101
7712175|NCT01723826|18991523|P2|STARTED|Overall Study||63
7712176|NCT01723826|18991524|P1|STARTED|Overall Study||47
7712177|NCT01723722|18991556|P2|NOT COMPLETED|Overall Study||0
7712178|NCT01723722|18991557|P1|NOT COMPLETED|Overall Study||0
7712179|NCT01723722|18991556|P2|COMPLETED|Overall Study||20
7712180|NCT01723722|18991557|P1|COMPLETED|Overall Study||20
7712181|NCT01723722|18991556|P2|STARTED|Overall Study||20
7712182|NCT01723722|18991557|P1|STARTED|Overall Study||20
7712183|NCT01723696|18991565|P2|NOT COMPLETED|Overall Study||13
7712184|NCT01723696|18991566|P1|NOT COMPLETED|Overall Study||17
7712185|NCT01723696|18991565|P2|COMPLETED|Overall Study||113
7712186|NCT01723696|18991566|P1|COMPLETED|Overall Study||109
7712187|NCT01723696|18991565|P2|STARTED|Overall Study||126
7712188|NCT01723696|18991566|P1|STARTED|Overall Study||126
7712189|NCT01723514|18991586|P8|NOT COMPLETED|Overall Study||0
7712190|NCT01723514|18991587|P7|NOT COMPLETED|Overall Study||0
7712191|NCT01723514|18991588|P6|NOT COMPLETED|Overall Study||0
7712192|NCT01723514|18991589|P5|NOT COMPLETED|Overall Study||0
7712193|NCT01723514|18991590|P4|NOT COMPLETED|Overall Study||0
7712194|NCT01723514|18991591|P3|NOT COMPLETED|Overall Study||0
7712195|NCT01723514|18991592|P2|NOT COMPLETED|Overall Study||0
7712196|NCT01723514|18991593|P1|NOT COMPLETED|Overall Study||0
7712197|NCT01723514|18991586|P8|COMPLETED|Overall Study||6
7712198|NCT01723514|18991587|P7|COMPLETED|Overall Study||6
7712199|NCT01723514|18991588|P6|COMPLETED|Overall Study||4
7712200|NCT01723514|18991589|P5|COMPLETED|Overall Study||6
7712201|NCT01723514|18991590|P4|COMPLETED|Overall Study||6
7712202|NCT01723514|18991591|P3|COMPLETED|Overall Study||6
7712203|NCT01723514|18991592|P2|COMPLETED|Overall Study||6
7712204|NCT01723514|18991593|P1|COMPLETED|Overall Study||8
7712205|NCT01723514|18991586|P8|STARTED|Overall Study||6
7712206|NCT01723514|18991587|P7|STARTED|Overall Study||6
7712207|NCT01723514|18991588|P6|STARTED|Overall Study||4
7712208|NCT01723514|18991589|P5|STARTED|Overall Study||6
7712209|NCT01723514|18991590|P4|STARTED|Overall Study||6
7712210|NCT01723514|18991591|P3|STARTED|Overall Study||6
7712211|NCT01723514|18991592|P2|STARTED|Overall Study||6
7712212|NCT01723514|18991593|P1|STARTED|Overall Study||8
7712213|NCT01723397|18991669|P2|NOT COMPLETED|Study Period 2||1
7712214|NCT01723397|18991670|P1|NOT COMPLETED|Study Period 2||0
7712215|NCT01723397|18991669|P2|COMPLETED|Study Period 2||5
7712216|NCT01723397|18991670|P1|COMPLETED|Study Period 2||7
7712217|NCT01723397|18991669|P2|STARTED|Study Period 2||6
7712218|NCT01723397|18991670|P1|STARTED|Study Period 2||7
7712219|NCT01723397|18991669|P2|NOT COMPLETED|Washout||0
7712220|NCT01723397|18991670|P1|NOT COMPLETED|Washout||0
7712221|NCT01723397|18991669|P2|COMPLETED|Washout||6
7712222|NCT01723397|18991670|P1|COMPLETED|Washout||7
7712223|NCT01723397|18991669|P2|STARTED|Washout||6
7712224|NCT01723397|18991670|P1|STARTED|Washout||7
7712225|NCT01723397|18991669|P2|NOT COMPLETED|Study Period 1||1
7712226|NCT01723397|18991670|P1|NOT COMPLETED|Study Period 1||0
7712227|NCT01723397|18991669|P2|COMPLETED|Study Period 1||6
7712228|NCT01723397|18991670|P1|COMPLETED|Study Period 1||7
7712229|NCT01723397|18991669|P2|STARTED|Study Period 1||7
7712230|NCT01723397|18991670|P1|STARTED|Study Period 1||7
7712231|NCT01723384|18991678|P2|NOT COMPLETED|Overall Study||0
7712232|NCT01723384|18991679|P1|NOT COMPLETED|Overall Study||0
7712233|NCT01723384|18991678|P2|COMPLETED|Overall Study||15
7712234|NCT01723384|18991679|P1|COMPLETED|Overall Study||15
7712235|NCT01723384|18991678|P2|STARTED|Overall Study||15
7712236|NCT01723384|18991679|P1|STARTED|Overall Study||15
7712237|NCT01723254|18991697|P8|NOT COMPLETED|Overall Study||3
7712238|NCT01723254|18991698|P7|NOT COMPLETED|Overall Study||1
7712239|NCT01723254|18991699|P6|NOT COMPLETED|Overall Study||2
7712240|NCT01723254|18991700|P5|NOT COMPLETED|Overall Study||2
7712241|NCT01723254|18991701|P4|NOT COMPLETED|Overall Study||2
7712242|NCT01723254|18991702|P3|NOT COMPLETED|Overall Study||3
7712243|NCT01723254|18991703|P2|NOT COMPLETED|Overall Study||3
7712244|NCT01723254|18991704|P1|NOT COMPLETED|Overall Study||1
7712245|NCT01723254|18991697|P8|COMPLETED|Overall Study||60
7712246|NCT01723254|18991698|P7|COMPLETED|Overall Study||19
7712247|NCT01723254|18991699|P6|COMPLETED|Overall Study||18
7712248|NCT01723254|18991700|P5|COMPLETED|Overall Study||18
7712249|NCT01723254|18991701|P4|COMPLETED|Overall Study||18
7712250|NCT01723254|18991702|P3|COMPLETED|Overall Study||17
7712251|NCT01723254|18991703|P2|COMPLETED|Overall Study||18
7712252|NCT01723254|18991704|P1|COMPLETED|Overall Study||5
7712253|NCT01723254|18991697|P8|STARTED|Overall Study||63
7712254|NCT01723254|18991698|P7|STARTED|Overall Study||20
7712255|NCT01723254|18991699|P6|STARTED|Overall Study||20
7712256|NCT01723254|18991700|P5|STARTED|Overall Study||20
7712257|NCT01723254|18991701|P4|STARTED|Overall Study||20
7712258|NCT01723254|18991702|P3|STARTED|Overall Study||20
7712259|NCT01723254|18991703|P2|STARTED|Overall Study||21
7712260|NCT01723254|18991704|P1|STARTED|Overall Study||6
7712261|NCT01723228|18991756|P2|NOT COMPLETED|Overall Study||11
7712262|NCT01723228|18991757|P1|NOT COMPLETED|Overall Study||8
7712263|NCT01723228|18991756|P2|COMPLETED|Overall Study||73
7712264|NCT01723228|18991757|P1|COMPLETED|Overall Study||78
7712265|NCT01723228|18991756|P2|STARTED|Overall Study||84
7712266|NCT01723228|18991757|P1|STARTED|Overall Study||86
7712267|NCT01723163|18991775|P2|NOT COMPLETED|12-Month Follow-up||28
7712268|NCT01723163|18991776|P1|NOT COMPLETED|12-Month Follow-up||24
7712269|NCT01723163|18991775|P2|COMPLETED|12-Month Follow-up||119
7712270|NCT01723163|18991776|P1|COMPLETED|12-Month Follow-up||111
7712271|NCT01723163|18991775|P2|STARTED|12-Month Follow-up||147
7712272|NCT01723163|18991776|P1|STARTED|12-Month Follow-up||135
7712273|NCT01723163|18991775|P2|NOT COMPLETED|6-Month Follow-up||15
7712274|NCT01723163|18991776|P1|NOT COMPLETED|6-Month Follow-up||18
7712275|NCT01723163|18991775|P2|COMPLETED|6-Month Follow-up||132
7712276|NCT01723163|18991776|P1|COMPLETED|6-Month Follow-up||118
7712277|NCT01723163|18991775|P2|STARTED|6-Month Follow-up||147
7712278|NCT01723163|18991776|P1|STARTED|6-Month Follow-up||136
7712279|NCT01723163|18991775|P2|NOT COMPLETED|3-Month Follow-up||19
7712280|NCT01723163|18991776|P1|NOT COMPLETED|3-Month Follow-up||13
7712281|NCT01723163|18991775|P2|COMPLETED|3-Month Follow-up||128
7712282|NCT01723163|18991776|P1|COMPLETED|3-Month Follow-up||124
7712283|NCT01723163|18991775|P2|STARTED|3-Month Follow-up||147
7712284|NCT01723163|18991776|P1|STARTED|3-Month Follow-up||137
7712285|NCT01723163|18991775|P2|NOT COMPLETED|Treatment Phase||7
7712286|NCT01723163|18991776|P1|NOT COMPLETED|Treatment Phase||19
7712287|NCT01723163|18991775|P2|COMPLETED|Treatment Phase||147
7712288|NCT01723163|18991776|P1|COMPLETED|Treatment Phase||137
7712289|NCT01723163|18991775|P2|STARTED|Treatment Phase||154
7712290|NCT01723163|18991776|P1|STARTED|Treatment Phase||156
7712291|NCT01723163|18991775|P2|NOT COMPLETED|Baseline||0
7712292|NCT01723163|18991776|P1|NOT COMPLETED|Baseline||0
7712293|NCT01723163|18991775|P2|COMPLETED|Baseline||154
7712294|NCT01723163|18991776|P1|COMPLETED|Baseline||156
7712295|NCT01723163|18991775|P2|STARTED|Baseline||154
7712296|NCT01723163|18991776|P1|STARTED|Baseline||156
7712297|NCT01723072|18991784|P2|NOT COMPLETED|Overall Study||21
7712298|NCT01723072|18991785|P1|NOT COMPLETED|Overall Study||11
7712299|NCT01723072|18991784|P2|COMPLETED|Overall Study||26
7712300|NCT01723072|18991785|P1|COMPLETED|Overall Study||33
7712301|NCT01723072|18991784|P2|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|47
7712302|NCT01723072|18991785|P1|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|44
7712303|NCT01722994|18991823|P2|NOT COMPLETED|Overall Study||17
7712304|NCT01722994|18991824|P1|NOT COMPLETED|Overall Study||25
7712305|NCT01722994|18991823|P2|COMPLETED|Overall Study||31
7712306|NCT01722994|18991824|P1|COMPLETED|Overall Study||24
7712307|NCT01722994|18991823|P2|STARTED|Overall Study||48
7712308|NCT01722994|18991824|P1|STARTED|Overall Study||49
7712309|NCT01722929|18991838|P1|NOT COMPLETED|Overall Study||0
7712310|NCT01722929|18991838|P1|COMPLETED|Overall Study||4
7712311|NCT01722929|18991838|P1|STARTED|Overall Study||4
7712312|NCT01722877|18991843|P1|NOT COMPLETED|Overall Study||2
7712313|NCT01722877|18991843|P1|COMPLETED|Overall Study||27
7712314|NCT01722877|18991843|P1|STARTED|Overall Study||29
7712315|NCT01722734|18991853|P3|NOT COMPLETED|Overall Study||2
7712316|NCT01722734|18991854|P2|NOT COMPLETED|Overall Study||1
7712317|NCT01722734|18991855|P1|NOT COMPLETED|Overall Study||2
7712318|NCT01722734|18991853|P3|COMPLETED|Overall Study||307
7712319|NCT01722734|18991854|P2|COMPLETED|Overall Study||276
7712320|NCT01722734|18991855|P1|COMPLETED|Overall Study||552
7712321|NCT01722734|18991853|P3|STARTED|Overall Study||309
7712322|NCT01722734|18991854|P2|STARTED|Overall Study||277
7712323|NCT01722734|18991855|P1|STARTED|Overall Study||554
7712324|NCT01722669|18991869|P6|NOT COMPLETED|Overall Study||2
7712325|NCT01722669|18991870|P5|NOT COMPLETED|Overall Study||0
7712326|NCT01722669|18991871|P4|NOT COMPLETED|Overall Study||0
7712327|NCT01722669|18991872|P3|NOT COMPLETED|Overall Study||0
7712328|NCT01722669|18991873|P2|NOT COMPLETED|Overall Study||0
7712329|NCT01722669|18991874|P1|NOT COMPLETED|Overall Study||0
7712330|NCT01722669|18991869|P6|COMPLETED|Overall Study||6
7712331|NCT01722669|18991870|P5|COMPLETED|Overall Study||10
7712332|NCT01722669|18991871|P4|COMPLETED|Overall Study||5
7712333|NCT01722669|18991872|P3|COMPLETED|Overall Study||5
7712334|NCT01722669|18991873|P2|COMPLETED|Overall Study||5
7712335|NCT01722669|18991874|P1|COMPLETED|Overall Study||5
7712336|NCT01722669|18991869|P6|STARTED|Overall Study|Antiphospholipid Antibody (ARM D): 6 evaluable and 2 withdrew consent without any data collected|8
7712337|NCT01722669|18991870|P5|STARTED|Overall Study||10
7712338|NCT01722669|18991871|P4|STARTED|Overall Study||5
7712339|NCT01722669|18991872|P3|STARTED|Overall Study||5
7712340|NCT01722669|18991873|P2|STARTED|Overall Study||5
7712341|NCT01722669|18991874|P1|STARTED|Overall Study||5
7712342|NCT01722643|18991896|P2|NOT COMPLETED|Overall Study||1
7712343|NCT01722643|18991897|P1|NOT COMPLETED|Overall Study||0
7712344|NCT01722643|18991896|P2|COMPLETED|Overall Study||30
7712345|NCT01722643|18991897|P1|COMPLETED|Overall Study||30
7712346|NCT01722643|18991896|P2|STARTED|Overall Study||31
7712347|NCT01722643|18991897|P1|STARTED|Overall Study||30
7712348|NCT01722552|18991905|P1|NOT COMPLETED|Overall Study||4
7712349|NCT01722552|18991905|P1|COMPLETED|Overall Study|Number of subjects who completed the intervention|116
7712350|NCT01722552|18991905|P1|STARTED|Overall Study|Number of subjects enrolled|120
7712351|NCT01722487|18991915|P2|NOT COMPLETED|Overall Study||7
7712352|NCT01722487|18991916|P1|NOT COMPLETED|Overall Study||2
7712353|NCT01722487|18991915|P2|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126
7712354|NCT01722487|18991916|P1|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134
7712355|NCT01722487|18991915|P2|STARTED|Overall Study||133
7712356|NCT01722487|18991916|P1|STARTED|Overall Study||136
7712357|NCT01722435|18991934|P1|NOT COMPLETED|Overall Study||0
7712358|NCT01722435|18991934|P1|COMPLETED|Overall Study||78
7712359|NCT01722435|18991934|P1|STARTED|Overall Study||78
7712360|NCT01722331|18991945|P7|NOT COMPLETED|Part 3||2
7712361|NCT01722331|18991946|P6|NOT COMPLETED|Part 3||3
7712362|NCT01722331|18991947|P5|NOT COMPLETED|Part 3||0
7712363|NCT01722331|18991948|P4|NOT COMPLETED|Part 3||1
7712364|NCT01722331|18991949|P3|NOT COMPLETED|Part 3||0
7712365|NCT01722331|18991950|P2|NOT COMPLETED|Part 3||17
7712366|NCT01722331|18991951|P1|NOT COMPLETED|Part 3||15
7712367|NCT01722331|18991945|P7|COMPLETED|Part 3||65
7712368|NCT01722331|18991946|P6|COMPLETED|Part 3||59
7712369|NCT01722331|18991947|P5|COMPLETED|Part 3||0
7712370|NCT01722331|18991948|P4|COMPLETED|Part 3||18
7712371|NCT01722331|18991949|P3|COMPLETED|Part 3||0
7712372|NCT01722331|18991950|P2|COMPLETED|Part 3||232
7712373|NCT01722331|18991951|P1|COMPLETED|Part 3||264
7712374|NCT01722331|18991945|P7|STARTED|Part 3||67
7712375|NCT01722331|18991946|P6|STARTED|Part 3||62
7712376|NCT01722331|18991947|P5|STARTED|Part 3||0
7712377|NCT01722331|18991948|P4|STARTED|Part 3||19
7712378|NCT01722331|18991949|P3|STARTED|Part 3||0
7712379|NCT01722331|18991950|P2|STARTED|Part 3||249
7712380|NCT01722331|18991951|P1|STARTED|Part 3||279
7712381|NCT01722331|18991945|P7|NOT COMPLETED|Part 2||7
7712382|NCT01722331|18991946|P6|NOT COMPLETED|Part 2||10
7712383|NCT01722331|18991947|P5|NOT COMPLETED|Part 2||0
7712384|NCT01722331|18991948|P4|NOT COMPLETED|Part 2||0
7712385|NCT01722331|18991949|P3|NOT COMPLETED|Part 2||31
7712386|NCT01722331|18991950|P2|NOT COMPLETED|Part 2||0
7712387|NCT01722331|18991951|P1|NOT COMPLETED|Part 2||19
7712388|NCT01722331|18991945|P7|COMPLETED|Part 2||67
7712389|NCT01722331|18991946|P6|COMPLETED|Part 2||62
7712390|NCT01722331|18991947|P5|COMPLETED|Part 2||0
7712391|NCT01722331|18991948|P4|COMPLETED|Part 2||19
7712392|NCT01722331|18991949|P3|COMPLETED|Part 2||0
7712393|NCT01722331|18991950|P2|COMPLETED|Part 2||249
7712394|NCT01722331|18991951|P1|COMPLETED|Part 2||279
7712395|NCT01722331|18991945|P7|STARTED|Part 2||74
7712396|NCT01722331|18991946|P6|STARTED|Part 2||72
7712397|NCT01722331|18991947|P5|STARTED|Part 2||0
7712398|NCT01722331|18991948|P4|STARTED|Part 2||19
7712399|NCT01722331|18991949|P3|STARTED|Part 2|1 participant who completed Part 1 did not enter Part 2|31
7712400|NCT01722331|18991950|P2|STARTED|Part 2||249
7712401|NCT01722331|18991951|P1|STARTED|Part 2||298
7712402|NCT01722331|18991945|P7|NOT COMPLETED|Part 1||0
7712403|NCT01722331|18991946|P6|NOT COMPLETED|Part 1||0
7712404|NCT01722331|18991947|P5|NOT COMPLETED|Part 1||9
7712405|NCT01722331|18991948|P4|NOT COMPLETED|Part 1||0
7712406|NCT01722331|18991949|P3|NOT COMPLETED|Part 1||9
7712407|NCT01722331|18991950|P2|NOT COMPLETED|Part 1||0
7712408|NCT01722331|18991951|P1|NOT COMPLETED|Part 1||10
7712409|NCT01722331|18991945|P7|COMPLETED|Part 1||74
7712410|NCT01722331|18991946|P6|COMPLETED|Part 1||72
7712411|NCT01722331|18991947|P5|COMPLETED|Part 1||0
7712412|NCT01722331|18991948|P4|COMPLETED|Part 1||19
7712413|NCT01722331|18991949|P3|COMPLETED|Part 1||32
7712414|NCT01722331|18991950|P2|COMPLETED|Part 1||249
7712415|NCT01722331|18991951|P1|COMPLETED|Part 1||298
7712416|NCT01722331|18991945|P7|STARTED|Part 1||74
7712417|NCT01722331|18991946|P6|STARTED|Part 1||72
7712418|NCT01722331|18991947|P5|STARTED|Part 1||9
7712419|NCT01722331|18991948|P4|STARTED|Part 1||19
7712420|NCT01722331|18991949|P3|STARTED|Part 1||41
7712421|NCT01722331|18991950|P2|STARTED|Part 1||249
7712422|NCT01722331|18991951|P1|STARTED|Part 1||308
7712423|NCT01722318|18991995|P5|NOT COMPLETED|Overall Study||18
7712424|NCT01722318|18991996|P4|NOT COMPLETED|Overall Study||20
7712425|NCT01722318|18991997|P3|NOT COMPLETED|Overall Study||20
7712426|NCT01722318|18991998|P2|NOT COMPLETED|Overall Study||20
7712427|NCT01722318|18991999|P1|NOT COMPLETED|Overall Study||14
7712428|NCT01722318|18991995|P5|COMPLETED|Overall Study||68
7712429|NCT01722318|18991996|P4|COMPLETED|Overall Study||65
7712430|NCT01722318|18991997|P3|COMPLETED|Overall Study||66
7712431|NCT01722318|18991998|P2|COMPLETED|Overall Study||65
7712432|NCT01722318|18991999|P1|COMPLETED|Overall Study||72
7712433|NCT01722318|18991995|P5|STARTED|Overall Study||86
7712434|NCT01722318|18991996|P4|STARTED|Overall Study||85
7712435|NCT01722318|18991997|P3|STARTED|Overall Study||86
7712436|NCT01722318|18991998|P2|STARTED|Overall Study||85
7712437|NCT01722318|18991999|P1|STARTED|Overall Study||86
7712438|NCT01722292|18992029|P3|NOT COMPLETED|Overall Study||0
7712439|NCT01722292|18992030|P2|NOT COMPLETED|Overall Study||0
7712440|NCT01722292|18992031|P1|NOT COMPLETED|Overall Study||0
7712441|NCT01722292|18992029|P3|COMPLETED|Overall Study||14
7712442|NCT01722292|18992030|P2|COMPLETED|Overall Study||6
7712443|NCT01722292|18992031|P1|COMPLETED|Overall Study||6
7712444|NCT01722292|18992029|P3|Received at Least One Dose of Study Drug|Overall Study||14
7712445|NCT01722292|18992030|P2|Received at Least One Dose of Study Drug|Overall Study||6
7712446|NCT01722292|18992031|P1|Received at Least One Dose of Study Drug|Overall Study||6
7712447|NCT01722292|18992029|P3|STARTED|Overall Study||14
7712448|NCT01722292|18992030|P2|STARTED|Overall Study||6
7712449|NCT01722292|18992031|P1|STARTED|Overall Study||6
7712450|NCT01722266|18992067|P4|NOT COMPLETED|Overall Study||0
7712451|NCT01722266|18992068|P3|NOT COMPLETED|Overall Study||5
7712452|NCT01722266|18992069|P2|NOT COMPLETED|Overall Study||3
7712453|NCT01722266|18992070|P1|NOT COMPLETED|Overall Study||1
7712454|NCT01722266|18992067|P4|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18
7712455|NCT01722266|18992068|P3|COMPLETED|Overall Study||13
7712456|NCT01722266|18992069|P2|COMPLETED|Overall Study||15
7712457|NCT01722266|18992070|P1|COMPLETED|Overall Study||17
7712458|NCT01722266|18992067|P4|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18
7712459|NCT01722266|18992068|P3|STARTED|Overall Study||18
7712460|NCT01722266|18992069|P2|STARTED|Overall Study||18
7712461|NCT01722266|18992070|P1|STARTED|Overall Study||18
7712462|NCT01722162|18992098|P2|NOT COMPLETED|Overall Study||6
7712463|NCT01722162|18992099|P1|NOT COMPLETED|Overall Study||5
7712464|NCT01722162|18992098|P2|COMPLETED|Overall Study||18
7712465|NCT01722162|18992099|P1|COMPLETED|Overall Study||18
7712466|NCT01722162|18992098|P2|STARTED|Overall Study||24
7712467|NCT01722162|18992099|P1|STARTED|Overall Study||23
7712468|NCT01722097|18992109|P2|NOT COMPLETED|Overall Study||5
7712469|NCT01722097|18992110|P1|NOT COMPLETED|Overall Study||6
7712470|NCT01722097|18992109|P2|COMPLETED|Overall Study||50
7712471|NCT01722097|18992110|P1|COMPLETED|Overall Study||49
7712472|NCT01722097|18992109|P2|STARTED|Overall Study||55
7712473|NCT01722097|18992110|P1|STARTED|Overall Study||55
7712474|NCT01722071|18992118|P2|NOT COMPLETED|Overall Study||0
7712475|NCT01722071|18992119|P1|NOT COMPLETED|Overall Study||1
7712476|NCT01722071|18992118|P2|COMPLETED|Overall Study||10
7712477|NCT01722071|18992119|P1|COMPLETED|Overall Study||9
7712478|NCT01722071|18992118|P2|STARTED|Overall Study||10
7712479|NCT01722071|18992119|P1|STARTED|Overall Study||10
7712480|NCT01722045|18992125|P1|NOT COMPLETED|Overall Study||28
7712481|NCT01722045|18992125|P1|COMPLETED|Overall Study||126
7712482|NCT01722045|18992125|P1|STARTED|Overall Study||154
7712483|NCT01721967|18992135|P1|NOT COMPLETED|Overall Study||3
7712484|NCT01721967|18992135|P1|COMPLETED|Overall Study||11
7712485|NCT01721967|18992135|P1|STARTED|Overall Study||14
7712486|NCT01721954|18992146|P2|NOT COMPLETED|Overall Study||69
7712487|NCT01721954|18992147|P1|NOT COMPLETED|Overall Study||70
7712488|NCT01721954|18992146|P2|COMPLETED|Overall Study||35
7712489|NCT01721954|18992147|P1|COMPLETED|Overall Study||35
7712490|NCT01721954|18992146|P2|STARTED|Overall Study||104
7712491|NCT01721954|18992147|P1|STARTED|Overall Study||105
7712492|NCT01721837|18992155|P1|NOT COMPLETED|Overall Study||0
7712493|NCT01721837|18992155|P1|COMPLETED|Overall Study||2120
7712494|NCT01721837|18992155|P1|STARTED|Overall Study||2120
7712495|NCT01721772|18992161|P2|NOT COMPLETED|Overall Study||192
7712496|NCT01721772|18992162|P1|NOT COMPLETED|Overall Study||111
7712497|NCT01721772|18992161|P2|COMPLETED|Overall Study|Continuing in treatment period|13
7712498|NCT01721772|18992162|P1|COMPLETED|Overall Study|Continuing in treatment period|95
7712499|NCT01721772|18992161|P2|STARTED|Overall Study||205
7712500|NCT01721772|18992162|P1|STARTED|Overall Study||206
7712501|NCT01721759|18992182|P1|NOT COMPLETED|Overall Study||102
7712502|NCT01721759|18992182|P1|COMPLETED|Overall Study|Completed=continuing to receive treatment|15
7712503|NCT01721759|18992182|P1|STARTED|Overall Study||117
7712504|NCT01721746|18992190|P3|NOT COMPLETED|Follow-Up Period||0
7712505|NCT01721746|18992191|P2|NOT COMPLETED|Follow-Up Period||0
7712506|NCT01721746|18992192|P1|NOT COMPLETED|Follow-Up Period||0
7712507|NCT01721746|18992190|P3|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|19
7712508|NCT01721746|18992191|P2|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|11
7712509|NCT01721746|18992192|P1|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|92
7712510|NCT01721746|18992190|P3|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|19
7712511|NCT01721746|18992191|P2|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|11
7712512|NCT01721746|18992192|P1|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|92
7712513|NCT01721746|18992190|P3|NOT COMPLETED|Treatment Period||57
7712514|NCT01721746|18992191|P2|NOT COMPLETED|Treatment Period||45
7712515|NCT01721746|18992192|P1|NOT COMPLETED|Treatment Period||233
7712516|NCT01721746|18992190|P3|COMPLETED|Treatment Period||0
7712517|NCT01721746|18992191|P2|COMPLETED|Treatment Period||0
7712518|NCT01721746|18992192|P1|COMPLETED|Treatment Period|Completed=Continuing in Treatment Period|35
7712519|NCT01721746|18992190|P3|STARTED|Treatment Period||57
7712520|NCT01721746|18992191|P2|STARTED|Treatment Period||45
7712521|NCT01721746|18992192|P1|STARTED|Treatment Period||268
7712522|NCT01721681|18992208|P1|NOT COMPLETED|Overall Study||0
7712523|NCT01721681|18992208|P1|COMPLETED|Overall Study||9
7712524|NCT01721681|18992208|P1|STARTED|Overall Study||9
7712525|NCT01721603|18992214|P1|NOT COMPLETED|Overall Study||0
7712526|NCT01721603|18992214|P1|COMPLETED|Overall Study||2
7712527|NCT01721603|18992214|P1|STARTED|Overall Study||2
7712528|NCT01721564|18992225|P1|NOT COMPLETED|Overall Study||0
7712529|NCT01721564|18992225|P1|COMPLETED|Overall Study||8
7712530|NCT01721564|18992225|P1|STARTED|Overall Study||8
7712531|NCT01721486|18992232|P2|NOT COMPLETED|Overall Study||1
7712532|NCT01721486|18992233|P1|NOT COMPLETED|Overall Study||1
7712533|NCT01721486|18992232|P2|COMPLETED|Overall Study||19
7712534|NCT01721486|18992233|P1|COMPLETED|Overall Study||20
7712535|NCT01721486|18992232|P2|STARTED|Overall Study||20
7712536|NCT01721486|18992233|P1|STARTED|Overall Study||21
7712537|NCT01721473|18992251|P6|NOT COMPLETED|Overall Study||0
7712538|NCT01721473|18992252|P5|NOT COMPLETED|Overall Study||0
7712539|NCT01721473|18992253|P4|NOT COMPLETED|Overall Study||0
7712540|NCT01721473|18992254|P3|NOT COMPLETED|Overall Study||0
7712541|NCT01721473|18992255|P2|NOT COMPLETED|Overall Study||0
7712542|NCT01721473|18992256|P1|NOT COMPLETED|Overall Study||0
7712543|NCT01721473|18992251|P6|COMPLETED|Overall Study||18
7712544|NCT01721473|18992252|P5|COMPLETED|Overall Study||22
7712545|NCT01721473|18992253|P4|COMPLETED|Overall Study||34
7712546|NCT01721473|18992254|P3|COMPLETED|Overall Study||41
7712547|NCT01721473|18992255|P2|COMPLETED|Overall Study||22
7712548|NCT01721473|18992256|P1|COMPLETED|Overall Study||47
7712549|NCT01721473|18992251|P6|STARTED|Overall Study||18
7712550|NCT01721473|18992252|P5|STARTED|Overall Study||22
7712551|NCT01721473|18992253|P4|STARTED|Overall Study||34
7712552|NCT01721473|18992254|P3|STARTED|Overall Study||41
7712553|NCT01721473|18992255|P2|STARTED|Overall Study||22
7712554|NCT01721473|18992256|P1|STARTED|Overall Study||47
7712555|NCT01721460|18992265|P1|NOT COMPLETED|Overall Study||1
7712556|NCT01721460|18992265|P1|COMPLETED|Overall Study||5
7712557|NCT01721460|18992265|P1|STARTED|Overall Study||6
7712558|NCT01721447|18992272|P1|NOT COMPLETED|Overall Study||0
7712559|NCT01721447|18992272|P1|COMPLETED|Overall Study||100
7712560|NCT01721447|18992272|P1|STARTED|Overall Study||100
7712561|NCT01721408|18992281|P2|NOT COMPLETED|Overall Study||24
7712562|NCT01721408|18992282|P1|NOT COMPLETED|Overall Study||36
7712563|NCT01721408|18992281|P2|COMPLETED|Overall Study||207
7712564|NCT01721408|18992282|P1|COMPLETED|Overall Study||196
7712565|NCT01721408|18992281|P2|STARTED|Overall Study|Number of participants treated.|231
7712566|NCT01721408|18992282|P1|STARTED|Overall Study|Number of participants treated.|232
7712567|NCT01721369|18992296|P1|NOT COMPLETED|Overall Study||12
7712568|NCT01721369|18992296|P1|COMPLETED|Overall Study||569
7712569|NCT01721369|18992296|P1|STARTED|Overall Study||581
7712570|NCT01721330|18992302|P2|NOT COMPLETED|Overall Study||1
7712571|NCT01721330|18992303|P1|NOT COMPLETED|Overall Study||0
7712572|NCT01721330|18992302|P2|COMPLETED|Overall Study||1
7712573|NCT01721330|18992303|P1|COMPLETED|Overall Study||1
7712574|NCT01721330|18992302|P2|STARTED|Overall Study||2
7712575|NCT01721330|18992303|P1|STARTED|Overall Study||1
7712576|NCT01721317|18992311|P2|NOT COMPLETED|Overall Study||4
7712577|NCT01721317|18992312|P1|NOT COMPLETED|Overall Study||2
7712578|NCT01721317|18992311|P2|COMPLETED|Overall Study||0
7712579|NCT01721317|18992312|P1|COMPLETED|Overall Study||0
7712580|NCT01721317|18992311|P2|STARTED|Overall Study||4
7712581|NCT01721317|18992312|P1|STARTED|Overall Study||2
7712582|NCT01721226|18992380|P2|NOT COMPLETED|Overall Study||7
7712583|NCT01721226|18992381|P1|NOT COMPLETED|Overall Study||5
7712584|NCT01721226|18992380|P2|COMPLETED|Overall Study||50
7712585|NCT01721226|18992381|P1|COMPLETED|Overall Study||50
7712586|NCT01721226|18992380|P2|Week 24|Overall Study||50
7712587|NCT01721226|18992381|P1|Week 24|Overall Study||50
7712588|NCT01721226|18992380|P2|Week 12|Overall Study||53
7712589|NCT01721226|18992381|P1|Week 12|Overall Study||48
7712590|NCT01721226|18992380|P2|Baseline|Overall Study||57
7712591|NCT01721226|18992381|P1|Baseline|Overall Study||53
7712592|NCT01721226|18992380|P2|STARTED|Overall Study||57
7712593|NCT01721226|18992381|P1|STARTED|Overall Study||55
7712594|NCT01721200|18992391|P2|NOT COMPLETED|Overall Study||5
7712595|NCT01721200|18992392|P1|NOT COMPLETED|Overall Study||3
7712596|NCT01721200|18992391|P2|COMPLETED|Overall Study||58
7712597|NCT01721200|18992392|P1|COMPLETED|Overall Study||59
7712598|NCT01721200|18992391|P2|Completed 2 Week Follow-up|Overall Study||61
7712599|NCT01721200|18992392|P1|Completed 2 Week Follow-up|Overall Study||60
7712600|NCT01721200|18992391|P2|STARTED|Overall Study||63
7712601|NCT01721200|18992392|P1|STARTED|Overall Study||62
7712602|NCT01721161|18992417|P2|NOT COMPLETED|Overall Study||7
7712603|NCT01721161|18992418|P1|NOT COMPLETED|Overall Study||4
7712604|NCT01721161|18992417|P2|COMPLETED|Overall Study||34
7712605|NCT01721161|18992418|P1|COMPLETED|Overall Study||37
7712606|NCT01721161|18992417|P2|STARTED|Overall Study||41
7712607|NCT01721161|18992418|P1|STARTED|Overall Study||41
7712608|NCT01721109|18992441|P1|NOT COMPLETED|Overall Study||7
7712609|NCT01721109|18992441|P1|COMPLETED|Overall Study|34 participants transitioned to commercial Stribild or to an individual patient use (IPU) program|43
7712610|NCT01721109|18992441|P1|STARTED|Overall Study||50
7712611|NCT01721096|18992456|P2|NOT COMPLETED|Overall Study||204
7712612|NCT01721096|18992457|P1|NOT COMPLETED|Overall Study||320
7712613|NCT01721096|18992456|P2|COMPLETED|Overall Study||9
7712614|NCT01721096|18992457|P1|COMPLETED|Overall Study||3
7712615|NCT01721096|18992456|P2|STARTED|Overall Study||213
7712616|NCT01721096|18992457|P1|STARTED|Overall Study||323
7712617|NCT01721070|18992636|P1|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1
7712618|NCT01721070|18992636|P1|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18
7712619|NCT01721070|18992636|P1|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19
7712620|NCT01721070|18992636|P1|NOT COMPLETED|SUF NT 15 mcg||0
7712621|NCT01721070|18992636|P1|COMPLETED|SUF NT 15 mcg||19
7712622|NCT01721070|18992636|P1|STARTED|SUF NT 15 mcg||19
7712623|NCT01721057|18992647|P7|NOT COMPLETED|Follow Up||0
7712624|NCT01721057|18992648|P6|NOT COMPLETED|Follow Up||0
7712625|NCT01721057|18992649|P5|NOT COMPLETED|Follow Up||0
7712626|NCT01721057|18992650|P4|NOT COMPLETED|Follow Up||0
7712627|NCT01721057|18992651|P3|NOT COMPLETED|Follow Up||0
7712628|NCT01721057|18992652|P2|NOT COMPLETED|Follow Up||0
7712629|NCT01721057|18992653|P1|NOT COMPLETED|Follow Up||0
7712630|NCT01721057|18992647|P7|COMPLETED|Follow Up||22
7712631|NCT01721057|18992648|P6|COMPLETED|Follow Up||19
7712632|NCT01721057|18992649|P5|COMPLETED|Follow Up||17
7712633|NCT01721057|18992650|P4|COMPLETED|Follow Up||0
7712634|NCT01721057|18992651|P3|COMPLETED|Follow Up||0
7712635|NCT01721057|18992652|P2|COMPLETED|Follow Up||0
7712636|NCT01721057|18992653|P1|COMPLETED|Follow Up||0
7712637|NCT01721057|18992647|P7|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|22
7712638|NCT01721057|18992648|P6|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
7712639|NCT01721057|18992649|P5|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|17
7712640|NCT01721057|18992650|P4|STARTED|Follow Up|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4 mg FollowUp|0
7712641|NCT01721057|18992651|P3|STARTED|Follow Up||0
7712642|NCT01721057|18992652|P2|STARTED|Follow Up||0
7712643|NCT01721057|18992653|P1|STARTED|Follow Up||0
7712644|NCT01721057|18992647|P7|NOT COMPLETED|Rescue Period||0
7712645|NCT01721057|18992648|P6|NOT COMPLETED|Rescue Period||0
7712646|NCT01721057|18992649|P5|NOT COMPLETED|Rescue Period||0
7712647|NCT01721057|18992650|P4|NOT COMPLETED|Rescue Period||3
7712648|NCT01721057|18992651|P3|NOT COMPLETED|Rescue Period||0
7712649|NCT01721057|18992652|P2|NOT COMPLETED|Rescue Period||0
7712650|NCT01721057|18992653|P1|NOT COMPLETED|Rescue Period||0
7712651|NCT01721057|18992647|P7|COMPLETED|Rescue Period||0
7712652|NCT01721057|18992648|P6|COMPLETED|Rescue Period||0
7712653|NCT01721057|18992649|P5|COMPLETED|Rescue Period||0
7712654|NCT01721057|18992650|P4|COMPLETED|Rescue Period||88
7712655|NCT01721057|18992651|P3|COMPLETED|Rescue Period||0
7712656|NCT01721057|18992652|P2|COMPLETED|Rescue Period||0
7712657|NCT01721057|18992653|P1|COMPLETED|Rescue Period||0
7712658|NCT01721057|18992647|P7|STARTED|Rescue Period||0
7712659|NCT01721057|18992648|P6|STARTED|Rescue Period||0
7712660|NCT01721057|18992649|P5|STARTED|Rescue Period||0
7712742|NCT01720602|18992825|P1|COMPLETED|Overall Study||10
7712743|NCT01720602|18992825|P1|STARTED|Overall Study||15
7712661|NCT01721057|18992650|P4|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|91
7712662|NCT01721057|18992651|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
7712663|NCT01721057|18992652|P2|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
7712664|NCT01721057|18992653|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
7712665|NCT01721057|18992647|P7|NOT COMPLETED|Treatment Period||0
7712666|NCT01721057|18992648|P6|NOT COMPLETED|Treatment Period||0
7712667|NCT01721057|18992649|P5|NOT COMPLETED|Treatment Period||0
7712668|NCT01721057|18992650|P4|NOT COMPLETED|Treatment Period||0
7712669|NCT01721057|18992651|P3|NOT COMPLETED|Treatment Period||23
7712670|NCT01721057|18992652|P2|NOT COMPLETED|Treatment Period||19
7712671|NCT01721057|18992653|P1|NOT COMPLETED|Treatment Period||28
7712672|NCT01721057|18992647|P7|COMPLETED|Treatment Period||0
7712673|NCT01721057|18992648|P6|COMPLETED|Treatment Period||0
7712674|NCT01721057|18992649|P5|COMPLETED|Treatment Period||0
7712675|NCT01721057|18992650|P4|COMPLETED|Treatment Period||0
7712676|NCT01721057|18992651|P3|COMPLETED|Treatment Period|"Completers include rescued participants."|204
7712677|NCT01721057|18992652|P2|COMPLETED|Treatment Period|"Completers include rescued participants."|210
7712678|NCT01721057|18992653|P1|COMPLETED|Treatment Period|"Completers include rescued participants."|200
7712679|NCT01721057|18992647|P7|Rescued|Treatment Period||0
7712680|NCT01721057|18992648|P6|Rescued|Treatment Period||0
7712681|NCT01721057|18992649|P5|Rescued|Treatment Period||0
7712682|NCT01721057|18992650|P4|Rescued|Treatment Period||0
7712683|NCT01721057|18992651|P3|Rescued|Treatment Period||15
7712684|NCT01721057|18992652|P2|Rescued|Treatment Period||21
7712685|NCT01721057|18992653|P1|Rescued|Treatment Period||55
7712686|NCT01721057|18992647|P7|Received at Least 1 Dose of Study Drug|Treatment Period||0
7712687|NCT01721057|18992648|P6|Received at Least 1 Dose of Study Drug|Treatment Period||0
7712688|NCT01721057|18992649|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
7712689|NCT01721057|18992650|P4|Received at Least 1 Dose of Study Drug|Treatment Period||0
7712690|NCT01721057|18992651|P3|Received at Least 1 Dose of Study Drug|Treatment Period||227
7712691|NCT01721057|18992652|P2|Received at Least 1 Dose of Study Drug|Treatment Period||229
7712692|NCT01721057|18992653|P1|Received at Least 1 Dose of Study Drug|Treatment Period||228
7712693|NCT01721057|18992647|P7|STARTED|Treatment Period||0
7712694|NCT01721057|18992648|P6|STARTED|Treatment Period||0
7712695|NCT01721057|18992649|P5|STARTED|Treatment Period||0
7712696|NCT01721057|18992650|P4|STARTED|Treatment Period||0
7712697|NCT01721057|18992651|P3|STARTED|Treatment Period||227
7712698|NCT01721057|18992652|P2|STARTED|Treatment Period||229
7712699|NCT01721057|18992653|P1|STARTED|Treatment Period||228
7712700|NCT01721044|18992726|P3|NOT COMPLETED|Follow Up||0
7712701|NCT01721044|18992727|P2|NOT COMPLETED|Follow Up||0
7712702|NCT01721044|18992728|P1|NOT COMPLETED|Follow Up||0
7712703|NCT01721044|18992726|P3|COMPLETED|Follow Up||20
7712704|NCT01721044|18992727|P2|COMPLETED|Follow Up||9
7712705|NCT01721044|18992728|P1|COMPLETED|Follow Up||19
7712706|NCT01721044|18992726|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|20
7712707|NCT01721044|18992727|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|9
7712708|NCT01721044|18992728|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
7712709|NCT01721044|18992726|P3|NOT COMPLETED|Treatment Period||19
7712710|NCT01721044|18992727|P2|NOT COMPLETED|Treatment Period||17
7712711|NCT01721044|18992728|P1|NOT COMPLETED|Treatment Period||32
7712712|NCT01721044|18992726|P3|COMPLETED|Treatment Period||158
7712713|NCT01721044|18992727|P2|COMPLETED|Treatment Period||157
7712714|NCT01721044|18992728|P1|COMPLETED|Treatment Period||144
7712715|NCT01721044|18992726|P3|Rescue Week 16-24|Treatment Period||33
7712716|NCT01721044|18992727|P2|Rescue Week 16-24|Treatment Period||38
7712717|NCT01721044|18992728|P1|Rescue Week 16-24|Treatment Period||56
7712718|NCT01721044|18992726|P3|STARTED|Treatment Period||177
7712719|NCT01721044|18992727|P2|STARTED|Treatment Period|Randomized to 4mg (N=11) but received 2mg due to moderate renal impairment were included in 4mg arm|174
7712720|NCT01721044|18992728|P1|STARTED|Treatment Period||176
7712721|NCT01720797|18992801|P2|NOT COMPLETED|Overall Study||0
7712722|NCT01720797|18992802|P1|NOT COMPLETED|Overall Study||3
7712723|NCT01720797|18992801|P2|COMPLETED|Overall Study||9
7712724|NCT01720797|18992802|P1|COMPLETED|Overall Study||9
7712725|NCT01720797|18992801|P2|STARTED|Overall Study||9
7712726|NCT01720797|18992802|P1|STARTED|Overall Study||12
7712727|NCT01720667|18992810|P2|NOT COMPLETED|Overall Study||1
7712728|NCT01720667|18992811|P1|NOT COMPLETED|Overall Study||4
7712729|NCT01720667|18992810|P2|COMPLETED|Overall Study||41
7712730|NCT01720667|18992811|P1|COMPLETED|Overall Study||60
7712731|NCT01720667|18992810|P2|Modified ITT|Overall Study||30
7712732|NCT01720667|18992811|P1|Modified ITT|Overall Study||53
7712733|NCT01720667|18992810|P2|Received 2nd Infusion of Alternate Drug|Overall Study||6
7712734|NCT01720667|18992811|P1|Received 2nd Infusion of Alternate Drug|Overall Study||27
7712735|NCT01720667|18992810|P2|Recieved Alternate Intervention|Overall Study||10
7712736|NCT01720667|18992811|P1|Recieved Alternate Intervention|Overall Study||45
7712737|NCT01720667|18992810|P2|Recieved Second Infusion of Same Drug|Overall Study||20
7712738|NCT01720667|18992811|P1|Recieved Second Infusion of Same Drug|Overall Study||50
7712739|NCT01720667|18992810|P2|STARTED|Overall Study||42
7712740|NCT01720667|18992811|P1|STARTED|Overall Study||64
7712741|NCT01720602|18992825|P1|NOT COMPLETED|Overall Study||5
7712744|NCT01720524|18992835|P2|NOT COMPLETED|Part B||14
7712745|NCT01720524|18992836|P1|NOT COMPLETED|Part B||7
7712746|NCT01720524|18992835|P2|COMPLETED|Part B||12
7712747|NCT01720524|18992836|P1|COMPLETED|Part B||20
7712748|NCT01720524|18992835|P2|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|26
7712749|NCT01720524|18992836|P1|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|27
7712750|NCT01720524|18992835|P2|NOT COMPLETED|Part A||12
7712751|NCT01720524|18992836|P1|NOT COMPLETED|Part A||7
7712752|NCT01720524|18992835|P2|COMPLETED|Part A||18
7712753|NCT01720524|18992836|P1|COMPLETED|Part A||22
7712754|NCT01720524|18992835|P2|STARTED|Part A||30
7712755|NCT01720524|18992836|P1|STARTED|Part A||29
7712756|NCT01720446|18992869|P4|NOT COMPLETED|Overall Study||20
7712757|NCT01720446|18992870|P3|NOT COMPLETED|Overall Study||20
7712758|NCT01720446|18992871|P2|NOT COMPLETED|Overall Study||11
7712759|NCT01720446|18992872|P1|NOT COMPLETED|Overall Study||14
7712760|NCT01720446|18992869|P4|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|805
7712761|NCT01720446|18992870|P3|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|804
7712762|NCT01720446|18992871|P2|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|811
7712763|NCT01720446|18992872|P1|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|812
7712764|NCT01720446|18992869|P4|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|159
7712765|NCT01720446|18992870|P3|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|151
7712766|NCT01720446|18992871|P2|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|186
7712767|NCT01720446|18992872|P1|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|164
7712768|NCT01720446|18992869|P4|STARTED|Overall Study||825
7712769|NCT01720446|18992870|P3|STARTED|Overall Study||824
7712770|NCT01720446|18992871|P2|STARTED|Overall Study||822
7712771|NCT01720446|18992872|P1|STARTED|Overall Study||826
7712772|NCT01720316|18992933|P2|NOT COMPLETED|Open-label Glycine||0
7712773|NCT01720316|18992934|P1|NOT COMPLETED|Open-label Glycine||0
7712774|NCT01720316|18992933|P2|COMPLETED|Open-label Glycine||1
7712775|NCT01720316|18992934|P1|COMPLETED|Open-label Glycine||1
7712776|NCT01720316|18992933|P2|STARTED|Open-label Glycine||1
7712777|NCT01720316|18992934|P1|STARTED|Open-label Glycine||1
7712778|NCT01720316|18992933|P2|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
7712779|NCT01720316|18992934|P1|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
7712780|NCT01720316|18992933|P2|COMPLETED|Double-Blind Glycine Placebo Crossover||1
7712781|NCT01720316|18992934|P1|COMPLETED|Double-Blind Glycine Placebo Crossover||1
7712782|NCT01720316|18992933|P2|STARTED|Double-Blind Glycine Placebo Crossover||1
7712783|NCT01720316|18992934|P1|STARTED|Double-Blind Glycine Placebo Crossover||1
7712784|NCT01720277|18992982|P2|NOT COMPLETED|Overall Study||558
7712785|NCT01720277|18992983|P1|NOT COMPLETED|Overall Study||503
7712786|NCT01720277|18992982|P2|COMPLETED|Overall Study|intent-to-treat approach|938
7712787|NCT01720277|18992983|P1|COMPLETED|Overall Study|intent-to-treat approach|958
7712788|NCT01720277|18992982|P2|STARTED|Overall Study||1496
7712789|NCT01720277|18992983|P1|STARTED|Overall Study||1461
7712790|NCT01720264|18992993|P1|NOT COMPLETED|Post-transplant (Day 16) to 1 Year||12
7712791|NCT01720264|18992993|P1|COMPLETED|Post-transplant (Day 16) to 1 Year||2
7712792|NCT01720264|18992993|P1|STARTED|Post-transplant (Day 16) to 1 Year||14
7712793|NCT01720264|18992993|P1|NOT COMPLETED|Transplant With Sitagliptin for 15 Days||1
7712794|NCT01720264|18992993|P1|COMPLETED|Transplant With Sitagliptin for 15 Days||14
7712795|NCT01720264|18992993|P1|STARTED|Transplant With Sitagliptin for 15 Days||15
7712796|NCT01720251|18993003|P3|NOT COMPLETED|Overall Study||0
7712797|NCT01720251|18993004|P2|NOT COMPLETED|Overall Study||2
7712798|NCT01720251|18993005|P1|NOT COMPLETED|Overall Study||1
7712799|NCT01720251|18993003|P3|COMPLETED|Overall Study||82
7712800|NCT01720251|18993004|P2|COMPLETED|Overall Study||77
7712801|NCT01720251|18993005|P1|COMPLETED|Overall Study||78
7712802|NCT01720251|18993003|P3|STARTED|Overall Study||82
7712803|NCT01720251|18993004|P2|STARTED|Overall Study||79
7712804|NCT01720251|18993005|P1|STARTED|Overall Study||79
7712805|NCT01720225|18993015|P2|NOT COMPLETED|Overall Study||1
7712806|NCT01720225|18993016|P1|NOT COMPLETED|Overall Study||3
7712807|NCT01720225|18993015|P2|COMPLETED|Overall Study||39
7712808|NCT01720225|18993016|P1|COMPLETED|Overall Study||70
7712809|NCT01720225|18993015|P2|STARTED|Overall Study||40
7712810|NCT01720225|18993016|P1|STARTED|Overall Study||73
7712811|NCT01720173|18993024|P1|NOT COMPLETED|Overall Study||0
7712812|NCT01720173|18993024|P1|COMPLETED|Overall Study||30
7712813|NCT01720173|18993024|P1|STARTED|Overall Study||30
7712814|NCT01720069|18993035|P3|NOT COMPLETED|Overall Study||15
7712815|NCT01720069|18993036|P2|NOT COMPLETED|Overall Study||15
7712816|NCT01720069|18993037|P1|NOT COMPLETED|Overall Study||5
7712817|NCT01720069|18993035|P3|COMPLETED|Overall Study||48
7712818|NCT01720069|18993036|P2|COMPLETED|Overall Study||56
7712819|NCT01720069|18993037|P1|COMPLETED|Overall Study||57
7712820|NCT01720069|18993035|P3|Full Anaylsis Set|Overall Study||63
7712821|NCT01720069|18993036|P2|Full Anaylsis Set|Overall Study||71
7712822|NCT01720069|18993037|P1|Full Anaylsis Set|Overall Study||62
7712823|NCT01720069|18993035|P3|STARTED|Overall Study||63
7712824|NCT01720069|18993036|P2|STARTED|Overall Study||71
7712825|NCT01720069|18993037|P1|STARTED|Overall Study||62
7712826|NCT01720043|18993063|P1|NOT COMPLETED|Overall Study||1
7712827|NCT01720043|18993063|P1|COMPLETED|Overall Study||7
7712828|NCT01720043|18993063|P1|STARTED|Overall Study||8
7712829|NCT01719900|18993069|P2|NOT COMPLETED|Overall Study||2
7712830|NCT01719900|18993070|P1|NOT COMPLETED|Overall Study||7
7712831|NCT01719900|18993069|P2|COMPLETED|Overall Study||22
7712832|NCT01719900|18993070|P1|COMPLETED|Overall Study||22
7712833|NCT01719900|18993069|P2|STARTED|Overall Study||24
7712834|NCT01719900|18993070|P1|STARTED|Overall Study||29
7712835|NCT01719861|18993092|P1|NOT COMPLETED|Cycle 2||1
7712836|NCT01719861|18993092|P1|COMPLETED|Cycle 2||1
7712837|NCT01719861|18993092|P1|STARTED|Cycle 2||2
7712838|NCT01719861|18993092|P1|NOT COMPLETED|Cycle 1||4
7712839|NCT01719861|18993092|P1|COMPLETED|Cycle 1||2
7712840|NCT01719861|18993092|P1|STARTED|Cycle 1||6
7712841|NCT01719783|18993102|P2|NOT COMPLETED|Dose 2||0
7712842|NCT01719783|18993103|P1|NOT COMPLETED|Dose 2||1
7712843|NCT01719783|18993102|P2|COMPLETED|Dose 2||10
7712844|NCT01719783|18993103|P1|COMPLETED|Dose 2||29
7712845|NCT01719783|18993102|P2|STARTED|Dose 2||10
7712846|NCT01719783|18993103|P1|STARTED|Dose 2||30
7712847|NCT01719783|18993102|P2|NOT COMPLETED|Dose 1||0
7712848|NCT01719783|18993103|P1|NOT COMPLETED|Dose 1||0
7712849|NCT01719783|18993102|P2|COMPLETED|Dose 1||10
7712850|NCT01719783|18993103|P1|COMPLETED|Dose 1||30
7712851|NCT01719783|18993102|P2|STARTED|Dose 1||10
7712852|NCT01719783|18993103|P1|STARTED|Dose 1||30
7712853|NCT01719757|18993189|P1|NOT COMPLETED|Overall Study||101
7712854|NCT01719757|18993189|P1|COMPLETED|Overall Study||258
7712855|NCT01719757|18993189|P1|STARTED|Overall Study||359
7712856|NCT01719744|18993197|P1|NOT COMPLETED|Overall Study||0
7712857|NCT01719744|18993197|P1|COMPLETED|Overall Study||25
7712858|NCT01719744|18993197|P1|STARTED|Overall Study||25
7712859|NCT01719653|18993208|P5|NOT COMPLETED|Overall Study||21
7712860|NCT01719653|18993209|P4|NOT COMPLETED|Overall Study||18
7712861|NCT01719653|18993210|P3|NOT COMPLETED|Overall Study||18
7712862|NCT01719653|18993211|P2|NOT COMPLETED|Overall Study||13
7712863|NCT01719653|18993212|P1|NOT COMPLETED|Overall Study||9
7712864|NCT01719653|18993208|P5|COMPLETED|Overall Study||200
7712865|NCT01719653|18993209|P4|COMPLETED|Overall Study||200
7712866|NCT01719653|18993210|P3|COMPLETED|Overall Study||200
7712867|NCT01719653|18993211|P2|COMPLETED|Overall Study||200
7712868|NCT01719653|18993212|P1|COMPLETED|Overall Study||200
7712869|NCT01719653|18993208|P5|STARTED|Overall Study||221
7712870|NCT01719653|18993209|P4|STARTED|Overall Study||218
7712871|NCT01719653|18993210|P3|STARTED|Overall Study||218
7712872|NCT01719653|18993211|P2|STARTED|Overall Study||213
7712873|NCT01719653|18993212|P1|STARTED|Overall Study||209
7712874|NCT01719367|18993234|P2|NOT COMPLETED|Overall Study||0
7712875|NCT01719367|18993235|P1|NOT COMPLETED|Overall Study||0
7712876|NCT01719367|18993234|P2|COMPLETED|Overall Study||19
7712877|NCT01719367|18993235|P1|COMPLETED|Overall Study||19
7712878|NCT01719367|18993234|P2|STARTED|Overall Study||19
7712879|NCT01719367|18993235|P1|STARTED|Overall Study||19
7712880|NCT01719224|18993243|P2|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
7712881|NCT01719224|18993244|P1|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
7712882|NCT01719224|18993243|P2|COMPLETED|Intervention 2: Position Change(At 3.5h)||16
7712883|NCT01719224|18993244|P1|COMPLETED|Intervention 2: Position Change(At 3.5h)||14
7712884|NCT01719224|18993243|P2|STARTED|Intervention 2: Position Change(At 3.5h)||16
7712885|NCT01719224|18993244|P1|STARTED|Intervention 2: Position Change(At 3.5h)||14
7712886|NCT01719224|18993243|P2|NOT COMPLETED|Intervention 1: Sleeping Position 1||2
7712887|NCT01719224|18993244|P1|NOT COMPLETED|Intervention 1: Sleeping Position 1||4
7712888|NCT01719224|18993243|P2|COMPLETED|Intervention 1: Sleeping Position 1||16
7712889|NCT01719224|18993244|P1|COMPLETED|Intervention 1: Sleeping Position 1||14
7712890|NCT01719224|18993243|P2|STARTED|Intervention 1: Sleeping Position 1||18
7712891|NCT01719224|18993244|P1|STARTED|Intervention 1: Sleeping Position 1||18
7712892|NCT01719172|18993253|P1|NOT COMPLETED|Overall Study||2
7712893|NCT01719172|18993253|P1|COMPLETED|Overall Study||28
7712894|NCT01719172|18993253|P1|STARTED|Overall Study||30
7712895|NCT01719003|18993267|P9|NOT COMPLETED|Overall Study||4
7712896|NCT01719003|18993268|P8|NOT COMPLETED|Overall Study||20
7712897|NCT01719003|18993269|P7|NOT COMPLETED|Overall Study||20
7712898|NCT01719003|18993270|P6|NOT COMPLETED|Overall Study||12
7712899|NCT01719003|18993271|P5|NOT COMPLETED|Overall Study||17
7712900|NCT01719003|18993272|P4|NOT COMPLETED|Overall Study||13
7712901|NCT01719003|18993273|P3|NOT COMPLETED|Overall Study||17
7712902|NCT01719003|18993274|P2|NOT COMPLETED|Overall Study||17
7712903|NCT01719003|18993275|P1|NOT COMPLETED|Overall Study||9
7712904|NCT01719003|18993267|P9|COMPLETED|Overall Study||49
7712905|NCT01719003|18993268|P8|COMPLETED|Overall Study||151
7712906|NCT01719003|18993269|P7|COMPLETED|Overall Study||150
7712907|NCT01719003|18993270|P6|COMPLETED|Overall Study||160
7712908|NCT01719003|18993271|P5|COMPLETED|Overall Study||150
7712909|NCT01719003|18993272|P4|COMPLETED|Overall Study||156
7712910|NCT01719003|18993273|P3|COMPLETED|Overall Study||154
7712911|NCT01719003|18993274|P2|COMPLETED|Overall Study||153
7712912|NCT01719003|18993275|P1|COMPLETED|Overall Study||161
7712913|NCT01719003|18993267|P9|STARTED|Overall Study||53
7712914|NCT01719003|18993268|P8|STARTED|Overall Study||171
7712915|NCT01719003|18993269|P7|STARTED|Overall Study||170
7712916|NCT01719003|18993270|P6|STARTED|Overall Study||172
7712917|NCT01719003|18993271|P5|STARTED|Overall Study||167
7712918|NCT01719003|18993272|P4|STARTED|Overall Study||169
7712919|NCT01719003|18993273|P3|STARTED|Overall Study||171
7712920|NCT01719003|18993274|P2|STARTED|Overall Study||170
7712921|NCT01719003|18993275|P1|STARTED|Overall Study||170
7712922|NCT01718691|18993312|P2|NOT COMPLETED|Overall Study||1
7712923|NCT01718691|18993313|P1|NOT COMPLETED|Overall Study||18
7712924|NCT01718691|18993312|P2|COMPLETED|Overall Study||9
7712925|NCT01718691|18993313|P1|COMPLETED|Overall Study||42
7712926|NCT01718691|18993312|P2|STARTED|Overall Study||10
7712927|NCT01718691|18993313|P1|STARTED|Overall Study||60
7712928|NCT01718535|18993356|P10|NOT COMPLETED|Overall Study||0
7712929|NCT01718535|18993357|P9|NOT COMPLETED|Overall Study||0
7712930|NCT01718535|18993358|P8|NOT COMPLETED|Overall Study||0
7712931|NCT01718535|18993359|P7|NOT COMPLETED|Overall Study||0
7712932|NCT01718535|18993360|P6|NOT COMPLETED|Overall Study||0
7712933|NCT01718535|18993361|P5|NOT COMPLETED|Overall Study||0
7712934|NCT01718535|18993362|P4|NOT COMPLETED|Overall Study||1
7712935|NCT01718535|18993363|P3|NOT COMPLETED|Overall Study||0
7712936|NCT01718535|18993364|P2|NOT COMPLETED|Overall Study||0
7712937|NCT01718535|18993365|P1|NOT COMPLETED|Overall Study||1
7712938|NCT01718535|18993356|P10|COMPLETED|Overall Study||1
7712939|NCT01718535|18993357|P9|COMPLETED|Overall Study||15
7712940|NCT01718535|18993358|P8|COMPLETED|Overall Study||6
7712941|NCT01718535|18993359|P7|COMPLETED|Overall Study||11
7712942|NCT01718535|18993360|P6|COMPLETED|Overall Study||40
7712943|NCT01718535|18993361|P5|COMPLETED|Overall Study||1
7712944|NCT01718535|18993362|P4|COMPLETED|Overall Study||7
7712945|NCT01718535|18993363|P3|COMPLETED|Overall Study||19
7712946|NCT01718535|18993364|P2|COMPLETED|Overall Study||95
7712947|NCT01718535|18993365|P1|COMPLETED|Overall Study||130
7712948|NCT01718535|18993356|P10|First Pass|Overall Study||1
7712949|NCT01718535|18993357|P9|First Pass|Overall Study||15
7712950|NCT01718535|18993358|P8|First Pass|Overall Study||6
7712951|NCT01718535|18993359|P7|First Pass|Overall Study||11
7712952|NCT01718535|18993360|P6|First Pass|Overall Study||39
7712953|NCT01718535|18993361|P5|First Pass|Overall Study||1
7712954|NCT01718535|18993362|P4|First Pass|Overall Study||7
7712955|NCT01718535|18993363|P3|First Pass|Overall Study||19
7712956|NCT01718535|18993364|P2|First Pass|Overall Study||94
7712957|NCT01718535|18993365|P1|First Pass|Overall Study||128
7712958|NCT01718535|18993356|P10|STARTED|Overall Study||1
7712959|NCT01718535|18993357|P9|STARTED|Overall Study||15
7712960|NCT01718535|18993358|P8|STARTED|Overall Study||6
7712961|NCT01718535|18993359|P7|STARTED|Overall Study||11
7712962|NCT01718535|18993360|P6|STARTED|Overall Study||40
7712963|NCT01718535|18993361|P5|STARTED|Overall Study||1
7712964|NCT01718535|18993362|P4|STARTED|Overall Study||8
7712965|NCT01718535|18993363|P3|STARTED|Overall Study||19
7712966|NCT01718535|18993364|P2|STARTED|Overall Study||95
7712967|NCT01718535|18993365|P1|STARTED|Overall Study||131
7712968|NCT01718522|18993387|P1|NOT COMPLETED|Overall Study||8
7712969|NCT01718522|18993387|P1|COMPLETED|Overall Study||67
7712970|NCT01718522|18993387|P1|STARTED|Overall Study||75
7712971|NCT01718509|18993403|P2|NOT COMPLETED|Overall Study||48
7712972|NCT01718509|18993404|P1|NOT COMPLETED|Overall Study||48
7712973|NCT01718509|18993403|P2|COMPLETED|Overall Study||147
7712974|NCT01718509|18993404|P1|COMPLETED|Overall Study||147
7712975|NCT01718509|18993403|P2|STARTED|Overall Study||195
7712976|NCT01718509|18993404|P1|STARTED|Overall Study||195
7712977|NCT01718483|18993450|P2|NOT COMPLETED|Overall Study||34
7712978|NCT01718483|18993451|P1|NOT COMPLETED|Overall Study||34
7712979|NCT01718483|18993450|P2|COMPLETED|Overall Study||158
7712980|NCT01718483|18993451|P1|COMPLETED|Overall Study||157
7712981|NCT01718483|18993450|P2|Treated|Overall Study||192
7712982|NCT01718483|18993451|P1|Treated|Overall Study||187
7712983|NCT01718483|18993450|P2|STARTED|Overall Study||192
7712984|NCT01718483|18993451|P1|STARTED|Overall Study||191
7712985|NCT01718444|18993497|P2|NOT COMPLETED|Overall Study||0
7712986|NCT01718444|18993498|P1|NOT COMPLETED|Overall Study||0
7712987|NCT01718444|18993497|P2|COMPLETED|Overall Study||0
7712988|NCT01718444|18993498|P1|COMPLETED|Overall Study||0
7712989|NCT01718444|18993497|P2|STARTED|Overall Study||0
7712990|NCT01718444|18993498|P1|STARTED|Overall Study||0
7712991|NCT01718353|18993506|P2|NOT COMPLETED|Overall Study||5
7712992|NCT01718353|18993507|P1|NOT COMPLETED|Overall Study||12
7712993|NCT01718353|18993506|P2|COMPLETED|Overall Study|Participants at study cut-off, AE, DP and consent withdrawn were considered completed.|17
7712994|NCT01718353|18993507|P1|COMPLETED|Overall Study|Participants at study cut-off, Adverse Event (AE), DP & consent withdrawn were considered completed.|29
7712995|NCT01718353|18993506|P2|Treated From Cycle 5|Overall Study|3 participants switched from Treatment B to A & 12 participants switched from Treatment A to B.|25
7712996|NCT01718353|18993507|P1|Treated From Cycle 5|Overall Study|12 participants switched from Treatment A to B & 3 participants switched from Treatment B to A.|23
7712997|NCT01718353|18993506|P2|Treated up to End of Cycle 4|Overall Study|6 participants discontinued before Cycle 5|16
7712998|NCT01718353|18993507|P1|Treated up to End of Cycle 4|Overall Study|7 participants discontinued before Cycle 5|32
7712999|NCT01718353|18993506|P2|Treated|Overall Study||22
7713000|NCT01718353|18993507|P1|Treated|Overall Study||39
7713001|NCT01718353|18993506|P2|STARTED|Overall Study||22
7713002|NCT01718353|18993507|P1|STARTED|Overall Study||41
7713003|NCT01718028|18993525|P2|NOT COMPLETED|Overall Study||0
7713004|NCT01718028|18993526|P1|NOT COMPLETED|Overall Study||0
7713005|NCT01718028|18993525|P2|COMPLETED|Overall Study||24
7713006|NCT01718028|18993526|P1|COMPLETED|Overall Study||25
7713007|NCT01718028|18993525|P2|STARTED|Overall Study||24
7713008|NCT01718028|18993526|P1|STARTED|Overall Study||25
7713009|NCT01717989|18993538|P1|NOT COMPLETED|Overall Study||1066
7713010|NCT01717989|18993538|P1|COMPLETED|Overall Study||1182
7713011|NCT01717989|18993538|P1|STARTED|Overall Study||2248
7713012|NCT01717976|18993606|P2|NOT COMPLETED|Overall Study||1
7713013|NCT01717976|18993607|P1|NOT COMPLETED|Overall Study||0
7713014|NCT01717976|18993606|P2|COMPLETED|Overall Study||256
7713015|NCT01717976|18993607|P1|COMPLETED|Overall Study||257
7713016|NCT01717976|18993606|P2|STARTED|Overall Study||257
7713017|NCT01717976|18993607|P1|STARTED|Overall Study||257
7713018|NCT01717898|18993621|P4|NOT COMPLETED|Overall Study||0
7713019|NCT01717898|18993622|P3|NOT COMPLETED|Overall Study||0
7713020|NCT01717898|18993623|P2|NOT COMPLETED|Overall Study||0
7713021|NCT01717898|18993624|P1|NOT COMPLETED|Overall Study||6
7713022|NCT01717898|18993621|P4|COMPLETED|Overall Study||0
7713023|NCT01717898|18993622|P3|COMPLETED|Overall Study||0
7713024|NCT01717898|18993623|P2|COMPLETED|Overall Study||0
7713025|NCT01717898|18993624|P1|COMPLETED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
7713026|NCT01717898|18993621|P4|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
7713027|NCT01717898|18993622|P3|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
7713028|NCT01717898|18993623|P2|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
7713029|NCT01717898|18993624|P1|STARTED|Overall Study||6
7713030|NCT01717872|18993651|P2|NOT COMPLETED|Overall Study||0
7713031|NCT01717872|18993652|P1|NOT COMPLETED|Overall Study||0
7713032|NCT01717872|18993651|P2|COMPLETED|Overall Study||25
7713033|NCT01717872|18993652|P1|COMPLETED|Overall Study||25
7713034|NCT01717872|18993651|P2|STARTED|Overall Study||25
7713035|NCT01717872|18993652|P1|STARTED|Overall Study||25
7713036|NCT01717859|18993662|P1|NOT COMPLETED|Overall Study||10
7713037|NCT01717859|18993662|P1|COMPLETED|Overall Study||44
7713038|NCT01717859|18993662|P1|3 Month|Overall Study||50
7713039|NCT01717859|18993662|P1|STARTED|Overall Study||54
7713040|NCT01717768|18993683|P12|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713041|NCT01717768|18993684|P11|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713042|NCT01717768|18993685|P10|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1
7713043|NCT01717768|18993686|P9|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713044|NCT01717768|18993687|P8|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2
7713045|NCT01717768|18993688|P7|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713046|NCT01717768|18993689|P6|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713047|NCT01717768|18993690|P5|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713048|NCT01717768|18993691|P4|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713049|NCT01717768|18993692|P3|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713050|NCT01717768|18993693|P2|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713051|NCT01717768|18993694|P1|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713052|NCT01717768|18993683|P12|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713053|NCT01717768|18993684|P11|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713054|NCT01717768|18993685|P10|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
7713055|NCT01717768|18993686|P9|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713056|NCT01717768|18993687|P8|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
7713057|NCT01717768|18993688|P7|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713058|NCT01717768|18993689|P6|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713059|NCT01717768|18993690|P5|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713060|NCT01717768|18993691|P4|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713061|NCT01717768|18993692|P3|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713062|NCT01717768|18993693|P2|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713063|NCT01717768|18993694|P1|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713064|NCT01717768|18993683|P12|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713065|NCT01717768|18993684|P11|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713066|NCT01717768|18993685|P10|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16
7713067|NCT01717768|18993686|P9|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713068|NCT01717768|18993687|P8|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17
7713069|NCT01717768|18993688|P7|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713070|NCT01717768|18993689|P6|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713071|NCT01717768|18993690|P5|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713072|NCT01717768|18993691|P4|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713073|NCT01717768|18993692|P3|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713074|NCT01717768|18993693|P2|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713075|NCT01717768|18993694|P1|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
7713076|NCT01717768|18993683|P12|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1
7713077|NCT01717768|18993684|P11|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713078|NCT01717768|18993685|P10|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713079|NCT01717768|18993686|P9|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713080|NCT01717768|18993687|P8|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713081|NCT01717768|18993688|P7|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713082|NCT01717768|18993689|P6|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713083|NCT01717768|18993690|P5|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713084|NCT01717768|18993691|P4|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713085|NCT01717768|18993692|P3|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713086|NCT01717768|18993693|P2|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713087|NCT01717768|18993694|P1|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713237|NCT01717768|18993688|P7|COMPLETED|Part 2 (Duration of 15 Days)||0
7713088|NCT01717768|18993683|P12|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15
7713089|NCT01717768|18993684|P11|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
7713090|NCT01717768|18993685|P10|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713091|NCT01717768|18993686|P9|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
7713092|NCT01717768|18993687|P8|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713093|NCT01717768|18993688|P7|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17
7713094|NCT01717768|18993689|P6|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713095|NCT01717768|18993690|P5|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713096|NCT01717768|18993691|P4|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713097|NCT01717768|18993692|P3|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713098|NCT01717768|18993693|P2|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713099|NCT01717768|18993694|P1|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713100|NCT01717768|18993683|P12|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
7713101|NCT01717768|18993684|P11|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
7713102|NCT01717768|18993685|P10|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713103|NCT01717768|18993686|P9|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
7713104|NCT01717768|18993687|P8|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713105|NCT01717768|18993688|P7|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17
7713106|NCT01717768|18993689|P6|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713107|NCT01717768|18993690|P5|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713108|NCT01717768|18993691|P4|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713109|NCT01717768|18993692|P3|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713110|NCT01717768|18993693|P2|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713111|NCT01717768|18993694|P1|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
7713112|NCT01717768|18993683|P12|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713113|NCT01717768|18993684|P11|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713114|NCT01717768|18993685|P10|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713115|NCT01717768|18993686|P9|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713116|NCT01717768|18993687|P8|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713117|NCT01717768|18993688|P7|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713118|NCT01717768|18993689|P6|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713119|NCT01717768|18993690|P5|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713120|NCT01717768|18993691|P4|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713121|NCT01717768|18993692|P3|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713122|NCT01717768|18993693|P2|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713123|NCT01717768|18993694|P1|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713124|NCT01717768|18993683|P12|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713125|NCT01717768|18993684|P11|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713126|NCT01717768|18993685|P10|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713127|NCT01717768|18993686|P9|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713128|NCT01717768|18993687|P8|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713129|NCT01717768|18993688|P7|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713130|NCT01717768|18993689|P6|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
7713131|NCT01717768|18993690|P5|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
7713132|NCT01717768|18993691|P4|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4
7713133|NCT01717768|18993692|P3|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713134|NCT01717768|18993693|P2|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713135|NCT01717768|18993694|P1|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713136|NCT01717768|18993683|P12|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713137|NCT01717768|18993684|P11|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713138|NCT01717768|18993685|P10|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713139|NCT01717768|18993686|P9|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713140|NCT01717768|18993687|P8|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713141|NCT01717768|18993688|P7|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713142|NCT01717768|18993689|P6|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
7713143|NCT01717768|18993690|P5|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
7713144|NCT01717768|18993691|P4|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4
7713145|NCT01717768|18993692|P3|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713146|NCT01717768|18993693|P2|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713147|NCT01717768|18993694|P1|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
7713148|NCT01717768|18993683|P12|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713149|NCT01717768|18993684|P11|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713150|NCT01717768|18993685|P10|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713151|NCT01717768|18993686|P9|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713152|NCT01717768|18993687|P8|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713153|NCT01717768|18993688|P7|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713154|NCT01717768|18993689|P6|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713155|NCT01717768|18993690|P5|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713156|NCT01717768|18993691|P4|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713157|NCT01717768|18993692|P3|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713158|NCT01717768|18993693|P2|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713159|NCT01717768|18993694|P1|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713160|NCT01717768|18993683|P12|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713161|NCT01717768|18993684|P11|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713162|NCT01717768|18993685|P10|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713163|NCT01717768|18993686|P9|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713164|NCT01717768|18993687|P8|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713165|NCT01717768|18993688|P7|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713166|NCT01717768|18993689|P6|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
7713167|NCT01717768|18993690|P5|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
7713168|NCT01717768|18993691|P4|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4
7713169|NCT01717768|18993692|P3|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713170|NCT01717768|18993693|P2|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713171|NCT01717768|18993694|P1|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713172|NCT01717768|18993683|P12|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713173|NCT01717768|18993684|P11|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713174|NCT01717768|18993685|P10|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713175|NCT01717768|18993686|P9|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713176|NCT01717768|18993687|P8|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713177|NCT01717768|18993688|P7|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713178|NCT01717768|18993689|P6|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
7713179|NCT01717768|18993690|P5|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
7713180|NCT01717768|18993691|P4|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4
7713181|NCT01717768|18993692|P3|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713182|NCT01717768|18993693|P2|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713183|NCT01717768|18993694|P1|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
7713184|NCT01717768|18993683|P12|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713185|NCT01717768|18993684|P11|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713186|NCT01717768|18993685|P10|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713187|NCT01717768|18993686|P9|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713188|NCT01717768|18993687|P8|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713189|NCT01717768|18993688|P7|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713190|NCT01717768|18993689|P6|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713191|NCT01717768|18993690|P5|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713192|NCT01717768|18993691|P4|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713193|NCT01717768|18993692|P3|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713194|NCT01717768|18993693|P2|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713195|NCT01717768|18993694|P1|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713196|NCT01717768|18993683|P12|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713197|NCT01717768|18993684|P11|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713198|NCT01717768|18993685|P10|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713199|NCT01717768|18993686|P9|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713200|NCT01717768|18993687|P8|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713201|NCT01717768|18993688|P7|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713202|NCT01717768|18993689|P6|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
7713203|NCT01717768|18993690|P5|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
7713204|NCT01717768|18993691|P4|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4
7713205|NCT01717768|18993692|P3|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713206|NCT01717768|18993693|P2|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713207|NCT01717768|18993694|P1|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713208|NCT01717768|18993683|P12|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713209|NCT01717768|18993684|P11|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713210|NCT01717768|18993685|P10|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713211|NCT01717768|18993686|P9|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713212|NCT01717768|18993687|P8|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713213|NCT01717768|18993688|P7|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713214|NCT01717768|18993689|P6|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
7713215|NCT01717768|18993690|P5|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
7713216|NCT01717768|18993691|P4|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4
7713217|NCT01717768|18993692|P3|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713218|NCT01717768|18993693|P2|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713219|NCT01717768|18993694|P1|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
7713220|NCT01717768|18993683|P12|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
7713221|NCT01717768|18993684|P11|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
7713222|NCT01717768|18993685|P10|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
7713223|NCT01717768|18993686|P9|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
7713224|NCT01717768|18993687|P8|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
7713225|NCT01717768|18993688|P7|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
7713226|NCT01717768|18993689|P6|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
7713227|NCT01717768|18993690|P5|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
7713228|NCT01717768|18993691|P4|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
7713229|NCT01717768|18993692|P3|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
7713230|NCT01717768|18993693|P2|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
7713231|NCT01717768|18993694|P1|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
7713232|NCT01717768|18993683|P12|COMPLETED|Part 2 (Duration of 15 Days)||0
7713233|NCT01717768|18993684|P11|COMPLETED|Part 2 (Duration of 15 Days)||0
7713234|NCT01717768|18993685|P10|COMPLETED|Part 2 (Duration of 15 Days)||0
7713235|NCT01717768|18993686|P9|COMPLETED|Part 2 (Duration of 15 Days)||0
7713236|NCT01717768|18993687|P8|COMPLETED|Part 2 (Duration of 15 Days)||0
7713238|NCT01717768|18993689|P6|COMPLETED|Part 2 (Duration of 15 Days)||0
7713239|NCT01717768|18993690|P5|COMPLETED|Part 2 (Duration of 15 Days)||0
7713240|NCT01717768|18993691|P4|COMPLETED|Part 2 (Duration of 15 Days)||0
7713241|NCT01717768|18993692|P3|COMPLETED|Part 2 (Duration of 15 Days)||17
7713242|NCT01717768|18993693|P2|COMPLETED|Part 2 (Duration of 15 Days)||0
7713243|NCT01717768|18993694|P1|COMPLETED|Part 2 (Duration of 15 Days)||0
7713244|NCT01717768|18993683|P12|STARTED|Part 2 (Duration of 15 Days)||0
7713245|NCT01717768|18993684|P11|STARTED|Part 2 (Duration of 15 Days)||0
7713246|NCT01717768|18993685|P10|STARTED|Part 2 (Duration of 15 Days)||0
7713247|NCT01717768|18993686|P9|STARTED|Part 2 (Duration of 15 Days)||0
7713248|NCT01717768|18993687|P8|STARTED|Part 2 (Duration of 15 Days)||0
7713249|NCT01717768|18993688|P7|STARTED|Part 2 (Duration of 15 Days)||0
7713250|NCT01717768|18993689|P6|STARTED|Part 2 (Duration of 15 Days)||0
7713251|NCT01717768|18993690|P5|STARTED|Part 2 (Duration of 15 Days)||0
7713252|NCT01717768|18993691|P4|STARTED|Part 2 (Duration of 15 Days)||0
7713253|NCT01717768|18993692|P3|STARTED|Part 2 (Duration of 15 Days)||17
7713254|NCT01717768|18993693|P2|STARTED|Part 2 (Duration of 15 Days)||0
7713255|NCT01717768|18993694|P1|STARTED|Part 2 (Duration of 15 Days)||0
7713256|NCT01717768|18993683|P12|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
7713257|NCT01717768|18993684|P11|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
7713258|NCT01717768|18993685|P10|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
7713259|NCT01717768|18993686|P9|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
7713260|NCT01717768|18993687|P8|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
7713261|NCT01717768|18993688|P7|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
7713262|NCT01717768|18993689|P6|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
7713263|NCT01717768|18993690|P5|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
7713264|NCT01717768|18993691|P4|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
7713265|NCT01717768|18993692|P3|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
7713266|NCT01717768|18993693|P2|NOT COMPLETED|Part 1 (Duration of 15 Days)||1
7713267|NCT01717768|18993694|P1|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
7713268|NCT01717768|18993683|P12|COMPLETED|Part 1 (Duration of 15 Days)||0
7713269|NCT01717768|18993684|P11|COMPLETED|Part 1 (Duration of 15 Days)||0
7713270|NCT01717768|18993685|P10|COMPLETED|Part 1 (Duration of 15 Days)||0
7713271|NCT01717768|18993686|P9|COMPLETED|Part 1 (Duration of 15 Days)||0
7713272|NCT01717768|18993687|P8|COMPLETED|Part 1 (Duration of 15 Days)||0
7713273|NCT01717768|18993688|P7|COMPLETED|Part 1 (Duration of 15 Days)||0
7713274|NCT01717768|18993689|P6|COMPLETED|Part 1 (Duration of 15 Days)||0
7713275|NCT01717768|18993690|P5|COMPLETED|Part 1 (Duration of 15 Days)||0
7713276|NCT01717768|18993691|P4|COMPLETED|Part 1 (Duration of 15 Days)||0
7713277|NCT01717768|18993692|P3|COMPLETED|Part 1 (Duration of 15 Days)||0
7713278|NCT01717768|18993693|P2|COMPLETED|Part 1 (Duration of 15 Days)||16
7713279|NCT01717768|18993694|P1|COMPLETED|Part 1 (Duration of 15 Days)||17
7713280|NCT01717768|18993683|P12|STARTED|Part 1 (Duration of 15 Days)||0
7713281|NCT01717768|18993684|P11|STARTED|Part 1 (Duration of 15 Days)||0
7713282|NCT01717768|18993685|P10|STARTED|Part 1 (Duration of 15 Days)||0
7713283|NCT01717768|18993686|P9|STARTED|Part 1 (Duration of 15 Days)||0
7713284|NCT01717768|18993687|P8|STARTED|Part 1 (Duration of 15 Days)||0
7713285|NCT01717768|18993688|P7|STARTED|Part 1 (Duration of 15 Days)||0
7713286|NCT01717768|18993689|P6|STARTED|Part 1 (Duration of 15 Days)||0
7713287|NCT01717768|18993690|P5|STARTED|Part 1 (Duration of 15 Days)||0
7713288|NCT01717768|18993691|P4|STARTED|Part 1 (Duration of 15 Days)||0
7713289|NCT01717768|18993692|P3|STARTED|Part 1 (Duration of 15 Days)||0
7713290|NCT01717768|18993693|P2|STARTED|Part 1 (Duration of 15 Days)||17
7713291|NCT01717768|18993694|P1|STARTED|Part 1 (Duration of 15 Days)||17
7713292|NCT01717742|18993734|P2|NOT COMPLETED|Overall Study||2
7713293|NCT01717742|18993735|P1|NOT COMPLETED|Overall Study||5
7713294|NCT01717742|18993734|P2|COMPLETED|Overall Study||47
7713295|NCT01717742|18993735|P1|COMPLETED|Overall Study||43
7713296|NCT01717742|18993734|P2|STARTED|Overall Study||49
7713297|NCT01717742|18993735|P1|STARTED|Overall Study||48
7713298|NCT01717638|18993774|P13|NOT COMPLETED|Overall Study||19
7713299|NCT01717638|18993775|P12|NOT COMPLETED|Overall Study||0
7713300|NCT01717638|18993776|P11|NOT COMPLETED|Overall Study||0
7713301|NCT01717638|18993777|P10|NOT COMPLETED|Overall Study||1
7713302|NCT01717638|18993778|P9|NOT COMPLETED|Overall Study||2
7713303|NCT01717638|18993779|P8|NOT COMPLETED|Overall Study||1
7713304|NCT01717638|18993780|P7|NOT COMPLETED|Overall Study||2
7713305|NCT01717638|18993781|P6|NOT COMPLETED|Overall Study||1
7713306|NCT01717638|18993782|P5|NOT COMPLETED|Overall Study||1
7713307|NCT01717638|18993783|P4|NOT COMPLETED|Overall Study||0
7713308|NCT01717638|18993784|P3|NOT COMPLETED|Overall Study||1
7713309|NCT01717638|18993785|P2|NOT COMPLETED|Overall Study||1
7713310|NCT01717638|18993786|P1|NOT COMPLETED|Overall Study||0
7713311|NCT01717638|18993774|P13|COMPLETED|Overall Study||190
7713312|NCT01717638|18993775|P12|COMPLETED|Overall Study||12
7713313|NCT01717638|18993776|P11|COMPLETED|Overall Study||11
7713314|NCT01717638|18993777|P10|COMPLETED|Overall Study||99
7713315|NCT01717638|18993778|P9|COMPLETED|Overall Study||26
7713316|NCT01717638|18993779|P8|COMPLETED|Overall Study||28
7713317|NCT01717638|18993780|P7|COMPLETED|Overall Study||41
7713318|NCT01717638|18993781|P6|COMPLETED|Overall Study||54
7713319|NCT01717638|18993782|P5|COMPLETED|Overall Study||63
7713320|NCT01717638|18993783|P4|COMPLETED|Overall Study||66
7713321|NCT01717638|18993784|P3|COMPLETED|Overall Study||59
7713322|NCT01717638|18993785|P2|COMPLETED|Overall Study||60
7713323|NCT01717638|18993786|P1|COMPLETED|Overall Study||67
7713324|NCT01717638|18993774|P13|STARTED|Overall Study||209
7713325|NCT01717638|18993775|P12|STARTED|Overall Study||12
7713326|NCT01717638|18993776|P11|STARTED|Overall Study||11
7713327|NCT01717638|18993777|P10|STARTED|Overall Study||100
7713328|NCT01717638|18993778|P9|STARTED|Overall Study||28
7713329|NCT01717638|18993779|P8|STARTED|Overall Study||29
7713330|NCT01717638|18993780|P7|STARTED|Overall Study||43
7713331|NCT01717638|18993781|P6|STARTED|Overall Study||55
7713332|NCT01717638|18993782|P5|STARTED|Overall Study||64
7713333|NCT01717638|18993783|P4|STARTED|Overall Study||66
7713334|NCT01717638|18993784|P3|STARTED|Overall Study||60
7713335|NCT01717638|18993785|P2|STARTED|Overall Study||61
7713336|NCT01717638|18993786|P1|STARTED|Overall Study||67
7713337|NCT01717521|18993928|P1|NOT COMPLETED|Overall Study||0
7713338|NCT01717521|18993928|P1|COMPLETED|Overall Study||20
7713339|NCT01717521|18993928|P1|STARTED|Overall Study||20
7713340|NCT01717482|18993947|P2|NOT COMPLETED|Overall Study||0
7713341|NCT01717482|18993948|P1|NOT COMPLETED|Overall Study||4
7713342|NCT01717482|18993947|P2|COMPLETED|Overall Study||2
7713343|NCT01717482|18993948|P1|COMPLETED|Overall Study||0
7713344|NCT01717482|18993947|P2|STARTED|Overall Study||2
7713345|NCT01717482|18993948|P1|STARTED|Overall Study||4
7713346|NCT01717456|18993962|P2|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
7713347|NCT01717456|18993963|P1|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
7713348|NCT01717456|18993962|P2|COMPLETED|Follow-Up 6 Months After End of Tx||2
7713349|NCT01717456|18993963|P1|COMPLETED|Follow-Up 6 Months After End of Tx||7
7713350|NCT01717456|18993962|P2|STARTED|Follow-Up 6 Months After End of Tx||6
7713351|NCT01717456|18993963|P1|STARTED|Follow-Up 6 Months After End of Tx||11
7713352|NCT01717456|18993962|P2|NOT COMPLETED|End of Treatment||2
7713353|NCT01717456|18993963|P1|NOT COMPLETED|End of Treatment||0
7713354|NCT01717456|18993962|P2|COMPLETED|End of Treatment||6
7713355|NCT01717456|18993963|P1|COMPLETED|End of Treatment||11
7713356|NCT01717456|18993962|P2|STARTED|End of Treatment||8
7713357|NCT01717456|18993963|P1|STARTED|End of Treatment||11
7713358|NCT01717391|18994031|P1|NOT COMPLETED|Overall Study||9
7713359|NCT01717391|18994031|P1|COMPLETED|Overall Study||27
7713360|NCT01717391|18994031|P1|STARTED|Overall Study||36
7713361|NCT01717326|18994060|P20|NOT COMPLETED|Overall Study||6
7713362|NCT01717326|18994061|P19|NOT COMPLETED|Overall Study||4
7713363|NCT01717326|18994062|P18|NOT COMPLETED|Overall Study||0
7713364|NCT01717326|18994063|P17|NOT COMPLETED|Overall Study||1
7713365|NCT01717326|18994064|P16|NOT COMPLETED|Overall Study||3
7713366|NCT01717326|18994065|P15|NOT COMPLETED|Overall Study||0
7713367|NCT01717326|18994066|P14|NOT COMPLETED|Overall Study||0
7713368|NCT01717326|18994067|P13|NOT COMPLETED|Overall Study||1
7713369|NCT01717326|18994068|P12|NOT COMPLETED|Overall Study||0
7713370|NCT01717326|18994069|P11|NOT COMPLETED|Overall Study||2
7713371|NCT01717326|18994070|P10|NOT COMPLETED|Overall Study||2
7713372|NCT01717326|18994071|P9|NOT COMPLETED|Overall Study||0
7713373|NCT01717326|18994072|P8|NOT COMPLETED|Overall Study||0
7713374|NCT01717326|18994073|P7|NOT COMPLETED|Overall Study||1
7713375|NCT01717326|18994074|P6|NOT COMPLETED|Overall Study||0
7713376|NCT01717326|18994075|P5|NOT COMPLETED|Overall Study||2
7713377|NCT01717326|18994076|P4|NOT COMPLETED|Overall Study||2
7713378|NCT01717326|18994077|P3|NOT COMPLETED|Overall Study||0
7713379|NCT01717326|18994078|P2|NOT COMPLETED|Overall Study||1
7713380|NCT01717326|18994079|P1|NOT COMPLETED|Overall Study||3
7713381|NCT01717326|18994060|P20|COMPLETED|Overall Study||15
7713382|NCT01717326|18994061|P19|COMPLETED|Overall Study||16
7713383|NCT01717326|18994062|P18|COMPLETED|Overall Study||31
7713384|NCT01717326|18994063|P17|COMPLETED|Overall Study||29
7713385|NCT01717326|18994064|P16|COMPLETED|Overall Study||27
7713386|NCT01717326|18994065|P15|COMPLETED|Overall Study||29
7713387|NCT01717326|18994066|P14|COMPLETED|Overall Study||32
7713388|NCT01717326|18994067|P13|COMPLETED|Overall Study||32
7713389|NCT01717326|18994068|P12|COMPLETED|Overall Study||33
7713390|NCT01717326|18994069|P11|COMPLETED|Overall Study||30
7713391|NCT01717326|18994070|P10|COMPLETED|Overall Study||29
7713392|NCT01717326|18994071|P9|COMPLETED|Overall Study||32
7713393|NCT01717326|18994072|P8|COMPLETED|Overall Study||29
7713394|NCT01717326|18994073|P7|COMPLETED|Overall Study||30
7713395|NCT01717326|18994074|P6|COMPLETED|Overall Study||31
7713396|NCT01717326|18994075|P5|COMPLETED|Overall Study||31
7713397|NCT01717326|18994076|P4|COMPLETED|Overall Study||28
7713398|NCT01717326|18994077|P3|COMPLETED|Overall Study||13
7713399|NCT01717326|18994078|P2|COMPLETED|Overall Study||26
7713400|NCT01717326|18994079|P1|COMPLETED|Overall Study||22
7713401|NCT01717326|18994060|P20|Treated|Overall Study||21
7713402|NCT01717326|18994061|P19|Treated|Overall Study||20
7713403|NCT01717326|18994062|P18|Treated|Overall Study||31
7713404|NCT01717326|18994063|P17|Treated|Overall Study||30
7713405|NCT01717326|18994064|P16|Treated|Overall Study||30
7713406|NCT01717326|18994065|P15|Treated|Overall Study||29
7713407|NCT01717326|18994066|P14|Treated|Overall Study||32
7713408|NCT01717326|18994067|P13|Treated|Overall Study||33
7713409|NCT01717326|18994068|P12|Treated|Overall Study||33
7713410|NCT01717326|18994069|P11|Treated|Overall Study||32
7713411|NCT01717326|18994070|P10|Treated|Overall Study||31
7713412|NCT01717326|18994071|P9|Treated|Overall Study||32
7713413|NCT01717326|18994072|P8|Treated|Overall Study||29
7713414|NCT01717326|18994073|P7|Treated|Overall Study||31
7713415|NCT01717326|18994074|P6|Treated|Overall Study||31
7713416|NCT01717326|18994075|P5|Treated|Overall Study||33
7713417|NCT01717326|18994076|P4|Treated|Overall Study||30
7713418|NCT01717326|18994077|P3|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12
7713419|NCT01717326|18994078|P2|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28
7713420|NCT01717326|18994079|P1|Treated|Overall Study||25
7713421|NCT01717326|18994060|P20|STARTED|Overall Study||21
7713422|NCT01717326|18994061|P19|STARTED|Overall Study||20
7713423|NCT01717326|18994062|P18|STARTED|Overall Study||31
7713424|NCT01717326|18994063|P17|STARTED|Overall Study||30
7713425|NCT01717326|18994064|P16|STARTED|Overall Study||30
7713426|NCT01717326|18994065|P15|STARTED|Overall Study||29
7713427|NCT01717326|18994066|P14|STARTED|Overall Study||32
7713428|NCT01717326|18994067|P13|STARTED|Overall Study||33
7713429|NCT01717326|18994068|P12|STARTED|Overall Study||33
7713430|NCT01717326|18994069|P11|STARTED|Overall Study||32
7713431|NCT01717326|18994070|P10|STARTED|Overall Study||31
7713432|NCT01717326|18994071|P9|STARTED|Overall Study||32
7713433|NCT01717326|18994072|P8|STARTED|Overall Study||29
7713434|NCT01717326|18994073|P7|STARTED|Overall Study||31
7713435|NCT01717326|18994074|P6|STARTED|Overall Study||31
7713436|NCT01717326|18994075|P5|STARTED|Overall Study||33
7713437|NCT01717326|18994076|P4|STARTED|Overall Study||30
7713438|NCT01717326|18994077|P3|STARTED|Overall Study||13
7713439|NCT01717326|18994078|P2|STARTED|Overall Study||27
7713440|NCT01717326|18994079|P1|STARTED|Overall Study||25
7713441|NCT01717313|18994343|P2|NOT COMPLETED|Phase B (Weeks 24 to 54)||16
7713442|NCT01717313|18994344|P1|NOT COMPLETED|Phase B (Weeks 24 to 54)||12
7713443|NCT01717313|18994343|P2|COMPLETED|Phase B (Weeks 24 to 54)||135
7713444|NCT01717313|18994344|P1|COMPLETED|Phase B (Weeks 24 to 54)||134
7713445|NCT01717313|18994343|P2|STARTED|Phase B (Weeks 24 to 54)||151
7713446|NCT01717313|18994344|P1|STARTED|Phase B (Weeks 24 to 54)||146
7713447|NCT01717313|18994343|P2|NOT COMPLETED|Interphase||0
7713448|NCT01717313|18994344|P1|NOT COMPLETED|Interphase||1
7713449|NCT01717313|18994343|P2|COMPLETED|Interphase||151
7713450|NCT01717313|18994344|P1|COMPLETED|Interphase||146
7713451|NCT01717313|18994343|P2|STARTED|Interphase||151
7713452|NCT01717313|18994344|P1|STARTED|Interphase||147
7713453|NCT01717313|18994343|P2|NOT COMPLETED|Phase A (Weeks 0 to 24)||13
7713454|NCT01717313|18994344|P1|NOT COMPLETED|Phase A (Weeks 0 to 24)||18
7713455|NCT01717313|18994343|P2|COMPLETED|Phase A (Weeks 0 to 24)||151
7713456|NCT01717313|18994344|P1|COMPLETED|Phase A (Weeks 0 to 24)||147
7713457|NCT01717313|18994343|P2|STARTED|Phase A (Weeks 0 to 24)||164
7713458|NCT01717313|18994344|P1|STARTED|Phase A (Weeks 0 to 24)||165
7713459|NCT01717287|18994382|P2|NOT COMPLETED|Overall Study||3
7713460|NCT01717287|18994383|P1|NOT COMPLETED|Overall Study||0
7713461|NCT01717287|18994382|P2|COMPLETED|Overall Study||25
7713462|NCT01717287|18994383|P1|COMPLETED|Overall Study||4
7713463|NCT01717287|18994382|P2|STARTED|Overall Study||28
7713464|NCT01717287|18994383|P1|STARTED|Overall Study||4
7713465|NCT01717209|18994405|P1|NOT COMPLETED|Overall Study||0
7713466|NCT01717209|18994405|P1|COMPLETED|Overall Study||14
7713467|NCT01717209|18994405|P1|STARTED|Overall Study||14
7713468|NCT01717053|18994414|P1|NOT COMPLETED|Overall Study||4
7713469|NCT01717053|18994414|P1|COMPLETED|Overall Study||33
7713470|NCT01717053|18994414|P1|STARTED|Overall Study||37
7713471|NCT01717040|18994423|P2|NOT COMPLETED|Overall Study||5
7713472|NCT01717040|18994424|P1|NOT COMPLETED|Overall Study||5
7713473|NCT01717040|18994423|P2|COMPLETED|Overall Study||15
7713474|NCT01717040|18994424|P1|COMPLETED|Overall Study||12
7713475|NCT01717040|18994423|P2|STARTED|Overall Study||20
7713476|NCT01717040|18994424|P1|STARTED|Overall Study||17
7713477|NCT01717014|18994430|P1|NOT COMPLETED|Overall Study||0
7713478|NCT01717014|18994430|P1|COMPLETED|Overall Study||8
7713479|NCT01717014|18994430|P1|STARTED|Overall Study||8
7713480|NCT01717001|18994440|P2|NOT COMPLETED|Overall Study||4
7713481|NCT01717001|18994441|P1|NOT COMPLETED|Overall Study||6
7713482|NCT01717001|18994440|P2|COMPLETED|Overall Study||24
7713483|NCT01717001|18994441|P1|COMPLETED|Overall Study||32
7713484|NCT01717001|18994440|P2|STARTED|Overall Study||28
7713485|NCT01717001|18994441|P1|STARTED|Overall Study||38
7713486|NCT01716754|18994451|P4|NOT COMPLETED|Overall Study||8
7713487|NCT01716754|18994452|P3|NOT COMPLETED|Overall Study||14
7713488|NCT01716754|18994453|P2|NOT COMPLETED|Overall Study||4
7713489|NCT01716754|18994454|P1|NOT COMPLETED|Overall Study||11
7713490|NCT01716754|18994451|P4|COMPLETED|Overall Study||89
7713491|NCT01716754|18994452|P3|COMPLETED|Overall Study||121
7713492|NCT01716754|18994453|P2|COMPLETED|Overall Study||36
7713493|NCT01716754|18994454|P1|COMPLETED|Overall Study||188
7713494|NCT01716754|18994451|P4|Safety Set|Overall Study||96
7713495|NCT01716754|18994452|P3|Safety Set|Overall Study||131
7713496|NCT01716754|18994453|P2|Safety Set|Overall Study||40
7713497|NCT01716754|18994454|P1|Safety Set|Overall Study||199
7713498|NCT01716754|18994451|P4|FAS|Overall Study||96
7713499|NCT01716754|18994452|P3|FAS|Overall Study||131
7713500|NCT01716754|18994453|P2|FAS|Overall Study||40
7713501|NCT01716754|18994454|P1|FAS|Overall Study||199
7713502|NCT01716754|18994451|P4|STARTED|Overall Study||97
7713503|NCT01716754|18994452|P3|STARTED|Overall Study||135
7713504|NCT01716754|18994453|P2|STARTED|Overall Study||40
7713505|NCT01716754|18994454|P1|STARTED|Overall Study||199
7713506|NCT01716715|18994477|P2|NOT COMPLETED|Overall Study||4
7713507|NCT01716715|18994478|P1|NOT COMPLETED|Overall Study||2
7713508|NCT01716715|18994477|P2|COMPLETED|Overall Study||50
7713509|NCT01716715|18994478|P1|COMPLETED|Overall Study||55
7713510|NCT01716715|18994477|P2|STARTED|Overall Study||54
7713511|NCT01716715|18994478|P1|STARTED|Overall Study||57
7713512|NCT01716663|18994494|P1|NOT COMPLETED|Overall Study||6
7713513|NCT01716663|18994494|P1|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228
7713514|NCT01716663|18994494|P1|Safety|Overall Study|Enrolled patients who had a study device inserted.|230
7713515|NCT01716663|18994494|P1|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234
7713516|NCT01716585|18994504|P2|NOT COMPLETED|Open-label Treatment||7
7713517|NCT01716585|18994505|P1|NOT COMPLETED|Open-label Treatment||0
7713518|NCT01716585|18994504|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150
7713519|NCT01716585|18994505|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
7713520|NCT01716585|18994504|P2|STARTED|Open-label Treatment||157
7713521|NCT01716585|18994505|P1|STARTED|Open-label Treatment|not applicable to this arm|0
7713522|NCT01716585|18994504|P2|NOT COMPLETED|Double-blind Treatment||2
7713523|NCT01716585|18994505|P1|NOT COMPLETED|Double-blind Treatment||13
7713524|NCT01716585|18994504|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157
7713525|NCT01716585|18994505|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464
7713526|NCT01716585|18994504|P2|Randomized But Not Treated|Double-blind Treatment||1
7713527|NCT01716585|18994505|P1|Randomized But Not Treated|Double-blind Treatment||4
7713528|NCT01716585|18994504|P2|STARTED|Double-blind Treatment||159
7713529|NCT01716585|18994505|P1|STARTED|Double-blind Treatment||477
7713530|NCT01716559|18994517|P1|NOT COMPLETED|Overall Study||111
7713531|NCT01716559|18994517|P1|COMPLETED|Overall Study||49
7713532|NCT01716559|18994517|P1|STARTED|Overall Study||160
7713533|NCT01716533|18994529|P4|NOT COMPLETED|Overall Study||8
7713534|NCT01716533|18994530|P3|NOT COMPLETED|Overall Study||5
7713535|NCT01716533|18994531|P2|NOT COMPLETED|Overall Study||0
7713536|NCT01716533|18994532|P1|NOT COMPLETED|Overall Study||0
7713537|NCT01716533|18994529|P4|COMPLETED|Overall Study||1
7713538|NCT01716533|18994530|P3|COMPLETED|Overall Study||0
7713539|NCT01716533|18994531|P2|COMPLETED|Overall Study||25
7713540|NCT01716533|18994532|P1|COMPLETED|Overall Study||7
7713541|NCT01716533|18994529|P4|STARTED|Overall Study||9
7713542|NCT01716533|18994530|P3|STARTED|Overall Study||5
7713543|NCT01716533|18994531|P2|STARTED|Overall Study||25
7713544|NCT01716533|18994532|P1|STARTED|Overall Study||7
7713545|NCT01716520|18994586|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
7713546|NCT01716520|18994587|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
7713547|NCT01716520|18994588|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
7713548|NCT01716520|18994589|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
7713549|NCT01716520|18994590|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
7713550|NCT01716520|18994591|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
7713551|NCT01716520|18994586|P6|COMPLETED|Treatment Period 3 (14 Days)||23
7713552|NCT01716520|18994587|P5|COMPLETED|Treatment Period 3 (14 Days)||29
7713553|NCT01716520|18994588|P4|COMPLETED|Treatment Period 3 (14 Days)||28
7713554|NCT01716520|18994589|P3|COMPLETED|Treatment Period 3 (14 Days)||25
7713555|NCT01716520|18994590|P2|COMPLETED|Treatment Period 3 (14 Days)||27
7713556|NCT01716520|18994591|P1|COMPLETED|Treatment Period 3 (14 Days)||27
7713557|NCT01716520|18994586|P6|STARTED|Treatment Period 3 (14 Days)||25
7713558|NCT01716520|18994587|P5|STARTED|Treatment Period 3 (14 Days)||29
7713559|NCT01716520|18994588|P4|STARTED|Treatment Period 3 (14 Days)||28
7713560|NCT01716520|18994589|P3|STARTED|Treatment Period 3 (14 Days)||26
7713561|NCT01716520|18994590|P2|STARTED|Treatment Period 3 (14 Days)||27
7713562|NCT01716520|18994591|P1|STARTED|Treatment Period 3 (14 Days)||27
7713563|NCT01716520|18994586|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
7713564|NCT01716520|18994587|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
7713565|NCT01716520|18994588|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
7713566|NCT01716520|18994589|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
7713567|NCT01716520|18994590|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
7713568|NCT01716520|18994591|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
7713569|NCT01716520|18994586|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||25
7713570|NCT01716520|18994587|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||29
7713571|NCT01716520|18994588|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||28
7713572|NCT01716520|18994589|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||26
7713573|NCT01716520|18994590|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||27
7713574|NCT01716520|18994591|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||27
7713575|NCT01716520|18994586|P6|STARTED|Washout Period 2 (10 to 14 Days)||27
7713576|NCT01716520|18994587|P5|STARTED|Washout Period 2 (10 to 14 Days)||29
7713577|NCT01716520|18994588|P4|STARTED|Washout Period 2 (10 to 14 Days)||28
7713578|NCT01716520|18994589|P3|STARTED|Washout Period 2 (10 to 14 Days)||27
7713579|NCT01716520|18994590|P2|STARTED|Washout Period 2 (10 to 14 Days)||28
7713580|NCT01716520|18994591|P1|STARTED|Washout Period 2 (10 to 14 Days)||29
7713581|NCT01716520|18994586|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
7713582|NCT01716520|18994587|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||2
7713583|NCT01716520|18994588|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
7713584|NCT01716520|18994589|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
7713585|NCT01716520|18994590|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
7713586|NCT01716520|18994591|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
7713587|NCT01716520|18994586|P6|COMPLETED|Treatment Period 2 (14 Days)||27
7713588|NCT01716520|18994587|P5|COMPLETED|Treatment Period 2 (14 Days)||29
7713589|NCT01716520|18994588|P4|COMPLETED|Treatment Period 2 (14 Days)||28
7713590|NCT01716520|18994589|P3|COMPLETED|Treatment Period 2 (14 Days)||27
7713591|NCT01716520|18994590|P2|COMPLETED|Treatment Period 2 (14 Days)||28
7713592|NCT01716520|18994591|P1|COMPLETED|Treatment Period 2 (14 Days)||29
7713593|NCT01716520|18994586|P6|STARTED|Treatment Period 2 (14 Days)||27
7713594|NCT01716520|18994587|P5|STARTED|Treatment Period 2 (14 Days)||31
7713595|NCT01716520|18994588|P4|STARTED|Treatment Period 2 (14 Days)||29
7713596|NCT01716520|18994589|P3|STARTED|Treatment Period 2 (14 Days)||27
7713597|NCT01716520|18994590|P2|STARTED|Treatment Period 2 (14 Days)||28
7713598|NCT01716520|18994591|P1|STARTED|Treatment Period 2 (14 Days)||29
7713599|NCT01716520|18994586|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2
7713600|NCT01716520|18994587|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
7713601|NCT01716520|18994588|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
7713602|NCT01716520|18994589|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
7713603|NCT01716520|18994590|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
7713604|NCT01716520|18994591|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
7713605|NCT01716520|18994586|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||27
7713606|NCT01716520|18994587|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||31
7713607|NCT01716520|18994588|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||29
7713608|NCT01716520|18994589|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||27
7713609|NCT01716520|18994590|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||28
7713610|NCT01716520|18994591|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||29
7713611|NCT01716520|18994586|P6|STARTED|Washout Period 1 (10 to 14 Days)||29
7713612|NCT01716520|18994587|P5|STARTED|Washout Period 1 (10 to 14 Days)||31
7713613|NCT01716520|18994588|P4|STARTED|Washout Period 1 (10 to 14 Days)||29
7713614|NCT01716520|18994589|P3|STARTED|Washout Period 1 (10 to 14 Days)||28
7713615|NCT01716520|18994590|P2|STARTED|Washout Period 1 (10 to 14 Days)||29
7713616|NCT01716520|18994591|P1|STARTED|Washout Period 1 (10 to 14 Days)||29
7713617|NCT01716520|18994586|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
7713618|NCT01716520|18994587|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
7713619|NCT01716520|18994588|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||1
7713620|NCT01716520|18994589|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||2
7713621|NCT01716520|18994590|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
7713622|NCT01716520|18994591|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
7713623|NCT01716520|18994586|P6|COMPLETED|Treatment Period 1 (14 Days)||29
7713624|NCT01716520|18994587|P5|COMPLETED|Treatment Period 1 (14 Days)||31
7713625|NCT01716520|18994588|P4|COMPLETED|Treatment Period 1 (14 Days)||29
7713626|NCT01716520|18994589|P3|COMPLETED|Treatment Period 1 (14 Days)||28
7713627|NCT01716520|18994590|P2|COMPLETED|Treatment Period 1 (14 Days)||29
7713628|NCT01716520|18994591|P1|COMPLETED|Treatment Period 1 (14 Days)||29
7713629|NCT01716520|18994586|P6|STARTED|Treatment Period 1 (14 Days)||30
7713630|NCT01716520|18994587|P5|STARTED|Treatment Period 1 (14 Days)||31
7713631|NCT01716520|18994588|P4|STARTED|Treatment Period 1 (14 Days)||30
7713632|NCT01716520|18994589|P3|STARTED|Treatment Period 1 (14 Days)||30
7713633|NCT01716520|18994590|P2|STARTED|Treatment Period 1 (14 Days)||30
7713634|NCT01716520|18994591|P1|STARTED|Treatment Period 1 (14 Days)||31
7713635|NCT01716468|18994607|P1|NOT COMPLETED|Overall Study||6
7713636|NCT01716468|18994607|P1|COMPLETED|Overall Study||11
7713637|NCT01716468|18994607|P1|STARTED|Overall Study||17
7713638|NCT01716455|18994617|P6|NOT COMPLETED|Overall Study||0
7713639|NCT01716455|18994618|P5|NOT COMPLETED|Overall Study||0
7713640|NCT01716455|18994619|P4|NOT COMPLETED|Overall Study||0
7713641|NCT01716455|18994620|P3|NOT COMPLETED|Overall Study||0
7713642|NCT01716455|18994621|P2|NOT COMPLETED|Overall Study||0
7713643|NCT01716455|18994622|P1|NOT COMPLETED|Overall Study||0
7713644|NCT01716455|18994617|P6|COMPLETED|Overall Study||8
7713645|NCT01716455|18994618|P5|COMPLETED|Overall Study||26
7713646|NCT01716455|18994619|P4|COMPLETED|Overall Study||8
7713647|NCT01716455|18994620|P3|COMPLETED|Overall Study||8
7713648|NCT01716455|18994621|P2|COMPLETED|Overall Study||8
7713649|NCT01716455|18994622|P1|COMPLETED|Overall Study||8
7713650|NCT01716455|18994617|P6|STARTED|Overall Study||8
7713651|NCT01716455|18994618|P5|STARTED|Overall Study||26
7713652|NCT01716455|18994619|P4|STARTED|Overall Study||8
7713653|NCT01716455|18994620|P3|STARTED|Overall Study||8
7713654|NCT01716455|18994621|P2|STARTED|Overall Study||8
7713655|NCT01716455|18994622|P1|STARTED|Overall Study||8
7713656|NCT01716234|18994646|P7|NOT COMPLETED|Overall Study||0
7713657|NCT01716234|18994647|P6|NOT COMPLETED|Overall Study||14
7713658|NCT01716234|18994648|P5|NOT COMPLETED|Overall Study||5
7713659|NCT01716234|18994649|P4|NOT COMPLETED|Overall Study||12
7713660|NCT01716234|18994650|P3|NOT COMPLETED|Overall Study||5
7713661|NCT01716234|18994651|P2|NOT COMPLETED|Overall Study||10
7713662|NCT01716234|18994652|P1|NOT COMPLETED|Overall Study||10
7713663|NCT01716234|18994646|P7|COMPLETED|Overall Study||1
7713664|NCT01716234|18994647|P6|COMPLETED|Overall Study||18
7713665|NCT01716234|18994648|P5|COMPLETED|Overall Study||10
7713666|NCT01716234|18994649|P4|COMPLETED|Overall Study||16
7713667|NCT01716234|18994650|P3|COMPLETED|Overall Study||15
7713668|NCT01716234|18994651|P2|COMPLETED|Overall Study||12
7713669|NCT01716234|18994652|P1|COMPLETED|Overall Study||14
7713670|NCT01716234|18994646|P7|Treated|Overall Study||1
7713671|NCT01716234|18994647|P6|Treated|Overall Study||30
7713672|NCT01716234|18994648|P5|Treated|Overall Study||15
7713673|NCT01716234|18994649|P4|Treated|Overall Study||28
7713674|NCT01716234|18994650|P3|Treated|Overall Study||19
7713675|NCT01716234|18994651|P2|Treated|Overall Study||21
7713676|NCT01716234|18994652|P1|Treated|Overall Study||22
7713677|NCT01716234|18994646|P7|STARTED|Overall Study||1
7713678|NCT01716234|18994647|P6|STARTED|Overall Study||32
7713679|NCT01716234|18994648|P5|STARTED|Overall Study||15
7713680|NCT01716234|18994649|P4|STARTED|Overall Study||28
7713681|NCT01716234|18994650|P3|STARTED|Overall Study||20
7713682|NCT01716234|18994651|P2|STARTED|Overall Study||22
7713683|NCT01716234|18994652|P1|STARTED|Overall Study||24
7713684|NCT01716221|18994689|P1|NOT COMPLETED|Overall Study||0
7713685|NCT01716221|18994689|P1|COMPLETED|Overall Study||1
7713686|NCT01716221|18994689|P1|STARTED|Overall Study||1
7713687|NCT01716169|18994715|P1|NOT COMPLETED|Overall Study||4
7713688|NCT01716169|18994715|P1|COMPLETED|Overall Study||6
7713689|NCT01716169|18994715|P1|Standard of Care Dressings Used|Overall Study||7
7713690|NCT01716169|18994715|P1|STARTED|Overall Study||10
7713691|NCT01716156|18994724|P3|NOT COMPLETED|Overall Study||2
7713692|NCT01716156|18994725|P2|NOT COMPLETED|Overall Study||1
7713693|NCT01716156|18994726|P1|NOT COMPLETED|Overall Study||2
7713694|NCT01716156|18994724|P3|COMPLETED|Overall Study||11
7713695|NCT01716156|18994725|P2|COMPLETED|Overall Study||3
7713696|NCT01716156|18994726|P1|COMPLETED|Overall Study||7
7713697|NCT01716156|18994724|P3|STARTED|Overall Study||13
7713698|NCT01716156|18994725|P2|STARTED|Overall Study||4
7713699|NCT01716156|18994726|P1|STARTED|Overall Study||9
7713700|NCT01716117|18994752|P2|NOT COMPLETED|Overall Study||2
7713701|NCT01716117|18994753|P1|NOT COMPLETED|Overall Study||7
7713702|NCT01716117|18994752|P2|COMPLETED|Overall Study||31
7713703|NCT01716117|18994753|P1|COMPLETED|Overall Study||173
7713704|NCT01716117|18994752|P2|6-Month Visit|Overall Study||32
7713705|NCT01716117|18994753|P1|6-Month Visit|Overall Study||174
7713706|NCT01716117|18994752|P2|1-Month Visit|Overall Study||33
7713707|NCT01716117|18994753|P1|1-Month Visit|Overall Study||176
7713708|NCT01716117|18994752|P2|Discharge|Overall Study||33
7713709|NCT01716117|18994753|P1|Discharge|Overall Study||177
7713710|NCT01716117|18994752|P2|STARTED|Overall Study||33
7713711|NCT01716117|18994753|P1|STARTED|Overall Study||180
7713712|NCT01716104|18994772|P2|NOT COMPLETED|Overall Study||7
7713713|NCT01716104|18994773|P1|NOT COMPLETED|Overall Study||6
7713714|NCT01716104|18994772|P2|COMPLETED|Overall Study||117
7713715|NCT01716104|18994773|P1|COMPLETED|Overall Study||119
7713716|NCT01716104|18994772|P2|STARTED|Overall Study||124
7713717|NCT01716104|18994773|P1|STARTED|Overall Study||125
7713718|NCT01716052|18994799|P2|NOT COMPLETED|Overall Study||1
7713719|NCT01716052|18994800|P1|NOT COMPLETED|Overall Study||1
7713720|NCT01716052|18994799|P2|COMPLETED|Overall Study||0
7713721|NCT01716052|18994800|P1|COMPLETED|Overall Study||0
7713722|NCT01716052|18994799|P2|STARTED|Overall Study||1
7713723|NCT01716052|18994800|P1|STARTED|Overall Study||1
7713724|NCT01716013|18994808|P2|NOT COMPLETED|Overall Study||0
7713725|NCT01716013|18994809|P1|NOT COMPLETED|Overall Study||3
7713726|NCT01716013|18994808|P2|COMPLETED|Overall Study||54
7713727|NCT01716013|18994809|P1|COMPLETED|Overall Study||105
7713728|NCT01716013|18994808|P2|STARTED|Overall Study||54
7713729|NCT01716013|18994809|P1|STARTED|Overall Study||108
7713730|NCT01715948|18994821|P1|NOT COMPLETED|Overall Study||1
7713731|NCT01715948|18994821|P1|COMPLETED|Overall Study||8
7713732|NCT01715948|18994821|P1|STARTED|Overall Study||9
7713733|NCT01715896|18994842|P2|NOT COMPLETED|Overall Study||11
7713734|NCT01715896|18994843|P1|NOT COMPLETED|Overall Study||3
7713735|NCT01715896|18994842|P2|COMPLETED|Overall Study||59
7713736|NCT01715896|18994843|P1|COMPLETED|Overall Study||65
7713737|NCT01715896|18994842|P2|STARTED|Overall Study||70
7713738|NCT01715896|18994843|P1|STARTED|Overall Study||68
7713739|NCT01715883|18994906|P1|NOT COMPLETED|Overall Study||1
7713740|NCT01715883|18994906|P1|COMPLETED|Overall Study||2
7713741|NCT01715883|18994906|P1|STARTED|Overall Study||3
7713742|NCT01715857|18994916|P1|NOT COMPLETED|Overall Study||96
7713743|NCT01715857|18994916|P1|COMPLETED|Overall Study||4004
7713744|NCT01715857|18994916|P1|STARTED|Overall Study||4100
7713745|NCT01715831|18994926|P1|NOT COMPLETED|Overall Study||1
7713746|NCT01715831|18994926|P1|COMPLETED|Overall Study||25
7713747|NCT01715831|18994926|P1|STARTED|Overall Study||26
7713748|NCT01715805|18994942|P4|NOT COMPLETED|Double-Blind or Continued Treatment||48
7713749|NCT01715805|18994943|P3|NOT COMPLETED|Double-Blind or Continued Treatment||56
7713750|NCT01715805|18994944|P2|NOT COMPLETED|Double-Blind or Continued Treatment||39
7713751|NCT01715805|18994945|P1|NOT COMPLETED|Double-Blind or Continued Treatment||0
7713752|NCT01715805|18994942|P4|COMPLETED|Double-Blind or Continued Treatment||222
7713753|NCT01715805|18994943|P3|COMPLETED|Double-Blind or Continued Treatment||213
7713754|NCT01715805|18994944|P2|COMPLETED|Double-Blind or Continued Treatment||222
7713755|NCT01715805|18994945|P1|COMPLETED|Double-Blind or Continued Treatment||0
7713756|NCT01715805|18994942|P4|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
7713757|NCT01715805|18994943|P3|Double-Blind Safety Population|Double-Blind or Continued Treatment||269
7713758|NCT01715805|18994944|P2|Double-Blind Safety Population|Double-Blind or Continued Treatment||258
7713759|NCT01715805|18994945|P1|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
7713760|NCT01715805|18994942|P4|STARTED|Double-Blind or Continued Treatment||270
7713761|NCT01715805|18994943|P3|STARTED|Double-Blind or Continued Treatment||269
7713762|NCT01715805|18994944|P2|STARTED|Double-Blind or Continued Treatment||261
7713763|NCT01715805|18994945|P1|STARTED|Double-Blind or Continued Treatment||0
7713764|NCT01715805|18994942|P4|NOT COMPLETED|Placebo + ADT Lead-in Period||0
7713765|NCT01715805|18994943|P3|NOT COMPLETED|Placebo + ADT Lead-in Period||0
7713766|NCT01715805|18994944|P2|NOT COMPLETED|Placebo + ADT Lead-in Period||0
7713767|NCT01715805|18994945|P1|NOT COMPLETED|Placebo + ADT Lead-in Period||215
7713768|NCT01715805|18994942|P4|COMPLETED|Placebo + ADT Lead-in Period||0
7713769|NCT01715805|18994943|P3|COMPLETED|Placebo + ADT Lead-in Period||0
7713770|NCT01715805|18994944|P2|COMPLETED|Placebo + ADT Lead-in Period||0
7713771|NCT01715805|18994945|P1|COMPLETED|Placebo + ADT Lead-in Period||807
7713772|NCT01715805|18994942|P4|STARTED|Placebo + ADT Lead-in Period||0
7713773|NCT01715805|18994943|P3|STARTED|Placebo + ADT Lead-in Period||0
7713774|NCT01715805|18994944|P2|STARTED|Placebo + ADT Lead-in Period||0
7713775|NCT01715805|18994945|P1|STARTED|Placebo + ADT Lead-in Period||1022
7713776|NCT01715415|18994959|P2|NOT COMPLETED|Open-label Treatment||2
7713777|NCT01715415|18994960|P1|NOT COMPLETED|Open-label Treatment||0
7713778|NCT01715415|18994959|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94
7713779|NCT01715415|18994960|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
7713780|NCT01715415|18994959|P2|STARTED|Open-label Treatment||96
7713781|NCT01715415|18994960|P1|STARTED|Open-label Treatment|not applicable to this arm|0
7713782|NCT01715415|18994959|P2|NOT COMPLETED|Double-blind Treatment||2
7713783|NCT01715415|18994960|P1|NOT COMPLETED|Double-blind Treatment||5
7713784|NCT01715415|18994959|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96
7713785|NCT01715415|18994960|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292
7713786|NCT01715415|18994959|P2|Randomized But Not Treated|Double-blind Treatment||1
7713787|NCT01715415|18994960|P1|Randomized But Not Treated|Double-blind Treatment||0
7713788|NCT01715415|18994959|P2|STARTED|Double-blind Treatment||98
7713789|NCT01715415|18994960|P1|STARTED|Double-blind Treatment||297
7713790|NCT01715298|18994974|P2|NOT COMPLETED|Overall Study||11
7713791|NCT01715298|18994975|P1|NOT COMPLETED|Overall Study||7
7713792|NCT01715298|18994974|P2|COMPLETED|Overall Study||205
7713793|NCT01715298|18994975|P1|COMPLETED|Overall Study||209
7713794|NCT01715298|18994974|P2|Full Analysis Set (FAS)|Overall Study||214
7713795|NCT01715298|18994975|P1|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215
7713796|NCT01715298|18994974|P2|STARTED|Overall Study||216
7713797|NCT01715298|18994975|P1|STARTED|Overall Study||216
7713798|NCT01715285|18995013|P3|NOT COMPLETED|Open-label (OL) Extension Phase||72
7713799|NCT01715285|18995014|P2|NOT COMPLETED|Open-label (OL) Extension Phase||0
7713800|NCT01715285|18995015|P1|NOT COMPLETED|Open-label (OL) Extension Phase||157
7713801|NCT01715285|18995013|P3|COMPLETED|Open-label (OL) Extension Phase||0
7713802|NCT01715285|18995014|P2|COMPLETED|Open-label (OL) Extension Phase||0
7713803|NCT01715285|18995015|P1|COMPLETED|Open-label (OL) Extension Phase||0
7713804|NCT01715285|18995013|P3|STARTED|Open-label (OL) Extension Phase||72
7713805|NCT01715285|18995014|P2|STARTED|Open-label (OL) Extension Phase||0
7713806|NCT01715285|18995015|P1|STARTED|Open-label (OL) Extension Phase||157
7713807|NCT01715285|18995013|P3|NOT COMPLETED|Treatment Period||0
7713808|NCT01715285|18995014|P2|NOT COMPLETED|Treatment Period||602
7713809|NCT01715285|18995015|P1|NOT COMPLETED|Treatment Period||597
7713810|NCT01715285|18995013|P3|COMPLETED|Treatment Period||0
7713811|NCT01715285|18995014|P2|COMPLETED|Treatment Period||0
7713812|NCT01715285|18995015|P1|COMPLETED|Treatment Period||0
7713813|NCT01715285|18995013|P3|Safety Population|Treatment Period||0
7713814|NCT01715285|18995014|P2|Safety Population|Treatment Period||602
7713815|NCT01715285|18995015|P1|Safety Population|Treatment Period||597
7713816|NCT01715285|18995013|P3|ITT Population|Treatment Period||0
7713817|NCT01715285|18995014|P2|ITT Population|Treatment Period||602
7713818|NCT01715285|18995015|P1|ITT Population|Treatment Period||597
7713819|NCT01715285|18995013|P3|STARTED|Treatment Period||0
7713820|NCT01715285|18995014|P2|STARTED|Treatment Period||602
7713821|NCT01715285|18995015|P1|STARTED|Treatment Period||597
7713822|NCT01715233|18995034|P1|NOT COMPLETED|Overall Study||0
7713823|NCT01715233|18995034|P1|COMPLETED|Overall Study||21
7713824|NCT01715233|18995034|P1|STARTED|Overall Study||21
7713825|NCT01715207|18995042|P2|NOT COMPLETED|Overall Study||1
7713826|NCT01715207|18995043|P1|NOT COMPLETED|Overall Study||1
7713827|NCT01715207|18995042|P2|COMPLETED|Overall Study||14
7713828|NCT01715207|18995043|P1|COMPLETED|Overall Study||14
7713829|NCT01715207|18995042|P2|STARTED|Overall Study||15
7713830|NCT01715207|18995043|P1|STARTED|Overall Study||15
7713831|NCT01715129|18995051|P1|NOT COMPLETED|Overall Study||9
7713832|NCT01715129|18995051|P1|COMPLETED|Overall Study||117
7713833|NCT01715129|18995051|P1|STARTED|Overall Study||126
7713834|NCT01715064|18995070|P2|NOT COMPLETED|Overall Study||0
7713835|NCT01715064|18995071|P1|NOT COMPLETED|Overall Study||0
7713836|NCT01715064|18995070|P2|COMPLETED|Overall Study||18
7713837|NCT01715064|18995071|P1|COMPLETED|Overall Study||18
7713838|NCT01715064|18995070|P2|STARTED|Overall Study||18
7713839|NCT01715064|18995071|P1|STARTED|Overall Study||18
7713840|NCT01714947|18995077|P1|NOT COMPLETED|Part B||3
7713841|NCT01714947|18995077|P1|COMPLETED|Part B||0
7713842|NCT01714947|18995077|P1|STARTED|Part B||3
7713843|NCT01714947|18995077|P1|NOT COMPLETED|Part A||0
7713844|NCT01714947|18995077|P1|COMPLETED|Part A||3
7713845|NCT01714947|18995077|P1|STARTED|Part A||3
7713846|NCT01714921|18995106|P1|NOT COMPLETED|Overall Study||193
7713847|NCT01714921|18995106|P1|COMPLETED|Overall Study||311
7713848|NCT01714921|18995106|P1|STARTED|Overall Study||504
7713849|NCT01714817|18995118|P2|NOT COMPLETED|Long-Term Extension (LTE) Period||70
7713850|NCT01714817|18995119|P1|NOT COMPLETED|Long-Term Extension (LTE) Period||67
7713851|NCT01714817|18995118|P2|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|53
7713852|NCT01714817|18995119|P1|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|62
7713853|NCT01714817|18995118|P2|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|123
7713854|NCT01714817|18995119|P1|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|129
7713855|NCT01714817|18995118|P2|NOT COMPLETED|Year 2 Period||38
7713856|NCT01714817|18995119|P1|NOT COMPLETED|Year 2 Period||26
7713857|NCT01714817|18995118|P2|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|123
7713858|NCT01714817|18995119|P1|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|129
7713859|NCT01714817|18995118|P2|STARTED|Year 2 Period|Started = Completed Year 1|161
7713860|NCT01714817|18995119|P1|STARTED|Year 2 Period|Started = Completed Year 1|155
7713861|NCT01714817|18995118|P2|NOT COMPLETED|Year 1 Period||42
7713862|NCT01714817|18995119|P1|NOT COMPLETED|Year 1 Period||48
7713863|NCT01714817|18995118|P2|COMPLETED|Year 1 Period|Completed = continued study through Year 1|161
7713864|NCT01714817|18995119|P1|COMPLETED|Year 1 Period|Completed = continued study through Year 1|155
7713865|NCT01714817|18995118|P2|Treated|Year 1 Period||203
7713866|NCT01714817|18995119|P1|Treated|Year 1 Period||202
7713867|NCT01714817|18995118|P2|STARTED|Year 1 Period||203
7713868|NCT01714817|18995119|P1|STARTED|Year 1 Period||203
7713869|NCT01714804|18995215|P2|NOT COMPLETED|Overall Study||0
7713870|NCT01714804|18995216|P1|NOT COMPLETED|Overall Study||1
7713871|NCT01714804|18995215|P2|COMPLETED|Overall Study||30
7713872|NCT01714804|18995216|P1|COMPLETED|Overall Study||29
7713873|NCT01714804|18995215|P2|STARTED|Overall Study||30
7713874|NCT01714804|18995216|P1|STARTED|Overall Study||30
7713875|NCT01714726|18995226|P4|NOT COMPLETED|Open-Label Period||28
7713876|NCT01714726|18995227|P3|NOT COMPLETED|Open-Label Period||19
7713877|NCT01714726|18995228|P2|NOT COMPLETED|Open-Label Period||0
7713878|NCT01714726|18995229|P1|NOT COMPLETED|Open-Label Period||0
7713879|NCT01714726|18995226|P4|COMPLETED|Open-Label Period||24
7713880|NCT01714726|18995227|P3|COMPLETED|Open-Label Period||33
7713881|NCT01714726|18995228|P2|COMPLETED|Open-Label Period||0
7713882|NCT01714726|18995229|P1|COMPLETED|Open-Label Period||0
7713883|NCT01714726|18995226|P4|STARTED|Open-Label Period||52
7713884|NCT01714726|18995227|P3|STARTED|Open-Label Period||52
7713885|NCT01714726|18995228|P2|STARTED|Open-Label Period||0
7713886|NCT01714726|18995229|P1|STARTED|Open-Label Period||0
7713887|NCT01714726|18995226|P4|NOT COMPLETED|Double-Blinded Induction Period||0
7713888|NCT01714726|18995227|P3|NOT COMPLETED|Double-Blinded Induction Period||0
7713889|NCT01714726|18995228|P2|NOT COMPLETED|Double-Blinded Induction Period||7
7713890|NCT01714726|18995229|P1|NOT COMPLETED|Double-Blinded Induction Period||8
7713891|NCT01714726|18995226|P4|COMPLETED|Double-Blinded Induction Period||0
7713892|NCT01714726|18995227|P3|COMPLETED|Double-Blinded Induction Period||0
7713893|NCT01714726|18995228|P2|COMPLETED|Double-Blinded Induction Period||52
7713894|NCT01714726|18995229|P1|COMPLETED|Double-Blinded Induction Period||52
7713895|NCT01714726|18995226|P4|STARTED|Double-Blinded Induction Period||0
7713896|NCT01714726|18995227|P3|STARTED|Double-Blinded Induction Period||0
7713897|NCT01714726|18995228|P2|STARTED|Double-Blinded Induction Period||59
7713898|NCT01714726|18995229|P1|STARTED|Double-Blinded Induction Period||60
7713899|NCT01714687|18995309|P2|NOT COMPLETED|Overall Study||4
7713900|NCT01714687|18995310|P1|NOT COMPLETED|Overall Study||3
7713901|NCT01714687|18995309|P2|COMPLETED|Overall Study||26
7713902|NCT01714687|18995310|P1|COMPLETED|Overall Study||26
7713903|NCT01714687|18995309|P2|STARTED|Overall Study||30
7713904|NCT01714687|18995310|P1|STARTED|Overall Study||29
7713905|NCT01714635|18995334|P3|NOT COMPLETED|Overall Study||2
7713906|NCT01714635|18995335|P2|NOT COMPLETED|Overall Study||0
7713907|NCT01714635|18995336|P1|NOT COMPLETED|Overall Study||2
7713908|NCT01714635|18995334|P3|COMPLETED|Overall Study||146
7713909|NCT01714635|18995335|P2|COMPLETED|Overall Study||150
7713910|NCT01714635|18995336|P1|COMPLETED|Overall Study||145
7713911|NCT01714635|18995334|P3|STARTED|Overall Study||148
7713912|NCT01714635|18995335|P2|STARTED|Overall Study||150
7713913|NCT01714635|18995336|P1|STARTED|Overall Study||147
7713914|NCT01714609|18995352|P2|NOT COMPLETED|Overall Study||0
7713915|NCT01714609|18995353|P1|NOT COMPLETED|Overall Study||1
7713916|NCT01714609|18995352|P2|COMPLETED|Overall Study||5
7713917|NCT01714609|18995353|P1|COMPLETED|Overall Study||4
7713918|NCT01714609|18995352|P2|STARTED|Overall Study||5
7713919|NCT01714609|18995353|P1|STARTED|Overall Study||5
7713920|NCT01714544|18995359|P1|NOT COMPLETED|Overall Study||3
7713921|NCT01714544|18995359|P1|COMPLETED|Overall Study||57
7713922|NCT01714544|18995359|P1|STARTED|Overall Study||60
7713923|NCT01714505|18995363|P2|NOT COMPLETED|Admission 2 (40 Hours)||0
7713924|NCT01714505|18995364|P1|NOT COMPLETED|Admission 2 (40 Hours)||0
7713925|NCT01714505|18995363|P2|COMPLETED|Admission 2 (40 Hours)||9
7713926|NCT01714505|18995364|P1|COMPLETED|Admission 2 (40 Hours)||9
7713927|NCT01714505|18995363|P2|STARTED|Admission 2 (40 Hours)||9
7713928|NCT01714505|18995364|P1|STARTED|Admission 2 (40 Hours)||9
7713929|NCT01714505|18995363|P2|NOT COMPLETED|Admission 1 (40 Hours)||1
7713930|NCT01714505|18995364|P1|NOT COMPLETED|Admission 1 (40 Hours)||1
7713931|NCT01714505|18995363|P2|COMPLETED|Admission 1 (40 Hours)||9
7713932|NCT01714505|18995364|P1|COMPLETED|Admission 1 (40 Hours)||9
7713933|NCT01714505|18995363|P2|STARTED|Admission 1 (40 Hours)||10
7713934|NCT01714505|18995364|P1|STARTED|Admission 1 (40 Hours)||10
7713935|NCT01714492|18995374|P1|NOT COMPLETED|Overall Study||0
7713936|NCT01714492|18995374|P1|COMPLETED|Overall Study||8
7713937|NCT01714492|18995374|P1|STARTED|Overall Study||8
7713938|NCT01714336|18995385|P2|NOT COMPLETED|Overall Study||0
7713939|NCT01714336|18995386|P1|NOT COMPLETED|Overall Study||0
7713940|NCT01714336|18995385|P2|COMPLETED|Overall Study||69
7713941|NCT01714336|18995386|P1|COMPLETED|Overall Study||69
7713942|NCT01714336|18995385|P2|STARTED|Overall Study||69
7713943|NCT01714336|18995386|P1|STARTED|Overall Study||69
7713944|NCT01714323|18995408|P2|NOT COMPLETED|Overall Study||172
7713945|NCT01714323|18995409|P1|NOT COMPLETED|Overall Study||164
7713946|NCT01714323|18995408|P2|COMPLETED|Overall Study||508
7713947|NCT01714323|18995409|P1|COMPLETED|Overall Study||513
7713948|NCT01714323|18995408|P2|STARTED|Overall Study||680
7713949|NCT01714323|18995409|P1|STARTED|Overall Study||677
7713950|NCT01714310|18995430|P3|NOT COMPLETED|Double Blind Adjunctive Treatment||0
7713951|NCT01714310|18995431|P2|NOT COMPLETED|Double Blind Adjunctive Treatment||3
7713952|NCT01714310|18995432|P1|NOT COMPLETED|Double Blind Adjunctive Treatment||2
7713953|NCT01714310|18995430|P3|COMPLETED|Double Blind Adjunctive Treatment||0
7713954|NCT01714310|18995431|P2|COMPLETED|Double Blind Adjunctive Treatment||11
7713955|NCT01714310|18995432|P1|COMPLETED|Double Blind Adjunctive Treatment||10
7713956|NCT01714310|18995430|P3|STARTED|Double Blind Adjunctive Treatment|No one remained on lisdexamfetamine alone in Period 2.|0
7713957|NCT01714310|18995431|P2|STARTED|Double Blind Adjunctive Treatment|Adjunctive placebo was initiated at beginning of Period 2, at study week 4.|14
7713958|NCT01714310|18995432|P1|STARTED|Double Blind Adjunctive Treatment|Adjunctive fluoxetine treatment was initiated at beginning of Period 2, at study week 4.|12
7713959|NCT01714310|18995430|P3|NOT COMPLETED|Open Lisdexamfetamine Titration||4
7713960|NCT01714310|18995431|P2|NOT COMPLETED|Open Lisdexamfetamine Titration||0
7713961|NCT01714310|18995432|P1|NOT COMPLETED|Open Lisdexamfetamine Titration||0
7713962|NCT01714310|18995430|P3|COMPLETED|Open Lisdexamfetamine Titration||30
7713963|NCT01714310|18995431|P2|COMPLETED|Open Lisdexamfetamine Titration||0
7713964|NCT01714310|18995432|P1|COMPLETED|Open Lisdexamfetamine Titration||0
7713965|NCT01714310|18995430|P3|STARTED|Open Lisdexamfetamine Titration||34
7713966|NCT01714310|18995431|P2|STARTED|Open Lisdexamfetamine Titration||0
7713967|NCT01714310|18995432|P1|STARTED|Open Lisdexamfetamine Titration||0
7713968|NCT01714232|18995479|P1|NOT COMPLETED|Overall Study||0
7713969|NCT01714232|18995479|P1|COMPLETED|Overall Study||106
7713970|NCT01714232|18995479|P1|STARTED|Overall Study||106
7713971|NCT01714063|18995485|P1|NOT COMPLETED|Overall Study||2
7713972|NCT01714063|18995485|P1|COMPLETED|Overall Study||32
7713973|NCT01714063|18995485|P1|STARTED|Overall Study||34
7713974|NCT01714024|18995500|P3|NOT COMPLETED|Overall Study||3
7713975|NCT01714024|18995501|P2|NOT COMPLETED|Overall Study||6
7713976|NCT01714024|18995502|P1|NOT COMPLETED|Overall Study||1
7713977|NCT01714024|18995500|P3|COMPLETED|Overall Study||8
7713978|NCT01714024|18995501|P2|COMPLETED|Overall Study||12
7713979|NCT01714024|18995502|P1|COMPLETED|Overall Study||12
7713980|NCT01714024|18995500|P3|STARTED|Overall Study||11
7713981|NCT01714024|18995501|P2|STARTED|Overall Study||18
7713982|NCT01714024|18995502|P1|STARTED|Overall Study||13
7713983|NCT01713998|18995522|P3|NOT COMPLETED|Overall Study||2
7713984|NCT01713998|18995523|P2|NOT COMPLETED|Overall Study||0
7713985|NCT01713998|18995524|P1|NOT COMPLETED|Overall Study||3
7713986|NCT01713998|18995522|P3|COMPLETED|Overall Study||14
7713987|NCT01713998|18995523|P2|COMPLETED|Overall Study||15
7713988|NCT01713998|18995524|P1|COMPLETED|Overall Study||13
7713989|NCT01713998|18995522|P3|STARTED|Overall Study||16
7713990|NCT01713998|18995523|P2|STARTED|Overall Study||15
7713991|NCT01713998|18995524|P1|STARTED|Overall Study||16
7713992|NCT01713946|18995545|P3|NOT COMPLETED|Overall Study||44
7713993|NCT01713946|18995546|P2|NOT COMPLETED|Overall Study||45
7713994|NCT01713946|18995547|P1|NOT COMPLETED|Overall Study||43
7713995|NCT01713946|18995545|P3|COMPLETED|Overall Study||75
7713996|NCT01713946|18995546|P2|COMPLETED|Overall Study||85
7713997|NCT01713946|18995547|P1|COMPLETED|Overall Study||74
7713998|NCT01713946|18995545|P3|Did Not Cont. in Post-Ext Phase|Overall Study||0
7713999|NCT01713946|18995546|P2|Did Not Cont. in Post-Ext Phase|Overall Study||2
7714000|NCT01713946|18995547|P1|Did Not Cont. in Post-Ext Phase|Overall Study||1
7714001|NCT01713946|18995545|P3|Did Not Continue in Ext Phase|Overall Study||0
7714002|NCT01713946|18995546|P2|Did Not Continue in Ext Phase|Overall Study||3
7714003|NCT01713946|18995547|P1|Did Not Continue in Ext Phase|Overall Study||0
7714004|NCT01713946|18995545|P3|Completed Post-Ext Phase|Overall Study||75
7714005|NCT01713946|18995546|P2|Completed Post-Ext Phase|Overall Study||85
7714006|NCT01713946|18995547|P1|Completed Post-Ext Phase|Overall Study||74
7714007|NCT01713946|18995545|P3|Continued in Post-Ext. Phase|Overall Study||81
7714008|NCT01713946|18995546|P2|Continued in Post-Ext. Phase|Overall Study||90
7714009|NCT01713946|18995547|P1|Continued in Post-Ext. Phase|Overall Study||78
7714010|NCT01713946|18995545|P3|Completed Ext. Phase|Overall Study||81
7714011|NCT01713946|18995546|P2|Completed Ext. Phase|Overall Study||92
7714012|NCT01713946|18995547|P1|Completed Ext. Phase|Overall Study||79
7714013|NCT01713946|18995545|P3|Continued in Ext. Phase|Overall Study||114
7714014|NCT01713946|18995546|P2|Continued in Ext. Phase|Overall Study||119
7714015|NCT01713946|18995547|P1|Continued in Ext. Phase|Overall Study||110
7714016|NCT01713946|18995545|P3|Completed Core Phase|Overall Study||114
7714017|NCT01713946|18995546|P2|Completed Core Phase|Overall Study||122
7714018|NCT01713946|18995547|P1|Completed Core Phase|Overall Study||110
7714019|NCT01713946|18995545|P3|STARTED|Overall Study|Of the 119 patients initially randomized to the Placebo arm, 5 patients never switched to everolimus|119
7714020|NCT01713946|18995546|P2|STARTED|Overall Study||130
7714021|NCT01713946|18995547|P1|STARTED|Overall Study||117
7714022|NCT01713933|18995638|P1|NOT COMPLETED|Overall Study||6
7714023|NCT01713933|18995638|P1|COMPLETED|Overall Study||31
7714024|NCT01713933|18995638|P1|STARTED|Overall Study||37
7714025|NCT01713868|18995654|P4|NOT COMPLETED|Overall Study||95
7714026|NCT01713868|18995655|P3|NOT COMPLETED|Overall Study||80
7714027|NCT01713868|18995656|P2|NOT COMPLETED|Overall Study||65
7714028|NCT01713868|18995657|P1|NOT COMPLETED|Overall Study||97
7714029|NCT01713868|18995654|P4|COMPLETED|Overall Study||305
7714030|NCT01713868|18995655|P3|COMPLETED|Overall Study||320
7714031|NCT01713868|18995656|P2|COMPLETED|Overall Study||335
7714032|NCT01713868|18995657|P1|COMPLETED|Overall Study||303
7714033|NCT01713868|18995654|P4|STARTED|Overall Study||400
7714034|NCT01713868|18995655|P3|STARTED|Overall Study||400
7714035|NCT01713868|18995656|P2|STARTED|Overall Study||400
7714036|NCT01713868|18995657|P1|STARTED|Overall Study||400
7714037|NCT01713686|18995687|P1|NOT COMPLETED|Overall Study||15
7714038|NCT01713686|18995687|P1|COMPLETED|Overall Study||110
7714039|NCT01713686|18995687|P1|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125
7714040|NCT01713660|18995696|P1|NOT COMPLETED|Overall Study||0
7714041|NCT01713660|18995696|P1|COMPLETED|Overall Study||37
7714042|NCT01713660|18995696|P1|STARTED|Overall Study||37
7714043|NCT01713621|18995704|P2|NOT COMPLETED|Overall Study||16
7714044|NCT01713621|18995705|P1|NOT COMPLETED|Overall Study||7
7714045|NCT01713621|18995704|P2|COMPLETED|Overall Study||1
7714046|NCT01713621|18995705|P1|COMPLETED|Overall Study||1
7714047|NCT01713621|18995704|P2|STARTED|Overall Study||17
7714048|NCT01713621|18995705|P1|STARTED|Overall Study||8
7714049|NCT01713608|18995715|P4|NOT COMPLETED|Overall Study||0
7714050|NCT01713608|18995716|P3|NOT COMPLETED|Overall Study||0
7714051|NCT01713608|18995717|P2|NOT COMPLETED|Overall Study||0
7714052|NCT01713608|18995718|P1|NOT COMPLETED|Overall Study||0
7714053|NCT01713608|18995715|P4|COMPLETED|Overall Study||12
7714054|NCT01713608|18995716|P3|COMPLETED|Overall Study||8
7714055|NCT01713608|18995717|P2|COMPLETED|Overall Study||6
7714056|NCT01713608|18995718|P1|COMPLETED|Overall Study||8
7714057|NCT01713608|18995715|P4|STARTED|Overall Study||12
7714058|NCT01713608|18995716|P3|STARTED|Overall Study||8
7714059|NCT01713608|18995717|P2|STARTED|Overall Study||6
7714060|NCT01713608|18995718|P1|STARTED|Overall Study||8
7714061|NCT01713582|18995757|P21|NOT COMPLETED|Overall Study||15
7714062|NCT01713582|18995758|P20|NOT COMPLETED|Overall Study||5
7714063|NCT01713582|18995759|P19|NOT COMPLETED|Overall Study||5
7714064|NCT01713582|18995760|P18|NOT COMPLETED|Overall Study||3
7714065|NCT01713582|18995761|P17|NOT COMPLETED|Overall Study||7
7714066|NCT01713582|18995762|P16|NOT COMPLETED|Overall Study||6
7714067|NCT01713582|18995763|P15|NOT COMPLETED|Overall Study||7
7714068|NCT01713582|18995764|P14|NOT COMPLETED|Overall Study||4
7714069|NCT01713582|18995765|P13|NOT COMPLETED|Overall Study||3
7714070|NCT01713582|18995766|P12|NOT COMPLETED|Overall Study||5
7714071|NCT01713582|18995767|P11|NOT COMPLETED|Overall Study||16
7714072|NCT01713582|18995768|P10|NOT COMPLETED|Overall Study||18
7714073|NCT01713582|18995769|P9|NOT COMPLETED|Overall Study||6
7714074|NCT01713582|18995770|P8|NOT COMPLETED|Overall Study||6
7714075|NCT01713582|18995771|P7|NOT COMPLETED|Overall Study||7
7714076|NCT01713582|18995772|P6|NOT COMPLETED|Overall Study||8
7714077|NCT01713582|18995773|P5|NOT COMPLETED|Overall Study||4
7714078|NCT01713582|18995774|P4|NOT COMPLETED|Overall Study||3
7714079|NCT01713582|18995775|P3|NOT COMPLETED|Overall Study||4
7714080|NCT01713582|18995776|P2|NOT COMPLETED|Overall Study||3
7714081|NCT01713582|18995777|P1|NOT COMPLETED|Overall Study||3
7714082|NCT01713582|18995757|P21|COMPLETED|Overall Study||0
7714083|NCT01713582|18995758|P20|COMPLETED|Overall Study||0
7714084|NCT01713582|18995759|P19|COMPLETED|Overall Study||0
7714085|NCT01713582|18995760|P18|COMPLETED|Overall Study||0
7714086|NCT01713582|18995761|P17|COMPLETED|Overall Study||0
7714087|NCT01713582|18995762|P16|COMPLETED|Overall Study||0
7714088|NCT01713582|18995763|P15|COMPLETED|Overall Study||0
7714089|NCT01713582|18995764|P14|COMPLETED|Overall Study||0
7714090|NCT01713582|18995765|P13|COMPLETED|Overall Study||0
7714091|NCT01713582|18995766|P12|COMPLETED|Overall Study||0
7714092|NCT01713582|18995767|P11|COMPLETED|Overall Study||0
7714093|NCT01713582|18995768|P10|COMPLETED|Overall Study||0
7714094|NCT01713582|18995769|P9|COMPLETED|Overall Study||0
7714095|NCT01713582|18995770|P8|COMPLETED|Overall Study||0
7714096|NCT01713582|18995771|P7|COMPLETED|Overall Study||0
7714097|NCT01713582|18995772|P6|COMPLETED|Overall Study||0
7714098|NCT01713582|18995773|P5|COMPLETED|Overall Study||0
7714099|NCT01713582|18995774|P4|COMPLETED|Overall Study||0
7714100|NCT01713582|18995775|P3|COMPLETED|Overall Study||0
7714101|NCT01713582|18995776|P2|COMPLETED|Overall Study||0
7714102|NCT01713582|18995777|P1|COMPLETED|Overall Study||0
7714103|NCT01713582|18995757|P21|STARTED|Overall Study|Number treated|15
7714104|NCT01713582|18995758|P20|STARTED|Overall Study|Number treated|5
7714105|NCT01713582|18995759|P19|STARTED|Overall Study|Number treated|5
7714106|NCT01713582|18995760|P18|STARTED|Overall Study|Number treated|3
7714107|NCT01713582|18995761|P17|STARTED|Overall Study|Number treated|7
7714108|NCT01713582|18995762|P16|STARTED|Overall Study|Number treated|6
7714109|NCT01713582|18995763|P15|STARTED|Overall Study|Number treated|7
7714110|NCT01713582|18995764|P14|STARTED|Overall Study|Number treated|4
7714111|NCT01713582|18995765|P13|STARTED|Overall Study|Number treated|3
7714112|NCT01713582|18995766|P12|STARTED|Overall Study|Number treated|5
7714113|NCT01713582|18995767|P11|STARTED|Overall Study|Number treated|16
7714114|NCT01713582|18995768|P10|STARTED|Overall Study|Number treated|18
7714115|NCT01713582|18995769|P9|STARTED|Overall Study|Number treated|6
7714116|NCT01713582|18995770|P8|STARTED|Overall Study|Number treated|6
7714117|NCT01713582|18995771|P7|STARTED|Overall Study|Number treated|7
7714118|NCT01713582|18995772|P6|STARTED|Overall Study|Number treated|8
7714119|NCT01713582|18995773|P5|STARTED|Overall Study|Number treated|4
7714120|NCT01713582|18995774|P4|STARTED|Overall Study|Number treated|3
7714121|NCT01713582|18995775|P3|STARTED|Overall Study|Number treated|4
7714122|NCT01713582|18995776|P2|STARTED|Overall Study|Number treated|3
7714123|NCT01713582|18995777|P1|STARTED|Overall Study|Number treated|3
7714124|NCT01713530|18995940|P2|NOT COMPLETED|Overall Study||19
7714125|NCT01713530|18995941|P1|NOT COMPLETED|Overall Study||25
7714126|NCT01713530|18995940|P2|COMPLETED|Overall Study||117
7714127|NCT01713530|18995941|P1|COMPLETED|Overall Study||113
7714128|NCT01713530|18995940|P2|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135
7714129|NCT01713530|18995941|P1|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136
7714130|NCT01713530|18995940|P2|STARTED|Overall Study||136
7714131|NCT01713530|18995941|P1|STARTED|Overall Study||138
7714132|NCT01713400|18995959|P2|NOT COMPLETED|Overall Study||0
7714133|NCT01713400|18995960|P1|NOT COMPLETED|Overall Study||0
7714134|NCT01713400|18995959|P2|COMPLETED|Overall Study||15
7714135|NCT01713400|18995960|P1|COMPLETED|Overall Study||15
7714136|NCT01713400|18995959|P2|STARTED|Overall Study||15
7714137|NCT01713400|18995960|P1|STARTED|Overall Study||15
7714138|NCT01713348|18995972|P4|NOT COMPLETED|Overall Study||0
7714139|NCT01713348|18995973|P3|NOT COMPLETED|Overall Study||2
7714140|NCT01713348|18995974|P2|NOT COMPLETED|Overall Study||2
7714141|NCT01713348|18995975|P1|NOT COMPLETED|Overall Study||4
7714142|NCT01713348|18995972|P4|COMPLETED|Overall Study||15
7714143|NCT01713348|18995973|P3|COMPLETED|Overall Study||28
7714144|NCT01713348|18995974|P2|COMPLETED|Overall Study||11
7714145|NCT01713348|18995975|P1|COMPLETED|Overall Study||25
7714146|NCT01713348|18995972|P4|STARTED|Overall Study||15
7714147|NCT01713348|18995973|P3|STARTED|Overall Study||30
7714148|NCT01713348|18995974|P2|STARTED|Overall Study||13
7714149|NCT01713348|18995975|P1|STARTED|Overall Study||29
7714150|NCT01713283|18996005|P2|NOT COMPLETED|Overall Study||3
7714151|NCT01713283|18996006|P1|NOT COMPLETED|Overall Study||11
7714152|NCT01713283|18996005|P2|COMPLETED|Overall Study||26
7714153|NCT01713283|18996006|P1|COMPLETED|Overall Study||20
7714154|NCT01713283|18996005|P2|STARTED|Overall Study||29
7714155|NCT01713283|18996006|P1|STARTED|Overall Study||31
7714156|NCT01713036|18996028|P1|NOT COMPLETED|Overall Study||1
7714157|NCT01713036|18996028|P1|COMPLETED|Overall Study||5
7714158|NCT01713036|18996028|P1|STARTED|Overall Study||6
7714159|NCT01712984|18996068|P3|NOT COMPLETED|Overall Study||10
7714160|NCT01712984|18996069|P2|NOT COMPLETED|Overall Study||16
7714161|NCT01712984|18996070|P1|NOT COMPLETED|Overall Study||16
7714162|NCT01712984|18996068|P3|COMPLETED|Overall Study||836
7714163|NCT01712984|18996069|P2|COMPLETED|Overall Study||821
7714164|NCT01712984|18996070|P1|COMPLETED|Overall Study||1656
7714165|NCT01712984|18996068|P3|STARTED|Overall Study||846
7714166|NCT01712984|18996069|P2|STARTED|Overall Study||837
7714167|NCT01712984|18996070|P1|STARTED|Overall Study||1672
7714168|NCT01712854|18996090|P1|NOT COMPLETED|Overall Study||1
7714169|NCT01712854|18996090|P1|COMPLETED|Overall Study||8
7714170|NCT01712854|18996090|P1|STARTED|Overall Study||9
7714171|NCT01712776|18996097|P2|NOT COMPLETED|Overall Study||0
7714172|NCT01712776|18996098|P1|NOT COMPLETED|Overall Study||0
7714173|NCT01712776|18996097|P2|COMPLETED|Overall Study||50
7714174|NCT01712776|18996098|P1|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50
7714175|NCT01712776|18996097|P2|STARTED|Overall Study||50
7714176|NCT01712776|18996098|P1|STARTED|Overall Study||50
7714177|NCT01712711|18996106|P2|NOT COMPLETED|Overall Study||0
7714178|NCT01712711|18996107|P1|NOT COMPLETED|Overall Study||0
7714179|NCT01712711|18996106|P2|COMPLETED|Overall Study||20
7714180|NCT01712711|18996107|P1|COMPLETED|Overall Study||20
7714181|NCT01712711|18996106|P2|STARTED|Overall Study||20
7714182|NCT01712711|18996107|P1|STARTED|Overall Study||20
7714183|NCT01712685|18996113|P1|NOT COMPLETED|Overall Study||1
7714184|NCT01712685|18996113|P1|COMPLETED|Overall Study||11
7714185|NCT01712685|18996113|P1|STARTED|Overall Study||12
7714186|NCT01712516|18996129|P4|NOT COMPLETED|Overall Study||13
7714187|NCT01712516|18996130|P3|NOT COMPLETED|Overall Study||6
7714188|NCT01712516|18996131|P2|NOT COMPLETED|Overall Study||10
7714189|NCT01712516|18996132|P1|NOT COMPLETED|Overall Study||6
7714190|NCT01712516|18996129|P4|COMPLETED|Overall Study||236
7714191|NCT01712516|18996130|P3|COMPLETED|Overall Study||245
7714192|NCT01712516|18996131|P2|COMPLETED|Overall Study||241
7714193|NCT01712516|18996132|P1|COMPLETED|Overall Study||244
7714194|NCT01712516|18996129|P4|Full Analysis Set|Overall Study||247
7714195|NCT01712516|18996130|P3|Full Analysis Set|Overall Study||250
7714196|NCT01712516|18996131|P2|Full Analysis Set|Overall Study||251
7714197|NCT01712516|18996132|P1|Full Analysis Set|Overall Study||250
7714198|NCT01712516|18996129|P4|Safety Set|Overall Study||248
7714199|NCT01712516|18996130|P3|Safety Set|Overall Study||251
7714200|NCT01712516|18996131|P2|Safety Set|Overall Study||251
7714201|NCT01712516|18996132|P1|Safety Set|Overall Study||250
7714202|NCT01712516|18996129|P4|STARTED|Overall Study||249
7714203|NCT01712516|18996130|P3|STARTED|Overall Study||251
7714204|NCT01712516|18996131|P2|STARTED|Overall Study||251
7714205|NCT01712516|18996132|P1|STARTED|Overall Study||250
7714206|NCT01712490|18996184|P2|NOT COMPLETED|Overall Study||670
7714207|NCT01712490|18996185|P1|NOT COMPLETED|Overall Study||664
7714208|NCT01712490|18996184|P2|COMPLETED|Overall Study||0
7714209|NCT01712490|18996185|P1|COMPLETED|Overall Study||0
7714210|NCT01712490|18996184|P2|Treated|Overall Study||659
7714211|NCT01712490|18996185|P1|Treated|Overall Study||662
7714212|NCT01712490|18996184|P2|STARTED|Overall Study||670
7714213|NCT01712490|18996185|P1|STARTED|Overall Study||664
7714214|NCT01712438|18996222|P1|NOT COMPLETED|Overall Study||37
7714215|NCT01712438|18996222|P1|COMPLETED|Overall Study||73
7714216|NCT01712438|18996222|P1|SURG Population|Overall Study||24
7714217|NCT01712438|18996222|P1|BLEED Population|Overall Study||94
7714218|NCT01712438|18996222|P1|PROPH Population|Overall Study||103
7714219|NCT01712438|18996222|P1|PP Population|Overall Study||95
7714220|NCT01712438|18996222|P1|ITT Population|Overall Study||108
7714221|NCT01712438|18996222|P1|SAF Population|Overall Study||108
7714222|NCT01712438|18996222|P1|STARTED|Overall Study||110
7714223|NCT01712399|18996232|P1|NOT COMPLETED|Overall Study||397
7714224|NCT01712399|18996232|P1|COMPLETED|Overall Study||0
7714225|NCT01712399|18996232|P1|STARTED|Overall Study||397
7714226|NCT01712360|18996249|P4|NOT COMPLETED|Overall Study||2
7714227|NCT01712360|18996250|P3|NOT COMPLETED|Overall Study||0
7714228|NCT01712360|18996251|P2|NOT COMPLETED|Overall Study||1
7714229|NCT01712360|18996252|P1|NOT COMPLETED|Overall Study||0
7714230|NCT01712360|18996249|P4|COMPLETED|Overall Study||4
7714231|NCT01712360|18996250|P3|COMPLETED|Overall Study||6
7714232|NCT01712360|18996251|P2|COMPLETED|Overall Study||21
7714233|NCT01712360|18996252|P1|COMPLETED|Overall Study||22
7714234|NCT01712360|18996249|P4|STARTED|Overall Study||6
7714235|NCT01712360|18996250|P3|STARTED|Overall Study||6
7714236|NCT01712360|18996251|P2|STARTED|Overall Study||22
7714237|NCT01712360|18996252|P1|STARTED|Overall Study||22
7714238|NCT01712334|18996278|P2|NOT COMPLETED|Treatment Period 2||0
7714239|NCT01712334|18996279|P1|NOT COMPLETED|Treatment Period 2||0
7714240|NCT01712334|18996278|P2|COMPLETED|Treatment Period 2||41
7714241|NCT01712334|18996279|P1|COMPLETED|Treatment Period 2||44
7714242|NCT01712334|18996278|P2|STARTED|Treatment Period 2||41
7714243|NCT01712334|18996279|P1|STARTED|Treatment Period 2||44
7714244|NCT01712334|18996278|P2|NOT COMPLETED|Treatment Period 1||2
7714245|NCT01712334|18996279|P1|NOT COMPLETED|Treatment Period 1||0
7714246|NCT01712334|18996278|P2|COMPLETED|Treatment Period 1||41
7714247|NCT01712334|18996279|P1|COMPLETED|Treatment Period 1||44
7714248|NCT01712334|18996278|P2|Received Treatment|Treatment Period 1||41
7714249|NCT01712334|18996279|P1|Received Treatment|Treatment Period 1||44
7714250|NCT01712334|18996278|P2|STARTED|Treatment Period 1||43
7714251|NCT01712334|18996279|P1|STARTED|Treatment Period 1||44
7714252|NCT01712256|18996287|P1|NOT COMPLETED|Overall Study||1
7714253|NCT01712256|18996287|P1|COMPLETED|Overall Study||32
7714254|NCT01712256|18996287|P1|STARTED|Overall Study||33
7714255|NCT01712230|18996299|P3|NOT COMPLETED|Overall Study||7
7714256|NCT01712230|18996300|P2|NOT COMPLETED|Overall Study||4
7714257|NCT01712230|18996301|P1|NOT COMPLETED|Overall Study||2
7714258|NCT01712230|18996299|P3|COMPLETED|Overall Study||11
7714259|NCT01712230|18996300|P2|COMPLETED|Overall Study||14
7714260|NCT01712230|18996301|P1|COMPLETED|Overall Study||9
7714261|NCT01712230|18996299|P3|STARTED|Overall Study||18
7714262|NCT01712230|18996300|P2|STARTED|Overall Study||18
7714263|NCT01712230|18996301|P1|STARTED|Overall Study||11
7714264|NCT01712204|18996317|P2|NOT COMPLETED|Overall Study||5
7714265|NCT01712204|18996318|P1|NOT COMPLETED|Overall Study||8
7714266|NCT01712204|18996317|P2|COMPLETED|Overall Study||36
7714267|NCT01712204|18996318|P1|COMPLETED|Overall Study||33
7714268|NCT01712204|18996317|P2|STARTED|Overall Study||41
7714269|NCT01712204|18996318|P1|STARTED|Overall Study||41
7714270|NCT01712178|18996326|P2|NOT COMPLETED|Overall Study||3
7714271|NCT01712178|18996327|P1|NOT COMPLETED|Overall Study||1
7714272|NCT01712178|18996326|P2|COMPLETED|Overall Study||47
7714273|NCT01712178|18996327|P1|COMPLETED|Overall Study||49
7714274|NCT01712178|18996326|P2|STARTED|Overall Study||50
7714275|NCT01712178|18996327|P1|STARTED|Overall Study||50
7714276|NCT01712074|18996352|P3|NOT COMPLETED|Double Blind Period||8
7714277|NCT01712074|18996353|P2|NOT COMPLETED|Double Blind Period||14
7714278|NCT01712074|18996354|P1|NOT COMPLETED|Double Blind Period||0
7714279|NCT01712074|18996352|P3|COMPLETED|Double Blind Period||86
7714280|NCT01712074|18996353|P2|COMPLETED|Double Blind Period||77
7714281|NCT01712074|18996354|P1|COMPLETED|Double Blind Period||0
7714282|NCT01712074|18996352|P3|STARTED|Double Blind Period||94
7714283|NCT01712074|18996353|P2|STARTED|Double Blind Period||91
7714284|NCT01712074|18996354|P1|STARTED|Double Blind Period||0
7714285|NCT01712074|18996352|P3|NOT COMPLETED|Placebo Run-in Period||0
7714286|NCT01712074|18996353|P2|NOT COMPLETED|Placebo Run-in Period||0
7714287|NCT01712074|18996354|P1|NOT COMPLETED|Placebo Run-in Period||10
7714288|NCT01712074|18996352|P3|COMPLETED|Placebo Run-in Period||0
7714289|NCT01712074|18996353|P2|COMPLETED|Placebo Run-in Period||0
7714290|NCT01712074|18996354|P1|COMPLETED|Placebo Run-in Period||185
7714291|NCT01712074|18996352|P3|STARTED|Placebo Run-in Period||0
7714292|NCT01712074|18996353|P2|STARTED|Placebo Run-in Period||0
7714293|NCT01712074|18996354|P1|STARTED|Placebo Run-in Period||195
7714294|NCT01712061|18996410|P3|NOT COMPLETED|Overall Study||11
7714295|NCT01712061|18996411|P2|NOT COMPLETED|Overall Study||26
7714296|NCT01712061|18996412|P1|NOT COMPLETED|Overall Study||10
7714297|NCT01712061|18996410|P3|COMPLETED|Overall Study||45
7714298|NCT01712061|18996411|P2|COMPLETED|Overall Study||114
7714299|NCT01712061|18996412|P1|COMPLETED|Overall Study||20
7714300|NCT01712061|18996410|P3|STARTED|Overall Study||56
7714301|NCT01712061|18996411|P2|STARTED|Overall Study||140
7714302|NCT01712061|18996412|P1|STARTED|Overall Study||30
7714303|NCT01712009|18996452|P3|NOT COMPLETED|Overall Study||21
7714304|NCT01712009|18996453|P2|NOT COMPLETED|Overall Study||29
7714305|NCT01712009|18996454|P1|NOT COMPLETED|Overall Study||38
7714306|NCT01712009|18996452|P3|COMPLETED|Overall Study||181
7714307|NCT01712009|18996453|P2|COMPLETED|Overall Study||171
7714308|NCT01712009|18996454|P1|COMPLETED|Overall Study||160
7714309|NCT01712009|18996452|P3|Received Naproxen / Loratadine|Overall Study||198
7714310|NCT01712009|18996453|P2|Received Naproxen / Loratadine|Overall Study||193
7714311|NCT01712009|18996454|P1|Received Naproxen / Loratadine|Overall Study||0
7714312|NCT01712009|18996452|P3|Received Pegfilgrastim|Overall Study||200
7714313|NCT01712009|18996453|P2|Received Pegfilgrastim|Overall Study||196
7714314|NCT01712009|18996454|P1|Received Pegfilgrastim|Overall Study||191
7714315|NCT01712009|18996452|P3|STARTED|Overall Study||202
7714316|NCT01712009|18996453|P2|STARTED|Overall Study||200
7714317|NCT01712009|18996454|P1|STARTED|Overall Study||198
7714318|NCT01711983|18996480|P1|NOT COMPLETED|36-Month Closure Evaluation||64
7714319|NCT01711983|18996480|P1|COMPLETED|36-Month Closure Evaluation||278
7714320|NCT01711983|18996480|P1|STARTED|36-Month Closure Evaluation||342
7714321|NCT01711983|18996480|P1|NOT COMPLETED|6-Month Closure Evaluation||26
7714322|NCT01711983|18996480|P1|COMPLETED|6-Month Closure Evaluation||342
7714323|NCT01711983|18996480|P1|STARTED|6-Month Closure Evaluation||368
7714324|NCT01711983|18996480|P1|NOT COMPLETED|6-Month Clinical Success Evaluation||32
7714325|NCT01711983|18996480|P1|COMPLETED|6-Month Clinical Success Evaluation||368
7714326|NCT01711983|18996480|P1|STARTED|6-Month Clinical Success Evaluation||400
7714327|NCT01711918|18996490|P1|NOT COMPLETED|Overall Study||2
7714328|NCT01711918|18996490|P1|COMPLETED|Overall Study||7
7714329|NCT01711918|18996490|P1|STARTED|Overall Study||9
7714330|NCT01711866|18996498|P1|NOT COMPLETED|Overall Study||8
7714331|NCT01711866|18996498|P1|COMPLETED|Overall Study||79
7714332|NCT01711866|18996498|P1|STARTED|Overall Study||87
7714333|NCT01711853|18996503|P1|NOT COMPLETED|Overall Study||3
7714334|NCT01711853|18996503|P1|COMPLETED|Overall Study||16
7714335|NCT01711853|18996503|P1|STARTED|Overall Study||19
7714336|NCT01711736|18996510|P2|NOT COMPLETED|Overall Study||8
7714337|NCT01711736|18996511|P1|NOT COMPLETED|Overall Study||12
7714338|NCT01711736|18996510|P2|COMPLETED|Overall Study|Up to Day 180|294
7714339|NCT01711736|18996511|P1|COMPLETED|Overall Study|Up to Day 180|287
7714340|NCT01711736|18996510|P2|STARTED|Overall Study||302
7714341|NCT01711736|18996511|P1|STARTED|Overall Study||299
7714342|NCT01711645|18996539|P1|NOT COMPLETED|Overall Study||19
7714343|NCT01711645|18996539|P1|COMPLETED|Overall Study||36
7714344|NCT01711645|18996539|P1|STARTED|Overall Study||55
7714345|NCT01711619|18996576|P2|NOT COMPLETED|Overall Study||24
7714346|NCT01711619|18996577|P1|NOT COMPLETED|Overall Study||18
7714347|NCT01711619|18996576|P2|COMPLETED|Overall Study||36
7714348|NCT01711619|18996577|P1|COMPLETED|Overall Study||38
7714349|NCT01711619|18996576|P2|STARTED|Overall Study||60
7714350|NCT01711619|18996577|P1|STARTED|Overall Study||56
7714351|NCT01711541|18996594|P5|NOT COMPLETED|Overall Study||0
7714352|NCT01711541|18996595|P4|NOT COMPLETED|Overall Study||1
7714353|NCT01711541|18996596|P3|NOT COMPLETED|Overall Study||0
7714354|NCT01711541|18996597|P2|NOT COMPLETED|Overall Study||1
7714355|NCT01711541|18996598|P1|NOT COMPLETED|Overall Study||0
7714356|NCT01711541|18996594|P5|COMPLETED|Overall Study||7
7714357|NCT01711541|18996595|P4|COMPLETED|Overall Study||5
7714358|NCT01711541|18996596|P3|COMPLETED|Overall Study||3
7714359|NCT01711541|18996597|P2|COMPLETED|Overall Study||3
7714360|NCT01711541|18996598|P1|COMPLETED|Overall Study||4
7714361|NCT01711541|18996594|P5|STARTED|Overall Study||7
7714362|NCT01711541|18996595|P4|STARTED|Overall Study||6
7714363|NCT01711541|18996596|P3|STARTED|Overall Study||3
7714364|NCT01711541|18996597|P2|STARTED|Overall Study||4
7714365|NCT01711541|18996598|P1|STARTED|Overall Study||4
7714366|NCT01711424|18996627|P1|NOT COMPLETED|Overall Study||0
7714367|NCT01711424|18996627|P1|COMPLETED|Overall Study||1209
7714368|NCT01711424|18996627|P1|STARTED|Overall Study||1209
7714369|NCT01711372|18996636|P2|NOT COMPLETED|Overall Study||0
7714370|NCT01711372|18996637|P1|NOT COMPLETED|Overall Study||0
7714371|NCT01711372|18996636|P2|COMPLETED|Overall Study||47
7714372|NCT01711372|18996637|P1|COMPLETED|Overall Study||66
7714373|NCT01711372|18996636|P2|STARTED|Overall Study||47
7714374|NCT01711372|18996637|P1|STARTED|Overall Study||66
7714375|NCT01711359|18996647|P3|NOT COMPLETED|Follow Up||28
7714376|NCT01711359|18996648|P2|NOT COMPLETED|Follow Up||15
7714377|NCT01711359|18996649|P1|NOT COMPLETED|Follow Up||25
7714378|NCT01711359|18996647|P3|COMPLETED|Follow Up||0
7714379|NCT01711359|18996648|P2|COMPLETED|Follow Up||0
7714380|NCT01711359|18996649|P1|COMPLETED|Follow Up||0
7714381|NCT01711359|18996647|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|28
7714382|NCT01711359|18996648|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|15
7714383|NCT01711359|18996649|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|25
7714384|NCT01711359|18996647|P3|NOT COMPLETED|Treatment Period||42
7714385|NCT01711359|18996648|P2|NOT COMPLETED|Treatment Period||24
7714386|NCT01711359|18996649|P1|NOT COMPLETED|Treatment Period||52
7714387|NCT01711359|18996647|P3|COMPLETED|Treatment Period||173
7714388|NCT01711359|18996648|P2|COMPLETED|Treatment Period||136
7714389|NCT01711359|18996649|P1|COMPLETED|Treatment Period||161
7714390|NCT01711359|18996647|P3|Rescued|Treatment Period||6
7714391|NCT01711359|18996648|P2|Rescued|Treatment Period||7
7714392|NCT01711359|18996649|P1|Rescued|Treatment Period||26
7714393|NCT01711359|18996647|P3|Received at Least One Dose of Study Drug|Treatment Period||215
7714394|NCT01711359|18996648|P2|Received at Least One Dose of Study Drug|Treatment Period||159
7714395|NCT01711359|18996649|P1|Received at Least One Dose of Study Drug|Treatment Period||210
7714396|NCT01711359|18996647|P3|STARTED|Treatment Period||215
7714397|NCT01711359|18996648|P2|STARTED|Treatment Period||160
7714398|NCT01711359|18996649|P1|STARTED|Treatment Period||213
7714399|NCT01711294|18996723|P3|NOT COMPLETED|Overall Study||0
7714400|NCT01711294|18996724|P2|NOT COMPLETED|Overall Study||0
7714401|NCT01711294|18996725|P1|NOT COMPLETED|Overall Study||0
7714402|NCT01711294|18996723|P3|COMPLETED|Overall Study||64
7714403|NCT01711294|18996724|P2|COMPLETED|Overall Study||65
7714404|NCT01711294|18996725|P1|COMPLETED|Overall Study||121
7714405|NCT01711294|18996723|P3|STARTED|Overall Study||64
7714406|NCT01711294|18996724|P2|STARTED|Overall Study||65
7714407|NCT01711294|18996725|P1|STARTED|Overall Study||121
7714408|NCT01711216|18996733|P1|NOT COMPLETED|Overall Study||217
7714409|NCT01711216|18996733|P1|COMPLETED|Overall Study||782
7714410|NCT01711216|18996733|P1|STARTED|Overall Study||999
7714411|NCT01711177|18996757|P3|NOT COMPLETED|Overall Study||0
7714412|NCT01711177|18996758|P2|NOT COMPLETED|Overall Study||0
7714413|NCT01711177|18996759|P1|NOT COMPLETED|Overall Study||0
7714414|NCT01711177|18996757|P3|COMPLETED|Overall Study||3
7714415|NCT01711177|18996758|P2|COMPLETED|Overall Study||3
7714416|NCT01711177|18996759|P1|COMPLETED|Overall Study||10
7714417|NCT01711177|18996757|P3|STARTED|Overall Study||3
7714418|NCT01711177|18996758|P2|STARTED|Overall Study||3
7714419|NCT01711177|18996759|P1|STARTED|Overall Study||10
7714420|NCT01710891|18996769|P2|NOT COMPLETED|Overall Study||0
7714421|NCT01710891|18996770|P1|NOT COMPLETED|Overall Study||0
7714422|NCT01710891|18996769|P2|COMPLETED|Overall Study||103
7714423|NCT01710891|18996770|P1|COMPLETED|Overall Study||95
7714424|NCT01710891|18996769|P2|STARTED|Overall Study||103
7714425|NCT01710891|18996770|P1|STARTED|Overall Study||95
7714426|NCT01710839|18996788|P2|NOT COMPLETED|Overall Study||6
7714427|NCT01710839|18996789|P1|NOT COMPLETED|Overall Study||1
7714428|NCT01710839|18996788|P2|COMPLETED|Overall Study||0
7714429|NCT01710839|18996789|P1|COMPLETED|Overall Study||23
7714430|NCT01710839|18996788|P2|STARTED|Overall Study||6
7714431|NCT01710839|18996789|P1|STARTED|Overall Study||24
7714432|NCT01710800|18996811|P1|NOT COMPLETED|Overall Study||22
7714433|NCT01710800|18996811|P1|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41
7714434|NCT01710800|18996811|P1|Received Placebo Intervention|Overall Study||45
7714435|NCT01710800|18996811|P1|Received PPI Intervention|Overall Study||44
7714436|NCT01710800|18996811|P1|STARTED|Overall Study|63 patients consented to be part of the study|63
7714437|NCT01710787|18996820|P3|NOT COMPLETED|Overall Study||0
7714438|NCT01710787|18996821|P2|NOT COMPLETED|Overall Study||0
7714439|NCT01710787|18996822|P1|NOT COMPLETED|Overall Study||0
7714440|NCT01710787|18996820|P3|COMPLETED|Overall Study||22
7714441|NCT01710787|18996821|P2|COMPLETED|Overall Study||44
7714442|NCT01710787|18996822|P1|COMPLETED|Overall Study||44
7714443|NCT01710787|18996820|P3|STARTED|Overall Study||22
7714444|NCT01710787|18996821|P2|STARTED|Overall Study||44
7714445|NCT01710787|18996822|P1|STARTED|Overall Study||44
7714446|NCT01710709|18996875|P1|NOT COMPLETED|Overall Study||173
7714447|NCT01710709|18996875|P1|COMPLETED|Overall Study||291
7714448|NCT01710709|18996875|P1|STARTED|Overall Study||464
7714449|NCT01710657|18996890|P3|NOT COMPLETED|Overall Study||32
7714450|NCT01710657|18996891|P2|NOT COMPLETED|Overall Study||12
7714451|NCT01710657|18996892|P1|NOT COMPLETED|Overall Study||18
7714452|NCT01710657|18996890|P3|COMPLETED|Overall Study||148
7714453|NCT01710657|18996891|P2|COMPLETED|Overall Study||171
7714454|NCT01710657|18996892|P1|COMPLETED|Overall Study||166
7714455|NCT01710657|18996890|P3|Maintenance Period (12 Weeks)|Overall Study||168
7714456|NCT01710657|18996891|P2|Maintenance Period (12 Weeks)|Overall Study||175
7714457|NCT01710657|18996892|P1|Maintenance Period (12 Weeks)|Overall Study||176
7714458|NCT01710657|18996890|P3|Titration Period (4 Weeks)|Overall Study||180
7714459|NCT01710657|18996891|P2|Titration Period (4 Weeks)|Overall Study||183
7714460|NCT01710657|18996892|P1|Titration Period (4 Weeks)|Overall Study||184
7714461|NCT01710657|18996890|P3|STARTED|Overall Study||180
7714462|NCT01710657|18996891|P2|STARTED|Overall Study||183
7714463|NCT01710657|18996892|P1|STARTED|Overall Study||184
7714464|NCT01710527|18996909|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
7714465|NCT01710527|18996910|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
7714466|NCT01710527|18996909|P2|COMPLETED|Period 3: Intervention Period 2||15
7714467|NCT01710527|18996910|P1|COMPLETED|Period 3: Intervention Period 2||16
7714468|NCT01710527|18996909|P2|STARTED|Period 3: Intervention Period 2||15
7714469|NCT01710527|18996910|P1|STARTED|Period 3: Intervention Period 2||16
7714470|NCT01710527|18996909|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||1
7714471|NCT01710527|18996910|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
7714472|NCT01710527|18996909|P2|COMPLETED|Period 2: Washout Period (7 Days)||15
7714473|NCT01710527|18996910|P1|COMPLETED|Period 2: Washout Period (7 Days)||16
7714474|NCT01710527|18996909|P2|STARTED|Period 2: Washout Period (7 Days)||16
7714475|NCT01710527|18996910|P1|STARTED|Period 2: Washout Period (7 Days)||16
7714476|NCT01710527|18996909|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
7714477|NCT01710527|18996910|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
7714478|NCT01710527|18996909|P2|COMPLETED|Period 1: Intervention Period 1||16
7714479|NCT01710527|18996910|P1|COMPLETED|Period 1: Intervention Period 1||16
7714480|NCT01710527|18996909|P2|STARTED|Period 1: Intervention Period 1||16
7714481|NCT01710527|18996910|P1|STARTED|Period 1: Intervention Period 1||16
7714482|NCT01710514|18996936|P2|NOT COMPLETED|Overall Study||7
7714483|NCT01710514|18996937|P1|NOT COMPLETED|Overall Study||7
7714484|NCT01710514|18996936|P2|COMPLETED|Overall Study||47
7714485|NCT01710514|18996937|P1|COMPLETED|Overall Study||47
7714738|NCT01709331|18997759|P1|STARTED|Overall Study||18
7714486|NCT01710514|18996936|P2|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54
7714487|NCT01710514|18996937|P1|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54
7714488|NCT01710514|18996936|P2|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47
7714489|NCT01710514|18996937|P1|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43
7714490|NCT01710514|18996936|P2|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48
7714491|NCT01710514|18996937|P1|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46
7714492|NCT01710514|18996936|P2|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54
7714493|NCT01710514|18996937|P1|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54
7714494|NCT01710514|18996936|P2|STARTED|Overall Study||54
7714495|NCT01710514|18996937|P1|STARTED|Overall Study||54
7714496|NCT01710501|18996958|P3|NOT COMPLETED|Overall Study||0
7714497|NCT01710501|18996959|P2|NOT COMPLETED|Overall Study||0
7714498|NCT01710501|18996960|P1|NOT COMPLETED|Overall Study||2
7714499|NCT01710501|18996958|P3|COMPLETED|Overall Study||30
7714500|NCT01710501|18996959|P2|COMPLETED|Overall Study||28
7714501|NCT01710501|18996960|P1|COMPLETED|Overall Study||27
7714502|NCT01710501|18996958|P3|STARTED|Overall Study||30
7714503|NCT01710501|18996959|P2|STARTED|Overall Study||28
7714504|NCT01710501|18996960|P1|STARTED|Overall Study||29
7714505|NCT01710358|18996992|P3|NOT COMPLETED|Follow-up Period||0
7714506|NCT01710358|18996993|P2|NOT COMPLETED|Follow-up Period||0
7714507|NCT01710358|18996994|P1|NOT COMPLETED|Follow-up Period||0
7714508|NCT01710358|18996992|P3|COMPLETED|Follow-up Period||20
7714509|NCT01710358|18996993|P2|COMPLETED|Follow-up Period||76
7714510|NCT01710358|18996994|P1|COMPLETED|Follow-up Period||33
7714511|NCT01710358|18996992|P3|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|20
7714512|NCT01710358|18996993|P2|STARTED|Follow-up Period|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4mg follow up.|76
7714513|NCT01710358|18996994|P1|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|33
7714514|NCT01710358|18996992|P3|NOT COMPLETED|Rescue Period||0
7714515|NCT01710358|18996993|P2|NOT COMPLETED|Rescue Period||31
7714516|NCT01710358|18996994|P1|NOT COMPLETED|Rescue Period||0
7714517|NCT01710358|18996992|P3|COMPLETED|Rescue Period||0
7714518|NCT01710358|18996993|P2|COMPLETED|Rescue Period||196
7714519|NCT01710358|18996994|P1|COMPLETED|Rescue Period||0
7714520|NCT01710358|18996992|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
7714521|NCT01710358|18996993|P2|STARTED|Rescue Period|Baricitinib 4 mg administered PO QD through Week 52. Participants continued background MTX therapy.|227
7714522|NCT01710358|18996994|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
7714523|NCT01710358|18996992|P3|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||15
7714524|NCT01710358|18996993|P2|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||22
7714525|NCT01710358|18996994|P1|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||16
7714526|NCT01710358|18996992|P3|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|252
7714527|NCT01710358|18996993|P2|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|402
7714528|NCT01710358|18996994|P1|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|294
7714529|NCT01710358|18996992|P3|Rescued|Treatment Period Part B (Weeks 24 to 52)||11
7714530|NCT01710358|18996993|P2|Rescued|Treatment Period Part B (Weeks 24 to 52)||8
7714531|NCT01710358|18996994|P1|Rescued|Treatment Period Part B (Weeks 24 to 52)||5
7714532|NCT01710358|18996992|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||267
7714533|NCT01710358|18996993|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||424
7714534|NCT01710358|18996994|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)|Participants originally randomized to placebo received baricitinib during Part B.|306
7714535|NCT01710358|18996992|P3|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|267
7714536|NCT01710358|18996993|P2|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|424
7714537|NCT01710358|18996994|P1|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|310
7714538|NCT01710358|18996992|P3|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||23
7714539|NCT01710358|18996993|P2|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||29
7714540|NCT01710358|18996994|P1|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||51
7714541|NCT01710358|18996992|P3|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|307
7714542|NCT01710358|18996993|P2|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|459
7714543|NCT01710358|18996994|P1|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|438
7714544|NCT01710358|18996992|P3|Rescued|Treatment Period Part A (Weeks 0 to 24)||40
7714545|NCT01710358|18996993|P2|Rescued|Treatment Period Part A (Weeks 0 to 24)||35
7714546|NCT01710358|18996994|P1|Rescued|Treatment Period Part A (Weeks 0 to 24)||128
7714547|NCT01710358|18996992|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||330
7714548|NCT01710358|18996993|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||487
7714549|NCT01710358|18996994|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||488
7714550|NCT01710358|18996992|P3|STARTED|Treatment Period Part A (Weeks 0 to 24)||330
7714551|NCT01710358|18996993|P2|STARTED|Treatment Period Part A (Weeks 0 to 24)||488
7714552|NCT01710358|18996994|P1|STARTED|Treatment Period Part A (Weeks 0 to 24)||489
7714553|NCT01710345|18997065|P3|NOT COMPLETED|Overall Study||1
7714554|NCT01710345|18997066|P2|NOT COMPLETED|Overall Study||5
7714555|NCT01710345|18997067|P1|NOT COMPLETED|Overall Study||3
7714556|NCT01710345|18997065|P3|COMPLETED|Overall Study||19
7714557|NCT01710345|18997066|P2|COMPLETED|Overall Study||35
7714558|NCT01710345|18997067|P1|COMPLETED|Overall Study||37
7714559|NCT01710345|18997065|P3|STARTED|Overall Study||20
7714560|NCT01710345|18997066|P2|STARTED|Overall Study||40
7714561|NCT01710345|18997067|P1|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40
7714562|NCT01710332|18997077|P2|NOT COMPLETED|Overall Study||0
7714563|NCT01710332|18997078|P1|NOT COMPLETED|Overall Study||0
7714564|NCT01710332|18997077|P2|COMPLETED|Overall Study||6
7714565|NCT01710332|18997078|P1|COMPLETED|Overall Study||6
7714566|NCT01710332|18997077|P2|STARTED|Overall Study||6
7714567|NCT01710332|18997078|P1|STARTED|Overall Study||6
7714568|NCT01710306|18997088|P2|NOT COMPLETED|Overall Study||30
7714569|NCT01710306|18997089|P1|NOT COMPLETED|Overall Study||18
7714570|NCT01710306|18997088|P2|COMPLETED|Overall Study||55
7714571|NCT01710306|18997089|P1|COMPLETED|Overall Study||68
7714572|NCT01710306|18997088|P2|STARTED|Overall Study||85
7714573|NCT01710306|18997089|P1|STARTED|Overall Study||86
7714574|NCT01710254|18997097|P1|NOT COMPLETED|Overall Study||0
7714575|NCT01710254|18997097|P1|COMPLETED|Overall Study||30
7714576|NCT01710254|18997097|P1|STARTED|Overall Study||30
7714577|NCT01710137|18997105|P2|NOT COMPLETED|Overall Study||14
7714578|NCT01710137|18997106|P1|NOT COMPLETED|Overall Study||24
7714579|NCT01710137|18997105|P2|COMPLETED|Overall Study||76
7714580|NCT01710137|18997106|P1|COMPLETED|Overall Study||65
7714581|NCT01710137|18997105|P2|STARTED|Overall Study||90
7714582|NCT01710137|18997106|P1|STARTED|Overall Study||89
7714583|NCT01710046|18997126|P2|NOT COMPLETED|Overall Study||0
7714584|NCT01710046|18997127|P1|NOT COMPLETED|Overall Study||1
7714585|NCT01710046|18997126|P2|COMPLETED|Overall Study||3
7714586|NCT01710046|18997127|P1|COMPLETED|Overall Study||8
7714587|NCT01710046|18997126|P2|STARTED|Overall Study||3
7714588|NCT01710046|18997127|P1|STARTED|Overall Study||9
7714589|NCT01710033|18997167|P5|NOT COMPLETED|Stage 2||1
7714590|NCT01710033|18997168|P4|NOT COMPLETED|Stage 2||0
7714591|NCT01710033|18997169|P3|NOT COMPLETED|Stage 2||0
7714592|NCT01710033|18997170|P2|NOT COMPLETED|Stage 2||0
7714593|NCT01710033|18997171|P1|NOT COMPLETED|Stage 2||0
7714594|NCT01710033|18997167|P5|COMPLETED|Stage 2||3
7714595|NCT01710033|18997168|P4|COMPLETED|Stage 2||0
7714596|NCT01710033|18997169|P3|COMPLETED|Stage 2||0
7714597|NCT01710033|18997170|P2|COMPLETED|Stage 2||0
7714598|NCT01710033|18997171|P1|COMPLETED|Stage 2||0
7714599|NCT01710033|18997167|P5|STARTED|Stage 2||4
7714600|NCT01710033|18997168|P4|STARTED|Stage 2||0
7714601|NCT01710033|18997169|P3|STARTED|Stage 2||0
7714602|NCT01710033|18997170|P2|STARTED|Stage 2||0
7714603|NCT01710033|18997171|P1|STARTED|Stage 2||0
7714604|NCT01710033|18997167|P5|NOT COMPLETED|Stage 1||0
7714605|NCT01710033|18997168|P4|NOT COMPLETED|Stage 1||0
7714606|NCT01710033|18997169|P3|NOT COMPLETED|Stage 1||0
7714607|NCT01710033|18997170|P2|NOT COMPLETED|Stage 1||0
7714608|NCT01710033|18997171|P1|NOT COMPLETED|Stage 1||0
7714609|NCT01710033|18997167|P5|COMPLETED|Stage 1||0
7714610|NCT01710033|18997168|P4|COMPLETED|Stage 1||6
7714611|NCT01710033|18997169|P3|COMPLETED|Stage 1||6
7714612|NCT01710033|18997170|P2|COMPLETED|Stage 1||6
7714613|NCT01710033|18997171|P1|COMPLETED|Stage 1||6
7714614|NCT01710033|18997167|P5|STARTED|Stage 1||0
7714615|NCT01710033|18997168|P4|STARTED|Stage 1||6
7714616|NCT01710033|18997169|P3|STARTED|Stage 1||6
7714617|NCT01710033|18997170|P2|STARTED|Stage 1||6
7714618|NCT01710033|18997171|P1|STARTED|Stage 1||6
7714619|NCT01710020|18997252|P1|NOT COMPLETED|Period 2||0
7714620|NCT01710020|18997252|P1|COMPLETED|Period 2||11
7714621|NCT01710020|18997252|P1|STARTED|Period 2||11
7714622|NCT01710020|18997252|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7714623|NCT01710020|18997252|P1|COMPLETED|Washout Period (at Least 14 Days)||11
7714624|NCT01710020|18997252|P1|STARTED|Washout Period (at Least 14 Days)||11
7714625|NCT01710020|18997252|P1|NOT COMPLETED|Period 1||1
7714626|NCT01710020|18997252|P1|COMPLETED|Period 1||11
7714627|NCT01710020|18997252|P1|STARTED|Period 1||12
7714628|NCT01709981|18997271|P2|NOT COMPLETED|Overall Study||0
7714629|NCT01709981|18997272|P1|NOT COMPLETED|Overall Study||0
7714630|NCT01709981|18997271|P2|COMPLETED|Overall Study||139
7714631|NCT01709981|18997272|P1|COMPLETED|Overall Study||141
7714632|NCT01709981|18997271|P2|STARTED|Overall Study||139
7714633|NCT01709981|18997272|P1|STARTED|Overall Study||141
7714634|NCT01709903|18997288|P2|NOT COMPLETED|Overall Study||39
7714635|NCT01709903|18997289|P1|NOT COMPLETED|Overall Study||29
7714636|NCT01709903|18997288|P2|COMPLETED|Overall Study||333
7714637|NCT01709903|18997289|P1|COMPLETED|Overall Study||343
7714638|NCT01709903|18997288|P2|STARTED|Overall Study|Randomized set|372
7714639|NCT01709903|18997289|P1|STARTED|Overall Study|Randomized set|372
7714640|NCT01709864|18997313|P2|NOT COMPLETED|Overall Study||11
7714641|NCT01709864|18997314|P1|NOT COMPLETED|Overall Study||7
7714642|NCT01709864|18997313|P2|COMPLETED|Overall Study||208
7714643|NCT01709864|18997314|P1|COMPLETED|Overall Study||215
7714644|NCT01709864|18997313|P2|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201
7714645|NCT01709864|18997314|P1|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204
7714646|NCT01709864|18997313|P2|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216
7714647|NCT01709864|18997314|P1|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222
7714648|NCT01709864|18997313|P2|STARTED|Overall Study||219
7714649|NCT01709864|18997314|P1|STARTED|Overall Study||222
7714650|NCT01709838|18997348|P1|NOT COMPLETED|Overall Study||67
7714651|NCT01709838|18997348|P1|COMPLETED|Overall Study||67
7714652|NCT01709838|18997348|P1|STARTED|Overall Study||134
7714653|NCT01709799|18997371|P3|NOT COMPLETED|Overall Study||3
7714654|NCT01709799|18997372|P2|NOT COMPLETED|Overall Study||3
7714655|NCT01709799|18997373|P1|NOT COMPLETED|Overall Study||3
7714656|NCT01709799|18997371|P3|COMPLETED|Overall Study||15
7714657|NCT01709799|18997372|P2|COMPLETED|Overall Study||18
7714658|NCT01709799|18997373|P1|COMPLETED|Overall Study||22
7714659|NCT01709799|18997371|P3|STARTED|Overall Study||18
7714660|NCT01709799|18997372|P2|STARTED|Overall Study||21
7714661|NCT01709799|18997373|P1|STARTED|Overall Study||25
7714662|NCT01709786|18997396|P1|NOT COMPLETED|Overall Study||0
7714663|NCT01709786|18997396|P1|COMPLETED|Overall Study||88
7714664|NCT01709786|18997396|P1|STARTED|Overall Study||88
7714665|NCT01709708|18997405|P2|NOT COMPLETED|Overall Study||2
7714666|NCT01709708|18997406|P1|NOT COMPLETED|Overall Study||1
7714667|NCT01709708|18997405|P2|COMPLETED|Overall Study||12
7714668|NCT01709708|18997406|P1|COMPLETED|Overall Study||26
7714669|NCT01709708|18997405|P2|STARTED|Overall Study||14
7714670|NCT01709708|18997406|P1|STARTED|Overall Study||27
7714671|NCT01709695|18997430|P2|NOT COMPLETED|Overall Study||1
7714672|NCT01709695|18997431|P1|NOT COMPLETED|Overall Study||1
7714673|NCT01709695|18997430|P2|COMPLETED|Overall Study||13
7714674|NCT01709695|18997431|P1|COMPLETED|Overall Study||12
7714675|NCT01709695|18997430|P2|STARTED|Overall Study||14
7714676|NCT01709695|18997431|P1|STARTED|Overall Study||13
7714677|NCT01709578|18997456|P3|NOT COMPLETED|Overall Study||51
7714678|NCT01709578|18997457|P2|NOT COMPLETED|Overall Study||56
7714679|NCT01709578|18997458|P1|NOT COMPLETED|Overall Study||80
7714680|NCT01709578|18997456|P3|COMPLETED|Overall Study||133
7714681|NCT01709578|18997457|P2|COMPLETED|Overall Study||125
7714682|NCT01709578|18997458|P1|COMPLETED|Overall Study||101
7714683|NCT01709578|18997456|P3|STARTED|Overall Study||184
7714684|NCT01709578|18997457|P2|STARTED|Overall Study||181
7714685|NCT01709578|18997458|P1|STARTED|Overall Study||181
7714686|NCT01709513|18997589|P3|NOT COMPLETED|Overall Study||30
7714687|NCT01709513|18997590|P2|NOT COMPLETED|Overall Study||43
7714688|NCT01709513|18997591|P1|NOT COMPLETED|Overall Study||21
7714689|NCT01709513|18997589|P3|COMPLETED|Overall Study||96
7714690|NCT01709513|18997590|P2|COMPLETED|Overall Study||82
7714691|NCT01709513|18997591|P1|COMPLETED|Overall Study||42
7714692|NCT01709513|18997589|P3|Treated|Overall Study||126
7714693|NCT01709513|18997590|P2|Treated|Overall Study||124
7714694|NCT01709513|18997591|P1|Treated|Overall Study||63
7714695|NCT01709513|18997589|P3|STARTED|Overall Study||126
7714696|NCT01709513|18997590|P2|STARTED|Overall Study||125
7714697|NCT01709513|18997591|P1|STARTED|Overall Study||63
7714698|NCT01709500|18997652|P2|NOT COMPLETED|Overall Study||82
7714699|NCT01709500|18997653|P1|NOT COMPLETED|Overall Study||167
7714700|NCT01709500|18997652|P2|COMPLETED|Overall Study||0
7714701|NCT01709500|18997653|P1|COMPLETED|Overall Study||0
7714702|NCT01709500|18997652|P2|Treated|Overall Study||81
7714703|NCT01709500|18997653|P1|Treated|Overall Study||167
7714704|NCT01709500|18997652|P2|STARTED|Overall Study||82
7714705|NCT01709500|18997653|P1|STARTED|Overall Study||167
7714706|NCT01709474|18997709|P2|NOT COMPLETED|Overall Study||0
7714707|NCT01709474|18997710|P1|NOT COMPLETED|Overall Study||0
7714708|NCT01709474|18997709|P2|COMPLETED|Overall Study||4
7714709|NCT01709474|18997710|P1|COMPLETED|Overall Study||3
7714710|NCT01709474|18997709|P2|STARTED|Overall Study||4
7714711|NCT01709474|18997710|P1|STARTED|Overall Study||3
7714712|NCT01709422|18997720|P2|NOT COMPLETED|Overall Study||0
7714713|NCT01709422|18997721|P1|NOT COMPLETED|Overall Study||0
7714714|NCT01709422|18997720|P2|COMPLETED|Overall Study||70
7714715|NCT01709422|18997721|P1|COMPLETED|Overall Study||70
7714716|NCT01709422|18997720|P2|STARTED|Overall Study||70
7714717|NCT01709422|18997721|P1|STARTED|Overall Study||70
7714718|NCT01709409|18997731|P2|NOT COMPLETED|Overall Study||0
7714719|NCT01709409|18997732|P1|NOT COMPLETED|Overall Study||1
7714720|NCT01709409|18997731|P2|COMPLETED|Overall Study||45
7714721|NCT01709409|18997732|P1|COMPLETED|Overall Study||42
7714722|NCT01709409|18997731|P2|STARTED|Overall Study||45
7714723|NCT01709409|18997732|P1|STARTED|Overall Study||43
7714724|NCT01709383|18997740|P2|NOT COMPLETED|Overall Study||0
7714725|NCT01709383|18997741|P1|NOT COMPLETED|Overall Study||1
7714726|NCT01709383|18997740|P2|COMPLETED|Overall Study||14
7714727|NCT01709383|18997741|P1|COMPLETED|Overall Study||23
7714728|NCT01709383|18997740|P2|Included in Analysis|Overall Study||13
7714729|NCT01709383|18997741|P1|Included in Analysis|Overall Study||22
7714730|NCT01709383|18997740|P2|Completed Follow-ups|Overall Study||14
7714731|NCT01709383|18997741|P1|Completed Follow-ups|Overall Study||23
7714732|NCT01709383|18997740|P2|Completed Treatment|Overall Study||14
7714733|NCT01709383|18997741|P1|Completed Treatment|Overall Study||24
7714734|NCT01709383|18997740|P2|STARTED|Overall Study||14
7714735|NCT01709383|18997741|P1|STARTED|Overall Study||24
7714736|NCT01709331|18997759|P1|NOT COMPLETED|Overall Study||1
7714737|NCT01709331|18997759|P1|COMPLETED|Overall Study||17
7714739|NCT01709318|18997772|P7|NOT COMPLETED|Overall Study||11
7714740|NCT01709318|18997773|P6|NOT COMPLETED|Overall Study||4
7714741|NCT01709318|18997774|P5|NOT COMPLETED|Overall Study||4
7714742|NCT01709318|18997775|P4|NOT COMPLETED|Overall Study||6
7714743|NCT01709318|18997776|P3|NOT COMPLETED|Overall Study||6
7714744|NCT01709318|18997777|P2|NOT COMPLETED|Overall Study||7
7714745|NCT01709318|18997778|P1|NOT COMPLETED|Overall Study||9
7714746|NCT01709318|18997772|P7|COMPLETED|Overall Study||171
7714747|NCT01709318|18997773|P6|COMPLETED|Overall Study||80
7714748|NCT01709318|18997774|P5|COMPLETED|Overall Study||74
7714749|NCT01709318|18997775|P4|COMPLETED|Overall Study||72
7714750|NCT01709318|18997776|P3|COMPLETED|Overall Study||71
7714751|NCT01709318|18997777|P2|COMPLETED|Overall Study||78
7714752|NCT01709318|18997778|P1|COMPLETED|Overall Study||73
7714753|NCT01709318|18997772|P7|Treated|Overall Study||178
7714754|NCT01709318|18997773|P6|Treated|Overall Study||86
7714755|NCT01709318|18997774|P5|Treated|Overall Study||77
7714756|NCT01709318|18997775|P4|Treated|Overall Study||77
7714757|NCT01709318|18997776|P3|Treated|Overall Study||78
7714758|NCT01709318|18997777|P2|Treated|Overall Study||85
7714759|NCT01709318|18997778|P1|Treated|Overall Study||79
7714760|NCT01709318|18997772|P7|STARTED|Overall Study||182
7714761|NCT01709318|18997773|P6|STARTED|Overall Study||84
7714762|NCT01709318|18997774|P5|STARTED|Overall Study||78
7714763|NCT01709318|18997775|P4|STARTED|Overall Study||78
7714764|NCT01709318|18997776|P3|STARTED|Overall Study||77
7714765|NCT01709318|18997777|P2|STARTED|Overall Study||85
7714766|NCT01709318|18997778|P1|STARTED|Overall Study||82
7714767|NCT01709305|18997871|P5|NOT COMPLETED|Phase 2||47
7714768|NCT01709305|18997872|P4|NOT COMPLETED|Phase 2||48
7714769|NCT01709305|18997873|P3|NOT COMPLETED|Phase 2||45
7714770|NCT01709305|18997874|P2|NOT COMPLETED|Phase 2||52
7714771|NCT01709305|18997875|P1|NOT COMPLETED|Phase 2||0
7714772|NCT01709305|18997871|P5|COMPLETED|Phase 2||507
7714773|NCT01709305|18997872|P4|COMPLETED|Phase 2||508
7714774|NCT01709305|18997873|P3|COMPLETED|Phase 2||505
7714775|NCT01709305|18997874|P2|COMPLETED|Phase 2||500
7714776|NCT01709305|18997875|P1|COMPLETED|Phase 2||0
7714777|NCT01709305|18997871|P5|STARTED|Phase 2||554
7714778|NCT01709305|18997872|P4|STARTED|Phase 2||556
7714779|NCT01709305|18997873|P3|STARTED|Phase 2||550
7714780|NCT01709305|18997874|P2|STARTED|Phase 2||552
7714781|NCT01709305|18997875|P1|STARTED|Phase 2||0
7714782|NCT01709305|18997871|P5|NOT COMPLETED|Phase 1||0
7714783|NCT01709305|18997872|P4|NOT COMPLETED|Phase 1||0
7714784|NCT01709305|18997873|P3|NOT COMPLETED|Phase 1||0
7714785|NCT01709305|18997874|P2|NOT COMPLETED|Phase 1||0
7714786|NCT01709305|18997875|P1|NOT COMPLETED|Phase 1||637
7714787|NCT01709305|18997871|P5|COMPLETED|Phase 1||0
7714788|NCT01709305|18997872|P4|COMPLETED|Phase 1||0
7714789|NCT01709305|18997873|P3|COMPLETED|Phase 1||0
7714790|NCT01709305|18997874|P2|COMPLETED|Phase 1||0
7714791|NCT01709305|18997875|P1|COMPLETED|Phase 1||4933
7714792|NCT01709305|18997871|P5|STARTED|Phase 1||0
7714793|NCT01709305|18997872|P4|STARTED|Phase 1||0
7714794|NCT01709305|18997873|P3|STARTED|Phase 1||0
7714795|NCT01709305|18997874|P2|STARTED|Phase 1||0
7714796|NCT01709305|18997875|P1|STARTED|Phase 1||5570
7714797|NCT01709227|18997912|P2|NOT COMPLETED|Overall Study||9
7714798|NCT01709227|18997913|P1|NOT COMPLETED|Overall Study||1
7714799|NCT01709227|18997912|P2|COMPLETED|Overall Study||32
7714800|NCT01709227|18997913|P1|COMPLETED|Overall Study||31
7714801|NCT01709227|18997912|P2|STARTED|Overall Study||41
7714802|NCT01709227|18997913|P1|STARTED|Overall Study||32
7714803|NCT01709162|18997939|P2|NOT COMPLETED|Overall Study||5
7714804|NCT01709162|18997940|P1|NOT COMPLETED|Overall Study||6
7714805|NCT01709162|18997939|P2|COMPLETED|Overall Study|Completed treatment as per protocol|0
7714806|NCT01709162|18997940|P1|COMPLETED|Overall Study|Completed treatment as per protocol|12
7714807|NCT01709162|18997939|P2|Still Receiving Treatment|Overall Study||0
7714808|NCT01709162|18997940|P1|Still Receiving Treatment|Overall Study||0
7714809|NCT01709162|18997939|P2|Received Treatment|Overall Study||4
7714810|NCT01709162|18997940|P1|Received Treatment|Overall Study||18
7714811|NCT01709162|18997939|P2|STARTED|Overall Study|Randomized|5
7714812|NCT01709162|18997940|P1|STARTED|Overall Study|Randomized|18
7714813|NCT01709149|18997955|P3|NOT COMPLETED|Double-blind, Placebo-controlled Phase||97
7714814|NCT01709149|18997956|P2|NOT COMPLETED|Double-blind, Placebo-controlled Phase||26
7714815|NCT01709149|18997957|P1|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
7714816|NCT01709149|18997955|P3|COMPLETED|Double-blind, Placebo-controlled Phase||204
7714817|NCT01709149|18997956|P2|COMPLETED|Double-blind, Placebo-controlled Phase||269
7714818|NCT01709149|18997957|P1|COMPLETED|Double-blind, Placebo-controlled Phase||0
7714819|NCT01709149|18997955|P3|STARTED|Double-blind, Placebo-controlled Phase||301
7714820|NCT01709149|18997956|P2|STARTED|Double-blind, Placebo-controlled Phase||295
7714821|NCT01709149|18997957|P1|STARTED|Double-blind, Placebo-controlled Phase||0
7714822|NCT01709149|18997955|P3|NOT COMPLETED|Open-label Lead-in Phase||0
7714823|NCT01709149|18997956|P2|NOT COMPLETED|Open-label Lead-in Phase||0
7714824|NCT01709149|18997957|P1|NOT COMPLETED|Open-label Lead-in Phase||115
7714825|NCT01709149|18997955|P3|COMPLETED|Open-label Lead-in Phase||0
7714826|NCT01709149|18997956|P2|COMPLETED|Open-label Lead-in Phase||0
7714827|NCT01709149|18997957|P1|COMPLETED|Open-label Lead-in Phase||596
7714828|NCT01709149|18997955|P3|STARTED|Open-label Lead-in Phase||0
7714829|NCT01709149|18997956|P2|STARTED|Open-label Lead-in Phase||0
7714830|NCT01709149|18997957|P1|STARTED|Open-label Lead-in Phase||711
7714831|NCT01709136|18997976|P1|NOT COMPLETED|Overall Study||0
7714832|NCT01709136|18997976|P1|COMPLETED|Overall Study||3
7714833|NCT01709136|18997976|P1|STARTED|Overall Study||3
7714834|NCT01709110|18997985|P2|NOT COMPLETED|Overall Study||168
7714835|NCT01709110|18997986|P1|NOT COMPLETED|Overall Study||185
7714836|NCT01709110|18997985|P2|COMPLETED|Overall Study||515
7714837|NCT01709110|18997986|P1|COMPLETED|Overall Study||498
7714838|NCT01709110|18997985|P2|Received at Least One Dose of Study Drug|Overall Study||680
7714839|NCT01709110|18997986|P1|Received at Least One Dose of Study Drug|Overall Study||680
7714840|NCT01709110|18997985|P2|STARTED|Overall Study||683
7714841|NCT01709110|18997986|P1|STARTED|Overall Study||683
7714842|NCT01709084|18998016|P2|NOT COMPLETED|Overall Study||15
7714843|NCT01709084|18998017|P1|NOT COMPLETED|Overall Study||16
7714844|NCT01709084|18998016|P2|COMPLETED|Overall Study||198
7714845|NCT01709084|18998017|P1|COMPLETED|Overall Study||197
7714846|NCT01709084|18998016|P2|Treated|Overall Study||211
7714847|NCT01709084|18998017|P1|Treated|Overall Study||213
7714848|NCT01709084|18998016|P2|STARTED|Overall Study||213
7714849|NCT01709084|18998017|P1|STARTED|Overall Study||213
7714850|NCT01709032|18998033|P1|NOT COMPLETED|Overall Study||3
7714851|NCT01709032|18998033|P1|COMPLETED|Overall Study||6
7714852|NCT01709032|18998033|P1|STARTED|Overall Study||9
7714853|NCT01708967|18998040|P2|NOT COMPLETED|Overall Study||7
7714854|NCT01708967|18998041|P1|NOT COMPLETED|Overall Study||0
7714855|NCT01708967|18998040|P2|COMPLETED|Overall Study||43
7714856|NCT01708967|18998041|P1|COMPLETED|Overall Study||50
7714857|NCT01708967|18998040|P2|STARTED|Overall Study||50
7714858|NCT01708967|18998041|P1|STARTED|Overall Study||50
7714859|NCT01708954|18998050|P3|NOT COMPLETED|Step 2||0
7714860|NCT01708954|18998051|P2|NOT COMPLETED|Step 2||7
7714861|NCT01708954|18998052|P1|NOT COMPLETED|Step 2||13
7714862|NCT01708954|18998050|P3|COMPLETED|Step 2||0
7714863|NCT01708954|18998051|P2|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
7714864|NCT01708954|18998052|P1|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
7714865|NCT01708954|18998050|P3|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0
7714866|NCT01708954|18998051|P2|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7
7714867|NCT01708954|18998052|P1|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13
7714868|NCT01708954|18998050|P3|NOT COMPLETED|Step 1||43
7714869|NCT01708954|18998051|P2|NOT COMPLETED|Step 1||40
7714870|NCT01708954|18998052|P1|NOT COMPLETED|Step 1||42
7714871|NCT01708954|18998050|P3|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
7714872|NCT01708954|18998051|P2|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
7714873|NCT01708954|18998052|P1|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
7714874|NCT01708954|18998050|P3|Patients With MET Status Data Available|Step 1||24
7714875|NCT01708954|18998051|P2|Patients With MET Status Data Available|Step 1||32
7714876|NCT01708954|18998052|P1|Patients With MET Status Data Available|Step 1||30
7714877|NCT01708954|18998050|P3|Eligible and Treated|Step 1||35
7714878|NCT01708954|18998051|P2|Eligible and Treated|Step 1||38
7714879|NCT01708954|18998052|P1|Eligible and Treated|Step 1||38
7714880|NCT01708954|18998050|P3|Started Protocol Therapy|Step 1||39
7714881|NCT01708954|18998051|P2|Started Protocol Therapy|Step 1||40
7714882|NCT01708954|18998052|P1|Started Protocol Therapy|Step 1||40
7714883|NCT01708954|18998050|P3|STARTED|Step 1||43
7714884|NCT01708954|18998051|P2|STARTED|Step 1||40
7714885|NCT01708954|18998052|P1|STARTED|Step 1||42
7714886|NCT01708941|18998077|P4|NOT COMPLETED|Overall Study||18
7714887|NCT01708941|18998078|P3|NOT COMPLETED|Overall Study||19
7714888|NCT01708941|18998079|P2|NOT COMPLETED|Overall Study||18
7714889|NCT01708941|18998080|P1|NOT COMPLETED|Overall Study||18
7714890|NCT01708941|18998077|P4|COMPLETED|Overall Study||4
7714891|NCT01708941|18998078|P3|COMPLETED|Overall Study||3
7714892|NCT01708941|18998079|P2|COMPLETED|Overall Study||5
7714893|NCT01708941|18998080|P1|COMPLETED|Overall Study||3
7714894|NCT01708941|18998077|P4|Eligible and Started Treatment|Overall Study||22
7714895|NCT01708941|18998078|P3|Eligible and Started Treatment|Overall Study||19
7714896|NCT01708941|18998079|P2|Eligible and Started Treatment|Overall Study||22
7714897|NCT01708941|18998080|P1|Eligible and Started Treatment|Overall Study||18
7714898|NCT01708941|18998077|P4|STARTED|Overall Study||22
7714899|NCT01708941|18998078|P3|STARTED|Overall Study||22
7714900|NCT01708941|18998079|P2|STARTED|Overall Study||23
7714901|NCT01708941|18998080|P1|STARTED|Overall Study||21
7714902|NCT01708915|18998098|P4|NOT COMPLETED|Overall Study||33
7714903|NCT01708915|18998099|P3|NOT COMPLETED|Overall Study||46
7714904|NCT01708915|18998100|P2|NOT COMPLETED|Overall Study||62
7714905|NCT01708915|18998101|P1|NOT COMPLETED|Overall Study||86
7714906|NCT01708915|18998098|P4|COMPLETED|Overall Study||169
7714907|NCT01708915|18998099|P3|COMPLETED|Overall Study||152
7714908|NCT01708915|18998100|P2|COMPLETED|Overall Study||139
7714909|NCT01708915|18998101|P1|COMPLETED|Overall Study||118
7714910|NCT01708915|18998098|P4|STARTED|Overall Study||202
7714911|NCT01708915|18998099|P3|STARTED|Overall Study||198
7714912|NCT01708915|18998100|P2|STARTED|Overall Study||201
7714913|NCT01708915|18998101|P1|STARTED|Overall Study||204
7714914|NCT01708902|18998130|P7|NOT COMPLETED|Overall Study||7
7714915|NCT01708902|18998131|P6|NOT COMPLETED|Overall Study||7
7714916|NCT01708902|18998132|P5|NOT COMPLETED|Overall Study||16
7714917|NCT01708902|18998133|P4|NOT COMPLETED|Overall Study||10
7714918|NCT01708902|18998134|P3|NOT COMPLETED|Overall Study||17
7714919|NCT01708902|18998135|P2|NOT COMPLETED|Overall Study||8
7714920|NCT01708902|18998136|P1|NOT COMPLETED|Overall Study||17
7714921|NCT01708902|18998130|P7|COMPLETED|Overall Study||65
7714922|NCT01708902|18998131|P6|COMPLETED|Overall Study||64
7714923|NCT01708902|18998132|P5|COMPLETED|Overall Study||131
7714924|NCT01708902|18998133|P4|COMPLETED|Overall Study||137
7714925|NCT01708902|18998134|P3|COMPLETED|Overall Study||127
7714926|NCT01708902|18998135|P2|COMPLETED|Overall Study||137
7714927|NCT01708902|18998136|P1|COMPLETED|Overall Study||130
7714928|NCT01708902|18998130|P7|STARTED|Overall Study||72
7714929|NCT01708902|18998131|P6|STARTED|Overall Study||71
7714930|NCT01708902|18998132|P5|STARTED|Overall Study||147
7714931|NCT01708902|18998133|P4|STARTED|Overall Study||147
7714932|NCT01708902|18998134|P3|STARTED|Overall Study||144
7714933|NCT01708902|18998135|P2|STARTED|Overall Study||145
7714934|NCT01708902|18998136|P1|STARTED|Overall Study||147
7714935|NCT01708629|18998199|P4|NOT COMPLETED|Overall Study||14
7714936|NCT01708629|18998200|P3|NOT COMPLETED|Overall Study||10
7714937|NCT01708629|18998201|P2|NOT COMPLETED|Overall Study||25
7714938|NCT01708629|18998202|P1|NOT COMPLETED|Overall Study||16
7714939|NCT01708629|18998199|P4|COMPLETED|Overall Study||301
7714940|NCT01708629|18998200|P3|COMPLETED|Overall Study||303
7714941|NCT01708629|18998201|P2|COMPLETED|Overall Study||604
7714942|NCT01708629|18998202|P1|COMPLETED|Overall Study||608
7714943|NCT01708629|18998199|P4|STARTED|Overall Study||315
7714944|NCT01708629|18998200|P3|STARTED|Overall Study||313
7714945|NCT01708629|18998201|P2|STARTED|Overall Study||629
7714946|NCT01708629|18998202|P1|STARTED|Overall Study||624
7714947|NCT01708603|18998219|P4|NOT COMPLETED|Overall Study||9
7714948|NCT01708603|18998220|P3|NOT COMPLETED|Overall Study||9
7714949|NCT01708603|18998221|P2|NOT COMPLETED|Overall Study||22
7714950|NCT01708603|18998222|P1|NOT COMPLETED|Overall Study||15
7714951|NCT01708603|18998219|P4|COMPLETED|Overall Study||300
7714952|NCT01708603|18998220|P3|COMPLETED|Overall Study||291
7714953|NCT01708603|18998221|P2|COMPLETED|Overall Study||588
7714954|NCT01708603|18998222|P1|COMPLETED|Overall Study||597
7714955|NCT01708603|18998219|P4|STARTED|Overall Study||309
7714956|NCT01708603|18998220|P3|STARTED|Overall Study||300
7714957|NCT01708603|18998221|P2|STARTED|Overall Study||610
7714958|NCT01708603|18998222|P1|STARTED|Overall Study||612
7714959|NCT01708590|18998243|P7|NOT COMPLETED|Withdrawal Phase||9
7714960|NCT01708590|18998244|P6|NOT COMPLETED|Withdrawal Phase||82
7714961|NCT01708590|18998245|P5|NOT COMPLETED|Withdrawal Phase||12
7714962|NCT01708590|18998246|P4|NOT COMPLETED|Withdrawal Phase||53
7714963|NCT01708590|18998247|P3|NOT COMPLETED|Withdrawal Phase||0
7714964|NCT01708590|18998248|P2|NOT COMPLETED|Withdrawal Phase||0
7714965|NCT01708590|18998249|P1|NOT COMPLETED|Withdrawal Phase||0
7714966|NCT01708590|18998243|P7|COMPLETED|Withdrawal Phase||74
7714967|NCT01708590|18998244|P6|COMPLETED|Withdrawal Phase||2
7714968|NCT01708590|18998245|P5|COMPLETED|Withdrawal Phase||45
7714969|NCT01708590|18998246|P4|COMPLETED|Withdrawal Phase||6
7714970|NCT01708590|18998247|P3|COMPLETED|Withdrawal Phase||0
7714971|NCT01708590|18998248|P2|COMPLETED|Withdrawal Phase||0
7714972|NCT01708590|18998249|P1|COMPLETED|Withdrawal Phase||0
7714973|NCT01708590|18998243|P7|STARTED|Withdrawal Phase||83
7714974|NCT01708590|18998244|P6|STARTED|Withdrawal Phase||84
7714975|NCT01708590|18998245|P5|STARTED|Withdrawal Phase||57
7714976|NCT01708590|18998246|P4|STARTED|Withdrawal Phase||59
7714977|NCT01708590|18998247|P3|STARTED|Withdrawal Phase||0
7714978|NCT01708590|18998248|P2|STARTED|Withdrawal Phase||0
7714979|NCT01708590|18998249|P1|STARTED|Withdrawal Phase||0
7714980|NCT01708590|18998243|P7|NOT COMPLETED|Induction Phase||0
7714981|NCT01708590|18998244|P6|NOT COMPLETED|Induction Phase||0
7714982|NCT01708590|18998245|P5|NOT COMPLETED|Induction Phase||0
7714983|NCT01708590|18998246|P4|NOT COMPLETED|Induction Phase||0
7714984|NCT01708590|18998247|P3|NOT COMPLETED|Induction Phase||11
7714985|NCT01708590|18998248|P2|NOT COMPLETED|Induction Phase||7
7714986|NCT01708590|18998249|P1|NOT COMPLETED|Induction Phase||10
7714987|NCT01708590|18998243|P7|COMPLETED|Induction Phase||0
7714988|NCT01708590|18998244|P6|COMPLETED|Induction Phase||0
7714989|NCT01708590|18998245|P5|COMPLETED|Induction Phase||0
7714990|NCT01708590|18998246|P4|COMPLETED|Induction Phase||0
7714991|NCT01708590|18998247|P3|COMPLETED|Induction Phase||209
7714992|NCT01708590|18998248|P2|COMPLETED|Induction Phase||212
7714993|NCT01708590|18998249|P1|COMPLETED|Induction Phase||212
7714994|NCT01708590|18998243|P7|STARTED|Induction Phase||0
7714995|NCT01708590|18998244|P6|STARTED|Induction Phase||0
7714996|NCT01708590|18998245|P5|STARTED|Induction Phase||0
7714997|NCT01708590|18998246|P4|STARTED|Induction Phase||0
7714998|NCT01708590|18998247|P3|STARTED|Induction Phase||220
7714999|NCT01708590|18998248|P2|STARTED|Induction Phase||219
7715000|NCT01708590|18998249|P1|STARTED|Induction Phase||222
7715001|NCT01708525|18998264|P1|NOT COMPLETED|Overall Study||0
7715002|NCT01708525|18998264|P1|COMPLETED|Overall Study||2
7715003|NCT01708525|18998264|P1|STARTED|Overall Study||2
7715004|NCT01708317|18998269|P1|NOT COMPLETED|Final Education Period||0
7715005|NCT01708317|18998269|P1|COMPLETED|Final Education Period||909
7715006|NCT01708317|18998269|P1|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909
7715007|NCT01708317|18998269|P1|NOT COMPLETED|ACASI + Education Period||0
7715008|NCT01708317|18998269|P1|COMPLETED|ACASI + Education Period||2601
7715009|NCT01708317|18998269|P1|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601
7715010|NCT01708317|18998269|P1|NOT COMPLETED|Initial Education Period||0
7715011|NCT01708317|18998269|P1|COMPLETED|Initial Education Period||982
7715012|NCT01708317|18998269|P1|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982
7715013|NCT01708317|18998269|P1|NOT COMPLETED|2010 Control Period||0
7715014|NCT01708317|18998269|P1|COMPLETED|2010 Control Period||3929
7715015|NCT01708317|18998269|P1|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929
7715016|NCT01708291|18998278|P2|NOT COMPLETED|Overall Study||1
7715017|NCT01708291|18998279|P1|NOT COMPLETED|Overall Study||2
7715018|NCT01708291|18998278|P2|COMPLETED|Overall Study||20
7715019|NCT01708291|18998279|P1|COMPLETED|Overall Study||19
7715020|NCT01708291|18998278|P2|STARTED|Overall Study||21
7715021|NCT01708291|18998279|P1|STARTED|Overall Study||21
7715022|NCT01708278|18998291|P6|NOT COMPLETED|Overall Study||0
7715023|NCT01708278|18998292|P5|NOT COMPLETED|Overall Study||0
7715024|NCT01708278|18998293|P4|NOT COMPLETED|Overall Study||0
7715025|NCT01708278|18998294|P3|NOT COMPLETED|Overall Study||0
7715026|NCT01708278|18998295|P2|NOT COMPLETED|Overall Study||0
7715027|NCT01708278|18998296|P1|NOT COMPLETED|Overall Study||0
7715028|NCT01708278|18998291|P6|COMPLETED|Overall Study||1
7715029|NCT01708278|18998292|P5|COMPLETED|Overall Study||1
7715030|NCT01708278|18998293|P4|COMPLETED|Overall Study||2
7715031|NCT01708278|18998294|P3|COMPLETED|Overall Study||2
7715032|NCT01708278|18998295|P2|COMPLETED|Overall Study||2
7715033|NCT01708278|18998296|P1|COMPLETED|Overall Study||1
7715034|NCT01708278|18998291|P6|STARTED|Overall Study||1
7715035|NCT01708278|18998292|P5|STARTED|Overall Study||1
7715036|NCT01708278|18998293|P4|STARTED|Overall Study||2
7715037|NCT01708278|18998294|P3|STARTED|Overall Study||2
7715038|NCT01708278|18998295|P2|STARTED|Overall Study||2
7715039|NCT01708278|18998296|P1|STARTED|Overall Study||1
7715040|NCT01708213|18998310|P1|NOT COMPLETED|Overall Study||1
7715041|NCT01708213|18998310|P1|COMPLETED|Overall Study||71
7715042|NCT01708213|18998310|P1|STARTED|Overall Study||72
7715043|NCT01708187|18998318|P2|NOT COMPLETED|Overall Study||1
7715044|NCT01708187|18998319|P1|NOT COMPLETED|Overall Study||0
7715045|NCT01708187|18998318|P2|COMPLETED|Overall Study||0
7715046|NCT01708187|18998319|P1|COMPLETED|Overall Study||1
7715047|NCT01708187|18998318|P2|STARTED|Overall Study||1
7715048|NCT01708187|18998319|P1|STARTED|Overall Study||1
7715049|NCT01708174|18998328|P3|NOT COMPLETED|Survival Follow-up||0
7715050|NCT01708174|18998329|P2|NOT COMPLETED|Survival Follow-up||0
7715051|NCT01708174|18998330|P1|NOT COMPLETED|Survival Follow-up||0
7715052|NCT01708174|18998328|P3|COMPLETED|Survival Follow-up||0
7715053|NCT01708174|18998329|P2|COMPLETED|Survival Follow-up||10
7715054|NCT01708174|18998330|P1|COMPLETED|Survival Follow-up||1
7715055|NCT01708174|18998328|P3|STARTED|Survival Follow-up||0
7715056|NCT01708174|18998329|P2|STARTED|Survival Follow-up||10
7715057|NCT01708174|18998330|P1|STARTED|Survival Follow-up||1
7715058|NCT01708174|18998328|P3|NOT COMPLETED|Treatment Period||1
7715059|NCT01708174|18998329|P2|NOT COMPLETED|Treatment Period||2
7715060|NCT01708174|18998330|P1|NOT COMPLETED|Treatment Period||1
7715061|NCT01708174|18998328|P3|COMPLETED|Treatment Period||3
7715062|NCT01708174|18998329|P2|COMPLETED|Treatment Period||14
7715063|NCT01708174|18998330|P1|COMPLETED|Treatment Period||1
7715064|NCT01708174|18998328|P3|Pharmacokinetic Analysis Set|Treatment Period||0
7715065|NCT01708174|18998329|P2|Pharmacokinetic Analysis Set|Treatment Period||13
7715066|NCT01708174|18998330|P1|Pharmacokinetic Analysis Set|Treatment Period||2
7715067|NCT01708174|18998328|P3|STARTED|Treatment Period||4
7715068|NCT01708174|18998329|P2|STARTED|Treatment Period||16
7715069|NCT01708174|18998330|P1|STARTED|Treatment Period||2
7715070|NCT01708161|18998362|P6|NOT COMPLETED|Overall Study||1
7715071|NCT01708161|18998363|P5|NOT COMPLETED|Overall Study||6
7715072|NCT01708161|18998364|P4|NOT COMPLETED|Overall Study||16
7715073|NCT01708161|18998365|P3|NOT COMPLETED|Overall Study||10
7715074|NCT01708161|18998366|P2|NOT COMPLETED|Overall Study||10
7715075|NCT01708161|18998367|P1|NOT COMPLETED|Overall Study||4
7715076|NCT01708161|18998362|P6|COMPLETED|Overall Study||0
7715077|NCT01708161|18998363|P5|COMPLETED|Overall Study||0
7715078|NCT01708161|18998364|P4|COMPLETED|Overall Study||0
7715079|NCT01708161|18998365|P3|COMPLETED|Overall Study||0
7715080|NCT01708161|18998366|P2|COMPLETED|Overall Study||0
7715081|NCT01708161|18998367|P1|COMPLETED|Overall Study||0
7715082|NCT01708161|18998362|P6|STARTED|Overall Study||1
7715083|NCT01708161|18998363|P5|STARTED|Overall Study||6
7715084|NCT01708161|18998364|P4|STARTED|Overall Study||16
7715085|NCT01708161|18998365|P3|STARTED|Overall Study||10
7715086|NCT01708161|18998366|P2|STARTED|Overall Study||10
7715087|NCT01708161|18998367|P1|STARTED|Overall Study||4
7715088|NCT01708122|18998409|P2|NOT COMPLETED|Overall Study||0
7715089|NCT01708122|18998410|P1|NOT COMPLETED|Overall Study||0
7715090|NCT01708122|18998409|P2|COMPLETED|Overall Study||26
7715091|NCT01708122|18998410|P1|COMPLETED|Overall Study||27
7715092|NCT01708122|18998409|P2|STARTED|Overall Study||26
7715093|NCT01708122|18998410|P1|STARTED|Overall Study||27
7715094|NCT01708057|18998418|P3|NOT COMPLETED|Overall Study||1
7715095|NCT01708057|18998419|P2|NOT COMPLETED|Overall Study||1
7715096|NCT01708057|18998420|P1|NOT COMPLETED|Overall Study||1
7715097|NCT01708057|18998418|P3|COMPLETED|Overall Study||0
7715098|NCT01708057|18998419|P2|COMPLETED|Overall Study||0
7715099|NCT01708057|18998420|P1|COMPLETED|Overall Study||0
7715100|NCT01708057|18998418|P3|STARTED|Overall Study||1
7715101|NCT01708057|18998419|P2|STARTED|Overall Study||1
7715102|NCT01708057|18998420|P1|STARTED|Overall Study||1
7715103|NCT01707992|18998479|P6|NOT COMPLETED|Active Treatment Phase (24 Months)||215
7715104|NCT01707992|18998480|P5|NOT COMPLETED|Active Treatment Phase (24 Months)||494
7715105|NCT01707992|18998481|P4|NOT COMPLETED|Active Treatment Phase (24 Months)||884
7715106|NCT01707992|18998482|P3|NOT COMPLETED|Active Treatment Phase (24 Months)||0
7715107|NCT01707992|18998483|P2|NOT COMPLETED|Active Treatment Phase (24 Months)||0
7715108|NCT01707992|18998484|P1|NOT COMPLETED|Active Treatment Phase (24 Months)||0
7715109|NCT01707992|18998479|P6|COMPLETED|Active Treatment Phase (24 Months)||0
7715110|NCT01707992|18998480|P5|COMPLETED|Active Treatment Phase (24 Months)||10
7715111|NCT01707992|18998481|P4|COMPLETED|Active Treatment Phase (24 Months)||7
7715112|NCT01707992|18998482|P3|COMPLETED|Active Treatment Phase (24 Months)||0
7715113|NCT01707992|18998483|P2|COMPLETED|Active Treatment Phase (24 Months)||0
7715114|NCT01707992|18998484|P1|COMPLETED|Active Treatment Phase (24 Months)||0
7715115|NCT01707992|18998479|P6|STARTED|Active Treatment Phase (24 Months)||215
7715116|NCT01707992|18998480|P5|STARTED|Active Treatment Phase (24 Months)||504
7715117|NCT01707992|18998481|P4|STARTED|Active Treatment Phase (24 Months)||891
7715118|NCT01707992|18998482|P3|STARTED|Active Treatment Phase (24 Months)||0
7715119|NCT01707992|18998483|P2|STARTED|Active Treatment Phase (24 Months)||0
7715120|NCT01707992|18998484|P1|STARTED|Active Treatment Phase (24 Months)||0
7715121|NCT01707992|18998479|P6|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
7715122|NCT01707992|18998480|P5|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
7715123|NCT01707992|18998481|P4|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
7715124|NCT01707992|18998482|P3|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||200
7715125|NCT01707992|18998483|P2|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||104
7715126|NCT01707992|18998484|P1|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||144
7715127|NCT01707992|18998479|P6|COMPLETED|Placebo-Controlled Phase (24 Months)||0
7715128|NCT01707992|18998480|P5|COMPLETED|Placebo-Controlled Phase (24 Months)||0
7715129|NCT01707992|18998481|P4|COMPLETED|Placebo-Controlled Phase (24 Months)||0
7715130|NCT01707992|18998482|P3|COMPLETED|Placebo-Controlled Phase (24 Months)||532
7715131|NCT01707992|18998483|P2|COMPLETED|Placebo-Controlled Phase (24 Months)||623
7715132|NCT01707992|18998484|P1|COMPLETED|Placebo-Controlled Phase (24 Months)||596
7715133|NCT01707992|18998479|P6|STARTED|Placebo-Controlled Phase (24 Months)||0
7715134|NCT01707992|18998480|P5|STARTED|Placebo-Controlled Phase (24 Months)||0
7715135|NCT01707992|18998481|P4|STARTED|Placebo-Controlled Phase (24 Months)||0
7715136|NCT01707992|18998482|P3|STARTED|Placebo-Controlled Phase (24 Months)||732
7715137|NCT01707992|18998483|P2|STARTED|Placebo-Controlled Phase (24 Months)||727
7715138|NCT01707992|18998484|P1|STARTED|Placebo-Controlled Phase (24 Months)||740
7715139|NCT01707693|18998536|P2|NOT COMPLETED|Time 3 Measures @ 6 Mth||5
7715140|NCT01707693|18998537|P1|NOT COMPLETED|Time 3 Measures @ 6 Mth||0
7715141|NCT01707693|18998536|P2|COMPLETED|Time 3 Measures @ 6 Mth||49
7715142|NCT01707693|18998537|P1|COMPLETED|Time 3 Measures @ 6 Mth||46
7715143|NCT01707693|18998536|P2|STARTED|Time 3 Measures @ 6 Mth||54
7715144|NCT01707693|18998537|P1|STARTED|Time 3 Measures @ 6 Mth||46
7715145|NCT01707693|18998536|P2|NOT COMPLETED|Overall Study Allocation||8
7715146|NCT01707693|18998537|P1|NOT COMPLETED|Overall Study Allocation||13
7715147|NCT01707693|18998536|P2|COMPLETED|Overall Study Allocation||54
7715148|NCT01707693|18998537|P1|COMPLETED|Overall Study Allocation||46
7715149|NCT01707693|18998536|P2|STARTED|Overall Study Allocation||62
7715150|NCT01707693|18998537|P1|STARTED|Overall Study Allocation||59
7715151|NCT01707667|18998551|P2|NOT COMPLETED|Period 2||0
7715152|NCT01707667|18998552|P1|NOT COMPLETED|Period 2||0
7715153|NCT01707667|18998551|P2|COMPLETED|Period 2||6
7715154|NCT01707667|18998552|P1|COMPLETED|Period 2||6
7715155|NCT01707667|18998551|P2|STARTED|Period 2||6
7715156|NCT01707667|18998552|P1|STARTED|Period 2||6
7715157|NCT01707667|18998551|P2|NOT COMPLETED|Period 1||0
7715158|NCT01707667|18998552|P1|NOT COMPLETED|Period 1||1
7715159|NCT01707667|18998551|P2|COMPLETED|Period 1||6
7715160|NCT01707667|18998552|P1|COMPLETED|Period 1||6
7715161|NCT01707667|18998551|P2|STARTED|Period 1||6
7715162|NCT01707667|18998552|P1|STARTED|Period 1||7
7715163|NCT01707654|18998570|P1|NOT COMPLETED|Overall Study||0
7715164|NCT01707654|18998570|P1|COMPLETED|Overall Study||9
7715165|NCT01707654|18998570|P1|STARTED|Overall Study||9
7715166|NCT01707472|18998577|P3|NOT COMPLETED|Overall Study||0
7715167|NCT01707472|18998578|P2|NOT COMPLETED|Overall Study||0
7715168|NCT01707472|18998579|P1|NOT COMPLETED|Overall Study||0
7715169|NCT01707472|18998577|P3|COMPLETED|Overall Study||8
7715170|NCT01707472|18998578|P2|COMPLETED|Overall Study||6
7715171|NCT01707472|18998579|P1|COMPLETED|Overall Study||4
7715172|NCT01707472|18998577|P3|STARTED|Overall Study||8
7715173|NCT01707472|18998578|P2|STARTED|Overall Study||6
7715174|NCT01707472|18998579|P1|STARTED|Overall Study||4
7715175|NCT01707381|18998602|P2|NOT COMPLETED|Period 2||0
7715176|NCT01707381|18998603|P1|NOT COMPLETED|Period 2||0
7715177|NCT01707381|18998602|P2|COMPLETED|Period 2||11
7715178|NCT01707381|18998603|P1|COMPLETED|Period 2||10
7715179|NCT01707381|18998602|P2|STARTED|Period 2||11
7715180|NCT01707381|18998603|P1|STARTED|Period 2||10
7715181|NCT01707381|18998602|P2|NOT COMPLETED|Period 1||2
7715182|NCT01707381|18998603|P1|NOT COMPLETED|Period 1||2
7715183|NCT01707381|18998602|P2|COMPLETED|Period 1||11
7715184|NCT01707381|18998603|P1|COMPLETED|Period 1||10
7715185|NCT01707381|18998602|P2|STARTED|Period 1||13
7715186|NCT01707381|18998603|P1|STARTED|Period 1||12
7715187|NCT01707368|18998613|P1|NOT COMPLETED|Overall Study||168
7715188|NCT01707368|18998613|P1|COMPLETED|Overall Study||393
7715189|NCT01707368|18998613|P1|STARTED|Overall Study||561
7715190|NCT01707290|18998622|P2|NOT COMPLETED|Overall Study||1
7715191|NCT01707290|18998623|P1|NOT COMPLETED|Overall Study||86
7715192|NCT01707290|18998622|P2|COMPLETED|Overall Study||3
7715193|NCT01707290|18998623|P1|COMPLETED|Overall Study||35
7715194|NCT01707290|18998622|P2|STARTED|Overall Study||4
7715195|NCT01707290|18998623|P1|STARTED|Overall Study||121
7715196|NCT01707238|18998646|P2|NOT COMPLETED|Overall Study||0
7715197|NCT01707238|18998647|P1|NOT COMPLETED|Overall Study||0
7715198|NCT01707238|18998646|P2|COMPLETED|Overall Study||52
7715199|NCT01707238|18998647|P1|COMPLETED|Overall Study||48
7715200|NCT01707238|18998646|P2|STARTED|Overall Study||52
7715201|NCT01707238|18998647|P1|STARTED|Overall Study||48
7715202|NCT01707225|18998663|P1|NOT COMPLETED|Overall Study||0
7715203|NCT01707225|18998663|P1|COMPLETED|Overall Study||10
7715204|NCT01707225|18998663|P1|STARTED|Overall Study||10
7715205|NCT01707147|18998668|P1|NOT COMPLETED|Overall Study||100
7715206|NCT01707147|18998668|P1|COMPLETED|Overall Study||3119
7715207|NCT01707147|18998668|P1|STARTED|Overall Study||3219
7715208|NCT01707095|18998678|P2|NOT COMPLETED|Overall Study||0
7715209|NCT01707095|18998679|P1|NOT COMPLETED|Overall Study||0
7715210|NCT01707095|18998678|P2|COMPLETED|Overall Study||42
7715211|NCT01707095|18998679|P1|COMPLETED|Overall Study||42
7715212|NCT01707095|18998678|P2|STARTED|Overall Study||42
7715213|NCT01707095|18998679|P1|STARTED|Overall Study||42
7715214|NCT01707043|18998689|P2|NOT COMPLETED|Overall Study||0
7715215|NCT01707043|18998690|P1|NOT COMPLETED|Overall Study||0
7715216|NCT01707043|18998689|P2|COMPLETED|Overall Study||10
7715217|NCT01707043|18998690|P1|COMPLETED|Overall Study||10
7715218|NCT01707043|18998689|P2|STARTED|Overall Study||10
7715219|NCT01707043|18998690|P1|STARTED|Overall Study||10
7715220|NCT01707030|18998700|P2|NOT COMPLETED|Overall Study||17
7715221|NCT01707030|18998701|P1|NOT COMPLETED|Overall Study||11
7715222|NCT01707030|18998700|P2|COMPLETED|Overall Study||54
7715223|NCT01707030|18998701|P1|COMPLETED|Overall Study||56
7715224|NCT01707030|18998700|P2|STARTED|Overall Study||71
7715225|NCT01707030|18998701|P1|STARTED|Overall Study||67
7715226|NCT01707004|18998719|P1|NOT COMPLETED|Overall Study||3
7715227|NCT01707004|18998719|P1|COMPLETED|Overall Study|3 participants were not eligible to proceed to Bone Marrow Transplant due to significant infections.|17
7715228|NCT01707004|18998719|P1|STARTED|Overall Study||20
7715229|NCT01706978|18998733|P2|NOT COMPLETED|Overall Study||6
7715230|NCT01706978|18998734|P1|NOT COMPLETED|Overall Study||9
7715231|NCT01706978|18998733|P2|COMPLETED|Overall Study||35
7715232|NCT01706978|18998734|P1|COMPLETED|Overall Study||38
7715233|NCT01706978|18998733|P2|STARTED|Overall Study||41
7715234|NCT01706978|18998734|P1|STARTED|Overall Study||47
7715235|NCT01706965|18998748|P2|NOT COMPLETED|Overall Study||1
7715236|NCT01706965|18998749|P1|NOT COMPLETED|Overall Study||1
7715237|NCT01706965|18998748|P2|COMPLETED|Overall Study||12
7715238|NCT01706965|18998749|P1|COMPLETED|Overall Study||13
7715239|NCT01706965|18998748|P2|STARTED|Overall Study||13
7715240|NCT01706965|18998749|P1|STARTED|Overall Study||14
7715241|NCT01706952|18998757|P1|NOT COMPLETED|Overall Study||8
7715242|NCT01706952|18998757|P1|COMPLETED|Overall Study||37
7715243|NCT01706952|18998757|P1|STARTED|Overall Study||45
7715244|NCT01706926|18998773|P4|NOT COMPLETED|Overall Study||5
7715245|NCT01706926|18998774|P3|NOT COMPLETED|Overall Study||6
7715246|NCT01706926|18998775|P2|NOT COMPLETED|Overall Study||4
7715247|NCT01706926|18998776|P1|NOT COMPLETED|Overall Study||6
7715248|NCT01706926|18998773|P4|COMPLETED|Overall Study||74
7715249|NCT01706926|18998774|P3|COMPLETED|Overall Study||79
7715250|NCT01706926|18998775|P2|COMPLETED|Overall Study||77
7715251|NCT01706926|18998776|P1|COMPLETED|Overall Study||75
7715252|NCT01706926|18998773|P4|STARTED|Overall Study||79
7715253|NCT01706926|18998774|P3|STARTED|Overall Study||85
7715254|NCT01706926|18998775|P2|STARTED|Overall Study||81
7715255|NCT01706926|18998776|P1|STARTED|Overall Study||81
7715256|NCT01706822|18998885|P1|NOT COMPLETED|Overall Study||0
7715257|NCT01706822|18998885|P1|COMPLETED|Overall Study||8
7715258|NCT01706822|18998885|P1|STARTED|Overall Study||8
7715259|NCT01706770|18998895|P2|NOT COMPLETED|Overall Study||0
7715260|NCT01706770|18998896|P1|NOT COMPLETED|Overall Study||2
7715261|NCT01706770|18998895|P2|COMPLETED|Overall Study||17
7715262|NCT01706770|18998896|P1|COMPLETED|Overall Study||31
7715263|NCT01706770|18998895|P2|STARTED|Overall Study||17
7715264|NCT01706770|18998896|P1|STARTED|Overall Study||33
7715265|NCT01706666|18998907|P3|NOT COMPLETED|Overall Study||0
7715266|NCT01706666|18998908|P2|NOT COMPLETED|Overall Study||0
7715267|NCT01706666|18998909|P1|NOT COMPLETED|Overall Study||0
7715268|NCT01706666|18998907|P3|COMPLETED|Overall Study||1
7715269|NCT01706666|18998908|P2|COMPLETED|Overall Study||1
7715270|NCT01706666|18998909|P1|COMPLETED|Overall Study||1
7715271|NCT01706666|18998907|P3|STARTED|Overall Study||1
7715272|NCT01706666|18998908|P2|STARTED|Overall Study||1
7715273|NCT01706666|18998909|P1|STARTED|Overall Study||1
7715274|NCT01706588|18998928|P5|NOT COMPLETED|Overall Study||0
7715275|NCT01706588|18998929|P4|NOT COMPLETED|Overall Study||0
7715276|NCT01706588|18998930|P3|NOT COMPLETED|Overall Study||0
7715277|NCT01706588|18998931|P2|NOT COMPLETED|Overall Study||0
7715278|NCT01706588|18998932|P1|NOT COMPLETED|Overall Study||0
7715279|NCT01706588|18998928|P5|COMPLETED|Overall Study||16
7715280|NCT01706588|18998929|P4|COMPLETED|Overall Study||14
7715281|NCT01706588|18998930|P3|COMPLETED|Overall Study||15
7715282|NCT01706588|18998931|P2|COMPLETED|Overall Study||15
7715283|NCT01706588|18998932|P1|COMPLETED|Overall Study||15
7715284|NCT01706588|18998928|P5|STARTED|Overall Study||16
7715285|NCT01706588|18998929|P4|STARTED|Overall Study||14
7715286|NCT01706588|18998930|P3|STARTED|Overall Study||15
7715287|NCT01706588|18998931|P2|STARTED|Overall Study||15
7715288|NCT01706588|18998932|P1|STARTED|Overall Study||15
7715289|NCT01706575|18998944|P1|NOT COMPLETED|Overall Study||12
7715290|NCT01706575|18998944|P1|COMPLETED|Overall Study||64
7715291|NCT01706575|18998944|P1|Treated|Overall Study||70
7715292|NCT01706575|18998944|P1|STARTED|Overall Study||76
7715293|NCT01706549|18998955|P1|NOT COMPLETED|Overall Study||0
7715294|NCT01706549|18998955|P1|COMPLETED|Overall Study||16
7715295|NCT01706549|18998955|P1|STARTED|Overall Study||16
7715296|NCT01706536|18998965|P5|NOT COMPLETED|Overall Study||2
7715297|NCT01706536|18998966|P4|NOT COMPLETED|Overall Study||4
7715298|NCT01706536|18998967|P3|NOT COMPLETED|Overall Study||5
7715299|NCT01706536|18998968|P2|NOT COMPLETED|Overall Study||4
7715300|NCT01706536|18998969|P1|NOT COMPLETED|Overall Study||4
7715301|NCT01706536|18998965|P5|COMPLETED|Overall Study||57
7715302|NCT01706536|18998966|P4|COMPLETED|Overall Study||53
7715303|NCT01706536|18998967|P3|COMPLETED|Overall Study||49
7715304|NCT01706536|18998968|P2|COMPLETED|Overall Study||51
7715305|NCT01706536|18998969|P1|COMPLETED|Overall Study||53
7715306|NCT01706536|18998965|P5|STARTED|Overall Study||59
7715307|NCT01706536|18998966|P4|STARTED|Overall Study||57
7715308|NCT01706536|18998967|P3|STARTED|Overall Study||54
7715309|NCT01706536|18998968|P2|STARTED|Overall Study||55
7715310|NCT01706536|18998969|P1|STARTED|Overall Study||57
7715311|NCT01706497|18999026|P1|NOT COMPLETED|Overall Study||0
7715312|NCT01706497|18999026|P1|COMPLETED|Overall Study||177
7715313|NCT01706497|18999026|P1|STARTED|Overall Study||177
7715314|NCT01706458|18999036|P2|NOT COMPLETED|Overall Study||4
7715315|NCT01706458|18999037|P1|NOT COMPLETED|Overall Study||3
7715316|NCT01706458|18999036|P2|COMPLETED|Overall Study||5
7715317|NCT01706458|18999037|P1|COMPLETED|Overall Study||6
7715318|NCT01706458|18999036|P2|STARTED|Overall Study||9
7715319|NCT01706458|18999037|P1|STARTED|Overall Study||9
7715320|NCT01706328|18999061|P3|NOT COMPLETED|12-week Double-blind Treatment Period||45
7715321|NCT01706328|18999062|P2|NOT COMPLETED|12-week Double-blind Treatment Period||46
7715322|NCT01706328|18999063|P1|NOT COMPLETED|12-week Double-blind Treatment Period||0
7715323|NCT01706328|18999061|P3|COMPLETED|12-week Double-blind Treatment Period||371
7715324|NCT01706328|18999062|P2|COMPLETED|12-week Double-blind Treatment Period||366
7715325|NCT01706328|18999063|P1|COMPLETED|12-week Double-blind Treatment Period||0
7715326|NCT01706328|18999061|P3|STARTED|12-week Double-blind Treatment Period||416
7715327|NCT01706328|18999062|P2|STARTED|12-week Double-blind Treatment Period||412
7715328|NCT01706328|18999063|P1|STARTED|12-week Double-blind Treatment Period||0
7715329|NCT01706328|18999061|P3|NOT COMPLETED|2-week Run-in Period||0
7715330|NCT01706328|18999062|P2|NOT COMPLETED|2-week Run-in Period||0
7715331|NCT01706328|18999063|P1|NOT COMPLETED|2-week Run-in Period||165
7715332|NCT01706328|18999061|P3|COMPLETED|2-week Run-in Period||0
7715333|NCT01706328|18999062|P2|COMPLETED|2-week Run-in Period||0
7715334|NCT01706328|18999063|P1|COMPLETED|2-week Run-in Period||828
7715335|NCT01706328|18999061|P3|STARTED|2-week Run-in Period||0
7715336|NCT01706328|18999062|P2|STARTED|2-week Run-in Period||0
7715337|NCT01706328|18999063|P1|STARTED|2-week Run-in Period||993
7715338|NCT01706263|18999073|P1|NOT COMPLETED|Overall Study||0
7715339|NCT01706263|18999073|P1|COMPLETED|Overall Study||28
7715340|NCT01706263|18999073|P1|STARTED|Overall Study||28
7715341|NCT01706250|18999082|P1|NOT COMPLETED|Overall Study||2
7715342|NCT01706250|18999082|P1|COMPLETED|Overall Study||18
7715343|NCT01706250|18999082|P1|STARTED|Overall Study||20
7715344|NCT01706198|18999113|P2|NOT COMPLETED|Overall Study||194
7715345|NCT01706198|18999114|P1|NOT COMPLETED|Overall Study||173
7715346|NCT01706198|18999113|P2|COMPLETED|Overall Study||1920
7715347|NCT01706198|18999114|P1|COMPLETED|Overall Study||1946
7715348|NCT01706198|18999113|P2|STARTED|Overall Study||2114
7715349|NCT01706198|18999114|P1|STARTED|Overall Study||2119
7715350|NCT01706159|18999166|P2|NOT COMPLETED|Overall Study||2
7715351|NCT01706159|18999167|P1|NOT COMPLETED|Overall Study||8
7715352|NCT01706159|18999166|P2|COMPLETED|Overall Study||4
7715353|NCT01706159|18999167|P1|COMPLETED|Overall Study||6
7715354|NCT01706159|18999166|P2|Completers (With Baron Score at Week 8)|Overall Study||3
7715355|NCT01706159|18999167|P1|Completers (With Baron Score at Week 8)|Overall Study||6
7715356|NCT01706159|18999166|P2|Exposed|Overall Study|One subject was not exposed to placebo.|5
7715357|NCT01706159|18999167|P1|Exposed|Overall Study|One subject was not exposed to rFXIII.|13
7715358|NCT01706159|18999166|P2|STARTED|Overall Study||6
7715359|NCT01706159|18999167|P1|STARTED|Overall Study||14
7715360|NCT01706146|18999181|P1|NOT COMPLETED|Overall Study||6
7715361|NCT01706146|18999181|P1|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53
7715362|NCT01706146|18999181|P1|STARTED|Overall Study||59
7715363|NCT01706081|18999188|P2|NOT COMPLETED|Overall Study||0
7715364|NCT01706081|18999189|P1|NOT COMPLETED|Overall Study||0
7715365|NCT01706081|18999188|P2|COMPLETED|Overall Study||42
7715366|NCT01706081|18999189|P1|COMPLETED|Overall Study||40
7715367|NCT01706081|18999188|P2|STARTED|Overall Study||42
7715368|NCT01706081|18999189|P1|STARTED|Overall Study||40
7715369|NCT01706003|18999201|P2|NOT COMPLETED|Overall Study||4
7715370|NCT01706003|18999202|P1|NOT COMPLETED|Overall Study||11
7715371|NCT01706003|18999201|P2|COMPLETED|Overall Study||18
7715372|NCT01706003|18999202|P1|COMPLETED|Overall Study||12
7715373|NCT01706003|18999201|P2|STARTED|Overall Study||22
7715374|NCT01706003|18999202|P1|STARTED|Overall Study||23
7715375|NCT01705977|18999210|P2|NOT COMPLETED|Overall Study||260
7715376|NCT01705977|18999211|P1|NOT COMPLETED|Overall Study||273
7715377|NCT01705977|18999210|P2|COMPLETED|Overall Study||1741
7715378|NCT01705977|18999211|P1|COMPLETED|Overall Study||1729
7715379|NCT01705977|18999210|P2|STARTED|Overall Study||2001
7715380|NCT01705977|18999211|P1|STARTED|Overall Study||2002
7715381|NCT01705730|18999229|P1|NOT COMPLETED|Overall Study||9
7715382|NCT01705730|18999229|P1|COMPLETED|Overall Study||59
7715383|NCT01705730|18999229|P1|STARTED|Overall Study|Participants who received study drug|68
7715384|NCT01705717|18999269|P2|NOT COMPLETED|Overall Study||5
7715385|NCT01705717|18999270|P1|NOT COMPLETED|Overall Study||2
7715386|NCT01705717|18999269|P2|COMPLETED|Overall Study||7
7715387|NCT01705717|18999270|P1|COMPLETED|Overall Study||35
7715388|NCT01705717|18999269|P2|STARTED|Overall Study||12
7715389|NCT01705717|18999270|P1|STARTED|Overall Study||37
7715390|NCT01705691|18999287|P2|NOT COMPLETED|Overall Study||6
7715391|NCT01705691|18999288|P1|NOT COMPLETED|Overall Study||3
7715392|NCT01705691|18999287|P2|COMPLETED|Overall Study||24
7715393|NCT01705691|18999288|P1|COMPLETED|Overall Study||16
7715394|NCT01705691|18999287|P2|STARTED|Overall Study||30
7715395|NCT01705691|18999288|P1|STARTED|Overall Study||19
7715396|NCT01705652|18999308|P2|NOT COMPLETED|Overall Study||3
7715397|NCT01705652|18999309|P1|NOT COMPLETED|Overall Study||3
7715398|NCT01705652|18999308|P2|COMPLETED|Overall Study||9
7715399|NCT01705652|18999309|P1|COMPLETED|Overall Study||6
7715400|NCT01705652|18999308|P2|STARTED|Overall Study||12
7715401|NCT01705652|18999309|P1|STARTED|Overall Study||9
7715402|NCT01705587|18999317|P2|NOT COMPLETED|Overall Study||1
7715403|NCT01705587|18999318|P1|NOT COMPLETED|Overall Study||0
7715404|NCT01705587|18999317|P2|COMPLETED|Overall Study||5
7715405|NCT01705587|18999318|P1|COMPLETED|Overall Study||7
7715406|NCT01705587|18999317|P2|STARTED|Overall Study||6
7715407|NCT01705587|18999318|P1|STARTED|Overall Study||7
7715408|NCT01705574|18999336|P4|NOT COMPLETED|Open-Label Extension Phase||5
7715409|NCT01705574|18999337|P3|NOT COMPLETED|Open-Label Extension Phase||11
7715410|NCT01705574|18999338|P2|NOT COMPLETED|Open-Label Extension Phase||0
7715411|NCT01705574|18999339|P1|NOT COMPLETED|Open-Label Extension Phase||15
7715412|NCT01705574|18999336|P4|COMPLETED|Open-Label Extension Phase||48
7715413|NCT01705574|18999337|P3|COMPLETED|Open-Label Extension Phase||148
7715414|NCT01705574|18999338|P2|COMPLETED|Open-Label Extension Phase||0
7715415|NCT01705574|18999339|P1|COMPLETED|Open-Label Extension Phase||231
7715416|NCT01705574|18999336|P4|STARTED|Open-Label Extension Phase|53 participants entered from the DB ATV+ RTV + TVD arm.|53
7715417|NCT01705574|18999337|P3|STARTED|Open-Label Extension Phase|159 participants entered from the DB ATV+RTV+TVD arm.|159
7715418|NCT01705574|18999338|P2|STARTED|Open-Label Extension Phase|Participants either entered the OL GEN arm or OL ATV+RTV+TVD arm.|0
7715419|NCT01705574|18999339|P1|STARTED|Open-Label Extension Phase||246
7715420|NCT01705574|18999336|P4|NOT COMPLETED|Double-Blind Phase||0
7715421|NCT01705574|18999337|P3|NOT COMPLETED|Double-Blind Phase||0
7715422|NCT01705574|18999338|P2|NOT COMPLETED|Double-Blind Phase||41
7715423|NCT01705574|18999339|P1|NOT COMPLETED|Double-Blind Phase||33
7715424|NCT01705574|18999336|P4|COMPLETED|Double-Blind Phase||0
7715425|NCT01705574|18999337|P3|COMPLETED|Double-Blind Phase||0
7715426|NCT01705574|18999338|P2|COMPLETED|Double-Blind Phase||249
7715427|NCT01705574|18999339|P1|COMPLETED|Double-Blind Phase||260
7715428|NCT01705574|18999336|P4|STARTED|Double-Blind Phase||0
7715429|NCT01705574|18999337|P3|STARTED|Double-Blind Phase||0
7715430|NCT01705574|18999338|P2|STARTED|Double-Blind Phase||290
7715431|NCT01705574|18999339|P1|STARTED|Double-Blind Phase||293
7715432|NCT01705509|18999356|P1|NOT COMPLETED|CPET w/ Ranexa||2
7715433|NCT01705509|18999356|P1|COMPLETED|CPET w/ Ranexa||5
7715434|NCT01705509|18999356|P1|STARTED|CPET w/ Ranexa||7
7715435|NCT01705509|18999356|P1|NOT COMPLETED|Inclusion CPET||7
7715436|NCT01705509|18999356|P1|COMPLETED|Inclusion CPET||7
7715437|NCT01705509|18999356|P1|STARTED|Inclusion CPET||14
7715438|NCT01705496|18999360|P1|NOT COMPLETED|Overall Study||4
7715439|NCT01705496|18999360|P1|COMPLETED|Overall Study||19
7715440|NCT01705496|18999360|P1|STARTED|Overall Study||23
7715441|NCT01705288|18999372|P2|NOT COMPLETED|Overall Study||0
7715442|NCT01705288|18999373|P1|NOT COMPLETED|Overall Study||0
7715443|NCT01705288|18999372|P2|COMPLETED|Overall Study||51
7715444|NCT01705288|18999373|P1|COMPLETED|Overall Study||52
7715445|NCT01705288|18999372|P2|STARTED|Overall Study||51
7715446|NCT01705288|18999373|P1|STARTED|Overall Study||52
7715447|NCT01705236|18999383|P1|NOT COMPLETED|Overall Study||27
7715448|NCT01705236|18999383|P1|COMPLETED|Overall Study||60
7715449|NCT01705236|18999383|P1|STARTED|Overall Study||87
7715450|NCT01705145|18999392|P1|NOT COMPLETED|Part B||1
7715451|NCT01705145|18999392|P1|COMPLETED|Part B||33
7715452|NCT01705145|18999392|P1|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34
7715453|NCT01705145|18999392|P1|NOT COMPLETED|Part A||0
7715454|NCT01705145|18999392|P1|COMPLETED|Part A||9
7715455|NCT01705145|18999392|P1|STARTED|Part A||9
7715456|NCT01705106|18999420|P1|NOT COMPLETED|Overall Study||0
7715457|NCT01705106|18999420|P1|COMPLETED|Overall Study||21
7715458|NCT01705106|18999420|P1|STARTED|Overall Study||21
7715459|NCT01705080|18999432|P4|NOT COMPLETED|Overall Study||42
7715460|NCT01705080|18999433|P3|NOT COMPLETED|Overall Study||5
7715461|NCT01705080|18999434|P2|NOT COMPLETED|Overall Study||16
7715462|NCT01705080|18999435|P1|NOT COMPLETED|Overall Study||15
7715463|NCT01705080|18999432|P4|COMPLETED|Overall Study||9
7715464|NCT01705080|18999433|P3|COMPLETED|Overall Study||27
7715465|NCT01705080|18999434|P2|COMPLETED|Overall Study||98
7715466|NCT01705080|18999435|P1|COMPLETED|Overall Study||142
7715467|NCT01705080|18999432|P4|1 Month|Overall Study||10
7715468|NCT01705080|18999433|P3|1 Month|Overall Study||27
7715469|NCT01705080|18999434|P2|1 Month|Overall Study||97
7715470|NCT01705080|18999435|P1|1 Month|Overall Study||148
7715471|NCT01705080|18999432|P4|Procedure|Overall Study||10
7715472|NCT01705080|18999433|P3|Procedure|Overall Study||29
7715473|NCT01705080|18999434|P2|Procedure|Overall Study||103
7715474|NCT01705080|18999435|P1|Procedure|Overall Study||149
7715475|NCT01705080|18999432|P4|STARTED|Overall Study||51
7715476|NCT01705080|18999433|P3|STARTED|Overall Study||32
7715477|NCT01705080|18999434|P2|STARTED|Overall Study||114
7715478|NCT01705080|18999435|P1|STARTED|Overall Study||157
7715479|NCT01704976|18999547|P2|NOT COMPLETED|Overall Study||2
7715480|NCT01704976|18999548|P1|NOT COMPLETED|Overall Study||1
7715481|NCT01704976|18999547|P2|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11
7715482|NCT01704976|18999548|P1|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13
7715483|NCT01704976|18999547|P2|STARTED|Overall Study||13
7715484|NCT01704976|18999548|P1|STARTED|Overall Study||14
7715485|NCT01704846|18999564|P2|NOT COMPLETED|Treatment Period 4||0
7715486|NCT01704846|18999565|P1|NOT COMPLETED|Treatment Period 4||0
7715487|NCT01704846|18999564|P2|COMPLETED|Treatment Period 4||29
7715488|NCT01704846|18999565|P1|COMPLETED|Treatment Period 4||30
7715489|NCT01704846|18999564|P2|STARTED|Treatment Period 4||29
7715490|NCT01704846|18999565|P1|STARTED|Treatment Period 4||30
7715491|NCT01704846|18999564|P2|NOT COMPLETED|Treatment Period 3||0
7715492|NCT01704846|18999565|P1|NOT COMPLETED|Treatment Period 3||0
7715493|NCT01704846|18999564|P2|COMPLETED|Treatment Period 3||29
7715494|NCT01704846|18999565|P1|COMPLETED|Treatment Period 3||30
7715495|NCT01704846|18999564|P2|STARTED|Treatment Period 3||29
7715496|NCT01704846|18999565|P1|STARTED|Treatment Period 3||30
7715497|NCT01704846|18999564|P2|NOT COMPLETED|Treatment Period 2||1
7715498|NCT01704846|18999565|P1|NOT COMPLETED|Treatment Period 2||0
7715499|NCT01704846|18999564|P2|COMPLETED|Treatment Period 2||29
7715500|NCT01704846|18999565|P1|COMPLETED|Treatment Period 2||30
7715501|NCT01704846|18999564|P2|STARTED|Treatment Period 2||30
7715502|NCT01704846|18999565|P1|STARTED|Treatment Period 2||30
7715503|NCT01704846|18999564|P2|NOT COMPLETED|Treatment Period 1||0
7715504|NCT01704846|18999565|P1|NOT COMPLETED|Treatment Period 1||0
7715505|NCT01704846|18999564|P2|COMPLETED|Treatment Period 1||30
7715506|NCT01704846|18999565|P1|COMPLETED|Treatment Period 1||30
7715507|NCT01704846|18999564|P2|STARTED|Treatment Period 1||30
7715508|NCT01704846|18999565|P1|STARTED|Treatment Period 1||30
7715509|NCT01704781|18999588|P5|NOT COMPLETED|Overall Study||0
7715510|NCT01704781|18999589|P4|NOT COMPLETED|Overall Study||0
7715511|NCT01704781|18999590|P3|NOT COMPLETED|Overall Study||0
7715512|NCT01704781|18999591|P2|NOT COMPLETED|Overall Study||0
7715513|NCT01704781|18999592|P1|NOT COMPLETED|Overall Study||0
7715514|NCT01704781|18999588|P5|COMPLETED|Overall Study||12
7715515|NCT01704781|18999589|P4|COMPLETED|Overall Study||12
7715516|NCT01704781|18999590|P3|COMPLETED|Overall Study||6
7715517|NCT01704781|18999591|P2|COMPLETED|Overall Study||3
7715518|NCT01704781|18999592|P1|COMPLETED|Overall Study||3
7715519|NCT01704781|18999588|P5|STARTED|Overall Study||12
7715520|NCT01704781|18999589|P4|STARTED|Overall Study||12
7715521|NCT01704781|18999590|P3|STARTED|Overall Study||6
7715522|NCT01704781|18999591|P2|STARTED|Overall Study||3
7715523|NCT01704781|18999592|P1|STARTED|Overall Study||3
7715524|NCT01704755|18999620|P2|NOT COMPLETED|Overall Study||7
7715525|NCT01704755|18999621|P1|NOT COMPLETED|Overall Study||12
7715526|NCT01704755|18999620|P2|COMPLETED|Overall Study||165
7715527|NCT01704755|18999621|P1|COMPLETED|Overall Study||196
7715528|NCT01704755|18999620|P2|Completed Study Drug|Overall Study||163
7715529|NCT01704755|18999621|P1|Completed Study Drug|Overall Study||204
7715530|NCT01704755|18999620|P2|STARTED|Overall Study||172
7715531|NCT01704755|18999621|P1|STARTED|Overall Study||208
7715532|NCT01704651|18999635|P2|NOT COMPLETED|Overall Study||7
7715533|NCT01704651|18999636|P1|NOT COMPLETED|Overall Study||5
7715534|NCT01704651|18999635|P2|COMPLETED|Overall Study||68
7715535|NCT01704651|18999636|P1|COMPLETED|Overall Study||66
7715536|NCT01704651|18999635|P2|STARTED|Overall Study||75
7715537|NCT01704651|18999636|P1|STARTED|Overall Study||71
7715538|NCT01704599|18999644|P1|NOT COMPLETED|Overall Study||1
7715539|NCT01704599|18999644|P1|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7
7715540|NCT01704599|18999644|P1|STARTED|Overall Study|Study was started January 22, 2010|8
7715541|NCT01704521|18999673|P2|NOT COMPLETED|Overall Study||0
7715542|NCT01704521|18999674|P1|NOT COMPLETED|Overall Study||0
7715543|NCT01704521|18999673|P2|COMPLETED|Overall Study||2
7715544|NCT01704521|18999674|P1|COMPLETED|Overall Study||3
7715545|NCT01704521|18999673|P2|STARTED|Overall Study||2
7715546|NCT01704521|18999674|P1|STARTED|Overall Study||3
7715547|NCT01704495|18999684|P4|NOT COMPLETED|Optional Safety Extension||31
7715548|NCT01704495|18999685|P3|NOT COMPLETED|Optional Safety Extension||31
7715549|NCT01704495|18999686|P2|NOT COMPLETED|Optional Safety Extension||33
7715550|NCT01704495|18999687|P1|NOT COMPLETED|Optional Safety Extension||29
7715551|NCT01704495|18999684|P4|COMPLETED|Optional Safety Extension||85
7715552|NCT01704495|18999685|P3|COMPLETED|Optional Safety Extension||83
7715553|NCT01704495|18999686|P2|COMPLETED|Optional Safety Extension||88
7715554|NCT01704495|18999687|P1|COMPLETED|Optional Safety Extension||87
7715555|NCT01704495|18999684|P4|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
7715556|NCT01704495|18999685|P3|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114
7715557|NCT01704495|18999686|P2|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121
7715558|NCT01704495|18999687|P1|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
7715559|NCT01704495|18999684|P4|NOT COMPLETED|Subjects Randomized||17
7715560|NCT01704495|18999685|P3|NOT COMPLETED|Subjects Randomized||16
7715561|NCT01704495|18999686|P2|NOT COMPLETED|Subjects Randomized||15
7715562|NCT01704495|18999687|P1|NOT COMPLETED|Subjects Randomized||22
7715563|NCT01704495|18999684|P4|COMPLETED|Subjects Randomized||145
7715564|NCT01704495|18999685|P3|COMPLETED|Subjects Randomized||144
7715565|NCT01704495|18999686|P2|COMPLETED|Subjects Randomized||141
7715566|NCT01704495|18999687|P1|COMPLETED|Subjects Randomized||140
7715567|NCT01704495|18999684|P4|STARTED|Subjects Randomized||162
7715568|NCT01704495|18999685|P3|STARTED|Subjects Randomized||160
7715569|NCT01704495|18999686|P2|STARTED|Subjects Randomized||156
7715570|NCT01704495|18999687|P1|STARTED|Subjects Randomized||162
7715571|NCT01704456|18999863|P2|NOT COMPLETED|Overall Study||14
7715572|NCT01704456|18999864|P1|NOT COMPLETED|Overall Study||8
7715573|NCT01704456|18999863|P2|COMPLETED|Overall Study||49
7715574|NCT01704456|18999864|P1|COMPLETED|Overall Study||59
7715575|NCT01704456|18999863|P2|STARTED|Overall Study||63
7715576|NCT01704456|18999864|P1|STARTED|Overall Study||67
7715577|NCT01704404|18999884|P6|NOT COMPLETED|Overall Study||0
7715578|NCT01704404|18999885|P5|NOT COMPLETED|Overall Study||1
7715579|NCT01704404|18999886|P4|NOT COMPLETED|Overall Study||3
7715580|NCT01704404|18999887|P3|NOT COMPLETED|Overall Study||1
7715581|NCT01704404|18999888|P2|NOT COMPLETED|Overall Study||1
7715582|NCT01704404|18999889|P1|NOT COMPLETED|Overall Study||1
7715583|NCT01704404|18999884|P6|COMPLETED|Overall Study||9
7715584|NCT01704404|18999885|P5|COMPLETED|Overall Study||10
7715585|NCT01704404|18999886|P4|COMPLETED|Overall Study||8
7715586|NCT01704404|18999887|P3|COMPLETED|Overall Study||9
7715587|NCT01704404|18999888|P2|COMPLETED|Overall Study||9
7715588|NCT01704404|18999889|P1|COMPLETED|Overall Study||10
7715589|NCT01704404|18999884|P6|STARTED|Overall Study||9
7715590|NCT01704404|18999885|P5|STARTED|Overall Study||11
7715591|NCT01704404|18999886|P4|STARTED|Overall Study||11
7715592|NCT01704404|18999887|P3|STARTED|Overall Study||10
7715593|NCT01704404|18999888|P2|STARTED|Overall Study||10
7715594|NCT01704404|18999889|P1|STARTED|Overall Study||11
7715595|NCT01704287|18999926|P5|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
7715596|NCT01704287|18999927|P4|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
7715597|NCT01704287|18999928|P3|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
7715598|NCT01704287|18999929|P2|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
7715599|NCT01704287|18999930|P1|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
7715600|NCT01704287|18999926|P5|COMPLETED|Switch to Pembrolizumab Treatment Period||7
7715601|NCT01704287|18999927|P4|COMPLETED|Switch to Pembrolizumab Treatment Period||15
7715602|NCT01704287|18999928|P3|COMPLETED|Switch to Pembrolizumab Treatment Period||0
7715603|NCT01704287|18999929|P2|COMPLETED|Switch to Pembrolizumab Treatment Period||0
7715604|NCT01704287|18999930|P1|COMPLETED|Switch to Pembrolizumab Treatment Period||0
7715605|NCT01704287|18999926|P5|STARTED|Switch to Pembrolizumab Treatment Period||45
7715606|NCT01704287|18999927|P4|STARTED|Switch to Pembrolizumab Treatment Period||53
7715607|NCT01704287|18999928|P3|STARTED|Switch to Pembrolizumab Treatment Period||0
7715608|NCT01704287|18999929|P2|STARTED|Switch to Pembrolizumab Treatment Period||0
7715609|NCT01704287|18999930|P1|STARTED|Switch to Pembrolizumab Treatment Period||0
7715610|NCT01704287|18999926|P5|NOT COMPLETED|Initial Treatment Period||0
7715611|NCT01704287|18999927|P4|NOT COMPLETED|Initial Treatment Period||0
7715612|NCT01704287|18999928|P3|NOT COMPLETED|Initial Treatment Period||173
7715613|NCT01704287|18999929|P2|NOT COMPLETED|Initial Treatment Period||134
7715614|NCT01704287|18999930|P1|NOT COMPLETED|Initial Treatment Period||147
7715615|NCT01704287|18999926|P5|COMPLETED|Initial Treatment Period||0
7715616|NCT01704287|18999927|P4|COMPLETED|Initial Treatment Period||0
7715617|NCT01704287|18999928|P3|COMPLETED|Initial Treatment Period||6
7715618|NCT01704287|18999929|P2|COMPLETED|Initial Treatment Period||47
7715619|NCT01704287|18999930|P1|COMPLETED|Initial Treatment Period||33
7715620|NCT01704287|18999926|P5|Treated|Initial Treatment Period||0
7715621|NCT01704287|18999927|P4|Treated|Initial Treatment Period||0
7715622|NCT01704287|18999928|P3|Treated|Initial Treatment Period||171
7715623|NCT01704287|18999929|P2|Treated|Initial Treatment Period||179
7715624|NCT01704287|18999930|P1|Treated|Initial Treatment Period||178
7715625|NCT01704287|18999926|P5|STARTED|Initial Treatment Period||0
7715626|NCT01704287|18999927|P4|STARTED|Initial Treatment Period||0
7715627|NCT01704287|18999928|P3|STARTED|Initial Treatment Period||179
7715628|NCT01704287|18999929|P2|STARTED|Initial Treatment Period||181
7715629|NCT01704287|18999930|P1|STARTED|Initial Treatment Period||180
7715630|NCT01704261|18999978|P2|NOT COMPLETED|Overall Study||15
7715631|NCT01704261|18999979|P1|NOT COMPLETED|Overall Study||13
7715632|NCT01704261|18999978|P2|COMPLETED|Overall Study||138
7715633|NCT01704261|18999979|P1|COMPLETED|Overall Study||141
7715634|NCT01704261|18999978|P2|STARTED|Overall Study||153
7715635|NCT01704261|18999979|P1|STARTED|Overall Study||154
7715636|NCT01704196|18999995|P2|NOT COMPLETED|Overall Study||24
7715637|NCT01704196|18999996|P1|NOT COMPLETED|Overall Study||19
7715638|NCT01704196|18999995|P2|COMPLETED|Overall Study||65
7715639|NCT01704196|18999996|P1|COMPLETED|Overall Study||71
7715640|NCT01704196|18999995|P2|STARTED|Overall Study||89
7715641|NCT01704196|18999996|P1|STARTED|Overall Study||90
7715642|NCT01704079|19000006|P2|NOT COMPLETED|Overall Study||23
7715643|NCT01704079|19000007|P1|NOT COMPLETED|Overall Study||14
7715644|NCT01704079|19000006|P2|COMPLETED|Overall Study||121
7715645|NCT01704079|19000007|P1|COMPLETED|Overall Study||58
7715646|NCT01704079|19000006|P2|Entered Extension Study|Overall Study||102
7715647|NCT01704079|19000007|P1|Entered Extension Study|Overall Study||53
7715648|NCT01704079|19000006|P2|STARTED|Overall Study||144
7715649|NCT01704079|19000007|P1|STARTED|Overall Study||72
7715650|NCT01703988|19000023|P4|NOT COMPLETED|Overall Study||1
7715651|NCT01703988|19000024|P3|NOT COMPLETED|Overall Study||0
7715652|NCT01703988|19000025|P2|NOT COMPLETED|Overall Study||0
7715653|NCT01703988|19000026|P1|NOT COMPLETED|Overall Study||0
7715654|NCT01703988|19000023|P4|COMPLETED|Overall Study||8
7715655|NCT01703988|19000024|P3|COMPLETED|Overall Study||9
7715656|NCT01703988|19000025|P2|COMPLETED|Overall Study||8
7715657|NCT01703988|19000026|P1|COMPLETED|Overall Study||8
7715658|NCT01703988|19000023|P4|STARTED|Overall Study||9
7715659|NCT01703988|19000024|P3|STARTED|Overall Study||9
7715660|NCT01703988|19000025|P2|STARTED|Overall Study||8
7715661|NCT01703988|19000026|P1|STARTED|Overall Study||8
7715662|NCT01703858|19000056|P3|NOT COMPLETED|Overall Study||0
7715663|NCT01703858|19000057|P2|NOT COMPLETED|Overall Study||1
7715664|NCT01703858|19000058|P1|NOT COMPLETED|Overall Study||0
7715665|NCT01703858|19000056|P3|COMPLETED|Overall Study||5
7715666|NCT01703858|19000057|P2|COMPLETED|Overall Study||4
7715667|NCT01703858|19000058|P1|COMPLETED|Overall Study||5
7715668|NCT01703858|19000056|P3|STARTED|Overall Study||5
7715669|NCT01703858|19000057|P2|STARTED|Overall Study||5
7715670|NCT01703858|19000058|P1|STARTED|Overall Study||5
7715671|NCT01703845|19000083|P2|NOT COMPLETED|Overall Study||0
7715672|NCT01703845|19000084|P1|NOT COMPLETED|Overall Study||3
7715673|NCT01703845|19000083|P2|COMPLETED|Overall Study||16
7715674|NCT01703845|19000084|P1|COMPLETED|Overall Study||13
7715675|NCT01703845|19000083|P2|STARTED|Overall Study|started are actually the randomized|16
7715676|NCT01703845|19000084|P1|STARTED|Overall Study|started are actually the randomized|16
7715677|NCT01703832|19000121|P2|NOT COMPLETED|Overall Study||0
7715678|NCT01703832|19000122|P1|NOT COMPLETED|Overall Study||1
7715679|NCT01703832|19000121|P2|COMPLETED|Overall Study||32
7715680|NCT01703832|19000122|P1|COMPLETED|Overall Study||32
7715681|NCT01703832|19000121|P2|STARTED|Overall Study||32
7715682|NCT01703832|19000122|P1|STARTED|Overall Study||33
7715683|NCT01703819|19000154|P2|NOT COMPLETED|Overall Study||2
7715684|NCT01703819|19000155|P1|NOT COMPLETED|Overall Study||0
7715685|NCT01703819|19000154|P2|COMPLETED|Overall Study||30
7715686|NCT01703819|19000155|P1|COMPLETED|Overall Study||34
7715687|NCT01703819|19000154|P2|STARTED|Overall Study||32
7715688|NCT01703819|19000155|P1|STARTED|Overall Study||34
7715689|NCT01703741|19000185|P1|NOT COMPLETED|Overall Study||18
7715690|NCT01703741|19000185|P1|COMPLETED|Overall Study||127
7715691|NCT01703741|19000185|P1|Per Protocol (PP) Population|Overall Study|Subjects having 24 hr pharmacokinetic (PK) data for testosterone, with no major protocol violations.|106
7715692|NCT01703741|19000185|P1|STARTED|Overall Study||145
7715693|NCT01703702|19000203|P2|NOT COMPLETED|Overall Study||22
7715694|NCT01703702|19000204|P1|NOT COMPLETED|Overall Study||36
7715695|NCT01703702|19000203|P2|COMPLETED|Overall Study||288
7715696|NCT01703702|19000204|P1|COMPLETED|Overall Study||272
7715697|NCT01703702|19000203|P2|STARTED|Overall Study||310
7715698|NCT01703702|19000204|P1|STARTED|Overall Study||308
7715699|NCT01703663|19000221|P2|NOT COMPLETED|Second Treatment Period||0
7715700|NCT01703663|19000222|P1|NOT COMPLETED|Second Treatment Period||0
7715701|NCT01703663|19000221|P2|COMPLETED|Second Treatment Period||8
7715702|NCT01703663|19000222|P1|COMPLETED|Second Treatment Period||11
7715703|NCT01703663|19000221|P2|STARTED|Second Treatment Period||8
7715704|NCT01703663|19000222|P1|STARTED|Second Treatment Period||11
7715705|NCT01703663|19000221|P2|NOT COMPLETED|First Treatment Period||0
7715706|NCT01703663|19000222|P1|NOT COMPLETED|First Treatment Period||0
7715707|NCT01703663|19000221|P2|COMPLETED|First Treatment Period||20
7715708|NCT01703663|19000222|P1|COMPLETED|First Treatment Period||20
7715709|NCT01703663|19000221|P2|STARTED|First Treatment Period||20
7715710|NCT01703663|19000222|P1|STARTED|First Treatment Period||20
7715711|NCT01703598|19000228|P1|NOT COMPLETED|Overall Study||0
7715712|NCT01703598|19000228|P1|COMPLETED|Overall Study||69
7715713|NCT01703598|19000228|P1|STARTED|Overall Study||69
7715714|NCT01703507|19000234|P2|NOT COMPLETED|Overall Study||0
7715715|NCT01703507|19000235|P1|NOT COMPLETED|Overall Study||1
7715716|NCT01703507|19000234|P2|COMPLETED|Overall Study||11
7715717|NCT01703507|19000235|P1|COMPLETED|Overall Study||5
7715718|NCT01703507|19000234|P2|STARTED|Overall Study||11
7715719|NCT01703507|19000235|P1|STARTED|Overall Study||6
7715720|NCT01703286|19000251|P6|NOT COMPLETED|Period 3 Including Washout||0
7715721|NCT01703286|19000252|P5|NOT COMPLETED|Period 3 Including Washout||0
7715722|NCT01703286|19000253|P4|NOT COMPLETED|Period 3 Including Washout||0
7715723|NCT01703286|19000254|P3|NOT COMPLETED|Period 3 Including Washout||0
7715724|NCT01703286|19000255|P2|NOT COMPLETED|Period 3 Including Washout||0
7715725|NCT01703286|19000256|P1|NOT COMPLETED|Period 3 Including Washout||0
7715726|NCT01703286|19000251|P6|COMPLETED|Period 3 Including Washout||6
7715727|NCT01703286|19000252|P5|COMPLETED|Period 3 Including Washout||7
7715728|NCT01703286|19000253|P4|COMPLETED|Period 3 Including Washout||5
7715729|NCT01703286|19000254|P3|COMPLETED|Period 3 Including Washout||7
7715730|NCT01703286|19000255|P2|COMPLETED|Period 3 Including Washout||7
7715731|NCT01703286|19000256|P1|COMPLETED|Period 3 Including Washout||7
7715732|NCT01703286|19000251|P6|STARTED|Period 3 Including Washout||6
7715733|NCT01703286|19000252|P5|STARTED|Period 3 Including Washout||7
7715734|NCT01703286|19000253|P4|STARTED|Period 3 Including Washout||5
7715735|NCT01703286|19000254|P3|STARTED|Period 3 Including Washout||7
7715736|NCT01703286|19000255|P2|STARTED|Period 3 Including Washout||7
7715737|NCT01703286|19000256|P1|STARTED|Period 3 Including Washout||7
7715738|NCT01703286|19000251|P6|NOT COMPLETED|Period 2 Including Washout||0
7715739|NCT01703286|19000252|P5|NOT COMPLETED|Period 2 Including Washout||0
7715740|NCT01703286|19000253|P4|NOT COMPLETED|Period 2 Including Washout||1
7715741|NCT01703286|19000254|P3|NOT COMPLETED|Period 2 Including Washout||0
7715742|NCT01703286|19000255|P2|NOT COMPLETED|Period 2 Including Washout||0
7715743|NCT01703286|19000256|P1|NOT COMPLETED|Period 2 Including Washout||0
7715744|NCT01703286|19000251|P6|COMPLETED|Period 2 Including Washout||6
7715745|NCT01703286|19000252|P5|COMPLETED|Period 2 Including Washout||7
7715746|NCT01703286|19000253|P4|COMPLETED|Period 2 Including Washout||5
7715747|NCT01703286|19000254|P3|COMPLETED|Period 2 Including Washout||7
7715748|NCT01703286|19000255|P2|COMPLETED|Period 2 Including Washout||7
7715749|NCT01703286|19000256|P1|COMPLETED|Period 2 Including Washout||7
7715750|NCT01703286|19000251|P6|STARTED|Period 2 Including Washout||6
7715751|NCT01703286|19000252|P5|STARTED|Period 2 Including Washout||7
7715752|NCT01703286|19000253|P4|STARTED|Period 2 Including Washout||6
7715753|NCT01703286|19000254|P3|STARTED|Period 2 Including Washout||7
7715754|NCT01703286|19000255|P2|STARTED|Period 2 Including Washout||7
7715755|NCT01703286|19000256|P1|STARTED|Period 2 Including Washout||7
7715756|NCT01703286|19000251|P6|NOT COMPLETED|Period 1 Including Washout||1
7715757|NCT01703286|19000252|P5|NOT COMPLETED|Period 1 Including Washout||0
7715758|NCT01703286|19000253|P4|NOT COMPLETED|Period 1 Including Washout||1
7715759|NCT01703286|19000254|P3|NOT COMPLETED|Period 1 Including Washout||0
7715760|NCT01703286|19000255|P2|NOT COMPLETED|Period 1 Including Washout||0
7715761|NCT01703286|19000256|P1|NOT COMPLETED|Period 1 Including Washout||0
7715762|NCT01703286|19000251|P6|COMPLETED|Period 1 Including Washout||6
7715763|NCT01703286|19000252|P5|COMPLETED|Period 1 Including Washout||7
7715764|NCT01703286|19000253|P4|COMPLETED|Period 1 Including Washout||6
7715765|NCT01703286|19000254|P3|COMPLETED|Period 1 Including Washout||7
7715766|NCT01703286|19000255|P2|COMPLETED|Period 1 Including Washout||7
7715767|NCT01703286|19000256|P1|COMPLETED|Period 1 Including Washout||7
7715768|NCT01703286|19000251|P6|STARTED|Period 1 Including Washout||7
7715769|NCT01703286|19000252|P5|STARTED|Period 1 Including Washout||7
7715770|NCT01703286|19000253|P4|STARTED|Period 1 Including Washout||7
7715771|NCT01703286|19000254|P3|STARTED|Period 1 Including Washout||7
7715772|NCT01703286|19000255|P2|STARTED|Period 1 Including Washout||7
7715773|NCT01703286|19000256|P1|STARTED|Period 1 Including Washout||7
7715774|NCT01703260|19000279|P3|NOT COMPLETED|Overall Study||3
7715775|NCT01703260|19000280|P2|NOT COMPLETED|Overall Study||4
7715776|NCT01703260|19000281|P1|NOT COMPLETED|Overall Study||3
7715777|NCT01703260|19000279|P3|COMPLETED|Overall Study||3
7715778|NCT01703260|19000280|P2|COMPLETED|Overall Study||3
7715779|NCT01703260|19000281|P1|COMPLETED|Overall Study||4
7715780|NCT01703260|19000279|P3|STARTED|Overall Study||6
7715781|NCT01703260|19000280|P2|STARTED|Overall Study||7
7715782|NCT01703260|19000281|P1|STARTED|Overall Study||7
7715783|NCT01703221|19000307|P3|NOT COMPLETED|Phase B - (Week 25 to 52)||5
7715784|NCT01703221|19000308|P2|NOT COMPLETED|Phase B - (Week 25 to 52)||14
7715785|NCT01703221|19000309|P1|NOT COMPLETED|Phase B - (Week 25 to 52)||16
7715786|NCT01703221|19000307|P3|COMPLETED|Phase B - (Week 25 to 52)||75
7715787|NCT01703221|19000308|P2|COMPLETED|Phase B - (Week 25 to 52)||147
7715788|NCT01703221|19000309|P1|COMPLETED|Phase B - (Week 25 to 52)||143
7715789|NCT01703221|19000307|P3|STARTED|Phase B - (Week 25 to 52)||80
7715790|NCT01703221|19000308|P2|STARTED|Phase B - (Week 25 to 52)||161
7715791|NCT01703221|19000309|P1|STARTED|Phase B - (Week 25 to 52)||159
7715792|NCT01703221|19000307|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
7715793|NCT01703221|19000308|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||4
7715794|NCT01703221|19000309|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||7
7715795|NCT01703221|19000307|P3|COMPLETED|Phase A (Up to 24 Weeks)||80
7715796|NCT01703221|19000308|P2|COMPLETED|Phase A (Up to 24 Weeks)||161
7715797|NCT01703221|19000309|P1|COMPLETED|Phase A (Up to 24 Weeks)||159
7715798|NCT01703221|19000307|P3|STARTED|Phase A (Up to 24 Weeks)||83
7715799|NCT01703221|19000308|P2|STARTED|Phase A (Up to 24 Weeks)||165
7715800|NCT01703221|19000309|P1|STARTED|Phase A (Up to 24 Weeks)||166
7715801|NCT01703208|19000340|P2|NOT COMPLETED|Overall Study||2102
7715802|NCT01703208|19000341|P1|NOT COMPLETED|Overall Study||2100
7715803|NCT01703208|19000340|P2|COMPLETED|Overall Study||0
7715804|NCT01703208|19000341|P1|COMPLETED|Overall Study||0
7715805|NCT01703208|19000340|P2|Treated|Overall Study||2100
7715806|NCT01703208|19000341|P1|Treated|Overall Study||2092
7715807|NCT01703208|19000340|P2|STARTED|Overall Study||2102
7715808|NCT01703208|19000341|P1|STARTED|Overall Study||2100
7715809|NCT01703169|19000395|P1|NOT COMPLETED|Overall Study||0
7715810|NCT01703169|19000395|P1|COMPLETED|Overall Study||13
7715811|NCT01703169|19000395|P1|STARTED|Overall Study||13
7715812|NCT01703091|19000405|P2|NOT COMPLETED|Overall Study||4
7715813|NCT01703091|19000406|P1|NOT COMPLETED|Overall Study||9
7715814|NCT01703091|19000405|P2|COMPLETED|Overall Study||95
7715815|NCT01703091|19000406|P1|COMPLETED|Overall Study||89
7715816|NCT01703091|19000405|P2|Received at Least One Dose of Study Drug|Overall Study||98
7715817|NCT01703091|19000406|P1|Received at Least One Dose of Study Drug|Overall Study||94
7715818|NCT01703091|19000405|P2|STARTED|Overall Study||99
7715819|NCT01703091|19000406|P1|STARTED|Overall Study||98
7715820|NCT01703065|19000424|P2|NOT COMPLETED|Overall Study||0
7715821|NCT01703065|19000425|P1|NOT COMPLETED|Overall Study||1
7715822|NCT01703065|19000424|P2|COMPLETED|Overall Study||0
7715823|NCT01703065|19000425|P1|COMPLETED|Overall Study||8
7715824|NCT01703065|19000424|P2|STARTED|Overall Study||0
7715825|NCT01703065|19000425|P1|STARTED|Overall Study||9
7715826|NCT01703039|19000440|P2|NOT COMPLETED|Overall Study||5
7715827|NCT01703039|19000441|P1|NOT COMPLETED|Overall Study||3
7715828|NCT01703039|19000440|P2|COMPLETED|Overall Study||7
7715829|NCT01703039|19000441|P1|COMPLETED|Overall Study||6
7715830|NCT01703039|19000440|P2|STARTED|Overall Study||12
7715831|NCT01703039|19000441|P1|STARTED|Overall Study||9
7715832|NCT01703000|19000455|P1|NOT COMPLETED|Overall Study||1
7715833|NCT01703000|19000455|P1|COMPLETED|Overall Study||99
7715834|NCT01703000|19000455|P1|STARTED|Overall Study||100
7715835|NCT01702987|19000488|P2|NOT COMPLETED|Overall Study||0
7715836|NCT01702987|19000489|P1|NOT COMPLETED|Overall Study||1
7715837|NCT01702987|19000488|P2|COMPLETED|Overall Study||12
7715838|NCT01702987|19000489|P1|COMPLETED|Overall Study||9
7715839|NCT01702987|19000488|P2|STARTED|Overall Study||12
7715840|NCT01702987|19000489|P1|STARTED|Overall Study||10
7715841|NCT01702961|19000495|P1|NOT COMPLETED|Overall Study||47
7715842|NCT01702961|19000495|P1|COMPLETED|Overall Study||28
7715843|NCT01702961|19000495|P1|STARTED|Overall Study||75
7715844|NCT01702909|19000501|P1|NOT COMPLETED|Overall Study||0
7715845|NCT01702909|19000501|P1|COMPLETED|Overall Study||7
7715846|NCT01702909|19000501|P1|STARTED|Overall Study||7
7715847|NCT01702896|19000507|P1|NOT COMPLETED|Overall Study||8
7715848|NCT01702896|19000507|P1|COMPLETED|Overall Study||0
7715849|NCT01702896|19000507|P1|STARTED|Overall Study||8
7715850|NCT01702844|19000513|P1|NOT COMPLETED|Overall Study||19
7715851|NCT01702844|19000513|P1|COMPLETED|Overall Study||23
7715852|NCT01702844|19000513|P1|Disease Progression|Overall Study||23
7715853|NCT01702844|19000513|P1|STARTED|Overall Study||42
7715854|NCT01702558|19000525|P5|NOT COMPLETED|Overall Study||42
7715855|NCT01702558|19000526|P4|NOT COMPLETED|Overall Study||47
7715856|NCT01702558|19000527|P3|NOT COMPLETED|Overall Study||5
7715857|NCT01702558|19000528|P2|NOT COMPLETED|Overall Study||4
7715858|NCT01702558|19000529|P1|NOT COMPLETED|Overall Study||4
7715859|NCT01702558|19000525|P5|COMPLETED|Overall Study||38
7715860|NCT01702558|19000526|P4|COMPLETED|Overall Study||34
7715861|NCT01702558|19000527|P3|COMPLETED|Overall Study||1
7715862|NCT01702558|19000528|P2|COMPLETED|Overall Study||1
7715863|NCT01702558|19000529|P1|COMPLETED|Overall Study||3
7715864|NCT01702558|19000525|P5|STARTED|Overall Study||80
7715865|NCT01702558|19000526|P4|STARTED|Overall Study||81
7715866|NCT01702558|19000527|P3|STARTED|Overall Study||6
7715867|NCT01702558|19000528|P2|STARTED|Overall Study||5
7715868|NCT01702558|19000529|P1|STARTED|Overall Study||7
7715869|NCT01702532|19000594|P2|NOT COMPLETED|Overall Study||1
7715870|NCT01702532|19000595|P1|NOT COMPLETED|Overall Study||0
7715871|NCT01702532|19000594|P2|COMPLETED|Overall Study||160
7715872|NCT01702532|19000595|P1|COMPLETED|Overall Study||161
7715873|NCT01702532|19000594|P2|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160
7715874|NCT01702532|19000595|P1|Safety Population|Overall Study||161
7715875|NCT01702532|19000594|P2|STARTED|Overall Study||161
7715876|NCT01702532|19000595|P1|STARTED|Overall Study||161
7715877|NCT01702519|19000605|P2|NOT COMPLETED|Period 2||0
7715878|NCT01702519|19000606|P1|NOT COMPLETED|Period 2||0
7715879|NCT01702519|19000605|P2|COMPLETED|Period 2||18
7715880|NCT01702519|19000606|P1|COMPLETED|Period 2||19
7715881|NCT01702519|19000605|P2|STARTED|Period 2||18
7715882|NCT01702519|19000606|P1|STARTED|Period 2||19
7715883|NCT01702519|19000605|P2|NOT COMPLETED|Washout Period||2
7715884|NCT01702519|19000606|P1|NOT COMPLETED|Washout Period||1
7715885|NCT01702519|19000605|P2|COMPLETED|Washout Period||18
7715886|NCT01702519|19000606|P1|COMPLETED|Washout Period||19
7715887|NCT01702519|19000605|P2|STARTED|Washout Period||20
7715888|NCT01702519|19000606|P1|STARTED|Washout Period||20
7715889|NCT01702519|19000605|P2|NOT COMPLETED|Period 1||0
7715890|NCT01702519|19000606|P1|NOT COMPLETED|Period 1||0
7715891|NCT01702519|19000605|P2|COMPLETED|Period 1||20
7715892|NCT01702519|19000606|P1|COMPLETED|Period 1||20
7715893|NCT01702519|19000605|P2|STARTED|Period 1||20
7715894|NCT01702519|19000606|P1|STARTED|Period 1||20
7715895|NCT01702454|19000624|P2|NOT COMPLETED|Overall Study||8
7715896|NCT01702454|19000625|P1|NOT COMPLETED|Overall Study||3
7715897|NCT01702454|19000624|P2|COMPLETED|Overall Study||221
7715898|NCT01702454|19000625|P1|COMPLETED|Overall Study||238
7715899|NCT01702454|19000624|P2|STARTED|Overall Study||229
7715900|NCT01702454|19000625|P1|STARTED|Overall Study||241
7715901|NCT01702428|19000707|P4|NOT COMPLETED|Overall Study||57
7715902|NCT01702428|19000708|P3|NOT COMPLETED|Overall Study||53
7715903|NCT01702428|19000709|P2|NOT COMPLETED|Overall Study||70
7715904|NCT01702428|19000710|P1|NOT COMPLETED|Overall Study||64
7715905|NCT01702428|19000707|P4|COMPLETED|Overall Study||1232
7715906|NCT01702428|19000708|P3|COMPLETED|Overall Study||1190
7715907|NCT01702428|19000709|P2|COMPLETED|Overall Study||1162
7715908|NCT01702428|19000710|P1|COMPLETED|Overall Study||1175
7715909|NCT01702428|19000707|P4|STARTED|Overall Study||1289
7715910|NCT01702428|19000708|P3|STARTED|Overall Study||1243
7715911|NCT01702428|19000709|P2|STARTED|Overall Study||1232
7715912|NCT01702428|19000710|P1|STARTED|Overall Study||1239
7715913|NCT01702363|19000797|P1|NOT COMPLETED|Overall Study||20
7715914|NCT01702363|19000797|P1|COMPLETED|Overall Study||111
7715915|NCT01702363|19000797|P1|STARTED|Overall Study||131
7715916|NCT01702311|19000814|P2|NOT COMPLETED|Overall Study||13
7715917|NCT01702311|19000815|P1|NOT COMPLETED|Overall Study||16
7715918|NCT01702311|19000814|P2|COMPLETED|Overall Study||100
7715919|NCT01702311|19000815|P1|COMPLETED|Overall Study||106
7715920|NCT01702311|19000814|P2|STARTED|Overall Study||113
7715921|NCT01702311|19000815|P1|STARTED|Overall Study||122
7715922|NCT01702298|19000845|P1|NOT COMPLETED|Overall Study||1
7715923|NCT01702298|19000845|P1|COMPLETED|Overall Study||41
7715924|NCT01702298|19000845|P1|STARTED|Overall Study||42
7715925|NCT01702259|19000858|P2|NOT COMPLETED|Overall Study||0
7715926|NCT01702259|19000859|P1|NOT COMPLETED|Overall Study||0
7715927|NCT01702259|19000858|P2|COMPLETED|Overall Study||34
7715928|NCT01702259|19000859|P1|COMPLETED|Overall Study||34
7715929|NCT01702259|19000858|P2|STARTED|Overall Study||34
7715930|NCT01702259|19000859|P1|STARTED|Overall Study||34
7715931|NCT01702246|19000873|P1|NOT COMPLETED|Overall Study||5
7715932|NCT01702246|19000873|P1|COMPLETED|Overall Study||19
7715933|NCT01702246|19000873|P1|STARTED|Overall Study||24
7715934|NCT01702233|19000885|P3|NOT COMPLETED|Overall Study||5
7715935|NCT01702233|19000886|P2|NOT COMPLETED|Overall Study||3
7715936|NCT01702233|19000887|P1|NOT COMPLETED|Overall Study||6
7715937|NCT01702233|19000885|P3|COMPLETED|Overall Study||31
7715938|NCT01702233|19000886|P2|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64
7715939|NCT01702233|19000887|P1|COMPLETED|Overall Study||66
7715940|NCT01702233|19000885|P3|Per Protocol Set|Overall Study||27
7715941|NCT01702233|19000886|P2|Per Protocol Set|Overall Study||58
7715942|NCT01702233|19000887|P1|Per Protocol Set|Overall Study||58
7715943|NCT01702233|19000885|P3|Full Analysis Set (ITT)|Overall Study||31
7715944|NCT01702233|19000886|P2|Full Analysis Set (ITT)|Overall Study||63
7715945|NCT01702233|19000887|P1|Full Analysis Set (ITT)|Overall Study||66
7715946|NCT01702233|19000885|P3|STARTED|Overall Study||36
7715947|NCT01702233|19000886|P2|STARTED|Overall Study||67
7715948|NCT01702233|19000887|P1|STARTED|Overall Study||72
7715949|NCT01702025|19000927|P4|NOT COMPLETED|Overall Study||0
7715950|NCT01702025|19000928|P3|NOT COMPLETED|Overall Study||1
7715951|NCT01702025|19000929|P2|NOT COMPLETED|Overall Study||1
7715952|NCT01702025|19000930|P1|NOT COMPLETED|Overall Study||2
7715953|NCT01702025|19000927|P4|COMPLETED|Overall Study||10
7715954|NCT01702025|19000928|P3|COMPLETED|Overall Study||9
7715955|NCT01702025|19000929|P2|COMPLETED|Overall Study||9
7715956|NCT01702025|19000930|P1|COMPLETED|Overall Study||9
7715957|NCT01702025|19000927|P4|STARTED|Overall Study||10
7715958|NCT01702025|19000928|P3|STARTED|Overall Study||10
7715959|NCT01702025|19000929|P2|STARTED|Overall Study||10
7715960|NCT01702025|19000930|P1|STARTED|Overall Study||11
7715961|NCT01701999|19000946|P2|NOT COMPLETED|Overall Study||0
7715962|NCT01701999|19000947|P1|NOT COMPLETED|Overall Study||0
7715963|NCT01701999|19000946|P2|COMPLETED|Overall Study||37
7715964|NCT01701999|19000947|P1|COMPLETED|Overall Study||8
7715965|NCT01701999|19000946|P2|STARTED|Overall Study||37
7715966|NCT01701999|19000947|P1|STARTED|Overall Study||8
7715967|NCT01701973|19000959|P8|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
7715968|NCT01701973|19000960|P7|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
7715969|NCT01701973|19000961|P6|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
7715970|NCT01701973|19000962|P5|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
7715971|NCT01701973|19000963|P4|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
7715972|NCT01701973|19000964|P3|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
7715973|NCT01701973|19000965|P2|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
7715974|NCT01701973|19000966|P1|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
7715975|NCT01701973|19000959|P8|COMPLETED|Aim 2: Second Intervention (1 Day)||3
7715976|NCT01701973|19000960|P7|COMPLETED|Aim 2: Second Intervention (1 Day)||5
7715977|NCT01701973|19000961|P6|COMPLETED|Aim 2: Second Intervention (1 Day)||3
7715978|NCT01701973|19000962|P5|COMPLETED|Aim 2: Second Intervention (1 Day)||2
7715979|NCT01701973|19000963|P4|COMPLETED|Aim 2: Second Intervention (1 Day)||4
7715980|NCT01701973|19000964|P3|COMPLETED|Aim 2: Second Intervention (1 Day)||5
7715981|NCT01701973|19000965|P2|COMPLETED|Aim 2: Second Intervention (1 Day)||0
7715982|NCT01701973|19000966|P1|COMPLETED|Aim 2: Second Intervention (1 Day)||0
7715983|NCT01701973|19000959|P8|STARTED|Aim 2: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 3 and 4.|3
7715984|NCT01701973|19000960|P7|STARTED|Aim 2: Second Intervention (1 Day)||5
7715985|NCT01701973|19000961|P6|STARTED|Aim 2: Second Intervention (1 Day)||3
7715986|NCT01701973|19000962|P5|STARTED|Aim 2: Second Intervention (1 Day)||2
7715987|NCT01701973|19000963|P4|STARTED|Aim 2: Second Intervention (1 Day)||4
7715988|NCT01701973|19000964|P3|STARTED|Aim 2: Second Intervention (1 Day)||5
7715989|NCT01701973|19000965|P2|STARTED|Aim 2: Second Intervention (1 Day)||0
7715990|NCT01701973|19000966|P1|STARTED|Aim 2: Second Intervention (1 Day)||0
7715991|NCT01701973|19000959|P8|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
7715992|NCT01701973|19000960|P7|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
7715993|NCT01701973|19000961|P6|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
7715994|NCT01701973|19000962|P5|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
7715995|NCT01701973|19000963|P4|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
7715996|NCT01701973|19000964|P3|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
7715997|NCT01701973|19000965|P2|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
7715998|NCT01701973|19000966|P1|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
7715999|NCT01701973|19000959|P8|COMPLETED|Aim 2: First Intervention (1 Day)||4
7716000|NCT01701973|19000960|P7|COMPLETED|Aim 2: First Intervention (1 Day)||5
7716001|NCT01701973|19000961|P6|COMPLETED|Aim 2: First Intervention (1 Day)||3
7716002|NCT01701973|19000962|P5|COMPLETED|Aim 2: First Intervention (1 Day)||2
7716003|NCT01701973|19000963|P4|COMPLETED|Aim 2: First Intervention (1 Day)||4
7716004|NCT01701973|19000964|P3|COMPLETED|Aim 2: First Intervention (1 Day)||5
7716005|NCT01701973|19000965|P2|COMPLETED|Aim 2: First Intervention (1 Day)||0
7716006|NCT01701973|19000966|P1|COMPLETED|Aim 2: First Intervention (1 Day)||0
7716007|NCT01701973|19000959|P8|STARTED|Aim 2: First Intervention (1 Day)||4
7716008|NCT01701973|19000960|P7|STARTED|Aim 2: First Intervention (1 Day)||5
7716009|NCT01701973|19000961|P6|STARTED|Aim 2: First Intervention (1 Day)||3
7716010|NCT01701973|19000962|P5|STARTED|Aim 2: First Intervention (1 Day)||2
7716011|NCT01701973|19000963|P4|STARTED|Aim 2: First Intervention (1 Day)||4
7716012|NCT01701973|19000964|P3|STARTED|Aim 2: First Intervention (1 Day)||5
7716013|NCT01701973|19000965|P2|STARTED|Aim 2: First Intervention (1 Day)||0
7716014|NCT01701973|19000966|P1|STARTED|Aim 2: First Intervention (1 Day)||0
7716015|NCT01701973|19000959|P8|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
7716016|NCT01701973|19000960|P7|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
7716017|NCT01701973|19000961|P6|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
7716018|NCT01701973|19000962|P5|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
7716019|NCT01701973|19000963|P4|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
7716020|NCT01701973|19000964|P3|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
7716021|NCT01701973|19000965|P2|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
7716022|NCT01701973|19000966|P1|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
7716023|NCT01701973|19000959|P8|COMPLETED|Aim 1: Second Intervention (1 Day)||0
7716024|NCT01701973|19000960|P7|COMPLETED|Aim 1: Second Intervention (1 Day)||0
7716025|NCT01701973|19000961|P6|COMPLETED|Aim 1: Second Intervention (1 Day)||0
7716026|NCT01701973|19000962|P5|COMPLETED|Aim 1: Second Intervention (1 Day)||0
7716027|NCT01701973|19000963|P4|COMPLETED|Aim 1: Second Intervention (1 Day)||0
7716028|NCT01701973|19000964|P3|COMPLETED|Aim 1: Second Intervention (1 Day)||0
7716029|NCT01701973|19000965|P2|COMPLETED|Aim 1: Second Intervention (1 Day)||17
7716030|NCT01701973|19000966|P1|COMPLETED|Aim 1: Second Intervention (1 Day)||22
7716031|NCT01701973|19000959|P8|STARTED|Aim 1: Second Intervention (1 Day)||0
7716032|NCT01701973|19000960|P7|STARTED|Aim 1: Second Intervention (1 Day)||0
7716033|NCT01701973|19000961|P6|STARTED|Aim 1: Second Intervention (1 Day)||0
7716034|NCT01701973|19000962|P5|STARTED|Aim 1: Second Intervention (1 Day)||0
7716035|NCT01701973|19000963|P4|STARTED|Aim 1: Second Intervention (1 Day)||0
7716036|NCT01701973|19000964|P3|STARTED|Aim 1: Second Intervention (1 Day)||0
7716037|NCT01701973|19000965|P2|STARTED|Aim 1: Second Intervention (1 Day)|3 subjects were lost to follow-up in between Periods 1 and 2.|17
7716038|NCT01701973|19000966|P1|STARTED|Aim 1: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 1 and 2.|22
7716039|NCT01701973|19000959|P8|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
7716040|NCT01701973|19000960|P7|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
7716041|NCT01701973|19000961|P6|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
7716042|NCT01701973|19000962|P5|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
7716043|NCT01701973|19000963|P4|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
7716044|NCT01701973|19000964|P3|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
7716045|NCT01701973|19000965|P2|NOT COMPLETED|Aim 1: First Intervention (1 Day)||1
7716046|NCT01701973|19000966|P1|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
7716047|NCT01701973|19000959|P8|COMPLETED|Aim 1: First Intervention (1 Day)||0
7716048|NCT01701973|19000960|P7|COMPLETED|Aim 1: First Intervention (1 Day)||0
7716049|NCT01701973|19000961|P6|COMPLETED|Aim 1: First Intervention (1 Day)||0
7716050|NCT01701973|19000962|P5|COMPLETED|Aim 1: First Intervention (1 Day)||0
7716051|NCT01701973|19000963|P4|COMPLETED|Aim 1: First Intervention (1 Day)||0
7716052|NCT01701973|19000964|P3|COMPLETED|Aim 1: First Intervention (1 Day)||0
7716053|NCT01701973|19000965|P2|COMPLETED|Aim 1: First Intervention (1 Day)||20
7716054|NCT01701973|19000966|P1|COMPLETED|Aim 1: First Intervention (1 Day)||23
7716055|NCT01701973|19000959|P8|STARTED|Aim 1: First Intervention (1 Day)||0
7716056|NCT01701973|19000960|P7|STARTED|Aim 1: First Intervention (1 Day)||0
7716057|NCT01701973|19000961|P6|STARTED|Aim 1: First Intervention (1 Day)||0
7716058|NCT01701973|19000962|P5|STARTED|Aim 1: First Intervention (1 Day)||0
7716059|NCT01701973|19000963|P4|STARTED|Aim 1: First Intervention (1 Day)||0
7716060|NCT01701973|19000964|P3|STARTED|Aim 1: First Intervention (1 Day)||0
7716061|NCT01701973|19000965|P2|STARTED|Aim 1: First Intervention (1 Day)||21
7716062|NCT01701973|19000966|P1|STARTED|Aim 1: First Intervention (1 Day)||23
7716063|NCT01701674|19001013|P1|NOT COMPLETED|Overall Study||1
7716064|NCT01701674|19001013|P1|COMPLETED|Overall Study||12
7716065|NCT01701674|19001013|P1|STARTED|Overall Study||13
7716066|NCT01701622|19001020|P1|NOT COMPLETED|Overall Study||0
7716067|NCT01701622|19001020|P1|COMPLETED|Overall Study||1
7716068|NCT01701622|19001020|P1|STARTED|Overall Study||1
7716069|NCT01701583|19001027|P2|NOT COMPLETED|Overall Study||0
7716070|NCT01701583|19001028|P1|NOT COMPLETED|Overall Study||2
7716071|NCT01701583|19001027|P2|COMPLETED|Overall Study||3
7716072|NCT01701583|19001028|P1|COMPLETED|Overall Study||5
7716073|NCT01701583|19001027|P2|STARTED|Overall Study||3
7716074|NCT01701583|19001028|P1|STARTED|Overall Study||7
7716075|NCT01701505|19001043|P6|NOT COMPLETED|Overall Study||0
7716076|NCT01701505|19001044|P5|NOT COMPLETED|Overall Study||0
7716077|NCT01701505|19001045|P4|NOT COMPLETED|Overall Study||0
7716078|NCT01701505|19001046|P3|NOT COMPLETED|Overall Study||0
7716079|NCT01701505|19001047|P2|NOT COMPLETED|Overall Study||0
7716080|NCT01701505|19001048|P1|NOT COMPLETED|Overall Study||0
7716081|NCT01701505|19001043|P6|COMPLETED|Overall Study||8
7716082|NCT01701505|19001044|P5|COMPLETED|Overall Study||8
7716083|NCT01701505|19001045|P4|COMPLETED|Overall Study||8
7716084|NCT01701505|19001046|P3|COMPLETED|Overall Study||8
7716085|NCT01701505|19001047|P2|COMPLETED|Overall Study||8
7716086|NCT01701505|19001048|P1|COMPLETED|Overall Study||8
7716087|NCT01701505|19001043|P6|STARTED|Overall Study||8
7716088|NCT01701505|19001044|P5|STARTED|Overall Study||8
7716089|NCT01701505|19001045|P4|STARTED|Overall Study||8
7716090|NCT01701505|19001046|P3|STARTED|Overall Study||8
7716091|NCT01701505|19001047|P2|STARTED|Overall Study||8
7716092|NCT01701505|19001048|P1|STARTED|Overall Study||8
7716093|NCT01701414|19001100|P2|NOT COMPLETED|Overall Study||1
7716094|NCT01701414|19001101|P1|NOT COMPLETED|Overall Study||1
7716095|NCT01701414|19001100|P2|COMPLETED|Overall Study||18
7716096|NCT01701414|19001101|P1|COMPLETED|Overall Study||18
7716097|NCT01701414|19001100|P2|STARTED|Overall Study||19
7716098|NCT01701414|19001101|P1|STARTED|Overall Study||19
7716099|NCT01701401|19001111|P4|NOT COMPLETED|Overall Study||6
7716100|NCT01701401|19001112|P3|NOT COMPLETED|Overall Study||5
7716101|NCT01701401|19001113|P2|NOT COMPLETED|Overall Study||9
7716102|NCT01701401|19001114|P1|NOT COMPLETED|Overall Study||10
7716103|NCT01701401|19001111|P4|COMPLETED|Overall Study||212
7716104|NCT01701401|19001112|P3|COMPLETED|Overall Study||212
7716105|NCT01701401|19001113|P2|COMPLETED|Overall Study||209
7716106|NCT01701401|19001114|P1|COMPLETED|Overall Study||207
7716107|NCT01701401|19001111|P4|STARTED|Overall Study||218
7716108|NCT01701401|19001112|P3|STARTED|Overall Study||217
7716109|NCT01701401|19001113|P2|STARTED|Overall Study||218
7716110|NCT01701401|19001114|P1|STARTED|Overall Study||217
7716111|NCT01701375|19001160|P1|NOT COMPLETED|Overall Study||0
7716112|NCT01701375|19001160|P1|COMPLETED|Overall Study||2
7716113|NCT01701375|19001160|P1|STARTED|Overall Study||2
7716114|NCT01701362|19001166|P2|NOT COMPLETED|Overall Study||56
7716115|NCT01701362|19001167|P1|NOT COMPLETED|Overall Study||42
7716116|NCT01701362|19001166|P2|COMPLETED|Overall Study||211
7716117|NCT01701362|19001167|P1|COMPLETED|Overall Study||233
7716118|NCT01701362|19001166|P2|TREATED|Overall Study||265
7716119|NCT01701362|19001167|P1|TREATED|Overall Study||274
7716120|NCT01701362|19001166|P2|STARTED|Overall Study||267
7716121|NCT01701362|19001167|P1|STARTED|Overall Study||275
7716122|NCT01701271|19001195|P1|NOT COMPLETED|Overall Study||0
7716123|NCT01701271|19001195|P1|COMPLETED|Overall Study||20
7716124|NCT01701271|19001195|P1|STARTED|Overall Study||20
7716125|NCT01701258|19001205|P13|NOT COMPLETED|EEG (Session 4)||0
7716126|NCT01701258|19001206|P12|NOT COMPLETED|EEG (Session 4)||0
7716127|NCT01701258|19001207|P11|NOT COMPLETED|EEG (Session 4)||0
7716128|NCT01701258|19001208|P10|NOT COMPLETED|EEG (Session 4)||0
7716129|NCT01701258|19001209|P9|NOT COMPLETED|EEG (Session 4)||0
7716130|NCT01701258|19001210|P8|NOT COMPLETED|EEG (Session 4)||0
7716131|NCT01701258|19001211|P7|NOT COMPLETED|EEG (Session 4)||0
7716132|NCT01701258|19001212|P6|NOT COMPLETED|EEG (Session 4)||0
7716133|NCT01701258|19001213|P5|NOT COMPLETED|EEG (Session 4)||0
7716134|NCT01701258|19001214|P4|NOT COMPLETED|EEG (Session 4)||0
7716135|NCT01701258|19001215|P3|NOT COMPLETED|EEG (Session 4)||0
7716136|NCT01701258|19001216|P2|NOT COMPLETED|EEG (Session 4)||0
7716137|NCT01701258|19001217|P1|NOT COMPLETED|EEG (Session 4)||0
7716138|NCT01701258|19001205|P13|COMPLETED|EEG (Session 4)||0
7716139|NCT01701258|19001206|P12|COMPLETED|EEG (Session 4)||0
7716140|NCT01701258|19001207|P11|COMPLETED|EEG (Session 4)||17
7716141|NCT01701258|19001208|P10|COMPLETED|EEG (Session 4)||0
7716142|NCT01701258|19001209|P9|COMPLETED|EEG (Session 4)||0
7716143|NCT01701258|19001210|P8|COMPLETED|EEG (Session 4)||16
7716144|NCT01701258|19001211|P7|COMPLETED|EEG (Session 4)||0
7716145|NCT01701258|19001212|P6|COMPLETED|EEG (Session 4)||0
7716146|NCT01701258|19001213|P5|COMPLETED|EEG (Session 4)||14
7716147|NCT01701258|19001214|P4|COMPLETED|EEG (Session 4)||0
7716148|NCT01701258|19001215|P3|COMPLETED|EEG (Session 4)||0
7716149|NCT01701258|19001216|P2|COMPLETED|EEG (Session 4)||19
7716150|NCT01701258|19001217|P1|COMPLETED|EEG (Session 4)||0
7716151|NCT01701258|19001205|P13|STARTED|EEG (Session 4)||0
7716152|NCT01701258|19001206|P12|STARTED|EEG (Session 4)||0
7716153|NCT01701258|19001207|P11|STARTED|EEG (Session 4)||17
7716154|NCT01701258|19001208|P10|STARTED|EEG (Session 4)||0
7716155|NCT01701258|19001209|P9|STARTED|EEG (Session 4)||0
7716156|NCT01701258|19001210|P8|STARTED|EEG (Session 4)||16
7716157|NCT01701258|19001211|P7|STARTED|EEG (Session 4)||0
7716158|NCT01701258|19001212|P6|STARTED|EEG (Session 4)||0
7716159|NCT01701258|19001213|P5|STARTED|EEG (Session 4)||14
7716160|NCT01701258|19001214|P4|STARTED|EEG (Session 4)||0
7716161|NCT01701258|19001215|P3|STARTED|EEG (Session 4)||0
7716162|NCT01701258|19001216|P2|STARTED|EEG (Session 4)||19
7716163|NCT01701258|19001217|P1|STARTED|EEG (Session 4)||0
7716164|NCT01701258|19001205|P13|NOT COMPLETED|PET (Session 3)||0
7716165|NCT01701258|19001206|P12|NOT COMPLETED|PET (Session 3)||0
7716166|NCT01701258|19001207|P11|NOT COMPLETED|PET (Session 3)||0
7716167|NCT01701258|19001208|P10|NOT COMPLETED|PET (Session 3)||0
7716168|NCT01701258|19001209|P9|NOT COMPLETED|PET (Session 3)||0
7716169|NCT01701258|19001210|P8|NOT COMPLETED|PET (Session 3)||0
7716170|NCT01701258|19001211|P7|NOT COMPLETED|PET (Session 3)||0
7716171|NCT01701258|19001212|P6|NOT COMPLETED|PET (Session 3)||0
7716172|NCT01701258|19001213|P5|NOT COMPLETED|PET (Session 3)||0
7716173|NCT01701258|19001214|P4|NOT COMPLETED|PET (Session 3)||0
7716174|NCT01701258|19001215|P3|NOT COMPLETED|PET (Session 3)||0
7716175|NCT01701258|19001216|P2|NOT COMPLETED|PET (Session 3)||0
7716176|NCT01701258|19001217|P1|NOT COMPLETED|PET (Session 3)||0
7716177|NCT01701258|19001205|P13|COMPLETED|PET (Session 3)||0
7716178|NCT01701258|19001206|P12|COMPLETED|PET (Session 3)||0
7716179|NCT01701258|19001207|P11|COMPLETED|PET (Session 3)||18
7716180|NCT01701258|19001208|P10|COMPLETED|PET (Session 3)||0
7716181|NCT01701258|19001209|P9|COMPLETED|PET (Session 3)||0
7716182|NCT01701258|19001210|P8|COMPLETED|PET (Session 3)||19
7716183|NCT01701258|19001211|P7|COMPLETED|PET (Session 3)||0
7716184|NCT01701258|19001212|P6|COMPLETED|PET (Session 3)||0
7716185|NCT01701258|19001213|P5|COMPLETED|PET (Session 3)||16
7716186|NCT01701258|19001214|P4|COMPLETED|PET (Session 3)||0
7716187|NCT01701258|19001215|P3|COMPLETED|PET (Session 3)||0
7716188|NCT01701258|19001216|P2|COMPLETED|PET (Session 3)||20
7716189|NCT01701258|19001217|P1|COMPLETED|PET (Session 3)||0
7716190|NCT01701258|19001205|P13|STARTED|PET (Session 3)||0
7716191|NCT01701258|19001206|P12|STARTED|PET (Session 3)||0
7716192|NCT01701258|19001207|P11|STARTED|PET (Session 3)||18
7716193|NCT01701258|19001208|P10|STARTED|PET (Session 3)||0
7716194|NCT01701258|19001209|P9|STARTED|PET (Session 3)||0
7716195|NCT01701258|19001210|P8|STARTED|PET (Session 3)||19
7716196|NCT01701258|19001211|P7|STARTED|PET (Session 3)||0
7716197|NCT01701258|19001212|P6|STARTED|PET (Session 3)||0
7716198|NCT01701258|19001213|P5|STARTED|PET (Session 3)||16
7716199|NCT01701258|19001214|P4|STARTED|PET (Session 3)||0
7716200|NCT01701258|19001215|P3|STARTED|PET (Session 3)||0
7716201|NCT01701258|19001216|P2|STARTED|PET (Session 3)||20
7716202|NCT01701258|19001217|P1|STARTED|PET (Session 3)||0
7716203|NCT01701258|19001205|P13|NOT COMPLETED|Drug+fMRI (Session 2)||0
7716204|NCT01701258|19001206|P12|NOT COMPLETED|Drug+fMRI (Session 2)||0
7716205|NCT01701258|19001207|P11|NOT COMPLETED|Drug+fMRI (Session 2)||0
7716206|NCT01701258|19001208|P10|NOT COMPLETED|Drug+fMRI (Session 2)||0
7716207|NCT01701258|19001209|P9|NOT COMPLETED|Drug+fMRI (Session 2)||0
7716208|NCT01701258|19001210|P8|NOT COMPLETED|Drug+fMRI (Session 2)||0
7716209|NCT01701258|19001211|P7|NOT COMPLETED|Drug+fMRI (Session 2)||0
7716210|NCT01701258|19001212|P6|NOT COMPLETED|Drug+fMRI (Session 2)||0
7716211|NCT01701258|19001213|P5|NOT COMPLETED|Drug+fMRI (Session 2)||0
7716212|NCT01701258|19001214|P4|NOT COMPLETED|Drug+fMRI (Session 2)||0
7716213|NCT01701258|19001215|P3|NOT COMPLETED|Drug+fMRI (Session 2)||0
7716214|NCT01701258|19001216|P2|NOT COMPLETED|Drug+fMRI (Session 2)||0
7716215|NCT01701258|19001217|P1|NOT COMPLETED|Drug+fMRI (Session 2)||0
7716216|NCT01701258|19001205|P13|COMPLETED|Drug+fMRI (Session 2)||7
7716217|NCT01701258|19001206|P12|COMPLETED|Drug+fMRI (Session 2)||10
7716218|NCT01701258|19001207|P11|COMPLETED|Drug+fMRI (Session 2)||0
7716219|NCT01701258|19001208|P10|COMPLETED|Drug+fMRI (Session 2)||6
7716220|NCT01701258|19001209|P9|COMPLETED|Drug+fMRI (Session 2)||6
7716221|NCT01701258|19001210|P8|COMPLETED|Drug+fMRI (Session 2)||0
7716222|NCT01701258|19001211|P7|COMPLETED|Drug+fMRI (Session 2)||8
7716223|NCT01701258|19001212|P6|COMPLETED|Drug+fMRI (Session 2)||9
7716224|NCT01701258|19001213|P5|COMPLETED|Drug+fMRI (Session 2)||0
7716225|NCT01701258|19001214|P4|COMPLETED|Drug+fMRI (Session 2)||11
7716226|NCT01701258|19001215|P3|COMPLETED|Drug+fMRI (Session 2)||11
7716227|NCT01701258|19001216|P2|COMPLETED|Drug+fMRI (Session 2)||0
7716228|NCT01701258|19001217|P1|COMPLETED|Drug+fMRI (Session 2)||0
7716229|NCT01701258|19001205|P13|Received Drug Challenge|Drug+fMRI (Session 2)||7
7716230|NCT01701258|19001206|P12|Received Drug Challenge|Drug+fMRI (Session 2)||10
7716231|NCT01701258|19001207|P11|Received Drug Challenge|Drug+fMRI (Session 2)||0
7716232|NCT01701258|19001208|P10|Received Drug Challenge|Drug+fMRI (Session 2)||6
7716233|NCT01701258|19001209|P9|Received Drug Challenge|Drug+fMRI (Session 2)||6
7716234|NCT01701258|19001210|P8|Received Drug Challenge|Drug+fMRI (Session 2)||0
7716235|NCT01701258|19001211|P7|Received Drug Challenge|Drug+fMRI (Session 2)||8
7716236|NCT01701258|19001212|P6|Received Drug Challenge|Drug+fMRI (Session 2)||9
7716237|NCT01701258|19001213|P5|Received Drug Challenge|Drug+fMRI (Session 2)||0
7716238|NCT01701258|19001214|P4|Received Drug Challenge|Drug+fMRI (Session 2)||11
7716239|NCT01701258|19001215|P3|Received Drug Challenge|Drug+fMRI (Session 2)||11
7716240|NCT01701258|19001216|P2|Received Drug Challenge|Drug+fMRI (Session 2)||0
7716241|NCT01701258|19001217|P1|Received Drug Challenge|Drug+fMRI (Session 2)||0
7716242|NCT01701258|19001205|P13|STARTED|Drug+fMRI (Session 2)||7
7716243|NCT01701258|19001206|P12|STARTED|Drug+fMRI (Session 2)||10
7716244|NCT01701258|19001207|P11|STARTED|Drug+fMRI (Session 2)||0
7716245|NCT01701258|19001208|P10|STARTED|Drug+fMRI (Session 2)||6
7716246|NCT01701258|19001209|P9|STARTED|Drug+fMRI (Session 2)||6
7716247|NCT01701258|19001210|P8|STARTED|Drug+fMRI (Session 2)||0
7716248|NCT01701258|19001211|P7|STARTED|Drug+fMRI (Session 2)||8
7716249|NCT01701258|19001212|P6|STARTED|Drug+fMRI (Session 2)||9
7716250|NCT01701258|19001213|P5|STARTED|Drug+fMRI (Session 2)||0
7716251|NCT01701258|19001214|P4|STARTED|Drug+fMRI (Session 2)||11
7716252|NCT01701258|19001215|P3|STARTED|Drug+fMRI (Session 2)||11
7716253|NCT01701258|19001216|P2|STARTED|Drug+fMRI (Session 2)||0
7716254|NCT01701258|19001217|P1|STARTED|Drug+fMRI (Session 2)||0
7716255|NCT01701258|19001205|P13|NOT COMPLETED|Assessment and Scheduling||0
7716256|NCT01701258|19001206|P12|NOT COMPLETED|Assessment and Scheduling||0
7716257|NCT01701258|19001207|P11|NOT COMPLETED|Assessment and Scheduling||0
7716258|NCT01701258|19001208|P10|NOT COMPLETED|Assessment and Scheduling||0
7716259|NCT01701258|19001209|P9|NOT COMPLETED|Assessment and Scheduling||0
7716260|NCT01701258|19001210|P8|NOT COMPLETED|Assessment and Scheduling||0
7716261|NCT01701258|19001211|P7|NOT COMPLETED|Assessment and Scheduling||0
7716262|NCT01701258|19001212|P6|NOT COMPLETED|Assessment and Scheduling||0
7716263|NCT01701258|19001213|P5|NOT COMPLETED|Assessment and Scheduling||0
7716264|NCT01701258|19001214|P4|NOT COMPLETED|Assessment and Scheduling||0
7716265|NCT01701258|19001215|P3|NOT COMPLETED|Assessment and Scheduling||0
7716266|NCT01701258|19001216|P2|NOT COMPLETED|Assessment and Scheduling||0
7716267|NCT01701258|19001217|P1|NOT COMPLETED|Assessment and Scheduling||83
7716268|NCT01701258|19001205|P13|COMPLETED|Assessment and Scheduling||0
7716269|NCT01701258|19001206|P12|COMPLETED|Assessment and Scheduling||0
7716270|NCT01701258|19001207|P11|COMPLETED|Assessment and Scheduling||0
7716271|NCT01701258|19001208|P10|COMPLETED|Assessment and Scheduling||0
7716272|NCT01701258|19001209|P9|COMPLETED|Assessment and Scheduling||0
7716273|NCT01701258|19001210|P8|COMPLETED|Assessment and Scheduling||0
7716274|NCT01701258|19001211|P7|COMPLETED|Assessment and Scheduling||0
7716275|NCT01701258|19001212|P6|COMPLETED|Assessment and Scheduling||0
7716276|NCT01701258|19001213|P5|COMPLETED|Assessment and Scheduling||0
7716277|NCT01701258|19001214|P4|COMPLETED|Assessment and Scheduling||0
7716278|NCT01701258|19001215|P3|COMPLETED|Assessment and Scheduling||0
7716279|NCT01701258|19001216|P2|COMPLETED|Assessment and Scheduling||0
7716280|NCT01701258|19001217|P1|COMPLETED|Assessment and Scheduling||70
7716281|NCT01701258|19001205|P13|Returned for EEG (Session 4)|Assessment and Scheduling||0
7716282|NCT01701258|19001206|P12|Returned for EEG (Session 4)|Assessment and Scheduling||0
7716283|NCT01701258|19001207|P11|Returned for EEG (Session 4)|Assessment and Scheduling||0
7716284|NCT01701258|19001208|P10|Returned for EEG (Session 4)|Assessment and Scheduling||0
7716285|NCT01701258|19001209|P9|Returned for EEG (Session 4)|Assessment and Scheduling||0
7716286|NCT01701258|19001210|P8|Returned for EEG (Session 4)|Assessment and Scheduling||0
7716287|NCT01701258|19001211|P7|Returned for EEG (Session 4)|Assessment and Scheduling||0
7716288|NCT01701258|19001212|P6|Returned for EEG (Session 4)|Assessment and Scheduling||0
7716289|NCT01701258|19001213|P5|Returned for EEG (Session 4)|Assessment and Scheduling||0
7716290|NCT01701258|19001214|P4|Returned for EEG (Session 4)|Assessment and Scheduling||0
7716291|NCT01701258|19001215|P3|Returned for EEG (Session 4)|Assessment and Scheduling||0
7716292|NCT01701258|19001216|P2|Returned for EEG (Session 4)|Assessment and Scheduling||0
7716293|NCT01701258|19001217|P1|Returned for EEG (Session 4)|Assessment and Scheduling||66
7716294|NCT01701258|19001205|P13|Returned for PET (Session 3)|Assessment and Scheduling||0
7716295|NCT01701258|19001206|P12|Returned for PET (Session 3)|Assessment and Scheduling||0
7716296|NCT01701258|19001207|P11|Returned for PET (Session 3)|Assessment and Scheduling||0
7716297|NCT01701258|19001208|P10|Returned for PET (Session 3)|Assessment and Scheduling||0
7716298|NCT01701258|19001209|P9|Returned for PET (Session 3)|Assessment and Scheduling||0
7716299|NCT01701258|19001210|P8|Returned for PET (Session 3)|Assessment and Scheduling||0
7716300|NCT01701258|19001211|P7|Returned for PET (Session 3)|Assessment and Scheduling||0
7716301|NCT01701258|19001212|P6|Returned for PET (Session 3)|Assessment and Scheduling||0
7716302|NCT01701258|19001213|P5|Returned for PET (Session 3)|Assessment and Scheduling||0
7716303|NCT01701258|19001214|P4|Returned for PET (Session 3)|Assessment and Scheduling||0
7716304|NCT01701258|19001215|P3|Returned for PET (Session 3)|Assessment and Scheduling||0
7716305|NCT01701258|19001216|P2|Returned for PET (Session 3)|Assessment and Scheduling||0
7716306|NCT01701258|19001217|P1|Returned for PET (Session 3)|Assessment and Scheduling||73
7716307|NCT01701258|19001205|P13|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
7716308|NCT01701258|19001206|P12|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
7716309|NCT01701258|19001207|P11|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
7716310|NCT01701258|19001208|P10|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
7716311|NCT01701258|19001209|P9|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
7716312|NCT01701258|19001210|P8|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
7716313|NCT01701258|19001211|P7|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
7716314|NCT01701258|19001212|P6|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
7716315|NCT01701258|19001213|P5|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
7716316|NCT01701258|19001214|P4|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
7716317|NCT01701258|19001215|P3|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
7716318|NCT01701258|19001216|P2|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
7716319|NCT01701258|19001217|P1|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||68
7716320|NCT01701258|19001205|P13|Eligible After Screening Visit|Assessment and Scheduling||0
7716321|NCT01701258|19001206|P12|Eligible After Screening Visit|Assessment and Scheduling||0
7716322|NCT01701258|19001207|P11|Eligible After Screening Visit|Assessment and Scheduling||0
7716323|NCT01701258|19001208|P10|Eligible After Screening Visit|Assessment and Scheduling||0
7716324|NCT01701258|19001209|P9|Eligible After Screening Visit|Assessment and Scheduling||0
7716325|NCT01701258|19001210|P8|Eligible After Screening Visit|Assessment and Scheduling||0
7716326|NCT01701258|19001211|P7|Eligible After Screening Visit|Assessment and Scheduling||0
7716327|NCT01701258|19001212|P6|Eligible After Screening Visit|Assessment and Scheduling||0
7716328|NCT01701258|19001213|P5|Eligible After Screening Visit|Assessment and Scheduling||0
7716329|NCT01701258|19001214|P4|Eligible After Screening Visit|Assessment and Scheduling||0
7716330|NCT01701258|19001215|P3|Eligible After Screening Visit|Assessment and Scheduling||0
7716331|NCT01701258|19001216|P2|Eligible After Screening Visit|Assessment and Scheduling||0
7716332|NCT01701258|19001217|P1|Eligible After Screening Visit|Assessment and Scheduling||96
7716333|NCT01701258|19001205|P13|STARTED|Assessment and Scheduling||0
7716334|NCT01701258|19001206|P12|STARTED|Assessment and Scheduling||0
7716335|NCT01701258|19001207|P11|STARTED|Assessment and Scheduling||0
7716336|NCT01701258|19001208|P10|STARTED|Assessment and Scheduling||0
7716337|NCT01701258|19001209|P9|STARTED|Assessment and Scheduling||0
7716338|NCT01701258|19001210|P8|STARTED|Assessment and Scheduling||0
7716339|NCT01701258|19001211|P7|STARTED|Assessment and Scheduling||0
7716340|NCT01701258|19001212|P6|STARTED|Assessment and Scheduling||0
7716341|NCT01701258|19001213|P5|STARTED|Assessment and Scheduling||0
7716342|NCT01701258|19001214|P4|STARTED|Assessment and Scheduling||0
7716343|NCT01701258|19001215|P3|STARTED|Assessment and Scheduling||0
7716344|NCT01701258|19001216|P2|STARTED|Assessment and Scheduling||0
7716345|NCT01701258|19001217|P1|STARTED|Assessment and Scheduling||153
7716346|NCT01701245|19001271|P2|NOT COMPLETED|Overall Study||15
7716347|NCT01701245|19001272|P1|NOT COMPLETED|Overall Study||12
7716348|NCT01701245|19001271|P2|COMPLETED|Overall Study||33
7716349|NCT01701245|19001272|P1|COMPLETED|Overall Study||37
7716350|NCT01701245|19001271|P2|FAS Matched Data|Overall Study||32
7716351|NCT01701245|19001272|P1|FAS Matched Data|Overall Study||42
7716352|NCT01701245|19001271|P2|FAS Unmatched Data|Overall Study|3 patients protocol violation|45
7716353|NCT01701245|19001272|P1|FAS Unmatched Data|Overall Study|1 patient protocol violation|48
7716354|NCT01701245|19001271|P2|STARTED|Overall Study||48
7716355|NCT01701245|19001272|P1|STARTED|Overall Study||49
7716356|NCT01701115|19001286|P2|NOT COMPLETED|Overall Study||0
7716357|NCT01701115|19001287|P1|NOT COMPLETED|Overall Study||2
7716358|NCT01701115|19001286|P2|COMPLETED|Overall Study||77
7716359|NCT01701115|19001287|P1|COMPLETED|Overall Study||75
7716360|NCT01701115|19001286|P2|STARTED|Overall Study||77
7716361|NCT01701115|19001287|P1|STARTED|Overall Study||77
7716362|NCT01701102|19001303|P4|NOT COMPLETED|Overall Study||0
7716363|NCT01701102|19001304|P3|NOT COMPLETED|Overall Study||0
7716364|NCT01701102|19001305|P2|NOT COMPLETED|Overall Study||0
7716365|NCT01701102|19001306|P1|NOT COMPLETED|Overall Study||0
7716366|NCT01701102|19001303|P4|COMPLETED|Overall Study||18
7716367|NCT01701102|19001304|P3|COMPLETED|Overall Study||10
7716368|NCT01701102|19001305|P2|COMPLETED|Overall Study||6
7716369|NCT01701102|19001306|P1|COMPLETED|Overall Study||22
7716370|NCT01701102|19001303|P4|STARTED|Overall Study||18
7716371|NCT01701102|19001304|P3|STARTED|Overall Study||10
7716372|NCT01701102|19001305|P2|STARTED|Overall Study||6
7716373|NCT01701102|19001306|P1|STARTED|Overall Study||22
7716374|NCT01701063|19001319|P3|NOT COMPLETED|Overall Study||2
7716375|NCT01701063|19001320|P2|NOT COMPLETED|Overall Study||1
7716376|NCT01701063|19001321|P1|NOT COMPLETED|Overall Study||0
7716377|NCT01701063|19001319|P3|COMPLETED|Overall Study||8
7716378|NCT01701063|19001320|P2|COMPLETED|Overall Study||18
7716379|NCT01701063|19001321|P1|COMPLETED|Overall Study||13
7716380|NCT01701063|19001319|P3|STARTED|Overall Study||10
7716381|NCT01701063|19001320|P2|STARTED|Overall Study||19
7716382|NCT01701063|19001321|P1|STARTED|Overall Study||13
7716383|NCT01701037|19001363|P1|NOT COMPLETED|Overall Study||0
7716384|NCT01701037|19001363|P1|COMPLETED|Overall Study||13
7716385|NCT01701037|19001363|P1|STARTED|Overall Study||13
7716386|NCT01701024|19001374|P2|NOT COMPLETED|Overall Study||9
7716387|NCT01701024|19001375|P1|NOT COMPLETED|Overall Study||10
7716388|NCT01701024|19001374|P2|COMPLETED|Overall Study||236
7716389|NCT01701024|19001375|P1|COMPLETED|Overall Study||243
7716390|NCT01701024|19001374|P2|STARTED|Overall Study||245
7716391|NCT01701024|19001375|P1|STARTED|Overall Study||253
7716392|NCT01701011|19001390|P3|NOT COMPLETED|Overall Study||34
7716393|NCT01701011|19001391|P2|NOT COMPLETED|Overall Study||24
7716394|NCT01701011|19001392|P1|NOT COMPLETED|Overall Study||35
7716395|NCT01701011|19001390|P3|COMPLETED|Overall Study||90
7716396|NCT01701011|19001391|P2|COMPLETED|Overall Study||102
7716397|NCT01701011|19001392|P1|COMPLETED|Overall Study||92
7716398|NCT01701011|19001390|P3|STARTED|Overall Study||124
7716399|NCT01701011|19001391|P2|STARTED|Overall Study||126
7716400|NCT01701011|19001392|P1|STARTED|Overall Study||127
7716401|NCT01700985|19001405|P2|NOT COMPLETED|Overall Study||1
7716402|NCT01700985|19001406|P1|NOT COMPLETED|Overall Study||0
7716403|NCT01700985|19001405|P2|COMPLETED|Overall Study||20
7716404|NCT01700985|19001406|P1|COMPLETED|Overall Study||23
7716405|NCT01700985|19001405|P2|STARTED|Overall Study||21
7716406|NCT01700985|19001406|P1|STARTED|Overall Study||23
7716407|NCT01700959|19001428|P6|NOT COMPLETED|Overall Study||25
7716408|NCT01700959|19001429|P5|NOT COMPLETED|Overall Study||27
7716409|NCT01700959|19001430|P4|NOT COMPLETED|Overall Study||35
7716410|NCT01700959|19001431|P3|NOT COMPLETED|Overall Study||40
7716411|NCT01700959|19001432|P2|NOT COMPLETED|Overall Study||24
7716412|NCT01700959|19001433|P1|NOT COMPLETED|Overall Study||27
7716413|NCT01700959|19001428|P6|COMPLETED|Overall Study||72
7716414|NCT01700959|19001429|P5|COMPLETED|Overall Study||69
7716415|NCT01700959|19001430|P4|COMPLETED|Overall Study||70
7716416|NCT01700959|19001431|P3|COMPLETED|Overall Study||65
7716417|NCT01700959|19001432|P2|COMPLETED|Overall Study||64
7716418|NCT01700959|19001433|P1|COMPLETED|Overall Study||62
7716419|NCT01700959|19001428|P6|STARTED|Overall Study||97
7716420|NCT01700959|19001429|P5|STARTED|Overall Study||96
7716421|NCT01700959|19001430|P4|STARTED|Overall Study||105
7716422|NCT01700959|19001431|P3|STARTED|Overall Study||105
7716423|NCT01700959|19001432|P2|STARTED|Overall Study||88
7716424|NCT01700959|19001433|P1|STARTED|Overall Study||89
7716425|NCT01700907|19001457|P2|NOT COMPLETED|Overall Study||0
7716426|NCT01700907|19001458|P1|NOT COMPLETED|Overall Study||0
7716427|NCT01700907|19001457|P2|COMPLETED|Overall Study||10
7716428|NCT01700907|19001458|P1|COMPLETED|Overall Study||10
7716429|NCT01700907|19001457|P2|STARTED|Overall Study||10
7716430|NCT01700907|19001458|P1|STARTED|Overall Study||10
7716431|NCT01700829|19001474|P2|NOT COMPLETED|Overall Study||1
7716432|NCT01700829|19001475|P1|NOT COMPLETED|Overall Study||1
7716433|NCT01700829|19001474|P2|COMPLETED|Overall Study||40
7716434|NCT01700829|19001475|P1|COMPLETED|Overall Study||40
7716435|NCT01700829|19001474|P2|STARTED|Overall Study||41
7716436|NCT01700829|19001475|P1|STARTED|Overall Study||41
7716437|NCT01700816|19001487|P2|NOT COMPLETED|Overall Study||0
7716438|NCT01700816|19001488|P1|NOT COMPLETED|Overall Study||0
7716439|NCT01700816|19001487|P2|COMPLETED|Overall Study||19
7716440|NCT01700816|19001488|P1|COMPLETED|Overall Study||21
7716441|NCT01700816|19001487|P2|STARTED|Overall Study||19
7716442|NCT01700816|19001488|P1|STARTED|Overall Study||21
7716443|NCT01700725|19001517|P3|NOT COMPLETED|Overall Study||0
7716444|NCT01700725|19001518|P2|NOT COMPLETED|Overall Study||0
7716445|NCT01700725|19001519|P1|NOT COMPLETED|Overall Study||0
7716446|NCT01700725|19001517|P3|COMPLETED|Overall Study||12
7716447|NCT01700725|19001518|P2|COMPLETED|Overall Study||14
7716448|NCT01700725|19001519|P1|COMPLETED|Overall Study||14
7716449|NCT01700725|19001517|P3|STARTED|Overall Study||12
7716450|NCT01700725|19001518|P2|STARTED|Overall Study||14
7716451|NCT01700725|19001519|P1|STARTED|Overall Study||14
7716452|NCT01700621|19001535|P2|NOT COMPLETED|Analyzed for Immunogenicity||7
7716453|NCT01700621|19001536|P1|NOT COMPLETED|Analyzed for Immunogenicity||13
7716454|NCT01700621|19001535|P2|COMPLETED|Analyzed for Immunogenicity||233
7716455|NCT01700621|19001536|P1|COMPLETED|Analyzed for Immunogenicity||227
7716456|NCT01700621|19001535|P2|STARTED|Analyzed for Immunogenicity||240
7716457|NCT01700621|19001536|P1|STARTED|Analyzed for Immunogenicity||240
7716458|NCT01700621|19001535|P2|NOT COMPLETED|Received Study Vaccines||0
7716459|NCT01700621|19001536|P1|NOT COMPLETED|Received Study Vaccines||0
7716460|NCT01700621|19001535|P2|COMPLETED|Received Study Vaccines||240
7716461|NCT01700621|19001536|P1|COMPLETED|Received Study Vaccines||240
7716462|NCT01700621|19001535|P2|STARTED|Received Study Vaccines||240
7716463|NCT01700621|19001536|P1|STARTED|Received Study Vaccines||240
7716464|NCT01700530|19001574|P3|NOT COMPLETED|Overall Study||1
7716465|NCT01700530|19001575|P2|NOT COMPLETED|Overall Study||3
7716466|NCT01700530|19001576|P1|NOT COMPLETED|Overall Study||0
7716467|NCT01700530|19001574|P3|COMPLETED|Overall Study||19
7716468|NCT01700530|19001575|P2|COMPLETED|Overall Study||18
7716469|NCT01700530|19001576|P1|COMPLETED|Overall Study||9
7716470|NCT01700530|19001574|P3|STARTED|Overall Study||20
7716471|NCT01700530|19001575|P2|STARTED|Overall Study||21
7716472|NCT01700530|19001576|P1|STARTED|Overall Study||9
7716473|NCT01700517|19001590|P3|NOT COMPLETED|Overall Study||0
7716474|NCT01700517|19001591|P2|NOT COMPLETED|Overall Study||0
7716475|NCT01700517|19001592|P1|NOT COMPLETED|Overall Study||0
7716476|NCT01700517|19001590|P3|COMPLETED|Overall Study||40
7716477|NCT01700517|19001591|P2|COMPLETED|Overall Study||40
7716478|NCT01700517|19001592|P1|COMPLETED|Overall Study||40
7716479|NCT01700517|19001590|P3|STARTED|Overall Study||40
7716480|NCT01700517|19001591|P2|STARTED|Overall Study||40
7716481|NCT01700517|19001592|P1|STARTED|Overall Study||40
7716482|NCT01700439|19001600|P1|NOT COMPLETED|Overall Study||889
7716483|NCT01700439|19001600|P1|COMPLETED|Overall Study||0
7716484|NCT01700439|19001600|P1|2 Year|Overall Study||215
7716485|NCT01700439|19001600|P1|1 Year|Overall Study||573
7716486|NCT01700439|19001600|P1|3 Month|Overall Study||778
7716487|NCT01700439|19001600|P1|Discharge|Overall Study||831
7716488|NCT01700439|19001600|P1|Study Valve Group|Overall Study|Received the Edwards INTUITY surgical aortic heart valve.|839
7716489|NCT01700439|19001600|P1|STARTED|Overall Study||889
7716490|NCT01700387|19001625|P2|NOT COMPLETED|Overall Study||4
7716491|NCT01700387|19001626|P1|NOT COMPLETED|Overall Study||4
7716492|NCT01700387|19001625|P2|COMPLETED|Overall Study||6
7716493|NCT01700387|19001626|P1|COMPLETED|Overall Study||6
7716494|NCT01700387|19001625|P2|STARTED|Overall Study||10
7716495|NCT01700387|19001626|P1|STARTED|Overall Study||10
7716496|NCT01700348|19001656|P1|NOT COMPLETED|Overall Study||23
7716497|NCT01700348|19001656|P1|COMPLETED|Overall Study||93
7716498|NCT01700348|19001656|P1|STARTED|Overall Study||116
7716499|NCT01700335|19001665|P2|NOT COMPLETED|Overall Study||4
7716500|NCT01700335|19001666|P1|NOT COMPLETED|Overall Study||1
7716501|NCT01700335|19001665|P2|COMPLETED|Overall Study||2
7716502|NCT01700335|19001666|P1|COMPLETED|Overall Study||2
7716503|NCT01700335|19001665|P2|STARTED|Overall Study||6
7716504|NCT01700335|19001666|P1|STARTED|Overall Study||3
7716505|NCT01700205|19001679|P2|NOT COMPLETED|Overall Study||15
7716506|NCT01700205|19001680|P1|NOT COMPLETED|Overall Study||15
7716507|NCT01700205|19001679|P2|COMPLETED|Overall Study|Mother-Infant Dyads|39
7716508|NCT01700205|19001680|P1|COMPLETED|Overall Study|Mother-Infant Dyads|44
7716509|NCT01700205|19001679|P2|STARTED|Overall Study|Mother-Infant Dyads|54
7716510|NCT01700205|19001680|P1|STARTED|Overall Study|Mother-Infant Dyads|59
7716511|NCT01700192|19001702|P2|NOT COMPLETED|Overall Study||128
7716512|NCT01700192|19001703|P1|NOT COMPLETED|Overall Study||180
7716513|NCT01700192|19001702|P2|COMPLETED|Overall Study||613
7716514|NCT01700192|19001703|P1|COMPLETED|Overall Study||561
7716515|NCT01700192|19001702|P2|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|738
7716516|NCT01700192|19001703|P1|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|743
7716517|NCT01700192|19001702|P2|Treated|Overall Study||741
7716518|NCT01700192|19001703|P1|Treated|Overall Study||740
7716519|NCT01700192|19001702|P2|STARTED|Overall Study||741
7716520|NCT01700192|19001703|P1|STARTED|Overall Study||741
7716521|NCT01700179|19001721|P1|NOT COMPLETED|Overall Study||2
7716522|NCT01700179|19001721|P1|COMPLETED|Overall Study||6
7716523|NCT01700179|19001721|P1|STARTED|Overall Study||8
7716524|NCT01700140|19001728|P3|NOT COMPLETED|Overall Study||1
7716525|NCT01700140|19001729|P2|NOT COMPLETED|Overall Study||9
7716526|NCT01700140|19001730|P1|NOT COMPLETED|Overall Study||6
7716527|NCT01700140|19001728|P3|COMPLETED|Overall Study||61
7716528|NCT01700140|19001729|P2|COMPLETED|Overall Study||57
7716529|NCT01700140|19001730|P1|COMPLETED|Overall Study||55
7716530|NCT01700140|19001728|P3|STARTED|Overall Study||62
7716531|NCT01700140|19001729|P2|STARTED|Overall Study||66
7716532|NCT01700140|19001730|P1|STARTED|Overall Study||61
7716533|NCT01700049|19001762|P1|NOT COMPLETED|Overall Study||1
7716534|NCT01700049|19001762|P1|COMPLETED|Overall Study||27
7716535|NCT01700049|19001762|P1|STARTED|Overall Study||28
7716536|NCT01700036|19001768|P1|NOT COMPLETED|Overall Study||0
7716537|NCT01700036|19001768|P1|COMPLETED|Overall Study||40
7716538|NCT01700036|19001768|P1|STARTED|Overall Study||40
7716539|NCT01699867|19001777|P1|NOT COMPLETED|Overall Study||3
7716540|NCT01699867|19001777|P1|COMPLETED|Overall Study||47
7716541|NCT01699867|19001777|P1|STARTED|Overall Study||50
7716542|NCT01699815|19001784|P2|NOT COMPLETED|Overall Study||8
7716543|NCT01699815|19001785|P1|NOT COMPLETED|Overall Study||5
7716544|NCT01699815|19001784|P2|COMPLETED|Overall Study||56
7716545|NCT01699815|19001785|P1|COMPLETED|Overall Study||57
7716546|NCT01699815|19001784|P2|STARTED|Overall Study||64
7716547|NCT01699815|19001785|P1|STARTED|Overall Study||62
7716548|NCT01699789|19001797|P2|NOT COMPLETED|Overall Study||126
7716549|NCT01699789|19001798|P1|NOT COMPLETED|Overall Study||102
7716550|NCT01699789|19001797|P2|COMPLETED|Overall Study|Clients in 46 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|514
7716551|NCT01699789|19001798|P1|COMPLETED|Overall Study|Clients in 44 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|504
7716552|NCT01699789|19001797|P2|12-Month Follow-Up|Overall Study||369
7716553|NCT01699789|19001798|P1|12-Month Follow-Up|Overall Study||364
7716554|NCT01699789|19001797|P2|6-Month Follow-Up|Overall Study||379
7716555|NCT01699789|19001798|P1|6-Month Follow-Up|Overall Study||380
7716556|NCT01699789|19001797|P2|Baseline|Overall Study||488
7716557|NCT01699789|19001798|P1|Baseline|Overall Study||492
7716558|NCT01699789|19001797|P2|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640
7716559|NCT01699789|19001798|P1|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606
7716560|NCT01699763|19001860|P1|NOT COMPLETED|Overall Study||0
7716561|NCT01699763|19001860|P1|COMPLETED|Overall Study||112
7716562|NCT01699763|19001860|P1|STARTED|Overall Study||112
7716563|NCT01699750|19001868|P2|NOT COMPLETED|Overall Study||3
7716564|NCT01699750|19001869|P1|NOT COMPLETED|Overall Study||0
7716565|NCT01699750|19001868|P2|COMPLETED|Overall Study||33
7716566|NCT01699750|19001869|P1|COMPLETED|Overall Study||34
7716567|NCT01699750|19001868|P2|STARTED|Overall Study||36
7716568|NCT01699750|19001869|P1|STARTED|Overall Study||34
7716569|NCT01699698|19001893|P2|NOT COMPLETED|Overall Study||5
7716570|NCT01699698|19001894|P1|NOT COMPLETED|Overall Study||2
7716571|NCT01699698|19001893|P2|COMPLETED|Overall Study||56
7716572|NCT01699698|19001894|P1|COMPLETED|Overall Study||42
7716573|NCT01699698|19001893|P2|STARTED|Overall Study||61
7716574|NCT01699698|19001894|P1|STARTED|Overall Study||44
7716575|NCT01699685|19001904|P2|NOT COMPLETED|Period 2||0
7716576|NCT01699685|19001905|P1|NOT COMPLETED|Period 2||1
7716577|NCT01699685|19001904|P2|COMPLETED|Period 2||36
7716578|NCT01699685|19001905|P1|COMPLETED|Period 2||35
7716579|NCT01699685|19001904|P2|STARTED|Period 2||36
7716580|NCT01699685|19001905|P1|STARTED|Period 2||36
7716581|NCT01699685|19001904|P2|NOT COMPLETED|Period 1||3
7716582|NCT01699685|19001905|P1|NOT COMPLETED|Period 1||3
7716583|NCT01699685|19001904|P2|COMPLETED|Period 1||36
7716584|NCT01699685|19001905|P1|COMPLETED|Period 1||36
7716585|NCT01699685|19001904|P2|Full Analysis Population (FAS)|Period 1||38
7716586|NCT01699685|19001905|P1|Full Analysis Population (FAS)|Period 1||38
7716587|NCT01699685|19001904|P2|Safety Population|Period 1||38
7716588|NCT01699685|19001905|P1|Safety Population|Period 1||39
7716589|NCT01699685|19001904|P2|STARTED|Period 1||39
7716590|NCT01699685|19001905|P1|STARTED|Period 1||39
7716591|NCT01699607|19001923|P2|NOT COMPLETED|Overall Study||0
7716592|NCT01699607|19001924|P1|NOT COMPLETED|Overall Study||0
7716593|NCT01699607|19001923|P2|COMPLETED|Overall Study||4
7716594|NCT01699607|19001924|P1|COMPLETED|Overall Study||6
7716595|NCT01699607|19001923|P2|STARTED|Overall Study||4
7716596|NCT01699607|19001924|P1|STARTED|Overall Study||6
7716597|NCT01699503|19001931|P2|NOT COMPLETED|Overall Study||1005
7716598|NCT01699503|19001932|P1|NOT COMPLETED|Overall Study||1000
7716599|NCT01699503|19001931|P2|COMPLETED|Overall Study||992
7716600|NCT01699503|19001932|P1|COMPLETED|Overall Study||1008
7716601|NCT01699503|19001931|P2|6 Month Follow-up|Overall Study||893
7716602|NCT01699503|19001932|P1|6 Month Follow-up|Overall Study||903
7716603|NCT01699503|19001931|P2|1 Month Follow-up|Overall Study||1022
7716604|NCT01699503|19001932|P1|1 Month Follow-up|Overall Study||998
7716605|NCT01699503|19001931|P2|Baseline|Overall Study||1693
7716606|NCT01699503|19001932|P1|Baseline|Overall Study||1723
7716607|NCT01699503|19001931|P2|STARTED|Overall Study||1997
7716608|NCT01699503|19001932|P1|STARTED|Overall Study||2008
7716609|NCT01699373|19001948|P2|NOT COMPLETED|Overall Study||0
7716610|NCT01699373|19001949|P1|NOT COMPLETED|Overall Study||0
7716611|NCT01699373|19001948|P2|COMPLETED|Overall Study||85
7716612|NCT01699373|19001949|P1|COMPLETED|Overall Study||85
7716613|NCT01699373|19001948|P2|STARTED|Overall Study||85
7716614|NCT01699373|19001949|P1|STARTED|Overall Study||85
7716615|NCT01699178|19001957|P2|NOT COMPLETED|Overall Study||32
7716616|NCT01699178|19001958|P1|NOT COMPLETED|Overall Study||19
7716617|NCT01699178|19001957|P2|COMPLETED|Overall Study||62
7716618|NCT01699178|19001958|P1|COMPLETED|Overall Study||69
7716619|NCT01699178|19001957|P2|STARTED|Overall Study||94
7716620|NCT01699178|19001958|P1|STARTED|Overall Study||88
7716621|NCT01699087|19001974|P1|NOT COMPLETED|Overall Study||24
7716622|NCT01699087|19001974|P1|COMPLETED|Overall Study||152
7716623|NCT01699087|19001974|P1|Treated|Overall Study||161
7716624|NCT01699087|19001974|P1|STARTED|Overall Study||176
7716625|NCT01699022|19001988|P1|NOT COMPLETED|Overall Study||3
7716626|NCT01699022|19001988|P1|COMPLETED|Overall Study||14
7716627|NCT01699022|19001988|P1|STARTED|Overall Study||17
7716628|NCT01698814|19002003|P2|NOT COMPLETED|Overall Study||3
7716629|NCT01698814|19002004|P1|NOT COMPLETED|Overall Study||2
7716630|NCT01698814|19002003|P2|COMPLETED|Overall Study||166
7716631|NCT01698814|19002004|P1|COMPLETED|Overall Study||329
7716632|NCT01698814|19002003|P2|STARTED|Overall Study||169
7716633|NCT01698814|19002004|P1|STARTED|Overall Study||331
7716634|NCT01698801|19002010|P1|NOT COMPLETED|Follow Up Phase||5
7716635|NCT01698801|19002010|P1|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6
7716636|NCT01698801|19002010|P1|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11
7716637|NCT01698801|19002010|P1|NOT COMPLETED|Treatment Phase||11
7716638|NCT01698801|19002010|P1|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15
7716639|NCT01698801|19002010|P1|STARTED|Treatment Phase||26
7716640|NCT01698775|19002021|P2|NOT COMPLETED|Phase B||11
7716641|NCT01698775|19002022|P1|NOT COMPLETED|Phase B||14
7716642|NCT01698775|19002021|P2|COMPLETED|Phase B||86
7716643|NCT01698775|19002022|P1|COMPLETED|Phase B||84
7716644|NCT01698775|19002021|P2|STARTED|Phase B||97
7716645|NCT01698775|19002022|P1|STARTED|Phase B||98
7716646|NCT01698775|19002021|P2|NOT COMPLETED|Phase A||9
7716647|NCT01698775|19002022|P1|NOT COMPLETED|Phase A||9
7716648|NCT01698775|19002021|P2|COMPLETED|Phase A||97
7716649|NCT01698775|19002022|P1|COMPLETED|Phase A||98
7716650|NCT01698775|19002021|P2|STARTED|Phase A||106
7716651|NCT01698775|19002022|P1|STARTED|Phase A||107
7716652|NCT01698710|19002048|P1|NOT COMPLETED|Overall Study||0
7716653|NCT01698710|19002048|P1|COMPLETED|Overall Study||5
7716654|NCT01698710|19002048|P1|STARTED|Overall Study||5
7716655|NCT01698684|19002057|P3|NOT COMPLETED|Overall Study||21
7716656|NCT01698684|19002058|P2|NOT COMPLETED|Overall Study||23
7716657|NCT01698684|19002059|P1|NOT COMPLETED|Overall Study||29
7716658|NCT01698684|19002057|P3|COMPLETED|Overall Study||127
7716659|NCT01698684|19002058|P2|COMPLETED|Overall Study||124
7716660|NCT01698684|19002059|P1|COMPLETED|Overall Study||116
7716661|NCT01698684|19002057|P3|Safety Population|Overall Study||146
7716662|NCT01698684|19002058|P2|Safety Population|Overall Study||146
7716663|NCT01698684|19002059|P1|Safety Population|Overall Study||143
7716664|NCT01698684|19002057|P3|ITT Population|Overall Study||139
7716665|NCT01698684|19002058|P2|ITT Population|Overall Study||139
7716666|NCT01698684|19002059|P1|ITT Population|Overall Study||136
7716667|NCT01698684|19002057|P3|STARTED|Overall Study||148
7716668|NCT01698684|19002058|P2|STARTED|Overall Study||147
7716669|NCT01698684|19002059|P1|STARTED|Overall Study||145
7716670|NCT01698554|19002071|P4|NOT COMPLETED|Overall Study||2
7716671|NCT01698554|19002072|P3|NOT COMPLETED|Overall Study||2
7716672|NCT01698554|19002073|P2|NOT COMPLETED|Overall Study||10
7716673|NCT01698554|19002074|P1|NOT COMPLETED|Overall Study||6
7716674|NCT01698554|19002071|P4|COMPLETED|Overall Study||77
7716675|NCT01698554|19002072|P3|COMPLETED|Overall Study||73
7716676|NCT01698554|19002073|P2|COMPLETED|Overall Study||147
7716677|NCT01698554|19002074|P1|COMPLETED|Overall Study||147
7716678|NCT01698554|19002071|P4|STARTED|Overall Study||79
7716679|NCT01698554|19002072|P3|STARTED|Overall Study||75
7716680|NCT01698554|19002073|P2|STARTED|Overall Study||157
7716681|NCT01698554|19002074|P1|STARTED|Overall Study||153
7716682|NCT01698528|19002102|P2|NOT COMPLETED|Overall Study||4
7716683|NCT01698528|19002103|P1|NOT COMPLETED|Overall Study||1
7716684|NCT01698528|19002102|P2|COMPLETED|Overall Study||16
7716685|NCT01698528|19002103|P1|COMPLETED|Overall Study||19
7716686|NCT01698528|19002102|P2|STARTED|Overall Study||20
7716687|NCT01698528|19002103|P1|STARTED|Overall Study||20
7716688|NCT01698502|19002119|P2|NOT COMPLETED|Overall Study||0
7716689|NCT01698502|19002120|P1|NOT COMPLETED|Overall Study||0
7716690|NCT01698502|19002119|P2|COMPLETED|Overall Study||10
7716691|NCT01698502|19002120|P1|COMPLETED|Overall Study||11
7716692|NCT01698502|19002119|P2|STARTED|Overall Study||10
7716693|NCT01698502|19002120|P1|STARTED|Overall Study||11
7716694|NCT01698463|19002128|P1|NOT COMPLETED|Overall Study||0
7716695|NCT01698463|19002128|P1|COMPLETED|Overall Study||11
7716696|NCT01698463|19002128|P1|STARTED|Overall Study||11
7716697|NCT01698333|19002138|P1|NOT COMPLETED|Overall Study||0
7716698|NCT01698333|19002138|P1|COMPLETED|Overall Study||25
7716699|NCT01698333|19002138|P1|STARTED|Overall Study||25
7716700|NCT01698320|19002144|P3|NOT COMPLETED|40-Week Open-Label Period||10
7716701|NCT01698320|19002145|P2|NOT COMPLETED|40-Week Open-Label Period||19
7716702|NCT01698320|19002146|P1|NOT COMPLETED|40-Week Open-Label Period||0
7716703|NCT01698320|19002144|P3|COMPLETED|40-Week Open-Label Period||146
7716704|NCT01698320|19002145|P2|COMPLETED|40-Week Open-Label Period||146
7716705|NCT01698320|19002146|P1|COMPLETED|40-Week Open-Label Period||0
7716706|NCT01698320|19002144|P3|STARTED|40-Week Open-Label Period||156
7716707|NCT01698320|19002145|P2|STARTED|40-Week Open-Label Period||165
7716708|NCT01698320|19002146|P1|STARTED|40-Week Open-Label Period||0
7716709|NCT01698320|19002144|P3|NOT COMPLETED|12-Week Double-Blind Period||12
7716710|NCT01698320|19002145|P2|NOT COMPLETED|12-Week Double-Blind Period||4
7716711|NCT01698320|19002146|P1|NOT COMPLETED|12-Week Double-Blind Period||0
7716712|NCT01698320|19002144|P3|COMPLETED|12-Week Double-Blind Period||156
7716713|NCT01698320|19002145|P2|COMPLETED|12-Week Double-Blind Period||165
7716714|NCT01698320|19002146|P1|COMPLETED|12-Week Double-Blind Period||0
7716715|NCT01698320|19002144|P3|Safety Population|12-Week Double-Blind Period||168
7716716|NCT01698320|19002145|P2|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170
7716717|NCT01698320|19002146|P1|Safety Population|12-Week Double-Blind Period||0
7716718|NCT01698320|19002144|P3|STARTED|12-Week Double-Blind Period||168
7716719|NCT01698320|19002145|P2|STARTED|12-Week Double-Blind Period||169
7716720|NCT01698320|19002146|P1|STARTED|12-Week Double-Blind Period||0
7716721|NCT01698320|19002144|P3|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
7716722|NCT01698320|19002145|P2|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
7716723|NCT01698320|19002146|P1|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27
7716724|NCT01698320|19002144|P3|COMPLETED|Run-In Period (Week -1 to Day 0)||0
7716725|NCT01698320|19002145|P2|COMPLETED|Run-In Period (Week -1 to Day 0)||0
7716726|NCT01698320|19002146|P1|COMPLETED|Run-In Period (Week -1 to Day 0)||337
7716727|NCT01698320|19002144|P3|STARTED|Run-In Period (Week -1 to Day 0)||0
7716728|NCT01698320|19002145|P2|STARTED|Run-In Period (Week -1 to Day 0)||0
7716729|NCT01698320|19002146|P1|STARTED|Run-In Period (Week -1 to Day 0)||364
7716730|NCT01698268|19002166|P2|NOT COMPLETED|Overall Study||1
7716731|NCT01698268|19002167|P1|NOT COMPLETED|Overall Study||2
7716732|NCT01698268|19002166|P2|COMPLETED|Overall Study||24
7716733|NCT01698268|19002167|P1|COMPLETED|Overall Study||23
7716734|NCT01698268|19002166|P2|STARTED|Overall Study||25
7716735|NCT01698268|19002167|P1|STARTED|Overall Study||25
7716736|NCT01698008|19002175|P2|NOT COMPLETED|Overall Study||2
7716737|NCT01698008|19002176|P1|NOT COMPLETED|Overall Study||1
7716738|NCT01698008|19002175|P2|COMPLETED|Overall Study||0
7716739|NCT01698008|19002176|P1|COMPLETED|Overall Study||2
7716740|NCT01698008|19002175|P2|STARTED|Overall Study||2
7716741|NCT01698008|19002176|P1|STARTED|Overall Study||3
7716742|NCT01697969|19002182|P1|NOT COMPLETED|Overall Study||3
7716743|NCT01697969|19002182|P1|COMPLETED|Overall Study||10
7716744|NCT01697969|19002182|P1|STARTED|Overall Study||13
7716745|NCT01697956|19002189|P2|NOT COMPLETED|Overall Study||1
7716746|NCT01697956|19002190|P1|NOT COMPLETED|Overall Study||1
7716747|NCT01697956|19002189|P2|COMPLETED|Overall Study||31
7716748|NCT01697956|19002190|P1|COMPLETED|Overall Study||66
7716749|NCT01697956|19002189|P2|Per Protocol Population|Overall Study||31
7716750|NCT01697956|19002190|P1|Per Protocol Population|Overall Study||66
7716751|NCT01697956|19002189|P2|STARTED|Overall Study|enrolled and randomized|32
7716752|NCT01697956|19002190|P1|STARTED|Overall Study|enrolled and randomized|67
7716753|NCT01697800|19002220|P2|NOT COMPLETED|Overall Study||1
7716754|NCT01697800|19002221|P1|NOT COMPLETED|Overall Study||0
7716755|NCT01697800|19002220|P2|COMPLETED|Overall Study||24
7716756|NCT01697800|19002221|P1|COMPLETED|Overall Study||15
7716757|NCT01697800|19002220|P2|STARTED|Overall Study||25
7716758|NCT01697800|19002221|P1|STARTED|Overall Study||15
7716759|NCT01697748|19002229|P2|NOT COMPLETED|Overall Study||68
7716760|NCT01697748|19002230|P1|NOT COMPLETED|Overall Study||58
7716761|NCT01697748|19002229|P2|COMPLETED|Overall Study||260
7716762|NCT01697748|19002230|P1|COMPLETED|Overall Study||271
7716763|NCT01697748|19002229|P2|STARTED|Overall Study||328
7716764|NCT01697748|19002230|P1|STARTED|Overall Study||329
7716765|NCT01697709|19002248|P2|NOT COMPLETED|Overall Study||28
7716766|NCT01697709|19002249|P1|NOT COMPLETED|Overall Study||30
7716767|NCT01697709|19002248|P2|COMPLETED|Overall Study||38
7716768|NCT01697709|19002249|P1|COMPLETED|Overall Study||34
7716769|NCT01697709|19002248|P2|STARTED|Overall Study||66
7716770|NCT01697709|19002249|P1|STARTED|Overall Study||64
7716771|NCT01697696|19002259|P2|NOT COMPLETED|Overall Study||47
7716772|NCT01697696|19002260|P1|NOT COMPLETED|Overall Study||47
7716773|NCT01697696|19002259|P2|COMPLETED|Overall Study||210
7716774|NCT01697696|19002260|P1|COMPLETED|Overall Study||207
7716775|NCT01697696|19002259|P2|Full Analysis Set (FAS)|Overall Study||255
7716776|NCT01697696|19002260|P1|Full Analysis Set (FAS)|Overall Study||251
7716777|NCT01697696|19002259|P2|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256
7716778|NCT01697696|19002260|P1|Safety Set|Overall Study||251
7716779|NCT01697696|19002259|P2|STARTED|Overall Study||257
7716780|NCT01697696|19002260|P1|STARTED|Overall Study||254
7716781|NCT01697592|19002292|P10|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
7716782|NCT01697592|19002293|P9|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
7716783|NCT01697592|19002294|P8|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
7716784|NCT01697592|19002295|P7|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
7716785|NCT01697592|19002296|P6|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
7716786|NCT01697592|19002297|P5|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
7716787|NCT01697592|19002298|P4|NOT COMPLETED|Phase B (Week 25 to Week 52)||3
7716788|NCT01697592|19002299|P3|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
7716789|NCT01697592|19002300|P2|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
7716790|NCT01697592|19002301|P1|NOT COMPLETED|Phase B (Week 25 to Week 52)||5
7716791|NCT01697592|19002292|P10|COMPLETED|Phase B (Week 25 to Week 52)||30
7716792|NCT01697592|19002293|P9|COMPLETED|Phase B (Week 25 to Week 52)||32
7716793|NCT01697592|19002294|P8|COMPLETED|Phase B (Week 25 to Week 52)||32
7716794|NCT01697592|19002295|P7|COMPLETED|Phase B (Week 25 to Week 52)||31
7716795|NCT01697592|19002296|P6|COMPLETED|Phase B (Week 25 to Week 52)||60
7716796|NCT01697592|19002297|P5|COMPLETED|Phase B (Week 25 to Week 52)||67
7716797|NCT01697592|19002298|P4|COMPLETED|Phase B (Week 25 to Week 52)||60
7716798|NCT01697592|19002299|P3|COMPLETED|Phase B (Week 25 to Week 52)||64
7716799|NCT01697592|19002300|P2|COMPLETED|Phase B (Week 25 to Week 52)||61
7716800|NCT01697592|19002301|P1|COMPLETED|Phase B (Week 25 to Week 52)||118
7716801|NCT01697592|19002292|P10|STARTED|Phase B (Week 25 to Week 52)||30
7716802|NCT01697592|19002293|P9|STARTED|Phase B (Week 25 to Week 52)||34
7716803|NCT01697592|19002294|P8|STARTED|Phase B (Week 25 to Week 52)||33
7716804|NCT01697592|19002295|P7|STARTED|Phase B (Week 25 to Week 52)||32
7716805|NCT01697592|19002296|P6|STARTED|Phase B (Week 25 to Week 52)||62
7716806|NCT01697592|19002297|P5|STARTED|Phase B (Week 25 to Week 52)||67
7716807|NCT01697592|19002298|P4|STARTED|Phase B (Week 25 to Week 52)||63
7716808|NCT01697592|19002299|P3|STARTED|Phase B (Week 25 to Week 52)||65
7716809|NCT01697592|19002300|P2|STARTED|Phase B (Week 25 to Week 52)||62
7716810|NCT01697592|19002301|P1|STARTED|Phase B (Week 25 to Week 52)||123
7716811|NCT01697592|19002292|P10|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
7716812|NCT01697592|19002293|P9|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
7716813|NCT01697592|19002294|P8|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
7716814|NCT01697592|19002295|P7|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
7716815|NCT01697592|19002296|P6|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
7716816|NCT01697592|19002297|P5|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
7716817|NCT01697592|19002298|P4|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
7716818|NCT01697592|19002299|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
7716819|NCT01697592|19002300|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
7716820|NCT01697592|19002301|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
7716821|NCT01697592|19002292|P10|COMPLETED|Phase A (Up to 24 Weeks)||30
7716822|NCT01697592|19002293|P9|COMPLETED|Phase A (Up to 24 Weeks)||34
7716823|NCT01697592|19002294|P8|COMPLETED|Phase A (Up to 24 Weeks)||33
7716824|NCT01697592|19002295|P7|COMPLETED|Phase A (Up to 24 Weeks)||32
7716825|NCT01697592|19002296|P6|COMPLETED|Phase A (Up to 24 Weeks)||62
7716826|NCT01697592|19002297|P5|COMPLETED|Phase A (Up to 24 Weeks)||67
7716827|NCT01697592|19002298|P4|COMPLETED|Phase A (Up to 24 Weeks)||63
7716828|NCT01697592|19002299|P3|COMPLETED|Phase A (Up to 24 Weeks)||65
7716829|NCT01697592|19002300|P2|COMPLETED|Phase A (Up to 24 Weeks)||62
7716830|NCT01697592|19002301|P1|COMPLETED|Phase A (Up to 24 Weeks)||123
7716831|NCT01697592|19002292|P10|STARTED|Phase A (Up to 24 Weeks)||32
7716832|NCT01697592|19002293|P9|STARTED|Phase A (Up to 24 Weeks)||34
7716833|NCT01697592|19002294|P8|STARTED|Phase A (Up to 24 Weeks)||33
7716834|NCT01697592|19002295|P7|STARTED|Phase A (Up to 24 Weeks)||34
7716835|NCT01697592|19002296|P6|STARTED|Phase A (Up to 24 Weeks)||63
7716836|NCT01697592|19002297|P5|STARTED|Phase A (Up to 24 Weeks)||67
7716837|NCT01697592|19002298|P4|STARTED|Phase A (Up to 24 Weeks)||65
7716838|NCT01697592|19002299|P3|STARTED|Phase A (Up to 24 Weeks)||66
7716839|NCT01697592|19002300|P2|STARTED|Phase A (Up to 24 Weeks)||65
7716840|NCT01697592|19002301|P1|STARTED|Phase A (Up to 24 Weeks)||126
7716841|NCT01697579|19002370|P7|NOT COMPLETED|Optional Extension-Cycles 2-6||69
7716842|NCT01697579|19002371|P6|NOT COMPLETED|Optional Extension-Cycles 2-6||35
7716843|NCT01697579|19002372|P5|NOT COMPLETED|Optional Extension-Cycles 2-6||0
7716844|NCT01697579|19002373|P4|NOT COMPLETED|Optional Extension-Cycles 2-6||0
7716845|NCT01697579|19002374|P3|NOT COMPLETED|Optional Extension-Cycles 2-6||0
7716846|NCT01697579|19002375|P2|NOT COMPLETED|Optional Extension-Cycles 2-6||0
7716847|NCT01697579|19002376|P1|NOT COMPLETED|Optional Extension-Cycles 2-6||0
7716848|NCT01697579|19002370|P7|COMPLETED|Optional Extension-Cycles 2-6||37
7716849|NCT01697579|19002371|P6|COMPLETED|Optional Extension-Cycles 2-6||12
7716850|NCT01697579|19002372|P5|COMPLETED|Optional Extension-Cycles 2-6||0
7716851|NCT01697579|19002373|P4|COMPLETED|Optional Extension-Cycles 2-6||0
7716852|NCT01697579|19002374|P3|COMPLETED|Optional Extension-Cycles 2-6||0
7716853|NCT01697579|19002375|P2|COMPLETED|Optional Extension-Cycles 2-6||0
7716854|NCT01697579|19002376|P1|COMPLETED|Optional Extension-Cycles 2-6||0
7716855|NCT01697579|19002370|P7|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|106
7716856|NCT01697579|19002371|P6|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|47
7716857|NCT01697579|19002372|P5|STARTED|Optional Extension-Cycles 2-6|21 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
7716858|NCT01697579|19002373|P4|STARTED|Optional Extension-Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
7716859|NCT01697579|19002374|P3|STARTED|Optional Extension-Cycles 2-6|25 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
7716860|NCT01697579|19002375|P2|STARTED|Optional Extension-Cycles 2-6|33 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
7716861|NCT01697579|19002376|P1|STARTED|Optional Extension-Cycles 2-6|47 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 5 mg/kg|0
7716862|NCT01697579|19002370|P7|NOT COMPLETED|Base Study-Cycle 1||0
7716863|NCT01697579|19002371|P6|NOT COMPLETED|Base Study-Cycle 1||0
7716864|NCT01697579|19002372|P5|NOT COMPLETED|Base Study-Cycle 1||3
7716865|NCT01697579|19002373|P4|NOT COMPLETED|Base Study-Cycle 1||1
7716866|NCT01697579|19002374|P3|NOT COMPLETED|Base Study-Cycle 1||1
7716867|NCT01697579|19002375|P2|NOT COMPLETED|Base Study-Cycle 1||1
7716868|NCT01697579|19002376|P1|NOT COMPLETED|Base Study-Cycle 1||2
7716869|NCT01697579|19002370|P7|COMPLETED|Base Study-Cycle 1||0
7716870|NCT01697579|19002371|P6|COMPLETED|Base Study-Cycle 1||0
7716871|NCT01697579|19002372|P5|COMPLETED|Base Study-Cycle 1||35
7716872|NCT01697579|19002373|P4|COMPLETED|Base Study-Cycle 1||40
7716873|NCT01697579|19002374|P3|COMPLETED|Base Study-Cycle 1||43
7716874|NCT01697579|19002375|P2|COMPLETED|Base Study-Cycle 1||42
7716875|NCT01697579|19002376|P1|COMPLETED|Base Study-Cycle 1||72
7716876|NCT01697579|19002370|P7|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
7716877|NCT01697579|19002371|P6|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
7716878|NCT01697579|19002372|P5|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|38
7716879|NCT01697579|19002373|P4|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|41
7716880|NCT01697579|19002374|P3|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|44
7716881|NCT01697579|19002375|P2|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|43
7716882|NCT01697579|19002376|P1|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|74
7716883|NCT01697501|19002488|P1|NOT COMPLETED|Overall Study||2
7716884|NCT01697501|19002488|P1|COMPLETED|Overall Study||86
7716885|NCT01697501|19002488|P1|STARTED|Overall Study||88
7716886|NCT01697462|19002531|P1|NOT COMPLETED|Overall Study||77
7716887|NCT01697462|19002531|P1|COMPLETED|Overall Study||181
7716888|NCT01697462|19002531|P1|STARTED|Overall Study||258
7716889|NCT01697449|19002538|P1|NOT COMPLETED|Overall Study||90
7716890|NCT01697449|19002538|P1|COMPLETED|Overall Study||101
7716891|NCT01697449|19002538|P1|STARTED|Overall Study||191
7716892|NCT01697358|19002549|P2|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55
7716893|NCT01697358|19002550|P1|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49
7716894|NCT01697358|19002549|P2|COMPLETED|Period II: 6-24M Long-term Follow-up||52
7716895|NCT01697358|19002550|P1|COMPLETED|Period II: 6-24M Long-term Follow-up||48
7716896|NCT01697358|19002549|P2|STARTED|Period II: 6-24M Long-term Follow-up||107
7716897|NCT01697358|19002550|P1|STARTED|Period II: 6-24M Long-term Follow-up||97
7716898|NCT01697358|19002549|P2|NOT COMPLETED|Period I: Randomization to 6 Months||1
7716899|NCT01697358|19002550|P1|NOT COMPLETED|Period I: Randomization to 6 Months||13
7716900|NCT01697358|19002549|P2|COMPLETED|Period I: Randomization to 6 Months||107
7716901|NCT01697358|19002550|P1|COMPLETED|Period I: Randomization to 6 Months||97
7716902|NCT01697358|19002549|P2|STARTED|Period I: Randomization to 6 Months||108
7716903|NCT01697358|19002550|P1|STARTED|Period I: Randomization to 6 Months||110
7716904|NCT01697345|19002566|P1|NOT COMPLETED|Overall Study||1
7716905|NCT01697345|19002566|P1|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12
7716906|NCT01697345|19002566|P1|STARTED|Overall Study||13
7716907|NCT01697332|19002585|P1|NOT COMPLETED|Overall Study||0
7716908|NCT01697332|19002585|P1|COMPLETED|Overall Study||1
7716909|NCT01697332|19002585|P1|STARTED|Overall Study||1
7716910|NCT01697319|19002591|P1|NOT COMPLETED|Extension Phase||15
7716911|NCT01697319|19002591|P1|COMPLETED|Extension Phase||0
7716912|NCT01697319|19002591|P1|STARTED|Extension Phase||15
7716913|NCT01697319|19002591|P1|NOT COMPLETED|Primary Phase||1
7716914|NCT01697319|19002591|P1|COMPLETED|Primary Phase||15
7716915|NCT01697319|19002591|P1|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16
7716916|NCT01696994|19002600|P2|NOT COMPLETED|Overall Study||8437
7716917|NCT01696994|19002601|P1|NOT COMPLETED|Overall Study||5192
7716918|NCT01696994|19002600|P2|COMPLETED|Overall Study||30668
7716919|NCT01696994|19002601|P1|COMPLETED|Overall Study||33919
7716920|NCT01696994|19002600|P2|STARTED|Overall Study||39105
7716921|NCT01696994|19002601|P1|STARTED|Overall Study||39111
7716922|NCT01696981|19002629|P2|NOT COMPLETED|Overall Study||10374
7716923|NCT01696981|19002630|P1|NOT COMPLETED|Overall Study||1201
7716924|NCT01696981|19002629|P2|COMPLETED|Overall Study||67071
7716925|NCT01696981|19002630|P1|COMPLETED|Overall Study||76254
7716926|NCT01696981|19002629|P2|STARTED|Overall Study||77445
7716927|NCT01696981|19002630|P1|STARTED|Overall Study||77455
7716928|NCT01696968|19002650|P2|NOT COMPLETED|Overall Study||6812
7716929|NCT01696968|19002651|P1|NOT COMPLETED|Overall Study||1201
7716930|NCT01696968|19002650|P2|COMPLETED|Overall Study||70633
7716931|NCT01696968|19002651|P1|COMPLETED|Overall Study||76255
7716932|NCT01696968|19002650|P2|STARTED|Overall Study||77445
7716933|NCT01696968|19002651|P1|STARTED|Overall Study||77456
7716934|NCT01696955|19002673|P2|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
7716935|NCT01696955|19002674|P1|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
7716936|NCT01696955|19002673|P2|COMPLETED|Failure on Cetuximab-Received Tivantinib|23 patients did not cross over|15
7716937|NCT01696955|19002674|P1|COMPLETED|Failure on Cetuximab-Received Tivantinib||0
7716938|NCT01696955|19002673|P2|STARTED|Failure on Cetuximab-Received Tivantinib||15
7716939|NCT01696955|19002674|P1|STARTED|Failure on Cetuximab-Received Tivantinib||0
7716940|NCT01696955|19002673|P2|NOT COMPLETED|Main Study||1
7716941|NCT01696955|19002674|P1|NOT COMPLETED|Main Study||2
7716942|NCT01696955|19002673|P2|COMPLETED|Main Study||38
7716943|NCT01696955|19002674|P1|COMPLETED|Main Study||40
7716944|NCT01696955|19002673|P2|STARTED|Main Study||39
7716945|NCT01696955|19002674|P1|STARTED|Main Study||42
7716946|NCT01696942|19002699|P2|NOT COMPLETED|Overall Study||3
7716947|NCT01696942|19002700|P1|NOT COMPLETED|Overall Study||2
7716948|NCT01696942|19002699|P2|COMPLETED|Overall Study||2
7716949|NCT01696942|19002700|P1|COMPLETED|Overall Study||3
7716950|NCT01696942|19002699|P2|STARTED|Overall Study||5
7716951|NCT01696942|19002700|P1|STARTED|Overall Study||5
7716952|NCT01696929|19002708|P1|NOT COMPLETED|Overall Study||1
7716953|NCT01696929|19002708|P1|COMPLETED|Overall Study||5
7716954|NCT01696929|19002708|P1|STARTED|Overall Study||6
7716955|NCT01696877|19002715|P2|NOT COMPLETED|Overall Study||1
7716956|NCT01696877|19002716|P1|NOT COMPLETED|Overall Study||0
7716957|NCT01696877|19002715|P2|COMPLETED|Overall Study||13
7716958|NCT01696877|19002716|P1|COMPLETED|Overall Study||15
7716959|NCT01696877|19002715|P2|STARTED|Overall Study||14
7716960|NCT01696877|19002716|P1|STARTED|Overall Study||15
7716961|NCT01696773|19002738|P2|NOT COMPLETED|Day 28, Second Intervention||0
7716962|NCT01696773|19002739|P1|NOT COMPLETED|Day 28, Second Intervention||0
7716963|NCT01696773|19002738|P2|COMPLETED|Day 28, Second Intervention||6
7716964|NCT01696773|19002739|P1|COMPLETED|Day 28, Second Intervention||5
7716965|NCT01696773|19002738|P2|STARTED|Day 28, Second Intervention||6
7716966|NCT01696773|19002739|P1|STARTED|Day 28, Second Intervention||5
7716967|NCT01696773|19002738|P2|NOT COMPLETED|Days 15-27, Washout||0
7716968|NCT01696773|19002739|P1|NOT COMPLETED|Days 15-27, Washout||1
7716969|NCT01696773|19002738|P2|COMPLETED|Days 15-27, Washout||6
7716970|NCT01696773|19002739|P1|COMPLETED|Days 15-27, Washout||5
7716971|NCT01696773|19002738|P2|STARTED|Days 15-27, Washout||6
7716972|NCT01696773|19002739|P1|STARTED|Days 15-27, Washout||6
7716973|NCT01696773|19002738|P2|NOT COMPLETED|Day 14, First Intervention||0
7716974|NCT01696773|19002739|P1|NOT COMPLETED|Day 14, First Intervention||0
7716975|NCT01696773|19002738|P2|COMPLETED|Day 14, First Intervention||6
7716976|NCT01696773|19002739|P1|COMPLETED|Day 14, First Intervention||6
7716977|NCT01696773|19002738|P2|STARTED|Day 14, First Intervention||6
7716978|NCT01696773|19002739|P1|STARTED|Day 14, First Intervention||6
7716979|NCT01696773|19002738|P2|NOT COMPLETED|Days 1-13, Washout||0
7716980|NCT01696773|19002739|P1|NOT COMPLETED|Days 1-13, Washout||0
7716981|NCT01696773|19002738|P2|COMPLETED|Days 1-13, Washout||6
7716982|NCT01696773|19002739|P1|COMPLETED|Days 1-13, Washout||6
7716983|NCT01696773|19002738|P2|STARTED|Days 1-13, Washout||6
7716984|NCT01696773|19002739|P1|STARTED|Days 1-13, Washout||6
7716985|NCT01696760|19002747|P2|NOT COMPLETED|Overall Study||0
7716986|NCT01696760|19002748|P1|NOT COMPLETED|Overall Study||0
7716987|NCT01696760|19002747|P2|COMPLETED|Overall Study||3
7716988|NCT01696760|19002748|P1|COMPLETED|Overall Study||9
7716989|NCT01696760|19002747|P2|STARTED|Overall Study||3
7716990|NCT01696760|19002748|P1|STARTED|Overall Study||9
7716991|NCT01696695|19002766|P1|NOT COMPLETED|Overall Study||882
7716992|NCT01696695|19002766|P1|COMPLETED|Overall Study||0
7716993|NCT01696695|19002766|P1|STARTED|Overall Study||882
7716994|NCT01696643|19002778|P2|NOT COMPLETED|Overall Study||535
7716995|NCT01696643|19002779|P1|NOT COMPLETED|Overall Study||529
7716996|NCT01696643|19002778|P2|COMPLETED|Overall Study||169
7716997|NCT01696643|19002779|P1|COMPLETED|Overall Study||174
7716998|NCT01696643|19002778|P2|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702
7716999|NCT01696643|19002779|P1|Received at Least 1 Dose of Study Drug|Overall Study||701
7717000|NCT01696643|19002778|P2|STARTED|Overall Study||704
7717001|NCT01696643|19002779|P1|STARTED|Overall Study||703
7717002|NCT01696396|19002798|P4|NOT COMPLETED|Overall Study||14
7717003|NCT01696396|19002799|P3|NOT COMPLETED|Overall Study||26
7717004|NCT01696396|19002800|P2|NOT COMPLETED|Overall Study||7
7717005|NCT01696396|19002801|P1|NOT COMPLETED|Overall Study||31
7717006|NCT01696396|19002798|P4|COMPLETED|Overall Study||28
7717007|NCT01696396|19002799|P3|COMPLETED|Overall Study||59
7717008|NCT01696396|19002800|P2|COMPLETED|Overall Study||20
7717009|NCT01696396|19002801|P1|COMPLETED|Overall Study||69
7717010|NCT01696396|19002798|P4|Entered Open-label Period|Overall Study||37
7717011|NCT01696396|19002799|P3|Entered Open-label Period|Overall Study||75
7717012|NCT01696396|19002800|P2|Entered Open-label Period|Overall Study||21
7717013|NCT01696396|19002801|P1|Entered Open-label Period|Overall Study||84
7717014|NCT01696396|19002798|P4|Received Study Drug|Overall Study||41
7717015|NCT01696396|19002799|P3|Received Study Drug|Overall Study||84
7717016|NCT01696396|19002800|P2|Received Study Drug|Overall Study||26
7717017|NCT01696396|19002801|P1|Received Study Drug|Overall Study||98
7717018|NCT01696396|19002798|P4|STARTED|Overall Study||42
7717019|NCT01696396|19002799|P3|STARTED|Overall Study||85
7717020|NCT01696396|19002800|P2|STARTED|Overall Study||27
7717021|NCT01696396|19002801|P1|STARTED|Overall Study||100
7717022|NCT01696357|19002845|P2|NOT COMPLETED|Overall Study||1
7717023|NCT01696357|19002846|P1|NOT COMPLETED|Overall Study||2
7717024|NCT01696357|19002845|P2|COMPLETED|Overall Study||41
7717025|NCT01696357|19002846|P1|COMPLETED|Overall Study||40
7717026|NCT01696357|19002845|P2|STARTED|Overall Study||42
7717027|NCT01696357|19002846|P1|STARTED|Overall Study||42
7717028|NCT01696279|19002852|P4|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||8
7717029|NCT01696279|19002853|P3|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
7717030|NCT01696279|19002854|P2|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
7717031|NCT01696279|19002855|P1|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
7717032|NCT01696279|19002852|P4|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||34
7717033|NCT01696279|19002853|P3|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
7717034|NCT01696279|19002854|P2|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
7717035|NCT01696279|19002855|P1|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
7717036|NCT01696279|19002852|P4|STARTED|Part 3: Lanthanum Carbonate (6 Months)|34 participants from Part 2a and 8 participants from Part 2b continued to Part 3|42
7717037|NCT01696279|19002853|P3|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
7717038|NCT01696279|19002854|P2|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
7717039|NCT01696279|19002855|P1|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
7717040|NCT01696279|19002852|P4|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717041|NCT01696279|19002853|P3|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||1
7717042|NCT01696279|19002854|P2|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717043|NCT01696279|19002855|P1|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717044|NCT01696279|19002852|P4|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717045|NCT01696279|19002853|P3|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||8
7717046|NCT01696279|19002854|P2|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717047|NCT01696279|19002855|P1|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717048|NCT01696279|19002852|P4|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717049|NCT01696279|19002853|P3|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||9
7717050|NCT01696279|19002854|P2|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717051|NCT01696279|19002855|P1|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717052|NCT01696279|19002852|P4|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717053|NCT01696279|19002853|P3|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717054|NCT01696279|19002854|P2|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717055|NCT01696279|19002855|P1|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717056|NCT01696279|19002852|P4|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717057|NCT01696279|19002853|P3|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
7717058|NCT01696279|19002854|P2|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717059|NCT01696279|19002855|P1|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717060|NCT01696279|19002852|P4|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717061|NCT01696279|19002853|P3|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
7717062|NCT01696279|19002854|P2|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717063|NCT01696279|19002855|P1|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717064|NCT01696279|19002852|P4|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717065|NCT01696279|19002853|P3|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)|9 new participants were enrolled in Part 2b|9
7717066|NCT01696279|19002854|P2|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717067|NCT01696279|19002855|P1|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
7717068|NCT01696279|19002852|P4|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
7717069|NCT01696279|19002853|P3|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
7717070|NCT01696279|19002854|P2|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||19
7717071|NCT01696279|19002855|P1|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
7717072|NCT01696279|19002852|P4|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
7717073|NCT01696279|19002853|P3|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
7717074|NCT01696279|19002854|P2|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||34
7717075|NCT01696279|19002855|P1|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
7717076|NCT01696279|19002852|P4|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
7717077|NCT01696279|19002853|P3|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
7717078|NCT01696279|19002854|P2|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||34
7717079|NCT01696279|19002855|P1|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
7717080|NCT01696279|19002852|P4|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
7717081|NCT01696279|19002853|P3|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
7717082|NCT01696279|19002854|P2|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||25
7717083|NCT01696279|19002855|P1|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
7717084|NCT01696279|19002852|P4|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
7717085|NCT01696279|19002853|P3|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
7717086|NCT01696279|19002854|P2|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||17
7717087|NCT01696279|19002855|P1|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
7717088|NCT01696279|19002852|P4|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
7717089|NCT01696279|19002853|P3|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
7717090|NCT01696279|19002854|P2|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||53
7717091|NCT01696279|19002855|P1|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
7717092|NCT01696279|19002852|P4|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
7717093|NCT01696279|19002853|P3|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
7717094|NCT01696279|19002854|P2|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||37
7717095|NCT01696279|19002855|P1|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
7717096|NCT01696279|19002852|P4|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
7717097|NCT01696279|19002853|P3|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
7717098|NCT01696279|19002854|P2|STARTED|Part 2a: Calcium Carbonate + Lanthanum|19 participants enrolled from Part 1 and 34 new participants enrolled in Part 2a|53
7717099|NCT01696279|19002855|P1|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
7717100|NCT01696279|19002852|P4|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
7717101|NCT01696279|19002853|P3|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
7717102|NCT01696279|19002854|P2|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
7717103|NCT01696279|19002855|P1|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||1
7717104|NCT01696279|19002852|P4|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
7717105|NCT01696279|19002853|P3|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
7717106|NCT01696279|19002854|P2|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
7717107|NCT01696279|19002855|P1|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||19
7717108|NCT01696279|19002852|P4|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
7717109|NCT01696279|19002853|P3|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
7717110|NCT01696279|19002854|P2|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
7717111|NCT01696279|19002855|P1|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||19
7717112|NCT01696279|19002852|P4|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
7717113|NCT01696279|19002853|P3|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
7717114|NCT01696279|19002854|P2|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
7717115|NCT01696279|19002855|P1|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||20
7717116|NCT01696279|19002852|P4|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
7717117|NCT01696279|19002853|P3|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
7717118|NCT01696279|19002854|P2|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
7717119|NCT01696279|19002855|P1|STARTED|Part 1: Single Dose Lanthanum Carbonate||20
7717120|NCT01696214|19002893|P4|NOT COMPLETED|Overall Study||0
7717121|NCT01696214|19002894|P3|NOT COMPLETED|Overall Study||0
7717122|NCT01696214|19002895|P2|NOT COMPLETED|Overall Study||0
7717123|NCT01696214|19002896|P1|NOT COMPLETED|Overall Study||1
7717124|NCT01696214|19002893|P4|COMPLETED|Overall Study||5
7717125|NCT01696214|19002894|P3|COMPLETED|Overall Study||5
7717126|NCT01696214|19002895|P2|COMPLETED|Overall Study||5
7717127|NCT01696214|19002896|P1|COMPLETED|Overall Study||4
7717128|NCT01696214|19002893|P4|STARTED|Overall Study||5
7717129|NCT01696214|19002894|P3|STARTED|Overall Study||5
7717130|NCT01696214|19002895|P2|STARTED|Overall Study||5
7717131|NCT01696214|19002896|P1|STARTED|Overall Study||5
7717132|NCT01696188|19002916|P2|NOT COMPLETED|Overall Study||1
7717133|NCT01696188|19002917|P1|NOT COMPLETED|Overall Study||1
7717134|NCT01696188|19002916|P2|COMPLETED|Overall Study||42
7717135|NCT01696188|19002917|P1|COMPLETED|Overall Study||40
7717136|NCT01696188|19002916|P2|STARTED|Overall Study||43
7717137|NCT01696188|19002917|P1|STARTED|Overall Study||41
7717138|NCT01696084|19002931|P2|NOT COMPLETED|Overall Study||146
7717139|NCT01696084|19002932|P1|NOT COMPLETED|Overall Study||131
7717140|NCT01696084|19002931|P2|COMPLETED|Overall Study||10
7717141|NCT01696084|19002932|P1|COMPLETED|Overall Study||22
7717142|NCT01696084|19002931|P2|STARTED|Overall Study||156
7717143|NCT01696084|19002932|P1|STARTED|Overall Study||153
7717144|NCT01696071|19002948|P2|NOT COMPLETED|Treatment Period 2: 4 Weeks||0
7717145|NCT01696071|19002949|P1|NOT COMPLETED|Treatment Period 2: 4 Weeks||1
7717146|NCT01696071|19002948|P2|COMPLETED|Treatment Period 2: 4 Weeks||47
7717147|NCT01696071|19002949|P1|COMPLETED|Treatment Period 2: 4 Weeks||50
7717148|NCT01696071|19002948|P2|STARTED|Treatment Period 2: 4 Weeks||47
7717149|NCT01696071|19002949|P1|STARTED|Treatment Period 2: 4 Weeks||51
7717150|NCT01696071|19002948|P2|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
7717151|NCT01696071|19002949|P1|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
7717152|NCT01696071|19002948|P2|COMPLETED|Treatment Period 1: 4 Weeks||47
7717153|NCT01696071|19002949|P1|COMPLETED|Treatment Period 1: 4 Weeks||51
7717154|NCT01696071|19002948|P2|STARTED|Treatment Period 1: 4 Weeks||47
7717155|NCT01696071|19002949|P1|STARTED|Treatment Period 1: 4 Weeks||51
7717156|NCT01696058|19002977|P2|NOT COMPLETED|Overall Study||31
7717157|NCT01696058|19002978|P1|NOT COMPLETED|Overall Study||43
7717158|NCT01696058|19002977|P2|COMPLETED|Overall Study||538
7717159|NCT01696058|19002978|P1|COMPLETED|Overall Study||523
7717160|NCT01696058|19002977|P2|STARTED|Overall Study||569
7717161|NCT01696058|19002978|P1|STARTED|Overall Study||566
7717162|NCT01696045|19003006|P2|NOT COMPLETED|Overall Study||7
7717163|NCT01696045|19003007|P1|NOT COMPLETED|Overall Study||3
7717164|NCT01696045|19003006|P2|COMPLETED|Overall Study||1
7717165|NCT01696045|19003007|P1|COMPLETED|Overall Study||1
7717166|NCT01696045|19003006|P2|STARTED|Overall Study||8
7717167|NCT01696045|19003007|P1|STARTED|Overall Study||4
7717168|NCT01695993|19003026|P3|NOT COMPLETED|Overall Study||6
7717169|NCT01695993|19003027|P2|NOT COMPLETED|Overall Study||5
7717170|NCT01695993|19003028|P1|NOT COMPLETED|Overall Study||5
7717171|NCT01695993|19003026|P3|COMPLETED|Overall Study||75
7717172|NCT01695993|19003027|P2|COMPLETED|Overall Study||75
7717173|NCT01695993|19003028|P1|COMPLETED|Overall Study||76
7717174|NCT01695993|19003026|P3|STARTED|Overall Study||81
7717175|NCT01695993|19003027|P2|STARTED|Overall Study||80
7717176|NCT01695993|19003028|P1|STARTED|Overall Study||81
7717177|NCT01695954|19003038|P2|NOT COMPLETED|Overall Study||2
7717178|NCT01695954|19003039|P1|NOT COMPLETED|Overall Study||4
7717179|NCT01695954|19003038|P2|COMPLETED|Overall Study||14
7717180|NCT01695954|19003039|P1|COMPLETED|Overall Study||14
7717181|NCT01695954|19003038|P2|STARTED|Overall Study||16
7717182|NCT01695954|19003039|P1|STARTED|Overall Study||18
7717183|NCT01695772|19003049|P1|NOT COMPLETED|Overall Study||38
7717184|NCT01695772|19003049|P1|COMPLETED|Overall Study||12
7717185|NCT01695772|19003049|P1|STARTED|Overall Study||50
7717186|NCT01695746|19003061|P1|NOT COMPLETED|Overall Study||12
7717187|NCT01695746|19003061|P1|COMPLETED|Overall Study||96
7717188|NCT01695746|19003061|P1|STARTED|Overall Study||108
7717189|NCT01695668|19003077|P2|NOT COMPLETED|Overall Study||17
7717190|NCT01695668|19003078|P1|NOT COMPLETED|Overall Study||15
7717191|NCT01695668|19003077|P2|COMPLETED|Overall Study||20
7717192|NCT01695668|19003078|P1|COMPLETED|Overall Study||23
7717193|NCT01695668|19003077|P2|STARTED|Overall Study||37
7717194|NCT01695668|19003078|P1|STARTED|Overall Study||38
7717195|NCT01695369|19003084|P1|NOT COMPLETED|Overall Study||0
7717196|NCT01695369|19003084|P1|COMPLETED|Overall Study||61
7717197|NCT01695369|19003084|P1|STARTED|Overall Study||61
7717198|NCT01695330|19003090|P2|NOT COMPLETED|Overall Study||0
7717199|NCT01695330|19003091|P1|NOT COMPLETED|Overall Study||47
7717200|NCT01695330|19003090|P2|COMPLETED|Overall Study||0
7717201|NCT01695330|19003091|P1|COMPLETED|Overall Study||5
7717202|NCT01695330|19003090|P2|STARTED|Overall Study||0
7717203|NCT01695330|19003091|P1|STARTED|Overall Study||52
7717204|NCT01695304|19003097|P2|NOT COMPLETED|Overall Study||0
7717205|NCT01695304|19003098|P1|NOT COMPLETED|Overall Study||0
7717206|NCT01695304|19003097|P2|COMPLETED|Overall Study|3 deaths & 2 drop out in the intervention group, contributed some information over the 26 weeks|120
7717207|NCT01695304|19003098|P1|COMPLETED|Overall Study|2 deaths & 1 drop out in the intervention group, contributed some information over the 26 weeks|120
7717208|NCT01695304|19003097|P2|STARTED|Overall Study||120
7717209|NCT01695304|19003098|P1|STARTED|Overall Study||120
7717210|NCT01695291|19003108|P2|NOT COMPLETED|Overall Study||7
7717211|NCT01695291|19003109|P1|NOT COMPLETED|Overall Study||2
7717212|NCT01695291|19003108|P2|COMPLETED|Overall Study||14
7717213|NCT01695291|19003109|P1|COMPLETED|Overall Study||8
7717214|NCT01695291|19003108|P2|STARTED|Overall Study||21
7717215|NCT01695291|19003109|P1|STARTED|Overall Study||10
7717216|NCT01695239|19003121|P14|NOT COMPLETED|Post-Treatment Follow-Up Period||5
7717217|NCT01695239|19003122|P13|NOT COMPLETED|Post-Treatment Follow-Up Period||9
7717218|NCT01695239|19003123|P12|NOT COMPLETED|Post-Treatment Follow-Up Period||1
7717219|NCT01695239|19003124|P11|NOT COMPLETED|Post-Treatment Follow-Up Period||0
7717220|NCT01695239|19003125|P10|NOT COMPLETED|Post-Treatment Follow-Up Period||0
7717221|NCT01695239|19003126|P9|NOT COMPLETED|Post-Treatment Follow-Up Period||0
7717222|NCT01695239|19003127|P8|NOT COMPLETED|Post-Treatment Follow-Up Period||0
7717223|NCT01695239|19003128|P7|NOT COMPLETED|Post-Treatment Follow-Up Period||0
7717224|NCT01695239|19003129|P6|NOT COMPLETED|Post-Treatment Follow-Up Period||0
7717225|NCT01695239|19003130|P5|NOT COMPLETED|Post-Treatment Follow-Up Period||0
7717226|NCT01695239|19003131|P4|NOT COMPLETED|Post-Treatment Follow-Up Period||0
7717227|NCT01695239|19003132|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||0
7717228|NCT01695239|19003133|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||0
7717229|NCT01695239|19003134|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||0
7717230|NCT01695239|19003121|P14|COMPLETED|Post-Treatment Follow-Up Period||166
7717231|NCT01695239|19003122|P13|COMPLETED|Post-Treatment Follow-Up Period||156
7717232|NCT01695239|19003123|P12|COMPLETED|Post-Treatment Follow-Up Period||0
7717233|NCT01695239|19003124|P11|COMPLETED|Post-Treatment Follow-Up Period||20
7717234|NCT01695239|19003125|P10|COMPLETED|Post-Treatment Follow-Up Period||0
7717235|NCT01695239|19003126|P9|COMPLETED|Post-Treatment Follow-Up Period||0
7717236|NCT01695239|19003127|P8|COMPLETED|Post-Treatment Follow-Up Period||0
7717237|NCT01695239|19003128|P7|COMPLETED|Post-Treatment Follow-Up Period||0
7717238|NCT01695239|19003129|P6|COMPLETED|Post-Treatment Follow-Up Period||0
7717239|NCT01695239|19003130|P5|COMPLETED|Post-Treatment Follow-Up Period||0
7717240|NCT01695239|19003131|P4|COMPLETED|Post-Treatment Follow-Up Period||0
7717241|NCT01695239|19003132|P3|COMPLETED|Post-Treatment Follow-Up Period||0
7717242|NCT01695239|19003133|P2|COMPLETED|Post-Treatment Follow-Up Period||0
7717243|NCT01695239|19003134|P1|COMPLETED|Post-Treatment Follow-Up Period||0
7717244|NCT01695239|19003121|P14|STARTED|Post-Treatment Follow-Up Period|IxeQ2W participants who entered post-treatment follow-up.|171
7717245|NCT01695239|19003122|P13|STARTED|Post-Treatment Follow-Up Period|IxeQ4W participants who entered post-treatment follow-up.|165
7717246|NCT01695239|19003123|P12|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received adalimumab.|1
7717247|NCT01695239|19003124|P11|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received PBO.|20
7717248|NCT01695239|19003125|P10|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
7717249|NCT01695239|19003126|P9|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
7717250|NCT01695239|19003127|P8|STARTED|Post-Treatment Follow-Up Period||0
7717251|NCT01695239|19003128|P7|STARTED|Post-Treatment Follow-Up Period||0
7717252|NCT01695239|19003129|P6|STARTED|Post-Treatment Follow-Up Period||0
7717253|NCT01695239|19003130|P5|STARTED|Post-Treatment Follow-Up Period||0
7717254|NCT01695239|19003131|P4|STARTED|Post-Treatment Follow-Up Period||0
7717255|NCT01695239|19003132|P3|STARTED|Post-Treatment Follow-Up Period||0
7717256|NCT01695239|19003133|P2|STARTED|Post-Treatment Follow-Up Period||0
7717257|NCT01695239|19003134|P1|STARTED|Post-Treatment Follow-Up Period||0
7717258|NCT01695239|19003121|P14|NOT COMPLETED|Extension Long-Term Extension Periods||0
7717259|NCT01695239|19003122|P13|NOT COMPLETED|Extension Long-Term Extension Periods||0
7717260|NCT01695239|19003123|P12|NOT COMPLETED|Extension Long-Term Extension Periods||0
7717261|NCT01695239|19003124|P11|NOT COMPLETED|Extension Long-Term Extension Periods||0
7717262|NCT01695239|19003125|P10|NOT COMPLETED|Extension Long-Term Extension Periods||61
7717263|NCT01695239|19003126|P9|NOT COMPLETED|Extension Long-Term Extension Periods||66
7717264|NCT01695239|19003127|P8|NOT COMPLETED|Extension Long-Term Extension Periods||0
7717265|NCT01695239|19003128|P7|NOT COMPLETED|Extension Long-Term Extension Periods||0
7717266|NCT01695239|19003129|P6|NOT COMPLETED|Extension Long-Term Extension Periods||0
7717267|NCT01695239|19003130|P5|NOT COMPLETED|Extension Long-Term Extension Periods||0
7717268|NCT01695239|19003131|P4|NOT COMPLETED|Extension Long-Term Extension Periods||0
7717269|NCT01695239|19003132|P3|NOT COMPLETED|Extension Long-Term Extension Periods||0
7717270|NCT01695239|19003133|P2|NOT COMPLETED|Extension Long-Term Extension Periods||0
7717271|NCT01695239|19003134|P1|NOT COMPLETED|Extension Long-Term Extension Periods||0
7717272|NCT01695239|19003121|P14|COMPLETED|Extension Long-Term Extension Periods||0
7717273|NCT01695239|19003122|P13|COMPLETED|Extension Long-Term Extension Periods||0
7717274|NCT01695239|19003123|P12|COMPLETED|Extension Long-Term Extension Periods||0
7717275|NCT01695239|19003124|P11|COMPLETED|Extension Long-Term Extension Periods||0
7717276|NCT01695239|19003125|P10|COMPLETED|Extension Long-Term Extension Periods||122
7717277|NCT01695239|19003126|P9|COMPLETED|Extension Long-Term Extension Periods||121
7717278|NCT01695239|19003127|P8|COMPLETED|Extension Long-Term Extension Periods||0
7717279|NCT01695239|19003128|P7|COMPLETED|Extension Long-Term Extension Periods||0
7717280|NCT01695239|19003129|P6|COMPLETED|Extension Long-Term Extension Periods||0
7717281|NCT01695239|19003130|P5|COMPLETED|Extension Long-Term Extension Periods||0
7717282|NCT01695239|19003131|P4|COMPLETED|Extension Long-Term Extension Periods||0
7717283|NCT01695239|19003132|P3|COMPLETED|Extension Long-Term Extension Periods||0
7717284|NCT01695239|19003133|P2|COMPLETED|Extension Long-Term Extension Periods||0
7717285|NCT01695239|19003134|P1|COMPLETED|Extension Long-Term Extension Periods||0
7717286|NCT01695239|19003121|P14|STARTED|Extension Long-Term Extension Periods||0
7717287|NCT01695239|19003122|P13|STARTED|Extension Long-Term Extension Periods||0
7717288|NCT01695239|19003123|P12|STARTED|Extension Long-Term Extension Periods||0
7717289|NCT01695239|19003124|P11|STARTED|Extension Long-Term Extension Periods||0
7717290|NCT01695239|19003125|P10|STARTED|Extension Long-Term Extension Periods|IxeQ2W who re-randomized to ixeQ2W.|183
7717291|NCT01695239|19003126|P9|STARTED|Extension Long-Term Extension Periods|IxeQ4W who re-randomized to ixeQ4W.|187
7717292|NCT01695239|19003127|P8|STARTED|Extension Long-Term Extension Periods|Only included combined extension participants.|0
7717293|NCT01695239|19003128|P7|STARTED|Extension Long-Term Extension Periods||0
7717294|NCT01695239|19003129|P6|STARTED|Extension Long-Term Extension Periods||0
7717295|NCT01695239|19003130|P5|STARTED|Extension Long-Term Extension Periods||0
7717296|NCT01695239|19003131|P4|STARTED|Extension Long-Term Extension Periods||0
7717297|NCT01695239|19003132|P3|STARTED|Extension Long-Term Extension Periods||0
7717298|NCT01695239|19003133|P2|STARTED|Extension Long-Term Extension Periods||0
7717299|NCT01695239|19003134|P1|STARTED|Extension Long-Term Extension Periods||0
7717300|NCT01695239|19003121|P14|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717301|NCT01695239|19003122|P13|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717302|NCT01695239|19003123|P12|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717303|NCT01695239|19003124|P11|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717304|NCT01695239|19003125|P10|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717305|NCT01695239|19003126|P9|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717306|NCT01695239|19003127|P8|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||11
7717307|NCT01695239|19003128|P7|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717308|NCT01695239|19003129|P6|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717309|NCT01695239|19003130|P5|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717310|NCT01695239|19003131|P4|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717311|NCT01695239|19003132|P3|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717312|NCT01695239|19003133|P2|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717313|NCT01695239|19003134|P1|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717314|NCT01695239|19003121|P14|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717315|NCT01695239|19003122|P13|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717316|NCT01695239|19003123|P12|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717317|NCT01695239|19003124|P11|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717318|NCT01695239|19003125|P10|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717319|NCT01695239|19003126|P9|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717320|NCT01695239|19003127|P8|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||77
7717321|NCT01695239|19003128|P7|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717322|NCT01695239|19003129|P6|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717323|NCT01695239|19003130|P5|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717324|NCT01695239|19003131|P4|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717325|NCT01695239|19003132|P3|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717326|NCT01695239|19003133|P2|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717327|NCT01695239|19003134|P1|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
7717328|NCT01695239|19003121|P14|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
7717329|NCT01695239|19003122|P13|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
7717330|NCT01695239|19003123|P12|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
7717331|NCT01695239|19003124|P11|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
7717332|NCT01695239|19003125|P10|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
7717333|NCT01695239|19003126|P9|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
7717334|NCT01695239|19003127|P8|STARTED|Placebo Washout (Week 24 Up To Week 32)|Adalimumab Q2W responders who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|88
7717335|NCT01695239|19003128|P7|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
7717336|NCT01695239|19003129|P6|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
7717337|NCT01695239|19003130|P5|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
7717338|NCT01695239|19003131|P4|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
7717339|NCT01695239|19003132|P3|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
7717340|NCT01695239|19003133|P2|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
7717341|NCT01695239|19003134|P1|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
7717342|NCT01695239|19003121|P14|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717343|NCT01695239|19003122|P13|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717344|NCT01695239|19003123|P12|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717345|NCT01695239|19003124|P11|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717346|NCT01695239|19003125|P10|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717347|NCT01695239|19003126|P9|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717348|NCT01695239|19003127|P8|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717349|NCT01695239|19003128|P7|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717350|NCT01695239|19003129|P6|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717351|NCT01695239|19003130|P5|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717352|NCT01695239|19003131|P4|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717353|NCT01695239|19003132|P3|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717354|NCT01695239|19003133|P2|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717355|NCT01695239|19003134|P1|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717356|NCT01695239|19003121|P14|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717357|NCT01695239|19003122|P13|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717358|NCT01695239|19003123|P12|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717359|NCT01695239|19003124|P11|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717360|NCT01695239|19003125|P10|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717361|NCT01695239|19003126|P9|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717362|NCT01695239|19003127|P8|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717363|NCT01695239|19003128|P7|COMPLETED|IR Participants (Week 16 Up To Week 24)||9
7717364|NCT01695239|19003129|P6|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
7717365|NCT01695239|19003130|P5|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
7717366|NCT01695239|19003131|P4|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717367|NCT01695239|19003132|P3|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717368|NCT01695239|19003133|P2|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717369|NCT01695239|19003134|P1|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
7717370|NCT01695239|19003121|P14|STARTED|IR Participants (Week 16 Up To Week 24)||0
7717371|NCT01695239|19003122|P13|STARTED|IR Participants (Week 16 Up To Week 24)||0
7717372|NCT01695239|19003123|P12|STARTED|IR Participants (Week 16 Up To Week 24)||0
7717373|NCT01695239|19003124|P11|STARTED|IR Participants (Week 16 Up To Week 24)||0
7717374|NCT01695239|19003125|P10|STARTED|IR Participants (Week 16 Up To Week 24)||0
7717375|NCT01695239|19003126|P9|STARTED|IR Participants (Week 16 Up To Week 24)||0
7717376|NCT01695239|19003127|P8|STARTED|IR Participants (Week 16 Up To Week 24)||0
7717377|NCT01695239|19003128|P7|STARTED|IR Participants (Week 16 Up To Week 24)|Adalimumab Q2W (IR) who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|9
7717378|NCT01695239|19003129|P6|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ2W and IR from ixeQ2W.|24
7717379|NCT01695239|19003130|P5|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ4W and IR from ixeQ4W.|24
7717380|NCT01695239|19003131|P4|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
7717381|NCT01695239|19003132|P3|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
7717382|NCT01695239|19003133|P2|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
7717383|NCT01695239|19003134|P1|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
7717384|NCT01695239|19003121|P14|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
7717385|NCT01695239|19003122|P13|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
7717386|NCT01695239|19003123|P12|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
7717387|NCT01695239|19003124|P11|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
7717388|NCT01695239|19003125|P10|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
7717389|NCT01695239|19003126|P9|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
7717390|NCT01695239|19003127|P8|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
7717391|NCT01695239|19003128|P7|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
7717392|NCT01695239|19003129|P6|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
7717393|NCT01695239|19003130|P5|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
7717394|NCT01695239|19003131|P4|NOT COMPLETED|Double-Blind (DB) Treatment Period||7
7717395|NCT01695239|19003132|P3|NOT COMPLETED|Double-Blind (DB) Treatment Period||10
7717396|NCT01695239|19003133|P2|NOT COMPLETED|Double-Blind (DB) Treatment Period||4
7717397|NCT01695239|19003134|P1|NOT COMPLETED|Double-Blind (DB) Treatment Period||15
7717398|NCT01695239|19003121|P14|COMPLETED|Double-Blind (DB) Treatment Period||0
7717399|NCT01695239|19003122|P13|COMPLETED|Double-Blind (DB) Treatment Period||0
7717400|NCT01695239|19003123|P12|COMPLETED|Double-Blind (DB) Treatment Period||0
7717401|NCT01695239|19003124|P11|COMPLETED|Double-Blind (DB) Treatment Period||0
7717402|NCT01695239|19003125|P10|COMPLETED|Double-Blind (DB) Treatment Period||0
7717403|NCT01695239|19003126|P9|COMPLETED|Double-Blind (DB) Treatment Period||0
7717404|NCT01695239|19003127|P8|COMPLETED|Double-Blind (DB) Treatment Period||0
7717405|NCT01695239|19003128|P7|COMPLETED|Double-Blind (DB) Treatment Period||0
7717406|NCT01695239|19003129|P6|COMPLETED|Double-Blind (DB) Treatment Period||0
7717407|NCT01695239|19003130|P5|COMPLETED|Double-Blind (DB) Treatment Period||0
7717408|NCT01695239|19003131|P4|COMPLETED|Double-Blind (DB) Treatment Period||96
7717409|NCT01695239|19003132|P3|COMPLETED|Double-Blind (DB) Treatment Period||97
7717410|NCT01695239|19003133|P2|COMPLETED|Double-Blind (DB) Treatment Period||97
7717411|NCT01695239|19003134|P1|COMPLETED|Double-Blind (DB) Treatment Period||91
7717412|NCT01695239|19003121|P14|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
7717413|NCT01695239|19003122|P13|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
7717414|NCT01695239|19003123|P12|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
7717415|NCT01695239|19003124|P11|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
7717416|NCT01695239|19003125|P10|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
7717417|NCT01695239|19003126|P9|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
7717418|NCT01695239|19003127|P8|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
7717495|NCT01694771|19003328|P1|STARTED|Overall Study||567
7717419|NCT01695239|19003128|P7|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
7717420|NCT01695239|19003129|P6|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
7717421|NCT01695239|19003130|P5|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
7717422|NCT01695239|19003131|P4|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||10
7717423|NCT01695239|19003132|P3|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||11
7717424|NCT01695239|19003133|P2|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||9
7717425|NCT01695239|19003134|P1|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||27
7717426|NCT01695239|19003121|P14|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
7717427|NCT01695239|19003122|P13|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
7717428|NCT01695239|19003123|P12|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
7717429|NCT01695239|19003124|P11|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
7717430|NCT01695239|19003125|P10|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
7717431|NCT01695239|19003126|P9|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
7717432|NCT01695239|19003127|P8|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
7717433|NCT01695239|19003128|P7|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
7717434|NCT01695239|19003129|P6|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
7717435|NCT01695239|19003130|P5|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
7717436|NCT01695239|19003131|P4|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||102
7717437|NCT01695239|19003132|P3|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||107
7717438|NCT01695239|19003133|P2|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||101
7717439|NCT01695239|19003134|P1|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||106
7717440|NCT01695239|19003121|P14|STARTED|Double-Blind (DB) Treatment Period||0
7717441|NCT01695239|19003122|P13|STARTED|Double-Blind (DB) Treatment Period||0
7717442|NCT01695239|19003123|P12|STARTED|Double-Blind (DB) Treatment Period||0
7717443|NCT01695239|19003124|P11|STARTED|Double-Blind (DB) Treatment Period||0
7717444|NCT01695239|19003125|P10|STARTED|Double-Blind (DB) Treatment Period||0
7717445|NCT01695239|19003126|P9|STARTED|Double-Blind (DB) Treatment Period||0
7717446|NCT01695239|19003127|P8|STARTED|Double-Blind (DB) Treatment Period||0
7717447|NCT01695239|19003128|P7|STARTED|Double-Blind (DB) Treatment Period||0
7717448|NCT01695239|19003129|P6|STARTED|Double-Blind (DB) Treatment Period||0
7717449|NCT01695239|19003130|P5|STARTED|Double-Blind (DB) Treatment Period||0
7717450|NCT01695239|19003131|P4|STARTED|Double-Blind (DB) Treatment Period||103
7717451|NCT01695239|19003132|P3|STARTED|Double-Blind (DB) Treatment Period||107
7717452|NCT01695239|19003133|P2|STARTED|Double-Blind (DB) Treatment Period||101
7717453|NCT01695239|19003134|P1|STARTED|Double-Blind (DB) Treatment Period||106
7717454|NCT01695135|19003275|P4|NOT COMPLETED|Open Label Extension Treatment Phase||70
7717455|NCT01695135|19003276|P3|NOT COMPLETED|Open Label Extension Treatment Phase||40
7717456|NCT01695135|19003277|P2|NOT COMPLETED|Open Label Extension Treatment Phase||0
7717457|NCT01695135|19003278|P1|NOT COMPLETED|Open Label Extension Treatment Phase||0
7717458|NCT01695135|19003275|P4|COMPLETED|Open Label Extension Treatment Phase||10
7717459|NCT01695135|19003276|P3|COMPLETED|Open Label Extension Treatment Phase||9
7717460|NCT01695135|19003277|P2|COMPLETED|Open Label Extension Treatment Phase||0
7717461|NCT01695135|19003278|P1|COMPLETED|Open Label Extension Treatment Phase||0
7717462|NCT01695135|19003275|P4|STARTED|Open Label Extension Treatment Phase||80
7717463|NCT01695135|19003276|P3|STARTED|Open Label Extension Treatment Phase||49
7717464|NCT01695135|19003277|P2|STARTED|Open Label Extension Treatment Phase||0
7717465|NCT01695135|19003278|P1|STARTED|Open Label Extension Treatment Phase||0
7717466|NCT01695135|19003275|P4|NOT COMPLETED|Double-blind Treatment Phase||0
7717467|NCT01695135|19003276|P3|NOT COMPLETED|Double-blind Treatment Phase||0
7717468|NCT01695135|19003277|P2|NOT COMPLETED|Double-blind Treatment Phase||139
7717469|NCT01695135|19003278|P1|NOT COMPLETED|Double-blind Treatment Phase||71
7717470|NCT01695135|19003275|P4|COMPLETED|Double-blind Treatment Phase||0
7717471|NCT01695135|19003276|P3|COMPLETED|Double-blind Treatment Phase||0
7717472|NCT01695135|19003277|P2|COMPLETED|Double-blind Treatment Phase||4
7717473|NCT01695135|19003278|P1|COMPLETED|Double-blind Treatment Phase||0
7717474|NCT01695135|19003275|P4|STARTED|Double-blind Treatment Phase||0
7717475|NCT01695135|19003276|P3|STARTED|Double-blind Treatment Phase||0
7717476|NCT01695135|19003277|P2|STARTED|Double-blind Treatment Phase||143
7717477|NCT01695135|19003278|P1|STARTED|Double-blind Treatment Phase||71
7717478|NCT01695044|19003302|P1|NOT COMPLETED|Overall Study||102
7717479|NCT01695044|19003302|P1|COMPLETED|Overall Study||17
7717480|NCT01695044|19003302|P1|STARTED|Overall Study||119
7717481|NCT01694966|19003315|P3|NOT COMPLETED|Overall Study||34
7717482|NCT01694966|19003316|P2|NOT COMPLETED|Overall Study||15
7717483|NCT01694966|19003317|P1|NOT COMPLETED|Overall Study||34
7717484|NCT01694966|19003315|P3|COMPLETED|Overall Study||464
7717485|NCT01694966|19003316|P2|COMPLETED|Overall Study||232
7717486|NCT01694966|19003317|P1|COMPLETED|Overall Study||470
7717487|NCT01694966|19003315|P3|STARTED|Overall Study||498
7717488|NCT01694966|19003316|P2|STARTED|Overall Study||247
7717489|NCT01694966|19003317|P1|STARTED|Overall Study||504
7717490|NCT01694771|19003327|P2|NOT COMPLETED|Overall Study||40
7717491|NCT01694771|19003328|P1|NOT COMPLETED|Overall Study||40
7717492|NCT01694771|19003327|P2|COMPLETED|Overall Study||525
7717493|NCT01694771|19003328|P1|COMPLETED|Overall Study||527
7717494|NCT01694771|19003327|P2|STARTED|Overall Study||565
7717496|NCT01694706|19003352|P3|NOT COMPLETED|Overall Study||0
7717497|NCT01694706|19003353|P2|NOT COMPLETED|Overall Study||1
7717498|NCT01694706|19003354|P1|NOT COMPLETED|Overall Study||1
7717499|NCT01694706|19003352|P3|COMPLETED|Overall Study||5
7717500|NCT01694706|19003353|P2|COMPLETED|Overall Study||4
7717501|NCT01694706|19003354|P1|COMPLETED|Overall Study||4
7717502|NCT01694706|19003352|P3|Received Faldaprevir Fed|Overall Study||5
7717503|NCT01694706|19003353|P2|Received Faldaprevir Fed|Overall Study||5
7717504|NCT01694706|19003354|P1|Received Faldaprevir Fed|Overall Study||4
7717505|NCT01694706|19003352|P3|Received Faldaprevir +OMP|Overall Study||5
7717506|NCT01694706|19003353|P2|Received Faldaprevir +OMP|Overall Study||5
7717507|NCT01694706|19003354|P1|Received Faldaprevir +OMP|Overall Study||5
7717508|NCT01694706|19003352|P3|Received Faldaprevir|Overall Study||5
7717509|NCT01694706|19003353|P2|Received Faldaprevir|Overall Study||5
7717510|NCT01694706|19003354|P1|Received Faldaprevir|Overall Study||5
7717511|NCT01694706|19003352|P3|STARTED|Overall Study||5
7717512|NCT01694706|19003353|P2|STARTED|Overall Study||5
7717513|NCT01694706|19003354|P1|STARTED|Overall Study||5
7717514|NCT01694667|19003371|P2|NOT COMPLETED|Overall Study||0
7717515|NCT01694667|19003372|P1|NOT COMPLETED|Overall Study||0
7717516|NCT01694667|19003371|P2|COMPLETED|Overall Study||28
7717517|NCT01694667|19003372|P1|COMPLETED|Overall Study||29
7717518|NCT01694667|19003371|P2|STARTED|Overall Study||28
7717519|NCT01694667|19003372|P1|STARTED|Overall Study||29
7717520|NCT01694641|19003392|P2|NOT COMPLETED|Overall Study||10
7717521|NCT01694641|19003393|P1|NOT COMPLETED|Overall Study||12
7717522|NCT01694641|19003392|P2|COMPLETED|Overall Study||71
7717523|NCT01694641|19003393|P1|COMPLETED|Overall Study||68
7717524|NCT01694641|19003392|P2|STARTED|Overall Study||81
7717525|NCT01694641|19003393|P1|STARTED|Overall Study||80
7717526|NCT01694563|19003401|P1|NOT COMPLETED|Overall Study||87
7717527|NCT01694563|19003401|P1|COMPLETED|Overall Study||278
7717528|NCT01694563|19003401|P1|STARTED|Overall Study||365
7717529|NCT01694485|19003413|P5|NOT COMPLETED|Overall Study||25
7717530|NCT01694485|19003414|P4|NOT COMPLETED|Overall Study||38
7717531|NCT01694485|19003415|P3|NOT COMPLETED|Overall Study||13
7717532|NCT01694485|19003416|P2|NOT COMPLETED|Overall Study||7
7717533|NCT01694485|19003417|P1|NOT COMPLETED|Overall Study||33
7717534|NCT01694485|19003413|P5|COMPLETED|Overall Study||55
7717535|NCT01694485|19003414|P4|COMPLETED|Overall Study||62
7717536|NCT01694485|19003415|P3|COMPLETED|Overall Study||27
7717537|NCT01694485|19003416|P2|COMPLETED|Overall Study||15
7717538|NCT01694485|19003417|P1|COMPLETED|Overall Study||84
7717539|NCT01694485|19003413|P5|Entered Open-label Period|Overall Study||68
7717540|NCT01694485|19003414|P4|Entered Open-label Period|Overall Study||88
7717541|NCT01694485|19003415|P3|Entered Open-label Period|Overall Study||36
7717542|NCT01694485|19003416|P2|Entered Open-label Period|Overall Study||19
7717543|NCT01694485|19003417|P1|Entered Open-label Period|Overall Study||100
7717544|NCT01694485|19003413|P5|Completed Week 8 Assessment|Overall Study||76
7717545|NCT01694485|19003414|P4|Completed Week 8 Assessment|Overall Study||94
7717546|NCT01694485|19003415|P3|Completed Week 8 Assessment|Overall Study||38
7717547|NCT01694485|19003416|P2|Completed Week 8 Assessment|Overall Study||18
7717548|NCT01694485|19003417|P1|Completed Week 8 Assessment|Overall Study||106
7717549|NCT01694485|19003413|P5|Received Treatment|Overall Study||79
7717550|NCT01694485|19003414|P4|Received Treatment|Overall Study||98
7717551|NCT01694485|19003415|P3|Received Treatment|Overall Study||40
7717552|NCT01694485|19003416|P2|Received Treatment|Overall Study||21
7717553|NCT01694485|19003417|P1|Received Treatment|Overall Study||116
7717554|NCT01694485|19003413|P5|STARTED|Overall Study||80
7717555|NCT01694485|19003414|P4|STARTED|Overall Study||100
7717556|NCT01694485|19003415|P3|STARTED|Overall Study||40
7717557|NCT01694485|19003416|P2|STARTED|Overall Study||22
7717558|NCT01694485|19003417|P1|STARTED|Overall Study||117
7717559|NCT01694433|19003451|P2|NOT COMPLETED|Overall Study||4
7717560|NCT01694433|19003452|P1|NOT COMPLETED|Overall Study||11
7717561|NCT01694433|19003451|P2|COMPLETED|Overall Study||29
7717562|NCT01694433|19003452|P1|COMPLETED|Overall Study||22
7717563|NCT01694433|19003451|P2|Baseline Visit|Overall Study||32
7717564|NCT01694433|19003452|P1|Baseline Visit|Overall Study||33
7717565|NCT01694433|19003451|P2|STARTED|Overall Study||33
7717566|NCT01694433|19003452|P1|STARTED|Overall Study||33
7717567|NCT01694420|19003460|P1|NOT COMPLETED|Overall Study||3
7717568|NCT01694420|19003460|P1|COMPLETED|Overall Study||30
7717569|NCT01694420|19003460|P1|STARTED|Overall Study||33
7717570|NCT01694199|19003471|P2|NOT COMPLETED|Overall Study||0
7717571|NCT01694199|19003472|P1|NOT COMPLETED|Overall Study||0
7717572|NCT01694199|19003471|P2|COMPLETED|Overall Study||68
7717573|NCT01694199|19003472|P1|COMPLETED|Overall Study||71
7717574|NCT01694199|19003471|P2|STARTED|Overall Study||68
7717575|NCT01694199|19003472|P1|STARTED|Overall Study||71
7717576|NCT01694186|19003488|P2|NOT COMPLETED|Overall Study||7
7717577|NCT01694186|19003489|P1|NOT COMPLETED|Overall Study||6
7717578|NCT01694186|19003488|P2|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|80
7717579|NCT01694186|19003489|P1|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|36
7717580|NCT01694186|19003488|P2|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|87
7717581|NCT01694186|19003489|P1|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|42
7717582|NCT01694121|19003497|P2|NOT COMPLETED|Overall Study||0
7717583|NCT01694121|19003498|P1|NOT COMPLETED|Overall Study||1
7717584|NCT01694121|19003497|P2|COMPLETED|Overall Study||227
7717585|NCT01694121|19003498|P1|COMPLETED|Overall Study||227
7717586|NCT01694121|19003497|P2|STARTED|Overall Study||227
7717587|NCT01694121|19003498|P1|STARTED|Overall Study||228
7717588|NCT01694108|19003512|P2|NOT COMPLETED|Overall Study||0
7717589|NCT01694108|19003513|P1|NOT COMPLETED|Overall Study||0
7717590|NCT01694108|19003512|P2|COMPLETED|Overall Study|100% follow-up|2133
7717591|NCT01694108|19003513|P1|COMPLETED|Overall Study|100% follow-up|2129
7717592|NCT01694108|19003512|P2|STARTED|Overall Study||2133
7717593|NCT01694108|19003513|P1|STARTED|Overall Study||2129
7717594|NCT01693900|19003569|P2|NOT COMPLETED|Overall Study||0
7717595|NCT01693900|19003570|P1|NOT COMPLETED|Overall Study||0
7717596|NCT01693900|19003569|P2|COMPLETED|Overall Study||25
7717597|NCT01693900|19003570|P1|COMPLETED|Overall Study||25
7717598|NCT01693900|19003569|P2|STARTED|Overall Study||25
7717599|NCT01693900|19003570|P1|STARTED|Overall Study||25
7717600|NCT01693653|19003584|P2|NOT COMPLETED|Overall Study||0
7717601|NCT01693653|19003585|P1|NOT COMPLETED|Overall Study||0
7717602|NCT01693653|19003584|P2|COMPLETED|Overall Study||0
7717603|NCT01693653|19003585|P1|COMPLETED|Overall Study||1
7717604|NCT01693653|19003584|P2|STARTED|Overall Study||0
7717605|NCT01693653|19003585|P1|STARTED|Overall Study||1
7717606|NCT01693614|19003612|P3|NOT COMPLETED|Overall Study||24
7717607|NCT01693614|19003613|P2|NOT COMPLETED|Overall Study||22
7717608|NCT01693614|19003614|P1|NOT COMPLETED|Overall Study||26
7717609|NCT01693614|19003612|P3|COMPLETED|Overall Study||0
7717610|NCT01693614|19003613|P2|COMPLETED|Overall Study||0
7717611|NCT01693614|19003614|P1|COMPLETED|Overall Study||0
7717612|NCT01693614|19003612|P3|STARTED|Overall Study||24
7717613|NCT01693614|19003613|P2|STARTED|Overall Study||22
7717614|NCT01693614|19003614|P1|STARTED|Overall Study||26
7717615|NCT01693523|19003639|P3|NOT COMPLETED|Overall Study||8
7717616|NCT01693523|19003640|P2|NOT COMPLETED|Overall Study||8
7717617|NCT01693523|19003641|P1|NOT COMPLETED|Overall Study||5
7717618|NCT01693523|19003639|P3|COMPLETED|Overall Study||27
7717619|NCT01693523|19003640|P2|COMPLETED|Overall Study||13
7717620|NCT01693523|19003641|P1|COMPLETED|Overall Study||18
7717621|NCT01693523|19003639|P3|STARTED|Overall Study||35
7717622|NCT01693523|19003640|P2|STARTED|Overall Study||21
7717623|NCT01693523|19003641|P1|STARTED|Overall Study||23
7717624|NCT01693484|19003651|P1|NOT COMPLETED|Overall Study||13
7717625|NCT01693484|19003651|P1|COMPLETED|Overall Study|Study closed by PI|0
7717626|NCT01693484|19003651|P1|STARTED|Overall Study||13
7717627|NCT01693367|19003657|P2|NOT COMPLETED|Overall Study||2
7717628|NCT01693367|19003658|P1|NOT COMPLETED|Overall Study||1
7717629|NCT01693367|19003657|P2|COMPLETED|Overall Study||1
7717630|NCT01693367|19003658|P1|COMPLETED|Overall Study||1
7717631|NCT01693367|19003657|P2|STARTED|Overall Study||3
7717632|NCT01693367|19003658|P1|STARTED|Overall Study||2
7717633|NCT01693250|19003676|P2|NOT COMPLETED|Overall Study||2
7717634|NCT01693250|19003677|P1|NOT COMPLETED|Overall Study||2
7717635|NCT01693250|19003676|P2|COMPLETED|Overall Study|15 teens completed 6 months post baseline assessment|15
7717636|NCT01693250|19003677|P1|COMPLETED|Overall Study|21 teens completed 6 months post baseline assessment|21
7717637|NCT01693250|19003676|P2|STARTED|Overall Study|three month post baseline assessment|17
7717638|NCT01693250|19003677|P1|STARTED|Overall Study|3 months post baseline assessment|23
7717639|NCT01693185|19003687|P2|NOT COMPLETED|Overall Study||6
7717640|NCT01693185|19003688|P1|NOT COMPLETED|Overall Study||0
7717641|NCT01693185|19003687|P2|COMPLETED|Overall Study||27
7717642|NCT01693185|19003688|P1|COMPLETED|Overall Study||27
7717643|NCT01693185|19003687|P2|STARTED|Overall Study||33
7717644|NCT01693185|19003688|P1|STARTED|Overall Study||27
7717645|NCT01693120|19003704|P1|NOT COMPLETED|Phased RF Study Procedure and Follow-up||17
7717646|NCT01693120|19003704|P1|COMPLETED|Phased RF Study Procedure and Follow-up|112 of the 129 subjects with a Phased RF procedure completed the 6-month follow-up visit|112
7717647|NCT01693120|19003704|P1|STARTED|Phased RF Study Procedure and Follow-up||129
7717648|NCT01693120|19003704|P1|NOT COMPLETED|Enrollment||70
7717649|NCT01693120|19003704|P1|COMPLETED|Enrollment|129 of the 199 enrolled subjects underwent a Phased RF study procedure|129
7717650|NCT01693120|19003704|P1|STARTED|Enrollment|70 subjects exited the study after consent, but prior to undergoing a study ablation procedure.|199
7717651|NCT01693068|19003713|P3|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||1
7717652|NCT01693068|19003714|P2|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
7717653|NCT01693068|19003715|P1|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
7717654|NCT01693068|19003713|P3|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||40
7717655|NCT01693068|19003714|P2|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
7717656|NCT01693068|19003715|P1|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
7717657|NCT01693068|19003713|P3|Treated|Cross-over (Dacarbazine To Pimasertib)||41
7717658|NCT01693068|19003714|P2|Treated|Cross-over (Dacarbazine To Pimasertib)||0
7717659|NCT01693068|19003715|P1|Treated|Cross-over (Dacarbazine To Pimasertib)||0
7717660|NCT01693068|19003713|P3|STARTED|Cross-over (Dacarbazine To Pimasertib)||41
7717661|NCT01693068|19003714|P2|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
7717662|NCT01693068|19003715|P1|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
7717663|NCT01693068|19003713|P3|NOT COMPLETED|Randomization Period||0
7717664|NCT01693068|19003714|P2|NOT COMPLETED|Randomization Period||5
7717665|NCT01693068|19003715|P1|NOT COMPLETED|Randomization Period||2
7717666|NCT01693068|19003713|P3|COMPLETED|Randomization Period||0
7717667|NCT01693068|19003714|P2|COMPLETED|Randomization Period||125
7717668|NCT01693068|19003715|P1|COMPLETED|Randomization Period||62
7717669|NCT01693068|19003713|P3|Treated|Randomization Period||0
7717670|NCT01693068|19003714|P2|Treated|Randomization Period||130
7717671|NCT01693068|19003715|P1|Treated|Randomization Period||61
7717672|NCT01693068|19003713|P3|STARTED|Randomization Period||0
7717673|NCT01693068|19003714|P2|STARTED|Randomization Period||130
7717674|NCT01693068|19003715|P1|STARTED|Randomization Period||64
7717675|NCT01693029|19003747|P2|NOT COMPLETED|Overall Study||57
7717676|NCT01693029|19003748|P1|NOT COMPLETED|Overall Study||44
7717677|NCT01693029|19003747|P2|COMPLETED|Overall Study||161
7717678|NCT01693029|19003748|P1|COMPLETED|Overall Study||173
7717679|NCT01693029|19003747|P2|STARTED|Overall Study||218
7717680|NCT01693029|19003748|P1|STARTED|Overall Study||217
7717681|NCT01692964|19003760|P1|NOT COMPLETED|Overall Study||0
7717682|NCT01692964|19003760|P1|COMPLETED|Overall Study||237
7717683|NCT01692964|19003760|P1|STARTED|Overall Study||237
7717684|NCT01692951|19003769|P4|NOT COMPLETED|Overall Study||0
7717685|NCT01692951|19003770|P3|NOT COMPLETED|Overall Study||0
7717686|NCT01692951|19003771|P2|NOT COMPLETED|Overall Study||0
7717687|NCT01692951|19003772|P1|NOT COMPLETED|Overall Study||0
7717688|NCT01692951|19003769|P4|COMPLETED|Overall Study||54
7717689|NCT01692951|19003770|P3|COMPLETED|Overall Study||18
7717690|NCT01692951|19003771|P2|COMPLETED|Overall Study||111
7717691|NCT01692951|19003772|P1|COMPLETED|Overall Study||37
7717692|NCT01692951|19003769|P4|STARTED|Overall Study||54
7717693|NCT01692951|19003770|P3|STARTED|Overall Study||18
7717694|NCT01692951|19003771|P2|STARTED|Overall Study||111
7717695|NCT01692951|19003772|P1|STARTED|Overall Study||37
7717696|NCT01692938|19003784|P2|NOT COMPLETED|Overall Study||4
7717697|NCT01692938|19003785|P1|NOT COMPLETED|Overall Study||4
7717698|NCT01692938|19003784|P2|COMPLETED|Overall Study||12
7717699|NCT01692938|19003785|P1|COMPLETED|Overall Study||12
7717700|NCT01692938|19003784|P2|STARTED|Overall Study||16
7717701|NCT01692938|19003785|P1|STARTED|Overall Study||16
7717702|NCT01692782|19003796|P3|NOT COMPLETED|Overall Study||10
7717703|NCT01692782|19003797|P2|NOT COMPLETED|Overall Study||56
7717704|NCT01692782|19003798|P1|NOT COMPLETED|Overall Study||20
7717705|NCT01692782|19003796|P3|COMPLETED|Overall Study||100
7717706|NCT01692782|19003797|P2|COMPLETED|Overall Study||59
7717707|NCT01692782|19003798|P1|COMPLETED|Overall Study||96
7717708|NCT01692782|19003796|P3|STARTED|Overall Study||110
7717709|NCT01692782|19003797|P2|STARTED|Overall Study||115
7717710|NCT01692782|19003798|P1|STARTED|Overall Study||116
7717711|NCT01692756|19003825|P4|NOT COMPLETED|Overall Study||0
7717712|NCT01692756|19003826|P3|NOT COMPLETED|Overall Study||2
7717713|NCT01692756|19003827|P2|NOT COMPLETED|Overall Study||1
7717714|NCT01692756|19003828|P1|NOT COMPLETED|Overall Study||1
7717715|NCT01692756|19003825|P4|COMPLETED|Overall Study||12
7717716|NCT01692756|19003826|P3|COMPLETED|Overall Study||11
7717717|NCT01692756|19003827|P2|COMPLETED|Overall Study||11
7717718|NCT01692756|19003828|P1|COMPLETED|Overall Study||11
7717719|NCT01692756|19003825|P4|STARTED|Overall Study||12
7717720|NCT01692756|19003826|P3|STARTED|Overall Study||13
7717721|NCT01692756|19003827|P2|STARTED|Overall Study||12
7717722|NCT01692756|19003828|P1|STARTED|Overall Study||12
7717723|NCT01692743|19003889|P3|NOT COMPLETED|Overall Study||27
7717724|NCT01692743|19003890|P2|NOT COMPLETED|Overall Study||35
7717725|NCT01692743|19003891|P1|NOT COMPLETED|Overall Study||27
7717726|NCT01692743|19003889|P3|COMPLETED|Overall Study||88
7717727|NCT01692743|19003890|P2|COMPLETED|Overall Study||81
7717728|NCT01692743|19003891|P1|COMPLETED|Overall Study||90
7717729|NCT01692743|19003889|P3|STARTED|Overall Study||115
7717730|NCT01692743|19003890|P2|STARTED|Overall Study||116
7717731|NCT01692743|19003891|P1|STARTED|Overall Study||117
7717732|NCT01692730|19003907|P2|NOT COMPLETED|Overall Study||227
7717733|NCT01692730|19003908|P1|NOT COMPLETED|Overall Study||225
7717734|NCT01692730|19003907|P2|COMPLETED|Overall Study||502
7717735|NCT01692730|19003908|P1|COMPLETED|Overall Study||498
7717736|NCT01692730|19003907|P2|STARTED|Overall Study||729
7717737|NCT01692730|19003908|P1|STARTED|Overall Study||723
7717738|NCT01692691|19003916|P1|NOT COMPLETED|Overall Study||0
7717739|NCT01692691|19003916|P1|COMPLETED|Overall Study||1
7717740|NCT01692691|19003916|P1|STARTED|Overall Study||1
7717741|NCT01692626|19003922|P2|NOT COMPLETED|Overall Study||6
7717742|NCT01692626|19003923|P1|NOT COMPLETED|Overall Study||4
7717743|NCT01692626|19003922|P2|COMPLETED|Overall Study||1
7717744|NCT01692626|19003923|P1|COMPLETED|Overall Study||2
7717745|NCT01692626|19003922|P2|STARTED|Overall Study||7
7717746|NCT01692626|19003923|P1|STARTED|Overall Study||6
7717747|NCT01692496|19003928|P1|NOT COMPLETED|Overall Study||0
7717748|NCT01692496|19003928|P1|COMPLETED|Overall Study||52
7717749|NCT01692496|19003928|P1|3 Weeks Pazopanib (Per Protocol PP)|Overall Study||50
7717750|NCT01692496|19003928|P1|STARTED|Overall Study||52
7717751|NCT01692340|19003941|P3|NOT COMPLETED|Overall Study||0
7717752|NCT01692340|19003942|P2|NOT COMPLETED|Overall Study||0
7717753|NCT01692340|19003943|P1|NOT COMPLETED|Overall Study||0
7717754|NCT01692340|19003941|P3|COMPLETED|Overall Study||0
7717755|NCT01692340|19003942|P2|COMPLETED|Overall Study||4
7717756|NCT01692340|19003943|P1|COMPLETED|Overall Study||8
7717757|NCT01692340|19003941|P3|STARTED|Overall Study||0
7717758|NCT01692340|19003942|P2|STARTED|Overall Study||4
7717759|NCT01692340|19003943|P1|STARTED|Overall Study||8
7717760|NCT01692301|19003958|P2|NOT COMPLETED|Overall Study||42
7717761|NCT01692301|19003959|P1|NOT COMPLETED|Overall Study||45
7717762|NCT01692301|19003958|P2|COMPLETED|Overall Study||183
7717763|NCT01692301|19003959|P1|COMPLETED|Overall Study||184
7717764|NCT01692301|19003958|P2|STARTED|Overall Study||225
7717857|NCT01691768|19004358|P2|STARTED|Overall Study||183
7717765|NCT01692301|19003959|P1|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229
7717766|NCT01692275|19003991|P2|NOT COMPLETED|Overall Study||59
7717767|NCT01692275|19003992|P1|NOT COMPLETED|Overall Study||66
7717768|NCT01692275|19003991|P2|COMPLETED|Overall Study||316
7717769|NCT01692275|19003992|P1|COMPLETED|Overall Study||309
7717770|NCT01692275|19003991|P2|STARTED|Overall Study||375
7717771|NCT01692275|19003992|P1|STARTED|Overall Study||375
7717772|NCT01692197|19004052|P1|NOT COMPLETED|Overall Study||3
7717773|NCT01692197|19004052|P1|COMPLETED|Overall Study||40
7717774|NCT01692197|19004052|P1|STARTED|Overall Study||43
7717775|NCT01691950|19004061|P2|NOT COMPLETED|Overall Study||0
7717776|NCT01691950|19004062|P1|NOT COMPLETED|Overall Study||10
7717777|NCT01691950|19004061|P2|COMPLETED|Overall Study||10
7717778|NCT01691950|19004062|P1|COMPLETED|Overall Study||10
7717779|NCT01691950|19004061|P2|STARTED|Overall Study||10
7717780|NCT01691950|19004062|P1|STARTED|Overall Study||20
7717781|NCT01691898|19004074|P6|NOT COMPLETED|Overall Study||35
7717782|NCT01691898|19004075|P5|NOT COMPLETED|Overall Study||14
7717783|NCT01691898|19004076|P4|NOT COMPLETED|Overall Study||5
7717784|NCT01691898|19004077|P3|NOT COMPLETED|Overall Study||9
7717785|NCT01691898|19004078|P2|NOT COMPLETED|Overall Study||44
7717786|NCT01691898|19004079|P1|NOT COMPLETED|Overall Study||47
7717787|NCT01691898|19004074|P6|COMPLETED|Overall Study||5
7717788|NCT01691898|19004075|P5|COMPLETED|Overall Study||26
7717789|NCT01691898|19004076|P4|COMPLETED|Overall Study||4
7717790|NCT01691898|19004077|P3|COMPLETED|Overall Study||11
7717791|NCT01691898|19004078|P2|COMPLETED|Overall Study||15
7717792|NCT01691898|19004079|P1|COMPLETED|Overall Study||16
7717793|NCT01691898|19004074|P6|STARTED|Overall Study||40
7717794|NCT01691898|19004075|P5|STARTED|Overall Study||40
7717795|NCT01691898|19004076|P4|STARTED|Overall Study||9
7717796|NCT01691898|19004077|P3|STARTED|Overall Study||20
7717797|NCT01691898|19004078|P2|STARTED|Overall Study||59
7717798|NCT01691898|19004079|P1|STARTED|Overall Study||63
7717799|NCT01691885|19004233|P2|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
7717800|NCT01691885|19004234|P1|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
7717801|NCT01691885|19004233|P2|COMPLETED|Treatment Period 2 (7-14 Days)||21
7717802|NCT01691885|19004234|P1|COMPLETED|Treatment Period 2 (7-14 Days)||21
7717803|NCT01691885|19004233|P2|STARTED|Treatment Period 2 (7-14 Days)||21
7717804|NCT01691885|19004234|P1|STARTED|Treatment Period 2 (7-14 Days)||21
7717805|NCT01691885|19004233|P2|NOT COMPLETED|Washout Period (7-9 Days)||1
7717806|NCT01691885|19004234|P1|NOT COMPLETED|Washout Period (7-9 Days)||0
7717807|NCT01691885|19004233|P2|COMPLETED|Washout Period (7-9 Days)||21
7717808|NCT01691885|19004234|P1|COMPLETED|Washout Period (7-9 Days)||21
7717809|NCT01691885|19004233|P2|STARTED|Washout Period (7-9 Days)||22
7717810|NCT01691885|19004234|P1|STARTED|Washout Period (7-9 Days)||21
7717811|NCT01691885|19004233|P2|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
7717812|NCT01691885|19004234|P1|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
7717813|NCT01691885|19004233|P2|COMPLETED|Treatment Period 1(7-14 Days)||22
7717814|NCT01691885|19004234|P1|COMPLETED|Treatment Period 1(7-14 Days)||21
7717815|NCT01691885|19004233|P2|STARTED|Treatment Period 1(7-14 Days)||23
7717816|NCT01691885|19004234|P1|STARTED|Treatment Period 1(7-14 Days)||22
7717817|NCT01691859|19004240|P1|NOT COMPLETED|Overall Study||347
7717818|NCT01691859|19004240|P1|COMPLETED|Overall Study||0
7717819|NCT01691859|19004240|P1|STARTED|Overall Study||347
7717820|NCT01691833|19004262|P3|NOT COMPLETED|Overall Study||0
7717821|NCT01691833|19004263|P2|NOT COMPLETED|Overall Study||1
7717822|NCT01691833|19004264|P1|NOT COMPLETED|Overall Study||1
7717823|NCT01691833|19004262|P3|COMPLETED|Overall Study||13
7717824|NCT01691833|19004263|P2|COMPLETED|Overall Study||49
7717825|NCT01691833|19004264|P1|COMPLETED|Overall Study||49
7717826|NCT01691833|19004262|P3|STARTED|Overall Study||13
7717827|NCT01691833|19004263|P2|STARTED|Overall Study||50
7717828|NCT01691833|19004264|P1|STARTED|Overall Study||50
7717829|NCT01691820|19004287|P3|NOT COMPLETED|Overall Study||1
7717830|NCT01691820|19004288|P2|NOT COMPLETED|Overall Study||34
7717831|NCT01691820|19004289|P1|NOT COMPLETED|Overall Study||29
7717832|NCT01691820|19004287|P3|COMPLETED|Overall Study||2
7717833|NCT01691820|19004288|P2|COMPLETED|Overall Study||110
7717834|NCT01691820|19004289|P1|COMPLETED|Overall Study||187
7717835|NCT01691820|19004287|P3|STARTED|Overall Study||3
7717836|NCT01691820|19004288|P2|STARTED|Overall Study||144
7717837|NCT01691820|19004289|P1|STARTED|Overall Study||216
7717838|NCT01691794|19004327|P3|NOT COMPLETED|Overall Study||10
7717839|NCT01691794|19004328|P2|NOT COMPLETED|Overall Study||18
7717840|NCT01691794|19004329|P1|NOT COMPLETED|Overall Study||1
7717841|NCT01691794|19004327|P3|COMPLETED|Overall Study|Completed baseline to End of Study|13
7717842|NCT01691794|19004328|P2|COMPLETED|Overall Study|Completed baseline to End of Study|15
7717843|NCT01691794|19004329|P1|COMPLETED|Overall Study|Completed baseline to End of Study|2
7717844|NCT01691794|19004327|P3|STARTED|Overall Study||23
7717845|NCT01691794|19004328|P2|STARTED|Overall Study||33
7717846|NCT01691794|19004329|P1|STARTED|Overall Study||3
7717847|NCT01691781|19004345|P2|NOT COMPLETED|Overall Study||7
7717848|NCT01691781|19004346|P1|NOT COMPLETED|Overall Study||7
7717849|NCT01691781|19004345|P2|COMPLETED|Overall Study||15
7717850|NCT01691781|19004346|P1|COMPLETED|Overall Study||12
7717851|NCT01691781|19004345|P2|STARTED|Overall Study||22
7717852|NCT01691781|19004346|P1|STARTED|Overall Study||19
7717853|NCT01691768|19004358|P2|NOT COMPLETED|Overall Study||16
7717854|NCT01691768|19004359|P1|NOT COMPLETED|Overall Study||15
7717855|NCT01691768|19004358|P2|COMPLETED|Overall Study||167
7717856|NCT01691768|19004359|P1|COMPLETED|Overall Study||174
7717858|NCT01691768|19004359|P1|STARTED|Overall Study||189
7717859|NCT01691690|19004383|P2|NOT COMPLETED|Overall Study||4
7717860|NCT01691690|19004384|P1|NOT COMPLETED|Overall Study||7
7717861|NCT01691690|19004383|P2|COMPLETED|Overall Study||121
7717862|NCT01691690|19004384|P1|COMPLETED|Overall Study||118
7717863|NCT01691690|19004383|P2|STARTED|Overall Study||125
7717864|NCT01691690|19004384|P1|STARTED|Overall Study||125
7717865|NCT01691612|19004394|P1|NOT COMPLETED|Overall Study||7
7717866|NCT01691612|19004394|P1|COMPLETED|Overall Study||7
7717867|NCT01691612|19004394|P1|Second Visit (Bronchoscopy)|Overall Study||7
7717868|NCT01691612|19004394|P1|First Visit (Allergen Challenge)|Overall Study||8
7717869|NCT01691612|19004394|P1|STARTED|Overall Study||14
7717870|NCT01691560|19004405|P4|NOT COMPLETED|Overall Study||0
7717871|NCT01691560|19004406|P3|NOT COMPLETED|Overall Study||0
7717872|NCT01691560|19004407|P2|NOT COMPLETED|Overall Study||0
7717873|NCT01691560|19004408|P1|NOT COMPLETED|Overall Study||0
7717874|NCT01691560|19004405|P4|COMPLETED|Overall Study||33
7717875|NCT01691560|19004406|P3|COMPLETED|Overall Study||34
7717876|NCT01691560|19004407|P2|COMPLETED|Overall Study||33
7717877|NCT01691560|19004408|P1|COMPLETED|Overall Study||34
7717878|NCT01691560|19004405|P4|STARTED|Overall Study||33
7717879|NCT01691560|19004406|P3|STARTED|Overall Study||34
7717880|NCT01691560|19004407|P2|STARTED|Overall Study||33
7717881|NCT01691560|19004408|P1|STARTED|Overall Study||34
7717882|NCT01691534|19004445|P7|NOT COMPLETED|Overall Study||1
7717883|NCT01691534|19004446|P6|NOT COMPLETED|Overall Study||1
7717884|NCT01691534|19004447|P5|NOT COMPLETED|Overall Study||0
7717885|NCT01691534|19004448|P4|NOT COMPLETED|Overall Study||1
7717886|NCT01691534|19004449|P3|NOT COMPLETED|Overall Study||1
7717887|NCT01691534|19004450|P2|NOT COMPLETED|Overall Study||1
7717888|NCT01691534|19004451|P1|NOT COMPLETED|Overall Study||0
7717889|NCT01691534|19004445|P7|COMPLETED|Overall Study||14
7717890|NCT01691534|19004446|P6|COMPLETED|Overall Study||14
7717891|NCT01691534|19004447|P5|COMPLETED|Overall Study||15
7717892|NCT01691534|19004448|P4|COMPLETED|Overall Study||14
7717893|NCT01691534|19004449|P3|COMPLETED|Overall Study||14
7717894|NCT01691534|19004450|P2|COMPLETED|Overall Study||14
7717895|NCT01691534|19004451|P1|COMPLETED|Overall Study||15
7717896|NCT01691534|19004445|P7|STARTED|Overall Study||15
7717897|NCT01691534|19004446|P6|STARTED|Overall Study||15
7717898|NCT01691534|19004447|P5|STARTED|Overall Study||15
7717899|NCT01691534|19004448|P4|STARTED|Overall Study||15
7717900|NCT01691534|19004449|P3|STARTED|Overall Study||15
7717901|NCT01691534|19004450|P2|STARTED|Overall Study||15
7717902|NCT01691534|19004451|P1|STARTED|Overall Study||15
7717903|NCT01691521|19004505|P3|NOT COMPLETED|Overall Study||9
7717904|NCT01691521|19004506|P2|NOT COMPLETED|Overall Study||16
7717905|NCT01691521|19004507|P1|NOT COMPLETED|Overall Study||12
7717906|NCT01691521|19004505|P3|COMPLETED|Overall Study||185
7717907|NCT01691521|19004506|P2|COMPLETED|Overall Study||175
7717908|NCT01691521|19004507|P1|COMPLETED|Overall Study||179
7717909|NCT01691521|19004505|P3|STARTED|Overall Study||194
7717910|NCT01691521|19004506|P2|STARTED|Overall Study||191
7717911|NCT01691521|19004507|P1|STARTED|Overall Study||191
7717912|NCT01691508|19004529|P2|NOT COMPLETED|Overall Study||3
7717913|NCT01691508|19004530|P1|NOT COMPLETED|Overall Study||4
7717914|NCT01691508|19004529|P2|COMPLETED|Overall Study||66
7717915|NCT01691508|19004530|P1|COMPLETED|Overall Study||62
7717916|NCT01691508|19004529|P2|STARTED|Overall Study||69
7717917|NCT01691508|19004530|P1|STARTED|Overall Study||66
7717918|NCT01691482|19004544|P2|NOT COMPLETED|Treatment Period 2||2
7717919|NCT01691482|19004545|P1|NOT COMPLETED|Treatment Period 2||1
7717920|NCT01691482|19004544|P2|COMPLETED|Treatment Period 2||26
7717921|NCT01691482|19004545|P1|COMPLETED|Treatment Period 2||27
7717922|NCT01691482|19004544|P2|STARTED|Treatment Period 2||28
7717923|NCT01691482|19004545|P1|STARTED|Treatment Period 2||28
7717924|NCT01691482|19004544|P2|NOT COMPLETED|Treatment Period 1||0
7717925|NCT01691482|19004545|P1|NOT COMPLETED|Treatment Period 1||0
7717926|NCT01691482|19004544|P2|COMPLETED|Treatment Period 1||28
7717927|NCT01691482|19004545|P1|COMPLETED|Treatment Period 1||28
7717928|NCT01691482|19004544|P2|STARTED|Treatment Period 1||28
7717929|NCT01691482|19004545|P1|STARTED|Treatment Period 1||28
7717930|NCT01691430|19004563|P2|NOT COMPLETED|Overall Study||20
7717931|NCT01691430|19004564|P1|NOT COMPLETED|Overall Study||22
7717932|NCT01691430|19004563|P2|COMPLETED|Overall Study||73
7717933|NCT01691430|19004564|P1|COMPLETED|Overall Study||70
7717934|NCT01691430|19004563|P2|Received Medication|Overall Study||93
7717935|NCT01691430|19004564|P1|Received Medication|Overall Study||92
7717936|NCT01691430|19004563|P2|STARTED|Overall Study||93
7717937|NCT01691430|19004564|P1|STARTED|Overall Study||92
7717938|NCT01691378|19004590|P2|NOT COMPLETED|Overall Study||2
7717939|NCT01691378|19004591|P1|NOT COMPLETED|Overall Study||7
7717940|NCT01691378|19004590|P2|COMPLETED|Overall Study||20
7717941|NCT01691378|19004591|P1|COMPLETED|Overall Study||15
7717942|NCT01691378|19004590|P2|STARTED|Overall Study||22
7717943|NCT01691378|19004591|P1|STARTED|Overall Study||22
7717944|NCT01691339|19004605|P4|NOT COMPLETED|Overall Study||0
7717945|NCT01691339|19004606|P3|NOT COMPLETED|Overall Study||0
7717946|NCT01691339|19004607|P2|NOT COMPLETED|Overall Study||0
7717947|NCT01691339|19004608|P1|NOT COMPLETED|Overall Study||0
7717948|NCT01691339|19004605|P4|COMPLETED|Overall Study||49
7717949|NCT01691339|19004606|P3|COMPLETED|Overall Study||51
7717950|NCT01691339|19004607|P2|COMPLETED|Overall Study||50
7717951|NCT01691339|19004608|P1|COMPLETED|Overall Study||50
7717952|NCT01691339|19004605|P4|STARTED|Overall Study||49
7717953|NCT01691339|19004606|P3|STARTED|Overall Study||51
7717954|NCT01691339|19004607|P2|STARTED|Overall Study||50
7717955|NCT01691339|19004608|P1|STARTED|Overall Study||50
7717956|NCT01691326|19004636|P2|NOT COMPLETED|Overall Study||0
7717957|NCT01691326|19004637|P1|NOT COMPLETED|Overall Study||0
7717958|NCT01691326|19004636|P2|COMPLETED|Overall Study||30
7717959|NCT01691326|19004637|P1|COMPLETED|Overall Study||30
7717960|NCT01691326|19004636|P2|STARTED|Overall Study||30
7717961|NCT01691326|19004637|P1|STARTED|Overall Study||30
7717962|NCT01691313|19004655|P4|NOT COMPLETED|Overall Study||0
7717963|NCT01691313|19004656|P3|NOT COMPLETED|Overall Study||0
7717964|NCT01691313|19004657|P2|NOT COMPLETED|Overall Study||0
7717965|NCT01691313|19004658|P1|NOT COMPLETED|Overall Study||0
7717966|NCT01691313|19004655|P4|COMPLETED|Overall Study||25
7717967|NCT01691313|19004656|P3|COMPLETED|Overall Study||25
7717968|NCT01691313|19004657|P2|COMPLETED|Overall Study||32
7717969|NCT01691313|19004658|P1|COMPLETED|Overall Study||22
7717970|NCT01691313|19004655|P4|STARTED|Overall Study||25
7717971|NCT01691313|19004656|P3|STARTED|Overall Study||25
7717972|NCT01691313|19004657|P2|STARTED|Overall Study||32
7717973|NCT01691313|19004658|P1|STARTED|Overall Study||22
7717974|NCT01691248|19004674|P2|NOT COMPLETED|Overall Study||114
7717975|NCT01691248|19004675|P1|NOT COMPLETED|Overall Study||111
7717976|NCT01691248|19004674|P2|COMPLETED|Overall Study||192
7717977|NCT01691248|19004675|P1|COMPLETED|Overall Study||194
7717978|NCT01691248|19004674|P2|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
7717979|NCT01691248|19004675|P1|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
7717980|NCT01691248|19004674|P2|Treated|Overall Study|Received at least 1 dose of study drug|299
7717981|NCT01691248|19004675|P1|Treated|Overall Study|Received at least 1 dose of study drug|301
7717982|NCT01691248|19004674|P2|STARTED|Overall Study|Randomized|306
7717983|NCT01691248|19004675|P1|STARTED|Overall Study|Randomized|305
7717984|NCT01691105|19004687|P2|NOT COMPLETED|12 Month Biochemical Verification||502
7717985|NCT01691105|19004688|P1|NOT COMPLETED|12 Month Biochemical Verification||424
7717986|NCT01691105|19004687|P2|COMPLETED|12 Month Biochemical Verification||65
7717987|NCT01691105|19004688|P1|COMPLETED|12 Month Biochemical Verification||53
7717988|NCT01691105|19004687|P2|STARTED|12 Month Biochemical Verification||567
7717989|NCT01691105|19004688|P1|STARTED|12 Month Biochemical Verification||477
7717990|NCT01691105|19004687|P2|NOT COMPLETED|12 Month Follow-up||101
7717991|NCT01691105|19004688|P1|NOT COMPLETED|12 Month Follow-up||72
7717992|NCT01691105|19004687|P2|COMPLETED|12 Month Follow-up||466
7717993|NCT01691105|19004688|P1|COMPLETED|12 Month Follow-up||405
7717994|NCT01691105|19004687|P2|STARTED|12 Month Follow-up||567
7717995|NCT01691105|19004688|P1|STARTED|12 Month Follow-up||477
7717996|NCT01691105|19004687|P2|NOT COMPLETED|6 Month Follow-up||71
7717997|NCT01691105|19004688|P1|NOT COMPLETED|6 Month Follow-up||52
7717998|NCT01691105|19004687|P2|COMPLETED|6 Month Follow-up||496
7717999|NCT01691105|19004688|P1|COMPLETED|6 Month Follow-up||425
7718000|NCT01691105|19004687|P2|STARTED|6 Month Follow-up||567
7718001|NCT01691105|19004688|P1|STARTED|6 Month Follow-up||477
7718002|NCT01691105|19004687|P2|NOT COMPLETED|1 Month Follow-up||41
7718003|NCT01691105|19004688|P1|NOT COMPLETED|1 Month Follow-up||43
7718004|NCT01691105|19004687|P2|COMPLETED|1 Month Follow-up||526
7718005|NCT01691105|19004688|P1|COMPLETED|1 Month Follow-up||434
7718006|NCT01691105|19004687|P2|STARTED|1 Month Follow-up||567
7718007|NCT01691105|19004688|P1|STARTED|1 Month Follow-up||477
7718008|NCT01691105|19004687|P2|NOT COMPLETED|Baseline||0
7718009|NCT01691105|19004688|P1|NOT COMPLETED|Baseline||0
7718010|NCT01691105|19004687|P2|COMPLETED|Baseline||567
7718011|NCT01691105|19004688|P1|COMPLETED|Baseline||477
7718012|NCT01691105|19004687|P2|STARTED|Baseline||567
7718013|NCT01691105|19004688|P1|STARTED|Baseline||477
7718014|NCT01691092|19004708|P1|NOT COMPLETED|Overall Study||41
7718015|NCT01691092|19004708|P1|COMPLETED|Overall Study||38
7718016|NCT01691092|19004708|P1|STARTED|Overall Study||79
7718017|NCT01691079|19004714|P2|NOT COMPLETED|Overall Study||0
7718018|NCT01691079|19004715|P1|NOT COMPLETED|Overall Study||0
7718019|NCT01691079|19004714|P2|COMPLETED|Overall Study||0
7718020|NCT01691079|19004715|P1|COMPLETED|Overall Study||0
7718021|NCT01691079|19004714|P2|STARTED|Overall Study||0
7718022|NCT01691079|19004715|P1|STARTED|Overall Study||0
7718023|NCT01691027|19004723|P1|NOT COMPLETED|Video Games Training||0
7718024|NCT01691027|19004723|P1|COMPLETED|Video Games Training|Four subjects were able to complete video games training module|4
7718025|NCT01691027|19004723|P1|STARTED|Video Games Training|Four subjects started video game training module|4
7718026|NCT01691027|19004723|P1|NOT COMPLETED|Line and Circle Tracing Training||0
7718027|NCT01691027|19004723|P1|COMPLETED|Line and Circle Tracing Training|Four subjects were able to complete line and circle tracing training module.|4
7718028|NCT01691027|19004723|P1|STARTED|Line and Circle Tracing Training|Four subjects started line and circle tracing training module|4
7718029|NCT01691027|19004723|P1|NOT COMPLETED|Scotoma Awareness||0
7718030|NCT01691027|19004723|P1|COMPLETED|Scotoma Awareness|Four subjects were able to complete scotoma awareness training module|4
7718031|NCT01691027|19004723|P1|STARTED|Scotoma Awareness|Four subjects started scotoma awareness training module|4
7718032|NCT01691014|19004732|P4|NOT COMPLETED|Overall Study||5
7718033|NCT01691014|19004733|P3|NOT COMPLETED|Overall Study||11
7718034|NCT01691014|19004734|P2|NOT COMPLETED|Overall Study||15
7718035|NCT01691014|19004735|P1|NOT COMPLETED|Overall Study||3
7718036|NCT01691014|19004732|P4|COMPLETED|Overall Study||4
7718037|NCT01691014|19004733|P3|COMPLETED|Overall Study||25
7718038|NCT01691014|19004734|P2|COMPLETED|Overall Study||11
7718039|NCT01691014|19004735|P1|COMPLETED|Overall Study||5
7718040|NCT01691014|19004732|P4|STARTED|Overall Study||9
7718041|NCT01691014|19004733|P3|STARTED|Overall Study||36
7718042|NCT01691014|19004734|P2|STARTED|Overall Study||26
7718043|NCT01691014|19004735|P1|STARTED|Overall Study||8
7718044|NCT01690988|19004780|P3|NOT COMPLETED|Overall Study||7
7718045|NCT01690988|19004781|P2|NOT COMPLETED|Overall Study||5
7718046|NCT01690988|19004782|P1|NOT COMPLETED|Overall Study||6
7718047|NCT01690988|19004780|P3|COMPLETED|Overall Study||216
7718048|NCT01690988|19004781|P2|COMPLETED|Overall Study||217
7718049|NCT01690988|19004782|P1|COMPLETED|Overall Study||221
7718050|NCT01690988|19004780|P3|STARTED|Overall Study||223
7718051|NCT01690988|19004781|P2|STARTED|Overall Study||222
7718052|NCT01690988|19004782|P1|STARTED|Overall Study||227
7718053|NCT01690923|19004807|P2|NOT COMPLETED|Overall Study||1
7718054|NCT01690923|19004808|P1|NOT COMPLETED|Overall Study||0
7718055|NCT01690923|19004807|P2|COMPLETED|Overall Study||10
7718056|NCT01690923|19004808|P1|COMPLETED|Overall Study||10
7718057|NCT01690923|19004807|P2|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11
7718058|NCT01690923|19004808|P1|STARTED|Overall Study||10
7718059|NCT01690663|19004817|P4|NOT COMPLETED|Overall Study||4
7718060|NCT01690663|19004818|P3|NOT COMPLETED|Overall Study||3
7718061|NCT01690663|19004819|P2|NOT COMPLETED|Overall Study||3
7718062|NCT01690663|19004820|P1|NOT COMPLETED|Overall Study||3
7718063|NCT01690663|19004817|P4|COMPLETED|Overall Study||20
7718064|NCT01690663|19004818|P3|COMPLETED|Overall Study||19
7718065|NCT01690663|19004819|P2|COMPLETED|Overall Study||17
7718066|NCT01690663|19004820|P1|COMPLETED|Overall Study||20
7718067|NCT01690663|19004817|P4|STARTED|Overall Study||24
7718068|NCT01690663|19004818|P3|STARTED|Overall Study||22
7718069|NCT01690663|19004819|P2|STARTED|Overall Study||20
7718070|NCT01690663|19004820|P1|STARTED|Overall Study||23
7718071|NCT01690546|19004834|P1|NOT COMPLETED|Overall Study||9
7718072|NCT01690546|19004834|P1|COMPLETED|Overall Study||26
7718073|NCT01690546|19004834|P1|Extended Release Injectable NTX|Overall Study||27
7718074|NCT01690546|19004834|P1|STARTED|Overall Study||35
7718075|NCT01690299|19004850|P6|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30
7718076|NCT01690299|19004851|P5|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33
7718077|NCT01690299|19004852|P4|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26
7718078|NCT01690299|19004853|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
7718079|NCT01690299|19004854|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
7718080|NCT01690299|19004855|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
7718081|NCT01690299|19004850|P6|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50
7718082|NCT01690299|19004851|P5|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41
7718083|NCT01690299|19004852|P4|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47
7718084|NCT01690299|19004853|P3|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
7718085|NCT01690299|19004854|P2|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
7718086|NCT01690299|19004855|P1|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
7718087|NCT01690299|19004850|P6|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|79
7718088|NCT01690299|19004851|P5|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|74
7718089|NCT01690299|19004852|P4|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|73
7718090|NCT01690299|19004853|P3|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
7718091|NCT01690299|19004854|P2|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
7718092|NCT01690299|19004855|P1|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
7718093|NCT01690299|19004850|P6|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|80
7718094|NCT01690299|19004851|P5|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|74
7718095|NCT01690299|19004852|P4|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|73
7718096|NCT01690299|19004853|P3|STARTED|Apremilast Extension Phase (Weeks16-104)||0
7718097|NCT01690299|19004854|P2|STARTED|Apremilast Extension Phase (Weeks16-104)||0
7718098|NCT01690299|19004855|P1|STARTED|Apremilast Extension Phase (Weeks16-104)||0
7718099|NCT01690299|19004850|P6|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
7718100|NCT01690299|19004851|P5|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
7718101|NCT01690299|19004852|P4|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
7718102|NCT01690299|19004853|P3|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2
7718103|NCT01690299|19004854|P2|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6
7718104|NCT01690299|19004855|P1|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9
7718105|NCT01690299|19004850|P6|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
7718106|NCT01690299|19004851|P5|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
7718107|NCT01690299|19004852|P4|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
7718108|NCT01690299|19004853|P3|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81
7718109|NCT01690299|19004854|P2|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77
7718110|NCT01690299|19004855|P1|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75
7718111|NCT01690299|19004850|P6|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
7718112|NCT01690299|19004851|P5|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
7718113|NCT01690299|19004852|P4|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
7718114|NCT01690299|19004853|P3|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
7718115|NCT01690299|19004854|P2|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
7718116|NCT01690299|19004855|P1|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|84
7718117|NCT01690299|19004850|P6|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
7718118|NCT01690299|19004851|P5|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
7718119|NCT01690299|19004852|P4|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
7718120|NCT01690299|19004853|P3|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
7718121|NCT01690299|19004854|P2|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
7718122|NCT01690299|19004855|P1|STARTED|Placebo-controlled Phase (Weeks 0-16)||84
7718123|NCT01690273|19004900|P3|NOT COMPLETED|Overall Study||0
7718124|NCT01690273|19004901|P2|NOT COMPLETED|Overall Study||0
7718125|NCT01690273|19004902|P1|NOT COMPLETED|Overall Study||0
7718126|NCT01690273|19004900|P3|COMPLETED|Overall Study||20
7718127|NCT01690273|19004901|P2|COMPLETED|Overall Study||17
7718128|NCT01690273|19004902|P1|COMPLETED|Overall Study||18
7718129|NCT01690273|19004900|P3|STARTED|Overall Study||20
7718130|NCT01690273|19004901|P2|STARTED|Overall Study||17
7718131|NCT01690273|19004902|P1|STARTED|Overall Study||18
7718132|NCT01690143|19004952|P1|NOT COMPLETED|Overall Study||1
7718133|NCT01690143|19004952|P1|COMPLETED|Overall Study||44
7718134|NCT01690143|19004952|P1|STARTED|Overall Study||45
7718135|NCT01690130|19004962|P2|NOT COMPLETED|Overall Study||0
7718136|NCT01690130|19004963|P1|NOT COMPLETED|Overall Study||1
7718137|NCT01690130|19004962|P2|COMPLETED|Overall Study||9
7718138|NCT01690130|19004963|P1|COMPLETED|Overall Study||9
7718139|NCT01690130|19004962|P2|STARTED|Overall Study||9
7718140|NCT01690130|19004963|P1|STARTED|Overall Study||10
7718141|NCT01690117|19004973|P2|NOT COMPLETED|Overall Study||14
7718142|NCT01690117|19004974|P1|NOT COMPLETED|Overall Study||16
7718143|NCT01690117|19004973|P2|COMPLETED|Overall Study||31
7718144|NCT01690117|19004974|P1|COMPLETED|Overall Study||31
7718145|NCT01690117|19004973|P2|Post-Measurement|Overall Study||40
7718146|NCT01690117|19004974|P1|Post-Measurement|Overall Study||41
7718147|NCT01690117|19004973|P2|STARTED|Overall Study||45
7718148|NCT01690117|19004974|P1|STARTED|Overall Study||47
7718149|NCT01690052|19005010|P2|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
7718150|NCT01690052|19005011|P1|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
7718151|NCT01690052|19005010|P2|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
7718152|NCT01690052|19005011|P1|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
7718153|NCT01690052|19005010|P2|STARTED|SECOND INTERVENTION: 4 WEEKS||6
7718154|NCT01690052|19005011|P1|STARTED|SECOND INTERVENTION: 4 WEEKS||6
7718155|NCT01690052|19005010|P2|NOT COMPLETED|Washout Period of 1 Week||0
7718156|NCT01690052|19005011|P1|NOT COMPLETED|Washout Period of 1 Week||0
7718157|NCT01690052|19005010|P2|COMPLETED|Washout Period of 1 Week||6
7718158|NCT01690052|19005011|P1|COMPLETED|Washout Period of 1 Week||6
7718159|NCT01690052|19005010|P2|STARTED|Washout Period of 1 Week||6
7718160|NCT01690052|19005011|P1|STARTED|Washout Period of 1 Week||6
7718161|NCT01690052|19005010|P2|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2
7718162|NCT01690052|19005011|P1|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1
7718163|NCT01690052|19005010|P2|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
7718164|NCT01690052|19005011|P1|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
7718165|NCT01690052|19005010|P2|STARTED|FIRST INTERVENTION: 4 WEEKS||8
7718166|NCT01690052|19005011|P1|STARTED|FIRST INTERVENTION: 4 WEEKS||7
7718167|NCT01690000|19005019|P2|NOT COMPLETED|Overall Study||6
7718168|NCT01690000|19005020|P1|NOT COMPLETED|Overall Study||3
7718169|NCT01690000|19005019|P2|COMPLETED|Overall Study||35
7718170|NCT01690000|19005020|P1|COMPLETED|Overall Study||37
7718171|NCT01690000|19005019|P2|STARTED|Overall Study||41
7718172|NCT01690000|19005020|P1|STARTED|Overall Study||40
7718173|NCT01689974|19005028|P2|NOT COMPLETED|Overall Study||5
7718174|NCT01689974|19005029|P1|NOT COMPLETED|Overall Study||5
7718175|NCT01689974|19005028|P2|COMPLETED|Overall Study||0
7718176|NCT01689974|19005029|P1|COMPLETED|Overall Study||0
7718177|NCT01689974|19005028|P2|STARTED|Overall Study||5
7718178|NCT01689974|19005029|P1|STARTED|Overall Study||5
7718179|NCT01689909|19005037|P2|NOT COMPLETED|Overall Study||0
7718180|NCT01689909|19005038|P1|NOT COMPLETED|Overall Study||0
7718181|NCT01689909|19005037|P2|COMPLETED|Overall Study||52
7718182|NCT01689909|19005038|P1|COMPLETED|Overall Study||51
7718183|NCT01689909|19005037|P2|STARTED|Overall Study||52
7718184|NCT01689909|19005038|P1|STARTED|Overall Study||51
7718185|NCT01689857|19005060|P2|NOT COMPLETED|Overall Study||2
7718186|NCT01689857|19005061|P1|NOT COMPLETED|Overall Study||5
7718187|NCT01689857|19005060|P2|COMPLETED|Overall Study||18
7718188|NCT01689857|19005061|P1|COMPLETED|Overall Study||15
7718189|NCT01689857|19005060|P2|STARTED|Overall Study||20
7718190|NCT01689857|19005061|P1|STARTED|Overall Study||20
7718191|NCT01689779|19005069|P2|NOT COMPLETED|Overall Study||0
7718192|NCT01689779|19005070|P1|NOT COMPLETED|Overall Study||0
7718193|NCT01689779|19005069|P2|COMPLETED|Overall Study||32
7718194|NCT01689779|19005070|P1|COMPLETED|Overall Study||28
7718195|NCT01689779|19005069|P2|STARTED|Overall Study||32
7718196|NCT01689779|19005070|P1|STARTED|Overall Study||28
7718197|NCT01689740|19005089|P3|NOT COMPLETED|Overall Study||0
7718198|NCT01689740|19005090|P2|NOT COMPLETED|Overall Study||0
7718199|NCT01689740|19005091|P1|NOT COMPLETED|Overall Study||0
7718200|NCT01689740|19005089|P3|COMPLETED|Overall Study||5
7718201|NCT01689740|19005090|P2|COMPLETED|Overall Study||3
7718202|NCT01689740|19005091|P1|COMPLETED|Overall Study||2
7718203|NCT01689740|19005089|P3|STARTED|Overall Study||5
7718204|NCT01689740|19005090|P2|STARTED|Overall Study||3
7718205|NCT01689740|19005091|P1|STARTED|Overall Study||2
7718206|NCT01689701|19005133|P2|NOT COMPLETED|Overall Study||6
7718207|NCT01689701|19005134|P1|NOT COMPLETED|Overall Study||5
7718208|NCT01689701|19005133|P2|COMPLETED|Overall Study||21
7718209|NCT01689701|19005134|P1|COMPLETED|Overall Study||22
7718210|NCT01689701|19005133|P2|STARTED|Overall Study||27
7718211|NCT01689701|19005134|P1|STARTED|Overall Study||27
7718212|NCT01689649|19005154|P1|NOT COMPLETED|Overall Study||22
7718213|NCT01689649|19005154|P1|COMPLETED|Overall Study||117
7718214|NCT01689649|19005154|P1|STARTED|Overall Study||139
7718215|NCT01689532|19005166|P2|NOT COMPLETED|Overall Study||9
7718216|NCT01689532|19005167|P1|NOT COMPLETED|Overall Study||14
7718217|NCT01689532|19005166|P2|COMPLETED|Overall Study||52
7718218|NCT01689532|19005167|P1|COMPLETED|Overall Study||47
7718219|NCT01689532|19005166|P2|STARTED|Overall Study||61
7718220|NCT01689532|19005167|P1|STARTED|Overall Study||61
7718221|NCT01689519|19005231|P2|NOT COMPLETED|Safety Population||245
7718222|NCT01689519|19005232|P1|NOT COMPLETED|Safety Population||248
7718223|NCT01689519|19005231|P2|COMPLETED|Safety Population||0
7718224|NCT01689519|19005232|P1|COMPLETED|Safety Population||0
7718225|NCT01689519|19005231|P2|STARTED|Safety Population||245
7718226|NCT01689519|19005232|P1|STARTED|Safety Population||248
7718227|NCT01689519|19005231|P2|NOT COMPLETED|Intent to Treat||248
7718228|NCT01689519|19005232|P1|NOT COMPLETED|Intent to Treat||247
7718229|NCT01689519|19005231|P2|COMPLETED|Intent to Treat||0
7718230|NCT01689519|19005232|P1|COMPLETED|Intent to Treat||0
7718231|NCT01689519|19005231|P2|STARTED|Intent to Treat||248
7718232|NCT01689519|19005232|P1|STARTED|Intent to Treat||247
7718233|NCT01689441|19005246|P2|NOT COMPLETED|Overall Study||0
7718234|NCT01689441|19005247|P1|NOT COMPLETED|Overall Study||0
7718235|NCT01689441|19005246|P2|COMPLETED|Overall Study||31
7718236|NCT01689441|19005247|P1|COMPLETED|Overall Study||36
7718237|NCT01689441|19005246|P2|STARTED|Overall Study||31
7718238|NCT01689441|19005247|P1|STARTED|Overall Study||36
7718239|NCT01689363|19005257|P8|NOT COMPLETED|Overall Study||0
7718240|NCT01689363|19005258|P7|NOT COMPLETED|Overall Study||0
7718241|NCT01689363|19005259|P6|NOT COMPLETED|Overall Study||0
7718242|NCT01689363|19005260|P5|NOT COMPLETED|Overall Study||0
7718243|NCT01689363|19005261|P4|NOT COMPLETED|Overall Study||0
7718244|NCT01689363|19005262|P3|NOT COMPLETED|Overall Study||0
7718245|NCT01689363|19005263|P2|NOT COMPLETED|Overall Study||1
7718246|NCT01689363|19005264|P1|NOT COMPLETED|Overall Study||0
7718247|NCT01689363|19005257|P8|COMPLETED|Overall Study||32
7718248|NCT01689363|19005258|P7|COMPLETED|Overall Study||32
7718249|NCT01689363|19005259|P6|COMPLETED|Overall Study||31
7718250|NCT01689363|19005260|P5|COMPLETED|Overall Study||31
7718251|NCT01689363|19005261|P4|COMPLETED|Overall Study||31
7718252|NCT01689363|19005262|P3|COMPLETED|Overall Study||32
7718253|NCT01689363|19005263|P2|COMPLETED|Overall Study||31
7718254|NCT01689363|19005264|P1|COMPLETED|Overall Study||32
7718255|NCT01689363|19005257|P8|STARTED|Overall Study||32
7718256|NCT01689363|19005258|P7|STARTED|Overall Study||32
7718257|NCT01689363|19005259|P6|STARTED|Overall Study||31
7718258|NCT01689363|19005260|P5|STARTED|Overall Study||31
7718259|NCT01689363|19005261|P4|STARTED|Overall Study||31
7718260|NCT01689363|19005262|P3|STARTED|Overall Study||32
7718261|NCT01689363|19005263|P2|STARTED|Overall Study||32
7718262|NCT01689363|19005264|P1|STARTED|Overall Study||32
7718263|NCT01689350|19005310|P2|NOT COMPLETED|Overall Study||0
7718264|NCT01689350|19005311|P1|NOT COMPLETED|Overall Study||0
7718265|NCT01689350|19005310|P2|COMPLETED|Overall Study||45
7718266|NCT01689350|19005311|P1|COMPLETED|Overall Study||47
7718267|NCT01689350|19005310|P2|STARTED|Overall Study||45
7718268|NCT01689350|19005311|P1|STARTED|Overall Study||47
7718269|NCT01689337|19005319|P1|NOT COMPLETED|Overall Study||1
7718270|NCT01689337|19005319|P1|COMPLETED|Overall Study||0
7718271|NCT01689337|19005319|P1|STARTED|Overall Study||1
7718272|NCT01689324|19005334|P1|NOT COMPLETED|Overall Study||0
7718273|NCT01689324|19005334|P1|COMPLETED|Overall Study||43
7718274|NCT01689324|19005334|P1|STARTED|Overall Study||43
7718275|NCT01689207|19005358|P11|NOT COMPLETED|Overall Study||0
7718276|NCT01689207|19005359|P10|NOT COMPLETED|Overall Study||0
7718277|NCT01689207|19005360|P9|NOT COMPLETED|Overall Study||1
7718278|NCT01689207|19005361|P8|NOT COMPLETED|Overall Study||0
7718279|NCT01689207|19005362|P7|NOT COMPLETED|Overall Study||0
7718280|NCT01689207|19005363|P6|NOT COMPLETED|Overall Study||1
7718281|NCT01689207|19005364|P5|NOT COMPLETED|Overall Study||2
7718282|NCT01689207|19005365|P4|NOT COMPLETED|Overall Study||0
7718283|NCT01689207|19005366|P3|NOT COMPLETED|Overall Study||0
7718284|NCT01689207|19005367|P2|NOT COMPLETED|Overall Study||1
7718285|NCT01689207|19005368|P1|NOT COMPLETED|Overall Study||0
7718286|NCT01689207|19005358|P11|COMPLETED|Overall Study|Subjects completed study|8
7718287|NCT01689207|19005359|P10|COMPLETED|Overall Study|Subjects completed study|10
7718288|NCT01689207|19005360|P9|COMPLETED|Overall Study|Subjects completed study|5
7718289|NCT01689207|19005361|P8|COMPLETED|Overall Study|Subjects completed study|10
7718290|NCT01689207|19005362|P7|COMPLETED|Overall Study|Subjects completed study|10
7718291|NCT01689207|19005363|P6|COMPLETED|Overall Study|Subjects completed study|7
7718292|NCT01689207|19005364|P5|COMPLETED|Overall Study|Subjects completed study|2
7718293|NCT01689207|19005365|P4|COMPLETED|Overall Study|Subjects completed study|8
7718294|NCT01689207|19005366|P3|COMPLETED|Overall Study|Subjects completed study|16
7718295|NCT01689207|19005367|P2|COMPLETED|Overall Study|Subjects completed study|7
7718296|NCT01689207|19005368|P1|COMPLETED|Overall Study|Subjects completed study|4
7718297|NCT01689207|19005358|P11|STARTED|Overall Study|Subjects randomised|8
7718298|NCT01689207|19005359|P10|STARTED|Overall Study|Subjects randomised|10
7718299|NCT01689207|19005360|P9|STARTED|Overall Study|Subjects randomised|6
7718300|NCT01689207|19005361|P8|STARTED|Overall Study|Subjects randomised|10
7718301|NCT01689207|19005362|P7|STARTED|Overall Study|Subjects randomised|10
7718302|NCT01689207|19005363|P6|STARTED|Overall Study|Subjects randomised|8
7718303|NCT01689207|19005364|P5|STARTED|Overall Study|Subjects randomised|4
7718304|NCT01689207|19005365|P4|STARTED|Overall Study|Subjects randomised|8
7718305|NCT01689207|19005366|P3|STARTED|Overall Study|Subjects randomised|16
7718306|NCT01689207|19005367|P2|STARTED|Overall Study|Subjects randomised|8
7718307|NCT01689207|19005368|P1|STARTED|Overall Study|Subjects randomised|4
7718308|NCT01689155|19005464|P1|NOT COMPLETED|Overall Study||0
7718309|NCT01689155|19005464|P1|COMPLETED|Overall Study||116
7718310|NCT01689155|19005464|P1|STARTED|Overall Study||116
7718311|NCT01688999|19005476|P3|NOT COMPLETED|Overall Study||3
7718312|NCT01688999|19005477|P2|NOT COMPLETED|Overall Study||1
7718313|NCT01688999|19005478|P1|NOT COMPLETED|Overall Study||8
7718314|NCT01688999|19005476|P3|COMPLETED|Overall Study||10
7718315|NCT01688999|19005477|P2|COMPLETED|Overall Study||5
7718316|NCT01688999|19005478|P1|COMPLETED|Overall Study||42
7718317|NCT01688999|19005476|P3|STARTED|Overall Study||13
7718318|NCT01688999|19005477|P2|STARTED|Overall Study||6
7718319|NCT01688999|19005478|P1|STARTED|Overall Study||50
7718320|NCT01688973|19005494|P2|NOT COMPLETED|Overall Study||3
7718321|NCT01688973|19005495|P1|NOT COMPLETED|Overall Study||2
7718322|NCT01688973|19005494|P2|COMPLETED|Overall Study||25
7718323|NCT01688973|19005495|P1|COMPLETED|Overall Study||25
7718324|NCT01688973|19005494|P2|Eligible/Evaluable Patients|Overall Study||25
7718325|NCT01688973|19005495|P1|Eligible/Evaluable Patients|Overall Study||25
7718326|NCT01688973|19005494|P2|STARTED|Overall Study||28
7718327|NCT01688973|19005495|P1|STARTED|Overall Study||27
7718328|NCT01688921|19005509|P2|NOT COMPLETED|Overall Study||15
7718329|NCT01688921|19005510|P1|NOT COMPLETED|Overall Study||16
7718330|NCT01688921|19005509|P2|COMPLETED|Overall Study||608
7718331|NCT01688921|19005510|P1|COMPLETED|Overall Study||611
7718332|NCT01688921|19005509|P2|STARTED|Overall Study||623
7718333|NCT01688921|19005510|P1|STARTED|Overall Study||627
7718334|NCT01688895|19005533|P1|NOT COMPLETED|Overall Study||0
7718335|NCT01688895|19005533|P1|COMPLETED|Overall Study||150
7718336|NCT01688895|19005533|P1|STARTED|Overall Study||150
7718337|NCT01688882|19005542|P2|NOT COMPLETED|Overall Study||1
7718338|NCT01688882|19005543|P1|NOT COMPLETED|Overall Study||3
7718339|NCT01688882|19005542|P2|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6
7718340|NCT01688882|19005543|P1|COMPLETED|Overall Study||10
7718341|NCT01688882|19005542|P2|Safety Follow-up|Overall Study||5
7718342|NCT01688882|19005543|P1|Safety Follow-up|Overall Study||11
7718343|NCT01688882|19005542|P2|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7
7718344|NCT01688882|19005543|P1|STARTED|Overall Study||13
7718345|NCT01688856|19005560|P3|NOT COMPLETED|Overall Study||3
7718346|NCT01688856|19005561|P2|NOT COMPLETED|Overall Study||4
7718347|NCT01688856|19005562|P1|NOT COMPLETED|Overall Study||7
7718348|NCT01688856|19005560|P3|COMPLETED|Overall Study||8
7718349|NCT01688856|19005561|P2|COMPLETED|Overall Study||24
7718350|NCT01688856|19005562|P1|COMPLETED|Overall Study||21
7718351|NCT01688856|19005560|P3|STARTED|Overall Study||11
7718352|NCT01688856|19005561|P2|STARTED|Overall Study||28
7718353|NCT01688856|19005562|P1|STARTED|Overall Study||28
7718354|NCT01688843|19005582|P1|NOT COMPLETED|Overall Study||0
7718355|NCT01688843|19005582|P1|COMPLETED|Overall Study||1060
7718356|NCT01688843|19005582|P1|STARTED|Overall Study||1060
7718357|NCT01688830|19005614|P21|NOT COMPLETED|Overall Study||0
7718358|NCT01688830|19005615|P20|NOT COMPLETED|Overall Study||0
7718359|NCT01688830|19005616|P19|NOT COMPLETED|Overall Study||0
7718360|NCT01688830|19005617|P18|NOT COMPLETED|Overall Study||0
7718361|NCT01688830|19005618|P17|NOT COMPLETED|Overall Study||0
7718362|NCT01688830|19005619|P16|NOT COMPLETED|Overall Study||0
7718363|NCT01688830|19005620|P15|NOT COMPLETED|Overall Study||0
7718364|NCT01688830|19005621|P14|NOT COMPLETED|Overall Study||0
7718365|NCT01688830|19005622|P13|NOT COMPLETED|Overall Study||0
7718366|NCT01688830|19005623|P12|NOT COMPLETED|Overall Study||0
7718367|NCT01688830|19005624|P11|NOT COMPLETED|Overall Study||1
7718368|NCT01688830|19005625|P10|NOT COMPLETED|Overall Study||0
7718369|NCT01688830|19005626|P9|NOT COMPLETED|Overall Study||0
7718370|NCT01688830|19005627|P8|NOT COMPLETED|Overall Study||0
7718371|NCT01688830|19005628|P7|NOT COMPLETED|Overall Study||0
7718372|NCT01688830|19005629|P6|NOT COMPLETED|Overall Study||0
7718373|NCT01688830|19005630|P5|NOT COMPLETED|Overall Study||0
7718374|NCT01688830|19005631|P4|NOT COMPLETED|Overall Study||0
7718375|NCT01688830|19005632|P3|NOT COMPLETED|Overall Study||0
7718376|NCT01688830|19005633|P2|NOT COMPLETED|Overall Study||0
7718377|NCT01688830|19005634|P1|NOT COMPLETED|Overall Study||0
7718378|NCT01688830|19005614|P21|COMPLETED|Overall Study||9
7718379|NCT01688830|19005615|P20|COMPLETED|Overall Study||3
7718380|NCT01688830|19005616|P19|COMPLETED|Overall Study||8
7718381|NCT01688830|19005617|P18|COMPLETED|Overall Study||9
7718382|NCT01688830|19005618|P17|COMPLETED|Overall Study||9
7718383|NCT01688830|19005619|P16|COMPLETED|Overall Study||9
7718384|NCT01688830|19005620|P15|COMPLETED|Overall Study||6
7718385|NCT01688830|19005621|P14|COMPLETED|Overall Study||6
7718386|NCT01688830|19005622|P13|COMPLETED|Overall Study||6
7718387|NCT01688830|19005623|P12|COMPLETED|Overall Study||6
7718388|NCT01688830|19005624|P11|COMPLETED|Overall Study||5
7718389|NCT01688830|19005625|P10|COMPLETED|Overall Study||6
7718390|NCT01688830|19005626|P9|COMPLETED|Overall Study||6
7718391|NCT01688830|19005627|P8|COMPLETED|Overall Study||6
7718392|NCT01688830|19005628|P7|COMPLETED|Overall Study||12
7718393|NCT01688830|19005629|P6|COMPLETED|Overall Study||6
7718394|NCT01688830|19005630|P5|COMPLETED|Overall Study||5
7718395|NCT01688830|19005631|P4|COMPLETED|Overall Study||6
7718396|NCT01688830|19005632|P3|COMPLETED|Overall Study||6
7718397|NCT01688830|19005633|P2|COMPLETED|Overall Study||6
7718398|NCT01688830|19005634|P1|COMPLETED|Overall Study||21
7718399|NCT01688830|19005614|P21|STARTED|Overall Study||9
7718400|NCT01688830|19005615|P20|STARTED|Overall Study||3
7718401|NCT01688830|19005616|P19|STARTED|Overall Study||8
7718402|NCT01688830|19005617|P18|STARTED|Overall Study||9
7718403|NCT01688830|19005618|P17|STARTED|Overall Study||9
7718404|NCT01688830|19005619|P16|STARTED|Overall Study||9
7718405|NCT01688830|19005620|P15|STARTED|Overall Study||6
7718406|NCT01688830|19005621|P14|STARTED|Overall Study||6
7718407|NCT01688830|19005622|P13|STARTED|Overall Study||6
7718408|NCT01688830|19005623|P12|STARTED|Overall Study||6
7718409|NCT01688830|19005624|P11|STARTED|Overall Study||6
7718410|NCT01688830|19005625|P10|STARTED|Overall Study||6
7718411|NCT01688830|19005626|P9|STARTED|Overall Study||6
7718412|NCT01688830|19005627|P8|STARTED|Overall Study||6
7718413|NCT01688830|19005628|P7|STARTED|Overall Study||12
7718414|NCT01688830|19005629|P6|STARTED|Overall Study||6
7718415|NCT01688830|19005630|P5|STARTED|Overall Study||5
7718416|NCT01688830|19005631|P4|STARTED|Overall Study||6
7718417|NCT01688830|19005632|P3|STARTED|Overall Study||6
7718418|NCT01688830|19005633|P2|STARTED|Overall Study||6
7718419|NCT01688830|19005634|P1|STARTED|Overall Study||21
7718420|NCT01688739|19005788|P10|NOT COMPLETED|Overall Study||0
7718421|NCT01688739|19005789|P9|NOT COMPLETED|Overall Study||0
7718422|NCT01688739|19005790|P8|NOT COMPLETED|Overall Study||0
7718423|NCT01688739|19005791|P7|NOT COMPLETED|Overall Study||0
7718424|NCT01688739|19005792|P6|NOT COMPLETED|Overall Study||0
7718425|NCT01688739|19005793|P5|NOT COMPLETED|Overall Study||0
7718426|NCT01688739|19005794|P4|NOT COMPLETED|Overall Study||0
7718427|NCT01688739|19005795|P3|NOT COMPLETED|Overall Study||0
7718428|NCT01688739|19005796|P2|NOT COMPLETED|Overall Study||0
7718429|NCT01688739|19005797|P1|NOT COMPLETED|Overall Study||1
7718430|NCT01688739|19005788|P10|COMPLETED|Overall Study||6
7718431|NCT01688739|19005789|P9|COMPLETED|Overall Study||6
7718432|NCT01688739|19005790|P8|COMPLETED|Overall Study||6
7718433|NCT01688739|19005791|P7|COMPLETED|Overall Study||6
7718434|NCT01688739|19005792|P6|COMPLETED|Overall Study||6
7718435|NCT01688739|19005793|P5|COMPLETED|Overall Study||6
7718436|NCT01688739|19005794|P4|COMPLETED|Overall Study||6
7718437|NCT01688739|19005795|P3|COMPLETED|Overall Study||3
7718438|NCT01688739|19005796|P2|COMPLETED|Overall Study||3
7718439|NCT01688739|19005797|P1|COMPLETED|Overall Study||12
7718440|NCT01688739|19005788|P10|Received Study Drug|Overall Study||6
7718441|NCT01688739|19005789|P9|Received Study Drug|Overall Study||6
7718442|NCT01688739|19005790|P8|Received Study Drug|Overall Study||6
7718443|NCT01688739|19005791|P7|Received Study Drug|Overall Study||6
7718444|NCT01688739|19005792|P6|Received Study Drug|Overall Study||6
7718445|NCT01688739|19005793|P5|Received Study Drug|Overall Study||6
7718446|NCT01688739|19005794|P4|Received Study Drug|Overall Study||6
7718447|NCT01688739|19005795|P3|Received Study Drug|Overall Study||3
7718448|NCT01688739|19005796|P2|Received Study Drug|Overall Study||3
7718449|NCT01688739|19005797|P1|Received Study Drug|Overall Study||12
7718450|NCT01688739|19005788|P10|STARTED|Overall Study||6
7718451|NCT01688739|19005789|P9|STARTED|Overall Study||6
7718452|NCT01688739|19005790|P8|STARTED|Overall Study||6
7718453|NCT01688739|19005791|P7|STARTED|Overall Study||6
7718454|NCT01688739|19005792|P6|STARTED|Overall Study||6
7718455|NCT01688739|19005793|P5|STARTED|Overall Study||6
7718456|NCT01688739|19005794|P4|STARTED|Overall Study||6
7718457|NCT01688739|19005795|P3|STARTED|Overall Study||3
7718458|NCT01688739|19005796|P2|STARTED|Overall Study||3
7718459|NCT01688739|19005797|P1|STARTED|Overall Study||13
7718460|NCT01688726|19005873|P2|NOT COMPLETED|Overall Study||1
7718461|NCT01688726|19005874|P1|NOT COMPLETED|Overall Study||1
7718462|NCT01688726|19005873|P2|COMPLETED|Overall Study||44
7718463|NCT01688726|19005874|P1|COMPLETED|Overall Study||45
7718464|NCT01688726|19005873|P2|STARTED|Overall Study||45
7718465|NCT01688726|19005874|P1|STARTED|Overall Study||46
7718466|NCT01688635|19005886|P2|NOT COMPLETED|Period 4||0
7718467|NCT01688635|19005887|P1|NOT COMPLETED|Period 4||0
7718468|NCT01688635|19005886|P2|COMPLETED|Period 4||42
7718469|NCT01688635|19005887|P1|COMPLETED|Period 4||40
7718470|NCT01688635|19005886|P2|STARTED|Period 4||42
7718471|NCT01688635|19005887|P1|STARTED|Period 4||40
7718472|NCT01688635|19005886|P2|NOT COMPLETED|Washout 3||0
7718473|NCT01688635|19005887|P1|NOT COMPLETED|Washout 3||1
7718474|NCT01688635|19005886|P2|COMPLETED|Washout 3||42
7718475|NCT01688635|19005887|P1|COMPLETED|Washout 3||40
7718476|NCT01688635|19005886|P2|STARTED|Washout 3||42
7718477|NCT01688635|19005887|P1|STARTED|Washout 3||41
7718478|NCT01688635|19005886|P2|NOT COMPLETED|Period 3||0
7718479|NCT01688635|19005887|P1|NOT COMPLETED|Period 3||0
7718480|NCT01688635|19005886|P2|COMPLETED|Period 3||42
7718481|NCT01688635|19005887|P1|COMPLETED|Period 3||41
7718482|NCT01688635|19005886|P2|STARTED|Period 3||42
7718483|NCT01688635|19005887|P1|STARTED|Period 3||41
7718484|NCT01688635|19005886|P2|NOT COMPLETED|Washout 2||2
7718485|NCT01688635|19005887|P1|NOT COMPLETED|Washout 2||3
7718486|NCT01688635|19005886|P2|COMPLETED|Washout 2||42
7718487|NCT01688635|19005887|P1|COMPLETED|Washout 2||41
7718488|NCT01688635|19005886|P2|STARTED|Washout 2||44
7718489|NCT01688635|19005887|P1|STARTED|Washout 2||44
7718490|NCT01688635|19005886|P2|NOT COMPLETED|Period 2||0
7718491|NCT01688635|19005887|P1|NOT COMPLETED|Period 2||0
7718492|NCT01688635|19005886|P2|COMPLETED|Period 2||44
7718493|NCT01688635|19005887|P1|COMPLETED|Period 2||44
7718494|NCT01688635|19005886|P2|STARTED|Period 2||44
7718495|NCT01688635|19005887|P1|STARTED|Period 2||44
7718496|NCT01688635|19005886|P2|NOT COMPLETED|Washout 1||2
7718497|NCT01688635|19005887|P1|NOT COMPLETED|Washout 1||1
7718498|NCT01688635|19005886|P2|COMPLETED|Washout 1||44
7718499|NCT01688635|19005887|P1|COMPLETED|Washout 1||44
7718500|NCT01688635|19005886|P2|STARTED|Washout 1||46
7718501|NCT01688635|19005887|P1|STARTED|Washout 1||45
7718502|NCT01688635|19005886|P2|NOT COMPLETED|Period 1||0
7718503|NCT01688635|19005887|P1|NOT COMPLETED|Period 1||0
7718504|NCT01688635|19005886|P2|COMPLETED|Period 1||46
7718505|NCT01688635|19005887|P1|COMPLETED|Period 1||45
7718506|NCT01688635|19005886|P2|Received at Least 1 Dose of Study Drug|Period 1||46
7718507|NCT01688635|19005887|P1|Received at Least 1 Dose of Study Drug|Period 1||45
7718508|NCT01688635|19005886|P2|STARTED|Period 1||46
7718509|NCT01688635|19005887|P1|STARTED|Period 1||45
7718510|NCT01688609|19005899|P1|NOT COMPLETED|Overall Study||0
7718511|NCT01688609|19005899|P1|COMPLETED|Overall Study||18
7718512|NCT01688609|19005899|P1|STARTED|Overall Study||18
7718513|NCT01688596|19005909|P2|NOT COMPLETED|Overall Study||9
7718514|NCT01688596|19005910|P1|NOT COMPLETED|Overall Study||8
7718515|NCT01688596|19005909|P2|COMPLETED|Overall Study||59
7718516|NCT01688596|19005910|P1|COMPLETED|Overall Study||59
7718517|NCT01688596|19005909|P2|STARTED|Overall Study||68
7718518|NCT01688596|19005910|P1|STARTED|Overall Study||67
7718519|NCT01688466|19005934|P2|NOT COMPLETED|Overall Study||7
7718520|NCT01688466|19005935|P1|NOT COMPLETED|Overall Study||2
7718521|NCT01688466|19005934|P2|COMPLETED|Overall Study||10
7718522|NCT01688466|19005935|P1|COMPLETED|Overall Study||15
7718523|NCT01688466|19005934|P2|STARTED|Overall Study||17
7718524|NCT01688466|19005935|P1|STARTED|Overall Study||17
7718525|NCT01688336|19005943|P1|NOT COMPLETED|Overall Study||0
7718526|NCT01688336|19005943|P1|COMPLETED|Overall Study||9
7718527|NCT01688336|19005943|P1|STARTED|Overall Study||9
7718528|NCT01688310|19005955|P2|NOT COMPLETED|Overall Study||0
7718529|NCT01688310|19005956|P1|NOT COMPLETED|Overall Study||0
7718530|NCT01688310|19005955|P2|COMPLETED|Overall Study||100
7718531|NCT01688310|19005956|P1|COMPLETED|Overall Study||100
7718532|NCT01688310|19005955|P2|STARTED|Overall Study||100
7718533|NCT01688310|19005956|P1|STARTED|Overall Study||100
7718534|NCT01688141|19005976|P2|NOT COMPLETED|Overall Study||0
7718535|NCT01688141|19005977|P1|NOT COMPLETED|Overall Study||0
7718536|NCT01688141|19005976|P2|COMPLETED|Overall Study||11651
7718537|NCT01688141|19005977|P1|COMPLETED|Overall Study||11706
7718538|NCT01688141|19005976|P2|STARTED|Overall Study||11651
7718539|NCT01688141|19005977|P1|STARTED|Overall Study||11706
7718540|NCT01688102|19005997|P2|NOT COMPLETED|Overall Study||18
7718541|NCT01688102|19005998|P1|NOT COMPLETED|Overall Study||16
7718542|NCT01688102|19005997|P2|COMPLETED|Overall Study||40
7718543|NCT01688102|19005998|P1|COMPLETED|Overall Study||44
7718544|NCT01688102|19005997|P2|STARTED|Overall Study||58
7718545|NCT01688102|19005998|P1|STARTED|Overall Study||60
7718546|NCT01688050|19006026|P1|NOT COMPLETED|Overall Study||31
7718547|NCT01688050|19006026|P1|COMPLETED|Overall Study||19
7718548|NCT01688050|19006026|P1|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|22
7718549|NCT01688050|19006026|P1|STARTED|Overall Study||50
7718550|NCT01688037|19006035|P3|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
7718551|NCT01688037|19006036|P2|NOT COMPLETED|Follow-up Period (Week 12 to 16)||1
7718552|NCT01688037|19006037|P1|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
7718553|NCT01688037|19006035|P3|COMPLETED|Follow-up Period (Week 12 to 16)||17
7718554|NCT01688037|19006036|P2|COMPLETED|Follow-up Period (Week 12 to 16)||21
7718555|NCT01688037|19006037|P1|COMPLETED|Follow-up Period (Week 12 to 16)||42
7718556|NCT01688037|19006035|P3|STARTED|Follow-up Period (Week 12 to 16)||17
7718557|NCT01688037|19006036|P2|STARTED|Follow-up Period (Week 12 to 16)||22
7718558|NCT01688037|19006037|P1|STARTED|Follow-up Period (Week 12 to 16)||42
7718559|NCT01688037|19006035|P3|NOT COMPLETED|Open-Label Period (Week 6 to 12)||4
7718560|NCT01688037|19006036|P2|NOT COMPLETED|Open-Label Period (Week 6 to 12)||3
7718561|NCT01688037|19006037|P1|NOT COMPLETED|Open-Label Period (Week 6 to 12)||5
7718562|NCT01688037|19006035|P3|COMPLETED|Open-Label Period (Week 6 to 12)||17
7718563|NCT01688037|19006036|P2|COMPLETED|Open-Label Period (Week 6 to 12)||22
7718564|NCT01688037|19006037|P1|COMPLETED|Open-Label Period (Week 6 to 12)||42
7718565|NCT01688037|19006035|P3|STARTED|Open-Label Period (Week 6 to 12)||21
7718566|NCT01688037|19006036|P2|STARTED|Open-Label Period (Week 6 to 12)||25
7718567|NCT01688037|19006037|P1|STARTED|Open-Label Period (Week 6 to 12)||47
7718568|NCT01688037|19006035|P3|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||6
7718569|NCT01688037|19006036|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||3
7718570|NCT01688037|19006037|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
7718571|NCT01688037|19006035|P3|COMPLETED|Double-Blind Period (Week 0 to 6)||21
7718572|NCT01688037|19006036|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||25
7718573|NCT01688037|19006037|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||47
7718574|NCT01688037|19006035|P3|STARTED|Double-Blind Period (Week 0 to 6)||27
7718575|NCT01688037|19006036|P2|STARTED|Double-Blind Period (Week 0 to 6)||28
7718576|NCT01688037|19006037|P1|STARTED|Double-Blind Period (Week 0 to 6)||54
7718577|NCT01687998|19006053|P2|NOT COMPLETED|Overall Study||120
7718578|NCT01687998|19006054|P1|NOT COMPLETED|Overall Study||112
7718579|NCT01687998|19006053|P2|COMPLETED|Overall Study||5934
7718580|NCT01687998|19006054|P1|COMPLETED|Overall Study||5926
7718581|NCT01687998|19006053|P2|Received at Least One Dose of Study Drug|Overall Study||6052
7718582|NCT01687998|19006054|P1|Received at Least One Dose of Study Drug|Overall Study||6036
7718583|NCT01687998|19006053|P2|STARTED|Overall Study||6054
7718584|NCT01687998|19006054|P1|STARTED|Overall Study||6038
7718585|NCT01687972|19006072|P2|NOT COMPLETED|Overall Study||0
7718586|NCT01687972|19006073|P1|NOT COMPLETED|Overall Study||0
7718587|NCT01687972|19006072|P2|COMPLETED|Overall Study||44
7718588|NCT01687972|19006073|P1|COMPLETED|Overall Study||44
7718589|NCT01687972|19006072|P2|STARTED|Overall Study||44
7718590|NCT01687972|19006073|P1|STARTED|Overall Study||44
7718591|NCT01687790|19006083|P1|NOT COMPLETED|Overall Study||0
7718592|NCT01687790|19006083|P1|COMPLETED|Overall Study||60
7718593|NCT01687790|19006083|P1|STARTED|Overall Study||60
7718594|NCT01687712|19006090|P2|NOT COMPLETED|Cycle 3||24
7718595|NCT01687712|19006091|P1|NOT COMPLETED|Cycle 3||24
7718596|NCT01687712|19006090|P2|COMPLETED|Cycle 3||0
7718597|NCT01687712|19006091|P1|COMPLETED|Cycle 3||4
7718598|NCT01687712|19006090|P2|Clinical Pregnancy|Cycle 3||0
7718599|NCT01687712|19006091|P1|Clinical Pregnancy|Cycle 3||5
7718600|NCT01687712|19006090|P2|Biochemically Pregnant|Cycle 3||2
7718601|NCT01687712|19006091|P1|Biochemically Pregnant|Cycle 3||7
7718602|NCT01687712|19006090|P2|Embryo Transfer|Cycle 3||24
7718603|NCT01687712|19006091|P1|Embryo Transfer|Cycle 3||26
7718604|NCT01687712|19006090|P2|Fertilization Performed|Cycle 3||24
7718605|NCT01687712|19006091|P1|Fertilization Performed|Cycle 3||27
7718606|NCT01687712|19006090|P2|Ooctye/Ovum Pick-Up|Cycle 3||24
7718607|NCT01687712|19006091|P1|Ooctye/Ovum Pick-Up|Cycle 3||27
7718608|NCT01687712|19006090|P2|Received hCG|Cycle 3||24
7718609|NCT01687712|19006091|P1|Received hCG|Cycle 3||27
7718610|NCT01687712|19006090|P2|STARTED|Cycle 3||24
7718611|NCT01687712|19006091|P1|STARTED|Cycle 3||28
7718612|NCT01687712|19006090|P2|NOT COMPLETED|Cycle 2||95
7718613|NCT01687712|19006091|P1|NOT COMPLETED|Cycle 2||93
7718614|NCT01687712|19006090|P2|COMPLETED|Cycle 2||25
7718615|NCT01687712|19006091|P1|COMPLETED|Cycle 2||16
7718616|NCT01687712|19006090|P2|Clinical Pregnancy|Cycle 2||26
7718617|NCT01687712|19006091|P1|Clinical Pregnancy|Cycle 2||17
7718618|NCT01687712|19006090|P2|Biochemical Pregnancy|Cycle 2||43
7718619|NCT01687712|19006091|P1|Biochemical Pregnancy|Cycle 2||35
7718620|NCT01687712|19006090|P2|Embryo Transfer|Cycle 2||117
7718621|NCT01687712|19006091|P1|Embryo Transfer|Cycle 2||101
7718622|NCT01687712|19006090|P2|Fertilization Performed|Cycle 2||119
7718623|NCT01687712|19006091|P1|Fertilization Performed|Cycle 2||106
7718624|NCT01687712|19006090|P2|Oocyte/Ovum Pick Up|Cycle 2||119
7718625|NCT01687712|19006091|P1|Oocyte/Ovum Pick Up|Cycle 2||107
7718626|NCT01687712|19006090|P2|Received hCG|Cycle 2||119
7718627|NCT01687712|19006091|P1|Received hCG|Cycle 2||107
7718628|NCT01687712|19006090|P2|STARTED|Cycle 2||120
7718629|NCT01687712|19006091|P1|STARTED|Cycle 2||109
7718630|NCT01687712|19006090|P2|NOT COMPLETED|Cycle 1||429
7718631|NCT01687712|19006091|P1|NOT COMPLETED|Cycle 1||448
7718632|NCT01687712|19006090|P2|COMPLETED|Cycle 1||122
7718633|NCT01687712|19006091|P1|COMPLETED|Cycle 1||101
7718634|NCT01687712|19006090|P2|Clinical Pregnancy|Cycle 1||138
7718635|NCT01687712|19006091|P1|Clinical Pregnancy|Cycle 1||114
7718636|NCT01687712|19006090|P2|Biochemical Pregnancy|Cycle 1||203
7718637|NCT01687712|19006091|P1|Biochemical Pregnancy|Cycle 1||163
7718638|NCT01687712|19006090|P2|Embryo Transfer|Cycle 1||483
7718639|NCT01687712|19006091|P1|Embryo Transfer|Cycle 1||466
7718640|NCT01687712|19006090|P2|Fertilization Performed|Cycle 1||512
7718641|NCT01687712|19006091|P1|Fertilization Performed|Cycle 1||508
7718642|NCT01687712|19006090|P2|Oocyte/Ovum Pick Up|Cycle 1||517
7718643|NCT01687712|19006091|P1|Oocyte/Ovum Pick Up|Cycle 1||513
7718644|NCT01687712|19006090|P2|Received hCG|Cycle 1||520
7718645|NCT01687712|19006091|P1|Received hCG|Cycle 1||516
7718646|NCT01687712|19006090|P2|STARTED|Cycle 1||551
7718647|NCT01687712|19006091|P1|STARTED|Cycle 1||549
7718648|NCT01687673|19006129|P1|NOT COMPLETED|Overall Study||1
7718649|NCT01687673|19006129|P1|COMPLETED|Overall Study||28
7718650|NCT01687673|19006129|P1|STARTED|Overall Study||29
7718651|NCT01687478|19006143|P2|NOT COMPLETED|Overall Study||39
7718652|NCT01687478|19006144|P1|NOT COMPLETED|Overall Study||32
7718653|NCT01687478|19006143|P2|COMPLETED|Overall Study||49
7718654|NCT01687478|19006144|P1|COMPLETED|Overall Study||56
7718655|NCT01687478|19006143|P2|Safety Analysis Set|Overall Study||87
7718656|NCT01687478|19006144|P1|Safety Analysis Set|Overall Study||88
7718657|NCT01687478|19006143|P2|STARTED|Overall Study||88
7718658|NCT01687478|19006144|P1|STARTED|Overall Study||88
7718659|NCT01687413|19006168|P2|NOT COMPLETED|Overall Study||4
7718660|NCT01687413|19006169|P1|NOT COMPLETED|Overall Study||1
7718661|NCT01687413|19006168|P2|COMPLETED|Overall Study||11
7718662|NCT01687413|19006169|P1|COMPLETED|Overall Study||26
7718663|NCT01687413|19006168|P2|STARTED|Overall Study||15
7718664|NCT01687413|19006169|P1|STARTED|Overall Study||27
7718665|NCT01687400|19006245|P1|NOT COMPLETED|Overall Study||0
7718666|NCT01687400|19006245|P1|COMPLETED|Overall Study||114
7718667|NCT01687400|19006245|P1|STARTED|Overall Study||114
7718668|NCT01687387|19006259|P3|NOT COMPLETED|Overall Study||38
7718669|NCT01687387|19006260|P2|NOT COMPLETED|Overall Study||38
7718670|NCT01687387|19006261|P1|NOT COMPLETED|Overall Study||41
7718671|NCT01687387|19006259|P3|COMPLETED|Overall Study||13
7718672|NCT01687387|19006260|P2|COMPLETED|Overall Study||12
7718673|NCT01687387|19006261|P1|COMPLETED|Overall Study||10
7718674|NCT01687387|19006259|P3|STARTED|Overall Study||51
7718675|NCT01687387|19006260|P2|STARTED|Overall Study||50
7718676|NCT01687387|19006261|P1|STARTED|Overall Study||51
7718677|NCT01687296|19006274|P2|NOT COMPLETED|Overall Study||5
7718678|NCT01687296|19006275|P1|NOT COMPLETED|Overall Study||7
7718679|NCT01687296|19006274|P2|COMPLETED|Overall Study||123
7718680|NCT01687296|19006275|P1|COMPLETED|Overall Study||116
7718681|NCT01687296|19006274|P2|STARTED|Overall Study||128
7718682|NCT01687296|19006275|P1|STARTED|Overall Study||123
7718683|NCT01687283|19006297|P2|NOT COMPLETED|Overall Study||27
7718684|NCT01687283|19006298|P1|NOT COMPLETED|Overall Study||35
7718685|NCT01687283|19006297|P2|COMPLETED|Overall Study||130
7718686|NCT01687283|19006298|P1|COMPLETED|Overall Study||123
7718687|NCT01687283|19006297|P2|STARTED|Overall Study||157
7718688|NCT01687283|19006298|P1|STARTED|Overall Study||158
7718689|NCT01687270|19006321|P1|NOT COMPLETED|Overall Study||12
7718690|NCT01687270|19006321|P1|COMPLETED|Overall Study||28
7718691|NCT01687270|19006321|P1|STARTED|Overall Study||40
7718692|NCT01687257|19006332|P3|NOT COMPLETED|Overall Study||6
7718693|NCT01687257|19006333|P2|NOT COMPLETED|Overall Study||4
7718694|NCT01687257|19006334|P1|NOT COMPLETED|Overall Study||8
7718695|NCT01687257|19006332|P3|COMPLETED|Overall Study||15
7718696|NCT01687257|19006333|P2|COMPLETED|Overall Study||0
7718697|NCT01687257|19006334|P1|COMPLETED|Overall Study||17
7718698|NCT01687257|19006332|P3|STARTED|Overall Study||21
7718699|NCT01687257|19006333|P2|STARTED|Overall Study||4
7718700|NCT01687257|19006334|P1|STARTED|Overall Study||25
7718701|NCT01687244|19006362|P2|NOT COMPLETED|Overall Study||0
7718702|NCT01687244|19006363|P1|NOT COMPLETED|Overall Study||0
7718703|NCT01687244|19006362|P2|COMPLETED|Overall Study||19
7718704|NCT01687244|19006363|P1|COMPLETED|Overall Study||21
7718705|NCT01687244|19006362|P2|STARTED|Overall Study||19
7718706|NCT01687244|19006363|P1|STARTED|Overall Study||21
7718707|NCT01687218|19006399|P6|NOT COMPLETED|Overall Study||0
7718708|NCT01687218|19006400|P5|NOT COMPLETED|Overall Study||1
7718709|NCT01687218|19006401|P4|NOT COMPLETED|Overall Study||2
7718710|NCT01687218|19006402|P3|NOT COMPLETED|Overall Study||1
7718711|NCT01687218|19006403|P2|NOT COMPLETED|Overall Study||3
7718712|NCT01687218|19006404|P1|NOT COMPLETED|Overall Study||3
7718713|NCT01687218|19006399|P6|COMPLETED|Overall Study||32
7718714|NCT01687218|19006400|P5|COMPLETED|Overall Study||32
7718715|NCT01687218|19006401|P4|COMPLETED|Overall Study||32
7718716|NCT01687218|19006402|P3|COMPLETED|Overall Study||30
7718717|NCT01687218|19006403|P2|COMPLETED|Overall Study||29
7718718|NCT01687218|19006404|P1|COMPLETED|Overall Study||30
7718719|NCT01687218|19006399|P6|STARTED|Overall Study||32
7718720|NCT01687218|19006400|P5|STARTED|Overall Study||33
7718721|NCT01687218|19006401|P4|STARTED|Overall Study||34
7718722|NCT01687218|19006402|P3|STARTED|Overall Study||31
7718723|NCT01687218|19006403|P2|STARTED|Overall Study||32
7718724|NCT01687218|19006404|P1|STARTED|Overall Study||33
7718725|NCT01687179|19006445|P2|NOT COMPLETED|Overall Study||4
7718726|NCT01687179|19006446|P1|NOT COMPLETED|Overall Study||1
7718727|NCT01687179|19006445|P2|COMPLETED|Overall Study||6
7718728|NCT01687179|19006446|P1|COMPLETED|Overall Study||2
7718729|NCT01687179|19006445|P2|STARTED|Overall Study||10
7718730|NCT01687179|19006446|P1|STARTED|Overall Study||3
7718731|NCT01687166|19006456|P4|NOT COMPLETED|Overall Study||2
7718732|NCT01687166|19006457|P3|NOT COMPLETED|Overall Study||14
7718733|NCT01687166|19006458|P2|NOT COMPLETED|Overall Study||27
7718734|NCT01687166|19006459|P1|NOT COMPLETED|Overall Study||28
7718735|NCT01687166|19006456|P4|COMPLETED|Overall Study||1
7718736|NCT01687166|19006457|P3|COMPLETED|Overall Study||42
7718737|NCT01687166|19006458|P2|COMPLETED|Overall Study||145
7718738|NCT01687166|19006459|P1|COMPLETED|Overall Study||139
7718739|NCT01687166|19006456|P4|STARTED|Overall Study||3
7718740|NCT01687166|19006457|P3|STARTED|Overall Study||56
7718741|NCT01687166|19006458|P2|STARTED|Overall Study||172
7718742|NCT01687166|19006459|P1|STARTED|Overall Study||167
7718743|NCT01687114|19006471|P1|NOT COMPLETED|Overall Study||0
7718744|NCT01687114|19006471|P1|COMPLETED|Overall Study||5
7718745|NCT01687114|19006471|P1|STARTED|Overall Study||5
7718746|NCT01687101|19006475|P1|NOT COMPLETED|Overall Study||7
7718747|NCT01687101|19006475|P1|COMPLETED|Overall Study||25
7718748|NCT01687101|19006475|P1|STARTED|Overall Study||32
7718749|NCT01687088|19006481|P2|NOT COMPLETED|Overall Study||0
7718750|NCT01687088|19006482|P1|NOT COMPLETED|Overall Study||0
7718751|NCT01687088|19006481|P2|COMPLETED|Overall Study||50
7718752|NCT01687088|19006482|P1|COMPLETED|Overall Study||50
7718753|NCT01687088|19006481|P2|STARTED|Overall Study||50
7718754|NCT01687088|19006482|P1|STARTED|Overall Study||50
7718755|NCT01687036|19006488|P1|NOT COMPLETED|Overall Study||0
7718756|NCT01687036|19006488|P1|COMPLETED|Overall Study||10
7718757|NCT01687036|19006488|P1|STARTED|Overall Study||10
7718758|NCT01686958|19006500|P1|NOT COMPLETED|Overall Study||1
7718759|NCT01686958|19006500|P1|COMPLETED|Overall Study|No. of patients who completed ALL assessments at 12 months post treatment; 1 pt only had PSA test.|29
7718760|NCT01686958|19006500|P1|STARTED|Overall Study||30
7718761|NCT01686932|19006513|P2|NOT COMPLETED|Period 2||0
7718762|NCT01686932|19006514|P1|NOT COMPLETED|Period 2||0
7718763|NCT01686932|19006513|P2|COMPLETED|Period 2||25
7718764|NCT01686932|19006514|P1|COMPLETED|Period 2||24
7718765|NCT01686932|19006513|P2|STARTED|Period 2||25
7718766|NCT01686932|19006514|P1|STARTED|Period 2||24
7718767|NCT01686932|19006513|P2|NOT COMPLETED|Period 1||1
7718768|NCT01686932|19006514|P1|NOT COMPLETED|Period 1||1
7718769|NCT01686932|19006513|P2|COMPLETED|Period 1||25
7718770|NCT01686932|19006514|P1|COMPLETED|Period 1||24
7718771|NCT01686932|19006513|P2|STARTED|Period 1||26
7718772|NCT01686932|19006514|P1|STARTED|Period 1||25
7718773|NCT01686828|19006544|P4|NOT COMPLETED|Overall Study||0
7718774|NCT01686828|19006545|P3|NOT COMPLETED|Overall Study||1
7718775|NCT01686828|19006546|P2|NOT COMPLETED|Overall Study||1
7718776|NCT01686828|19006547|P1|NOT COMPLETED|Overall Study||1
7718777|NCT01686828|19006544|P4|COMPLETED|Overall Study||13
7718778|NCT01686828|19006545|P3|COMPLETED|Overall Study||12
7718779|NCT01686828|19006546|P2|COMPLETED|Overall Study||13
7718780|NCT01686828|19006547|P1|COMPLETED|Overall Study||12
7718781|NCT01686828|19006544|P4|STARTED|Overall Study||13
7718782|NCT01686828|19006545|P3|STARTED|Overall Study||13
7718783|NCT01686828|19006546|P2|STARTED|Overall Study||14
7718784|NCT01686828|19006547|P1|STARTED|Overall Study||13
7718785|NCT01686750|19006567|P2|NOT COMPLETED|Overall Study||0
7718786|NCT01686750|19006568|P1|NOT COMPLETED|Overall Study||0
7718787|NCT01686750|19006567|P2|COMPLETED|Overall Study||10725
7718788|NCT01686750|19006568|P1|COMPLETED|Overall Study||11001
7718789|NCT01686750|19006567|P2|STARTED|Overall Study||10725
7718790|NCT01686750|19006568|P1|STARTED|Overall Study||11001
7718791|NCT01686646|19006608|P4|NOT COMPLETED|Overall Study||0
7718792|NCT01686646|19006609|P3|NOT COMPLETED|Overall Study||0
7718793|NCT01686646|19006610|P2|NOT COMPLETED|Overall Study||0
7718794|NCT01686646|19006611|P1|NOT COMPLETED|Overall Study||0
7718795|NCT01686646|19006608|P4|COMPLETED|Overall Study||75
7718796|NCT01686646|19006609|P3|COMPLETED|Overall Study||75
7718797|NCT01686646|19006610|P2|COMPLETED|Overall Study||45
7718798|NCT01686646|19006611|P1|COMPLETED|Overall Study||45
7718799|NCT01686646|19006608|P4|Safety Population|Overall Study||75
7718800|NCT01686646|19006609|P3|Safety Population|Overall Study||74
7718801|NCT01686646|19006610|P2|Safety Population|Overall Study||45
7718802|NCT01686646|19006611|P1|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46
7718803|NCT01686646|19006608|P4|Intent to Treat Population|Overall Study||75
7718804|NCT01686646|19006609|P3|Intent to Treat Population|Overall Study||75
7718805|NCT01686646|19006610|P2|Intent to Treat Population|Overall Study||45
7718806|NCT01686646|19006611|P1|Intent to Treat Population|Overall Study||45
7718807|NCT01686646|19006608|P4|STARTED|Overall Study||75
7718808|NCT01686646|19006609|P3|STARTED|Overall Study||75
7718809|NCT01686646|19006610|P2|STARTED|Overall Study||45
7718810|NCT01686646|19006611|P1|STARTED|Overall Study||45
7718811|NCT01686633|19006660|P3|NOT COMPLETED|Overall Study||25
7718812|NCT01686633|19006661|P2|NOT COMPLETED|Overall Study||32
7718813|NCT01686633|19006662|P1|NOT COMPLETED|Overall Study||51
7718814|NCT01686633|19006660|P3|COMPLETED|Overall Study||321
7718815|NCT01686633|19006661|P2|COMPLETED|Overall Study||314
7718816|NCT01686633|19006662|P1|COMPLETED|Overall Study||296
7718817|NCT01686633|19006660|P3|STARTED|Overall Study||346
7718818|NCT01686633|19006661|P2|STARTED|Overall Study||346
7718819|NCT01686633|19006662|P1|STARTED|Overall Study||347
7718820|NCT01686581|19006685|P1|NOT COMPLETED|Overall Study||177
7718821|NCT01686581|19006685|P1|COMPLETED|Overall Study||464
7718822|NCT01686581|19006685|P1|Completed 24 Months|Overall Study||128
7718823|NCT01686581|19006685|P1|Safety Analysis Set; Received Study Drug|Overall Study||633
7718824|NCT01686581|19006685|P1|STARTED|Overall Study||641
7718825|NCT01686568|19006698|P2|NOT COMPLETED|Sub-Study||2
7718826|NCT01686568|19006699|P1|NOT COMPLETED|Sub-Study||2
7718827|NCT01686568|19006698|P2|COMPLETED|Sub-Study||9
7718828|NCT01686568|19006699|P1|COMPLETED|Sub-Study||12
7718829|NCT01686568|19006698|P2|STARTED|Sub-Study||11
7718830|NCT01686568|19006699|P1|STARTED|Sub-Study||14
7718831|NCT01686568|19006698|P2|NOT COMPLETED|Main Study||4
7718832|NCT01686568|19006699|P1|NOT COMPLETED|Main Study||2
7718833|NCT01686568|19006698|P2|COMPLETED|Main Study||11
7718834|NCT01686568|19006699|P1|COMPLETED|Main Study||14
7718835|NCT01686568|19006698|P2|STARTED|Main Study||15
7718836|NCT01686568|19006699|P1|STARTED|Main Study||16
7718837|NCT01686503|19006725|P4|NOT COMPLETED|Overall Study||1
7718838|NCT01686503|19006726|P3|NOT COMPLETED|Overall Study||2
7718839|NCT01686503|19006727|P2|NOT COMPLETED|Overall Study||3
7718840|NCT01686503|19006728|P1|NOT COMPLETED|Overall Study||1
7718841|NCT01686503|19006725|P4|COMPLETED|Overall Study||32
7718842|NCT01686503|19006726|P3|COMPLETED|Overall Study||64
7718843|NCT01686503|19006727|P2|COMPLETED|Overall Study||63
7718844|NCT01686503|19006728|P1|COMPLETED|Overall Study||65
7718845|NCT01686503|19006725|P4|STARTED|Overall Study||33
7718846|NCT01686503|19006726|P3|STARTED|Overall Study||66
7718847|NCT01686503|19006727|P2|STARTED|Overall Study||66
7718848|NCT01686503|19006728|P1|STARTED|Overall Study||66
7718849|NCT01686451|19006744|P2|NOT COMPLETED|Overall Study||0
7718850|NCT01686451|19006745|P1|NOT COMPLETED|Overall Study||0
7718851|NCT01686451|19006744|P2|COMPLETED|Overall Study||27
7718852|NCT01686451|19006745|P1|COMPLETED|Overall Study||33
7718853|NCT01686451|19006744|P2|STARTED|Overall Study||27
7718854|NCT01686451|19006745|P1|STARTED|Overall Study||33
7718855|NCT01686438|19006776|P3|NOT COMPLETED|Overall Study||13
7718856|NCT01686438|19006777|P2|NOT COMPLETED|Overall Study||9
7718857|NCT01686438|19006778|P1|NOT COMPLETED|Overall Study||8
7718858|NCT01686438|19006776|P3|COMPLETED|Overall Study||24
7718859|NCT01686438|19006777|P2|COMPLETED|Overall Study||26
7718860|NCT01686438|19006778|P1|COMPLETED|Overall Study||7
7718861|NCT01686438|19006776|P3|6-Month Follow Up|Overall Study||24
7718862|NCT01686438|19006777|P2|6-Month Follow Up|Overall Study||26
7718863|NCT01686438|19006778|P1|6-Month Follow Up|Overall Study||7
7718864|NCT01686438|19006776|P3|3-Month Follow Up|Overall Study||17
7718865|NCT01686438|19006777|P2|3-Month Follow Up|Overall Study||21
7718866|NCT01686438|19006778|P1|3-Month Follow Up|Overall Study||7
7718867|NCT01686438|19006776|P3|2-Week Follow Up|Overall Study||27
7718868|NCT01686438|19006777|P2|2-Week Follow Up|Overall Study||31
7718869|NCT01686438|19006778|P1|2-Week Follow Up|Overall Study||12
7718870|NCT01686438|19006776|P3|STARTED|Overall Study||37
7718871|NCT01686438|19006777|P2|STARTED|Overall Study||35
7718872|NCT01686438|19006778|P1|STARTED|Overall Study||15
7718873|NCT01686373|19006826|P2|NOT COMPLETED|Overall Study||2
7718874|NCT01686373|19006827|P1|NOT COMPLETED|Overall Study||3
7718875|NCT01686373|19006826|P2|COMPLETED|Overall Study||38
7718876|NCT01686373|19006827|P1|COMPLETED|Overall Study||31
7718877|NCT01686373|19006826|P2|Received 15 Treatment Sessions|Overall Study||39
7718878|NCT01686373|19006827|P1|Received 15 Treatment Sessions|Overall Study||33
7718879|NCT01686373|19006826|P2|STARTED|Overall Study||40
7718880|NCT01686373|19006827|P1|STARTED|Overall Study||34
7718881|NCT01686165|19006833|P1|NOT COMPLETED|Overall Study||0
7718882|NCT01686165|19006833|P1|COMPLETED|Overall Study||5
7718883|NCT01686165|19006833|P1|STARTED|Overall Study||5
7718884|NCT01686152|19006843|P3|NOT COMPLETED|Overall Study||9
7718885|NCT01686152|19006844|P2|NOT COMPLETED|Overall Study||35
7718886|NCT01686152|19006845|P1|NOT COMPLETED|Overall Study||41
7718887|NCT01686152|19006843|P3|COMPLETED|Overall Study||75
7718888|NCT01686152|19006844|P2|COMPLETED|Overall Study||218
7718889|NCT01686152|19006845|P1|COMPLETED|Overall Study||211
7718890|NCT01686152|19006843|P3|STARTED|Overall Study||84
7718891|NCT01686152|19006844|P2|STARTED|Overall Study||253
7718892|NCT01686152|19006845|P1|STARTED|Overall Study||252
7718893|NCT01685996|19006855|P2|NOT COMPLETED|Overall Study||13
7718894|NCT01685996|19006856|P1|NOT COMPLETED|Overall Study||16
7718895|NCT01685996|19006855|P2|COMPLETED|Overall Study||27
7718896|NCT01685996|19006856|P1|COMPLETED|Overall Study||18
7718897|NCT01685996|19006855|P2|STARTED|Overall Study||40
7718898|NCT01685996|19006856|P1|STARTED|Overall Study||34
7718899|NCT01685983|19006864|P1|NOT COMPLETED|Overall Study||82
7718900|NCT01685983|19006864|P1|COMPLETED|Overall Study||0
7718901|NCT01685983|19006864|P1|STARTED|Overall Study||82
7718902|NCT01685840|19006876|P2|NOT COMPLETED|Overall Study||332
7718903|NCT01685840|19006877|P1|NOT COMPLETED|Overall Study||329
7718904|NCT01685840|19006876|P2|COMPLETED|Overall Study||114
7718905|NCT01685840|19006877|P1|COMPLETED|Overall Study||119
7718906|NCT01685840|19006876|P2|STARTED|Overall Study||446
7718907|NCT01685840|19006877|P1|STARTED|Overall Study||448
7718908|NCT01685801|19006921|P4|NOT COMPLETED|Open-label Period (8 Weeks)||0
7718909|NCT01685801|19006922|P3|NOT COMPLETED|Open-label Period (8 Weeks)||0
7718910|NCT01685801|19006923|P2|NOT COMPLETED|Open-label Period (8 Weeks)||0
7718911|NCT01685801|19006924|P1|NOT COMPLETED|Open-label Period (8 Weeks)||0
7718912|NCT01685801|19006921|P4|COMPLETED|Open-label Period (8 Weeks)||4
7718913|NCT01685801|19006922|P3|COMPLETED|Open-label Period (8 Weeks)||7
7718914|NCT01685801|19006923|P2|COMPLETED|Open-label Period (8 Weeks)||5
7718915|NCT01685801|19006924|P1|COMPLETED|Open-label Period (8 Weeks)||5
7718916|NCT01685801|19006921|P4|STARTED|Open-label Period (8 Weeks)||4
7718917|NCT01685801|19006922|P3|STARTED|Open-label Period (8 Weeks)||7
7718918|NCT01685801|19006923|P2|STARTED|Open-label Period (8 Weeks)||5
7718919|NCT01685801|19006924|P1|STARTED|Open-label Period (8 Weeks)||5
7718920|NCT01685801|19006921|P4|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
7718921|NCT01685801|19006922|P3|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
7718922|NCT01685801|19006923|P2|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
7718923|NCT01685801|19006924|P1|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
7718924|NCT01685801|19006921|P4|COMPLETED|Washout Period 2 (4 Weeks)||4
7718925|NCT01685801|19006922|P3|COMPLETED|Washout Period 2 (4 Weeks)||7
7718926|NCT01685801|19006923|P2|COMPLETED|Washout Period 2 (4 Weeks)||5
7718927|NCT01685801|19006924|P1|COMPLETED|Washout Period 2 (4 Weeks)||5
7718928|NCT01685801|19006921|P4|STARTED|Washout Period 2 (4 Weeks)||4
7718929|NCT01685801|19006922|P3|STARTED|Washout Period 2 (4 Weeks)||7
7718930|NCT01685801|19006923|P2|STARTED|Washout Period 2 (4 Weeks)||5
7718931|NCT01685801|19006924|P1|STARTED|Washout Period 2 (4 Weeks)||5
7718932|NCT01685801|19006921|P4|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
7718933|NCT01685801|19006922|P3|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
7718934|NCT01685801|19006923|P2|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
7718935|NCT01685801|19006924|P1|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
7718936|NCT01685801|19006921|P4|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4
7718937|NCT01685801|19006922|P3|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7
7718938|NCT01685801|19006923|P2|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
7718939|NCT01685801|19006924|P1|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
7718940|NCT01685801|19006921|P4|STARTED|Cycle 2 Period 2 (2 Weeks)||5
7718941|NCT01685801|19006922|P3|STARTED|Cycle 2 Period 2 (2 Weeks)||7
7718942|NCT01685801|19006923|P2|STARTED|Cycle 2 Period 2 (2 Weeks)||6
7718943|NCT01685801|19006924|P1|STARTED|Cycle 2 Period 2 (2 Weeks)||5
7718944|NCT01685801|19006921|P4|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
7718945|NCT01685801|19006922|P3|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
7718946|NCT01685801|19006923|P2|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
7718947|NCT01685801|19006924|P1|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
7718948|NCT01685801|19006921|P4|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
7718949|NCT01685801|19006922|P3|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7
7718950|NCT01685801|19006923|P2|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6
7718951|NCT01685801|19006924|P1|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
7718952|NCT01685801|19006921|P4|STARTED|Cycle 2 Period 1 (2 Weeks)||5
7718953|NCT01685801|19006922|P3|STARTED|Cycle 2 Period 1 (2 Weeks)||7
7718954|NCT01685801|19006923|P2|STARTED|Cycle 2 Period 1 (2 Weeks)||6
7718955|NCT01685801|19006924|P1|STARTED|Cycle 2 Period 1 (2 Weeks)||5
7718956|NCT01685801|19006921|P4|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
7718957|NCT01685801|19006922|P3|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
7718958|NCT01685801|19006923|P2|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
7718959|NCT01685801|19006924|P1|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
7718960|NCT01685801|19006921|P4|COMPLETED|Washout Period 1 (4 Weeks)||5
7718961|NCT01685801|19006922|P3|COMPLETED|Washout Period 1 (4 Weeks)||7
7718962|NCT01685801|19006923|P2|COMPLETED|Washout Period 1 (4 Weeks)||6
7718963|NCT01685801|19006924|P1|COMPLETED|Washout Period 1 (4 Weeks)||5
7718964|NCT01685801|19006921|P4|STARTED|Washout Period 1 (4 Weeks)||5
7718965|NCT01685801|19006922|P3|STARTED|Washout Period 1 (4 Weeks)||7
7718966|NCT01685801|19006923|P2|STARTED|Washout Period 1 (4 Weeks)||6
7718967|NCT01685801|19006924|P1|STARTED|Washout Period 1 (4 Weeks)||5
7718968|NCT01685801|19006921|P4|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1
7718969|NCT01685801|19006922|P3|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
7718970|NCT01685801|19006923|P2|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
7718971|NCT01685801|19006924|P1|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
7718972|NCT01685801|19006921|P4|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
7718973|NCT01685801|19006922|P3|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7
7718974|NCT01685801|19006923|P2|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6
7718975|NCT01685801|19006924|P1|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
7718976|NCT01685801|19006921|P4|STARTED|Cycle 1 Period 2 (2 Weeks)||6
7718977|NCT01685801|19006922|P3|STARTED|Cycle 1 Period 2 (2 Weeks)||7
7718978|NCT01685801|19006923|P2|STARTED|Cycle 1 Period 2 (2 Weeks)||6
7718979|NCT01685801|19006924|P1|STARTED|Cycle 1 Period 2 (2 Weeks)||5
7718980|NCT01685801|19006921|P4|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
7718981|NCT01685801|19006922|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
7718982|NCT01685801|19006923|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
7718983|NCT01685801|19006924|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
7718984|NCT01685801|19006921|P4|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
7718985|NCT01685801|19006922|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7
7718986|NCT01685801|19006923|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
7718987|NCT01685801|19006924|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
7718988|NCT01685801|19006921|P4|STARTED|Cycle 1 Period 1 (2 Weeks)||6
7718989|NCT01685801|19006922|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||7
7718990|NCT01685801|19006923|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||6
7718991|NCT01685801|19006924|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||5
7718992|NCT01685697|19006946|P2|NOT COMPLETED|Overall Study||3
7718993|NCT01685697|19006947|P1|NOT COMPLETED|Overall Study||3
7718994|NCT01685697|19006946|P2|COMPLETED|Overall Study||28
7718995|NCT01685697|19006947|P1|COMPLETED|Overall Study||28
7718996|NCT01685697|19006946|P2|STARTED|Overall Study||31
7718997|NCT01685697|19006947|P1|STARTED|Overall Study||31
7718998|NCT01685684|19006955|P3|NOT COMPLETED|Double-blind Maintenance Phase||96
7718999|NCT01685684|19006956|P2|NOT COMPLETED|Double-blind Maintenance Phase||71
7719000|NCT01685684|19006957|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
7719001|NCT01685684|19006955|P3|COMPLETED|Double-blind Maintenance Phase||100
7719002|NCT01685684|19006956|P2|COMPLETED|Double-blind Maintenance Phase||122
7719003|NCT01685684|19006957|P1|COMPLETED|Double-blind Maintenance Phase||0
7719004|NCT01685684|19006955|P3|STARTED|Double-blind Maintenance Phase||196
7719005|NCT01685684|19006956|P2|STARTED|Double-blind Maintenance Phase||193
7719006|NCT01685684|19006957|P1|STARTED|Double-blind Maintenance Phase||0
7719007|NCT01685684|19006955|P3|NOT COMPLETED|Titration Phase||0
7719008|NCT01685684|19006956|P2|NOT COMPLETED|Titration Phase||0
7719009|NCT01685684|19006957|P1|NOT COMPLETED|Titration Phase||351
7719010|NCT01685684|19006955|P3|COMPLETED|Titration Phase||0
7719011|NCT01685684|19006956|P2|COMPLETED|Titration Phase||0
7719012|NCT01685684|19006957|P1|COMPLETED|Titration Phase||389
7719013|NCT01685684|19006955|P3|STARTED|Titration Phase||0
7719014|NCT01685684|19006956|P2|STARTED|Titration Phase||0
7719015|NCT01685684|19006957|P1|STARTED|Titration Phase||740
7719016|NCT01685606|19006981|P1|NOT COMPLETED|Overall Study||1
7719017|NCT01685606|19006981|P1|COMPLETED|Overall Study||5
7719018|NCT01685606|19006981|P1|STARTED|Overall Study||6
7719019|NCT01685567|19006986|P1|NOT COMPLETED|Overall Study||0
7719020|NCT01685567|19006986|P1|COMPLETED|Overall Study||219
7719021|NCT01685567|19006986|P1|STARTED|Overall Study||219
7719022|NCT01685463|19006996|P2|NOT COMPLETED|Overall Study||0
7719023|NCT01685463|19006997|P1|NOT COMPLETED|Overall Study||0
7719024|NCT01685463|19006996|P2|COMPLETED|Overall Study||8
7719025|NCT01685463|19006997|P1|COMPLETED|Overall Study||10
7719026|NCT01685463|19006996|P2|STARTED|Overall Study||8
7719027|NCT01685463|19006997|P1|STARTED|Overall Study||10
7719028|NCT01685437|19007009|P1|NOT COMPLETED|Overall Study||31
7719029|NCT01685437|19007009|P1|COMPLETED|Overall Study||158
7719030|NCT01685437|19007009|P1|STARTED|Overall Study||189
7719031|NCT01685372|19007023|P2|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
7719032|NCT01685372|19007024|P1|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||3
7719033|NCT01685372|19007023|P2|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||5
7719034|NCT01685372|19007024|P1|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
7719035|NCT01685372|19007023|P2|STARTED|Timepoint 3 (T3): 3rd Blood Draw||9
7719036|NCT01685372|19007024|P1|STARTED|Timepoint 3 (T3): 3rd Blood Draw||7
7719037|NCT01685372|19007023|P2|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
7719038|NCT01685372|19007024|P1|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
7719039|NCT01685372|19007023|P2|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||9
7719040|NCT01685372|19007024|P1|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||7
7719041|NCT01685372|19007023|P2|STARTED|Timepoint 2 (T2): 2nd Blood Draw||9
7719042|NCT01685372|19007024|P1|STARTED|Timepoint 2 (T2): 2nd Blood Draw||7
7719043|NCT01685372|19007023|P2|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
7719044|NCT01685372|19007024|P1|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
7719045|NCT01685372|19007023|P2|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
7719046|NCT01685372|19007024|P1|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
7719047|NCT01685372|19007023|P2|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
7719048|NCT01685372|19007024|P1|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
7719049|NCT01685320|19007046|P2|NOT COMPLETED|Overall Study||0
7719050|NCT01685320|19007047|P1|NOT COMPLETED|Overall Study||0
7719051|NCT01685320|19007046|P2|COMPLETED|Overall Study||15
7719052|NCT01685320|19007047|P1|COMPLETED|Overall Study||15
7719053|NCT01685320|19007046|P2|STARTED|Overall Study||15
7719054|NCT01685320|19007047|P1|STARTED|Overall Study||15
7719055|NCT01685242|19007057|P2|NOT COMPLETED|Overall Study||3
7719056|NCT01685242|19007058|P1|NOT COMPLETED|Overall Study||1
7719057|NCT01685242|19007057|P2|COMPLETED|Overall Study||47
7719058|NCT01685242|19007058|P1|COMPLETED|Overall Study||49
7719059|NCT01685242|19007057|P2|STARTED|Overall Study||50
7719060|NCT01685242|19007058|P1|STARTED|Overall Study||50
7719061|NCT01685229|19007114|P2|NOT COMPLETED|Overall Study||16
7719062|NCT01685229|19007115|P1|NOT COMPLETED|Overall Study||26
7719063|NCT01685229|19007114|P2|COMPLETED|Overall Study||36
7719064|NCT01685229|19007115|P1|COMPLETED|Overall Study||120
7719065|NCT01685229|19007114|P2|STARTED|Overall Study||52
7719066|NCT01685229|19007115|P1|STARTED|Overall Study||146
7719067|NCT01685216|19007141|P1|NOT COMPLETED|Overall Study||1
7719068|NCT01685216|19007141|P1|COMPLETED|Overall Study||6
7719069|NCT01685216|19007141|P1|STARTED|Overall Study||7
7719070|NCT01685203|19007158|P7|NOT COMPLETED|Overall Study||0
7719071|NCT01685203|19007159|P6|NOT COMPLETED|Overall Study||3
7719072|NCT01685203|19007160|P5|NOT COMPLETED|Overall Study||0
7719073|NCT01685203|19007161|P4|NOT COMPLETED|Overall Study||1
7719074|NCT01685203|19007162|P3|NOT COMPLETED|Overall Study||0
7719075|NCT01685203|19007163|P2|NOT COMPLETED|Overall Study||3
7719076|NCT01685203|19007164|P1|NOT COMPLETED|Overall Study||4
7719077|NCT01685203|19007158|P7|COMPLETED|Overall Study||52
7719078|NCT01685203|19007159|P6|COMPLETED|Overall Study||44
7719079|NCT01685203|19007160|P5|COMPLETED|Overall Study||49
7719080|NCT01685203|19007161|P4|COMPLETED|Overall Study||41
7719081|NCT01685203|19007162|P3|COMPLETED|Overall Study||40
7719082|NCT01685203|19007163|P2|COMPLETED|Overall Study||39
7719083|NCT01685203|19007164|P1|COMPLETED|Overall Study||40
7719084|NCT01685203|19007158|P7|Completed Study Drug|Overall Study||52
7719085|NCT01685203|19007159|P6|Completed Study Drug|Overall Study||43
7719086|NCT01685203|19007160|P5|Completed Study Drug|Overall Study||49
7719087|NCT01685203|19007161|P4|Completed Study Drug|Overall Study||42
7719088|NCT01685203|19007162|P3|Completed Study Drug|Overall Study||39
7719089|NCT01685203|19007163|P2|Completed Study Drug|Overall Study||40
7719090|NCT01685203|19007164|P1|Completed Study Drug|Overall Study||42
7719091|NCT01685203|19007158|P7|STARTED|Overall Study||52
7719092|NCT01685203|19007159|P6|STARTED|Overall Study||47
7719093|NCT01685203|19007160|P5|STARTED|Overall Study||49
7719094|NCT01685203|19007161|P4|STARTED|Overall Study||42
7719095|NCT01685203|19007162|P3|STARTED|Overall Study||40
7719096|NCT01685203|19007163|P2|STARTED|Overall Study||42
7719097|NCT01685203|19007164|P1|STARTED|Overall Study||44
7719098|NCT01685138|19007208|P1|NOT COMPLETED|Overall Study||92
7719099|NCT01685138|19007208|P1|COMPLETED|Overall Study||32
7719100|NCT01685138|19007208|P1|Discontinued From Study|Overall Study||51
7719101|NCT01685138|19007208|P1|Entered Survival Follow-up|Overall Study||63
7719102|NCT01685138|19007208|P1|Entered Post-treatment Efficacy f/up|Overall Study||10
7719103|NCT01685138|19007208|P1|Discontinued From Treatment Phase|Overall Study||124
7719104|NCT01685138|19007208|P1|STARTED|Overall Study||124
7719105|NCT01685073|19007224|P2|NOT COMPLETED|Overall Study||32
7719106|NCT01685073|19007225|P1|NOT COMPLETED|Overall Study||30
7719107|NCT01685073|19007224|P2|COMPLETED|Overall Study|Retained in treatment through 12 weeks|33
7719108|NCT01685073|19007225|P1|COMPLETED|Overall Study|Retained in treatment through 12 weeks|32
7719109|NCT01685073|19007224|P2|STARTED|Overall Study|Randomized|65
7719110|NCT01685073|19007225|P1|STARTED|Overall Study|Randomized|62
7719111|NCT01685060|19007233|P1|NOT COMPLETED|Overall Study||140
7719112|NCT01685060|19007233|P1|COMPLETED|Overall Study||0
7719113|NCT01685060|19007233|P1|Discontinued From Study|Overall Study||35
7719114|NCT01685060|19007233|P1|Entered Survival Follow up|Overall Study||98
7719115|NCT01685060|19007233|P1|Entered Post-treatment Efficacy f/u|Overall Study||7
7719116|NCT01685060|19007233|P1|STARTED|Overall Study||140
7719117|NCT01685047|19007248|P1|NOT COMPLETED|Overall Study||85
7719118|NCT01685047|19007248|P1|COMPLETED|Overall Study||396
7719119|NCT01685047|19007248|P1|STARTED|Overall Study|481 subjects signed the consent. 1 subject was withdrawn prior to the baseline visit.|481
7719120|NCT01685021|19007252|P1|NOT COMPLETED|Overall Study||16
7719121|NCT01685021|19007252|P1|COMPLETED|Overall Study|Last patient last visit date. Study was Terminated prematurely.|6
7719122|NCT01685021|19007252|P1|STARTED|Overall Study||22
7719123|NCT01684943|19007264|P3|NOT COMPLETED|Overall Study||1
7719124|NCT01684943|19007265|P2|NOT COMPLETED|Overall Study||1
7719125|NCT01684943|19007266|P1|NOT COMPLETED|Overall Study||9
7719126|NCT01684943|19007264|P3|COMPLETED|Overall Study||0
7719127|NCT01684943|19007265|P2|COMPLETED|Overall Study||2
7719128|NCT01684943|19007266|P1|COMPLETED|Overall Study||20
7719129|NCT01684943|19007264|P3|STARTED|Overall Study||1
7719130|NCT01684943|19007265|P2|STARTED|Overall Study||3
7719131|NCT01684943|19007266|P1|STARTED|Overall Study||29
7719132|NCT01684930|19007285|P2|NOT COMPLETED|Overall Study||1
7719133|NCT01684930|19007286|P1|NOT COMPLETED|Overall Study||3
7719134|NCT01684930|19007285|P2|COMPLETED|Overall Study||13
7719135|NCT01684930|19007286|P1|COMPLETED|Overall Study||9
7719136|NCT01684930|19007285|P2|STARTED|Overall Study||14
7719137|NCT01684930|19007286|P1|STARTED|Overall Study||12
7719138|NCT01684917|19007306|P4|NOT COMPLETED|Overall Study||0
7719139|NCT01684917|19007307|P3|NOT COMPLETED|Overall Study||0
7719140|NCT01684917|19007308|P2|NOT COMPLETED|Overall Study||0
7719141|NCT01684917|19007309|P1|NOT COMPLETED|Overall Study||0
7719142|NCT01684917|19007306|P4|COMPLETED|Overall Study||5
7719143|NCT01684917|19007307|P3|COMPLETED|Overall Study||13
7719144|NCT01684917|19007308|P2|COMPLETED|Overall Study||7
7719145|NCT01684917|19007309|P1|COMPLETED|Overall Study||11
7719146|NCT01684917|19007306|P4|STARTED|Overall Study||5
7719147|NCT01684917|19007307|P3|STARTED|Overall Study||13
7719148|NCT01684917|19007308|P2|STARTED|Overall Study||7
7719149|NCT01684917|19007309|P1|STARTED|Overall Study||11
7719150|NCT01684878|19007343|P4|NOT COMPLETED|Part 2: Randomized Phase||78
7719151|NCT01684878|19007344|P3|NOT COMPLETED|Part 2: Randomized Phase||78
7719152|NCT01684878|19007345|P2|NOT COMPLETED|Part 2: Randomized Phase||0
7719153|NCT01684878|19007346|P1|NOT COMPLETED|Part 2: Randomized Phase||0
7719154|NCT01684878|19007343|P4|COMPLETED|Part 2: Randomized Phase||0
7719155|NCT01684878|19007344|P3|COMPLETED|Part 2: Randomized Phase||0
7719156|NCT01684878|19007345|P2|COMPLETED|Part 2: Randomized Phase||0
7719157|NCT01684878|19007346|P1|COMPLETED|Part 2: Randomized Phase||0
7719158|NCT01684878|19007343|P4|Participants Mis-randomized|Part 2: Randomized Phase||0
7719159|NCT01684878|19007344|P3|Participants Mis-randomized|Part 2: Randomized Phase||2
7719160|NCT01684878|19007345|P2|Participants Mis-randomized|Part 2: Randomized Phase||0
7719161|NCT01684878|19007346|P1|Participants Mis-randomized|Part 2: Randomized Phase||0
7719162|NCT01684878|19007343|P4|Participants Randomized But Not Treated|Part 2: Randomized Phase||2
7719163|NCT01684878|19007344|P3|Participants Randomized But Not Treated|Part 2: Randomized Phase||1
7719164|NCT01684878|19007345|P2|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
7719165|NCT01684878|19007346|P1|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
7719166|NCT01684878|19007343|P4|STARTED|Part 2: Randomized Phase||78
7719167|NCT01684878|19007344|P3|STARTED|Part 2: Randomized Phase||78
7719168|NCT01684878|19007345|P2|STARTED|Part 2: Randomized Phase||0
7719169|NCT01684878|19007346|P1|STARTED|Part 2: Randomized Phase||0
7719170|NCT01684878|19007343|P4|NOT COMPLETED|Part 1: Safety Run in Phase||0
7719171|NCT01684878|19007344|P3|NOT COMPLETED|Part 1: Safety Run in Phase||0
7719172|NCT01684878|19007345|P2|NOT COMPLETED|Part 1: Safety Run in Phase||23
7719173|NCT01684878|19007346|P1|NOT COMPLETED|Part 1: Safety Run in Phase||16
7719174|NCT01684878|19007343|P4|COMPLETED|Part 1: Safety Run in Phase||0
7719175|NCT01684878|19007344|P3|COMPLETED|Part 1: Safety Run in Phase||0
7719176|NCT01684878|19007345|P2|COMPLETED|Part 1: Safety Run in Phase||5
7719177|NCT01684878|19007346|P1|COMPLETED|Part 1: Safety Run in Phase||6
7719178|NCT01684878|19007343|P4|STARTED|Part 1: Safety Run in Phase||0
7719179|NCT01684878|19007344|P3|STARTED|Part 1: Safety Run in Phase||0
7719180|NCT01684878|19007345|P2|STARTED|Part 1: Safety Run in Phase||28
7719181|NCT01684878|19007346|P1|STARTED|Part 1: Safety Run in Phase||22
7719182|NCT01684839|19007370|P1|NOT COMPLETED|Overall Study||0
7719183|NCT01684839|19007370|P1|COMPLETED|Overall Study||9
7719184|NCT01684839|19007370|P1|STARTED|Overall Study||9
7719185|NCT01684826|19007374|P1|NOT COMPLETED|Overall Study||10
7719186|NCT01684826|19007374|P1|COMPLETED|Overall Study||39
7719187|NCT01684826|19007374|P1|Collected Dose and Image Information|Overall Study||39
7719188|NCT01684826|19007374|P1|STARTED|Overall Study||49
7719189|NCT01684748|19007382|P2|NOT COMPLETED|Second Intervention - 8 Weeks||0
7719190|NCT01684748|19007383|P1|NOT COMPLETED|Second Intervention - 8 Weeks||0
7719191|NCT01684748|19007382|P2|COMPLETED|Second Intervention - 8 Weeks||8
7719192|NCT01684748|19007383|P1|COMPLETED|Second Intervention - 8 Weeks||8
7719193|NCT01684748|19007382|P2|STARTED|Second Intervention - 8 Weeks||8
7719194|NCT01684748|19007383|P1|STARTED|Second Intervention - 8 Weeks||8
7719195|NCT01684748|19007382|P2|NOT COMPLETED|First Intervention - 8 Weeks||2
7719196|NCT01684748|19007383|P1|NOT COMPLETED|First Intervention - 8 Weeks||2
7719197|NCT01684748|19007382|P2|COMPLETED|First Intervention - 8 Weeks||8
7719198|NCT01684748|19007383|P1|COMPLETED|First Intervention - 8 Weeks||8
7719199|NCT01684748|19007382|P2|STARTED|First Intervention - 8 Weeks||10
7719200|NCT01684748|19007383|P1|STARTED|First Intervention - 8 Weeks||10
7719201|NCT01684722|19007394|P4|NOT COMPLETED|Overall Study||110
7719202|NCT01684722|19007395|P3|NOT COMPLETED|Overall Study||94
7719203|NCT01684722|19007396|P2|NOT COMPLETED|Overall Study||77
7719204|NCT01684722|19007397|P1|NOT COMPLETED|Overall Study||97
7719205|NCT01684722|19007394|P4|COMPLETED|Overall Study||260
7719206|NCT01684722|19007395|P3|COMPLETED|Overall Study||226
7719207|NCT01684722|19007396|P2|COMPLETED|Overall Study||212
7719208|NCT01684722|19007397|P1|COMPLETED|Overall Study||236
7719209|NCT01684722|19007394|P4|STARTED|Overall Study||370
7719210|NCT01684722|19007395|P3|STARTED|Overall Study||320
7719211|NCT01684722|19007396|P2|STARTED|Overall Study||289
7719212|NCT01684722|19007397|P1|STARTED|Overall Study||333
7719213|NCT01684592|19007413|P2|NOT COMPLETED|Overall Study||24
7719214|NCT01684592|19007414|P1|NOT COMPLETED|Overall Study||26
7719215|NCT01684592|19007413|P2|COMPLETED|Overall Study||40
7719216|NCT01684592|19007414|P1|COMPLETED|Overall Study||38
7719217|NCT01684592|19007413|P2|STARTED|Overall Study||64
7719218|NCT01684592|19007414|P1|STARTED|Overall Study||64
7719219|NCT01684566|19007434|P2|NOT COMPLETED|Overall Study||7
7719220|NCT01684566|19007435|P1|NOT COMPLETED|Overall Study||16
7719221|NCT01684566|19007434|P2|COMPLETED|Overall Study||49
7719222|NCT01684566|19007435|P1|COMPLETED|Overall Study||44
7719223|NCT01684566|19007434|P2|Treated (ITT)|Overall Study||52
7719224|NCT01684566|19007435|P1|Treated (ITT)|Overall Study||57
7719225|NCT01684566|19007434|P2|STARTED|Overall Study||56
7719226|NCT01684566|19007435|P1|STARTED|Overall Study||60
7719227|NCT01684436|19007457|P1|NOT COMPLETED|Overall Study||1
7719228|NCT01684436|19007457|P1|COMPLETED|Overall Study||29
7719229|NCT01684436|19007457|P1|STARTED|Overall Study||30
7719230|NCT01684423|19007471|P5|NOT COMPLETED|Overall Study||0
7719231|NCT01684423|19007472|P4|NOT COMPLETED|Overall Study||0
7719232|NCT01684423|19007473|P3|NOT COMPLETED|Overall Study||1
7719233|NCT01684423|19007474|P2|NOT COMPLETED|Overall Study||0
7719234|NCT01684423|19007475|P1|NOT COMPLETED|Overall Study||0
7719235|NCT01684423|19007471|P5|COMPLETED|Overall Study||7
7719236|NCT01684423|19007472|P4|COMPLETED|Overall Study||19
7719237|NCT01684423|19007473|P3|COMPLETED|Overall Study||12
7719238|NCT01684423|19007474|P2|COMPLETED|Overall Study||13
7719239|NCT01684423|19007475|P1|COMPLETED|Overall Study||11
7719240|NCT01684423|19007471|P5|STARTED|Overall Study||7
7719241|NCT01684423|19007472|P4|STARTED|Overall Study||19
7719242|NCT01684423|19007473|P3|STARTED|Overall Study||13
7719243|NCT01684423|19007474|P2|STARTED|Overall Study||13
7719244|NCT01684423|19007475|P1|STARTED|Overall Study||11
7719245|NCT01684410|19007512|P3|NOT COMPLETED|Overall Study||0
7719246|NCT01684410|19007513|P2|NOT COMPLETED|Overall Study||0
7719247|NCT01684410|19007514|P1|NOT COMPLETED|Overall Study||0
7719248|NCT01684410|19007512|P3|COMPLETED|Overall Study||10
7719249|NCT01684410|19007513|P2|COMPLETED|Overall Study||10
7719250|NCT01684410|19007514|P1|COMPLETED|Overall Study||10
7719251|NCT01684410|19007512|P3|STARTED|Overall Study||10
7719252|NCT01684410|19007513|P2|STARTED|Overall Study||10
7719253|NCT01684410|19007514|P1|STARTED|Overall Study||10
7719254|NCT01684215|19007532|P4|NOT COMPLETED|Phase 2||43
7719255|NCT01684215|19007533|P3|NOT COMPLETED|Phase 2||0
7719256|NCT01684215|19007534|P2|NOT COMPLETED|Phase 2||0
7719257|NCT01684215|19007535|P1|NOT COMPLETED|Phase 2||0
7719258|NCT01684215|19007532|P4|COMPLETED|Phase 2||0
7719259|NCT01684215|19007533|P3|COMPLETED|Phase 2||0
7719260|NCT01684215|19007534|P2|COMPLETED|Phase 2||0
7719261|NCT01684215|19007535|P1|COMPLETED|Phase 2||0
7719262|NCT01684215|19007532|P4|Treated|Phase 2||42
7719263|NCT01684215|19007533|P3|Treated|Phase 2||0
7719264|NCT01684215|19007534|P2|Treated|Phase 2||0
7719265|NCT01684215|19007535|P1|Treated|Phase 2||0
7719266|NCT01684215|19007532|P4|STARTED|Phase 2|Eligible participants who consented for Phase 2.|43
7719267|NCT01684215|19007533|P3|STARTED|Phase 2||0
7719268|NCT01684215|19007534|P2|STARTED|Phase 2||0
7719269|NCT01684215|19007535|P1|STARTED|Phase 2||0
7719270|NCT01684215|19007532|P4|NOT COMPLETED|Phase 1, Part 2||0
7719271|NCT01684215|19007533|P3|NOT COMPLETED|Phase 1, Part 2||6
7719272|NCT01684215|19007534|P2|NOT COMPLETED|Phase 1, Part 2||0
7719273|NCT01684215|19007535|P1|NOT COMPLETED|Phase 1, Part 2||0
7719274|NCT01684215|19007532|P4|COMPLETED|Phase 1, Part 2||0
7719275|NCT01684215|19007533|P3|COMPLETED|Phase 1, Part 2||0
7719276|NCT01684215|19007534|P2|COMPLETED|Phase 1, Part 2||0
7719277|NCT01684215|19007535|P1|COMPLETED|Phase 1, Part 2||0
7719278|NCT01684215|19007532|P4|STARTED|Phase 1, Part 2||0
7719279|NCT01684215|19007533|P3|STARTED|Phase 1, Part 2|Eligible participants who consented for Phase 1 Part 2.|6
7719280|NCT01684215|19007534|P2|STARTED|Phase 1, Part 2||0
7719281|NCT01684215|19007535|P1|STARTED|Phase 1, Part 2||0
7719282|NCT01684215|19007532|P4|NOT COMPLETED|Phase 1, Part 1||0
7719283|NCT01684215|19007533|P3|NOT COMPLETED|Phase 1, Part 1||0
7719284|NCT01684215|19007534|P2|NOT COMPLETED|Phase 1, Part 1||6
7719285|NCT01684215|19007535|P1|NOT COMPLETED|Phase 1, Part 1||6
7719286|NCT01684215|19007532|P4|COMPLETED|Phase 1, Part 1||0
7719287|NCT01684215|19007533|P3|COMPLETED|Phase 1, Part 1||0
7719288|NCT01684215|19007534|P2|COMPLETED|Phase 1, Part 1||0
7719289|NCT01684215|19007535|P1|COMPLETED|Phase 1, Part 1||0
7719290|NCT01684215|19007532|P4|Treated|Phase 1, Part 1||0
7719291|NCT01684215|19007533|P3|Treated|Phase 1, Part 1||0
7719292|NCT01684215|19007534|P2|Treated|Phase 1, Part 1||6
7719293|NCT01684215|19007535|P1|Treated|Phase 1, Part 1||6
7719294|NCT01684215|19007532|P4|STARTED|Phase 1, Part 1||0
7719295|NCT01684215|19007533|P3|STARTED|Phase 1, Part 1||0
7719296|NCT01684215|19007534|P2|STARTED|Phase 1, Part 1||6
7719297|NCT01684215|19007535|P1|STARTED|Phase 1, Part 1||6
7719298|NCT01684046|19007609|P2|NOT COMPLETED|Period 2, Second 30 Days||0
7719299|NCT01684046|19007610|P1|NOT COMPLETED|Period 2, Second 30 Days||0
7719300|NCT01684046|19007609|P2|COMPLETED|Period 2, Second 30 Days||93
7719301|NCT01684046|19007610|P1|COMPLETED|Period 2, Second 30 Days||97
7719302|NCT01684046|19007609|P2|STARTED|Period 2, Second 30 Days||93
7719303|NCT01684046|19007610|P1|STARTED|Period 2, Second 30 Days||97
7719304|NCT01684046|19007609|P2|NOT COMPLETED|Period 1, First 30 Days||2
7719305|NCT01684046|19007610|P1|NOT COMPLETED|Period 1, First 30 Days||0
7719306|NCT01684046|19007609|P2|COMPLETED|Period 1, First 30 Days||93
7719307|NCT01684046|19007610|P1|COMPLETED|Period 1, First 30 Days||97
7719308|NCT01684046|19007609|P2|STARTED|Period 1, First 30 Days||95
7719309|NCT01684046|19007610|P1|STARTED|Period 1, First 30 Days||97
7719310|NCT01684033|19007616|P2|NOT COMPLETED|Period 2, Second 30 Days||0
7719311|NCT01684033|19007617|P1|NOT COMPLETED|Period 2, Second 30 Days||1
7719312|NCT01684033|19007616|P2|COMPLETED|Period 2, Second 30 Days||98
7719313|NCT01684033|19007617|P1|COMPLETED|Period 2, Second 30 Days||94
7719314|NCT01684033|19007616|P2|STARTED|Period 2, Second 30 Days||98
7719315|NCT01684033|19007617|P1|STARTED|Period 2, Second 30 Days||95
7719316|NCT01684033|19007616|P2|NOT COMPLETED|Period 1, First 30 Days||1
7719317|NCT01684033|19007617|P1|NOT COMPLETED|Period 1, First 30 Days||4
7719318|NCT01684033|19007616|P2|COMPLETED|Period 1, First 30 Days||98
7719319|NCT01684033|19007617|P1|COMPLETED|Period 1, First 30 Days||95
7719320|NCT01684033|19007616|P2|STARTED|Period 1, First 30 Days||99
7719321|NCT01684033|19007617|P1|STARTED|Period 1, First 30 Days||99
7719322|NCT01684020|19007627|P2|NOT COMPLETED|Overall Study||0
7719323|NCT01684020|19007628|P1|NOT COMPLETED|Overall Study||1
7719324|NCT01684020|19007627|P2|COMPLETED|Overall Study||5
7719325|NCT01684020|19007628|P1|COMPLETED|Overall Study||4
7719326|NCT01684020|19007627|P2|STARTED|Overall Study||5
7719327|NCT01684020|19007628|P1|STARTED|Overall Study||5
7719328|NCT01684007|19007652|P2|NOT COMPLETED|Overall Study||0
7719329|NCT01684007|19007653|P1|NOT COMPLETED|Overall Study||0
7719330|NCT01684007|19007652|P2|COMPLETED|Overall Study||50
7719331|NCT01684007|19007653|P1|COMPLETED|Overall Study||53
7719332|NCT01684007|19007652|P2|STARTED|Overall Study||50
7719333|NCT01684007|19007653|P1|STARTED|Overall Study||53
7719334|NCT01683994|19007666|P5|NOT COMPLETED|Overall Study||1
7719335|NCT01683994|19007667|P4|NOT COMPLETED|Overall Study||3
7719336|NCT01683994|19007668|P3|NOT COMPLETED|Overall Study||0
7719337|NCT01683994|19007669|P2|NOT COMPLETED|Overall Study||0
7719338|NCT01683994|19007670|P1|NOT COMPLETED|Overall Study||1
7719339|NCT01683994|19007666|P5|COMPLETED|Overall Study||12
7719340|NCT01683994|19007667|P4|COMPLETED|Overall Study||10
7719341|NCT01683994|19007668|P3|COMPLETED|Overall Study||7
7719342|NCT01683994|19007669|P2|COMPLETED|Overall Study||8
7719343|NCT01683994|19007670|P1|COMPLETED|Overall Study||3
7719344|NCT01683994|19007666|P5|# of Patients Who Received Treatment|Overall Study||13
7719345|NCT01683994|19007667|P4|# of Patients Who Received Treatment|Overall Study||12
7719346|NCT01683994|19007668|P3|# of Patients Who Received Treatment|Overall Study||7
7719347|NCT01683994|19007669|P2|# of Patients Who Received Treatment|Overall Study||8
7719348|NCT01683994|19007670|P1|# of Patients Who Received Treatment|Overall Study||4
7719349|NCT01683994|19007666|P5|STARTED|Overall Study||13
7719350|NCT01683994|19007667|P4|STARTED|Overall Study||13
7719351|NCT01683994|19007668|P3|STARTED|Overall Study||7
7719352|NCT01683994|19007669|P2|STARTED|Overall Study||8
7719353|NCT01683994|19007670|P1|STARTED|Overall Study||4
7719354|NCT01683864|19007699|P3|NOT COMPLETED|Overall Study||0
7719355|NCT01683864|19007700|P2|NOT COMPLETED|Overall Study||0
7719356|NCT01683864|19007701|P1|NOT COMPLETED|Overall Study||0
7719357|NCT01683864|19007699|P3|COMPLETED|Overall Study||0
7719358|NCT01683864|19007700|P2|COMPLETED|Overall Study||0
7719359|NCT01683864|19007701|P1|COMPLETED|Overall Study||0
7719360|NCT01683864|19007699|P3|STARTED|Overall Study||0
7719361|NCT01683864|19007700|P2|STARTED|Overall Study||0
7719362|NCT01683864|19007701|P1|STARTED|Overall Study||0
7719363|NCT01683838|19007711|P2|NOT COMPLETED|Overall Study||12
7719364|NCT01683838|19007712|P1|NOT COMPLETED|Overall Study||26
7719365|NCT01683838|19007711|P2|COMPLETED|Overall Study||88
7719366|NCT01683838|19007712|P1|COMPLETED|Overall Study||78
7719367|NCT01683838|19007711|P2|Efficacy Population|Overall Study||93
7719368|NCT01683838|19007712|P1|Efficacy Population|Overall Study||89
7719369|NCT01683838|19007711|P2|Safety Population|Overall Study||100
7719370|NCT01683838|19007712|P1|Safety Population|Overall Study||103
7719371|NCT01683838|19007711|P2|Intent to Treat (ITT) Population|Overall Study||100
7719372|NCT01683838|19007712|P1|Intent to Treat (ITT) Population|Overall Study||103
7719373|NCT01683838|19007711|P2|STARTED|Overall Study||100
7719374|NCT01683838|19007712|P1|STARTED|Overall Study||104
7719375|NCT01683812|19007734|P1|NOT COMPLETED|Overall Study||0
7719376|NCT01683812|19007734|P1|COMPLETED|Overall Study||23
7719377|NCT01683812|19007734|P1|STARTED|Overall Study||23
7719378|NCT01683630|19007741|P2|NOT COMPLETED|Overall Study||0
7719379|NCT01683630|19007742|P1|NOT COMPLETED|Overall Study||0
7719380|NCT01683630|19007741|P2|COMPLETED|Overall Study||445
7719381|NCT01683630|19007742|P1|COMPLETED|Overall Study||1404
7719382|NCT01683630|19007741|P2|STARTED|Overall Study||445
7719383|NCT01683630|19007742|P1|STARTED|Overall Study||1404
7719384|NCT01683604|19007752|P1|NOT COMPLETED|Overall Study||5
7719385|NCT01683604|19007752|P1|COMPLETED|Overall Study||32
7719386|NCT01683604|19007752|P1|STARTED|Overall Study||37
7719387|NCT01683565|19007917|P2|NOT COMPLETED|Overall Study||1
7719388|NCT01683565|19007918|P1|NOT COMPLETED|Overall Study||3
7719389|NCT01683565|19007917|P2|COMPLETED|Overall Study||15
7719390|NCT01683565|19007918|P1|COMPLETED|Overall Study||12
7719391|NCT01683565|19007917|P2|STARTED|Overall Study||16
7719392|NCT01683565|19007918|P1|STARTED|Overall Study||15
7719393|NCT01683526|19007932|P2|NOT COMPLETED|Overall Study||0
7719394|NCT01683526|19007933|P1|NOT COMPLETED|Overall Study||0
7719395|NCT01683526|19007932|P2|COMPLETED|Overall Study||57
7719396|NCT01683526|19007933|P1|COMPLETED|Overall Study||60
7719397|NCT01683526|19007932|P2|STARTED|Overall Study||57
7719398|NCT01683526|19007933|P1|STARTED|Overall Study||60
7719399|NCT01683409|19007952|P5|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||3
7719400|NCT01683409|19007953|P4|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
7719401|NCT01683409|19007954|P3|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||1
7719402|NCT01683409|19007955|P2|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
7719403|NCT01683409|19007956|P1|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
7719404|NCT01683409|19007952|P5|COMPLETED|Washout Period 2 (Weeks 29-32)||9
7719405|NCT01683409|19007953|P4|COMPLETED|Washout Period 2 (Weeks 29-32)||6
7719406|NCT01683409|19007954|P3|COMPLETED|Washout Period 2 (Weeks 29-32)||7
7719407|NCT01683409|19007955|P2|COMPLETED|Washout Period 2 (Weeks 29-32)||6
7719408|NCT01683409|19007956|P1|COMPLETED|Washout Period 2 (Weeks 29-32)||6
7719409|NCT01683409|19007952|P5|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 8 participants.|12
7719410|NCT01683409|19007953|P4|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 16 participants.|6
7719411|NCT01683409|19007954|P3|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 17 participants.|8
7719412|NCT01683409|19007955|P2|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 11 participants.|6
7719413|NCT01683409|19007956|P1|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 18 participants.|6
7719414|NCT01683409|19007952|P5|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
7719415|NCT01683409|19007953|P4|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||2
7719416|NCT01683409|19007954|P3|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||1
7719417|NCT01683409|19007955|P2|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||4
7719418|NCT01683409|19007956|P1|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
7719419|NCT01683409|19007952|P5|COMPLETED|Washout Period 1 (Weeks 25-28)||20
7719420|NCT01683409|19007953|P4|COMPLETED|Washout Period 1 (Weeks 25-28)||22
7719421|NCT01683409|19007954|P3|COMPLETED|Washout Period 1 (Weeks 25-28)||25
7719422|NCT01683409|19007955|P2|COMPLETED|Washout Period 1 (Weeks 25-28)||17
7719423|NCT01683409|19007956|P1|COMPLETED|Washout Period 1 (Weeks 25-28)||24
7719424|NCT01683409|19007952|P5|STARTED|Washout Period 1 (Weeks 25-28)||23
7719425|NCT01683409|19007953|P4|STARTED|Washout Period 1 (Weeks 25-28)||24
7719426|NCT01683409|19007954|P3|STARTED|Washout Period 1 (Weeks 25-28)||26
7719427|NCT01683409|19007955|P2|STARTED|Washout Period 1 (Weeks 25-28)||21
7719428|NCT01683409|19007956|P1|STARTED|Washout Period 1 (Weeks 25-28)||27
7719429|NCT01683409|19007952|P5|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
7719430|NCT01683409|19007953|P4|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
7719431|NCT01683409|19007954|P3|NOT COMPLETED|Treatment Period (Weeks 1-24)||1
7719432|NCT01683409|19007955|P2|NOT COMPLETED|Treatment Period (Weeks 1-24)||4
7719433|NCT01683409|19007956|P1|NOT COMPLETED|Treatment Period (Weeks 1-24)||0
7719434|NCT01683409|19007952|P5|COMPLETED|Treatment Period (Weeks 1-24)||23
7719435|NCT01683409|19007953|P4|COMPLETED|Treatment Period (Weeks 1-24)||24
7719436|NCT01683409|19007954|P3|COMPLETED|Treatment Period (Weeks 1-24)||26
7719437|NCT01683409|19007955|P2|COMPLETED|Treatment Period (Weeks 1-24)||21
7719438|NCT01683409|19007956|P1|COMPLETED|Treatment Period (Weeks 1-24)||27
7719439|NCT01683409|19007952|P5|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
7719440|NCT01683409|19007953|P4|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
7719441|NCT01683409|19007954|P3|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
7719442|NCT01683409|19007955|P2|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
7719443|NCT01683409|19007956|P1|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||27
7719444|NCT01683409|19007952|P5|STARTED|Treatment Period (Weeks 1-24)||25
7719445|NCT01683409|19007953|P4|STARTED|Treatment Period (Weeks 1-24)||26
7719446|NCT01683409|19007954|P3|STARTED|Treatment Period (Weeks 1-24)||27
7719447|NCT01683409|19007955|P2|STARTED|Treatment Period (Weeks 1-24)||25
7719448|NCT01683409|19007956|P1|STARTED|Treatment Period (Weeks 1-24)||27
7719449|NCT01683383|19007999|P2|NOT COMPLETED|Overall Study||0
7719450|NCT01683383|19008000|P1|NOT COMPLETED|Overall Study||1
7719451|NCT01683383|19007999|P2|COMPLETED|Overall Study||51
7719452|NCT01683383|19008000|P1|COMPLETED|Overall Study||49
7719453|NCT01683383|19007999|P2|Transported and Treated|Overall Study||51
7719454|NCT01683383|19008000|P1|Transported and Treated|Overall Study||49
7719455|NCT01683383|19007999|P2|STARTED|Overall Study||51
7719456|NCT01683383|19008000|P1|STARTED|Overall Study||50
7719457|NCT01683331|19008016|P2|NOT COMPLETED|Overall Study||0
7719458|NCT01683331|19008017|P1|NOT COMPLETED|Overall Study||0
7719459|NCT01683331|19008016|P2|COMPLETED|Overall Study||18
7719460|NCT01683331|19008017|P1|COMPLETED|Overall Study||18
7719461|NCT01683331|19008016|P2|24 Months|Overall Study||18
7719462|NCT01683331|19008017|P1|24 Months|Overall Study||18
7719463|NCT01683331|19008016|P2|12 Months|Overall Study||18
7719464|NCT01683331|19008017|P1|12 Months|Overall Study||18
7719465|NCT01683331|19008016|P2|Began Dosage|Overall Study||18
7719466|NCT01683331|19008017|P1|Began Dosage|Overall Study||18
7719467|NCT01683331|19008016|P2|STARTED|Overall Study||18
7719468|NCT01683331|19008017|P1|STARTED|Overall Study||18
7719469|NCT01683266|19008027|P2|NOT COMPLETED|Overall Study||50
7719470|NCT01683266|19008028|P1|NOT COMPLETED|Overall Study||55
7719471|NCT01683266|19008027|P2|COMPLETED|Overall Study||225
7719472|NCT01683266|19008028|P1|COMPLETED|Overall Study||219
7719473|NCT01683266|19008027|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
7719474|NCT01683266|19008028|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
7719475|NCT01683266|19008027|P2|STARTED|Overall Study||275
7719476|NCT01683266|19008028|P1|STARTED|Overall Study||274
7719477|NCT01683071|19008062|P6|NOT COMPLETED|Part 2||15
7719478|NCT01683071|19008063|P5|NOT COMPLETED|Part 2||17
7719479|NCT01683071|19008064|P4|NOT COMPLETED|Part 2||0
7719480|NCT01683071|19008065|P3|NOT COMPLETED|Part 2||0
7719481|NCT01683071|19008066|P2|NOT COMPLETED|Part 2||0
7719482|NCT01683071|19008067|P1|NOT COMPLETED|Part 2||0
7719483|NCT01683071|19008062|P6|COMPLETED|Part 2||82
7719484|NCT01683071|19008063|P5|COMPLETED|Part 2||82
7719485|NCT01683071|19008064|P4|COMPLETED|Part 2||0
7719486|NCT01683071|19008065|P3|COMPLETED|Part 2||0
7719487|NCT01683071|19008066|P2|COMPLETED|Part 2||0
7719488|NCT01683071|19008067|P1|COMPLETED|Part 2||0
7719489|NCT01683071|19008062|P6|STARTED|Part 2||97
7719490|NCT01683071|19008063|P5|STARTED|Part 2||99
7719491|NCT01683071|19008064|P4|STARTED|Part 2||0
7719492|NCT01683071|19008065|P3|STARTED|Part 2||0
7719493|NCT01683071|19008066|P2|STARTED|Part 2||0
7719494|NCT01683071|19008067|P1|STARTED|Part 2||0
7719495|NCT01683071|19008062|P6|NOT COMPLETED|Part 1||0
7719496|NCT01683071|19008063|P5|NOT COMPLETED|Part 1||0
7719497|NCT01683071|19008064|P4|NOT COMPLETED|Part 1||5
7719498|NCT01683071|19008065|P3|NOT COMPLETED|Part 1||3
7719499|NCT01683071|19008066|P2|NOT COMPLETED|Part 1||4
7719500|NCT01683071|19008067|P1|NOT COMPLETED|Part 1||4
7719501|NCT01683071|19008062|P6|COMPLETED|Part 1||0
7719502|NCT01683071|19008063|P5|COMPLETED|Part 1||0
7719503|NCT01683071|19008064|P4|COMPLETED|Part 1||20
7719504|NCT01683071|19008065|P3|COMPLETED|Part 1||22
7719505|NCT01683071|19008066|P2|COMPLETED|Part 1||22
7719506|NCT01683071|19008067|P1|COMPLETED|Part 1||21
7719507|NCT01683071|19008062|P6|STARTED|Part 1||0
7719508|NCT01683071|19008063|P5|STARTED|Part 1||0
7719509|NCT01683071|19008064|P4|STARTED|Part 1||25
7719510|NCT01683071|19008065|P3|STARTED|Part 1||25
7719511|NCT01683071|19008066|P2|STARTED|Part 1||26
7719512|NCT01683071|19008067|P1|STARTED|Part 1||25
7719513|NCT01683058|19008093|P1|NOT COMPLETED|Overall Study||29
7719514|NCT01683058|19008093|P1|COMPLETED|Overall Study||45
7719515|NCT01683058|19008093|P1|STARTED|Overall Study||74
7719516|NCT01683019|19008124|P3|NOT COMPLETED|Overall Study||4
7719517|NCT01683019|19008125|P2|NOT COMPLETED|Overall Study||1
7719518|NCT01683019|19008126|P1|NOT COMPLETED|Overall Study||2
7719519|NCT01683019|19008124|P3|COMPLETED|Overall Study||15
7719520|NCT01683019|19008125|P2|COMPLETED|Overall Study||14
7719521|NCT01683019|19008126|P1|COMPLETED|Overall Study||16
7719522|NCT01683019|19008124|P3|STARTED|Overall Study||19
7719523|NCT01683019|19008125|P2|STARTED|Overall Study||15
7719524|NCT01683019|19008126|P1|STARTED|Overall Study||18
7719525|NCT01682954|19008136|P2|NOT COMPLETED|Overall Study||5
7719526|NCT01682954|19008137|P1|NOT COMPLETED|Overall Study||5
7719527|NCT01682954|19008136|P2|COMPLETED|Overall Study||33
7719528|NCT01682954|19008137|P1|COMPLETED|Overall Study||35
7719529|NCT01682954|19008136|P2|STARTED|Overall Study||38
7719530|NCT01682954|19008137|P1|STARTED|Overall Study||40
7719531|NCT01682928|19008147|P2|NOT COMPLETED|Overall Study||0
7719532|NCT01682928|19008148|P1|NOT COMPLETED|Overall Study||0
7719533|NCT01682928|19008147|P2|COMPLETED|Overall Study||2
7719534|NCT01682928|19008148|P1|COMPLETED|Overall Study||2
7719535|NCT01682928|19008147|P2|STARTED|Overall Study|2 subjects in this Arm|2
7719536|NCT01682928|19008148|P1|STARTED|Overall Study|2 subjects in this Arm|2
7719537|NCT01682876|19008160|P4|NOT COMPLETED|Overall Study||19
7719538|NCT01682876|19008161|P3|NOT COMPLETED|Overall Study||11
7719539|NCT01682876|19008162|P2|NOT COMPLETED|Overall Study||20
7719540|NCT01682876|19008163|P1|NOT COMPLETED|Overall Study||21
7719541|NCT01682876|19008160|P4|COMPLETED|Overall Study||157
7719542|NCT01682876|19008161|P3|COMPLETED|Overall Study||169
7719543|NCT01682876|19008162|P2|COMPLETED|Overall Study||163
7719544|NCT01682876|19008163|P1|COMPLETED|Overall Study||155
7719545|NCT01682876|19008160|P4|STARTED|Overall Study||176
7719546|NCT01682876|19008161|P3|STARTED|Overall Study||180
7719547|NCT01682876|19008162|P2|STARTED|Overall Study||183
7719548|NCT01682876|19008163|P1|STARTED|Overall Study||176
7719549|NCT01682863|19008209|P3|NOT COMPLETED|Overall Study||24
7719550|NCT01682863|19008210|P2|NOT COMPLETED|Overall Study||17
7719551|NCT01682863|19008211|P1|NOT COMPLETED|Overall Study||27
7719552|NCT01682863|19008209|P3|COMPLETED|Overall Study||183
7719553|NCT01682863|19008210|P2|COMPLETED|Overall Study||187
7719554|NCT01682863|19008211|P1|COMPLETED|Overall Study||177
7719555|NCT01682863|19008209|P3|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207
7719556|NCT01682863|19008210|P2|Randomized Set|Overall Study||204
7719557|NCT01682863|19008211|P1|Randomized Set|Overall Study||204
7719558|NCT01682863|19008209|P3|Full Analysis Set (FAS)|Overall Study||206
7719559|NCT01682863|19008210|P2|Full Analysis Set (FAS)|Overall Study||204
7719560|NCT01682863|19008211|P1|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204
7719561|NCT01682863|19008209|P3|Safety Set|Overall Study||206
7719562|NCT01682863|19008210|P2|Safety Set|Overall Study||204
7719563|NCT01682863|19008211|P1|Safety Set|Overall Study||204
7719564|NCT01682863|19008209|P3|STARTED|Overall Study||207
7719565|NCT01682863|19008210|P2|STARTED|Overall Study||204
7719566|NCT01682863|19008211|P1|STARTED|Overall Study||204
7719567|NCT01682837|19008240|P1|NOT COMPLETED|Fourth Intervention (4 Weeks)||0
7719568|NCT01682837|19008240|P1|COMPLETED|Fourth Intervention (4 Weeks)||30
7719569|NCT01682837|19008240|P1|Received Placebo|Fourth Intervention (4 Weeks)||7
7719570|NCT01682837|19008240|P1|Received KCl|Fourth Intervention (4 Weeks)||8
7719571|NCT01682837|19008240|P1|Received KCit|Fourth Intervention (4 Weeks)||9
7719662|NCT01682148|19008454|P1|COMPLETED|Overall Study||40
7719572|NCT01682837|19008240|P1|Received KMgCit|Fourth Intervention (4 Weeks)||6
7719573|NCT01682837|19008240|P1|STARTED|Fourth Intervention (4 Weeks)||30
7719574|NCT01682837|19008240|P1|NOT COMPLETED|Third Intervention (4 Weeks)||0
7719575|NCT01682837|19008240|P1|COMPLETED|Third Intervention (4 Weeks)||30
7719576|NCT01682837|19008240|P1|Received Placebo|Third Intervention (4 Weeks)||7
7719577|NCT01682837|19008240|P1|Received KCl|Third Intervention (4 Weeks)||7
7719578|NCT01682837|19008240|P1|Received KCit|Third Intervention (4 Weeks)||7
7719579|NCT01682837|19008240|P1|Received KMgCit|Third Intervention (4 Weeks)||9
7719580|NCT01682837|19008240|P1|STARTED|Third Intervention (4 Weeks)||30
7719581|NCT01682837|19008240|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
7719582|NCT01682837|19008240|P1|COMPLETED|Second Intervention (4 Weeks)||30
7719583|NCT01682837|19008240|P1|Received Placebo|Second Intervention (4 Weeks)||9
7719584|NCT01682837|19008240|P1|Received KCl|Second Intervention (4 Weeks)||8
7719585|NCT01682837|19008240|P1|Received KCit|Second Intervention (4 Weeks)||6
7719586|NCT01682837|19008240|P1|Received KMgCit|Second Intervention (4 Weeks)||7
7719587|NCT01682837|19008240|P1|STARTED|Second Intervention (4 Weeks)||30
7719588|NCT01682837|19008240|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
7719589|NCT01682837|19008240|P1|COMPLETED|First Intervention (4 Weeks)||30
7719590|NCT01682837|19008240|P1|Received Placebo|First Intervention (4 Weeks)||7
7719591|NCT01682837|19008240|P1|Received KCl|First Intervention (4 Weeks)||7
7719592|NCT01682837|19008240|P1|Received KCit|First Intervention (4 Weeks)||8
7719593|NCT01682837|19008240|P1|Received KMgCit|First Intervention (4 Weeks)||8
7719594|NCT01682837|19008240|P1|STARTED|First Intervention (4 Weeks)||30
7719595|NCT01682837|19008240|P1|NOT COMPLETED|Baseline||5
7719596|NCT01682837|19008240|P1|COMPLETED|Baseline||30
7719597|NCT01682837|19008240|P1|STARTED|Baseline||35
7719598|NCT01682759|19008284|P2|NOT COMPLETED|Overall Study||70
7719599|NCT01682759|19008285|P1|NOT COMPLETED|Overall Study||69
7719600|NCT01682759|19008284|P2|COMPLETED|Overall Study||305
7719601|NCT01682759|19008285|P1|COMPLETED|Overall Study||307
7719602|NCT01682759|19008284|P2|Treated|Overall Study||375
7719603|NCT01682759|19008285|P1|Treated|Overall Study||375
7719604|NCT01682759|19008284|P2|STARTED|Overall Study||375
7719605|NCT01682759|19008285|P1|STARTED|Overall Study||376
7719606|NCT01682720|19008309|P4|NOT COMPLETED|Overall Study||39
7719607|NCT01682720|19008310|P3|NOT COMPLETED|Overall Study||7
7719608|NCT01682720|19008311|P2|NOT COMPLETED|Overall Study||5
7719609|NCT01682720|19008312|P1|NOT COMPLETED|Overall Study||85
7719610|NCT01682720|19008309|P4|COMPLETED|Overall Study||211
7719611|NCT01682720|19008310|P3|COMPLETED|Overall Study||5
7719612|NCT01682720|19008311|P2|COMPLETED|Overall Study||69
7719613|NCT01682720|19008312|P1|COMPLETED|Overall Study||0
7719614|NCT01682720|19008309|P4|Included in Full Analysis Set|Overall Study||250
7719615|NCT01682720|19008310|P3|Included in Full Analysis Set|Overall Study||11
7719616|NCT01682720|19008311|P2|Included in Full Analysis Set|Overall Study||73
7719617|NCT01682720|19008312|P1|Included in Full Analysis Set|Overall Study||0
7719618|NCT01682720|19008309|P4|STARTED|Overall Study||250
7719619|NCT01682720|19008310|P3|STARTED|Overall Study||12
7719620|NCT01682720|19008311|P2|STARTED|Overall Study||74
7719621|NCT01682720|19008312|P1|STARTED|Overall Study||85
7719622|NCT01682681|19008329|P1|NOT COMPLETED|Overall Study||332
7719623|NCT01682681|19008329|P1|COMPLETED|Overall Study||902
7719624|NCT01682681|19008329|P1|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232
7719625|NCT01682681|19008329|P1|STARTED|Overall Study||1234
7719626|NCT01682642|19008339|P2|NOT COMPLETED|Overall Study||1
7719627|NCT01682642|19008340|P1|NOT COMPLETED|Overall Study||0
7719628|NCT01682642|19008339|P2|COMPLETED|Overall Study||58
7719629|NCT01682642|19008340|P1|COMPLETED|Overall Study||61
7719630|NCT01682642|19008339|P2|STARTED|Overall Study||59
7719631|NCT01682642|19008340|P1|STARTED|Overall Study||61
7719632|NCT01682603|19008358|P1|NOT COMPLETED|Overall Study||3
7719633|NCT01682603|19008358|P1|COMPLETED|Overall Study||34
7719634|NCT01682603|19008358|P1|STARTED|Overall Study||37
7719635|NCT01682538|19008372|P1|NOT COMPLETED|Overall Study||0
7719636|NCT01682538|19008372|P1|COMPLETED|Overall Study||12
7719637|NCT01682538|19008372|P1|STARTED|Overall Study||12
7719638|NCT01682512|19008403|P3|NOT COMPLETED|Overall Study||18
7719639|NCT01682512|19008404|P2|NOT COMPLETED|Overall Study||71
7719640|NCT01682512|19008405|P1|NOT COMPLETED|Overall Study||72
7719641|NCT01682512|19008403|P3|COMPLETED|Overall Study||48
7719642|NCT01682512|19008404|P2|COMPLETED|Overall Study||40
7719643|NCT01682512|19008405|P1|COMPLETED|Overall Study||44
7719644|NCT01682512|19008403|P3|Randomized in Part-II|Overall Study||0
7719645|NCT01682512|19008404|P2|Randomized in Part-II|Overall Study||46
7719646|NCT01682512|19008405|P1|Randomized in Part-II|Overall Study||50
7719647|NCT01682512|19008403|P3|Randomized in Part-I|Overall Study||66
7719648|NCT01682512|19008404|P2|Randomized in Part-I|Overall Study||65
7719649|NCT01682512|19008405|P1|Randomized in Part-I|Overall Study||66
7719650|NCT01682512|19008403|P3|STARTED|Overall Study||66
7719651|NCT01682512|19008404|P2|STARTED|Overall Study||111
7719652|NCT01682512|19008405|P1|STARTED|Overall Study||116
7719653|NCT01682460|19008430|P1|NOT COMPLETED|Overall Study||4
7719654|NCT01682460|19008430|P1|COMPLETED|Overall Study||11
7719655|NCT01682460|19008430|P1|STARTED|Overall Study||15
7719656|NCT01682213|19008445|P1|NOT COMPLETED|Overall Study||2
7719657|NCT01682213|19008445|P1|COMPLETED|Overall Study||21
7719658|NCT01682213|19008445|P1|STARTED|Overall Study||23
7719659|NCT01682148|19008453|P2|NOT COMPLETED|Overall Study||3
7719660|NCT01682148|19008454|P1|NOT COMPLETED|Overall Study||4
7719661|NCT01682148|19008453|P2|COMPLETED|Overall Study||41
7719663|NCT01682148|19008453|P2|STARTED|Overall Study||44
7719664|NCT01682148|19008454|P1|STARTED|Overall Study||44
7719665|NCT01682135|19008478|P3|NOT COMPLETED|Overall Study||0
7719666|NCT01682135|19008479|P2|NOT COMPLETED|Overall Study||0
7719667|NCT01682135|19008480|P1|NOT COMPLETED|Overall Study||0
7719668|NCT01682135|19008478|P3|COMPLETED|Overall Study||12
7719669|NCT01682135|19008479|P2|COMPLETED|Overall Study||10
7719670|NCT01682135|19008480|P1|COMPLETED|Overall Study||6
7719671|NCT01682135|19008478|P3|Received at Least 1 Dose of Study Drug|Overall Study||12
7719672|NCT01682135|19008479|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
7719673|NCT01682135|19008480|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
7719674|NCT01682135|19008478|P3|STARTED|Overall Study||12
7719675|NCT01682135|19008479|P2|STARTED|Overall Study||10
7719676|NCT01682135|19008480|P1|STARTED|Overall Study||6
7719677|NCT01682083|19008514|P2|NOT COMPLETED|Overall Study||155
7719678|NCT01682083|19008515|P1|NOT COMPLETED|Overall Study||107
7719679|NCT01682083|19008514|P2|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off.|277
7719680|NCT01682083|19008515|P1|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off. 3 patients were untreated|331
7719681|NCT01682083|19008514|P2|STARTED|Overall Study||432
7719682|NCT01682083|19008515|P1|STARTED|Overall Study||438
7719683|NCT01682044|19008527|P1|NOT COMPLETED|Overall Study||4
7719684|NCT01682044|19008527|P1|COMPLETED|Overall Study||16
7719685|NCT01682044|19008527|P1|STARTED|Overall Study||20
7719686|NCT01682031|19008539|P2|NOT COMPLETED|Overall Study||5
7719687|NCT01682031|19008540|P1|NOT COMPLETED|Overall Study||1
7719688|NCT01682031|19008539|P2|COMPLETED|Overall Study||5
7719689|NCT01682031|19008540|P1|COMPLETED|Overall Study||7
7719690|NCT01682031|19008539|P2|STARTED|Overall Study||10
7719691|NCT01682031|19008540|P1|STARTED|Overall Study||8
7719692|NCT01681992|19008563|P3|NOT COMPLETED|Overall Study||83
7719693|NCT01681992|19008564|P2|NOT COMPLETED|Overall Study||70
7719694|NCT01681992|19008565|P1|NOT COMPLETED|Overall Study||66
7719695|NCT01681992|19008563|P3|COMPLETED|Overall Study||1443
7719696|NCT01681992|19008564|P2|COMPLETED|Overall Study||1427
7719697|NCT01681992|19008565|P1|COMPLETED|Overall Study||1427
7719698|NCT01681992|19008563|P3|STARTED|Overall Study||1526
7719699|NCT01681992|19008564|P2|STARTED|Overall Study||1497
7719700|NCT01681992|19008565|P1|STARTED|Overall Study||1493
7719701|NCT01681849|19008654|P3|NOT COMPLETED|Overall Study||39
7719702|NCT01681849|19008655|P2|NOT COMPLETED|Overall Study||7
7719703|NCT01681849|19008656|P1|NOT COMPLETED|Overall Study||8
7719704|NCT01681849|19008654|P3|COMPLETED|Overall Study||17
7719705|NCT01681849|19008655|P2|COMPLETED|Overall Study||6
7719706|NCT01681849|19008656|P1|COMPLETED|Overall Study||7
7719707|NCT01681849|19008654|P3|STARTED|Overall Study||56
7719708|NCT01681849|19008655|P2|STARTED|Overall Study||13
7719709|NCT01681849|19008656|P1|STARTED|Overall Study||15
7719710|NCT01681836|19008665|P2|NOT COMPLETED|Second Intervention||1
7719711|NCT01681836|19008666|P1|NOT COMPLETED|Second Intervention||0
7719712|NCT01681836|19008665|P2|COMPLETED|Second Intervention||4
7719713|NCT01681836|19008666|P1|COMPLETED|Second Intervention||6
7719714|NCT01681836|19008665|P2|STARTED|Second Intervention||5
7719715|NCT01681836|19008666|P1|STARTED|Second Intervention||6
7719716|NCT01681836|19008665|P2|NOT COMPLETED|Washout Period of 3-7 Days||0
7719717|NCT01681836|19008666|P1|NOT COMPLETED|Washout Period of 3-7 Days||0
7719718|NCT01681836|19008665|P2|COMPLETED|Washout Period of 3-7 Days||5
7719719|NCT01681836|19008666|P1|COMPLETED|Washout Period of 3-7 Days||6
7719720|NCT01681836|19008665|P2|STARTED|Washout Period of 3-7 Days||5
7719721|NCT01681836|19008666|P1|STARTED|Washout Period of 3-7 Days||6
7719722|NCT01681836|19008665|P2|NOT COMPLETED|First Intervention||0
7719723|NCT01681836|19008666|P1|NOT COMPLETED|First Intervention||0
7719724|NCT01681836|19008665|P2|COMPLETED|First Intervention||5
7719725|NCT01681836|19008666|P1|COMPLETED|First Intervention||6
7719726|NCT01681836|19008665|P2|STARTED|First Intervention||5
7719727|NCT01681836|19008666|P1|STARTED|First Intervention||6
7719728|NCT01681810|19008690|P1|NOT COMPLETED|Overall Study||0
7719729|NCT01681810|19008690|P1|COMPLETED|Overall Study||20
7719730|NCT01681810|19008690|P1|STARTED|Overall Study||20
7719731|NCT01681771|19008700|P2|NOT COMPLETED|Overall Study||2
7719732|NCT01681771|19008701|P1|NOT COMPLETED|Overall Study||4
7719733|NCT01681771|19008700|P2|COMPLETED|Overall Study||23
7719734|NCT01681771|19008701|P1|COMPLETED|Overall Study||21
7719735|NCT01681771|19008700|P2|STARTED|Overall Study||25
7719736|NCT01681771|19008701|P1|STARTED|Overall Study||25
7719737|NCT01681628|19008709|P2|NOT COMPLETED|19 Months Follow-up||43
7719738|NCT01681628|19008710|P1|NOT COMPLETED|19 Months Follow-up||62
7719739|NCT01681628|19008709|P2|COMPLETED|19 Months Follow-up||64
7719740|NCT01681628|19008710|P1|COMPLETED|19 Months Follow-up||52
7719741|NCT01681628|19008709|P2|STARTED|19 Months Follow-up||107
7719742|NCT01681628|19008710|P1|STARTED|19 Months Follow-up||114
7719743|NCT01681628|19008709|P2|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15
7719744|NCT01681628|19008710|P1|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0
7719745|NCT01681628|19008709|P2|COMPLETED|Time 2 to Time 3 (One Week Later).||107
7719746|NCT01681628|19008710|P1|COMPLETED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
7719747|NCT01681628|19008709|P2|STARTED|Time 2 to Time 3 (One Week Later).||122
7719748|NCT01681628|19008710|P1|STARTED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
7719749|NCT01681628|19008709|P2|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6
7719750|NCT01681628|19008710|P1|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14
7719839|NCT01681186|19009058|P3|COMPLETED|Fourth Intervention||0
7719751|NCT01681628|19008709|P2|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122
7719752|NCT01681628|19008710|P1|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114
7719753|NCT01681628|19008709|P2|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
7719754|NCT01681628|19008710|P1|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
7719755|NCT01681589|19008724|P3|NOT COMPLETED|Overall Study||0
7719756|NCT01681589|19008725|P2|NOT COMPLETED|Overall Study||0
7719757|NCT01681589|19008726|P1|NOT COMPLETED|Overall Study||0
7719758|NCT01681589|19008724|P3|COMPLETED|Overall Study||0
7719759|NCT01681589|19008725|P2|COMPLETED|Overall Study||0
7719760|NCT01681589|19008726|P1|COMPLETED|Overall Study||0
7719761|NCT01681589|19008724|P3|STARTED|Overall Study||0
7719762|NCT01681589|19008725|P2|STARTED|Overall Study||0
7719763|NCT01681589|19008726|P1|STARTED|Overall Study||0
7719764|NCT01681576|19008739|P2|NOT COMPLETED|Period 2||1
7719765|NCT01681576|19008740|P1|NOT COMPLETED|Period 2||4
7719766|NCT01681576|19008739|P2|COMPLETED|Period 2||35
7719767|NCT01681576|19008740|P1|COMPLETED|Period 2||30
7719768|NCT01681576|19008739|P2|STARTED|Period 2|Period 2: LCZ696 400mg|36
7719769|NCT01681576|19008740|P1|STARTED|Period 2|Period 2: Valsartan 320mg|34
7719770|NCT01681576|19008739|P2|NOT COMPLETED|Period 1||0
7719771|NCT01681576|19008740|P1|NOT COMPLETED|Period 1||2
7719772|NCT01681576|19008739|P2|COMPLETED|Period 1||36
7719773|NCT01681576|19008740|P1|COMPLETED|Period 1||34
7719774|NCT01681576|19008739|P2|STARTED|Period 1||36
7719775|NCT01681576|19008740|P1|STARTED|Period 1||36
7719776|NCT01681511|19008756|P2|NOT COMPLETED|Overall Study||14
7719777|NCT01681511|19008757|P1|NOT COMPLETED|Overall Study||18
7719778|NCT01681511|19008756|P2|COMPLETED|Overall Study||35
7719779|NCT01681511|19008757|P1|COMPLETED|Overall Study||28
7719780|NCT01681511|19008756|P2|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14
7719781|NCT01681511|19008757|P1|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16
7719782|NCT01681511|19008756|P2|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46
7719783|NCT01681511|19008757|P1|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45
7719784|NCT01681511|19008756|P2|STARTED|Overall Study|All randomized subjects in the TIC arm.|49
7719785|NCT01681511|19008757|P1|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46
7719786|NCT01681472|19008775|P4|NOT COMPLETED|Overall Study||0
7719787|NCT01681472|19008776|P3|NOT COMPLETED|Overall Study||0
7719788|NCT01681472|19008777|P2|NOT COMPLETED|Overall Study||1
7719789|NCT01681472|19008778|P1|NOT COMPLETED|Overall Study||0
7719790|NCT01681472|19008775|P4|COMPLETED|Overall Study||8
7719791|NCT01681472|19008776|P3|COMPLETED|Overall Study||8
7719792|NCT01681472|19008777|P2|COMPLETED|Overall Study||7
7719793|NCT01681472|19008778|P1|COMPLETED|Overall Study||8
7719794|NCT01681472|19008775|P4|STARTED|Overall Study||8
7719795|NCT01681472|19008776|P3|STARTED|Overall Study||8
7719796|NCT01681472|19008777|P2|STARTED|Overall Study||8
7719797|NCT01681472|19008778|P1|STARTED|Overall Study||8
7719798|NCT01681433|19008958|P2|NOT COMPLETED|Overall Study||33
7719799|NCT01681433|19008959|P1|NOT COMPLETED|Overall Study||32
7719800|NCT01681433|19008958|P2|COMPLETED|Overall Study||3
7719801|NCT01681433|19008959|P1|COMPLETED|Overall Study||4
7719802|NCT01681433|19008958|P2|STARTED|Overall Study||36
7719803|NCT01681433|19008959|P1|STARTED|Overall Study||36
7719804|NCT01681368|19008977|P1|NOT COMPLETED|Overall Study||2
7719805|NCT01681368|19008977|P1|COMPLETED|Overall Study||9
7719806|NCT01681368|19008977|P1|STARTED|Overall Study||11
7719807|NCT01681277|19008994|P5|NOT COMPLETED|Overall Study||0
7719808|NCT01681277|19008995|P4|NOT COMPLETED|Overall Study||0
7719809|NCT01681277|19008996|P3|NOT COMPLETED|Overall Study||0
7719810|NCT01681277|19008997|P2|NOT COMPLETED|Overall Study||0
7719811|NCT01681277|19008998|P1|NOT COMPLETED|Overall Study||1
7719812|NCT01681277|19008994|P5|COMPLETED|Overall Study||9
7719813|NCT01681277|19008995|P4|COMPLETED|Overall Study||9
7719814|NCT01681277|19008996|P3|COMPLETED|Overall Study||9
7719815|NCT01681277|19008997|P2|COMPLETED|Overall Study||9
7719816|NCT01681277|19008998|P1|COMPLETED|Overall Study||11
7719817|NCT01681277|19008994|P5|STARTED|Overall Study||9
7719818|NCT01681277|19008995|P4|STARTED|Overall Study||9
7719819|NCT01681277|19008996|P3|STARTED|Overall Study||9
7719820|NCT01681277|19008997|P2|STARTED|Overall Study||9
7719821|NCT01681277|19008998|P1|STARTED|Overall Study||12
7719822|NCT01681212|19009039|P1|NOT COMPLETED|Overall Study||6
7719823|NCT01681212|19009039|P1|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15
7719824|NCT01681212|19009039|P1|Received Treatment|Overall Study||15
7719825|NCT01681212|19009039|P1|STARTED|Overall Study|Enrolled|21
7719826|NCT01681186|19009053|P8|NOT COMPLETED|Fourth Intervention||1
7719827|NCT01681186|19009054|P7|NOT COMPLETED|Fourth Intervention||0
7719828|NCT01681186|19009055|P6|NOT COMPLETED|Fourth Intervention||0
7719829|NCT01681186|19009056|P5|NOT COMPLETED|Fourth Intervention||0
7719830|NCT01681186|19009057|P4|NOT COMPLETED|Fourth Intervention||0
7719831|NCT01681186|19009058|P3|NOT COMPLETED|Fourth Intervention||0
7719832|NCT01681186|19009059|P2|NOT COMPLETED|Fourth Intervention||0
7719833|NCT01681186|19009060|P1|NOT COMPLETED|Fourth Intervention||0
7719834|NCT01681186|19009053|P8|COMPLETED|Fourth Intervention||5
7719835|NCT01681186|19009054|P7|COMPLETED|Fourth Intervention||5
7719836|NCT01681186|19009055|P6|COMPLETED|Fourth Intervention||0
7719837|NCT01681186|19009056|P5|COMPLETED|Fourth Intervention||0
7719838|NCT01681186|19009057|P4|COMPLETED|Fourth Intervention||0
7719840|NCT01681186|19009059|P2|COMPLETED|Fourth Intervention||0
7719841|NCT01681186|19009060|P1|COMPLETED|Fourth Intervention||0
7719842|NCT01681186|19009053|P8|STARTED|Fourth Intervention||6
7719843|NCT01681186|19009054|P7|STARTED|Fourth Intervention||5
7719844|NCT01681186|19009055|P6|STARTED|Fourth Intervention||0
7719845|NCT01681186|19009056|P5|STARTED|Fourth Intervention||0
7719846|NCT01681186|19009057|P4|STARTED|Fourth Intervention||0
7719847|NCT01681186|19009058|P3|STARTED|Fourth Intervention||0
7719848|NCT01681186|19009059|P2|STARTED|Fourth Intervention||0
7719849|NCT01681186|19009060|P1|STARTED|Fourth Intervention||0
7719850|NCT01681186|19009053|P8|NOT COMPLETED|Washout Period From Third Intervention||0
7719851|NCT01681186|19009054|P7|NOT COMPLETED|Washout Period From Third Intervention||1
7719852|NCT01681186|19009055|P6|NOT COMPLETED|Washout Period From Third Intervention||0
7719853|NCT01681186|19009056|P5|NOT COMPLETED|Washout Period From Third Intervention||0
7719854|NCT01681186|19009057|P4|NOT COMPLETED|Washout Period From Third Intervention||0
7719855|NCT01681186|19009058|P3|NOT COMPLETED|Washout Period From Third Intervention||0
7719856|NCT01681186|19009059|P2|NOT COMPLETED|Washout Period From Third Intervention||0
7719857|NCT01681186|19009060|P1|NOT COMPLETED|Washout Period From Third Intervention||0
7719858|NCT01681186|19009053|P8|COMPLETED|Washout Period From Third Intervention||6
7719859|NCT01681186|19009054|P7|COMPLETED|Washout Period From Third Intervention||5
7719860|NCT01681186|19009055|P6|COMPLETED|Washout Period From Third Intervention||0
7719861|NCT01681186|19009056|P5|COMPLETED|Washout Period From Third Intervention||0
7719862|NCT01681186|19009057|P4|COMPLETED|Washout Period From Third Intervention||0
7719863|NCT01681186|19009058|P3|COMPLETED|Washout Period From Third Intervention||0
7719864|NCT01681186|19009059|P2|COMPLETED|Washout Period From Third Intervention||0
7719865|NCT01681186|19009060|P1|COMPLETED|Washout Period From Third Intervention||0
7719866|NCT01681186|19009053|P8|STARTED|Washout Period From Third Intervention||6
7719867|NCT01681186|19009054|P7|STARTED|Washout Period From Third Intervention||6
7719868|NCT01681186|19009055|P6|STARTED|Washout Period From Third Intervention||0
7719869|NCT01681186|19009056|P5|STARTED|Washout Period From Third Intervention||0
7719870|NCT01681186|19009057|P4|STARTED|Washout Period From Third Intervention||0
7719871|NCT01681186|19009058|P3|STARTED|Washout Period From Third Intervention||0
7719872|NCT01681186|19009059|P2|STARTED|Washout Period From Third Intervention||0
7719873|NCT01681186|19009060|P1|STARTED|Washout Period From Third Intervention||0
7719874|NCT01681186|19009053|P8|NOT COMPLETED|Third Intervention||0
7719875|NCT01681186|19009054|P7|NOT COMPLETED|Third Intervention||0
7719876|NCT01681186|19009055|P6|NOT COMPLETED|Third Intervention||0
7719877|NCT01681186|19009056|P5|NOT COMPLETED|Third Intervention||0
7719878|NCT01681186|19009057|P4|NOT COMPLETED|Third Intervention||0
7719879|NCT01681186|19009058|P3|NOT COMPLETED|Third Intervention||0
7719880|NCT01681186|19009059|P2|NOT COMPLETED|Third Intervention||0
7719881|NCT01681186|19009060|P1|NOT COMPLETED|Third Intervention||0
7719882|NCT01681186|19009053|P8|COMPLETED|Third Intervention||6
7719883|NCT01681186|19009054|P7|COMPLETED|Third Intervention||6
7719884|NCT01681186|19009055|P6|COMPLETED|Third Intervention||0
7719885|NCT01681186|19009056|P5|COMPLETED|Third Intervention||0
7719886|NCT01681186|19009057|P4|COMPLETED|Third Intervention||0
7719887|NCT01681186|19009058|P3|COMPLETED|Third Intervention||0
7719888|NCT01681186|19009059|P2|COMPLETED|Third Intervention||0
7719889|NCT01681186|19009060|P1|COMPLETED|Third Intervention||0
7719890|NCT01681186|19009053|P8|STARTED|Third Intervention||6
7719891|NCT01681186|19009054|P7|STARTED|Third Intervention||6
7719892|NCT01681186|19009055|P6|STARTED|Third Intervention||0
7719893|NCT01681186|19009056|P5|STARTED|Third Intervention||0
7719894|NCT01681186|19009057|P4|STARTED|Third Intervention||0
7719895|NCT01681186|19009058|P3|STARTED|Third Intervention||0
7719896|NCT01681186|19009059|P2|STARTED|Third Intervention||0
7719897|NCT01681186|19009060|P1|STARTED|Third Intervention||0
7719898|NCT01681186|19009053|P8|NOT COMPLETED|Washout Period From Second Intervention||1
7719899|NCT01681186|19009054|P7|NOT COMPLETED|Washout Period From Second Intervention||1
7719900|NCT01681186|19009055|P6|NOT COMPLETED|Washout Period From Second Intervention||0
7719901|NCT01681186|19009056|P5|NOT COMPLETED|Washout Period From Second Intervention||0
7719902|NCT01681186|19009057|P4|NOT COMPLETED|Washout Period From Second Intervention||0
7719903|NCT01681186|19009058|P3|NOT COMPLETED|Washout Period From Second Intervention||0
7719904|NCT01681186|19009059|P2|NOT COMPLETED|Washout Period From Second Intervention||0
7719905|NCT01681186|19009060|P1|NOT COMPLETED|Washout Period From Second Intervention||0
7719906|NCT01681186|19009053|P8|COMPLETED|Washout Period From Second Intervention||6
7719907|NCT01681186|19009054|P7|COMPLETED|Washout Period From Second Intervention||6
7719908|NCT01681186|19009055|P6|COMPLETED|Washout Period From Second Intervention||0
7719909|NCT01681186|19009056|P5|COMPLETED|Washout Period From Second Intervention||0
7719910|NCT01681186|19009057|P4|COMPLETED|Washout Period From Second Intervention||0
7719911|NCT01681186|19009058|P3|COMPLETED|Washout Period From Second Intervention||0
7719912|NCT01681186|19009059|P2|COMPLETED|Washout Period From Second Intervention||0
7719913|NCT01681186|19009060|P1|COMPLETED|Washout Period From Second Intervention||0
7719914|NCT01681186|19009053|P8|STARTED|Washout Period From Second Intervention||7
7719915|NCT01681186|19009054|P7|STARTED|Washout Period From Second Intervention||7
7719916|NCT01681186|19009055|P6|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
7719917|NCT01681186|19009056|P5|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
7719999|NCT01681121|19009114|P1|STARTED|Overall Study||44
7719918|NCT01681186|19009057|P4|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
7719919|NCT01681186|19009058|P3|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
7719920|NCT01681186|19009059|P2|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
7719921|NCT01681186|19009060|P1|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
7719922|NCT01681186|19009053|P8|NOT COMPLETED|Second Intervention||0
7719923|NCT01681186|19009054|P7|NOT COMPLETED|Second Intervention||0
7719924|NCT01681186|19009055|P6|NOT COMPLETED|Second Intervention||0
7719925|NCT01681186|19009056|P5|NOT COMPLETED|Second Intervention||0
7719926|NCT01681186|19009057|P4|NOT COMPLETED|Second Intervention||0
7719927|NCT01681186|19009058|P3|NOT COMPLETED|Second Intervention||0
7719928|NCT01681186|19009059|P2|NOT COMPLETED|Second Intervention||0
7719929|NCT01681186|19009060|P1|NOT COMPLETED|Second Intervention||0
7719930|NCT01681186|19009053|P8|COMPLETED|Second Intervention||7
7719931|NCT01681186|19009054|P7|COMPLETED|Second Intervention||7
7719932|NCT01681186|19009055|P6|COMPLETED|Second Intervention||2
7719933|NCT01681186|19009056|P5|COMPLETED|Second Intervention||3
7719934|NCT01681186|19009057|P4|COMPLETED|Second Intervention||3
7719935|NCT01681186|19009058|P3|COMPLETED|Second Intervention||2
7719936|NCT01681186|19009059|P2|COMPLETED|Second Intervention||2
7719937|NCT01681186|19009060|P1|COMPLETED|Second Intervention||4
7719938|NCT01681186|19009053|P8|STARTED|Second Intervention||7
7719939|NCT01681186|19009054|P7|STARTED|Second Intervention||7
7719940|NCT01681186|19009055|P6|STARTED|Second Intervention||2
7719941|NCT01681186|19009056|P5|STARTED|Second Intervention||3
7719942|NCT01681186|19009057|P4|STARTED|Second Intervention||3
7719943|NCT01681186|19009058|P3|STARTED|Second Intervention||2
7719944|NCT01681186|19009059|P2|STARTED|Second Intervention||2
7719945|NCT01681186|19009060|P1|STARTED|Second Intervention||4
7719946|NCT01681186|19009053|P8|NOT COMPLETED|Washout Period From First Intervention||0
7719947|NCT01681186|19009054|P7|NOT COMPLETED|Washout Period From First Intervention||0
7719948|NCT01681186|19009055|P6|NOT COMPLETED|Washout Period From First Intervention||0
7719949|NCT01681186|19009056|P5|NOT COMPLETED|Washout Period From First Intervention||0
7719950|NCT01681186|19009057|P4|NOT COMPLETED|Washout Period From First Intervention||0
7719951|NCT01681186|19009058|P3|NOT COMPLETED|Washout Period From First Intervention||0
7719952|NCT01681186|19009059|P2|NOT COMPLETED|Washout Period From First Intervention||0
7719953|NCT01681186|19009060|P1|NOT COMPLETED|Washout Period From First Intervention||0
7719954|NCT01681186|19009053|P8|COMPLETED|Washout Period From First Intervention||7
7719955|NCT01681186|19009054|P7|COMPLETED|Washout Period From First Intervention||7
7719956|NCT01681186|19009055|P6|COMPLETED|Washout Period From First Intervention||2
7719957|NCT01681186|19009056|P5|COMPLETED|Washout Period From First Intervention||3
7719958|NCT01681186|19009057|P4|COMPLETED|Washout Period From First Intervention||3
7719959|NCT01681186|19009058|P3|COMPLETED|Washout Period From First Intervention||2
7719960|NCT01681186|19009059|P2|COMPLETED|Washout Period From First Intervention||2
7719961|NCT01681186|19009060|P1|COMPLETED|Washout Period From First Intervention||4
7719962|NCT01681186|19009053|P8|STARTED|Washout Period From First Intervention||7
7719963|NCT01681186|19009054|P7|STARTED|Washout Period From First Intervention||7
7719964|NCT01681186|19009055|P6|STARTED|Washout Period From First Intervention||2
7719965|NCT01681186|19009056|P5|STARTED|Washout Period From First Intervention||3
7719966|NCT01681186|19009057|P4|STARTED|Washout Period From First Intervention||3
7719967|NCT01681186|19009058|P3|STARTED|Washout Period From First Intervention||2
7719968|NCT01681186|19009059|P2|STARTED|Washout Period From First Intervention||2
7719969|NCT01681186|19009060|P1|STARTED|Washout Period From First Intervention||4
7719970|NCT01681186|19009053|P8|NOT COMPLETED|First Intervention||0
7719971|NCT01681186|19009054|P7|NOT COMPLETED|First Intervention||0
7719972|NCT01681186|19009055|P6|NOT COMPLETED|First Intervention||0
7719973|NCT01681186|19009056|P5|NOT COMPLETED|First Intervention||0
7719974|NCT01681186|19009057|P4|NOT COMPLETED|First Intervention||0
7719975|NCT01681186|19009058|P3|NOT COMPLETED|First Intervention||0
7719976|NCT01681186|19009059|P2|NOT COMPLETED|First Intervention||0
7719977|NCT01681186|19009060|P1|NOT COMPLETED|First Intervention||0
7719978|NCT01681186|19009053|P8|COMPLETED|First Intervention||7
7719979|NCT01681186|19009054|P7|COMPLETED|First Intervention||7
7719980|NCT01681186|19009055|P6|COMPLETED|First Intervention||2
7719981|NCT01681186|19009056|P5|COMPLETED|First Intervention||3
7719982|NCT01681186|19009057|P4|COMPLETED|First Intervention||3
7719983|NCT01681186|19009058|P3|COMPLETED|First Intervention||2
7719984|NCT01681186|19009059|P2|COMPLETED|First Intervention||2
7719985|NCT01681186|19009060|P1|COMPLETED|First Intervention||4
7719986|NCT01681186|19009053|P8|STARTED|First Intervention||7
7719987|NCT01681186|19009054|P7|STARTED|First Intervention||7
7719988|NCT01681186|19009055|P6|STARTED|First Intervention||2
7719989|NCT01681186|19009056|P5|STARTED|First Intervention||3
7719990|NCT01681186|19009057|P4|STARTED|First Intervention||3
7719991|NCT01681186|19009058|P3|STARTED|First Intervention||2
7719992|NCT01681186|19009059|P2|STARTED|First Intervention||2
7719993|NCT01681186|19009060|P1|STARTED|First Intervention||4
7719994|NCT01681121|19009113|P2|NOT COMPLETED|Overall Study||11
7719995|NCT01681121|19009114|P1|NOT COMPLETED|Overall Study||8
7719996|NCT01681121|19009113|P2|COMPLETED|Overall Study||38
7719997|NCT01681121|19009114|P1|COMPLETED|Overall Study||36
7719998|NCT01681121|19009113|P2|STARTED|Overall Study||49
7720000|NCT01681095|19009122|P2|NOT COMPLETED|Overall Study||0
7720001|NCT01681095|19009123|P1|NOT COMPLETED|Overall Study||0
7720002|NCT01681095|19009122|P2|COMPLETED|Overall Study||55
7720003|NCT01681095|19009123|P1|COMPLETED|Overall Study||55
7720004|NCT01681095|19009122|P2|STARTED|Overall Study||55
7720005|NCT01681095|19009123|P1|STARTED|Overall Study||55
7720006|NCT01681069|19009163|P2|NOT COMPLETED|Overall Study||7
7720007|NCT01681069|19009164|P1|NOT COMPLETED|Overall Study||5
7720008|NCT01681069|19009163|P2|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53
7720009|NCT01681069|19009164|P1|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55
7720010|NCT01681069|19009163|P2|Full Analysis Set (FAS)|Overall Study||60
7720011|NCT01681069|19009164|P1|Full Analysis Set (FAS)|Overall Study||57
7720012|NCT01681069|19009163|P2|STARTED|Overall Study||60
7720013|NCT01681069|19009164|P1|STARTED|Overall Study||60
7720014|NCT01681030|19009177|P3|NOT COMPLETED|Overall Study||0
7720015|NCT01681030|19009178|P2|NOT COMPLETED|Overall Study||0
7720016|NCT01681030|19009179|P1|NOT COMPLETED|Overall Study||0
7720017|NCT01681030|19009177|P3|COMPLETED|Overall Study||11
7720018|NCT01681030|19009178|P2|COMPLETED|Overall Study||18
7720019|NCT01681030|19009179|P1|COMPLETED|Overall Study||13
7720020|NCT01681030|19009177|P3|STARTED|Overall Study||11
7720021|NCT01681030|19009178|P2|STARTED|Overall Study||18
7720022|NCT01681030|19009179|P1|STARTED|Overall Study||13
7720023|NCT01681004|19009201|P2|NOT COMPLETED|Study Completion||8
7720024|NCT01681004|19009202|P1|NOT COMPLETED|Study Completion||12
7720025|NCT01681004|19009201|P2|COMPLETED|Study Completion||36
7720026|NCT01681004|19009202|P1|COMPLETED|Study Completion||89
7720027|NCT01681004|19009201|P2|STARTED|Study Completion||44
7720028|NCT01681004|19009202|P1|STARTED|Study Completion||101
7720029|NCT01681004|19009201|P2|NOT COMPLETED|Primary Endpoint: 6 Months||2
7720030|NCT01681004|19009202|P1|NOT COMPLETED|Primary Endpoint: 6 Months||1
7720031|NCT01681004|19009201|P2|COMPLETED|Primary Endpoint: 6 Months||44
7720032|NCT01681004|19009202|P1|COMPLETED|Primary Endpoint: 6 Months||101
7720033|NCT01681004|19009201|P2|Crossover to Surgical Treatment|Primary Endpoint: 6 Months|Crossover to surgical treatment allowed per study protocol after the 6-month visit was complete.|39
7720034|NCT01681004|19009202|P1|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||0
7720035|NCT01681004|19009201|P2|STARTED|Primary Endpoint: 6 Months||46
7720036|NCT01681004|19009202|P1|STARTED|Primary Endpoint: 6 Months||102
7720037|NCT01680991|19009259|P3|NOT COMPLETED|Overall Study||4
7720038|NCT01680991|19009260|P2|NOT COMPLETED|Overall Study||19
7720039|NCT01680991|19009261|P1|NOT COMPLETED|Overall Study||8
7720040|NCT01680991|19009259|P3|COMPLETED|Overall Study||9
7720041|NCT01680991|19009260|P2|COMPLETED|Overall Study||4
7720042|NCT01680991|19009261|P1|COMPLETED|Overall Study||4
7720043|NCT01680991|19009259|P3|STARTED|Overall Study||13
7720044|NCT01680991|19009260|P2|STARTED|Overall Study||23
7720045|NCT01680991|19009261|P1|STARTED|Overall Study||12
7720046|NCT01680965|19009324|P4|NOT COMPLETED|Overall Study||6
7720047|NCT01680965|19009325|P3|NOT COMPLETED|Overall Study||0
7720048|NCT01680965|19009326|P2|NOT COMPLETED|Overall Study||0
7720049|NCT01680965|19009327|P1|NOT COMPLETED|Overall Study||0
7720050|NCT01680965|19009324|P4|COMPLETED|Overall Study||26
7720051|NCT01680965|19009325|P3|COMPLETED|Overall Study||6
7720052|NCT01680965|19009326|P2|COMPLETED|Overall Study||3
7720053|NCT01680965|19009327|P1|COMPLETED|Overall Study||3
7720054|NCT01680965|19009324|P4|STARTED|Overall Study||32
7720055|NCT01680965|19009325|P3|STARTED|Overall Study||6
7720056|NCT01680965|19009326|P2|STARTED|Overall Study||3
7720057|NCT01680965|19009327|P1|STARTED|Overall Study||3
7720058|NCT01680900|19009338|P2|NOT COMPLETED|Overall Study||1
7720059|NCT01680900|19009339|P1|NOT COMPLETED|Overall Study||4
7720060|NCT01680900|19009338|P2|COMPLETED|Overall Study||11
7720061|NCT01680900|19009339|P1|COMPLETED|Overall Study||20
7720062|NCT01680900|19009338|P2|STARTED|Overall Study||12
7720063|NCT01680900|19009339|P1|STARTED|Overall Study||24
7720064|NCT01680887|19009357|P2|NOT COMPLETED|Overall Study||24
7720065|NCT01680887|19009358|P1|NOT COMPLETED|Overall Study||29
7720066|NCT01680887|19009357|P2|COMPLETED|Overall Study||52
7720067|NCT01680887|19009358|P1|COMPLETED|Overall Study||51
7720068|NCT01680887|19009357|P2|STARTED|Overall Study||76
7720069|NCT01680887|19009358|P1|STARTED|Overall Study||80
7720070|NCT01680861|19009368|P2|NOT COMPLETED|First 12 Months Post-transplant||0
7720071|NCT01680861|19009369|P1|NOT COMPLETED|First 12 Months Post-transplant||0
7720072|NCT01680861|19009368|P2|COMPLETED|First 12 Months Post-transplant||15
7720073|NCT01680861|19009369|P1|COMPLETED|First 12 Months Post-transplant||15
7720074|NCT01680861|19009368|P2|STARTED|First 12 Months Post-transplant||15
7720075|NCT01680861|19009369|P1|STARTED|First 12 Months Post-transplant||15
7720076|NCT01680861|19009368|P2|NOT COMPLETED|Early Post-transplant Period||1
7720077|NCT01680861|19009369|P1|NOT COMPLETED|Early Post-transplant Period||1
7720078|NCT01680861|19009368|P2|COMPLETED|Early Post-transplant Period||15
7720079|NCT01680861|19009369|P1|COMPLETED|Early Post-transplant Period||15
7720080|NCT01680861|19009368|P2|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16
7720081|NCT01680861|19009369|P1|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16
7720082|NCT01680848|19009387|P1|NOT COMPLETED|Overall Study||93
7720083|NCT01680848|19009387|P1|COMPLETED|Overall Study||189
7720084|NCT01680848|19009387|P1|STARTED|Overall Study||282
7720085|NCT01680835|19009391|P1|NOT COMPLETED|Overall Study||25
7720086|NCT01680835|19009391|P1|COMPLETED|Overall Study||83
7720087|NCT01680835|19009391|P1|STARTED|Overall Study||108
7720088|NCT01680783|19009407|P2|NOT COMPLETED|Overall Study||0
7720089|NCT01680783|19009408|P1|NOT COMPLETED|Overall Study||0
7720090|NCT01680783|19009407|P2|COMPLETED|Overall Study||44
7720091|NCT01680783|19009408|P1|COMPLETED|Overall Study||39
7720092|NCT01680783|19009407|P2|STARTED|Overall Study||44
7720093|NCT01680783|19009408|P1|STARTED|Overall Study||39
7720094|NCT01680666|19009426|P2|NOT COMPLETED|Overall Study||0
7720095|NCT01680666|19009427|P1|NOT COMPLETED|Overall Study||0
7720096|NCT01680666|19009426|P2|COMPLETED|Overall Study||66
7720097|NCT01680666|19009427|P1|COMPLETED|Overall Study||84
7720098|NCT01680666|19009426|P2|STARTED|Overall Study||66
7720099|NCT01680666|19009427|P1|STARTED|Overall Study||84
7720100|NCT01680653|19009441|P1|NOT COMPLETED|Overall Study||0
7720101|NCT01680653|19009441|P1|COMPLETED|Overall Study||57
7720102|NCT01680653|19009441|P1|STARTED|Overall Study||57
7720103|NCT01680549|19009453|P2|NOT COMPLETED|Overall Study||8
7720104|NCT01680549|19009454|P1|NOT COMPLETED|Overall Study||5
7720105|NCT01680549|19009453|P2|COMPLETED|Overall Study||17
7720106|NCT01680549|19009454|P1|COMPLETED|Overall Study||20
7720107|NCT01680549|19009453|P2|STARTED|Overall Study||25
7720108|NCT01680549|19009454|P1|STARTED|Overall Study||25
7720109|NCT01680497|19009466|P1|NOT COMPLETED|Overall Study||2
7720110|NCT01680497|19009466|P1|COMPLETED|Overall Study||68
7720111|NCT01680497|19009466|P1|STARTED|Overall Study||70
7720112|NCT01680458|19009476|P1|NOT COMPLETED|Overall Study||3
7720113|NCT01680458|19009476|P1|COMPLETED|Overall Study||27
7720114|NCT01680458|19009476|P1|STARTED|Overall Study||30
7720115|NCT01680341|19009487|P2|NOT COMPLETED|Overall Study||17
7720116|NCT01680341|19009488|P1|NOT COMPLETED|Overall Study||21
7720117|NCT01680341|19009487|P2|COMPLETED|Overall Study||119
7720118|NCT01680341|19009488|P1|COMPLETED|Overall Study||115
7720119|NCT01680341|19009487|P2|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134
7720120|NCT01680341|19009488|P1|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135
7720121|NCT01680341|19009487|P2|STARTED|Overall Study||136
7720122|NCT01680341|19009488|P1|STARTED|Overall Study||136
7720123|NCT01680328|19009508|P1|NOT COMPLETED|Overall Study||2
7720124|NCT01680328|19009508|P1|COMPLETED|Overall Study||80
7720125|NCT01680328|19009508|P1|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2
7720126|NCT01680328|19009508|P1|STARTED|Overall Study||82
7720127|NCT01680172|19009546|P2|NOT COMPLETED|Overall Study||0
7720128|NCT01680172|19009547|P1|NOT COMPLETED|Overall Study||0
7720129|NCT01680172|19009546|P2|COMPLETED|Overall Study||2
7720130|NCT01680172|19009547|P1|COMPLETED|Overall Study||3
7720131|NCT01680172|19009546|P2|STARTED|Overall Study||2
7720132|NCT01680172|19009547|P1|STARTED|Overall Study||3
7720133|NCT01680159|19009559|P1|NOT COMPLETED|Increased Dose Period||8
7720134|NCT01680159|19009559|P1|COMPLETED|Increased Dose Period||43
7720135|NCT01680159|19009559|P1|STARTED|Increased Dose Period||51
7720136|NCT01680159|19009559|P1|NOT COMPLETED|Screening Period||7
7720137|NCT01680159|19009559|P1|COMPLETED|Screening Period||39
7720138|NCT01680159|19009559|P1|STARTED|Screening Period||46
7720139|NCT01680016|19009586|P4|NOT COMPLETED|Overall Study||5
7720140|NCT01680016|19009587|P3|NOT COMPLETED|Overall Study||5
7720141|NCT01680016|19009588|P2|NOT COMPLETED|Overall Study||8
7720142|NCT01680016|19009589|P1|NOT COMPLETED|Overall Study||6
7720143|NCT01680016|19009586|P4|COMPLETED|Overall Study||195
7720144|NCT01680016|19009587|P3|COMPLETED|Overall Study||196
7720145|NCT01680016|19009588|P2|COMPLETED|Overall Study||114
7720146|NCT01680016|19009589|P1|COMPLETED|Overall Study||115
7720147|NCT01680016|19009586|P4|STARTED|Overall Study||200
7720148|NCT01680016|19009587|P3|STARTED|Overall Study||201
7720149|NCT01680016|19009588|P2|STARTED|Overall Study||122
7720150|NCT01680016|19009589|P1|STARTED|Overall Study||121
7720151|NCT01679613|19009651|P4|NOT COMPLETED|Overall Study||2
7720152|NCT01679613|19009652|P3|NOT COMPLETED|Overall Study||2
7720153|NCT01679613|19009653|P2|NOT COMPLETED|Overall Study||1
7720154|NCT01679613|19009654|P1|NOT COMPLETED|Overall Study||0
7720155|NCT01679613|19009651|P4|COMPLETED|Overall Study||11
7720156|NCT01679613|19009652|P3|COMPLETED|Overall Study||11
7720157|NCT01679613|19009653|P2|COMPLETED|Overall Study||3
7720158|NCT01679613|19009654|P1|COMPLETED|Overall Study||4
7720159|NCT01679613|19009651|P4|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
7720160|NCT01679613|19009652|P3|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
7720161|NCT01679613|19009653|P2|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
7720162|NCT01679613|19009654|P1|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
7720163|NCT01679613|19009651|P4|Received Nintedanib (Main)|Overall Study||11
7720164|NCT01679613|19009652|P3|Received Nintedanib (Main)|Overall Study||13
7720165|NCT01679613|19009653|P2|Received Nintedanib (Main)|Overall Study||0
7720166|NCT01679613|19009654|P1|Received Nintedanib (Main)|Overall Study||0
7720167|NCT01679613|19009651|P4|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
7720168|NCT01679613|19009652|P3|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
7720169|NCT01679613|19009653|P2|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4
7720170|NCT01679613|19009654|P1|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4
7720171|NCT01679613|19009651|P4|Received Nintedanib (Pilot)|Overall Study||0
7720172|NCT01679613|19009652|P3|Received Nintedanib (Pilot)|Overall Study||0
7720173|NCT01679613|19009653|P2|Received Nintedanib (Pilot)|Overall Study||3
7720174|NCT01679613|19009654|P1|Received Nintedanib (Pilot)|Overall Study||4
7720175|NCT01679613|19009651|P4|STARTED|Overall Study||13
7720176|NCT01679613|19009652|P3|STARTED|Overall Study||13
7720177|NCT01679613|19009653|P2|STARTED|Overall Study||4
7720178|NCT01679613|19009654|P1|STARTED|Overall Study||4
7720179|NCT01679600|19009667|P2|NOT COMPLETED|Overall Study||0
7720180|NCT01679600|19009668|P1|NOT COMPLETED|Overall Study||0
7720181|NCT01679600|19009667|P2|COMPLETED|Overall Study||7
7720182|NCT01679600|19009668|P1|COMPLETED|Overall Study||7
7720183|NCT01679600|19009667|P2|STARTED|Overall Study||7
7720184|NCT01679600|19009668|P1|STARTED|Overall Study||7
7720185|NCT01679405|19009676|P2|NOT COMPLETED|Overall Study||5
7720186|NCT01679405|19009677|P1|NOT COMPLETED|Overall Study||2
7720187|NCT01679405|19009676|P2|COMPLETED|Overall Study||1
7720188|NCT01679405|19009677|P1|COMPLETED|Overall Study||1
7720189|NCT01679405|19009676|P2|STARTED|Overall Study||6
7720190|NCT01679405|19009677|P1|STARTED|Overall Study||3
7720191|NCT01679314|19009693|P2|NOT COMPLETED|Overall Study||0
7720192|NCT01679314|19009694|P1|NOT COMPLETED|Overall Study||2
7720193|NCT01679314|19009693|P2|COMPLETED|Overall Study||28
7720194|NCT01679314|19009694|P1|COMPLETED|Overall Study||24
7720195|NCT01679314|19009693|P2|STARTED|Overall Study||28
7720196|NCT01679314|19009694|P1|STARTED|Overall Study||26
7720197|NCT01679301|19009712|P3|NOT COMPLETED|Study Period||0
7720198|NCT01679301|19009713|P2|NOT COMPLETED|Study Period||0
7720199|NCT01679301|19009714|P1|NOT COMPLETED|Study Period||0
7720200|NCT01679301|19009712|P3|COMPLETED|Study Period||4
7720201|NCT01679301|19009713|P2|COMPLETED|Study Period||4
7720202|NCT01679301|19009714|P1|COMPLETED|Study Period||0
7720203|NCT01679301|19009712|P3|STARTED|Study Period||4
7720204|NCT01679301|19009713|P2|STARTED|Study Period||4
7720205|NCT01679301|19009714|P1|STARTED|Study Period||0
7720206|NCT01679301|19009712|P3|NOT COMPLETED|Screening Period||0
7720207|NCT01679301|19009713|P2|NOT COMPLETED|Screening Period||0
7720208|NCT01679301|19009714|P1|NOT COMPLETED|Screening Period||3
7720209|NCT01679301|19009712|P3|COMPLETED|Screening Period||0
7720210|NCT01679301|19009713|P2|COMPLETED|Screening Period||0
7720211|NCT01679301|19009714|P1|COMPLETED|Screening Period||8
7720212|NCT01679301|19009712|P3|STARTED|Screening Period||0
7720213|NCT01679301|19009713|P2|STARTED|Screening Period||0
7720214|NCT01679301|19009714|P1|STARTED|Screening Period||11
7720215|NCT01679236|19009722|P2|NOT COMPLETED|Overall Study||15
7720216|NCT01679236|19009723|P1|NOT COMPLETED|Overall Study||15
7720217|NCT01679236|19009722|P2|COMPLETED|Overall Study||10
7720218|NCT01679236|19009723|P1|COMPLETED|Overall Study||15
7720219|NCT01679236|19009722|P2|STARTED|Overall Study||25
7720220|NCT01679236|19009723|P1|STARTED|Overall Study||30
7720221|NCT01679197|19009729|P1|NOT COMPLETED|Overall Study||4
7720222|NCT01679197|19009729|P1|COMPLETED|Overall Study||19
7720223|NCT01679197|19009729|P1|STARTED|Overall Study||23
7720224|NCT01679028|19009748|P6|NOT COMPLETED|Overall Study||0
7720225|NCT01679028|19009749|P5|NOT COMPLETED|Overall Study||0
7720226|NCT01679028|19009750|P4|NOT COMPLETED|Overall Study||0
7720227|NCT01679028|19009751|P3|NOT COMPLETED|Overall Study||0
7720228|NCT01679028|19009752|P2|NOT COMPLETED|Overall Study||0
7720229|NCT01679028|19009753|P1|NOT COMPLETED|Overall Study||0
7720230|NCT01679028|19009748|P6|COMPLETED|Overall Study||6
7720231|NCT01679028|19009749|P5|COMPLETED|Overall Study||2
7720232|NCT01679028|19009750|P4|COMPLETED|Overall Study||4
7720233|NCT01679028|19009751|P3|COMPLETED|Overall Study||2
7720234|NCT01679028|19009752|P2|COMPLETED|Overall Study||4
7720235|NCT01679028|19009753|P1|COMPLETED|Overall Study||2
7720236|NCT01679028|19009748|P6|STARTED|Overall Study||6
7720237|NCT01679028|19009749|P5|STARTED|Overall Study||2
7720238|NCT01679028|19009750|P4|STARTED|Overall Study||4
7720239|NCT01679028|19009751|P3|STARTED|Overall Study||2
7720240|NCT01679028|19009752|P2|STARTED|Overall Study||4
7720241|NCT01679028|19009753|P1|STARTED|Overall Study||2
7720242|NCT01679002|19009770|P3|NOT COMPLETED|Overall Study||0
7720243|NCT01679002|19009771|P2|NOT COMPLETED|Overall Study||1
7720244|NCT01679002|19009772|P1|NOT COMPLETED|Overall Study||1
7720245|NCT01679002|19009770|P3|COMPLETED|Overall Study||4
7720246|NCT01679002|19009771|P2|COMPLETED|Overall Study||3
7720247|NCT01679002|19009772|P1|COMPLETED|Overall Study||3
7720248|NCT01679002|19009770|P3|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
7720249|NCT01679002|19009771|P2|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
7720250|NCT01679002|19009772|P1|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3
7720251|NCT01679002|19009770|P3|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
7720252|NCT01679002|19009771|P2|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
7720253|NCT01679002|19009772|P1|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
7720254|NCT01679002|19009770|P3|BIA 2-093 900 mg Once-daily Period|Overall Study||4
7720255|NCT01679002|19009771|P2|BIA 2-093 900 mg Once-daily Period|Overall Study||3
7720256|NCT01679002|19009772|P1|BIA 2-093 900 mg Once-daily Period|Overall Study||4
7720257|NCT01679002|19009770|P3|STARTED|Overall Study||4
7720258|NCT01679002|19009771|P2|STARTED|Overall Study||4
7720259|NCT01679002|19009772|P1|STARTED|Overall Study||4
7720260|NCT01678976|19009788|P2|NOT COMPLETED|Second Period||0
7720261|NCT01678976|19009789|P1|NOT COMPLETED|Second Period||0
7720262|NCT01678976|19009788|P2|COMPLETED|Second Period||6
7720263|NCT01678976|19009789|P1|COMPLETED|Second Period||6
7720264|NCT01678976|19009788|P2|STARTED|Second Period||6
7720265|NCT01678976|19009789|P1|STARTED|Second Period||6
7720266|NCT01678976|19009788|P2|NOT COMPLETED|First Period||1
7720267|NCT01678976|19009789|P1|NOT COMPLETED|First Period||0
7720268|NCT01678976|19009788|P2|COMPLETED|First Period||6
7720269|NCT01678976|19009789|P1|COMPLETED|First Period||6
7720270|NCT01678976|19009788|P2|STARTED|First Period||7
7720271|NCT01678976|19009789|P1|STARTED|First Period||6
7720272|NCT01678924|19009803|P4|NOT COMPLETED|Overall Study||18
7720273|NCT01678924|19009804|P3|NOT COMPLETED|Overall Study||2
7720274|NCT01678924|19009805|P2|NOT COMPLETED|Overall Study||12
7720275|NCT01678924|19009806|P1|NOT COMPLETED|Overall Study||10
7720276|NCT01678924|19009803|P4|COMPLETED|Overall Study||105
7720277|NCT01678924|19009804|P3|COMPLETED|Overall Study||28
7720278|NCT01678924|19009805|P2|COMPLETED|Overall Study||51
7720279|NCT01678924|19009806|P1|COMPLETED|Overall Study||54
7720280|NCT01678924|19009803|P4|STARTED|Overall Study||123
7720281|NCT01678924|19009804|P3|STARTED|Overall Study||30
7720282|NCT01678924|19009805|P2|STARTED|Overall Study||63
7720283|NCT01678924|19009806|P1|STARTED|Overall Study||64
7720284|NCT01678911|19009937|P2|NOT COMPLETED|Second Intervention||0
7720285|NCT01678911|19009938|P1|NOT COMPLETED|Second Intervention||2
7720286|NCT01678911|19009937|P2|COMPLETED|Second Intervention||1
7720287|NCT01678911|19009938|P1|COMPLETED|Second Intervention||2
7720288|NCT01678911|19009937|P2|STARTED|Second Intervention||1
7720289|NCT01678911|19009938|P1|STARTED|Second Intervention||4
7720290|NCT01678911|19009937|P2|NOT COMPLETED|First Intervention||0
7720291|NCT01678911|19009938|P1|NOT COMPLETED|First Intervention||0
7720292|NCT01678911|19009937|P2|COMPLETED|First Intervention||1
7720293|NCT01678911|19009938|P1|COMPLETED|First Intervention||4
7720294|NCT01678911|19009937|P2|Cross Over|First Intervention||1
7720295|NCT01678911|19009938|P1|Cross Over|First Intervention||4
7720296|NCT01678911|19009937|P2|STARTED|First Intervention||1
7720297|NCT01678911|19009938|P1|STARTED|First Intervention||4
7720298|NCT01678898|19009955|P3|NOT COMPLETED|PB-102-F02||0
7720299|NCT01678898|19009956|P2|NOT COMPLETED|PB-102-F02||0
7720300|NCT01678898|19009957|P1|NOT COMPLETED|PB-102-F02||0
7720301|NCT01678898|19009955|P3|COMPLETED|PB-102-F02||4
7720302|NCT01678898|19009956|P2|COMPLETED|PB-102-F02||6
7720303|NCT01678898|19009957|P1|COMPLETED|PB-102-F02||6
7720304|NCT01678898|19009955|P3|STARTED|PB-102-F02||4
7720305|NCT01678898|19009956|P2|STARTED|PB-102-F02||6
7720306|NCT01678898|19009957|P1|STARTED|PB-102-F02||6
7720307|NCT01678898|19009955|P3|NOT COMPLETED|PB-102-F01||0
7720308|NCT01678898|19009956|P2|NOT COMPLETED|PB-102-F01||2
7720309|NCT01678898|19009957|P1|NOT COMPLETED|PB-102-F01||0
7720310|NCT01678898|19009955|P3|COMPLETED|PB-102-F01||4
7720311|NCT01678898|19009956|P2|COMPLETED|PB-102-F01||6
7720312|NCT01678898|19009957|P1|COMPLETED|PB-102-F01||6
7720313|NCT01678898|19009955|P3|STARTED|PB-102-F01||4
7720314|NCT01678898|19009956|P2|STARTED|PB-102-F01||8
7720315|NCT01678898|19009957|P1|STARTED|PB-102-F01||6
7720316|NCT01678885|19010037|P5|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17
7720317|NCT01678885|19010038|P4|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
7720318|NCT01678885|19010039|P3|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
7720319|NCT01678885|19010040|P2|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
7720320|NCT01678885|19010041|P1|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
7720321|NCT01678885|19010037|P5|COMPLETED|Phase II; 8 Week Low Calorie Diet||70
7720322|NCT01678885|19010038|P4|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
7720323|NCT01678885|19010039|P3|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
7720324|NCT01678885|19010040|P2|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
7720325|NCT01678885|19010041|P1|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
7720326|NCT01678885|19010037|P5|STARTED|Phase II; 8 Week Low Calorie Diet||87
7720327|NCT01678885|19010038|P4|STARTED|Phase II; 8 Week Low Calorie Diet||0
7720328|NCT01678885|19010039|P3|STARTED|Phase II; 8 Week Low Calorie Diet||0
7720329|NCT01678885|19010040|P2|STARTED|Phase II; 8 Week Low Calorie Diet||0
7720330|NCT01678885|19010041|P1|STARTED|Phase II; 8 Week Low Calorie Diet||0
7720331|NCT01678885|19010037|P5|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
7720332|NCT01678885|19010038|P4|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
7720333|NCT01678885|19010039|P3|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1
7720334|NCT01678885|19010040|P2|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
7720335|NCT01678885|19010041|P1|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
7720336|NCT01678885|19010037|P5|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
7720337|NCT01678885|19010038|P4|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21
7720338|NCT01678885|19010039|P3|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
7720339|NCT01678885|19010040|P2|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15
7720340|NCT01678885|19010041|P1|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
7720341|NCT01678885|19010037|P5|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0
7720342|NCT01678885|19010038|P4|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24
7720343|NCT01678885|19010039|P3|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23
7720344|NCT01678885|19010040|P2|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18
7720345|NCT01678885|19010041|P1|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22
7720346|NCT01678846|19010051|P2|NOT COMPLETED|Overall Study||0
7720347|NCT01678846|19010052|P1|NOT COMPLETED|Overall Study||0
7720348|NCT01678846|19010051|P2|COMPLETED|Overall Study||1899
7720349|NCT01678846|19010052|P1|COMPLETED|Overall Study||1921
7720350|NCT01678846|19010051|P2|STARTED|Overall Study||1899
7720351|NCT01678846|19010052|P1|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921
7720352|NCT01678820|19010067|P3|NOT COMPLETED|Overall Study||57
7720353|NCT01678820|19010068|P2|NOT COMPLETED|Overall Study||63
7720354|NCT01678820|19010069|P1|NOT COMPLETED|Overall Study||62
7720355|NCT01678820|19010067|P3|COMPLETED|Overall Study||43
7720356|NCT01678820|19010068|P2|COMPLETED|Overall Study||36
7720357|NCT01678820|19010069|P1|COMPLETED|Overall Study||38
7720358|NCT01678820|19010067|P3|Treated With Double-blind Study Drug|Overall Study||98
7720359|NCT01678820|19010068|P2|Treated With Double-blind Study Drug|Overall Study||97
7720360|NCT01678820|19010069|P1|Treated With Double-blind Study Drug|Overall Study||100
7720361|NCT01678820|19010067|P3|STARTED|Overall Study||100
7720362|NCT01678820|19010068|P2|STARTED|Overall Study||99
7720363|NCT01678820|19010069|P1|STARTED|Overall Study||100
7720364|NCT01678807|19010114|P3|NOT COMPLETED|Overall Study||0
7720365|NCT01678807|19010115|P2|NOT COMPLETED|Overall Study||5
7720366|NCT01678807|19010116|P1|NOT COMPLETED|Overall Study||4
7720367|NCT01678807|19010114|P3|COMPLETED|Overall Study||65
7720368|NCT01678807|19010115|P2|COMPLETED|Overall Study||60
7720369|NCT01678807|19010116|P1|COMPLETED|Overall Study||61
7720370|NCT01678807|19010114|P3|STARTED|Overall Study||65
7720371|NCT01678807|19010115|P2|STARTED|Overall Study||65
7720372|NCT01678807|19010116|P1|STARTED|Overall Study||65
7720373|NCT01678560|19010129|P2|NOT COMPLETED|Overall Study||6
7720374|NCT01678560|19010130|P1|NOT COMPLETED|Overall Study||4
7720375|NCT01678560|19010129|P2|COMPLETED|Overall Study||20
7720376|NCT01678560|19010130|P1|COMPLETED|Overall Study||22
7720377|NCT01678560|19010129|P2|STARTED|Overall Study||26
7720378|NCT01678560|19010130|P1|STARTED|Overall Study||26
7720379|NCT01678443|19010144|P1|NOT COMPLETED|Overall Study||0
7720380|NCT01678443|19010144|P1|COMPLETED|Overall Study||2
7720381|NCT01678443|19010144|P1|STARTED|Overall Study||2
7720382|NCT01678313|19010151|P2|NOT COMPLETED|Prostate Biopsy at 3 Months||12
7720383|NCT01678313|19010152|P1|NOT COMPLETED|Prostate Biopsy at 3 Months||11
7720384|NCT01678313|19010151|P2|COMPLETED|Prostate Biopsy at 3 Months||37
7720385|NCT01678313|19010152|P1|COMPLETED|Prostate Biopsy at 3 Months||45
7720386|NCT01678313|19010151|P2|STARTED|Prostate Biopsy at 3 Months||49
7720387|NCT01678313|19010152|P1|STARTED|Prostate Biopsy at 3 Months||56
7720388|NCT01678313|19010151|P2|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9
7720389|NCT01678313|19010152|P1|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8
7720390|NCT01678313|19010151|P2|COMPLETED|PSA >4 ng/dL at 3 Months||49
7720391|NCT01678313|19010152|P1|COMPLETED|PSA >4 ng/dL at 3 Months||56
7720392|NCT01678313|19010151|P2|STARTED|PSA >4 ng/dL at 3 Months||58
7720393|NCT01678313|19010152|P1|STARTED|PSA >4 ng/dL at 3 Months||64
7720394|NCT01678313|19010151|P2|NOT COMPLETED|Completed the 3-month Therapy||12
7720395|NCT01678313|19010152|P1|NOT COMPLETED|Completed the 3-month Therapy||6
7720396|NCT01678313|19010151|P2|COMPLETED|Completed the 3-month Therapy||58
7720397|NCT01678313|19010152|P1|COMPLETED|Completed the 3-month Therapy||64
7720398|NCT01678313|19010151|P2|STARTED|Completed the 3-month Therapy||70
7720399|NCT01678313|19010152|P1|STARTED|Completed the 3-month Therapy||70
7720400|NCT01678209|19010171|P3|NOT COMPLETED|Overall Study||18
7720401|NCT01678209|19010172|P2|NOT COMPLETED|Overall Study||18
7720402|NCT01678209|19010173|P1|NOT COMPLETED|Overall Study||17
7720403|NCT01678209|19010171|P3|COMPLETED|Overall Study||22
7720404|NCT01678209|19010172|P2|COMPLETED|Overall Study||22
7720405|NCT01678209|19010173|P1|COMPLETED|Overall Study||30
7720406|NCT01678209|19010171|P3|STARTED|Overall Study||40
7720407|NCT01678209|19010172|P2|STARTED|Overall Study||40
7720408|NCT01678209|19010173|P1|STARTED|Overall Study||47
7720409|NCT01678196|19010201|P2|NOT COMPLETED|Overall Study||0
7720410|NCT01678196|19010202|P1|NOT COMPLETED|Overall Study||0
7720411|NCT01678196|19010201|P2|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32
7720412|NCT01678196|19010202|P1|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34
7720413|NCT01678196|19010201|P2|STARTED|Overall Study||32
7720414|NCT01678196|19010202|P1|STARTED|Overall Study||34
7720415|NCT01678144|19010214|P1|NOT COMPLETED|Stage 2: MAR Regular and MAR Expanded||0
7720416|NCT01678144|19010214|P1|COMPLETED|Stage 2: MAR Regular and MAR Expanded||5
7720417|NCT01678144|19010214|P1|STARTED|Stage 2: MAR Regular and MAR Expanded||5
7720418|NCT01678144|19010214|P1|NOT COMPLETED|Stage 1: MAR Classic||1
7720419|NCT01678144|19010214|P1|COMPLETED|Stage 1: MAR Classic||6
7720420|NCT01678144|19010214|P1|STARTED|Stage 1: MAR Classic||7
7720421|NCT01678131|19010233|P3|NOT COMPLETED|Overall Study||2
7720422|NCT01678131|19010234|P2|NOT COMPLETED|Overall Study||1
7720423|NCT01678131|19010235|P1|NOT COMPLETED|Overall Study||0
7720424|NCT01678131|19010233|P3|COMPLETED|Overall Study||9
7720425|NCT01678131|19010234|P2|COMPLETED|Overall Study||9
7720426|NCT01678131|19010235|P1|COMPLETED|Overall Study||10
7720427|NCT01678131|19010233|P3|STARTED|Overall Study||11
7720428|NCT01678131|19010234|P2|STARTED|Overall Study||10
7720429|NCT01678131|19010235|P1|STARTED|Overall Study||10
7720430|NCT01677988|19010243|P1|NOT COMPLETED|Overall Study||2
7720431|NCT01677988|19010243|P1|COMPLETED|Overall Study||1
7720432|NCT01677988|19010243|P1|STARTED|Overall Study||3
7720433|NCT01677936|19010256|P2|NOT COMPLETED|Overall Study||5
7720434|NCT01677936|19010257|P1|NOT COMPLETED|Overall Study||9
7720435|NCT01677936|19010256|P2|COMPLETED|Overall Study|Full analysis dataset completers|15
7720436|NCT01677936|19010257|P1|COMPLETED|Overall Study|Full analysis dataset completers|22
7720437|NCT01677936|19010256|P2|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20
7720438|NCT01677936|19010257|P1|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31
7720439|NCT01677910|19010268|P4|NOT COMPLETED|Open-Label Extension Period (OLE)||36
7720440|NCT01677910|19010269|P3|NOT COMPLETED|Open-Label Extension Period (OLE)||0
7720441|NCT01677910|19010270|P2|NOT COMPLETED|Open-Label Extension Period (OLE)||0
7720442|NCT01677910|19010271|P1|NOT COMPLETED|Open-Label Extension Period (OLE)||0
7720443|NCT01677910|19010268|P4|COMPLETED|Open-Label Extension Period (OLE)||79
7720444|NCT01677910|19010269|P3|COMPLETED|Open-Label Extension Period (OLE)||0
7720445|NCT01677910|19010270|P2|COMPLETED|Open-Label Extension Period (OLE)||0
7720446|NCT01677910|19010271|P1|COMPLETED|Open-Label Extension Period (OLE)||0
7720447|NCT01677910|19010268|P4|STARTED|Open-Label Extension Period (OLE)||115
7720448|NCT01677910|19010269|P3|STARTED|Open-Label Extension Period (OLE)||0
7720449|NCT01677910|19010270|P2|STARTED|Open-Label Extension Period (OLE)||0
7720450|NCT01677910|19010271|P1|STARTED|Open-Label Extension Period (OLE)||0
7720451|NCT01677910|19010268|P4|NOT COMPLETED|Double-Blind Treatment Period||0
7720452|NCT01677910|19010269|P3|NOT COMPLETED|Double-Blind Treatment Period||7
7720453|NCT01677910|19010270|P2|NOT COMPLETED|Double-Blind Treatment Period||3
7720454|NCT01677910|19010271|P1|NOT COMPLETED|Double-Blind Treatment Period||7
7720455|NCT01677910|19010268|P4|COMPLETED|Double-Blind Treatment Period||0
7720456|NCT01677910|19010269|P3|COMPLETED|Double-Blind Treatment Period||38
7720457|NCT01677910|19010270|P2|COMPLETED|Double-Blind Treatment Period||42
7720458|NCT01677910|19010271|P1|COMPLETED|Double-Blind Treatment Period||38
7720459|NCT01677910|19010268|P4|STARTED|Double-Blind Treatment Period||0
7720460|NCT01677910|19010269|P3|STARTED|Double-Blind Treatment Period||45
7720461|NCT01677910|19010270|P2|STARTED|Double-Blind Treatment Period||45
7720462|NCT01677910|19010271|P1|STARTED|Double-Blind Treatment Period||45
7720463|NCT01677858|19010298|P5|NOT COMPLETED|Overall Study||85
7720464|NCT01677858|19010299|P4|NOT COMPLETED|Overall Study||6
7720465|NCT01677858|19010300|P3|NOT COMPLETED|Overall Study||14
7720466|NCT01677858|19010301|P2|NOT COMPLETED|Overall Study||2
7720467|NCT01677858|19010302|P1|NOT COMPLETED|Overall Study||3
7720468|NCT01677858|19010298|P5|COMPLETED|Overall Study|Completed indicates participants ongoing in study|4
7720469|NCT01677858|19010299|P4|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
7720470|NCT01677858|19010300|P3|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
7720471|NCT01677858|19010301|P2|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
7720472|NCT01677858|19010302|P1|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
7720473|NCT01677858|19010298|P5|STARTED|Overall Study||89
7720474|NCT01677858|19010299|P4|STARTED|Overall Study||6
7720475|NCT01677858|19010300|P3|STARTED|Overall Study||15
7720476|NCT01677858|19010301|P2|STARTED|Overall Study||3
7720477|NCT01677858|19010302|P1|STARTED|Overall Study||3
7720478|NCT01677767|19010375|P1|NOT COMPLETED|Overall Study||22
7720479|NCT01677767|19010375|P1|COMPLETED|Overall Study||102
7720480|NCT01677767|19010375|P1|STARTED|Overall Study||124
7720481|NCT01677624|19010389|P1|NOT COMPLETED|Overall Study||1
7720482|NCT01677624|19010389|P1|COMPLETED|Overall Study||27
7720483|NCT01677624|19010389|P1|STARTED|Overall Study||28
7720484|NCT01677507|19010394|P2|NOT COMPLETED|Second Assigment||5
7720485|NCT01677507|19010395|P1|NOT COMPLETED|Second Assigment||3
7720486|NCT01677507|19010394|P2|COMPLETED|Second Assigment||51
7720487|NCT01677507|19010395|P1|COMPLETED|Second Assigment||60
7720488|NCT01677507|19010394|P2|STARTED|Second Assigment||56
7720489|NCT01677507|19010395|P1|STARTED|Second Assigment||63
7720490|NCT01677507|19010394|P2|NOT COMPLETED|Initial Assignment||2
7720491|NCT01677507|19010395|P1|NOT COMPLETED|Initial Assignment||0
7720492|NCT01677507|19010394|P2|COMPLETED|Initial Assignment||56
7720493|NCT01677507|19010395|P1|COMPLETED|Initial Assignment||63
7720494|NCT01677507|19010394|P2|STARTED|Initial Assignment||58
7720495|NCT01677507|19010395|P1|STARTED|Initial Assignment||63
7720496|NCT01677377|19010408|P3|NOT COMPLETED|Overall Study||6
7720497|NCT01677377|19010409|P2|NOT COMPLETED|Overall Study||1
7720498|NCT01677377|19010410|P1|NOT COMPLETED|Overall Study||1
7720499|NCT01677377|19010408|P3|COMPLETED|Overall Study||9
7720500|NCT01677377|19010409|P2|COMPLETED|Overall Study||14
7720501|NCT01677377|19010410|P1|COMPLETED|Overall Study||14
7720502|NCT01677377|19010408|P3|STARTED|Overall Study||15
7720503|NCT01677377|19010409|P2|STARTED|Overall Study||15
7720504|NCT01677377|19010410|P1|STARTED|Overall Study||15
7720505|NCT01677312|19010609|P2|NOT COMPLETED|Overall Study||0
7720506|NCT01677312|19010610|P1|NOT COMPLETED|Overall Study||0
7720507|NCT01677312|19010609|P2|COMPLETED|Overall Study||36
7720508|NCT01677312|19010610|P1|COMPLETED|Overall Study||36
7720509|NCT01677312|19010609|P2|STARTED|Overall Study||36
7720510|NCT01677312|19010610|P1|STARTED|Overall Study||36
7720511|NCT01677299|19010626|P4|NOT COMPLETED|Overall Study||1
7720512|NCT01677299|19010627|P3|NOT COMPLETED|Overall Study||1
7720513|NCT01677299|19010628|P2|NOT COMPLETED|Overall Study||3
7720514|NCT01677299|19010629|P1|NOT COMPLETED|Overall Study||0
7720515|NCT01677299|19010626|P4|COMPLETED|Overall Study||5
7720516|NCT01677299|19010627|P3|COMPLETED|Overall Study||5
7720517|NCT01677299|19010628|P2|COMPLETED|Overall Study||3
7720518|NCT01677299|19010629|P1|COMPLETED|Overall Study||6
7720519|NCT01677299|19010626|P4|STARTED|Overall Study||6
7720520|NCT01677299|19010627|P3|STARTED|Overall Study||6
7720521|NCT01677299|19010628|P2|STARTED|Overall Study||6
7720522|NCT01677299|19010629|P1|STARTED|Overall Study||6
7720523|NCT01677286|19010651|P1|NOT COMPLETED|Overall Study||11
7720524|NCT01677286|19010651|P1|COMPLETED|Overall Study||14
7720525|NCT01677286|19010651|P1|STARTED|Overall Study||25
7720526|NCT01677195|19010661|P3|NOT COMPLETED|Overall Study||30
7720527|NCT01677195|19010662|P2|NOT COMPLETED|Overall Study||32
7720528|NCT01677195|19010663|P1|NOT COMPLETED|Overall Study||29
7720529|NCT01677195|19010661|P3|COMPLETED|Overall Study||50
7720530|NCT01677195|19010662|P2|COMPLETED|Overall Study||51
7720531|NCT01677195|19010663|P1|COMPLETED|Overall Study||42
7720532|NCT01677195|19010661|P3|STARTED|Overall Study||80
7720533|NCT01677195|19010662|P2|STARTED|Overall Study||83
7720534|NCT01677195|19010663|P1|STARTED|Overall Study||71
7720535|NCT01677182|19010674|P3|NOT COMPLETED|Overall Study||39
7720536|NCT01677182|19010675|P2|NOT COMPLETED|Overall Study||28
7720537|NCT01677182|19010676|P1|NOT COMPLETED|Overall Study||34
7720538|NCT01677182|19010674|P3|COMPLETED|Overall Study||143
7720539|NCT01677182|19010675|P2|COMPLETED|Overall Study||141
7720540|NCT01677182|19010676|P1|COMPLETED|Overall Study||150
7720541|NCT01677182|19010674|P3|STARTED|Overall Study||182
7720542|NCT01677182|19010675|P2|STARTED|Overall Study||169
7720543|NCT01677182|19010676|P1|STARTED|Overall Study||184
7720544|NCT01676961|19010708|P1|NOT COMPLETED|Overall Study||5
7720545|NCT01676961|19010708|P1|COMPLETED|Overall Study||0
7720546|NCT01676961|19010708|P1|STARTED|Overall Study||5
7720547|NCT01676909|19010715|P2|NOT COMPLETED|Overall Study||14
7720548|NCT01676909|19010716|P1|NOT COMPLETED|Overall Study||18
7720549|NCT01676909|19010715|P2|COMPLETED|Overall Study|14 not completed (5 withdrawn, 9 timed out|104
7720550|NCT01676909|19010716|P1|COMPLETED|Overall Study|18 not completed (3 withdrawn, 15 timed out)|106
7720551|NCT01676909|19010715|P2|Post-Treatment Assessment|Overall Study|11 not completed (5 withdrawn, 6 timed out)|107
7720552|NCT01676909|19010716|P1|Post-Treatment Assessment|Overall Study|19 not completed (3 withdrawn, 15 timed out, 1 declined)|105
7720553|NCT01676909|19010715|P2|STARTED|Overall Study||118
7720554|NCT01676909|19010716|P1|STARTED|Overall Study||124
7720555|NCT01676896|19010781|P3|NOT COMPLETED|Overall Study||19
7720556|NCT01676896|19010782|P2|NOT COMPLETED|Overall Study||7
7720557|NCT01676896|19010783|P1|NOT COMPLETED|Overall Study||12
7720558|NCT01676896|19010781|P3|COMPLETED|Overall Study||81
7720559|NCT01676896|19010782|P2|COMPLETED|Overall Study||89
7720560|NCT01676896|19010783|P1|COMPLETED|Overall Study||84
7720561|NCT01676896|19010781|P3|STARTED|Overall Study||100
7720562|NCT01676896|19010782|P2|STARTED|Overall Study||96
7720563|NCT01676896|19010783|P1|STARTED|Overall Study||96
7720564|NCT01676831|19010880|P2|NOT COMPLETED|Overall Study||1
7720565|NCT01676831|19010881|P1|NOT COMPLETED|Overall Study||0
7720566|NCT01676831|19010880|P2|COMPLETED|Overall Study||4
7720567|NCT01676831|19010881|P1|COMPLETED|Overall Study||8
7720568|NCT01676831|19010880|P2|STARTED|Overall Study||5
7720569|NCT01676831|19010881|P1|STARTED|Overall Study||8
7720570|NCT01676727|19010891|P1|NOT COMPLETED|Overall Study||32
7720571|NCT01676727|19010891|P1|COMPLETED|Overall Study||68
7720572|NCT01676727|19010891|P1|Implanted|Overall Study||92
7720573|NCT01676727|19010891|P1|STARTED|Overall Study||100
7720574|NCT01676714|19010896|P1|NOT COMPLETED|Overall Study||0
7720575|NCT01676714|19010896|P1|COMPLETED|Overall Study||10
7720576|NCT01676714|19010896|P1|STARTED|Overall Study||10
7720577|NCT01676701|19010905|P2|NOT COMPLETED|Overall Study||4
7720578|NCT01676701|19010906|P1|NOT COMPLETED|Overall Study||4
7720579|NCT01676701|19010905|P2|COMPLETED|Overall Study||0
7720580|NCT01676701|19010906|P1|COMPLETED|Overall Study||0
7720581|NCT01676701|19010905|P2|Completed Post-Treatment Follow-Up|Overall Study||4
7720582|NCT01676701|19010906|P1|Completed Post-Treatment Follow-Up|Overall Study||4
7720583|NCT01676701|19010905|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
7720584|NCT01676701|19010906|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
7720585|NCT01676701|19010905|P2|STARTED|Overall Study||4
7720586|NCT01676701|19010906|P1|STARTED|Overall Study||4
7720587|NCT01676532|19010932|P1|NOT COMPLETED|Overall Study||0
7720588|NCT01676532|19010932|P1|COMPLETED|Overall Study||127
7720589|NCT01676532|19010932|P1|STARTED|Overall Study||127
7720590|NCT01676415|19010943|P2|NOT COMPLETED|Overall Study||0
7720591|NCT01676415|19010944|P1|NOT COMPLETED|Overall Study||0
7720592|NCT01676415|19010943|P2|COMPLETED|Overall Study||5
7720593|NCT01676415|19010944|P1|COMPLETED|Overall Study||4
7720594|NCT01676415|19010943|P2|STARTED|Overall Study||5
7720595|NCT01676415|19010944|P1|STARTED|Overall Study||4
7720596|NCT01676311|19010958|P2|NOT COMPLETED|Overall Study||2
7720597|NCT01676311|19010959|P1|NOT COMPLETED|Overall Study||0
7720598|NCT01676311|19010958|P2|COMPLETED|Overall Study||5
7720599|NCT01676311|19010959|P1|COMPLETED|Overall Study||7
7720600|NCT01676311|19010958|P2|STARTED|Overall Study||7
7720601|NCT01676311|19010959|P1|STARTED|Overall Study||7
7720602|NCT01676298|19010981|P8|NOT COMPLETED|Overall Study||0
7720603|NCT01676298|19010982|P7|NOT COMPLETED|Overall Study||0
7720604|NCT01676298|19010983|P6|NOT COMPLETED|Overall Study||0
7720605|NCT01676298|19010984|P5|NOT COMPLETED|Overall Study||0
7720606|NCT01676298|19010985|P4|NOT COMPLETED|Overall Study||0
7720607|NCT01676298|19010986|P3|NOT COMPLETED|Overall Study||0
7720608|NCT01676298|19010987|P2|NOT COMPLETED|Overall Study||0
7720609|NCT01676298|19010988|P1|NOT COMPLETED|Overall Study||0
7720610|NCT01676298|19010981|P8|COMPLETED|Overall Study||1
7720611|NCT01676298|19010982|P7|COMPLETED|Overall Study||1
7720612|NCT01676298|19010983|P6|COMPLETED|Overall Study||1
7720613|NCT01676298|19010984|P5|COMPLETED|Overall Study||1
7720614|NCT01676298|19010985|P4|COMPLETED|Overall Study||1
7720615|NCT01676298|19010986|P3|COMPLETED|Overall Study||1
7720616|NCT01676298|19010987|P2|COMPLETED|Overall Study||1
7720617|NCT01676298|19010988|P1|COMPLETED|Overall Study||1
7720618|NCT01676298|19010981|P8|Participated in All Tests|Overall Study||1
7720619|NCT01676298|19010982|P7|Participated in All Tests|Overall Study||1
7720620|NCT01676298|19010983|P6|Participated in All Tests|Overall Study||1
7720621|NCT01676298|19010984|P5|Participated in All Tests|Overall Study||1
7720622|NCT01676298|19010985|P4|Participated in All Tests|Overall Study||1
7720623|NCT01676298|19010986|P3|Participated in All Tests|Overall Study||1
7720624|NCT01676298|19010987|P2|Participated in All Tests|Overall Study||1
7720625|NCT01676298|19010988|P1|Participated in All Tests|Overall Study||1
7720626|NCT01676298|19010981|P8|All Genotypes Confirmed With Reference|Overall Study||1
7720627|NCT01676298|19010982|P7|All Genotypes Confirmed With Reference|Overall Study||1
7720628|NCT01676298|19010983|P6|All Genotypes Confirmed With Reference|Overall Study||1
7720629|NCT01676298|19010984|P5|All Genotypes Confirmed With Reference|Overall Study||1
7720630|NCT01676298|19010985|P4|All Genotypes Confirmed With Reference|Overall Study||1
7720631|NCT01676298|19010986|P3|All Genotypes Confirmed With Reference|Overall Study||1
7720632|NCT01676298|19010987|P2|All Genotypes Confirmed With Reference|Overall Study||1
7720633|NCT01676298|19010988|P1|All Genotypes Confirmed With Reference|Overall Study||1
7720634|NCT01676298|19010981|P8|STARTED|Overall Study||1
7720635|NCT01676298|19010982|P7|STARTED|Overall Study||1
7720636|NCT01676298|19010983|P6|STARTED|Overall Study||1
7720637|NCT01676298|19010984|P5|STARTED|Overall Study||1
7720638|NCT01676298|19010985|P4|STARTED|Overall Study||1
7720639|NCT01676298|19010986|P3|STARTED|Overall Study||1
7720640|NCT01676298|19010987|P2|STARTED|Overall Study||1
7720641|NCT01676298|19010988|P1|STARTED|Overall Study||1
7720642|NCT01676220|19011008|P2|NOT COMPLETED|Overall Study||125
7720643|NCT01676220|19011009|P1|NOT COMPLETED|Overall Study||102
7720644|NCT01676220|19011008|P2|COMPLETED|Overall Study||314
7720645|NCT01676220|19011009|P1|COMPLETED|Overall Study||337
7720646|NCT01676220|19011008|P2|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|430
7720647|NCT01676220|19011009|P1|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|432
7720648|NCT01676220|19011008|P2|Treated|Overall Study||438
7720649|NCT01676220|19011009|P1|Treated|Overall Study||435
7720650|NCT01676220|19011008|P2|STARTED|Overall Study||439
7720651|NCT01676220|19011009|P1|STARTED|Overall Study||439
7720652|NCT01676116|19011041|P2|NOT COMPLETED|Overall Study||29
7720653|NCT01676116|19011042|P1|NOT COMPLETED|Overall Study||16
7720654|NCT01676116|19011041|P2|COMPLETED|Overall Study||117
7720655|NCT01676116|19011042|P1|COMPLETED|Overall Study||276
7720656|NCT01676116|19011041|P2|STARTED|Overall Study||146
7720657|NCT01676116|19011042|P1|STARTED|Overall Study||292
7720658|NCT01676012|19011064|P1|NOT COMPLETED|Overall Study||3
7720659|NCT01676012|19011064|P1|COMPLETED|Overall Study||29
7720660|NCT01676012|19011064|P1|STARTED|Overall Study||32
7720661|NCT01675960|19011070|P2|NOT COMPLETED|Overall Study||0
7720662|NCT01675960|19011071|P1|NOT COMPLETED|Overall Study||0
7720663|NCT01675960|19011070|P2|COMPLETED|Overall Study||0
7720664|NCT01675960|19011071|P1|COMPLETED|Overall Study||2
7720665|NCT01675960|19011070|P2|STARTED|Overall Study||0
7720666|NCT01675960|19011071|P1|STARTED|Overall Study||2
7720667|NCT01675830|19011079|P1|NOT COMPLETED|Overall Study||0
7720668|NCT01675830|19011079|P1|COMPLETED|Overall Study||10
7720669|NCT01675830|19011079|P1|STARTED|Overall Study||10
7720670|NCT01675778|19011084|P1|NOT COMPLETED|Overall Study||0
7720671|NCT01675778|19011084|P1|COMPLETED|Overall Study||174
7720672|NCT01675778|19011084|P1|STARTED|Overall Study||174
7720673|NCT01675765|19011108|P2|NOT COMPLETED|Overall Study||8
7720674|NCT01675765|19011109|P1|NOT COMPLETED|Overall Study||11
7720675|NCT01675765|19011108|P2|COMPLETED|Overall Study||14
7720676|NCT01675765|19011109|P1|COMPLETED|Overall Study||27
7720677|NCT01675765|19011108|P2|STARTED|Overall Study||22
7720678|NCT01675765|19011109|P1|STARTED|Overall Study||38
7720679|NCT01675661|19011125|P2|NOT COMPLETED|Overall Study||46
7720680|NCT01675661|19011126|P1|NOT COMPLETED|Overall Study||40
7720681|NCT01675661|19011125|P2|COMPLETED|Overall Study||103
7720682|NCT01675661|19011126|P1|COMPLETED|Overall Study||113
7720683|NCT01675661|19011125|P2|STARTED|Overall Study||149
7720684|NCT01675661|19011126|P1|STARTED|Overall Study||153
7720685|NCT01675635|19011134|P2|NOT COMPLETED|Overall Study||0
7720686|NCT01675635|19011135|P1|NOT COMPLETED|Overall Study||0
7720687|NCT01675635|19011134|P2|COMPLETED|Overall Study||117
7720688|NCT01675635|19011135|P1|COMPLETED|Overall Study||117
7720689|NCT01675635|19011134|P2|STARTED|Overall Study||117
7720690|NCT01675635|19011135|P1|STARTED|Overall Study||117
7720691|NCT01675622|19011155|P2|NOT COMPLETED|Overall Study||24
7720692|NCT01675622|19011156|P1|NOT COMPLETED|Overall Study||26
7720693|NCT01675622|19011155|P2|COMPLETED|Overall Study||96
7720694|NCT01675622|19011156|P1|COMPLETED|Overall Study||96
7720695|NCT01675622|19011155|P2|STARTED|Overall Study||120
7720696|NCT01675622|19011156|P1|STARTED|Overall Study||122
7720697|NCT01675596|19011180|P1|NOT COMPLETED|Overall Study||8
7720698|NCT01675596|19011180|P1|COMPLETED|Overall Study||191
7720699|NCT01675596|19011180|P1|STARTED|Overall Study|One patient did not receive the study device.|199
7720700|NCT01675544|19011186|P1|NOT COMPLETED|Overall Study||2
7720701|NCT01675544|19011186|P1|COMPLETED|Overall Study||44
7720702|NCT01675544|19011186|P1|STARTED|Overall Study||46
7720703|NCT01675531|19011191|P1|NOT COMPLETED|Overall Study||25
7720704|NCT01675531|19011191|P1|COMPLETED|Overall Study||41
7720705|NCT01675531|19011191|P1|STARTED|Overall Study||66
7720706|NCT01675492|19011198|P1|NOT COMPLETED|Overall Study||42
7720707|NCT01675492|19011198|P1|COMPLETED|Overall Study||42
7720708|NCT01675492|19011198|P1|STARTED|Overall Study||84
7720709|NCT01675479|19011203|P1|NOT COMPLETED|Overall Study||11
7720710|NCT01675479|19011203|P1|COMPLETED|Overall Study||58
7720711|NCT01675479|19011203|P1|STARTED|Overall Study||69
7720712|NCT01675453|19011210|P2|NOT COMPLETED|Overall Study||0
7720713|NCT01675453|19011211|P1|NOT COMPLETED|Overall Study||0
7720714|NCT01675453|19011210|P2|COMPLETED|Overall Study||20
7720715|NCT01675453|19011211|P1|COMPLETED|Overall Study||20
7720716|NCT01675453|19011210|P2|STARTED|Overall Study||20
7720717|NCT01675453|19011211|P1|STARTED|Overall Study||20
7720718|NCT01675427|19011217|P1|NOT COMPLETED|Overall Study||34
7720719|NCT01675427|19011217|P1|COMPLETED|Overall Study||4732
7720720|NCT01675427|19011217|P1|STARTED|Overall Study||4766
7720721|NCT01675297|19011504|P2|NOT COMPLETED|Overall Study||48
7720722|NCT01675297|19011505|P1|NOT COMPLETED|Overall Study||164
7720723|NCT01675297|19011504|P2|COMPLETED|Overall Study||199
7720724|NCT01675297|19011505|P1|COMPLETED|Overall Study||642
7720725|NCT01675297|19011504|P2|STARTED|Overall Study||247
7720726|NCT01675297|19011505|P1|STARTED|Overall Study||806
7720727|NCT01675167|19011517|P3|NOT COMPLETED|Double-blind Treatment Phase||110
7720728|NCT01675167|19011518|P2|NOT COMPLETED|Double-blind Treatment Phase||48
7720729|NCT01675167|19011519|P1|NOT COMPLETED|Double-blind Treatment Phase||0
7720730|NCT01675167|19011517|P3|COMPLETED|Double-blind Treatment Phase||147
7720731|NCT01675167|19011518|P2|COMPLETED|Double-blind Treatment Phase||206
7720732|NCT01675167|19011519|P1|COMPLETED|Double-blind Treatment Phase||0
7720733|NCT01675167|19011517|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257
7720734|NCT01675167|19011518|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254
7720735|NCT01675167|19011519|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
7720736|NCT01675167|19011517|P3|NOT COMPLETED|Open-label Titration Phase||0
7720737|NCT01675167|19011518|P2|NOT COMPLETED|Open-label Titration Phase||0
7720738|NCT01675167|19011519|P1|NOT COMPLETED|Open-label Titration Phase||304
7720739|NCT01675167|19011517|P3|COMPLETED|Open-label Titration Phase||0
7720740|NCT01675167|19011518|P2|COMPLETED|Open-label Titration Phase||0
7720741|NCT01675167|19011519|P1|COMPLETED|Open-label Titration Phase||511
7720742|NCT01675167|19011517|P3|STARTED|Open-label Titration Phase||0
7720743|NCT01675167|19011518|P2|STARTED|Open-label Titration Phase||0
7720744|NCT01675167|19011519|P1|STARTED|Open-label Titration Phase||815
7720745|NCT01675141|19011541|P1|NOT COMPLETED|Overall Study||11
7720746|NCT01675141|19011541|P1|COMPLETED|Overall Study||0
7720747|NCT01675141|19011541|P1|STARTED|Overall Study||11
7720748|NCT01675128|19011554|P3|NOT COMPLETED|Overall Study||1
7720749|NCT01675128|19011555|P2|NOT COMPLETED|Overall Study||2
7720750|NCT01675128|19011556|P1|NOT COMPLETED|Overall Study||2
7720751|NCT01675128|19011554|P3|COMPLETED|Overall Study||9
7720752|NCT01675128|19011555|P2|COMPLETED|Overall Study||8
7720753|NCT01675128|19011556|P1|COMPLETED|Overall Study||2
7720754|NCT01675128|19011554|P3|STARTED|Overall Study||10
7720755|NCT01675128|19011555|P2|STARTED|Overall Study||10
7720756|NCT01675128|19011556|P1|STARTED|Overall Study||4
7720757|NCT01675063|19011578|P1|NOT COMPLETED|Overall Study||0
7720758|NCT01675063|19011578|P1|COMPLETED|Overall Study||77
7720759|NCT01675063|19011578|P1|STARTED|Overall Study||77
7720760|NCT01675050|19011584|P2|NOT COMPLETED|Second Period Treatment||0
7720761|NCT01675050|19011585|P1|NOT COMPLETED|Second Period Treatment||0
7720762|NCT01675050|19011584|P2|COMPLETED|Second Period Treatment||2
7720763|NCT01675050|19011585|P1|COMPLETED|Second Period Treatment||1
7720764|NCT01675050|19011584|P2|STARTED|Second Period Treatment||2
7720765|NCT01675050|19011585|P1|STARTED|Second Period Treatment||1
7720766|NCT01675050|19011584|P2|NOT COMPLETED|Wash Out Period||0
7720767|NCT01675050|19011585|P1|NOT COMPLETED|Wash Out Period||0
7720768|NCT01675050|19011584|P2|COMPLETED|Wash Out Period||2
7720769|NCT01675050|19011585|P1|COMPLETED|Wash Out Period||1
7720770|NCT01675050|19011584|P2|STARTED|Wash Out Period||2
7720771|NCT01675050|19011585|P1|STARTED|Wash Out Period||1
7720772|NCT01675050|19011584|P2|NOT COMPLETED|Period One Treatment||0
7720773|NCT01675050|19011585|P1|NOT COMPLETED|Period One Treatment||1
7720774|NCT01675050|19011584|P2|COMPLETED|Period One Treatment||2
7720775|NCT01675050|19011585|P1|COMPLETED|Period One Treatment||1
7720776|NCT01675050|19011584|P2|STARTED|Period One Treatment||2
7720777|NCT01675050|19011585|P1|STARTED|Period One Treatment||2
7720778|NCT01675011|19011595|P2|NOT COMPLETED|Overall Study||1
7720779|NCT01675011|19011596|P1|NOT COMPLETED|Overall Study||3
7720780|NCT01675011|19011595|P2|COMPLETED|Overall Study||0
7720781|NCT01675011|19011596|P1|COMPLETED|Overall Study||0
7720782|NCT01675011|19011595|P2|STARTED|Overall Study||1
7720783|NCT01675011|19011596|P1|STARTED|Overall Study||3
7720784|NCT01674725|19011604|P2|NOT COMPLETED|Overall Study||1
7720785|NCT01674725|19011605|P1|NOT COMPLETED|Overall Study||3
7720786|NCT01674725|19011604|P2|COMPLETED|Overall Study||94
7720787|NCT01674725|19011605|P1|COMPLETED|Overall Study||89
7720788|NCT01674725|19011604|P2|STARTED|Overall Study||95
7720789|NCT01674725|19011605|P1|STARTED|Overall Study||92
7720790|NCT01674712|19011624|P5|NOT COMPLETED|Overall Study||11
7720791|NCT01674712|19011625|P4|NOT COMPLETED|Overall Study||8
7720792|NCT01674712|19011626|P3|NOT COMPLETED|Overall Study||9
7720793|NCT01674712|19011627|P2|NOT COMPLETED|Overall Study||9
7720794|NCT01674712|19011628|P1|NOT COMPLETED|Overall Study||10
7720795|NCT01674712|19011624|P5|COMPLETED|Overall Study||102
7720796|NCT01674712|19011625|P4|COMPLETED|Overall Study||108
7720797|NCT01674712|19011626|P3|COMPLETED|Overall Study||106
7720798|NCT01674712|19011627|P2|COMPLETED|Overall Study||108
7720799|NCT01674712|19011628|P1|COMPLETED|Overall Study||104
7720800|NCT01674712|19011624|P5|Safety Subject Sample|Overall Study||112
7720801|NCT01674712|19011625|P4|Safety Subject Sample|Overall Study||115
7720802|NCT01674712|19011626|P3|Safety Subject Sample|Overall Study||113
7720803|NCT01674712|19011627|P2|Safety Subject Sample|Overall Study||117
7720804|NCT01674712|19011628|P1|Safety Subject Sample|Overall Study||111
7720805|NCT01674712|19011624|P5|Full Analysis Subject Sample|Overall Study||111
7720806|NCT01674712|19011625|P4|Full Analysis Subject Sample|Overall Study||112
7720807|NCT01674712|19011626|P3|Full Analysis Subject Sample|Overall Study||110
7720808|NCT01674712|19011627|P2|Full Analysis Subject Sample|Overall Study||114
7720809|NCT01674712|19011628|P1|Full Analysis Subject Sample|Overall Study||109
7720810|NCT01674712|19011624|P5|STARTED|Overall Study||113
7720811|NCT01674712|19011625|P4|STARTED|Overall Study||116
7720812|NCT01674712|19011626|P3|STARTED|Overall Study||115
7720813|NCT01674712|19011627|P2|STARTED|Overall Study||117
7720814|NCT01674712|19011628|P1|STARTED|Overall Study||114
7720815|NCT01674647|19011652|P2|NOT COMPLETED|30-day Safety Follow-up Period||41
7720816|NCT01674647|19011653|P1|NOT COMPLETED|30-day Safety Follow-up Period||58
7720817|NCT01674647|19011652|P2|COMPLETED|30-day Safety Follow-up Period||446
7720818|NCT01674647|19011653|P1|COMPLETED|30-day Safety Follow-up Period||924
7720819|NCT01674647|19011652|P2|STARTED|30-day Safety Follow-up Period||487
7720820|NCT01674647|19011653|P1|STARTED|30-day Safety Follow-up Period||982
7720821|NCT01674647|19011652|P2|NOT COMPLETED|Treatment Period||102
7720822|NCT01674647|19011653|P1|NOT COMPLETED|Treatment Period||156
7720823|NCT01674647|19011652|P2|COMPLETED|Treatment Period||400
7720824|NCT01674647|19011653|P1|COMPLETED|Treatment Period||846
7720825|NCT01674647|19011652|P2|Subjects Received Treatment|Treatment Period||499
7720826|NCT01674647|19011653|P1|Subjects Received Treatment|Treatment Period||988
7720827|NCT01674647|19011652|P2|STARTED|Treatment Period||502
7720828|NCT01674647|19011653|P1|STARTED|Treatment Period||1002
7720829|NCT01674634|19011679|P1|NOT COMPLETED|Overall Study||6
7720830|NCT01674634|19011679|P1|COMPLETED|Overall Study||709
7720831|NCT01674634|19011679|P1|STARTED|Overall Study||715
7720832|NCT01674621|19011699|P5|NOT COMPLETED|Overall Study||6
7720833|NCT01674621|19011700|P4|NOT COMPLETED|Overall Study||6
7720834|NCT01674621|19011701|P3|NOT COMPLETED|Overall Study||7
7720835|NCT01674621|19011702|P2|NOT COMPLETED|Overall Study||8
7720836|NCT01674621|19011703|P1|NOT COMPLETED|Overall Study||5
7720837|NCT01674621|19011699|P5|COMPLETED|Overall Study||44
7720838|NCT01674621|19011700|P4|COMPLETED|Overall Study||45
7720839|NCT01674621|19011701|P3|COMPLETED|Overall Study||41
7720840|NCT01674621|19011702|P2|COMPLETED|Overall Study||43
7720841|NCT01674621|19011703|P1|COMPLETED|Overall Study||45
7720842|NCT01674621|19011699|P5|Safety Population|Overall Study||50
7720843|NCT01674621|19011700|P4|Safety Population|Overall Study||51
7720844|NCT01674621|19011701|P3|Safety Population|Overall Study||47
7720845|NCT01674621|19011702|P2|Safety Population|Overall Study||51
7720846|NCT01674621|19011703|P1|Safety Population|Overall Study||50
7720847|NCT01674621|19011699|P5|Modified Intent-to-Treat Population|Overall Study||46
7720848|NCT01674621|19011700|P4|Modified Intent-to-Treat Population|Overall Study||49
7720849|NCT01674621|19011701|P3|Modified Intent-to-Treat Population|Overall Study||43
7720850|NCT01674621|19011702|P2|Modified Intent-to-Treat Population|Overall Study||46
7720851|NCT01674621|19011703|P1|Modified Intent-to-Treat Population|Overall Study||47
7720852|NCT01674621|19011699|P5|STARTED|Overall Study||50
7720853|NCT01674621|19011700|P4|STARTED|Overall Study||51
7720854|NCT01674621|19011701|P3|STARTED|Overall Study||48
7720855|NCT01674621|19011702|P2|STARTED|Overall Study||51
7720856|NCT01674621|19011703|P1|STARTED|Overall Study||50
7720857|NCT01674569|19011780|P6|NOT COMPLETED|Overall Study||2
7720858|NCT01674569|19011781|P5|NOT COMPLETED|Overall Study||2
7720859|NCT01674569|19011782|P4|NOT COMPLETED|Overall Study||1
7720860|NCT01674569|19011783|P3|NOT COMPLETED|Overall Study||2
7720861|NCT01674569|19011784|P2|NOT COMPLETED|Overall Study||3
7720862|NCT01674569|19011785|P1|NOT COMPLETED|Overall Study||0
7720863|NCT01674569|19011780|P6|COMPLETED|Overall Study||1
7720864|NCT01674569|19011781|P5|COMPLETED|Overall Study||5
7720865|NCT01674569|19011782|P4|COMPLETED|Overall Study||9
7720866|NCT01674569|19011783|P3|COMPLETED|Overall Study||2
7720867|NCT01674569|19011784|P2|COMPLETED|Overall Study||5
7720868|NCT01674569|19011785|P1|COMPLETED|Overall Study||3
7720869|NCT01674569|19011780|P6|STARTED|Overall Study||3
7720870|NCT01674569|19011781|P5|STARTED|Overall Study||7
7720871|NCT01674569|19011782|P4|STARTED|Overall Study||10
7720872|NCT01674569|19011783|P3|STARTED|Overall Study||4
7720873|NCT01674569|19011784|P2|STARTED|Overall Study||8
7720874|NCT01674569|19011785|P1|STARTED|Overall Study||3
7720875|NCT01674478|19011791|P2|NOT COMPLETED|Overall Study||0
7720876|NCT01674478|19011792|P1|NOT COMPLETED|Overall Study||0
7720877|NCT01674478|19011791|P2|COMPLETED|Overall Study||9
7720878|NCT01674478|19011792|P1|COMPLETED|Overall Study||9
7720879|NCT01674478|19011791|P2|STARTED|Overall Study||9
7720880|NCT01674478|19011792|P1|STARTED|Overall Study||9
7720881|NCT01674062|19011806|P2|NOT COMPLETED|Overall Study||29
7720882|NCT01674062|19011807|P1|NOT COMPLETED|Overall Study||66
7720883|NCT01674062|19011806|P2|COMPLETED|Overall Study||0
7720884|NCT01674062|19011807|P1|COMPLETED|Overall Study||0
7720885|NCT01674062|19011806|P2|STARTED|Overall Study||29
7720886|NCT01674062|19011807|P1|STARTED|Overall Study||66
7720887|NCT01674010|19011822|P3|NOT COMPLETED|Randomization Phase 2||61
7720888|NCT01674010|19011823|P2|NOT COMPLETED|Randomization Phase 2||62
7720889|NCT01674010|19011824|P1|NOT COMPLETED|Randomization Phase 2||0
7720890|NCT01674010|19011822|P3|COMPLETED|Randomization Phase 2||3
7720891|NCT01674010|19011823|P2|COMPLETED|Randomization Phase 2||3
7720892|NCT01674010|19011824|P1|COMPLETED|Randomization Phase 2||0
7720893|NCT01674010|19011822|P3|STARTED|Randomization Phase 2||64
7720894|NCT01674010|19011823|P2|STARTED|Randomization Phase 2||65
7720895|NCT01674010|19011824|P1|STARTED|Randomization Phase 2||0
7720896|NCT01674010|19011822|P3|NOT COMPLETED|Open Treatment Phase 1||0
7720897|NCT01674010|19011823|P2|NOT COMPLETED|Open Treatment Phase 1||0
7720898|NCT01674010|19011824|P1|NOT COMPLETED|Open Treatment Phase 1||180
7720899|NCT01674010|19011822|P3|COMPLETED|Open Treatment Phase 1||0
7720900|NCT01674010|19011823|P2|COMPLETED|Open Treatment Phase 1||0
7720901|NCT01674010|19011824|P1|COMPLETED|Open Treatment Phase 1||129
7720902|NCT01674010|19011822|P3|STARTED|Open Treatment Phase 1||0
7720903|NCT01674010|19011823|P2|STARTED|Open Treatment Phase 1||0
7720904|NCT01674010|19011824|P1|STARTED|Open Treatment Phase 1||309
7720905|NCT01673984|19011843|P2|NOT COMPLETED|Overall Study||6
7720906|NCT01673984|19011844|P1|NOT COMPLETED|Overall Study||10
7720907|NCT01673984|19011843|P2|COMPLETED|Overall Study||1
7720908|NCT01673984|19011844|P1|COMPLETED|Overall Study||4
7720909|NCT01673984|19011843|P2|STARTED|Overall Study||7
7720910|NCT01673984|19011844|P1|STARTED|Overall Study||14
7720911|NCT01673919|19011862|P1|NOT COMPLETED|Overall Study||0
7720912|NCT01673919|19011862|P1|COMPLETED|Overall Study||7
7720913|NCT01673919|19011862|P1|STARTED|Overall Study||7
7720914|NCT01673893|19011886|P1|NOT COMPLETED|Overall Study||0
7720915|NCT01673893|19011886|P1|COMPLETED|Overall Study||59
7720916|NCT01673893|19011886|P1|STARTED|Overall Study||59
7720917|NCT01673867|19011894|P2|NOT COMPLETED|Treatment||268
7720918|NCT01673867|19011895|P1|NOT COMPLETED|Treatment||244
7720919|NCT01673867|19011894|P2|COMPLETED|Treatment||0
7720920|NCT01673867|19011895|P1|COMPLETED|Treatment||43
7720921|NCT01673867|19011894|P2|STARTED|Treatment||268
7720922|NCT01673867|19011895|P1|STARTED|Treatment||287
7720923|NCT01673867|19011894|P2|NOT COMPLETED|Randomization||22
7720924|NCT01673867|19011895|P1|NOT COMPLETED|Randomization||5
7720925|NCT01673867|19011894|P2|COMPLETED|Randomization||268
7720926|NCT01673867|19011895|P1|COMPLETED|Randomization||287
7720927|NCT01673867|19011894|P2|STARTED|Randomization||290
7720928|NCT01673867|19011895|P1|STARTED|Randomization||292
7720929|NCT01673854|19011921|P1|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19
7720930|NCT01673854|19011921|P1|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0
7720931|NCT01673854|19011921|P1|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19
7720932|NCT01673854|19011921|P1|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27
7720933|NCT01673854|19011921|P1|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19
7720934|NCT01673854|19011921|P1|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46
7720935|NCT01673854|19011921|P1|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0
7720936|NCT01673854|19011921|P1|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46
7720937|NCT01673854|19011921|P1|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46
7720938|NCT01673828|19011931|P2|NOT COMPLETED|Overall Study||0
7720939|NCT01673828|19011932|P1|NOT COMPLETED|Overall Study||0
7720940|NCT01673828|19011931|P2|COMPLETED|Overall Study||6
7720941|NCT01673828|19011932|P1|COMPLETED|Overall Study||7
7720942|NCT01673828|19011931|P2|STARTED|Overall Study||6
7720943|NCT01673828|19011932|P1|STARTED|Overall Study||7
7720944|NCT01673802|19011938|P1|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0
7720945|NCT01673802|19011938|P1|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10
7720946|NCT01673802|19011938|P1|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10
7720947|NCT01673802|19011938|P1|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0
7720948|NCT01673802|19011938|P1|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8
7720949|NCT01673802|19011938|P1|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8
7720950|NCT01673698|19011944|P2|NOT COMPLETED|Overall Study||13
7720951|NCT01673698|19011945|P1|NOT COMPLETED|Overall Study||51
7720952|NCT01673698|19011944|P2|COMPLETED|Overall Study||126
7720953|NCT01673698|19011945|P1|COMPLETED|Overall Study||136
7720954|NCT01673698|19011944|P2|STARTED|Overall Study||139
7720955|NCT01673698|19011945|P1|STARTED|Overall Study||187
7720956|NCT01673646|19011956|P3|NOT COMPLETED|Overall Study||4
7720957|NCT01673646|19011957|P2|NOT COMPLETED|Overall Study||7
7720958|NCT01673646|19011958|P1|NOT COMPLETED|Overall Study||4
7720959|NCT01673646|19011956|P3|COMPLETED|Overall Study||7
7720960|NCT01673646|19011957|P2|COMPLETED|Overall Study||4
7720961|NCT01673646|19011958|P1|COMPLETED|Overall Study||7
7720962|NCT01673646|19011956|P3|Discontinued Beyond 24 Months|Overall Study||1
7720963|NCT01673646|19011957|P2|Discontinued Beyond 24 Months|Overall Study||4
7720964|NCT01673646|19011958|P1|Discontinued Beyond 24 Months|Overall Study||0
7720965|NCT01673646|19011956|P3|Treated Beyond 24 Months|Overall Study||8
7720966|NCT01673646|19011957|P2|Treated Beyond 24 Months|Overall Study||8
7720967|NCT01673646|19011958|P1|Treated Beyond 24 Months|Overall Study||7
7720968|NCT01673646|19011956|P3|Did Not Enter Ext. Phase|Overall Study||1
7720969|NCT01673646|19011957|P2|Did Not Enter Ext. Phase|Overall Study||1
7720970|NCT01673646|19011958|P1|Did Not Enter Ext. Phase|Overall Study||2
7720971|NCT01673646|19011956|P3|Entered Ext. Phase|Overall Study||9
7720972|NCT01673646|19011957|P2|Entered Ext. Phase|Overall Study||9
7720973|NCT01673646|19011958|P1|Entered Ext. Phase|Overall Study||7
7720974|NCT01673646|19011956|P3|Completed Core Phase|Overall Study||10
7720975|NCT01673646|19011957|P2|Completed Core Phase|Overall Study||10
7720976|NCT01673646|19011958|P1|Completed Core Phase|Overall Study||9
7720977|NCT01673646|19011956|P3|Entered/Treated in Core Phase|Overall Study||11
7720978|NCT01673646|19011957|P2|Entered/Treated in Core Phase|Overall Study||11
7720979|NCT01673646|19011958|P1|Entered/Treated in Core Phase|Overall Study||11
7720980|NCT01673646|19011956|P3|STARTED|Overall Study||11
7720981|NCT01673646|19011957|P2|STARTED|Overall Study||11
7720982|NCT01673646|19011958|P1|STARTED|Overall Study||11
7720983|NCT01673620|19011997|P2|NOT COMPLETED|Overall Study||0
7720984|NCT01673620|19011998|P1|NOT COMPLETED|Overall Study||1
7720985|NCT01673620|19011997|P2|COMPLETED|Overall Study||22
7720986|NCT01673620|19011998|P1|COMPLETED|Overall Study||46
7720987|NCT01673620|19011997|P2|STARTED|Overall Study||22
7720988|NCT01673620|19011998|P1|STARTED|Overall Study||47
7720989|NCT01673594|19012008|P2|NOT COMPLETED|Overall Study||6
7720990|NCT01673594|19012009|P1|NOT COMPLETED|Overall Study||6
7720991|NCT01673594|19012008|P2|COMPLETED|Overall Study||13
7720992|NCT01673594|19012009|P1|COMPLETED|Overall Study||12
7720993|NCT01673594|19012008|P2|STARTED|Overall Study||19
7720994|NCT01673594|19012009|P1|STARTED|Overall Study||18
7720995|NCT01673568|19012019|P2|NOT COMPLETED|Overall Study||0
7720996|NCT01673568|19012020|P1|NOT COMPLETED|Overall Study||0
7720997|NCT01673568|19012019|P2|COMPLETED|Overall Study||28
7720998|NCT01673568|19012020|P1|COMPLETED|Overall Study||28
7720999|NCT01673568|19012019|P2|STARTED|Overall Study||28
7721000|NCT01673568|19012020|P1|STARTED|Overall Study||28
7721001|NCT01673490|19012028|P1|NOT COMPLETED|Overall Study||7
7721002|NCT01673490|19012028|P1|COMPLETED|Overall Study||52
7721003|NCT01673490|19012028|P1|STARTED|Overall Study||59
7721004|NCT01673425|19012041|P1|NOT COMPLETED|Overall Study||1
7721005|NCT01673425|19012041|P1|COMPLETED|Overall Study||4
7721006|NCT01673425|19012041|P1|STARTED|Overall Study||5
7721007|NCT01673386|19012045|P2|NOT COMPLETED|Overall Study||27
7721008|NCT01673386|19012046|P1|NOT COMPLETED|Overall Study||25
7721009|NCT01673386|19012045|P2|COMPLETED|Overall Study|Of 4 subjects, 3 subjects discontinued sunitinib early, completed planned treatment with tivozanib.|4
7721010|NCT01673386|19012046|P1|COMPLETED|Overall Study|Of 2 subjects, 1 subject discontinued tivozanib early, completed planned treatment with sunitinib.|2
7721011|NCT01673386|19012045|P2|STARTED|Overall Study||31
7721012|NCT01673386|19012046|P1|STARTED|Overall Study||27
7721013|NCT01673373|19012076|P1|NOT COMPLETED|Overall Study||2
7721014|NCT01673373|19012076|P1|COMPLETED|Overall Study|Completed primary endpoint follow up.|66
7721015|NCT01673373|19012076|P1|STARTED|Overall Study||68
7721016|NCT01673347|19012092|P1|NOT COMPLETED|Overall Study||7
7721017|NCT01673347|19012092|P1|COMPLETED|Overall Study||17
7721018|NCT01673347|19012092|P1|STARTED|Overall Study||24
7721019|NCT01673282|19012101|P2|NOT COMPLETED|Overall Study||26
7721020|NCT01673282|19012102|P1|NOT COMPLETED|Overall Study||33
7721021|NCT01673282|19012101|P2|COMPLETED|Overall Study||132
7721022|NCT01673282|19012102|P1|COMPLETED|Overall Study||120
7721023|NCT01673282|19012101|P2|STARTED|Overall Study||158
7721024|NCT01673282|19012102|P1|STARTED|Overall Study||153
7721025|NCT01673256|19012108|P1|NOT COMPLETED|Overall Study||0
7721026|NCT01673256|19012108|P1|COMPLETED|Overall Study||90
7721027|NCT01673256|19012108|P1|STARTED|Overall Study||90
7721028|NCT01673191|19012114|P2|NOT COMPLETED|Overall Study||0
7721029|NCT01673191|19012115|P1|NOT COMPLETED|Overall Study||0
7721030|NCT01673191|19012114|P2|COMPLETED|Overall Study||11
7721031|NCT01673191|19012115|P1|COMPLETED|Overall Study||26
7721032|NCT01673191|19012114|P2|STARTED|Overall Study||11
7721033|NCT01673191|19012115|P1|STARTED|Overall Study||26
7721034|NCT01673178|19012138|P5|NOT COMPLETED|Overall Study||2
7721035|NCT01673178|19012139|P4|NOT COMPLETED|Overall Study||8
7721036|NCT01673178|19012140|P3|NOT COMPLETED|Overall Study||3
7721037|NCT01673178|19012141|P2|NOT COMPLETED|Overall Study||2
7721038|NCT01673178|19012142|P1|NOT COMPLETED|Overall Study||3
7721039|NCT01673178|19012138|P5|COMPLETED|Overall Study||19
7721040|NCT01673178|19012139|P4|COMPLETED|Overall Study||14
7721041|NCT01673178|19012140|P3|COMPLETED|Overall Study||18
7721042|NCT01673178|19012141|P2|COMPLETED|Overall Study||19
7721043|NCT01673178|19012142|P1|COMPLETED|Overall Study||19
7721044|NCT01673178|19012138|P5|STARTED|Overall Study||21
7721045|NCT01673178|19012139|P4|STARTED|Overall Study||22
7721046|NCT01673178|19012140|P3|STARTED|Overall Study||21
7721047|NCT01673178|19012141|P2|STARTED|Overall Study||21
7721048|NCT01673178|19012142|P1|STARTED|Overall Study||22
7721049|NCT01673126|19012381|P2|NOT COMPLETED|Overall Study||3
7721050|NCT01673126|19012382|P1|NOT COMPLETED|Overall Study||4
7721051|NCT01673126|19012381|P2|COMPLETED|Overall Study||23
7721052|NCT01673126|19012382|P1|COMPLETED|Overall Study||32
7721053|NCT01673126|19012381|P2|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26
7721054|NCT01673126|19012382|P1|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36
7721055|NCT01673113|19012390|P2|NOT COMPLETED|Overall Study||0
7721056|NCT01673113|19012391|P1|NOT COMPLETED|Overall Study||0
7721057|NCT01673113|19012390|P2|COMPLETED|Overall Study||11
7721058|NCT01673113|19012391|P1|COMPLETED|Overall Study||11
7721059|NCT01673113|19012390|P2|STARTED|Overall Study||11
7721060|NCT01673113|19012391|P1|STARTED|Overall Study||11
7721061|NCT01673061|19012400|P2|NOT COMPLETED|Overall Study||0
7721062|NCT01673061|19012401|P1|NOT COMPLETED|Overall Study||0
7721063|NCT01673061|19012400|P2|COMPLETED|Overall Study||0
7721064|NCT01673061|19012401|P1|COMPLETED|Overall Study||0
7721065|NCT01673061|19012400|P2|STARTED|Overall Study||0
7721066|NCT01673061|19012401|P1|STARTED|Overall Study||0
7721067|NCT01673022|19012417|P1|NOT COMPLETED|Overall Study||8
7721068|NCT01673022|19012417|P1|COMPLETED|Overall Study||422
7721069|NCT01673022|19012417|P1|STARTED|Overall Study||430
7721070|NCT01673009|19012421|P1|NOT COMPLETED|Overall Study||13
7721071|NCT01673009|19012421|P1|COMPLETED|Overall Study||23
7721072|NCT01673009|19012421|P1|STARTED|Overall Study||36
7721073|NCT01672996|19012433|P3|NOT COMPLETED|Overall Study||0
7721074|NCT01672996|19012434|P2|NOT COMPLETED|Overall Study||0
7721075|NCT01672996|19012435|P1|NOT COMPLETED|Overall Study||0
7721076|NCT01672996|19012433|P3|COMPLETED|Overall Study||6
7721077|NCT01672996|19012434|P2|COMPLETED|Overall Study||30
7721078|NCT01672996|19012435|P1|COMPLETED|Overall Study||30
7721079|NCT01672996|19012433|P3|STARTED|Overall Study||6
7721080|NCT01672996|19012434|P2|STARTED|Overall Study||30
7721081|NCT01672996|19012435|P1|STARTED|Overall Study||30
7721082|NCT01672983|19012471|P6|NOT COMPLETED|Overall Study||0
7721083|NCT01672983|19012472|P5|NOT COMPLETED|Overall Study||0
7721084|NCT01672983|19012473|P4|NOT COMPLETED|Overall Study||0
7721085|NCT01672983|19012474|P3|NOT COMPLETED|Overall Study||0
7721086|NCT01672983|19012475|P2|NOT COMPLETED|Overall Study||0
7721087|NCT01672983|19012476|P1|NOT COMPLETED|Overall Study||0
7721088|NCT01672983|19012471|P6|COMPLETED|Overall Study||18
7721089|NCT01672983|19012472|P5|COMPLETED|Overall Study||19
7721090|NCT01672983|19012473|P4|COMPLETED|Overall Study||18
7721091|NCT01672983|19012474|P3|COMPLETED|Overall Study||19
7721092|NCT01672983|19012475|P2|COMPLETED|Overall Study||18
7721093|NCT01672983|19012476|P1|COMPLETED|Overall Study||18
7721094|NCT01672983|19012471|P6|Completed Study Drug|Overall Study||17
7721095|NCT01672983|19012472|P5|Completed Study Drug|Overall Study||12
7721096|NCT01672983|19012473|P4|Completed Study Drug|Overall Study||18
7721097|NCT01672983|19012474|P3|Completed Study Drug|Overall Study||18
7721098|NCT01672983|19012475|P2|Completed Study Drug|Overall Study||17
7721099|NCT01672983|19012476|P1|Completed Study Drug|Overall Study||18
7721100|NCT01672983|19012471|P6|STARTED|Overall Study||18
7721101|NCT01672983|19012472|P5|STARTED|Overall Study||19
7721102|NCT01672983|19012473|P4|STARTED|Overall Study||18
7721103|NCT01672983|19012474|P3|STARTED|Overall Study||19
7721104|NCT01672983|19012475|P2|STARTED|Overall Study||18
7721105|NCT01672983|19012476|P1|STARTED|Overall Study||18
7721106|NCT01672970|19012506|P1|NOT COMPLETED|Overall Study||47
7721107|NCT01672970|19012506|P1|COMPLETED|Overall Study||244
7721108|NCT01672970|19012506|P1|Treated|Overall Study||290
7721109|NCT01672970|19012506|P1|STARTED|Overall Study||291
7721110|NCT01672957|19012542|P1|NOT COMPLETED|Overall Study||55
7721111|NCT01672957|19012542|P1|COMPLETED|Overall Study||73
7721112|NCT01672957|19012542|P1|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123
7721113|NCT01672957|19012542|P1|STARTED|Overall Study||128
7721114|NCT01672892|19012557|P2|NOT COMPLETED|Overall Study||3
7721115|NCT01672892|19012558|P1|NOT COMPLETED|Overall Study||7
7721116|NCT01672892|19012557|P2|COMPLETED|Overall Study||149
7721117|NCT01672892|19012558|P1|COMPLETED|Overall Study||130
7721118|NCT01672892|19012557|P2|Adverse Event Population|Overall Study||144
7721119|NCT01672892|19012558|P1|Adverse Event Population|Overall Study||125
7721120|NCT01672892|19012557|P2|Eligible Population|Overall Study||149
7721121|NCT01672892|19012558|P1|Eligible Population|Overall Study||130
7721122|NCT01672892|19012557|P2|STARTED|Overall Study||152
7721123|NCT01672892|19012558|P1|STARTED|Overall Study||137
7721124|NCT01672879|19012587|P3|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||8
7721125|NCT01672879|19012588|P2|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||17
7721126|NCT01672879|19012589|P1|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||15
7721127|NCT01672879|19012587|P3|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
7721128|NCT01672879|19012588|P2|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
7721129|NCT01672879|19012589|P1|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
7721130|NCT01672879|19012587|P3|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|8
7721131|NCT01672879|19012588|P2|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|17
7721132|NCT01672879|19012589|P1|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
7721133|NCT01672879|19012587|P3|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
7721134|NCT01672879|19012588|P2|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
7721135|NCT01672879|19012589|P1|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||87
7721136|NCT01672879|19012587|P3|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
7721137|NCT01672879|19012588|P2|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
7721138|NCT01672879|19012589|P1|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
7721139|NCT01672879|19012587|P3|STARTED|Blinded Phase (Up to 240 Weeks)||86
7721140|NCT01672879|19012588|P2|STARTED|Blinded Phase (Up to 240 Weeks)||86
7721141|NCT01672879|19012589|P1|STARTED|Blinded Phase (Up to 240 Weeks)||87
7721142|NCT01672866|19012604|P3|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||16
7721143|NCT01672866|19012605|P2|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||15
7721144|NCT01672866|19012606|P1|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||11
7721145|NCT01672866|19012604|P3|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
7721146|NCT01672866|19012605|P2|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
7721147|NCT01672866|19012606|P1|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
7721148|NCT01672866|19012604|P3|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|16
7721149|NCT01672866|19012605|P2|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
7721150|NCT01672866|19012606|P1|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|11
7721151|NCT01672866|19012604|P3|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
7721152|NCT01672866|19012605|P2|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
7721153|NCT01672866|19012606|P1|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
7721154|NCT01672866|19012604|P3|COMPLETED|Blinded Phase (up to 240 Weeks)||0
7721155|NCT01672866|19012605|P2|COMPLETED|Blinded Phase (up to 240 Weeks)||0
7721156|NCT01672866|19012606|P1|COMPLETED|Blinded Phase (up to 240 Weeks)||0
7721157|NCT01672866|19012604|P3|STARTED|Blinded Phase (up to 240 Weeks)||74
7721158|NCT01672866|19012605|P2|STARTED|Blinded Phase (up to 240 Weeks)||74
7721159|NCT01672866|19012606|P1|STARTED|Blinded Phase (up to 240 Weeks)||74
7721160|NCT01672853|19012621|P3|NOT COMPLETED|Overall Study||14
7721161|NCT01672853|19012622|P2|NOT COMPLETED|Overall Study||17
7721162|NCT01672853|19012623|P1|NOT COMPLETED|Overall Study||10
7721163|NCT01672853|19012621|P3|COMPLETED|Overall Study||65
7721164|NCT01672853|19012622|P2|COMPLETED|Overall Study||60
7721165|NCT01672853|19012623|P1|COMPLETED|Overall Study||69
7721166|NCT01672853|19012621|P3|STARTED|Overall Study||79
7721167|NCT01672853|19012622|P2|STARTED|Overall Study||77
7721168|NCT01672853|19012623|P1|STARTED|Overall Study||79
7721169|NCT01672827|19012640|P1|NOT COMPLETED|Overall Study||0
7721170|NCT01672827|19012640|P1|COMPLETED|Overall Study||276
7721171|NCT01672827|19012640|P1|STARTED|Overall Study||276
7721172|NCT01672801|19012648|P2|NOT COMPLETED|Overall Study||1
7721173|NCT01672801|19012649|P1|NOT COMPLETED|Overall Study||0
7721174|NCT01672801|19012648|P2|COMPLETED|Overall Study||8
7721175|NCT01672801|19012649|P1|COMPLETED|Overall Study||9
7721176|NCT01672801|19012648|P2|STARTED|Overall Study||9
7721177|NCT01672801|19012649|P1|STARTED|Overall Study||9
7721178|NCT01672788|19012657|P4|NOT COMPLETED|Treatment Period 4 (3 Days)||0
7721179|NCT01672788|19012658|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
7721180|NCT01672788|19012659|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
7721181|NCT01672788|19012660|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
7721182|NCT01672788|19012657|P4|COMPLETED|Treatment Period 4 (3 Days)||8
7721183|NCT01672788|19012658|P3|COMPLETED|Treatment Period 4 (3 Days)||9
7721184|NCT01672788|19012659|P2|COMPLETED|Treatment Period 4 (3 Days)||9
7721185|NCT01672788|19012660|P1|COMPLETED|Treatment Period 4 (3 Days)||9
7721186|NCT01672788|19012657|P4|STARTED|Treatment Period 4 (3 Days)||8
7721187|NCT01672788|19012658|P3|STARTED|Treatment Period 4 (3 Days)||9
7721188|NCT01672788|19012659|P2|STARTED|Treatment Period 4 (3 Days)||9
7721189|NCT01672788|19012660|P1|STARTED|Treatment Period 4 (3 Days)||9
7721190|NCT01672788|19012657|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
7721191|NCT01672788|19012658|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
7721192|NCT01672788|19012659|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
7721193|NCT01672788|19012660|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
7721194|NCT01672788|19012657|P4|COMPLETED|Washout Period 3 (7 Days)||8
7721195|NCT01672788|19012658|P3|COMPLETED|Washout Period 3 (7 Days)||9
7721196|NCT01672788|19012659|P2|COMPLETED|Washout Period 3 (7 Days)||9
7721197|NCT01672788|19012660|P1|COMPLETED|Washout Period 3 (7 Days)||9
7721198|NCT01672788|19012657|P4|STARTED|Washout Period 3 (7 Days)||8
7721199|NCT01672788|19012658|P3|STARTED|Washout Period 3 (7 Days)||9
7721200|NCT01672788|19012659|P2|STARTED|Washout Period 3 (7 Days)||9
7721201|NCT01672788|19012660|P1|STARTED|Washout Period 3 (7 Days)||9
7721202|NCT01672788|19012657|P4|NOT COMPLETED|Treatment Period 3 (3 Days)||0
7721203|NCT01672788|19012658|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
7721204|NCT01672788|19012659|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
7721205|NCT01672788|19012660|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
7721206|NCT01672788|19012657|P4|COMPLETED|Treatment Period 3 (3 Days)||8
7721207|NCT01672788|19012658|P3|COMPLETED|Treatment Period 3 (3 Days)||9
7721208|NCT01672788|19012659|P2|COMPLETED|Treatment Period 3 (3 Days)||9
7721209|NCT01672788|19012660|P1|COMPLETED|Treatment Period 3 (3 Days)||9
7721210|NCT01672788|19012657|P4|STARTED|Treatment Period 3 (3 Days)||8
7721211|NCT01672788|19012658|P3|STARTED|Treatment Period 3 (3 Days)||9
7721212|NCT01672788|19012659|P2|STARTED|Treatment Period 3 (3 Days)||9
7721213|NCT01672788|19012660|P1|STARTED|Treatment Period 3 (3 Days)||9
7721214|NCT01672788|19012657|P4|NOT COMPLETED|Washout Period 2 (7 Days)||1
7721215|NCT01672788|19012658|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
7721216|NCT01672788|19012659|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
7721217|NCT01672788|19012660|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
7721218|NCT01672788|19012657|P4|COMPLETED|Washout Period 2 (7 Days)||8
7721219|NCT01672788|19012658|P3|COMPLETED|Washout Period 2 (7 Days)||9
7721220|NCT01672788|19012659|P2|COMPLETED|Washout Period 2 (7 Days)||9
7721221|NCT01672788|19012660|P1|COMPLETED|Washout Period 2 (7 Days)||9
7721222|NCT01672788|19012657|P4|STARTED|Washout Period 2 (7 Days)||9
7721223|NCT01672788|19012658|P3|STARTED|Washout Period 2 (7 Days)||9
7721224|NCT01672788|19012659|P2|STARTED|Washout Period 2 (7 Days)||9
7721225|NCT01672788|19012660|P1|STARTED|Washout Period 2 (7 Days)||9
7721226|NCT01672788|19012657|P4|NOT COMPLETED|Treatment Period 2 (3 Days)||0
7721227|NCT01672788|19012658|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
7721228|NCT01672788|19012659|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||0
7721229|NCT01672788|19012660|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
7721230|NCT01672788|19012657|P4|COMPLETED|Treatment Period 2 (3 Days)||9
7721231|NCT01672788|19012658|P3|COMPLETED|Treatment Period 2 (3 Days)||9
7721232|NCT01672788|19012659|P2|COMPLETED|Treatment Period 2 (3 Days)||9
7721233|NCT01672788|19012660|P1|COMPLETED|Treatment Period 2 (3 Days)||9
7721234|NCT01672788|19012657|P4|STARTED|Treatment Period 2 (3 Days)||9
7721235|NCT01672788|19012658|P3|STARTED|Treatment Period 2 (3 Days)||9
7721236|NCT01672788|19012659|P2|STARTED|Treatment Period 2 (3 Days)||9
7721237|NCT01672788|19012660|P1|STARTED|Treatment Period 2 (3 Days)||9
7721238|NCT01672788|19012657|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
7721239|NCT01672788|19012658|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
7721240|NCT01672788|19012659|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
7721241|NCT01672788|19012660|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
7721242|NCT01672788|19012657|P4|COMPLETED|Washout Period 1 (7 Days)||9
7721243|NCT01672788|19012658|P3|COMPLETED|Washout Period 1 (7 Days)||9
7721244|NCT01672788|19012659|P2|COMPLETED|Washout Period 1 (7 Days)||9
7721245|NCT01672788|19012660|P1|COMPLETED|Washout Period 1 (7 Days)||9
7721246|NCT01672788|19012657|P4|STARTED|Washout Period 1 (7 Days)||9
7721247|NCT01672788|19012658|P3|STARTED|Washout Period 1 (7 Days)||9
7721248|NCT01672788|19012659|P2|STARTED|Washout Period 1 (7 Days)||9
7721249|NCT01672788|19012660|P1|STARTED|Washout Period 1 (7 Days)||9
7721250|NCT01672788|19012657|P4|NOT COMPLETED|Treatment Period 1 (3 Days)||0
7721251|NCT01672788|19012658|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
7721252|NCT01672788|19012659|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
7721253|NCT01672788|19012660|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
7721254|NCT01672788|19012657|P4|COMPLETED|Treatment Period 1 (3 Days)||9
7721255|NCT01672788|19012658|P3|COMPLETED|Treatment Period 1 (3 Days)||9
7721256|NCT01672788|19012659|P2|COMPLETED|Treatment Period 1 (3 Days)||9
7721257|NCT01672788|19012660|P1|COMPLETED|Treatment Period 1 (3 Days)||9
7721258|NCT01672788|19012657|P4|STARTED|Treatment Period 1 (3 Days)||9
7721259|NCT01672788|19012658|P3|STARTED|Treatment Period 1 (3 Days)||9
7721260|NCT01672788|19012659|P2|STARTED|Treatment Period 1 (3 Days)||9
7721261|NCT01672788|19012660|P1|STARTED|Treatment Period 1 (3 Days)||9
7721262|NCT01672736|19012690|P1|NOT COMPLETED|Overall Study||3
7721263|NCT01672736|19012690|P1|COMPLETED|Overall Study|3 patients taken off study due to non-availability of further study (Linsitinib) drug supply.|16
7721264|NCT01672736|19012690|P1|STARTED|Overall Study|Phase I study part stopped early due to manufacturer's decision to stop further drug development.|19
7721265|NCT01672723|19012694|P2|NOT COMPLETED|Second Intervention||0
7721266|NCT01672723|19012695|P1|NOT COMPLETED|Second Intervention||0
7721267|NCT01672723|19012694|P2|COMPLETED|Second Intervention||15
7721268|NCT01672723|19012695|P1|COMPLETED|Second Intervention||16
7721269|NCT01672723|19012694|P2|STARTED|Second Intervention||15
7721270|NCT01672723|19012695|P1|STARTED|Second Intervention||16
7721271|NCT01672723|19012694|P2|NOT COMPLETED|Washout Period of 10 Days||0
7721272|NCT01672723|19012695|P1|NOT COMPLETED|Washout Period of 10 Days||0
7721273|NCT01672723|19012694|P2|COMPLETED|Washout Period of 10 Days||15
7721274|NCT01672723|19012695|P1|COMPLETED|Washout Period of 10 Days||16
7721275|NCT01672723|19012694|P2|STARTED|Washout Period of 10 Days||15
7721276|NCT01672723|19012695|P1|STARTED|Washout Period of 10 Days||16
7721277|NCT01672723|19012694|P2|NOT COMPLETED|First Intervention||0
7721278|NCT01672723|19012695|P1|NOT COMPLETED|First Intervention||3
7721279|NCT01672723|19012694|P2|COMPLETED|First Intervention||15
7721280|NCT01672723|19012695|P1|COMPLETED|First Intervention||16
7721281|NCT01672723|19012694|P2|STARTED|First Intervention||15
7721282|NCT01672723|19012695|P1|STARTED|First Intervention||19
7721283|NCT01672710|19012707|P2|NOT COMPLETED|3 Month Follow up||4
7721284|NCT01672710|19012708|P1|NOT COMPLETED|3 Month Follow up||6
7721285|NCT01672710|19012707|P2|COMPLETED|3 Month Follow up||5
7721286|NCT01672710|19012708|P1|COMPLETED|3 Month Follow up||16
7721287|NCT01672710|19012707|P2|STARTED|3 Month Follow up||9
7721288|NCT01672710|19012708|P1|STARTED|3 Month Follow up||22
7721289|NCT01672710|19012707|P2|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||1
7721290|NCT01672710|19012708|P1|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||0
7721291|NCT01672710|19012707|P2|COMPLETED|Waitlist Assessed After Sauna Regimen||9
7721292|NCT01672710|19012708|P1|COMPLETED|Waitlist Assessed After Sauna Regimen|non applicable, cannot compare the immediate start and waitlist in this period|22
7721293|NCT01672710|19012707|P2|STARTED|Waitlist Assessed After Sauna Regimen|waitlisted group receive the 4 week intervention and complete 7 day assessments|10
7721294|NCT01672710|19012708|P1|STARTED|Waitlist Assessed After Sauna Regimen|immediate start group no further assessments until 3 month follow up|22
7721295|NCT01672710|19012707|P2|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
7721296|NCT01672710|19012708|P1|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
7721297|NCT01672710|19012707|P2|COMPLETED|Controlled Comparison 5 Week Follow-up|waitlist group repeat baseline assessments after 4 week time period then begin sauna|10
7721298|NCT01672710|19012708|P1|COMPLETED|Controlled Comparison 5 Week Follow-up|sauna intervention group repeat all assessments 7 days after complete the regimen|22
7721299|NCT01672710|19012707|P2|STARTED|Controlled Comparison 5 Week Follow-up||10
7721300|NCT01672710|19012708|P1|STARTED|Controlled Comparison 5 Week Follow-up||22
7721301|NCT01672658|19012718|P2|NOT COMPLETED|Overall Study||1
7721302|NCT01672658|19012719|P1|NOT COMPLETED|Overall Study||0
7721303|NCT01672658|19012718|P2|COMPLETED|Overall Study||14
7721304|NCT01672658|19012719|P1|COMPLETED|Overall Study||16
7721305|NCT01672658|19012718|P2|STARTED|Overall Study||15
7721306|NCT01672658|19012719|P1|STARTED|Overall Study||16
7721307|NCT01672294|19012743|P4|NOT COMPLETED|Overall Study||13
7721308|NCT01672294|19012744|P3|NOT COMPLETED|Overall Study||11
7721309|NCT01672294|19012745|P2|NOT COMPLETED|Overall Study||21
7721310|NCT01672294|19012746|P1|NOT COMPLETED|Overall Study||6
7721311|NCT01672294|19012743|P4|COMPLETED|Overall Study||59
7721312|NCT01672294|19012744|P3|COMPLETED|Overall Study||61
7721313|NCT01672294|19012745|P2|COMPLETED|Overall Study||50
7721314|NCT01672294|19012746|P1|COMPLETED|Overall Study||65
7721315|NCT01672294|19012743|P4|STARTED|Overall Study||72
7721316|NCT01672294|19012744|P3|STARTED|Overall Study||72
7721317|NCT01672294|19012745|P2|STARTED|Overall Study||71
7721318|NCT01672294|19012746|P1|STARTED|Overall Study||71
7721319|NCT01672242|19012768|P2|NOT COMPLETED|Period 2||0
7721320|NCT01672242|19012769|P1|NOT COMPLETED|Period 2||0
7721321|NCT01672242|19012768|P2|COMPLETED|Period 2||2
7721322|NCT01672242|19012769|P1|COMPLETED|Period 2||4
7721323|NCT01672242|19012768|P2|STARTED|Period 2||2
7721324|NCT01672242|19012769|P1|STARTED|Period 2||4
7721325|NCT01672242|19012768|P2|NOT COMPLETED|Period 1||0
7721326|NCT01672242|19012769|P1|NOT COMPLETED|Period 1||0
7721327|NCT01672242|19012768|P2|COMPLETED|Period 1||2
7721328|NCT01672242|19012769|P1|COMPLETED|Period 1||4
7721329|NCT01672242|19012768|P2|STARTED|Period 1||2
7721330|NCT01672242|19012769|P1|STARTED|Period 1||4
7721331|NCT01671839|19012775|P1|NOT COMPLETED|Overall Study||18
7721332|NCT01671839|19012775|P1|COMPLETED|Overall Study||37
7721333|NCT01671839|19012775|P1|5-year Follow-up|Overall Study||37
7721334|NCT01671839|19012775|P1|3-year Follow-up|Overall Study||45
7721335|NCT01671839|19012775|P1|STARTED|Overall Study||55
7721336|NCT01671748|19012791|P2|NOT COMPLETED|12 Week Treatment Phase||0
7721337|NCT01671748|19012792|P1|NOT COMPLETED|12 Week Treatment Phase||0
7721338|NCT01671748|19012791|P2|COMPLETED|12 Week Treatment Phase||17
7721339|NCT01671748|19012792|P1|COMPLETED|12 Week Treatment Phase||19
7721340|NCT01671748|19012791|P2|STARTED|12 Week Treatment Phase||17
7721341|NCT01671748|19012792|P1|STARTED|12 Week Treatment Phase||19
7721342|NCT01671748|19012791|P2|NOT COMPLETED|4 Week run-in Phase||0
7721343|NCT01671748|19012792|P1|NOT COMPLETED|4 Week run-in Phase||11
7721344|NCT01671748|19012791|P2|COMPLETED|4 Week run-in Phase||0
7721345|NCT01671748|19012792|P1|COMPLETED|4 Week run-in Phase||36
7721346|NCT01671748|19012791|P2|STARTED|4 Week run-in Phase||0
7721347|NCT01671748|19012792|P1|STARTED|4 Week run-in Phase||47
7721348|NCT01671605|19012812|P2|NOT COMPLETED|Overall Study||0
7721349|NCT01671605|19012813|P1|NOT COMPLETED|Overall Study||0
7721350|NCT01671605|19012812|P2|COMPLETED|Overall Study||31
7721351|NCT01671605|19012813|P1|COMPLETED|Overall Study||72
7721352|NCT01671605|19012812|P2|STARTED|Overall Study||31
7721353|NCT01671605|19012813|P1|STARTED|Overall Study||72
7721354|NCT01671488|19012819|P1|NOT COMPLETED|Overall Study||1
7721355|NCT01671488|19012819|P1|COMPLETED|Overall Study||10
7721356|NCT01671488|19012819|P1|STARTED|Overall Study||11
7721357|NCT01671345|19012827|P2|NOT COMPLETED|Overall Study||9
7721358|NCT01671345|19012828|P1|NOT COMPLETED|Overall Study||13
7721359|NCT01671345|19012827|P2|COMPLETED|Overall Study||83
7721360|NCT01671345|19012828|P1|COMPLETED|Overall Study||64
7721361|NCT01671345|19012827|P2|STARTED|Overall Study||92
7721362|NCT01671345|19012828|P1|STARTED|Overall Study||77
7721363|NCT01671332|19012842|P2|NOT COMPLETED|Overall Study||1
7721364|NCT01671332|19012843|P1|NOT COMPLETED|Overall Study||1
7721365|NCT01671332|19012842|P2|COMPLETED|Overall Study||39
7721366|NCT01671332|19012843|P1|COMPLETED|Overall Study||39
7721367|NCT01671332|19012842|P2|Crossed Over to Docetaxel Plus Suramin|Overall Study|Participants with disease progression on Docetaxel Arm were allowed to crossover to Suramin.|13
7721368|NCT01671332|19012843|P1|Crossed Over to Docetaxel Plus Suramin|Overall Study||0
7721369|NCT01671332|19012842|P2|STARTED|Overall Study||40
7721370|NCT01671332|19012843|P1|STARTED|Overall Study||40
7721371|NCT01671319|19012857|P1|NOT COMPLETED|Overall Study||1
7721372|NCT01671319|19012857|P1|COMPLETED|Overall Study||41
7721373|NCT01671319|19012857|P1|STARTED|Overall Study||42
7721374|NCT01671293|19012865|P2|NOT COMPLETED|Overall Study||2
7721375|NCT01671293|19012866|P1|NOT COMPLETED|Overall Study||3
7721376|NCT01671293|19012865|P2|COMPLETED|Overall Study||32
7721377|NCT01671293|19012866|P1|COMPLETED|Overall Study||33
7721378|NCT01671293|19012865|P2|STARTED|Overall Study||34
7721379|NCT01671293|19012866|P1|STARTED|Overall Study||36
7721380|NCT01671280|19012872|P1|NOT COMPLETED|Overall Study||2
7721381|NCT01671280|19012872|P1|COMPLETED|Overall Study||401
7721382|NCT01671280|19012872|P1|STARTED|Overall Study|The number is enrollment.|403
7721383|NCT01671176|19012878|P1|NOT COMPLETED|Overall Study||0
7721384|NCT01671176|19012878|P1|COMPLETED|Overall Study||30
7721385|NCT01671176|19012878|P1|STARTED|Overall Study||30
7721386|NCT01671111|19012883|P1|NOT COMPLETED|Overall Study||30
7721387|NCT01671111|19012883|P1|COMPLETED|Overall Study||0
7721388|NCT01671111|19012883|P1|STARTED|Overall Study||30
7721389|NCT01671085|19012895|P2|NOT COMPLETED|Overall Study||0
7721390|NCT01671085|19012896|P1|NOT COMPLETED|Overall Study||1
7721391|NCT01671085|19012895|P2|COMPLETED|Overall Study||2
7721392|NCT01671085|19012896|P1|COMPLETED|Overall Study||10
7721393|NCT01671085|19012895|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
7721394|NCT01671085|19012896|P1|Received at Least 1 Dose of Study Drug|Overall Study||11
7721395|NCT01671085|19012895|P2|STARTED|Overall Study||2
7721396|NCT01671085|19012896|P1|STARTED|Overall Study|1 participant who dropped out was replaced.|11
7721397|NCT01671059|19012907|P1|NOT COMPLETED|Overall Study||5
7721398|NCT01671059|19012907|P1|COMPLETED|Overall Study||75
7721399|NCT01671059|19012907|P1|STARTED|Overall Study||80
7721400|NCT01671007|19012939|P9|NOT COMPLETED|Overall Study||0
7721401|NCT01671007|19012940|P8|NOT COMPLETED|Overall Study||132
7721402|NCT01671007|19012941|P7|NOT COMPLETED|Overall Study||21
7721403|NCT01671007|19012942|P6|NOT COMPLETED|Overall Study||112
7721404|NCT01671007|19012943|P5|NOT COMPLETED|Overall Study||25
7721405|NCT01671007|19012944|P4|NOT COMPLETED|Overall Study||368
7721406|NCT01671007|19012945|P3|NOT COMPLETED|Overall Study||366
7721407|NCT01671007|19012946|P2|NOT COMPLETED|Overall Study||651
7721408|NCT01671007|19012947|P1|NOT COMPLETED|Overall Study||321
7721409|NCT01671007|19012939|P9|COMPLETED|Overall Study||2
7721410|NCT01671007|19012940|P8|COMPLETED|Overall Study||394
7721411|NCT01671007|19012941|P7|COMPLETED|Overall Study||59
7721412|NCT01671007|19012942|P6|COMPLETED|Overall Study||401
7721413|NCT01671007|19012943|P5|COMPLETED|Overall Study||155
7721414|NCT01671007|19012944|P4|COMPLETED|Overall Study||1846
7721415|NCT01671007|19012945|P3|COMPLETED|Overall Study||1667
7721416|NCT01671007|19012946|P2|COMPLETED|Overall Study||2183
7721417|NCT01671007|19012947|P1|COMPLETED|Overall Study||1768
7721418|NCT01671007|19012939|P9|All Eligible|Overall Study||2
7721419|NCT01671007|19012940|P8|All Eligible|Overall Study||507
7721420|NCT01671007|19012941|P7|All Eligible|Overall Study||79
7721421|NCT01671007|19012942|P6|All Eligible|Overall Study||507
7721422|NCT01671007|19012943|P5|All Eligible|Overall Study||180
7721423|NCT01671007|19012944|P4|All Eligible|Overall Study||2197
7721424|NCT01671007|19012945|P3|All Eligible|Overall Study||2008
7721425|NCT01671007|19012946|P2|All Eligible|Overall Study||2758
7721426|NCT01671007|19012947|P1|All Eligible|Overall Study||2066
7721427|NCT01671007|19012939|P9|STARTED|Overall Study||2
7721428|NCT01671007|19012940|P8|STARTED|Overall Study||526
7721429|NCT01671007|19012941|P7|STARTED|Overall Study||80
7721430|NCT01671007|19012942|P6|STARTED|Overall Study||513
7721431|NCT01671007|19012943|P5|STARTED|Overall Study||180
7721432|NCT01671007|19012944|P4|STARTED|Overall Study||2214
7721433|NCT01671007|19012945|P3|STARTED|Overall Study||2033
7721434|NCT01671007|19012946|P2|STARTED|Overall Study||2834
7721435|NCT01671007|19012947|P1|STARTED|Overall Study||2089
7721436|NCT01670825|19012982|P2|NOT COMPLETED|Overall Study||0
7721437|NCT01670825|19012983|P1|NOT COMPLETED|Overall Study||0
7721438|NCT01670825|19012982|P2|COMPLETED|Overall Study||39
7721439|NCT01670825|19012983|P1|COMPLETED|Overall Study||42
7721440|NCT01670825|19012982|P2|STARTED|Overall Study||39
7721441|NCT01670825|19012983|P1|STARTED|Overall Study||42
7721442|NCT01670760|19013049|P1|NOT COMPLETED|Overall Study||0
7721443|NCT01670760|19013049|P1|COMPLETED|Overall Study||20
7721444|NCT01670760|19013049|P1|STARTED|Overall Study||20
7721445|NCT01670721|19013053|P1|NOT COMPLETED|Overall Study||53
7721446|NCT01670721|19013053|P1|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122
7721447|NCT01670721|19013053|P1|STARTED|Overall Study||175
7721448|NCT01670656|19013065|P5|NOT COMPLETED|Overall Study||11
7721449|NCT01670656|19013066|P4|NOT COMPLETED|Overall Study||6
7721450|NCT01670656|19013067|P3|NOT COMPLETED|Overall Study||8
7721451|NCT01670656|19013068|P2|NOT COMPLETED|Overall Study||7
7721452|NCT01670656|19013069|P1|NOT COMPLETED|Overall Study||3
7721453|NCT01670656|19013065|P5|COMPLETED|Overall Study||79
7721454|NCT01670656|19013066|P4|COMPLETED|Overall Study||79
7721455|NCT01670656|19013067|P3|COMPLETED|Overall Study||79
7721456|NCT01670656|19013068|P2|COMPLETED|Overall Study||84
7721457|NCT01670656|19013069|P1|COMPLETED|Overall Study||83
7721458|NCT01670656|19013065|P5|Treated|Overall Study||90
7721459|NCT01670656|19013066|P4|Treated|Overall Study||85
7721460|NCT01670656|19013067|P3|Treated|Overall Study||86
7721461|NCT01670656|19013068|P2|Treated|Overall Study||91
7721462|NCT01670656|19013069|P1|Treated|Overall Study||86
7721463|NCT01670656|19013065|P5|STARTED|Overall Study||90
7721464|NCT01670656|19013066|P4|STARTED|Overall Study||85
7721465|NCT01670656|19013067|P3|STARTED|Overall Study||87
7721466|NCT01670656|19013068|P2|STARTED|Overall Study||91
7721467|NCT01670656|19013069|P1|STARTED|Overall Study||86
7721468|NCT01670526|19013098|P2|NOT COMPLETED|Overall Study||6
7721469|NCT01670526|19013099|P1|NOT COMPLETED|Overall Study||12
7721470|NCT01670526|19013098|P2|COMPLETED|Overall Study||39
7721471|NCT01670526|19013099|P1|COMPLETED|Overall Study||37
7721472|NCT01670526|19013098|P2|STARTED|Overall Study||45
7721473|NCT01670526|19013099|P1|STARTED|Overall Study||49
7721474|NCT01670500|19013113|P2|NOT COMPLETED|Overall Study||0
7721475|NCT01670500|19013114|P1|NOT COMPLETED|Overall Study||1
7721476|NCT01670500|19013113|P2|COMPLETED|Overall Study|4 pts received <4 cycles of assigned chemo; 2 pts received add'l non-protocol chemo before surgery|60
7721477|NCT01670500|19013114|P1|COMPLETED|Overall Study|1 patient withdrew after 3 cycles; 5 patients received additional non-protocol chemo before surgery|57
7721478|NCT01670500|19013113|P2|STARTED|Overall Study||60
7721479|NCT01670500|19013114|P1|STARTED|Overall Study||58
7721480|NCT01670487|19013130|P2|NOT COMPLETED|Overall Study||0
7721481|NCT01670487|19013131|P1|NOT COMPLETED|Overall Study||0
7721482|NCT01670487|19013130|P2|COMPLETED|Overall Study||150
7721483|NCT01670487|19013131|P1|COMPLETED|Overall Study||150
7721484|NCT01670487|19013130|P2|STARTED|Overall Study||150
7721485|NCT01670487|19013131|P1|STARTED|Overall Study||150
7721486|NCT01670292|19013137|P1|NOT COMPLETED|Overall Study||14
7721487|NCT01670292|19013137|P1|COMPLETED|Overall Study||68
7721488|NCT01670292|19013137|P1|STARTED|Overall Study||82
7721489|NCT01670279|19013178|P4|NOT COMPLETED|Overall Study||1
7721490|NCT01670279|19013179|P3|NOT COMPLETED|Overall Study||0
7721491|NCT01670279|19013180|P2|NOT COMPLETED|Overall Study||2
7721492|NCT01670279|19013181|P1|NOT COMPLETED|Overall Study||0
7721493|NCT01670279|19013178|P4|COMPLETED|Overall Study||4
7721494|NCT01670279|19013179|P3|COMPLETED|Overall Study||0
7721495|NCT01670279|19013180|P2|COMPLETED|Overall Study||5
7721496|NCT01670279|19013181|P1|COMPLETED|Overall Study||6
7721497|NCT01670279|19013178|P4|STARTED|Overall Study||5
7721498|NCT01670279|19013179|P3|STARTED|Overall Study||0
7721499|NCT01670279|19013180|P2|STARTED|Overall Study||7
7721500|NCT01670279|19013181|P1|STARTED|Overall Study||6
7721501|NCT01670201|19013216|P1|NOT COMPLETED|Overall Study||0
7721502|NCT01670201|19013216|P1|COMPLETED|Overall Study||8
7721503|NCT01670201|19013216|P1|STARTED|Overall Study||8
7721504|NCT01670188|19013223|P2|NOT COMPLETED|Overall Study||1
7721505|NCT01670188|19013224|P1|NOT COMPLETED|Overall Study||0
7721506|NCT01670188|19013223|P2|COMPLETED|Overall Study||39
7721507|NCT01670188|19013224|P1|COMPLETED|Overall Study||38
7721508|NCT01670188|19013223|P2|STARTED|Overall Study||40
7721509|NCT01670188|19013224|P1|STARTED|Overall Study||38
7721510|NCT01670110|19013232|P2|NOT COMPLETED|Overall Study||3
7721511|NCT01670110|19013233|P1|NOT COMPLETED|Overall Study||4
7721512|NCT01670110|19013232|P2|COMPLETED|Overall Study||12
7721513|NCT01670110|19013233|P1|COMPLETED|Overall Study||29
7721514|NCT01670110|19013232|P2|STARTED|Overall Study||15
7721515|NCT01670110|19013233|P1|STARTED|Overall Study||33
7721516|NCT01670045|19013253|P1|NOT COMPLETED|Overall Study||16
7721517|NCT01670045|19013253|P1|COMPLETED|Overall Study||27
7721518|NCT01670045|19013253|P1|STARTED|Overall Study||43
7721519|NCT01670019|19013271|P2|NOT COMPLETED|Overall Study||0
7721520|NCT01670019|19013272|P1|NOT COMPLETED|Overall Study||9
7721521|NCT01670019|19013271|P2|COMPLETED|Overall Study||23
7721522|NCT01670019|19013272|P1|COMPLETED|Overall Study||14
7721523|NCT01670019|19013271|P2|STARTED|Overall Study||23
7721524|NCT01670019|19013272|P1|STARTED|Overall Study||23
7721525|NCT01669902|19013286|P1|NOT COMPLETED|Overall Study||29
7721526|NCT01669902|19013286|P1|COMPLETED|Overall Study||78
7721527|NCT01669902|19013286|P1|STARTED|Overall Study||107
7721528|NCT01669863|19013313|P1|NOT COMPLETED|Overall Study||0
7721529|NCT01669863|19013313|P1|COMPLETED|Overall Study||6
7721530|NCT01669863|19013313|P1|STARTED|Overall Study||6
7721531|NCT01669811|19013321|P2|NOT COMPLETED|Overall Study||11
7721532|NCT01669811|19013322|P1|NOT COMPLETED|Overall Study||3
7721533|NCT01669811|19013321|P2|COMPLETED|Overall Study||131
7721534|NCT01669811|19013322|P1|COMPLETED|Overall Study||142
7721535|NCT01669811|19013321|P2|STARTED|Overall Study||142
7721536|NCT01669811|19013322|P1|STARTED|Overall Study||145
7721537|NCT01669798|19013340|P1|NOT COMPLETED|Overall Study||5
7721538|NCT01669798|19013340|P1|COMPLETED|Overall Study||27
7721539|NCT01669798|19013340|P1|STARTED|Overall Study||32
7721540|NCT01669785|19013356|P3|NOT COMPLETED|Overall Study||0
7721541|NCT01669785|19013357|P2|NOT COMPLETED|Overall Study||0
7721542|NCT01669785|19013358|P1|NOT COMPLETED|Overall Study||0
7721543|NCT01669785|19013356|P3|COMPLETED|Overall Study||46
7721544|NCT01669785|19013357|P2|COMPLETED|Overall Study||48
7721545|NCT01669785|19013358|P1|COMPLETED|Overall Study||45
7721546|NCT01669785|19013356|P3|STARTED|Overall Study||46
7721547|NCT01669785|19013357|P2|STARTED|Overall Study||48
7721548|NCT01669785|19013358|P1|STARTED|Overall Study||45
7721549|NCT01669720|19013395|P2|NOT COMPLETED|Overall Study||0
7721550|NCT01669720|19013396|P1|NOT COMPLETED|Overall Study||0
7721551|NCT01669720|19013395|P2|COMPLETED|Overall Study||3
7721552|NCT01669720|19013396|P1|COMPLETED|Overall Study||7
7721553|NCT01669720|19013395|P2|STARTED|Overall Study||3
7721554|NCT01669720|19013396|P1|STARTED|Overall Study||7
7721555|NCT01669642|19013409|P6|NOT COMPLETED|Overall Study||10
7721556|NCT01669642|19013410|P5|NOT COMPLETED|Overall Study||0
7721557|NCT01669642|19013411|P4|NOT COMPLETED|Overall Study||1
7721558|NCT01669642|19013412|P3|NOT COMPLETED|Overall Study||0
7721559|NCT01669642|19013413|P2|NOT COMPLETED|Overall Study||0
7721560|NCT01669642|19013414|P1|NOT COMPLETED|Overall Study||0
7721561|NCT01669642|19013409|P6|COMPLETED|Overall Study||0
7721562|NCT01669642|19013410|P5|COMPLETED|Overall Study||20
7721563|NCT01669642|19013411|P4|COMPLETED|Overall Study||20
7721564|NCT01669642|19013412|P3|COMPLETED|Overall Study||20
7721565|NCT01669642|19013413|P2|COMPLETED|Overall Study||20
7721566|NCT01669642|19013414|P1|COMPLETED|Overall Study||20
7721567|NCT01669642|19013409|P6|STARTED|Overall Study||10
7721568|NCT01669642|19013410|P5|STARTED|Overall Study||20
7721569|NCT01669642|19013411|P4|STARTED|Overall Study||21
7721570|NCT01669642|19013412|P3|STARTED|Overall Study||20
7721571|NCT01669642|19013413|P2|STARTED|Overall Study||20
7721572|NCT01669642|19013414|P1|STARTED|Overall Study||20
7721573|NCT01669629|19013446|P2|NOT COMPLETED|Period 2||0
7721574|NCT01669629|19013447|P1|NOT COMPLETED|Period 2||0
7721575|NCT01669629|19013446|P2|COMPLETED|Period 2||89
7721576|NCT01669629|19013447|P1|COMPLETED|Period 2||91
7721577|NCT01669629|19013446|P2|STARTED|Period 2||89
7721578|NCT01669629|19013447|P1|STARTED|Period 2||91
7721579|NCT01669629|19013446|P2|NOT COMPLETED|Period 1||2
7721580|NCT01669629|19013447|P1|NOT COMPLETED|Period 1||1
7721581|NCT01669629|19013446|P2|COMPLETED|Period 1||89
7721582|NCT01669629|19013447|P1|COMPLETED|Period 1||91
7721583|NCT01669629|19013446|P2|STARTED|Period 1||91
7721584|NCT01669629|19013447|P1|STARTED|Period 1||92
7721585|NCT01669603|19013463|P2|NOT COMPLETED|Overall Study||38
7721586|NCT01669603|19013464|P1|NOT COMPLETED|Overall Study||37
7721587|NCT01669603|19013463|P2|COMPLETED|Overall Study||57
7721588|NCT01669603|19013464|P1|COMPLETED|Overall Study||58
7721589|NCT01669603|19013463|P2|STARTED|Overall Study||95
7721590|NCT01669603|19013464|P1|STARTED|Overall Study||95
7721591|NCT01669577|19013470|P1|NOT COMPLETED|Overall Study||134
7721592|NCT01669577|19013470|P1|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200
7721593|NCT01669577|19013470|P1|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334
7721594|NCT01669538|19013476|P2|NOT COMPLETED|Overall Study||9
7721595|NCT01669538|19013477|P1|NOT COMPLETED|Overall Study||12
7721596|NCT01669538|19013476|P2|COMPLETED|Overall Study||33
7721597|NCT01669538|19013477|P1|COMPLETED|Overall Study||28
7721598|NCT01669538|19013476|P2|STARTED|Overall Study||42
7721599|NCT01669538|19013477|P1|STARTED|Overall Study||40
7721600|NCT01669434|19013491|P2|NOT COMPLETED|Overall Study||7
7721601|NCT01669434|19013492|P1|NOT COMPLETED|Overall Study||9
7721602|NCT01669434|19013491|P2|COMPLETED|Overall Study||138
7721603|NCT01669434|19013492|P1|COMPLETED|Overall Study||137
7721604|NCT01669434|19013491|P2|STARTED|Overall Study||145
7721605|NCT01669434|19013492|P1|STARTED|Overall Study||146
7721606|NCT01669421|19013508|P1|NOT COMPLETED|Phase 3: Standard Dose Therapy||0
7721607|NCT01669421|19013508|P1|COMPLETED|Phase 3: Standard Dose Therapy||8
7721608|NCT01669421|19013508|P1|STARTED|Phase 3: Standard Dose Therapy||8
7721609|NCT01669421|19013508|P1|NOT COMPLETED|Phase 2: Double Dose Therapy||0
7721610|NCT01669421|19013508|P1|COMPLETED|Phase 2: Double Dose Therapy||8
7721611|NCT01669421|19013508|P1|STARTED|Phase 2: Double Dose Therapy||8
7721612|NCT01669421|19013508|P1|NOT COMPLETED|Phase 1: Standard Dose Therapy||2
7721613|NCT01669421|19013508|P1|COMPLETED|Phase 1: Standard Dose Therapy||8
7721614|NCT01669421|19013508|P1|STARTED|Phase 1: Standard Dose Therapy||10
7721615|NCT01669174|19013527|P2|NOT COMPLETED|Overall Study||6
7721616|NCT01669174|19013528|P1|NOT COMPLETED|Overall Study||6
7721617|NCT01669174|19013527|P2|COMPLETED|Overall Study||28
7721618|NCT01669174|19013528|P1|COMPLETED|Overall Study||27
7721619|NCT01669174|19013527|P2|STARTED|Overall Study||34
7721620|NCT01669174|19013528|P1|STARTED|Overall Study||33
7721621|NCT01669148|19013539|P1|NOT COMPLETED|Overall Study||70
7721622|NCT01669148|19013539|P1|COMPLETED|Overall Study||426
7721623|NCT01669148|19013539|P1|STARTED|Overall Study||496
7721624|NCT01669122|19013544|P1|NOT COMPLETED|Period IV||0
7721625|NCT01669122|19013544|P1|COMPLETED|Period IV||37
7721626|NCT01669122|19013544|P1|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37
7721627|NCT01669122|19013544|P1|NOT COMPLETED|Period III||0
7721628|NCT01669122|19013544|P1|COMPLETED|Period III||37
7721629|NCT01669122|19013544|P1|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37
7721630|NCT01669122|19013544|P1|NOT COMPLETED|Washout Period III||0
7721631|NCT01669122|19013544|P1|COMPLETED|Washout Period III||37
7721632|NCT01669122|19013544|P1|STARTED|Washout Period III||37
7721633|NCT01669122|19013544|P1|NOT COMPLETED|Washout Period II||2
7721634|NCT01669122|19013544|P1|COMPLETED|Washout Period II||37
7721635|NCT01669122|19013544|P1|STARTED|Washout Period II||39
7721636|NCT01669122|19013544|P1|NOT COMPLETED|Period II||0
7721637|NCT01669122|19013544|P1|COMPLETED|Period II||39
7721638|NCT01669122|19013544|P1|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39
7721639|NCT01669122|19013544|P1|NOT COMPLETED|Washout Period I||0
7721640|NCT01669122|19013544|P1|COMPLETED|Washout Period I||39
7721641|NCT01669122|19013544|P1|STARTED|Washout Period I||39
7721642|NCT01669122|19013544|P1|NOT COMPLETED|Period I||1
7721643|NCT01669122|19013544|P1|COMPLETED|Period I||39
7721644|NCT01669122|19013544|P1|Safety Population|Period I||39
7721645|NCT01669122|19013544|P1|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40
7721646|NCT01669096|19013574|P1|NOT COMPLETED|Overall Study||0
7721647|NCT01669096|19013574|P1|COMPLETED|Overall Study||20
7721648|NCT01669096|19013574|P1|STARTED|Overall Study||20
7721649|NCT01668966|19013611|P1|NOT COMPLETED|Overall Study||4
7721650|NCT01668966|19013611|P1|COMPLETED|Overall Study||19
7721651|NCT01668966|19013611|P1|Treated|Overall Study||21
7721652|NCT01668966|19013611|P1|STARTED|Overall Study||23
7721653|NCT01668940|19013631|P4|NOT COMPLETED|Overall Study||0
7721654|NCT01668940|19013632|P3|NOT COMPLETED|Overall Study||0
7721655|NCT01668940|19013633|P2|NOT COMPLETED|Overall Study||0
7721656|NCT01668940|19013634|P1|NOT COMPLETED|Overall Study||0
7721657|NCT01668940|19013631|P4|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
7721658|NCT01668940|19013632|P3|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|9
7721659|NCT01668940|19013633|P2|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
7721660|NCT01668940|19013634|P1|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|17
7721661|NCT01668940|19013631|P4|STARTED|Overall Study||14
7721662|NCT01668940|19013632|P3|STARTED|Overall Study||9
7721663|NCT01668940|19013633|P2|STARTED|Overall Study||14
7721664|NCT01668940|19013634|P1|STARTED|Overall Study||17
7721665|NCT01668836|19013648|P4|NOT COMPLETED|Overall Study||0
7721666|NCT01668836|19013649|P3|NOT COMPLETED|Overall Study||0
7721667|NCT01668836|19013650|P2|NOT COMPLETED|Overall Study||0
7721668|NCT01668836|19013651|P1|NOT COMPLETED|Overall Study||0
7721669|NCT01668836|19013648|P4|COMPLETED|Overall Study||12
7721670|NCT01668836|19013649|P3|COMPLETED|Overall Study||12
7721671|NCT01668836|19013650|P2|COMPLETED|Overall Study||12
7721672|NCT01668836|19013651|P1|COMPLETED|Overall Study||12
7721673|NCT01668836|19013648|P4|STARTED|Overall Study||12
7721674|NCT01668836|19013649|P3|STARTED|Overall Study||12
7721675|NCT01668836|19013650|P2|STARTED|Overall Study||12
7721676|NCT01668836|19013651|P1|STARTED|Overall Study||12
7721677|NCT01668797|19013707|P4|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96
7721678|NCT01668797|19013708|P3|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83
7721679|NCT01668797|19013709|P2|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
7721680|NCT01668797|19013710|P1|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
7721681|NCT01668797|19013707|P4|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9
7721682|NCT01668797|19013708|P3|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14
7721683|NCT01668797|19013709|P2|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
7721684|NCT01668797|19013710|P1|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
7721685|NCT01668797|19013707|P4|STARTED|Phase C (Double-Blind Maintenance Phase)||105
7721686|NCT01668797|19013708|P3|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97
7721687|NCT01668797|19013709|P2|STARTED|Phase C (Double-Blind Maintenance Phase)||0
7721688|NCT01668797|19013710|P1|STARTED|Phase C (Double-Blind Maintenance Phase)||0
7721689|NCT01668797|19013707|P4|NOT COMPLETED|Phase B (Stabilization Phase)||0
7721690|NCT01668797|19013708|P3|NOT COMPLETED|Phase B (Stabilization Phase)||0
7721691|NCT01668797|19013709|P2|NOT COMPLETED|Phase B (Stabilization Phase)||262
7721692|NCT01668797|19013710|P1|NOT COMPLETED|Phase B (Stabilization Phase)||0
7721693|NCT01668797|19013707|P4|COMPLETED|Phase B (Stabilization Phase)||0
7721694|NCT01668797|19013708|P3|COMPLETED|Phase B (Stabilization Phase)||0
7721695|NCT01668797|19013709|P2|COMPLETED|Phase B (Stabilization Phase)||202
7721696|NCT01668797|19013710|P1|COMPLETED|Phase B (Stabilization Phase)||0
7721697|NCT01668797|19013707|P4|STARTED|Phase B (Stabilization Phase)||0
7721698|NCT01668797|19013708|P3|STARTED|Phase B (Stabilization Phase)||0
7721699|NCT01668797|19013709|P2|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464
7721700|NCT01668797|19013710|P1|STARTED|Phase B (Stabilization Phase)||0
7721701|NCT01668797|19013707|P4|NOT COMPLETED|Phase A (Conversion Phase)||0
7721702|NCT01668797|19013708|P3|NOT COMPLETED|Phase A (Conversion Phase)||0
7721703|NCT01668797|19013709|P2|NOT COMPLETED|Phase A (Conversion Phase)||0
7721704|NCT01668797|19013710|P1|NOT COMPLETED|Phase A (Conversion Phase)||60
7721705|NCT01668797|19013707|P4|COMPLETED|Phase A (Conversion Phase)||0
7721706|NCT01668797|19013708|P3|COMPLETED|Phase A (Conversion Phase)||0
7721707|NCT01668797|19013709|P2|COMPLETED|Phase A (Conversion Phase)||0
7721708|NCT01668797|19013710|P1|COMPLETED|Phase A (Conversion Phase)||346
7721709|NCT01668797|19013707|P4|STARTED|Phase A (Conversion Phase)||0
7721710|NCT01668797|19013708|P3|STARTED|Phase A (Conversion Phase)||0
7721711|NCT01668797|19013709|P2|STARTED|Phase A (Conversion Phase)||0
7721712|NCT01668797|19013710|P1|STARTED|Phase A (Conversion Phase)||406
7721713|NCT01668784|19013775|P2|NOT COMPLETED|Treated (Overall)||369
7721714|NCT01668784|19013776|P1|NOT COMPLETED|Treated (Overall)||339
7721715|NCT01668784|19013775|P2|COMPLETED|Treated (Overall)||28
7721716|NCT01668784|19013776|P1|COMPLETED|Treated (Overall)||67
7721717|NCT01668784|19013775|P2|STARTED|Treated (Overall)||397
7721718|NCT01668784|19013776|P1|STARTED|Treated (Overall)||406
7721719|NCT01668784|19013775|P2|NOT COMPLETED|Randomized (Pre-treatment)||14
7721720|NCT01668784|19013776|P1|NOT COMPLETED|Randomized (Pre-treatment)||4
7721721|NCT01668784|19013775|P2|COMPLETED|Randomized (Pre-treatment)||397
7721722|NCT01668784|19013776|P1|COMPLETED|Randomized (Pre-treatment)||406
7721723|NCT01668784|19013775|P2|STARTED|Randomized (Pre-treatment)||411
7721724|NCT01668784|19013776|P1|STARTED|Randomized (Pre-treatment)||410
7721725|NCT01668667|19013804|P4|NOT COMPLETED|Overall Study||23
7721726|NCT01668667|19013805|P3|NOT COMPLETED|Overall Study||31
7721727|NCT01668667|19013806|P2|NOT COMPLETED|Overall Study||26
7721728|NCT01668667|19013807|P1|NOT COMPLETED|Overall Study||31
7721729|NCT01668667|19013804|P4|COMPLETED|Overall Study||102
7721730|NCT01668667|19013805|P3|COMPLETED|Overall Study||94
7721731|NCT01668667|19013806|P2|COMPLETED|Overall Study||99
7721732|NCT01668667|19013807|P1|COMPLETED|Overall Study||95
7721733|NCT01668667|19013804|P4|STARTED|Overall Study||125
7721734|NCT01668667|19013805|P3|STARTED|Overall Study||125
7721735|NCT01668667|19013806|P2|STARTED|Overall Study||125
7721736|NCT01668667|19013807|P1|STARTED|Overall Study||126
7721737|NCT01668654|19013829|P1|NOT COMPLETED|Overall Study||4
7721738|NCT01668654|19013829|P1|COMPLETED|Overall Study||0
7721739|NCT01668654|19013829|P1|STARTED|Overall Study||4
7721740|NCT01668628|19013872|P3|NOT COMPLETED|Overall Study||0
7721741|NCT01668628|19013873|P2|NOT COMPLETED|Overall Study||0
7721742|NCT01668628|19013874|P1|NOT COMPLETED|Overall Study||2
7721743|NCT01668628|19013872|P3|COMPLETED|Overall Study||367
7721744|NCT01668628|19013873|P2|COMPLETED|Overall Study||359
7721745|NCT01668628|19013874|P1|COMPLETED|Overall Study||347
7721746|NCT01668628|19013872|P3|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367
7721747|NCT01668628|19013873|P2|STARTED|Overall Study||359
7721748|NCT01668628|19013874|P1|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349
7721749|NCT01668589|19013890|P4|NOT COMPLETED|Overall Study||35
7721750|NCT01668589|19013891|P3|NOT COMPLETED|Overall Study||35
7721751|NCT01668589|19013892|P2|NOT COMPLETED|Overall Study||58
7721752|NCT01668589|19013893|P1|NOT COMPLETED|Overall Study||139
7721753|NCT01668589|19013890|P4|COMPLETED|Overall Study||266
7721754|NCT01668589|19013891|P3|COMPLETED|Overall Study||265
7721755|NCT01668589|19013892|P2|COMPLETED|Overall Study||242
7721756|NCT01668589|19013893|P1|COMPLETED|Overall Study||461
7721757|NCT01668589|19013890|P4|Received Denosumab|Overall Study||301
7721758|NCT01668589|19013891|P3|Received Denosumab|Overall Study||300
7721759|NCT01668589|19013892|P2|Received Denosumab|Overall Study||300
7721760|NCT01668589|19013893|P1|Received Denosumab|Overall Study||599
7721761|NCT01668589|19013890|P4|STARTED|Overall Study||301
7721762|NCT01668589|19013891|P3|STARTED|Overall Study||300
7721763|NCT01668589|19013892|P2|STARTED|Overall Study||300
7721764|NCT01668589|19013893|P1|STARTED|Overall Study||600
7721765|NCT01668537|19013933|P2|NOT COMPLETED|Overall Study||10
7721766|NCT01668537|19013934|P1|NOT COMPLETED|Overall Study||22
7721767|NCT01668537|19013933|P2|COMPLETED|Overall Study||314
7721768|NCT01668537|19013934|P1|COMPLETED|Overall Study||305
7721769|NCT01668537|19013933|P2|STARTED|Overall Study||324
7721770|NCT01668537|19013934|P1|STARTED|Overall Study||327
7721771|NCT01668355|19013976|P2|NOT COMPLETED|Overall Study||2
7721772|NCT01668355|19013977|P1|NOT COMPLETED|Overall Study||9
7721773|NCT01668355|19013976|P2|COMPLETED|Overall Study||165
7721774|NCT01668355|19013977|P1|COMPLETED|Overall Study||155
7721775|NCT01668355|19013976|P2|STARTED|Overall Study||167
7721776|NCT01668355|19013977|P1|STARTED|Overall Study||164
7721777|NCT01668173|19013997|P1|NOT COMPLETED|Overall Study||7
7721778|NCT01668173|19013997|P1|COMPLETED|Overall Study||0
7721779|NCT01668173|19013997|P1|STARTED|Overall Study||7
7721780|NCT01668147|19014001|P1|NOT COMPLETED|Overall Study||6
7721781|NCT01668147|19014001|P1|COMPLETED|Overall Study||7
7721782|NCT01668147|19014001|P1|STARTED|Overall Study||13
7721783|NCT01668030|19014009|P2|NOT COMPLETED|Overall Study||0
7721784|NCT01668030|19014010|P1|NOT COMPLETED|Overall Study||0
7721785|NCT01668030|19014009|P2|COMPLETED|Overall Study||10
7721786|NCT01668030|19014010|P1|COMPLETED|Overall Study||10
7721787|NCT01668030|19014009|P2|STARTED|Overall Study||10
7721788|NCT01668030|19014010|P1|STARTED|Overall Study||10
7721789|NCT01668017|19014020|P5|NOT COMPLETED|Overall Study||0
7721790|NCT01668017|19014021|P4|NOT COMPLETED|Overall Study||0
7721791|NCT01668017|19014022|P3|NOT COMPLETED|Overall Study||0
7721792|NCT01668017|19014023|P2|NOT COMPLETED|Overall Study||0
7721793|NCT01668017|19014024|P1|NOT COMPLETED|Overall Study||0
7721794|NCT01668017|19014020|P5|COMPLETED|Overall Study||2
7721795|NCT01668017|19014021|P4|COMPLETED|Overall Study||5
7721796|NCT01668017|19014022|P3|COMPLETED|Overall Study||6
7721797|NCT01668017|19014023|P2|COMPLETED|Overall Study||9
7721798|NCT01668017|19014024|P1|COMPLETED|Overall Study||4
7721799|NCT01668017|19014020|P5|STARTED|Overall Study||2
7721800|NCT01668017|19014021|P4|STARTED|Overall Study||5
7721801|NCT01668017|19014022|P3|STARTED|Overall Study||6
7721802|NCT01668017|19014023|P2|STARTED|Overall Study||9
7721803|NCT01668017|19014024|P1|STARTED|Overall Study||4
7721804|NCT01668004|19014131|P1|NOT COMPLETED|Overall Study||25
7721805|NCT01668004|19014131|P1|COMPLETED|Overall Study||76
7721806|NCT01668004|19014131|P1|Treated|Overall Study||101
7721807|NCT01668004|19014131|P1|STARTED|Overall Study||101
7721808|NCT01667978|19014144|P2|NOT COMPLETED|Overall Study||0
7721809|NCT01667978|19014145|P1|NOT COMPLETED|Overall Study||2
7721810|NCT01667978|19014144|P2|COMPLETED|Overall Study||17
7721811|NCT01667978|19014145|P1|COMPLETED|Overall Study||16
7721812|NCT01667978|19014144|P2|STARTED|Overall Study||17
7721813|NCT01667978|19014145|P1|STARTED|Overall Study||18
7721814|NCT01667926|19014153|P3|NOT COMPLETED|Overall Study||11
7721815|NCT01667926|19014154|P2|NOT COMPLETED|Overall Study||4
7721816|NCT01667926|19014155|P1|NOT COMPLETED|Overall Study||5
7721817|NCT01667926|19014153|P3|COMPLETED|Overall Study|Participants in the screen fail group were not randomized in the study.|0
7721818|NCT01667926|19014154|P2|COMPLETED|Overall Study||9
7721819|NCT01667926|19014155|P1|COMPLETED|Overall Study||8
7721820|NCT01667926|19014153|P3|STARTED|Overall Study||11
7721821|NCT01667926|19014154|P2|STARTED|Overall Study||13
7721822|NCT01667926|19014155|P1|STARTED|Overall Study||13
7721823|NCT01667900|19014168|P20|NOT COMPLETED|Part B||0
7721824|NCT01667900|19014169|P19|NOT COMPLETED|Part B||0
7721825|NCT01667900|19014170|P18|NOT COMPLETED|Part B||0
7721826|NCT01667900|19014171|P17|NOT COMPLETED|Part B||1
7721827|NCT01667900|19014172|P16|NOT COMPLETED|Part B||0
7721828|NCT01667900|19014173|P15|NOT COMPLETED|Part B||0
7721829|NCT01667900|19014174|P14|NOT COMPLETED|Part B||0
7721830|NCT01667900|19014175|P13|NOT COMPLETED|Part B||0
7721831|NCT01667900|19014176|P12|NOT COMPLETED|Part B||0
7721832|NCT01667900|19014177|P11|NOT COMPLETED|Part B||0
7721833|NCT01667900|19014178|P10|NOT COMPLETED|Part B||0
7721834|NCT01667900|19014179|P9|NOT COMPLETED|Part B||0
7721835|NCT01667900|19014180|P8|NOT COMPLETED|Part B||0
7721836|NCT01667900|19014181|P7|NOT COMPLETED|Part B||0
7721837|NCT01667900|19014182|P6|NOT COMPLETED|Part B||0
7721838|NCT01667900|19014183|P5|NOT COMPLETED|Part B||0
7721839|NCT01667900|19014184|P4|NOT COMPLETED|Part B||0
7721840|NCT01667900|19014185|P3|NOT COMPLETED|Part B||0
7721841|NCT01667900|19014186|P2|NOT COMPLETED|Part B||0
7721842|NCT01667900|19014187|P1|NOT COMPLETED|Part B||0
7721843|NCT01667900|19014168|P20|COMPLETED|Part B||10
7721844|NCT01667900|19014169|P19|COMPLETED|Part B||10
7721845|NCT01667900|19014170|P18|COMPLETED|Part B||11
7721846|NCT01667900|19014171|P17|COMPLETED|Part B||10
7721847|NCT01667900|19014172|P16|COMPLETED|Part B||0
7721848|NCT01667900|19014173|P15|COMPLETED|Part B||0
7721849|NCT01667900|19014174|P14|COMPLETED|Part B||0
7721850|NCT01667900|19014175|P13|COMPLETED|Part B||0
7721851|NCT01667900|19014176|P12|COMPLETED|Part B||0
7721852|NCT01667900|19014177|P11|COMPLETED|Part B||0
7721853|NCT01667900|19014178|P10|COMPLETED|Part B||0
7721854|NCT01667900|19014179|P9|COMPLETED|Part B||0
7721855|NCT01667900|19014180|P8|COMPLETED|Part B||0
7721856|NCT01667900|19014181|P7|COMPLETED|Part B||0
7721857|NCT01667900|19014182|P6|COMPLETED|Part B||0
7721858|NCT01667900|19014183|P5|COMPLETED|Part B||0
7721859|NCT01667900|19014184|P4|COMPLETED|Part B||0
7721860|NCT01667900|19014185|P3|COMPLETED|Part B||0
7721861|NCT01667900|19014186|P2|COMPLETED|Part B||0
7721862|NCT01667900|19014187|P1|COMPLETED|Part B||0
7721863|NCT01667900|19014168|P20|STARTED|Part B||10
7721864|NCT01667900|19014169|P19|STARTED|Part B||10
7721865|NCT01667900|19014170|P18|STARTED|Part B||11
7721866|NCT01667900|19014171|P17|STARTED|Part B||11
7721867|NCT01667900|19014172|P16|STARTED|Part B|Part A participants did not participate in Part B.|0
7721868|NCT01667900|19014173|P15|STARTED|Part B|Part A participants did not participate in Part B.|0
7721869|NCT01667900|19014174|P14|STARTED|Part B|Part A participants did not participate in Part B.|0
7721870|NCT01667900|19014175|P13|STARTED|Part B|Part A participants did not participate in Part B.|0
7721871|NCT01667900|19014176|P12|STARTED|Part B|Part A participants did not participate in Part B.|0
7721872|NCT01667900|19014177|P11|STARTED|Part B|Part A participants did not participate in Part B.|0
7721873|NCT01667900|19014178|P10|STARTED|Part B|Part A participants did not participate in Part B.|0
7721874|NCT01667900|19014179|P9|STARTED|Part B|Part A participants did not participate in Part B.|0
7721875|NCT01667900|19014180|P8|STARTED|Part B|Part A participants did not participate in Part B.|0
7721876|NCT01667900|19014181|P7|STARTED|Part B|Part A participants did not participate in Part B.|0
7721877|NCT01667900|19014182|P6|STARTED|Part B|Part A participants did not participate in Part B.|0
7721878|NCT01667900|19014183|P5|STARTED|Part B|Part A participants did not participate in Part B.|0
7721879|NCT01667900|19014184|P4|STARTED|Part B|Part A participants did not participate in Part B.|0
7721880|NCT01667900|19014185|P3|STARTED|Part B|Part A participants did not participate in Part B.|0
7721881|NCT01667900|19014186|P2|STARTED|Part B|Part A participants did not participate in Part B.|0
7721882|NCT01667900|19014187|P1|STARTED|Part B|Part A participants did not participate in Part B.|0
7721883|NCT01667900|19014168|P20|NOT COMPLETED|Part A, Period 3||0
7721884|NCT01667900|19014169|P19|NOT COMPLETED|Part A, Period 3||0
7721885|NCT01667900|19014170|P18|NOT COMPLETED|Part A, Period 3||0
7721886|NCT01667900|19014171|P17|NOT COMPLETED|Part A, Period 3||0
7721887|NCT01667900|19014172|P16|NOT COMPLETED|Part A, Period 3||0
7721888|NCT01667900|19014173|P15|NOT COMPLETED|Part A, Period 3||0
7721889|NCT01667900|19014174|P14|NOT COMPLETED|Part A, Period 3||0
7721890|NCT01667900|19014175|P13|NOT COMPLETED|Part A, Period 3||0
7721891|NCT01667900|19014176|P12|NOT COMPLETED|Part A, Period 3||0
7721892|NCT01667900|19014177|P11|NOT COMPLETED|Part A, Period 3||0
7721893|NCT01667900|19014178|P10|NOT COMPLETED|Part A, Period 3||0
7721894|NCT01667900|19014179|P9|NOT COMPLETED|Part A, Period 3||0
7721895|NCT01667900|19014180|P8|NOT COMPLETED|Part A, Period 3||0
7721896|NCT01667900|19014181|P7|NOT COMPLETED|Part A, Period 3||0
7721897|NCT01667900|19014182|P6|NOT COMPLETED|Part A, Period 3||0
7721898|NCT01667900|19014183|P5|NOT COMPLETED|Part A, Period 3||0
7721899|NCT01667900|19014184|P4|NOT COMPLETED|Part A, Period 3||0
7721900|NCT01667900|19014185|P3|NOT COMPLETED|Part A, Period 3||0
7721901|NCT01667900|19014186|P2|NOT COMPLETED|Part A, Period 3||0
7721902|NCT01667900|19014187|P1|NOT COMPLETED|Part A, Period 3||0
7721903|NCT01667900|19014168|P20|COMPLETED|Part A, Period 3||0
7721904|NCT01667900|19014169|P19|COMPLETED|Part A, Period 3||0
7721905|NCT01667900|19014170|P18|COMPLETED|Part A, Period 3||0
7721906|NCT01667900|19014171|P17|COMPLETED|Part A, Period 3||0
7721907|NCT01667900|19014172|P16|COMPLETED|Part A, Period 3||1
7721908|NCT01667900|19014173|P15|COMPLETED|Part A, Period 3||1
7721909|NCT01667900|19014174|P14|COMPLETED|Part A, Period 3||1
7721910|NCT01667900|19014175|P13|COMPLETED|Part A, Period 3||1
7721911|NCT01667900|19014176|P12|COMPLETED|Part A, Period 3||1
7721912|NCT01667900|19014177|P11|COMPLETED|Part A, Period 3||1
7721913|NCT01667900|19014178|P10|COMPLETED|Part A, Period 3||1
7721914|NCT01667900|19014179|P9|COMPLETED|Part A, Period 3||1
7721915|NCT01667900|19014180|P8|COMPLETED|Part A, Period 3||1
7721916|NCT01667900|19014181|P7|COMPLETED|Part A, Period 3||1
7721917|NCT01667900|19014182|P6|COMPLETED|Part A, Period 3||1
7721918|NCT01667900|19014183|P5|COMPLETED|Part A, Period 3||1
7721919|NCT01667900|19014184|P4|COMPLETED|Part A, Period 3||1
7721920|NCT01667900|19014185|P3|COMPLETED|Part A, Period 3||1
7721921|NCT01667900|19014186|P2|COMPLETED|Part A, Period 3||1
7721922|NCT01667900|19014187|P1|COMPLETED|Part A, Period 3||1
7721923|NCT01667900|19014168|P20|STARTED|Part A, Period 3||0
7721924|NCT01667900|19014169|P19|STARTED|Part A, Period 3||0
7721925|NCT01667900|19014170|P18|STARTED|Part A, Period 3||0
7721926|NCT01667900|19014171|P17|STARTED|Part A, Period 3||0
7721927|NCT01667900|19014172|P16|STARTED|Part A, Period 3||1
7721928|NCT01667900|19014173|P15|STARTED|Part A, Period 3||1
7721929|NCT01667900|19014174|P14|STARTED|Part A, Period 3||1
7721930|NCT01667900|19014175|P13|STARTED|Part A, Period 3||1
7721931|NCT01667900|19014176|P12|STARTED|Part A, Period 3||1
7721932|NCT01667900|19014177|P11|STARTED|Part A, Period 3||1
7721933|NCT01667900|19014178|P10|STARTED|Part A, Period 3||1
7721934|NCT01667900|19014179|P9|STARTED|Part A, Period 3||1
7721935|NCT01667900|19014180|P8|STARTED|Part A, Period 3||1
7721936|NCT01667900|19014181|P7|STARTED|Part A, Period 3||1
7721937|NCT01667900|19014182|P6|STARTED|Part A, Period 3||1
7721938|NCT01667900|19014183|P5|STARTED|Part A, Period 3||1
7721939|NCT01667900|19014184|P4|STARTED|Part A, Period 3||1
7721940|NCT01667900|19014185|P3|STARTED|Part A, Period 3||1
7721941|NCT01667900|19014186|P2|STARTED|Part A, Period 3||1
7721942|NCT01667900|19014187|P1|STARTED|Part A, Period 3||1
7721943|NCT01667900|19014168|P20|NOT COMPLETED|Part A, Washout 2||0
7721944|NCT01667900|19014169|P19|NOT COMPLETED|Part A, Washout 2||0
7721945|NCT01667900|19014170|P18|NOT COMPLETED|Part A, Washout 2||0
7721946|NCT01667900|19014171|P17|NOT COMPLETED|Part A, Washout 2||0
7721947|NCT01667900|19014172|P16|NOT COMPLETED|Part A, Washout 2||0
7721948|NCT01667900|19014173|P15|NOT COMPLETED|Part A, Washout 2||0
7721949|NCT01667900|19014174|P14|NOT COMPLETED|Part A, Washout 2||0
7721950|NCT01667900|19014175|P13|NOT COMPLETED|Part A, Washout 2||0
7721951|NCT01667900|19014176|P12|NOT COMPLETED|Part A, Washout 2||0
7721952|NCT01667900|19014177|P11|NOT COMPLETED|Part A, Washout 2||0
7721953|NCT01667900|19014178|P10|NOT COMPLETED|Part A, Washout 2||0
7721954|NCT01667900|19014179|P9|NOT COMPLETED|Part A, Washout 2||0
7721955|NCT01667900|19014180|P8|NOT COMPLETED|Part A, Washout 2||0
7721956|NCT01667900|19014181|P7|NOT COMPLETED|Part A, Washout 2||0
7721957|NCT01667900|19014182|P6|NOT COMPLETED|Part A, Washout 2||0
7721958|NCT01667900|19014183|P5|NOT COMPLETED|Part A, Washout 2||0
7721959|NCT01667900|19014184|P4|NOT COMPLETED|Part A, Washout 2||0
7721960|NCT01667900|19014185|P3|NOT COMPLETED|Part A, Washout 2||0
7721961|NCT01667900|19014186|P2|NOT COMPLETED|Part A, Washout 2||0
7721962|NCT01667900|19014187|P1|NOT COMPLETED|Part A, Washout 2||0
7721963|NCT01667900|19014168|P20|COMPLETED|Part A, Washout 2||0
7721964|NCT01667900|19014169|P19|COMPLETED|Part A, Washout 2||0
7721965|NCT01667900|19014170|P18|COMPLETED|Part A, Washout 2||0
7721966|NCT01667900|19014171|P17|COMPLETED|Part A, Washout 2||0
7721967|NCT01667900|19014172|P16|COMPLETED|Part A, Washout 2||1
7721968|NCT01667900|19014173|P15|COMPLETED|Part A, Washout 2||1
7721969|NCT01667900|19014174|P14|COMPLETED|Part A, Washout 2||1
7721970|NCT01667900|19014175|P13|COMPLETED|Part A, Washout 2||1
7721971|NCT01667900|19014176|P12|COMPLETED|Part A, Washout 2||1
7721972|NCT01667900|19014177|P11|COMPLETED|Part A, Washout 2||1
7721973|NCT01667900|19014178|P10|COMPLETED|Part A, Washout 2||1
7721974|NCT01667900|19014179|P9|COMPLETED|Part A, Washout 2||1
7721975|NCT01667900|19014180|P8|COMPLETED|Part A, Washout 2||1
7721976|NCT01667900|19014181|P7|COMPLETED|Part A, Washout 2||1
7721977|NCT01667900|19014182|P6|COMPLETED|Part A, Washout 2||1
7721978|NCT01667900|19014183|P5|COMPLETED|Part A, Washout 2||1
7721979|NCT01667900|19014184|P4|COMPLETED|Part A, Washout 2||1
7721980|NCT01667900|19014185|P3|COMPLETED|Part A, Washout 2||1
7721981|NCT01667900|19014186|P2|COMPLETED|Part A, Washout 2||1
7721982|NCT01667900|19014187|P1|COMPLETED|Part A, Washout 2||1
7721983|NCT01667900|19014168|P20|STARTED|Part A, Washout 2||0
7721984|NCT01667900|19014169|P19|STARTED|Part A, Washout 2||0
7721985|NCT01667900|19014170|P18|STARTED|Part A, Washout 2||0
7721986|NCT01667900|19014171|P17|STARTED|Part A, Washout 2||0
7721987|NCT01667900|19014172|P16|STARTED|Part A, Washout 2||1
7721988|NCT01667900|19014173|P15|STARTED|Part A, Washout 2||1
7721989|NCT01667900|19014174|P14|STARTED|Part A, Washout 2||1
7721990|NCT01667900|19014175|P13|STARTED|Part A, Washout 2||1
7721991|NCT01667900|19014176|P12|STARTED|Part A, Washout 2||1
7721992|NCT01667900|19014177|P11|STARTED|Part A, Washout 2||1
7721993|NCT01667900|19014178|P10|STARTED|Part A, Washout 2||1
7721994|NCT01667900|19014179|P9|STARTED|Part A, Washout 2||1
7721995|NCT01667900|19014180|P8|STARTED|Part A, Washout 2||1
7721996|NCT01667900|19014181|P7|STARTED|Part A, Washout 2||1
7721997|NCT01667900|19014182|P6|STARTED|Part A, Washout 2||1
7721998|NCT01667900|19014183|P5|STARTED|Part A, Washout 2||1
7721999|NCT01667900|19014184|P4|STARTED|Part A, Washout 2||1
7722000|NCT01667900|19014185|P3|STARTED|Part A, Washout 2||1
7722001|NCT01667900|19014186|P2|STARTED|Part A, Washout 2||1
7722002|NCT01667900|19014187|P1|STARTED|Part A, Washout 2||1
7722003|NCT01667900|19014168|P20|NOT COMPLETED|Part A, Period 2||0
7722004|NCT01667900|19014169|P19|NOT COMPLETED|Part A, Period 2||0
7722005|NCT01667900|19014170|P18|NOT COMPLETED|Part A, Period 2||0
7722006|NCT01667900|19014171|P17|NOT COMPLETED|Part A, Period 2||0
7722007|NCT01667900|19014172|P16|NOT COMPLETED|Part A, Period 2||0
7722008|NCT01667900|19014173|P15|NOT COMPLETED|Part A, Period 2||0
7722009|NCT01667900|19014174|P14|NOT COMPLETED|Part A, Period 2||0
7722010|NCT01667900|19014175|P13|NOT COMPLETED|Part A, Period 2||0
7722011|NCT01667900|19014176|P12|NOT COMPLETED|Part A, Period 2||0
7722012|NCT01667900|19014177|P11|NOT COMPLETED|Part A, Period 2||0
7722013|NCT01667900|19014178|P10|NOT COMPLETED|Part A, Period 2||0
7722014|NCT01667900|19014179|P9|NOT COMPLETED|Part A, Period 2||0
7722015|NCT01667900|19014180|P8|NOT COMPLETED|Part A, Period 2||0
7722016|NCT01667900|19014181|P7|NOT COMPLETED|Part A, Period 2||0
7722017|NCT01667900|19014182|P6|NOT COMPLETED|Part A, Period 2||0
7722018|NCT01667900|19014183|P5|NOT COMPLETED|Part A, Period 2||0
7722019|NCT01667900|19014184|P4|NOT COMPLETED|Part A, Period 2||0
7722020|NCT01667900|19014185|P3|NOT COMPLETED|Part A, Period 2||0
7722021|NCT01667900|19014186|P2|NOT COMPLETED|Part A, Period 2||0
7722022|NCT01667900|19014187|P1|NOT COMPLETED|Part A, Period 2||0
7722023|NCT01667900|19014168|P20|COMPLETED|Part A, Period 2||0
7722024|NCT01667900|19014169|P19|COMPLETED|Part A, Period 2||0
7722025|NCT01667900|19014170|P18|COMPLETED|Part A, Period 2||0
7722026|NCT01667900|19014171|P17|COMPLETED|Part A, Period 2||0
7722027|NCT01667900|19014172|P16|COMPLETED|Part A, Period 2||1
7722028|NCT01667900|19014173|P15|COMPLETED|Part A, Period 2||1
7722029|NCT01667900|19014174|P14|COMPLETED|Part A, Period 2||1
7722030|NCT01667900|19014175|P13|COMPLETED|Part A, Period 2||1
7722031|NCT01667900|19014176|P12|COMPLETED|Part A, Period 2||1
7722032|NCT01667900|19014177|P11|COMPLETED|Part A, Period 2||1
7722033|NCT01667900|19014178|P10|COMPLETED|Part A, Period 2||1
7722034|NCT01667900|19014179|P9|COMPLETED|Part A, Period 2||1
7722035|NCT01667900|19014180|P8|COMPLETED|Part A, Period 2||1
7722036|NCT01667900|19014181|P7|COMPLETED|Part A, Period 2||1
7722037|NCT01667900|19014182|P6|COMPLETED|Part A, Period 2||1
7722038|NCT01667900|19014183|P5|COMPLETED|Part A, Period 2||1
7722039|NCT01667900|19014184|P4|COMPLETED|Part A, Period 2||1
7722040|NCT01667900|19014185|P3|COMPLETED|Part A, Period 2||1
7722041|NCT01667900|19014186|P2|COMPLETED|Part A, Period 2||1
7722042|NCT01667900|19014187|P1|COMPLETED|Part A, Period 2||1
7722043|NCT01667900|19014168|P20|STARTED|Part A, Period 2||0
7722044|NCT01667900|19014169|P19|STARTED|Part A, Period 2||0
7722045|NCT01667900|19014170|P18|STARTED|Part A, Period 2||0
7722046|NCT01667900|19014171|P17|STARTED|Part A, Period 2||0
7722047|NCT01667900|19014172|P16|STARTED|Part A, Period 2||1
7722048|NCT01667900|19014173|P15|STARTED|Part A, Period 2||1
7722049|NCT01667900|19014174|P14|STARTED|Part A, Period 2||1
7722050|NCT01667900|19014175|P13|STARTED|Part A, Period 2||1
7722051|NCT01667900|19014176|P12|STARTED|Part A, Period 2||1
7722052|NCT01667900|19014177|P11|STARTED|Part A, Period 2||1
7722053|NCT01667900|19014178|P10|STARTED|Part A, Period 2||1
7722054|NCT01667900|19014179|P9|STARTED|Part A, Period 2||1
7722055|NCT01667900|19014180|P8|STARTED|Part A, Period 2||1
7722056|NCT01667900|19014181|P7|STARTED|Part A, Period 2||1
7722057|NCT01667900|19014182|P6|STARTED|Part A, Period 2||1
7722058|NCT01667900|19014183|P5|STARTED|Part A, Period 2||1
7722059|NCT01667900|19014184|P4|STARTED|Part A, Period 2||1
7722060|NCT01667900|19014185|P3|STARTED|Part A, Period 2||1
7722061|NCT01667900|19014186|P2|STARTED|Part A, Period 2||1
7722062|NCT01667900|19014187|P1|STARTED|Part A, Period 2||1
7722063|NCT01667900|19014168|P20|NOT COMPLETED|Part A, Washout 1||0
7722064|NCT01667900|19014169|P19|NOT COMPLETED|Part A, Washout 1||0
7722065|NCT01667900|19014170|P18|NOT COMPLETED|Part A, Washout 1||0
7722066|NCT01667900|19014171|P17|NOT COMPLETED|Part A, Washout 1||0
7722067|NCT01667900|19014172|P16|NOT COMPLETED|Part A, Washout 1||0
7722068|NCT01667900|19014173|P15|NOT COMPLETED|Part A, Washout 1||0
7722069|NCT01667900|19014174|P14|NOT COMPLETED|Part A, Washout 1||0
7722070|NCT01667900|19014175|P13|NOT COMPLETED|Part A, Washout 1||0
7722071|NCT01667900|19014176|P12|NOT COMPLETED|Part A, Washout 1||0
7722072|NCT01667900|19014177|P11|NOT COMPLETED|Part A, Washout 1||0
7722073|NCT01667900|19014178|P10|NOT COMPLETED|Part A, Washout 1||0
7722074|NCT01667900|19014179|P9|NOT COMPLETED|Part A, Washout 1||0
7722075|NCT01667900|19014180|P8|NOT COMPLETED|Part A, Washout 1||0
7722076|NCT01667900|19014181|P7|NOT COMPLETED|Part A, Washout 1||0
7722077|NCT01667900|19014182|P6|NOT COMPLETED|Part A, Washout 1||0
7722078|NCT01667900|19014183|P5|NOT COMPLETED|Part A, Washout 1||0
7722079|NCT01667900|19014184|P4|NOT COMPLETED|Part A, Washout 1||0
7722080|NCT01667900|19014185|P3|NOT COMPLETED|Part A, Washout 1||0
7722081|NCT01667900|19014186|P2|NOT COMPLETED|Part A, Washout 1||0
7722082|NCT01667900|19014187|P1|NOT COMPLETED|Part A, Washout 1||0
7722083|NCT01667900|19014168|P20|COMPLETED|Part A, Washout 1||0
7722084|NCT01667900|19014169|P19|COMPLETED|Part A, Washout 1||0
7722085|NCT01667900|19014170|P18|COMPLETED|Part A, Washout 1||0
7722086|NCT01667900|19014171|P17|COMPLETED|Part A, Washout 1||0
7722087|NCT01667900|19014172|P16|COMPLETED|Part A, Washout 1||1
7722088|NCT01667900|19014173|P15|COMPLETED|Part A, Washout 1||1
7722089|NCT01667900|19014174|P14|COMPLETED|Part A, Washout 1||1
7722090|NCT01667900|19014175|P13|COMPLETED|Part A, Washout 1||1
7722091|NCT01667900|19014176|P12|COMPLETED|Part A, Washout 1||1
7722092|NCT01667900|19014177|P11|COMPLETED|Part A, Washout 1||1
7722093|NCT01667900|19014178|P10|COMPLETED|Part A, Washout 1||1
7722094|NCT01667900|19014179|P9|COMPLETED|Part A, Washout 1||1
7722095|NCT01667900|19014180|P8|COMPLETED|Part A, Washout 1||1
7722096|NCT01667900|19014181|P7|COMPLETED|Part A, Washout 1||1
7722097|NCT01667900|19014182|P6|COMPLETED|Part A, Washout 1||1
7722098|NCT01667900|19014183|P5|COMPLETED|Part A, Washout 1||1
7722099|NCT01667900|19014184|P4|COMPLETED|Part A, Washout 1||1
7722100|NCT01667900|19014185|P3|COMPLETED|Part A, Washout 1||1
7722101|NCT01667900|19014186|P2|COMPLETED|Part A, Washout 1||1
7722102|NCT01667900|19014187|P1|COMPLETED|Part A, Washout 1||1
7722103|NCT01667900|19014168|P20|STARTED|Part A, Washout 1||0
7722104|NCT01667900|19014169|P19|STARTED|Part A, Washout 1||0
7722105|NCT01667900|19014170|P18|STARTED|Part A, Washout 1||0
7722106|NCT01667900|19014171|P17|STARTED|Part A, Washout 1||0
7722107|NCT01667900|19014172|P16|STARTED|Part A, Washout 1||1
7722108|NCT01667900|19014173|P15|STARTED|Part A, Washout 1||1
7722109|NCT01667900|19014174|P14|STARTED|Part A, Washout 1||1
7722110|NCT01667900|19014175|P13|STARTED|Part A, Washout 1||1
7722111|NCT01667900|19014176|P12|STARTED|Part A, Washout 1||1
7722112|NCT01667900|19014177|P11|STARTED|Part A, Washout 1||1
7722113|NCT01667900|19014178|P10|STARTED|Part A, Washout 1||1
7722114|NCT01667900|19014179|P9|STARTED|Part A, Washout 1||1
7722115|NCT01667900|19014180|P8|STARTED|Part A, Washout 1||1
7722116|NCT01667900|19014181|P7|STARTED|Part A, Washout 1||1
7722117|NCT01667900|19014182|P6|STARTED|Part A, Washout 1||1
7722118|NCT01667900|19014183|P5|STARTED|Part A, Washout 1||1
7722119|NCT01667900|19014184|P4|STARTED|Part A, Washout 1||1
7722120|NCT01667900|19014185|P3|STARTED|Part A, Washout 1||1
7722121|NCT01667900|19014186|P2|STARTED|Part A, Washout 1||1
7722122|NCT01667900|19014187|P1|STARTED|Part A, Washout 1||1
7722123|NCT01667900|19014168|P20|NOT COMPLETED|Part A, Period 1||0
7722124|NCT01667900|19014169|P19|NOT COMPLETED|Part A, Period 1||0
7722125|NCT01667900|19014170|P18|NOT COMPLETED|Part A, Period 1||0
7722126|NCT01667900|19014171|P17|NOT COMPLETED|Part A, Period 1||0
7722127|NCT01667900|19014172|P16|NOT COMPLETED|Part A, Period 1||0
7722128|NCT01667900|19014173|P15|NOT COMPLETED|Part A, Period 1||0
7722129|NCT01667900|19014174|P14|NOT COMPLETED|Part A, Period 1||0
7722130|NCT01667900|19014175|P13|NOT COMPLETED|Part A, Period 1||0
7722131|NCT01667900|19014176|P12|NOT COMPLETED|Part A, Period 1||0
7722132|NCT01667900|19014177|P11|NOT COMPLETED|Part A, Period 1||0
7722133|NCT01667900|19014178|P10|NOT COMPLETED|Part A, Period 1||0
7722134|NCT01667900|19014179|P9|NOT COMPLETED|Part A, Period 1||0
7722135|NCT01667900|19014180|P8|NOT COMPLETED|Part A, Period 1||0
7722136|NCT01667900|19014181|P7|NOT COMPLETED|Part A, Period 1||0
7722137|NCT01667900|19014182|P6|NOT COMPLETED|Part A, Period 1||0
7722138|NCT01667900|19014183|P5|NOT COMPLETED|Part A, Period 1||0
7722139|NCT01667900|19014184|P4|NOT COMPLETED|Part A, Period 1||0
7722140|NCT01667900|19014185|P3|NOT COMPLETED|Part A, Period 1||0
7722141|NCT01667900|19014186|P2|NOT COMPLETED|Part A, Period 1||0
7722142|NCT01667900|19014187|P1|NOT COMPLETED|Part A, Period 1||0
7722143|NCT01667900|19014168|P20|COMPLETED|Part A, Period 1||0
7722144|NCT01667900|19014169|P19|COMPLETED|Part A, Period 1||0
7722145|NCT01667900|19014170|P18|COMPLETED|Part A, Period 1||0
7722146|NCT01667900|19014171|P17|COMPLETED|Part A, Period 1||0
7722147|NCT01667900|19014172|P16|COMPLETED|Part A, Period 1||1
7722148|NCT01667900|19014173|P15|COMPLETED|Part A, Period 1||1
7722149|NCT01667900|19014174|P14|COMPLETED|Part A, Period 1||1
7722150|NCT01667900|19014175|P13|COMPLETED|Part A, Period 1||1
7722151|NCT01667900|19014176|P12|COMPLETED|Part A, Period 1||1
7722152|NCT01667900|19014177|P11|COMPLETED|Part A, Period 1||1
7722153|NCT01667900|19014178|P10|COMPLETED|Part A, Period 1||1
7722154|NCT01667900|19014179|P9|COMPLETED|Part A, Period 1||1
7722155|NCT01667900|19014180|P8|COMPLETED|Part A, Period 1||1
7722156|NCT01667900|19014181|P7|COMPLETED|Part A, Period 1||1
7722157|NCT01667900|19014182|P6|COMPLETED|Part A, Period 1||1
7722158|NCT01667900|19014183|P5|COMPLETED|Part A, Period 1||1
7722159|NCT01667900|19014184|P4|COMPLETED|Part A, Period 1||1
7722160|NCT01667900|19014185|P3|COMPLETED|Part A, Period 1||1
7722161|NCT01667900|19014186|P2|COMPLETED|Part A, Period 1||1
7722162|NCT01667900|19014187|P1|COMPLETED|Part A, Period 1||1
7722163|NCT01667900|19014168|P20|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
7722164|NCT01667900|19014169|P19|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
7722165|NCT01667900|19014170|P18|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
7722166|NCT01667900|19014171|P17|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
7722167|NCT01667900|19014172|P16|STARTED|Part A, Period 1||1
7722168|NCT01667900|19014173|P15|STARTED|Part A, Period 1||1
7722169|NCT01667900|19014174|P14|STARTED|Part A, Period 1||1
7722170|NCT01667900|19014175|P13|STARTED|Part A, Period 1||1
7722171|NCT01667900|19014176|P12|STARTED|Part A, Period 1||1
7722172|NCT01667900|19014177|P11|STARTED|Part A, Period 1||1
7722173|NCT01667900|19014178|P10|STARTED|Part A, Period 1||1
7722174|NCT01667900|19014179|P9|STARTED|Part A, Period 1||1
7722175|NCT01667900|19014180|P8|STARTED|Part A, Period 1||1
7722176|NCT01667900|19014181|P7|STARTED|Part A, Period 1||1
7722177|NCT01667900|19014182|P6|STARTED|Part A, Period 1||1
7722178|NCT01667900|19014183|P5|STARTED|Part A, Period 1||1
7722179|NCT01667900|19014184|P4|STARTED|Part A, Period 1||1
7722180|NCT01667900|19014185|P3|STARTED|Part A, Period 1||1
7722181|NCT01667900|19014186|P2|STARTED|Part A, Period 1||1
7722182|NCT01667900|19014187|P1|STARTED|Part A, Period 1||1
7722183|NCT01667848|19014227|P2|NOT COMPLETED|Overall Study||0
7722184|NCT01667848|19014228|P1|NOT COMPLETED|Overall Study||0
7722185|NCT01667848|19014227|P2|COMPLETED|Overall Study||81
7722186|NCT01667848|19014228|P1|COMPLETED|Overall Study||67
7722187|NCT01667848|19014227|P2|STARTED|Overall Study||81
7722188|NCT01667848|19014228|P1|STARTED|Overall Study||67
7722189|NCT01667796|19014238|P2|NOT COMPLETED|Overall Study||1
7722190|NCT01667796|19014239|P1|NOT COMPLETED|Overall Study||3
7722191|NCT01667796|19014238|P2|COMPLETED|Overall Study||29
7722192|NCT01667796|19014239|P1|COMPLETED|Overall Study||24
7722193|NCT01667796|19014238|P2|STARTED|Overall Study||30
7722194|NCT01667796|19014239|P1|STARTED|Overall Study||27
7722195|NCT01667731|19014257|P5|NOT COMPLETED|Overall Study||28
7722196|NCT01667731|19014258|P4|NOT COMPLETED|Overall Study||2
7722197|NCT01667731|19014259|P3|NOT COMPLETED|Overall Study||2
7722198|NCT01667731|19014260|P2|NOT COMPLETED|Overall Study||16
7722199|NCT01667731|19014261|P1|NOT COMPLETED|Overall Study||5
7722200|NCT01667731|19014257|P5|COMPLETED|Overall Study||87
7722201|NCT01667731|19014258|P4|COMPLETED|Overall Study||15
7722202|NCT01667731|19014259|P3|COMPLETED|Overall Study||22
7722203|NCT01667731|19014260|P2|COMPLETED|Overall Study||26
7722204|NCT01667731|19014261|P1|COMPLETED|Overall Study||21
7722205|NCT01667731|19014257|P5|STARTED|Overall Study||115
7722206|NCT01667731|19014258|P4|STARTED|Overall Study||17
7722207|NCT01667731|19014259|P3|STARTED|Overall Study||24
7722208|NCT01667731|19014260|P2|STARTED|Overall Study||42
7722209|NCT01667731|19014261|P1|STARTED|Overall Study||26
7722210|NCT01667679|19014316|P2|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
7722211|NCT01667679|19014317|P1|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
7722212|NCT01667679|19014316|P2|COMPLETED|Treatment Period 2 (<=12 Weeks)||85
7722213|NCT01667679|19014317|P1|COMPLETED|Treatment Period 2 (<=12 Weeks)||100
7722214|NCT01667679|19014316|P2|STARTED|Treatment Period 2 (<=12 Weeks)||107
7722215|NCT01667679|19014317|P1|STARTED|Treatment Period 2 (<=12 Weeks)||122
7722216|NCT01667679|19014316|P2|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30
7722217|NCT01667679|19014317|P1|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16
7722218|NCT01667679|19014316|P2|COMPLETED|Treatment Period 1 (<=12 Weeks)||107
7722219|NCT01667679|19014317|P1|COMPLETED|Treatment Period 1 (<=12 Weeks)||122
7722220|NCT01667679|19014316|P2|STARTED|Treatment Period 1 (<=12 Weeks)||137
7722221|NCT01667679|19014317|P1|STARTED|Treatment Period 1 (<=12 Weeks)||138
7722222|NCT01667562|19014375|P2|NOT COMPLETED|Erlotinib Phase||3
7722223|NCT01667562|19014376|P1|NOT COMPLETED|Erlotinib Phase||0
7722224|NCT01667562|19014375|P2|COMPLETED|Erlotinib Phase||27
7722225|NCT01667562|19014376|P1|COMPLETED|Erlotinib Phase||0
7722226|NCT01667562|19014375|P2|STARTED|Erlotinib Phase||30
7722227|NCT01667562|19014376|P1|STARTED|Erlotinib Phase||0
7722228|NCT01667562|19014375|P2|NOT COMPLETED|Diagnostic Phase||0
7722229|NCT01667562|19014376|P1|NOT COMPLETED|Diagnostic Phase||30
7722230|NCT01667562|19014375|P2|COMPLETED|Diagnostic Phase||0
7722231|NCT01667562|19014376|P1|COMPLETED|Diagnostic Phase||345
7722232|NCT01667562|19014375|P2|STARTED|Diagnostic Phase||0
7722233|NCT01667562|19014376|P1|STARTED|Diagnostic Phase||375
7722234|NCT01667549|19014390|P5|NOT COMPLETED|Overall Study||1
7722235|NCT01667549|19014391|P4|NOT COMPLETED|Overall Study||6
7722236|NCT01667549|19014392|P3|NOT COMPLETED|Overall Study||7
7722237|NCT01667549|19014393|P2|NOT COMPLETED|Overall Study||5
7722238|NCT01667549|19014394|P1|NOT COMPLETED|Overall Study||3
7722239|NCT01667549|19014390|P5|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
7722240|NCT01667549|19014391|P4|COMPLETED|Overall Study|14 dyads= 14 infants, 14 mothers|14
7722241|NCT01667549|19014392|P3|COMPLETED|Overall Study|14 dyads=14 infants, 14 mothers|14
7722242|NCT01667549|19014393|P2|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
7722243|NCT01667549|19014394|P1|COMPLETED|Overall Study|17 dyads=17 infants, 17 mothers|17
7722244|NCT01667549|19014390|P5|STARTED|Overall Study|16 dyads=16 infants, 16 mothers|16
7722245|NCT01667549|19014391|P4|STARTED|Overall Study|20 dyads= 20 infants, 20 mothers|20
7722246|NCT01667549|19014392|P3|STARTED|Overall Study|21 dyads=21 infants, 21 mothers|21
7722247|NCT01667549|19014393|P2|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
7722248|NCT01667549|19014394|P1|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
7722249|NCT01667536|19014426|P1|NOT COMPLETED|Overall Study||0
7722250|NCT01667536|19014426|P1|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105
7722251|NCT01667536|19014426|P1|STARTED|Overall Study||105
7722252|NCT01667471|19014437|P1|NOT COMPLETED|Overall Study||0
7722253|NCT01667471|19014437|P1|COMPLETED|Overall Study||7
7722254|NCT01667471|19014437|P1|STARTED|Overall Study||7
7722255|NCT01667432|19014453|P1|NOT COMPLETED|Overall Study||57
7722256|NCT01667432|19014453|P1|COMPLETED|Overall Study||84
7722257|NCT01667432|19014453|P1|STARTED|Overall Study||141
7722258|NCT01667419|19014462|P4|NOT COMPLETED|Overall Study||39
7722259|NCT01667419|19014463|P3|NOT COMPLETED|Overall Study||36
7722260|NCT01667419|19014464|P2|NOT COMPLETED|Overall Study||47
7722261|NCT01667419|19014465|P1|NOT COMPLETED|Overall Study||43
7722262|NCT01667419|19014462|P4|COMPLETED|Overall Study||52
7722263|NCT01667419|19014463|P3|COMPLETED|Overall Study||57
7722264|NCT01667419|19014464|P2|COMPLETED|Overall Study||110
7722265|NCT01667419|19014465|P1|COMPLETED|Overall Study||114
7722266|NCT01667419|19014462|P4|STARTED|Overall Study||91
7722267|NCT01667419|19014463|P3|STARTED|Overall Study||93
7722268|NCT01667419|19014464|P2|STARTED|Overall Study||157
7722269|NCT01667419|19014465|P1|STARTED|Overall Study||157
7722270|NCT01667250|19014495|P3|NOT COMPLETED|Randomised Period||0
7722271|NCT01667250|19014496|P2|NOT COMPLETED|Randomised Period||1
7722272|NCT01667250|19014497|P1|NOT COMPLETED|Randomised Period||1
7722273|NCT01667250|19014495|P3|COMPLETED|Randomised Period||0
7722274|NCT01667250|19014496|P2|COMPLETED|Randomised Period||28
7722275|NCT01667250|19014497|P1|COMPLETED|Randomised Period||29
7722276|NCT01667250|19014495|P3|STARTED|Randomised Period||0
7722277|NCT01667250|19014496|P2|STARTED|Randomised Period||29
7722278|NCT01667250|19014497|P1|STARTED|Randomised Period||30
7722279|NCT01667250|19014495|P3|NOT COMPLETED|Run-in (no Treatment)||14
7722280|NCT01667250|19014496|P2|NOT COMPLETED|Run-in (no Treatment)||0
7722281|NCT01667250|19014497|P1|NOT COMPLETED|Run-in (no Treatment)||0
7722282|NCT01667250|19014495|P3|COMPLETED|Run-in (no Treatment)||59
7722283|NCT01667250|19014496|P2|COMPLETED|Run-in (no Treatment)||0
7722284|NCT01667250|19014497|P1|COMPLETED|Run-in (no Treatment)||0
7722285|NCT01667250|19014495|P3|STARTED|Run-in (no Treatment)||73
7722286|NCT01667250|19014496|P2|STARTED|Run-in (no Treatment)||0
7722287|NCT01667250|19014497|P1|STARTED|Run-in (no Treatment)||0
7722288|NCT01667224|19014513|P2|NOT COMPLETED|Overall Study||2
7722289|NCT01667224|19014514|P1|NOT COMPLETED|Overall Study||4
7722290|NCT01667224|19014513|P2|COMPLETED|Overall Study||38
7722291|NCT01667224|19014514|P1|COMPLETED|Overall Study||36
7722292|NCT01667224|19014513|P2|STARTED|Overall Study||40
7722293|NCT01667224|19014514|P1|STARTED|Overall Study||40
7722294|NCT01667107|19014528|P2|NOT COMPLETED|Overall Study||7
7722295|NCT01667107|19014529|P1|NOT COMPLETED|Overall Study||4
7722296|NCT01667107|19014528|P2|COMPLETED|Overall Study||11
7722297|NCT01667107|19014529|P1|COMPLETED|Overall Study||4
7722298|NCT01667107|19014528|P2|STARTED|Overall Study||18
7722299|NCT01667107|19014529|P1|STARTED|Overall Study||8
7722300|NCT01667029|19014545|P2|NOT COMPLETED|Overall Study||1
7722301|NCT01667029|19014546|P1|NOT COMPLETED|Overall Study||1
7722302|NCT01667029|19014545|P2|COMPLETED|Overall Study||3
7722303|NCT01667029|19014546|P1|COMPLETED|Overall Study||3
7722304|NCT01667029|19014545|P2|STARTED|Overall Study||4
7722305|NCT01667029|19014546|P1|STARTED|Overall Study||4
7722306|NCT01666951|19014588|P2|NOT COMPLETED|Overall Study||1
7722307|NCT01666951|19014589|P1|NOT COMPLETED|Overall Study||1
7722308|NCT01666951|19014588|P2|COMPLETED|Overall Study||17
7722309|NCT01666951|19014589|P1|COMPLETED|Overall Study||17
7722310|NCT01666951|19014588|P2|STARTED|Overall Study||18
7722311|NCT01666951|19014589|P1|STARTED|Overall Study||18
7722312|NCT01666912|19014627|P2|NOT COMPLETED|Overall Study||11
7722313|NCT01666912|19014628|P1|NOT COMPLETED|Overall Study||21
7722314|NCT01666912|19014627|P2|COMPLETED|Overall Study||37
7722315|NCT01666912|19014628|P1|COMPLETED|Overall Study||27
7722316|NCT01666912|19014627|P2|STARTED|Overall Study||48
7722317|NCT01666912|19014628|P1|STARTED|Overall Study||48
7722318|NCT01666782|19014640|P2|NOT COMPLETED|Overall Study||1
7722319|NCT01666782|19014641|P1|NOT COMPLETED|Overall Study||4
7722320|NCT01666782|19014640|P2|COMPLETED|Overall Study||50
7722321|NCT01666782|19014641|P1|COMPLETED|Overall Study||50
7722322|NCT01666782|19014640|P2|STARTED|Overall Study||51
7722323|NCT01666782|19014641|P1|STARTED|Overall Study||54
7722324|NCT01666652|19014662|P5|NOT COMPLETED|Overall Study||1
7722325|NCT01666652|19014663|P4|NOT COMPLETED|Overall Study||4
7722326|NCT01666652|19014664|P3|NOT COMPLETED|Overall Study||1
7722327|NCT01666652|19014665|P2|NOT COMPLETED|Overall Study||1
7722328|NCT01666652|19014666|P1|NOT COMPLETED|Overall Study||2
7722329|NCT01666652|19014662|P5|COMPLETED|Overall Study||19
7722330|NCT01666652|19014663|P4|COMPLETED|Overall Study||16
7722331|NCT01666652|19014664|P3|COMPLETED|Overall Study||19
7722332|NCT01666652|19014665|P2|COMPLETED|Overall Study||19
7722333|NCT01666652|19014666|P1|COMPLETED|Overall Study||18
7722334|NCT01666652|19014662|P5|STARTED|Overall Study||20
7722335|NCT01666652|19014663|P4|STARTED|Overall Study||20
7722336|NCT01666652|19014664|P3|STARTED|Overall Study||20
7722337|NCT01666652|19014665|P2|STARTED|Overall Study||20
7722338|NCT01666652|19014666|P1|STARTED|Overall Study||20
7722339|NCT01666444|19014715|P2|NOT COMPLETED|Overall Study||1
7722340|NCT01666444|19014716|P1|NOT COMPLETED|Overall Study||2
7722341|NCT01666444|19014715|P2|COMPLETED|Overall Study||147
7722342|NCT01666444|19014716|P1|COMPLETED|Overall Study||147
7722343|NCT01666444|19014715|P2|STARTED|Overall Study||148
7722344|NCT01666444|19014716|P1|STARTED|Overall Study||149
7722345|NCT01666314|19014734|P4|NOT COMPLETED|Overall Study||36
7722346|NCT01666314|19014735|P3|NOT COMPLETED|Overall Study||36
7722347|NCT01666314|19014736|P2|NOT COMPLETED|Overall Study||32
7722348|NCT01666314|19014737|P1|NOT COMPLETED|Overall Study||33
7722349|NCT01666314|19014734|P4|COMPLETED|Overall Study||0
7722350|NCT01666314|19014735|P3|COMPLETED|Overall Study||0
7722351|NCT01666314|19014736|P2|COMPLETED|Overall Study||0
7722352|NCT01666314|19014737|P1|COMPLETED|Overall Study||0
7722353|NCT01666314|19014734|P4|STARTED|Overall Study||36
7722354|NCT01666314|19014735|P3|STARTED|Overall Study||36
7722355|NCT01666314|19014736|P2|STARTED|Overall Study||32
7722356|NCT01666314|19014737|P1|STARTED|Overall Study||33
7722357|NCT01666210|19014848|P2|NOT COMPLETED|Overall Study||1
7722358|NCT01666210|19014849|P1|NOT COMPLETED|Overall Study||2
7722359|NCT01666210|19014848|P2|COMPLETED|Overall Study||29
7722360|NCT01666210|19014849|P1|COMPLETED|Overall Study||28
7722361|NCT01666210|19014848|P2|STARTED|Overall Study||30
7722362|NCT01666210|19014849|P1|STARTED|Overall Study||30
7722363|NCT01666197|19014861|P2|NOT COMPLETED|Overall Study||0
7722364|NCT01666197|19014862|P1|NOT COMPLETED|Overall Study||0
7722365|NCT01666197|19014861|P2|COMPLETED|Overall Study||50
7722366|NCT01666197|19014862|P1|COMPLETED|Overall Study||50
7722367|NCT01666197|19014861|P2|STARTED|Overall Study||50
7722368|NCT01666197|19014862|P1|STARTED|Overall Study||50
7722369|NCT01666145|19014868|P1|NOT COMPLETED|Overall Study||0
7722370|NCT01666145|19014868|P1|COMPLETED|Overall Study||14
7722371|NCT01666145|19014868|P1|STARTED|Overall Study||14
7722372|NCT01666119|19014873|P1|NOT COMPLETED|Overall Study||52
7722373|NCT01666119|19014873|P1|COMPLETED|Overall Study||197
7722374|NCT01666119|19014873|P1|STARTED|Overall Study||249
7722375|NCT01666002|19014880|P2|NOT COMPLETED|Overall Study||0
7722376|NCT01666002|19014881|P1|NOT COMPLETED|Overall Study||5
7722377|NCT01666002|19014880|P2|COMPLETED|Overall Study||10
7722378|NCT01666002|19014881|P1|COMPLETED|Overall Study||12
7722379|NCT01666002|19014880|P2|STARTED|Overall Study||10
7722380|NCT01666002|19014881|P1|STARTED|Overall Study||17
7722381|NCT01665950|19014892|P3|NOT COMPLETED|Overall Study||1
7722382|NCT01665950|19014893|P2|NOT COMPLETED|Overall Study||0
7722383|NCT01665950|19014894|P1|NOT COMPLETED|Overall Study||1
7722384|NCT01665950|19014892|P3|COMPLETED|Overall Study||1
7722385|NCT01665950|19014893|P2|COMPLETED|Overall Study||0
7722386|NCT01665950|19014894|P1|COMPLETED|Overall Study||1
7722387|NCT01665950|19014892|P3|STARTED|Overall Study||2
7722388|NCT01665950|19014893|P2|STARTED|Overall Study||0
7722389|NCT01665950|19014894|P1|STARTED|Overall Study||2
7722390|NCT01665911|19014902|P1|NOT COMPLETED|Overall Study||6
7722391|NCT01665911|19014902|P1|COMPLETED|Overall Study||22
7722392|NCT01665911|19014902|P1|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22
7722393|NCT01665911|19014902|P1|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22
7722394|NCT01665911|19014902|P1|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25
7722395|NCT01665911|19014902|P1|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23
7722396|NCT01665911|19014902|P1|0 mg Fluoride in 200 ml Milk|Overall Study||22
7722397|NCT01665911|19014902|P1|STARTED|Overall Study||28
7722398|NCT01665872|19014910|P2|NOT COMPLETED|12 Month Follow-up||3
7722399|NCT01665872|19014911|P1|NOT COMPLETED|12 Month Follow-up||14
7722400|NCT01665872|19014910|P2|COMPLETED|12 Month Follow-up||47
7722401|NCT01665872|19014911|P1|COMPLETED|12 Month Follow-up||58
7722402|NCT01665872|19014910|P2|STARTED|12 Month Follow-up||50
7722403|NCT01665872|19014911|P1|STARTED|12 Month Follow-up||72
7722404|NCT01665872|19014910|P2|NOT COMPLETED|6 Month Follow-up||1
7722405|NCT01665872|19014911|P1|NOT COMPLETED|6 Month Follow-up||6
7722406|NCT01665872|19014910|P2|COMPLETED|6 Month Follow-up||49
7722407|NCT01665872|19014911|P1|COMPLETED|6 Month Follow-up||66
7722408|NCT01665872|19014910|P2|STARTED|6 Month Follow-up||50
7722409|NCT01665872|19014911|P1|STARTED|6 Month Follow-up||72
7722410|NCT01665872|19014910|P2|NOT COMPLETED|Treatment||17
7722411|NCT01665872|19014911|P1|NOT COMPLETED|Treatment||15
7722412|NCT01665872|19014910|P2|COMPLETED|Treatment||50
7722413|NCT01665872|19014911|P1|COMPLETED|Treatment||72
7722414|NCT01665872|19014910|P2|STARTED|Treatment||67
7722415|NCT01665872|19014911|P1|STARTED|Treatment||87
7722416|NCT01665872|19014910|P2|NOT COMPLETED|Screening||0
7722417|NCT01665872|19014911|P1|NOT COMPLETED|Screening||0
7722418|NCT01665872|19014910|P2|COMPLETED|Screening||172
7722419|NCT01665872|19014911|P1|COMPLETED|Screening||172
7722420|NCT01665872|19014910|P2|STARTED|Screening||172
7722421|NCT01665872|19014911|P1|STARTED|Screening||172
7722422|NCT01665807|19014928|P3|NOT COMPLETED|Overall Study||1
7722423|NCT01665807|19014929|P2|NOT COMPLETED|Overall Study||0
7722424|NCT01665807|19014930|P1|NOT COMPLETED|Overall Study||2
7722425|NCT01665807|19014928|P3|COMPLETED|Overall Study||401
7722426|NCT01665807|19014929|P2|COMPLETED|Overall Study||58
7722427|NCT01665807|19014930|P1|COMPLETED|Overall Study||409
7722428|NCT01665807|19014928|P3|STARTED|Overall Study||402
7722429|NCT01665807|19014929|P2|STARTED|Overall Study||58
7722430|NCT01665807|19014930|P1|STARTED|Overall Study||411
7722431|NCT01665768|19014941|P1|NOT COMPLETED|Overall Study||23
7722432|NCT01665768|19014941|P1|COMPLETED|Overall Study||26
7722433|NCT01665768|19014941|P1|STARTED|Overall Study||49
7722434|NCT01665599|19014946|P1|NOT COMPLETED|Overall Study||8
7722435|NCT01665599|19014946|P1|COMPLETED|Overall Study||172
7722436|NCT01665599|19014946|P1|STARTED|Overall Study||180
7722437|NCT01665508|19014966|P1|NOT COMPLETED|Overall Study||5
7722438|NCT01665508|19014966|P1|COMPLETED|Overall Study||7
7722439|NCT01665508|19014966|P1|STARTED|Overall Study||12
7722440|NCT01665430|19014982|P1|NOT COMPLETED|Overall Study||9
7722441|NCT01665430|19014982|P1|COMPLETED|Overall Study||29
7722442|NCT01665430|19014982|P1|STARTED|Overall Study||38
7722443|NCT01665170|19014998|P2|NOT COMPLETED|Overall Study||0
7722444|NCT01665170|19014999|P1|NOT COMPLETED|Overall Study||0
7722445|NCT01665170|19014998|P2|COMPLETED|Overall Study||30
7722446|NCT01665170|19014999|P1|COMPLETED|Overall Study|Last TSST/ last patient out|30
7722447|NCT01665170|19014998|P2|After TSST|Overall Study||30
7722448|NCT01665170|19014999|P1|After TSST|Overall Study||30
7722449|NCT01665170|19014998|P2|During TSST|Overall Study||30
7722450|NCT01665170|19014999|P1|During TSST|Overall Study||30
7722451|NCT01665170|19014998|P2|Bevore TSST|Overall Study||30
7722452|NCT01665170|19014999|P1|Bevore TSST|Overall Study||30
7722453|NCT01665170|19014998|P2|STARTED|Overall Study||30
7722454|NCT01665170|19014999|P1|STARTED|Overall Study|First patient in|30
7722455|NCT01665157|19015050|P3|NOT COMPLETED|Overall Study||0
7722456|NCT01665157|19015051|P2|NOT COMPLETED|Overall Study||0
7722457|NCT01665157|19015052|P1|NOT COMPLETED|Overall Study||0
7722458|NCT01665157|19015050|P3|COMPLETED|Overall Study||60
7722459|NCT01665157|19015051|P2|COMPLETED|Overall Study||60
7722460|NCT01665157|19015052|P1|COMPLETED|Overall Study||60
7722461|NCT01665157|19015050|P3|STARTED|Overall Study||60
7722462|NCT01665157|19015051|P2|STARTED|Overall Study||60
7722463|NCT01665157|19015052|P1|STARTED|Overall Study||60
7722464|NCT01665144|19015080|P2|NOT COMPLETED|Overall Study||122
7722465|NCT01665144|19015081|P1|NOT COMPLETED|Overall Study||202
7722466|NCT01665144|19015080|P2|COMPLETED|Overall Study||424
7722467|NCT01665144|19015081|P1|COMPLETED|Overall Study||903
7722468|NCT01665144|19015080|P2|Full Analysis Set|Overall Study||546
7722469|NCT01665144|19015081|P1|Full Analysis Set|Overall Study||1099
7722470|NCT01665144|19015080|P2|Safety Set|Overall Study||546
7722471|NCT01665144|19015081|P1|Safety Set|Overall Study||1099
7722472|NCT01665144|19015080|P2|STARTED|Overall Study||546
7722473|NCT01665144|19015081|P1|STARTED|Overall Study||1105
7722474|NCT01665092|19015091|P4|NOT COMPLETED|Overall Study||1
7722475|NCT01665092|19015092|P3|NOT COMPLETED|Overall Study||2
7722476|NCT01665092|19015093|P2|NOT COMPLETED|Overall Study||0
7722477|NCT01665092|19015094|P1|NOT COMPLETED|Overall Study||0
7722478|NCT01665092|19015091|P4|COMPLETED|Overall Study||105
7722479|NCT01665092|19015092|P3|COMPLETED|Overall Study||32
7722480|NCT01665092|19015093|P2|COMPLETED|Overall Study||35
7722481|NCT01665092|19015094|P1|COMPLETED|Overall Study||75
7722482|NCT01665092|19015091|P4|STARTED|Overall Study||106
7722483|NCT01665092|19015092|P3|STARTED|Overall Study||34
7722484|NCT01665092|19015093|P2|STARTED|Overall Study||35
7722485|NCT01665092|19015094|P1|STARTED|Overall Study||75
7722486|NCT01665053|19015106|P2|NOT COMPLETED|Overall Study||15
7722487|NCT01665053|19015107|P1|NOT COMPLETED|Overall Study||32
7722488|NCT01665053|19015106|P2|COMPLETED|Overall Study||831
7722489|NCT01665053|19015107|P1|COMPLETED|Overall Study||806
7722490|NCT01665053|19015106|P2|Death With No 12-month Clinical FU|Overall Study||9
7722491|NCT01665053|19015107|P1|Death With No 12-month Clinical FU|Overall Study||9
7722492|NCT01665053|19015106|P2|No 12-Month F/U|Overall Study||15
7722493|NCT01665053|19015107|P1|No 12-Month F/U|Overall Study||32
7722494|NCT01665053|19015106|P2|Completed 12-Month Clinical F/U|Overall Study||822
7722495|NCT01665053|19015107|P1|Completed 12-Month Clinical F/U|Overall Study||797
7722496|NCT01665053|19015106|P2|STARTED|Overall Study||846
7722497|NCT01665053|19015107|P1|STARTED|Overall Study||838
7722498|NCT01665040|19015145|P1|NOT COMPLETED|Overall Study||4
7722499|NCT01665040|19015145|P1|COMPLETED|Overall Study||36
7722500|NCT01665040|19015145|P1|STARTED|Overall Study||40
7722501|NCT01664975|19015152|P2|NOT COMPLETED|Overall Study||3
7722502|NCT01664975|19015153|P1|NOT COMPLETED|Overall Study||5
7722503|NCT01664975|19015152|P2|COMPLETED|Overall Study||51
7722504|NCT01664975|19015153|P1|COMPLETED|Overall Study||52
7722505|NCT01664975|19015152|P2|STARTED|Overall Study||54
7722506|NCT01664975|19015153|P1|STARTED|Overall Study||57
7722507|NCT01664949|19015161|P2|NOT COMPLETED|Overall Study||25
7722508|NCT01664949|19015162|P1|NOT COMPLETED|Overall Study||24
7722509|NCT01664949|19015161|P2|COMPLETED|Overall Study||211
7722510|NCT01664949|19015162|P1|COMPLETED|Overall Study||200
7722511|NCT01664949|19015161|P2|STARTED|Overall Study||236
7722512|NCT01664949|19015162|P1|STARTED|Overall Study||224
7722513|NCT01664923|19015178|P2|NOT COMPLETED|Period 2: Open-label Phase-36 Months||23
7722514|NCT01664923|19015179|P1|NOT COMPLETED|Period 2: Open-label Phase-36 Months||41
7722515|NCT01664923|19015178|P2|COMPLETED|Period 2: Open-label Phase-36 Months||15
7722516|NCT01664923|19015179|P1|COMPLETED|Period 2: Open-label Phase-36 Months||52
7722517|NCT01664923|19015178|P2|Treated|Period 2: Open-label Phase-36 Months||37
7722518|NCT01664923|19015179|P1|Treated|Period 2: Open-label Phase-36 Months||93
7722519|NCT01664923|19015178|P2|STARTED|Period 2: Open-label Phase-36 Months||38
7722520|NCT01664923|19015179|P1|STARTED|Period 2: Open-label Phase-36 Months||93
7722521|NCT01664923|19015178|P2|NOT COMPLETED|Period1:Double Blind Phase-29 Months||160
7722522|NCT01664923|19015179|P1|NOT COMPLETED|Period1:Double Blind Phase-29 Months||105
7722523|NCT01664923|19015178|P2|COMPLETED|Period1:Double Blind Phase-29 Months||38
7722524|NCT01664923|19015179|P1|COMPLETED|Period1:Double Blind Phase-29 Months||93
7722525|NCT01664923|19015178|P2|Received Study Treatment|Period1:Double Blind Phase-29 Months||198
7722526|NCT01664923|19015179|P1|Received Study Treatment|Period1:Double Blind Phase-29 Months||197
7722527|NCT01664923|19015178|P2|STARTED|Period1:Double Blind Phase-29 Months||198
7722528|NCT01664923|19015179|P1|STARTED|Period1:Double Blind Phase-29 Months||198
7722529|NCT01664897|19015199|P1|NOT COMPLETED|Overall Study||0
7722530|NCT01664897|19015199|P1|COMPLETED|Overall Study||29
7722531|NCT01664897|19015199|P1|STARTED|Overall Study||29
7722532|NCT01664858|19015210|P3|NOT COMPLETED|Overall Study||6
7722533|NCT01664858|19015211|P2|NOT COMPLETED|Overall Study||13
7722534|NCT01664858|19015212|P1|NOT COMPLETED|Overall Study||14
7722535|NCT01664858|19015210|P3|COMPLETED|Overall Study||234
7722536|NCT01664858|19015211|P2|COMPLETED|Overall Study||468
7722537|NCT01664858|19015212|P1|COMPLETED|Overall Study||467
7722538|NCT01664858|19015210|P3|STARTED|Overall Study||240
7722539|NCT01664858|19015211|P2|STARTED|Overall Study||481
7722540|NCT01664858|19015212|P1|STARTED|Overall Study||481
7722541|NCT01664806|19015228|P2|NOT COMPLETED|Overall Study||0
7722542|NCT01664806|19015229|P1|NOT COMPLETED|Overall Study||0
7722543|NCT01664806|19015228|P2|COMPLETED|Overall Study||20
7722544|NCT01664806|19015229|P1|COMPLETED|Overall Study||20
7722545|NCT01664806|19015228|P2|STARTED|Overall Study||20
7722546|NCT01664806|19015229|P1|STARTED|Overall Study||20
7722547|NCT01664793|19015239|P2|NOT COMPLETED|Overall Study||0
7722548|NCT01664793|19015240|P1|NOT COMPLETED|Overall Study||0
7722549|NCT01664793|19015239|P2|COMPLETED|Overall Study||38626
7722550|NCT01664793|19015240|P1|COMPLETED|Overall Study||49039
7722551|NCT01664793|19015239|P2|STARTED|Overall Study||38626
7722552|NCT01664793|19015240|P1|STARTED|Overall Study||49039
7722553|NCT01664741|19015251|P3|NOT COMPLETED|Overall Study||0
7722554|NCT01664741|19015252|P2|NOT COMPLETED|Overall Study||0
7722555|NCT01664741|19015253|P1|NOT COMPLETED|Overall Study||0
7722556|NCT01664741|19015251|P3|COMPLETED|Overall Study||13
7722557|NCT01664741|19015252|P2|COMPLETED|Overall Study||6
7722558|NCT01664741|19015253|P1|COMPLETED|Overall Study||6
7722559|NCT01664741|19015251|P3|STARTED|Overall Study||13
7722560|NCT01664741|19015252|P2|STARTED|Overall Study||6
7722561|NCT01664741|19015253|P1|STARTED|Overall Study||6
7722562|NCT01664624|19015270|P4|NOT COMPLETED|Overall Study||0
7722563|NCT01664624|19015271|P3|NOT COMPLETED|Overall Study||0
7722564|NCT01664624|19015272|P2|NOT COMPLETED|Overall Study||1
7722565|NCT01664624|19015273|P1|NOT COMPLETED|Overall Study||0
7722566|NCT01664624|19015270|P4|COMPLETED|Overall Study||9
7722567|NCT01664624|19015271|P3|COMPLETED|Overall Study||10
7722568|NCT01664624|19015272|P2|COMPLETED|Overall Study||10
7722569|NCT01664624|19015273|P1|COMPLETED|Overall Study||10
7722570|NCT01664624|19015270|P4|STARTED|Overall Study||9
7722571|NCT01664624|19015271|P3|STARTED|Overall Study||10
7722572|NCT01664624|19015272|P2|STARTED|Overall Study||11
7722573|NCT01664624|19015273|P1|STARTED|Overall Study||10
7722574|NCT01664559|19015305|P2|NOT COMPLETED|Overall Study||0
7722575|NCT01664559|19015306|P1|NOT COMPLETED|Overall Study||0
7722576|NCT01664559|19015305|P2|COMPLETED|Overall Study||33
7722577|NCT01664559|19015306|P1|COMPLETED|Overall Study||34
7722578|NCT01664559|19015305|P2|STARTED|Overall Study||33
7722579|NCT01664559|19015306|P1|STARTED|Overall Study||34
7722580|NCT01664533|19015320|P1|NOT COMPLETED|Overall Study||57
7722581|NCT01664533|19015320|P1|COMPLETED|Overall Study||0
7722582|NCT01664533|19015320|P1|STARTED|Overall Study||57
7722583|NCT01664494|19015328|P1|NOT COMPLETED|Overall Study||193
7722584|NCT01664494|19015328|P1|COMPLETED|Overall Study||370
7722585|NCT01664494|19015328|P1|STARTED|Overall Study||563
7722586|NCT01664247|19015335|P2|NOT COMPLETED|Overall Study||41
7722587|NCT01664247|19015336|P1|NOT COMPLETED|Overall Study||14
7722588|NCT01664247|19015335|P2|COMPLETED|Overall Study||131
7722589|NCT01664247|19015336|P1|COMPLETED|Overall Study||160
7722590|NCT01664247|19015335|P2|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170
7722591|NCT01664247|19015336|P1|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173
7722592|NCT01664247|19015335|P2|STARTED|Overall Study||172
7722593|NCT01664247|19015336|P1|STARTED|Overall Study||174
7722594|NCT01664130|19015358|P1|NOT COMPLETED|Overall Study||2
7722595|NCT01664130|19015358|P1|COMPLETED|Overall Study||33
7722596|NCT01664130|19015358|P1|STARTED|Overall Study||35
7722597|NCT01664117|19015381|P1|NOT COMPLETED|Overall Study||0
7722598|NCT01664117|19015381|P1|COMPLETED|Overall Study||209
7722599|NCT01664117|19015381|P1|STARTED|Overall Study||209
7722600|NCT01664104|19015436|P1|NOT COMPLETED|Overall Study||16
7722601|NCT01664104|19015436|P1|COMPLETED|Overall Study||120
7722602|NCT01664104|19015436|P1|STARTED|Overall Study||136
7722603|NCT01664091|19015503|P1|NOT COMPLETED|Overall Study||6
7722604|NCT01664091|19015503|P1|COMPLETED|Overall Study||26
7722605|NCT01664091|19015503|P1|STARTED|Overall Study||32
7722606|NCT01664078|19015511|P1|NOT COMPLETED|Overall Study||69
7722607|NCT01664078|19015511|P1|COMPLETED|Overall Study||121
7722608|NCT01664078|19015511|P1|STARTED|Overall Study||190
7722609|NCT01664052|19015564|P2|NOT COMPLETED|Phase 2||4
7722610|NCT01664052|19015565|P1|NOT COMPLETED|Phase 2||0
7722611|NCT01664052|19015564|P2|COMPLETED|Phase 2||31
7722612|NCT01664052|19015565|P1|COMPLETED|Phase 2||0
7722613|NCT01664052|19015564|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10
7722614|NCT01664052|19015565|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0
7722615|NCT01664052|19015564|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10
7722616|NCT01664052|19015565|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0
7722617|NCT01664052|19015564|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10
7722618|NCT01664052|19015565|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0
7722619|NCT01664052|19015564|P2|HSG 1 Hour Post Placement|Phase 2||31
7722620|NCT01664052|19015565|P1|HSG 1 Hour Post Placement|Phase 2||0
7722621|NCT01664052|19015564|P2|Insert Placed|Phase 2||31
7722622|NCT01664052|19015565|P1|Insert Placed|Phase 2||0
7722623|NCT01664052|19015564|P2|STARTED|Phase 2||35
7722624|NCT01664052|19015565|P1|STARTED|Phase 2|Screened and enrolled|0
7722625|NCT01664052|19015564|P2|NOT COMPLETED|Phase 1||0
7722626|NCT01664052|19015565|P1|NOT COMPLETED|Phase 1||7
7722627|NCT01664052|19015564|P2|COMPLETED|Phase 1||0
7722628|NCT01664052|19015565|P1|COMPLETED|Phase 1||24
7722629|NCT01664052|19015564|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0
7722630|NCT01664052|19015565|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7
7722631|NCT01664052|19015564|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0
7722632|NCT01664052|19015565|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8
7722633|NCT01664052|19015564|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0
7722634|NCT01664052|19015565|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9
7722635|NCT01664052|19015564|P2|HSG 1 Hour Post Placement|Phase 1||0
7722636|NCT01664052|19015565|P1|HSG 1 Hour Post Placement|Phase 1||24
7722637|NCT01664052|19015564|P2|Insert Placed in at Least One Tube|Phase 1||0
7722638|NCT01664052|19015565|P1|Insert Placed in at Least One Tube|Phase 1||25
7722639|NCT01664052|19015564|P2|STARTED|Phase 1||0
7722640|NCT01664052|19015565|P1|STARTED|Phase 1|Screening and enrollment|31
7722641|NCT01664039|19015583|P2|NOT COMPLETED|Overall Study||9
7722642|NCT01664039|19015584|P1|NOT COMPLETED|Overall Study||6
7722643|NCT01664039|19015583|P2|COMPLETED|Overall Study||43
7722644|NCT01664039|19015584|P1|COMPLETED|Overall Study||46
7722645|NCT01664039|19015583|P2|STARTED|Overall Study||52
7722646|NCT01664039|19015584|P1|STARTED|Overall Study||52
7722647|NCT01663987|19015606|P2|NOT COMPLETED|Overall Study||6
7722648|NCT01663987|19015607|P1|NOT COMPLETED|Overall Study||13
7722649|NCT01663987|19015606|P2|COMPLETED|Overall Study||34
7722650|NCT01663987|19015607|P1|COMPLETED|Overall Study||26
7722651|NCT01663987|19015606|P2|STARTED|Overall Study||40
7722652|NCT01663987|19015607|P1|STARTED|Overall Study||39
7722653|NCT01663935|19015635|P1|NOT COMPLETED|Overall Study||0
7722654|NCT01663935|19015635|P1|COMPLETED|Overall Study||20
7722655|NCT01663935|19015635|P1|STARTED|Overall Study||20
7722656|NCT01663922|19015640|P2|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
7722657|NCT01663922|19015641|P1|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
7722658|NCT01663922|19015640|P2|COMPLETED|Third Intervention (14 Days or 5 Days)||9
7722659|NCT01663922|19015641|P1|COMPLETED|Third Intervention (14 Days or 5 Days)||8
7722660|NCT01663922|19015640|P2|STARTED|Third Intervention (14 Days or 5 Days)||9
7722661|NCT01663922|19015641|P1|STARTED|Third Intervention (14 Days or 5 Days)||8
7722662|NCT01663922|19015640|P2|NOT COMPLETED|Washout (7 Days)||0
7722663|NCT01663922|19015641|P1|NOT COMPLETED|Washout (7 Days)||0
7722664|NCT01663922|19015640|P2|COMPLETED|Washout (7 Days)||9
7722665|NCT01663922|19015641|P1|COMPLETED|Washout (7 Days)||8
7722666|NCT01663922|19015640|P2|STARTED|Washout (7 Days)||9
7722667|NCT01663922|19015641|P1|STARTED|Washout (7 Days)||8
7722668|NCT01663922|19015640|P2|NOT COMPLETED|Second Intervention (14 Days)||0
7722669|NCT01663922|19015641|P1|NOT COMPLETED|Second Intervention (14 Days)||0
7722670|NCT01663922|19015640|P2|COMPLETED|Second Intervention (14 Days)||9
7722671|NCT01663922|19015641|P1|COMPLETED|Second Intervention (14 Days)||8
7722672|NCT01663922|19015640|P2|STARTED|Second Intervention (14 Days)||9
7722673|NCT01663922|19015641|P1|STARTED|Second Intervention (14 Days)||8
7722674|NCT01663922|19015640|P2|NOT COMPLETED|Washout (7 Days)||0
7722675|NCT01663922|19015641|P1|NOT COMPLETED|Washout (7 Days)||0
7722676|NCT01663922|19015640|P2|COMPLETED|Washout (7 Days)||9
7722677|NCT01663922|19015641|P1|COMPLETED|Washout (7 Days)||8
7722678|NCT01663922|19015640|P2|STARTED|Washout (7 Days)||9
7722679|NCT01663922|19015641|P1|STARTED|Washout (7 Days)||8
7722680|NCT01663922|19015640|P2|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
7722681|NCT01663922|19015641|P1|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
7722682|NCT01663922|19015640|P2|COMPLETED|First Intervention (14 Days or 5 Days)||9
7722683|NCT01663922|19015641|P1|COMPLETED|First Intervention (14 Days or 5 Days)||8
7722684|NCT01663922|19015640|P2|STARTED|First Intervention (14 Days or 5 Days)||9
7722685|NCT01663922|19015641|P1|STARTED|First Intervention (14 Days or 5 Days)||8
7722686|NCT01663896|19015646|P1|NOT COMPLETED|Overall Study||43
7722687|NCT01663896|19015646|P1|COMPLETED|Overall Study||375
7722688|NCT01663896|19015646|P1|STARTED|Overall Study||418
7722689|NCT01663857|19015657|P4|NOT COMPLETED|Overall Study||4
7722690|NCT01663857|19015658|P3|NOT COMPLETED|Overall Study||10
7722691|NCT01663857|19015659|P2|NOT COMPLETED|Overall Study||1
7722692|NCT01663857|19015660|P1|NOT COMPLETED|Overall Study||0
7722693|NCT01663857|19015657|P4|COMPLETED|Overall Study||48
7722694|NCT01663857|19015658|P3|COMPLETED|Overall Study||48
7722695|NCT01663857|19015659|P2|COMPLETED|Overall Study||1
7722696|NCT01663857|19015660|P1|COMPLETED|Overall Study||6
7722697|NCT01663857|19015657|P4|Received at Least One Dose of Study Drug|Overall Study||52
7722698|NCT01663857|19015658|P3|Received at Least One Dose of Study Drug|Overall Study||58
7722699|NCT01663857|19015659|P2|Received at Least One Dose of Study Drug|Overall Study||2
7722700|NCT01663857|19015660|P1|Received at Least One Dose of Study Drug|Overall Study||6
7722701|NCT01663857|19015657|P4|STARTED|Overall Study||52
7722702|NCT01663857|19015658|P3|STARTED|Overall Study||58
7722703|NCT01663857|19015659|P2|STARTED|Overall Study||2
7722704|NCT01663857|19015660|P1|STARTED|Overall Study||6
7722705|NCT01663779|19015679|P2|NOT COMPLETED|Overall Study||0
7722706|NCT01663779|19015680|P1|NOT COMPLETED|Overall Study||0
7722707|NCT01663779|19015679|P2|COMPLETED|Overall Study||23
7722708|NCT01663779|19015680|P1|COMPLETED|Overall Study||27
7722709|NCT01663779|19015679|P2|STARTED|Overall Study||23
7722710|NCT01663779|19015680|P1|STARTED|Overall Study||27
7722711|NCT01663740|19015688|P2|NOT COMPLETED|Overall Study||8
7722712|NCT01663740|19015689|P1|NOT COMPLETED|Overall Study||16
7722713|NCT01663740|19015688|P2|COMPLETED|Overall Study||13
7722714|NCT01663740|19015689|P1|COMPLETED|Overall Study||22
7722715|NCT01663740|19015688|P2|STARTED|Overall Study|Safety Population|21
7722716|NCT01663740|19015689|P1|STARTED|Overall Study|Safety Population|38
7722717|NCT01663727|19015749|P2|NOT COMPLETED|Overall Study||238
7722718|NCT01663727|19015750|P1|NOT COMPLETED|Overall Study||242
7722719|NCT01663727|19015749|P2|COMPLETED|Overall Study||1
7722720|NCT01663727|19015750|P1|COMPLETED|Overall Study||0
7722721|NCT01663727|19015749|P2|STARTED|Overall Study||239
7722722|NCT01663727|19015750|P1|STARTED|Overall Study||242
7722723|NCT01663714|19015782|P1|NOT COMPLETED|Long-Term Follow-Up||6
7722724|NCT01663714|19015782|P1|COMPLETED|Long-Term Follow-Up||16
7722725|NCT01663714|19015782|P1|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22
7722726|NCT01663714|19015782|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30
7722727|NCT01663714|19015782|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
7722728|NCT01663714|19015782|P1|STARTED|Dosimetric and Therapeutic Treatment||30
7722729|NCT01663636|19015811|P2|NOT COMPLETED|Parent SMS Acceptability Assessment||0
7722730|NCT01663636|19015812|P1|NOT COMPLETED|Parent SMS Acceptability Assessment||0
7722731|NCT01663636|19015811|P2|COMPLETED|Parent SMS Acceptability Assessment||130
7722732|NCT01663636|19015812|P1|COMPLETED|Parent SMS Acceptability Assessment||135
7722733|NCT01663636|19015811|P2|STARTED|Parent SMS Acceptability Assessment||130
7722734|NCT01663636|19015812|P1|STARTED|Parent SMS Acceptability Assessment||135
7722735|NCT01663636|19015811|P2|NOT COMPLETED|Infant SMS Reminder Feasibility Study||31
7722736|NCT01663636|19015812|P1|NOT COMPLETED|Infant SMS Reminder Feasibility Study||25
7722737|NCT01663636|19015811|P2|COMPLETED|Infant SMS Reminder Feasibility Study||130
7722738|NCT01663636|19015812|P1|COMPLETED|Infant SMS Reminder Feasibility Study||135
7722739|NCT01663636|19015811|P2|STARTED|Infant SMS Reminder Feasibility Study||161
7722740|NCT01663636|19015812|P1|STARTED|Infant SMS Reminder Feasibility Study||160
7722741|NCT01663623|19015820|P2|NOT COMPLETED|Overall Study||20
7722742|NCT01663623|19015821|P1|NOT COMPLETED|Overall Study||12
7722743|NCT01663623|19015820|P2|COMPLETED|Overall Study||33
7722744|NCT01663623|19015821|P1|COMPLETED|Overall Study||40
7722745|NCT01663623|19015820|P2|STARTED|Overall Study||53
7722746|NCT01663623|19015821|P1|STARTED|Overall Study||52
7722747|NCT01663532|19015831|P2|NOT COMPLETED|Overall Study||107
7722748|NCT01663532|19015832|P1|NOT COMPLETED|Overall Study||74
7722749|NCT01663532|19015831|P2|COMPLETED|Overall Study||65
7722750|NCT01663532|19015832|P1|COMPLETED|Overall Study||94
7722751|NCT01663532|19015831|P2|STARTED|Overall Study||172
7722752|NCT01663532|19015832|P1|STARTED|Overall Study||168
7722753|NCT01663506|19015850|P1|NOT COMPLETED|Overall Study||8
7722754|NCT01663506|19015850|P1|COMPLETED|Overall Study||15
7722755|NCT01663506|19015850|P1|STARTED|Overall Study||23
7722756|NCT01663402|19015881|P2|NOT COMPLETED|Overall Study||2084
7722757|NCT01663402|19015882|P1|NOT COMPLETED|Overall Study||1515
7722758|NCT01663402|19015881|P2|COMPLETED|Overall Study||7378
7722759|NCT01663402|19015882|P1|COMPLETED|Overall Study||7947
7722760|NCT01663402|19015881|P2|Treated|Overall Study||9451
7722761|NCT01663402|19015882|P1|Treated|Overall Study||9443
7722762|NCT01663402|19015881|P2|STARTED|Overall Study||9462
7722763|NCT01663402|19015882|P1|STARTED|Overall Study||9462
7722764|NCT01663363|19015916|P1|NOT COMPLETED|Overall Study||0
7722765|NCT01663363|19015916|P1|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170
7722766|NCT01663363|19015916|P1|STARTED|Overall Study|334 Eyes were treated among 170 participants|170
7722767|NCT01663285|19015921|P1|NOT COMPLETED|Overall Study||0
7722768|NCT01663285|19015921|P1|COMPLETED|Overall Study||1
7722769|NCT01663285|19015921|P1|STARTED|Overall Study||1
7722770|NCT01663272|19015927|P3|NOT COMPLETED|Overall Study||0
7722771|NCT01663272|19015928|P2|NOT COMPLETED|Overall Study||0
7722772|NCT01663272|19015929|P1|NOT COMPLETED|Overall Study||0
7722773|NCT01663272|19015927|P3|COMPLETED|Overall Study||1
7722774|NCT01663272|19015928|P2|COMPLETED|Overall Study||6
7722775|NCT01663272|19015929|P1|COMPLETED|Overall Study||5
7722776|NCT01663272|19015927|P3|STARTED|Overall Study||1
7722777|NCT01663272|19015928|P2|STARTED|Overall Study||6
7722778|NCT01663272|19015929|P1|STARTED|Overall Study||5
7722779|NCT01663259|19015934|P1|NOT COMPLETED|Overall Study||0
7722780|NCT01663259|19015934|P1|COMPLETED|Overall Study||42
7722781|NCT01663259|19015934|P1|STARTED|Overall Study||42
7722782|NCT01663233|19015945|P2|NOT COMPLETED|Overall Study||7
7722783|NCT01663233|19015946|P1|NOT COMPLETED|Overall Study||4
7722784|NCT01663233|19015945|P2|COMPLETED|Overall Study||129
7722785|NCT01663233|19015946|P1|COMPLETED|Overall Study||126
7722786|NCT01663233|19015945|P2|STARTED|Overall Study||136
7722787|NCT01663233|19015946|P1|STARTED|Overall Study||130
7722788|NCT01663103|19015970|P2|NOT COMPLETED|Overall Study||2
7722789|NCT01663103|19015971|P1|NOT COMPLETED|Overall Study||3
7722790|NCT01663103|19015970|P2|COMPLETED|Overall Study||19
7722791|NCT01663103|19015971|P1|COMPLETED|Overall Study||18
7722792|NCT01663103|19015970|P2|STARTED|Overall Study||21
7722793|NCT01663103|19015971|P1|STARTED|Overall Study||21
7722794|NCT01663012|19015987|P1|NOT COMPLETED|Overall Study||0
7722795|NCT01663012|19015987|P1|COMPLETED|Overall Study||20
7722796|NCT01663012|19015987|P1|STARTED|Overall Study||20
7722797|NCT01662999|19015999|P6|NOT COMPLETED|Period 3||0
7722798|NCT01662999|19016000|P5|NOT COMPLETED|Period 3||0
7722799|NCT01662999|19016001|P4|NOT COMPLETED|Period 3||0
7722800|NCT01662999|19016002|P3|NOT COMPLETED|Period 3||0
7722801|NCT01662999|19016003|P2|NOT COMPLETED|Period 3||1
7722802|NCT01662999|19016004|P1|NOT COMPLETED|Period 3||0
7722803|NCT01662999|19015999|P6|COMPLETED|Period 3||7
7722804|NCT01662999|19016000|P5|COMPLETED|Period 3||7
7722805|NCT01662999|19016001|P4|COMPLETED|Period 3||7
7722806|NCT01662999|19016002|P3|COMPLETED|Period 3||7
7722807|NCT01662999|19016003|P2|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6
7722808|NCT01662999|19016004|P1|COMPLETED|Period 3||7
7722809|NCT01662999|19015999|P6|STARTED|Period 3||7
7722810|NCT01662999|19016000|P5|STARTED|Period 3||7
7722811|NCT01662999|19016001|P4|STARTED|Period 3||7
7722812|NCT01662999|19016002|P3|STARTED|Period 3||7
7722813|NCT01662999|19016003|P2|STARTED|Period 3||7
7722814|NCT01662999|19016004|P1|STARTED|Period 3||7
7722815|NCT01662999|19015999|P6|NOT COMPLETED|Period 2||0
7722816|NCT01662999|19016000|P5|NOT COMPLETED|Period 2||0
7722817|NCT01662999|19016001|P4|NOT COMPLETED|Period 2||0
7722818|NCT01662999|19016002|P3|NOT COMPLETED|Period 2||0
7722819|NCT01662999|19016003|P2|NOT COMPLETED|Period 2||0
7722820|NCT01662999|19016004|P1|NOT COMPLETED|Period 2||0
7722821|NCT01662999|19015999|P6|COMPLETED|Period 2||7
7722822|NCT01662999|19016000|P5|COMPLETED|Period 2||7
7722823|NCT01662999|19016001|P4|COMPLETED|Period 2||7
7722824|NCT01662999|19016002|P3|COMPLETED|Period 2||7
7722825|NCT01662999|19016003|P2|COMPLETED|Period 2||7
7722826|NCT01662999|19016004|P1|COMPLETED|Period 2||7
7722827|NCT01662999|19015999|P6|STARTED|Period 2||7
7722828|NCT01662999|19016000|P5|STARTED|Period 2||7
7722829|NCT01662999|19016001|P4|STARTED|Period 2||7
7722830|NCT01662999|19016002|P3|STARTED|Period 2||7
7722831|NCT01662999|19016003|P2|STARTED|Period 2||7
7722832|NCT01662999|19016004|P1|STARTED|Period 2||7
7722833|NCT01662999|19015999|P6|NOT COMPLETED|Period 1||0
7722834|NCT01662999|19016000|P5|NOT COMPLETED|Period 1||0
7722835|NCT01662999|19016001|P4|NOT COMPLETED|Period 1||0
7722836|NCT01662999|19016002|P3|NOT COMPLETED|Period 1||0
7722837|NCT01662999|19016003|P2|NOT COMPLETED|Period 1||0
7722838|NCT01662999|19016004|P1|NOT COMPLETED|Period 1||0
7722839|NCT01662999|19015999|P6|COMPLETED|Period 1||7
7722840|NCT01662999|19016000|P5|COMPLETED|Period 1||7
7722841|NCT01662999|19016001|P4|COMPLETED|Period 1||7
7722842|NCT01662999|19016002|P3|COMPLETED|Period 1||7
7722843|NCT01662999|19016003|P2|COMPLETED|Period 1||7
7722844|NCT01662999|19016004|P1|COMPLETED|Period 1||7
7722845|NCT01662999|19015999|P6|STARTED|Period 1||7
7722846|NCT01662999|19016000|P5|STARTED|Period 1||7
7722847|NCT01662999|19016001|P4|STARTED|Period 1||7
7722848|NCT01662999|19016002|P3|STARTED|Period 1||7
7722849|NCT01662999|19016003|P2|STARTED|Period 1||7
7722850|NCT01662999|19016004|P1|STARTED|Period 1||7
7722851|NCT01662986|19016075|P2|NOT COMPLETED|Overall Study||13
7722852|NCT01662986|19016076|P1|NOT COMPLETED|Overall Study||18
7722853|NCT01662986|19016075|P2|COMPLETED|Overall Study||26
7722854|NCT01662986|19016076|P1|COMPLETED|Overall Study||22
7722855|NCT01662986|19016075|P2|STARTED|Overall Study||39
7722856|NCT01662986|19016076|P1|STARTED|Overall Study||40
7722857|NCT01662960|19016112|P4|NOT COMPLETED|3 Month Follow-up||2
7722858|NCT01662960|19016113|P3|NOT COMPLETED|3 Month Follow-up||3
7722859|NCT01662960|19016114|P2|NOT COMPLETED|3 Month Follow-up||3
7722860|NCT01662960|19016115|P1|NOT COMPLETED|3 Month Follow-up||3
7722861|NCT01662960|19016112|P4|COMPLETED|3 Month Follow-up||13
7722862|NCT01662960|19016113|P3|COMPLETED|3 Month Follow-up||5
7722863|NCT01662960|19016114|P2|COMPLETED|3 Month Follow-up||16
7722864|NCT01662960|19016115|P1|COMPLETED|3 Month Follow-up||21
7722865|NCT01662960|19016112|P4|STARTED|3 Month Follow-up||15
7722866|NCT01662960|19016113|P3|STARTED|3 Month Follow-up||8
7722867|NCT01662960|19016114|P2|STARTED|3 Month Follow-up||19
7722868|NCT01662960|19016115|P1|STARTED|3 Month Follow-up||24
7722869|NCT01662960|19016112|P4|NOT COMPLETED|End of 4 Week Treatment Period||0
7722870|NCT01662960|19016113|P3|NOT COMPLETED|End of 4 Week Treatment Period||1
7722871|NCT01662960|19016114|P2|NOT COMPLETED|End of 4 Week Treatment Period||4
7722872|NCT01662960|19016115|P1|NOT COMPLETED|End of 4 Week Treatment Period||1
7722873|NCT01662960|19016112|P4|COMPLETED|End of 4 Week Treatment Period||15
7722874|NCT01662960|19016113|P3|COMPLETED|End of 4 Week Treatment Period||8
7722875|NCT01662960|19016114|P2|COMPLETED|End of 4 Week Treatment Period||19
7722876|NCT01662960|19016115|P1|COMPLETED|End of 4 Week Treatment Period||24
7722877|NCT01662960|19016112|P4|STARTED|End of 4 Week Treatment Period||15
7722878|NCT01662960|19016113|P3|STARTED|End of 4 Week Treatment Period||9
7722879|NCT01662960|19016114|P2|STARTED|End of 4 Week Treatment Period||23
7722880|NCT01662960|19016115|P1|STARTED|End of 4 Week Treatment Period||25
7722881|NCT01662908|19016147|P2|NOT COMPLETED|Overall Study||5
7722882|NCT01662908|19016148|P1|NOT COMPLETED|Overall Study||6
7722883|NCT01662908|19016147|P2|COMPLETED|Overall Study||23
7722884|NCT01662908|19016148|P1|COMPLETED|Overall Study||50
7722885|NCT01662908|19016147|P2|STARTED|Overall Study||28
7722886|NCT01662908|19016148|P1|STARTED|Overall Study||56
7722887|NCT01662895|19016164|P2|NOT COMPLETED|Overall Study||1
7722888|NCT01662895|19016165|P1|NOT COMPLETED|Overall Study||0
7722889|NCT01662895|19016164|P2|COMPLETED|Overall Study||20
7722890|NCT01662895|19016165|P1|COMPLETED|Overall Study||21
7722891|NCT01662895|19016164|P2|Initiated Study Drug|Overall Study||21
7722892|NCT01662895|19016165|P1|Initiated Study Drug|Overall Study||21
7722893|NCT01662895|19016164|P2|STARTED|Overall Study||21
7722894|NCT01662895|19016165|P1|STARTED|Overall Study||21
7722895|NCT01662882|19016188|P3|NOT COMPLETED|Overall Study||0
7722896|NCT01662882|19016189|P2|NOT COMPLETED|Overall Study||0
7722897|NCT01662882|19016190|P1|NOT COMPLETED|Overall Study||0
7722898|NCT01662882|19016188|P3|COMPLETED|Overall Study||15
7722899|NCT01662882|19016189|P2|COMPLETED|Overall Study||18
7722900|NCT01662882|19016190|P1|COMPLETED|Overall Study||15
7722901|NCT01662882|19016188|P3|STARTED|Overall Study||15
7722902|NCT01662882|19016189|P2|STARTED|Overall Study||18
7722903|NCT01662882|19016190|P1|STARTED|Overall Study||15
7722904|NCT01662856|19016203|P2|NOT COMPLETED|Primary Part II||2
7722905|NCT01662856|19016204|P1|NOT COMPLETED|Primary Part II||10
7722906|NCT01662856|19016203|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|55
7722907|NCT01662856|19016204|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|99
7722908|NCT01662856|19016203|P2|Completed Study up to Week 6|Primary Part II||56
7722909|NCT01662856|19016204|P1|Completed Study up to Week 6|Primary Part II||106
7722910|NCT01662856|19016203|P2|STARTED|Primary Part II||57
7722911|NCT01662856|19016204|P1|STARTED|Primary Part II||109
7722912|NCT01662856|19016203|P2|NOT COMPLETED|Part I + Part II (Overall Study)||2
7722913|NCT01662856|19016204|P1|NOT COMPLETED|Part I + Part II (Overall Study)||16
7722914|NCT01662856|19016203|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|55
7722915|NCT01662856|19016204|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|152
7722916|NCT01662856|19016203|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||56
7722917|NCT01662856|19016204|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||164
7722918|NCT01662856|19016203|P2|STARTED|Part I + Part II (Overall Study)||57
7722919|NCT01662856|19016204|P1|STARTED|Part I + Part II (Overall Study)||168
7722920|NCT01662791|19016218|P2|NOT COMPLETED|Part 2 - Interventional||0
7722921|NCT01662791|19016219|P1|NOT COMPLETED|Part 2 - Interventional||0
7722922|NCT01662791|19016218|P2|COMPLETED|Part 2 - Interventional||0
7722923|NCT01662791|19016219|P1|COMPLETED|Part 2 - Interventional||8
7722924|NCT01662791|19016218|P2|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0
7722925|NCT01662791|19016219|P1|STARTED|Part 2 - Interventional||8
7722926|NCT01662791|19016218|P2|NOT COMPLETED|Part 1 - Observational||0
7722927|NCT01662791|19016219|P1|NOT COMPLETED|Part 1 - Observational||0
7722928|NCT01662791|19016218|P2|COMPLETED|Part 1 - Observational||41
7722929|NCT01662791|19016219|P1|COMPLETED|Part 1 - Observational||8
7722930|NCT01662791|19016218|P2|STARTED|Part 1 - Observational||41
7722931|NCT01662791|19016219|P1|STARTED|Part 1 - Observational||8
7722932|NCT01662778|19016241|P4|NOT COMPLETED|Period 4||0
7722933|NCT01662778|19016242|P3|NOT COMPLETED|Period 4||0
7722934|NCT01662778|19016243|P2|NOT COMPLETED|Period 4||0
7722935|NCT01662778|19016244|P1|NOT COMPLETED|Period 4||0
7722936|NCT01662778|19016241|P4|COMPLETED|Period 4||4
7722937|NCT01662778|19016242|P3|COMPLETED|Period 4||6
7722938|NCT01662778|19016243|P2|COMPLETED|Period 4||5
7722939|NCT01662778|19016244|P1|COMPLETED|Period 4||6
7722940|NCT01662778|19016241|P4|STARTED|Period 4||4
7722941|NCT01662778|19016242|P3|STARTED|Period 4||6
7722942|NCT01662778|19016243|P2|STARTED|Period 4||5
7722943|NCT01662778|19016244|P1|STARTED|Period 4||6
7722944|NCT01662778|19016241|P4|NOT COMPLETED|Period 3||0
7722945|NCT01662778|19016242|P3|NOT COMPLETED|Period 3||0
7722946|NCT01662778|19016243|P2|NOT COMPLETED|Period 3||0
7722947|NCT01662778|19016244|P1|NOT COMPLETED|Period 3||0
7722948|NCT01662778|19016241|P4|COMPLETED|Period 3||4
7722949|NCT01662778|19016242|P3|COMPLETED|Period 3||6
7722950|NCT01662778|19016243|P2|COMPLETED|Period 3||5
7722951|NCT01662778|19016244|P1|COMPLETED|Period 3||6
7722952|NCT01662778|19016241|P4|STARTED|Period 3||4
7722953|NCT01662778|19016242|P3|STARTED|Period 3||6
7722954|NCT01662778|19016243|P2|STARTED|Period 3||5
7722955|NCT01662778|19016244|P1|STARTED|Period 3||6
7722956|NCT01662778|19016241|P4|NOT COMPLETED|Period 2||0
7722957|NCT01662778|19016242|P3|NOT COMPLETED|Period 2||0
7722958|NCT01662778|19016243|P2|NOT COMPLETED|Period 2||0
7722959|NCT01662778|19016244|P1|NOT COMPLETED|Period 2||0
7722960|NCT01662778|19016241|P4|COMPLETED|Period 2||4
7722961|NCT01662778|19016242|P3|COMPLETED|Period 2||6
7722962|NCT01662778|19016243|P2|COMPLETED|Period 2||5
7722963|NCT01662778|19016244|P1|COMPLETED|Period 2||6
7722964|NCT01662778|19016241|P4|STARTED|Period 2||4
7722965|NCT01662778|19016242|P3|STARTED|Period 2||6
7722966|NCT01662778|19016243|P2|STARTED|Period 2||5
7722967|NCT01662778|19016244|P1|STARTED|Period 2||6
7722968|NCT01662778|19016241|P4|NOT COMPLETED|Period 1||0
7722969|NCT01662778|19016242|P3|NOT COMPLETED|Period 1||0
7722970|NCT01662778|19016243|P2|NOT COMPLETED|Period 1||0
7722971|NCT01662778|19016244|P1|NOT COMPLETED|Period 1||0
7722972|NCT01662778|19016241|P4|COMPLETED|Period 1||4
7722973|NCT01662778|19016242|P3|COMPLETED|Period 1||6
7722974|NCT01662778|19016243|P2|COMPLETED|Period 1||5
7722975|NCT01662778|19016244|P1|COMPLETED|Period 1||6
7722976|NCT01662778|19016241|P4|STARTED|Period 1||4
7722977|NCT01662778|19016242|P3|STARTED|Period 1||6
7722978|NCT01662778|19016243|P2|STARTED|Period 1||5
7722979|NCT01662778|19016244|P1|STARTED|Period 1||6
7722980|NCT01662765|19016268|P2|NOT COMPLETED|Overall Study||2
7722981|NCT01662765|19016269|P1|NOT COMPLETED|Overall Study||1
7722982|NCT01662765|19016268|P2|COMPLETED|Overall Study||40
7722983|NCT01662765|19016269|P1|COMPLETED|Overall Study||41
7722984|NCT01662765|19016268|P2|STARTED|Overall Study||42
7722985|NCT01662765|19016269|P1|STARTED|Overall Study||42
7722986|NCT01662752|19016281|P1|NOT COMPLETED|Overall Study||0
7722987|NCT01662752|19016281|P1|COMPLETED|Overall Study||30
7722988|NCT01662752|19016281|P1|STARTED|Overall Study||30
7722989|NCT01662648|19016289|P2|NOT COMPLETED|Overall Study||178
7722990|NCT01662648|19016290|P1|NOT COMPLETED|Overall Study||147
7722991|NCT01662648|19016289|P2|COMPLETED|Overall Study||419
7722992|NCT01662648|19016290|P1|COMPLETED|Overall Study||373
7722993|NCT01662648|19016289|P2|STARTED|Overall Study||597
7722994|NCT01662648|19016290|P1|STARTED|Overall Study||520
7722995|NCT01662635|19016312|P1|NOT COMPLETED|Overall Study||30
7722996|NCT01662635|19016312|P1|COMPLETED|Overall Study||200
7722997|NCT01662635|19016312|P1|STARTED|Overall Study||230
7722998|NCT01662583|19016321|P3|NOT COMPLETED|Overall Study||0
7722999|NCT01662583|19016322|P2|NOT COMPLETED|Overall Study||0
7723000|NCT01662583|19016323|P1|NOT COMPLETED|Overall Study||0
7723001|NCT01662583|19016321|P3|COMPLETED|Overall Study||219
7723002|NCT01662583|19016322|P2|COMPLETED|Overall Study||225
7723003|NCT01662583|19016323|P1|COMPLETED|Overall Study||216
7723004|NCT01662583|19016321|P3|STARTED|Overall Study||219
7723005|NCT01662583|19016322|P2|STARTED|Overall Study||225
7723006|NCT01662583|19016323|P1|STARTED|Overall Study||216
7723007|NCT01662531|19016336|P1|NOT COMPLETED|Overall Study||0
7723008|NCT01662531|19016336|P1|COMPLETED|Overall Study||27
7723009|NCT01662531|19016336|P1|STARTED|Overall Study||27
7723010|NCT01662505|19016363|P3|NOT COMPLETED|Overall Study||8
7723011|NCT01662505|19016364|P2|NOT COMPLETED|Overall Study||4
7723012|NCT01662505|19016365|P1|NOT COMPLETED|Overall Study||7
7723013|NCT01662505|19016363|P3|COMPLETED|Overall Study||0
7723014|NCT01662505|19016364|P2|COMPLETED|Overall Study||0
7723015|NCT01662505|19016365|P1|COMPLETED|Overall Study||0
7723016|NCT01662505|19016363|P3|STARTED|Overall Study||8
7723017|NCT01662505|19016364|P2|STARTED|Overall Study||4
7723018|NCT01662505|19016365|P1|STARTED|Overall Study||7
7723019|NCT01662492|19016389|P3|NOT COMPLETED|Overall Study||6
7723020|NCT01662492|19016390|P2|NOT COMPLETED|Overall Study||1
7723021|NCT01662492|19016391|P1|NOT COMPLETED|Overall Study||3
7723022|NCT01662492|19016389|P3|COMPLETED|Overall Study||31
7723023|NCT01662492|19016390|P2|COMPLETED|Overall Study||42
7723024|NCT01662492|19016391|P1|COMPLETED|Overall Study||42
7723025|NCT01662492|19016389|P3|STARTED|Overall Study||37
7723026|NCT01662492|19016390|P2|STARTED|Overall Study||43
7723027|NCT01662492|19016391|P1|STARTED|Overall Study||45
7723028|NCT01662440|19016415|P4|NOT COMPLETED|Overall Study||4
7723029|NCT01662440|19016416|P3|NOT COMPLETED|Overall Study||6
7723030|NCT01662440|19016417|P2|NOT COMPLETED|Overall Study||6
7723031|NCT01662440|19016418|P1|NOT COMPLETED|Overall Study||9
7723032|NCT01662440|19016415|P4|COMPLETED|Overall Study||52
7723033|NCT01662440|19016416|P3|COMPLETED|Overall Study||215
7723034|NCT01662440|19016417|P2|COMPLETED|Overall Study||211
7723035|NCT01662440|19016418|P1|COMPLETED|Overall Study||158
7723036|NCT01662440|19016415|P4|STARTED|Overall Study||56
7723037|NCT01662440|19016416|P3|STARTED|Overall Study||221
7723038|NCT01662440|19016417|P2|STARTED|Overall Study||217
7723039|NCT01662440|19016418|P1|STARTED|Overall Study||167
7723040|NCT01662362|19016466|P1|NOT COMPLETED|Overall Study||38
7723041|NCT01662362|19016466|P1|COMPLETED|Overall Study||25
7723042|NCT01662362|19016466|P1|STARTED|Overall Study||63
7723043|NCT01662336|19016471|P1|NOT COMPLETED|Overall Study||66
7723044|NCT01662336|19016471|P1|COMPLETED|Overall Study||107
7723045|NCT01662336|19016471|P1|Completed Month 12 Visit|Overall Study||109
7723046|NCT01662336|19016471|P1|Completed Month 6 Visit|Overall Study||142
7723047|NCT01662336|19016471|P1|STARTED|Overall Study||173
7723048|NCT01662310|19016497|P5|NOT COMPLETED|Open-Label Extension Phase||10
7723049|NCT01662310|19016498|P4|NOT COMPLETED|Open-Label Extension Phase||11
7723050|NCT01662310|19016499|P3|NOT COMPLETED|Open-Label Extension Phase||0
7723051|NCT01662310|19016500|P2|NOT COMPLETED|Open-Label Extension Phase||0
7723052|NCT01662310|19016501|P1|NOT COMPLETED|Open-Label Extension Phase||0
7723053|NCT01662310|19016497|P5|COMPLETED|Open-Label Extension Phase||49
7723054|NCT01662310|19016498|P4|COMPLETED|Open-Label Extension Phase||36
7723055|NCT01662310|19016499|P3|COMPLETED|Open-Label Extension Phase||0
7723056|NCT01662310|19016500|P2|COMPLETED|Open-Label Extension Phase||0
7723057|NCT01662310|19016501|P1|COMPLETED|Open-Label Extension Phase||0
7723058|NCT01662310|19016497|P5|STARTED|Open-Label Extension Phase||59
7723059|NCT01662310|19016498|P4|STARTED|Open-Label Extension Phase||47
7723060|NCT01662310|19016499|P3|STARTED|Open-Label Extension Phase||0
7723061|NCT01662310|19016500|P2|STARTED|Open-Label Extension Phase||0
7723062|NCT01662310|19016501|P1|STARTED|Open-Label Extension Phase||0
7723063|NCT01662310|19016497|P5|NOT COMPLETED|Double-Blind Phase||0
7723064|NCT01662310|19016498|P4|NOT COMPLETED|Double-Blind Phase||0
7723065|NCT01662310|19016499|P3|NOT COMPLETED|Double-Blind Phase||5
7723066|NCT01662310|19016500|P2|NOT COMPLETED|Double-Blind Phase||15
7723067|NCT01662310|19016501|P1|NOT COMPLETED|Double-Blind Phase||0
7723068|NCT01662310|19016497|P5|COMPLETED|Double-Blind Phase||0
7723069|NCT01662310|19016498|P4|COMPLETED|Double-Blind Phase||0
7723070|NCT01662310|19016499|P3|COMPLETED|Double-Blind Phase||66
7723071|NCT01662310|19016500|P2|COMPLETED|Double-Blind Phase||50
7723072|NCT01662310|19016501|P1|COMPLETED|Double-Blind Phase||0
7723073|NCT01662310|19016497|P5|Treated|Double-Blind Phase||0
7723074|NCT01662310|19016498|P4|Treated|Double-Blind Phase||0
7723075|NCT01662310|19016499|P3|Treated|Double-Blind Phase||71
7723076|NCT01662310|19016500|P2|Treated|Double-Blind Phase||64
7723077|NCT01662310|19016501|P1|Treated|Double-Blind Phase||0
7723078|NCT01662310|19016497|P5|STARTED|Double-Blind Phase||0
7723079|NCT01662310|19016498|P4|STARTED|Double-Blind Phase||0
7723080|NCT01662310|19016499|P3|STARTED|Double-Blind Phase||71
7723081|NCT01662310|19016500|P2|STARTED|Double-Blind Phase||65
7723082|NCT01662310|19016501|P1|STARTED|Double-Blind Phase||0
7723083|NCT01662310|19016497|P5|NOT COMPLETED|Run-In or Stabilization Phase||0
7723084|NCT01662310|19016498|P4|NOT COMPLETED|Run-In or Stabilization Phase||0
7723085|NCT01662310|19016499|P3|NOT COMPLETED|Run-In or Stabilization Phase||0
7723086|NCT01662310|19016500|P2|NOT COMPLETED|Run-In or Stabilization Phase||0
7723087|NCT01662310|19016501|P1|NOT COMPLETED|Run-In or Stabilization Phase||65
7723088|NCT01662310|19016497|P5|COMPLETED|Run-In or Stabilization Phase||0
7723089|NCT01662310|19016498|P4|COMPLETED|Run-In or Stabilization Phase||0
7723090|NCT01662310|19016499|P3|COMPLETED|Run-In or Stabilization Phase||0
7723091|NCT01662310|19016500|P2|COMPLETED|Run-In or Stabilization Phase||0
7723092|NCT01662310|19016501|P1|COMPLETED|Run-In or Stabilization Phase||136
7723093|NCT01662310|19016497|P5|STARTED|Run-In or Stabilization Phase||0
7723094|NCT01662310|19016498|P4|STARTED|Run-In or Stabilization Phase||0
7723095|NCT01662310|19016499|P3|STARTED|Run-In or Stabilization Phase||0
7723096|NCT01662310|19016500|P2|STARTED|Run-In or Stabilization Phase||0
7723097|NCT01662310|19016501|P1|STARTED|Run-In or Stabilization Phase||201
7723098|NCT01662297|19016535|P2|NOT COMPLETED|Overall Study||0
7723099|NCT01662297|19016536|P1|NOT COMPLETED|Overall Study||0
7723100|NCT01662297|19016535|P2|COMPLETED|Overall Study||1
7723101|NCT01662297|19016536|P1|COMPLETED|Overall Study||0
7723102|NCT01662297|19016535|P2|STARTED|Overall Study||1
7723103|NCT01662297|19016536|P1|STARTED|Overall Study||0
7723104|NCT01662115|19016561|P3|NOT COMPLETED|Overall Study||0
7723105|NCT01662115|19016562|P2|NOT COMPLETED|Overall Study||0
7723106|NCT01662115|19016563|P1|NOT COMPLETED|Overall Study||0
7723107|NCT01662115|19016561|P3|COMPLETED|Overall Study||0
7723108|NCT01662115|19016562|P2|COMPLETED|Overall Study||2
7723109|NCT01662115|19016563|P1|COMPLETED|Overall Study||2
7723110|NCT01662115|19016561|P3|STARTED|Overall Study||0
7723111|NCT01662115|19016562|P2|STARTED|Overall Study||2
7723112|NCT01662115|19016563|P1|STARTED|Overall Study||2
7723113|NCT01662102|19016582|P2|NOT COMPLETED|Overall Study||0
7723114|NCT01662102|19016583|P1|NOT COMPLETED|Overall Study||1
7723115|NCT01662102|19016582|P2|COMPLETED|Overall Study||0
7723116|NCT01662102|19016583|P1|COMPLETED|Overall Study||0
7723117|NCT01662102|19016582|P2|STARTED|Overall Study||0
7723118|NCT01662102|19016583|P1|STARTED|Overall Study||1
7723119|NCT01662063|19016591|P3|NOT COMPLETED|Overall Study||1
7723120|NCT01662063|19016592|P2|NOT COMPLETED|Overall Study||29
7723121|NCT01662063|19016593|P1|NOT COMPLETED|Overall Study||5
7723122|NCT01662063|19016591|P3|COMPLETED|Overall Study||0
7723123|NCT01662063|19016592|P2|COMPLETED|Overall Study||144
7723124|NCT01662063|19016593|P1|COMPLETED|Overall Study||39
7723125|NCT01662063|19016591|P3|STARTED|Overall Study||1
7723126|NCT01662063|19016592|P2|STARTED|Overall Study||173
7723127|NCT01662063|19016593|P1|STARTED|Overall Study||44
7723128|NCT01662024|19016672|P1|NOT COMPLETED|Overall Study||5
7723129|NCT01662024|19016672|P1|COMPLETED|Overall Study||15
7723130|NCT01662024|19016672|P1|STARTED|Overall Study||20
7723131|NCT01661972|19016684|P2|NOT COMPLETED|Overall Study||4
7723132|NCT01661972|19016685|P1|NOT COMPLETED|Overall Study||2
7723133|NCT01661972|19016684|P2|COMPLETED|Overall Study||46
7723134|NCT01661972|19016685|P1|COMPLETED|Overall Study||11
7723135|NCT01661972|19016684|P2|STARTED|Overall Study||50
7723136|NCT01661972|19016685|P1|STARTED|Overall Study||13
7723137|NCT01661946|19016697|P2|NOT COMPLETED|Overall Study||0
7723138|NCT01661946|19016698|P1|NOT COMPLETED|Overall Study||0
7723139|NCT01661946|19016697|P2|COMPLETED|Overall Study||5
7723140|NCT01661946|19016698|P1|COMPLETED|Overall Study||5
7723141|NCT01661946|19016697|P2|STARTED|Overall Study||5
7723142|NCT01661946|19016698|P1|STARTED|Overall Study||5
7723143|NCT01661933|19016704|P1|NOT COMPLETED|High-dose Gluten Challenge||2
7723144|NCT01661933|19016704|P1|COMPLETED|High-dose Gluten Challenge||8
7723145|NCT01661933|19016704|P1|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10
7723146|NCT01661933|19016704|P1|NOT COMPLETED|Low-dose Gluten Challenge||2
7723147|NCT01661933|19016704|P1|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10
7723148|NCT01661933|19016704|P1|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12
7723149|NCT01661933|19016704|P1|NOT COMPLETED|Gluten Micro-challenge||0
7723150|NCT01661933|19016704|P1|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12
7723151|NCT01661933|19016704|P1|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12
7723152|NCT01661881|19016711|P1|NOT COMPLETED|Overall Study||1
7723153|NCT01661881|19016711|P1|COMPLETED|Overall Study||22
7723154|NCT01661881|19016711|P1|STARTED|Overall Study||23
7723155|NCT01661790|19016719|P2|NOT COMPLETED|Overall Study||2
7723156|NCT01661790|19016720|P1|NOT COMPLETED|Overall Study||0
7723157|NCT01661790|19016719|P2|COMPLETED|Overall Study||34
7723158|NCT01661790|19016720|P1|COMPLETED|Overall Study||36
7723159|NCT01661790|19016719|P2|STARTED|Overall Study||36
7723160|NCT01661790|19016720|P1|STARTED|Overall Study||36
7723161|NCT01661764|19016732|P6|NOT COMPLETED|Overall Study||2
7723162|NCT01661764|19016733|P5|NOT COMPLETED|Overall Study||3
7723163|NCT01661764|19016734|P4|NOT COMPLETED|Overall Study||2
7723164|NCT01661764|19016735|P3|NOT COMPLETED|Overall Study||3
7723165|NCT01661764|19016736|P2|NOT COMPLETED|Overall Study||5
7723166|NCT01661764|19016737|P1|NOT COMPLETED|Overall Study||2
7723167|NCT01661764|19016732|P6|COMPLETED|Overall Study||18
7723168|NCT01661764|19016733|P5|COMPLETED|Overall Study||16
7723169|NCT01661764|19016734|P4|COMPLETED|Overall Study||24
7723170|NCT01661764|19016735|P3|COMPLETED|Overall Study||22
7723171|NCT01661764|19016736|P2|COMPLETED|Overall Study||20
7723172|NCT01661764|19016737|P1|COMPLETED|Overall Study||24
7723173|NCT01661764|19016732|P6|STARTED|Overall Study||20
7723174|NCT01661764|19016733|P5|STARTED|Overall Study||19
7723175|NCT01661764|19016734|P4|STARTED|Overall Study||26
7723176|NCT01661764|19016735|P3|STARTED|Overall Study||25
7723177|NCT01661764|19016736|P2|STARTED|Overall Study||25
7723178|NCT01661764|19016737|P1|STARTED|Overall Study||26
7723179|NCT01661712|19016801|P2|NOT COMPLETED|Overall Study||0
7723180|NCT01661712|19016802|P1|NOT COMPLETED|Overall Study||0
7723181|NCT01661712|19016801|P2|COMPLETED|Overall Study|sham stimulation night|18
7723182|NCT01661712|19016802|P1|COMPLETED|Overall Study|night on transcutaneous electrical stimulation|18
7723183|NCT01661712|19016801|P2|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
7723184|NCT01661712|19016802|P1|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
7723185|NCT01661712|19016801|P2|STARTED|Overall Study|initial night on transcutaneous electrical stimulation|18
7723186|NCT01661712|19016802|P1|STARTED|Overall Study|initial sham stimulation night|18
7723187|NCT01661686|19016820|P2|NOT COMPLETED|Overall Study||2
7723188|NCT01661686|19016821|P1|NOT COMPLETED|Overall Study||2
7723189|NCT01661686|19016820|P2|COMPLETED|Overall Study||47
7723190|NCT01661686|19016821|P1|COMPLETED|Overall Study||47
7723191|NCT01661686|19016820|P2|STARTED|Overall Study||49
7723192|NCT01661686|19016821|P1|STARTED|Overall Study||49
7723193|NCT01661621|19016837|P2|NOT COMPLETED|Overall Study||0
7723194|NCT01661621|19016838|P1|NOT COMPLETED|Overall Study||0
7723195|NCT01661621|19016837|P2|COMPLETED|Overall Study||279
7723196|NCT01661621|19016838|P1|COMPLETED|Overall Study||116
7723197|NCT01661621|19016837|P2|STARTED|Overall Study||279
7723198|NCT01661621|19016838|P1|STARTED|Overall Study||116
7723199|NCT01661595|19016862|P4|NOT COMPLETED|Phase 2: Week 5-8.||0
7723200|NCT01661595|19016863|P3|NOT COMPLETED|Phase 2: Week 5-8.||1
7723201|NCT01661595|19016864|P2|NOT COMPLETED|Phase 2: Week 5-8.||0
7723202|NCT01661595|19016865|P1|NOT COMPLETED|Phase 2: Week 5-8.||0
7723203|NCT01661595|19016862|P4|COMPLETED|Phase 2: Week 5-8.||4
7723204|NCT01661595|19016863|P3|COMPLETED|Phase 2: Week 5-8.||4
7723205|NCT01661595|19016864|P2|COMPLETED|Phase 2: Week 5-8.||4
7723206|NCT01661595|19016865|P1|COMPLETED|Phase 2: Week 5-8.||4
7723207|NCT01661595|19016862|P4|STARTED|Phase 2: Week 5-8.||4
7723208|NCT01661595|19016863|P3|STARTED|Phase 2: Week 5-8.||5
7723209|NCT01661595|19016864|P2|STARTED|Phase 2: Week 5-8.||4
7723210|NCT01661595|19016865|P1|STARTED|Phase 2: Week 5-8.||4
7723211|NCT01661595|19016862|P4|NOT COMPLETED|Phase 1: Week 0-4||0
7723212|NCT01661595|19016863|P3|NOT COMPLETED|Phase 1: Week 0-4||0
7723213|NCT01661595|19016864|P2|NOT COMPLETED|Phase 1: Week 0-4||0
7723214|NCT01661595|19016865|P1|NOT COMPLETED|Phase 1: Week 0-4||1
7723215|NCT01661595|19016862|P4|COMPLETED|Phase 1: Week 0-4||4
7723216|NCT01661595|19016863|P3|COMPLETED|Phase 1: Week 0-4||5
7723217|NCT01661595|19016864|P2|COMPLETED|Phase 1: Week 0-4||4
7723218|NCT01661595|19016865|P1|COMPLETED|Phase 1: Week 0-4||4
7723219|NCT01661595|19016862|P4|STARTED|Phase 1: Week 0-4||4
7723220|NCT01661595|19016863|P3|STARTED|Phase 1: Week 0-4||5
7723221|NCT01661595|19016864|P2|STARTED|Phase 1: Week 0-4||4
7723222|NCT01661595|19016865|P1|STARTED|Phase 1: Week 0-4||5
7723223|NCT01661283|19016970|P1|NOT COMPLETED|Overall Study||0
7723224|NCT01661283|19016970|P1|COMPLETED|Overall Study||25
7723225|NCT01661283|19016970|P1|STARTED|Overall Study|15 patients enrolled in the first stage; 10 patients enrolled in the second stage|25
7723226|NCT01661270|19016981|P2|NOT COMPLETED|Overall Study||0
7723227|NCT01661270|19016982|P1|NOT COMPLETED|Overall Study||0
7723228|NCT01661270|19016981|P2|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223
7723229|NCT01661270|19016982|P1|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109
7723230|NCT01661270|19016981|P2|Other Reasons|Overall Study||2
7723231|NCT01661270|19016982|P1|Other Reasons|Overall Study||0
7723232|NCT01661270|19016981|P2|Participant's Request|Overall Study|Met EOT criteria|48
7723233|NCT01661270|19016982|P1|Participant's Request|Overall Study|Met EOT criteria|15
7723234|NCT01661270|19016981|P2|Physician Decision|Overall Study|Met EOT criteria|8
7723235|NCT01661270|19016982|P1|Physician Decision|Overall Study|Met EOT criteria|1
7723236|NCT01661270|19016981|P2|Disease Progression|Overall Study|Met EOT criteria|118
7723237|NCT01661270|19016982|P1|Disease Progression|Overall Study|Met EOT criteria|67
7723238|NCT01661270|19016981|P2|Adverse Event|Overall Study|Met EOT criteria|47
7723239|NCT01661270|19016982|P1|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26
7723240|NCT01661270|19016981|P2|STARTED|Overall Study||223
7723241|NCT01661270|19016982|P1|STARTED|Overall Study||109
7723242|NCT01661205|19016993|P1|NOT COMPLETED|Overall Study||2
7723243|NCT01661205|19016993|P1|COMPLETED|Overall Study||24
7723244|NCT01661205|19016993|P1|STARTED|Overall Study||26
7723245|NCT01661179|19017004|P1|NOT COMPLETED|Overall Study||6
7723246|NCT01661179|19017004|P1|COMPLETED|Overall Study||8
7723247|NCT01661179|19017004|P1|STARTED|Overall Study||14
7723248|NCT01661140|19017008|P3|NOT COMPLETED|Double-Blind Period||50
7723249|NCT01661140|19017009|P2|NOT COMPLETED|Double-Blind Period||41
7723250|NCT01661140|19017010|P1|NOT COMPLETED|Double-Blind Period||0
7723251|NCT01661140|19017008|P3|COMPLETED|Double-Blind Period||86
7723252|NCT01661140|19017009|P2|COMPLETED|Double-Blind Period||95
7723253|NCT01661140|19017010|P1|COMPLETED|Double-Blind Period||0
7723254|NCT01661140|19017008|P3|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
7723255|NCT01661140|19017009|P2|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
7723256|NCT01661140|19017010|P1|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0
7723257|NCT01661140|19017008|P3|NOT COMPLETED|Open-Label Period||0
7723258|NCT01661140|19017009|P2|NOT COMPLETED|Open-Label Period||0
7723259|NCT01661140|19017010|P1|NOT COMPLETED|Open-Label Period||76
7723260|NCT01661140|19017008|P3|COMPLETED|Open-Label Period||0
7723261|NCT01661140|19017009|P2|COMPLETED|Open-Label Period||0
7723262|NCT01661140|19017010|P1|COMPLETED|Open-Label Period||351
7723263|NCT01661140|19017008|P3|STARTED|Open-Label Period||0
7723264|NCT01661140|19017009|P2|STARTED|Open-Label Period||0
7723265|NCT01661140|19017010|P1|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427
7723266|NCT01661114|19017051|P1|NOT COMPLETED|Overall Study||0
7723267|NCT01661114|19017051|P1|COMPLETED|Overall Study||39
7723268|NCT01661114|19017051|P1|STARTED|Overall Study||39
7723269|NCT01661088|19017056|P1|NOT COMPLETED|IMRT With FDR Gemcitabine||2
7723270|NCT01661088|19017056|P1|COMPLETED|IMRT With FDR Gemcitabine||19
7723271|NCT01661088|19017056|P1|STARTED|IMRT With FDR Gemcitabine||21
7723272|NCT01661088|19017056|P1|NOT COMPLETED|FOLFIRINOX||4
7723273|NCT01661088|19017056|P1|COMPLETED|FOLFIRINOX||21
7723274|NCT01661088|19017056|P1|STARTED|FOLFIRINOX||25
7723275|NCT01661062|19017062|P1|NOT COMPLETED|Overall Study||5
7723276|NCT01661062|19017062|P1|COMPLETED|Overall Study||18
7723277|NCT01661062|19017062|P1|STARTED|Overall Study||23
7723278|NCT01660906|19017067|P1|NOT COMPLETED|Overall Study||3
7723279|NCT01660906|19017067|P1|COMPLETED|Overall Study||36
7723280|NCT01660906|19017067|P1|STARTED|Overall Study||39
7723281|NCT01660893|19017079|P3|NOT COMPLETED|Overall Study||0
7723282|NCT01660893|19017080|P2|NOT COMPLETED|Overall Study||0
7723283|NCT01660893|19017081|P1|NOT COMPLETED|Overall Study||0
7723284|NCT01660893|19017079|P3|COMPLETED|Overall Study||6
7723285|NCT01660893|19017080|P2|COMPLETED|Overall Study||10
7723286|NCT01660893|19017081|P1|COMPLETED|Overall Study||10
7723287|NCT01660893|19017079|P3|STARTED|Overall Study||6
7723288|NCT01660893|19017080|P2|STARTED|Overall Study||10
7723289|NCT01660893|19017081|P1|STARTED|Overall Study||10
7723290|NCT01660815|19017128|P1|NOT COMPLETED|Overall Study||0
7723291|NCT01660815|19017128|P1|COMPLETED|Overall Study||7
7723292|NCT01660815|19017128|P1|STARTED|Overall Study||7
7723293|NCT01660802|19017135|P2|NOT COMPLETED|Overall Study||11
7723294|NCT01660802|19017136|P1|NOT COMPLETED|Overall Study||4
7723295|NCT01660802|19017135|P2|COMPLETED|Overall Study||121
7723296|NCT01660802|19017136|P1|COMPLETED|Overall Study||126
7723297|NCT01660802|19017135|P2|STARTED|Overall Study||132
7723298|NCT01660802|19017136|P1|STARTED|Overall Study||130
7723299|NCT01660763|19017150|P2|NOT COMPLETED|Overall Study||61
7723300|NCT01660763|19017151|P1|NOT COMPLETED|Overall Study||100
7723301|NCT01660763|19017150|P2|COMPLETED|Overall Study||43
7723302|NCT01660763|19017151|P1|COMPLETED|Overall Study||215
7723303|NCT01660763|19017150|P2|STARTED|Overall Study||104
7723304|NCT01660763|19017151|P1|STARTED|Overall Study||315
7723305|NCT01660737|19017157|P1|NOT COMPLETED|Overall Study||0
7723306|NCT01660737|19017157|P1|COMPLETED|Overall Study||123
7723307|NCT01660737|19017157|P1|STARTED|Overall Study||123
7723308|NCT01660698|19017174|P2|NOT COMPLETED|Overall Study||0
7723309|NCT01660698|19017175|P1|NOT COMPLETED|Overall Study||0
7723310|NCT01660698|19017174|P2|COMPLETED|Overall Study||10
7723311|NCT01660698|19017175|P1|COMPLETED|Overall Study||10
7723312|NCT01660698|19017174|P2|STARTED|Overall Study||10
7723313|NCT01660698|19017175|P1|STARTED|Overall Study||10
7723314|NCT01660672|19017185|P1|NOT COMPLETED|Overall Study||0
7723315|NCT01660672|19017185|P1|COMPLETED|Overall Study||7
7723316|NCT01660672|19017185|P1|STARTED|Overall Study||7
7723317|NCT01660451|19017199|P3|NOT COMPLETED|Overall Study||105
7723318|NCT01660451|19017200|P2|NOT COMPLETED|Overall Study||17
7723319|NCT01660451|19017201|P1|NOT COMPLETED|Overall Study||17
7723320|NCT01660451|19017199|P3|COMPLETED|Overall Study||37
7723321|NCT01660451|19017200|P2|COMPLETED|Overall Study||34
7723322|NCT01660451|19017201|P1|COMPLETED|Overall Study||16
7723323|NCT01660451|19017199|P3|STARTED|Overall Study||142
7723324|NCT01660451|19017200|P2|STARTED|Overall Study||51
7723325|NCT01660451|19017201|P1|STARTED|Overall Study||33
7723326|NCT01660412|19017229|P2|NOT COMPLETED|Overall Study||3
7723327|NCT01660412|19017230|P1|NOT COMPLETED|Overall Study||0
7723328|NCT01660412|19017229|P2|COMPLETED|Overall Study||28
7723329|NCT01660412|19017230|P1|COMPLETED|Overall Study||29
7723330|NCT01660412|19017229|P2|Injection 4|Overall Study||31
7723331|NCT01660412|19017230|P1|Injection 4|Overall Study||29
7723332|NCT01660412|19017229|P2|Injection 3|Overall Study||31
7723333|NCT01660412|19017230|P1|Injection 3|Overall Study||29
7723334|NCT01660412|19017229|P2|Injection 2|Overall Study||31
7723335|NCT01660412|19017230|P1|Injection 2|Overall Study||29
7723336|NCT01660412|19017229|P2|Injection 1|Overall Study||31
7723337|NCT01660412|19017230|P1|Injection 1|Overall Study||29
7723338|NCT01660412|19017229|P2|Other|Overall Study||4
7723339|NCT01660412|19017230|P1|Other|Overall Study||2
7723340|NCT01660412|19017229|P2|Appendicular Structures|Overall Study||11
7723341|NCT01660412|19017230|P1|Appendicular Structures|Overall Study||17
7723342|NCT01660412|19017229|P2|Thorax|Overall Study||9
7723343|NCT01660412|19017230|P1|Thorax|Overall Study||9
7723344|NCT01660412|19017229|P2|Head|Overall Study||4
7723345|NCT01660412|19017230|P1|Head|Overall Study||1
7723346|NCT01660412|19017229|P2|STARTED|Overall Study||31
7723347|NCT01660412|19017230|P1|STARTED|Overall Study||29
7723348|NCT01660334|19017236|P1|NOT COMPLETED|Overall Study||1
7723349|NCT01660334|19017236|P1|COMPLETED|Overall Study||12
7723350|NCT01660334|19017236|P1|STARTED|Overall Study||13
7723351|NCT01660321|19017241|P1|NOT COMPLETED|Overall Study||0
7723352|NCT01660321|19017241|P1|COMPLETED|Overall Study||26
7723353|NCT01660321|19017241|P1|STARTED|Overall Study||26
7723354|NCT01660230|19017265|P12|NOT COMPLETED|Overall Study||0
7723355|NCT01660230|19017266|P11|NOT COMPLETED|Overall Study||0
7723356|NCT01660230|19017267|P10|NOT COMPLETED|Overall Study||0
7723357|NCT01660230|19017268|P9|NOT COMPLETED|Overall Study||0
7723358|NCT01660230|19017269|P8|NOT COMPLETED|Overall Study||0
7723359|NCT01660230|19017270|P7|NOT COMPLETED|Overall Study||0
7723360|NCT01660230|19017271|P6|NOT COMPLETED|Overall Study||0
7723361|NCT01660230|19017272|P5|NOT COMPLETED|Overall Study||0
7723362|NCT01660230|19017273|P4|NOT COMPLETED|Overall Study||0
7723363|NCT01660230|19017274|P3|NOT COMPLETED|Overall Study||0
7723364|NCT01660230|19017275|P2|NOT COMPLETED|Overall Study||0
7723365|NCT01660230|19017276|P1|NOT COMPLETED|Overall Study||0
7723366|NCT01660230|19017265|P12|COMPLETED|Overall Study||14
7723367|NCT01660230|19017266|P11|COMPLETED|Overall Study||6
7723368|NCT01660230|19017267|P10|COMPLETED|Overall Study||6
7723369|NCT01660230|19017268|P9|COMPLETED|Overall Study||6
7723370|NCT01660230|19017269|P8|COMPLETED|Overall Study||6
7723371|NCT01660230|19017270|P7|COMPLETED|Overall Study||4
7723372|NCT01660230|19017271|P6|COMPLETED|Overall Study||2
7723373|NCT01660230|19017272|P5|COMPLETED|Overall Study||4
7723374|NCT01660230|19017273|P4|COMPLETED|Overall Study||4
7723375|NCT01660230|19017274|P3|COMPLETED|Overall Study||4
7723376|NCT01660230|19017275|P2|COMPLETED|Overall Study||4
7723377|NCT01660230|19017276|P1|COMPLETED|Overall Study||4
7723378|NCT01660230|19017265|P12|STARTED|Overall Study||14
7723379|NCT01660230|19017266|P11|STARTED|Overall Study||6
7723380|NCT01660230|19017267|P10|STARTED|Overall Study||6
7723381|NCT01660230|19017268|P9|STARTED|Overall Study||6
7723382|NCT01660230|19017269|P8|STARTED|Overall Study||6
7723383|NCT01660230|19017270|P7|STARTED|Overall Study||4
7723384|NCT01660230|19017271|P6|STARTED|Overall Study||2
7723385|NCT01660230|19017272|P5|STARTED|Overall Study||4
7723386|NCT01660230|19017273|P4|STARTED|Overall Study||4
7723387|NCT01660230|19017274|P3|STARTED|Overall Study||4
7723388|NCT01660230|19017275|P2|STARTED|Overall Study||4
7723389|NCT01660230|19017276|P1|STARTED|Overall Study||4
7723390|NCT01660191|19017448|P3|NOT COMPLETED|End of Treatment||1
7723391|NCT01660191|19017449|P2|NOT COMPLETED|End of Treatment||6
7723392|NCT01660191|19017450|P1|NOT COMPLETED|End of Treatment||1
7723393|NCT01660191|19017448|P3|COMPLETED|End of Treatment||43
7723394|NCT01660191|19017449|P2|COMPLETED|End of Treatment||39
7723395|NCT01660191|19017450|P1|COMPLETED|End of Treatment||44
7723396|NCT01660191|19017448|P3|STARTED|End of Treatment||44
7723397|NCT01660191|19017449|P2|STARTED|End of Treatment||45
7723398|NCT01660191|19017450|P1|STARTED|End of Treatment||45
7723399|NCT01660191|19017448|P3|NOT COMPLETED|Randomization||0
7723400|NCT01660191|19017449|P2|NOT COMPLETED|Randomization||0
7723401|NCT01660191|19017450|P1|NOT COMPLETED|Randomization||0
7723402|NCT01660191|19017448|P3|COMPLETED|Randomization||44
7723403|NCT01660191|19017449|P2|COMPLETED|Randomization||45
7723404|NCT01660191|19017450|P1|COMPLETED|Randomization||45
7723405|NCT01660191|19017448|P3|STARTED|Randomization||44
7723406|NCT01660191|19017449|P2|STARTED|Randomization||45
7723407|NCT01660191|19017450|P1|STARTED|Randomization||45
7723408|NCT01660191|19017448|P3|NOT COMPLETED|Enrollment and Washout||0
7723409|NCT01660191|19017449|P2|NOT COMPLETED|Enrollment and Washout||0
7723410|NCT01660191|19017450|P1|NOT COMPLETED|Enrollment and Washout||0
7723411|NCT01660191|19017448|P3|COMPLETED|Enrollment and Washout||44
7723412|NCT01660191|19017449|P2|COMPLETED|Enrollment and Washout||45
7723413|NCT01660191|19017450|P1|COMPLETED|Enrollment and Washout||45
7723414|NCT01660191|19017448|P3|STARTED|Enrollment and Washout||44
7723415|NCT01660191|19017449|P2|STARTED|Enrollment and Washout||45
7723416|NCT01660191|19017450|P1|STARTED|Enrollment and Washout||45
7723417|NCT01660022|19017479|P6|NOT COMPLETED|Second Sequence (42 Days)||0
7723418|NCT01660022|19017480|P5|NOT COMPLETED|Second Sequence (42 Days)||0
7723419|NCT01660022|19017481|P4|NOT COMPLETED|Second Sequence (42 Days)||0
7723420|NCT01660022|19017482|P3|NOT COMPLETED|Second Sequence (42 Days)||0
7723421|NCT01660022|19017483|P2|NOT COMPLETED|Second Sequence (42 Days)||0
7723422|NCT01660022|19017484|P1|NOT COMPLETED|Second Sequence (42 Days)||0
7723423|NCT01660022|19017479|P6|COMPLETED|Second Sequence (42 Days)||16
7723424|NCT01660022|19017480|P5|COMPLETED|Second Sequence (42 Days)||6
7723425|NCT01660022|19017481|P4|COMPLETED|Second Sequence (42 Days)||7
7723426|NCT01660022|19017482|P3|COMPLETED|Second Sequence (42 Days)||8
7723427|NCT01660022|19017483|P2|COMPLETED|Second Sequence (42 Days)||7
7723428|NCT01660022|19017484|P1|COMPLETED|Second Sequence (42 Days)||8
7723429|NCT01660022|19017479|P6|STARTED|Second Sequence (42 Days)||16
7723430|NCT01660022|19017480|P5|STARTED|Second Sequence (42 Days)||6
7723431|NCT01660022|19017481|P4|STARTED|Second Sequence (42 Days)||7
7723432|NCT01660022|19017482|P3|STARTED|Second Sequence (42 Days)||8
7723433|NCT01660022|19017483|P2|STARTED|Second Sequence (42 Days)||7
7723434|NCT01660022|19017484|P1|STARTED|Second Sequence (42 Days)||8
7723435|NCT01660022|19017479|P6|NOT COMPLETED|First Sequence (7 Days)||4
7723436|NCT01660022|19017480|P5|NOT COMPLETED|First Sequence (7 Days)||1
7723437|NCT01660022|19017481|P4|NOT COMPLETED|First Sequence (7 Days)||1
7723438|NCT01660022|19017482|P3|NOT COMPLETED|First Sequence (7 Days)||0
7723439|NCT01660022|19017483|P2|NOT COMPLETED|First Sequence (7 Days)||1
7723440|NCT01660022|19017484|P1|NOT COMPLETED|First Sequence (7 Days)||0
7723441|NCT01660022|19017479|P6|COMPLETED|First Sequence (7 Days)||16
7723442|NCT01660022|19017480|P5|COMPLETED|First Sequence (7 Days)||6
7723443|NCT01660022|19017481|P4|COMPLETED|First Sequence (7 Days)||7
7723444|NCT01660022|19017482|P3|COMPLETED|First Sequence (7 Days)||8
7723445|NCT01660022|19017483|P2|COMPLETED|First Sequence (7 Days)||7
7723446|NCT01660022|19017484|P1|COMPLETED|First Sequence (7 Days)||8
7723447|NCT01660022|19017479|P6|STARTED|First Sequence (7 Days)||20
7723448|NCT01660022|19017480|P5|STARTED|First Sequence (7 Days)||7
7723449|NCT01660022|19017481|P4|STARTED|First Sequence (7 Days)||8
7723450|NCT01660022|19017482|P3|STARTED|First Sequence (7 Days)||8
7723451|NCT01660022|19017483|P2|STARTED|First Sequence (7 Days)||8
7723452|NCT01660022|19017484|P1|STARTED|First Sequence (7 Days)||8
7723453|NCT01659996|19017543|P3|NOT COMPLETED|Overall Study||11
7723454|NCT01659996|19017544|P2|NOT COMPLETED|Overall Study||7
7723455|NCT01659996|19017545|P1|NOT COMPLETED|Overall Study||8
7723456|NCT01659996|19017543|P3|COMPLETED|Overall Study||461
7723457|NCT01659996|19017544|P2|COMPLETED|Overall Study||388
7723458|NCT01659996|19017545|P1|COMPLETED|Overall Study||413
7723459|NCT01659996|19017543|P3|STARTED|Overall Study||472
7723460|NCT01659996|19017544|P2|STARTED|Overall Study||395
7723461|NCT01659996|19017545|P1|STARTED|Overall Study||421
7723462|NCT01659866|19017579|P2|NOT COMPLETED|Overall Study||0
7723463|NCT01659866|19017580|P1|NOT COMPLETED|Overall Study||0
7723464|NCT01659866|19017579|P2|COMPLETED|Overall Study||80
7723465|NCT01659866|19017580|P1|COMPLETED|Overall Study||430
7723466|NCT01659866|19017579|P2|STARTED|Overall Study||80
7723467|NCT01659866|19017580|P1|STARTED|Overall Study||430
7723468|NCT01659853|19017586|P2|NOT COMPLETED|Treatment Period 2||0
7723469|NCT01659853|19017587|P1|NOT COMPLETED|Treatment Period 2||0
7723470|NCT01659853|19017586|P2|COMPLETED|Treatment Period 2||35
7723471|NCT01659853|19017587|P1|COMPLETED|Treatment Period 2||33
7723472|NCT01659853|19017586|P2|STARTED|Treatment Period 2||35
7723473|NCT01659853|19017587|P1|STARTED|Treatment Period 2||33
7723474|NCT01659853|19017586|P2|NOT COMPLETED|Washout , 3 to 7 Days||0
7723475|NCT01659853|19017587|P1|NOT COMPLETED|Washout , 3 to 7 Days||2
7723476|NCT01659853|19017586|P2|COMPLETED|Washout , 3 to 7 Days||35
7723477|NCT01659853|19017587|P1|COMPLETED|Washout , 3 to 7 Days||33
7723478|NCT01659853|19017586|P2|STARTED|Washout , 3 to 7 Days||35
7723479|NCT01659853|19017587|P1|STARTED|Washout , 3 to 7 Days||35
7723480|NCT01659853|19017586|P2|NOT COMPLETED|Treatment Period 1||0
7723481|NCT01659853|19017587|P1|NOT COMPLETED|Treatment Period 1||0
7723482|NCT01659853|19017586|P2|COMPLETED|Treatment Period 1||35
7723483|NCT01659853|19017587|P1|COMPLETED|Treatment Period 1||35
7723484|NCT01659853|19017586|P2|STARTED|Treatment Period 1||35
7723485|NCT01659853|19017587|P1|STARTED|Treatment Period 1||35
7723486|NCT01659736|19017597|P2|NOT COMPLETED|3-month Follow-up||1
7723487|NCT01659736|19017598|P1|NOT COMPLETED|3-month Follow-up||0
7723488|NCT01659736|19017597|P2|COMPLETED|3-month Follow-up||9
7723489|NCT01659736|19017598|P1|COMPLETED|3-month Follow-up||9
7723490|NCT01659736|19017597|P2|STARTED|3-month Follow-up||10
7723491|NCT01659736|19017598|P1|STARTED|3-month Follow-up||9
7723492|NCT01659736|19017597|P2|NOT COMPLETED|Treatment Period||2
7723493|NCT01659736|19017598|P1|NOT COMPLETED|Treatment Period||5
7723494|NCT01659736|19017597|P2|COMPLETED|Treatment Period||10
7723495|NCT01659736|19017598|P1|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9
7723496|NCT01659736|19017597|P2|STARTED|Treatment Period||12
7723497|NCT01659736|19017598|P1|STARTED|Treatment Period||14
7723498|NCT01659567|19017612|P1|NOT COMPLETED|Overall Study||123
7723499|NCT01659567|19017612|P1|COMPLETED|Overall Study||393
7723500|NCT01659567|19017612|P1|STARTED|Overall Study||516
7723501|NCT01659554|19017629|P1|NOT COMPLETED|Overall Study||4
7723502|NCT01659554|19017629|P1|COMPLETED|Overall Study||0
7723503|NCT01659554|19017629|P1|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4
7723504|NCT01659320|19017636|P1|NOT COMPLETED|Overall Study||3
7723505|NCT01659320|19017636|P1|COMPLETED|Overall Study||13
7723506|NCT01659320|19017636|P1|STARTED|Overall Study||16
7723507|NCT01659268|19017642|P2|NOT COMPLETED|Overall Study||0
7723508|NCT01659268|19017643|P1|NOT COMPLETED|Overall Study||0
7723509|NCT01659268|19017642|P2|COMPLETED|Overall Study||8
7723510|NCT01659268|19017643|P1|COMPLETED|Overall Study||9
7723511|NCT01659268|19017642|P2|STARTED|Overall Study||8
7723512|NCT01659268|19017643|P1|STARTED|Overall Study||9
7723513|NCT01659125|19017655|P1|NOT COMPLETED|Overall Study||14
7723514|NCT01659125|19017655|P1|COMPLETED|Overall Study||12
7723515|NCT01659125|19017655|P1|Completed 6-month Follow-up|Overall Study||12
7723516|NCT01659125|19017655|P1|Completed 3-month Follow-up|Overall Study||16
7723517|NCT01659125|19017655|P1|Completed the Posttreatment Assessment|Overall Study||17
7723518|NCT01659125|19017655|P1|Initiated Treatment|Overall Study||24
7723519|NCT01659125|19017655|P1|STARTED|Overall Study||26
7723520|NCT01659021|19017662|P2|NOT COMPLETED|Long-Term Follow Up||4
7723521|NCT01659021|19017663|P1|NOT COMPLETED|Long-Term Follow Up||5
7723522|NCT01659021|19017662|P2|COMPLETED|Long-Term Follow Up||65
7723523|NCT01659021|19017663|P1|COMPLETED|Long-Term Follow Up||133
7723524|NCT01659021|19017662|P2|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|69
7723525|NCT01659021|19017663|P1|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|138
7723526|NCT01659021|19017662|P2|NOT COMPLETED|Main Study||37
7723527|NCT01659021|19017663|P1|NOT COMPLETED|Main Study||74
7723528|NCT01659021|19017662|P2|COMPLETED|Main Study||50
7723529|NCT01659021|19017663|P1|COMPLETED|Main Study||100
7723530|NCT01659021|19017662|P2|Randomized and Treated|Main Study||86
7723531|NCT01659021|19017663|P1|Randomized and Treated|Main Study||173
7723532|NCT01659021|19017662|P2|STARTED|Main Study||87
7723533|NCT01659021|19017663|P1|STARTED|Main Study||174
7723534|NCT01658943|19017681|P2|NOT COMPLETED|Overall Study||67
7723535|NCT01658943|19017682|P1|NOT COMPLETED|Overall Study||70
7723536|NCT01658943|19017681|P2|COMPLETED|Overall Study||0
7723537|NCT01658943|19017682|P1|COMPLETED|Overall Study||0
7723538|NCT01658943|19017681|P2|Eligible and Began Protocol Therapy|Overall Study||58
7723539|NCT01658943|19017682|P1|Eligible and Began Protocol Therapy|Overall Study||62
7723540|NCT01658943|19017681|P2|Eligible|Overall Study||58
7723541|NCT01658943|19017682|P1|Eligible|Overall Study||63
7723542|NCT01658943|19017681|P2|STARTED|Overall Study||67
7723543|NCT01658943|19017682|P1|STARTED|Overall Study||70
7723544|NCT01658904|19017697|P3|NOT COMPLETED|Overall Study||0
7723545|NCT01658904|19017698|P2|NOT COMPLETED|Overall Study||0
7723546|NCT01658904|19017699|P1|NOT COMPLETED|Overall Study||2
7723547|NCT01658904|19017697|P3|COMPLETED|Overall Study||0
7723548|NCT01658904|19017698|P2|COMPLETED|Overall Study||0
7723549|NCT01658904|19017699|P1|COMPLETED|Overall Study||1
7723550|NCT01658904|19017697|P3|STARTED|Overall Study||0
7723551|NCT01658904|19017698|P2|STARTED|Overall Study||0
7723552|NCT01658904|19017699|P1|STARTED|Overall Study||3
7723553|NCT01658839|19017716|P1|NOT COMPLETED|Overall Study||0
7723554|NCT01658839|19017716|P1|COMPLETED|Overall Study||25
7723555|NCT01658839|19017716|P1|STARTED|Overall Study||25
7723556|NCT01658813|19017725|P1|NOT COMPLETED|Overall Study||3
7723557|NCT01658813|19017725|P1|COMPLETED|Overall Study||15
7723558|NCT01658813|19017725|P1|Treated|Overall Study||18
7723559|NCT01658813|19017725|P1|Eligible|Overall Study||18
7723560|NCT01658813|19017725|P1|STARTED|Overall Study||18
7723561|NCT01658735|19017736|P3|NOT COMPLETED|Overall Study||4
7723562|NCT01658735|19017737|P2|NOT COMPLETED|Overall Study||7
7723563|NCT01658735|19017738|P1|NOT COMPLETED|Overall Study||5
7723564|NCT01658735|19017736|P3|COMPLETED|Overall Study||34
7723565|NCT01658735|19017737|P2|COMPLETED|Overall Study||29
7723566|NCT01658735|19017738|P1|COMPLETED|Overall Study||34
7723567|NCT01658735|19017736|P3|STARTED|Overall Study||38
7723568|NCT01658735|19017737|P2|STARTED|Overall Study||36
7723569|NCT01658735|19017738|P1|STARTED|Overall Study||39
7723570|NCT01658657|19017769|P2|NOT COMPLETED|Overall Study||3
7723571|NCT01658657|19017770|P1|NOT COMPLETED|Overall Study||3
7723572|NCT01658657|19017769|P2|COMPLETED|Overall Study||7
7723573|NCT01658657|19017770|P1|COMPLETED|Overall Study||4
7723574|NCT01658657|19017769|P2|STARTED|Overall Study||10
7723575|NCT01658657|19017770|P1|STARTED|Overall Study||7
7723576|NCT01658579|19017780|P4|NOT COMPLETED|Treatment Period B||1
7723577|NCT01658579|19017781|P3|NOT COMPLETED|Treatment Period B||0
7723578|NCT01658579|19017782|P2|NOT COMPLETED|Treatment Period B||0
7723579|NCT01658579|19017783|P1|NOT COMPLETED|Treatment Period B||0
7723580|NCT01658579|19017780|P4|COMPLETED|Treatment Period B||12
7723581|NCT01658579|19017781|P3|COMPLETED|Treatment Period B||14
7723582|NCT01658579|19017782|P2|COMPLETED|Treatment Period B||15
7723583|NCT01658579|19017783|P1|COMPLETED|Treatment Period B||14
7723584|NCT01658579|19017780|P4|STARTED|Treatment Period B||13
7723585|NCT01658579|19017781|P3|STARTED|Treatment Period B||14
7723586|NCT01658579|19017782|P2|STARTED|Treatment Period B||15
7723587|NCT01658579|19017783|P1|STARTED|Treatment Period B||14
7723588|NCT01658579|19017780|P4|NOT COMPLETED|Treatment Period A||1
7723589|NCT01658579|19017781|P3|NOT COMPLETED|Treatment Period A||1
7723590|NCT01658579|19017782|P2|NOT COMPLETED|Treatment Period A||0
7723591|NCT01658579|19017783|P1|NOT COMPLETED|Treatment Period A||1
7723592|NCT01658579|19017780|P4|COMPLETED|Treatment Period A||13
7723593|NCT01658579|19017781|P3|COMPLETED|Treatment Period A||14
7723594|NCT01658579|19017782|P2|COMPLETED|Treatment Period A||15
7723595|NCT01658579|19017783|P1|COMPLETED|Treatment Period A||14
7723596|NCT01658579|19017780|P4|STARTED|Treatment Period A||14
7723597|NCT01658579|19017781|P3|STARTED|Treatment Period A||15
7723598|NCT01658579|19017782|P2|STARTED|Treatment Period A||15
7723599|NCT01658579|19017783|P1|STARTED|Treatment Period A||15
7723600|NCT01658514|19017811|P3|NOT COMPLETED|Overall Study||2
7723601|NCT01658514|19017812|P2|NOT COMPLETED|Overall Study||0
7723602|NCT01658514|19017813|P1|NOT COMPLETED|Overall Study||1
7723603|NCT01658514|19017811|P3|COMPLETED|Overall Study||12
7723604|NCT01658514|19017812|P2|COMPLETED|Overall Study||11
7723605|NCT01658514|19017813|P1|COMPLETED|Overall Study||13
7723606|NCT01658514|19017811|P3|Completed - Severe RI Cohort Only|Overall Study||3
7723607|NCT01658514|19017812|P2|Completed - Severe RI Cohort Only|Overall Study||2
7723608|NCT01658514|19017813|P1|Completed - Severe RI Cohort Only|Overall Study||3
7723609|NCT01658514|19017811|P3|Started - Severe RI Cohort Only|Overall Study||3
7723610|NCT01658514|19017812|P2|Started - Severe RI Cohort Only|Overall Study||2
7723611|NCT01658514|19017813|P1|Started - Severe RI Cohort Only|Overall Study||3
7723612|NCT01658514|19017811|P3|Completed - Moderate RI Cohort Only|Overall Study||2
7723613|NCT01658514|19017812|P2|Completed - Moderate RI Cohort Only|Overall Study||4
7723614|NCT01658514|19017813|P1|Completed - Moderate RI Cohort Only|Overall Study||3
7723615|NCT01658514|19017811|P3|Started - Moderate RI Cohort Only|Overall Study||4
7723616|NCT01658514|19017812|P2|Started - Moderate RI Cohort Only|Overall Study||4
7723617|NCT01658514|19017813|P1|Started - Moderate RI Cohort Only|Overall Study||4
7723618|NCT01658514|19017811|P3|Completed - Mild RI Cohort Only|Overall Study||4
7723619|NCT01658514|19017812|P2|Completed - Mild RI Cohort Only|Overall Study||3
7723620|NCT01658514|19017813|P1|Completed - Mild RI Cohort Only|Overall Study||4
7723621|NCT01658514|19017811|P3|Started - Mild RI Cohort Only|Overall Study||4
7723622|NCT01658514|19017812|P2|Started - Mild RI Cohort Only|Overall Study||3
7723623|NCT01658514|19017813|P1|Started - Mild RI Cohort Only|Overall Study||4
7723624|NCT01658514|19017811|P3|Completed - Normal RF Cohort Only|Overall Study||3
7723625|NCT01658514|19017812|P2|Completed - Normal RF Cohort Only|Overall Study||2
7723626|NCT01658514|19017813|P1|Completed - Normal RF Cohort Only|Overall Study||3
7723627|NCT01658514|19017811|P3|Started - Normal RF Cohort Only|Overall Study||3
7723628|NCT01658514|19017812|P2|Started - Normal RF Cohort Only|Overall Study||2
7723629|NCT01658514|19017813|P1|Started - Normal RF Cohort Only|Overall Study||3
7723630|NCT01658514|19017811|P3|Completed Treatment C|Overall Study||12
7723631|NCT01658514|19017812|P2|Completed Treatment C|Overall Study||11
7723632|NCT01658514|19017813|P1|Completed Treatment C|Overall Study||13
7723633|NCT01658514|19017811|P3|Completed Treatment B|Overall Study||14
7723634|NCT01658514|19017812|P2|Completed Treatment B|Overall Study||11
7723635|NCT01658514|19017813|P1|Completed Treatment B|Overall Study||13
7723636|NCT01658514|19017811|P3|Completed Treatment A|Overall Study||12
7723637|NCT01658514|19017812|P2|Completed Treatment A|Overall Study||11
7723638|NCT01658514|19017813|P1|Completed Treatment A|Overall Study||14
7723639|NCT01658514|19017811|P3|STARTED|Overall Study||14
7723640|NCT01658514|19017812|P2|STARTED|Overall Study||11
7723641|NCT01658514|19017813|P1|STARTED|Overall Study||14
7723642|NCT01658436|19017824|P2|NOT COMPLETED|Overall Study||11
7723643|NCT01658436|19017825|P1|NOT COMPLETED|Overall Study||20
7723644|NCT01658436|19017824|P2|COMPLETED|Overall Study||0
7723645|NCT01658436|19017825|P1|COMPLETED|Overall Study||0
7723646|NCT01658436|19017824|P2|STARTED|Overall Study||11
7723647|NCT01658436|19017825|P1|STARTED|Overall Study||20
7723648|NCT01658228|19017834|P2|NOT COMPLETED|Overall Study||8
7723649|NCT01658228|19017835|P1|NOT COMPLETED|Overall Study||7
7723650|NCT01658228|19017834|P2|COMPLETED|Overall Study||23
7723651|NCT01658228|19017835|P1|COMPLETED|Overall Study||23
7723652|NCT01658228|19017834|P2|STARTED|Overall Study||31
7723653|NCT01658228|19017835|P1|STARTED|Overall Study||30
7723654|NCT01658150|19017845|P1|NOT COMPLETED|Overall Study||1
7723655|NCT01658150|19017845|P1|COMPLETED|Overall Study||10
7723656|NCT01658150|19017845|P1|STARTED|Overall Study||11
7723657|NCT01658072|19017867|P2|NOT COMPLETED|Overall Study||2
7723658|NCT01658072|19017868|P1|NOT COMPLETED|Overall Study||4
7723659|NCT01658072|19017867|P2|COMPLETED|Overall Study||43
7723660|NCT01658072|19017868|P1|COMPLETED|Overall Study||41
7723661|NCT01658072|19017867|P2|STARTED|Overall Study||45
7723662|NCT01658072|19017868|P1|STARTED|Overall Study||45
7723663|NCT01658059|19017874|P2|NOT COMPLETED|Second Intervention- 2 Days||0
7723664|NCT01658059|19017875|P1|NOT COMPLETED|Second Intervention- 2 Days||0
7723665|NCT01658059|19017874|P2|COMPLETED|Second Intervention- 2 Days||5
7723666|NCT01658059|19017875|P1|COMPLETED|Second Intervention- 2 Days||6
7723667|NCT01658059|19017874|P2|STARTED|Second Intervention- 2 Days||5
7723668|NCT01658059|19017875|P1|STARTED|Second Intervention- 2 Days||6
7723669|NCT01658059|19017874|P2|NOT COMPLETED|Washout Period- 14 Days||0
7723670|NCT01658059|19017875|P1|NOT COMPLETED|Washout Period- 14 Days||0
7723671|NCT01658059|19017874|P2|COMPLETED|Washout Period- 14 Days||5
7723672|NCT01658059|19017875|P1|COMPLETED|Washout Period- 14 Days||6
7723673|NCT01658059|19017874|P2|STARTED|Washout Period- 14 Days||5
7723674|NCT01658059|19017875|P1|STARTED|Washout Period- 14 Days||6
7723675|NCT01658059|19017874|P2|NOT COMPLETED|First Intervention- 2 Days||5
7723676|NCT01658059|19017875|P1|NOT COMPLETED|First Intervention- 2 Days||6
7723677|NCT01658059|19017874|P2|COMPLETED|First Intervention- 2 Days||5
7723678|NCT01658059|19017875|P1|COMPLETED|First Intervention- 2 Days||6
7723679|NCT01658059|19017874|P2|STARTED|First Intervention- 2 Days||10
7723680|NCT01658059|19017875|P1|STARTED|First Intervention- 2 Days||12
7723681|NCT01658020|19017883|P2|NOT COMPLETED|Overall Study||9
7723682|NCT01658020|19017884|P1|NOT COMPLETED|Overall Study||8
7723683|NCT01658020|19017883|P2|COMPLETED|Overall Study||158
7723684|NCT01658020|19017884|P1|COMPLETED|Overall Study||167
7723685|NCT01658020|19017883|P2|STARTED|Overall Study||167
7723686|NCT01658020|19017884|P1|STARTED|Overall Study||175
7723687|NCT01657903|19017900|P1|NOT COMPLETED|Overall Study||2
7723688|NCT01657903|19017900|P1|COMPLETED|Overall Study||54
7723689|NCT01657903|19017900|P1|Received NaF/KNO3 Toothpaste 2|Overall Study||55
7723690|NCT01657903|19017900|P1|Received NaF/KNO3 Toothpaste 3|Overall Study||54
7723691|NCT01657903|19017900|P1|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55
7723692|NCT01657903|19017900|P1|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56
7723693|NCT01657903|19017900|P1|STARTED|Overall Study||56
7723694|NCT01657877|19017922|P1|NOT COMPLETED|Overall Study||14
7723695|NCT01657877|19017922|P1|COMPLETED|Overall Study||65
7723696|NCT01657877|19017922|P1|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71
7723697|NCT01657877|19017922|P1|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69
7723698|NCT01657877|19017922|P1|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71
7723699|NCT01657877|19017922|P1|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75
7723700|NCT01657877|19017922|P1|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70
7723701|NCT01657877|19017922|P1|STARTED|Overall Study||79
7723702|NCT01657799|19017942|P3|NOT COMPLETED|Overall Study||102
7723703|NCT01657799|19017943|P2|NOT COMPLETED|Overall Study||103
7723704|NCT01657799|19017944|P1|NOT COMPLETED|Overall Study||102
7723705|NCT01657799|19017942|P3|COMPLETED|Overall Study||0
7723706|NCT01657799|19017943|P2|COMPLETED|Overall Study||0
7723707|NCT01657799|19017944|P1|COMPLETED|Overall Study||0
7723708|NCT01657799|19017942|P3|Received Treatment|Overall Study||102
7723709|NCT01657799|19017943|P2|Received Treatment|Overall Study||103
7723710|NCT01657799|19017944|P1|Received Treatment|Overall Study||101
7723711|NCT01657799|19017942|P3|STARTED|Overall Study||102
7723712|NCT01657799|19017943|P2|STARTED|Overall Study||103
7723713|NCT01657799|19017944|P1|STARTED|Overall Study||102
7723714|NCT01657760|19017963|P4|NOT COMPLETED|Overall Study||3
7723715|NCT01657760|19017964|P3|NOT COMPLETED|Overall Study||1
7723716|NCT01657760|19017965|P2|NOT COMPLETED|Overall Study||1
7723717|NCT01657760|19017966|P1|NOT COMPLETED|Overall Study||1
7723718|NCT01657760|19017963|P4|COMPLETED|Overall Study||4
7723719|NCT01657760|19017964|P3|COMPLETED|Overall Study||6
7723720|NCT01657760|19017965|P2|COMPLETED|Overall Study||6
7723721|NCT01657760|19017966|P1|COMPLETED|Overall Study||4
7723722|NCT01657760|19017963|P4|STARTED|Overall Study||7
7723723|NCT01657760|19017964|P3|STARTED|Overall Study||7
7723724|NCT01657760|19017965|P2|STARTED|Overall Study||7
7723725|NCT01657760|19017966|P1|STARTED|Overall Study||5
7723726|NCT01657617|19017978|P1|NOT COMPLETED|Overall Study||0
7723727|NCT01657617|19017978|P1|COMPLETED|Overall Study||35
7723728|NCT01657617|19017978|P1|STARTED|Overall Study||35
7723729|NCT01657461|19017985|P2|NOT COMPLETED|Overall Study||20
7723730|NCT01657461|19017986|P1|NOT COMPLETED|Overall Study||10
7723731|NCT01657461|19017985|P2|COMPLETED|Overall Study||78
7723732|NCT01657461|19017986|P1|COMPLETED|Overall Study||88
7723733|NCT01657461|19017985|P2|STARTED|Overall Study||98
7723734|NCT01657461|19017986|P1|STARTED|Overall Study||98
7723735|NCT01657370|19018016|P6|NOT COMPLETED|Overall Study||4
7723736|NCT01657370|19018017|P5|NOT COMPLETED|Overall Study||7
7723737|NCT01657370|19018018|P4|NOT COMPLETED|Overall Study||5
7723738|NCT01657370|19018019|P3|NOT COMPLETED|Overall Study||7
7723739|NCT01657370|19018020|P2|NOT COMPLETED|Overall Study||4
7723740|NCT01657370|19018021|P1|NOT COMPLETED|Overall Study||6
7723741|NCT01657370|19018016|P6|COMPLETED|Overall Study||27
7723742|NCT01657370|19018017|P5|COMPLETED|Overall Study||27
7723743|NCT01657370|19018018|P4|COMPLETED|Overall Study||28
7723744|NCT01657370|19018019|P3|COMPLETED|Overall Study||25
7723745|NCT01657370|19018020|P2|COMPLETED|Overall Study||28
7723746|NCT01657370|19018021|P1|COMPLETED|Overall Study||27
7723747|NCT01657370|19018016|P6|STARTED|Overall Study||31
7723748|NCT01657370|19018017|P5|STARTED|Overall Study||34
7723749|NCT01657370|19018018|P4|STARTED|Overall Study||33
7723750|NCT01657370|19018019|P3|STARTED|Overall Study||32
7723751|NCT01657370|19018020|P2|STARTED|Overall Study||32
7723752|NCT01657370|19018021|P1|STARTED|Overall Study||33
7723753|NCT01657344|19018103|P7|NOT COMPLETED|Overall Study||0
7723754|NCT01657344|19018104|P6|NOT COMPLETED|Overall Study||0
7723755|NCT01657344|19018105|P5|NOT COMPLETED|Overall Study||0
7723756|NCT01657344|19018106|P4|NOT COMPLETED|Overall Study||0
7723757|NCT01657344|19018107|P3|NOT COMPLETED|Overall Study||0
7723758|NCT01657344|19018108|P2|NOT COMPLETED|Overall Study||0
7723759|NCT01657344|19018109|P1|NOT COMPLETED|Overall Study||0
7723760|NCT01657344|19018103|P7|COMPLETED|Overall Study||140776
7723761|NCT01657344|19018104|P6|COMPLETED|Overall Study||316477
7723762|NCT01657344|19018105|P5|COMPLETED|Overall Study||157802
7723763|NCT01657344|19018106|P4|COMPLETED|Overall Study||376517
7723764|NCT01657344|19018107|P3|COMPLETED|Overall Study||196300
7723765|NCT01657344|19018108|P2|COMPLETED|Overall Study||409967
7723766|NCT01657344|19018109|P1|COMPLETED|Overall Study||421622
7723767|NCT01657344|19018103|P7|STARTED|Overall Study||140776
7723768|NCT01657344|19018104|P6|STARTED|Overall Study||316477
7723769|NCT01657344|19018105|P5|STARTED|Overall Study||157802
7723770|NCT01657344|19018106|P4|STARTED|Overall Study||376517
7723771|NCT01657344|19018107|P3|STARTED|Overall Study||196300
7723772|NCT01657344|19018108|P2|STARTED|Overall Study||409967
7723773|NCT01657344|19018109|P1|STARTED|Overall Study||421622
7723774|NCT01657305|19018119|P1|NOT COMPLETED|Overall Study||25
7723775|NCT01657305|19018119|P1|COMPLETED|Overall Study||82
7723776|NCT01657305|19018119|P1|STARTED|Overall Study||107
7723777|NCT01657292|19018169|P1|NOT COMPLETED|Overall Study||10
7723778|NCT01657292|19018169|P1|COMPLETED|Overall Study||51
7723779|NCT01657292|19018169|P1|STARTED|Overall Study||61
7723780|NCT01657266|19018178|P2|NOT COMPLETED|Overall Study||5
7723781|NCT01657266|19018179|P1|NOT COMPLETED|Overall Study||4
7723782|NCT01657266|19018178|P2|COMPLETED|Overall Study||70
7723783|NCT01657266|19018179|P1|COMPLETED|Overall Study||69
7723784|NCT01657266|19018178|P2|STARTED|Overall Study||75
7723785|NCT01657266|19018179|P1|STARTED|Overall Study||73
7723786|NCT01657253|19018201|P2|NOT COMPLETED|Overall Study||18
7723787|NCT01657253|19018202|P1|NOT COMPLETED|Overall Study||17
7723788|NCT01657253|19018201|P2|COMPLETED|Overall Study||72
7723789|NCT01657253|19018202|P1|COMPLETED|Overall Study||76
7723790|NCT01657253|19018201|P2|STARTED|Overall Study||90
7723791|NCT01657253|19018202|P1|STARTED|Overall Study||93
7723792|NCT01657162|19018214|P2|NOT COMPLETED|Overall Study||75
7723793|NCT01657162|19018215|P1|NOT COMPLETED|Overall Study||59
7723794|NCT01657162|19018214|P2|COMPLETED|Overall Study||506
7723795|NCT01657162|19018215|P1|COMPLETED|Overall Study||499
7723796|NCT01657162|19018214|P2|Study 005 mITT Population|Overall Study||568
7723797|NCT01657162|19018215|P1|Study 005 mITT Population|Overall Study||544
7723798|NCT01657162|19018214|P2|Study 005 Safety Population|Overall Study||580
7723799|NCT01657162|19018215|P1|Study 005 Safety Population|Overall Study||553
7723800|NCT01657162|19018214|P2|Study 005 ITT Population|Overall Study||581
7723801|NCT01657162|19018215|P1|Study 005 ITT Population|Overall Study||558
7723802|NCT01657162|19018214|P2|Completed Study 003|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|637
7723803|NCT01657162|19018215|P1|Completed Study 003|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|606
7723804|NCT01657162|19018214|P2|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|711
7723805|NCT01657162|19018215|P1|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|690
7723806|NCT01657162|19018214|P2|Study 003 ITT Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|821
7723807|NCT01657162|19018215|P1|Study 003 ITT Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|824
7723808|NCT01657162|19018214|P2|STARTED|Overall Study||581
7723809|NCT01657162|19018215|P1|STARTED|Overall Study||558
7723810|NCT01657032|19018243|P2|NOT COMPLETED|Overall Study||7
7723811|NCT01657032|19018244|P1|NOT COMPLETED|Overall Study||0
7723812|NCT01657032|19018243|P2|COMPLETED|Overall Study||37
7723813|NCT01657032|19018244|P1|COMPLETED|Overall Study||44
7723814|NCT01657032|19018243|P2|STARTED|Overall Study||44
7723815|NCT01657032|19018244|P1|STARTED|Overall Study||44
7723816|NCT01657019|19018270|P1|NOT COMPLETED|Overall Study||235
7723817|NCT01657019|19018270|P1|COMPLETED|Overall Study||369
7723818|NCT01657019|19018270|P1|STARTED|Overall Study||604
7723819|NCT01656967|19018284|P2|NOT COMPLETED|Overall Study||2
7723820|NCT01656967|19018285|P1|NOT COMPLETED|Overall Study||4
7723821|NCT01656967|19018284|P2|COMPLETED|Overall Study||31
7723822|NCT01656967|19018285|P1|COMPLETED|Overall Study||29
7723823|NCT01656967|19018284|P2|ETT Insertion|Overall Study||31
7723824|NCT01656967|19018285|P1|ETT Insertion|Overall Study||29
7723825|NCT01656967|19018284|P2|SGA Placement|Overall Study||33
7723826|NCT01656967|19018285|P1|SGA Placement|Overall Study||32
7723827|NCT01656967|19018284|P2|STARTED|Overall Study||33
7723828|NCT01656967|19018285|P1|STARTED|Overall Study||33
7723829|NCT01656889|19018311|P2|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9
7723830|NCT01656889|19018312|P1|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4
7723831|NCT01656889|19018311|P2|COMPLETED|Post Treatment Follow-Up, 3 Months||204
7723832|NCT01656889|19018312|P1|COMPLETED|Post Treatment Follow-Up, 3 Months||206
7723833|NCT01656889|19018311|P2|STARTED|Post Treatment Follow-Up, 3 Months||213
7723834|NCT01656889|19018312|P1|STARTED|Post Treatment Follow-Up, 3 Months||210
7723835|NCT01656889|19018311|P2|NOT COMPLETED|Treatment Period, 12 Weeks||11
7723836|NCT01656889|19018312|P1|NOT COMPLETED|Treatment Period, 12 Weeks||12
7723837|NCT01656889|19018311|P2|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214
7723838|NCT01656889|19018312|P1|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210
7723839|NCT01656889|19018311|P2|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225
7723840|NCT01656889|19018312|P1|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222
7723841|NCT01656850|19018332|P2|NOT COMPLETED|Second Intervention (3 Months)||0
7723842|NCT01656850|19018333|P1|NOT COMPLETED|Second Intervention (3 Months)||0
7723843|NCT01656850|19018332|P2|COMPLETED|Second Intervention (3 Months)||16
7723844|NCT01656850|19018333|P1|COMPLETED|Second Intervention (3 Months)||17
7723845|NCT01656850|19018332|P2|STARTED|Second Intervention (3 Months)||16
7723846|NCT01656850|19018333|P1|STARTED|Second Intervention (3 Months)||17
7723847|NCT01656850|19018332|P2|NOT COMPLETED|Washout (2 Weeks)||0
7723848|NCT01656850|19018333|P1|NOT COMPLETED|Washout (2 Weeks)||0
7723849|NCT01656850|19018332|P2|COMPLETED|Washout (2 Weeks)||16
7723850|NCT01656850|19018333|P1|COMPLETED|Washout (2 Weeks)||17
7723851|NCT01656850|19018332|P2|STARTED|Washout (2 Weeks)||16
7723852|NCT01656850|19018333|P1|STARTED|Washout (2 Weeks)||17
7723853|NCT01656850|19018332|P2|NOT COMPLETED|First Intervention (3 Months)||4
7723854|NCT01656850|19018333|P1|NOT COMPLETED|First Intervention (3 Months)||3
7723855|NCT01656850|19018332|P2|COMPLETED|First Intervention (3 Months)||16
7723856|NCT01656850|19018333|P1|COMPLETED|First Intervention (3 Months)||17
7723857|NCT01656850|19018332|P2|STARTED|First Intervention (3 Months)||20
7723858|NCT01656850|19018333|P1|STARTED|First Intervention (3 Months)||20
7723859|NCT01656772|19018413|P2|NOT COMPLETED|Overall Study||0
7723860|NCT01656772|19018414|P1|NOT COMPLETED|Overall Study||0
7723861|NCT01656772|19018413|P2|COMPLETED|Overall Study||77
7723862|NCT01656772|19018414|P1|COMPLETED|Overall Study||43
7723863|NCT01656772|19018413|P2|STARTED|Overall Study||77
7723864|NCT01656772|19018414|P1|STARTED|Overall Study||43
7723865|NCT01656759|19018424|P2|NOT COMPLETED|Overall Study||3
7723866|NCT01656759|19018425|P1|NOT COMPLETED|Overall Study||2
7723867|NCT01656759|19018424|P2|COMPLETED|Overall Study||22
7723868|NCT01656759|19018425|P1|COMPLETED|Overall Study||25
7723869|NCT01656759|19018424|P2|STARTED|Overall Study||25
7723870|NCT01656759|19018425|P1|STARTED|Overall Study||27
7723871|NCT01656733|19018439|P2|NOT COMPLETED|Overall Study||4
7723872|NCT01656733|19018440|P1|NOT COMPLETED|Overall Study||0
7723873|NCT01656733|19018439|P2|COMPLETED|Overall Study||66
7723874|NCT01656733|19018440|P1|COMPLETED|Overall Study||67
7723875|NCT01656733|19018439|P2|Visit 8 (6 Months Postpartum)|Overall Study||28
7723876|NCT01656733|19018440|P1|Visit 8 (6 Months Postpartum)|Overall Study||30
7723877|NCT01656733|19018439|P2|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||50
7723878|NCT01656733|19018440|P1|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||47
7723879|NCT01656733|19018439|P2|Participants With Perinatal Outcomes|Overall Study||66
7723880|NCT01656733|19018440|P1|Participants With Perinatal Outcomes|Overall Study||67
7723881|NCT01656733|19018439|P2|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||47
7723882|NCT01656733|19018440|P1|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||39
7723883|NCT01656733|19018439|P2|Visit 5 (6 Weeks After Quit Date)|Overall Study||36
7723884|NCT01656733|19018440|P1|Visit 5 (6 Weeks After Quit Date)|Overall Study||37
7723885|NCT01656733|19018439|P2|Visit 4 (4 Weeks After Quit Date)|Overall Study||30
7723886|NCT01656733|19018440|P1|Visit 4 (4 Weeks After Quit Date)|Overall Study||32
7723887|NCT01656733|19018439|P2|Visit 3 (3 Weeks After Quit Date)|Overall Study||34
7723888|NCT01656733|19018440|P1|Visit 3 (3 Weeks After Quit Date)|Overall Study||33
7723889|NCT01656733|19018439|P2|Visit 2 (2 Weeks After Quit Date)|Overall Study||44
7723890|NCT01656733|19018440|P1|Visit 2 (2 Weeks After Quit Date)|Overall Study||32
7723891|NCT01656733|19018439|P2|Visit 1 (1 Week After Quit Date)|Overall Study||42
7723892|NCT01656733|19018440|P1|Visit 1 (1 Week After Quit Date)|Overall Study||45
7723893|NCT01656733|19018439|P2|STARTED|Overall Study|5 discontinued after BL visit ( lost to follow up)|70
7723894|NCT01656733|19018440|P1|STARTED|Overall Study|4 discontinued after BL visit (lost to follow up)|67
7723895|NCT01656629|19018455|P3|NOT COMPLETED|Overall Study||2
7723896|NCT01656629|19018456|P2|NOT COMPLETED|Overall Study||2
7723897|NCT01656629|19018457|P1|NOT COMPLETED|Overall Study||5
7723898|NCT01656629|19018455|P3|COMPLETED|Overall Study||14
7723899|NCT01656629|19018456|P2|COMPLETED|Overall Study||16
7723900|NCT01656629|19018457|P1|COMPLETED|Overall Study||16
7723901|NCT01656629|19018455|P3|STARTED|Overall Study||16
7723902|NCT01656629|19018456|P2|STARTED|Overall Study||18
7723903|NCT01656629|19018457|P1|STARTED|Overall Study||21
7723904|NCT01656486|19018471|P1|NOT COMPLETED|Overall Study||0
7723905|NCT01656486|19018471|P1|COMPLETED|Overall Study||1
7723906|NCT01656486|19018471|P1|STARTED|Overall Study||1
7723907|NCT01656460|19018475|P4|NOT COMPLETED|Overall Study||0
7723908|NCT01656460|19018476|P3|NOT COMPLETED|Overall Study||0
7723909|NCT01656460|19018477|P2|NOT COMPLETED|Overall Study||0
7723910|NCT01656460|19018478|P1|NOT COMPLETED|Overall Study||0
7723911|NCT01656460|19018475|P4|COMPLETED|Overall Study||3
7723912|NCT01656460|19018476|P3|COMPLETED|Overall Study||3
7723913|NCT01656460|19018477|P2|COMPLETED|Overall Study||3
7723914|NCT01656460|19018478|P1|COMPLETED|Overall Study||3
7723915|NCT01656460|19018475|P4|STARTED|Overall Study||3
7723916|NCT01656460|19018476|P3|STARTED|Overall Study||3
7723917|NCT01656460|19018477|P2|STARTED|Overall Study||3
7723918|NCT01656460|19018478|P1|STARTED|Overall Study||3
7723919|NCT01656434|19018490|P2|NOT COMPLETED|Overall Study||580
7723920|NCT01656434|19018491|P1|NOT COMPLETED|Overall Study||2401
7723921|NCT01656434|19018490|P2|COMPLETED|Overall Study||40
7723922|NCT01656434|19018491|P1|COMPLETED|Overall Study||152
7723923|NCT01656434|19018490|P2|Treated|Overall Study||604
7723924|NCT01656434|19018491|P1|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466
7723925|NCT01656434|19018490|P2|STARTED|Overall Study||620
7723926|NCT01656434|19018491|P1|STARTED|Overall Study||2553
7723927|NCT01656408|19018517|P10|NOT COMPLETED|Overall Study||3
7723928|NCT01656408|19018518|P9|NOT COMPLETED|Overall Study||2
7723929|NCT01656408|19018519|P8|NOT COMPLETED|Overall Study||1
7723930|NCT01656408|19018520|P7|NOT COMPLETED|Overall Study||1
7723931|NCT01656408|19018521|P6|NOT COMPLETED|Overall Study||2
7723932|NCT01656408|19018522|P5|NOT COMPLETED|Overall Study||1
7723933|NCT01656408|19018523|P4|NOT COMPLETED|Overall Study||0
7723934|NCT01656408|19018524|P3|NOT COMPLETED|Overall Study||2
7723935|NCT01656408|19018525|P2|NOT COMPLETED|Overall Study||0
7723936|NCT01656408|19018526|P1|NOT COMPLETED|Overall Study||1
7723937|NCT01656408|19018517|P10|COMPLETED|Overall Study||15
7723938|NCT01656408|19018518|P9|COMPLETED|Overall Study||16
7723939|NCT01656408|19018519|P8|COMPLETED|Overall Study||7
7723940|NCT01656408|19018520|P7|COMPLETED|Overall Study||9
7723941|NCT01656408|19018521|P6|COMPLETED|Overall Study||7
7723942|NCT01656408|19018522|P5|COMPLETED|Overall Study||8
7723943|NCT01656408|19018523|P4|COMPLETED|Overall Study||7
7723944|NCT01656408|19018524|P3|COMPLETED|Overall Study||6
7723945|NCT01656408|19018525|P2|COMPLETED|Overall Study||8
7723946|NCT01656408|19018526|P1|COMPLETED|Overall Study||7
7723947|NCT01656408|19018517|P10|STARTED|Overall Study||18
7723948|NCT01656408|19018518|P9|STARTED|Overall Study||18
7723949|NCT01656408|19018519|P8|STARTED|Overall Study||8
7723950|NCT01656408|19018520|P7|STARTED|Overall Study||10
7723951|NCT01656408|19018521|P6|STARTED|Overall Study||9
7723952|NCT01656408|19018522|P5|STARTED|Overall Study||9
7723953|NCT01656408|19018523|P4|STARTED|Overall Study||7
7723954|NCT01656408|19018524|P3|STARTED|Overall Study||8
7723955|NCT01656408|19018525|P2|STARTED|Overall Study||8
7723956|NCT01656408|19018526|P1|STARTED|Overall Study||8
7723957|NCT01656395|19018721|P8|NOT COMPLETED|Overall Study||0
7723958|NCT01656395|19018722|P7|NOT COMPLETED|Overall Study||0
7723959|NCT01656395|19018723|P6|NOT COMPLETED|Overall Study||40
7723960|NCT01656395|19018724|P5|NOT COMPLETED|Overall Study||14
7723961|NCT01656395|19018725|P4|NOT COMPLETED|Overall Study||12
7723962|NCT01656395|19018726|P3|NOT COMPLETED|Overall Study||36
7723963|NCT01656395|19018727|P2|NOT COMPLETED|Overall Study||34
7723964|NCT01656395|19018728|P1|NOT COMPLETED|Overall Study||17
7723965|NCT01656395|19018721|P8|COMPLETED|Overall Study||0
7723966|NCT01656395|19018722|P7|COMPLETED|Overall Study||0
7723967|NCT01656395|19018723|P6|COMPLETED|Overall Study||94
7723968|NCT01656395|19018724|P5|COMPLETED|Overall Study||46
7723969|NCT01656395|19018725|P4|COMPLETED|Overall Study||41
7723970|NCT01656395|19018726|P3|COMPLETED|Overall Study||106
7723971|NCT01656395|19018727|P2|COMPLETED|Overall Study||93
7723972|NCT01656395|19018728|P1|COMPLETED|Overall Study||43
7723973|NCT01656395|19018721|P8|Treated Participants|Overall Study||0
7723974|NCT01656395|19018722|P7|Treated Participants|Overall Study||0
7723975|NCT01656395|19018723|P6|Treated Participants|Overall Study||126
7723976|NCT01656395|19018724|P5|Treated Participants|Overall Study||60
7723977|NCT01656395|19018725|P4|Treated Participants|Overall Study||52
7723978|NCT01656395|19018726|P3|Treated Participants|Overall Study||135
7723979|NCT01656395|19018727|P2|Treated Participants|Overall Study||126
7723980|NCT01656395|19018728|P1|Treated Participants|Overall Study||58
7723981|NCT01656395|19018721|P8|STARTED|Overall Study||0
7723982|NCT01656395|19018722|P7|STARTED|Overall Study||0
7723983|NCT01656395|19018723|P6|STARTED|Overall Study||134
7723984|NCT01656395|19018724|P5|STARTED|Overall Study||60
7723985|NCT01656395|19018725|P4|STARTED|Overall Study||53
7723986|NCT01656395|19018726|P3|STARTED|Overall Study||142
7723987|NCT01656395|19018727|P2|STARTED|Overall Study||127
7723988|NCT01656395|19018728|P1|STARTED|Overall Study||60
7723989|NCT01656304|19018814|P1|NOT COMPLETED|Overall Study||1
7723990|NCT01656304|19018814|P1|COMPLETED|Overall Study||15
7723991|NCT01656304|19018814|P1|STARTED|Overall Study||16
7723992|NCT01656252|19018823|P1|NOT COMPLETED|Phase II||0
7723993|NCT01656252|19018823|P1|COMPLETED|Phase II||0
7723994|NCT01656252|19018823|P1|STARTED|Phase II||0
7723995|NCT01656252|19018823|P1|NOT COMPLETED|Phase I||0
7723996|NCT01656252|19018823|P1|COMPLETED|Phase I||14
7723997|NCT01656252|19018823|P1|STARTED|Phase I||14
7723998|NCT01656200|19018855|P1|NOT COMPLETED|Overall Study||1
7723999|NCT01656200|19018855|P1|COMPLETED|Overall Study||16
7724000|NCT01656200|19018855|P1|STARTED|Overall Study||17
7724001|NCT01656187|19018863|P2|NOT COMPLETED|Second Intervention (24 Weeks)||3
7724002|NCT01656187|19018864|P1|NOT COMPLETED|Second Intervention (24 Weeks)||1
7724003|NCT01656187|19018863|P2|COMPLETED|Second Intervention (24 Weeks)||19
7724004|NCT01656187|19018864|P1|COMPLETED|Second Intervention (24 Weeks)||13
7724005|NCT01656187|19018863|P2|STARTED|Second Intervention (24 Weeks)||22
7724006|NCT01656187|19018864|P1|STARTED|Second Intervention (24 Weeks)||14
7724007|NCT01656187|19018863|P2|NOT COMPLETED|Washout (4 Weeks)||1
7724008|NCT01656187|19018864|P1|NOT COMPLETED|Washout (4 Weeks)||0
7724009|NCT01656187|19018863|P2|COMPLETED|Washout (4 Weeks)||22
7724010|NCT01656187|19018864|P1|COMPLETED|Washout (4 Weeks)||14
7724011|NCT01656187|19018863|P2|STARTED|Washout (4 Weeks)||23
7724012|NCT01656187|19018864|P1|STARTED|Washout (4 Weeks)||14
7724013|NCT01656187|19018863|P2|NOT COMPLETED|First Intervention (24 Weeks)||3
7724014|NCT01656187|19018864|P1|NOT COMPLETED|First Intervention (24 Weeks)||6
7724015|NCT01656187|19018863|P2|COMPLETED|First Intervention (24 Weeks)||23
7724016|NCT01656187|19018864|P1|COMPLETED|First Intervention (24 Weeks)||14
7724017|NCT01656187|19018863|P2|STARTED|First Intervention (24 Weeks)||26
7724018|NCT01656187|19018864|P1|STARTED|First Intervention (24 Weeks)||20
7724019|NCT01656161|19018870|P1|NOT COMPLETED|Overall Study||7
7724020|NCT01656161|19018870|P1|COMPLETED|Overall Study|Per protocol analysis set|113
7724021|NCT01656161|19018870|P1|Received Triptorelin at Day 169|Overall Study||115
7724022|NCT01656161|19018870|P1|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120
7724023|NCT01656161|19018870|P1|STARTED|Overall Study|Intention to treat analysis set|120
7724024|NCT01656031|19018884|P1|NOT COMPLETED|Overall Study||0
7724025|NCT01656031|19018884|P1|COMPLETED|Overall Study||39
7724026|NCT01656031|19018884|P1|STARTED|Overall Study||39
7724027|NCT01655901|19018888|P6|NOT COMPLETED|Third Intervention (Hour 3)||0
7724028|NCT01655901|19018889|P5|NOT COMPLETED|Third Intervention (Hour 3)||1
7724029|NCT01655901|19018890|P4|NOT COMPLETED|Third Intervention (Hour 3)||0
7724030|NCT01655901|19018891|P3|NOT COMPLETED|Third Intervention (Hour 3)||1
7724031|NCT01655901|19018892|P2|NOT COMPLETED|Third Intervention (Hour 3)||1
7724032|NCT01655901|19018893|P1|NOT COMPLETED|Third Intervention (Hour 3)||1
7724033|NCT01655901|19018888|P6|COMPLETED|Third Intervention (Hour 3)||5
7724034|NCT01655901|19018889|P5|COMPLETED|Third Intervention (Hour 3)||4
7724035|NCT01655901|19018890|P4|COMPLETED|Third Intervention (Hour 3)||5
7724036|NCT01655901|19018891|P3|COMPLETED|Third Intervention (Hour 3)||4
7724037|NCT01655901|19018892|P2|COMPLETED|Third Intervention (Hour 3)||4
7724038|NCT01655901|19018893|P1|COMPLETED|Third Intervention (Hour 3)||4
7724039|NCT01655901|19018888|P6|STARTED|Third Intervention (Hour 3)||5
7724040|NCT01655901|19018889|P5|STARTED|Third Intervention (Hour 3)||5
7724041|NCT01655901|19018890|P4|STARTED|Third Intervention (Hour 3)||5
7724042|NCT01655901|19018891|P3|STARTED|Third Intervention (Hour 3)||5
7724043|NCT01655901|19018892|P2|STARTED|Third Intervention (Hour 3)||5
7724044|NCT01655901|19018893|P1|STARTED|Third Intervention (Hour 3)||5
7724045|NCT01655901|19018888|P6|NOT COMPLETED|Washout (1 Week)||0
7724046|NCT01655901|19018889|P5|NOT COMPLETED|Washout (1 Week)||0
7724047|NCT01655901|19018890|P4|NOT COMPLETED|Washout (1 Week)||0
7724048|NCT01655901|19018891|P3|NOT COMPLETED|Washout (1 Week)||0
7724049|NCT01655901|19018892|P2|NOT COMPLETED|Washout (1 Week)||0
7724050|NCT01655901|19018893|P1|NOT COMPLETED|Washout (1 Week)||0
7724051|NCT01655901|19018888|P6|COMPLETED|Washout (1 Week)||5
7724052|NCT01655901|19018889|P5|COMPLETED|Washout (1 Week)||5
7724053|NCT01655901|19018890|P4|COMPLETED|Washout (1 Week)||5
7724054|NCT01655901|19018891|P3|COMPLETED|Washout (1 Week)||5
7724055|NCT01655901|19018892|P2|COMPLETED|Washout (1 Week)||5
7724056|NCT01655901|19018893|P1|COMPLETED|Washout (1 Week)||5
7724057|NCT01655901|19018888|P6|STARTED|Washout (1 Week)||5
7724058|NCT01655901|19018889|P5|STARTED|Washout (1 Week)||5
7724059|NCT01655901|19018890|P4|STARTED|Washout (1 Week)||5
7724060|NCT01655901|19018891|P3|STARTED|Washout (1 Week)||5
7724061|NCT01655901|19018892|P2|STARTED|Washout (1 Week)||5
7724062|NCT01655901|19018893|P1|STARTED|Washout (1 Week)||5
7724063|NCT01655901|19018888|P6|NOT COMPLETED|Second Intervention (Hour 2)||0
7724064|NCT01655901|19018889|P5|NOT COMPLETED|Second Intervention (Hour 2)||0
7724065|NCT01655901|19018890|P4|NOT COMPLETED|Second Intervention (Hour 2)||0
7724066|NCT01655901|19018891|P3|NOT COMPLETED|Second Intervention (Hour 2)||0
7724067|NCT01655901|19018892|P2|NOT COMPLETED|Second Intervention (Hour 2)||0
7724068|NCT01655901|19018893|P1|NOT COMPLETED|Second Intervention (Hour 2)||0
7724069|NCT01655901|19018888|P6|COMPLETED|Second Intervention (Hour 2)||5
7724070|NCT01655901|19018889|P5|COMPLETED|Second Intervention (Hour 2)||5
7724071|NCT01655901|19018890|P4|COMPLETED|Second Intervention (Hour 2)||5
7724072|NCT01655901|19018891|P3|COMPLETED|Second Intervention (Hour 2)||5
7724073|NCT01655901|19018892|P2|COMPLETED|Second Intervention (Hour 2)||5
7724074|NCT01655901|19018893|P1|COMPLETED|Second Intervention (Hour 2)||5
7724075|NCT01655901|19018888|P6|STARTED|Second Intervention (Hour 2)||5
7724076|NCT01655901|19018889|P5|STARTED|Second Intervention (Hour 2)||5
7724077|NCT01655901|19018890|P4|STARTED|Second Intervention (Hour 2)||5
7724078|NCT01655901|19018891|P3|STARTED|Second Intervention (Hour 2)||5
7724079|NCT01655901|19018892|P2|STARTED|Second Intervention (Hour 2)||5
7724080|NCT01655901|19018893|P1|STARTED|Second Intervention (Hour 2)||5
7724081|NCT01655901|19018888|P6|NOT COMPLETED|Washout (1 Week)||0
7724082|NCT01655901|19018889|P5|NOT COMPLETED|Washout (1 Week)||0
7724083|NCT01655901|19018890|P4|NOT COMPLETED|Washout (1 Week)||0
7724084|NCT01655901|19018891|P3|NOT COMPLETED|Washout (1 Week)||0
7724085|NCT01655901|19018892|P2|NOT COMPLETED|Washout (1 Week)||0
7724086|NCT01655901|19018893|P1|NOT COMPLETED|Washout (1 Week)||0
7724087|NCT01655901|19018888|P6|COMPLETED|Washout (1 Week)||5
7724088|NCT01655901|19018889|P5|COMPLETED|Washout (1 Week)||5
7724089|NCT01655901|19018890|P4|COMPLETED|Washout (1 Week)||5
7724090|NCT01655901|19018891|P3|COMPLETED|Washout (1 Week)||5
7724091|NCT01655901|19018892|P2|COMPLETED|Washout (1 Week)||5
7724092|NCT01655901|19018893|P1|COMPLETED|Washout (1 Week)||5
7724093|NCT01655901|19018888|P6|STARTED|Washout (1 Week)||5
7724094|NCT01655901|19018889|P5|STARTED|Washout (1 Week)||5
7724095|NCT01655901|19018890|P4|STARTED|Washout (1 Week)||5
7724096|NCT01655901|19018891|P3|STARTED|Washout (1 Week)||5
7724097|NCT01655901|19018892|P2|STARTED|Washout (1 Week)||5
7724098|NCT01655901|19018893|P1|STARTED|Washout (1 Week)||5
7724099|NCT01655901|19018888|P6|NOT COMPLETED|First Intervention (Hour 1)||0
7724100|NCT01655901|19018889|P5|NOT COMPLETED|First Intervention (Hour 1)||0
7724101|NCT01655901|19018890|P4|NOT COMPLETED|First Intervention (Hour 1)||0
7724102|NCT01655901|19018891|P3|NOT COMPLETED|First Intervention (Hour 1)||0
7724103|NCT01655901|19018892|P2|NOT COMPLETED|First Intervention (Hour 1)||0
7724104|NCT01655901|19018893|P1|NOT COMPLETED|First Intervention (Hour 1)||0
7724105|NCT01655901|19018888|P6|COMPLETED|First Intervention (Hour 1)||5
7724106|NCT01655901|19018889|P5|COMPLETED|First Intervention (Hour 1)||5
7724107|NCT01655901|19018890|P4|COMPLETED|First Intervention (Hour 1)||5
7724108|NCT01655901|19018891|P3|COMPLETED|First Intervention (Hour 1)||5
7724109|NCT01655901|19018892|P2|COMPLETED|First Intervention (Hour 1)||5
7724110|NCT01655901|19018893|P1|COMPLETED|First Intervention (Hour 1)||5
7724111|NCT01655901|19018888|P6|STARTED|First Intervention (Hour 1)||5
7724112|NCT01655901|19018889|P5|STARTED|First Intervention (Hour 1)||5
7724113|NCT01655901|19018890|P4|STARTED|First Intervention (Hour 1)||5
7724114|NCT01655901|19018891|P3|STARTED|First Intervention (Hour 1)||5
7724115|NCT01655901|19018892|P2|STARTED|First Intervention (Hour 1)||5
7724116|NCT01655901|19018893|P1|STARTED|First Intervention (Hour 1)||5
7724117|NCT01655823|19018907|P5|NOT COMPLETED|Overall Study||1
7724118|NCT01655823|19018908|P4|NOT COMPLETED|Overall Study||1
7724119|NCT01655823|19018909|P3|NOT COMPLETED|Overall Study||0
7724120|NCT01655823|19018910|P2|NOT COMPLETED|Overall Study||2
7724121|NCT01655823|19018911|P1|NOT COMPLETED|Overall Study||0
7724122|NCT01655823|19018907|P5|COMPLETED|Overall Study||25
7724123|NCT01655823|19018908|P4|COMPLETED|Overall Study||24
7724124|NCT01655823|19018909|P3|COMPLETED|Overall Study||24
7724125|NCT01655823|19018910|P2|COMPLETED|Overall Study||23
7724126|NCT01655823|19018911|P1|COMPLETED|Overall Study||25
7724127|NCT01655823|19018907|P5|STARTED|Overall Study||26
7724128|NCT01655823|19018908|P4|STARTED|Overall Study||25
7724129|NCT01655823|19018909|P3|STARTED|Overall Study||24
7724130|NCT01655823|19018910|P2|STARTED|Overall Study||25
7724131|NCT01655823|19018911|P1|STARTED|Overall Study||25
7724132|NCT01655719|19018923|P1|NOT COMPLETED|Overall Study||0
7724133|NCT01655719|19018923|P1|COMPLETED|Overall Study||1
7724134|NCT01655719|19018923|P1|STARTED|Overall Study||1
7724135|NCT01655563|19018931|P2|NOT COMPLETED|Overall Study||0
7724136|NCT01655563|19018932|P1|NOT COMPLETED|Overall Study||0
7724137|NCT01655563|19018931|P2|COMPLETED|Overall Study||35
7724138|NCT01655563|19018932|P1|COMPLETED|Overall Study||18
7724139|NCT01655563|19018931|P2|STARTED|Overall Study||35
7724140|NCT01655563|19018932|P1|STARTED|Overall Study||18
7724141|NCT01655498|19018942|P1|NOT COMPLETED|Overall Study||5
7724142|NCT01655498|19018942|P1|COMPLETED|Overall Study||56
7724143|NCT01655498|19018942|P1|STARTED|Overall Study||61
7724144|NCT01655381|19018949|P1|NOT COMPLETED|Overall Study||3
7724145|NCT01655381|19018949|P1|COMPLETED|Overall Study||12
7724146|NCT01655381|19018949|P1|STARTED|Overall Study||15
7724147|NCT01655329|19018969|P1|NOT COMPLETED|Overall Study||0
7724148|NCT01655329|19018969|P1|COMPLETED|Overall Study||10
7724149|NCT01655329|19018969|P1|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10
7724150|NCT01655069|19018989|P4|NOT COMPLETED|Overall Study||4
7724151|NCT01655069|19018990|P3|NOT COMPLETED|Overall Study||2
7724152|NCT01655069|19018991|P2|NOT COMPLETED|Overall Study||12
7724153|NCT01655069|19018992|P1|NOT COMPLETED|Overall Study||8
7724154|NCT01655069|19018989|P4|COMPLETED|Overall Study||11
7724155|NCT01655069|19018990|P3|COMPLETED|Overall Study||12
7724156|NCT01655069|19018991|P2|COMPLETED|Overall Study||46
7724157|NCT01655069|19018992|P1|COMPLETED|Overall Study||53
7724158|NCT01655069|19018989|P4|Full Analysis Set (FAS)|Overall Study||15
7724159|NCT01655069|19018990|P3|Full Analysis Set (FAS)|Overall Study||14
7724160|NCT01655069|19018991|P2|Full Analysis Set (FAS)|Overall Study||57
7724161|NCT01655069|19018992|P1|Full Analysis Set (FAS)|Overall Study||60
7724162|NCT01655069|19018989|P4|Safety Analysis Set (SAF)|Overall Study||15
7724163|NCT01655069|19018990|P3|Safety Analysis Set (SAF)|Overall Study||14
7724164|NCT01655069|19018991|P2|Safety Analysis Set (SAF)|Overall Study||57
7724165|NCT01655069|19018992|P1|Safety Analysis Set (SAF)|Overall Study||61
7724166|NCT01655069|19018989|P4|STARTED|Overall Study||15
7724167|NCT01655069|19018990|P3|STARTED|Overall Study||14
7724168|NCT01655069|19018991|P2|STARTED|Overall Study||58
7724169|NCT01655069|19018992|P1|STARTED|Overall Study||61
7724170|NCT01655043|19019007|P1|NOT COMPLETED|Overall Study||0
7724171|NCT01655043|19019007|P1|COMPLETED|Overall Study||20
7724172|NCT01655043|19019007|P1|STARTED|Overall Study||20
7724173|NCT01654887|19019013|P2|NOT COMPLETED|Overall Study||0
7724174|NCT01654887|19019014|P1|NOT COMPLETED|Overall Study||0
7724175|NCT01654887|19019013|P2|COMPLETED|Overall Study||88
7724176|NCT01654887|19019014|P1|COMPLETED|Overall Study||103
7724177|NCT01654887|19019013|P2|STARTED|Overall Study||88
7724178|NCT01654887|19019014|P1|STARTED|Overall Study||103
7724179|NCT01654861|19019030|P1|NOT COMPLETED|Overall Study||0
7724180|NCT01654861|19019030|P1|COMPLETED|Overall Study||3
7724181|NCT01654861|19019030|P1|STARTED|Overall Study||3
7724182|NCT01654796|19019038|P3|NOT COMPLETED|Overall Study||1
7724183|NCT01654796|19019039|P2|NOT COMPLETED|Overall Study||3
7724184|NCT01654796|19019040|P1|NOT COMPLETED|Overall Study||1
7724185|NCT01654796|19019038|P3|COMPLETED|Overall Study||28
7724186|NCT01654796|19019039|P2|COMPLETED|Overall Study||26
7724187|NCT01654796|19019040|P1|COMPLETED|Overall Study||25
7724188|NCT01654796|19019038|P3|STARTED|Overall Study||29
7724189|NCT01654796|19019039|P2|STARTED|Overall Study||29
7724190|NCT01654796|19019040|P1|STARTED|Overall Study||26
7724191|NCT01654666|19019052|P3|NOT COMPLETED|Overall Study||14
7724192|NCT01654666|19019053|P2|NOT COMPLETED|Overall Study||13
7724193|NCT01654666|19019054|P1|NOT COMPLETED|Overall Study||15
7724194|NCT01654666|19019052|P3|COMPLETED|Overall Study||49
7724195|NCT01654666|19019053|P2|COMPLETED|Overall Study||50
7724196|NCT01654666|19019054|P1|COMPLETED|Overall Study||48
7724197|NCT01654666|19019052|P3|Primary Analysis|Overall Study||54
7724198|NCT01654666|19019053|P2|Primary Analysis|Overall Study||56
7724199|NCT01654666|19019054|P1|Primary Analysis|Overall Study||52
7724200|NCT01654666|19019052|P3|STARTED|Overall Study||63
7724201|NCT01654666|19019053|P2|STARTED|Overall Study||63
7724202|NCT01654666|19019054|P1|STARTED|Overall Study||63
7724203|NCT01654601|19019079|P2|NOT COMPLETED|2nd Administration||1
7724204|NCT01654601|19019080|P1|NOT COMPLETED|2nd Administration||1
7724205|NCT01654601|19019079|P2|COMPLETED|2nd Administration||11
7724206|NCT01654601|19019080|P1|COMPLETED|2nd Administration||11
7724207|NCT01654601|19019079|P2|STARTED|2nd Administration||12
7724208|NCT01654601|19019080|P1|STARTED|2nd Administration||12
7724209|NCT01654601|19019079|P2|NOT COMPLETED|1st Administration||2
7724210|NCT01654601|19019080|P1|NOT COMPLETED|1st Administration||2
7724211|NCT01654601|19019079|P2|COMPLETED|1st Administration||12
7724212|NCT01654601|19019080|P1|COMPLETED|1st Administration||12
7724213|NCT01654601|19019079|P2|STARTED|1st Administration||14
7724214|NCT01654601|19019080|P1|STARTED|1st Administration||14
7724215|NCT01654549|19019094|P2|NOT COMPLETED|Overall Study||1
7724216|NCT01654549|19019095|P1|NOT COMPLETED|Overall Study||0
7724217|NCT01654549|19019094|P2|COMPLETED|Overall Study||19
7724218|NCT01654549|19019095|P1|COMPLETED|Overall Study||20
7724219|NCT01654549|19019094|P2|STARTED|Overall Study||20
7724220|NCT01654549|19019095|P1|STARTED|Overall Study||20
7724221|NCT01654536|19019107|P2|NOT COMPLETED|Overall Study||38
7724222|NCT01654536|19019108|P1|NOT COMPLETED|Overall Study||44
7724223|NCT01654536|19019107|P2|COMPLETED|Overall Study||331
7724224|NCT01654536|19019108|P1|COMPLETED|Overall Study||324
7724225|NCT01654536|19019107|P2|STARTED|Overall Study||369
7724226|NCT01654536|19019108|P1|STARTED|Overall Study||368
7724227|NCT01654523|19019144|P1|NOT COMPLETED|Overall Study||1
7724228|NCT01654523|19019144|P1|COMPLETED|Overall Study||19
7724229|NCT01654523|19019144|P1|STARTED|Overall Study||20
7724230|NCT01654445|19019150|P2|NOT COMPLETED|Overall Study||0
7724231|NCT01654445|19019151|P1|NOT COMPLETED|Overall Study||0
7724232|NCT01654445|19019150|P2|COMPLETED|Overall Study||25
7724233|NCT01654445|19019151|P1|COMPLETED|Overall Study||25
7724234|NCT01654445|19019150|P2|STARTED|Overall Study||25
7724235|NCT01654445|19019151|P1|STARTED|Overall Study||25
7724236|NCT01654380|19019163|P4|NOT COMPLETED|Part B, Period 4||0
7724237|NCT01654380|19019164|P3|NOT COMPLETED|Part B, Period 4||0
7724238|NCT01654380|19019165|P2|NOT COMPLETED|Part B, Period 4||0
7724239|NCT01654380|19019166|P1|NOT COMPLETED|Part B, Period 4||0
7724240|NCT01654380|19019163|P4|COMPLETED|Part B, Period 4||7
7724241|NCT01654380|19019164|P3|COMPLETED|Part B, Period 4||6
7724242|NCT01654380|19019165|P2|COMPLETED|Part B, Period 4||0
7724243|NCT01654380|19019166|P1|COMPLETED|Part B, Period 4||0
7724244|NCT01654380|19019163|P4|STARTED|Part B, Period 4||7
7724245|NCT01654380|19019164|P3|STARTED|Part B, Period 4||6
7724246|NCT01654380|19019165|P2|STARTED|Part B, Period 4||0
7724247|NCT01654380|19019166|P1|STARTED|Part B, Period 4||0
7724248|NCT01654380|19019163|P4|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
7724249|NCT01654380|19019164|P3|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
7724250|NCT01654380|19019165|P2|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
7724251|NCT01654380|19019166|P1|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
7724252|NCT01654380|19019163|P4|COMPLETED|Part B, Washout of at Least 6 Days||7
7724253|NCT01654380|19019164|P3|COMPLETED|Part B, Washout of at Least 6 Days||6
7724254|NCT01654380|19019165|P2|COMPLETED|Part B, Washout of at Least 6 Days||0
7724255|NCT01654380|19019166|P1|COMPLETED|Part B, Washout of at Least 6 Days||0
7724256|NCT01654380|19019163|P4|STARTED|Part B, Washout of at Least 6 Days||7
7724257|NCT01654380|19019164|P3|STARTED|Part B, Washout of at Least 6 Days||6
7724258|NCT01654380|19019165|P2|STARTED|Part B, Washout of at Least 6 Days||0
7724259|NCT01654380|19019166|P1|STARTED|Part B, Washout of at Least 6 Days||0
7724260|NCT01654380|19019163|P4|NOT COMPLETED|Part B, Period 3||0
7724261|NCT01654380|19019164|P3|NOT COMPLETED|Part B, Period 3||0
7724262|NCT01654380|19019165|P2|NOT COMPLETED|Part B, Period 3||0
7724263|NCT01654380|19019166|P1|NOT COMPLETED|Part B, Period 3||0
7724264|NCT01654380|19019163|P4|COMPLETED|Part B, Period 3||7
7724265|NCT01654380|19019164|P3|COMPLETED|Part B, Period 3||6
7724266|NCT01654380|19019165|P2|COMPLETED|Part B, Period 3||0
7724267|NCT01654380|19019166|P1|COMPLETED|Part B, Period 3||0
7724268|NCT01654380|19019163|P4|STARTED|Part B, Period 3||7
7724269|NCT01654380|19019164|P3|STARTED|Part B, Period 3||6
7724270|NCT01654380|19019165|P2|STARTED|Part B, Period 3||0
7724271|NCT01654380|19019166|P1|STARTED|Part B, Period 3||0
7724272|NCT01654380|19019163|P4|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
7724273|NCT01654380|19019164|P3|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
7724274|NCT01654380|19019165|P2|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
7724275|NCT01654380|19019166|P1|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
7724276|NCT01654380|19019163|P4|COMPLETED|Part B, Washout of at Least 6 Days||7
7724277|NCT01654380|19019164|P3|COMPLETED|Part B, Washout of at Least 6 Days||6
7724278|NCT01654380|19019165|P2|COMPLETED|Part B, Washout of at Least 6 Days||0
7724279|NCT01654380|19019166|P1|COMPLETED|Part B, Washout of at Least 6 Days||0
7724280|NCT01654380|19019163|P4|STARTED|Part B, Washout of at Least 6 Days||7
7724281|NCT01654380|19019164|P3|STARTED|Part B, Washout of at Least 6 Days||6
7724282|NCT01654380|19019165|P2|STARTED|Part B, Washout of at Least 6 Days||0
7724283|NCT01654380|19019166|P1|STARTED|Part B, Washout of at Least 6 Days||0
7724284|NCT01654380|19019163|P4|NOT COMPLETED|Part B, Period 2||0
7724285|NCT01654380|19019164|P3|NOT COMPLETED|Part B, Period 2||0
7724286|NCT01654380|19019165|P2|NOT COMPLETED|Part B, Period 2||0
7724287|NCT01654380|19019166|P1|NOT COMPLETED|Part B, Period 2||0
7724288|NCT01654380|19019163|P4|COMPLETED|Part B, Period 2||7
7724289|NCT01654380|19019164|P3|COMPLETED|Part B, Period 2||6
7724290|NCT01654380|19019165|P2|COMPLETED|Part B, Period 2||0
7724291|NCT01654380|19019166|P1|COMPLETED|Part B, Period 2||0
7724292|NCT01654380|19019163|P4|STARTED|Part B, Period 2||7
7724293|NCT01654380|19019164|P3|STARTED|Part B, Period 2||6
7724294|NCT01654380|19019165|P2|STARTED|Part B, Period 2||0
7724295|NCT01654380|19019166|P1|STARTED|Part B, Period 2||0
7724296|NCT01654380|19019163|P4|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
7724297|NCT01654380|19019164|P3|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
7724298|NCT01654380|19019165|P2|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
7724299|NCT01654380|19019166|P1|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
7724300|NCT01654380|19019163|P4|COMPLETED|Part B, Washout of at Least 6 Days||7
7724301|NCT01654380|19019164|P3|COMPLETED|Part B, Washout of at Least 6 Days||6
7724302|NCT01654380|19019165|P2|COMPLETED|Part B, Washout of at Least 6 Days||0
7724303|NCT01654380|19019166|P1|COMPLETED|Part B, Washout of at Least 6 Days||0
7724304|NCT01654380|19019163|P4|STARTED|Part B, Washout of at Least 6 Days||7
7724305|NCT01654380|19019164|P3|STARTED|Part B, Washout of at Least 6 Days||6
7724306|NCT01654380|19019165|P2|STARTED|Part B, Washout of at Least 6 Days||0
7724307|NCT01654380|19019166|P1|STARTED|Part B, Washout of at Least 6 Days||0
7724308|NCT01654380|19019163|P4|NOT COMPLETED|Part B, Period 1||0
7724309|NCT01654380|19019164|P3|NOT COMPLETED|Part B, Period 1||1
7724310|NCT01654380|19019165|P2|NOT COMPLETED|Part B, Period 1||0
7724311|NCT01654380|19019166|P1|NOT COMPLETED|Part B, Period 1||0
7724312|NCT01654380|19019163|P4|COMPLETED|Part B, Period 1||7
7724313|NCT01654380|19019164|P3|COMPLETED|Part B, Period 1|Participant who did not complete received only 1 dose of LY2605541 74.1 mU/min IV for 8 hours|6
7724314|NCT01654380|19019165|P2|COMPLETED|Part B, Period 1||0
7724315|NCT01654380|19019166|P1|COMPLETED|Part B, Period 1||0
7724316|NCT01654380|19019163|P4|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
7724317|NCT01654380|19019164|P3|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
7724318|NCT01654380|19019165|P2|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
7724319|NCT01654380|19019166|P1|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
7724320|NCT01654380|19019163|P4|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
7724321|NCT01654380|19019164|P3|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
7724322|NCT01654380|19019165|P2|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
7724323|NCT01654380|19019166|P1|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
7724324|NCT01654380|19019163|P4|NOT COMPLETED|Part A, Period 4||0
7724325|NCT01654380|19019164|P3|NOT COMPLETED|Part A, Period 4||0
7724326|NCT01654380|19019165|P2|NOT COMPLETED|Part A, Period 4||0
7724327|NCT01654380|19019166|P1|NOT COMPLETED|Part A, Period 4||0
7724328|NCT01654380|19019163|P4|COMPLETED|Part A, Period 4||0
7724329|NCT01654380|19019164|P3|COMPLETED|Part A, Period 4||0
7724330|NCT01654380|19019165|P2|COMPLETED|Part A, Period 4||4
7724331|NCT01654380|19019166|P1|COMPLETED|Part A, Period 4||4
7724332|NCT01654380|19019163|P4|STARTED|Part A, Period 4||0
7724333|NCT01654380|19019164|P3|STARTED|Part A, Period 4||0
7724334|NCT01654380|19019165|P2|STARTED|Part A, Period 4||4
7724335|NCT01654380|19019166|P1|STARTED|Part A, Period 4||4
7724336|NCT01654380|19019163|P4|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
7724337|NCT01654380|19019164|P3|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
7724338|NCT01654380|19019165|P2|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
7724339|NCT01654380|19019166|P1|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
7724340|NCT01654380|19019163|P4|COMPLETED|Part A, Washout of at Least 6 Days||0
7724341|NCT01654380|19019164|P3|COMPLETED|Part A, Washout of at Least 6 Days||0
7724342|NCT01654380|19019165|P2|COMPLETED|Part A, Washout of at Least 6 Days||4
7724343|NCT01654380|19019166|P1|COMPLETED|Part A, Washout of at Least 6 Days||4
7724344|NCT01654380|19019163|P4|STARTED|Part A, Washout of at Least 6 Days||0
7724345|NCT01654380|19019164|P3|STARTED|Part A, Washout of at Least 6 Days||0
7724346|NCT01654380|19019165|P2|STARTED|Part A, Washout of at Least 6 Days||4
7724347|NCT01654380|19019166|P1|STARTED|Part A, Washout of at Least 6 Days||4
7724348|NCT01654380|19019163|P4|NOT COMPLETED|Part A, Period 3||0
7724349|NCT01654380|19019164|P3|NOT COMPLETED|Part A, Period 3||0
7724350|NCT01654380|19019165|P2|NOT COMPLETED|Part A, Period 3||0
7724351|NCT01654380|19019166|P1|NOT COMPLETED|Part A, Period 3||0
7724352|NCT01654380|19019163|P4|COMPLETED|Part A, Period 3||0
7724353|NCT01654380|19019164|P3|COMPLETED|Part A, Period 3||0
7724354|NCT01654380|19019165|P2|COMPLETED|Part A, Period 3||4
7724355|NCT01654380|19019166|P1|COMPLETED|Part A, Period 3||4
7724356|NCT01654380|19019163|P4|STARTED|Part A, Period 3||0
7724357|NCT01654380|19019164|P3|STARTED|Part A, Period 3||0
7724358|NCT01654380|19019165|P2|STARTED|Part A, Period 3||4
7724359|NCT01654380|19019166|P1|STARTED|Part A, Period 3||4
7724360|NCT01654380|19019163|P4|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
7724361|NCT01654380|19019164|P3|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
7724362|NCT01654380|19019165|P2|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
7724363|NCT01654380|19019166|P1|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
7724364|NCT01654380|19019163|P4|COMPLETED|Part A, Washout of at Least 6 Days||0
7724365|NCT01654380|19019164|P3|COMPLETED|Part A, Washout of at Least 6 Days||0
7724366|NCT01654380|19019165|P2|COMPLETED|Part A, Washout of at Least 6 Days||4
7724367|NCT01654380|19019166|P1|COMPLETED|Part A, Washout of at Least 6 Days||4
7724368|NCT01654380|19019163|P4|STARTED|Part A, Washout of at Least 6 Days||0
7724369|NCT01654380|19019164|P3|STARTED|Part A, Washout of at Least 6 Days||0
7724370|NCT01654380|19019165|P2|STARTED|Part A, Washout of at Least 6 Days||4
7724371|NCT01654380|19019166|P1|STARTED|Part A, Washout of at Least 6 Days||4
7724372|NCT01654380|19019163|P4|NOT COMPLETED|Part A, Period 2||0
7724373|NCT01654380|19019164|P3|NOT COMPLETED|Part A, Period 2||0
7724374|NCT01654380|19019165|P2|NOT COMPLETED|Part A, Period 2||0
7724375|NCT01654380|19019166|P1|NOT COMPLETED|Part A, Period 2||0
7724376|NCT01654380|19019163|P4|COMPLETED|Part A, Period 2||0
7724377|NCT01654380|19019164|P3|COMPLETED|Part A, Period 2||0
7724378|NCT01654380|19019165|P2|COMPLETED|Part A, Period 2||4
7724379|NCT01654380|19019166|P1|COMPLETED|Part A, Period 2||4
7724380|NCT01654380|19019163|P4|STARTED|Part A, Period 2||0
7724381|NCT01654380|19019164|P3|STARTED|Part A, Period 2||0
7724382|NCT01654380|19019165|P2|STARTED|Part A, Period 2||4
7724383|NCT01654380|19019166|P1|STARTED|Part A, Period 2||4
7724384|NCT01654380|19019163|P4|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
7724385|NCT01654380|19019164|P3|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
7724386|NCT01654380|19019165|P2|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
7724387|NCT01654380|19019166|P1|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
7724388|NCT01654380|19019163|P4|COMPLETED|Part A, Washout of at Least 6 Days||0
7724389|NCT01654380|19019164|P3|COMPLETED|Part A, Washout of at Least 6 Days||0
7724390|NCT01654380|19019165|P2|COMPLETED|Part A, Washout of at Least 6 Days||4
7724391|NCT01654380|19019166|P1|COMPLETED|Part A, Washout of at Least 6 Days||4
7724392|NCT01654380|19019163|P4|STARTED|Part A, Washout of at Least 6 Days||0
7724393|NCT01654380|19019164|P3|STARTED|Part A, Washout of at Least 6 Days||0
7724394|NCT01654380|19019165|P2|STARTED|Part A, Washout of at Least 6 Days||4
7724395|NCT01654380|19019166|P1|STARTED|Part A, Washout of at Least 6 Days||4
7724396|NCT01654380|19019163|P4|NOT COMPLETED|Part A, Period 1||0
7724397|NCT01654380|19019164|P3|NOT COMPLETED|Part A, Period 1||0
7724398|NCT01654380|19019165|P2|NOT COMPLETED|Part A, Period 1||0
7724399|NCT01654380|19019166|P1|NOT COMPLETED|Part A, Period 1||0
7724400|NCT01654380|19019163|P4|COMPLETED|Part A, Period 1||0
7724401|NCT01654380|19019164|P3|COMPLETED|Part A, Period 1||0
7724402|NCT01654380|19019165|P2|COMPLETED|Part A, Period 1||4
7724403|NCT01654380|19019166|P1|COMPLETED|Part A, Period 1||4
7724404|NCT01654380|19019163|P4|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
7724405|NCT01654380|19019164|P3|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
7724406|NCT01654380|19019165|P2|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
7724407|NCT01654380|19019166|P1|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
7724408|NCT01654380|19019163|P4|STARTED|Part A, Period 1||0
7724409|NCT01654380|19019164|P3|STARTED|Part A, Period 1||0
7724410|NCT01654380|19019165|P2|STARTED|Part A, Period 1||4
7724411|NCT01654380|19019166|P1|STARTED|Part A, Period 1||4
7724412|NCT01654315|19019194|P3|NOT COMPLETED|Overall Study||0
7724413|NCT01654315|19019195|P2|NOT COMPLETED|Overall Study||0
7724414|NCT01654315|19019196|P1|NOT COMPLETED|Overall Study||0
7724415|NCT01654315|19019194|P3|COMPLETED|Overall Study||9
7724416|NCT01654315|19019195|P2|COMPLETED|Overall Study||10
7724417|NCT01654315|19019196|P1|COMPLETED|Overall Study||15
7724418|NCT01654315|19019194|P3|STARTED|Overall Study||9
7724419|NCT01654315|19019195|P2|STARTED|Overall Study||10
7724420|NCT01654315|19019196|P1|STARTED|Overall Study||15
7724421|NCT01654302|19019209|P2|NOT COMPLETED|Second Intervention (Day 7)||1
7724422|NCT01654302|19019210|P1|NOT COMPLETED|Second Intervention (Day 7)||1
7724423|NCT01654302|19019209|P2|COMPLETED|Second Intervention (Day 7)||19
7724424|NCT01654302|19019210|P1|COMPLETED|Second Intervention (Day 7)||19
7724425|NCT01654302|19019209|P2|STARTED|Second Intervention (Day 7)||20
7724426|NCT01654302|19019210|P1|STARTED|Second Intervention (Day 7)||20
7724427|NCT01654302|19019209|P2|NOT COMPLETED|First Intervention (Day 1)||0
7724428|NCT01654302|19019210|P1|NOT COMPLETED|First Intervention (Day 1)||0
7724429|NCT01654302|19019209|P2|COMPLETED|First Intervention (Day 1)||20
7724430|NCT01654302|19019210|P1|COMPLETED|First Intervention (Day 1)||20
7724431|NCT01654302|19019209|P2|STARTED|First Intervention (Day 1)||20
7724432|NCT01654302|19019210|P1|STARTED|First Intervention (Day 1)||20
7724433|NCT01654289|19019219|P3|NOT COMPLETED|Overall Study||5
7724434|NCT01654289|19019220|P2|NOT COMPLETED|Overall Study||28
7724435|NCT01654289|19019221|P1|NOT COMPLETED|Overall Study||27
7724436|NCT01654289|19019219|P3|COMPLETED|Overall Study||133
7724437|NCT01654289|19019220|P2|COMPLETED|Overall Study||109
7724438|NCT01654289|19019221|P1|COMPLETED|Overall Study||111
7724439|NCT01654289|19019219|P3|STARTED|Overall Study||138
7724440|NCT01654289|19019220|P2|STARTED|Overall Study||137
7724441|NCT01654289|19019221|P1|STARTED|Overall Study||138
7724442|NCT01654276|19019259|P1|NOT COMPLETED|Overall Study||6
7724443|NCT01654276|19019259|P1|COMPLETED|Overall Study||18
7724444|NCT01654276|19019259|P1|Visit 4 (6months)|Overall Study||18
7724445|NCT01654276|19019259|P1|Visit 3 (4 Months)|Overall Study||18
7724446|NCT01654276|19019259|P1|Visit 2 (2 Months)|Overall Study||19
7724447|NCT01654276|19019259|P1|STARTED|Overall Study||24
7724448|NCT01654263|19019283|P6|NOT COMPLETED|Overall Study||1
7724449|NCT01654263|19019284|P5|NOT COMPLETED|Overall Study||1
7724450|NCT01654263|19019285|P4|NOT COMPLETED|Overall Study||1
7724451|NCT01654263|19019286|P3|NOT COMPLETED|Overall Study||2
7724452|NCT01654263|19019287|P2|NOT COMPLETED|Overall Study||0
7724453|NCT01654263|19019288|P1|NOT COMPLETED|Overall Study||0
7724454|NCT01654263|19019283|P6|COMPLETED|Overall Study||148
7724455|NCT01654263|19019284|P5|COMPLETED|Overall Study||139
7724456|NCT01654263|19019285|P4|COMPLETED|Overall Study||144
7724457|NCT01654263|19019286|P3|COMPLETED|Overall Study||137
7724458|NCT01654263|19019287|P2|COMPLETED|Overall Study||147
7724459|NCT01654263|19019288|P1|COMPLETED|Overall Study||164
7724460|NCT01654263|19019283|P6|STARTED|Overall Study||149
7724461|NCT01654263|19019284|P5|STARTED|Overall Study||140
7724462|NCT01654263|19019285|P4|STARTED|Overall Study||145
7724463|NCT01654263|19019286|P3|STARTED|Overall Study||139
7724464|NCT01654263|19019287|P2|STARTED|Overall Study||147
7724465|NCT01654263|19019288|P1|STARTED|Overall Study||164
7724466|NCT01654250|19019313|P2|NOT COMPLETED|Overall Study||0
7724467|NCT01654250|19019314|P1|NOT COMPLETED|Overall Study||1
7724468|NCT01654250|19019313|P2|COMPLETED|Overall Study||42
7724469|NCT01654250|19019314|P1|COMPLETED|Overall Study||43
7724470|NCT01654250|19019313|P2|STARTED|Overall Study||42
7724471|NCT01654250|19019314|P1|STARTED|Overall Study||44
7724472|NCT01654224|19019331|P2|NOT COMPLETED|Overall Study||12
7724473|NCT01654224|19019332|P1|NOT COMPLETED|Overall Study||6
7724474|NCT01654224|19019331|P2|COMPLETED|Overall Study||98
7724475|NCT01654224|19019332|P1|COMPLETED|Overall Study||89
7724476|NCT01654224|19019331|P2|STARTED|Overall Study||110
7724477|NCT01654224|19019332|P1|STARTED|Overall Study||95
7724478|NCT01654107|19019344|P2|NOT COMPLETED|Overall Study||8
7724479|NCT01654107|19019345|P1|NOT COMPLETED|Overall Study||3
7724480|NCT01654107|19019344|P2|COMPLETED|Overall Study||22
7724481|NCT01654107|19019345|P1|COMPLETED|Overall Study||25
7724482|NCT01654107|19019344|P2|STARTED|Overall Study||30
7724483|NCT01654107|19019345|P1|STARTED|Overall Study||28
7724484|NCT01654068|19019351|P1|NOT COMPLETED|Overall Study||0
7724485|NCT01654068|19019351|P1|COMPLETED|Overall Study||14
7724486|NCT01654068|19019351|P1|STARTED|Overall Study||14
7724487|NCT01653964|19019357|P1|NOT COMPLETED|Overall Study||0
7724488|NCT01653964|19019357|P1|COMPLETED|Overall Study||82
7724489|NCT01653964|19019357|P1|STARTED|Overall Study||82
7724490|NCT01653912|19019363|P6|NOT COMPLETED|Phase 2: GSK2110183 125 mg||8
7724491|NCT01653912|19019364|P5|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
7724492|NCT01653912|19019365|P4|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
7724493|NCT01653912|19019366|P3|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
7724494|NCT01653912|19019367|P2|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
7724495|NCT01653912|19019368|P1|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
7724496|NCT01653912|19019363|P6|COMPLETED|Phase 2: GSK2110183 125 mg||22
7724497|NCT01653912|19019364|P5|COMPLETED|Phase 2: GSK2110183 125 mg||0
7724498|NCT01653912|19019365|P4|COMPLETED|Phase 2: GSK2110183 125 mg||0
7724499|NCT01653912|19019366|P3|COMPLETED|Phase 2: GSK2110183 125 mg||0
7724500|NCT01653912|19019367|P2|COMPLETED|Phase 2: GSK2110183 125 mg||0
7724501|NCT01653912|19019368|P1|COMPLETED|Phase 2: GSK2110183 125 mg||0
7724502|NCT01653912|19019363|P6|STARTED|Phase 2: GSK2110183 125 mg|Per SAP, Cohort B (n=2) data was summarized in phase 2 total column as cohort B had <10 subjects.|30
7724503|NCT01653912|19019364|P5|STARTED|Phase 2: GSK2110183 125 mg||0
7724504|NCT01653912|19019365|P4|STARTED|Phase 2: GSK2110183 125 mg||0
7724505|NCT01653912|19019366|P3|STARTED|Phase 2: GSK2110183 125 mg||0
7724506|NCT01653912|19019367|P2|STARTED|Phase 2: GSK2110183 125 mg||0
7724507|NCT01653912|19019368|P1|STARTED|Phase 2: GSK2110183 125 mg||0
7724508|NCT01653912|19019363|P6|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
7724509|NCT01653912|19019364|P5|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
7724510|NCT01653912|19019365|P4|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
7724511|NCT01653912|19019366|P3|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
7724512|NCT01653912|19019367|P2|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
7724513|NCT01653912|19019368|P1|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
7724514|NCT01653912|19019363|P6|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
7724515|NCT01653912|19019364|P5|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||3
7724516|NCT01653912|19019365|P4|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
7724517|NCT01653912|19019366|P3|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
7724518|NCT01653912|19019367|P2|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
7724519|NCT01653912|19019368|P1|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
7724520|NCT01653912|19019363|P6|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
7724521|NCT01653912|19019364|P5|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||3
7724522|NCT01653912|19019365|P4|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
7724523|NCT01653912|19019366|P3|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
7724524|NCT01653912|19019367|P2|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
7724525|NCT01653912|19019368|P1|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
7724526|NCT01653912|19019363|P6|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
7724527|NCT01653912|19019364|P5|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
7724528|NCT01653912|19019365|P4|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||2
7724529|NCT01653912|19019366|P3|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
7724530|NCT01653912|19019367|P2|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
7724531|NCT01653912|19019368|P1|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
7724532|NCT01653912|19019363|P6|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
7724533|NCT01653912|19019364|P5|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
7724534|NCT01653912|19019365|P4|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||10
7724535|NCT01653912|19019366|P3|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
7724536|NCT01653912|19019367|P2|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
7724537|NCT01653912|19019368|P1|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
7724538|NCT01653912|19019363|P6|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
7724539|NCT01653912|19019364|P5|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
7724540|NCT01653912|19019365|P4|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||12
7724541|NCT01653912|19019366|P3|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
7724542|NCT01653912|19019367|P2|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
7724543|NCT01653912|19019368|P1|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
7724544|NCT01653912|19019363|P6|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
7724545|NCT01653912|19019364|P5|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
7724546|NCT01653912|19019365|P4|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
7724547|NCT01653912|19019366|P3|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||2
7724548|NCT01653912|19019367|P2|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
7724549|NCT01653912|19019368|P1|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
7724550|NCT01653912|19019363|P6|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
7724551|NCT01653912|19019364|P5|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
7724552|NCT01653912|19019365|P4|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
7724553|NCT01653912|19019366|P3|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||4
7724554|NCT01653912|19019367|P2|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
7724555|NCT01653912|19019368|P1|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
7724556|NCT01653912|19019363|P6|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
7724557|NCT01653912|19019364|P5|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
7724558|NCT01653912|19019365|P4|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
7724559|NCT01653912|19019366|P3|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||6
7724560|NCT01653912|19019367|P2|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
7724561|NCT01653912|19019368|P1|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
7724562|NCT01653912|19019363|P6|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
7724563|NCT01653912|19019364|P5|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
7724564|NCT01653912|19019365|P4|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
7724565|NCT01653912|19019366|P3|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
7724566|NCT01653912|19019367|P2|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||1
7724567|NCT01653912|19019368|P1|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
7724568|NCT01653912|19019363|P6|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
7724569|NCT01653912|19019364|P5|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
7724570|NCT01653912|19019365|P4|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
7724571|NCT01653912|19019366|P3|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
7724572|NCT01653912|19019367|P2|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||3
7724573|NCT01653912|19019368|P1|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
7724574|NCT01653912|19019363|P6|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
7724575|NCT01653912|19019364|P5|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
7724576|NCT01653912|19019365|P4|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
7724577|NCT01653912|19019366|P3|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
7724578|NCT01653912|19019367|P2|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||4
7724579|NCT01653912|19019368|P1|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
7724580|NCT01653912|19019363|P6|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
7724581|NCT01653912|19019364|P5|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
7724582|NCT01653912|19019365|P4|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
7724583|NCT01653912|19019366|P3|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
7724584|NCT01653912|19019367|P2|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
7724585|NCT01653912|19019368|P1|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
7724586|NCT01653912|19019363|P6|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
7724587|NCT01653912|19019364|P5|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
7724588|NCT01653912|19019365|P4|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
7724589|NCT01653912|19019366|P3|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
7724590|NCT01653912|19019367|P2|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
7724591|NCT01653912|19019368|P1|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||4
7724592|NCT01653912|19019363|P6|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
7724593|NCT01653912|19019364|P5|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
7724594|NCT01653912|19019365|P4|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
7724595|NCT01653912|19019366|P3|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
7724596|NCT01653912|19019367|P2|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
7724597|NCT01653912|19019368|P1|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||4
7724598|NCT01653782|19019386|P3|NOT COMPLETED|Overall Study||6
7724599|NCT01653782|19019387|P2|NOT COMPLETED|Overall Study||18
7724600|NCT01653782|19019388|P1|NOT COMPLETED|Overall Study||16
7724601|NCT01653782|19019386|P3|COMPLETED|Overall Study||46
7724602|NCT01653782|19019387|P2|COMPLETED|Overall Study||37
7724603|NCT01653782|19019388|P1|COMPLETED|Overall Study||36
7724604|NCT01653782|19019386|P3|STARTED|Overall Study||52
7724605|NCT01653782|19019387|P2|STARTED|Overall Study||55
7724606|NCT01653782|19019388|P1|STARTED|Overall Study||52
7724607|NCT01653743|19019398|P2|NOT COMPLETED|Overall Study||0
7724608|NCT01653743|19019399|P1|NOT COMPLETED|Overall Study||4
7724609|NCT01653743|19019398|P2|COMPLETED|Overall Study||27
7724610|NCT01653743|19019399|P1|COMPLETED|Overall Study||50
7724611|NCT01653743|19019398|P2|STARTED|Overall Study||27
7724612|NCT01653743|19019399|P1|STARTED|Overall Study||54
7724613|NCT01653704|19019415|P2|NOT COMPLETED|Overall Study||1
7724614|NCT01653704|19019416|P1|NOT COMPLETED|Overall Study||2
7724615|NCT01653704|19019415|P2|COMPLETED|Overall Study||20
7724616|NCT01653704|19019416|P1|COMPLETED|Overall Study||19
7724617|NCT01653704|19019415|P2|STARTED|Overall Study||21
7724618|NCT01653704|19019416|P1|STARTED|Overall Study||21
7724619|NCT01653587|19019424|P2|NOT COMPLETED|Overall Study||0
7724620|NCT01653587|19019425|P1|NOT COMPLETED|Overall Study||0
7724621|NCT01653587|19019424|P2|COMPLETED|Overall Study||120
7724622|NCT01653587|19019425|P1|COMPLETED|Overall Study||120
7724623|NCT01653587|19019424|P2|STARTED|Overall Study||120
7724624|NCT01653587|19019425|P1|STARTED|Overall Study||120
7724625|NCT01653509|19019437|P2|NOT COMPLETED|Overall Study||0
7724626|NCT01653509|19019438|P1|NOT COMPLETED|Overall Study||0
7724627|NCT01653509|19019437|P2|COMPLETED|Overall Study||13
7724628|NCT01653509|19019438|P1|COMPLETED|Overall Study||12
7724629|NCT01653509|19019437|P2|STARTED|Overall Study||13
7724630|NCT01653509|19019438|P1|STARTED|Overall Study||12
7724631|NCT01653418|19019456|P1|NOT COMPLETED|Overall Study||0
7724632|NCT01653418|19019456|P1|COMPLETED|Overall Study||10
7724633|NCT01653418|19019456|P1|STARTED|Overall Study||10
7724634|NCT01653405|19019470|P2|NOT COMPLETED|Overall Study||1068803
7724635|NCT01653405|19019471|P1|NOT COMPLETED|Overall Study||3765
7724636|NCT01653405|19019470|P2|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|179979
7724637|NCT01653405|19019471|P1|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|8029
7724638|NCT01653405|19019470|P2|STARTED|Overall Study||1248782
7724639|NCT01653405|19019471|P1|STARTED|Overall Study||11794
7724640|NCT01653327|19019485|P1|NOT COMPLETED|Overall Study||1
7724641|NCT01653327|19019485|P1|COMPLETED|Overall Study||10
7724642|NCT01653327|19019485|P1|STARTED|Overall Study||11
7724643|NCT01653288|19019495|P2|NOT COMPLETED|Overall Study||1
7724644|NCT01653288|19019496|P1|NOT COMPLETED|Overall Study||10
7724645|NCT01653288|19019495|P2|COMPLETED|Overall Study||35
7724646|NCT01653288|19019496|P1|COMPLETED|Overall Study||26
7724647|NCT01653288|19019495|P2|STARTED|Overall Study||36
7724648|NCT01653288|19019496|P1|STARTED|Overall Study||36
7724649|NCT01653262|19019510|P1|NOT COMPLETED|Overall Study||3
7724650|NCT01653262|19019510|P1|COMPLETED|Overall Study||26
7724651|NCT01653262|19019510|P1|STARTED|Overall Study||29
7724652|NCT01653210|19019523|P1|NOT COMPLETED|Overall Study||3
7724653|NCT01653210|19019523|P1|COMPLETED|Overall Study||12
7724654|NCT01653210|19019523|P1|STARTED|Overall Study||15
7724655|NCT01653158|19019528|P8|NOT COMPLETED|Overall Study||15
7724656|NCT01653158|19019529|P7|NOT COMPLETED|Overall Study||2
7724657|NCT01653158|19019530|P6|NOT COMPLETED|Overall Study||1
7724658|NCT01653158|19019531|P5|NOT COMPLETED|Overall Study||1
7724659|NCT01653158|19019532|P4|NOT COMPLETED|Overall Study||2
7724660|NCT01653158|19019533|P3|NOT COMPLETED|Overall Study||0
7724661|NCT01653158|19019534|P2|NOT COMPLETED|Overall Study||0
7724662|NCT01653158|19019535|P1|NOT COMPLETED|Overall Study||1
7724663|NCT01653158|19019528|P8|COMPLETED|Overall Study||4
7724664|NCT01653158|19019529|P7|COMPLETED|Overall Study||7
7724665|NCT01653158|19019530|P6|COMPLETED|Overall Study||2
7724666|NCT01653158|19019531|P5|COMPLETED|Overall Study||2
7724667|NCT01653158|19019532|P4|COMPLETED|Overall Study||1
7724668|NCT01653158|19019533|P3|COMPLETED|Overall Study||3
7724669|NCT01653158|19019534|P2|COMPLETED|Overall Study||3
7724670|NCT01653158|19019535|P1|COMPLETED|Overall Study||2
7724671|NCT01653158|19019528|P8|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19
7724672|NCT01653158|19019529|P7|STARTED|Overall Study||9
7724673|NCT01653158|19019530|P6|STARTED|Overall Study||3
7724674|NCT01653158|19019531|P5|STARTED|Overall Study||3
7724675|NCT01653158|19019532|P4|STARTED|Overall Study||3
7724676|NCT01653158|19019533|P3|STARTED|Overall Study||3
7724677|NCT01653158|19019534|P2|STARTED|Overall Study||3
7724678|NCT01653158|19019535|P1|STARTED|Overall Study||3
7724679|NCT01653132|19019807|P2|NOT COMPLETED|Second Intervention||0
7724680|NCT01653132|19019808|P1|NOT COMPLETED|Second Intervention||0
7724681|NCT01653132|19019807|P2|COMPLETED|Second Intervention||5
7724682|NCT01653132|19019808|P1|COMPLETED|Second Intervention||4
7724683|NCT01653132|19019807|P2|STARTED|Second Intervention||5
7724684|NCT01653132|19019808|P1|STARTED|Second Intervention||4
7724685|NCT01653132|19019807|P2|NOT COMPLETED|Washout 1-2 Months||0
7724686|NCT01653132|19019808|P1|NOT COMPLETED|Washout 1-2 Months||0
7724687|NCT01653132|19019807|P2|COMPLETED|Washout 1-2 Months||5
7724688|NCT01653132|19019808|P1|COMPLETED|Washout 1-2 Months||4
7724689|NCT01653132|19019807|P2|STARTED|Washout 1-2 Months||5
7724690|NCT01653132|19019808|P1|STARTED|Washout 1-2 Months||4
7724691|NCT01653132|19019807|P2|NOT COMPLETED|First Intervention||0
7724692|NCT01653132|19019808|P1|NOT COMPLETED|First Intervention||1
7724693|NCT01653132|19019807|P2|COMPLETED|First Intervention||5
7724694|NCT01653132|19019808|P1|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4
7724695|NCT01653132|19019807|P2|STARTED|First Intervention||5
7724696|NCT01653132|19019808|P1|STARTED|First Intervention||5
7724697|NCT01653028|19019827|P5|NOT COMPLETED|Overall Study||0
7724698|NCT01653028|19019828|P4|NOT COMPLETED|Overall Study||0
7724699|NCT01653028|19019829|P3|NOT COMPLETED|Overall Study||0
7724700|NCT01653028|19019830|P2|NOT COMPLETED|Overall Study||0
7724701|NCT01653028|19019831|P1|NOT COMPLETED|Overall Study||0
7724702|NCT01653028|19019827|P5|COMPLETED|Overall Study||29
7724703|NCT01653028|19019828|P4|COMPLETED|Overall Study||10
7724704|NCT01653028|19019829|P3|COMPLETED|Overall Study||11
7724705|NCT01653028|19019830|P2|COMPLETED|Overall Study||10
7724706|NCT01653028|19019831|P1|COMPLETED|Overall Study||12
7724707|NCT01653028|19019827|P5|STARTED|Overall Study||29
7724708|NCT01653028|19019828|P4|STARTED|Overall Study||10
7724709|NCT01653028|19019829|P3|STARTED|Overall Study||11
7724710|NCT01653028|19019830|P2|STARTED|Overall Study||10
7724711|NCT01653028|19019831|P1|STARTED|Overall Study||12
7724712|NCT01652976|19019858|P1|NOT COMPLETED|Overall Study||0
7724713|NCT01652976|19019858|P1|COMPLETED|Overall Study||44
7724714|NCT01652976|19019858|P1|STARTED|Overall Study||44
7724715|NCT01652885|19019872|P1|NOT COMPLETED|Overall Study||1
7724716|NCT01652885|19019872|P1|COMPLETED|Overall Study||22
7724717|NCT01652885|19019872|P1|STARTED|Overall Study||23
7724718|NCT01652872|19019899|P2|NOT COMPLETED|Overall Study||153
7724719|NCT01652872|19019900|P1|NOT COMPLETED|Overall Study||145
7724720|NCT01652872|19019899|P2|COMPLETED|Overall Study||226
7724721|NCT01652872|19019900|P1|COMPLETED|Overall Study||232
7724722|NCT01652872|19019899|P2|Received Investigational Product|Overall Study||377
7724723|NCT01652872|19019900|P1|Received Investigational Product|Overall Study||377
7724724|NCT01652872|19019899|P2|STARTED|Overall Study||379
7724725|NCT01652872|19019900|P1|STARTED|Overall Study||377
7724726|NCT01652729|19019917|P3|NOT COMPLETED|Overall Study||14
7724727|NCT01652729|19019918|P2|NOT COMPLETED|Overall Study||13
7724728|NCT01652729|19019919|P1|NOT COMPLETED|Overall Study||27
7724729|NCT01652729|19019917|P3|COMPLETED|Overall Study||47
7724730|NCT01652729|19019918|P2|COMPLETED|Overall Study||109
7724731|NCT01652729|19019919|P1|COMPLETED|Overall Study|The double-enrolled subject's reasons for withdrawal were LTFU and PV. Only PV is shown below.|155
7724732|NCT01652729|19019917|P3|Meal Test Evaluable|Overall Study||15
7724733|NCT01652729|19019918|P2|Meal Test Evaluable|Overall Study||31
7724734|NCT01652729|19019919|P1|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44
7724735|NCT01652729|19019917|P3|Meal Test Subjects|Overall Study||20
7724736|NCT01652729|19019918|P2|Meal Test Subjects|Overall Study||41
7724737|NCT01652729|19019919|P1|Meal Test Subjects|Overall Study||60
7724738|NCT01652729|19019917|P3|Evaluable|Overall Study||43
7724739|NCT01652729|19019918|P2|Evaluable|Overall Study||91
7724740|NCT01652729|19019919|P1|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143
7724741|NCT01652729|19019917|P3|Treated|Overall Study||61
7724742|NCT01652729|19019918|P2|Treated|Overall Study||122
7724743|NCT01652729|19019919|P1|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181
7724744|NCT01652729|19019917|P3|Modified Intent-to-Treat|Overall Study||61
7724745|NCT01652729|19019918|P2|Modified Intent-to-Treat|Overall Study||122
7724746|NCT01652729|19019919|P1|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181
7724747|NCT01652729|19019917|P3|STARTED|Overall Study||61
7724748|NCT01652729|19019918|P2|STARTED|Overall Study||122
7724749|NCT01652729|19019919|P1|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182
7724750|NCT01652716|19019941|P2|NOT COMPLETED|Overall Study||46
7724751|NCT01652716|19019942|P1|NOT COMPLETED|Overall Study||56
7724752|NCT01652716|19019941|P2|COMPLETED|Overall Study|* completed study|102
7724753|NCT01652716|19019942|P1|COMPLETED|Overall Study|* completed study|173
7724754|NCT01652716|19019941|P2|Completed 28-week|Overall Study||118
7724755|NCT01652716|19019942|P1|Completed 28-week|Overall Study||197
7724756|NCT01652716|19019941|P2|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148
7724757|NCT01652716|19019942|P1|STARTED|Overall Study||229
7724758|NCT01652703|19019962|P6|NOT COMPLETED|Overall Study||2
7724759|NCT01652703|19019963|P5|NOT COMPLETED|Overall Study||1
7724760|NCT01652703|19019964|P4|NOT COMPLETED|Overall Study||2
7724761|NCT01652703|19019965|P3|NOT COMPLETED|Overall Study||3
7724762|NCT01652703|19019966|P2|NOT COMPLETED|Overall Study||1
7724763|NCT01652703|19019967|P1|NOT COMPLETED|Overall Study||0
7724764|NCT01652703|19019962|P6|COMPLETED|Overall Study||51
7724765|NCT01652703|19019963|P5|COMPLETED|Overall Study||51
7724766|NCT01652703|19019964|P4|COMPLETED|Overall Study||50
7724767|NCT01652703|19019965|P3|COMPLETED|Overall Study||47
7724768|NCT01652703|19019966|P2|COMPLETED|Overall Study||50
7724769|NCT01652703|19019967|P1|COMPLETED|Overall Study||52
7724770|NCT01652703|19019962|P6|Received Treatment|Overall Study||53
7724771|NCT01652703|19019963|P5|Received Treatment|Overall Study||51
7724772|NCT01652703|19019964|P4|Received Treatment|Overall Study||52
7724773|NCT01652703|19019965|P3|Received Treatment|Overall Study||49
7724774|NCT01652703|19019966|P2|Received Treatment|Overall Study||50
7724775|NCT01652703|19019967|P1|Received Treatment|Overall Study||52
7724776|NCT01652703|19019962|P6|STARTED|Overall Study||53
7724777|NCT01652703|19019963|P5|STARTED|Overall Study||52
7724778|NCT01652703|19019964|P4|STARTED|Overall Study||52
7724779|NCT01652703|19019965|P3|STARTED|Overall Study||50
7724780|NCT01652703|19019966|P2|STARTED|Overall Study||51
7724781|NCT01652703|19019967|P1|STARTED|Overall Study||52
7724782|NCT01652690|19020025|P2|NOT COMPLETED|Overall Study||21
7724783|NCT01652690|19020026|P1|NOT COMPLETED|Overall Study||35
7724784|NCT01652690|19020025|P2|COMPLETED|Overall Study||279
7724785|NCT01652690|19020026|P1|COMPLETED|Overall Study||265
7724786|NCT01652690|19020025|P2|STARTED|Overall Study||300
7724787|NCT01652690|19020026|P1|STARTED|Overall Study||300
7724788|NCT01652664|19020060|P2|NOT COMPLETED|Overall Study||1
7724789|NCT01652664|19020061|P1|NOT COMPLETED|Overall Study||6
7724790|NCT01652664|19020060|P2|COMPLETED|Overall Study||74
7724791|NCT01652664|19020061|P1|COMPLETED|Overall Study||71
7724792|NCT01652664|19020060|P2|STARTED|Overall Study||75
7724793|NCT01652664|19020061|P1|STARTED|Overall Study||77
7724794|NCT01652573|19020070|P2|NOT COMPLETED|Overall Study||1
7724795|NCT01652573|19020071|P1|NOT COMPLETED|Overall Study||0
7724796|NCT01652573|19020070|P2|COMPLETED|Overall Study||10
7724797|NCT01652573|19020071|P1|COMPLETED|Overall Study||10
7724798|NCT01652573|19020070|P2|STARTED|Overall Study||11
7724799|NCT01652573|19020071|P1|STARTED|Overall Study||10
7724800|NCT01652534|19020113|P2|NOT COMPLETED|Overall Study||0
7724801|NCT01652534|19020114|P1|NOT COMPLETED|Overall Study||1
7724802|NCT01652534|19020113|P2|COMPLETED|Overall Study||1
7724803|NCT01652534|19020114|P1|COMPLETED|Overall Study||1
7724804|NCT01652534|19020113|P2|STARTED|Overall Study||1
7724805|NCT01652534|19020114|P1|STARTED|Overall Study||2
7724806|NCT01652495|19020142|P2|NOT COMPLETED|Overall Study||2
7724807|NCT01652495|19020143|P1|NOT COMPLETED|Overall Study||2
7724808|NCT01652495|19020142|P2|COMPLETED|Overall Study||20
7724809|NCT01652495|19020143|P1|COMPLETED|Overall Study||20
7724810|NCT01652495|19020142|P2|STARTED|Overall Study||22
7724811|NCT01652495|19020143|P1|STARTED|Overall Study||22
7724812|NCT01652469|19020155|P2|NOT COMPLETED|Overall Study||6
7724813|NCT01652469|19020156|P1|NOT COMPLETED|Overall Study||1
7724814|NCT01652469|19020155|P2|COMPLETED|Overall Study||36
7724815|NCT01652469|19020156|P1|COMPLETED|Overall Study||37
7724816|NCT01652469|19020155|P2|STARTED|Overall Study||42
7724817|NCT01652469|19020156|P1|STARTED|Overall Study||38
7724818|NCT01652287|19020172|P2|NOT COMPLETED|Overall Study||0
7724819|NCT01652287|19020173|P1|NOT COMPLETED|Overall Study||2
7724820|NCT01652287|19020172|P2|COMPLETED|Overall Study||31
7724821|NCT01652287|19020173|P1|COMPLETED|Overall Study|• Did not receive allocated intervention (withdrew consent) (n=2)|29
7724822|NCT01652287|19020172|P2|STARTED|Overall Study||31
7724823|NCT01652287|19020173|P1|STARTED|Overall Study||31
7724824|NCT01652040|19020181|P2|NOT COMPLETED|Overall Study||2
7724825|NCT01652040|19020182|P1|NOT COMPLETED|Overall Study||2
7724826|NCT01652040|19020181|P2|COMPLETED|Overall Study||11
7724827|NCT01652040|19020182|P1|COMPLETED|Overall Study||11
7724828|NCT01652040|19020181|P2|STARTED|Overall Study||13
7724829|NCT01652040|19020182|P1|STARTED|Overall Study||13
7724830|NCT01652001|19020192|P2|NOT COMPLETED|Overall Study||6
7724831|NCT01652001|19020193|P1|NOT COMPLETED|Overall Study||9
7724832|NCT01652001|19020192|P2|COMPLETED|Overall Study||79
7724833|NCT01652001|19020193|P1|COMPLETED|Overall Study||91
7724834|NCT01652001|19020192|P2|STARTED|Overall Study||85
7724835|NCT01652001|19020193|P1|STARTED|Overall Study||100
7724836|NCT01651949|19020204|P3|NOT COMPLETED|Overall Study||31
7724837|NCT01651949|19020205|P2|NOT COMPLETED|Overall Study||86
7724838|NCT01651949|19020206|P1|NOT COMPLETED|Overall Study||53
7724839|NCT01651949|19020204|P3|COMPLETED|Overall Study||282
7724840|NCT01651949|19020205|P2|COMPLETED|Overall Study||1015
7724841|NCT01651949|19020206|P1|COMPLETED|Overall Study||1053
7724842|NCT01651949|19020204|P3|Vaccination 3|Overall Study||291
7724843|NCT01651949|19020205|P2|Vaccination 3|Overall Study||1037
7724844|NCT01651949|19020206|P1|Vaccination 3|Overall Study||1067
7724845|NCT01651949|19020204|P3|Vaccination 2|Overall Study||298
7724846|NCT01651949|19020205|P2|Vaccination 2|Overall Study||1069
7724847|NCT01651949|19020206|P1|Vaccination 2|Overall Study||1089
7724848|NCT01651949|19020204|P3|Vaccination 1|Overall Study||313
7724849|NCT01651949|19020205|P2|Vaccination 1|Overall Study||1099
7724850|NCT01651949|19020206|P1|Vaccination 1|Overall Study||1103
7724851|NCT01651949|19020204|P3|STARTED|Overall Study||313
7724852|NCT01651949|19020205|P2|STARTED|Overall Study||1101
7724853|NCT01651949|19020206|P1|STARTED|Overall Study||1106
7724854|NCT01651936|19020226|P3|NOT COMPLETED|Extension Study||14
7724855|NCT01651936|19020227|P2|NOT COMPLETED|Extension Study||0
7724856|NCT01651936|19020228|P1|NOT COMPLETED|Extension Study||0
7724857|NCT01651936|19020226|P3|COMPLETED|Extension Study||0
7724858|NCT01651936|19020227|P2|COMPLETED|Extension Study||0
7724859|NCT01651936|19020228|P1|COMPLETED|Extension Study||0
7724860|NCT01651936|19020226|P3|STARTED|Extension Study|Includes completers and early escapees from the Base Study|14
7724861|NCT01651936|19020227|P2|STARTED|Extension Study||0
7724862|NCT01651936|19020228|P1|STARTED|Extension Study||0
7724863|NCT01651936|19020226|P3|NOT COMPLETED|Base Study||0
7724864|NCT01651936|19020227|P2|NOT COMPLETED|Base Study||25
7724865|NCT01651936|19020228|P1|NOT COMPLETED|Base Study||27
7724866|NCT01651936|19020226|P3|COMPLETED|Base Study||0
7724867|NCT01651936|19020227|P2|COMPLETED|Base Study||1
7724868|NCT01651936|19020228|P1|COMPLETED|Base Study||3
7724869|NCT01651936|19020226|P3|STARTED|Base Study||0
7724870|NCT01651936|19020227|P2|STARTED|Base Study||26
7724871|NCT01651936|19020228|P1|STARTED|Base Study||30
7724872|NCT01651806|19020254|P5|NOT COMPLETED|Overall Study||0
7724873|NCT01651806|19020255|P4|NOT COMPLETED|Overall Study||0
7724874|NCT01651806|19020256|P3|NOT COMPLETED|Overall Study||0
7724875|NCT01651806|19020257|P2|NOT COMPLETED|Overall Study||0
7724876|NCT01651806|19020258|P1|NOT COMPLETED|Overall Study||0
7724877|NCT01651806|19020254|P5|COMPLETED|Overall Study||8
7724878|NCT01651806|19020255|P4|COMPLETED|Overall Study||7
7724879|NCT01651806|19020256|P3|COMPLETED|Overall Study||25
7724880|NCT01651806|19020257|P2|COMPLETED|Overall Study||12
7724881|NCT01651806|19020258|P1|COMPLETED|Overall Study||13
7724882|NCT01651806|19020254|P5|STARTED|Overall Study||8
7724883|NCT01651806|19020255|P4|STARTED|Overall Study||7
7724884|NCT01651806|19020256|P3|STARTED|Overall Study||25
7724885|NCT01651806|19020257|P2|STARTED|Overall Study||12
7724886|NCT01651806|19020258|P1|STARTED|Overall Study||13
7724887|NCT01651793|19020275|P4|NOT COMPLETED|Overall Study||1
7724888|NCT01651793|19020276|P3|NOT COMPLETED|Overall Study||0
7724889|NCT01651793|19020277|P2|NOT COMPLETED|Overall Study||0
7724890|NCT01651793|19020278|P1|NOT COMPLETED|Overall Study||0
7724891|NCT01651793|19020275|P4|COMPLETED|Overall Study||5
7724892|NCT01651793|19020276|P3|COMPLETED|Overall Study||6
7724893|NCT01651793|19020277|P2|COMPLETED|Overall Study||6
7724894|NCT01651793|19020278|P1|COMPLETED|Overall Study||6
7724895|NCT01651793|19020275|P4|STARTED|Overall Study||6
7724896|NCT01651793|19020276|P3|STARTED|Overall Study||6
7724897|NCT01651793|19020277|P2|STARTED|Overall Study||6
7724898|NCT01651793|19020278|P1|STARTED|Overall Study||6
7724899|NCT01651780|19020298|P2|NOT COMPLETED|Overall Study||10
7724900|NCT01651780|19020299|P1|NOT COMPLETED|Overall Study||11
7724901|NCT01651780|19020298|P2|COMPLETED|Overall Study||388
7724902|NCT01651780|19020299|P1|COMPLETED|Overall Study||394
7724903|NCT01651780|19020298|P2|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|0
7724904|NCT01651780|19020299|P1|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|65
7724905|NCT01651780|19020298|P2|Received at Least 1 Dose of Study Drug|Overall Study||394
7724906|NCT01651780|19020299|P1|Received at Least 1 Dose of Study Drug|Overall Study|All but 1 participant in the bivalirudin group (withdrew consent) comprised the ITT population.|393
7724907|NCT01651780|19020298|P2|Intent-To-Treat (ITT) Population|Overall Study||398
7724908|NCT01651780|19020299|P1|Intent-To-Treat (ITT) Population|Overall Study||404
7724909|NCT01651780|19020298|P2|STARTED|Overall Study||398
7724910|NCT01651780|19020299|P1|STARTED|Overall Study||405
7724911|NCT01651442|19020331|P6|NOT COMPLETED|Phase II Treatment||10
7724912|NCT01651442|19020332|P5|NOT COMPLETED|Phase II Treatment||6
7724913|NCT01651442|19020333|P4|NOT COMPLETED|Phase II Treatment||12
7724914|NCT01651442|19020334|P3|NOT COMPLETED|Phase II Treatment||2
7724915|NCT01651442|19020335|P2|NOT COMPLETED|Phase II Treatment||0
7724916|NCT01651442|19020336|P1|NOT COMPLETED|Phase II Treatment||0
7724917|NCT01651442|19020331|P6|COMPLETED|Phase II Treatment||17
7724918|NCT01651442|19020332|P5|COMPLETED|Phase II Treatment||21
7724919|NCT01651442|19020333|P4|COMPLETED|Phase II Treatment||15
7724920|NCT01651442|19020334|P3|COMPLETED|Phase II Treatment||25
7724921|NCT01651442|19020335|P2|COMPLETED|Phase II Treatment||0
7724922|NCT01651442|19020336|P1|COMPLETED|Phase II Treatment||0
7724923|NCT01651442|19020331|P6|STARTED|Phase II Treatment||27
7724924|NCT01651442|19020332|P5|STARTED|Phase II Treatment||27
7724925|NCT01651442|19020333|P4|STARTED|Phase II Treatment||27
7724926|NCT01651442|19020334|P3|STARTED|Phase II Treatment||27
7724927|NCT01651442|19020335|P2|STARTED|Phase II Treatment||0
7724928|NCT01651442|19020336|P1|STARTED|Phase II Treatment||0
7724929|NCT01651442|19020331|P6|NOT COMPLETED|Phase I Treatment||0
7724930|NCT01651442|19020332|P5|NOT COMPLETED|Phase I Treatment||0
7724931|NCT01651442|19020333|P4|NOT COMPLETED|Phase I Treatment||0
7724932|NCT01651442|19020334|P3|NOT COMPLETED|Phase I Treatment||0
7724933|NCT01651442|19020335|P2|NOT COMPLETED|Phase I Treatment||27
7724934|NCT01651442|19020336|P1|NOT COMPLETED|Phase I Treatment||16
7724935|NCT01651442|19020331|P6|COMPLETED|Phase I Treatment||0
7724936|NCT01651442|19020332|P5|COMPLETED|Phase I Treatment||0
7724937|NCT01651442|19020333|P4|COMPLETED|Phase I Treatment||0
7724938|NCT01651442|19020334|P3|COMPLETED|Phase I Treatment||0
7724939|NCT01651442|19020335|P2|COMPLETED|Phase I Treatment||80
7724940|NCT01651442|19020336|P1|COMPLETED|Phase I Treatment||88
7724941|NCT01651442|19020331|P6|STARTED|Phase I Treatment||0
7724942|NCT01651442|19020332|P5|STARTED|Phase I Treatment||0
7724943|NCT01651442|19020333|P4|STARTED|Phase I Treatment||0
7724944|NCT01651442|19020334|P3|STARTED|Phase I Treatment||0
7724945|NCT01651442|19020335|P2|STARTED|Phase I Treatment||107
7724946|NCT01651442|19020336|P1|STARTED|Phase I Treatment||104
7724947|NCT01651403|19020350|P2|NOT COMPLETED|Open-Label Phase (Weeks 49/73-120/144)||16
7724948|NCT01651403|19020351|P1|NOT COMPLETED|Open-Label Phase (Weeks 49/73-120/144)||27
7724949|NCT01651403|19020350|P2|COMPLETED|Open-Label Phase (Weeks 49/73-120/144)||9
7724950|NCT01651403|19020351|P1|COMPLETED|Open-Label Phase (Weeks 49/73-120/144)||29
7724951|NCT01651403|19020350|P2|STARTED|Open-Label Phase (Weeks 49/73-120/144)|1 participant completed the Double-Blind Period but did not enter the Open-Label Phase.|25
7724952|NCT01651403|19020351|P1|STARTED|Open-Label Phase (Weeks 49/73-120/144)||56
7724953|NCT01651403|19020350|P2|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4
7724954|NCT01651403|19020351|P1|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4
7724955|NCT01651403|19020350|P2|COMPLETED|Double-Blind Period (Through Week 48/72)||26
7724956|NCT01651403|19020351|P1|COMPLETED|Double-Blind Period (Through Week 48/72)||56
7724957|NCT01651403|19020350|P2|STARTED|Double-Blind Period (Through Week 48/72)||30
7724958|NCT01651403|19020351|P1|STARTED|Double-Blind Period (Through Week 48/72)||60
7724959|NCT01651351|19020383|P2|NOT COMPLETED|Overall Study||0
7724960|NCT01651351|19020384|P1|NOT COMPLETED|Overall Study||0
7724961|NCT01651351|19020383|P2|COMPLETED|Overall Study||15
7724962|NCT01651351|19020384|P1|COMPLETED|Overall Study||15
7724963|NCT01651351|19020383|P2|STARTED|Overall Study||15
7724964|NCT01651351|19020384|P1|STARTED|Overall Study||15
7724965|NCT01651260|19020401|P1|NOT COMPLETED|Overall Study||3
7724966|NCT01651260|19020401|P1|COMPLETED|Overall Study||62
7724967|NCT01651260|19020401|P1|STARTED|Overall Study||65
7724968|NCT01651208|19020408|P2|NOT COMPLETED|Overall Study||16
7724969|NCT01651208|19020409|P1|NOT COMPLETED|Overall Study||14
7724970|NCT01651208|19020408|P2|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209
7724971|NCT01651208|19020409|P1|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213
7724972|NCT01651208|19020408|P2|STARTED|Overall Study||225
7724973|NCT01651208|19020409|P1|STARTED|Overall Study||227
7724974|NCT01651117|19020421|P4|NOT COMPLETED|Overall Study||2
7724975|NCT01651117|19020422|P3|NOT COMPLETED|Overall Study||2
7724976|NCT01651117|19020423|P2|NOT COMPLETED|Overall Study||3
7724977|NCT01651117|19020424|P1|NOT COMPLETED|Overall Study||2
7724978|NCT01651117|19020421|P4|COMPLETED|Overall Study||68
7724979|NCT01651117|19020422|P3|COMPLETED|Overall Study||47
7724980|NCT01651117|19020423|P2|COMPLETED|Overall Study||202
7724981|NCT01651117|19020424|P1|COMPLETED|Overall Study||154
7724982|NCT01651117|19020421|P4|STARTED|Overall Study||70
7724983|NCT01651117|19020422|P3|STARTED|Overall Study||49
7724984|NCT01651117|19020423|P2|STARTED|Overall Study||205
7724985|NCT01651117|19020424|P1|STARTED|Overall Study||156
7724986|NCT01651104|19020490|P1|NOT COMPLETED|Overall Study||0
7724987|NCT01651104|19020490|P1|COMPLETED|Overall Study||63
7724988|NCT01651104|19020490|P1|STARTED|Overall Study||63
7724989|NCT01651078|19020497|P1|NOT COMPLETED|Overall Study||26
7724990|NCT01651078|19020497|P1|COMPLETED|Overall Study||16
7724991|NCT01651078|19020497|P1|STARTED|Overall Study|Two (2) out of 44 patients were enrolled but did not go on to have the NeuroBlate Procedure.|42
7724992|NCT01651052|19020504|P1|NOT COMPLETED|Overall Study||26
7724993|NCT01651052|19020504|P1|COMPLETED|Overall Study||107
7724994|NCT01651052|19020504|P1|Study Valve Group|Overall Study||133
7724995|NCT01651052|19020504|P1|STARTED|Overall Study||133
7724996|NCT01651039|19020524|P1|NOT COMPLETED|Overall Study||30
7724997|NCT01651039|19020524|P1|COMPLETED|Overall Study||2
7724998|NCT01651039|19020524|P1|STARTED|Overall Study||32
7724999|NCT01651000|19020537|P2|NOT COMPLETED|Overall Study||28
7725000|NCT01651000|19020538|P1|NOT COMPLETED|Overall Study||10
7725001|NCT01651000|19020537|P2|COMPLETED|Overall Study||113
7725002|NCT01651000|19020538|P1|COMPLETED|Overall Study||62
7725003|NCT01651000|19020537|P2|Entered Extension Study|Overall Study||93
7725004|NCT01651000|19020538|P1|Entered Extension Study|Overall Study||50
7725005|NCT01651000|19020537|P2|STARTED|Overall Study||141
7725006|NCT01651000|19020538|P1|STARTED|Overall Study||72
7725007|NCT01650844|19020552|P2|NOT COMPLETED|Overall Study||4
7725008|NCT01650844|19020553|P1|NOT COMPLETED|Overall Study||1
7725009|NCT01650844|19020552|P2|COMPLETED|Overall Study||196
7725010|NCT01650844|19020553|P1|COMPLETED|Overall Study||199
7725011|NCT01650844|19020552|P2|STARTED|Overall Study||200
7725012|NCT01650844|19020553|P1|STARTED|Overall Study||200
7725013|NCT01650831|19020559|P1|NOT COMPLETED|Overall Study||1
7725014|NCT01650831|19020559|P1|COMPLETED|Overall Study||112
7725015|NCT01650831|19020559|P1|STARTED|Overall Study||113
7725016|NCT01650805|19020569|P2|NOT COMPLETED|Overall Study||0
7725017|NCT01650805|19020570|P1|NOT COMPLETED|Overall Study||1
7725018|NCT01650805|19020569|P2|COMPLETED|Overall Study||152
7725019|NCT01650805|19020570|P1|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154
7725020|NCT01650805|19020569|P2|STARTED|Overall Study||152
7725021|NCT01650805|19020570|P1|STARTED|Overall Study|Started means patient has been randomized.|155
7725022|NCT01650779|19020580|P1|NOT COMPLETED|Overall Study||1
7725023|NCT01650779|19020580|P1|COMPLETED|Overall Study||14
7725024|NCT01650779|19020580|P1|STARTED|Overall Study||15
7725025|NCT01650636|19020589|P2|NOT COMPLETED|9 Month Visit||0
7725026|NCT01650636|19020590|P1|NOT COMPLETED|9 Month Visit||0
7725027|NCT01650636|19020589|P2|COMPLETED|9 Month Visit||129
7725028|NCT01650636|19020590|P1|COMPLETED|9 Month Visit||135
7725029|NCT01650636|19020589|P2|STARTED|9 Month Visit||129
7725030|NCT01650636|19020590|P1|STARTED|9 Month Visit||135
7725031|NCT01650636|19020589|P2|NOT COMPLETED|Washout up to 9 Months||3
7725032|NCT01650636|19020590|P1|NOT COMPLETED|Washout up to 9 Months||6
7725033|NCT01650636|19020589|P2|COMPLETED|Washout up to 9 Months||129
7725034|NCT01650636|19020590|P1|COMPLETED|Washout up to 9 Months||135
7725035|NCT01650636|19020589|P2|STARTED|Washout up to 9 Months||132
7725036|NCT01650636|19020590|P1|STARTED|Washout up to 9 Months||141
7725037|NCT01650636|19020589|P2|NOT COMPLETED|5 Month Visit||0
7725038|NCT01650636|19020590|P1|NOT COMPLETED|5 Month Visit||0
7725039|NCT01650636|19020589|P2|COMPLETED|5 Month Visit||132
7725040|NCT01650636|19020590|P1|COMPLETED|5 Month Visit||141
7725041|NCT01650636|19020589|P2|STARTED|5 Month Visit||132
7725042|NCT01650636|19020590|P1|STARTED|5 Month Visit||141
7725043|NCT01650636|19020589|P2|NOT COMPLETED|Washout up to 5 Months||18
7725044|NCT01650636|19020590|P1|NOT COMPLETED|Washout up to 5 Months||9
7725045|NCT01650636|19020589|P2|COMPLETED|Washout up to 5 Months||132
7725046|NCT01650636|19020590|P1|COMPLETED|Washout up to 5 Months||141
7725047|NCT01650636|19020589|P2|STARTED|Washout up to 5 Months||150
7725048|NCT01650636|19020590|P1|STARTED|Washout up to 5 Months||150
7725049|NCT01650636|19020589|P2|NOT COMPLETED|Intervention Phase||0
7725050|NCT01650636|19020590|P1|NOT COMPLETED|Intervention Phase||0
7725051|NCT01650636|19020589|P2|COMPLETED|Intervention Phase||150
7725052|NCT01650636|19020590|P1|COMPLETED|Intervention Phase||150
7725053|NCT01650636|19020589|P2|STARTED|Intervention Phase||150
7725054|NCT01650636|19020590|P1|STARTED|Intervention Phase||150
7725055|NCT01650584|19020610|P1|NOT COMPLETED|Overall Study||0
7725056|NCT01650584|19020610|P1|COMPLETED|Overall Study||35
7725057|NCT01650584|19020610|P1|STARTED|Overall Study|Each participant received one of 2 treatments in each eye.|35
7725058|NCT01650545|19020617|P2|NOT COMPLETED|Overall Study||0
7725059|NCT01650545|19020618|P1|NOT COMPLETED|Overall Study||0
7725060|NCT01650545|19020617|P2|COMPLETED|Overall Study||10
7725061|NCT01650545|19020618|P1|COMPLETED|Overall Study||11
7725062|NCT01650545|19020617|P2|STARTED|Overall Study||10
7725063|NCT01650545|19020618|P1|STARTED|Overall Study||11
7725064|NCT01650519|19020630|P2|NOT COMPLETED|Overall Study||0
7725065|NCT01650519|19020631|P1|NOT COMPLETED|Overall Study||1
7725066|NCT01650519|19020630|P2|COMPLETED|Overall Study||31
7725067|NCT01650519|19020631|P1|COMPLETED|Overall Study||19
7725068|NCT01650519|19020630|P2|STARTED|Overall Study||31
7725069|NCT01650519|19020631|P1|STARTED|Overall Study||20
7725070|NCT01650402|19020651|P2|NOT COMPLETED|Overall Study||14
7725071|NCT01650402|19020652|P1|NOT COMPLETED|Overall Study||20
7725072|NCT01650402|19020651|P2|COMPLETED|Overall Study||86
7725073|NCT01650402|19020652|P1|COMPLETED|Overall Study||79
7725074|NCT01650402|19020651|P2|STARTED|Overall Study||100
7725075|NCT01650402|19020652|P1|STARTED|Overall Study||99
7725076|NCT01650350|19020660|P1|NOT COMPLETED|Overall Study||0
7725077|NCT01650350|19020660|P1|COMPLETED|Overall Study||7
7725078|NCT01650350|19020660|P1|STARTED|Overall Study||7
7725079|NCT01650324|19020671|P5|NOT COMPLETED|Overall Study||0
7725080|NCT01650324|19020672|P4|NOT COMPLETED|Overall Study||0
7725081|NCT01650324|19020673|P3|NOT COMPLETED|Overall Study||0
7725082|NCT01650324|19020674|P2|NOT COMPLETED|Overall Study||0
7725083|NCT01650324|19020675|P1|NOT COMPLETED|Overall Study||0
7725084|NCT01650324|19020671|P5|COMPLETED|Overall Study||6
7725085|NCT01650324|19020672|P4|COMPLETED|Overall Study||6
7725086|NCT01650324|19020673|P3|COMPLETED|Overall Study||6
7725087|NCT01650324|19020674|P2|COMPLETED|Overall Study||6
7725088|NCT01650324|19020675|P1|COMPLETED|Overall Study||8
7725089|NCT01650324|19020671|P5|STARTED|Overall Study||6
7725090|NCT01650324|19020672|P4|STARTED|Overall Study||6
7725091|NCT01650324|19020673|P3|STARTED|Overall Study||6
7725092|NCT01650324|19020674|P2|STARTED|Overall Study||6
7725093|NCT01650324|19020675|P1|STARTED|Overall Study||8
7725094|NCT01650298|19020706|P2|NOT COMPLETED|Overall Study||6
7725095|NCT01650298|19020707|P1|NOT COMPLETED|Overall Study||5
7725096|NCT01650298|19020706|P2|COMPLETED|Overall Study||42
7725097|NCT01650298|19020707|P1|COMPLETED|Overall Study||11
7725098|NCT01650298|19020706|P2|STARTED|Overall Study||48
7725099|NCT01650298|19020707|P1|STARTED|Overall Study||16
7725100|NCT01650285|19020713|P1|NOT COMPLETED|Overall Study||1
7725101|NCT01650285|19020713|P1|COMPLETED|Overall Study||4
7725102|NCT01650285|19020713|P1|STARTED|Overall Study||5
7725103|NCT01650259|19020720|P2|NOT COMPLETED|Overall Study||235
7725104|NCT01650259|19020721|P1|NOT COMPLETED|Overall Study||1043
7725105|NCT01650259|19020720|P2|COMPLETED|Overall Study||2128
7725106|NCT01650259|19020721|P1|COMPLETED|Overall Study||1470
7725107|NCT01650259|19020720|P2|STARTED|Overall Study|Started are the registered patients|2363
7725108|NCT01650259|19020721|P1|STARTED|Overall Study|Started are the registered patients|2513
7725109|NCT01650246|19020726|P1|NOT COMPLETED|Overall Study||143
7725110|NCT01650246|19020726|P1|COMPLETED|Overall Study||0
7725111|NCT01650246|19020726|P1|STARTED|Overall Study||143
7725112|NCT01650194|19020731|P1|NOT COMPLETED|Overall Study||47
7725113|NCT01650194|19020731|P1|COMPLETED|Overall Study||13
7725114|NCT01650194|19020731|P1|Treated|Overall Study||60
7725115|NCT01650194|19020731|P1|STARTED|Overall Study||60
7725116|NCT01649947|19020756|P2|NOT COMPLETED|Overall Study||18
7725117|NCT01649947|19020757|P1|NOT COMPLETED|Overall Study||12
7725118|NCT01649947|19020756|P2|COMPLETED|Overall Study||2
7725119|NCT01649947|19020757|P1|COMPLETED|Overall Study||0
7725120|NCT01649947|19020756|P2|STARTED|Overall Study||20
7725121|NCT01649947|19020757|P1|STARTED|Overall Study||12
7725122|NCT01649856|19020767|P2|NOT COMPLETED|Overall Study||78
7725123|NCT01649856|19020768|P1|NOT COMPLETED|Overall Study||139
7725124|NCT01649856|19020767|P2|COMPLETED|Overall Study||125
7725125|NCT01649856|19020768|P1|COMPLETED|Overall Study||230
7725126|NCT01649856|19020767|P2|STARTED|Overall Study||203
7725127|NCT01649856|19020768|P1|STARTED|Overall Study||369
7725128|NCT01649804|19020800|P1|NOT COMPLETED|Overall Study||8
7725129|NCT01649804|19020800|P1|COMPLETED|Overall Study||4
7725130|NCT01649804|19020800|P1|STARTED|Overall Study||12
7725131|NCT01649791|19020812|P1|NOT COMPLETED|Overall Study||3
7725132|NCT01649791|19020812|P1|COMPLETED|Overall Study||5
7725133|NCT01649791|19020812|P1|STARTED|Overall Study||8
7725134|NCT01649765|19020821|P2|NOT COMPLETED|Overall Study||8
7725135|NCT01649765|19020822|P1|NOT COMPLETED|Overall Study||9
7725136|NCT01649765|19020821|P2|COMPLETED|Overall Study||45
7725137|NCT01649765|19020822|P1|COMPLETED|Overall Study||31
7725138|NCT01649765|19020821|P2|STARTED|Overall Study||53
7725139|NCT01649765|19020822|P1|STARTED|Overall Study||40
7725140|NCT01649609|19020850|P2|NOT COMPLETED|Overall Study||0
7725141|NCT01649609|19020851|P1|NOT COMPLETED|Overall Study||0
7725142|NCT01649609|19020850|P2|COMPLETED|Overall Study||20
7725143|NCT01649609|19020851|P1|COMPLETED|Overall Study||20
7725144|NCT01649609|19020850|P2|STARTED|Overall Study||20
7725145|NCT01649609|19020851|P1|STARTED|Overall Study||20
7725146|NCT01649596|19020861|P2|NOT COMPLETED|Overall Study||0
7725147|NCT01649596|19020862|P1|NOT COMPLETED|Overall Study||0
7725148|NCT01649596|19020861|P2|COMPLETED|Overall Study||48
7725149|NCT01649596|19020862|P1|COMPLETED|Overall Study||46
7725150|NCT01649596|19020861|P2|STARTED|Overall Study||48
7725151|NCT01649596|19020862|P1|STARTED|Overall Study||46
7725152|NCT01649557|19020873|P3|NOT COMPLETED|Overall Study||9
7725153|NCT01649557|19020874|P2|NOT COMPLETED|Overall Study||14
7725154|NCT01649557|19020875|P1|NOT COMPLETED|Overall Study||44
7725155|NCT01649557|19020873|P3|COMPLETED|Overall Study||15
7725156|NCT01649557|19020874|P2|COMPLETED|Overall Study||27
7725157|NCT01649557|19020875|P1|COMPLETED|Overall Study||135
7725158|NCT01649557|19020873|P3|52-week Enrollers|Overall Study||2
7725159|NCT01649557|19020874|P2|52-week Enrollers|Overall Study||6
7725160|NCT01649557|19020875|P1|52-week Enrollers|Overall Study||20
7725161|NCT01649557|19020873|P3|6-week Enrollers|Overall Study||22
7725162|NCT01649557|19020874|P2|6-week Enrollers|Overall Study||35
7725163|NCT01649557|19020875|P1|6-week Enrollers|Overall Study||159
7725164|NCT01649557|19020873|P3|STARTED|Overall Study||24
7725165|NCT01649557|19020874|P2|STARTED|Overall Study||41
7725166|NCT01649557|19020875|P1|STARTED|Overall Study||179
7725167|NCT01649505|19020912|P2|NOT COMPLETED|Overall Study||1
7725168|NCT01649505|19020913|P1|NOT COMPLETED|Overall Study||1
7725169|NCT01649505|19020912|P2|COMPLETED|Overall Study||0
7725170|NCT01649505|19020913|P1|COMPLETED|Overall Study||0
7725171|NCT01649505|19020912|P2|STARTED|Overall Study||1
7725172|NCT01649505|19020913|P1|STARTED|Overall Study||1
7725173|NCT01649427|19020921|P2|NOT COMPLETED|Overall Study||12
7725174|NCT01649427|19020922|P1|NOT COMPLETED|Overall Study||11
7725175|NCT01649427|19020921|P2|COMPLETED|Overall Study||26
7725176|NCT01649427|19020922|P1|COMPLETED|Overall Study||24
7725177|NCT01649427|19020921|P2|STARTED|Overall Study||38
7725178|NCT01649427|19020922|P1|STARTED|Overall Study||35
7725179|NCT01649375|19020941|P5|NOT COMPLETED|Week 16 up to Week 260||5
7725180|NCT01649375|19020942|P4|NOT COMPLETED|Week 16 up to Week 260||12
7725181|NCT01649375|19020943|P3|NOT COMPLETED|Week 16 up to Week 260||0
7725182|NCT01649375|19020944|P2|NOT COMPLETED|Week 16 up to Week 260||13
7725183|NCT01649375|19020945|P1|NOT COMPLETED|Week 16 up to Week 260||20
7725184|NCT01649375|19020941|P5|COMPLETED|Week 16 up to Week 260||29
7725185|NCT01649375|19020942|P4|COMPLETED|Week 16 up to Week 260||20
7725186|NCT01649375|19020943|P3|COMPLETED|Week 16 up to Week 260||0
7725187|NCT01649375|19020944|P2|COMPLETED|Week 16 up to Week 260||53
7725188|NCT01649375|19020945|P1|COMPLETED|Week 16 up to Week 260||48
7725189|NCT01649375|19020941|P5|STARTED|Week 16 up to Week 260||34
7725190|NCT01649375|19020942|P4|STARTED|Week 16 up to Week 260||32
7725191|NCT01649375|19020943|P3|STARTED|Week 16 up to Week 260||0
7725192|NCT01649375|19020944|P2|STARTED|Week 16 up to Week 260||66
7725193|NCT01649375|19020945|P1|STARTED|Week 16 up to Week 260||68
7725194|NCT01649375|19020941|P5|NOT COMPLETED|Up to Week 16||0
7725195|NCT01649375|19020942|P4|NOT COMPLETED|Up to Week 16||0
7725196|NCT01649375|19020943|P3|NOT COMPLETED|Up to Week 16||8
7725197|NCT01649375|19020944|P2|NOT COMPLETED|Up to Week 16||6
7725198|NCT01649375|19020945|P1|NOT COMPLETED|Up to Week 16||5
7725199|NCT01649375|19020941|P5|COMPLETED|Up to Week 16||0
7725200|NCT01649375|19020942|P4|COMPLETED|Up to Week 16||0
7725201|NCT01649375|19020943|P3|COMPLETED|Up to Week 16||66
7725202|NCT01649375|19020944|P2|COMPLETED|Up to Week 16||66
7725203|NCT01649375|19020945|P1|COMPLETED|Up to Week 16||68
7725204|NCT01649375|19020941|P5|STARTED|Up to Week 16||0
7725205|NCT01649375|19020942|P4|STARTED|Up to Week 16||0
7725206|NCT01649375|19020943|P3|STARTED|Up to Week 16||74
7725207|NCT01649375|19020944|P2|STARTED|Up to Week 16||72
7725208|NCT01649375|19020945|P1|STARTED|Up to Week 16||73
7725209|NCT01649362|19020976|P2|NOT COMPLETED|Overall Study||14
7725210|NCT01649362|19020977|P1|NOT COMPLETED|Overall Study||1
7725211|NCT01649362|19020976|P2|COMPLETED|Overall Study||40
7725212|NCT01649362|19020977|P1|COMPLETED|Overall Study||46
7725213|NCT01649362|19020976|P2|STARTED|Overall Study||54
7725214|NCT01649362|19020977|P1|STARTED|Overall Study||47
7725215|NCT01649297|19020992|P5|NOT COMPLETED|Overall Study||4
7725216|NCT01649297|19020993|P4|NOT COMPLETED|Overall Study||19
7725217|NCT01649297|19020994|P3|NOT COMPLETED|Overall Study||17
7725218|NCT01649297|19020995|P2|NOT COMPLETED|Overall Study||13
7725219|NCT01649297|19020996|P1|NOT COMPLETED|Overall Study||14
7725220|NCT01649297|19020992|P5|COMPLETED|Overall Study||103
7725221|NCT01649297|19020993|P4|COMPLETED|Overall Study||201
7725222|NCT01649297|19020994|P3|COMPLETED|Overall Study||202
7725223|NCT01649297|19020995|P2|COMPLETED|Overall Study||205
7725224|NCT01649297|19020996|P1|COMPLETED|Overall Study||205
7725225|NCT01649297|19020992|P5|STARTED|Overall Study|randomised|107
7725226|NCT01649297|19020993|P4|STARTED|Overall Study|randomised|220
7725227|NCT01649297|19020994|P3|STARTED|Overall Study|randomised|219
7725228|NCT01649297|19020995|P2|STARTED|Overall Study|randomised|218
7725229|NCT01649297|19020996|P1|STARTED|Overall Study|randomised|219
7725230|NCT01649271|19021015|P2|NOT COMPLETED|Overall Study||7
7725231|NCT01649271|19021016|P1|NOT COMPLETED|Overall Study||6
7725232|NCT01649271|19021015|P2|COMPLETED|Overall Study||0
7725233|NCT01649271|19021016|P1|COMPLETED|Overall Study||0
7725234|NCT01649271|19021015|P2|STARTED|Overall Study||7
7725235|NCT01649271|19021016|P1|STARTED|Overall Study||6
7725236|NCT01649232|19021031|P2|NOT COMPLETED|Overall Study||0
7725237|NCT01649232|19021032|P1|NOT COMPLETED|Overall Study||2
7725238|NCT01649232|19021031|P2|COMPLETED|Overall Study||30
7725239|NCT01649232|19021032|P1|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28
7725240|NCT01649232|19021031|P2|STARTED|Overall Study||30
7725241|NCT01649232|19021032|P1|STARTED|Overall Study||30
7725242|NCT01649180|19021052|P1|NOT COMPLETED|Overall Study||0
7725243|NCT01649180|19021052|P1|COMPLETED|Overall Study||3
7725244|NCT01649180|19021052|P1|STARTED|Overall Study||3
7725245|NCT01648959|19021060|P1|NOT COMPLETED|Overall Study||0
7725246|NCT01648959|19021060|P1|COMPLETED|Overall Study||5
7725247|NCT01648959|19021060|P1|STARTED|Overall Study||5
7725248|NCT01648920|19021064|P1|NOT COMPLETED|Overall Study||0
7725249|NCT01648920|19021064|P1|COMPLETED|Overall Study||50
7725250|NCT01648920|19021064|P1|STARTED|Overall Study||50
7725251|NCT01648790|19021088|P5|NOT COMPLETED|Treatment 5||0
7725252|NCT01648790|19021089|P4|NOT COMPLETED|Treatment 5||0
7725253|NCT01648790|19021090|P3|NOT COMPLETED|Treatment 5||0
7725254|NCT01648790|19021091|P2|NOT COMPLETED|Treatment 5||0
7725255|NCT01648790|19021092|P1|NOT COMPLETED|Treatment 5||0
7725256|NCT01648790|19021088|P5|COMPLETED|Treatment 5||4
7725257|NCT01648790|19021089|P4|COMPLETED|Treatment 5||3
7725258|NCT01648790|19021090|P3|COMPLETED|Treatment 5||4
7725259|NCT01648790|19021091|P2|COMPLETED|Treatment 5||4
7725260|NCT01648790|19021092|P1|COMPLETED|Treatment 5||4
7725261|NCT01648790|19021088|P5|STARTED|Treatment 5||4
7725262|NCT01648790|19021089|P4|STARTED|Treatment 5||3
7725263|NCT01648790|19021090|P3|STARTED|Treatment 5||4
7725264|NCT01648790|19021091|P2|STARTED|Treatment 5||4
7725265|NCT01648790|19021092|P1|STARTED|Treatment 5||4
7725266|NCT01648790|19021088|P5|NOT COMPLETED|Treatment 4||0
7725267|NCT01648790|19021089|P4|NOT COMPLETED|Treatment 4||0
7725268|NCT01648790|19021090|P3|NOT COMPLETED|Treatment 4||0
7725269|NCT01648790|19021091|P2|NOT COMPLETED|Treatment 4||0
7725270|NCT01648790|19021092|P1|NOT COMPLETED|Treatment 4||0
7725271|NCT01648790|19021088|P5|COMPLETED|Treatment 4||4
7725272|NCT01648790|19021089|P4|COMPLETED|Treatment 4||3
7725273|NCT01648790|19021090|P3|COMPLETED|Treatment 4||4
7725274|NCT01648790|19021091|P2|COMPLETED|Treatment 4||4
7725275|NCT01648790|19021092|P1|COMPLETED|Treatment 4||4
7725276|NCT01648790|19021088|P5|STARTED|Treatment 4||4
7725277|NCT01648790|19021089|P4|STARTED|Treatment 4||3
7725278|NCT01648790|19021090|P3|STARTED|Treatment 4||4
7725279|NCT01648790|19021091|P2|STARTED|Treatment 4||4
7725280|NCT01648790|19021092|P1|STARTED|Treatment 4||4
7725281|NCT01648790|19021088|P5|NOT COMPLETED|Treatment 3||0
7725282|NCT01648790|19021089|P4|NOT COMPLETED|Treatment 3||1
7725283|NCT01648790|19021090|P3|NOT COMPLETED|Treatment 3||0
7725284|NCT01648790|19021091|P2|NOT COMPLETED|Treatment 3||0
7725285|NCT01648790|19021092|P1|NOT COMPLETED|Treatment 3||0
7725286|NCT01648790|19021088|P5|COMPLETED|Treatment 3||4
7725287|NCT01648790|19021089|P4|COMPLETED|Treatment 3||3
7725288|NCT01648790|19021090|P3|COMPLETED|Treatment 3||4
7725289|NCT01648790|19021091|P2|COMPLETED|Treatment 3||4
7725290|NCT01648790|19021092|P1|COMPLETED|Treatment 3||4
7725291|NCT01648790|19021088|P5|STARTED|Treatment 3||4
7725292|NCT01648790|19021089|P4|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4
7725293|NCT01648790|19021090|P3|STARTED|Treatment 3||4
7725294|NCT01648790|19021091|P2|STARTED|Treatment 3||4
7725295|NCT01648790|19021092|P1|STARTED|Treatment 3||4
7725296|NCT01648790|19021088|P5|NOT COMPLETED|Treatment 2||0
7725297|NCT01648790|19021089|P4|NOT COMPLETED|Treatment 2||0
7725298|NCT01648790|19021090|P3|NOT COMPLETED|Treatment 2||0
7725299|NCT01648790|19021091|P2|NOT COMPLETED|Treatment 2||0
7725300|NCT01648790|19021092|P1|NOT COMPLETED|Treatment 2||0
7725301|NCT01648790|19021088|P5|COMPLETED|Treatment 2||4
7725302|NCT01648790|19021089|P4|COMPLETED|Treatment 2||4
7725303|NCT01648790|19021090|P3|COMPLETED|Treatment 2||4
7725304|NCT01648790|19021091|P2|COMPLETED|Treatment 2||4
7725305|NCT01648790|19021092|P1|COMPLETED|Treatment 2||4
7725306|NCT01648790|19021088|P5|STARTED|Treatment 2||4
7725307|NCT01648790|19021089|P4|STARTED|Treatment 2||4
7725308|NCT01648790|19021090|P3|STARTED|Treatment 2||4
7725309|NCT01648790|19021091|P2|STARTED|Treatment 2||4
7725310|NCT01648790|19021092|P1|STARTED|Treatment 2||4
7725311|NCT01648790|19021088|P5|NOT COMPLETED|Treatment 1||0
7725312|NCT01648790|19021089|P4|NOT COMPLETED|Treatment 1||0
7725313|NCT01648790|19021090|P3|NOT COMPLETED|Treatment 1||0
7725314|NCT01648790|19021091|P2|NOT COMPLETED|Treatment 1||0
7725315|NCT01648790|19021092|P1|NOT COMPLETED|Treatment 1||0
7725316|NCT01648790|19021088|P5|COMPLETED|Treatment 1||4
7725317|NCT01648790|19021089|P4|COMPLETED|Treatment 1||4
7725318|NCT01648790|19021090|P3|COMPLETED|Treatment 1||4
7725319|NCT01648790|19021091|P2|COMPLETED|Treatment 1||4
7725320|NCT01648790|19021092|P1|COMPLETED|Treatment 1||4
7725321|NCT01648790|19021088|P5|Received at Least 1 Dose of Study Drug|Treatment 1||4
7725322|NCT01648790|19021089|P4|Received at Least 1 Dose of Study Drug|Treatment 1||4
7725323|NCT01648790|19021090|P3|Received at Least 1 Dose of Study Drug|Treatment 1||4
7725324|NCT01648790|19021091|P2|Received at Least 1 Dose of Study Drug|Treatment 1||4
7725325|NCT01648790|19021092|P1|Received at Least 1 Dose of Study Drug|Treatment 1||4
7725326|NCT01648790|19021088|P5|STARTED|Treatment 1||4
7725327|NCT01648790|19021089|P4|STARTED|Treatment 1||4
7725328|NCT01648790|19021090|P3|STARTED|Treatment 1||4
7725329|NCT01648790|19021091|P2|STARTED|Treatment 1||4
7725330|NCT01648790|19021092|P1|STARTED|Treatment 1||4
7725331|NCT01648764|19021127|P14|NOT COMPLETED|Overall Study||3
7725332|NCT01648764|19021128|P13|NOT COMPLETED|Overall Study||4
7725333|NCT01648764|19021129|P12|NOT COMPLETED|Overall Study||5
7725334|NCT01648764|19021130|P11|NOT COMPLETED|Overall Study||0
7725335|NCT01648764|19021131|P10|NOT COMPLETED|Overall Study||3
7725336|NCT01648764|19021132|P9|NOT COMPLETED|Overall Study||0
7725337|NCT01648764|19021133|P8|NOT COMPLETED|Overall Study||0
7725338|NCT01648764|19021134|P7|NOT COMPLETED|Overall Study||5
7725339|NCT01648764|19021135|P6|NOT COMPLETED|Overall Study||2
7725340|NCT01648764|19021136|P5|NOT COMPLETED|Overall Study||0
7725341|NCT01648764|19021137|P4|NOT COMPLETED|Overall Study||0
7725342|NCT01648764|19021138|P3|NOT COMPLETED|Overall Study||0
7725343|NCT01648764|19021139|P2|NOT COMPLETED|Overall Study||1
7725344|NCT01648764|19021140|P1|NOT COMPLETED|Overall Study||0
7725345|NCT01648764|19021127|P14|COMPLETED|Overall Study||9
7725346|NCT01648764|19021128|P13|COMPLETED|Overall Study||3
7725347|NCT01648764|19021129|P12|COMPLETED|Overall Study||4
7725348|NCT01648764|19021130|P11|COMPLETED|Overall Study||3
7725349|NCT01648764|19021131|P10|COMPLETED|Overall Study||4
7725350|NCT01648764|19021132|P9|COMPLETED|Overall Study||3
7725351|NCT01648764|19021133|P8|COMPLETED|Overall Study||3
7725352|NCT01648764|19021134|P7|COMPLETED|Overall Study||4
7725353|NCT01648764|19021135|P6|COMPLETED|Overall Study||3
7725354|NCT01648764|19021136|P5|COMPLETED|Overall Study||3
7725355|NCT01648764|19021137|P4|COMPLETED|Overall Study||3
7725356|NCT01648764|19021138|P3|COMPLETED|Overall Study||3
7725357|NCT01648764|19021139|P2|COMPLETED|Overall Study||2
7725358|NCT01648764|19021140|P1|COMPLETED|Overall Study||3
7725359|NCT01648764|19021127|P14|Received at Least 1 Dose of Study Drug|Overall Study||12
7725360|NCT01648764|19021128|P13|Received at Least 1 Dose of Study Drug|Overall Study||7
7725361|NCT01648764|19021129|P12|Received at Least 1 Dose of Study Drug|Overall Study||9
7725362|NCT01648764|19021130|P11|Received at Least 1 Dose of Study Drug|Overall Study||3
7725363|NCT01648764|19021131|P10|Received at Least 1 Dose of Study Drug|Overall Study||7
7725364|NCT01648764|19021132|P9|Received at Least 1 Dose of Study Drug|Overall Study||3
7725365|NCT01648764|19021133|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
7725366|NCT01648764|19021134|P7|Received at Least 1 Dose of Study Drug|Overall Study||9
7725367|NCT01648764|19021135|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
7725368|NCT01648764|19021136|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
7725369|NCT01648764|19021137|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
7725370|NCT01648764|19021138|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
7725371|NCT01648764|19021139|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
7725372|NCT01648764|19021140|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
7725373|NCT01648764|19021127|P14|STARTED|Overall Study||12
7725374|NCT01648764|19021128|P13|STARTED|Overall Study||7
7725375|NCT01648764|19021129|P12|STARTED|Overall Study||9
7725376|NCT01648764|19021130|P11|STARTED|Overall Study||3
7725377|NCT01648764|19021131|P10|STARTED|Overall Study||7
7725378|NCT01648764|19021132|P9|STARTED|Overall Study||3
7725379|NCT01648764|19021133|P8|STARTED|Overall Study||3
7725380|NCT01648764|19021134|P7|STARTED|Overall Study||9
7725381|NCT01648764|19021135|P6|STARTED|Overall Study||5
7725382|NCT01648764|19021136|P5|STARTED|Overall Study||3
7725383|NCT01648764|19021137|P4|STARTED|Overall Study||3
7725384|NCT01648764|19021138|P3|STARTED|Overall Study||3
7725385|NCT01648764|19021139|P2|STARTED|Overall Study||3
7725386|NCT01648764|19021140|P1|STARTED|Overall Study||3
7725387|NCT01648699|19021292|P1|NOT COMPLETED|Overall Study||5
7725388|NCT01648699|19021292|P1|COMPLETED|Overall Study||15
7725389|NCT01648699|19021292|P1|STARTED|Overall Study||20
7725390|NCT01648582|19021321|P3|NOT COMPLETED|Overall Study||32
7725391|NCT01648582|19021322|P2|NOT COMPLETED|Overall Study||38
7725392|NCT01648582|19021323|P1|NOT COMPLETED|Overall Study||32
7725393|NCT01648582|19021321|P3|COMPLETED|Overall Study||227
7725394|NCT01648582|19021322|P2|COMPLETED|Overall Study||219
7725395|NCT01648582|19021323|P1|COMPLETED|Overall Study||226
7725396|NCT01648582|19021321|P3|Modified Intent-to-Treat Population|Overall Study||250
7725397|NCT01648582|19021322|P2|Modified Intent-to-Treat Population|Overall Study||252
7725398|NCT01648582|19021323|P1|Modified Intent-to-Treat Population|Overall Study||253
7725399|NCT01648582|19021321|P3|Received at Least One Dose of Study Drug|Overall Study||259
7725400|NCT01648582|19021322|P2|Received at Least One Dose of Study Drug|Overall Study||257
7725401|NCT01648582|19021323|P1|Received at Least One Dose of Study Drug|Overall Study||258
7725402|NCT01648582|19021321|P3|STARTED|Overall Study||259
7725403|NCT01648582|19021322|P2|STARTED|Overall Study||257
7725404|NCT01648582|19021323|P1|STARTED|Overall Study||258
7725405|NCT01648530|19021392|P1|NOT COMPLETED|Overall Study||10874
7725406|NCT01648530|19021392|P1|COMPLETED|Overall Study||5915
7725407|NCT01648530|19021392|P1|STARTED|Overall Study||16789
7725408|NCT01648491|19021398|P1|NOT COMPLETED|Overall Study||0
7725409|NCT01648491|19021398|P1|COMPLETED|Overall Study||1
7725410|NCT01648491|19021398|P1|STARTED|Overall Study||1
7725411|NCT01648452|19021405|P1|NOT COMPLETED|Overall Study||0
7725412|NCT01648452|19021405|P1|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5
7725413|NCT01648452|19021405|P1|STARTED|Overall Study||5
7725414|NCT01648348|19021426|P6|NOT COMPLETED|Overall Study||6
7725415|NCT01648348|19021427|P5|NOT COMPLETED|Overall Study||3
7725416|NCT01648348|19021428|P4|NOT COMPLETED|Overall Study||0
7725417|NCT01648348|19021429|P3|NOT COMPLETED|Overall Study||1
7725418|NCT01648348|19021430|P2|NOT COMPLETED|Overall Study||0
7725419|NCT01648348|19021431|P1|NOT COMPLETED|Overall Study||2
7725420|NCT01648348|19021426|P6|COMPLETED|Overall Study||43
7725421|NCT01648348|19021427|P5|COMPLETED|Overall Study||49
7725422|NCT01648348|19021428|P4|COMPLETED|Overall Study||3
7725423|NCT01648348|19021429|P3|COMPLETED|Overall Study||3
7725424|NCT01648348|19021430|P2|COMPLETED|Overall Study||3
7725425|NCT01648348|19021431|P1|COMPLETED|Overall Study||3
7725426|NCT01648348|19021426|P6|STARTED|Overall Study||49
7725427|NCT01648348|19021427|P5|STARTED|Overall Study||52
7725428|NCT01648348|19021428|P4|STARTED|Overall Study||3
7725429|NCT01648348|19021429|P3|STARTED|Overall Study||4
7725430|NCT01648348|19021430|P2|STARTED|Overall Study||3
7725431|NCT01648348|19021431|P1|STARTED|Overall Study||5
7725432|NCT01648322|19021460|P4|NOT COMPLETED|Overall Study||4
7725433|NCT01648322|19021461|P3|NOT COMPLETED|Overall Study||5
7725434|NCT01648322|19021462|P2|NOT COMPLETED|Overall Study||5
7725435|NCT01648322|19021463|P1|NOT COMPLETED|Overall Study||2
7725436|NCT01648322|19021460|P4|COMPLETED|Overall Study||61
7725437|NCT01648322|19021461|P3|COMPLETED|Overall Study||60
7725438|NCT01648322|19021462|P2|COMPLETED|Overall Study||62
7725439|NCT01648322|19021463|P1|COMPLETED|Overall Study||33
7725440|NCT01648322|19021460|P4|STARTED|Overall Study||65
7725441|NCT01648322|19021461|P3|STARTED|Overall Study||65
7725442|NCT01648322|19021462|P2|STARTED|Overall Study||67
7725443|NCT01648322|19021463|P1|STARTED|Overall Study||35
7725444|NCT01648296|19021509|P2|NOT COMPLETED|Overall Study||0
7725445|NCT01648296|19021510|P1|NOT COMPLETED|Overall Study||0
7725446|NCT01648296|19021509|P2|COMPLETED|Overall Study||17
7725447|NCT01648296|19021510|P1|COMPLETED|Overall Study||11
7725448|NCT01648296|19021509|P2|STARTED|Overall Study||17
7725449|NCT01648296|19021510|P1|STARTED|Overall Study||11
7725450|NCT01648283|19021518|P1|NOT COMPLETED|Overall Study||14
7725451|NCT01648283|19021518|P1|COMPLETED|Overall Study||64
7725452|NCT01648283|19021518|P1|STARTED|Overall Study||78
7725453|NCT01648270|19021524|P1|NOT COMPLETED|Cyclosporine + Sublingual Buprenorphine||0
7725454|NCT01648270|19021524|P1|COMPLETED|Cyclosporine + Sublingual Buprenorphine||13
7725455|NCT01648270|19021524|P1|STARTED|Cyclosporine + Sublingual Buprenorphine||13
7725456|NCT01648270|19021524|P1|NOT COMPLETED|Cyclosporine Plus IV Buprenorphine||0
7725457|NCT01648270|19021524|P1|COMPLETED|Cyclosporine Plus IV Buprenorphine||13
7725458|NCT01648270|19021524|P1|STARTED|Cyclosporine Plus IV Buprenorphine||13
7725459|NCT01648270|19021524|P1|NOT COMPLETED|Sublingual Buprenorphine||0
7725460|NCT01648270|19021524|P1|COMPLETED|Sublingual Buprenorphine||13
7725461|NCT01648270|19021524|P1|STARTED|Sublingual Buprenorphine||13
7725462|NCT01648270|19021524|P1|NOT COMPLETED|Intravenous Buprenorphine||12
7725463|NCT01648270|19021524|P1|COMPLETED|Intravenous Buprenorphine||13
7725464|NCT01648270|19021524|P1|STARTED|Intravenous Buprenorphine||25
7725465|NCT01648166|19021536|P2|NOT COMPLETED|Overall Study||100
7725466|NCT01648166|19021537|P1|NOT COMPLETED|Overall Study||53
7725467|NCT01648166|19021536|P2|COMPLETED|Overall Study||267
7725468|NCT01648166|19021537|P1|COMPLETED|Overall Study||100
7725469|NCT01648166|19021536|P2|STARTED|Overall Study||367
7725470|NCT01648166|19021537|P1|STARTED|Overall Study||153
7725471|NCT01648140|19021547|P4|NOT COMPLETED|Overall Study||2
7725472|NCT01648140|19021548|P3|NOT COMPLETED|Overall Study||8
7725473|NCT01648140|19021549|P2|NOT COMPLETED|Overall Study||12
7725474|NCT01648140|19021550|P1|NOT COMPLETED|Overall Study||12
7725475|NCT01648140|19021547|P4|COMPLETED|Overall Study||11
7725476|NCT01648140|19021548|P3|COMPLETED|Overall Study||9
7725477|NCT01648140|19021549|P2|COMPLETED|Overall Study||28
7725478|NCT01648140|19021550|P1|COMPLETED|Overall Study||29
7725479|NCT01648140|19021547|P4|STARTED|Overall Study||13
7725480|NCT01648140|19021548|P3|STARTED|Overall Study||17
7725481|NCT01648140|19021549|P2|STARTED|Overall Study||40
7725482|NCT01648140|19021550|P1|STARTED|Overall Study||41
7725483|NCT01648101|19021715|P3|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
7725484|NCT01648101|19021716|P2|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
7725485|NCT01648101|19021717|P1|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
7725486|NCT01648101|19021715|P3|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3
7725487|NCT01648101|19021716|P2|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
7725488|NCT01648101|19021717|P1|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
7725489|NCT01648101|19021715|P3|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3
7725490|NCT01648101|19021716|P2|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2
7725491|NCT01648101|19021717|P1|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1
7725492|NCT01648101|19021715|P3|NOT COMPLETED|Transition Phase (4 Weeks)||4
7725493|NCT01648101|19021716|P2|NOT COMPLETED|Transition Phase (4 Weeks)||5
7725494|NCT01648101|19021717|P1|NOT COMPLETED|Transition Phase (4 Weeks)||5
7725495|NCT01648101|19021715|P3|COMPLETED|Transition Phase (4 Weeks)||5
7725496|NCT01648101|19021716|P2|COMPLETED|Transition Phase (4 Weeks)||13
7725497|NCT01648101|19021717|P1|COMPLETED|Transition Phase (4 Weeks)||12
7725498|NCT01648101|19021715|P3|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9
7725499|NCT01648101|19021716|P2|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18
7725500|NCT01648101|19021717|P1|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17
7725501|NCT01648101|19021715|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||6
7725502|NCT01648101|19021716|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
7725503|NCT01648101|19021717|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
7725504|NCT01648101|19021715|P3|COMPLETED|Maintenance Phase (12 Weeks)||12
7725505|NCT01648101|19021716|P2|COMPLETED|Maintenance Phase (12 Weeks)||20
7725506|NCT01648101|19021717|P1|COMPLETED|Maintenance Phase (12 Weeks)||20
7725507|NCT01648101|19021715|P3|STARTED|Maintenance Phase (12 Weeks)||18
7725508|NCT01648101|19021716|P2|STARTED|Maintenance Phase (12 Weeks)||23
7725509|NCT01648101|19021717|P1|STARTED|Maintenance Phase (12 Weeks)||23
7725510|NCT01648101|19021715|P3|NOT COMPLETED|Titration Phase (4 Weeks)||6
7725511|NCT01648101|19021716|P2|NOT COMPLETED|Titration Phase (4 Weeks)||3
7725512|NCT01648101|19021717|P1|NOT COMPLETED|Titration Phase (4 Weeks)||2
7725513|NCT01648101|19021715|P3|COMPLETED|Titration Phase (4 Weeks)||18
7725514|NCT01648101|19021716|P2|COMPLETED|Titration Phase (4 Weeks)||23
7725515|NCT01648101|19021717|P1|COMPLETED|Titration Phase (4 Weeks)||23
7725516|NCT01648101|19021715|P3|STARTED|Titration Phase (4 Weeks)||24
7725517|NCT01648101|19021716|P2|STARTED|Titration Phase (4 Weeks)||26
7725518|NCT01648101|19021717|P1|STARTED|Titration Phase (4 Weeks)||25
7725519|NCT01647958|19021767|P2|NOT COMPLETED|Extended Follow-up Phase||0
7725520|NCT01647958|19021768|P1|NOT COMPLETED|Extended Follow-up Phase||8
7725521|NCT01647958|19021767|P2|COMPLETED|Extended Follow-up Phase||0
7725522|NCT01647958|19021768|P1|COMPLETED|Extended Follow-up Phase|The 8 lost to follow up patients are of the combined Treatment and Control cohort of 52 patients|52
7725523|NCT01647958|19021767|P2|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients combined into 1 cohort for this period=60, 0 under Control|0
7725524|NCT01647958|19021768|P1|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients were combined into 1 cohort for this follow up. 39+21=60|60
7725525|NCT01647958|19021767|P2|NOT COMPLETED|Continuation Phase||0
7725526|NCT01647958|19021768|P1|NOT COMPLETED|Continuation Phase||39
7725527|NCT01647958|19021767|P2|COMPLETED|Continuation Phase|21 Control patients received TIF crossover procedure following 6-month follow-up visit.|21
7725528|NCT01647958|19021768|P1|COMPLETED|Continuation Phase|Treatment-arm patients received TIF procedure during Initial Study phase|0
7725529|NCT01647958|19021767|P2|STARTED|Continuation Phase||21
7725530|NCT01647958|19021768|P1|STARTED|Continuation Phase||39
7725531|NCT01647958|19021767|P2|NOT COMPLETED|Initial Study||3
7725532|NCT01647958|19021768|P1|NOT COMPLETED|Initial Study||2
7725533|NCT01647958|19021767|P2|COMPLETED|Initial Study||21
7725534|NCT01647958|19021768|P1|COMPLETED|Initial Study||39
7725535|NCT01647958|19021767|P2|STARTED|Initial Study||24
7725536|NCT01647958|19021768|P1|STARTED|Initial Study||41
7725537|NCT01647945|19021820|P4|NOT COMPLETED|Overall Study||1
7725538|NCT01647945|19021821|P3|NOT COMPLETED|Overall Study||2
7725539|NCT01647945|19021822|P2|NOT COMPLETED|Overall Study||0
7725540|NCT01647945|19021823|P1|NOT COMPLETED|Overall Study||0
7725541|NCT01647945|19021820|P4|COMPLETED|Overall Study||5
7725542|NCT01647945|19021821|P3|COMPLETED|Overall Study||3
7725543|NCT01647945|19021822|P2|COMPLETED|Overall Study||6
7725544|NCT01647945|19021823|P1|COMPLETED|Overall Study||6
7725545|NCT01647945|19021820|P4|STARTED|Overall Study||6
7725546|NCT01647945|19021821|P3|STARTED|Overall Study||5
7725547|NCT01647945|19021822|P2|STARTED|Overall Study||6
7725548|NCT01647945|19021823|P1|STARTED|Overall Study||6
7725549|NCT01647737|19021843|P2|NOT COMPLETED|Overall Study||5
7725550|NCT01647737|19021844|P1|NOT COMPLETED|Overall Study||4
7725551|NCT01647737|19021843|P2|COMPLETED|Overall Study||25
7725552|NCT01647737|19021844|P1|COMPLETED|Overall Study||26
7725553|NCT01647737|19021843|P2|STARTED|Overall Study||30
7725554|NCT01647737|19021844|P1|STARTED|Overall Study||30
7725555|NCT01647711|19021855|P5|NOT COMPLETED|Overall Study||6
7725556|NCT01647711|19021856|P4|NOT COMPLETED|Overall Study||11
7725557|NCT01647711|19021857|P3|NOT COMPLETED|Overall Study||9
7725558|NCT01647711|19021858|P2|NOT COMPLETED|Overall Study||3
7725559|NCT01647711|19021859|P1|NOT COMPLETED|Overall Study||6
7725560|NCT01647711|19021855|P5|COMPLETED|Overall Study||0
7725561|NCT01647711|19021856|P4|COMPLETED|Overall Study||0
7725562|NCT01647711|19021857|P3|COMPLETED|Overall Study||0
7725563|NCT01647711|19021858|P2|COMPLETED|Overall Study||0
7725564|NCT01647711|19021859|P1|COMPLETED|Overall Study||0
7725565|NCT01647711|19021855|P5|STARTED|Overall Study||6
7725566|NCT01647711|19021856|P4|STARTED|Overall Study||11
7725567|NCT01647711|19021857|P3|STARTED|Overall Study||9
7725568|NCT01647711|19021858|P2|STARTED|Overall Study||3
7725569|NCT01647711|19021859|P1|STARTED|Overall Study||6
7725570|NCT01647581|19021886|P2|NOT COMPLETED|Overall Study||31
7725571|NCT01647581|19021887|P1|NOT COMPLETED|Overall Study||17
7725572|NCT01647581|19021886|P2|COMPLETED|Overall Study||520
7725573|NCT01647581|19021887|P1|COMPLETED|Overall Study||530
7725574|NCT01647581|19021886|P2|STARTED|Overall Study||551
7725575|NCT01647581|19021887|P1|STARTED|Overall Study||547
7725576|NCT01647542|19021896|P3|NOT COMPLETED|Overall Study||72
7725577|NCT01647542|19021897|P2|NOT COMPLETED|Overall Study||73
7725578|NCT01647542|19021898|P1|NOT COMPLETED|Overall Study||76
7725579|NCT01647542|19021896|P3|COMPLETED|Overall Study||59
7725580|NCT01647542|19021897|P2|COMPLETED|Overall Study||58
7725581|NCT01647542|19021898|P1|COMPLETED|Overall Study||55
7725582|NCT01647542|19021896|P3|STARTED|Overall Study||131
7725583|NCT01647542|19021897|P2|STARTED|Overall Study||131
7725584|NCT01647542|19021898|P1|STARTED|Overall Study||131
7725585|NCT01647516|19021918|P6|NOT COMPLETED|Open-Label Period||56
7725586|NCT01647516|19021919|P5|NOT COMPLETED|Open-Label Period||51
7725587|NCT01647516|19021920|P4|NOT COMPLETED|Open-Label Period||49
7725588|NCT01647516|19021921|P3|NOT COMPLETED|Open-Label Period||0
7725589|NCT01647516|19021922|P2|NOT COMPLETED|Open-Label Period||0
7725590|NCT01647516|19021923|P1|NOT COMPLETED|Open-Label Period||0
7725591|NCT01647516|19021918|P6|COMPLETED|Open-Label Period||3
7725592|NCT01647516|19021919|P5|COMPLETED|Open-Label Period||5
7725593|NCT01647516|19021920|P4|COMPLETED|Open-Label Period||6
7725594|NCT01647516|19021921|P3|COMPLETED|Open-Label Period||0
7725595|NCT01647516|19021922|P2|COMPLETED|Open-Label Period||0
7725596|NCT01647516|19021923|P1|COMPLETED|Open-Label Period||0
7725597|NCT01647516|19021918|P6|STARTED|Open-Label Period|"The participants were:
~non-responders at Week 8,completed the MP or had disease relapse during MP"|59
7725598|NCT01647516|19021919|P5|STARTED|Open-Label Period|"The participants were:
~non-responders at Week 8,completed the MP or had disease relapse during MP"|56
7725599|NCT01647516|19021920|P4|STARTED|Open-Label Period|"The participants were:
~non-responders at Week 8,completed the MP or had disease relapse during MP"|55
7725600|NCT01647516|19021921|P3|STARTED|Open-Label Period||0
7725601|NCT01647516|19021922|P2|STARTED|Open-Label Period||0
7725602|NCT01647516|19021923|P1|STARTED|Open-Label Period||0
7725603|NCT01647516|19021918|P6|NOT COMPLETED|Maintenance Period (MP)||0
7725604|NCT01647516|19021919|P5|NOT COMPLETED|Maintenance Period (MP)||0
7725605|NCT01647516|19021920|P4|NOT COMPLETED|Maintenance Period (MP)||0
7725606|NCT01647516|19021921|P3|NOT COMPLETED|Maintenance Period (MP)||2
7725607|NCT01647516|19021922|P2|NOT COMPLETED|Maintenance Period (MP)||6
7725608|NCT01647516|19021923|P1|NOT COMPLETED|Maintenance Period (MP)||4
7725609|NCT01647516|19021918|P6|COMPLETED|Maintenance Period (MP)||0
7725610|NCT01647516|19021919|P5|COMPLETED|Maintenance Period (MP)||0
7725611|NCT01647516|19021920|P4|COMPLETED|Maintenance Period (MP)||0
7725612|NCT01647516|19021921|P3|COMPLETED|Maintenance Period (MP)||40
7725613|NCT01647516|19021922|P2|COMPLETED|Maintenance Period (MP)||30
7725614|NCT01647516|19021923|P1|COMPLETED|Maintenance Period (MP)||21
7725615|NCT01647516|19021918|P6|STARTED|Maintenance Period (MP)||0
7725616|NCT01647516|19021919|P5|STARTED|Maintenance Period (MP)||0
7725617|NCT01647516|19021920|P4|STARTED|Maintenance Period (MP)||0
7725618|NCT01647516|19021921|P3|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|42
7725619|NCT01647516|19021922|P2|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|36
7725620|NCT01647516|19021923|P1|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|25
7725621|NCT01647516|19021918|P6|NOT COMPLETED|Induction Period (IP)||0
7725622|NCT01647516|19021919|P5|NOT COMPLETED|Induction Period (IP)||0
7725623|NCT01647516|19021920|P4|NOT COMPLETED|Induction Period (IP)||0
7725624|NCT01647516|19021921|P3|NOT COMPLETED|Induction Period (IP)||4
7725625|NCT01647516|19021922|P2|NOT COMPLETED|Induction Period (IP)||3
7725626|NCT01647516|19021923|P1|NOT COMPLETED|Induction Period (IP)||6
7725627|NCT01647516|19021918|P6|COMPLETED|Induction Period (IP)||0
7725628|NCT01647516|19021919|P5|COMPLETED|Induction Period (IP)||0
7725629|NCT01647516|19021920|P4|COMPLETED|Induction Period (IP)||0
7725630|NCT01647516|19021921|P3|COMPLETED|Induction Period (IP)||63
7725631|NCT01647516|19021922|P2|COMPLETED|Induction Period (IP)||63
7725632|NCT01647516|19021923|P1|COMPLETED|Induction Period (IP)||60
7725633|NCT01647516|19021918|P6|Received Study Drug|Induction Period (IP)||0
7725634|NCT01647516|19021919|P5|Received Study Drug|Induction Period (IP)||0
7725635|NCT01647516|19021920|P4|Received Study Drug|Induction Period (IP)||0
7725636|NCT01647516|19021921|P3|Received Study Drug|Induction Period (IP)||67
7725637|NCT01647516|19021922|P2|Received Study Drug|Induction Period (IP)||65
7725638|NCT01647516|19021923|P1|Received Study Drug|Induction Period (IP)||65
7725639|NCT01647516|19021918|P6|STARTED|Induction Period (IP)||0
7725640|NCT01647516|19021919|P5|STARTED|Induction Period (IP)||0
7725641|NCT01647516|19021920|P4|STARTED|Induction Period (IP)||0
7725642|NCT01647516|19021921|P3|STARTED|Induction Period (IP)||67
7725643|NCT01647516|19021922|P2|STARTED|Induction Period (IP)||66
7725644|NCT01647516|19021923|P1|STARTED|Induction Period (IP)||66
7725645|NCT01647464|19021962|P1|NOT COMPLETED|Overall Study||0
7725646|NCT01647464|19021962|P1|COMPLETED|Overall Study||10
7725647|NCT01647464|19021962|P1|STARTED|Overall Study||10
7725648|NCT01647438|19021968|P2|NOT COMPLETED|Overall Study||0
7725649|NCT01647438|19021969|P1|NOT COMPLETED|Overall Study||0
7725650|NCT01647438|19021968|P2|COMPLETED|Overall Study||31
7725651|NCT01647438|19021969|P1|COMPLETED|Overall Study||32
7725652|NCT01647438|19021968|P2|STARTED|Overall Study||31
7725653|NCT01647438|19021969|P1|STARTED|Overall Study||32
7725654|NCT01647282|19021979|P2|NOT COMPLETED|Overall Study||5
7725655|NCT01647282|19021980|P1|NOT COMPLETED|Overall Study||7
7725656|NCT01647282|19021979|P2|COMPLETED|Overall Study||25
7725657|NCT01647282|19021980|P1|COMPLETED|Overall Study||23
7725658|NCT01647282|19021979|P2|STARTED|Overall Study||30
7725659|NCT01647282|19021980|P1|STARTED|Overall Study||30
7725660|NCT01647217|19021990|P2|NOT COMPLETED|Overall Study||1
7725661|NCT01647217|19021991|P1|NOT COMPLETED|Overall Study||1
7725662|NCT01647217|19021990|P2|COMPLETED|Overall Study||8
7725663|NCT01647217|19021991|P1|COMPLETED|Overall Study||7
7725664|NCT01647217|19021990|P2|STARTED|Overall Study||9
7725665|NCT01647217|19021991|P1|STARTED|Overall Study||8
7725666|NCT01646827|19022001|P2|NOT COMPLETED|Overall Study||5
7725667|NCT01646827|19022002|P1|NOT COMPLETED|Overall Study||2
7725668|NCT01646827|19022001|P2|COMPLETED|Overall Study||14
7725669|NCT01646827|19022002|P1|COMPLETED|Overall Study||16
7725670|NCT01646827|19022001|P2|STARTED|Overall Study||19
7725671|NCT01646827|19022002|P1|STARTED|Overall Study||18
7725672|NCT01646814|19022032|P2|NOT COMPLETED|Overall Study||6
7725673|NCT01646814|19022033|P1|NOT COMPLETED|Overall Study||11
7725674|NCT01646814|19022032|P2|COMPLETED|Overall Study||120
7725675|NCT01646814|19022033|P1|COMPLETED|Overall Study||110
7725676|NCT01646814|19022032|P2|STARTED|Overall Study||126
7725677|NCT01646814|19022033|P1|STARTED|Overall Study||121
7725678|NCT01646762|19022039|P1|NOT COMPLETED|Overall Study||0
7725679|NCT01646762|19022039|P1|COMPLETED|Overall Study||13
7725680|NCT01646762|19022039|P1|STARTED|Overall Study||13
7725681|NCT01646671|19022051|P3|NOT COMPLETED|Overall Study||0
7725682|NCT01646671|19022052|P2|NOT COMPLETED|Overall Study||0
7725683|NCT01646671|19022053|P1|NOT COMPLETED|Overall Study||0
7725684|NCT01646671|19022051|P3|COMPLETED|Overall Study||21
7725685|NCT01646671|19022052|P2|COMPLETED|Overall Study||11
7725686|NCT01646671|19022053|P1|COMPLETED|Overall Study||3
7725687|NCT01646671|19022051|P3|STARTED|Overall Study||21
7725688|NCT01646671|19022052|P2|STARTED|Overall Study||11
7725689|NCT01646671|19022053|P1|STARTED|Overall Study||3
7725690|NCT01646645|19022087|P1|NOT COMPLETED|Overall Study||30
7725691|NCT01646645|19022087|P1|COMPLETED|Overall Study||28
7725692|NCT01646645|19022087|P1|STARTED|Overall Study||58
7725693|NCT01646398|19022094|P2|NOT COMPLETED|Overall Study||0
7725694|NCT01646398|19022095|P1|NOT COMPLETED|Overall Study||1
7725695|NCT01646398|19022094|P2|COMPLETED|Overall Study||382
7725696|NCT01646398|19022095|P1|COMPLETED|Overall Study||381
7725697|NCT01646398|19022094|P2|STARTED|Overall Study||382
7725698|NCT01646398|19022095|P1|STARTED|Overall Study||382
7725699|NCT01646385|19022111|P2|NOT COMPLETED|Overall Study||871
7725700|NCT01646385|19022112|P1|NOT COMPLETED|Overall Study||838
7725701|NCT01646385|19022111|P2|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993
7725702|NCT01646385|19022112|P1|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691
7725703|NCT01646385|19022111|P2|STARTED|Overall Study||2864
7725704|NCT01646385|19022112|P1|STARTED|Overall Study||3529
7725705|NCT01646346|19022143|P1|NOT COMPLETED|Overall Study||0
7725706|NCT01646346|19022143|P1|COMPLETED|Overall Study||46
7725707|NCT01646346|19022143|P1|STARTED|Overall Study||46
7725708|NCT01646320|19022155|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7
7725709|NCT01646320|19022156|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6
7725710|NCT01646320|19022155|P2|COMPLETED|Long-term Period (Weeks 24 to 52)||140
7725711|NCT01646320|19022156|P1|COMPLETED|Long-term Period (Weeks 24 to 52)||141
7725712|NCT01646320|19022155|P2|STARTED|Long-term Period (Weeks 24 to 52)||147
7725713|NCT01646320|19022156|P1|STARTED|Long-term Period (Weeks 24 to 52)||147
7725714|NCT01646320|19022155|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7
7725715|NCT01646320|19022156|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12
7725716|NCT01646320|19022155|P2|COMPLETED|Short-term Period (Day 1 to Week 24)||153
7725717|NCT01646320|19022156|P1|COMPLETED|Short-term Period (Day 1 to Week 24)||148
7725718|NCT01646320|19022155|P2|STARTED|Short-term Period (Day 1 to Week 24)||160
7725719|NCT01646320|19022156|P1|STARTED|Short-term Period (Day 1 to Week 24)||160
7725720|NCT01646268|19022172|P2|NOT COMPLETED|Overall Study||16
7725721|NCT01646268|19022173|P1|NOT COMPLETED|Overall Study||11
7725722|NCT01646268|19022172|P2|COMPLETED|Overall Study||107
7725723|NCT01646268|19022173|P1|COMPLETED|Overall Study||113
7725724|NCT01646268|19022172|P2|STARTED|Overall Study||123
7725725|NCT01646268|19022173|P1|STARTED|Overall Study||124
7725726|NCT01646255|19022187|P2|NOT COMPLETED|Overall Study||14
7725727|NCT01646255|19022188|P1|NOT COMPLETED|Overall Study||21
7725728|NCT01646255|19022187|P2|COMPLETED|Overall Study||160
7725729|NCT01646255|19022188|P1|COMPLETED|Overall Study||151
7725730|NCT01646255|19022187|P2|STARTED|Overall Study||174
7725731|NCT01646255|19022188|P1|STARTED|Overall Study||172
7725732|NCT01646216|19022220|P2|NOT COMPLETED|Overall Study||13
7725733|NCT01646216|19022221|P1|NOT COMPLETED|Overall Study||11
7725734|NCT01646216|19022220|P2|COMPLETED|Overall Study||4
7725735|NCT01646216|19022221|P1|COMPLETED|Overall Study||6
7725736|NCT01646216|19022220|P2|STARTED|Overall Study||17
7725737|NCT01646216|19022221|P1|STARTED|Overall Study||17
7725738|NCT01646203|19022243|P3|NOT COMPLETED|Overall Study||1
7725739|NCT01646203|19022244|P2|NOT COMPLETED|Overall Study||2
7725740|NCT01646203|19022245|P1|NOT COMPLETED|Overall Study||2
7725741|NCT01646203|19022243|P3|COMPLETED|Overall Study||6
7725742|NCT01646203|19022244|P2|COMPLETED|Overall Study||3
7725743|NCT01646203|19022245|P1|COMPLETED|Overall Study||0
7725744|NCT01646203|19022243|P3|Received at Least One Dose of Study Drug|Overall Study||7
7725745|NCT01646203|19022244|P2|Received at Least One Dose of Study Drug|Overall Study||5
7725746|NCT01646203|19022245|P1|Received at Least One Dose of Study Drug|Overall Study||2
7725747|NCT01646203|19022243|P3|STARTED|Overall Study||7
7725748|NCT01646203|19022244|P2|STARTED|Overall Study||5
7725749|NCT01646203|19022245|P1|STARTED|Overall Study||2
7725750|NCT01646177|19022274|P12|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||83
7725751|NCT01646177|19022275|P11|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||80
7725752|NCT01646177|19022276|P10|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||76
7725753|NCT01646177|19022277|P9|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||31
7725754|NCT01646177|19022278|P8|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
7725755|NCT01646177|19022279|P7|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
7725756|NCT01646177|19022280|P6|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
7725757|NCT01646177|19022281|P5|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
7725758|NCT01646177|19022282|P4|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
7725759|NCT01646177|19022283|P3|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
7725760|NCT01646177|19022284|P2|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
7725761|NCT01646177|19022285|P1|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
7725762|NCT01646177|19022274|P12|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||230
7725763|NCT01646177|19022275|P11|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||225
7725764|NCT01646177|19022276|P10|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||233
7725765|NCT01646177|19022277|P9|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||126
7725766|NCT01646177|19022278|P8|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
7725767|NCT01646177|19022279|P7|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
7725768|NCT01646177|19022280|P6|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
7725769|NCT01646177|19022281|P5|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
7725770|NCT01646177|19022282|P4|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
7725771|NCT01646177|19022283|P3|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
7725772|NCT01646177|19022284|P2|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
7725773|NCT01646177|19022285|P1|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
7725774|NCT01646177|19022274|P12|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||313
7725775|NCT01646177|19022275|P11|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||305
7725776|NCT01646177|19022276|P10|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||309
7725777|NCT01646177|19022277|P9|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||157
7725778|NCT01646177|19022278|P8|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
7725779|NCT01646177|19022279|P7|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
7725780|NCT01646177|19022280|P6|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
7725781|NCT01646177|19022281|P5|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
7725782|NCT01646177|19022282|P4|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
7725783|NCT01646177|19022283|P3|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
7725784|NCT01646177|19022284|P2|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
7725785|NCT01646177|19022285|P1|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
7725786|NCT01646177|19022274|P12|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|313
7725787|NCT01646177|19022275|P11|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|305
7725788|NCT01646177|19022276|P10|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|309
7725789|NCT01646177|19022277|P9|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|157
7725790|NCT01646177|19022278|P8|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
7725791|NCT01646177|19022279|P7|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
7725792|NCT01646177|19022280|P6|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
7725856|NCT01646177|19022284|P2|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13
7725793|NCT01646177|19022281|P5|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
7725794|NCT01646177|19022282|P4|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
7725795|NCT01646177|19022283|P3|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
7725796|NCT01646177|19022284|P2|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
7725797|NCT01646177|19022285|P1|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
7725798|NCT01646177|19022274|P12|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
7725799|NCT01646177|19022275|P11|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
7725800|NCT01646177|19022276|P10|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
7725801|NCT01646177|19022277|P9|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
7725802|NCT01646177|19022278|P8|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||107
7725803|NCT01646177|19022279|P7|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||116
7725804|NCT01646177|19022280|P6|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||113
7725805|NCT01646177|19022281|P5|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||48
7725806|NCT01646177|19022282|P4|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
7725807|NCT01646177|19022283|P3|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
7725808|NCT01646177|19022284|P2|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
7725809|NCT01646177|19022285|P1|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
7725810|NCT01646177|19022274|P12|COMPLETED|Long-Term Extension Period (Week 12-264)||0
7725811|NCT01646177|19022275|P11|COMPLETED|Long-Term Extension Period (Week 12-264)||0
7725812|NCT01646177|19022276|P10|COMPLETED|Long-Term Extension Period (Week 12-264)||0
7725813|NCT01646177|19022277|P9|COMPLETED|Long-Term Extension Period (Week 12-264)||0
7725814|NCT01646177|19022278|P8|COMPLETED|Long-Term Extension Period (Week 12-264)||255
7725815|NCT01646177|19022279|P7|COMPLETED|Long-Term Extension Period (Week 12-264)||244
7725816|NCT01646177|19022280|P6|COMPLETED|Long-Term Extension Period (Week 12-264)||256
7725817|NCT01646177|19022281|P5|COMPLETED|Long-Term Extension Period (Week 12-264)||135
7725818|NCT01646177|19022282|P4|COMPLETED|Long-Term Extension Period (Week 12-264)||0
7725819|NCT01646177|19022283|P3|COMPLETED|Long-Term Extension Period (Week 12-264)||0
7725820|NCT01646177|19022284|P2|COMPLETED|Long-Term Extension Period (Week 12-264)||0
7725821|NCT01646177|19022285|P1|COMPLETED|Long-Term Extension Period (Week 12-264)||0
7725822|NCT01646177|19022274|P12|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
7725823|NCT01646177|19022275|P11|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
7725824|NCT01646177|19022276|P10|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
7725825|NCT01646177|19022277|P9|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
7725826|NCT01646177|19022278|P8|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||362
7725827|NCT01646177|19022279|P7|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||360
7725828|NCT01646177|19022280|P6|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||369
7725829|NCT01646177|19022281|P5|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||183
7725830|NCT01646177|19022282|P4|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
7725831|NCT01646177|19022283|P3|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
7725832|NCT01646177|19022284|P2|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
7725833|NCT01646177|19022285|P1|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
7725834|NCT01646177|19022274|P12|STARTED|Long-Term Extension Period (Week 12-264)||0
7725835|NCT01646177|19022275|P11|STARTED|Long-Term Extension Period (Week 12-264)||0
7725836|NCT01646177|19022276|P10|STARTED|Long-Term Extension Period (Week 12-264)||0
7725837|NCT01646177|19022277|P9|STARTED|Long-Term Extension Period (Week 12-264)||0
7725838|NCT01646177|19022278|P8|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|362
7725839|NCT01646177|19022279|P7|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|360
7725840|NCT01646177|19022280|P6|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|369
7725841|NCT01646177|19022281|P5|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|183
7725842|NCT01646177|19022282|P4|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
7725843|NCT01646177|19022283|P3|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
7725844|NCT01646177|19022284|P2|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
7725845|NCT01646177|19022285|P1|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
7725846|NCT01646177|19022274|P12|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
7725847|NCT01646177|19022275|P11|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
7725848|NCT01646177|19022276|P10|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
7725849|NCT01646177|19022277|P9|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
7725850|NCT01646177|19022278|P8|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
7725851|NCT01646177|19022279|P7|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
7725852|NCT01646177|19022280|P6|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
7725853|NCT01646177|19022281|P5|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
7725854|NCT01646177|19022282|P4|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22
7725855|NCT01646177|19022283|P3|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26
7725857|NCT01646177|19022285|P1|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10
7725858|NCT01646177|19022274|P12|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
7725859|NCT01646177|19022275|P11|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
7725860|NCT01646177|19022276|P10|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
7725861|NCT01646177|19022277|P9|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
7725862|NCT01646177|19022278|P8|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
7725863|NCT01646177|19022279|P7|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
7725864|NCT01646177|19022280|P6|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
7725865|NCT01646177|19022281|P5|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
7725866|NCT01646177|19022282|P4|COMPLETED|Blinded Induction Dosing (Week 0-12)||363
7725867|NCT01646177|19022283|P3|COMPLETED|Blinded Induction Dosing (Week 0-12)||360
7725868|NCT01646177|19022284|P2|COMPLETED|Blinded Induction Dosing (Week 0-12)||369
7725869|NCT01646177|19022285|P1|COMPLETED|Blinded Induction Dosing (Week 0-12)||183
7725870|NCT01646177|19022274|P12|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
7725871|NCT01646177|19022275|P11|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
7725872|NCT01646177|19022276|P10|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
7725873|NCT01646177|19022277|P9|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
7725874|NCT01646177|19022278|P8|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
7725875|NCT01646177|19022279|P7|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
7725876|NCT01646177|19022280|P6|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
7725877|NCT01646177|19022281|P5|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
7725878|NCT01646177|19022282|P4|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||384
7725879|NCT01646177|19022283|P3|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
7725880|NCT01646177|19022284|P2|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
7725881|NCT01646177|19022285|P1|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||193
7725882|NCT01646177|19022274|P12|STARTED|Blinded Induction Dosing (Week 0-12)||0
7725883|NCT01646177|19022275|P11|STARTED|Blinded Induction Dosing (Week 0-12)||0
7725884|NCT01646177|19022276|P10|STARTED|Blinded Induction Dosing (Week 0-12)||0
7725885|NCT01646177|19022277|P9|STARTED|Blinded Induction Dosing (Week 0-12)||0
7725886|NCT01646177|19022278|P8|STARTED|Blinded Induction Dosing (Week 0-12)||0
7725887|NCT01646177|19022279|P7|STARTED|Blinded Induction Dosing (Week 0-12)||0
7725888|NCT01646177|19022280|P6|STARTED|Blinded Induction Dosing (Week 0-12)||0
7725889|NCT01646177|19022281|P5|STARTED|Blinded Induction Dosing (Week 0-12)||0
7725890|NCT01646177|19022282|P4|STARTED|Blinded Induction Dosing (Week 0-12)||385
7725891|NCT01646177|19022283|P3|STARTED|Blinded Induction Dosing (Week 0-12)||386
7725892|NCT01646177|19022284|P2|STARTED|Blinded Induction Dosing (Week 0-12)||382
7725893|NCT01646177|19022285|P1|STARTED|Blinded Induction Dosing (Week 0-12)||193
7725894|NCT01646151|19022371|P1|NOT COMPLETED|Overall Study||170
7725895|NCT01646151|19022371|P1|COMPLETED|Overall Study||2410
7725896|NCT01646151|19022371|P1|STARTED|Overall Study||2580
7725897|NCT01646138|19022387|P5|NOT COMPLETED|Overall Study||2
7725898|NCT01646138|19022388|P4|NOT COMPLETED|Overall Study||0
7725899|NCT01646138|19022389|P3|NOT COMPLETED|Overall Study||0
7725900|NCT01646138|19022390|P2|NOT COMPLETED|Overall Study||0
7725901|NCT01646138|19022391|P1|NOT COMPLETED|Overall Study||0
7725902|NCT01646138|19022387|P5|COMPLETED|Overall Study||13
7725903|NCT01646138|19022388|P4|COMPLETED|Overall Study||19
7725904|NCT01646138|19022389|P3|COMPLETED|Overall Study||5
7725905|NCT01646138|19022390|P2|COMPLETED|Overall Study||4
7725906|NCT01646138|19022391|P1|COMPLETED|Overall Study||5
7725907|NCT01646138|19022387|P5|STARTED|Overall Study||15
7725908|NCT01646138|19022388|P4|STARTED|Overall Study||19
7725909|NCT01646138|19022389|P3|STARTED|Overall Study||5
7725910|NCT01646138|19022390|P2|STARTED|Overall Study||4
7725911|NCT01646138|19022391|P1|STARTED|Overall Study||5
7725912|NCT01646125|19022405|P2|NOT COMPLETED|Overall Study||28
7725913|NCT01646125|19022406|P1|NOT COMPLETED|Overall Study||31
7725914|NCT01646125|19022405|P2|COMPLETED|Overall Study||0
7725915|NCT01646125|19022406|P1|COMPLETED|Overall Study||0
7725916|NCT01646125|19022405|P2|STARTED|Overall Study||28
7725917|NCT01646125|19022406|P1|STARTED|Overall Study||31
7725918|NCT01646073|19022431|P2|NOT COMPLETED|Period B (12 Weeks)||13
7725919|NCT01646073|19022432|P1|NOT COMPLETED|Period B (12 Weeks)||1
7725920|NCT01646073|19022431|P2|COMPLETED|Period B (12 Weeks)||320
7725921|NCT01646073|19022432|P1|COMPLETED|Period B (12 Weeks)||84
7725922|NCT01646073|19022431|P2|STARTED|Period B (12 Weeks)||333
7725923|NCT01646073|19022432|P1|STARTED|Period B (12 Weeks)||85
7725924|NCT01646073|19022431|P2|NOT COMPLETED|Period A (12 Weeks)||5
7725925|NCT01646073|19022432|P1|NOT COMPLETED|Period A (12 Weeks)||2
7725926|NCT01646073|19022431|P2|COMPLETED|Period A (12 Weeks)||333
7725927|NCT01646073|19022432|P1|COMPLETED|Period A (12 Weeks)||85
7725928|NCT01646073|19022431|P2|STARTED|Period A (12 Weeks)||338
7725929|NCT01646073|19022432|P1|STARTED|Period A (12 Weeks)||87
7725930|NCT01646021|19022473|P2|NOT COMPLETED|Overall Study||141
7725931|NCT01646021|19022474|P1|NOT COMPLETED|Overall Study||139
7725932|NCT01646021|19022473|P2|COMPLETED|Overall Study||0
7725933|NCT01646021|19022474|P1|COMPLETED|Overall Study||0
7725934|NCT01646021|19022473|P2|Treated|Overall Study||139
7725935|NCT01646021|19022474|P1|Treated|Overall Study||139
7725936|NCT01646021|19022473|P2|STARTED|Overall Study||141
7725937|NCT01646021|19022474|P1|STARTED|Overall Study||139
7725938|NCT01645930|19022511|P1|NOT COMPLETED|Overall Study||43
7725939|NCT01645930|19022511|P1|COMPLETED|Overall Study||0
7725940|NCT01645930|19022511|P1|STARTED|Overall Study||43
7725941|NCT01645735|19022528|P2|NOT COMPLETED|Overall Study||1
7725942|NCT01645735|19022529|P1|NOT COMPLETED|Overall Study||4
7725943|NCT01645735|19022528|P2|COMPLETED|Overall Study||16
7725944|NCT01645735|19022529|P1|COMPLETED|Overall Study||28
7725945|NCT01645735|19022528|P2|STARTED|Overall Study||17
7725946|NCT01645735|19022529|P1|STARTED|Overall Study||32
7725947|NCT01645709|19022543|P2|NOT COMPLETED|Overall Study||0
7725948|NCT01645709|19022544|P1|NOT COMPLETED|Overall Study||0
7725949|NCT01645709|19022543|P2|COMPLETED|Overall Study|Study was terminated; not made unblind|0
7725950|NCT01645709|19022544|P1|COMPLETED|Overall Study|Study was terminated; not made unblind|0
7725951|NCT01645709|19022543|P2|STARTED|Overall Study|Study was terminated; not made unblind|0
7725952|NCT01645709|19022544|P1|STARTED|Overall Study|Study was terminated; not made unblind|0
7725953|NCT01645280|19022571|P5|NOT COMPLETED|Overall Study||8
7725954|NCT01645280|19022572|P4|NOT COMPLETED|Overall Study||6
7725955|NCT01645280|19022573|P3|NOT COMPLETED|Overall Study||6
7725956|NCT01645280|19022574|P2|NOT COMPLETED|Overall Study||3
7725957|NCT01645280|19022575|P1|NOT COMPLETED|Overall Study||6
7725958|NCT01645280|19022571|P5|COMPLETED|Overall Study||47
7725959|NCT01645280|19022572|P4|COMPLETED|Overall Study||48
7725960|NCT01645280|19022573|P3|COMPLETED|Overall Study||49
7725961|NCT01645280|19022574|P2|COMPLETED|Overall Study||51
7725962|NCT01645280|19022575|P1|COMPLETED|Overall Study||49
7725963|NCT01645280|19022571|P5|STARTED|Overall Study||55
7725964|NCT01645280|19022572|P4|STARTED|Overall Study||54
7725965|NCT01645280|19022573|P3|STARTED|Overall Study||55
7725966|NCT01645280|19022574|P2|STARTED|Overall Study||54
7725967|NCT01645280|19022575|P1|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55
7725968|NCT01645176|19022603|P1|NOT COMPLETED|Overall Study||5
7725969|NCT01645176|19022603|P1|COMPLETED|Overall Study||16
7725970|NCT01645176|19022603|P1|STARTED|Overall Study||21
7725971|NCT01645111|19022607|P1|NOT COMPLETED|Overall Study||15
7725972|NCT01645111|19022607|P1|COMPLETED|Overall Study||35
7725973|NCT01645111|19022607|P1|STARTED|Overall Study||50
7725974|NCT01645098|19022613|P2|NOT COMPLETED|Overall Study||0
7725975|NCT01645098|19022614|P1|NOT COMPLETED|Overall Study||0
7725976|NCT01645098|19022613|P2|COMPLETED|Overall Study||29
7725977|NCT01645098|19022614|P1|COMPLETED|Overall Study||24
7725978|NCT01645098|19022613|P2|STARTED|Overall Study||29
7725979|NCT01645098|19022614|P1|STARTED|Overall Study||24
7725980|NCT01645059|19022628|P1|NOT COMPLETED|Overall Study||0
7725981|NCT01645059|19022628|P1|COMPLETED|Overall Study||129
7725982|NCT01645059|19022628|P1|STARTED|Overall Study||129
7725983|NCT01644890|19022648|P2|NOT COMPLETED|Overall Study||215
7725984|NCT01644890|19022649|P1|NOT COMPLETED|Overall Study||216
7725985|NCT01644890|19022648|P2|COMPLETED|Overall Study||3
7725986|NCT01644890|19022649|P1|COMPLETED|Overall Study||2
7725987|NCT01644890|19022648|P2|STARTED|Overall Study||218
7725988|NCT01644890|19022649|P1|STARTED|Overall Study||218
7725989|NCT01644734|19022659|P1|NOT COMPLETED|Overall Study||266
7725990|NCT01644734|19022659|P1|COMPLETED|Overall Study||1016
7725991|NCT01644734|19022659|P1|STARTED|Overall Study|Patients with documentation of treatment.|1282
7725992|NCT01644695|19022664|P1|NOT COMPLETED|Overall Study||0
7725993|NCT01644695|19022664|P1|COMPLETED|Overall Study||85
7725994|NCT01644695|19022664|P1|STARTED|Overall Study||85
7725995|NCT01644643|19022673|P4|NOT COMPLETED|Overall Study||10
7725996|NCT01644643|19022674|P3|NOT COMPLETED|Overall Study||5
7725997|NCT01644643|19022675|P2|NOT COMPLETED|Overall Study||0
7725998|NCT01644643|19022676|P1|NOT COMPLETED|Overall Study||2
7725999|NCT01644643|19022673|P4|COMPLETED|Overall Study||143
7726000|NCT01644643|19022674|P3|COMPLETED|Overall Study||148
7726001|NCT01644643|19022675|P2|COMPLETED|Overall Study||12
7726002|NCT01644643|19022676|P1|COMPLETED|Overall Study||13
7726003|NCT01644643|19022673|P4|STARTED|Overall Study||153
7726004|NCT01644643|19022674|P3|STARTED|Overall Study||153
7726005|NCT01644643|19022675|P2|STARTED|Overall Study||12
7726006|NCT01644643|19022676|P1|STARTED|Overall Study||15
7726007|NCT01644617|19022841|P3|NOT COMPLETED|Overall Study||7
7726008|NCT01644617|19022842|P2|NOT COMPLETED|Overall Study||5
7726009|NCT01644617|19022843|P1|NOT COMPLETED|Overall Study||6
7726010|NCT01644617|19022841|P3|COMPLETED|Overall Study||34
7726011|NCT01644617|19022842|P2|COMPLETED|Overall Study||36
7726012|NCT01644617|19022843|P1|COMPLETED|Overall Study||36
7726013|NCT01644617|19022841|P3|STARTED|Overall Study||41
7726014|NCT01644617|19022842|P2|STARTED|Overall Study||41
7726015|NCT01644617|19022843|P1|STARTED|Overall Study||42
7726016|NCT01644565|19022893|P9|NOT COMPLETED|Overall Study||1
7726017|NCT01644565|19022894|P8|NOT COMPLETED|Overall Study||2
7726018|NCT01644565|19022895|P7|NOT COMPLETED|Overall Study||0
7726019|NCT01644565|19022896|P6|NOT COMPLETED|Overall Study||0
7726020|NCT01644565|19022897|P5|NOT COMPLETED|Overall Study||1
7726021|NCT01644565|19022898|P4|NOT COMPLETED|Overall Study||1
7726022|NCT01644565|19022899|P3|NOT COMPLETED|Overall Study||0
7726023|NCT01644565|19022900|P2|NOT COMPLETED|Overall Study||0
7726024|NCT01644565|19022901|P1|NOT COMPLETED|Overall Study||1
7726025|NCT01644565|19022893|P9|COMPLETED|Overall Study||7
7726026|NCT01644565|19022894|P8|COMPLETED|Overall Study||8
7726027|NCT01644565|19022895|P7|COMPLETED|Overall Study||7
7726028|NCT01644565|19022896|P6|COMPLETED|Overall Study||7
7726029|NCT01644565|19022897|P5|COMPLETED|Overall Study||4
7726030|NCT01644565|19022898|P4|COMPLETED|Overall Study||4
7726031|NCT01644565|19022899|P3|COMPLETED|Overall Study||5
7726032|NCT01644565|19022900|P2|COMPLETED|Overall Study||5
7726033|NCT01644565|19022901|P1|COMPLETED|Overall Study||4
7726034|NCT01644565|19022893|P9|STARTED|Overall Study||8
7726035|NCT01644565|19022894|P8|STARTED|Overall Study||10
7726036|NCT01644565|19022895|P7|STARTED|Overall Study||7
7726037|NCT01644565|19022896|P6|STARTED|Overall Study||7
7726038|NCT01644565|19022897|P5|STARTED|Overall Study||5
7726039|NCT01644565|19022898|P4|STARTED|Overall Study||5
7726040|NCT01644565|19022899|P3|STARTED|Overall Study||5
7726041|NCT01644565|19022900|P2|STARTED|Overall Study||5
7726042|NCT01644565|19022901|P1|STARTED|Overall Study||5
7726043|NCT01644500|19022942|P3|NOT COMPLETED|Overall Study||15
7726044|NCT01644500|19022943|P2|NOT COMPLETED|Overall Study||24
7726045|NCT01644500|19022944|P1|NOT COMPLETED|Overall Study||22
7726046|NCT01644500|19022942|P3|COMPLETED|Overall Study||230
7726047|NCT01644500|19022943|P2|COMPLETED|Overall Study||224
7726048|NCT01644500|19022944|P1|COMPLETED|Overall Study||222
7726049|NCT01644500|19022942|P3|Modified Intent-to-treat Population|Overall Study||242
7726050|NCT01644500|19022943|P2|Modified Intent-to-treat Population|Overall Study||239
7726051|NCT01644500|19022944|P1|Modified Intent-to-treat Population|Overall Study||239
7726052|NCT01644500|19022942|P3|Received at Least One Dose of Study Drug|Overall Study||243
7726053|NCT01644500|19022943|P2|Received at Least One Dose of Study Drug|Overall Study||248
7726054|NCT01644500|19022944|P1|Received at Least One Dose of Study Drug|Overall Study||244
7726055|NCT01644500|19022942|P3|STARTED|Overall Study||245
7726056|NCT01644500|19022943|P2|STARTED|Overall Study||248
7726057|NCT01644500|19022944|P1|STARTED|Overall Study||244
7726058|NCT01644474|19023014|P2|NOT COMPLETED|Overall Study||8
7726059|NCT01644474|19023015|P1|NOT COMPLETED|Overall Study||7
7726060|NCT01644474|19023014|P2|COMPLETED|Overall Study||44
7726061|NCT01644474|19023015|P1|COMPLETED|Overall Study||44
7726062|NCT01644474|19023014|P2|Treated|Overall Study||52
7726063|NCT01644474|19023015|P1|Treated|Overall Study||51
7726064|NCT01644474|19023014|P2|STARTED|Overall Study|Randomized|52
7726065|NCT01644474|19023015|P1|STARTED|Overall Study|Randomized|51
7726066|NCT01644396|19023055|P1|NOT COMPLETED|Overall Study||0
7726067|NCT01644396|19023055|P1|COMPLETED|Overall Study||50
7726068|NCT01644396|19023055|P1|STARTED|Overall Study||50
7726069|NCT01644331|19023099|P2|NOT COMPLETED|Overall Study||10
7726070|NCT01644331|19023100|P1|NOT COMPLETED|Overall Study||11
7726071|NCT01644331|19023099|P2|COMPLETED|Overall Study||118
7726072|NCT01644331|19023100|P1|COMPLETED|Overall Study||118
7726073|NCT01644331|19023099|P2|STARTED|Overall Study||128
7726074|NCT01644331|19023100|P1|STARTED|Overall Study||129
7726075|NCT01644292|19023132|P1|NOT COMPLETED|Overall Study||0
7726076|NCT01644292|19023132|P1|COMPLETED|Overall Study||2
7726077|NCT01644292|19023132|P1|STARTED|Overall Study||2
7726078|NCT01644240|19023139|P3|NOT COMPLETED|Overall Study||0
7726079|NCT01644240|19023140|P2|NOT COMPLETED|Overall Study||0
7726080|NCT01644240|19023141|P1|NOT COMPLETED|Overall Study||0
7726081|NCT01644240|19023139|P3|COMPLETED|Overall Study||6
7726082|NCT01644240|19023140|P2|COMPLETED|Overall Study||4
7726083|NCT01644240|19023141|P1|COMPLETED|Overall Study||6
7726084|NCT01644240|19023139|P3|STARTED|Overall Study||6
7726085|NCT01644240|19023140|P2|STARTED|Overall Study||4
7726086|NCT01644240|19023141|P1|STARTED|Overall Study||6
7726087|NCT01644188|19023199|P2|NOT COMPLETED|Overall Study||75
7726088|NCT01644188|19023200|P1|NOT COMPLETED|Overall Study||122
7726089|NCT01644188|19023199|P2|COMPLETED|Overall Study||166
7726090|NCT01644188|19023200|P1|COMPLETED|Overall Study||357
7726091|NCT01644188|19023199|P2|Treated|Overall Study||241
7726092|NCT01644188|19023200|P1|Treated|Overall Study||479
7726093|NCT01644188|19023199|P2|STARTED|Overall Study|Randomized|241
7726094|NCT01644188|19023200|P1|STARTED|Overall Study|Randomized|479
7726095|NCT01644175|19023258|P2|NOT COMPLETED|Overall Study||53
7726096|NCT01644175|19023259|P1|NOT COMPLETED|Overall Study||32
7726097|NCT01644175|19023258|P2|COMPLETED|Overall Study||156
7726098|NCT01644175|19023259|P1|COMPLETED|Overall Study||75
7726099|NCT01644175|19023258|P2|Treated|Overall Study||207
7726100|NCT01644175|19023259|P1|Treated|Overall Study||107
7726101|NCT01644175|19023258|P2|STARTED|Overall Study|Randomized|209
7726102|NCT01644175|19023259|P1|STARTED|Overall Study|Randomized|107
7726103|NCT01644149|19023311|P2|NOT COMPLETED|Overall Study||1
7726104|NCT01644149|19023312|P1|NOT COMPLETED|Overall Study||4
7726105|NCT01644149|19023311|P2|COMPLETED|Overall Study|28 day serum samples were not obtained from one NS subject.|39
7726106|NCT01644149|19023312|P1|COMPLETED|Overall Study|One subject discontinued prior to vaccination. 28 day serum samples not obtained from 3 subjects.|39
7726107|NCT01644149|19023311|P2|STARTED|Overall Study||40
7726108|NCT01644149|19023312|P1|STARTED|Overall Study||43
7726109|NCT01644058|19023322|P1|NOT COMPLETED|Overall Study||0
7726110|NCT01644058|19023322|P1|COMPLETED|Overall Study||18
7726111|NCT01644058|19023322|P1|STARTED|Overall Study||18
7726112|NCT01643928|19023332|P5|NOT COMPLETED|Overall Study||2
7726113|NCT01643928|19023333|P4|NOT COMPLETED|Overall Study||3
7726114|NCT01643928|19023334|P3|NOT COMPLETED|Overall Study||3
7726115|NCT01643928|19023335|P2|NOT COMPLETED|Overall Study||2
7726116|NCT01643928|19023336|P1|NOT COMPLETED|Overall Study||10
7726117|NCT01643928|19023332|P5|COMPLETED|Overall Study||28
7726118|NCT01643928|19023333|P4|COMPLETED|Overall Study||27
7726119|NCT01643928|19023334|P3|COMPLETED|Overall Study||30
7726120|NCT01643928|19023335|P2|COMPLETED|Overall Study||30
7726121|NCT01643928|19023336|P1|COMPLETED|Overall Study||48
7726122|NCT01643928|19023332|P5|STARTED|Overall Study||30
7726123|NCT01643928|19023333|P4|STARTED|Overall Study||30
7726124|NCT01643928|19023334|P3|STARTED|Overall Study||33
7726125|NCT01643928|19023335|P2|STARTED|Overall Study||32
7726126|NCT01643928|19023336|P1|STARTED|Overall Study||58
7726127|NCT01643902|19023621|P1|NOT COMPLETED|Overall Study||0
7726128|NCT01643902|19023621|P1|COMPLETED|Overall Study||20
7726129|NCT01643902|19023621|P1|STARTED|Overall Study||20
7726130|NCT01643876|19023626|P1|NOT COMPLETED|Overall Study||0
7726131|NCT01643876|19023626|P1|COMPLETED|Overall Study||48
7726132|NCT01643876|19023626|P1|STARTED|Overall Study||48
7726133|NCT01643850|19023640|P9|NOT COMPLETED|Overall Study||1
7726134|NCT01643850|19023641|P8|NOT COMPLETED|Overall Study||0
7726135|NCT01643850|19023642|P7|NOT COMPLETED|Overall Study||1
7726136|NCT01643850|19023643|P6|NOT COMPLETED|Overall Study||0
7726137|NCT01643850|19023644|P5|NOT COMPLETED|Overall Study||3
7726138|NCT01643850|19023645|P4|NOT COMPLETED|Overall Study||0
7726139|NCT01643850|19023646|P3|NOT COMPLETED|Overall Study||1
7726140|NCT01643850|19023647|P2|NOT COMPLETED|Overall Study||0
7726141|NCT01643850|19023648|P1|NOT COMPLETED|Overall Study||0
7726142|NCT01643850|19023640|P9|COMPLETED|Overall Study||3
7726143|NCT01643850|19023641|P8|COMPLETED|Overall Study||4
7726144|NCT01643850|19023642|P7|COMPLETED|Overall Study||3
7726145|NCT01643850|19023643|P6|COMPLETED|Overall Study||3
7726146|NCT01643850|19023644|P5|COMPLETED|Overall Study||0
7726147|NCT01643850|19023645|P4|COMPLETED|Overall Study||3
7726148|NCT01643850|19023646|P3|COMPLETED|Overall Study||7
7726149|NCT01643850|19023647|P2|COMPLETED|Overall Study||2
7726150|NCT01643850|19023648|P1|COMPLETED|Overall Study||5
7726151|NCT01643850|19023640|P9|STARTED|Overall Study||4
7726152|NCT01643850|19023641|P8|STARTED|Overall Study||4
7726153|NCT01643850|19023642|P7|STARTED|Overall Study||4
7726154|NCT01643850|19023643|P6|STARTED|Overall Study||3
7726155|NCT01643850|19023644|P5|STARTED|Overall Study||3
7726156|NCT01643850|19023645|P4|STARTED|Overall Study||3
7726157|NCT01643850|19023646|P3|STARTED|Overall Study||8
7726158|NCT01643850|19023647|P2|STARTED|Overall Study||2
7726159|NCT01643850|19023648|P1|STARTED|Overall Study||5
7726160|NCT01643798|19023787|P2|NOT COMPLETED|Pretreatment 2 and Stimulation||0
7726161|NCT01643798|19023788|P1|NOT COMPLETED|Pretreatment 2 and Stimulation||0
7726162|NCT01643798|19023787|P2|COMPLETED|Pretreatment 2 and Stimulation||8
7726163|NCT01643798|19023788|P1|COMPLETED|Pretreatment 2 and Stimulation||6
7726164|NCT01643798|19023787|P2|STARTED|Pretreatment 2 and Stimulation||8
7726165|NCT01643798|19023788|P1|STARTED|Pretreatment 2 and Stimulation||6
7726166|NCT01643798|19023787|P2|NOT COMPLETED|Pretreatment 1 and Stimulation||0
7726167|NCT01643798|19023788|P1|NOT COMPLETED|Pretreatment 1 and Stimulation||1
7726168|NCT01643798|19023787|P2|COMPLETED|Pretreatment 1 and Stimulation||8
7726169|NCT01643798|19023788|P1|COMPLETED|Pretreatment 1 and Stimulation||6
7726170|NCT01643798|19023787|P2|STARTED|Pretreatment 1 and Stimulation||8
7726171|NCT01643798|19023788|P1|STARTED|Pretreatment 1 and Stimulation||7
7726172|NCT01643772|19023803|P4|NOT COMPLETED|Overall Study||2
7726173|NCT01643772|19023804|P3|NOT COMPLETED|Overall Study||0
7726174|NCT01643772|19023805|P2|NOT COMPLETED|Overall Study||0
7726175|NCT01643772|19023806|P1|NOT COMPLETED|Overall Study||0
7726176|NCT01643772|19023803|P4|COMPLETED|Overall Study||14
7726177|NCT01643772|19023804|P3|COMPLETED|Overall Study||15
7726178|NCT01643772|19023805|P2|COMPLETED|Overall Study||15
7726179|NCT01643772|19023806|P1|COMPLETED|Overall Study||15
7726180|NCT01643772|19023803|P4|STARTED|Overall Study||16
7726181|NCT01643772|19023804|P3|STARTED|Overall Study||15
7726182|NCT01643772|19023805|P2|STARTED|Overall Study||15
7726183|NCT01643772|19023806|P1|STARTED|Overall Study||15
7726184|NCT01643668|19023846|P1|NOT COMPLETED|Overall Study||1
7726185|NCT01643668|19023846|P1|COMPLETED|Overall Study||33
7726186|NCT01643668|19023846|P1|STARTED|Overall Study||34
7726187|NCT01643616|19023860|P2|NOT COMPLETED|Overall Study||0
7726188|NCT01643616|19023861|P1|NOT COMPLETED|Overall Study||0
7726189|NCT01643616|19023860|P2|COMPLETED|Overall Study||125
7726190|NCT01643616|19023861|P1|COMPLETED|Overall Study||125
7726191|NCT01643616|19023860|P2|STARTED|Overall Study||125
7726192|NCT01643616|19023861|P1|STARTED|Overall Study||125
7726193|NCT01643525|19023871|P1|NOT COMPLETED|Overall Study||0
7726194|NCT01643525|19023871|P1|COMPLETED|Overall Study||29
7726195|NCT01643525|19023871|P1|STARTED|Overall Study||29
7726196|NCT01643473|19023877|P2|NOT COMPLETED|Overall Study||0
7726197|NCT01643473|19023878|P1|NOT COMPLETED|Overall Study||1
7726198|NCT01643473|19023877|P2|COMPLETED|Overall Study||21
7726199|NCT01643473|19023878|P1|COMPLETED|Overall Study||20
7726200|NCT01643473|19023877|P2|STARTED|Overall Study||21
7726201|NCT01643473|19023878|P1|STARTED|Overall Study||21
7726202|NCT01643382|19023892|P2|NOT COMPLETED|Overall Study||0
7726203|NCT01643382|19023893|P1|NOT COMPLETED|Overall Study||0
7726204|NCT01643382|19023892|P2|COMPLETED|Overall Study||30
7726205|NCT01643382|19023893|P1|COMPLETED|Overall Study||30
7726206|NCT01643382|19023892|P2|STARTED|Overall Study||30
7726207|NCT01643382|19023893|P1|STARTED|Overall Study||30
7726208|NCT01643213|19023901|P2|NOT COMPLETED|Overall Study||0
7726209|NCT01643213|19023902|P1|NOT COMPLETED|Overall Study||1
7726210|NCT01643213|19023901|P2|COMPLETED|Overall Study||14
7726211|NCT01643213|19023902|P1|COMPLETED|Overall Study||12
7726212|NCT01643213|19023901|P2|STARTED|Overall Study||14
7726213|NCT01643213|19023902|P1|STARTED|Overall Study||13
7726214|NCT01643044|19023910|P2|NOT COMPLETED|Overall Study||5
7726215|NCT01643044|19023911|P1|NOT COMPLETED|Overall Study||4
7726216|NCT01643044|19023910|P2|COMPLETED|Overall Study||19
7726217|NCT01643044|19023911|P1|COMPLETED|Overall Study||20
7726218|NCT01643044|19023910|P2|STARTED|Overall Study||24
7726219|NCT01643044|19023911|P1|STARTED|Overall Study||24
7726220|NCT01642914|19023920|P3|NOT COMPLETED|Overall Study||40
7726221|NCT01642914|19023921|P2|NOT COMPLETED|Overall Study||32
7726222|NCT01642914|19023922|P1|NOT COMPLETED|Overall Study||46
7726223|NCT01642914|19023920|P3|COMPLETED|Overall Study||120
7726224|NCT01642914|19023921|P2|COMPLETED|Overall Study||122
7726225|NCT01642914|19023922|P1|COMPLETED|Overall Study||127
7726226|NCT01642914|19023920|P3|STARTED|Overall Study||160
7726227|NCT01642914|19023921|P2|STARTED|Overall Study||154
7726228|NCT01642914|19023922|P1|STARTED|Overall Study||173
7726229|NCT01642732|19023997|P1|NOT COMPLETED|Overall Study||1
7726230|NCT01642732|19023997|P1|COMPLETED|Overall Study||0
7726231|NCT01642732|19023997|P1|STARTED|Overall Study||1
7726232|NCT01642615|19024002|P3|NOT COMPLETED|Double Blind Maintenance Phase||6
7726233|NCT01642615|19024003|P2|NOT COMPLETED|Double Blind Maintenance Phase||7
7726234|NCT01642615|19024004|P1|NOT COMPLETED|Double Blind Maintenance Phase||0
7726235|NCT01642615|19024002|P3|COMPLETED|Double Blind Maintenance Phase||20
7726236|NCT01642615|19024003|P2|COMPLETED|Double Blind Maintenance Phase||18
7726237|NCT01642615|19024004|P1|COMPLETED|Double Blind Maintenance Phase||0
7726238|NCT01642615|19024002|P3|STARTED|Double Blind Maintenance Phase||26
7726239|NCT01642615|19024003|P2|STARTED|Double Blind Maintenance Phase||25
7726240|NCT01642615|19024004|P1|STARTED|Double Blind Maintenance Phase||0
7726241|NCT01642615|19024002|P3|NOT COMPLETED|Open Label Maintenance Phase||0
7726242|NCT01642615|19024003|P2|NOT COMPLETED|Open Label Maintenance Phase||0
7726243|NCT01642615|19024004|P1|NOT COMPLETED|Open Label Maintenance Phase||5
7726244|NCT01642615|19024002|P3|COMPLETED|Open Label Maintenance Phase||0
7726245|NCT01642615|19024003|P2|COMPLETED|Open Label Maintenance Phase||0
7726246|NCT01642615|19024004|P1|COMPLETED|Open Label Maintenance Phase||58
7726247|NCT01642615|19024002|P3|Safety Analysis Set|Open Label Maintenance Phase||0
7726248|NCT01642615|19024003|P2|Safety Analysis Set|Open Label Maintenance Phase||0
7726249|NCT01642615|19024004|P1|Safety Analysis Set|Open Label Maintenance Phase||62
7726250|NCT01642615|19024002|P3|STARTED|Open Label Maintenance Phase||0
7726251|NCT01642615|19024003|P2|STARTED|Open Label Maintenance Phase||0
7726252|NCT01642615|19024004|P1|STARTED|Open Label Maintenance Phase||63
7726253|NCT01642602|19024018|P1|NOT COMPLETED|Overall Study||2
7726254|NCT01642602|19024018|P1|COMPLETED|Overall Study||102
7726255|NCT01642602|19024018|P1|STARTED|Overall Study||104
7726256|NCT01642589|19024025|P2|NOT COMPLETED|Overall Study||1
7726257|NCT01642589|19024026|P1|NOT COMPLETED|Overall Study||1
7726258|NCT01642589|19024025|P2|COMPLETED|Overall Study||99
7726259|NCT01642589|19024026|P1|COMPLETED|Overall Study||199
7726260|NCT01642589|19024025|P2|STARTED|Overall Study||100
7726261|NCT01642589|19024026|P1|STARTED|Overall Study||200
7726262|NCT01642485|19024040|P8|NOT COMPLETED|Period 2, Day 3||0
7726263|NCT01642485|19024041|P7|NOT COMPLETED|Period 2, Day 3||0
7726264|NCT01642485|19024042|P6|NOT COMPLETED|Period 2, Day 3||0
7726265|NCT01642485|19024043|P5|NOT COMPLETED|Period 2, Day 3||0
7726266|NCT01642485|19024044|P4|NOT COMPLETED|Period 2, Day 3||0
7726267|NCT01642485|19024045|P3|NOT COMPLETED|Period 2, Day 3||0
7726268|NCT01642485|19024046|P2|NOT COMPLETED|Period 2, Day 3||0
7726269|NCT01642485|19024047|P1|NOT COMPLETED|Period 2, Day 3||0
7726270|NCT01642485|19024040|P8|COMPLETED|Period 2, Day 3||4
7726271|NCT01642485|19024041|P7|COMPLETED|Period 2, Day 3||4
7726272|NCT01642485|19024042|P6|COMPLETED|Period 2, Day 3||4
7726273|NCT01642485|19024043|P5|COMPLETED|Period 2, Day 3||4
7726274|NCT01642485|19024044|P4|COMPLETED|Period 2, Day 3||4
7726275|NCT01642485|19024045|P3|COMPLETED|Period 2, Day 3||4
7726276|NCT01642485|19024046|P2|COMPLETED|Period 2, Day 3||4
7726277|NCT01642485|19024047|P1|COMPLETED|Period 2, Day 3||4
7726278|NCT01642485|19024040|P8|STARTED|Period 2, Day 3||4
7726279|NCT01642485|19024041|P7|STARTED|Period 2, Day 3||4
7726280|NCT01642485|19024042|P6|STARTED|Period 2, Day 3||4
7726281|NCT01642485|19024043|P5|STARTED|Period 2, Day 3||4
7726282|NCT01642485|19024044|P4|STARTED|Period 2, Day 3||4
7726283|NCT01642485|19024045|P3|STARTED|Period 2, Day 3||4
7726284|NCT01642485|19024046|P2|STARTED|Period 2, Day 3||4
7726285|NCT01642485|19024047|P1|STARTED|Period 2, Day 3||4
7726286|NCT01642485|19024040|P8|NOT COMPLETED|Period 2, Day 2||0
7726287|NCT01642485|19024041|P7|NOT COMPLETED|Period 2, Day 2||0
7726288|NCT01642485|19024042|P6|NOT COMPLETED|Period 2, Day 2||0
7726289|NCT01642485|19024043|P5|NOT COMPLETED|Period 2, Day 2||0
7726290|NCT01642485|19024044|P4|NOT COMPLETED|Period 2, Day 2||0
7726291|NCT01642485|19024045|P3|NOT COMPLETED|Period 2, Day 2||0
7726292|NCT01642485|19024046|P2|NOT COMPLETED|Period 2, Day 2||0
7726293|NCT01642485|19024047|P1|NOT COMPLETED|Period 2, Day 2||0
7726294|NCT01642485|19024040|P8|COMPLETED|Period 2, Day 2||4
7726295|NCT01642485|19024041|P7|COMPLETED|Period 2, Day 2||4
7726296|NCT01642485|19024042|P6|COMPLETED|Period 2, Day 2||4
7726297|NCT01642485|19024043|P5|COMPLETED|Period 2, Day 2||4
7726298|NCT01642485|19024044|P4|COMPLETED|Period 2, Day 2||4
7726299|NCT01642485|19024045|P3|COMPLETED|Period 2, Day 2||4
7726300|NCT01642485|19024046|P2|COMPLETED|Period 2, Day 2||4
7726301|NCT01642485|19024047|P1|COMPLETED|Period 2, Day 2||4
7726302|NCT01642485|19024040|P8|STARTED|Period 2, Day 2||4
7726303|NCT01642485|19024041|P7|STARTED|Period 2, Day 2||4
7726304|NCT01642485|19024042|P6|STARTED|Period 2, Day 2||4
7726305|NCT01642485|19024043|P5|STARTED|Period 2, Day 2||4
7726306|NCT01642485|19024044|P4|STARTED|Period 2, Day 2||4
7726307|NCT01642485|19024045|P3|STARTED|Period 2, Day 2||4
7726308|NCT01642485|19024046|P2|STARTED|Period 2, Day 2||4
7726309|NCT01642485|19024047|P1|STARTED|Period 2, Day 2||4
7726310|NCT01642485|19024040|P8|NOT COMPLETED|Period 2, Day 1||0
7726311|NCT01642485|19024041|P7|NOT COMPLETED|Period 2, Day 1||0
7726312|NCT01642485|19024042|P6|NOT COMPLETED|Period 2, Day 1||0
7726313|NCT01642485|19024043|P5|NOT COMPLETED|Period 2, Day 1||0
7726314|NCT01642485|19024044|P4|NOT COMPLETED|Period 2, Day 1||0
7726315|NCT01642485|19024045|P3|NOT COMPLETED|Period 2, Day 1||0
7726316|NCT01642485|19024046|P2|NOT COMPLETED|Period 2, Day 1||0
7726317|NCT01642485|19024047|P1|NOT COMPLETED|Period 2, Day 1||0
7726318|NCT01642485|19024040|P8|COMPLETED|Period 2, Day 1||4
7726319|NCT01642485|19024041|P7|COMPLETED|Period 2, Day 1||4
7726320|NCT01642485|19024042|P6|COMPLETED|Period 2, Day 1||4
7726321|NCT01642485|19024043|P5|COMPLETED|Period 2, Day 1||4
7726322|NCT01642485|19024044|P4|COMPLETED|Period 2, Day 1||4
7726323|NCT01642485|19024045|P3|COMPLETED|Period 2, Day 1||4
7726324|NCT01642485|19024046|P2|COMPLETED|Period 2, Day 1||4
7726325|NCT01642485|19024047|P1|COMPLETED|Period 2, Day 1||4
7726326|NCT01642485|19024040|P8|STARTED|Period 2, Day 1||4
7726327|NCT01642485|19024041|P7|STARTED|Period 2, Day 1||4
7726328|NCT01642485|19024042|P6|STARTED|Period 2, Day 1||4
7726329|NCT01642485|19024043|P5|STARTED|Period 2, Day 1||4
7726330|NCT01642485|19024044|P4|STARTED|Period 2, Day 1||4
7726331|NCT01642485|19024045|P3|STARTED|Period 2, Day 1||4
7726332|NCT01642485|19024046|P2|STARTED|Period 2, Day 1||4
7726333|NCT01642485|19024047|P1|STARTED|Period 2, Day 1||4
7726334|NCT01642485|19024040|P8|NOT COMPLETED|Period 1, Day 3||0
7726335|NCT01642485|19024041|P7|NOT COMPLETED|Period 1, Day 3||0
7726336|NCT01642485|19024042|P6|NOT COMPLETED|Period 1, Day 3||0
7726337|NCT01642485|19024043|P5|NOT COMPLETED|Period 1, Day 3||0
7726338|NCT01642485|19024044|P4|NOT COMPLETED|Period 1, Day 3||0
7726339|NCT01642485|19024045|P3|NOT COMPLETED|Period 1, Day 3||0
7726340|NCT01642485|19024046|P2|NOT COMPLETED|Period 1, Day 3||0
7726341|NCT01642485|19024047|P1|NOT COMPLETED|Period 1, Day 3||0
7726342|NCT01642485|19024040|P8|COMPLETED|Period 1, Day 3||4
7726343|NCT01642485|19024041|P7|COMPLETED|Period 1, Day 3||4
7726344|NCT01642485|19024042|P6|COMPLETED|Period 1, Day 3||4
7726345|NCT01642485|19024043|P5|COMPLETED|Period 1, Day 3||4
7726346|NCT01642485|19024044|P4|COMPLETED|Period 1, Day 3||4
7726347|NCT01642485|19024045|P3|COMPLETED|Period 1, Day 3||4
7726348|NCT01642485|19024046|P2|COMPLETED|Period 1, Day 3||4
7726349|NCT01642485|19024047|P1|COMPLETED|Period 1, Day 3||4
7726350|NCT01642485|19024040|P8|STARTED|Period 1, Day 3||4
7726351|NCT01642485|19024041|P7|STARTED|Period 1, Day 3||4
7726352|NCT01642485|19024042|P6|STARTED|Period 1, Day 3||4
7726353|NCT01642485|19024043|P5|STARTED|Period 1, Day 3||4
7726354|NCT01642485|19024044|P4|STARTED|Period 1, Day 3||4
7726355|NCT01642485|19024045|P3|STARTED|Period 1, Day 3||4
7726356|NCT01642485|19024046|P2|STARTED|Period 1, Day 3||4
7726357|NCT01642485|19024047|P1|STARTED|Period 1, Day 3||4
7726358|NCT01642485|19024040|P8|NOT COMPLETED|Period 1, Day 2||0
7726359|NCT01642485|19024041|P7|NOT COMPLETED|Period 1, Day 2||0
7726360|NCT01642485|19024042|P6|NOT COMPLETED|Period 1, Day 2||0
7726361|NCT01642485|19024043|P5|NOT COMPLETED|Period 1, Day 2||0
7726362|NCT01642485|19024044|P4|NOT COMPLETED|Period 1, Day 2||0
7726363|NCT01642485|19024045|P3|NOT COMPLETED|Period 1, Day 2||0
7726364|NCT01642485|19024046|P2|NOT COMPLETED|Period 1, Day 2||0
7726365|NCT01642485|19024047|P1|NOT COMPLETED|Period 1, Day 2||0
7726366|NCT01642485|19024040|P8|COMPLETED|Period 1, Day 2||4
7726367|NCT01642485|19024041|P7|COMPLETED|Period 1, Day 2||4
7726368|NCT01642485|19024042|P6|COMPLETED|Period 1, Day 2||4
7726369|NCT01642485|19024043|P5|COMPLETED|Period 1, Day 2||4
7726370|NCT01642485|19024044|P4|COMPLETED|Period 1, Day 2||4
7726371|NCT01642485|19024045|P3|COMPLETED|Period 1, Day 2||4
7726372|NCT01642485|19024046|P2|COMPLETED|Period 1, Day 2||4
7726373|NCT01642485|19024047|P1|COMPLETED|Period 1, Day 2||4
7726374|NCT01642485|19024040|P8|STARTED|Period 1, Day 2||4
7726375|NCT01642485|19024041|P7|STARTED|Period 1, Day 2||4
7726376|NCT01642485|19024042|P6|STARTED|Period 1, Day 2||4
7726377|NCT01642485|19024043|P5|STARTED|Period 1, Day 2||4
7726378|NCT01642485|19024044|P4|STARTED|Period 1, Day 2||4
7726379|NCT01642485|19024045|P3|STARTED|Period 1, Day 2||4
7726380|NCT01642485|19024046|P2|STARTED|Period 1, Day 2||4
7726381|NCT01642485|19024047|P1|STARTED|Period 1, Day 2||4
7726382|NCT01642485|19024040|P8|NOT COMPLETED|Period 1, Day 1||0
7726383|NCT01642485|19024041|P7|NOT COMPLETED|Period 1, Day 1||0
7726384|NCT01642485|19024042|P6|NOT COMPLETED|Period 1, Day 1||0
7726385|NCT01642485|19024043|P5|NOT COMPLETED|Period 1, Day 1||0
7726386|NCT01642485|19024044|P4|NOT COMPLETED|Period 1, Day 1||0
7726387|NCT01642485|19024045|P3|NOT COMPLETED|Period 1, Day 1||0
7726388|NCT01642485|19024046|P2|NOT COMPLETED|Period 1, Day 1||0
7726389|NCT01642485|19024047|P1|NOT COMPLETED|Period 1, Day 1||0
7726390|NCT01642485|19024040|P8|COMPLETED|Period 1, Day 1||4
7726391|NCT01642485|19024041|P7|COMPLETED|Period 1, Day 1||4
7726392|NCT01642485|19024042|P6|COMPLETED|Period 1, Day 1||4
7726393|NCT01642485|19024043|P5|COMPLETED|Period 1, Day 1||4
7726394|NCT01642485|19024044|P4|COMPLETED|Period 1, Day 1||4
7726395|NCT01642485|19024045|P3|COMPLETED|Period 1, Day 1||4
7726396|NCT01642485|19024046|P2|COMPLETED|Period 1, Day 1||4
7726397|NCT01642485|19024047|P1|COMPLETED|Period 1, Day 1||4
7726398|NCT01642485|19024040|P8|STARTED|Period 1, Day 1||4
7726399|NCT01642485|19024041|P7|STARTED|Period 1, Day 1||4
7726400|NCT01642485|19024042|P6|STARTED|Period 1, Day 1||4
7726401|NCT01642485|19024043|P5|STARTED|Period 1, Day 1||4
7726402|NCT01642485|19024044|P4|STARTED|Period 1, Day 1||4
7726403|NCT01642485|19024045|P3|STARTED|Period 1, Day 1||4
7726404|NCT01642485|19024046|P2|STARTED|Period 1, Day 1||4
7726405|NCT01642485|19024047|P1|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4
7726406|NCT01642407|19024065|P1|NOT COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||2
7726407|NCT01642407|19024065|P1|COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||1
7726408|NCT01642407|19024065|P1|STARTED|Part 2(Week17 to Maximum of 119.6 Weeks)||3
7726409|NCT01642407|19024065|P1|NOT COMPLETED|Part 1 (Screening Till Week 16)||3
7726410|NCT01642407|19024065|P1|COMPLETED|Part 1 (Screening Till Week 16)||3
7726411|NCT01642407|19024065|P1|STARTED|Part 1 (Screening Till Week 16)||6
7726412|NCT01642277|19024112|P2|NOT COMPLETED|Overall Study||0
7726413|NCT01642277|19024113|P1|NOT COMPLETED|Overall Study||24
7726414|NCT01642277|19024112|P2|COMPLETED|Overall Study||60
7726415|NCT01642277|19024113|P1|COMPLETED|Overall Study||50
7726416|NCT01642277|19024112|P2|STARTED|Overall Study||60
7726417|NCT01642277|19024113|P1|STARTED|Overall Study||74
7726418|NCT01642251|19024125|P4|NOT COMPLETED|Overall Study||23
7726419|NCT01642251|19024126|P3|NOT COMPLETED|Overall Study||22
7726420|NCT01642251|19024127|P2|NOT COMPLETED|Overall Study||0
7726421|NCT01642251|19024128|P1|NOT COMPLETED|Overall Study||0
7726422|NCT01642251|19024125|P4|COMPLETED|Overall Study||49
7726423|NCT01642251|19024126|P3|COMPLETED|Overall Study||53
7726424|NCT01642251|19024127|P2|COMPLETED|Overall Study||6
7726425|NCT01642251|19024128|P1|COMPLETED|Overall Study||3
7726426|NCT01642251|19024125|P4|Eligible and Treated|Overall Study||64
7726427|NCT01642251|19024126|P3|Eligible and Treated|Overall Study||64
7726428|NCT01642251|19024127|P2|Eligible and Treated|Overall Study||6
7726429|NCT01642251|19024128|P1|Eligible and Treated|Overall Study||3
7726430|NCT01642251|19024125|P4|Eligible|Overall Study||69
7726431|NCT01642251|19024126|P3|Eligible|Overall Study||72
7726432|NCT01642251|19024127|P2|Eligible|Overall Study||6
7726433|NCT01642251|19024128|P1|Eligible|Overall Study||3
7726434|NCT01642251|19024125|P4|Started Protocol Therapy|Overall Study||66
7726435|NCT01642251|19024126|P3|Started Protocol Therapy|Overall Study||66
7726436|NCT01642251|19024127|P2|Started Protocol Therapy|Overall Study||6
7726437|NCT01642251|19024128|P1|Started Protocol Therapy|Overall Study||3
7726438|NCT01642251|19024125|P4|STARTED|Overall Study||72
7726439|NCT01642251|19024126|P3|STARTED|Overall Study||75
7726440|NCT01642251|19024127|P2|STARTED|Overall Study||6
7726441|NCT01642251|19024128|P1|STARTED|Overall Study||3
7726442|NCT01642238|19024143|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7726443|NCT01642238|19024144|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7726444|NCT01642238|19024143|P2|COMPLETED|Second Intervention (1 Day)||8
7726445|NCT01642238|19024144|P1|COMPLETED|Second Intervention (1 Day)||7
7726446|NCT01642238|19024143|P2|STARTED|Second Intervention (1 Day)||8
7726447|NCT01642238|19024144|P1|STARTED|Second Intervention (1 Day)||7
7726448|NCT01642238|19024143|P2|NOT COMPLETED|Washout (1-2 Weeks)||0
7726449|NCT01642238|19024144|P1|NOT COMPLETED|Washout (1-2 Weeks)||0
7726450|NCT01642238|19024143|P2|COMPLETED|Washout (1-2 Weeks)||8
7726451|NCT01642238|19024144|P1|COMPLETED|Washout (1-2 Weeks)||7
7726452|NCT01642238|19024143|P2|STARTED|Washout (1-2 Weeks)||8
7726453|NCT01642238|19024144|P1|STARTED|Washout (1-2 Weeks)||7
7726454|NCT01642238|19024143|P2|NOT COMPLETED|First Intervention (1 Day)||0
7726455|NCT01642238|19024144|P1|NOT COMPLETED|First Intervention (1 Day)||0
7726456|NCT01642238|19024143|P2|COMPLETED|First Intervention (1 Day)||8
7726457|NCT01642238|19024144|P1|COMPLETED|First Intervention (1 Day)||7
7726458|NCT01642238|19024143|P2|STARTED|First Intervention (1 Day)||8
7726459|NCT01642238|19024144|P1|STARTED|First Intervention (1 Day)||7
7726460|NCT01642212|19024166|P5|NOT COMPLETED|Open-label Extension||8
7726461|NCT01642212|19024167|P4|NOT COMPLETED|Open-label Extension||10
7726462|NCT01642212|19024168|P3|NOT COMPLETED|Open-label Extension||0
7726463|NCT01642212|19024169|P2|NOT COMPLETED|Open-label Extension||0
7726464|NCT01642212|19024170|P1|NOT COMPLETED|Open-label Extension||0
7726465|NCT01642212|19024166|P5|COMPLETED|Open-label Extension||37
7726466|NCT01642212|19024167|P4|COMPLETED|Open-label Extension||27
7726467|NCT01642212|19024168|P3|COMPLETED|Open-label Extension||0
7726468|NCT01642212|19024169|P2|COMPLETED|Open-label Extension||0
7726469|NCT01642212|19024170|P1|COMPLETED|Open-label Extension||0
7726470|NCT01642212|19024166|P5|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45
7726471|NCT01642212|19024167|P4|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37
7726472|NCT01642212|19024168|P3|STARTED|Open-label Extension||0
7726473|NCT01642212|19024169|P2|STARTED|Open-label Extension||0
7726474|NCT01642212|19024170|P1|STARTED|Open-label Extension||0
7726475|NCT01642212|19024166|P5|NOT COMPLETED|Double-blind Treatment||0
7726476|NCT01642212|19024167|P4|NOT COMPLETED|Double-blind Treatment||0
7726477|NCT01642212|19024168|P3|NOT COMPLETED|Double-blind Treatment||2
7726478|NCT01642212|19024169|P2|NOT COMPLETED|Double-blind Treatment||3
7726479|NCT01642212|19024170|P1|NOT COMPLETED|Double-blind Treatment||0
7726480|NCT01642212|19024166|P5|COMPLETED|Double-blind Treatment||0
7726481|NCT01642212|19024167|P4|COMPLETED|Double-blind Treatment||0
7726482|NCT01642212|19024168|P3|COMPLETED|Double-blind Treatment||49
7726483|NCT01642212|19024169|P2|COMPLETED|Double-blind Treatment||39
7726484|NCT01642212|19024170|P1|COMPLETED|Double-blind Treatment||0
7726485|NCT01642212|19024166|P5|STARTED|Double-blind Treatment||0
7726486|NCT01642212|19024167|P4|STARTED|Double-blind Treatment||0
7726487|NCT01642212|19024168|P3|STARTED|Double-blind Treatment||51
7726488|NCT01642212|19024169|P2|STARTED|Double-blind Treatment||42
7726489|NCT01642212|19024170|P1|STARTED|Double-blind Treatment||0
7726490|NCT01642212|19024166|P5|NOT COMPLETED|Single-blind Baseline||0
7726491|NCT01642212|19024167|P4|NOT COMPLETED|Single-blind Baseline||0
7726492|NCT01642212|19024168|P3|NOT COMPLETED|Single-blind Baseline||0
7726493|NCT01642212|19024169|P2|NOT COMPLETED|Single-blind Baseline||0
7726494|NCT01642212|19024170|P1|NOT COMPLETED|Single-blind Baseline||26
7726495|NCT01642212|19024166|P5|COMPLETED|Single-blind Baseline||0
7726496|NCT01642212|19024167|P4|COMPLETED|Single-blind Baseline||0
7726497|NCT01642212|19024168|P3|COMPLETED|Single-blind Baseline||0
7726498|NCT01642212|19024169|P2|COMPLETED|Single-blind Baseline||0
7726499|NCT01642212|19024170|P1|COMPLETED|Single-blind Baseline||93
7726500|NCT01642212|19024166|P5|STARTED|Single-blind Baseline||0
7726501|NCT01642212|19024167|P4|STARTED|Single-blind Baseline||0
7726502|NCT01642212|19024168|P3|STARTED|Single-blind Baseline||0
7726503|NCT01642212|19024169|P2|STARTED|Single-blind Baseline||0
7726504|NCT01642212|19024170|P1|STARTED|Single-blind Baseline||119
7726505|NCT01642147|19024220|P2|NOT COMPLETED|Overall Study||0
7726506|NCT01642147|19024221|P1|NOT COMPLETED|Overall Study||0
7726507|NCT01642147|19024220|P2|COMPLETED|Overall Study||30
7726508|NCT01642147|19024221|P1|COMPLETED|Overall Study||30
7726509|NCT01642147|19024220|P2|STARTED|Overall Study||30
7726510|NCT01642147|19024221|P1|STARTED|Overall Study||30
7726511|NCT01642082|19024249|P1|NOT COMPLETED|Overall Study||0
7726512|NCT01642082|19024249|P1|COMPLETED|Overall Study||28
7726513|NCT01642082|19024249|P1|STARTED|Overall Study||28
7726514|NCT01642004|19024265|P2|NOT COMPLETED|Treatment||127
7726515|NCT01642004|19024266|P1|NOT COMPLETED|Treatment||110
7726516|NCT01642004|19024265|P2|COMPLETED|Treatment||2
7726517|NCT01642004|19024266|P1|COMPLETED|Treatment||21
7726518|NCT01642004|19024265|P2|STARTED|Treatment||129
7726519|NCT01642004|19024266|P1|STARTED|Treatment||131
7726520|NCT01642004|19024265|P2|NOT COMPLETED|Randomization||8
7726521|NCT01642004|19024266|P1|NOT COMPLETED|Randomization||4
7726522|NCT01642004|19024265|P2|COMPLETED|Randomization||129
7726523|NCT01642004|19024266|P1|COMPLETED|Randomization||131
7726524|NCT01642004|19024265|P2|STARTED|Randomization||137
7726525|NCT01642004|19024266|P1|STARTED|Randomization||135
7726526|NCT01641991|19024300|P4|NOT COMPLETED|Overall Study||16
7726527|NCT01641991|19024301|P3|NOT COMPLETED|Overall Study||17
7726528|NCT01641991|19024302|P2|NOT COMPLETED|Overall Study||8
7726529|NCT01641991|19024303|P1|NOT COMPLETED|Overall Study||9
7726530|NCT01641991|19024300|P4|COMPLETED|Overall Study||66
7726531|NCT01641991|19024301|P3|COMPLETED|Overall Study||65
7726532|NCT01641991|19024302|P2|COMPLETED|Overall Study||74
7726533|NCT01641991|19024303|P1|COMPLETED|Overall Study||73
7726534|NCT01641991|19024300|P4|STARTED|Overall Study||82
7726535|NCT01641991|19024301|P3|STARTED|Overall Study||82
7726536|NCT01641991|19024302|P2|STARTED|Overall Study||82
7726537|NCT01641991|19024303|P1|STARTED|Overall Study||82
7726538|NCT01641978|19024379|P1|NOT COMPLETED|Overall Study||0
7726539|NCT01641978|19024379|P1|COMPLETED|Overall Study||125
7726540|NCT01641978|19024379|P1|STARTED|Overall Study||125
7726541|NCT01641952|19024387|P1|NOT COMPLETED|Overall Study||34
7726542|NCT01641952|19024387|P1|COMPLETED|Overall Study||471
7726543|NCT01641952|19024387|P1|Treated|Overall Study||504
7726544|NCT01641952|19024387|P1|STARTED|Overall Study||505
7726545|NCT01641939|19024403|P3|NOT COMPLETED|Overall Study||70
7726546|NCT01641939|19024404|P2|NOT COMPLETED|Overall Study||228
7726547|NCT01641939|19024405|P1|NOT COMPLETED|Overall Study||117
7726548|NCT01641939|19024403|P3|COMPLETED|Overall Study||0
7726549|NCT01641939|19024404|P2|COMPLETED|Overall Study||0
7726550|NCT01641939|19024405|P1|COMPLETED|Overall Study||0
7726551|NCT01641939|19024403|P3|Stage 2|Overall Study||0
7726552|NCT01641939|19024404|P2|Stage 2|Overall Study||153
7726553|NCT01641939|19024405|P1|Stage 2|Overall Study||80
7726554|NCT01641939|19024403|P3|Stage 1|Overall Study||70
7726555|NCT01641939|19024404|P2|Stage 1|Overall Study||75
7726556|NCT01641939|19024405|P1|Stage 1|Overall Study||37
7726557|NCT01641939|19024403|P3|STARTED|Overall Study||70
7726558|NCT01641939|19024404|P2|STARTED|Overall Study||228
7726559|NCT01641939|19024405|P1|STARTED|Overall Study||117
7726560|NCT01641926|19024448|P4|NOT COMPLETED|Overall Study||4
7726561|NCT01641926|19024449|P3|NOT COMPLETED|Overall Study||11
7726562|NCT01641926|19024450|P2|NOT COMPLETED|Overall Study||15
7726563|NCT01641926|19024451|P1|NOT COMPLETED|Overall Study||28
7726564|NCT01641926|19024448|P4|COMPLETED|Overall Study||53
7726565|NCT01641926|19024449|P3|COMPLETED|Overall Study||46
7726566|NCT01641926|19024450|P2|COMPLETED|Overall Study||130
7726567|NCT01641926|19024451|P1|COMPLETED|Overall Study||115
7726568|NCT01641926|19024448|P4|Treated (All Participants as Treated)|Overall Study||57
7726569|NCT01641926|19024449|P3|Treated (All Participants as Treated)|Overall Study||56
7726570|NCT01641926|19024450|P2|Treated (All Participants as Treated)|Overall Study||144
7726571|NCT01641926|19024451|P1|Treated (All Participants as Treated)|Overall Study||142
7726572|NCT01641926|19024448|P4|STARTED|Overall Study||57
7726573|NCT01641926|19024449|P3|STARTED|Overall Study||57
7726574|NCT01641926|19024450|P2|STARTED|Overall Study||145
7726575|NCT01641926|19024451|P1|STARTED|Overall Study||143
7726576|NCT01641900|19024479|P2|NOT COMPLETED|Overall Study||2
7726577|NCT01641900|19024480|P1|NOT COMPLETED|Overall Study||2
7726578|NCT01641900|19024479|P2|COMPLETED|Overall Study||29
7726579|NCT01641900|19024480|P1|COMPLETED|Overall Study||26
7726580|NCT01641900|19024479|P2|Completed Drug Intervention|Overall Study||29
7726656|NCT01641692|19024728|P4|NOT COMPLETED|Washout Period 3 or Follow-up||1
7726581|NCT01641900|19024480|P1|Completed Drug Intervention|Overall Study|n=1,assigned to drug intervention first, completed the session and dropped out of the study.|26
7726582|NCT01641900|19024479|P2|Completed Placebo Intervention|Overall Study|n=2,both assigned to placebo intervention first, completed the session and dropped out of the study.|29
7726583|NCT01641900|19024480|P1|Completed Placebo Intervention|Overall Study|n=1,assigned to placebo intervention first, completed the session and dropped out of the study.|27
7726584|NCT01641900|19024479|P2|STARTED|Overall Study||31
7726585|NCT01641900|19024480|P1|STARTED|Overall Study||28
7726586|NCT01641861|19024492|P2|NOT COMPLETED|Overall Study||25
7726587|NCT01641861|19024493|P1|NOT COMPLETED|Overall Study||35
7726588|NCT01641861|19024492|P2|COMPLETED|Overall Study||217
7726589|NCT01641861|19024493|P1|COMPLETED|Overall Study||211
7726590|NCT01641861|19024492|P2|STARTED|Overall Study||242
7726591|NCT01641861|19024493|P1|STARTED|Overall Study||246
7726592|NCT01641835|19024507|P1|NOT COMPLETED|Overall Study||0
7726593|NCT01641835|19024507|P1|COMPLETED|Overall Study||303
7726594|NCT01641835|19024507|P1|STARTED|Overall Study||303
7726595|NCT01641822|19024514|P3|NOT COMPLETED|Comparative Phase||10
7726596|NCT01641822|19024515|P2|NOT COMPLETED|Comparative Phase||6
7726597|NCT01641822|19024516|P1|NOT COMPLETED|Comparative Phase||0
7726598|NCT01641822|19024514|P3|COMPLETED|Comparative Phase||37
7726599|NCT01641822|19024515|P2|COMPLETED|Comparative Phase||37
7726600|NCT01641822|19024516|P1|COMPLETED|Comparative Phase||0
7726601|NCT01641822|19024514|P3|Received Randomized Study Drug Treatment|Comparative Phase||46
7726602|NCT01641822|19024515|P2|Received Randomized Study Drug Treatment|Comparative Phase||42
7726603|NCT01641822|19024516|P1|Received Randomized Study Drug Treatment|Comparative Phase||0
7726604|NCT01641822|19024514|P3|STARTED|Comparative Phase||47
7726605|NCT01641822|19024515|P2|STARTED|Comparative Phase||43
7726606|NCT01641822|19024516|P1|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0
7726607|NCT01641822|19024514|P3|NOT COMPLETED|Run-in Phase||0
7726608|NCT01641822|19024515|P2|NOT COMPLETED|Run-in Phase||0
7726609|NCT01641822|19024516|P1|NOT COMPLETED|Run-in Phase||14
7726610|NCT01641822|19024514|P3|COMPLETED|Run-in Phase||0
7726611|NCT01641822|19024515|P2|COMPLETED|Run-in Phase||0
7726612|NCT01641822|19024516|P1|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93
7726613|NCT01641822|19024514|P3|STARTED|Run-in Phase||0
7726614|NCT01641822|19024515|P2|STARTED|Run-in Phase||0
7726615|NCT01641822|19024516|P1|STARTED|Run-in Phase||107
7726616|NCT01641809|19024537|P4|NOT COMPLETED|Open-label (Week 96 to Week 324)||0
7726617|NCT01641809|19024538|P3|NOT COMPLETED|Open-label (Week 96 to Week 324)||8
7726618|NCT01641809|19024539|P2|NOT COMPLETED|Open-label (Week 96 to Week 324)||12
7726619|NCT01641809|19024540|P1|NOT COMPLETED|Open-label (Week 96 to Week 324)||16
7726620|NCT01641809|19024537|P4|COMPLETED|Open-label (Week 96 to Week 324)||0
7726621|NCT01641809|19024538|P3|COMPLETED|Open-label (Week 96 to Week 324)||43
7726622|NCT01641809|19024539|P2|COMPLETED|Open-label (Week 96 to Week 324)||35
7726623|NCT01641809|19024540|P1|COMPLETED|Open-label (Week 96 to Week 324)||30
7726624|NCT01641809|19024537|P4|STARTED|Open-label (Week 96 to Week 324)|Participants completed study at Week 96 and did not enter open-label phase|0
7726625|NCT01641809|19024538|P3|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|51
7726626|NCT01641809|19024539|P2|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|47
7726627|NCT01641809|19024540|P1|STARTED|Open-label (Week 96 to Week 324)||46
7726628|NCT01641809|19024537|P4|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
7726629|NCT01641809|19024538|P3|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||3
7726630|NCT01641809|19024539|P2|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||5
7726631|NCT01641809|19024540|P1|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
7726632|NCT01641809|19024537|P4|COMPLETED|Maintenance Phase (Week 24 to Week 96)||41
7726633|NCT01641809|19024538|P3|COMPLETED|Maintenance Phase (Week 24 to Week 96)||52
7726634|NCT01641809|19024539|P2|COMPLETED|Maintenance Phase (Week 24 to Week 96)||48
7726635|NCT01641809|19024540|P1|COMPLETED|Maintenance Phase (Week 24 to Week 96)||46
7726636|NCT01641809|19024537|P4|STARTED|Maintenance Phase (Week 24 to Week 96)||47
7726637|NCT01641809|19024538|P3|STARTED|Maintenance Phase (Week 24 to Week 96)||55
7726638|NCT01641809|19024539|P2|STARTED|Maintenance Phase (Week 24 to Week 96)||53
7726639|NCT01641809|19024540|P1|STARTED|Maintenance Phase (Week 24 to Week 96)||52
7726640|NCT01641809|19024537|P4|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||15
7726641|NCT01641809|19024538|P3|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||6
7726642|NCT01641809|19024539|P2|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||7
7726643|NCT01641809|19024540|P1|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||8
7726644|NCT01641809|19024537|P4|COMPLETED|Induction Phase (Day 1 to Week 24)||47
7726645|NCT01641809|19024538|P3|COMPLETED|Induction Phase (Day 1 to Week 24)||55
7726646|NCT01641809|19024539|P2|COMPLETED|Induction Phase (Day 1 to Week 24)||53
7726647|NCT01641809|19024540|P1|COMPLETED|Induction Phase (Day 1 to Week 24)||52
7726648|NCT01641809|19024537|P4|STARTED|Induction Phase (Day 1 to Week 24)||62
7726649|NCT01641809|19024538|P3|STARTED|Induction Phase (Day 1 to Week 24)||61
7726650|NCT01641809|19024539|P2|STARTED|Induction Phase (Day 1 to Week 24)||60
7726651|NCT01641809|19024540|P1|STARTED|Induction Phase (Day 1 to Week 24)||60
7726652|NCT01641692|19024724|P8|NOT COMPLETED|Washout Period 3 or Follow-up||0
7726653|NCT01641692|19024725|P7|NOT COMPLETED|Washout Period 3 or Follow-up||1
7726654|NCT01641692|19024726|P6|NOT COMPLETED|Washout Period 3 or Follow-up||2
7726655|NCT01641692|19024727|P5|NOT COMPLETED|Washout Period 3 or Follow-up||0
7726657|NCT01641692|19024729|P3|NOT COMPLETED|Washout Period 3 or Follow-up||1
7726658|NCT01641692|19024730|P2|NOT COMPLETED|Washout Period 3 or Follow-up||0
7726659|NCT01641692|19024731|P1|NOT COMPLETED|Washout Period 3 or Follow-up||1
7726660|NCT01641692|19024724|P8|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38
7726661|NCT01641692|19024725|P7|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
7726662|NCT01641692|19024726|P6|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37
7726663|NCT01641692|19024727|P5|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40
7726664|NCT01641692|19024728|P4|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41
7726665|NCT01641692|19024729|P3|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36
7726666|NCT01641692|19024730|P2|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
7726667|NCT01641692|19024731|P1|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42
7726668|NCT01641692|19024724|P8|STARTED|Washout Period 3 or Follow-up||38
7726669|NCT01641692|19024725|P7|STARTED|Washout Period 3 or Follow-up||33
7726670|NCT01641692|19024726|P6|STARTED|Washout Period 3 or Follow-up||39
7726671|NCT01641692|19024727|P5|STARTED|Washout Period 3 or Follow-up||40
7726672|NCT01641692|19024728|P4|STARTED|Washout Period 3 or Follow-up||42
7726673|NCT01641692|19024729|P3|STARTED|Washout Period 3 or Follow-up||37
7726674|NCT01641692|19024730|P2|STARTED|Washout Period 3 or Follow-up||32
7726675|NCT01641692|19024731|P1|STARTED|Washout Period 3 or Follow-up||43
7726676|NCT01641692|19024724|P8|NOT COMPLETED|Treatment Period 3||0
7726677|NCT01641692|19024725|P7|NOT COMPLETED|Treatment Period 3||2
7726678|NCT01641692|19024726|P6|NOT COMPLETED|Treatment Period 3||0
7726679|NCT01641692|19024727|P5|NOT COMPLETED|Treatment Period 3||0
7726680|NCT01641692|19024728|P4|NOT COMPLETED|Treatment Period 3||0
7726681|NCT01641692|19024729|P3|NOT COMPLETED|Treatment Period 3||1
7726682|NCT01641692|19024730|P2|NOT COMPLETED|Treatment Period 3||1
7726683|NCT01641692|19024731|P1|NOT COMPLETED|Treatment Period 3||0
7726684|NCT01641692|19024724|P8|COMPLETED|Treatment Period 3||38
7726685|NCT01641692|19024725|P7|COMPLETED|Treatment Period 3||33
7726686|NCT01641692|19024726|P6|COMPLETED|Treatment Period 3||39
7726687|NCT01641692|19024727|P5|COMPLETED|Treatment Period 3||40
7726688|NCT01641692|19024728|P4|COMPLETED|Treatment Period 3||42
7726689|NCT01641692|19024729|P3|COMPLETED|Treatment Period 3||37
7726690|NCT01641692|19024730|P2|COMPLETED|Treatment Period 3||32
7726691|NCT01641692|19024731|P1|COMPLETED|Treatment Period 3||43
7726692|NCT01641692|19024724|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
7726693|NCT01641692|19024725|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35
7726694|NCT01641692|19024726|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39
7726695|NCT01641692|19024727|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40
7726696|NCT01641692|19024728|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42
7726697|NCT01641692|19024729|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
7726698|NCT01641692|19024730|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33
7726699|NCT01641692|19024731|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43
7726700|NCT01641692|19024724|P8|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
7726701|NCT01641692|19024725|P7|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
7726702|NCT01641692|19024726|P6|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
7726703|NCT01641692|19024727|P5|NOT COMPLETED|Washout Period 2 (12-14 Days)||3
7726704|NCT01641692|19024728|P4|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
7726705|NCT01641692|19024729|P3|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
7726706|NCT01641692|19024730|P2|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
7726707|NCT01641692|19024731|P1|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
7726708|NCT01641692|19024724|P8|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
7726709|NCT01641692|19024725|P7|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
7726710|NCT01641692|19024726|P6|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
7726711|NCT01641692|19024727|P5|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
7726712|NCT01641692|19024728|P4|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41
7726713|NCT01641692|19024729|P3|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
7726714|NCT01641692|19024730|P2|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46
7726715|NCT01641692|19024731|P1|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30
7726716|NCT01641692|19024724|P8|STARTED|Washout Period 2 (12-14 Days)||35
7726717|NCT01641692|19024725|P7|STARTED|Washout Period 2 (12-14 Days)||43
7726718|NCT01641692|19024726|P6|STARTED|Washout Period 2 (12-14 Days)||43
7726719|NCT01641692|19024727|P5|STARTED|Washout Period 2 (12-14 Days)||37
7726720|NCT01641692|19024728|P4|STARTED|Washout Period 2 (12-14 Days)||41
7726721|NCT01641692|19024729|P3|STARTED|Washout Period 2 (12-14 Days)||40
7726722|NCT01641692|19024730|P2|STARTED|Washout Period 2 (12-14 Days)||46
7726723|NCT01641692|19024731|P1|STARTED|Washout Period 2 (12-14 Days)||30
7726724|NCT01641692|19024724|P8|NOT COMPLETED|Treatment Period 2||1
7726725|NCT01641692|19024725|P7|NOT COMPLETED|Treatment Period 2||0
7726726|NCT01641692|19024726|P6|NOT COMPLETED|Treatment Period 2||2
7726727|NCT01641692|19024727|P5|NOT COMPLETED|Treatment Period 2||0
7726728|NCT01641692|19024728|P4|NOT COMPLETED|Treatment Period 2||0
7726729|NCT01641692|19024729|P3|NOT COMPLETED|Treatment Period 2||0
7726730|NCT01641692|19024730|P2|NOT COMPLETED|Treatment Period 2||0
7726731|NCT01641692|19024731|P1|NOT COMPLETED|Treatment Period 2||3
7726732|NCT01641692|19024724|P8|COMPLETED|Treatment Period 2||35
7726733|NCT01641692|19024725|P7|COMPLETED|Treatment Period 2||43
7726734|NCT01641692|19024726|P6|COMPLETED|Treatment Period 2||43
7726735|NCT01641692|19024727|P5|COMPLETED|Treatment Period 2||37
7726736|NCT01641692|19024728|P4|COMPLETED|Treatment Period 2||41
7726737|NCT01641692|19024729|P3|COMPLETED|Treatment Period 2||40
7726738|NCT01641692|19024730|P2|COMPLETED|Treatment Period 2||46
7726739|NCT01641692|19024731|P1|COMPLETED|Treatment Period 2||30
7726740|NCT01641692|19024724|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36
7726741|NCT01641692|19024725|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43
7726742|NCT01641692|19024726|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45
7726743|NCT01641692|19024727|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37
7726744|NCT01641692|19024728|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41
7726745|NCT01641692|19024729|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40
7726746|NCT01641692|19024730|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46
7726747|NCT01641692|19024731|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33
7726748|NCT01641692|19024724|P8|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
7726749|NCT01641692|19024725|P7|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
7726750|NCT01641692|19024726|P6|NOT COMPLETED|Washout Period 1 (12-14 Days)||0
7726751|NCT01641692|19024727|P5|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
7726752|NCT01641692|19024728|P4|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
7726753|NCT01641692|19024729|P3|NOT COMPLETED|Washout Period 1 (12-14 Days)||3
7726754|NCT01641692|19024730|P2|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
7726755|NCT01641692|19024731|P1|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
7726756|NCT01641692|19024724|P8|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
7726757|NCT01641692|19024725|P7|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
7726758|NCT01641692|19024726|P6|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37
7726759|NCT01641692|19024727|P5|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35
7726760|NCT01641692|19024728|P4|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
7726761|NCT01641692|19024729|P3|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
7726762|NCT01641692|19024730|P2|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44
7726763|NCT01641692|19024731|P1|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
7726764|NCT01641692|19024724|P8|STARTED|Washout Period 1 (12-14 Days)||48
7726765|NCT01641692|19024725|P7|STARTED|Washout Period 1 (12-14 Days)||38
7726766|NCT01641692|19024726|P6|STARTED|Washout Period 1 (12-14 Days)||37
7726767|NCT01641692|19024727|P5|STARTED|Washout Period 1 (12-14 Days)||39
7726768|NCT01641692|19024728|P4|STARTED|Washout Period 1 (12-14 Days)||41
7726769|NCT01641692|19024729|P3|STARTED|Washout Period 1 (12-14 Days)||50
7726770|NCT01641692|19024730|P2|STARTED|Washout Period 1 (12-14 Days)||45
7726771|NCT01641692|19024731|P1|STARTED|Washout Period 1 (12-14 Days)||40
7726772|NCT01641692|19024724|P8|NOT COMPLETED|Treatment Period 1||3
7726773|NCT01641692|19024725|P7|NOT COMPLETED|Treatment Period 1||0
7726774|NCT01641692|19024726|P6|NOT COMPLETED|Treatment Period 1||2
7726775|NCT01641692|19024727|P5|NOT COMPLETED|Treatment Period 1||4
7726776|NCT01641692|19024728|P4|NOT COMPLETED|Treatment Period 1||0
7726777|NCT01641692|19024729|P3|NOT COMPLETED|Treatment Period 1||1
7726778|NCT01641692|19024730|P2|NOT COMPLETED|Treatment Period 1||0
7726779|NCT01641692|19024731|P1|NOT COMPLETED|Treatment Period 1||2
7726780|NCT01641692|19024724|P8|COMPLETED|Treatment Period 1||48
7726781|NCT01641692|19024725|P7|COMPLETED|Treatment Period 1||38
7726782|NCT01641692|19024726|P6|COMPLETED|Treatment Period 1||37
7726783|NCT01641692|19024727|P5|COMPLETED|Treatment Period 1||39
7726784|NCT01641692|19024728|P4|COMPLETED|Treatment Period 1||41
7726785|NCT01641692|19024729|P3|COMPLETED|Treatment Period 1||50
7726786|NCT01641692|19024730|P2|COMPLETED|Treatment Period 1||45
7726787|NCT01641692|19024731|P1|COMPLETED|Treatment Period 1||40
7726788|NCT01641692|19024724|P8|STARTED|Treatment Period 1||51
7726789|NCT01641692|19024725|P7|STARTED|Treatment Period 1||38
7726790|NCT01641692|19024726|P6|STARTED|Treatment Period 1||39
7726791|NCT01641692|19024727|P5|STARTED|Treatment Period 1||43
7726792|NCT01641692|19024728|P4|STARTED|Treatment Period 1||41
7726793|NCT01641692|19024729|P3|STARTED|Treatment Period 1||51
7726794|NCT01641692|19024730|P2|STARTED|Treatment Period 1||45
7726795|NCT01641692|19024731|P1|STARTED|Treatment Period 1||42
7726796|NCT01641653|19024920|P2|NOT COMPLETED|Overall Study||0
7726797|NCT01641653|19024921|P1|NOT COMPLETED|Overall Study||0
7726798|NCT01641653|19024920|P2|COMPLETED|Overall Study||30
7726799|NCT01641653|19024921|P1|COMPLETED|Overall Study||30
7726800|NCT01641653|19024920|P2|STARTED|Overall Study||30
7726801|NCT01641653|19024921|P1|STARTED|Overall Study||30
7726802|NCT01641640|19024931|P1|NOT COMPLETED|Overall Study||36
7726803|NCT01641640|19024931|P1|COMPLETED|Overall Study||292
7726804|NCT01641640|19024931|P1|Enrolled and Treated|Overall Study||327
7726805|NCT01641640|19024931|P1|STARTED|Overall Study||328
7726806|NCT01641601|19024942|P2|NOT COMPLETED|Overall Study||5
7726807|NCT01641601|19024943|P1|NOT COMPLETED|Overall Study||3
7726808|NCT01641601|19024942|P2|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
7726809|NCT01641601|19024943|P1|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
7726810|NCT01641601|19024942|P2|STARTED|Overall Study||5
7726811|NCT01641601|19024943|P1|STARTED|Overall Study||3
7726812|NCT01641471|19024953|P2|NOT COMPLETED|Overall Study||27
7726813|NCT01641471|19024954|P1|NOT COMPLETED|Overall Study||23
7726814|NCT01641471|19024953|P2|COMPLETED|Overall Study||31
7726815|NCT01641471|19024954|P1|COMPLETED|Overall Study||35
7726816|NCT01641471|19024953|P2|STARTED|Overall Study||58
7726817|NCT01641471|19024954|P1|STARTED|Overall Study||58
7726818|NCT01641445|19024968|P2|NOT COMPLETED|Overall Study||5
7726819|NCT01641445|19024969|P1|NOT COMPLETED|Overall Study||10
7726820|NCT01641445|19024968|P2|COMPLETED|Overall Study||36
7726821|NCT01641445|19024969|P1|COMPLETED|Overall Study||31
7726822|NCT01641445|19024968|P2|STARTED|Overall Study||41
7726823|NCT01641445|19024969|P1|STARTED|Overall Study||41
7726824|NCT01641380|19024983|P2|NOT COMPLETED|Third Injection Cycle||5
7726825|NCT01641380|19024984|P1|NOT COMPLETED|Third Injection Cycle||3
7726826|NCT01641380|19024983|P2|COMPLETED|Third Injection Cycle||33
7726827|NCT01641380|19024984|P1|COMPLETED|Third Injection Cycle||36
7726828|NCT01641380|19024983|P2|STARTED|Third Injection Cycle||38
7726829|NCT01641380|19024984|P1|STARTED|Third Injection Cycle||39
7726830|NCT01641380|19024983|P2|NOT COMPLETED|Second Injection Cycle||6
7726831|NCT01641380|19024984|P1|NOT COMPLETED|Second Injection Cycle||4
7726832|NCT01641380|19024983|P2|COMPLETED|Second Injection Cycle||38
7726833|NCT01641380|19024984|P1|COMPLETED|Second Injection Cycle||39
7726834|NCT01641380|19024983|P2|STARTED|Second Injection Cycle||44
7726835|NCT01641380|19024984|P1|STARTED|Second Injection Cycle||43
7726836|NCT01641380|19024983|P2|NOT COMPLETED|First Injection Cycle||6
7726837|NCT01641380|19024984|P1|NOT COMPLETED|First Injection Cycle||7
7726838|NCT01641380|19024983|P2|COMPLETED|First Injection Cycle||44
7726839|NCT01641380|19024984|P1|COMPLETED|First Injection Cycle||43
7726840|NCT01641380|19024983|P2|STARTED|First Injection Cycle||50
7726841|NCT01641380|19024984|P1|STARTED|First Injection Cycle||50
7726842|NCT01641367|19025001|P8|NOT COMPLETED|Randomized Adherence Intervention||24
7726843|NCT01641367|19025002|P7|NOT COMPLETED|Randomized Adherence Intervention||19
7726844|NCT01641367|19025003|P6|NOT COMPLETED|Randomized Adherence Intervention||0
7726845|NCT01641367|19025004|P5|NOT COMPLETED|Randomized Adherence Intervention||0
7726846|NCT01641367|19025005|P4|NOT COMPLETED|Randomized Adherence Intervention||0
7726847|NCT01641367|19025006|P3|NOT COMPLETED|Randomized Adherence Intervention||0
7726848|NCT01641367|19025007|P2|NOT COMPLETED|Randomized Adherence Intervention||0
7726849|NCT01641367|19025008|P1|NOT COMPLETED|Randomized Adherence Intervention||0
7726850|NCT01641367|19025001|P8|COMPLETED|Randomized Adherence Intervention||240
7726851|NCT01641367|19025002|P7|COMPLETED|Randomized Adherence Intervention||238
7726852|NCT01641367|19025003|P6|COMPLETED|Randomized Adherence Intervention||0
7726853|NCT01641367|19025004|P5|COMPLETED|Randomized Adherence Intervention||0
7726854|NCT01641367|19025005|P4|COMPLETED|Randomized Adherence Intervention||0
7726855|NCT01641367|19025006|P3|COMPLETED|Randomized Adherence Intervention||0
7726856|NCT01641367|19025007|P2|COMPLETED|Randomized Adherence Intervention||0
7726857|NCT01641367|19025008|P1|COMPLETED|Randomized Adherence Intervention||0
7726858|NCT01641367|19025001|P8|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||202
7726859|NCT01641367|19025002|P7|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||196
7726860|NCT01641367|19025003|P6|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
7726861|NCT01641367|19025004|P5|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
7726862|NCT01641367|19025005|P4|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
7726863|NCT01641367|19025006|P3|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
7726864|NCT01641367|19025007|P2|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
7726865|NCT01641367|19025008|P1|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
7726866|NCT01641367|19025001|P8|STARTED|Randomized Adherence Intervention||264
7726867|NCT01641367|19025002|P7|STARTED|Randomized Adherence Intervention||257
7726868|NCT01641367|19025003|P6|STARTED|Randomized Adherence Intervention||0
7726869|NCT01641367|19025004|P5|STARTED|Randomized Adherence Intervention||0
7726870|NCT01641367|19025005|P4|STARTED|Randomized Adherence Intervention||0
7726871|NCT01641367|19025006|P3|STARTED|Randomized Adherence Intervention||0
7726872|NCT01641367|19025007|P2|STARTED|Randomized Adherence Intervention||0
7726873|NCT01641367|19025008|P1|STARTED|Randomized Adherence Intervention||0
7726874|NCT01641367|19025001|P8|NOT COMPLETED|Cohorts||0
7726875|NCT01641367|19025002|P7|NOT COMPLETED|Cohorts||0
7726876|NCT01641367|19025003|P6|NOT COMPLETED|Cohorts||1
7726877|NCT01641367|19025004|P5|NOT COMPLETED|Cohorts||3
7726878|NCT01641367|19025005|P4|NOT COMPLETED|Cohorts||0
7726879|NCT01641367|19025006|P3|NOT COMPLETED|Cohorts||4
7726880|NCT01641367|19025007|P2|NOT COMPLETED|Cohorts||1
7726881|NCT01641367|19025008|P1|NOT COMPLETED|Cohorts||34
7726882|NCT01641367|19025001|P8|COMPLETED|Cohorts||0
7726883|NCT01641367|19025002|P7|COMPLETED|Cohorts||0
7726884|NCT01641367|19025003|P6|COMPLETED|Cohorts||33
7726885|NCT01641367|19025004|P5|COMPLETED|Cohorts||67
7726886|NCT01641367|19025005|P4|COMPLETED|Cohorts||8
7726887|NCT01641367|19025006|P3|COMPLETED|Cohorts||68
7726888|NCT01641367|19025007|P2|COMPLETED|Cohorts||73
7726889|NCT01641367|19025008|P1|COMPLETED|Cohorts||253
7726890|NCT01641367|19025001|P8|Followed 72 Weeks on Step 1/2|Cohorts||0
7726891|NCT01641367|19025002|P7|Followed 72 Weeks on Step 1/2|Cohorts||0
7726892|NCT01641367|19025003|P6|Followed 72 Weeks on Step 1/2|Cohorts||30
7726893|NCT01641367|19025004|P5|Followed 72 Weeks on Step 1/2|Cohorts||52
7726894|NCT01641367|19025005|P4|Followed 72 Weeks on Step 1/2|Cohorts||6
7726895|NCT01641367|19025006|P3|Followed 72 Weeks on Step 1/2|Cohorts||60
7726896|NCT01641367|19025007|P2|Followed 72 Weeks on Step 1/2|Cohorts||60
7726897|NCT01641367|19025008|P1|Followed 72 Weeks on Step 1/2|Cohorts||211
7726898|NCT01641367|19025001|P8|STARTED|Cohorts||0
7726899|NCT01641367|19025002|P7|STARTED|Cohorts||0
7726900|NCT01641367|19025003|P6|STARTED|Cohorts||34
7726901|NCT01641367|19025004|P5|STARTED|Cohorts||70
7726902|NCT01641367|19025005|P4|STARTED|Cohorts||8
7726903|NCT01641367|19025006|P3|STARTED|Cohorts||72
7726904|NCT01641367|19025007|P2|STARTED|Cohorts||74
7726905|NCT01641367|19025008|P1|STARTED|Cohorts||287
7726906|NCT01641237|19025259|P4|NOT COMPLETED|Period IV||0
7726907|NCT01641237|19025260|P3|NOT COMPLETED|Period IV||0
7726908|NCT01641237|19025261|P2|NOT COMPLETED|Period IV||0
7726909|NCT01641237|19025262|P1|NOT COMPLETED|Period IV||0
7726910|NCT01641237|19025259|P4|COMPLETED|Period IV||15
7726911|NCT01641237|19025260|P3|COMPLETED|Period IV||15
7726912|NCT01641237|19025261|P2|COMPLETED|Period IV||15
7726913|NCT01641237|19025262|P1|COMPLETED|Period IV||15
7726914|NCT01641237|19025259|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
7726915|NCT01641237|19025260|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
7726916|NCT01641237|19025261|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
7726917|NCT01641237|19025262|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
7726918|NCT01641237|19025259|P4|NOT COMPLETED|Period III||0
7726919|NCT01641237|19025260|P3|NOT COMPLETED|Period III||0
7726920|NCT01641237|19025261|P2|NOT COMPLETED|Period III||0
7726921|NCT01641237|19025262|P1|NOT COMPLETED|Period III||1
7726922|NCT01641237|19025259|P4|COMPLETED|Period III||16
7726923|NCT01641237|19025260|P3|COMPLETED|Period III||15
7726924|NCT01641237|19025261|P2|COMPLETED|Period III||14
7726925|NCT01641237|19025262|P1|COMPLETED|Period III||15
7726926|NCT01641237|19025259|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
7726927|NCT01641237|19025260|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15
7726928|NCT01641237|19025261|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
7726929|NCT01641237|19025262|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
7726930|NCT01641237|19025259|P4|NOT COMPLETED|Period II||0
7726931|NCT01641237|19025260|P3|NOT COMPLETED|Period II||0
7726932|NCT01641237|19025261|P2|NOT COMPLETED|Period II||0
7726933|NCT01641237|19025262|P1|NOT COMPLETED|Period II||1
7726934|NCT01641237|19025259|P4|COMPLETED|Period II||15
7726935|NCT01641237|19025260|P3|COMPLETED|Period II||16
7726936|NCT01641237|19025261|P2|COMPLETED|Period II||16
7726937|NCT01641237|19025262|P1|COMPLETED|Period II||14
7726938|NCT01641237|19025259|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
7726939|NCT01641237|19025260|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
7726940|NCT01641237|19025261|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
7726941|NCT01641237|19025262|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
7726942|NCT01641237|19025259|P4|NOT COMPLETED|Period I||0
7726943|NCT01641237|19025260|P3|NOT COMPLETED|Period I||0
7726944|NCT01641237|19025261|P2|NOT COMPLETED|Period I||0
7726945|NCT01641237|19025262|P1|NOT COMPLETED|Period I||0
7726946|NCT01641237|19025259|P4|COMPLETED|Period I||15
7726947|NCT01641237|19025260|P3|COMPLETED|Period I||15
7726948|NCT01641237|19025261|P2|COMPLETED|Period I||16
7726949|NCT01641237|19025262|P1|COMPLETED|Period I||16
7726950|NCT01641237|19025259|P4|STARTED|Period I||15
7726951|NCT01641237|19025260|P3|STARTED|Period I||15
7726952|NCT01641237|19025261|P2|STARTED|Period I||16
7726953|NCT01641237|19025262|P1|STARTED|Period I||16
7726954|NCT01641198|19025287|P3|NOT COMPLETED|At 15-20 Years of Function||2
7726955|NCT01641198|19025288|P2|NOT COMPLETED|At 15-20 Years of Function||1
7726956|NCT01641198|19025289|P1|NOT COMPLETED|At 15-20 Years of Function||6
7726957|NCT01641198|19025287|P3|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation, 1 death|9
7726958|NCT01641198|19025288|P2|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation|6
7726959|NCT01641198|19025289|P1|COMPLETED|At 15-20 Years of Function|Participants: 5 interval violation, 1 death|6
7726960|NCT01641198|19025287|P3|STARTED|At 15-20 Years of Function||11
7726961|NCT01641198|19025288|P2|STARTED|At 15-20 Years of Function||7
7726962|NCT01641198|19025289|P1|STARTED|At 15-20 Years of Function||12
7726963|NCT01641198|19025287|P3|NOT COMPLETED|After 24 Months of Function||6
7726964|NCT01641198|19025288|P2|NOT COMPLETED|After 24 Months of Function||9
7726965|NCT01641198|19025289|P1|NOT COMPLETED|After 24 Months of Function||4
7726966|NCT01641198|19025287|P3|COMPLETED|After 24 Months of Function|Participants: 6 interval violation. Implants: 2 bone loss not measurable|11
7726967|NCT01641198|19025288|P2|COMPLETED|After 24 Months of Function|Participants: 9 interval violation|7
7726968|NCT01641198|19025289|P1|COMPLETED|After 24 Months of Function|Participants: 4 interval violation. Implants: 3 bone loss not measurable|12
7726969|NCT01641198|19025287|P3|STARTED|After 24 Months of Function||17
7726970|NCT01641198|19025288|P2|STARTED|After 24 Months of Function||16
7726971|NCT01641198|19025289|P1|STARTED|After 24 Months of Function||16
7726972|NCT01641198|19025287|P3|NOT COMPLETED|After 12 Months of Function||2
7726973|NCT01641198|19025288|P2|NOT COMPLETED|After 12 Months of Function||3
7726974|NCT01641198|19025289|P1|NOT COMPLETED|After 12 Months of Function||4
7726975|NCT01641198|19025287|P3|COMPLETED|After 12 Months of Function|Participants: 2 interval violation. Implants: 3 bone loss not measurable|17
7726976|NCT01641198|19025288|P2|COMPLETED|After 12 Months of Function|Participants: 2 interval violation, 1 adverse event. Implants: 3 bone loss not measurable|16
7726977|NCT01641198|19025289|P1|COMPLETED|After 12 Months of Function|Participants: 3 interval violation, 1 protocol violation. Implants: 13 bone loss not measurable|16
7726978|NCT01641198|19025287|P3|STARTED|After 12 Months of Function||19
7726979|NCT01641198|19025288|P2|STARTED|After 12 Months of Function||19
7726980|NCT01641198|19025289|P1|STARTED|After 12 Months of Function||20
7726981|NCT01641159|19025305|P2|NOT COMPLETED|Overall Study||2
7726982|NCT01641159|19025306|P1|NOT COMPLETED|Overall Study||2
7726983|NCT01641159|19025305|P2|COMPLETED|Overall Study||25
7726984|NCT01641159|19025306|P1|COMPLETED|Overall Study||33
7726985|NCT01641159|19025305|P2|STARTED|Overall Study||27
7726986|NCT01641159|19025306|P1|STARTED|Overall Study||35
7726987|NCT01641133|19025317|P3|NOT COMPLETED|Overall Study||8
7726988|NCT01641133|19025318|P2|NOT COMPLETED|Overall Study||9
7726989|NCT01641133|19025319|P1|NOT COMPLETED|Overall Study||10
7726990|NCT01641133|19025317|P3|COMPLETED|Overall Study||90
7726991|NCT01641133|19025318|P2|COMPLETED|Overall Study||90
7726992|NCT01641133|19025319|P1|COMPLETED|Overall Study||87
7726993|NCT01641133|19025317|P3|STARTED|Overall Study||98
7726994|NCT01641133|19025318|P2|STARTED|Overall Study||99
7726995|NCT01641133|19025319|P1|STARTED|Overall Study||97
7726996|NCT01641120|19025360|P1|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0
7726997|NCT01641120|19025360|P1|COMPLETED|30 Gauge Needle Weeks 2 and 3||20
7726998|NCT01641120|19025360|P1|STARTED|30 Gauge Needle Weeks 2 and 3||20
7726999|NCT01641120|19025360|P1|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0
7727000|NCT01641120|19025360|P1|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20
7727001|NCT01641120|19025360|P1|STARTED|25 Gauge Needle Weeks 1, 4, 5||20
7727002|NCT01641081|19025372|P10|NOT COMPLETED|Period 5||0
7727003|NCT01641081|19025373|P9|NOT COMPLETED|Period 5||0
7727004|NCT01641081|19025374|P8|NOT COMPLETED|Period 5||0
7727005|NCT01641081|19025375|P7|NOT COMPLETED|Period 5||0
7727006|NCT01641081|19025376|P6|NOT COMPLETED|Period 5||0
7727007|NCT01641081|19025377|P5|NOT COMPLETED|Period 5||0
7727008|NCT01641081|19025378|P4|NOT COMPLETED|Period 5||0
7727009|NCT01641081|19025379|P3|NOT COMPLETED|Period 5||2
7727010|NCT01641081|19025380|P2|NOT COMPLETED|Period 5||0
7727011|NCT01641081|19025381|P1|NOT COMPLETED|Period 5||0
7727012|NCT01641081|19025372|P10|COMPLETED|Period 5||14
7727013|NCT01641081|19025373|P9|COMPLETED|Period 5||14
7727014|NCT01641081|19025374|P8|COMPLETED|Period 5||14
7727015|NCT01641081|19025375|P7|COMPLETED|Period 5||16
7727016|NCT01641081|19025376|P6|COMPLETED|Period 5||18
7727017|NCT01641081|19025377|P5|COMPLETED|Period 5||16
7727018|NCT01641081|19025378|P4|COMPLETED|Period 5||20
7727019|NCT01641081|19025379|P3|COMPLETED|Period 5||12
7727020|NCT01641081|19025380|P2|COMPLETED|Period 5||17
7727021|NCT01641081|19025381|P1|COMPLETED|Period 5||16
7727022|NCT01641081|19025372|P10|STARTED|Period 5||14
7727023|NCT01641081|19025373|P9|STARTED|Period 5||14
7727024|NCT01641081|19025374|P8|STARTED|Period 5||14
7727025|NCT01641081|19025375|P7|STARTED|Period 5||16
7727026|NCT01641081|19025376|P6|STARTED|Period 5||18
7727027|NCT01641081|19025377|P5|STARTED|Period 5||16
7727028|NCT01641081|19025378|P4|STARTED|Period 5||20
7727029|NCT01641081|19025379|P3|STARTED|Period 5||14
7727030|NCT01641081|19025380|P2|STARTED|Period 5||17
7727031|NCT01641081|19025381|P1|STARTED|Period 5||16
7727032|NCT01641081|19025372|P10|NOT COMPLETED|Period 4||0
7727033|NCT01641081|19025373|P9|NOT COMPLETED|Period 4||0
7727034|NCT01641081|19025374|P8|NOT COMPLETED|Period 4||0
7727035|NCT01641081|19025375|P7|NOT COMPLETED|Period 4||0
7727036|NCT01641081|19025376|P6|NOT COMPLETED|Period 4||0
7727037|NCT01641081|19025377|P5|NOT COMPLETED|Period 4||0
7727038|NCT01641081|19025378|P4|NOT COMPLETED|Period 4||1
7727039|NCT01641081|19025379|P3|NOT COMPLETED|Period 4||0
7727040|NCT01641081|19025380|P2|NOT COMPLETED|Period 4||1
7727041|NCT01641081|19025381|P1|NOT COMPLETED|Period 4||0
7727042|NCT01641081|19025372|P10|COMPLETED|Period 4||14
7727043|NCT01641081|19025373|P9|COMPLETED|Period 4||14
7727044|NCT01641081|19025374|P8|COMPLETED|Period 4||14
7727045|NCT01641081|19025375|P7|COMPLETED|Period 4||16
7727046|NCT01641081|19025376|P6|COMPLETED|Period 4||18
7727047|NCT01641081|19025377|P5|COMPLETED|Period 4||16
7727048|NCT01641081|19025378|P4|COMPLETED|Period 4||20
7727049|NCT01641081|19025379|P3|COMPLETED|Period 4||14
7727050|NCT01641081|19025380|P2|COMPLETED|Period 4||17
7727051|NCT01641081|19025381|P1|COMPLETED|Period 4||16
7727052|NCT01641081|19025372|P10|STARTED|Period 4||14
7727053|NCT01641081|19025373|P9|STARTED|Period 4||14
7727054|NCT01641081|19025374|P8|STARTED|Period 4||14
7727055|NCT01641081|19025375|P7|STARTED|Period 4||16
7727056|NCT01641081|19025376|P6|STARTED|Period 4||18
7727057|NCT01641081|19025377|P5|STARTED|Period 4||16
7727058|NCT01641081|19025378|P4|STARTED|Period 4||21
7727059|NCT01641081|19025379|P3|STARTED|Period 4||14
7727060|NCT01641081|19025380|P2|STARTED|Period 4||18
7727061|NCT01641081|19025381|P1|STARTED|Period 4||16
7727062|NCT01641081|19025372|P10|NOT COMPLETED|Period 3||0
7727063|NCT01641081|19025373|P9|NOT COMPLETED|Period 3||1
7727064|NCT01641081|19025374|P8|NOT COMPLETED|Period 3||0
7727065|NCT01641081|19025375|P7|NOT COMPLETED|Period 3||0
7727066|NCT01641081|19025376|P6|NOT COMPLETED|Period 3||0
7727067|NCT01641081|19025377|P5|NOT COMPLETED|Period 3||0
7727068|NCT01641081|19025378|P4|NOT COMPLETED|Period 3||0
7727069|NCT01641081|19025379|P3|NOT COMPLETED|Period 3||1
7727070|NCT01641081|19025380|P2|NOT COMPLETED|Period 3||0
7727071|NCT01641081|19025381|P1|NOT COMPLETED|Period 3||0
7727072|NCT01641081|19025372|P10|COMPLETED|Period 3||14
7727073|NCT01641081|19025373|P9|COMPLETED|Period 3||14
7727074|NCT01641081|19025374|P8|COMPLETED|Period 3||14
7727075|NCT01641081|19025375|P7|COMPLETED|Period 3||16
7727076|NCT01641081|19025376|P6|COMPLETED|Period 3||18
7727077|NCT01641081|19025377|P5|COMPLETED|Period 3||16
7727078|NCT01641081|19025378|P4|COMPLETED|Period 3||21
7727079|NCT01641081|19025379|P3|COMPLETED|Period 3||14
7727080|NCT01641081|19025380|P2|COMPLETED|Period 3||18
7727081|NCT01641081|19025381|P1|COMPLETED|Period 3||16
7727082|NCT01641081|19025372|P10|STARTED|Period 3||14
7727083|NCT01641081|19025373|P9|STARTED|Period 3||15
7727084|NCT01641081|19025374|P8|STARTED|Period 3||14
7727085|NCT01641081|19025375|P7|STARTED|Period 3||16
7727086|NCT01641081|19025376|P6|STARTED|Period 3||18
7727087|NCT01641081|19025377|P5|STARTED|Period 3||16
7727088|NCT01641081|19025378|P4|STARTED|Period 3||21
7727089|NCT01641081|19025379|P3|STARTED|Period 3||15
7727090|NCT01641081|19025380|P2|STARTED|Period 3||18
7727091|NCT01641081|19025381|P1|STARTED|Period 3||16
7727092|NCT01641081|19025372|P10|NOT COMPLETED|Period 2||0
7727093|NCT01641081|19025373|P9|NOT COMPLETED|Period 2||0
7727094|NCT01641081|19025374|P8|NOT COMPLETED|Period 2||0
7727095|NCT01641081|19025375|P7|NOT COMPLETED|Period 2||2
7727096|NCT01641081|19025376|P6|NOT COMPLETED|Period 2||1
7727097|NCT01641081|19025377|P5|NOT COMPLETED|Period 2||0
7727098|NCT01641081|19025378|P4|NOT COMPLETED|Period 2||1
7727099|NCT01641081|19025379|P3|NOT COMPLETED|Period 2||0
7727100|NCT01641081|19025380|P2|NOT COMPLETED|Period 2||0
7727101|NCT01641081|19025381|P1|NOT COMPLETED|Period 2||1
7727102|NCT01641081|19025372|P10|COMPLETED|Period 2||14
7727103|NCT01641081|19025373|P9|COMPLETED|Period 2||15
7727104|NCT01641081|19025374|P8|COMPLETED|Period 2||14
7727105|NCT01641081|19025375|P7|COMPLETED|Period 2||16
7727106|NCT01641081|19025376|P6|COMPLETED|Period 2||18
7727107|NCT01641081|19025377|P5|COMPLETED|Period 2||16
7727108|NCT01641081|19025378|P4|COMPLETED|Period 2||21
7727109|NCT01641081|19025379|P3|COMPLETED|Period 2||15
7727110|NCT01641081|19025380|P2|COMPLETED|Period 2||18
7727111|NCT01641081|19025381|P1|COMPLETED|Period 2||16
7727112|NCT01641081|19025372|P10|STARTED|Period 2||14
7727113|NCT01641081|19025373|P9|STARTED|Period 2||15
7727114|NCT01641081|19025374|P8|STARTED|Period 2||14
7727115|NCT01641081|19025375|P7|STARTED|Period 2||18
7727116|NCT01641081|19025376|P6|STARTED|Period 2||19
7727117|NCT01641081|19025377|P5|STARTED|Period 2||16
7727118|NCT01641081|19025378|P4|STARTED|Period 2||22
7727119|NCT01641081|19025379|P3|STARTED|Period 2||15
7727120|NCT01641081|19025380|P2|STARTED|Period 2||18
7727121|NCT01641081|19025381|P1|STARTED|Period 2||17
7727122|NCT01641081|19025372|P10|NOT COMPLETED|Period 1||0
7727123|NCT01641081|19025373|P9|NOT COMPLETED|Period 1||0
7727124|NCT01641081|19025374|P8|NOT COMPLETED|Period 1||3
7727125|NCT01641081|19025375|P7|NOT COMPLETED|Period 1||1
7727126|NCT01641081|19025376|P6|NOT COMPLETED|Period 1||0
7727127|NCT01641081|19025377|P5|NOT COMPLETED|Period 1||1
7727128|NCT01641081|19025378|P4|NOT COMPLETED|Period 1||0
7727129|NCT01641081|19025379|P3|NOT COMPLETED|Period 1||0
7727130|NCT01641081|19025380|P2|NOT COMPLETED|Period 1||0
7727131|NCT01641081|19025381|P1|NOT COMPLETED|Period 1||1
7727132|NCT01641081|19025372|P10|COMPLETED|Period 1||14
7727133|NCT01641081|19025373|P9|COMPLETED|Period 1||15
7727134|NCT01641081|19025374|P8|COMPLETED|Period 1||14
7727135|NCT01641081|19025375|P7|COMPLETED|Period 1||18
7727136|NCT01641081|19025376|P6|COMPLETED|Period 1||19
7727137|NCT01641081|19025377|P5|COMPLETED|Period 1||16
7727138|NCT01641081|19025378|P4|COMPLETED|Period 1||22
7727139|NCT01641081|19025379|P3|COMPLETED|Period 1||15
7727140|NCT01641081|19025380|P2|COMPLETED|Period 1||18
7727141|NCT01641081|19025381|P1|COMPLETED|Period 1||17
7727142|NCT01641081|19025372|P10|STARTED|Period 1||14
7727143|NCT01641081|19025373|P9|STARTED|Period 1||15
7727144|NCT01641081|19025374|P8|STARTED|Period 1||17
7727145|NCT01641081|19025375|P7|STARTED|Period 1||19
7727146|NCT01641081|19025376|P6|STARTED|Period 1||19
7727147|NCT01641081|19025377|P5|STARTED|Period 1||17
7727148|NCT01641081|19025378|P4|STARTED|Period 1||22
7727149|NCT01641081|19025379|P3|STARTED|Period 1||15
7727150|NCT01641081|19025380|P2|STARTED|Period 1||18
7727151|NCT01641081|19025381|P1|STARTED|Period 1||18
7727152|NCT01641042|19025400|P2|NOT COMPLETED|Overall Study||0
7727153|NCT01641042|19025401|P1|NOT COMPLETED|Overall Study||0
7727154|NCT01641042|19025400|P2|COMPLETED|Overall Study||43
7727155|NCT01641042|19025401|P1|COMPLETED|Overall Study||43
7727156|NCT01641042|19025400|P2|STARTED|Overall Study||43
7727157|NCT01641042|19025401|P1|STARTED|Overall Study||43
7727158|NCT01640964|19025450|P3|NOT COMPLETED|Overall Study||3
7727159|NCT01640964|19025451|P2|NOT COMPLETED|Overall Study||1
7727160|NCT01640964|19025452|P1|NOT COMPLETED|Overall Study||1
7727161|NCT01640964|19025450|P3|COMPLETED|Overall Study||3
7727162|NCT01640964|19025451|P2|COMPLETED|Overall Study||19
7727163|NCT01640964|19025452|P1|COMPLETED|Overall Study||19
7727164|NCT01640964|19025450|P3|STARTED|Overall Study||6
7727165|NCT01640964|19025451|P2|STARTED|Overall Study||20
7727166|NCT01640964|19025452|P1|STARTED|Overall Study||20
7727167|NCT01640951|19025475|P8|NOT COMPLETED|Overall Study||16
7727168|NCT01640951|19025476|P7|NOT COMPLETED|Overall Study||18
7727169|NCT01640951|19025477|P6|NOT COMPLETED|Overall Study||47
7727170|NCT01640951|19025478|P5|NOT COMPLETED|Overall Study||13
7727171|NCT01640951|19025479|P4|NOT COMPLETED|Overall Study||45
7727172|NCT01640951|19025480|P3|NOT COMPLETED|Overall Study||42
7727173|NCT01640951|19025481|P2|NOT COMPLETED|Overall Study||15
7727174|NCT01640951|19025482|P1|NOT COMPLETED|Overall Study||46
7727175|NCT01640951|19025475|P8|COMPLETED|Overall Study||17
7727176|NCT01640951|19025476|P7|COMPLETED|Overall Study||94
7727177|NCT01640951|19025477|P6|COMPLETED|Overall Study||13
7727178|NCT01640951|19025478|P5|COMPLETED|Overall Study||82
7727179|NCT01640951|19025479|P4|COMPLETED|Overall Study||10
7727180|NCT01640951|19025480|P3|COMPLETED|Overall Study||126
7727181|NCT01640951|19025481|P2|COMPLETED|Overall Study||60
7727182|NCT01640951|19025482|P1|COMPLETED|Overall Study||31
7727183|NCT01640951|19025475|P8|STARTED|Overall Study||33
7727184|NCT01640951|19025476|P7|STARTED|Overall Study||112
7727185|NCT01640951|19025477|P6|STARTED|Overall Study||60
7727186|NCT01640951|19025478|P5|STARTED|Overall Study||95
7727187|NCT01640951|19025479|P4|STARTED|Overall Study||55
7727188|NCT01640951|19025480|P3|STARTED|Overall Study||168
7727189|NCT01640951|19025481|P2|STARTED|Overall Study||75
7727190|NCT01640951|19025482|P1|STARTED|Overall Study||77
7727191|NCT01640925|19025584|P2|NOT COMPLETED|Overall Study||11
7727192|NCT01640925|19025585|P1|NOT COMPLETED|Overall Study||14
7727193|NCT01640925|19025584|P2|COMPLETED|Overall Study||164
7727194|NCT01640925|19025585|P1|COMPLETED|Overall Study||161
7727195|NCT01640925|19025584|P2|STARTED|Overall Study||175
7727196|NCT01640925|19025585|P1|STARTED|Overall Study||175
7727197|NCT01640873|19025599|P2|NOT COMPLETED|Overall Study||1
7727198|NCT01640873|19025600|P1|NOT COMPLETED|Overall Study||2
7727199|NCT01640873|19025599|P2|COMPLETED|Overall Study||10
7727200|NCT01640873|19025600|P1|COMPLETED|Overall Study||20
7727201|NCT01640873|19025599|P2|STARTED|Overall Study||11
7727202|NCT01640873|19025600|P1|STARTED|Overall Study||22
7727203|NCT01640834|19025619|P3|NOT COMPLETED|Overall Study||0
7727204|NCT01640834|19025620|P2|NOT COMPLETED|Overall Study||0
7727205|NCT01640834|19025621|P1|NOT COMPLETED|Overall Study||0
7727206|NCT01640834|19025619|P3|COMPLETED|Overall Study||4
7727207|NCT01640834|19025620|P2|COMPLETED|Overall Study||8
7727208|NCT01640834|19025621|P1|COMPLETED|Overall Study||8
7727209|NCT01640834|19025619|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
7727210|NCT01640834|19025620|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
7727211|NCT01640834|19025621|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
7727212|NCT01640834|19025619|P3|STARTED|Overall Study||4
7727213|NCT01640834|19025620|P2|STARTED|Overall Study||8
7727214|NCT01640834|19025621|P1|STARTED|Overall Study||8
7727215|NCT01640808|19025650|P2|NOT COMPLETED|Overall Study||16
7727216|NCT01640808|19025651|P1|NOT COMPLETED|Overall Study||58
7727217|NCT01640808|19025650|P2|COMPLETED|Overall Study||291
7727218|NCT01640808|19025651|P1|COMPLETED|Overall Study||251
7727219|NCT01640808|19025650|P2|Subjects Received Treatment|Overall Study||305
7727220|NCT01640808|19025651|P1|Subjects Received Treatment|Overall Study||305
7727221|NCT01640808|19025650|P2|STARTED|Overall Study||307
7727222|NCT01640808|19025651|P1|STARTED|Overall Study||309
7727223|NCT01640548|19025661|P1|NOT COMPLETED|Overall Study||0
7727224|NCT01640548|19025661|P1|COMPLETED|Overall Study||309
7727225|NCT01640548|19025661|P1|STARTED|Overall Study||309
7727226|NCT01640379|19025677|P2|NOT COMPLETED|Overall Study||12
7727227|NCT01640379|19025678|P1|NOT COMPLETED|Overall Study||14
7727228|NCT01640379|19025677|P2|COMPLETED|Overall Study||125
7727229|NCT01640379|19025678|P1|COMPLETED|Overall Study||135
7727230|NCT01640379|19025677|P2|STARTED|Overall Study||137
7727231|NCT01640379|19025678|P1|STARTED|Overall Study||149
7727232|NCT01640366|19025686|P1|NOT COMPLETED|Overall Study||22
7727233|NCT01640366|19025686|P1|COMPLETED|Overall Study||178
7727234|NCT01640366|19025686|P1|Day 90 Follow-up|Overall Study||178
7727235|NCT01640366|19025686|P1|Day 42 Follow-up|Overall Study||177
7727236|NCT01640366|19025686|P1|Day 21 Follow-up|Overall Study||185
7727237|NCT01640366|19025686|P1|STARTED|Overall Study||200
7727238|NCT01640353|19025699|P1|NOT COMPLETED|Overall Study||45
7727239|NCT01640353|19025699|P1|COMPLETED|Overall Study||149
7727240|NCT01640353|19025699|P1|Month 18|Overall Study||150
7727241|NCT01640353|19025699|P1|Month 12|Overall Study||160
7727242|NCT01640353|19025699|P1|Month 6|Overall Study||168
7727243|NCT01640353|19025699|P1|Month 3|Overall Study||169
7727244|NCT01640353|19025699|P1|Month 1|Overall Study||171
7727245|NCT01640353|19025699|P1|Treated|Overall Study||172
7727246|NCT01640353|19025699|P1|STARTED|Overall Study||194
7727247|NCT01640340|19025711|P2|NOT COMPLETED|Overall Study||0
7727248|NCT01640340|19025712|P1|NOT COMPLETED|Overall Study||0
7727249|NCT01640340|19025711|P2|COMPLETED|Overall Study||20
7727250|NCT01640340|19025712|P1|COMPLETED|Overall Study||20
7727251|NCT01640340|19025711|P2|Overall Complete Response Rate|Overall Study||20
7727252|NCT01640340|19025712|P1|Overall Complete Response Rate|Overall Study||20
7727253|NCT01640340|19025711|P2|STARTED|Overall Study||20
7727254|NCT01640340|19025712|P1|STARTED|Overall Study||20
7727255|NCT01640327|19025732|P2|NOT COMPLETED|Overall Study||0
7727256|NCT01640327|19025733|P1|NOT COMPLETED|Overall Study||0
7727257|NCT01640327|19025732|P2|COMPLETED|Overall Study||63
7727258|NCT01640327|19025733|P1|COMPLETED|Overall Study||63
7727259|NCT01640327|19025732|P2|STARTED|Overall Study||63
7727260|NCT01640327|19025733|P1|STARTED|Overall Study||63
7727261|NCT01640314|19025747|P2|NOT COMPLETED|Overall Study||1
7727262|NCT01640314|19025748|P1|NOT COMPLETED|Overall Study||0
7727263|NCT01640314|19025747|P2|COMPLETED|Overall Study||62
7727264|NCT01640314|19025748|P1|COMPLETED|Overall Study||63
7727265|NCT01640314|19025747|P2|STARTED|Overall Study||63
7727266|NCT01640314|19025748|P1|STARTED|Overall Study||63
7727267|NCT01640288|19025764|P2|NOT COMPLETED|Overall Study||23
7727268|NCT01640288|19025765|P1|NOT COMPLETED|Overall Study||30
7727269|NCT01640288|19025764|P2|COMPLETED|Overall Study||48
7727270|NCT01640288|19025765|P1|COMPLETED|Overall Study|One subject was lost to followup but rec'd the gas and images were obtained|70
7727271|NCT01640288|19025764|P2|Did Not Receive Allocated Intervention|Overall Study||18
7727272|NCT01640288|19025765|P1|Did Not Receive Allocated Intervention|Overall Study||26
7727273|NCT01640288|19025764|P2|Received Allocated Intervention|Overall Study|53 rec'd the gas (exc. 1 images not obtained due to equipment failure, 4 poor images = 48 )|48
7727274|NCT01640288|19025765|P1|Received Allocated Intervention|Overall Study|74 rec'd the gas (inc. 4 images were not obtained due to equipment failure = 70)|70
7727275|NCT01640288|19025764|P2|STARTED|Overall Study||71
7727276|NCT01640288|19025765|P1|STARTED|Overall Study||100
7727277|NCT01640249|19025782|P7|NOT COMPLETED|Period 3||0
7727278|NCT01640249|19025783|P6|NOT COMPLETED|Period 3||0
7727279|NCT01640249|19025784|P5|NOT COMPLETED|Period 3||0
7727280|NCT01640249|19025785|P4|NOT COMPLETED|Period 3||1
7727281|NCT01640249|19025786|P3|NOT COMPLETED|Period 3||0
7727282|NCT01640249|19025787|P2|NOT COMPLETED|Period 3||0
7727283|NCT01640249|19025788|P1|NOT COMPLETED|Period 3||0
7727284|NCT01640249|19025782|P7|COMPLETED|Period 3||0
7727285|NCT01640249|19025783|P6|COMPLETED|Period 3||0
7727286|NCT01640249|19025784|P5|COMPLETED|Period 3||0
7727287|NCT01640249|19025785|P4|COMPLETED|Period 3||1
7727288|NCT01640249|19025786|P3|COMPLETED|Period 3||2
7727289|NCT01640249|19025787|P2|COMPLETED|Period 3||2
7727290|NCT01640249|19025788|P1|COMPLETED|Period 3||2
7727291|NCT01640249|19025782|P7|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
7727292|NCT01640249|19025783|P6|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
7727293|NCT01640249|19025784|P5|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
7727294|NCT01640249|19025785|P4|STARTED|Period 3||2
7727295|NCT01640249|19025786|P3|STARTED|Period 3||2
7727296|NCT01640249|19025787|P2|STARTED|Period 3||2
7727297|NCT01640249|19025788|P1|STARTED|Period 3||2
7727298|NCT01640249|19025782|P7|NOT COMPLETED|Period 2||0
7727299|NCT01640249|19025783|P6|NOT COMPLETED|Period 2||0
7727300|NCT01640249|19025784|P5|NOT COMPLETED|Period 2||0
7727301|NCT01640249|19025785|P4|NOT COMPLETED|Period 2||0
7727302|NCT01640249|19025786|P3|NOT COMPLETED|Period 2||0
7727303|NCT01640249|19025787|P2|NOT COMPLETED|Period 2||0
7727304|NCT01640249|19025788|P1|NOT COMPLETED|Period 2||0
7727305|NCT01640249|19025782|P7|COMPLETED|Period 2||2
7727306|NCT01640249|19025783|P6|COMPLETED|Period 2||4
7727307|NCT01640249|19025784|P5|COMPLETED|Period 2||2
7727308|NCT01640249|19025785|P4|COMPLETED|Period 2||2
7727309|NCT01640249|19025786|P3|COMPLETED|Period 2||2
7727310|NCT01640249|19025787|P2|COMPLETED|Period 2||2
7727311|NCT01640249|19025788|P1|COMPLETED|Period 2||2
7727312|NCT01640249|19025782|P7|STARTED|Period 2||2
7727313|NCT01640249|19025783|P6|STARTED|Period 2||4
7727314|NCT01640249|19025784|P5|STARTED|Period 2||2
7727315|NCT01640249|19025785|P4|STARTED|Period 2||2
7727316|NCT01640249|19025786|P3|STARTED|Period 2||2
7727317|NCT01640249|19025787|P2|STARTED|Period 2||2
7727318|NCT01640249|19025788|P1|STARTED|Period 2||2
7727319|NCT01640249|19025782|P7|NOT COMPLETED|Period 1||0
7727320|NCT01640249|19025783|P6|NOT COMPLETED|Period 1||1
7727321|NCT01640249|19025784|P5|NOT COMPLETED|Period 1||0
7727322|NCT01640249|19025785|P4|NOT COMPLETED|Period 1||0
7727323|NCT01640249|19025786|P3|NOT COMPLETED|Period 1||0
7727324|NCT01640249|19025787|P2|NOT COMPLETED|Period 1||0
7727325|NCT01640249|19025788|P1|NOT COMPLETED|Period 1||1
7727326|NCT01640249|19025782|P7|COMPLETED|Period 1||2
7727327|NCT01640249|19025783|P6|COMPLETED|Period 1||4
7727328|NCT01640249|19025784|P5|COMPLETED|Period 1||2
7727329|NCT01640249|19025785|P4|COMPLETED|Period 1||2
7727330|NCT01640249|19025786|P3|COMPLETED|Period 1||2
7727331|NCT01640249|19025787|P2|COMPLETED|Period 1||2
7727332|NCT01640249|19025788|P1|COMPLETED|Period 1||2
7727333|NCT01640249|19025782|P7|Received at Least 1 Dose of Study Drug|Period 1||2
7727334|NCT01640249|19025783|P6|Received at Least 1 Dose of Study Drug|Period 1||5
7727335|NCT01640249|19025784|P5|Received at Least 1 Dose of Study Drug|Period 1||2
7727336|NCT01640249|19025785|P4|Received at Least 1 Dose of Study Drug|Period 1||2
7727337|NCT01640249|19025786|P3|Received at Least 1 Dose of Study Drug|Period 1||2
7727338|NCT01640249|19025787|P2|Received at Least 1 Dose of Study Drug|Period 1||2
7727339|NCT01640249|19025788|P1|Received at Least 1 Dose of Study Drug|Period 1||3
7727340|NCT01640249|19025782|P7|STARTED|Period 1||2
7727341|NCT01640249|19025783|P6|STARTED|Period 1||5
7727342|NCT01640249|19025784|P5|STARTED|Period 1||2
7727343|NCT01640249|19025785|P4|STARTED|Period 1||2
7727344|NCT01640249|19025786|P3|STARTED|Period 1||2
7727345|NCT01640249|19025787|P2|STARTED|Period 1||2
7727346|NCT01640249|19025788|P1|STARTED|Period 1||3
7727347|NCT01640197|19025814|P2|NOT COMPLETED|Overall Study||0
7727348|NCT01640197|19025815|P1|NOT COMPLETED|Overall Study||0
7727349|NCT01640197|19025814|P2|COMPLETED|Overall Study||30
7727350|NCT01640197|19025815|P1|COMPLETED|Overall Study||30
7727351|NCT01640197|19025814|P2|STARTED|Overall Study||30
7727352|NCT01640197|19025815|P1|STARTED|Overall Study||30
7727353|NCT01640184|19025836|P3|NOT COMPLETED|Overall Study||2
7727354|NCT01640184|19025837|P2|NOT COMPLETED|Overall Study||2
7727355|NCT01640184|19025838|P1|NOT COMPLETED|Overall Study||8
7727356|NCT01640184|19025836|P3|COMPLETED|Overall Study||20
7727357|NCT01640184|19025837|P2|COMPLETED|Overall Study||21
7727358|NCT01640184|19025838|P1|COMPLETED|Overall Study||26
7727359|NCT01640184|19025836|P3|STARTED|Overall Study||22
7727360|NCT01640184|19025837|P2|STARTED|Overall Study||23
7727361|NCT01640184|19025838|P1|STARTED|Overall Study||34
7727362|NCT01640171|19025860|P1|NOT COMPLETED|Overall Study||0
7727363|NCT01640171|19025860|P1|COMPLETED|Overall Study||57
7727364|NCT01640171|19025860|P1|STARTED|Overall Study||57
7727365|NCT01640054|19025867|P1|NOT COMPLETED|Overall Study||6
7727366|NCT01640054|19025867|P1|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109
7727367|NCT01640054|19025867|P1|Did Not Receive Treatment|Overall Study||0
7727368|NCT01640054|19025867|P1|STARTED|Overall Study|Patients who received treatment|115
7727369|NCT01639872|19025877|P2|NOT COMPLETED|Overall Study||5
7727370|NCT01639872|19025878|P1|NOT COMPLETED|Overall Study||10
7727371|NCT01639872|19025877|P2|COMPLETED|Overall Study||20
7727372|NCT01639872|19025878|P1|COMPLETED|Overall Study||14
7727373|NCT01639872|19025877|P2|STARTED|Overall Study||25
7727374|NCT01639872|19025878|P1|STARTED|Overall Study||24
7727375|NCT01639833|19025888|P2|NOT COMPLETED|Overall Study||4
7727376|NCT01639833|19025889|P1|NOT COMPLETED|Overall Study||6
7727377|NCT01639833|19025888|P2|COMPLETED|Overall Study||41
7727378|NCT01639833|19025889|P1|COMPLETED|Overall Study||39
7727379|NCT01639833|19025888|P2|STARTED|Overall Study||45
7727380|NCT01639833|19025889|P1|STARTED|Overall Study||45
7727381|NCT01639755|19025897|P1|NOT COMPLETED|Overall Study||19
7727382|NCT01639755|19025897|P1|COMPLETED|Overall Study||0
7727383|NCT01639755|19025897|P1|STARTED|Overall Study||19
7727384|NCT01639742|19025905|P1|NOT COMPLETED|Overall Study||18
7727385|NCT01639742|19025905|P1|COMPLETED|Overall Study||0
7727386|NCT01639742|19025905|P1|STARTED|Overall Study||18
7727387|NCT01639729|19025913|P6|NOT COMPLETED|Overall Study||0
7727388|NCT01639729|19025914|P5|NOT COMPLETED|Overall Study||0
7727389|NCT01639729|19025915|P4|NOT COMPLETED|Overall Study||1
7727390|NCT01639729|19025916|P3|NOT COMPLETED|Overall Study||1
7727391|NCT01639729|19025917|P2|NOT COMPLETED|Overall Study||0
7727392|NCT01639729|19025918|P1|NOT COMPLETED|Overall Study||1
7727393|NCT01639729|19025913|P6|COMPLETED|Overall Study||4
7727394|NCT01639729|19025914|P5|COMPLETED|Overall Study||4
7727395|NCT01639729|19025915|P4|COMPLETED|Overall Study||4
7727396|NCT01639729|19025916|P3|COMPLETED|Overall Study||3
7727397|NCT01639729|19025917|P2|COMPLETED|Overall Study||4
7727398|NCT01639729|19025918|P1|COMPLETED|Overall Study||3
7727399|NCT01639729|19025913|P6|STARTED|Overall Study||4
7727400|NCT01639729|19025914|P5|STARTED|Overall Study||4
7727401|NCT01639729|19025915|P4|STARTED|Overall Study||5
7727402|NCT01639729|19025916|P3|STARTED|Overall Study||4
7727403|NCT01639729|19025917|P2|STARTED|Overall Study||4
7727404|NCT01639729|19025918|P1|STARTED|Overall Study||4
7727405|NCT01639703|19025940|P1|NOT COMPLETED|Overall Study||12
7727406|NCT01639703|19025940|P1|COMPLETED|Overall Study||84
7727407|NCT01639703|19025940|P1|STARTED|Overall Study||96
7727408|NCT01639599|19025984|P3|NOT COMPLETED|Overall Study||0
7727409|NCT01639599|19025985|P2|NOT COMPLETED|Overall Study||1
7727410|NCT01639599|19025986|P1|NOT COMPLETED|Overall Study||0
7727411|NCT01639599|19025984|P3|COMPLETED|Overall Study||50
7727412|NCT01639599|19025985|P2|COMPLETED|Overall Study||49
7727413|NCT01639599|19025986|P1|COMPLETED|Overall Study||50
7727414|NCT01639599|19025984|P3|STARTED|Overall Study||50
7727415|NCT01639599|19025985|P2|STARTED|Overall Study||50
7727416|NCT01639599|19025986|P1|STARTED|Overall Study||50
7727417|NCT01639560|19026005|P2|NOT COMPLETED|Overall Study||29
7727418|NCT01639560|19026006|P1|NOT COMPLETED|Overall Study||19
7727419|NCT01639560|19026005|P2|COMPLETED|Overall Study||19
7727420|NCT01639560|19026006|P1|COMPLETED|Overall Study||26
7727421|NCT01639560|19026005|P2|End of Treatment|Overall Study||20
7727422|NCT01639560|19026006|P1|End of Treatment|Overall Study||28
7727423|NCT01639560|19026005|P2|STARTED|Overall Study||48
7727424|NCT01639560|19026006|P1|STARTED|Overall Study||45
7727425|NCT01639495|19026018|P1|NOT COMPLETED|Overall Study||16
7727426|NCT01639495|19026018|P1|COMPLETED|Overall Study||132
7727427|NCT01639495|19026018|P1|Primary Effectiveness Cohort|Overall Study||138
7727428|NCT01639495|19026018|P1|Safety Cohort|Overall Study||144
7727429|NCT01639495|19026018|P1|STARTED|Overall Study|Patients who signed the informed consent.|148
7727430|NCT01639469|19026028|P2|NOT COMPLETED|Overall Study||3
7727431|NCT01639469|19026029|P1|NOT COMPLETED|Overall Study||5
7727432|NCT01639469|19026028|P2|COMPLETED|Overall Study||77
7727433|NCT01639469|19026029|P1|COMPLETED|Overall Study||84
7727434|NCT01639469|19026028|P2|STARTED|Overall Study||80
7727435|NCT01639469|19026029|P1|STARTED|Overall Study||89
7727436|NCT01639443|19026037|P2|NOT COMPLETED|Overall Study||0
7727437|NCT01639443|19026038|P1|NOT COMPLETED|Overall Study||0
7727529|NCT01638013|19026373|P3|COMPLETED|Overall Study||296
7727438|NCT01639443|19026037|P2|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855
7727439|NCT01639443|19026038|P1|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180
7727440|NCT01639443|19026037|P2|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855
7727441|NCT01639443|19026038|P1|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180
7727442|NCT01639352|19026054|P1|NOT COMPLETED|Overall Study||0
7727443|NCT01639352|19026054|P1|COMPLETED|Overall Study||20
7727444|NCT01639352|19026054|P1|STARTED|Overall Study||20
7727445|NCT01639339|19026065|P2|NOT COMPLETED|Overall Study||38
7727446|NCT01639339|19026066|P1|NOT COMPLETED|Overall Study||54
7727447|NCT01639339|19026065|P2|COMPLETED|Overall Study||186
7727448|NCT01639339|19026066|P1|COMPLETED|Overall Study||170
7727449|NCT01639339|19026065|P2|STARTED|Overall Study||224
7727450|NCT01639339|19026066|P1|STARTED|Overall Study||224
7727451|NCT01639222|19026084|P1|NOT COMPLETED|Overall Study||0
7727452|NCT01639222|19026084|P1|COMPLETED|Overall Study||55
7727453|NCT01639222|19026084|P1|STARTED|Overall Study||55
7727454|NCT01639157|19026094|P2|NOT COMPLETED|Overall Study||0
7727455|NCT01639157|19026095|P1|NOT COMPLETED|Overall Study||0
7727456|NCT01639157|19026094|P2|COMPLETED|Overall Study||5
7727457|NCT01639157|19026095|P1|COMPLETED|Overall Study||4
7727458|NCT01639157|19026094|P2|STARTED|Overall Study||5
7727459|NCT01639157|19026095|P1|STARTED|Overall Study||4
7727460|NCT01639144|19026155|P2|NOT COMPLETED|Overall Study||5
7727461|NCT01639144|19026156|P1|NOT COMPLETED|Overall Study||10
7727462|NCT01639144|19026155|P2|COMPLETED|Overall Study||250
7727463|NCT01639144|19026156|P1|COMPLETED|Overall Study||250
7727464|NCT01639144|19026155|P2|STARTED|Overall Study||255
7727465|NCT01639144|19026156|P1|STARTED|Overall Study||260
7727466|NCT01639040|19026164|P2|NOT COMPLETED|Overall Study||0
7727467|NCT01639040|19026165|P1|NOT COMPLETED|Overall Study||1
7727468|NCT01639040|19026164|P2|COMPLETED|Overall Study||21
7727469|NCT01639040|19026165|P1|COMPLETED|Overall Study||9
7727470|NCT01639040|19026164|P2|STARTED|Overall Study||21
7727471|NCT01639040|19026165|P1|STARTED|Overall Study||10
7727472|NCT01639001|19026183|P2|NOT COMPLETED|Overall Study||77
7727473|NCT01639001|19026184|P1|NOT COMPLETED|Overall Study||75
7727474|NCT01639001|19026183|P2|COMPLETED|Overall Study||26
7727475|NCT01639001|19026184|P1|COMPLETED|Overall Study||29
7727476|NCT01639001|19026183|P2|Treated|Overall Study||101
7727477|NCT01639001|19026184|P1|Treated|Overall Study||104
7727478|NCT01639001|19026183|P2|STARTED|Overall Study||103
7727479|NCT01639001|19026184|P1|STARTED|Overall Study||104
7727480|NCT01638819|19026230|P2|NOT COMPLETED|Overall Study||0
7727481|NCT01638819|19026231|P1|NOT COMPLETED|Overall Study||1
7727482|NCT01638819|19026230|P2|COMPLETED|Overall Study||15
7727483|NCT01638819|19026231|P1|COMPLETED|Overall Study||14
7727484|NCT01638819|19026230|P2|Second Intervention (24 Weeks)|Overall Study||15
7727485|NCT01638819|19026231|P1|Second Intervention (24 Weeks)|Overall Study||14
7727486|NCT01638819|19026230|P2|First Intervention (8 Weeks)|Overall Study||15
7727487|NCT01638819|19026231|P1|First Intervention (8 Weeks)|Overall Study||15
7727488|NCT01638819|19026230|P2|STARTED|Overall Study||15
7727489|NCT01638819|19026231|P1|STARTED|Overall Study||15
7727490|NCT01638559|19026240|P1|NOT COMPLETED|Overall Study||3
7727491|NCT01638559|19026240|P1|COMPLETED|Overall Study|Completion through the time of the primary endpoint (outcome).|85
7727492|NCT01638559|19026240|P1|STARTED|Overall Study||88
7727493|NCT01638546|19026258|P2|NOT COMPLETED|Overall Study||3
7727494|NCT01638546|19026259|P1|NOT COMPLETED|Overall Study||1
7727495|NCT01638546|19026258|P2|COMPLETED|Overall Study||42
7727496|NCT01638546|19026259|P1|COMPLETED|Overall Study||51
7727497|NCT01638546|19026258|P2|STARTED|Overall Study||45
7727498|NCT01638546|19026259|P1|STARTED|Overall Study||52
7727499|NCT01638507|19026271|P1|NOT COMPLETED|Overall Study||6
7727500|NCT01638507|19026271|P1|COMPLETED|Overall Study||224
7727501|NCT01638507|19026271|P1|STARTED|Overall Study||230
7727502|NCT01638468|19026284|P1|NOT COMPLETED|Overall Study||0
7727503|NCT01638468|19026284|P1|COMPLETED|Overall Study||7
7727504|NCT01638468|19026284|P1|STARTED|Overall Study||7
7727505|NCT01638429|19026298|P1|NOT COMPLETED|Overall Study||1
7727506|NCT01638429|19026298|P1|COMPLETED|Overall Study||11
7727507|NCT01638429|19026298|P1|Post-treatment Testing|Overall Study||11
7727508|NCT01638429|19026298|P1|Antibiotic Treatment|Overall Study||11
7727509|NCT01638429|19026298|P1|Pre-treatment Testing|Overall Study||11
7727510|NCT01638429|19026298|P1|STARTED|Overall Study||12
7727511|NCT01638416|19026328|P2|NOT COMPLETED|Overall Study||42
7727512|NCT01638416|19026329|P1|NOT COMPLETED|Overall Study||33
7727513|NCT01638416|19026328|P2|COMPLETED|Overall Study||2462
7727514|NCT01638416|19026329|P1|COMPLETED|Overall Study||2457
7727515|NCT01638416|19026328|P2|STARTED|Overall Study||2504
7727516|NCT01638416|19026329|P1|STARTED|Overall Study||2490
7727517|NCT01638390|19026349|P1|NOT COMPLETED|Overall Study||21
7727518|NCT01638390|19026349|P1|COMPLETED|Overall Study|treated eyes|336
7727519|NCT01638390|19026349|P1|STARTED|Overall Study|enrolled|357
7727520|NCT01638312|19026363|P2|NOT COMPLETED|Overall Study||0
7727521|NCT01638312|19026364|P1|NOT COMPLETED|Overall Study||0
7727522|NCT01638312|19026363|P2|COMPLETED|Overall Study||30
7727523|NCT01638312|19026364|P1|COMPLETED|Overall Study||20
7727524|NCT01638312|19026363|P2|STARTED|Overall Study||30
7727525|NCT01638312|19026364|P1|STARTED|Overall Study||20
7727526|NCT01638013|19026373|P3|NOT COMPLETED|Overall Study||121
7727527|NCT01638013|19026374|P2|NOT COMPLETED|Overall Study||78
7727528|NCT01638013|19026375|P1|NOT COMPLETED|Overall Study||131
7727530|NCT01638013|19026374|P2|COMPLETED|Overall Study||147
7727531|NCT01638013|19026375|P1|COMPLETED|Overall Study||70
7727532|NCT01638013|19026373|P3|STARTED|Overall Study||417
7727533|NCT01638013|19026374|P2|STARTED|Overall Study||225
7727534|NCT01638013|19026375|P1|STARTED|Overall Study||201
7727535|NCT01638000|19026508|P2|NOT COMPLETED|Overall Study||71
7727536|NCT01638000|19026509|P1|NOT COMPLETED|Overall Study||60
7727537|NCT01638000|19026508|P2|COMPLETED|Overall Study||873
7727538|NCT01638000|19026509|P1|COMPLETED|Overall Study||883
7727539|NCT01638000|19026508|P2|Received at Least 1 Double-Blind Dose|Overall Study||934
7727540|NCT01638000|19026509|P1|Received at Least 1 Double-Blind Dose|Overall Study||936
7727541|NCT01638000|19026508|P2|STARTED|Overall Study||944
7727542|NCT01638000|19026509|P1|STARTED|Overall Study||943
7727543|NCT01637961|19026607|P1|NOT COMPLETED|Overall Study||2
7727544|NCT01637961|19026607|P1|COMPLETED|Overall Study|Eligible and treated patients.|21
7727545|NCT01637961|19026607|P1|STARTED|Overall Study||23
7727546|NCT01637935|19026622|P2|NOT COMPLETED|Overall Study||0
7727547|NCT01637935|19026623|P1|NOT COMPLETED|Overall Study||0
7727548|NCT01637935|19026622|P2|COMPLETED|Overall Study||158918
7727549|NCT01637935|19026623|P1|COMPLETED|Overall Study||34181
7727550|NCT01637935|19026622|P2|STARTED|Overall Study||158918
7727551|NCT01637935|19026623|P1|STARTED|Overall Study||34181
7727552|NCT01637922|19026639|P2|NOT COMPLETED|Overall Study||5
7727553|NCT01637922|19026640|P1|NOT COMPLETED|Overall Study||2
7727554|NCT01637922|19026639|P2|COMPLETED|Overall Study||14
7727555|NCT01637922|19026640|P1|COMPLETED|Overall Study||13
7727556|NCT01637922|19026639|P2|STARTED|Overall Study||19
7727557|NCT01637922|19026640|P1|STARTED|Overall Study||15
7727558|NCT01637870|19026663|P1|NOT COMPLETED|Overall Study||0
7727559|NCT01637870|19026663|P1|COMPLETED|Overall Study||110
7727560|NCT01637870|19026663|P1|STARTED|Overall Study||110
7727561|NCT01637623|19026670|P3|NOT COMPLETED|Overall Study||3
7727562|NCT01637623|19026671|P2|NOT COMPLETED|Overall Study||0
7727563|NCT01637623|19026672|P1|NOT COMPLETED|Overall Study||1
7727564|NCT01637623|19026670|P3|COMPLETED|Overall Study||25
7727565|NCT01637623|19026671|P2|COMPLETED|Overall Study||30
7727566|NCT01637623|19026672|P1|COMPLETED|Overall Study||28
7727567|NCT01637623|19026670|P3|Analyzed|Overall Study||28
7727568|NCT01637623|19026671|P2|Analyzed|Overall Study||30
7727569|NCT01637623|19026672|P1|Analyzed|Overall Study||28
7727570|NCT01637623|19026670|P3|Did Not Receive Intervention|Overall Study||1
7727571|NCT01637623|19026671|P2|Did Not Receive Intervention|Overall Study||0
7727572|NCT01637623|19026672|P1|Did Not Receive Intervention|Overall Study||1
7727573|NCT01637623|19026670|P3|Received Intervention|Overall Study||27
7727574|NCT01637623|19026671|P2|Received Intervention|Overall Study||30
7727575|NCT01637623|19026672|P1|Received Intervention|Overall Study||28
7727576|NCT01637623|19026670|P3|STARTED|Overall Study||28
7727577|NCT01637623|19026671|P2|STARTED|Overall Study||30
7727578|NCT01637623|19026672|P1|STARTED|Overall Study||29
7727579|NCT01637584|19026712|P2|NOT COMPLETED|Overall Study||3
7727580|NCT01637584|19026713|P1|NOT COMPLETED|Overall Study||1
7727581|NCT01637584|19026712|P2|COMPLETED|Overall Study||17
7727582|NCT01637584|19026713|P1|COMPLETED|Overall Study||19
7727583|NCT01637584|19026712|P2|STARTED|Overall Study||20
7727584|NCT01637584|19026713|P1|STARTED|Overall Study||20
7727585|NCT01637402|19026720|P2|NOT COMPLETED|Treatment Regiments Post Week 12||4
7727586|NCT01637402|19026721|P1|NOT COMPLETED|Treatment Regiments Post Week 12||9
7727587|NCT01637402|19026720|P2|COMPLETED|Treatment Regiments Post Week 12||14
7727588|NCT01637402|19026721|P1|COMPLETED|Treatment Regiments Post Week 12||5
7727589|NCT01637402|19026720|P2|STARTED|Treatment Regiments Post Week 12|Patients who progressed after decline on standard dose|18
7727590|NCT01637402|19026721|P1|STARTED|Treatment Regiments Post Week 12|Patients continuing on standard dose|14
7727591|NCT01637402|19026720|P2|NOT COMPLETED|Week 12 Evaluation||0
7727592|NCT01637402|19026721|P1|NOT COMPLETED|Week 12 Evaluation||6
7727593|NCT01637402|19026720|P2|COMPLETED|Week 12 Evaluation||0
7727594|NCT01637402|19026721|P1|COMPLETED|Week 12 Evaluation||32
7727595|NCT01637402|19026720|P2|STARTED|Week 12 Evaluation|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
7727596|NCT01637402|19026721|P1|STARTED|Week 12 Evaluation||38
7727597|NCT01637402|19026720|P2|NOT COMPLETED|Standard Dose Regimen||0
7727598|NCT01637402|19026721|P1|NOT COMPLETED|Standard Dose Regimen||3
7727599|NCT01637402|19026720|P2|COMPLETED|Standard Dose Regimen||0
7727600|NCT01637402|19026721|P1|COMPLETED|Standard Dose Regimen||38
7727601|NCT01637402|19026720|P2|STARTED|Standard Dose Regimen|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
7727602|NCT01637402|19026721|P1|STARTED|Standard Dose Regimen||41
7727603|NCT01637272|19026752|P1|NOT COMPLETED|Overall Study||20
7727604|NCT01637272|19026752|P1|COMPLETED|Overall Study||23
7727605|NCT01637272|19026752|P1|Completed Core But Did no Enter Ext..|Overall Study||4
7727606|NCT01637272|19026752|P1|Entered Extension Phase|Overall Study||27
7727607|NCT01637272|19026752|P1|Completed Core Phase (sc + LAR)|Overall Study||31
7727608|NCT01637272|19026752|P1|Completed sc Phase|Overall Study||33
7727609|NCT01637272|19026752|P1|STARTED|Overall Study||43
7727610|NCT01637246|19026814|P1|NOT COMPLETED|Overall Study||2139
7727611|NCT01637246|19026814|P1|COMPLETED|Overall Study||2246
7727612|NCT01637246|19026814|P1|STARTED|Overall Study||4385
7727613|NCT01637090|19026822|P1|NOT COMPLETED|Overall Study||3
7727614|NCT01637090|19026822|P1|COMPLETED|Overall Study||0
7727615|NCT01637090|19026822|P1|STARTED|Overall Study||3
7727616|NCT01637077|19026832|P2|NOT COMPLETED|Overall Study||1
7727617|NCT01637077|19026833|P1|NOT COMPLETED|Overall Study||4
7727618|NCT01637077|19026832|P2|COMPLETED|Overall Study||22
7727619|NCT01637077|19026833|P1|COMPLETED|Overall Study||19
7727620|NCT01637077|19026832|P2|STARTED|Overall Study||23
7727621|NCT01637077|19026833|P1|STARTED|Overall Study||23
7727622|NCT01636986|19026861|P2|NOT COMPLETED|Overall Study||2
7727623|NCT01636986|19026862|P1|NOT COMPLETED|Overall Study||0
7727624|NCT01636986|19026861|P2|COMPLETED|Overall Study||30
7727625|NCT01636986|19026862|P1|COMPLETED|Overall Study||30
7727626|NCT01636986|19026861|P2|STARTED|Overall Study||32
7727627|NCT01636986|19026862|P1|STARTED|Overall Study||30
7727628|NCT01636960|19026868|P1|NOT COMPLETED|Maintenance Phase||7
7727629|NCT01636960|19026868|P1|COMPLETED|Maintenance Phase||0
7727630|NCT01636960|19026868|P1|STARTED|Maintenance Phase||7
7727631|NCT01636960|19026868|P1|NOT COMPLETED|Induction Phase||2
7727632|NCT01636960|19026868|P1|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7
7727633|NCT01636960|19026868|P1|STARTED|Induction Phase||9
7727634|NCT01636947|19026876|P2|NOT COMPLETED|Overall Study||11
7727635|NCT01636947|19026877|P1|NOT COMPLETED|Overall Study||12
7727636|NCT01636947|19026876|P2|COMPLETED|Overall Study||239
7727637|NCT01636947|19026877|P1|COMPLETED|Overall Study||232
7727638|NCT01636947|19026876|P2|Treated|Overall Study||248
7727639|NCT01636947|19026877|P1|Treated|Overall Study||242
7727640|NCT01636947|19026876|P2|STARTED|Overall Study||250
7727641|NCT01636947|19026877|P1|STARTED|Overall Study||244
7727642|NCT01636934|19026899|P2|NOT COMPLETED|Overall Study||3
7727643|NCT01636934|19026900|P1|NOT COMPLETED|Overall Study||6
7727644|NCT01636934|19026899|P2|COMPLETED|Overall Study||21
7727645|NCT01636934|19026900|P1|COMPLETED|Overall Study||19
7727646|NCT01636934|19026899|P2|STARTED|Overall Study||24
7727647|NCT01636934|19026900|P1|STARTED|Overall Study||25
7727648|NCT01636882|19026908|P1|NOT COMPLETED|Overall Study||0
7727649|NCT01636882|19026908|P1|COMPLETED|Overall Study||16
7727650|NCT01636882|19026908|P1|STARTED|Overall Study||16
7727651|NCT01636778|19026912|P3|NOT COMPLETED|Follow-up Period After Part 2||4
7727652|NCT01636778|19026913|P2|NOT COMPLETED|Follow-up Period After Part 2||0
7727653|NCT01636778|19026914|P1|NOT COMPLETED|Follow-up Period After Part 2||0
7727654|NCT01636778|19026912|P3|COMPLETED|Follow-up Period After Part 2||37
7727655|NCT01636778|19026913|P2|COMPLETED|Follow-up Period After Part 2||0
7727656|NCT01636778|19026914|P1|COMPLETED|Follow-up Period After Part 2||0
7727657|NCT01636778|19026912|P3|STARTED|Follow-up Period After Part 2||41
7727658|NCT01636778|19026913|P2|STARTED|Follow-up Period After Part 2||0
7727659|NCT01636778|19026914|P1|STARTED|Follow-up Period After Part 2||0
7727660|NCT01636778|19026912|P3|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
7727661|NCT01636778|19026913|P2|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10
7727662|NCT01636778|19026914|P1|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
7727663|NCT01636778|19026912|P3|COMPLETED|Antiviral Treatment Period (Part 2)||0
7727664|NCT01636778|19026913|P2|COMPLETED|Antiviral Treatment Period (Part 2)||31
7727665|NCT01636778|19026914|P1|COMPLETED|Antiviral Treatment Period (Part 2)||0
7727666|NCT01636778|19026912|P3|STARTED|Antiviral Treatment Period (Part 2)||0
7727667|NCT01636778|19026913|P2|STARTED|Antiviral Treatment Period (Part 2)||41
7727668|NCT01636778|19026914|P1|STARTED|Antiviral Treatment Period (Part 2)||0
7727669|NCT01636778|19026912|P3|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
7727670|NCT01636778|19026913|P2|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
7727671|NCT01636778|19026914|P1|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4
7727672|NCT01636778|19026912|P3|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
7727673|NCT01636778|19026913|P2|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
7727674|NCT01636778|19026914|P1|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41
7727675|NCT01636778|19026912|P3|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
7727676|NCT01636778|19026913|P2|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
7727677|NCT01636778|19026914|P1|STARTED|Pre-Antiviral Treatment Period (Part 1)||45
7727678|NCT01636765|19026977|P1|NOT COMPLETED|Overall Study||0
7727679|NCT01636765|19026977|P1|COMPLETED|Overall Study||104
7727680|NCT01636765|19026977|P1|STARTED|Overall Study||104
7727681|NCT01636713|19026985|P3|NOT COMPLETED|Overall Study||23
7727682|NCT01636713|19026986|P2|NOT COMPLETED|Overall Study||28
7727683|NCT01636713|19026987|P1|NOT COMPLETED|Overall Study||32
7727684|NCT01636713|19026985|P3|COMPLETED|Overall Study||170
7727685|NCT01636713|19026986|P2|COMPLETED|Overall Study||166
7727686|NCT01636713|19026987|P1|COMPLETED|Overall Study||161
7727687|NCT01636713|19026985|P3|STARTED|Overall Study||193
7727688|NCT01636713|19026986|P2|STARTED|Overall Study||194
7727689|NCT01636713|19026987|P1|STARTED|Overall Study||193
7727690|NCT01636687|19027004|P5|NOT COMPLETED|Follow-up Period||1
7727691|NCT01636687|19027005|P4|NOT COMPLETED|Follow-up Period||0
7727692|NCT01636687|19027006|P3|NOT COMPLETED|Follow-up Period||0
7727693|NCT01636687|19027007|P2|NOT COMPLETED|Follow-up Period||0
7727694|NCT01636687|19027008|P1|NOT COMPLETED|Follow-up Period||1
7727695|NCT01636687|19027004|P5|COMPLETED|Follow-up Period||1
7727696|NCT01636687|19027005|P4|COMPLETED|Follow-up Period||20
7727697|NCT01636687|19027006|P3|COMPLETED|Follow-up Period||21
7727698|NCT01636687|19027007|P2|COMPLETED|Follow-up Period||45
7727699|NCT01636687|19027008|P1|COMPLETED|Follow-up Period||37
7727700|NCT01636687|19027004|P5|STARTED|Follow-up Period||2
7727701|NCT01636687|19027005|P4|STARTED|Follow-up Period||20
7727702|NCT01636687|19027006|P3|STARTED|Follow-up Period||21
7727703|NCT01636687|19027007|P2|STARTED|Follow-up Period||45
7727704|NCT01636687|19027008|P1|STARTED|Follow-up Period||38
7727705|NCT01636687|19027004|P5|NOT COMPLETED|Extension Period||0
7727706|NCT01636687|19027005|P4|NOT COMPLETED|Extension Period||28
7727707|NCT01636687|19027006|P3|NOT COMPLETED|Extension Period||25
7727708|NCT01636687|19027007|P2|NOT COMPLETED|Extension Period||54
7727709|NCT01636687|19027008|P1|NOT COMPLETED|Extension Period||47
7727710|NCT01636687|19027004|P5|COMPLETED|Extension Period||0
7727711|NCT01636687|19027005|P4|COMPLETED|Extension Period||0
7727712|NCT01636687|19027006|P3|COMPLETED|Extension Period||0
7727713|NCT01636687|19027007|P2|COMPLETED|Extension Period||0
7727714|NCT01636687|19027008|P1|COMPLETED|Extension Period||0
7727715|NCT01636687|19027004|P5|STARTED|Extension Period||0
7727716|NCT01636687|19027005|P4|STARTED|Extension Period||28
7727717|NCT01636687|19027006|P3|STARTED|Extension Period||25
7727718|NCT01636687|19027007|P2|STARTED|Extension Period||54
7727719|NCT01636687|19027008|P1|STARTED|Extension Period||47
7727720|NCT01636687|19027004|P5|NOT COMPLETED|Maintenance Period||2
7727721|NCT01636687|19027005|P4|NOT COMPLETED|Maintenance Period||0
7727722|NCT01636687|19027006|P3|NOT COMPLETED|Maintenance Period||2
7727723|NCT01636687|19027007|P2|NOT COMPLETED|Maintenance Period||2
7727724|NCT01636687|19027008|P1|NOT COMPLETED|Maintenance Period||8
7727725|NCT01636687|19027004|P5|COMPLETED|Maintenance Period||1
7727726|NCT01636687|19027005|P4|COMPLETED|Maintenance Period||28
7727727|NCT01636687|19027006|P3|COMPLETED|Maintenance Period||26
7727728|NCT01636687|19027007|P2|COMPLETED|Maintenance Period||58
7727729|NCT01636687|19027008|P1|COMPLETED|Maintenance Period||50
7727730|NCT01636687|19027004|P5|STARTED|Maintenance Period||3
7727731|NCT01636687|19027005|P4|STARTED|Maintenance Period||28
7727732|NCT01636687|19027006|P3|STARTED|Maintenance Period||28
7727733|NCT01636687|19027007|P2|STARTED|Maintenance Period||60
7727734|NCT01636687|19027008|P1|STARTED|Maintenance Period||58
7727735|NCT01636687|19027004|P5|NOT COMPLETED|Induction Period||2
7727736|NCT01636687|19027005|P4|NOT COMPLETED|Induction Period||0
7727737|NCT01636687|19027006|P3|NOT COMPLETED|Induction Period||0
7727738|NCT01636687|19027007|P2|NOT COMPLETED|Induction Period||0
7727739|NCT01636687|19027008|P1|NOT COMPLETED|Induction Period||3
7727740|NCT01636687|19027004|P5|COMPLETED|Induction Period||59
7727741|NCT01636687|19027005|P4|COMPLETED|Induction Period||0
7727742|NCT01636687|19027006|P3|COMPLETED|Induction Period||0
7727743|NCT01636687|19027007|P2|COMPLETED|Induction Period||60
7727744|NCT01636687|19027008|P1|COMPLETED|Induction Period||58
7727745|NCT01636687|19027004|P5|STARTED|Induction Period||61
7727746|NCT01636687|19027005|P4|STARTED|Induction Period||0
7727747|NCT01636687|19027006|P3|STARTED|Induction Period||0
7727748|NCT01636687|19027007|P2|STARTED|Induction Period||60
7727749|NCT01636687|19027008|P1|STARTED|Induction Period||61
7727750|NCT01636661|19027097|P2|NOT COMPLETED|Overall Study||0
7727751|NCT01636661|19027098|P1|NOT COMPLETED|Overall Study||0
7727752|NCT01636661|19027097|P2|COMPLETED|Overall Study||6
7727753|NCT01636661|19027098|P1|COMPLETED|Overall Study||5
7727754|NCT01636661|19027097|P2|STARTED|Overall Study||6
7727755|NCT01636661|19027098|P1|STARTED|Overall Study||5
7727756|NCT01636466|19027108|P2|NOT COMPLETED|Overall Study||0
7727757|NCT01636466|19027109|P1|NOT COMPLETED|Overall Study||1
7727758|NCT01636466|19027108|P2|COMPLETED|Overall Study||0
7727759|NCT01636466|19027109|P1|COMPLETED|Overall Study||0
7727760|NCT01636466|19027108|P2|STARTED|Overall Study||0
7727761|NCT01636466|19027109|P1|STARTED|Overall Study||1
7727762|NCT01636453|19027117|P1|NOT COMPLETED|Overall Study||8
7727763|NCT01636453|19027117|P1|COMPLETED|Overall Study||112
7727764|NCT01636453|19027117|P1|STARTED|Overall Study||120
7727765|NCT01636414|19027136|P3|NOT COMPLETED|Overall Study||9
7727766|NCT01636414|19027137|P2|NOT COMPLETED|Overall Study||6
7727767|NCT01636414|19027138|P1|NOT COMPLETED|Overall Study||3
7727768|NCT01636414|19027136|P3|COMPLETED|Overall Study||65
7727769|NCT01636414|19027137|P2|COMPLETED|Overall Study||60
7727770|NCT01636414|19027138|P1|COMPLETED|Overall Study||61
7727771|NCT01636414|19027136|P3|STARTED|Overall Study||74
7727772|NCT01636414|19027137|P2|STARTED|Overall Study||66
7727773|NCT01636414|19027138|P1|STARTED|Overall Study||64
7727774|NCT01636362|19027149|P1|NOT COMPLETED|Overall Study||8
7727775|NCT01636362|19027149|P1|COMPLETED|Overall Study||37
7727776|NCT01636362|19027149|P1|STARTED|Overall Study||45
7727777|NCT01636297|19027158|P3|NOT COMPLETED|Overall Study||1
7727778|NCT01636297|19027159|P2|NOT COMPLETED|Overall Study||4
7727779|NCT01636297|19027160|P1|NOT COMPLETED|Overall Study||4
7727780|NCT01636297|19027158|P3|COMPLETED|Overall Study||19
7727781|NCT01636297|19027159|P2|COMPLETED|Overall Study||36
7727782|NCT01636297|19027160|P1|COMPLETED|Overall Study||36
7727783|NCT01636297|19027158|P3|STARTED|Overall Study||20
7727784|NCT01636297|19027159|P2|STARTED|Overall Study||40
7727785|NCT01636297|19027160|P1|STARTED|Overall Study||40
7727786|NCT01636284|19027174|P1|NOT COMPLETED|Overall Study||0
7727787|NCT01636284|19027174|P1|COMPLETED|Overall Study||16
7727788|NCT01636284|19027174|P1|STARTED|Overall Study||16
7727789|NCT01636258|19027180|P2|NOT COMPLETED|Overall Study||0
7727790|NCT01636258|19027181|P1|NOT COMPLETED|Overall Study||1
7727791|NCT01636258|19027180|P2|COMPLETED|Overall Study||14
7727792|NCT01636258|19027181|P1|COMPLETED|Overall Study||12
7727793|NCT01636258|19027180|P2|STARTED|Overall Study||14
7727794|NCT01636258|19027181|P1|STARTED|Overall Study||13
7727795|NCT01636206|19027197|P2|NOT COMPLETED|Overall Study||51
7727796|NCT01636206|19027198|P1|NOT COMPLETED|Overall Study||19
7727797|NCT01636206|19027197|P2|COMPLETED|Overall Study||170
7727798|NCT01636206|19027198|P1|COMPLETED|Overall Study||92
7727799|NCT01636206|19027197|P2|STARTED|Overall Study||221
7727800|NCT01636206|19027198|P1|STARTED|Overall Study||111
7727801|NCT01636102|19027206|P2|NOT COMPLETED|Overall Study||0
7727802|NCT01636102|19027207|P1|NOT COMPLETED|Overall Study||0
7727803|NCT01636102|19027206|P2|COMPLETED|Overall Study||63
7727804|NCT01636102|19027207|P1|COMPLETED|Overall Study||63
7727805|NCT01636102|19027206|P2|STARTED|Overall Study||63
7727806|NCT01636102|19027207|P1|STARTED|Overall Study||63
7727807|NCT01636076|19027221|P2|NOT COMPLETED|Overall Study||25
7727808|NCT01636076|19027222|P1|NOT COMPLETED|Overall Study||17
7727809|NCT01636076|19027221|P2|COMPLETED|Overall Study||288
7727810|NCT01636076|19027222|P1|COMPLETED|Overall Study||299
7727811|NCT01636076|19027221|P2|STARTED|Overall Study||313
7727812|NCT01636076|19027222|P1|STARTED|Overall Study||316
7727813|NCT01636063|19027284|P2|NOT COMPLETED|Overall Study||0
7727814|NCT01636063|19027285|P1|NOT COMPLETED|Overall Study||0
7727815|NCT01636063|19027284|P2|COMPLETED|Overall Study||21
7727816|NCT01636063|19027285|P1|COMPLETED|Overall Study||21
7727817|NCT01636063|19027284|P2|STARTED|Overall Study||21
7727818|NCT01636063|19027285|P1|STARTED|Overall Study||21
7727819|NCT01635998|19027293|P2|NOT COMPLETED|Overall Study||7
7727820|NCT01635998|19027294|P1|NOT COMPLETED|Overall Study||4
7727821|NCT01635998|19027293|P2|COMPLETED|Overall Study||15
7727822|NCT01635998|19027294|P1|COMPLETED|Overall Study||24
7727823|NCT01635998|19027293|P2|STARTED|Overall Study||22
7727824|NCT01635998|19027294|P1|STARTED|Overall Study||28
7727825|NCT01635933|19027322|P2|NOT COMPLETED|Overall Study||8
7727826|NCT01635933|19027323|P1|NOT COMPLETED|Overall Study||2
7727827|NCT01635933|19027322|P2|COMPLETED|Overall Study||177
7727828|NCT01635933|19027323|P1|COMPLETED|Overall Study||176
7727829|NCT01635933|19027322|P2|STARTED|Overall Study||185
7727830|NCT01635933|19027323|P1|STARTED|Overall Study||178
7727831|NCT01635920|19027335|P2|NOT COMPLETED|Overall Study||1
7727832|NCT01635920|19027336|P1|NOT COMPLETED|Overall Study||3
7727833|NCT01635920|19027335|P2|COMPLETED|Overall Study||125
7727834|NCT01635920|19027336|P1|COMPLETED|Overall Study||122
7727835|NCT01635920|19027335|P2|STARTED|Overall Study||126
7727836|NCT01635920|19027336|P1|STARTED|Overall Study||125
7727837|NCT01635881|19027344|P1|NOT COMPLETED|Overall Study||0
7727838|NCT01635881|19027344|P1|COMPLETED|Overall Study||60
7727839|NCT01635881|19027344|P1|STARTED|Overall Study||60
7727840|NCT01635855|19027349|P1|NOT COMPLETED|Overall Study||4
7727841|NCT01635855|19027349|P1|COMPLETED|Overall Study||113
7727842|NCT01635855|19027349|P1|STARTED|Overall Study||117
7727843|NCT01635764|19027358|P1|NOT COMPLETED|Overall Study||273
7727844|NCT01635764|19027358|P1|COMPLETED|Overall Study||235
7727845|NCT01635764|19027358|P1|STARTED|Overall Study||508
7727846|NCT01635504|19027386|P1|NOT COMPLETED|Overall Study||0
7727847|NCT01635504|19027386|P1|COMPLETED|Overall Study||5
7727848|NCT01635504|19027386|P1|STARTED|Overall Study||5
7727849|NCT01635439|19027393|P2|NOT COMPLETED|Overall Study||0
7727850|NCT01635439|19027394|P1|NOT COMPLETED|Overall Study||0
7727851|NCT01635439|19027393|P2|COMPLETED|Overall Study||100
7727852|NCT01635439|19027394|P1|COMPLETED|Overall Study||100
7727853|NCT01635439|19027393|P2|STARTED|Overall Study||100
7727854|NCT01635439|19027394|P1|STARTED|Overall Study||100
7727855|NCT01635283|19027408|P1|NOT COMPLETED|Overall Study||4
7727856|NCT01635283|19027408|P1|COMPLETED|Overall Study||1
7727857|NCT01635283|19027408|P1|STARTED|Overall Study||5
7727858|NCT01635244|19027419|P3|NOT COMPLETED|Overall Study||2
7727859|NCT01635244|19027420|P2|NOT COMPLETED|Overall Study||1
7727860|NCT01635244|19027421|P1|NOT COMPLETED|Overall Study||1
7727861|NCT01635244|19027419|P3|COMPLETED|Overall Study||18
7727862|NCT01635244|19027420|P2|COMPLETED|Overall Study||21
7727863|NCT01635244|19027421|P1|COMPLETED|Overall Study||17
7727864|NCT01635244|19027419|P3|STARTED|Overall Study||20
7727865|NCT01635244|19027420|P2|STARTED|Overall Study||22
7727866|NCT01635244|19027421|P1|STARTED|Overall Study||18
7727867|NCT01635218|19027432|P3|NOT COMPLETED|Overall Study||6
7727868|NCT01635218|19027433|P2|NOT COMPLETED|Overall Study||7
7727869|NCT01635218|19027434|P1|NOT COMPLETED|Overall Study||3
7727870|NCT01635218|19027432|P3|COMPLETED|Overall Study||37
7727871|NCT01635218|19027433|P2|COMPLETED|Overall Study||39
7727872|NCT01635218|19027434|P1|COMPLETED|Overall Study||41
7727873|NCT01635218|19027432|P3|STARTED|Overall Study||43
7727874|NCT01635218|19027433|P2|STARTED|Overall Study||46
7727875|NCT01635218|19027434|P1|STARTED|Overall Study||44
7727876|NCT01635153|19027456|P2|NOT COMPLETED|Overall Study||43
7727877|NCT01635153|19027457|P1|NOT COMPLETED|Overall Study||40
7727878|NCT01635153|19027456|P2|COMPLETED|Overall Study||36
7727879|NCT01635153|19027457|P1|COMPLETED|Overall Study||32
7727880|NCT01635153|19027456|P2|STARTED|Overall Study||79
7727881|NCT01635153|19027457|P1|STARTED|Overall Study||72
7727882|NCT01635101|19027470|P3|NOT COMPLETED|Overall Study||17
7727883|NCT01635101|19027471|P2|NOT COMPLETED|Overall Study||12
7727884|NCT01635101|19027472|P1|NOT COMPLETED|Overall Study||9
7727885|NCT01635101|19027470|P3|COMPLETED|Overall Study||52
7727886|NCT01635101|19027471|P2|COMPLETED|Overall Study||55
7727887|NCT01635101|19027472|P1|COMPLETED|Overall Study||52
7727888|NCT01635101|19027470|P3|Pharmacokinetics Evaluable Population|Overall Study||58
7727889|NCT01635101|19027471|P2|Pharmacokinetics Evaluable Population|Overall Study||59
7727890|NCT01635101|19027472|P1|Pharmacokinetics Evaluable Population|Overall Study||50
7727891|NCT01635101|19027470|P3|Modified Intent to Treat (mITT)|Overall Study||69
7727892|NCT01635101|19027471|P2|Modified Intent to Treat (mITT)|Overall Study||67
7727893|NCT01635101|19027472|P1|Modified Intent to Treat (mITT)|Overall Study||61
7727894|NCT01635101|19027470|P3|Safety Population|Overall Study||69
7727895|NCT01635101|19027471|P2|Safety Population|Overall Study||67
7727896|NCT01635101|19027472|P1|Safety Population|Overall Study||61
7727897|NCT01635101|19027470|P3|STARTED|Overall Study||69
7727898|NCT01635101|19027471|P2|STARTED|Overall Study||67
7727899|NCT01635101|19027472|P1|STARTED|Overall Study||61
7727900|NCT01635062|19027497|P2|NOT COMPLETED|Overall Study||0
7727901|NCT01635062|19027498|P1|NOT COMPLETED|Overall Study||0
7727902|NCT01635062|19027497|P2|COMPLETED|Overall Study||9
7727903|NCT01635062|19027498|P1|COMPLETED|Overall Study||9
7727904|NCT01635062|19027497|P2|Post-Randomization Sodium Loaded|Overall Study||9
7727905|NCT01635062|19027498|P1|Post-Randomization Sodium Loaded|Overall Study||9
7727906|NCT01635062|19027497|P2|Post-randomization Sodium Restriction|Overall Study||9
7727907|NCT01635062|19027498|P1|Post-randomization Sodium Restriction|Overall Study||9
7727908|NCT01635062|19027497|P2|Sodium Loading Baseline Visit|Overall Study||9
7727909|NCT01635062|19027498|P1|Sodium Loading Baseline Visit|Overall Study||9
7727910|NCT01635062|19027497|P2|Sodium Restriction Baseline Visit|Overall Study||9
7727911|NCT01635062|19027498|P1|Sodium Restriction Baseline Visit|Overall Study||9
7727912|NCT01635062|19027497|P2|STARTED|Overall Study||9
7727913|NCT01635062|19027498|P1|STARTED|Overall Study||9
7727914|NCT01634854|19027510|P2|NOT COMPLETED|Overall Study||7
7727915|NCT01634854|19027511|P1|NOT COMPLETED|Overall Study||2
7727916|NCT01634854|19027510|P2|COMPLETED|Overall Study||59
7727917|NCT01634854|19027511|P1|COMPLETED|Overall Study||62
7727918|NCT01634854|19027510|P2|STARTED|Overall Study||66
7727919|NCT01634854|19027511|P1|STARTED|Overall Study||64
7727920|NCT01634659|19027531|P2|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0
7727921|NCT01634659|19027532|P1|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3
7727922|NCT01634659|19027531|P2|COMPLETED|Period 2 - Second 8 Days of Wear||158
7727923|NCT01634659|19027532|P1|COMPLETED|Period 2 - Second 8 Days of Wear||152
7727924|NCT01634659|19027531|P2|STARTED|Period 2 - Second 8 Days of Wear||158
7727925|NCT01634659|19027532|P1|STARTED|Period 2 - Second 8 Days of Wear||155
7727926|NCT01634659|19027531|P2|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
7727927|NCT01634659|19027532|P1|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
7727928|NCT01634659|19027531|P2|COMPLETED|Period 1 - First 8 Days of Wear||158
7727929|NCT01634659|19027532|P1|COMPLETED|Period 1 - First 8 Days of Wear||155
7727930|NCT01634659|19027531|P2|STARTED|Period 1 - First 8 Days of Wear||158
7727931|NCT01634659|19027532|P1|STARTED|Period 1 - First 8 Days of Wear||155
7727932|NCT01634620|19027542|P1|NOT COMPLETED|Overall Study||0
7727933|NCT01634620|19027542|P1|COMPLETED|Overall Study||200
7727934|NCT01634620|19027542|P1|STARTED|Overall Study||200
7727935|NCT01634555|19027562|P1|NOT COMPLETED|Overall Study||4
7727936|NCT01634555|19027562|P1|COMPLETED|Overall Study|Completed the required treatment and assessment.|25
7727937|NCT01634555|19027562|P1|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25
7727938|NCT01634555|19027562|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
7727939|NCT01634555|19027562|P1|STARTED|Overall Study||29
7727940|NCT01634360|19027573|P2|NOT COMPLETED|Overall Study||136
7727941|NCT01634360|19027574|P1|NOT COMPLETED|Overall Study||49
7727942|NCT01634360|19027573|P2|COMPLETED|Overall Study||0
7727943|NCT01634360|19027574|P1|COMPLETED|Overall Study||0
7727944|NCT01634360|19027573|P2|STARTED|Overall Study||136
7727945|NCT01634360|19027574|P1|STARTED|Overall Study||49
7727946|NCT01634269|19027584|P1|NOT COMPLETED|Overall Study||2
7727947|NCT01634269|19027584|P1|COMPLETED|Overall Study||18
7727948|NCT01634269|19027584|P1|24 Month|Overall Study||18
7727949|NCT01634269|19027584|P1|12 Month|Overall Study||20
7727950|NCT01634269|19027584|P1|6 Month|Overall Study||20
7727951|NCT01634269|19027584|P1|30 Days|Overall Study||20
7727952|NCT01634269|19027584|P1|STARTED|Overall Study||20
7727953|NCT01634256|19027631|P2|NOT COMPLETED|Overall Study||8
7727954|NCT01634256|19027632|P1|NOT COMPLETED|Overall Study||4
7727955|NCT01634256|19027631|P2|COMPLETED|Overall Study||22
7727956|NCT01634256|19027632|P1|COMPLETED|Overall Study||26
7727957|NCT01634256|19027631|P2|STARTED|Overall Study||30
7727958|NCT01634256|19027632|P1|STARTED|Overall Study||30
7727959|NCT01634243|19027648|P2|NOT COMPLETED|Overall Study||5
7727960|NCT01634243|19027649|P1|NOT COMPLETED|Overall Study||6
7727961|NCT01634243|19027648|P2|COMPLETED|Overall Study||38
7727962|NCT01634243|19027649|P1|COMPLETED|Overall Study||15
7727963|NCT01634243|19027648|P2|STARTED|Overall Study||43
7727964|NCT01634243|19027649|P1|STARTED|Overall Study||21
7727965|NCT01634165|19027675|P4|NOT COMPLETED|Period 4||0
7727966|NCT01634165|19027676|P3|NOT COMPLETED|Period 4||0
7727967|NCT01634165|19027677|P2|NOT COMPLETED|Period 4||0
7727968|NCT01634165|19027678|P1|NOT COMPLETED|Period 4||0
7727969|NCT01634165|19027675|P4|COMPLETED|Period 4||6
7727970|NCT01634165|19027676|P3|COMPLETED|Period 4||6
7727971|NCT01634165|19027677|P2|COMPLETED|Period 4||5
7727972|NCT01634165|19027678|P1|COMPLETED|Period 4||6
7727973|NCT01634165|19027675|P4|STARTED|Period 4||6
7727974|NCT01634165|19027676|P3|STARTED|Period 4||6
7727975|NCT01634165|19027677|P2|STARTED|Period 4||5
7727976|NCT01634165|19027678|P1|STARTED|Period 4||6
7727977|NCT01634165|19027675|P4|NOT COMPLETED|Period 3||0
7727978|NCT01634165|19027676|P3|NOT COMPLETED|Period 3||0
7727979|NCT01634165|19027677|P2|NOT COMPLETED|Period 3||0
7727980|NCT01634165|19027678|P1|NOT COMPLETED|Period 3||0
7727981|NCT01634165|19027675|P4|COMPLETED|Period 3||6
7727982|NCT01634165|19027676|P3|COMPLETED|Period 3||6
7727983|NCT01634165|19027677|P2|COMPLETED|Period 3||5
7727984|NCT01634165|19027678|P1|COMPLETED|Period 3||6
7727985|NCT01634165|19027675|P4|STARTED|Period 3||6
7727986|NCT01634165|19027676|P3|STARTED|Period 3||6
7727987|NCT01634165|19027677|P2|STARTED|Period 3||5
7727988|NCT01634165|19027678|P1|STARTED|Period 3||6
7727989|NCT01634165|19027675|P4|NOT COMPLETED|Period 2||0
7727990|NCT01634165|19027676|P3|NOT COMPLETED|Period 2||0
7727991|NCT01634165|19027677|P2|NOT COMPLETED|Period 2||1
7727992|NCT01634165|19027678|P1|NOT COMPLETED|Period 2||0
7727993|NCT01634165|19027675|P4|COMPLETED|Period 2||6
7727994|NCT01634165|19027676|P3|COMPLETED|Period 2||6
7727995|NCT01634165|19027677|P2|COMPLETED|Period 2||5
7727996|NCT01634165|19027678|P1|COMPLETED|Period 2||6
7727997|NCT01634165|19027675|P4|STARTED|Period 2||6
7727998|NCT01634165|19027676|P3|STARTED|Period 2||6
7727999|NCT01634165|19027677|P2|STARTED|Period 2||6
7728000|NCT01634165|19027678|P1|STARTED|Period 2||6
7728001|NCT01634165|19027675|P4|NOT COMPLETED|Period 1||0
7728002|NCT01634165|19027676|P3|NOT COMPLETED|Period 1||0
7728003|NCT01634165|19027677|P2|NOT COMPLETED|Period 1||0
7728004|NCT01634165|19027678|P1|NOT COMPLETED|Period 1||0
7728005|NCT01634165|19027675|P4|COMPLETED|Period 1||6
7728006|NCT01634165|19027676|P3|COMPLETED|Period 1||6
7728007|NCT01634165|19027677|P2|COMPLETED|Period 1||6
7728008|NCT01634165|19027678|P1|COMPLETED|Period 1||6
7728009|NCT01634165|19027675|P4|Received at Least 1 Dose of Study Drug|Period 1||6
7728010|NCT01634165|19027676|P3|Received at Least 1 Dose of Study Drug|Period 1||6
7728011|NCT01634165|19027677|P2|Received at Least 1 Dose of Study Drug|Period 1||6
7728012|NCT01634165|19027678|P1|Received at Least 1 Dose of Study Drug|Period 1||6
7728013|NCT01634165|19027675|P4|STARTED|Period 1||6
7728014|NCT01634165|19027676|P3|STARTED|Period 1||6
7728015|NCT01634165|19027677|P2|STARTED|Period 1||6
7728016|NCT01634165|19027678|P1|STARTED|Period 1||6
7728017|NCT01634152|19027711|P3|NOT COMPLETED|Overall Study||4
7728018|NCT01634152|19027712|P2|NOT COMPLETED|Overall Study||1
7728019|NCT01634152|19027713|P1|NOT COMPLETED|Overall Study||4
7728020|NCT01634152|19027711|P3|COMPLETED|Overall Study||126
7728021|NCT01634152|19027712|P2|COMPLETED|Overall Study||136
7728022|NCT01634152|19027713|P1|COMPLETED|Overall Study||130
7728023|NCT01634152|19027711|P3|STARTED|Overall Study||130
7728024|NCT01634152|19027712|P2|STARTED|Overall Study||137
7728025|NCT01634152|19027713|P1|STARTED|Overall Study||134
7728026|NCT01634139|19027796|P3|NOT COMPLETED|Overall Study||5
7728027|NCT01634139|19027797|P2|NOT COMPLETED|Overall Study||6
7728028|NCT01634139|19027798|P1|NOT COMPLETED|Overall Study||10
7728029|NCT01634139|19027796|P3|COMPLETED|Overall Study||130
7728030|NCT01634139|19027797|P2|COMPLETED|Overall Study||130
7728031|NCT01634139|19027798|P1|COMPLETED|Overall Study||122
7728032|NCT01634139|19027796|P3|STARTED|Overall Study||135
7728033|NCT01634139|19027797|P2|STARTED|Overall Study||136
7728034|NCT01634139|19027798|P1|STARTED|Overall Study||132
7728035|NCT01634113|19027899|P3|NOT COMPLETED|Overall Study||1
7728036|NCT01634113|19027900|P2|NOT COMPLETED|Overall Study||0
7728037|NCT01634113|19027901|P1|NOT COMPLETED|Overall Study||0
7728038|NCT01634113|19027899|P3|COMPLETED|Overall Study||31
7728039|NCT01634113|19027900|P2|COMPLETED|Overall Study||36
7728040|NCT01634113|19027901|P1|COMPLETED|Overall Study||34
7728041|NCT01634113|19027899|P3|STARTED|Overall Study||32
7728042|NCT01634113|19027900|P2|STARTED|Overall Study||36
7728043|NCT01634113|19027901|P1|STARTED|Overall Study||34
7728044|NCT01634100|19027945|P6|NOT COMPLETED|Overall Study||0
7728045|NCT01634100|19027946|P5|NOT COMPLETED|Overall Study||0
7728046|NCT01634100|19027947|P4|NOT COMPLETED|Overall Study||0
7728047|NCT01634100|19027948|P3|NOT COMPLETED|Overall Study||1
7728048|NCT01634100|19027949|P2|NOT COMPLETED|Overall Study||0
7728049|NCT01634100|19027950|P1|NOT COMPLETED|Overall Study||1
7728050|NCT01634100|19027945|P6|COMPLETED|Overall Study||3
7728051|NCT01634100|19027946|P5|COMPLETED|Overall Study||3
7728052|NCT01634100|19027947|P4|COMPLETED|Overall Study||3
7728053|NCT01634100|19027948|P3|COMPLETED|Overall Study||2
7728054|NCT01634100|19027949|P2|COMPLETED|Overall Study||3
7728055|NCT01634100|19027950|P1|COMPLETED|Overall Study||2
7728056|NCT01634100|19027945|P6|Received Empa + Probenecid|Overall Study||3
7728057|NCT01634100|19027946|P5|Received Empa + Probenecid|Overall Study||3
7728058|NCT01634100|19027947|P4|Received Empa + Probenecid|Overall Study||3
7728059|NCT01634100|19027948|P3|Received Empa + Probenecid|Overall Study||2
7728060|NCT01634100|19027949|P2|Received Empa + Probenecid|Overall Study||3
7728061|NCT01634100|19027950|P1|Received Empa + Probenecid|Overall Study||2
7728062|NCT01634100|19027945|P6|Received Empa + Rifampicin|Overall Study||3
7728063|NCT01634100|19027946|P5|Received Empa + Rifampicin|Overall Study||3
7728064|NCT01634100|19027947|P4|Received Empa + Rifampicin|Overall Study||3
7728065|NCT01634100|19027948|P3|Received Empa + Rifampicin|Overall Study||3
7728066|NCT01634100|19027949|P2|Received Empa + Rifampicin|Overall Study||3
7728067|NCT01634100|19027950|P1|Received Empa + Rifampicin|Overall Study||3
7728068|NCT01634100|19027945|P6|Received Empa Alone|Overall Study||3
7728069|NCT01634100|19027946|P5|Received Empa Alone|Overall Study||3
7728070|NCT01634100|19027947|P4|Received Empa Alone|Overall Study||3
7728071|NCT01634100|19027948|P3|Received Empa Alone|Overall Study||3
7728072|NCT01634100|19027949|P2|Received Empa Alone|Overall Study||3
7728073|NCT01634100|19027950|P1|Received Empa Alone|Overall Study||3
7728074|NCT01634100|19027945|P6|STARTED|Overall Study||3
7728075|NCT01634100|19027946|P5|STARTED|Overall Study||3
7728076|NCT01634100|19027947|P4|STARTED|Overall Study||3
7728077|NCT01634100|19027948|P3|STARTED|Overall Study||3
7728078|NCT01634100|19027949|P2|STARTED|Overall Study||3
7728079|NCT01634100|19027950|P1|STARTED|Overall Study||3
7728080|NCT01633944|19027966|P3|NOT COMPLETED|Double-blind Treatment Phase||58
7728081|NCT01633944|19027967|P2|NOT COMPLETED|Double-blind Treatment Phase||54
7728082|NCT01633944|19027968|P1|NOT COMPLETED|Double-blind Treatment Phase||0
7728083|NCT01633944|19027966|P3|COMPLETED|Double-blind Treatment Phase||174
7728084|NCT01633944|19027967|P2|COMPLETED|Double-blind Treatment Phase||176
7728085|NCT01633944|19027968|P1|COMPLETED|Double-blind Treatment Phase||0
7728086|NCT01633944|19027966|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232
7728087|NCT01633944|19027967|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230
7728088|NCT01633944|19027968|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
7728089|NCT01633944|19027966|P3|NOT COMPLETED|Open-label Titration Phase||0
7728090|NCT01633944|19027967|P2|NOT COMPLETED|Open-label Titration Phase||0
7728091|NCT01633944|19027968|P1|NOT COMPLETED|Open-label Titration Phase||290
7728092|NCT01633944|19027966|P3|COMPLETED|Open-label Titration Phase||0
7728093|NCT01633944|19027967|P2|COMPLETED|Open-label Titration Phase||0
7728094|NCT01633944|19027968|P1|COMPLETED|Open-label Titration Phase||462
7728095|NCT01633944|19027966|P3|STARTED|Open-label Titration Phase||0
7728096|NCT01633944|19027967|P2|STARTED|Open-label Titration Phase||0
7728097|NCT01633944|19027968|P1|STARTED|Open-label Titration Phase||752
7728098|NCT01633892|19027988|P1|NOT COMPLETED|Overall Study||0
7728099|NCT01633892|19027988|P1|COMPLETED|Overall Study||5
7728100|NCT01633892|19027988|P1|STARTED|Overall Study||5
7728101|NCT01633853|19027998|P2|NOT COMPLETED|Overall Study||0
7728102|NCT01633853|19027999|P1|NOT COMPLETED|Overall Study||0
7728103|NCT01633853|19027998|P2|COMPLETED|Overall Study||100
7728104|NCT01633853|19027999|P1|COMPLETED|Overall Study||104
7728105|NCT01633853|19027998|P2|STARTED|Overall Study||100
7728106|NCT01633853|19027999|P1|STARTED|Overall Study||104
7728107|NCT01633827|19028013|P2|NOT COMPLETED|Second Intervention||0
7728108|NCT01633827|19028014|P1|NOT COMPLETED|Second Intervention||0
7728109|NCT01633827|19028013|P2|COMPLETED|Second Intervention||11
7728110|NCT01633827|19028014|P1|COMPLETED|Second Intervention||11
7728111|NCT01633827|19028013|P2|STARTED|Second Intervention||11
7728112|NCT01633827|19028014|P1|STARTED|Second Intervention||11
7728113|NCT01633827|19028013|P2|NOT COMPLETED|Washout Period||0
7728114|NCT01633827|19028014|P1|NOT COMPLETED|Washout Period||0
7728115|NCT01633827|19028013|P2|COMPLETED|Washout Period||11
7728116|NCT01633827|19028014|P1|COMPLETED|Washout Period||11
7728117|NCT01633827|19028013|P2|STARTED|Washout Period||11
7728118|NCT01633827|19028014|P1|STARTED|Washout Period||11
7728119|NCT01633827|19028013|P2|NOT COMPLETED|First Intervention||0
7728120|NCT01633827|19028014|P1|NOT COMPLETED|First Intervention||0
7728121|NCT01633827|19028013|P2|COMPLETED|First Intervention||11
7728122|NCT01633827|19028014|P1|COMPLETED|First Intervention||11
7728123|NCT01633827|19028013|P2|STARTED|First Intervention||11
7728124|NCT01633827|19028014|P1|STARTED|First Intervention||11
7728125|NCT01633814|19028027|P1|NOT COMPLETED|Overall Study||0
7728126|NCT01633814|19028027|P1|COMPLETED|Overall Study||4
7728127|NCT01633814|19028027|P1|STARTED|Overall Study||4
7728128|NCT01633788|19028036|P4|NOT COMPLETED|Overall Study||13
7728129|NCT01633788|19028037|P3|NOT COMPLETED|Overall Study||10
7728130|NCT01633788|19028038|P2|NOT COMPLETED|Overall Study||8
7728131|NCT01633788|19028039|P1|NOT COMPLETED|Overall Study||7
7728132|NCT01633788|19028036|P4|COMPLETED|Overall Study||45
7728133|NCT01633788|19028037|P3|COMPLETED|Overall Study||49
7728134|NCT01633788|19028038|P2|COMPLETED|Overall Study||50
7728135|NCT01633788|19028039|P1|COMPLETED|Overall Study||50
7728136|NCT01633788|19028036|P4|STARTED|Overall Study||58
7728137|NCT01633788|19028037|P3|STARTED|Overall Study||59
7728138|NCT01633788|19028038|P2|STARTED|Overall Study||58
7728139|NCT01633788|19028039|P1|STARTED|Overall Study||57
7728140|NCT01633320|19028059|P2|NOT COMPLETED|Overall Study||0
7728141|NCT01633320|19028060|P1|NOT COMPLETED|Overall Study||0
7728142|NCT01633320|19028059|P2|COMPLETED|Overall Study||68
7728143|NCT01633320|19028060|P1|COMPLETED|Overall Study||132
7728144|NCT01633320|19028059|P2|STARTED|Overall Study||68
7728145|NCT01633320|19028060|P1|STARTED|Overall Study||132
7728146|NCT01633112|19028071|P3|NOT COMPLETED|Overall Study||92
7728147|NCT01633112|19028072|P2|NOT COMPLETED|Overall Study||60
7728148|NCT01633112|19028073|P1|NOT COMPLETED|Overall Study||53
7728149|NCT01633112|19028071|P3|COMPLETED|Overall Study||250
7728150|NCT01633112|19028072|P2|COMPLETED|Overall Study||310
7728151|NCT01633112|19028073|P1|COMPLETED|Overall Study||299
7728152|NCT01633112|19028071|P3|STARTED|Overall Study||342
7728153|NCT01633112|19028072|P2|STARTED|Overall Study||370
7728154|NCT01633112|19028073|P1|STARTED|Overall Study||352
7728155|NCT01633060|19028108|P2|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
7728156|NCT01633060|19028109|P1|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||16
7728157|NCT01633060|19028108|P2|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
7728158|NCT01633060|19028109|P1|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
7728159|NCT01633060|19028108|P2|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
7728160|NCT01633060|19028109|P1|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|16
7728161|NCT01633060|19028108|P2|NOT COMPLETED|Treatment Phase||140
7728162|NCT01633060|19028109|P1|NOT COMPLETED|Treatment Phase||288
7728163|NCT01633060|19028108|P2|COMPLETED|Treatment Phase||0
7728164|NCT01633060|19028109|P1|COMPLETED|Treatment Phase||0
7728165|NCT01633060|19028108|P2|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||0
7728166|NCT01633060|19028109|P1|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||63
7728167|NCT01633060|19028108|P2|Safety Set (SS)|Treatment Phase||140
7728168|NCT01633060|19028109|P1|Safety Set (SS)|Treatment Phase||288
7728169|NCT01633060|19028108|P2|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||81
7728170|NCT01633060|19028109|P1|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||132
7728171|NCT01633060|19028108|P2|FAS - ctDNA PIK3CA Mutant|Treatment Phase||35
7728172|NCT01633060|19028109|P1|FAS - ctDNA PIK3CA Mutant|Treatment Phase||100
7728173|NCT01633060|19028108|P2|STARTED|Treatment Phase||140
7728174|NCT01633060|19028109|P1|STARTED|Treatment Phase||288
7728175|NCT01633060|19028108|P2|NOT COMPLETED|Randomization Phase||3
7728176|NCT01633060|19028109|P1|NOT COMPLETED|Randomization Phase||1
7728177|NCT01633060|19028108|P2|COMPLETED|Randomization Phase||140
7728178|NCT01633060|19028109|P1|COMPLETED|Randomization Phase||288
7728179|NCT01633060|19028108|P2|STARTED|Randomization Phase|All randomized patients|143
7728180|NCT01633060|19028109|P1|STARTED|Randomization Phase|All randomized patients|289
7728181|NCT01632995|19028134|P1|NOT COMPLETED|Main Study Follow-up Period||120
7728182|NCT01632995|19028134|P1|COMPLETED|Main Study Follow-up Period||437
7728183|NCT01632995|19028134|P1|STARTED|Main Study Follow-up Period||557
7728184|NCT01632995|19028134|P1|NOT COMPLETED|Pre-screening to Enrollment Period||512
7728185|NCT01632995|19028134|P1|COMPLETED|Pre-screening to Enrollment Period||557
7728186|NCT01632995|19028134|P1|STARTED|Pre-screening to Enrollment Period||1069
7728187|NCT01632904|19028149|P2|NOT COMPLETED|Overall Study||6
7728188|NCT01632904|19028150|P1|NOT COMPLETED|Overall Study||7
7728189|NCT01632904|19028149|P2|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50
7728190|NCT01632904|19028150|P1|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47
7728191|NCT01632904|19028149|P2|STARTED|Overall Study||56
7728192|NCT01632904|19028150|P1|STARTED|Overall Study||54
7728193|NCT01632891|19028161|P2|NOT COMPLETED|Overall Study||1
7728194|NCT01632891|19028162|P1|NOT COMPLETED|Overall Study||1
7728195|NCT01632891|19028161|P2|COMPLETED|Overall Study||25
7728196|NCT01632891|19028162|P1|COMPLETED|Overall Study||25
7728197|NCT01632891|19028161|P2|STARTED|Overall Study||26
7728198|NCT01632891|19028162|P1|STARTED|Overall Study||26
7728199|NCT01632878|19028186|P1|NOT COMPLETED|Treatment||158
7728200|NCT01632878|19028186|P1|COMPLETED|Treatment||1105
7728201|NCT01632878|19028186|P1|STARTED|Treatment||1263
7728202|NCT01632878|19028186|P1|NOT COMPLETED|Screening||268
7728203|NCT01632878|19028186|P1|COMPLETED|Screening||1263
7728204|NCT01632878|19028186|P1|STARTED|Screening||1531
7728205|NCT01632800|19028190|P1|NOT COMPLETED|Overall Study||1
7728206|NCT01632800|19028190|P1|COMPLETED|Overall Study||25
7728207|NCT01632800|19028190|P1|STARTED|Overall Study||26
7728208|NCT01632735|19028196|P2|NOT COMPLETED|Overall Study||3
7728209|NCT01632735|19028197|P1|NOT COMPLETED|Overall Study||4
7728210|NCT01632735|19028196|P2|COMPLETED|Overall Study||37
7728211|NCT01632735|19028197|P1|COMPLETED|Overall Study||36
7728212|NCT01632735|19028196|P2|STARTED|Overall Study||40
7728213|NCT01632735|19028197|P1|STARTED|Overall Study||40
7728214|NCT01632709|19028213|P4|NOT COMPLETED|Overall Study||1
7728215|NCT01632709|19028214|P3|NOT COMPLETED|Overall Study||0
7728216|NCT01632709|19028215|P2|NOT COMPLETED|Overall Study||1
7728217|NCT01632709|19028216|P1|NOT COMPLETED|Overall Study||2
7728218|NCT01632709|19028213|P4|COMPLETED|Overall Study||3
7728219|NCT01632709|19028214|P3|COMPLETED|Overall Study||5
7728220|NCT01632709|19028215|P2|COMPLETED|Overall Study||2
7728221|NCT01632709|19028216|P1|COMPLETED|Overall Study||2
7728222|NCT01632709|19028213|P4|Completed Visit 2 (Received Injection)|Overall Study||3
7728223|NCT01632709|19028214|P3|Completed Visit 2 (Received Injection)|Overall Study||5
7728224|NCT01632709|19028215|P2|Completed Visit 2 (Received Injection)|Overall Study||2
7728225|NCT01632709|19028216|P1|Completed Visit 2 (Received Injection)|Overall Study||4
7728226|NCT01632709|19028213|P4|STARTED|Overall Study||4
7728227|NCT01632709|19028214|P3|STARTED|Overall Study||5
7728228|NCT01632709|19028215|P2|STARTED|Overall Study||3
7728229|NCT01632709|19028216|P1|STARTED|Overall Study||4
7728230|NCT01632683|19028242|P2|NOT COMPLETED|Overall Study||0
7728231|NCT01632683|19028243|P1|NOT COMPLETED|Overall Study||0
7728232|NCT01632683|19028242|P2|COMPLETED|Overall Study||552
7728233|NCT01632683|19028243|P1|COMPLETED|Overall Study||548
7728234|NCT01632683|19028242|P2|STARTED|Overall Study||552
7728235|NCT01632683|19028243|P1|STARTED|Overall Study||548
7728236|NCT01632579|19028257|P9|NOT COMPLETED|Period 3 (Third Intervention)||0
7728237|NCT01632579|19028258|P8|NOT COMPLETED|Period 3 (Third Intervention)||0
7728238|NCT01632579|19028259|P7|NOT COMPLETED|Period 3 (Third Intervention)||0
7728239|NCT01632579|19028260|P6|NOT COMPLETED|Period 3 (Third Intervention)||0
7728240|NCT01632579|19028261|P5|NOT COMPLETED|Period 3 (Third Intervention)||0
7728241|NCT01632579|19028262|P4|NOT COMPLETED|Period 3 (Third Intervention)||0
7728242|NCT01632579|19028263|P3|NOT COMPLETED|Period 3 (Third Intervention)||0
7728243|NCT01632579|19028264|P2|NOT COMPLETED|Period 3 (Third Intervention)||0
7728244|NCT01632579|19028265|P1|NOT COMPLETED|Period 3 (Third Intervention)||0
7728245|NCT01632579|19028257|P9|COMPLETED|Period 3 (Third Intervention)||2
7728246|NCT01632579|19028258|P8|COMPLETED|Period 3 (Third Intervention)||6
7728247|NCT01632579|19028259|P7|COMPLETED|Period 3 (Third Intervention)||2
7728248|NCT01632579|19028260|P6|COMPLETED|Period 3 (Third Intervention)||2
7728249|NCT01632579|19028261|P5|COMPLETED|Period 3 (Third Intervention)||6
7728250|NCT01632579|19028262|P4|COMPLETED|Period 3 (Third Intervention)||2
7728251|NCT01632579|19028263|P3|COMPLETED|Period 3 (Third Intervention)||2
7728252|NCT01632579|19028264|P2|COMPLETED|Period 3 (Third Intervention)||6
7728253|NCT01632579|19028265|P1|COMPLETED|Period 3 (Third Intervention)||0
7728254|NCT01632579|19028257|P9|Received at Least 1 Dose|Period 3 (Third Intervention)||2
7728255|NCT01632579|19028258|P8|Received at Least 1 Dose|Period 3 (Third Intervention)||6
7728256|NCT01632579|19028259|P7|Received at Least 1 Dose|Period 3 (Third Intervention)||2
7728257|NCT01632579|19028260|P6|Received at Least 1 Dose|Period 3 (Third Intervention)||2
7728258|NCT01632579|19028261|P5|Received at Least 1 Dose|Period 3 (Third Intervention)||6
7728259|NCT01632579|19028262|P4|Received at Least 1 Dose|Period 3 (Third Intervention)||2
7728260|NCT01632579|19028263|P3|Received at Least 1 Dose|Period 3 (Third Intervention)||2
7728261|NCT01632579|19028264|P2|Received at Least 1 Dose|Period 3 (Third Intervention)||6
7728262|NCT01632579|19028265|P1|Received at Least 1 Dose|Period 3 (Third Intervention)||0
7728263|NCT01632579|19028257|P9|STARTED|Period 3 (Third Intervention)||2
7728264|NCT01632579|19028258|P8|STARTED|Period 3 (Third Intervention)||6
7728265|NCT01632579|19028259|P7|STARTED|Period 3 (Third Intervention)||2
7728266|NCT01632579|19028260|P6|STARTED|Period 3 (Third Intervention)||2
7728267|NCT01632579|19028261|P5|STARTED|Period 3 (Third Intervention)||6
7728268|NCT01632579|19028262|P4|STARTED|Period 3 (Third Intervention)||2
7728269|NCT01632579|19028263|P3|STARTED|Period 3 (Third Intervention)||2
7728270|NCT01632579|19028264|P2|STARTED|Period 3 (Third Intervention)||6
7728271|NCT01632579|19028265|P1|STARTED|Period 3 (Third Intervention)||0
7728272|NCT01632579|19028257|P9|NOT COMPLETED|Washout Period||0
7728273|NCT01632579|19028258|P8|NOT COMPLETED|Washout Period||0
7728274|NCT01632579|19028259|P7|NOT COMPLETED|Washout Period||0
7728275|NCT01632579|19028260|P6|NOT COMPLETED|Washout Period||0
7728276|NCT01632579|19028261|P5|NOT COMPLETED|Washout Period||0
7728277|NCT01632579|19028262|P4|NOT COMPLETED|Washout Period||0
7728278|NCT01632579|19028263|P3|NOT COMPLETED|Washout Period||0
7728279|NCT01632579|19028264|P2|NOT COMPLETED|Washout Period||0
7728280|NCT01632579|19028265|P1|NOT COMPLETED|Washout Period||0
7728281|NCT01632579|19028257|P9|COMPLETED|Washout Period||2
7728282|NCT01632579|19028258|P8|COMPLETED|Washout Period||6
7728283|NCT01632579|19028259|P7|COMPLETED|Washout Period||2
7728284|NCT01632579|19028260|P6|COMPLETED|Washout Period||2
7728285|NCT01632579|19028261|P5|COMPLETED|Washout Period||6
7728286|NCT01632579|19028262|P4|COMPLETED|Washout Period||2
7728287|NCT01632579|19028263|P3|COMPLETED|Washout Period||2
7728288|NCT01632579|19028264|P2|COMPLETED|Washout Period||6
7728289|NCT01632579|19028265|P1|COMPLETED|Washout Period||0
7728290|NCT01632579|19028257|P9|STARTED|Washout Period||2
7728291|NCT01632579|19028258|P8|STARTED|Washout Period||6
7728292|NCT01632579|19028259|P7|STARTED|Washout Period||2
7728293|NCT01632579|19028260|P6|STARTED|Washout Period||2
7728294|NCT01632579|19028261|P5|STARTED|Washout Period||6
7728295|NCT01632579|19028262|P4|STARTED|Washout Period||2
7728296|NCT01632579|19028263|P3|STARTED|Washout Period||2
7728297|NCT01632579|19028264|P2|STARTED|Washout Period||6
7728298|NCT01632579|19028265|P1|STARTED|Washout Period||0
7728299|NCT01632579|19028257|P9|NOT COMPLETED|Period 2 (Second Intervention)||0
7728300|NCT01632579|19028258|P8|NOT COMPLETED|Period 2 (Second Intervention)||0
7728301|NCT01632579|19028259|P7|NOT COMPLETED|Period 2 (Second Intervention)||0
7728302|NCT01632579|19028260|P6|NOT COMPLETED|Period 2 (Second Intervention)||0
7728303|NCT01632579|19028261|P5|NOT COMPLETED|Period 2 (Second Intervention)||0
7728304|NCT01632579|19028262|P4|NOT COMPLETED|Period 2 (Second Intervention)||0
7728305|NCT01632579|19028263|P3|NOT COMPLETED|Period 2 (Second Intervention)||0
7728306|NCT01632579|19028264|P2|NOT COMPLETED|Period 2 (Second Intervention)||0
7728307|NCT01632579|19028265|P1|NOT COMPLETED|Period 2 (Second Intervention)||1
7728308|NCT01632579|19028257|P9|COMPLETED|Period 2 (Second Intervention)||2
7728309|NCT01632579|19028258|P8|COMPLETED|Period 2 (Second Intervention)||6
7728310|NCT01632579|19028259|P7|COMPLETED|Period 2 (Second Intervention)||2
7728311|NCT01632579|19028260|P6|COMPLETED|Period 2 (Second Intervention)||2
7728312|NCT01632579|19028261|P5|COMPLETED|Period 2 (Second Intervention)||6
7728313|NCT01632579|19028262|P4|COMPLETED|Period 2 (Second Intervention)||2
7728314|NCT01632579|19028263|P3|COMPLETED|Period 2 (Second Intervention)||2
7728315|NCT01632579|19028264|P2|COMPLETED|Period 2 (Second Intervention)||6
7728316|NCT01632579|19028265|P1|COMPLETED|Period 2 (Second Intervention)||0
7728317|NCT01632579|19028257|P9|Received at Least 1 Dose|Period 2 (Second Intervention)||2
7728318|NCT01632579|19028258|P8|Received at Least 1 Dose|Period 2 (Second Intervention)||6
7728319|NCT01632579|19028259|P7|Received at Least 1 Dose|Period 2 (Second Intervention)||2
7728320|NCT01632579|19028260|P6|Received at Least 1 Dose|Period 2 (Second Intervention)||2
7728321|NCT01632579|19028261|P5|Received at Least 1 Dose|Period 2 (Second Intervention)||6
7728322|NCT01632579|19028262|P4|Received at Least 1 Dose|Period 2 (Second Intervention)||2
7728323|NCT01632579|19028263|P3|Received at Least 1 Dose|Period 2 (Second Intervention)||2
7728324|NCT01632579|19028264|P2|Received at Least 1 Dose|Period 2 (Second Intervention)||6
7728325|NCT01632579|19028265|P1|Received at Least 1 Dose|Period 2 (Second Intervention)||1
7728326|NCT01632579|19028257|P9|STARTED|Period 2 (Second Intervention)||2
7728327|NCT01632579|19028258|P8|STARTED|Period 2 (Second Intervention)||6
7728328|NCT01632579|19028259|P7|STARTED|Period 2 (Second Intervention)||2
7728329|NCT01632579|19028260|P6|STARTED|Period 2 (Second Intervention)||2
7728330|NCT01632579|19028261|P5|STARTED|Period 2 (Second Intervention)||6
7728331|NCT01632579|19028262|P4|STARTED|Period 2 (Second Intervention)||2
7728332|NCT01632579|19028263|P3|STARTED|Period 2 (Second Intervention)||2
7728333|NCT01632579|19028264|P2|STARTED|Period 2 (Second Intervention)||6
7728334|NCT01632579|19028265|P1|STARTED|Period 2 (Second Intervention)||1
7728335|NCT01632579|19028257|P9|NOT COMPLETED|Washout Period||0
7728336|NCT01632579|19028258|P8|NOT COMPLETED|Washout Period||0
7728337|NCT01632579|19028259|P7|NOT COMPLETED|Washout Period||0
7728338|NCT01632579|19028260|P6|NOT COMPLETED|Washout Period||0
7728339|NCT01632579|19028261|P5|NOT COMPLETED|Washout Period||0
7728340|NCT01632579|19028262|P4|NOT COMPLETED|Washout Period||0
7728341|NCT01632579|19028263|P3|NOT COMPLETED|Washout Period||0
7728342|NCT01632579|19028264|P2|NOT COMPLETED|Washout Period||0
7728343|NCT01632579|19028265|P1|NOT COMPLETED|Washout Period||1
7728344|NCT01632579|19028257|P9|COMPLETED|Washout Period||2
7728345|NCT01632579|19028258|P8|COMPLETED|Washout Period||6
7728346|NCT01632579|19028259|P7|COMPLETED|Washout Period||2
7728347|NCT01632579|19028260|P6|COMPLETED|Washout Period||2
7728348|NCT01632579|19028261|P5|COMPLETED|Washout Period||6
7728349|NCT01632579|19028262|P4|COMPLETED|Washout Period||2
7728350|NCT01632579|19028263|P3|COMPLETED|Washout Period||2
7728351|NCT01632579|19028264|P2|COMPLETED|Washout Period||6
7728352|NCT01632579|19028265|P1|COMPLETED|Washout Period||1
7728353|NCT01632579|19028257|P9|STARTED|Washout Period||2
7728354|NCT01632579|19028258|P8|STARTED|Washout Period||6
7728355|NCT01632579|19028259|P7|STARTED|Washout Period||2
7728356|NCT01632579|19028260|P6|STARTED|Washout Period||2
7728357|NCT01632579|19028261|P5|STARTED|Washout Period||6
7728358|NCT01632579|19028262|P4|STARTED|Washout Period||2
7728359|NCT01632579|19028263|P3|STARTED|Washout Period||2
7728360|NCT01632579|19028264|P2|STARTED|Washout Period||6
7728361|NCT01632579|19028265|P1|STARTED|Washout Period||2
7728362|NCT01632579|19028257|P9|NOT COMPLETED|Period 1 (First Intervention)||0
7728363|NCT01632579|19028258|P8|NOT COMPLETED|Period 1 (First Intervention)||0
7728364|NCT01632579|19028259|P7|NOT COMPLETED|Period 1 (First Intervention)||0
7728365|NCT01632579|19028260|P6|NOT COMPLETED|Period 1 (First Intervention)||0
7728366|NCT01632579|19028261|P5|NOT COMPLETED|Period 1 (First Intervention)||0
7728367|NCT01632579|19028262|P4|NOT COMPLETED|Period 1 (First Intervention)||0
7728368|NCT01632579|19028263|P3|NOT COMPLETED|Period 1 (First Intervention)||0
7728369|NCT01632579|19028264|P2|NOT COMPLETED|Period 1 (First Intervention)||0
7728370|NCT01632579|19028265|P1|NOT COMPLETED|Period 1 (First Intervention)||0
7728371|NCT01632579|19028257|P9|COMPLETED|Period 1 (First Intervention)||2
7728372|NCT01632579|19028258|P8|COMPLETED|Period 1 (First Intervention)||6
7728373|NCT01632579|19028259|P7|COMPLETED|Period 1 (First Intervention)||2
7728374|NCT01632579|19028260|P6|COMPLETED|Period 1 (First Intervention)||2
7728375|NCT01632579|19028261|P5|COMPLETED|Period 1 (First Intervention)||6
7728376|NCT01632579|19028262|P4|COMPLETED|Period 1 (First Intervention)||2
7728377|NCT01632579|19028263|P3|COMPLETED|Period 1 (First Intervention)||2
7728378|NCT01632579|19028264|P2|COMPLETED|Period 1 (First Intervention)||6
7728379|NCT01632579|19028265|P1|COMPLETED|Period 1 (First Intervention)||2
7728380|NCT01632579|19028257|P9|Received at Least 1 Dose|Period 1 (First Intervention)||2
7728381|NCT01632579|19028258|P8|Received at Least 1 Dose|Period 1 (First Intervention)||6
7728382|NCT01632579|19028259|P7|Received at Least 1 Dose|Period 1 (First Intervention)||2
7728383|NCT01632579|19028260|P6|Received at Least 1 Dose|Period 1 (First Intervention)||2
7728384|NCT01632579|19028261|P5|Received at Least 1 Dose|Period 1 (First Intervention)||6
7728385|NCT01632579|19028262|P4|Received at Least 1 Dose|Period 1 (First Intervention)||2
7728386|NCT01632579|19028263|P3|Received at Least 1 Dose|Period 1 (First Intervention)||2
7728387|NCT01632579|19028264|P2|Received at Least 1 Dose|Period 1 (First Intervention)||6
7728388|NCT01632579|19028265|P1|Received at Least 1 Dose|Period 1 (First Intervention)||2
7728389|NCT01632579|19028257|P9|STARTED|Period 1 (First Intervention)||2
7728390|NCT01632579|19028258|P8|STARTED|Period 1 (First Intervention)||6
7728391|NCT01632579|19028259|P7|STARTED|Period 1 (First Intervention)||2
7728392|NCT01632579|19028260|P6|STARTED|Period 1 (First Intervention)||2
7728393|NCT01632579|19028261|P5|STARTED|Period 1 (First Intervention)||6
7728394|NCT01632579|19028262|P4|STARTED|Period 1 (First Intervention)||2
7728395|NCT01632579|19028263|P3|STARTED|Period 1 (First Intervention)||2
7728396|NCT01632579|19028264|P2|STARTED|Period 1 (First Intervention)||6
7728397|NCT01632579|19028265|P1|STARTED|Period 1 (First Intervention)||2
7728398|NCT01632566|19028332|P5|NOT COMPLETED|Overall Study||2
7728399|NCT01632566|19028333|P4|NOT COMPLETED|Overall Study||2
7728400|NCT01632566|19028334|P3|NOT COMPLETED|Overall Study||9
7728401|NCT01632566|19028335|P2|NOT COMPLETED|Overall Study||3
7728402|NCT01632566|19028336|P1|NOT COMPLETED|Overall Study||0
7728403|NCT01632566|19028332|P5|COMPLETED|Overall Study||4
7728404|NCT01632566|19028333|P4|COMPLETED|Overall Study||4
7728405|NCT01632566|19028334|P3|COMPLETED|Overall Study||0
7728406|NCT01632566|19028335|P2|COMPLETED|Overall Study||7
7728407|NCT01632566|19028336|P1|COMPLETED|Overall Study||8
7728408|NCT01632566|19028332|P5|Received at Least One Dose Simvastatin|Overall Study||4
7728409|NCT01632566|19028333|P4|Received at Least One Dose Simvastatin|Overall Study||4
7728410|NCT01632566|19028334|P3|Received at Least One Dose Simvastatin|Overall Study||9
7728411|NCT01632566|19028335|P2|Received at Least One Dose Simvastatin|Overall Study||10
7728412|NCT01632566|19028336|P1|Received at Least One Dose Simvastatin|Overall Study||0
7728413|NCT01632566|19028332|P5|Received at Least One Dose LY3031207|Overall Study||0
7728414|NCT01632566|19028333|P4|Received at Least One Dose LY3031207|Overall Study||0
7728415|NCT01632566|19028334|P3|Received at Least One Dose LY3031207|Overall Study||9
7728416|NCT01632566|19028335|P2|Received at Least One Dose LY3031207|Overall Study||10
7728417|NCT01632566|19028336|P1|Received at Least One Dose LY3031207|Overall Study||8
7728418|NCT01632566|19028332|P5|STARTED|Overall Study||6
7728419|NCT01632566|19028333|P4|STARTED|Overall Study||6
7728420|NCT01632566|19028334|P3|STARTED|Overall Study||9
7728421|NCT01632566|19028335|P2|STARTED|Overall Study||10
7728422|NCT01632566|19028336|P1|STARTED|Overall Study||8
7728423|NCT01632423|19028374|P1|NOT COMPLETED|Overall Study||246
7728424|NCT01632423|19028374|P1|COMPLETED|Overall Study||10091
7728425|NCT01632423|19028374|P1|STARTED|Overall Study||10337
7728426|NCT01632345|19028387|P7|NOT COMPLETED|Treatment: Part II||11
7728427|NCT01632345|19028388|P6|NOT COMPLETED|Treatment: Part II||11
7728428|NCT01632345|19028389|P5|NOT COMPLETED|Treatment: Part II||0
7728429|NCT01632345|19028390|P4|NOT COMPLETED|Treatment: Part II||0
7728430|NCT01632345|19028391|P3|NOT COMPLETED|Treatment: Part II||0
7728431|NCT01632345|19028392|P2|NOT COMPLETED|Treatment: Part II||0
7728432|NCT01632345|19028393|P1|NOT COMPLETED|Treatment: Part II||0
7728433|NCT01632345|19028387|P7|COMPLETED|Treatment: Part II||55
7728434|NCT01632345|19028388|P6|COMPLETED|Treatment: Part II||55
7728435|NCT01632345|19028389|P5|COMPLETED|Treatment: Part II||0
7728436|NCT01632345|19028390|P4|COMPLETED|Treatment: Part II||0
7728437|NCT01632345|19028391|P3|COMPLETED|Treatment: Part II||0
7728438|NCT01632345|19028392|P2|COMPLETED|Treatment: Part II||0
7728439|NCT01632345|19028393|P1|COMPLETED|Treatment: Part II||0
7728440|NCT01632345|19028387|P7|Treated|Treatment: Part II||66
7728441|NCT01632345|19028388|P6|Treated|Treatment: Part II||66
7728442|NCT01632345|19028389|P5|Treated|Treatment: Part II||0
7728443|NCT01632345|19028390|P4|Treated|Treatment: Part II||0
7728444|NCT01632345|19028391|P3|Treated|Treatment: Part II||0
7728445|NCT01632345|19028392|P2|Treated|Treatment: Part II||0
7728446|NCT01632345|19028393|P1|Treated|Treatment: Part II||0
7728447|NCT01632345|19028387|P7|STARTED|Treatment: Part II|66 new participants enrolled at efavirenz treatment in Part II.|66
7728448|NCT01632345|19028388|P6|STARTED|Treatment: Part II|66 new participants enrolled at 100 mg dose in Part II.|66
7728449|NCT01632345|19028389|P5|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
7728450|NCT01632345|19028390|P4|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
7728451|NCT01632345|19028391|P3|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
7728452|NCT01632345|19028392|P2|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
7728453|NCT01632345|19028393|P1|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
7728454|NCT01632345|19028387|P7|NOT COMPLETED|Treatment: Part I||0
7728455|NCT01632345|19028388|P6|NOT COMPLETED|Treatment: Part I||0
7728456|NCT01632345|19028389|P5|NOT COMPLETED|Treatment: Part I||13
7728457|NCT01632345|19028390|P4|NOT COMPLETED|Treatment: Part I||8
7728458|NCT01632345|19028391|P3|NOT COMPLETED|Treatment: Part I||10
7728459|NCT01632345|19028392|P2|NOT COMPLETED|Treatment: Part I||15
7728460|NCT01632345|19028393|P1|NOT COMPLETED|Treatment: Part I||12
7728461|NCT01632345|19028387|P7|COMPLETED|Treatment: Part I||0
7728462|NCT01632345|19028388|P6|COMPLETED|Treatment: Part I||0
7728463|NCT01632345|19028389|P5|COMPLETED|Treatment: Part I||30
7728464|NCT01632345|19028390|P4|COMPLETED|Treatment: Part I||33
7728465|NCT01632345|19028391|P3|COMPLETED|Treatment: Part I||32
7728466|NCT01632345|19028392|P2|COMPLETED|Treatment: Part I||28
7728467|NCT01632345|19028393|P1|COMPLETED|Treatment: Part I||29
7728468|NCT01632345|19028387|P7|Treated|Treatment: Part I||0
7728469|NCT01632345|19028388|P6|Treated|Treatment: Part I||0
7728470|NCT01632345|19028389|P5|Treated|Treatment: Part I||43
7728471|NCT01632345|19028390|P4|Treated|Treatment: Part I||41
7728472|NCT01632345|19028391|P3|Treated|Treatment: Part I||42
7728473|NCT01632345|19028392|P2|Treated|Treatment: Part I||43
7728474|NCT01632345|19028393|P1|Treated|Treatment: Part I||40
7728475|NCT01632345|19028387|P7|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
7728476|NCT01632345|19028388|P6|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
7728477|NCT01632345|19028389|P5|STARTED|Treatment: Part I||43
7728478|NCT01632345|19028390|P4|STARTED|Treatment: Part I||41
7728479|NCT01632345|19028391|P3|STARTED|Treatment: Part I||42
7728480|NCT01632345|19028392|P2|STARTED|Treatment: Part I||43
7728481|NCT01632345|19028393|P1|STARTED|Treatment: Part I||41
7728482|NCT01632345|19028387|P7|NOT COMPLETED|Randomized Participants||0
7728483|NCT01632345|19028388|P6|NOT COMPLETED|Randomized Participants||0
7728484|NCT01632345|19028389|P5|NOT COMPLETED|Randomized Participants||0
7728485|NCT01632345|19028390|P4|NOT COMPLETED|Randomized Participants||0
7728486|NCT01632345|19028391|P3|NOT COMPLETED|Randomized Participants||0
7728487|NCT01632345|19028392|P2|NOT COMPLETED|Randomized Participants||0
7728488|NCT01632345|19028393|P1|NOT COMPLETED|Randomized Participants||0
7728489|NCT01632345|19028387|P7|COMPLETED|Randomized Participants||66
7728490|NCT01632345|19028388|P6|COMPLETED|Randomized Participants||66
7728491|NCT01632345|19028389|P5|COMPLETED|Randomized Participants||43
7728492|NCT01632345|19028390|P4|COMPLETED|Randomized Participants||41
7728493|NCT01632345|19028391|P3|COMPLETED|Randomized Participants||42
7728494|NCT01632345|19028392|P2|COMPLETED|Randomized Participants||43
7728495|NCT01632345|19028393|P1|COMPLETED|Randomized Participants||41
7728496|NCT01632345|19028387|P7|STARTED|Randomized Participants||66
7728497|NCT01632345|19028388|P6|STARTED|Randomized Participants||66
7728498|NCT01632345|19028389|P5|STARTED|Randomized Participants||43
7728499|NCT01632345|19028390|P4|STARTED|Randomized Participants||41
7728500|NCT01632345|19028391|P3|STARTED|Randomized Participants||42
7728501|NCT01632345|19028392|P2|STARTED|Randomized Participants||43
7728502|NCT01632345|19028393|P1|STARTED|Randomized Participants||41
7728503|NCT01632306|19028455|P3|NOT COMPLETED|Overall Study||0
7728504|NCT01632306|19028456|P2|NOT COMPLETED|Overall Study||0
7728505|NCT01632306|19028457|P1|NOT COMPLETED|Overall Study||1
7728506|NCT01632306|19028455|P3|COMPLETED|Overall Study||0
7728507|NCT01632306|19028456|P2|COMPLETED|Overall Study||10
7728508|NCT01632306|19028457|P1|COMPLETED|Overall Study||2
7728509|NCT01632306|19028455|P3|Received at Least One Dose of Study Drug|Overall Study||0
7728510|NCT01632306|19028456|P2|Received at Least One Dose of Study Drug|Overall Study||10
7728511|NCT01632306|19028457|P1|Received at Least One Dose of Study Drug|Overall Study||3
7728512|NCT01632306|19028455|P3|STARTED|Overall Study||0
7728513|NCT01632306|19028456|P2|STARTED|Overall Study||10
7728514|NCT01632306|19028457|P1|STARTED|Overall Study||3
7728515|NCT01632280|19028473|P2|NOT COMPLETED|Overall Study||0
7728516|NCT01632280|19028474|P1|NOT COMPLETED|Overall Study||1
7728517|NCT01632280|19028473|P2|COMPLETED|Overall Study||6
7728518|NCT01632280|19028474|P1|COMPLETED|Overall Study||5
7728519|NCT01632280|19028473|P2|STARTED|Overall Study||6
7728520|NCT01632280|19028474|P1|STARTED|Overall Study||6
7728521|NCT01632267|19028484|P1|NOT COMPLETED|Overall Study||7
7728522|NCT01632267|19028484|P1|COMPLETED|Overall Study||97
7728523|NCT01632267|19028484|P1|STARTED|Overall Study||104
7728524|NCT01632241|19028490|P2|NOT COMPLETED|Open-label (Week 52 to Week 76)||22
7728525|NCT01632241|19028491|P1|NOT COMPLETED|Open-label (Week 52 to Week 76)||10
7728526|NCT01632241|19028490|P2|COMPLETED|Open-label (Week 52 to Week 76)||220
7728527|NCT01632241|19028491|P1|COMPLETED|Open-label (Week 52 to Week 76)||107
7728528|NCT01632241|19028490|P2|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|242
7728529|NCT01632241|19028491|P1|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|117
7728530|NCT01632241|19028490|P2|NOT COMPLETED|Double-blinded (Up to Week 52)||79
7728531|NCT01632241|19028491|P1|NOT COMPLETED|Double-blinded (Up to Week 52)||44
7728532|NCT01632241|19028490|P2|COMPLETED|Double-blinded (Up to Week 52)||252
7728533|NCT01632241|19028491|P1|COMPLETED|Double-blinded (Up to Week 52)||121
7728534|NCT01632241|19028490|P2|STARTED|Double-blinded (Up to Week 52)||331
7728535|NCT01632241|19028491|P1|STARTED|Double-blinded (Up to Week 52)||165
7728536|NCT01632215|19028541|P2|NOT COMPLETED|Overall Study||1
7728537|NCT01632215|19028542|P1|NOT COMPLETED|Overall Study||2
7728538|NCT01632215|19028541|P2|COMPLETED|Overall Study||19
7728539|NCT01632215|19028542|P1|COMPLETED|Overall Study||18
7728540|NCT01632215|19028541|P2|STARTED|Overall Study||20
7728541|NCT01632215|19028542|P1|STARTED|Overall Study||20
7728542|NCT01632202|19028552|P2|NOT COMPLETED|Overall Study||0
7728543|NCT01632202|19028553|P1|NOT COMPLETED|Overall Study||0
7728544|NCT01632202|19028552|P2|COMPLETED|Overall Study||7
7728545|NCT01632202|19028553|P1|COMPLETED|Overall Study||1
7728546|NCT01632202|19028552|P2|STARTED|Overall Study||7
7728547|NCT01632202|19028553|P1|STARTED|Overall Study||1
7728548|NCT01632150|19028561|P1|NOT COMPLETED|Overall Study||40
7728549|NCT01632150|19028561|P1|COMPLETED|Overall Study|Completed=still receiving treatment|0
7728550|NCT01632150|19028561|P1|Received Cyclophosphamide|Overall Study||11
7728551|NCT01632150|19028561|P1|STARTED|Overall Study||40
7728552|NCT01632020|19028570|P2|NOT COMPLETED|Overall Study||0
7728553|NCT01632020|19028571|P1|NOT COMPLETED|Overall Study||2
7728554|NCT01632020|19028570|P2|COMPLETED|Overall Study||3
7728555|NCT01632020|19028571|P1|COMPLETED|Overall Study||2
7728556|NCT01632020|19028570|P2|STARTED|Overall Study||3
7728557|NCT01632020|19028571|P1|STARTED|Overall Study||4
7728558|NCT01631929|19028581|P2|NOT COMPLETED|Overall Study||0
7728559|NCT01631929|19028582|P1|NOT COMPLETED|Overall Study||0
7728560|NCT01631929|19028581|P2|COMPLETED|Overall Study||6
7728561|NCT01631929|19028582|P1|COMPLETED|Overall Study||6
7728562|NCT01631929|19028581|P2|STARTED|Overall Study||6
7728563|NCT01631929|19028582|P1|STARTED|Overall Study||6
7728564|NCT01631864|19028590|P2|NOT COMPLETED|Overall Study||4
7728565|NCT01631864|19028591|P1|NOT COMPLETED|Overall Study||2
7728566|NCT01631864|19028590|P2|COMPLETED|Overall Study||44
7728567|NCT01631864|19028591|P1|COMPLETED|Overall Study||48
7728568|NCT01631864|19028590|P2|STARTED|Overall Study||48
7728569|NCT01631864|19028591|P1|STARTED|Overall Study||50
7728570|NCT01631825|19028603|P1|NOT COMPLETED|Overall Study||65
7728571|NCT01631825|19028603|P1|COMPLETED|Overall Study||256
7728572|NCT01631825|19028603|P1|STARTED|Overall Study||321
7728573|NCT01631812|19028623|P1|NOT COMPLETED|Overall Study||37
7728574|NCT01631812|19028623|P1|COMPLETED|Overall Study||93
7728575|NCT01631812|19028623|P1|STARTED|Overall Study||130
7728576|NCT01631747|19028633|P2|NOT COMPLETED|One Year Infant Outcomes||9
7728577|NCT01631747|19028634|P1|NOT COMPLETED|One Year Infant Outcomes||13
7728578|NCT01631747|19028633|P2|COMPLETED|One Year Infant Outcomes||130
7728579|NCT01631747|19028634|P1|COMPLETED|One Year Infant Outcomes||123
7728580|NCT01631747|19028633|P2|STARTED|One Year Infant Outcomes||139
7728581|NCT01631747|19028634|P1|STARTED|One Year Infant Outcomes||136
7728582|NCT01631747|19028633|P2|NOT COMPLETED|Live Birth||1
7728583|NCT01631747|19028634|P1|NOT COMPLETED|Live Birth||4
7728584|NCT01631747|19028633|P2|COMPLETED|Live Birth||139
7728585|NCT01631747|19028634|P1|COMPLETED|Live Birth||136
7728586|NCT01631747|19028633|P2|STARTED|Live Birth||140
7728587|NCT01631747|19028634|P1|STARTED|Live Birth||140
7728588|NCT01631747|19028633|P2|NOT COMPLETED|Randomization Through End of Pregnancy||0
7728589|NCT01631747|19028634|P1|NOT COMPLETED|Randomization Through End of Pregnancy||1
7728590|NCT01631747|19028633|P2|COMPLETED|Randomization Through End of Pregnancy||140
7728591|NCT01631747|19028634|P1|COMPLETED|Randomization Through End of Pregnancy||140
7728592|NCT01631747|19028633|P2|STARTED|Randomization Through End of Pregnancy||140
7728593|NCT01631747|19028634|P1|STARTED|Randomization Through End of Pregnancy||141
7728594|NCT01631682|19028676|P4|NOT COMPLETED|Overall Study||2
7728595|NCT01631682|19028677|P3|NOT COMPLETED|Overall Study||31
7728596|NCT01631682|19028678|P2|NOT COMPLETED|Overall Study||45
7728597|NCT01631682|19028679|P1|NOT COMPLETED|Overall Study||31
7728598|NCT01631682|19028676|P4|COMPLETED|Overall Study||5
7728599|NCT01631682|19028677|P3|COMPLETED|Overall Study||13
7728600|NCT01631682|19028678|P2|COMPLETED|Overall Study||21
7728601|NCT01631682|19028679|P1|COMPLETED|Overall Study||24
7728602|NCT01631682|19028676|P4|STARTED|Overall Study||7
7728603|NCT01631682|19028677|P3|STARTED|Overall Study||44
7728604|NCT01631682|19028678|P2|STARTED|Overall Study||66
7728605|NCT01631682|19028679|P1|STARTED|Overall Study||55
7728606|NCT01631656|19028691|P2|NOT COMPLETED|Overall Study||0
7728607|NCT01631656|19028692|P1|NOT COMPLETED|Overall Study||0
7728608|NCT01631656|19028691|P2|COMPLETED|Overall Study||5
7728609|NCT01631656|19028692|P1|COMPLETED|Overall Study||5
7728610|NCT01631656|19028691|P2|STARTED|Overall Study||5
7728611|NCT01631656|19028692|P1|STARTED|Overall Study||5
7728612|NCT01631630|19028700|P2|NOT COMPLETED|Overall Study||0
7728613|NCT01631630|19028701|P1|NOT COMPLETED|Overall Study||3
7728614|NCT01631630|19028700|P2|COMPLETED|Overall Study||8
7728615|NCT01631630|19028701|P1|COMPLETED|Overall Study||5
7728616|NCT01631630|19028700|P2|STARTED|Overall Study||8
7728617|NCT01631630|19028701|P1|STARTED|Overall Study||8
7728618|NCT01631474|19028816|P5|NOT COMPLETED|Overall Study||13
7728619|NCT01631474|19028817|P4|NOT COMPLETED|Overall Study||11
7728620|NCT01631474|19028818|P3|NOT COMPLETED|Overall Study||9
7728621|NCT01631474|19028819|P2|NOT COMPLETED|Overall Study||12
7728622|NCT01631474|19028820|P1|NOT COMPLETED|Overall Study||14
7728623|NCT01631474|19028816|P5|COMPLETED|Overall Study||62
7728624|NCT01631474|19028817|P4|COMPLETED|Overall Study||59
7728625|NCT01631474|19028818|P3|COMPLETED|Overall Study||61
7728626|NCT01631474|19028819|P2|COMPLETED|Overall Study||64
7728627|NCT01631474|19028820|P1|COMPLETED|Overall Study||58
7728628|NCT01631474|19028816|P5|STARTED|Overall Study||75
7728629|NCT01631474|19028817|P4|STARTED|Overall Study||70
7728630|NCT01631474|19028818|P3|STARTED|Overall Study||70
7728631|NCT01631474|19028819|P2|STARTED|Overall Study||76
7728632|NCT01631474|19028820|P1|STARTED|Overall Study||72
7728633|NCT01631435|19028857|P1|NOT COMPLETED|Overall Study||9
7728634|NCT01631435|19028857|P1|COMPLETED|Overall Study||66
7728635|NCT01631435|19028857|P1|STARTED|Overall Study||75
7728636|NCT01631331|19028862|P1|NOT COMPLETED|Overall Study||4
7728637|NCT01631331|19028862|P1|COMPLETED|Overall Study||11
7728638|NCT01631331|19028862|P1|STARTED|Overall Study||15
7728639|NCT01631227|19028871|P2|NOT COMPLETED|Overall Study||22
7728640|NCT01631227|19028872|P1|NOT COMPLETED|Overall Study||30
7728641|NCT01631227|19028871|P2|COMPLETED|Overall Study||310
7728642|NCT01631227|19028872|P1|COMPLETED|Overall Study||303
7728643|NCT01631227|19028871|P2|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331
7728644|NCT01631227|19028872|P1|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330
7728645|NCT01631227|19028871|P2|Safety Subject Sample|Overall Study||332
7728646|NCT01631227|19028872|P1|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332
7728647|NCT01631227|19028871|P2|STARTED|Overall Study||332
7728648|NCT01631227|19028872|P1|STARTED|Overall Study||333
7728649|NCT01631214|19028880|P2|NOT COMPLETED|Overall Study||523
7728650|NCT01631214|19028881|P1|NOT COMPLETED|Overall Study||544
7728651|NCT01631214|19028880|P2|COMPLETED|Overall Study||1523
7728652|NCT01631214|19028881|P1|COMPLETED|Overall Study||1503
7728653|NCT01631214|19028880|P2|Completed Primary Analysis Period|Overall Study||1574
7728654|NCT01631214|19028881|P1|Completed Primary Analysis Period|Overall Study||1576
7728655|NCT01631214|19028880|P2|Completed Double-blind Period|Overall Study||1831
7728656|NCT01631214|19028881|P1|Completed Double-blind Period|Overall Study||1823
7728657|NCT01631214|19028880|P2|Received Double-blind Treatment|Overall Study||2038
7728658|NCT01631214|19028881|P1|Received Double-blind Treatment|Overall Study||2040
7728659|NCT01631214|19028880|P2|STARTED|Overall Study||2046
7728660|NCT01631214|19028881|P1|STARTED|Overall Study||2047
7728661|NCT01631149|19028945|P2|NOT COMPLETED|Overall Study||0
7728662|NCT01631149|19028946|P1|NOT COMPLETED|Overall Study||0
7728663|NCT01631149|19028945|P2|COMPLETED|Overall Study||12
7728664|NCT01631149|19028946|P1|COMPLETED|Overall Study||12
7728665|NCT01631149|19028945|P2|STARTED|Overall Study||12
7728666|NCT01631149|19028946|P1|STARTED|Overall Study||12
7728667|NCT01631110|19028962|P2|NOT COMPLETED|Overall Study||0
7728668|NCT01631110|19028963|P1|NOT COMPLETED|Overall Study||0
7728669|NCT01631110|19028962|P2|COMPLETED|Overall Study||55
7728670|NCT01631110|19028963|P1|COMPLETED|Overall Study||55
7728671|NCT01631110|19028962|P2|STARTED|Overall Study||55
7728672|NCT01631110|19028963|P1|STARTED|Overall Study||55
7728673|NCT01631071|19028977|P2|NOT COMPLETED|Overall Study||0
7728674|NCT01631071|19028978|P1|NOT COMPLETED|Overall Study||0
7728675|NCT01631071|19028977|P2|COMPLETED|Overall Study||55
7728676|NCT01631071|19028978|P1|COMPLETED|Overall Study||55
7728677|NCT01631071|19028977|P2|STARTED|Overall Study||55
7728678|NCT01631071|19028978|P1|STARTED|Overall Study||55
7728679|NCT01630811|19028990|P2|NOT COMPLETED|Second Washout (4 Weeks)||0
7728680|NCT01630811|19028991|P1|NOT COMPLETED|Second Washout (4 Weeks)||0
7728681|NCT01630811|19028990|P2|COMPLETED|Second Washout (4 Weeks)||6
7728682|NCT01630811|19028991|P1|COMPLETED|Second Washout (4 Weeks)||6
7728683|NCT01630811|19028990|P2|STARTED|Second Washout (4 Weeks)||6
7728684|NCT01630811|19028991|P1|STARTED|Second Washout (4 Weeks)||6
7728685|NCT01630811|19028990|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
7728686|NCT01630811|19028991|P1|NOT COMPLETED|Second Intervention (8 Weeks)||1
7728687|NCT01630811|19028990|P2|COMPLETED|Second Intervention (8 Weeks)||6
7728688|NCT01630811|19028991|P1|COMPLETED|Second Intervention (8 Weeks)||6
7728689|NCT01630811|19028990|P2|STARTED|Second Intervention (8 Weeks)||6
7728690|NCT01630811|19028991|P1|STARTED|Second Intervention (8 Weeks)||7
7728691|NCT01630811|19028990|P2|NOT COMPLETED|Washout (4 Weeks)||0
7728692|NCT01630811|19028991|P1|NOT COMPLETED|Washout (4 Weeks)||0
7728693|NCT01630811|19028990|P2|COMPLETED|Washout (4 Weeks)||6
7728694|NCT01630811|19028991|P1|COMPLETED|Washout (4 Weeks)||7
7728695|NCT01630811|19028990|P2|STARTED|Washout (4 Weeks)||6
7728696|NCT01630811|19028991|P1|STARTED|Washout (4 Weeks)||7
7728697|NCT01630811|19028990|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
7728698|NCT01630811|19028991|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
7728699|NCT01630811|19028990|P2|COMPLETED|First Intervention (8 Weeks)||6
7728700|NCT01630811|19028991|P1|COMPLETED|First Intervention (8 Weeks)||7
7728701|NCT01630811|19028990|P2|STARTED|First Intervention (8 Weeks)||6
7728702|NCT01630811|19028991|P1|STARTED|First Intervention (8 Weeks)||7
7728703|NCT01630694|19029003|P2|NOT COMPLETED|Overall Study||0
7728704|NCT01630694|19029004|P1|NOT COMPLETED|Overall Study||0
7728705|NCT01630694|19029003|P2|COMPLETED|Overall Study||16
7728706|NCT01630694|19029004|P1|COMPLETED|Overall Study||12
7728707|NCT01630694|19029003|P2|STARTED|Overall Study||16
7728708|NCT01630694|19029004|P1|STARTED|Overall Study||12
7728709|NCT01630616|19029018|P6|NOT COMPLETED|Overall Study||0
7728710|NCT01630616|19029019|P5|NOT COMPLETED|Overall Study||0
7728711|NCT01630616|19029020|P4|NOT COMPLETED|Overall Study||3
7728712|NCT01630616|19029021|P3|NOT COMPLETED|Overall Study||0
7728713|NCT01630616|19029022|P2|NOT COMPLETED|Overall Study||0
7728714|NCT01630616|19029023|P1|NOT COMPLETED|Overall Study||0
7728715|NCT01630616|19029018|P6|COMPLETED|Overall Study||2
7728716|NCT01630616|19029019|P5|COMPLETED|Overall Study||6
7728717|NCT01630616|19029020|P4|COMPLETED|Overall Study||9
7728718|NCT01630616|19029021|P3|COMPLETED|Overall Study||3
7728719|NCT01630616|19029022|P2|COMPLETED|Overall Study||3
7728720|NCT01630616|19029023|P1|COMPLETED|Overall Study||5
7728721|NCT01630616|19029018|P6|STARTED|Overall Study||2
7728722|NCT01630616|19029019|P5|STARTED|Overall Study||6
7728723|NCT01630616|19029020|P4|STARTED|Overall Study||12
7728724|NCT01630616|19029021|P3|STARTED|Overall Study||3
7728725|NCT01630616|19029022|P2|STARTED|Overall Study||3
7728726|NCT01630616|19029023|P1|STARTED|Overall Study||5
7728727|NCT01630200|19029098|P2|NOT COMPLETED|Overall Study||6
7728728|NCT01630200|19029099|P1|NOT COMPLETED|Overall Study||7
7728729|NCT01630200|19029098|P2|COMPLETED|Overall Study||34
7728730|NCT01630200|19029099|P1|COMPLETED|Overall Study||33
7728731|NCT01630200|19029098|P2|STARTED|Overall Study||40
7728732|NCT01630200|19029099|P1|STARTED|Overall Study||40
7728733|NCT01630135|19029123|P2|NOT COMPLETED|Overall Study||2
7728734|NCT01630135|19029124|P1|NOT COMPLETED|Overall Study||0
7728735|NCT01630135|19029123|P2|COMPLETED|Overall Study||128
7728736|NCT01630135|19029124|P1|COMPLETED|Overall Study||131
7728737|NCT01630135|19029123|P2|STARTED|Overall Study||130
7728738|NCT01630135|19029124|P1|STARTED|Overall Study||131
7728739|NCT01630109|19029163|P3|NOT COMPLETED|Overall Study||0
7728740|NCT01630109|19029164|P2|NOT COMPLETED|Overall Study||0
7728741|NCT01630109|19029165|P1|NOT COMPLETED|Overall Study||0
7728742|NCT01630109|19029163|P3|COMPLETED|Overall Study||3
7728743|NCT01630109|19029164|P2|COMPLETED|Overall Study||1
7728744|NCT01630109|19029165|P1|COMPLETED|Overall Study||1
7728745|NCT01630109|19029163|P3|STARTED|Overall Study||3
7728746|NCT01630109|19029164|P2|STARTED|Overall Study||1
7728747|NCT01630109|19029165|P1|STARTED|Overall Study||1
7728748|NCT01629966|19029188|P3|NOT COMPLETED|Overall Study||66
7728749|NCT01629966|19029189|P2|NOT COMPLETED|Overall Study||52
7728750|NCT01629966|19029190|P1|NOT COMPLETED|Overall Study||41
7728751|NCT01629966|19029188|P3|COMPLETED|Overall Study||159
7728752|NCT01629966|19029189|P2|COMPLETED|Overall Study||175
7728753|NCT01629966|19029190|P1|COMPLETED|Overall Study||180
7728754|NCT01629966|19029188|P3|STARTED|Overall Study||225
7728755|NCT01629966|19029189|P2|STARTED|Overall Study||227
7728756|NCT01629966|19029190|P1|STARTED|Overall Study||221
7728757|NCT01629953|19029203|P2|NOT COMPLETED|Overall Study||15
7728758|NCT01629953|19029204|P1|NOT COMPLETED|Overall Study||13
7728759|NCT01629953|19029203|P2|COMPLETED|Overall Study||60
7728760|NCT01629953|19029204|P1|COMPLETED|Overall Study||52
7728761|NCT01629953|19029203|P2|STARTED|Overall Study||75
7728762|NCT01629953|19029204|P1|STARTED|Overall Study||65
7728763|NCT01629862|19029214|P2|NOT COMPLETED|Overall Study||2
7728764|NCT01629862|19029215|P1|NOT COMPLETED|Overall Study||2
7728765|NCT01629862|19029214|P2|COMPLETED|Overall Study||23
7728766|NCT01629862|19029215|P1|COMPLETED|Overall Study||26
7728767|NCT01629862|19029214|P2|STARTED|Overall Study||25
7728768|NCT01629862|19029215|P1|STARTED|Overall Study||28
7728769|NCT01629823|19029224|P3|NOT COMPLETED|Washout Period||0
7728770|NCT01629823|19029225|P2|NOT COMPLETED|Washout Period||6
7728771|NCT01629823|19029226|P1|NOT COMPLETED|Washout Period||3
7728772|NCT01629823|19029224|P3|COMPLETED|Washout Period||50
7728773|NCT01629823|19029225|P2|COMPLETED|Washout Period||51
7728774|NCT01629823|19029226|P1|COMPLETED|Washout Period||51
7728775|NCT01629823|19029224|P3|STARTED|Washout Period||50
7728776|NCT01629823|19029225|P2|STARTED|Washout Period||57
7728777|NCT01629823|19029226|P1|STARTED|Washout Period||54
7728778|NCT01629823|19029224|P3|NOT COMPLETED|Trial Period||10
7728779|NCT01629823|19029225|P2|NOT COMPLETED|Trial Period||13
7728780|NCT01629823|19029226|P1|NOT COMPLETED|Trial Period||13
7728781|NCT01629823|19029224|P3|COMPLETED|Trial Period||49
7728782|NCT01629823|19029225|P2|COMPLETED|Trial Period||56
7728783|NCT01629823|19029226|P1|COMPLETED|Trial Period||53
7728784|NCT01629823|19029224|P3|STARTED|Trial Period||59
7728785|NCT01629823|19029225|P2|STARTED|Trial Period||69
7728786|NCT01629823|19029226|P1|STARTED|Trial Period||66
7728787|NCT01629797|19029234|P1|NOT COMPLETED|Overall Study||18
7728788|NCT01629797|19029234|P1|COMPLETED|Overall Study||82
7728789|NCT01629797|19029234|P1|STARTED|Overall Study||100
7728790|NCT01629784|19029241|P1|NOT COMPLETED|Overall Study||6
7728791|NCT01629784|19029241|P1|COMPLETED|Overall Study||25
7728792|NCT01629784|19029241|P1|STARTED|Overall Study||31
7728793|NCT01629771|19029250|P2|NOT COMPLETED|Overall Study||0
7728794|NCT01629771|19029251|P1|NOT COMPLETED|Overall Study||0
7728795|NCT01629771|19029250|P2|COMPLETED|Overall Study||36
7728796|NCT01629771|19029251|P1|COMPLETED|Overall Study||36
7728797|NCT01629771|19029250|P2|STARTED|Overall Study||36
7728798|NCT01629771|19029251|P1|STARTED|Overall Study||36
7728799|NCT01629706|19029261|P1|NOT COMPLETED|Phase 2 Habitual||10
7728800|NCT01629706|19029261|P1|COMPLETED|Phase 2 Habitual||48
7728801|NCT01629706|19029261|P1|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58
7728802|NCT01629706|19029261|P1|NOT COMPLETED|Phase 1 PureVision||9
7728803|NCT01629706|19029261|P1|COMPLETED|Phase 1 PureVision||35
7728804|NCT01629706|19029261|P1|STARTED|Phase 1 PureVision||44
7728805|NCT01629693|19029289|P2|NOT COMPLETED|Overall Study||10
7728806|NCT01629693|19029290|P1|NOT COMPLETED|Overall Study||5
7728807|NCT01629693|19029289|P2|COMPLETED|Overall Study||178
7728808|NCT01629693|19029290|P1|COMPLETED|Overall Study||188
7728809|NCT01629693|19029289|P2|STARTED|Overall Study||188
7728810|NCT01629693|19029290|P1|STARTED|Overall Study||193
7728811|NCT01629667|19029299|P3|NOT COMPLETED|Overall Study||45
7728812|NCT01629667|19029300|P2|NOT COMPLETED|Overall Study||41
7728813|NCT01629667|19029301|P1|NOT COMPLETED|Overall Study||47
7728814|NCT01629667|19029299|P3|COMPLETED|Overall Study||14
7728815|NCT01629667|19029300|P2|COMPLETED|Overall Study||17
7728816|NCT01629667|19029301|P1|COMPLETED|Overall Study||12
7728817|NCT01629667|19029299|P3|Randomized and Treated|Overall Study||59
7728818|NCT01629667|19029300|P2|Randomized and Treated|Overall Study||57
7728819|NCT01629667|19029301|P1|Randomized and Treated|Overall Study||57
7728820|NCT01629667|19029299|P3|STARTED|Overall Study||59
7728821|NCT01629667|19029300|P2|STARTED|Overall Study||58
7728822|NCT01629667|19029301|P1|STARTED|Overall Study||59
7728823|NCT01629615|19029383|P1|NOT COMPLETED|Overall Study||0
7728824|NCT01629615|19029383|P1|COMPLETED|Overall Study||50
7728825|NCT01629615|19029383|P1|STARTED|Overall Study||50
7728826|NCT01629589|19029392|P2|NOT COMPLETED|Overall Study||7
7728827|NCT01629589|19029393|P1|NOT COMPLETED|Overall Study||8
7728828|NCT01629589|19029392|P2|COMPLETED|Overall Study||204
7728829|NCT01629589|19029393|P1|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204
7728830|NCT01629589|19029392|P2|STARTED|Overall Study||211
7728831|NCT01629589|19029393|P1|STARTED|Overall Study||212
7728832|NCT01629563|19029411|P2|NOT COMPLETED|Overall Study||53
7728833|NCT01629563|19029412|P1|NOT COMPLETED|Overall Study||61
7728834|NCT01629563|19029411|P2|COMPLETED|Overall Study||170
7728835|NCT01629563|19029412|P1|COMPLETED|Overall Study||167
7728836|NCT01629563|19029411|P2|Started Treatment Course 4|Overall Study||176
7728837|NCT01629563|19029412|P1|Started Treatment Course 4|Overall Study||178
7728838|NCT01629563|19029411|P2|Started Treatment Course 3|Overall Study||190
7728839|NCT01629563|19029412|P1|Started Treatment Course 3|Overall Study||191
7728840|NCT01629563|19029411|P2|Started Treatment Course 2|Overall Study||207
7728841|NCT01629563|19029412|P1|Started Treatment Course 2|Overall Study||213
7728842|NCT01629563|19029411|P2|Safety Population|Overall Study||221
7728843|NCT01629563|19029412|P1|Safety Population|Overall Study||230
7728844|NCT01629563|19029411|P2|STARTED|Overall Study|2 subjects randomised to 10mg received 5mg treatment in error (FAS 1: 10mg, Safety Set: 5mg)|223
7728845|NCT01629563|19029412|P1|STARTED|Overall Study||228
7728846|NCT01629511|19029434|P4|NOT COMPLETED|Overall Study||0
7728847|NCT01629511|19029435|P3|NOT COMPLETED|Overall Study||0
7728848|NCT01629511|19029436|P2|NOT COMPLETED|Overall Study||0
7728849|NCT01629511|19029437|P1|NOT COMPLETED|Overall Study||0
7728850|NCT01629511|19029434|P4|COMPLETED|Overall Study||3
7728851|NCT01629511|19029435|P3|COMPLETED|Overall Study||8
7728852|NCT01629511|19029436|P2|COMPLETED|Overall Study||0
7728853|NCT01629511|19029437|P1|COMPLETED|Overall Study||4
7728854|NCT01629511|19029434|P4|STARTED|Overall Study||3
7728855|NCT01629511|19029435|P3|STARTED|Overall Study||8
7728856|NCT01629511|19029436|P2|STARTED|Overall Study||0
7728857|NCT01629511|19029437|P1|STARTED|Overall Study||4
7728858|NCT01629329|19029469|P2|NOT COMPLETED|Overall Study||0
7728859|NCT01629329|19029470|P1|NOT COMPLETED|Overall Study||0
7728860|NCT01629329|19029469|P2|COMPLETED|Overall Study||0
7728861|NCT01629329|19029470|P1|COMPLETED|Overall Study||0
7728862|NCT01629329|19029469|P2|STARTED|Overall Study||0
7728863|NCT01629329|19029470|P1|STARTED|Overall Study||0
7728864|NCT01629290|19029478|P1|NOT COMPLETED|Overall Study||0
7728865|NCT01629290|19029478|P1|COMPLETED|Overall Study||15
7728866|NCT01629290|19029478|P1|STARTED|Overall Study||15
7728867|NCT01629134|19029488|P1|NOT COMPLETED|Overall Study||0
7728868|NCT01629134|19029488|P1|COMPLETED|Overall Study||62
7728869|NCT01629134|19029488|P1|STARTED|Overall Study||62
7728870|NCT01628965|19029501|P1|NOT COMPLETED|Overall Study||49
7728871|NCT01628965|19029501|P1|COMPLETED|Overall Study||94
7728872|NCT01628965|19029501|P1|STARTED|Overall Study||143
7728873|NCT01628926|19029510|P3|NOT COMPLETED|Overall Study||17
7728874|NCT01628926|19029511|P2|NOT COMPLETED|Overall Study||23
7728875|NCT01628926|19029512|P1|NOT COMPLETED|Overall Study||26
7728876|NCT01628926|19029510|P3|COMPLETED|Overall Study||68
7728877|NCT01628926|19029511|P2|COMPLETED|Overall Study||144
7728878|NCT01628926|19029512|P1|COMPLETED|Overall Study||142
7728879|NCT01628926|19029510|P3|STARTED|Overall Study||85
7728880|NCT01628926|19029511|P2|STARTED|Overall Study||167
7728881|NCT01628926|19029512|P1|STARTED|Overall Study||168
7728882|NCT01628913|19029561|P2|NOT COMPLETED|Overall Study||31
7728883|NCT01628913|19029562|P1|NOT COMPLETED|Overall Study||31
7728884|NCT01628913|19029561|P2|COMPLETED|Overall Study||0
7728885|NCT01628913|19029562|P1|COMPLETED|Overall Study||0
7728886|NCT01628913|19029561|P2|STARTED|Overall Study||31
7728887|NCT01628913|19029562|P1|STARTED|Overall Study||31
7728888|NCT01628874|19029576|P2|NOT COMPLETED|Overall Study||3
7728889|NCT01628874|19029577|P1|NOT COMPLETED|Overall Study||5
7728890|NCT01628874|19029576|P2|COMPLETED|Overall Study||29
7728891|NCT01628874|19029577|P1|COMPLETED|Overall Study||29
7728892|NCT01628874|19029576|P2|STARTED|Overall Study||32
7728893|NCT01628874|19029577|P1|STARTED|Overall Study||34
7728894|NCT01628848|19029593|P2|NOT COMPLETED|Overall Study||14
7728895|NCT01628848|19029594|P1|NOT COMPLETED|Overall Study||12
7728896|NCT01628848|19029593|P2|COMPLETED|Overall Study||73
7728897|NCT01628848|19029594|P1|COMPLETED|Overall Study||75
7728898|NCT01628848|19029593|P2|STARTED|Overall Study||87
7728899|NCT01628848|19029594|P1|STARTED|Overall Study||87
7728900|NCT01628718|19029624|P2|NOT COMPLETED|Overall Study||25
7728901|NCT01628718|19029625|P1|NOT COMPLETED|Overall Study||27
7728902|NCT01628718|19029624|P2|COMPLETED|Overall Study||37
7728903|NCT01628718|19029625|P1|COMPLETED|Overall Study||33
7728904|NCT01628718|19029624|P2|STARTED|Overall Study||62
7728905|NCT01628718|19029625|P1|STARTED|Overall Study||60
7728906|NCT01628692|19029637|P6|NOT COMPLETED|Overall Study||9
7728907|NCT01628692|19029638|P5|NOT COMPLETED|Overall Study||4
7728908|NCT01628692|19029639|P4|NOT COMPLETED|Overall Study||1
7728909|NCT01628692|19029640|P3|NOT COMPLETED|Overall Study||8
7728910|NCT01628692|19029641|P2|NOT COMPLETED|Overall Study||6
7728911|NCT01628692|19029642|P1|NOT COMPLETED|Overall Study||7
7728912|NCT01628692|19029637|P6|COMPLETED|Overall Study||0
7728913|NCT01628692|19029638|P5|COMPLETED|Overall Study||8
7728914|NCT01628692|19029639|P4|COMPLETED|Overall Study||19
7728915|NCT01628692|19029640|P3|COMPLETED|Overall Study||43
7728916|NCT01628692|19029641|P2|COMPLETED|Overall Study||17
7728917|NCT01628692|19029642|P1|COMPLETED|Overall Study||46
7728918|NCT01628692|19029637|P6|STARTED|Overall Study||9
7728919|NCT01628692|19029638|P5|STARTED|Overall Study||12
7728920|NCT01628692|19029639|P4|STARTED|Overall Study||20
7728921|NCT01628692|19029640|P3|STARTED|Overall Study||51
7728922|NCT01628692|19029641|P2|STARTED|Overall Study||23
7728923|NCT01628692|19029642|P1|STARTED|Overall Study||53
7728924|NCT01628614|19029686|P1|NOT COMPLETED|Overall Study||1775
7728925|NCT01628614|19029686|P1|COMPLETED|Overall Study||3037
7728926|NCT01628614|19029686|P1|STARTED|Overall Study||4812
7728927|NCT01628601|19029692|P1|NOT COMPLETED|Overall Study||41
7728928|NCT01628601|19029692|P1|COMPLETED|Overall Study||351
7728929|NCT01628601|19029692|P1|STARTED|Overall Study||392
7728930|NCT01628588|19029700|P1|NOT COMPLETED|Overall Study||16
7728931|NCT01628588|19029700|P1|COMPLETED|Overall Study||838
7728932|NCT01628588|19029700|P1|STARTED|Overall Study||854
7728933|NCT01628549|19029712|P4|NOT COMPLETED|Overall Study||9
7728934|NCT01628549|19029713|P3|NOT COMPLETED|Overall Study||10
7728935|NCT01628549|19029714|P2|NOT COMPLETED|Overall Study||12
7728936|NCT01628549|19029715|P1|NOT COMPLETED|Overall Study||9
7728937|NCT01628549|19029712|P4|COMPLETED|Overall Study||57
7728938|NCT01628549|19029713|P3|COMPLETED|Overall Study||60
7728939|NCT01628549|19029714|P2|COMPLETED|Overall Study||64
7728940|NCT01628549|19029715|P1|COMPLETED|Overall Study||64
7728941|NCT01628549|19029712|P4|STARTED|Overall Study||66
7728942|NCT01628549|19029713|P3|STARTED|Overall Study||70
7728943|NCT01628549|19029714|P2|STARTED|Overall Study||76
7728944|NCT01628549|19029715|P1|STARTED|Overall Study||73
7728945|NCT01628523|19029749|P1|NOT COMPLETED|Overall Study||0
7728946|NCT01628523|19029749|P1|COMPLETED|Overall Study||219
7728947|NCT01628523|19029749|P1|STARTED|Overall Study||219
7728948|NCT01628510|19029756|P2|NOT COMPLETED|Overall Study||5
7728949|NCT01628510|19029757|P1|NOT COMPLETED|Overall Study||3
7728950|NCT01628510|19029756|P2|COMPLETED|Overall Study||44
7728951|NCT01628510|19029757|P1|COMPLETED|Overall Study||48
7728952|NCT01628510|19029756|P2|STARTED|Overall Study||49
7728953|NCT01628510|19029757|P1|STARTED|Overall Study||51
7728954|NCT01628367|19029767|P2|NOT COMPLETED|Overall Study||0
7728955|NCT01628367|19029768|P1|NOT COMPLETED|Overall Study||1
7728956|NCT01628367|19029767|P2|COMPLETED|Overall Study||16
7728957|NCT01628367|19029768|P1|COMPLETED|Overall Study||15
7728958|NCT01628367|19029767|P2|STARTED|Overall Study||16
7728959|NCT01628367|19029768|P1|STARTED|Overall Study||16
7728960|NCT01628250|19029780|P2|NOT COMPLETED|Overall Study||0
7728961|NCT01628250|19029781|P1|NOT COMPLETED|Overall Study||0
7728962|NCT01628250|19029780|P2|COMPLETED|Overall Study||50
7728963|NCT01628250|19029781|P1|COMPLETED|Overall Study||49
7728964|NCT01628250|19029780|P2|STARTED|Overall Study||50
7728965|NCT01628250|19029781|P1|STARTED|Overall Study||49
7728966|NCT01628198|19029787|P1|NOT COMPLETED|Overall Study||18
7728967|NCT01628198|19029787|P1|COMPLETED|Overall Study||20
7728968|NCT01628198|19029787|P1|STARTED|Overall Study||38
7728969|NCT01628159|19029800|P1|NOT COMPLETED|Overall Study||164
7728970|NCT01628159|19029800|P1|COMPLETED|Overall Study||493
7728971|NCT01628159|19029800|P1|STARTED|Overall Study||657
7728972|NCT01628120|19029814|P1|NOT COMPLETED|Overall Study||44
7728973|NCT01628120|19029814|P1|COMPLETED|Overall Study||129
7728974|NCT01628120|19029814|P1|Treated|Overall Study||170
7728975|NCT01628120|19029814|P1|STARTED|Overall Study||173
7728976|NCT01628107|19029839|P1|NOT COMPLETED|Overall Study||119
7728977|NCT01628107|19029839|P1|COMPLETED|Overall Study||295
7728978|NCT01628107|19029839|P1|Treated|Overall Study||406
7728979|NCT01628107|19029839|P1|STARTED|Overall Study||414
7728980|NCT01628042|19029868|P4|NOT COMPLETED|Overall Study||0
7728981|NCT01628042|19029869|P3|NOT COMPLETED|Overall Study||0
7728982|NCT01628042|19029870|P2|NOT COMPLETED|Overall Study||0
7728983|NCT01628042|19029871|P1|NOT COMPLETED|Overall Study||0
7728984|NCT01628042|19029868|P4|COMPLETED|Overall Study||8
7728985|NCT01628042|19029869|P3|COMPLETED|Overall Study||8
7728986|NCT01628042|19029870|P2|COMPLETED|Overall Study||8
7728987|NCT01628042|19029871|P1|COMPLETED|Overall Study||8
7728988|NCT01628042|19029868|P4|STARTED|Overall Study||8
7728989|NCT01628042|19029869|P3|STARTED|Overall Study||8
7728990|NCT01628042|19029870|P2|STARTED|Overall Study||8
7728991|NCT01628042|19029871|P1|STARTED|Overall Study||8
7728992|NCT01628016|19029892|P3|NOT COMPLETED|Posttraining to 5 Follow-ups||5
7728993|NCT01628016|19029893|P2|NOT COMPLETED|Posttraining to 5 Follow-ups||7
7728994|NCT01628016|19029894|P1|NOT COMPLETED|Posttraining to 5 Follow-ups||4
7728995|NCT01628016|19029892|P3|COMPLETED|Posttraining to 5 Follow-ups||18
7728996|NCT01628016|19029893|P2|COMPLETED|Posttraining to 5 Follow-ups||20
7728997|NCT01628016|19029894|P1|COMPLETED|Posttraining to 5 Follow-ups||23
7728998|NCT01628016|19029892|P3|STARTED|Posttraining to 5 Follow-ups||23
7728999|NCT01628016|19029893|P2|STARTED|Posttraining to 5 Follow-ups||27
7729000|NCT01628016|19029894|P1|STARTED|Posttraining to 5 Follow-ups||27
7729001|NCT01628016|19029892|P3|NOT COMPLETED|Pretraining to Posttraining||0
7729002|NCT01628016|19029893|P2|NOT COMPLETED|Pretraining to Posttraining||0
7729003|NCT01628016|19029894|P1|NOT COMPLETED|Pretraining to Posttraining||0
7729004|NCT01628016|19029892|P3|COMPLETED|Pretraining to Posttraining||23
7729005|NCT01628016|19029893|P2|COMPLETED|Pretraining to Posttraining||27
7729006|NCT01628016|19029894|P1|COMPLETED|Pretraining to Posttraining||27
7729007|NCT01628016|19029892|P3|STARTED|Pretraining to Posttraining||23
7729008|NCT01628016|19029893|P2|STARTED|Pretraining to Posttraining||27
7729009|NCT01628016|19029894|P1|STARTED|Pretraining to Posttraining||27
7729010|NCT01627899|19029905|P1|NOT COMPLETED|Overall Study||5
7729011|NCT01627899|19029905|P1|COMPLETED|Overall Study||0
7729012|NCT01627899|19029905|P1|STARTED|Overall Study||5
7729013|NCT01627860|19029915|P2|NOT COMPLETED|Overall Study||6
7729014|NCT01627860|19029916|P1|NOT COMPLETED|Overall Study||12
7729015|NCT01627860|19029915|P2|COMPLETED|Overall Study||14
7729016|NCT01627860|19029916|P1|COMPLETED|Overall Study||23
7729017|NCT01627860|19029915|P2|STARTED|Overall Study||20
7729018|NCT01627860|19029916|P1|STARTED|Overall Study||35
7729019|NCT01627782|19029930|P4|NOT COMPLETED|Overall Study||6
7729020|NCT01627782|19029931|P3|NOT COMPLETED|Overall Study||15
7729021|NCT01627782|19029932|P2|NOT COMPLETED|Overall Study||6
7729022|NCT01627782|19029933|P1|NOT COMPLETED|Overall Study||16
7729023|NCT01627782|19029930|P4|COMPLETED|Overall Study||11
7729024|NCT01627782|19029931|P3|COMPLETED|Overall Study||1
7729025|NCT01627782|19029932|P2|COMPLETED|Overall Study||12
7729026|NCT01627782|19029933|P1|COMPLETED|Overall Study||1
7729027|NCT01627782|19029930|P4|Treated|Overall Study||17
7729028|NCT01627782|19029931|P3|Treated|Overall Study||16
7729029|NCT01627782|19029932|P2|Treated|Overall Study||18
7729030|NCT01627782|19029933|P1|Treated|Overall Study||16
7729031|NCT01627782|19029930|P4|STARTED|Overall Study||17
7729032|NCT01627782|19029931|P3|STARTED|Overall Study||16
7729033|NCT01627782|19029932|P2|STARTED|Overall Study||18
7729034|NCT01627782|19029933|P1|STARTED|Overall Study||17
7729035|NCT01627691|19029989|P1|NOT COMPLETED|Overall Study||18
7729036|NCT01627691|19029989|P1|COMPLETED|Overall Study||232
7729037|NCT01627691|19029989|P1|Primary Endpoint (30days)|Overall Study||239
7729038|NCT01627691|19029989|P1|STARTED|Overall Study||250
7729039|NCT01627574|19030002|P2|NOT COMPLETED|Overall Study||18
7729040|NCT01627574|19030003|P1|NOT COMPLETED|Overall Study||21
7729041|NCT01627574|19030002|P2|COMPLETED|Overall Study||112
7729042|NCT01627574|19030003|P1|COMPLETED|Overall Study||121
7729043|NCT01627574|19030002|P2|STARTED|Overall Study||130
7729044|NCT01627574|19030003|P1|STARTED|Overall Study||142
7729045|NCT01627561|19030017|P2|NOT COMPLETED|Overall Study||3
7729046|NCT01627561|19030018|P1|NOT COMPLETED|Overall Study||1
7729047|NCT01627561|19030017|P2|COMPLETED|Overall Study||71
7729048|NCT01627561|19030018|P1|COMPLETED|Overall Study||73
7729049|NCT01627561|19030017|P2|STARTED|Overall Study||74
7729050|NCT01627561|19030018|P1|STARTED|Overall Study||74
7729051|NCT01627340|19030084|P2|NOT COMPLETED|Overall Study||4
7729052|NCT01627340|19030085|P1|NOT COMPLETED|Overall Study||12
7729053|NCT01627340|19030084|P2|COMPLETED|Overall Study||254
7729054|NCT01627340|19030085|P1|COMPLETED|Overall Study||404
7729055|NCT01627340|19030084|P2|STARTED|Overall Study||258
7729056|NCT01627340|19030085|P1|STARTED|Overall Study||416
7729057|NCT01627327|19030103|P2|NOT COMPLETED|Overall Study||39
7729058|NCT01627327|19030104|P1|NOT COMPLETED|Overall Study||19
7729059|NCT01627327|19030103|P2|COMPLETED|Overall Study||274
7729060|NCT01627327|19030104|P1|COMPLETED|Overall Study||291
7729061|NCT01627327|19030103|P2|STARTED|Overall Study||313
7729062|NCT01627327|19030104|P1|STARTED|Overall Study||310
7729063|NCT01627288|19030118|P4|NOT COMPLETED|Overall Study||0
7729064|NCT01627288|19030119|P3|NOT COMPLETED|Overall Study||0
7729065|NCT01627288|19030120|P2|NOT COMPLETED|Overall Study||0
7729066|NCT01627288|19030121|P1|NOT COMPLETED|Overall Study||0
7729067|NCT01627288|19030118|P4|COMPLETED|Overall Study||0
7729068|NCT01627288|19030119|P3|COMPLETED|Overall Study||6
7729069|NCT01627288|19030120|P2|COMPLETED|Overall Study||3
7729070|NCT01627288|19030121|P1|COMPLETED|Overall Study||3
7729071|NCT01627288|19030118|P4|STARTED|Overall Study||0
7729072|NCT01627288|19030119|P3|STARTED|Overall Study||6
7729073|NCT01627288|19030120|P2|STARTED|Overall Study||3
7729074|NCT01627288|19030121|P1|STARTED|Overall Study||3
7729075|NCT01627249|19030154|P3|NOT COMPLETED|Overall Study||12
7729076|NCT01627249|19030155|P2|NOT COMPLETED|Overall Study||12
7729077|NCT01627249|19030156|P1|NOT COMPLETED|Overall Study||16
7729078|NCT01627249|19030154|P3|COMPLETED|Overall Study||206
7729079|NCT01627249|19030155|P2|COMPLETED|Overall Study||206
7729080|NCT01627249|19030156|P1|COMPLETED|Overall Study||208
7729081|NCT01627249|19030154|P3|STARTED|Overall Study||218
7729082|NCT01627249|19030155|P2|STARTED|Overall Study||218
7729083|NCT01627249|19030156|P1|STARTED|Overall Study||224
7729084|NCT01627067|19030191|P1|NOT COMPLETED|Overall Study||1
7729085|NCT01627067|19030191|P1|COMPLETED|Overall Study||22
7729086|NCT01627067|19030191|P1|STARTED|Overall Study||23
7729087|NCT01627002|19030201|P9|NOT COMPLETED|Overall Study||0
7729088|NCT01627002|19030202|P8|NOT COMPLETED|Overall Study||0
7729089|NCT01627002|19030203|P7|NOT COMPLETED|Overall Study||0
7729090|NCT01627002|19030204|P6|NOT COMPLETED|Overall Study||0
7729091|NCT01627002|19030205|P5|NOT COMPLETED|Overall Study||0
7729092|NCT01627002|19030206|P4|NOT COMPLETED|Overall Study||0
7729093|NCT01627002|19030207|P3|NOT COMPLETED|Overall Study||0
7729094|NCT01627002|19030208|P2|NOT COMPLETED|Overall Study||0
7729095|NCT01627002|19030209|P1|NOT COMPLETED|Overall Study||0
7729096|NCT01627002|19030201|P9|COMPLETED|Overall Study||7
7729097|NCT01627002|19030202|P8|COMPLETED|Overall Study||5
7729098|NCT01627002|19030203|P7|COMPLETED|Overall Study||10
7729099|NCT01627002|19030204|P6|COMPLETED|Overall Study||9
7729100|NCT01627002|19030205|P5|COMPLETED|Overall Study||2
7729101|NCT01627002|19030206|P4|COMPLETED|Overall Study||4
7729102|NCT01627002|19030207|P3|COMPLETED|Overall Study||4
7729103|NCT01627002|19030208|P2|COMPLETED|Overall Study||4
7729104|NCT01627002|19030209|P1|COMPLETED|Overall Study||4
7729105|NCT01627002|19030201|P9|STARTED|Overall Study||7
7729106|NCT01627002|19030202|P8|STARTED|Overall Study||5
7729107|NCT01627002|19030203|P7|STARTED|Overall Study||10
7729108|NCT01627002|19030204|P6|STARTED|Overall Study||9
7729109|NCT01627002|19030205|P5|STARTED|Overall Study||2
7729110|NCT01627002|19030206|P4|STARTED|Overall Study||4
7729111|NCT01627002|19030207|P3|STARTED|Overall Study||4
7729112|NCT01627002|19030208|P2|STARTED|Overall Study||4
7729113|NCT01627002|19030209|P1|STARTED|Overall Study||4
7729114|NCT01626989|19030260|P3|NOT COMPLETED|Second Intervention (Night 2)||0
7729115|NCT01626989|19030261|P2|NOT COMPLETED|Second Intervention (Night 2)||0
7729116|NCT01626989|19030262|P1|NOT COMPLETED|Second Intervention (Night 2)||0
7729117|NCT01626989|19030260|P3|COMPLETED|Second Intervention (Night 2)||12
7729118|NCT01626989|19030261|P2|COMPLETED|Second Intervention (Night 2)||15
7729119|NCT01626989|19030262|P1|COMPLETED|Second Intervention (Night 2)||0
7729120|NCT01626989|19030260|P3|STARTED|Second Intervention (Night 2)||12
7729121|NCT01626989|19030261|P2|STARTED|Second Intervention (Night 2)||15
7729122|NCT01626989|19030262|P1|STARTED|Second Intervention (Night 2)||0
7729123|NCT01626989|19030260|P3|NOT COMPLETED|Fist Intervention (Night 1)||0
7729124|NCT01626989|19030261|P2|NOT COMPLETED|Fist Intervention (Night 1)||0
7729125|NCT01626989|19030262|P1|NOT COMPLETED|Fist Intervention (Night 1)||0
7729126|NCT01626989|19030260|P3|COMPLETED|Fist Intervention (Night 1)||12
7729127|NCT01626989|19030261|P2|COMPLETED|Fist Intervention (Night 1)||15
7729128|NCT01626989|19030262|P1|COMPLETED|Fist Intervention (Night 1)||0
7729129|NCT01626989|19030260|P3|STARTED|Fist Intervention (Night 1)||12
7729130|NCT01626989|19030261|P2|STARTED|Fist Intervention (Night 1)||15
7729131|NCT01626989|19030262|P1|STARTED|Fist Intervention (Night 1)||0
7729132|NCT01626989|19030260|P3|NOT COMPLETED|Screening Period||0
7729133|NCT01626989|19030261|P2|NOT COMPLETED|Screening Period||0
7729134|NCT01626989|19030262|P1|NOT COMPLETED|Screening Period||17
7729135|NCT01626989|19030260|P3|COMPLETED|Screening Period||0
7729136|NCT01626989|19030261|P2|COMPLETED|Screening Period||0
7729137|NCT01626989|19030262|P1|COMPLETED|Screening Period||27
7729138|NCT01626989|19030260|P3|STARTED|Screening Period||0
7729139|NCT01626989|19030261|P2|STARTED|Screening Period||0
7729140|NCT01626989|19030262|P1|STARTED|Screening Period||44
7729141|NCT01626820|19030311|P2|NOT COMPLETED|Overall Study||0
7729142|NCT01626820|19030312|P1|NOT COMPLETED|Overall Study||0
7729143|NCT01626820|19030311|P2|COMPLETED|Overall Study||57
7729144|NCT01626820|19030312|P1|COMPLETED|Overall Study||56
7729145|NCT01626820|19030311|P2|STARTED|Overall Study||57
7729146|NCT01626820|19030312|P1|STARTED|Overall Study||56
7729147|NCT01626690|19030334|P2|NOT COMPLETED|Overall Study||0
7729148|NCT01626690|19030335|P1|NOT COMPLETED|Overall Study||2
7729149|NCT01626690|19030334|P2|COMPLETED|Overall Study||51
7729150|NCT01626690|19030335|P1|COMPLETED|Overall Study||47
7729151|NCT01626690|19030334|P2|STARTED|Overall Study||51
7729152|NCT01626690|19030335|P1|STARTED|Overall Study||49
7729153|NCT01626664|19030357|P3|NOT COMPLETED|Crossover Period||0
7729154|NCT01626664|19030358|P2|NOT COMPLETED|Crossover Period||0
7729155|NCT01626664|19030359|P1|NOT COMPLETED|Crossover Period||0
7729156|NCT01626664|19030357|P3|COMPLETED|Crossover Period||18
7729157|NCT01626664|19030358|P2|COMPLETED|Crossover Period||0
7729158|NCT01626664|19030359|P1|COMPLETED|Crossover Period||0
7729159|NCT01626664|19030357|P3|STARTED|Crossover Period||18
7729160|NCT01626664|19030358|P2|STARTED|Crossover Period||0
7729161|NCT01626664|19030359|P1|STARTED|Crossover Period||0
7729162|NCT01626664|19030357|P3|NOT COMPLETED|Randomization Period||0
7729163|NCT01626664|19030358|P2|NOT COMPLETED|Randomization Period||0
7729164|NCT01626664|19030359|P1|NOT COMPLETED|Randomization Period||0
7729165|NCT01626664|19030357|P3|COMPLETED|Randomization Period||0
7729166|NCT01626664|19030358|P2|COMPLETED|Randomization Period||24
7729167|NCT01626664|19030359|P1|COMPLETED|Randomization Period||47
7729168|NCT01626664|19030357|P3|STARTED|Randomization Period||0
7729169|NCT01626664|19030358|P2|STARTED|Randomization Period||24
7729170|NCT01626664|19030359|P1|STARTED|Randomization Period||47
7729171|NCT01626495|19030372|P1|NOT COMPLETED|Overall Study||52
7729172|NCT01626495|19030372|P1|COMPLETED|Overall Study|Follow up phase completed as per protocol|21
7729173|NCT01626495|19030372|P1|Intervention|Overall Study||62
7729174|NCT01626495|19030372|P1|STARTED|Overall Study|Number of enrolled subjects|73
7729175|NCT01626456|19030381|P2|NOT COMPLETED|Overall Study||117
7729176|NCT01626456|19030382|P1|NOT COMPLETED|Overall Study||35
7729177|NCT01626456|19030381|P2|COMPLETED|Overall Study||251
7729178|NCT01626456|19030382|P1|COMPLETED|Overall Study||75
7729179|NCT01626456|19030381|P2|STARTED|Overall Study||368
7729180|NCT01626456|19030382|P1|STARTED|Overall Study||110
7729181|NCT01626391|19030412|P2|NOT COMPLETED|Overall Study||0
7729182|NCT01626391|19030413|P1|NOT COMPLETED|Overall Study||2
7729183|NCT01626391|19030412|P2|COMPLETED|Overall Study||4
7729184|NCT01626391|19030413|P1|COMPLETED|Overall Study||3
7729185|NCT01626391|19030412|P2|STARTED|Overall Study||4
7729186|NCT01626391|19030413|P1|STARTED|Overall Study||5
7729187|NCT01626352|19030419|P1|NOT COMPLETED|Overall Study||10
7729188|NCT01626352|19030419|P1|COMPLETED|Overall Study||12
7729189|NCT01626352|19030419|P1|STARTED|Overall Study||22
7729190|NCT01626118|19030433|P4|NOT COMPLETED|Overall Study||3
7729191|NCT01626118|19030434|P3|NOT COMPLETED|Overall Study||2
7729192|NCT01626118|19030435|P2|NOT COMPLETED|Overall Study||2
7729193|NCT01626118|19030436|P1|NOT COMPLETED|Overall Study||2
7729194|NCT01626118|19030433|P4|COMPLETED|Overall Study||91
7729195|NCT01626118|19030434|P3|COMPLETED|Overall Study||90
7729196|NCT01626118|19030435|P2|COMPLETED|Overall Study||91
7729197|NCT01626118|19030436|P1|COMPLETED|Overall Study||92
7729198|NCT01626118|19030433|P4|STARTED|Overall Study||94
7729199|NCT01626118|19030434|P3|STARTED|Overall Study||92
7729200|NCT01626118|19030435|P2|STARTED|Overall Study||93
7729201|NCT01626118|19030436|P1|STARTED|Overall Study||94
7729202|NCT01626092|19030474|P1|NOT COMPLETED|Overall Study||0
7729203|NCT01626092|19030474|P1|COMPLETED|Overall Study||3
7729204|NCT01626092|19030474|P1|STARTED|Overall Study||3
7729205|NCT01626079|19030482|P2|NOT COMPLETED|Overall Study||216
7729206|NCT01626079|19030483|P1|NOT COMPLETED|Overall Study||167
7729207|NCT01626079|19030482|P2|COMPLETED|Overall Study||96
7729208|NCT01626079|19030483|P1|COMPLETED|Overall Study||135
7729209|NCT01626079|19030482|P2|STARTED|Overall Study||312
7729210|NCT01626079|19030483|P1|STARTED|Overall Study||302
7729211|NCT01625988|19030856|P2|NOT COMPLETED|Overall Study||13
7729212|NCT01625988|19030857|P1|NOT COMPLETED|Overall Study||14
7729213|NCT01625988|19030856|P2|COMPLETED|Overall Study||97
7729214|NCT01625988|19030857|P1|COMPLETED|Overall Study||94
7729215|NCT01625988|19030856|P2|Received at Least One Dose of Study Drug|Overall Study||110
7729216|NCT01625988|19030857|P1|Received at Least One Dose of Study Drug|Overall Study||107
7729217|NCT01625988|19030856|P2|STARTED|Overall Study||110
7729218|NCT01625988|19030857|P1|STARTED|Overall Study|One participant was randomized inappropriately and was discontinued before start of study treatment.|108
7729219|NCT01625923|19030871|P1|NOT COMPLETED|Overall Study||0
7729220|NCT01625923|19030871|P1|COMPLETED|Overall Study||3
7729221|NCT01625923|19030871|P1|STARTED|Overall Study||3
7729222|NCT01625910|19030881|P2|NOT COMPLETED|Overall Study||4
7729223|NCT01625910|19030882|P1|NOT COMPLETED|Overall Study||3
7729224|NCT01625910|19030881|P2|COMPLETED|Overall Study||33
7729225|NCT01625910|19030882|P1|COMPLETED|Overall Study||32
7729226|NCT01625910|19030881|P2|STARTED|Overall Study||37
7729227|NCT01625910|19030882|P1|STARTED|Overall Study||35
7729228|NCT01625845|19030892|P2|NOT COMPLETED|Overall Study||3
7729229|NCT01625845|19030893|P1|NOT COMPLETED|Overall Study||5
7729230|NCT01625845|19030892|P2|COMPLETED|Overall Study||3
7729231|NCT01625845|19030893|P1|COMPLETED|Overall Study||5
7729232|NCT01625845|19030892|P2|STARTED|Overall Study||6
7729233|NCT01625845|19030893|P1|STARTED|Overall Study||10
7729234|NCT01625689|19030913|P2|NOT COMPLETED|Overall Study||1
7729235|NCT01625689|19030914|P1|NOT COMPLETED|Overall Study||2
7729236|NCT01625689|19030913|P2|COMPLETED|Overall Study||149
7729237|NCT01625689|19030914|P1|COMPLETED|Overall Study||148
7729238|NCT01625689|19030913|P2|STARTED|Overall Study||150
7729239|NCT01625689|19030914|P1|STARTED|Overall Study||150
7729240|NCT01625507|19030924|P1|NOT COMPLETED|Overall Study||10
7729241|NCT01625507|19030924|P1|COMPLETED|Overall Study||63
7729242|NCT01625507|19030924|P1|STARTED|Overall Study||73
7729243|NCT01625455|19030939|P2|NOT COMPLETED|Overall Study||0
7729244|NCT01625455|19030940|P1|NOT COMPLETED|Overall Study||0
7729245|NCT01625455|19030939|P2|COMPLETED|Overall Study||3
7729246|NCT01625455|19030940|P1|COMPLETED|Overall Study||2
7729247|NCT01625455|19030939|P2|STARTED|Overall Study||3
7729248|NCT01625455|19030940|P1|STARTED|Overall Study||2
7729249|NCT01625416|19030950|P2|NOT COMPLETED|Overall Study||7
7729250|NCT01625416|19030951|P1|NOT COMPLETED|Overall Study||9
7729251|NCT01625416|19030950|P2|COMPLETED|Overall Study||54
7729252|NCT01625416|19030951|P1|COMPLETED|Overall Study||51
7729253|NCT01625416|19030950|P2|STARTED|Overall Study||61
7729254|NCT01625416|19030951|P1|STARTED|Overall Study||60
7729255|NCT01625377|19030969|P2|NOT COMPLETED|Overall Study||22
7729256|NCT01625377|19030970|P1|NOT COMPLETED|Overall Study||7
7729257|NCT01625377|19030969|P2|COMPLETED|Overall Study||71
7729258|NCT01625377|19030970|P1|COMPLETED|Overall Study||88
7729259|NCT01625377|19030969|P2|Intent to Treat Population|Overall Study||90
7729260|NCT01625377|19030970|P1|Intent to Treat Population|Overall Study||93
7729261|NCT01625377|19030969|P2|Safety Set of Population|Overall Study||90
7729262|NCT01625377|19030970|P1|Safety Set of Population|Overall Study||94
7729263|NCT01625377|19030969|P2|STARTED|Overall Study||93
7729264|NCT01625377|19030970|P1|STARTED|Overall Study|"Started indicates randomized patients."|95
7729265|NCT01625338|19031003|P3|NOT COMPLETED|Overall Study||39
7729266|NCT01625338|19031004|P2|NOT COMPLETED|Overall Study||44
7729267|NCT01625338|19031005|P1|NOT COMPLETED|Overall Study||32
7729268|NCT01625338|19031003|P3|COMPLETED|Overall Study||181
7729269|NCT01625338|19031004|P2|COMPLETED|Overall Study||156
7729270|NCT01625338|19031005|P1|COMPLETED|Overall Study||82
7729271|NCT01625338|19031003|P3|STARTED|Overall Study||220
7729272|NCT01625338|19031004|P2|STARTED|Overall Study||200
7729273|NCT01625338|19031005|P1|STARTED|Overall Study||114
7729274|NCT01625286|19031032|P7|NOT COMPLETED|Overall Study||56
7729275|NCT01625286|19031033|P6|NOT COMPLETED|Overall Study||54
7729276|NCT01625286|19031034|P5|NOT COMPLETED|Overall Study||6
7729277|NCT01625286|19031035|P4|NOT COMPLETED|Overall Study||7
7729278|NCT01625286|19031036|P3|NOT COMPLETED|Overall Study||5
7729279|NCT01625286|19031037|P2|NOT COMPLETED|Overall Study||8
7729280|NCT01625286|19031038|P1|NOT COMPLETED|Overall Study||12
7729281|NCT01625286|19031032|P7|COMPLETED|Overall Study||0
7729282|NCT01625286|19031033|P6|COMPLETED|Overall Study||0
7729283|NCT01625286|19031034|P5|COMPLETED|Overall Study||0
7729284|NCT01625286|19031035|P4|COMPLETED|Overall Study||0
7729285|NCT01625286|19031036|P3|COMPLETED|Overall Study||0
7729286|NCT01625286|19031037|P2|COMPLETED|Overall Study||0
7729287|NCT01625286|19031038|P1|COMPLETED|Overall Study||0
7729288|NCT01625286|19031032|P7|Did Not Receive AZD5363/Placebo Trt|Overall Study||1
7729289|NCT01625286|19031033|P6|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
7729290|NCT01625286|19031034|P5|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
7729291|NCT01625286|19031035|P4|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
7729292|NCT01625286|19031036|P3|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
7729293|NCT01625286|19031037|P2|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
7729294|NCT01625286|19031038|P1|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
7729295|NCT01625286|19031032|P7|Received AZD5363/Placebo Treatment|Overall Study||55
7729296|NCT01625286|19031033|P6|Received AZD5363/Placebo Treatment|Overall Study||54
7729297|NCT01625286|19031034|P5|Received AZD5363/Placebo Treatment|Overall Study||6
7729298|NCT01625286|19031035|P4|Received AZD5363/Placebo Treatment|Overall Study||7
7729299|NCT01625286|19031036|P3|Received AZD5363/Placebo Treatment|Overall Study||5
7729300|NCT01625286|19031037|P2|Received AZD5363/Placebo Treatment|Overall Study||8
7729301|NCT01625286|19031038|P1|Received AZD5363/Placebo Treatment|Overall Study||12
7729302|NCT01625286|19031032|P7|STARTED|Overall Study||56
7729303|NCT01625286|19031033|P6|STARTED|Overall Study||54
7729304|NCT01625286|19031034|P5|STARTED|Overall Study||6
7729305|NCT01625286|19031035|P4|STARTED|Overall Study||7
7729306|NCT01625286|19031036|P3|STARTED|Overall Study||5
7729307|NCT01625286|19031037|P2|STARTED|Overall Study||8
7729308|NCT01625286|19031038|P1|STARTED|Overall Study||12
7729309|NCT01625221|19031117|P1|NOT COMPLETED|Overall Study||7
7729310|NCT01625221|19031117|P1|COMPLETED|Overall Study||28
7729311|NCT01625221|19031117|P1|STARTED|Overall Study||35
7729312|NCT01625182|19031124|P2|NOT COMPLETED|Overall Study||11
7729313|NCT01625182|19031125|P1|NOT COMPLETED|Overall Study||20
7729314|NCT01625182|19031124|P2|COMPLETED|Overall Study||41
7729315|NCT01625182|19031125|P1|COMPLETED|Overall Study||34
7729316|NCT01625182|19031124|P2|STARTED|Overall Study||52
7729317|NCT01625182|19031125|P1|STARTED|Overall Study||54
7729318|NCT01625169|19031138|P1|NOT COMPLETED|Overall Study||0
7729319|NCT01625169|19031138|P1|COMPLETED|Overall Study||9
7729320|NCT01625169|19031138|P1|STARTED|Overall Study||9
7729321|NCT01625104|19031153|P2|NOT COMPLETED|Overall Study||0
7729322|NCT01625104|19031154|P1|NOT COMPLETED|Overall Study||0
7729323|NCT01625104|19031153|P2|COMPLETED|Overall Study||434
7729324|NCT01625104|19031154|P1|COMPLETED|Overall Study||448
7729325|NCT01625104|19031153|P2|STARTED|Overall Study||434
7729326|NCT01625104|19031154|P1|STARTED|Overall Study||448
7729327|NCT01625091|19031162|P2|NOT COMPLETED|Post-intervention||2
7729328|NCT01625091|19031163|P1|NOT COMPLETED|Post-intervention||4
7729329|NCT01625091|19031162|P2|COMPLETED|Post-intervention||85
7729330|NCT01625091|19031163|P1|COMPLETED|Post-intervention||81
7729331|NCT01625091|19031162|P2|7 Months|Post-intervention||85
7729332|NCT01625091|19031163|P1|7 Months|Post-intervention||81
7729333|NCT01625091|19031162|P2|STARTED|Post-intervention||87
7729334|NCT01625091|19031163|P1|STARTED|Post-intervention||85
7729335|NCT01625091|19031162|P2|NOT COMPLETED|Intervention||11
7729336|NCT01625091|19031163|P1|NOT COMPLETED|Intervention||11
7729337|NCT01625091|19031162|P2|COMPLETED|Intervention||87
7729338|NCT01625091|19031163|P1|COMPLETED|Intervention||85
7729339|NCT01625091|19031162|P2|4 Months|Intervention||87
7729340|NCT01625091|19031163|P1|4 Months|Intervention||85
7729341|NCT01625091|19031162|P2|2 Months|Intervention||93
7729342|NCT01625091|19031163|P1|2 Months|Intervention||90
7729343|NCT01625091|19031162|P2|STARTED|Intervention||98
7729344|NCT01625091|19031163|P1|STARTED|Intervention||96
7729345|NCT01625013|19031175|P1|NOT COMPLETED|Overall Study||32
7729346|NCT01625013|19031175|P1|COMPLETED|Overall Study||48
7729347|NCT01625013|19031175|P1|STARTED|Overall Study||80
7729348|NCT01624974|19031181|P2|NOT COMPLETED|Period V of Treatment (4 Weeks)||0
7729349|NCT01624974|19031182|P1|NOT COMPLETED|Period V of Treatment (4 Weeks)||5
7729350|NCT01624974|19031181|P2|COMPLETED|Period V of Treatment (4 Weeks)||42
7729351|NCT01624974|19031182|P1|COMPLETED|Period V of Treatment (4 Weeks)||39
7729352|NCT01624974|19031181|P2|STARTED|Period V of Treatment (4 Weeks)||42
7729353|NCT01624974|19031182|P1|STARTED|Period V of Treatment (4 Weeks)||44
7729354|NCT01624974|19031181|P2|NOT COMPLETED|Period IV Washout (4 Weeks)||3
7729355|NCT01624974|19031182|P1|NOT COMPLETED|Period IV Washout (4 Weeks)||3
7729356|NCT01624974|19031181|P2|COMPLETED|Period IV Washout (4 Weeks)||42
7729357|NCT01624974|19031182|P1|COMPLETED|Period IV Washout (4 Weeks)||44
7729358|NCT01624974|19031181|P2|STARTED|Period IV Washout (4 Weeks)||45
7729359|NCT01624974|19031182|P1|STARTED|Period IV Washout (4 Weeks)||47
7729360|NCT01624974|19031181|P2|NOT COMPLETED|Period III of Treatment (4 Weeks)||8
7729361|NCT01624974|19031182|P1|NOT COMPLETED|Period III of Treatment (4 Weeks)||7
7729362|NCT01624974|19031181|P2|COMPLETED|Period III of Treatment (4 Weeks)||45
7729363|NCT01624974|19031182|P1|COMPLETED|Period III of Treatment (4 Weeks)||47
7729364|NCT01624974|19031181|P2|STARTED|Period III of Treatment (4 Weeks)||53
7729365|NCT01624974|19031182|P1|STARTED|Period III of Treatment (4 Weeks)||54
7729366|NCT01624948|19031206|P2|NOT COMPLETED|Overall Study||0
7729367|NCT01624948|19031207|P1|NOT COMPLETED|Overall Study||0
7729368|NCT01624948|19031206|P2|COMPLETED|Overall Study||20
7729369|NCT01624948|19031207|P1|COMPLETED|Overall Study||20
7729370|NCT01624948|19031206|P2|STARTED|Overall Study||20
7729371|NCT01624948|19031207|P1|STARTED|Overall Study||20
7729372|NCT01624870|19031223|P1|NOT COMPLETED|Overall Study||27
7729373|NCT01624870|19031223|P1|COMPLETED|Overall Study|Completed 6 month follow up|173
7729374|NCT01624870|19031223|P1|STARTED|Overall Study|provided informed consent|200
7729375|NCT01624740|19031231|P2|NOT COMPLETED|Second Intervention (3-4 Days)||0
7729376|NCT01624740|19031232|P1|NOT COMPLETED|Second Intervention (3-4 Days)||1
7729377|NCT01624740|19031231|P2|COMPLETED|Second Intervention (3-4 Days)||9
7729378|NCT01624740|19031232|P1|COMPLETED|Second Intervention (3-4 Days)||8
7729379|NCT01624740|19031231|P2|STARTED|Second Intervention (3-4 Days)||9
7729380|NCT01624740|19031232|P1|STARTED|Second Intervention (3-4 Days)||9
7729381|NCT01624740|19031231|P2|NOT COMPLETED|Washout (1 Hour)||0
7729382|NCT01624740|19031232|P1|NOT COMPLETED|Washout (1 Hour)||0
7729383|NCT01624740|19031231|P2|COMPLETED|Washout (1 Hour)||9
7729384|NCT01624740|19031232|P1|COMPLETED|Washout (1 Hour)||9
7729385|NCT01624740|19031231|P2|STARTED|Washout (1 Hour)||9
7729386|NCT01624740|19031232|P1|STARTED|Washout (1 Hour)||9
7729387|NCT01624740|19031231|P2|NOT COMPLETED|First Intervention (3-4 Days)||0
7729388|NCT01624740|19031232|P1|NOT COMPLETED|First Intervention (3-4 Days)||0
7729389|NCT01624740|19031231|P2|COMPLETED|First Intervention (3-4 Days)||9
7729390|NCT01624740|19031232|P1|COMPLETED|First Intervention (3-4 Days)||9
7729391|NCT01624740|19031231|P2|STARTED|First Intervention (3-4 Days)||9
7729392|NCT01624740|19031232|P1|STARTED|First Intervention (3-4 Days)||9
7729393|NCT01624662|19031243|P4|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
7729394|NCT01624662|19031244|P3|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
7729395|NCT01624662|19031245|P2|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
7729396|NCT01624662|19031246|P1|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
7729397|NCT01624662|19031243|P4|COMPLETED|Open-Label Extension Phase (Wks 17-24)||78
7729398|NCT01624662|19031244|P3|COMPLETED|Open-Label Extension Phase (Wks 17-24)||71
7729399|NCT01624662|19031245|P2|COMPLETED|Open-Label Extension Phase (Wks 17-24)||76
7729400|NCT01624662|19031246|P1|COMPLETED|Open-Label Extension Phase (Wks 17-24)||69
7729401|NCT01624662|19031243|P4|STARTED|Open-Label Extension Phase (Wks 17-24)||79
7729402|NCT01624662|19031244|P3|STARTED|Open-Label Extension Phase (Wks 17-24)||72
7729403|NCT01624662|19031245|P2|STARTED|Open-Label Extension Phase (Wks 17-24)||78
7729404|NCT01624662|19031246|P1|STARTED|Open-Label Extension Phase (Wks 17-24)||70
7729405|NCT01624662|19031243|P4|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||0
7729406|NCT01624662|19031244|P3|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
7729407|NCT01624662|19031245|P2|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||3
7729408|NCT01624662|19031246|P1|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||10
7729409|NCT01624662|19031243|P4|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||82
7729410|NCT01624662|19031244|P3|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
7729411|NCT01624662|19031245|P2|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||78
7729412|NCT01624662|19031246|P1|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
7729413|NCT01624662|19031243|P4|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
7729414|NCT01624662|19031244|P3|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
7729415|NCT01624662|19031245|P2|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
7729416|NCT01624662|19031246|P1|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
7729417|NCT01624467|19031317|P1|NOT COMPLETED|Overall Study||31
7729418|NCT01624467|19031317|P1|COMPLETED|Overall Study||44
7729419|NCT01624467|19031317|P1|Received at Least One Dose of Study Drug|Overall Study||75
7729420|NCT01624467|19031317|P1|STARTED|Overall Study||75
7729421|NCT01624363|19031330|P1|NOT COMPLETED|Overall Study||0
7729422|NCT01624363|19031330|P1|COMPLETED|Overall Study||341
7729423|NCT01624363|19031330|P1|STARTED|Overall Study||341
7729424|NCT01624350|19031334|P1|NOT COMPLETED|Overall Study||25
7729425|NCT01624350|19031334|P1|COMPLETED|Overall Study||75
7729426|NCT01624350|19031334|P1|STARTED|Overall Study||100
7729427|NCT01624259|19031356|P2|NOT COMPLETED|Overall Study||31
7729428|NCT01624259|19031357|P1|NOT COMPLETED|Overall Study||30
7729429|NCT01624259|19031356|P2|COMPLETED|Overall Study|Completed the study on study treatment|269
7729430|NCT01624259|19031357|P1|COMPLETED|Overall Study|Completed the study on study treatment|269
7729431|NCT01624259|19031356|P2|Received at Least One Dose of Study Drug|Overall Study||300
7729432|NCT01624259|19031357|P1|Received at Least One Dose of Study Drug|Overall Study||299
7729433|NCT01624259|19031356|P2|STARTED|Overall Study||300
7729434|NCT01624259|19031357|P1|STARTED|Overall Study||299
7729435|NCT01624233|19031406|P1|NOT COMPLETED|Period 6: Follow-up||9
7729436|NCT01624233|19031406|P1|COMPLETED|Period 6: Follow-up||79
7729437|NCT01624233|19031406|P1|STARTED|Period 6: Follow-up|Period 6 included participants received a dose of drug and exhibited the required neutrophil count.|88
7729438|NCT01624233|19031406|P1|NOT COMPLETED|Period 5 - Retreatment Period||10
7729439|NCT01624233|19031406|P1|COMPLETED|Period 5 - Retreatment Period||70
7729440|NCT01624233|19031406|P1|STARTED|Period 5 - Retreatment Period|Period 5 included (participants with erythrodermic Ps or pustular Ps) or Period 4 completers.|80
7729441|NCT01624233|19031406|P1|NOT COMPLETED|Period 4 - Drug Free Period||61
7729442|NCT01624233|19031406|P1|COMPLETED|Period 4 - Drug Free Period||9
7729443|NCT01624233|19031406|P1|Physician Decision|Period 4 - Drug Free Period|1 participant who discontinued due to physician decision is included in the participants relapsed.|1
7729444|NCT01624233|19031406|P1|Adverse Event|Period 4 - Drug Free Period|1 participant who discontinued due to adverse event is included in the participants who relapsed.|1
7729445|NCT01624233|19031406|P1|STARTED|Period 4 - Drug Free Period|Only responders in participants with plaque Ps moved to the Drug Free Period 4.|70
7729446|NCT01624233|19031406|P1|NOT COMPLETED|Period 3 - Maintenance||7
7729447|NCT01624233|19031406|P1|COMPLETED|Period 3 - Maintenance||83
7729448|NCT01624233|19031406|P1|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90
7729449|NCT01624233|19031406|P1|STARTED|Period 3 - Maintenance||90
7729450|NCT01624233|19031406|P1|NOT COMPLETED|Period 2 - Induction||1
7729451|NCT01624233|19031406|P1|COMPLETED|Period 2 - Induction||90
7729452|NCT01624233|19031406|P1|Plaque Ps|Period 2 - Induction||78
7729453|NCT01624233|19031406|P1|Pustular Ps|Period 2 - Induction||5
7729454|NCT01624233|19031406|P1|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8
7729455|NCT01624233|19031406|P1|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91
7729456|NCT01624233|19031406|P1|STARTED|Period 2 - Induction||91
7729457|NCT01624194|19031438|P2|NOT COMPLETED|Overall Study||0
7729458|NCT01624194|19031439|P1|NOT COMPLETED|Overall Study||2
7729459|NCT01624194|19031438|P2|COMPLETED|Overall Study||18
7729460|NCT01624194|19031439|P1|COMPLETED|Overall Study||14
7729461|NCT01624194|19031438|P2|STARTED|Overall Study||18
7729462|NCT01624194|19031439|P1|STARTED|Overall Study||16
7729463|NCT01624168|19031480|P3|NOT COMPLETED|Overall Study||6
7729464|NCT01624168|19031481|P2|NOT COMPLETED|Overall Study||12
7729465|NCT01624168|19031482|P1|NOT COMPLETED|Overall Study||4
7729466|NCT01624168|19031480|P3|COMPLETED|Overall Study||22
7729467|NCT01624168|19031481|P2|COMPLETED|Overall Study||16
7729468|NCT01624168|19031482|P1|COMPLETED|Overall Study||15
7729469|NCT01624168|19031480|P3|STARTED|Overall Study||28
7729470|NCT01624168|19031481|P2|STARTED|Overall Study||28
7729471|NCT01624168|19031482|P1|STARTED|Overall Study||19
7729472|NCT01624142|19031507|P2|NOT COMPLETED|Overall Study||16
7729473|NCT01624142|19031508|P1|NOT COMPLETED|Overall Study||32
7729474|NCT01624142|19031507|P2|COMPLETED|Overall Study||178
7729475|NCT01624142|19031508|P1|COMPLETED|Overall Study||74
7729476|NCT01624142|19031507|P2|STARTED|Overall Study||194
7729477|NCT01624142|19031508|P1|STARTED|Overall Study||106
7729478|NCT01624090|19031533|P4|NOT COMPLETED|Overall Study||0
7729479|NCT01624090|19031534|P3|NOT COMPLETED|Overall Study||7
7729480|NCT01624090|19031535|P2|NOT COMPLETED|Overall Study||2
7729481|NCT01624090|19031536|P1|NOT COMPLETED|Overall Study||0
7729482|NCT01624090|19031533|P4|COMPLETED|Overall Study||2
7729483|NCT01624090|19031534|P3|COMPLETED|Overall Study||3
7729484|NCT01624090|19031535|P2|COMPLETED|Overall Study||0
7729485|NCT01624090|19031536|P1|COMPLETED|Overall Study||2
7729486|NCT01624090|19031533|P4|STARTED|Overall Study||2
7729487|NCT01624090|19031534|P3|STARTED|Overall Study||10
7729488|NCT01624090|19031535|P2|STARTED|Overall Study||2
7729489|NCT01624090|19031536|P1|STARTED|Overall Study||2
7729490|NCT01623869|19031550|P1|NOT COMPLETED|Overall Study||0
7729491|NCT01623869|19031550|P1|COMPLETED|Overall Study||16
7729492|NCT01623869|19031550|P1|STARTED|Overall Study||16
7729493|NCT01623830|19031558|P2|NOT COMPLETED|Overall Study||9
7729494|NCT01623830|19031559|P1|NOT COMPLETED|Overall Study||7
7729495|NCT01623830|19031558|P2|COMPLETED|Overall Study||35
7729496|NCT01623830|19031559|P1|COMPLETED|Overall Study||38
7729497|NCT01623830|19031558|P2|STARTED|Overall Study||44
7729498|NCT01623830|19031559|P1|STARTED|Overall Study||45
7729499|NCT01623752|19031576|P3|NOT COMPLETED|Phase 2 (78 Weeks)||0
7729500|NCT01623752|19031577|P2|NOT COMPLETED|Phase 2 (78 Weeks)||18
7729501|NCT01623752|19031578|P1|NOT COMPLETED|Phase 2 (78 Weeks)||66
7729502|NCT01623752|19031576|P3|COMPLETED|Phase 2 (78 Weeks)||0
7729503|NCT01623752|19031577|P2|COMPLETED|Phase 2 (78 Weeks)||98
7729504|NCT01623752|19031578|P1|COMPLETED|Phase 2 (78 Weeks)||225
7729505|NCT01623752|19031576|P3|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|0
7729506|NCT01623752|19031577|P2|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|116
7729507|NCT01623752|19031578|P1|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|291
7729508|NCT01623752|19031576|P3|NOT COMPLETED|Phase 1 (78 Weeks)||2
7729509|NCT01623752|19031577|P2|NOT COMPLETED|Phase 1 (78 Weeks)||207
7729510|NCT01623752|19031578|P1|NOT COMPLETED|Phase 1 (78 Weeks)||631
7729511|NCT01623752|19031576|P3|COMPLETED|Phase 1 (78 Weeks)||1
7729512|NCT01623752|19031577|P2|COMPLETED|Phase 1 (78 Weeks)||233
7729513|NCT01623752|19031578|P1|COMPLETED|Phase 1 (78 Weeks)||747
7729514|NCT01623752|19031576|P3|STARTED|Phase 1 (78 Weeks)||3
7729515|NCT01623752|19031577|P2|STARTED|Phase 1 (78 Weeks)||440
7729516|NCT01623752|19031578|P1|STARTED|Phase 1 (78 Weeks)||1378
7729517|NCT01623739|19031663|P2|NOT COMPLETED|Overall Study||4
7729518|NCT01623739|19031664|P1|NOT COMPLETED|Overall Study||2
7729519|NCT01623739|19031663|P2|COMPLETED|Overall Study||15
7729520|NCT01623739|19031664|P1|COMPLETED|Overall Study||17
7729521|NCT01623739|19031663|P2|STARTED|Overall Study||19
7729522|NCT01623739|19031664|P1|STARTED|Overall Study||19
7729523|NCT01623596|19031681|P2|NOT COMPLETED|Overall Study||100
7729524|NCT01623596|19031682|P1|NOT COMPLETED|Overall Study||62
7729525|NCT01623596|19031681|P2|COMPLETED|Overall Study||339
7729526|NCT01623596|19031682|P1|COMPLETED|Overall Study||374
7729527|NCT01623596|19031681|P2|On Switched Treatment|Overall Study||214
7729528|NCT01623596|19031682|P1|On Switched Treatment|Overall Study||22
7729529|NCT01623596|19031681|P2|On Randomized Treatment|Overall Study||125
7729530|NCT01623596|19031682|P1|On Randomized Treatment|Overall Study||352
7729531|NCT01623596|19031681|P2|STARTED|Overall Study||439
7729532|NCT01623596|19031682|P1|STARTED|Overall Study||436
7729533|NCT01623531|19031700|P2|NOT COMPLETED|Overall Study||2
7729534|NCT01623531|19031701|P1|NOT COMPLETED|Overall Study||4
7729535|NCT01623531|19031700|P2|COMPLETED|Overall Study||29
7729536|NCT01623531|19031701|P1|COMPLETED|Overall Study||27
7729537|NCT01623531|19031700|P2|STARTED|Overall Study||31
7729538|NCT01623531|19031701|P1|STARTED|Overall Study||31
7729539|NCT01623479|19031741|P1|NOT COMPLETED|Overall Study||0
7729540|NCT01623479|19031741|P1|COMPLETED|Overall Study||585
7729541|NCT01623479|19031741|P1|STARTED|Overall Study||585
7729542|NCT01623466|19031749|P2|NOT COMPLETED|Overall Study||0
7729543|NCT01623466|19031750|P1|NOT COMPLETED|Overall Study||1
7729544|NCT01623466|19031749|P2|COMPLETED|Overall Study||18
7729545|NCT01623466|19031750|P1|COMPLETED|Overall Study||17
7729546|NCT01623466|19031749|P2|STARTED|Overall Study||18
7729547|NCT01623466|19031750|P1|STARTED|Overall Study||18
7729548|NCT01623323|19031764|P1|NOT COMPLETED|Overall Study||104
7729549|NCT01623323|19031764|P1|COMPLETED|Overall Study||601
7729550|NCT01623323|19031764|P1|STARTED|Overall Study||705
7729551|NCT01623310|19031768|P1|NOT COMPLETED|Overall Study||79
7729552|NCT01623310|19031768|P1|COMPLETED|Overall Study||144
7729553|NCT01623310|19031768|P1|STARTED|Overall Study||223
7729554|NCT01623271|19031777|P1|NOT COMPLETED|Overall Study||2
7729555|NCT01623271|19031777|P1|COMPLETED|Overall Study||3
7729556|NCT01623271|19031777|P1|STARTED|Overall Study||5
7729557|NCT01623167|19031784|P3|NOT COMPLETED|Overall Study||13
7729558|NCT01623167|19031785|P2|NOT COMPLETED|Overall Study||14
7729559|NCT01623167|19031786|P1|NOT COMPLETED|Overall Study||17
7729560|NCT01623167|19031784|P3|COMPLETED|Overall Study||18
7729561|NCT01623167|19031785|P2|COMPLETED|Overall Study||17
7729562|NCT01623167|19031786|P1|COMPLETED|Overall Study||13
7729563|NCT01623167|19031784|P3|STARTED|Overall Study||31
7729564|NCT01623167|19031785|P2|STARTED|Overall Study||31
7729565|NCT01623167|19031786|P1|STARTED|Overall Study||30
7729566|NCT01623154|19031794|P1|NOT COMPLETED|Overall Study||4
7729567|NCT01623154|19031794|P1|COMPLETED|Overall Study||95
7729568|NCT01623154|19031794|P1|Available for Analysis|Overall Study||95
7729569|NCT01623154|19031794|P1|STARTED|Overall Study||99
7729570|NCT01623115|19031802|P2|NOT COMPLETED|Overall Study||77
7729571|NCT01623115|19031803|P1|NOT COMPLETED|Overall Study||33
7729572|NCT01623115|19031802|P2|COMPLETED|Overall Study||246
7729573|NCT01623115|19031803|P1|COMPLETED|Overall Study||130
7729574|NCT01623115|19031802|P2|Treated|Overall Study||322
7729575|NCT01623115|19031803|P1|Treated|Overall Study||163
7729576|NCT01623115|19031802|P2|STARTED|Overall Study|Randomized|323
7729577|NCT01623115|19031803|P1|STARTED|Overall Study|Randomized|163
7729578|NCT01623050|19031863|P1|NOT COMPLETED|Overall Study||9
7729579|NCT01623050|19031863|P1|COMPLETED|Overall Study||27
7729580|NCT01623050|19031863|P1|Treated|Overall Study||34
7729581|NCT01623050|19031863|P1|STARTED|Overall Study||36
7729582|NCT01623037|19031871|P1|NOT COMPLETED|Overall Study||0
7729583|NCT01623037|19031871|P1|COMPLETED|Overall Study||15
7729584|NCT01623037|19031871|P1|STARTED|Overall Study||15
7729585|NCT01622699|19031882|P2|NOT COMPLETED|Overall Study||0
7729586|NCT01622699|19031883|P1|NOT COMPLETED|Overall Study||0
7729587|NCT01622699|19031882|P2|COMPLETED|Overall Study||217
7729588|NCT01622699|19031883|P1|COMPLETED|Overall Study||213
7729589|NCT01622699|19031882|P2|STARTED|Overall Study||217
7729590|NCT01622699|19031883|P1|STARTED|Overall Study||213
7729591|NCT01622673|19031901|P6|NOT COMPLETED|Treatment Period 5||0
7729592|NCT01622673|19031902|P5|NOT COMPLETED|Treatment Period 5||0
7729593|NCT01622673|19031903|P4|NOT COMPLETED|Treatment Period 5||0
7729594|NCT01622673|19031904|P3|NOT COMPLETED|Treatment Period 5||0
7729595|NCT01622673|19031905|P2|NOT COMPLETED|Treatment Period 5||0
7729596|NCT01622673|19031906|P1|NOT COMPLETED|Treatment Period 5||0
7729597|NCT01622673|19031901|P6|COMPLETED|Treatment Period 5||4
7729598|NCT01622673|19031902|P5|COMPLETED|Treatment Period 5||4
7729599|NCT01622673|19031903|P4|COMPLETED|Treatment Period 5||4
7729600|NCT01622673|19031904|P3|COMPLETED|Treatment Period 5||4
7729601|NCT01622673|19031905|P2|COMPLETED|Treatment Period 5||3
7729602|NCT01622673|19031906|P1|COMPLETED|Treatment Period 5||4
7729603|NCT01622673|19031901|P6|STARTED|Treatment Period 5||4
7729604|NCT01622673|19031902|P5|STARTED|Treatment Period 5||4
7729605|NCT01622673|19031903|P4|STARTED|Treatment Period 5||4
7729606|NCT01622673|19031904|P3|STARTED|Treatment Period 5||4
7729607|NCT01622673|19031905|P2|STARTED|Treatment Period 5||3
7729608|NCT01622673|19031906|P1|STARTED|Treatment Period 5||4
7729609|NCT01622673|19031901|P6|NOT COMPLETED|Treatment Period 4||0
7729610|NCT01622673|19031902|P5|NOT COMPLETED|Treatment Period 4||0
7729611|NCT01622673|19031903|P4|NOT COMPLETED|Treatment Period 4||0
7729612|NCT01622673|19031904|P3|NOT COMPLETED|Treatment Period 4||0
7729613|NCT01622673|19031905|P2|NOT COMPLETED|Treatment Period 4||0
7729614|NCT01622673|19031906|P1|NOT COMPLETED|Treatment Period 4||0
7729615|NCT01622673|19031901|P6|COMPLETED|Treatment Period 4||4
7729616|NCT01622673|19031902|P5|COMPLETED|Treatment Period 4||4
7729617|NCT01622673|19031903|P4|COMPLETED|Treatment Period 4||4
7729618|NCT01622673|19031904|P3|COMPLETED|Treatment Period 4||4
7729619|NCT01622673|19031905|P2|COMPLETED|Treatment Period 4||3
7729620|NCT01622673|19031906|P1|COMPLETED|Treatment Period 4||4
7729621|NCT01622673|19031901|P6|STARTED|Treatment Period 4||4
7729622|NCT01622673|19031902|P5|STARTED|Treatment Period 4||4
7729623|NCT01622673|19031903|P4|STARTED|Treatment Period 4||4
7729624|NCT01622673|19031904|P3|STARTED|Treatment Period 4||4
7729625|NCT01622673|19031905|P2|STARTED|Treatment Period 4||3
7729626|NCT01622673|19031906|P1|STARTED|Treatment Period 4||4
7729627|NCT01622673|19031901|P6|NOT COMPLETED|Treatment Period 3||0
7729628|NCT01622673|19031902|P5|NOT COMPLETED|Treatment Period 3||0
7729629|NCT01622673|19031903|P4|NOT COMPLETED|Treatment Period 3||0
7729630|NCT01622673|19031904|P3|NOT COMPLETED|Treatment Period 3||0
7729631|NCT01622673|19031905|P2|NOT COMPLETED|Treatment Period 3||1
7729632|NCT01622673|19031906|P1|NOT COMPLETED|Treatment Period 3||0
7729633|NCT01622673|19031901|P6|COMPLETED|Treatment Period 3||4
7729634|NCT01622673|19031902|P5|COMPLETED|Treatment Period 3||4
7729635|NCT01622673|19031903|P4|COMPLETED|Treatment Period 3||4
7729636|NCT01622673|19031904|P3|COMPLETED|Treatment Period 3||4
7729637|NCT01622673|19031905|P2|COMPLETED|Treatment Period 3||3
7729638|NCT01622673|19031906|P1|COMPLETED|Treatment Period 3||4
7729639|NCT01622673|19031901|P6|STARTED|Treatment Period 3||4
7729640|NCT01622673|19031902|P5|STARTED|Treatment Period 3||4
7729641|NCT01622673|19031903|P4|STARTED|Treatment Period 3||4
7729642|NCT01622673|19031904|P3|STARTED|Treatment Period 3||4
7729643|NCT01622673|19031905|P2|STARTED|Treatment Period 3||4
7729644|NCT01622673|19031906|P1|STARTED|Treatment Period 3||4
7729645|NCT01622673|19031901|P6|NOT COMPLETED|Treatment Period 2||0
7729646|NCT01622673|19031902|P5|NOT COMPLETED|Treatment Period 2||0
7729647|NCT01622673|19031903|P4|NOT COMPLETED|Treatment Period 2||1
7729648|NCT01622673|19031904|P3|NOT COMPLETED|Treatment Period 2||0
7729649|NCT01622673|19031905|P2|NOT COMPLETED|Treatment Period 2||0
7729650|NCT01622673|19031906|P1|NOT COMPLETED|Treatment Period 2||0
7729651|NCT01622673|19031901|P6|COMPLETED|Treatment Period 2||4
7729652|NCT01622673|19031902|P5|COMPLETED|Treatment Period 2||4
7729653|NCT01622673|19031903|P4|COMPLETED|Treatment Period 2||4
7729654|NCT01622673|19031904|P3|COMPLETED|Treatment Period 2||4
7729655|NCT01622673|19031905|P2|COMPLETED|Treatment Period 2||4
7729656|NCT01622673|19031906|P1|COMPLETED|Treatment Period 2||4
7729657|NCT01622673|19031901|P6|STARTED|Treatment Period 2||4
7729658|NCT01622673|19031902|P5|STARTED|Treatment Period 2||4
7729659|NCT01622673|19031903|P4|STARTED|Treatment Period 2||5
7729660|NCT01622673|19031904|P3|STARTED|Treatment Period 2||4
7729661|NCT01622673|19031905|P2|STARTED|Treatment Period 2||4
7729662|NCT01622673|19031906|P1|STARTED|Treatment Period 2||4
7729663|NCT01622673|19031901|P6|NOT COMPLETED|Treatment Period 1||0
7729664|NCT01622673|19031902|P5|NOT COMPLETED|Treatment Period 1||0
7729665|NCT01622673|19031903|P4|NOT COMPLETED|Treatment Period 1||1
7729666|NCT01622673|19031904|P3|NOT COMPLETED|Treatment Period 1||0
7729667|NCT01622673|19031905|P2|NOT COMPLETED|Treatment Period 1||1
7729668|NCT01622673|19031906|P1|NOT COMPLETED|Treatment Period 1||0
7729669|NCT01622673|19031901|P6|COMPLETED|Treatment Period 1||4
7729670|NCT01622673|19031902|P5|COMPLETED|Treatment Period 1||4
7729671|NCT01622673|19031903|P4|COMPLETED|Treatment Period 1||5
7729672|NCT01622673|19031904|P3|COMPLETED|Treatment Period 1||4
7729673|NCT01622673|19031905|P2|COMPLETED|Treatment Period 1||4
7729674|NCT01622673|19031906|P1|COMPLETED|Treatment Period 1||4
7729675|NCT01622673|19031901|P6|STARTED|Treatment Period 1||4
7729676|NCT01622673|19031902|P5|STARTED|Treatment Period 1||4
7729677|NCT01622673|19031903|P4|STARTED|Treatment Period 1||6
7729678|NCT01622673|19031904|P3|STARTED|Treatment Period 1||4
7729679|NCT01622673|19031905|P2|STARTED|Treatment Period 1||5
7729680|NCT01622673|19031906|P1|STARTED|Treatment Period 1||4
7729681|NCT01622660|19031941|P1|NOT COMPLETED|Overall Study||1
7729682|NCT01622660|19031941|P1|COMPLETED|Overall Study||1
7729683|NCT01622660|19031941|P1|STARTED|Overall Study||2
7729684|NCT01622569|19031949|P4|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
7729685|NCT01622569|19031950|P3|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||3
7729686|NCT01622569|19031951|P2|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
7729687|NCT01622569|19031952|P1|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
7729688|NCT01622569|19031949|P4|COMPLETED|Open-Label Extension Phase (Wks 17-24)||73
7729689|NCT01622569|19031950|P3|COMPLETED|Open-Label Extension Phase (Wks 17-24)||64
7729690|NCT01622569|19031951|P2|COMPLETED|Open-Label Extension Phase (Wks 17-24)||70
7729691|NCT01622569|19031952|P1|COMPLETED|Open-Label Extension Phase (Wks 17-24)||67
7729692|NCT01622569|19031949|P4|STARTED|Open-Label Extension Phase (Wks 17-24)||75
7729693|NCT01622569|19031950|P3|STARTED|Open-Label Extension Phase (Wks 17-24)||67
7729694|NCT01622569|19031951|P2|STARTED|Open-Label Extension Phase (Wks 17-24)||72
7729695|NCT01622569|19031952|P1|STARTED|Open-Label Extension Phase (Wks 17-24)||68
7729696|NCT01622569|19031949|P4|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
7729697|NCT01622569|19031950|P3|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||9
7729698|NCT01622569|19031951|P2|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||6
7729699|NCT01622569|19031952|P1|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||12
7729700|NCT01622569|19031949|P4|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
7729701|NCT01622569|19031950|P3|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||71
7729702|NCT01622569|19031951|P2|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||75
7729703|NCT01622569|19031952|P1|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
7729704|NCT01622569|19031949|P4|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
7729705|NCT01622569|19031950|P3|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
7729706|NCT01622569|19031951|P2|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
7729707|NCT01622569|19031952|P1|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
7729708|NCT01622543|19032021|P2|NOT COMPLETED|Overall Study||0
7729709|NCT01622543|19032022|P1|NOT COMPLETED|Overall Study||0
7729710|NCT01622543|19032021|P2|COMPLETED|Overall Study||52
7729711|NCT01622543|19032022|P1|COMPLETED|Overall Study||51
7729712|NCT01622543|19032021|P2|STARTED|Overall Study||52
7729713|NCT01622543|19032022|P1|STARTED|Overall Study||51
7729714|NCT01622348|19032037|P3|NOT COMPLETED|Overall Study||1
7729715|NCT01622348|19032038|P2|NOT COMPLETED|Overall Study||0
7729716|NCT01622348|19032039|P1|NOT COMPLETED|Overall Study||1
7729717|NCT01622348|19032037|P3|COMPLETED|Overall Study||14
7729718|NCT01622348|19032038|P2|COMPLETED|Overall Study||14
7729719|NCT01622348|19032039|P1|COMPLETED|Overall Study||14
7729720|NCT01622348|19032037|P3|STARTED|Overall Study||15
7729721|NCT01622348|19032038|P2|STARTED|Overall Study||14
7729722|NCT01622348|19032039|P1|STARTED|Overall Study||15
7729723|NCT01622296|19032047|P2|NOT COMPLETED|Second Intervention||0
7729724|NCT01622296|19032048|P1|NOT COMPLETED|Second Intervention||0
7729725|NCT01622296|19032047|P2|COMPLETED|Second Intervention||10
7729726|NCT01622296|19032048|P1|COMPLETED|Second Intervention||10
7729727|NCT01622296|19032047|P2|STARTED|Second Intervention||10
7729728|NCT01622296|19032048|P1|STARTED|Second Intervention||10
7729729|NCT01622296|19032047|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
7729730|NCT01622296|19032048|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
7729731|NCT01622296|19032047|P2|COMPLETED|Washout Period of at Least 1 Week||10
7729732|NCT01622296|19032048|P1|COMPLETED|Washout Period of at Least 1 Week||10
7729733|NCT01622296|19032047|P2|STARTED|Washout Period of at Least 1 Week||10
7729734|NCT01622296|19032048|P1|STARTED|Washout Period of at Least 1 Week||10
7729735|NCT01622296|19032047|P2|NOT COMPLETED|First Intervention||0
7729736|NCT01622296|19032048|P1|NOT COMPLETED|First Intervention||0
7729737|NCT01622296|19032047|P2|COMPLETED|First Intervention||10
7729738|NCT01622296|19032048|P1|COMPLETED|First Intervention||10
7729739|NCT01622296|19032047|P2|STARTED|First Intervention||10
7729740|NCT01622296|19032048|P1|STARTED|First Intervention||10
7729741|NCT01622257|19032056|P3|NOT COMPLETED|Overall Study||0
7729742|NCT01622257|19032057|P2|NOT COMPLETED|Overall Study||0
7729743|NCT01622257|19032058|P1|NOT COMPLETED|Overall Study||0
7729744|NCT01622257|19032056|P3|COMPLETED|Overall Study||66
7729745|NCT01622257|19032057|P2|COMPLETED|Overall Study||66
7729746|NCT01622257|19032058|P1|COMPLETED|Overall Study||66
7729747|NCT01622257|19032056|P3|STARTED|Overall Study||66
7729748|NCT01622257|19032057|P2|STARTED|Overall Study||66
7729749|NCT01622257|19032058|P1|STARTED|Overall Study||66
7729750|NCT01622231|19032078|P1|NOT COMPLETED|Overall Study||2
7729751|NCT01622231|19032078|P1|COMPLETED|Overall Study||59
7729752|NCT01622231|19032078|P1|STARTED|Overall Study||61
7729753|NCT01621880|19032108|P2|NOT COMPLETED|Overall Study||5
7729754|NCT01621880|19032109|P1|NOT COMPLETED|Overall Study||10
7729755|NCT01621880|19032108|P2|COMPLETED|Overall Study||49
7729756|NCT01621880|19032109|P1|COMPLETED|Overall Study||48
7729757|NCT01621880|19032108|P2|STARTED|Overall Study||54
7729758|NCT01621880|19032109|P1|STARTED|Overall Study||58
7729759|NCT01621802|19032123|P6|NOT COMPLETED|Overall Study||12
7729760|NCT01621802|19032124|P5|NOT COMPLETED|Overall Study||35
7729761|NCT01621802|19032125|P4|NOT COMPLETED|Overall Study||11
7729762|NCT01621802|19032126|P3|NOT COMPLETED|Overall Study||33
7729763|NCT01621802|19032127|P2|NOT COMPLETED|Overall Study||23
7729764|NCT01621802|19032128|P1|NOT COMPLETED|Overall Study||47
7729765|NCT01621802|19032123|P6|COMPLETED|Overall Study||477
7729766|NCT01621802|19032124|P5|COMPLETED|Overall Study||1284
7729767|NCT01621802|19032125|P4|COMPLETED|Overall Study||292
7729768|NCT01621802|19032126|P3|COMPLETED|Overall Study||763
7729769|NCT01621802|19032127|P2|COMPLETED|Overall Study||275
7729770|NCT01621802|19032128|P1|COMPLETED|Overall Study||755
7729771|NCT01621802|19032123|P6|STARTED|Overall Study||489
7729772|NCT01621802|19032124|P5|STARTED|Overall Study||1319
7729773|NCT01621802|19032125|P4|STARTED|Overall Study||303
7729774|NCT01621802|19032126|P3|STARTED|Overall Study||796
7729775|NCT01621802|19032127|P2|STARTED|Overall Study||298
7729776|NCT01621802|19032128|P1|STARTED|Overall Study||802
7729777|NCT01621776|19032235|P3|NOT COMPLETED|Overall Study||0
7729778|NCT01621776|19032236|P2|NOT COMPLETED|Overall Study||0
7729779|NCT01621776|19032237|P1|NOT COMPLETED|Overall Study||0
7729780|NCT01621776|19032235|P3|COMPLETED|Overall Study||18
7729781|NCT01621776|19032236|P2|COMPLETED|Overall Study||40
7729782|NCT01621776|19032237|P1|COMPLETED|Overall Study||41
7729783|NCT01621776|19032235|P3|STARTED|Overall Study||18
7729784|NCT01621776|19032236|P2|STARTED|Overall Study||40
7729785|NCT01621776|19032237|P1|STARTED|Overall Study||41
7729786|NCT01621737|19032251|P1|NOT COMPLETED|Overall Study||0
7729787|NCT01621737|19032251|P1|COMPLETED|Overall Study||0
7729788|NCT01621737|19032251|P1|STARTED|Overall Study||0
7729789|NCT01621672|19032271|P2|NOT COMPLETED|Overall Study||0
7729790|NCT01621672|19032272|P1|NOT COMPLETED|Overall Study||0
7729791|NCT01621672|19032271|P2|COMPLETED|Overall Study||17
7729792|NCT01621672|19032272|P1|COMPLETED|Overall Study||25
7729793|NCT01621672|19032271|P2|STARTED|Overall Study||17
7729794|NCT01621672|19032272|P1|STARTED|Overall Study||25
7729795|NCT01621633|19032282|P4|NOT COMPLETED|Overall Study||0
7729796|NCT01621633|19032283|P3|NOT COMPLETED|Overall Study||0
7729797|NCT01621633|19032284|P2|NOT COMPLETED|Overall Study||0
7729798|NCT01621633|19032285|P1|NOT COMPLETED|Overall Study||0
7729799|NCT01621633|19032282|P4|COMPLETED|Overall Study||8
7729800|NCT01621633|19032283|P3|COMPLETED|Overall Study||8
7729801|NCT01621633|19032284|P2|COMPLETED|Overall Study||8
7729802|NCT01621633|19032285|P1|COMPLETED|Overall Study||8
7729803|NCT01621633|19032282|P4|STARTED|Overall Study||8
7729804|NCT01621633|19032283|P3|STARTED|Overall Study||8
7729805|NCT01621633|19032284|P2|STARTED|Overall Study||8
7729806|NCT01621633|19032285|P1|STARTED|Overall Study||8
7729807|NCT01621542|19032313|P6|NOT COMPLETED|Overall Study||9
7729808|NCT01621542|19032314|P5|NOT COMPLETED|Overall Study||9
7729809|NCT01621542|19032315|P4|NOT COMPLETED|Overall Study||28
7729810|NCT01621542|19032316|P3|NOT COMPLETED|Overall Study||6
7729811|NCT01621542|19032317|P2|NOT COMPLETED|Overall Study||5
7729812|NCT01621542|19032318|P1|NOT COMPLETED|Overall Study||5
7729813|NCT01621542|19032313|P6|COMPLETED|Overall Study||0
7729814|NCT01621542|19032314|P5|COMPLETED|Overall Study||0
7729815|NCT01621542|19032315|P4|COMPLETED|Overall Study||0
7729816|NCT01621542|19032316|P3|COMPLETED|Overall Study||0
7729817|NCT01621542|19032317|P2|COMPLETED|Overall Study||0
7729818|NCT01621542|19032318|P1|COMPLETED|Overall Study||0
7729819|NCT01621542|19032313|P6|STARTED|Overall Study||9
7729820|NCT01621542|19032314|P5|STARTED|Overall Study||9
7729821|NCT01621542|19032315|P4|STARTED|Overall Study||28
7729822|NCT01621542|19032316|P3|STARTED|Overall Study||6
7729823|NCT01621542|19032317|P2|STARTED|Overall Study||5
7729824|NCT01621542|19032318|P1|STARTED|Overall Study||5
7729825|NCT01621490|19032359|P9|NOT COMPLETED|Overall Study||8
7729826|NCT01621490|19032360|P8|NOT COMPLETED|Overall Study||10
7729827|NCT01621490|19032361|P7|NOT COMPLETED|Overall Study||11
7729828|NCT01621490|19032362|P6|NOT COMPLETED|Overall Study||24
7729829|NCT01621490|19032363|P5|NOT COMPLETED|Overall Study||6
7729830|NCT01621490|19032364|P4|NOT COMPLETED|Overall Study||9
7729831|NCT01621490|19032365|P3|NOT COMPLETED|Overall Study||11
7729832|NCT01621490|19032366|P2|NOT COMPLETED|Overall Study||44
7729833|NCT01621490|19032367|P1|NOT COMPLETED|Overall Study||41
7729834|NCT01621490|19032359|P9|COMPLETED|Overall Study||2
7729835|NCT01621490|19032360|P8|COMPLETED|Overall Study||0
7729836|NCT01621490|19032361|P7|COMPLETED|Overall Study||0
7729837|NCT01621490|19032362|P6|COMPLETED|Overall Study||1
7729838|NCT01621490|19032363|P5|COMPLETED|Overall Study||0
7729839|NCT01621490|19032364|P4|COMPLETED|Overall Study||1
7729840|NCT01621490|19032365|P3|COMPLETED|Overall Study||0
7729841|NCT01621490|19032366|P2|COMPLETED|Overall Study||0
7729842|NCT01621490|19032367|P1|COMPLETED|Overall Study||0
7729843|NCT01621490|19032359|P9|STARTED|Overall Study||10
7729844|NCT01621490|19032360|P8|STARTED|Overall Study||10
7729845|NCT01621490|19032361|P7|STARTED|Overall Study||11
7729846|NCT01621490|19032362|P6|STARTED|Overall Study||25
7729847|NCT01621490|19032363|P5|STARTED|Overall Study||6
7729848|NCT01621490|19032364|P4|STARTED|Overall Study||10
7729849|NCT01621490|19032365|P3|STARTED|Overall Study||11
7729850|NCT01621490|19032366|P2|STARTED|Overall Study||44
7729851|NCT01621490|19032367|P1|STARTED|Overall Study||41
7729852|NCT01621477|19032593|P1|NOT COMPLETED|Overall Study||0
7729853|NCT01621477|19032593|P1|COMPLETED|Overall Study||17
7729854|NCT01621477|19032593|P1|STARTED|Overall Study||17
7729855|NCT01621230|19032605|P2|NOT COMPLETED|Overall Study||0
7729856|NCT01621230|19032606|P1|NOT COMPLETED|Overall Study||0
7729857|NCT01621230|19032605|P2|COMPLETED|Overall Study||156
7729858|NCT01621230|19032606|P1|COMPLETED|Overall Study||154
7729859|NCT01621230|19032605|P2|STARTED|Overall Study||156
7729860|NCT01621230|19032606|P1|STARTED|Overall Study||154
7729861|NCT01621191|19032619|P1|NOT COMPLETED|Overall Study||25
7729862|NCT01621191|19032619|P1|COMPLETED|Overall Study||124
7729863|NCT01621191|19032619|P1|Had at Least 1 Post-Baseline Observation|Overall Study||148
7729864|NCT01621191|19032619|P1|Received at Least 1 Dose of Study Drug|Overall Study||149
7729865|NCT01621191|19032619|P1|STARTED|Overall Study||149
7729866|NCT01621178|19032633|P3|NOT COMPLETED|Overall Study||36
7729867|NCT01621178|19032634|P2|NOT COMPLETED|Overall Study||30
7729868|NCT01621178|19032635|P1|NOT COMPLETED|Overall Study||31
7729869|NCT01621178|19032633|P3|COMPLETED|Overall Study||157
7729870|NCT01621178|19032634|P2|COMPLETED|Overall Study||160
7729871|NCT01621178|19032635|P1|COMPLETED|Overall Study||163
7729872|NCT01621178|19032633|P3|Modified Intent to Treat Population|Overall Study||183
7729873|NCT01621178|19032634|P2|Modified Intent to Treat Population|Overall Study||180
7729874|NCT01621178|19032635|P1|Modified Intent to Treat Population|Overall Study||186
7729875|NCT01621178|19032633|P3|Received at Least One Dose of Study Drug|Overall Study||192
7729876|NCT01621178|19032634|P2|Received at Least One Dose of Study Drug|Overall Study||190
7729877|NCT01621178|19032635|P1|Received at Least One Dose of Study Drug|Overall Study||194
7729878|NCT01621178|19032633|P3|STARTED|Overall Study||193
7729879|NCT01621178|19032634|P2|STARTED|Overall Study||190
7729880|NCT01621178|19032635|P1|STARTED|Overall Study||194
7729881|NCT01621126|19032727|P1|NOT COMPLETED|Overall Study||6
7729882|NCT01621126|19032727|P1|COMPLETED|Overall Study||34
7729883|NCT01621126|19032727|P1|STARTED|Overall Study||40
7729884|NCT01621009|19032735|P4|NOT COMPLETED|Overall Study||53
7729885|NCT01621009|19032736|P3|NOT COMPLETED|Overall Study||63
7729886|NCT01621009|19032737|P2|NOT COMPLETED|Overall Study||51
7729887|NCT01621009|19032738|P1|NOT COMPLETED|Overall Study||43
7729888|NCT01621009|19032735|P4|COMPLETED|Overall Study||60
7729889|NCT01621009|19032736|P3|COMPLETED|Overall Study||58
7729890|NCT01621009|19032737|P2|COMPLETED|Overall Study||65
7729891|NCT01621009|19032738|P1|COMPLETED|Overall Study||70
7729892|NCT01621009|19032735|P4|STARTED|Overall Study||113
7729893|NCT01621009|19032736|P3|STARTED|Overall Study||121
7729894|NCT01621009|19032737|P2|STARTED|Overall Study||116
7729895|NCT01621009|19032738|P1|STARTED|Overall Study||113
7729896|NCT01620983|19032749|P3|NOT COMPLETED|Overall Study||15
7729897|NCT01620983|19032750|P2|NOT COMPLETED|Overall Study||22
7729898|NCT01620983|19032751|P1|NOT COMPLETED|Overall Study||19
7729899|NCT01620983|19032749|P3|COMPLETED|Overall Study||122
7729900|NCT01620983|19032750|P2|COMPLETED|Overall Study||113
7729901|NCT01620983|19032751|P1|COMPLETED|Overall Study||111
7729902|NCT01620983|19032749|P3|STARTED|Overall Study||137
7729903|NCT01620983|19032750|P2|STARTED|Overall Study||135
7729904|NCT01620983|19032751|P1|STARTED|Overall Study||130
7729905|NCT01620762|19032780|P3|NOT COMPLETED|Overall Study||53
7729906|NCT01620762|19032781|P2|NOT COMPLETED|Overall Study||58
7729907|NCT01620762|19032782|P1|NOT COMPLETED|Overall Study||48
7729908|NCT01620762|19032780|P3|COMPLETED|Overall Study||417
7729909|NCT01620762|19032781|P2|COMPLETED|Overall Study||412
7729910|NCT01620762|19032782|P1|COMPLETED|Overall Study||420
7729911|NCT01620762|19032780|P3|STARTED|Overall Study||470
7729912|NCT01620762|19032781|P2|STARTED|Overall Study||470
7729913|NCT01620762|19032782|P1|STARTED|Overall Study||468
7729914|NCT01620593|19032810|P2|NOT COMPLETED|Overall Study||1
7729915|NCT01620593|19032811|P1|NOT COMPLETED|Overall Study||4
7729916|NCT01620593|19032810|P2|COMPLETED|Overall Study||19
7729917|NCT01620593|19032811|P1|COMPLETED|Overall Study||17
7729918|NCT01620593|19032810|P2|STARTED|Overall Study||20
7729919|NCT01620593|19032811|P1|STARTED|Overall Study||21
7729920|NCT01620567|19032827|P2|NOT COMPLETED|Overall Study||5
7729921|NCT01620567|19032828|P1|NOT COMPLETED|Overall Study||3
7729922|NCT01620567|19032827|P2|COMPLETED|Overall Study||20
7729923|NCT01620567|19032828|P1|COMPLETED|Overall Study||20
7729924|NCT01620567|19032827|P2|STARTED|Overall Study||25
7729925|NCT01620567|19032828|P1|STARTED|Overall Study||23
7729926|NCT01620528|19032843|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||14
7729927|NCT01620528|19032844|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||17
7729928|NCT01620528|19032845|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||20
7729929|NCT01620528|19032843|P3|COMPLETED|Post-Treatment Follow-Up Period||37
7729930|NCT01620528|19032844|P2|COMPLETED|Post-Treatment Follow-Up Period||31
7729931|NCT01620528|19032845|P1|COMPLETED|Post-Treatment Follow-Up Period||48
7729932|NCT01620528|19032843|P3|Completed PTFU Month 12|Post-Treatment Follow-Up Period||19
7729933|NCT01620528|19032844|P2|Completed PTFU Month 12|Post-Treatment Follow-Up Period||5
7729934|NCT01620528|19032845|P1|Completed PTFU Month 12|Post-Treatment Follow-Up Period||2
7729935|NCT01620528|19032843|P3|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|18
7729936|NCT01620528|19032844|P2|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|26
7729937|NCT01620528|19032845|P1|Completed PTFU Month 6|Post-Treatment Follow-Up Period||46
7729938|NCT01620528|19032843|P3|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|51
7729939|NCT01620528|19032844|P2|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|48
7729940|NCT01620528|19032845|P1|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|68
7729941|NCT01620528|19032843|P3|NOT COMPLETED|Treatment Period||66
7729942|NCT01620528|19032844|P2|NOT COMPLETED|Treatment Period||53
7729943|NCT01620528|19032845|P1|NOT COMPLETED|Treatment Period||100
7729944|NCT01620528|19032843|P3|COMPLETED|Treatment Period||183
7729945|NCT01620528|19032844|P2|COMPLETED|Treatment Period||196
7729946|NCT01620528|19032845|P1|COMPLETED|Treatment Period||274
7729947|NCT01620528|19032843|P3|STARTED|Treatment Period|1 subject did not receive study drug|249
7729948|NCT01620528|19032844|P2|STARTED|Treatment Period||249
7729949|NCT01620528|19032845|P1|STARTED|Treatment Period||374
7729950|NCT01620489|19033185|P2|NOT COMPLETED|Overall Study||34
7729951|NCT01620489|19033186|P1|NOT COMPLETED|Overall Study||35
7729952|NCT01620489|19033185|P2|COMPLETED|Overall Study|2 subjects did not take trial product|105
7729953|NCT01620489|19033186|P1|COMPLETED|Overall Study||105
7729954|NCT01620489|19033185|P2|Exposed|Overall Study|2 subjects did not take trial product|137
7729955|NCT01620489|19033186|P1|Exposed|Overall Study||140
7729956|NCT01620489|19033185|P2|STARTED|Overall Study||139
7729957|NCT01620489|19033186|P1|STARTED|Overall Study||140
7729958|NCT01620255|19033207|P5|NOT COMPLETED|Overall Study||6
7729959|NCT01620255|19033208|P4|NOT COMPLETED|Overall Study||3
7729960|NCT01620255|19033209|P3|NOT COMPLETED|Overall Study||2
7729961|NCT01620255|19033210|P2|NOT COMPLETED|Overall Study||6
7729962|NCT01620255|19033211|P1|NOT COMPLETED|Overall Study||4
7729963|NCT01620255|19033207|P5|COMPLETED|Overall Study||64
7729964|NCT01620255|19033208|P4|COMPLETED|Overall Study||70
7729965|NCT01620255|19033209|P3|COMPLETED|Overall Study||68
7729966|NCT01620255|19033210|P2|COMPLETED|Overall Study||65
7729967|NCT01620255|19033211|P1|COMPLETED|Overall Study||69
7729968|NCT01620255|19033207|P5|Treated|Overall Study||70
7729969|NCT01620255|19033208|P4|Treated|Overall Study||73
7729970|NCT01620255|19033209|P3|Treated|Overall Study||70
7729971|NCT01620255|19033210|P2|Treated|Overall Study||71
7729972|NCT01620255|19033211|P1|Treated|Overall Study||73
7729973|NCT01620255|19033207|P5|STARTED|Overall Study||70
7729974|NCT01620255|19033208|P4|STARTED|Overall Study||73
7729975|NCT01620255|19033209|P3|STARTED|Overall Study||70
7729976|NCT01620255|19033210|P2|STARTED|Overall Study||71
7729977|NCT01620255|19033211|P1|STARTED|Overall Study||73
7729978|NCT01620177|19033288|P1|NOT COMPLETED|Overall Study||79
7729979|NCT01620177|19033288|P1|COMPLETED|Overall Study||19
7729980|NCT01620177|19033288|P1|STARTED|Overall Study||98
7729981|NCT01620138|19033313|P2|NOT COMPLETED|Overall Study||0
7729982|NCT01620138|19033314|P1|NOT COMPLETED|Overall Study||6
7729983|NCT01620138|19033313|P2|COMPLETED|Overall Study||9
7729984|NCT01620138|19033314|P1|COMPLETED|Overall Study||6
7729985|NCT01620138|19033313|P2|STARTED|Overall Study||9
7729986|NCT01620138|19033314|P1|STARTED|Overall Study||12
7729987|NCT01620086|19033322|P3|NOT COMPLETED|Overall Study||0
7729988|NCT01620086|19033323|P2|NOT COMPLETED|Overall Study||7
7729989|NCT01620086|19033324|P1|NOT COMPLETED|Overall Study||5
7729990|NCT01620086|19033322|P3|COMPLETED|Overall Study||2
7729991|NCT01620086|19033323|P2|COMPLETED|Overall Study||4
7729992|NCT01620086|19033324|P1|COMPLETED|Overall Study||8
7729993|NCT01620086|19033322|P3|STARTED|Overall Study||2
7729994|NCT01620086|19033323|P2|STARTED|Overall Study||11
7729995|NCT01620086|19033324|P1|STARTED|Overall Study||13
7729996|NCT01620060|19033343|P1|NOT COMPLETED|Overall Study||15
7729997|NCT01620060|19033343|P1|COMPLETED|Overall Study||90
7729998|NCT01620060|19033343|P1|STARTED|Overall Study||105
7729999|NCT01620047|19033352|P3|NOT COMPLETED|Overall Study||0
7730000|NCT01620047|19033353|P2|NOT COMPLETED|Overall Study||0
7730001|NCT01620047|19033354|P1|NOT COMPLETED|Overall Study||0
7730002|NCT01620047|19033352|P3|COMPLETED|Overall Study||20
7730003|NCT01620047|19033353|P2|COMPLETED|Overall Study||20
7730004|NCT01620047|19033354|P1|COMPLETED|Overall Study||20
7730005|NCT01620047|19033352|P3|STARTED|Overall Study||20
7730006|NCT01620047|19033353|P2|STARTED|Overall Study||20
7730007|NCT01620047|19033354|P1|STARTED|Overall Study||20
7730008|NCT01619982|19033364|P2|NOT COMPLETED|Overall Study||0
7730009|NCT01619982|19033365|P1|NOT COMPLETED|Overall Study||0
7730010|NCT01619982|19033364|P2|COMPLETED|Overall Study||12
7730011|NCT01619982|19033365|P1|COMPLETED|Overall Study||20
7730012|NCT01619982|19033364|P2|STARTED|Overall Study||12
7730013|NCT01619982|19033365|P1|STARTED|Overall Study||20
7730014|NCT01619878|19033381|P1|NOT COMPLETED|Follow-up at 12 Months of Age||3
7730015|NCT01619878|19033381|P1|COMPLETED|Follow-up at 12 Months of Age||17
7730016|NCT01619878|19033381|P1|STARTED|Follow-up at 12 Months of Age||20
7730017|NCT01619878|19033381|P1|NOT COMPLETED|6 Week Follow-up Phase||1
7730018|NCT01619878|19033381|P1|COMPLETED|6 Week Follow-up Phase||19
7730019|NCT01619878|19033381|P1|STARTED|6 Week Follow-up Phase||20
7730020|NCT01619852|19033395|P2|NOT COMPLETED|3 Month Follow up||34
7730021|NCT01619852|19033396|P1|NOT COMPLETED|3 Month Follow up||31
7730022|NCT01619852|19033395|P2|COMPLETED|3 Month Follow up||40
7730023|NCT01619852|19033396|P1|COMPLETED|3 Month Follow up||43
7730024|NCT01619852|19033395|P2|STARTED|3 Month Follow up||74
7730025|NCT01619852|19033396|P1|STARTED|3 Month Follow up||74
7730026|NCT01619852|19033395|P2|NOT COMPLETED|24 Hour Assessment||1
7730027|NCT01619852|19033396|P1|NOT COMPLETED|24 Hour Assessment||1
7730028|NCT01619852|19033395|P2|COMPLETED|24 Hour Assessment||74
7730029|NCT01619852|19033396|P1|COMPLETED|24 Hour Assessment||74
7730030|NCT01619852|19033395|P2|STARTED|24 Hour Assessment||75
7730031|NCT01619852|19033396|P1|STARTED|24 Hour Assessment||75
7730032|NCT01619800|19033412|P2|NOT COMPLETED|Overall Study||0
7730033|NCT01619800|19033413|P1|NOT COMPLETED|Overall Study||2
7730034|NCT01619800|19033412|P2|COMPLETED|Overall Study||0
7730035|NCT01619800|19033413|P1|COMPLETED|Overall Study||0
7730036|NCT01619800|19033412|P2|STARTED|Overall Study||0
7730037|NCT01619800|19033413|P1|STARTED|Overall Study||2
7730038|NCT01619787|19033421|P1|NOT COMPLETED|Overall Study||5
7730039|NCT01619787|19033421|P1|COMPLETED|Overall Study||212
7730040|NCT01619787|19033421|P1|STARTED|Overall Study||217
7730041|NCT01619774|19033430|P1|NOT COMPLETED|Overall Study||0
7730042|NCT01619774|19033430|P1|COMPLETED|Overall Study||23
7730043|NCT01619774|19033430|P1|STARTED|Overall Study||23
7730044|NCT01619579|19033438|P2|NOT COMPLETED|Overall Study||3
7730045|NCT01619579|19033439|P1|NOT COMPLETED|Overall Study||0
7730046|NCT01619579|19033438|P2|COMPLETED|Overall Study||14
7730047|NCT01619579|19033439|P1|COMPLETED|Overall Study||5
7730048|NCT01619579|19033438|P2|STARTED|Overall Study||17
7730049|NCT01619579|19033439|P1|STARTED|Overall Study||5
7730050|NCT01619423|19033453|P4|NOT COMPLETED|Part 2b||0
7730051|NCT01619423|19033454|P3|NOT COMPLETED|Part 2b||0
7730052|NCT01619423|19033455|P2|NOT COMPLETED|Part 2b||0
7730053|NCT01619423|19033456|P1|NOT COMPLETED|Part 2b||0
7730054|NCT01619423|19033453|P4|COMPLETED|Part 2b||0
7730055|NCT01619423|19033454|P3|COMPLETED|Part 2b||45
7730056|NCT01619423|19033455|P2|COMPLETED|Part 2b||44
7730057|NCT01619423|19033456|P1|COMPLETED|Part 2b||45
7730058|NCT01619423|19033453|P4|STARTED|Part 2b||0
7730059|NCT01619423|19033454|P3|STARTED|Part 2b||45
7730060|NCT01619423|19033455|P2|STARTED|Part 2b||44
7730061|NCT01619423|19033456|P1|STARTED|Part 2b||45
7730062|NCT01619423|19033453|P4|NOT COMPLETED|Part 2a||0
7730063|NCT01619423|19033454|P3|NOT COMPLETED|Part 2a||0
7730064|NCT01619423|19033455|P2|NOT COMPLETED|Part 2a||0
7730065|NCT01619423|19033456|P1|NOT COMPLETED|Part 2a||0
7730066|NCT01619423|19033453|P4|COMPLETED|Part 2a||11
7730067|NCT01619423|19033454|P3|COMPLETED|Part 2a||0
7730068|NCT01619423|19033455|P2|COMPLETED|Part 2a||13
7730069|NCT01619423|19033456|P1|COMPLETED|Part 2a||15
7730070|NCT01619423|19033453|P4|STARTED|Part 2a||11
7730071|NCT01619423|19033454|P3|STARTED|Part 2a||0
7730072|NCT01619423|19033455|P2|STARTED|Part 2a||13
7730073|NCT01619423|19033456|P1|STARTED|Part 2a||15
7730074|NCT01619423|19033453|P4|NOT COMPLETED|Part 1 (Dose Escalation)||0
7730075|NCT01619423|19033454|P3|NOT COMPLETED|Part 1 (Dose Escalation)||0
7730076|NCT01619423|19033455|P2|NOT COMPLETED|Part 1 (Dose Escalation)||2
7730077|NCT01619423|19033456|P1|NOT COMPLETED|Part 1 (Dose Escalation)||0
7730078|NCT01619423|19033453|P4|COMPLETED|Part 1 (Dose Escalation)||5
7730079|NCT01619423|19033454|P3|COMPLETED|Part 1 (Dose Escalation)||3
7730080|NCT01619423|19033455|P2|COMPLETED|Part 1 (Dose Escalation)||3
7730081|NCT01619423|19033456|P1|COMPLETED|Part 1 (Dose Escalation)||0
7730082|NCT01619423|19033453|P4|STARTED|Part 1 (Dose Escalation)||5
7730083|NCT01619423|19033454|P3|STARTED|Part 1 (Dose Escalation)||3
7730084|NCT01619423|19033455|P2|STARTED|Part 1 (Dose Escalation)||5
7730085|NCT01619423|19033456|P1|STARTED|Part 1 (Dose Escalation)||0
7730086|NCT01619410|19033469|P2|NOT COMPLETED|Overall Study||4
7730087|NCT01619410|19033470|P1|NOT COMPLETED|Overall Study||7
7730088|NCT01619410|19033469|P2|COMPLETED|Overall Study||7
7730089|NCT01619410|19033470|P1|COMPLETED|Overall Study||7
7730090|NCT01619410|19033469|P2|STARTED|Overall Study||11
7730091|NCT01619410|19033470|P1|STARTED|Overall Study||14
7730092|NCT01619085|19033482|P1|NOT COMPLETED|Overall Study||369
7730093|NCT01619085|19033482|P1|COMPLETED|Overall Study|Total 341 patients did not complete the trial.|366
7730094|NCT01619085|19033482|P1|STARTED|Overall Study|27 patients were ongoing on trial at database lock. 1 patient was not treated with trial drugs.|735
7730095|NCT01619059|19033488|P2|NOT COMPLETED|Long-Term (LT) Treatment Period||9
7730096|NCT01619059|19033489|P1|NOT COMPLETED|Long-Term (LT) Treatment Period||8
7730097|NCT01619059|19033488|P2|COMPLETED|Long-Term (LT) Treatment Period||133
7730098|NCT01619059|19033489|P1|COMPLETED|Long-Term (LT) Treatment Period||147
7730099|NCT01619059|19033488|P2|STARTED|Long-Term (LT) Treatment Period||142
7730100|NCT01619059|19033489|P1|STARTED|Long-Term (LT) Treatment Period||155
7730101|NCT01619059|19033488|P2|NOT COMPLETED|Short-Term (ST) Treatment Period||11
7730102|NCT01619059|19033489|P1|NOT COMPLETED|Short-Term (ST) Treatment Period||6
7730103|NCT01619059|19033488|P2|COMPLETED|Short-Term (ST) Treatment Period||142
7730104|NCT01619059|19033489|P1|COMPLETED|Short-Term (ST) Treatment Period||156
7730105|NCT01619059|19033488|P2|STARTED|Short-Term (ST) Treatment Period||153
7730106|NCT01619059|19033489|P1|STARTED|Short-Term (ST) Treatment Period||162
7730107|NCT01618968|19033505|P4|NOT COMPLETED|Overall Study||1
7730108|NCT01618968|19033506|P3|NOT COMPLETED|Overall Study||0
7730109|NCT01618968|19033507|P2|NOT COMPLETED|Overall Study||0
7730110|NCT01618968|19033508|P1|NOT COMPLETED|Overall Study||1
7730111|NCT01618968|19033505|P4|COMPLETED|Overall Study||11
7730112|NCT01618968|19033506|P3|COMPLETED|Overall Study||12
7730113|NCT01618968|19033507|P2|COMPLETED|Overall Study||12
7730114|NCT01618968|19033508|P1|COMPLETED|Overall Study||12
7730115|NCT01618968|19033505|P4|Received Treatment C|Overall Study||11
7730116|NCT01618968|19033506|P3|Received Treatment C|Overall Study||12
7730117|NCT01618968|19033507|P2|Received Treatment C|Overall Study||12
7730118|NCT01618968|19033508|P1|Received Treatment C|Overall Study||12
7730119|NCT01618968|19033505|P4|Received Treatment B|Overall Study||12
7730120|NCT01618968|19033506|P3|Received Treatment B|Overall Study||12
7730121|NCT01618968|19033507|P2|Received Treatment B|Overall Study||12
7730122|NCT01618968|19033508|P1|Received Treatment B|Overall Study||13
7730123|NCT01618968|19033505|P4|Received Treatment A|Overall Study||11
7730124|NCT01618968|19033506|P3|Received Treatment A|Overall Study||12
7730125|NCT01618968|19033507|P2|Received Treatment A|Overall Study||12
7730126|NCT01618968|19033508|P1|Received Treatment A|Overall Study||12
7730127|NCT01618968|19033505|P4|STARTED|Overall Study||12
7730128|NCT01618968|19033506|P3|STARTED|Overall Study||12
7730129|NCT01618968|19033507|P2|STARTED|Overall Study||12
7730130|NCT01618968|19033508|P1|STARTED|Overall Study||13
7730131|NCT01618955|19033527|P4|NOT COMPLETED|Overall Study||0
7730132|NCT01618955|19033528|P3|NOT COMPLETED|Overall Study||0
7730133|NCT01618955|19033529|P2|NOT COMPLETED|Overall Study||0
7730134|NCT01618955|19033530|P1|NOT COMPLETED|Overall Study||0
7730135|NCT01618955|19033527|P4|COMPLETED|Overall Study||20
7730136|NCT01618955|19033528|P3|COMPLETED|Overall Study||31
7730137|NCT01618955|19033529|P2|COMPLETED|Overall Study||30
7730138|NCT01618955|19033530|P1|COMPLETED|Overall Study||20
7730139|NCT01618955|19033527|P4|STARTED|Overall Study||20
7730140|NCT01618955|19033528|P3|STARTED|Overall Study||31
7730141|NCT01618955|19033529|P2|STARTED|Overall Study||30
7730142|NCT01618955|19033530|P1|STARTED|Overall Study||20
7730143|NCT01618942|19033554|P2|NOT COMPLETED|Overall Study||0
7730144|NCT01618942|19033555|P1|NOT COMPLETED|Overall Study||0
7730145|NCT01618942|19033554|P2|COMPLETED|Overall Study||50
7730146|NCT01618942|19033555|P1|COMPLETED|Overall Study||50
7730147|NCT01618942|19033554|P2|STARTED|Overall Study||50
7730148|NCT01618942|19033555|P1|STARTED|Overall Study||50
7730149|NCT01618916|19033581|P6|NOT COMPLETED|Overall Study||0
7730150|NCT01618916|19033582|P5|NOT COMPLETED|Overall Study||1
7730151|NCT01618916|19033583|P4|NOT COMPLETED|Overall Study||2
7730152|NCT01618916|19033584|P3|NOT COMPLETED|Overall Study||1
7730153|NCT01618916|19033585|P2|NOT COMPLETED|Overall Study||1
7730154|NCT01618916|19033586|P1|NOT COMPLETED|Overall Study||2
7730155|NCT01618916|19033581|P6|COMPLETED|Overall Study||4
7730156|NCT01618916|19033582|P5|COMPLETED|Overall Study||4
7730157|NCT01618916|19033583|P4|COMPLETED|Overall Study||7
7730158|NCT01618916|19033584|P3|COMPLETED|Overall Study||10
7730159|NCT01618916|19033585|P2|COMPLETED|Overall Study||9
7730160|NCT01618916|19033586|P1|COMPLETED|Overall Study||10
7730161|NCT01618916|19033581|P6|Received At Least 1 Dose of Study Drug|Overall Study||4
7730162|NCT01618916|19033582|P5|Received At Least 1 Dose of Study Drug|Overall Study||5
7730163|NCT01618916|19033583|P4|Received At Least 1 Dose of Study Drug|Overall Study||9
7730164|NCT01618916|19033584|P3|Received At Least 1 Dose of Study Drug|Overall Study||11
7730165|NCT01618916|19033585|P2|Received At Least 1 Dose of Study Drug|Overall Study||10
7730166|NCT01618916|19033586|P1|Received At Least 1 Dose of Study Drug|Overall Study||12
7730167|NCT01618916|19033581|P6|STARTED|Overall Study||4
7730168|NCT01618916|19033582|P5|STARTED|Overall Study||5
7730169|NCT01618916|19033583|P4|STARTED|Overall Study||9
7730170|NCT01618916|19033584|P3|STARTED|Overall Study||11
7730171|NCT01618916|19033585|P2|STARTED|Overall Study||10
7730172|NCT01618916|19033586|P1|STARTED|Overall Study||12
7730173|NCT01618864|19033616|P1|NOT COMPLETED|Overall Study||4
7730174|NCT01618864|19033616|P1|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19
7730175|NCT01618864|19033616|P1|Completed 2 Weeks|Overall Study||19
7730176|NCT01618864|19033616|P1|STARTED|Overall Study||23
7730177|NCT01618838|19033625|P1|NOT COMPLETED|Overall Study||4
7730178|NCT01618838|19033625|P1|COMPLETED|Overall Study||0
7730179|NCT01618838|19033625|P1|STARTED|Overall Study||4
7730180|NCT01618708|19033633|P2|NOT COMPLETED|Overall Study||46
7730181|NCT01618708|19033634|P1|NOT COMPLETED|Overall Study||44
7730182|NCT01618708|19033633|P2|COMPLETED|Overall Study||136
7730183|NCT01618708|19033634|P1|COMPLETED|Overall Study||131
7730184|NCT01618708|19033633|P2|Treated|Overall Study||180
7730185|NCT01618708|19033634|P1|Treated|Overall Study||172
7730186|NCT01618708|19033633|P2|STARTED|Overall Study||182
7730187|NCT01618708|19033634|P1|STARTED|Overall Study||175
7730188|NCT01618695|19033650|P4|NOT COMPLETED|Overall Study||36
7730189|NCT01618695|19033651|P3|NOT COMPLETED|Overall Study||30
7730190|NCT01618695|19033652|P2|NOT COMPLETED|Overall Study||20
7730191|NCT01618695|19033653|P1|NOT COMPLETED|Overall Study||25
7730192|NCT01618695|19033650|P4|COMPLETED|Overall Study||144
7730193|NCT01618695|19033651|P3|COMPLETED|Overall Study||147
7730194|NCT01618695|19033652|P2|COMPLETED|Overall Study||156
7730195|NCT01618695|19033653|P1|COMPLETED|Overall Study||152
7730196|NCT01618695|19033650|P4|Treated (Safety Analysis Set)|Overall Study||180
7730197|NCT01618695|19033651|P3|Treated (Safety Analysis Set)|Overall Study||175
7730198|NCT01618695|19033652|P2|Treated (Safety Analysis Set)|Overall Study||176
7730199|NCT01618695|19033653|P1|Treated (Safety Analysis Set)|Overall Study||176
7730200|NCT01618695|19033650|P4|STARTED|Overall Study||180
7730201|NCT01618695|19033651|P3|STARTED|Overall Study||177
7730202|NCT01618695|19033652|P2|STARTED|Overall Study||176
7730203|NCT01618695|19033653|P1|STARTED|Overall Study||177
7730204|NCT01618669|19033677|P2|NOT COMPLETED|Overall Study||23
7730205|NCT01618669|19033678|P1|NOT COMPLETED|Overall Study||34
7730206|NCT01618669|19033677|P2|COMPLETED|Overall Study||546
7730207|NCT01618669|19033678|P1|COMPLETED|Overall Study||544
7730208|NCT01618669|19033677|P2|Received Treatment|Overall Study||567
7730209|NCT01618669|19033678|P1|Received Treatment|Overall Study||575
7730210|NCT01618669|19033677|P2|STARTED|Overall Study||569
7730211|NCT01618669|19033678|P1|STARTED|Overall Study||578
7730212|NCT01618422|19033724|P2|NOT COMPLETED|Overall Study||0
7730213|NCT01618422|19033725|P1|NOT COMPLETED|Overall Study||0
7730214|NCT01618422|19033724|P2|COMPLETED|Overall Study||111
7730215|NCT01618422|19033725|P1|COMPLETED|Overall Study||114
7730216|NCT01618422|19033724|P2|STARTED|Overall Study||111
7730217|NCT01618422|19033725|P1|STARTED|Overall Study||114
7730218|NCT01618344|19033731|P1|NOT COMPLETED|Overall Study||9
7730219|NCT01618344|19033731|P1|COMPLETED|Overall Study||23
7730220|NCT01618344|19033731|P1|STARTED|Overall Study||32
7730221|NCT01618305|19033737|P2|NOT COMPLETED|Overall Study||10
7730222|NCT01618305|19033738|P1|NOT COMPLETED|Overall Study||15
7730223|NCT01618305|19033737|P2|COMPLETED|Overall Study||196
7730224|NCT01618305|19033738|P1|COMPLETED|Overall Study||187
7730225|NCT01618305|19033737|P2|STARTED|Overall Study||206
7730226|NCT01618305|19033738|P1|STARTED|Overall Study||202
7730227|NCT01618266|19033780|P1|NOT COMPLETED|Overall Study||96
7730228|NCT01618266|19033780|P1|COMPLETED|Overall Study||279
7730229|NCT01618266|19033780|P1|STARTED|Overall Study||375
7730230|NCT01618240|19033795|P1|NOT COMPLETED|Overall Study||0
7730231|NCT01618240|19033795|P1|COMPLETED|Overall Study||30
7730232|NCT01618240|19033795|P1|STARTED|Overall Study||30
7730233|NCT01618227|19033802|P2|NOT COMPLETED|Overall Study||2
7730234|NCT01618227|19033803|P1|NOT COMPLETED|Overall Study||0
7730235|NCT01618227|19033802|P2|COMPLETED|Overall Study||0
7730236|NCT01618227|19033803|P1|COMPLETED|Overall Study||2
7730237|NCT01618227|19033802|P2|STARTED|Overall Study||2
7730238|NCT01618227|19033803|P1|STARTED|Overall Study||2
7730239|NCT01618214|19033817|P2|NOT COMPLETED|Overall Study||13
7730240|NCT01618214|19033818|P1|NOT COMPLETED|Overall Study||10
7730241|NCT01618214|19033817|P2|COMPLETED|Overall Study||159
7730242|NCT01618214|19033818|P1|COMPLETED|Overall Study||162
7730243|NCT01618214|19033817|P2|Exposed|Overall Study||172
7730244|NCT01618214|19033818|P1|Exposed|Overall Study||172
7730245|NCT01618214|19033817|P2|STARTED|Overall Study||172
7730246|NCT01618214|19033818|P1|STARTED|Overall Study||172
7730247|NCT01618162|19033834|P2|NOT COMPLETED|Overall Study||35
7730248|NCT01618162|19033835|P1|NOT COMPLETED|Overall Study||38
7730249|NCT01618162|19033834|P2|COMPLETED|Overall Study||111
7730250|NCT01618162|19033835|P1|COMPLETED|Overall Study||251
7730251|NCT01618162|19033834|P2|Exposed|Overall Study||146
7730252|NCT01618162|19033835|P1|Exposed|Overall Study||288
7730253|NCT01618162|19033834|P2|STARTED|Overall Study||146
7730254|NCT01618162|19033835|P1|STARTED|Overall Study||289
7730255|NCT01618019|19033855|P2|NOT COMPLETED|Overall Study||14
7730256|NCT01618019|19033856|P1|NOT COMPLETED|Overall Study||14
7730257|NCT01618019|19033855|P2|COMPLETED|Overall Study||40
7730258|NCT01618019|19033856|P1|COMPLETED|Overall Study||41
7730259|NCT01618019|19033855|P2|STARTED|Overall Study||54
7730260|NCT01618019|19033856|P1|STARTED|Overall Study||55
7730261|NCT01617967|19033882|P6|NOT COMPLETED|Overall Study||1
7730262|NCT01617967|19033883|P5|NOT COMPLETED|Overall Study||0
7730263|NCT01617967|19033884|P4|NOT COMPLETED|Overall Study||1
7730264|NCT01617967|19033885|P3|NOT COMPLETED|Overall Study||0
7730265|NCT01617967|19033886|P2|NOT COMPLETED|Overall Study||0
7730266|NCT01617967|19033887|P1|NOT COMPLETED|Overall Study||1
7730267|NCT01617967|19033882|P6|COMPLETED|Overall Study||8
7730268|NCT01617967|19033883|P5|COMPLETED|Overall Study||3
7730269|NCT01617967|19033884|P4|COMPLETED|Overall Study||6
7730270|NCT01617967|19033885|P3|COMPLETED|Overall Study||3
7730271|NCT01617967|19033886|P2|COMPLETED|Overall Study||3
7730272|NCT01617967|19033887|P1|COMPLETED|Overall Study||3
7730273|NCT01617967|19033882|P6|STARTED|Overall Study||9
7730274|NCT01617967|19033883|P5|STARTED|Overall Study||3
7730275|NCT01617967|19033884|P4|STARTED|Overall Study||7
7730276|NCT01617967|19033885|P3|STARTED|Overall Study||3
7730277|NCT01617967|19033886|P2|STARTED|Overall Study||3
7730278|NCT01617967|19033887|P1|STARTED|Overall Study||4
7730279|NCT01617681|19033941|P5|NOT COMPLETED|Period 2 Open Label||6
7730280|NCT01617681|19033942|P4|NOT COMPLETED|Period 2 Open Label||0
7730281|NCT01617681|19033943|P3|NOT COMPLETED|Period 2 Open Label||0
7730282|NCT01617681|19033944|P2|NOT COMPLETED|Period 2 Open Label||0
7730283|NCT01617681|19033945|P1|NOT COMPLETED|Period 2 Open Label||0
7730284|NCT01617681|19033941|P5|COMPLETED|Period 2 Open Label||114
7730285|NCT01617681|19033942|P4|COMPLETED|Period 2 Open Label||0
7730286|NCT01617681|19033943|P3|COMPLETED|Period 2 Open Label||0
7730287|NCT01617681|19033944|P2|COMPLETED|Period 2 Open Label||0
7730288|NCT01617681|19033945|P1|COMPLETED|Period 2 Open Label||0
7730289|NCT01617681|19033941|P5|STARTED|Period 2 Open Label||120
7730290|NCT01617681|19033942|P4|STARTED|Period 2 Open Label||0
7730291|NCT01617681|19033943|P3|STARTED|Period 2 Open Label||0
7730292|NCT01617681|19033944|P2|STARTED|Period 2 Open Label||0
7730293|NCT01617681|19033945|P1|STARTED|Period 2 Open Label||0
7730294|NCT01617681|19033941|P5|NOT COMPLETED|Period 1 Double Blind||0
7730295|NCT01617681|19033942|P4|NOT COMPLETED|Period 1 Double Blind||2
7730296|NCT01617681|19033943|P3|NOT COMPLETED|Period 1 Double Blind||1
7730297|NCT01617681|19033944|P2|NOT COMPLETED|Period 1 Double Blind||1
7730298|NCT01617681|19033945|P1|NOT COMPLETED|Period 1 Double Blind||3
7730299|NCT01617681|19033941|P5|COMPLETED|Period 1 Double Blind||0
7730300|NCT01617681|19033942|P4|COMPLETED|Period 1 Double Blind||29
7730301|NCT01617681|19033943|P3|COMPLETED|Period 1 Double Blind||32
7730302|NCT01617681|19033944|P2|COMPLETED|Period 1 Double Blind||30
7730303|NCT01617681|19033945|P1|COMPLETED|Period 1 Double Blind||29
7730304|NCT01617681|19033941|P5|Full Analysis Set (FAS)|Period 1 Double Blind||0
7730305|NCT01617681|19033942|P4|Full Analysis Set (FAS)|Period 1 Double Blind||31
7730306|NCT01617681|19033943|P3|Full Analysis Set (FAS)|Period 1 Double Blind||33
7730307|NCT01617681|19033944|P2|Full Analysis Set (FAS)|Period 1 Double Blind||31
7730308|NCT01617681|19033945|P1|Full Analysis Set (FAS)|Period 1 Double Blind||31
7730309|NCT01617681|19033941|P5|STARTED|Period 1 Double Blind||0
7730310|NCT01617681|19033942|P4|STARTED|Period 1 Double Blind||31
7730311|NCT01617681|19033943|P3|STARTED|Period 1 Double Blind||33
7730312|NCT01617681|19033944|P2|STARTED|Period 1 Double Blind||31
7730313|NCT01617681|19033945|P1|STARTED|Period 1 Double Blind||32
7730314|NCT01617668|19033966|P4|NOT COMPLETED|Overall Study||15
7730315|NCT01617668|19033967|P3|NOT COMPLETED|Overall Study||23
7730316|NCT01617668|19033968|P2|NOT COMPLETED|Overall Study||9
7730317|NCT01617668|19033969|P1|NOT COMPLETED|Overall Study||13
7730318|NCT01617668|19033966|P4|COMPLETED|Overall Study||38
7730319|NCT01617668|19033967|P3|COMPLETED|Overall Study||32
7730320|NCT01617668|19033968|P2|COMPLETED|Overall Study||41
7730321|NCT01617668|19033969|P1|COMPLETED|Overall Study||38
7730322|NCT01617668|19033966|P4|Randomized Patients|Overall Study||55
7730323|NCT01617668|19033967|P3|Randomized Patients|Overall Study||55
7730324|NCT01617668|19033968|P2|Randomized Patients|Overall Study||54
7730325|NCT01617668|19033969|P1|Randomized Patients|Overall Study||51
7730326|NCT01617668|19033966|P4|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53
7730327|NCT01617668|19033967|P3|STARTED|Overall Study||55
7730328|NCT01617668|19033968|P2|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50
7730329|NCT01617668|19033969|P1|STARTED|Overall Study||51
7730330|NCT01617655|19034010|P2|NOT COMPLETED|Overall Study||29
7730331|NCT01617655|19034011|P1|NOT COMPLETED|Overall Study||9
7730332|NCT01617655|19034010|P2|COMPLETED|Overall Study||43
7730333|NCT01617655|19034011|P1|COMPLETED|Overall Study||26
7730334|NCT01617655|19034010|P2|Treated|Overall Study||72
7730335|NCT01617655|19034011|P1|Treated|Overall Study||35
7730336|NCT01617655|19034010|P2|STARTED|Overall Study|Randomized|72
7730337|NCT01617655|19034011|P1|STARTED|Overall Study|Randomized|35
7730338|NCT01617629|19034071|P1|NOT COMPLETED|Overall Study||6
7730339|NCT01617629|19034071|P1|COMPLETED|Overall Study||3
7730340|NCT01617629|19034071|P1|STARTED|Overall Study||9
7730341|NCT01617603|19034079|P3|NOT COMPLETED|Overall Study||1
7730342|NCT01617603|19034080|P2|NOT COMPLETED|Overall Study||2
7730343|NCT01617603|19034081|P1|NOT COMPLETED|Overall Study||3
7730344|NCT01617603|19034079|P3|COMPLETED|Overall Study||20
7730345|NCT01617603|19034080|P2|COMPLETED|Overall Study||19
7730346|NCT01617603|19034081|P1|COMPLETED|Overall Study||17
7730347|NCT01617603|19034079|P3|STARTED|Overall Study||21
7730348|NCT01617603|19034080|P2|STARTED|Overall Study||21
7730349|NCT01617603|19034081|P1|STARTED|Overall Study||20
7730350|NCT01617577|19034091|P2|NOT COMPLETED|Overall Study||0
7730351|NCT01617577|19034092|P1|NOT COMPLETED|Overall Study||0
7730352|NCT01617577|19034091|P2|COMPLETED|Overall Study||3
7730353|NCT01617577|19034092|P1|COMPLETED|Overall Study||5
7730354|NCT01617577|19034091|P2|STARTED|Overall Study||3
7730355|NCT01617577|19034092|P1|STARTED|Overall Study||5
7730356|NCT01617460|19034099|P1|NOT COMPLETED|Overall Study||40
7730357|NCT01617460|19034099|P1|COMPLETED|Overall Study||46
7730358|NCT01617460|19034099|P1|STARTED|Overall Study||86
7730359|NCT01617447|19034105|P2|NOT COMPLETED|Overall Study||3
7730360|NCT01617447|19034106|P1|NOT COMPLETED|Overall Study||0
7730361|NCT01617447|19034105|P2|COMPLETED|Overall Study||42
7730362|NCT01617447|19034106|P1|COMPLETED|Overall Study||47
7730363|NCT01617447|19034105|P2|STARTED|Overall Study||45
7730364|NCT01617447|19034106|P1|STARTED|Overall Study||47
7730365|NCT01617434|19034114|P2|NOT COMPLETED|Overall Study||51
7730366|NCT01617434|19034115|P1|NOT COMPLETED|Overall Study||35
7730367|NCT01617434|19034114|P2|COMPLETED|Overall Study||174
7730368|NCT01617434|19034115|P1|COMPLETED|Overall Study||191
7730369|NCT01617434|19034114|P2|Exposed|Overall Study||225
7730370|NCT01617434|19034115|P1|Exposed|Overall Study||225
7730371|NCT01617434|19034114|P2|STARTED|Overall Study||225
7730372|NCT01617434|19034115|P1|STARTED|Overall Study||226
7730373|NCT01617421|19034137|P1|NOT COMPLETED|Overall Study||6
7730374|NCT01617421|19034137|P1|COMPLETED|Overall Study||12
7730375|NCT01617421|19034137|P1|STARTED|Overall Study||18
7730376|NCT01617369|19034144|P1|NOT COMPLETED|Overall Study||0
7730377|NCT01617369|19034144|P1|COMPLETED|Overall Study||12
7730378|NCT01617369|19034144|P1|STARTED|Overall Study||12
7730379|NCT01617187|19034154|P4|NOT COMPLETED|Treatment Through Study Completion||10
7730380|NCT01617187|19034155|P3|NOT COMPLETED|Treatment Through Study Completion||5
7730381|NCT01617187|19034156|P2|NOT COMPLETED|Treatment Through Study Completion||11
7730382|NCT01617187|19034157|P1|NOT COMPLETED|Treatment Through Study Completion||11
7730383|NCT01617187|19034154|P4|COMPLETED|Treatment Through Study Completion||91
7730384|NCT01617187|19034155|P3|COMPLETED|Treatment Through Study Completion||41
7730385|NCT01617187|19034156|P2|COMPLETED|Treatment Through Study Completion||102
7730386|NCT01617187|19034157|P1|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86
7730387|NCT01617187|19034154|P4|STARTED|Treatment Through Study Completion|Treated|101
7730388|NCT01617187|19034155|P3|STARTED|Treatment Through Study Completion|Treated|46
7730389|NCT01617187|19034156|P2|STARTED|Treatment Through Study Completion|Treated|113
7730390|NCT01617187|19034157|P1|STARTED|Treatment Through Study Completion|Treated|97
7730391|NCT01617187|19034154|P4|NOT COMPLETED|Randomization Through Start Treatment||2
7730392|NCT01617187|19034155|P3|NOT COMPLETED|Randomization Through Start Treatment||0
7730393|NCT01617187|19034156|P2|NOT COMPLETED|Randomization Through Start Treatment||0
7730394|NCT01617187|19034157|P1|NOT COMPLETED|Randomization Through Start Treatment||1
7730395|NCT01617187|19034154|P4|COMPLETED|Randomization Through Start Treatment||101
7730396|NCT01617187|19034155|P3|COMPLETED|Randomization Through Start Treatment||46
7730397|NCT01617187|19034156|P2|COMPLETED|Randomization Through Start Treatment||113
7730398|NCT01617187|19034157|P1|COMPLETED|Randomization Through Start Treatment||97
7730399|NCT01617187|19034154|P4|STARTED|Randomization Through Start Treatment|Randomized|103
7730400|NCT01617187|19034155|P3|STARTED|Randomization Through Start Treatment|Randomized|46
7730401|NCT01617187|19034156|P2|STARTED|Randomization Through Start Treatment|Randomized|113
7730402|NCT01617187|19034157|P1|STARTED|Randomization Through Start Treatment|Randomized|98
7730403|NCT01617148|19034227|P1|NOT COMPLETED|Overall Study||0
7730404|NCT01617148|19034227|P1|COMPLETED|Overall Study||26
7730405|NCT01617148|19034227|P1|STARTED|Overall Study||26
7730406|NCT01617083|19034241|P3|NOT COMPLETED|Overall Study||0
7730407|NCT01617083|19034242|P2|NOT COMPLETED|Overall Study||0
7730408|NCT01617083|19034243|P1|NOT COMPLETED|Overall Study||0
7730409|NCT01617083|19034241|P3|COMPLETED|Overall Study||15
7730410|NCT01617083|19034242|P2|COMPLETED|Overall Study||14
7730411|NCT01617083|19034243|P1|COMPLETED|Overall Study||18
7730412|NCT01617083|19034241|P3|STARTED|Overall Study||15
7730413|NCT01617083|19034242|P2|STARTED|Overall Study||14
7730414|NCT01617083|19034243|P1|STARTED|Overall Study||18
7730415|NCT01617070|19034254|P1|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1
7730416|NCT01617070|19034254|P1|COMPLETED|BH4 and LNAA (4 Weeks)||9
7730417|NCT01617070|19034254|P1|STARTED|BH4 and LNAA (4 Weeks)||10
7730418|NCT01617070|19034254|P1|NOT COMPLETED|BH4 Therapy (4 Weeks)||0
7730419|NCT01617070|19034254|P1|COMPLETED|BH4 Therapy (4 Weeks)||10
7730420|NCT01617070|19034254|P1|STARTED|BH4 Therapy (4 Weeks)||10
7730421|NCT01617070|19034254|P1|NOT COMPLETED|Washout (4 Weeks)||0
7730422|NCT01617070|19034254|P1|COMPLETED|Washout (4 Weeks)||10
7730423|NCT01617070|19034254|P1|STARTED|Washout (4 Weeks)||10
7730424|NCT01617070|19034254|P1|NOT COMPLETED|LNAA (4 Weeks)||0
7730425|NCT01617070|19034254|P1|COMPLETED|LNAA (4 Weeks)||10
7730426|NCT01617070|19034254|P1|STARTED|LNAA (4 Weeks)||10
7730427|NCT01617005|19034272|P1|NOT COMPLETED|Overall Study||2
7730428|NCT01617005|19034272|P1|COMPLETED|Overall Study||48
7730429|NCT01617005|19034272|P1|STARTED|Overall Study||50
7730430|NCT01616953|19034281|P2|NOT COMPLETED|Overall Study||0
7730431|NCT01616953|19034282|P1|NOT COMPLETED|Overall Study||2
7730432|NCT01616953|19034281|P2|COMPLETED|Overall Study||8
7730433|NCT01616953|19034282|P1|COMPLETED|Overall Study||8
7730434|NCT01616953|19034281|P2|6 Months Post-loading|Overall Study||8
7730435|NCT01616953|19034282|P1|6 Months Post-loading|Overall Study||8
7730436|NCT01616953|19034281|P2|Implant Uncovery|Overall Study||8
7730437|NCT01616953|19034282|P1|Implant Uncovery|Overall Study||8
7730438|NCT01616953|19034281|P2|Implant Placement Surgery|Overall Study||8
7730439|NCT01616953|19034282|P1|Implant Placement Surgery|Overall Study||9
7730440|NCT01616953|19034281|P2|STARTED|Overall Study||8
7730441|NCT01616953|19034282|P1|STARTED|Overall Study||10
7730442|NCT01616771|19034290|P1|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4
7730443|NCT01616771|19034290|P1|COMPLETED|Smaller Sized GVL for 5 Sec||19
7730444|NCT01616771|19034290|P1|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23
7730445|NCT01616771|19034290|P1|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0
7730446|NCT01616771|19034290|P1|COMPLETED|GVL Selected by Weight for 5 Sec||23
7730447|NCT01616771|19034290|P1|STARTED|GVL Selected by Weight for 5 Sec||23
7730448|NCT01616771|19034290|P1|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0
7730449|NCT01616771|19034290|P1|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23
7730450|NCT01616771|19034290|P1|STARTED|Macintosh Laryngoscopy for 5 Sec||23
7730451|NCT01616693|19034303|P4|NOT COMPLETED|Blood Analyzed for Immunogenicity||1
7730452|NCT01616693|19034304|P3|NOT COMPLETED|Blood Analyzed for Immunogenicity||6
7730453|NCT01616693|19034305|P2|NOT COMPLETED|Blood Analyzed for Immunogenicity||2
7730454|NCT01616693|19034306|P1|NOT COMPLETED|Blood Analyzed for Immunogenicity||4
7730455|NCT01616693|19034303|P4|COMPLETED|Blood Analyzed for Immunogenicity||135
7730456|NCT01616693|19034304|P3|COMPLETED|Blood Analyzed for Immunogenicity||136
7730457|NCT01616693|19034305|P2|COMPLETED|Blood Analyzed for Immunogenicity||143
7730458|NCT01616693|19034306|P1|COMPLETED|Blood Analyzed for Immunogenicity||137
7730459|NCT01616693|19034303|P4|STARTED|Blood Analyzed for Immunogenicity||136
7730460|NCT01616693|19034304|P3|STARTED|Blood Analyzed for Immunogenicity||142
7730461|NCT01616693|19034305|P2|STARTED|Blood Analyzed for Immunogenicity||145
7730462|NCT01616693|19034306|P1|STARTED|Blood Analyzed for Immunogenicity||141
7730463|NCT01616693|19034303|P4|NOT COMPLETED|Received Both Vaccines||19
7730464|NCT01616693|19034304|P3|NOT COMPLETED|Received Both Vaccines||12
7730465|NCT01616693|19034305|P2|NOT COMPLETED|Received Both Vaccines||10
7730466|NCT01616693|19034306|P1|NOT COMPLETED|Received Both Vaccines||13
7730467|NCT01616693|19034303|P4|COMPLETED|Received Both Vaccines||136
7730468|NCT01616693|19034304|P3|COMPLETED|Received Both Vaccines||142
7730469|NCT01616693|19034305|P2|COMPLETED|Received Both Vaccines||145
7730470|NCT01616693|19034306|P1|COMPLETED|Received Both Vaccines||141
7730471|NCT01616693|19034303|P4|STARTED|Received Both Vaccines||155
7730472|NCT01616693|19034304|P3|STARTED|Received Both Vaccines||154
7730473|NCT01616693|19034305|P2|STARTED|Received Both Vaccines||155
7730474|NCT01616693|19034306|P1|STARTED|Received Both Vaccines||154
7730475|NCT01616693|19034303|P4|NOT COMPLETED|Evaluated for Safety||0
7730476|NCT01616693|19034304|P3|NOT COMPLETED|Evaluated for Safety||1
7730477|NCT01616693|19034305|P2|NOT COMPLETED|Evaluated for Safety||0
7730478|NCT01616693|19034306|P1|NOT COMPLETED|Evaluated for Safety||1
7730479|NCT01616693|19034303|P4|COMPLETED|Evaluated for Safety||155
7730480|NCT01616693|19034304|P3|COMPLETED|Evaluated for Safety||154
7730481|NCT01616693|19034305|P2|COMPLETED|Evaluated for Safety||155
7730482|NCT01616693|19034306|P1|COMPLETED|Evaluated for Safety||154
7730483|NCT01616693|19034303|P4|STARTED|Evaluated for Safety||155
7730484|NCT01616693|19034304|P3|STARTED|Evaluated for Safety||155
7730485|NCT01616693|19034305|P2|STARTED|Evaluated for Safety||155
7730486|NCT01616693|19034306|P1|STARTED|Evaluated for Safety||155
7730487|NCT01616576|19034358|P2|NOT COMPLETED|Overall Study||0
7730488|NCT01616576|19034359|P1|NOT COMPLETED|Overall Study||0
7730489|NCT01616576|19034358|P2|COMPLETED|Overall Study||18
7730490|NCT01616576|19034359|P1|COMPLETED|Overall Study||18
7730491|NCT01616576|19034358|P2|STARTED|Overall Study||18
7730492|NCT01616576|19034359|P1|STARTED|Overall Study||18
7730493|NCT01616459|19034372|P4|NOT COMPLETED|Overall Study||8
7730494|NCT01616459|19034373|P3|NOT COMPLETED|Overall Study||10
7730495|NCT01616459|19034374|P2|NOT COMPLETED|Overall Study||17
7730496|NCT01616459|19034375|P1|NOT COMPLETED|Overall Study||4
7730497|NCT01616459|19034372|P4|COMPLETED|Overall Study||233
7730498|NCT01616459|19034373|P3|COMPLETED|Overall Study||220
7730499|NCT01616459|19034374|P2|COMPLETED|Overall Study||223
7730500|NCT01616459|19034375|P1|COMPLETED|Overall Study||236
7730501|NCT01616459|19034372|P4|STARTED|Overall Study||241
7730502|NCT01616459|19034373|P3|STARTED|Overall Study||230
7730503|NCT01616459|19034374|P2|STARTED|Overall Study||240
7730504|NCT01616459|19034375|P1|STARTED|Overall Study||240
7730505|NCT01616173|19034476|P3|NOT COMPLETED|Overall Study||0
7730506|NCT01616173|19034477|P2|NOT COMPLETED|Overall Study||2
7730507|NCT01616173|19034478|P1|NOT COMPLETED|Overall Study||0
7730508|NCT01616173|19034476|P3|COMPLETED|Overall Study||27
7730509|NCT01616173|19034477|P2|COMPLETED|Overall Study||24
7730510|NCT01616173|19034478|P1|COMPLETED|Overall Study||27
7730511|NCT01616173|19034476|P3|STARTED|Overall Study||27
7730512|NCT01616173|19034477|P2|STARTED|Overall Study||26
7730513|NCT01616173|19034478|P1|STARTED|Overall Study||27
7730514|NCT01616160|19034492|P1|NOT COMPLETED|Overall Study||2
7730515|NCT01616160|19034492|P1|COMPLETED|Overall Study||9
7730516|NCT01616160|19034492|P1|STARTED|Overall Study||11
7730517|NCT01616082|19034499|P2|NOT COMPLETED|Overall Study||2
7730518|NCT01616082|19034500|P1|NOT COMPLETED|Overall Study||0
7730519|NCT01616082|19034499|P2|COMPLETED|Overall Study||18
7730520|NCT01616082|19034500|P1|COMPLETED|Overall Study||19
7730521|NCT01616082|19034499|P2|STARTED|Overall Study||20
7730522|NCT01616082|19034500|P1|STARTED|Overall Study||19
7730523|NCT01616056|19034510|P1|NOT COMPLETED|Overall Study||1
7730524|NCT01616056|19034510|P1|COMPLETED|Overall Study||19
7730525|NCT01616056|19034510|P1|STARTED|Overall Study||20
7730526|NCT01615939|19034524|P2|NOT COMPLETED|Overall Study||0
7730527|NCT01615939|19034525|P1|NOT COMPLETED|Overall Study||5
7730528|NCT01615939|19034524|P2|COMPLETED|Overall Study||4
7730529|NCT01615939|19034525|P1|COMPLETED|Overall Study||8
7730530|NCT01615939|19034524|P2|STARTED|Overall Study||4
7730531|NCT01615939|19034525|P1|STARTED|Overall Study||13
7730532|NCT01615822|19034538|P3|NOT COMPLETED|Period 2||2
7730533|NCT01615822|19034539|P2|NOT COMPLETED|Period 2||1
7730534|NCT01615822|19034540|P1|NOT COMPLETED|Period 2||0
7730535|NCT01615822|19034538|P3|COMPLETED|Period 2||4
7730536|NCT01615822|19034539|P2|COMPLETED|Period 2||8
7730537|NCT01615822|19034540|P1|COMPLETED|Period 2||7
7730538|NCT01615822|19034538|P3|STARTED|Period 2||6
7730539|NCT01615822|19034539|P2|STARTED|Period 2||9
7730540|NCT01615822|19034540|P1|STARTED|Period 2||7
7730541|NCT01615822|19034538|P3|NOT COMPLETED|Period 1||0
7730542|NCT01615822|19034539|P2|NOT COMPLETED|Period 1||2
7730543|NCT01615822|19034540|P1|NOT COMPLETED|Period 1||1
7730544|NCT01615822|19034538|P3|COMPLETED|Period 1||6
7730545|NCT01615822|19034539|P2|COMPLETED|Period 1||9
7730546|NCT01615822|19034540|P1|COMPLETED|Period 1||7
7730547|NCT01615822|19034538|P3|STARTED|Period 1||6
7730548|NCT01615822|19034539|P2|STARTED|Period 1||11
7730549|NCT01615822|19034540|P1|STARTED|Period 1||8
7730550|NCT01615809|19034557|P1|NOT COMPLETED|Overall Study||10
7730551|NCT01615809|19034557|P1|COMPLETED|Overall Study||22
7730552|NCT01615809|19034557|P1|STARTED|Overall Study|basal visit|32
7730553|NCT01615731|19034565|P2|NOT COMPLETED|Overall Study||2
7730554|NCT01615731|19034566|P1|NOT COMPLETED|Overall Study||3
7730555|NCT01615731|19034565|P2|COMPLETED|Overall Study||24
7730556|NCT01615731|19034566|P1|COMPLETED|Overall Study||21
7730557|NCT01615731|19034565|P2|STARTED|Overall Study||26
7730558|NCT01615731|19034566|P1|STARTED|Overall Study||24
7730559|NCT01615484|19034588|P2|NOT COMPLETED|Overall Study||0
7730560|NCT01615484|19034589|P1|NOT COMPLETED|Overall Study||0
7730561|NCT01615484|19034588|P2|COMPLETED|Overall Study||24
7730562|NCT01615484|19034589|P1|COMPLETED|Overall Study||0
7730563|NCT01615484|19034588|P2|STARTED|Overall Study||24
7730564|NCT01615484|19034589|P1|STARTED|Overall Study||0
7730565|NCT01615367|19034607|P2|NOT COMPLETED|Overall Study||6
7730566|NCT01615367|19034608|P1|NOT COMPLETED|Overall Study||5
7730567|NCT01615367|19034607|P2|COMPLETED|Overall Study|11 TAU participants chose to participate in NEW Tx after the completion of the waitlist period.|13
7730568|NCT01615367|19034608|P1|COMPLETED|Overall Study||14
7730569|NCT01615367|19034607|P2|STARTED|Overall Study||19
7730570|NCT01615367|19034608|P1|STARTED|Overall Study||19
7730571|NCT01615328|19034628|P2|NOT COMPLETED|Overall Study||5
7730572|NCT01615328|19034629|P1|NOT COMPLETED|Overall Study||3
7730573|NCT01615328|19034628|P2|COMPLETED|Overall Study||38
7730574|NCT01615328|19034629|P1|COMPLETED|Overall Study||39
7730575|NCT01615328|19034628|P2|STARTED|Overall Study||43
7730576|NCT01615328|19034629|P1|STARTED|Overall Study||42
7730577|NCT01615263|19034641|P2|NOT COMPLETED|Overall Study||2
7730578|NCT01615263|19034642|P1|NOT COMPLETED|Overall Study||0
7730579|NCT01615263|19034641|P2|COMPLETED|Overall Study||18
7730580|NCT01615263|19034642|P1|COMPLETED|Overall Study||20
7730581|NCT01615263|19034641|P2|STARTED|Overall Study||20
7730582|NCT01615263|19034642|P1|STARTED|Overall Study||20
7730583|NCT01615198|19034656|P2|NOT COMPLETED|Overall Study||19
7730584|NCT01615198|19034657|P1|NOT COMPLETED|Overall Study||24
7730585|NCT01615198|19034656|P2|COMPLETED|Overall Study||273
7730586|NCT01615198|19034657|P1|COMPLETED|Overall Study||272
7730587|NCT01615198|19034656|P2|ABPM Dipper Status Subset|Overall Study||84
7730588|NCT01615198|19034657|P1|ABPM Dipper Status Subset|Overall Study||82
7730589|NCT01615198|19034656|P2|Safety Set|Overall Study||292
7730590|NCT01615198|19034657|P1|Safety Set|Overall Study||296
7730591|NCT01615198|19034656|P2|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157
7730592|NCT01615198|19034657|P1|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154
7730593|NCT01615198|19034656|P2|Full Analysis Set|Overall Study||292
7730594|NCT01615198|19034657|P1|Full Analysis Set|Overall Study||296
7730595|NCT01615198|19034656|P2|STARTED|Overall Study||292
7730596|NCT01615198|19034657|P1|STARTED|Overall Study||296
7730597|NCT01615029|19034690|P5|NOT COMPLETED|Overall Study||32
7730598|NCT01615029|19034691|P4|NOT COMPLETED|Overall Study||3
7730599|NCT01615029|19034692|P3|NOT COMPLETED|Overall Study||4
7730600|NCT01615029|19034693|P2|NOT COMPLETED|Overall Study||3
7730601|NCT01615029|19034694|P1|NOT COMPLETED|Overall Study||3
7730602|NCT01615029|19034690|P5|COMPLETED|Overall Study||0
7730603|NCT01615029|19034691|P4|COMPLETED|Overall Study||0
7730604|NCT01615029|19034692|P3|COMPLETED|Overall Study||0
7730605|NCT01615029|19034693|P2|COMPLETED|Overall Study||0
7730606|NCT01615029|19034694|P1|COMPLETED|Overall Study||0
7730607|NCT01615029|19034690|P5|STARTED|Overall Study||32
7730608|NCT01615029|19034691|P4|STARTED|Overall Study||3
7730609|NCT01615029|19034692|P3|STARTED|Overall Study||4
7730610|NCT01615029|19034693|P2|STARTED|Overall Study||3
7730611|NCT01615029|19034694|P1|STARTED|Overall Study||3
7730612|NCT01614912|19034715|P1|NOT COMPLETED|Overall Study||125
7730613|NCT01614912|19034715|P1|COMPLETED|Overall Study||159
7730614|NCT01614912|19034715|P1|STARTED|Overall Study||284
7730615|NCT01614899|19034729|P3|NOT COMPLETED|Overall Study||42
7730616|NCT01614899|19034730|P2|NOT COMPLETED|Overall Study||39
7730617|NCT01614899|19034731|P1|NOT COMPLETED|Overall Study||44
7730618|NCT01614899|19034729|P3|COMPLETED|Overall Study||110
7730619|NCT01614899|19034730|P2|COMPLETED|Overall Study||116
7730620|NCT01614899|19034731|P1|COMPLETED|Overall Study||106
7730621|NCT01614899|19034729|P3|STARTED|Overall Study||152
7730622|NCT01614899|19034730|P2|STARTED|Overall Study||155
7730623|NCT01614899|19034731|P1|STARTED|Overall Study||150
7730624|NCT01614886|19034762|P2|NOT COMPLETED|Overall Study||26
7730625|NCT01614886|19034763|P1|NOT COMPLETED|Overall Study||20
7730626|NCT01614886|19034762|P2|COMPLETED|Overall Study||83
7730627|NCT01614886|19034763|P1|COMPLETED|Overall Study||87
7730628|NCT01614886|19034762|P2|Full Analysis Set (FAS)|Overall Study||105
7730629|NCT01614886|19034763|P1|Full Analysis Set (FAS)|Overall Study||104
7730630|NCT01614886|19034762|P2|Safety Population (SAF)|Overall Study||108
7730631|NCT01614886|19034763|P1|Safety Population (SAF)|Overall Study||107
7730632|NCT01614886|19034762|P2|STARTED|Overall Study||109
7730633|NCT01614886|19034763|P1|STARTED|Overall Study||107
7730634|NCT01614847|19034779|P2|NOT COMPLETED|Day 2 (24 Hours Later)||0
7730635|NCT01614847|19034780|P1|NOT COMPLETED|Day 2 (24 Hours Later)||0
7730636|NCT01614847|19034779|P2|COMPLETED|Day 2 (24 Hours Later)||4
7730637|NCT01614847|19034780|P1|COMPLETED|Day 2 (24 Hours Later)||4
7730638|NCT01614847|19034779|P2|STARTED|Day 2 (24 Hours Later)|On Day 2, these subjects received Drop A (hyaluronate).|4
7730639|NCT01614847|19034780|P1|STARTED|Day 2 (24 Hours Later)|On Day 2, these subject will received Drop B (normal saline).|4
7730640|NCT01614847|19034779|P2|NOT COMPLETED|Day 1||0
7730641|NCT01614847|19034780|P1|NOT COMPLETED|Day 1||0
7730642|NCT01614847|19034779|P2|COMPLETED|Day 1|See Arm 1 comments.|4
7730643|NCT01614847|19034780|P1|COMPLETED|Day 1||4
7730644|NCT01614847|19034779|P2|STARTED|Day 1|The other 4 subjects, not to Group 1, received Drop B (saline) on Day 1.|4
7730645|NCT01614847|19034780|P1|STARTED|Day 1|Four subjects chosen at random received Drop A (hyaluronate) during Day 1.|4
7730646|NCT01614821|19034791|P1|NOT COMPLETED|Overall Study||0
7730647|NCT01614821|19034791|P1|COMPLETED|Overall Study||63
7730648|NCT01614821|19034791|P1|STARTED|Overall Study||63
7730649|NCT01614795|19034804|P4|NOT COMPLETED|Overall Study||12
7730650|NCT01614795|19034805|P3|NOT COMPLETED|Overall Study||11
7730651|NCT01614795|19034806|P2|NOT COMPLETED|Overall Study||12
7730652|NCT01614795|19034807|P1|NOT COMPLETED|Overall Study||11
7730653|NCT01614795|19034804|P4|COMPLETED|Overall Study||0
7730654|NCT01614795|19034805|P3|COMPLETED|Overall Study||0
7730655|NCT01614795|19034806|P2|COMPLETED|Overall Study||0
7730656|NCT01614795|19034807|P1|COMPLETED|Overall Study||0
7730657|NCT01614795|19034804|P4|STARTED|Overall Study||12
7730658|NCT01614795|19034805|P3|STARTED|Overall Study||11
7730659|NCT01614795|19034806|P2|STARTED|Overall Study||12
7730660|NCT01614795|19034807|P1|STARTED|Overall Study||11
7730661|NCT01614769|19034827|P6|NOT COMPLETED|Period 3||0
7730662|NCT01614769|19034828|P5|NOT COMPLETED|Period 3||0
7730663|NCT01614769|19034829|P4|NOT COMPLETED|Period 3||0
7730664|NCT01614769|19034830|P3|NOT COMPLETED|Period 3||1
7730665|NCT01614769|19034831|P2|NOT COMPLETED|Period 3||0
7730666|NCT01614769|19034832|P1|NOT COMPLETED|Period 3||0
7730667|NCT01614769|19034827|P6|COMPLETED|Period 3||1
7730668|NCT01614769|19034828|P5|COMPLETED|Period 3||1
7730669|NCT01614769|19034829|P4|COMPLETED|Period 3||0
7730670|NCT01614769|19034830|P3|COMPLETED|Period 3||1
7730671|NCT01614769|19034831|P2|COMPLETED|Period 3||1
7730672|NCT01614769|19034832|P1|COMPLETED|Period 3||1
7730673|NCT01614769|19034827|P6|STARTED|Period 3||1
7730674|NCT01614769|19034828|P5|STARTED|Period 3||1
7730675|NCT01614769|19034829|P4|STARTED|Period 3||0
7730676|NCT01614769|19034830|P3|STARTED|Period 3||2
7730677|NCT01614769|19034831|P2|STARTED|Period 3||1
7730678|NCT01614769|19034832|P1|STARTED|Period 3||1
7730679|NCT01614769|19034827|P6|NOT COMPLETED|7-Day Washout||0
7730680|NCT01614769|19034828|P5|NOT COMPLETED|7-Day Washout||0
7730681|NCT01614769|19034829|P4|NOT COMPLETED|7-Day Washout||0
7730682|NCT01614769|19034830|P3|NOT COMPLETED|7-Day Washout||0
7730683|NCT01614769|19034831|P2|NOT COMPLETED|7-Day Washout||0
7730684|NCT01614769|19034832|P1|NOT COMPLETED|7-Day Washout||0
7730685|NCT01614769|19034827|P6|COMPLETED|7-Day Washout||1
7730686|NCT01614769|19034828|P5|COMPLETED|7-Day Washout||1
7730687|NCT01614769|19034829|P4|COMPLETED|7-Day Washout||0
7730688|NCT01614769|19034830|P3|COMPLETED|7-Day Washout||2
7730689|NCT01614769|19034831|P2|COMPLETED|7-Day Washout||1
7730690|NCT01614769|19034832|P1|COMPLETED|7-Day Washout||1
7730691|NCT01614769|19034827|P6|STARTED|7-Day Washout||1
7730692|NCT01614769|19034828|P5|STARTED|7-Day Washout||1
7730693|NCT01614769|19034829|P4|STARTED|7-Day Washout||0
7730694|NCT01614769|19034830|P3|STARTED|7-Day Washout||2
7730695|NCT01614769|19034831|P2|STARTED|7-Day Washout||1
7730696|NCT01614769|19034832|P1|STARTED|7-Day Washout||1
7730697|NCT01614769|19034827|P6|NOT COMPLETED|Period 2||0
7730698|NCT01614769|19034828|P5|NOT COMPLETED|Period 2||0
7730699|NCT01614769|19034829|P4|NOT COMPLETED|Period 2||0
7730700|NCT01614769|19034830|P3|NOT COMPLETED|Period 2||0
7730701|NCT01614769|19034831|P2|NOT COMPLETED|Period 2||0
7730702|NCT01614769|19034832|P1|NOT COMPLETED|Period 2||0
7730703|NCT01614769|19034827|P6|COMPLETED|Period 2||1
7730704|NCT01614769|19034828|P5|COMPLETED|Period 2||1
7730705|NCT01614769|19034829|P4|COMPLETED|Period 2||0
7730706|NCT01614769|19034830|P3|COMPLETED|Period 2||2
7730707|NCT01614769|19034831|P2|COMPLETED|Period 2||1
7730708|NCT01614769|19034832|P1|COMPLETED|Period 2||1
7730709|NCT01614769|19034827|P6|STARTED|Period 2||1
7730710|NCT01614769|19034828|P5|STARTED|Period 2||1
7730711|NCT01614769|19034829|P4|STARTED|Period 2||0
7730712|NCT01614769|19034830|P3|STARTED|Period 2||2
7730713|NCT01614769|19034831|P2|STARTED|Period 2||1
7730714|NCT01614769|19034832|P1|STARTED|Period 2||1
7730715|NCT01614769|19034827|P6|NOT COMPLETED|7-Day Washout||0
7730716|NCT01614769|19034828|P5|NOT COMPLETED|7-Day Washout||0
7730717|NCT01614769|19034829|P4|NOT COMPLETED|7-Day Washout||0
7730718|NCT01614769|19034830|P3|NOT COMPLETED|7-Day Washout||0
7730719|NCT01614769|19034831|P2|NOT COMPLETED|7-Day Washout||0
7730720|NCT01614769|19034832|P1|NOT COMPLETED|7-Day Washout||0
7730721|NCT01614769|19034827|P6|COMPLETED|7-Day Washout||1
7730722|NCT01614769|19034828|P5|COMPLETED|7-Day Washout||1
7730723|NCT01614769|19034829|P4|COMPLETED|7-Day Washout||0
7730724|NCT01614769|19034830|P3|COMPLETED|7-Day Washout||2
7730725|NCT01614769|19034831|P2|COMPLETED|7-Day Washout||1
7730726|NCT01614769|19034832|P1|COMPLETED|7-Day Washout||1
7730727|NCT01614769|19034827|P6|STARTED|7-Day Washout||1
7730728|NCT01614769|19034828|P5|STARTED|7-Day Washout||1
7730729|NCT01614769|19034829|P4|STARTED|7-Day Washout||0
7730730|NCT01614769|19034830|P3|STARTED|7-Day Washout||2
7730731|NCT01614769|19034831|P2|STARTED|7-Day Washout||1
7730732|NCT01614769|19034832|P1|STARTED|7-Day Washout||1
7730733|NCT01614769|19034827|P6|NOT COMPLETED|Period 1||1
7730734|NCT01614769|19034828|P5|NOT COMPLETED|Period 1||0
7730735|NCT01614769|19034829|P4|NOT COMPLETED|Period 1||2
7730736|NCT01614769|19034830|P3|NOT COMPLETED|Period 1||0
7730737|NCT01614769|19034831|P2|NOT COMPLETED|Period 1||0
7730738|NCT01614769|19034832|P1|NOT COMPLETED|Period 1||1
7730739|NCT01614769|19034827|P6|COMPLETED|Period 1||1
7730740|NCT01614769|19034828|P5|COMPLETED|Period 1||1
7730741|NCT01614769|19034829|P4|COMPLETED|Period 1||0
7730742|NCT01614769|19034830|P3|COMPLETED|Period 1||2
7730743|NCT01614769|19034831|P2|COMPLETED|Period 1||1
7730744|NCT01614769|19034832|P1|COMPLETED|Period 1||1
7730745|NCT01614769|19034827|P6|STARTED|Period 1||2
7730746|NCT01614769|19034828|P5|STARTED|Period 1||1
7730747|NCT01614769|19034829|P4|STARTED|Period 1||2
7730748|NCT01614769|19034830|P3|STARTED|Period 1||2
7730749|NCT01614769|19034831|P2|STARTED|Period 1||1
7730750|NCT01614769|19034832|P1|STARTED|Period 1||2
7730751|NCT01614743|19034848|P2|NOT COMPLETED|Overall Study||0
7730752|NCT01614743|19034849|P1|NOT COMPLETED|Overall Study||1
7730753|NCT01614743|19034848|P2|COMPLETED|Overall Study|Subject in the placebo group (5) also received the treatment (IncobotulinumtoxinA) at Visit 5.|5
7730754|NCT01614743|19034849|P1|COMPLETED|Overall Study||3
7730755|NCT01614743|19034848|P2|STARTED|Overall Study||5
7730756|NCT01614743|19034849|P1|STARTED|Overall Study||4
7730757|NCT01614613|19034861|P1|NOT COMPLETED|Overall Study||0
7730758|NCT01614613|19034861|P1|COMPLETED|Overall Study||146
7730759|NCT01614613|19034861|P1|STARTED|Overall Study||146
7730760|NCT01614600|19034869|P1|NOT COMPLETED|Overall Study||4
7730761|NCT01614600|19034869|P1|COMPLETED|Overall Study||84
7730762|NCT01614600|19034869|P1|STARTED|Overall Study||88
7730763|NCT01614574|19034873|P1|NOT COMPLETED|Overall Study||0
7730764|NCT01614574|19034873|P1|COMPLETED|Overall Study||6
7730765|NCT01614574|19034873|P1|STARTED|Overall Study||6
7730766|NCT01614509|19034889|P2|NOT COMPLETED|Overall Study||3
7730767|NCT01614509|19034890|P1|NOT COMPLETED|Overall Study||1
7730768|NCT01614509|19034889|P2|COMPLETED|Overall Study||18
7730769|NCT01614509|19034890|P1|COMPLETED|Overall Study||23
7730770|NCT01614509|19034889|P2|STARTED|Overall Study||21
7730771|NCT01614509|19034890|P1|STARTED|Overall Study||24
7730772|NCT01614470|19034900|P3|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
7730773|NCT01614470|19034901|P2|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
7730774|NCT01614470|19034902|P1|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
7730775|NCT01614470|19034900|P3|COMPLETED|Part 2: Open-label Period (16 Weeks)||36
7730776|NCT01614470|19034901|P2|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
7730777|NCT01614470|19034902|P1|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
7730778|NCT01614470|19034900|P3|STARTED|Part 2: Open-label Period (16 Weeks)||36
7730779|NCT01614470|19034901|P2|STARTED|Part 2: Open-label Period (16 Weeks)||0
7730780|NCT01614470|19034902|P1|STARTED|Part 2: Open-label Period (16 Weeks)||0
7730781|NCT01614470|19034900|P3|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
7730782|NCT01614470|19034901|P2|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
7730783|NCT01614470|19034902|P1|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
7730784|NCT01614470|19034900|P3|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
7730785|NCT01614470|19034901|P2|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
7730786|NCT01614470|19034902|P1|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
7730787|NCT01614470|19034900|P3|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0
7730788|NCT01614470|19034901|P2|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
7730789|NCT01614470|19034902|P1|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
7730790|NCT01614470|19034900|P3|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
7730791|NCT01614470|19034901|P2|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
7730792|NCT01614470|19034902|P1|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
7730793|NCT01614470|19034900|P3|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
7730794|NCT01614470|19034901|P2|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
7730795|NCT01614470|19034902|P1|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
7730796|NCT01614470|19034900|P3|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0
7730797|NCT01614470|19034901|P2|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
7730798|NCT01614470|19034902|P1|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
7730799|NCT01614470|19034900|P3|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
7730800|NCT01614470|19034901|P2|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1
7730801|NCT01614470|19034902|P1|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2
7730802|NCT01614470|19034900|P3|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
7730803|NCT01614470|19034901|P2|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
7730804|NCT01614470|19034902|P1|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
7730805|NCT01614470|19034900|P3|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0
7730806|NCT01614470|19034901|P2|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19
7730807|NCT01614470|19034902|P1|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20
7730808|NCT01614457|19034924|P2|NOT COMPLETED|Overall Study||0
7730809|NCT01614457|19034925|P1|NOT COMPLETED|Overall Study||2
7730810|NCT01614457|19034924|P2|COMPLETED|Overall Study||35
7730811|NCT01614457|19034925|P1|COMPLETED|Overall Study||32
7730812|NCT01614457|19034924|P2|STARTED|Overall Study||35
7730813|NCT01614457|19034925|P1|STARTED|Overall Study||34
7730814|NCT01614392|19034943|P2|NOT COMPLETED|Overall Study||3
7730815|NCT01614392|19034944|P1|NOT COMPLETED|Overall Study||1
7730816|NCT01614392|19034943|P2|COMPLETED|Overall Study||24
7730817|NCT01614392|19034944|P1|COMPLETED|Overall Study||24
7730818|NCT01614392|19034943|P2|STARTED|Overall Study||27
7730819|NCT01614392|19034944|P1|STARTED|Overall Study||25
7730820|NCT01614249|19034952|P2|NOT COMPLETED|Overall Study||23
7730821|NCT01614249|19034953|P1|NOT COMPLETED|Overall Study||11
7730822|NCT01614249|19034952|P2|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86
7730823|NCT01614249|19034953|P1|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96
7730824|NCT01614249|19034952|P2|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86
7730825|NCT01614249|19034953|P1|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96
7730826|NCT01614249|19034952|P2|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92
7730827|NCT01614249|19034953|P1|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98
7730828|NCT01614249|19034952|P2|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109
7730829|NCT01614249|19034953|P1|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107
7730830|NCT01614210|19034959|P1|NOT COMPLETED|Overall Study||0
7730831|NCT01614210|19034959|P1|COMPLETED|Overall Study||52
7730832|NCT01614210|19034959|P1|STARTED|Overall Study||52
7730833|NCT01614093|19034967|P1|NOT COMPLETED|Overall Study||1
7730834|NCT01614093|19034967|P1|COMPLETED|Overall Study||16
7730835|NCT01614093|19034967|P1|STARTED|Overall Study||17
7730836|NCT01613768|19034972|P1|NOT COMPLETED|Overall Study||0
7730837|NCT01613768|19034972|P1|COMPLETED|Overall Study||29
7730838|NCT01613768|19034972|P1|STARTED|Overall Study||29
7730839|NCT01613716|19034980|P1|NOT COMPLETED|Overall Study||7
7730840|NCT01613716|19034980|P1|COMPLETED|Overall Study||23
7730841|NCT01613716|19034980|P1|STARTED|Overall Study||30
7730842|NCT01613599|19034985|P1|NOT COMPLETED|Overall Study||25
7730843|NCT01613599|19034985|P1|COMPLETED|Overall Study||72
7730844|NCT01613599|19034985|P1|STARTED|Overall Study||97
7730845|NCT01613417|19035000|P2|NOT COMPLETED|Second Injection||0
7730846|NCT01613417|19035001|P1|NOT COMPLETED|Second Injection||0
7730847|NCT01613417|19035000|P2|COMPLETED|Second Injection||109
7730848|NCT01613417|19035001|P1|COMPLETED|Second Injection||100
7730849|NCT01613417|19035000|P2|STARTED|Second Injection||109
7730850|NCT01613417|19035001|P1|STARTED|Second Injection||100
7730851|NCT01613417|19035000|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||7
7730852|NCT01613417|19035001|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||13
7730853|NCT01613417|19035000|P2|COMPLETED|Washout (no Second Injection/MRI)||109
7730854|NCT01613417|19035001|P1|COMPLETED|Washout (no Second Injection/MRI)||100
7730855|NCT01613417|19035000|P2|STARTED|Washout (no Second Injection/MRI)||116
7730856|NCT01613417|19035001|P1|STARTED|Washout (no Second Injection/MRI)||113
7730857|NCT01613417|19035000|P2|NOT COMPLETED|First Injection||0
7730858|NCT01613417|19035001|P1|NOT COMPLETED|First Injection||0
7730859|NCT01613417|19035000|P2|COMPLETED|First Injection||116
7730860|NCT01613417|19035001|P1|COMPLETED|First Injection||113
7730861|NCT01613417|19035000|P2|STARTED|First Injection||116
7730862|NCT01613417|19035001|P1|STARTED|First Injection||113
7730863|NCT01613378|19035038|P1|NOT COMPLETED|Overall Study||39
7730864|NCT01613378|19035038|P1|COMPLETED|Overall Study||161
7730865|NCT01613378|19035038|P1|STARTED|Overall Study||200
7730866|NCT01613339|19035056|P2|NOT COMPLETED|Overall Study||1
7730867|NCT01613339|19035057|P1|NOT COMPLETED|Overall Study||3
7730868|NCT01613339|19035056|P2|COMPLETED|Overall Study||21
7730869|NCT01613339|19035057|P1|COMPLETED|Overall Study||21
7730870|NCT01613339|19035056|P2|STARTED|Overall Study||22
7730871|NCT01613339|19035057|P1|STARTED|Overall Study||24
7730872|NCT01613326|19035068|P2|NOT COMPLETED|Overall Study||14
7730873|NCT01613326|19035069|P1|NOT COMPLETED|Overall Study||13
7730874|NCT01613326|19035068|P2|COMPLETED|Overall Study||316
7730875|NCT01613326|19035069|P1|COMPLETED|Overall Study||314
7730876|NCT01613326|19035068|P2|STARTED|Overall Study||330
7730877|NCT01613326|19035069|P1|STARTED|Overall Study||327
7730878|NCT01613313|19035103|P4|NOT COMPLETED|Overall Study||0
7730879|NCT01613313|19035104|P3|NOT COMPLETED|Overall Study||0
7730880|NCT01613313|19035105|P2|NOT COMPLETED|Overall Study||0
7730881|NCT01613313|19035106|P1|NOT COMPLETED|Overall Study||0
7730882|NCT01613313|19035103|P4|COMPLETED|Overall Study||4
7730883|NCT01613313|19035104|P3|COMPLETED|Overall Study||4
7730884|NCT01613313|19035105|P2|COMPLETED|Overall Study||4
7730885|NCT01613313|19035106|P1|COMPLETED|Overall Study||2
7730886|NCT01613313|19035103|P4|STARTED|Overall Study||4
7730887|NCT01613313|19035104|P3|STARTED|Overall Study||4
7730888|NCT01613313|19035105|P2|STARTED|Overall Study||4
7730889|NCT01613313|19035106|P1|STARTED|Overall Study||2
7730890|NCT01613248|19035126|P6|NOT COMPLETED|Overall Study||38
7730891|NCT01613248|19035127|P5|NOT COMPLETED|Overall Study||35
7730892|NCT01613248|19035128|P4|NOT COMPLETED|Overall Study||38
7730893|NCT01613248|19035129|P3|NOT COMPLETED|Overall Study||33
7730894|NCT01613248|19035130|P2|NOT COMPLETED|Overall Study||34
7730895|NCT01613248|19035131|P1|NOT COMPLETED|Overall Study||29
7730896|NCT01613248|19035126|P6|COMPLETED|Overall Study||102
7730897|NCT01613248|19035127|P5|COMPLETED|Overall Study||104
7730898|NCT01613248|19035128|P4|COMPLETED|Overall Study||101
7730899|NCT01613248|19035129|P3|COMPLETED|Overall Study||106
7730900|NCT01613248|19035130|P2|COMPLETED|Overall Study||104
7730901|NCT01613248|19035131|P1|COMPLETED|Overall Study||110
7730902|NCT01613248|19035126|P6|STARTED|Overall Study||140
7730903|NCT01613248|19035127|P5|STARTED|Overall Study||139
7730904|NCT01613248|19035128|P4|STARTED|Overall Study||139
7730905|NCT01613248|19035129|P3|STARTED|Overall Study||139
7730906|NCT01613248|19035130|P2|STARTED|Overall Study||138
7730907|NCT01613248|19035131|P1|STARTED|Overall Study||139
7730908|NCT01613222|19035229|P1|NOT COMPLETED|Overall Study||12
7730909|NCT01613222|19035229|P1|COMPLETED|Overall Study||51
7730910|NCT01613222|19035229|P1|STARTED|Overall Study||63
7730911|NCT01613131|19035244|P2|NOT COMPLETED|Overall Study||5
7730912|NCT01613131|19035245|P1|NOT COMPLETED|Overall Study||3
7730913|NCT01613131|19035244|P2|COMPLETED|Overall Study||13
7730914|NCT01613131|19035245|P1|COMPLETED|Overall Study||17
7730915|NCT01613131|19035244|P2|STARTED|Overall Study||18
7730916|NCT01613131|19035245|P1|STARTED|Overall Study||20
7730917|NCT01613027|19035273|P1|NOT COMPLETED|Overall Study||8
7730918|NCT01613027|19035273|P1|COMPLETED|Overall Study||127
7730919|NCT01613027|19035273|P1|STARTED|Overall Study||135
7730920|NCT01613014|19035294|P2|NOT COMPLETED|Overall Study||12
7730921|NCT01613014|19035295|P1|NOT COMPLETED|Overall Study||18
7730922|NCT01613014|19035294|P2|COMPLETED|Overall Study||63
7730923|NCT01613014|19035295|P1|COMPLETED|Overall Study||57
7730924|NCT01613014|19035294|P2|STARTED|Overall Study||75
7730925|NCT01613014|19035295|P1|STARTED|Overall Study||75
7730926|NCT01612884|19035303|P2|NOT COMPLETED|Overall Study||0
7730927|NCT01612884|19035304|P1|NOT COMPLETED|Overall Study||0
7730928|NCT01612884|19035303|P2|COMPLETED|Overall Study||18
7730929|NCT01612884|19035304|P1|COMPLETED|Overall Study||19
7730930|NCT01612884|19035303|P2|STARTED|Overall Study||18
7730931|NCT01612884|19035304|P1|STARTED|Overall Study||19
7730932|NCT01612858|19035316|P2|NOT COMPLETED|Overall Study||1
7730933|NCT01612858|19035317|P1|NOT COMPLETED|Overall Study||5
7730934|NCT01612858|19035316|P2|COMPLETED|Overall Study||3
7730935|NCT01612858|19035317|P1|COMPLETED|Overall Study||11
7730936|NCT01612858|19035316|P2|STARTED|Overall Study||4
7730937|NCT01612858|19035317|P1|STARTED|Overall Study||16
7730938|NCT01612793|19035327|P2|NOT COMPLETED|Overall Study||0
7730939|NCT01612793|19035328|P1|NOT COMPLETED|Overall Study||0
7730940|NCT01612793|19035327|P2|COMPLETED|Overall Study||2
7730941|NCT01612793|19035328|P1|COMPLETED|Overall Study||2
7730942|NCT01612793|19035327|P2|STARTED|Overall Study||2
7730943|NCT01612793|19035328|P1|STARTED|Overall Study||2
7730944|NCT01612780|19035334|P1|NOT COMPLETED|Overall Study||6
7730945|NCT01612780|19035334|P1|COMPLETED|Overall Study||76
7730946|NCT01612780|19035334|P1|STARTED|Overall Study||82
7730947|NCT01612767|19035340|P1|NOT COMPLETED|Overall Study||42
7730948|NCT01612767|19035340|P1|COMPLETED|Overall Study||287
7730949|NCT01612767|19035340|P1|STARTED|Overall Study||329
7730950|NCT01612702|19035396|P2|NOT COMPLETED|Overall Study||11
7730951|NCT01612702|19035397|P1|NOT COMPLETED|Overall Study||11
7730952|NCT01612702|19035396|P2|COMPLETED|Overall Study||134
7730953|NCT01612702|19035397|P1|COMPLETED|Overall Study||135
7730954|NCT01612702|19035396|P2|STARTED|Overall Study||145
7730955|NCT01612702|19035397|P1|STARTED|Overall Study||146
7730956|NCT01612676|19035411|P4|NOT COMPLETED|Overall Study||3
7730957|NCT01612676|19035412|P3|NOT COMPLETED|Overall Study||1
7730958|NCT01612676|19035413|P2|NOT COMPLETED|Overall Study||4
7730959|NCT01612676|19035414|P1|NOT COMPLETED|Overall Study||2
7730960|NCT01612676|19035411|P4|COMPLETED|Overall Study||10
7730961|NCT01612676|19035412|P3|COMPLETED|Overall Study||4
7730962|NCT01612676|19035413|P2|COMPLETED|Overall Study||3
7730963|NCT01612676|19035414|P1|COMPLETED|Overall Study||4
7730964|NCT01612676|19035411|P4|Dosed|Overall Study||13
7730965|NCT01612676|19035412|P3|Dosed|Overall Study||5
7730966|NCT01612676|19035413|P2|Dosed|Overall Study||7
7730967|NCT01612676|19035414|P1|Dosed|Overall Study||5
7730968|NCT01612676|19035411|P4|STARTED|Overall Study||13
7730969|NCT01612676|19035412|P3|STARTED|Overall Study||5
7730970|NCT01612676|19035413|P2|STARTED|Overall Study||7
7730971|NCT01612676|19035414|P1|STARTED|Overall Study||6
7730972|NCT01612546|19035470|P1|NOT COMPLETED|Overall Study||0
7730973|NCT01612546|19035470|P1|COMPLETED|Overall Study||10
7730974|NCT01612546|19035470|P1|STARTED|Overall Study||10
7730975|NCT01612494|19035480|P2|NOT COMPLETED|Overall Study||0
7730976|NCT01612494|19035481|P1|NOT COMPLETED|Overall Study||0
7730977|NCT01612494|19035480|P2|COMPLETED|Overall Study||23
7730978|NCT01612494|19035481|P1|COMPLETED|Overall Study||21
7730979|NCT01612494|19035480|P2|STARTED|Overall Study||23
7730980|NCT01612494|19035481|P1|STARTED|Overall Study||21
7730981|NCT01612351|19035487|P1|NOT COMPLETED|Post-Operative Treatment||0
7730982|NCT01612351|19035487|P1|COMPLETED|Post-Operative Treatment|One patient completed chemotherapy then withdrew before surgery.|39
7730983|NCT01612351|19035487|P1|STARTED|Post-Operative Treatment||39
7730984|NCT01612351|19035487|P1|NOT COMPLETED|Transoral Surgery||0
7730985|NCT01612351|19035487|P1|COMPLETED|Transoral Surgery||39
7730986|NCT01612351|19035487|P1|STARTED|Transoral Surgery|One patient completed chemotherapy then withdrew before surgery.|39
7730987|NCT01612351|19035487|P1|NOT COMPLETED|Chemotherapy||0
7730988|NCT01612351|19035487|P1|COMPLETED|Chemotherapy||40
7730989|NCT01612351|19035487|P1|STARTED|Chemotherapy||40
7730990|NCT01612221|19035501|P2|NOT COMPLETED|Overall Study||0
7730991|NCT01612221|19035502|P1|NOT COMPLETED|Overall Study||0
7730992|NCT01612221|19035501|P2|COMPLETED|Overall Study||50
7730993|NCT01612221|19035502|P1|COMPLETED|Overall Study||50
7730994|NCT01612221|19035501|P2|STARTED|Overall Study||50
7730995|NCT01612221|19035502|P1|STARTED|Overall Study||50
7730996|NCT01612156|19035512|P2|NOT COMPLETED|Overall Study||0
7730997|NCT01612156|19035513|P1|NOT COMPLETED|Overall Study||2
7730998|NCT01612156|19035512|P2|COMPLETED|Overall Study||48
7730999|NCT01612156|19035513|P1|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40
7731000|NCT01612156|19035512|P2|STARTED|Overall Study||48
7731001|NCT01612156|19035513|P1|STARTED|Overall Study||42
7731002|NCT01612000|19035525|P4|NOT COMPLETED|Overall Study||10
7731003|NCT01612000|19035526|P3|NOT COMPLETED|Overall Study||7
7731004|NCT01612000|19035527|P2|NOT COMPLETED|Overall Study||5
7731005|NCT01612000|19035528|P1|NOT COMPLETED|Overall Study||9
7731006|NCT01612000|19035525|P4|COMPLETED|Overall Study||76
7731007|NCT01612000|19035526|P3|COMPLETED|Overall Study||78
7731008|NCT01612000|19035527|P2|COMPLETED|Overall Study||81
7731009|NCT01612000|19035528|P1|COMPLETED|Overall Study||75
7731010|NCT01612000|19035525|P4|STARTED|Overall Study||86
7731011|NCT01612000|19035526|P3|STARTED|Overall Study||85
7731012|NCT01612000|19035527|P2|STARTED|Overall Study||86
7731013|NCT01612000|19035528|P1|STARTED|Overall Study||84
7731014|NCT01611974|19035553|P3|NOT COMPLETED|Overall Study||16
7731015|NCT01611974|19035554|P2|NOT COMPLETED|Overall Study||15
7731016|NCT01611974|19035555|P1|NOT COMPLETED|Overall Study||15
7731017|NCT01611974|19035553|P3|COMPLETED|Overall Study||24
7731018|NCT01611974|19035554|P2|COMPLETED|Overall Study||25
7731019|NCT01611974|19035555|P1|COMPLETED|Overall Study||25
7731020|NCT01611974|19035553|P3|STARTED|Overall Study||40
7731021|NCT01611974|19035554|P2|STARTED|Overall Study||40
7731022|NCT01611974|19035555|P1|STARTED|Overall Study||40
7731023|NCT01611948|19035592|P2|NOT COMPLETED|Overall Study||12
7731024|NCT01611948|19035593|P1|NOT COMPLETED|Overall Study||14
7731025|NCT01611948|19035592|P2|COMPLETED|Overall Study||26
7731026|NCT01611948|19035593|P1|COMPLETED|Overall Study||18
7731027|NCT01611948|19035592|P2|STARTED|Overall Study||38
7731028|NCT01611948|19035593|P1|STARTED|Overall Study||32
7731029|NCT01611935|19035601|P2|NOT COMPLETED|Overall Study||0
7731030|NCT01611935|19035602|P1|NOT COMPLETED|Overall Study||1
7731031|NCT01611935|19035601|P2|COMPLETED|Overall Study||51
7731032|NCT01611935|19035602|P1|COMPLETED|Overall Study||49
7731033|NCT01611935|19035601|P2|STARTED|Overall Study||51
7731034|NCT01611935|19035602|P1|STARTED|Overall Study||50
7731035|NCT01611883|19035614|P2|NOT COMPLETED|Overall Study||1
7731036|NCT01611883|19035615|P1|NOT COMPLETED|Overall Study||1
7731037|NCT01611883|19035614|P2|COMPLETED|Overall Study||76
7731038|NCT01611883|19035615|P1|COMPLETED|Overall Study||74
7731039|NCT01611883|19035614|P2|STARTED|Overall Study||77
7731040|NCT01611883|19035615|P1|STARTED|Overall Study||75
7731041|NCT01611857|19035641|P2|NOT COMPLETED|Overall Study||2
7731042|NCT01611857|19035642|P1|NOT COMPLETED|Overall Study||0
7731043|NCT01611857|19035641|P2|COMPLETED|Overall Study||32
7731044|NCT01611857|19035642|P1|COMPLETED|Overall Study||15
7731045|NCT01611857|19035641|P2|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32
7731046|NCT01611857|19035642|P1|Tivantinib 360 mg|Overall Study||7
7731047|NCT01611857|19035641|P2|Tivantinib 240 mg|Overall Study||0
7731048|NCT01611857|19035642|P1|Tivantinib 240 mg|Overall Study||3
7731049|NCT01611857|19035641|P2|Tivantinib 120 mg|Overall Study||0
7731050|NCT01611857|19035642|P1|Tivantinib 120 mg|Overall Study||5
7731051|NCT01611857|19035641|P2|STARTED|Overall Study||34
7731052|NCT01611857|19035642|P1|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15
7731053|NCT01611792|19035654|P2|NOT COMPLETED|Followup: at 6 Months||13
7731054|NCT01611792|19035655|P1|NOT COMPLETED|Followup: at 6 Months||6
7731055|NCT01611792|19035654|P2|COMPLETED|Followup: at 6 Months||7
7731056|NCT01611792|19035655|P1|COMPLETED|Followup: at 6 Months||11
7731057|NCT01611792|19035654|P2|STARTED|Followup: at 6 Months||20
7731058|NCT01611792|19035655|P1|STARTED|Followup: at 6 Months||17
7731059|NCT01611792|19035654|P2|NOT COMPLETED|Follow-up: at 11 Weeks||0
7731060|NCT01611792|19035655|P1|NOT COMPLETED|Follow-up: at 11 Weeks||0
7731061|NCT01611792|19035654|P2|COMPLETED|Follow-up: at 11 Weeks||20
7731062|NCT01611792|19035655|P1|COMPLETED|Follow-up: at 11 Weeks||17
7731063|NCT01611792|19035654|P2|STARTED|Follow-up: at 11 Weeks||20
7731064|NCT01611792|19035655|P1|STARTED|Follow-up: at 11 Weeks||17
7731065|NCT01611792|19035654|P2|NOT COMPLETED|Initial Period: Time 0||9
7731066|NCT01611792|19035655|P1|NOT COMPLETED|Initial Period: Time 0||12
7731067|NCT01611792|19035654|P2|COMPLETED|Initial Period: Time 0||20
7731068|NCT01611792|19035655|P1|COMPLETED|Initial Period: Time 0||17
7731069|NCT01611792|19035654|P2|STARTED|Initial Period: Time 0||29
7731070|NCT01611792|19035655|P1|STARTED|Initial Period: Time 0||29
7731071|NCT01611779|19035671|P1|NOT COMPLETED|Overall Study||0
7731072|NCT01611779|19035671|P1|COMPLETED|Overall Study||5
7731073|NCT01611779|19035671|P1|STARTED|Overall Study||5
7731074|NCT01611662|19035680|P1|NOT COMPLETED|Overall Study||1
7731075|NCT01611662|19035680|P1|COMPLETED|Overall Study||31
7731076|NCT01611662|19035680|P1|STARTED|Overall Study||32
7731077|NCT01611571|19035687|P3|NOT COMPLETED|Overall Study||1
7731078|NCT01611571|19035688|P2|NOT COMPLETED|Overall Study||0
7731079|NCT01611571|19035689|P1|NOT COMPLETED|Overall Study||1
7731080|NCT01611571|19035687|P3|COMPLETED|Overall Study||9
7731081|NCT01611571|19035688|P2|COMPLETED|Overall Study||10
7731082|NCT01611571|19035689|P1|COMPLETED|Overall Study||10
7731083|NCT01611571|19035687|P3|STARTED|Overall Study||10
7731084|NCT01611571|19035688|P2|STARTED|Overall Study||10
7731085|NCT01611571|19035689|P1|STARTED|Overall Study||11
7731086|NCT01611558|19035709|P1|NOT COMPLETED|Maintenance Phase||2
7731087|NCT01611558|19035709|P1|COMPLETED|Maintenance Phase||0
7731088|NCT01611558|19035709|P1|STARTED|Maintenance Phase||2
7731089|NCT01611558|19035709|P1|NOT COMPLETED|Induction Phase||38
7731090|NCT01611558|19035709|P1|COMPLETED|Induction Phase||2
7731091|NCT01611558|19035709|P1|STARTED|Induction Phase||40
7731092|NCT01611298|19035715|P1|NOT COMPLETED|Overall Study||2
7731093|NCT01611298|19035715|P1|COMPLETED|Overall Study||5
7731094|NCT01611298|19035715|P1|STARTED|Overall Study||7
7731095|NCT01611259|19035720|P1|NOT COMPLETED|Overall Study||14
7731096|NCT01611259|19035720|P1|COMPLETED|Overall Study||34
7731097|NCT01611259|19035720|P1|STARTED|Overall Study||48
7731098|NCT01611194|19035726|P2|NOT COMPLETED|Overall Study||3
7731099|NCT01611194|19035727|P1|NOT COMPLETED|Overall Study||0
7731100|NCT01611194|19035726|P2|COMPLETED|Overall Study||32
7731101|NCT01611194|19035727|P1|COMPLETED|Overall Study||36
7731102|NCT01611194|19035726|P2|STARTED|Overall Study||35
7731103|NCT01611194|19035727|P1|STARTED|Overall Study||36
7731104|NCT01611155|19035765|P2|NOT COMPLETED|Overall Study||7
7731105|NCT01611155|19035766|P1|NOT COMPLETED|Overall Study||9
7731106|NCT01611155|19035765|P2|COMPLETED|Overall Study||18
7731107|NCT01611155|19035766|P1|COMPLETED|Overall Study||16
7731108|NCT01611155|19035765|P2|Received Treatment|Overall Study||25
7731109|NCT01611155|19035766|P1|Received Treatment|Overall Study||25
7731110|NCT01611155|19035765|P2|STARTED|Overall Study||25
7731111|NCT01611155|19035766|P1|STARTED|Overall Study||25
7731112|NCT01611090|19035776|P3|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||5
7731113|NCT01611090|19035777|P2|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
7731114|NCT01611090|19035778|P1|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
7731115|NCT01611090|19035776|P3|COMPLETED|Cross Over (Placebo to Ibrutinib)||178
7731116|NCT01611090|19035777|P2|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
7731117|NCT01611090|19035778|P1|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
7731118|NCT01611090|19035776|P3|Treated|Cross Over (Placebo to Ibrutinib)||183
7731119|NCT01611090|19035777|P2|Treated|Cross Over (Placebo to Ibrutinib)||0
7731120|NCT01611090|19035778|P1|Treated|Cross Over (Placebo to Ibrutinib)||0
7731121|NCT01611090|19035776|P3|STARTED|Cross Over (Placebo to Ibrutinib)||183
7731122|NCT01611090|19035777|P2|STARTED|Cross Over (Placebo to Ibrutinib)||0
7731123|NCT01611090|19035778|P1|STARTED|Cross Over (Placebo to Ibrutinib)||0
7731124|NCT01611090|19035776|P3|NOT COMPLETED|Randomized Period||0
7731125|NCT01611090|19035777|P2|NOT COMPLETED|Randomized Period||29
7731126|NCT01611090|19035778|P1|NOT COMPLETED|Randomized Period||30
7731127|NCT01611090|19035776|P3|COMPLETED|Randomized Period||0
7731128|NCT01611090|19035777|P2|COMPLETED|Randomized Period||260
7731129|NCT01611090|19035778|P1|COMPLETED|Randomized Period||259
7731130|NCT01611090|19035776|P3|Treated|Randomized Period||0
7731131|NCT01611090|19035777|P2|Treated|Randomized Period||287
7731132|NCT01611090|19035778|P1|Treated|Randomized Period||287
7731133|NCT01611090|19035776|P3|STARTED|Randomized Period||0
7731134|NCT01611090|19035777|P2|STARTED|Randomized Period||289
7731135|NCT01611090|19035778|P1|STARTED|Randomized Period||289
7731136|NCT01610791|19035811|P1|NOT COMPLETED|Overall Study||21
7731137|NCT01610791|19035811|P1|COMPLETED|Overall Study||100
7731138|NCT01610791|19035811|P1|STARTED|Overall Study||121
7731139|NCT01610752|19035835|P3|NOT COMPLETED|Overall Study||4
7731140|NCT01610752|19035836|P2|NOT COMPLETED|Overall Study||0
7731141|NCT01610752|19035837|P1|NOT COMPLETED|Overall Study||0
7731142|NCT01610752|19035835|P3|COMPLETED|Overall Study||13
7731143|NCT01610752|19035836|P2|COMPLETED|Overall Study||19
7731144|NCT01610752|19035837|P1|COMPLETED|Overall Study||18
7731145|NCT01610752|19035835|P3|STARTED|Overall Study||17
7731146|NCT01610752|19035836|P2|STARTED|Overall Study||19
7731147|NCT01610752|19035837|P1|STARTED|Overall Study||18
7731148|NCT01610713|19035859|P2|NOT COMPLETED|Overall Study||1
7731149|NCT01610713|19035860|P1|NOT COMPLETED|Overall Study||6
7731150|NCT01610713|19035859|P2|COMPLETED|Overall Study||76
7731151|NCT01610713|19035860|P1|COMPLETED|Overall Study||71
7731152|NCT01610713|19035859|P2|STARTED|Overall Study||77
7731153|NCT01610713|19035860|P1|STARTED|Overall Study||77
7731154|NCT01610700|19035918|P2|NOT COMPLETED|Overall Study||3
7731155|NCT01610700|19035919|P1|NOT COMPLETED|Overall Study||3
7731156|NCT01610700|19035918|P2|COMPLETED|Overall Study||77
7731157|NCT01610700|19035919|P1|COMPLETED|Overall Study||77
7731158|NCT01610700|19035918|P2|STARTED|Overall Study||80
7731159|NCT01610700|19035919|P1|STARTED|Overall Study||80
7731160|NCT01610687|19035973|P1|NOT COMPLETED|Overall Study||67
7731161|NCT01610687|19035973|P1|COMPLETED|Overall Study||70
7731162|NCT01610687|19035973|P1|STARTED|Overall Study||137
7731163|NCT01610596|19035986|P2|NOT COMPLETED|Overall Study||1
7731164|NCT01610596|19035987|P1|NOT COMPLETED|Overall Study||0
7731165|NCT01610596|19035986|P2|COMPLETED|Overall Study||35
7731166|NCT01610596|19035987|P1|COMPLETED|Overall Study||36
7731167|NCT01610596|19035986|P2|STARTED|Overall Study||36
7731168|NCT01610596|19035987|P1|STARTED|Overall Study||36
7731169|NCT01610570|19036003|P4|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
7731170|NCT01610570|19036004|P3|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
7731171|NCT01610570|19036005|P2|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
7731172|NCT01610570|19036006|P1|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
7731173|NCT01610570|19036003|P4|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
7731174|NCT01610570|19036004|P3|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
7731175|NCT01610570|19036005|P2|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
7731176|NCT01610570|19036006|P1|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
7731177|NCT01610570|19036003|P4|STARTED|Ph II >/= 12 mo. & </=17yrs||0
7731178|NCT01610570|19036004|P3|STARTED|Ph II >/= 12 mo. & </=17yrs||0
7731179|NCT01610570|19036005|P2|STARTED|Ph II >/= 12 mo. & </=17yrs||0
7731180|NCT01610570|19036006|P1|STARTED|Ph II >/= 12 mo. & </=17yrs||0
7731181|NCT01610570|19036003|P4|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
7731182|NCT01610570|19036004|P3|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
7731183|NCT01610570|19036005|P2|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
7731184|NCT01610570|19036006|P1|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
7731185|NCT01610570|19036003|P4|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6
7731186|NCT01610570|19036004|P3|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
7731187|NCT01610570|19036005|P2|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
7731188|NCT01610570|19036006|P1|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
7731189|NCT01610570|19036003|P4|STARTED|Ph II >/= 18yrs of Age at Enrollment||6
7731190|NCT01610570|19036004|P3|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
7731191|NCT01610570|19036005|P2|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
7731192|NCT01610570|19036006|P1|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
7731193|NCT01610570|19036003|P4|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
7731194|NCT01610570|19036004|P3|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
7731195|NCT01610570|19036005|P2|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
7731196|NCT01610570|19036006|P1|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
7731197|NCT01610570|19036003|P4|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
7731198|NCT01610570|19036004|P3|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
7731199|NCT01610570|19036005|P2|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2
7731200|NCT01610570|19036006|P1|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
7731201|NCT01610570|19036003|P4|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
7731202|NCT01610570|19036004|P3|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
7731203|NCT01610570|19036005|P2|STARTED|Ph I >/= 12 mo. Children & Adolescents||2
7731204|NCT01610570|19036006|P1|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
7731205|NCT01610557|19036045|P5|NOT COMPLETED|Post-36-Week Extension Phase||3
7731206|NCT01610557|19036046|P4|NOT COMPLETED|Post-36-Week Extension Phase||0
7731207|NCT01610557|19036047|P3|NOT COMPLETED|Post-36-Week Extension Phase||0
7731208|NCT01610557|19036048|P2|NOT COMPLETED|Post-36-Week Extension Phase||0
7731209|NCT01610557|19036049|P1|NOT COMPLETED|Post-36-Week Extension Phase||0
7731210|NCT01610557|19036045|P5|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52
7731211|NCT01610557|19036046|P4|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
7731212|NCT01610557|19036047|P3|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
7731213|NCT01610557|19036048|P2|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
7731214|NCT01610557|19036049|P1|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
7731215|NCT01610557|19036045|P5|STARTED|Post-36-Week Extension Phase||55
7731216|NCT01610557|19036046|P4|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
7731217|NCT01610557|19036047|P3|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
7731218|NCT01610557|19036048|P2|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
7731219|NCT01610557|19036049|P1|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
7731220|NCT01610557|19036045|P5|NOT COMPLETED|36-Week Randomized Crossover Phase||0
7731221|NCT01610557|19036046|P4|NOT COMPLETED|36-Week Randomized Crossover Phase||0
7731222|NCT01610557|19036047|P3|NOT COMPLETED|36-Week Randomized Crossover Phase||0
7731223|NCT01610557|19036048|P2|NOT COMPLETED|36-Week Randomized Crossover Phase||1
7731224|NCT01610557|19036049|P1|NOT COMPLETED|36-Week Randomized Crossover Phase||0
7731305|NCT01610154|19036229|P1|COMPLETED|Overall Study||84
7731225|NCT01610557|19036045|P5|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
7731226|NCT01610557|19036046|P4|COMPLETED|36-Week Randomized Crossover Phase||13
7731227|NCT01610557|19036047|P3|COMPLETED|36-Week Randomized Crossover Phase||14
7731228|NCT01610557|19036048|P2|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12
7731229|NCT01610557|19036049|P1|COMPLETED|36-Week Randomized Crossover Phase||16
7731230|NCT01610557|19036045|P5|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
7731231|NCT01610557|19036046|P4|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13
7731232|NCT01610557|19036047|P3|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14
7731233|NCT01610557|19036048|P2|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13
7731234|NCT01610557|19036049|P1|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16
7731235|NCT01610492|19036062|P1|NOT COMPLETED|Overall Study||6
7731236|NCT01610492|19036062|P1|COMPLETED|Overall Study||8
7731237|NCT01610492|19036062|P1|STARTED|Overall Study||14
7731238|NCT01610453|19036106|P1|NOT COMPLETED|Overall Study||0
7731239|NCT01610453|19036106|P1|COMPLETED|Overall Study||150
7731240|NCT01610453|19036106|P1|STARTED|Overall Study||150
7731241|NCT01610427|19036111|P1|NOT COMPLETED|Overall Study||0
7731242|NCT01610427|19036111|P1|COMPLETED|Overall Study||22
7731243|NCT01610427|19036111|P1|STARTED|Overall Study||22
7731244|NCT01610414|19036128|P2|NOT COMPLETED|After Month 25||53
7731245|NCT01610414|19036129|P1|NOT COMPLETED|After Month 25||48
7731246|NCT01610414|19036128|P2|COMPLETED|After Month 25||871
7731247|NCT01610414|19036129|P1|COMPLETED|After Month 25||874
7731248|NCT01610414|19036128|P2|STARTED|After Month 25||924
7731249|NCT01610414|19036129|P1|STARTED|After Month 25||922
7731250|NCT01610414|19036128|P2|NOT COMPLETED|Month 13 - Month 25||70
7731251|NCT01610414|19036129|P1|NOT COMPLETED|Month 13 - Month 25||65
7731252|NCT01610414|19036128|P2|COMPLETED|Month 13 - Month 25||854
7731253|NCT01610414|19036129|P1|COMPLETED|Month 13 - Month 25||857
7731254|NCT01610414|19036128|P2|STARTED|Month 13 - Month 25||924
7731255|NCT01610414|19036129|P1|STARTED|Month 13 - Month 25||922
7731256|NCT01610414|19036128|P2|NOT COMPLETED|Study Start - Month 13||129
7731257|NCT01610414|19036129|P1|NOT COMPLETED|Study Start - Month 13||115
7731258|NCT01610414|19036128|P2|COMPLETED|Study Start - Month 13||795
7731259|NCT01610414|19036129|P1|COMPLETED|Study Start - Month 13||807
7731260|NCT01610414|19036128|P2|STARTED|Study Start - Month 13||924
7731261|NCT01610414|19036129|P1|STARTED|Study Start - Month 13||922
7731262|NCT01610297|19036158|P1|NOT COMPLETED|Overall Study||1
7731263|NCT01610297|19036158|P1|COMPLETED|Overall Study||26
7731264|NCT01610297|19036158|P1|STARTED|Overall Study||27
7731265|NCT01610284|19036168|P2|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||29
7731266|NCT01610284|19036169|P1|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||89
7731267|NCT01610284|19036168|P2|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
7731268|NCT01610284|19036169|P1|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
7731269|NCT01610284|19036168|P2|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|29
7731270|NCT01610284|19036169|P1|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|89
7731271|NCT01610284|19036168|P2|NOT COMPLETED|Treatment Phase||569
7731272|NCT01610284|19036169|P1|NOT COMPLETED|Treatment Phase||574
7731273|NCT01610284|19036168|P2|COMPLETED|Treatment Phase||0
7731274|NCT01610284|19036169|P1|COMPLETED|Treatment Phase||0
7731275|NCT01610284|19036168|P2|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||0
7731276|NCT01610284|19036169|P1|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||35
7731277|NCT01610284|19036168|P2|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||0
7731278|NCT01610284|19036169|P1|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||93
7731279|NCT01610284|19036168|P2|STARTED|Treatment Phase||569
7731280|NCT01610284|19036169|P1|STARTED|Treatment Phase||574
7731281|NCT01610284|19036168|P2|NOT COMPLETED|Randomization Phase||2
7731282|NCT01610284|19036169|P1|NOT COMPLETED|Randomization Phase||2
7731283|NCT01610284|19036168|P2|COMPLETED|Randomization Phase||569
7731284|NCT01610284|19036169|P1|COMPLETED|Randomization Phase||574
7731285|NCT01610284|19036168|P2|Safety Set (SS)|Randomization Phase||570
7731286|NCT01610284|19036169|P1|Safety Set (SS)|Randomization Phase||573
7731287|NCT01610284|19036168|P2|STARTED|Randomization Phase||571
7731288|NCT01610284|19036169|P1|STARTED|Randomization Phase||576
7731289|NCT01610271|19036191|P2|NOT COMPLETED|Overall Study||4
7731290|NCT01610271|19036192|P1|NOT COMPLETED|Overall Study||2
7731291|NCT01610271|19036191|P2|COMPLETED|Overall Study||146
7731292|NCT01610271|19036192|P1|COMPLETED|Overall Study||148
7731293|NCT01610271|19036191|P2|STARTED|Overall Study||150
7731294|NCT01610271|19036192|P1|STARTED|Overall Study||150
7731295|NCT01610167|19036207|P3|NOT COMPLETED|Overall Study||2
7731296|NCT01610167|19036208|P2|NOT COMPLETED|Overall Study||0
7731297|NCT01610167|19036209|P1|NOT COMPLETED|Overall Study||0
7731298|NCT01610167|19036207|P3|COMPLETED|Overall Study||48
7731299|NCT01610167|19036208|P2|COMPLETED|Overall Study||49
7731300|NCT01610167|19036209|P1|COMPLETED|Overall Study||52
7731301|NCT01610167|19036207|P3|STARTED|Overall Study||50
7731302|NCT01610167|19036208|P2|STARTED|Overall Study||49
7731303|NCT01610167|19036209|P1|STARTED|Overall Study||52
7731304|NCT01610154|19036229|P1|NOT COMPLETED|Overall Study||1
7731306|NCT01610154|19036229|P1|STARTED|Overall Study||85
7731307|NCT01610076|19036246|P2|NOT COMPLETED|Overall Study||5
7731308|NCT01610076|19036247|P1|NOT COMPLETED|Overall Study||3
7731309|NCT01610076|19036246|P2|COMPLETED|Overall Study||100
7731310|NCT01610076|19036247|P1|COMPLETED|Overall Study||100
7731311|NCT01610076|19036246|P2|STARTED|Overall Study||105
7731312|NCT01610076|19036247|P1|STARTED|Overall Study||103
7731313|NCT01610063|19036258|P2|NOT COMPLETED|Overall Study||20
7731314|NCT01610063|19036259|P1|NOT COMPLETED|Overall Study||42
7731315|NCT01610063|19036258|P2|COMPLETED|Overall Study||93
7731316|NCT01610063|19036259|P1|COMPLETED|Overall Study||72
7731317|NCT01610063|19036258|P2|Completed 8-week|Overall Study||93
7731318|NCT01610063|19036259|P1|Completed 8-week|Overall Study||72
7731319|NCT01610063|19036258|P2|Completed 4-week|Overall Study||98
7731320|NCT01610063|19036259|P1|Completed 4-week|Overall Study||86
7731321|NCT01610063|19036258|P2|Completed 2-week|Overall Study||105
7731322|NCT01610063|19036259|P1|Completed 2-week|Overall Study||97
7731323|NCT01610063|19036258|P2|Baseline|Overall Study||113
7731324|NCT01610063|19036259|P1|Baseline|Overall Study||114
7731325|NCT01610063|19036258|P2|STARTED|Overall Study||113
7731326|NCT01610063|19036259|P1|STARTED|Overall Study||114
7731327|NCT01610037|19036282|P3|NOT COMPLETED|Treatment and Follow up Period||26
7731328|NCT01610037|19036283|P2|NOT COMPLETED|Treatment and Follow up Period||28
7731329|NCT01610037|19036284|P1|NOT COMPLETED|Treatment and Follow up Period||25
7731330|NCT01610037|19036282|P3|COMPLETED|Treatment and Follow up Period||378
7731331|NCT01610037|19036283|P2|COMPLETED|Treatment and Follow up Period||377
7731332|NCT01610037|19036284|P1|COMPLETED|Treatment and Follow up Period||382
7731333|NCT01610037|19036282|P3|STARTED|Treatment and Follow up Period||404
7731334|NCT01610037|19036283|P2|STARTED|Treatment and Follow up Period||405
7731335|NCT01610037|19036284|P1|STARTED|Treatment and Follow up Period||407
7731336|NCT01610037|19036282|P3|NOT COMPLETED|All Patients||84
7731337|NCT01610037|19036283|P2|NOT COMPLETED|All Patients||51
7731338|NCT01610037|19036284|P1|NOT COMPLETED|All Patients||59
7731339|NCT01610037|19036282|P3|COMPLETED|All Patients||320
7731340|NCT01610037|19036283|P2|COMPLETED|All Patients||354
7731341|NCT01610037|19036284|P1|COMPLETED|All Patients||348
7731342|NCT01610037|19036282|P3|Full Analysis Set (FAS)|All Patients||403
7731343|NCT01610037|19036283|P2|Full Analysis Set (FAS)|All Patients||405
7731344|NCT01610037|19036284|P1|Full Analysis Set (FAS)|All Patients||407
7731345|NCT01610037|19036282|P3|Randomized Set (RAN)|All Patients||404
7731346|NCT01610037|19036283|P2|Randomized Set (RAN)|All Patients||405
7731347|NCT01610037|19036284|P1|Randomized Set (RAN)|All Patients||407
7731348|NCT01610037|19036282|P3|STARTED|All Patients||404
7731349|NCT01610037|19036283|P2|STARTED|All Patients||405
7731350|NCT01610037|19036284|P1|STARTED|All Patients||407
7731351|NCT01610011|19036327|P2|NOT COMPLETED|Overall Study||0
7731352|NCT01610011|19036328|P1|NOT COMPLETED|Overall Study||10
7731353|NCT01610011|19036327|P2|COMPLETED|Overall Study||2
7731354|NCT01610011|19036328|P1|COMPLETED|Overall Study||9
7731355|NCT01610011|19036327|P2|STARTED|Overall Study||2
7731356|NCT01610011|19036328|P1|STARTED|Overall Study||19
7731357|NCT01609933|19036334|P1|NOT COMPLETED|Overall Study||4
7731358|NCT01609933|19036334|P1|COMPLETED|Overall Study||28
7731359|NCT01609933|19036334|P1|STARTED|Overall Study||32
7731360|NCT01609842|19036345|P2|NOT COMPLETED|Concurrent Intervention Control||0
7731361|NCT01609842|19036346|P1|NOT COMPLETED|Concurrent Intervention Control||2
7731362|NCT01609842|19036345|P2|COMPLETED|Concurrent Intervention Control||4869
7731363|NCT01609842|19036346|P1|COMPLETED|Concurrent Intervention Control||706
7731364|NCT01609842|19036345|P2|STARTED|Concurrent Intervention Control|Nonintervention sites patients during the period prior and post enrollment at the intervention sites|4869
7731365|NCT01609842|19036346|P1|STARTED|Concurrent Intervention Control||708
7731366|NCT01609842|19036345|P2|NOT COMPLETED|Post-Intervention Control||0
7731367|NCT01609842|19036346|P1|NOT COMPLETED|Post-Intervention Control||0
7731368|NCT01609842|19036345|P2|COMPLETED|Post-Intervention Control||2917
7731369|NCT01609842|19036346|P1|COMPLETED|Post-Intervention Control||0
7731370|NCT01609842|19036345|P2|STARTED|Post-Intervention Control|Intervention sites patients after enrollment period ended who did not receive the intervention.|2917
7731371|NCT01609842|19036346|P1|STARTED|Post-Intervention Control||0
7731372|NCT01609842|19036345|P2|NOT COMPLETED|Pre-Intervention Control||0
7731373|NCT01609842|19036346|P1|NOT COMPLETED|Pre-Intervention Control||0
7731374|NCT01609842|19036345|P2|COMPLETED|Pre-Intervention Control||6081
7731375|NCT01609842|19036346|P1|COMPLETED|Pre-Intervention Control||0
7731376|NCT01609842|19036345|P2|STARTED|Pre-Intervention Control|Intervention sites patients prior to enrollment period who did not receive the intervention|6081
7731377|NCT01609842|19036346|P1|STARTED|Pre-Intervention Control||0
7731378|NCT01609790|19036373|P3|NOT COMPLETED|Overall Study||8
7731379|NCT01609790|19036374|P2|NOT COMPLETED|Overall Study||7
7731380|NCT01609790|19036375|P1|NOT COMPLETED|Overall Study||1
7731381|NCT01609790|19036373|P3|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|57
7731382|NCT01609790|19036374|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
7731383|NCT01609790|19036375|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|6
7731384|NCT01609790|19036373|P3|STARTED|Overall Study||65
7731385|NCT01609790|19036374|P2|STARTED|Overall Study||65
7731386|NCT01609790|19036375|P1|STARTED|Overall Study||7
7731387|NCT01609582|19036394|P2|NOT COMPLETED|Overall Study||1604
7731388|NCT01609582|19036395|P1|NOT COMPLETED|Overall Study||1603
7731389|NCT01609582|19036394|P2|COMPLETED|Overall Study||0
7731390|NCT01609582|19036395|P1|COMPLETED|Overall Study||0
7731391|NCT01609582|19036394|P2|Treated|Overall Study||1601
7731392|NCT01609582|19036395|P1|Treated|Overall Study||1603
7731393|NCT01609582|19036394|P2|STARTED|Overall Study||1604
7731394|NCT01609582|19036395|P1|STARTED|Overall Study||1603
7731395|NCT01609543|19036403|P1|NOT COMPLETED|Overall Study||42
7731396|NCT01609543|19036403|P1|COMPLETED|Overall Study||20
7731397|NCT01609543|19036403|P1|STARTED|Overall Study||62
7731398|NCT01609478|19036412|P3|NOT COMPLETED|Overall Study||9
7731399|NCT01609478|19036413|P2|NOT COMPLETED|Overall Study||2
7731400|NCT01609478|19036414|P1|NOT COMPLETED|Overall Study||7
7731401|NCT01609478|19036412|P3|COMPLETED|Overall Study||107
7731402|NCT01609478|19036413|P2|COMPLETED|Overall Study||106
7731403|NCT01609478|19036414|P1|COMPLETED|Overall Study||104
7731404|NCT01609478|19036412|P3|Full Analysis Set (FAS)|Overall Study||115
7731405|NCT01609478|19036413|P2|Full Analysis Set (FAS)|Overall Study||108
7731406|NCT01609478|19036414|P1|Full Analysis Set (FAS)|Overall Study||110
7731407|NCT01609478|19036412|P3|STARTED|Overall Study||116
7731408|NCT01609478|19036413|P2|STARTED|Overall Study||108
7731409|NCT01609478|19036414|P1|STARTED|Overall Study||111
7731410|NCT01609348|19036480|P2|NOT COMPLETED|Overall Study||0
7731411|NCT01609348|19036481|P1|NOT COMPLETED|Overall Study||0
7731412|NCT01609348|19036480|P2|COMPLETED|Overall Study||2
7731413|NCT01609348|19036481|P1|COMPLETED|Overall Study||3
7731414|NCT01609348|19036480|P2|STARTED|Overall Study||2
7731415|NCT01609348|19036481|P1|STARTED|Overall Study||3
7731416|NCT01609296|19036487|P1|NOT COMPLETED|Overall Study||120
7731417|NCT01609296|19036487|P1|COMPLETED|Overall Study||1286
7731418|NCT01609296|19036487|P1|STARTED|Overall Study||1406
7731419|NCT01609257|19036500|P2|NOT COMPLETED|Overall Study||8
7731420|NCT01609257|19036501|P1|NOT COMPLETED|Overall Study||6
7731421|NCT01609257|19036500|P2|COMPLETED|Overall Study||57
7731422|NCT01609257|19036501|P1|COMPLETED|Overall Study||61
7731423|NCT01609257|19036500|P2|Received Challenge Product|Overall Study||53
7731424|NCT01609257|19036501|P1|Received Challenge Product|Overall Study||56
7731425|NCT01609257|19036500|P2|Received 2 Doses|Overall Study||64
7731426|NCT01609257|19036501|P1|Received 2 Doses|Overall Study||63
7731427|NCT01609257|19036500|P2|STARTED|Overall Study||65
7731428|NCT01609257|19036501|P1|STARTED|Overall Study||67
7731429|NCT01609231|19036573|P2|NOT COMPLETED|Overall Study||3
7731430|NCT01609231|19036574|P1|NOT COMPLETED|Overall Study||3
7731431|NCT01609231|19036573|P2|COMPLETED|Overall Study||2
7731432|NCT01609231|19036574|P1|COMPLETED|Overall Study||3
7731433|NCT01609231|19036573|P2|STARTED|Overall Study||5
7731434|NCT01609231|19036574|P1|STARTED|Overall Study||6
7731435|NCT01609062|19036584|P2|NOT COMPLETED|Extension Phase||10
7731436|NCT01609062|19036585|P1|NOT COMPLETED|Extension Phase||15
7731437|NCT01609062|19036584|P2|COMPLETED|Extension Phase|EAP = Expanded Access Program|0
7731438|NCT01609062|19036585|P1|COMPLETED|Extension Phase||0
7731439|NCT01609062|19036584|P2|STARTED|Extension Phase||10
7731440|NCT01609062|19036585|P1|STARTED|Extension Phase||15
7731441|NCT01609062|19036584|P2|NOT COMPLETED|Primary Phase||0
7731442|NCT01609062|19036585|P1|NOT COMPLETED|Primary Phase||0
7731443|NCT01609062|19036584|P2|COMPLETED|Primary Phase||10
7731444|NCT01609062|19036585|P1|COMPLETED|Primary Phase||15
7731445|NCT01609062|19036584|P2|STARTED|Primary Phase||10
7731446|NCT01609062|19036585|P1|STARTED|Primary Phase||15
7731447|NCT01609023|19036628|P1|NOT COMPLETED|Overall Study||33
7731448|NCT01609023|19036628|P1|COMPLETED|Overall Study||34
7731449|NCT01609023|19036628|P1|STARTED|Overall Study||67
7731450|NCT01609010|19036640|P2|NOT COMPLETED|Overall Study||37
7731451|NCT01609010|19036641|P1|NOT COMPLETED|Overall Study||43
7731452|NCT01609010|19036640|P2|COMPLETED|Overall Study||120
7731453|NCT01609010|19036641|P1|COMPLETED|Overall Study||113
7731454|NCT01609010|19036640|P2|Entering Cycle 2|Overall Study||124
7731455|NCT01609010|19036641|P1|Entering Cycle 2|Overall Study||120
7731456|NCT01609010|19036640|P2|STARTED|Overall Study||157
7731457|NCT01609010|19036641|P1|STARTED|Overall Study||156
7731458|NCT01608971|19036667|P2|NOT COMPLETED|Overall Study||0
7731459|NCT01608971|19036668|P1|NOT COMPLETED|Overall Study||0
7731460|NCT01608971|19036667|P2|COMPLETED|Overall Study||15
7731461|NCT01608971|19036668|P1|COMPLETED|Overall Study||15
7731462|NCT01608971|19036667|P2|STARTED|Overall Study||15
7731463|NCT01608971|19036668|P1|STARTED|Overall Study||15
7731464|NCT01608815|19036683|P3|NOT COMPLETED|Overall Study||0
7731465|NCT01608815|19036684|P2|NOT COMPLETED|Overall Study||0
7731466|NCT01608815|19036685|P1|NOT COMPLETED|Overall Study||0
7731467|NCT01608815|19036683|P3|COMPLETED|Overall Study||5
7731468|NCT01608815|19036684|P2|COMPLETED|Overall Study||7
7731469|NCT01608815|19036685|P1|COMPLETED|Overall Study||188
7731470|NCT01608815|19036683|P3|STARTED|Overall Study||5
7731471|NCT01608815|19036684|P2|STARTED|Overall Study||7
7731472|NCT01608815|19036685|P1|STARTED|Overall Study||188
7731473|NCT01608724|19036702|P1|NOT COMPLETED|Overall Study||243
7731474|NCT01608724|19036702|P1|COMPLETED|Overall Study||1180
7731475|NCT01608724|19036702|P1|Treated|Overall Study||1361
7731476|NCT01608724|19036702|P1|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423
7731477|NCT01608672|19036709|P1|NOT COMPLETED|Overall Study||0
7731478|NCT01608672|19036709|P1|COMPLETED|Overall Study||207
7731479|NCT01608672|19036709|P1|STARTED|Overall Study||207
7731480|NCT01608659|19036715|P1|NOT COMPLETED|Overall Study||16
7731481|NCT01608659|19036715|P1|COMPLETED|Overall Study||94
7731482|NCT01608659|19036715|P1|STARTED|Overall Study||110
7731483|NCT01608490|19036723|P2|NOT COMPLETED|Overall Study||15
7731484|NCT01608490|19036724|P1|NOT COMPLETED|Overall Study||17
7731485|NCT01608490|19036723|P2|COMPLETED|Overall Study||142
7731486|NCT01608490|19036724|P1|COMPLETED|Overall Study||141
7731487|NCT01608490|19036723|P2|STARTED|Overall Study||157
7731488|NCT01608490|19036724|P1|STARTED|Overall Study||158
7731489|NCT01608321|19036744|P2|NOT COMPLETED|Overall Study||0
7731490|NCT01608321|19036745|P1|NOT COMPLETED|Overall Study||1
7731491|NCT01608321|19036744|P2|COMPLETED|Overall Study||4
7731492|NCT01608321|19036745|P1|COMPLETED|Overall Study||12
7731493|NCT01608321|19036744|P2|STARTED|Overall Study||4
7731494|NCT01608321|19036745|P1|STARTED|Overall Study||13
7731495|NCT01608308|19036753|P2|NOT COMPLETED|Overall Study||2
7731496|NCT01608308|19036754|P1|NOT COMPLETED|Overall Study||0
7731497|NCT01608308|19036753|P2|COMPLETED|Overall Study||29
7731498|NCT01608308|19036754|P1|COMPLETED|Overall Study||31
7731499|NCT01608308|19036753|P2|STARTED|Overall Study||31
7731500|NCT01608308|19036754|P1|STARTED|Overall Study||31
7731501|NCT01608295|19036778|P2|NOT COMPLETED|Overall Study||5
7731502|NCT01608295|19036779|P1|NOT COMPLETED|Overall Study||6
7731503|NCT01608295|19036778|P2|COMPLETED|Overall Study||25
7731504|NCT01608295|19036779|P1|COMPLETED|Overall Study||20
7731505|NCT01608295|19036778|P2|STARTED|Overall Study||30
7731506|NCT01608295|19036779|P1|STARTED|Overall Study||26
7731507|NCT01608100|19036790|P1|NOT COMPLETED|Overall Study||0
7731508|NCT01608100|19036790|P1|COMPLETED|Overall Study||1101
7731509|NCT01608100|19036790|P1|STARTED|Overall Study||1101
7731510|NCT01608087|19036817|P3|NOT COMPLETED|Overall Study||0
7731511|NCT01608087|19036818|P2|NOT COMPLETED|Overall Study||2
7731512|NCT01608087|19036819|P1|NOT COMPLETED|Overall Study||0
7731513|NCT01608087|19036817|P3|COMPLETED|Overall Study||31
7731514|NCT01608087|19036818|P2|COMPLETED|Overall Study||28
7731515|NCT01608087|19036819|P1|COMPLETED|Overall Study||30
7731516|NCT01608087|19036817|P3|STARTED|Overall Study||31
7731517|NCT01608087|19036818|P2|STARTED|Overall Study||30
7731518|NCT01608087|19036819|P1|STARTED|Overall Study||30
7731519|NCT01608061|19036835|P2|NOT COMPLETED|Extension Period||2
7731520|NCT01608061|19036836|P1|NOT COMPLETED|Extension Period||0
7731521|NCT01608061|19036835|P2|COMPLETED|Extension Period||14
7731522|NCT01608061|19036836|P1|COMPLETED|Extension Period||14
7731523|NCT01608061|19036835|P2|STARTED|Extension Period||16
7731524|NCT01608061|19036836|P1|STARTED|Extension Period||14
7731525|NCT01608061|19036835|P2|NOT COMPLETED|Long Term Follow-Up||5
7731526|NCT01608061|19036836|P1|NOT COMPLETED|Long Term Follow-Up||7
7731527|NCT01608061|19036835|P2|COMPLETED|Long Term Follow-Up||16
7731528|NCT01608061|19036836|P1|COMPLETED|Long Term Follow-Up||14
7731529|NCT01608061|19036835|P2|STARTED|Long Term Follow-Up||21
7731530|NCT01608061|19036836|P1|STARTED|Long Term Follow-Up||21
7731531|NCT01608061|19036835|P2|NOT COMPLETED|Blinded Period||0
7731532|NCT01608061|19036836|P1|NOT COMPLETED|Blinded Period||0
7731533|NCT01608061|19036835|P2|COMPLETED|Blinded Period||21
7731534|NCT01608061|19036836|P1|COMPLETED|Blinded Period||21
7731535|NCT01608061|19036835|P2|STARTED|Blinded Period||21
7731536|NCT01608061|19036836|P1|STARTED|Blinded Period||21
7731537|NCT01607957|19036849|P2|NOT COMPLETED|Overall Study||215
7731538|NCT01607957|19036850|P1|NOT COMPLETED|Overall Study||372
7731539|NCT01607957|19036849|P2|COMPLETED|Overall Study||51
7731540|NCT01607957|19036850|P1|COMPLETED|Overall Study||162
7731541|NCT01607957|19036849|P2|Treated|Overall Study||265
7731542|NCT01607957|19036850|P1|Treated|Overall Study||533
7731543|NCT01607957|19036849|P2|STARTED|Overall Study||266
7731544|NCT01607957|19036850|P1|STARTED|Overall Study||534
7731545|NCT01607853|19036860|P1|NOT COMPLETED|Overall Study||0
7731546|NCT01607853|19036860|P1|COMPLETED|Overall Study||24
7731547|NCT01607853|19036860|P1|STARTED|Overall Study||24
7731548|NCT01607658|19036971|P4|NOT COMPLETED|Overall Study||11
7731549|NCT01607658|19036972|P3|NOT COMPLETED|Overall Study||11
7731550|NCT01607658|19036973|P2|NOT COMPLETED|Overall Study||11
7731551|NCT01607658|19036974|P1|NOT COMPLETED|Overall Study||9
7731552|NCT01607658|19036971|P4|COMPLETED|Overall Study||52
7731553|NCT01607658|19036972|P3|COMPLETED|Overall Study||47
7731554|NCT01607658|19036973|P2|COMPLETED|Overall Study||56
7731555|NCT01607658|19036974|P1|COMPLETED|Overall Study||56
7731556|NCT01607658|19036971|P4|STARTED|Overall Study||63
7731557|NCT01607658|19036972|P3|STARTED|Overall Study||58
7731558|NCT01607658|19036973|P2|STARTED|Overall Study||67
7731559|NCT01607658|19036974|P1|STARTED|Overall Study||65
7731560|NCT01607645|19036998|P2|NOT COMPLETED|Overall Study||0
7731561|NCT01607645|19036999|P1|NOT COMPLETED|Overall Study||0
7731562|NCT01607645|19036998|P2|COMPLETED|Overall Study||3
7731563|NCT01607645|19036999|P1|COMPLETED|Overall Study||4
7731564|NCT01607645|19036998|P2|STARTED|Overall Study||3
7731565|NCT01607645|19036999|P1|STARTED|Overall Study||4
7731566|NCT01607593|19037029|P1|NOT COMPLETED|Overall Study||93
7731567|NCT01607593|19037029|P1|COMPLETED|Overall Study||29
7731568|NCT01607593|19037029|P1|STARTED|Overall Study||122
7731569|NCT01607554|19037035|P1|NOT COMPLETED|Overall Study||2
7731570|NCT01607554|19037035|P1|COMPLETED|Overall Study||0
7731571|NCT01607554|19037035|P1|STARTED|Overall Study||2
7731572|NCT01607476|19037048|P3|NOT COMPLETED|Overall Study||3
7731573|NCT01607476|19037049|P2|NOT COMPLETED|Overall Study||0
7731574|NCT01607476|19037050|P1|NOT COMPLETED|Overall Study||1
7731575|NCT01607476|19037048|P3|COMPLETED|Overall Study||30
7731576|NCT01607476|19037049|P2|COMPLETED|Overall Study||30
7731577|NCT01607476|19037050|P1|COMPLETED|Overall Study||24
7731578|NCT01607476|19037048|P3|STARTED|Overall Study||33
7731579|NCT01607476|19037049|P2|STARTED|Overall Study||30
7731580|NCT01607476|19037050|P1|STARTED|Overall Study||25
7731581|NCT01607450|19037068|P7|NOT COMPLETED|Overall Study||0
7731582|NCT01607450|19037069|P6|NOT COMPLETED|Overall Study||0
7731583|NCT01607450|19037070|P5|NOT COMPLETED|Overall Study||0
7731584|NCT01607450|19037071|P4|NOT COMPLETED|Overall Study||0
7731585|NCT01607450|19037072|P3|NOT COMPLETED|Overall Study||0
7731586|NCT01607450|19037073|P2|NOT COMPLETED|Overall Study||0
7731587|NCT01607450|19037074|P1|NOT COMPLETED|Overall Study||0
7731588|NCT01607450|19037068|P7|COMPLETED|Overall Study||0
7731589|NCT01607450|19037069|P6|COMPLETED|Overall Study||0
7731590|NCT01607450|19037070|P5|COMPLETED|Overall Study||1
7731591|NCT01607450|19037071|P4|COMPLETED|Overall Study||11
7731592|NCT01607450|19037072|P3|COMPLETED|Overall Study||7
7731593|NCT01607450|19037073|P2|COMPLETED|Overall Study||8
7731594|NCT01607450|19037074|P1|COMPLETED|Overall Study||6
7731595|NCT01607450|19037068|P7|STARTED|Overall Study||0
7731596|NCT01607450|19037069|P6|STARTED|Overall Study||0
7731597|NCT01607450|19037070|P5|STARTED|Overall Study||1
7731598|NCT01607450|19037071|P4|STARTED|Overall Study||11
7731599|NCT01607450|19037072|P3|STARTED|Overall Study||7
7731600|NCT01607450|19037073|P2|STARTED|Overall Study||8
7731601|NCT01607450|19037074|P1|STARTED|Overall Study||6
7731602|NCT01607411|19037118|P4|NOT COMPLETED|Period IV||0
7731603|NCT01607411|19037119|P3|NOT COMPLETED|Period IV||0
7731604|NCT01607411|19037120|P2|NOT COMPLETED|Period IV||0
7731605|NCT01607411|19037121|P1|NOT COMPLETED|Period IV||0
7731606|NCT01607411|19037118|P4|COMPLETED|Period IV||14
7731607|NCT01607411|19037119|P3|COMPLETED|Period IV||14
7731608|NCT01607411|19037120|P2|COMPLETED|Period IV||14
7731609|NCT01607411|19037121|P1|COMPLETED|Period IV||13
7731610|NCT01607411|19037118|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
7731611|NCT01607411|19037119|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
7731612|NCT01607411|19037120|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
7731613|NCT01607411|19037121|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13
7731614|NCT01607411|19037118|P4|NOT COMPLETED|Period III||0
7731615|NCT01607411|19037119|P3|NOT COMPLETED|Period III||0
7731616|NCT01607411|19037120|P2|NOT COMPLETED|Period III||0
7731617|NCT01607411|19037121|P1|NOT COMPLETED|Period III||0
7731618|NCT01607411|19037118|P4|COMPLETED|Period III||13
7731619|NCT01607411|19037119|P3|COMPLETED|Period III||14
7731620|NCT01607411|19037120|P2|COMPLETED|Period III||14
7731621|NCT01607411|19037121|P1|COMPLETED|Period III||14
7731622|NCT01607411|19037118|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13
7731623|NCT01607411|19037119|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
7731624|NCT01607411|19037120|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
7731625|NCT01607411|19037121|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
7731626|NCT01607411|19037118|P4|NOT COMPLETED|Period II||0
7731627|NCT01607411|19037119|P3|NOT COMPLETED|Period II||0
7731628|NCT01607411|19037120|P2|NOT COMPLETED|Period II||0
7731629|NCT01607411|19037121|P1|NOT COMPLETED|Period II||0
7731630|NCT01607411|19037118|P4|COMPLETED|Period II||14
7731631|NCT01607411|19037119|P3|COMPLETED|Period II||13
7731632|NCT01607411|19037120|P2|COMPLETED|Period II||14
7731633|NCT01607411|19037121|P1|COMPLETED|Period II||14
7731634|NCT01607411|19037118|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
7731635|NCT01607411|19037119|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13
7731636|NCT01607411|19037120|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
7731637|NCT01607411|19037121|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
7731638|NCT01607411|19037118|P4|NOT COMPLETED|Period I||0
7731639|NCT01607411|19037119|P3|NOT COMPLETED|Period I||0
7731640|NCT01607411|19037120|P2|NOT COMPLETED|Period I||0
7731641|NCT01607411|19037121|P1|NOT COMPLETED|Period I||0
7731642|NCT01607411|19037118|P4|COMPLETED|Period I||14
7731643|NCT01607411|19037119|P3|COMPLETED|Period I||14
7731644|NCT01607411|19037120|P2|COMPLETED|Period I||13
7731645|NCT01607411|19037121|P1|COMPLETED|Period I||14
7731646|NCT01607411|19037118|P4|STARTED|Period I||14
7731647|NCT01607411|19037119|P3|STARTED|Period I||14
7731648|NCT01607411|19037120|P2|STARTED|Period I||13
7731649|NCT01607411|19037121|P1|STARTED|Period I||14
7731650|NCT01607398|19037144|P2|NOT COMPLETED|Overall Study||2
7731651|NCT01607398|19037145|P1|NOT COMPLETED|Overall Study||2
7731652|NCT01607398|19037144|P2|COMPLETED|Overall Study||26
7731653|NCT01607398|19037145|P1|COMPLETED|Overall Study||26
7731654|NCT01607398|19037144|P2|STARTED|Overall Study||28
7731655|NCT01607398|19037145|P1|STARTED|Overall Study||28
7731656|NCT01607346|19037189|P1|NOT COMPLETED|Overall Study||3
7731657|NCT01607346|19037189|P1|COMPLETED|Overall Study||7
7731658|NCT01607346|19037189|P1|STARTED|Overall Study||10
7731659|NCT01607320|19037205|P2|NOT COMPLETED|Overall Study||0
7731660|NCT01607320|19037206|P1|NOT COMPLETED|Overall Study||0
7731661|NCT01607320|19037205|P2|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
7731662|NCT01607320|19037206|P1|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0
7731663|NCT01607320|19037205|P2|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
7731664|NCT01607320|19037206|P1|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
7731665|NCT01607255|19037214|P3|NOT COMPLETED|Overall Study||0
7731666|NCT01607255|19037215|P2|NOT COMPLETED|Overall Study||0
7731667|NCT01607255|19037216|P1|NOT COMPLETED|Overall Study||0
7731668|NCT01607255|19037214|P3|COMPLETED|Overall Study||159
7731669|NCT01607255|19037215|P2|COMPLETED|Overall Study||160
7731670|NCT01607255|19037216|P1|COMPLETED|Overall Study||161
7731671|NCT01607255|19037214|P3|STARTED|Overall Study||159
7731672|NCT01607255|19037215|P2|STARTED|Overall Study||160
7731673|NCT01607255|19037216|P1|STARTED|Overall Study||161
7731674|NCT01607203|19037226|P2|NOT COMPLETED|Overall Study||0
7731675|NCT01607203|19037227|P1|NOT COMPLETED|Overall Study||0
7731676|NCT01607203|19037226|P2|COMPLETED|Overall Study||61
7731677|NCT01607203|19037227|P1|COMPLETED|Overall Study||59
7731678|NCT01607203|19037226|P2|STARTED|Overall Study||61
7731679|NCT01607203|19037227|P1|STARTED|Overall Study||59
7731680|NCT01607112|19037239|P2|NOT COMPLETED|Overall Study||0
7731681|NCT01607112|19037240|P1|NOT COMPLETED|Overall Study||0
7731682|NCT01607112|19037239|P2|COMPLETED|Overall Study||59
7731683|NCT01607112|19037240|P1|COMPLETED|Overall Study||60
7731684|NCT01607112|19037239|P2|STARTED|Overall Study||59
7731685|NCT01607112|19037240|P1|STARTED|Overall Study||60
7731686|NCT01606852|19037276|P2|NOT COMPLETED|Overall Study||0
7731687|NCT01606852|19037277|P1|NOT COMPLETED|Overall Study||0
7731688|NCT01606852|19037276|P2|COMPLETED|Overall Study||8
7731689|NCT01606852|19037277|P1|COMPLETED|Overall Study||7
7731690|NCT01606852|19037276|P2|STARTED|Overall Study||8
7731691|NCT01606852|19037277|P1|STARTED|Overall Study||7
7731692|NCT01606800|19037287|P2|NOT COMPLETED|Overall Study||2
7731693|NCT01606800|19037288|P1|NOT COMPLETED|Overall Study||5
7731694|NCT01606800|19037287|P2|COMPLETED|Overall Study||21
7731695|NCT01606800|19037288|P1|COMPLETED|Overall Study||17
7731696|NCT01606800|19037287|P2|Treated|Overall Study||23
7731697|NCT01606800|19037288|P1|Treated|Overall Study||22
7731698|NCT01606800|19037287|P2|STARTED|Overall Study||23
7731699|NCT01606800|19037288|P1|STARTED|Overall Study||22
7731700|NCT01606787|19037296|P2|NOT COMPLETED|Overall Study||7
7731701|NCT01606787|19037297|P1|NOT COMPLETED|Overall Study||4
7731702|NCT01606787|19037296|P2|COMPLETED|Overall Study||98
7731703|NCT01606787|19037297|P1|COMPLETED|Overall Study||101
7731704|NCT01606787|19037296|P2|STARTED|Overall Study||105
7731705|NCT01606787|19037297|P1|STARTED|Overall Study||105
7731706|NCT01606761|19037308|P5|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||8
7731707|NCT01606761|19037309|P4|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||2
7731708|NCT01606761|19037310|P3|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||17
7731709|NCT01606761|19037311|P2|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||10
7731710|NCT01606761|19037312|P1|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||4
7731711|NCT01606761|19037308|P5|COMPLETED|Safety Follow-up Period (Week 52-68)||11
7731712|NCT01606761|19037309|P4|COMPLETED|Safety Follow-up Period (Week 52-68)||7
7731713|NCT01606761|19037310|P3|COMPLETED|Safety Follow-up Period (Week 52-68)||45
7731714|NCT01606761|19037311|P2|COMPLETED|Safety Follow-up Period (Week 52-68)||55
7731715|NCT01606761|19037312|P1|COMPLETED|Safety Follow-up Period (Week 52-68)||24
7731716|NCT01606761|19037308|P5|Safety Population|Safety Follow-up Period (Week 52-68)||19
7731717|NCT01606761|19037309|P4|Safety Population|Safety Follow-up Period (Week 52-68)||7
7731718|NCT01606761|19037310|P3|Safety Population|Safety Follow-up Period (Week 52-68)||62
7731719|NCT01606761|19037311|P2|Safety Population|Safety Follow-up Period (Week 52-68)||65
7731720|NCT01606761|19037312|P1|Safety Population|Safety Follow-up Period (Week 52-68)||28
7731721|NCT01606761|19037308|P5|STARTED|Safety Follow-up Period (Week 52-68)||19
7731722|NCT01606761|19037309|P4|STARTED|Safety Follow-up Period (Week 52-68)||9
7731723|NCT01606761|19037310|P3|STARTED|Safety Follow-up Period (Week 52-68)||62
7731724|NCT01606761|19037311|P2|STARTED|Safety Follow-up Period (Week 52-68)||65
7731725|NCT01606761|19037312|P1|STARTED|Safety Follow-up Period (Week 52-68)||28
7731726|NCT01606761|19037308|P5|NOT COMPLETED|Week 24 to Week 52||20
7731727|NCT01606761|19037309|P4|NOT COMPLETED|Week 24 to Week 52||17
7731728|NCT01606761|19037310|P3|NOT COMPLETED|Week 24 to Week 52||33
7731729|NCT01606761|19037311|P2|NOT COMPLETED|Week 24 to Week 52||33
7731730|NCT01606761|19037312|P1|NOT COMPLETED|Week 24 to Week 52||0
7731731|NCT01606761|19037308|P5|COMPLETED|Week 24 to Week 52||106
7731732|NCT01606761|19037309|P4|COMPLETED|Week 24 to Week 52||109
7731733|NCT01606761|19037310|P3|COMPLETED|Week 24 to Week 52||212
7731734|NCT01606761|19037311|P2|COMPLETED|Week 24 to Week 52||204
7731735|NCT01606761|19037312|P1|COMPLETED|Week 24 to Week 52||0
7731736|NCT01606761|19037308|P5|Treated|Week 24 to Week 52||126
7731737|NCT01606761|19037309|P4|Treated|Week 24 to Week 52||124
7731738|NCT01606761|19037310|P3|Treated|Week 24 to Week 52||245
7731739|NCT01606761|19037311|P2|Treated|Week 24 to Week 52||237
7731740|NCT01606761|19037312|P1|Treated|Week 24 to Week 52||0
7731741|NCT01606761|19037308|P5|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (48) and Week 24 (78) were included.|126
7731742|NCT01606761|19037309|P4|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (46) and Week 24 (80) were included.|126
7731743|NCT01606761|19037310|P3|STARTED|Week 24 to Week 52||245
7731744|NCT01606761|19037311|P2|STARTED|Week 24 to Week 52||237
7731745|NCT01606761|19037312|P1|STARTED|Week 24 to Week 52||0
7731746|NCT01606761|19037308|P5|NOT COMPLETED|Prior to Week 24||0
7731747|NCT01606761|19037309|P4|NOT COMPLETED|Prior to Week 24||0
7731748|NCT01606761|19037310|P3|NOT COMPLETED|Prior to Week 24||47
7731749|NCT01606761|19037311|P2|NOT COMPLETED|Prior to Week 24||55
7731750|NCT01606761|19037312|P1|NOT COMPLETED|Prior to Week 24||42
7731751|NCT01606761|19037308|P5|COMPLETED|Prior to Week 24||0
7731752|NCT01606761|19037309|P4|COMPLETED|Prior to Week 24||0
7731753|NCT01606761|19037310|P3|COMPLETED|Prior to Week 24||245
7731754|NCT01606761|19037311|P2|COMPLETED|Prior to Week 24||237
7731755|NCT01606761|19037312|P1|COMPLETED|Prior to Week 24||252
7731756|NCT01606761|19037308|P5|Participants Re-randomized at Week 18|Prior to Week 24||0
7731757|NCT01606761|19037309|P4|Participants Re-randomized at Week 18|Prior to Week 24||0
7731758|NCT01606761|19037310|P3|Participants Re-randomized at Week 18|Prior to Week 24||0
7731759|NCT01606761|19037311|P2|Participants Re-randomized at Week 18|Prior to Week 24||0
7731760|NCT01606761|19037312|P1|Participants Re-randomized at Week 18|Prior to Week 24|Out of 94, 46 were re-randomized to sirukumab 50 mg and 48 were re-randomized to 100 mg group.|94
7731761|NCT01606761|19037308|P5|STARTED|Prior to Week 24||0
7731762|NCT01606761|19037309|P4|STARTED|Prior to Week 24||0
7731763|NCT01606761|19037310|P3|STARTED|Prior to Week 24||292
7731764|NCT01606761|19037311|P2|STARTED|Prior to Week 24||292
7731765|NCT01606761|19037312|P1|STARTED|Prior to Week 24||294
7731766|NCT01606748|19037338|P2|NOT COMPLETED|Overall Study||0
7731767|NCT01606748|19037339|P1|NOT COMPLETED|Overall Study||3
7731768|NCT01606748|19037338|P2|COMPLETED|Overall Study||17
7731769|NCT01606748|19037339|P1|COMPLETED|Overall Study||15
7731770|NCT01606748|19037338|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
7731771|NCT01606748|19037339|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
7731772|NCT01606748|19037338|P2|STARTED|Overall Study||17
7731773|NCT01606748|19037339|P1|STARTED|Overall Study||18
7731774|NCT01606735|19037370|P3|NOT COMPLETED|Overall Study||0
7731775|NCT01606735|19037371|P2|NOT COMPLETED|Overall Study||0
7731776|NCT01606735|19037372|P1|NOT COMPLETED|Overall Study||0
7731777|NCT01606735|19037370|P3|COMPLETED|Overall Study||58
7731778|NCT01606735|19037371|P2|COMPLETED|Overall Study||56
7731779|NCT01606735|19037372|P1|COMPLETED|Overall Study||58
7731780|NCT01606735|19037370|P3|STARTED|Overall Study||58
7731781|NCT01606735|19037371|P2|STARTED|Overall Study||56
7731782|NCT01606735|19037372|P1|STARTED|Overall Study||58
7731783|NCT01606709|19037382|P2|NOT COMPLETED|Overall Study||0
7731784|NCT01606709|19037383|P1|NOT COMPLETED|Overall Study||0
7731785|NCT01606709|19037382|P2|COMPLETED|Overall Study||3
7731786|NCT01606709|19037383|P1|COMPLETED|Overall Study||4
7731787|NCT01606709|19037382|P2|STARTED|Overall Study||3
7731788|NCT01606709|19037383|P1|STARTED|Overall Study||4
7731789|NCT01606670|19037391|P1|NOT COMPLETED|Overall Study||16
7731790|NCT01606670|19037391|P1|COMPLETED|Overall Study||77
7731791|NCT01606670|19037391|P1|Full Analysis Set|Overall Study||70
7731792|NCT01606670|19037391|P1|Safety Set|Overall Study||93
7731793|NCT01606670|19037391|P1|STARTED|Overall Study||93
7731794|NCT01606319|19037401|P2|NOT COMPLETED|Overall Study||40
7731795|NCT01606319|19037402|P1|NOT COMPLETED|Overall Study||34
7731796|NCT01606319|19037401|P2|COMPLETED|Overall Study||110
7731797|NCT01606319|19037402|P1|COMPLETED|Overall Study||116
7731798|NCT01606319|19037401|P2|STARTED|Overall Study||150
7731799|NCT01606319|19037402|P1|STARTED|Overall Study||150
7731800|NCT01606306|19037420|P6|NOT COMPLETED|Overall Study||11
7731801|NCT01606306|19037421|P5|NOT COMPLETED|Overall Study||11
7731802|NCT01606306|19037422|P4|NOT COMPLETED|Overall Study||13
7731803|NCT01606306|19037423|P3|NOT COMPLETED|Overall Study||14
7731804|NCT01606306|19037424|P2|NOT COMPLETED|Overall Study||10
7731805|NCT01606306|19037425|P1|NOT COMPLETED|Overall Study||15
7731806|NCT01606306|19037420|P6|COMPLETED|Overall Study||36
7731807|NCT01606306|19037421|P5|COMPLETED|Overall Study||41
7731808|NCT01606306|19037422|P4|COMPLETED|Overall Study||38
7731809|NCT01606306|19037423|P3|COMPLETED|Overall Study||37
7731810|NCT01606306|19037424|P2|COMPLETED|Overall Study||39
7731811|NCT01606306|19037425|P1|COMPLETED|Overall Study||35
7731812|NCT01606306|19037420|P6|Completed Third Treatment Period|Overall Study||36
7731813|NCT01606306|19037421|P5|Completed Third Treatment Period|Overall Study||41
7731814|NCT01606306|19037422|P4|Completed Third Treatment Period|Overall Study||38
7731815|NCT01606306|19037423|P3|Completed Third Treatment Period|Overall Study||37
7731816|NCT01606306|19037424|P2|Completed Third Treatment Period|Overall Study||39
7731817|NCT01606306|19037425|P1|Completed Third Treatment Period|Overall Study||35
7731818|NCT01606306|19037420|P6|Completed Second Treatment Period|Overall Study||41
7731819|NCT01606306|19037421|P5|Completed Second Treatment Period|Overall Study||46
7731820|NCT01606306|19037422|P4|Completed Second Treatment Period|Overall Study||44
7731821|NCT01606306|19037423|P3|Completed Second Treatment Period|Overall Study||43
7731822|NCT01606306|19037424|P2|Completed Second Treatment Period|Overall Study||38
7731823|NCT01606306|19037425|P1|Completed Second Treatment Period|Overall Study||41
7731824|NCT01606306|19037420|P6|Completed First Treatment Period|Overall Study||44
7731825|NCT01606306|19037421|P5|Completed First Treatment Period|Overall Study||47
7731826|NCT01606306|19037422|P4|Completed First Treatment Period|Overall Study||45
7731827|NCT01606306|19037423|P3|Completed First Treatment Period|Overall Study||47
7731828|NCT01606306|19037424|P2|Completed First Treatment Period|Overall Study||47
7731829|NCT01606306|19037425|P1|Completed First Treatment Period|Overall Study||43
7731830|NCT01606306|19037420|P6|STARTED|Overall Study||47
7731831|NCT01606306|19037421|P5|STARTED|Overall Study||52
7731832|NCT01606306|19037422|P4|STARTED|Overall Study||51
7731833|NCT01606306|19037423|P3|STARTED|Overall Study||51
7731834|NCT01606306|19037424|P2|STARTED|Overall Study||49
7731835|NCT01606306|19037425|P1|STARTED|Overall Study||50
7731836|NCT01606254|19037435|P4|NOT COMPLETED|Overall Study||3
7731837|NCT01606254|19037436|P3|NOT COMPLETED|Overall Study||0
7731838|NCT01606254|19037437|P2|NOT COMPLETED|Overall Study||4
7731839|NCT01606254|19037438|P1|NOT COMPLETED|Overall Study||2
7731840|NCT01606254|19037435|P4|COMPLETED|Overall Study||11
7731841|NCT01606254|19037436|P3|COMPLETED|Overall Study||14
7731842|NCT01606254|19037437|P2|COMPLETED|Overall Study||10
7731843|NCT01606254|19037438|P1|COMPLETED|Overall Study||12
7731844|NCT01606254|19037435|P4|STARTED|Overall Study||14
7731845|NCT01606254|19037436|P3|STARTED|Overall Study||14
7731846|NCT01606254|19037437|P2|STARTED|Overall Study||14
7731847|NCT01606254|19037438|P1|STARTED|Overall Study||14
7731848|NCT01606228|19037520|P1|NOT COMPLETED|Overall Study||29
7731849|NCT01606228|19037520|P1|COMPLETED|Overall Study||159
7731850|NCT01606228|19037520|P1|STARTED|Overall Study||188
7731851|NCT01606202|19037537|P2|NOT COMPLETED|Overall Study||3
7731852|NCT01606202|19037538|P1|NOT COMPLETED|Overall Study||7
7731853|NCT01606202|19037537|P2|COMPLETED|Overall Study||57
7731854|NCT01606202|19037538|P1|COMPLETED|Overall Study||49
7731855|NCT01606202|19037537|P2|STARTED|Overall Study||60
7731856|NCT01606202|19037538|P1|STARTED|Overall Study||56
7731857|NCT01606189|19037570|P6|NOT COMPLETED|Third Intenvention (14-20 Days)||1
7731858|NCT01606189|19037571|P5|NOT COMPLETED|Third Intenvention (14-20 Days)||0
7731859|NCT01606189|19037572|P4|NOT COMPLETED|Third Intenvention (14-20 Days)||0
7731860|NCT01606189|19037573|P3|NOT COMPLETED|Third Intenvention (14-20 Days)||0
7731861|NCT01606189|19037574|P2|NOT COMPLETED|Third Intenvention (14-20 Days)||0
7731862|NCT01606189|19037575|P1|NOT COMPLETED|Third Intenvention (14-20 Days)||0
7731863|NCT01606189|19037570|P6|COMPLETED|Third Intenvention (14-20 Days)||6
7731864|NCT01606189|19037571|P5|COMPLETED|Third Intenvention (14-20 Days)||8
7731865|NCT01606189|19037572|P4|COMPLETED|Third Intenvention (14-20 Days)||8
7731866|NCT01606189|19037573|P3|COMPLETED|Third Intenvention (14-20 Days)||8
7731867|NCT01606189|19037574|P2|COMPLETED|Third Intenvention (14-20 Days)||8
7731868|NCT01606189|19037575|P1|COMPLETED|Third Intenvention (14-20 Days)||8
7731869|NCT01606189|19037570|P6|STARTED|Third Intenvention (14-20 Days)||7
7731870|NCT01606189|19037571|P5|STARTED|Third Intenvention (14-20 Days)||8
7731871|NCT01606189|19037572|P4|STARTED|Third Intenvention (14-20 Days)||8
7731872|NCT01606189|19037573|P3|STARTED|Third Intenvention (14-20 Days)||8
7731873|NCT01606189|19037574|P2|STARTED|Third Intenvention (14-20 Days)||8
7731874|NCT01606189|19037575|P1|STARTED|Third Intenvention (14-20 Days)||8
7731875|NCT01606189|19037570|P6|NOT COMPLETED|Second Intenvention (14-20 Days)||1
7731876|NCT01606189|19037571|P5|NOT COMPLETED|Second Intenvention (14-20 Days)||0
7731877|NCT01606189|19037572|P4|NOT COMPLETED|Second Intenvention (14-20 Days)||0
7731878|NCT01606189|19037573|P3|NOT COMPLETED|Second Intenvention (14-20 Days)||0
7731879|NCT01606189|19037574|P2|NOT COMPLETED|Second Intenvention (14-20 Days)||0
7731880|NCT01606189|19037575|P1|NOT COMPLETED|Second Intenvention (14-20 Days)||0
7731881|NCT01606189|19037570|P6|COMPLETED|Second Intenvention (14-20 Days)||7
7731882|NCT01606189|19037571|P5|COMPLETED|Second Intenvention (14-20 Days)||8
7731883|NCT01606189|19037572|P4|COMPLETED|Second Intenvention (14-20 Days)||8
7731884|NCT01606189|19037573|P3|COMPLETED|Second Intenvention (14-20 Days)||8
7731885|NCT01606189|19037574|P2|COMPLETED|Second Intenvention (14-20 Days)||8
7731886|NCT01606189|19037575|P1|COMPLETED|Second Intenvention (14-20 Days)||8
7731887|NCT01606189|19037570|P6|STARTED|Second Intenvention (14-20 Days)||8
7731888|NCT01606189|19037571|P5|STARTED|Second Intenvention (14-20 Days)||8
7731889|NCT01606189|19037572|P4|STARTED|Second Intenvention (14-20 Days)||8
7731890|NCT01606189|19037573|P3|STARTED|Second Intenvention (14-20 Days)||8
7731891|NCT01606189|19037574|P2|STARTED|Second Intenvention (14-20 Days)||8
7731892|NCT01606189|19037575|P1|STARTED|Second Intenvention (14-20 Days)||8
7731893|NCT01606189|19037570|P6|NOT COMPLETED|First Intenvention (14-20 Days)||0
7731894|NCT01606189|19037571|P5|NOT COMPLETED|First Intenvention (14-20 Days)||0
7731895|NCT01606189|19037572|P4|NOT COMPLETED|First Intenvention (14-20 Days)||0
7731896|NCT01606189|19037573|P3|NOT COMPLETED|First Intenvention (14-20 Days)||0
7731897|NCT01606189|19037574|P2|NOT COMPLETED|First Intenvention (14-20 Days)||0
7731898|NCT01606189|19037575|P1|NOT COMPLETED|First Intenvention (14-20 Days)||0
7731899|NCT01606189|19037570|P6|COMPLETED|First Intenvention (14-20 Days)||8
7731900|NCT01606189|19037571|P5|COMPLETED|First Intenvention (14-20 Days)||8
7731901|NCT01606189|19037572|P4|COMPLETED|First Intenvention (14-20 Days)||8
7731902|NCT01606189|19037573|P3|COMPLETED|First Intenvention (14-20 Days)||8
7731903|NCT01606189|19037574|P2|COMPLETED|First Intenvention (14-20 Days)||8
7731904|NCT01606189|19037575|P1|COMPLETED|First Intenvention (14-20 Days)||8
7731905|NCT01606189|19037570|P6|STARTED|First Intenvention (14-20 Days)||8
7731906|NCT01606189|19037571|P5|STARTED|First Intenvention (14-20 Days)||8
7731907|NCT01606189|19037572|P4|STARTED|First Intenvention (14-20 Days)||8
7731908|NCT01606189|19037573|P3|STARTED|First Intenvention (14-20 Days)||8
7731909|NCT01606189|19037574|P2|STARTED|First Intenvention (14-20 Days)||8
7731910|NCT01606189|19037575|P1|STARTED|First Intenvention (14-20 Days)||8
7731911|NCT01606176|19037609|P2|NOT COMPLETED|Overall Study||3
7731912|NCT01606176|19037610|P1|NOT COMPLETED|Overall Study||4
7731913|NCT01606176|19037609|P2|COMPLETED|Overall Study||31
7731914|NCT01606176|19037610|P1|COMPLETED|Overall Study||32
7731915|NCT01606176|19037609|P2|STARTED|Overall Study||34
7731916|NCT01606176|19037610|P1|STARTED|Overall Study||36
7731917|NCT01606150|19037646|P2|NOT COMPLETED|Overall Study||0
7731918|NCT01606150|19037647|P1|NOT COMPLETED|Overall Study||0
7731919|NCT01606150|19037646|P2|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
7731920|NCT01606150|19037647|P1|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
7731921|NCT01606150|19037646|P2|STARTED|Overall Study||0
7731922|NCT01606150|19037647|P1|STARTED|Overall Study||0
7731923|NCT01606137|19037655|P1|NOT COMPLETED|Overall Study||262
7731924|NCT01606137|19037655|P1|COMPLETED|Overall Study||245
7731925|NCT01606137|19037655|P1|STARTED|Overall Study||507
7731926|NCT01606124|19037677|P2|NOT COMPLETED|Overall Study||0
7731927|NCT01606124|19037678|P1|NOT COMPLETED|Overall Study||0
7731928|NCT01606124|19037677|P2|COMPLETED|Overall Study||20
7731929|NCT01606124|19037678|P1|COMPLETED|Overall Study||19
7731930|NCT01606124|19037677|P2|STARTED|Overall Study||20
7731931|NCT01606124|19037678|P1|STARTED|Overall Study||19
7731932|NCT01606007|19037689|P3|NOT COMPLETED|Overall Study||10
7731933|NCT01606007|19037690|P2|NOT COMPLETED|Overall Study||19
7731934|NCT01606007|19037691|P1|NOT COMPLETED|Overall Study||15
7731935|NCT01606007|19037689|P3|COMPLETED|Overall Study||169
7731936|NCT01606007|19037690|P2|COMPLETED|Overall Study||160
7731937|NCT01606007|19037691|P1|COMPLETED|Overall Study||161
7731938|NCT01606007|19037689|P3|STARTED|Overall Study||179
7731939|NCT01606007|19037690|P2|STARTED|Overall Study||179
7731940|NCT01606007|19037691|P1|STARTED|Overall Study||176
7731941|NCT01605942|19037713|P2|NOT COMPLETED|Overall Study||0
7731942|NCT01605942|19037714|P1|NOT COMPLETED|Overall Study||0
7731943|NCT01605942|19037713|P2|COMPLETED|Overall Study||2
7731944|NCT01605942|19037714|P1|COMPLETED|Overall Study||6
7731945|NCT01605942|19037713|P2|STARTED|Overall Study||2
7731946|NCT01605942|19037714|P1|STARTED|Overall Study||6
7731947|NCT01605916|19037726|P5|NOT COMPLETED|Overall Study||6
7731948|NCT01605916|19037727|P4|NOT COMPLETED|Overall Study||6
7731949|NCT01605916|19037728|P3|NOT COMPLETED|Overall Study||3
7731950|NCT01605916|19037729|P2|NOT COMPLETED|Overall Study||4
7731951|NCT01605916|19037730|P1|NOT COMPLETED|Overall Study||4
7731952|NCT01605916|19037726|P5|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
7731953|NCT01605916|19037727|P4|COMPLETED|Overall Study||0
7731954|NCT01605916|19037728|P3|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
7731955|NCT01605916|19037729|P2|COMPLETED|Overall Study||0
7731956|NCT01605916|19037730|P1|COMPLETED|Overall Study||0
7731957|NCT01605916|19037726|P5|STARTED|Overall Study||7
7731958|NCT01605916|19037727|P4|STARTED|Overall Study||6
7731959|NCT01605916|19037728|P3|STARTED|Overall Study||4
7731960|NCT01605916|19037729|P2|STARTED|Overall Study||4
7731961|NCT01605916|19037730|P1|STARTED|Overall Study||4
7731962|NCT01605903|19037805|P2|NOT COMPLETED|Overall Study||0
7731963|NCT01605903|19037806|P1|NOT COMPLETED|Overall Study||0
7731964|NCT01605903|19037805|P2|COMPLETED|Overall Study||343
7731965|NCT01605903|19037806|P1|COMPLETED|Overall Study||345
7731966|NCT01605903|19037805|P2|STARTED|Overall Study||343
7731967|NCT01605903|19037806|P1|STARTED|Overall Study||345
7731968|NCT01605890|19037812|P1|NOT COMPLETED|Overall Study||2
7731969|NCT01605890|19037812|P1|COMPLETED|Overall Study||28
7731970|NCT01605890|19037812|P1|STARTED|Overall Study||30
7731971|NCT01605877|19037827|P1|NOT COMPLETED|Overall Study||1
7731972|NCT01605877|19037827|P1|COMPLETED|Overall Study||63
7731973|NCT01605877|19037827|P1|STARTED|Overall Study||64
7731974|NCT01605825|19037891|P2|NOT COMPLETED|Overall Study||3
7731975|NCT01605825|19037892|P1|NOT COMPLETED|Overall Study||10
7731976|NCT01605825|19037891|P2|COMPLETED|Overall Study||25
7731977|NCT01605825|19037892|P1|COMPLETED|Overall Study||45
7731978|NCT01605825|19037891|P2|STARTED|Overall Study||28
7731979|NCT01605825|19037892|P1|STARTED|Overall Study||55
7731980|NCT01605799|19037900|P2|NOT COMPLETED|Overall Study||1
7731981|NCT01605799|19037901|P1|NOT COMPLETED|Overall Study||2
7731982|NCT01605799|19037900|P2|COMPLETED|Overall Study||15
7731983|NCT01605799|19037901|P1|COMPLETED|Overall Study||15
7731984|NCT01605799|19037900|P2|STARTED|Overall Study||16
7731985|NCT01605799|19037901|P1|STARTED|Overall Study||17
7731986|NCT01605669|19037909|P1|NOT COMPLETED|Overall Study||0
7731987|NCT01605669|19037909|P1|COMPLETED|Overall Study||50
7731988|NCT01605669|19037909|P1|STARTED|Overall Study||50
7731989|NCT01605617|19037916|P2|NOT COMPLETED|Second Intervention||0
7731990|NCT01605617|19037917|P1|NOT COMPLETED|Second Intervention||0
7731991|NCT01605617|19037916|P2|COMPLETED|Second Intervention||0
7731992|NCT01605617|19037917|P1|COMPLETED|Second Intervention||0
7731993|NCT01605617|19037916|P2|STARTED|Second Intervention||0
7731994|NCT01605617|19037917|P1|STARTED|Second Intervention||0
7731995|NCT01605617|19037916|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
7731996|NCT01605617|19037917|P1|NOT COMPLETED|Washout Period of 4 Weeks||2
7731997|NCT01605617|19037916|P2|COMPLETED|Washout Period of 4 Weeks||0
7731998|NCT01605617|19037917|P1|COMPLETED|Washout Period of 4 Weeks||0
7731999|NCT01605617|19037916|P2|STARTED|Washout Period of 4 Weeks||1
7732000|NCT01605617|19037917|P1|STARTED|Washout Period of 4 Weeks||2
7732001|NCT01605617|19037916|P2|NOT COMPLETED|First Intervention||1
7732002|NCT01605617|19037917|P1|NOT COMPLETED|First Intervention||0
7732003|NCT01605617|19037916|P2|COMPLETED|First Intervention||1
7732004|NCT01605617|19037917|P1|COMPLETED|First Intervention||2
7732005|NCT01605617|19037916|P2|STARTED|First Intervention||2
7732006|NCT01605617|19037917|P1|STARTED|First Intervention||2
7732007|NCT01605552|19037937|P2|NOT COMPLETED|Overall Study||2
7732008|NCT01605552|19037938|P1|NOT COMPLETED|Overall Study||6
7732009|NCT01605552|19037937|P2|COMPLETED|Overall Study||14
7732010|NCT01605552|19037938|P1|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7
7732011|NCT01605552|19037937|P2|STARTED|Overall Study||16
7732012|NCT01605552|19037938|P1|STARTED|Overall Study||13
7732013|NCT01605539|19037952|P3|NOT COMPLETED|Overall Study||0
7732014|NCT01605539|19037953|P2|NOT COMPLETED|Overall Study||1
7732015|NCT01605539|19037954|P1|NOT COMPLETED|Overall Study||0
7732016|NCT01605539|19037952|P3|COMPLETED|Overall Study||4
7732017|NCT01605539|19037953|P2|COMPLETED|Overall Study||2
7732018|NCT01605539|19037954|P1|COMPLETED|Overall Study||3
7732019|NCT01605539|19037952|P3|STARTED|Overall Study||4
7732020|NCT01605539|19037953|P2|STARTED|Overall Study||3
7732021|NCT01605539|19037954|P1|STARTED|Overall Study||3
7732022|NCT01605461|19037976|P1|NOT COMPLETED|Overall Study||4
7732023|NCT01605461|19037976|P1|COMPLETED|Overall Study||8
7732024|NCT01605461|19037976|P1|STARTED|Overall Study||12
7732025|NCT01605435|19037985|P2|NOT COMPLETED|Overall Study||0
7732026|NCT01605435|19037986|P1|NOT COMPLETED|Overall Study||0
7732027|NCT01605435|19037985|P2|COMPLETED|Overall Study||3
7732028|NCT01605435|19037986|P1|COMPLETED|Overall Study||2
7732029|NCT01605435|19037985|P2|STARTED|Overall Study||3
7732030|NCT01605435|19037986|P1|STARTED|Overall Study||2
7732031|NCT01605396|19038035|P2|NOT COMPLETED|Overall Study||40
7732032|NCT01605396|19038036|P1|NOT COMPLETED|Overall Study||40
7732033|NCT01605396|19038035|P2|COMPLETED|Overall Study||0
7732034|NCT01605396|19038036|P1|COMPLETED|Overall Study||0
7732035|NCT01605396|19038035|P2|Treated|Overall Study||40
7732036|NCT01605396|19038036|P1|Treated|Overall Study||39
7732037|NCT01605396|19038035|P2|STARTED|Overall Study||40
7732038|NCT01605396|19038036|P1|STARTED|Overall Study||40
7732039|NCT01605370|19038050|P2|NOT COMPLETED|Overall Study||0
7732040|NCT01605370|19038051|P1|NOT COMPLETED|Overall Study||1
7732041|NCT01605370|19038050|P2|COMPLETED|Overall Study||0
7732042|NCT01605370|19038051|P1|COMPLETED|Overall Study||0
7732043|NCT01605370|19038050|P2|STARTED|Overall Study||0
7732044|NCT01605370|19038051|P1|STARTED|Overall Study||1
7732045|NCT01605292|19038059|P2|NOT COMPLETED|Overall Study||0
7732046|NCT01605292|19038060|P1|NOT COMPLETED|Overall Study||0
7732047|NCT01605292|19038059|P2|COMPLETED|Overall Study||347
7732048|NCT01605292|19038060|P1|COMPLETED|Overall Study||351
7732049|NCT01605292|19038059|P2|STARTED|Overall Study||347
7732050|NCT01605292|19038060|P1|STARTED|Overall Study||351
7732051|NCT01605227|19038086|P2|NOT COMPLETED|Overall Study||329
7732052|NCT01605227|19038087|P1|NOT COMPLETED|Overall Study||621
7732053|NCT01605227|19038086|P2|COMPLETED|Overall Study||17
7732054|NCT01605227|19038087|P1|COMPLETED|Overall Study||61
7732055|NCT01605227|19038086|P2|STARTED|Overall Study||346
7732056|NCT01605227|19038087|P1|STARTED|Overall Study||682
7732057|NCT01605136|19038099|P2|NOT COMPLETED|Safety Follow-Up Period||2
7732058|NCT01605136|19038100|P1|NOT COMPLETED|Safety Follow-Up Period||1
7732059|NCT01605136|19038099|P2|COMPLETED|Safety Follow-Up Period||40
7732060|NCT01605136|19038100|P1|COMPLETED|Safety Follow-Up Period||44
7732061|NCT01605136|19038099|P2|STARTED|Safety Follow-Up Period||42
7732062|NCT01605136|19038100|P1|STARTED|Safety Follow-Up Period||45
7732063|NCT01605136|19038099|P2|NOT COMPLETED|Study Period||3
7732064|NCT01605136|19038100|P1|NOT COMPLETED|Study Period||3
7732065|NCT01605136|19038099|P2|COMPLETED|Study Period||42
7732066|NCT01605136|19038100|P1|COMPLETED|Study Period||45
7732067|NCT01605136|19038099|P2|STARTED|Study Period||45
7732068|NCT01605136|19038100|P1|STARTED|Study Period||48
7732069|NCT01605032|19038118|P1|NOT COMPLETED|Overall Study||1
7732070|NCT01605032|19038118|P1|COMPLETED|Overall Study||18
7732071|NCT01605032|19038118|P1|STARTED|Overall Study||19
7732072|NCT01605019|19038129|P2|NOT COMPLETED|Overall Study||0
7732073|NCT01605019|19038130|P1|NOT COMPLETED|Overall Study||3
7732074|NCT01605019|19038129|P2|COMPLETED|Overall Study||0
7732075|NCT01605019|19038130|P1|COMPLETED|Overall Study||1
7732076|NCT01605019|19038129|P2|STARTED|Overall Study||0
7732077|NCT01605019|19038130|P1|STARTED|Overall Study||4
7732078|NCT01604941|19038140|P6|NOT COMPLETED|Overall Study||7
7732079|NCT01604941|19038141|P5|NOT COMPLETED|Overall Study||1
7732080|NCT01604941|19038142|P4|NOT COMPLETED|Overall Study||3
7732081|NCT01604941|19038143|P3|NOT COMPLETED|Overall Study||3
7732082|NCT01604941|19038144|P2|NOT COMPLETED|Overall Study||4
7732083|NCT01604941|19038145|P1|NOT COMPLETED|Overall Study||11
7732084|NCT01604941|19038140|P6|COMPLETED|Overall Study||0
7732085|NCT01604941|19038141|P5|COMPLETED|Overall Study||3
7732086|NCT01604941|19038142|P4|COMPLETED|Overall Study||0
7732087|NCT01604941|19038143|P3|COMPLETED|Overall Study||0
7732088|NCT01604941|19038144|P2|COMPLETED|Overall Study||0
7732089|NCT01604941|19038145|P1|COMPLETED|Overall Study||0
7732090|NCT01604941|19038140|P6|STARTED|Overall Study||7
7732091|NCT01604941|19038141|P5|STARTED|Overall Study||4
7732092|NCT01604941|19038142|P4|STARTED|Overall Study||3
7732093|NCT01604941|19038143|P3|STARTED|Overall Study||3
7732094|NCT01604941|19038144|P2|STARTED|Overall Study||4
7732095|NCT01604941|19038145|P1|STARTED|Overall Study||11
7732096|NCT01604850|19038173|P2|NOT COMPLETED|Overall Study||30
7732097|NCT01604850|19038174|P1|NOT COMPLETED|Overall Study||52
7732098|NCT01604850|19038173|P2|COMPLETED|Overall Study||69
7732099|NCT01604850|19038174|P1|COMPLETED|Overall Study||51
7732100|NCT01604850|19038173|P2|Enrolled and Treated|Overall Study||98
7732101|NCT01604850|19038174|P1|Enrolled and Treated|Overall Study||103
7732102|NCT01604850|19038173|P2|STARTED|Overall Study||99
7732103|NCT01604850|19038174|P1|STARTED|Overall Study||103
7732104|NCT01604824|19038194|P6|NOT COMPLETED|Open-label Extension (OLE) Period||0
7732105|NCT01604824|19038195|P5|NOT COMPLETED|Open-label Extension (OLE) Period||3
7732106|NCT01604824|19038196|P4|NOT COMPLETED|Open-label Extension (OLE) Period||0
7732107|NCT01604824|19038197|P3|NOT COMPLETED|Open-label Extension (OLE) Period||0
7732108|NCT01604824|19038198|P2|NOT COMPLETED|Open-label Extension (OLE) Period||0
7732109|NCT01604824|19038199|P1|NOT COMPLETED|Open-label Extension (OLE) Period||0
7732110|NCT01604824|19038194|P6|COMPLETED|Open-label Extension (OLE) Period||10
7732111|NCT01604824|19038195|P5|COMPLETED|Open-label Extension (OLE) Period||10
7732112|NCT01604824|19038196|P4|COMPLETED|Open-label Extension (OLE) Period||0
7732113|NCT01604824|19038197|P3|COMPLETED|Open-label Extension (OLE) Period||0
7732114|NCT01604824|19038198|P2|COMPLETED|Open-label Extension (OLE) Period||0
7732115|NCT01604824|19038199|P1|COMPLETED|Open-label Extension (OLE) Period||0
7732116|NCT01604824|19038194|P6|Completed Study|Open-label Extension (OLE) Period||10
7732117|NCT01604824|19038195|P5|Completed Study|Open-label Extension (OLE) Period||10
7732118|NCT01604824|19038196|P4|Completed Study|Open-label Extension (OLE) Period||0
7732119|NCT01604824|19038197|P3|Completed Study|Open-label Extension (OLE) Period||0
7732120|NCT01604824|19038198|P2|Completed Study|Open-label Extension (OLE) Period||0
7732121|NCT01604824|19038199|P1|Completed Study|Open-label Extension (OLE) Period||0
7732122|NCT01604824|19038194|P6|Started Open-label Extension Period|Open-label Extension (OLE) Period||10
7732123|NCT01604824|19038195|P5|Started Open-label Extension Period|Open-label Extension (OLE) Period|Two subjects chose not to enter OLE period|11
7732124|NCT01604824|19038196|P4|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
7732125|NCT01604824|19038197|P3|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
7732126|NCT01604824|19038198|P2|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
7732127|NCT01604824|19038199|P1|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
7732128|NCT01604824|19038194|P6|STARTED|Open-label Extension (OLE) Period|Completed DB follow-up (Day 155)|10
7732129|NCT01604824|19038195|P5|STARTED|Open-label Extension (OLE) Period|Completed DB Period (Day 99)|13
7732130|NCT01604824|19038196|P4|STARTED|Open-label Extension (OLE) Period||0
7732131|NCT01604824|19038197|P3|STARTED|Open-label Extension (OLE) Period||0
7732132|NCT01604824|19038198|P2|STARTED|Open-label Extension (OLE) Period||0
7732133|NCT01604824|19038199|P1|STARTED|Open-label Extension (OLE) Period||0
7732134|NCT01604824|19038194|P6|NOT COMPLETED|Double-blind (DB) Period||0
7732135|NCT01604824|19038195|P5|NOT COMPLETED|Double-blind (DB) Period||0
7732136|NCT01604824|19038196|P4|NOT COMPLETED|Double-blind (DB) Period||0
7732137|NCT01604824|19038197|P3|NOT COMPLETED|Double-blind (DB) Period||0
7732138|NCT01604824|19038198|P2|NOT COMPLETED|Double-blind (DB) Period||0
7732139|NCT01604824|19038199|P1|NOT COMPLETED|Double-blind (DB) Period||0
7732140|NCT01604824|19038194|P6|COMPLETED|Double-blind (DB) Period||0
7732141|NCT01604824|19038195|P5|COMPLETED|Double-blind (DB) Period||0
7732142|NCT01604824|19038196|P4|COMPLETED|Double-blind (DB) Period||5
7732143|NCT01604824|19038197|P3|COMPLETED|Double-blind (DB) Period||5
7732144|NCT01604824|19038198|P2|COMPLETED|Double-blind (DB) Period||7
7732145|NCT01604824|19038199|P1|COMPLETED|Double-blind (DB) Period||6
7732146|NCT01604824|19038194|P6|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
7732147|NCT01604824|19038195|P5|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
7732148|NCT01604824|19038196|P4|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
7732149|NCT01604824|19038197|P3|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
7732150|NCT01604824|19038198|P2|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||7
7732151|NCT01604824|19038199|P1|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||6
7732152|NCT01604824|19038194|P6|Completed DB Period (Day 99)|Double-blind (DB) Period||0
7732153|NCT01604824|19038195|P5|Completed DB Period (Day 99)|Double-blind (DB) Period||0
7732154|NCT01604824|19038196|P4|Completed DB Period (Day 99)|Double-blind (DB) Period||5
7732155|NCT01604824|19038197|P3|Completed DB Period (Day 99)|Double-blind (DB) Period||5
7732156|NCT01604824|19038198|P2|Completed DB Period (Day 99)|Double-blind (DB) Period||7
7732157|NCT01604824|19038199|P1|Completed DB Period (Day 99)|Double-blind (DB) Period||6
7732158|NCT01604824|19038194|P6|STARTED|Double-blind (DB) Period||0
7732159|NCT01604824|19038195|P5|STARTED|Double-blind (DB) Period||0
7732160|NCT01604824|19038196|P4|STARTED|Double-blind (DB) Period||5
7732161|NCT01604824|19038197|P3|STARTED|Double-blind (DB) Period||5
7732162|NCT01604824|19038198|P2|STARTED|Double-blind (DB) Period||7
7732163|NCT01604824|19038199|P1|STARTED|Double-blind (DB) Period||6
7732164|NCT01604785|19038229|P2|NOT COMPLETED|Overall Study||1
7732165|NCT01604785|19038230|P1|NOT COMPLETED|Overall Study||7
7732166|NCT01604785|19038229|P2|COMPLETED|Overall Study||36
7732167|NCT01604785|19038230|P1|COMPLETED|Overall Study||30
7732168|NCT01604785|19038229|P2|STARTED|Overall Study||37
7732169|NCT01604785|19038230|P1|STARTED|Overall Study||37
7732170|NCT01604772|19038240|P1|NOT COMPLETED|Overall Study||0
7732171|NCT01604772|19038240|P1|COMPLETED|Overall Study||16
7732172|NCT01604772|19038240|P1|STARTED|Overall Study||16
7732173|NCT01604408|19038249|P2|NOT COMPLETED|Observation Period||3
7732174|NCT01604408|19038250|P1|NOT COMPLETED|Observation Period||1
7732175|NCT01604408|19038249|P2|COMPLETED|Observation Period||84
7732176|NCT01604408|19038250|P1|COMPLETED|Observation Period||85
7732177|NCT01604408|19038249|P2|STARTED|Observation Period||87
7732178|NCT01604408|19038250|P1|STARTED|Observation Period||86
7732179|NCT01604408|19038249|P2|NOT COMPLETED|Treatment Period 6||2
7732180|NCT01604408|19038250|P1|NOT COMPLETED|Treatment Period 6||2
7732181|NCT01604408|19038249|P2|COMPLETED|Treatment Period 6||87
7732182|NCT01604408|19038250|P1|COMPLETED|Treatment Period 6||86
7732183|NCT01604408|19038249|P2|STARTED|Treatment Period 6||89
7732184|NCT01604408|19038250|P1|STARTED|Treatment Period 6||88
7732185|NCT01604408|19038249|P2|NOT COMPLETED|Treatment Period 5||0
7732186|NCT01604408|19038250|P1|NOT COMPLETED|Treatment Period 5||4
7732187|NCT01604408|19038249|P2|COMPLETED|Treatment Period 5||89
7732188|NCT01604408|19038250|P1|COMPLETED|Treatment Period 5||88
7732189|NCT01604408|19038249|P2|STARTED|Treatment Period 5||89
7732190|NCT01604408|19038250|P1|STARTED|Treatment Period 5||92
7732191|NCT01604408|19038249|P2|NOT COMPLETED|Treatment Period 4||2
7732192|NCT01604408|19038250|P1|NOT COMPLETED|Treatment Period 4||3
7732193|NCT01604408|19038249|P2|COMPLETED|Treatment Period 4||89
7732194|NCT01604408|19038250|P1|COMPLETED|Treatment Period 4||92
7732195|NCT01604408|19038249|P2|STARTED|Treatment Period 4||91
7732196|NCT01604408|19038250|P1|STARTED|Treatment Period 4||95
7732197|NCT01604408|19038249|P2|NOT COMPLETED|Treatment Period 3||5
7732198|NCT01604408|19038250|P1|NOT COMPLETED|Treatment Period 3||5
7732199|NCT01604408|19038249|P2|COMPLETED|Treatment Period 3||91
7732200|NCT01604408|19038250|P1|COMPLETED|Treatment Period 3||95
7732201|NCT01604408|19038249|P2|STARTED|Treatment Period 3||96
7732202|NCT01604408|19038250|P1|STARTED|Treatment Period 3||100
7732203|NCT01604408|19038249|P2|NOT COMPLETED|Treatment Period 2||2
7732204|NCT01604408|19038250|P1|NOT COMPLETED|Treatment Period 2||2
7732205|NCT01604408|19038249|P2|COMPLETED|Treatment Period 2||96
7732206|NCT01604408|19038250|P1|COMPLETED|Treatment Period 2||100
7732207|NCT01604408|19038249|P2|STARTED|Treatment Period 2||98
7732208|NCT01604408|19038250|P1|STARTED|Treatment Period 2||102
7732209|NCT01604408|19038249|P2|NOT COMPLETED|Treatment Period 1||1
7732210|NCT01604408|19038250|P1|NOT COMPLETED|Treatment Period 1||0
7732211|NCT01604408|19038249|P2|COMPLETED|Treatment Period 1||98
7732212|NCT01604408|19038250|P1|COMPLETED|Treatment Period 1||102
7732213|NCT01604408|19038249|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||99
7732214|NCT01604408|19038250|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||102
7732215|NCT01604408|19038249|P2|STARTED|Treatment Period 1||99
7732216|NCT01604408|19038250|P1|STARTED|Treatment Period 1||102
7732217|NCT01604343|19038265|P5|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||29
7732218|NCT01604343|19038266|P4|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||10
7732219|NCT01604343|19038267|P3|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||33
7732220|NCT01604343|19038268|P2|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||7
7732221|NCT01604343|19038269|P1|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||30
7732222|NCT01604343|19038265|P5|COMPLETED|Safety Follow-up Period (Week 104-120)||85
7732223|NCT01604343|19038266|P4|COMPLETED|Safety Follow-up Period (Week 104-120)||26
7732224|NCT01604343|19038267|P3|COMPLETED|Safety Follow-up Period (Week 104-120)||72
7732225|NCT01604343|19038268|P2|COMPLETED|Safety Follow-up Period (Week 104-120)||20
7732226|NCT01604343|19038269|P1|COMPLETED|Safety Follow-up Period (Week 104-120)||79
7732227|NCT01604343|19038265|P5|Safety Population|Safety Follow-up Period (Week 104-120)||114
7732228|NCT01604343|19038266|P4|Safety Population|Safety Follow-up Period (Week 104-120)||36
7732229|NCT01604343|19038267|P3|Safety Population|Safety Follow-up Period (Week 104-120)||105
7732230|NCT01604343|19038268|P2|Safety Population|Safety Follow-up Period (Week 104-120)||26
7732231|NCT01604343|19038269|P1|Safety Population|Safety Follow-up Period (Week 104-120)||109
7732232|NCT01604343|19038265|P5|STARTED|Safety Follow-up Period (Week 104-120)||114
7732233|NCT01604343|19038266|P4|STARTED|Safety Follow-up Period (Week 104-120)||36
7732234|NCT01604343|19038267|P3|STARTED|Safety Follow-up Period (Week 104-120)||105
7732235|NCT01604343|19038268|P2|STARTED|Safety Follow-up Period (Week 104-120)||27
7732236|NCT01604343|19038269|P1|STARTED|Safety Follow-up Period (Week 104-120)||109
7732237|NCT01604343|19038265|P5|NOT COMPLETED|Week 52 to Week 104||41
7732238|NCT01604343|19038266|P4|NOT COMPLETED|Week 52 to Week 104||46
7732239|NCT01604343|19038267|P3|NOT COMPLETED|Week 52 to Week 104||67
7732240|NCT01604343|19038268|P2|NOT COMPLETED|Week 52 to Week 104||43
7732241|NCT01604343|19038269|P1|NOT COMPLETED|Week 52 to Week 104||0
7732242|NCT01604343|19038265|P5|COMPLETED|Week 52 to Week 104||429
7732243|NCT01604343|19038266|P4|COMPLETED|Week 52 to Week 104||195
7732244|NCT01604343|19038267|P3|COMPLETED|Week 52 to Week 104||414
7732245|NCT01604343|19038268|P2|COMPLETED|Week 52 to Week 104||200
7732246|NCT01604343|19038269|P1|COMPLETED|Week 52 to Week 104||0
7732247|NCT01604343|19038265|P5|Treated|Week 52 to Week 104||470
7732248|NCT01604343|19038266|P4|Treated|Week 52 to Week 104||241
7732249|NCT01604343|19038267|P3|Treated|Week 52 to Week 104||481
7732250|NCT01604343|19038268|P2|Treated|Week 52 to Week 104||242
7732251|NCT01604343|19038269|P1|Treated|Week 52 to Week 104||0
7732252|NCT01604343|19038265|P5|STARTED|Week 52 to Week 104||470
7732253|NCT01604343|19038266|P4|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (92), 40 (12) and 52 were included|241
7732254|NCT01604343|19038267|P3|STARTED|Week 52 to Week 104||481
7732255|NCT01604343|19038268|P2|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (95), 40 (12) and 52 were included|243
7732256|NCT01604343|19038269|P1|STARTED|Week 52 to Week 104||0
7732257|NCT01604343|19038265|P5|NOT COMPLETED|Prior to W52 Administration(Through W52)||87
7732258|NCT01604343|19038266|P4|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
7732259|NCT01604343|19038267|P3|NOT COMPLETED|Prior to W52 Administration(Through W52)||76
7732260|NCT01604343|19038268|P2|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
7732261|NCT01604343|19038269|P1|NOT COMPLETED|Prior to W52 Administration(Through W52)||98
7732262|NCT01604343|19038265|P5|COMPLETED|Prior to W52 Administration(Through W52)||470
7732263|NCT01604343|19038266|P4|COMPLETED|Prior to W52 Administration(Through W52)||0
7732264|NCT01604343|19038267|P3|COMPLETED|Prior to W52 Administration(Through W52)||481
7732265|NCT01604343|19038268|P2|COMPLETED|Prior to W52 Administration(Through W52)||0
7732266|NCT01604343|19038269|P1|COMPLETED|Prior to W52 Administration(Through W52)||458
7732267|NCT01604343|19038265|P5|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
7732268|NCT01604343|19038266|P4|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
7732269|NCT01604343|19038267|P3|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
7732270|NCT01604343|19038268|P2|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
7732271|NCT01604343|19038269|P1|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)|Out of 24, 12 were re-randomized to sirukumab 50 mg and 12 were re-randomized to 100 mg group.|24
7732272|NCT01604343|19038265|P5|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
7732273|NCT01604343|19038266|P4|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
7732274|NCT01604343|19038267|P3|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
7732275|NCT01604343|19038268|P2|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
7732276|NCT01604343|19038269|P1|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)|Out of 187, 95 were re-randomized to sirukumab 50 mg and 92 were re-randomized to 100 mg group.|187
7732277|NCT01604343|19038265|P5|STARTED|Prior to W52 Administration(Through W52)||557
7732278|NCT01604343|19038266|P4|STARTED|Prior to W52 Administration(Through W52)||0
7732279|NCT01604343|19038267|P3|STARTED|Prior to W52 Administration(Through W52)||557
7732280|NCT01604343|19038268|P2|STARTED|Prior to W52 Administration(Through W52)||0
7732281|NCT01604343|19038269|P1|STARTED|Prior to W52 Administration(Through W52)||556
7732282|NCT01604291|19038382|P4|NOT COMPLETED|Overall Study||0
7732283|NCT01604291|19038383|P3|NOT COMPLETED|Overall Study||0
7732284|NCT01604291|19038384|P2|NOT COMPLETED|Overall Study||0
7732285|NCT01604291|19038385|P1|NOT COMPLETED|Overall Study||0
7732286|NCT01604291|19038382|P4|COMPLETED|Overall Study||44
7732287|NCT01604291|19038383|P3|COMPLETED|Overall Study||193
7732288|NCT01604291|19038384|P2|COMPLETED|Overall Study||443
7732289|NCT01604291|19038385|P1|COMPLETED|Overall Study||311
7732290|NCT01604291|19038382|P4|STARTED|Overall Study||44
7732291|NCT01604291|19038383|P3|STARTED|Overall Study||193
7732292|NCT01604291|19038384|P2|STARTED|Overall Study||443
7732293|NCT01604291|19038385|P1|STARTED|Overall Study||311
7732294|NCT01604278|19038434|P2|NOT COMPLETED|Overall Study||13
7732295|NCT01604278|19038435|P1|NOT COMPLETED|Overall Study||14
7732296|NCT01604278|19038434|P2|COMPLETED|Overall Study||210
7732297|NCT01604278|19038435|P1|COMPLETED|Overall Study||212
7732298|NCT01604278|19038434|P2|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220
7732299|NCT01604278|19038435|P1|Full Analysis Set|Overall Study||226
7732300|NCT01604278|19038434|P2|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221
7732301|NCT01604278|19038435|P1|Safety Set|Overall Study||226
7732302|NCT01604278|19038434|P2|STARTED|Overall Study||223
7732303|NCT01604278|19038435|P1|STARTED|Overall Study||226
7732304|NCT01604265|19038461|P2|NOT COMPLETED|Overall Study||0
7732305|NCT01604265|19038462|P1|NOT COMPLETED|Overall Study||2
7732306|NCT01604265|19038461|P2|COMPLETED|Overall Study||32
7732307|NCT01604265|19038462|P1|COMPLETED|Overall Study||32
7732308|NCT01604265|19038461|P2|STARTED|Overall Study||32
7732309|NCT01604265|19038462|P1|STARTED|Overall Study||34
7732310|NCT01604122|19038498|P2|NOT COMPLETED|Overall Study||0
7732311|NCT01604122|19038499|P1|NOT COMPLETED|Overall Study||0
7732312|NCT01604122|19038498|P2|COMPLETED|Overall Study||32
7732313|NCT01604122|19038499|P1|COMPLETED|Overall Study||60
7732314|NCT01604122|19038498|P2|STARTED|Overall Study||32
7732315|NCT01604122|19038499|P1|STARTED|Overall Study||60
7732316|NCT01604109|19038546|P2|NOT COMPLETED|Overall Study||34
7732317|NCT01604109|19038547|P1|NOT COMPLETED|Overall Study||33
7732318|NCT01604109|19038546|P2|COMPLETED|Overall Study||112
7732319|NCT01604109|19038547|P1|COMPLETED|Overall Study||117
7732320|NCT01604109|19038546|P2|STARTED|Overall Study||146
7732321|NCT01604109|19038547|P1|STARTED|Overall Study||150
7732322|NCT01603940|19038555|P2|NOT COMPLETED|Overall Study||0
7732323|NCT01603940|19038556|P1|NOT COMPLETED|Overall Study||0
7732324|NCT01603940|19038555|P2|COMPLETED|Overall Study||14
7732325|NCT01603940|19038556|P1|COMPLETED|Overall Study||16
7732326|NCT01603940|19038555|P2|STARTED|Overall Study||14
7732327|NCT01603940|19038556|P1|STARTED|Overall Study||16
7732328|NCT01603875|19038573|P3|NOT COMPLETED|Overall Study||9
7732329|NCT01603875|19038574|P2|NOT COMPLETED|Overall Study||8
7732330|NCT01603875|19038575|P1|NOT COMPLETED|Overall Study||7
7732331|NCT01603875|19038573|P3|COMPLETED|Overall Study||26
7732332|NCT01603875|19038574|P2|COMPLETED|Overall Study||27
7732333|NCT01603875|19038575|P1|COMPLETED|Overall Study||28
7732334|NCT01603875|19038573|P3|STARTED|Overall Study||35
7732335|NCT01603875|19038574|P2|STARTED|Overall Study||35
7732336|NCT01603875|19038575|P1|STARTED|Overall Study||35
7732337|NCT01603641|19038595|P1|NOT COMPLETED|Overall Study||35
7732338|NCT01603641|19038595|P1|COMPLETED|Overall Study||335
7732339|NCT01603641|19038595|P1|Modified Intent-to-treat Population|Overall Study||366
7732340|NCT01603641|19038595|P1|Safety Population (Treated)|Overall Study||367
7732341|NCT01603641|19038595|P1|STARTED|Overall Study||370
7732342|NCT01603628|19038602|P3|NOT COMPLETED|Overall Study||2
7732343|NCT01603628|19038603|P2|NOT COMPLETED|Overall Study||3
7732344|NCT01603628|19038604|P1|NOT COMPLETED|Overall Study||3
7732345|NCT01603628|19038602|P3|COMPLETED|Overall Study||128
7732346|NCT01603628|19038603|P2|COMPLETED|Overall Study||123
7732347|NCT01603628|19038604|P1|COMPLETED|Overall Study||125
7732348|NCT01603628|19038602|P3|Safety Population: Received Treatment|Overall Study||128
7732349|NCT01603628|19038603|P2|Safety Population: Received Treatment|Overall Study||126
7732350|NCT01603628|19038604|P1|Safety Population: Received Treatment|Overall Study||128
7732351|NCT01603628|19038602|P3|STARTED|Overall Study||130
7732352|NCT01603628|19038603|P2|STARTED|Overall Study||126
7732353|NCT01603628|19038604|P1|STARTED|Overall Study||128
7732354|NCT01603615|19038621|P1|NOT COMPLETED|Overall Study||34
7732355|NCT01603615|19038621|P1|COMPLETED|Overall Study||186
7732356|NCT01603615|19038621|P1|Safety Population (Treated)|Overall Study||213
7732357|NCT01603615|19038621|P1|STARTED|Overall Study||220
7732358|NCT01603602|19038628|P3|NOT COMPLETED|Overall Study||1
7732359|NCT01603602|19038629|P2|NOT COMPLETED|Overall Study||0
7732360|NCT01603602|19038630|P1|NOT COMPLETED|Overall Study||2
7732361|NCT01603602|19038628|P3|COMPLETED|Overall Study||79
7732362|NCT01603602|19038629|P2|COMPLETED|Overall Study||78
7732363|NCT01603602|19038630|P1|COMPLETED|Overall Study||75
7732364|NCT01603602|19038628|P3|STARTED|Overall Study||80
7732365|NCT01603602|19038629|P2|STARTED|Overall Study||78
7732366|NCT01603602|19038630|P1|STARTED|Overall Study||77
7732367|NCT01603459|19038650|P1|NOT COMPLETED|Overall Study||18
7732368|NCT01603459|19038650|P1|COMPLETED|Overall Study||137
7732369|NCT01603459|19038650|P1|STARTED|Overall Study||155
7732370|NCT01603420|19038772|P2|NOT COMPLETED|Overall Study||0
7732371|NCT01603420|19038773|P1|NOT COMPLETED|Overall Study||0
7732372|NCT01603420|19038772|P2|COMPLETED|Overall Study||1
7732373|NCT01603420|19038773|P1|COMPLETED|Overall Study||1
7732374|NCT01603420|19038772|P2|STARTED|Overall Study||1
7732375|NCT01603420|19038773|P1|STARTED|Overall Study||1
7732376|NCT01603394|19038801|P1|NOT COMPLETED|Overall Study||1
7732377|NCT01603394|19038801|P1|COMPLETED|Overall Study||8
7732378|NCT01603394|19038801|P1|STARTED|Overall Study||9
7732379|NCT01603368|19038818|P2|NOT COMPLETED|Overall Study||0
7732380|NCT01603368|19038819|P1|NOT COMPLETED|Overall Study||0
7732381|NCT01603368|19038818|P2|COMPLETED|Overall Study||66
7732382|NCT01603368|19038819|P1|COMPLETED|Overall Study||68
7732383|NCT01603368|19038818|P2|STARTED|Overall Study||66
7732384|NCT01603368|19038819|P1|STARTED|Overall Study||68
7732385|NCT01603355|19038855|P1|NOT COMPLETED|Overall Study||2
7732386|NCT01603355|19038855|P1|COMPLETED|Overall Study||1
7732387|NCT01603355|19038855|P1|STARTED|Overall Study||3
7732388|NCT01603277|19038861|P2|NOT COMPLETED|Overall Study||18
7732389|NCT01603277|19038862|P1|NOT COMPLETED|Overall Study||14
7732390|NCT01603277|19038861|P2|COMPLETED|Overall Study||64
7732391|NCT01603277|19038862|P1|COMPLETED|Overall Study||64
7732392|NCT01603277|19038861|P2|STARTED|Overall Study||82
7732393|NCT01603277|19038862|P1|STARTED|Overall Study||78
7732394|NCT01603121|19038868|P2|NOT COMPLETED|Second Intervention, 10 Hours||0
7732395|NCT01603121|19038869|P1|NOT COMPLETED|Second Intervention, 10 Hours||1
7732396|NCT01603121|19038868|P2|COMPLETED|Second Intervention, 10 Hours||0
7732397|NCT01603121|19038869|P1|COMPLETED|Second Intervention, 10 Hours||0
7732398|NCT01603121|19038868|P2|STARTED|Second Intervention, 10 Hours||0
7732399|NCT01603121|19038869|P1|STARTED|Second Intervention, 10 Hours||1
7732400|NCT01603121|19038868|P2|NOT COMPLETED|First Intervention, 10 Hours||0
7732401|NCT01603121|19038869|P1|NOT COMPLETED|First Intervention, 10 Hours||0
7732402|NCT01603121|19038868|P2|COMPLETED|First Intervention, 10 Hours||0
7732403|NCT01603121|19038869|P1|COMPLETED|First Intervention, 10 Hours||1
7732404|NCT01603121|19038868|P2|STARTED|First Intervention, 10 Hours||0
7732405|NCT01603121|19038869|P1|STARTED|First Intervention, 10 Hours||1
7732406|NCT01603082|19038881|P2|NOT COMPLETED|Overall Study||1
7732407|NCT01603082|19038882|P1|NOT COMPLETED|Overall Study||2
7732408|NCT01603082|19038881|P2|COMPLETED|Overall Study|Completed the study|48
7732409|NCT01603082|19038882|P1|COMPLETED|Overall Study|Completed the study.|49
7732410|NCT01603082|19038881|P2|STARTED|Overall Study|Randomized|49
7732411|NCT01603082|19038882|P1|STARTED|Overall Study|Randomized|51
7732412|NCT01603056|19038892|P2|NOT COMPLETED|Overall Study||14
7732413|NCT01603056|19038893|P1|NOT COMPLETED|Overall Study||34
7732414|NCT01603056|19038892|P2|COMPLETED|Overall Study||190
7732415|NCT01603056|19038893|P1|COMPLETED|Overall Study||379
7732416|NCT01603056|19038892|P2|STARTED|Overall Study||204
7732417|NCT01603056|19038893|P1|STARTED|Overall Study||413
7732418|NCT01603043|19038923|P2|NOT COMPLETED|Overall Study||3
7732419|NCT01603043|19038924|P1|NOT COMPLETED|Overall Study||7
7732420|NCT01603043|19038923|P2|COMPLETED|Overall Study||0
7732421|NCT01603043|19038924|P1|COMPLETED|Overall Study||0
7732422|NCT01603043|19038923|P2|STARTED|Overall Study||3
7732423|NCT01603043|19038924|P1|STARTED|Overall Study||7
7732424|NCT01602965|19038936|P2|NOT COMPLETED|Overall Study||2
7732425|NCT01602965|19038937|P1|NOT COMPLETED|Overall Study||4
7732426|NCT01602965|19038936|P2|COMPLETED|Overall Study||18
7732427|NCT01602965|19038937|P1|COMPLETED|Overall Study||16
7732428|NCT01602965|19038936|P2|STARTED|Overall Study||20
7732429|NCT01602965|19038937|P1|STARTED|Overall Study||20
7732430|NCT01602744|19038945|P2|NOT COMPLETED|Overall Study||23
7732431|NCT01602744|19038946|P1|NOT COMPLETED|Overall Study||30
7732432|NCT01602744|19038945|P2|COMPLETED|Overall Study||160
7732433|NCT01602744|19038946|P1|COMPLETED|Overall Study||146
7732434|NCT01602744|19038945|P2|STARTED|Overall Study||183
7732435|NCT01602744|19038946|P1|STARTED|Overall Study||176
7732436|NCT01602731|19038962|P1|NOT COMPLETED|Overall Study||30
7732437|NCT01602731|19038962|P1|COMPLETED|Overall Study||15
7732438|NCT01602731|19038962|P1|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24
7732439|NCT01602731|19038962|P1|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44
7732440|NCT01602731|19038962|P1|STARTED|Overall Study||45
7732441|NCT01602692|19038970|P2|NOT COMPLETED|Overall Study||0
7732442|NCT01602692|19038971|P1|NOT COMPLETED|Overall Study||0
7732443|NCT01602692|19038970|P2|COMPLETED|Overall Study||20
7732444|NCT01602692|19038971|P1|COMPLETED|Overall Study||20
7732445|NCT01602692|19038970|P2|STARTED|Overall Study||20
7732446|NCT01602692|19038971|P1|STARTED|Overall Study||20
7732447|NCT01602679|19038991|P2|NOT COMPLETED|Overall Study||0
7732448|NCT01602679|19038992|P1|NOT COMPLETED|Overall Study||0
7732449|NCT01602679|19038991|P2|COMPLETED|Overall Study||3
7732450|NCT01602679|19038992|P1|COMPLETED|Overall Study||4
7732451|NCT01602679|19038991|P2|STARTED|Overall Study||3
7732452|NCT01602679|19038992|P1|STARTED|Overall Study||4
7732453|NCT01602666|19039004|P2|NOT COMPLETED|Radiation Therapy on Protocol||31
7732454|NCT01602666|19039005|P1|NOT COMPLETED|Radiation Therapy on Protocol||10
7732455|NCT01602666|19039004|P2|COMPLETED|Radiation Therapy on Protocol||82
7732456|NCT01602666|19039005|P1|COMPLETED|Radiation Therapy on Protocol||60
7732457|NCT01602666|19039004|P2|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||16
7732458|NCT01602666|19039005|P1|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||0
7732459|NCT01602666|19039004|P2|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||74
7732460|NCT01602666|19039005|P1|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||0
7732461|NCT01602666|19039004|P2|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||0
7732462|NCT01602666|19039005|P1|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||66
7732463|NCT01602666|19039004|P2|STARTED|Radiation Therapy on Protocol||113
7732464|NCT01602666|19039005|P1|STARTED|Radiation Therapy on Protocol||70
7732465|NCT01602666|19039004|P2|NOT COMPLETED|Induction Chemotherapy||24
7732466|NCT01602666|19039005|P1|NOT COMPLETED|Induction Chemotherapy||37
7732467|NCT01602666|19039004|P2|COMPLETED|Induction Chemotherapy||113
7732468|NCT01602666|19039005|P1|COMPLETED|Induction Chemotherapy||70
7732469|NCT01602666|19039004|P2|STARTED|Induction Chemotherapy||137
7732470|NCT01602666|19039005|P1|STARTED|Induction Chemotherapy||107
7732471|NCT01602614|19039021|P4|NOT COMPLETED|Overall Study||0
7732472|NCT01602614|19039022|P3|NOT COMPLETED|Overall Study||0
7732473|NCT01602614|19039023|P2|NOT COMPLETED|Overall Study||0
7732474|NCT01602614|19039024|P1|NOT COMPLETED|Overall Study||0
7732475|NCT01602614|19039021|P4|COMPLETED|Overall Study||0
7732476|NCT01602614|19039022|P3|COMPLETED|Overall Study||8
7732477|NCT01602614|19039023|P2|COMPLETED|Overall Study||10
7732478|NCT01602614|19039024|P1|COMPLETED|Overall Study||0
7732479|NCT01602614|19039021|P4|STARTED|Overall Study||0
7732480|NCT01602614|19039022|P3|STARTED|Overall Study||8
7732481|NCT01602614|19039023|P2|STARTED|Overall Study||10
7732482|NCT01602614|19039024|P1|STARTED|Overall Study||0
7732483|NCT01602562|19039092|P2|NOT COMPLETED|Overall Study||3
7732484|NCT01602562|19039093|P1|NOT COMPLETED|Overall Study||5
7732485|NCT01602562|19039092|P2|COMPLETED|Overall Study||16
7732486|NCT01602562|19039093|P1|COMPLETED|Overall Study||16
7732487|NCT01602562|19039092|P2|STARTED|Overall Study||19
7732488|NCT01602562|19039093|P1|STARTED|Overall Study||21
7732489|NCT01602549|19039129|P2|NOT COMPLETED|Overall Study||1
7732490|NCT01602549|19039130|P1|NOT COMPLETED|Overall Study||1
7732491|NCT01602549|19039129|P2|COMPLETED|Overall Study||37
7732492|NCT01602549|19039130|P1|COMPLETED|Overall Study||18
7732493|NCT01602549|19039129|P2|STARTED|Overall Study||38
7732494|NCT01602549|19039130|P1|STARTED|Overall Study||19
7732495|NCT01602510|19039209|P3|NOT COMPLETED|Randomized Phase||73
7732496|NCT01602510|19039210|P2|NOT COMPLETED|Randomized Phase||74
7732497|NCT01602510|19039211|P1|NOT COMPLETED|Randomized Phase||0
7732498|NCT01602510|19039209|P3|COMPLETED|Randomized Phase||58
7732499|NCT01602510|19039210|P2|COMPLETED|Randomized Phase||59
7732500|NCT01602510|19039211|P1|COMPLETED|Randomized Phase||0
7732501|NCT01602510|19039209|P3|STARTED|Randomized Phase||131
7732502|NCT01602510|19039210|P2|STARTED|Randomized Phase||133
7732503|NCT01602510|19039211|P1|STARTED|Randomized Phase||0
7732504|NCT01602510|19039209|P3|NOT COMPLETED|Open Label Phase||0
7732505|NCT01602510|19039210|P2|NOT COMPLETED|Open Label Phase||0
7732506|NCT01602510|19039211|P1|NOT COMPLETED|Open Label Phase||303
7732507|NCT01602510|19039209|P3|COMPLETED|Open Label Phase||0
7732508|NCT01602510|19039210|P2|COMPLETED|Open Label Phase||0
7732509|NCT01602510|19039211|P1|COMPLETED|Open Label Phase||117
7732510|NCT01602510|19039209|P3|STARTED|Open Label Phase||0
7732511|NCT01602510|19039210|P2|STARTED|Open Label Phase||0
7732512|NCT01602510|19039211|P1|STARTED|Open Label Phase||420
7732513|NCT01602484|19039237|P2|NOT COMPLETED|Overall Study||1
7732514|NCT01602484|19039238|P1|NOT COMPLETED|Overall Study||0
7732515|NCT01602484|19039237|P2|COMPLETED|Overall Study||24
7732516|NCT01602484|19039238|P1|COMPLETED|Overall Study||25
7732517|NCT01602484|19039237|P2|STARTED|Overall Study||25
7732518|NCT01602484|19039238|P1|STARTED|Overall Study||25
7732519|NCT01602471|19039250|P1|NOT COMPLETED|Overall Study||0
7732520|NCT01602471|19039250|P1|COMPLETED|Overall Study||4
7732521|NCT01602471|19039250|P1|STARTED|Overall Study||4
7732522|NCT01602419|19039254|P1|NOT COMPLETED|Overall Study||29
7732523|NCT01602419|19039254|P1|COMPLETED|Overall Study||91
7732524|NCT01602419|19039254|P1|EFF Population|Overall Study||91
7732525|NCT01602419|19039254|P1|ITT Population|Overall Study||102
7732526|NCT01602419|19039254|P1|SAF Population|Overall Study||111
7732527|NCT01602419|19039254|P1|STARTED|Overall Study||120
7732528|NCT01602380|19039309|P2|NOT COMPLETED|Overall Study||101
7732529|NCT01602380|19039310|P1|NOT COMPLETED|Overall Study||93
7732530|NCT01602380|19039309|P2|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|131
7732531|NCT01602380|19039310|P1|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|137
7732532|NCT01602380|19039309|P2|STARTED|Overall Study||232
7732533|NCT01602380|19039310|P1|STARTED|Overall Study||230
7732534|NCT01602341|19039334|P2|NOT COMPLETED|Overall Study||1
7732535|NCT01602341|19039335|P1|NOT COMPLETED|Overall Study||0
7732536|NCT01602341|19039334|P2|COMPLETED|Overall Study||41
7732537|NCT01602341|19039335|P1|COMPLETED|Overall Study||44
7732538|NCT01602341|19039334|P2|STARTED|Overall Study||42
7732539|NCT01602341|19039335|P1|STARTED|Overall Study||44
7732540|NCT01602315|19039376|P7|NOT COMPLETED|Overall Study||29
7732541|NCT01602315|19039377|P6|NOT COMPLETED|Overall Study||35
7732542|NCT01602315|19039378|P5|NOT COMPLETED|Overall Study||71
7732543|NCT01602315|19039379|P4|NOT COMPLETED|Overall Study||6
7732544|NCT01602315|19039380|P3|NOT COMPLETED|Overall Study||18
7732545|NCT01602315|19039381|P2|NOT COMPLETED|Overall Study||5
7732546|NCT01602315|19039382|P1|NOT COMPLETED|Overall Study||16
7732547|NCT01602315|19039376|P7|COMPLETED|Overall Study||0
7732548|NCT01602315|19039377|P6|COMPLETED|Overall Study||0
7732549|NCT01602315|19039378|P5|COMPLETED|Overall Study||0
7732550|NCT01602315|19039379|P4|COMPLETED|Overall Study||0
7732551|NCT01602315|19039380|P3|COMPLETED|Overall Study||0
7732552|NCT01602315|19039381|P2|COMPLETED|Overall Study||0
7732553|NCT01602315|19039382|P1|COMPLETED|Overall Study||0
7732554|NCT01602315|19039376|P7|STARTED|Overall Study||29
7732555|NCT01602315|19039377|P6|STARTED|Overall Study||35
7732556|NCT01602315|19039378|P5|STARTED|Overall Study||71
7732557|NCT01602315|19039379|P4|STARTED|Overall Study||6
7732558|NCT01602315|19039380|P3|STARTED|Overall Study||18
7732559|NCT01602315|19039381|P2|STARTED|Overall Study||5
7732560|NCT01602315|19039382|P1|STARTED|Overall Study||16
7732561|NCT01602224|19039471|P3|NOT COMPLETED|Overall Study||6
7732562|NCT01602224|19039472|P2|NOT COMPLETED|Overall Study||8
7732563|NCT01602224|19039473|P1|NOT COMPLETED|Overall Study||8
7732564|NCT01602224|19039471|P3|COMPLETED|Overall Study||66
7732565|NCT01602224|19039472|P2|COMPLETED|Overall Study||66
7732566|NCT01602224|19039473|P1|COMPLETED|Overall Study||66
7732567|NCT01602224|19039471|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
7732568|NCT01602224|19039472|P2|Received at Least 1 Dose of Study Drug|Overall Study||74
7732569|NCT01602224|19039473|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
7732570|NCT01602224|19039471|P3|STARTED|Overall Study||72
7732571|NCT01602224|19039472|P2|STARTED|Overall Study||74
7732572|NCT01602224|19039473|P1|STARTED|Overall Study||74
7732573|NCT01602198|19039519|P2|NOT COMPLETED|Overall Study||0
7732574|NCT01602198|19039520|P1|NOT COMPLETED|Overall Study||0
7732575|NCT01602198|19039519|P2|COMPLETED|Overall Study||1
7732576|NCT01602198|19039520|P1|COMPLETED|Overall Study||0
7732577|NCT01602198|19039519|P2|STARTED|Overall Study||1
7732578|NCT01602198|19039520|P1|STARTED|Overall Study||0
7732579|NCT01602172|19039529|P3|NOT COMPLETED|Overall Study||0
7732580|NCT01602172|19039530|P2|NOT COMPLETED|Overall Study||6
7732581|NCT01602172|19039531|P1|NOT COMPLETED|Overall Study||5
7732582|NCT01602172|19039529|P3|COMPLETED|Overall Study||22
7732583|NCT01602172|19039530|P2|COMPLETED|Overall Study||17
7732584|NCT01602172|19039531|P1|COMPLETED|Overall Study||32
7732585|NCT01602172|19039529|P3|STARTED|Overall Study||22
7732586|NCT01602172|19039530|P2|STARTED|Overall Study||23
7732587|NCT01602172|19039531|P1|STARTED|Overall Study||37
7732588|NCT01602120|19039558|P4|NOT COMPLETED|Overall Study||53
7732589|NCT01602120|19039559|P3|NOT COMPLETED|Overall Study||17
7732590|NCT01602120|19039560|P2|NOT COMPLETED|Overall Study||60
7732591|NCT01602120|19039561|P1|NOT COMPLETED|Overall Study||29
7732592|NCT01602120|19039558|P4|COMPLETED|Overall Study||0
7732593|NCT01602120|19039559|P3|COMPLETED|Overall Study||0
7732594|NCT01602120|19039560|P2|COMPLETED|Overall Study||0
7732595|NCT01602120|19039561|P1|COMPLETED|Overall Study||0
7732596|NCT01602120|19039558|P4|STARTED|Overall Study||53
7732597|NCT01602120|19039559|P3|STARTED|Overall Study||17
7732598|NCT01602120|19039560|P2|STARTED|Overall Study||60
7732599|NCT01602120|19039561|P1|STARTED|Overall Study||29
7732600|NCT01602068|19039575|P2|NOT COMPLETED|Overall Study||0
7732601|NCT01602068|19039576|P1|NOT COMPLETED|Overall Study||0
7732602|NCT01602068|19039575|P2|COMPLETED|Overall Study||22
7732603|NCT01602068|19039576|P1|COMPLETED|Overall Study||23
7732604|NCT01602068|19039575|P2|STARTED|Overall Study|Day before surgery|22
7732605|NCT01602068|19039576|P1|STARTED|Overall Study|Day before surgery|23
7732606|NCT01602016|19039582|P1|NOT COMPLETED|Overall Study||0
7732607|NCT01602016|19039582|P1|COMPLETED|Overall Study||0
7732608|NCT01602016|19039582|P1|STARTED|Overall Study||0
7732609|NCT01601977|19039589|P1|NOT COMPLETED|Overall Study||0
7732610|NCT01601977|19039589|P1|COMPLETED|Overall Study||10
7732611|NCT01601977|19039589|P1|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10
7732612|NCT01601873|19039609|P2|NOT COMPLETED|Overall Study||3
7732613|NCT01601873|19039610|P1|NOT COMPLETED|Overall Study||2
7732614|NCT01601873|19039609|P2|COMPLETED|Overall Study||44
7732615|NCT01601873|19039610|P1|COMPLETED|Overall Study||48
7732616|NCT01601873|19039609|P2|STARTED|Overall Study||47
7732617|NCT01601873|19039610|P1|STARTED|Overall Study||50
7732618|NCT01601847|19039636|P2|NOT COMPLETED|Overall Study||10
7732619|NCT01601847|19039637|P1|NOT COMPLETED|Overall Study||13
7732620|NCT01601847|19039636|P2|COMPLETED|Overall Study||137
7732621|NCT01601847|19039637|P1|COMPLETED|Overall Study||140
7732622|NCT01601847|19039636|P2|STARTED|Overall Study||147
7732623|NCT01601847|19039637|P1|STARTED|Overall Study||153
7732624|NCT01601821|19039649|P2|NOT COMPLETED|Overall Study||29
7732625|NCT01601821|19039650|P1|NOT COMPLETED|Overall Study||29
7732626|NCT01601821|19039649|P2|COMPLETED|Overall Study||91
7732627|NCT01601821|19039650|P1|COMPLETED|Overall Study||96
7732628|NCT01601821|19039649|P2|STARTED|Overall Study||120
7732629|NCT01601821|19039650|P1|STARTED|Overall Study||125
7732630|NCT01601782|19039680|P1|NOT COMPLETED|Overall Study||0
7732631|NCT01601782|19039680|P1|COMPLETED|Overall Study||16
7732632|NCT01601782|19039680|P1|STARTED|Overall Study||16
7732633|NCT01601704|19039686|P2|NOT COMPLETED|Overall Study||4
7732634|NCT01601704|19039687|P1|NOT COMPLETED|Overall Study||1
7732635|NCT01601704|19039686|P2|COMPLETED|Overall Study||4450
7732636|NCT01601704|19039687|P1|COMPLETED|Overall Study||4455
7732637|NCT01601704|19039686|P2|Treated|Overall Study||4450
7732638|NCT01601704|19039687|P1|Treated|Overall Study||4455
7732639|NCT01601704|19039686|P2|STARTED|Overall Study||4454
7732640|NCT01601704|19039687|P1|STARTED|Overall Study||4456
7732641|NCT01601691|19039701|P1|NOT COMPLETED|Overall Study||0
7732642|NCT01601691|19039701|P1|COMPLETED|Overall Study||10
7732643|NCT01601691|19039701|P1|STARTED|Overall Study||10
7732644|NCT01601626|19039708|P3|NOT COMPLETED|Overall Study||2
7732645|NCT01601626|19039709|P2|NOT COMPLETED|Overall Study||5
7732646|NCT01601626|19039710|P1|NOT COMPLETED|Overall Study||3
7732647|NCT01601626|19039708|P3|COMPLETED|Overall Study||21
7732648|NCT01601626|19039709|P2|COMPLETED|Overall Study||19
7732649|NCT01601626|19039710|P1|COMPLETED|Overall Study||21
7732650|NCT01601626|19039708|P3|STARTED|Overall Study||23
7732651|NCT01601626|19039709|P2|STARTED|Overall Study||24
7732652|NCT01601626|19039710|P1|STARTED|Overall Study||24
7732653|NCT01601535|19039799|P6|NOT COMPLETED|Phase 2||12
7732654|NCT01601535|19039800|P5|NOT COMPLETED|Phase 2||19
7732655|NCT01601535|19039801|P4|NOT COMPLETED|Phase 2||0
7732656|NCT01601535|19039802|P3|NOT COMPLETED|Phase 2||0
7732657|NCT01601535|19039803|P2|NOT COMPLETED|Phase 2||0
7732658|NCT01601535|19039804|P1|NOT COMPLETED|Phase 2||0
7732659|NCT01601535|19039799|P6|COMPLETED|Phase 2||0
7732660|NCT01601535|19039800|P5|COMPLETED|Phase 2||1
7732661|NCT01601535|19039801|P4|COMPLETED|Phase 2||0
7732662|NCT01601535|19039802|P3|COMPLETED|Phase 2||0
7732663|NCT01601535|19039803|P2|COMPLETED|Phase 2||0
7732664|NCT01601535|19039804|P1|COMPLETED|Phase 2||0
7732665|NCT01601535|19039799|P6|STARTED|Phase 2||12
7732666|NCT01601535|19039800|P5|STARTED|Phase 2||20
7732667|NCT01601535|19039801|P4|STARTED|Phase 2||0
7732668|NCT01601535|19039802|P3|STARTED|Phase 2||0
7732669|NCT01601535|19039803|P2|STARTED|Phase 2||0
7732670|NCT01601535|19039804|P1|STARTED|Phase 2||0
7732671|NCT01601535|19039799|P6|NOT COMPLETED|Phase 1||0
7732672|NCT01601535|19039800|P5|NOT COMPLETED|Phase 1||0
7732673|NCT01601535|19039801|P4|NOT COMPLETED|Phase 1||4
7732674|NCT01601535|19039802|P3|NOT COMPLETED|Phase 1||5
7732675|NCT01601535|19039803|P2|NOT COMPLETED|Phase 1||6
7732676|NCT01601535|19039804|P1|NOT COMPLETED|Phase 1||6
7732677|NCT01601535|19039799|P6|COMPLETED|Phase 1||0
7732678|NCT01601535|19039800|P5|COMPLETED|Phase 1||0
7732679|NCT01601535|19039801|P4|COMPLETED|Phase 1||0
7732680|NCT01601535|19039802|P3|COMPLETED|Phase 1||1
7732681|NCT01601535|19039803|P2|COMPLETED|Phase 1||0
7732682|NCT01601535|19039804|P1|COMPLETED|Phase 1||0
7732683|NCT01601535|19039799|P6|STARTED|Phase 1||0
7732684|NCT01601535|19039800|P5|STARTED|Phase 1||0
7732685|NCT01601535|19039801|P4|STARTED|Phase 1||4
7732686|NCT01601535|19039802|P3|STARTED|Phase 1||6
7732687|NCT01601535|19039803|P2|STARTED|Phase 1||6
7732688|NCT01601535|19039804|P1|STARTED|Phase 1||6
7732689|NCT01601496|19039860|P1|NOT COMPLETED|Overall Study||15
7732690|NCT01601496|19039860|P1|COMPLETED|Overall Study|Completed 12-M F/up|102
7732691|NCT01601496|19039860|P1|STARTED|Overall Study|Enrolled|117
7732692|NCT01601470|19039868|P1|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0
7732693|NCT01601470|19039868|P1|COMPLETED|Period 3 - LCZ696+Sildenafil||27
7732694|NCT01601470|19039868|P1|Safety Set|Period 3 - LCZ696+Sildenafil||27
7732695|NCT01601470|19039868|P1|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27
7732696|NCT01601470|19039868|P1|STARTED|Period 3 - LCZ696+Sildenafil||27
7732697|NCT01601470|19039868|P1|NOT COMPLETED|Period 2 - LCZ696||1
7732698|NCT01601470|19039868|P1|COMPLETED|Period 2 - LCZ696||27
7732699|NCT01601470|19039868|P1|Safety Set|Period 2 - LCZ696||27
7732700|NCT01601470|19039868|P1|PK Analysis Set|Period 2 - LCZ696||27
7732701|NCT01601470|19039868|P1|STARTED|Period 2 - LCZ696||28
7732702|NCT01601470|19039868|P1|NOT COMPLETED|Period 1 - Sildenafil||0
7732703|NCT01601470|19039868|P1|COMPLETED|Period 1 - Sildenafil||28
7732704|NCT01601470|19039868|P1|Safety Set|Period 1 - Sildenafil||28
7732705|NCT01601470|19039868|P1|PK Analysis Set|Period 1 - Sildenafil||28
7732706|NCT01601470|19039868|P1|STARTED|Period 1 - Sildenafil||28
7732707|NCT01601431|19039885|P2|NOT COMPLETED|Overall Study||3
7732708|NCT01601431|19039886|P1|NOT COMPLETED|Overall Study||12
7732709|NCT01601431|19039885|P2|COMPLETED|Overall Study||214
7732710|NCT01601431|19039886|P1|COMPLETED|Overall Study||211
7732711|NCT01601431|19039885|P2|STARTED|Overall Study||217
7732712|NCT01601431|19039886|P1|STARTED|Overall Study||223
7732713|NCT01601236|19039898|P6|NOT COMPLETED|Overall Study||1
7732714|NCT01601236|19039899|P5|NOT COMPLETED|Overall Study||3
7732715|NCT01601236|19039900|P4|NOT COMPLETED|Overall Study||2
7732716|NCT01601236|19039901|P3|NOT COMPLETED|Overall Study||6
7732717|NCT01601236|19039902|P2|NOT COMPLETED|Overall Study||1
7732718|NCT01601236|19039903|P1|NOT COMPLETED|Overall Study||5
7732719|NCT01601236|19039898|P6|COMPLETED|Overall Study||0
7732720|NCT01601236|19039899|P5|COMPLETED|Overall Study||0
7732721|NCT01601236|19039900|P4|COMPLETED|Overall Study||4
7732722|NCT01601236|19039901|P3|COMPLETED|Overall Study||8
7732723|NCT01601236|19039902|P2|COMPLETED|Overall Study||2
7732724|NCT01601236|19039903|P1|COMPLETED|Overall Study||2
7732725|NCT01601236|19039898|P6|STARTED|Overall Study||1
7732726|NCT01601236|19039899|P5|STARTED|Overall Study||3
7732727|NCT01601236|19039900|P4|STARTED|Overall Study||6
7732728|NCT01601236|19039901|P3|STARTED|Overall Study||14
7732729|NCT01601236|19039902|P2|STARTED|Overall Study||3
7732730|NCT01601236|19039903|P1|STARTED|Overall Study||7
7732731|NCT01601132|19039939|P1|NOT COMPLETED|Overall Study||2
7732732|NCT01601132|19039939|P1|COMPLETED|Overall Study||28
7732733|NCT01601132|19039939|P1|STARTED|Overall Study||30
7732734|NCT01601067|19039958|P2|NOT COMPLETED|Overall Study||22
7732735|NCT01601067|19039959|P1|NOT COMPLETED|Overall Study||33
7732736|NCT01601067|19039958|P2|COMPLETED|Overall Study||34
7732737|NCT01601067|19039959|P1|COMPLETED|Overall Study||30
7732738|NCT01601067|19039958|P2|STARTED|Overall Study||56
7732739|NCT01601067|19039959|P1|STARTED|Overall Study||63
7732740|NCT01600950|19039967|P2|NOT COMPLETED|Period 2||0
7732741|NCT01600950|19039968|P1|NOT COMPLETED|Period 2||0
7732742|NCT01600950|19039967|P2|COMPLETED|Period 2||10
7732743|NCT01600950|19039968|P1|COMPLETED|Period 2||10
7732744|NCT01600950|19039967|P2|STARTED|Period 2||10
7732745|NCT01600950|19039968|P1|STARTED|Period 2||10
7732746|NCT01600950|19039967|P2|NOT COMPLETED|Period 1||0
7732747|NCT01600950|19039968|P1|NOT COMPLETED|Period 1||0
7732748|NCT01600950|19039967|P2|COMPLETED|Period 1||10
7732749|NCT01600950|19039968|P1|COMPLETED|Period 1||10
7732750|NCT01600950|19039967|P2|STARTED|Period 1||10
7732751|NCT01600950|19039968|P1|STARTED|Period 1||10
7732752|NCT01600885|19039984|P2|NOT COMPLETED|Second Period||0
7732753|NCT01600885|19039985|P1|NOT COMPLETED|Second Period||0
7732754|NCT01600885|19039984|P2|COMPLETED|Second Period||8
7732755|NCT01600885|19039985|P1|COMPLETED|Second Period||8
7732756|NCT01600885|19039984|P2|STARTED|Second Period||8
7732757|NCT01600885|19039985|P1|STARTED|Second Period||8
7732758|NCT01600885|19039984|P2|NOT COMPLETED|Wash Out Period||0
7732759|NCT01600885|19039985|P1|NOT COMPLETED|Wash Out Period||0
7732760|NCT01600885|19039984|P2|COMPLETED|Wash Out Period||8
7732761|NCT01600885|19039985|P1|COMPLETED|Wash Out Period||8
7732762|NCT01600885|19039984|P2|STARTED|Wash Out Period||8
7732763|NCT01600885|19039985|P1|STARTED|Wash Out Period||8
7732764|NCT01600885|19039984|P2|NOT COMPLETED|First Period||1
7732765|NCT01600885|19039985|P1|NOT COMPLETED|First Period||2
7732766|NCT01600885|19039984|P2|COMPLETED|First Period||8
7732767|NCT01600885|19039985|P1|COMPLETED|First Period||8
7732768|NCT01600885|19039984|P2|STARTED|First Period||9
7732769|NCT01600885|19039985|P1|STARTED|First Period||10
7732770|NCT01600729|19039995|P1|NOT COMPLETED|Overall Study||1
7732771|NCT01600729|19039995|P1|COMPLETED|Overall Study||65
7732772|NCT01600729|19039995|P1|STARTED|Overall Study||66
7732773|NCT01600716|19040002|P2|NOT COMPLETED|Overall Study||7
7732774|NCT01600716|19040003|P1|NOT COMPLETED|Overall Study||7
7732775|NCT01600716|19040002|P2|COMPLETED|Overall Study||71
7732776|NCT01600716|19040003|P1|COMPLETED|Overall Study||59
7732777|NCT01600716|19040002|P2|STARTED|Overall Study||78
7732778|NCT01600716|19040003|P1|STARTED|Overall Study||66
7732779|NCT01600703|19040019|P2|NOT COMPLETED|Second Intervention||0
7732780|NCT01600703|19040020|P1|NOT COMPLETED|Second Intervention||0
7732781|NCT01600703|19040019|P2|COMPLETED|Second Intervention||8
7732782|NCT01600703|19040020|P1|COMPLETED|Second Intervention||7
7732783|NCT01600703|19040019|P2|STARTED|Second Intervention||8
7732784|NCT01600703|19040020|P1|STARTED|Second Intervention||7
7732785|NCT01600703|19040019|P2|NOT COMPLETED|First Intervention||0
7732786|NCT01600703|19040020|P1|NOT COMPLETED|First Intervention||0
7732787|NCT01600703|19040019|P2|COMPLETED|First Intervention||8
7732788|NCT01600703|19040020|P1|COMPLETED|First Intervention||7
7732789|NCT01600703|19040019|P2|STARTED|First Intervention||8
7732790|NCT01600703|19040020|P1|STARTED|First Intervention||7
7732791|NCT01600677|19040030|P2|NOT COMPLETED|Overall Study||0
7732792|NCT01600677|19040031|P1|NOT COMPLETED|Overall Study||0
7732793|NCT01600677|19040030|P2|COMPLETED|Overall Study||4
7732794|NCT01600677|19040031|P1|COMPLETED|Overall Study||7
7732795|NCT01600677|19040030|P2|STARTED|Overall Study||4
7732796|NCT01600677|19040031|P1|STARTED|Overall Study||7
7732797|NCT01600638|19040041|P1|NOT COMPLETED|Overall Study||0
7732798|NCT01600638|19040041|P1|COMPLETED|Overall Study||25
7732799|NCT01600638|19040041|P1|STARTED|Overall Study||25
7732800|NCT01600586|19040051|P2|NOT COMPLETED|Overall Study||3
7732801|NCT01600586|19040052|P1|NOT COMPLETED|Overall Study||3
7732802|NCT01600586|19040051|P2|COMPLETED|Overall Study||48
7732803|NCT01600586|19040052|P1|COMPLETED|Overall Study||46
7732804|NCT01600586|19040051|P2|STARTED|Overall Study||51
7732805|NCT01600586|19040052|P1|STARTED|Overall Study||49
7732806|NCT01600495|19040068|P2|NOT COMPLETED|Overall Study||0
7732807|NCT01600495|19040069|P1|NOT COMPLETED|Overall Study||0
7732808|NCT01600495|19040068|P2|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
7732809|NCT01600495|19040069|P1|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
7732810|NCT01600495|19040068|P2|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23
7732811|NCT01600495|19040069|P1|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23
7732812|NCT01600482|19040083|P2|NOT COMPLETED|Overall Study||0
7732813|NCT01600482|19040084|P1|NOT COMPLETED|Overall Study||0
7732814|NCT01600482|19040083|P2|COMPLETED|Overall Study||59
7732815|NCT01600482|19040084|P1|COMPLETED|Overall Study|Last 26 patients allocated to CELT ACD|148
7732816|NCT01600482|19040083|P2|STARTED|Overall Study|Last 26 patients allocated to CELT ACD|59
7732817|NCT01600482|19040084|P1|STARTED|Overall Study||148
7732818|NCT01600326|19040104|P2|NOT COMPLETED|Overall Study||1
7732819|NCT01600326|19040105|P1|NOT COMPLETED|Overall Study||1
7732820|NCT01600326|19040104|P2|COMPLETED|Overall Study||14
7732821|NCT01600326|19040105|P1|COMPLETED|Overall Study||14
7732822|NCT01600326|19040104|P2|Primary Outcome Measure Data Collection|Overall Study||15
7732823|NCT01600326|19040105|P1|Primary Outcome Measure Data Collection|Overall Study||15
7732824|NCT01600326|19040104|P2|STARTED|Overall Study||15
7732825|NCT01600326|19040105|P1|STARTED|Overall Study||15
7732826|NCT01600287|19040115|P2|NOT COMPLETED|Overall Study||0
7732827|NCT01600287|19040116|P1|NOT COMPLETED|Overall Study||0
7732828|NCT01600287|19040115|P2|COMPLETED|Overall Study||20
7732829|NCT01600287|19040116|P1|COMPLETED|Overall Study||20
7732830|NCT01600287|19040115|P2|STARTED|Overall Study||20
7732831|NCT01600287|19040116|P1|STARTED|Overall Study||20
7732832|NCT01600222|19040156|P1|NOT COMPLETED|Overall Study||2
7732833|NCT01600222|19040156|P1|COMPLETED|Overall Study||35
7732834|NCT01600222|19040156|P1|STARTED|Overall Study||37
7732835|NCT01600170|19040181|P2|NOT COMPLETED|Period 2||0
7732836|NCT01600170|19040182|P1|NOT COMPLETED|Period 2||1
7732837|NCT01600170|19040181|P2|COMPLETED|Period 2||5
7732838|NCT01600170|19040182|P1|COMPLETED|Period 2|One subject moved away from the area due to job responsibilities and dropped out of study.|5
7732839|NCT01600170|19040181|P2|STARTED|Period 2|These 5 were on placebo in Period 1 and on Atorvastatin in Period 2.|5
7732840|NCT01600170|19040182|P1|STARTED|Period 2|These 6 were on atorvastatin in period 1 and on placebo in Period 2.|6
7732841|NCT01600170|19040181|P2|NOT COMPLETED|Period 1||0
7732842|NCT01600170|19040182|P1|NOT COMPLETED|Period 1||0
7732843|NCT01600170|19040181|P2|COMPLETED|Period 1||5
7732844|NCT01600170|19040182|P1|COMPLETED|Period 1||6
7732845|NCT01600170|19040181|P2|STARTED|Period 1|Participants were assigned placebo for 12 wks followed by a washout and then atorvastatin.|5
7732846|NCT01600170|19040182|P1|STARTED|Period 1|Participants were assigned atorvastatin for 12 wks followed by a washout and then placebo.|6
7732847|NCT01600105|19040206|P2|NOT COMPLETED|Sub Study V||0
7732848|NCT01600105|19040207|P1|NOT COMPLETED|Sub Study V||2
7732849|NCT01600105|19040206|P2|COMPLETED|Sub Study V||0
7732850|NCT01600105|19040207|P1|COMPLETED|Sub Study V||50
7732851|NCT01600105|19040206|P2|STARTED|Sub Study V||0
7732852|NCT01600105|19040207|P1|STARTED|Sub Study V||52
7732853|NCT01600105|19040206|P2|NOT COMPLETED|Sub Study IV||0
7732854|NCT01600105|19040207|P1|NOT COMPLETED|Sub Study IV||0
7732855|NCT01600105|19040206|P2|COMPLETED|Sub Study IV||8
7732856|NCT01600105|19040207|P1|COMPLETED|Sub Study IV||41
7732857|NCT01600105|19040206|P2|STARTED|Sub Study IV||8
7732858|NCT01600105|19040207|P1|STARTED|Sub Study IV||41
7732859|NCT01600105|19040206|P2|NOT COMPLETED|Sub Study III||0
7732860|NCT01600105|19040207|P1|NOT COMPLETED|Sub Study III||5
7732861|NCT01600105|19040206|P2|COMPLETED|Sub Study III||0
7732862|NCT01600105|19040207|P1|COMPLETED|Sub Study III||34
7732863|NCT01600105|19040206|P2|STARTED|Sub Study III||0
7732864|NCT01600105|19040207|P1|STARTED|Sub Study III||39
7732865|NCT01600105|19040206|P2|NOT COMPLETED|Sub Study II||0
7732866|NCT01600105|19040207|P1|NOT COMPLETED|Sub Study II||5
7732867|NCT01600105|19040206|P2|COMPLETED|Sub Study II||0
7732868|NCT01600105|19040207|P1|COMPLETED|Sub Study II||60
7732869|NCT01600105|19040206|P2|STARTED|Sub Study II||0
7732870|NCT01600105|19040207|P1|STARTED|Sub Study II||65
7732871|NCT01600105|19040206|P2|NOT COMPLETED|Sub Study I||10
7732872|NCT01600105|19040207|P1|NOT COMPLETED|Sub Study I||0
7732873|NCT01600105|19040206|P2|COMPLETED|Sub Study I||11
7732874|NCT01600105|19040207|P1|COMPLETED|Sub Study I||19
7732875|NCT01600105|19040206|P2|STARTED|Sub Study I||21
7732876|NCT01600105|19040207|P1|STARTED|Sub Study I||19
7732877|NCT01600105|19040206|P2|NOT COMPLETED|Total Participants||10
7732878|NCT01600105|19040207|P1|NOT COMPLETED|Total Participants||41
7732879|NCT01600105|19040206|P2|COMPLETED|Total Participants||11
7732880|NCT01600105|19040207|P1|COMPLETED|Total Participants||214
7732881|NCT01600105|19040206|P2|STARTED|Total Participants||21
7732882|NCT01600105|19040207|P1|STARTED|Total Participants||255
7732883|NCT01600092|19040235|P2|NOT COMPLETED|Overall Study||16
7732884|NCT01600092|19040236|P1|NOT COMPLETED|Overall Study||18
7732885|NCT01600092|19040235|P2|COMPLETED|Overall Study||491
7732886|NCT01600092|19040236|P1|COMPLETED|Overall Study||495
7732887|NCT01600092|19040235|P2|Received All 3 Vaccinations|Overall Study||494
7732888|NCT01600092|19040236|P1|Received All 3 Vaccinations|Overall Study||500
7732889|NCT01600092|19040235|P2|Received at Least 1 Vaccination|Overall Study||504
7732890|NCT01600092|19040236|P1|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510
7732891|NCT01600092|19040235|P2|STARTED|Overall Study||507
7732892|NCT01600092|19040236|P1|STARTED|Overall Study||513
7732893|NCT01600053|19040250|P1|NOT COMPLETED|Overall Study||11
7732894|NCT01600053|19040250|P1|COMPLETED|Overall Study||0
7732895|NCT01600053|19040250|P1|STARTED|Overall Study||11
7732896|NCT01600014|19040255|P2|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0
7732897|NCT01600014|19040256|P1|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3
7732898|NCT01600014|19040255|P2|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20
7732899|NCT01600014|19040256|P1|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39
7732900|NCT01600014|19040255|P2|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20
7732901|NCT01600014|19040256|P1|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42
7732902|NCT01600014|19040255|P2|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10
7732903|NCT01600014|19040256|P1|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12
7732904|NCT01600014|19040255|P2|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39
7732905|NCT01600014|19040256|P1|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80
7732906|NCT01600014|19040255|P2|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49
7732907|NCT01600014|19040256|P1|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92
7732908|NCT01600014|19040255|P2|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0
7732909|NCT01600014|19040256|P1|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288
7732910|NCT01600014|19040255|P2|COMPLETED|1. Cycle & Observation Period D1 to W52||0
7732911|NCT01600014|19040256|P1|COMPLETED|1. Cycle & Observation Period D1 to W52||162
7732912|NCT01600014|19040255|P2|STARTED|1. Cycle & Observation Period D1 to W52||0
7732913|NCT01600014|19040256|P1|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450
7732914|NCT01599832|19040274|P1|NOT COMPLETED|Overall Study||0
7732915|NCT01599832|19040274|P1|COMPLETED|Overall Study||20
7732916|NCT01599832|19040274|P1|STARTED|Overall Study||20
7732917|NCT01599806|19040284|P2|NOT COMPLETED|Overall Study||41
7732918|NCT01599806|19040285|P1|NOT COMPLETED|Overall Study||43
7732919|NCT01599806|19040284|P2|COMPLETED|Overall Study||476
7732920|NCT01599806|19040285|P1|COMPLETED|Overall Study||473
7732921|NCT01599806|19040284|P2|STARTED|Overall Study||517
7732922|NCT01599806|19040285|P1|STARTED|Overall Study||516
7732923|NCT01599793|19040409|P1|NOT COMPLETED|Overall Study||2
7732924|NCT01599793|19040409|P1|COMPLETED|Overall Study||17
7732925|NCT01599793|19040409|P1|STARTED|Overall Study||19
7732926|NCT01599754|19040421|P2|NOT COMPLETED|Overall Study||360
7732927|NCT01599754|19040422|P1|NOT COMPLETED|Overall Study||363
7732928|NCT01599754|19040421|P2|COMPLETED|Overall Study||1
7732929|NCT01599754|19040422|P1|COMPLETED|Overall Study||0
7732930|NCT01599754|19040421|P2|Treated|Overall Study||360
7732931|NCT01599754|19040422|P1|Treated|Overall Study||360
7732932|NCT01599754|19040421|P2|STARTED|Overall Study||361
7732933|NCT01599754|19040422|P1|STARTED|Overall Study||363
7732934|NCT01599741|19040444|P1|NOT COMPLETED|Overall Study||3
7732935|NCT01599741|19040444|P1|COMPLETED|Overall Study||48
7732936|NCT01599741|19040444|P1|Collected Dose and Image Information|Overall Study||48
7732937|NCT01599741|19040444|P1|STARTED|Overall Study||51
7732938|NCT01599650|19040453|P3|NOT COMPLETED|Overall Study||27
7732939|NCT01599650|19040454|P2|NOT COMPLETED|Overall Study||26
7732940|NCT01599650|19040455|P1|NOT COMPLETED|Overall Study||22
7732941|NCT01599650|19040453|P3|COMPLETED|Overall Study||65
7732942|NCT01599650|19040454|P2|COMPLETED|Overall Study||154
7732943|NCT01599650|19040455|P1|COMPLETED|Overall Study||161
7732944|NCT01599650|19040453|P3|Completed 6 Mos|Overall Study||80
7732945|NCT01599650|19040454|P2|Completed 6 Mos|Overall Study||170
7732946|NCT01599650|19040455|P1|Completed 6 Mos|Overall Study||174
7732947|NCT01599650|19040453|P3|STARTED|Overall Study||92
7732948|NCT01599650|19040454|P2|STARTED|Overall Study||180
7732949|NCT01599650|19040455|P1|STARTED|Overall Study||183
7732950|NCT01599637|19040494|P3|NOT COMPLETED|Overall Study||0
7732951|NCT01599637|19040495|P2|NOT COMPLETED|Overall Study||2
7732952|NCT01599637|19040496|P1|NOT COMPLETED|Overall Study||1
7732953|NCT01599637|19040494|P3|COMPLETED|Overall Study||10
7732954|NCT01599637|19040495|P2|COMPLETED|Overall Study||8
7732955|NCT01599637|19040496|P1|COMPLETED|Overall Study||19
7732956|NCT01599637|19040494|P3|STARTED|Overall Study||10
7732957|NCT01599637|19040495|P2|STARTED|Overall Study||10
7732958|NCT01599637|19040496|P1|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20
7732959|NCT01599585|19040543|P2|NOT COMPLETED|Overall Study||17
7732960|NCT01599585|19040544|P1|NOT COMPLETED|Overall Study||22
7732961|NCT01599585|19040543|P2|COMPLETED|Overall Study||42
7732962|NCT01599585|19040544|P1|COMPLETED|Overall Study||40
7732963|NCT01599585|19040543|P2|STARTED|Overall Study||59
7732964|NCT01599585|19040544|P1|STARTED|Overall Study||62
7732965|NCT01599325|19040582|P1|NOT COMPLETED|Extension Phase||15
7732966|NCT01599325|19040582|P1|COMPLETED|Extension Phase||0
7732967|NCT01599325|19040582|P1|STARTED|Extension Phase||15
7732968|NCT01599325|19040582|P1|NOT COMPLETED|Primary Parent Phase||57
7732969|NCT01599325|19040582|P1|COMPLETED|Primary Parent Phase|Participants still on study treatment at time of study closure|15
7732970|NCT01599325|19040582|P1|Pharmacokinetic (PK) Population|Primary Parent Phase|Includes all participants with evaluable azacitidine plasma PK profiles.|12
7732971|NCT01599325|19040582|P1|Intent to Treat (ITT) Population|Primary Parent Phase|Includes all participants who were enrolled into the study|72
7732972|NCT01599325|19040582|P1|STARTED|Primary Parent Phase||72
7732973|NCT01599234|19040606|P2|NOT COMPLETED|Overall Study||15
7732974|NCT01599234|19040607|P1|NOT COMPLETED|Overall Study||17
7732975|NCT01599234|19040606|P2|COMPLETED|Overall Study||155
7732976|NCT01599234|19040607|P1|COMPLETED|Overall Study||150
7732977|NCT01599234|19040606|P2|STARTED|Overall Study||170
7732978|NCT01599234|19040607|P1|STARTED|Overall Study||167
7732979|NCT01599104|19040632|P3|NOT COMPLETED|Overall Study||26
7732980|NCT01599104|19040633|P2|NOT COMPLETED|Overall Study||14
7732981|NCT01599104|19040634|P1|NOT COMPLETED|Overall Study||16
7732982|NCT01599104|19040632|P3|COMPLETED|Overall Study||363
7732983|NCT01599104|19040633|P2|COMPLETED|Overall Study||371
7732984|NCT01599104|19040634|P1|COMPLETED|Overall Study||371
7732985|NCT01599104|19040632|P3|STARTED|Overall Study||389
7732986|NCT01599104|19040633|P2|STARTED|Overall Study||385
7732987|NCT01599104|19040634|P1|STARTED|Overall Study||387
7732988|NCT01598987|19040672|P1|NOT COMPLETED|Baseline to 24 Month||8
7732989|NCT01598987|19040672|P1|COMPLETED|Baseline to 24 Month||48
7732990|NCT01598987|19040672|P1|STARTED|Baseline to 24 Month||56
7732991|NCT01598987|19040672|P1|NOT COMPLETED|Baseline to Month 12||6
7732992|NCT01598987|19040672|P1|COMPLETED|Baseline to Month 12||50
7732993|NCT01598987|19040672|P1|STARTED|Baseline to Month 12||56
7732994|NCT01598922|19040708|P2|NOT COMPLETED|Overall Study||10
7732995|NCT01598922|19040709|P1|NOT COMPLETED|Overall Study||3
7732996|NCT01598922|19040708|P2|COMPLETED|Overall Study|Sample size (N)|30
7732997|NCT01598922|19040709|P1|COMPLETED|Overall Study|Sample size (N)|34
7732998|NCT01598922|19040708|P2|STARTED|Overall Study|Sample size (N)|40
7732999|NCT01598922|19040709|P1|STARTED|Overall Study|sample size (N)|37
7733000|NCT01598896|19040731|P2|NOT COMPLETED|Overall Study||2
7733001|NCT01598896|19040732|P1|NOT COMPLETED|Overall Study||0
7733002|NCT01598896|19040731|P2|COMPLETED|Overall Study||2
7733003|NCT01598896|19040732|P1|COMPLETED|Overall Study||3
7733004|NCT01598896|19040731|P2|STARTED|Overall Study||4
7733005|NCT01598896|19040732|P1|STARTED|Overall Study||3
7733006|NCT01598831|19040746|P2|NOT COMPLETED|Overall Study||136
7733007|NCT01598831|19040747|P1|NOT COMPLETED|Overall Study||119
7733008|NCT01598831|19040746|P2|COMPLETED|Overall Study||278
7733009|NCT01598831|19040747|P1|COMPLETED|Overall Study||283
7733010|NCT01598831|19040746|P2|Received at Least 1 Dose Study Treatment|Overall Study||405
7733011|NCT01598831|19040747|P1|Received at Least 1 Dose Study Treatment|Overall Study||395
7733012|NCT01598831|19040746|P2|STARTED|Overall Study||414
7733013|NCT01598831|19040747|P1|STARTED|Overall Study||402
7733014|NCT01598779|19040763|P1|NOT COMPLETED|Overall Study||0
7733015|NCT01598779|19040763|P1|COMPLETED|Overall Study||150
7733016|NCT01598779|19040763|P1|STARTED|Overall Study||150
7733017|NCT01598753|19040771|P4|NOT COMPLETED|Overall Study||15
7733018|NCT01598753|19040772|P3|NOT COMPLETED|Overall Study||8
7733019|NCT01598753|19040773|P2|NOT COMPLETED|Overall Study||15
7733020|NCT01598753|19040774|P1|NOT COMPLETED|Overall Study||12
7733021|NCT01598753|19040771|P4|COMPLETED|Overall Study||19
7733022|NCT01598753|19040772|P3|COMPLETED|Overall Study||24
7733023|NCT01598753|19040773|P2|COMPLETED|Overall Study||16
7733024|NCT01598753|19040774|P1|COMPLETED|Overall Study||25
7733025|NCT01598753|19040771|P4|STARTED|Overall Study||34
7733026|NCT01598753|19040772|P3|STARTED|Overall Study||32
7733027|NCT01598753|19040773|P2|STARTED|Overall Study||31
7733028|NCT01598753|19040774|P1|STARTED|Overall Study||37
7733029|NCT01598740|19040786|P2|NOT COMPLETED|Period 2||0
7733030|NCT01598740|19040787|P1|NOT COMPLETED|Period 2||1
7733031|NCT01598740|19040786|P2|COMPLETED|Period 2||9
7733032|NCT01598740|19040787|P1|COMPLETED|Period 2||7
7733033|NCT01598740|19040786|P2|STARTED|Period 2||9
7733034|NCT01598740|19040787|P1|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8
7733035|NCT01598740|19040786|P2|NOT COMPLETED|Period 1||0
7733036|NCT01598740|19040787|P1|NOT COMPLETED|Period 1||0
7733037|NCT01598740|19040786|P2|COMPLETED|Period 1||9
7733038|NCT01598740|19040787|P1|COMPLETED|Period 1||9
7733039|NCT01598740|19040786|P2|STARTED|Period 1||9
7733040|NCT01598740|19040787|P1|STARTED|Period 1||9
7733041|NCT01598701|19040797|P2|NOT COMPLETED|Overall Study||9
7733042|NCT01598701|19040798|P1|NOT COMPLETED|Overall Study||5
7733043|NCT01598701|19040797|P2|COMPLETED|Overall Study||41
7733044|NCT01598701|19040798|P1|COMPLETED|Overall Study||45
7733045|NCT01598701|19040797|P2|STARTED|Overall Study||50
7733046|NCT01598701|19040798|P1|STARTED|Overall Study||50
7733047|NCT01598662|19040814|P2|NOT COMPLETED|Overall Study||21
7733048|NCT01598662|19040815|P1|NOT COMPLETED|Overall Study||11
7733049|NCT01598662|19040814|P2|COMPLETED|Overall Study||0
7733050|NCT01598662|19040815|P1|COMPLETED|Overall Study||0
7733051|NCT01598662|19040814|P2|Patients Returned for 6 wk Postpartum|Overall Study||2
7733052|NCT01598662|19040815|P1|Patients Returned for 6 wk Postpartum|Overall Study||0
7733053|NCT01598662|19040814|P2|Patients Who Received IUD|Overall Study||18
7733054|NCT01598662|19040815|P1|Patients Who Received IUD|Overall Study|Subjects did not return at 6 weeks for IUD insertion.|0
7733055|NCT01598662|19040814|P2|STARTED|Overall Study||21
7733056|NCT01598662|19040815|P1|STARTED|Overall Study||11
7733057|NCT01598610|19040821|P1|NOT COMPLETED|Overall Study||1
7733058|NCT01598610|19040821|P1|COMPLETED|Overall Study||219
7733059|NCT01598610|19040821|P1|STARTED|Overall Study||220
7733060|NCT01598545|19040830|P1|NOT COMPLETED|Overall Study||0
7733061|NCT01598545|19040830|P1|COMPLETED|Overall Study||20
7733062|NCT01598545|19040830|P1|STARTED|Overall Study||20
7733063|NCT01598532|19040838|P1|NOT COMPLETED|Overall Study||11
7733064|NCT01598532|19040838|P1|COMPLETED|Overall Study||11
7733065|NCT01598532|19040838|P1|STARTED|Overall Study||22
7733066|NCT01598506|19040847|P1|NOT COMPLETED|Overall Study||2
7733067|NCT01598506|19040847|P1|COMPLETED|Overall Study||20
7733068|NCT01598506|19040847|P1|STARTED|Overall Study||22
7733069|NCT01598428|19040852|P1|NOT COMPLETED|Overall Study||0
7733070|NCT01598428|19040852|P1|COMPLETED|Overall Study||20
7733071|NCT01598428|19040852|P1|STARTED|Overall Study||20
7733072|NCT01598350|19040861|P1|NOT COMPLETED|Overall Study||0
7733073|NCT01598350|19040861|P1|COMPLETED|Overall Study||6
7733074|NCT01598350|19040861|P1|STARTED|Overall Study||6
7733075|NCT01598311|19040867|P2|NOT COMPLETED|Overall Study||61
7733076|NCT01598311|19040868|P1|NOT COMPLETED|Overall Study||47
7733077|NCT01598311|19040867|P2|COMPLETED|Overall Study||244
7733078|NCT01598311|19040868|P1|COMPLETED|Overall Study||256
7733079|NCT01598311|19040867|P2|Treated and Confirmed CDAD|Overall Study||292
7733080|NCT01598311|19040868|P1|Treated and Confirmed CDAD|Overall Study||285
7733081|NCT01598311|19040867|P2|Treated|Overall Study||301
7733082|NCT01598311|19040868|P1|Treated|Overall Study||294
7733083|NCT01598311|19040867|P2|STARTED|Overall Study||305
7733084|NCT01598311|19040868|P1|STARTED|Overall Study||303
7733085|NCT01598298|19040884|P2|NOT COMPLETED|Overall Study||41
7733086|NCT01598298|19040885|P1|NOT COMPLETED|Overall Study||40
7733087|NCT01598298|19040884|P2|COMPLETED|Overall Study||108
7733088|NCT01598298|19040885|P1|COMPLETED|Overall Study||110
7733089|NCT01598298|19040884|P2|Patients Evaluable for Adverse Events|Overall Study||141
7733090|NCT01598298|19040885|P1|Patients Evaluable for Adverse Events|Overall Study||138
7733091|NCT01598298|19040884|P2|Patients Evaluable for Primary Endpoint|Overall Study||128
7733092|NCT01598298|19040885|P1|Patients Evaluable for Primary Endpoint|Overall Study||127
7733093|NCT01598298|19040884|P2|STARTED|Overall Study||149
7733094|NCT01598298|19040885|P1|STARTED|Overall Study||150
7733095|NCT01598207|19040897|P2|NOT COMPLETED|Overall Study||0
7733096|NCT01598207|19040898|P1|NOT COMPLETED|Overall Study||1
7733097|NCT01598207|19040897|P2|COMPLETED|Overall Study||6
7733098|NCT01598207|19040898|P1|COMPLETED|Overall Study||6
7733099|NCT01598207|19040897|P2|STARTED|Overall Study||6
7733100|NCT01598207|19040898|P1|STARTED|Overall Study||7
7733101|NCT01598194|19040918|P2|NOT COMPLETED|Overall Study||0
7733102|NCT01598194|19040919|P1|NOT COMPLETED|Overall Study||0
7733103|NCT01598194|19040918|P2|COMPLETED|Overall Study||30
7733104|NCT01598194|19040919|P1|COMPLETED|Overall Study||30
7733105|NCT01598194|19040918|P2|1 Pass With 22Gpc for Histology|Overall Study|1 participant's pass could not be performed|29
7733106|NCT01598194|19040919|P1|1 Pass With 22Gpc for Histology|Overall Study|3 participants passes could not be performed|27
7733107|NCT01598194|19040918|P2|1 Pass With 22Gpc for Cytology|Overall Study||30
7733108|NCT01598194|19040919|P1|1 Pass With 22Gpc for Cytology|Overall Study|1 participant's pass could not be performed|29
7733109|NCT01598194|19040918|P2|2 Passes With 25G for Cytology|Overall Study||30
7733110|NCT01598194|19040919|P1|2 Passes With 25G for Cytology|Overall Study||30
7733111|NCT01598194|19040918|P2|STARTED|Overall Study||30
7733112|NCT01598194|19040919|P1|STARTED|Overall Study||30
7733113|NCT01598129|19040929|P1|NOT COMPLETED|Overall Study||9
7733114|NCT01598129|19040929|P1|COMPLETED|Overall Study||3
7733115|NCT01598129|19040929|P1|STARTED|Overall Study||12
7733116|NCT01598090|19040941|P3|NOT COMPLETED|Follow-up Period||28
7733117|NCT01598090|19040942|P2|NOT COMPLETED|Follow-up Period||35
7733118|NCT01598090|19040943|P1|NOT COMPLETED|Follow-up Period||5
7733119|NCT01598090|19040941|P3|COMPLETED|Follow-up Period||171
7733120|NCT01598090|19040942|P2|COMPLETED|Follow-up Period||364
7733121|NCT01598090|19040943|P1|COMPLETED|Follow-up Period||21
7733122|NCT01598090|19040941|P3|STARTED|Follow-up Period|Includes 28 participants who re-joined from treatment period to follow-up period.|199
7733123|NCT01598090|19040942|P2|STARTED|Follow-up Period|Includes 60 participants who re-joined from treatment period to follow-up period.|399
7733124|NCT01598090|19040943|P1|STARTED|Follow-up Period|Includes 10 participants who re-joined from treatment period to follow-up period.|26
7733125|NCT01598090|19040941|P3|NOT COMPLETED|Treatment Period||35
7733126|NCT01598090|19040942|P2|NOT COMPLETED|Treatment Period||72
7733127|NCT01598090|19040943|P1|NOT COMPLETED|Treatment Period||11
7733128|NCT01598090|19040941|P3|COMPLETED|Treatment Period||171
7733129|NCT01598090|19040942|P2|COMPLETED|Treatment Period||339
7733130|NCT01598090|19040943|P1|COMPLETED|Treatment Period||16
7733131|NCT01598090|19040941|P3|STARTED|Treatment Period||206
7733132|NCT01598090|19040942|P2|STARTED|Treatment Period||411
7733133|NCT01598090|19040943|P1|STARTED|Treatment Period||27
7733134|NCT01598064|19040969|P2|NOT COMPLETED|Overall Study||0
7733135|NCT01598064|19040970|P1|NOT COMPLETED|Overall Study||0
7733136|NCT01598064|19040969|P2|COMPLETED|Overall Study||24
7733137|NCT01598064|19040970|P1|COMPLETED|Overall Study||25
7733138|NCT01598064|19040969|P2|STARTED|Overall Study||24
7733139|NCT01598064|19040970|P1|STARTED|Overall Study||25
7733140|NCT01598025|19040980|P2|NOT COMPLETED|Overall Study||3
7733141|NCT01598025|19040981|P1|NOT COMPLETED|Overall Study||0
7733142|NCT01598025|19040980|P2|COMPLETED|Overall Study||0
7733143|NCT01598025|19040981|P1|COMPLETED|Overall Study||0
7733144|NCT01598025|19040980|P2|STARTED|Overall Study||3
7733145|NCT01598025|19040981|P1|STARTED|Overall Study||0
7733146|NCT01597908|19040990|P2|NOT COMPLETED|Overall Study||352
7733147|NCT01597908|19040991|P1|NOT COMPLETED|Overall Study||352
7733148|NCT01597908|19040990|P2|COMPLETED|Overall Study||0
7733149|NCT01597908|19040991|P1|COMPLETED|Overall Study||0
7733150|NCT01597908|19040990|P2|Ongoing|Overall Study||202
7733151|NCT01597908|19040991|P1|Ongoing|Overall Study||236
7733152|NCT01597908|19040990|P2|STARTED|Overall Study||352
7733153|NCT01597908|19040991|P1|STARTED|Overall Study||352
7733154|NCT01597856|19041006|P3|NOT COMPLETED|Overall Study||54
7733155|NCT01597856|19041007|P2|NOT COMPLETED|Overall Study||26
7733156|NCT01597856|19041008|P1|NOT COMPLETED|Overall Study||22
7733157|NCT01597856|19041006|P3|COMPLETED|Overall Study||120
7733158|NCT01597856|19041007|P2|COMPLETED|Overall Study||61
7733159|NCT01597856|19041008|P1|COMPLETED|Overall Study||63
7733160|NCT01597856|19041006|P3|Week 4 Follow-up|Overall Study||129
7733161|NCT01597856|19041007|P2|Week 4 Follow-up|Overall Study||67
7733162|NCT01597856|19041008|P1|Week 4 Follow-up|Overall Study||62
7733163|NCT01597856|19041006|P3|STARTED|Overall Study||174
7733164|NCT01597856|19041007|P2|STARTED|Overall Study||87
7733165|NCT01597856|19041008|P1|STARTED|Overall Study||85
7733166|NCT01597843|19041025|P3|NOT COMPLETED|Overall Study||0
7733167|NCT01597843|19041026|P2|NOT COMPLETED|Overall Study||0
7733168|NCT01597843|19041027|P1|NOT COMPLETED|Overall Study||0
7733169|NCT01597843|19041025|P3|COMPLETED|Overall Study||81
7733170|NCT01597843|19041026|P2|COMPLETED|Overall Study||122
7733171|NCT01597843|19041027|P1|COMPLETED|Overall Study||79
7733172|NCT01597843|19041025|P3|Survey 3 Responses|Overall Study||76
7733173|NCT01597843|19041026|P2|Survey 3 Responses|Overall Study||56
7733174|NCT01597843|19041027|P1|Survey 3 Responses|Overall Study||65
7733175|NCT01597843|19041025|P3|Survey 2 Responses|Overall Study||58
7733176|NCT01597843|19041026|P2|Survey 2 Responses|Overall Study||42
7733177|NCT01597843|19041027|P1|Survey 2 Responses|Overall Study||52
7733178|NCT01597843|19041025|P3|Survey 1 Responses|Overall Study||59
7733179|NCT01597843|19041026|P2|Survey 1 Responses|Overall Study||71
7733180|NCT01597843|19041027|P1|Survey 1 Responses|Overall Study||45
7733181|NCT01597843|19041025|P3|STARTED|Overall Study||81
7733182|NCT01597843|19041026|P2|STARTED|Overall Study||122
7733183|NCT01597843|19041027|P1|STARTED|Overall Study||79
7733184|NCT01597791|19041037|P2|NOT COMPLETED|Overall Study||10
7733185|NCT01597791|19041038|P1|NOT COMPLETED|Overall Study||8
7733186|NCT01597791|19041037|P2|COMPLETED|Overall Study||18
7733187|NCT01597791|19041038|P1|COMPLETED|Overall Study||20
7733188|NCT01597791|19041037|P2|STARTED|Overall Study||28
7733189|NCT01597791|19041038|P1|STARTED|Overall Study||28
7733190|NCT01597687|19041047|P3|NOT COMPLETED|Overall Study||0
7733191|NCT01597687|19041048|P2|NOT COMPLETED|Overall Study||0
7733192|NCT01597687|19041049|P1|NOT COMPLETED|Overall Study||0
7733193|NCT01597687|19041047|P3|COMPLETED|Overall Study||147
7733194|NCT01597687|19041048|P2|COMPLETED|Overall Study||89
7733195|NCT01597687|19041049|P1|COMPLETED|Overall Study||76
7733196|NCT01597687|19041047|P3|STARTED|Overall Study||147
7733197|NCT01597687|19041048|P2|STARTED|Overall Study||89
7733198|NCT01597687|19041049|P1|STARTED|Overall Study||76
7733199|NCT01597635|19041125|P3|NOT COMPLETED|Part B||4
7733200|NCT01597635|19041126|P2|NOT COMPLETED|Part B||6
7733201|NCT01597635|19041127|P1|NOT COMPLETED|Part B||0
7733202|NCT01597635|19041125|P3|COMPLETED|Part B||15
7733203|NCT01597635|19041126|P2|COMPLETED|Part B||14
7733204|NCT01597635|19041127|P1|COMPLETED|Part B||0
7733205|NCT01597635|19041125|P3|STARTED|Part B||19
7733206|NCT01597635|19041126|P2|STARTED|Part B||20
7733207|NCT01597635|19041127|P1|STARTED|Part B||0
7733208|NCT01597635|19041125|P3|NOT COMPLETED|Part A||0
7733209|NCT01597635|19041126|P2|NOT COMPLETED|Part A||0
7733210|NCT01597635|19041127|P1|NOT COMPLETED|Part A||3
7733211|NCT01597635|19041125|P3|COMPLETED|Part A||0
7733212|NCT01597635|19041126|P2|COMPLETED|Part A||0
7733213|NCT01597635|19041127|P1|COMPLETED|Part A||2
7733214|NCT01597635|19041125|P3|STARTED|Part A||0
7733215|NCT01597635|19041126|P2|STARTED|Part A||0
7733216|NCT01597635|19041127|P1|STARTED|Part A||5
7733217|NCT01597622|19041190|P1|NOT COMPLETED|Overall Study||38
7733218|NCT01597622|19041190|P1|COMPLETED|Overall Study||104
7733219|NCT01597622|19041190|P1|STARTED|Overall Study||142
7733220|NCT01597596|19041197|P2|NOT COMPLETED|Overall Study||1
7733221|NCT01597596|19041198|P1|NOT COMPLETED|Overall Study||1
7733222|NCT01597596|19041197|P2|COMPLETED|Overall Study||2
7733223|NCT01597596|19041198|P1|COMPLETED|Overall Study||0
7733224|NCT01597596|19041197|P2|STARTED|Overall Study||3
7733225|NCT01597596|19041198|P1|STARTED|Overall Study||1
7733226|NCT01597557|19041212|P2|NOT COMPLETED|Overall Study||3
7733227|NCT01597557|19041213|P1|NOT COMPLETED|Overall Study||4
7733228|NCT01597557|19041212|P2|COMPLETED|Overall Study||126
7733229|NCT01597557|19041213|P1|COMPLETED|Overall Study||128
7733230|NCT01597557|19041212|P2|STARTED|Overall Study||129
7733231|NCT01597557|19041213|P1|STARTED|Overall Study||132
7733232|NCT01597505|19041225|P2|NOT COMPLETED|Overall Study||33
7733233|NCT01597505|19041226|P1|NOT COMPLETED|Overall Study||44
7733234|NCT01597505|19041225|P2|COMPLETED|Overall Study||265
7733235|NCT01597505|19041226|P1|COMPLETED|Overall Study||264
7733236|NCT01597505|19041225|P2|Treated|Overall Study||286
7733237|NCT01597505|19041226|P1|Treated|Overall Study|One participant was instead randomized to vancomycin|305
7733238|NCT01597505|19041225|P2|STARTED|Overall Study|Randomized participants|298
7733239|NCT01597505|19041226|P1|STARTED|Overall Study|Randomized participants|308
7733240|NCT01597492|19041260|P2|NOT COMPLETED|Overall Study||4
7733241|NCT01597492|19041261|P1|NOT COMPLETED|Overall Study||6
7733242|NCT01597492|19041260|P2|COMPLETED|Overall Study||41
7733243|NCT01597492|19041261|P1|COMPLETED|Overall Study||28
7733244|NCT01597492|19041260|P2|STARTED|Overall Study||45
7733245|NCT01597492|19041261|P1|STARTED|Overall Study||34
7733246|NCT01597479|19041269|P2|NOT COMPLETED|Overall Study||0
7733247|NCT01597479|19041270|P1|NOT COMPLETED|Overall Study||2
7733248|NCT01597479|19041269|P2|COMPLETED|Overall Study||26
7733249|NCT01597479|19041270|P1|COMPLETED|Overall Study||24
7733250|NCT01597479|19041269|P2|STARTED|Overall Study||26
7733251|NCT01597479|19041270|P1|STARTED|Overall Study||26
7733252|NCT01597440|19041279|P2|NOT COMPLETED|Overall Study||0
7733253|NCT01597440|19041280|P1|NOT COMPLETED|Overall Study||0
7733254|NCT01597440|19041279|P2|COMPLETED|Overall Study||0
7733255|NCT01597440|19041280|P1|COMPLETED|Overall Study||1
7733256|NCT01597440|19041279|P2|STARTED|Overall Study||0
7733257|NCT01597440|19041280|P1|STARTED|Overall Study||1
7733258|NCT01597388|19041297|P9|NOT COMPLETED|Overall Study||0
7733259|NCT01597388|19041298|P8|NOT COMPLETED|Overall Study||0
7733260|NCT01597388|19041299|P7|NOT COMPLETED|Overall Study||0
7733261|NCT01597388|19041300|P6|NOT COMPLETED|Overall Study||0
7733262|NCT01597388|19041301|P5|NOT COMPLETED|Overall Study||0
7733263|NCT01597388|19041302|P4|NOT COMPLETED|Overall Study||0
7733264|NCT01597388|19041303|P3|NOT COMPLETED|Overall Study||0
7733265|NCT01597388|19041304|P2|NOT COMPLETED|Overall Study||0
7733266|NCT01597388|19041305|P1|NOT COMPLETED|Overall Study||0
7733267|NCT01597388|19041297|P9|COMPLETED|Overall Study||2
7733268|NCT01597388|19041298|P8|COMPLETED|Overall Study||5
7733269|NCT01597388|19041299|P7|COMPLETED|Overall Study||8
7733270|NCT01597388|19041300|P6|COMPLETED|Overall Study||4
7733271|NCT01597388|19041301|P5|COMPLETED|Overall Study||37
7733272|NCT01597388|19041302|P4|COMPLETED|Overall Study||10
7733273|NCT01597388|19041303|P3|COMPLETED|Overall Study||14
7733274|NCT01597388|19041304|P2|COMPLETED|Overall Study||13
7733275|NCT01597388|19041305|P1|COMPLETED|Overall Study||6
7733276|NCT01597388|19041297|P9|STARTED|Overall Study||2
7733277|NCT01597388|19041298|P8|STARTED|Overall Study||5
7733278|NCT01597388|19041299|P7|STARTED|Overall Study||8
7733279|NCT01597388|19041300|P6|STARTED|Overall Study||4
7733280|NCT01597388|19041301|P5|STARTED|Overall Study||37
7733281|NCT01597388|19041302|P4|STARTED|Overall Study||10
7733282|NCT01597388|19041303|P3|STARTED|Overall Study||14
7733283|NCT01597388|19041304|P2|STARTED|Overall Study||13
7733284|NCT01597388|19041305|P1|STARTED|Overall Study||6
7733285|NCT01597375|19041556|P2|NOT COMPLETED|Second Intervention||1
7733286|NCT01597375|19041557|P1|NOT COMPLETED|Second Intervention||1
7733287|NCT01597375|19041556|P2|COMPLETED|Second Intervention||21
7733288|NCT01597375|19041557|P1|COMPLETED|Second Intervention||19
7733289|NCT01597375|19041556|P2|STARTED|Second Intervention||22
7733290|NCT01597375|19041557|P1|STARTED|Second Intervention||20
7733291|NCT01597375|19041556|P2|NOT COMPLETED|Washout (2 Weeks)||0
7733292|NCT01597375|19041557|P1|NOT COMPLETED|Washout (2 Weeks)||1
7733293|NCT01597375|19041556|P2|COMPLETED|Washout (2 Weeks)||22
7733294|NCT01597375|19041557|P1|COMPLETED|Washout (2 Weeks)||20
7733295|NCT01597375|19041556|P2|STARTED|Washout (2 Weeks)||22
7733296|NCT01597375|19041557|P1|STARTED|Washout (2 Weeks)||21
7733297|NCT01597375|19041556|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
7733298|NCT01597375|19041557|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
7733299|NCT01597375|19041556|P2|COMPLETED|First Intervention (4 Weeks)||22
7733300|NCT01597375|19041557|P1|COMPLETED|First Intervention (4 Weeks)||21
7733301|NCT01597375|19041556|P2|STARTED|First Intervention (4 Weeks)||23
7733302|NCT01597375|19041557|P1|STARTED|First Intervention (4 Weeks)||23
7733303|NCT01597258|19041574|P1|NOT COMPLETED|Overall Study||1
7733304|NCT01597258|19041574|P1|COMPLETED|Overall Study||2028
7733305|NCT01597258|19041574|P1|STARTED|Overall Study||2029
7733306|NCT01597245|19041583|P21|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||36
7733307|NCT01597245|19041584|P20|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||167
7733308|NCT01597245|19041585|P19|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||10
7733309|NCT01597245|19041586|P18|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||6
7733310|NCT01597245|19041587|P17|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||16
7733311|NCT01597245|19041588|P16|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733312|NCT01597245|19041589|P15|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733313|NCT01597245|19041590|P14|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733314|NCT01597245|19041591|P13|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733315|NCT01597245|19041592|P12|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733316|NCT01597245|19041593|P11|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733317|NCT01597245|19041594|P10|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733318|NCT01597245|19041595|P9|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733319|NCT01597245|19041596|P8|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733320|NCT01597245|19041597|P7|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733321|NCT01597245|19041598|P6|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733322|NCT01597245|19041599|P5|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733323|NCT01597245|19041600|P4|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733324|NCT01597245|19041601|P3|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733325|NCT01597245|19041602|P2|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733326|NCT01597245|19041603|P1|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733327|NCT01597245|19041583|P21|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||212
7733328|NCT01597245|19041584|P20|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||489
7733329|NCT01597245|19041585|P19|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||14
7733330|NCT01597245|19041586|P18|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733331|NCT01597245|19041587|P17|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733332|NCT01597245|19041588|P16|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733333|NCT01597245|19041589|P15|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733334|NCT01597245|19041590|P14|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733335|NCT01597245|19041591|P13|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733336|NCT01597245|19041592|P12|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733337|NCT01597245|19041593|P11|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733338|NCT01597245|19041594|P10|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733339|NCT01597245|19041595|P9|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733340|NCT01597245|19041596|P8|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733341|NCT01597245|19041597|P7|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733342|NCT01597245|19041598|P6|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733343|NCT01597245|19041599|P5|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733344|NCT01597245|19041600|P4|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733345|NCT01597245|19041601|P3|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733346|NCT01597245|19041602|P2|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733347|NCT01597245|19041603|P1|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733348|NCT01597245|19041583|P21|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|248
7733349|NCT01597245|19041584|P20|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|656
7733350|NCT01597245|19041585|P19|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|24
7733351|NCT01597245|19041586|P18|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|6
7733352|NCT01597245|19041587|P17|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|16
7733353|NCT01597245|19041588|P16|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
7733354|NCT01597245|19041589|P15|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
7733355|NCT01597245|19041590|P14|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733356|NCT01597245|19041591|P13|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733357|NCT01597245|19041592|P12|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733358|NCT01597245|19041593|P11|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733359|NCT01597245|19041594|P10|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733360|NCT01597245|19041595|P9|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733361|NCT01597245|19041596|P8|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733362|NCT01597245|19041597|P7|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733363|NCT01597245|19041598|P6|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733364|NCT01597245|19041599|P5|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733365|NCT01597245|19041600|P4|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733366|NCT01597245|19041601|P3|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733367|NCT01597245|19041602|P2|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733368|NCT01597245|19041603|P1|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
7733369|NCT01597245|19041583|P21|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733370|NCT01597245|19041584|P20|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733371|NCT01597245|19041585|P19|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733372|NCT01597245|19041586|P18|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733373|NCT01597245|19041587|P17|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733374|NCT01597245|19041588|P16|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||228
7733375|NCT01597245|19041589|P15|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||225
7733376|NCT01597245|19041590|P14|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||26
7733377|NCT01597245|19041591|P13|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733378|NCT01597245|19041592|P12|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733379|NCT01597245|19041593|P11|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733380|NCT01597245|19041594|P10|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733381|NCT01597245|19041595|P9|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733382|NCT01597245|19041596|P8|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733383|NCT01597245|19041597|P7|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733384|NCT01597245|19041598|P6|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733385|NCT01597245|19041599|P5|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733386|NCT01597245|19041600|P4|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733387|NCT01597245|19041601|P3|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733388|NCT01597245|19041602|P2|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733389|NCT01597245|19041603|P1|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733390|NCT01597245|19041583|P21|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733391|NCT01597245|19041584|P20|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733392|NCT01597245|19041585|P19|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733393|NCT01597245|19041586|P18|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733394|NCT01597245|19041587|P17|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733395|NCT01597245|19041588|P16|COMPLETED|Long Term Extension (Week 60 - Week 264)||774
7733396|NCT01597245|19041589|P15|COMPLETED|Long Term Extension (Week 60 - Week 264)||754
7733397|NCT01597245|19041590|P14|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733398|NCT01597245|19041591|P13|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733399|NCT01597245|19041592|P12|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733400|NCT01597245|19041593|P11|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733401|NCT01597245|19041594|P10|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733402|NCT01597245|19041595|P9|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733403|NCT01597245|19041596|P8|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733404|NCT01597245|19041597|P7|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733405|NCT01597245|19041598|P6|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733406|NCT01597245|19041599|P5|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733407|NCT01597245|19041600|P4|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733408|NCT01597245|19041601|P3|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733409|NCT01597245|19041602|P2|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733410|NCT01597245|19041603|P1|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
7733411|NCT01597245|19041583|P21|STARTED|Long Term Extension (Week 60 - Week 264)||0
7733412|NCT01597245|19041584|P20|STARTED|Long Term Extension (Week 60 - Week 264)||0
7733413|NCT01597245|19041585|P19|STARTED|Long Term Extension (Week 60 - Week 264)||0
7733414|NCT01597245|19041586|P18|STARTED|Long Term Extension (Week 60 - Week 264)||0
7733415|NCT01597245|19041587|P17|STARTED|Long Term Extension (Week 60 - Week 264)||0
7733481|NCT01597245|19041590|P14|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
7733416|NCT01597245|19041588|P16|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe in all dosing regimens, including participants who switched PBO to ixe.|1002
7733417|NCT01597245|19041589|P15|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe at the start of the long-term extension.|979
7733418|NCT01597245|19041590|P14|STARTED|Long Term Extension (Week 60 - Week 264)|Participants who received placebo at the start of the long-term extension period.|26
7733419|NCT01597245|19041591|P13|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
7733420|NCT01597245|19041592|P12|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
7733421|NCT01597245|19041593|P11|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
7733422|NCT01597245|19041594|P10|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
7733423|NCT01597245|19041595|P9|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
7733424|NCT01597245|19041596|P8|STARTED|Long Term Extension (Week 60 - Week 264)||0
7733425|NCT01597245|19041597|P7|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
7733426|NCT01597245|19041598|P6|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
7733427|NCT01597245|19041599|P5|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
7733428|NCT01597245|19041600|P4|STARTED|Long Term Extension (Week 60 - Week 264)||0
7733429|NCT01597245|19041601|P3|STARTED|Long Term Extension (Week 60 - Week 264)||0
7733430|NCT01597245|19041602|P2|STARTED|Long Term Extension (Week 60 - Week 264)||0
7733431|NCT01597245|19041603|P1|STARTED|Long Term Extension (Week 60 - Week 264)||0
7733432|NCT01597245|19041583|P21|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733433|NCT01597245|19041584|P20|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733434|NCT01597245|19041585|P19|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733435|NCT01597245|19041586|P18|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733436|NCT01597245|19041587|P17|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733437|NCT01597245|19041588|P16|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733438|NCT01597245|19041589|P15|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733439|NCT01597245|19041590|P14|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733440|NCT01597245|19041591|P13|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12
7733441|NCT01597245|19041592|P12|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19
7733442|NCT01597245|19041593|P11|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22
7733443|NCT01597245|19041594|P10|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||121
7733444|NCT01597245|19041595|P9|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20
7733445|NCT01597245|19041596|P8|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3
7733446|NCT01597245|19041597|P7|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89
7733447|NCT01597245|19041598|P6|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||38
7733448|NCT01597245|19041599|P5|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||161
7733449|NCT01597245|19041600|P4|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733450|NCT01597245|19041601|P3|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733451|NCT01597245|19041602|P2|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733452|NCT01597245|19041603|P1|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733453|NCT01597245|19041583|P21|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733454|NCT01597245|19041584|P20|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733455|NCT01597245|19041585|P19|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733456|NCT01597245|19041586|P18|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733457|NCT01597245|19041587|P17|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733458|NCT01597245|19041588|P16|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733459|NCT01597245|19041589|P15|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733460|NCT01597245|19041590|P14|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733461|NCT01597245|19041591|P13|COMPLETED|Maintenance Period (Week 12 to Week 60)||37
7733462|NCT01597245|19041592|P12|COMPLETED|Maintenance Period (Week 12 to Week 60)||56
7733463|NCT01597245|19041593|P11|COMPLETED|Maintenance Period (Week 12 to Week 60)||178
7733464|NCT01597245|19041594|P10|COMPLETED|Maintenance Period (Week 12 to Week 60)||11
7733465|NCT01597245|19041595|P9|COMPLETED|Maintenance Period (Week 12 to Week 60)||135
7733466|NCT01597245|19041596|P8|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733467|NCT01597245|19041597|P7|COMPLETED|Maintenance Period (Week 12 to Week 60)||92
7733468|NCT01597245|19041598|P6|COMPLETED|Maintenance Period (Week 12 to Week 60)||149
7733469|NCT01597245|19041599|P5|COMPLETED|Maintenance Period (Week 12 to Week 60)||15
7733470|NCT01597245|19041600|P4|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733471|NCT01597245|19041601|P3|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733472|NCT01597245|19041602|P2|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733473|NCT01597245|19041603|P1|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
7733474|NCT01597245|19041583|P21|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
7733475|NCT01597245|19041584|P20|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
7733476|NCT01597245|19041585|P19|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
7733477|NCT01597245|19041586|P18|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
7733478|NCT01597245|19041587|P17|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
7733479|NCT01597245|19041588|P16|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
7733480|NCT01597245|19041589|P15|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
7733482|NCT01597245|19041591|P13|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49
7733483|NCT01597245|19041592|P12|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75
7733484|NCT01597245|19041593|P11|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200
7733485|NCT01597245|19041594|P10|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132
7733486|NCT01597245|19041595|P9|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155
7733487|NCT01597245|19041596|P8|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3
7733488|NCT01597245|19041597|P7|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181
7733489|NCT01597245|19041598|P6|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187
7733490|NCT01597245|19041599|P5|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176
7733491|NCT01597245|19041600|P4|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
7733492|NCT01597245|19041601|P3|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
7733493|NCT01597245|19041602|P2|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
7733494|NCT01597245|19041603|P1|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
7733495|NCT01597245|19041583|P21|STARTED|Maintenance Period (Week 12 to Week 60)||0
7733496|NCT01597245|19041584|P20|STARTED|Maintenance Period (Week 12 to Week 60)||0
7733497|NCT01597245|19041585|P19|STARTED|Maintenance Period (Week 12 to Week 60)||0
7733498|NCT01597245|19041586|P18|STARTED|Maintenance Period (Week 12 to Week 60)||0
7733499|NCT01597245|19041587|P17|STARTED|Maintenance Period (Week 12 to Week 60)||0
7733500|NCT01597245|19041588|P16|STARTED|Maintenance Period (Week 12 to Week 60)||0
7733501|NCT01597245|19041589|P15|STARTED|Maintenance Period (Week 12 to Week 60)||0
7733502|NCT01597245|19041590|P14|STARTED|Maintenance Period (Week 12 to Week 60)||0
7733503|NCT01597245|19041591|P13|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|49
7733504|NCT01597245|19041592|P12|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|75
7733505|NCT01597245|19041593|P11|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|200
7733506|NCT01597245|19041594|P10|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|132
7733507|NCT01597245|19041595|P9|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|155
7733508|NCT01597245|19041596|P8|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|3
7733509|NCT01597245|19041597|P7|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|181
7733510|NCT01597245|19041598|P6|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|187
7733511|NCT01597245|19041599|P5|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|176
7733512|NCT01597245|19041600|P4|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
7733513|NCT01597245|19041601|P3|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
7733514|NCT01597245|19041602|P2|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
7733515|NCT01597245|19041603|P1|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
7733516|NCT01597245|19041583|P21|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
7733517|NCT01597245|19041584|P20|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
7733518|NCT01597245|19041585|P19|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
7733519|NCT01597245|19041586|P18|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
7733520|NCT01597245|19041587|P17|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
7733521|NCT01597245|19041588|P16|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
7733522|NCT01597245|19041589|P15|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
7733523|NCT01597245|19041590|P14|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
7733524|NCT01597245|19041591|P13|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
7733525|NCT01597245|19041592|P12|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
7733526|NCT01597245|19041593|P11|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
7733527|NCT01597245|19041594|P10|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
7733528|NCT01597245|19041595|P9|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
7733529|NCT01597245|19041596|P8|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
7733530|NCT01597245|19041597|P7|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
7733531|NCT01597245|19041598|P6|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
7733532|NCT01597245|19041599|P5|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
7733533|NCT01597245|19041600|P4|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9
7733534|NCT01597245|19041601|P3|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19
7733535|NCT01597245|19041602|P2|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25
7733536|NCT01597245|19041603|P1|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10
7733537|NCT01597245|19041583|P21|COMPLETED|Induction Period (Week 0 - Week 12)||0
7733538|NCT01597245|19041584|P20|COMPLETED|Induction Period (Week 0 - Week 12)||0
7733539|NCT01597245|19041585|P19|COMPLETED|Induction Period (Week 0 - Week 12)||0
7733540|NCT01597245|19041586|P18|COMPLETED|Induction Period (Week 0 - Week 12)||0
7733541|NCT01597245|19041587|P17|COMPLETED|Induction Period (Week 0 - Week 12)||0
7733542|NCT01597245|19041588|P16|COMPLETED|Induction Period (Week 0 - Week 12)||0
7733543|NCT01597245|19041589|P15|COMPLETED|Induction Period (Week 0 - Week 12)||0
7733544|NCT01597245|19041590|P14|COMPLETED|Induction Period (Week 0 - Week 12)||0
7733545|NCT01597245|19041591|P13|COMPLETED|Induction Period (Week 0 - Week 12)||0
7733546|NCT01597245|19041592|P12|COMPLETED|Induction Period (Week 0 - Week 12)||0
7733547|NCT01597245|19041593|P11|COMPLETED|Induction Period (Week 0 - Week 12)||0
7733548|NCT01597245|19041594|P10|COMPLETED|Induction Period (Week 0 - Week 12)||0
7733549|NCT01597245|19041595|P9|COMPLETED|Induction Period (Week 0 - Week 12)||0
7733550|NCT01597245|19041596|P8|COMPLETED|Induction Period (Week 0 - Week 12)||0
7733551|NCT01597245|19041597|P7|COMPLETED|Induction Period (Week 0 - Week 12)||0
7733552|NCT01597245|19041598|P6|COMPLETED|Induction Period (Week 0 - Week 12)||0
7733553|NCT01597245|19041599|P5|COMPLETED|Induction Period (Week 0 - Week 12)||0
7733554|NCT01597245|19041600|P4|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342
7733555|NCT01597245|19041601|P3|COMPLETED|Induction Period (Week 0 - Week 12)||328
7733556|NCT01597245|19041602|P2|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333
7733557|NCT01597245|19041603|P1|COMPLETED|Induction Period (Week 0 - Week 12)||158
7733558|NCT01597245|19041583|P21|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
7733559|NCT01597245|19041584|P20|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
7733560|NCT01597245|19041585|P19|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
7733561|NCT01597245|19041586|P18|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
7733562|NCT01597245|19041587|P17|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
7733563|NCT01597245|19041588|P16|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
7733564|NCT01597245|19041589|P15|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
7733565|NCT01597245|19041590|P14|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
7733566|NCT01597245|19041591|P13|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
7733567|NCT01597245|19041592|P12|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
7733568|NCT01597245|19041593|P11|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
7733569|NCT01597245|19041594|P10|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
7733570|NCT01597245|19041595|P9|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
7733571|NCT01597245|19041596|P8|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
7733572|NCT01597245|19041597|P7|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
7733573|NCT01597245|19041598|P6|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
7733574|NCT01597245|19041599|P5|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
7733575|NCT01597245|19041600|P4|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350
7733576|NCT01597245|19041601|P3|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347
7733577|NCT01597245|19041602|P2|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357
7733578|NCT01597245|19041603|P1|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167
7733579|NCT01597245|19041583|P21|STARTED|Induction Period (Week 0 - Week 12)||0
7733580|NCT01597245|19041584|P20|STARTED|Induction Period (Week 0 - Week 12)||0
7733581|NCT01597245|19041585|P19|STARTED|Induction Period (Week 0 - Week 12)||0
7733582|NCT01597245|19041586|P18|STARTED|Induction Period (Week 0 - Week 12)||0
7733583|NCT01597245|19041587|P17|STARTED|Induction Period (Week 0 - Week 12)||0
7733584|NCT01597245|19041588|P16|STARTED|Induction Period (Week 0 - Week 12)||0
7733585|NCT01597245|19041589|P15|STARTED|Induction Period (Week 0 - Week 12)||0
7733586|NCT01597245|19041590|P14|STARTED|Induction Period (Week 0 - Week 12)||0
7733587|NCT01597245|19041591|P13|STARTED|Induction Period (Week 0 - Week 12)||0
7733588|NCT01597245|19041592|P12|STARTED|Induction Period (Week 0 - Week 12)||0
7733589|NCT01597245|19041593|P11|STARTED|Induction Period (Week 0 - Week 12)||0
7733590|NCT01597245|19041594|P10|STARTED|Induction Period (Week 0 - Week 12)||0
7733591|NCT01597245|19041595|P9|STARTED|Induction Period (Week 0 - Week 12)||0
7733592|NCT01597245|19041596|P8|STARTED|Induction Period (Week 0 - Week 12)||0
7733593|NCT01597245|19041597|P7|STARTED|Induction Period (Week 0 - Week 12)||0
7733594|NCT01597245|19041598|P6|STARTED|Induction Period (Week 0 - Week 12)||0
7733595|NCT01597245|19041599|P5|STARTED|Induction Period (Week 0 - Week 12)||0
7733596|NCT01597245|19041600|P4|STARTED|Induction Period (Week 0 - Week 12)||351
7733597|NCT01597245|19041601|P3|STARTED|Induction Period (Week 0 - Week 12)||347
7733598|NCT01597245|19041602|P2|STARTED|Induction Period (Week 0 - Week 12)||358
7733599|NCT01597245|19041603|P1|STARTED|Induction Period (Week 0 - Week 12)||168
7733600|NCT01597193|19041701|P7|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||11
7733601|NCT01597193|19041702|P6|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||23
7733602|NCT01597193|19041703|P5|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||16
7733603|NCT01597193|19041704|P4|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||20
7733604|NCT01597193|19041705|P3|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||14
7733605|NCT01597193|19041706|P2|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
7733606|NCT01597193|19041707|P1|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
7733607|NCT01597193|19041701|P7|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
7733608|NCT01597193|19041702|P6|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
7733609|NCT01597193|19041703|P5|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
7733610|NCT01597193|19041704|P4|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
7733611|NCT01597193|19041705|P3|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
7733612|NCT01597193|19041706|P2|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
7733613|NCT01597193|19041707|P1|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
7733614|NCT01597193|19041701|P7|STARTED|Stage 2: Dose Expansion (1067 Days)||11
7733615|NCT01597193|19041702|P6|STARTED|Stage 2: Dose Expansion (1067 Days)||23
7733616|NCT01597193|19041703|P5|STARTED|Stage 2: Dose Expansion (1067 Days)||16
7733617|NCT01597193|19041704|P4|STARTED|Stage 2: Dose Expansion (1067 Days)||20
7733618|NCT01597193|19041705|P3|STARTED|Stage 2: Dose Expansion (1067 Days)||14
7733619|NCT01597193|19041706|P2|STARTED|Stage 2: Dose Expansion (1067 Days)||0
7733620|NCT01597193|19041707|P1|STARTED|Stage 2: Dose Expansion (1067 Days)||0
7733621|NCT01597193|19041701|P7|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
7733622|NCT01597193|19041702|P6|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
7733623|NCT01597193|19041703|P5|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
7733624|NCT01597193|19041704|P4|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
7733625|NCT01597193|19041705|P3|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
7733626|NCT01597193|19041706|P2|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||8
7733627|NCT01597193|19041707|P1|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||7
7733628|NCT01597193|19041701|P7|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
7733629|NCT01597193|19041702|P6|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
7733630|NCT01597193|19041703|P5|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
7733631|NCT01597193|19041704|P4|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
7733632|NCT01597193|19041705|P3|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
7733633|NCT01597193|19041706|P2|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
7733634|NCT01597193|19041707|P1|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
7733635|NCT01597193|19041701|P7|STARTED|Stage 1: Dose Escalation (141 Days)||0
7733636|NCT01597193|19041702|P6|STARTED|Stage 1: Dose Escalation (141 Days)||0
7733637|NCT01597193|19041703|P5|STARTED|Stage 1: Dose Escalation (141 Days)||0
7733638|NCT01597193|19041704|P4|STARTED|Stage 1: Dose Escalation (141 Days)||0
7733639|NCT01597193|19041705|P3|STARTED|Stage 1: Dose Escalation (141 Days)||0
7733640|NCT01597193|19041706|P2|STARTED|Stage 1: Dose Escalation (141 Days)||8
7733641|NCT01597193|19041707|P1|STARTED|Stage 1: Dose Escalation (141 Days)||7
7733642|NCT01597141|19041788|P2|NOT COMPLETED|Overall Study||0
7733643|NCT01597141|19041789|P1|NOT COMPLETED|Overall Study||0
7733644|NCT01597141|19041788|P2|COMPLETED|Overall Study||50
7733645|NCT01597141|19041789|P1|COMPLETED|Overall Study||50
7733646|NCT01597141|19041788|P2|STARTED|Overall Study||50
7733647|NCT01597141|19041789|P1|STARTED|Overall Study||50
7733648|NCT01597128|19041799|P2|NOT COMPLETED|Overall Study||0
7733649|NCT01597128|19041800|P1|NOT COMPLETED|Overall Study||0
7733650|NCT01597128|19041799|P2|COMPLETED|Overall Study||17
7733651|NCT01597128|19041800|P1|COMPLETED|Overall Study||18
7733652|NCT01597128|19041799|P2|STARTED|Overall Study||17
7733653|NCT01597128|19041800|P1|STARTED|Overall Study||18
7733654|NCT01597050|19041826|P2|NOT COMPLETED|Overall Study||0
7733655|NCT01597050|19041827|P1|NOT COMPLETED|Overall Study||1
7733656|NCT01597050|19041826|P2|COMPLETED|Overall Study||18
7733657|NCT01597050|19041827|P1|COMPLETED|Overall Study||35
7733658|NCT01597050|19041826|P2|STARTED|Overall Study||18
7733659|NCT01597050|19041827|P1|STARTED|Overall Study||36
7733660|NCT01596972|19041835|P2|NOT COMPLETED|Overall Study||14
7733661|NCT01596972|19041836|P1|NOT COMPLETED|Overall Study||1
7733662|NCT01596972|19041835|P2|COMPLETED|Overall Study||12
7733663|NCT01596972|19041836|P1|COMPLETED|Overall Study||24
7733664|NCT01596972|19041835|P2|STARTED|Overall Study||26
7733665|NCT01596972|19041836|P1|STARTED|Overall Study||25
7733666|NCT01596842|19041848|P2|NOT COMPLETED|Overall Study||0
7733667|NCT01596842|19041849|P1|NOT COMPLETED|Overall Study||2
7733668|NCT01596842|19041848|P2|COMPLETED|Overall Study||7
7733669|NCT01596842|19041849|P1|COMPLETED|Overall Study||8
7733670|NCT01596842|19041848|P2|STARTED|Overall Study||7
7733671|NCT01596842|19041849|P1|STARTED|Overall Study||10
7733672|NCT01596751|19041865|P8|NOT COMPLETED|Overall Study||0
7733673|NCT01596751|19041866|P7|NOT COMPLETED|Overall Study||0
7733674|NCT01596751|19041867|P6|NOT COMPLETED|Overall Study||0
7733675|NCT01596751|19041868|P5|NOT COMPLETED|Overall Study||0
7733676|NCT01596751|19041869|P4|NOT COMPLETED|Overall Study||0
7733677|NCT01596751|19041870|P3|NOT COMPLETED|Overall Study||0
7733678|NCT01596751|19041871|P2|NOT COMPLETED|Overall Study||0
7733679|NCT01596751|19041872|P1|NOT COMPLETED|Overall Study||0
7733680|NCT01596751|19041865|P8|COMPLETED|Overall Study||22
7733681|NCT01596751|19041866|P7|COMPLETED|Overall Study||17
7733682|NCT01596751|19041867|P6|COMPLETED|Overall Study||6
7733683|NCT01596751|19041868|P5|COMPLETED|Overall Study||4
7733684|NCT01596751|19041869|P4|COMPLETED|Overall Study||6
7733685|NCT01596751|19041870|P3|COMPLETED|Overall Study||3
7733686|NCT01596751|19041871|P2|COMPLETED|Overall Study||4
7733687|NCT01596751|19041872|P1|COMPLETED|Overall Study||5
7733688|NCT01596751|19041865|P8|STARTED|Overall Study||22
7733689|NCT01596751|19041866|P7|STARTED|Overall Study||17
7733690|NCT01596751|19041867|P6|STARTED|Overall Study||6
7733691|NCT01596751|19041868|P5|STARTED|Overall Study||4
7733692|NCT01596751|19041869|P4|STARTED|Overall Study||6
7733693|NCT01596751|19041870|P3|STARTED|Overall Study||3
7733694|NCT01596751|19041871|P2|STARTED|Overall Study||4
7733695|NCT01596751|19041872|P1|STARTED|Overall Study||5
7733696|NCT01596699|19041895|P2|NOT COMPLETED|Overall Study||0
7733697|NCT01596699|19041896|P1|NOT COMPLETED|Overall Study||0
7733698|NCT01596699|19041895|P2|COMPLETED|Overall Study||6
7733699|NCT01596699|19041896|P1|COMPLETED|Overall Study||10
7733700|NCT01596699|19041895|P2|STARTED|Overall Study||6
7733701|NCT01596699|19041896|P1|STARTED|Overall Study||10
7733702|NCT01596582|19041908|P2|NOT COMPLETED|Overall Study||7
7733703|NCT01596582|19041909|P1|NOT COMPLETED|Overall Study||4
7733704|NCT01596582|19041908|P2|COMPLETED|Overall Study||173
7733705|NCT01596582|19041909|P1|COMPLETED|Overall Study||168
7733706|NCT01596582|19041908|P2|STARTED|Overall Study||180
7733707|NCT01596582|19041909|P1|STARTED|Overall Study||172
7733708|NCT01596504|19041936|P3|NOT COMPLETED|Overall Study||1
7733709|NCT01596504|19041937|P2|NOT COMPLETED|Overall Study||3
7733710|NCT01596504|19041938|P1|NOT COMPLETED|Overall Study||2
7733711|NCT01596504|19041936|P3|COMPLETED|Overall Study||46
7733712|NCT01596504|19041937|P2|COMPLETED|Overall Study||44
7733713|NCT01596504|19041938|P1|COMPLETED|Overall Study||46
7733714|NCT01596504|19041936|P3|STARTED|Overall Study||47
7733715|NCT01596504|19041937|P2|STARTED|Overall Study||47
7733716|NCT01596504|19041938|P1|STARTED|Overall Study||48
7733717|NCT01596335|19041996|P2|NOT COMPLETED|Overall Study||9
7733718|NCT01596335|19041997|P1|NOT COMPLETED|Overall Study||5
7733719|NCT01596335|19041996|P2|COMPLETED|Overall Study||6
7733720|NCT01596335|19041997|P1|COMPLETED|Overall Study||11
7733721|NCT01596335|19041996|P2|STARTED|Overall Study||15
7733722|NCT01596335|19041997|P1|STARTED|Overall Study||16
7733723|NCT01596283|19042009|P2|NOT COMPLETED|Overall Study||0
7733724|NCT01596283|19042010|P1|NOT COMPLETED|Overall Study||0
7733725|NCT01596283|19042009|P2|COMPLETED|Overall Study||66
7733726|NCT01596283|19042010|P1|COMPLETED|Overall Study||69
7733727|NCT01596283|19042009|P2|STARTED|Overall Study||66
7733728|NCT01596283|19042010|P1|STARTED|Overall Study||69
7733729|NCT01596231|19042026|P2|NOT COMPLETED|Overall Study||0
7733730|NCT01596231|19042027|P1|NOT COMPLETED|Overall Study||0
7733731|NCT01596231|19042026|P2|COMPLETED|Overall Study||10
7733732|NCT01596231|19042027|P1|COMPLETED|Overall Study||10
7733733|NCT01596231|19042026|P2|STARTED|Overall Study||10
7733734|NCT01596231|19042027|P1|STARTED|Overall Study||10
7733735|NCT01596127|19042033|P1|NOT COMPLETED|Overall Study||1
7733736|NCT01596127|19042033|P1|COMPLETED|Overall Study||3
7733737|NCT01596127|19042033|P1|STARTED|Overall Study||4
7733738|NCT01596088|19042038|P1|NOT COMPLETED|Overall Study||0
7733739|NCT01596088|19042038|P1|COMPLETED|Overall Study||2
7733740|NCT01596088|19042038|P1|STARTED|Overall Study||2
7733741|NCT01596062|19042045|P3|NOT COMPLETED|Overall Study||3
7733742|NCT01596062|19042046|P2|NOT COMPLETED|Overall Study||0
7733743|NCT01596062|19042047|P1|NOT COMPLETED|Overall Study||1
7733744|NCT01596062|19042045|P3|COMPLETED|Overall Study||4
7733745|NCT01596062|19042046|P2|COMPLETED|Overall Study||6
7733746|NCT01596062|19042047|P1|COMPLETED|Overall Study||2
7733747|NCT01596062|19042045|P3|STARTED|Overall Study||7
7733748|NCT01596062|19042046|P2|STARTED|Overall Study||6
7733749|NCT01596062|19042047|P1|STARTED|Overall Study||3
7733750|NCT01595854|19042084|P5|NOT COMPLETED|Overall Study||0
7733751|NCT01595854|19042085|P4|NOT COMPLETED|Overall Study||0
7733752|NCT01595854|19042086|P3|NOT COMPLETED|Overall Study||0
7733753|NCT01595854|19042087|P2|NOT COMPLETED|Overall Study||0
7733754|NCT01595854|19042088|P1|NOT COMPLETED|Overall Study||0
7733755|NCT01595854|19042084|P5|COMPLETED|Overall Study||12
7733756|NCT01595854|19042085|P4|COMPLETED|Overall Study||4
7733757|NCT01595854|19042086|P3|COMPLETED|Overall Study||8
7733758|NCT01595854|19042087|P2|COMPLETED|Overall Study||4
7733759|NCT01595854|19042088|P1|COMPLETED|Overall Study||8
7733760|NCT01595854|19042084|P5|STARTED|Overall Study||12
7733761|NCT01595854|19042085|P4|STARTED|Overall Study||4
7733762|NCT01595854|19042086|P3|STARTED|Overall Study||8
7733763|NCT01595854|19042087|P2|STARTED|Overall Study||4
7733764|NCT01595854|19042088|P1|STARTED|Overall Study||8
7733765|NCT01595646|19042111|P3|NOT COMPLETED|Overall Study||0
7733766|NCT01595646|19042112|P2|NOT COMPLETED|Overall Study||0
7733767|NCT01595646|19042113|P1|NOT COMPLETED|Overall Study||1
7733768|NCT01595646|19042111|P3|COMPLETED|Overall Study||12
7733769|NCT01595646|19042112|P2|COMPLETED|Overall Study||12
7733770|NCT01595646|19042113|P1|COMPLETED|Overall Study||12
7733771|NCT01595646|19042111|P3|STARTED|Overall Study||12
7733772|NCT01595646|19042112|P2|STARTED|Overall Study||12
7733773|NCT01595646|19042113|P1|STARTED|Overall Study||13
7733774|NCT01595529|19042135|P2|NOT COMPLETED|Overall Study||20
7733775|NCT01595529|19042136|P1|NOT COMPLETED|Overall Study||24
7733776|NCT01595529|19042135|P2|COMPLETED|Overall Study||325
7733777|NCT01595529|19042136|P1|COMPLETED|Overall Study||324
7733778|NCT01595529|19042135|P2|Completed All Milestones|Overall Study||318
7733779|NCT01595529|19042136|P1|Completed All Milestones|Overall Study||318
7733780|NCT01595529|19042135|P2|Per-protocol With Stool Sample at TOC|Overall Study||289
7733781|NCT01595529|19042136|P1|Per-protocol With Stool Sample at TOC|Overall Study||280
7733782|NCT01595529|19042135|P2|Per-protocol Without Treatment Failure|Overall Study||305
7733783|NCT01595529|19042136|P1|Per-protocol Without Treatment Failure|Overall Study||306
7733784|NCT01595529|19042135|P2|Per-protocol, Completed 80% of Dose|Overall Study||314
7733785|NCT01595529|19042136|P1|Per-protocol, Completed 80% of Dose|Overall Study||308
7733786|NCT01595529|19042135|P2|ITT With Stool Sample at TOC|Overall Study||310
7733787|NCT01595529|19042136|P1|ITT With Stool Sample at TOC|Overall Study||298
7733788|NCT01595529|19042135|P2|ITT Without Treatment Failure|Overall Study||322
7733789|NCT01595529|19042136|P1|ITT Without Treatment Failure|Overall Study||326
7733790|NCT01595529|19042135|P2|Evaluated for Primary Endpoint, ITT|Overall Study||336
7733791|NCT01595529|19042136|P1|Evaluated for Primary Endpoint, ITT|Overall Study||328
7733792|NCT01595529|19042135|P2|Treated|Overall Study||340
7733793|NCT01595529|19042136|P1|Treated|Overall Study||337
7733794|NCT01595529|19042135|P2|STARTED|Overall Study||345
7733795|NCT01595529|19042136|P1|STARTED|Overall Study||348
7733796|NCT01595516|19042167|P3|NOT COMPLETED|Overall Study||0
7733797|NCT01595516|19042168|P2|NOT COMPLETED|Overall Study||0
7733798|NCT01595516|19042169|P1|NOT COMPLETED|Overall Study||0
7733799|NCT01595516|19042167|P3|COMPLETED|Overall Study||12
7733800|NCT01595516|19042168|P2|COMPLETED|Overall Study||16
7733801|NCT01595516|19042169|P1|COMPLETED|Overall Study||16
7733802|NCT01595516|19042167|P3|STARTED|Overall Study||12
7733803|NCT01595516|19042168|P2|STARTED|Overall Study||16
7733804|NCT01595516|19042169|P1|STARTED|Overall Study||16
7733805|NCT01595438|19042199|P2|NOT COMPLETED|Overall Study||41
7733806|NCT01595438|19042200|P1|NOT COMPLETED|Overall Study||43
7733807|NCT01595438|19042199|P2|COMPLETED|Overall Study||476
7733808|NCT01595438|19042200|P1|COMPLETED|Overall Study||473
7733809|NCT01595438|19042199|P2|STARTED|Overall Study||517
7733810|NCT01595438|19042200|P1|STARTED|Overall Study||516
7733811|NCT01595386|19042326|P2|NOT COMPLETED|Overall Study||0
7733812|NCT01595386|19042327|P1|NOT COMPLETED|Overall Study||0
7733813|NCT01595386|19042326|P2|COMPLETED|Overall Study||19
7733814|NCT01595386|19042327|P1|COMPLETED|Overall Study||21
7733815|NCT01595386|19042326|P2|STARTED|Overall Study||19
7733816|NCT01595386|19042327|P1|STARTED|Overall Study||21
7733817|NCT01595282|19042355|P2|NOT COMPLETED|Overall Study||0
7733818|NCT01595282|19042356|P1|NOT COMPLETED|Overall Study||0
7733819|NCT01595282|19042355|P2|COMPLETED|Overall Study||47
7733820|NCT01595282|19042356|P1|COMPLETED|Overall Study||47
7733821|NCT01595282|19042355|P2|STARTED|Overall Study||47
7733822|NCT01595282|19042356|P1|STARTED|Overall Study||47
7733823|NCT01595009|19042368|P4|NOT COMPLETED|Extension||11
7733824|NCT01595009|19042369|P3|NOT COMPLETED|Extension||4
7733825|NCT01595009|19042370|P2|NOT COMPLETED|Extension||0
7733826|NCT01595009|19042371|P1|NOT COMPLETED|Extension||0
7733827|NCT01595009|19042368|P4|COMPLETED|Extension||0
7733828|NCT01595009|19042369|P3|COMPLETED|Extension||0
7733829|NCT01595009|19042370|P2|COMPLETED|Extension||0
7733830|NCT01595009|19042371|P1|COMPLETED|Extension||0
7733831|NCT01595009|19042368|P4|STARTED|Extension||11
7733832|NCT01595009|19042369|P3|STARTED|Extension||4
7733833|NCT01595009|19042370|P2|STARTED|Extension||0
7733834|NCT01595009|19042371|P1|STARTED|Extension||0
7733835|NCT01595009|19042368|P4|NOT COMPLETED|Core||0
7733836|NCT01595009|19042369|P3|NOT COMPLETED|Core||0
7733837|NCT01595009|19042370|P2|NOT COMPLETED|Core||120
7733838|NCT01595009|19042371|P1|NOT COMPLETED|Core||126
7733839|NCT01595009|19042368|P4|COMPLETED|Core||0
7733840|NCT01595009|19042369|P3|COMPLETED|Core||0
7733841|NCT01595009|19042370|P2|COMPLETED|Core||0
7733842|NCT01595009|19042371|P1|COMPLETED|Core||0
7733843|NCT01595009|19042368|P4|STARTED|Core||0
7733844|NCT01595009|19042369|P3|STARTED|Core||0
7733845|NCT01595009|19042370|P2|STARTED|Core||120
7733846|NCT01595009|19042371|P1|STARTED|Core||126
7733847|NCT01594970|19042406|P3|NOT COMPLETED|Overall Study||66
7733848|NCT01594970|19042407|P2|NOT COMPLETED|Overall Study||82
7733849|NCT01594970|19042408|P1|NOT COMPLETED|Overall Study||75
7733850|NCT01594970|19042406|P3|COMPLETED|Overall Study||191
7733851|NCT01594970|19042407|P2|COMPLETED|Overall Study||166
7733852|NCT01594970|19042408|P1|COMPLETED|Overall Study||220
7733853|NCT01594970|19042406|P3|STARTED|Overall Study||257
7733854|NCT01594970|19042407|P2|STARTED|Overall Study||248
7733855|NCT01594970|19042408|P1|STARTED|Overall Study||295
7733856|NCT01594853|19042427|P2|NOT COMPLETED|Overall Study||3
7733857|NCT01594853|19042428|P1|NOT COMPLETED|Overall Study||2
7733858|NCT01594853|19042427|P2|COMPLETED|Overall Study||12
7733859|NCT01594853|19042428|P1|COMPLETED|Overall Study||14
7733860|NCT01594853|19042427|P2|STARTED|Overall Study||15
7733861|NCT01594853|19042428|P1|STARTED|Overall Study||16
7733862|NCT01594827|19042436|P2|NOT COMPLETED|Overall Study||0
7733863|NCT01594827|19042437|P1|NOT COMPLETED|Overall Study||4
7733864|NCT01594827|19042436|P2|COMPLETED|Overall Study||15
7733865|NCT01594827|19042437|P1|COMPLETED|Overall Study||10
7733866|NCT01594827|19042436|P2|STARTED|Overall Study||15
7733867|NCT01594827|19042437|P1|STARTED|Overall Study||14
7733868|NCT01594762|19042461|P2|NOT COMPLETED|Overall Study||10
7733869|NCT01594762|19042462|P1|NOT COMPLETED|Overall Study||11
7733870|NCT01594762|19042461|P2|COMPLETED|Overall Study||93
7733871|NCT01594762|19042462|P1|COMPLETED|Overall Study||86
7733872|NCT01594762|19042461|P2|STARTED|Overall Study||103
7733873|NCT01594762|19042462|P1|STARTED|Overall Study||97
7733874|NCT01594749|19042474|P2|NOT COMPLETED|Overall Study||18
7733875|NCT01594749|19042475|P1|NOT COMPLETED|Overall Study||22
7733876|NCT01594749|19042474|P2|COMPLETED|Overall Study||490
7733877|NCT01594749|19042475|P1|COMPLETED|Overall Study||485
7733878|NCT01594749|19042474|P2|Treated|Overall Study||498
7733879|NCT01594749|19042475|P1|Treated|Overall Study||503
7733880|NCT01594749|19042474|P2|STARTED|Overall Study||508
7733881|NCT01594749|19042475|P1|STARTED|Overall Study||507
7733882|NCT01594528|19042494|P3|NOT COMPLETED|Overall Study||0
7733883|NCT01594528|19042495|P2|NOT COMPLETED|Overall Study||0
7733884|NCT01594528|19042496|P1|NOT COMPLETED|Overall Study||0
7733885|NCT01594528|19042494|P3|COMPLETED|Overall Study||16
7733886|NCT01594528|19042495|P2|COMPLETED|Overall Study||17
7733887|NCT01594528|19042496|P1|COMPLETED|Overall Study||16
7733888|NCT01594528|19042494|P3|STARTED|Overall Study||16
7733889|NCT01594528|19042495|P2|STARTED|Overall Study||17
7733890|NCT01594528|19042496|P1|STARTED|Overall Study||16
7733891|NCT01594515|19042512|P10|NOT COMPLETED|Overall Study||0
7733892|NCT01594515|19042513|P9|NOT COMPLETED|Overall Study||0
7733893|NCT01594515|19042514|P8|NOT COMPLETED|Overall Study||0
7733894|NCT01594515|19042515|P7|NOT COMPLETED|Overall Study||0
7733895|NCT01594515|19042516|P6|NOT COMPLETED|Overall Study||0
7733896|NCT01594515|19042517|P5|NOT COMPLETED|Overall Study||0
7733897|NCT01594515|19042518|P4|NOT COMPLETED|Overall Study||0
7733898|NCT01594515|19042519|P3|NOT COMPLETED|Overall Study||0
7733899|NCT01594515|19042520|P2|NOT COMPLETED|Overall Study||0
7733900|NCT01594515|19042521|P1|NOT COMPLETED|Overall Study||0
7733901|NCT01594515|19042512|P10|COMPLETED|Overall Study||16
7733902|NCT01594515|19042513|P9|COMPLETED|Overall Study||6
7733903|NCT01594515|19042514|P8|COMPLETED|Overall Study||6
7733904|NCT01594515|19042515|P7|COMPLETED|Overall Study||6
7733905|NCT01594515|19042516|P6|COMPLETED|Overall Study||6
7733906|NCT01594515|19042517|P5|COMPLETED|Overall Study||6
7733907|NCT01594515|19042518|P4|COMPLETED|Overall Study||6
7733908|NCT01594515|19042519|P3|COMPLETED|Overall Study||6
7733909|NCT01594515|19042520|P2|COMPLETED|Overall Study||6
7733910|NCT01594515|19042521|P1|COMPLETED|Overall Study||6
7733911|NCT01594515|19042512|P10|STARTED|Overall Study||16
7733912|NCT01594515|19042513|P9|STARTED|Overall Study||6
7733913|NCT01594515|19042514|P8|STARTED|Overall Study||6
7733914|NCT01594515|19042515|P7|STARTED|Overall Study||6
7733915|NCT01594515|19042516|P6|STARTED|Overall Study||6
7733916|NCT01594515|19042517|P5|STARTED|Overall Study||6
7733917|NCT01594515|19042518|P4|STARTED|Overall Study||6
7733918|NCT01594515|19042519|P3|STARTED|Overall Study||6
7733919|NCT01594515|19042520|P2|STARTED|Overall Study||6
7733920|NCT01594515|19042521|P1|STARTED|Overall Study||6
7733921|NCT01594476|19042613|P2|NOT COMPLETED|Overall Study||3
7733922|NCT01594476|19042614|P1|NOT COMPLETED|Overall Study||1
7733923|NCT01594476|19042613|P2|COMPLETED|Overall Study||97
7733924|NCT01594476|19042614|P1|COMPLETED|Overall Study||100
7733925|NCT01594476|19042613|P2|Pregnant|Overall Study||5
7733926|NCT01594476|19042614|P1|Pregnant|Overall Study||2
7733927|NCT01594476|19042613|P2|IUD Expulsion|Overall Study||0
7733928|NCT01594476|19042614|P1|IUD Expulsion|Overall Study||2
7733929|NCT01594476|19042613|P2|IUD Removal|Overall Study||5
7733930|NCT01594476|19042614|P1|IUD Removal|Overall Study||3
7733931|NCT01594476|19042613|P2|Excluded After Allocation|Overall Study||3
7733932|NCT01594476|19042614|P1|Excluded After Allocation|Overall Study||1
7733933|NCT01594476|19042613|P2|Received Intervention|Overall Study||73
7733934|NCT01594476|19042614|P1|Received Intervention|Overall Study||66
7733935|NCT01594476|19042613|P2|STARTED|Overall Study||100
7733936|NCT01594476|19042614|P1|STARTED|Overall Study||101
7733937|NCT01594424|19042632|P1|NOT COMPLETED|Overall Study||2
7733938|NCT01594424|19042632|P1|COMPLETED|Overall Study||8
7733939|NCT01594424|19042632|P1|STARTED|Overall Study||10
7733940|NCT01594411|19042636|P1|NOT COMPLETED|Overall Study||2
7733941|NCT01594411|19042636|P1|COMPLETED|Overall Study||249
7733942|NCT01594411|19042636|P1|STARTED|Overall Study||251
7733943|NCT01594385|19042645|P2|NOT COMPLETED|Overall Study||0
7733944|NCT01594385|19042646|P1|NOT COMPLETED|Overall Study||0
7733945|NCT01594385|19042645|P2|COMPLETED|Overall Study||13
7733946|NCT01594385|19042646|P1|COMPLETED|Overall Study||17
7733947|NCT01594385|19042645|P2|STARTED|Overall Study||13
7733948|NCT01594385|19042646|P1|STARTED|Overall Study||17
7733949|NCT01594333|19042670|P2|NOT COMPLETED|Overall Study||151
7733950|NCT01594333|19042671|P1|NOT COMPLETED|Overall Study||161
7733951|NCT01594333|19042670|P2|COMPLETED|Overall Study||2244
7733952|NCT01594333|19042671|P1|COMPLETED|Overall Study||2230
7733953|NCT01594333|19042670|P2|STARTED|Overall Study||2395
7733954|NCT01594333|19042671|P1|STARTED|Overall Study||2391
7733955|NCT01594294|19042699|P2|NOT COMPLETED|Overall Study||4
7733956|NCT01594294|19042700|P1|NOT COMPLETED|Overall Study||3
7733957|NCT01594294|19042699|P2|COMPLETED|Overall Study||36
7733958|NCT01594294|19042700|P1|COMPLETED|Overall Study||36
7733959|NCT01594294|19042699|P2|STARTED|Overall Study||40
7733960|NCT01594294|19042700|P1|STARTED|Overall Study||39
7733961|NCT01594281|19042717|P3|NOT COMPLETED|Non-Interventional Follow Up Phase||2
7733962|NCT01594281|19042718|P2|NOT COMPLETED|Non-Interventional Follow Up Phase||2
7733963|NCT01594281|19042719|P1|NOT COMPLETED|Non-Interventional Follow Up Phase||3
7733964|NCT01594281|19042717|P3|COMPLETED|Non-Interventional Follow Up Phase||23
7733965|NCT01594281|19042718|P2|COMPLETED|Non-Interventional Follow Up Phase||19
7733966|NCT01594281|19042719|P1|COMPLETED|Non-Interventional Follow Up Phase||25
7733967|NCT01594281|19042717|P3|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||25
7733968|NCT01594281|19042718|P2|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||20
7733969|NCT01594281|19042719|P1|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||28
7733970|NCT01594281|19042717|P3|STARTED|Non-Interventional Follow Up Phase|3 patients exited after completing Core Phase and did not start the Follow-Up Phase|25
7733971|NCT01594281|19042718|P2|STARTED|Non-Interventional Follow Up Phase|5 patients exited after completing Core Phase and did not start the Follow-Up Phase|21
7733972|NCT01594281|19042719|P1|STARTED|Non-Interventional Follow Up Phase|1 patient exited after completing Core Phase and did not start the Follow-Up Phase|28
7733973|NCT01594281|19042717|P3|NOT COMPLETED|Interventional Core Phase||8
7733974|NCT01594281|19042718|P2|NOT COMPLETED|Interventional Core Phase||10
7733975|NCT01594281|19042719|P1|NOT COMPLETED|Interventional Core Phase||7
7733976|NCT01594281|19042717|P3|COMPLETED|Interventional Core Phase||28
7733977|NCT01594281|19042718|P2|COMPLETED|Interventional Core Phase||26
7733978|NCT01594281|19042719|P1|COMPLETED|Interventional Core Phase||29
7733979|NCT01594281|19042717|P3|Full Analysis Set (FAS)|Interventional Core Phase||36
7733980|NCT01594281|19042718|P2|Full Analysis Set (FAS)|Interventional Core Phase||35
7733981|NCT01594281|19042719|P1|Full Analysis Set (FAS)|Interventional Core Phase||35
7733982|NCT01594281|19042717|P3|STARTED|Interventional Core Phase||36
7733983|NCT01594281|19042718|P2|STARTED|Interventional Core Phase||36
7733984|NCT01594281|19042719|P1|STARTED|Interventional Core Phase||36
7733985|NCT01594125|19042759|P5|NOT COMPLETED|Overall Study||7
7733986|NCT01594125|19042760|P4|NOT COMPLETED|Overall Study||4
7733987|NCT01594125|19042761|P3|NOT COMPLETED|Overall Study||3
7733988|NCT01594125|19042762|P2|NOT COMPLETED|Overall Study||12
7733989|NCT01594125|19042763|P1|NOT COMPLETED|Overall Study||4
7733990|NCT01594125|19042759|P5|COMPLETED|Overall Study||0
7733991|NCT01594125|19042760|P4|COMPLETED|Overall Study||0
7733992|NCT01594125|19042761|P3|COMPLETED|Overall Study||0
7733993|NCT01594125|19042762|P2|COMPLETED|Overall Study||0
7733994|NCT01594125|19042763|P1|COMPLETED|Overall Study||0
7733995|NCT01594125|19042759|P5|STARTED|Overall Study||7
7733996|NCT01594125|19042760|P4|STARTED|Overall Study||4
7733997|NCT01594125|19042761|P3|STARTED|Overall Study||3
7733998|NCT01594125|19042762|P2|STARTED|Overall Study||12
7733999|NCT01594125|19042763|P1|STARTED|Overall Study||4
7734000|NCT01593852|19042797|P2|NOT COMPLETED|Overall Study||0
7734001|NCT01593852|19042798|P1|NOT COMPLETED|Overall Study||0
7734002|NCT01593852|19042797|P2|COMPLETED|Overall Study||68
7734003|NCT01593852|19042798|P1|COMPLETED|Overall Study||68
7734004|NCT01593852|19042797|P2|STARTED|Overall Study||68
7734005|NCT01593852|19042798|P1|STARTED|Overall Study||68
7734006|NCT01593787|19042823|P3|NOT COMPLETED|Overall Study||0
7734007|NCT01593787|19042824|P2|NOT COMPLETED|Overall Study||0
7734008|NCT01593787|19042825|P1|NOT COMPLETED|Overall Study||1
7734009|NCT01593787|19042823|P3|COMPLETED|Overall Study||18
7734010|NCT01593787|19042824|P2|COMPLETED|Overall Study||8
7734011|NCT01593787|19042825|P1|COMPLETED|Overall Study||5
7734012|NCT01593787|19042823|P3|STARTED|Overall Study||18
7734013|NCT01593787|19042824|P2|STARTED|Overall Study||8
7734014|NCT01593787|19042825|P1|STARTED|Overall Study||6
7734015|NCT01593748|19042865|P2|NOT COMPLETED|Overall Study||0
7734016|NCT01593748|19042866|P1|NOT COMPLETED|Overall Study||0
7734017|NCT01593748|19042865|P2|COMPLETED|Overall Study||45
7734018|NCT01593748|19042866|P1|COMPLETED|Overall Study||45
7734019|NCT01593748|19042865|P2|STARTED|Overall Study||45
7734020|NCT01593748|19042866|P1|STARTED|Overall Study||45
7734021|NCT01593722|19042882|P2|NOT COMPLETED|Overall Study||0
7734022|NCT01593722|19042883|P1|NOT COMPLETED|Overall Study||0
7734023|NCT01593722|19042882|P2|COMPLETED|Overall Study||6
7734024|NCT01593722|19042883|P1|COMPLETED|Overall Study||6
7734025|NCT01593722|19042882|P2|STARTED|Overall Study||6
7734026|NCT01593722|19042883|P1|STARTED|Overall Study||6
7734027|NCT01593696|19042901|P4|NOT COMPLETED|Dose Expansion||0
7734028|NCT01593696|19042902|P3|NOT COMPLETED|Dose Expansion||1
7734029|NCT01593696|19042903|P2|NOT COMPLETED|Dose Expansion||0
7734030|NCT01593696|19042904|P1|NOT COMPLETED|Dose Expansion||0
7734031|NCT01593696|19042901|P4|COMPLETED|Dose Expansion||16
7734032|NCT01593696|19042902|P3|COMPLETED|Dose Expansion||15
7734033|NCT01593696|19042903|P2|COMPLETED|Dose Expansion||0
7734034|NCT01593696|19042904|P1|COMPLETED|Dose Expansion||0
7734035|NCT01593696|19042901|P4|STARTED|Dose Expansion||16
7734036|NCT01593696|19042902|P3|STARTED|Dose Expansion||16
7734037|NCT01593696|19042903|P2|STARTED|Dose Expansion||0
7734038|NCT01593696|19042904|P1|STARTED|Dose Expansion||0
7734039|NCT01593696|19042901|P4|NOT COMPLETED|Dose Escalation||0
7734040|NCT01593696|19042902|P3|NOT COMPLETED|Dose Escalation||0
7734041|NCT01593696|19042903|P2|NOT COMPLETED|Dose Escalation||0
7734042|NCT01593696|19042904|P1|NOT COMPLETED|Dose Escalation||2
7734043|NCT01593696|19042901|P4|COMPLETED|Dose Escalation||0
7734044|NCT01593696|19042902|P3|COMPLETED|Dose Escalation||0
7734045|NCT01593696|19042903|P2|COMPLETED|Dose Escalation||5
7734046|NCT01593696|19042904|P1|COMPLETED|Dose Escalation||14
7734047|NCT01593696|19042901|P4|No Prior Transplant|Dose Escalation||0
7734048|NCT01593696|19042902|P3|No Prior Transplant|Dose Escalation||0
7734049|NCT01593696|19042903|P2|No Prior Transplant|Dose Escalation||4
7734050|NCT01593696|19042904|P1|No Prior Transplant|Dose Escalation||9
7734051|NCT01593696|19042901|P4|Prior Transplant|Dose Escalation||0
7734052|NCT01593696|19042902|P3|Prior Transplant|Dose Escalation||0
7734053|NCT01593696|19042903|P2|Prior Transplant|Dose Escalation||1
7734054|NCT01593696|19042904|P1|Prior Transplant|Dose Escalation||7
7734055|NCT01593696|19042901|P4|STARTED|Dose Escalation||0
7734056|NCT01593696|19042902|P3|STARTED|Dose Escalation||0
7734057|NCT01593696|19042903|P2|STARTED|Dose Escalation||5
7734058|NCT01593696|19042904|P1|STARTED|Dose Escalation||16
7734059|NCT01593670|19042938|P1|NOT COMPLETED|Overall Study||0
7734060|NCT01593670|19042938|P1|COMPLETED|Overall Study||9
7734061|NCT01593670|19042938|P1|STARTED|Overall Study||9
7734062|NCT01593592|19042948|P2|NOT COMPLETED|Overall Study||0
7734063|NCT01593592|19042949|P1|NOT COMPLETED|Overall Study||0
7734064|NCT01593592|19042948|P2|COMPLETED|Overall Study||35
7734065|NCT01593592|19042949|P1|COMPLETED|Overall Study||35
7734066|NCT01593592|19042948|P2|STARTED|Overall Study||35
7734067|NCT01593592|19042949|P1|STARTED|Overall Study||35
7734068|NCT01593254|19042961|P2|NOT COMPLETED|Follow-Up Period||11
7734069|NCT01593254|19042962|P1|NOT COMPLETED|Follow-Up Period||3
7734070|NCT01593254|19042961|P2|COMPLETED|Follow-Up Period||17
7734071|NCT01593254|19042962|P1|COMPLETED|Follow-Up Period||11
7734072|NCT01593254|19042961|P2|STARTED|Follow-Up Period||28
7734073|NCT01593254|19042962|P1|STARTED|Follow-Up Period||14
7734074|NCT01593254|19042961|P2|NOT COMPLETED|Treatment Period||31
7734075|NCT01593254|19042962|P1|NOT COMPLETED|Treatment Period||14
7734076|NCT01593254|19042961|P2|COMPLETED|Treatment Period||143
7734077|NCT01593254|19042962|P1|COMPLETED|Treatment Period||72
7734078|NCT01593254|19042961|P2|Crossed Over to Dasatinib|Treatment Period||0
7734079|NCT01593254|19042962|P1|Crossed Over to Dasatinib|Treatment Period||42
7734080|NCT01593254|19042961|P2|STARTED|Treatment Period||174
7734081|NCT01593254|19042962|P1|STARTED|Treatment Period||86
7734082|NCT01593215|19042971|P2|NOT COMPLETED|Overall Study||0
7734083|NCT01593215|19042972|P1|NOT COMPLETED|Overall Study||1
7734084|NCT01593215|19042971|P2|COMPLETED|Overall Study||25
7734085|NCT01593215|19042972|P1|COMPLETED|Overall Study||24
7734086|NCT01593215|19042971|P2|STARTED|Overall Study||25
7734087|NCT01593215|19042972|P1|STARTED|Overall Study||25
7734088|NCT01592864|19042980|P2|NOT COMPLETED|Overall Study||1
7734089|NCT01592864|19042981|P1|NOT COMPLETED|Overall Study||0
7734090|NCT01592864|19042980|P2|COMPLETED|Overall Study||57
7734091|NCT01592864|19042981|P1|COMPLETED|Overall Study||60
7734092|NCT01592864|19042980|P2|STARTED|Overall Study||58
7734093|NCT01592864|19042981|P1|STARTED|Overall Study||60
7734094|NCT01592851|19042995|P2|NOT COMPLETED|Overall Study||0
7734095|NCT01592851|19042996|P1|NOT COMPLETED|Overall Study||0
7734096|NCT01592851|19042995|P2|COMPLETED|Overall Study||57
7734097|NCT01592851|19042996|P1|COMPLETED|Overall Study||56
7734098|NCT01592851|19042995|P2|STARTED|Overall Study||57
7734099|NCT01592851|19042996|P1|STARTED|Overall Study||56
7734100|NCT01592799|19043012|P1|NOT COMPLETED|Overall Study||0
7734101|NCT01592799|19043012|P1|COMPLETED|Overall Study||501
7734102|NCT01592799|19043012|P1|STARTED|Overall Study||501
7734103|NCT01592786|19043042|P1|NOT COMPLETED|Overall Study||138
7734104|NCT01592786|19043042|P1|COMPLETED|Overall Study||765
7734105|NCT01592786|19043042|P1|STARTED|Overall Study|Participants in the Safety Population are being presented.|903
7734106|NCT01592773|19043046|P1|NOT COMPLETED|Overall Study||666
7734107|NCT01592773|19043046|P1|COMPLETED|Overall Study||81
7734108|NCT01592773|19043046|P1|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747
7734109|NCT01592760|19043053|P3|NOT COMPLETED|24-hour Follow-Up||2
7734110|NCT01592760|19043054|P2|NOT COMPLETED|24-hour Follow-Up||3
7734111|NCT01592760|19043055|P1|NOT COMPLETED|24-hour Follow-Up||4
7734112|NCT01592760|19043053|P3|COMPLETED|24-hour Follow-Up||43
7734113|NCT01592760|19043054|P2|COMPLETED|24-hour Follow-Up||87
7734114|NCT01592760|19043055|P1|COMPLETED|24-hour Follow-Up||86
7734115|NCT01592760|19043053|P3|STARTED|24-hour Follow-Up||45
7734116|NCT01592760|19043054|P2|STARTED|24-hour Follow-Up||90
7734117|NCT01592760|19043055|P1|STARTED|24-hour Follow-Up||90
7734118|NCT01592760|19043053|P3|NOT COMPLETED|Perioperative to Discharge||0
7734119|NCT01592760|19043054|P2|NOT COMPLETED|Perioperative to Discharge||0
7734120|NCT01592760|19043055|P1|NOT COMPLETED|Perioperative to Discharge||0
7734121|NCT01592760|19043053|P3|COMPLETED|Perioperative to Discharge||45
7734122|NCT01592760|19043054|P2|COMPLETED|Perioperative to Discharge||90
7734123|NCT01592760|19043055|P1|COMPLETED|Perioperative to Discharge||90
7734124|NCT01592760|19043053|P3|STARTED|Perioperative to Discharge||45
7734125|NCT01592760|19043054|P2|STARTED|Perioperative to Discharge||90
7734126|NCT01592760|19043055|P1|STARTED|Perioperative to Discharge||90
7734127|NCT01592747|19043099|P3|NOT COMPLETED|Overall Study||108
7734128|NCT01592747|19043100|P2|NOT COMPLETED|Overall Study||111
7734129|NCT01592747|19043101|P1|NOT COMPLETED|Overall Study||116
7734130|NCT01592747|19043099|P3|COMPLETED|Overall Study||50
7734131|NCT01592747|19043100|P2|COMPLETED|Overall Study||50
7734132|NCT01592747|19043101|P1|COMPLETED|Overall Study||44
7734133|NCT01592747|19043099|P3|STARTED|Overall Study|Based on Randomized Population|158
7734134|NCT01592747|19043100|P2|STARTED|Overall Study|Based on Randomized Population|161
7734135|NCT01592747|19043101|P1|STARTED|Overall Study|Based on Randomized Population|160
7734136|NCT01592708|19043144|P2|NOT COMPLETED|Overall Study||0
7734137|NCT01592708|19043145|P1|NOT COMPLETED|Overall Study||3
7734138|NCT01592708|19043144|P2|COMPLETED|Overall Study||137
7734139|NCT01592708|19043145|P1|COMPLETED|Overall Study||93
7734140|NCT01592708|19043144|P2|STARTED|Overall Study||137
7734141|NCT01592708|19043145|P1|STARTED|Overall Study||96
7734142|NCT01592695|19043161|P2|NOT COMPLETED|Overall Study||4
7734143|NCT01592695|19043162|P1|NOT COMPLETED|Overall Study||8
7734144|NCT01592695|19043161|P2|COMPLETED|Overall Study||28
7734145|NCT01592695|19043162|P1|COMPLETED|Overall Study||23
7734146|NCT01592695|19043161|P2|STARTED|Overall Study||32
7734147|NCT01592695|19043162|P1|STARTED|Overall Study||31
7734148|NCT01592500|19043184|P4|NOT COMPLETED|Overall Study||2
7734149|NCT01592500|19043185|P3|NOT COMPLETED|Overall Study||0
7734150|NCT01592500|19043186|P2|NOT COMPLETED|Overall Study||0
7734151|NCT01592500|19043187|P1|NOT COMPLETED|Overall Study||1
7734152|NCT01592500|19043184|P4|COMPLETED|Overall Study||11
7734153|NCT01592500|19043185|P3|COMPLETED|Overall Study||14
7734154|NCT01592500|19043186|P2|COMPLETED|Overall Study||15
7734155|NCT01592500|19043187|P1|COMPLETED|Overall Study||13
7734156|NCT01592500|19043184|P4|STARTED|Overall Study|Randomized Participants|13
7734157|NCT01592500|19043185|P3|STARTED|Overall Study||14
7734158|NCT01592500|19043186|P2|STARTED|Overall Study||15
7734159|NCT01592500|19043187|P1|STARTED|Overall Study|Randomized Participants|14
7734160|NCT01592435|19043209|P1|NOT COMPLETED|Overall Study||0
7734161|NCT01592435|19043209|P1|COMPLETED|Overall Study||76
7734162|NCT01592435|19043209|P1|STARTED|Overall Study||76
7734163|NCT01592409|19043217|P2|NOT COMPLETED|Overall Study||1
7734164|NCT01592409|19043218|P1|NOT COMPLETED|Overall Study||0
7734165|NCT01592409|19043217|P2|COMPLETED|Overall Study||31
7734166|NCT01592409|19043218|P1|COMPLETED|Overall Study||67
7734167|NCT01592409|19043217|P2|STARTED|Overall Study||32
7734168|NCT01592409|19043218|P1|STARTED|Overall Study||67
7734169|NCT01592396|19043226|P2|NOT COMPLETED|Overall Study||0
7734170|NCT01592396|19043227|P1|NOT COMPLETED|Overall Study||0
7734171|NCT01592396|19043226|P2|COMPLETED|Overall Study||10
7734172|NCT01592396|19043227|P1|COMPLETED|Overall Study||10
7734173|NCT01592396|19043226|P2|STARTED|Overall Study||10
7734174|NCT01592396|19043227|P1|STARTED|Overall Study||10
7734175|NCT01592383|19043242|P1|NOT COMPLETED|Overall Study||1
7734176|NCT01592383|19043242|P1|COMPLETED|Overall Study||1
7734177|NCT01592383|19043242|P1|STARTED|Overall Study||2
7734178|NCT01592344|19043253|P2|NOT COMPLETED|Overall Study||5
7734179|NCT01592344|19043254|P1|NOT COMPLETED|Overall Study||4
7734180|NCT01592344|19043253|P2|COMPLETED|Overall Study||44
7734181|NCT01592344|19043254|P1|COMPLETED|Overall Study||41
7734182|NCT01592344|19043253|P2|STARTED|Overall Study||49
7734183|NCT01592344|19043254|P1|STARTED|Overall Study||45
7734184|NCT01592292|19043268|P4|NOT COMPLETED|Overall Study||1
7734185|NCT01592292|19043269|P3|NOT COMPLETED|Overall Study||3
7734186|NCT01592292|19043270|P2|NOT COMPLETED|Overall Study||5
7734187|NCT01592292|19043271|P1|NOT COMPLETED|Overall Study||6
7734188|NCT01592292|19043268|P4|COMPLETED|Overall Study||10
7734189|NCT01592292|19043269|P3|COMPLETED|Overall Study||10
7734190|NCT01592292|19043270|P2|COMPLETED|Overall Study||15
7734191|NCT01592292|19043271|P1|COMPLETED|Overall Study|Participants who completed 12 months visit.|40
7734192|NCT01592292|19043268|P4|Standard Population Set (SPS)|Overall Study||7
7734193|NCT01592292|19043269|P3|Standard Population Set (SPS)|Overall Study||7
7734194|NCT01592292|19043270|P2|Standard Population Set (SPS)|Overall Study||10
7734195|NCT01592292|19043271|P1|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31
7734196|NCT01592292|19043268|P4|Intention to Treat (ITT) Set|Overall Study||8
7734197|NCT01592292|19043269|P3|Intention to Treat (ITT) Set|Overall Study||10
7734198|NCT01592292|19043270|P2|Intention to Treat (ITT) Set|Overall Study||13
7734199|NCT01592292|19043271|P1|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34
7734200|NCT01592292|19043268|P4|STARTED|Overall Study||11
7734201|NCT01592292|19043269|P3|STARTED|Overall Study||13
7734202|NCT01592292|19043270|P2|STARTED|Overall Study||20
7734203|NCT01592292|19043271|P1|STARTED|Overall Study||46
7734204|NCT01592240|19043310|P7|NOT COMPLETED|Overall Study||3
7734205|NCT01592240|19043311|P6|NOT COMPLETED|Overall Study||3
7734206|NCT01592240|19043312|P5|NOT COMPLETED|Overall Study||7
7734207|NCT01592240|19043313|P4|NOT COMPLETED|Overall Study||3
7734208|NCT01592240|19043314|P3|NOT COMPLETED|Overall Study||7
7734209|NCT01592240|19043315|P2|NOT COMPLETED|Overall Study||11
7734210|NCT01592240|19043316|P1|NOT COMPLETED|Overall Study||3
7734211|NCT01592240|19043310|P7|COMPLETED|Overall Study||48
7734212|NCT01592240|19043311|P6|COMPLETED|Overall Study||47
7734213|NCT01592240|19043312|P5|COMPLETED|Overall Study||44
7734214|NCT01592240|19043313|P4|COMPLETED|Overall Study||47
7734215|NCT01592240|19043314|P3|COMPLETED|Overall Study||45
7734216|NCT01592240|19043315|P2|COMPLETED|Overall Study||39
7734217|NCT01592240|19043316|P1|COMPLETED|Overall Study||47
7734218|NCT01592240|19043310|P7|STARTED|Overall Study||51
7734219|NCT01592240|19043311|P6|STARTED|Overall Study||50
7734220|NCT01592240|19043312|P5|STARTED|Overall Study||51
7734221|NCT01592240|19043313|P4|STARTED|Overall Study||50
7734222|NCT01592240|19043314|P3|STARTED|Overall Study||52
7734223|NCT01592240|19043315|P2|STARTED|Overall Study||50
7734224|NCT01592240|19043316|P1|STARTED|Overall Study||50
7734225|NCT01592071|19043496|P1|NOT COMPLETED|Overall Study||0
7734226|NCT01592071|19043496|P1|COMPLETED|Overall Study||120
7734227|NCT01592071|19043496|P1|STARTED|Overall Study||120
7734228|NCT01592045|19043509|P2|NOT COMPLETED|Overall Study||2
7734229|NCT01592045|19043510|P1|NOT COMPLETED|Overall Study||5
7734230|NCT01592045|19043509|P2|COMPLETED|Overall Study||12
7734231|NCT01592045|19043510|P1|COMPLETED|Overall Study||9
7734232|NCT01592045|19043509|P2|Completed Course 5|Overall Study||12
7734233|NCT01592045|19043510|P1|Completed Course 5|Overall Study||9
7734234|NCT01592045|19043509|P2|Completed Course 4|Overall Study||12
7734235|NCT01592045|19043510|P1|Completed Course 4|Overall Study||11
7734236|NCT01592045|19043509|P2|Completed Course 3|Overall Study||13
7734237|NCT01592045|19043510|P1|Completed Course 3|Overall Study||11
7734238|NCT01592045|19043509|P2|Completed Course 2|Overall Study||13
7734239|NCT01592045|19043510|P1|Completed Course 2|Overall Study||13
7734240|NCT01592045|19043509|P2|Completed Course 1|Overall Study||14
7734241|NCT01592045|19043510|P1|Completed Course 1|Overall Study||13
7734242|NCT01592045|19043509|P2|STARTED|Overall Study||14
7734243|NCT01592045|19043510|P1|STARTED|Overall Study||14
7734244|NCT01592006|19043518|P1|NOT COMPLETED|Overall Study||0
7734245|NCT01592006|19043518|P1|COMPLETED|Overall Study||3
7734246|NCT01592006|19043518|P1|STARTED|Overall Study||3
7734247|NCT01591954|19043523|P1|NOT COMPLETED|Overall Study||0
7734248|NCT01591954|19043523|P1|COMPLETED|Overall Study||1
7734249|NCT01591954|19043523|P1|STARTED|Overall Study||1
7734250|NCT01591863|19043528|P1|NOT COMPLETED|Overall Study||14
7734251|NCT01591863|19043528|P1|COMPLETED|Overall Study||24
7734252|NCT01591863|19043528|P1|STARTED|Overall Study||38
7734253|NCT01591837|19043540|P2|NOT COMPLETED|Overall Study||0
7734254|NCT01591837|19043541|P1|NOT COMPLETED|Overall Study||0
7734255|NCT01591837|19043540|P2|COMPLETED|Overall Study||60
7734256|NCT01591837|19043541|P1|COMPLETED|Overall Study||60
7734257|NCT01591837|19043540|P2|STARTED|Overall Study||60
7734258|NCT01591837|19043541|P1|STARTED|Overall Study||60
7734259|NCT01591785|19043557|P2|NOT COMPLETED|Overall Study||2
7734260|NCT01591785|19043558|P1|NOT COMPLETED|Overall Study||4
7734261|NCT01591785|19043557|P2|COMPLETED|Overall Study||28
7734262|NCT01591785|19043558|P1|COMPLETED|Overall Study||26
7734263|NCT01591785|19043557|P2|STARTED|Overall Study||30
7734264|NCT01591785|19043558|P1|STARTED|Overall Study||30
7734265|NCT01591746|19043572|P2|NOT COMPLETED|Overall Study||0
7734266|NCT01591746|19043573|P1|NOT COMPLETED|Overall Study||0
7734267|NCT01591746|19043572|P2|COMPLETED|Overall Study||63
7734268|NCT01591746|19043573|P1|COMPLETED|Overall Study||68
7734269|NCT01591746|19043572|P2|STARTED|Overall Study||63
7734270|NCT01591746|19043573|P1|STARTED|Overall Study||68
7734271|NCT01591733|19043589|P1|NOT COMPLETED|Overall Study||0
7734272|NCT01591733|19043589|P1|COMPLETED|Overall Study||48
7734273|NCT01591733|19043589|P1|STARTED|Overall Study||48
7734274|NCT01591681|19043600|P1|NOT COMPLETED|Overall Study||4
7734275|NCT01591681|19043600|P1|COMPLETED|Overall Study||45
7734276|NCT01591681|19043600|P1|STARTED|Overall Study||49
7734277|NCT01591655|19043628|P2|NOT COMPLETED|Overall Study||63
7734278|NCT01591655|19043629|P1|NOT COMPLETED|Overall Study||72
7734279|NCT01591655|19043628|P2|COMPLETED|Overall Study||57
7734280|NCT01591655|19043629|P1|COMPLETED|Overall Study||168
7734281|NCT01591655|19043628|P2|STARTED|Overall Study||120
7734282|NCT01591655|19043629|P1|STARTED|Overall Study||240
7734283|NCT01591616|19043647|P1|NOT COMPLETED|Overall Study||1
7734284|NCT01591616|19043647|P1|COMPLETED|Overall Study||15
7734285|NCT01591616|19043647|P1|STARTED|Overall Study||16
7734286|NCT01591499|19043788|P4|NOT COMPLETED|Second Intervention (up to 24 Days)||3
7734287|NCT01591499|19043789|P3|NOT COMPLETED|Second Intervention (up to 24 Days)||3
7734288|NCT01591499|19043790|P2|NOT COMPLETED|Second Intervention (up to 24 Days)||3
7734289|NCT01591499|19043791|P1|NOT COMPLETED|Second Intervention (up to 24 Days)||6
7734290|NCT01591499|19043788|P4|COMPLETED|Second Intervention (up to 24 Days)||34
7734291|NCT01591499|19043789|P3|COMPLETED|Second Intervention (up to 24 Days)||28
7734292|NCT01591499|19043790|P2|COMPLETED|Second Intervention (up to 24 Days)||34
7734293|NCT01591499|19043791|P1|COMPLETED|Second Intervention (up to 24 Days)||27
7734294|NCT01591499|19043788|P4|STARTED|Second Intervention (up to 24 Days)||37
7734295|NCT01591499|19043789|P3|STARTED|Second Intervention (up to 24 Days)||31
7734296|NCT01591499|19043790|P2|STARTED|Second Intervention (up to 24 Days)||37
7734297|NCT01591499|19043791|P1|STARTED|Second Intervention (up to 24 Days)||33
7734298|NCT01591499|19043788|P4|NOT COMPLETED|First Intervention (up to 24 Days)||0
7734299|NCT01591499|19043789|P3|NOT COMPLETED|First Intervention (up to 24 Days)||0
7734300|NCT01591499|19043790|P2|NOT COMPLETED|First Intervention (up to 24 Days)||0
7734301|NCT01591499|19043791|P1|NOT COMPLETED|First Intervention (up to 24 Days)||0
7734302|NCT01591499|19043788|P4|COMPLETED|First Intervention (up to 24 Days)||37
7734303|NCT01591499|19043789|P3|COMPLETED|First Intervention (up to 24 Days)||31
7734304|NCT01591499|19043790|P2|COMPLETED|First Intervention (up to 24 Days)||37
7734305|NCT01591499|19043791|P1|COMPLETED|First Intervention (up to 24 Days)||33
7734306|NCT01591499|19043788|P4|STARTED|First Intervention (up to 24 Days)||37
7734307|NCT01591499|19043789|P3|STARTED|First Intervention (up to 24 Days)||31
7734308|NCT01591499|19043790|P2|STARTED|First Intervention (up to 24 Days)||37
7734309|NCT01591499|19043791|P1|STARTED|First Intervention (up to 24 Days)||33
7734310|NCT01591499|19043788|P4|NOT COMPLETED|Baseline Visit||2
7734311|NCT01591499|19043789|P3|NOT COMPLETED|Baseline Visit||0
7734312|NCT01591499|19043790|P2|NOT COMPLETED|Baseline Visit||2
7734313|NCT01591499|19043791|P1|NOT COMPLETED|Baseline Visit||0
7734314|NCT01591499|19043788|P4|COMPLETED|Baseline Visit||37
7734315|NCT01591499|19043789|P3|COMPLETED|Baseline Visit||31
7734316|NCT01591499|19043790|P2|COMPLETED|Baseline Visit||37
7734317|NCT01591499|19043791|P1|COMPLETED|Baseline Visit||33
7734318|NCT01591499|19043788|P4|STARTED|Baseline Visit||39
7734319|NCT01591499|19043789|P3|STARTED|Baseline Visit||31
7734320|NCT01591499|19043790|P2|STARTED|Baseline Visit||39
7734321|NCT01591499|19043791|P1|STARTED|Baseline Visit||33
7734322|NCT01591460|19043857|P1|NOT COMPLETED|Overall Study||26
7734323|NCT01591460|19043857|P1|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139
7734324|NCT01591460|19043857|P1|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165
7734325|NCT01591408|19043939|P2|NOT COMPLETED|Overall Study||8
7734326|NCT01591408|19043940|P1|NOT COMPLETED|Overall Study||12
7734327|NCT01591408|19043939|P2|COMPLETED|Overall Study||24
7734328|NCT01591408|19043940|P1|COMPLETED|Overall Study||24
7734329|NCT01591408|19043939|P2|STARTED|Overall Study||32
7734330|NCT01591408|19043940|P1|STARTED|Overall Study||36
7734331|NCT01591382|19043948|P2|NOT COMPLETED|Overall Study||2
7734332|NCT01591382|19043949|P1|NOT COMPLETED|Overall Study||3
7734333|NCT01591382|19043948|P2|COMPLETED|Overall Study||30
7734334|NCT01591382|19043949|P1|COMPLETED|Overall Study||29
7734335|NCT01591382|19043948|P2|STARTED|Overall Study||32
7734336|NCT01591382|19043949|P1|STARTED|Overall Study||32
7734337|NCT01591317|19043966|P3|NOT COMPLETED|Overall Study||0
7734338|NCT01591317|19043967|P2|NOT COMPLETED|Overall Study||0
7734339|NCT01591317|19043968|P1|NOT COMPLETED|Overall Study||0
7734340|NCT01591317|19043966|P3|COMPLETED|Overall Study||10
7734341|NCT01591317|19043967|P2|COMPLETED|Overall Study||10
7734342|NCT01591317|19043968|P1|COMPLETED|Overall Study||10
7734343|NCT01591317|19043966|P3|STARTED|Overall Study||10
7734344|NCT01591317|19043967|P2|STARTED|Overall Study||10
7734345|NCT01591317|19043968|P1|STARTED|Overall Study||10
7734346|NCT01591161|19043996|P2|NOT COMPLETED|Overall Study||56
7734347|NCT01591161|19043997|P1|NOT COMPLETED|Overall Study||71
7734348|NCT01591161|19043996|P2|COMPLETED|Overall Study||68
7734349|NCT01591161|19043997|P1|COMPLETED|Overall Study||174
7734350|NCT01591161|19043996|P2|STARTED|Overall Study||124
7734351|NCT01591161|19043997|P1|STARTED|Overall Study||245
7734352|NCT01591096|19044017|P1|NOT COMPLETED|Overall Study||1
7734353|NCT01591096|19044017|P1|COMPLETED|Overall Study||0
7734354|NCT01591096|19044017|P1|STARTED|Overall Study||1
7734355|NCT01591044|19044026|P3|NOT COMPLETED|Overall Study||4
7734356|NCT01591044|19044027|P2|NOT COMPLETED|Overall Study||9
7734357|NCT01591044|19044028|P1|NOT COMPLETED|Overall Study||7
7734358|NCT01591044|19044026|P3|COMPLETED|Overall Study||96
7734359|NCT01591044|19044027|P2|COMPLETED|Overall Study||91
7734360|NCT01591044|19044028|P1|COMPLETED|Overall Study||94
7734361|NCT01591044|19044026|P3|STARTED|Overall Study||100
7734362|NCT01591044|19044027|P2|STARTED|Overall Study||100
7734363|NCT01591044|19044028|P1|STARTED|Overall Study||101
7734364|NCT01591018|19044038|P2|NOT COMPLETED|Overall Study||0
7734365|NCT01591018|19044039|P1|NOT COMPLETED|Overall Study||0
7734366|NCT01591018|19044038|P2|COMPLETED|Overall Study||60
7734367|NCT01591018|19044039|P1|COMPLETED|Overall Study||60
7734368|NCT01591018|19044038|P2|STARTED|Overall Study||60
7734369|NCT01591018|19044039|P1|STARTED|Overall Study||60
7734370|NCT01591005|19044053|P4|NOT COMPLETED|Overall Study||0
7734371|NCT01591005|19044054|P3|NOT COMPLETED|Overall Study||0
7734372|NCT01591005|19044055|P2|NOT COMPLETED|Overall Study||0
7734373|NCT01591005|19044056|P1|NOT COMPLETED|Overall Study||0
7734374|NCT01591005|19044053|P4|COMPLETED|Overall Study||68
7734375|NCT01591005|19044054|P3|COMPLETED|Overall Study||68
7734376|NCT01591005|19044055|P2|COMPLETED|Overall Study||53
7734377|NCT01591005|19044056|P1|COMPLETED|Overall Study||53
7734378|NCT01591005|19044053|P4|STARTED|Overall Study||68
7734379|NCT01591005|19044054|P3|STARTED|Overall Study||68
7734380|NCT01591005|19044055|P2|STARTED|Overall Study||53
7734381|NCT01591005|19044056|P1|STARTED|Overall Study||53
7734382|NCT01590979|19044092|P2|NOT COMPLETED|Overall Study||0
7734383|NCT01590979|19044093|P1|NOT COMPLETED|Overall Study||0
7734384|NCT01590979|19044092|P2|COMPLETED|Overall Study||27
7734385|NCT01590979|19044093|P1|COMPLETED|Overall Study||27
7734386|NCT01590979|19044092|P2|STARTED|Overall Study||27
7734387|NCT01590979|19044093|P1|STARTED|Overall Study||27
7734388|NCT01590888|19044102|P3|NOT COMPLETED|Overall Study||1
7734389|NCT01590888|19044103|P2|NOT COMPLETED|Overall Study||0
7734390|NCT01590888|19044104|P1|NOT COMPLETED|Overall Study||4
7734391|NCT01590888|19044102|P3|COMPLETED|Overall Study||34
7734392|NCT01590888|19044103|P2|COMPLETED|Overall Study||38
7734393|NCT01590888|19044104|P1|COMPLETED|Overall Study||32
7734394|NCT01590888|19044102|P3|STARTED|Overall Study||35
7734395|NCT01590888|19044103|P2|STARTED|Overall Study||38
7734396|NCT01590888|19044104|P1|STARTED|Overall Study||36
7734397|NCT01590875|19044150|P2|NOT COMPLETED|Overall Study||0
7734398|NCT01590875|19044151|P1|NOT COMPLETED|Overall Study||0
7734399|NCT01590875|19044150|P2|COMPLETED|Overall Study||10
7734400|NCT01590875|19044151|P1|COMPLETED|Overall Study||10
7734401|NCT01590875|19044150|P2|STARTED|Overall Study||10
7734402|NCT01590875|19044151|P1|STARTED|Overall Study||10
7734403|NCT01590810|19044164|P5|NOT COMPLETED|Overall Study||0
7734404|NCT01590810|19044165|P4|NOT COMPLETED|Overall Study||0
7734405|NCT01590810|19044166|P3|NOT COMPLETED|Overall Study||1
7734406|NCT01590810|19044167|P2|NOT COMPLETED|Overall Study||1
7734407|NCT01590810|19044168|P1|NOT COMPLETED|Overall Study||0
7734408|NCT01590810|19044164|P5|COMPLETED|Overall Study||2
7734409|NCT01590810|19044165|P4|COMPLETED|Overall Study||8
7734410|NCT01590810|19044166|P3|COMPLETED|Overall Study||7
7734411|NCT01590810|19044167|P2|COMPLETED|Overall Study||7
7734412|NCT01590810|19044168|P1|COMPLETED|Overall Study||8
7734413|NCT01590810|19044164|P5|STARTED|Overall Study||2
7734414|NCT01590810|19044165|P4|STARTED|Overall Study||8
7734415|NCT01590810|19044166|P3|STARTED|Overall Study||8
7734416|NCT01590810|19044167|P2|STARTED|Overall Study||8
7734417|NCT01590810|19044168|P1|STARTED|Overall Study||8
7734418|NCT01590797|19044313|P2|NOT COMPLETED|Overall Study||16
7734419|NCT01590797|19044314|P1|NOT COMPLETED|Overall Study||17
7734420|NCT01590797|19044313|P2|COMPLETED|Overall Study||217
7734421|NCT01590797|19044314|P1|COMPLETED|Overall Study||217
7734422|NCT01590797|19044313|P2|STARTED|Overall Study||233
7734423|NCT01590797|19044314|P1|STARTED|Overall Study||234
7734424|NCT01590771|19044330|P2|NOT COMPLETED|Overall Study||39
7734425|NCT01590771|19044331|P1|NOT COMPLETED|Overall Study||19
7734426|NCT01590771|19044330|P2|COMPLETED|Overall Study||210
7734427|NCT01590771|19044331|P1|COMPLETED|Overall Study||230
7734428|NCT01590771|19044330|P2|STARTED|Overall Study||249
7734429|NCT01590771|19044331|P1|STARTED|Overall Study||249
7734430|NCT01590758|19044359|P2|NOT COMPLETED|Overall Study||7
7734431|NCT01590758|19044360|P1|NOT COMPLETED|Overall Study||5
7734432|NCT01590758|19044359|P2|COMPLETED|Overall Study||97
7734433|NCT01590758|19044360|P1|COMPLETED|Overall Study||80
7734434|NCT01590758|19044359|P2|STARTED|Overall Study||104
7734435|NCT01590758|19044360|P1|STARTED|Overall Study||85
7734436|NCT01590563|19044370|P1|NOT COMPLETED|Overall Study||1
7734437|NCT01590563|19044370|P1|COMPLETED|Overall Study||14
7734438|NCT01590563|19044370|P1|STARTED|Overall Study||15
7734439|NCT01590550|19044376|P1|NOT COMPLETED|Overall Study||0
7734440|NCT01590550|19044376|P1|COMPLETED|Overall Study||18
7734441|NCT01590550|19044376|P1|STARTED|Overall Study||18
7734442|NCT01590433|19044384|P2|NOT COMPLETED|Overall Study||22
7734443|NCT01590433|19044385|P1|NOT COMPLETED|Overall Study||52
7734444|NCT01590433|19044384|P2|COMPLETED|Overall Study||33
7734445|NCT01590433|19044385|P1|COMPLETED|Overall Study||75
7734446|NCT01590433|19044384|P2|STARTED|Overall Study||55
7734447|NCT01590433|19044385|P1|STARTED|Overall Study||127
7734448|NCT01590394|19044391|P1|NOT COMPLETED|Overall Study||0
7734449|NCT01590394|19044391|P1|COMPLETED|Overall Study||3
7734450|NCT01590394|19044391|P1|STARTED|Overall Study||3
7734451|NCT01590264|19044395|P1|NOT COMPLETED|Overall Study||0
7734452|NCT01590264|19044395|P1|COMPLETED|Overall Study||5
7734453|NCT01590264|19044395|P1|STARTED|Overall Study||5
7734454|NCT01590238|19044400|P1|NOT COMPLETED|Overall Study||2
7734455|NCT01590238|19044400|P1|COMPLETED|Overall Study||13
7734456|NCT01590238|19044400|P1|STARTED|Overall Study||15
7734457|NCT01590212|19044407|P3|NOT COMPLETED|Overall Study||5
7734458|NCT01590212|19044408|P2|NOT COMPLETED|Overall Study||4
7734459|NCT01590212|19044409|P1|NOT COMPLETED|Overall Study||3
7734460|NCT01590212|19044407|P3|COMPLETED|Overall Study||9
7734461|NCT01590212|19044408|P2|COMPLETED|Overall Study||5
7734462|NCT01590212|19044409|P1|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9
7734463|NCT01590212|19044407|P3|Post-intervention|Overall Study|failed contact=1|10
7734464|NCT01590212|19044408|P2|Post-intervention|Overall Study|failed contact=2; withdrew=1|6
7734465|NCT01590212|19044409|P1|Post-intervention|Overall Study|failed contact=3|7
7734466|NCT01590212|19044407|P3|Baseline (Pre-intervention)|Overall Study|failed contact=2|12
7734467|NCT01590212|19044408|P2|Baseline (Pre-intervention)|Overall Study||9
7734468|NCT01590212|19044409|P1|Baseline (Pre-intervention)|Overall Study|withdrew=2|10
7734469|NCT01590212|19044407|P3|STARTED|Overall Study||14
7734470|NCT01590212|19044408|P2|STARTED|Overall Study||9
7734471|NCT01590212|19044409|P1|STARTED|Overall Study||12
7734472|NCT01590082|19044428|P2|NOT COMPLETED|Overall Study||0
7734473|NCT01590082|19044429|P1|NOT COMPLETED|Overall Study||2
7734474|NCT01590082|19044428|P2|COMPLETED|Overall Study||1
7734475|NCT01590082|19044429|P1|COMPLETED|Overall Study||9
7734476|NCT01590082|19044428|P2|STARTED|Overall Study||1
7734477|NCT01590082|19044429|P1|STARTED|Overall Study||11
7734478|NCT01590017|19044435|P1|NOT COMPLETED|Overall Study||4
7734479|NCT01590017|19044435|P1|COMPLETED|Overall Study||37
7734480|NCT01590017|19044435|P1|STARTED|Overall Study||41
7734481|NCT01589978|19044440|P1|NOT COMPLETED|Overall Study||0
7734482|NCT01589978|19044440|P1|COMPLETED|Overall Study||2681
7734483|NCT01589978|19044440|P1|STARTED|Overall Study||2681
7734484|NCT01589926|19044466|P2|NOT COMPLETED|Overall Study||0
7734485|NCT01589926|19044467|P1|NOT COMPLETED|Overall Study||0
7734486|NCT01589926|19044466|P2|COMPLETED|Overall Study||0
7734487|NCT01589926|19044467|P1|COMPLETED|Overall Study||0
7734488|NCT01589926|19044466|P2|STARTED|Overall Study||0
7734489|NCT01589926|19044467|P1|STARTED|Overall Study||0
7734490|NCT01589822|19044488|P3|NOT COMPLETED|Overall Study||1
7734491|NCT01589822|19044489|P2|NOT COMPLETED|Overall Study||3
7734492|NCT01589822|19044490|P1|NOT COMPLETED|Overall Study||4
7734493|NCT01589822|19044488|P3|COMPLETED|Overall Study||40
7734494|NCT01589822|19044489|P2|COMPLETED|Overall Study||86
7734495|NCT01589822|19044490|P1|COMPLETED|Overall Study||80
7734496|NCT01589822|19044488|P3|STARTED|Overall Study||41
7734497|NCT01589822|19044489|P2|STARTED|Overall Study||89
7734498|NCT01589822|19044490|P1|STARTED|Overall Study||84
7734499|NCT01589770|19044509|P2|NOT COMPLETED|Overall Study||5
7734500|NCT01589770|19044510|P1|NOT COMPLETED|Overall Study||8
7734501|NCT01589770|19044509|P2|COMPLETED|Overall Study||56
7734502|NCT01589770|19044510|P1|COMPLETED|Overall Study||59
7734503|NCT01589770|19044509|P2|STARTED|Overall Study||61
7734504|NCT01589770|19044510|P1|STARTED|Overall Study||67
7734505|NCT01589653|19044520|P2|NOT COMPLETED|Overall Study||11
7734506|NCT01589653|19044521|P1|NOT COMPLETED|Overall Study||7
7734507|NCT01589653|19044520|P2|COMPLETED|Overall Study||68
7734508|NCT01589653|19044521|P1|COMPLETED|Overall Study||69
7734509|NCT01589653|19044520|P2|Exposed|Overall Study||78
7734510|NCT01589653|19044521|P1|Exposed|Overall Study||76
7734511|NCT01589653|19044520|P2|STARTED|Overall Study||79
7734512|NCT01589653|19044521|P1|STARTED|Overall Study||76
7734513|NCT01589601|19044537|P2|NOT COMPLETED|Overall Study||49
7734514|NCT01589601|19044538|P1|NOT COMPLETED|Overall Study||47
7734515|NCT01589601|19044537|P2|COMPLETED|Overall Study||26
7734516|NCT01589601|19044538|P1|COMPLETED|Overall Study||28
7734517|NCT01589601|19044537|P2|STARTED|Overall Study||75
7734518|NCT01589601|19044538|P1|STARTED|Overall Study||75
7734519|NCT01589510|19044556|P1|NOT COMPLETED|Overall Study||33
7734520|NCT01589510|19044556|P1|COMPLETED|Overall Study||386
7734521|NCT01589510|19044556|P1|STARTED|Overall Study||419
7734522|NCT01589497|19044571|P4|NOT COMPLETED|Overall Study||1
7734523|NCT01589497|19044572|P3|NOT COMPLETED|Overall Study||1
7734524|NCT01589497|19044573|P2|NOT COMPLETED|Overall Study||1
7734525|NCT01589497|19044574|P1|NOT COMPLETED|Overall Study||1
7734526|NCT01589497|19044571|P4|COMPLETED|Overall Study||17
7734527|NCT01589497|19044572|P3|COMPLETED|Overall Study||15
7734528|NCT01589497|19044573|P2|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|16
7734529|NCT01589497|19044574|P1|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|17
7734530|NCT01589497|19044571|P4|STARTED|Overall Study||18
7734531|NCT01589497|19044572|P3|STARTED|Overall Study||16
7734532|NCT01589497|19044573|P2|STARTED|Overall Study||17
7734533|NCT01589497|19044574|P1|STARTED|Overall Study||18
7734534|NCT01589484|19044675|P1|NOT COMPLETED|Overall Study||4
7734535|NCT01589484|19044675|P1|COMPLETED|Overall Study||100
7734536|NCT01589484|19044675|P1|STARTED|Overall Study||104
7734537|NCT01589445|19044680|P1|NOT COMPLETED|002 (Metformin)-3 Months||9
7734538|NCT01589445|19044680|P1|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61
7734539|NCT01589445|19044680|P1|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70
7734540|NCT01589445|19044680|P1|NOT COMPLETED|001 (Pioglitazone) -3 Months||7
7734541|NCT01589445|19044680|P1|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70
7734542|NCT01589445|19044680|P1|STARTED|001 (Pioglitazone) -3 Months||77
7734543|NCT01589315|19044696|P1|NOT COMPLETED|Overall Study||1
7734544|NCT01589315|19044696|P1|COMPLETED|Overall Study||16
7734545|NCT01589315|19044696|P1|STARTED|Overall Study||17
7734546|NCT01589302|19044700|P1|NOT COMPLETED|Overall Study||2
7734547|NCT01589302|19044700|P1|COMPLETED|Overall Study||152
7734548|NCT01589302|19044700|P1|Non-Del17p Patients|Overall Study||76
7734549|NCT01589302|19044700|P1|Del17p Patients|Overall Study||76
7734550|NCT01589302|19044700|P1|STARTED|Overall Study||154
7734551|NCT01589237|19044723|P4|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
7734552|NCT01589237|19044724|P3|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
7734553|NCT01589237|19044725|P2|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6
7734554|NCT01589237|19044726|P1|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5
7734555|NCT01589237|19044723|P4|COMPLETED|Part B (Planned for 78 Week-terminated)||0
7734556|NCT01589237|19044724|P3|COMPLETED|Part B (Planned for 78 Week-terminated)||0
7734557|NCT01589237|19044725|P2|COMPLETED|Part B (Planned for 78 Week-terminated)||0
7734558|NCT01589237|19044726|P1|COMPLETED|Part B (Planned for 78 Week-terminated)||0
7734559|NCT01589237|19044723|P4|STARTED|Part B (Planned for 78 Week-terminated)||4
7734560|NCT01589237|19044724|P3|STARTED|Part B (Planned for 78 Week-terminated)||4
7734561|NCT01589237|19044725|P2|STARTED|Part B (Planned for 78 Week-terminated)||6
7734562|NCT01589237|19044726|P1|STARTED|Part B (Planned for 78 Week-terminated)||5
7734563|NCT01589237|19044723|P4|NOT COMPLETED|Part A (52 Weeks)||0
7734564|NCT01589237|19044724|P3|NOT COMPLETED|Part A (52 Weeks)||2
7734565|NCT01589237|19044725|P2|NOT COMPLETED|Part A (52 Weeks)||3
7734566|NCT01589237|19044726|P1|NOT COMPLETED|Part A (52 Weeks)||2
7734567|NCT01589237|19044723|P4|COMPLETED|Part A (52 Weeks)||5
7734568|NCT01589237|19044724|P3|COMPLETED|Part A (52 Weeks)||8
7734569|NCT01589237|19044725|P2|COMPLETED|Part A (52 Weeks)||9
7734570|NCT01589237|19044726|P1|COMPLETED|Part A (52 Weeks)||9
7734571|NCT01589237|19044723|P4|STARTED|Part A (52 Weeks)||5
7734572|NCT01589237|19044724|P3|STARTED|Part A (52 Weeks)||10
7734573|NCT01589237|19044725|P2|STARTED|Part A (52 Weeks)||12
7734574|NCT01589237|19044726|P1|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11
7734575|NCT01589185|19044777|P5|NOT COMPLETED|Overall Study||1
7734576|NCT01589185|19044778|P4|NOT COMPLETED|Overall Study||3
7734577|NCT01589185|19044779|P3|NOT COMPLETED|Overall Study||4
7734578|NCT01589185|19044780|P2|NOT COMPLETED|Overall Study||2
7734579|NCT01589185|19044781|P1|NOT COMPLETED|Overall Study||2
7734580|NCT01589185|19044777|P5|COMPLETED|Overall Study||15
7734581|NCT01589185|19044778|P4|COMPLETED|Overall Study||5
7734582|NCT01589185|19044779|P3|COMPLETED|Overall Study||6
7734583|NCT01589185|19044780|P2|COMPLETED|Overall Study||6
7734584|NCT01589185|19044781|P1|COMPLETED|Overall Study||4
7734585|NCT01589185|19044777|P5|STARTED|Overall Study||16
7734586|NCT01589185|19044778|P4|STARTED|Overall Study||8
7734587|NCT01589185|19044779|P3|STARTED|Overall Study||10
7734588|NCT01589185|19044780|P2|STARTED|Overall Study||8
7734589|NCT01589185|19044781|P1|STARTED|Overall Study||6
7734590|NCT01589094|19044814|P1|NOT COMPLETED|Overall Study||2
7734591|NCT01589094|19044814|P1|COMPLETED|Overall Study||49
7734592|NCT01589094|19044814|P1|STARTED|Overall Study||51
7734593|NCT01588990|19044821|P1|NOT COMPLETED|Phase B||16
7734594|NCT01588990|19044821|P1|COMPLETED|Phase B|A total of 37 participants had disease progression in Phase B and ended Phase B.|37
7734595|NCT01588990|19044821|P1|STARTED|Phase B|Of 58 participants who had documented disease progression in Phase A, 53 entered in Phase B.|53
7734596|NCT01588990|19044821|P1|NOT COMPLETED|Phase A||70
7734597|NCT01588990|19044821|P1|COMPLETED|Phase A|A total of 58 participants had disease progression in Phase A and ended Phase A.|58
7734598|NCT01588990|19044821|P1|STARTED|Phase A||128
7734599|NCT01588951|19044849|P3|NOT COMPLETED|Overall Study||1
7734600|NCT01588951|19044850|P2|NOT COMPLETED|Overall Study||0
7734601|NCT01588951|19044851|P1|NOT COMPLETED|Overall Study||0
7734602|NCT01588951|19044849|P3|COMPLETED|Overall Study||5
7734603|NCT01588951|19044850|P2|COMPLETED|Overall Study||2
7734604|NCT01588951|19044851|P1|COMPLETED|Overall Study||2
7734605|NCT01588951|19044849|P3|STARTED|Overall Study||6
7734606|NCT01588951|19044850|P2|STARTED|Overall Study||2
7734607|NCT01588951|19044851|P1|STARTED|Overall Study||2
7734608|NCT01588821|19044859|P1|NOT COMPLETED|Overall Study||0
7734609|NCT01588821|19044859|P1|COMPLETED|Overall Study||37
7734610|NCT01588821|19044859|P1|STARTED|Overall Study||37
7734611|NCT01588561|19044869|P2|NOT COMPLETED|Overall Study||0
7734612|NCT01588561|19044870|P1|NOT COMPLETED|Overall Study||0
7734613|NCT01588561|19044869|P2|COMPLETED|Overall Study||1
7734614|NCT01588561|19044870|P1|COMPLETED|Overall Study||14
7734615|NCT01588561|19044869|P2|Second Injection (Visit 2)|Overall Study||1
7734616|NCT01588561|19044870|P1|Second Injection (Visit 2)|Overall Study||14
7734617|NCT01588561|19044869|P2|Rest Period|Overall Study||1
7734618|NCT01588561|19044870|P1|Rest Period|Overall Study||14
7734619|NCT01588561|19044869|P2|First Injection (Visit 1)|Overall Study||1
7734620|NCT01588561|19044870|P1|First Injection (Visit 1)|Overall Study||14
7734621|NCT01588561|19044869|P2|STARTED|Overall Study||1
7734622|NCT01588561|19044870|P1|STARTED|Overall Study||14
7734623|NCT01588548|19044887|P6|NOT COMPLETED|Overall Study||6
7734624|NCT01588548|19044888|P5|NOT COMPLETED|Overall Study||6
7734625|NCT01588548|19044889|P4|NOT COMPLETED|Overall Study||7
7734626|NCT01588548|19044890|P3|NOT COMPLETED|Overall Study||6
7734627|NCT01588548|19044891|P2|NOT COMPLETED|Overall Study||7
7734628|NCT01588548|19044892|P1|NOT COMPLETED|Overall Study||3
7734629|NCT01588548|19044887|P6|COMPLETED|Overall Study||0
7734630|NCT01588548|19044888|P5|COMPLETED|Overall Study||0
7734631|NCT01588548|19044889|P4|COMPLETED|Overall Study||0
7734632|NCT01588548|19044890|P3|COMPLETED|Overall Study||0
7734633|NCT01588548|19044891|P2|COMPLETED|Overall Study||0
7734634|NCT01588548|19044892|P1|COMPLETED|Overall Study||0
7734635|NCT01588548|19044887|P6|Cycle 1 Day 21|Overall Study||3
7734636|NCT01588548|19044888|P5|Cycle 1 Day 21|Overall Study||3
7734637|NCT01588548|19044889|P4|Cycle 1 Day 21|Overall Study||5
7734638|NCT01588548|19044890|P3|Cycle 1 Day 21|Overall Study||2
7734639|NCT01588548|19044891|P2|Cycle 1 Day 21|Overall Study||5
7734640|NCT01588548|19044892|P1|Cycle 1 Day 21|Overall Study||3
7734641|NCT01588548|19044887|P6|STARTED|Overall Study||6
7734642|NCT01588548|19044888|P5|STARTED|Overall Study||6
7734643|NCT01588548|19044889|P4|STARTED|Overall Study||7
7734644|NCT01588548|19044890|P3|STARTED|Overall Study||6
7734645|NCT01588548|19044891|P2|STARTED|Overall Study||7
7734646|NCT01588548|19044892|P1|STARTED|Overall Study||3
7734647|NCT01588509|19044908|P2|NOT COMPLETED|Overall Study||0
7734648|NCT01588509|19044909|P1|NOT COMPLETED|Overall Study||1
7734649|NCT01588509|19044908|P2|COMPLETED|Overall Study||30
7734650|NCT01588509|19044909|P1|COMPLETED|Overall Study||29
7734651|NCT01588509|19044908|P2|Received Treatment|Overall Study||30
7734652|NCT01588509|19044909|P1|Received Treatment|Overall Study||30
7734653|NCT01588509|19044908|P2|STARTED|Overall Study||30
7734654|NCT01588509|19044909|P1|STARTED|Overall Study||30
7734655|NCT01588496|19044932|P3|NOT COMPLETED|Overall Study||0
7734656|NCT01588496|19044933|P2|NOT COMPLETED|Overall Study||1
7734657|NCT01588496|19044934|P1|NOT COMPLETED|Overall Study||0
7734658|NCT01588496|19044932|P3|COMPLETED|Overall Study||33
7734659|NCT01588496|19044933|P2|COMPLETED|Overall Study||16
7734660|NCT01588496|19044934|P1|COMPLETED|Overall Study||8
7734661|NCT01588496|19044932|P3|Received Treatment|Overall Study||33
7734662|NCT01588496|19044933|P2|Received Treatment|Overall Study||16
7734663|NCT01588496|19044934|P1|Received Treatment|Overall Study||8
7734664|NCT01588496|19044932|P3|STARTED|Overall Study||33
7734665|NCT01588496|19044933|P2|STARTED|Overall Study||17
7734666|NCT01588496|19044934|P1|STARTED|Overall Study||8
7734667|NCT01588470|19044959|P1|NOT COMPLETED|Overall Study||80
7734668|NCT01588470|19044959|P1|COMPLETED|Overall Study|Completed Dec. 2011|50
7734669|NCT01588470|19044959|P1|STARTED|Overall Study|First enrolled April 2007|130
7734670|NCT01588457|19044970|P4|NOT COMPLETED|Randomization 2||5
7734671|NCT01588457|19044971|P3|NOT COMPLETED|Randomization 2||5
7734672|NCT01588457|19044972|P2|NOT COMPLETED|Randomization 2||28
7734673|NCT01588457|19044973|P1|NOT COMPLETED|Randomization 2||20
7734674|NCT01588457|19044970|P4|COMPLETED|Randomization 2||13
7734675|NCT01588457|19044971|P3|COMPLETED|Randomization 2||12
7734676|NCT01588457|19044972|P2|COMPLETED|Randomization 2||3
7734677|NCT01588457|19044973|P1|COMPLETED|Randomization 2||1
7734678|NCT01588457|19044970|P4|STARTED|Randomization 2|Assignment of Lamotrigine plus monotherapy for symptoms of depression|18
7734679|NCT01588457|19044971|P3|STARTED|Randomization 2|Assignment of Quetiapine plus monotherapy for symptoms of depression|17
7734680|NCT01588457|19044972|P2|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|31
7734681|NCT01588457|19044973|P1|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|21
7734682|NCT01588457|19044970|P4|NOT COMPLETED|Randomization 1||0
7734683|NCT01588457|19044971|P3|NOT COMPLETED|Randomization 1||0
7734684|NCT01588457|19044972|P2|NOT COMPLETED|Randomization 1||16
7734685|NCT01588457|19044973|P1|NOT COMPLETED|Randomization 1||23
7734686|NCT01588457|19044970|P4|COMPLETED|Randomization 1||0
7734687|NCT01588457|19044971|P3|COMPLETED|Randomization 1||0
7734688|NCT01588457|19044972|P2|COMPLETED|Randomization 1||43
7734689|NCT01588457|19044973|P1|COMPLETED|Randomization 1||30
7734690|NCT01588457|19044970|P4|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
7734691|NCT01588457|19044971|P3|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
7734692|NCT01588457|19044972|P2|STARTED|Randomization 1||59
7734693|NCT01588457|19044973|P1|STARTED|Randomization 1||53
7734694|NCT01588444|19044995|P2|NOT COMPLETED|Overall Study||0
7734695|NCT01588444|19044996|P1|NOT COMPLETED|Overall Study||0
7734696|NCT01588444|19044995|P2|COMPLETED|Overall Study||20
7734697|NCT01588444|19044996|P1|COMPLETED|Overall Study||20
7734698|NCT01588444|19044995|P2|STARTED|Overall Study||20
7734699|NCT01588444|19044996|P1|STARTED|Overall Study||20
7734700|NCT01588418|19045002|P2|NOT COMPLETED|Overall Study||0
7734701|NCT01588418|19045003|P1|NOT COMPLETED|Overall Study||0
7734702|NCT01588418|19045002|P2|COMPLETED|Overall Study||4
7734703|NCT01588418|19045003|P1|COMPLETED|Overall Study||11
7734704|NCT01588418|19045002|P2|STARTED|Overall Study||4
7734705|NCT01588418|19045003|P1|STARTED|Overall Study||11
7734706|NCT01588405|19045009|P1|NOT COMPLETED|Overall Study||2
7734707|NCT01588405|19045009|P1|COMPLETED|Overall Study||31
7734708|NCT01588405|19045009|P1|STARTED|Overall Study||33
7734709|NCT01588366|19045038|P6|NOT COMPLETED|Overall Study||2
7734710|NCT01588366|19045039|P5|NOT COMPLETED|Overall Study||0
7734711|NCT01588366|19045040|P4|NOT COMPLETED|Overall Study||1
7734712|NCT01588366|19045041|P3|NOT COMPLETED|Overall Study||0
7734713|NCT01588366|19045042|P2|NOT COMPLETED|Overall Study||1
7734714|NCT01588366|19045043|P1|NOT COMPLETED|Overall Study||0
7734715|NCT01588366|19045038|P6|COMPLETED|Overall Study||7
7734716|NCT01588366|19045039|P5|COMPLETED|Overall Study||3
7734717|NCT01588366|19045040|P4|COMPLETED|Overall Study||6
7734718|NCT01588366|19045041|P3|COMPLETED|Overall Study||2
7734719|NCT01588366|19045042|P2|COMPLETED|Overall Study||6
7734720|NCT01588366|19045043|P1|COMPLETED|Overall Study||2
7734721|NCT01588366|19045038|P6|Received at Least One Dose of Study Drug|Overall Study||9
7734722|NCT01588366|19045039|P5|Received at Least One Dose of Study Drug|Overall Study||3
7734723|NCT01588366|19045040|P4|Received at Least One Dose of Study Drug|Overall Study||7
7734724|NCT01588366|19045041|P3|Received at Least One Dose of Study Drug|Overall Study||2
7734725|NCT01588366|19045042|P2|Received at Least One Dose of Study Drug|Overall Study||7
7734726|NCT01588366|19045043|P1|Received at Least One Dose of Study Drug|Overall Study||2
7734727|NCT01588366|19045038|P6|STARTED|Overall Study||9
7734728|NCT01588366|19045039|P5|STARTED|Overall Study||3
7734729|NCT01588366|19045040|P4|STARTED|Overall Study||7
7734730|NCT01588366|19045041|P3|STARTED|Overall Study||2
7734731|NCT01588366|19045042|P2|STARTED|Overall Study||7
7734732|NCT01588366|19045043|P1|STARTED|Overall Study||2
7734733|NCT01588353|19045071|P3|NOT COMPLETED|Step3||2
7734734|NCT01588353|19045072|P2|NOT COMPLETED|Step3||0
7734735|NCT01588353|19045073|P1|NOT COMPLETED|Step3||0
7734736|NCT01588353|19045071|P3|COMPLETED|Step3||23
7734737|NCT01588353|19045072|P2|COMPLETED|Step3||0
7734738|NCT01588353|19045073|P1|COMPLETED|Step3||0
7734739|NCT01588353|19045071|P3|STARTED|Step3||25
7734740|NCT01588353|19045072|P2|STARTED|Step3||0
7734741|NCT01588353|19045073|P1|STARTED|Step3||0
7734742|NCT01588353|19045071|P3|NOT COMPLETED|Step2||0
7734743|NCT01588353|19045072|P2|NOT COMPLETED|Step2||1
7734744|NCT01588353|19045073|P1|NOT COMPLETED|Step2||0
7734745|NCT01588353|19045071|P3|COMPLETED|Step2||0
7734746|NCT01588353|19045072|P2|COMPLETED|Step2||70
7734747|NCT01588353|19045073|P1|COMPLETED|Step2||0
7734748|NCT01588353|19045071|P3|STARTED|Step2||0
7734749|NCT01588353|19045072|P2|STARTED|Step2||71
7734750|NCT01588353|19045073|P1|STARTED|Step2||0
7734751|NCT01588353|19045071|P3|NOT COMPLETED|Step1||0
7734752|NCT01588353|19045072|P2|NOT COMPLETED|Step1||0
7734753|NCT01588353|19045073|P1|NOT COMPLETED|Step1||0
7734754|NCT01588353|19045071|P3|COMPLETED|Step1||0
7734755|NCT01588353|19045072|P2|COMPLETED|Step1||0
7734756|NCT01588353|19045073|P1|COMPLETED|Step1||6
7734757|NCT01588353|19045071|P3|STARTED|Step1||0
7734758|NCT01588353|19045072|P2|STARTED|Step1||0
7734759|NCT01588353|19045073|P1|STARTED|Step1||6
7734760|NCT01588236|19045092|P3|NOT COMPLETED|Overall Study||25
7734761|NCT01588236|19045093|P2|NOT COMPLETED|Overall Study||28
7734762|NCT01588236|19045094|P1|NOT COMPLETED|Overall Study||16
7734763|NCT01588236|19045092|P3|COMPLETED|Overall Study||69
7734764|NCT01588236|19045093|P2|COMPLETED|Overall Study||66
7734765|NCT01588236|19045094|P1|COMPLETED|Overall Study||76
7734766|NCT01588236|19045092|P3|STARTED|Overall Study||94
7734767|NCT01588236|19045093|P2|STARTED|Overall Study||94
7734768|NCT01588236|19045094|P1|STARTED|Overall Study||92
7734769|NCT01588197|19045122|P2|NOT COMPLETED|Overall Study||1
7734770|NCT01588197|19045123|P1|NOT COMPLETED|Overall Study||1
7734771|NCT01588197|19045122|P2|COMPLETED|Overall Study||9
7734772|NCT01588197|19045123|P1|COMPLETED|Overall Study||9
7734773|NCT01588197|19045122|P2|STARTED|Overall Study||10
7734774|NCT01588197|19045123|P1|STARTED|Overall Study||10
7734775|NCT01588184|19045139|P6|NOT COMPLETED|Overall Study||4
7734776|NCT01588184|19045140|P5|NOT COMPLETED|Overall Study||2
7734777|NCT01588184|19045141|P4|NOT COMPLETED|Overall Study||3
7734778|NCT01588184|19045142|P3|NOT COMPLETED|Overall Study||2
7734779|NCT01588184|19045143|P2|NOT COMPLETED|Overall Study||13
7734780|NCT01588184|19045144|P1|NOT COMPLETED|Overall Study||3
7734781|NCT01588184|19045139|P6|COMPLETED|Overall Study||10
7734782|NCT01588184|19045140|P5|COMPLETED|Overall Study||14
7734783|NCT01588184|19045141|P4|COMPLETED|Overall Study||3
7734784|NCT01588184|19045142|P3|COMPLETED|Overall Study||5
7734785|NCT01588184|19045143|P2|COMPLETED|Overall Study||28
7734786|NCT01588184|19045144|P1|COMPLETED|Overall Study||8
7734787|NCT01588184|19045139|P6|STARTED|Overall Study||14
7734788|NCT01588184|19045140|P5|STARTED|Overall Study||16
7734789|NCT01588184|19045141|P4|STARTED|Overall Study||6
7734790|NCT01588184|19045142|P3|STARTED|Overall Study||7
7734791|NCT01588184|19045143|P2|STARTED|Overall Study||41
7734792|NCT01588184|19045144|P1|STARTED|Overall Study||11
7734793|NCT01588158|19045172|P2|NOT COMPLETED|Overall Study||0
7734794|NCT01588158|19045173|P1|NOT COMPLETED|Overall Study||0
7734795|NCT01588158|19045172|P2|COMPLETED|Overall Study||3
7734796|NCT01588158|19045173|P1|COMPLETED|Overall Study||4
7734797|NCT01588158|19045172|P2|STARTED|Overall Study||3
7734798|NCT01588158|19045173|P1|STARTED|Overall Study||4
7734799|NCT01588106|19045197|P2|NOT COMPLETED|Overall Study||4
7734800|NCT01588106|19045198|P1|NOT COMPLETED|Overall Study||5
7734801|NCT01588106|19045197|P2|COMPLETED|Overall Study||72
7734802|NCT01588106|19045198|P1|COMPLETED|Overall Study||73
7734803|NCT01588106|19045197|P2|STARTED|Overall Study||76
7734804|NCT01588106|19045198|P1|STARTED|Overall Study||78
7734805|NCT01587989|19045206|P3|NOT COMPLETED|Randomized Study Treatment||1
7734806|NCT01587989|19045207|P2|NOT COMPLETED|Randomized Study Treatment||2
7734807|NCT01587989|19045208|P1|NOT COMPLETED|Randomized Study Treatment||0
7734808|NCT01587989|19045206|P3|COMPLETED|Randomized Study Treatment||32
7734809|NCT01587989|19045207|P2|COMPLETED|Randomized Study Treatment||30
7734810|NCT01587989|19045208|P1|COMPLETED|Randomized Study Treatment||0
7734811|NCT01587989|19045206|P3|STARTED|Randomized Study Treatment||33
7734812|NCT01587989|19045207|P2|STARTED|Randomized Study Treatment||32
7734813|NCT01587989|19045208|P1|STARTED|Randomized Study Treatment||0
7734814|NCT01587989|19045206|P3|NOT COMPLETED|12-Week Open-Label Run-In Period||0
7734815|NCT01587989|19045207|P2|NOT COMPLETED|12-Week Open-Label Run-In Period||0
7734816|NCT01587989|19045208|P1|NOT COMPLETED|12-Week Open-Label Run-In Period||12
7734817|NCT01587989|19045206|P3|COMPLETED|12-Week Open-Label Run-In Period||0
7734818|NCT01587989|19045207|P2|COMPLETED|12-Week Open-Label Run-In Period||0
7734819|NCT01587989|19045208|P1|COMPLETED|12-Week Open-Label Run-In Period||65
7734820|NCT01587989|19045206|P3|STARTED|12-Week Open-Label Run-In Period||0
7734821|NCT01587989|19045207|P2|STARTED|12-Week Open-Label Run-In Period||0
7734822|NCT01587989|19045208|P1|STARTED|12-Week Open-Label Run-In Period||77
7734823|NCT01587963|19045232|P2|NOT COMPLETED|Overall Study||0
7734824|NCT01587963|19045233|P1|NOT COMPLETED|Overall Study||1
7734825|NCT01587963|19045232|P2|COMPLETED|Overall Study||4
7734826|NCT01587963|19045233|P1|COMPLETED|Overall Study||6
7734827|NCT01587963|19045232|P2|STARTED|Overall Study||4
7734828|NCT01587963|19045233|P1|STARTED|Overall Study||7
7734829|NCT01587950|19045239|P1|NOT COMPLETED|Period 3||0
7734830|NCT01587950|19045239|P1|COMPLETED|Period 3||12
7734831|NCT01587950|19045239|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5
7734832|NCT01587950|19045239|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3
7734833|NCT01587950|19045239|P1|Received 5% KNO3 Solution (2 Minutes)|Period 3||3
7734834|NCT01587950|19045239|P1|Received 5% KNO3 Solution (5 Minutes)|Period 3||5
7734835|NCT01587950|19045239|P1|Received Sterile Water (5 Minutes)|Period 3||5
7734836|NCT01587950|19045239|P1|Received 5% KNO3 Solution (10 Minutes)|Period 3||4
7734837|NCT01587950|19045239|P1|Received Sterile Water (2 Minutes)|Period 3||2
7734838|NCT01587950|19045239|P1|Received Sterile Water (10 Minutes)|Period 3||5
7734839|NCT01587950|19045239|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4
7734840|NCT01587950|19045239|P1|STARTED|Period 3||12
7734841|NCT01587950|19045239|P1|NOT COMPLETED|Washout 2||0
7734842|NCT01587950|19045239|P1|COMPLETED|Washout 2||12
7734843|NCT01587950|19045239|P1|STARTED|Washout 2||12
7734844|NCT01587950|19045239|P1|NOT COMPLETED|Period 2||0
7734845|NCT01587950|19045239|P1|COMPLETED|Period 2||12
7734846|NCT01587950|19045239|P1|Received 5% KNO3 Solution (5 Minutes)|Period 2||2
7734847|NCT01587950|19045239|P1|Received Sterile Water (10 Minutes)|Period 2||2
7734848|NCT01587950|19045239|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4
7734849|NCT01587950|19045239|P1|Received Sterile Water (5 Minutes)|Period 2||2
7734850|NCT01587950|19045239|P1|Received 5% KNO3 Solution (2 Minutes)|Period 2||6
7734851|NCT01587950|19045239|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6
7734852|NCT01587950|19045239|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2
7734853|NCT01587950|19045239|P1|Received 5% KNO3 Solution (10 Minutes)|Period 2||4
7734854|NCT01587950|19045239|P1|Received Sterile Water (2 Minutes)|Period 2||8
7734855|NCT01587950|19045239|P1|STARTED|Period 2||12
7734856|NCT01587950|19045239|P1|NOT COMPLETED|Washout 1||0
7734857|NCT01587950|19045239|P1|COMPLETED|Washout 1||12
7734858|NCT01587950|19045239|P1|STARTED|Washout 1||12
7734859|NCT01587950|19045239|P1|NOT COMPLETED|Period 1||0
7734860|NCT01587950|19045239|P1|COMPLETED|Period 1||12
7734861|NCT01587950|19045239|P1|Received Sterile Water (5 Minutes)|Period 1||5
7734862|NCT01587950|19045239|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5
7734863|NCT01587950|19045239|P1|Received Sterile Water (10 Minutes)|Period 1||5
7734864|NCT01587950|19045239|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3
7734865|NCT01587950|19045239|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4
7734866|NCT01587950|19045239|P1|Received 5% KNO3 Solution (10 Minutes)|Period 1||4
7734867|NCT01587950|19045239|P1|Received Sterile Water (2 Minutes)|Period 1||2
7734868|NCT01587950|19045239|P1|Received 5% KNO3 Solution (2 Minutes)|Period 1||3
7734869|NCT01587950|19045239|P1|Received 5% KNO3 Solution (5 Minutes)|Period 1||5
7734870|NCT01587950|19045239|P1|STARTED|Period 1||12
7734871|NCT01587924|19045273|P4|NOT COMPLETED|Overall Study||1
7734872|NCT01587924|19045274|P3|NOT COMPLETED|Overall Study||4
7734873|NCT01587924|19045275|P2|NOT COMPLETED|Overall Study||4
7734874|NCT01587924|19045276|P1|NOT COMPLETED|Overall Study||4
7734875|NCT01587924|19045273|P4|COMPLETED|Overall Study||19
7734876|NCT01587924|19045274|P3|COMPLETED|Overall Study||17
7734877|NCT01587924|19045275|P2|COMPLETED|Overall Study||17
7734878|NCT01587924|19045276|P1|COMPLETED|Overall Study||17
7734879|NCT01587924|19045273|P4|STARTED|Overall Study||20
7734880|NCT01587924|19045274|P3|STARTED|Overall Study||21
7734881|NCT01587924|19045275|P2|STARTED|Overall Study||21
7734882|NCT01587924|19045276|P1|STARTED|Overall Study||21
7734883|NCT01587898|19045377|P4|NOT COMPLETED|Overall Study||2
7734884|NCT01587898|19045378|P3|NOT COMPLETED|Overall Study||2
7734885|NCT01587898|19045379|P2|NOT COMPLETED|Overall Study||5
7734886|NCT01587898|19045380|P1|NOT COMPLETED|Overall Study||4
7734887|NCT01587898|19045377|P4|COMPLETED|Overall Study||17
7734888|NCT01587898|19045378|P3|COMPLETED|Overall Study||16
7734889|NCT01587898|19045379|P2|COMPLETED|Overall Study||12
7734890|NCT01587898|19045380|P1|COMPLETED|Overall Study||14
7734891|NCT01587898|19045377|P4|STARTED|Overall Study||19
7734892|NCT01587898|19045378|P3|STARTED|Overall Study||18
7734893|NCT01587898|19045379|P2|STARTED|Overall Study||17
7734894|NCT01587898|19045380|P1|STARTED|Overall Study||18
7734895|NCT01587885|19045556|P2|NOT COMPLETED|Treatment Period 2||0
7734896|NCT01587885|19045557|P1|NOT COMPLETED|Treatment Period 2||0
7734897|NCT01587885|19045556|P2|COMPLETED|Treatment Period 2||19
7734898|NCT01587885|19045557|P1|COMPLETED|Treatment Period 2||26
7734899|NCT01587885|19045556|P2|STARTED|Treatment Period 2||19
7734900|NCT01587885|19045557|P1|STARTED|Treatment Period 2||26
7734901|NCT01587885|19045556|P2|NOT COMPLETED|Treatment Period 1||3
7734902|NCT01587885|19045557|P1|NOT COMPLETED|Treatment Period 1||0
7734903|NCT01587885|19045556|P2|COMPLETED|Treatment Period 1||19
7734904|NCT01587885|19045557|P1|COMPLETED|Treatment Period 1||26
7734905|NCT01587885|19045556|P2|STARTED|Treatment Period 1||22
7734906|NCT01587885|19045557|P1|STARTED|Treatment Period 1||26
7734907|NCT01587703|19045588|P19|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734908|NCT01587703|19045589|P18|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734909|NCT01587703|19045590|P17|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||13
7734910|NCT01587703|19045591|P16|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||21
7734911|NCT01587703|19045592|P15|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||19
7734912|NCT01587703|19045593|P14|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||22
7734913|NCT01587703|19045594|P13|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||14
7734914|NCT01587703|19045595|P12|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||12
7734915|NCT01587703|19045596|P11|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734916|NCT01587703|19045597|P10|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734917|NCT01587703|19045598|P9|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734918|NCT01587703|19045599|P8|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734919|NCT01587703|19045600|P7|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734920|NCT01587703|19045601|P6|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734921|NCT01587703|19045602|P5|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734922|NCT01587703|19045603|P4|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734923|NCT01587703|19045604|P3|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734924|NCT01587703|19045605|P2|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734925|NCT01587703|19045606|P1|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734926|NCT01587703|19045588|P19|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734927|NCT01587703|19045589|P18|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734928|NCT01587703|19045590|P17|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734929|NCT01587703|19045591|P16|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734930|NCT01587703|19045592|P15|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734931|NCT01587703|19045593|P14|COMPLETED|Part2(Median Exposure of 1.41 Months)||1
7734932|NCT01587703|19045594|P13|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734933|NCT01587703|19045595|P12|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734934|NCT01587703|19045596|P11|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734935|NCT01587703|19045597|P10|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734936|NCT01587703|19045598|P9|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734937|NCT01587703|19045599|P8|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734938|NCT01587703|19045600|P7|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734939|NCT01587703|19045601|P6|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734940|NCT01587703|19045602|P5|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734941|NCT01587703|19045603|P4|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734942|NCT01587703|19045604|P3|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734943|NCT01587703|19045605|P2|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734944|NCT01587703|19045606|P1|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
7734945|NCT01587703|19045588|P19|STARTED|Part2(Median Exposure of 1.41 Months)||0
7734946|NCT01587703|19045589|P18|STARTED|Part2(Median Exposure of 1.41 Months)||0
7734947|NCT01587703|19045590|P17|STARTED|Part2(Median Exposure of 1.41 Months)||13
7734948|NCT01587703|19045591|P16|STARTED|Part2(Median Exposure of 1.41 Months)||21
7734949|NCT01587703|19045592|P15|STARTED|Part2(Median Exposure of 1.41 Months)||19
7734950|NCT01587703|19045593|P14|STARTED|Part2(Median Exposure of 1.41 Months)||23
7734951|NCT01587703|19045594|P13|STARTED|Part2(Median Exposure of 1.41 Months)||14
7734952|NCT01587703|19045595|P12|STARTED|Part2(Median Exposure of 1.41 Months)||12
7734953|NCT01587703|19045596|P11|STARTED|Part2(Median Exposure of 1.41 Months)||0
7734954|NCT01587703|19045597|P10|STARTED|Part2(Median Exposure of 1.41 Months)||0
7734955|NCT01587703|19045598|P9|STARTED|Part2(Median Exposure of 1.41 Months)||0
7734956|NCT01587703|19045599|P8|STARTED|Part2(Median Exposure of 1.41 Months)||0
7734957|NCT01587703|19045600|P7|STARTED|Part2(Median Exposure of 1.41 Months)||0
7734958|NCT01587703|19045601|P6|STARTED|Part2(Median Exposure of 1.41 Months)||0
7734959|NCT01587703|19045602|P5|STARTED|Part2(Median Exposure of 1.41 Months)||0
7734960|NCT01587703|19045603|P4|STARTED|Part2(Median Exposure of 1.41 Months)||0
7734961|NCT01587703|19045604|P3|STARTED|Part2(Median Exposure of 1.41 Months)||0
7734962|NCT01587703|19045605|P2|STARTED|Part2(Median Exposure of 1.41 Months)||0
7734963|NCT01587703|19045606|P1|STARTED|Part2(Median Exposure of 1.41 Months)||0
7734964|NCT01587703|19045588|P19|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
7734965|NCT01587703|19045589|P18|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
7734966|NCT01587703|19045590|P17|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734967|NCT01587703|19045591|P16|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734968|NCT01587703|19045592|P15|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734969|NCT01587703|19045593|P14|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734970|NCT01587703|19045594|P13|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734971|NCT01587703|19045595|P12|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734972|NCT01587703|19045596|P11|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734973|NCT01587703|19045597|P10|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734974|NCT01587703|19045598|P9|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734975|NCT01587703|19045599|P8|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734976|NCT01587703|19045600|P7|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734977|NCT01587703|19045601|P6|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734978|NCT01587703|19045602|P5|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734979|NCT01587703|19045603|P4|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734980|NCT01587703|19045604|P3|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734981|NCT01587703|19045605|P2|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734982|NCT01587703|19045606|P1|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734983|NCT01587703|19045588|P19|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734984|NCT01587703|19045589|P18|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734985|NCT01587703|19045590|P17|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734986|NCT01587703|19045591|P16|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734987|NCT01587703|19045592|P15|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734988|NCT01587703|19045593|P14|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734989|NCT01587703|19045594|P13|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734990|NCT01587703|19045595|P12|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734991|NCT01587703|19045596|P11|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734992|NCT01587703|19045597|P10|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734993|NCT01587703|19045598|P9|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734994|NCT01587703|19045599|P8|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734995|NCT01587703|19045600|P7|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734996|NCT01587703|19045601|P6|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734997|NCT01587703|19045602|P5|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734998|NCT01587703|19045603|P4|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7734999|NCT01587703|19045604|P3|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7735000|NCT01587703|19045605|P2|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7735001|NCT01587703|19045606|P1|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
7735002|NCT01587703|19045588|P19|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
7735003|NCT01587703|19045589|P18|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
7735004|NCT01587703|19045590|P17|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
7735005|NCT01587703|19045591|P16|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
7735006|NCT01587703|19045592|P15|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
7735007|NCT01587703|19045593|P14|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
7735008|NCT01587703|19045594|P13|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
7735009|NCT01587703|19045595|P12|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
7735010|NCT01587703|19045596|P11|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
7735011|NCT01587703|19045597|P10|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
7735012|NCT01587703|19045598|P9|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
7735013|NCT01587703|19045599|P8|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
7735014|NCT01587703|19045600|P7|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
7735015|NCT01587703|19045601|P6|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
7735016|NCT01587703|19045602|P5|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
7735017|NCT01587703|19045603|P4|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
7735018|NCT01587703|19045604|P3|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
7735019|NCT01587703|19045605|P2|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
7735020|NCT01587703|19045606|P1|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
7735021|NCT01587703|19045588|P19|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735022|NCT01587703|19045589|P18|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735023|NCT01587703|19045590|P17|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735024|NCT01587703|19045591|P16|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735025|NCT01587703|19045592|P15|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735026|NCT01587703|19045593|P14|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735027|NCT01587703|19045594|P13|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735028|NCT01587703|19045595|P12|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735029|NCT01587703|19045596|P11|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735030|NCT01587703|19045597|P10|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735031|NCT01587703|19045598|P9|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735032|NCT01587703|19045599|P8|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735033|NCT01587703|19045600|P7|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735034|NCT01587703|19045601|P6|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735035|NCT01587703|19045602|P5|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735036|NCT01587703|19045603|P4|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735037|NCT01587703|19045604|P3|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735038|NCT01587703|19045605|P2|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735039|NCT01587703|19045606|P1|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735040|NCT01587703|19045588|P19|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
7735041|NCT01587703|19045589|P18|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
7735042|NCT01587703|19045590|P17|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735043|NCT01587703|19045591|P16|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735044|NCT01587703|19045592|P15|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735045|NCT01587703|19045593|P14|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735046|NCT01587703|19045594|P13|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735047|NCT01587703|19045595|P12|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735048|NCT01587703|19045596|P11|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735049|NCT01587703|19045597|P10|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735050|NCT01587703|19045598|P9|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735051|NCT01587703|19045599|P8|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735052|NCT01587703|19045600|P7|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735053|NCT01587703|19045601|P6|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735054|NCT01587703|19045602|P5|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735055|NCT01587703|19045603|P4|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735056|NCT01587703|19045604|P3|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735057|NCT01587703|19045605|P2|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735058|NCT01587703|19045606|P1|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
7735059|NCT01587703|19045588|P19|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
7735060|NCT01587703|19045589|P18|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
7735061|NCT01587703|19045590|P17|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
7735062|NCT01587703|19045591|P16|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
7735063|NCT01587703|19045592|P15|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
7735064|NCT01587703|19045593|P14|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
7735065|NCT01587703|19045594|P13|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
7735066|NCT01587703|19045595|P12|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
7735067|NCT01587703|19045596|P11|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
7735068|NCT01587703|19045597|P10|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
7735069|NCT01587703|19045598|P9|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
7735070|NCT01587703|19045599|P8|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
7735071|NCT01587703|19045600|P7|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
7735072|NCT01587703|19045601|P6|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
7735073|NCT01587703|19045602|P5|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
7735074|NCT01587703|19045603|P4|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
7735075|NCT01587703|19045604|P3|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
7735076|NCT01587703|19045605|P2|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
7735077|NCT01587703|19045606|P1|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
7735078|NCT01587703|19045588|P19|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735079|NCT01587703|19045589|P18|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735080|NCT01587703|19045590|P17|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735081|NCT01587703|19045591|P16|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735082|NCT01587703|19045592|P15|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735083|NCT01587703|19045593|P14|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735084|NCT01587703|19045594|P13|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735085|NCT01587703|19045595|P12|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735086|NCT01587703|19045596|P11|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735087|NCT01587703|19045597|P10|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735088|NCT01587703|19045598|P9|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735089|NCT01587703|19045599|P8|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735090|NCT01587703|19045600|P7|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735091|NCT01587703|19045601|P6|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735092|NCT01587703|19045602|P5|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735093|NCT01587703|19045603|P4|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735094|NCT01587703|19045604|P3|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735095|NCT01587703|19045605|P2|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735096|NCT01587703|19045606|P1|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735097|NCT01587703|19045588|P19|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
7735098|NCT01587703|19045589|P18|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
7735099|NCT01587703|19045590|P17|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735100|NCT01587703|19045591|P16|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735101|NCT01587703|19045592|P15|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735102|NCT01587703|19045593|P14|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735103|NCT01587703|19045594|P13|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735104|NCT01587703|19045595|P12|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735105|NCT01587703|19045596|P11|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735106|NCT01587703|19045597|P10|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735107|NCT01587703|19045598|P9|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735108|NCT01587703|19045599|P8|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735109|NCT01587703|19045600|P7|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735110|NCT01587703|19045601|P6|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735111|NCT01587703|19045602|P5|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735112|NCT01587703|19045603|P4|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735113|NCT01587703|19045604|P3|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735114|NCT01587703|19045605|P2|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735115|NCT01587703|19045606|P1|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
7735116|NCT01587703|19045588|P19|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
7735117|NCT01587703|19045589|P18|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
7735118|NCT01587703|19045590|P17|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
7735119|NCT01587703|19045591|P16|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
7735120|NCT01587703|19045592|P15|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
7735121|NCT01587703|19045593|P14|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
7735122|NCT01587703|19045594|P13|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
7735123|NCT01587703|19045595|P12|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
7735124|NCT01587703|19045596|P11|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
7735125|NCT01587703|19045597|P10|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
7735126|NCT01587703|19045598|P9|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
7735127|NCT01587703|19045599|P8|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
7735128|NCT01587703|19045600|P7|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
7735129|NCT01587703|19045601|P6|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
7735130|NCT01587703|19045602|P5|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
7735131|NCT01587703|19045603|P4|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
7735132|NCT01587703|19045604|P3|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
7735133|NCT01587703|19045605|P2|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
7735134|NCT01587703|19045606|P1|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
7735135|NCT01587703|19045588|P19|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735136|NCT01587703|19045589|P18|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735137|NCT01587703|19045590|P17|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735138|NCT01587703|19045591|P16|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735139|NCT01587703|19045592|P15|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735140|NCT01587703|19045593|P14|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735141|NCT01587703|19045594|P13|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735142|NCT01587703|19045595|P12|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735143|NCT01587703|19045596|P11|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735144|NCT01587703|19045597|P10|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735145|NCT01587703|19045598|P9|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735146|NCT01587703|19045599|P8|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735147|NCT01587703|19045600|P7|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735148|NCT01587703|19045601|P6|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735149|NCT01587703|19045602|P5|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735150|NCT01587703|19045603|P4|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735151|NCT01587703|19045604|P3|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735152|NCT01587703|19045605|P2|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735153|NCT01587703|19045606|P1|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735154|NCT01587703|19045588|P19|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
7735155|NCT01587703|19045589|P18|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
7735156|NCT01587703|19045590|P17|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735157|NCT01587703|19045591|P16|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735158|NCT01587703|19045592|P15|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735159|NCT01587703|19045593|P14|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735160|NCT01587703|19045594|P13|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735161|NCT01587703|19045595|P12|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735162|NCT01587703|19045596|P11|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735163|NCT01587703|19045597|P10|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735164|NCT01587703|19045598|P9|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735165|NCT01587703|19045599|P8|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735166|NCT01587703|19045600|P7|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735167|NCT01587703|19045601|P6|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735168|NCT01587703|19045602|P5|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735169|NCT01587703|19045603|P4|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735170|NCT01587703|19045604|P3|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735171|NCT01587703|19045605|P2|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735172|NCT01587703|19045606|P1|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735173|NCT01587703|19045588|P19|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
7735174|NCT01587703|19045589|P18|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
7735175|NCT01587703|19045590|P17|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735176|NCT01587703|19045591|P16|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735177|NCT01587703|19045592|P15|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735178|NCT01587703|19045593|P14|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735179|NCT01587703|19045594|P13|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735180|NCT01587703|19045595|P12|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735181|NCT01587703|19045596|P11|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735182|NCT01587703|19045597|P10|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735183|NCT01587703|19045598|P9|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735184|NCT01587703|19045599|P8|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735185|NCT01587703|19045600|P7|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735186|NCT01587703|19045601|P6|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735187|NCT01587703|19045602|P5|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735188|NCT01587703|19045603|P4|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735189|NCT01587703|19045604|P3|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735190|NCT01587703|19045605|P2|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735191|NCT01587703|19045606|P1|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
7735192|NCT01587703|19045588|P19|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735193|NCT01587703|19045589|P18|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735194|NCT01587703|19045590|P17|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735195|NCT01587703|19045591|P16|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735196|NCT01587703|19045592|P15|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735197|NCT01587703|19045593|P14|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735198|NCT01587703|19045594|P13|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735199|NCT01587703|19045595|P12|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735200|NCT01587703|19045596|P11|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||5
7735201|NCT01587703|19045597|P10|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||10
7735202|NCT01587703|19045598|P9|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||3
7735203|NCT01587703|19045599|P8|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735204|NCT01587703|19045600|P7|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735205|NCT01587703|19045601|P6|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735206|NCT01587703|19045602|P5|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735207|NCT01587703|19045603|P4|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735208|NCT01587703|19045604|P3|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735209|NCT01587703|19045605|P2|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735210|NCT01587703|19045606|P1|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735211|NCT01587703|19045588|P19|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735212|NCT01587703|19045589|P18|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735213|NCT01587703|19045590|P17|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735214|NCT01587703|19045591|P16|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735215|NCT01587703|19045592|P15|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735216|NCT01587703|19045593|P14|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735217|NCT01587703|19045594|P13|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735218|NCT01587703|19045595|P12|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735219|NCT01587703|19045596|P11|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735220|NCT01587703|19045597|P10|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735221|NCT01587703|19045598|P9|COMPLETED|Part1 BID(Median Exposure of 1.41months)||1
7735222|NCT01587703|19045599|P8|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735223|NCT01587703|19045600|P7|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735224|NCT01587703|19045601|P6|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735225|NCT01587703|19045602|P5|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735226|NCT01587703|19045603|P4|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735227|NCT01587703|19045604|P3|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735228|NCT01587703|19045605|P2|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735229|NCT01587703|19045606|P1|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
7735230|NCT01587703|19045588|P19|STARTED|Part1 BID(Median Exposure of 1.41months)||0
7735231|NCT01587703|19045589|P18|STARTED|Part1 BID(Median Exposure of 1.41months)||0
7735232|NCT01587703|19045590|P17|STARTED|Part1 BID(Median Exposure of 1.41months)||0
7735233|NCT01587703|19045591|P16|STARTED|Part1 BID(Median Exposure of 1.41months)||0
7735234|NCT01587703|19045592|P15|STARTED|Part1 BID(Median Exposure of 1.41months)||0
7735235|NCT01587703|19045593|P14|STARTED|Part1 BID(Median Exposure of 1.41months)||0
7735236|NCT01587703|19045594|P13|STARTED|Part1 BID(Median Exposure of 1.41months)||0
7735237|NCT01587703|19045595|P12|STARTED|Part1 BID(Median Exposure of 1.41months)||0
7735238|NCT01587703|19045596|P11|STARTED|Part1 BID(Median Exposure of 1.41months)||5
7735239|NCT01587703|19045597|P10|STARTED|Part1 BID(Median Exposure of 1.41months)||10
7735240|NCT01587703|19045598|P9|STARTED|Part1 BID(Median Exposure of 1.41months)||4
7735241|NCT01587703|19045599|P8|STARTED|Part1 BID(Median Exposure of 1.41months)||0
7735242|NCT01587703|19045600|P7|STARTED|Part1 BID(Median Exposure of 1.41months)||0
7735243|NCT01587703|19045601|P6|STARTED|Part1 BID(Median Exposure of 1.41months)||0
7735244|NCT01587703|19045602|P5|STARTED|Part1 BID(Median Exposure of 1.41months)||0
7735245|NCT01587703|19045603|P4|STARTED|Part1 BID(Median Exposure of 1.41months)||0
7735246|NCT01587703|19045604|P3|STARTED|Part1 BID(Median Exposure of 1.41months)||0
7735247|NCT01587703|19045605|P2|STARTED|Part1 BID(Median Exposure of 1.41months)||0
7735248|NCT01587703|19045606|P1|STARTED|Part1 BID(Median Exposure of 1.41months)||0
7735249|NCT01587703|19045588|P19|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735250|NCT01587703|19045589|P18|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735251|NCT01587703|19045590|P17|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735252|NCT01587703|19045591|P16|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735253|NCT01587703|19045592|P15|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735254|NCT01587703|19045593|P14|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735255|NCT01587703|19045594|P13|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735256|NCT01587703|19045595|P12|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735257|NCT01587703|19045596|P11|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735258|NCT01587703|19045597|P10|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735259|NCT01587703|19045598|P9|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735260|NCT01587703|19045599|P8|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||9
7735261|NCT01587703|19045600|P7|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||32
7735262|NCT01587703|19045601|P6|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||8
7735263|NCT01587703|19045602|P5|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
7735264|NCT01587703|19045603|P4|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
7735265|NCT01587703|19045604|P3|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
7735266|NCT01587703|19045605|P2|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
7735267|NCT01587703|19045606|P1|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
7735268|NCT01587703|19045588|P19|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735269|NCT01587703|19045589|P18|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735270|NCT01587703|19045590|P17|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735271|NCT01587703|19045591|P16|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735272|NCT01587703|19045592|P15|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735273|NCT01587703|19045593|P14|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735274|NCT01587703|19045594|P13|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735275|NCT01587703|19045595|P12|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735276|NCT01587703|19045596|P11|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735277|NCT01587703|19045597|P10|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735278|NCT01587703|19045598|P9|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735279|NCT01587703|19045599|P8|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735280|NCT01587703|19045600|P7|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735281|NCT01587703|19045601|P6|COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
7735282|NCT01587703|19045602|P5|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735283|NCT01587703|19045603|P4|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735284|NCT01587703|19045604|P3|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735285|NCT01587703|19045605|P2|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735286|NCT01587703|19045606|P1|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
7735287|NCT01587703|19045588|P19|STARTED|Part1 QD(Median Exposure of 1.38months)||0
7735288|NCT01587703|19045589|P18|STARTED|Part1 QD(Median Exposure of 1.38months)||0
7735289|NCT01587703|19045590|P17|STARTED|Part1 QD(Median Exposure of 1.38months)||0
7735290|NCT01587703|19045591|P16|STARTED|Part1 QD(Median Exposure of 1.38months)||0
7735291|NCT01587703|19045592|P15|STARTED|Part1 QD(Median Exposure of 1.38months)||0
7735292|NCT01587703|19045593|P14|STARTED|Part1 QD(Median Exposure of 1.38months)||0
7735293|NCT01587703|19045594|P13|STARTED|Part1 QD(Median Exposure of 1.38months)||0
7735294|NCT01587703|19045595|P12|STARTED|Part1 QD(Median Exposure of 1.38months)||0
7735295|NCT01587703|19045596|P11|STARTED|Part1 QD(Median Exposure of 1.38months)||0
7735296|NCT01587703|19045597|P10|STARTED|Part1 QD(Median Exposure of 1.38months)||0
7735297|NCT01587703|19045598|P9|STARTED|Part1 QD(Median Exposure of 1.38months)||0
7735298|NCT01587703|19045599|P8|STARTED|Part1 QD(Median Exposure of 1.38months)||9
7735299|NCT01587703|19045600|P7|STARTED|Part1 QD(Median Exposure of 1.38months)||32
7735300|NCT01587703|19045601|P6|STARTED|Part1 QD(Median Exposure of 1.38months)||9
7735301|NCT01587703|19045602|P5|STARTED|Part1 QD(Median Exposure of 1.38months)||4
7735302|NCT01587703|19045603|P4|STARTED|Part1 QD(Median Exposure of 1.38months)||3
7735303|NCT01587703|19045604|P3|STARTED|Part1 QD(Median Exposure of 1.38months)||1
7735304|NCT01587703|19045605|P2|STARTED|Part1 QD(Median Exposure of 1.38months)||4
7735305|NCT01587703|19045606|P1|STARTED|Part1 QD(Median Exposure of 1.38months)||3
7735306|NCT01587651|19046013|P3|NOT COMPLETED|Overall Study||1
7735307|NCT01587651|19046014|P2|NOT COMPLETED|Overall Study||3
7735308|NCT01587651|19046015|P1|NOT COMPLETED|Overall Study||0
7735309|NCT01587651|19046013|P3|COMPLETED|Overall Study||34
7735310|NCT01587651|19046014|P2|COMPLETED|Overall Study||38
7735311|NCT01587651|19046015|P1|COMPLETED|Overall Study||34
7735312|NCT01587651|19046013|P3|STARTED|Overall Study||35
7735313|NCT01587651|19046014|P2|STARTED|Overall Study||41
7735314|NCT01587651|19046015|P1|STARTED|Overall Study||34
7735315|NCT01587274|19046045|P3|NOT COMPLETED|Overall Study||3
7735316|NCT01587274|19046046|P2|NOT COMPLETED|Overall Study||5
7735317|NCT01587274|19046047|P1|NOT COMPLETED|Overall Study||4
7735318|NCT01587274|19046045|P3|COMPLETED|Overall Study||104
7735319|NCT01587274|19046046|P2|COMPLETED|Overall Study||103
7735320|NCT01587274|19046047|P1|COMPLETED|Overall Study||104
7735321|NCT01587274|19046045|P3|STARTED|Overall Study||107
7735322|NCT01587274|19046046|P2|STARTED|Overall Study||108
7735323|NCT01587274|19046047|P1|STARTED|Overall Study||108
7735324|NCT01587118|19046055|P1|NOT COMPLETED|Overall Study||7
7735325|NCT01587118|19046055|P1|COMPLETED|Overall Study||11
7735326|NCT01587118|19046055|P1|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18
7735327|NCT01587105|19046062|P2|NOT COMPLETED|Overall Study||43
7735328|NCT01587105|19046063|P1|NOT COMPLETED|Overall Study||6
7735329|NCT01587105|19046062|P2|COMPLETED|Overall Study||138
7735330|NCT01587105|19046063|P1|COMPLETED|Overall Study||144
7735331|NCT01587105|19046062|P2|STARTED|Overall Study||181
7735332|NCT01587105|19046063|P1|STARTED|Overall Study||150
7735333|NCT01587079|19046079|P1|NOT COMPLETED|Overall Study||39
7735334|NCT01587079|19046079|P1|COMPLETED|Overall Study||120
7735335|NCT01587079|19046079|P1|STARTED|Overall Study||159
7735336|NCT01587040|19046205|P4|NOT COMPLETED|Overall Study||4
7735337|NCT01587040|19046206|P3|NOT COMPLETED|Overall Study||37
7735338|NCT01587040|19046207|P2|NOT COMPLETED|Overall Study||3
7735339|NCT01587040|19046208|P1|NOT COMPLETED|Overall Study||17
7735340|NCT01587040|19046205|P4|COMPLETED|Overall Study||0
7735341|NCT01587040|19046206|P3|COMPLETED|Overall Study||0
7735342|NCT01587040|19046207|P2|COMPLETED|Overall Study||0
7735343|NCT01587040|19046208|P1|COMPLETED|Overall Study||0
7735344|NCT01587040|19046205|P4|STARTED|Overall Study||4
7735345|NCT01587040|19046206|P3|STARTED|Overall Study||37
7735346|NCT01587040|19046207|P2|STARTED|Overall Study||3
7735347|NCT01587040|19046208|P1|STARTED|Overall Study||17
7735348|NCT01587027|19046228|P2|NOT COMPLETED|Discharge (1 Day)||0
7735349|NCT01587027|19046229|P1|NOT COMPLETED|Discharge (1 Day)||0
7735350|NCT01587027|19046228|P2|COMPLETED|Discharge (1 Day)||8
7735351|NCT01587027|19046229|P1|COMPLETED|Discharge (1 Day)||8
7735352|NCT01587027|19046228|P2|STARTED|Discharge (1 Day)||8
7735353|NCT01587027|19046229|P1|STARTED|Discharge (1 Day)||8
7735354|NCT01587027|19046228|P2|NOT COMPLETED|Third Intervention (1 Day)||0
7735355|NCT01587027|19046229|P1|NOT COMPLETED|Third Intervention (1 Day)||0
7735356|NCT01587027|19046228|P2|COMPLETED|Third Intervention (1 Day)||8
7735357|NCT01587027|19046229|P1|COMPLETED|Third Intervention (1 Day)||8
7735358|NCT01587027|19046228|P2|STARTED|Third Intervention (1 Day)||8
7735359|NCT01587027|19046229|P1|STARTED|Third Intervention (1 Day)||8
7735360|NCT01587027|19046228|P2|NOT COMPLETED|Washout (1 Day)||0
7735361|NCT01587027|19046229|P1|NOT COMPLETED|Washout (1 Day)||0
7735362|NCT01587027|19046228|P2|COMPLETED|Washout (1 Day)||8
7735363|NCT01587027|19046229|P1|COMPLETED|Washout (1 Day)||8
7735364|NCT01587027|19046228|P2|STARTED|Washout (1 Day)||8
7735365|NCT01587027|19046229|P1|STARTED|Washout (1 Day)||8
7735366|NCT01587027|19046228|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7735367|NCT01587027|19046229|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7735368|NCT01587027|19046228|P2|COMPLETED|Second Intervention (1 Day)||8
7735369|NCT01587027|19046229|P1|COMPLETED|Second Intervention (1 Day)||8
7735370|NCT01587027|19046228|P2|STARTED|Second Intervention (1 Day)||8
7735371|NCT01587027|19046229|P1|STARTED|Second Intervention (1 Day)||8
7735372|NCT01587027|19046228|P2|NOT COMPLETED|Washout (1 Day)||0
7735373|NCT01587027|19046229|P1|NOT COMPLETED|Washout (1 Day)||0
7735374|NCT01587027|19046228|P2|COMPLETED|Washout (1 Day)||8
7735375|NCT01587027|19046229|P1|COMPLETED|Washout (1 Day)||8
7735376|NCT01587027|19046228|P2|STARTED|Washout (1 Day)||8
7735377|NCT01587027|19046229|P1|STARTED|Washout (1 Day)||8
7735378|NCT01587027|19046228|P2|NOT COMPLETED|First Intervention (1 Day)||0
7735379|NCT01587027|19046229|P1|NOT COMPLETED|First Intervention (1 Day)||0
7735380|NCT01587027|19046228|P2|COMPLETED|First Intervention (1 Day)||8
7735381|NCT01587027|19046229|P1|COMPLETED|First Intervention (1 Day)||8
7735382|NCT01587027|19046228|P2|STARTED|First Intervention (1 Day)||8
7735383|NCT01587027|19046229|P1|STARTED|First Intervention (1 Day)||8
7735384|NCT01587014|19046235|P1|NOT COMPLETED|Overall Study||2
7735385|NCT01587014|19046235|P1|COMPLETED|Overall Study||24
7735386|NCT01587014|19046235|P1|STARTED|Overall Study||26
7735387|NCT01587001|19046242|P2|NOT COMPLETED|Overall Study||1
7735388|NCT01587001|19046243|P1|NOT COMPLETED|Overall Study||6
7735389|NCT01587001|19046242|P2|COMPLETED|Overall Study||2
7735390|NCT01587001|19046243|P1|COMPLETED|Overall Study||8
7735391|NCT01587001|19046242|P2|STARTED|Overall Study||3
7735392|NCT01587001|19046243|P1|STARTED|Overall Study||14
7735393|NCT01586975|19046254|P3|NOT COMPLETED|Overall Study||0
7735394|NCT01586975|19046255|P2|NOT COMPLETED|Overall Study||0
7735395|NCT01586975|19046256|P1|NOT COMPLETED|Overall Study||0
7735396|NCT01586975|19046254|P3|COMPLETED|Overall Study||46
7735397|NCT01586975|19046255|P2|COMPLETED|Overall Study||32
7735398|NCT01586975|19046256|P1|COMPLETED|Overall Study||15
7735399|NCT01586975|19046254|P3|STARTED|Overall Study||46
7735400|NCT01586975|19046255|P2|STARTED|Overall Study||32
7735401|NCT01586975|19046256|P1|STARTED|Overall Study||15
7735402|NCT01586962|19046264|P1|NOT COMPLETED|Overall Study||0
7735403|NCT01586962|19046264|P1|COMPLETED|Overall Study||56
7735404|NCT01586962|19046264|P1|STARTED|Overall Study||56
7735405|NCT01586910|19046272|P2|NOT COMPLETED|Overall Study||71
7735406|NCT01586910|19046273|P1|NOT COMPLETED|Overall Study||15
7735407|NCT01586910|19046272|P2|COMPLETED|Overall Study||796
7735408|NCT01586910|19046273|P1|COMPLETED|Overall Study||864
7735409|NCT01586910|19046272|P2|STARTED|Overall Study||867
7735410|NCT01586910|19046273|P1|STARTED|Overall Study||879
7735411|NCT01586897|19046328|P2|NOT COMPLETED|Overall Study||0
7735412|NCT01586897|19046329|P1|NOT COMPLETED|Overall Study||0
7735413|NCT01586897|19046328|P2|COMPLETED|Overall Study||26
7735414|NCT01586897|19046329|P1|COMPLETED|Overall Study||26
7735415|NCT01586897|19046328|P2|STARTED|Overall Study||26
7735416|NCT01586897|19046329|P1|STARTED|Overall Study||26
7735417|NCT01586819|19046347|P2|NOT COMPLETED|Overall Study||0
7735418|NCT01586819|19046348|P1|NOT COMPLETED|Overall Study||1
7735419|NCT01586819|19046347|P2|COMPLETED|Overall Study||14
7735420|NCT01586819|19046348|P1|COMPLETED|Overall Study||11
7735421|NCT01586819|19046347|P2|STARTED|Overall Study||14
7735422|NCT01586819|19046348|P1|STARTED|Overall Study||12
7735423|NCT01586806|19046359|P3|NOT COMPLETED|Overall Study||2
7735424|NCT01586806|19046360|P2|NOT COMPLETED|Overall Study||4
7735425|NCT01586806|19046361|P1|NOT COMPLETED|Overall Study||3
7735426|NCT01586806|19046359|P3|COMPLETED|Overall Study||63
7735427|NCT01586806|19046360|P2|COMPLETED|Overall Study||61
7735428|NCT01586806|19046361|P1|COMPLETED|Overall Study||62
7735429|NCT01586806|19046359|P3|STARTED|Overall Study||65
7735430|NCT01586806|19046360|P2|STARTED|Overall Study||65
7735431|NCT01586806|19046361|P1|STARTED|Overall Study||65
7735432|NCT01586741|19046384|P3|NOT COMPLETED|Overall Study||2
7735433|NCT01586741|19046385|P2|NOT COMPLETED|Overall Study||0
7735434|NCT01586741|19046386|P1|NOT COMPLETED|Overall Study||1
7735435|NCT01586741|19046384|P3|COMPLETED|Overall Study||30
7735436|NCT01586741|19046385|P2|COMPLETED|Overall Study||29
7735437|NCT01586741|19046386|P1|COMPLETED|Overall Study||27
7735438|NCT01586741|19046384|P3|STARTED|Overall Study||32
7735439|NCT01586741|19046385|P2|STARTED|Overall Study||29
7735440|NCT01586741|19046386|P1|STARTED|Overall Study||28
7735441|NCT01586364|19046394|P1|NOT COMPLETED|Overall Study||117
7735442|NCT01586364|19046394|P1|COMPLETED|Overall Study||184
7735443|NCT01586364|19046394|P1|STARTED|Overall Study||301
7735444|NCT01586338|19046447|P1|NOT COMPLETED|Overall Study||8
7735445|NCT01586338|19046447|P1|COMPLETED|Overall Study||229
7735446|NCT01586338|19046447|P1|STARTED|Overall Study||237
7735447|NCT01586312|19046459|P2|NOT COMPLETED|Overall Study||0
7735448|NCT01586312|19046460|P1|NOT COMPLETED|Overall Study||0
7735449|NCT01586312|19046459|P2|COMPLETED|Overall Study||15
7735450|NCT01586312|19046460|P1|COMPLETED|Overall Study||15
7735451|NCT01586312|19046459|P2|STARTED|Overall Study||15
7735452|NCT01586312|19046460|P1|STARTED|Overall Study||15
7735453|NCT01586195|19046470|P1|NOT COMPLETED|Overall Study||26
7735454|NCT01586195|19046470|P1|COMPLETED|Overall Study||5
7735455|NCT01586195|19046470|P1|STARTED|Overall Study||31
7735456|NCT01586156|19046484|P3|NOT COMPLETED|Overall Study||0
7735457|NCT01586156|19046485|P2|NOT COMPLETED|Overall Study||1
7735458|NCT01586156|19046486|P1|NOT COMPLETED|Overall Study||0
7735459|NCT01586156|19046484|P3|COMPLETED|Overall Study||10
7735460|NCT01586156|19046485|P2|COMPLETED|Overall Study||9
7735461|NCT01586156|19046486|P1|COMPLETED|Overall Study||10
7735462|NCT01586156|19046484|P3|STARTED|Overall Study||10
7735463|NCT01586156|19046485|P2|STARTED|Overall Study||10
7735464|NCT01586156|19046486|P1|STARTED|Overall Study||10
7735465|NCT01586091|19046515|P3|NOT COMPLETED|Overall Study||0
7735466|NCT01586091|19046516|P2|NOT COMPLETED|Overall Study||0
7735467|NCT01586091|19046517|P1|NOT COMPLETED|Overall Study||0
7735468|NCT01586091|19046515|P3|COMPLETED|Overall Study||6
7735469|NCT01586091|19046516|P2|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
7735470|NCT01586091|19046517|P1|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
7735471|NCT01586091|19046515|P3|STARTED|Overall Study||6
7735472|NCT01586091|19046516|P2|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
7735473|NCT01586091|19046517|P1|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
7735474|NCT01586026|19046531|P3|NOT COMPLETED|Overall Study||0
7735475|NCT01586026|19046532|P2|NOT COMPLETED|Overall Study||0
7735476|NCT01586026|19046533|P1|NOT COMPLETED|Overall Study||0
7735477|NCT01586026|19046531|P3|COMPLETED|Overall Study||271
7735478|NCT01586026|19046532|P2|COMPLETED|Overall Study||414
7735479|NCT01586026|19046533|P1|COMPLETED|Overall Study||350
7735480|NCT01586026|19046531|P3|STARTED|Overall Study||271
7735481|NCT01586026|19046532|P2|STARTED|Overall Study||414
7735482|NCT01586026|19046533|P1|STARTED|Overall Study||350
7735483|NCT01585987|19046543|P2|NOT COMPLETED|Treated||49
7735484|NCT01585987|19046544|P1|NOT COMPLETED|Treated||54
7735485|NCT01585987|19046543|P2|COMPLETED|Treated||2
7735486|NCT01585987|19046544|P1|COMPLETED|Treated||3
7735487|NCT01585987|19046543|P2|STARTED|Treated||51
7735488|NCT01585987|19046544|P1|STARTED|Treated||57
7735489|NCT01585987|19046543|P2|NOT COMPLETED|Randomized||6
7735490|NCT01585987|19046544|P1|NOT COMPLETED|Randomized||0
7735491|NCT01585987|19046543|P2|COMPLETED|Randomized||51
7735492|NCT01585987|19046544|P1|COMPLETED|Randomized||57
7735493|NCT01585987|19046543|P2|STARTED|Randomized||57
7735494|NCT01585987|19046544|P1|STARTED|Randomized||57
7735495|NCT01585961|19046559|P1|NOT COMPLETED|Overall Study||33
7735496|NCT01585961|19046559|P1|COMPLETED|Overall Study||478
7735497|NCT01585961|19046559|P1|Safety|Overall Study|Patients ablated with study catheter|508
7735498|NCT01585961|19046559|P1|STARTED|Overall Study||511
7735499|NCT01585779|19046576|P2|NOT COMPLETED|Overall Study||7
7735500|NCT01585779|19046577|P1|NOT COMPLETED|Overall Study||10
7735501|NCT01585779|19046576|P2|COMPLETED|Overall Study||21
7735502|NCT01585779|19046577|P1|COMPLETED|Overall Study||26
7735503|NCT01585779|19046576|P2|STARTED|Overall Study||28
7735504|NCT01585779|19046577|P1|STARTED|Overall Study||36
7735505|NCT01585766|19046637|P6|NOT COMPLETED|Overall Study||0
7735506|NCT01585766|19046638|P5|NOT COMPLETED|Overall Study||0
7735507|NCT01585766|19046639|P4|NOT COMPLETED|Overall Study||0
7735508|NCT01585766|19046640|P3|NOT COMPLETED|Overall Study||2
7735509|NCT01585766|19046641|P2|NOT COMPLETED|Overall Study||2
7735510|NCT01585766|19046642|P1|NOT COMPLETED|Overall Study||0
7735511|NCT01585766|19046637|P6|COMPLETED|Overall Study||6
7735512|NCT01585766|19046638|P5|COMPLETED|Overall Study||3
7735513|NCT01585766|19046639|P4|COMPLETED|Overall Study||4
7735514|NCT01585766|19046640|P3|COMPLETED|Overall Study||1
7735515|NCT01585766|19046641|P2|COMPLETED|Overall Study||3
7735516|NCT01585766|19046642|P1|COMPLETED|Overall Study||7
7735517|NCT01585766|19046637|P6|STARTED|Overall Study||6
7735518|NCT01585766|19046638|P5|STARTED|Overall Study||3
7735519|NCT01585766|19046639|P4|STARTED|Overall Study||4
7735520|NCT01585766|19046640|P3|STARTED|Overall Study||3
7735521|NCT01585766|19046641|P2|STARTED|Overall Study||5
7735522|NCT01585766|19046642|P1|STARTED|Overall Study||7
7735523|NCT01585597|19046741|P1|NOT COMPLETED|Overall Study||0
7735524|NCT01585597|19046741|P1|COMPLETED|Overall Study||20
7735525|NCT01585597|19046741|P1|STARTED|Overall Study||20
7735526|NCT01585584|19046746|P1|NOT COMPLETED|Overall Study||4
7735527|NCT01585584|19046746|P1|COMPLETED|Overall Study||6
7735528|NCT01585584|19046746|P1|STARTED|Overall Study||10
7735529|NCT01585558|19046753|P3|NOT COMPLETED|Overall Study||15
7735530|NCT01585558|19046754|P2|NOT COMPLETED|Overall Study||12
7735531|NCT01585558|19046755|P1|NOT COMPLETED|Overall Study||13
7735532|NCT01585558|19046753|P3|COMPLETED|Overall Study||34
7735533|NCT01585558|19046754|P2|COMPLETED|Overall Study||57
7735534|NCT01585558|19046755|P1|COMPLETED|Overall Study||49
7735535|NCT01585558|19046753|P3|STARTED|Overall Study||49
7735536|NCT01585558|19046754|P2|STARTED|Overall Study||69
7735537|NCT01585558|19046755|P1|STARTED|Overall Study||62
7735538|NCT01585441|19046936|P2|NOT COMPLETED|Overall Study||0
7735539|NCT01585441|19046937|P1|NOT COMPLETED|Overall Study||0
7735540|NCT01585441|19046936|P2|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
7735541|NCT01585441|19046937|P1|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
7735542|NCT01585441|19046936|P2|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2
7735543|NCT01585441|19046937|P1|Final Study Safety Visit|Overall Study||3
7735544|NCT01585441|19046936|P2|Received Finasteride at Month 3|Overall Study||2
7735545|NCT01585441|19046937|P1|Received Finasteride at Month 3|Overall Study||2
7735546|NCT01585441|19046936|P2|Month 3|Overall Study||3
7735547|NCT01585441|19046937|P1|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2
7735548|NCT01585441|19046936|P2|STARTED|Overall Study||3
7735549|NCT01585441|19046937|P1|STARTED|Overall Study||3
7735550|NCT01585428|19046989|P2|NOT COMPLETED|Overall Study||0
7735551|NCT01585428|19046990|P1|NOT COMPLETED|Overall Study||1
7735552|NCT01585428|19046989|P2|COMPLETED|Overall Study||11
7735553|NCT01585428|19046990|P1|COMPLETED|Overall Study||17
7735554|NCT01585428|19046989|P2|STARTED|Overall Study||11
7735555|NCT01585428|19046990|P1|STARTED|Overall Study||18
7735556|NCT01585324|19046998|P1|NOT COMPLETED|Overall Study||0
7735557|NCT01585324|19046998|P1|COMPLETED|Overall Study||30
7735558|NCT01585324|19046998|P1|STARTED|Overall Study||30
7735559|NCT01585298|19047014|P1|NOT COMPLETED|Overall Study||37
7735560|NCT01585298|19047014|P1|COMPLETED|Overall Study||6961
7735561|NCT01585298|19047014|P1|STARTED|Overall Study||6998
7735562|NCT01585272|19047022|P1|NOT COMPLETED|Overall Study||39
7735563|NCT01585272|19047022|P1|COMPLETED|Overall Study||82
7735564|NCT01585272|19047022|P1|Exelon Patch 10 cm2|Overall Study||96
7735565|NCT01585272|19047022|P1|Exelon Patch 5 cm2|Overall Study||114
7735566|NCT01585272|19047022|P1|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102
7735567|NCT01585272|19047022|P1|STARTED|Overall Study||121
7735568|NCT01585246|19047035|P5|NOT COMPLETED|Overall Study||2
7735569|NCT01585246|19047036|P4|NOT COMPLETED|Overall Study||4
7735570|NCT01585246|19047037|P3|NOT COMPLETED|Overall Study||4
7735571|NCT01585246|19047038|P2|NOT COMPLETED|Overall Study||1
7735572|NCT01585246|19047039|P1|NOT COMPLETED|Overall Study||0
7735573|NCT01585246|19047035|P5|COMPLETED|Overall Study||9
7735574|NCT01585246|19047036|P4|COMPLETED|Overall Study||6
7735575|NCT01585246|19047037|P3|COMPLETED|Overall Study||16
7735576|NCT01585246|19047038|P2|COMPLETED|Overall Study||3
7735577|NCT01585246|19047039|P1|COMPLETED|Overall Study||3
7735578|NCT01585246|19047035|P5|STARTED|Overall Study||11
7735579|NCT01585246|19047036|P4|STARTED|Overall Study||10
7735580|NCT01585246|19047037|P3|STARTED|Overall Study||20
7735581|NCT01585246|19047038|P2|STARTED|Overall Study||4
7735582|NCT01585246|19047039|P1|STARTED|Overall Study||3
7735583|NCT01585207|19047054|P1|NOT COMPLETED|Overall Study||0
7735584|NCT01585207|19047054|P1|COMPLETED|Overall Study||4
7735585|NCT01585207|19047054|P1|STARTED|Overall Study||4
7735586|NCT01585194|19047058|P1|NOT COMPLETED|Overall Study||4
7735587|NCT01585194|19047058|P1|COMPLETED|Overall Study||35
7735588|NCT01585194|19047058|P1|STARTED|Overall Study||39
7735589|NCT01585168|19047067|P4|NOT COMPLETED|Overall Study||1
7735590|NCT01585168|19047068|P3|NOT COMPLETED|Overall Study||1
7735591|NCT01585168|19047069|P2|NOT COMPLETED|Overall Study||1
7735592|NCT01585168|19047070|P1|NOT COMPLETED|Overall Study||3
7735593|NCT01585168|19047067|P4|COMPLETED|Overall Study||18
7735594|NCT01585168|19047068|P3|COMPLETED|Overall Study||15
7735595|NCT01585168|19047069|P2|COMPLETED|Overall Study||17
7735596|NCT01585168|19047070|P1|COMPLETED|Overall Study||15
7735597|NCT01585168|19047067|P4|STARTED|Overall Study||19
7735598|NCT01585168|19047068|P3|STARTED|Overall Study||16
7735599|NCT01585168|19047069|P2|STARTED|Overall Study||18
7735600|NCT01585168|19047070|P1|STARTED|Overall Study||18
7735601|NCT01585155|19047090|P1|NOT COMPLETED|Overall Study||5
7735602|NCT01585155|19047090|P1|COMPLETED|Overall Study||16
7735603|NCT01585155|19047090|P1|STARTED|Overall Study||21
7735604|NCT01585129|19047099|P2|NOT COMPLETED|Overall Study||0
7735605|NCT01585129|19047100|P1|NOT COMPLETED|Overall Study||0
7735606|NCT01585129|19047099|P2|COMPLETED|Overall Study||39
7735607|NCT01585129|19047100|P1|COMPLETED|Overall Study||41
7735608|NCT01585129|19047099|P2|STARTED|Overall Study||39
7735609|NCT01585129|19047100|P1|STARTED|Overall Study||41
7735610|NCT01585038|19047112|P2|NOT COMPLETED|Overall Study||2
7735611|NCT01585038|19047113|P1|NOT COMPLETED|Overall Study||2
7735612|NCT01585038|19047112|P2|COMPLETED|Overall Study||18
7735613|NCT01585038|19047113|P1|COMPLETED|Overall Study||18
7735614|NCT01585038|19047112|P2|STARTED|Overall Study||20
7735615|NCT01585038|19047113|P1|STARTED|Overall Study||20
7735616|NCT01585025|19047128|P3|NOT COMPLETED|Overall Study||4
7735617|NCT01585025|19047129|P2|NOT COMPLETED|Overall Study||3
7735618|NCT01585025|19047130|P1|NOT COMPLETED|Overall Study||0
7735619|NCT01585025|19047128|P3|COMPLETED|Overall Study||8
7735620|NCT01585025|19047129|P2|COMPLETED|Overall Study||10
7735621|NCT01585025|19047130|P1|COMPLETED|Overall Study||10
7735622|NCT01585025|19047128|P3|STARTED|Overall Study||12
7735623|NCT01585025|19047129|P2|STARTED|Overall Study||13
7735624|NCT01585025|19047130|P1|STARTED|Overall Study||10
7735625|NCT01584843|19047160|P6|NOT COMPLETED|Second Treatment Period||1
7735626|NCT01584843|19047161|P5|NOT COMPLETED|Second Treatment Period||0
7735627|NCT01584843|19047162|P4|NOT COMPLETED|Second Treatment Period||0
7735628|NCT01584843|19047163|P3|NOT COMPLETED|Second Treatment Period||0
7735629|NCT01584843|19047164|P2|NOT COMPLETED|Second Treatment Period||0
7735630|NCT01584843|19047165|P1|NOT COMPLETED|Second Treatment Period||0
7735631|NCT01584843|19047160|P6|COMPLETED|Second Treatment Period||0
7735632|NCT01584843|19047161|P5|COMPLETED|Second Treatment Period||3
7735633|NCT01584843|19047162|P4|COMPLETED|Second Treatment Period||6
7735634|NCT01584843|19047163|P3|COMPLETED|Second Treatment Period||2
7735635|NCT01584843|19047164|P2|COMPLETED|Second Treatment Period||1
7735636|NCT01584843|19047165|P1|COMPLETED|Second Treatment Period||2
7735637|NCT01584843|19047160|P6|STARTED|Second Treatment Period||1
7735638|NCT01584843|19047161|P5|STARTED|Second Treatment Period||3
7735639|NCT01584843|19047162|P4|STARTED|Second Treatment Period||6
7735640|NCT01584843|19047163|P3|STARTED|Second Treatment Period||2
7735641|NCT01584843|19047164|P2|STARTED|Second Treatment Period||1
7735642|NCT01584843|19047165|P1|STARTED|Second Treatment Period||2
7735643|NCT01584843|19047160|P6|NOT COMPLETED|First Treatment Period||2
7735644|NCT01584843|19047161|P5|NOT COMPLETED|First Treatment Period||0
7735645|NCT01584843|19047162|P4|NOT COMPLETED|First Treatment Period||0
7735646|NCT01584843|19047163|P3|NOT COMPLETED|First Treatment Period||1
7735647|NCT01584843|19047164|P2|NOT COMPLETED|First Treatment Period||0
7735648|NCT01584843|19047165|P1|NOT COMPLETED|First Treatment Period||0
7735649|NCT01584843|19047160|P6|COMPLETED|First Treatment Period||9
7735650|NCT01584843|19047161|P5|COMPLETED|First Treatment Period||10
7735651|NCT01584843|19047162|P4|COMPLETED|First Treatment Period||10
7735652|NCT01584843|19047163|P3|COMPLETED|First Treatment Period||2
7735653|NCT01584843|19047164|P2|COMPLETED|First Treatment Period||4
7735654|NCT01584843|19047165|P1|COMPLETED|First Treatment Period||3
7735655|NCT01584843|19047160|P6|STARTED|First Treatment Period||11
7735656|NCT01584843|19047161|P5|STARTED|First Treatment Period||10
7735657|NCT01584843|19047162|P4|STARTED|First Treatment Period||10
7735658|NCT01584843|19047163|P3|STARTED|First Treatment Period||3
7735659|NCT01584843|19047164|P2|STARTED|First Treatment Period||4
7735660|NCT01584843|19047165|P1|STARTED|First Treatment Period||3
7735661|NCT01584648|19047276|P2|NOT COMPLETED|Overall Study||212
7735662|NCT01584648|19047277|P1|NOT COMPLETED|Overall Study||211
7735663|NCT01584648|19047276|P2|COMPLETED|Overall Study||0
7735664|NCT01584648|19047277|P1|COMPLETED|Overall Study||0
7735665|NCT01584648|19047276|P2|Ongoing|Overall Study||147
7735666|NCT01584648|19047277|P1|Ongoing|Overall Study||154
7735667|NCT01584648|19047276|P2|STARTED|Overall Study||212
7735668|NCT01584648|19047277|P1|STARTED|Overall Study||211
7735669|NCT01584609|19047317|P2|NOT COMPLETED|Overall Study||4
7735670|NCT01584609|19047318|P1|NOT COMPLETED|Overall Study||12
7735671|NCT01584609|19047317|P2|COMPLETED|Overall Study||96
7735672|NCT01584609|19047318|P1|COMPLETED|Overall Study||86
7735673|NCT01584609|19047317|P2|STARTED|Overall Study||100
7735674|NCT01584609|19047318|P1|STARTED|Overall Study||98
7735675|NCT01584544|19047343|P5|NOT COMPLETED|Overall Study||0
7735676|NCT01584544|19047344|P4|NOT COMPLETED|Overall Study||0
7735677|NCT01584544|19047345|P3|NOT COMPLETED|Overall Study||0
7735678|NCT01584544|19047346|P2|NOT COMPLETED|Overall Study||0
7735679|NCT01584544|19047347|P1|NOT COMPLETED|Overall Study||0
7735680|NCT01584544|19047343|P5|COMPLETED|Overall Study||6
7735681|NCT01584544|19047344|P4|COMPLETED|Overall Study||3
7735682|NCT01584544|19047345|P3|COMPLETED|Overall Study||6
7735683|NCT01584544|19047346|P2|COMPLETED|Overall Study||6
7735684|NCT01584544|19047347|P1|COMPLETED|Overall Study||3
7735685|NCT01584544|19047343|P5|STARTED|Overall Study||6
7735686|NCT01584544|19047344|P4|STARTED|Overall Study||3
7735687|NCT01584544|19047345|P3|STARTED|Overall Study||6
7735688|NCT01584544|19047346|P2|STARTED|Overall Study||6
7735689|NCT01584544|19047347|P1|STARTED|Overall Study||3
7735690|NCT01584518|19047361|P2|NOT COMPLETED|Overall Study||0
7735691|NCT01584518|19047362|P1|NOT COMPLETED|Overall Study||0
7735692|NCT01584518|19047361|P2|COMPLETED|Overall Study||25
7735693|NCT01584518|19047362|P1|COMPLETED|Overall Study||25
7735694|NCT01584518|19047361|P2|STARTED|Overall Study||25
7735695|NCT01584518|19047362|P1|STARTED|Overall Study||25
7735696|NCT01584479|19047372|P4|NOT COMPLETED|Overall Study||0
7735697|NCT01584479|19047373|P3|NOT COMPLETED|Overall Study||0
7735698|NCT01584479|19047374|P2|NOT COMPLETED|Overall Study||0
7735699|NCT01584479|19047375|P1|NOT COMPLETED|Overall Study||0
7735700|NCT01584479|19047372|P4|COMPLETED|Overall Study||1847
7735701|NCT01584479|19047373|P3|COMPLETED|Overall Study||852
7735702|NCT01584479|19047374|P2|COMPLETED|Overall Study||1686
7735703|NCT01584479|19047375|P1|COMPLETED|Overall Study||732
7735704|NCT01584479|19047372|P4|STARTED|Overall Study||1847
7735705|NCT01584479|19047373|P3|STARTED|Overall Study||852
7735706|NCT01584479|19047374|P2|STARTED|Overall Study||1686
7735707|NCT01584479|19047375|P1|STARTED|Overall Study||732
7735708|NCT01584388|19047385|P1|NOT COMPLETED|Overall Study||0
7735709|NCT01584388|19047385|P1|COMPLETED|Overall Study||30
7735710|NCT01584388|19047385|P1|STARTED|Overall Study||30
7735711|NCT01584232|19047405|P2|NOT COMPLETED|Overall Study||3
7735712|NCT01584232|19047406|P1|NOT COMPLETED|Overall Study||8
7735713|NCT01584232|19047405|P2|COMPLETED|Overall Study||177
7735714|NCT01584232|19047406|P1|COMPLETED|Overall Study||173
7735715|NCT01584232|19047405|P2|Received at Least 1 Dose of Study Drug|Overall Study||180
7735716|NCT01584232|19047406|P1|Received at Least 1 Dose of Study Drug|Overall Study||181
7735717|NCT01584232|19047405|P2|STARTED|Overall Study||180
7735718|NCT01584232|19047406|P1|STARTED|Overall Study||181
7735719|NCT01584024|19047422|P1|NOT COMPLETED|Overall Study||13
7735720|NCT01584024|19047422|P1|COMPLETED|Overall Study||29
7735721|NCT01584024|19047422|P1|STARTED|Overall Study||42
7735722|NCT01583985|19047431|P2|NOT COMPLETED|Overall Study||3
7735723|NCT01583985|19047432|P1|NOT COMPLETED|Overall Study||3
7735724|NCT01583985|19047431|P2|COMPLETED|Overall Study||117
7735725|NCT01583985|19047432|P1|COMPLETED|Overall Study||117
7735726|NCT01583985|19047431|P2|Included in Primary Analysis|Overall Study||119
7735727|NCT01583985|19047432|P1|Included in Primary Analysis|Overall Study||119
7735728|NCT01583985|19047431|P2|STARTED|Overall Study||120
7735729|NCT01583985|19047432|P1|STARTED|Overall Study||120
7735730|NCT01583894|19047446|P1|NOT COMPLETED|Overall Study||15
7735731|NCT01583894|19047446|P1|COMPLETED|Overall Study||813
7735732|NCT01583894|19047446|P1|STARTED|Overall Study||828
7735733|NCT01583868|19047452|P2|NOT COMPLETED|Overall Study||4
7735734|NCT01583868|19047453|P1|NOT COMPLETED|Overall Study||4
7735735|NCT01583868|19047452|P2|COMPLETED|Overall Study||104
7735736|NCT01583868|19047453|P1|COMPLETED|Overall Study||104
7735737|NCT01583868|19047452|P2|STARTED|Overall Study||108
7735738|NCT01583868|19047453|P1|STARTED|Overall Study||108
7735739|NCT01583686|19047472|P5|NOT COMPLETED|Overall Study||0
7735740|NCT01583686|19047473|P4|NOT COMPLETED|Overall Study||0
7735741|NCT01583686|19047474|P3|NOT COMPLETED|Overall Study||0
7735742|NCT01583686|19047475|P2|NOT COMPLETED|Overall Study||0
7735743|NCT01583686|19047476|P1|NOT COMPLETED|Overall Study||0
7735744|NCT01583686|19047472|P5|COMPLETED|Overall Study||3
7735745|NCT01583686|19047473|P4|COMPLETED|Overall Study||3
7735746|NCT01583686|19047474|P3|COMPLETED|Overall Study||3
7735747|NCT01583686|19047475|P2|COMPLETED|Overall Study||3
7735748|NCT01583686|19047476|P1|COMPLETED|Overall Study||3
7735749|NCT01583686|19047472|P5|STARTED|Overall Study||3
7735750|NCT01583686|19047473|P4|STARTED|Overall Study||3
7735751|NCT01583686|19047474|P3|STARTED|Overall Study||3
7735752|NCT01583686|19047475|P2|STARTED|Overall Study||3
7735753|NCT01583686|19047476|P1|STARTED|Overall Study||3
7735754|NCT01583647|19047493|P2|NOT COMPLETED|Overall Study||0
7735755|NCT01583647|19047494|P1|NOT COMPLETED|Overall Study||0
7735756|NCT01583647|19047493|P2|COMPLETED|Overall Study||0
7735757|NCT01583647|19047494|P1|COMPLETED|Overall Study||10
7735758|NCT01583647|19047493|P2|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0
7735759|NCT01583647|19047494|P1|STARTED|Overall Study||10
7735760|NCT01583543|19047506|P1|NOT COMPLETED|Overall Study||0
7735761|NCT01583543|19047506|P1|COMPLETED|Overall Study||12
7735762|NCT01583543|19047506|P1|STARTED|Overall Study||12
7735763|NCT01583530|19047519|P6|NOT COMPLETED|Overall Study||3
7735764|NCT01583530|19047520|P5|NOT COMPLETED|Overall Study||5
7735765|NCT01583530|19047521|P4|NOT COMPLETED|Overall Study||1
7735766|NCT01583530|19047522|P3|NOT COMPLETED|Overall Study||0
7735767|NCT01583530|19047523|P2|NOT COMPLETED|Overall Study||3
7735768|NCT01583530|19047524|P1|NOT COMPLETED|Overall Study||0
7735769|NCT01583530|19047519|P6|COMPLETED|Overall Study||17
7735770|NCT01583530|19047520|P5|COMPLETED|Overall Study||15
7735771|NCT01583530|19047521|P4|COMPLETED|Overall Study||18
7735772|NCT01583530|19047522|P3|COMPLETED|Overall Study||20
7735773|NCT01583530|19047523|P2|COMPLETED|Overall Study||17
7735774|NCT01583530|19047524|P1|COMPLETED|Overall Study||19
7735775|NCT01583530|19047519|P6|STARTED|Overall Study||20
7735776|NCT01583530|19047520|P5|STARTED|Overall Study||20
7735777|NCT01583530|19047521|P4|STARTED|Overall Study||19
7735778|NCT01583530|19047522|P3|STARTED|Overall Study||20
7735779|NCT01583530|19047523|P2|STARTED|Overall Study||20
7735780|NCT01583530|19047524|P1|STARTED|Overall Study||19
7735781|NCT01583452|19047570|P2|NOT COMPLETED|Overall Study||0
7735782|NCT01583452|19047571|P1|NOT COMPLETED|Overall Study||0
7735783|NCT01583452|19047570|P2|COMPLETED|Overall Study||20
7735784|NCT01583452|19047571|P1|COMPLETED|Overall Study||21
7735785|NCT01583452|19047570|P2|STARTED|Overall Study||20
7735786|NCT01583452|19047571|P1|STARTED|Overall Study||21
7735787|NCT01583374|19047586|P9|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||10
7735788|NCT01583374|19047587|P8|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||9
7735789|NCT01583374|19047588|P7|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||18
7735790|NCT01583374|19047589|P6|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||17
7735791|NCT01583374|19047590|P5|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||31
7735792|NCT01583374|19047591|P4|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||13
7735793|NCT01583374|19047592|P3|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||20
7735794|NCT01583374|19047593|P2|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||26
7735795|NCT01583374|19047594|P1|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||0
7735796|NCT01583374|19047586|P9|COMPLETED|Long-Term Extension Phase Weeks 52-260||10
7735797|NCT01583374|19047587|P8|COMPLETED|Long-Term Extension Phase Weeks 52-260||12
7735798|NCT01583374|19047588|P7|COMPLETED|Long-Term Extension Phase Weeks 52-260||20
7735799|NCT01583374|19047589|P6|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
7735800|NCT01583374|19047590|P5|COMPLETED|Long-Term Extension Phase Weeks 52-260||50
7735801|NCT01583374|19047591|P4|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
7735802|NCT01583374|19047592|P3|COMPLETED|Long-Term Extension Phase Weeks 52-260||41
7735803|NCT01583374|19047593|P2|COMPLETED|Long-Term Extension Phase Weeks 52-260||40
7735804|NCT01583374|19047594|P1|COMPLETED|Long-Term Extension Phase Weeks 52-260||0
7735805|NCT01583374|19047586|P9|STARTED|Long-Term Extension Phase Weeks 52-260||20
7735806|NCT01583374|19047587|P8|STARTED|Long-Term Extension Phase Weeks 52-260||21
7735807|NCT01583374|19047588|P7|STARTED|Long-Term Extension Phase Weeks 52-260||38
7735808|NCT01583374|19047589|P6|STARTED|Long-Term Extension Phase Weeks 52-260||39
7735809|NCT01583374|19047590|P5|STARTED|Long-Term Extension Phase Weeks 52-260||81
7735810|NCT01583374|19047591|P4|STARTED|Long-Term Extension Phase Weeks 52-260||35
7735811|NCT01583374|19047592|P3|STARTED|Long-Term Extension Phase Weeks 52-260||61
7735812|NCT01583374|19047593|P2|STARTED|Long-Term Extension Phase Weeks 52-260||66
7735813|NCT01583374|19047594|P1|STARTED|Long-Term Extension Phase Weeks 52-260||0
7735814|NCT01583374|19047586|P9|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||2
7735815|NCT01583374|19047587|P8|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||3
7735816|NCT01583374|19047588|P7|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
7735817|NCT01583374|19047589|P6|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
7735818|NCT01583374|19047590|P5|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
7735819|NCT01583374|19047591|P4|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
7735820|NCT01583374|19047592|P3|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||4
7735821|NCT01583374|19047593|P2|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
7735822|NCT01583374|19047594|P1|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||0
7735823|NCT01583374|19047586|P9|COMPLETED|Extension Phase (Weeks 24 to 52)||21
7735824|NCT01583374|19047587|P8|COMPLETED|Extension Phase (Weeks 24 to 52)||22
7735825|NCT01583374|19047588|P7|COMPLETED|Extension Phase (Weeks 24 to 52)||43
7735826|NCT01583374|19047589|P6|COMPLETED|Extension Phase (Weeks 24 to 52)||43
7735827|NCT01583374|19047590|P5|COMPLETED|Extension Phase (Weeks 24 to 52)||85
7735828|NCT01583374|19047591|P4|COMPLETED|Extension Phase (Weeks 24 to 52)||41
7735829|NCT01583374|19047592|P3|COMPLETED|Extension Phase (Weeks 24 to 52)||61
7735830|NCT01583374|19047593|P2|COMPLETED|Extension Phase (Weeks 24 to 52)||69
7735831|NCT01583374|19047594|P1|COMPLETED|Extension Phase (Weeks 24 to 52)||0
7735832|NCT01583374|19047586|P9|STARTED|Extension Phase (Weeks 24 to 52)||23
7735833|NCT01583374|19047587|P8|STARTED|Extension Phase (Weeks 24 to 52)||25
7735834|NCT01583374|19047588|P7|STARTED|Extension Phase (Weeks 24 to 52)||48
7735835|NCT01583374|19047589|P6|STARTED|Extension Phase (Weeks 24 to 52)||48
7735836|NCT01583374|19047590|P5|STARTED|Extension Phase (Weeks 24 to 52)||91
7735837|NCT01583374|19047591|P4|STARTED|Extension Phase (Weeks 24 to 52)||47
7735838|NCT01583374|19047592|P3|STARTED|Extension Phase (Weeks 24 to 52)||65
7735839|NCT01583374|19047593|P2|STARTED|Extension Phase (Weeks 24 to 52)||74
7735840|NCT01583374|19047594|P1|STARTED|Extension Phase (Weeks 24 to 52)||0
7735841|NCT01583374|19047586|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7735842|NCT01583374|19047587|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7735843|NCT01583374|19047588|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7735844|NCT01583374|19047589|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7735845|NCT01583374|19047590|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7735846|NCT01583374|19047591|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7735847|NCT01583374|19047592|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||25
7735848|NCT01583374|19047593|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||16
7735849|NCT01583374|19047594|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||19
7735850|NCT01583374|19047586|P9|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7735851|NCT01583374|19047587|P8|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7735852|NCT01583374|19047588|P7|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7735853|NCT01583374|19047589|P6|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7735854|NCT01583374|19047590|P5|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7735855|NCT01583374|19047591|P4|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7735856|NCT01583374|19047592|P3|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|138
7735857|NCT01583374|19047593|P2|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|147
7735858|NCT01583374|19047594|P1|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|145
7735859|NCT01583374|19047586|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
7735860|NCT01583374|19047587|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
7735861|NCT01583374|19047588|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
7735862|NCT01583374|19047589|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
7735863|NCT01583374|19047590|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
7735864|NCT01583374|19047591|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
7735865|NCT01583374|19047592|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|49
7735866|NCT01583374|19047593|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||49
7735867|NCT01583374|19047594|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|51
7735868|NCT01583374|19047586|P9|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
7735869|NCT01583374|19047587|P8|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
7735870|NCT01583374|19047588|P7|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
7735871|NCT01583374|19047589|P6|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
7735872|NCT01583374|19047590|P5|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
7735873|NCT01583374|19047591|P4|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
7735874|NCT01583374|19047592|P3|Completed Week 16|Placebo-controlled Phase (Week 0-24)||144
7735875|NCT01583374|19047593|P2|Completed Week 16|Placebo-controlled Phase (Week 0-24)||151
7735876|NCT01583374|19047594|P1|Completed Week 16|Placebo-controlled Phase (Week 0-24)||150
7735877|NCT01583374|19047586|P9|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
7735878|NCT01583374|19047587|P8|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
7735879|NCT01583374|19047588|P7|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
7735880|NCT01583374|19047589|P6|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
7735881|NCT01583374|19047590|P5|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
7735882|NCT01583374|19047591|P4|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
7735883|NCT01583374|19047592|P3|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
7735884|NCT01583374|19047593|P2|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
7735885|NCT01583374|19047594|P1|Received Treatment|Placebo-controlled Phase (Week 0-24)||164
7735886|NCT01583374|19047586|P9|STARTED|Placebo-controlled Phase (Week 0-24)||0
7735887|NCT01583374|19047587|P8|STARTED|Placebo-controlled Phase (Week 0-24)||0
7735888|NCT01583374|19047588|P7|STARTED|Placebo-controlled Phase (Week 0-24)||0
7735889|NCT01583374|19047589|P6|STARTED|Placebo-controlled Phase (Week 0-24)||0
7735890|NCT01583374|19047590|P5|STARTED|Placebo-controlled Phase (Week 0-24)||0
7735891|NCT01583374|19047591|P4|STARTED|Placebo-controlled Phase (Week 0-24)||0
7735892|NCT01583374|19047592|P3|STARTED|Placebo-controlled Phase (Week 0-24)||163
7735893|NCT01583374|19047593|P2|STARTED|Placebo-controlled Phase (Week 0-24)||163
7735894|NCT01583374|19047594|P1|STARTED|Placebo-controlled Phase (Week 0-24)||164
7735895|NCT01583218|19047636|P2|NOT COMPLETED|Overall Study||283
7735896|NCT01583218|19047637|P1|NOT COMPLETED|Overall Study||289
7735897|NCT01583218|19047636|P2|COMPLETED|Overall Study||3471
7735898|NCT01583218|19047637|P1|COMPLETED|Overall Study||3470
7735899|NCT01583218|19047636|P2|STARTED|Overall Study||3754
7735900|NCT01583218|19047637|P1|STARTED|Overall Study||3759
7735901|NCT01583179|19047657|P2|NOT COMPLETED|Overall Study||2
7735902|NCT01583179|19047658|P1|NOT COMPLETED|Overall Study||1
7735903|NCT01583179|19047657|P2|COMPLETED|Overall Study||10
7735904|NCT01583179|19047658|P1|COMPLETED|Overall Study||13
7735905|NCT01583179|19047657|P2|STARTED|Overall Study||12
7735906|NCT01583179|19047658|P1|STARTED|Overall Study||14
7735907|NCT01583166|19047668|P2|NOT COMPLETED|Overall Study||6
7735908|NCT01583166|19047669|P1|NOT COMPLETED|Overall Study||4
7735909|NCT01583166|19047668|P2|COMPLETED|Overall Study||39
7735910|NCT01583166|19047669|P1|COMPLETED|Overall Study||41
7735911|NCT01583166|19047668|P2|STARTED|Overall Study||45
7735912|NCT01583166|19047669|P1|STARTED|Overall Study||45
7735913|NCT01583101|19047683|P2|NOT COMPLETED|Overall Study||0
7735914|NCT01583101|19047684|P1|NOT COMPLETED|Overall Study||0
7735915|NCT01583101|19047683|P2|COMPLETED|Overall Study||1161
7735916|NCT01583101|19047684|P1|COMPLETED|Overall Study||1076
7735917|NCT01583101|19047683|P2|STARTED|Overall Study||1161
7735918|NCT01583101|19047684|P1|STARTED|Overall Study||1076
7735919|NCT01582971|19047692|P2|NOT COMPLETED|Overall Study||37
7735920|NCT01582971|19047693|P1|NOT COMPLETED|Overall Study||39
7735921|NCT01582971|19047692|P2|COMPLETED|Overall Study||91
7735922|NCT01582971|19047693|P1|COMPLETED|Overall Study||89
7735923|NCT01582971|19047692|P2|STARTED|Overall Study||128
7735924|NCT01582971|19047693|P1|STARTED|Overall Study||128
7735925|NCT01582945|19047711|P1|NOT COMPLETED|Overall Study||2
7735926|NCT01582945|19047711|P1|COMPLETED|Overall Study||12
7735927|NCT01582945|19047711|P1|STARTED|Overall Study||14
7735928|NCT01582880|19047715|P1|NOT COMPLETED|Overall Study||0
7735929|NCT01582880|19047715|P1|COMPLETED|Overall Study||1
7735930|NCT01582880|19047715|P1|STARTED|Overall Study||1
7735931|NCT01582854|19047725|P2|NOT COMPLETED|Overall Study||34
7735932|NCT01582854|19047726|P1|NOT COMPLETED|Overall Study||36
7735933|NCT01582854|19047725|P2|COMPLETED|Overall Study||221
7735934|NCT01582854|19047726|P1|COMPLETED|Overall Study||212
7735935|NCT01582854|19047725|P2|STARTED|Overall Study||255
7735936|NCT01582854|19047726|P1|STARTED|Overall Study||248
7735937|NCT01582789|19047754|P2|NOT COMPLETED|Second Intervention (14 Days)||0
7735938|NCT01582789|19047755|P1|NOT COMPLETED|Second Intervention (14 Days)||1
7735939|NCT01582789|19047754|P2|COMPLETED|Second Intervention (14 Days)||27
7735940|NCT01582789|19047755|P1|COMPLETED|Second Intervention (14 Days)||33
7735941|NCT01582789|19047754|P2|STARTED|Second Intervention (14 Days)||27
7735942|NCT01582789|19047755|P1|STARTED|Second Intervention (14 Days)||34
7735943|NCT01582789|19047754|P2|NOT COMPLETED|First Intervention (14 Days)||0
7735944|NCT01582789|19047755|P1|NOT COMPLETED|First Intervention (14 Days)||0
7735945|NCT01582789|19047754|P2|COMPLETED|First Intervention (14 Days)||27
7735946|NCT01582789|19047755|P1|COMPLETED|First Intervention (14 Days)||34
7735947|NCT01582789|19047754|P2|STARTED|First Intervention (14 Days)||27
7735948|NCT01582789|19047755|P1|STARTED|First Intervention (14 Days)||34
7735949|NCT01582490|19047773|P2|NOT COMPLETED|Overall Study||1
7735950|NCT01582490|19047774|P1|NOT COMPLETED|Overall Study||1
7735951|NCT01582490|19047773|P2|COMPLETED|Overall Study||9
7735952|NCT01582490|19047774|P1|COMPLETED|Overall Study||8
7735953|NCT01582490|19047773|P2|STARTED|Overall Study||10
7735954|NCT01582490|19047774|P1|STARTED|Overall Study||9
7735955|NCT01582477|19047796|P2|NOT COMPLETED|Overall Study||0
7735956|NCT01582477|19047797|P1|NOT COMPLETED|Overall Study||0
7735957|NCT01582477|19047796|P2|COMPLETED|Overall Study||12
7735958|NCT01582477|19047797|P1|COMPLETED|Overall Study||12
7735959|NCT01582477|19047796|P2|STARTED|Overall Study||12
7735960|NCT01582477|19047797|P1|STARTED|Overall Study||12
7735961|NCT01582451|19047815|P2|NOT COMPLETED|Overall Study||20
7735962|NCT01582451|19047816|P1|NOT COMPLETED|Overall Study||32
7735963|NCT01582451|19047815|P2|COMPLETED|Overall Study||139
7735964|NCT01582451|19047816|P1|COMPLETED|Overall Study||275
7735965|NCT01582451|19047815|P2|Received at Least 1 Dose of Study Drug|Overall Study||159
7735966|NCT01582451|19047816|P1|Received at Least 1 Dose of Study Drug|Overall Study||305
7735967|NCT01582451|19047815|P2|STARTED|Overall Study||159
7735968|NCT01582451|19047816|P1|STARTED|Overall Study||307
7735969|NCT01582308|19047858|P10|NOT COMPLETED|Period 5||0
7735970|NCT01582308|19047859|P9|NOT COMPLETED|Period 5||0
7735971|NCT01582308|19047860|P8|NOT COMPLETED|Period 5||0
7735972|NCT01582308|19047861|P7|NOT COMPLETED|Period 5||0
7735973|NCT01582308|19047862|P6|NOT COMPLETED|Period 5||0
7735974|NCT01582308|19047863|P5|NOT COMPLETED|Period 5||0
7735975|NCT01582308|19047864|P4|NOT COMPLETED|Period 5||0
7735976|NCT01582308|19047865|P3|NOT COMPLETED|Period 5||0
7735977|NCT01582308|19047866|P2|NOT COMPLETED|Period 5||0
7735978|NCT01582308|19047867|P1|NOT COMPLETED|Period 5||0
7735979|NCT01582308|19047858|P10|COMPLETED|Period 5||1
7735980|NCT01582308|19047859|P9|COMPLETED|Period 5||2
7735981|NCT01582308|19047860|P8|COMPLETED|Period 5||2
7735982|NCT01582308|19047861|P7|COMPLETED|Period 5||2
7735983|NCT01582308|19047862|P6|COMPLETED|Period 5||1
7735984|NCT01582308|19047863|P5|COMPLETED|Period 5||2
7735985|NCT01582308|19047864|P4|COMPLETED|Period 5||2
7735986|NCT01582308|19047865|P3|COMPLETED|Period 5||2
7735987|NCT01582308|19047866|P2|COMPLETED|Period 5||2
7735988|NCT01582308|19047867|P1|COMPLETED|Period 5||1
7735989|NCT01582308|19047858|P10|STARTED|Period 5||1
7735990|NCT01582308|19047859|P9|STARTED|Period 5||2
7735991|NCT01582308|19047860|P8|STARTED|Period 5||2
7735992|NCT01582308|19047861|P7|STARTED|Period 5||2
7735993|NCT01582308|19047862|P6|STARTED|Period 5||1
7735994|NCT01582308|19047863|P5|STARTED|Period 5||2
7735995|NCT01582308|19047864|P4|STARTED|Period 5||2
7735996|NCT01582308|19047865|P3|STARTED|Period 5||2
7735997|NCT01582308|19047866|P2|STARTED|Period 5||2
7735998|NCT01582308|19047867|P1|STARTED|Period 5||1
7735999|NCT01582308|19047858|P10|NOT COMPLETED|10-day Washout Following Period 4||0
7736000|NCT01582308|19047859|P9|NOT COMPLETED|10-day Washout Following Period 4||0
7736001|NCT01582308|19047860|P8|NOT COMPLETED|10-day Washout Following Period 4||0
7736002|NCT01582308|19047861|P7|NOT COMPLETED|10-day Washout Following Period 4||0
7736003|NCT01582308|19047862|P6|NOT COMPLETED|10-day Washout Following Period 4||0
7736004|NCT01582308|19047863|P5|NOT COMPLETED|10-day Washout Following Period 4||0
7736005|NCT01582308|19047864|P4|NOT COMPLETED|10-day Washout Following Period 4||0
7736006|NCT01582308|19047865|P3|NOT COMPLETED|10-day Washout Following Period 4||0
7736007|NCT01582308|19047866|P2|NOT COMPLETED|10-day Washout Following Period 4||0
7736008|NCT01582308|19047867|P1|NOT COMPLETED|10-day Washout Following Period 4||0
7736009|NCT01582308|19047858|P10|COMPLETED|10-day Washout Following Period 4||1
7736010|NCT01582308|19047859|P9|COMPLETED|10-day Washout Following Period 4||2
7736011|NCT01582308|19047860|P8|COMPLETED|10-day Washout Following Period 4||2
7736012|NCT01582308|19047861|P7|COMPLETED|10-day Washout Following Period 4||2
7736013|NCT01582308|19047862|P6|COMPLETED|10-day Washout Following Period 4||1
7736014|NCT01582308|19047863|P5|COMPLETED|10-day Washout Following Period 4||2
7736015|NCT01582308|19047864|P4|COMPLETED|10-day Washout Following Period 4||2
7736016|NCT01582308|19047865|P3|COMPLETED|10-day Washout Following Period 4||2
7736017|NCT01582308|19047866|P2|COMPLETED|10-day Washout Following Period 4||2
7736018|NCT01582308|19047867|P1|COMPLETED|10-day Washout Following Period 4||1
7736019|NCT01582308|19047858|P10|STARTED|10-day Washout Following Period 4||1
7736020|NCT01582308|19047859|P9|STARTED|10-day Washout Following Period 4||2
7736021|NCT01582308|19047860|P8|STARTED|10-day Washout Following Period 4||2
7736022|NCT01582308|19047861|P7|STARTED|10-day Washout Following Period 4||2
7736023|NCT01582308|19047862|P6|STARTED|10-day Washout Following Period 4||1
7736024|NCT01582308|19047863|P5|STARTED|10-day Washout Following Period 4||2
7736025|NCT01582308|19047864|P4|STARTED|10-day Washout Following Period 4||2
7736026|NCT01582308|19047865|P3|STARTED|10-day Washout Following Period 4||2
7736027|NCT01582308|19047866|P2|STARTED|10-day Washout Following Period 4||2
7736028|NCT01582308|19047867|P1|STARTED|10-day Washout Following Period 4||1
7736029|NCT01582308|19047858|P10|NOT COMPLETED|Period 4||1
7736030|NCT01582308|19047859|P9|NOT COMPLETED|Period 4||0
7736031|NCT01582308|19047860|P8|NOT COMPLETED|Period 4||0
7736032|NCT01582308|19047861|P7|NOT COMPLETED|Period 4||0
7736033|NCT01582308|19047862|P6|NOT COMPLETED|Period 4||1
7736034|NCT01582308|19047863|P5|NOT COMPLETED|Period 4||0
7736035|NCT01582308|19047864|P4|NOT COMPLETED|Period 4||0
7736036|NCT01582308|19047865|P3|NOT COMPLETED|Period 4||0
7736037|NCT01582308|19047866|P2|NOT COMPLETED|Period 4||0
7736038|NCT01582308|19047867|P1|NOT COMPLETED|Period 4||1
7736039|NCT01582308|19047858|P10|COMPLETED|Period 4||1
7736040|NCT01582308|19047859|P9|COMPLETED|Period 4||2
7736041|NCT01582308|19047860|P8|COMPLETED|Period 4||2
7736042|NCT01582308|19047861|P7|COMPLETED|Period 4||2
7736043|NCT01582308|19047862|P6|COMPLETED|Period 4||1
7736044|NCT01582308|19047863|P5|COMPLETED|Period 4||2
7736045|NCT01582308|19047864|P4|COMPLETED|Period 4||2
7736046|NCT01582308|19047865|P3|COMPLETED|Period 4||2
7736047|NCT01582308|19047866|P2|COMPLETED|Period 4||2
7736048|NCT01582308|19047867|P1|COMPLETED|Period 4||1
7736049|NCT01582308|19047858|P10|STARTED|Period 4||2
7736050|NCT01582308|19047859|P9|STARTED|Period 4||2
7736051|NCT01582308|19047860|P8|STARTED|Period 4||2
7736052|NCT01582308|19047861|P7|STARTED|Period 4||2
7736053|NCT01582308|19047862|P6|STARTED|Period 4||2
7736054|NCT01582308|19047863|P5|STARTED|Period 4||2
7736055|NCT01582308|19047864|P4|STARTED|Period 4||2
7736056|NCT01582308|19047865|P3|STARTED|Period 4||2
7736057|NCT01582308|19047866|P2|STARTED|Period 4||2
7736058|NCT01582308|19047867|P1|STARTED|Period 4||2
7736059|NCT01582308|19047858|P10|NOT COMPLETED|10-day Washout Following Period 3||0
7736060|NCT01582308|19047859|P9|NOT COMPLETED|10-day Washout Following Period 3||0
7736061|NCT01582308|19047860|P8|NOT COMPLETED|10-day Washout Following Period 3||0
7736062|NCT01582308|19047861|P7|NOT COMPLETED|10-day Washout Following Period 3||0
7736063|NCT01582308|19047862|P6|NOT COMPLETED|10-day Washout Following Period 3||0
7736064|NCT01582308|19047863|P5|NOT COMPLETED|10-day Washout Following Period 3||0
7736065|NCT01582308|19047864|P4|NOT COMPLETED|10-day Washout Following Period 3||0
7736066|NCT01582308|19047865|P3|NOT COMPLETED|10-day Washout Following Period 3||0
7736067|NCT01582308|19047866|P2|NOT COMPLETED|10-day Washout Following Period 3||0
7736068|NCT01582308|19047867|P1|NOT COMPLETED|10-day Washout Following Period 3||0
7736069|NCT01582308|19047858|P10|COMPLETED|10-day Washout Following Period 3||2
7736070|NCT01582308|19047859|P9|COMPLETED|10-day Washout Following Period 3||2
7736071|NCT01582308|19047860|P8|COMPLETED|10-day Washout Following Period 3||2
7736072|NCT01582308|19047861|P7|COMPLETED|10-day Washout Following Period 3||2
7736073|NCT01582308|19047862|P6|COMPLETED|10-day Washout Following Period 3||2
7736074|NCT01582308|19047863|P5|COMPLETED|10-day Washout Following Period 3||2
7736075|NCT01582308|19047864|P4|COMPLETED|10-day Washout Following Period 3||2
7736076|NCT01582308|19047865|P3|COMPLETED|10-day Washout Following Period 3||2
7736077|NCT01582308|19047866|P2|COMPLETED|10-day Washout Following Period 3||2
7736078|NCT01582308|19047867|P1|COMPLETED|10-day Washout Following Period 3||2
7736079|NCT01582308|19047858|P10|STARTED|10-day Washout Following Period 3||2
7736080|NCT01582308|19047859|P9|STARTED|10-day Washout Following Period 3||2
7736081|NCT01582308|19047860|P8|STARTED|10-day Washout Following Period 3||2
7736082|NCT01582308|19047861|P7|STARTED|10-day Washout Following Period 3||2
7736083|NCT01582308|19047862|P6|STARTED|10-day Washout Following Period 3||2
7736084|NCT01582308|19047863|P5|STARTED|10-day Washout Following Period 3||2
7736085|NCT01582308|19047864|P4|STARTED|10-day Washout Following Period 3||2
7736086|NCT01582308|19047865|P3|STARTED|10-day Washout Following Period 3||2
7736087|NCT01582308|19047866|P2|STARTED|10-day Washout Following Period 3||2
7736088|NCT01582308|19047867|P1|STARTED|10-day Washout Following Period 3||2
7736089|NCT01582308|19047858|P10|NOT COMPLETED|Period 3||0
7736090|NCT01582308|19047859|P9|NOT COMPLETED|Period 3||0
7736091|NCT01582308|19047860|P8|NOT COMPLETED|Period 3||0
7736092|NCT01582308|19047861|P7|NOT COMPLETED|Period 3||0
7736093|NCT01582308|19047862|P6|NOT COMPLETED|Period 3||0
7736094|NCT01582308|19047863|P5|NOT COMPLETED|Period 3||0
7736095|NCT01582308|19047864|P4|NOT COMPLETED|Period 3||0
7736096|NCT01582308|19047865|P3|NOT COMPLETED|Period 3||0
7736097|NCT01582308|19047866|P2|NOT COMPLETED|Period 3||0
7736098|NCT01582308|19047867|P1|NOT COMPLETED|Period 3||0
7736099|NCT01582308|19047858|P10|COMPLETED|Period 3||2
7736100|NCT01582308|19047859|P9|COMPLETED|Period 3||2
7736101|NCT01582308|19047860|P8|COMPLETED|Period 3||2
7736102|NCT01582308|19047861|P7|COMPLETED|Period 3||2
7736103|NCT01582308|19047862|P6|COMPLETED|Period 3||2
7736104|NCT01582308|19047863|P5|COMPLETED|Period 3||2
7736105|NCT01582308|19047864|P4|COMPLETED|Period 3||2
7736106|NCT01582308|19047865|P3|COMPLETED|Period 3||2
7736107|NCT01582308|19047866|P2|COMPLETED|Period 3||2
7736108|NCT01582308|19047867|P1|COMPLETED|Period 3||2
7736109|NCT01582308|19047858|P10|STARTED|Period 3||2
7736110|NCT01582308|19047859|P9|STARTED|Period 3||2
7736111|NCT01582308|19047860|P8|STARTED|Period 3||2
7736112|NCT01582308|19047861|P7|STARTED|Period 3||2
7736113|NCT01582308|19047862|P6|STARTED|Period 3||2
7736114|NCT01582308|19047863|P5|STARTED|Period 3||2
7736115|NCT01582308|19047864|P4|STARTED|Period 3||2
7736116|NCT01582308|19047865|P3|STARTED|Period 3||2
7736117|NCT01582308|19047866|P2|STARTED|Period 3||2
7736118|NCT01582308|19047867|P1|STARTED|Period 3||2
7736119|NCT01582308|19047858|P10|NOT COMPLETED|10-day Washout Following Period 2||0
7736120|NCT01582308|19047859|P9|NOT COMPLETED|10-day Washout Following Period 2||0
7736121|NCT01582308|19047860|P8|NOT COMPLETED|10-day Washout Following Period 2||0
7736122|NCT01582308|19047861|P7|NOT COMPLETED|10-day Washout Following Period 2||0
7736123|NCT01582308|19047862|P6|NOT COMPLETED|10-day Washout Following Period 2||0
7736124|NCT01582308|19047863|P5|NOT COMPLETED|10-day Washout Following Period 2||0
7736125|NCT01582308|19047864|P4|NOT COMPLETED|10-day Washout Following Period 2||0
7736126|NCT01582308|19047865|P3|NOT COMPLETED|10-day Washout Following Period 2||0
7736127|NCT01582308|19047866|P2|NOT COMPLETED|10-day Washout Following Period 2||0
7736128|NCT01582308|19047867|P1|NOT COMPLETED|10-day Washout Following Period 2||0
7736129|NCT01582308|19047858|P10|COMPLETED|10-day Washout Following Period 2||2
7736130|NCT01582308|19047859|P9|COMPLETED|10-day Washout Following Period 2||2
7736131|NCT01582308|19047860|P8|COMPLETED|10-day Washout Following Period 2||2
7736132|NCT01582308|19047861|P7|COMPLETED|10-day Washout Following Period 2||2
7736133|NCT01582308|19047862|P6|COMPLETED|10-day Washout Following Period 2||2
7736134|NCT01582308|19047863|P5|COMPLETED|10-day Washout Following Period 2||2
7736135|NCT01582308|19047864|P4|COMPLETED|10-day Washout Following Period 2||2
7736136|NCT01582308|19047865|P3|COMPLETED|10-day Washout Following Period 2||2
7736137|NCT01582308|19047866|P2|COMPLETED|10-day Washout Following Period 2||2
7736138|NCT01582308|19047867|P1|COMPLETED|10-day Washout Following Period 2||2
7736139|NCT01582308|19047858|P10|STARTED|10-day Washout Following Period 2||2
7736140|NCT01582308|19047859|P9|STARTED|10-day Washout Following Period 2||2
7736141|NCT01582308|19047860|P8|STARTED|10-day Washout Following Period 2||2
7736142|NCT01582308|19047861|P7|STARTED|10-day Washout Following Period 2||2
7736143|NCT01582308|19047862|P6|STARTED|10-day Washout Following Period 2||2
7736144|NCT01582308|19047863|P5|STARTED|10-day Washout Following Period 2||2
7736145|NCT01582308|19047864|P4|STARTED|10-day Washout Following Period 2||2
7736146|NCT01582308|19047865|P3|STARTED|10-day Washout Following Period 2||2
7736147|NCT01582308|19047866|P2|STARTED|10-day Washout Following Period 2||2
7736148|NCT01582308|19047867|P1|STARTED|10-day Washout Following Period 2||2
7736149|NCT01582308|19047858|P10|NOT COMPLETED|Period 2||0
7736150|NCT01582308|19047859|P9|NOT COMPLETED|Period 2||0
7736151|NCT01582308|19047860|P8|NOT COMPLETED|Period 2||0
7736152|NCT01582308|19047861|P7|NOT COMPLETED|Period 2||0
7736153|NCT01582308|19047862|P6|NOT COMPLETED|Period 2||0
7736154|NCT01582308|19047863|P5|NOT COMPLETED|Period 2||0
7736155|NCT01582308|19047864|P4|NOT COMPLETED|Period 2||0
7736156|NCT01582308|19047865|P3|NOT COMPLETED|Period 2||0
7736157|NCT01582308|19047866|P2|NOT COMPLETED|Period 2||0
7736158|NCT01582308|19047867|P1|NOT COMPLETED|Period 2||0
7736159|NCT01582308|19047858|P10|COMPLETED|Period 2||2
7736160|NCT01582308|19047859|P9|COMPLETED|Period 2||2
7736161|NCT01582308|19047860|P8|COMPLETED|Period 2||2
7736162|NCT01582308|19047861|P7|COMPLETED|Period 2||2
7736163|NCT01582308|19047862|P6|COMPLETED|Period 2||2
7736164|NCT01582308|19047863|P5|COMPLETED|Period 2||2
7736165|NCT01582308|19047864|P4|COMPLETED|Period 2||2
7736166|NCT01582308|19047865|P3|COMPLETED|Period 2||2
7736167|NCT01582308|19047866|P2|COMPLETED|Period 2||2
7736168|NCT01582308|19047867|P1|COMPLETED|Period 2||2
7736169|NCT01582308|19047858|P10|STARTED|Period 2||2
7736170|NCT01582308|19047859|P9|STARTED|Period 2||2
7736171|NCT01582308|19047860|P8|STARTED|Period 2||2
7736172|NCT01582308|19047861|P7|STARTED|Period 2||2
7736173|NCT01582308|19047862|P6|STARTED|Period 2||2
7736174|NCT01582308|19047863|P5|STARTED|Period 2||2
7736175|NCT01582308|19047864|P4|STARTED|Period 2||2
7736176|NCT01582308|19047865|P3|STARTED|Period 2||2
7736177|NCT01582308|19047866|P2|STARTED|Period 2||2
7736178|NCT01582308|19047867|P1|STARTED|Period 2||2
7736179|NCT01582308|19047858|P10|NOT COMPLETED|10-day Washout Following Period 1||0
7736180|NCT01582308|19047859|P9|NOT COMPLETED|10-day Washout Following Period 1||0
7736181|NCT01582308|19047860|P8|NOT COMPLETED|10-day Washout Following Period 1||0
7736182|NCT01582308|19047861|P7|NOT COMPLETED|10-day Washout Following Period 1||0
7736183|NCT01582308|19047862|P6|NOT COMPLETED|10-day Washout Following Period 1||0
7736184|NCT01582308|19047863|P5|NOT COMPLETED|10-day Washout Following Period 1||1
7736185|NCT01582308|19047864|P4|NOT COMPLETED|10-day Washout Following Period 1||0
7736186|NCT01582308|19047865|P3|NOT COMPLETED|10-day Washout Following Period 1||0
7736187|NCT01582308|19047866|P2|NOT COMPLETED|10-day Washout Following Period 1||0
7736188|NCT01582308|19047867|P1|NOT COMPLETED|10-day Washout Following Period 1||0
7736189|NCT01582308|19047858|P10|COMPLETED|10-day Washout Following Period 1||2
7736190|NCT01582308|19047859|P9|COMPLETED|10-day Washout Following Period 1||2
7736191|NCT01582308|19047860|P8|COMPLETED|10-day Washout Following Period 1||2
7736192|NCT01582308|19047861|P7|COMPLETED|10-day Washout Following Period 1||2
7736193|NCT01582308|19047862|P6|COMPLETED|10-day Washout Following Period 1||2
7736194|NCT01582308|19047863|P5|COMPLETED|10-day Washout Following Period 1||2
7736195|NCT01582308|19047864|P4|COMPLETED|10-day Washout Following Period 1||2
7736196|NCT01582308|19047865|P3|COMPLETED|10-day Washout Following Period 1||2
7736197|NCT01582308|19047866|P2|COMPLETED|10-day Washout Following Period 1||2
7736198|NCT01582308|19047867|P1|COMPLETED|10-day Washout Following Period 1||2
7736199|NCT01582308|19047858|P10|STARTED|10-day Washout Following Period 1||2
7736200|NCT01582308|19047859|P9|STARTED|10-day Washout Following Period 1||2
7736201|NCT01582308|19047860|P8|STARTED|10-day Washout Following Period 1||2
7736202|NCT01582308|19047861|P7|STARTED|10-day Washout Following Period 1||2
7736203|NCT01582308|19047862|P6|STARTED|10-day Washout Following Period 1||2
7736204|NCT01582308|19047863|P5|STARTED|10-day Washout Following Period 1||3
7736205|NCT01582308|19047864|P4|STARTED|10-day Washout Following Period 1||2
7736206|NCT01582308|19047865|P3|STARTED|10-day Washout Following Period 1||2
7736207|NCT01582308|19047866|P2|STARTED|10-day Washout Following Period 1||2
7736208|NCT01582308|19047867|P1|STARTED|10-day Washout Following Period 1||2
7736209|NCT01582308|19047858|P10|NOT COMPLETED|Period 1||0
7736210|NCT01582308|19047859|P9|NOT COMPLETED|Period 1||0
7736211|NCT01582308|19047860|P8|NOT COMPLETED|Period 1||0
7736212|NCT01582308|19047861|P7|NOT COMPLETED|Period 1||1
7736213|NCT01582308|19047862|P6|NOT COMPLETED|Period 1||0
7736214|NCT01582308|19047863|P5|NOT COMPLETED|Period 1||0
7736215|NCT01582308|19047864|P4|NOT COMPLETED|Period 1||0
7736216|NCT01582308|19047865|P3|NOT COMPLETED|Period 1||0
7736217|NCT01582308|19047866|P2|NOT COMPLETED|Period 1||0
7736218|NCT01582308|19047867|P1|NOT COMPLETED|Period 1||0
7736219|NCT01582308|19047858|P10|COMPLETED|Period 1||2
7736220|NCT01582308|19047859|P9|COMPLETED|Period 1||2
7736221|NCT01582308|19047860|P8|COMPLETED|Period 1||2
7736222|NCT01582308|19047861|P7|COMPLETED|Period 1||2
7736223|NCT01582308|19047862|P6|COMPLETED|Period 1||2
7736224|NCT01582308|19047863|P5|COMPLETED|Period 1||3
7736225|NCT01582308|19047864|P4|COMPLETED|Period 1||2
7736226|NCT01582308|19047865|P3|COMPLETED|Period 1||2
7736227|NCT01582308|19047866|P2|COMPLETED|Period 1||2
7736228|NCT01582308|19047867|P1|COMPLETED|Period 1||2
7736229|NCT01582308|19047858|P10|STARTED|Period 1||2
7736230|NCT01582308|19047859|P9|STARTED|Period 1||2
7736231|NCT01582308|19047860|P8|STARTED|Period 1||2
7736232|NCT01582308|19047861|P7|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3
7736233|NCT01582308|19047862|P6|STARTED|Period 1||2
7736234|NCT01582308|19047863|P5|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3
7736235|NCT01582308|19047864|P4|STARTED|Period 1||2
7736236|NCT01582308|19047865|P3|STARTED|Period 1||2
7736237|NCT01582308|19047866|P2|STARTED|Period 1||2
7736238|NCT01582308|19047867|P1|STARTED|Period 1||2
7736239|NCT01582282|19047895|P3|NOT COMPLETED|Overall Study||0
7736240|NCT01582282|19047896|P2|NOT COMPLETED|Overall Study||2
7736241|NCT01582282|19047897|P1|NOT COMPLETED|Overall Study||2
7736242|NCT01582282|19047895|P3|COMPLETED|Overall Study||8
7736243|NCT01582282|19047896|P2|COMPLETED|Overall Study||12
7736244|NCT01582282|19047897|P1|COMPLETED|Overall Study||13
7736245|NCT01582282|19047895|P3|STARTED|Overall Study||8
7736246|NCT01582282|19047896|P2|STARTED|Overall Study||14
7736247|NCT01582282|19047897|P1|STARTED|Overall Study||15
7736248|NCT01582243|19047920|P1|NOT COMPLETED|Overall Study||3
7736249|NCT01582243|19047920|P1|COMPLETED|Overall Study||37
7736250|NCT01582243|19047920|P1|STARTED|Overall Study||40
7736251|NCT01582178|19047931|P2|NOT COMPLETED|Overall Study||5
7736252|NCT01582178|19047932|P1|NOT COMPLETED|Overall Study||6
7736253|NCT01582178|19047931|P2|COMPLETED|Overall Study||101
7736254|NCT01582178|19047932|P1|COMPLETED|Overall Study||100
7736255|NCT01582178|19047931|P2|STARTED|Overall Study||106
7736256|NCT01582178|19047932|P1|STARTED|Overall Study||106
7736257|NCT01582152|19047940|P2|NOT COMPLETED|Overall Study||6
7736258|NCT01582152|19047941|P1|NOT COMPLETED|Overall Study||6
7736259|NCT01582152|19047940|P2|COMPLETED|Overall Study||0
7736260|NCT01582152|19047941|P1|COMPLETED|Overall Study||0
7736261|NCT01582152|19047940|P2|STARTED|Overall Study||6
7736262|NCT01582152|19047941|P1|STARTED|Overall Study||6
7736263|NCT01582139|19047951|P2|NOT COMPLETED|Overall Study||0
7736264|NCT01582139|19047952|P1|NOT COMPLETED|Overall Study||0
7736265|NCT01582139|19047951|P2|COMPLETED|Overall Study||6
7736266|NCT01582139|19047952|P1|COMPLETED|Overall Study||6
7736267|NCT01582139|19047951|P2|STARTED|Overall Study||6
7736268|NCT01582139|19047952|P1|STARTED|Overall Study||6
7736269|NCT01582100|19047964|P1|NOT COMPLETED|Overall Study||2
7736270|NCT01582100|19047964|P1|COMPLETED|Overall Study||0
7736271|NCT01582100|19047964|P1|STARTED|Overall Study||2
7736272|NCT01582061|19047970|P2|NOT COMPLETED|Overall Study||36
7736273|NCT01582061|19047971|P1|NOT COMPLETED|Overall Study||28
7736274|NCT01582061|19047970|P2|COMPLETED|Overall Study||19
7736275|NCT01582061|19047971|P1|COMPLETED|Overall Study||21
7736276|NCT01582061|19047970|P2|STARTED|Overall Study||55
7736277|NCT01582061|19047971|P1|STARTED|Overall Study||49
7736278|NCT01582009|19048021|P1|NOT COMPLETED|Overall Study||2
7736279|NCT01582009|19048021|P1|COMPLETED|Overall Study||24
7736280|NCT01582009|19048021|P1|STARTED|Overall Study||26
7736281|NCT01581970|19048029|P1|NOT COMPLETED|Overall Study||0
7736282|NCT01581970|19048029|P1|COMPLETED|Overall Study||7
7736283|NCT01581970|19048029|P1|STARTED|Overall Study||7
7736284|NCT01581931|19048038|P2|NOT COMPLETED|Second Period||0
7736285|NCT01581931|19048039|P1|NOT COMPLETED|Second Period||0
7736286|NCT01581931|19048038|P2|COMPLETED|Second Period||15
7736287|NCT01581931|19048039|P1|COMPLETED|Second Period||16
7736288|NCT01581931|19048038|P2|STARTED|Second Period||15
7736289|NCT01581931|19048039|P1|STARTED|Second Period||16
7736290|NCT01581931|19048038|P2|NOT COMPLETED|Washout||1
7736291|NCT01581931|19048039|P1|NOT COMPLETED|Washout||0
7736292|NCT01581931|19048038|P2|COMPLETED|Washout||15
7736293|NCT01581931|19048039|P1|COMPLETED|Washout||16
7736294|NCT01581931|19048038|P2|STARTED|Washout||16
7736295|NCT01581931|19048039|P1|STARTED|Washout||16
7736296|NCT01581931|19048038|P2|NOT COMPLETED|First Period||0
7736297|NCT01581931|19048039|P1|NOT COMPLETED|First Period||0
7736298|NCT01581931|19048038|P2|COMPLETED|First Period||16
7736299|NCT01581931|19048039|P1|COMPLETED|First Period||16
7736300|NCT01581931|19048038|P2|STARTED|First Period||16
7736301|NCT01581931|19048039|P1|STARTED|First Period||16
7736302|NCT01581710|19048053|P2|NOT COMPLETED|Second Intervention (14days)||2
7736303|NCT01581710|19048054|P1|NOT COMPLETED|Second Intervention (14days)||0
7736304|NCT01581710|19048053|P2|COMPLETED|Second Intervention (14days)||12
7736305|NCT01581710|19048054|P1|COMPLETED|Second Intervention (14days)||18
7736306|NCT01581710|19048053|P2|STARTED|Second Intervention (14days)||14
7736307|NCT01581710|19048054|P1|STARTED|Second Intervention (14days)||18
7736308|NCT01581710|19048053|P2|NOT COMPLETED|Washout Period (14days)||0
7736309|NCT01581710|19048054|P1|NOT COMPLETED|Washout Period (14days)||0
7736310|NCT01581710|19048053|P2|COMPLETED|Washout Period (14days)||14
7736311|NCT01581710|19048054|P1|COMPLETED|Washout Period (14days)||18
7736312|NCT01581710|19048053|P2|STARTED|Washout Period (14days)||14
7736313|NCT01581710|19048054|P1|STARTED|Washout Period (14days)||18
7736314|NCT01581710|19048053|P2|NOT COMPLETED|First Intervention (14days)||0
7736315|NCT01581710|19048054|P1|NOT COMPLETED|First Intervention (14days)||0
7736316|NCT01581710|19048053|P2|COMPLETED|First Intervention (14days)||14
7736317|NCT01581710|19048054|P1|COMPLETED|First Intervention (14days)||18
7736318|NCT01581710|19048053|P2|STARTED|First Intervention (14days)||14
7736319|NCT01581710|19048054|P1|STARTED|First Intervention (14days)||18
7736320|NCT01581684|19048092|P10|NOT COMPLETED|Overall Study||0
7736321|NCT01581684|19048093|P9|NOT COMPLETED|Overall Study||1
7736322|NCT01581684|19048094|P8|NOT COMPLETED|Overall Study||0
7736323|NCT01581684|19048095|P7|NOT COMPLETED|Overall Study||0
7736324|NCT01581684|19048096|P6|NOT COMPLETED|Overall Study||0
7736325|NCT01581684|19048097|P5|NOT COMPLETED|Overall Study||0
7736326|NCT01581684|19048098|P4|NOT COMPLETED|Overall Study||0
7736327|NCT01581684|19048099|P3|NOT COMPLETED|Overall Study||0
7736328|NCT01581684|19048100|P2|NOT COMPLETED|Overall Study||0
7736329|NCT01581684|19048101|P1|NOT COMPLETED|Overall Study||0
7736330|NCT01581684|19048092|P10|COMPLETED|Overall Study||5
7736331|NCT01581684|19048093|P9|COMPLETED|Overall Study||0
7736332|NCT01581684|19048094|P8|COMPLETED|Overall Study||6
7736333|NCT01581684|19048095|P7|COMPLETED|Overall Study||6
7736334|NCT01581684|19048096|P6|COMPLETED|Overall Study||6
7736335|NCT01581684|19048097|P5|COMPLETED|Overall Study||6
7736336|NCT01581684|19048098|P4|COMPLETED|Overall Study||6
7736337|NCT01581684|19048099|P3|COMPLETED|Overall Study||6
7736338|NCT01581684|19048100|P2|COMPLETED|Overall Study||6
7736339|NCT01581684|19048101|P1|COMPLETED|Overall Study||14
7736340|NCT01581684|19048092|P10|STARTED|Overall Study||5
7736341|NCT01581684|19048093|P9|STARTED|Overall Study||1
7736342|NCT01581684|19048094|P8|STARTED|Overall Study||6
7736343|NCT01581684|19048095|P7|STARTED|Overall Study||6
7736344|NCT01581684|19048096|P6|STARTED|Overall Study||6
7736345|NCT01581684|19048097|P5|STARTED|Overall Study||6
7736346|NCT01581684|19048098|P4|STARTED|Overall Study||6
7736347|NCT01581684|19048099|P3|STARTED|Overall Study||6
7736348|NCT01581684|19048100|P2|STARTED|Overall Study||6
7736349|NCT01581684|19048101|P1|STARTED|Overall Study||14
7736350|NCT01581658|19048176|P4|NOT COMPLETED|Overall Study||0
7736351|NCT01581658|19048177|P3|NOT COMPLETED|Overall Study||0
7736352|NCT01581658|19048178|P2|NOT COMPLETED|Overall Study||0
7736353|NCT01581658|19048179|P1|NOT COMPLETED|Overall Study||0
7736354|NCT01581658|19048176|P4|COMPLETED|Overall Study||8
7736355|NCT01581658|19048177|P3|COMPLETED|Overall Study||8
7736356|NCT01581658|19048178|P2|COMPLETED|Overall Study||8
7736357|NCT01581658|19048179|P1|COMPLETED|Overall Study||8
7736358|NCT01581658|19048176|P4|STARTED|Overall Study||8
7736359|NCT01581658|19048177|P3|STARTED|Overall Study||8
7736360|NCT01581658|19048178|P2|STARTED|Overall Study||8
7736361|NCT01581658|19048179|P1|STARTED|Overall Study||8
7736362|NCT01581619|19048197|P1|NOT COMPLETED|Overall Study||2
7736363|NCT01581619|19048197|P1|COMPLETED|Overall Study||52
7736364|NCT01581619|19048197|P1|STARTED|Overall Study||54
7736365|NCT01581541|19048205|P11|NOT COMPLETED|Overall Study||0
7736366|NCT01581541|19048206|P10|NOT COMPLETED|Overall Study||0
7736367|NCT01581541|19048207|P9|NOT COMPLETED|Overall Study||0
7736368|NCT01581541|19048208|P8|NOT COMPLETED|Overall Study||0
7736369|NCT01581541|19048209|P7|NOT COMPLETED|Overall Study||0
7736370|NCT01581541|19048210|P6|NOT COMPLETED|Overall Study||0
7736371|NCT01581541|19048211|P5|NOT COMPLETED|Overall Study||0
7736372|NCT01581541|19048212|P4|NOT COMPLETED|Overall Study||0
7736373|NCT01581541|19048213|P3|NOT COMPLETED|Overall Study||0
7736374|NCT01581541|19048214|P2|NOT COMPLETED|Overall Study||0
7736375|NCT01581541|19048215|P1|NOT COMPLETED|Overall Study||0
7736376|NCT01581541|19048205|P11|COMPLETED|Overall Study||1
7736377|NCT01581541|19048206|P10|COMPLETED|Overall Study||3
7736378|NCT01581541|19048207|P9|COMPLETED|Overall Study||1
7736379|NCT01581541|19048208|P8|COMPLETED|Overall Study||2
7736380|NCT01581541|19048209|P7|COMPLETED|Overall Study||1
7736381|NCT01581541|19048210|P6|COMPLETED|Overall Study||3
7736382|NCT01581541|19048211|P5|COMPLETED|Overall Study||2
7736383|NCT01581541|19048212|P4|COMPLETED|Overall Study||1
7736384|NCT01581541|19048213|P3|COMPLETED|Overall Study||1
7736385|NCT01581541|19048214|P2|COMPLETED|Overall Study||1
7736386|NCT01581541|19048215|P1|COMPLETED|Overall Study||1
7736387|NCT01581541|19048205|P11|STARTED|Overall Study||1
7736388|NCT01581541|19048206|P10|STARTED|Overall Study||3
7736389|NCT01581541|19048207|P9|STARTED|Overall Study||1
7736390|NCT01581541|19048208|P8|STARTED|Overall Study||2
7736391|NCT01581541|19048209|P7|STARTED|Overall Study||1
7736392|NCT01581541|19048210|P6|STARTED|Overall Study||3
7736393|NCT01581541|19048211|P5|STARTED|Overall Study||2
7736394|NCT01581541|19048212|P4|STARTED|Overall Study||1
7736395|NCT01581541|19048213|P3|STARTED|Overall Study||1
7736396|NCT01581541|19048214|P2|STARTED|Overall Study||1
7736397|NCT01581541|19048215|P1|STARTED|Overall Study||1
7736398|NCT01581437|19048339|P1|NOT COMPLETED|Overall Study||0
7736399|NCT01581437|19048339|P1|COMPLETED|Overall Study||78
7736400|NCT01581437|19048339|P1|STARTED|Overall Study||78
7736401|NCT01581307|19048350|P1|NOT COMPLETED|Overall Study||1
7736402|NCT01581307|19048350|P1|COMPLETED|Overall Study||8
7736403|NCT01581307|19048350|P1|STARTED|Overall Study||9
7736404|NCT01581281|19048359|P3|NOT COMPLETED|Overall Study||12
7736405|NCT01581281|19048360|P2|NOT COMPLETED|Overall Study||6
7736406|NCT01581281|19048361|P1|NOT COMPLETED|Overall Study||15
7736407|NCT01581281|19048359|P3|COMPLETED|Overall Study||132
7736408|NCT01581281|19048360|P2|COMPLETED|Overall Study||66
7736409|NCT01581281|19048361|P1|COMPLETED|Overall Study||130
7736410|NCT01581281|19048359|P3|STARTED|Overall Study||144
7736411|NCT01581281|19048360|P2|STARTED|Overall Study||72
7736412|NCT01581281|19048361|P1|STARTED|Overall Study||145
7736413|NCT01581021|19048383|P2|NOT COMPLETED|Overall Study||11
7736414|NCT01581021|19048384|P1|NOT COMPLETED|Overall Study||10
7736415|NCT01581021|19048383|P2|COMPLETED|Overall Study||18
7736416|NCT01581021|19048384|P1|COMPLETED|Overall Study||19
7736417|NCT01581021|19048383|P2|STARTED|Overall Study||29
7736418|NCT01581021|19048384|P1|STARTED|Overall Study||29
7736419|NCT01581008|19048398|P2|NOT COMPLETED|Overall Study||6
7736420|NCT01581008|19048399|P1|NOT COMPLETED|Overall Study||1
7736421|NCT01581008|19048398|P2|COMPLETED|Overall Study||7
7736422|NCT01581008|19048399|P1|COMPLETED|Overall Study||16
7736423|NCT01581008|19048398|P2|STARTED|Overall Study||13
7736424|NCT01581008|19048399|P1|STARTED|Overall Study||17
7736425|NCT01580995|19048411|P2|NOT COMPLETED|Overall Study||2
7736426|NCT01580995|19048412|P1|NOT COMPLETED|Overall Study||2
7736427|NCT01580995|19048411|P2|COMPLETED|Overall Study||7
7736428|NCT01580995|19048412|P1|COMPLETED|Overall Study||8
7736429|NCT01580995|19048411|P2|STARTED|Overall Study||9
7736430|NCT01580995|19048412|P1|STARTED|Overall Study||10
7736431|NCT01580969|19048421|P3|NOT COMPLETED|Overall Study||0
7736432|NCT01580969|19048422|P2|NOT COMPLETED|Overall Study||0
7736433|NCT01580969|19048423|P1|NOT COMPLETED|Overall Study||3
7736434|NCT01580969|19048421|P3|COMPLETED|Overall Study||13
7736435|NCT01580969|19048422|P2|COMPLETED|Overall Study||3
7736436|NCT01580969|19048423|P1|COMPLETED|Overall Study||3
7736437|NCT01580969|19048421|P3|STARTED|Overall Study||13
7736438|NCT01580969|19048422|P2|STARTED|Overall Study||3
7736439|NCT01580969|19048423|P1|STARTED|Overall Study||6
7736440|NCT01580904|19048457|P2|NOT COMPLETED|Overall Study||7
7736441|NCT01580904|19048458|P1|NOT COMPLETED|Overall Study||4
7736442|NCT01580904|19048457|P2|COMPLETED|Overall Study||42
7736443|NCT01580904|19048458|P1|COMPLETED|Overall Study||47
7736444|NCT01580904|19048457|P2|STARTED|Overall Study||49
7736445|NCT01580904|19048458|P1|STARTED|Overall Study||51
7736446|NCT01580670|19048470|P1|NOT COMPLETED|Maintenance Period (Week 14 to 54)||2
7736447|NCT01580670|19048470|P1|COMPLETED|Maintenance Period (Week 14 to 54)||12
7736448|NCT01580670|19048470|P1|STARTED|Maintenance Period (Week 14 to 54)||14
7736449|NCT01580670|19048470|P1|NOT COMPLETED|Induction Period (Week 0 to 14)||0
7736450|NCT01580670|19048470|P1|COMPLETED|Induction Period (Week 0 to 14)||14
7736451|NCT01580670|19048470|P1|STARTED|Induction Period (Week 0 to 14)||14
7736452|NCT01580618|19048481|P2|NOT COMPLETED|Overall Study||0
7736453|NCT01580618|19048482|P1|NOT COMPLETED|Overall Study||1
7736454|NCT01580618|19048481|P2|COMPLETED|Overall Study||12
7736455|NCT01580618|19048482|P1|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7
7736456|NCT01580618|19048481|P2|STARTED|Overall Study||12
7736457|NCT01580618|19048482|P1|STARTED|Overall Study||8
7736458|NCT01580592|19048498|P3|NOT COMPLETED|Overall Study||0
7736459|NCT01580592|19048499|P2|NOT COMPLETED|Overall Study||0
7736460|NCT01580592|19048500|P1|NOT COMPLETED|Overall Study||0
7736461|NCT01580592|19048498|P3|COMPLETED|Overall Study||12
7736462|NCT01580592|19048499|P2|COMPLETED|Overall Study||9
7736463|NCT01580592|19048500|P1|COMPLETED|Overall Study||10
7736464|NCT01580592|19048498|P3|STARTED|Overall Study||12
7736465|NCT01580592|19048499|P2|STARTED|Overall Study||9
7736466|NCT01580592|19048500|P1|STARTED|Overall Study||10
7736467|NCT01580488|19048511|P1|NOT COMPLETED|Overall Study||1
7736468|NCT01580488|19048511|P1|COMPLETED|Overall Study||23
7736469|NCT01580488|19048511|P1|STARTED|Overall Study||24
7736470|NCT01580423|19048555|P2|NOT COMPLETED|Second Intervention||0
7736471|NCT01580423|19048556|P1|NOT COMPLETED|Second Intervention||0
7736472|NCT01580423|19048555|P2|COMPLETED|Second Intervention||8
7736473|NCT01580423|19048556|P1|COMPLETED|Second Intervention||8
7736474|NCT01580423|19048555|P2|STARTED|Second Intervention||8
7736475|NCT01580423|19048556|P1|STARTED|Second Intervention||8
7736476|NCT01580423|19048555|P2|NOT COMPLETED|First Intervention||0
7736477|NCT01580423|19048556|P1|NOT COMPLETED|First Intervention||0
7736478|NCT01580423|19048555|P2|COMPLETED|First Intervention||8
7736479|NCT01580423|19048556|P1|COMPLETED|First Intervention||8
7736480|NCT01580423|19048555|P2|STARTED|First Intervention||8
7736481|NCT01580423|19048556|P1|STARTED|First Intervention||8
7736482|NCT01580410|19048568|P2|NOT COMPLETED|Overall Study||8
7736483|NCT01580410|19048569|P1|NOT COMPLETED|Overall Study||11
7736484|NCT01580410|19048568|P2|COMPLETED|Overall Study||60
7736485|NCT01580410|19048569|P1|COMPLETED|Overall Study||57
7736486|NCT01580410|19048568|P2|STARTED|Overall Study||68
7736487|NCT01580410|19048569|P1|STARTED|Overall Study||68
7736488|NCT01580306|19048585|P4|NOT COMPLETED|Overall Study||0
7736489|NCT01580306|19048586|P3|NOT COMPLETED|Overall Study||0
7736490|NCT01580306|19048587|P2|NOT COMPLETED|Overall Study||0
7736491|NCT01580306|19048588|P1|NOT COMPLETED|Overall Study||0
7736492|NCT01580306|19048585|P4|COMPLETED|Overall Study||8
7736493|NCT01580306|19048586|P3|COMPLETED|Overall Study||8
7736494|NCT01580306|19048587|P2|COMPLETED|Overall Study||8
7736495|NCT01580306|19048588|P1|COMPLETED|Overall Study||8
7736496|NCT01580306|19048585|P4|STARTED|Overall Study||8
7736497|NCT01580306|19048586|P3|STARTED|Overall Study||8
7736498|NCT01580306|19048587|P2|STARTED|Overall Study||8
7736499|NCT01580306|19048588|P1|STARTED|Overall Study||8
7736500|NCT01580293|19048617|P3|NOT COMPLETED|Part B||2
7736501|NCT01580293|19048618|P2|NOT COMPLETED|Part B||0
7736502|NCT01580293|19048619|P1|NOT COMPLETED|Part B||0
7736503|NCT01580293|19048617|P3|COMPLETED|Part B||17
7736504|NCT01580293|19048618|P2|COMPLETED|Part B||0
7736505|NCT01580293|19048619|P1|COMPLETED|Part B||0
7736506|NCT01580293|19048617|P3|STARTED|Part B|11 participants were enrolled in Part B only, 8 participants switched from Part A to Part B.|19
7736507|NCT01580293|19048618|P2|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
7736508|NCT01580293|19048619|P1|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
7736509|NCT01580293|19048617|P3|NOT COMPLETED|Part A_Extension||0
7736510|NCT01580293|19048618|P2|NOT COMPLETED|Part A_Extension||12
7736511|NCT01580293|19048619|P1|NOT COMPLETED|Part A_Extension||0
7736512|NCT01580293|19048617|P3|COMPLETED|Part A_Extension||0
7736513|NCT01580293|19048618|P2|COMPLETED|Part A_Extension||95
7736514|NCT01580293|19048619|P1|COMPLETED|Part A_Extension||14
7736515|NCT01580293|19048617|P3|STARTED|Part A_Extension|Participants in Part B were not counted for part A|0
7736516|NCT01580293|19048618|P2|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|107
7736517|NCT01580293|19048619|P1|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|14
7736518|NCT01580293|19048617|P3|NOT COMPLETED|Part A_Main Trial||0
7736519|NCT01580293|19048618|P2|NOT COMPLETED|Part A_Main Trial||6
7736520|NCT01580293|19048619|P1|NOT COMPLETED|Part A_Main Trial||2
7736521|NCT01580293|19048617|P3|COMPLETED|Part A_Main Trial||0
7736522|NCT01580293|19048618|P2|COMPLETED|Part A_Main Trial||108
7736523|NCT01580293|19048619|P1|COMPLETED|Part A_Main Trial||18
7736524|NCT01580293|19048617|P3|STARTED|Part A_Main Trial|Participants in Part B were not counted for Part A|0
7736525|NCT01580293|19048618|P2|STARTED|Part A_Main Trial||114
7736526|NCT01580293|19048619|P1|STARTED|Part A_Main Trial||20
7736527|NCT01580098|19048704|P3|NOT COMPLETED|Overall Study||3
7736528|NCT01580098|19048705|P2|NOT COMPLETED|Overall Study||13
7736529|NCT01580098|19048706|P1|NOT COMPLETED|Overall Study||15
7736530|NCT01580098|19048704|P3|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0
7736531|NCT01580098|19048705|P2|COMPLETED|Overall Study||101
7736532|NCT01580098|19048706|P1|COMPLETED|Overall Study||61
7736533|NCT01580098|19048704|P3|STARTED|Overall Study||3
7736534|NCT01580098|19048705|P2|STARTED|Overall Study||114
7736535|NCT01580098|19048706|P1|STARTED|Overall Study||76
7736536|NCT01580072|19048729|P3|NOT COMPLETED|Overall Study||0
7736537|NCT01580072|19048730|P2|NOT COMPLETED|Overall Study||9
7736538|NCT01580072|19048731|P1|NOT COMPLETED|Overall Study||12
7736539|NCT01580072|19048729|P3|COMPLETED|Overall Study||0
7736540|NCT01580072|19048730|P2|COMPLETED|Overall Study||28
7736541|NCT01580072|19048731|P1|COMPLETED|Overall Study||16
7736542|NCT01580072|19048729|P3|STARTED|Overall Study||0
7736543|NCT01580072|19048730|P2|STARTED|Overall Study||37
7736544|NCT01580072|19048731|P1|STARTED|Overall Study||28
7736545|NCT01580020|19048759|P4|NOT COMPLETED|Overall Study||2
7736546|NCT01580020|19048760|P3|NOT COMPLETED|Overall Study||4
7736547|NCT01580020|19048761|P2|NOT COMPLETED|Overall Study||7
7736548|NCT01580020|19048762|P1|NOT COMPLETED|Overall Study||1
7736549|NCT01580020|19048759|P4|COMPLETED|Overall Study||20
7736550|NCT01580020|19048760|P3|COMPLETED|Overall Study||57
7736551|NCT01580020|19048761|P2|COMPLETED|Overall Study||33
7736552|NCT01580020|19048762|P1|COMPLETED|Overall Study||51
7736553|NCT01580020|19048759|P4|STARTED|Overall Study||22
7736554|NCT01580020|19048760|P3|STARTED|Overall Study||61
7736555|NCT01580020|19048761|P2|STARTED|Overall Study||40
7736556|NCT01580020|19048762|P1|STARTED|Overall Study||52
7736557|NCT01579916|19048806|P2|NOT COMPLETED|Overall Study||2
7736558|NCT01579916|19048807|P1|NOT COMPLETED|Overall Study||8
7736559|NCT01579916|19048806|P2|COMPLETED|Overall Study||59
7736560|NCT01579916|19048807|P1|COMPLETED|Overall Study||234
7736561|NCT01579916|19048806|P2|STARTED|Overall Study||61
7736562|NCT01579916|19048807|P1|STARTED|Overall Study||242
7736563|NCT01579812|19048833|P1|NOT COMPLETED|Overall Study||52
7736564|NCT01579812|19048833|P1|COMPLETED|Overall Study||38
7736565|NCT01579812|19048833|P1|STARTED|Overall Study||90
7736566|NCT01579747|19048843|P2|NOT COMPLETED|Overall Study||0
7736567|NCT01579747|19048844|P1|NOT COMPLETED|Overall Study||0
7736568|NCT01579747|19048843|P2|COMPLETED|Overall Study||12
7736569|NCT01579747|19048844|P1|COMPLETED|Overall Study||12
7736570|NCT01579747|19048843|P2|STARTED|Overall Study||12
7736571|NCT01579747|19048844|P1|STARTED|Overall Study||12
7736572|NCT01579669|19048854|P2|NOT COMPLETED|Overall Study||0
7736573|NCT01579669|19048855|P1|NOT COMPLETED|Overall Study||36
7736574|NCT01579669|19048854|P2|COMPLETED|Overall Study||41
7736575|NCT01579669|19048855|P1|COMPLETED|Overall Study||134
7736576|NCT01579669|19048854|P2|STARTED|Overall Study||41
7736577|NCT01579669|19048855|P1|STARTED|Overall Study||170
7736578|NCT01579578|19048867|P2|NOT COMPLETED|Overall Study||12
7736579|NCT01579578|19048868|P1|NOT COMPLETED|Overall Study||13
7736580|NCT01579578|19048867|P2|COMPLETED|Overall Study||0
7736581|NCT01579578|19048868|P1|COMPLETED|Overall Study||0
7736582|NCT01579578|19048867|P2|Ongoing|Overall Study||0
7736583|NCT01579578|19048868|P1|Ongoing|Overall Study||3
7736584|NCT01579578|19048867|P2|STARTED|Overall Study||12
7736585|NCT01579578|19048868|P1|STARTED|Overall Study||13
7736586|NCT01579565|19048880|P2|NOT COMPLETED|Treated||3
7736587|NCT01579565|19048881|P1|NOT COMPLETED|Treated||2
7736588|NCT01579565|19048880|P2|COMPLETED|Treated||201
7736589|NCT01579565|19048881|P1|COMPLETED|Treated||200
7736590|NCT01579565|19048880|P2|STARTED|Treated||204
7736591|NCT01579565|19048881|P1|STARTED|Treated||202
7736592|NCT01579565|19048880|P2|NOT COMPLETED|Randomized||5
7736593|NCT01579565|19048881|P1|NOT COMPLETED|Randomized||5
7736594|NCT01579565|19048880|P2|COMPLETED|Randomized||204
7736595|NCT01579565|19048881|P1|COMPLETED|Randomized||202
7736596|NCT01579565|19048880|P2|STARTED|Randomized||209
7736597|NCT01579565|19048881|P1|STARTED|Randomized||207
7736598|NCT01579513|19048911|P2|NOT COMPLETED|1 Year Neurodevelopmental Follow up||27
7736599|NCT01579513|19048912|P1|NOT COMPLETED|1 Year Neurodevelopmental Follow up||20
7736600|NCT01579513|19048911|P2|COMPLETED|1 Year Neurodevelopmental Follow up||68
7736601|NCT01579513|19048912|P1|COMPLETED|1 Year Neurodevelopmental Follow up||61
7736602|NCT01579513|19048911|P2|STARTED|1 Year Neurodevelopmental Follow up||95
7736603|NCT01579513|19048912|P1|STARTED|1 Year Neurodevelopmental Follow up||81
7736604|NCT01579513|19048911|P2|NOT COMPLETED|Primary Hospitalization||4
7736605|NCT01579513|19048912|P1|NOT COMPLETED|Primary Hospitalization||10
7736606|NCT01579513|19048911|P2|COMPLETED|Primary Hospitalization||95
7736607|NCT01579513|19048912|P1|COMPLETED|Primary Hospitalization||81
7736608|NCT01579513|19048911|P2|STARTED|Primary Hospitalization||99
7736609|NCT01579513|19048912|P1|STARTED|Primary Hospitalization||91
7736610|NCT01579474|19048932|P6|NOT COMPLETED|Overall Study||1
7736611|NCT01579474|19048933|P5|NOT COMPLETED|Overall Study||1
7736612|NCT01579474|19048934|P4|NOT COMPLETED|Overall Study||0
7736613|NCT01579474|19048935|P3|NOT COMPLETED|Overall Study||2
7736614|NCT01579474|19048936|P2|NOT COMPLETED|Overall Study||13
7736615|NCT01579474|19048937|P1|NOT COMPLETED|Overall Study||3
7736616|NCT01579474|19048932|P6|COMPLETED|Overall Study||1
7736617|NCT01579474|19048933|P5|COMPLETED|Overall Study||9
7736618|NCT01579474|19048934|P4|COMPLETED|Overall Study||3
7736619|NCT01579474|19048935|P3|COMPLETED|Overall Study||27
7736620|NCT01579474|19048936|P2|COMPLETED|Overall Study||30
7736621|NCT01579474|19048937|P1|COMPLETED|Overall Study||41
7736622|NCT01579474|19048932|P6|STARTED|Overall Study||2
7736623|NCT01579474|19048933|P5|STARTED|Overall Study||10
7736624|NCT01579474|19048934|P4|STARTED|Overall Study||3
7736625|NCT01579474|19048935|P3|STARTED|Overall Study||29
7736626|NCT01579474|19048936|P2|STARTED|Overall Study||43
7736627|NCT01579474|19048937|P1|STARTED|Overall Study||44
7736628|NCT01579318|19049011|P1|NOT COMPLETED|Overall Study||1
7736629|NCT01579318|19049011|P1|COMPLETED|Overall Study||1
7736630|NCT01579318|19049011|P1|STARTED|Overall Study||2
7736631|NCT01579305|19049024|P2|NOT COMPLETED|Overall Study||27
7736632|NCT01579305|19049025|P1|NOT COMPLETED|Overall Study||21
7736633|NCT01579305|19049024|P2|COMPLETED|Overall Study||115
7736634|NCT01579305|19049025|P1|COMPLETED|Overall Study||118
7736635|NCT01579305|19049024|P2|Continued After Treatment|Overall Study||141
7736636|NCT01579305|19049025|P1|Continued After Treatment|Overall Study||139
7736637|NCT01579305|19049024|P2|Discontinued Before Treatment|Overall Study||1
7736638|NCT01579305|19049025|P1|Discontinued Before Treatment|Overall Study||0
7736639|NCT01579305|19049024|P2|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142
7736640|NCT01579305|19049025|P1|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139
7736641|NCT01579214|19049033|P2|NOT COMPLETED|Overall Study||0
7736642|NCT01579214|19049034|P1|NOT COMPLETED|Overall Study||0
7736643|NCT01579214|19049033|P2|COMPLETED|Overall Study||138
7736644|NCT01579214|19049034|P1|COMPLETED|Overall Study||45
7736645|NCT01579214|19049033|P2|STARTED|Overall Study||138
7736646|NCT01579214|19049034|P1|STARTED|Overall Study||45
7736647|NCT01579084|19049052|P10|NOT COMPLETED|Overall Study||0
7736648|NCT01579084|19049053|P9|NOT COMPLETED|Overall Study||0
7736649|NCT01579084|19049054|P8|NOT COMPLETED|Overall Study||0
7736650|NCT01579084|19049055|P7|NOT COMPLETED|Overall Study||0
7736651|NCT01579084|19049056|P6|NOT COMPLETED|Overall Study||0
7736652|NCT01579084|19049057|P5|NOT COMPLETED|Overall Study||0
7736653|NCT01579084|19049058|P4|NOT COMPLETED|Overall Study||0
7736654|NCT01579084|19049059|P3|NOT COMPLETED|Overall Study||0
7736655|NCT01579084|19049060|P2|NOT COMPLETED|Overall Study||0
7736656|NCT01579084|19049061|P1|NOT COMPLETED|Overall Study||0
7736657|NCT01579084|19049052|P10|COMPLETED|Overall Study||4
7736658|NCT01579084|19049053|P9|COMPLETED|Overall Study||4
7736659|NCT01579084|19049054|P8|COMPLETED|Overall Study||4
7736660|NCT01579084|19049055|P7|COMPLETED|Overall Study||4
7736661|NCT01579084|19049056|P6|COMPLETED|Overall Study||8
7736662|NCT01579084|19049057|P5|COMPLETED|Overall Study||8
7736663|NCT01579084|19049058|P4|COMPLETED|Overall Study||8
7736664|NCT01579084|19049059|P3|COMPLETED|Overall Study||8
7736665|NCT01579084|19049060|P2|COMPLETED|Overall Study||8
7736666|NCT01579084|19049061|P1|COMPLETED|Overall Study||8
7736667|NCT01579084|19049052|P10|STARTED|Overall Study||4
7736668|NCT01579084|19049053|P9|STARTED|Overall Study||4
7736669|NCT01579084|19049054|P8|STARTED|Overall Study||4
7736670|NCT01579084|19049055|P7|STARTED|Overall Study||4
7736671|NCT01579084|19049056|P6|STARTED|Overall Study||8
7736672|NCT01579084|19049057|P5|STARTED|Overall Study||8
7736673|NCT01579084|19049058|P4|STARTED|Overall Study||8
7736674|NCT01579084|19049059|P3|STARTED|Overall Study||8
7736675|NCT01579084|19049060|P2|STARTED|Overall Study||8
7736676|NCT01579084|19049061|P1|STARTED|Overall Study||8
7736677|NCT01579045|19049089|P1|NOT COMPLETED|Overall Study||0
7736678|NCT01579045|19049089|P1|COMPLETED|Overall Study||24
7736679|NCT01579045|19049089|P1|STARTED|Overall Study||24
7736680|NCT01579006|19049106|P1|NOT COMPLETED|Overall Study||33
7736681|NCT01579006|19049106|P1|COMPLETED|Overall Study||151
7736682|NCT01579006|19049106|P1|STARTED|Overall Study||184
7736683|NCT01578993|19049145|P1|NOT COMPLETED|Overall Study||0
7736684|NCT01578993|19049145|P1|COMPLETED|Overall Study||101
7736685|NCT01578993|19049145|P1|STARTED|Overall Study||101
7736686|NCT01578980|19049149|P1|NOT COMPLETED|Overall Study||0
7736687|NCT01578980|19049149|P1|COMPLETED|Overall Study||20
7736688|NCT01578980|19049149|P1|STARTED|Overall Study||20
7736689|NCT01578967|19049154|P1|NOT COMPLETED|Overall Study||0
7736690|NCT01578967|19049154|P1|COMPLETED|Overall Study||41
7736691|NCT01578967|19049154|P1|STARTED|Overall Study||41
7736692|NCT01578902|19049163|P1|NOT COMPLETED|Overall Study||0
7736693|NCT01578902|19049163|P1|COMPLETED|Overall Study||84
7736694|NCT01578902|19049163|P1|STARTED|Overall Study||84
7736695|NCT01578850|19049174|P3|NOT COMPLETED|Period 2||14
7736696|NCT01578850|19049175|P2|NOT COMPLETED|Period 2||13
7736697|NCT01578850|19049176|P1|NOT COMPLETED|Period 2||0
7736698|NCT01578850|19049174|P3|COMPLETED|Period 2||162
7736699|NCT01578850|19049175|P2|COMPLETED|Period 2||154
7736700|NCT01578850|19049176|P1|COMPLETED|Period 2||0
7736701|NCT01578850|19049174|P3|STARTED|Period 2|One participants in PBO did not receive treatment.|176
7736702|NCT01578850|19049175|P2|STARTED|Period 2|Two participants in ETN did not receive treatment.|167
7736703|NCT01578850|19049176|P1|STARTED|Period 2||0
7736704|NCT01578850|19049174|P3|NOT COMPLETED|Period 1||0
7736705|NCT01578850|19049175|P2|NOT COMPLETED|Period 1||0
7736706|NCT01578850|19049176|P1|NOT COMPLETED|Period 1||37
7736707|NCT01578850|19049174|P3|COMPLETED|Period 1||0
7736708|NCT01578850|19049175|P2|COMPLETED|Period 1||0
7736709|NCT01578850|19049176|P1|COMPLETED|Period 1||452
7736710|NCT01578850|19049174|P3|STARTED|Period 1||0
7736711|NCT01578850|19049175|P2|STARTED|Period 1||0
7736712|NCT01578850|19049176|P1|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489
7736713|NCT01578785|19049228|P2|NOT COMPLETED|Overall Study||119
7736714|NCT01578785|19049229|P1|NOT COMPLETED|Overall Study||59
7736715|NCT01578785|19049228|P2|COMPLETED|Overall Study||0
7736716|NCT01578785|19049229|P1|COMPLETED|Overall Study||0
7736717|NCT01578785|19049228|P2|STARTED|Overall Study||119
7736718|NCT01578785|19049229|P1|STARTED|Overall Study||59
7736719|NCT01578772|19049241|P1|NOT COMPLETED|Overall Study||0
7736720|NCT01578772|19049241|P1|COMPLETED|Overall Study||17
7736721|NCT01578772|19049241|P1|STARTED|Overall Study||17
7736722|NCT01578707|19049250|P2|NOT COMPLETED|Overall Study||0
7736723|NCT01578707|19049251|P1|NOT COMPLETED|Overall Study||0
7736724|NCT01578707|19049250|P2|COMPLETED|Overall Study||195
7736725|NCT01578707|19049251|P1|COMPLETED|Overall Study||196
7736726|NCT01578707|19049250|P2|STARTED|Overall Study||195
7736727|NCT01578707|19049251|P1|STARTED|Overall Study||196
7736728|NCT01578577|19049270|P3|NOT COMPLETED|Overall Study||35
7736729|NCT01578577|19049271|P2|NOT COMPLETED|Overall Study||40
7736730|NCT01578577|19049272|P1|NOT COMPLETED|Overall Study||51
7736731|NCT01578577|19049270|P3|COMPLETED|Overall Study||278
7736732|NCT01578577|19049271|P2|COMPLETED|Overall Study||262
7736733|NCT01578577|19049272|P1|COMPLETED|Overall Study||254
7736734|NCT01578577|19049270|P3|STARTED|Overall Study||313
7736735|NCT01578577|19049271|P2|STARTED|Overall Study||302
7736736|NCT01578577|19049272|P1|STARTED|Overall Study||305
7736737|NCT01578551|19049294|P2|NOT COMPLETED|Overall Study||0
7736738|NCT01578551|19049295|P1|NOT COMPLETED|Overall Study||1
7736739|NCT01578551|19049294|P2|COMPLETED|Overall Study||6
7736740|NCT01578551|19049295|P1|COMPLETED|Overall Study||18
7736741|NCT01578551|19049294|P2|STARTED|Overall Study||6
7736742|NCT01578551|19049295|P1|STARTED|Overall Study||19
7736743|NCT01578499|19049307|P2|NOT COMPLETED|Overall Study||43
7736744|NCT01578499|19049308|P1|NOT COMPLETED|Overall Study||34
7736745|NCT01578499|19049307|P2|COMPLETED|Overall Study||22
7736746|NCT01578499|19049308|P1|COMPLETED|Overall Study||32
7736747|NCT01578499|19049307|P2|Intent to Treat Population: CD30+|Overall Study||64
7736748|NCT01578499|19049308|P1|Intent to Treat Population: CD30+|Overall Study||64
7736749|NCT01578499|19049307|P2|Safety Population: Treated|Overall Study||62
7736750|NCT01578499|19049308|P1|Safety Population: Treated|Overall Study||66
7736751|NCT01578499|19049307|P2|STARTED|Overall Study||65
7736752|NCT01578499|19049308|P1|STARTED|Overall Study||66
7736753|NCT01578486|19049342|P1|NOT COMPLETED|Overall Study||5
7736754|NCT01578486|19049342|P1|COMPLETED|Overall Study||8
7736755|NCT01578486|19049342|P1|STARTED|Overall Study||13
7736756|NCT01578330|19049353|P1|NOT COMPLETED|Overall Study||7
7736757|NCT01578330|19049353|P1|COMPLETED|Overall Study||35
7736758|NCT01578330|19049353|P1|Per Protocol Population|Overall Study||35
7736759|NCT01578330|19049353|P1|STARTED|Overall Study||42
7736760|NCT01578317|19049362|P2|NOT COMPLETED|Overall Study||1
7736761|NCT01578317|19049363|P1|NOT COMPLETED|Overall Study||0
7736762|NCT01578317|19049362|P2|COMPLETED|Overall Study||20
7736763|NCT01578317|19049363|P1|COMPLETED|Overall Study||22
7736764|NCT01578317|19049362|P2|Analysis Population|Overall Study||20
7736765|NCT01578317|19049363|P1|Analysis Population|Overall Study||22
7736766|NCT01578317|19049362|P2|STARTED|Overall Study||21
7736767|NCT01578317|19049363|P1|STARTED|Overall Study||22
7736768|NCT01578278|19049373|P4|NOT COMPLETED|Overall Study||9
7736769|NCT01578278|19049374|P3|NOT COMPLETED|Overall Study||4
7736770|NCT01578278|19049375|P2|NOT COMPLETED|Overall Study||2
7736771|NCT01578278|19049376|P1|NOT COMPLETED|Overall Study||4
7736772|NCT01578278|19049373|P4|COMPLETED|Overall Study||139
7736773|NCT01578278|19049374|P3|COMPLETED|Overall Study||150
7736774|NCT01578278|19049375|P2|COMPLETED|Overall Study||150
7736775|NCT01578278|19049376|P1|COMPLETED|Overall Study||148
7736776|NCT01578278|19049373|P4|STARTED|Overall Study||148
7736777|NCT01578278|19049374|P3|STARTED|Overall Study||154
7736778|NCT01578278|19049375|P2|STARTED|Overall Study||152
7736779|NCT01578278|19049376|P1|STARTED|Overall Study||152
7736780|NCT01578239|19049388|P2|NOT COMPLETED|Overall Study||25
7736781|NCT01578239|19049389|P1|NOT COMPLETED|Overall Study||22
7736782|NCT01578239|19049388|P2|COMPLETED|Overall Study||88
7736783|NCT01578239|19049389|P1|COMPLETED|Overall Study||94
7736784|NCT01578239|19049388|P2|STARTED|Overall Study||113
7736785|NCT01578239|19049389|P1|STARTED|Overall Study||116
7736786|NCT01578187|19049395|P1|NOT COMPLETED|Usability Phase||1
7736787|NCT01578187|19049395|P1|COMPLETED|Usability Phase||47
7736788|NCT01578187|19049395|P1|STARTED|Usability Phase||48
7736789|NCT01578187|19049395|P1|NOT COMPLETED|Label Comprehension Phase||0
7736790|NCT01578187|19049395|P1|COMPLETED|Label Comprehension Phase||63
7736791|NCT01578187|19049395|P1|STARTED|Label Comprehension Phase||63
7736792|NCT01578044|19049403|P2|NOT COMPLETED|Overall Study||0
7736793|NCT01578044|19049404|P1|NOT COMPLETED|Overall Study||0
7736794|NCT01578044|19049403|P2|COMPLETED|Overall Study||6
7736795|NCT01578044|19049404|P1|COMPLETED|Overall Study||6
7736796|NCT01578044|19049403|P2|STARTED|Overall Study||6
7736797|NCT01578044|19049404|P1|STARTED|Overall Study||6
7736798|NCT01578031|19049414|P4|NOT COMPLETED|Overall Study||0
7736799|NCT01578031|19049415|P3|NOT COMPLETED|Overall Study||0
7736800|NCT01578031|19049416|P2|NOT COMPLETED|Overall Study||34
7736801|NCT01578031|19049417|P1|NOT COMPLETED|Overall Study||62
7736802|NCT01578031|19049414|P4|COMPLETED|Overall Study|Only baseline data collected|30
7736803|NCT01578031|19049415|P3|COMPLETED|Overall Study|Only baseline data collected|12
7736804|NCT01578031|19049416|P2|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|35
7736805|NCT01578031|19049417|P1|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|67
7736806|NCT01578031|19049414|P4|STARTED|Overall Study||30
7736807|NCT01578031|19049415|P3|STARTED|Overall Study||12
7736808|NCT01578031|19049416|P2|STARTED|Overall Study||69
7736809|NCT01578031|19049417|P1|STARTED|Overall Study||129
7736810|NCT01577966|19049433|P1|NOT COMPLETED|Overall Study||0
7736811|NCT01577966|19049433|P1|COMPLETED|Overall Study||9
7736812|NCT01577966|19049433|P1|STARTED|Overall Study||9
7736813|NCT01577758|19049437|P8|NOT COMPLETED|mCRC Expansion Phase||25
7736814|NCT01577758|19049438|P7|NOT COMPLETED|mCRC Expansion Phase||0
7736815|NCT01577758|19049439|P6|NOT COMPLETED|mCRC Expansion Phase||0
7736816|NCT01577758|19049440|P5|NOT COMPLETED|mCRC Expansion Phase||0
7736817|NCT01577758|19049441|P4|NOT COMPLETED|mCRC Expansion Phase||0
7736818|NCT01577758|19049442|P3|NOT COMPLETED|mCRC Expansion Phase||0
7736819|NCT01577758|19049443|P2|NOT COMPLETED|mCRC Expansion Phase||0
7736820|NCT01577758|19049444|P1|NOT COMPLETED|mCRC Expansion Phase||0
7736821|NCT01577758|19049437|P8|COMPLETED|mCRC Expansion Phase||0
7736822|NCT01577758|19049438|P7|COMPLETED|mCRC Expansion Phase||0
7736823|NCT01577758|19049439|P6|COMPLETED|mCRC Expansion Phase||0
7736824|NCT01577758|19049440|P5|COMPLETED|mCRC Expansion Phase||0
7736825|NCT01577758|19049441|P4|COMPLETED|mCRC Expansion Phase||0
7736826|NCT01577758|19049442|P3|COMPLETED|mCRC Expansion Phase||0
7736827|NCT01577758|19049443|P2|COMPLETED|mCRC Expansion Phase||0
7736828|NCT01577758|19049444|P1|COMPLETED|mCRC Expansion Phase||0
7736829|NCT01577758|19049437|P8|STARTED|mCRC Expansion Phase||25
7736830|NCT01577758|19049438|P7|STARTED|mCRC Expansion Phase||0
7736831|NCT01577758|19049439|P6|STARTED|mCRC Expansion Phase||0
7736832|NCT01577758|19049440|P5|STARTED|mCRC Expansion Phase||0
7736833|NCT01577758|19049441|P4|STARTED|mCRC Expansion Phase||0
7736834|NCT01577758|19049442|P3|STARTED|mCRC Expansion Phase||0
7736835|NCT01577758|19049443|P2|STARTED|mCRC Expansion Phase||0
7736836|NCT01577758|19049444|P1|STARTED|mCRC Expansion Phase||0
7736837|NCT01577758|19049437|P8|NOT COMPLETED|Dose Escalation Phase||0
7736838|NCT01577758|19049438|P7|NOT COMPLETED|Dose Escalation Phase||1
7736839|NCT01577758|19049439|P6|NOT COMPLETED|Dose Escalation Phase||4
7736840|NCT01577758|19049440|P5|NOT COMPLETED|Dose Escalation Phase||6
7736841|NCT01577758|19049441|P4|NOT COMPLETED|Dose Escalation Phase||2
7736842|NCT01577758|19049442|P3|NOT COMPLETED|Dose Escalation Phase||2
7736843|NCT01577758|19049443|P2|NOT COMPLETED|Dose Escalation Phase||2
7736844|NCT01577758|19049444|P1|NOT COMPLETED|Dose Escalation Phase||2
7736845|NCT01577758|19049437|P8|COMPLETED|Dose Escalation Phase||0
7736846|NCT01577758|19049438|P7|COMPLETED|Dose Escalation Phase||0
7736847|NCT01577758|19049439|P6|COMPLETED|Dose Escalation Phase||0
7736848|NCT01577758|19049440|P5|COMPLETED|Dose Escalation Phase||0
7736849|NCT01577758|19049441|P4|COMPLETED|Dose Escalation Phase||0
7736850|NCT01577758|19049442|P3|COMPLETED|Dose Escalation Phase||0
7736851|NCT01577758|19049443|P2|COMPLETED|Dose Escalation Phase||0
7736852|NCT01577758|19049444|P1|COMPLETED|Dose Escalation Phase||0
7736853|NCT01577758|19049437|P8|STARTED|Dose Escalation Phase||0
7736854|NCT01577758|19049438|P7|STARTED|Dose Escalation Phase||1
7736855|NCT01577758|19049439|P6|STARTED|Dose Escalation Phase||4
7736856|NCT01577758|19049440|P5|STARTED|Dose Escalation Phase||6
7736857|NCT01577758|19049441|P4|STARTED|Dose Escalation Phase||2
7736858|NCT01577758|19049442|P3|STARTED|Dose Escalation Phase||2
7736859|NCT01577758|19049443|P2|STARTED|Dose Escalation Phase||2
7736860|NCT01577758|19049444|P1|STARTED|Dose Escalation Phase||2
7736861|NCT01577745|19049483|P6|NOT COMPLETED|Overall Study||4
7736862|NCT01577745|19049484|P5|NOT COMPLETED|Overall Study||5
7736863|NCT01577745|19049485|P4|NOT COMPLETED|Overall Study||6
7736864|NCT01577745|19049486|P3|NOT COMPLETED|Overall Study||2
7736865|NCT01577745|19049487|P2|NOT COMPLETED|Overall Study||3
7736866|NCT01577745|19049488|P1|NOT COMPLETED|Overall Study||3
7736867|NCT01577745|19049483|P6|COMPLETED|Overall Study||1
7736868|NCT01577745|19049484|P5|COMPLETED|Overall Study||0
7736869|NCT01577745|19049485|P4|COMPLETED|Overall Study||0
7736870|NCT01577745|19049486|P3|COMPLETED|Overall Study||1
7736871|NCT01577745|19049487|P2|COMPLETED|Overall Study||0
7736872|NCT01577745|19049488|P1|COMPLETED|Overall Study||0
7736873|NCT01577745|19049483|P6|STARTED|Overall Study||5
7736874|NCT01577745|19049484|P5|STARTED|Overall Study||5
7736875|NCT01577745|19049485|P4|STARTED|Overall Study||6
7736876|NCT01577745|19049486|P3|STARTED|Overall Study||3
7736877|NCT01577745|19049487|P2|STARTED|Overall Study||3
7736878|NCT01577745|19049488|P1|STARTED|Overall Study||3
7736879|NCT01577732|19049605|P1|NOT COMPLETED|Overall Study||0
7736880|NCT01577732|19049605|P1|COMPLETED|Overall Study||300
7736881|NCT01577732|19049605|P1|STARTED|Overall Study||300
7736882|NCT01577706|19049612|P3|NOT COMPLETED|Third Intervention (1 Day)||0
7736883|NCT01577706|19049613|P2|NOT COMPLETED|Third Intervention (1 Day)||0
7736884|NCT01577706|19049614|P1|NOT COMPLETED|Third Intervention (1 Day)||0
7736885|NCT01577706|19049612|P3|COMPLETED|Third Intervention (1 Day)||3
7736886|NCT01577706|19049613|P2|COMPLETED|Third Intervention (1 Day)||1
7736887|NCT01577706|19049614|P1|COMPLETED|Third Intervention (1 Day)||3
7736888|NCT01577706|19049612|P3|STARTED|Third Intervention (1 Day)||3
7736889|NCT01577706|19049613|P2|STARTED|Third Intervention (1 Day)||1
7736890|NCT01577706|19049614|P1|STARTED|Third Intervention (1 Day)||3
7736891|NCT01577706|19049612|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
7736892|NCT01577706|19049613|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
7736893|NCT01577706|19049614|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
7736894|NCT01577706|19049612|P3|COMPLETED|Washout (at Least 1 Week)||3
7736895|NCT01577706|19049613|P2|COMPLETED|Washout (at Least 1 Week)||1
7736896|NCT01577706|19049614|P1|COMPLETED|Washout (at Least 1 Week)||3
7736897|NCT01577706|19049612|P3|STARTED|Washout (at Least 1 Week)||3
7736898|NCT01577706|19049613|P2|STARTED|Washout (at Least 1 Week)||1
7736899|NCT01577706|19049614|P1|STARTED|Washout (at Least 1 Week)||3
7736900|NCT01577706|19049612|P3|NOT COMPLETED|Second Intervention (1 Day)||0
7736901|NCT01577706|19049613|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7736902|NCT01577706|19049614|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7736903|NCT01577706|19049612|P3|COMPLETED|Second Intervention (1 Day)||3
7736904|NCT01577706|19049613|P2|COMPLETED|Second Intervention (1 Day)||1
7736905|NCT01577706|19049614|P1|COMPLETED|Second Intervention (1 Day)||3
7736906|NCT01577706|19049612|P3|STARTED|Second Intervention (1 Day)||3
7736907|NCT01577706|19049613|P2|STARTED|Second Intervention (1 Day)||1
7736908|NCT01577706|19049614|P1|STARTED|Second Intervention (1 Day)||3
7736909|NCT01577706|19049612|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
7736910|NCT01577706|19049613|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
7736911|NCT01577706|19049614|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
7736912|NCT01577706|19049612|P3|COMPLETED|Washout (at Least 1 Week)||3
7736913|NCT01577706|19049613|P2|COMPLETED|Washout (at Least 1 Week)||1
7736914|NCT01577706|19049614|P1|COMPLETED|Washout (at Least 1 Week)||3
7736915|NCT01577706|19049612|P3|STARTED|Washout (at Least 1 Week)||3
7736916|NCT01577706|19049613|P2|STARTED|Washout (at Least 1 Week)||1
7736917|NCT01577706|19049614|P1|STARTED|Washout (at Least 1 Week)||3
7736918|NCT01577706|19049612|P3|NOT COMPLETED|First Intervention (1 Day)||0
7736919|NCT01577706|19049613|P2|NOT COMPLETED|First Intervention (1 Day)||0
7736920|NCT01577706|19049614|P1|NOT COMPLETED|First Intervention (1 Day)||0
7736921|NCT01577706|19049612|P3|COMPLETED|First Intervention (1 Day)||3
7736922|NCT01577706|19049613|P2|COMPLETED|First Intervention (1 Day)||1
7736923|NCT01577706|19049614|P1|COMPLETED|First Intervention (1 Day)||3
7736924|NCT01577706|19049612|P3|STARTED|First Intervention (1 Day)||3
7736925|NCT01577706|19049613|P2|STARTED|First Intervention (1 Day)||1
7736926|NCT01577706|19049614|P1|STARTED|First Intervention (1 Day)||3
7736927|NCT01577628|19049642|P3|NOT COMPLETED|Overall Study||2
7736928|NCT01577628|19049643|P2|NOT COMPLETED|Overall Study||0
7736929|NCT01577628|19049644|P1|NOT COMPLETED|Overall Study||0
7736930|NCT01577628|19049642|P3|COMPLETED|Overall Study||0
7736931|NCT01577628|19049643|P2|COMPLETED|Overall Study||0
7736932|NCT01577628|19049644|P1|COMPLETED|Overall Study||0
7736933|NCT01577628|19049642|P3|STARTED|Overall Study||2
7736934|NCT01577628|19049643|P2|STARTED|Overall Study||0
7736935|NCT01577628|19049644|P1|STARTED|Overall Study||0
7736936|NCT01577537|19049670|P2|NOT COMPLETED|Overall Study||7
7736937|NCT01577537|19049671|P1|NOT COMPLETED|Overall Study||8
7736938|NCT01577537|19049670|P2|COMPLETED|Overall Study||116
7736939|NCT01577537|19049671|P1|COMPLETED|Overall Study||120
7736940|NCT01577537|19049670|P2|STARTED|Overall Study||123
7736941|NCT01577537|19049671|P1|STARTED|Overall Study||128
7736942|NCT01577381|19049689|P4|NOT COMPLETED|Overall Study||2
7736943|NCT01577381|19049690|P3|NOT COMPLETED|Overall Study||3
7736944|NCT01577381|19049691|P2|NOT COMPLETED|Overall Study||3
7736945|NCT01577381|19049692|P1|NOT COMPLETED|Overall Study||2
7736946|NCT01577381|19049689|P4|COMPLETED|Overall Study||0
7736947|NCT01577381|19049690|P3|COMPLETED|Overall Study||0
7736948|NCT01577381|19049691|P2|COMPLETED|Overall Study||0
7736949|NCT01577381|19049692|P1|COMPLETED|Overall Study||0
7736950|NCT01577381|19049689|P4|STARTED|Overall Study||2
7736951|NCT01577381|19049690|P3|STARTED|Overall Study||3
7736952|NCT01577381|19049691|P2|STARTED|Overall Study||3
7736953|NCT01577381|19049692|P1|STARTED|Overall Study||2
7736954|NCT01577329|19049823|P2|NOT COMPLETED|Overall Study||0
7736955|NCT01577329|19049824|P1|NOT COMPLETED|Overall Study||3
7736956|NCT01577329|19049823|P2|COMPLETED|Overall Study||22
7736957|NCT01577329|19049824|P1|COMPLETED|Overall Study||16
7736958|NCT01577329|19049823|P2|STARTED|Overall Study||22
7736959|NCT01577329|19049824|P1|STARTED|Overall Study||19
7736960|NCT01577238|19049832|P2|NOT COMPLETED|Overall Study||12
7736961|NCT01577238|19049833|P1|NOT COMPLETED|Overall Study||10
7736962|NCT01577238|19049832|P2|COMPLETED|Overall Study||111
7736963|NCT01577238|19049833|P1|COMPLETED|Overall Study||117
7736964|NCT01577238|19049832|P2|STARTED|Overall Study||123
7736965|NCT01577238|19049833|P1|STARTED|Overall Study||127
7736966|NCT01577186|19049847|P1|NOT COMPLETED|Overall Study||130
7736967|NCT01577186|19049847|P1|COMPLETED|Overall Study||350
7736968|NCT01577186|19049847|P1|STARTED|Overall Study||480
7736969|NCT01577160|19049855|P1|NOT COMPLETED|Overall Study||98
7736970|NCT01577160|19049855|P1|COMPLETED|Overall Study||255
7736971|NCT01577160|19049855|P1|STARTED|Overall Study||353
7736972|NCT01577108|19049865|P2|NOT COMPLETED|Overall Study||6
7736973|NCT01577108|19049866|P1|NOT COMPLETED|Overall Study||5
7736974|NCT01577108|19049865|P2|COMPLETED|Overall Study||50
7736975|NCT01577108|19049866|P1|COMPLETED|Overall Study||49
7736976|NCT01577108|19049865|P2|STARTED|Overall Study||56
7736977|NCT01577108|19049866|P1|STARTED|Overall Study||54
7736978|NCT01576952|19049874|P2|NOT COMPLETED|Overall Study||55
7736979|NCT01576952|19049875|P1|NOT COMPLETED|Overall Study||41
7736980|NCT01576952|19049874|P2|COMPLETED|Overall Study||33
7736981|NCT01576952|19049875|P1|COMPLETED|Overall Study||139
7736982|NCT01576952|19049874|P2|mITT Population|Overall Study||85
7736983|NCT01576952|19049875|P1|mITT Population|Overall Study||168
7736984|NCT01576952|19049874|P2|Safety Population|Overall Study||85
7736985|NCT01576952|19049875|P1|Safety Population|Overall Study||169
7736986|NCT01576952|19049874|P2|STARTED|Overall Study||88
7736987|NCT01576952|19049875|P1|STARTED|Overall Study||180
7736988|NCT01576939|19049881|P1|NOT COMPLETED|Overall Study||0
7736989|NCT01576939|19049881|P1|COMPLETED|Overall Study||30
7736990|NCT01576939|19049881|P1|STARTED|Overall Study||30
7736991|NCT01576874|19049891|P2|NOT COMPLETED|Overall Study||0
7736992|NCT01576874|19049892|P1|NOT COMPLETED|Overall Study||0
7736993|NCT01576874|19049891|P2|COMPLETED|Overall Study||72
7736994|NCT01576874|19049892|P1|COMPLETED|Overall Study||72
7736995|NCT01576874|19049891|P2|STARTED|Overall Study||72
7736996|NCT01576874|19049892|P1|STARTED|Overall Study||72
7736997|NCT01576809|19049902|P1|NOT COMPLETED|Overall Study||0
7736998|NCT01576809|19049902|P1|COMPLETED|Overall Study||51
7736999|NCT01576809|19049902|P1|STARTED|Overall Study||51
7737000|NCT01576783|19049910|P2|NOT COMPLETED|Overall Study||17
7737001|NCT01576783|19049911|P1|NOT COMPLETED|Overall Study||20
7737002|NCT01576783|19049910|P2|COMPLETED|Overall Study||171
7737003|NCT01576783|19049911|P1|COMPLETED|Overall Study||169
7737004|NCT01576783|19049910|P2|STARTED|Overall Study||188
7737005|NCT01576783|19049911|P1|STARTED|Overall Study||189
7737006|NCT01576718|19049937|P7|NOT COMPLETED|Treatment Period||30
7737007|NCT01576718|19049938|P6|NOT COMPLETED|Treatment Period||48
7737008|NCT01576718|19049939|P5|NOT COMPLETED|Treatment Period||27
7737009|NCT01576718|19049940|P4|NOT COMPLETED|Treatment Period||31
7737010|NCT01576718|19049941|P3|NOT COMPLETED|Treatment Period||20
7737011|NCT01576718|19049942|P2|NOT COMPLETED|Treatment Period||25
7737012|NCT01576718|19049943|P1|NOT COMPLETED|Treatment Period||0
7737013|NCT01576718|19049937|P7|COMPLETED|Treatment Period||77
7737014|NCT01576718|19049938|P6|COMPLETED|Treatment Period||58
7737015|NCT01576718|19049939|P5|COMPLETED|Treatment Period||80
7737016|NCT01576718|19049940|P4|COMPLETED|Treatment Period||75
7737017|NCT01576718|19049941|P3|COMPLETED|Treatment Period||87
7737018|NCT01576718|19049942|P2|COMPLETED|Treatment Period||82
7737019|NCT01576718|19049943|P1|COMPLETED|Treatment Period||0
7737020|NCT01576718|19049937|P7|Efficacy Population (Full Analysis Set)|Treatment Period||103
7737021|NCT01576718|19049938|P6|Efficacy Population (Full Analysis Set)|Treatment Period||105
7737022|NCT01576718|19049939|P5|Efficacy Population (Full Analysis Set)|Treatment Period||107
7737023|NCT01576718|19049940|P4|Efficacy Population (Full Analysis Set)|Treatment Period||102
7737024|NCT01576718|19049941|P3|Efficacy Population (Full Analysis Set)|Treatment Period||106
7737025|NCT01576718|19049942|P2|Efficacy Population (Full Analysis Set)|Treatment Period||107
7737026|NCT01576718|19049943|P1|Efficacy Population (Full Analysis Set)|Treatment Period||0
7737027|NCT01576718|19049937|P7|Safety Population|Treatment Period||106
7737028|NCT01576718|19049938|P6|Safety Population|Treatment Period||106
7737029|NCT01576718|19049939|P5|Safety Population|Treatment Period||107
7737030|NCT01576718|19049940|P4|Safety Population|Treatment Period||106
7737031|NCT01576718|19049941|P3|Safety Population|Treatment Period||107
7737032|NCT01576718|19049942|P2|Safety Population|Treatment Period||107
7737033|NCT01576718|19049943|P1|Safety Population|Treatment Period||0
7737034|NCT01576718|19049937|P7|STARTED|Treatment Period||107
7737035|NCT01576718|19049938|P6|STARTED|Treatment Period||106
7737036|NCT01576718|19049939|P5|STARTED|Treatment Period||107
7737037|NCT01576718|19049940|P4|STARTED|Treatment Period||106
7737038|NCT01576718|19049941|P3|STARTED|Treatment Period||107
7737039|NCT01576718|19049942|P2|STARTED|Treatment Period||107
7737040|NCT01576718|19049943|P1|STARTED|Treatment Period||0
7737041|NCT01576718|19049937|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7737042|NCT01576718|19049938|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7737043|NCT01576718|19049939|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7737044|NCT01576718|19049940|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7737045|NCT01576718|19049941|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7737046|NCT01576718|19049942|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7737047|NCT01576718|19049943|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249
7737048|NCT01576718|19049937|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7737049|NCT01576718|19049938|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7737050|NCT01576718|19049939|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7737051|NCT01576718|19049940|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7737052|NCT01576718|19049941|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7737053|NCT01576718|19049942|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7737054|NCT01576718|19049943|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)|Participants randomized into the Treatment Period|640
7737055|NCT01576718|19049937|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
7737056|NCT01576718|19049938|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
7737057|NCT01576718|19049939|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
7737058|NCT01576718|19049940|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
7737059|NCT01576718|19049941|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
7737060|NCT01576718|19049942|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
7737061|NCT01576718|19049943|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||889
7737062|NCT01576705|19050039|P4|NOT COMPLETED|Overall Study||3
7737063|NCT01576705|19050040|P3|NOT COMPLETED|Overall Study||5
7737064|NCT01576705|19050041|P2|NOT COMPLETED|Overall Study||8
7737065|NCT01576705|19050042|P1|NOT COMPLETED|Overall Study||3
7737066|NCT01576705|19050039|P4|COMPLETED|Overall Study||41
7737067|NCT01576705|19050040|P3|COMPLETED|Overall Study||38
7737068|NCT01576705|19050041|P2|COMPLETED|Overall Study||37
7737069|NCT01576705|19050042|P1|COMPLETED|Overall Study||40
7737070|NCT01576705|19050039|P4|STARTED|Overall Study||44
7737071|NCT01576705|19050040|P3|STARTED|Overall Study||43
7737072|NCT01576705|19050041|P2|STARTED|Overall Study||45
7737073|NCT01576705|19050042|P1|STARTED|Overall Study||43
7737074|NCT01576588|19050056|P1|NOT COMPLETED|Overall Study||2
7737075|NCT01576588|19050056|P1|COMPLETED|Overall Study||23
7737076|NCT01576588|19050056|P1|STARTED|Overall Study||25
7737077|NCT01576575|19050063|P1|NOT COMPLETED|Buprenorphine + Ketoconazole||0
7737078|NCT01576575|19050063|P1|COMPLETED|Buprenorphine + Ketoconazole||14
7737079|NCT01576575|19050063|P1|STARTED|Buprenorphine + Ketoconazole||14
7737080|NCT01576575|19050063|P1|NOT COMPLETED|Buprenorphine + Grapefruit||1
7737081|NCT01576575|19050063|P1|COMPLETED|Buprenorphine + Grapefruit||14
7737082|NCT01576575|19050063|P1|STARTED|Buprenorphine + Grapefruit||15
7737083|NCT01576575|19050063|P1|NOT COMPLETED|Buprenorphine + Rifampin||3
7737084|NCT01576575|19050063|P1|COMPLETED|Buprenorphine + Rifampin||15
7737085|NCT01576575|19050063|P1|STARTED|Buprenorphine + Rifampin||18
7737086|NCT01576575|19050063|P1|NOT COMPLETED|Buprenorphine Control||3
7737087|NCT01576575|19050063|P1|COMPLETED|Buprenorphine Control||18
7737088|NCT01576575|19050063|P1|STARTED|Buprenorphine Control||21
7737089|NCT01576549|19050073|P1|NOT COMPLETED|Overall Study||2
7737090|NCT01576549|19050073|P1|COMPLETED|Overall Study||0
7737091|NCT01576549|19050073|P1|Completed Post-Treatment Follow-Up|Overall Study|Each participant discontinued dosing and completed the Post-Treatment Follow-Up Period.|2
7737092|NCT01576549|19050073|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
7737093|NCT01576549|19050073|P1|STARTED|Overall Study||2
7737094|NCT01576536|19050081|P1|NOT COMPLETED|Overall Study||0
7737095|NCT01576536|19050081|P1|COMPLETED|Overall Study||117
7737096|NCT01576536|19050081|P1|STARTED|Overall Study||117
7737097|NCT01576484|19050089|P2|NOT COMPLETED|Overall Study||19
7737098|NCT01576484|19050090|P1|NOT COMPLETED|Overall Study||5
7737099|NCT01576484|19050089|P2|COMPLETED|Overall Study||27
7737100|NCT01576484|19050090|P1|COMPLETED|Overall Study||7
7737101|NCT01576484|19050089|P2|STARTED|Overall Study||46
7737102|NCT01576484|19050090|P1|STARTED|Overall Study||12
7737103|NCT01576471|19050156|P2|NOT COMPLETED|Overall Study||9
7737104|NCT01576471|19050157|P1|NOT COMPLETED|Overall Study||8
7737105|NCT01576471|19050156|P2|COMPLETED|Overall Study||116
7737106|NCT01576471|19050157|P1|COMPLETED|Overall Study||117
7737107|NCT01576471|19050156|P2|STARTED|Overall Study||125
7737108|NCT01576471|19050157|P1|STARTED|Overall Study||125
7737109|NCT01576406|19050169|P6|NOT COMPLETED|Overall Study||12
7737110|NCT01576406|19050170|P5|NOT COMPLETED|Overall Study||8
7737111|NCT01576406|19050171|P4|NOT COMPLETED|Overall Study||9
7737112|NCT01576406|19050172|P3|NOT COMPLETED|Overall Study||16
7737113|NCT01576406|19050173|P2|NOT COMPLETED|Overall Study||8
7737114|NCT01576406|19050174|P1|NOT COMPLETED|Overall Study||6
7737115|NCT01576406|19050169|P6|COMPLETED|Overall Study||4
7737116|NCT01576406|19050170|P5|COMPLETED|Overall Study||8
7737117|NCT01576406|19050171|P4|COMPLETED|Overall Study||1
7737118|NCT01576406|19050172|P3|COMPLETED|Overall Study||4
7737119|NCT01576406|19050173|P2|COMPLETED|Overall Study||7
7737120|NCT01576406|19050174|P1|COMPLETED|Overall Study||5
7737121|NCT01576406|19050169|P6|STARTED|Overall Study||16
7737122|NCT01576406|19050170|P5|STARTED|Overall Study||16
7737123|NCT01576406|19050171|P4|STARTED|Overall Study||10
7737124|NCT01576406|19050172|P3|STARTED|Overall Study||20
7737125|NCT01576406|19050173|P2|STARTED|Overall Study||15
7737126|NCT01576406|19050174|P1|STARTED|Overall Study||11
7737127|NCT01576367|19050422|P1|NOT COMPLETED|Overall Study||3
7737128|NCT01576367|19050422|P1|COMPLETED|Overall Study||14
7737129|NCT01576367|19050422|P1|STARTED|Overall Study||17
7737130|NCT01576341|19050430|P1|NOT COMPLETED|Overall Study||93
7737131|NCT01576341|19050430|P1|COMPLETED|Overall Study||324
7737132|NCT01576341|19050430|P1|STARTED|Overall Study||417
7737133|NCT01576276|19050439|P2|NOT COMPLETED|Overall Study||11
7737134|NCT01576276|19050440|P1|NOT COMPLETED|Overall Study||8
7737135|NCT01576276|19050439|P2|COMPLETED|Overall Study||18
7737136|NCT01576276|19050440|P1|COMPLETED|Overall Study||14
7737137|NCT01576276|19050439|P2|STARTED|Overall Study||29
7737138|NCT01576276|19050440|P1|STARTED|Overall Study||22
7737139|NCT01576172|19050449|P2|NOT COMPLETED|Overall Study||1
7737140|NCT01576172|19050450|P1|NOT COMPLETED|Overall Study||5
7737141|NCT01576172|19050449|P2|COMPLETED|Overall Study||79
7737142|NCT01576172|19050450|P1|COMPLETED|Overall Study||74
7737143|NCT01576172|19050449|P2|STARTED|Overall Study||80
7737144|NCT01576172|19050450|P1|STARTED|Overall Study||79
7737145|NCT01576159|19050468|P4|NOT COMPLETED|Overall Study||1
7737146|NCT01576159|19050469|P3|NOT COMPLETED|Overall Study||1
7737147|NCT01576159|19050470|P2|NOT COMPLETED|Overall Study||1
7737148|NCT01576159|19050471|P1|NOT COMPLETED|Overall Study||1
7737149|NCT01576159|19050468|P4|COMPLETED|Overall Study||11
7737150|NCT01576159|19050469|P3|COMPLETED|Overall Study||11
7737151|NCT01576159|19050470|P2|COMPLETED|Overall Study||11
7737152|NCT01576159|19050471|P1|COMPLETED|Overall Study||11
7737153|NCT01576159|19050468|P4|STARTED|Overall Study||12
7737154|NCT01576159|19050469|P3|STARTED|Overall Study||12
7737155|NCT01576159|19050470|P2|STARTED|Overall Study||12
7737156|NCT01576159|19050471|P1|STARTED|Overall Study||12
7737157|NCT01576146|19050489|P1|NOT COMPLETED|Extension Period 2||17
7737158|NCT01576146|19050489|P1|COMPLETED|Extension Period 2||0
7737159|NCT01576146|19050489|P1|STARTED|Extension Period 2|Three participants who completed Extension Period 1 did not enroll in Period 2|17
7737160|NCT01576146|19050489|P1|NOT COMPLETED|Extension Period 1||10
7737161|NCT01576146|19050489|P1|COMPLETED|Extension Period 1||20
7737162|NCT01576146|19050489|P1|STARTED|Extension Period 1||30
7737163|NCT01576120|19050498|P2|NOT COMPLETED|Overall Study||0
7737164|NCT01576120|19050499|P1|NOT COMPLETED|Overall Study||0
7737165|NCT01576120|19050498|P2|COMPLETED|Overall Study||19
7737166|NCT01576120|19050499|P1|COMPLETED|Overall Study||21
7737167|NCT01576120|19050498|P2|STARTED|Overall Study||19
7737168|NCT01576120|19050499|P1|STARTED|Overall Study||21
7737169|NCT01576055|19050507|P2|NOT COMPLETED|Overall Study||6
7737170|NCT01576055|19050508|P1|NOT COMPLETED|Overall Study||19
7737171|NCT01576055|19050507|P2|COMPLETED|Overall Study||64
7737172|NCT01576055|19050508|P1|COMPLETED|Overall Study||178
7737173|NCT01576055|19050507|P2|STARTED|Overall Study||70
7737174|NCT01576055|19050508|P1|STARTED|Overall Study||197
7737175|NCT01576042|19050522|P2|NOT COMPLETED|Overall Study||0
7737176|NCT01576042|19050523|P1|NOT COMPLETED|Overall Study||2
7737177|NCT01576042|19050522|P2|COMPLETED|Overall Study||14
7737178|NCT01576042|19050523|P1|COMPLETED|Overall Study||11
7737179|NCT01576042|19050522|P2|Switched to the Other Arm|Overall Study||1
7737180|NCT01576042|19050523|P1|Switched to the Other Arm|Overall Study||5
7737181|NCT01576042|19050522|P2|STARTED|Overall Study||14
7737182|NCT01576042|19050523|P1|STARTED|Overall Study||13
7737183|NCT01576016|19050545|P2|NOT COMPLETED|MRI Safety||74
7737184|NCT01576016|19050546|P1|NOT COMPLETED|MRI Safety||0
7737185|NCT01576016|19050545|P2|COMPLETED|MRI Safety||181
7737186|NCT01576016|19050546|P1|COMPLETED|MRI Safety||0
7737187|NCT01576016|19050545|P2|STARTED|MRI Safety|255 enrollments includes 30 supplemental scans performed in Australia using the same scan protocol.|255
7737188|NCT01576016|19050546|P1|STARTED|MRI Safety||0
7737189|NCT01576016|19050545|P2|NOT COMPLETED|Lead Safety||0
7737190|NCT01576016|19050546|P1|NOT COMPLETED|Lead Safety||273
7737191|NCT01576016|19050545|P2|COMPLETED|Lead Safety||0
7737192|NCT01576016|19050546|P1|COMPLETED|Lead Safety||647
7737193|NCT01576016|19050545|P2|STARTED|Lead Safety||0
7737194|NCT01576016|19050546|P1|STARTED|Lead Safety||920
7737195|NCT01576003|19050565|P3|NOT COMPLETED|Overall Study||0
7737196|NCT01576003|19050566|P2|NOT COMPLETED|Overall Study||2
7737197|NCT01576003|19050567|P1|NOT COMPLETED|Overall Study||1
7737198|NCT01576003|19050565|P3|COMPLETED|Overall Study||4
7737199|NCT01576003|19050566|P2|COMPLETED|Overall Study||1
7737200|NCT01576003|19050567|P1|COMPLETED|Overall Study||1
7737201|NCT01576003|19050565|P3|STARTED|Overall Study||4
7737202|NCT01576003|19050566|P2|STARTED|Overall Study||3
7737203|NCT01576003|19050567|P1|STARTED|Overall Study||2
7737204|NCT01575912|19050585|P3|NOT COMPLETED|Overall Study||0
7737205|NCT01575912|19050586|P2|NOT COMPLETED|Overall Study||0
7737206|NCT01575912|19050587|P1|NOT COMPLETED|Overall Study||0
7737207|NCT01575912|19050585|P3|COMPLETED|Overall Study||30
7737208|NCT01575912|19050586|P2|COMPLETED|Overall Study||32
7737209|NCT01575912|19050587|P1|COMPLETED|Overall Study||30
7737210|NCT01575912|19050585|P3|STARTED|Overall Study||30
7737211|NCT01575912|19050586|P2|STARTED|Overall Study||32
7737212|NCT01575912|19050587|P1|STARTED|Overall Study||30
7737213|NCT01575899|19050598|P3|NOT COMPLETED|Overall Study||2
7737214|NCT01575899|19050599|P2|NOT COMPLETED|Overall Study||5
7737215|NCT01575899|19050600|P1|NOT COMPLETED|Overall Study||5
7737216|NCT01575899|19050598|P3|COMPLETED|Overall Study||60
7737217|NCT01575899|19050599|P2|COMPLETED|Overall Study||68
7737218|NCT01575899|19050600|P1|COMPLETED|Overall Study||68
7737219|NCT01575899|19050598|P3|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62
7737220|NCT01575899|19050599|P2|STARTED|Overall Study||73
7737221|NCT01575899|19050600|P1|STARTED|Overall Study||73
7737222|NCT01575873|19050614|P4|NOT COMPLETED|Overall Study||67
7737223|NCT01575873|19050615|P3|NOT COMPLETED|Overall Study||74
7737224|NCT01575873|19050616|P2|NOT COMPLETED|Overall Study||36
7737225|NCT01575873|19050617|P1|NOT COMPLETED|Overall Study||28
7737226|NCT01575873|19050614|P4|COMPLETED|Overall Study||186
7737227|NCT01575873|19050615|P3|COMPLETED|Overall Study||178
7737228|NCT01575873|19050616|P2|COMPLETED|Overall Study||109
7737229|NCT01575873|19050617|P1|COMPLETED|Overall Study||117
7737230|NCT01575873|19050614|P4|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|251
7737231|NCT01575873|19050615|P3|Received Study Drug|Overall Study|Participants who received oral risedronate|246
7737232|NCT01575873|19050616|P2|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|142
7737233|NCT01575873|19050617|P1|Received Study Drug|Overall Study|Participants who received oral risedronate|140
7737234|NCT01575873|19050614|P4|STARTED|Overall Study||253
7737235|NCT01575873|19050615|P3|STARTED|Overall Study||252
7737236|NCT01575873|19050616|P2|STARTED|Overall Study||145
7737237|NCT01575873|19050617|P1|STARTED|Overall Study||145
7737238|NCT01575860|19050641|P1|NOT COMPLETED|Overall Study||2
7737239|NCT01575860|19050641|P1|COMPLETED|Overall Study||6
7737240|NCT01575860|19050641|P1|STARTED|Overall Study||8
7737241|NCT01575834|19050649|P2|NOT COMPLETED|Overall Study||738
7737242|NCT01575834|19050650|P1|NOT COMPLETED|Overall Study||699
7737243|NCT01575834|19050649|P2|COMPLETED|Overall Study|Completed 36-month study period|2851
7737244|NCT01575834|19050650|P1|COMPLETED|Overall Study|Completed 36-month study period|2892
7737245|NCT01575834|19050649|P2|Completed 24-month Study Period|Overall Study||2994
7737246|NCT01575834|19050650|P1|Completed 24-month Study Period|Overall Study||3032
7737247|NCT01575834|19050649|P2|Completed Double-blind Period|Overall Study||3185
7737248|NCT01575834|19050650|P1|Completed Double-blind Period|Overall Study||3205
7737249|NCT01575834|19050649|P2|Received Double-blind Treatment|Overall Study||3575
7737250|NCT01575834|19050650|P1|Received Double-blind Treatment|Overall Study|Six participants received a dose of romosozumab in error during the double-blind period.|3582
7737251|NCT01575834|19050649|P2|STARTED|Overall Study||3589
7737252|NCT01575834|19050650|P1|STARTED|Overall Study||3591
7737253|NCT01575808|19050702|P2|NOT COMPLETED|Overall Study||0
7737254|NCT01575808|19050703|P1|NOT COMPLETED|Overall Study||3
7737255|NCT01575808|19050702|P2|COMPLETED|Overall Study||68
7737256|NCT01575808|19050703|P1|COMPLETED|Overall Study|Study ongoing. All 103 assessed for primary invasiveness endpoints,100 for primary efficacy endpoint|100
7737257|NCT01575808|19050702|P2|STARTED|Overall Study||68
7737258|NCT01575808|19050703|P1|STARTED|Overall Study||103
7737259|NCT01575769|19050750|P1|NOT COMPLETED|Overall Study||41
7737260|NCT01575769|19050750|P1|COMPLETED|Overall Study||0
7737261|NCT01575769|19050750|P1|STARTED|Overall Study||41
7737262|NCT01575756|19050776|P2|NOT COMPLETED|Treatment Period 2||0
7737263|NCT01575756|19050777|P1|NOT COMPLETED|Treatment Period 2||0
7737264|NCT01575756|19050776|P2|COMPLETED|Treatment Period 2||11
7737265|NCT01575756|19050777|P1|COMPLETED|Treatment Period 2||11
7737266|NCT01575756|19050776|P2|STARTED|Treatment Period 2||11
7737267|NCT01575756|19050777|P1|STARTED|Treatment Period 2||11
7737268|NCT01575756|19050776|P2|NOT COMPLETED|Treatment Period 1||0
7737269|NCT01575756|19050777|P1|NOT COMPLETED|Treatment Period 1||0
7737270|NCT01575756|19050776|P2|COMPLETED|Treatment Period 1||11
7737271|NCT01575756|19050777|P1|COMPLETED|Treatment Period 1||11
7737272|NCT01575756|19050776|P2|STARTED|Treatment Period 1||11
7737273|NCT01575756|19050777|P1|STARTED|Treatment Period 1||11
7737274|NCT01575561|19050808|P1|NOT COMPLETED|Overall Study||39
7737275|NCT01575561|19050808|P1|COMPLETED|Overall Study||338
7737276|NCT01575561|19050808|P1|STARTED|Overall Study||377
7737277|NCT01575522|19050820|P1|NOT COMPLETED|Overall Study||0
7737278|NCT01575522|19050820|P1|COMPLETED|Overall Study||22
7737279|NCT01575522|19050820|P1|STARTED|Overall Study||22
7737280|NCT01575275|19050828|P1|NOT COMPLETED|Overall Study||0
7737281|NCT01575275|19050828|P1|COMPLETED|Overall Study||8
7737282|NCT01575275|19050828|P1|STARTED|Overall Study||8
7737283|NCT01575197|19050838|P3|NOT COMPLETED|Overall Study||6
7737284|NCT01575197|19050839|P2|NOT COMPLETED|Overall Study||9
7737285|NCT01575197|19050840|P1|NOT COMPLETED|Overall Study||3
7737286|NCT01575197|19050838|P3|COMPLETED|Overall Study||146
7737287|NCT01575197|19050839|P2|COMPLETED|Overall Study||143
7737288|NCT01575197|19050840|P1|COMPLETED|Overall Study||149
7737289|NCT01575197|19050838|P3|STARTED|Overall Study||152
7737290|NCT01575197|19050839|P2|STARTED|Overall Study||152
7737291|NCT01575197|19050840|P1|STARTED|Overall Study||152
7737292|NCT01575106|19050853|P1|NOT COMPLETED|Overall Study||14
7737293|NCT01575106|19050853|P1|COMPLETED|Overall Study||24
7737294|NCT01575106|19050853|P1|STARTED|Overall Study||38
7737295|NCT01575080|19050859|P1|NOT COMPLETED|Overall Study||0
7737296|NCT01575080|19050859|P1|COMPLETED|Overall Study||102
7737297|NCT01575080|19050859|P1|STARTED|Overall Study||102
7737298|NCT01575054|19050868|P2|NOT COMPLETED|Overall Study||26
7737299|NCT01575054|19050869|P1|NOT COMPLETED|Overall Study||29
7737300|NCT01575054|19050868|P2|COMPLETED|Overall Study||209
7737301|NCT01575054|19050869|P1|COMPLETED|Overall Study||204
7737302|NCT01575054|19050868|P2|STARTED|Overall Study||235
7737303|NCT01575054|19050869|P1|STARTED|Overall Study||233
7737304|NCT01575028|19050885|P2|NOT COMPLETED|Overall Study||1
7737305|NCT01575028|19050886|P1|NOT COMPLETED|Overall Study||0
7737306|NCT01575028|19050885|P2|COMPLETED|Overall Study||0
7737307|NCT01575028|19050886|P1|COMPLETED|Overall Study||2
7737308|NCT01575028|19050885|P2|STARTED|Overall Study||1
7737309|NCT01575028|19050886|P1|STARTED|Overall Study||2
7737310|NCT01574807|19050892|P2|NOT COMPLETED|Second Appointment||0
7737311|NCT01574807|19050893|P1|NOT COMPLETED|Second Appointment||0
7737312|NCT01574807|19050892|P2|COMPLETED|Second Appointment||50
7737313|NCT01574807|19050893|P1|COMPLETED|Second Appointment||50
7737314|NCT01574807|19050892|P2|STARTED|Second Appointment||50
7737315|NCT01574807|19050893|P1|STARTED|Second Appointment||50
7737316|NCT01574807|19050892|P2|NOT COMPLETED|Wash Out Period 2 Weeks||0
7737317|NCT01574807|19050893|P1|NOT COMPLETED|Wash Out Period 2 Weeks||0
7737318|NCT01574807|19050892|P2|COMPLETED|Wash Out Period 2 Weeks||50
7737319|NCT01574807|19050893|P1|COMPLETED|Wash Out Period 2 Weeks||50
7737320|NCT01574807|19050892|P2|STARTED|Wash Out Period 2 Weeks||50
7737321|NCT01574807|19050893|P1|STARTED|Wash Out Period 2 Weeks||50
7737322|NCT01574807|19050892|P2|NOT COMPLETED|First Appointment||0
7737323|NCT01574807|19050893|P1|NOT COMPLETED|First Appointment||0
7737324|NCT01574807|19050892|P2|COMPLETED|First Appointment||50
7737325|NCT01574807|19050893|P1|COMPLETED|First Appointment||50
7737326|NCT01574807|19050892|P2|STARTED|First Appointment||50
7737327|NCT01574807|19050893|P1|STARTED|First Appointment||50
7737328|NCT01574716|19050903|P5|NOT COMPLETED|Part 2||70
7737329|NCT01574716|19050904|P4|NOT COMPLETED|Part 2||137
7737330|NCT01574716|19050905|P3|NOT COMPLETED|Part 2||0
7737331|NCT01574716|19050906|P2|NOT COMPLETED|Part 2||0
7737332|NCT01574716|19050907|P1|NOT COMPLETED|Part 2||0
7737333|NCT01574716|19050903|P5|COMPLETED|Part 2||0
7737334|NCT01574716|19050904|P4|COMPLETED|Part 2||2
7737335|NCT01574716|19050905|P3|COMPLETED|Part 2||0
7737336|NCT01574716|19050906|P2|COMPLETED|Part 2||0
7737337|NCT01574716|19050907|P1|COMPLETED|Part 2||0
7737338|NCT01574716|19050903|P5|Treated Participants|Part 2||67
7737339|NCT01574716|19050904|P4|Treated Participants|Part 2||140
7737340|NCT01574716|19050905|P3|Treated Participants|Part 2||0
7737341|NCT01574716|19050906|P2|Treated Participants|Part 2||0
7737342|NCT01574716|19050907|P1|Treated Participants|Part 2||0
7737343|NCT01574716|19050903|P5|STARTED|Part 2||70
7737344|NCT01574716|19050904|P4|STARTED|Part 2||139
7737345|NCT01574716|19050905|P3|STARTED|Part 2||0
7737346|NCT01574716|19050906|P2|STARTED|Part 2||0
7737347|NCT01574716|19050907|P1|STARTED|Part 2||0
7737348|NCT01574716|19050903|P5|NOT COMPLETED|Part 1||0
7737349|NCT01574716|19050904|P4|NOT COMPLETED|Part 1||0
7737350|NCT01574716|19050905|P3|NOT COMPLETED|Part 1||9
7737351|NCT01574716|19050906|P2|NOT COMPLETED|Part 1||4
7737352|NCT01574716|19050907|P1|NOT COMPLETED|Part 1||3
7737353|NCT01574716|19050903|P5|COMPLETED|Part 1||0
7737354|NCT01574716|19050904|P4|COMPLETED|Part 1||0
7737355|NCT01574716|19050905|P3|COMPLETED|Part 1||0
7737356|NCT01574716|19050906|P2|COMPLETED|Part 1||0
7737357|NCT01574716|19050907|P1|COMPLETED|Part 1||0
7737358|NCT01574716|19050903|P5|STARTED|Part 1||0
7737359|NCT01574716|19050904|P4|STARTED|Part 1||0
7737360|NCT01574716|19050905|P3|STARTED|Part 1||9
7737361|NCT01574716|19050906|P2|STARTED|Part 1||4
7737362|NCT01574716|19050907|P1|STARTED|Part 1||3
7737363|NCT01574703|19050930|P4|NOT COMPLETED|Overall Study||114
7737364|NCT01574703|19050931|P3|NOT COMPLETED|Overall Study||105
7737365|NCT01574703|19050932|P2|NOT COMPLETED|Overall Study||112
7737366|NCT01574703|19050933|P1|NOT COMPLETED|Overall Study||125
7737367|NCT01574703|19050930|P4|COMPLETED|Overall Study||1007
7737368|NCT01574703|19050931|P3|COMPLETED|Overall Study||1011
7737369|NCT01574703|19050932|P2|COMPLETED|Overall Study||1054
7737370|NCT01574703|19050933|P1|COMPLETED|Overall Study||1067
7737371|NCT01574703|19050930|P4|STARTED|Overall Study||1121
7737372|NCT01574703|19050931|P3|STARTED|Overall Study||1116
7737373|NCT01574703|19050932|P2|STARTED|Overall Study||1166
7737374|NCT01574703|19050933|P1|STARTED|Overall Study||1192
7737375|NCT01574651|19050977|P2|NOT COMPLETED|Overall Study||52
7737376|NCT01574651|19050978|P1|NOT COMPLETED|Overall Study||61
7737377|NCT01574651|19050977|P2|COMPLETED|Overall Study||406
7737378|NCT01574651|19050978|P1|COMPLETED|Overall Study||415
7737379|NCT01574651|19050977|P2|Per Protocol Set (PPS)|Overall Study||374
7737380|NCT01574651|19050978|P1|Per Protocol Set (PPS)|Overall Study||373
7737381|NCT01574651|19050977|P2|Full Analysis Set (FAS)|Overall Study||458
7737382|NCT01574651|19050978|P1|Full Analysis Set (FAS)|Overall Study||476
7737383|NCT01574651|19050977|P2|STARTED|Overall Study||458
7737384|NCT01574651|19050978|P1|STARTED|Overall Study||476
7737385|NCT01574612|19051000|P1|NOT COMPLETED|Overall Study||8
7737386|NCT01574612|19051000|P1|COMPLETED|Overall Study||46
7737387|NCT01574612|19051000|P1|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54
7737388|NCT01574352|19051006|P2|NOT COMPLETED|Overall Study||13
7737389|NCT01574352|19051007|P1|NOT COMPLETED|Overall Study||7
7737390|NCT01574352|19051006|P2|COMPLETED|Overall Study|Participated in the last follow up measurement.|38
7737391|NCT01574352|19051007|P1|COMPLETED|Overall Study|Participated in the last follow up measurement.|48
7737392|NCT01574352|19051006|P2|STARTED|Overall Study|56 participants where randomized, but 5 dropped out prior to baseline measurements.|51
7737393|NCT01574352|19051007|P1|STARTED|Overall Study|59 participants where randomized, but 4 dropped out prior to baseline measurements.|55
7737394|NCT01574326|19051019|P2|NOT COMPLETED|Overall Study||19
7737395|NCT01574326|19051020|P1|NOT COMPLETED|Overall Study||16
7737396|NCT01574326|19051019|P2|COMPLETED|Overall Study||31
7737397|NCT01574326|19051020|P1|COMPLETED|Overall Study||35
7737398|NCT01574326|19051019|P2|Treated|Overall Study||49
7737399|NCT01574326|19051020|P1|Treated|Overall Study||51
7737400|NCT01574326|19051019|P2|STARTED|Overall Study||50
7737401|NCT01574326|19051020|P1|STARTED|Overall Study||51
7737402|NCT01574287|19051031|P1|NOT COMPLETED|Overall Study||0
7737403|NCT01574287|19051031|P1|COMPLETED|Overall Study||4
7737404|NCT01574287|19051031|P1|STARTED|Overall Study||4
7737405|NCT01574248|19051038|P2|NOT COMPLETED|Overall Study||0
7737406|NCT01574248|19051039|P1|NOT COMPLETED|Overall Study||3
7737407|NCT01574248|19051038|P2|COMPLETED|Overall Study||18
7737408|NCT01574248|19051039|P1|COMPLETED|Overall Study||12
7737409|NCT01574248|19051038|P2|STARTED|Overall Study||18
7737410|NCT01574248|19051039|P1|STARTED|Overall Study||15
7737411|NCT01574183|19051059|P2|NOT COMPLETED|Overall Study||18
7737412|NCT01574183|19051060|P1|NOT COMPLETED|Overall Study||27
7737413|NCT01574183|19051059|P2|COMPLETED|Overall Study||17
7737414|NCT01574183|19051060|P1|COMPLETED|Overall Study||14
7737415|NCT01574183|19051059|P2|STARTED|Overall Study||35
7737416|NCT01574183|19051060|P1|STARTED|Overall Study||41
7737417|NCT01574157|19051072|P2|NOT COMPLETED|Overall Study||8
7737418|NCT01574157|19051073|P1|NOT COMPLETED|Overall Study||4
7737419|NCT01574157|19051072|P2|COMPLETED|Overall Study||31
7737420|NCT01574157|19051073|P1|COMPLETED|Overall Study||31
7737421|NCT01574157|19051072|P2|Month 3|Overall Study||33
7737422|NCT01574157|19051073|P1|Month 3|Overall Study||31
7737423|NCT01574157|19051072|P2|STARTED|Overall Study||39
7737424|NCT01574157|19051073|P1|STARTED|Overall Study||35
7737425|NCT01574144|19051089|P1|NOT COMPLETED|Overall Study||0
7737426|NCT01574144|19051089|P1|COMPLETED|Overall Study||70
7737427|NCT01574144|19051089|P1|STARTED|Overall Study||70
7737428|NCT01574105|19051096|P2|NOT COMPLETED|Overall Study||0
7737429|NCT01574105|19051097|P1|NOT COMPLETED|Overall Study||0
7737430|NCT01574105|19051096|P2|COMPLETED|Overall Study||37
7737431|NCT01574105|19051097|P1|COMPLETED|Overall Study||29
7737432|NCT01574105|19051096|P2|STARTED|Overall Study||37
7737433|NCT01574105|19051097|P1|STARTED|Overall Study||29
7737434|NCT01574079|19051107|P2|NOT COMPLETED|Overall Study||2
7737435|NCT01574079|19051108|P1|NOT COMPLETED|Overall Study||1
7737436|NCT01574079|19051107|P2|COMPLETED|Overall Study||13
7737437|NCT01574079|19051108|P1|COMPLETED|Overall Study||17
7737438|NCT01574079|19051107|P2|STARTED|Overall Study||15
7737439|NCT01574079|19051108|P1|STARTED|Overall Study||18
7737440|NCT01573949|19051118|P1|NOT COMPLETED|Overall Study||0
7737441|NCT01573949|19051118|P1|COMPLETED|Overall Study||7
7737442|NCT01573949|19051118|P1|STARTED|Overall Study||7
7737443|NCT01573910|19051127|P2|NOT COMPLETED|Overall Study||17
7737444|NCT01573910|19051128|P1|NOT COMPLETED|Overall Study||20
7737445|NCT01573910|19051127|P2|COMPLETED|Overall Study||476
7737446|NCT01573910|19051128|P1|COMPLETED|Overall Study||469
7737447|NCT01573910|19051127|P2|STARTED|Overall Study||493
7737448|NCT01573910|19051128|P1|STARTED|Overall Study||489
7737449|NCT01573767|19051140|P4|NOT COMPLETED|Overall Study||24
7737450|NCT01573767|19051141|P3|NOT COMPLETED|Overall Study||14
7737451|NCT01573767|19051142|P2|NOT COMPLETED|Overall Study||21
7737452|NCT01573767|19051143|P1|NOT COMPLETED|Overall Study||22
7737453|NCT01573767|19051140|P4|COMPLETED|Overall Study||90
7737454|NCT01573767|19051141|P3|COMPLETED|Overall Study||99
7737455|NCT01573767|19051142|P2|COMPLETED|Overall Study||93
7737456|NCT01573767|19051143|P1|COMPLETED|Overall Study||93
7737457|NCT01573767|19051140|P4|STARTED|Overall Study||114
7737458|NCT01573767|19051141|P3|STARTED|Overall Study||113
7737459|NCT01573767|19051142|P2|STARTED|Overall Study||114
7737460|NCT01573767|19051143|P1|STARTED|Overall Study||115
7737461|NCT01573624|19051177|P7|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
7737462|NCT01573624|19051178|P6|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
7737463|NCT01573624|19051179|P5|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||2
7737464|NCT01573624|19051180|P4|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
7737465|NCT01573624|19051181|P3|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
7737466|NCT01573624|19051182|P2|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
7737467|NCT01573624|19051183|P1|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
7737468|NCT01573624|19051177|P7|COMPLETED|Period 6 : Follow-up Period (7 Days)||48
7737469|NCT01573624|19051178|P6|COMPLETED|Period 6 : Follow-up Period (7 Days)||38
7737470|NCT01573624|19051179|P5|COMPLETED|Period 6 : Follow-up Period (7 Days)||49
7737471|NCT01573624|19051180|P4|COMPLETED|Period 6 : Follow-up Period (7 Days)||53
7737472|NCT01573624|19051181|P3|COMPLETED|Period 6 : Follow-up Period (7 Days)||43
7737473|NCT01573624|19051182|P2|COMPLETED|Period 6 : Follow-up Period (7 Days)||47
7737474|NCT01573624|19051183|P1|COMPLETED|Period 6 : Follow-up Period (7 Days)||45
7737475|NCT01573624|19051177|P7|STARTED|Period 6 : Follow-up Period (7 Days)||48
7737476|NCT01573624|19051178|P6|STARTED|Period 6 : Follow-up Period (7 Days)||39
7737477|NCT01573624|19051179|P5|STARTED|Period 6 : Follow-up Period (7 Days)||51
7737478|NCT01573624|19051180|P4|STARTED|Period 6 : Follow-up Period (7 Days)||53
7737479|NCT01573624|19051181|P3|STARTED|Period 6 : Follow-up Period (7 Days)||43
7737480|NCT01573624|19051182|P2|STARTED|Period 6 : Follow-up Period (7 Days)||47
7737481|NCT01573624|19051183|P1|STARTED|Period 6 : Follow-up Period (7 Days)||46
7737482|NCT01573624|19051177|P7|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||4
7737483|NCT01573624|19051178|P6|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||2
7737484|NCT01573624|19051179|P5|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
7737485|NCT01573624|19051180|P4|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
7737486|NCT01573624|19051181|P3|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
7737487|NCT01573624|19051182|P2|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
7737488|NCT01573624|19051183|P1|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||3
7737489|NCT01573624|19051177|P7|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||48
7737490|NCT01573624|19051178|P6|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||39
7737491|NCT01573624|19051179|P5|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||51
7737492|NCT01573624|19051180|P4|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||53
7737493|NCT01573624|19051181|P3|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||43
7737494|NCT01573624|19051182|P2|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||47
7737495|NCT01573624|19051183|P1|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||46
7737496|NCT01573624|19051177|P7|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
7737497|NCT01573624|19051178|P6|STARTED|Period 5 : Treatment Period 3 (14 Days)||41
7737498|NCT01573624|19051179|P5|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
7737499|NCT01573624|19051180|P4|STARTED|Period 5 : Treatment Period 3 (14 Days)||53
7737500|NCT01573624|19051181|P3|STARTED|Period 5 : Treatment Period 3 (14 Days)||43
7737501|NCT01573624|19051182|P2|STARTED|Period 5 : Treatment Period 3 (14 Days)||48
7737502|NCT01573624|19051183|P1|STARTED|Period 5 : Treatment Period 3 (14 Days)||49
7737503|NCT01573624|19051177|P7|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||3
7737504|NCT01573624|19051178|P6|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
7737505|NCT01573624|19051179|P5|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
7737506|NCT01573624|19051180|P4|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
7737507|NCT01573624|19051181|P3|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
7737508|NCT01573624|19051182|P2|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||4
7737509|NCT01573624|19051183|P1|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
7737510|NCT01573624|19051177|P7|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
7737511|NCT01573624|19051178|P6|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||41
7737512|NCT01573624|19051179|P5|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
7737513|NCT01573624|19051180|P4|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||53
7737514|NCT01573624|19051181|P3|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||43
7737515|NCT01573624|19051182|P2|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||48
7737516|NCT01573624|19051183|P1|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||49
7737517|NCT01573624|19051177|P7|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
7737518|NCT01573624|19051178|P6|STARTED|Period 4 : Washout Period 2 (12-14 Days)||43
7737519|NCT01573624|19051179|P5|STARTED|Period 4 : Washout Period 2 (12-14 Days)||53
7737520|NCT01573624|19051180|P4|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
7737521|NCT01573624|19051181|P3|STARTED|Period 4 : Washout Period 2 (12-14 Days)||45
7737522|NCT01573624|19051182|P2|STARTED|Period 4 : Washout Period 2 (12-14 Days)||52
7737523|NCT01573624|19051183|P1|STARTED|Period 4 : Washout Period 2 (12-14 Days)||50
7737524|NCT01573624|19051177|P7|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||0
7737525|NCT01573624|19051178|P6|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||5
7737526|NCT01573624|19051179|P5|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
7737527|NCT01573624|19051180|P4|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||1
7737528|NCT01573624|19051181|P3|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
7737529|NCT01573624|19051182|P2|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||6
7737530|NCT01573624|19051183|P1|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||7
7737531|NCT01573624|19051177|P7|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
7737532|NCT01573624|19051178|P6|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||43
7737533|NCT01573624|19051179|P5|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||53
7737534|NCT01573624|19051180|P4|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
7737535|NCT01573624|19051181|P3|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||45
7737536|NCT01573624|19051182|P2|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||52
7737537|NCT01573624|19051183|P1|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||50
7737538|NCT01573624|19051177|P7|STARTED|Period 3 : Treatment Period 2 (14 Days)||55
7737539|NCT01573624|19051178|P6|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
7737540|NCT01573624|19051179|P5|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
7737541|NCT01573624|19051180|P4|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
7737542|NCT01573624|19051181|P3|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
7737543|NCT01573624|19051182|P2|STARTED|Period 3 : Treatment Period 2 (14 Days)||58
7737544|NCT01573624|19051183|P1|STARTED|Period 3 : Treatment Period 2 (14 Days)||57
7737545|NCT01573624|19051177|P7|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||2
7737546|NCT01573624|19051178|P6|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
7737547|NCT01573624|19051179|P5|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||0
7737548|NCT01573624|19051180|P4|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||5
7737549|NCT01573624|19051181|P3|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
7737550|NCT01573624|19051182|P2|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
7737551|NCT01573624|19051183|P1|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
7737552|NCT01573624|19051177|P7|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||55
7737553|NCT01573624|19051178|P6|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
7737554|NCT01573624|19051179|P5|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
7737555|NCT01573624|19051180|P4|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
7737556|NCT01573624|19051181|P3|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
7737557|NCT01573624|19051182|P2|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||58
7737558|NCT01573624|19051183|P1|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||57
7737559|NCT01573624|19051177|P7|STARTED|Period 2 : Washout Period 1 (12-14 Days)||57
7737560|NCT01573624|19051178|P6|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
7737561|NCT01573624|19051179|P5|STARTED|Period 2 : Washout Period 1 (12-14 Days)||56
7737562|NCT01573624|19051180|P4|STARTED|Period 2 : Washout Period 1 (12-14 Days)||61
7737563|NCT01573624|19051181|P3|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
7737564|NCT01573624|19051182|P2|STARTED|Period 2 : Washout Period 1 (12-14 Days)||59
7737565|NCT01573624|19051183|P1|STARTED|Period 2 : Washout Period 1 (12-14 Days)||58
7737566|NCT01573624|19051177|P7|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
7737567|NCT01573624|19051178|P6|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||4
7737568|NCT01573624|19051179|P5|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
7737569|NCT01573624|19051180|P4|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
7737570|NCT01573624|19051181|P3|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||9
7737571|NCT01573624|19051182|P2|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||3
7737572|NCT01573624|19051183|P1|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||6
7737573|NCT01573624|19051177|P7|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||57
7737574|NCT01573624|19051178|P6|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
7737575|NCT01573624|19051179|P5|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||56
7737576|NCT01573624|19051180|P4|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||61
7737577|NCT01573624|19051181|P3|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
7737578|NCT01573624|19051182|P2|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||59
7737579|NCT01573624|19051183|P1|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||58
7737580|NCT01573624|19051177|P7|STARTED|Period 1 : Treatment Period 1 (14 Days)||59
7737581|NCT01573624|19051178|P6|STARTED|Period 1 : Treatment Period 1 (14 Days)||55
7737582|NCT01573624|19051179|P5|STARTED|Period 1 : Treatment Period 1 (14 Days)||58
7737583|NCT01573624|19051180|P4|STARTED|Period 1 : Treatment Period 1 (14 Days)||63
7737584|NCT01573624|19051181|P3|STARTED|Period 1 : Treatment Period 1 (14 Days)||60
7737585|NCT01573624|19051182|P2|STARTED|Period 1 : Treatment Period 1 (14 Days)||62
7737586|NCT01573624|19051183|P1|STARTED|Period 1 : Treatment Period 1 (14 Days)||64
7737587|NCT01573572|19051230|P1|NOT COMPLETED|Overall Study||28
7737588|NCT01573572|19051230|P1|COMPLETED|Overall Study||103
7737589|NCT01573572|19051230|P1|STARTED|Overall Study||131
7737590|NCT01573533|19051234|P1|NOT COMPLETED|Overall Study||0
7737591|NCT01573533|19051234|P1|COMPLETED|Overall Study||9
7737592|NCT01573533|19051234|P1|STARTED|Overall Study||9
7737593|NCT01573442|19051243|P2|NOT COMPLETED|Overall Study||10
7737594|NCT01573442|19051244|P1|NOT COMPLETED|Overall Study||9
7737595|NCT01573442|19051243|P2|COMPLETED|Overall Study||104
7737596|NCT01573442|19051244|P1|COMPLETED|Overall Study||104
7737597|NCT01573442|19051243|P2|STARTED|Overall Study||114
7737598|NCT01573442|19051244|P1|STARTED|Overall Study||113
7737599|NCT01573325|19051280|P1|NOT COMPLETED|Overall Study||0
7737600|NCT01573325|19051280|P1|COMPLETED|Overall Study||50
7737601|NCT01573325|19051280|P1|STARTED|Overall Study||50
7737602|NCT01573273|19051289|P12|NOT COMPLETED|MRI 2||0
7737603|NCT01573273|19051290|P11|NOT COMPLETED|MRI 2||0
7737604|NCT01573273|19051291|P10|NOT COMPLETED|MRI 2||0
7737605|NCT01573273|19051292|P9|NOT COMPLETED|MRI 2||0
7737606|NCT01573273|19051293|P8|NOT COMPLETED|MRI 2||0
7737607|NCT01573273|19051294|P7|NOT COMPLETED|MRI 2||0
7737608|NCT01573273|19051295|P6|NOT COMPLETED|MRI 2||0
7737609|NCT01573273|19051296|P5|NOT COMPLETED|MRI 2||0
7737610|NCT01573273|19051297|P4|NOT COMPLETED|MRI 2||0
7737611|NCT01573273|19051298|P3|NOT COMPLETED|MRI 2||0
7737612|NCT01573273|19051299|P2|NOT COMPLETED|MRI 2||0
7737613|NCT01573273|19051300|P1|NOT COMPLETED|MRI 2||0
7737614|NCT01573273|19051289|P12|COMPLETED|MRI 2||28
7737615|NCT01573273|19051290|P11|COMPLETED|MRI 2||27
7737616|NCT01573273|19051291|P10|COMPLETED|MRI 2||0
7737617|NCT01573273|19051292|P9|COMPLETED|MRI 2||0
7737618|NCT01573273|19051293|P8|COMPLETED|MRI 2||0
7737619|NCT01573273|19051294|P7|COMPLETED|MRI 2||0
7737620|NCT01573273|19051295|P6|COMPLETED|MRI 2||18
7737621|NCT01573273|19051296|P5|COMPLETED|MRI 2||23
7737622|NCT01573273|19051297|P4|COMPLETED|MRI 2||0
7737623|NCT01573273|19051298|P3|COMPLETED|MRI 2||0
7737624|NCT01573273|19051299|P2|COMPLETED|MRI 2||0
7737625|NCT01573273|19051300|P1|COMPLETED|MRI 2||0
7737626|NCT01573273|19051289|P12|STARTED|MRI 2||28
7737627|NCT01573273|19051290|P11|STARTED|MRI 2||27
7737628|NCT01573273|19051291|P10|STARTED|MRI 2||0
7737629|NCT01573273|19051292|P9|STARTED|MRI 2||0
7737630|NCT01573273|19051293|P8|STARTED|MRI 2||0
7737631|NCT01573273|19051294|P7|STARTED|MRI 2||0
7737632|NCT01573273|19051295|P6|STARTED|MRI 2||18
7737633|NCT01573273|19051296|P5|STARTED|MRI 2||23
7737634|NCT01573273|19051297|P4|STARTED|MRI 2||0
7737635|NCT01573273|19051298|P3|STARTED|MRI 2||0
7737636|NCT01573273|19051299|P2|STARTED|MRI 2||0
7737637|NCT01573273|19051300|P1|STARTED|MRI 2||0
7737638|NCT01573273|19051289|P12|NOT COMPLETED|MRI 1||0
7737639|NCT01573273|19051290|P11|NOT COMPLETED|MRI 1||0
7737640|NCT01573273|19051291|P10|NOT COMPLETED|MRI 1||0
7737641|NCT01573273|19051292|P9|NOT COMPLETED|MRI 1||0
7737642|NCT01573273|19051293|P8|NOT COMPLETED|MRI 1||0
7737643|NCT01573273|19051294|P7|NOT COMPLETED|MRI 1||0
7737644|NCT01573273|19051295|P6|NOT COMPLETED|MRI 1||0
7737645|NCT01573273|19051296|P5|NOT COMPLETED|MRI 1||0
7737646|NCT01573273|19051297|P4|NOT COMPLETED|MRI 1||0
7737647|NCT01573273|19051298|P3|NOT COMPLETED|MRI 1||0
7737648|NCT01573273|19051299|P2|NOT COMPLETED|MRI 1||0
7737649|NCT01573273|19051300|P1|NOT COMPLETED|MRI 1||0
7737650|NCT01573273|19051289|P12|COMPLETED|MRI 1||0
7737651|NCT01573273|19051290|P11|COMPLETED|MRI 1||0
7737652|NCT01573273|19051291|P10|COMPLETED|MRI 1||29
7737653|NCT01573273|19051292|P9|COMPLETED|MRI 1||28
7737654|NCT01573273|19051293|P8|COMPLETED|MRI 1||0
7737655|NCT01573273|19051294|P7|COMPLETED|MRI 1||0
7737656|NCT01573273|19051295|P6|COMPLETED|MRI 1||0
7737657|NCT01573273|19051296|P5|COMPLETED|MRI 1||0
7737658|NCT01573273|19051297|P4|COMPLETED|MRI 1||23
7737659|NCT01573273|19051298|P3|COMPLETED|MRI 1||19
7737660|NCT01573273|19051299|P2|COMPLETED|MRI 1||0
7737661|NCT01573273|19051300|P1|COMPLETED|MRI 1||0
7737662|NCT01573273|19051289|P12|STARTED|MRI 1||0
7737663|NCT01573273|19051290|P11|STARTED|MRI 1||0
7737664|NCT01573273|19051291|P10|STARTED|MRI 1||29
7737665|NCT01573273|19051292|P9|STARTED|MRI 1||28
7737666|NCT01573273|19051293|P8|STARTED|MRI 1||0
7737667|NCT01573273|19051294|P7|STARTED|MRI 1||0
7737668|NCT01573273|19051295|P6|STARTED|MRI 1||0
7737669|NCT01573273|19051296|P5|STARTED|MRI 1||0
7737670|NCT01573273|19051297|P4|STARTED|MRI 1||23
7737671|NCT01573273|19051298|P3|STARTED|MRI 1||19
7737672|NCT01573273|19051299|P2|STARTED|MRI 1||0
7737673|NCT01573273|19051300|P1|STARTED|MRI 1||0
7737674|NCT01573273|19051289|P12|NOT COMPLETED|TSST : Trier Social Stress Task||0
7737675|NCT01573273|19051290|P11|NOT COMPLETED|TSST : Trier Social Stress Task||0
7737676|NCT01573273|19051291|P10|NOT COMPLETED|TSST : Trier Social Stress Task||0
7737677|NCT01573273|19051292|P9|NOT COMPLETED|TSST : Trier Social Stress Task||0
7737678|NCT01573273|19051293|P8|NOT COMPLETED|TSST : Trier Social Stress Task||0
7737679|NCT01573273|19051294|P7|NOT COMPLETED|TSST : Trier Social Stress Task||0
7737680|NCT01573273|19051295|P6|NOT COMPLETED|TSST : Trier Social Stress Task||0
7737681|NCT01573273|19051296|P5|NOT COMPLETED|TSST : Trier Social Stress Task||0
7737682|NCT01573273|19051297|P4|NOT COMPLETED|TSST : Trier Social Stress Task||0
7737683|NCT01573273|19051298|P3|NOT COMPLETED|TSST : Trier Social Stress Task||0
7737684|NCT01573273|19051299|P2|NOT COMPLETED|TSST : Trier Social Stress Task||0
7737685|NCT01573273|19051300|P1|NOT COMPLETED|TSST : Trier Social Stress Task||0
7737686|NCT01573273|19051289|P12|COMPLETED|TSST : Trier Social Stress Task||0
7737687|NCT01573273|19051290|P11|COMPLETED|TSST : Trier Social Stress Task||0
7737688|NCT01573273|19051291|P10|COMPLETED|TSST : Trier Social Stress Task||0
7737689|NCT01573273|19051292|P9|COMPLETED|TSST : Trier Social Stress Task||0
7737690|NCT01573273|19051293|P8|COMPLETED|TSST : Trier Social Stress Task||31
7737691|NCT01573273|19051294|P7|COMPLETED|TSST : Trier Social Stress Task||32
7737692|NCT01573273|19051295|P6|COMPLETED|TSST : Trier Social Stress Task||0
7737693|NCT01573273|19051296|P5|COMPLETED|TSST : Trier Social Stress Task||0
7737694|NCT01573273|19051297|P4|COMPLETED|TSST : Trier Social Stress Task||0
7737695|NCT01573273|19051298|P3|COMPLETED|TSST : Trier Social Stress Task||0
7737696|NCT01573273|19051299|P2|COMPLETED|TSST : Trier Social Stress Task||25
7737697|NCT01573273|19051300|P1|COMPLETED|TSST : Trier Social Stress Task||24
7737698|NCT01573273|19051289|P12|STARTED|TSST : Trier Social Stress Task||0
7737699|NCT01573273|19051290|P11|STARTED|TSST : Trier Social Stress Task||0
7737700|NCT01573273|19051291|P10|STARTED|TSST : Trier Social Stress Task||0
7737701|NCT01573273|19051292|P9|STARTED|TSST : Trier Social Stress Task||0
7737702|NCT01573273|19051293|P8|STARTED|TSST : Trier Social Stress Task||31
7737703|NCT01573273|19051294|P7|STARTED|TSST : Trier Social Stress Task||32
7737704|NCT01573273|19051295|P6|STARTED|TSST : Trier Social Stress Task||0
7737705|NCT01573273|19051296|P5|STARTED|TSST : Trier Social Stress Task||0
7737706|NCT01573273|19051297|P4|STARTED|TSST : Trier Social Stress Task||0
7737707|NCT01573273|19051298|P3|STARTED|TSST : Trier Social Stress Task||0
7737708|NCT01573273|19051299|P2|STARTED|TSST : Trier Social Stress Task||25
7737709|NCT01573273|19051300|P1|STARTED|TSST : Trier Social Stress Task||24
7737710|NCT01573260|19051340|P2|NOT COMPLETED|Overall Study||0
7737711|NCT01573260|19051341|P1|NOT COMPLETED|Overall Study||0
7737712|NCT01573260|19051340|P2|COMPLETED|Overall Study||15
7737713|NCT01573260|19051341|P1|COMPLETED|Overall Study||18
7737714|NCT01573260|19051340|P2|STARTED|Overall Study||15
7737715|NCT01573260|19051341|P1|STARTED|Overall Study||18
7737716|NCT01573052|19051375|P2|NOT COMPLETED|Overall Study||6
7737717|NCT01573052|19051376|P1|NOT COMPLETED|Overall Study||3
7737718|NCT01573052|19051375|P2|COMPLETED|Overall Study||11
7737719|NCT01573052|19051376|P1|COMPLETED|Overall Study||6
7737720|NCT01573052|19051375|P2|STARTED|Overall Study||17
7737721|NCT01573052|19051376|P1|STARTED|Overall Study||9
7737722|NCT01573000|19051388|P2|NOT COMPLETED|Long-Term Follow-Up||1
7737723|NCT01573000|19051389|P1|NOT COMPLETED|Long-Term Follow-Up||3
7737724|NCT01573000|19051388|P2|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4
7737725|NCT01573000|19051389|P1|COMPLETED|Long-Term Follow-Up||11
7737726|NCT01573000|19051388|P2|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5
7737727|NCT01573000|19051389|P1|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14
7737728|NCT01573000|19051388|P2|NOT COMPLETED|Crossover Phase||18
7737729|NCT01573000|19051389|P1|NOT COMPLETED|Crossover Phase||0
7737730|NCT01573000|19051388|P2|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1
7737731|NCT01573000|19051389|P1|COMPLETED|Crossover Phase||0
7737732|NCT01573000|19051388|P2|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19
7737733|NCT01573000|19051389|P1|STARTED|Crossover Phase||0
7737734|NCT01573000|19051388|P2|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
7737735|NCT01573000|19051389|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
7737736|NCT01573000|19051388|P2|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1
7737737|NCT01573000|19051389|P1|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7
7737738|NCT01573000|19051388|P2|STARTED|Dosimetric and Therapeutic Treatment||36
7737739|NCT01573000|19051389|P1|STARTED|Dosimetric and Therapeutic Treatment||42
7737740|NCT01572948|19051485|P2|NOT COMPLETED|Overall Study||1
7737741|NCT01572948|19051486|P1|NOT COMPLETED|Overall Study||1
7737742|NCT01572948|19051485|P2|COMPLETED|Overall Study||15
7737743|NCT01572948|19051486|P1|COMPLETED|Overall Study||10
7737744|NCT01572948|19051485|P2|STARTED|Overall Study||16
7737745|NCT01572948|19051486|P1|STARTED|Overall Study||11
7737746|NCT01572922|19051502|P1|NOT COMPLETED|Overall Study||3
7737747|NCT01572922|19051502|P1|COMPLETED|Overall Study||139
7737748|NCT01572922|19051502|P1|STARTED|Overall Study||142
7737749|NCT01572909|19051514|P2|NOT COMPLETED|Overall Study||25
7737750|NCT01572909|19051515|P1|NOT COMPLETED|Overall Study||32
7737751|NCT01572909|19051514|P2|COMPLETED|Overall Study||123
7737752|NCT01572909|19051515|P1|COMPLETED|Overall Study||120
7737753|NCT01572909|19051514|P2|STARTED|Overall Study||148
7737754|NCT01572909|19051515|P1|STARTED|Overall Study||152
7737755|NCT01572844|19051559|P2|NOT COMPLETED|Overall Study||1
7737756|NCT01572844|19051560|P1|NOT COMPLETED|Overall Study||1
7737757|NCT01572844|19051559|P2|COMPLETED|Overall Study||2
7737758|NCT01572844|19051560|P1|COMPLETED|Overall Study||2
7737759|NCT01572844|19051559|P2|STARTED|Overall Study||3
7737760|NCT01572844|19051560|P1|STARTED|Overall Study||3
7737761|NCT01572792|19051578|P5|NOT COMPLETED|Extension Study||32
7737762|NCT01572792|19051579|P4|NOT COMPLETED|Extension Study||29
7737763|NCT01572792|19051580|P3|NOT COMPLETED|Extension Study||26
7737764|NCT01572792|19051581|P2|NOT COMPLETED|Extension Study||29
7737765|NCT01572792|19051582|P1|NOT COMPLETED|Extension Study||25
7737766|NCT01572792|19051578|P5|COMPLETED|Extension Study||160
7737767|NCT01572792|19051579|P4|COMPLETED|Extension Study||165
7737768|NCT01572792|19051580|P3|COMPLETED|Extension Study||179
7737769|NCT01572792|19051581|P2|COMPLETED|Extension Study||155
7737770|NCT01572792|19051582|P1|COMPLETED|Extension Study||121
7737771|NCT01572792|19051578|P5|STARTED|Extension Study||192
7737772|NCT01572792|19051579|P4|STARTED|Extension Study||194
7737773|NCT01572792|19051580|P3|STARTED|Extension Study||205
7737774|NCT01572792|19051581|P2|STARTED|Extension Study||184
7737775|NCT01572792|19051582|P1|STARTED|Extension Study||146
7737776|NCT01572792|19051578|P5|NOT COMPLETED|Lead-in Study||69
7737777|NCT01572792|19051579|P4|NOT COMPLETED|Lead-in Study||72
7737778|NCT01572792|19051580|P3|NOT COMPLETED|Lead-in Study||62
7737779|NCT01572792|19051581|P2|NOT COMPLETED|Lead-in Study||66
7737780|NCT01572792|19051582|P1|NOT COMPLETED|Lead-in Study||101
7737781|NCT01572792|19051578|P5|COMPLETED|Lead-in Study||270
7737782|NCT01572792|19051579|P4|COMPLETED|Lead-in Study||268
7737783|NCT01572792|19051580|P3|COMPLETED|Lead-in Study||276
7737784|NCT01572792|19051581|P2|COMPLETED|Lead-in Study||272
7737785|NCT01572792|19051582|P1|COMPLETED|Lead-in Study||236
7737786|NCT01572792|19051578|P5|STARTED|Lead-in Study||339
7737787|NCT01572792|19051579|P4|STARTED|Lead-in Study||340
7737788|NCT01572792|19051580|P3|STARTED|Lead-in Study||338
7737789|NCT01572792|19051581|P2|STARTED|Lead-in Study||338
7737790|NCT01572792|19051582|P1|STARTED|Lead-in Study||337
7737791|NCT01572740|19051631|P2|NOT COMPLETED|Overall Study||5
7737792|NCT01572740|19051632|P1|NOT COMPLETED|Overall Study||6
7737793|NCT01572740|19051631|P2|COMPLETED|Overall Study||125
7737794|NCT01572740|19051632|P1|COMPLETED|Overall Study||121
7737795|NCT01572740|19051631|P2|STARTED|Overall Study||130
7737796|NCT01572740|19051632|P1|STARTED|Overall Study||127
7737797|NCT01572727|19051662|P2|NOT COMPLETED|Overall Study||209
7737798|NCT01572727|19051663|P1|NOT COMPLETED|Overall Study||207
7737799|NCT01572727|19051662|P2|COMPLETED|Overall Study||0
7737800|NCT01572727|19051663|P1|COMPLETED|Overall Study||0
7737801|NCT01572727|19051662|P2|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201
7737802|NCT01572727|19051663|P1|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202
7737803|NCT01572727|19051662|P2|STARTED|Overall Study||209
7737804|NCT01572727|19051663|P1|STARTED|Overall Study||207
7737805|NCT01572675|19051685|P2|NOT COMPLETED|Overall Study||223
7737806|NCT01572675|19051686|P1|NOT COMPLETED|Overall Study||237
7737807|NCT01572675|19051685|P2|COMPLETED|Overall Study||56
7737808|NCT01572675|19051686|P1|COMPLETED|Overall Study||31
7737809|NCT01572675|19051685|P2|STARTED|Overall Study||279
7737810|NCT01572675|19051686|P1|STARTED|Overall Study||268
7737811|NCT01572428|19051785|P2|NOT COMPLETED|Overall Study||1
7737812|NCT01572428|19051786|P1|NOT COMPLETED|Overall Study||3
7737813|NCT01572428|19051785|P2|COMPLETED|Overall Study||401
7737814|NCT01572428|19051786|P1|COMPLETED|Overall Study||399
7737815|NCT01572428|19051785|P2|STARTED|Overall Study||402
7737816|NCT01572428|19051786|P1|STARTED|Overall Study||402
7737817|NCT01572389|19051804|P2|NOT COMPLETED|Overall Study||21
7737818|NCT01572389|19051805|P1|NOT COMPLETED|Overall Study||46
7737819|NCT01572389|19051804|P2|COMPLETED|Overall Study||68
7737820|NCT01572389|19051805|P1|COMPLETED|Overall Study||90
7737821|NCT01572389|19051804|P2|STARTED|Overall Study||89
7737822|NCT01572389|19051805|P1|STARTED|Overall Study||136
7737823|NCT01572298|19051815|P2|NOT COMPLETED|Overall Study||1
7737824|NCT01572298|19051816|P1|NOT COMPLETED|Overall Study||2
7737825|NCT01572298|19051815|P2|COMPLETED|Overall Study||12
7737826|NCT01572298|19051816|P1|COMPLETED|Overall Study||12
7737827|NCT01572298|19051815|P2|STARTED|Overall Study||13
7737828|NCT01572298|19051816|P1|STARTED|Overall Study||14
7737829|NCT01572207|19051826|P2|NOT COMPLETED|Overall Study||3
7737830|NCT01572207|19051827|P1|NOT COMPLETED|Overall Study||2
7737831|NCT01572207|19051826|P2|COMPLETED|Overall Study||13
7737832|NCT01572207|19051827|P1|COMPLETED|Overall Study||12
7737833|NCT01572207|19051826|P2|STARTED|Overall Study||16
7737834|NCT01572207|19051827|P1|STARTED|Overall Study||14
7737835|NCT01572038|19051837|P1|NOT COMPLETED|Overall Study||991
7737836|NCT01572038|19051837|P1|COMPLETED|Overall Study||445
7737837|NCT01572038|19051837|P1|Received at Least One Dose of Study Drug|Overall Study||1436
7737838|NCT01572038|19051837|P1|STARTED|Overall Study|All participants who were enrolled in the study.|1436
7737839|NCT01571557|19051943|P1|NOT COMPLETED|Overall Study||0
7737840|NCT01571557|19051943|P1|COMPLETED|Overall Study||573
7737841|NCT01571557|19051943|P1|STARTED|Overall Study||573
7737842|NCT01571453|19051952|P2|NOT COMPLETED|Overall Study||62
7737843|NCT01571453|19051953|P1|NOT COMPLETED|Overall Study||38
7737844|NCT01571453|19051952|P2|COMPLETED|Overall Study||164
7737845|NCT01571453|19051953|P1|COMPLETED|Overall Study||173
7737846|NCT01571453|19051952|P2|STARTED|Overall Study||226
7737847|NCT01571453|19051953|P1|STARTED|Overall Study||211
7737848|NCT01571427|19051971|P2|NOT COMPLETED|Overall Study||0
7737849|NCT01571427|19051972|P1|NOT COMPLETED|Overall Study||0
7737850|NCT01571427|19051971|P2|COMPLETED|Overall Study||42
7737851|NCT01571427|19051972|P1|COMPLETED|Overall Study||41
7737852|NCT01571427|19051971|P2|STARTED|Overall Study||42
7737853|NCT01571427|19051972|P1|STARTED|Overall Study||41
7737854|NCT01571362|19052000|P3|NOT COMPLETED|Double-Blind Treatment Period||39
7737855|NCT01571362|19052001|P2|NOT COMPLETED|Double-Blind Treatment Period||53
7737856|NCT01571362|19052002|P1|NOT COMPLETED|Double-Blind Treatment Period||0
7737857|NCT01571362|19052000|P3|COMPLETED|Double-Blind Treatment Period||107
7737858|NCT01571362|19052001|P2|COMPLETED|Double-Blind Treatment Period||81
7737859|NCT01571362|19052002|P1|COMPLETED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
7737860|NCT01571362|19052000|P3|STARTED|Double-Blind Treatment Period||146
7737861|NCT01571362|19052001|P2|STARTED|Double-Blind Treatment Period||134
7737862|NCT01571362|19052002|P1|STARTED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
7737863|NCT01571362|19052000|P3|NOT COMPLETED|Open-Label Conversion + Titration Period||0
7737864|NCT01571362|19052001|P2|NOT COMPLETED|Open-Label Conversion + Titration Period||0
7737865|NCT01571362|19052002|P1|NOT COMPLETED|Open-Label Conversion + Titration Period||129
7737866|NCT01571362|19052000|P3|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
7737867|NCT01571362|19052001|P2|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
7737868|NCT01571362|19052002|P1|COMPLETED|Open-Label Conversion + Titration Period||281
7737869|NCT01571362|19052000|P3|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
7737870|NCT01571362|19052001|P2|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
7737871|NCT01571362|19052002|P1|STARTED|Open-Label Conversion + Titration Period||410
7737872|NCT01571284|19052172|P1|NOT COMPLETED|Overall Study||169
7737873|NCT01571284|19052172|P1|COMPLETED|Overall Study|403 participants with DP and 209 with adverse events were considered as completed.|612
7737874|NCT01571284|19052172|P1|Safety Population|Overall Study||779
7737875|NCT01571284|19052172|P1|STARTED|Overall Study||781
7737876|NCT01571232|19052195|P2|NOT COMPLETED|Overall Study||1
7737877|NCT01571232|19052196|P1|NOT COMPLETED|Overall Study||1
7737878|NCT01571232|19052195|P2|COMPLETED|Overall Study||9
7737879|NCT01571232|19052196|P1|COMPLETED|Overall Study||9
7737880|NCT01571232|19052195|P2|STARTED|Overall Study||10
7737881|NCT01571232|19052196|P1|STARTED|Overall Study||10
7737882|NCT01570868|19052208|P2|NOT COMPLETED|Overall Study||8
7737883|NCT01570868|19052209|P1|NOT COMPLETED|Overall Study||43
7737884|NCT01570868|19052208|P2|COMPLETED|Overall Study||0
7737885|NCT01570868|19052209|P1|COMPLETED|Overall Study||0
7737886|NCT01570868|19052208|P2|STARTED|Overall Study||8
7737887|NCT01570868|19052209|P1|STARTED|Overall Study||43
7737888|NCT01570751|19052221|P2|NOT COMPLETED|Period B (16 Weeks)||1
7737889|NCT01570751|19052222|P1|NOT COMPLETED|Period B (16 Weeks)||1
7737890|NCT01570751|19052221|P2|COMPLETED|Period B (16 Weeks)||66
7737891|NCT01570751|19052222|P1|COMPLETED|Period B (16 Weeks)||69
7737892|NCT01570751|19052221|P2|Exposed|Period B (16 Weeks)||67
7737893|NCT01570751|19052222|P1|Exposed|Period B (16 Weeks)||70
7737894|NCT01570751|19052221|P2|STARTED|Period B (16 Weeks)||67
7737895|NCT01570751|19052222|P1|STARTED|Period B (16 Weeks)||70
7737896|NCT01570751|19052221|P2|NOT COMPLETED|Period A (16 Weeks)||5
7737897|NCT01570751|19052222|P1|NOT COMPLETED|Period A (16 Weeks)||3
7737898|NCT01570751|19052221|P2|COMPLETED|Period A (16 Weeks)||67
7737899|NCT01570751|19052222|P1|COMPLETED|Period A (16 Weeks)||70
7737900|NCT01570751|19052221|P2|Exposed|Period A (16 Weeks)||72
7737901|NCT01570751|19052222|P1|Exposed|Period A (16 Weeks)||73
7737902|NCT01570751|19052221|P2|STARTED|Period A (16 Weeks)||72
7737903|NCT01570751|19052222|P1|STARTED|Period A (16 Weeks)||73
7737904|NCT01570686|19052240|P2|NOT COMPLETED|Overall Study||16
7737905|NCT01570686|19052241|P1|NOT COMPLETED|Overall Study||22
7737906|NCT01570686|19052240|P2|COMPLETED|Overall Study||278
7737907|NCT01570686|19052241|P1|COMPLETED|Overall Study||274
7737908|NCT01570686|19052240|P2|Safety and Full Analysis Set (FAS)|Overall Study||294
7737909|NCT01570686|19052241|P1|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295
7737910|NCT01570686|19052240|P2|STARTED|Overall Study||294
7737911|NCT01570686|19052241|P1|STARTED|Overall Study||296
7737912|NCT01570634|19052267|P1|NOT COMPLETED|Overall Study||0
7737913|NCT01570634|19052267|P1|COMPLETED|Overall Study||2
7737914|NCT01570634|19052267|P1|STARTED|Overall Study||2
7737915|NCT01570491|19052277|P2|NOT COMPLETED|Overall Study||1
7737916|NCT01570491|19052278|P1|NOT COMPLETED|Overall Study||5
7737917|NCT01570491|19052277|P2|COMPLETED|Overall Study||18
7737918|NCT01570491|19052278|P1|COMPLETED|Overall Study||14
7737919|NCT01570491|19052277|P2|STARTED|Overall Study||19
7737920|NCT01570491|19052278|P1|STARTED|Overall Study||19
7737921|NCT01570387|19052294|P4|NOT COMPLETED|Overall Study||2
7737922|NCT01570387|19052295|P3|NOT COMPLETED|Overall Study||0
7737923|NCT01570387|19052296|P2|NOT COMPLETED|Overall Study||0
7737924|NCT01570387|19052297|P1|NOT COMPLETED|Overall Study||1
7737925|NCT01570387|19052294|P4|COMPLETED|Overall Study||10
7737926|NCT01570387|19052295|P3|COMPLETED|Overall Study||6
7737927|NCT01570387|19052296|P2|COMPLETED|Overall Study||3
7737928|NCT01570387|19052297|P1|COMPLETED|Overall Study||5
7737929|NCT01570387|19052294|P4|Response to Maximal Tolerated Dose|Overall Study||6
7737930|NCT01570387|19052295|P3|Response to Maximal Tolerated Dose|Overall Study||3
7737931|NCT01570387|19052296|P2|Response to Maximal Tolerated Dose|Overall Study||0
7737932|NCT01570387|19052297|P1|Response to Maximal Tolerated Dose|Overall Study||0
7737933|NCT01570387|19052294|P4|Dose Limiting Toxicity|Overall Study||12
7737934|NCT01570387|19052295|P3|Dose Limiting Toxicity|Overall Study||6
7737935|NCT01570387|19052296|P2|Dose Limiting Toxicity|Overall Study||0
7737936|NCT01570387|19052297|P1|Dose Limiting Toxicity|Overall Study||0
7737937|NCT01570387|19052294|P4|STARTED|Overall Study||12
7737938|NCT01570387|19052295|P3|STARTED|Overall Study||6
7737939|NCT01570387|19052296|P2|STARTED|Overall Study||3
7737940|NCT01570387|19052297|P1|STARTED|Overall Study||6
7737941|NCT01570361|19052309|P2|NOT COMPLETED|Overall Study||75
7737942|NCT01570361|19052310|P1|NOT COMPLETED|Overall Study||82
7737943|NCT01570361|19052309|P2|COMPLETED|Overall Study||52
7737944|NCT01570361|19052310|P1|COMPLETED|Overall Study||46
7737945|NCT01570361|19052309|P2|AAD Therapy Only|Overall Study||108
7737946|NCT01570361|19052310|P1|AAD Therapy Only|Overall Study||0
7737947|NCT01570361|19052309|P2|Cross-over (AAD Therapy to RF Ablation)|Overall Study||15
7737948|NCT01570361|19052310|P1|Cross-over (AAD Therapy to RF Ablation)|Overall Study||0
7737949|NCT01570361|19052309|P2|Received Study Treatment|Overall Study||123
7737950|NCT01570361|19052310|P1|Received Study Treatment|Overall Study||102
7737951|NCT01570361|19052309|P2|STARTED|Overall Study||127
7737952|NCT01570361|19052310|P1|STARTED|Overall Study||128
7737953|NCT01570348|19052337|P1|NOT COMPLETED|Overall Study||0
7737954|NCT01570348|19052337|P1|COMPLETED|Overall Study||2
7737955|NCT01570348|19052337|P1|STARTED|Overall Study||2
7737956|NCT01570309|19052353|P2|NOT COMPLETED|Overall Study||3
7737957|NCT01570309|19052354|P1|NOT COMPLETED|Overall Study||3
7737958|NCT01570309|19052353|P2|COMPLETED|Overall Study||45
7737959|NCT01570309|19052354|P1|COMPLETED|Overall Study||45
7737960|NCT01570309|19052353|P2|STARTED|Overall Study||48
7737961|NCT01570309|19052354|P1|STARTED|Overall Study||48
7737962|NCT01570283|19052371|P6|NOT COMPLETED|Cohort 3: Dose Level 3||2
7737963|NCT01570283|19052372|P5|NOT COMPLETED|Cohort 3: Dose Level 3||0
7737964|NCT01570283|19052373|P4|NOT COMPLETED|Cohort 3: Dose Level 3||0
7737965|NCT01570283|19052374|P3|NOT COMPLETED|Cohort 3: Dose Level 3||0
7737966|NCT01570283|19052375|P2|NOT COMPLETED|Cohort 3: Dose Level 3||0
7737967|NCT01570283|19052376|P1|NOT COMPLETED|Cohort 3: Dose Level 3||0
7737968|NCT01570283|19052371|P6|COMPLETED|Cohort 3: Dose Level 3||10
7737969|NCT01570283|19052372|P5|COMPLETED|Cohort 3: Dose Level 3||1
7737970|NCT01570283|19052373|P4|COMPLETED|Cohort 3: Dose Level 3||0
7737971|NCT01570283|19052374|P3|COMPLETED|Cohort 3: Dose Level 3||0
7737972|NCT01570283|19052375|P2|COMPLETED|Cohort 3: Dose Level 3||0
7737973|NCT01570283|19052376|P1|COMPLETED|Cohort 3: Dose Level 3||0
7737974|NCT01570283|19052371|P6|STARTED|Cohort 3: Dose Level 3||12
7737975|NCT01570283|19052372|P5|STARTED|Cohort 3: Dose Level 3||1
7737976|NCT01570283|19052373|P4|STARTED|Cohort 3: Dose Level 3||0
7737977|NCT01570283|19052374|P3|STARTED|Cohort 3: Dose Level 3||0
7737978|NCT01570283|19052375|P2|STARTED|Cohort 3: Dose Level 3||0
7737979|NCT01570283|19052376|P1|STARTED|Cohort 3: Dose Level 3||0
7737980|NCT01570283|19052371|P6|NOT COMPLETED|Cohort 2: Dose Level 2||0
7737981|NCT01570283|19052372|P5|NOT COMPLETED|Cohort 2: Dose Level 2||0
7737982|NCT01570283|19052373|P4|NOT COMPLETED|Cohort 2: Dose Level 2||1
7737983|NCT01570283|19052374|P3|NOT COMPLETED|Cohort 2: Dose Level 2||1
7737984|NCT01570283|19052375|P2|NOT COMPLETED|Cohort 2: Dose Level 2||0
7737985|NCT01570283|19052376|P1|NOT COMPLETED|Cohort 2: Dose Level 2||0
7737986|NCT01570283|19052371|P6|COMPLETED|Cohort 2: Dose Level 2||0
7737987|NCT01570283|19052372|P5|COMPLETED|Cohort 2: Dose Level 2||0
7737988|NCT01570283|19052373|P4|COMPLETED|Cohort 2: Dose Level 2||1
7737989|NCT01570283|19052374|P3|COMPLETED|Cohort 2: Dose Level 2||1
7737990|NCT01570283|19052375|P2|COMPLETED|Cohort 2: Dose Level 2||0
7737991|NCT01570283|19052376|P1|COMPLETED|Cohort 2: Dose Level 2||0
7737992|NCT01570283|19052371|P6|STARTED|Cohort 2: Dose Level 2||0
7737993|NCT01570283|19052372|P5|STARTED|Cohort 2: Dose Level 2||0
7737994|NCT01570283|19052373|P4|STARTED|Cohort 2: Dose Level 2||2
7737995|NCT01570283|19052374|P3|STARTED|Cohort 2: Dose Level 2||2
7737996|NCT01570283|19052375|P2|STARTED|Cohort 2: Dose Level 2||0
7737997|NCT01570283|19052376|P1|STARTED|Cohort 2: Dose Level 2||0
7737998|NCT01570283|19052371|P6|NOT COMPLETED|Cohort 1: Dose Level 1||0
7737999|NCT01570283|19052372|P5|NOT COMPLETED|Cohort 1: Dose Level 1||0
7738000|NCT01570283|19052373|P4|NOT COMPLETED|Cohort 1: Dose Level 1||0
7738001|NCT01570283|19052374|P3|NOT COMPLETED|Cohort 1: Dose Level 1||0
7738002|NCT01570283|19052375|P2|NOT COMPLETED|Cohort 1: Dose Level 1||2
7738003|NCT01570283|19052376|P1|NOT COMPLETED|Cohort 1: Dose Level 1||0
7738004|NCT01570283|19052371|P6|COMPLETED|Cohort 1: Dose Level 1||0
7738005|NCT01570283|19052372|P5|COMPLETED|Cohort 1: Dose Level 1||0
7738006|NCT01570283|19052373|P4|COMPLETED|Cohort 1: Dose Level 1||0
7738007|NCT01570283|19052374|P3|COMPLETED|Cohort 1: Dose Level 1||0
7738008|NCT01570283|19052375|P2|COMPLETED|Cohort 1: Dose Level 1||1
7738009|NCT01570283|19052376|P1|COMPLETED|Cohort 1: Dose Level 1||1
7738010|NCT01570283|19052371|P6|STARTED|Cohort 1: Dose Level 1||0
7738011|NCT01570283|19052372|P5|STARTED|Cohort 1: Dose Level 1||0
7738012|NCT01570283|19052373|P4|STARTED|Cohort 1: Dose Level 1||0
7738013|NCT01570283|19052374|P3|STARTED|Cohort 1: Dose Level 1||0
7738014|NCT01570283|19052375|P2|STARTED|Cohort 1: Dose Level 1||3
7738015|NCT01570283|19052376|P1|STARTED|Cohort 1: Dose Level 1||1
7738016|NCT01570244|19052393|P1|NOT COMPLETED|Microgynon+Faldaprevir||1
7738017|NCT01570244|19052393|P1|COMPLETED|Microgynon+Faldaprevir||15
7738018|NCT01570244|19052393|P1|STARTED|Microgynon+Faldaprevir||16
7738019|NCT01570244|19052393|P1|NOT COMPLETED|Microgynon||0
7738020|NCT01570244|19052393|P1|COMPLETED|Microgynon||16
7738021|NCT01570244|19052393|P1|STARTED|Microgynon||16
7738022|NCT01570192|19052415|P2|NOT COMPLETED|Overall Study||13
7738023|NCT01570192|19052416|P1|NOT COMPLETED|Overall Study||7
7738024|NCT01570192|19052415|P2|COMPLETED|Overall Study||17
7738025|NCT01570192|19052416|P1|COMPLETED|Overall Study||6
7738026|NCT01570192|19052415|P2|STARTED|Overall Study||30
7738027|NCT01570192|19052416|P1|STARTED|Overall Study||13
7738028|NCT01570036|19052456|P2|NOT COMPLETED|Overall Study||122
7738029|NCT01570036|19052457|P1|NOT COMPLETED|Overall Study||118
7738030|NCT01570036|19052456|P2|COMPLETED|Overall Study||17
7738031|NCT01570036|19052457|P1|COMPLETED|Overall Study||18
7738032|NCT01570036|19052456|P2|Booster Series Completed|Overall Study||30
7738033|NCT01570036|19052457|P1|Booster Series Completed|Overall Study||40
7738034|NCT01570036|19052456|P2|Primary Vaccine Series Completed|Overall Study||132
7738035|NCT01570036|19052457|P1|Primary Vaccine Series Completed|Overall Study||121
7738036|NCT01570036|19052456|P2|STARTED|Overall Study||139
7738037|NCT01570036|19052457|P1|STARTED|Overall Study||136
7738038|NCT01569841|19052469|P2|NOT COMPLETED|Period B (6 Weeks)||0
7738039|NCT01569841|19052470|P1|NOT COMPLETED|Period B (6 Weeks)||0
7738040|NCT01569841|19052469|P2|COMPLETED|Period B (6 Weeks)||11
7738041|NCT01569841|19052470|P1|COMPLETED|Period B (6 Weeks)||12
7738042|NCT01569841|19052469|P2|Exposed|Period B (6 Weeks)||11
7738043|NCT01569841|19052470|P1|Exposed|Period B (6 Weeks)||12
7738044|NCT01569841|19052469|P2|STARTED|Period B (6 Weeks)||11
7738045|NCT01569841|19052470|P1|STARTED|Period B (6 Weeks)||12
7738046|NCT01569841|19052469|P2|NOT COMPLETED|Period A (6 Weeks)||1
7738047|NCT01569841|19052470|P1|NOT COMPLETED|Period A (6 Weeks)||0
7738048|NCT01569841|19052469|P2|COMPLETED|Period A (6 Weeks)||11
7738049|NCT01569841|19052470|P1|COMPLETED|Period A (6 Weeks)||12
7738050|NCT01569841|19052469|P2|Exposed|Period A (6 Weeks)||12
7738051|NCT01569841|19052470|P1|Exposed|Period A (6 Weeks)||12
7738052|NCT01569841|19052469|P2|STARTED|Period A (6 Weeks)||12
7738053|NCT01569841|19052470|P1|STARTED|Period A (6 Weeks)||12
7738054|NCT01569828|19052488|P2|NOT COMPLETED|Overall Study||0
7738055|NCT01569828|19052489|P1|NOT COMPLETED|Overall Study||0
7738056|NCT01569828|19052488|P2|COMPLETED|Overall Study||6
7738057|NCT01569828|19052489|P1|COMPLETED|Overall Study||6
7738058|NCT01569828|19052488|P2|STARTED|Overall Study||6
7738059|NCT01569828|19052489|P1|STARTED|Overall Study||6
7738060|NCT01569815|19052511|P4|NOT COMPLETED|Overall Study||0
7738061|NCT01569815|19052512|P3|NOT COMPLETED|Overall Study||0
7738062|NCT01569815|19052513|P2|NOT COMPLETED|Overall Study||0
7738063|NCT01569815|19052514|P1|NOT COMPLETED|Overall Study||0
7738064|NCT01569815|19052511|P4|COMPLETED|Overall Study||8
7738065|NCT01569815|19052512|P3|COMPLETED|Overall Study||8
7738066|NCT01569815|19052513|P2|COMPLETED|Overall Study||8
7738067|NCT01569815|19052514|P1|COMPLETED|Overall Study||8
7738068|NCT01569815|19052511|P4|STARTED|Overall Study||8
7738069|NCT01569815|19052512|P3|STARTED|Overall Study||8
7738070|NCT01569815|19052513|P2|STARTED|Overall Study||8
7738071|NCT01569815|19052514|P1|STARTED|Overall Study||8
7738072|NCT01569763|19052559|P2|NOT COMPLETED|Overall Study||7
7738073|NCT01569763|19052560|P1|NOT COMPLETED|Overall Study||3
7738074|NCT01569763|19052559|P2|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44
7738075|NCT01569763|19052560|P1|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99
7738076|NCT01569763|19052559|P2|Treated|Overall Study||51
7738077|NCT01569763|19052560|P1|Treated|Overall Study||102
7738078|NCT01569763|19052559|P2|STARTED|Overall Study||51
7738079|NCT01569763|19052560|P1|STARTED|Overall Study||102
7738080|NCT01569737|19052570|P1|NOT COMPLETED|Overall Study||3
7738081|NCT01569737|19052570|P1|COMPLETED|Overall Study||95
7738082|NCT01569737|19052570|P1|STARTED|Overall Study||98
7738083|NCT01569607|19052576|P2|NOT COMPLETED|Overall Study||1
7738084|NCT01569607|19052577|P1|NOT COMPLETED|Overall Study||1
7738085|NCT01569607|19052576|P2|COMPLETED|Overall Study||10
7738086|NCT01569607|19052577|P1|COMPLETED|Overall Study||10
7738087|NCT01569607|19052576|P2|STARTED|Overall Study||11
7738088|NCT01569607|19052577|P1|STARTED|Overall Study||11
7738089|NCT01569594|19052599|P1|NOT COMPLETED|Overall Study||67
7738090|NCT01569594|19052599|P1|COMPLETED|Overall Study||163
7738091|NCT01569594|19052599|P1|STARTED|Overall Study||230
7738092|NCT01569568|19052605|P2|NOT COMPLETED|Overall Study||2
7738093|NCT01569568|19052606|P1|NOT COMPLETED|Overall Study||0
7738094|NCT01569568|19052605|P2|COMPLETED|Overall Study||27
7738095|NCT01569568|19052606|P1|COMPLETED|Overall Study||20
7738096|NCT01569568|19052605|P2|STARTED|Overall Study||29
7738097|NCT01569568|19052606|P1|STARTED|Overall Study||20
7738098|NCT01569529|19052620|P2|NOT COMPLETED|Overall Study||0
7738099|NCT01569529|19052621|P1|NOT COMPLETED|Overall Study||0
7738100|NCT01569529|19052620|P2|COMPLETED|Overall Study||394
7738101|NCT01569529|19052621|P1|COMPLETED|Overall Study||2676
7738102|NCT01569529|19052620|P2|STARTED|Overall Study||394
7738103|NCT01569529|19052621|P1|STARTED|Overall Study||2676
7738104|NCT01569464|19052629|P2|NOT COMPLETED|Overall Study||5
7738105|NCT01569464|19052630|P1|NOT COMPLETED|Overall Study||10
7738106|NCT01569464|19052629|P2|COMPLETED|Overall Study||44
7738107|NCT01569464|19052630|P1|COMPLETED|Overall Study||91
7738108|NCT01569464|19052629|P2|STARTED|Overall Study||49
7738109|NCT01569464|19052630|P1|STARTED|Overall Study||101
7738110|NCT01569451|19052668|P2|NOT COMPLETED|Overall Study||13
7738111|NCT01569451|19052669|P1|NOT COMPLETED|Overall Study||14
7738112|NCT01569451|19052668|P2|COMPLETED|Overall Study||14
7738113|NCT01569451|19052669|P1|COMPLETED|Overall Study||12
7738114|NCT01569451|19052668|P2|STARTED|Overall Study||27
7738115|NCT01569451|19052669|P1|STARTED|Overall Study||26
7738116|NCT01569438|19052697|P2|NOT COMPLETED|Overall Study||22
7738117|NCT01569438|19052698|P1|NOT COMPLETED|Overall Study||7
7738118|NCT01569438|19052697|P2|COMPLETED|Overall Study||33
7738119|NCT01569438|19052698|P1|COMPLETED|Overall Study||45
7738120|NCT01569438|19052697|P2|Titration Set|Overall Study||36
7738121|NCT01569438|19052698|P1|Titration Set|Overall Study||38
7738122|NCT01569438|19052697|P2|Treated|Overall Study||54
7738123|NCT01569438|19052698|P1|Treated|Overall Study||51
7738124|NCT01569438|19052697|P2|STARTED|Overall Study||55
7738125|NCT01569438|19052698|P1|STARTED|Overall Study||52
7738126|NCT01569295|19052712|P2|NOT COMPLETED|Overall Study||209
7738127|NCT01569295|19052713|P1|NOT COMPLETED|Overall Study||207
7738128|NCT01569295|19052712|P2|COMPLETED|Overall Study||0
7738129|NCT01569295|19052713|P1|COMPLETED|Overall Study||0
7738130|NCT01569295|19052712|P2|Long-Term Follow-up|Overall Study||161
7738131|NCT01569295|19052713|P1|Long-Term Follow-up|Overall Study||109
7738132|NCT01569295|19052712|P2|STARTED|Overall Study||209
7738133|NCT01569295|19052713|P1|STARTED|Overall Study||207
7738134|NCT01569191|19052729|P2|NOT COMPLETED|Overall Study||0
7738135|NCT01569191|19052730|P1|NOT COMPLETED|Overall Study||0
7738136|NCT01569191|19052729|P2|COMPLETED|Overall Study||7
7738137|NCT01569191|19052730|P1|COMPLETED|Overall Study||11
7738138|NCT01569191|19052729|P2|STARTED|Overall Study||7
7738139|NCT01569191|19052730|P1|STARTED|Overall Study||11
7738140|NCT01569152|19052750|P3|NOT COMPLETED|Safety Extension, Period 3||55
7738141|NCT01569152|19052751|P2|NOT COMPLETED|Safety Extension, Period 3||0
7738142|NCT01569152|19052752|P1|NOT COMPLETED|Safety Extension, Period 3||0
7738143|NCT01569152|19052750|P3|COMPLETED|Safety Extension, Period 3||0
7738144|NCT01569152|19052751|P2|COMPLETED|Safety Extension, Period 3||0
7738145|NCT01569152|19052752|P1|COMPLETED|Safety Extension, Period 3||0
7738146|NCT01569152|19052750|P3|STARTED|Safety Extension, Period 3|Includes 29 completers and 26 early escapees from Base Study Phase IIa|55
7738147|NCT01569152|19052751|P2|STARTED|Safety Extension, Period 3||0
7738148|NCT01569152|19052752|P1|STARTED|Safety Extension, Period 3||0
7738149|NCT01569152|19052750|P3|NOT COMPLETED|Phase IIa, Period 1||0
7738150|NCT01569152|19052751|P2|NOT COMPLETED|Phase IIa, Period 1||32
7738151|NCT01569152|19052752|P1|NOT COMPLETED|Phase IIa, Period 1||21
7738152|NCT01569152|19052750|P3|COMPLETED|Phase IIa, Period 1||0
7738153|NCT01569152|19052751|P2|COMPLETED|Phase IIa, Period 1||9
7738154|NCT01569152|19052752|P1|COMPLETED|Phase IIa, Period 1||20
7738155|NCT01569152|19052750|P3|STARTED|Phase IIa, Period 1||0
7738156|NCT01569152|19052751|P2|STARTED|Phase IIa, Period 1||41
7738157|NCT01569152|19052752|P1|STARTED|Phase IIa, Period 1||41
7738158|NCT01569126|19052815|P6|NOT COMPLETED|Overall Study||0
7738159|NCT01569126|19052816|P5|NOT COMPLETED|Overall Study||0
7738160|NCT01569126|19052817|P4|NOT COMPLETED|Overall Study||0
7738161|NCT01569126|19052818|P3|NOT COMPLETED|Overall Study||0
7738162|NCT01569126|19052819|P2|NOT COMPLETED|Overall Study||0
7738163|NCT01569126|19052820|P1|NOT COMPLETED|Overall Study||0
7738164|NCT01569126|19052815|P6|COMPLETED|Overall Study||12
7738165|NCT01569126|19052816|P5|COMPLETED|Overall Study||12
7738166|NCT01569126|19052817|P4|COMPLETED|Overall Study||8
7738167|NCT01569126|19052818|P3|COMPLETED|Overall Study||8
7738168|NCT01569126|19052819|P2|COMPLETED|Overall Study||8
7738169|NCT01569126|19052820|P1|COMPLETED|Overall Study||8
7738170|NCT01569126|19052815|P6|Received at Least 1 Dose of Study Drug|Overall Study||12
7738171|NCT01569126|19052816|P5|Received at Least 1 Dose of Study Drug|Overall Study||12
7738172|NCT01569126|19052817|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
7738173|NCT01569126|19052818|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
7738174|NCT01569126|19052819|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
7738175|NCT01569126|19052820|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
7738176|NCT01569126|19052815|P6|STARTED|Overall Study||12
7738177|NCT01569126|19052816|P5|STARTED|Overall Study||12
7738178|NCT01569126|19052817|P4|STARTED|Overall Study||8
7738179|NCT01569126|19052818|P3|STARTED|Overall Study||8
7738180|NCT01569126|19052819|P2|STARTED|Overall Study||8
7738181|NCT01569126|19052820|P1|STARTED|Overall Study||8
7738182|NCT01569087|19052858|P3|NOT COMPLETED|Overall Study||1
7738183|NCT01569087|19052859|P2|NOT COMPLETED|Overall Study||0
7738184|NCT01569087|19052860|P1|NOT COMPLETED|Overall Study||1
7738185|NCT01569087|19052858|P3|COMPLETED|Overall Study||18
7738186|NCT01569087|19052859|P2|COMPLETED|Overall Study||20
7738187|NCT01569087|19052860|P1|COMPLETED|Overall Study||20
7738188|NCT01569087|19052858|P3|STARTED|Overall Study||19
7738189|NCT01569087|19052859|P2|STARTED|Overall Study||20
7738190|NCT01569087|19052860|P1|STARTED|Overall Study||21
7738191|NCT01569074|19052888|P5|NOT COMPLETED|Overall Study||8
7738192|NCT01569074|19052889|P4|NOT COMPLETED|Overall Study||8
7738193|NCT01569074|19052890|P3|NOT COMPLETED|Overall Study||12
7738194|NCT01569074|19052891|P2|NOT COMPLETED|Overall Study||9
7738195|NCT01569074|19052892|P1|NOT COMPLETED|Overall Study||7
7738196|NCT01569074|19052888|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
7738197|NCT01569074|19052889|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
7738198|NCT01569074|19052890|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21
7738199|NCT01569074|19052891|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
7738200|NCT01569074|19052892|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
7738201|NCT01569074|19052888|P5|Randomised But Did Not Receive Treatment|Overall Study||0
7738202|NCT01569074|19052889|P4|Randomised But Did Not Receive Treatment|Overall Study||0
7738203|NCT01569074|19052890|P3|Randomised But Did Not Receive Treatment|Overall Study||0
7738204|NCT01569074|19052891|P2|Randomised But Did Not Receive Treatment|Overall Study||0
7738205|NCT01569074|19052892|P1|Randomised But Did Not Receive Treatment|Overall Study||0
7738206|NCT01569074|19052888|P5|STARTED|Overall Study|Patients who received treatment|33
7738207|NCT01569074|19052889|P4|STARTED|Overall Study|Patients who received treatment|33
7738208|NCT01569074|19052890|P3|STARTED|Overall Study|Patients who received treatment|33
7738209|NCT01569074|19052891|P2|STARTED|Overall Study|Patients who received treatment|33
7738210|NCT01569074|19052892|P1|STARTED|Overall Study|Patients who received treatment|31
7738211|NCT01569022|19052948|P2|NOT COMPLETED|Second Intervention||2
7738212|NCT01569022|19052949|P1|NOT COMPLETED|Second Intervention||2
7738213|NCT01569022|19052948|P2|COMPLETED|Second Intervention||18
7738214|NCT01569022|19052949|P1|COMPLETED|Second Intervention||17
7738215|NCT01569022|19052948|P2|STARTED|Second Intervention||20
7738216|NCT01569022|19052949|P1|STARTED|Second Intervention||19
7738217|NCT01569022|19052948|P2|NOT COMPLETED|First Intervention||1
7738218|NCT01569022|19052949|P1|NOT COMPLETED|First Intervention||2
7738219|NCT01569022|19052948|P2|COMPLETED|First Intervention||20
7738220|NCT01569022|19052949|P1|COMPLETED|First Intervention||19
7738221|NCT01569022|19052948|P2|STARTED|First Intervention||21
7738222|NCT01569022|19052949|P1|STARTED|First Intervention||21
7738223|NCT01568944|19052963|P2|NOT COMPLETED|Overall Study||0
7738224|NCT01568944|19052964|P1|NOT COMPLETED|Overall Study||0
7738225|NCT01568944|19052963|P2|COMPLETED|Overall Study||10
7738226|NCT01568944|19052964|P1|COMPLETED|Overall Study||8
7738227|NCT01568944|19052963|P2|STARTED|Overall Study||10
7738228|NCT01568944|19052964|P1|STARTED|Overall Study||8
7738229|NCT01568905|19052983|P3|NOT COMPLETED|Overall Study||0
7738230|NCT01568905|19052984|P2|NOT COMPLETED|Overall Study||0
7738231|NCT01568905|19052985|P1|NOT COMPLETED|Overall Study||1
7738232|NCT01568905|19052983|P3|COMPLETED|Overall Study||12
7738233|NCT01568905|19052984|P2|COMPLETED|Overall Study||11
7738234|NCT01568905|19052985|P1|COMPLETED|Overall Study||12
7738235|NCT01568905|19052983|P3|STARTED|Overall Study||12
7738236|NCT01568905|19052984|P2|STARTED|Overall Study||11
7738237|NCT01568905|19052985|P1|STARTED|Overall Study||13
7738238|NCT01568892|19053004|P2|NOT COMPLETED|Open-label Phase||3
7738239|NCT01568892|19053005|P1|NOT COMPLETED|Open-label Phase||6
7738240|NCT01568892|19053004|P2|COMPLETED|Open-label Phase||13
7738241|NCT01568892|19053005|P1|COMPLETED|Open-label Phase||7
7738242|NCT01568892|19053004|P2|STARTED|Open-label Phase||16
7738243|NCT01568892|19053005|P1|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13
7738244|NCT01568892|19053004|P2|NOT COMPLETED|Double-blind Phase||0
7738245|NCT01568892|19053005|P1|NOT COMPLETED|Double-blind Phase||0
7738246|NCT01568892|19053004|P2|COMPLETED|Double-blind Phase||16
7738247|NCT01568892|19053005|P1|COMPLETED|Double-blind Phase||14
7738248|NCT01568892|19053004|P2|STARTED|Double-blind Phase||16
7738249|NCT01568892|19053005|P1|STARTED|Double-blind Phase||14
7738250|NCT01568866|19053075|P2|NOT COMPLETED|Overall Study||416
7738251|NCT01568866|19053076|P1|NOT COMPLETED|Overall Study||438
7738252|NCT01568866|19053075|P2|COMPLETED|Overall Study|Indicates participants still receiving treatment|48
7738253|NCT01568866|19053076|P1|COMPLETED|Overall Study|Indicates participants still receiving treatment|27
7738254|NCT01568866|19053075|P2|Received Treatment|Overall Study||463
7738255|NCT01568866|19053076|P1|Received Treatment|Overall Study||456
7738256|NCT01568866|19053075|P2|STARTED|Overall Study||464
7738257|NCT01568866|19053076|P1|STARTED|Overall Study||465
7738258|NCT01568827|19053098|P2|NOT COMPLETED|Intervention 2 (5 Days)||0
7738259|NCT01568827|19053099|P1|NOT COMPLETED|Intervention 2 (5 Days)||0
7738260|NCT01568827|19053098|P2|COMPLETED|Intervention 2 (5 Days)||5
7738261|NCT01568827|19053099|P1|COMPLETED|Intervention 2 (5 Days)||5
7738262|NCT01568827|19053098|P2|STARTED|Intervention 2 (5 Days)||5
7738263|NCT01568827|19053099|P1|STARTED|Intervention 2 (5 Days)||5
7738264|NCT01568827|19053098|P2|NOT COMPLETED|Washout (2 Days)||0
7738265|NCT01568827|19053099|P1|NOT COMPLETED|Washout (2 Days)||0
7738266|NCT01568827|19053098|P2|COMPLETED|Washout (2 Days)||5
7738267|NCT01568827|19053099|P1|COMPLETED|Washout (2 Days)||5
7738268|NCT01568827|19053098|P2|STARTED|Washout (2 Days)||5
7738269|NCT01568827|19053099|P1|STARTED|Washout (2 Days)||5
7738270|NCT01568827|19053098|P2|NOT COMPLETED|First Intervention (6 Days)||0
7738271|NCT01568827|19053099|P1|NOT COMPLETED|First Intervention (6 Days)||0
7738272|NCT01568827|19053098|P2|COMPLETED|First Intervention (6 Days)||5
7738273|NCT01568827|19053099|P1|COMPLETED|First Intervention (6 Days)||5
7738274|NCT01568827|19053098|P2|STARTED|First Intervention (6 Days)||5
7738275|NCT01568827|19053099|P1|STARTED|First Intervention (6 Days)||5
7738276|NCT01568606|19053105|P1|NOT COMPLETED|Overall Study||0
7738277|NCT01568606|19053105|P1|COMPLETED|Overall Study||20
7738278|NCT01568606|19053105|P1|STARTED|Overall Study||20
7738279|NCT01568593|19053111|P2|NOT COMPLETED|Overall Study||3
7738280|NCT01568593|19053112|P1|NOT COMPLETED|Overall Study||7
7738281|NCT01568593|19053111|P2|COMPLETED|Overall Study||42
7738282|NCT01568593|19053112|P1|COMPLETED|Overall Study||41
7738283|NCT01568593|19053111|P2|STARTED|Overall Study||45
7738284|NCT01568593|19053112|P1|STARTED|Overall Study||48
7738285|NCT01568528|19053121|P3|NOT COMPLETED|Overall Study||0
7738286|NCT01568528|19053122|P2|NOT COMPLETED|Overall Study||0
7738287|NCT01568528|19053123|P1|NOT COMPLETED|Overall Study||0
7738288|NCT01568528|19053121|P3|COMPLETED|Overall Study||9
7738289|NCT01568528|19053122|P2|COMPLETED|Overall Study||11
7738290|NCT01568528|19053123|P1|COMPLETED|Overall Study||19
7738291|NCT01568528|19053121|P3|STARTED|Overall Study||9
7738292|NCT01568528|19053122|P2|STARTED|Overall Study||11
7738293|NCT01568528|19053123|P1|STARTED|Overall Study||19
7738294|NCT01568424|19053143|P1|NOT COMPLETED|Overall Study||0
7738295|NCT01568424|19053143|P1|COMPLETED|Overall Study||25
7738296|NCT01568424|19053143|P1|STARTED|Overall Study||25
7738297|NCT01568112|19053157|P4|NOT COMPLETED|Overall Study||12
7738298|NCT01568112|19053158|P3|NOT COMPLETED|Overall Study||7
7738299|NCT01568112|19053159|P2|NOT COMPLETED|Overall Study||8
7738300|NCT01568112|19053160|P1|NOT COMPLETED|Overall Study||5
7738301|NCT01568112|19053157|P4|COMPLETED|Overall Study||30
7738302|NCT01568112|19053158|P3|COMPLETED|Overall Study||36
7738303|NCT01568112|19053159|P2|COMPLETED|Overall Study||36
7738304|NCT01568112|19053160|P1|COMPLETED|Overall Study||39
7738305|NCT01568112|19053157|P4|STARTED|Overall Study||42
7738306|NCT01568112|19053158|P3|STARTED|Overall Study||43
7738307|NCT01568112|19053159|P2|STARTED|Overall Study||44
7738308|NCT01568112|19053160|P1|STARTED|Overall Study||44
7738309|NCT01568073|19053283|P5|NOT COMPLETED|Overall Study||9
7738310|NCT01568073|19053284|P4|NOT COMPLETED|Overall Study||11
7738311|NCT01568073|19053285|P3|NOT COMPLETED|Overall Study||12
7738312|NCT01568073|19053286|P2|NOT COMPLETED|Overall Study||15
7738313|NCT01568073|19053287|P1|NOT COMPLETED|Overall Study||11
7738314|NCT01568073|19053283|P5|COMPLETED|Overall Study||107
7738315|NCT01568073|19053284|P4|COMPLETED|Overall Study||108
7738316|NCT01568073|19053285|P3|COMPLETED|Overall Study||110
7738317|NCT01568073|19053286|P2|COMPLETED|Overall Study||107
7738318|NCT01568073|19053287|P1|COMPLETED|Overall Study||110
7738319|NCT01568073|19053283|P5|STARTED|Overall Study||116
7738320|NCT01568073|19053284|P4|STARTED|Overall Study||119
7738321|NCT01568073|19053285|P3|STARTED|Overall Study||122
7738322|NCT01568073|19053286|P2|STARTED|Overall Study||122
7738323|NCT01568073|19053287|P1|STARTED|Overall Study||121
7738324|NCT01568047|19053318|P4|NOT COMPLETED|Overall Study||1
7738325|NCT01568047|19053319|P3|NOT COMPLETED|Overall Study||1
7738326|NCT01568047|19053320|P2|NOT COMPLETED|Overall Study||1
7738327|NCT01568047|19053321|P1|NOT COMPLETED|Overall Study||1
7738328|NCT01568047|19053318|P4|COMPLETED|Overall Study||9
7738329|NCT01568047|19053319|P3|COMPLETED|Overall Study||9
7738330|NCT01568047|19053320|P2|COMPLETED|Overall Study||9
7738331|NCT01568047|19053321|P1|COMPLETED|Overall Study||9
7738332|NCT01568047|19053318|P4|STARTED|Overall Study||10
7738333|NCT01568047|19053319|P3|STARTED|Overall Study||10
7738334|NCT01568047|19053320|P2|STARTED|Overall Study||10
7738335|NCT01568047|19053321|P1|STARTED|Overall Study||10
7738336|NCT01568034|19053339|P4|NOT COMPLETED|Overall Study||0
7738337|NCT01568034|19053340|P3|NOT COMPLETED|Overall Study||0
7738338|NCT01568034|19053341|P2|NOT COMPLETED|Overall Study||0
7738339|NCT01568034|19053342|P1|NOT COMPLETED|Overall Study||1
7738340|NCT01568034|19053339|P4|COMPLETED|Overall Study||3
7738341|NCT01568034|19053340|P3|COMPLETED|Overall Study||3
7738342|NCT01568034|19053341|P2|COMPLETED|Overall Study||2
7738343|NCT01568034|19053342|P1|COMPLETED|Overall Study||1
7738344|NCT01568034|19053339|P4|Placebo|Overall Study||3
7738345|NCT01568034|19053340|P3|Placebo|Overall Study||3
7738346|NCT01568034|19053341|P2|Placebo|Overall Study||2
7738347|NCT01568034|19053342|P1|Placebo|Overall Study||1
7738348|NCT01568034|19053339|P4|100 mg BIA 9-1067|Overall Study||3
7738349|NCT01568034|19053340|P3|100 mg BIA 9-1067|Overall Study||3
7738350|NCT01568034|19053341|P2|100 mg BIA 9-1067|Overall Study||2
7738351|NCT01568034|19053342|P1|100 mg BIA 9-1067|Overall Study||2
7738352|NCT01568034|19053339|P4|50 mg BIA 9-1067|Overall Study||3
7738353|NCT01568034|19053340|P3|50 mg BIA 9-1067|Overall Study||3
7738354|NCT01568034|19053341|P2|50 mg BIA 9-1067|Overall Study||2
7738355|NCT01568034|19053342|P1|50 mg BIA 9-1067|Overall Study||2
7738356|NCT01568034|19053339|P4|25 mg BIA 9-1067|Overall Study||3
7738357|NCT01568034|19053340|P3|25 mg BIA 9-1067|Overall Study||3
7738358|NCT01568034|19053341|P2|25 mg BIA 9-1067|Overall Study||2
7738359|NCT01568034|19053342|P1|25 mg BIA 9-1067|Overall Study||2
7738360|NCT01568034|19053339|P4|STARTED|Overall Study||3
7738361|NCT01568034|19053340|P3|STARTED|Overall Study||3
7738362|NCT01568034|19053341|P2|STARTED|Overall Study||2
7738363|NCT01568034|19053342|P1|STARTED|Overall Study||2
7738364|NCT01568021|19053360|P1|NOT COMPLETED|Overall Study||16
7738365|NCT01568021|19053360|P1|COMPLETED|Overall Study||83
7738366|NCT01568021|19053360|P1|STARTED|Overall Study||99
7738367|NCT01568008|19053366|P1|NOT COMPLETED|Overall Study||234
7738368|NCT01568008|19053366|P1|COMPLETED|Overall Study||699
7738369|NCT01568008|19053366|P1|STARTED|Overall Study||933
7738370|NCT01567943|19053377|P3|NOT COMPLETED|Overall Study||0
7738371|NCT01567943|19053378|P2|NOT COMPLETED|Overall Study||10
7738372|NCT01567943|19053379|P1|NOT COMPLETED|Overall Study||14
7738373|NCT01567943|19053377|P3|COMPLETED|Overall Study||44
7738374|NCT01567943|19053378|P2|COMPLETED|Overall Study||29
7738375|NCT01567943|19053379|P1|COMPLETED|Overall Study||26
7738376|NCT01567943|19053377|P3|STARTED|Overall Study||44
7738377|NCT01567943|19053378|P2|STARTED|Overall Study||39
7738378|NCT01567943|19053379|P1|STARTED|Overall Study||40
7738379|NCT01567891|19053387|P1|NOT COMPLETED|Overall Study||3
7738380|NCT01567891|19053387|P1|COMPLETED|Overall Study||6
7738381|NCT01567891|19053387|P1|Received T-cell|Overall Study||6
7738382|NCT01567891|19053387|P1|STARTED|Overall Study||9
7738383|NCT01567865|19053405|P4|NOT COMPLETED|Evaluated for Immunogenicity||30
7738384|NCT01567865|19053406|P3|NOT COMPLETED|Evaluated for Immunogenicity||19
7738385|NCT01567865|19053407|P2|NOT COMPLETED|Evaluated for Immunogenicity||25
7738386|NCT01567865|19053408|P1|NOT COMPLETED|Evaluated for Immunogenicity||17
7738387|NCT01567865|19053405|P4|COMPLETED|Evaluated for Immunogenicity||194
7738388|NCT01567865|19053406|P3|COMPLETED|Evaluated for Immunogenicity||192
7738389|NCT01567865|19053407|P2|COMPLETED|Evaluated for Immunogenicity||195
7738390|NCT01567865|19053408|P1|COMPLETED|Evaluated for Immunogenicity||146
7738391|NCT01567865|19053405|P4|STARTED|Evaluated for Immunogenicity||224
7738392|NCT01567865|19053406|P3|STARTED|Evaluated for Immunogenicity||211
7738393|NCT01567865|19053407|P2|STARTED|Evaluated for Immunogenicity||220
7738394|NCT01567865|19053408|P1|STARTED|Evaluated for Immunogenicity||163
7738395|NCT01567865|19053405|P4|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
7738396|NCT01567865|19053406|P3|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
7738397|NCT01567865|19053407|P2|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
7738398|NCT01567865|19053408|P1|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
7738399|NCT01567865|19053405|P4|COMPLETED|Enrolled and Vaccinated (Day 0)||224
7738400|NCT01567865|19053406|P3|COMPLETED|Enrolled and Vaccinated (Day 0)||211
7738401|NCT01567865|19053407|P2|COMPLETED|Enrolled and Vaccinated (Day 0)||220
7738402|NCT01567865|19053408|P1|COMPLETED|Enrolled and Vaccinated (Day 0)||163
7738403|NCT01567865|19053405|P4|STARTED|Enrolled and Vaccinated (Day 0)||224
7738404|NCT01567865|19053406|P3|STARTED|Enrolled and Vaccinated (Day 0)||211
7738405|NCT01567865|19053407|P2|STARTED|Enrolled and Vaccinated (Day 0)||220
7738406|NCT01567865|19053408|P1|STARTED|Enrolled and Vaccinated (Day 0)||163
7738407|NCT01567852|19053438|P2|NOT COMPLETED|Overall Study||7
7738408|NCT01567852|19053439|P1|NOT COMPLETED|Overall Study||4
7738409|NCT01567852|19053438|P2|COMPLETED|Overall Study||5
7738410|NCT01567852|19053439|P1|COMPLETED|Overall Study||4
7738411|NCT01567852|19053438|P2|STARTED|Overall Study||12
7738412|NCT01567852|19053439|P1|STARTED|Overall Study||8
7738413|NCT01567839|19053447|P1|NOT COMPLETED|Overall Study||0
7738414|NCT01567839|19053447|P1|COMPLETED|Overall Study||60
7738415|NCT01567839|19053447|P1|STARTED|Overall Study||60
7738416|NCT01567826|19053457|P2|NOT COMPLETED|Overall Study||2
7738417|NCT01567826|19053458|P1|NOT COMPLETED|Overall Study||3
7738418|NCT01567826|19053457|P2|COMPLETED|Overall Study||42
7738419|NCT01567826|19053458|P1|COMPLETED|Overall Study||40
7738420|NCT01567826|19053457|P2|STARTED|Overall Study||44
7738421|NCT01567826|19053458|P1|STARTED|Overall Study||43
7738422|NCT01567527|19053484|P5|NOT COMPLETED|Double-blind, Placebo-controlled Phase||95
7738423|NCT01567527|19053485|P4|NOT COMPLETED|Double-blind, Placebo-controlled Phase||69
7738424|NCT01567527|19053486|P3|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
7738425|NCT01567527|19053487|P2|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
7738426|NCT01567527|19053488|P1|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
7738427|NCT01567527|19053484|P5|COMPLETED|Double-blind, Placebo-controlled Phase||38
7738428|NCT01567527|19053485|P4|COMPLETED|Double-blind, Placebo-controlled Phase||64
7738429|NCT01567527|19053486|P3|COMPLETED|Double-blind, Placebo-controlled Phase||0
7738430|NCT01567527|19053487|P2|COMPLETED|Double-blind, Placebo-controlled Phase||0
7738431|NCT01567527|19053488|P1|COMPLETED|Double-blind, Placebo-controlled Phase||0
7738432|NCT01567527|19053484|P5|STARTED|Double-blind, Placebo-controlled Phase||133
7738433|NCT01567527|19053485|P4|STARTED|Double-blind, Placebo-controlled Phase||133
7738434|NCT01567527|19053486|P3|STARTED|Double-blind, Placebo-controlled Phase|Subjects were randomized to Aripiprazole IM Depot and placebo groups in this phase of the study|0
7738435|NCT01567527|19053487|P2|STARTED|Double-blind, Placebo-controlled Phase||0
7738436|NCT01567527|19053488|P1|STARTED|Double-blind, Placebo-controlled Phase||0
7738437|NCT01567527|19053484|P5|NOT COMPLETED|IM Depot Stabilization.||0
7738438|NCT01567527|19053485|P4|NOT COMPLETED|IM Depot Stabilization.||0
7738439|NCT01567527|19053486|P3|NOT COMPLETED|IM Depot Stabilization.||159
7738440|NCT01567527|19053487|P2|NOT COMPLETED|IM Depot Stabilization.||0
7738441|NCT01567527|19053488|P1|NOT COMPLETED|IM Depot Stabilization.||0
7738442|NCT01567527|19053484|P5|COMPLETED|IM Depot Stabilization.||0
7738443|NCT01567527|19053485|P4|COMPLETED|IM Depot Stabilization.||0
7738444|NCT01567527|19053486|P3|COMPLETED|IM Depot Stabilization.||266
7738445|NCT01567527|19053487|P2|COMPLETED|IM Depot Stabilization.||0
7738446|NCT01567527|19053488|P1|COMPLETED|IM Depot Stabilization.||0
7738447|NCT01567527|19053484|P5|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
7738448|NCT01567527|19053485|P4|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
7738449|NCT01567527|19053486|P3|STARTED|IM Depot Stabilization.||425
7738450|NCT01567527|19053487|P2|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
7738451|NCT01567527|19053488|P1|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
7738452|NCT01567527|19053484|P5|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
7738453|NCT01567527|19053485|P4|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
7738454|NCT01567527|19053486|P3|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
7738455|NCT01567527|19053487|P2|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||207
7738456|NCT01567527|19053488|P1|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
7738457|NCT01567527|19053484|P5|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
7738458|NCT01567527|19053485|P4|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
7738459|NCT01567527|19053486|P3|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
7738460|NCT01567527|19053487|P2|COMPLETED|Oral Aripiprazole Stabilization Phase.||425
7738461|NCT01567527|19053488|P1|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
7738462|NCT01567527|19053484|P5|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
7738463|NCT01567527|19053485|P4|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
7738464|NCT01567527|19053486|P3|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
7738465|NCT01567527|19053487|P2|STARTED|Oral Aripiprazole Stabilization Phase.|265 of the 632 subjects who started this phase entered the Oral Stabilization Phase directly.|632
7738466|NCT01567527|19053488|P1|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
7738467|NCT01567527|19053484|P5|NOT COMPLETED|Conversion Phase.||0
7738468|NCT01567527|19053485|P4|NOT COMPLETED|Conversion Phase.||0
7738469|NCT01567527|19053486|P3|NOT COMPLETED|Conversion Phase.||0
7738470|NCT01567527|19053487|P2|NOT COMPLETED|Conversion Phase.||0
7738471|NCT01567527|19053488|P1|NOT COMPLETED|Conversion Phase.||99
7738472|NCT01567527|19053484|P5|COMPLETED|Conversion Phase.||0
7738473|NCT01567527|19053485|P4|COMPLETED|Conversion Phase.||0
7738474|NCT01567527|19053486|P3|COMPLETED|Conversion Phase.||0
7738475|NCT01567527|19053487|P2|COMPLETED|Conversion Phase.||0
7738476|NCT01567527|19053488|P1|COMPLETED|Conversion Phase.||367
7738477|NCT01567527|19053484|P5|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
7738478|NCT01567527|19053485|P4|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
7738479|NCT01567527|19053486|P3|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
7738480|NCT01567527|19053487|P2|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
7738481|NCT01567527|19053488|P1|STARTED|Conversion Phase.||466
7738482|NCT01567462|19053505|P2|NOT COMPLETED|Overall Study||7
7738483|NCT01567462|19053506|P1|NOT COMPLETED|Overall Study||4
7738484|NCT01567462|19053505|P2|COMPLETED|Overall Study||38
7738485|NCT01567462|19053506|P1|COMPLETED|Overall Study||41
7738486|NCT01567462|19053505|P2|STARTED|Overall Study||45
7738487|NCT01567462|19053506|P1|STARTED|Overall Study||45
7738488|NCT01567371|19053518|P1|NOT COMPLETED|Overall Study||0
7738489|NCT01567371|19053518|P1|COMPLETED|Overall Study||30
7738490|NCT01567371|19053518|P1|STARTED|Overall Study||30
7738491|NCT01567306|19053529|P6|NOT COMPLETED|Overall Study||3
7738492|NCT01567306|19053530|P5|NOT COMPLETED|Overall Study||7
7738493|NCT01567306|19053531|P4|NOT COMPLETED|Overall Study||5
7738494|NCT01567306|19053532|P3|NOT COMPLETED|Overall Study||0
7738495|NCT01567306|19053533|P2|NOT COMPLETED|Overall Study||2
7738496|NCT01567306|19053534|P1|NOT COMPLETED|Overall Study||3
7738497|NCT01567306|19053529|P6|COMPLETED|Overall Study||23
7738498|NCT01567306|19053530|P5|COMPLETED|Overall Study||18
7738499|NCT01567306|19053531|P4|COMPLETED|Overall Study||19
7738500|NCT01567306|19053532|P3|COMPLETED|Overall Study||24
7738501|NCT01567306|19053533|P2|COMPLETED|Overall Study||23
7738502|NCT01567306|19053534|P1|COMPLETED|Overall Study||24
7738503|NCT01567306|19053529|P6|STARTED|Overall Study||26
7738504|NCT01567306|19053530|P5|STARTED|Overall Study||25
7738505|NCT01567306|19053531|P4|STARTED|Overall Study||24
7738506|NCT01567306|19053532|P3|STARTED|Overall Study||24
7738507|NCT01567306|19053533|P2|STARTED|Overall Study||25
7738508|NCT01567306|19053534|P1|STARTED|Overall Study||27
7738509|NCT01567163|19053548|P1|NOT COMPLETED|Overall Study||4
7738510|NCT01567163|19053548|P1|COMPLETED|Overall Study||18
7738511|NCT01567163|19053548|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18
7738512|NCT01567163|19053548|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
7738513|NCT01567163|19053548|P1|STARTED|Overall Study||22
7738514|NCT01567150|19053560|P2|NOT COMPLETED|Overall Study||2
7738515|NCT01567150|19053561|P1|NOT COMPLETED|Overall Study||2
7738516|NCT01567150|19053560|P2|COMPLETED|Overall Study||16
7738517|NCT01567150|19053561|P1|COMPLETED|Overall Study||19
7738518|NCT01567150|19053560|P2|STARTED|Overall Study||18
7738519|NCT01567150|19053561|P1|STARTED|Overall Study||21
7738520|NCT01567085|19053569|P1|NOT COMPLETED|Overall Study||20
7738521|NCT01567085|19053569|P1|COMPLETED|Overall Study||60
7738522|NCT01567085|19053569|P1|Received at Least 1 Dose of Study Drug|Overall Study||80
7738523|NCT01567085|19053569|P1|STARTED|Overall Study||80
7738524|NCT01567020|19053579|P4|NOT COMPLETED|Overall Study||1
7738525|NCT01567020|19053580|P3|NOT COMPLETED|Overall Study||2
7738526|NCT01567020|19053581|P2|NOT COMPLETED|Overall Study||5
7738527|NCT01567020|19053582|P1|NOT COMPLETED|Overall Study||7
7738528|NCT01567020|19053579|P4|COMPLETED|Overall Study||10
7738529|NCT01567020|19053580|P3|COMPLETED|Overall Study||18
7738530|NCT01567020|19053581|P2|COMPLETED|Overall Study||41
7738531|NCT01567020|19053582|P1|COMPLETED|Overall Study||21
7738532|NCT01567020|19053579|P4|STARTED|Overall Study||11
7738533|NCT01567020|19053580|P3|STARTED|Overall Study||20
7738534|NCT01567020|19053581|P2|STARTED|Overall Study||46
7738535|NCT01567020|19053582|P1|STARTED|Overall Study||28
7738536|NCT01566981|19053606|P2|NOT COMPLETED|Overall Study||8
7738537|NCT01566981|19053607|P1|NOT COMPLETED|Overall Study||5
7738538|NCT01566981|19053606|P2|COMPLETED|Overall Study||54
7738539|NCT01566981|19053607|P1|COMPLETED|Overall Study||53
7738540|NCT01566981|19053606|P2|STARTED|Overall Study||62
7738541|NCT01566981|19053607|P1|STARTED|Overall Study||58
7738542|NCT01566838|19053619|P2|NOT COMPLETED|Overall Study||0
7738543|NCT01566838|19053620|P1|NOT COMPLETED|Overall Study||3
7738544|NCT01566838|19053619|P2|COMPLETED|Overall Study||42
7738545|NCT01566838|19053620|P1|COMPLETED|Overall Study||38
7738546|NCT01566838|19053619|P2|STARTED|Overall Study||42
7738547|NCT01566838|19053620|P1|STARTED|Overall Study||41
7738548|NCT01566773|19053636|P1|NOT COMPLETED|Overall Study||30
7738549|NCT01566773|19053636|P1|COMPLETED|Overall Study||110
7738550|NCT01566773|19053636|P1|Spiriva® Handihaler®|Overall Study||62
7738551|NCT01566773|19053636|P1|Placebo MDI|Overall Study||62
7738552|NCT01566773|19053636|P1|GP MDI 0.6 µg BID|Overall Study||59
7738553|NCT01566773|19053636|P1|GP MDI 1.2 µg BID|Overall Study||57
7738554|NCT01566773|19053636|P1|GP MDI 2.4 µg BID|Overall Study||64
7738555|NCT01566773|19053636|P1|GP MDI 4.6 µg BID|Overall Study||62
7738556|NCT01566773|19053636|P1|GP MDI 9 µg BID|Overall Study||64
7738557|NCT01566773|19053636|P1|GP MDI 18 µg BID|Overall Study||64
7738558|NCT01566773|19053636|P1|STARTED|Overall Study||140
7738559|NCT01566721|19053845|P2|NOT COMPLETED|Overall Study||710
7738560|NCT01566721|19053846|P1|NOT COMPLETED|Overall Study||1867
7738561|NCT01566721|19053845|P2|COMPLETED|Overall Study||0
7738562|NCT01566721|19053846|P1|COMPLETED|Overall Study||0
7738563|NCT01566721|19053845|P2|Received Treatment|Overall Study||709
7738564|NCT01566721|19053846|P1|Received Treatment|Overall Study||1864
7738565|NCT01566721|19053845|P2|STARTED|Overall Study||710
7738566|NCT01566721|19053846|P1|STARTED|Overall Study||1867
7738567|NCT01566695|19053871|P2|NOT COMPLETED|Overall Study||99
7738568|NCT01566695|19053872|P1|NOT COMPLETED|Overall Study||95
7738569|NCT01566695|19053871|P2|COMPLETED|Overall Study||10
7738570|NCT01566695|19053872|P1|COMPLETED|Overall Study||12
7738571|NCT01566695|19053871|P2|STARTED|Overall Study||109
7738572|NCT01566695|19053872|P1|STARTED|Overall Study||107
7738573|NCT01566682|19053974|P1|NOT COMPLETED|Overall Study||46
7738574|NCT01566682|19053974|P1|COMPLETED|Overall Study||374
7738575|NCT01566682|19053974|P1|STARTED|Overall Study||420
7738576|NCT01566630|19053980|P2|NOT COMPLETED|Overall Study||0
7738577|NCT01566630|19053981|P1|NOT COMPLETED|Overall Study||0
7738578|NCT01566630|19053980|P2|COMPLETED|Overall Study||1
7738579|NCT01566630|19053981|P1|COMPLETED|Overall Study||2
7738580|NCT01566630|19053980|P2|STARTED|Overall Study||1
7738581|NCT01566630|19053981|P1|STARTED|Overall Study||2
7738582|NCT01566604|19054037|P2|NOT COMPLETED|Overall Study||11
7738583|NCT01566604|19054038|P1|NOT COMPLETED|Overall Study||24
7738584|NCT01566604|19054037|P2|COMPLETED|Overall Study||143
7738585|NCT01566604|19054038|P1|COMPLETED|Overall Study||282
7738586|NCT01566604|19054037|P2|FAS, Serial Spirometry Subgroup|Overall Study||58
7738587|NCT01566604|19054038|P1|FAS, Serial Spirometry Subgroup|Overall Study||134
7738588|NCT01566604|19054037|P2|Full Analysis Set (FAS)|Overall Study||154
7738589|NCT01566604|19054038|P1|Full Analysis Set (FAS)|Overall Study||305
7738590|NCT01566604|19054037|P2|Safety Set|Overall Study||154
7738591|NCT01566604|19054038|P1|Safety Set|Overall Study||305
7738592|NCT01566604|19054037|P2|STARTED|Overall Study||154
7738593|NCT01566604|19054038|P1|STARTED|Overall Study||306
7738594|NCT01566539|19054072|P9|NOT COMPLETED|Within Subject Group||0
7738595|NCT01566539|19054073|P8|NOT COMPLETED|Within Subject Group||0
7738596|NCT01566539|19054074|P7|NOT COMPLETED|Within Subject Group||0
7738597|NCT01566539|19054075|P6|NOT COMPLETED|Within Subject Group||0
7738598|NCT01566539|19054076|P5|NOT COMPLETED|Within Subject Group||0
7738599|NCT01566539|19054077|P4|NOT COMPLETED|Within Subject Group||3
7738600|NCT01566539|19054078|P3|NOT COMPLETED|Within Subject Group||0
7738601|NCT01566539|19054079|P2|NOT COMPLETED|Within Subject Group||0
7738602|NCT01566539|19054080|P1|NOT COMPLETED|Within Subject Group||0
7738603|NCT01566539|19054072|P9|COMPLETED|Within Subject Group||0
7738604|NCT01566539|19054073|P8|COMPLETED|Within Subject Group||0
7738605|NCT01566539|19054074|P7|COMPLETED|Within Subject Group||0
7738606|NCT01566539|19054075|P6|COMPLETED|Within Subject Group||0
7738607|NCT01566539|19054076|P5|COMPLETED|Within Subject Group||0
7738608|NCT01566539|19054077|P4|COMPLETED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|153
7738609|NCT01566539|19054078|P3|COMPLETED|Within Subject Group||0
7738610|NCT01566539|19054079|P2|COMPLETED|Within Subject Group||0
7738611|NCT01566539|19054080|P1|COMPLETED|Within Subject Group||0
7738612|NCT01566539|19054072|P9|STARTED|Within Subject Group||0
7738613|NCT01566539|19054073|P8|STARTED|Within Subject Group||0
7738614|NCT01566539|19054074|P7|STARTED|Within Subject Group||0
7738615|NCT01566539|19054075|P6|STARTED|Within Subject Group||0
7738616|NCT01566539|19054076|P5|STARTED|Within Subject Group||0
7738617|NCT01566539|19054077|P4|STARTED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|156
7738618|NCT01566539|19054078|P3|STARTED|Within Subject Group||0
7738619|NCT01566539|19054079|P2|STARTED|Within Subject Group||0
7738620|NCT01566539|19054080|P1|STARTED|Within Subject Group||0
7738621|NCT01566539|19054072|P9|NOT COMPLETED|Main Study Period||0
7738622|NCT01566539|19054073|P8|NOT COMPLETED|Main Study Period||0
7738623|NCT01566539|19054074|P7|NOT COMPLETED|Main Study Period||0
7738624|NCT01566539|19054075|P6|NOT COMPLETED|Main Study Period||3
7738625|NCT01566539|19054076|P5|NOT COMPLETED|Main Study Period||0
7738626|NCT01566539|19054077|P4|NOT COMPLETED|Main Study Period||0
7738627|NCT01566539|19054078|P3|NOT COMPLETED|Main Study Period||0
7738628|NCT01566539|19054079|P2|NOT COMPLETED|Main Study Period||0
7738629|NCT01566539|19054080|P1|NOT COMPLETED|Main Study Period||1
7738630|NCT01566539|19054072|P9|COMPLETED|Main Study Period||1
7738631|NCT01566539|19054073|P8|COMPLETED|Main Study Period||30
7738632|NCT01566539|19054074|P7|COMPLETED|Main Study Period||30
7738633|NCT01566539|19054075|P6|COMPLETED|Main Study Period||40
7738634|NCT01566539|19054076|P5|COMPLETED|Main Study Period||40
7738635|NCT01566539|19054077|P4|COMPLETED|Main Study Period||0
7738636|NCT01566539|19054078|P3|COMPLETED|Main Study Period||104
7738637|NCT01566539|19054079|P2|COMPLETED|Main Study Period||100
7738638|NCT01566539|19054080|P1|COMPLETED|Main Study Period||100
7738639|NCT01566539|19054072|P9|STARTED|Main Study Period||1
7738640|NCT01566539|19054073|P8|STARTED|Main Study Period||30
7738641|NCT01566539|19054074|P7|STARTED|Main Study Period||30
7738642|NCT01566539|19054075|P6|STARTED|Main Study Period||43
7738643|NCT01566539|19054076|P5|STARTED|Main Study Period||40
7738644|NCT01566539|19054077|P4|STARTED|Main Study Period||0
7738645|NCT01566539|19054078|P3|STARTED|Main Study Period||104
7738646|NCT01566539|19054079|P2|STARTED|Main Study Period||100
7738647|NCT01566539|19054080|P1|STARTED|Main Study Period||101
7738648|NCT01566526|19054133|P1|NOT COMPLETED|Overall Study||0
7738649|NCT01566526|19054133|P1|COMPLETED|Overall Study||26
7738650|NCT01566526|19054133|P1|STARTED|Overall Study||26
7738651|NCT01566500|19054143|P1|NOT COMPLETED|Overall Study||0
7738652|NCT01566500|19054143|P1|COMPLETED|Overall Study||140
7738653|NCT01566500|19054143|P1|STARTED|Overall Study||140
7738654|NCT01566461|19054149|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
7738655|NCT01566461|19054150|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
7738656|NCT01566461|19054149|P2|COMPLETED|IN.PACT SFA II Phase||55
7738657|NCT01566461|19054150|P1|COMPLETED|IN.PACT SFA II Phase||109
7738658|NCT01566461|19054149|P2|STARTED|IN.PACT SFA II Phase||60
7738659|NCT01566461|19054150|P1|STARTED|IN.PACT SFA II Phase||121
7738660|NCT01566461|19054149|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
7738661|NCT01566461|19054150|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
7738662|NCT01566461|19054149|P2|COMPLETED|IN.PACT SFA I Phase||49
7738663|NCT01566461|19054150|P1|COMPLETED|IN.PACT SFA I Phase||88
7738664|NCT01566461|19054149|P2|STARTED|IN.PACT SFA I Phase||51
7738665|NCT01566461|19054150|P1|STARTED|IN.PACT SFA I Phase||99
7738666|NCT01566435|19054194|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0
7738667|NCT01566435|19054194|P1|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2
7738668|NCT01566435|19054194|P1|STARTED|ACF Definitive Chemoradiation-cetuximab||2
7738669|NCT01566435|19054194|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1
7738670|NCT01566435|19054194|P1|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27
7738671|NCT01566435|19054194|P1|STARTED|ACF Definitive Chemoradiation-cisplatin||28
7738672|NCT01566435|19054194|P1|NOT COMPLETED|ACF Induction Therapy||0
7738673|NCT01566435|19054194|P1|COMPLETED|ACF Induction Therapy||30
7738674|NCT01566435|19054194|P1|STARTED|ACF Induction Therapy||30
7738675|NCT01566409|19054215|P2|NOT COMPLETED|Overall Study||5
7738676|NCT01566409|19054216|P1|NOT COMPLETED|Overall Study||2
7738677|NCT01566409|19054215|P2|COMPLETED|Overall Study||48
7738678|NCT01566409|19054216|P1|COMPLETED|Overall Study||47
7738679|NCT01566409|19054215|P2|STARTED|Overall Study||53
7738680|NCT01566409|19054216|P1|STARTED|Overall Study||49
7738681|NCT01566370|19054224|P2|NOT COMPLETED|Overall Study||1
7738682|NCT01566370|19054225|P1|NOT COMPLETED|Overall Study||2
7738683|NCT01566370|19054224|P2|COMPLETED|Overall Study||0
7738684|NCT01566370|19054225|P1|COMPLETED|Overall Study||0
7738685|NCT01566370|19054224|P2|STARTED|Overall Study||1
7738686|NCT01566370|19054225|P1|STARTED|Overall Study||2
7738687|NCT01566331|19054251|P2|NOT COMPLETED|Overall Study||0
7738688|NCT01566331|19054252|P1|NOT COMPLETED|Overall Study||0
7738689|NCT01566331|19054251|P2|COMPLETED|Overall Study||40
7738690|NCT01566331|19054252|P1|COMPLETED|Overall Study||40
7738691|NCT01566331|19054251|P2|STARTED|Overall Study||40
7738692|NCT01566331|19054252|P1|STARTED|Overall Study||40
7738693|NCT01566214|19054260|P2|NOT COMPLETED|Overall Study||0
7738694|NCT01566214|19054261|P1|NOT COMPLETED|Overall Study||3
7738695|NCT01566214|19054260|P2|COMPLETED|Overall Study||6
7738696|NCT01566214|19054261|P1|COMPLETED|Overall Study||3
7738697|NCT01566214|19054260|P2|STARTED|Overall Study||6
7738698|NCT01566214|19054261|P1|STARTED|Overall Study||6
7738699|NCT01566162|19054291|P1|NOT COMPLETED|Overall Study||36
7738700|NCT01566162|19054291|P1|COMPLETED|Overall Study||155
7738701|NCT01566162|19054291|P1|STARTED|Overall Study||191
7738702|NCT01566149|19054305|P2|NOT COMPLETED|Overall Study||2
7738703|NCT01566149|19054306|P1|NOT COMPLETED|Overall Study||3
7738704|NCT01566149|19054305|P2|COMPLETED|Overall Study||23
7738705|NCT01566149|19054306|P1|COMPLETED|Overall Study||21
7738706|NCT01566149|19054305|P2|STARTED|Overall Study||25
7738707|NCT01566149|19054306|P1|STARTED|Overall Study||24
7738708|NCT01566084|19054322|P2|NOT COMPLETED|Overall Study||0
7738709|NCT01566084|19054323|P1|NOT COMPLETED|Overall Study||0
7738710|NCT01566084|19054322|P2|COMPLETED|Overall Study||10
7738711|NCT01566084|19054323|P1|COMPLETED|Overall Study||7
7738712|NCT01566084|19054322|P2|STARTED|Overall Study||10
7738713|NCT01566084|19054323|P1|STARTED|Overall Study||7
7738714|NCT01565993|19054339|P2|NOT COMPLETED|Overall Study||3
7738715|NCT01565993|19054340|P1|NOT COMPLETED|Overall Study||0
7738716|NCT01565993|19054339|P2|COMPLETED|Overall Study||39
7738717|NCT01565993|19054340|P1|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66
7738718|NCT01565993|19054339|P2|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42
7738719|NCT01565993|19054340|P1|STARTED|Overall Study||66
7738720|NCT01565980|19054348|P2|NOT COMPLETED|Overall Study||4
7738721|NCT01565980|19054349|P1|NOT COMPLETED|Overall Study||4
7738722|NCT01565980|19054348|P2|COMPLETED|Overall Study||16
7738723|NCT01565980|19054349|P1|COMPLETED|Overall Study||16
7738724|NCT01565980|19054348|P2|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20
7738725|NCT01565980|19054349|P1|STARTED|Overall Study||20
7738726|NCT01565941|19054369|P2|NOT COMPLETED|Overall Study||4
7738727|NCT01565941|19054370|P1|NOT COMPLETED|Overall Study||11
7738728|NCT01565941|19054369|P2|COMPLETED|Overall Study||349
7738729|NCT01565941|19054370|P1|COMPLETED|Overall Study||349
7738730|NCT01565941|19054369|P2|STARTED|Overall Study||353
7738731|NCT01565941|19054370|P1|STARTED|Overall Study||360
7738732|NCT01565928|19054412|P1|NOT COMPLETED|Overall Study||22
7738733|NCT01565928|19054412|P1|COMPLETED|Overall Study||0
7738734|NCT01565928|19054412|P1|STARTED|Overall Study||22
7738735|NCT01565902|19054429|P4|NOT COMPLETED|Overall Study||0
7738736|NCT01565902|19054430|P3|NOT COMPLETED|Overall Study||0
7738737|NCT01565902|19054431|P2|NOT COMPLETED|Overall Study||0
7738738|NCT01565902|19054432|P1|NOT COMPLETED|Overall Study||0
7738739|NCT01565902|19054429|P4|COMPLETED|Overall Study||16
7738740|NCT01565902|19054430|P3|COMPLETED|Overall Study||8
7738741|NCT01565902|19054431|P2|COMPLETED|Overall Study||8
7738742|NCT01565902|19054432|P1|COMPLETED|Overall Study||8
7738743|NCT01565902|19054429|P4|STARTED|Overall Study||16
7738744|NCT01565902|19054430|P3|STARTED|Overall Study||8
7738745|NCT01565902|19054431|P2|STARTED|Overall Study||8
7738746|NCT01565902|19054432|P1|STARTED|Overall Study||8
7738747|NCT01565889|19054466|P6|NOT COMPLETED|Part B||4
7738748|NCT01565889|19054467|P5|NOT COMPLETED|Part B||0
7738749|NCT01565889|19054468|P4|NOT COMPLETED|Part B||0
7738750|NCT01565889|19054469|P3|NOT COMPLETED|Part B||0
7738751|NCT01565889|19054470|P2|NOT COMPLETED|Part B||0
7738752|NCT01565889|19054471|P1|NOT COMPLETED|Part B||0
7738753|NCT01565889|19054466|P6|COMPLETED|Part B||19
7738754|NCT01565889|19054467|P5|COMPLETED|Part B||0
7738755|NCT01565889|19054468|P4|COMPLETED|Part B||0
7738756|NCT01565889|19054469|P3|COMPLETED|Part B||0
7738757|NCT01565889|19054470|P2|COMPLETED|Part B||0
7738758|NCT01565889|19054471|P1|COMPLETED|Part B||0
7738759|NCT01565889|19054466|P6|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23
7738760|NCT01565889|19054467|P5|STARTED|Part B||0
7738761|NCT01565889|19054468|P4|STARTED|Part B||0
7738762|NCT01565889|19054469|P3|STARTED|Part B||0
7738763|NCT01565889|19054470|P2|STARTED|Part B||0
7738764|NCT01565889|19054471|P1|STARTED|Part B||0
7738765|NCT01565889|19054466|P6|NOT COMPLETED|Part A||0
7738766|NCT01565889|19054467|P5|NOT COMPLETED|Part A||0
7738767|NCT01565889|19054468|P4|NOT COMPLETED|Part A||0
7738768|NCT01565889|19054469|P3|NOT COMPLETED|Part A||0
7738769|NCT01565889|19054470|P2|NOT COMPLETED|Part A||0
7738770|NCT01565889|19054471|P1|NOT COMPLETED|Part A||1
7738771|NCT01565889|19054466|P6|COMPLETED|Part A||0
7738772|NCT01565889|19054467|P5|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7
7738773|NCT01565889|19054468|P4|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7
7738774|NCT01565889|19054469|P3|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8
7738775|NCT01565889|19054470|P2|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4
7738776|NCT01565889|19054471|P1|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11
7738777|NCT01565889|19054466|P6|STARTED|Part A||0
7738778|NCT01565889|19054467|P5|STARTED|Part A||7
7738779|NCT01565889|19054468|P4|STARTED|Part A||7
7738780|NCT01565889|19054469|P3|STARTED|Part A||8
7738781|NCT01565889|19054470|P2|STARTED|Part A||4
7738782|NCT01565889|19054471|P1|STARTED|Part A||12
7738783|NCT01565850|19054502|P2|NOT COMPLETED|Overall Study||8
7738784|NCT01565850|19054503|P1|NOT COMPLETED|Overall Study||20
7738785|NCT01565850|19054502|P2|COMPLETED|Overall Study||42
7738786|NCT01565850|19054503|P1|COMPLETED|Overall Study||83
7738787|NCT01565850|19054502|P2|STARTED|Overall Study||50
7738788|NCT01565850|19054503|P1|STARTED|Overall Study||103
7738789|NCT01565707|19054523|P4|NOT COMPLETED|Overall Study||5
7738790|NCT01565707|19054524|P3|NOT COMPLETED|Overall Study||3
7738791|NCT01565707|19054525|P2|NOT COMPLETED|Overall Study||8
7738792|NCT01565707|19054526|P1|NOT COMPLETED|Overall Study||9
7738793|NCT01565707|19054523|P4|COMPLETED|Overall Study||17
7738794|NCT01565707|19054524|P3|COMPLETED|Overall Study||16
7738795|NCT01565707|19054525|P2|COMPLETED|Overall Study||65
7738796|NCT01565707|19054526|P1|COMPLETED|Overall Study||66
7738797|NCT01565707|19054523|P4|Treated|Overall Study||22
7738798|NCT01565707|19054524|P3|Treated|Overall Study||19
7738799|NCT01565707|19054525|P2|Treated|Overall Study||73
7738800|NCT01565707|19054526|P1|Treated|Overall Study||73
7738801|NCT01565707|19054523|P4|STARTED|Overall Study||22
7738802|NCT01565707|19054524|P3|STARTED|Overall Study||19
7738803|NCT01565707|19054525|P2|STARTED|Overall Study||73
7738804|NCT01565707|19054526|P1|STARTED|Overall Study||75
7738805|NCT01565694|19054617|P1|NOT COMPLETED|Fixed-Dose Assessment Period||4
7738806|NCT01565694|19054617|P1|COMPLETED|Fixed-Dose Assessment Period||58
7738807|NCT01565694|19054617|P1|STARTED|Fixed-Dose Assessment Period||62
7738808|NCT01565694|19054617|P1|NOT COMPLETED|Dose-Titration Period||14
7738809|NCT01565694|19054617|P1|COMPLETED|Dose-Titration Period||62
7738810|NCT01565694|19054617|P1|STARTED|Dose-Titration Period||76
7738811|NCT01565668|19054638|P2|NOT COMPLETED|Overall Study||38
7738812|NCT01565668|19054639|P1|NOT COMPLETED|Overall Study||38
7738813|NCT01565668|19054638|P2|COMPLETED|Overall Study||0
7738814|NCT01565668|19054639|P1|COMPLETED|Overall Study||0
7738815|NCT01565668|19054638|P2|Completed Long-term Follow-up|Overall Study||0
7738816|NCT01565668|19054639|P1|Completed Long-term Follow-up|Overall Study||0
7738817|NCT01565668|19054638|P2|Started Long-term Follow-up|Overall Study||33
7738818|NCT01565668|19054639|P1|Started Long-term Follow-up|Overall Study||36
7738819|NCT01565668|19054638|P2|Completed 30-day Follow-up|Overall Study||5
7738820|NCT01565668|19054639|P1|Completed 30-day Follow-up|Overall Study||11
7738821|NCT01565668|19054638|P2|Started 30-day Follow-up|Overall Study||37
7738822|NCT01565668|19054639|P1|Started 30-day Follow-up|Overall Study||37
7738823|NCT01565668|19054638|P2|Completed Treatment Per Protocol|Overall Study||0
7738824|NCT01565668|19054639|P1|Completed Treatment Per Protocol|Overall Study||0
7738825|NCT01565668|19054638|P2|STARTED|Overall Study||38
7738826|NCT01565668|19054639|P1|STARTED|Overall Study||38
7738827|NCT01565642|19054663|P2|NOT COMPLETED|Overall Study||1
7738828|NCT01565642|19054664|P1|NOT COMPLETED|Overall Study||2
7738829|NCT01565642|19054663|P2|COMPLETED|Overall Study||150
7738830|NCT01565642|19054664|P1|COMPLETED|Overall Study||149
7738831|NCT01565642|19054663|P2|STARTED|Overall Study||151
7738832|NCT01565642|19054664|P1|STARTED|Overall Study||151
7738833|NCT01565616|19054686|P1|NOT COMPLETED|Overall Study||0
7738834|NCT01565616|19054686|P1|COMPLETED|Overall Study||22
7738835|NCT01565616|19054686|P1|Second Component: Related or Unrelated|Overall Study||17
7738836|NCT01565616|19054686|P1|First Component: 5 Related Donors|Overall Study||5
7738837|NCT01565616|19054686|P1|STARTED|Overall Study||22
7738838|NCT01565564|19054699|P2|NOT COMPLETED|Overall Study||1
7738839|NCT01565564|19054700|P1|NOT COMPLETED|Overall Study||5
7738840|NCT01565564|19054699|P2|COMPLETED|Overall Study||361
7738841|NCT01565564|19054700|P1|COMPLETED|Overall Study||339
7738842|NCT01565564|19054699|P2|STARTED|Overall Study||362
7738843|NCT01565564|19054700|P1|STARTED|Overall Study||344
7738844|NCT01565551|19054710|P2|NOT COMPLETED|Overall Study||0
7738845|NCT01565551|19054711|P1|NOT COMPLETED|Overall Study||0
7738846|NCT01565551|19054710|P2|COMPLETED|Overall Study||51
7738847|NCT01565551|19054711|P1|COMPLETED|Overall Study||586
7738848|NCT01565551|19054710|P2|6-Month Outcomes|Overall Study||30
7738849|NCT01565551|19054711|P1|6-Month Outcomes|Overall Study||412
7738850|NCT01565551|19054710|P2|Neuroimaging|Overall Study||25
7738851|NCT01565551|19054711|P1|Neuroimaging|Overall Study||233
7738852|NCT01565551|19054710|P2|Biospecimens/Biomarkers|Overall Study||22
7738853|NCT01565551|19054711|P1|Biospecimens/Biomarkers|Overall Study||479
7738854|NCT01565551|19054710|P2|Clinical/Demographics|Overall Study||51
7738855|NCT01565551|19054711|P1|Clinical/Demographics|Overall Study||586
7738856|NCT01565551|19054710|P2|STARTED|Overall Study||51
7738857|NCT01565551|19054711|P1|STARTED|Overall Study||586
7738858|NCT01565538|19054719|P2|NOT COMPLETED|Overall Study||0
7738859|NCT01565538|19054720|P1|NOT COMPLETED|Overall Study||0
7738860|NCT01565538|19054719|P2|COMPLETED|Overall Study||62
7738861|NCT01565538|19054720|P1|COMPLETED|Overall Study||61
7738862|NCT01565538|19054719|P2|STARTED|Overall Study||62
7738863|NCT01565538|19054720|P1|STARTED|Overall Study||61
7738864|NCT01565499|19054730|P1|NOT COMPLETED|Overall Study||8
7738865|NCT01565499|19054730|P1|COMPLETED|Overall Study||75
7738866|NCT01565499|19054730|P1|STARTED|Overall Study||83
7738867|NCT01565382|19054744|P2|NOT COMPLETED|Overall Study||0
7738868|NCT01565382|19054745|P1|NOT COMPLETED|Overall Study||0
7738869|NCT01565382|19054744|P2|COMPLETED|Overall Study||7
7738870|NCT01565382|19054745|P1|COMPLETED|Overall Study||40
7738871|NCT01565382|19054744|P2|STARTED|Overall Study||7
7738872|NCT01565382|19054745|P1|STARTED|Overall Study||40
7738873|NCT01565369|19054750|P1|NOT COMPLETED|Overall Study||0
7738874|NCT01565369|19054750|P1|COMPLETED|Overall Study||35
7738875|NCT01565369|19054750|P1|STARTED|Overall Study||35
7738876|NCT01565356|19054756|P1|NOT COMPLETED|Overall Study||0
7738877|NCT01565356|19054756|P1|COMPLETED|Overall Study||41
7738878|NCT01565356|19054756|P1|STARTED|Overall Study||41
7738879|NCT01565343|19054764|P3|NOT COMPLETED|Overall Study||0
7738880|NCT01565343|19054765|P2|NOT COMPLETED|Overall Study||0
7738881|NCT01565343|19054766|P1|NOT COMPLETED|Overall Study||1
7738882|NCT01565343|19054764|P3|COMPLETED|Overall Study||10
7738883|NCT01565343|19054765|P2|COMPLETED|Overall Study||4
7738884|NCT01565343|19054766|P1|COMPLETED|Overall Study||10
7738885|NCT01565343|19054764|P3|STARTED|Overall Study||10
7738886|NCT01565343|19054765|P2|STARTED|Overall Study||4
7738887|NCT01565343|19054766|P1|STARTED|Overall Study||11
7738888|NCT01565330|19054777|P4|NOT COMPLETED|Overall Study||0
7738889|NCT01565330|19054778|P3|NOT COMPLETED|Overall Study||0
7738890|NCT01565330|19054779|P2|NOT COMPLETED|Overall Study||0
7738891|NCT01565330|19054780|P1|NOT COMPLETED|Overall Study||0
7738892|NCT01565330|19054777|P4|COMPLETED|Overall Study||7
7738893|NCT01565330|19054778|P3|COMPLETED|Overall Study||4
7738894|NCT01565330|19054779|P2|COMPLETED|Overall Study||4
7738895|NCT01565330|19054780|P1|COMPLETED|Overall Study||5
7738896|NCT01565330|19054777|P4|STARTED|Overall Study||7
7738897|NCT01565330|19054778|P3|STARTED|Overall Study||4
7738898|NCT01565330|19054779|P2|STARTED|Overall Study||4
7738899|NCT01565330|19054780|P1|STARTED|Overall Study||5
7738900|NCT01565291|19054796|P2|NOT COMPLETED|Overall Study||0
7738901|NCT01565291|19054797|P1|NOT COMPLETED|Overall Study||1
7738902|NCT01565291|19054796|P2|COMPLETED|Overall Study||16
7738903|NCT01565291|19054797|P1|COMPLETED|Overall Study||15
7738904|NCT01565291|19054796|P2|STARTED|Overall Study||16
7738905|NCT01565291|19054797|P1|STARTED|Overall Study||16
7738906|NCT01565148|19054809|P4|NOT COMPLETED|Overall Study||13
7738907|NCT01565148|19054810|P3|NOT COMPLETED|Overall Study||7
7738908|NCT01565148|19054811|P2|NOT COMPLETED|Overall Study||15
7738909|NCT01565148|19054812|P1|NOT COMPLETED|Overall Study||15
7738910|NCT01565148|19054809|P4|COMPLETED|Overall Study||32
7738911|NCT01565148|19054810|P3|COMPLETED|Overall Study||40
7738912|NCT01565148|19054811|P2|COMPLETED|Overall Study||31
7738913|NCT01565148|19054812|P1|COMPLETED|Overall Study||32
7738914|NCT01565148|19054809|P4|STARTED|Overall Study||45
7738915|NCT01565148|19054810|P3|STARTED|Overall Study||47
7738916|NCT01565148|19054811|P2|STARTED|Overall Study||46
7738917|NCT01565148|19054812|P1|STARTED|Overall Study||47
7738918|NCT01565083|19054848|P2|NOT COMPLETED|Overall Study||39
7738919|NCT01565083|19054849|P1|NOT COMPLETED|Overall Study||33
7738920|NCT01565083|19054848|P2|COMPLETED|Overall Study||68
7738921|NCT01565083|19054849|P1|COMPLETED|Overall Study||73
7738922|NCT01565083|19054848|P2|STARTED|Overall Study||107
7738923|NCT01565083|19054849|P1|STARTED|Overall Study||106
7738924|NCT01564953|19054875|P1|NOT COMPLETED|Overall Study||0
7738925|NCT01564953|19054875|P1|COMPLETED|Overall Study||143
7738926|NCT01564953|19054875|P1|STARTED|Overall Study||143
7738927|NCT01564914|19054885|P2|NOT COMPLETED|Overall Study||0
7738928|NCT01564914|19054886|P1|NOT COMPLETED|Overall Study||0
7738929|NCT01564914|19054885|P2|COMPLETED|Overall Study||6
7738930|NCT01564914|19054886|P1|COMPLETED|Overall Study||16
7738931|NCT01564914|19054885|P2|STARTED|Overall Study||6
7738932|NCT01564914|19054886|P1|STARTED|Overall Study||16
7738933|NCT01564862|19054900|P3|NOT COMPLETED|Overall Study||30
7738934|NCT01564862|19054901|P2|NOT COMPLETED|Overall Study||34
7738935|NCT01564862|19054902|P1|NOT COMPLETED|Overall Study||30
7738936|NCT01564862|19054900|P3|COMPLETED|Overall Study||164
7738937|NCT01564862|19054901|P2|COMPLETED|Overall Study||176
7738938|NCT01564862|19054902|P1|COMPLETED|Overall Study||168
7738939|NCT01564862|19054900|P3|Received Treatment|Overall Study||191
7738940|NCT01564862|19054901|P2|Received Treatment|Overall Study||207
7738941|NCT01564862|19054902|P1|Received Treatment|Overall Study||196
7738942|NCT01564862|19054900|P3|STARTED|Overall Study||194
7738943|NCT01564862|19054901|P2|STARTED|Overall Study||210
7738944|NCT01564862|19054902|P1|STARTED|Overall Study||198
7738945|NCT01564784|19054953|P2|NOT COMPLETED|Overall Study||133
7738946|NCT01564784|19054954|P1|NOT COMPLETED|Overall Study||134
7738947|NCT01564784|19054953|P2|COMPLETED|Overall Study||10
7738948|NCT01564784|19054954|P1|COMPLETED|Overall Study||30
7738949|NCT01564784|19054953|P2|STARTED|Overall Study|Treated (162 randomized)|143
7738950|NCT01564784|19054954|P1|STARTED|Overall Study|Treated (164 randomized)|164
7738951|NCT01564758|19054981|P1|NOT COMPLETED|Overall Study||14
7738952|NCT01564758|19054981|P1|COMPLETED|Overall Study||85
7738953|NCT01564758|19054981|P1|STARTED|Overall Study||99
7738954|NCT01564732|19054988|P2|NOT COMPLETED|Overall Study||5
7738955|NCT01564732|19054989|P1|NOT COMPLETED|Overall Study||6
7738956|NCT01564732|19054988|P2|COMPLETED|Overall Study||0
7738957|NCT01564732|19054989|P1|COMPLETED|Overall Study||0
7738958|NCT01564732|19054988|P2|STARTED|Overall Study||5
7738959|NCT01564732|19054989|P1|STARTED|Overall Study||6
7738960|NCT01564706|19055005|P1|NOT COMPLETED|Overall Study||0
7738961|NCT01564706|19055005|P1|COMPLETED|Overall Study||9
7738962|NCT01564706|19055005|P1|STARTED|Overall Study||9
7738963|NCT01564693|19055012|P3|NOT COMPLETED|Overall Study||0
7738964|NCT01564693|19055013|P2|NOT COMPLETED|Overall Study||0
7738965|NCT01564693|19055014|P1|NOT COMPLETED|Overall Study||0
7738966|NCT01564693|19055012|P3|COMPLETED|Overall Study||2
7738967|NCT01564693|19055013|P2|COMPLETED|Overall Study||4
7738968|NCT01564693|19055014|P1|COMPLETED|Overall Study||9
7738969|NCT01564693|19055012|P3|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2
7738970|NCT01564693|19055013|P2|STARTED|Overall Study||4
7738971|NCT01564693|19055014|P1|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9
7738972|NCT01564628|19055022|P3|NOT COMPLETED|Overall Study||2
7738973|NCT01564628|19055023|P2|NOT COMPLETED|Overall Study||2
7738974|NCT01564628|19055024|P1|NOT COMPLETED|Overall Study||4
7738975|NCT01564628|19055022|P3|COMPLETED|Overall Study||61
7738976|NCT01564628|19055023|P2|COMPLETED|Overall Study||56
7738977|NCT01564628|19055024|P1|COMPLETED|Overall Study||181
7738978|NCT01564628|19055022|P3|STARTED|Overall Study||63
7738979|NCT01564628|19055023|P2|STARTED|Overall Study||58
7738980|NCT01564628|19055024|P1|STARTED|Overall Study||185
7738981|NCT01564537|19055030|P2|NOT COMPLETED|Overall Study||6
7738982|NCT01564537|19055031|P1|NOT COMPLETED|Overall Study||6
7738983|NCT01564537|19055030|P2|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|356
7738984|NCT01564537|19055031|P1|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|354
7738985|NCT01564537|19055030|P2|Safety Population: Received Study Drug|Overall Study||360
7738986|NCT01564537|19055031|P1|Safety Population: Received Study Drug|Overall Study||360
7738987|NCT01564537|19055030|P2|STARTED|Overall Study||362
7738988|NCT01564537|19055031|P1|STARTED|Overall Study||360
7738989|NCT01564459|19055054|P3|NOT COMPLETED|Double-blind Treatment||1
7738990|NCT01564459|19055055|P2|NOT COMPLETED|Double-blind Treatment||0
7738991|NCT01564459|19055056|P1|NOT COMPLETED|Double-blind Treatment||0
7738992|NCT01564459|19055054|P3|COMPLETED|Double-blind Treatment||82
7738993|NCT01564459|19055055|P2|COMPLETED|Double-blind Treatment||87
7738994|NCT01564459|19055056|P1|COMPLETED|Double-blind Treatment||0
7738995|NCT01564459|19055054|P3|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83
7738996|NCT01564459|19055055|P2|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87
7738997|NCT01564459|19055056|P1|STARTED|Double-blind Treatment||0
7738998|NCT01564459|19055054|P3|NOT COMPLETED|Run-In||0
7738999|NCT01564459|19055055|P2|NOT COMPLETED|Run-In||0
7739000|NCT01564459|19055056|P1|NOT COMPLETED|Run-In||12
7739001|NCT01564459|19055054|P3|COMPLETED|Run-In||83
7739002|NCT01564459|19055055|P2|COMPLETED|Run-In||87
7739003|NCT01564459|19055056|P1|COMPLETED|Run-In||0
7739004|NCT01564459|19055054|P3|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83
7739005|NCT01564459|19055055|P2|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87
7739006|NCT01564459|19055056|P1|STARTED|Run-In||12
7739007|NCT01564407|19055080|P5|NOT COMPLETED|Overall Study||0
7739008|NCT01564407|19055081|P4|NOT COMPLETED|Overall Study||1
7739009|NCT01564407|19055082|P3|NOT COMPLETED|Overall Study||0
7739010|NCT01564407|19055083|P2|NOT COMPLETED|Overall Study||2
7739011|NCT01564407|19055084|P1|NOT COMPLETED|Overall Study||0
7739012|NCT01564407|19055080|P5|COMPLETED|Overall Study||0
7739013|NCT01564407|19055081|P4|COMPLETED|Overall Study||1
7739014|NCT01564407|19055082|P3|COMPLETED|Overall Study||4
7739015|NCT01564407|19055083|P2|COMPLETED|Overall Study||3
7739016|NCT01564407|19055084|P1|COMPLETED|Overall Study||4
7739017|NCT01564407|19055080|P5|STARTED|Overall Study||0
7739018|NCT01564407|19055081|P4|STARTED|Overall Study||2
7739019|NCT01564407|19055082|P3|STARTED|Overall Study||4
7739020|NCT01564407|19055083|P2|STARTED|Overall Study||5
7739021|NCT01564407|19055084|P1|STARTED|Overall Study||4
7739022|NCT01564394|19055125|P2|NOT COMPLETED|Overall Study||10
7739023|NCT01564394|19055126|P1|NOT COMPLETED|Overall Study||6
7739024|NCT01564394|19055125|P2|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20
7739025|NCT01564394|19055126|P1|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24
7739026|NCT01564394|19055125|P2|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
7739027|NCT01564394|19055126|P1|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
7739028|NCT01564277|19055140|P2|NOT COMPLETED|Overall Study||1
7739029|NCT01564277|19055141|P1|NOT COMPLETED|Overall Study||1
7739030|NCT01564277|19055140|P2|COMPLETED|Overall Study||11
7739031|NCT01564277|19055141|P1|COMPLETED|Overall Study||11
7739032|NCT01564277|19055140|P2|STARTED|Overall Study||12
7739033|NCT01564277|19055141|P1|STARTED|Overall Study||12
7739034|NCT01563978|19055159|P2|NOT COMPLETED|Overall Study||2
7739035|NCT01563978|19055160|P1|NOT COMPLETED|Overall Study||4
7739036|NCT01563978|19055159|P2|COMPLETED|Overall Study||65
7739037|NCT01563978|19055160|P1|COMPLETED|Overall Study||64
7739038|NCT01563978|19055159|P2|Randomised But Did Not Receive Treatment|Overall Study||0
7739039|NCT01563978|19055160|P1|Randomised But Did Not Receive Treatment|Overall Study||0
7739040|NCT01563978|19055159|P2|STARTED|Overall Study|Patients who received treatment.|67
7739041|NCT01563978|19055160|P1|STARTED|Overall Study|Patients who received treatment.|68
7739042|NCT01563913|19055186|P2|NOT COMPLETED|Overall Study||0
7739043|NCT01563913|19055187|P1|NOT COMPLETED|Overall Study||2
7739044|NCT01563913|19055186|P2|COMPLETED|Overall Study||15
7739045|NCT01563913|19055187|P1|COMPLETED|Overall Study||13
7739046|NCT01563913|19055186|P2|STARTED|Overall Study||15
7739047|NCT01563913|19055187|P1|STARTED|Overall Study||15
7739048|NCT01563536|19055199|P2|NOT COMPLETED|Overall Study||2
7739049|NCT01563536|19055200|P1|NOT COMPLETED|Overall Study||1
7739050|NCT01563536|19055199|P2|COMPLETED|Overall Study||4
7739051|NCT01563536|19055200|P1|COMPLETED|Overall Study||5
7739052|NCT01563536|19055199|P2|STARTED|Overall Study||6
7739053|NCT01563536|19055200|P1|STARTED|Overall Study||6
7739054|NCT01563406|19055232|P4|NOT COMPLETED|Overall Study||0
7739055|NCT01563406|19055233|P3|NOT COMPLETED|Overall Study||0
7739056|NCT01563406|19055234|P2|NOT COMPLETED|Overall Study||0
7739057|NCT01563406|19055235|P1|NOT COMPLETED|Overall Study||0
7739058|NCT01563406|19055232|P4|COMPLETED|Overall Study|112 hubs|29
7739059|NCT01563406|19055233|P3|COMPLETED|Overall Study|101 hubs|30
7739060|NCT01563406|19055234|P2|COMPLETED|Overall Study|102 hubs|30
7739061|NCT01563406|19055235|P1|COMPLETED|Overall Study|194 hubs|60
7739062|NCT01563406|19055232|P4|STARTED|Overall Study|112 hubs|29
7739063|NCT01563406|19055233|P3|STARTED|Overall Study|101 hubs|30
7739064|NCT01563406|19055234|P2|STARTED|Overall Study|102 hubs|30
7739065|NCT01563406|19055235|P1|STARTED|Overall Study|194 hubs|60
7739066|NCT01563198|19055253|P1|NOT COMPLETED|After Training||0
7739067|NCT01563198|19055253|P1|COMPLETED|After Training||47979
7739068|NCT01563198|19055253|P1|STARTED|After Training||47979
7739069|NCT01563198|19055253|P1|NOT COMPLETED|Baseline||0
7739070|NCT01563198|19055253|P1|COMPLETED|Baseline||49733
7739071|NCT01563198|19055253|P1|STARTED|Baseline||49733
7739072|NCT01563185|19055259|P1|NOT COMPLETED|Overall Study||2
7739073|NCT01563185|19055259|P1|COMPLETED|Overall Study||10
7739074|NCT01563185|19055259|P1|STARTED|Overall Study||12
7739075|NCT01563172|19055273|P1|NOT COMPLETED|Overall Study||13
7739076|NCT01563172|19055273|P1|COMPLETED|Overall Study||52
7739077|NCT01563172|19055273|P1|Control Dentifrice|Overall Study||60
7739078|NCT01563172|19055273|P1|Experimental Dentifrice 1.5g/ 45 Sec|Overall Study||58
7739079|NCT01563172|19055273|P1|Experimental Dentifrice 1.5g/ 2min|Overall Study||58
7739080|NCT01563172|19055273|P1|Experimental Dentifrice 0.5g/45 Sec|Overall Study||59
7739081|NCT01563172|19055273|P1|Experimental Dentifrice 0.5g/2 Min|Overall Study||59
7739082|NCT01563172|19055273|P1|STARTED|Overall Study||65
7739083|NCT01563081|19055302|P2|NOT COMPLETED|Overall Study||0
7739084|NCT01563081|19055303|P1|NOT COMPLETED|Overall Study||0
7739085|NCT01563081|19055302|P2|COMPLETED|Overall Study||30
7739086|NCT01563081|19055303|P1|COMPLETED|Overall Study||30
7739087|NCT01563081|19055302|P2|STARTED|Overall Study||30
7739088|NCT01563081|19055303|P1|STARTED|Overall Study||30
7739089|NCT01563055|19055316|P1|NOT COMPLETED|Overall Study||0
7739090|NCT01563055|19055316|P1|COMPLETED|Overall Study||10
7739091|NCT01563055|19055316|P1|STARTED|Overall Study||10
7739092|NCT01563029|19055379|P5|NOT COMPLETED|Overall Study||29
7739093|NCT01563029|19055380|P4|NOT COMPLETED|Overall Study||33
7739094|NCT01563029|19055381|P3|NOT COMPLETED|Overall Study||33
7739095|NCT01563029|19055382|P2|NOT COMPLETED|Overall Study||24
7739096|NCT01563029|19055383|P1|NOT COMPLETED|Overall Study||53
7739097|NCT01563029|19055379|P5|COMPLETED|Overall Study||89
7739098|NCT01563029|19055380|P4|COMPLETED|Overall Study||85
7739099|NCT01563029|19055381|P3|COMPLETED|Overall Study||87
7739100|NCT01563029|19055382|P2|COMPLETED|Overall Study||94
7739101|NCT01563029|19055383|P1|COMPLETED|Overall Study||66
7739102|NCT01563029|19055379|P5|STARTED|Overall Study||118
7739103|NCT01563029|19055380|P4|STARTED|Overall Study||118
7739104|NCT01563029|19055381|P3|STARTED|Overall Study||120
7739105|NCT01563029|19055382|P2|STARTED|Overall Study||118
7739106|NCT01563029|19055383|P1|STARTED|Overall Study||119
7739107|NCT01563003|19055433|P2|NOT COMPLETED|Overall Study||0
7739108|NCT01563003|19055434|P1|NOT COMPLETED|Overall Study||0
7739109|NCT01563003|19055433|P2|COMPLETED|Overall Study||15
7739110|NCT01563003|19055434|P1|COMPLETED|Overall Study||16
7739111|NCT01563003|19055433|P2|STARTED|Overall Study||15
7739112|NCT01563003|19055434|P1|STARTED|Overall Study||16
7739113|NCT01562886|19055444|P1|NOT COMPLETED|Overall Study||1
7739114|NCT01562886|19055444|P1|COMPLETED|Overall Study||13
7739115|NCT01562886|19055444|P1|STARTED|Overall Study||14
7739116|NCT01562873|19055449|P2|NOT COMPLETED|Overall Study||0
7739117|NCT01562873|19055450|P1|NOT COMPLETED|Overall Study||21
7739118|NCT01562873|19055449|P2|COMPLETED|Overall Study||0
7739119|NCT01562873|19055450|P1|COMPLETED|Overall Study||0
7739120|NCT01562873|19055449|P2|STARTED|Overall Study|The observed number of objective responses in Cohort A was not sufficient for Cohort B to open.|0
7739121|NCT01562873|19055450|P1|STARTED|Overall Study||21
7739122|NCT01562782|19055459|P2|NOT COMPLETED|Overall Study||5
7739123|NCT01562782|19055460|P1|NOT COMPLETED|Overall Study||4
7739124|NCT01562782|19055459|P2|COMPLETED|Overall Study||15
7739125|NCT01562782|19055460|P1|COMPLETED|Overall Study||15
7739126|NCT01562782|19055459|P2|STARTED|Overall Study||20
7739127|NCT01562782|19055460|P1|STARTED|Overall Study||19
7739128|NCT01562756|19055484|P1|NOT COMPLETED|Overall Study||0
7739129|NCT01562756|19055484|P1|COMPLETED|Overall Study||6
7739130|NCT01562756|19055484|P1|STARTED|Overall Study||6
7739131|NCT01562743|19055489|P1|NOT COMPLETED|Overall Study||52
7739132|NCT01562743|19055489|P1|COMPLETED|Overall Study||133
7739133|NCT01562743|19055489|P1|STARTED|Overall Study||185
7739134|NCT01562678|19055501|P2|NOT COMPLETED|Overall Study||2
7739135|NCT01562678|19055502|P1|NOT COMPLETED|Overall Study||6
7739136|NCT01562678|19055501|P2|COMPLETED|Overall Study||12
7739137|NCT01562678|19055502|P1|COMPLETED|Overall Study||8
7739138|NCT01562678|19055501|P2|STARTED|Overall Study||14
7739139|NCT01562678|19055502|P1|STARTED|Overall Study||14
7739140|NCT01562613|19055508|P1|NOT COMPLETED|Overall Study||4
7739141|NCT01562613|19055508|P1|COMPLETED|Overall Study||529
7739142|NCT01562613|19055508|P1|STARTED|Overall Study||533
7739143|NCT01562548|19055518|P4|NOT COMPLETED|Overall Study||0
7739144|NCT01562548|19055519|P3|NOT COMPLETED|Overall Study||1
7739145|NCT01562548|19055520|P2|NOT COMPLETED|Overall Study||0
7739146|NCT01562548|19055521|P1|NOT COMPLETED|Overall Study||0
7739147|NCT01562548|19055518|P4|COMPLETED|Overall Study||14
7739148|NCT01562548|19055519|P3|COMPLETED|Overall Study||24
7739149|NCT01562548|19055520|P2|COMPLETED|Overall Study||15
7739150|NCT01562548|19055521|P1|COMPLETED|Overall Study||25
7739151|NCT01562548|19055518|P4|STARTED|Overall Study||14
7739152|NCT01562548|19055519|P3|STARTED|Overall Study||25
7739153|NCT01562548|19055520|P2|STARTED|Overall Study||15
7739154|NCT01562548|19055521|P1|STARTED|Overall Study||25
7739155|NCT01562444|19055574|P3|NOT COMPLETED|Overall Study||7
7739156|NCT01562444|19055575|P2|NOT COMPLETED|Overall Study||2
7739157|NCT01562444|19055576|P1|NOT COMPLETED|Overall Study||5
7739158|NCT01562444|19055574|P3|COMPLETED|Overall Study||99
7739159|NCT01562444|19055575|P2|COMPLETED|Overall Study||49
7739160|NCT01562444|19055576|P1|COMPLETED|Overall Study||43
7739161|NCT01562444|19055574|P3|STARTED|Overall Study||106
7739162|NCT01562444|19055575|P2|STARTED|Overall Study||51
7739163|NCT01562444|19055576|P1|STARTED|Overall Study||48
7739164|NCT01562379|19055826|P5|NOT COMPLETED|Overall Study||40
7739165|NCT01562379|19055827|P4|NOT COMPLETED|Overall Study||57
7739166|NCT01562379|19055828|P3|NOT COMPLETED|Overall Study||62
7739167|NCT01562379|19055829|P2|NOT COMPLETED|Overall Study||97
7739168|NCT01562379|19055830|P1|NOT COMPLETED|Overall Study||126
7739169|NCT01562379|19055826|P5|COMPLETED|Overall Study||785
7739170|NCT01562379|19055827|P4|COMPLETED|Overall Study||786
7739171|NCT01562379|19055828|P3|COMPLETED|Overall Study||789
7739172|NCT01562379|19055829|P2|COMPLETED|Overall Study||1395
7739173|NCT01562379|19055830|P1|COMPLETED|Overall Study||1312
7739174|NCT01562379|19055826|P5|STARTED|Overall Study||825
7739175|NCT01562379|19055827|P4|STARTED|Overall Study||843
7739176|NCT01562379|19055828|P3|STARTED|Overall Study||851
7739177|NCT01562379|19055829|P2|STARTED|Overall Study||1492
7739178|NCT01562379|19055830|P1|STARTED|Overall Study||1438
7739179|NCT01562327|19055842|P1|NOT COMPLETED|Overall Study||8
7739180|NCT01562327|19055842|P1|COMPLETED|Overall Study||42
7739181|NCT01562327|19055842|P1|STARTED|Overall Study||50
7739182|NCT01562314|19055872|P2|NOT COMPLETED|Overall Study||8
7739183|NCT01562314|19055873|P1|NOT COMPLETED|Overall Study||13
7739184|NCT01562314|19055872|P2|COMPLETED|Overall Study||23
7739185|NCT01562314|19055873|P1|COMPLETED|Overall Study||16
7739186|NCT01562314|19055872|P2|Per Protocol (PP) Analysis Set|Overall Study||27
7739187|NCT01562314|19055873|P1|Per Protocol (PP) Analysis Set|Overall Study||17
7739188|NCT01562314|19055872|P2|Intent-to-Treat (ITT) Analysis Set|Overall Study||31
7739189|NCT01562314|19055873|P1|Intent-to-Treat (ITT) Analysis Set|Overall Study||29
7739190|NCT01562314|19055872|P2|Received at Least 1 Dose of Study Drug|Overall Study||31
7739191|NCT01562314|19055873|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
7739192|NCT01562314|19055872|P2|STARTED|Overall Study||31
7739193|NCT01562314|19055873|P1|STARTED|Overall Study||29
7739194|NCT01562275|19055930|P13|NOT COMPLETED|Stage 2||5
7739195|NCT01562275|19055931|P12|NOT COMPLETED|Stage 2||14
7739196|NCT01562275|19055932|P11|NOT COMPLETED|Stage 2||0
7739197|NCT01562275|19055933|P10|NOT COMPLETED|Stage 2||0
7739198|NCT01562275|19055934|P9|NOT COMPLETED|Stage 2||0
7739199|NCT01562275|19055935|P8|NOT COMPLETED|Stage 2||0
7739200|NCT01562275|19055936|P7|NOT COMPLETED|Stage 2||0
7739201|NCT01562275|19055937|P6|NOT COMPLETED|Stage 2||0
7739202|NCT01562275|19055938|P5|NOT COMPLETED|Stage 2||0
7739203|NCT01562275|19055939|P4|NOT COMPLETED|Stage 2||0
7739204|NCT01562275|19055940|P3|NOT COMPLETED|Stage 2||0
7739205|NCT01562275|19055941|P2|NOT COMPLETED|Stage 2||0
7739206|NCT01562275|19055942|P1|NOT COMPLETED|Stage 2||0
7739207|NCT01562275|19055930|P13|COMPLETED|Stage 2||0
7739208|NCT01562275|19055931|P12|COMPLETED|Stage 2||0
7739209|NCT01562275|19055932|P11|COMPLETED|Stage 2||0
7739210|NCT01562275|19055933|P10|COMPLETED|Stage 2||0
7739211|NCT01562275|19055934|P9|COMPLETED|Stage 2||0
7739212|NCT01562275|19055935|P8|COMPLETED|Stage 2||0
7739213|NCT01562275|19055936|P7|COMPLETED|Stage 2||0
7739214|NCT01562275|19055937|P6|COMPLETED|Stage 2||0
7739215|NCT01562275|19055938|P5|COMPLETED|Stage 2||0
7739216|NCT01562275|19055939|P4|COMPLETED|Stage 2||0
7739217|NCT01562275|19055940|P3|COMPLETED|Stage 2||0
7739218|NCT01562275|19055941|P2|COMPLETED|Stage 2||0
7739219|NCT01562275|19055942|P1|COMPLETED|Stage 2||0
7739220|NCT01562275|19055930|P13|STARTED|Stage 2||5
7739221|NCT01562275|19055931|P12|STARTED|Stage 2||14
7739222|NCT01562275|19055932|P11|STARTED|Stage 2||0
7739223|NCT01562275|19055933|P10|STARTED|Stage 2||0
7739224|NCT01562275|19055934|P9|STARTED|Stage 2||0
7739225|NCT01562275|19055935|P8|STARTED|Stage 2||0
7739226|NCT01562275|19055936|P7|STARTED|Stage 2||0
7739227|NCT01562275|19055937|P6|STARTED|Stage 2||0
7739228|NCT01562275|19055938|P5|STARTED|Stage 2||0
7739229|NCT01562275|19055939|P4|STARTED|Stage 2||0
7739230|NCT01562275|19055940|P3|STARTED|Stage 2||0
7739231|NCT01562275|19055941|P2|STARTED|Stage 2||0
7739232|NCT01562275|19055942|P1|STARTED|Stage 2||0
7739233|NCT01562275|19055930|P13|NOT COMPLETED|Stage 1||0
7739234|NCT01562275|19055931|P12|NOT COMPLETED|Stage 1||0
7739235|NCT01562275|19055932|P11|NOT COMPLETED|Stage 1||3
7739236|NCT01562275|19055933|P10|NOT COMPLETED|Stage 1||7
7739237|NCT01562275|19055934|P9|NOT COMPLETED|Stage 1||3
7739238|NCT01562275|19055935|P8|NOT COMPLETED|Stage 1||7
7739239|NCT01562275|19055936|P7|NOT COMPLETED|Stage 1||3
7739240|NCT01562275|19055937|P6|NOT COMPLETED|Stage 1||4
7739241|NCT01562275|19055938|P5|NOT COMPLETED|Stage 1||4
7739242|NCT01562275|19055939|P4|NOT COMPLETED|Stage 1||4
7739243|NCT01562275|19055940|P3|NOT COMPLETED|Stage 1||3
7739244|NCT01562275|19055941|P2|NOT COMPLETED|Stage 1||7
7739245|NCT01562275|19055942|P1|NOT COMPLETED|Stage 1||3
7739246|NCT01562275|19055930|P13|COMPLETED|Stage 1||0
7739247|NCT01562275|19055931|P12|COMPLETED|Stage 1||0
7739248|NCT01562275|19055932|P11|COMPLETED|Stage 1||0
7739249|NCT01562275|19055933|P10|COMPLETED|Stage 1||0
7739250|NCT01562275|19055934|P9|COMPLETED|Stage 1||0
7739251|NCT01562275|19055935|P8|COMPLETED|Stage 1||0
7739252|NCT01562275|19055936|P7|COMPLETED|Stage 1||0
7739253|NCT01562275|19055937|P6|COMPLETED|Stage 1||0
7739254|NCT01562275|19055938|P5|COMPLETED|Stage 1||0
7739255|NCT01562275|19055939|P4|COMPLETED|Stage 1||0
7739256|NCT01562275|19055940|P3|COMPLETED|Stage 1||0
7739257|NCT01562275|19055941|P2|COMPLETED|Stage 1||0
7739258|NCT01562275|19055942|P1|COMPLETED|Stage 1||0
7739259|NCT01562275|19055930|P13|STARTED|Stage 1||0
7739260|NCT01562275|19055931|P12|STARTED|Stage 1||0
7739261|NCT01562275|19055932|P11|STARTED|Stage 1||3
7739262|NCT01562275|19055933|P10|STARTED|Stage 1||7
7739263|NCT01562275|19055934|P9|STARTED|Stage 1||3
7739264|NCT01562275|19055935|P8|STARTED|Stage 1||7
7739265|NCT01562275|19055936|P7|STARTED|Stage 1||3
7739266|NCT01562275|19055937|P6|STARTED|Stage 1||4
7739267|NCT01562275|19055938|P5|STARTED|Stage 1||4
7739268|NCT01562275|19055939|P4|STARTED|Stage 1||4
7739269|NCT01562275|19055940|P3|STARTED|Stage 1||3
7739270|NCT01562275|19055941|P2|STARTED|Stage 1||7
7739271|NCT01562275|19055942|P1|STARTED|Stage 1||3
7739272|NCT01562132|19056074|P2|NOT COMPLETED|Overall Study||0
7739273|NCT01562132|19056075|P1|NOT COMPLETED|Overall Study||0
7739274|NCT01562132|19056074|P2|COMPLETED|Overall Study||3
7739275|NCT01562132|19056075|P1|COMPLETED|Overall Study||3
7739276|NCT01562132|19056074|P2|STARTED|Overall Study||3
7739277|NCT01562132|19056075|P1|STARTED|Overall Study||3
7739278|NCT01562028|19056083|P2|NOT COMPLETED|Overall Study||2
7739279|NCT01562028|19056084|P1|NOT COMPLETED|Overall Study||3
7739280|NCT01562028|19056083|P2|COMPLETED|Overall Study||70
7739281|NCT01562028|19056084|P1|COMPLETED|Overall Study||34
7739282|NCT01562028|19056083|P2|STARTED|Overall Study||72
7739283|NCT01562028|19056084|P1|STARTED|Overall Study||37
7739284|NCT01561989|19056104|P2|NOT COMPLETED|Overall Study||6
7739285|NCT01561989|19056105|P1|NOT COMPLETED|Overall Study||5
7739286|NCT01561989|19056104|P2|COMPLETED|Overall Study||0
7739287|NCT01561989|19056105|P1|COMPLETED|Overall Study||0
7739288|NCT01561989|19056104|P2|STARTED|Overall Study||6
7739289|NCT01561989|19056105|P1|STARTED|Overall Study||5
7739290|NCT01561976|19056127|P6|NOT COMPLETED|Period 3||0
7739291|NCT01561976|19056128|P5|NOT COMPLETED|Period 3||0
7739292|NCT01561976|19056129|P4|NOT COMPLETED|Period 3||0
7739293|NCT01561976|19056130|P3|NOT COMPLETED|Period 3||0
7739294|NCT01561976|19056131|P2|NOT COMPLETED|Period 3||0
7739295|NCT01561976|19056132|P1|NOT COMPLETED|Period 3||0
7739296|NCT01561976|19056127|P6|COMPLETED|Period 3||4
7739297|NCT01561976|19056128|P5|COMPLETED|Period 3||5
7739298|NCT01561976|19056129|P4|COMPLETED|Period 3||4
7739299|NCT01561976|19056130|P3|COMPLETED|Period 3||3
7739300|NCT01561976|19056131|P2|COMPLETED|Period 3||5
7739301|NCT01561976|19056132|P1|COMPLETED|Period 3||4
7739302|NCT01561976|19056127|P6|STARTED|Period 3||4
7739303|NCT01561976|19056128|P5|STARTED|Period 3||5
7739304|NCT01561976|19056129|P4|STARTED|Period 3||4
7739305|NCT01561976|19056130|P3|STARTED|Period 3||3
7739306|NCT01561976|19056131|P2|STARTED|Period 3||5
7739307|NCT01561976|19056132|P1|STARTED|Period 3||4
7739308|NCT01561976|19056127|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
7739309|NCT01561976|19056128|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
7739310|NCT01561976|19056129|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
7739311|NCT01561976|19056130|P3|NOT COMPLETED|Washout Period 2 (7 Days)||1
7739312|NCT01561976|19056131|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
7739313|NCT01561976|19056132|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
7739314|NCT01561976|19056127|P6|COMPLETED|Washout Period 2 (7 Days)||4
7739315|NCT01561976|19056128|P5|COMPLETED|Washout Period 2 (7 Days)||5
7739316|NCT01561976|19056129|P4|COMPLETED|Washout Period 2 (7 Days)||4
7739317|NCT01561976|19056130|P3|COMPLETED|Washout Period 2 (7 Days)||3
7739318|NCT01561976|19056131|P2|COMPLETED|Washout Period 2 (7 Days)||5
7739319|NCT01561976|19056132|P1|COMPLETED|Washout Period 2 (7 Days)||4
7739320|NCT01561976|19056127|P6|STARTED|Washout Period 2 (7 Days)||4
7739321|NCT01561976|19056128|P5|STARTED|Washout Period 2 (7 Days)||5
7739322|NCT01561976|19056129|P4|STARTED|Washout Period 2 (7 Days)||4
7739323|NCT01561976|19056130|P3|STARTED|Washout Period 2 (7 Days)||4
7739324|NCT01561976|19056131|P2|STARTED|Washout Period 2 (7 Days)||5
7739325|NCT01561976|19056132|P1|STARTED|Washout Period 2 (7 Days)||5
7739326|NCT01561976|19056127|P6|NOT COMPLETED|Period 2||0
7739327|NCT01561976|19056128|P5|NOT COMPLETED|Period 2||0
7739328|NCT01561976|19056129|P4|NOT COMPLETED|Period 2||0
7739329|NCT01561976|19056130|P3|NOT COMPLETED|Period 2||0
7739330|NCT01561976|19056131|P2|NOT COMPLETED|Period 2||0
7739331|NCT01561976|19056132|P1|NOT COMPLETED|Period 2||0
7739332|NCT01561976|19056127|P6|COMPLETED|Period 2||4
7739333|NCT01561976|19056128|P5|COMPLETED|Period 2||5
7739334|NCT01561976|19056129|P4|COMPLETED|Period 2||4
7739335|NCT01561976|19056130|P3|COMPLETED|Period 2||4
7739336|NCT01561976|19056131|P2|COMPLETED|Period 2||5
7739337|NCT01561976|19056132|P1|COMPLETED|Period 2||5
7739338|NCT01561976|19056127|P6|STARTED|Period 2||4
7739339|NCT01561976|19056128|P5|STARTED|Period 2||5
7739340|NCT01561976|19056129|P4|STARTED|Period 2||4
7739341|NCT01561976|19056130|P3|STARTED|Period 2||4
7739342|NCT01561976|19056131|P2|STARTED|Period 2||5
7739343|NCT01561976|19056132|P1|STARTED|Period 2||5
7739344|NCT01561976|19056127|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
7739345|NCT01561976|19056128|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
7739346|NCT01561976|19056129|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
7739347|NCT01561976|19056130|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
7739348|NCT01561976|19056131|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
7739349|NCT01561976|19056132|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
7739350|NCT01561976|19056127|P6|COMPLETED|Washout Period 1 (7 Days)||4
7739351|NCT01561976|19056128|P5|COMPLETED|Washout Period 1 (7 Days)||5
7739352|NCT01561976|19056129|P4|COMPLETED|Washout Period 1 (7 Days)||4
7739353|NCT01561976|19056130|P3|COMPLETED|Washout Period 1 (7 Days)||4
7739354|NCT01561976|19056131|P2|COMPLETED|Washout Period 1 (7 Days)||5
7739355|NCT01561976|19056132|P1|COMPLETED|Washout Period 1 (7 Days)||5
7739356|NCT01561976|19056127|P6|STARTED|Washout Period 1 (7 Days)||5
7739357|NCT01561976|19056128|P5|STARTED|Washout Period 1 (7 Days)||5
7739358|NCT01561976|19056129|P4|STARTED|Washout Period 1 (7 Days)||5
7739359|NCT01561976|19056130|P3|STARTED|Washout Period 1 (7 Days)||4
7739360|NCT01561976|19056131|P2|STARTED|Washout Period 1 (7 Days)||5
7739361|NCT01561976|19056132|P1|STARTED|Washout Period 1 (7 Days)||5
7739362|NCT01561976|19056127|P6|NOT COMPLETED|Period 1||0
7739363|NCT01561976|19056128|P5|NOT COMPLETED|Period 1||0
7739364|NCT01561976|19056129|P4|NOT COMPLETED|Period 1||0
7739365|NCT01561976|19056130|P3|NOT COMPLETED|Period 1||1
7739366|NCT01561976|19056131|P2|NOT COMPLETED|Period 1||0
7739367|NCT01561976|19056132|P1|NOT COMPLETED|Period 1||0
7739368|NCT01561976|19056127|P6|COMPLETED|Period 1||5
7739369|NCT01561976|19056128|P5|COMPLETED|Period 1||5
7739370|NCT01561976|19056129|P4|COMPLETED|Period 1||5
7739371|NCT01561976|19056130|P3|COMPLETED|Period 1||4
7739372|NCT01561976|19056131|P2|COMPLETED|Period 1||5
7739373|NCT01561976|19056132|P1|COMPLETED|Period 1||5
7739374|NCT01561976|19056127|P6|STARTED|Period 1||5
7739375|NCT01561976|19056128|P5|STARTED|Period 1||5
7739376|NCT01561976|19056129|P4|STARTED|Period 1||5
7739377|NCT01561976|19056130|P3|STARTED|Period 1||5
7739378|NCT01561976|19056131|P2|STARTED|Period 1||5
7739379|NCT01561976|19056132|P1|STARTED|Period 1||5
7739380|NCT01561898|19056165|P4|NOT COMPLETED|Overall Study||20
7739381|NCT01561898|19056166|P3|NOT COMPLETED|Overall Study||44
7739382|NCT01561898|19056167|P2|NOT COMPLETED|Overall Study||41
7739383|NCT01561898|19056168|P1|NOT COMPLETED|Overall Study||2
7739384|NCT01561898|19056165|P4|COMPLETED|Overall Study||12
7739385|NCT01561898|19056166|P3|COMPLETED|Overall Study||53
7739386|NCT01561898|19056167|P2|COMPLETED|Overall Study||51
7739387|NCT01561898|19056168|P1|COMPLETED|Overall Study||5
7739388|NCT01561898|19056165|P4|STARTED|Overall Study||32
7739389|NCT01561898|19056166|P3|STARTED|Overall Study||97
7739390|NCT01561898|19056167|P2|STARTED|Overall Study||92
7739391|NCT01561898|19056168|P1|STARTED|Overall Study||7
7739392|NCT01561833|19056180|P1|NOT COMPLETED|Overall Study||0
7739393|NCT01561833|19056180|P1|COMPLETED|Overall Study||12
7739394|NCT01561833|19056180|P1|STARTED|Overall Study||12
7739395|NCT01561755|19056186|P2|NOT COMPLETED|Overall Study||1
7739396|NCT01561755|19056187|P1|NOT COMPLETED|Overall Study||0
7739397|NCT01561755|19056186|P2|COMPLETED|Overall Study||5
7739398|NCT01561755|19056187|P1|COMPLETED|Overall Study||6
7739399|NCT01561755|19056186|P2|STARTED|Overall Study||6
7739400|NCT01561755|19056187|P1|STARTED|Overall Study||6
7739401|NCT01561716|19056211|P6|NOT COMPLETED|Overall Study||0
7739402|NCT01561716|19056212|P5|NOT COMPLETED|Overall Study||0
7739403|NCT01561716|19056213|P4|NOT COMPLETED|Overall Study||0
7739404|NCT01561716|19056214|P3|NOT COMPLETED|Overall Study||0
7739405|NCT01561716|19056215|P2|NOT COMPLETED|Overall Study||0
7739406|NCT01561716|19056216|P1|NOT COMPLETED|Overall Study||0
7739407|NCT01561716|19056211|P6|COMPLETED|Overall Study||5
7739408|NCT01561716|19056212|P5|COMPLETED|Overall Study||5
7739409|NCT01561716|19056213|P4|COMPLETED|Overall Study||5
7739410|NCT01561716|19056214|P3|COMPLETED|Overall Study||5
7739411|NCT01561716|19056215|P2|COMPLETED|Overall Study||5
7739412|NCT01561716|19056216|P1|COMPLETED|Overall Study||5
7739413|NCT01561716|19056211|P6|STARTED|Overall Study||5
7739414|NCT01561716|19056212|P5|STARTED|Overall Study||5
7739415|NCT01561716|19056213|P4|STARTED|Overall Study||5
7739416|NCT01561716|19056214|P3|STARTED|Overall Study||5
7739417|NCT01561716|19056215|P2|STARTED|Overall Study||5
7739418|NCT01561716|19056216|P1|STARTED|Overall Study||5
7739419|NCT01561703|19056232|P2|NOT COMPLETED|Overall Study||6
7739420|NCT01561703|19056233|P1|NOT COMPLETED|Overall Study||8
7739421|NCT01561703|19056232|P2|COMPLETED|Overall Study||24
7739422|NCT01561703|19056233|P1|COMPLETED|Overall Study||20
7739423|NCT01561703|19056232|P2|STARTED|Overall Study||30
7739424|NCT01561703|19056233|P1|STARTED|Overall Study||28
7739425|NCT01561560|19056239|P2|NOT COMPLETED|Second Two Weeks of Wear||1
7739426|NCT01561560|19056240|P1|NOT COMPLETED|Second Two Weeks of Wear||0
7739427|NCT01561560|19056239|P2|COMPLETED|Second Two Weeks of Wear||58
7739428|NCT01561560|19056240|P1|COMPLETED|Second Two Weeks of Wear||60
7739429|NCT01561560|19056239|P2|STARTED|Second Two Weeks of Wear||59
7739430|NCT01561560|19056240|P1|STARTED|Second Two Weeks of Wear||60
7739431|NCT01561560|19056239|P2|NOT COMPLETED|First Two Weeks of Wear||2
7739432|NCT01561560|19056240|P1|NOT COMPLETED|First Two Weeks of Wear||0
7739433|NCT01561560|19056239|P2|COMPLETED|First Two Weeks of Wear||59
7739434|NCT01561560|19056240|P1|COMPLETED|First Two Weeks of Wear||60
7739435|NCT01561560|19056239|P2|STARTED|First Two Weeks of Wear||61
7739436|NCT01561560|19056240|P1|STARTED|First Two Weeks of Wear||60
7739437|NCT01561495|19056246|P1|NOT COMPLETED|Overall Study||0
7739438|NCT01561495|19056246|P1|COMPLETED|Overall Study||1
7739439|NCT01561495|19056246|P1|STARTED|Overall Study||1
7739440|NCT01561469|19056252|P2|NOT COMPLETED|Overall Study||0
7739441|NCT01561469|19056253|P1|NOT COMPLETED|Overall Study||0
7739442|NCT01561469|19056252|P2|COMPLETED|Overall Study||87
7739443|NCT01561469|19056253|P1|COMPLETED|Overall Study||101
7739444|NCT01561469|19056252|P2|STARTED|Overall Study||87
7739445|NCT01561469|19056253|P1|STARTED|Overall Study||101
7739446|NCT01561430|19056275|P4|NOT COMPLETED|Overall Study||13
7739447|NCT01561430|19056276|P3|NOT COMPLETED|Overall Study||17
7739448|NCT01561430|19056277|P2|NOT COMPLETED|Overall Study||15
7739449|NCT01561430|19056278|P1|NOT COMPLETED|Overall Study||1
7739450|NCT01561430|19056275|P4|COMPLETED|Overall Study||7
7739451|NCT01561430|19056276|P3|COMPLETED|Overall Study||1
7739452|NCT01561430|19056277|P2|COMPLETED|Overall Study||8
7739453|NCT01561430|19056278|P1|COMPLETED|Overall Study||8
7739454|NCT01561430|19056275|P4|Received at Least One Dose of Study Drug|Overall Study||20
7739455|NCT01561430|19056276|P3|Received at Least One Dose of Study Drug|Overall Study||18
7739456|NCT01561430|19056277|P2|Received at Least One Dose of Study Drug|Overall Study||23
7739457|NCT01561430|19056278|P1|Received at Least One Dose of Study Drug|Overall Study||9
7739458|NCT01561430|19056275|P4|STARTED|Overall Study||20
7739459|NCT01561430|19056276|P3|STARTED|Overall Study||18
7739460|NCT01561430|19056277|P2|STARTED|Overall Study||23
7739461|NCT01561430|19056278|P1|STARTED|Overall Study||9
7739462|NCT01561378|19056318|P2|NOT COMPLETED|Overall Study||0
7739463|NCT01561378|19056319|P1|NOT COMPLETED|Overall Study||0
7739464|NCT01561378|19056318|P2|COMPLETED|Overall Study||11
7739465|NCT01561378|19056319|P1|COMPLETED|Overall Study||11
7739466|NCT01561378|19056318|P2|STARTED|Overall Study||11
7739467|NCT01561378|19056319|P1|STARTED|Overall Study||11
7739468|NCT01561313|19056341|P2|NOT COMPLETED|Overall Study||0
7739469|NCT01561313|19056342|P1|NOT COMPLETED|Overall Study||2
7739470|NCT01561313|19056341|P2|COMPLETED|Overall Study||31
7739471|NCT01561313|19056342|P1|COMPLETED|Overall Study||31
7739472|NCT01561313|19056341|P2|STARTED|Overall Study||31
7739473|NCT01561313|19056342|P1|STARTED|Overall Study||33
7739474|NCT01561300|19056360|P2|NOT COMPLETED|Second Intervention||0
7739475|NCT01561300|19056361|P1|NOT COMPLETED|Second Intervention||0
7739476|NCT01561300|19056360|P2|COMPLETED|Second Intervention||15
7739477|NCT01561300|19056361|P1|COMPLETED|Second Intervention||14
7739478|NCT01561300|19056360|P2|STARTED|Second Intervention||15
7739479|NCT01561300|19056361|P1|STARTED|Second Intervention||14
7739480|NCT01561300|19056360|P2|NOT COMPLETED|Washout on Placebo||0
7739481|NCT01561300|19056361|P1|NOT COMPLETED|Washout on Placebo||0
7739482|NCT01561300|19056360|P2|COMPLETED|Washout on Placebo||15
7739483|NCT01561300|19056361|P1|COMPLETED|Washout on Placebo||14
7739484|NCT01561300|19056360|P2|STARTED|Washout on Placebo||15
7739485|NCT01561300|19056361|P1|STARTED|Washout on Placebo||14
7739486|NCT01561300|19056360|P2|NOT COMPLETED|First Intervention||0
7739487|NCT01561300|19056361|P1|NOT COMPLETED|First Intervention||0
7739488|NCT01561300|19056360|P2|COMPLETED|First Intervention||15
7739489|NCT01561300|19056361|P1|COMPLETED|First Intervention||14
7739490|NCT01561300|19056360|P2|STARTED|First Intervention||15
7739491|NCT01561300|19056361|P1|STARTED|First Intervention||14
7739492|NCT01561300|19056360|P2|NOT COMPLETED|Run in on Placebo||0
7739493|NCT01561300|19056361|P1|NOT COMPLETED|Run in on Placebo||1
7739494|NCT01561300|19056360|P2|COMPLETED|Run in on Placebo||15
7739495|NCT01561300|19056361|P1|COMPLETED|Run in on Placebo||14
7739496|NCT01561300|19056360|P2|STARTED|Run in on Placebo||15
7739497|NCT01561300|19056361|P1|STARTED|Run in on Placebo||15
7739498|NCT01561079|19056372|P1|NOT COMPLETED|Overall Study||78
7739499|NCT01561079|19056372|P1|COMPLETED|Overall Study||49
7739500|NCT01561079|19056372|P1|STARTED|Overall Study||127
7739501|NCT01561053|19056419|P4|NOT COMPLETED|Overall Study||23
7739502|NCT01561053|19056420|P3|NOT COMPLETED|Overall Study||21
7739503|NCT01561053|19056421|P2|NOT COMPLETED|Overall Study||36
7739504|NCT01561053|19056422|P1|NOT COMPLETED|Overall Study||35
7739505|NCT01561053|19056419|P4|COMPLETED|Overall Study||64
7739506|NCT01561053|19056420|P3|COMPLETED|Overall Study||61
7739507|NCT01561053|19056421|P2|COMPLETED|Overall Study||56
7739508|NCT01561053|19056422|P1|COMPLETED|Overall Study||51
7739509|NCT01561053|19056419|P4|Evaluable Subjects|Overall Study||80
7739510|NCT01561053|19056420|P3|Evaluable Subjects|Overall Study||78
7739511|NCT01561053|19056421|P2|Evaluable Subjects|Overall Study||86
7739512|NCT01561053|19056422|P1|Evaluable Subjects|Overall Study||78
7739513|NCT01561053|19056419|P4|Randomized Not Treated|Overall Study||7
7739514|NCT01561053|19056420|P3|Randomized Not Treated|Overall Study||4
7739515|NCT01561053|19056421|P2|Randomized Not Treated|Overall Study||6
7739516|NCT01561053|19056422|P1|Randomized Not Treated|Overall Study||8
7739517|NCT01561053|19056419|P4|Patients With Baseline MMSE:22-26|Overall Study||45
7739518|NCT01561053|19056420|P3|Patients With Baseline MMSE:22-26|Overall Study||35
7739519|NCT01561053|19056421|P2|Patients With Baseline MMSE:22-26|Overall Study||52
7739520|NCT01561053|19056422|P1|Patients With Baseline MMSE:22-26|Overall Study||39
7739521|NCT01561053|19056419|P4|Patients With Baseline MMSE:18-21|Overall Study||42
7739522|NCT01561053|19056420|P3|Patients With Baseline MMSE:18-21|Overall Study||47
7739523|NCT01561053|19056421|P2|Patients With Baseline MMSE:18-21|Overall Study||40
7739524|NCT01561053|19056422|P1|Patients With Baseline MMSE:18-21|Overall Study||47
7739525|NCT01561053|19056419|P4|STARTED|Overall Study||87
7739526|NCT01561053|19056420|P3|STARTED|Overall Study||82
7739527|NCT01561053|19056421|P2|STARTED|Overall Study||92
7739528|NCT01561053|19056422|P1|STARTED|Overall Study||86
7739529|NCT01560988|19056458|P2|NOT COMPLETED|Second Intervention (Six Weeks)||2
7739530|NCT01560988|19056459|P1|NOT COMPLETED|Second Intervention (Six Weeks)||2
7739531|NCT01560988|19056458|P2|COMPLETED|Second Intervention (Six Weeks)||22
7739532|NCT01560988|19056459|P1|COMPLETED|Second Intervention (Six Weeks)||18
7739533|NCT01560988|19056458|P2|STARTED|Second Intervention (Six Weeks)||24
7739534|NCT01560988|19056459|P1|STARTED|Second Intervention (Six Weeks)||20
7739535|NCT01560988|19056458|P2|NOT COMPLETED|Washout (Six Weeks)||2
7739536|NCT01560988|19056459|P1|NOT COMPLETED|Washout (Six Weeks)||2
7739537|NCT01560988|19056458|P2|COMPLETED|Washout (Six Weeks)||24
7739538|NCT01560988|19056459|P1|COMPLETED|Washout (Six Weeks)||20
7739539|NCT01560988|19056458|P2|STARTED|Washout (Six Weeks)||26
7739540|NCT01560988|19056459|P1|STARTED|Washout (Six Weeks)||22
7739541|NCT01560988|19056458|P2|NOT COMPLETED|First Intervention (Six Weeks)||4
7739542|NCT01560988|19056459|P1|NOT COMPLETED|First Intervention (Six Weeks)||10
7739543|NCT01560988|19056458|P2|COMPLETED|First Intervention (Six Weeks)||26
7739544|NCT01560988|19056459|P1|COMPLETED|First Intervention (Six Weeks)||22
7739545|NCT01560988|19056458|P2|STARTED|First Intervention (Six Weeks)||30
7739546|NCT01560988|19056459|P1|STARTED|First Intervention (Six Weeks)||32
7739547|NCT01560975|19056482|P1|NOT COMPLETED|Overall Study||0
7739548|NCT01560975|19056482|P1|COMPLETED|Overall Study||10
7739549|NCT01560975|19056482|P1|STARTED|Overall Study||10
7739550|NCT01560949|19056495|P1|NOT COMPLETED|Surgery Phase||3
7739551|NCT01560949|19056495|P1|COMPLETED|Surgery Phase||15
7739552|NCT01560949|19056495|P1|STARTED|Surgery Phase||18
7739553|NCT01560949|19056495|P1|NOT COMPLETED|Chemoradiation Phase: With Gemcitabine||0
7739554|NCT01560949|19056495|P1|COMPLETED|Chemoradiation Phase: With Gemcitabine||23
7739555|NCT01560949|19056495|P1|STARTED|Chemoradiation Phase: With Gemcitabine||23
7739556|NCT01560949|19056495|P1|NOT COMPLETED|Systemic Phase: mFOLFIRINOX||6
7739557|NCT01560949|19056495|P1|COMPLETED|Systemic Phase: mFOLFIRINOX||27
7739558|NCT01560949|19056495|P1|STARTED|Systemic Phase: mFOLFIRINOX||33
7739559|NCT01560923|19056510|P2|NOT COMPLETED|Overall Study||0
7739560|NCT01560923|19056511|P1|NOT COMPLETED|Overall Study||0
7739561|NCT01560923|19056510|P2|COMPLETED|Overall Study||22
7739562|NCT01560923|19056511|P1|COMPLETED|Overall Study||24
7739563|NCT01560923|19056510|P2|STARTED|Overall Study||22
7739564|NCT01560923|19056511|P1|STARTED|Overall Study||24
7739565|NCT01560871|19056529|P2|NOT COMPLETED|Overall Study||2
7739566|NCT01560871|19056530|P1|NOT COMPLETED|Overall Study||6
7739567|NCT01560871|19056529|P2|COMPLETED|Overall Study||5
7739568|NCT01560871|19056530|P1|COMPLETED|Overall Study||3
7739569|NCT01560871|19056529|P2|STARTED|Overall Study||7
7739570|NCT01560871|19056530|P1|STARTED|Overall Study||9
7739571|NCT01560819|19056546|P2|NOT COMPLETED|Overall Study||0
7739572|NCT01560819|19056547|P1|NOT COMPLETED|Overall Study||1
7739573|NCT01560819|19056546|P2|COMPLETED|Overall Study||10
7739574|NCT01560819|19056547|P1|COMPLETED|Overall Study||9
7739575|NCT01560819|19056546|P2|STARTED|Overall Study||10
7739576|NCT01560819|19056547|P1|STARTED|Overall Study||10
7739577|NCT01560780|19056553|P2|NOT COMPLETED|Overall Study||12
7739578|NCT01560780|19056554|P1|NOT COMPLETED|Overall Study||13
7739579|NCT01560780|19056553|P2|COMPLETED|Overall Study||30
7739580|NCT01560780|19056554|P1|COMPLETED|Overall Study||29
7739581|NCT01560780|19056553|P2|Completed Study Drug for 12 Months|Overall Study||27
7739582|NCT01560780|19056554|P1|Completed Study Drug for 12 Months|Overall Study||27
7739583|NCT01560780|19056553|P2|Clinical Follow-Up at 12 Months|Overall Study||42
7739584|NCT01560780|19056554|P1|Clinical Follow-Up at 12 Months|Overall Study||42
7739585|NCT01560780|19056553|P2|STARTED|Overall Study||42
7739586|NCT01560780|19056554|P1|STARTED|Overall Study||42
7739587|NCT01560624|19056574|P2|NOT COMPLETED|Overall Study||189
7739588|NCT01560624|19056575|P1|NOT COMPLETED|Overall Study||198
7739589|NCT01560624|19056574|P2|COMPLETED|Overall Study||155
7739590|NCT01560624|19056575|P1|COMPLETED|Overall Study||148
7739591|NCT01560624|19056574|P2|Early Discontinuation From Treatment|Overall Study||56
7739592|NCT01560624|19056575|P1|Early Discontinuation From Treatment|Overall Study||107
7739593|NCT01560624|19056574|P2|Clinical Worsening Event|Overall Study||133
7739594|NCT01560624|19056575|P1|Clinical Worsening Event|Overall Study||91
7739595|NCT01560624|19056574|P2|STARTED|Overall Study||344
7739596|NCT01560624|19056575|P1|STARTED|Overall Study||346
7739597|NCT01560507|19056590|P3|NOT COMPLETED|Overall Study||2
7739598|NCT01560507|19056591|P2|NOT COMPLETED|Overall Study||2
7739599|NCT01560507|19056592|P1|NOT COMPLETED|Overall Study||4
7739600|NCT01560507|19056590|P3|COMPLETED|Overall Study||0
7739601|NCT01560507|19056591|P2|COMPLETED|Overall Study||0
7739602|NCT01560507|19056592|P1|COMPLETED|Overall Study||1
7739603|NCT01560507|19056590|P3|STARTED|Overall Study||2
7739604|NCT01560507|19056591|P2|STARTED|Overall Study||2
7739605|NCT01560507|19056592|P1|STARTED|Overall Study||5
7739606|NCT01560429|19056605|P2|NOT COMPLETED|Overall Study||6
7739607|NCT01560429|19056606|P1|NOT COMPLETED|Overall Study||3
7739608|NCT01560429|19056605|P2|COMPLETED|Overall Study||20
7739609|NCT01560429|19056606|P1|COMPLETED|Overall Study||23
7739610|NCT01560429|19056605|P2|STARTED|Overall Study||26
7739611|NCT01560429|19056606|P1|STARTED|Overall Study||26
7739612|NCT01560416|19056616|P2|NOT COMPLETED|Crossover Phase||0
7739613|NCT01560416|19056617|P1|NOT COMPLETED|Crossover Phase||0
7739614|NCT01560416|19056616|P2|COMPLETED|Crossover Phase||0
7739615|NCT01560416|19056617|P1|COMPLETED|Crossover Phase||7
7739616|NCT01560416|19056616|P2|STARTED|Crossover Phase||0
7739617|NCT01560416|19056617|P1|STARTED|Crossover Phase||7
7739618|NCT01560416|19056616|P2|NOT COMPLETED|Randomized Phase||0
7739619|NCT01560416|19056617|P1|NOT COMPLETED|Randomized Phase||7
7739620|NCT01560416|19056616|P2|COMPLETED|Randomized Phase||35
7739621|NCT01560416|19056617|P1|COMPLETED|Randomized Phase||8
7739622|NCT01560416|19056616|P2|STARTED|Randomized Phase||35
7739623|NCT01560416|19056617|P1|STARTED|Randomized Phase||15
7739624|NCT01560403|19056635|P2|NOT COMPLETED|Overall Study||1
7739625|NCT01560403|19056636|P1|NOT COMPLETED|Overall Study||0
7739626|NCT01560403|19056635|P2|COMPLETED|Overall Study||8
7739627|NCT01560403|19056636|P1|COMPLETED|Overall Study||5
7739628|NCT01560403|19056635|P2|STARTED|Overall Study||9
7739629|NCT01560403|19056636|P1|STARTED|Overall Study||5
7739630|NCT01560377|19056642|P1|NOT COMPLETED|Overall Study||0
7739631|NCT01560377|19056642|P1|COMPLETED|Overall Study||147
7739632|NCT01560377|19056642|P1|Eligible for Analysis|Overall Study||139
7739633|NCT01560377|19056642|P1|STARTED|Overall Study||147
7739634|NCT01560286|19056647|P1|NOT COMPLETED|Overall Study||0
7739635|NCT01560286|19056647|P1|COMPLETED|Overall Study||24
7739636|NCT01560286|19056647|P1|STARTED|Overall Study||24
7739637|NCT01560260|19056660|P1|NOT COMPLETED|Overall Study||0
7739638|NCT01560260|19056660|P1|COMPLETED|Overall Study||20
7739639|NCT01560260|19056660|P1|STARTED|Overall Study||20
7739640|NCT01560234|19056684|P8|NOT COMPLETED|Overall Study||2
7739641|NCT01560234|19056685|P7|NOT COMPLETED|Overall Study||0
7739642|NCT01560234|19056686|P6|NOT COMPLETED|Overall Study||2
7739643|NCT01560234|19056687|P5|NOT COMPLETED|Overall Study||0
7739644|NCT01560234|19056688|P4|NOT COMPLETED|Overall Study||0
7739645|NCT01560234|19056689|P3|NOT COMPLETED|Overall Study||1
7739646|NCT01560234|19056690|P2|NOT COMPLETED|Overall Study||0
7739647|NCT01560234|19056691|P1|NOT COMPLETED|Overall Study||3
7739648|NCT01560234|19056684|P8|COMPLETED|Overall Study||6
7739649|NCT01560234|19056685|P7|COMPLETED|Overall Study||4
7739650|NCT01560234|19056686|P6|COMPLETED|Overall Study||2
7739651|NCT01560234|19056687|P5|COMPLETED|Overall Study||4
7739652|NCT01560234|19056688|P4|COMPLETED|Overall Study||3
7739653|NCT01560234|19056689|P3|COMPLETED|Overall Study||3
7739654|NCT01560234|19056690|P2|COMPLETED|Overall Study||4
7739655|NCT01560234|19056691|P1|COMPLETED|Overall Study||13
7739656|NCT01560234|19056684|P8|STARTED|Overall Study||8
7739657|NCT01560234|19056685|P7|STARTED|Overall Study||4
7739658|NCT01560234|19056686|P6|STARTED|Overall Study||4
7739659|NCT01560234|19056687|P5|STARTED|Overall Study||4
7739660|NCT01560234|19056688|P4|STARTED|Overall Study||3
7739661|NCT01560234|19056689|P3|STARTED|Overall Study||4
7739662|NCT01560234|19056690|P2|STARTED|Overall Study||4
7739663|NCT01560234|19056691|P1|STARTED|Overall Study||16
7739664|NCT01560143|19056765|P1|NOT COMPLETED|Overall Study||0
7739665|NCT01560143|19056765|P1|COMPLETED|Overall Study||12
7739666|NCT01560143|19056765|P1|STARTED|Overall Study||12
7739667|NCT01559948|19056771|P2|NOT COMPLETED|Overall Study||0
7739668|NCT01559948|19056772|P1|NOT COMPLETED|Overall Study||0
7739669|NCT01559948|19056771|P2|COMPLETED|Overall Study||15
7739670|NCT01559948|19056772|P1|COMPLETED|Overall Study||15
7739671|NCT01559948|19056771|P2|STARTED|Overall Study||15
7739672|NCT01559948|19056772|P1|STARTED|Overall Study||15
7739673|NCT01559935|19056786|P1|NOT COMPLETED|Maintenance Phase||54
7739674|NCT01559935|19056786|P1|COMPLETED|Maintenance Phase||0
7739675|NCT01559935|19056786|P1|STARTED|Maintenance Phase||54
7739676|NCT01559935|19056786|P1|NOT COMPLETED|BiRD Phase||4
7739677|NCT01559935|19056786|P1|COMPLETED|BiRD Phase||54
7739678|NCT01559935|19056786|P1|STARTED|BiRD Phase||58
7739679|NCT01559935|19056786|P1|NOT COMPLETED|Car Phase||14
7739680|NCT01559935|19056786|P1|COMPLETED|Car Phase||58
7739681|NCT01559935|19056786|P1|STARTED|Car Phase||72
7739682|NCT01559922|19056796|P2|NOT COMPLETED|Overall Study||10
7739683|NCT01559922|19056797|P1|NOT COMPLETED|Overall Study||4
7739684|NCT01559922|19056796|P2|COMPLETED|Overall Study||87
7739685|NCT01559922|19056797|P1|COMPLETED|Overall Study||46
7739686|NCT01559922|19056796|P2|STARTED|Overall Study||97
7739687|NCT01559922|19056797|P1|STARTED|Overall Study||50
7739688|NCT01559857|19056805|P2|NOT COMPLETED|Overall Study||0
7739689|NCT01559857|19056806|P1|NOT COMPLETED|Overall Study||0
7739690|NCT01559857|19056805|P2|COMPLETED|Overall Study||18
7739691|NCT01559857|19056806|P1|COMPLETED|Overall Study||19
7739692|NCT01559857|19056805|P2|STARTED|Overall Study||18
7739693|NCT01559857|19056806|P1|STARTED|Overall Study||19
7739694|NCT01559844|19056822|P1|NOT COMPLETED|Overall Study||25
7739695|NCT01559844|19056822|P1|COMPLETED|Overall Study||36
7739696|NCT01559844|19056822|P1|STARTED|Overall Study||61
7739697|NCT01559675|19056835|P2|NOT COMPLETED|Overall Study||14
7739698|NCT01559675|19056836|P1|NOT COMPLETED|Overall Study||15
7739699|NCT01559675|19056835|P2|COMPLETED|Overall Study||49
7739700|NCT01559675|19056836|P1|COMPLETED|Overall Study||43
7739701|NCT01559675|19056835|P2|STARTED|Overall Study||63
7739702|NCT01559675|19056836|P1|STARTED|Overall Study||58
7739703|NCT01559649|19056844|P2|NOT COMPLETED|Overall Study||6
7739704|NCT01559649|19056845|P1|NOT COMPLETED|Overall Study||19
7739705|NCT01559649|19056844|P2|COMPLETED|Overall Study||9
7739706|NCT01559649|19056845|P1|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250
7739707|NCT01559649|19056844|P2|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15
7739708|NCT01559649|19056845|P1|STARTED|Overall Study||269
7739709|NCT01559506|19056858|P2|NOT COMPLETED|Overall Study||3
7739710|NCT01559506|19056859|P1|NOT COMPLETED|Overall Study||0
7739711|NCT01559506|19056858|P2|COMPLETED|Overall Study||18
7739712|NCT01559506|19056859|P1|COMPLETED|Overall Study||20
7739713|NCT01559506|19056858|P2|STARTED|Overall Study||21
7739714|NCT01559506|19056859|P1|STARTED|Overall Study||20
7739715|NCT01559454|19056867|P2|NOT COMPLETED|Overall Study||6
7739716|NCT01559454|19056868|P1|NOT COMPLETED|Overall Study||3
7739717|NCT01559454|19056867|P2|COMPLETED|Overall Study||4
7739718|NCT01559454|19056868|P1|COMPLETED|Overall Study||6
7739719|NCT01559454|19056867|P2|STARTED|Overall Study||10
7739720|NCT01559454|19056868|P1|STARTED|Overall Study||9
7739721|NCT01559389|19056886|P2|NOT COMPLETED|Overall Study||20
7739722|NCT01559389|19056887|P1|NOT COMPLETED|Overall Study||20
7739723|NCT01559389|19056886|P2|COMPLETED|Overall Study||49
7739724|NCT01559389|19056887|P1|COMPLETED|Overall Study||49
7739725|NCT01559389|19056886|P2|STARTED|Overall Study||69
7739726|NCT01559389|19056887|P1|STARTED|Overall Study||69
7739727|NCT01559311|19056900|P3|NOT COMPLETED|Overall Study||8
7739728|NCT01559311|19056901|P2|NOT COMPLETED|Overall Study||6
7739729|NCT01559311|19056902|P1|NOT COMPLETED|Overall Study||3
7739730|NCT01559311|19056900|P3|COMPLETED|Overall Study|12-Month|26
7739731|NCT01559311|19056901|P2|COMPLETED|Overall Study|12-Month|28
7739732|NCT01559311|19056902|P1|COMPLETED|Overall Study|12-Month|27
7739733|NCT01559311|19056900|P3|6-Month|Overall Study||28
7739734|NCT01559311|19056901|P2|6-Month|Overall Study||33
7739735|NCT01559311|19056902|P1|6-Month|Overall Study||27
7739736|NCT01559311|19056900|P3|3-Month|Overall Study||29
7739737|NCT01559311|19056901|P2|3-Month|Overall Study||34
7739738|NCT01559311|19056902|P1|3-Month|Overall Study||27
7739739|NCT01559311|19056900|P3|1-Month|Overall Study||29
7739740|NCT01559311|19056901|P2|1-Month|Overall Study||34
7739741|NCT01559311|19056902|P1|1-Month|Overall Study||27
7739742|NCT01559311|19056900|P3|Implant|Overall Study||32
7739743|NCT01559311|19056901|P2|Implant|Overall Study||34
7739744|NCT01559311|19056902|P1|Implant|Overall Study||28
7739745|NCT01559311|19056900|P3|STARTED|Overall Study|Enrollment & Baseline|34
7739746|NCT01559311|19056901|P2|STARTED|Overall Study|Enrollment & Baseline|34
7739747|NCT01559311|19056902|P1|STARTED|Overall Study|Enrollment & Baseline|30
7739748|NCT01559259|19056918|P5|NOT COMPLETED|Overall Study||0
7739749|NCT01559259|19056919|P4|NOT COMPLETED|Overall Study||1
7739750|NCT01559259|19056920|P3|NOT COMPLETED|Overall Study||1
7739751|NCT01559259|19056921|P2|NOT COMPLETED|Overall Study||1
7739752|NCT01559259|19056922|P1|NOT COMPLETED|Overall Study||0
7739753|NCT01559259|19056918|P5|COMPLETED|Overall Study||92
7739754|NCT01559259|19056919|P4|COMPLETED|Overall Study||88
7739755|NCT01559259|19056920|P3|COMPLETED|Overall Study||92
7739756|NCT01559259|19056921|P2|COMPLETED|Overall Study||89
7739757|NCT01559259|19056922|P1|COMPLETED|Overall Study||30
7739758|NCT01559259|19056918|P5|STARTED|Overall Study||92
7739759|NCT01559259|19056919|P4|STARTED|Overall Study||89
7739760|NCT01559259|19056920|P3|STARTED|Overall Study||93
7739761|NCT01559259|19056921|P2|STARTED|Overall Study||90
7739762|NCT01559259|19056922|P1|STARTED|Overall Study||30
7739763|NCT01559129|19057011|P2|NOT COMPLETED|Open-label Extension Period||2
7739764|NCT01559129|19057012|P1|NOT COMPLETED|Open-label Extension Period||6
7739765|NCT01559129|19057011|P2|COMPLETED|Open-label Extension Period||0
7739766|NCT01559129|19057012|P1|COMPLETED|Open-label Extension Period||0
7739767|NCT01559129|19057011|P2|STARTED|Open-label Extension Period|Two participants elected not to enter the Extension Phase.|2
7739768|NCT01559129|19057012|P1|STARTED|Open-label Extension Period|One participant elected not to enter the Extension Phase.|6
7739769|NCT01559129|19057011|P2|NOT COMPLETED|Treatment Phase||7
7739770|NCT01559129|19057012|P1|NOT COMPLETED|Treatment Phase||5
7739771|NCT01559129|19057011|P2|COMPLETED|Treatment Phase||4
7739772|NCT01559129|19057012|P1|COMPLETED|Treatment Phase||7
7739773|NCT01559129|19057011|P2|Received Treatment|Treatment Phase||10
7739774|NCT01559129|19057012|P1|Received Treatment|Treatment Phase||12
7739775|NCT01559129|19057011|P2|STARTED|Treatment Phase||11
7739776|NCT01559129|19057012|P1|STARTED|Treatment Phase||12
7739777|NCT01559116|19057088|P1|NOT COMPLETED|Overall Study||26
7739778|NCT01559116|19057088|P1|COMPLETED|Overall Study|Completed all 4 treatment periods|193
7739779|NCT01559116|19057088|P1|STARTED|Overall Study|Randomised|219
7739780|NCT01559090|19057159|P3|NOT COMPLETED|Stage II||0
7739781|NCT01559090|19057160|P2|NOT COMPLETED|Stage II||0
7739782|NCT01559090|19057161|P1|NOT COMPLETED|Stage II||1
7739783|NCT01559090|19057159|P3|COMPLETED|Stage II||2
7739784|NCT01559090|19057160|P2|COMPLETED|Stage II||3
7739785|NCT01559090|19057161|P1|COMPLETED|Stage II||3
7739786|NCT01559090|19057159|P3|STARTED|Stage II|One subject who completed Stage I did not agree to participate in Stage II|2
7739787|NCT01559090|19057160|P2|STARTED|Stage II||3
7739788|NCT01559090|19057161|P1|STARTED|Stage II||4
7739789|NCT01559090|19057159|P3|NOT COMPLETED|Stage I||3
7739790|NCT01559090|19057160|P2|NOT COMPLETED|Stage I||2
7739791|NCT01559090|19057161|P1|NOT COMPLETED|Stage I||2
7739792|NCT01559090|19057159|P3|COMPLETED|Stage I||3
7739793|NCT01559090|19057160|P2|COMPLETED|Stage I||3
7739794|NCT01559090|19057161|P1|COMPLETED|Stage I||4
7739795|NCT01559090|19057159|P3|STARTED|Stage I||6
7739796|NCT01559090|19057160|P2|STARTED|Stage I||5
7739797|NCT01559090|19057161|P1|STARTED|Stage I||6
7739798|NCT01559064|19057181|P3|NOT COMPLETED|Overall Study||2
7739799|NCT01559064|19057182|P2|NOT COMPLETED|Overall Study||1
7739800|NCT01559064|19057183|P1|NOT COMPLETED|Overall Study||1
7739801|NCT01559064|19057181|P3|COMPLETED|Overall Study||57
7739802|NCT01559064|19057182|P2|COMPLETED|Overall Study||39
7739803|NCT01559064|19057183|P1|COMPLETED|Overall Study||15
7739804|NCT01559064|19057181|P3|STARTED|Overall Study||59
7739805|NCT01559064|19057182|P2|STARTED|Overall Study||40
7739806|NCT01559064|19057183|P1|STARTED|Overall Study||16
7739807|NCT01559012|19057193|P2|NOT COMPLETED|Overall Study||1
7739808|NCT01559012|19057194|P1|NOT COMPLETED|Overall Study||0
7739809|NCT01559012|19057193|P2|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6
7739810|NCT01559012|19057194|P1|COMPLETED|Overall Study||6
7739811|NCT01559012|19057193|P2|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7
7739812|NCT01559012|19057194|P1|STARTED|Overall Study||6
7739813|NCT01558791|19057219|P2|NOT COMPLETED|Overall Study||0
7739814|NCT01558791|19057220|P1|NOT COMPLETED|Overall Study||0
7739815|NCT01558791|19057219|P2|COMPLETED|Overall Study||629
7739816|NCT01558791|19057220|P1|COMPLETED|Overall Study||607
7739817|NCT01558791|19057219|P2|STARTED|Overall Study||629
7739818|NCT01558791|19057220|P1|STARTED|Overall Study||607
7739819|NCT01558752|19057234|P2|NOT COMPLETED|Overall Study||0
7739820|NCT01558752|19057235|P1|NOT COMPLETED|Overall Study||2
7739821|NCT01558752|19057234|P2|COMPLETED|Overall Study||46
7739822|NCT01558752|19057235|P1|COMPLETED|Overall Study||40
7739823|NCT01558752|19057234|P2|STARTED|Overall Study||46
7739824|NCT01558752|19057235|P1|STARTED|Overall Study||42
7739825|NCT01558739|19057241|P1|NOT COMPLETED|Overall Study||17
7739826|NCT01558739|19057241|P1|COMPLETED|Overall Study||31
7739827|NCT01558739|19057241|P1|STARTED|Overall Study||48
7739828|NCT01558700|19057255|P2|NOT COMPLETED|Overall Study||0
7739829|NCT01558700|19057256|P1|NOT COMPLETED|Overall Study||0
7739830|NCT01558700|19057255|P2|COMPLETED|Overall Study||21
7739831|NCT01558700|19057256|P1|COMPLETED|Overall Study||19
7739832|NCT01558700|19057255|P2|STARTED|Overall Study||21
7739833|NCT01558700|19057256|P1|STARTED|Overall Study||19
7739834|NCT01558674|19057266|P2|NOT COMPLETED|Part 2||0
7739835|NCT01558674|19057267|P1|NOT COMPLETED|Part 2||0
7739836|NCT01558674|19057266|P2|COMPLETED|Part 2||0
7739837|NCT01558674|19057267|P1|COMPLETED|Part 2||0
7739838|NCT01558674|19057266|P2|STARTED|Part 2||0
7739839|NCT01558674|19057267|P1|STARTED|Part 2||0
7739840|NCT01558674|19057266|P2|NOT COMPLETED|Part 1||0
7739841|NCT01558674|19057267|P1|NOT COMPLETED|Part 1||11
7739842|NCT01558674|19057266|P2|COMPLETED|Part 1||0
7739843|NCT01558674|19057267|P1|COMPLETED|Part 1||0
7739844|NCT01558674|19057266|P2|STARTED|Part 1||0
7739845|NCT01558674|19057267|P1|STARTED|Part 1||11
7739846|NCT01558661|19057311|P1|NOT COMPLETED|Overall Study||0
7739847|NCT01558661|19057311|P1|COMPLETED|Overall Study||33
7739848|NCT01558661|19057311|P1|Second Stage|Overall Study||15
7739849|NCT01558661|19057311|P1|First Stage|Overall Study||18
7739850|NCT01558661|19057311|P1|STARTED|Overall Study||33
7739851|NCT01558635|19057318|P1|NOT COMPLETED|Overall Study||6
7739852|NCT01558635|19057318|P1|COMPLETED|Overall Study||11
7739853|NCT01558635|19057318|P1|6 Months Post-procedure|Overall Study||14
7739854|NCT01558635|19057318|P1|3 Months Post-procedure|Overall Study||14
7739855|NCT01558635|19057318|P1|Discharge /1 Month Post-procedure|Overall Study||15
7739856|NCT01558635|19057318|P1|Treated|Overall Study||17
7739857|NCT01558635|19057318|P1|STARTED|Overall Study||17
7739858|NCT01558596|19057335|P2|NOT COMPLETED|Overall Study||1
7739859|NCT01558596|19057336|P1|NOT COMPLETED|Overall Study||3
7739860|NCT01558596|19057335|P2|COMPLETED|Overall Study||100
7739861|NCT01558596|19057336|P1|COMPLETED|Overall Study||101
7739862|NCT01558596|19057335|P2|STARTED|Overall Study||101
7739863|NCT01558596|19057336|P1|STARTED|Overall Study||104
7739864|NCT01558492|19057342|P1|NOT COMPLETED|Overall Study||0
7739865|NCT01558492|19057342|P1|COMPLETED|Overall Study||3
7739866|NCT01558492|19057342|P1|STARTED|Overall Study||3
7739867|NCT01558297|19057351|P3|NOT COMPLETED|Overall Study||1
7739868|NCT01558297|19057352|P2|NOT COMPLETED|Overall Study||2
7739869|NCT01558297|19057353|P1|NOT COMPLETED|Overall Study||2
7739870|NCT01558297|19057351|P3|COMPLETED|Overall Study||29
7739871|NCT01558297|19057352|P2|COMPLETED|Overall Study||27
7739872|NCT01558297|19057353|P1|COMPLETED|Overall Study||28
7739873|NCT01558297|19057351|P3|STARTED|Overall Study||30
7739874|NCT01558297|19057352|P2|STARTED|Overall Study||29
7739875|NCT01558297|19057353|P1|STARTED|Overall Study||30
7739876|NCT01558271|19057370|P3|NOT COMPLETED|Overall Study||17
7739877|NCT01558271|19057371|P2|NOT COMPLETED|Overall Study||11
7739878|NCT01558271|19057372|P1|NOT COMPLETED|Overall Study||18
7739879|NCT01558271|19057370|P3|COMPLETED|Overall Study||124
7739880|NCT01558271|19057371|P2|COMPLETED|Overall Study||59
7739881|NCT01558271|19057372|P1|COMPLETED|Overall Study||263
7739882|NCT01558271|19057370|P3|Completed 26 Weeks|Overall Study||128
7739883|NCT01558271|19057371|P2|Completed 26 Weeks|Overall Study||63
7739884|NCT01558271|19057372|P1|Completed 26 Weeks|Overall Study||271
7739885|NCT01558271|19057370|P3|Received at Least 1 Dose of Study Drug|Overall Study||137
7739886|NCT01558271|19057371|P2|Received at Least 1 Dose of Study Drug|Overall Study||70
7739887|NCT01558271|19057372|P1|Received at Least 1 Dose of Study Drug|Overall Study||280
7739888|NCT01558271|19057370|P3|STARTED|Overall Study||141
7739889|NCT01558271|19057371|P2|STARTED|Overall Study||70
7739890|NCT01558271|19057372|P1|STARTED|Overall Study||281
7739891|NCT01558128|19057434|P1|NOT COMPLETED|Overall Study||0
7739892|NCT01558128|19057434|P1|COMPLETED|Overall Study||1
7739893|NCT01558128|19057434|P1|STARTED|Overall Study||1
7739894|NCT01558089|19057438|P1|NOT COMPLETED|Overall Study||13
7739895|NCT01558089|19057438|P1|COMPLETED|Overall Study||63
7739896|NCT01558089|19057438|P1|STARTED|Overall Study||76
7739897|NCT01558063|19057455|P6|NOT COMPLETED|Overall Study||0
7739898|NCT01558063|19057456|P5|NOT COMPLETED|Overall Study||0
7739899|NCT01558063|19057457|P4|NOT COMPLETED|Overall Study||0
7739900|NCT01558063|19057458|P3|NOT COMPLETED|Overall Study||0
7739901|NCT01558063|19057459|P2|NOT COMPLETED|Overall Study||0
7739902|NCT01558063|19057460|P1|NOT COMPLETED|Overall Study||0
7739903|NCT01558063|19057455|P6|COMPLETED|Overall Study||5
7739904|NCT01558063|19057456|P5|COMPLETED|Overall Study||9
7739905|NCT01558063|19057457|P4|COMPLETED|Overall Study||5
7739906|NCT01558063|19057458|P3|COMPLETED|Overall Study||8
7739907|NCT01558063|19057459|P2|COMPLETED|Overall Study||6
7739908|NCT01558063|19057460|P1|COMPLETED|Overall Study||5
7739909|NCT01558063|19057455|P6|STARTED|Overall Study||5
7739910|NCT01558063|19057456|P5|STARTED|Overall Study||9
7739911|NCT01558063|19057457|P4|STARTED|Overall Study||5
7739912|NCT01558063|19057458|P3|STARTED|Overall Study||8
7739913|NCT01558063|19057459|P2|STARTED|Overall Study||6
7739914|NCT01558063|19057460|P1|STARTED|Overall Study||5
7739915|NCT01557959|19057481|P1|NOT COMPLETED|Overall Study||0
7739916|NCT01557959|19057481|P1|COMPLETED|Overall Study||45
7739917|NCT01557959|19057481|P1|STARTED|Overall Study||45
7739918|NCT01557946|19057491|P2|NOT COMPLETED|Overall Study||0
7739919|NCT01557946|19057492|P1|NOT COMPLETED|Overall Study||3
7739920|NCT01557946|19057491|P2|COMPLETED|Overall Study|2 subjects with unusable imaging data.|12
7739921|NCT01557946|19057492|P1|COMPLETED|Overall Study|20 consented and scanned - 1 subject's data not used due to ongoing neurological condition.|17
7739922|NCT01557946|19057491|P2|STARTED|Overall Study||12
7739923|NCT01557946|19057492|P1|STARTED|Overall Study||20
7739924|NCT01557920|19057498|P2|NOT COMPLETED|Overall Study||3
7739925|NCT01557920|19057499|P1|NOT COMPLETED|Overall Study||3
7739926|NCT01557920|19057498|P2|COMPLETED|Overall Study||6
7739927|NCT01557920|19057499|P1|COMPLETED|Overall Study||6
7739928|NCT01557920|19057498|P2|STARTED|Overall Study||9
7739929|NCT01557920|19057499|P1|STARTED|Overall Study||9
7739930|NCT01557894|19057534|P2|NOT COMPLETED|Overall Study||5
7739931|NCT01557894|19057535|P1|NOT COMPLETED|Overall Study||3
7739932|NCT01557894|19057534|P2|COMPLETED|Overall Study||33
7739933|NCT01557894|19057535|P1|COMPLETED|Overall Study||35
7739934|NCT01557894|19057534|P2|STARTED|Overall Study||38
7739935|NCT01557894|19057535|P1|STARTED|Overall Study||38
7739936|NCT01557881|19057549|P1|NOT COMPLETED|Overall Study||0
7739937|NCT01557881|19057549|P1|COMPLETED|Overall Study||98
7739938|NCT01557881|19057549|P1|STARTED|Overall Study||98
7739939|NCT01557868|19057557|P2|NOT COMPLETED|Overall Study||30
7739940|NCT01557868|19057558|P1|NOT COMPLETED|Overall Study||27
7739941|NCT01557868|19057557|P2|COMPLETED|Overall Study||65
7739942|NCT01557868|19057558|P1|COMPLETED|Overall Study||76
7739943|NCT01557868|19057557|P2|STARTED|Overall Study||95
7739944|NCT01557868|19057558|P1|STARTED|Overall Study||103
7739945|NCT01557842|19057568|P2|NOT COMPLETED|Overall Study||6
7739946|NCT01557842|19057569|P1|NOT COMPLETED|Overall Study||9
7739947|NCT01557842|19057568|P2|COMPLETED|Overall Study||0
7739948|NCT01557842|19057569|P1|COMPLETED|Overall Study||0
7739949|NCT01557842|19057568|P2|STARTED|Overall Study||6
7739950|NCT01557842|19057569|P1|STARTED|Overall Study||9
7739951|NCT01557790|19057577|P1|NOT COMPLETED|Overall Study||1
7739952|NCT01557790|19057577|P1|COMPLETED|Overall Study||4
7739953|NCT01557790|19057577|P1|STARTED|Overall Study||5
7739954|NCT01557751|19057581|P1|NOT COMPLETED|Overall Study||3
7739955|NCT01557751|19057581|P1|COMPLETED|Overall Study||153
7739956|NCT01557751|19057581|P1|STARTED|Overall Study||156
7739957|NCT01557699|19057588|P3|NOT COMPLETED|Overall Study||0
7739958|NCT01557699|19057589|P2|NOT COMPLETED|Overall Study||0
7739959|NCT01557699|19057590|P1|NOT COMPLETED|Overall Study||0
7739960|NCT01557699|19057588|P3|COMPLETED|Overall Study||20
7739961|NCT01557699|19057589|P2|COMPLETED|Overall Study||20
7739962|NCT01557699|19057590|P1|COMPLETED|Overall Study||20
7739963|NCT01557699|19057588|P3|STARTED|Overall Study||20
7739964|NCT01557699|19057589|P2|STARTED|Overall Study||20
7739965|NCT01557699|19057590|P1|STARTED|Overall Study||20
7739966|NCT01557595|19057622|P1|NOT COMPLETED|Overall Study||8
7739967|NCT01557595|19057622|P1|COMPLETED|Overall Study||14
7739968|NCT01557595|19057622|P1|STARTED|Overall Study||22
7739969|NCT01557582|19057626|P1|NOT COMPLETED|Overall Study||6
7739970|NCT01557582|19057626|P1|COMPLETED|Overall Study||97
7739971|NCT01557582|19057626|P1|STARTED|Overall Study||103
7739972|NCT01557569|19057634|P2|NOT COMPLETED|Overall Study||7
7739973|NCT01557569|19057635|P1|NOT COMPLETED|Overall Study||5
7739974|NCT01557569|19057634|P2|COMPLETED|Overall Study||0
7739975|NCT01557569|19057635|P1|COMPLETED|Overall Study||1
7739976|NCT01557569|19057634|P2|Completed 2-wk Residential Stay|Overall Study||1
7739977|NCT01557569|19057635|P1|Completed 2-wk Residential Stay|Overall Study||3
7739978|NCT01557569|19057634|P2|STARTED|Overall Study|Those who received at least one dose of medication|7
7739979|NCT01557569|19057635|P1|STARTED|Overall Study|Those who received at least one dose of medication|6
7739980|NCT01557517|19057643|P2|NOT COMPLETED|Overall Study||4
7739981|NCT01557517|19057644|P1|NOT COMPLETED|Overall Study||2
7739982|NCT01557517|19057643|P2|COMPLETED|Overall Study||17
7739983|NCT01557517|19057644|P1|COMPLETED|Overall Study||17
7739984|NCT01557517|19057643|P2|STARTED|Overall Study||21
7739985|NCT01557517|19057644|P1|STARTED|Overall Study||19
7739986|NCT01557504|19057670|P2|NOT COMPLETED|Overall Study||0
7739987|NCT01557504|19057671|P1|NOT COMPLETED|Overall Study||1
7739988|NCT01557504|19057670|P2|COMPLETED|Overall Study||12
7739989|NCT01557504|19057671|P1|COMPLETED|Overall Study||12
7739990|NCT01557504|19057670|P2|STARTED|Overall Study||12
7739991|NCT01557504|19057671|P1|STARTED|Overall Study||13
7739992|NCT01557400|19057694|P1|NOT COMPLETED|Overall Study||57
7739993|NCT01557400|19057694|P1|COMPLETED|Overall Study||37
7739994|NCT01557400|19057694|P1|Received at Least 1 Dose of Study Drug|Overall Study||94
7739995|NCT01557400|19057694|P1|STARTED|Overall Study||94
7739996|NCT01557348|19057706|P2|NOT COMPLETED|Overall Study||90
7739997|NCT01557348|19057707|P1|NOT COMPLETED|Overall Study||80
7739998|NCT01557348|19057706|P2|COMPLETED|Overall Study||417
7739999|NCT01557348|19057707|P1|COMPLETED|Overall Study||524
7740000|NCT01557348|19057706|P2|Safety Population|Overall Study||507
7740001|NCT01557348|19057707|P1|Safety Population|Overall Study||604
7740002|NCT01557348|19057706|P2|STARTED|Overall Study||507
7740003|NCT01557348|19057707|P1|STARTED|Overall Study||604
7740004|NCT01557322|19057749|P2|NOT COMPLETED|Overall Study||0
7740005|NCT01557322|19057750|P1|NOT COMPLETED|Overall Study||0
7740006|NCT01557322|19057749|P2|COMPLETED|Overall Study||1543
7740007|NCT01557322|19057750|P1|COMPLETED|Overall Study||211
7740008|NCT01557322|19057749|P2|STARTED|Overall Study||1543
7740009|NCT01557322|19057750|P1|STARTED|Overall Study||211
7740010|NCT01557283|19057824|P1|NOT COMPLETED|Overall Study||44
7740011|NCT01557283|19057824|P1|COMPLETED|Overall Study||96
7740012|NCT01557283|19057824|P1|STARTED|Overall Study||140
7740013|NCT01557166|19057836|P2|NOT COMPLETED|Overall Study||37
7740014|NCT01557166|19057837|P1|NOT COMPLETED|Overall Study||46
7740015|NCT01557166|19057836|P2|COMPLETED|Overall Study||142
7740016|NCT01557166|19057837|P1|COMPLETED|Overall Study||134
7740017|NCT01557166|19057836|P2|Exposed|Overall Study||179
7740018|NCT01557166|19057837|P1|Exposed|Overall Study||176
7740019|NCT01557166|19057836|P2|STARTED|Overall Study||179
7740020|NCT01557166|19057837|P1|STARTED|Overall Study||180
7740021|NCT01556997|19057852|P3|NOT COMPLETED|Overall Study||32
7740022|NCT01556997|19057853|P2|NOT COMPLETED|Overall Study||28
7740023|NCT01556997|19057854|P1|NOT COMPLETED|Overall Study||26
7740024|NCT01556997|19057852|P3|COMPLETED|Overall Study||246
7740025|NCT01556997|19057853|P2|COMPLETED|Overall Study||252
7740026|NCT01556997|19057854|P1|COMPLETED|Overall Study||253
7740027|NCT01556997|19057852|P3|STARTED|Overall Study||278
7740028|NCT01556997|19057853|P2|STARTED|Overall Study||280
7740029|NCT01556997|19057854|P1|STARTED|Overall Study||279
7740030|NCT01556932|19057865|P2|NOT COMPLETED|Second Treament||0
7740031|NCT01556932|19057866|P1|NOT COMPLETED|Second Treament||0
7740032|NCT01556932|19057865|P2|COMPLETED|Second Treament||8
7740033|NCT01556932|19057866|P1|COMPLETED|Second Treament||12
7740034|NCT01556932|19057865|P2|Recieved|Second Treament||8
7740035|NCT01556932|19057866|P1|Recieved|Second Treament||12
7740036|NCT01556932|19057865|P2|STARTED|Second Treament||8
7740037|NCT01556932|19057866|P1|STARTED|Second Treament||12
7740038|NCT01556932|19057865|P2|NOT COMPLETED|Time Point 60 Minutes||1
7740039|NCT01556932|19057866|P1|NOT COMPLETED|Time Point 60 Minutes||1
7740040|NCT01556932|19057865|P2|COMPLETED|Time Point 60 Minutes||8
7740041|NCT01556932|19057866|P1|COMPLETED|Time Point 60 Minutes||12
7740042|NCT01556932|19057865|P2|Recieved|Time Point 60 Minutes||8
7740043|NCT01556932|19057866|P1|Recieved|Time Point 60 Minutes||12
7740044|NCT01556932|19057865|P2|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9
7740045|NCT01556932|19057866|P1|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13
7740046|NCT01556932|19057865|P2|NOT COMPLETED|Baseline First Treatment||0
7740047|NCT01556932|19057866|P1|NOT COMPLETED|Baseline First Treatment||0
7740048|NCT01556932|19057865|P2|COMPLETED|Baseline First Treatment||9
7740049|NCT01556932|19057866|P1|COMPLETED|Baseline First Treatment||13
7740050|NCT01556932|19057865|P2|Recieved|Baseline First Treatment||9
7740051|NCT01556932|19057866|P1|Recieved|Baseline First Treatment||13
7740052|NCT01556932|19057865|P2|STARTED|Baseline First Treatment||9
7740053|NCT01556932|19057866|P1|STARTED|Baseline First Treatment||13
7740054|NCT01556906|19057871|P1|NOT COMPLETED|Overall Study||0
7740055|NCT01556906|19057871|P1|COMPLETED|Overall Study||6
7740056|NCT01556906|19057871|P1|STARTED|Overall Study||6
7740057|NCT01556763|19057892|P3|NOT COMPLETED|Overall Study||0
7740058|NCT01556763|19057893|P2|NOT COMPLETED|Overall Study||1
7740059|NCT01556763|19057894|P1|NOT COMPLETED|Overall Study||0
7740060|NCT01556763|19057892|P3|COMPLETED|Overall Study||8
7740061|NCT01556763|19057893|P2|COMPLETED|Overall Study||8
7740062|NCT01556763|19057894|P1|COMPLETED|Overall Study||4
7740063|NCT01556763|19057892|P3|STARTED|Overall Study||8
7740064|NCT01556763|19057893|P2|STARTED|Overall Study||9
7740065|NCT01556763|19057894|P1|STARTED|Overall Study||4
7740066|NCT01556724|19057932|P2|NOT COMPLETED|Overall Study||0
7740067|NCT01556724|19057933|P1|NOT COMPLETED|Overall Study||0
7740068|NCT01556724|19057932|P2|COMPLETED|Overall Study||14
7740069|NCT01556724|19057933|P1|COMPLETED|Overall Study||16
7740070|NCT01556724|19057932|P2|STARTED|Overall Study||14
7740071|NCT01556724|19057933|P1|STARTED|Overall Study||16
7740072|NCT01556633|19057949|P2|NOT COMPLETED|Overall Study||0
7740073|NCT01556633|19057950|P1|NOT COMPLETED|Overall Study||0
7740074|NCT01556633|19057949|P2|COMPLETED|Overall Study||6
7740075|NCT01556633|19057950|P1|COMPLETED|Overall Study||10
7740076|NCT01556633|19057949|P2|STARTED|Overall Study||6
7740077|NCT01556633|19057950|P1|STARTED|Overall Study||10
7740078|NCT01556594|19057975|P3|NOT COMPLETED|Overall Study||0
7740079|NCT01556594|19057976|P2|NOT COMPLETED|Overall Study||0
7740080|NCT01556594|19057977|P1|NOT COMPLETED|Overall Study||0
7740081|NCT01556594|19057975|P3|COMPLETED|Overall Study||6
7740082|NCT01556594|19057976|P2|COMPLETED|Overall Study||2
7740083|NCT01556594|19057977|P1|COMPLETED|Overall Study||10
7740084|NCT01556594|19057975|P3|STARTED|Overall Study||6
7740085|NCT01556594|19057976|P2|STARTED|Overall Study||2
7740086|NCT01556594|19057977|P1|STARTED|Overall Study||10
7740087|NCT01556581|19058013|P2|NOT COMPLETED|Overall Study||0
7740088|NCT01556581|19058014|P1|NOT COMPLETED|Overall Study||0
7740089|NCT01556581|19058013|P2|COMPLETED|Overall Study||58
7740090|NCT01556581|19058014|P1|COMPLETED|Overall Study||61
7740091|NCT01556581|19058013|P2|STARTED|Overall Study||58
7740092|NCT01556581|19058014|P1|STARTED|Overall Study||61
7740093|NCT01556451|19058024|P1|NOT COMPLETED|Overall Study||0
7740094|NCT01556451|19058024|P1|COMPLETED|Overall Study||180
7740095|NCT01556451|19058024|P1|STARTED|Overall Study||180
7740096|NCT01556438|19058033|P2|NOT COMPLETED|Overall Study||11
7740097|NCT01556438|19058034|P1|NOT COMPLETED|Overall Study||4
7740098|NCT01556438|19058033|P2|COMPLETED|Overall Study||1
7740099|NCT01556438|19058034|P1|COMPLETED|Overall Study||0
7740100|NCT01556438|19058033|P2|Received BTZ SC|Overall Study||8
7740101|NCT01556438|19058034|P1|Received BTZ SC|Overall Study||0
7740102|NCT01556438|19058033|P2|Received BTZ IV|Overall Study||4
7740103|NCT01556438|19058034|P1|Received BTZ IV|Overall Study||4
7740104|NCT01556438|19058033|P2|Received at Least 1 Dose of Study Drug|Overall Study|300 mg tabalumab IV|12
7740105|NCT01556438|19058034|P1|Received at Least 1 Dose of Study Drug|Overall Study|100 mg tabalumab IV|4
7740106|NCT01556438|19058033|P2|STARTED|Overall Study||12
7740107|NCT01556438|19058034|P1|STARTED|Overall Study||4
7740108|NCT01556425|19058063|P4|NOT COMPLETED|Overall Study||0
7740109|NCT01556425|19058064|P3|NOT COMPLETED|Overall Study||0
7740110|NCT01556425|19058065|P2|NOT COMPLETED|Overall Study||0
7740111|NCT01556425|19058066|P1|NOT COMPLETED|Overall Study||0
7740112|NCT01556425|19058063|P4|COMPLETED|Overall Study||18
7740113|NCT01556425|19058064|P3|COMPLETED|Overall Study||18
7740114|NCT01556425|19058065|P2|COMPLETED|Overall Study||23
7740115|NCT01556425|19058066|P1|COMPLETED|Overall Study||25
7740116|NCT01556425|19058063|P4|STARTED|Overall Study||18
7740117|NCT01556425|19058064|P3|STARTED|Overall Study||18
7740118|NCT01556425|19058065|P2|STARTED|Overall Study||23
7740119|NCT01556425|19058066|P1|STARTED|Overall Study||25
7740120|NCT01556347|19058080|P1|NOT COMPLETED|Recovery Phase||0
7740121|NCT01556347|19058080|P1|COMPLETED|Recovery Phase||2
7740122|NCT01556347|19058080|P1|STARTED|Recovery Phase||2
7740123|NCT01556347|19058080|P1|NOT COMPLETED|Bortezomib Treatment Phase||0
7740124|NCT01556347|19058080|P1|COMPLETED|Bortezomib Treatment Phase||2
7740125|NCT01556347|19058080|P1|STARTED|Bortezomib Treatment Phase||2
7740126|NCT01556347|19058080|P1|NOT COMPLETED|Induction Immunotherapy||0
7740127|NCT01556347|19058080|P1|COMPLETED|Induction Immunotherapy||2
7740128|NCT01556347|19058080|P1|STARTED|Induction Immunotherapy||2
7740129|NCT01556204|19058110|P2|NOT COMPLETED|Overall Study||0
7740130|NCT01556204|19058111|P1|NOT COMPLETED|Overall Study||0
7740131|NCT01556204|19058110|P2|COMPLETED|Overall Study||38
7740132|NCT01556204|19058111|P1|COMPLETED|Overall Study||35
7740133|NCT01556204|19058110|P2|STARTED|Overall Study||38
7740134|NCT01556204|19058111|P1|STARTED|Overall Study||35
7740135|NCT01556165|19058121|P2|NOT COMPLETED|Overall Study||7
7740136|NCT01556165|19058122|P1|NOT COMPLETED|Overall Study||12
7740137|NCT01556165|19058121|P2|COMPLETED|Overall Study||58
7740138|NCT01556165|19058122|P1|COMPLETED|Overall Study||53
7740139|NCT01556165|19058121|P2|STARTED|Overall Study||65
7740140|NCT01556165|19058122|P1|STARTED|Overall Study||65
7740141|NCT01556100|19058134|P1|NOT COMPLETED|Overall Study||6
7740142|NCT01556100|19058134|P1|COMPLETED|Overall Study||34
7740143|NCT01556100|19058134|P1|STARTED|Overall Study||40
7740144|NCT01556061|19058141|P2|NOT COMPLETED|Overall Study||0
7740145|NCT01556061|19058142|P1|NOT COMPLETED|Overall Study||0
7740146|NCT01556061|19058141|P2|COMPLETED|Overall Study||25
7740147|NCT01556061|19058142|P1|COMPLETED|Overall Study||25
7740148|NCT01556061|19058141|P2|STARTED|Overall Study||25
7740149|NCT01556061|19058142|P1|STARTED|Overall Study||25
7740150|NCT01556009|19058154|P2|NOT COMPLETED|Overall Study||0
7740151|NCT01556009|19058155|P1|NOT COMPLETED|Overall Study||0
7740152|NCT01556009|19058154|P2|COMPLETED|Overall Study||0
7740153|NCT01556009|19058155|P1|COMPLETED|Overall Study||0
7740154|NCT01556009|19058154|P2|STARTED|Overall Study||0
7740155|NCT01556009|19058155|P1|STARTED|Overall Study||0
7740156|NCT01555983|19058163|P6|NOT COMPLETED|Overall Study||1
7740157|NCT01555983|19058164|P5|NOT COMPLETED|Overall Study||1
7740158|NCT01555983|19058165|P4|NOT COMPLETED|Overall Study||0
7740159|NCT01555983|19058166|P3|NOT COMPLETED|Overall Study||0
7740160|NCT01555983|19058167|P2|NOT COMPLETED|Overall Study||0
7740161|NCT01555983|19058168|P1|NOT COMPLETED|Overall Study||1
7740162|NCT01555983|19058163|P6|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6
7740163|NCT01555983|19058164|P5|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4
7740164|NCT01555983|19058165|P4|COMPLETED|Overall Study||7
7740165|NCT01555983|19058166|P3|COMPLETED|Overall Study||7
7740166|NCT01555983|19058167|P2|COMPLETED|Overall Study||7
7740167|NCT01555983|19058168|P1|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8
7740168|NCT01555983|19058163|P6|STARTED|Overall Study||7
7740169|NCT01555983|19058164|P5|STARTED|Overall Study||5
7740170|NCT01555983|19058165|P4|STARTED|Overall Study||7
7740171|NCT01555983|19058166|P3|STARTED|Overall Study||7
7740172|NCT01555983|19058167|P2|STARTED|Overall Study||7
7740173|NCT01555983|19058168|P1|STARTED|Overall Study||9
7740174|NCT01555957|19058178|P2|NOT COMPLETED|Overall Study||0
7740175|NCT01555957|19058179|P1|NOT COMPLETED|Overall Study||0
7740176|NCT01555957|19058178|P2|COMPLETED|Overall Study||20
7740177|NCT01555957|19058179|P1|COMPLETED|Overall Study||20
7740178|NCT01555957|19058178|P2|STARTED|Overall Study||20
7740179|NCT01555957|19058179|P1|STARTED|Overall Study||20
7740180|NCT01555931|19058189|P2|NOT COMPLETED|Overall Study||5
7740181|NCT01555931|19058190|P1|NOT COMPLETED|Overall Study||2
7740182|NCT01555931|19058189|P2|COMPLETED|Overall Study||13
7740183|NCT01555931|19058190|P1|COMPLETED|Overall Study||15
7740184|NCT01555931|19058189|P2|STARTED|Overall Study||18
7740185|NCT01555931|19058190|P1|STARTED|Overall Study||17
7740186|NCT01555762|19058198|P1|NOT COMPLETED|Overall Study||274
7740187|NCT01555762|19058198|P1|COMPLETED|Overall Study||128
7740188|NCT01555762|19058198|P1|Efficacy Population|Overall Study||358
7740189|NCT01555762|19058198|P1|Safety Population|Overall Study||383
7740190|NCT01555762|19058198|P1|STARTED|Overall Study||402
7740191|NCT01555697|19058216|P8|NOT COMPLETED|Overall Study||0
7740192|NCT01555697|19058217|P7|NOT COMPLETED|Overall Study||0
7740193|NCT01555697|19058218|P6|NOT COMPLETED|Overall Study||0
7740194|NCT01555697|19058219|P5|NOT COMPLETED|Overall Study||0
7740195|NCT01555697|19058220|P4|NOT COMPLETED|Overall Study||0
7740196|NCT01555697|19058221|P3|NOT COMPLETED|Overall Study||0
7740197|NCT01555697|19058222|P2|NOT COMPLETED|Overall Study||0
7740198|NCT01555697|19058223|P1|NOT COMPLETED|Overall Study||0
7740199|NCT01555697|19058216|P8|COMPLETED|Overall Study||10
7740200|NCT01555697|19058217|P7|COMPLETED|Overall Study||10
7740201|NCT01555697|19058218|P6|COMPLETED|Overall Study||10
7740202|NCT01555697|19058219|P5|COMPLETED|Overall Study||10
7740203|NCT01555697|19058220|P4|COMPLETED|Overall Study||10
7740204|NCT01555697|19058221|P3|COMPLETED|Overall Study||10
7740205|NCT01555697|19058222|P2|COMPLETED|Overall Study||10
7740206|NCT01555697|19058223|P1|COMPLETED|Overall Study||10
7740207|NCT01555697|19058216|P8|6 Hours Lab Testing Day 2|Overall Study||10
7740208|NCT01555697|19058217|P7|6 Hours Lab Testing Day 2|Overall Study||10
7740209|NCT01555697|19058218|P6|6 Hours Lab Testing Day 2|Overall Study||10
7740210|NCT01555697|19058219|P5|6 Hours Lab Testing Day 2|Overall Study||10
7740211|NCT01555697|19058220|P4|6 Hours Lab Testing Day 2|Overall Study||10
7740212|NCT01555697|19058221|P3|6 Hours Lab Testing Day 2|Overall Study||10
7740213|NCT01555697|19058222|P2|6 Hours Lab Testing Day 2|Overall Study||10
7740214|NCT01555697|19058223|P1|6 Hours Lab Testing Day 2|Overall Study||10
7740215|NCT01555697|19058216|P8|Approx 7 Day Washout|Overall Study||10
7740216|NCT01555697|19058217|P7|Approx 7 Day Washout|Overall Study||10
7740217|NCT01555697|19058218|P6|Approx 7 Day Washout|Overall Study||10
7740218|NCT01555697|19058219|P5|Approx 7 Day Washout|Overall Study||10
7740219|NCT01555697|19058220|P4|Approx 7 Day Washout|Overall Study||10
7740220|NCT01555697|19058221|P3|Approx 7 Day Washout|Overall Study||10
7740221|NCT01555697|19058222|P2|Approx 7 Day Washout|Overall Study||10
7740222|NCT01555697|19058223|P1|Approx 7 Day Washout|Overall Study||10
7740223|NCT01555697|19058216|P8|6 Hours Lab Testing Day 1|Overall Study||10
7740224|NCT01555697|19058217|P7|6 Hours Lab Testing Day 1|Overall Study||10
7740225|NCT01555697|19058218|P6|6 Hours Lab Testing Day 1|Overall Study||10
7740226|NCT01555697|19058219|P5|6 Hours Lab Testing Day 1|Overall Study||10
7740227|NCT01555697|19058220|P4|6 Hours Lab Testing Day 1|Overall Study||10
7740228|NCT01555697|19058221|P3|6 Hours Lab Testing Day 1|Overall Study||10
7740229|NCT01555697|19058222|P2|6 Hours Lab Testing Day 1|Overall Study||10
7740230|NCT01555697|19058223|P1|6 Hours Lab Testing Day 1|Overall Study||10
7740231|NCT01555697|19058216|P8|STARTED|Overall Study||10
7740232|NCT01555697|19058217|P7|STARTED|Overall Study||10
7740233|NCT01555697|19058218|P6|STARTED|Overall Study||10
7740234|NCT01555697|19058219|P5|STARTED|Overall Study||10
7740235|NCT01555697|19058220|P4|STARTED|Overall Study||10
7740236|NCT01555697|19058221|P3|STARTED|Overall Study||10
7740237|NCT01555697|19058222|P2|STARTED|Overall Study||10
7740238|NCT01555697|19058223|P1|STARTED|Overall Study||10
7740239|NCT01555567|19058247|P4|NOT COMPLETED|Return to Activity||1
7740240|NCT01555567|19058248|P3|NOT COMPLETED|Return to Activity||0
7740241|NCT01555567|19058249|P2|NOT COMPLETED|Return to Activity||2
7740242|NCT01555567|19058250|P1|NOT COMPLETED|Return to Activity||1
7740243|NCT01555567|19058247|P4|COMPLETED|Return to Activity||8
7740244|NCT01555567|19058248|P3|COMPLETED|Return to Activity||8
7740245|NCT01555567|19058249|P2|COMPLETED|Return to Activity||10
7740246|NCT01555567|19058250|P1|COMPLETED|Return to Activity||10
7740247|NCT01555567|19058247|P4|STARTED|Return to Activity||9
7740248|NCT01555567|19058248|P3|STARTED|Return to Activity||8
7740249|NCT01555567|19058249|P2|STARTED|Return to Activity||12
7740250|NCT01555567|19058250|P1|STARTED|Return to Activity||11
7740251|NCT01555567|19058247|P4|NOT COMPLETED|12 Week||0
7740252|NCT01555567|19058248|P3|NOT COMPLETED|12 Week||1
7740253|NCT01555567|19058249|P2|NOT COMPLETED|12 Week||1
7740254|NCT01555567|19058250|P1|NOT COMPLETED|12 Week||1
7740255|NCT01555567|19058247|P4|COMPLETED|12 Week||9
7740256|NCT01555567|19058248|P3|COMPLETED|12 Week||8
7740257|NCT01555567|19058249|P2|COMPLETED|12 Week||12
7740258|NCT01555567|19058250|P1|COMPLETED|12 Week||11
7740259|NCT01555567|19058247|P4|STARTED|12 Week||9
7740260|NCT01555567|19058248|P3|STARTED|12 Week||9
7740261|NCT01555567|19058249|P2|STARTED|12 Week||13
7740262|NCT01555567|19058250|P1|STARTED|12 Week||12
7740263|NCT01555541|19058264|P1|NOT COMPLETED|Autologous Stem Cell Transplantation||0
7740264|NCT01555541|19058264|P1|COMPLETED|Autologous Stem Cell Transplantation||12
7740265|NCT01555541|19058264|P1|STARTED|Autologous Stem Cell Transplantation|7 patients didn't move forward due to non-response/progression on last line of therapy prior to ASCT|12
7740266|NCT01555541|19058264|P1|NOT COMPLETED|OVA Treatment||0
7740267|NCT01555541|19058264|P1|COMPLETED|OVA Treatment||19
7740268|NCT01555541|19058264|P1|STARTED|OVA Treatment||19
7740269|NCT01555541|19058264|P1|NOT COMPLETED|Salvage Response Assessment||0
7740270|NCT01555541|19058264|P1|COMPLETED|Salvage Response Assessment||19
7740271|NCT01555541|19058264|P1|STARTED|Salvage Response Assessment||19
7740272|NCT01555489|19058271|P1|NOT COMPLETED|Overall Study||0
7740273|NCT01555489|19058271|P1|COMPLETED|Overall Study||11
7740274|NCT01555489|19058271|P1|STARTED|Overall Study||11
7740275|NCT01555463|19058278|P2|NOT COMPLETED|Follow up||45
7740276|NCT01555463|19058279|P1|NOT COMPLETED|Follow up||38
7740277|NCT01555463|19058278|P2|COMPLETED|Follow up||394
7740278|NCT01555463|19058279|P1|COMPLETED|Follow up||409
7740279|NCT01555463|19058278|P2|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439
7740280|NCT01555463|19058279|P1|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447
7740281|NCT01555463|19058278|P2|NOT COMPLETED|Treatment||79
7740282|NCT01555463|19058279|P1|NOT COMPLETED|Treatment||64
7740283|NCT01555463|19058278|P2|COMPLETED|Treatment||399
7740284|NCT01555463|19058279|P1|COMPLETED|Treatment||419
7740285|NCT01555463|19058278|P2|STARTED|Treatment||478
7740286|NCT01555463|19058279|P1|STARTED|Treatment||483
7740287|NCT01555164|19058321|P2|NOT COMPLETED|Overall Study||35
7740288|NCT01555164|19058322|P1|NOT COMPLETED|Overall Study||40
7740289|NCT01555164|19058321|P2|COMPLETED|Overall Study||185
7740290|NCT01555164|19058322|P1|COMPLETED|Overall Study||182
7740291|NCT01555164|19058321|P2|STARTED|Overall Study||220
7740292|NCT01555164|19058322|P1|STARTED|Overall Study||222
7740293|NCT01555151|19058336|P4|NOT COMPLETED|Overall Study||10
7740294|NCT01555151|19058337|P3|NOT COMPLETED|Overall Study||6
7740295|NCT01555151|19058338|P2|NOT COMPLETED|Overall Study||8
7740296|NCT01555151|19058339|P1|NOT COMPLETED|Overall Study||13
7740297|NCT01555151|19058336|P4|COMPLETED|Overall Study||176
7740298|NCT01555151|19058337|P3|COMPLETED|Overall Study||178
7740299|NCT01555151|19058338|P2|COMPLETED|Overall Study||173
7740300|NCT01555151|19058339|P1|COMPLETED|Overall Study||175
7740301|NCT01555151|19058336|P4|Safety Set (SAF)|Overall Study||186
7740302|NCT01555151|19058337|P3|Safety Set (SAF)|Overall Study||183
7740303|NCT01555151|19058338|P2|Safety Set (SAF)|Overall Study||180
7740304|NCT01555151|19058339|P1|Safety Set (SAF)|Overall Study||186
7740305|NCT01555151|19058336|P4|STARTED|Overall Study||186
7740306|NCT01555151|19058337|P3|STARTED|Overall Study||184
7740307|NCT01555151|19058338|P2|STARTED|Overall Study||181
7740308|NCT01555151|19058339|P1|STARTED|Overall Study||188
7740309|NCT01555138|19058392|P2|NOT COMPLETED|Overall Study||38
7740310|NCT01555138|19058393|P1|NOT COMPLETED|Overall Study||47
7740311|NCT01555138|19058392|P2|COMPLETED|Overall Study||250
7740312|NCT01555138|19058393|P1|COMPLETED|Overall Study||246
7740313|NCT01555138|19058392|P2|STARTED|Overall Study||288
7740314|NCT01555138|19058393|P1|STARTED|Overall Study||293
7740315|NCT01555125|19058422|P5|NOT COMPLETED|Follow-Up Period||0
7740316|NCT01555125|19058423|P4|NOT COMPLETED|Follow-Up Period||1
7740317|NCT01555125|19058424|P3|NOT COMPLETED|Follow-Up Period||1
7740318|NCT01555125|19058425|P2|NOT COMPLETED|Follow-Up Period||1
7740319|NCT01555125|19058426|P1|NOT COMPLETED|Follow-Up Period||4
7740320|NCT01555125|19058422|P5|COMPLETED|Follow-Up Period||0
7740321|NCT01555125|19058423|P4|COMPLETED|Follow-Up Period||17
7740322|NCT01555125|19058424|P3|COMPLETED|Follow-Up Period||18
7740323|NCT01555125|19058425|P2|COMPLETED|Follow-Up Period||30
7740324|NCT01555125|19058426|P1|COMPLETED|Follow-Up Period||32
7740325|NCT01555125|19058422|P5|STARTED|Follow-Up Period||0
7740326|NCT01555125|19058423|P4|STARTED|Follow-Up Period||18
7740327|NCT01555125|19058424|P3|STARTED|Follow-Up Period||19
7740328|NCT01555125|19058425|P2|STARTED|Follow-Up Period||31
7740329|NCT01555125|19058426|P1|STARTED|Follow-Up Period||36
7740330|NCT01555125|19058422|P5|NOT COMPLETED|Extension||0
7740331|NCT01555125|19058423|P4|NOT COMPLETED|Extension||22
7740332|NCT01555125|19058424|P3|NOT COMPLETED|Extension||23
7740333|NCT01555125|19058425|P2|NOT COMPLETED|Extension||51
7740334|NCT01555125|19058426|P1|NOT COMPLETED|Extension||45
7740335|NCT01555125|19058422|P5|COMPLETED|Extension||0
7740336|NCT01555125|19058423|P4|COMPLETED|Extension||1
7740337|NCT01555125|19058424|P3|COMPLETED|Extension||0
7740338|NCT01555125|19058425|P2|COMPLETED|Extension||0
7740339|NCT01555125|19058426|P1|COMPLETED|Extension||1
7740340|NCT01555125|19058422|P5|STARTED|Extension||0
7740341|NCT01555125|19058423|P4|STARTED|Extension||23
7740342|NCT01555125|19058424|P3|STARTED|Extension||23
7740343|NCT01555125|19058425|P2|STARTED|Extension||51
7740344|NCT01555125|19058426|P1|STARTED|Extension||46
7740345|NCT01555125|19058422|P5|NOT COMPLETED|Maintenance Period||0
7740346|NCT01555125|19058423|P4|NOT COMPLETED|Maintenance Period||2
7740347|NCT01555125|19058424|P3|NOT COMPLETED|Maintenance Period||4
7740348|NCT01555125|19058425|P2|NOT COMPLETED|Maintenance Period||4
7740349|NCT01555125|19058426|P1|NOT COMPLETED|Maintenance Period||10
7740350|NCT01555125|19058422|P5|COMPLETED|Maintenance Period||0
7740351|NCT01555125|19058423|P4|COMPLETED|Maintenance Period||25
7740352|NCT01555125|19058424|P3|COMPLETED|Maintenance Period||25
7740353|NCT01555125|19058425|P2|COMPLETED|Maintenance Period||52
7740354|NCT01555125|19058426|P1|COMPLETED|Maintenance Period||48
7740355|NCT01555125|19058422|P5|STARTED|Maintenance Period||0
7740356|NCT01555125|19058423|P4|STARTED|Maintenance Period||27
7740357|NCT01555125|19058424|P3|STARTED|Maintenance Period||29
7740358|NCT01555125|19058425|P2|STARTED|Maintenance Period||56
7740359|NCT01555125|19058426|P1|STARTED|Maintenance Period||58
7740360|NCT01555125|19058422|P5|NOT COMPLETED|Induction Period||3
7740361|NCT01555125|19058423|P4|NOT COMPLETED|Induction Period||0
7740362|NCT01555125|19058424|P3|NOT COMPLETED|Induction Period||0
7740363|NCT01555125|19058425|P2|NOT COMPLETED|Induction Period||3
7740364|NCT01555125|19058426|P1|NOT COMPLETED|Induction Period||1
7740365|NCT01555125|19058422|P5|COMPLETED|Induction Period||56
7740366|NCT01555125|19058423|P4|COMPLETED|Induction Period||0
7740367|NCT01555125|19058424|P3|COMPLETED|Induction Period||0
7740368|NCT01555125|19058425|P2|COMPLETED|Induction Period||56
7740369|NCT01555125|19058426|P1|COMPLETED|Induction Period||58
7740370|NCT01555125|19058422|P5|STARTED|Induction Period||59
7740371|NCT01555125|19058423|P4|STARTED|Induction Period||0
7740372|NCT01555125|19058424|P3|STARTED|Induction Period||0
7740373|NCT01555125|19058425|P2|STARTED|Induction Period||59
7740374|NCT01555125|19058426|P1|STARTED|Induction Period||59
7740375|NCT01555073|19058519|P4|NOT COMPLETED|Overall Study||5
7740376|NCT01555073|19058520|P3|NOT COMPLETED|Overall Study||0
7740377|NCT01555073|19058521|P2|NOT COMPLETED|Overall Study||2
7740378|NCT01555073|19058522|P1|NOT COMPLETED|Overall Study||1
7740379|NCT01555073|19058519|P4|COMPLETED|Overall Study||1
7740380|NCT01555073|19058520|P3|COMPLETED|Overall Study||7
7740381|NCT01555073|19058521|P2|COMPLETED|Overall Study||1
7740382|NCT01555073|19058522|P1|COMPLETED|Overall Study||6
7740383|NCT01555073|19058519|P4|STARTED|Overall Study||6
7740384|NCT01555073|19058520|P3|STARTED|Overall Study||7
7740385|NCT01555073|19058521|P2|STARTED|Overall Study||3
7740386|NCT01555073|19058522|P1|STARTED|Overall Study||7
7740387|NCT01555021|19058538|P2|NOT COMPLETED|Overall Study||2
7740388|NCT01555021|19058539|P1|NOT COMPLETED|Overall Study||1
7740389|NCT01555021|19058538|P2|COMPLETED|Overall Study|None of the AGT subjects competed month 1, month 3, or month 6 follow up visits.|0
7740390|NCT01555021|19058539|P1|COMPLETED|Overall Study|One treatment as usual subject completed 1 month, 3 month, and 6 month follow up visits|1
7740391|NCT01555021|19058538|P2|STARTED|Overall Study||2
7740392|NCT01555021|19058539|P1|STARTED|Overall Study||2
7740393|NCT01554982|19058551|P1|NOT COMPLETED|Overall Study||43
7740394|NCT01554982|19058551|P1|COMPLETED|Overall Study||125
7740395|NCT01554982|19058551|P1|Received Drug|Overall Study||166
7740396|NCT01554982|19058551|P1|STARTED|Overall Study||168
7740397|NCT01554904|19058564|P1|NOT COMPLETED|Overall Study||4
7740398|NCT01554904|19058564|P1|COMPLETED|Overall Study||14
7740399|NCT01554904|19058564|P1|Home Sleep Study 2|Overall Study||14
7740400|NCT01554904|19058564|P1|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14
7740401|NCT01554904|19058564|P1|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17
7740402|NCT01554904|19058564|P1|Home Sleep Study 1|Overall Study|After informed consent signed.|18
7740403|NCT01554904|19058564|P1|STARTED|Overall Study||18
7740404|NCT01554891|19058572|P3|NOT COMPLETED|Overall Study||2
7740405|NCT01554891|19058573|P2|NOT COMPLETED|Overall Study||5
7740406|NCT01554891|19058574|P1|NOT COMPLETED|Overall Study||7
7740407|NCT01554891|19058572|P3|COMPLETED|Overall Study||55
7740408|NCT01554891|19058573|P2|COMPLETED|Overall Study||115
7740409|NCT01554891|19058574|P1|COMPLETED|Overall Study||98
7740410|NCT01554891|19058572|P3|STARTED|Overall Study||57
7740411|NCT01554891|19058573|P2|STARTED|Overall Study||120
7740412|NCT01554891|19058574|P1|STARTED|Overall Study||105
7740413|NCT01554683|19058582|P6|NOT COMPLETED|Overall Study||0
7740414|NCT01554683|19058583|P5|NOT COMPLETED|Overall Study||0
7740415|NCT01554683|19058584|P4|NOT COMPLETED|Overall Study||0
7740416|NCT01554683|19058585|P3|NOT COMPLETED|Overall Study||0
7740417|NCT01554683|19058586|P2|NOT COMPLETED|Overall Study||0
7740418|NCT01554683|19058587|P1|NOT COMPLETED|Overall Study||0
7740419|NCT01554683|19058582|P6|COMPLETED|Overall Study||0
7740420|NCT01554683|19058583|P5|COMPLETED|Overall Study||1
7740421|NCT01554683|19058584|P4|COMPLETED|Overall Study||2
7740422|NCT01554683|19058585|P3|COMPLETED|Overall Study||3
7740423|NCT01554683|19058586|P2|COMPLETED|Overall Study||1
7740424|NCT01554683|19058587|P1|COMPLETED|Overall Study||2
7740425|NCT01554683|19058582|P6|STARTED|Overall Study||0
7740426|NCT01554683|19058583|P5|STARTED|Overall Study||1
7740427|NCT01554683|19058584|P4|STARTED|Overall Study||2
7740428|NCT01554683|19058585|P3|STARTED|Overall Study||3
7740429|NCT01554683|19058586|P2|STARTED|Overall Study||1
7740430|NCT01554683|19058587|P1|STARTED|Overall Study||2
7740431|NCT01554618|19058609|P2|NOT COMPLETED|Open-Label Extension Period||5
7740432|NCT01554618|19058610|P1|NOT COMPLETED|Open-Label Extension Period||3
7740433|NCT01554618|19058609|P2|COMPLETED|Open-Label Extension Period||18
7740434|NCT01554618|19058610|P1|COMPLETED|Open-Label Extension Period||46
7740435|NCT01554618|19058609|P2|STARTED|Open-Label Extension Period||23
7740436|NCT01554618|19058610|P1|STARTED|Open-Label Extension Period|1 patient who was noncompliant with study medication did not enter the open-label extension period|49
7740437|NCT01554618|19058609|P2|NOT COMPLETED|Controlled Assessment Period||1
7740438|NCT01554618|19058610|P1|NOT COMPLETED|Controlled Assessment Period||8
7740439|NCT01554618|19058609|P2|COMPLETED|Controlled Assessment Period||23
7740440|NCT01554618|19058610|P1|COMPLETED|Controlled Assessment Period||50
7740441|NCT01554618|19058609|P2|STARTED|Controlled Assessment Period||24
7740442|NCT01554618|19058610|P1|STARTED|Controlled Assessment Period||58
7740443|NCT01554618|19058609|P2|NOT COMPLETED|Randomized Through Start of Treatment||0
7740444|NCT01554618|19058610|P1|NOT COMPLETED|Randomized Through Start of Treatment||1
7740445|NCT01554618|19058609|P2|COMPLETED|Randomized Through Start of Treatment||24
7740446|NCT01554618|19058610|P1|COMPLETED|Randomized Through Start of Treatment||58
7740447|NCT01554618|19058609|P2|STARTED|Randomized Through Start of Treatment||24
7740448|NCT01554618|19058610|P1|STARTED|Randomized Through Start of Treatment||59
7740449|NCT01554579|19058662|P2|NOT COMPLETED|Overall Study||27
7740450|NCT01554579|19058663|P1|NOT COMPLETED|Overall Study||10
7740451|NCT01554579|19058662|P2|COMPLETED|Overall Study||58
7740452|NCT01554579|19058663|P1|COMPLETED|Overall Study||76
7740453|NCT01554579|19058662|P2|STARTED|Overall Study||85
7740454|NCT01554579|19058663|P1|STARTED|Overall Study||86
7740455|NCT01554527|19058676|P3|NOT COMPLETED|Overall Study||8
7740456|NCT01554527|19058677|P2|NOT COMPLETED|Overall Study||0
7740457|NCT01554527|19058678|P1|NOT COMPLETED|Overall Study||1
7740458|NCT01554527|19058676|P3|COMPLETED|Overall Study||25
7740459|NCT01554527|19058677|P2|COMPLETED|Overall Study||38
7740460|NCT01554527|19058678|P1|COMPLETED|Overall Study||33
7740461|NCT01554527|19058676|P3|Completed as a Control|Overall Study||1
7740462|NCT01554527|19058677|P2|Completed as a Control|Overall Study||0
7740463|NCT01554527|19058678|P1|Completed as a Control|Overall Study||33
7740464|NCT01554527|19058676|P3|Initiated CPAP Treatment at Home|Overall Study||28
7740465|NCT01554527|19058677|P2|Initiated CPAP Treatment at Home|Overall Study||38
7740466|NCT01554527|19058678|P1|Initiated CPAP Treatment at Home|Overall Study||0
7740467|NCT01554527|19058676|P3|Had CPAP Titration|Overall Study||30
7740468|NCT01554527|19058677|P2|Had CPAP Titration|Overall Study||38
7740469|NCT01554527|19058678|P1|Had CPAP Titration|Overall Study|No control group members received CPAP (definitionally)|0
7740470|NCT01554527|19058676|P3|Crossed Over to Control|Overall Study||2
7740471|NCT01554527|19058677|P2|Crossed Over to Control|Overall Study||0
7740472|NCT01554527|19058678|P1|Crossed Over to Control|Overall Study||0
7740473|NCT01554527|19058676|P3|STARTED|Overall Study||33
7740474|NCT01554527|19058677|P2|STARTED|Overall Study||38
7740475|NCT01554527|19058678|P1|STARTED|Overall Study||34
7740476|NCT01554488|19058707|P2|NOT COMPLETED|Overall Study||3
7740477|NCT01554488|19058708|P1|NOT COMPLETED|Overall Study||1
7740478|NCT01554488|19058707|P2|COMPLETED|Overall Study||9
7740479|NCT01554488|19058708|P1|COMPLETED|Overall Study||12
7740480|NCT01554488|19058707|P2|STARTED|Overall Study||12
7740481|NCT01554488|19058708|P1|STARTED|Overall Study||13
7740482|NCT01554241|19058734|P4|NOT COMPLETED|Overall Study||1
7740483|NCT01554241|19058735|P3|NOT COMPLETED|Overall Study||4
7740484|NCT01554241|19058736|P2|NOT COMPLETED|Overall Study||1
7740485|NCT01554241|19058737|P1|NOT COMPLETED|Overall Study||3
7740486|NCT01554241|19058734|P4|COMPLETED|Overall Study||13
7740487|NCT01554241|19058735|P3|COMPLETED|Overall Study||20
7740488|NCT01554241|19058736|P2|COMPLETED|Overall Study||19
7740489|NCT01554241|19058737|P1|COMPLETED|Overall Study||20
7740490|NCT01554241|19058734|P4|STARTED|Overall Study||14
7740491|NCT01554241|19058735|P3|STARTED|Overall Study||24
7740492|NCT01554241|19058736|P2|STARTED|Overall Study||20
7740493|NCT01554241|19058737|P1|STARTED|Overall Study||23
7740494|NCT01554176|19058753|P5|NOT COMPLETED|Run-out Phase||0
7740495|NCT01554176|19058754|P4|NOT COMPLETED|Run-out Phase||1
7740496|NCT01554176|19058755|P3|NOT COMPLETED|Run-out Phase||0
7740497|NCT01554176|19058756|P2|NOT COMPLETED|Run-out Phase||0
7740498|NCT01554176|19058757|P1|NOT COMPLETED|Run-out Phase||0
7740499|NCT01554176|19058753|P5|COMPLETED|Run-out Phase||59
7740500|NCT01554176|19058754|P4|COMPLETED|Run-out Phase||27
7740501|NCT01554176|19058755|P3|COMPLETED|Run-out Phase||29
7740502|NCT01554176|19058756|P2|COMPLETED|Run-out Phase||0
7740503|NCT01554176|19058757|P1|COMPLETED|Run-out Phase||0
7740504|NCT01554176|19058753|P5|Treated|Run-out Phase||59
7740505|NCT01554176|19058754|P4|Treated|Run-out Phase||28
7740506|NCT01554176|19058755|P3|Treated|Run-out Phase||29
7740507|NCT01554176|19058756|P2|Treated|Run-out Phase||0
7740508|NCT01554176|19058757|P1|Treated|Run-out Phase||0
7740509|NCT01554176|19058753|P5|STARTED|Run-out Phase||59
7740510|NCT01554176|19058754|P4|STARTED|Run-out Phase||28
7740511|NCT01554176|19058755|P3|STARTED|Run-out Phase||29
7740512|NCT01554176|19058756|P2|STARTED|Run-out Phase||0
7740513|NCT01554176|19058757|P1|STARTED|Run-out Phase||0
7740514|NCT01554176|19058753|P5|NOT COMPLETED|Treatment Phase||0
7740515|NCT01554176|19058754|P4|NOT COMPLETED|Treatment Phase||0
7740516|NCT01554176|19058755|P3|NOT COMPLETED|Treatment Phase||0
7740517|NCT01554176|19058756|P2|NOT COMPLETED|Treatment Phase||5
7740518|NCT01554176|19058757|P1|NOT COMPLETED|Treatment Phase||8
7740519|NCT01554176|19058753|P5|COMPLETED|Treatment Phase||0
7740520|NCT01554176|19058754|P4|COMPLETED|Treatment Phase||0
7740521|NCT01554176|19058755|P3|COMPLETED|Treatment Phase||0
7740522|NCT01554176|19058756|P2|COMPLETED|Treatment Phase||59
7740523|NCT01554176|19058757|P1|COMPLETED|Treatment Phase||57
7740524|NCT01554176|19058753|P5|Treated|Treatment Phase||0
7740525|NCT01554176|19058754|P4|Treated|Treatment Phase||0
7740526|NCT01554176|19058755|P3|Treated|Treatment Phase||0
7740527|NCT01554176|19058756|P2|Treated|Treatment Phase||64
7740528|NCT01554176|19058757|P1|Treated|Treatment Phase||64
7740529|NCT01554176|19058753|P5|STARTED|Treatment Phase||0
7740530|NCT01554176|19058754|P4|STARTED|Treatment Phase||0
7740531|NCT01554176|19058755|P3|STARTED|Treatment Phase||0
7740532|NCT01554176|19058756|P2|STARTED|Treatment Phase||64
7740533|NCT01554176|19058757|P1|STARTED|Treatment Phase||65
7740534|NCT01554163|19058784|P2|NOT COMPLETED|Overall Study||10
7740535|NCT01554163|19058785|P1|NOT COMPLETED|Overall Study||8
7740536|NCT01554163|19058784|P2|COMPLETED|Overall Study||109
7740537|NCT01554163|19058785|P1|COMPLETED|Overall Study||112
7740538|NCT01554163|19058784|P2|Number Treated|Overall Study||119
7740539|NCT01554163|19058785|P1|Number Treated|Overall Study||119
7740540|NCT01554163|19058784|P2|STARTED|Overall Study||119
7740541|NCT01554163|19058785|P1|STARTED|Overall Study||120
7740542|NCT01553916|19058803|P1|NOT COMPLETED|Overall Study||3
7740543|NCT01553916|19058803|P1|COMPLETED|Overall Study||16
7740544|NCT01553916|19058803|P1|STARTED|Overall Study||19
7740545|NCT01553851|19058820|P1|NOT COMPLETED|Overall Study||3
7740546|NCT01553851|19058820|P1|COMPLETED|Overall Study||17
7740547|NCT01553851|19058820|P1|STARTED|Overall Study||20
7740548|NCT01553747|19058835|P3|NOT COMPLETED|Overall Study||109
7740549|NCT01553747|19058836|P2|NOT COMPLETED|Overall Study||119
7740550|NCT01553747|19058837|P1|NOT COMPLETED|Overall Study||131
7740551|NCT01553747|19058835|P3|COMPLETED|Overall Study||273
7740552|NCT01553747|19058836|P2|COMPLETED|Overall Study||264
7740553|NCT01553747|19058837|P1|COMPLETED|Overall Study||250
7740554|NCT01553747|19058835|P3|Participated in Blinded-Placebo Period|Overall Study||272
7740555|NCT01553747|19058836|P2|Participated in Blinded-Placebo Period|Overall Study||253
7740556|NCT01553747|19058837|P1|Participated in Blinded-Placebo Period|Overall Study||246
7740557|NCT01553747|19058835|P3|Attended Week 26 Visit|Overall Study||278
7740558|NCT01553747|19058836|P2|Attended Week 26 Visit|Overall Study||271
7740559|NCT01553747|19058837|P1|Attended Week 26 Visit|Overall Study||259
7740560|NCT01553747|19058835|P3|Attended Week 12 Visit|Overall Study||312
7740561|NCT01553747|19058836|P2|Attended Week 12 Visit|Overall Study||301
7740562|NCT01553747|19058837|P1|Attended Week 12 Visit|Overall Study||296
7740563|NCT01553747|19058835|P3|STARTED|Overall Study||382
7740564|NCT01553747|19058836|P2|STARTED|Overall Study||383
7740565|NCT01553747|19058837|P1|STARTED|Overall Study||381
7740566|NCT01553708|19058889|P2|NOT COMPLETED|Overall Study||0
7740567|NCT01553708|19058890|P1|NOT COMPLETED|Overall Study||0
7740568|NCT01553708|19058889|P2|COMPLETED|Overall Study||17
7740569|NCT01553708|19058890|P1|COMPLETED|Overall Study||17
7740570|NCT01553708|19058889|P2|STARTED|Overall Study||17
7740571|NCT01553708|19058890|P1|STARTED|Overall Study||17
7740572|NCT01553591|19058899|P3|NOT COMPLETED|Overall Study||158
7740573|NCT01553591|19058900|P2|NOT COMPLETED|Overall Study||169
7740574|NCT01553591|19058901|P1|NOT COMPLETED|Overall Study||172
7740575|NCT01553591|19058899|P3|COMPLETED|Overall Study||269
7740576|NCT01553591|19058900|P2|COMPLETED|Overall Study||257
7740577|NCT01553591|19058901|P1|COMPLETED|Overall Study||257
7740578|NCT01553591|19058899|P3|Attended Week 26 Visit|Overall Study||290
7740579|NCT01553591|19058900|P2|Attended Week 26 Visit|Overall Study||291
7740580|NCT01553591|19058901|P1|Attended Week 26 Visit|Overall Study||289
7740581|NCT01553591|19058899|P3|Attended Week 12 Visit|Overall Study||342
7740582|NCT01553591|19058900|P2|Attended Week 12 Visit|Overall Study||330
7740583|NCT01553591|19058901|P1|Attended Week 12 Visit|Overall Study||341
7740584|NCT01553591|19058899|P3|STARTED|Overall Study||427
7740585|NCT01553591|19058900|P2|STARTED|Overall Study||426
7740586|NCT01553591|19058901|P1|STARTED|Overall Study||429
7740587|NCT01553539|19058951|P1|NOT COMPLETED|Overall Study||0
7740588|NCT01553539|19058951|P1|COMPLETED|Overall Study||20
7740589|NCT01553539|19058951|P1|STARTED|Overall Study||20
7740590|NCT01553318|19058961|P2|NOT COMPLETED|Overall Study||2
7740591|NCT01553318|19058962|P1|NOT COMPLETED|Overall Study||3
7740592|NCT01553318|19058961|P2|COMPLETED|Overall Study||25
7740593|NCT01553318|19058962|P1|COMPLETED|Overall Study||21
7740594|NCT01553318|19058961|P2|STARTED|Overall Study||27
7740595|NCT01553318|19058962|P1|STARTED|Overall Study||24
7740596|NCT01553292|19058974|P1|NOT COMPLETED|Overall Study||0
7740597|NCT01553292|19058974|P1|COMPLETED|Overall Study||21
7740598|NCT01553292|19058974|P1|STARTED|Overall Study||21
7740599|NCT01553279|19058992|P2|NOT COMPLETED|Period 2: Toddler Vaccinations||7
7740600|NCT01553279|19058993|P1|NOT COMPLETED|Period 2: Toddler Vaccinations||3
7740601|NCT01553279|19058992|P2|COMPLETED|Period 2: Toddler Vaccinations||132
7740602|NCT01553279|19058993|P1|COMPLETED|Period 2: Toddler Vaccinations||134
7740603|NCT01553279|19058992|P2|STARTED|Period 2: Toddler Vaccinations||139
7740604|NCT01553279|19058993|P1|STARTED|Period 2: Toddler Vaccinations||137
7740605|NCT01553279|19058992|P2|NOT COMPLETED|Interim Period||2
7740606|NCT01553279|19058993|P1|NOT COMPLETED|Interim Period||3
7740607|NCT01553279|19058992|P2|COMPLETED|Interim Period||139
7740608|NCT01553279|19058993|P1|COMPLETED|Interim Period||137
7740609|NCT01553279|19058992|P2|STARTED|Interim Period||141
7740610|NCT01553279|19058993|P1|STARTED|Interim Period||140
7740611|NCT01553279|19058992|P2|NOT COMPLETED|Part 1 (Infant Vaccinations)||1
7740612|NCT01553279|19058993|P1|NOT COMPLETED|Part 1 (Infant Vaccinations)||2
7740613|NCT01553279|19058992|P2|COMPLETED|Part 1 (Infant Vaccinations)||141
7740614|NCT01553279|19058993|P1|COMPLETED|Part 1 (Infant Vaccinations)||140
7740615|NCT01553279|19058992|P2|STARTED|Part 1 (Infant Vaccinations)||142
7740616|NCT01553279|19058993|P1|STARTED|Part 1 (Infant Vaccinations)||142
7740617|NCT01553240|19059050|P1|NOT COMPLETED|Overall Study||0
7740618|NCT01553240|19059050|P1|COMPLETED|Overall Study||0
7740619|NCT01553240|19059050|P1|STARTED|Overall Study||0
7740620|NCT01553201|19059057|P2|NOT COMPLETED|Overall Study||0
7740621|NCT01553201|19059058|P1|NOT COMPLETED|Overall Study||0
7740622|NCT01553201|19059057|P2|COMPLETED|Overall Study||15
7740623|NCT01553201|19059058|P1|COMPLETED|Overall Study||15
7740624|NCT01553201|19059057|P2|STARTED|Overall Study||15
7740625|NCT01553201|19059058|P1|STARTED|Overall Study||15
7740626|NCT01553188|19059068|P4|NOT COMPLETED|Overall Study||0
7740627|NCT01553188|19059069|P3|NOT COMPLETED|Overall Study||2
7740628|NCT01553188|19059070|P2|NOT COMPLETED|Overall Study||1
7740629|NCT01553188|19059071|P1|NOT COMPLETED|Overall Study||1
7740630|NCT01553188|19059068|P4|COMPLETED|Overall Study||11
7740631|NCT01553188|19059069|P3|COMPLETED|Overall Study||14
7740632|NCT01553188|19059070|P2|COMPLETED|Overall Study||5
7740633|NCT01553188|19059071|P1|COMPLETED|Overall Study||2
7740634|NCT01553188|19059068|P4|STARTED|Overall Study||11
7740635|NCT01553188|19059069|P3|STARTED|Overall Study||16
7740636|NCT01553188|19059070|P2|STARTED|Overall Study||6
7740637|NCT01553188|19059071|P1|STARTED|Overall Study||3
7740638|NCT01553136|19059098|P2|NOT COMPLETED|Overall Study||22
7740639|NCT01553136|19059099|P1|NOT COMPLETED|Overall Study||16
7740640|NCT01553136|19059098|P2|COMPLETED|Overall Study||45
7740641|NCT01553136|19059099|P1|COMPLETED|Overall Study||48
7740642|NCT01553136|19059098|P2|Completed Treatment|Overall Study||52
7740643|NCT01553136|19059099|P1|Completed Treatment|Overall Study||55
7740644|NCT01553136|19059098|P2|STARTED|Overall Study||67
7740645|NCT01553136|19059099|P1|STARTED|Overall Study||64
7740646|NCT01553084|19059116|P3|NOT COMPLETED|Overall Study||35
7740647|NCT01553084|19059117|P2|NOT COMPLETED|Overall Study||13
7740648|NCT01553084|19059118|P1|NOT COMPLETED|Overall Study||15
7740649|NCT01553084|19059116|P3|COMPLETED|Overall Study||389
7740650|NCT01553084|19059117|P2|COMPLETED|Overall Study||408
7740651|NCT01553084|19059118|P1|COMPLETED|Overall Study||226
7740652|NCT01553084|19059116|P3|STARTED|Overall Study||424
7740653|NCT01553084|19059117|P2|STARTED|Overall Study||421
7740654|NCT01553084|19059118|P1|STARTED|Overall Study||241
7740655|NCT01553058|19059137|P3|NOT COMPLETED|Overall Study||3
7740656|NCT01553058|19059138|P2|NOT COMPLETED|Overall Study||1
7740657|NCT01553058|19059139|P1|NOT COMPLETED|Overall Study||1
7740658|NCT01553058|19059137|P3|COMPLETED|Overall Study||30
7740659|NCT01553058|19059138|P2|COMPLETED|Overall Study||30
7740660|NCT01553058|19059139|P1|COMPLETED|Overall Study||32
7740661|NCT01553058|19059137|P3|STARTED|Overall Study||33
7740662|NCT01553058|19059138|P2|STARTED|Overall Study||31
7740663|NCT01553058|19059139|P1|STARTED|Overall Study||33
7740664|NCT01552954|19059200|P2|NOT COMPLETED|Overall Study||6
7740665|NCT01552954|19059201|P1|NOT COMPLETED|Overall Study||5
7740666|NCT01552954|19059200|P2|COMPLETED|Overall Study||119
7740667|NCT01552954|19059201|P1|COMPLETED|Overall Study||126
7740668|NCT01552954|19059200|P2|STARTED|Overall Study||125
7740669|NCT01552954|19059201|P1|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131
7740670|NCT01552928|19059217|P4|NOT COMPLETED|Period 4||0
7740671|NCT01552928|19059218|P3|NOT COMPLETED|Period 4||0
7740672|NCT01552928|19059219|P2|NOT COMPLETED|Period 4||0
7740673|NCT01552928|19059220|P1|NOT COMPLETED|Period 4||0
7740674|NCT01552928|19059217|P4|COMPLETED|Period 4||16
7740675|NCT01552928|19059218|P3|COMPLETED|Period 4||14
7740676|NCT01552928|19059219|P2|COMPLETED|Period 4||15
7740677|NCT01552928|19059220|P1|COMPLETED|Period 4||14
7740678|NCT01552928|19059217|P4|STARTED|Period 4||16
7740679|NCT01552928|19059218|P3|STARTED|Period 4||14
7740680|NCT01552928|19059219|P2|STARTED|Period 4||15
7740681|NCT01552928|19059220|P1|STARTED|Period 4||14
7740682|NCT01552928|19059217|P4|NOT COMPLETED|Period 3||0
7740683|NCT01552928|19059218|P3|NOT COMPLETED|Period 3||1
7740684|NCT01552928|19059219|P2|NOT COMPLETED|Period 3||0
7740685|NCT01552928|19059220|P1|NOT COMPLETED|Period 3||0
7740686|NCT01552928|19059217|P4|COMPLETED|Period 3||16
7740687|NCT01552928|19059218|P3|COMPLETED|Period 3||14
7740688|NCT01552928|19059219|P2|COMPLETED|Period 3||15
7740689|NCT01552928|19059220|P1|COMPLETED|Period 3||14
7740690|NCT01552928|19059217|P4|STARTED|Period 3||16
7740691|NCT01552928|19059218|P3|STARTED|Period 3||15
7740692|NCT01552928|19059219|P2|STARTED|Period 3||15
7740693|NCT01552928|19059220|P1|STARTED|Period 3||14
7740694|NCT01552928|19059217|P4|NOT COMPLETED|Period 2||0
7740695|NCT01552928|19059218|P3|NOT COMPLETED|Period 2||0
7740696|NCT01552928|19059219|P2|NOT COMPLETED|Period 2||0
7740697|NCT01552928|19059220|P1|NOT COMPLETED|Period 2||0
7740698|NCT01552928|19059217|P4|COMPLETED|Period 2||16
7740699|NCT01552928|19059218|P3|COMPLETED|Period 2||15
7740700|NCT01552928|19059219|P2|COMPLETED|Period 2||15
7740701|NCT01552928|19059220|P1|COMPLETED|Period 2||14
7740702|NCT01552928|19059217|P4|STARTED|Period 2||16
7740703|NCT01552928|19059218|P3|STARTED|Period 2||15
7740704|NCT01552928|19059219|P2|STARTED|Period 2||15
7740705|NCT01552928|19059220|P1|STARTED|Period 2||14
7740706|NCT01552928|19059217|P4|NOT COMPLETED|Period 1||0
7740707|NCT01552928|19059218|P3|NOT COMPLETED|Period 1||0
7740708|NCT01552928|19059219|P2|NOT COMPLETED|Period 1||0
7740709|NCT01552928|19059220|P1|NOT COMPLETED|Period 1||0
7740710|NCT01552928|19059217|P4|COMPLETED|Period 1||16
7740711|NCT01552928|19059218|P3|COMPLETED|Period 1||15
7740712|NCT01552928|19059219|P2|COMPLETED|Period 1||15
7740713|NCT01552928|19059220|P1|COMPLETED|Period 1||14
7740714|NCT01552928|19059217|P4|STARTED|Period 1||16
7740715|NCT01552928|19059218|P3|STARTED|Period 1||15
7740716|NCT01552928|19059219|P2|STARTED|Period 1||15
7740717|NCT01552928|19059220|P1|STARTED|Period 1||14
7740718|NCT01552915|19059267|P3|NOT COMPLETED|Overall Study||27
7740719|NCT01552915|19059268|P2|NOT COMPLETED|Overall Study||29
7740720|NCT01552915|19059269|P1|NOT COMPLETED|Overall Study||23
7740721|NCT01552915|19059267|P3|COMPLETED|Overall Study||157
7740722|NCT01552915|19059268|P2|COMPLETED|Overall Study||155
7740723|NCT01552915|19059269|P1|COMPLETED|Overall Study||68
7740724|NCT01552915|19059267|P3|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184
7740725|NCT01552915|19059268|P2|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184
7740726|NCT01552915|19059269|P1|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91
7740727|NCT01552902|19059292|P3|NOT COMPLETED|Overall Study||33
7740728|NCT01552902|19059293|P2|NOT COMPLETED|Overall Study||37
7740729|NCT01552902|19059294|P1|NOT COMPLETED|Overall Study||13
7740730|NCT01552902|19059292|P3|COMPLETED|Overall Study||186
7740731|NCT01552902|19059293|P2|COMPLETED|Overall Study||181
7740732|NCT01552902|19059294|P1|COMPLETED|Overall Study||97
7740733|NCT01552902|19059292|P3|STARTED|Overall Study||219
7740734|NCT01552902|19059293|P2|STARTED|Overall Study||218
7740735|NCT01552902|19059294|P1|STARTED|Overall Study||110
7740736|NCT01552889|19059316|P2|NOT COMPLETED|Overall Study||5
7740737|NCT01552889|19059317|P1|NOT COMPLETED|Overall Study||11
7740738|NCT01552889|19059316|P2|COMPLETED|Overall Study||95
7740739|NCT01552889|19059317|P1|COMPLETED|Overall Study||90
7740740|NCT01552889|19059316|P2|STARTED|Overall Study||100
7740741|NCT01552889|19059317|P1|STARTED|Overall Study||101
7740742|NCT01552876|19059327|P2|NOT COMPLETED|Overall Study||0
7740743|NCT01552876|19059328|P1|NOT COMPLETED|Overall Study||0
7740744|NCT01552876|19059327|P2|COMPLETED|Overall Study||20
7740745|NCT01552876|19059328|P1|COMPLETED|Overall Study||20
7740746|NCT01552876|19059327|P2|STARTED|Overall Study||20
7740747|NCT01552876|19059328|P1|STARTED|Overall Study||20
7740748|NCT01552772|19059344|P1|NOT COMPLETED|Overall Study||4
7740749|NCT01552772|19059344|P1|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56
7740750|NCT01552772|19059344|P1|STARTED|Overall Study||60
7740751|NCT01552694|19059360|P2|NOT COMPLETED|Overall Study||2
7740752|NCT01552694|19059361|P1|NOT COMPLETED|Overall Study||0
7740753|NCT01552694|19059360|P2|COMPLETED|Overall Study||18
7740754|NCT01552694|19059361|P1|COMPLETED|Overall Study||18
7740755|NCT01552694|19059360|P2|STARTED|Overall Study||20
7740756|NCT01552694|19059361|P1|STARTED|Overall Study||18
7740757|NCT01552681|19059377|P2|NOT COMPLETED|Overall Study||1
7740758|NCT01552681|19059378|P1|NOT COMPLETED|Overall Study||5
7740759|NCT01552681|19059377|P2|COMPLETED|Overall Study||18
7740760|NCT01552681|19059378|P1|COMPLETED|Overall Study||28
7740761|NCT01552681|19059377|P2|STARTED|Overall Study||19
7740762|NCT01552681|19059378|P1|STARTED|Overall Study||33
7740763|NCT01552603|19059426|P1|NOT COMPLETED|Overall Study||1
7740764|NCT01552603|19059426|P1|COMPLETED|Overall Study||13
7740765|NCT01552603|19059426|P1|STARTED|Overall Study||14
7740766|NCT01552408|19059433|P2|NOT COMPLETED|Overall Study||2
7740767|NCT01552408|19059434|P1|NOT COMPLETED|Overall Study||4
7740768|NCT01552408|19059433|P2|COMPLETED|Overall Study||18
7740769|NCT01552408|19059434|P1|COMPLETED|Overall Study||16
7740770|NCT01552408|19059433|P2|STARTED|Overall Study||20
7740771|NCT01552408|19059434|P1|STARTED|Overall Study||20
7740772|NCT01552369|19059456|P2|NOT COMPLETED|Overall Study||9
7740773|NCT01552369|19059457|P1|NOT COMPLETED|Overall Study||8
7740774|NCT01552369|19059456|P2|COMPLETED|Overall Study||96
7740775|NCT01552369|19059457|P1|COMPLETED|Overall Study||92
7740776|NCT01552369|19059456|P2|Final Follow up|Overall Study||96
7740777|NCT01552369|19059457|P1|Final Follow up|Overall Study||92
7740778|NCT01552369|19059456|P2|One Year|Overall Study||105
7740779|NCT01552369|19059457|P1|One Year|Overall Study||100
7740780|NCT01552369|19059456|P2|STARTED|Overall Study||105
7740781|NCT01552369|19059457|P1|STARTED|Overall Study||100
7740782|NCT01552343|19059485|P2|NOT COMPLETED|Overall Study||0
7740783|NCT01552343|19059486|P1|NOT COMPLETED|Overall Study||0
7740784|NCT01552343|19059485|P2|COMPLETED|Overall Study||27
7740785|NCT01552343|19059486|P1|COMPLETED|Overall Study||29
7740786|NCT01552343|19059485|P2|STARTED|Overall Study||27
7740787|NCT01552343|19059486|P1|STARTED|Overall Study||29
7740788|NCT01552213|19059509|P2|NOT COMPLETED|Overall Study||8
7740789|NCT01552213|19059510|P1|NOT COMPLETED|Overall Study||13
7740790|NCT01552213|19059509|P2|COMPLETED|Overall Study||37
7740791|NCT01552213|19059510|P1|COMPLETED|Overall Study||37
7740792|NCT01552213|19059509|P2|Analyzed|Overall Study||41
7740793|NCT01552213|19059510|P1|Analyzed|Overall Study||42
7740794|NCT01552213|19059509|P2|STARTED|Overall Study||45
7740795|NCT01552213|19059510|P1|STARTED|Overall Study||50
7740796|NCT01552057|19059546|P2|NOT COMPLETED|Overall Study||48
7740797|NCT01552057|19059547|P1|NOT COMPLETED|Overall Study||30
7740798|NCT01552057|19059546|P2|COMPLETED|Overall Study||149
7740799|NCT01552057|19059547|P1|COMPLETED|Overall Study||166
7740800|NCT01552057|19059546|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
7740801|NCT01552057|19059547|P1|Received at Least 1 Dose of Study Drug|Overall Study||194
7740802|NCT01552057|19059546|P2|STARTED|Overall Study||197
7740803|NCT01552057|19059547|P1|STARTED|Overall Study||196
7740804|NCT01551979|19059581|P2|NOT COMPLETED|Overall Study||2
7740805|NCT01551979|19059582|P1|NOT COMPLETED|Overall Study||2
7740806|NCT01551979|19059581|P2|COMPLETED|Overall Study||5
7740807|NCT01551979|19059582|P1|COMPLETED|Overall Study||8
7740808|NCT01551979|19059581|P2|1 Week Post Treatment|Overall Study||6
7740809|NCT01551979|19059582|P1|1 Week Post Treatment|Overall Study||10
7740810|NCT01551979|19059581|P2|Last Day of Treatment (After 5 Days)|Overall Study||7
7740811|NCT01551979|19059582|P1|Last Day of Treatment (After 5 Days)|Overall Study||10
7740812|NCT01551979|19059581|P2|STARTED|Overall Study||7
7740813|NCT01551979|19059582|P1|STARTED|Overall Study||10
7740814|NCT01551888|19059598|P2|NOT COMPLETED|Period 2||0
7740815|NCT01551888|19059599|P1|NOT COMPLETED|Period 2||0
7740816|NCT01551888|19059598|P2|COMPLETED|Period 2||12
7740817|NCT01551888|19059599|P1|COMPLETED|Period 2||12
7740818|NCT01551888|19059598|P2|STARTED|Period 2||12
7740819|NCT01551888|19059599|P1|STARTED|Period 2||12
7740820|NCT01551888|19059598|P2|NOT COMPLETED|Period 1||0
7740821|NCT01551888|19059599|P1|NOT COMPLETED|Period 1||0
7740822|NCT01551888|19059598|P2|COMPLETED|Period 1||12
7740823|NCT01551888|19059599|P1|COMPLETED|Period 1||12
7740824|NCT01551888|19059598|P2|STARTED|Period 1||12
7740825|NCT01551888|19059599|P1|STARTED|Period 1||12
7740826|NCT01551758|19059613|P2|NOT COMPLETED|Overall Study||105
7740827|NCT01551758|19059614|P1|NOT COMPLETED|Overall Study||94
7740828|NCT01551758|19059613|P2|COMPLETED|Overall Study||1291
7740829|NCT01551758|19059614|P1|COMPLETED|Overall Study||1309
7740830|NCT01551758|19059613|P2|STARTED|Overall Study||1396
7740831|NCT01551758|19059614|P1|STARTED|Overall Study||1403
7740832|NCT01551745|19059652|P1|NOT COMPLETED|Overall Study||3
7740833|NCT01551745|19059652|P1|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses"|2
7740834|NCT01551745|19059652|P1|STARTED|Overall Study||5
7740835|NCT01551693|19059661|P2|NOT COMPLETED|Overall Study||2
7740836|NCT01551693|19059662|P1|NOT COMPLETED|Overall Study||1
7740837|NCT01551693|19059661|P2|COMPLETED|Overall Study||0
7740838|NCT01551693|19059662|P1|COMPLETED|Overall Study||0
7740839|NCT01551693|19059661|P2|STARTED|Overall Study||2
7740840|NCT01551693|19059662|P1|STARTED|Overall Study||1
7740841|NCT01551550|19059674|P2|NOT COMPLETED|Overall Study||1
7740842|NCT01551550|19059675|P1|NOT COMPLETED|Overall Study||0
7740843|NCT01551550|19059674|P2|COMPLETED|Overall Study||40
7740844|NCT01551550|19059675|P1|COMPLETED|Overall Study||41
7740845|NCT01551550|19059674|P2|STARTED|Overall Study||41
7740846|NCT01551550|19059675|P1|STARTED|Overall Study||41
7740847|NCT01551420|19059683|P2|NOT COMPLETED|Home Use (Part B)||1
7740848|NCT01551420|19059684|P1|NOT COMPLETED|Home Use (Part B)||6
7740849|NCT01551420|19059683|P2|COMPLETED|Home Use (Part B)||7
7740850|NCT01551420|19059684|P1|COMPLETED|Home Use (Part B)||18
7740851|NCT01551420|19059683|P2|STARTED|Home Use (Part B)||8
7740852|NCT01551420|19059684|P1|STARTED|Home Use (Part B)||24
7740853|NCT01551420|19059683|P2|NOT COMPLETED|Screened for Part B Eligibility||3
7740854|NCT01551420|19059684|P1|NOT COMPLETED|Screened for Part B Eligibility||9
7740855|NCT01551420|19059683|P2|COMPLETED|Screened for Part B Eligibility||8
7740856|NCT01551420|19059684|P1|COMPLETED|Screened for Part B Eligibility||24
7740857|NCT01551420|19059683|P2|STARTED|Screened for Part B Eligibility||11
7740858|NCT01551420|19059684|P1|STARTED|Screened for Part B Eligibility||33
7740859|NCT01551420|19059683|P2|NOT COMPLETED|In-laboratory (Part A)||2
7740860|NCT01551420|19059684|P1|NOT COMPLETED|In-laboratory (Part A)||6
7740861|NCT01551420|19059683|P2|COMPLETED|In-laboratory (Part A)||11
7740862|NCT01551420|19059684|P1|COMPLETED|In-laboratory (Part A)||33
7740863|NCT01551420|19059683|P2|STARTED|In-laboratory (Part A)||13
7740864|NCT01551420|19059684|P1|STARTED|In-laboratory (Part A)||39
7740865|NCT01551355|19059714|P6|NOT COMPLETED|Overall Study||6
7740866|NCT01551355|19059715|P5|NOT COMPLETED|Overall Study||9
7740867|NCT01551355|19059716|P4|NOT COMPLETED|Overall Study||24
7740868|NCT01551355|19059717|P3|NOT COMPLETED|Overall Study||34
7740869|NCT01551355|19059718|P2|NOT COMPLETED|Overall Study||49
7740870|NCT01551355|19059719|P1|NOT COMPLETED|Overall Study||51
7740871|NCT01551355|19059714|P6|COMPLETED|Overall Study||65
7740872|NCT01551355|19059715|P5|COMPLETED|Overall Study||55
7740873|NCT01551355|19059716|P4|COMPLETED|Overall Study||411
7740874|NCT01551355|19059717|P3|COMPLETED|Overall Study||459
7740875|NCT01551355|19059718|P2|COMPLETED|Overall Study||545
7740876|NCT01551355|19059719|P1|COMPLETED|Overall Study||571
7740877|NCT01551355|19059714|P6|STARTED|Overall Study||71
7740878|NCT01551355|19059715|P5|STARTED|Overall Study||64
7740879|NCT01551355|19059716|P4|STARTED|Overall Study||435
7740880|NCT01551355|19059717|P3|STARTED|Overall Study||493
7740881|NCT01551355|19059718|P2|STARTED|Overall Study||594
7740882|NCT01551355|19059719|P1|STARTED|Overall Study||622
7740883|NCT01551303|19059733|P2|NOT COMPLETED|Overall Study||7
7740884|NCT01551303|19059734|P1|NOT COMPLETED|Overall Study||4
7740885|NCT01551303|19059733|P2|COMPLETED|Overall Study||15
7740886|NCT01551303|19059734|P1|COMPLETED|Overall Study||21
7740887|NCT01551303|19059733|P2|STARTED|Overall Study||22
7740888|NCT01551303|19059734|P1|STARTED|Overall Study||25
7740889|NCT01551212|19059742|P2|NOT COMPLETED|Overall Study||20
7740890|NCT01551212|19059743|P1|NOT COMPLETED|Overall Study||5
7740891|NCT01551212|19059742|P2|COMPLETED|Overall Study||148
7740892|NCT01551212|19059743|P1|COMPLETED|Overall Study||166
7740893|NCT01551212|19059742|P2|Per Protocol Set (PP)|Overall Study||101
7740894|NCT01551212|19059743|P1|Per Protocol Set (PP)|Overall Study||110
7740895|NCT01551212|19059742|P2|Safety Set|Overall Study||164
7740896|NCT01551212|19059743|P1|Safety Set|Overall Study||169
7740897|NCT01551212|19059742|P2|Full Anylsis Set (FAS)|Overall Study||164
7740898|NCT01551212|19059743|P1|Full Anylsis Set (FAS)|Overall Study||169
7740899|NCT01551212|19059742|P2|STARTED|Overall Study||168
7740900|NCT01551212|19059743|P1|STARTED|Overall Study||171
7740901|NCT01551199|19059761|P1|NOT COMPLETED|Overall Study||5
7740902|NCT01551199|19059761|P1|COMPLETED|Overall Study||2
7740903|NCT01551199|19059761|P1|STARTED|Overall Study||7
7740904|NCT01551186|19059769|P2|NOT COMPLETED|Overall Study||13
7740905|NCT01551186|19059770|P1|NOT COMPLETED|Overall Study||20
7740906|NCT01551186|19059769|P2|COMPLETED|Overall Study||40
7740907|NCT01551186|19059770|P1|COMPLETED|Overall Study||30
7740908|NCT01551186|19059769|P2|STARTED|Overall Study||53
7740909|NCT01551186|19059770|P1|STARTED|Overall Study||50
7740910|NCT01551173|19059778|P2|NOT COMPLETED|Overall Study||32
7740911|NCT01551173|19059779|P1|NOT COMPLETED|Overall Study||28
7740912|NCT01551173|19059778|P2|COMPLETED|Overall Study||186
7740913|NCT01551173|19059779|P1|COMPLETED|Overall Study||190
7740914|NCT01551173|19059778|P2|Full Analysis Set (FAS)|Overall Study||214
7740915|NCT01551173|19059779|P1|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210
7740916|NCT01551173|19059778|P2|STARTED|Overall Study||218
7740917|NCT01551173|19059779|P1|STARTED|Overall Study|"Started indicates randomized"|218
7740918|NCT01551095|19059790|P1|NOT COMPLETED|Overall Study||0
7740919|NCT01551095|19059790|P1|COMPLETED|Overall Study||7
7740920|NCT01551095|19059790|P1|STARTED|Overall Study||7
7740921|NCT01551082|19059795|P1|NOT COMPLETED|Overall Study||0
7740922|NCT01551082|19059795|P1|COMPLETED|Overall Study||12
7740923|NCT01551082|19059795|P1|STARTED|Overall Study||12
7740924|NCT01551056|19059801|P2|NOT COMPLETED|Overall Study||0
7740925|NCT01551056|19059802|P1|NOT COMPLETED|Overall Study||2
7740926|NCT01551056|19059801|P2|COMPLETED|Overall Study||45
7740927|NCT01551056|19059802|P1|COMPLETED|Overall Study||44
7740928|NCT01551056|19059801|P2|STARTED|Overall Study||45
7740929|NCT01551056|19059802|P1|STARTED|Overall Study||46
7740930|NCT01550965|19059856|P1|NOT COMPLETED|Overall Study||110
7740931|NCT01550965|19059856|P1|COMPLETED|Overall Study||353
7740932|NCT01550965|19059856|P1|STARTED|Overall Study||463
7740933|NCT01550952|19059875|P1|NOT COMPLETED|Overall Study||0
7740934|NCT01550952|19059875|P1|COMPLETED|Overall Study||10
7740935|NCT01550952|19059875|P1|STARTED|Overall Study||10
7740936|NCT01550809|19059885|P2|NOT COMPLETED|Overall Study||0
7740937|NCT01550809|19059886|P1|NOT COMPLETED|Overall Study||0
7740938|NCT01550809|19059885|P2|COMPLETED|Overall Study||6
7740939|NCT01550809|19059886|P1|COMPLETED|Overall Study||6
7740940|NCT01550809|19059885|P2|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6
7740941|NCT01550809|19059886|P1|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6
7740942|NCT01550757|19059900|P4|NOT COMPLETED|Overall Study||54
7740943|NCT01550757|19059901|P3|NOT COMPLETED|Overall Study||45
7740944|NCT01550757|19059902|P2|NOT COMPLETED|Overall Study||14
7740945|NCT01550757|19059903|P1|NOT COMPLETED|Overall Study||23
7740946|NCT01550757|19059900|P4|COMPLETED|Overall Study||90
7740947|NCT01550757|19059901|P3|COMPLETED|Overall Study||85
7740948|NCT01550757|19059902|P2|COMPLETED|Overall Study||38
7740949|NCT01550757|19059903|P1|COMPLETED|Overall Study||33
7740950|NCT01550757|19059900|P4|STARTED|Overall Study||144
7740951|NCT01550757|19059901|P3|STARTED|Overall Study||130
7740952|NCT01550757|19059902|P2|STARTED|Overall Study||52
7740953|NCT01550757|19059903|P1|STARTED|Overall Study||56
7740954|NCT01550744|19059913|P3|NOT COMPLETED|Double-Blind||67
7740955|NCT01550744|19059914|P2|NOT COMPLETED|Double-Blind||17
7740956|NCT01550744|19059915|P1|NOT COMPLETED|Double-Blind||0
7740957|NCT01550744|19059913|P3|COMPLETED|Double-Blind||235
7740958|NCT01550744|19059914|P2|COMPLETED|Double-Blind||59
7740959|NCT01550744|19059915|P1|COMPLETED|Double-Blind||0
7740960|NCT01550744|19059913|P3|STARTED|Double-Blind||302
7740961|NCT01550744|19059914|P2|STARTED|Double-Blind||76
7740962|NCT01550744|19059915|P1|STARTED|Double-Blind||0
7740963|NCT01550744|19059913|P3|NOT COMPLETED|Open-Label||0
7740964|NCT01550744|19059914|P2|NOT COMPLETED|Open-Label||0
7740965|NCT01550744|19059915|P1|NOT COMPLETED|Open-Label||100
7740966|NCT01550744|19059913|P3|COMPLETED|Open-Label||0
7740967|NCT01550744|19059914|P2|COMPLETED|Open-Label||0
7740968|NCT01550744|19059915|P1|COMPLETED|Open-Label||378
7740969|NCT01550744|19059913|P3|STARTED|Open-Label||0
7740970|NCT01550744|19059914|P2|STARTED|Open-Label||0
7740971|NCT01550744|19059915|P1|STARTED|Open-Label||478
7740972|NCT01550731|19059930|P2|NOT COMPLETED|Overall Study||0
7740973|NCT01550731|19059931|P1|NOT COMPLETED|Overall Study||0
7740974|NCT01550731|19059930|P2|COMPLETED|Overall Study||209
7740975|NCT01550731|19059931|P1|COMPLETED|Overall Study||205
7740976|NCT01550731|19059930|P2|STARTED|Overall Study||209
7740977|NCT01550731|19059931|P1|STARTED|Overall Study||205
7740978|NCT01550705|19059939|P1|NOT COMPLETED|Overall Study||1
7740979|NCT01550705|19059939|P1|COMPLETED|Overall Study||10
7740980|NCT01550705|19059939|P1|STARTED|Overall Study||11
7740981|NCT01550549|19059944|P1|NOT COMPLETED|Overall Study||0
7740982|NCT01550549|19059944|P1|COMPLETED|Overall Study||151
7740983|NCT01550549|19059944|P1|STARTED|Overall Study||151
7740984|NCT01550510|19059958|P2|NOT COMPLETED|Overall Study||0
7740985|NCT01550510|19059959|P1|NOT COMPLETED|Overall Study||0
7740986|NCT01550510|19059958|P2|COMPLETED|Overall Study||0
7740987|NCT01550510|19059959|P1|COMPLETED|Overall Study||4
7740988|NCT01550510|19059958|P2|STARTED|Overall Study||0
7740989|NCT01550510|19059959|P1|STARTED|Overall Study||4
7740990|NCT01550471|19059967|P6|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
7740991|NCT01550471|19059968|P5|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
7740992|NCT01550471|19059969|P4|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
7740993|NCT01550471|19059970|P3|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
7740994|NCT01550471|19059971|P2|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
7740995|NCT01550471|19059972|P1|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
7740996|NCT01550471|19059967|P6|COMPLETED|Third Wash Out Period (3 Weeks)||3
7740997|NCT01550471|19059968|P5|COMPLETED|Third Wash Out Period (3 Weeks)||4
7740998|NCT01550471|19059969|P4|COMPLETED|Third Wash Out Period (3 Weeks)||4
7740999|NCT01550471|19059970|P3|COMPLETED|Third Wash Out Period (3 Weeks)||3
7741000|NCT01550471|19059971|P2|COMPLETED|Third Wash Out Period (3 Weeks)||4
7741001|NCT01550471|19059972|P1|COMPLETED|Third Wash Out Period (3 Weeks)||3
7741002|NCT01550471|19059967|P6|STARTED|Third Wash Out Period (3 Weeks)||3
7741003|NCT01550471|19059968|P5|STARTED|Third Wash Out Period (3 Weeks)||4
7741004|NCT01550471|19059969|P4|STARTED|Third Wash Out Period (3 Weeks)||4
7741005|NCT01550471|19059970|P3|STARTED|Third Wash Out Period (3 Weeks)||3
7741006|NCT01550471|19059971|P2|STARTED|Third Wash Out Period (3 Weeks)||4
7741007|NCT01550471|19059972|P1|STARTED|Third Wash Out Period (3 Weeks)||3
7741008|NCT01550471|19059967|P6|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
7741009|NCT01550471|19059968|P5|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
7741010|NCT01550471|19059969|P4|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
7741011|NCT01550471|19059970|P3|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
7741012|NCT01550471|19059971|P2|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
7741013|NCT01550471|19059972|P1|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
7741014|NCT01550471|19059967|P6|COMPLETED|Third Treatment Period (3 Weeks)||3
7741015|NCT01550471|19059968|P5|COMPLETED|Third Treatment Period (3 Weeks)||4
7741016|NCT01550471|19059969|P4|COMPLETED|Third Treatment Period (3 Weeks)||4
7741017|NCT01550471|19059970|P3|COMPLETED|Third Treatment Period (3 Weeks)||3
7741018|NCT01550471|19059971|P2|COMPLETED|Third Treatment Period (3 Weeks)||4
7741019|NCT01550471|19059972|P1|COMPLETED|Third Treatment Period (3 Weeks)||3
7741020|NCT01550471|19059967|P6|STARTED|Third Treatment Period (3 Weeks)||3
7741021|NCT01550471|19059968|P5|STARTED|Third Treatment Period (3 Weeks)||4
7741022|NCT01550471|19059969|P4|STARTED|Third Treatment Period (3 Weeks)||4
7741023|NCT01550471|19059970|P3|STARTED|Third Treatment Period (3 Weeks)||3
7741024|NCT01550471|19059971|P2|STARTED|Third Treatment Period (3 Weeks)||4
7741025|NCT01550471|19059972|P1|STARTED|Third Treatment Period (3 Weeks)||3
7741026|NCT01550471|19059967|P6|NOT COMPLETED|Second Wash Out Period (3 Weeks)||1
7741027|NCT01550471|19059968|P5|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
7741028|NCT01550471|19059969|P4|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
7741029|NCT01550471|19059970|P3|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
7741030|NCT01550471|19059971|P2|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
7741031|NCT01550471|19059972|P1|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
7741032|NCT01550471|19059967|P6|COMPLETED|Second Wash Out Period (3 Weeks)||3
7741033|NCT01550471|19059968|P5|COMPLETED|Second Wash Out Period (3 Weeks)||4
7741034|NCT01550471|19059969|P4|COMPLETED|Second Wash Out Period (3 Weeks)||4
7741035|NCT01550471|19059970|P3|COMPLETED|Second Wash Out Period (3 Weeks)||3
7741036|NCT01550471|19059971|P2|COMPLETED|Second Wash Out Period (3 Weeks)||4
7741037|NCT01550471|19059972|P1|COMPLETED|Second Wash Out Period (3 Weeks)||3
7741038|NCT01550471|19059967|P6|STARTED|Second Wash Out Period (3 Weeks)||4
7741039|NCT01550471|19059968|P5|STARTED|Second Wash Out Period (3 Weeks)||4
7741040|NCT01550471|19059969|P4|STARTED|Second Wash Out Period (3 Weeks)||4
7741041|NCT01550471|19059970|P3|STARTED|Second Wash Out Period (3 Weeks)||3
7741042|NCT01550471|19059971|P2|STARTED|Second Wash Out Period (3 Weeks)||4
7741043|NCT01550471|19059972|P1|STARTED|Second Wash Out Period (3 Weeks)||3
7741044|NCT01550471|19059967|P6|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
7741045|NCT01550471|19059968|P5|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
7741046|NCT01550471|19059969|P4|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
7741047|NCT01550471|19059970|P3|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
7741048|NCT01550471|19059971|P2|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
7741049|NCT01550471|19059972|P1|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
7741050|NCT01550471|19059967|P6|COMPLETED|Second Treatment Period (3 Weeks)||4
7741051|NCT01550471|19059968|P5|COMPLETED|Second Treatment Period (3 Weeks)||4
7741052|NCT01550471|19059969|P4|COMPLETED|Second Treatment Period (3 Weeks)||4
7741053|NCT01550471|19059970|P3|COMPLETED|Second Treatment Period (3 Weeks)||3
7741054|NCT01550471|19059971|P2|COMPLETED|Second Treatment Period (3 Weeks)||4
7741055|NCT01550471|19059972|P1|COMPLETED|Second Treatment Period (3 Weeks)||3
7741056|NCT01550471|19059967|P6|STARTED|Second Treatment Period (3 Weeks)||4
7741057|NCT01550471|19059968|P5|STARTED|Second Treatment Period (3 Weeks)||4
7741058|NCT01550471|19059969|P4|STARTED|Second Treatment Period (3 Weeks)||4
7741059|NCT01550471|19059970|P3|STARTED|Second Treatment Period (3 Weeks)||3
7741060|NCT01550471|19059971|P2|STARTED|Second Treatment Period (3 Weeks)||4
7741061|NCT01550471|19059972|P1|STARTED|Second Treatment Period (3 Weeks)||3
7741062|NCT01550471|19059967|P6|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
7741063|NCT01550471|19059968|P5|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
7741064|NCT01550471|19059969|P4|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
7741065|NCT01550471|19059970|P3|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
7741066|NCT01550471|19059971|P2|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
7741067|NCT01550471|19059972|P1|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
7741068|NCT01550471|19059967|P6|COMPLETED|First Wash Out Period (3 Weeks)||4
7741069|NCT01550471|19059968|P5|COMPLETED|First Wash Out Period (3 Weeks)||4
7741070|NCT01550471|19059969|P4|COMPLETED|First Wash Out Period (3 Weeks)||4
7741071|NCT01550471|19059970|P3|COMPLETED|First Wash Out Period (3 Weeks)||3
7741072|NCT01550471|19059971|P2|COMPLETED|First Wash Out Period (3 Weeks)||4
7741073|NCT01550471|19059972|P1|COMPLETED|First Wash Out Period (3 Weeks)||3
7741074|NCT01550471|19059967|P6|STARTED|First Wash Out Period (3 Weeks)||4
7741075|NCT01550471|19059968|P5|STARTED|First Wash Out Period (3 Weeks)||4
7741076|NCT01550471|19059969|P4|STARTED|First Wash Out Period (3 Weeks)||4
7741077|NCT01550471|19059970|P3|STARTED|First Wash Out Period (3 Weeks)||3
7741078|NCT01550471|19059971|P2|STARTED|First Wash Out Period (3 Weeks)||4
7741079|NCT01550471|19059972|P1|STARTED|First Wash Out Period (3 Weeks)||3
7741080|NCT01550471|19059967|P6|NOT COMPLETED|First Treatment Period (3 Weeks)||0
7741081|NCT01550471|19059968|P5|NOT COMPLETED|First Treatment Period (3 Weeks)||0
7741082|NCT01550471|19059969|P4|NOT COMPLETED|First Treatment Period (3 Weeks)||0
7741083|NCT01550471|19059970|P3|NOT COMPLETED|First Treatment Period (3 Weeks)||0
7741084|NCT01550471|19059971|P2|NOT COMPLETED|First Treatment Period (3 Weeks)||0
7741085|NCT01550471|19059972|P1|NOT COMPLETED|First Treatment Period (3 Weeks)||0
7741086|NCT01550471|19059967|P6|COMPLETED|First Treatment Period (3 Weeks)||4
7741087|NCT01550471|19059968|P5|COMPLETED|First Treatment Period (3 Weeks)||4
7741088|NCT01550471|19059969|P4|COMPLETED|First Treatment Period (3 Weeks)||4
7741089|NCT01550471|19059970|P3|COMPLETED|First Treatment Period (3 Weeks)||3
7741090|NCT01550471|19059971|P2|COMPLETED|First Treatment Period (3 Weeks)||4
7741091|NCT01550471|19059972|P1|COMPLETED|First Treatment Period (3 Weeks)||3
7741092|NCT01550471|19059967|P6|STARTED|First Treatment Period (3 Weeks)||4
7741093|NCT01550471|19059968|P5|STARTED|First Treatment Period (3 Weeks)||4
7741094|NCT01550471|19059969|P4|STARTED|First Treatment Period (3 Weeks)||4
7741095|NCT01550471|19059970|P3|STARTED|First Treatment Period (3 Weeks)||3
7741096|NCT01550471|19059971|P2|STARTED|First Treatment Period (3 Weeks)||4
7741097|NCT01550471|19059972|P1|STARTED|First Treatment Period (3 Weeks)||3
7741098|NCT01550471|19059967|P6|NOT COMPLETED|Run-In Period (3 Weeks)||0
7741099|NCT01550471|19059968|P5|NOT COMPLETED|Run-In Period (3 Weeks)||0
7741100|NCT01550471|19059969|P4|NOT COMPLETED|Run-In Period (3 Weeks)||0
7741101|NCT01550471|19059970|P3|NOT COMPLETED|Run-In Period (3 Weeks)||0
7741102|NCT01550471|19059971|P2|NOT COMPLETED|Run-In Period (3 Weeks)||0
7741103|NCT01550471|19059972|P1|NOT COMPLETED|Run-In Period (3 Weeks)||0
7741104|NCT01550471|19059967|P6|COMPLETED|Run-In Period (3 Weeks)||4
7741105|NCT01550471|19059968|P5|COMPLETED|Run-In Period (3 Weeks)||4
7741106|NCT01550471|19059969|P4|COMPLETED|Run-In Period (3 Weeks)||4
7741107|NCT01550471|19059970|P3|COMPLETED|Run-In Period (3 Weeks)||3
7741108|NCT01550471|19059971|P2|COMPLETED|Run-In Period (3 Weeks)||4
7741109|NCT01550471|19059972|P1|COMPLETED|Run-In Period (3 Weeks)||3
7741110|NCT01550471|19059967|P6|STARTED|Run-In Period (3 Weeks)||4
7741111|NCT01550471|19059968|P5|STARTED|Run-In Period (3 Weeks)||4
7741112|NCT01550471|19059969|P4|STARTED|Run-In Period (3 Weeks)||4
7741113|NCT01550471|19059970|P3|STARTED|Run-In Period (3 Weeks)||3
7741114|NCT01550471|19059971|P2|STARTED|Run-In Period (3 Weeks)||4
7741115|NCT01550471|19059972|P1|STARTED|Run-In Period (3 Weeks)||3
7741116|NCT01550367|19059981|P1|NOT COMPLETED|Overall Study||0
7741117|NCT01550367|19059981|P1|COMPLETED|Overall Study||30
7741118|NCT01550367|19059981|P1|600 mg/d HCQ|Overall Study||17
7741119|NCT01550367|19059981|P1|1200 mg/d HCQ|Overall Study||13
7741120|NCT01550367|19059981|P1|STARTED|Overall Study||30
7741121|NCT01550341|19060008|P2|NOT COMPLETED|Overall Study||0
7741122|NCT01550341|19060009|P1|NOT COMPLETED|Overall Study||0
7741123|NCT01550341|19060008|P2|COMPLETED|Overall Study||18
7741124|NCT01550341|19060009|P1|COMPLETED|Overall Study||32
7741125|NCT01550341|19060008|P2|STARTED|Overall Study||18
7741126|NCT01550341|19060009|P1|STARTED|Overall Study||32
7741127|NCT01550302|19060043|P2|NOT COMPLETED|Overall Study||0
7741128|NCT01550302|19060044|P1|NOT COMPLETED|Overall Study||0
7741129|NCT01550302|19060043|P2|COMPLETED|Overall Study||5
7741130|NCT01550302|19060044|P1|COMPLETED|Overall Study||5
7741131|NCT01550302|19060043|P2|STARTED|Overall Study||5
7741132|NCT01550302|19060044|P1|STARTED|Overall Study||5
7741133|NCT01550289|19060064|P2|NOT COMPLETED|Overall Study||4
7741134|NCT01550289|19060065|P1|NOT COMPLETED|Overall Study||13
7741135|NCT01550289|19060064|P2|COMPLETED|Overall Study||57
7741136|NCT01550289|19060065|P1|COMPLETED|Overall Study||115
7741137|NCT01550289|19060064|P2|STARTED|Overall Study||61
7741138|NCT01550289|19060065|P1|STARTED|Overall Study||128
7741139|NCT01550224|19060097|P2|NOT COMPLETED|Overall Study||0
7741140|NCT01550224|19060098|P1|NOT COMPLETED|Overall Study||0
7741141|NCT01550224|19060097|P2|COMPLETED|Overall Study||20
7741142|NCT01550224|19060098|P1|COMPLETED|Overall Study||3
7741143|NCT01550224|19060097|P2|STARTED|Overall Study||20
7741144|NCT01550224|19060098|P1|STARTED|Overall Study||3
7741145|NCT01549977|19060122|P2|NOT COMPLETED|Overall Study||0
7741146|NCT01549977|19060123|P1|NOT COMPLETED|Overall Study||0
7741147|NCT01549977|19060122|P2|COMPLETED|Overall Study||0
7741148|NCT01549977|19060123|P1|COMPLETED|Overall Study||1
7741149|NCT01549977|19060122|P2|STARTED|Overall Study||0
7741150|NCT01549977|19060123|P1|STARTED|Overall Study||1
7741151|NCT01549964|19060141|P4|NOT COMPLETED|80-Week Extension Period||137
7741152|NCT01549964|19060142|P3|NOT COMPLETED|80-Week Extension Period||140
7741153|NCT01549964|19060143|P2|NOT COMPLETED|80-Week Extension Period||138
7741154|NCT01549964|19060144|P1|NOT COMPLETED|80-Week Extension Period||66
7741155|NCT01549964|19060141|P4|COMPLETED|80-Week Extension Period||0
7741156|NCT01549964|19060142|P3|COMPLETED|80-Week Extension Period||0
7741157|NCT01549964|19060143|P2|COMPLETED|80-Week Extension Period||0
7741158|NCT01549964|19060144|P1|COMPLETED|80-Week Extension Period||0
7741159|NCT01549964|19060141|P4|STARTED|80-Week Extension Period||137
7741160|NCT01549964|19060142|P3|STARTED|80-Week Extension Period||140
7741161|NCT01549964|19060143|P2|STARTED|80-Week Extension Period||138
7741162|NCT01549964|19060144|P1|STARTED|80-Week Extension Period||66
7741163|NCT01549964|19060141|P4|NOT COMPLETED|24-Week Treatment Period||121
7741164|NCT01549964|19060142|P3|NOT COMPLETED|24-Week Treatment Period||116
7741165|NCT01549964|19060143|P2|NOT COMPLETED|24-Week Treatment Period||111
7741166|NCT01549964|19060144|P1|NOT COMPLETED|24-Week Treatment Period||61
7741167|NCT01549964|19060141|P4|COMPLETED|24-Week Treatment Period||140
7741168|NCT01549964|19060142|P3|COMPLETED|24-Week Treatment Period||147
7741169|NCT01549964|19060143|P2|COMPLETED|24-Week Treatment Period||149
7741170|NCT01549964|19060144|P1|COMPLETED|24-Week Treatment Period||71
7741171|NCT01549964|19060141|P4|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
7741172|NCT01549964|19060142|P3|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263
7741173|NCT01549964|19060143|P2|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
7741174|NCT01549964|19060144|P1|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132
7741175|NCT01549964|19060141|P4|STARTED|24-Week Treatment Period||261
7741176|NCT01549964|19060142|P3|STARTED|24-Week Treatment Period||263
7741177|NCT01549964|19060143|P2|STARTED|24-Week Treatment Period||260
7741178|NCT01549964|19060144|P1|STARTED|24-Week Treatment Period||132
7741179|NCT01549951|19060162|P1|NOT COMPLETED|Overall Study||50
7741180|NCT01549951|19060162|P1|COMPLETED|Overall Study||0
7741181|NCT01549951|19060162|P1|Primary Reason Off Study Treatment|Overall Study||50
7741182|NCT01549951|19060162|P1|STARTED|Overall Study||50
7741183|NCT01549925|19060180|P2|NOT COMPLETED|Overall Study||0
7741184|NCT01549925|19060181|P1|NOT COMPLETED|Overall Study||0
7741185|NCT01549925|19060180|P2|COMPLETED|Overall Study||25
7741186|NCT01549925|19060181|P1|COMPLETED|Overall Study||25
7741187|NCT01549925|19060180|P2|STARTED|Overall Study||25
7741188|NCT01549925|19060181|P1|STARTED|Overall Study||25
7741189|NCT01549873|19060189|P2|NOT COMPLETED|Overall Study||1
7741190|NCT01549873|19060190|P1|NOT COMPLETED|Overall Study||0
7741191|NCT01549873|19060189|P2|COMPLETED|Overall Study||14
7741192|NCT01549873|19060190|P1|COMPLETED|Overall Study||15
7741193|NCT01549873|19060189|P2|STARTED|Overall Study||15
7741194|NCT01549873|19060190|P1|STARTED|Overall Study||15
7741195|NCT01549860|19060202|P2|NOT COMPLETED|Overall Study||1
7741196|NCT01549860|19060203|P1|NOT COMPLETED|Overall Study||2
7741197|NCT01549860|19060202|P2|COMPLETED|Overall Study||40
7741198|NCT01549860|19060203|P1|COMPLETED|Overall Study||38
7741199|NCT01549860|19060202|P2|STARTED|Overall Study||41
7741200|NCT01549860|19060203|P1|STARTED|Overall Study||40
7741201|NCT01549652|19060216|P4|NOT COMPLETED|Overall Study||11
7741202|NCT01549652|19060217|P3|NOT COMPLETED|Overall Study||17
7741203|NCT01549652|19060218|P2|NOT COMPLETED|Overall Study||12
7741204|NCT01549652|19060219|P1|NOT COMPLETED|Overall Study||12
7741205|NCT01549652|19060216|P4|COMPLETED|Overall Study||25
7741206|NCT01549652|19060217|P3|COMPLETED|Overall Study||23
7741207|NCT01549652|19060218|P2|COMPLETED|Overall Study||18
7741208|NCT01549652|19060219|P1|COMPLETED|Overall Study||15
7741209|NCT01549652|19060216|P4|STARTED|Overall Study||36
7741210|NCT01549652|19060217|P3|STARTED|Overall Study||40
7741211|NCT01549652|19060218|P2|STARTED|Overall Study||30
7741212|NCT01549652|19060219|P1|STARTED|Overall Study||27
7741213|NCT01549613|19060237|P2|NOT COMPLETED|Overall Study||11
7741214|NCT01549613|19060238|P1|NOT COMPLETED|Overall Study||11
7741215|NCT01549613|19060237|P2|COMPLETED|Overall Study||39
7741216|NCT01549613|19060238|P1|COMPLETED|Overall Study||39
7741217|NCT01549613|19060237|P2|STARTED|Overall Study||50
7741218|NCT01549613|19060238|P1|STARTED|Overall Study||50
7741219|NCT01549587|19060246|P2|NOT COMPLETED|Overall Study||37
7741220|NCT01549587|19060247|P1|NOT COMPLETED|Overall Study||39
7741221|NCT01549587|19060246|P2|COMPLETED|Overall Study||336
7741222|NCT01549587|19060247|P1|COMPLETED|Overall Study||334
7741223|NCT01549587|19060246|P2|STARTED|Overall Study||373
7741224|NCT01549587|19060247|P1|STARTED|Overall Study||373
7741225|NCT01549405|19060265|P2|NOT COMPLETED|Overall Study||0
7741226|NCT01549405|19060266|P1|NOT COMPLETED|Overall Study||0
7741227|NCT01549405|19060265|P2|COMPLETED|Overall Study||20
7741228|NCT01549405|19060266|P1|COMPLETED|Overall Study||20
7741229|NCT01549405|19060265|P2|STARTED|Overall Study||20
7741230|NCT01549405|19060266|P1|STARTED|Overall Study||20
7741231|NCT01549392|19060276|P2|NOT COMPLETED|Overall Study||0
7741232|NCT01549392|19060277|P1|NOT COMPLETED|Overall Study||1
7741233|NCT01549392|19060276|P2|COMPLETED|Overall Study||0
7741234|NCT01549392|19060277|P1|COMPLETED|Overall Study||2
7741235|NCT01549392|19060276|P2|STARTED|Overall Study||0
7741236|NCT01549392|19060277|P1|STARTED|Overall Study||3
7741237|NCT01549340|19060283|P1|NOT COMPLETED|Overall Study||8405
7741238|NCT01549340|19060283|P1|COMPLETED|Overall Study|Completed 5 years of AIT|385
7741239|NCT01549340|19060283|P1|Started AIT|Overall Study||3182
7741240|NCT01549340|19060283|P1|STARTED|Overall Study|Advised to receive AIT|8790
7741241|NCT01549314|19060297|P3|NOT COMPLETED|Overall Study||2
7741242|NCT01549314|19060298|P2|NOT COMPLETED|Overall Study||5
7741243|NCT01549314|19060299|P1|NOT COMPLETED|Overall Study||4
7741244|NCT01549314|19060297|P3|COMPLETED|Overall Study||24
7741245|NCT01549314|19060298|P2|COMPLETED|Overall Study||21
7741246|NCT01549314|19060299|P1|COMPLETED|Overall Study||23
7741247|NCT01549314|19060297|P3|STARTED|Overall Study||26
7741248|NCT01549314|19060298|P2|STARTED|Overall Study||26
7741249|NCT01549314|19060299|P1|STARTED|Overall Study|1 subject signed the consent form but dropped out prior to any study procedures or data collection.|27
7741250|NCT01549275|19060315|P2|NOT COMPLETED|Overall Study||0
7741251|NCT01549275|19060316|P1|NOT COMPLETED|Overall Study||1
7741252|NCT01549275|19060315|P2|COMPLETED|Overall Study||29
7741253|NCT01549275|19060316|P1|COMPLETED|Overall Study||75
7741254|NCT01549275|19060315|P2|STARTED|Overall Study||29
7741255|NCT01549275|19060316|P1|STARTED|Overall Study||76
7741256|NCT01549223|19060328|P2|NOT COMPLETED|Overall Study||0
7741257|NCT01549223|19060329|P1|NOT COMPLETED|Overall Study||0
7741258|NCT01549223|19060328|P2|COMPLETED|Overall Study||30
7741259|NCT01549223|19060329|P1|COMPLETED|Overall Study||30
7741260|NCT01549223|19060328|P2|STARTED|Overall Study||30
7741261|NCT01549223|19060329|P1|STARTED|Overall Study||30
7741262|NCT01549041|19060339|P2|NOT COMPLETED|Overall Study||8
7741263|NCT01549041|19060340|P1|NOT COMPLETED|Overall Study||2
7741264|NCT01549041|19060339|P2|COMPLETED|Overall Study||10
7741265|NCT01549041|19060340|P1|COMPLETED|Overall Study||10
7741266|NCT01549041|19060339|P2|STARTED|Overall Study||18
7741267|NCT01549041|19060340|P1|STARTED|Overall Study||12
7741268|NCT01549002|19060350|P2|NOT COMPLETED|Overall Study||4
7741269|NCT01549002|19060351|P1|NOT COMPLETED|Overall Study||0
7741270|NCT01549002|19060350|P2|COMPLETED|Overall Study||6
7741271|NCT01549002|19060351|P1|COMPLETED|Overall Study||10
7741272|NCT01549002|19060350|P2|STARTED|Overall Study||10
7741273|NCT01549002|19060351|P1|STARTED|Overall Study||10
7741274|NCT01548885|19060361|P1|NOT COMPLETED|Overall Study||0
7741275|NCT01548885|19060361|P1|COMPLETED|Overall Study||146
7741276|NCT01548885|19060361|P1|STARTED|Overall Study||146
7741277|NCT01548833|19060366|P1|NOT COMPLETED|Overall Study||0
7741278|NCT01548833|19060366|P1|COMPLETED|Overall Study||39
7741279|NCT01548833|19060366|P1|STARTED|Overall Study||39
7741280|NCT01548768|19060378|P4|NOT COMPLETED|Overall Study||4
7741281|NCT01548768|19060379|P3|NOT COMPLETED|Overall Study||1
7741282|NCT01548768|19060380|P2|NOT COMPLETED|Overall Study||2
7741283|NCT01548768|19060381|P1|NOT COMPLETED|Overall Study||1
7741284|NCT01548768|19060378|P4|COMPLETED|Overall Study||117
7741285|NCT01548768|19060379|P3|COMPLETED|Overall Study||15
7741286|NCT01548768|19060380|P2|COMPLETED|Overall Study||2
7741287|NCT01548768|19060381|P1|COMPLETED|Overall Study||7
7741288|NCT01548768|19060378|P4|STARTED|Overall Study||121
7741289|NCT01548768|19060379|P3|STARTED|Overall Study||16
7741290|NCT01548768|19060380|P2|STARTED|Overall Study||4
7741291|NCT01548768|19060381|P1|STARTED|Overall Study||8
7741292|NCT01548742|19060398|P2|NOT COMPLETED|Overall Study||4
7741293|NCT01548742|19060399|P1|NOT COMPLETED|Overall Study||13
7741294|NCT01548742|19060398|P2|COMPLETED|Overall Study||54
7741295|NCT01548742|19060399|P1|COMPLETED|Overall Study||45
7741296|NCT01548742|19060398|P2|STARTED|Overall Study||58
7741297|NCT01548742|19060399|P1|STARTED|Overall Study||58
7741298|NCT01548690|19060417|P4|NOT COMPLETED|Overall Study||5
7741299|NCT01548690|19060418|P3|NOT COMPLETED|Overall Study||5
7741300|NCT01548690|19060419|P2|NOT COMPLETED|Overall Study||3
7741301|NCT01548690|19060420|P1|NOT COMPLETED|Overall Study||0
7741302|NCT01548690|19060417|P4|COMPLETED|Overall Study||10
7741303|NCT01548690|19060418|P3|COMPLETED|Overall Study||8
7741304|NCT01548690|19060419|P2|COMPLETED|Overall Study||7
7741305|NCT01548690|19060420|P1|COMPLETED|Overall Study||9
7741306|NCT01548690|19060417|P4|Evaluable (72 Hours on Infusion)|Overall Study||12
7741307|NCT01548690|19060418|P3|Evaluable (72 Hours on Infusion)|Overall Study||12
7741308|NCT01548690|19060419|P2|Evaluable (72 Hours on Infusion)|Overall Study||6
7741309|NCT01548690|19060420|P1|Evaluable (72 Hours on Infusion)|Overall Study||6
7741310|NCT01548690|19060417|P4|STARTED|Overall Study||15
7741311|NCT01548690|19060418|P3|STARTED|Overall Study||13
7741312|NCT01548690|19060419|P2|STARTED|Overall Study||10
7741313|NCT01548690|19060420|P1|STARTED|Overall Study||9
7741314|NCT01548651|19060448|P2|NOT COMPLETED|Overall Study||0
7741315|NCT01548651|19060449|P1|NOT COMPLETED|Overall Study||1
7741316|NCT01548651|19060448|P2|COMPLETED|Overall Study||4
7741317|NCT01548651|19060449|P1|COMPLETED|Overall Study||3
7741318|NCT01548651|19060448|P2|STARTED|Overall Study||4
7741319|NCT01548651|19060449|P1|STARTED|Overall Study||4
7741320|NCT01548638|19060459|P1|NOT COMPLETED|Overall Study||4
7741321|NCT01548638|19060459|P1|COMPLETED|Overall Study||9
7741322|NCT01548638|19060459|P1|STARTED|Overall Study||13
7741323|NCT01548599|19060471|P2|NOT COMPLETED|Overall Study||2
7741324|NCT01548599|19060472|P1|NOT COMPLETED|Overall Study||6
7741325|NCT01548599|19060471|P2|COMPLETED|Overall Study||66
7741326|NCT01548599|19060472|P1|COMPLETED|Overall Study||66
7741327|NCT01548599|19060471|P2|STARTED|Overall Study||68
7741328|NCT01548599|19060472|P1|STARTED|Overall Study||72
7741329|NCT01548573|19060488|P1|NOT COMPLETED|Overall Study||5
7741330|NCT01548573|19060488|P1|COMPLETED|Overall Study||14
7741331|NCT01548573|19060488|P1|STARTED|Overall Study||19
7741332|NCT01548417|19060497|P2|NOT COMPLETED|Overall Study||2
7741333|NCT01548417|19060498|P1|NOT COMPLETED|Overall Study||0
7741334|NCT01548417|19060497|P2|COMPLETED|Overall Study||26
7741335|NCT01548417|19060498|P1|COMPLETED|Overall Study||28
7741336|NCT01548417|19060497|P2|STARTED|Overall Study||28
7741337|NCT01548417|19060498|P1|STARTED|Overall Study||28
7741338|NCT01548404|19060508|P2|NOT COMPLETED|Overall Study||14
7741339|NCT01548404|19060509|P1|NOT COMPLETED|Overall Study||30
7741340|NCT01548404|19060508|P2|COMPLETED|Overall Study||41
7741341|NCT01548404|19060509|P1|COMPLETED|Overall Study||24
7741342|NCT01548404|19060508|P2|STARTED|Overall Study||55
7741343|NCT01548404|19060509|P1|STARTED|Overall Study||54
7741344|NCT01548339|19060533|P2|NOT COMPLETED|Overall Study||1
7741345|NCT01548339|19060534|P1|NOT COMPLETED|Overall Study||6
7741346|NCT01548339|19060533|P2|COMPLETED|Overall Study||41
7741347|NCT01548339|19060534|P1|COMPLETED|Overall Study||38
7741348|NCT01548339|19060533|P2|STARTED|Overall Study||42
7741349|NCT01548339|19060534|P1|STARTED|Overall Study||44
7741350|NCT01548287|19060548|P5|NOT COMPLETED|Randomized Period||0
7741351|NCT01548287|19060549|P4|NOT COMPLETED|Randomized Period||0
7741352|NCT01548287|19060550|P3|NOT COMPLETED|Randomized Period||7
7741353|NCT01548287|19060551|P2|NOT COMPLETED|Randomized Period||2
7741354|NCT01548287|19060552|P1|NOT COMPLETED|Randomized Period||0
7741355|NCT01548287|19060548|P5|COMPLETED|Randomized Period||0
7741356|NCT01548287|19060549|P4|COMPLETED|Randomized Period||20
7741357|NCT01548287|19060550|P3|COMPLETED|Randomized Period||13
7741358|NCT01548287|19060551|P2|COMPLETED|Randomized Period||20
7741359|NCT01548287|19060552|P1|COMPLETED|Randomized Period||19
7741360|NCT01548287|19060548|P5|STARTED|Randomized Period||0
7741361|NCT01548287|19060549|P4|STARTED|Randomized Period||20
7741362|NCT01548287|19060550|P3|STARTED|Randomized Period||20
7741363|NCT01548287|19060551|P2|STARTED|Randomized Period||22
7741364|NCT01548287|19060552|P1|STARTED|Randomized Period||19
7741365|NCT01548287|19060548|P5|NOT COMPLETED|Screening||83
7741366|NCT01548287|19060549|P4|NOT COMPLETED|Screening||0
7741367|NCT01548287|19060550|P3|NOT COMPLETED|Screening||0
7741368|NCT01548287|19060551|P2|NOT COMPLETED|Screening||0
7741369|NCT01548287|19060552|P1|NOT COMPLETED|Screening||0
7741370|NCT01548287|19060548|P5|COMPLETED|Screening||0
7741371|NCT01548287|19060549|P4|COMPLETED|Screening||20
7741372|NCT01548287|19060550|P3|COMPLETED|Screening||20
7741373|NCT01548287|19060551|P2|COMPLETED|Screening||22
7741374|NCT01548287|19060552|P1|COMPLETED|Screening||19
7741375|NCT01548287|19060548|P5|STARTED|Screening||83
7741376|NCT01548287|19060549|P4|STARTED|Screening||20
7741377|NCT01548287|19060550|P3|STARTED|Screening||20
7741378|NCT01548287|19060551|P2|STARTED|Screening||22
7741379|NCT01548287|19060552|P1|STARTED|Screening||19
7741380|NCT01548040|19060584|P2|NOT COMPLETED|Overall Study||10
7741381|NCT01548040|19060585|P1|NOT COMPLETED|Overall Study||13
7741382|NCT01548040|19060584|P2|COMPLETED|Overall Study||45
7741383|NCT01548040|19060585|P1|COMPLETED|Overall Study||43
7741384|NCT01548040|19060584|P2|STARTED|Overall Study||55
7741385|NCT01548040|19060585|P1|STARTED|Overall Study||56
7741386|NCT01547806|19060593|P1|NOT COMPLETED|Overall Study||0
7741387|NCT01547806|19060593|P1|COMPLETED|Overall Study||49
7741388|NCT01547806|19060593|P1|STARTED|Overall Study||49
7741389|NCT01547728|19060609|P1|NOT COMPLETED|Overall Study||41
7741390|NCT01547728|19060609|P1|COMPLETED|Overall Study||1
7741391|NCT01547728|19060609|P1|STARTED|Overall Study||42
7741392|NCT01547715|19060616|P3|NOT COMPLETED|Overall Study||0
7741393|NCT01547715|19060617|P2|NOT COMPLETED|Overall Study||0
7741394|NCT01547715|19060618|P1|NOT COMPLETED|Overall Study||0
7741395|NCT01547715|19060616|P3|COMPLETED|Overall Study||60
7741396|NCT01547715|19060617|P2|COMPLETED|Overall Study||60
7741397|NCT01547715|19060618|P1|COMPLETED|Overall Study||60
7741398|NCT01547715|19060616|P3|STARTED|Overall Study||60
7741399|NCT01547715|19060617|P2|STARTED|Overall Study||60
7741400|NCT01547715|19060618|P1|STARTED|Overall Study||60
7741401|NCT01547598|19060718|P2|NOT COMPLETED|Overall Study||5
7741402|NCT01547598|19060719|P1|NOT COMPLETED|Overall Study||6
7741403|NCT01547598|19060718|P2|COMPLETED|Overall Study||63
7741404|NCT01547598|19060719|P1|COMPLETED|Overall Study||61
7741405|NCT01547598|19060718|P2|STARTED|Overall Study||68
7741406|NCT01547598|19060719|P1|STARTED|Overall Study||67
7741407|NCT01547390|19060736|P2|NOT COMPLETED|Overall Study||10
7741408|NCT01547390|19060737|P1|NOT COMPLETED|Overall Study||13
7741409|NCT01547390|19060736|P2|COMPLETED|Overall Study||16
7741410|NCT01547390|19060737|P1|COMPLETED|Overall Study||14
7741411|NCT01547390|19060736|P2|STARTED|Overall Study||26
7741412|NCT01547390|19060737|P1|STARTED|Overall Study||27
7741413|NCT01547299|19060747|P2|NOT COMPLETED|Overall Study||2
7741414|NCT01547299|19060748|P1|NOT COMPLETED|Overall Study||2
7741415|NCT01547299|19060747|P2|COMPLETED|Overall Study||25
7741416|NCT01547299|19060748|P1|COMPLETED|Overall Study||23
7741417|NCT01547299|19060747|P2|STARTED|Overall Study||27
7741418|NCT01547299|19060748|P1|STARTED|Overall Study||25
7741419|NCT01547286|19060814|P1|NOT COMPLETED|Overall Study||2
7741420|NCT01547286|19060814|P1|COMPLETED|Overall Study||5
7741421|NCT01547286|19060814|P1|STARTED|Overall Study||7
7741422|NCT01547247|19060823|P2|NOT COMPLETED|Overall Study||6
7741423|NCT01547247|19060824|P1|NOT COMPLETED|Overall Study||6
7741424|NCT01547247|19060823|P2|COMPLETED|Overall Study||98
7741425|NCT01547247|19060824|P1|COMPLETED|Overall Study||98
7741426|NCT01547247|19060823|P2|STARTED|Overall Study||104
7741427|NCT01547247|19060824|P1|STARTED|Overall Study||104
7741428|NCT01547130|19060834|P2|NOT COMPLETED|Overall Study||5
7741429|NCT01547130|19060835|P1|NOT COMPLETED|Overall Study||9
7741430|NCT01547130|19060834|P2|COMPLETED|Overall Study||68
7741431|NCT01547130|19060835|P1|COMPLETED|Overall Study||65
7741432|NCT01547130|19060834|P2|STARTED|Overall Study||73
7741433|NCT01547130|19060835|P1|STARTED|Overall Study||74
7741434|NCT01547000|19060851|P2|NOT COMPLETED|Overall Study||0
7741435|NCT01547000|19060852|P1|NOT COMPLETED|Overall Study||0
7741436|NCT01547000|19060851|P2|COMPLETED|Overall Study||16
7741437|NCT01547000|19060852|P1|COMPLETED|Overall Study||18
7741438|NCT01547000|19060851|P2|STARTED|Overall Study||16
7741439|NCT01547000|19060852|P1|STARTED|Overall Study||18
7741440|NCT01546922|19060858|P2|NOT COMPLETED|Second Period of 10 Weeks||3
7741441|NCT01546922|19060859|P1|NOT COMPLETED|Second Period of 10 Weeks||3
7741442|NCT01546922|19060858|P2|COMPLETED|Second Period of 10 Weeks||25
7741443|NCT01546922|19060859|P1|COMPLETED|Second Period of 10 Weeks||22
7741444|NCT01546922|19060858|P2|STARTED|Second Period of 10 Weeks||28
7741445|NCT01546922|19060859|P1|STARTED|Second Period of 10 Weeks||25
7741446|NCT01546922|19060858|P2|NOT COMPLETED|First Period of 10 Weeks||2
7741447|NCT01546922|19060859|P1|NOT COMPLETED|First Period of 10 Weeks||5
7741448|NCT01546922|19060858|P2|COMPLETED|First Period of 10 Weeks||28
7741449|NCT01546922|19060859|P1|COMPLETED|First Period of 10 Weeks||25
7741450|NCT01546922|19060858|P2|STARTED|First Period of 10 Weeks||30
7741451|NCT01546922|19060859|P1|STARTED|First Period of 10 Weeks||30
7741452|NCT01546883|19060865|P1|NOT COMPLETED|Overall Study||12
7741453|NCT01546883|19060865|P1|COMPLETED|Overall Study||2
7741454|NCT01546883|19060865|P1|STARTED|Overall Study||14
7741455|NCT01546688|19060871|P2|NOT COMPLETED|Overall Study||5
7741456|NCT01546688|19060872|P1|NOT COMPLETED|Overall Study||3
7741457|NCT01546688|19060871|P2|COMPLETED|Overall Study||28
7741458|NCT01546688|19060872|P1|COMPLETED|Overall Study||15
7741459|NCT01546688|19060871|P2|STARTED|Overall Study||33
7741460|NCT01546688|19060872|P1|STARTED|Overall Study||18
7741461|NCT01546675|19060886|P2|NOT COMPLETED|Overall Study||0
7741462|NCT01546675|19060887|P1|NOT COMPLETED|Overall Study||0
7741463|NCT01546675|19060886|P2|COMPLETED|Overall Study||1
7741464|NCT01546675|19060887|P1|COMPLETED|Overall Study||1
7741465|NCT01546675|19060886|P2|STARTED|Overall Study||1
7741466|NCT01546675|19060887|P1|STARTED|Overall Study||1
7741467|NCT01546649|19060904|P2|NOT COMPLETED|Overall Study||9
7741468|NCT01546649|19060905|P1|NOT COMPLETED|Overall Study||8
7741469|NCT01546649|19060904|P2|COMPLETED|Overall Study||75
7741470|NCT01546649|19060905|P1|COMPLETED|Overall Study||75
7741471|NCT01546649|19060904|P2|STARTED|Overall Study||84
7741472|NCT01546649|19060905|P1|STARTED|Overall Study||83
7741473|NCT01546636|19060927|P2|NOT COMPLETED|Overall Study||0
7741474|NCT01546636|19060928|P1|NOT COMPLETED|Overall Study||0
7741475|NCT01546636|19060927|P2|COMPLETED|Overall Study||34
7741476|NCT01546636|19060928|P1|COMPLETED|Overall Study||36
7741477|NCT01546636|19060927|P2|STARTED|Overall Study||34
7741478|NCT01546636|19060928|P1|STARTED|Overall Study||36
7741479|NCT01546623|19060940|P2|NOT COMPLETED|Overall Study||6
7741480|NCT01546623|19060941|P1|NOT COMPLETED|Overall Study||6
7741481|NCT01546623|19060940|P2|COMPLETED|Overall Study||74
7741482|NCT01546623|19060941|P1|COMPLETED|Overall Study||76
7741483|NCT01546623|19060940|P2|Received Study Drug|Overall Study||79
7741484|NCT01546623|19060941|P1|Received Study Drug|Overall Study||81
7741485|NCT01546623|19060940|P2|STARTED|Overall Study||80
7741486|NCT01546623|19060941|P1|STARTED|Overall Study||82
7741487|NCT01546519|19060971|P4|NOT COMPLETED|Overall Study||6
7741488|NCT01546519|19060972|P3|NOT COMPLETED|Overall Study||8
7741489|NCT01546519|19060973|P2|NOT COMPLETED|Overall Study||8
7741490|NCT01546519|19060974|P1|NOT COMPLETED|Overall Study||9
7741491|NCT01546519|19060971|P4|COMPLETED|Overall Study||0
7741492|NCT01546519|19060972|P3|COMPLETED|Overall Study||0
7741493|NCT01546519|19060973|P2|COMPLETED|Overall Study||0
7741494|NCT01546519|19060974|P1|COMPLETED|Overall Study||0
7741495|NCT01546519|19060971|P4|Safety-Evaluable Participants|Overall Study||6
7741496|NCT01546519|19060972|P3|Safety-Evaluable Participants|Overall Study||8
7741497|NCT01546519|19060973|P2|Safety-Evaluable Participants|Overall Study||8
7741498|NCT01546519|19060974|P1|Safety-Evaluable Participants|Overall Study||9
7741499|NCT01546519|19060971|P4|STARTED|Overall Study||6
7741500|NCT01546519|19060972|P3|STARTED|Overall Study||8
7741501|NCT01546519|19060973|P2|STARTED|Overall Study||8
7741502|NCT01546519|19060974|P1|STARTED|Overall Study||9
7741503|NCT01546454|19061016|P1|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0
7741504|NCT01546454|19061016|P1|COMPLETED|Estrogen/Progesterone Replacement Cycle||4
7741505|NCT01546454|19061016|P1|STARTED|Estrogen/Progesterone Replacement Cycle||4
7741506|NCT01546454|19061016|P1|NOT COMPLETED|Eligard Treatment||0
7741507|NCT01546454|19061016|P1|COMPLETED|Eligard Treatment||4
7741508|NCT01546454|19061016|P1|STARTED|Eligard Treatment||4
7741509|NCT01546454|19061016|P1|NOT COMPLETED|Oral Contraceptive Cycle||0
7741510|NCT01546454|19061016|P1|COMPLETED|Oral Contraceptive Cycle||4
7741511|NCT01546454|19061016|P1|STARTED|Oral Contraceptive Cycle||4
7741512|NCT01546454|19061016|P1|NOT COMPLETED|Natural Menstrual Cycle||0
7741513|NCT01546454|19061016|P1|COMPLETED|Natural Menstrual Cycle||4
7741514|NCT01546454|19061016|P1|STARTED|Natural Menstrual Cycle||4
7741515|NCT01546402|19061024|P2|NOT COMPLETED|Overall Study||0
7741516|NCT01546402|19061025|P1|NOT COMPLETED|Overall Study||0
7741517|NCT01546402|19061024|P2|COMPLETED|Overall Study||10
7741518|NCT01546402|19061025|P1|COMPLETED|Overall Study||10
7741519|NCT01546402|19061024|P2|STARTED|Overall Study||10
7741520|NCT01546402|19061025|P1|STARTED|Overall Study||10
7741521|NCT01546285|19061033|P1|NOT COMPLETED|Overall Study||0
7741522|NCT01546285|19061033|P1|COMPLETED|Overall Study||66
7741523|NCT01546285|19061033|P1|STARTED|Overall Study||66
7741524|NCT01546207|19061039|P1|NOT COMPLETED|Overall Study||1
7741525|NCT01546207|19061039|P1|COMPLETED|Overall Study||3
7741526|NCT01546207|19061039|P1|STARTED|Overall Study||4
7741527|NCT01546194|19061045|P2|NOT COMPLETED|Overall Study||35
7741528|NCT01546194|19061046|P1|NOT COMPLETED|Overall Study||36
7741529|NCT01546194|19061045|P2|COMPLETED|Overall Study||65
7741530|NCT01546194|19061046|P1|COMPLETED|Overall Study||64
7741531|NCT01546194|19061045|P2|STARTED|Overall Study||100
7741532|NCT01546194|19061046|P1|STARTED|Overall Study||100
7741533|NCT01546168|19061054|P2|NOT COMPLETED|Overall Study||0
7741534|NCT01546168|19061055|P1|NOT COMPLETED|Overall Study||4
7741535|NCT01546168|19061054|P2|COMPLETED|Overall Study||33
7741536|NCT01546168|19061055|P1|COMPLETED|Overall Study||51
7741537|NCT01546168|19061054|P2|STARTED|Overall Study||33
7741538|NCT01546168|19061055|P1|STARTED|Overall Study||55
7741539|NCT01546155|19061067|P1|NOT COMPLETED|Overall Study||3
7741540|NCT01546155|19061067|P1|COMPLETED|Overall Study||8
7741541|NCT01546155|19061067|P1|STARTED|Overall Study||11
7741542|NCT01546142|19061073|P2|NOT COMPLETED|Overall Study||34
7741543|NCT01546142|19061074|P1|NOT COMPLETED|Overall Study||44
7741544|NCT01546142|19061073|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224
7741545|NCT01546142|19061074|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214
7741546|NCT01546142|19061073|P2|Received Treatment|Overall Study||257
7741547|NCT01546142|19061074|P1|Received Treatment|Overall Study||257
7741548|NCT01546142|19061073|P2|STARTED|Overall Study||258
7741549|NCT01546142|19061074|P1|STARTED|Overall Study||258
7741550|NCT01546038|19061092|P9|NOT COMPLETED|Overall Study||43
7741551|NCT01546038|19061093|P8|NOT COMPLETED|Overall Study||84
7741552|NCT01546038|19061094|P7|NOT COMPLETED|Overall Study||53
7741553|NCT01546038|19061095|P6|NOT COMPLETED|Overall Study||4
7741554|NCT01546038|19061096|P5|NOT COMPLETED|Overall Study||10
7741555|NCT01546038|19061097|P4|NOT COMPLETED|Overall Study||3
7741556|NCT01546038|19061098|P3|NOT COMPLETED|Overall Study||4
7741557|NCT01546038|19061099|P2|NOT COMPLETED|Overall Study||6
7741558|NCT01546038|19061100|P1|NOT COMPLETED|Overall Study||16
7741559|NCT01546038|19061092|P9|COMPLETED|Overall Study||1
7741560|NCT01546038|19061093|P8|COMPLETED|Overall Study||4
7741561|NCT01546038|19061094|P7|COMPLETED|Overall Study||18
7741562|NCT01546038|19061095|P6|COMPLETED|Overall Study||2
7741563|NCT01546038|19061096|P5|COMPLETED|Overall Study||6
7741564|NCT01546038|19061097|P4|COMPLETED|Overall Study||0
7741565|NCT01546038|19061098|P3|COMPLETED|Overall Study||0
7741566|NCT01546038|19061099|P2|COMPLETED|Overall Study||0
7741567|NCT01546038|19061100|P1|COMPLETED|Overall Study||1
7741568|NCT01546038|19061092|P9|Received Treatment|Overall Study||41
7741569|NCT01546038|19061093|P8|Received Treatment|Overall Study||84
7741570|NCT01546038|19061094|P7|Received Treatment|Overall Study||69
7741571|NCT01546038|19061095|P6|Received Treatment|Overall Study||6
7741572|NCT01546038|19061096|P5|Received Treatment|Overall Study||16
7741573|NCT01546038|19061097|P4|Received Treatment|Overall Study||3
7741574|NCT01546038|19061098|P3|Received Treatment|Overall Study||4
7741575|NCT01546038|19061099|P2|Received Treatment|Overall Study||6
7741576|NCT01546038|19061100|P1|Received Treatment|Overall Study||17
7741577|NCT01546038|19061092|P9|STARTED|Overall Study||44
7741578|NCT01546038|19061093|P8|STARTED|Overall Study||88
7741579|NCT01546038|19061094|P7|STARTED|Overall Study||71
7741580|NCT01546038|19061095|P6|STARTED|Overall Study||6
7741581|NCT01546038|19061096|P5|STARTED|Overall Study||16
7741582|NCT01546038|19061097|P4|STARTED|Overall Study||3
7741583|NCT01546038|19061098|P3|STARTED|Overall Study||4
7741584|NCT01546038|19061099|P2|STARTED|Overall Study||6
7741585|NCT01546038|19061100|P1|STARTED|Overall Study||17
7741586|NCT01545843|19061263|P3|NOT COMPLETED|Overall Study||4
7741587|NCT01545843|19061264|P2|NOT COMPLETED|Overall Study||7
7741588|NCT01545843|19061265|P1|NOT COMPLETED|Overall Study||3
7741589|NCT01545843|19061263|P3|COMPLETED|Overall Study||21
7741590|NCT01545843|19061264|P2|COMPLETED|Overall Study||17
7741591|NCT01545843|19061265|P1|COMPLETED|Overall Study||16
7741592|NCT01545843|19061263|P3|STARTED|Overall Study||25
7741593|NCT01545843|19061264|P2|STARTED|Overall Study||24
7741594|NCT01545843|19061265|P1|STARTED|Overall Study||19
7741595|NCT01545817|19061294|P2|NOT COMPLETED|Everolimus||38
7741596|NCT01545817|19061295|P1|NOT COMPLETED|Everolimus||0
7741597|NCT01545817|19061294|P2|COMPLETED|Everolimus||0
7741598|NCT01545817|19061295|P1|COMPLETED|Everolimus||0
7741599|NCT01545817|19061294|P2|STARTED|Everolimus||38
7741600|NCT01545817|19061295|P1|STARTED|Everolimus||0
7741601|NCT01545817|19061294|P2|NOT COMPLETED|Pazopanib||0
7741602|NCT01545817|19061295|P1|NOT COMPLETED|Pazopanib||74
7741603|NCT01545817|19061294|P2|COMPLETED|Pazopanib||0
7741604|NCT01545817|19061295|P1|COMPLETED|Pazopanib||0
7741605|NCT01545817|19061294|P2|STARTED|Pazopanib||0
7741606|NCT01545817|19061295|P1|STARTED|Pazopanib||74
7741607|NCT01545765|19061306|P1|NOT COMPLETED|Overall Study||0
7741608|NCT01545765|19061306|P1|COMPLETED|Overall Study||31
7741609|NCT01545765|19061306|P1|STARTED|Overall Study||31
7741610|NCT01545700|19061323|P6|NOT COMPLETED|Overall Study||0
7741611|NCT01545700|19061324|P5|NOT COMPLETED|Overall Study||1
7741612|NCT01545700|19061325|P4|NOT COMPLETED|Overall Study||0
7741613|NCT01545700|19061326|P3|NOT COMPLETED|Overall Study||2
7741614|NCT01545700|19061327|P2|NOT COMPLETED|Overall Study||1
7741615|NCT01545700|19061328|P1|NOT COMPLETED|Overall Study||1
7741616|NCT01545700|19061323|P6|COMPLETED|Overall Study||33
7741617|NCT01545700|19061324|P5|COMPLETED|Overall Study||32
7741618|NCT01545700|19061325|P4|COMPLETED|Overall Study||34
7741619|NCT01545700|19061326|P3|COMPLETED|Overall Study||31
7741620|NCT01545700|19061327|P2|COMPLETED|Overall Study||32
7741621|NCT01545700|19061328|P1|COMPLETED|Overall Study||33
7741622|NCT01545700|19061323|P6|STARTED|Overall Study||33
7741623|NCT01545700|19061324|P5|STARTED|Overall Study||33
7741624|NCT01545700|19061325|P4|STARTED|Overall Study||34
7741625|NCT01545700|19061326|P3|STARTED|Overall Study||33
7741626|NCT01545700|19061327|P2|STARTED|Overall Study||33
7741627|NCT01545700|19061328|P1|STARTED|Overall Study||34
7741628|NCT01545648|19061362|P1|NOT COMPLETED|Overall Study||0
7741629|NCT01545648|19061362|P1|COMPLETED|Overall Study||4
7741630|NCT01545648|19061362|P1|6 Months of Treatment|Overall Study||4
7741631|NCT01545648|19061362|P1|STARTED|Overall Study||4
7741632|NCT01545583|19061377|P9|NOT COMPLETED|Overall Study||0
7741633|NCT01545583|19061378|P8|NOT COMPLETED|Overall Study||0
7741634|NCT01545583|19061379|P7|NOT COMPLETED|Overall Study||0
7741635|NCT01545583|19061380|P6|NOT COMPLETED|Overall Study||0
7741636|NCT01545583|19061381|P5|NOT COMPLETED|Overall Study||0
7741637|NCT01545583|19061382|P4|NOT COMPLETED|Overall Study||0
7741638|NCT01545583|19061383|P3|NOT COMPLETED|Overall Study||0
7741639|NCT01545583|19061384|P2|NOT COMPLETED|Overall Study||0
7741640|NCT01545583|19061385|P1|NOT COMPLETED|Overall Study||0
7741641|NCT01545583|19061377|P9|COMPLETED|Overall Study||6
7741642|NCT01545583|19061378|P8|COMPLETED|Overall Study||6
7741643|NCT01545583|19061379|P7|COMPLETED|Overall Study||6
7741644|NCT01545583|19061380|P6|COMPLETED|Overall Study||6
7741645|NCT01545583|19061381|P5|COMPLETED|Overall Study||6
7741646|NCT01545583|19061382|P4|COMPLETED|Overall Study||6
7741647|NCT01545583|19061383|P3|COMPLETED|Overall Study||6
7741648|NCT01545583|19061384|P2|COMPLETED|Overall Study||2
7741649|NCT01545583|19061385|P1|COMPLETED|Overall Study||12
7741650|NCT01545583|19061377|P9|Received at Least 1 Dose of Study Drug|Overall Study||6
7741651|NCT01545583|19061378|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
7741652|NCT01545583|19061379|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
7741653|NCT01545583|19061380|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
7741654|NCT01545583|19061381|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
7741655|NCT01545583|19061382|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
7741656|NCT01545583|19061383|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
7741657|NCT01545583|19061384|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
7741658|NCT01545583|19061385|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
7741659|NCT01545583|19061377|P9|STARTED|Overall Study||6
7741660|NCT01545583|19061378|P8|STARTED|Overall Study||6
7741661|NCT01545583|19061379|P7|STARTED|Overall Study||6
7741662|NCT01545583|19061380|P6|STARTED|Overall Study||6
7741663|NCT01545583|19061381|P5|STARTED|Overall Study||6
7741664|NCT01545583|19061382|P4|STARTED|Overall Study||6
7741665|NCT01545583|19061383|P3|STARTED|Overall Study||6
7741666|NCT01545583|19061384|P2|STARTED|Overall Study||2
7741667|NCT01545583|19061385|P1|STARTED|Overall Study||12
7741668|NCT01545518|19061437|P1|NOT COMPLETED|Overall Study||0
7741669|NCT01545518|19061437|P1|COMPLETED|Overall Study||20
7741670|NCT01545518|19061437|P1|STARTED|Overall Study||20
7741671|NCT01545388|19061444|P3|NOT COMPLETED|Overall Study||8
7741672|NCT01545388|19061445|P2|NOT COMPLETED|Overall Study||11
7741673|NCT01545388|19061446|P1|NOT COMPLETED|Overall Study||8
7741674|NCT01545388|19061444|P3|COMPLETED|Overall Study||58
7741675|NCT01545388|19061445|P2|COMPLETED|Overall Study||122
7741676|NCT01545388|19061446|P1|COMPLETED|Overall Study||130
7741677|NCT01545388|19061444|P3|STARTED|Overall Study||66
7741678|NCT01545388|19061445|P2|STARTED|Overall Study||133
7741679|NCT01545388|19061446|P1|STARTED|Overall Study||138
7741680|NCT01545375|19061465|P2|NOT COMPLETED|Overall Study||90
7741681|NCT01545375|19061466|P1|NOT COMPLETED|Overall Study||97
7741682|NCT01545375|19061465|P2|COMPLETED|Overall Study||813
7741683|NCT01545375|19061466|P1|COMPLETED|Overall Study||803
7741684|NCT01545375|19061465|P2|STARTED|Overall Study||903
7741685|NCT01545375|19061466|P1|STARTED|Overall Study||900
7741686|NCT01545336|19061522|P2|NOT COMPLETED|Overall Study||0
7741687|NCT01545336|19061523|P1|NOT COMPLETED|Overall Study||0
7741688|NCT01545336|19061522|P2|COMPLETED|Overall Study||6
7741689|NCT01545336|19061523|P1|COMPLETED|Overall Study||12
7741690|NCT01545336|19061522|P2|STARTED|Overall Study||6
7741691|NCT01545336|19061523|P1|STARTED|Overall Study||12
7741692|NCT01545232|19061535|P2|NOT COMPLETED|Overall Study||0
7741693|NCT01545232|19061536|P1|NOT COMPLETED|Overall Study||0
7741694|NCT01545232|19061535|P2|COMPLETED|Overall Study||342
7741695|NCT01545232|19061536|P1|COMPLETED|Overall Study||338
7741696|NCT01545232|19061535|P2|STARTED|Overall Study||342
7741697|NCT01545232|19061536|P1|STARTED|Overall Study||338
7741698|NCT01545193|19061568|P2|NOT COMPLETED|Overall Study||1
7741699|NCT01545193|19061569|P1|NOT COMPLETED|Overall Study||0
7741700|NCT01545193|19061568|P2|COMPLETED|Overall Study||149
7741701|NCT01545193|19061569|P1|COMPLETED|Overall Study||150
7741702|NCT01545193|19061568|P2|STARTED|Overall Study||150
7741703|NCT01545193|19061569|P1|STARTED|Overall Study||150
7741704|NCT01545141|19061585|P4|NOT COMPLETED|Overall Study||0
7741705|NCT01545141|19061586|P3|NOT COMPLETED|Overall Study||0
7741706|NCT01545141|19061587|P2|NOT COMPLETED|Overall Study||0
7741707|NCT01545141|19061588|P1|NOT COMPLETED|Overall Study||0
7741708|NCT01545141|19061585|P4|COMPLETED|Overall Study||7
7741709|NCT01545141|19061586|P3|COMPLETED|Overall Study||3
7741710|NCT01545141|19061587|P2|COMPLETED|Overall Study||3
7741711|NCT01545141|19061588|P1|COMPLETED|Overall Study||2
7741712|NCT01545141|19061585|P4|STARTED|Overall Study||7
7741713|NCT01545141|19061586|P3|STARTED|Overall Study||3
7741714|NCT01545141|19061587|P2|STARTED|Overall Study||3
7741715|NCT01545141|19061588|P1|STARTED|Overall Study||2
7741716|NCT01545076|19061598|P5|NOT COMPLETED|IgPro10 Rescue Period||0
7741717|NCT01545076|19061599|P4|NOT COMPLETED|IgPro10 Rescue Period||0
7741718|NCT01545076|19061600|P3|NOT COMPLETED|IgPro10 Rescue Period||0
7741719|NCT01545076|19061601|P2|NOT COMPLETED|IgPro10 Rescue Period||0
7741720|NCT01545076|19061602|P1|NOT COMPLETED|IgPro10 Rescue Period||0
7741721|NCT01545076|19061598|P5|COMPLETED|IgPro10 Rescue Period||60
7741722|NCT01545076|19061599|P4|COMPLETED|IgPro10 Rescue Period||0
7741723|NCT01545076|19061600|P3|COMPLETED|IgPro10 Rescue Period||0
7741724|NCT01545076|19061601|P2|COMPLETED|IgPro10 Rescue Period||0
7741725|NCT01545076|19061602|P1|COMPLETED|IgPro10 Rescue Period||0
7741726|NCT01545076|19061598|P5|STARTED|IgPro10 Rescue Period||60
7741727|NCT01545076|19061599|P4|STARTED|IgPro10 Rescue Period||0
7741728|NCT01545076|19061600|P3|STARTED|IgPro10 Rescue Period||0
7741729|NCT01545076|19061601|P2|STARTED|IgPro10 Rescue Period||0
7741730|NCT01545076|19061602|P1|STARTED|IgPro10 Rescue Period||0
7741731|NCT01545076|19061598|P5|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
7741732|NCT01545076|19061599|P4|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||36
7741733|NCT01545076|19061600|P3|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||21
7741734|NCT01545076|19061601|P2|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||19
7741735|NCT01545076|19061602|P1|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
7741736|NCT01545076|19061598|P5|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
7741737|NCT01545076|19061599|P4|COMPLETED|IgPro20 Subcutaneous Treatment Period||21
7741738|NCT01545076|19061600|P3|COMPLETED|IgPro20 Subcutaneous Treatment Period||36
7741739|NCT01545076|19061601|P2|COMPLETED|IgPro20 Subcutaneous Treatment Period||39
7741740|NCT01545076|19061602|P1|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
7741741|NCT01545076|19061598|P5|STARTED|IgPro20 Subcutaneous Treatment Period||0
7741742|NCT01545076|19061599|P4|STARTED|IgPro20 Subcutaneous Treatment Period||57
7741743|NCT01545076|19061600|P3|STARTED|IgPro20 Subcutaneous Treatment Period||57
7741744|NCT01545076|19061601|P2|STARTED|IgPro20 Subcutaneous Treatment Period||58
7741745|NCT01545076|19061602|P1|STARTED|IgPro20 Subcutaneous Treatment Period||0
7741746|NCT01545076|19061598|P5|NOT COMPLETED|IgPro10 Restabilization Period||0
7741747|NCT01545076|19061599|P4|NOT COMPLETED|IgPro10 Restabilization Period||0
7741748|NCT01545076|19061600|P3|NOT COMPLETED|IgPro10 Restabilization Period||0
7741749|NCT01545076|19061601|P2|NOT COMPLETED|IgPro10 Restabilization Period||0
7741750|NCT01545076|19061602|P1|NOT COMPLETED|IgPro10 Restabilization Period||36
7741751|NCT01545076|19061598|P5|COMPLETED|IgPro10 Restabilization Period||0
7741752|NCT01545076|19061599|P4|COMPLETED|IgPro10 Restabilization Period||0
7741753|NCT01545076|19061600|P3|COMPLETED|IgPro10 Restabilization Period||0
7741754|NCT01545076|19061601|P2|COMPLETED|IgPro10 Restabilization Period||0
7741755|NCT01545076|19061602|P1|COMPLETED|IgPro10 Restabilization Period||172
7741756|NCT01545076|19061598|P5|STARTED|IgPro10 Restabilization Period||0
7741757|NCT01545076|19061599|P4|STARTED|IgPro10 Restabilization Period||0
7741758|NCT01545076|19061600|P3|STARTED|IgPro10 Restabilization Period||0
7741759|NCT01545076|19061601|P2|STARTED|IgPro10 Restabilization Period||0
7741760|NCT01545076|19061602|P1|STARTED|IgPro10 Restabilization Period||208
7741761|NCT01544998|19061652|P2|NOT COMPLETED|Second Intervention (3 Hours)||0
7741762|NCT01544998|19061653|P1|NOT COMPLETED|Second Intervention (3 Hours)||0
7741763|NCT01544998|19061652|P2|COMPLETED|Second Intervention (3 Hours)||15
7741764|NCT01544998|19061653|P1|COMPLETED|Second Intervention (3 Hours)||26
7741765|NCT01544998|19061652|P2|STARTED|Second Intervention (3 Hours)||15
7741766|NCT01544998|19061653|P1|STARTED|Second Intervention (3 Hours)||26
7741767|NCT01544998|19061652|P2|NOT COMPLETED|Washout (1 Week)||0
7741768|NCT01544998|19061653|P1|NOT COMPLETED|Washout (1 Week)||0
7741769|NCT01544998|19061652|P2|COMPLETED|Washout (1 Week)||15
7741770|NCT01544998|19061653|P1|COMPLETED|Washout (1 Week)||26
7741771|NCT01544998|19061652|P2|STARTED|Washout (1 Week)||15
7741772|NCT01544998|19061653|P1|STARTED|Washout (1 Week)||26
7741773|NCT01544998|19061652|P2|NOT COMPLETED|First Intervention (3 Hours)||0
7741774|NCT01544998|19061653|P1|NOT COMPLETED|First Intervention (3 Hours)||0
7741775|NCT01544998|19061652|P2|COMPLETED|First Intervention (3 Hours)||15
7741776|NCT01544998|19061653|P1|COMPLETED|First Intervention (3 Hours)||26
7741777|NCT01544998|19061652|P2|STARTED|First Intervention (3 Hours)||15
7741778|NCT01544998|19061653|P1|STARTED|First Intervention (3 Hours)||26
7741779|NCT01544920|19061673|P2|NOT COMPLETED|Overall Study||23
7741780|NCT01544920|19061674|P1|NOT COMPLETED|Overall Study||19
7741781|NCT01544920|19061673|P2|COMPLETED|Overall Study||346
7741782|NCT01544920|19061674|P1|COMPLETED|Overall Study||349
7741783|NCT01544920|19061673|P2|STARTED|Overall Study||369
7741784|NCT01544920|19061674|P1|STARTED|Overall Study||368
7741785|NCT01544595|19061688|P6|NOT COMPLETED|Status at Week 156||15
7741786|NCT01544595|19061689|P5|NOT COMPLETED|Status at Week 156||38
7741787|NCT01544595|19061690|P4|NOT COMPLETED|Status at Week 156||166
7741788|NCT01544595|19061691|P3|NOT COMPLETED|Status at Week 156||140
7741789|NCT01544595|19061692|P2|NOT COMPLETED|Status at Week 156||78
7741790|NCT01544595|19061693|P1|NOT COMPLETED|Status at Week 156||117
7741791|NCT01544595|19061688|P6|COMPLETED|Status at Week 156||38
7741792|NCT01544595|19061689|P5|COMPLETED|Status at Week 156||60
7741793|NCT01544595|19061690|P4|COMPLETED|Status at Week 156||15
7741794|NCT01544595|19061691|P3|COMPLETED|Status at Week 156||10
7741795|NCT01544595|19061692|P2|COMPLETED|Status at Week 156||285
7741796|NCT01544595|19061693|P1|COMPLETED|Status at Week 156||184
7741797|NCT01544595|19061688|P6|STARTED|Status at Week 156||53
7741798|NCT01544595|19061689|P5|STARTED|Status at Week 156||98
7741799|NCT01544595|19061690|P4|STARTED|Status at Week 156||181
7741800|NCT01544595|19061691|P3|STARTED|Status at Week 156||150
7741801|NCT01544595|19061692|P2|STARTED|Status at Week 156||363
7741802|NCT01544595|19061693|P1|STARTED|Status at Week 156||301
7741803|NCT01544595|19061688|P6|NOT COMPLETED|Status at Week 68||0
7741804|NCT01544595|19061689|P5|NOT COMPLETED|Status at Week 68||0
7741805|NCT01544595|19061690|P4|NOT COMPLETED|Status at Week 68||51
7741806|NCT01544595|19061691|P3|NOT COMPLETED|Status at Week 68||63
7741807|NCT01544595|19061692|P2|NOT COMPLETED|Status at Week 68||17
7741808|NCT01544595|19061693|P1|NOT COMPLETED|Status at Week 68||39
7741809|NCT01544595|19061688|P6|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
7741810|NCT01544595|19061689|P5|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
7741811|NCT01544595|19061690|P4|COMPLETED|Status at Week 68||130
7741812|NCT01544595|19061691|P3|COMPLETED|Status at Week 68||87
7741813|NCT01544595|19061692|P2|COMPLETED|Status at Week 68||346
7741814|NCT01544595|19061693|P1|COMPLETED|Status at Week 68||262
7741815|NCT01544595|19061688|P6|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
7741816|NCT01544595|19061689|P5|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
7741817|NCT01544595|19061690|P4|STARTED|Status at Week 68||181
7741818|NCT01544595|19061691|P3|STARTED|Status at Week 68||150
7741819|NCT01544595|19061692|P2|STARTED|Status at Week 68||363
7741820|NCT01544595|19061693|P1|STARTED|Status at Week 68||301
7741821|NCT01544582|19061769|P4|NOT COMPLETED|Analysis Population||39
7741822|NCT01544582|19061770|P3|NOT COMPLETED|Analysis Population||102
7741823|NCT01544582|19061771|P2|NOT COMPLETED|Analysis Population||118
7741824|NCT01544582|19061772|P1|NOT COMPLETED|Analysis Population||0
7741825|NCT01544582|19061769|P4|COMPLETED|Analysis Population||35
7741826|NCT01544582|19061770|P3|COMPLETED|Analysis Population||205
7741827|NCT01544582|19061771|P2|COMPLETED|Analysis Population||180
7741828|NCT01544582|19061772|P1|COMPLETED|Analysis Population||0
7741829|NCT01544582|19061769|P4|STARTED|Analysis Population||74
7741830|NCT01544582|19061770|P3|STARTED|Analysis Population||307
7741831|NCT01544582|19061771|P2|STARTED|Analysis Population||298
7741832|NCT01544582|19061772|P1|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0
7741833|NCT01544582|19061769|P4|NOT COMPLETED|Screening/Eligibility||0
7741834|NCT01544582|19061770|P3|NOT COMPLETED|Screening/Eligibility||0
7741835|NCT01544582|19061771|P2|NOT COMPLETED|Screening/Eligibility||0
7741836|NCT01544582|19061772|P1|NOT COMPLETED|Screening/Eligibility||34
7741837|NCT01544582|19061769|P4|COMPLETED|Screening/Eligibility||0
7741838|NCT01544582|19061770|P3|COMPLETED|Screening/Eligibility||0
7741839|NCT01544582|19061771|P2|COMPLETED|Screening/Eligibility||0
7741840|NCT01544582|19061772|P1|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679
7741841|NCT01544582|19061769|P4|Analysis Population|Screening/Eligibility||0
7741842|NCT01544582|19061770|P3|Analysis Population|Screening/Eligibility||0
7741843|NCT01544582|19061771|P2|Analysis Population|Screening/Eligibility||0
7741844|NCT01544582|19061772|P1|Analysis Population|Screening/Eligibility||679
7741845|NCT01544582|19061769|P4|STARTED|Screening/Eligibility||0
7741846|NCT01544582|19061770|P3|STARTED|Screening/Eligibility||0
7741847|NCT01544582|19061771|P2|STARTED|Screening/Eligibility||0
7741848|NCT01544582|19061772|P1|STARTED|Screening/Eligibility||713
7741849|NCT01544491|19061832|P2|NOT COMPLETED|Overall Study||3
7741850|NCT01544491|19061833|P1|NOT COMPLETED|Overall Study||5
7741851|NCT01544491|19061832|P2|COMPLETED|Overall Study||51
7741852|NCT01544491|19061833|P1|COMPLETED|Overall Study||47
7741853|NCT01544491|19061832|P2|STARTED|Overall Study||54
7741854|NCT01544491|19061833|P1|STARTED|Overall Study||52
7741855|NCT01544478|19061859|P1|NOT COMPLETED|Overall Study||118
7741856|NCT01544478|19061859|P1|COMPLETED|Overall Study||912
7741857|NCT01544478|19061859|P1|Vaccination 3|Overall Study||1019
7741858|NCT01544478|19061859|P1|Vaccination 2|Overall Study||1026
7741859|NCT01544478|19061859|P1|Vaccination 1|Overall Study||1030
7741860|NCT01544478|19061859|P1|STARTED|Overall Study||1030
7741861|NCT01544361|19061868|P5|NOT COMPLETED|Overall Study||0
7741862|NCT01544361|19061869|P4|NOT COMPLETED|Overall Study||0
7741863|NCT01544361|19061870|P3|NOT COMPLETED|Overall Study||0
7741864|NCT01544361|19061871|P2|NOT COMPLETED|Overall Study||0
7741865|NCT01544361|19061872|P1|NOT COMPLETED|Overall Study||0
7741866|NCT01544361|19061868|P5|COMPLETED|Overall Study||6
7741867|NCT01544361|19061869|P4|COMPLETED|Overall Study||6
7741868|NCT01544361|19061870|P3|COMPLETED|Overall Study||6
7741869|NCT01544361|19061871|P2|COMPLETED|Overall Study||6
7741870|NCT01544361|19061872|P1|COMPLETED|Overall Study||8
7741871|NCT01544361|19061868|P5|STARTED|Overall Study||6
7741872|NCT01544361|19061869|P4|STARTED|Overall Study||6
7741873|NCT01544361|19061870|P3|STARTED|Overall Study||6
7741874|NCT01544361|19061871|P2|STARTED|Overall Study||6
7741875|NCT01544361|19061872|P1|STARTED|Overall Study||8
7741876|NCT01544348|19061902|P8|NOT COMPLETED|Overall Study||0
7741877|NCT01544348|19061903|P7|NOT COMPLETED|Overall Study||2
7741878|NCT01544348|19061904|P6|NOT COMPLETED|Overall Study||3
7741879|NCT01544348|19061905|P5|NOT COMPLETED|Overall Study||1
7741880|NCT01544348|19061906|P4|NOT COMPLETED|Overall Study||0
7741881|NCT01544348|19061907|P3|NOT COMPLETED|Overall Study||0
7741882|NCT01544348|19061908|P2|NOT COMPLETED|Overall Study||0
7741883|NCT01544348|19061909|P1|NOT COMPLETED|Overall Study||2
7741884|NCT01544348|19061902|P8|COMPLETED|Overall Study||8
7741885|NCT01544348|19061903|P7|COMPLETED|Overall Study||12
7741886|NCT01544348|19061904|P6|COMPLETED|Overall Study||16
7741887|NCT01544348|19061905|P5|COMPLETED|Overall Study||15
7741888|NCT01544348|19061906|P4|COMPLETED|Overall Study||3
7741889|NCT01544348|19061907|P3|COMPLETED|Overall Study||3
7741890|NCT01544348|19061908|P2|COMPLETED|Overall Study||6
7741891|NCT01544348|19061909|P1|COMPLETED|Overall Study||15
7741892|NCT01544348|19061902|P8|Treated|Overall Study||8
7741893|NCT01544348|19061903|P7|Treated|Overall Study||14
7741894|NCT01544348|19061904|P6|Treated|Overall Study||18
7741895|NCT01544348|19061905|P5|Treated|Overall Study||15
7741896|NCT01544348|19061906|P4|Treated|Overall Study||3
7741897|NCT01544348|19061907|P3|Treated|Overall Study||3
7741898|NCT01544348|19061908|P2|Treated|Overall Study||6
7741899|NCT01544348|19061909|P1|Treated|Overall Study||17
7741900|NCT01544348|19061902|P8|STARTED|Overall Study||8
7741901|NCT01544348|19061903|P7|STARTED|Overall Study||14
7741902|NCT01544348|19061904|P6|STARTED|Overall Study||19
7741903|NCT01544348|19061905|P5|STARTED|Overall Study||16
7741904|NCT01544348|19061906|P4|STARTED|Overall Study||3
7741905|NCT01544348|19061907|P3|STARTED|Overall Study||3
7741906|NCT01544348|19061908|P2|STARTED|Overall Study||6
7741907|NCT01544348|19061909|P1|STARTED|Overall Study||17
7741908|NCT01544309|19061951|P2|NOT COMPLETED|Overall Study||11
7741909|NCT01544309|19061952|P1|NOT COMPLETED|Overall Study||20
7741910|NCT01544309|19061951|P2|COMPLETED|Overall Study||514
7741911|NCT01544309|19061952|P1|COMPLETED|Overall Study||504
7741912|NCT01544309|19061951|P2|STARTED|Overall Study||525
7741913|NCT01544309|19061952|P1|STARTED|Overall Study||524
7741914|NCT01544179|19061990|P2|NOT COMPLETED|Overall Study||46
7741915|NCT01544179|19061991|P1|NOT COMPLETED|Overall Study||63
7741916|NCT01544179|19061990|P2|COMPLETED|Overall Study|Patients are ongoing in the study|86
7741917|NCT01544179|19061991|P1|COMPLETED|Overall Study|Patients are ongoing in the study|70
7741918|NCT01544179|19061990|P2|Did Not Receive Treatment|Overall Study||0
7741919|NCT01544179|19061991|P1|Did Not Receive Treatment|Overall Study||1
7741920|NCT01544179|19061990|P2|Received Treatment|Overall Study||132
7741921|NCT01544179|19061991|P1|Received Treatment|Overall Study||132
7741922|NCT01544179|19061990|P2|STARTED|Overall Study||132
7741923|NCT01544179|19061991|P1|STARTED|Overall Study||133
7741924|NCT01544166|19062019|P1|NOT COMPLETED|Overall Study||0
7741925|NCT01544166|19062019|P1|COMPLETED|Overall Study||44
7741926|NCT01544166|19062019|P1|STARTED|Overall Study||44
7741927|NCT01544153|19062084|P4|NOT COMPLETED|Overall Study||0
7741928|NCT01544153|19062085|P3|NOT COMPLETED|Overall Study||1
7741929|NCT01544153|19062086|P2|NOT COMPLETED|Overall Study||1
7741930|NCT01544153|19062087|P1|NOT COMPLETED|Overall Study||0
7741931|NCT01544153|19062084|P4|COMPLETED|Overall Study||1317
7741932|NCT01544153|19062085|P3|COMPLETED|Overall Study||1313
7741933|NCT01544153|19062086|P2|COMPLETED|Overall Study||1323
7741934|NCT01544153|19062087|P1|COMPLETED|Overall Study||1337
7741935|NCT01544153|19062084|P4|STARTED|Overall Study||1317
7741936|NCT01544153|19062085|P3|STARTED|Overall Study||1314
7741937|NCT01544153|19062086|P2|STARTED|Overall Study||1324
7741938|NCT01544153|19062087|P1|STARTED|Overall Study||1337
7741939|NCT01544127|19062104|P3|NOT COMPLETED|Overall Study||14
7741940|NCT01544127|19062105|P2|NOT COMPLETED|Overall Study||6
7741941|NCT01544127|19062106|P1|NOT COMPLETED|Overall Study||11
7741942|NCT01544127|19062104|P3|COMPLETED|Overall Study||52
7741943|NCT01544127|19062105|P2|COMPLETED|Overall Study||27
7741944|NCT01544127|19062106|P1|COMPLETED|Overall Study||22
7741945|NCT01544127|19062104|P3|STARTED|Overall Study||66
7741946|NCT01544127|19062105|P2|STARTED|Overall Study||33
7741947|NCT01544127|19062106|P1|STARTED|Overall Study||33
7741948|NCT01544114|19062126|P3|NOT COMPLETED|Overall Study||5
7741949|NCT01544114|19062127|P2|NOT COMPLETED|Overall Study||4
7741950|NCT01544114|19062128|P1|NOT COMPLETED|Overall Study||1
7741951|NCT01544114|19062126|P3|COMPLETED|Overall Study|completed study and received 6 months of study drug|17
7741952|NCT01544114|19062127|P2|COMPLETED|Overall Study|completed study and received 6 months of study drug|16
7741953|NCT01544114|19062128|P1|COMPLETED|Overall Study|completed study and received 6 months of study drug|3
7741954|NCT01544114|19062126|P3|STARTED|Overall Study||22
7741955|NCT01544114|19062127|P2|STARTED|Overall Study||20
7741956|NCT01544114|19062128|P1|STARTED|Overall Study||4
7741957|NCT01544088|19062159|P2|NOT COMPLETED|Overall Study||21
7741958|NCT01544088|19062160|P1|NOT COMPLETED|Overall Study||37
7741959|NCT01544088|19062159|P2|COMPLETED|Overall Study||79
7741960|NCT01544088|19062160|P1|COMPLETED|Overall Study||61
7741961|NCT01544088|19062159|P2|STARTED|Overall Study||100
7741962|NCT01544088|19062160|P1|STARTED|Overall Study||98
7741963|NCT01544062|19062174|P2|NOT COMPLETED|Overall Study||0
7741964|NCT01544062|19062175|P1|NOT COMPLETED|Overall Study||0
7741965|NCT01544062|19062174|P2|COMPLETED|Overall Study||35
7741966|NCT01544062|19062175|P1|COMPLETED|Overall Study||33
7741967|NCT01544062|19062174|P2|STARTED|Overall Study||35
7741968|NCT01544062|19062175|P1|STARTED|Overall Study||33
7741969|NCT01544023|19062221|P1|NOT COMPLETED|Overall Study||0
7741970|NCT01544023|19062221|P1|COMPLETED|Overall Study||207
7741971|NCT01544023|19062221|P1|STARTED|Overall Study|retrospective|207
7741972|NCT01543958|19062226|P1|NOT COMPLETED|Overall Study||4
7741973|NCT01543958|19062226|P1|COMPLETED|Overall Study||36
7741974|NCT01543958|19062226|P1|STARTED|Overall Study||40
7741975|NCT01543828|19062281|P2|NOT COMPLETED|Treatment 2||0
7741976|NCT01543828|19062282|P1|NOT COMPLETED|Treatment 2||1
7741977|NCT01543828|19062281|P2|COMPLETED|Treatment 2||19
7741978|NCT01543828|19062282|P1|COMPLETED|Treatment 2||19
7741979|NCT01543828|19062281|P2|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19
7741980|NCT01543828|19062282|P1|STARTED|Treatment 2||20
7741981|NCT01543828|19062281|P2|NOT COMPLETED|Treatment 1||0
7741982|NCT01543828|19062282|P1|NOT COMPLETED|Treatment 1||0
7741983|NCT01543828|19062281|P2|COMPLETED|Treatment 1||20
7741984|NCT01543828|19062282|P1|COMPLETED|Treatment 1||20
7741985|NCT01543828|19062281|P2|STARTED|Treatment 1||20
7741986|NCT01543828|19062282|P1|STARTED|Treatment 1||20
7741987|NCT01543776|19062292|P2|NOT COMPLETED|Overall Study||2
7741988|NCT01543776|19062293|P1|NOT COMPLETED|Overall Study||2
7741989|NCT01543776|19062292|P2|COMPLETED|Overall Study||34
7741990|NCT01543776|19062293|P1|COMPLETED|Overall Study||34
7741991|NCT01543776|19062292|P2|STARTED|Overall Study||36
7741992|NCT01543776|19062293|P1|STARTED|Overall Study||36
7741993|NCT01543685|19062312|P5|NOT COMPLETED|Overall Study||4
7741994|NCT01543685|19062313|P4|NOT COMPLETED|Overall Study||0
7741995|NCT01543685|19062314|P3|NOT COMPLETED|Overall Study||2
7741996|NCT01543685|19062315|P2|NOT COMPLETED|Overall Study||3
7741997|NCT01543685|19062316|P1|NOT COMPLETED|Overall Study||3
7741998|NCT01543685|19062312|P5|COMPLETED|Overall Study||90
7741999|NCT01543685|19062313|P4|COMPLETED|Overall Study||93
7742000|NCT01543685|19062314|P3|COMPLETED|Overall Study||89
7742001|NCT01543685|19062315|P2|COMPLETED|Overall Study||88
7742002|NCT01543685|19062316|P1|COMPLETED|Overall Study||90
7742003|NCT01543685|19062312|P5|STARTED|Overall Study||94
7742004|NCT01543685|19062313|P4|STARTED|Overall Study||93
7742005|NCT01543685|19062314|P3|STARTED|Overall Study||91
7742006|NCT01543685|19062315|P2|STARTED|Overall Study||91
7742007|NCT01543685|19062316|P1|STARTED|Overall Study||93
7742008|NCT01543607|19062363|P1|NOT COMPLETED|Overall Study||0
7742009|NCT01543607|19062363|P1|COMPLETED|Overall Study||1
7742010|NCT01543607|19062363|P1|STARTED|Overall Study||1
7742011|NCT01543581|19062369|P2|NOT COMPLETED|Overall Study||0
7742012|NCT01543581|19062370|P1|NOT COMPLETED|Overall Study||0
7742013|NCT01543581|19062369|P2|COMPLETED|Overall Study||0
7742014|NCT01543581|19062370|P1|COMPLETED|Overall Study||1
7742015|NCT01543581|19062369|P2|STARTED|Overall Study||0
7742016|NCT01543581|19062370|P1|STARTED|Overall Study||1
7742017|NCT01543568|19062376|P1|NOT COMPLETED|Overall Study||1
7742018|NCT01543568|19062376|P1|COMPLETED|Overall Study||45
7742019|NCT01543568|19062376|P1|STARTED|Overall Study||46
7742020|NCT01543503|19062388|P2|NOT COMPLETED|Overall Study||87
7742021|NCT01543503|19062389|P1|NOT COMPLETED|Overall Study||76
7742022|NCT01543503|19062388|P2|COMPLETED|Overall Study||711
7742023|NCT01543503|19062389|P1|COMPLETED|Overall Study||350
7742024|NCT01543503|19062388|P2|STARTED|Overall Study||798
7742025|NCT01543503|19062389|P1|STARTED|Overall Study||426
7742026|NCT01543204|19062433|P1|NOT COMPLETED|Overall Study||8
7742027|NCT01543204|19062433|P1|COMPLETED|Overall Study||56
7742028|NCT01543204|19062433|P1|STARTED|Overall Study||64
7742029|NCT01543178|19062480|P3|NOT COMPLETED|Double-blind Period||37
7742030|NCT01543178|19062481|P2|NOT COMPLETED|Double-blind Period||44
7742031|NCT01543178|19062482|P1|NOT COMPLETED|Double-blind Period||0
7742032|NCT01543178|19062480|P3|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271
7742033|NCT01543178|19062481|P2|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284
7742034|NCT01543178|19062482|P1|COMPLETED|Double-blind Period||0
7742035|NCT01543178|19062480|P3|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308
7742036|NCT01543178|19062481|P2|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328
7742037|NCT01543178|19062482|P1|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0
7742038|NCT01543178|19062480|P3|NOT COMPLETED|Open-label Period||0
7742039|NCT01543178|19062481|P2|NOT COMPLETED|Open-label Period||0
7742040|NCT01543178|19062482|P1|NOT COMPLETED|Open-label Period||1947
7742041|NCT01543178|19062480|P3|COMPLETED|Open-label Period||0
7742042|NCT01543178|19062481|P2|COMPLETED|Open-label Period||0
7742043|NCT01543178|19062482|P1|COMPLETED|Open-label Period||636
7742044|NCT01543178|19062480|P3|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0
7742045|NCT01543178|19062481|P2|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0
7742046|NCT01543178|19062482|P1|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583
7742047|NCT01543087|19062495|P6|NOT COMPLETED|Booster Stage (26 Months)||0
7742048|NCT01543087|19062496|P5|NOT COMPLETED|Booster Stage (26 Months)||2
7742049|NCT01543087|19062497|P4|NOT COMPLETED|Booster Stage (26 Months)||0
7742050|NCT01543087|19062498|P3|NOT COMPLETED|Booster Stage (26 Months)||1
7742051|NCT01543087|19062499|P2|NOT COMPLETED|Booster Stage (26 Months)||1
7742052|NCT01543087|19062500|P1|NOT COMPLETED|Booster Stage (26 Months)||0
7742053|NCT01543087|19062495|P6|COMPLETED|Booster Stage (26 Months)||32
7742054|NCT01543087|19062496|P5|COMPLETED|Booster Stage (26 Months)||54
7742055|NCT01543087|19062497|P4|COMPLETED|Booster Stage (26 Months)||64
7742056|NCT01543087|19062498|P3|COMPLETED|Booster Stage (26 Months)||91
7742057|NCT01543087|19062499|P2|COMPLETED|Booster Stage (26 Months)||59
7742058|NCT01543087|19062500|P1|COMPLETED|Booster Stage (26 Months)||0
7742059|NCT01543087|19062495|P6|Vaccinated|Booster Stage (26 Months)||32
7742060|NCT01543087|19062496|P5|Vaccinated|Booster Stage (26 Months)||54
7742061|NCT01543087|19062497|P4|Vaccinated|Booster Stage (26 Months)||64
7742062|NCT01543087|19062498|P3|Vaccinated|Booster Stage (26 Months)||92
7742063|NCT01543087|19062499|P2|Vaccinated|Booster Stage (26 Months)||59
7742064|NCT01543087|19062500|P1|Vaccinated|Booster Stage (26 Months)||0
7742065|NCT01543087|19062495|P6|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|32
7742066|NCT01543087|19062496|P5|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|56
7742067|NCT01543087|19062497|P4|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|64
7742068|NCT01543087|19062498|P3|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|92
7742069|NCT01543087|19062499|P2|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|60
7742070|NCT01543087|19062500|P1|STARTED|Booster Stage (26 Months)|Group1 participants (primary study B1971015)were not invited to participate in Booster stage (BS).|0
7742071|NCT01543087|19062495|P6|NOT COMPLETED|Stage 1 (48 Months)||0
7742072|NCT01543087|19062496|P5|NOT COMPLETED|Stage 1 (48 Months)||3
7742073|NCT01543087|19062497|P4|NOT COMPLETED|Stage 1 (48 Months)||8
7742074|NCT01543087|19062498|P3|NOT COMPLETED|Stage 1 (48 Months)||40
7742075|NCT01543087|19062499|P2|NOT COMPLETED|Stage 1 (48 Months)||10
7742076|NCT01543087|19062500|P1|NOT COMPLETED|Stage 1 (48 Months)||14
7742077|NCT01543087|19062495|P6|COMPLETED|Stage 1 (48 Months)||46
7742078|NCT01543087|19062496|P5|COMPLETED|Stage 1 (48 Months)||83
7742079|NCT01543087|19062497|P4|COMPLETED|Stage 1 (48 Months)||108
7742080|NCT01543087|19062498|P3|COMPLETED|Stage 1 (48 Months)||237
7742081|NCT01543087|19062499|P2|COMPLETED|Stage 1 (48 Months)||93
7742082|NCT01543087|19062500|P1|COMPLETED|Stage 1 (48 Months)||56
7742083|NCT01543087|19062495|P6|Safety Population|Stage 1 (48 Months)||46
7742084|NCT01543087|19062496|P5|Safety Population|Stage 1 (48 Months)||86
7742085|NCT01543087|19062497|P4|Safety Population|Stage 1 (48 Months)||116
7742086|NCT01543087|19062498|P3|Safety Population|Stage 1 (48 Months)||277
7742087|NCT01543087|19062499|P2|Safety Population|Stage 1 (48 Months)||101
7742088|NCT01543087|19062500|P1|Safety Population|Stage 1 (48 Months)||70
7742089|NCT01543087|19062495|P6|STARTED|Stage 1 (48 Months)||46
7742090|NCT01543087|19062496|P5|STARTED|Stage 1 (48 Months)||86
7742091|NCT01543087|19062497|P4|STARTED|Stage 1 (48 Months)||116
7742092|NCT01543087|19062498|P3|STARTED|Stage 1 (48 Months)||277
7742093|NCT01543087|19062499|P2|STARTED|Stage 1 (48 Months)||103
7742094|NCT01543087|19062500|P1|STARTED|Stage 1 (48 Months)||70
7742095|NCT01543074|19062641|P4|NOT COMPLETED|Overall Study||0
7742096|NCT01543074|19062642|P3|NOT COMPLETED|Overall Study||0
7742097|NCT01543074|19062643|P2|NOT COMPLETED|Overall Study||0
7742098|NCT01543074|19062644|P1|NOT COMPLETED|Overall Study||0
7742099|NCT01543074|19062641|P4|COMPLETED|Overall Study||6
7742100|NCT01543074|19062642|P3|COMPLETED|Overall Study||5
7742101|NCT01543074|19062643|P2|COMPLETED|Overall Study||7
7742102|NCT01543074|19062644|P1|COMPLETED|Overall Study||5
7742103|NCT01543074|19062641|P4|STARTED|Overall Study||6
7742104|NCT01543074|19062642|P3|STARTED|Overall Study||5
7742105|NCT01543074|19062643|P2|STARTED|Overall Study||7
7742106|NCT01543074|19062644|P1|STARTED|Overall Study||5
7742107|NCT01542957|19062664|P2|NOT COMPLETED|12-month Follow-up||13
7742108|NCT01542957|19062665|P1|NOT COMPLETED|12-month Follow-up||16
7742109|NCT01542957|19062664|P2|COMPLETED|12-month Follow-up||40
7742110|NCT01542957|19062665|P1|COMPLETED|12-month Follow-up||37
7742111|NCT01542957|19062664|P2|STARTED|12-month Follow-up||53
7742112|NCT01542957|19062665|P1|STARTED|12-month Follow-up||53
7742113|NCT01542957|19062664|P2|NOT COMPLETED|3-month Follow-up||8
7742114|NCT01542957|19062665|P1|NOT COMPLETED|3-month Follow-up||3
7742115|NCT01542957|19062664|P2|COMPLETED|3-month Follow-up||45
7742116|NCT01542957|19062665|P1|COMPLETED|3-month Follow-up||50
7742117|NCT01542957|19062664|P2|STARTED|3-month Follow-up||53
7742118|NCT01542957|19062665|P1|STARTED|3-month Follow-up||53
7742119|NCT01542957|19062664|P2|NOT COMPLETED|End of Therapy||10
7742120|NCT01542957|19062665|P1|NOT COMPLETED|End of Therapy||12
7742121|NCT01542957|19062664|P2|COMPLETED|End of Therapy||53
7742122|NCT01542957|19062665|P1|COMPLETED|End of Therapy||53
7742123|NCT01542957|19062664|P2|STARTED|End of Therapy||63
7742124|NCT01542957|19062665|P1|STARTED|End of Therapy||65
7742125|NCT01542788|19062677|P2|NOT COMPLETED|Overall Study||71
7742126|NCT01542788|19062678|P1|NOT COMPLETED|Overall Study||55
7742127|NCT01542788|19062677|P2|COMPLETED|Overall Study||0
7742128|NCT01542788|19062678|P1|COMPLETED|Overall Study||154
7742129|NCT01542788|19062677|P2|Randomized and Treated|Overall Study||71
7742130|NCT01542788|19062678|P1|Randomized and Treated|Overall Study||207
7742131|NCT01542788|19062677|P2|STARTED|Overall Study||71
7742132|NCT01542788|19062678|P1|STARTED|Overall Study||209
7742133|NCT01542684|19062694|P1|NOT COMPLETED|Overall Study||0
7742134|NCT01542684|19062694|P1|COMPLETED|Overall Study||8
7742135|NCT01542684|19062694|P1|STARTED|Overall Study||8
7742136|NCT01542645|19062700|P2|NOT COMPLETED|Overall Study||3
7742137|NCT01542645|19062701|P1|NOT COMPLETED|Overall Study||5
7742138|NCT01542645|19062700|P2|COMPLETED|Overall Study||79
7742139|NCT01542645|19062701|P1|COMPLETED|Overall Study||77
7742140|NCT01542645|19062700|P2|STARTED|Overall Study||82
7742141|NCT01542645|19062701|P1|STARTED|Overall Study||82
7742142|NCT01542632|19062725|P6|NOT COMPLETED|Overall Study||0
7742143|NCT01542632|19062726|P5|NOT COMPLETED|Overall Study||4
7742144|NCT01542632|19062727|P4|NOT COMPLETED|Overall Study||2
7742145|NCT01542632|19062728|P3|NOT COMPLETED|Overall Study||1
7742146|NCT01542632|19062729|P2|NOT COMPLETED|Overall Study||1
7742147|NCT01542632|19062730|P1|NOT COMPLETED|Overall Study||0
7742148|NCT01542632|19062725|P6|COMPLETED|Overall Study||24
7742149|NCT01542632|19062726|P5|COMPLETED|Overall Study||17
7742150|NCT01542632|19062727|P4|COMPLETED|Overall Study||19
7742151|NCT01542632|19062728|P3|COMPLETED|Overall Study||23
7742152|NCT01542632|19062729|P2|COMPLETED|Overall Study||24
7742153|NCT01542632|19062730|P1|COMPLETED|Overall Study||25
7742154|NCT01542632|19062725|P6|STARTED|Overall Study||24
7742155|NCT01542632|19062726|P5|STARTED|Overall Study||21
7742156|NCT01542632|19062727|P4|STARTED|Overall Study||21
7742157|NCT01542632|19062728|P3|STARTED|Overall Study||24
7742158|NCT01542632|19062729|P2|STARTED|Overall Study||25
7742159|NCT01542632|19062730|P1|STARTED|Overall Study||25
7742160|NCT01542541|19062776|P2|NOT COMPLETED|Overall Study||0
7742161|NCT01542541|19062777|P1|NOT COMPLETED|Overall Study||8
7742162|NCT01542541|19062776|P2|COMPLETED|Overall Study||30
7742163|NCT01542541|19062777|P1|COMPLETED|Overall Study||30
7742164|NCT01542541|19062776|P2|STARTED|Overall Study||30
7742165|NCT01542541|19062777|P1|STARTED|Overall Study||38
7742166|NCT01542528|19062787|P2|NOT COMPLETED|Overall Study||7
7742167|NCT01542528|19062788|P1|NOT COMPLETED|Overall Study||12
7742168|NCT01542528|19062787|P2|COMPLETED|Overall Study||49
7742169|NCT01542528|19062788|P1|COMPLETED|Overall Study||49
7742170|NCT01542528|19062787|P2|STARTED|Overall Study||56
7742171|NCT01542528|19062788|P1|STARTED|Overall Study||61
7742172|NCT01542502|19062796|P2|NOT COMPLETED|Overall Study||0
7742173|NCT01542502|19062797|P1|NOT COMPLETED|Overall Study||0
7742174|NCT01542502|19062796|P2|COMPLETED|Overall Study||6
7742175|NCT01542502|19062797|P1|COMPLETED|Overall Study||6
7742176|NCT01542502|19062796|P2|STARTED|Overall Study||6
7742177|NCT01542502|19062797|P1|STARTED|Overall Study||6
7742178|NCT01542398|19062807|P2|NOT COMPLETED|Overall Study||13
7742179|NCT01542398|19062808|P1|NOT COMPLETED|Overall Study||8
7742180|NCT01542398|19062807|P2|COMPLETED|Overall Study||67
7742181|NCT01542398|19062808|P1|COMPLETED|Overall Study||71
7742182|NCT01542398|19062807|P2|Post-Intervention Assessment|Overall Study||80
7742183|NCT01542398|19062808|P1|Post-Intervention Assessment|Overall Study||78
7742184|NCT01542398|19062807|P2|STARTED|Overall Study||80
7742185|NCT01542398|19062808|P1|STARTED|Overall Study||79
7742186|NCT01542372|19062816|P2|NOT COMPLETED|Overall Study||0
7742187|NCT01542372|19062817|P1|NOT COMPLETED|Overall Study||0
7742188|NCT01542372|19062816|P2|COMPLETED|Overall Study||11
7742189|NCT01542372|19062817|P1|COMPLETED|Overall Study||11
7742190|NCT01542372|19062816|P2|STARTED|Overall Study||11
7742191|NCT01542372|19062817|P1|STARTED|Overall Study||11
7742192|NCT01542307|19062832|P2|NOT COMPLETED|Overall Study||0
7742193|NCT01542307|19062833|P1|NOT COMPLETED|Overall Study||0
7742194|NCT01542307|19062832|P2|COMPLETED|Overall Study||22
7742195|NCT01542307|19062833|P1|COMPLETED|Overall Study||22
7742196|NCT01542307|19062832|P2|STARTED|Overall Study|Each subject inhaled Medical Air for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
7742197|NCT01542307|19062833|P1|STARTED|Overall Study|Each subject inhaled Oxygen for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
7742198|NCT01542255|19062853|P1|NOT COMPLETED|Overall Study||0
7742199|NCT01542255|19062853|P1|COMPLETED|Overall Study||7
7742200|NCT01542255|19062853|P1|Analyzed for Time to Progression|Overall Study||7
7742201|NCT01542255|19062853|P1|STARTED|Overall Study||7
7742202|NCT01542229|19062860|P2|NOT COMPLETED|Overall Study||36
7742203|NCT01542229|19062861|P1|NOT COMPLETED|Overall Study||23
7742204|NCT01542229|19062860|P2|COMPLETED|Overall Study||30
7742205|NCT01542229|19062861|P1|COMPLETED|Overall Study||45
7742206|NCT01542229|19062860|P2|STARTED|Overall Study||66
7742207|NCT01542229|19062861|P1|STARTED|Overall Study||68
7742208|NCT01542125|19062887|P2|NOT COMPLETED|Overall Study||0
7742209|NCT01542125|19062888|P1|NOT COMPLETED|Overall Study||0
7742210|NCT01542125|19062887|P2|COMPLETED|Overall Study||141
7742211|NCT01542125|19062888|P1|COMPLETED|Overall Study||140
7742212|NCT01542125|19062887|P2|STARTED|Overall Study||141
7742213|NCT01542125|19062888|P1|STARTED|Overall Study||140
7742214|NCT01542034|19062896|P2|NOT COMPLETED|Overall Study||23
7742215|NCT01542034|19062897|P1|NOT COMPLETED|Overall Study||30
7742216|NCT01542034|19062896|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227
7742217|NCT01542034|19062897|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226
7742218|NCT01542034|19062896|P2|Received Treatment|Overall Study||249
7742219|NCT01542034|19062897|P1|Received Treatment|Overall Study||256
7742220|NCT01542034|19062896|P2|STARTED|Overall Study||250
7742221|NCT01542034|19062897|P1|STARTED|Overall Study||256
7742222|NCT01541969|19062911|P2|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13
7742223|NCT01541969|19062912|P1|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11
7742224|NCT01541969|19062911|P2|COMPLETED|Open Label Extension (12-36 Weeks)||35
7742225|NCT01541969|19062912|P1|COMPLETED|Open Label Extension (12-36 Weeks)||33
7742226|NCT01541969|19062911|P2|STARTED|Open Label Extension (12-36 Weeks)||48
7742227|NCT01541969|19062912|P1|STARTED|Open Label Extension (12-36 Weeks)||44
7742228|NCT01541969|19062911|P2|NOT COMPLETED|Double-blind (0-12 Weeks)||2
7742229|NCT01541969|19062912|P1|NOT COMPLETED|Double-blind (0-12 Weeks)||6
7742230|NCT01541969|19062911|P2|COMPLETED|Double-blind (0-12 Weeks)||48
7742231|NCT01541969|19062912|P1|COMPLETED|Double-blind (0-12 Weeks)||44
7742232|NCT01541969|19062911|P2|STARTED|Double-blind (0-12 Weeks)||50
7742233|NCT01541969|19062912|P1|STARTED|Double-blind (0-12 Weeks)||50
7742234|NCT01541930|19062928|P1|NOT COMPLETED|Overall Study||1
7742235|NCT01541930|19062928|P1|COMPLETED|Overall Study||20
7742236|NCT01541930|19062928|P1|STARTED|Overall Study||21
7742237|NCT01541917|19062950|P2|NOT COMPLETED|Overall Study||9
7742238|NCT01541917|19062951|P1|NOT COMPLETED|Overall Study||15
7742239|NCT01541917|19062950|P2|COMPLETED|Overall Study||136
7742240|NCT01541917|19062951|P1|COMPLETED|Overall Study||129
7742241|NCT01541917|19062950|P2|STARTED|Overall Study||145
7742242|NCT01541917|19062951|P1|STARTED|Overall Study||144
7742243|NCT01541891|19062969|P2|NOT COMPLETED|Overall Study||1
7742244|NCT01541891|19062970|P1|NOT COMPLETED|Overall Study||1
7742245|NCT01541891|19062969|P2|COMPLETED|Overall Study||14
7742246|NCT01541891|19062970|P1|COMPLETED|Overall Study||14
7742247|NCT01541891|19062969|P2|STARTED|Overall Study||15
7742248|NCT01541891|19062970|P1|STARTED|Overall Study||15
7742249|NCT01541865|19062980|P1|NOT COMPLETED|Overall Study||22
7742250|NCT01541865|19062980|P1|COMPLETED|Overall Study||124
7742251|NCT01541865|19062980|P1|STARTED|Overall Study||146
7742252|NCT01541826|19062998|P3|NOT COMPLETED|Overall Study||0
7742253|NCT01541826|19062999|P2|NOT COMPLETED|Overall Study||3
7742254|NCT01541826|19063000|P1|NOT COMPLETED|Overall Study||4
7742255|NCT01541826|19062998|P3|COMPLETED|Overall Study||6
7742256|NCT01541826|19062999|P2|COMPLETED|Overall Study||25
7742257|NCT01541826|19063000|P1|COMPLETED|Overall Study||24
7742258|NCT01541826|19062998|P3|STARTED|Overall Study||6
7742259|NCT01541826|19062999|P2|STARTED|Overall Study||28
7742260|NCT01541826|19063000|P1|STARTED|Overall Study||28
7742261|NCT01541748|19063067|P1|NOT COMPLETED|Overall Study||31
7742262|NCT01541748|19063067|P1|COMPLETED|Overall Study||43
7742263|NCT01541748|19063067|P1|STARTED|Overall Study|74 subjects were consented; however, 5 were screen failures and 1 did not receive the study device.|74
7742264|NCT01541735|19063090|P2|NOT COMPLETED|Overall Study||0
7742265|NCT01541735|19063091|P1|NOT COMPLETED|Overall Study||0
7742266|NCT01541735|19063090|P2|COMPLETED|Overall Study||7
7742267|NCT01541735|19063091|P1|COMPLETED|Overall Study||7
7742268|NCT01541735|19063090|P2|STARTED|Overall Study||7
7742269|NCT01541735|19063091|P1|STARTED|Overall Study||7
7742270|NCT01541644|19063103|P1|NOT COMPLETED|Overall Study||3
7742271|NCT01541644|19063103|P1|COMPLETED|Overall Study||24
7742272|NCT01541644|19063103|P1|STARTED|Overall Study||27
7742273|NCT01541553|19063109|P2|NOT COMPLETED|Overall Study||14
7742274|NCT01541553|19063110|P1|NOT COMPLETED|Overall Study||12
7742275|NCT01541553|19063109|P2|COMPLETED|Overall Study||148
7742276|NCT01541553|19063110|P1|COMPLETED|Overall Study||155
7742277|NCT01541553|19063109|P2|STARTED|Overall Study||162
7742278|NCT01541553|19063110|P1|STARTED|Overall Study||167
7742279|NCT01541397|19063122|P2|NOT COMPLETED|Overall Study||2
7742280|NCT01541397|19063123|P1|NOT COMPLETED|Overall Study||4
7742281|NCT01541397|19063122|P2|COMPLETED|Overall Study||0
7742282|NCT01541397|19063123|P1|COMPLETED|Overall Study||0
7742283|NCT01541397|19063122|P2|STARTED|Overall Study||2
7742284|NCT01541397|19063123|P1|STARTED|Overall Study||4
7742285|NCT01541384|19063138|P3|NOT COMPLETED|Overall Study||2
7742286|NCT01541384|19063139|P2|NOT COMPLETED|Overall Study||1
7742287|NCT01541384|19063140|P1|NOT COMPLETED|Overall Study||0
7742288|NCT01541384|19063138|P3|COMPLETED|Overall Study||38
7742289|NCT01541384|19063139|P2|COMPLETED|Overall Study||39
7742290|NCT01541384|19063140|P1|COMPLETED|Overall Study||40
7742291|NCT01541384|19063138|P3|STARTED|Overall Study||40
7742292|NCT01541384|19063139|P2|STARTED|Overall Study||40
7742293|NCT01541384|19063140|P1|STARTED|Overall Study||40
7742294|NCT01541371|19063148|P1|NOT COMPLETED|Overall Study||77
7742295|NCT01541371|19063148|P1|COMPLETED|Overall Study||326
7742296|NCT01541371|19063148|P1|Full Analysis Set|Overall Study||394
7742297|NCT01541371|19063148|P1|STARTED|Overall Study||403
7742298|NCT01541358|19063171|P1|NOT COMPLETED|Overall Study||0
7742299|NCT01541358|19063171|P1|COMPLETED|Overall Study||2
7742300|NCT01541358|19063171|P1|STARTED|Overall Study||2
7742301|NCT01541254|19063177|P1|NOT COMPLETED|Overall Study||6
7742302|NCT01541254|19063177|P1|COMPLETED|Overall Study||30
7742303|NCT01541254|19063177|P1|STARTED|Overall Study||36
7742304|NCT01541215|19063184|P2|NOT COMPLETED|Follow up 1 (Weeks 53-104)||0
7742305|NCT01541215|19063185|P1|NOT COMPLETED|Follow up 1 (Weeks 53-104)||2
7742306|NCT01541215|19063184|P2|COMPLETED|Follow up 1 (Weeks 53-104)||0
7742307|NCT01541215|19063185|P1|COMPLETED|Follow up 1 (Weeks 53-104)||50
7742308|NCT01541215|19063184|P2|STARTED|Follow up 1 (Weeks 53-104)|Follow up was not planned for the subjects who received placebo.|0
7742309|NCT01541215|19063185|P1|STARTED|Follow up 1 (Weeks 53-104)|Subjects who provided safety follow up data were included.|52
7742310|NCT01541215|19063184|P2|NOT COMPLETED|Treatment Period (52 Weeks)||16
7742311|NCT01541215|19063185|P1|NOT COMPLETED|Treatment Period (52 Weeks)||10
7742312|NCT01541215|19063184|P2|COMPLETED|Treatment Period (52 Weeks)||53
7742313|NCT01541215|19063185|P1|COMPLETED|Treatment Period (52 Weeks)||56
7742314|NCT01541215|19063184|P2|Exposed|Treatment Period (52 Weeks)||68
7742315|NCT01541215|19063185|P1|Exposed|Treatment Period (52 Weeks)||66
7742316|NCT01541215|19063184|P2|STARTED|Treatment Period (52 Weeks)||69
7742317|NCT01541215|19063185|P1|STARTED|Treatment Period (52 Weeks)||66
7742318|NCT01540981|19063331|P2|NOT COMPLETED|Overall Study||0
7742319|NCT01540981|19063332|P1|NOT COMPLETED|Overall Study||1
7742320|NCT01540981|19063331|P2|COMPLETED|Overall Study||6
7742321|NCT01540981|19063332|P1|COMPLETED|Overall Study||5
7742322|NCT01540981|19063331|P2|STARTED|Overall Study||6
7742323|NCT01540981|19063332|P1|STARTED|Overall Study||6
7742324|NCT01540851|19063342|P2|NOT COMPLETED|Overall Study||18
7742325|NCT01540851|19063343|P1|NOT COMPLETED|Overall Study||21
7742326|NCT01540851|19063342|P2|COMPLETED|Overall Study||136
7742327|NCT01540851|19063343|P1|COMPLETED|Overall Study||133
7742328|NCT01540851|19063342|P2|STARTED|Overall Study||154
7742329|NCT01540851|19063343|P1|STARTED|Overall Study||154
7742330|NCT01540838|19063355|P2|NOT COMPLETED|Overall Study||23
7742331|NCT01540838|19063356|P1|NOT COMPLETED|Overall Study||22
7742332|NCT01540838|19063355|P2|COMPLETED|Overall Study||164
7742333|NCT01540838|19063356|P1|COMPLETED|Overall Study||166
7742334|NCT01540838|19063355|P2|STARTED|Overall Study||187
7742335|NCT01540838|19063356|P1|STARTED|Overall Study||188
7742336|NCT01540825|19063389|P11|NOT COMPLETED|Overall Study||0
7742337|NCT01540825|19063390|P10|NOT COMPLETED|Overall Study||0
7742338|NCT01540825|19063391|P9|NOT COMPLETED|Overall Study||0
7742339|NCT01540825|19063392|P8|NOT COMPLETED|Overall Study||0
7742340|NCT01540825|19063393|P7|NOT COMPLETED|Overall Study||0
7742341|NCT01540825|19063394|P6|NOT COMPLETED|Overall Study||0
7742342|NCT01540825|19063395|P5|NOT COMPLETED|Overall Study||0
7742343|NCT01540825|19063396|P4|NOT COMPLETED|Overall Study||0
7742344|NCT01540825|19063397|P3|NOT COMPLETED|Overall Study||0
7742345|NCT01540825|19063398|P2|NOT COMPLETED|Overall Study||0
7742346|NCT01540825|19063399|P1|NOT COMPLETED|Overall Study||0
7742347|NCT01540825|19063389|P11|COMPLETED|Overall Study||6
7742348|NCT01540825|19063390|P10|COMPLETED|Overall Study||6
7742349|NCT01540825|19063391|P9|COMPLETED|Overall Study||6
7742350|NCT01540825|19063392|P8|COMPLETED|Overall Study||6
7742351|NCT01540825|19063393|P7|COMPLETED|Overall Study||6
7742352|NCT01540825|19063394|P6|COMPLETED|Overall Study||6
7742353|NCT01540825|19063395|P5|COMPLETED|Overall Study||6
7742354|NCT01540825|19063396|P4|COMPLETED|Overall Study||6
7742355|NCT01540825|19063397|P3|COMPLETED|Overall Study||6
7742356|NCT01540825|19063398|P2|COMPLETED|Overall Study||6
7742357|NCT01540825|19063399|P1|COMPLETED|Overall Study||20
7742358|NCT01540825|19063389|P11|STARTED|Overall Study||6
7742359|NCT01540825|19063390|P10|STARTED|Overall Study||6
7742360|NCT01540825|19063391|P9|STARTED|Overall Study||6
7742361|NCT01540825|19063392|P8|STARTED|Overall Study||6
7742362|NCT01540825|19063393|P7|STARTED|Overall Study||6
7742363|NCT01540825|19063394|P6|STARTED|Overall Study||6
7742364|NCT01540825|19063395|P5|STARTED|Overall Study||6
7742365|NCT01540825|19063396|P4|STARTED|Overall Study||6
7742366|NCT01540825|19063397|P3|STARTED|Overall Study||6
7742367|NCT01540825|19063398|P2|STARTED|Overall Study||6
7742368|NCT01540825|19063399|P1|STARTED|Overall Study||20
7742369|NCT01540773|19063495|P2|NOT COMPLETED|Second Intervention||0
7742370|NCT01540773|19063496|P1|NOT COMPLETED|Second Intervention||0
7742371|NCT01540773|19063495|P2|COMPLETED|Second Intervention||8
7742372|NCT01540773|19063496|P1|COMPLETED|Second Intervention||8
7742373|NCT01540773|19063495|P2|STARTED|Second Intervention||8
7742374|NCT01540773|19063496|P1|STARTED|Second Intervention||8
7742375|NCT01540773|19063495|P2|NOT COMPLETED|Wash Out Period of 1 Week||0
7742376|NCT01540773|19063496|P1|NOT COMPLETED|Wash Out Period of 1 Week||0
7742377|NCT01540773|19063495|P2|COMPLETED|Wash Out Period of 1 Week||8
7742378|NCT01540773|19063496|P1|COMPLETED|Wash Out Period of 1 Week||8
7742379|NCT01540773|19063495|P2|STARTED|Wash Out Period of 1 Week||8
7742380|NCT01540773|19063496|P1|STARTED|Wash Out Period of 1 Week||8
7742381|NCT01540773|19063495|P2|NOT COMPLETED|First Intervention||0
7742382|NCT01540773|19063496|P1|NOT COMPLETED|First Intervention||0
7742383|NCT01540773|19063495|P2|COMPLETED|First Intervention||8
7742384|NCT01540773|19063496|P1|COMPLETED|First Intervention||8
7742385|NCT01540773|19063495|P2|STARTED|First Intervention||8
7742386|NCT01540773|19063496|P1|STARTED|First Intervention||8
7742387|NCT01540565|19063506|P1|NOT COMPLETED|Overall Study||2
7742388|NCT01540565|19063506|P1|COMPLETED|Overall Study||50
7742389|NCT01540565|19063506|P1|STARTED|Overall Study||52
7742390|NCT01540513|19063516|P1|NOT COMPLETED|Overall Study||0
7742391|NCT01540513|19063516|P1|COMPLETED|Overall Study||12
7742392|NCT01540513|19063516|P1|STARTED|Overall Study||12
7742393|NCT01540487|19063525|P2|NOT COMPLETED|Overall Study||0
7742394|NCT01540487|19063526|P1|NOT COMPLETED|Overall Study||1
7742395|NCT01540487|19063525|P2|COMPLETED|Overall Study||24
7742396|NCT01540487|19063526|P1|COMPLETED|Overall Study||23
7742397|NCT01540487|19063525|P2|STARTED|Overall Study||24
7742398|NCT01540487|19063526|P1|STARTED|Overall Study||24
7742399|NCT01540409|19063562|P2|NOT COMPLETED|Overall Study||0
7742400|NCT01540409|19063563|P1|NOT COMPLETED|Overall Study||0
7742401|NCT01540409|19063562|P2|COMPLETED|Overall Study||6
7742402|NCT01540409|19063563|P1|COMPLETED|Overall Study||6
7742403|NCT01540409|19063562|P2|STARTED|Overall Study||6
7742404|NCT01540409|19063563|P1|STARTED|Overall Study||6
7742405|NCT01540370|19063572|P1|NOT COMPLETED|Overall Study||2
7742406|NCT01540370|19063572|P1|COMPLETED|Overall Study||100
7742407|NCT01540370|19063572|P1|STARTED|Overall Study||102
7742408|NCT01540266|19063583|P6|NOT COMPLETED|Overall Study||0
7742409|NCT01540266|19063584|P5|NOT COMPLETED|Overall Study||0
7742410|NCT01540266|19063585|P4|NOT COMPLETED|Overall Study||0
7742411|NCT01540266|19063586|P3|NOT COMPLETED|Overall Study||1
7742412|NCT01540266|19063587|P2|NOT COMPLETED|Overall Study||1
7742413|NCT01540266|19063588|P1|NOT COMPLETED|Overall Study||6
7742414|NCT01540266|19063583|P6|COMPLETED|Overall Study||19
7742415|NCT01540266|19063584|P5|COMPLETED|Overall Study||20
7742416|NCT01540266|19063585|P4|COMPLETED|Overall Study||38
7742417|NCT01540266|19063586|P3|COMPLETED|Overall Study||59
7742418|NCT01540266|19063587|P2|COMPLETED|Overall Study||41
7742419|NCT01540266|19063588|P1|COMPLETED|Overall Study||57
7742420|NCT01540266|19063583|P6|STARTED|Overall Study||19
7742421|NCT01540266|19063584|P5|STARTED|Overall Study||20
7742422|NCT01540266|19063585|P4|STARTED|Overall Study||38
7742423|NCT01540266|19063586|P3|STARTED|Overall Study||60
7742424|NCT01540266|19063587|P2|STARTED|Overall Study||42
7742425|NCT01540266|19063588|P1|STARTED|Overall Study||63
7742426|NCT01540162|19063604|P2|NOT COMPLETED|Overall Study||0
7742427|NCT01540162|19063605|P1|NOT COMPLETED|Overall Study||0
7742428|NCT01540162|19063604|P2|COMPLETED|Overall Study||32
7742429|NCT01540162|19063605|P1|COMPLETED|Overall Study||30
7742430|NCT01540162|19063604|P2|STARTED|Overall Study||32
7742431|NCT01540162|19063605|P1|STARTED|Overall Study||30
7742432|NCT01540045|19063615|P1|NOT COMPLETED|Overall Study||0
7742433|NCT01540045|19063615|P1|COMPLETED|Overall Study||40
7742434|NCT01540045|19063615|P1|STARTED|Overall Study||40
7742435|NCT01539980|19063654|P1|NOT COMPLETED|Overall Study||0
7742436|NCT01539980|19063654|P1|COMPLETED|Overall Study||30
7742437|NCT01539980|19063654|P1|STARTED|Overall Study||30
7742438|NCT01539837|19063665|P3|NOT COMPLETED|Overall Study||2
7742439|NCT01539837|19063666|P2|NOT COMPLETED|Overall Study||1
7742440|NCT01539837|19063667|P1|NOT COMPLETED|Overall Study||0
7742441|NCT01539837|19063665|P3|COMPLETED|Overall Study||5
7742442|NCT01539837|19063666|P2|COMPLETED|Overall Study||6
7742443|NCT01539837|19063667|P1|COMPLETED|Overall Study||8
7742444|NCT01539837|19063665|P3|STARTED|Overall Study||7
7742445|NCT01539837|19063666|P2|STARTED|Overall Study||7
7742446|NCT01539837|19063667|P1|STARTED|Overall Study||8
7742447|NCT01539811|19063680|P2|NOT COMPLETED|Overall Study||0
7742448|NCT01539811|19063681|P1|NOT COMPLETED|Overall Study||0
7742449|NCT01539811|19063680|P2|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
7742450|NCT01539811|19063681|P1|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
7742451|NCT01539811|19063680|P2|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
7742452|NCT01539811|19063681|P1|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
7742453|NCT01539759|19063689|P2|NOT COMPLETED|Overall Study||8
7742454|NCT01539759|19063690|P1|NOT COMPLETED|Overall Study||6
7742455|NCT01539759|19063689|P2|COMPLETED|Overall Study||48
7742456|NCT01539759|19063690|P1|COMPLETED|Overall Study||50
7742457|NCT01539759|19063689|P2|IUD in Place at 6 Months Posptartum|Overall Study||40
7742458|NCT01539759|19063690|P1|IUD in Place at 6 Months Posptartum|Overall Study||32
7742459|NCT01539759|19063689|P2|IUD Removal|Overall Study||7
7742460|NCT01539759|19063690|P1|IUD Removal|Overall Study||2
7742461|NCT01539759|19063689|P2|IUD Expulsion|Overall Study||4
7742462|NCT01539759|19063690|P1|IUD Expulsion|Overall Study||1
7742463|NCT01539759|19063689|P2|Had Successful IUD Placement|Overall Study||53
7742464|NCT01539759|19063690|P1|Had Successful IUD Placement|Overall Study||34
7742465|NCT01539759|19063689|P2|STARTED|Overall Study||56
7742466|NCT01539759|19063690|P1|STARTED|Overall Study||56
7742467|NCT01539694|19063700|P2|NOT COMPLETED|Overall Study||1
7742468|NCT01539694|19063701|P1|NOT COMPLETED|Overall Study||1
7742469|NCT01539694|19063700|P2|COMPLETED|Overall Study||62
7742470|NCT01539694|19063701|P1|COMPLETED|Overall Study||62
7742471|NCT01539694|19063700|P2|STARTED|Overall Study||63
7742472|NCT01539694|19063701|P1|STARTED|Overall Study||63
7742473|NCT01539642|19063711|P2|NOT COMPLETED|Overall Study||31
7742474|NCT01539642|19063712|P1|NOT COMPLETED|Overall Study||36
7742475|NCT01539642|19063711|P2|COMPLETED|Overall Study||27
7742476|NCT01539642|19063712|P1|COMPLETED|Overall Study||78
7742477|NCT01539642|19063711|P2|STARTED|Overall Study||58
7742478|NCT01539642|19063712|P1|STARTED|Overall Study||114
7742479|NCT01539590|19063720|P2|NOT COMPLETED|Overall Study||0
7742480|NCT01539590|19063721|P1|NOT COMPLETED|Overall Study||3
7742481|NCT01539590|19063720|P2|COMPLETED|Overall Study||2
7742482|NCT01539590|19063721|P1|COMPLETED|Overall Study||0
7742483|NCT01539590|19063720|P2|Complete Study Treatment|Overall Study||2
7742484|NCT01539590|19063721|P1|Complete Study Treatment|Overall Study||1
7742485|NCT01539590|19063720|P2|STARTED|Overall Study||2
7742486|NCT01539590|19063721|P1|STARTED|Overall Study||3
7742487|NCT01539538|19063729|P2|NOT COMPLETED|Overall Study||44
7742488|NCT01539538|19063730|P1|NOT COMPLETED|Overall Study||31
7742489|NCT01539538|19063729|P2|COMPLETED|Overall Study||136
7742490|NCT01539538|19063730|P1|COMPLETED|Overall Study||146
7742491|NCT01539538|19063729|P2|STARTED|Overall Study||180
7742492|NCT01539538|19063730|P1|STARTED|Overall Study||177
7742493|NCT01539525|19063739|P3|NOT COMPLETED|Overall Study||17
7742494|NCT01539525|19063740|P2|NOT COMPLETED|Overall Study||16
7742495|NCT01539525|19063741|P1|NOT COMPLETED|Overall Study||20
7742496|NCT01539525|19063739|P3|COMPLETED|Overall Study||134
7742497|NCT01539525|19063740|P2|COMPLETED|Overall Study||127
7742498|NCT01539525|19063741|P1|COMPLETED|Overall Study||125
7742499|NCT01539525|19063739|P3|STARTED|Overall Study||151
7742500|NCT01539525|19063740|P2|STARTED|Overall Study||143
7742501|NCT01539525|19063741|P1|STARTED|Overall Study||145
7742502|NCT01539512|19063760|P2|NOT COMPLETED|Overall Study||13
7742503|NCT01539512|19063761|P1|NOT COMPLETED|Overall Study||23
7742504|NCT01539512|19063760|P2|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97
7742505|NCT01539512|19063761|P1|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87
7742506|NCT01539512|19063760|P2|STARTED|Overall Study||110
7742507|NCT01539512|19063761|P1|STARTED|Overall Study||110
7742508|NCT01539317|19063777|P2|NOT COMPLETED|Overall Study||0
7742509|NCT01539317|19063778|P1|NOT COMPLETED|Overall Study||1
7742510|NCT01539317|19063777|P2|COMPLETED|Overall Study||25
7742511|NCT01539317|19063778|P1|COMPLETED|Overall Study||24
7742512|NCT01539317|19063777|P2|STARTED|Overall Study||25
7742513|NCT01539317|19063778|P1|STARTED|Overall Study||25
7742514|NCT01539291|19063796|P4|NOT COMPLETED|Study GS-US-312-0117||26
7742515|NCT01539291|19063797|P3|NOT COMPLETED|Study GS-US-312-0117||22
7742516|NCT01539291|19063798|P2|NOT COMPLETED|Study GS-US-312-0117||2
7742517|NCT01539291|19063799|P1|NOT COMPLETED|Study GS-US-312-0117||41
7742518|NCT01539291|19063796|P4|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|18
7742519|NCT01539291|19063797|P3|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|20
7742520|NCT01539291|19063798|P2|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|2
7742521|NCT01539291|19063799|P1|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|30
7742522|NCT01539291|19063796|P4|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|44
7742523|NCT01539291|19063797|P3|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|42
7742524|NCT01539291|19063798|P2|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|4
7742525|NCT01539291|19063799|P1|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|71
7742526|NCT01539291|19063796|P4|NOT COMPLETED|Study GS-US-312-0116||0
7742527|NCT01539291|19063797|P3|NOT COMPLETED|Study GS-US-312-0116||0
7742528|NCT01539291|19063798|P2|NOT COMPLETED|Study GS-US-312-0116||0
7742529|NCT01539291|19063799|P1|NOT COMPLETED|Study GS-US-312-0116||25
7742530|NCT01539291|19063796|P4|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|44
7742531|NCT01539291|19063797|P3|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|42
7742532|NCT01539291|19063798|P2|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|4
7742533|NCT01539291|19063799|P1|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|81
7742534|NCT01539291|19063796|P4|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|44
7742535|NCT01539291|19063797|P3|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|42
7742536|NCT01539291|19063798|P2|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|4
7742537|NCT01539291|19063799|P1|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|106
7742538|NCT01539239|19063871|P2|NOT COMPLETED|Overall Study||17
7742539|NCT01539239|19063872|P1|NOT COMPLETED|Overall Study||12
7742540|NCT01539239|19063871|P2|COMPLETED|Overall Study||170
7742541|NCT01539239|19063872|P1|COMPLETED|Overall Study||357
7742542|NCT01539239|19063871|P2|STARTED|Overall Study||187
7742543|NCT01539239|19063872|P1|STARTED|Overall Study||369
7742544|NCT01539135|19063882|P2|NOT COMPLETED|Overall Study||0
7742545|NCT01539135|19063883|P1|NOT COMPLETED|Overall Study||0
7742546|NCT01539135|19063882|P2|COMPLETED|Overall Study||37
7742547|NCT01539135|19063883|P1|COMPLETED|Overall Study||43
7742548|NCT01539135|19063882|P2|STARTED|Overall Study||37
7742549|NCT01539135|19063883|P1|STARTED|Overall Study||43
7742550|NCT01539083|19063895|P3|NOT COMPLETED|After Randomization (TP and VTP)||23
7742551|NCT01539083|19063896|P2|NOT COMPLETED|After Randomization (TP and VTP)||21
7742552|NCT01539083|19063897|P1|NOT COMPLETED|After Randomization (TP and VTP)||0
7742553|NCT01539083|19063895|P3|COMPLETED|After Randomization (TP and VTP)||80
7742554|NCT01539083|19063896|P2|COMPLETED|After Randomization (TP and VTP)||79
7742555|NCT01539083|19063897|P1|COMPLETED|After Randomization (TP and VTP)||0
7742556|NCT01539083|19063895|P3|Safety Population|After Randomization (TP and VTP)||103
7742557|NCT01539083|19063896|P2|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99
7742558|NCT01539083|19063897|P1|Safety Population|After Randomization (TP and VTP)||0
7742559|NCT01539083|19063895|P3|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidation treatment phase.|103
7742560|NCT01539083|19063896|P2|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100
7742561|NCT01539083|19063897|P1|STARTED|After Randomization (TP and VTP)||0
7742562|NCT01539083|19063895|P3|NOT COMPLETED|Before Randomization (VCD Induction)||0
7742563|NCT01539083|19063896|P2|NOT COMPLETED|Before Randomization (VCD Induction)||0
7742564|NCT01539083|19063897|P1|NOT COMPLETED|Before Randomization (VCD Induction)||53
7742565|NCT01539083|19063895|P3|COMPLETED|Before Randomization (VCD Induction)||0
7742566|NCT01539083|19063896|P2|COMPLETED|Before Randomization (VCD Induction)||0
7742567|NCT01539083|19063897|P1|COMPLETED|Before Randomization (VCD Induction)||203
7742568|NCT01539083|19063895|P3|Treated|Before Randomization (VCD Induction)||0
7742569|NCT01539083|19063896|P2|Treated|Before Randomization (VCD Induction)||0
7742570|NCT01539083|19063897|P1|Treated|Before Randomization (VCD Induction)||254
7742571|NCT01539083|19063895|P3|STARTED|Before Randomization (VCD Induction)||0
7742572|NCT01539083|19063896|P2|STARTED|Before Randomization (VCD Induction)||0
7742573|NCT01539083|19063897|P1|STARTED|Before Randomization (VCD Induction)||256
7742574|NCT01539070|19063920|P2|NOT COMPLETED|Overall Study||39
7742575|NCT01539070|19063921|P1|NOT COMPLETED|Overall Study||59
7742576|NCT01539070|19063920|P2|COMPLETED|Overall Study||99
7742577|NCT01539070|19063921|P1|COMPLETED|Overall Study||109
7742578|NCT01539070|19063920|P2|STARTED|Overall Study||138
7742579|NCT01539070|19063921|P1|STARTED|Overall Study||168
7742580|NCT01538862|19063933|P1|NOT COMPLETED|Overall Study||0
7742581|NCT01538862|19063933|P1|COMPLETED|Overall Study||7
7742582|NCT01538862|19063933|P1|STARTED|Overall Study||7
7742583|NCT01538719|19063941|P2|NOT COMPLETED|Overall Study||0
7742584|NCT01538719|19063942|P1|NOT COMPLETED|Overall Study||2
7742585|NCT01538719|19063941|P2|COMPLETED|Overall Study||12
7742586|NCT01538719|19063942|P1|COMPLETED|Overall Study||5
7742587|NCT01538719|19063941|P2|STARTED|Overall Study||12
7742588|NCT01538719|19063942|P1|STARTED|Overall Study||7
7742589|NCT01538615|19063952|P2|NOT COMPLETED|Overall Study||12
7742590|NCT01538615|19063953|P1|NOT COMPLETED|Overall Study||22
7742591|NCT01538615|19063952|P2|COMPLETED|Overall Study||146
7742592|NCT01538615|19063953|P1|COMPLETED|Overall Study||140
7742593|NCT01538615|19063952|P2|STARTED|Overall Study||158
7742594|NCT01538615|19063953|P1|STARTED|Overall Study||162
7742595|NCT01538472|19063965|P1|NOT COMPLETED|Overall Study||4
7742596|NCT01538472|19063965|P1|COMPLETED|Overall Study||36
7742597|NCT01538472|19063965|P1|STARTED|Overall Study||40
7742598|NCT01538199|19063976|P4|NOT COMPLETED|Overall Study||2
7742599|NCT01538199|19063977|P3|NOT COMPLETED|Overall Study||1
7742600|NCT01538199|19063978|P2|NOT COMPLETED|Overall Study||3
7742601|NCT01538199|19063979|P1|NOT COMPLETED|Overall Study||2
7742602|NCT01538199|19063976|P4|COMPLETED|Overall Study|Completer excluded from analyses because determined to be not eligible at end of study.|1
7742603|NCT01538199|19063977|P3|COMPLETED|Overall Study|1 non-completer included in analyses because only missed follow up, completed all treatment visits.|3
7742604|NCT01538199|19063978|P2|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
7742605|NCT01538199|19063979|P1|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
7742606|NCT01538199|19063976|P4|STARTED|Overall Study||3
7742607|NCT01538199|19063977|P3|STARTED|Overall Study||4
7742608|NCT01538199|19063978|P2|STARTED|Overall Study||11
7742609|NCT01538199|19063979|P1|STARTED|Overall Study||10
7742610|NCT01537900|19064002|P1|NOT COMPLETED|Overall Study||0
7742611|NCT01537900|19064002|P1|COMPLETED|Overall Study||4
7742612|NCT01537900|19064002|P1|STARTED|Overall Study||4
7742613|NCT01537887|19064013|P6|NOT COMPLETED|Period 3||0
7742614|NCT01537887|19064014|P5|NOT COMPLETED|Period 3||0
7742615|NCT01537887|19064015|P4|NOT COMPLETED|Period 3||0
7742616|NCT01537887|19064016|P3|NOT COMPLETED|Period 3||1
7742617|NCT01537887|19064017|P2|NOT COMPLETED|Period 3||1
7742618|NCT01537887|19064018|P1|NOT COMPLETED|Period 3||0
7742619|NCT01537887|19064013|P6|COMPLETED|Period 3||11
7742620|NCT01537887|19064014|P5|COMPLETED|Period 3||11
7742621|NCT01537887|19064015|P4|COMPLETED|Period 3||12
7742622|NCT01537887|19064016|P3|COMPLETED|Period 3||10
7742623|NCT01537887|19064017|P2|COMPLETED|Period 3||10
7742624|NCT01537887|19064018|P1|COMPLETED|Period 3||12
7742625|NCT01537887|19064013|P6|STARTED|Period 3||11
7742626|NCT01537887|19064014|P5|STARTED|Period 3||11
7742627|NCT01537887|19064015|P4|STARTED|Period 3||12
7742628|NCT01537887|19064016|P3|STARTED|Period 3||11
7742629|NCT01537887|19064017|P2|STARTED|Period 3||11
7742630|NCT01537887|19064018|P1|STARTED|Period 3||12
7742631|NCT01537887|19064013|P6|NOT COMPLETED|Period 2||0
7742632|NCT01537887|19064014|P5|NOT COMPLETED|Period 2||0
7742633|NCT01537887|19064015|P4|NOT COMPLETED|Period 2||0
7742634|NCT01537887|19064016|P3|NOT COMPLETED|Period 2||0
7742635|NCT01537887|19064017|P2|NOT COMPLETED|Period 2||1
7742636|NCT01537887|19064018|P1|NOT COMPLETED|Period 2||0
7742637|NCT01537887|19064013|P6|COMPLETED|Period 2||11
7742638|NCT01537887|19064014|P5|COMPLETED|Period 2||11
7742639|NCT01537887|19064015|P4|COMPLETED|Period 2||12
7742640|NCT01537887|19064016|P3|COMPLETED|Period 2||11
7742641|NCT01537887|19064017|P2|COMPLETED|Period 2||11
7742642|NCT01537887|19064018|P1|COMPLETED|Period 2||12
7742643|NCT01537887|19064013|P6|STARTED|Period 2||11
7742644|NCT01537887|19064014|P5|STARTED|Period 2||11
7742645|NCT01537887|19064015|P4|STARTED|Period 2||12
7742646|NCT01537887|19064016|P3|STARTED|Period 2||11
7742647|NCT01537887|19064017|P2|STARTED|Period 2||12
7742648|NCT01537887|19064018|P1|STARTED|Period 2||12
7742649|NCT01537887|19064013|P6|NOT COMPLETED|Period 1||1
7742650|NCT01537887|19064014|P5|NOT COMPLETED|Period 1||1
7742651|NCT01537887|19064015|P4|NOT COMPLETED|Period 1||0
7742652|NCT01537887|19064016|P3|NOT COMPLETED|Period 1||1
7742653|NCT01537887|19064017|P2|NOT COMPLETED|Period 1||0
7742654|NCT01537887|19064018|P1|NOT COMPLETED|Period 1||0
7742655|NCT01537887|19064013|P6|COMPLETED|Period 1||11
7742656|NCT01537887|19064014|P5|COMPLETED|Period 1||11
7742657|NCT01537887|19064015|P4|COMPLETED|Period 1||12
7742658|NCT01537887|19064016|P3|COMPLETED|Period 1||11
7742659|NCT01537887|19064017|P2|COMPLETED|Period 1||12
7742660|NCT01537887|19064018|P1|COMPLETED|Period 1||12
7742661|NCT01537887|19064013|P6|Received at Least 1 Dose of Study Drug|Period 1||12
7742662|NCT01537887|19064014|P5|Received at Least 1 Dose of Study Drug|Period 1||12
7742663|NCT01537887|19064015|P4|Received at Least 1 Dose of Study Drug|Period 1||12
7742664|NCT01537887|19064016|P3|Received at Least 1 Dose of Study Drug|Period 1||11
7742665|NCT01537887|19064017|P2|Received at Least 1 Dose of Study Drug|Period 1||12
7742666|NCT01537887|19064018|P1|Received at Least 1 Dose of Study Drug|Period 1||12
7742667|NCT01537887|19064013|P6|STARTED|Period 1||12
7742668|NCT01537887|19064014|P5|STARTED|Period 1||12
7742669|NCT01537887|19064015|P4|STARTED|Period 1||12
7742670|NCT01537887|19064016|P3|STARTED|Period 1||12
7742671|NCT01537887|19064017|P2|STARTED|Period 1||12
7742672|NCT01537887|19064018|P1|STARTED|Period 1||12
7742673|NCT01537835|19064032|P3|NOT COMPLETED|Overall Study||0
7742674|NCT01537835|19064033|P2|NOT COMPLETED|Overall Study||0
7742675|NCT01537835|19064034|P1|NOT COMPLETED|Overall Study||0
7742676|NCT01537835|19064032|P3|COMPLETED|Overall Study||35
7742677|NCT01537835|19064033|P2|COMPLETED|Overall Study||37
7742678|NCT01537835|19064034|P1|COMPLETED|Overall Study||37
7742679|NCT01537835|19064032|P3|STARTED|Overall Study||35
7742680|NCT01537835|19064033|P2|STARTED|Overall Study||37
7742681|NCT01537835|19064034|P1|STARTED|Overall Study||37
7742682|NCT01537783|19064047|P2|NOT COMPLETED|Overall Study||2
7742683|NCT01537783|19064048|P1|NOT COMPLETED|Overall Study||11
7742684|NCT01537783|19064047|P2|COMPLETED|Overall Study||23
7742685|NCT01537783|19064048|P1|COMPLETED|Overall Study||14
7742686|NCT01537783|19064047|P2|STARTED|Overall Study||25
7742687|NCT01537783|19064048|P1|STARTED|Overall Study||25
7742688|NCT01537666|19064058|P4|NOT COMPLETED|Overall Study||0
7742689|NCT01537666|19064059|P3|NOT COMPLETED|Overall Study||0
7742690|NCT01537666|19064060|P2|NOT COMPLETED|Overall Study||0
7742691|NCT01537666|19064061|P1|NOT COMPLETED|Overall Study||0
7742692|NCT01537666|19064058|P4|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7
7742693|NCT01537666|19064059|P3|COMPLETED|Overall Study||6
7742694|NCT01537666|19064060|P2|COMPLETED|Overall Study||6
7742695|NCT01537666|19064061|P1|COMPLETED|Overall Study||6
7742696|NCT01537666|19064058|P4|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7
7742697|NCT01537666|19064059|P3|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
7742698|NCT01537666|19064060|P2|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
7742699|NCT01537666|19064061|P1|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
7742700|NCT01537549|19064099|P1|NOT COMPLETED|Overall Study||3
7742701|NCT01537549|19064099|P1|COMPLETED|Overall Study||8
7742702|NCT01537549|19064099|P1|STARTED|Overall Study||11
7742703|NCT01537432|19064107|P2|NOT COMPLETED|Overall Study||2
7742704|NCT01537432|19064108|P1|NOT COMPLETED|Overall Study||6
7742705|NCT01537432|19064107|P2|COMPLETED|Overall Study||10
7742706|NCT01537432|19064108|P1|COMPLETED|Overall Study||18
7742707|NCT01537432|19064107|P2|STARTED|Overall Study||12
7742708|NCT01537432|19064108|P1|STARTED|Overall Study||24
7742709|NCT01537419|19064118|P2|NOT COMPLETED|Overall Study||12
7742710|NCT01537419|19064119|P1|NOT COMPLETED|Overall Study||11
7742711|NCT01537419|19064118|P2|COMPLETED|Overall Study||54
7742712|NCT01537419|19064119|P1|COMPLETED|Overall Study||52
7742713|NCT01537419|19064118|P2|STARTED|Overall Study||66
7742714|NCT01537419|19064119|P1|STARTED|Overall Study||63
7742715|NCT01537393|19064131|P2|NOT COMPLETED|Overall Study||191
7742716|NCT01537393|19064132|P1|NOT COMPLETED|Overall Study||154
7742717|NCT01537393|19064131|P2|COMPLETED|Overall Study||507
7742718|NCT01537393|19064132|P1|COMPLETED|Overall Study||553
7742719|NCT01537393|19064131|P2|STARTED|Overall Study||698
7742720|NCT01537393|19064132|P1|STARTED|Overall Study||707
7742721|NCT01537367|19064143|P3|NOT COMPLETED|Overall Study||0
7742722|NCT01537367|19064144|P2|NOT COMPLETED|Overall Study||0
7742723|NCT01537367|19064145|P1|NOT COMPLETED|Overall Study||0
7742724|NCT01537367|19064143|P3|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613
7742725|NCT01537367|19064144|P2|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610
7742726|NCT01537367|19064145|P1|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615
7742727|NCT01537367|19064143|P3|STARTED|Overall Study||613
7742728|NCT01537367|19064144|P2|STARTED|Overall Study||610
7742729|NCT01537367|19064145|P1|STARTED|Overall Study||615
7742730|NCT01537315|19064161|P2|NOT COMPLETED|Overall Study||0
7742731|NCT01537315|19064162|P1|NOT COMPLETED|Overall Study||0
7742732|NCT01537315|19064161|P2|COMPLETED|Overall Study||7
7742733|NCT01537315|19064162|P1|COMPLETED|Overall Study||1
7742734|NCT01537315|19064161|P2|STARTED|Overall Study||7
7742735|NCT01537315|19064162|P1|STARTED|Overall Study||1
7742736|NCT01537302|19064168|P1|NOT COMPLETED|Overall Study||2
7742737|NCT01537302|19064168|P1|COMPLETED|Overall Study||199
7742738|NCT01537302|19064168|P1|STARTED|Overall Study||201
7742739|NCT01537211|19064177|P2|NOT COMPLETED|Overall Study||1
7742740|NCT01537211|19064178|P1|NOT COMPLETED|Overall Study||0
7742741|NCT01537211|19064177|P2|COMPLETED|Overall Study||5
7742742|NCT01537211|19064178|P1|COMPLETED|Overall Study||4
7742743|NCT01537211|19064177|P2|STARTED|Overall Study||6
7742744|NCT01537211|19064178|P1|STARTED|Overall Study||4
7742745|NCT01537198|19064212|P1|NOT COMPLETED|Overall Study||154
7742746|NCT01537198|19064212|P1|COMPLETED|Overall Study||463
7742747|NCT01537198|19064212|P1|STARTED|Overall Study||617
7742748|NCT01537185|19064220|P4|NOT COMPLETED|Overall Study||2
7742749|NCT01537185|19064221|P3|NOT COMPLETED|Overall Study||6
7742750|NCT01537185|19064222|P2|NOT COMPLETED|Overall Study||6
7742751|NCT01537185|19064223|P1|NOT COMPLETED|Overall Study||3
7742752|NCT01537185|19064220|P4|COMPLETED|Overall Study||8
7742753|NCT01537185|19064221|P3|COMPLETED|Overall Study||4
7742754|NCT01537185|19064222|P2|COMPLETED|Overall Study||6
7742755|NCT01537185|19064223|P1|COMPLETED|Overall Study||7
7742756|NCT01537185|19064220|P4|STARTED|Overall Study||10
7742757|NCT01537185|19064221|P3|STARTED|Overall Study||10
7742758|NCT01537185|19064222|P2|STARTED|Overall Study||12
7742759|NCT01537185|19064223|P1|STARTED|Overall Study||10
7742760|NCT01537133|19064241|P4|NOT COMPLETED|Overall Study||0
7742761|NCT01537133|19064242|P3|NOT COMPLETED|Overall Study||0
7742762|NCT01537133|19064243|P2|NOT COMPLETED|Overall Study||0
7742763|NCT01537133|19064244|P1|NOT COMPLETED|Overall Study||3
7742764|NCT01537133|19064241|P4|COMPLETED|Overall Study||21
7742765|NCT01537133|19064242|P3|COMPLETED|Overall Study||21
7742766|NCT01537133|19064243|P2|COMPLETED|Overall Study||14
7742767|NCT01537133|19064244|P1|COMPLETED|Overall Study||25
7742768|NCT01537133|19064241|P4|STARTED|Overall Study||21
7742769|NCT01537133|19064242|P3|STARTED|Overall Study||21
7742770|NCT01537133|19064243|P2|STARTED|Overall Study||14
7742771|NCT01537133|19064244|P1|STARTED|Overall Study||28
7742772|NCT01537120|19064260|P1|NOT COMPLETED|12 Weeks Vildagliptin||0
7742773|NCT01537120|19064260|P1|COMPLETED|12 Weeks Vildagliptin||23
7742774|NCT01537120|19064260|P1|STARTED|12 Weeks Vildagliptin||23
7742775|NCT01537120|19064260|P1|NOT COMPLETED|3 Weeks Placebo||1
7742776|NCT01537120|19064260|P1|COMPLETED|3 Weeks Placebo||23
7742777|NCT01537120|19064260|P1|STARTED|3 Weeks Placebo||24
7742778|NCT01537120|19064260|P1|NOT COMPLETED|8 Weeks Washout||1
7742779|NCT01537120|19064260|P1|COMPLETED|8 Weeks Washout||24
7742780|NCT01537120|19064260|P1|STARTED|8 Weeks Washout||25
7742781|NCT01537120|19064260|P1|NOT COMPLETED|Enrolled||0
7742782|NCT01537120|19064260|P1|COMPLETED|Enrolled||25
7742783|NCT01537120|19064260|P1|STARTED|Enrolled||25
7742784|NCT01537081|19064273|P3|NOT COMPLETED|Overall Study||16
7742785|NCT01537081|19064274|P2|NOT COMPLETED|Overall Study||38
7742786|NCT01537081|19064275|P1|NOT COMPLETED|Overall Study||39
7742787|NCT01537081|19064273|P3|COMPLETED|Overall Study||547
7742788|NCT01537081|19064274|P2|COMPLETED|Overall Study||1086
7742789|NCT01537081|19064275|P1|COMPLETED|Overall Study||1084
7742790|NCT01537081|19064273|P3|Modified Intent to Treat Population|Overall Study||556
7742791|NCT01537081|19064274|P2|Modified Intent to Treat Population|Overall Study||1109
7742792|NCT01537081|19064275|P1|Modified Intent to Treat Population|Overall Study||1106
7742793|NCT01537081|19064273|P3|Safety Population|Overall Study||561
7742794|NCT01537081|19064274|P2|Safety Population|Overall Study||1122
7742795|NCT01537081|19064275|P1|Safety Population|Overall Study||1122
7742796|NCT01537081|19064273|P3|STARTED|Overall Study||563
7742797|NCT01537081|19064274|P2|STARTED|Overall Study||1124
7742798|NCT01537081|19064275|P1|STARTED|Overall Study||1123
7742799|NCT01537068|19064288|P2|NOT COMPLETED|Overall Study||3
7742800|NCT01537068|19064289|P1|NOT COMPLETED|Overall Study||4
7742801|NCT01537068|19064288|P2|COMPLETED|Overall Study||26
7742802|NCT01537068|19064289|P1|COMPLETED|Overall Study||26
7742803|NCT01537068|19064288|P2|STARTED|Overall Study||29
7742804|NCT01537068|19064289|P1|STARTED|Overall Study||30
7742805|NCT01537042|19064301|P2|NOT COMPLETED|Overall Study||5
7742806|NCT01537042|19064302|P1|NOT COMPLETED|Overall Study||0
7742807|NCT01537042|19064301|P2|COMPLETED|Overall Study||15
7742808|NCT01537042|19064302|P1|COMPLETED|Overall Study||10
7742809|NCT01537042|19064301|P2|STARTED|Overall Study||20
7742810|NCT01537042|19064302|P1|STARTED|Overall Study||10
7742811|NCT01537029|19064338|P1|NOT COMPLETED|Overall Study||0
7742812|NCT01537029|19064338|P1|COMPLETED|Overall Study||15
7742813|NCT01537029|19064338|P1|STARTED|Overall Study||15
7742814|NCT01536951|19064344|P9|NOT COMPLETED|Third Intervention||0
7742815|NCT01536951|19064345|P8|NOT COMPLETED|Third Intervention||0
7742816|NCT01536951|19064346|P7|NOT COMPLETED|Third Intervention||0
7742817|NCT01536951|19064347|P6|NOT COMPLETED|Third Intervention||0
7742818|NCT01536951|19064348|P5|NOT COMPLETED|Third Intervention||0
7742819|NCT01536951|19064349|P4|NOT COMPLETED|Third Intervention||0
7742820|NCT01536951|19064350|P3|NOT COMPLETED|Third Intervention||0
7742821|NCT01536951|19064351|P2|NOT COMPLETED|Third Intervention||0
7742822|NCT01536951|19064352|P1|NOT COMPLETED|Third Intervention||0
7742823|NCT01536951|19064344|P9|COMPLETED|Third Intervention||9
7742824|NCT01536951|19064345|P8|COMPLETED|Third Intervention||8
7742825|NCT01536951|19064346|P7|COMPLETED|Third Intervention||9
7742826|NCT01536951|19064347|P6|COMPLETED|Third Intervention||9
7742827|NCT01536951|19064348|P5|COMPLETED|Third Intervention||9
7742828|NCT01536951|19064349|P4|COMPLETED|Third Intervention||8
7742829|NCT01536951|19064350|P3|COMPLETED|Third Intervention||2
7742830|NCT01536951|19064351|P2|COMPLETED|Third Intervention||3
7742831|NCT01536951|19064352|P1|COMPLETED|Third Intervention||3
7742832|NCT01536951|19064344|P9|STARTED|Third Intervention||9
7742833|NCT01536951|19064345|P8|STARTED|Third Intervention||8
7742834|NCT01536951|19064346|P7|STARTED|Third Intervention||9
7742835|NCT01536951|19064347|P6|STARTED|Third Intervention||9
7742836|NCT01536951|19064348|P5|STARTED|Third Intervention||9
7742837|NCT01536951|19064349|P4|STARTED|Third Intervention||8
7742838|NCT01536951|19064350|P3|STARTED|Third Intervention||2
7742839|NCT01536951|19064351|P2|STARTED|Third Intervention||3
7742840|NCT01536951|19064352|P1|STARTED|Third Intervention||3
7742841|NCT01536951|19064344|P9|NOT COMPLETED|Second Intervention and Washout Period 2||0
7742842|NCT01536951|19064345|P8|NOT COMPLETED|Second Intervention and Washout Period 2||1
7742843|NCT01536951|19064346|P7|NOT COMPLETED|Second Intervention and Washout Period 2||0
7742844|NCT01536951|19064347|P6|NOT COMPLETED|Second Intervention and Washout Period 2||0
7742845|NCT01536951|19064348|P5|NOT COMPLETED|Second Intervention and Washout Period 2||0
7742846|NCT01536951|19064349|P4|NOT COMPLETED|Second Intervention and Washout Period 2||0
7742847|NCT01536951|19064350|P3|NOT COMPLETED|Second Intervention and Washout Period 2||0
7742848|NCT01536951|19064351|P2|NOT COMPLETED|Second Intervention and Washout Period 2||0
7742849|NCT01536951|19064352|P1|NOT COMPLETED|Second Intervention and Washout Period 2||0
7742850|NCT01536951|19064344|P9|COMPLETED|Second Intervention and Washout Period 2||9
7742851|NCT01536951|19064345|P8|COMPLETED|Second Intervention and Washout Period 2||8
7742852|NCT01536951|19064346|P7|COMPLETED|Second Intervention and Washout Period 2||9
7742853|NCT01536951|19064347|P6|COMPLETED|Second Intervention and Washout Period 2||9
7742854|NCT01536951|19064348|P5|COMPLETED|Second Intervention and Washout Period 2||9
7742855|NCT01536951|19064349|P4|COMPLETED|Second Intervention and Washout Period 2||8
7742856|NCT01536951|19064350|P3|COMPLETED|Second Intervention and Washout Period 2||2
7742857|NCT01536951|19064351|P2|COMPLETED|Second Intervention and Washout Period 2||3
7742858|NCT01536951|19064352|P1|COMPLETED|Second Intervention and Washout Period 2||3
7742859|NCT01536951|19064344|P9|STARTED|Second Intervention and Washout Period 2||9
7742860|NCT01536951|19064345|P8|STARTED|Second Intervention and Washout Period 2||9
7742861|NCT01536951|19064346|P7|STARTED|Second Intervention and Washout Period 2||9
7742862|NCT01536951|19064347|P6|STARTED|Second Intervention and Washout Period 2||9
7742863|NCT01536951|19064348|P5|STARTED|Second Intervention and Washout Period 2||9
7742864|NCT01536951|19064349|P4|STARTED|Second Intervention and Washout Period 2||8
7742865|NCT01536951|19064350|P3|STARTED|Second Intervention and Washout Period 2||2
7742866|NCT01536951|19064351|P2|STARTED|Second Intervention and Washout Period 2||3
7742867|NCT01536951|19064352|P1|STARTED|Second Intervention and Washout Period 2||3
7742868|NCT01536951|19064344|P9|NOT COMPLETED|First Intervention and Washout Period 1||0
7742869|NCT01536951|19064345|P8|NOT COMPLETED|First Intervention and Washout Period 1||0
7742870|NCT01536951|19064346|P7|NOT COMPLETED|First Intervention and Washout Period 1||0
7742871|NCT01536951|19064347|P6|NOT COMPLETED|First Intervention and Washout Period 1||0
7742872|NCT01536951|19064348|P5|NOT COMPLETED|First Intervention and Washout Period 1||0
7742873|NCT01536951|19064349|P4|NOT COMPLETED|First Intervention and Washout Period 1||0
7742874|NCT01536951|19064350|P3|NOT COMPLETED|First Intervention and Washout Period 1||1
7742875|NCT01536951|19064351|P2|NOT COMPLETED|First Intervention and Washout Period 1||0
7742876|NCT01536951|19064352|P1|NOT COMPLETED|First Intervention and Washout Period 1||0
7742877|NCT01536951|19064344|P9|COMPLETED|First Intervention and Washout Period 1||9
7742878|NCT01536951|19064345|P8|COMPLETED|First Intervention and Washout Period 1||9
7742879|NCT01536951|19064346|P7|COMPLETED|First Intervention and Washout Period 1||9
7742880|NCT01536951|19064347|P6|COMPLETED|First Intervention and Washout Period 1||9
7742881|NCT01536951|19064348|P5|COMPLETED|First Intervention and Washout Period 1||9
7742882|NCT01536951|19064349|P4|COMPLETED|First Intervention and Washout Period 1||8
7742883|NCT01536951|19064350|P3|COMPLETED|First Intervention and Washout Period 1||2
7742884|NCT01536951|19064351|P2|COMPLETED|First Intervention and Washout Period 1||3
7742885|NCT01536951|19064352|P1|COMPLETED|First Intervention and Washout Period 1||3
7742886|NCT01536951|19064344|P9|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
7742887|NCT01536951|19064345|P8|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
7742888|NCT01536951|19064346|P7|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
7742889|NCT01536951|19064347|P6|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
7742890|NCT01536951|19064348|P5|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
7742891|NCT01536951|19064349|P4|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8
7742892|NCT01536951|19064350|P3|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
7742893|NCT01536951|19064351|P2|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
7742894|NCT01536951|19064352|P1|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1|Across all reporting groups, study drug is LY3009104, moxifloxacin, or placebo.|3
7742895|NCT01536951|19064344|P9|STARTED|First Intervention and Washout Period 1||9
7742896|NCT01536951|19064345|P8|STARTED|First Intervention and Washout Period 1||9
7742897|NCT01536951|19064346|P7|STARTED|First Intervention and Washout Period 1||9
7742898|NCT01536951|19064347|P6|STARTED|First Intervention and Washout Period 1||9
7742899|NCT01536951|19064348|P5|STARTED|First Intervention and Washout Period 1||9
7742900|NCT01536951|19064349|P4|STARTED|First Intervention and Washout Period 1||8
7742901|NCT01536951|19064350|P3|STARTED|First Intervention and Washout Period 1||3
7742902|NCT01536951|19064351|P2|STARTED|First Intervention and Washout Period 1||3
7742903|NCT01536951|19064352|P1|STARTED|First Intervention and Washout Period 1||3
7742904|NCT01536938|19064382|P3|NOT COMPLETED|Overall Study||8
7742905|NCT01536938|19064383|P2|NOT COMPLETED|Overall Study||7
7742906|NCT01536938|19064384|P1|NOT COMPLETED|Overall Study||6
7742907|NCT01536938|19064382|P3|COMPLETED|Overall Study||93
7742908|NCT01536938|19064383|P2|COMPLETED|Overall Study||94
7742909|NCT01536938|19064384|P1|COMPLETED|Overall Study||94
7742910|NCT01536938|19064382|P3|STARTED|Overall Study||101
7742911|NCT01536938|19064383|P2|STARTED|Overall Study||101
7742912|NCT01536938|19064384|P1|STARTED|Overall Study||100
7742913|NCT01536886|19064396|P4|NOT COMPLETED|Overall Study||3
7742914|NCT01536886|19064397|P3|NOT COMPLETED|Overall Study||2
7742915|NCT01536886|19064398|P2|NOT COMPLETED|Overall Study||8
7742916|NCT01536886|19064399|P1|NOT COMPLETED|Overall Study||5
7742917|NCT01536886|19064396|P4|COMPLETED|Overall Study||48
7742918|NCT01536886|19064397|P3|COMPLETED|Overall Study||47
7742919|NCT01536886|19064398|P2|COMPLETED|Overall Study||127
7742920|NCT01536886|19064399|P1|COMPLETED|Overall Study||136
7742921|NCT01536886|19064396|P4|STARTED|Overall Study||51
7742922|NCT01536886|19064397|P3|STARTED|Overall Study||49
7742923|NCT01536886|19064398|P2|STARTED|Overall Study||135
7742924|NCT01536886|19064399|P1|STARTED|Overall Study||141
7742925|NCT01536860|19064409|P3|NOT COMPLETED|Third Intervention (1 Day)||0
7742926|NCT01536860|19064410|P2|NOT COMPLETED|Third Intervention (1 Day)||0
7742927|NCT01536860|19064411|P1|NOT COMPLETED|Third Intervention (1 Day)||0
7742928|NCT01536860|19064409|P3|COMPLETED|Third Intervention (1 Day)||4
7742929|NCT01536860|19064410|P2|COMPLETED|Third Intervention (1 Day)||4
7742930|NCT01536860|19064411|P1|COMPLETED|Third Intervention (1 Day)||3
7742931|NCT01536860|19064409|P3|STARTED|Third Intervention (1 Day)||4
7742932|NCT01536860|19064410|P2|STARTED|Third Intervention (1 Day)||4
7742933|NCT01536860|19064411|P1|STARTED|Third Intervention (1 Day)||3
7742934|NCT01536860|19064409|P3|NOT COMPLETED|Washout Period (3 Days)||0
7742935|NCT01536860|19064410|P2|NOT COMPLETED|Washout Period (3 Days)||0
7742936|NCT01536860|19064411|P1|NOT COMPLETED|Washout Period (3 Days)||1
7742937|NCT01536860|19064409|P3|COMPLETED|Washout Period (3 Days)||4
7742938|NCT01536860|19064410|P2|COMPLETED|Washout Period (3 Days)||4
7742939|NCT01536860|19064411|P1|COMPLETED|Washout Period (3 Days)||3
7742940|NCT01536860|19064409|P3|STARTED|Washout Period (3 Days)||4
7742941|NCT01536860|19064410|P2|STARTED|Washout Period (3 Days)||4
7742942|NCT01536860|19064411|P1|STARTED|Washout Period (3 Days)||4
7742943|NCT01536860|19064409|P3|NOT COMPLETED|Second Intervention (1 Day)||0
7742944|NCT01536860|19064410|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7742945|NCT01536860|19064411|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7742946|NCT01536860|19064409|P3|COMPLETED|Second Intervention (1 Day)||4
7742947|NCT01536860|19064410|P2|COMPLETED|Second Intervention (1 Day)||4
7742948|NCT01536860|19064411|P1|COMPLETED|Second Intervention (1 Day)||4
7742949|NCT01536860|19064409|P3|STARTED|Second Intervention (1 Day)||4
7742950|NCT01536860|19064410|P2|STARTED|Second Intervention (1 Day)||4
7742951|NCT01536860|19064411|P1|STARTED|Second Intervention (1 Day)||4
7742952|NCT01536860|19064409|P3|NOT COMPLETED|Washout Period (3 Days)||0
7742953|NCT01536860|19064410|P2|NOT COMPLETED|Washout Period (3 Days)||0
7742954|NCT01536860|19064411|P1|NOT COMPLETED|Washout Period (3 Days)||0
7742955|NCT01536860|19064409|P3|COMPLETED|Washout Period (3 Days)||4
7742956|NCT01536860|19064410|P2|COMPLETED|Washout Period (3 Days)||4
7742957|NCT01536860|19064411|P1|COMPLETED|Washout Period (3 Days)||4
7742958|NCT01536860|19064409|P3|STARTED|Washout Period (3 Days)||4
7742959|NCT01536860|19064410|P2|STARTED|Washout Period (3 Days)||4
7742960|NCT01536860|19064411|P1|STARTED|Washout Period (3 Days)||4
7742961|NCT01536860|19064409|P3|NOT COMPLETED|First Intervention (1 Day)||0
7742962|NCT01536860|19064410|P2|NOT COMPLETED|First Intervention (1 Day)||0
7742963|NCT01536860|19064411|P1|NOT COMPLETED|First Intervention (1 Day)||0
7742964|NCT01536860|19064409|P3|COMPLETED|First Intervention (1 Day)||4
7742965|NCT01536860|19064410|P2|COMPLETED|First Intervention (1 Day)||4
7742966|NCT01536860|19064411|P1|COMPLETED|First Intervention (1 Day)||4
7742967|NCT01536860|19064409|P3|STARTED|First Intervention (1 Day)||4
7742968|NCT01536860|19064410|P2|STARTED|First Intervention (1 Day)||4
7742969|NCT01536860|19064411|P1|STARTED|First Intervention (1 Day)||4
7742970|NCT01536704|19064419|P4|NOT COMPLETED|Period 4||0
7742971|NCT01536704|19064420|P3|NOT COMPLETED|Period 4||0
7742972|NCT01536704|19064421|P2|NOT COMPLETED|Period 4||0
7742973|NCT01536704|19064422|P1|NOT COMPLETED|Period 4||0
7742974|NCT01536704|19064419|P4|COMPLETED|Period 4||10
7742975|NCT01536704|19064420|P3|COMPLETED|Period 4||10
7742976|NCT01536704|19064421|P2|COMPLETED|Period 4||11
7742977|NCT01536704|19064422|P1|COMPLETED|Period 4||12
7742978|NCT01536704|19064419|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
7742979|NCT01536704|19064420|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
7742980|NCT01536704|19064421|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
7742981|NCT01536704|19064422|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12
7742982|NCT01536704|19064419|P4|NOT COMPLETED|Washout Period 3||0
7742983|NCT01536704|19064420|P3|NOT COMPLETED|Washout Period 3||1
7742984|NCT01536704|19064421|P2|NOT COMPLETED|Washout Period 3||0
7742985|NCT01536704|19064422|P1|NOT COMPLETED|Washout Period 3||0
7742986|NCT01536704|19064419|P4|COMPLETED|Washout Period 3||10
7742987|NCT01536704|19064420|P3|COMPLETED|Washout Period 3||11
7742988|NCT01536704|19064421|P2|COMPLETED|Washout Period 3||12
7742989|NCT01536704|19064422|P1|COMPLETED|Washout Period 3||10
7742990|NCT01536704|19064419|P4|STARTED|Washout Period 3||10
7742991|NCT01536704|19064420|P3|STARTED|Washout Period 3||12
7742992|NCT01536704|19064421|P2|STARTED|Washout Period 3||12
7742993|NCT01536704|19064422|P1|STARTED|Washout Period 3||10
7742994|NCT01536704|19064419|P4|NOT COMPLETED|Period 3||1
7742995|NCT01536704|19064420|P3|NOT COMPLETED|Period 3||0
7742996|NCT01536704|19064421|P2|NOT COMPLETED|Period 3||0
7742997|NCT01536704|19064422|P1|NOT COMPLETED|Period 3||0
7742998|NCT01536704|19064419|P4|COMPLETED|Period 3||10
7742999|NCT01536704|19064420|P3|COMPLETED|Period 3||12
7743000|NCT01536704|19064421|P2|COMPLETED|Period 3||12
7743001|NCT01536704|19064422|P1|COMPLETED|Period 3||10
7743002|NCT01536704|19064419|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11
7743089|NCT01536405|19064621|P2|COMPLETED|Visit 4 to Extended Study Follow-up||595
7743003|NCT01536704|19064420|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
7743004|NCT01536704|19064421|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
7743005|NCT01536704|19064422|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10
7743006|NCT01536704|19064419|P4|NOT COMPLETED|Washout Period 2||1
7743007|NCT01536704|19064420|P3|NOT COMPLETED|Washout Period 2||0
7743008|NCT01536704|19064421|P2|NOT COMPLETED|Washout Period 2||0
7743009|NCT01536704|19064422|P1|NOT COMPLETED|Washout Period 2||1
7743010|NCT01536704|19064419|P4|COMPLETED|Washout Period 2||12
7743011|NCT01536704|19064420|P3|COMPLETED|Washout Period 2||10
7743012|NCT01536704|19064421|P2|COMPLETED|Washout Period 2||11
7743013|NCT01536704|19064422|P1|COMPLETED|Washout Period 2||12
7743014|NCT01536704|19064419|P4|STARTED|Washout Period 2||13
7743015|NCT01536704|19064420|P3|STARTED|Washout Period 2||10
7743016|NCT01536704|19064421|P2|STARTED|Washout Period 2||11
7743017|NCT01536704|19064422|P1|STARTED|Washout Period 2||13
7743018|NCT01536704|19064419|P4|NOT COMPLETED|Period 2||0
7743019|NCT01536704|19064420|P3|NOT COMPLETED|Period 2||0
7743020|NCT01536704|19064421|P2|NOT COMPLETED|Period 2||0
7743021|NCT01536704|19064422|P1|NOT COMPLETED|Period 2||0
7743022|NCT01536704|19064419|P4|COMPLETED|Period 2||13
7743023|NCT01536704|19064420|P3|COMPLETED|Period 2||10
7743024|NCT01536704|19064421|P2|COMPLETED|Period 2||11
7743025|NCT01536704|19064422|P1|COMPLETED|Period 2||13
7743026|NCT01536704|19064419|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
7743027|NCT01536704|19064420|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10
7743028|NCT01536704|19064421|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
7743029|NCT01536704|19064422|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
7743030|NCT01536704|19064419|P4|NOT COMPLETED|Washout Period 1||0
7743031|NCT01536704|19064420|P3|NOT COMPLETED|Washout Period 1||0
7743032|NCT01536704|19064421|P2|NOT COMPLETED|Washout Period 1||2
7743033|NCT01536704|19064422|P1|NOT COMPLETED|Washout Period 1||1
7743034|NCT01536704|19064419|P4|COMPLETED|Washout Period 1||13
7743035|NCT01536704|19064420|P3|COMPLETED|Washout Period 1||13
7743036|NCT01536704|19064421|P2|COMPLETED|Washout Period 1||10
7743037|NCT01536704|19064422|P1|COMPLETED|Washout Period 1||11
7743038|NCT01536704|19064419|P4|STARTED|Washout Period 1||13
7743039|NCT01536704|19064420|P3|STARTED|Washout Period 1||13
7743040|NCT01536704|19064421|P2|STARTED|Washout Period 1||12
7743041|NCT01536704|19064422|P1|STARTED|Washout Period 1||12
7743042|NCT01536704|19064419|P4|NOT COMPLETED|Period 1||0
7743043|NCT01536704|19064420|P3|NOT COMPLETED|Period 1||0
7743044|NCT01536704|19064421|P2|NOT COMPLETED|Period 1||0
7743045|NCT01536704|19064422|P1|NOT COMPLETED|Period 1||0
7743046|NCT01536704|19064419|P4|COMPLETED|Period 1||13
7743047|NCT01536704|19064420|P3|COMPLETED|Period 1||13
7743048|NCT01536704|19064421|P2|COMPLETED|Period 1||12
7743049|NCT01536704|19064422|P1|COMPLETED|Period 1||12
7743050|NCT01536704|19064419|P4|STARTED|Period 1||13
7743051|NCT01536704|19064420|P3|STARTED|Period 1||13
7743052|NCT01536704|19064421|P2|STARTED|Period 1||12
7743053|NCT01536704|19064422|P1|STARTED|Period 1||12
7743054|NCT01536587|19064452|P1|NOT COMPLETED|Overall Study||2
7743055|NCT01536587|19064452|P1|COMPLETED|Overall Study||30
7743056|NCT01536587|19064452|P1|STARTED|Overall Study||32
7743057|NCT01536574|19064491|P2|NOT COMPLETED|Overall Study||7
7743058|NCT01536574|19064492|P1|NOT COMPLETED|Overall Study||6
7743059|NCT01536574|19064491|P2|COMPLETED|Overall Study||126
7743060|NCT01536574|19064492|P1|COMPLETED|Overall Study||156
7743061|NCT01536574|19064491|P2|STARTED|Overall Study||133
7743062|NCT01536574|19064492|P1|STARTED|Overall Study||162
7743063|NCT01536561|19064510|P1|NOT COMPLETED|Long-Term Follow-Up||0
7743064|NCT01536561|19064510|P1|COMPLETED|Long-Term Follow-Up||13
7743065|NCT01536561|19064510|P1|STARTED|Long-Term Follow-Up||13
7743066|NCT01536561|19064510|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59
7743067|NCT01536561|19064510|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
7743068|NCT01536561|19064510|P1|STARTED|Dosimetric and Therapeutic Treatment||59
7743069|NCT01536535|19064550|P2|NOT COMPLETED|Overall Study||13
7743070|NCT01536535|19064551|P1|NOT COMPLETED|Overall Study||15
7743071|NCT01536535|19064550|P2|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|237
7743072|NCT01536535|19064551|P1|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|163
7743073|NCT01536535|19064550|P2|STARTED|Overall Study||250
7743074|NCT01536535|19064551|P1|STARTED|Overall Study||178
7743075|NCT01536496|19064563|P2|NOT COMPLETED|Overall Study||1
7743076|NCT01536496|19064564|P1|NOT COMPLETED|Overall Study||2
7743077|NCT01536496|19064563|P2|COMPLETED|Overall Study||56
7743078|NCT01536496|19064564|P1|COMPLETED|Overall Study||55
7743079|NCT01536496|19064563|P2|STARTED|Overall Study||57
7743080|NCT01536496|19064564|P1|STARTED|Overall Study||57
7743081|NCT01536418|19064600|P2|NOT COMPLETED|Overall Study||66
7743082|NCT01536418|19064601|P1|NOT COMPLETED|Overall Study||69
7743083|NCT01536418|19064600|P2|COMPLETED|Overall Study||60
7743084|NCT01536418|19064601|P1|COMPLETED|Overall Study||58
7743085|NCT01536418|19064600|P2|STARTED|Overall Study||126
7743086|NCT01536418|19064601|P1|STARTED|Overall Study||127
7743087|NCT01536405|19064621|P2|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23
7743088|NCT01536405|19064622|P1|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20
7743090|NCT01536405|19064622|P1|COMPLETED|Visit 4 to Extended Study Follow-up||595
7743091|NCT01536405|19064621|P2|STARTED|Visit 4 to Extended Study Follow-up||618
7743092|NCT01536405|19064622|P1|STARTED|Visit 4 to Extended Study Follow-up||615
7743093|NCT01536405|19064621|P2|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16
7743094|NCT01536405|19064622|P1|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20
7743095|NCT01536405|19064621|P2|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618
7743096|NCT01536405|19064622|P1|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615
7743097|NCT01536405|19064621|P2|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632
7743098|NCT01536405|19064622|P1|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634
7743099|NCT01536405|19064621|P2|STARTED|Visit 3 (Vaccination 2) to Visit 4||634
7743100|NCT01536405|19064622|P1|STARTED|Visit 3 (Vaccination 2) to Visit 4||635
7743101|NCT01536405|19064621|P2|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28
7743102|NCT01536405|19064622|P1|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31
7743103|NCT01536405|19064621|P2|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634
7743104|NCT01536405|19064622|P1|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635
7743105|NCT01536405|19064621|P2|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662
7743106|NCT01536405|19064622|P1|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666
7743107|NCT01536405|19064621|P2|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40
7743108|NCT01536405|19064622|P1|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32
7743109|NCT01536405|19064621|P2|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662
7743110|NCT01536405|19064622|P1|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666
7743111|NCT01536405|19064621|P2|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702
7743112|NCT01536405|19064622|P1|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698
7743113|NCT01536405|19064621|P2|STARTED|Visit 1 (Vaccination 1) to Visit 2||702
7743114|NCT01536405|19064622|P1|STARTED|Visit 1 (Vaccination 1) to Visit 2||698
7743115|NCT01536405|19064621|P2|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4
7743116|NCT01536405|19064622|P1|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8
7743117|NCT01536405|19064621|P2|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702
7743118|NCT01536405|19064622|P1|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698
7743119|NCT01536405|19064621|P2|STARTED|Randomization to Visit 1 (Vaccination 1)||706
7743120|NCT01536405|19064622|P1|STARTED|Randomization to Visit 1 (Vaccination 1)||706
7743121|NCT01536379|19064660|P2|NOT COMPLETED|Overall Study||3
7743122|NCT01536379|19064661|P1|NOT COMPLETED|Overall Study||2
7743123|NCT01536379|19064660|P2|COMPLETED|Overall Study||9
7743124|NCT01536379|19064661|P1|COMPLETED|Overall Study||11
7743125|NCT01536379|19064660|P2|STARTED|Overall Study||12
7743126|NCT01536379|19064661|P1|STARTED|Overall Study||13
7743127|NCT01536366|19064737|P2|NOT COMPLETED|Overall Study||4
7743128|NCT01536366|19064738|P1|NOT COMPLETED|Overall Study||13
7743129|NCT01536366|19064737|P2|COMPLETED|Overall Study||9
7743130|NCT01536366|19064738|P1|COMPLETED|Overall Study||1
7743131|NCT01536366|19064737|P2|Follow-up|Overall Study||9
7743132|NCT01536366|19064738|P1|Follow-up|Overall Study||13
7743133|NCT01536366|19064737|P2|Repaglinide|Overall Study||13
7743134|NCT01536366|19064738|P1|Repaglinide|Overall Study||14
7743135|NCT01536366|19064737|P2|BIA 9-1067 + Repaglinide|Overall Study||10
7743136|NCT01536366|19064738|P1|BIA 9-1067 + Repaglinide|Overall Study||14
7743137|NCT01536366|19064737|P2|STARTED|Overall Study||13
7743138|NCT01536366|19064738|P1|STARTED|Overall Study||14
7743139|NCT01536262|19064753|P3|NOT COMPLETED|Overall Study||2
7743140|NCT01536262|19064754|P2|NOT COMPLETED|Overall Study||2
7743141|NCT01536262|19064755|P1|NOT COMPLETED|Overall Study||8
7743142|NCT01536262|19064753|P3|COMPLETED|Overall Study||39
7743143|NCT01536262|19064754|P2|COMPLETED|Overall Study||38
7743144|NCT01536262|19064755|P1|COMPLETED|Overall Study||33
7743145|NCT01536262|19064753|P3|STARTED|Overall Study||41
7743146|NCT01536262|19064754|P2|STARTED|Overall Study||40
7743147|NCT01536262|19064755|P1|STARTED|Overall Study||41
7743148|NCT01536197|19064771|P2|NOT COMPLETED|Overall Study||0
7743149|NCT01536197|19064772|P1|NOT COMPLETED|Overall Study||0
7743150|NCT01536197|19064771|P2|COMPLETED|Overall Study||10
7743151|NCT01536197|19064772|P1|COMPLETED|Overall Study||23
7743152|NCT01536197|19064771|P2|STARTED|Overall Study||10
7743153|NCT01536197|19064772|P1|STARTED|Overall Study||23
7743154|NCT01536184|19064782|P2|NOT COMPLETED|Overall Study||0
7743155|NCT01536184|19064783|P1|NOT COMPLETED|Overall Study||0
7743156|NCT01536184|19064782|P2|COMPLETED|Overall Study||4
7743157|NCT01536184|19064783|P1|COMPLETED|Overall Study||8
7743158|NCT01536184|19064782|P2|STARTED|Overall Study||4
7743159|NCT01536184|19064783|P1|STARTED|Overall Study||8
7743160|NCT01536171|19064797|P1|NOT COMPLETED|Overall Study||1
7743161|NCT01536171|19064797|P1|COMPLETED|Overall Study||21
7743162|NCT01536171|19064797|P1|STARTED|Overall Study||22
7743163|NCT01536145|19064802|P11|NOT COMPLETED|Overall Study||10
7743164|NCT01536145|19064803|P10|NOT COMPLETED|Overall Study||6
7743165|NCT01536145|19064804|P9|NOT COMPLETED|Overall Study||3
7743166|NCT01536145|19064805|P8|NOT COMPLETED|Overall Study||4
7743167|NCT01536145|19064806|P7|NOT COMPLETED|Overall Study||2
7743168|NCT01536145|19064807|P6|NOT COMPLETED|Overall Study||3
7743169|NCT01536145|19064808|P5|NOT COMPLETED|Overall Study||2
7743170|NCT01536145|19064809|P4|NOT COMPLETED|Overall Study||2
7743171|NCT01536145|19064810|P3|NOT COMPLETED|Overall Study||2
7743172|NCT01536145|19064811|P2|NOT COMPLETED|Overall Study||4
7743173|NCT01536145|19064812|P1|NOT COMPLETED|Overall Study||3
7743174|NCT01536145|19064802|P11|COMPLETED|Overall Study||0
7743175|NCT01536145|19064803|P10|COMPLETED|Overall Study||1
7743176|NCT01536145|19064804|P9|COMPLETED|Overall Study||0
7743177|NCT01536145|19064805|P8|COMPLETED|Overall Study||0
7743178|NCT01536145|19064806|P7|COMPLETED|Overall Study||1
7743179|NCT01536145|19064807|P6|COMPLETED|Overall Study||0
7743180|NCT01536145|19064808|P5|COMPLETED|Overall Study||2
7743181|NCT01536145|19064809|P4|COMPLETED|Overall Study||1
7743182|NCT01536145|19064810|P3|COMPLETED|Overall Study||1
7743183|NCT01536145|19064811|P2|COMPLETED|Overall Study||0
7743184|NCT01536145|19064812|P1|COMPLETED|Overall Study||0
7743185|NCT01536145|19064802|P11|STARTED|Overall Study||10
7743186|NCT01536145|19064803|P10|STARTED|Overall Study||7
7743187|NCT01536145|19064804|P9|STARTED|Overall Study||3
7743188|NCT01536145|19064805|P8|STARTED|Overall Study||4
7743189|NCT01536145|19064806|P7|STARTED|Overall Study||3
7743190|NCT01536145|19064807|P6|STARTED|Overall Study||3
7743191|NCT01536145|19064808|P5|STARTED|Overall Study||4
7743192|NCT01536145|19064809|P4|STARTED|Overall Study||3
7743193|NCT01536145|19064810|P3|STARTED|Overall Study||3
7743194|NCT01536145|19064811|P2|STARTED|Overall Study||4
7743195|NCT01536145|19064812|P1|STARTED|Overall Study||3
7743196|NCT01536119|19064919|P2|NOT COMPLETED|Overall Study||14
7743197|NCT01536119|19064920|P1|NOT COMPLETED|Overall Study||17
7743198|NCT01536119|19064919|P2|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200
7743199|NCT01536119|19064920|P1|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197
7743200|NCT01536119|19064919|P2|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214
7743201|NCT01536119|19064920|P1|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214
7743202|NCT01536093|19064946|P2|NOT COMPLETED|Overall Study||3
7743203|NCT01536093|19064947|P1|NOT COMPLETED|Overall Study||3
7743204|NCT01536093|19064946|P2|COMPLETED|Overall Study||21
7743205|NCT01536093|19064947|P1|COMPLETED|Overall Study||21
7743206|NCT01536093|19064946|P2|STARTED|Overall Study||24
7743207|NCT01536093|19064947|P1|STARTED|Overall Study||24
7743208|NCT01536067|19064963|P1|NOT COMPLETED|Overall Study||1
7743209|NCT01536067|19064963|P1|COMPLETED|Overall Study||2
7743210|NCT01536067|19064963|P1|STARTED|Overall Study||3
7743211|NCT01536015|19064976|P2|NOT COMPLETED|Overall Study||10
7743212|NCT01536015|19064977|P1|NOT COMPLETED|Overall Study||8
7743213|NCT01536015|19064976|P2|COMPLETED|Overall Study||3
7743214|NCT01536015|19064977|P1|COMPLETED|Overall Study||4
7743215|NCT01536015|19064976|P2|STARTED|Overall Study||13
7743216|NCT01536015|19064977|P1|STARTED|Overall Study||12
7743217|NCT01535976|19064995|P2|NOT COMPLETED|Overall Study||1
7743218|NCT01535976|19064996|P1|NOT COMPLETED|Overall Study||1
7743219|NCT01535976|19064995|P2|COMPLETED|Overall Study||26
7743220|NCT01535976|19064996|P1|COMPLETED|Overall Study||26
7743221|NCT01535976|19064995|P2|STARTED|Overall Study||27
7743222|NCT01535976|19064996|P1|STARTED|Overall Study||27
7743223|NCT01535937|19065004|P2|NOT COMPLETED|Overall Study||0
7743224|NCT01535937|19065005|P1|NOT COMPLETED|Overall Study||0
7743225|NCT01535937|19065004|P2|COMPLETED|Overall Study||28
7743226|NCT01535937|19065005|P1|COMPLETED|Overall Study||27
7743227|NCT01535937|19065004|P2|STARTED|Overall Study||28
7743228|NCT01535937|19065005|P1|STARTED|Overall Study||27
7743229|NCT01535807|19065015|P2|NOT COMPLETED|Overall Study||2
7743230|NCT01535807|19065016|P1|NOT COMPLETED|Overall Study||2
7743231|NCT01535807|19065015|P2|COMPLETED|Overall Study||20
7743232|NCT01535807|19065016|P1|COMPLETED|Overall Study||20
7743233|NCT01535807|19065015|P2|STARTED|Overall Study||22
7743234|NCT01535807|19065016|P1|STARTED|Overall Study||22
7743235|NCT01535729|19065022|P1|NOT COMPLETED|Overall Study||416
7743236|NCT01535729|19065022|P1|COMPLETED|Overall Study||49
7743237|NCT01535729|19065022|P1|Treated|Overall Study||385
7743238|NCT01535729|19065022|P1|STARTED|Overall Study||465
7743239|NCT01535664|19065049|P1|NOT COMPLETED|Overall Study||0
7743240|NCT01535664|19065049|P1|COMPLETED|Overall Study||20
7743241|NCT01535664|19065049|P1|STARTED|Overall Study||20
7743242|NCT01535638|19065063|P6|NOT COMPLETED|Treatment 3 (Single Dose)||0
7743243|NCT01535638|19065064|P5|NOT COMPLETED|Treatment 3 (Single Dose)||0
7743244|NCT01535638|19065065|P4|NOT COMPLETED|Treatment 3 (Single Dose)||1
7743245|NCT01535638|19065066|P3|NOT COMPLETED|Treatment 3 (Single Dose)||0
7743246|NCT01535638|19065067|P2|NOT COMPLETED|Treatment 3 (Single Dose)||0
7743247|NCT01535638|19065068|P1|NOT COMPLETED|Treatment 3 (Single Dose)||0
7743248|NCT01535638|19065063|P6|COMPLETED|Treatment 3 (Single Dose)||2
7743249|NCT01535638|19065064|P5|COMPLETED|Treatment 3 (Single Dose)||3
7743250|NCT01535638|19065065|P4|COMPLETED|Treatment 3 (Single Dose)||2
7743251|NCT01535638|19065066|P3|COMPLETED|Treatment 3 (Single Dose)||3
7743252|NCT01535638|19065067|P2|COMPLETED|Treatment 3 (Single Dose)||3
7743253|NCT01535638|19065068|P1|COMPLETED|Treatment 3 (Single Dose)||3
7743254|NCT01535638|19065063|P6|STARTED|Treatment 3 (Single Dose)||2
7743255|NCT01535638|19065064|P5|STARTED|Treatment 3 (Single Dose)||3
7743256|NCT01535638|19065065|P4|STARTED|Treatment 3 (Single Dose)||3
7743257|NCT01535638|19065066|P3|STARTED|Treatment 3 (Single Dose)||3
7743258|NCT01535638|19065067|P2|STARTED|Treatment 3 (Single Dose)||3
7743259|NCT01535638|19065068|P1|STARTED|Treatment 3 (Single Dose)||3
7743260|NCT01535638|19065063|P6|NOT COMPLETED|Treatment 2 (Single Dose)||0
7743261|NCT01535638|19065064|P5|NOT COMPLETED|Treatment 2 (Single Dose)||0
7743262|NCT01535638|19065065|P4|NOT COMPLETED|Treatment 2 (Single Dose)||0
7743263|NCT01535638|19065066|P3|NOT COMPLETED|Treatment 2 (Single Dose)||0
7743264|NCT01535638|19065067|P2|NOT COMPLETED|Treatment 2 (Single Dose)||0
7743265|NCT01535638|19065068|P1|NOT COMPLETED|Treatment 2 (Single Dose)||0
7743266|NCT01535638|19065063|P6|COMPLETED|Treatment 2 (Single Dose)||2
7743267|NCT01535638|19065064|P5|COMPLETED|Treatment 2 (Single Dose)||3
7743268|NCT01535638|19065065|P4|COMPLETED|Treatment 2 (Single Dose)||3
7743269|NCT01535638|19065066|P3|COMPLETED|Treatment 2 (Single Dose)||3
7743270|NCT01535638|19065067|P2|COMPLETED|Treatment 2 (Single Dose)||3
7743271|NCT01535638|19065068|P1|COMPLETED|Treatment 2 (Single Dose)||3
7743272|NCT01535638|19065063|P6|STARTED|Treatment 2 (Single Dose)||2
7743273|NCT01535638|19065064|P5|STARTED|Treatment 2 (Single Dose)||3
7743274|NCT01535638|19065065|P4|STARTED|Treatment 2 (Single Dose)||3
7743275|NCT01535638|19065066|P3|STARTED|Treatment 2 (Single Dose)||3
7743276|NCT01535638|19065067|P2|STARTED|Treatment 2 (Single Dose)||3
7743277|NCT01535638|19065068|P1|STARTED|Treatment 2 (Single Dose)||3
7743278|NCT01535638|19065063|P6|NOT COMPLETED|Treatment 1 (Single Dose)||1
7743279|NCT01535638|19065064|P5|NOT COMPLETED|Treatment 1 (Single Dose)||0
7743280|NCT01535638|19065065|P4|NOT COMPLETED|Treatment 1 (Single Dose)||0
7743281|NCT01535638|19065066|P3|NOT COMPLETED|Treatment 1 (Single Dose)||0
7743282|NCT01535638|19065067|P2|NOT COMPLETED|Treatment 1 (Single Dose)||0
7743283|NCT01535638|19065068|P1|NOT COMPLETED|Treatment 1 (Single Dose)||0
7743284|NCT01535638|19065063|P6|COMPLETED|Treatment 1 (Single Dose)||2
7743285|NCT01535638|19065064|P5|COMPLETED|Treatment 1 (Single Dose)||3
7743286|NCT01535638|19065065|P4|COMPLETED|Treatment 1 (Single Dose)||3
7743287|NCT01535638|19065066|P3|COMPLETED|Treatment 1 (Single Dose)||3
7743288|NCT01535638|19065067|P2|COMPLETED|Treatment 1 (Single Dose)||3
7743289|NCT01535638|19065068|P1|COMPLETED|Treatment 1 (Single Dose)||3
7743290|NCT01535638|19065063|P6|STARTED|Treatment 1 (Single Dose)||3
7743291|NCT01535638|19065064|P5|STARTED|Treatment 1 (Single Dose)||3
7743292|NCT01535638|19065065|P4|STARTED|Treatment 1 (Single Dose)||3
7743293|NCT01535638|19065066|P3|STARTED|Treatment 1 (Single Dose)||3
7743294|NCT01535638|19065067|P2|STARTED|Treatment 1 (Single Dose)||3
7743295|NCT01535638|19065068|P1|STARTED|Treatment 1 (Single Dose)||3
7743296|NCT01535599|19065082|P2|NOT COMPLETED|Overall Study||96
7743297|NCT01535599|19065083|P1|NOT COMPLETED|Overall Study||50
7743298|NCT01535599|19065082|P2|COMPLETED|Overall Study||250
7743299|NCT01535599|19065083|P1|COMPLETED|Overall Study||297
7743300|NCT01535599|19065082|P2|STARTED|Overall Study||346
7743301|NCT01535599|19065083|P1|STARTED|Overall Study||347
7743302|NCT01535573|19065096|P3|NOT COMPLETED|Overall Study||19
7743303|NCT01535573|19065097|P2|NOT COMPLETED|Overall Study||21
7743304|NCT01535573|19065098|P1|NOT COMPLETED|Overall Study||8
7743305|NCT01535573|19065096|P3|COMPLETED|Overall Study||24
7743306|NCT01535573|19065097|P2|COMPLETED|Overall Study||23
7743307|NCT01535573|19065098|P1|COMPLETED|Overall Study||13
7743308|NCT01535573|19065096|P3|STARTED|Overall Study||43
7743309|NCT01535573|19065097|P2|STARTED|Overall Study||44
7743310|NCT01535573|19065098|P1|STARTED|Overall Study||21
7743311|NCT01535560|19065117|P2|NOT COMPLETED|Overall Study||96
7743312|NCT01535560|19065118|P1|NOT COMPLETED|Overall Study||37
7743313|NCT01535560|19065117|P2|COMPLETED|Overall Study||179
7743314|NCT01535560|19065118|P1|COMPLETED|Overall Study||237
7743315|NCT01535560|19065117|P2|STARTED|Overall Study||275
7743316|NCT01535560|19065118|P1|STARTED|Overall Study||274
7743317|NCT01535443|19065128|P1|NOT COMPLETED|Overall Study||3
7743318|NCT01535443|19065128|P1|COMPLETED|Overall Study||32
7743319|NCT01535443|19065128|P1|STARTED|Overall Study||35
7743320|NCT01535365|19065145|P2|NOT COMPLETED|Overall Study||0
7743321|NCT01535365|19065146|P1|NOT COMPLETED|Overall Study||0
7743322|NCT01535365|19065145|P2|COMPLETED|Overall Study||29
7743323|NCT01535365|19065146|P1|COMPLETED|Overall Study||31
7743324|NCT01535365|19065145|P2|STARTED|Overall Study||29
7743325|NCT01535365|19065146|P1|STARTED|Overall Study||31
7743326|NCT01535326|19065157|P3|NOT COMPLETED|Overall Study||0
7743327|NCT01535326|19065158|P2|NOT COMPLETED|Overall Study||0
7743328|NCT01535326|19065159|P1|NOT COMPLETED|Overall Study||0
7743329|NCT01535326|19065157|P3|COMPLETED|Overall Study||90
7743330|NCT01535326|19065158|P2|COMPLETED|Overall Study||90
7743331|NCT01535326|19065159|P1|COMPLETED|Overall Study||90
7743332|NCT01535326|19065157|P3|STARTED|Overall Study||90
7743333|NCT01535326|19065158|P2|STARTED|Overall Study||90
7743334|NCT01535326|19065159|P1|STARTED|Overall Study||90
7743335|NCT01535287|19065178|P2|NOT COMPLETED|Overall Study||6
7743336|NCT01535287|19065179|P1|NOT COMPLETED|Overall Study||5
7743337|NCT01535287|19065178|P2|COMPLETED|Overall Study||64
7743338|NCT01535287|19065179|P1|COMPLETED|Overall Study||65
7743339|NCT01535287|19065178|P2|STARTED|Overall Study||70
7743340|NCT01535287|19065179|P1|STARTED|Overall Study||70
7743341|NCT01535261|19065195|P1|NOT COMPLETED|Overall Study||50
7743342|NCT01535261|19065195|P1|COMPLETED|Overall Study||307
7743343|NCT01535261|19065195|P1|STARTED|Overall Study||357
7743344|NCT01535235|19065208|P2|NOT COMPLETED|Overall Study||0
7743345|NCT01535235|19065209|P1|NOT COMPLETED|Overall Study||1
7743346|NCT01535235|19065208|P2|COMPLETED|Overall Study||15
7743347|NCT01535235|19065209|P1|COMPLETED|Overall Study||15
7743348|NCT01535235|19065208|P2|STARTED|Overall Study||15
7743349|NCT01535235|19065209|P1|STARTED|Overall Study||16
7743350|NCT01535222|19065223|P6|NOT COMPLETED|Overall Study||0
7743351|NCT01535222|19065224|P5|NOT COMPLETED|Overall Study||0
7743352|NCT01535222|19065225|P4|NOT COMPLETED|Overall Study||0
7743353|NCT01535222|19065226|P3|NOT COMPLETED|Overall Study||1
7743354|NCT01535222|19065227|P2|NOT COMPLETED|Overall Study||0
7743355|NCT01535222|19065228|P1|NOT COMPLETED|Overall Study||0
7743356|NCT01535222|19065223|P6|COMPLETED|Overall Study||8
7743357|NCT01535222|19065224|P5|COMPLETED|Overall Study||6
7743358|NCT01535222|19065225|P4|COMPLETED|Overall Study||6
7743359|NCT01535222|19065226|P3|COMPLETED|Overall Study||6
7743360|NCT01535222|19065227|P2|COMPLETED|Overall Study||3
7743361|NCT01535222|19065228|P1|COMPLETED|Overall Study||3
7743362|NCT01535222|19065223|P6|STARTED|Overall Study||8
7743363|NCT01535222|19065224|P5|STARTED|Overall Study||6
7743364|NCT01535222|19065225|P4|STARTED|Overall Study||6
7743365|NCT01535222|19065226|P3|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7
7743366|NCT01535222|19065227|P2|STARTED|Overall Study||3
7743367|NCT01535222|19065228|P1|STARTED|Overall Study||3
7743368|NCT01535118|19065248|P1|NOT COMPLETED|Overall Study||0
7743369|NCT01535118|19065248|P1|COMPLETED|Overall Study||2765
7743370|NCT01535118|19065248|P1|STARTED|Overall Study||2765
7743371|NCT01535053|19065259|P2|NOT COMPLETED|Overall Study||2
7743372|NCT01535053|19065260|P1|NOT COMPLETED|Overall Study||1
7743373|NCT01535053|19065259|P2|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|26
7743374|NCT01535053|19065260|P1|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|28
7743375|NCT01535053|19065259|P2|STARTED|Overall Study||28
7743376|NCT01535053|19065260|P1|STARTED|Overall Study||29
7743377|NCT01535040|19065278|P2|NOT COMPLETED|Overall Study||21
7743378|NCT01535040|19065279|P1|NOT COMPLETED|Overall Study||30
7743379|NCT01535040|19065278|P2|COMPLETED|Overall Study||44
7743380|NCT01535040|19065279|P1|COMPLETED|Overall Study||35
7743381|NCT01535040|19065278|P2|STARTED|Overall Study||65
7743382|NCT01535040|19065279|P1|STARTED|Overall Study||65
7743383|NCT01535014|19065295|P4|NOT COMPLETED|Overall Study||0
7743384|NCT01535014|19065296|P3|NOT COMPLETED|Overall Study||1
7743385|NCT01535014|19065297|P2|NOT COMPLETED|Overall Study||6
7743386|NCT01535014|19065298|P1|NOT COMPLETED|Overall Study||2
7743387|NCT01535014|19065295|P4|COMPLETED|Overall Study||33
7743388|NCT01535014|19065296|P3|COMPLETED|Overall Study||49
7743389|NCT01535014|19065297|P2|COMPLETED|Overall Study||194
7743390|NCT01535014|19065298|P1|COMPLETED|Overall Study||208
7743391|NCT01535014|19065295|P4|STARTED|Overall Study||33
7743392|NCT01535014|19065296|P3|STARTED|Overall Study||50
7743393|NCT01535014|19065297|P2|STARTED|Overall Study||200
7743394|NCT01535014|19065298|P1|STARTED|Overall Study||210
7743395|NCT01535001|19065332|P2|NOT COMPLETED|Overall Study||6
7743396|NCT01535001|19065333|P1|NOT COMPLETED|Overall Study||3
7743397|NCT01535001|19065332|P2|COMPLETED|Overall Study||44
7743398|NCT01535001|19065333|P1|COMPLETED|Overall Study||47
7743399|NCT01535001|19065332|P2|STARTED|Overall Study||50
7743400|NCT01535001|19065333|P1|STARTED|Overall Study||50
7743401|NCT01534975|19065359|P4|NOT COMPLETED|Overall Study||0
7743402|NCT01534975|19065360|P3|NOT COMPLETED|Overall Study||0
7743403|NCT01534975|19065361|P2|NOT COMPLETED|Overall Study||0
7743404|NCT01534975|19065362|P1|NOT COMPLETED|Overall Study||0
7743405|NCT01534975|19065359|P4|COMPLETED|Overall Study||84
7743406|NCT01534975|19065360|P3|COMPLETED|Overall Study||160
7743407|NCT01534975|19065361|P2|COMPLETED|Overall Study||133
7743408|NCT01534975|19065362|P1|COMPLETED|Overall Study||136
7743409|NCT01534975|19065359|P4|STARTED|Overall Study||84
7743410|NCT01534975|19065360|P3|STARTED|Overall Study||160
7743411|NCT01534975|19065361|P2|STARTED|Overall Study||133
7743412|NCT01534975|19065362|P1|STARTED|Overall Study||136
7743413|NCT01534962|19065376|P4|NOT COMPLETED|Overall Study||32
7743414|NCT01534962|19065377|P3|NOT COMPLETED|Overall Study||24
7743415|NCT01534962|19065378|P2|NOT COMPLETED|Overall Study||26
7743416|NCT01534962|19065379|P1|NOT COMPLETED|Overall Study||37
7743417|NCT01534962|19065376|P4|COMPLETED|Overall Study||24
7743418|NCT01534962|19065377|P3|COMPLETED|Overall Study||34
7743419|NCT01534962|19065378|P2|COMPLETED|Overall Study||34
7743420|NCT01534962|19065379|P1|COMPLETED|Overall Study||30
7743421|NCT01534962|19065376|P4|STARTED|Overall Study||56
7743422|NCT01534962|19065377|P3|STARTED|Overall Study||58
7743423|NCT01534962|19065378|P2|STARTED|Overall Study||60
7743424|NCT01534962|19065379|P1|STARTED|Overall Study||67
7743425|NCT01534910|19065411|P2|NOT COMPLETED|Overall Study||4
7743426|NCT01534910|19065412|P1|NOT COMPLETED|Overall Study||4
7743427|NCT01534910|19065411|P2|COMPLETED|Overall Study||28
7743428|NCT01534910|19065412|P1|COMPLETED|Overall Study||29
7743429|NCT01534910|19065411|P2|STARTED|Overall Study||32
7743430|NCT01534910|19065412|P1|STARTED|Overall Study||33
7743431|NCT01534897|19065420|P1|NOT COMPLETED|Overall Study||0
7743432|NCT01534897|19065420|P1|COMPLETED|Overall Study||10
7743433|NCT01534897|19065420|P1|Day 37 Iodine-131 Treatment|Overall Study||6
7743434|NCT01534897|19065420|P1|Day 25 Iodine-131 Scan|Overall Study||10
7743435|NCT01534897|19065420|P1|STARTED|Overall Study||10
7743436|NCT01534689|19065428|P1|NOT COMPLETED|Overall Study||0
7743437|NCT01534689|19065428|P1|COMPLETED|Overall Study||105
7743438|NCT01534689|19065428|P1|STARTED|Overall Study||105
7743439|NCT01534676|19065436|P2|NOT COMPLETED|Overall Study||1
7743440|NCT01534676|19065437|P1|NOT COMPLETED|Overall Study||2
7743441|NCT01534676|19065436|P2|COMPLETED|Overall Study||0
7743442|NCT01534676|19065437|P1|COMPLETED|Overall Study||0
7743443|NCT01534676|19065436|P2|STARTED|Overall Study||1
7743444|NCT01534676|19065437|P1|STARTED|Overall Study||2
7743445|NCT01534663|19065445|P2|NOT COMPLETED|Overall Study||3
7743446|NCT01534663|19065446|P1|NOT COMPLETED|Overall Study||2
7743447|NCT01534663|19065445|P2|COMPLETED|Overall Study||14
7743448|NCT01534663|19065446|P1|COMPLETED|Overall Study||12
7743449|NCT01534663|19065445|P2|STARTED|Overall Study||17
7743450|NCT01534663|19065446|P1|STARTED|Overall Study||14
7743451|NCT01534637|19065480|P1|NOT COMPLETED|Overall Study||9
7743452|NCT01534637|19065480|P1|COMPLETED|Overall Study||13
7743453|NCT01534637|19065480|P1|STARTED|Overall Study||22
7743454|NCT01534533|19065490|P4|NOT COMPLETED|Overall Study||4
7743455|NCT01534533|19065491|P3|NOT COMPLETED|Overall Study||8
7743456|NCT01534533|19065492|P2|NOT COMPLETED|Overall Study||3
7743457|NCT01534533|19065493|P1|NOT COMPLETED|Overall Study||8
7743458|NCT01534533|19065490|P4|COMPLETED|Overall Study||44
7743459|NCT01534533|19065491|P3|COMPLETED|Overall Study||40
7743460|NCT01534533|19065492|P2|COMPLETED|Overall Study||45
7743461|NCT01534533|19065493|P1|COMPLETED|Overall Study||40
7743462|NCT01534533|19065490|P4|STARTED|Overall Study||48
7743463|NCT01534533|19065491|P3|STARTED|Overall Study||48
7743464|NCT01534533|19065492|P2|STARTED|Overall Study||48
7743465|NCT01534533|19065493|P1|STARTED|Overall Study||48
7743466|NCT01534520|19065521|P2|NOT COMPLETED|Overall Study||1
7743467|NCT01534520|19065522|P1|NOT COMPLETED|Overall Study||0
7743468|NCT01534520|19065521|P2|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28
7743469|NCT01534520|19065522|P1|COMPLETED|Overall Study||30
7743470|NCT01534520|19065521|P2|STARTED|Overall Study||29
7743471|NCT01534520|19065522|P1|STARTED|Overall Study||30
7743472|NCT01534416|19065536|P2|NOT COMPLETED|Overall Study||0
7743473|NCT01534416|19065537|P1|NOT COMPLETED|Overall Study||0
7743474|NCT01534416|19065536|P2|COMPLETED|Overall Study||64
7743475|NCT01534416|19065537|P1|COMPLETED|Overall Study||68
7743476|NCT01534416|19065536|P2|STARTED|Overall Study||64
7743477|NCT01534416|19065537|P1|STARTED|Overall Study||68
7743478|NCT01534351|19065556|P3|NOT COMPLETED|Overall Study||0
7743479|NCT01534351|19065557|P2|NOT COMPLETED|Overall Study||0
7743480|NCT01534351|19065558|P1|NOT COMPLETED|Overall Study||1
7743481|NCT01534351|19065556|P3|COMPLETED|Overall Study||0
7743482|NCT01534351|19065557|P2|COMPLETED|Overall Study||0
7743483|NCT01534351|19065558|P1|COMPLETED|Overall Study||0
7743484|NCT01534351|19065556|P3|STARTED|Overall Study||0
7743485|NCT01534351|19065557|P2|STARTED|Overall Study||0
7743486|NCT01534351|19065558|P1|STARTED|Overall Study||1
7743487|NCT01534273|19065579|P7|NOT COMPLETED|Period 2||0
7743488|NCT01534273|19065580|P6|NOT COMPLETED|Period 2||0
7743489|NCT01534273|19065581|P5|NOT COMPLETED|Period 2||0
7743490|NCT01534273|19065582|P4|NOT COMPLETED|Period 2||0
7743491|NCT01534273|19065583|P3|NOT COMPLETED|Period 2||0
7743492|NCT01534273|19065584|P2|NOT COMPLETED|Period 2||0
7743493|NCT01534273|19065585|P1|NOT COMPLETED|Period 2||0
7743494|NCT01534273|19065579|P7|COMPLETED|Period 2||0
7743495|NCT01534273|19065580|P6|COMPLETED|Period 2||0
7743496|NCT01534273|19065581|P5|COMPLETED|Period 2||0
7743497|NCT01534273|19065582|P4|COMPLETED|Period 2||6
7743498|NCT01534273|19065583|P3|COMPLETED|Period 2||2
7743499|NCT01534273|19065584|P2|COMPLETED|Period 2||0
7743500|NCT01534273|19065585|P1|COMPLETED|Period 2||0
7743501|NCT01534273|19065579|P7|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
7743502|NCT01534273|19065580|P6|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
7743503|NCT01534273|19065581|P5|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
7743504|NCT01534273|19065582|P4|STARTED|Period 2||6
7743505|NCT01534273|19065583|P3|STARTED|Period 2||2
7743506|NCT01534273|19065584|P2|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
7743507|NCT01534273|19065585|P1|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
7743508|NCT01534273|19065579|P7|NOT COMPLETED|Period 1||0
7743509|NCT01534273|19065580|P6|NOT COMPLETED|Period 1||0
7743510|NCT01534273|19065581|P5|NOT COMPLETED|Period 1||0
7743511|NCT01534273|19065582|P4|NOT COMPLETED|Period 1||1
7743512|NCT01534273|19065583|P3|NOT COMPLETED|Period 1||0
7743513|NCT01534273|19065584|P2|NOT COMPLETED|Period 1||0
7743514|NCT01534273|19065585|P1|NOT COMPLETED|Period 1||0
7743515|NCT01534273|19065579|P7|COMPLETED|Period 1||6
7743516|NCT01534273|19065580|P6|COMPLETED|Period 1||3
7743517|NCT01534273|19065581|P5|COMPLETED|Period 1||3
7743518|NCT01534273|19065582|P4|COMPLETED|Period 1||6
7743519|NCT01534273|19065583|P3|COMPLETED|Period 1||2
7743520|NCT01534273|19065584|P2|COMPLETED|Period 1||6
7743521|NCT01534273|19065585|P1|COMPLETED|Period 1||3
7743522|NCT01534273|19065579|P7|Received at Least 1 Dose of Study Drug|Period 1||6
7743523|NCT01534273|19065580|P6|Received at Least 1 Dose of Study Drug|Period 1||3
7743524|NCT01534273|19065581|P5|Received at Least 1 Dose of Study Drug|Period 1||3
7743525|NCT01534273|19065582|P4|Received at Least 1 Dose of Study Drug|Period 1||7
7743526|NCT01534273|19065583|P3|Received at Least 1 Dose of Study Drug|Period 1||2
7743527|NCT01534273|19065584|P2|Received at Least 1 Dose of Study Drug|Period 1||6
7743528|NCT01534273|19065585|P1|Received at Least 1 Dose of Study Drug|Period 1||3
7743529|NCT01534273|19065579|P7|STARTED|Period 1||6
7743530|NCT01534273|19065580|P6|STARTED|Period 1||3
7743531|NCT01534273|19065581|P5|STARTED|Period 1||3
7743532|NCT01534273|19065582|P4|STARTED|Period 1||7
7743533|NCT01534273|19065583|P3|STARTED|Period 1||2
7743534|NCT01534273|19065584|P2|STARTED|Period 1||6
7743535|NCT01534273|19065585|P1|STARTED|Period 1||3
7743536|NCT01534260|19065612|P2|NOT COMPLETED|Overall Study||20
7743537|NCT01534260|19065613|P1|NOT COMPLETED|Overall Study||16
7743538|NCT01534260|19065612|P2|COMPLETED|Overall Study||0
7743539|NCT01534260|19065613|P1|COMPLETED|Overall Study||1
7743540|NCT01534260|19065612|P2|STARTED|Overall Study||20
7743541|NCT01534260|19065613|P1|STARTED|Overall Study||17
7743542|NCT01534208|19065623|P2|NOT COMPLETED|Overall Study||49
7743543|NCT01534208|19065624|P1|NOT COMPLETED|Overall Study||57
7743544|NCT01534208|19065623|P2|COMPLETED|Overall Study||234
7743545|NCT01534208|19065624|P1|COMPLETED|Overall Study||159
7743546|NCT01534208|19065623|P2|STARTED|Overall Study||283
7743547|NCT01534208|19065624|P1|STARTED|Overall Study||216
7743548|NCT01534195|19065642|P2|NOT COMPLETED|Overall Study||1
7743549|NCT01534195|19065643|P1|NOT COMPLETED|Overall Study||1
7743550|NCT01534195|19065642|P2|COMPLETED|Overall Study||5
7743551|NCT01534195|19065643|P1|COMPLETED|Overall Study||4
7743552|NCT01534195|19065642|P2|STARTED|Overall Study||6
7743553|NCT01534195|19065643|P1|STARTED|Overall Study||5
7743554|NCT01534182|19065657|P2|NOT COMPLETED|Overall Study||10
7743555|NCT01534182|19065658|P1|NOT COMPLETED|Overall Study||12
7743556|NCT01534182|19065657|P2|COMPLETED|Overall Study||58
7743557|NCT01534182|19065658|P1|COMPLETED|Overall Study||218
7743558|NCT01534182|19065657|P2|Full Analysis Set|Overall Study||62
7743559|NCT01534182|19065658|P1|Full Analysis Set|Overall Study||229
7743560|NCT01534182|19065657|P2|Safety Set|Overall Study||64
7743561|NCT01534182|19065658|P1|Safety Set|Overall Study||230
7743562|NCT01534182|19065657|P2|STARTED|Overall Study||68
7743563|NCT01534182|19065658|P1|STARTED|Overall Study||230
7743564|NCT01534143|19065673|P1|NOT COMPLETED|Overall Study||0
7743565|NCT01534143|19065673|P1|COMPLETED|Overall Study||1
7743566|NCT01534143|19065673|P1|STARTED|Overall Study||1
7743567|NCT01534078|19065689|P1|NOT COMPLETED|Overall Study||2
7743568|NCT01534078|19065689|P1|COMPLETED|Overall Study||32
7743569|NCT01534078|19065689|P1|STARTED|Overall Study||34
7743570|NCT01534052|19065696|P1|NOT COMPLETED|Overall Study||0
7743571|NCT01534052|19065696|P1|COMPLETED|Overall Study||52
7743572|NCT01534052|19065696|P1|Treatment Received|Overall Study||52
7743573|NCT01534052|19065696|P1|STARTED|Overall Study||52
7743574|NCT01534013|19065702|P2|NOT COMPLETED|Overall Study||0
7743575|NCT01534013|19065703|P1|NOT COMPLETED|Overall Study||2
7743576|NCT01534013|19065702|P2|COMPLETED|Overall Study||6
7743577|NCT01534013|19065703|P1|COMPLETED|Overall Study||6
7743578|NCT01534013|19065702|P2|STARTED|Overall Study||6
7743579|NCT01534013|19065703|P1|STARTED|Overall Study||8
7743580|NCT01533974|19065711|P2|NOT COMPLETED|Overall Study||50
7743581|NCT01533974|19065712|P1|NOT COMPLETED|Overall Study||51
7743582|NCT01533974|19065711|P2|COMPLETED|Overall Study||176
7743583|NCT01533974|19065712|P1|COMPLETED|Overall Study||173
7743584|NCT01533974|19065711|P2|STARTED|Overall Study||226
7743585|NCT01533974|19065712|P1|STARTED|Overall Study||224
7743586|NCT01533948|19065718|P1|NOT COMPLETED|Overall Study||0
7743587|NCT01533948|19065718|P1|COMPLETED|Overall Study||25
7743588|NCT01533948|19065718|P1|STARTED|Overall Study||25
7743589|NCT01533935|19065726|P5|NOT COMPLETED|Overall Study||8
7743590|NCT01533935|19065727|P4|NOT COMPLETED|Overall Study||7
7743591|NCT01533935|19065728|P3|NOT COMPLETED|Overall Study||8
7743592|NCT01533935|19065729|P2|NOT COMPLETED|Overall Study||13
7743593|NCT01533935|19065730|P1|NOT COMPLETED|Overall Study||6
7743594|NCT01533935|19065726|P5|COMPLETED|Overall Study|All treatment periods|50
7743595|NCT01533935|19065727|P4|COMPLETED|Overall Study|All treatment periods|52
7743596|NCT01533935|19065728|P3|COMPLETED|Overall Study|All treatment periods|50
7743597|NCT01533935|19065729|P2|COMPLETED|Overall Study|All treatment periods|45
7743598|NCT01533935|19065730|P1|COMPLETED|Overall Study|All treatment periods|52
7743599|NCT01533935|19065726|P5|Received Tio+Olo 5/5|Overall Study||55
7743600|NCT01533935|19065727|P4|Received Tio+Olo 5/5|Overall Study||54
7743601|NCT01533935|19065728|P3|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1
7743602|NCT01533935|19065729|P2|Received Tio+Olo 5/5|Overall Study||58
7743603|NCT01533935|19065730|P1|Received Tio+Olo 5/5|Overall Study||56
7743604|NCT01533935|19065726|P5|Received Tio+Olo 2.5/5|Overall Study||56
7743605|NCT01533935|19065727|P4|Received Tio+Olo 2.5/5|Overall Study||56
7743606|NCT01533935|19065728|P3|Received Tio+Olo 2.5/5|Overall Study||49
7743607|NCT01533935|19065729|P2|Received Tio+Olo 2.5/5|Overall Study||0
7743608|NCT01533935|19065730|P1|Received Tio+Olo 2.5/5|Overall Study||58
7743609|NCT01533935|19065726|P5|Received Tio 5|Overall Study||52
7743610|NCT01533935|19065727|P4|Received Tio 5|Overall Study||0
7743611|NCT01533935|19065728|P3|Received Tio 5|Overall Study||58
7743612|NCT01533935|19065729|P2|Received Tio 5|Overall Study||54
7743613|NCT01533935|19065730|P1|Received Tio 5|Overall Study||54
7743614|NCT01533935|19065726|P5|Received Olo 5|Overall Study||0
7743615|NCT01533935|19065727|P4|Received Olo 5|Overall Study||59
7743616|NCT01533935|19065728|P3|Received Olo 5|Overall Study||55
7743617|NCT01533935|19065729|P2|Received Olo 5|Overall Study||52
7743618|NCT01533935|19065730|P1|Received Olo 5|Overall Study||52
7743619|NCT01533935|19065726|P5|Received Placebo|Overall Study||58
7743620|NCT01533935|19065727|P4|Received Placebo|Overall Study||57
7743621|NCT01533935|19065728|P3|Received Placebo|Overall Study||52
7743622|NCT01533935|19065729|P2|Received Placebo|Overall Study||47
7743623|NCT01533935|19065730|P1|Received Placebo|Overall Study||0
7743624|NCT01533935|19065726|P5|STARTED|Overall Study||58
7743625|NCT01533935|19065727|P4|STARTED|Overall Study||59
7743626|NCT01533935|19065728|P3|STARTED|Overall Study||58
7743627|NCT01533935|19065729|P2|STARTED|Overall Study||58
7743628|NCT01533935|19065730|P1|STARTED|Overall Study||58
7743629|NCT01533922|19065757|P5|NOT COMPLETED|Overall Study||6
7743630|NCT01533922|19065758|P4|NOT COMPLETED|Overall Study||5
7743631|NCT01533922|19065759|P3|NOT COMPLETED|Overall Study||10
7743632|NCT01533922|19065760|P2|NOT COMPLETED|Overall Study||12
7743633|NCT01533922|19065761|P1|NOT COMPLETED|Overall Study||10
7743634|NCT01533922|19065757|P5|COMPLETED|Overall Study|Completed all treatment arms|53
7743635|NCT01533922|19065758|P4|COMPLETED|Overall Study|Completed all treatment arms|53
7743636|NCT01533922|19065759|P3|COMPLETED|Overall Study|Completed all treatment arms|50
7743637|NCT01533922|19065760|P2|COMPLETED|Overall Study|Completed all treatment arms|47
7743638|NCT01533922|19065761|P1|COMPLETED|Overall Study|Completed all treatment arms|49
7743639|NCT01533922|19065757|P5|Received Tio+Olo 5/5|Overall Study||56
7743640|NCT01533922|19065758|P4|Received Tio+Olo 5/5|Overall Study||53
7743641|NCT01533922|19065759|P3|Received Tio+Olo 5/5|Overall Study||0
7743642|NCT01533922|19065760|P2|Received Tio+Olo 5/5|Overall Study||59
7743643|NCT01533922|19065761|P1|Received Tio+Olo 5/5|Overall Study||58
7743644|NCT01533922|19065757|P5|Received Tio+Olo 2.5/5|Overall Study||56
7743645|NCT01533922|19065758|P4|Received Tio+Olo 2.5/5|Overall Study||55
7743646|NCT01533922|19065759|P3|Received Tio+Olo 2.5/5|Overall Study||52
7743647|NCT01533922|19065760|P2|Received Tio+Olo 2.5/5|Overall Study||0
7743648|NCT01533922|19065761|P1|Received Tio+Olo 2.5/5|Overall Study||59
7743649|NCT01533922|19065757|P5|Received Tio 5|Overall Study||54
7743650|NCT01533922|19065758|P4|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1
7743651|NCT01533922|19065759|P3|Received Tio 5|Overall Study||59
7743652|NCT01533922|19065760|P2|Received Tio 5|Overall Study||58
7743653|NCT01533922|19065761|P1|Received Tio 5|Overall Study||54
7743654|NCT01533922|19065757|P5|Received Olo 5|Overall Study||0
7743655|NCT01533922|19065758|P4|Received Olo 5|Overall Study||57
7743656|NCT01533922|19065759|P3|Received Olo 5|Overall Study||57
7743657|NCT01533922|19065760|P2|Received Olo 5|Overall Study||52
7743658|NCT01533922|19065761|P1|Received Olo 5|Overall Study||51
7743659|NCT01533922|19065757|P5|Received Placebo|Overall Study||59
7743660|NCT01533922|19065758|P4|Received Placebo|Overall Study||57
7743661|NCT01533922|19065759|P3|Received Placebo|Overall Study||57
7743662|NCT01533922|19065760|P2|Received Placebo|Overall Study||49
7743663|NCT01533922|19065761|P1|Received Placebo|Overall Study||0
7743664|NCT01533922|19065757|P5|STARTED|Overall Study||59
7743665|NCT01533922|19065758|P4|STARTED|Overall Study||58
7743666|NCT01533922|19065759|P3|STARTED|Overall Study||60
7743667|NCT01533922|19065760|P2|STARTED|Overall Study||59
7743668|NCT01533922|19065761|P1|STARTED|Overall Study||59
7743669|NCT01533753|19065790|P2|NOT COMPLETED|Overall Study||0
7743670|NCT01533753|19065791|P1|NOT COMPLETED|Overall Study||0
7743671|NCT01533753|19065790|P2|COMPLETED|Overall Study||3
7743672|NCT01533753|19065791|P1|COMPLETED|Overall Study||2
7743673|NCT01533753|19065790|P2|STARTED|Overall Study||3
7743674|NCT01533753|19065791|P1|STARTED|Overall Study||2
7743675|NCT01533688|19065806|P3|NOT COMPLETED|Overall Study||8
7743676|NCT01533688|19065807|P2|NOT COMPLETED|Overall Study||10
7743677|NCT01533688|19065808|P1|NOT COMPLETED|Overall Study||8
7743678|NCT01533688|19065806|P3|COMPLETED|Overall Study||63
7743679|NCT01533688|19065807|P2|COMPLETED|Overall Study||60
7743680|NCT01533688|19065808|P1|COMPLETED|Overall Study||63
7743681|NCT01533688|19065806|P3|STARTED|Overall Study||71
7743682|NCT01533688|19065807|P2|STARTED|Overall Study||70
7743683|NCT01533688|19065808|P1|STARTED|Overall Study||71
7743684|NCT01533597|19065821|P2|NOT COMPLETED|Overall Study||10
7743685|NCT01533597|19065822|P1|NOT COMPLETED|Overall Study||6
7743686|NCT01533597|19065821|P2|COMPLETED|Overall Study||25
7743687|NCT01533597|19065822|P1|COMPLETED|Overall Study||29
7743688|NCT01533597|19065821|P2|STARTED|Overall Study||35
7743689|NCT01533597|19065822|P1|STARTED|Overall Study||35
7743690|NCT01533493|19065840|P2|NOT COMPLETED|Overall Study||3
7743691|NCT01533493|19065841|P1|NOT COMPLETED|Overall Study||5
7743692|NCT01533493|19065840|P2|COMPLETED|Overall Study||11
7743693|NCT01533493|19065841|P1|COMPLETED|Overall Study||7
7743694|NCT01533493|19065840|P2|STARTED|Overall Study||14
7743695|NCT01533493|19065841|P1|STARTED|Overall Study||12
7743696|NCT01533428|19065849|P2|NOT COMPLETED|Overall Study||8
7743697|NCT01533428|19065850|P1|NOT COMPLETED|Overall Study||9
7743698|NCT01533428|19065849|P2|COMPLETED|Overall Study||175
7743699|NCT01533428|19065850|P1|COMPLETED|Overall Study||177
7743700|NCT01533428|19065849|P2|STARTED|Overall Study||183
7743701|NCT01533428|19065850|P1|STARTED|Overall Study||186
7743702|NCT01533259|19065890|P1|NOT COMPLETED|Overall Study||0
7743703|NCT01533259|19065890|P1|COMPLETED|Overall Study||48
7743704|NCT01533259|19065890|P1|STARTED|Overall Study||48
7743705|NCT01533246|19065896|P1|NOT COMPLETED|Overall Study||2
7743706|NCT01533246|19065896|P1|COMPLETED|Overall Study||15
7743707|NCT01533246|19065896|P1|STARTED|Overall Study||17
7743708|NCT01533207|19065907|P2|NOT COMPLETED|Overall Study||0
7743709|NCT01533207|19065908|P1|NOT COMPLETED|Overall Study||0
7743710|NCT01533207|19065907|P2|COMPLETED|Overall Study||18
7743711|NCT01533207|19065908|P1|COMPLETED|Overall Study||20
7743712|NCT01533207|19065907|P2|STARTED|Overall Study||18
7743713|NCT01533207|19065908|P1|STARTED|Overall Study||20
7743714|NCT01533181|19065920|P2|NOT COMPLETED|Overall Study||1
7743715|NCT01533181|19065921|P1|NOT COMPLETED|Overall Study||1
7743716|NCT01533181|19065920|P2|COMPLETED|Overall Study||28
7743717|NCT01533181|19065921|P1|COMPLETED|Overall Study||14
7743718|NCT01533181|19065920|P2|STARTED|Overall Study||29
7743719|NCT01533181|19065921|P1|STARTED|Overall Study||15
7743720|NCT01533116|19065937|P4|NOT COMPLETED|Overall Study||0
7743721|NCT01533116|19065938|P3|NOT COMPLETED|Overall Study||1
7743722|NCT01533116|19065939|P2|NOT COMPLETED|Overall Study||1
7743723|NCT01533116|19065940|P1|NOT COMPLETED|Overall Study||2
7743724|NCT01533116|19065937|P4|COMPLETED|Overall Study||12
7743725|NCT01533116|19065938|P3|COMPLETED|Overall Study||12
7743726|NCT01533116|19065939|P2|COMPLETED|Overall Study||12
7743727|NCT01533116|19065940|P1|COMPLETED|Overall Study||12
7743728|NCT01533116|19065937|P4|STARTED|Overall Study||12
7743729|NCT01533116|19065938|P3|STARTED|Overall Study||13
7743730|NCT01533116|19065939|P2|STARTED|Overall Study||13
7743731|NCT01533116|19065940|P1|STARTED|Overall Study||14
7743732|NCT01533077|19065970|P4|NOT COMPLETED|Overall Study||0
7743733|NCT01533077|19065971|P3|NOT COMPLETED|Overall Study||0
7743734|NCT01533077|19065972|P2|NOT COMPLETED|Overall Study||1
7743735|NCT01533077|19065973|P1|NOT COMPLETED|Overall Study||1
7743736|NCT01533077|19065970|P4|COMPLETED|Overall Study||4
7743737|NCT01533077|19065971|P3|COMPLETED|Overall Study||4
7743738|NCT01533077|19065972|P2|COMPLETED|Overall Study||4
7743739|NCT01533077|19065973|P1|COMPLETED|Overall Study||4
7743740|NCT01533077|19065970|P4|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
7743741|NCT01533077|19065971|P3|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
7743742|NCT01533077|19065972|P2|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
7743743|NCT01533077|19065973|P1|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
7743744|NCT01533077|19065970|P4|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
7743745|NCT01533077|19065971|P3|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
7743746|NCT01533077|19065972|P2|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
7743747|NCT01533077|19065973|P1|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
7743748|NCT01533077|19065970|P4|Sinemet® 100/25|Overall Study||4
7743749|NCT01533077|19065971|P3|Sinemet® 100/25|Overall Study||4
7743750|NCT01533077|19065972|P2|Sinemet® 100/25|Overall Study||5
7743751|NCT01533077|19065973|P1|Sinemet® 100/25|Overall Study||4
7743752|NCT01533077|19065970|P4|BIA 9-1067 50 mg|Overall Study||4
7743753|NCT01533077|19065971|P3|BIA 9-1067 50 mg|Overall Study||4
7743754|NCT01533077|19065972|P2|BIA 9-1067 50 mg|Overall Study||5
7743755|NCT01533077|19065973|P1|BIA 9-1067 50 mg|Overall Study||5
7743756|NCT01533077|19065970|P4|STARTED|Overall Study||4
7743757|NCT01533077|19065971|P3|STARTED|Overall Study||4
7743758|NCT01533077|19065972|P2|STARTED|Overall Study||5
7743759|NCT01533077|19065973|P1|STARTED|Overall Study||5
7743760|NCT01533038|19066029|P2|NOT COMPLETED|Overall Study||1
7743761|NCT01533038|19066030|P1|NOT COMPLETED|Overall Study||0
7743762|NCT01533038|19066029|P2|COMPLETED|Overall Study||34
7743763|NCT01533038|19066030|P1|COMPLETED|Overall Study||45
7743764|NCT01533038|19066029|P2|STARTED|Overall Study||35
7743765|NCT01533038|19066030|P1|STARTED|Overall Study||45
7743766|NCT01532999|19066038|P2|NOT COMPLETED|Overall Study||18
7743767|NCT01532999|19066039|P1|NOT COMPLETED|Overall Study||31
7743768|NCT01532999|19066038|P2|COMPLETED|Overall Study||77
7743769|NCT01532999|19066039|P1|COMPLETED|Overall Study||65
7743770|NCT01532999|19066038|P2|STARTED|Overall Study||95
7743771|NCT01532999|19066039|P1|STARTED|Overall Study||96
7743772|NCT01532986|19066063|P2|NOT COMPLETED|Overall Study||24
7743773|NCT01532986|19066064|P1|NOT COMPLETED|Overall Study||23
7743774|NCT01532986|19066063|P2|COMPLETED|Overall Study||138
7743775|NCT01532986|19066064|P1|COMPLETED|Overall Study||143
7743776|NCT01532986|19066063|P2|STARTED|Overall Study||162
7743777|NCT01532986|19066064|P1|STARTED|Overall Study||166
7743778|NCT01532973|19066097|P10|NOT COMPLETED|Part 3||0
7743779|NCT01532973|19066098|P9|NOT COMPLETED|Part 3||0
7743780|NCT01532973|19066099|P8|NOT COMPLETED|Part 3||0
7743781|NCT01532973|19066100|P7|NOT COMPLETED|Part 3||0
7743782|NCT01532973|19066101|P6|NOT COMPLETED|Part 3||0
7743783|NCT01532973|19066102|P5|NOT COMPLETED|Part 3||0
7743784|NCT01532973|19066103|P4|NOT COMPLETED|Part 3||0
7743785|NCT01532973|19066104|P3|NOT COMPLETED|Part 3||0
7743786|NCT01532973|19066105|P2|NOT COMPLETED|Part 3||0
7743787|NCT01532973|19066106|P1|NOT COMPLETED|Part 3||0
7743788|NCT01532973|19066097|P10|COMPLETED|Part 3||6
7743789|NCT01532973|19066098|P9|COMPLETED|Part 3||6
7743790|NCT01532973|19066099|P8|COMPLETED|Part 3||0
7743791|NCT01532973|19066100|P7|COMPLETED|Part 3||0
7743792|NCT01532973|19066101|P6|COMPLETED|Part 3||0
7743793|NCT01532973|19066102|P5|COMPLETED|Part 3||0
7743794|NCT01532973|19066103|P4|COMPLETED|Part 3||0
7743795|NCT01532973|19066104|P3|COMPLETED|Part 3||0
7743796|NCT01532973|19066105|P2|COMPLETED|Part 3||0
7743797|NCT01532973|19066106|P1|COMPLETED|Part 3||0
7743798|NCT01532973|19066097|P10|STARTED|Part 3||6
7743799|NCT01532973|19066098|P9|STARTED|Part 3||6
7743800|NCT01532973|19066099|P8|STARTED|Part 3||0
7743801|NCT01532973|19066100|P7|STARTED|Part 3||0
7743802|NCT01532973|19066101|P6|STARTED|Part 3||0
7743803|NCT01532973|19066102|P5|STARTED|Part 3||0
7743804|NCT01532973|19066103|P4|STARTED|Part 3||0
7743805|NCT01532973|19066104|P3|STARTED|Part 3||0
7743806|NCT01532973|19066105|P2|STARTED|Part 3||0
7743807|NCT01532973|19066106|P1|STARTED|Part 3||0
7743808|NCT01532973|19066097|P10|NOT COMPLETED|Part 2||0
7743809|NCT01532973|19066098|P9|NOT COMPLETED|Part 2||0
7743810|NCT01532973|19066099|P8|NOT COMPLETED|Part 2||0
7743811|NCT01532973|19066100|P7|NOT COMPLETED|Part 2||0
7743812|NCT01532973|19066101|P6|NOT COMPLETED|Part 2||0
7743813|NCT01532973|19066102|P5|NOT COMPLETED|Part 2||0
7743814|NCT01532973|19066103|P4|NOT COMPLETED|Part 2||0
7743815|NCT01532973|19066104|P3|NOT COMPLETED|Part 2||0
7743816|NCT01532973|19066105|P2|NOT COMPLETED|Part 2||0
7743817|NCT01532973|19066106|P1|NOT COMPLETED|Part 2||0
7743818|NCT01532973|19066097|P10|COMPLETED|Part 2||0
7743819|NCT01532973|19066098|P9|COMPLETED|Part 2||0
7743820|NCT01532973|19066099|P8|COMPLETED|Part 2||0
7743821|NCT01532973|19066100|P7|COMPLETED|Part 2||6
7743822|NCT01532973|19066101|P6|COMPLETED|Part 2||6
7743823|NCT01532973|19066102|P5|COMPLETED|Part 2||6
7743824|NCT01532973|19066103|P4|COMPLETED|Part 2||0
7743825|NCT01532973|19066104|P3|COMPLETED|Part 2||0
7743826|NCT01532973|19066105|P2|COMPLETED|Part 2||0
7743827|NCT01532973|19066106|P1|COMPLETED|Part 2||0
7743828|NCT01532973|19066097|P10|STARTED|Part 2||0
7743829|NCT01532973|19066098|P9|STARTED|Part 2||0
7743830|NCT01532973|19066099|P8|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0
7743831|NCT01532973|19066100|P7|STARTED|Part 2||6
7743832|NCT01532973|19066101|P6|STARTED|Part 2||6
7743833|NCT01532973|19066102|P5|STARTED|Part 2||6
7743834|NCT01532973|19066103|P4|STARTED|Part 2||0
7743835|NCT01532973|19066104|P3|STARTED|Part 2||0
7743836|NCT01532973|19066105|P2|STARTED|Part 2||0
7743837|NCT01532973|19066106|P1|STARTED|Part 2||0
7743838|NCT01532973|19066097|P10|NOT COMPLETED|Part 1||0
7743839|NCT01532973|19066098|P9|NOT COMPLETED|Part 1||0
7743840|NCT01532973|19066099|P8|NOT COMPLETED|Part 1||0
7743841|NCT01532973|19066100|P7|NOT COMPLETED|Part 1||0
7743842|NCT01532973|19066101|P6|NOT COMPLETED|Part 1||0
7743843|NCT01532973|19066102|P5|NOT COMPLETED|Part 1||0
7743844|NCT01532973|19066103|P4|NOT COMPLETED|Part 1||0
7743845|NCT01532973|19066104|P3|NOT COMPLETED|Part 1||0
7743846|NCT01532973|19066105|P2|NOT COMPLETED|Part 1||0
7743847|NCT01532973|19066106|P1|NOT COMPLETED|Part 1||0
7743848|NCT01532973|19066097|P10|COMPLETED|Part 1||0
7743849|NCT01532973|19066098|P9|COMPLETED|Part 1||0
7743850|NCT01532973|19066099|P8|COMPLETED|Part 1||0
7743851|NCT01532973|19066100|P7|COMPLETED|Part 1||0
7743852|NCT01532973|19066101|P6|COMPLETED|Part 1||0
7743853|NCT01532973|19066102|P5|COMPLETED|Part 1||0
7743854|NCT01532973|19066103|P4|COMPLETED|Part 1||0
7743855|NCT01532973|19066104|P3|COMPLETED|Part 1||6
7743856|NCT01532973|19066105|P2|COMPLETED|Part 1||6
7743857|NCT01532973|19066106|P1|COMPLETED|Part 1||6
7743858|NCT01532973|19066097|P10|STARTED|Part 1||0
7743859|NCT01532973|19066098|P9|STARTED|Part 1||0
7743860|NCT01532973|19066099|P8|STARTED|Part 1||0
7743861|NCT01532973|19066100|P7|STARTED|Part 1||0
7743862|NCT01532973|19066101|P6|STARTED|Part 1||0
7743863|NCT01532973|19066102|P5|STARTED|Part 1||0
7743864|NCT01532973|19066103|P4|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0
7743865|NCT01532973|19066104|P3|STARTED|Part 1||6
7743866|NCT01532973|19066105|P2|STARTED|Part 1||6
7743867|NCT01532973|19066106|P1|STARTED|Part 1||6
7743868|NCT01532934|19066148|P2|NOT COMPLETED|Overall Study||13
7743869|NCT01532934|19066149|P1|NOT COMPLETED|Overall Study||14
7743870|NCT01532934|19066148|P2|COMPLETED|Overall Study||39
7743871|NCT01532934|19066149|P1|COMPLETED|Overall Study||39
7743872|NCT01532934|19066148|P2|STARTED|Overall Study||52
7743873|NCT01532934|19066149|P1|STARTED|Overall Study||53
7743874|NCT01532921|19066159|P1|NOT COMPLETED|Overall Study||16
7743875|NCT01532921|19066159|P1|COMPLETED|Overall Study||69
7743876|NCT01532921|19066159|P1|6 Months Follow Up|Overall Study||68
7743877|NCT01532921|19066159|P1|Discharge|Overall Study||75
7743878|NCT01532921|19066159|P1|Implantation Procedure|Overall Study||76
7743879|NCT01532921|19066159|P1|STARTED|Overall Study||85
7743880|NCT01532869|19066181|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3
7743881|NCT01532869|19066182|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7
7743882|NCT01532869|19066181|P2|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27
7743883|NCT01532869|19066182|P1|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24
7743884|NCT01532869|19066181|P2|STARTED|Open-label Period (Week 48 to Week 96)||30
7743885|NCT01532869|19066182|P1|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31
7743886|NCT01532869|19066181|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13
7743887|NCT01532869|19066182|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11
7743888|NCT01532869|19066181|P2|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30
7743889|NCT01532869|19066182|P1|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33
7743890|NCT01532869|19066181|P2|STARTED|Blinded-Treatment Period (Up to Week 48)||43
7743891|NCT01532869|19066182|P1|STARTED|Blinded-Treatment Period (Up to Week 48)||44
7743892|NCT01532869|19066181|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
7743893|NCT01532869|19066182|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
7743894|NCT01532869|19066181|P2|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35
7743895|NCT01532869|19066182|P1|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36
7743896|NCT01532869|19066181|P2|STARTED|Blinded-Treatment Period (Up to Week 24)||43
7743897|NCT01532869|19066182|P1|STARTED|Blinded-Treatment Period (Up to Week 24)||44
7743898|NCT01532830|19066219|P1|NOT COMPLETED|Overall Study||4
7743899|NCT01532830|19066219|P1|COMPLETED|Overall Study||26
7743900|NCT01532830|19066219|P1|STARTED|Overall Study||30
7743901|NCT01532817|19066228|P1|NOT COMPLETED|Overall Study||0
7743902|NCT01532817|19066228|P1|COMPLETED|Overall Study||30
7743903|NCT01532817|19066228|P1|STARTED|Overall Study||30
7743904|NCT01532700|19066232|P1|NOT COMPLETED|Overall Study||0
7743905|NCT01532700|19066232|P1|COMPLETED|Overall Study||28
7743906|NCT01532700|19066232|P1|STARTED|Overall Study||28
7743907|NCT01532648|19066241|P2|NOT COMPLETED|Overall Study||17
7743908|NCT01532648|19066242|P1|NOT COMPLETED|Overall Study||36
7743909|NCT01532648|19066241|P2|COMPLETED|Overall Study||238
7743910|NCT01532648|19066242|P1|COMPLETED|Overall Study||219
7743911|NCT01532648|19066241|P2|Intent-To-Treat Population|Overall Study||228
7743912|NCT01532648|19066242|P1|Intent-To-Treat Population|Overall Study||230
7743913|NCT01532648|19066241|P2|Safety Population|Overall Study||255
7743914|NCT01532648|19066242|P1|Safety Population|Overall Study||255
7743915|NCT01532648|19066241|P2|STARTED|Overall Study||255
7743916|NCT01532648|19066242|P1|STARTED|Overall Study||255
7743917|NCT01532635|19066260|P1|NOT COMPLETED|Overall Study||0
7743918|NCT01532635|19066260|P1|COMPLETED|Overall Study||4
7743919|NCT01532635|19066260|P1|STARTED|Overall Study||4
7743920|NCT01532570|19066276|P4|NOT COMPLETED|Overall Study||0
7743921|NCT01532570|19066277|P3|NOT COMPLETED|Overall Study||0
7743922|NCT01532570|19066278|P2|NOT COMPLETED|Overall Study||1
7743923|NCT01532570|19066279|P1|NOT COMPLETED|Overall Study||1
7743924|NCT01532570|19066276|P4|COMPLETED|Overall Study||4
7743925|NCT01532570|19066277|P3|COMPLETED|Overall Study||1
7743926|NCT01532570|19066278|P2|COMPLETED|Overall Study||1
7743927|NCT01532570|19066279|P1|COMPLETED|Overall Study||10
7743928|NCT01532570|19066276|P4|STARTED|Overall Study||4
7743929|NCT01532570|19066277|P3|STARTED|Overall Study||1
7743930|NCT01532570|19066278|P2|STARTED|Overall Study||2
7743931|NCT01532570|19066279|P1|STARTED|Overall Study||11
7743932|NCT01532453|19066312|P2|NOT COMPLETED|Overall Study||70
7743933|NCT01532453|19066313|P1|NOT COMPLETED|Overall Study||27
7743934|NCT01532453|19066312|P2|COMPLETED|Overall Study||90
7743935|NCT01532453|19066313|P1|COMPLETED|Overall Study||54
7743936|NCT01532453|19066312|P2|STARTED|Overall Study||160
7743937|NCT01532453|19066313|P1|STARTED|Overall Study||81
7743938|NCT01532414|19066324|P3|NOT COMPLETED|Overall Study||3
7743939|NCT01532414|19066325|P2|NOT COMPLETED|Overall Study||2
7743940|NCT01532414|19066326|P1|NOT COMPLETED|Overall Study||7
7743941|NCT01532414|19066324|P3|COMPLETED|Overall Study||35
7743942|NCT01532414|19066325|P2|COMPLETED|Overall Study||19
7743943|NCT01532414|19066326|P1|COMPLETED|Overall Study||85
7743944|NCT01532414|19066324|P3|STARTED|Overall Study||38
7743945|NCT01532414|19066325|P2|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21
7743946|NCT01532414|19066326|P1|STARTED|Overall Study||92
7743947|NCT01532388|19066336|P2|NOT COMPLETED|12-month Follow-up||67
7743948|NCT01532388|19066337|P1|NOT COMPLETED|12-month Follow-up||69
7743949|NCT01532388|19066336|P2|COMPLETED|12-month Follow-up||34
7743950|NCT01532388|19066337|P1|COMPLETED|12-month Follow-up||32
7743951|NCT01532388|19066336|P2|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
7743952|NCT01532388|19066337|P1|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
7743953|NCT01532388|19066336|P2|NOT COMPLETED|6-month Follow-up||66
7743954|NCT01532388|19066337|P1|NOT COMPLETED|6-month Follow-up||74
7743955|NCT01532388|19066336|P2|COMPLETED|6-month Follow-up||35
7743956|NCT01532388|19066337|P1|COMPLETED|6-month Follow-up||27
7743957|NCT01532388|19066336|P2|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
7743958|NCT01532388|19066337|P1|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
7743959|NCT01532388|19066336|P2|NOT COMPLETED|3-month Follow-up||68
7743960|NCT01532388|19066337|P1|NOT COMPLETED|3-month Follow-up||68
7743961|NCT01532388|19066336|P2|COMPLETED|3-month Follow-up||33
7743962|NCT01532388|19066337|P1|COMPLETED|3-month Follow-up||33
7743963|NCT01532388|19066336|P2|STARTED|3-month Follow-up||101
7743964|NCT01532388|19066337|P1|STARTED|3-month Follow-up||101
7743965|NCT01532362|19066367|P2|NOT COMPLETED|Overall Study||0
7743966|NCT01532362|19066368|P1|NOT COMPLETED|Overall Study||0
7743967|NCT01532362|19066367|P2|COMPLETED|Overall Study||0
7743968|NCT01532362|19066368|P1|COMPLETED|Overall Study||1
7743969|NCT01532362|19066367|P2|STARTED|Overall Study||0
7743970|NCT01532362|19066368|P1|STARTED|Overall Study||1
7743971|NCT01532349|19066378|P2|NOT COMPLETED|Overall Study||5
7743972|NCT01532349|19066379|P1|NOT COMPLETED|Overall Study||2
7743973|NCT01532349|19066378|P2|COMPLETED|Overall Study||12
7743974|NCT01532349|19066379|P1|COMPLETED|Overall Study||15
7743975|NCT01532349|19066378|P2|STARTED|Overall Study||17
7743976|NCT01532349|19066379|P1|STARTED|Overall Study||17
7743977|NCT01532141|19066388|P3|NOT COMPLETED|Overall Study||0
7743978|NCT01532141|19066389|P2|NOT COMPLETED|Overall Study||0
7743979|NCT01532141|19066390|P1|NOT COMPLETED|Overall Study||1
7743980|NCT01532141|19066388|P3|COMPLETED|Overall Study||8
7743981|NCT01532141|19066389|P2|COMPLETED|Overall Study||8
7743982|NCT01532141|19066390|P1|COMPLETED|Overall Study||8
7743983|NCT01532141|19066388|P3|Period 3|Overall Study||8
7743984|NCT01532141|19066389|P2|Period 3|Overall Study||8
7743985|NCT01532141|19066390|P1|Period 3|Overall Study||8
7743986|NCT01532141|19066388|P3|Period 2|Overall Study||8
7743987|NCT01532141|19066389|P2|Period 2|Overall Study||8
7743988|NCT01532141|19066390|P1|Period 2|Overall Study||8
7743989|NCT01532141|19066388|P3|Period 1|Overall Study||8
7743990|NCT01532141|19066389|P2|Period 1|Overall Study||8
7743991|NCT01532141|19066390|P1|Period 1|Overall Study||9
7743992|NCT01532141|19066388|P3|STARTED|Overall Study||8
7743993|NCT01532141|19066389|P2|STARTED|Overall Study||8
7743994|NCT01532141|19066390|P1|STARTED|Overall Study||9
7743995|NCT01532128|19066408|P3|NOT COMPLETED|Overall Study||0
7743996|NCT01532128|19066409|P2|NOT COMPLETED|Overall Study||0
7743997|NCT01532128|19066410|P1|NOT COMPLETED|Overall Study||0
7743998|NCT01532128|19066408|P3|COMPLETED|Overall Study||8
7743999|NCT01532128|19066409|P2|COMPLETED|Overall Study||8
7744000|NCT01532128|19066410|P1|COMPLETED|Overall Study||8
7744001|NCT01532128|19066408|P3|STARTED|Overall Study||8
7744002|NCT01532128|19066409|P2|STARTED|Overall Study||8
7744003|NCT01532128|19066410|P1|STARTED|Overall Study||8
7744004|NCT01532089|19066427|P2|NOT COMPLETED|Overall Study||0
7744005|NCT01532089|19066428|P1|NOT COMPLETED|Overall Study||0
7744006|NCT01532089|19066427|P2|COMPLETED|Overall Study||43
7744007|NCT01532089|19066428|P1|COMPLETED|Overall Study||45
7744008|NCT01532089|19066427|P2|STARTED|Overall Study||43
7744009|NCT01532089|19066428|P1|STARTED|Overall Study||45
7744010|NCT01531998|19066442|P1|NOT COMPLETED|Overall Study||3
7744011|NCT01531998|19066442|P1|COMPLETED|Overall Study||8
7744012|NCT01531998|19066442|P1|STARTED|Overall Study||11
7744013|NCT01531959|19066449|P2|NOT COMPLETED|Overall Study||2
7744014|NCT01531959|19066450|P1|NOT COMPLETED|Overall Study||2
7744015|NCT01531959|19066449|P2|COMPLETED|Overall Study||66
7744016|NCT01531959|19066450|P1|COMPLETED|Overall Study||66
7744017|NCT01531959|19066449|P2|STARTED|Overall Study||68
7744018|NCT01531959|19066450|P1|STARTED|Overall Study||68
7744019|NCT01531894|19066464|P1|NOT COMPLETED|Overall Study||9
7744020|NCT01531894|19066464|P1|COMPLETED|Overall Study||2
7744021|NCT01531894|19066464|P1|STARTED|Overall Study||11
7744022|NCT01531738|19066470|P2|NOT COMPLETED|Overall Study||0
7744023|NCT01531738|19066471|P1|NOT COMPLETED|Overall Study||0
7744024|NCT01531738|19066470|P2|COMPLETED|Overall Study||11
7744025|NCT01531738|19066471|P1|COMPLETED|Overall Study||11
7744026|NCT01531738|19066470|P2|STARTED|Overall Study||11
7744027|NCT01531738|19066471|P1|STARTED|Overall Study||11
7744028|NCT01531725|19066481|P1|NOT COMPLETED|Overall Study||5
7744029|NCT01531725|19066481|P1|COMPLETED|Overall Study||197
7744030|NCT01531725|19066481|P1|STARTED|Overall Study|5 patients with protocol violation were excluded.|202
7744031|NCT01531673|19066499|P13|NOT COMPLETED|Overall Study||0
7744032|NCT01531673|19066500|P12|NOT COMPLETED|Overall Study||0
7744033|NCT01531673|19066501|P11|NOT COMPLETED|Overall Study||0
7744034|NCT01531673|19066502|P10|NOT COMPLETED|Overall Study||1
7744035|NCT01531673|19066503|P9|NOT COMPLETED|Overall Study||0
7744036|NCT01531673|19066504|P8|NOT COMPLETED|Overall Study||0
7744037|NCT01531673|19066505|P7|NOT COMPLETED|Overall Study||0
7744038|NCT01531673|19066506|P6|NOT COMPLETED|Overall Study||1
7744039|NCT01531673|19066507|P5|NOT COMPLETED|Overall Study||1
7744040|NCT01531673|19066508|P4|NOT COMPLETED|Overall Study||1
7744041|NCT01531673|19066509|P3|NOT COMPLETED|Overall Study||0
7744042|NCT01531673|19066510|P2|NOT COMPLETED|Overall Study||1
7744043|NCT01531673|19066511|P1|NOT COMPLETED|Overall Study||0
7744044|NCT01531673|19066499|P13|COMPLETED|Overall Study||14
7744045|NCT01531673|19066500|P12|COMPLETED|Overall Study||4
7744046|NCT01531673|19066501|P11|COMPLETED|Overall Study||16
7744047|NCT01531673|19066502|P10|COMPLETED|Overall Study||18
7744048|NCT01531673|19066503|P9|COMPLETED|Overall Study||17
7744049|NCT01531673|19066504|P8|COMPLETED|Overall Study||9
7744050|NCT01531673|19066505|P7|COMPLETED|Overall Study||17
7744051|NCT01531673|19066506|P6|COMPLETED|Overall Study||18
7744052|NCT01531673|19066507|P5|COMPLETED|Overall Study||7
7744053|NCT01531673|19066508|P4|COMPLETED|Overall Study||17
7744054|NCT01531673|19066509|P3|COMPLETED|Overall Study||8
7744055|NCT01531673|19066510|P2|COMPLETED|Overall Study||7
7744056|NCT01531673|19066511|P1|COMPLETED|Overall Study||33
7744057|NCT01531673|19066499|P13|STARTED|Overall Study||14
7744058|NCT01531673|19066500|P12|STARTED|Overall Study||4
7744059|NCT01531673|19066501|P11|STARTED|Overall Study||16
7744060|NCT01531673|19066502|P10|STARTED|Overall Study||19
7744061|NCT01531673|19066503|P9|STARTED|Overall Study||17
7744062|NCT01531673|19066504|P8|STARTED|Overall Study||9
7744063|NCT01531673|19066505|P7|STARTED|Overall Study||17
7744064|NCT01531673|19066506|P6|STARTED|Overall Study||19
7744065|NCT01531673|19066507|P5|STARTED|Overall Study||8
7744066|NCT01531673|19066508|P4|STARTED|Overall Study||18
7744067|NCT01531673|19066509|P3|STARTED|Overall Study||8
7744068|NCT01531673|19066510|P2|STARTED|Overall Study||8
7744069|NCT01531673|19066511|P1|STARTED|Overall Study||33
7744070|NCT01531439|19066622|P2|NOT COMPLETED|Overall Study||1
7744071|NCT01531439|19066623|P1|NOT COMPLETED|Overall Study||4
7744072|NCT01531439|19066622|P2|COMPLETED|Overall Study||42
7744073|NCT01531439|19066623|P1|COMPLETED|Overall Study||37
7744074|NCT01531439|19066622|P2|STARTED|Overall Study||43
7744075|NCT01531439|19066623|P1|STARTED|Overall Study||41
7744076|NCT01531387|19066637|P2|NOT COMPLETED|Overall Study||11
7744077|NCT01531387|19066638|P1|NOT COMPLETED|Overall Study||11
7744078|NCT01531387|19066637|P2|COMPLETED|Overall Study||0
7744079|NCT01531387|19066638|P1|COMPLETED|Overall Study||0
7744080|NCT01531387|19066637|P2|STARTED|Overall Study||11
7744081|NCT01531387|19066638|P1|STARTED|Overall Study||11
7744082|NCT01531374|19066655|P3|NOT COMPLETED|Overall Study||283
7744083|NCT01531374|19066656|P2|NOT COMPLETED|Overall Study||142
7744084|NCT01531374|19066657|P1|NOT COMPLETED|Overall Study||364
7744085|NCT01531374|19066655|P3|COMPLETED|Overall Study||836
7744086|NCT01531374|19066656|P2|COMPLETED|Overall Study||231
7744087|NCT01531374|19066657|P1|COMPLETED|Overall Study||921
7744088|NCT01531374|19066655|P3|STARTED|Overall Study||1119
7744089|NCT01531374|19066656|P2|STARTED|Overall Study||373
7744090|NCT01531374|19066657|P1|STARTED|Overall Study||1285
7744091|NCT01531335|19066721|P2|NOT COMPLETED|Overall Study||0
7744092|NCT01531335|19066722|P1|NOT COMPLETED|Overall Study||0
7744093|NCT01531335|19066721|P2|COMPLETED|Overall Study||40
7744094|NCT01531335|19066722|P1|COMPLETED|Overall Study||40
7744095|NCT01531335|19066721|P2|STARTED|Overall Study||40
7744096|NCT01531335|19066722|P1|STARTED|Overall Study||40
7744097|NCT01531205|19066730|P1|NOT COMPLETED|Overall Study||1
7744098|NCT01531205|19066730|P1|COMPLETED|Overall Study||1
7744099|NCT01531205|19066730|P1|STARTED|Overall Study||2
7744100|NCT01531153|19066742|P3|NOT COMPLETED|Overall Study||15
7744101|NCT01531153|19066743|P2|NOT COMPLETED|Overall Study||9
7744102|NCT01531153|19066744|P1|NOT COMPLETED|Overall Study||10
7744103|NCT01531153|19066742|P3|COMPLETED|Overall Study||15
7744104|NCT01531153|19066743|P2|COMPLETED|Overall Study||22
7744105|NCT01531153|19066744|P1|COMPLETED|Overall Study||22
7744106|NCT01531153|19066742|P3|STARTED|Overall Study||30
7744107|NCT01531153|19066743|P2|STARTED|Overall Study||31
7744108|NCT01531153|19066744|P1|STARTED|Overall Study||32
7744109|NCT01530997|19066800|P1|NOT COMPLETED|Overall Study||2
7744110|NCT01530997|19066800|P1|COMPLETED|Overall Study||43
7744111|NCT01530997|19066800|P1|STARTED|Overall Study||45
7744112|NCT01530880|19066820|P1|NOT COMPLETED|Overall Study||0
7744113|NCT01530880|19066820|P1|COMPLETED|Overall Study||35
7744114|NCT01530880|19066820|P1|STARTED|Overall Study||35
7744115|NCT01530477|19066834|P3|NOT COMPLETED|Overall Study||0
7744116|NCT01530477|19066835|P2|NOT COMPLETED|Overall Study||0
7744117|NCT01530477|19066836|P1|NOT COMPLETED|Overall Study||0
7744118|NCT01530477|19066834|P3|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53
7744119|NCT01530477|19066835|P2|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12
7744120|NCT01530477|19066836|P1|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17
7744121|NCT01530477|19066834|P3|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53
7744122|NCT01530477|19066835|P2|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12
7744123|NCT01530477|19066836|P1|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17
7744124|NCT01530464|19066844|P2|NOT COMPLETED|Washout (24h)||1
7744125|NCT01530464|19066845|P1|NOT COMPLETED|Washout (24h)||0
7744126|NCT01530464|19066844|P2|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7
7744127|NCT01530464|19066845|P1|COMPLETED|Washout (24h)||9
7744128|NCT01530464|19066844|P2|STARTED|Washout (24h)||8
7744129|NCT01530464|19066845|P1|STARTED|Washout (24h)||9
7744130|NCT01530464|19066844|P2|NOT COMPLETED|Third Intervention (24h)||0
7744131|NCT01530464|19066845|P1|NOT COMPLETED|Third Intervention (24h)||0
7744132|NCT01530464|19066844|P2|COMPLETED|Third Intervention (24h)||8
7744133|NCT01530464|19066845|P1|COMPLETED|Third Intervention (24h)||9
7744134|NCT01530464|19066844|P2|STARTED|Third Intervention (24h)||8
7744135|NCT01530464|19066845|P1|STARTED|Third Intervention (24h)||9
7744136|NCT01530464|19066844|P2|NOT COMPLETED|Washout (24h)||0
7744137|NCT01530464|19066845|P1|NOT COMPLETED|Washout (24h)||1
7744138|NCT01530464|19066844|P2|COMPLETED|Washout (24h)||8
7744139|NCT01530464|19066845|P1|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9
7744140|NCT01530464|19066844|P2|STARTED|Washout (24h)||8
7744141|NCT01530464|19066845|P1|STARTED|Washout (24h)||10
7744142|NCT01530464|19066844|P2|NOT COMPLETED|Second Intervention (24h)||0
7744143|NCT01530464|19066845|P1|NOT COMPLETED|Second Intervention (24h)||0
7744144|NCT01530464|19066844|P2|COMPLETED|Second Intervention (24h)||8
7744145|NCT01530464|19066845|P1|COMPLETED|Second Intervention (24h)||10
7744146|NCT01530464|19066844|P2|STARTED|Second Intervention (24h)||8
7744147|NCT01530464|19066845|P1|STARTED|Second Intervention (24h)||10
7744148|NCT01530464|19066844|P2|NOT COMPLETED|Washout (24h)||0
7744149|NCT01530464|19066845|P1|NOT COMPLETED|Washout (24h)||0
7744150|NCT01530464|19066844|P2|COMPLETED|Washout (24h)||8
7744151|NCT01530464|19066845|P1|COMPLETED|Washout (24h)||10
7744152|NCT01530464|19066844|P2|STARTED|Washout (24h)||8
7744153|NCT01530464|19066845|P1|STARTED|Washout (24h)||10
7744154|NCT01530464|19066844|P2|NOT COMPLETED|First Intervention (24h)||0
7744155|NCT01530464|19066845|P1|NOT COMPLETED|First Intervention (24h)||0
7744156|NCT01530464|19066844|P2|COMPLETED|First Intervention (24h)||8
7744157|NCT01530464|19066845|P1|COMPLETED|First Intervention (24h)||10
7744158|NCT01530464|19066844|P2|STARTED|First Intervention (24h)||8
7744159|NCT01530464|19066845|P1|STARTED|First Intervention (24h)||10
7744160|NCT01530399|19066878|P6|NOT COMPLETED|Overall Study||1
7744161|NCT01530399|19066879|P5|NOT COMPLETED|Overall Study||0
7744162|NCT01530399|19066880|P4|NOT COMPLETED|Overall Study||0
7744163|NCT01530399|19066881|P3|NOT COMPLETED|Overall Study||1
7744164|NCT01530399|19066882|P2|NOT COMPLETED|Overall Study||2
7744165|NCT01530399|19066883|P1|NOT COMPLETED|Overall Study||1
7744166|NCT01530399|19066878|P6|COMPLETED|Overall Study||6
7744167|NCT01530399|19066879|P5|COMPLETED|Overall Study||6
7744168|NCT01530399|19066880|P4|COMPLETED|Overall Study||10
7744169|NCT01530399|19066881|P3|COMPLETED|Overall Study||7
7744170|NCT01530399|19066882|P2|COMPLETED|Overall Study||8
7744171|NCT01530399|19066883|P1|COMPLETED|Overall Study||7
7744172|NCT01530399|19066878|P6|STARTED|Overall Study||7
7744173|NCT01530399|19066879|P5|STARTED|Overall Study||6
7744174|NCT01530399|19066880|P4|STARTED|Overall Study||10
7744175|NCT01530399|19066881|P3|STARTED|Overall Study||8
7744176|NCT01530399|19066882|P2|STARTED|Overall Study||10
7744177|NCT01530399|19066883|P1|STARTED|Overall Study||8
7744178|NCT01530334|19066897|P1|NOT COMPLETED|Overall Study||51
7744179|NCT01530334|19066897|P1|COMPLETED|Overall Study||10
7744180|NCT01530334|19066897|P1|STARTED|Overall Study||61
7744181|NCT01530243|19066910|P4|NOT COMPLETED|Overall Study||2
7744182|NCT01530243|19066911|P3|NOT COMPLETED|Overall Study||3
7744183|NCT01530243|19066912|P2|NOT COMPLETED|Overall Study||3
7744184|NCT01530243|19066913|P1|NOT COMPLETED|Overall Study||2
7744185|NCT01530243|19066910|P4|COMPLETED|Overall Study||24
7744186|NCT01530243|19066911|P3|COMPLETED|Overall Study||23
7744187|NCT01530243|19066912|P2|COMPLETED|Overall Study||23
7744188|NCT01530243|19066913|P1|COMPLETED|Overall Study||24
7744189|NCT01530243|19066910|P4|STARTED|Overall Study||26
7744190|NCT01530243|19066911|P3|STARTED|Overall Study||26
7744191|NCT01530243|19066912|P2|STARTED|Overall Study||26
7744192|NCT01530243|19066913|P1|STARTED|Overall Study||26
7744193|NCT01530178|19066933|P2|NOT COMPLETED|Overall Study||0
7744194|NCT01530178|19066934|P1|NOT COMPLETED|Overall Study||0
7744195|NCT01530178|19066933|P2|COMPLETED|Overall Study||6
7744196|NCT01530178|19066934|P1|COMPLETED|Overall Study||2
7744197|NCT01530178|19066933|P2|STARTED|Overall Study||6
7744198|NCT01530178|19066934|P1|STARTED|Overall Study||2
7744199|NCT01530087|19066944|P1|NOT COMPLETED|Overall Study||2
7744200|NCT01530087|19066944|P1|COMPLETED|Overall Study||1
7744201|NCT01530087|19066944|P1|STARTED|Overall Study||3
7744202|NCT01529827|19066949|P1|NOT COMPLETED|Overall Study||0
7744203|NCT01529827|19066949|P1|COMPLETED|Overall Study||94
7744204|NCT01529827|19066949|P1|STARTED|Overall Study||94
7744205|NCT01529749|19066960|P4|NOT COMPLETED|Overall Study||2
7744206|NCT01529749|19066961|P3|NOT COMPLETED|Overall Study||2
7744207|NCT01529749|19066962|P2|NOT COMPLETED|Overall Study||2
7744208|NCT01529749|19066963|P1|NOT COMPLETED|Overall Study||0
7744209|NCT01529749|19066960|P4|COMPLETED|Overall Study||10
7744210|NCT01529749|19066961|P3|COMPLETED|Overall Study||10
7744211|NCT01529749|19066962|P2|COMPLETED|Overall Study||10
7744212|NCT01529749|19066963|P1|COMPLETED|Overall Study||12
7744213|NCT01529749|19066960|P4|STARTED|Overall Study||12
7744214|NCT01529749|19066961|P3|STARTED|Overall Study||12
7744215|NCT01529749|19066962|P2|STARTED|Overall Study||12
7744216|NCT01529749|19066963|P1|STARTED|Overall Study||12
7744217|NCT01529645|19067047|P10|NOT COMPLETED|Overall Study||0
7744218|NCT01529645|19067048|P9|NOT COMPLETED|Overall Study||1
7744219|NCT01529645|19067049|P8|NOT COMPLETED|Overall Study||0
7744220|NCT01529645|19067050|P7|NOT COMPLETED|Overall Study||2
7744221|NCT01529645|19067051|P6|NOT COMPLETED|Overall Study||1
7744222|NCT01529645|19067052|P5|NOT COMPLETED|Overall Study||2
7744223|NCT01529645|19067053|P4|NOT COMPLETED|Overall Study||2
7744224|NCT01529645|19067054|P3|NOT COMPLETED|Overall Study||2
7744225|NCT01529645|19067055|P2|NOT COMPLETED|Overall Study||1
7744226|NCT01529645|19067056|P1|NOT COMPLETED|Overall Study||2
7744227|NCT01529645|19067047|P10|COMPLETED|Overall Study||42
7744228|NCT01529645|19067048|P9|COMPLETED|Overall Study||41
7744229|NCT01529645|19067049|P8|COMPLETED|Overall Study||42
7744230|NCT01529645|19067050|P7|COMPLETED|Overall Study||40
7744231|NCT01529645|19067051|P6|COMPLETED|Overall Study||41
7744232|NCT01529645|19067052|P5|COMPLETED|Overall Study||40
7744233|NCT01529645|19067053|P4|COMPLETED|Overall Study||40
7744234|NCT01529645|19067054|P3|COMPLETED|Overall Study||40
7744235|NCT01529645|19067055|P2|COMPLETED|Overall Study||41
7744236|NCT01529645|19067056|P1|COMPLETED|Overall Study||40
7744237|NCT01529645|19067047|P10|STARTED|Overall Study||42
7744238|NCT01529645|19067048|P9|STARTED|Overall Study||42
7744239|NCT01529645|19067049|P8|STARTED|Overall Study||42
7744240|NCT01529645|19067050|P7|STARTED|Overall Study||42
7744241|NCT01529645|19067051|P6|STARTED|Overall Study||42
7744242|NCT01529645|19067052|P5|STARTED|Overall Study||42
7744243|NCT01529645|19067053|P4|STARTED|Overall Study||42
7744244|NCT01529645|19067054|P3|STARTED|Overall Study||42
7744245|NCT01529645|19067055|P2|STARTED|Overall Study||42
7744246|NCT01529645|19067056|P1|STARTED|Overall Study||42
7744247|NCT01529632|19067154|P2|NOT COMPLETED|Overall Study||3
7744248|NCT01529632|19067155|P1|NOT COMPLETED|Overall Study||3
7744249|NCT01529632|19067154|P2|COMPLETED|Overall Study||100
7744250|NCT01529632|19067155|P1|COMPLETED|Overall Study||87
7744251|NCT01529632|19067154|P2|STARTED|Overall Study||103
7744252|NCT01529632|19067155|P1|STARTED|Overall Study||90
7744253|NCT01529606|19067175|P2|NOT COMPLETED|Overall Study||18
7744254|NCT01529606|19067176|P1|NOT COMPLETED|Overall Study||21
7744255|NCT01529606|19067175|P2|COMPLETED|Overall Study||29
7744256|NCT01529606|19067176|P1|COMPLETED|Overall Study||34
7744257|NCT01529606|19067175|P2|STARTED|Overall Study||47
7744258|NCT01529606|19067176|P1|STARTED|Overall Study||55
7744259|NCT01529515|19067188|P4|NOT COMPLETED|DOUBLE BLIND PHASE||12
7744260|NCT01529515|19067189|P3|NOT COMPLETED|DOUBLE BLIND PHASE||23
7744261|NCT01529515|19067190|P2|NOT COMPLETED|DOUBLE BLIND PHASE||0
7744262|NCT01529515|19067191|P1|NOT COMPLETED|DOUBLE BLIND PHASE||0
7744263|NCT01529515|19067188|P4|COMPLETED|DOUBLE BLIND PHASE||148
7744264|NCT01529515|19067189|P3|COMPLETED|DOUBLE BLIND PHASE||122
7744265|NCT01529515|19067190|P2|COMPLETED|DOUBLE BLIND PHASE||0
7744266|NCT01529515|19067191|P1|COMPLETED|DOUBLE BLIND PHASE||0
7744267|NCT01529515|19067188|P4|STARTED|DOUBLE BLIND PHASE||160
7744268|NCT01529515|19067189|P3|STARTED|DOUBLE BLIND PHASE||145
7744269|NCT01529515|19067190|P2|STARTED|DOUBLE BLIND PHASE||0
7744270|NCT01529515|19067191|P1|STARTED|DOUBLE BLIND PHASE||0
7744271|NCT01529515|19067188|P4|NOT COMPLETED|MAINTENANCE PHASE||0
7744272|NCT01529515|19067189|P3|NOT COMPLETED|MAINTENANCE PHASE||0
7744273|NCT01529515|19067190|P2|NOT COMPLETED|MAINTENANCE PHASE||74
7744274|NCT01529515|19067191|P1|NOT COMPLETED|MAINTENANCE PHASE||0
7744275|NCT01529515|19067188|P4|COMPLETED|MAINTENANCE PHASE||0
7744276|NCT01529515|19067189|P3|COMPLETED|MAINTENANCE PHASE||0
7744277|NCT01529515|19067190|P2|COMPLETED|MAINTENANCE PHASE||305
7744278|NCT01529515|19067191|P1|COMPLETED|MAINTENANCE PHASE||0
7744279|NCT01529515|19067188|P4|STARTED|MAINTENANCE PHASE||0
7744280|NCT01529515|19067189|P3|STARTED|MAINTENANCE PHASE||0
7744281|NCT01529515|19067190|P2|STARTED|MAINTENANCE PHASE||379
7744282|NCT01529515|19067191|P1|STARTED|MAINTENANCE PHASE||0
7744283|NCT01529515|19067188|P4|NOT COMPLETED|TRANSITION PHASE||0
7744284|NCT01529515|19067189|P3|NOT COMPLETED|TRANSITION PHASE||0
7744285|NCT01529515|19067190|P2|NOT COMPLETED|TRANSITION PHASE||0
7744286|NCT01529515|19067191|P1|NOT COMPLETED|TRANSITION PHASE||127
7744287|NCT01529515|19067188|P4|COMPLETED|TRANSITION PHASE||0
7744288|NCT01529515|19067189|P3|COMPLETED|TRANSITION PHASE||0
7744289|NCT01529515|19067190|P2|COMPLETED|TRANSITION PHASE||0
7744290|NCT01529515|19067191|P1|COMPLETED|TRANSITION PHASE||379
7744291|NCT01529515|19067188|P4|STARTED|TRANSITION PHASE||0
7744292|NCT01529515|19067189|P3|STARTED|TRANSITION PHASE||0
7744293|NCT01529515|19067190|P2|STARTED|TRANSITION PHASE||0
7744294|NCT01529515|19067191|P1|STARTED|TRANSITION PHASE||506
7744295|NCT01529502|19067210|P6|NOT COMPLETED|Overall Study||0
7744296|NCT01529502|19067211|P5|NOT COMPLETED|Overall Study||0
7744297|NCT01529502|19067212|P4|NOT COMPLETED|Overall Study||2
7744298|NCT01529502|19067213|P3|NOT COMPLETED|Overall Study||0
7744299|NCT01529502|19067214|P2|NOT COMPLETED|Overall Study||0
7744300|NCT01529502|19067215|P1|NOT COMPLETED|Overall Study||0
7744301|NCT01529502|19067210|P6|COMPLETED|Overall Study||2
7744302|NCT01529502|19067211|P5|COMPLETED|Overall Study||2
7744303|NCT01529502|19067212|P4|COMPLETED|Overall Study||1
7744304|NCT01529502|19067213|P3|COMPLETED|Overall Study||2
7744305|NCT01529502|19067214|P2|COMPLETED|Overall Study||3
7744306|NCT01529502|19067215|P1|COMPLETED|Overall Study||2
7744307|NCT01529502|19067210|P6|STARTED|Overall Study||2
7744308|NCT01529502|19067211|P5|STARTED|Overall Study||2
7744309|NCT01529502|19067212|P4|STARTED|Overall Study||3
7744310|NCT01529502|19067213|P3|STARTED|Overall Study||2
7744311|NCT01529502|19067214|P2|STARTED|Overall Study||3
7744312|NCT01529502|19067215|P1|STARTED|Overall Study||2
7744313|NCT01529450|19067228|P2|NOT COMPLETED|Overall Study||2
7744314|NCT01529450|19067229|P1|NOT COMPLETED|Overall Study||0
7744315|NCT01529450|19067228|P2|COMPLETED|Overall Study||6
7744316|NCT01529450|19067229|P1|COMPLETED|Overall Study||3
7744317|NCT01529450|19067228|P2|STARTED|Overall Study||8
7744318|NCT01529450|19067229|P1|STARTED|Overall Study||3
7744319|NCT01529385|19067238|P2|NOT COMPLETED|Overall Study||1
7744320|NCT01529385|19067239|P1|NOT COMPLETED|Overall Study||2
7744321|NCT01529385|19067238|P2|COMPLETED|Overall Study||39
7744322|NCT01529385|19067239|P1|COMPLETED|Overall Study||38
7744323|NCT01529385|19067238|P2|Received Intervention|Overall Study||40
7744324|NCT01529385|19067239|P1|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39
7744325|NCT01529385|19067238|P2|STARTED|Overall Study||40
7744326|NCT01529385|19067239|P1|STARTED|Overall Study||40
7744327|NCT01529346|19067268|P5|NOT COMPLETED|Overall Study||0
7744328|NCT01529346|19067269|P4|NOT COMPLETED|Overall Study||0
7744329|NCT01529346|19067270|P3|NOT COMPLETED|Overall Study||2
7744330|NCT01529346|19067271|P2|NOT COMPLETED|Overall Study||1
7744331|NCT01529346|19067272|P1|NOT COMPLETED|Overall Study||2
7744332|NCT01529346|19067268|P5|COMPLETED|Overall Study||36
7744333|NCT01529346|19067269|P4|COMPLETED|Overall Study||36
7744334|NCT01529346|19067270|P3|COMPLETED|Overall Study||52
7744335|NCT01529346|19067271|P2|COMPLETED|Overall Study||53
7744336|NCT01529346|19067272|P1|COMPLETED|Overall Study||53
7744337|NCT01529346|19067268|P5|STARTED|Overall Study||36
7744338|NCT01529346|19067269|P4|STARTED|Overall Study||36
7744339|NCT01529346|19067270|P3|STARTED|Overall Study||54
7744340|NCT01529346|19067271|P2|STARTED|Overall Study||54
7744341|NCT01529346|19067272|P1|STARTED|Overall Study||55
7744342|NCT01529268|19067360|P2|NOT COMPLETED|Overall Study||3
7744343|NCT01529268|19067361|P1|NOT COMPLETED|Overall Study||12
7744344|NCT01529268|19067360|P2|COMPLETED|Overall Study||78
7744345|NCT01529268|19067361|P1|COMPLETED|Overall Study||76
7744346|NCT01529268|19067360|P2|Completed 52-week Biopsy|Overall Study||75
7744347|NCT01529268|19067361|P1|Completed 52-week Biopsy|Overall Study||71
7744348|NCT01529268|19067360|P2|STARTED|Overall Study||81
7744349|NCT01529268|19067361|P1|STARTED|Overall Study||88
7744350|NCT01529203|19067415|P1|NOT COMPLETED|Overall Study||3
7744351|NCT01529203|19067415|P1|COMPLETED|Overall Study||57
7744352|NCT01529203|19067415|P1|STARTED|Overall Study||60
7744353|NCT01529112|19067423|P2|NOT COMPLETED|Overall Study||41
7744354|NCT01529112|19067424|P1|NOT COMPLETED|Overall Study||69
7744355|NCT01529112|19067423|P2|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5
7744356|NCT01529112|19067424|P1|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20
7744357|NCT01529112|19067423|P2|STARTED|Overall Study||46
7744358|NCT01529112|19067424|P1|STARTED|Overall Study||89
7744359|NCT01529060|19067451|P2|NOT COMPLETED|Overall Study||0
7744360|NCT01529060|19067452|P1|NOT COMPLETED|Overall Study||0
7744361|NCT01529060|19067451|P2|COMPLETED|Overall Study||10
7744362|NCT01529060|19067452|P1|COMPLETED|Overall Study||10
7744363|NCT01529060|19067451|P2|STARTED|Overall Study||10
7744364|NCT01529060|19067452|P1|STARTED|Overall Study||10
7744365|NCT01529034|19067460|P1|NOT COMPLETED|Overall Study||174
7744366|NCT01529034|19067460|P1|COMPLETED|Overall Study|Completed under initial protocol duration of 2 years; amended protocol open-ended duration|1
7744367|NCT01529034|19067460|P1|Exposed|Overall Study|Treated at least 1 seizure cluster with USL261|161
7744368|NCT01529034|19067460|P1|STARTED|Overall Study|Completed Study P261-401 and rolled over to Study P261-402|175
7744369|NCT01528969|19067475|P2|NOT COMPLETED|Overall Study||0
7744370|NCT01528969|19067476|P1|NOT COMPLETED|Overall Study||2
7744371|NCT01528969|19067475|P2|COMPLETED|Overall Study||38
7744372|NCT01528969|19067476|P1|COMPLETED|Overall Study||35
7744373|NCT01528969|19067475|P2|STARTED|Overall Study||38
7744374|NCT01528969|19067476|P1|STARTED|Overall Study||37
7744375|NCT01528891|19067484|P2|NOT COMPLETED|Overall Study||0
7744376|NCT01528891|19067485|P1|NOT COMPLETED|Overall Study||0
7744377|NCT01528891|19067484|P2|COMPLETED|Overall Study||200
7744378|NCT01528891|19067485|P1|COMPLETED|Overall Study||200
7744379|NCT01528891|19067484|P2|STARTED|Overall Study||200
7744380|NCT01528891|19067485|P1|STARTED|Overall Study||200
7744381|NCT01528878|19067497|P1|NOT COMPLETED|Overall Study||0
7744382|NCT01528878|19067497|P1|COMPLETED|Overall Study||30
7744383|NCT01528878|19067497|P1|STARTED|Overall Study||30
7744384|NCT01528787|19067509|P4|NOT COMPLETED|Overall Study||1
7744385|NCT01528787|19067510|P3|NOT COMPLETED|Overall Study||1
7744386|NCT01528787|19067511|P2|NOT COMPLETED|Overall Study||0
7744387|NCT01528787|19067512|P1|NOT COMPLETED|Overall Study||0
7744388|NCT01528787|19067509|P4|COMPLETED|Overall Study||22
7744389|NCT01528787|19067510|P3|COMPLETED|Overall Study||18
7744390|NCT01528787|19067511|P2|COMPLETED|Overall Study||21
7744391|NCT01528787|19067512|P1|COMPLETED|Overall Study||22
7744392|NCT01528787|19067509|P4|STARTED|Overall Study||23
7744393|NCT01528787|19067510|P3|STARTED|Overall Study||19
7744394|NCT01528787|19067511|P2|STARTED|Overall Study||21
7744395|NCT01528787|19067512|P1|STARTED|Overall Study||22
7744396|NCT01528735|19067524|P2|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0
7744397|NCT01528735|19067525|P1|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1
7744398|NCT01528735|19067524|P2|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12
7744399|NCT01528735|19067525|P1|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10
7744400|NCT01528735|19067524|P2|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12
7744401|NCT01528735|19067525|P1|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11
7744402|NCT01528735|19067524|P2|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
7744403|NCT01528735|19067525|P1|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
7744404|NCT01528735|19067524|P2|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12
7744405|NCT01528735|19067525|P1|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11
7744406|NCT01528735|19067524|P2|STARTED|Treatment Period 1: Faldap/Del/RBV||13
7744407|NCT01528735|19067525|P1|STARTED|Treatment Period 1: Faldap/Del/RBV||12
7744408|NCT01528709|19067627|P2|NOT COMPLETED|Overall Study||15
7744409|NCT01528709|19067628|P1|NOT COMPLETED|Overall Study||13
7744410|NCT01528709|19067627|P2|COMPLETED|Overall Study||72
7744411|NCT01528709|19067628|P1|COMPLETED|Overall Study||73
7744412|NCT01528709|19067627|P2|STARTED|Overall Study||87
7744413|NCT01528709|19067628|P1|STARTED|Overall Study||86
7744414|NCT01528696|19067638|P2|NOT COMPLETED|Overall Study||19
7744415|NCT01528696|19067639|P1|NOT COMPLETED|Overall Study||18
7744416|NCT01528696|19067638|P2|COMPLETED|Overall Study||0
7744417|NCT01528696|19067639|P1|COMPLETED|Overall Study||0
7744418|NCT01528696|19067638|P2|Hospital Stay (2-5 Days)|Overall Study||19
7744419|NCT01528696|19067639|P1|Hospital Stay (2-5 Days)|Overall Study||18
7744420|NCT01528696|19067638|P2|STARTED|Overall Study||19
7744421|NCT01528696|19067639|P1|STARTED|Overall Study||18
7744422|NCT01528605|19067655|P6|NOT COMPLETED|Overall Study||0
7744423|NCT01528605|19067656|P5|NOT COMPLETED|Overall Study||0
7744424|NCT01528605|19067657|P4|NOT COMPLETED|Overall Study||1
7744425|NCT01528605|19067658|P3|NOT COMPLETED|Overall Study||1
7744426|NCT01528605|19067659|P2|NOT COMPLETED|Overall Study||0
7744427|NCT01528605|19067660|P1|NOT COMPLETED|Overall Study||2
7744428|NCT01528605|19067655|P6|COMPLETED|Overall Study||28
7744429|NCT01528605|19067656|P5|COMPLETED|Overall Study||28
7744430|NCT01528605|19067657|P4|COMPLETED|Overall Study||27
7744431|NCT01528605|19067658|P3|COMPLETED|Overall Study||27
7744432|NCT01528605|19067659|P2|COMPLETED|Overall Study||28
7744433|NCT01528605|19067660|P1|COMPLETED|Overall Study||26
7744434|NCT01528605|19067655|P6|STARTED|Overall Study||28
7744435|NCT01528605|19067656|P5|STARTED|Overall Study||28
7744436|NCT01528605|19067657|P4|STARTED|Overall Study||28
7744437|NCT01528605|19067658|P3|STARTED|Overall Study||28
7744438|NCT01528605|19067659|P2|STARTED|Overall Study||28
7744439|NCT01528605|19067660|P1|STARTED|Overall Study||28
7744440|NCT01528592|19067684|P1|NOT COMPLETED|Overall Study||0
7744441|NCT01528592|19067684|P1|COMPLETED|Overall Study||18
7744442|NCT01528592|19067684|P1|STARTED|Overall Study||18
7744443|NCT01528345|19067690|P2|NOT COMPLETED|Overall Study||50
7744444|NCT01528345|19067691|P1|NOT COMPLETED|Overall Study||47
7744445|NCT01528345|19067690|P2|COMPLETED|Overall Study||0
7744446|NCT01528345|19067691|P1|COMPLETED|Overall Study||0
7744447|NCT01528345|19067690|P2|STARTED|Overall Study||50
7744448|NCT01528345|19067691|P1|STARTED|Overall Study||47
7744449|NCT01528332|19067709|P2|NOT COMPLETED|Overall Study||2
7744450|NCT01528332|19067710|P1|NOT COMPLETED|Overall Study||4
7744451|NCT01528332|19067709|P2|COMPLETED|Overall Study||84
7744452|NCT01528332|19067710|P1|COMPLETED|Overall Study||81
7744453|NCT01528332|19067709|P2|STARTED|Overall Study||86
7744454|NCT01528332|19067710|P1|STARTED|Overall Study||85
7744455|NCT01528319|19067716|P1|NOT COMPLETED|Overall Study||1
7744456|NCT01528319|19067716|P1|COMPLETED|Overall Study||23
7744457|NCT01528319|19067716|P1|12 Weeks After Surgery|Overall Study||24
7744458|NCT01528319|19067716|P1|STARTED|Overall Study||24
7744459|NCT01528293|19067727|P2|NOT COMPLETED|Overall Study||0
7744460|NCT01528293|19067728|P1|NOT COMPLETED|Overall Study||1
7744461|NCT01528293|19067727|P2|COMPLETED|Overall Study||1
7744462|NCT01528293|19067728|P1|COMPLETED|Overall Study||0
7744463|NCT01528293|19067727|P2|STARTED|Overall Study||1
7744464|NCT01528293|19067728|P1|STARTED|Overall Study||1
7744465|NCT01528254|19067742|P2|NOT COMPLETED|Overall Study||216
7744466|NCT01528254|19067743|P1|NOT COMPLETED|Overall Study||187
7744467|NCT01528254|19067742|P2|COMPLETED|Overall Study||787
7744468|NCT01528254|19067743|P1|COMPLETED|Overall Study||811
7744469|NCT01528254|19067742|P2|Completed Treatment Period 3|Overall Study||115
7744470|NCT01528254|19067743|P1|Completed Treatment Period 3|Overall Study||109
7744471|NCT01528254|19067742|P2|Completed Treatment Period 2|Overall Study||399
7744472|NCT01528254|19067743|P1|Completed Treatment Period 2|Overall Study||244
7744473|NCT01528254|19067742|P2|Completed Treatment Period 1|Overall Study||273
7744474|NCT01528254|19067743|P1|Completed Treatment Period 1|Overall Study||458
7744475|NCT01528254|19067742|P2|Full Analysis Set (FAS)|Overall Study||989
7744476|NCT01528254|19067743|P1|Full Analysis Set (FAS)|Overall Study||983
7744477|NCT01528254|19067742|P2|Safety Set|Overall Study||1001
7744478|NCT01528254|19067743|P1|Safety Set|Overall Study||998
7744479|NCT01528254|19067742|P2|STARTED|Overall Study||1003
7744480|NCT01528254|19067743|P1|STARTED|Overall Study||998
7744481|NCT01528228|19067766|P2|NOT COMPLETED|Overall Study||1
7744482|NCT01528228|19067767|P1|NOT COMPLETED|Overall Study||1
7744483|NCT01528228|19067766|P2|COMPLETED|Overall Study||9
7744484|NCT01528228|19067767|P1|COMPLETED|Overall Study||9
7744485|NCT01528228|19067766|P2|STARTED|Overall Study||10
7744486|NCT01528228|19067767|P1|STARTED|Overall Study||10
7744487|NCT01528215|19067775|P2|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
7744488|NCT01528215|19067776|P1|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
7744489|NCT01528215|19067775|P2|COMPLETED|1 Year Follow-up to 5 Year Follow-up||45
7744490|NCT01528215|19067776|P1|COMPLETED|1 Year Follow-up to 5 Year Follow-up||40
7744491|NCT01528215|19067775|P2|STARTED|1 Year Follow-up to 5 Year Follow-up||60
7744492|NCT01528215|19067776|P1|STARTED|1 Year Follow-up to 5 Year Follow-up||55
7744493|NCT01528215|19067775|P2|NOT COMPLETED|Enrollment to 1 Year Follow-up||1
7744494|NCT01528215|19067776|P1|NOT COMPLETED|Enrollment to 1 Year Follow-up||4
7744495|NCT01528215|19067775|P2|COMPLETED|Enrollment to 1 Year Follow-up||60
7744496|NCT01528215|19067776|P1|COMPLETED|Enrollment to 1 Year Follow-up||55
7744497|NCT01528215|19067775|P2|STARTED|Enrollment to 1 Year Follow-up||61
7744498|NCT01528215|19067776|P1|STARTED|Enrollment to 1 Year Follow-up||59
7744499|NCT01528150|19067784|P1|NOT COMPLETED|Overall Study||44
7744500|NCT01528150|19067784|P1|COMPLETED|Overall Study||422
7744501|NCT01528150|19067784|P1|STARTED|Overall Study||466
7744502|NCT01528124|19067795|P7|NOT COMPLETED|Overall Study||0
7744503|NCT01528124|19067796|P6|NOT COMPLETED|Overall Study||0
7744504|NCT01528124|19067797|P5|NOT COMPLETED|Overall Study||0
7744505|NCT01528124|19067798|P4|NOT COMPLETED|Overall Study||0
7744506|NCT01528124|19067799|P3|NOT COMPLETED|Overall Study||0
7744507|NCT01528124|19067800|P2|NOT COMPLETED|Overall Study||0
7744508|NCT01528124|19067801|P1|NOT COMPLETED|Overall Study||0
7744509|NCT01528124|19067795|P7|COMPLETED|Overall Study||6
7744510|NCT01528124|19067796|P6|COMPLETED|Overall Study||6
7744511|NCT01528124|19067797|P5|COMPLETED|Overall Study||5
7744512|NCT01528124|19067798|P4|COMPLETED|Overall Study||6
7744513|NCT01528124|19067799|P3|COMPLETED|Overall Study||6
7744514|NCT01528124|19067800|P2|COMPLETED|Overall Study||6
7744515|NCT01528124|19067801|P1|COMPLETED|Overall Study||6
7744516|NCT01528124|19067795|P7|Received Study Drug|Overall Study||6
7744517|NCT01528124|19067796|P6|Received Study Drug|Overall Study||6
7744518|NCT01528124|19067797|P5|Received Study Drug|Overall Study||5
7744519|NCT01528124|19067798|P4|Received Study Drug|Overall Study||6
7744520|NCT01528124|19067799|P3|Received Study Drug|Overall Study||6
7744521|NCT01528124|19067800|P2|Received Study Drug|Overall Study||6
7744522|NCT01528124|19067801|P1|Received Study Drug|Overall Study||6
7744523|NCT01528124|19067795|P7|STARTED|Overall Study||6
7744524|NCT01528124|19067796|P6|STARTED|Overall Study||6
7744525|NCT01528124|19067797|P5|STARTED|Overall Study||5
7744526|NCT01528124|19067798|P4|STARTED|Overall Study||6
7744527|NCT01528124|19067799|P3|STARTED|Overall Study||6
7744528|NCT01528124|19067800|P2|STARTED|Overall Study||6
7744529|NCT01528124|19067801|P1|STARTED|Overall Study||6
7744530|NCT01528072|19067835|P1|NOT COMPLETED|Overall Study||74
7744531|NCT01528072|19067835|P1|COMPLETED|Overall Study||66
7744532|NCT01528072|19067835|P1|STARTED|Overall Study||140
7744533|NCT01528033|19067841|P2|NOT COMPLETED|Follow Up||44
7744534|NCT01528033|19067842|P1|NOT COMPLETED|Follow Up||46
7744535|NCT01528033|19067841|P2|COMPLETED|Follow Up||207
7744536|NCT01528033|19067842|P1|COMPLETED|Follow Up||210
7744537|NCT01528033|19067841|P2|STARTED|Follow Up||251
7744538|NCT01528033|19067842|P1|STARTED|Follow Up||256
7744539|NCT01528033|19067841|P2|NOT COMPLETED|Primary Endpoint Assessment ITT||15
7744540|NCT01528033|19067842|P1|NOT COMPLETED|Primary Endpoint Assessment ITT||17
7744541|NCT01528033|19067841|P2|COMPLETED|Primary Endpoint Assessment ITT||251
7744542|NCT01528033|19067842|P1|COMPLETED|Primary Endpoint Assessment ITT||256
7744543|NCT01528033|19067841|P2|STARTED|Primary Endpoint Assessment ITT||266
7744544|NCT01528033|19067842|P1|STARTED|Primary Endpoint Assessment ITT||273
7744545|NCT01527942|19067854|P2|NOT COMPLETED|Overall Study||0
7744546|NCT01527942|19067855|P1|NOT COMPLETED|Overall Study||0
7744547|NCT01527942|19067854|P2|COMPLETED|Overall Study||18
7744548|NCT01527942|19067855|P1|COMPLETED|Overall Study||16
7744549|NCT01527942|19067854|P2|STARTED|Overall Study||18
7744550|NCT01527942|19067855|P1|STARTED|Overall Study||16
7744551|NCT01527682|19067865|P1|NOT COMPLETED|Overall Study||8
7744552|NCT01527682|19067865|P1|COMPLETED|Overall Study||29
7744553|NCT01527682|19067865|P1|STARTED|Overall Study||37
7744554|NCT01527513|19067873|P2|NOT COMPLETED|Eligible for 1-Year Open Label Period||17
7744555|NCT01527513|19067874|P1|NOT COMPLETED|Eligible for 1-Year Open Label Period||0
7744556|NCT01527513|19067873|P2|COMPLETED|Eligible for 1-Year Open Label Period||95
7744557|NCT01527513|19067874|P1|COMPLETED|Eligible for 1-Year Open Label Period||0
7744558|NCT01527513|19067873|P2|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112
7744559|NCT01527513|19067874|P1|STARTED|Eligible for 1-Year Open Label Period||0
7744560|NCT01527513|19067873|P2|NOT COMPLETED|Double Blind Period (DB) - Part I||8
7744561|NCT01527513|19067874|P1|NOT COMPLETED|Double Blind Period (DB) - Part I||3
7744562|NCT01527513|19067873|P2|COMPLETED|Double Blind Period (DB) - Part I||75
7744563|NCT01527513|19067874|P1|COMPLETED|Double Blind Period (DB) - Part I||37
7744564|NCT01527513|19067873|P2|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66
7744565|NCT01527513|19067874|P1|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36
7744566|NCT01527513|19067873|P2|Efficacy PP Population|Double Blind Period (DB) - Part I||67
7744567|NCT01527513|19067874|P1|Efficacy PP Population|Double Blind Period (DB) - Part I||37
7744568|NCT01527513|19067873|P2|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75
7744569|NCT01527513|19067874|P1|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37
7744570|NCT01527513|19067873|P2|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75
7744571|NCT01527513|19067874|P1|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37
7744572|NCT01527513|19067873|P2|Entered Maintenance Period|Double Blind Period (DB) - Part I||76
7744573|NCT01527513|19067874|P1|Entered Maintenance Period|Double Blind Period (DB) - Part I||40
7744574|NCT01527513|19067873|P2|Safety Population|Double Blind Period (DB) - Part I||83
7744575|NCT01527513|19067874|P1|Safety Population|Double Blind Period (DB) - Part I||40
7744576|NCT01527513|19067873|P2|Randomized|Double Blind Period (DB) - Part I||83
7744577|NCT01527513|19067874|P1|Randomized|Double Blind Period (DB) - Part I||40
7744578|NCT01527513|19067873|P2|STARTED|Double Blind Period (DB) - Part I||83
7744579|NCT01527513|19067874|P1|STARTED|Double Blind Period (DB) - Part I||40
7744580|NCT01527500|19067888|P2|NOT COMPLETED|Part B||0
7744581|NCT01527500|19067889|P1|NOT COMPLETED|Part B||1
7744582|NCT01527500|19067888|P2|COMPLETED|Part B||1
7744583|NCT01527500|19067889|P1|COMPLETED|Part B||6
7744584|NCT01527500|19067888|P2|STARTED|Part B||1
7744585|NCT01527500|19067889|P1|STARTED|Part B||7
7744586|NCT01527500|19067888|P2|NOT COMPLETED|Part A||13
7744587|NCT01527500|19067889|P1|NOT COMPLETED|Part A||30
7744588|NCT01527500|19067888|P2|COMPLETED|Part A||38
7744589|NCT01527500|19067889|P1|COMPLETED|Part A||69
7744590|NCT01527500|19067888|P2|STARTED|Part A||51
7744591|NCT01527500|19067889|P1|STARTED|Part A||99
7744592|NCT01527487|19067919|P2|NOT COMPLETED|Overall Study||7
7744593|NCT01527487|19067920|P1|NOT COMPLETED|Overall Study||8
7744594|NCT01527487|19067919|P2|COMPLETED|Overall Study||15
7744595|NCT01527487|19067920|P1|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46
7744596|NCT01527487|19067919|P2|STARTED|Overall Study||22
7744597|NCT01527487|19067920|P1|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54
7744598|NCT01527383|19067934|P2|NOT COMPLETED|Overall Study||4
7744599|NCT01527383|19067935|P1|NOT COMPLETED|Overall Study||15
7744600|NCT01527383|19067934|P2|COMPLETED|Overall Study||58
7744601|NCT01527383|19067935|P1|COMPLETED|Overall Study||277
7744602|NCT01527383|19067934|P2|Vaccination 4 (~Day 90)|Overall Study||58
7744603|NCT01527383|19067935|P1|Vaccination 4 (~Day 90)|Overall Study||277
7744604|NCT01527383|19067934|P2|Vaccination 3 (~Day 60)|Overall Study||58
7744605|NCT01527383|19067935|P1|Vaccination 3 (~Day 60)|Overall Study||278
7744606|NCT01527383|19067934|P2|Vaccination 2 (~Day 30)|Overall Study||61
7744607|NCT01527383|19067935|P1|Vaccination 2 (~Day 30)|Overall Study||283
7744608|NCT01527383|19067934|P2|Vaccination 1 (Day 1)|Overall Study||62
7744609|NCT01527383|19067935|P1|Vaccination 1 (Day 1)|Overall Study||291
7744610|NCT01527383|19067934|P2|STARTED|Overall Study||62
7744611|NCT01527383|19067935|P1|STARTED|Overall Study||292
7744612|NCT01527370|19067949|P1|NOT COMPLETED|Overall Study||6
7744613|NCT01527370|19067949|P1|COMPLETED|Overall Study||244
7744614|NCT01527370|19067949|P1|STARTED|Overall Study||250
7744615|NCT01527357|19067957|P2|NOT COMPLETED|Overall Study||9
7744616|NCT01527357|19067958|P1|NOT COMPLETED|Overall Study||17
7744617|NCT01527357|19067957|P2|COMPLETED|Overall Study||230
7744618|NCT01527357|19067958|P1|COMPLETED|Overall Study||465
7744619|NCT01527357|19067957|P2|Efficacy Population|Overall Study||239
7744620|NCT01527357|19067958|P1|Efficacy Population|Overall Study|Two participants did not receive study treatment.|480
7744621|NCT01527357|19067957|P2|STARTED|Overall Study||239
7744622|NCT01527357|19067958|P1|STARTED|Overall Study||482
7744623|NCT01527292|19067980|P2|NOT COMPLETED|Overall Study||3
7744624|NCT01527292|19067981|P1|NOT COMPLETED|Overall Study||0
7744625|NCT01527292|19067980|P2|COMPLETED|Overall Study||0
7744626|NCT01527292|19067981|P1|COMPLETED|Overall Study||0
7744627|NCT01527292|19067980|P2|STARTED|Overall Study||3
7744628|NCT01527292|19067981|P1|STARTED|Overall Study||0
7744629|NCT01527162|19067997|P2|NOT COMPLETED|Overall Study||0
7744630|NCT01527162|19067998|P1|NOT COMPLETED|Overall Study||0
7744631|NCT01527162|19067997|P2|COMPLETED|Overall Study||5
7744632|NCT01527162|19067998|P1|COMPLETED|Overall Study||6
7744633|NCT01527162|19067997|P2|STARTED|Overall Study||5
7744634|NCT01527162|19067998|P1|STARTED|Overall Study||6
7744635|NCT01527149|19068008|P1|NOT COMPLETED|Overall Study||2
7744636|NCT01527149|19068008|P1|COMPLETED|Overall Study||35
7744637|NCT01527149|19068008|P1|STARTED|Overall Study||37
7744638|NCT01527110|19068023|P1|NOT COMPLETED|Overall Study||1
7744639|NCT01527110|19068023|P1|COMPLETED|Overall Study||20
7744640|NCT01527110|19068023|P1|STARTED|Overall Study||21
7744641|NCT01527045|19068071|P3|NOT COMPLETED|Overall Study||0
7744642|NCT01527045|19068072|P2|NOT COMPLETED|Overall Study||0
7744643|NCT01527045|19068073|P1|NOT COMPLETED|Overall Study||1
7744644|NCT01527045|19068071|P3|COMPLETED|Overall Study||12
7744645|NCT01527045|19068072|P2|COMPLETED|Overall Study||5
7744646|NCT01527045|19068073|P1|COMPLETED|Overall Study||29
7744647|NCT01527045|19068071|P3|STARTED|Overall Study||12
7744648|NCT01527045|19068072|P2|STARTED|Overall Study||5
7744649|NCT01527045|19068073|P1|STARTED|Overall Study||30
7744650|NCT01527006|19068104|P2|NOT COMPLETED|Extension Phase||8
7744651|NCT01527006|19068105|P1|NOT COMPLETED|Extension Phase||6
7744652|NCT01527006|19068104|P2|COMPLETED|Extension Phase||14
7744653|NCT01527006|19068105|P1|COMPLETED|Extension Phase||13
7744654|NCT01527006|19068104|P2|STARTED|Extension Phase||22
7744655|NCT01527006|19068105|P1|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19
7744656|NCT01527006|19068104|P2|NOT COMPLETED|Core Study||6
7744657|NCT01527006|19068105|P1|NOT COMPLETED|Core Study||2
7744658|NCT01527006|19068104|P2|COMPLETED|Core Study||22
7744659|NCT01527006|19068105|P1|COMPLETED|Core Study||20
7744660|NCT01527006|19068104|P2|STARTED|Core Study||28
7744661|NCT01527006|19068105|P1|STARTED|Core Study||22
7744662|NCT01526928|19068161|P6|NOT COMPLETED|Overall Study||6
7744663|NCT01526928|19068162|P5|NOT COMPLETED|Overall Study||95
7744664|NCT01526928|19068163|P4|NOT COMPLETED|Overall Study||245
7744665|NCT01526928|19068164|P3|NOT COMPLETED|Overall Study||209
7744666|NCT01526928|19068165|P2|NOT COMPLETED|Overall Study||19
7744667|NCT01526928|19068166|P1|NOT COMPLETED|Overall Study||38
7744668|NCT01526928|19068161|P6|COMPLETED|Overall Study||0
7744669|NCT01526928|19068162|P5|COMPLETED|Overall Study||0
7744670|NCT01526928|19068163|P4|COMPLETED|Overall Study||0
7744671|NCT01526928|19068164|P3|COMPLETED|Overall Study||0
7744672|NCT01526928|19068165|P2|COMPLETED|Overall Study||0
7744673|NCT01526928|19068166|P1|COMPLETED|Overall Study||0
7744674|NCT01526928|19068161|P6|Started Phase 2|Overall Study||0
7744675|NCT01526928|19068162|P5|Started Phase 2|Overall Study||82
7744676|NCT01526928|19068163|P4|Started Phase 2|Overall Study||228
7744677|NCT01526928|19068164|P3|Started Phase 2|Overall Study||191
7744678|NCT01526928|19068165|P2|Started Phase 2|Overall Study||0
7744679|NCT01526928|19068166|P1|Started Phase 2|Overall Study||0
7744680|NCT01526928|19068161|P6|Started Phase 1|Overall Study||6
7744681|NCT01526928|19068162|P5|Started Phase 1|Overall Study||13
7744682|NCT01526928|19068163|P4|Started Phase 1|Overall Study||17
7744683|NCT01526928|19068164|P3|Started Phase 1|Overall Study||18
7744684|NCT01526928|19068165|P2|Started Phase 1|Overall Study||19
7744685|NCT01526928|19068166|P1|Started Phase 1|Overall Study||38
7744686|NCT01526928|19068161|P6|STARTED|Overall Study||6
7744687|NCT01526928|19068162|P5|STARTED|Overall Study||95
7744688|NCT01526928|19068163|P4|STARTED|Overall Study||245
7744689|NCT01526928|19068164|P3|STARTED|Overall Study||209
7744690|NCT01526928|19068165|P2|STARTED|Overall Study||19
7744691|NCT01526928|19068166|P1|STARTED|Overall Study||38
7744692|NCT01526902|19068285|P2|NOT COMPLETED|Overall Study||0
7744693|NCT01526902|19068286|P1|NOT COMPLETED|Overall Study||0
7744694|NCT01526902|19068285|P2|COMPLETED|Overall Study||24
7744695|NCT01526902|19068286|P1|COMPLETED|Overall Study||25
7744696|NCT01526902|19068285|P2|STARTED|Overall Study||24
7744697|NCT01526902|19068286|P1|STARTED|Overall Study||25
7744698|NCT01526889|19068304|P2|NOT COMPLETED|Treatment Extension Period||0
7744699|NCT01526889|19068305|P1|NOT COMPLETED|Treatment Extension Period||1
7744700|NCT01526889|19068304|P2|COMPLETED|Treatment Extension Period||0
7744701|NCT01526889|19068305|P1|COMPLETED|Treatment Extension Period||4
7744702|NCT01526889|19068304|P2|STARTED|Treatment Extension Period||0
7744703|NCT01526889|19068305|P1|STARTED|Treatment Extension Period||5
7744704|NCT01526889|19068304|P2|NOT COMPLETED|Treatment Period||0
7744705|NCT01526889|19068305|P1|NOT COMPLETED|Treatment Period||2
7744706|NCT01526889|19068304|P2|COMPLETED|Treatment Period||7
7744707|NCT01526889|19068305|P1|COMPLETED|Treatment Period||16
7744708|NCT01526889|19068304|P2|STARTED|Treatment Period||7
7744709|NCT01526889|19068305|P1|STARTED|Treatment Period||18
7744710|NCT01526785|19068326|P1|NOT COMPLETED|Overall Study||13
7744711|NCT01526785|19068326|P1|COMPLETED|Overall Study||100
7744712|NCT01526785|19068326|P1|STARTED|Overall Study||113
7744713|NCT01526733|19068336|P2|NOT COMPLETED|Phase 2||0
7744714|NCT01526733|19068337|P1|NOT COMPLETED|Phase 2||0
7744715|NCT01526733|19068336|P2|COMPLETED|Phase 2||12
7744716|NCT01526733|19068337|P1|COMPLETED|Phase 2||10
7744717|NCT01526733|19068336|P2|STARTED|Phase 2||12
7744718|NCT01526733|19068337|P1|STARTED|Phase 2||10
7744719|NCT01526733|19068336|P2|NOT COMPLETED|Washout Period of 5 to 21 Days||0
7744720|NCT01526733|19068337|P1|NOT COMPLETED|Washout Period of 5 to 21 Days||0
7744721|NCT01526733|19068336|P2|COMPLETED|Washout Period of 5 to 21 Days||12
7744722|NCT01526733|19068337|P1|COMPLETED|Washout Period of 5 to 21 Days||10
7744723|NCT01526733|19068336|P2|STARTED|Washout Period of 5 to 21 Days||12
7744724|NCT01526733|19068337|P1|STARTED|Washout Period of 5 to 21 Days||10
7744725|NCT01526733|19068336|P2|NOT COMPLETED|Phase 1||1
7744726|NCT01526733|19068337|P1|NOT COMPLETED|Phase 1||2
7744727|NCT01526733|19068336|P2|COMPLETED|Phase 1||12
7744728|NCT01526733|19068337|P1|COMPLETED|Phase 1||10
7744729|NCT01526733|19068336|P2|Received at Least 1 Dose of Study Drug|Phase 1||13
7744730|NCT01526733|19068337|P1|Received at Least 1 Dose of Study Drug|Phase 1||12
7744731|NCT01526733|19068336|P2|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13
7744732|NCT01526733|19068337|P1|STARTED|Phase 1||12
7744733|NCT01526629|19068355|P1|NOT COMPLETED|Overall Study||46
7744734|NCT01526629|19068355|P1|COMPLETED|Overall Study||308
7744735|NCT01526629|19068355|P1|STARTED|Overall Study||354
7744736|NCT01526577|19068364|P5|NOT COMPLETED|Overall Study||2
7744737|NCT01526577|19068365|P4|NOT COMPLETED|Overall Study||1
7744738|NCT01526577|19068366|P3|NOT COMPLETED|Overall Study||1
7744739|NCT01526577|19068367|P2|NOT COMPLETED|Overall Study||0
7744740|NCT01526577|19068368|P1|NOT COMPLETED|Overall Study||1
7744741|NCT01526577|19068364|P5|COMPLETED|Overall Study||8
7744742|NCT01526577|19068365|P4|COMPLETED|Overall Study||8
7744743|NCT01526577|19068366|P3|COMPLETED|Overall Study||32
7744744|NCT01526577|19068367|P2|COMPLETED|Overall Study||12
7744745|NCT01526577|19068368|P1|COMPLETED|Overall Study||48
7744746|NCT01526577|19068364|P5|STARTED|Overall Study|2 more subjects were enrolled as the substitutes for 2 withdrawn subjects before the administration.|10
7744747|NCT01526577|19068365|P4|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|9
7744748|NCT01526577|19068366|P3|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|33
7744749|NCT01526577|19068367|P2|STARTED|Overall Study||12
7744750|NCT01526577|19068368|P1|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|49
7744751|NCT01526551|19068376|P1|NOT COMPLETED|Overall Study||424
7744752|NCT01526551|19068376|P1|COMPLETED|Overall Study||511
7744753|NCT01526551|19068376|P1|STARTED|Overall Study||935
7744754|NCT01526538|19068383|P2|NOT COMPLETED|Overall Study||4
7744755|NCT01526538|19068384|P1|NOT COMPLETED|Overall Study||9
7744756|NCT01526538|19068383|P2|COMPLETED|Overall Study||18
7744757|NCT01526538|19068384|P1|COMPLETED|Overall Study||21
7744758|NCT01526538|19068383|P2|STARTED|Overall Study||22
7744759|NCT01526538|19068384|P1|STARTED|Overall Study||30
7744760|NCT01526356|19068397|P3|NOT COMPLETED|Overall Study||12
7744761|NCT01526356|19068398|P2|NOT COMPLETED|Overall Study||10
7744762|NCT01526356|19068399|P1|NOT COMPLETED|Overall Study||8
7744763|NCT01526356|19068397|P3|COMPLETED|Overall Study||45
7744764|NCT01526356|19068398|P2|COMPLETED|Overall Study||53
7744765|NCT01526356|19068399|P1|COMPLETED|Overall Study||51
7744766|NCT01526356|19068397|P3|STARTED|Overall Study||57
7744767|NCT01526356|19068398|P2|STARTED|Overall Study||63
7744768|NCT01526356|19068399|P1|STARTED|Overall Study||59
7744769|NCT01526343|19068425|P1|NOT COMPLETED|Overall Study||0
7744770|NCT01526343|19068425|P1|COMPLETED|Overall Study||47
7744771|NCT01526343|19068425|P1|STARTED|Overall Study||47
7744772|NCT01526213|19068436|P6|NOT COMPLETED|Period 3 (5 Days)||0
7744773|NCT01526213|19068437|P5|NOT COMPLETED|Period 3 (5 Days)||0
7744774|NCT01526213|19068438|P4|NOT COMPLETED|Period 3 (5 Days)||0
7744775|NCT01526213|19068439|P3|NOT COMPLETED|Period 3 (5 Days)||0
7744776|NCT01526213|19068440|P2|NOT COMPLETED|Period 3 (5 Days)||0
7744777|NCT01526213|19068441|P1|NOT COMPLETED|Period 3 (5 Days)||0
7744778|NCT01526213|19068436|P6|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
7744779|NCT01526213|19068437|P5|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
7744780|NCT01526213|19068438|P4|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
7744781|NCT01526213|19068439|P3|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
7744782|NCT01526213|19068440|P2|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
7744783|NCT01526213|19068441|P1|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
7744784|NCT01526213|19068436|P6|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
7744785|NCT01526213|19068437|P5|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
7744786|NCT01526213|19068438|P4|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
7744787|NCT01526213|19068439|P3|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
7744788|NCT01526213|19068440|P2|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
7744789|NCT01526213|19068441|P1|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
7744790|NCT01526213|19068436|P6|NOT COMPLETED|Washout 2 (10 Days)||0
7744791|NCT01526213|19068437|P5|NOT COMPLETED|Washout 2 (10 Days)||0
7744792|NCT01526213|19068438|P4|NOT COMPLETED|Washout 2 (10 Days)||0
7744793|NCT01526213|19068439|P3|NOT COMPLETED|Washout 2 (10 Days)||0
7744794|NCT01526213|19068440|P2|NOT COMPLETED|Washout 2 (10 Days)||0
7744795|NCT01526213|19068441|P1|NOT COMPLETED|Washout 2 (10 Days)||0
7744796|NCT01526213|19068436|P6|COMPLETED|Washout 2 (10 Days)||3
7744797|NCT01526213|19068437|P5|COMPLETED|Washout 2 (10 Days)||3
7744798|NCT01526213|19068438|P4|COMPLETED|Washout 2 (10 Days)||3
7744799|NCT01526213|19068439|P3|COMPLETED|Washout 2 (10 Days)||3
7744800|NCT01526213|19068440|P2|COMPLETED|Washout 2 (10 Days)||3
7744801|NCT01526213|19068441|P1|COMPLETED|Washout 2 (10 Days)||3
7744802|NCT01526213|19068436|P6|STARTED|Washout 2 (10 Days)||3
7744803|NCT01526213|19068437|P5|STARTED|Washout 2 (10 Days)||3
7744804|NCT01526213|19068438|P4|STARTED|Washout 2 (10 Days)||3
7744805|NCT01526213|19068439|P3|STARTED|Washout 2 (10 Days)||3
7744806|NCT01526213|19068440|P2|STARTED|Washout 2 (10 Days)||3
7744807|NCT01526213|19068441|P1|STARTED|Washout 2 (10 Days)||3
7744808|NCT01526213|19068436|P6|NOT COMPLETED|Period 2 (5 Days)||0
7744809|NCT01526213|19068437|P5|NOT COMPLETED|Period 2 (5 Days)||0
7744810|NCT01526213|19068438|P4|NOT COMPLETED|Period 2 (5 Days)||0
7744811|NCT01526213|19068439|P3|NOT COMPLETED|Period 2 (5 Days)||0
7744812|NCT01526213|19068440|P2|NOT COMPLETED|Period 2 (5 Days)||0
7744813|NCT01526213|19068441|P1|NOT COMPLETED|Period 2 (5 Days)||0
7744814|NCT01526213|19068436|P6|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
7744815|NCT01526213|19068437|P5|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
7744816|NCT01526213|19068438|P4|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
7744817|NCT01526213|19068439|P3|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
7744818|NCT01526213|19068440|P2|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
7744819|NCT01526213|19068441|P1|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
7744820|NCT01526213|19068436|P6|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
7744821|NCT01526213|19068437|P5|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
7744822|NCT01526213|19068438|P4|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
7744823|NCT01526213|19068439|P3|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
7744824|NCT01526213|19068440|P2|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
7744825|NCT01526213|19068441|P1|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
7744826|NCT01526213|19068436|P6|NOT COMPLETED|Washout 1 (10 Days)||0
7744827|NCT01526213|19068437|P5|NOT COMPLETED|Washout 1 (10 Days)||0
7744828|NCT01526213|19068438|P4|NOT COMPLETED|Washout 1 (10 Days)||0
7744829|NCT01526213|19068439|P3|NOT COMPLETED|Washout 1 (10 Days)||0
7744830|NCT01526213|19068440|P2|NOT COMPLETED|Washout 1 (10 Days)||0
7744831|NCT01526213|19068441|P1|NOT COMPLETED|Washout 1 (10 Days)||0
7744832|NCT01526213|19068436|P6|COMPLETED|Washout 1 (10 Days)||3
7744833|NCT01526213|19068437|P5|COMPLETED|Washout 1 (10 Days)||3
7744834|NCT01526213|19068438|P4|COMPLETED|Washout 1 (10 Days)||3
7744835|NCT01526213|19068439|P3|COMPLETED|Washout 1 (10 Days)||3
7744836|NCT01526213|19068440|P2|COMPLETED|Washout 1 (10 Days)||3
7744837|NCT01526213|19068441|P1|COMPLETED|Washout 1 (10 Days)||3
7744838|NCT01526213|19068436|P6|STARTED|Washout 1 (10 Days)||3
7744839|NCT01526213|19068437|P5|STARTED|Washout 1 (10 Days)||3
7744840|NCT01526213|19068438|P4|STARTED|Washout 1 (10 Days)||3
7744841|NCT01526213|19068439|P3|STARTED|Washout 1 (10 Days)||3
7744842|NCT01526213|19068440|P2|STARTED|Washout 1 (10 Days)||3
7744843|NCT01526213|19068441|P1|STARTED|Washout 1 (10 Days)||3
7744844|NCT01526213|19068436|P6|NOT COMPLETED|Period 1 (5 Days)||0
7744845|NCT01526213|19068437|P5|NOT COMPLETED|Period 1 (5 Days)||0
7744846|NCT01526213|19068438|P4|NOT COMPLETED|Period 1 (5 Days)||0
7744847|NCT01526213|19068439|P3|NOT COMPLETED|Period 1 (5 Days)||0
7744848|NCT01526213|19068440|P2|NOT COMPLETED|Period 1 (5 Days)||0
7744849|NCT01526213|19068441|P1|NOT COMPLETED|Period 1 (5 Days)||0
7744850|NCT01526213|19068436|P6|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
7744851|NCT01526213|19068437|P5|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
7744852|NCT01526213|19068438|P4|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
7744853|NCT01526213|19068439|P3|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
7744854|NCT01526213|19068440|P2|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
7744855|NCT01526213|19068441|P1|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
7744856|NCT01526213|19068436|P6|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3
7744857|NCT01526213|19068437|P5|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
7744858|NCT01526213|19068438|P4|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
7744859|NCT01526213|19068439|P3|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
7744860|NCT01526213|19068440|P2|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
7744861|NCT01526213|19068441|P1|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
7744862|NCT01526148|19068454|P2|NOT COMPLETED|Overall Study||13
7744863|NCT01526148|19068455|P1|NOT COMPLETED|Overall Study||14
7744864|NCT01526148|19068454|P2|COMPLETED|Overall Study||11
7744865|NCT01526148|19068455|P1|COMPLETED|Overall Study||4
7744866|NCT01526148|19068454|P2|STARTED|Overall Study||24
7744867|NCT01526148|19068455|P1|STARTED|Overall Study||18
7744868|NCT01526057|19068466|P3|NOT COMPLETED|Overall Study||6
7744869|NCT01526057|19068467|P2|NOT COMPLETED|Overall Study||3
7744870|NCT01526057|19068468|P1|NOT COMPLETED|Overall Study||9
7744871|NCT01526057|19068466|P3|COMPLETED|Overall Study||67
7744872|NCT01526057|19068467|P2|COMPLETED|Overall Study||71
7744873|NCT01526057|19068468|P1|COMPLETED|Overall Study||64
7744874|NCT01526057|19068466|P3|STARTED|Overall Study||73
7744875|NCT01526057|19068467|P2|STARTED|Overall Study||74
7744876|NCT01526057|19068468|P1|STARTED|Overall Study||73
7744877|NCT01525927|19068553|P1|NOT COMPLETED|Overall Study||0
7744878|NCT01525927|19068553|P1|COMPLETED|Overall Study||0
7744879|NCT01525927|19068553|P1|STARTED|Overall Study||0
7744880|NCT01525875|19068567|P2|NOT COMPLETED|Open-label Period||2
7744881|NCT01525875|19068568|P1|NOT COMPLETED|Open-label Period||0
7744882|NCT01525875|19068567|P2|COMPLETED|Open-label Period||18
7744883|NCT01525875|19068568|P1|COMPLETED|Open-label Period||21
7744884|NCT01525875|19068567|P2|STARTED|Open-label Period||20
7744885|NCT01525875|19068568|P1|STARTED|Open-label Period||21
7744886|NCT01525875|19068567|P2|NOT COMPLETED|Placebo-controlled Period||2
7744887|NCT01525875|19068568|P1|NOT COMPLETED|Placebo-controlled Period||1
7744888|NCT01525875|19068567|P2|COMPLETED|Placebo-controlled Period||20
7744889|NCT01525875|19068568|P1|COMPLETED|Placebo-controlled Period||21
7744890|NCT01525875|19068567|P2|STARTED|Placebo-controlled Period||22
7744891|NCT01525875|19068568|P1|STARTED|Placebo-controlled Period||22
7744892|NCT01525862|19068582|P1|NOT COMPLETED|Overall Study||0
7744893|NCT01525862|19068582|P1|COMPLETED|Overall Study||21
7744894|NCT01525862|19068582|P1|STARTED|Overall Study||21
7744895|NCT01525849|19068591|P2|NOT COMPLETED|Overall Study||16
7744896|NCT01525849|19068592|P1|NOT COMPLETED|Overall Study||5
7744897|NCT01525849|19068591|P2|COMPLETED|Overall Study||59
7744898|NCT01525849|19068592|P1|COMPLETED|Overall Study||71
7744899|NCT01525849|19068591|P2|6-Months|Overall Study||60
7744900|NCT01525849|19068592|P1|6-Months|Overall Study||73
7744901|NCT01525849|19068591|P2|Treated|Overall Study|14 withdrew before treatment: 8 didn't want FESS, 1 too busy, 2 medical issues, 3 excl. criteria.|61
7744902|NCT01525849|19068592|P1|Treated|Overall Study|2 withdrew before treatment: 1 didn't want balloon dilation, 1 unrelated medical issue.|74
7744903|NCT01525849|19068591|P2|STARTED|Overall Study||75
7744904|NCT01525849|19068592|P1|STARTED|Overall Study||76
7744905|NCT01525745|19068608|P2|NOT COMPLETED|Overall Study||1
7744906|NCT01525745|19068609|P1|NOT COMPLETED|Overall Study||1
7744907|NCT01525745|19068608|P2|COMPLETED|Overall Study||1
7744908|NCT01525745|19068609|P1|COMPLETED|Overall Study||3
7744909|NCT01525745|19068608|P2|STARTED|Overall Study||2
7744910|NCT01525745|19068609|P1|STARTED|Overall Study||4
7744911|NCT01525667|19068626|P3|NOT COMPLETED|Overall Study||0
7744912|NCT01525667|19068627|P2|NOT COMPLETED|Overall Study||0
7744913|NCT01525667|19068628|P1|NOT COMPLETED|Overall Study||0
7744914|NCT01525667|19068626|P3|COMPLETED|Overall Study||7
7744915|NCT01525667|19068627|P2|COMPLETED|Overall Study||6
7744916|NCT01525667|19068628|P1|COMPLETED|Overall Study||7
7744917|NCT01525667|19068626|P3|STARTED|Overall Study||7
7744918|NCT01525667|19068627|P2|STARTED|Overall Study||6
7744919|NCT01525667|19068628|P1|STARTED|Overall Study||7
7744920|NCT01525641|19068648|P1|NOT COMPLETED|Overall Study||180
7744921|NCT01525641|19068648|P1|COMPLETED|Overall Study||435
7744922|NCT01525641|19068648|P1|STARTED|Overall Study||615
7744923|NCT01525628|19068662|P5|NOT COMPLETED|Overall Study||3
7744924|NCT01525628|19068663|P4|NOT COMPLETED|Overall Study||4
7744925|NCT01525628|19068664|P3|NOT COMPLETED|Overall Study||5
7744926|NCT01525628|19068665|P2|NOT COMPLETED|Overall Study||5
7744927|NCT01525628|19068666|P1|NOT COMPLETED|Overall Study||2
7744928|NCT01525628|19068662|P5|COMPLETED|Overall Study||4
7744929|NCT01525628|19068663|P4|COMPLETED|Overall Study||10
7744930|NCT01525628|19068664|P3|COMPLETED|Overall Study||11
7744931|NCT01525628|19068665|P2|COMPLETED|Overall Study||14
7744932|NCT01525628|19068666|P1|COMPLETED|Overall Study||14
7744933|NCT01525628|19068662|P5|STARTED|Overall Study||7
7744934|NCT01525628|19068663|P4|STARTED|Overall Study||14
7744935|NCT01525628|19068664|P3|STARTED|Overall Study||16
7744936|NCT01525628|19068665|P2|STARTED|Overall Study||19
7744937|NCT01525628|19068666|P1|STARTED|Overall Study||16
7744938|NCT01525615|19068733|P3|NOT COMPLETED|Overall Study||6
7744939|NCT01525615|19068734|P2|NOT COMPLETED|Overall Study||7
7744940|NCT01525615|19068735|P1|NOT COMPLETED|Overall Study||14
7744941|NCT01525615|19068733|P3|COMPLETED|Overall Study||133
7744942|NCT01525615|19068734|P2|COMPLETED|Overall Study||126
7744943|NCT01525615|19068735|P1|COMPLETED|Overall Study||118
7744944|NCT01525615|19068733|P3|STARTED|Overall Study||139
7744945|NCT01525615|19068734|P2|STARTED|Overall Study||133
7744946|NCT01525615|19068735|P1|STARTED|Overall Study||132
7744947|NCT01525602|19068787|P8|NOT COMPLETED|Overall Study||7
7744948|NCT01525602|19068788|P7|NOT COMPLETED|Overall Study||6
7744949|NCT01525602|19068789|P6|NOT COMPLETED|Overall Study||7
7744950|NCT01525602|19068790|P5|NOT COMPLETED|Overall Study||33
7744951|NCT01525602|19068791|P4|NOT COMPLETED|Overall Study||6
7744952|NCT01525602|19068792|P3|NOT COMPLETED|Overall Study||3
7744953|NCT01525602|19068793|P2|NOT COMPLETED|Overall Study||3
7744954|NCT01525602|19068794|P1|NOT COMPLETED|Overall Study||9
7744955|NCT01525602|19068787|P8|COMPLETED|Overall Study||0
7744956|NCT01525602|19068788|P7|COMPLETED|Overall Study||0
7744957|NCT01525602|19068789|P6|COMPLETED|Overall Study||0
7744958|NCT01525602|19068790|P5|COMPLETED|Overall Study||0
7744959|NCT01525602|19068791|P4|COMPLETED|Overall Study||0
7744960|NCT01525602|19068792|P3|COMPLETED|Overall Study||0
7744961|NCT01525602|19068793|P2|COMPLETED|Overall Study||0
7744962|NCT01525602|19068794|P1|COMPLETED|Overall Study||0
7744963|NCT01525602|19068787|P8|STARTED|Overall Study||7
7744964|NCT01525602|19068788|P7|STARTED|Overall Study||6
7744965|NCT01525602|19068789|P6|STARTED|Overall Study||7
7744966|NCT01525602|19068790|P5|STARTED|Overall Study||33
7744967|NCT01525602|19068791|P4|STARTED|Overall Study||6
7744968|NCT01525602|19068792|P3|STARTED|Overall Study||3
7744969|NCT01525602|19068793|P2|STARTED|Overall Study||3
7744970|NCT01525602|19068794|P1|STARTED|Overall Study||9
7744971|NCT01525589|19068865|P3|NOT COMPLETED|Overall Study||35
7744972|NCT01525589|19068866|P2|NOT COMPLETED|Overall Study||20
7744973|NCT01525589|19068867|P1|NOT COMPLETED|Overall Study||56
7744974|NCT01525589|19068865|P3|COMPLETED|Overall Study||0
7744975|NCT01525589|19068866|P2|COMPLETED|Overall Study||0
7744976|NCT01525589|19068867|P1|COMPLETED|Overall Study||0
7744977|NCT01525589|19068865|P3|STARTED|Overall Study||35
7744978|NCT01525589|19068866|P2|STARTED|Overall Study||20
7744979|NCT01525589|19068867|P1|STARTED|Overall Study||56
7744980|NCT01525563|19068911|P1|NOT COMPLETED|Overall Study||212
7744981|NCT01525563|19068911|P1|COMPLETED|Overall Study|6 Months Follow-up|788
7744982|NCT01525563|19068911|P1|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838
7744983|NCT01525563|19068911|P1|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910
7744984|NCT01525563|19068911|P1|STARTED|Overall Study||1000
7744985|NCT01525550|19068923|P2|NOT COMPLETED|Overall Study||45
7744986|NCT01525550|19068924|P1|NOT COMPLETED|Overall Study||61
7744987|NCT01525550|19068923|P2|COMPLETED|Overall Study||0
7744988|NCT01525550|19068924|P1|COMPLETED|Overall Study||0
7744989|NCT01525550|19068923|P2|STARTED|Overall Study||45
7744990|NCT01525550|19068924|P1|STARTED|Overall Study||61
7744991|NCT01525420|19068986|P2|NOT COMPLETED|Overall Study||24
7744992|NCT01525420|19068987|P1|NOT COMPLETED|Overall Study||16
7744993|NCT01525420|19068986|P2|COMPLETED|Overall Study||38
7744994|NCT01525420|19068987|P1|COMPLETED|Overall Study||43
7744995|NCT01525420|19068986|P2|STARTED|Overall Study||62
7744996|NCT01525420|19068987|P1|STARTED|Overall Study||59
7744997|NCT01525407|19068995|P2|NOT COMPLETED|Overall Study||4
7744998|NCT01525407|19068996|P1|NOT COMPLETED|Overall Study||3
7744999|NCT01525407|19068995|P2|COMPLETED|Overall Study||38
7745000|NCT01525407|19068996|P1|COMPLETED|Overall Study||38
7745001|NCT01525407|19068995|P2|STARTED|Overall Study||42
7745002|NCT01525407|19068996|P1|STARTED|Overall Study||41
7745003|NCT01525329|19069012|P2|NOT COMPLETED|Overall Study||0
7745004|NCT01525329|19069013|P1|NOT COMPLETED|Overall Study||0
7745005|NCT01525329|19069012|P2|COMPLETED|Overall Study||14
7745006|NCT01525329|19069013|P1|COMPLETED|Overall Study||4
7745007|NCT01525329|19069012|P2|STARTED|Overall Study||14
7745008|NCT01525329|19069013|P1|STARTED|Overall Study||4
7745009|NCT01525238|19069030|P3|NOT COMPLETED|Overall Study||0
7745010|NCT01525238|19069031|P2|NOT COMPLETED|Overall Study||0
7745011|NCT01525238|19069032|P1|NOT COMPLETED|Overall Study||1
7745012|NCT01525238|19069030|P3|COMPLETED|Overall Study||8
7745013|NCT01525238|19069031|P2|COMPLETED|Overall Study||8
7745014|NCT01525238|19069032|P1|COMPLETED|Overall Study||7
7745015|NCT01525238|19069030|P3|STARTED|Overall Study||8
7745016|NCT01525238|19069031|P2|STARTED|Overall Study||8
7745017|NCT01525238|19069032|P1|STARTED|Overall Study||8
7745018|NCT01525225|19069097|P1|NOT COMPLETED|Treated||0
7745019|NCT01525225|19069097|P1|COMPLETED|Treated||2
7745020|NCT01525225|19069097|P1|STARTED|Treated||2
7745021|NCT01525225|19069097|P1|NOT COMPLETED|Enrollment||2
7745022|NCT01525225|19069097|P1|COMPLETED|Enrollment||2
7745023|NCT01525225|19069097|P1|STARTED|Enrollment||4
7745024|NCT01525173|19069104|P2|NOT COMPLETED|Overall Study||5
7745025|NCT01525173|19069105|P1|NOT COMPLETED|Overall Study||7
7745026|NCT01525173|19069104|P2|COMPLETED|Overall Study||62
7745027|NCT01525173|19069105|P1|COMPLETED|Overall Study||63
7745028|NCT01525173|19069104|P2|STARTED|Overall Study||67
7745029|NCT01525173|19069105|P1|STARTED|Overall Study||70
7745030|NCT01525082|19069111|P1|NOT COMPLETED|Overall Study||1
7745031|NCT01525082|19069111|P1|COMPLETED|Overall Study||19
7745032|NCT01525082|19069111|P1|STARTED|Overall Study||20
7745033|NCT01524991|19069122|P1|NOT COMPLETED|Overall Study||34
7745034|NCT01524991|19069122|P1|COMPLETED|Overall Study||2
7745035|NCT01524991|19069122|P1|STARTED|Overall Study||36
7745036|NCT01524978|19069140|P11|NOT COMPLETED|Overall Study||28
7745037|NCT01524978|19069141|P10|NOT COMPLETED|Overall Study||9
7745038|NCT01524978|19069142|P9|NOT COMPLETED|Overall Study||12
7745039|NCT01524978|19069143|P8|NOT COMPLETED|Overall Study||12
7745040|NCT01524978|19069144|P7|NOT COMPLETED|Overall Study||26
7745041|NCT01524978|19069145|P6|NOT COMPLETED|Overall Study||9
7745042|NCT01524978|19069146|P5|NOT COMPLETED|Overall Study||9
7745043|NCT01524978|19069147|P4|NOT COMPLETED|Overall Study||27
7745044|NCT01524978|19069148|P3|NOT COMPLETED|Overall Study||10
7745045|NCT01524978|19069149|P2|NOT COMPLETED|Overall Study||4
7745046|NCT01524978|19069150|P1|NOT COMPLETED|Overall Study||62
7745047|NCT01524978|19069140|P11|COMPLETED|Overall Study||0
7745048|NCT01524978|19069141|P10|COMPLETED|Overall Study||0
7745049|NCT01524978|19069142|P9|COMPLETED|Overall Study||0
7745050|NCT01524978|19069143|P8|COMPLETED|Overall Study||0
7745051|NCT01524978|19069144|P7|COMPLETED|Overall Study||0
7745052|NCT01524978|19069145|P6|COMPLETED|Overall Study||0
7745053|NCT01524978|19069146|P5|COMPLETED|Overall Study||0
7745054|NCT01524978|19069147|P4|COMPLETED|Overall Study||0
7745055|NCT01524978|19069148|P3|COMPLETED|Overall Study||0
7745056|NCT01524978|19069149|P2|COMPLETED|Overall Study||0
7745057|NCT01524978|19069150|P1|COMPLETED|Overall Study||0
7745058|NCT01524978|19069140|P11|STARTED|Overall Study||28
7745059|NCT01524978|19069141|P10|STARTED|Overall Study||9
7745060|NCT01524978|19069142|P9|STARTED|Overall Study||12
7745061|NCT01524978|19069143|P8|STARTED|Overall Study||12
7745062|NCT01524978|19069144|P7|STARTED|Overall Study||26
7745063|NCT01524978|19069145|P6|STARTED|Overall Study||9
7745064|NCT01524978|19069146|P5|STARTED|Overall Study||9
7745065|NCT01524978|19069147|P4|STARTED|Overall Study||27
7745066|NCT01524978|19069148|P3|STARTED|Overall Study||10
7745067|NCT01524978|19069149|P2|STARTED|Overall Study||4
7745068|NCT01524978|19069150|P1|STARTED|Overall Study||62
7745069|NCT01524913|19069278|P3|NOT COMPLETED|Overall Study||0
7745070|NCT01524913|19069279|P2|NOT COMPLETED|Overall Study||0
7745071|NCT01524913|19069280|P1|NOT COMPLETED|Overall Study||4
7745072|NCT01524913|19069278|P3|COMPLETED|Overall Study||31
7745073|NCT01524913|19069279|P2|COMPLETED|Overall Study||36
7745074|NCT01524913|19069280|P1|COMPLETED|Overall Study||31
7745075|NCT01524913|19069278|P3|STARTED|Overall Study||31
7745076|NCT01524913|19069279|P2|STARTED|Overall Study||36
7745077|NCT01524913|19069280|P1|STARTED|Overall Study||35
7745078|NCT01524900|19069302|P5|NOT COMPLETED|Overall Study||0
7745079|NCT01524900|19069303|P4|NOT COMPLETED|Overall Study||1
7745080|NCT01524900|19069304|P3|NOT COMPLETED|Overall Study||1
7745081|NCT01524900|19069305|P2|NOT COMPLETED|Overall Study||14
7745082|NCT01524900|19069306|P1|NOT COMPLETED|Overall Study||6
7745083|NCT01524900|19069302|P5|COMPLETED|Overall Study||40
7745084|NCT01524900|19069303|P4|COMPLETED|Overall Study||21
7745085|NCT01524900|19069304|P3|COMPLETED|Overall Study||29
7745086|NCT01524900|19069305|P2|COMPLETED|Overall Study||232
7745087|NCT01524900|19069306|P1|COMPLETED|Overall Study||43
7745088|NCT01524900|19069302|P5|STARTED|Overall Study||40
7745089|NCT01524900|19069303|P4|STARTED|Overall Study||22
7745090|NCT01524900|19069304|P3|STARTED|Overall Study||30
7745091|NCT01524900|19069305|P2|STARTED|Overall Study||246
7745092|NCT01524900|19069306|P1|STARTED|Overall Study||49
7745093|NCT01524887|19069351|P3|NOT COMPLETED|Overall Study||86
7745094|NCT01524887|19069352|P2|NOT COMPLETED|Overall Study||90
7745095|NCT01524887|19069353|P1|NOT COMPLETED|Overall Study||85
7745096|NCT01524887|19069351|P3|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
7745097|NCT01524887|19069352|P2|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
7745098|NCT01524887|19069353|P1|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
7745099|NCT01524887|19069351|P3|Received Treatment|Overall Study||83
7745100|NCT01524887|19069352|P2|Received Treatment|Overall Study||85
7745101|NCT01524887|19069353|P1|Received Treatment|Overall Study||83
7745102|NCT01524887|19069351|P3|STARTED|Overall Study||86
7745103|NCT01524887|19069352|P2|STARTED|Overall Study||90
7745104|NCT01524887|19069353|P1|STARTED|Overall Study||85
7745105|NCT01524796|19069397|P1|NOT COMPLETED|Overall Study||28
7745106|NCT01524796|19069397|P1|COMPLETED|Overall Study||100
7745107|NCT01524796|19069397|P1|STARTED|Overall Study||128
7745108|NCT01524783|19069412|P2|NOT COMPLETED|Randomized and Treated||84
7745109|NCT01524783|19069413|P1|NOT COMPLETED|Randomized and Treated||155
7745110|NCT01524783|19069412|P2|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|13
7745111|NCT01524783|19069413|P1|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|48
7745112|NCT01524783|19069412|P2|STARTED|Randomized and Treated||97
7745113|NCT01524783|19069413|P1|STARTED|Randomized and Treated||203
7745114|NCT01524783|19069412|P2|NOT COMPLETED|Randomized But Not Treated||0
7745115|NCT01524783|19069413|P1|NOT COMPLETED|Randomized But Not Treated||2
7745116|NCT01524783|19069412|P2|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|97
7745117|NCT01524783|19069413|P1|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|203
7745118|NCT01524783|19069412|P2|STARTED|Randomized But Not Treated||97
7745119|NCT01524783|19069413|P1|STARTED|Randomized But Not Treated||205
7745120|NCT01524770|19069421|P2|NOT COMPLETED|Second Intervention||0
7745121|NCT01524770|19069422|P1|NOT COMPLETED|Second Intervention||0
7745122|NCT01524770|19069421|P2|COMPLETED|Second Intervention||23
7745123|NCT01524770|19069422|P1|COMPLETED|Second Intervention||23
7745124|NCT01524770|19069421|P2|STARTED|Second Intervention||23
7745125|NCT01524770|19069422|P1|STARTED|Second Intervention||23
7745126|NCT01524770|19069421|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
7745127|NCT01524770|19069422|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
7745128|NCT01524770|19069421|P2|COMPLETED|Washout Period of at Least 28 Days||23
7745129|NCT01524770|19069422|P1|COMPLETED|Washout Period of at Least 28 Days||23
7745130|NCT01524770|19069421|P2|STARTED|Washout Period of at Least 28 Days||23
7745131|NCT01524770|19069422|P1|STARTED|Washout Period of at Least 28 Days||23
7745132|NCT01524770|19069421|P2|NOT COMPLETED|First Intervention||1
7745133|NCT01524770|19069422|P1|NOT COMPLETED|First Intervention||3
7745134|NCT01524770|19069421|P2|COMPLETED|First Intervention||23
7745135|NCT01524770|19069422|P1|COMPLETED|First Intervention||23
7745136|NCT01524770|19069421|P2|Received at Least 1 Dose of Study Drug|First Intervention||24
7745137|NCT01524770|19069422|P1|Received at Least 1 Dose of Study Drug|First Intervention||26
7745138|NCT01524770|19069421|P2|STARTED|First Intervention||24
7745139|NCT01524770|19069422|P1|STARTED|First Intervention||26
7745140|NCT01524692|19069432|P1|NOT COMPLETED|Overall Study||3
7745141|NCT01524692|19069432|P1|COMPLETED|Overall Study||32
7745142|NCT01524692|19069432|P1|STARTED|Overall Study||35
7745143|NCT01524679|19069442|P2|NOT COMPLETED|Overall Study||9
7745144|NCT01524679|19069443|P1|NOT COMPLETED|Overall Study||23
7745145|NCT01524679|19069442|P2|COMPLETED|Overall Study||49
7745146|NCT01524679|19069443|P1|COMPLETED|Overall Study||89
7745147|NCT01524679|19069442|P2|STARTED|Overall Study||58
7745148|NCT01524679|19069443|P1|STARTED|Overall Study||112
7745149|NCT01524627|19069455|P2|NOT COMPLETED|Overall Study||2
7745150|NCT01524627|19069456|P1|NOT COMPLETED|Overall Study||1
7745151|NCT01524627|19069455|P2|COMPLETED|Overall Study||19
7745152|NCT01524627|19069456|P1|COMPLETED|Overall Study||21
7745153|NCT01524627|19069455|P2|STARTED|Overall Study||21
7745154|NCT01524627|19069456|P1|STARTED|Overall Study||22
7745155|NCT01524302|19069464|P2|NOT COMPLETED|Overall Study||0
7745156|NCT01524302|19069465|P1|NOT COMPLETED|Overall Study||0
7745157|NCT01524302|19069464|P2|COMPLETED|Overall Study||6
7745158|NCT01524302|19069465|P1|COMPLETED|Overall Study||6
7745159|NCT01524302|19069464|P2|STARTED|Overall Study||6
7745160|NCT01524302|19069465|P1|STARTED|Overall Study||6
7745161|NCT01524289|19069483|P2|NOT COMPLETED|Overall Study||14
7745162|NCT01524289|19069484|P1|NOT COMPLETED|Overall Study||30
7745163|NCT01524289|19069483|P2|COMPLETED|Overall Study||88
7745164|NCT01524289|19069484|P1|COMPLETED|Overall Study||174
7745165|NCT01524289|19069483|P2|Treated|Overall Study||102
7745166|NCT01524289|19069484|P1|Treated|Overall Study||203
7745167|NCT01524289|19069483|P2|STARTED|Overall Study||102
7745168|NCT01524289|19069484|P1|STARTED|Overall Study||204
7745169|NCT01524224|19069542|P8|NOT COMPLETED|Overall Study||6
7745170|NCT01524224|19069543|P7|NOT COMPLETED|Overall Study||3
7745171|NCT01524224|19069544|P6|NOT COMPLETED|Overall Study||2
7745172|NCT01524224|19069545|P5|NOT COMPLETED|Overall Study||4
7745173|NCT01524224|19069546|P4|NOT COMPLETED|Overall Study||2
7745174|NCT01524224|19069547|P3|NOT COMPLETED|Overall Study||2
7745175|NCT01524224|19069548|P2|NOT COMPLETED|Overall Study||1
7745176|NCT01524224|19069549|P1|NOT COMPLETED|Overall Study||3
7745177|NCT01524224|19069542|P8|COMPLETED|Overall Study||0
7745178|NCT01524224|19069543|P7|COMPLETED|Overall Study||0
7745179|NCT01524224|19069544|P6|COMPLETED|Overall Study||1
7745180|NCT01524224|19069545|P5|COMPLETED|Overall Study||0
7745181|NCT01524224|19069546|P4|COMPLETED|Overall Study||1
7745182|NCT01524224|19069547|P3|COMPLETED|Overall Study||1
7745183|NCT01524224|19069548|P2|COMPLETED|Overall Study||2
7745184|NCT01524224|19069549|P1|COMPLETED|Overall Study||1
7745185|NCT01524224|19069542|P8|Received at Least One Dose of Study Drug|Overall Study||6
7745186|NCT01524224|19069543|P7|Received at Least One Dose of Study Drug|Overall Study||3
7745187|NCT01524224|19069544|P6|Received at Least One Dose of Study Drug|Overall Study||3
7745188|NCT01524224|19069545|P5|Received at Least One Dose of Study Drug|Overall Study||4
7745189|NCT01524224|19069546|P4|Received at Least One Dose of Study Drug|Overall Study||3
7745190|NCT01524224|19069547|P3|Received at Least One Dose of Study Drug|Overall Study||3
7745191|NCT01524224|19069548|P2|Received at Least One Dose of Study Drug|Overall Study||3
7745192|NCT01524224|19069549|P1|Received at Least One Dose of Study Drug|Overall Study||4
7745193|NCT01524224|19069542|P8|STARTED|Overall Study||6
7745194|NCT01524224|19069543|P7|STARTED|Overall Study||3
7745195|NCT01524224|19069544|P6|STARTED|Overall Study||3
7745196|NCT01524224|19069545|P5|STARTED|Overall Study||4
7745197|NCT01524224|19069546|P4|STARTED|Overall Study||3
7745198|NCT01524224|19069547|P3|STARTED|Overall Study||3
7745199|NCT01524224|19069548|P2|STARTED|Overall Study||3
7745200|NCT01524224|19069549|P1|STARTED|Overall Study||4
7745201|NCT01524198|19069585|P2|NOT COMPLETED|Overall Study||16
7745202|NCT01524198|19069586|P1|NOT COMPLETED|Overall Study||23
7745203|NCT01524198|19069585|P2|COMPLETED|Overall Study||458
7745204|NCT01524198|19069586|P1|COMPLETED|Overall Study||448
7745205|NCT01524198|19069585|P2|STARTED|Overall Study||474
7745206|NCT01524198|19069586|P1|STARTED|Overall Study||471
7745207|NCT01524133|19069597|P3|NOT COMPLETED|Overall Study 52 Weeks||27
7745208|NCT01524133|19069598|P2|NOT COMPLETED|Overall Study 52 Weeks||20
7745209|NCT01524133|19069599|P1|NOT COMPLETED|Overall Study 52 Weeks||21
7745210|NCT01524133|19069597|P3|COMPLETED|Overall Study 52 Weeks||40
7745211|NCT01524133|19069598|P2|COMPLETED|Overall Study 52 Weeks||49
7745212|NCT01524133|19069599|P1|COMPLETED|Overall Study 52 Weeks||50
7745213|NCT01524133|19069597|P3|STARTED|Overall Study 52 Weeks||67
7745214|NCT01524133|19069598|P2|STARTED|Overall Study 52 Weeks||69
7745215|NCT01524133|19069599|P1|STARTED|Overall Study 52 Weeks||71
7745216|NCT01524133|19069597|P3|NOT COMPLETED|Treatment Phase||36
7745217|NCT01524133|19069598|P2|NOT COMPLETED|Treatment Phase||32
7745218|NCT01524133|19069599|P1|NOT COMPLETED|Treatment Phase||19
7745219|NCT01524133|19069597|P3|COMPLETED|Treatment Phase|Completed both assigned treatments|31
7745220|NCT01524133|19069598|P2|COMPLETED|Treatment Phase|Completed Both Assigned Treatments|37
7745221|NCT01524133|19069599|P1|COMPLETED|Treatment Phase|Completed Both Assigned treatment|52
7745222|NCT01524133|19069597|P3|STARTED|Treatment Phase||67
7745223|NCT01524133|19069598|P2|STARTED|Treatment Phase||69
7745224|NCT01524133|19069599|P1|STARTED|Treatment Phase||71
7745225|NCT01523964|19069614|P4|NOT COMPLETED|Overall Study||0
7745226|NCT01523964|19069615|P3|NOT COMPLETED|Overall Study||0
7745227|NCT01523964|19069616|P2|NOT COMPLETED|Overall Study||0
7745228|NCT01523964|19069617|P1|NOT COMPLETED|Overall Study||0
7745229|NCT01523964|19069614|P4|COMPLETED|Overall Study||15
7745230|NCT01523964|19069615|P3|COMPLETED|Overall Study||16
7745231|NCT01523964|19069616|P2|COMPLETED|Overall Study||30
7745232|NCT01523964|19069617|P1|COMPLETED|Overall Study||31
7745233|NCT01523964|19069614|P4|STARTED|Overall Study||15
7745234|NCT01523964|19069615|P3|STARTED|Overall Study||16
7745235|NCT01523964|19069616|P2|STARTED|Overall Study||30
7745236|NCT01523964|19069617|P1|STARTED|Overall Study||31
7745237|NCT01523899|19069629|P2|NOT COMPLETED|Overall Study||0
7745238|NCT01523899|19069630|P1|NOT COMPLETED|Overall Study||0
7745239|NCT01523899|19069629|P2|COMPLETED|Overall Study||126
7745240|NCT01523899|19069630|P1|COMPLETED|Overall Study||126
7745241|NCT01523899|19069629|P2|STARTED|Overall Study||126
7745242|NCT01523899|19069630|P1|STARTED|Overall Study||126
7745243|NCT01523886|19069642|P2|NOT COMPLETED|Overall Study||1
7745244|NCT01523886|19069643|P1|NOT COMPLETED|Overall Study||0
7745245|NCT01523886|19069642|P2|COMPLETED|Overall Study||23
7745246|NCT01523886|19069643|P1|COMPLETED|Overall Study||25
7745247|NCT01523886|19069642|P2|STARTED|Overall Study||24
7745248|NCT01523886|19069643|P1|STARTED|Overall Study||25
7745249|NCT01523873|19069649|P1|NOT COMPLETED|Overall Study||422
7745250|NCT01523873|19069649|P1|COMPLETED|Overall Study||35499
7745251|NCT01523873|19069649|P1|Administered With Dotarem|Overall Study||35474
7745252|NCT01523873|19069649|P1|STARTED|Overall Study||35921
7745253|NCT01523834|19069656|P1|NOT COMPLETED|Overall Study||31
7745254|NCT01523834|19069656|P1|COMPLETED|Overall Study||4
7745255|NCT01523834|19069656|P1|Maintenance Phase|Overall Study|Started Maintenance Phase|6
7745256|NCT01523834|19069656|P1|Consolidation Phase|Overall Study|Started Consolidation Phase|7
7745257|NCT01523834|19069656|P1|STARTED|Overall Study|Started Induction Phase|35
7745258|NCT01523821|19069667|P3|NOT COMPLETED|Overall Study||0
7745259|NCT01523821|19069668|P2|NOT COMPLETED|Overall Study||0
7745260|NCT01523821|19069669|P1|NOT COMPLETED|Overall Study||0
7745261|NCT01523821|19069667|P3|COMPLETED|Overall Study||6
7745262|NCT01523821|19069668|P2|COMPLETED|Overall Study||6
7745263|NCT01523821|19069669|P1|COMPLETED|Overall Study||8
7745264|NCT01523821|19069667|P3|STARTED|Overall Study||6
7745265|NCT01523821|19069668|P2|STARTED|Overall Study||6
7745266|NCT01523821|19069669|P1|STARTED|Overall Study||8
7745267|NCT01523782|19069695|P3|NOT COMPLETED|Overall Study||5
7745268|NCT01523782|19069696|P2|NOT COMPLETED|Overall Study||0
7745269|NCT01523782|19069697|P1|NOT COMPLETED|Overall Study||1
7745270|NCT01523782|19069695|P3|COMPLETED|Overall Study||9
7745271|NCT01523782|19069696|P2|COMPLETED|Overall Study||13
7745272|NCT01523782|19069697|P1|COMPLETED|Overall Study||2
7745273|NCT01523782|19069695|P3|STARTED|Overall Study||14
7745274|NCT01523782|19069696|P2|STARTED|Overall Study||13
7745275|NCT01523782|19069697|P1|STARTED|Overall Study||3
7745276|NCT01523756|19069744|P2|NOT COMPLETED|Test Period 2||1
7745277|NCT01523756|19069745|P1|NOT COMPLETED|Test Period 2||0
7745278|NCT01523756|19069744|P2|COMPLETED|Test Period 2||7
7745279|NCT01523756|19069745|P1|COMPLETED|Test Period 2||10
7745280|NCT01523756|19069744|P2|STARTED|Test Period 2||8
7745281|NCT01523756|19069745|P1|STARTED|Test Period 2||10
7745282|NCT01523756|19069744|P2|NOT COMPLETED|Test Period 1||0
7745283|NCT01523756|19069745|P1|NOT COMPLETED|Test Period 1||1
7745284|NCT01523756|19069744|P2|COMPLETED|Test Period 1||8
7745285|NCT01523756|19069745|P1|COMPLETED|Test Period 1||10
7745286|NCT01523756|19069744|P2|STARTED|Test Period 1||8
7745287|NCT01523756|19069745|P1|STARTED|Test Period 1||11
7745288|NCT01523756|19069744|P2|NOT COMPLETED|Baseline Period||1
7745289|NCT01523756|19069745|P1|NOT COMPLETED|Baseline Period||0
7745290|NCT01523756|19069744|P2|COMPLETED|Baseline Period||8
7745291|NCT01523756|19069745|P1|COMPLETED|Baseline Period||11
7745292|NCT01523756|19069744|P2|STARTED|Baseline Period||9
7745293|NCT01523756|19069745|P1|STARTED|Baseline Period||11
7745294|NCT01523743|19069753|P2|NOT COMPLETED|Period 2||2
7745295|NCT01523743|19069754|P1|NOT COMPLETED|Period 2||1
7745296|NCT01523743|19069753|P2|COMPLETED|Period 2||58
7745297|NCT01523743|19069754|P1|COMPLETED|Period 2||52
7745298|NCT01523743|19069753|P2|STARTED|Period 2||60
7745299|NCT01523743|19069754|P1|STARTED|Period 2||53
7745300|NCT01523743|19069753|P2|NOT COMPLETED|Period 1||2
7745301|NCT01523743|19069754|P1|NOT COMPLETED|Period 1||10
7745302|NCT01523743|19069753|P2|COMPLETED|Period 1||60
7745303|NCT01523743|19069754|P1|COMPLETED|Period 1||53
7745304|NCT01523743|19069753|P2|STARTED|Period 1||62
7745305|NCT01523743|19069754|P1|STARTED|Period 1||63
7745306|NCT01523613|19069763|P3|NOT COMPLETED|Overall Study||12
7745307|NCT01523613|19069764|P2|NOT COMPLETED|Overall Study||5
7745308|NCT01523613|19069765|P1|NOT COMPLETED|Overall Study||7
7745309|NCT01523613|19069763|P3|COMPLETED|Overall Study|- 42 paired restorations (21R and 21F)|21
7745310|NCT01523613|19069764|P2|COMPLETED|Overall Study|- 25 single restorations (25F)|25
7745311|NCT01523613|19069765|P1|COMPLETED|Overall Study|- 23 single restorations (23R)|23
7745312|NCT01523613|19069763|P3|STARTED|Overall Study|- 66 paired restorations (33R + 33F)|33
7745313|NCT01523613|19069764|P2|STARTED|Overall Study|- 30 single restorations (30 F)|30
7745314|NCT01523613|19069765|P1|STARTED|Overall Study|- 30 single restorations (30 R)|30
7745315|NCT01523587|19069777|P2|NOT COMPLETED|Overall Study||397
7745316|NCT01523587|19069778|P1|NOT COMPLETED|Overall Study||398
7745317|NCT01523587|19069777|P2|COMPLETED|Overall Study||0
7745318|NCT01523587|19069778|P1|COMPLETED|Overall Study||0
7745319|NCT01523587|19069777|P2|Treated|Overall Study||395
7745320|NCT01523587|19069778|P1|Treated|Overall Study||392
7745321|NCT01523587|19069777|P2|STARTED|Overall Study||397
7745322|NCT01523587|19069778|P1|STARTED|Overall Study||398
7745323|NCT01523496|19069802|P4|NOT COMPLETED|Overall Study||3
7745324|NCT01523496|19069803|P3|NOT COMPLETED|Overall Study||12
7745325|NCT01523496|19069804|P2|NOT COMPLETED|Overall Study||4
7745326|NCT01523496|19069805|P1|NOT COMPLETED|Overall Study||10
7745327|NCT01523496|19069802|P4|COMPLETED|Overall Study||27
7745328|NCT01523496|19069803|P3|COMPLETED|Overall Study||46
7745329|NCT01523496|19069804|P2|COMPLETED|Overall Study||32
7745330|NCT01523496|19069805|P1|COMPLETED|Overall Study||56
7745331|NCT01523496|19069802|P4|STARTED|Overall Study||30
7745332|NCT01523496|19069803|P3|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|58
7745333|NCT01523496|19069804|P2|STARTED|Overall Study||36
7745334|NCT01523496|19069805|P1|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|66
7745335|NCT01523457|19069821|P2|NOT COMPLETED|Overall Study||2
7745336|NCT01523457|19069822|P1|NOT COMPLETED|Overall Study||7
7745337|NCT01523457|19069821|P2|COMPLETED|Overall Study||29
7745338|NCT01523457|19069822|P1|COMPLETED|Overall Study||37
7745339|NCT01523457|19069821|P2|STARTED|Overall Study||31
7745340|NCT01523457|19069822|P1|STARTED|Overall Study||44
7745341|NCT01523392|19069840|P2|NOT COMPLETED|Treatment Period 2||0
7745342|NCT01523392|19069841|P1|NOT COMPLETED|Treatment Period 2||0
7745343|NCT01523392|19069840|P2|COMPLETED|Treatment Period 2||14
7745344|NCT01523392|19069841|P1|COMPLETED|Treatment Period 2||17
7745345|NCT01523392|19069840|P2|STARTED|Treatment Period 2||14
7745346|NCT01523392|19069841|P1|STARTED|Treatment Period 2||17
7745347|NCT01523392|19069840|P2|NOT COMPLETED|Washout Period - 10 to 14 Days||0
7745348|NCT01523392|19069841|P1|NOT COMPLETED|Washout Period - 10 to 14 Days||1
7745349|NCT01523392|19069840|P2|COMPLETED|Washout Period - 10 to 14 Days||14
7745350|NCT01523392|19069841|P1|COMPLETED|Washout Period - 10 to 14 Days||17
7745351|NCT01523392|19069840|P2|STARTED|Washout Period - 10 to 14 Days||14
7745352|NCT01523392|19069841|P1|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18
7745353|NCT01523392|19069840|P2|NOT COMPLETED|Treatment Period 1||0
7745354|NCT01523392|19069841|P1|NOT COMPLETED|Treatment Period 1||3
7745355|NCT01523392|19069840|P2|COMPLETED|Treatment Period 1||14
7745356|NCT01523392|19069841|P1|COMPLETED|Treatment Period 1||17
7745357|NCT01523392|19069840|P2|STARTED|Treatment Period 1||14
7745358|NCT01523392|19069841|P1|STARTED|Treatment Period 1||20
7745359|NCT01523366|19069857|P2|NOT COMPLETED|Treatment Period 2||0
7745360|NCT01523366|19069858|P1|NOT COMPLETED|Treatment Period 2||1
7745361|NCT01523366|19069857|P2|COMPLETED|Treatment Period 2||20
7745362|NCT01523366|19069858|P1|COMPLETED|Treatment Period 2||18
7745363|NCT01523366|19069857|P2|STARTED|Treatment Period 2||20
7745364|NCT01523366|19069858|P1|STARTED|Treatment Period 2||19
7745365|NCT01523366|19069857|P2|NOT COMPLETED|Washout Period - 10-14 Days||0
7745366|NCT01523366|19069858|P1|NOT COMPLETED|Washout Period - 10-14 Days||0
7745367|NCT01523366|19069857|P2|COMPLETED|Washout Period - 10-14 Days||20
7745368|NCT01523366|19069858|P1|COMPLETED|Washout Period - 10-14 Days||19
7745369|NCT01523366|19069857|P2|STARTED|Washout Period - 10-14 Days||20
7745370|NCT01523366|19069858|P1|STARTED|Washout Period - 10-14 Days||19
7745371|NCT01523366|19069857|P2|NOT COMPLETED|Treatment Period 1||0
7745372|NCT01523366|19069858|P1|NOT COMPLETED|Treatment Period 1||1
7745373|NCT01523366|19069857|P2|COMPLETED|Treatment Period 1||20
7745374|NCT01523366|19069858|P1|COMPLETED|Treatment Period 1||19
7745375|NCT01523366|19069857|P2|STARTED|Treatment Period 1||20
7745376|NCT01523366|19069858|P1|STARTED|Treatment Period 1||20
7745377|NCT01523301|19069874|P2|NOT COMPLETED|Overall Study||32
7745378|NCT01523301|19069875|P1|NOT COMPLETED|Overall Study||35
7745379|NCT01523301|19069874|P2|COMPLETED|Overall Study||164
7745380|NCT01523301|19069875|P1|COMPLETED|Overall Study||149
7745381|NCT01523301|19069874|P2|STARTED|Overall Study||196
7745382|NCT01523301|19069875|P1|STARTED|Overall Study||184
7745383|NCT01523275|19069895|P2|NOT COMPLETED|Overall Study||2
7745384|NCT01523275|19069896|P1|NOT COMPLETED|Overall Study||2
7745385|NCT01523275|19069895|P2|COMPLETED|Overall Study||7
7745386|NCT01523275|19069896|P1|COMPLETED|Overall Study||4
7745387|NCT01523275|19069895|P2|STARTED|Overall Study||9
7745388|NCT01523275|19069896|P1|STARTED|Overall Study||6
7745389|NCT01522976|19069909|P3|NOT COMPLETED|Overall Study||93
7745390|NCT01522976|19069910|P2|NOT COMPLETED|Overall Study||92
7745391|NCT01522976|19069911|P1|NOT COMPLETED|Overall Study||97
7745392|NCT01522976|19069909|P3|COMPLETED|Overall Study||0
7745393|NCT01522976|19069910|P2|COMPLETED|Overall Study||0
7745394|NCT01522976|19069911|P1|COMPLETED|Overall Study||0
7745395|NCT01522976|19069909|P3|STARTED|Overall Study||93
7745396|NCT01522976|19069910|P2|STARTED|Overall Study||92
7745397|NCT01522976|19069911|P1|STARTED|Overall Study||97
7745398|NCT01522963|19069938|P4|NOT COMPLETED|Overall Study||6
7745399|NCT01522963|19069939|P3|NOT COMPLETED|Overall Study||3
7745400|NCT01522963|19069940|P2|NOT COMPLETED|Overall Study||3
7745401|NCT01522963|19069941|P1|NOT COMPLETED|Overall Study||2
7745402|NCT01522963|19069938|P4|COMPLETED|Overall Study||18
7745403|NCT01522963|19069939|P3|COMPLETED|Overall Study||22
7745404|NCT01522963|19069940|P2|COMPLETED|Overall Study||22
7745405|NCT01522963|19069941|P1|COMPLETED|Overall Study||22
7745406|NCT01522963|19069938|P4|STARTED|Overall Study||24
7745407|NCT01522963|19069939|P3|STARTED|Overall Study||25
7745408|NCT01522963|19069940|P2|STARTED|Overall Study||25
7745409|NCT01522963|19069941|P1|STARTED|Overall Study||24
7745410|NCT01522950|19069956|P3|NOT COMPLETED|Overall Study||5
7745411|NCT01522950|19069957|P2|NOT COMPLETED|Overall Study||5
7745412|NCT01522950|19069958|P1|NOT COMPLETED|Overall Study||6
7745413|NCT01522950|19069956|P3|COMPLETED|Overall Study||22
7745414|NCT01522950|19069957|P2|COMPLETED|Overall Study||18
7745415|NCT01522950|19069958|P1|COMPLETED|Overall Study||20
7745416|NCT01522950|19069956|P3|STARTED|Overall Study||27
7745417|NCT01522950|19069957|P2|STARTED|Overall Study||23
7745418|NCT01522950|19069958|P1|STARTED|Overall Study||26
7745419|NCT01522937|19069975|P1|NOT COMPLETED|Overall Study||0
7745420|NCT01522937|19069975|P1|COMPLETED|Overall Study||146
7745421|NCT01522937|19069975|P1|STARTED|Overall Study||146
7745422|NCT01522924|19069985|P2|NOT COMPLETED|Overall Study||0
7745423|NCT01522924|19069986|P1|NOT COMPLETED|Overall Study||0
7745424|NCT01522924|19069985|P2|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52
7745425|NCT01522924|19069986|P1|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42
7745426|NCT01522924|19069985|P2|STARTED|Overall Study|There were 52 dental students in the control group.|52
7745427|NCT01522924|19069986|P1|STARTED|Overall Study|There were 42 dental students in the intervention group.|42
7745428|NCT01522755|19070004|P1|NOT COMPLETED|Overall Study||0
7745429|NCT01522755|19070004|P1|COMPLETED|Overall Study||409
7745430|NCT01522755|19070004|P1|STARTED|Overall Study||409
7745431|NCT01522703|19070014|P2|NOT COMPLETED|Overall Study||6
7745432|NCT01522703|19070015|P1|NOT COMPLETED|Overall Study||5
7745433|NCT01522703|19070014|P2|COMPLETED|Overall Study||20
7745434|NCT01522703|19070015|P1|COMPLETED|Overall Study||20
7745435|NCT01522703|19070014|P2|STARTED|Overall Study||26
7745436|NCT01522703|19070015|P1|STARTED|Overall Study||25
7745437|NCT01522651|19070026|P5|NOT COMPLETED|Overall Study||6
7745438|NCT01522651|19070027|P4|NOT COMPLETED|Overall Study||8
7745439|NCT01522651|19070028|P3|NOT COMPLETED|Overall Study||4
7745440|NCT01522651|19070029|P2|NOT COMPLETED|Overall Study||8
7745441|NCT01522651|19070030|P1|NOT COMPLETED|Overall Study||9
7745442|NCT01522651|19070026|P5|COMPLETED|Overall Study||21
7745443|NCT01522651|19070027|P4|COMPLETED|Overall Study||20
7745444|NCT01522651|19070028|P3|COMPLETED|Overall Study||22
7745445|NCT01522651|19070029|P2|COMPLETED|Overall Study||19
7745446|NCT01522651|19070030|P1|COMPLETED|Overall Study||17
7745447|NCT01522651|19070026|P5|STARTED|Overall Study||27
7745448|NCT01522651|19070027|P4|STARTED|Overall Study||28
7745449|NCT01522651|19070028|P3|STARTED|Overall Study||26
7745450|NCT01522651|19070029|P2|STARTED|Overall Study||27
7745451|NCT01522651|19070030|P1|STARTED|Overall Study||26
7745452|NCT01522456|19070057|P1|NOT COMPLETED|Overall Study||8
7745453|NCT01522456|19070057|P1|COMPLETED|Overall Study||65
7745454|NCT01522456|19070057|P1|STARTED|Overall Study||73
7745455|NCT01522443|19070120|P2|NOT COMPLETED|Overall Study||55
7745456|NCT01522443|19070121|P1|NOT COMPLETED|Overall Study||53
7745457|NCT01522443|19070120|P2|COMPLETED|Overall Study||3
7745458|NCT01522443|19070121|P1|COMPLETED|Overall Study||8
7745459|NCT01522443|19070120|P2|STARTED|Overall Study||58
7745460|NCT01522443|19070121|P1|STARTED|Overall Study||61
7745461|NCT01522404|19070133|P2|NOT COMPLETED|Second Intervention (up to Week 58)||0
7745462|NCT01522404|19070134|P1|NOT COMPLETED|Second Intervention (up to Week 58)||1
7745463|NCT01522404|19070133|P2|COMPLETED|Second Intervention (up to Week 58)||19
7745464|NCT01522404|19070134|P1|COMPLETED|Second Intervention (up to Week 58)||17
7745465|NCT01522404|19070133|P2|STARTED|Second Intervention (up to Week 58)||19
7745466|NCT01522404|19070134|P1|STARTED|Second Intervention (up to Week 58)||18
7745467|NCT01522404|19070133|P2|NOT COMPLETED|First Intervention (up to Week 29)||0
7745468|NCT01522404|19070134|P1|NOT COMPLETED|First Intervention (up to Week 29)||2
7745469|NCT01522404|19070133|P2|COMPLETED|First Intervention (up to Week 29)||19
7745470|NCT01522404|19070134|P1|COMPLETED|First Intervention (up to Week 29)||18
7745471|NCT01522404|19070133|P2|STARTED|First Intervention (up to Week 29)||19
7745472|NCT01522404|19070134|P1|STARTED|First Intervention (up to Week 29)||20
7745473|NCT01522391|19070152|P2|NOT COMPLETED|Overall Study||1
7745474|NCT01522391|19070153|P1|NOT COMPLETED|Overall Study||1
7745475|NCT01522391|19070152|P2|COMPLETED|Overall Study||20
7745476|NCT01522391|19070153|P1|COMPLETED|Overall Study||19
7745477|NCT01522391|19070152|P2|STARTED|Overall Study||21
7745478|NCT01522391|19070153|P1|STARTED|Overall Study||20
7745479|NCT01522339|19070213|P1|NOT COMPLETED|Overall Study||0
7745480|NCT01522339|19070213|P1|COMPLETED|Overall Study||15
7745481|NCT01522339|19070213|P1|STARTED|Overall Study||15
7745482|NCT01522248|19070220|P2|NOT COMPLETED|Overall Study||0
7745483|NCT01522248|19070221|P1|NOT COMPLETED|Overall Study||1
7745484|NCT01522248|19070220|P2|COMPLETED|Overall Study||10
7745485|NCT01522248|19070221|P1|COMPLETED|Overall Study||9
7745486|NCT01522248|19070220|P2|STARTED|Overall Study||10
7745487|NCT01522248|19070221|P1|STARTED|Overall Study||10
7745488|NCT01522235|19070236|P2|NOT COMPLETED|Overall Study||1
7745489|NCT01522235|19070237|P1|NOT COMPLETED|Overall Study||1
7745490|NCT01522235|19070236|P2|COMPLETED|Overall Study||2
7745491|NCT01522235|19070237|P1|COMPLETED|Overall Study||2
7745492|NCT01522235|19070236|P2|Randomized|Overall Study||3
7745493|NCT01522235|19070237|P1|Randomized|Overall Study||2
7745494|NCT01522235|19070236|P2|STARTED|Overall Study||3
7745495|NCT01522235|19070237|P1|STARTED|Overall Study||3
7745496|NCT01522131|19070255|P2|NOT COMPLETED|Overall Study||0
7745497|NCT01522131|19070256|P1|NOT COMPLETED|Overall Study||2
7745498|NCT01522131|19070255|P2|COMPLETED|Overall Study||17
7745499|NCT01522131|19070256|P1|COMPLETED|Overall Study||14
7745500|NCT01522131|19070255|P2|STARTED|Overall Study||17
7745501|NCT01522131|19070256|P1|STARTED|Overall Study||16
7745502|NCT01521949|19070264|P1|NOT COMPLETED|Overall Study||0
7745503|NCT01521949|19070264|P1|COMPLETED|Overall Study||21
7745504|NCT01521949|19070264|P1|STARTED|Overall Study||21
7745505|NCT01521923|19070273|P4|NOT COMPLETED|Overall Study||13
7745506|NCT01521923|19070274|P3|NOT COMPLETED|Overall Study||15
7745507|NCT01521923|19070275|P2|NOT COMPLETED|Overall Study||9
7745508|NCT01521923|19070276|P1|NOT COMPLETED|Overall Study||7
7745509|NCT01521923|19070273|P4|COMPLETED|Overall Study||70
7745510|NCT01521923|19070274|P3|COMPLETED|Overall Study||112
7745511|NCT01521923|19070275|P2|COMPLETED|Overall Study||72
7745512|NCT01521923|19070276|P1|COMPLETED|Overall Study||59
7745513|NCT01521923|19070273|P4|STARTED|Overall Study||83
7745514|NCT01521923|19070274|P3|STARTED|Overall Study||127
7745515|NCT01521923|19070275|P2|STARTED|Overall Study||81
7745516|NCT01521923|19070276|P1|STARTED|Overall Study||66
7745517|NCT01521897|19070396|P1|NOT COMPLETED|Overall Study||23
7745518|NCT01521897|19070396|P1|COMPLETED|Overall Study||1120
7745519|NCT01521897|19070396|P1|STARTED|Overall Study||1143
7745520|NCT01521884|19070408|P1|NOT COMPLETED|Overall Study||27
7745521|NCT01521884|19070408|P1|COMPLETED|Overall Study||35
7745522|NCT01521884|19070408|P1|STARTED|Overall Study||62
7745523|NCT01521871|19070427|P2|NOT COMPLETED|Overall Study||0
7745524|NCT01521871|19070428|P1|NOT COMPLETED|Overall Study||0
7745525|NCT01521871|19070427|P2|COMPLETED|Overall Study||32
7745526|NCT01521871|19070428|P1|COMPLETED|Overall Study||32
7745527|NCT01521871|19070427|P2|STARTED|Overall Study||32
7745528|NCT01521871|19070428|P1|STARTED|Overall Study||32
7745529|NCT01521845|19070468|P2|NOT COMPLETED|Overall Study||5
7745530|NCT01521845|19070469|P1|NOT COMPLETED|Overall Study||9
7745531|NCT01521845|19070468|P2|COMPLETED|Overall Study||47
7745532|NCT01521845|19070469|P1|COMPLETED|Overall Study||43
7745533|NCT01521845|19070468|P2|STARTED|Overall Study||52
7745534|NCT01521845|19070469|P1|STARTED|Overall Study||52
7745535|NCT01521780|19070479|P3|NOT COMPLETED|Overall Study||0
7745536|NCT01521780|19070480|P2|NOT COMPLETED|Overall Study||0
7745537|NCT01521780|19070481|P1|NOT COMPLETED|Overall Study||0
7745538|NCT01521780|19070479|P3|COMPLETED|Overall Study||2
7745539|NCT01521780|19070480|P2|COMPLETED|Overall Study||1
7745540|NCT01521780|19070481|P1|COMPLETED|Overall Study||9
7745541|NCT01521780|19070479|P3|STARTED|Overall Study||2
7745542|NCT01521780|19070480|P2|STARTED|Overall Study||1
7745543|NCT01521780|19070481|P1|STARTED|Overall Study||9
7745544|NCT01521559|19070505|P2|NOT COMPLETED|Overall Study||18
7745545|NCT01521559|19070506|P1|NOT COMPLETED|Overall Study||15
7745546|NCT01521559|19070505|P2|COMPLETED|Overall Study||73
7745547|NCT01521559|19070506|P1|COMPLETED|Overall Study||77
7745548|NCT01521559|19070505|P2|Completed Week 52|Overall Study||73
7745549|NCT01521559|19070506|P1|Completed Week 52|Overall Study||77
7745550|NCT01521559|19070505|P2|Completed Week 24|Overall Study||85
7745551|NCT01521559|19070506|P1|Completed Week 24|Overall Study||83
7745552|NCT01521559|19070505|P2|STARTED|Overall Study||91
7745553|NCT01521559|19070506|P1|STARTED|Overall Study||92
7745554|NCT01521546|19070520|P2|NOT COMPLETED|Overall Study||0
7745555|NCT01521546|19070521|P1|NOT COMPLETED|Overall Study||2
7745556|NCT01521546|19070520|P2|COMPLETED|Overall Study||20
7745557|NCT01521546|19070521|P1|COMPLETED|Overall Study||20
7745558|NCT01521546|19070520|P2|STARTED|Overall Study||20
7745559|NCT01521546|19070521|P1|STARTED|Overall Study||22
7745560|NCT01521507|19070529|P2|NOT COMPLETED|Stage 2: Observational Design||2
7745561|NCT01521507|19070530|P1|NOT COMPLETED|Stage 2: Observational Design||4
7745562|NCT01521507|19070529|P2|COMPLETED|Stage 2: Observational Design||92
7745563|NCT01521507|19070530|P1|COMPLETED|Stage 2: Observational Design||94
7745564|NCT01521507|19070529|P2|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1
7745565|NCT01521507|19070530|P1|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2
7745566|NCT01521507|19070529|P2|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9
7745567|NCT01521507|19070530|P1|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11
7745568|NCT01521507|19070529|P2|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82
7745569|NCT01521507|19070530|P1|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81
7745570|NCT01521507|19070529|P2|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93
7745571|NCT01521507|19070530|P1|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0
7745572|NCT01521507|19070529|P2|STARTED|Stage 2: Observational Design||94
7745573|NCT01521507|19070530|P1|STARTED|Stage 2: Observational Design||98
7745574|NCT01521507|19070529|P2|NOT COMPLETED|Stage 1: Randomized Design||5
7745575|NCT01521507|19070530|P1|NOT COMPLETED|Stage 1: Randomized Design||3
7745576|NCT01521507|19070529|P2|COMPLETED|Stage 1: Randomized Design||94
7745577|NCT01521507|19070530|P1|COMPLETED|Stage 1: Randomized Design||98
7745578|NCT01521507|19070529|P2|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98
7745579|NCT01521507|19070530|P1|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99
7745580|NCT01521507|19070529|P2|STARTED|Stage 1: Randomized Design||99
7745581|NCT01521507|19070530|P1|STARTED|Stage 1: Randomized Design||101
7745582|NCT01521494|19070552|P5|NOT COMPLETED|Overall Study||7
7745583|NCT01521494|19070553|P4|NOT COMPLETED|Overall Study||21
7745584|NCT01521494|19070554|P3|NOT COMPLETED|Overall Study||12
7745585|NCT01521494|19070555|P2|NOT COMPLETED|Overall Study||5
7745586|NCT01521494|19070556|P1|NOT COMPLETED|Overall Study||2
7745587|NCT01521494|19070552|P5|COMPLETED|Overall Study||30
7745588|NCT01521494|19070553|P4|COMPLETED|Overall Study||15
7745589|NCT01521494|19070554|P3|COMPLETED|Overall Study||23
7745590|NCT01521494|19070555|P2|COMPLETED|Overall Study||31
7745591|NCT01521494|19070556|P1|COMPLETED|Overall Study||37
7745592|NCT01521494|19070552|P5|STARTED|Overall Study||37
7745593|NCT01521494|19070553|P4|STARTED|Overall Study||36
7745594|NCT01521494|19070554|P3|STARTED|Overall Study||35
7745595|NCT01521494|19070555|P2|STARTED|Overall Study||36
7745596|NCT01521494|19070556|P1|STARTED|Overall Study||39
7745597|NCT01521364|19070578|P1|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1
7745598|NCT01521364|19070578|P1|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5
7745599|NCT01521364|19070578|P1|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6
7745600|NCT01521364|19070578|P1|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1
7745601|NCT01521364|19070578|P1|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6
7745602|NCT01521364|19070578|P1|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7
7745603|NCT01521364|19070578|P1|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0
7745604|NCT01521364|19070578|P1|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7
7745605|NCT01521364|19070578|P1|STARTED|Linezolid Without Clarithromycin (1 wk)||7
7745606|NCT01521260|19070591|P2|NOT COMPLETED|Overall Study||0
7745607|NCT01521260|19070592|P1|NOT COMPLETED|Overall Study||0
7745608|NCT01521260|19070591|P2|COMPLETED|Overall Study||15
7745609|NCT01521260|19070592|P1|COMPLETED|Overall Study||15
7745610|NCT01521260|19070591|P2|STARTED|Overall Study||15
7745611|NCT01521260|19070592|P1|STARTED|Overall Study||15
7745612|NCT01521143|19070602|P4|NOT COMPLETED|Overall Study||7
7745613|NCT01521143|19070603|P3|NOT COMPLETED|Overall Study||8
7745614|NCT01521143|19070604|P2|NOT COMPLETED|Overall Study||26
7745615|NCT01521143|19070605|P1|NOT COMPLETED|Overall Study||29
7745616|NCT01521143|19070602|P4|COMPLETED|Overall Study||0
7745617|NCT01521143|19070603|P3|COMPLETED|Overall Study||0
7745618|NCT01521143|19070604|P2|COMPLETED|Overall Study||10
7745619|NCT01521143|19070605|P1|COMPLETED|Overall Study||11
7745620|NCT01521143|19070602|P4|Received Treatment|Overall Study||4
7745621|NCT01521143|19070603|P3|Received Treatment|Overall Study||3
7745622|NCT01521143|19070604|P2|Received Treatment|Overall Study||20
7745623|NCT01521143|19070605|P1|Received Treatment|Overall Study||20
7745624|NCT01521143|19070602|P4|STARTED|Overall Study||7
7745625|NCT01521143|19070603|P3|STARTED|Overall Study||8
7745626|NCT01521143|19070604|P2|STARTED|Overall Study||36
7745627|NCT01521143|19070605|P1|STARTED|Overall Study||40
7745628|NCT01521026|19070637|P2|NOT COMPLETED|Overall Study||3
7745629|NCT01521026|19070638|P1|NOT COMPLETED|Overall Study||15
7745630|NCT01521026|19070637|P2|COMPLETED|Overall Study||28
7745631|NCT01521026|19070638|P1|COMPLETED|Overall Study||23
7745632|NCT01521026|19070637|P2|STARTED|Overall Study||31
7745633|NCT01521026|19070638|P1|STARTED|Overall Study||38
7745634|NCT01520987|19070654|P8|NOT COMPLETED|Overall Study||0
7745635|NCT01520987|19070655|P7|NOT COMPLETED|Overall Study||0
7745636|NCT01520987|19070656|P6|NOT COMPLETED|Overall Study||1
7745637|NCT01520987|19070657|P5|NOT COMPLETED|Overall Study||0
7745638|NCT01520987|19070658|P4|NOT COMPLETED|Overall Study||0
7745639|NCT01520987|19070659|P3|NOT COMPLETED|Overall Study||0
7745640|NCT01520987|19070660|P2|NOT COMPLETED|Overall Study||0
7745641|NCT01520987|19070661|P1|NOT COMPLETED|Overall Study||1
7745642|NCT01520987|19070654|P8|COMPLETED|Overall Study||14
7745643|NCT01520987|19070655|P7|COMPLETED|Overall Study||12
7745644|NCT01520987|19070656|P6|COMPLETED|Overall Study||13
7745645|NCT01520987|19070657|P5|COMPLETED|Overall Study||14
7745646|NCT01520987|19070658|P4|COMPLETED|Overall Study||15
7745647|NCT01520987|19070659|P3|COMPLETED|Overall Study||11
7745648|NCT01520987|19070660|P2|COMPLETED|Overall Study||12
7745649|NCT01520987|19070661|P1|COMPLETED|Overall Study||12
7745650|NCT01520987|19070654|P8|Dosed|Overall Study||14
7745651|NCT01520987|19070655|P7|Dosed|Overall Study||12
7745652|NCT01520987|19070656|P6|Dosed|Overall Study||14
7745653|NCT01520987|19070657|P5|Dosed|Overall Study||14
7745654|NCT01520987|19070658|P4|Dosed|Overall Study||15
7745655|NCT01520987|19070659|P3|Dosed|Overall Study||11
7745656|NCT01520987|19070660|P2|Dosed|Overall Study||12
7745657|NCT01520987|19070661|P1|Dosed|Overall Study||13
7745658|NCT01520987|19070654|P8|STARTED|Overall Study||14
7745659|NCT01520987|19070655|P7|STARTED|Overall Study||12
7745660|NCT01520987|19070656|P6|STARTED|Overall Study||14
7745661|NCT01520987|19070657|P5|STARTED|Overall Study||14
7745662|NCT01520987|19070658|P4|STARTED|Overall Study||15
7745663|NCT01520987|19070659|P3|STARTED|Overall Study||11
7745664|NCT01520987|19070660|P2|STARTED|Overall Study||12
7745665|NCT01520987|19070661|P1|STARTED|Overall Study||13
7745666|NCT01520922|19070721|P2|NOT COMPLETED|Survival Follow-up||0
7745667|NCT01520922|19070722|P1|NOT COMPLETED|Survival Follow-up||1
7745668|NCT01520922|19070721|P2|COMPLETED|Survival Follow-up||40
7745669|NCT01520922|19070722|P1|COMPLETED|Survival Follow-up||20
7745670|NCT01520922|19070721|P2|STARTED|Survival Follow-up||40
7745671|NCT01520922|19070722|P1|STARTED|Survival Follow-up||21
7745672|NCT01520922|19070721|P2|NOT COMPLETED|Follow up||1
7745673|NCT01520922|19070722|P1|NOT COMPLETED|Follow up||0
7745674|NCT01520922|19070721|P2|COMPLETED|Follow up||44
7745675|NCT01520922|19070722|P1|COMPLETED|Follow up||44
7745676|NCT01520922|19070721|P2|STARTED|Follow up||45
7745677|NCT01520922|19070722|P1|STARTED|Follow up||44
7745678|NCT01520922|19070721|P2|NOT COMPLETED|Treatment Phase||8
7745679|NCT01520922|19070722|P1|NOT COMPLETED|Treatment Phase||5
7745680|NCT01520922|19070721|P2|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45
7745681|NCT01520922|19070722|P1|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39
7745682|NCT01520922|19070721|P2|STARTED|Treatment Phase||53
7745683|NCT01520922|19070722|P1|STARTED|Treatment Phase||44
7745684|NCT01520909|19070784|P3|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7
7745685|NCT01520909|19070785|P2|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
7745686|NCT01520909|19070786|P1|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
7745687|NCT01520909|19070784|P3|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80
7745688|NCT01520909|19070785|P2|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
7745689|NCT01520909|19070786|P1|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
7745690|NCT01520909|19070784|P3|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87
7745691|NCT01520909|19070785|P2|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
7745692|NCT01520909|19070786|P1|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
7745693|NCT01520909|19070784|P3|NOT COMPLETED|Part 1 (Randomized Period)||0
7745694|NCT01520909|19070785|P2|NOT COMPLETED|Part 1 (Randomized Period)||2
7745695|NCT01520909|19070786|P1|NOT COMPLETED|Part 1 (Randomized Period)||1
7745696|NCT01520909|19070784|P3|COMPLETED|Part 1 (Randomized Period)||0
7745697|NCT01520909|19070785|P2|COMPLETED|Part 1 (Randomized Period)||61
7745698|NCT01520909|19070786|P1|COMPLETED|Part 1 (Randomized Period)||28
7745699|NCT01520909|19070784|P3|STARTED|Part 1 (Randomized Period)||0
7745700|NCT01520909|19070785|P2|STARTED|Part 1 (Randomized Period)||63
7745701|NCT01520909|19070786|P1|STARTED|Part 1 (Randomized Period)||29
7745702|NCT01520727|19070857|P9|NOT COMPLETED|Overall Study||0
7745703|NCT01520727|19070858|P8|NOT COMPLETED|Overall Study||0
7745704|NCT01520727|19070859|P7|NOT COMPLETED|Overall Study||0
7745705|NCT01520727|19070860|P6|NOT COMPLETED|Overall Study||0
7745706|NCT01520727|19070861|P5|NOT COMPLETED|Overall Study||0
7745707|NCT01520727|19070862|P4|NOT COMPLETED|Overall Study||0
7745708|NCT01520727|19070863|P3|NOT COMPLETED|Overall Study||0
7745709|NCT01520727|19070864|P2|NOT COMPLETED|Overall Study||0
7745710|NCT01520727|19070865|P1|NOT COMPLETED|Overall Study||0
7745711|NCT01520727|19070857|P9|COMPLETED|Overall Study||16
7745712|NCT01520727|19070858|P8|COMPLETED|Overall Study||6
7745713|NCT01520727|19070859|P7|COMPLETED|Overall Study||6
7745714|NCT01520727|19070860|P6|COMPLETED|Overall Study||6
7745715|NCT01520727|19070861|P5|COMPLETED|Overall Study||6
7745716|NCT01520727|19070862|P4|COMPLETED|Overall Study||6
7745717|NCT01520727|19070863|P3|COMPLETED|Overall Study||6
7745718|NCT01520727|19070864|P2|COMPLETED|Overall Study||6
7745719|NCT01520727|19070865|P1|COMPLETED|Overall Study||6
7745720|NCT01520727|19070857|P9|STARTED|Overall Study||16
7745721|NCT01520727|19070858|P8|STARTED|Overall Study||6
7745722|NCT01520727|19070859|P7|STARTED|Overall Study||6
7745723|NCT01520727|19070860|P6|STARTED|Overall Study||6
7745724|NCT01520727|19070861|P5|STARTED|Overall Study||6
7745725|NCT01520727|19070862|P4|STARTED|Overall Study||6
7745726|NCT01520727|19070863|P3|STARTED|Overall Study||6
7745727|NCT01520727|19070864|P2|STARTED|Overall Study||6
7745728|NCT01520727|19070865|P1|STARTED|Overall Study||6
7745729|NCT01520714|19070903|P2|NOT COMPLETED|Overall Study||6
7745730|NCT01520714|19070904|P1|NOT COMPLETED|Overall Study||0
7745731|NCT01520714|19070903|P2|COMPLETED|Overall Study||5
7745732|NCT01520714|19070904|P1|COMPLETED|Overall Study||0
7745733|NCT01520714|19070903|P2|STARTED|Overall Study||11
7745734|NCT01520714|19070904|P1|STARTED|Overall Study||0
7745735|NCT01520688|19070910|P7|NOT COMPLETED|Overall Study||5
7745736|NCT01520688|19070911|P6|NOT COMPLETED|Overall Study||0
7745737|NCT01520688|19070912|P5|NOT COMPLETED|Overall Study||1
7745738|NCT01520688|19070913|P4|NOT COMPLETED|Overall Study||1
7745739|NCT01520688|19070914|P3|NOT COMPLETED|Overall Study||0
7745740|NCT01520688|19070915|P2|NOT COMPLETED|Overall Study||2
7745741|NCT01520688|19070916|P1|NOT COMPLETED|Overall Study||0
7745742|NCT01520688|19070910|P7|COMPLETED|Overall Study||0
7745743|NCT01520688|19070911|P6|COMPLETED|Overall Study||5
7745744|NCT01520688|19070912|P5|COMPLETED|Overall Study||4
7745745|NCT01520688|19070913|P4|COMPLETED|Overall Study||4
7745746|NCT01520688|19070914|P3|COMPLETED|Overall Study||4
7745747|NCT01520688|19070915|P2|COMPLETED|Overall Study||2
7745748|NCT01520688|19070916|P1|COMPLETED|Overall Study||4
7745749|NCT01520688|19070910|P7|STARTED|Overall Study||5
7745750|NCT01520688|19070911|P6|STARTED|Overall Study||5
7745751|NCT01520688|19070912|P5|STARTED|Overall Study||5
7745752|NCT01520688|19070913|P4|STARTED|Overall Study||5
7745753|NCT01520688|19070914|P3|STARTED|Overall Study||4
7745754|NCT01520688|19070915|P2|STARTED|Overall Study||4
7745755|NCT01520688|19070916|P1|STARTED|Overall Study||4
7745756|NCT01520558|19070928|P3|NOT COMPLETED|Overall Study||3
7745757|NCT01520558|19070929|P2|NOT COMPLETED|Overall Study||2
7745758|NCT01520558|19070930|P1|NOT COMPLETED|Overall Study||2
7745759|NCT01520558|19070928|P3|COMPLETED|Overall Study||3
7745760|NCT01520558|19070929|P2|COMPLETED|Overall Study||1
7745761|NCT01520558|19070930|P1|COMPLETED|Overall Study||1
7745762|NCT01520558|19070928|P3|STARTED|Overall Study||6
7745763|NCT01520558|19070929|P2|STARTED|Overall Study||3
7745764|NCT01520558|19070930|P1|STARTED|Overall Study||3
7745765|NCT01520532|19070938|P1|NOT COMPLETED|Overall Study||0
7745766|NCT01520532|19070938|P1|COMPLETED|Overall Study||60
7745767|NCT01520532|19070938|P1|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60
7745768|NCT01520519|19070944|P1|NOT COMPLETED|Overall Study||0
7745769|NCT01520519|19070944|P1|COMPLETED|Overall Study||40
7745770|NCT01520519|19070944|P1|STARTED|Overall Study||40
7745771|NCT01520506|19070949|P1|NOT COMPLETED|Overall Study||6
7745772|NCT01520506|19070949|P1|COMPLETED|Overall Study||44
7745773|NCT01520506|19070949|P1|STARTED|Overall Study||50
7745774|NCT01520454|19070959|P4|NOT COMPLETED|Overall Study||0
7745775|NCT01520454|19070960|P3|NOT COMPLETED|Overall Study||0
7745776|NCT01520454|19070961|P2|NOT COMPLETED|Overall Study||0
7745777|NCT01520454|19070962|P1|NOT COMPLETED|Overall Study||0
7745778|NCT01520454|19070959|P4|COMPLETED|Overall Study||6
7745779|NCT01520454|19070960|P3|COMPLETED|Overall Study||5
7745780|NCT01520454|19070961|P2|COMPLETED|Overall Study||6
7745781|NCT01520454|19070962|P1|COMPLETED|Overall Study||9
7745782|NCT01520454|19070959|P4|STARTED|Overall Study||6
7745783|NCT01520454|19070960|P3|STARTED|Overall Study||5
7745784|NCT01520454|19070961|P2|STARTED|Overall Study||6
7745785|NCT01520454|19070962|P1|STARTED|Overall Study||9
7745786|NCT01520402|19071004|P1|NOT COMPLETED|Overall Study||5
7745787|NCT01520402|19071004|P1|COMPLETED|Overall Study||30
7745788|NCT01520402|19071004|P1|STARTED|Overall Study||35
7745789|NCT01520363|19071017|P2|NOT COMPLETED|Overall Study||0
7745790|NCT01520363|19071018|P1|NOT COMPLETED|Overall Study||2
7745791|NCT01520363|19071017|P2|COMPLETED|Overall Study||26
7745792|NCT01520363|19071018|P1|COMPLETED|Overall Study||24
7745793|NCT01520363|19071017|P2|STARTED|Overall Study||26
7745794|NCT01520363|19071018|P1|STARTED|Overall Study||26
7745795|NCT01520324|19071092|P1|NOT COMPLETED|Overall Study||1
7745796|NCT01520324|19071092|P1|COMPLETED|Overall Study||52
7745797|NCT01520324|19071092|P1|STARTED|Overall Study||53
7745798|NCT01520207|19071105|P2|NOT COMPLETED|Overall Study||0
7745799|NCT01520207|19071106|P1|NOT COMPLETED|Overall Study||2
7745800|NCT01520207|19071105|P2|COMPLETED|Overall Study||25
7745801|NCT01520207|19071106|P1|COMPLETED|Overall Study||25
7745802|NCT01520207|19071105|P2|STARTED|Overall Study||25
7745803|NCT01520207|19071106|P1|STARTED|Overall Study||27
7745804|NCT01520038|19071112|P1|NOT COMPLETED|Overall Study||1
7745805|NCT01520038|19071112|P1|COMPLETED|Overall Study||1
7745806|NCT01520038|19071112|P1|STARTED|Overall Study||2
7745807|NCT01519960|19071121|P3|NOT COMPLETED|Overall Study||10
7745808|NCT01519960|19071122|P2|NOT COMPLETED|Overall Study||50
7745809|NCT01519960|19071123|P1|NOT COMPLETED|Overall Study||101
7745810|NCT01519960|19071121|P3|COMPLETED|Overall Study||0
7745811|NCT01519960|19071122|P2|COMPLETED|Overall Study||0
7745812|NCT01519960|19071123|P1|COMPLETED|Overall Study||0
7745813|NCT01519960|19071121|P3|Completed FU Week 24|Overall Study||10
7745814|NCT01519960|19071122|P2|Completed FU Week 24|Overall Study||15
7745815|NCT01519960|19071123|P1|Completed FU Week 24|Overall Study||101
7745816|NCT01519960|19071121|P3|Completed Follow-Up (FU) Week 12|Overall Study||10
7745817|NCT01519960|19071122|P2|Completed Follow-Up (FU) Week 12|Overall Study||26
7745818|NCT01519960|19071123|P1|Completed Follow-Up (FU) Week 12|Overall Study||101
7745819|NCT01519960|19071121|P3|Completed Week 48|Overall Study||10
7745820|NCT01519960|19071122|P2|Completed Week 48|Overall Study||47
7745821|NCT01519960|19071123|P1|Completed Week 48|Overall Study||99
7745822|NCT01519960|19071121|P3|STARTED|Overall Study||10
7745823|NCT01519960|19071122|P2|STARTED|Overall Study||50
7745824|NCT01519960|19071123|P1|STARTED|Overall Study||101
7745825|NCT01519947|19071233|P4|NOT COMPLETED|Overall Study||8
7745826|NCT01519947|19071234|P3|NOT COMPLETED|Overall Study||7
7745827|NCT01519947|19071235|P2|NOT COMPLETED|Overall Study||4
7745828|NCT01519947|19071236|P1|NOT COMPLETED|Overall Study||2
7745829|NCT01519947|19071233|P4|COMPLETED|Overall Study||34
7745830|NCT01519947|19071234|P3|COMPLETED|Overall Study||8
7745831|NCT01519947|19071235|P2|COMPLETED|Overall Study||7
7745832|NCT01519947|19071236|P1|COMPLETED|Overall Study||17
7745833|NCT01519947|19071233|P4|STARTED|Overall Study||42
7745834|NCT01519947|19071234|P3|STARTED|Overall Study||15
7745835|NCT01519947|19071235|P2|STARTED|Overall Study||11
7745836|NCT01519947|19071236|P1|STARTED|Overall Study||19
7745837|NCT01519934|19071266|P1|NOT COMPLETED|Overall Study||3
7745838|NCT01519934|19071266|P1|COMPLETED|Overall Study||45
7745839|NCT01519934|19071266|P1|STARTED|Overall Study||48
7745840|NCT01519921|19071275|P2|NOT COMPLETED|Overall Study||15
7745841|NCT01519921|19071276|P1|NOT COMPLETED|Overall Study||21
7745842|NCT01519921|19071275|P2|COMPLETED|Overall Study||49
7745843|NCT01519921|19071276|P1|COMPLETED|Overall Study||65
7745844|NCT01519921|19071275|P2|STARTED|Overall Study||64
7745845|NCT01519921|19071276|P1|STARTED|Overall Study||86
7745846|NCT01519882|19071300|P2|NOT COMPLETED|Overall Study||0
7745847|NCT01519882|19071301|P1|NOT COMPLETED|Overall Study||0
7745848|NCT01519882|19071300|P2|COMPLETED|Overall Study||0
7745849|NCT01519882|19071301|P1|COMPLETED|Overall Study||1
7745850|NCT01519882|19071300|P2|STARTED|Overall Study||0
7745851|NCT01519882|19071301|P1|STARTED|Overall Study||1
7745852|NCT01519869|19071325|P1|NOT COMPLETED|Overall Study||1
7745853|NCT01519869|19071325|P1|COMPLETED|Overall Study||27
7745854|NCT01519869|19071325|P1|STARTED|Overall Study||28
7745855|NCT01519817|19071329|P4|NOT COMPLETED|Overall Study||1
7745856|NCT01519817|19071330|P3|NOT COMPLETED|Overall Study||0
7745857|NCT01519817|19071331|P2|NOT COMPLETED|Overall Study||0
7745858|NCT01519817|19071332|P1|NOT COMPLETED|Overall Study||1
7745859|NCT01519817|19071329|P4|COMPLETED|Overall Study||10
7745860|NCT01519817|19071330|P3|COMPLETED|Overall Study||16
7745861|NCT01519817|19071331|P2|COMPLETED|Overall Study||3
7745862|NCT01519817|19071332|P1|COMPLETED|Overall Study||3
7745863|NCT01519817|19071329|P4|STARTED|Overall Study||11
7745864|NCT01519817|19071330|P3|STARTED|Overall Study||16
7745865|NCT01519817|19071331|P2|STARTED|Overall Study||3
7745866|NCT01519817|19071332|P1|STARTED|Overall Study||4
7745867|NCT01519791|19071372|P2|NOT COMPLETED|Overall Study||368
7745868|NCT01519791|19071373|P1|NOT COMPLETED|Overall Study||152
7745869|NCT01519791|19071372|P2|COMPLETED|Overall Study||292
7745870|NCT01519791|19071373|P1|COMPLETED|Overall Study||67
7745871|NCT01519791|19071372|P2|Completed Week 52|Overall Study||500
7745872|NCT01519791|19071373|P1|Completed Week 52|Overall Study||143
7745873|NCT01519791|19071372|P2|STARTED|Overall Study||660
7745874|NCT01519791|19071373|P1|STARTED|Overall Study||219
7745875|NCT01519778|19071437|P1|NOT COMPLETED|Overall Study||14
7745876|NCT01519778|19071437|P1|COMPLETED|Overall Study||186
7745877|NCT01519778|19071437|P1|STARTED|Overall Study||200
7745878|NCT01519765|19071443|P2|NOT COMPLETED|Overall Study||2
7745879|NCT01519765|19071444|P1|NOT COMPLETED|Overall Study||3
7745880|NCT01519765|19071443|P2|COMPLETED|Overall Study||34
7745881|NCT01519765|19071444|P1|COMPLETED|Overall Study||34
7745882|NCT01519765|19071443|P2|STARTED|Overall Study||36
7745883|NCT01519765|19071444|P1|STARTED|Overall Study||37
7745884|NCT01519713|19071493|P3|NOT COMPLETED|Overall Study||0
7745885|NCT01519713|19071494|P2|NOT COMPLETED|Overall Study||0
7745886|NCT01519713|19071495|P1|NOT COMPLETED|Overall Study||0
7745887|NCT01519713|19071493|P3|COMPLETED|Overall Study||4
7745888|NCT01519713|19071494|P2|COMPLETED|Overall Study||2
7745889|NCT01519713|19071495|P1|COMPLETED|Overall Study||194
7745890|NCT01519713|19071493|P3|STARTED|Overall Study||4
7745891|NCT01519713|19071494|P2|STARTED|Overall Study||2
7745892|NCT01519713|19071495|P1|STARTED|Overall Study||194
7745893|NCT01519700|19071522|P4|NOT COMPLETED|Overall Study||7
7745894|NCT01519700|19071523|P3|NOT COMPLETED|Overall Study||7
7745895|NCT01519700|19071524|P2|NOT COMPLETED|Overall Study||6
7745896|NCT01519700|19071525|P1|NOT COMPLETED|Overall Study||9
7745897|NCT01519700|19071522|P4|COMPLETED|Overall Study||47
7745898|NCT01519700|19071523|P3|COMPLETED|Overall Study||48
7745899|NCT01519700|19071524|P2|COMPLETED|Overall Study||49
7745900|NCT01519700|19071525|P1|COMPLETED|Overall Study||45
7745901|NCT01519700|19071522|P4|Treated Cycle 6 Neupogen|Overall Study||49
7745902|NCT01519700|19071523|P3|Treated Cycle 6 Neupogen|Overall Study||0
7745903|NCT01519700|19071524|P2|Treated Cycle 6 Neupogen|Overall Study||49
7745904|NCT01519700|19071525|P1|Treated Cycle 6 Neupogen|Overall Study||0
7745905|NCT01519700|19071522|P4|Treated Cycle 6 EP2006|Overall Study||0
7745906|NCT01519700|19071523|P3|Treated Cycle 6 EP2006|Overall Study||48
7745907|NCT01519700|19071524|P2|Treated Cycle 6 EP2006|Overall Study||0
7745908|NCT01519700|19071525|P1|Treated Cycle 6 EP2006|Overall Study||45
7745909|NCT01519700|19071522|P4|Treated Cycle 5 Neupogen|Overall Study||50
7745910|NCT01519700|19071523|P3|Treated Cycle 5 Neupogen|Overall Study||48
7745911|NCT01519700|19071524|P2|Treated Cycle 5 Neupogen|Overall Study||0
7745912|NCT01519700|19071525|P1|Treated Cycle 5 Neupogen|Overall Study||0
7745913|NCT01519700|19071522|P4|Treated Cycle 5 EP2006|Overall Study||0
7745914|NCT01519700|19071523|P3|Treated Cycle 5 EP2006|Overall Study||0
7745915|NCT01519700|19071524|P2|Treated Cycle 5 EP2006|Overall Study||49
7745916|NCT01519700|19071525|P1|Treated Cycle 5 EP2006|Overall Study||46
7745917|NCT01519700|19071522|P4|Treated Cycle 4 Neupogen|Overall Study||50
7745918|NCT01519700|19071523|P3|Treated Cycle 4 Neupogen|Overall Study||0
7745919|NCT01519700|19071524|P2|Treated Cycle 4 Neupogen|Overall Study||51
7745920|NCT01519700|19071525|P1|Treated Cycle 4 Neupogen|Overall Study||0
7745921|NCT01519700|19071522|P4|Treated Cycle 4 EP2006|Overall Study||0
7745922|NCT01519700|19071523|P3|Treated Cycle 4 EP2006|Overall Study||50
7745923|NCT01519700|19071524|P2|Treated Cycle 4 EP2006|Overall Study||0
7745924|NCT01519700|19071525|P1|Treated Cycle 4 EP2006|Overall Study||51
7745925|NCT01519700|19071522|P4|Treated Cycle 3 Neupogen|Overall Study||51
7745926|NCT01519700|19071523|P3|Treated Cycle 3 Neupogen|Overall Study||54
7745927|NCT01519700|19071524|P2|Treated Cycle 3 Neupogen|Overall Study||0
7745928|NCT01519700|19071525|P1|Treated Cycle 3 Neupogen|Overall Study||0
7745929|NCT01519700|19071522|P4|Treated Cycle 3 EP2006|Overall Study||0
7745930|NCT01519700|19071523|P3|Treated Cycle 3 EP2006|Overall Study||0
7745931|NCT01519700|19071524|P2|Treated Cycle 3 EP2006|Overall Study||51
7745932|NCT01519700|19071525|P1|Treated Cycle 3 EP2006|Overall Study||51
7745933|NCT01519700|19071522|P4|Treated Cycle 2 Neupogen|Overall Study||51
7745934|NCT01519700|19071523|P3|Treated Cycle 2 Neupogen|Overall Study||0
7745935|NCT01519700|19071524|P2|Treated Cycle 2 Neupogen|Overall Study||52
7745936|NCT01519700|19071525|P1|Treated Cycle 2 Neupogen|Overall Study||0
7745937|NCT01519700|19071522|P4|Treated Cycle 2 EP2006|Overall Study||0
7745938|NCT01519700|19071523|P3|Treated Cycle 2 EP2006|Overall Study||55
7745939|NCT01519700|19071524|P2|Treated Cycle 2 EP2006|Overall Study||0
7745940|NCT01519700|19071525|P1|Treated Cycle 2 EP2006|Overall Study||52
7745941|NCT01519700|19071522|P4|Treated Cycle 1 Neupogen|Overall Study||52
7745942|NCT01519700|19071523|P3|Treated Cycle 1 Neupogen|Overall Study||55
7745943|NCT01519700|19071524|P2|Treated Cycle 1 Neupogen|Overall Study||0
7745944|NCT01519700|19071525|P1|Treated Cycle 1 Neupogen|Overall Study||0
7745945|NCT01519700|19071522|P4|Treated Cycle 1 EP2006|Overall Study||0
7745946|NCT01519700|19071523|P3|Treated Cycle 1 EP2006|Overall Study||0
7745947|NCT01519700|19071524|P2|Treated Cycle 1 EP2006|Overall Study||54
7745948|NCT01519700|19071525|P1|Treated Cycle 1 EP2006|Overall Study||53
7745949|NCT01519700|19071522|P4|STARTED|Overall Study||54
7745950|NCT01519700|19071523|P3|STARTED|Overall Study||55
7745951|NCT01519700|19071524|P2|STARTED|Overall Study||55
7745952|NCT01519700|19071525|P1|STARTED|Overall Study||54
7745953|NCT01519674|19071560|P3|NOT COMPLETED|Overall Study||12
7745954|NCT01519674|19071561|P2|NOT COMPLETED|Overall Study||13
7745955|NCT01519674|19071562|P1|NOT COMPLETED|Overall Study||21
7745956|NCT01519674|19071560|P3|COMPLETED|Overall Study||181
7745957|NCT01519674|19071561|P2|COMPLETED|Overall Study||182
7745958|NCT01519674|19071562|P1|COMPLETED|Overall Study||173
7745959|NCT01519674|19071560|P3|Exposed|Overall Study||190
7745960|NCT01519674|19071561|P2|Exposed|Overall Study||193
7745961|NCT01519674|19071562|P1|Exposed|Overall Study||192
7745962|NCT01519674|19071560|P3|STARTED|Overall Study||193
7745963|NCT01519674|19071561|P2|STARTED|Overall Study||195
7745964|NCT01519674|19071562|P1|STARTED|Overall Study||194
7745965|NCT01519661|19071600|P1|NOT COMPLETED|Overall Study||61
7745966|NCT01519661|19071600|P1|COMPLETED|Overall Study||96
7745967|NCT01519661|19071600|P1|STARTED|Overall Study||157
7745968|NCT01519648|19071617|P2|NOT COMPLETED|Overall Study||0
7745969|NCT01519648|19071618|P1|NOT COMPLETED|Overall Study||0
7745970|NCT01519648|19071617|P2|COMPLETED|Overall Study||306
7745971|NCT01519648|19071618|P1|COMPLETED|Overall Study||502
7745972|NCT01519648|19071617|P2|STARTED|Overall Study||306
7745973|NCT01519648|19071618|P1|STARTED|Overall Study||502
7745974|NCT01519635|19071626|P2|NOT COMPLETED|Overall Study||3
7745975|NCT01519635|19071627|P1|NOT COMPLETED|Overall Study||1
7745976|NCT01519635|19071626|P2|COMPLETED|Overall Study||9
7745977|NCT01519635|19071627|P1|COMPLETED|Overall Study||11
7745978|NCT01519635|19071626|P2|STARTED|Overall Study||12
7745979|NCT01519635|19071627|P1|STARTED|Overall Study||12
7745980|NCT01519570|19071635|P2|NOT COMPLETED|Overall Study||0
7745981|NCT01519570|19071636|P1|NOT COMPLETED|Overall Study||0
7745982|NCT01519570|19071635|P2|COMPLETED|Overall Study||2089
7745983|NCT01519570|19071636|P1|COMPLETED|Overall Study||500
7745984|NCT01519570|19071635|P2|STARTED|Overall Study||2089
7745985|NCT01519570|19071636|P1|STARTED|Overall Study||500
7745986|NCT01519518|19071644|P2|NOT COMPLETED|Overall Study||10
7745987|NCT01519518|19071645|P1|NOT COMPLETED|Overall Study||7
7745988|NCT01519518|19071644|P2|COMPLETED|Overall Study||905
7745989|NCT01519518|19071645|P1|COMPLETED|Overall Study||907
7745990|NCT01519518|19071644|P2|STARTED|Overall Study||915
7745991|NCT01519518|19071645|P1|STARTED|Overall Study||914
7745992|NCT01519466|19071659|P2|NOT COMPLETED|Overall Study||0
7745993|NCT01519466|19071660|P1|NOT COMPLETED|Overall Study||0
7745994|NCT01519466|19071659|P2|COMPLETED|Overall Study||16
7745995|NCT01519466|19071660|P1|COMPLETED|Overall Study||33
7745996|NCT01519466|19071659|P2|STARTED|Overall Study||16
7745997|NCT01519466|19071660|P1|STARTED|Overall Study||33
7745998|NCT01519427|19071670|P1|NOT COMPLETED|Overall Study||2
7745999|NCT01519427|19071670|P1|COMPLETED|Overall Study||0
7746000|NCT01519427|19071670|P1|STARTED|Overall Study||2
7746001|NCT01519414|19071679|P3|NOT COMPLETED|Post Cross-over||0
7746002|NCT01519414|19071680|P2|NOT COMPLETED|Post Cross-over||0
7746003|NCT01519414|19071681|P1|NOT COMPLETED|Post Cross-over||0
7746004|NCT01519414|19071679|P3|COMPLETED|Post Cross-over||12
7746005|NCT01519414|19071680|P2|COMPLETED|Post Cross-over||14
7746006|NCT01519414|19071681|P1|COMPLETED|Post Cross-over||52
7746007|NCT01519414|19071679|P3|STARTED|Post Cross-over||12
7746008|NCT01519414|19071680|P2|STARTED|Post Cross-over||14
7746009|NCT01519414|19071681|P1|STARTED|Post Cross-over||52
7746010|NCT01519414|19071679|P3|NOT COMPLETED|Pre Cross-over||0
7746011|NCT01519414|19071680|P2|NOT COMPLETED|Pre Cross-over||0
7746012|NCT01519414|19071681|P1|NOT COMPLETED|Pre Cross-over||0
7746013|NCT01519414|19071679|P3|COMPLETED|Pre Cross-over||0
7746014|NCT01519414|19071680|P2|COMPLETED|Pre Cross-over||26
7746015|NCT01519414|19071681|P1|COMPLETED|Pre Cross-over||52
7746016|NCT01519414|19071679|P3|STARTED|Pre Cross-over||0
7746017|NCT01519414|19071680|P2|STARTED|Pre Cross-over||26
7746018|NCT01519414|19071681|P1|STARTED|Pre Cross-over||52
7746019|NCT01519323|19071702|P2|NOT COMPLETED|Overall Study||3
7746020|NCT01519323|19071703|P1|NOT COMPLETED|Overall Study||3
7746021|NCT01519323|19071702|P2|COMPLETED|Overall Study||0
7746022|NCT01519323|19071703|P1|COMPLETED|Overall Study||0
7746023|NCT01519323|19071702|P2|STARTED|Overall Study||3
7746024|NCT01519323|19071703|P1|STARTED|Overall Study||3
7746025|NCT01519284|19071719|P5|NOT COMPLETED|Overall Study||0
7746026|NCT01519284|19071720|P4|NOT COMPLETED|Overall Study||0
7746027|NCT01519284|19071721|P3|NOT COMPLETED|Overall Study||2
7746028|NCT01519284|19071722|P2|NOT COMPLETED|Overall Study||0
7746029|NCT01519284|19071723|P1|NOT COMPLETED|Overall Study||0
7746030|NCT01519284|19071719|P5|COMPLETED|Overall Study||16
7746031|NCT01519284|19071720|P4|COMPLETED|Overall Study||16
7746032|NCT01519284|19071721|P3|COMPLETED|Overall Study||16
7746033|NCT01519284|19071722|P2|COMPLETED|Overall Study||16
7746034|NCT01519284|19071723|P1|COMPLETED|Overall Study||16
7746035|NCT01519284|19071719|P5|STARTED|Overall Study||16
7746036|NCT01519284|19071720|P4|STARTED|Overall Study||16
7746037|NCT01519284|19071721|P3|STARTED|Overall Study||18
7746038|NCT01519284|19071722|P2|STARTED|Overall Study||16
7746039|NCT01519284|19071723|P1|STARTED|Overall Study||16
7746040|NCT01519271|19071752|P2|NOT COMPLETED|Phase 2||0
7746041|NCT01519271|19071753|P1|NOT COMPLETED|Phase 2||0
7746042|NCT01519271|19071752|P2|COMPLETED|Phase 2||14
7746043|NCT01519271|19071753|P1|COMPLETED|Phase 2||12
7746044|NCT01519271|19071752|P2|STARTED|Phase 2||14
7746045|NCT01519271|19071753|P1|STARTED|Phase 2|2 participants discontinued after Phase 1|12
7746046|NCT01519271|19071752|P2|NOT COMPLETED|Phase 1||1
7746047|NCT01519271|19071753|P1|NOT COMPLETED|Phase 1||0
7746048|NCT01519271|19071752|P2|COMPLETED|Phase 1|1 participant discontinued participation in the middle of phase 1.|13
7746049|NCT01519271|19071753|P1|COMPLETED|Phase 1||14
7746050|NCT01519271|19071752|P2|STARTED|Phase 1||14
7746051|NCT01519271|19071753|P1|STARTED|Phase 1||14
7746052|NCT01519245|19071763|P2|NOT COMPLETED|Overall Study||2
7746053|NCT01519245|19071764|P1|NOT COMPLETED|Overall Study||1
7746054|NCT01519245|19071763|P2|COMPLETED|Overall Study||18
7746055|NCT01519245|19071764|P1|COMPLETED|Overall Study||23
7746056|NCT01519245|19071763|P2|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2
7746057|NCT01519245|19071764|P1|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6
7746058|NCT01519245|19071763|P2|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18
7746059|NCT01519245|19071764|P1|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21
7746060|NCT01519245|19071763|P2|STARTED|Overall Study||20
7746061|NCT01519245|19071764|P1|STARTED|Overall Study||24
7746062|NCT01519206|19071776|P1|NOT COMPLETED|Overall Study||5
7746063|NCT01519206|19071776|P1|COMPLETED|Overall Study||27
7746064|NCT01519206|19071776|P1|STARTED|Overall Study||32
7746065|NCT01519167|19071790|P2|NOT COMPLETED|Overall Study||8
7746066|NCT01519167|19071791|P1|NOT COMPLETED|Overall Study||0
7746067|NCT01519167|19071790|P2|COMPLETED|Overall Study||81
7746068|NCT01519167|19071791|P1|COMPLETED|Overall Study||1
7746069|NCT01519167|19071790|P2|STARTED|Overall Study||89
7746070|NCT01519167|19071791|P1|STARTED|Overall Study||1
7746071|NCT01519089|19071817|P2|NOT COMPLETED|Overall Study||15
7746072|NCT01519089|19071818|P1|NOT COMPLETED|Overall Study||7
7746073|NCT01519089|19071817|P2|COMPLETED|Overall Study||33
7746074|NCT01519089|19071818|P1|COMPLETED|Overall Study||40
7746075|NCT01519089|19071817|P2|Received Treatment|Overall Study||47
7746076|NCT01519089|19071818|P1|Received Treatment|Overall Study||47
7746077|NCT01519089|19071817|P2|STARTED|Overall Study||48
7746078|NCT01519089|19071818|P1|STARTED|Overall Study||47
7746079|NCT01519063|19071939|P2|NOT COMPLETED|Overall Study||5
7746080|NCT01519063|19071940|P1|NOT COMPLETED|Overall Study||7
7746081|NCT01519063|19071939|P2|COMPLETED|Overall Study||25
7746082|NCT01519063|19071940|P1|COMPLETED|Overall Study||19
7746083|NCT01519063|19071939|P2|STARTED|Overall Study||30
7746084|NCT01519063|19071940|P1|STARTED|Overall Study||26
7746085|NCT01518972|19071960|P2|NOT COMPLETED|Overall Study||4
7746086|NCT01518972|19071961|P1|NOT COMPLETED|Overall Study||6
7746087|NCT01518972|19071960|P2|COMPLETED|Overall Study||11
7746088|NCT01518972|19071961|P1|COMPLETED|Overall Study||9
7746089|NCT01518972|19071960|P2|STARTED|Overall Study||15
7746090|NCT01518972|19071961|P1|STARTED|Overall Study||15
7746091|NCT01518946|19071975|P3|NOT COMPLETED|Randomized Phase (Second Intervention)||0
7746092|NCT01518946|19071976|P2|NOT COMPLETED|Randomized Phase (Second Intervention)||0
7746093|NCT01518946|19071977|P1|NOT COMPLETED|Randomized Phase (Second Intervention)||0
7746094|NCT01518946|19071975|P3|COMPLETED|Randomized Phase (Second Intervention)||10
7746095|NCT01518946|19071976|P2|COMPLETED|Randomized Phase (Second Intervention)||9
7746096|NCT01518946|19071977|P1|COMPLETED|Randomized Phase (Second Intervention)||0
7746097|NCT01518946|19071975|P3|STARTED|Randomized Phase (Second Intervention)||10
7746098|NCT01518946|19071976|P2|STARTED|Randomized Phase (Second Intervention)||9
7746099|NCT01518946|19071977|P1|STARTED|Randomized Phase (Second Intervention)||0
7746100|NCT01518946|19071975|P3|NOT COMPLETED|Randomized Phase (First Intervention)||0
7746101|NCT01518946|19071976|P2|NOT COMPLETED|Randomized Phase (First Intervention)||1
7746102|NCT01518946|19071977|P1|NOT COMPLETED|Randomized Phase (First Intervention)||0
7746103|NCT01518946|19071975|P3|COMPLETED|Randomized Phase (First Intervention)||10
7746104|NCT01518946|19071976|P2|COMPLETED|Randomized Phase (First Intervention)||9
7746105|NCT01518946|19071977|P1|COMPLETED|Randomized Phase (First Intervention)||0
7746106|NCT01518946|19071975|P3|STARTED|Randomized Phase (First Intervention)||10
7746107|NCT01518946|19071976|P2|STARTED|Randomized Phase (First Intervention)||10
7746108|NCT01518946|19071977|P1|STARTED|Randomized Phase (First Intervention)||0
7746109|NCT01518946|19071975|P3|NOT COMPLETED|Open-label Phase||0
7746110|NCT01518946|19071976|P2|NOT COMPLETED|Open-label Phase||0
7746111|NCT01518946|19071977|P1|NOT COMPLETED|Open-label Phase||4
7746112|NCT01518946|19071975|P3|COMPLETED|Open-label Phase||0
7746113|NCT01518946|19071976|P2|COMPLETED|Open-label Phase||0
7746114|NCT01518946|19071977|P1|COMPLETED|Open-label Phase||20
7746115|NCT01518946|19071975|P3|STARTED|Open-label Phase||0
7746116|NCT01518946|19071976|P2|STARTED|Open-label Phase||0
7746117|NCT01518946|19071977|P1|STARTED|Open-label Phase||24
7746118|NCT01518868|19071984|P2|NOT COMPLETED|Overall Study||4
7746119|NCT01518868|19071985|P1|NOT COMPLETED|Overall Study||4
7746120|NCT01518868|19071984|P2|COMPLETED|Overall Study||59
7746121|NCT01518868|19071985|P1|COMPLETED|Overall Study||59
7746122|NCT01518868|19071984|P2|STARTED|Overall Study||63
7746123|NCT01518868|19071985|P1|STARTED|Overall Study||63
7746124|NCT01518530|19071993|P1|NOT COMPLETED|Post-Treatment Follow-up||0
7746125|NCT01518530|19071993|P1|COMPLETED|Post-Treatment Follow-up||9
7746126|NCT01518530|19071993|P1|STARTED|Post-Treatment Follow-up||9
7746127|NCT01518530|19071993|P1|NOT COMPLETED|Active Treatment Period||1
7746128|NCT01518530|19071993|P1|COMPLETED|Active Treatment Period||9
7746129|NCT01518530|19071993|P1|STARTED|Active Treatment Period||10
7746130|NCT01518374|19071997|P1|NOT COMPLETED|Overall Study||7
7746131|NCT01518374|19071997|P1|COMPLETED|Overall Study||1761
7746132|NCT01518374|19071997|P1|STARTED|Overall Study||1768
7746133|NCT01518322|19072001|P1|NOT COMPLETED|Overall Study||13
7746134|NCT01518322|19072001|P1|COMPLETED|Overall Study||222
7746135|NCT01518322|19072001|P1|STARTED|Overall Study||235
7746136|NCT01518309|19072014|P1|NOT COMPLETED|Overall Study||39
7746137|NCT01518309|19072014|P1|COMPLETED|Overall Study||0
7746138|NCT01518309|19072014|P1|STARTED|Overall Study||39
7746139|NCT01518270|19072018|P1|NOT COMPLETED|Overall Study||0
7746140|NCT01518270|19072018|P1|COMPLETED|Overall Study||179
7746141|NCT01518270|19072018|P1|STARTED|Overall Study||179
7746142|NCT01518257|19072026|P2|NOT COMPLETED|Overall Study||0
7746143|NCT01518257|19072027|P1|NOT COMPLETED|Overall Study||2
7746144|NCT01518257|19072026|P2|COMPLETED|Overall Study||60
7746145|NCT01518257|19072027|P1|COMPLETED|Overall Study||59
7746146|NCT01518257|19072026|P2|STARTED|Overall Study||60
7746147|NCT01518257|19072027|P1|STARTED|Overall Study||61
7746148|NCT01518244|19072049|P1|NOT COMPLETED|Overall Study||3
7746149|NCT01518244|19072049|P1|COMPLETED|Overall Study||47
7746150|NCT01518244|19072049|P1|STARTED|Overall Study||50
7746151|NCT01518192|19072057|P3|NOT COMPLETED|Overall Study||35
7746152|NCT01518192|19072058|P2|NOT COMPLETED|Overall Study||26
7746153|NCT01518192|19072059|P1|NOT COMPLETED|Overall Study||29
7746154|NCT01518192|19072057|P3|COMPLETED|Overall Study||224
7746155|NCT01518192|19072058|P2|COMPLETED|Overall Study||114
7746156|NCT01518192|19072059|P1|COMPLETED|Overall Study||116
7746157|NCT01518192|19072057|P3|STARTED|Overall Study||259
7746158|NCT01518192|19072058|P2|STARTED|Overall Study||140
7746159|NCT01518192|19072059|P1|STARTED|Overall Study||145
7746160|NCT01518153|19072080|P3|NOT COMPLETED|Donor Lymphocyte Infusion||1
7746161|NCT01518153|19072081|P2|NOT COMPLETED|Donor Lymphocyte Infusion||2
7746162|NCT01518153|19072082|P1|NOT COMPLETED|Donor Lymphocyte Infusion||0
7746163|NCT01518153|19072080|P3|COMPLETED|Donor Lymphocyte Infusion||3
7746164|NCT01518153|19072081|P2|COMPLETED|Donor Lymphocyte Infusion||1
7746165|NCT01518153|19072082|P1|COMPLETED|Donor Lymphocyte Infusion||0
7746166|NCT01518153|19072080|P3|STARTED|Donor Lymphocyte Infusion||4
7746167|NCT01518153|19072081|P2|STARTED|Donor Lymphocyte Infusion||3
7746168|NCT01518153|19072082|P1|STARTED|Donor Lymphocyte Infusion||0
7746169|NCT01518153|19072080|P3|NOT COMPLETED|Stem Cell Transplant||0
7746170|NCT01518153|19072081|P2|NOT COMPLETED|Stem Cell Transplant||0
7746171|NCT01518153|19072082|P1|NOT COMPLETED|Stem Cell Transplant||9
7746172|NCT01518153|19072080|P3|COMPLETED|Stem Cell Transplant||0
7746173|NCT01518153|19072081|P2|COMPLETED|Stem Cell Transplant||0
7746174|NCT01518153|19072082|P1|COMPLETED|Stem Cell Transplant||7
7746175|NCT01518153|19072080|P3|STARTED|Stem Cell Transplant||0
7746176|NCT01518153|19072081|P2|STARTED|Stem Cell Transplant||0
7746177|NCT01518153|19072082|P1|STARTED|Stem Cell Transplant||16
7746178|NCT01517984|19072093|P4|NOT COMPLETED|Overall Study||1
7746179|NCT01517984|19072094|P3|NOT COMPLETED|Overall Study||4
7746180|NCT01517984|19072095|P2|NOT COMPLETED|Overall Study||23
7746181|NCT01517984|19072096|P1|NOT COMPLETED|Overall Study||5
7746182|NCT01517984|19072093|P4|COMPLETED|Overall Study||6
7746183|NCT01517984|19072094|P3|COMPLETED|Overall Study||10
7746184|NCT01517984|19072095|P2|COMPLETED|Overall Study||3
7746185|NCT01517984|19072096|P1|COMPLETED|Overall Study||0
7746186|NCT01517984|19072093|P4|STARTED|Overall Study||7
7746187|NCT01517984|19072094|P3|STARTED|Overall Study||14
7746188|NCT01517984|19072095|P2|STARTED|Overall Study||26
7746189|NCT01517984|19072096|P1|STARTED|Overall Study||5
7746190|NCT01517893|19072122|P2|NOT COMPLETED|Overall Study||0
7746191|NCT01517893|19072123|P1|NOT COMPLETED|Overall Study||3
7746192|NCT01517893|19072122|P2|COMPLETED|Overall Study||7
7746193|NCT01517893|19072123|P1|COMPLETED|Overall Study||5
7746194|NCT01517893|19072122|P2|STARTED|Overall Study||7
7746195|NCT01517893|19072123|P1|STARTED|Overall Study||8
7746196|NCT01517867|19072145|P2|NOT COMPLETED|Overall Study||65
7746197|NCT01517867|19072146|P1|NOT COMPLETED|Overall Study||63
7746198|NCT01517867|19072145|P2|COMPLETED|Overall Study||15
7746199|NCT01517867|19072146|P1|COMPLETED|Overall Study||18
7746200|NCT01517867|19072145|P2|STARTED|Overall Study||80
7746201|NCT01517867|19072146|P1|STARTED|Overall Study||81
7746202|NCT01517763|19072157|P3|NOT COMPLETED|Overall Study||0
7746203|NCT01517763|19072158|P2|NOT COMPLETED|Overall Study||0
7746204|NCT01517763|19072159|P1|NOT COMPLETED|Overall Study||0
7746205|NCT01517763|19072157|P3|COMPLETED|Overall Study||0
7746206|NCT01517763|19072158|P2|COMPLETED|Overall Study||0
7746207|NCT01517763|19072159|P1|COMPLETED|Overall Study||0
7746208|NCT01517763|19072157|P3|STARTED|Overall Study||0
7746209|NCT01517763|19072158|P2|STARTED|Overall Study||0
7746210|NCT01517763|19072159|P1|STARTED|Overall Study||0
7746211|NCT01517750|19072174|P4|NOT COMPLETED|Overall Study||1
7746212|NCT01517750|19072175|P3|NOT COMPLETED|Overall Study||4
7746213|NCT01517750|19072176|P2|NOT COMPLETED|Overall Study||2
7746214|NCT01517750|19072177|P1|NOT COMPLETED|Overall Study||1
7746215|NCT01517750|19072174|P4|COMPLETED|Overall Study||18
7746216|NCT01517750|19072175|P3|COMPLETED|Overall Study||17
7746217|NCT01517750|19072176|P2|COMPLETED|Overall Study||17
7746218|NCT01517750|19072177|P1|COMPLETED|Overall Study||20
7746219|NCT01517750|19072174|P4|STARTED|Overall Study||19
7746220|NCT01517750|19072175|P3|STARTED|Overall Study||21
7746221|NCT01517750|19072176|P2|STARTED|Overall Study||19
7746222|NCT01517750|19072177|P1|STARTED|Overall Study||21
7746223|NCT01517659|19072207|P1|NOT COMPLETED|Overall Study||0
7746224|NCT01517659|19072207|P1|COMPLETED|Overall Study||45
7746225|NCT01517659|19072207|P1|STARTED|Overall Study||45
7746226|NCT01517529|19072214|P1|NOT COMPLETED|Overall Study||0
7746227|NCT01517529|19072214|P1|COMPLETED|Overall Study||10
7746228|NCT01517529|19072214|P1|STARTED|Overall Study||10
7746229|NCT01517412|19072221|P2|NOT COMPLETED|Overall Study||24
7746230|NCT01517412|19072222|P1|NOT COMPLETED|Overall Study||36
7746231|NCT01517412|19072221|P2|COMPLETED|Overall Study||202
7746232|NCT01517412|19072222|P1|COMPLETED|Overall Study||189
7746233|NCT01517412|19072221|P2|STARTED|Overall Study||226
7746234|NCT01517412|19072222|P1|STARTED|Overall Study||225
7746235|NCT01517373|19072251|P6|NOT COMPLETED|Treatment Period||7
7746236|NCT01517373|19072252|P5|NOT COMPLETED|Treatment Period||6
7746237|NCT01517373|19072253|P4|NOT COMPLETED|Treatment Period||7
7746238|NCT01517373|19072254|P3|NOT COMPLETED|Treatment Period||6
7746239|NCT01517373|19072255|P2|NOT COMPLETED|Treatment Period||4
7746240|NCT01517373|19072256|P1|NOT COMPLETED|Treatment Period||0
7746241|NCT01517373|19072251|P6|COMPLETED|Treatment Period||54
7746242|NCT01517373|19072252|P5|COMPLETED|Treatment Period||55
7746243|NCT01517373|19072253|P4|COMPLETED|Treatment Period||54
7746244|NCT01517373|19072254|P3|COMPLETED|Treatment Period||54
7746245|NCT01517373|19072255|P2|COMPLETED|Treatment Period||57
7746246|NCT01517373|19072256|P1|COMPLETED|Treatment Period||0
7746247|NCT01517373|19072251|P6|STARTED|Treatment Period||61
7746248|NCT01517373|19072252|P5|STARTED|Treatment Period||61
7746249|NCT01517373|19072253|P4|STARTED|Treatment Period||61
7746250|NCT01517373|19072254|P3|STARTED|Treatment Period||60
7746251|NCT01517373|19072255|P2|STARTED|Treatment Period||61
7746252|NCT01517373|19072256|P1|STARTED|Treatment Period||0
7746253|NCT01517373|19072251|P6|NOT COMPLETED|Run-in Period||0
7746254|NCT01517373|19072252|P5|NOT COMPLETED|Run-in Period||0
7746255|NCT01517373|19072253|P4|NOT COMPLETED|Run-in Period||0
7746256|NCT01517373|19072254|P3|NOT COMPLETED|Run-in Period||0
7746257|NCT01517373|19072255|P2|NOT COMPLETED|Run-in Period||0
7746258|NCT01517373|19072256|P1|NOT COMPLETED|Run-in Period||57
7746259|NCT01517373|19072251|P6|COMPLETED|Run-in Period||0
7746260|NCT01517373|19072252|P5|COMPLETED|Run-in Period||0
7746261|NCT01517373|19072253|P4|COMPLETED|Run-in Period||0
7746262|NCT01517373|19072254|P3|COMPLETED|Run-in Period||0
7746263|NCT01517373|19072255|P2|COMPLETED|Run-in Period||0
7746264|NCT01517373|19072256|P1|COMPLETED|Run-in Period||304
7746265|NCT01517373|19072251|P6|STARTED|Run-in Period||0
7746266|NCT01517373|19072252|P5|STARTED|Run-in Period||0
7746267|NCT01517373|19072253|P4|STARTED|Run-in Period||0
7746268|NCT01517373|19072254|P3|STARTED|Run-in Period||0
7746269|NCT01517373|19072255|P2|STARTED|Run-in Period||0
7746270|NCT01517373|19072256|P1|STARTED|Run-in Period||361
7746271|NCT01517295|19072326|P2|NOT COMPLETED|Overall Study||0
7746272|NCT01517295|19072327|P1|NOT COMPLETED|Overall Study||1
7746273|NCT01517295|19072326|P2|COMPLETED|Overall Study||14
7746274|NCT01517295|19072327|P1|COMPLETED|Overall Study||15
7746275|NCT01517295|19072326|P2|STARTED|Overall Study||14
7746276|NCT01517295|19072327|P1|STARTED|Overall Study||16
7746277|NCT01517282|19072341|P4|NOT COMPLETED|Overall Study||1
7746278|NCT01517282|19072342|P3|NOT COMPLETED|Overall Study||1
7746279|NCT01517282|19072343|P2|NOT COMPLETED|Overall Study||1
7746280|NCT01517282|19072344|P1|NOT COMPLETED|Overall Study||1
7746281|NCT01517282|19072341|P4|COMPLETED|Overall Study||5
7746282|NCT01517282|19072342|P3|COMPLETED|Overall Study||8
7746283|NCT01517282|19072343|P2|COMPLETED|Overall Study||7
7746284|NCT01517282|19072344|P1|COMPLETED|Overall Study||8
7746285|NCT01517282|19072341|P4|STARTED|Overall Study||6
7746286|NCT01517282|19072342|P3|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9
7746287|NCT01517282|19072343|P2|STARTED|Overall Study||8
7746288|NCT01517282|19072344|P1|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9
7746289|NCT01517178|19072378|P2|NOT COMPLETED|Period 2||2
7746290|NCT01517178|19072379|P1|NOT COMPLETED|Period 2||6
7746291|NCT01517178|19072378|P2|COMPLETED|Period 2||4
7746292|NCT01517178|19072379|P1|COMPLETED|Period 2||5
7746293|NCT01517178|19072378|P2|STARTED|Period 2||6
7746294|NCT01517178|19072379|P1|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11
7746295|NCT01517178|19072378|P2|NOT COMPLETED|Period 1||5
7746296|NCT01517178|19072379|P1|NOT COMPLETED|Period 1||4
7746297|NCT01517178|19072378|P2|COMPLETED|Period 1||6
7746298|NCT01517178|19072379|P1|COMPLETED|Period 1||12
7746299|NCT01517178|19072378|P2|STARTED|Period 1||11
7746300|NCT01517178|19072379|P1|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16
7746301|NCT01517074|19072385|P1|NOT COMPLETED|Overall Study||0
7746302|NCT01517074|19072385|P1|COMPLETED|Overall Study||5
7746303|NCT01517074|19072385|P1|STARTED|Overall Study||5
7746304|NCT01516970|19072407|P2|NOT COMPLETED|Overall Study||21
7746305|NCT01516970|19072408|P1|NOT COMPLETED|Overall Study||18
7746306|NCT01516970|19072407|P2|COMPLETED|Overall Study||132
7746307|NCT01516970|19072408|P1|COMPLETED|Overall Study||141
7746308|NCT01516970|19072407|P2|STARTED|Overall Study||153
7746309|NCT01516970|19072408|P1|STARTED|Overall Study||159
7746310|NCT01516957|19072423|P4|NOT COMPLETED|Open-label Phase||156
7746311|NCT01516957|19072424|P3|NOT COMPLETED|Open-label Phase||0
7746312|NCT01516957|19072425|P2|NOT COMPLETED|Open-label Phase||0
7746313|NCT01516957|19072426|P1|NOT COMPLETED|Open-label Phase||0
7746314|NCT01516957|19072423|P4|COMPLETED|Open-label Phase||0
7746315|NCT01516957|19072424|P3|COMPLETED|Open-label Phase||0
7746316|NCT01516957|19072425|P2|COMPLETED|Open-label Phase||0
7746317|NCT01516957|19072426|P1|COMPLETED|Open-label Phase||0
7746318|NCT01516957|19072423|P4|STARTED|Open-label Phase||156
7746319|NCT01516957|19072424|P3|STARTED|Open-label Phase||0
7746320|NCT01516957|19072425|P2|STARTED|Open-label Phase||0
7746321|NCT01516957|19072426|P1|STARTED|Open-label Phase||0
7746322|NCT01516957|19072423|P4|NOT COMPLETED|Placebo-controlled Phase||0
7746323|NCT01516957|19072424|P3|NOT COMPLETED|Placebo-controlled Phase||5
7746324|NCT01516957|19072425|P2|NOT COMPLETED|Placebo-controlled Phase||4
7746325|NCT01516957|19072426|P1|NOT COMPLETED|Placebo-controlled Phase||3
7746326|NCT01516957|19072423|P4|COMPLETED|Placebo-controlled Phase||0
7746327|NCT01516957|19072424|P3|COMPLETED|Placebo-controlled Phase||51
7746328|NCT01516957|19072425|P2|COMPLETED|Placebo-controlled Phase||53
7746329|NCT01516957|19072426|P1|COMPLETED|Placebo-controlled Phase||52
7746330|NCT01516957|19072423|P4|STARTED|Placebo-controlled Phase||0
7746331|NCT01516957|19072424|P3|STARTED|Placebo-controlled Phase||56
7746332|NCT01516957|19072425|P2|STARTED|Placebo-controlled Phase||57
7746333|NCT01516957|19072426|P1|STARTED|Placebo-controlled Phase||55
7746334|NCT01516892|19072447|P1|NOT COMPLETED|Overall Study||343
7746335|NCT01516892|19072447|P1|COMPLETED|Overall Study||373
7746336|NCT01516892|19072447|P1|STARTED|Overall Study||716
7746337|NCT01516879|19072455|P2|NOT COMPLETED|Overall Study||34
7746338|NCT01516879|19072456|P1|NOT COMPLETED|Overall Study||16
7746339|NCT01516879|19072455|P2|COMPLETED|Overall Study||568
7746340|NCT01516879|19072456|P1|COMPLETED|Overall Study||287
7746341|NCT01516879|19072455|P2|Received Treatment|Overall Study||599
7746342|NCT01516879|19072456|P1|Received Treatment|Overall Study||302
7746343|NCT01516879|19072455|P2|STARTED|Overall Study||602
7746344|NCT01516879|19072456|P1|STARTED|Overall Study||303
7746345|NCT01516749|19072490|P1|NOT COMPLETED|Follow-up Off Therapy||1
7746346|NCT01516749|19072490|P1|COMPLETED|Follow-up Off Therapy||4
7746347|NCT01516749|19072490|P1|STARTED|Follow-up Off Therapy||5
7746348|NCT01516749|19072490|P1|NOT COMPLETED|Active Therapy||1
7746349|NCT01516749|19072490|P1|COMPLETED|Active Therapy||5
7746350|NCT01516749|19072490|P1|STARTED|Active Therapy||6
7746351|NCT01516736|19072499|P2|NOT COMPLETED|Overall Study||13
7746352|NCT01516736|19072500|P1|NOT COMPLETED|Overall Study||20
7746353|NCT01516736|19072499|P2|COMPLETED|Overall Study||140
7746354|NCT01516736|19072500|P1|COMPLETED|Overall Study||135
7746355|NCT01516736|19072499|P2|STARTED|Overall Study||153
7746356|NCT01516736|19072500|P1|STARTED|Overall Study||155
7746357|NCT01516684|19072522|P2|NOT COMPLETED|Overall Study||0
7746358|NCT01516684|19072523|P1|NOT COMPLETED|Overall Study||0
7746359|NCT01516684|19072522|P2|COMPLETED|Overall Study|"Overall number of units (trials) completed was 152
~Trials were randomized for each arm, not participants"|0
7746360|NCT01516684|19072523|P1|COMPLETED|Overall Study|Trials were randomized for each arm, not participants|0
7746361|NCT01516684|19072522|P2|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.
~Trials were randomized for each arm, not participants"|0
7746362|NCT01516684|19072523|P1|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.
~Trials were randomized for each arm, not participants"|0
7746363|NCT01516632|19072539|P2|NOT COMPLETED|Overall Study||15
7746364|NCT01516632|19072540|P1|NOT COMPLETED|Overall Study||24
7746365|NCT01516632|19072539|P2|COMPLETED|Overall Study||48
7746366|NCT01516632|19072540|P1|COMPLETED|Overall Study||77
7746367|NCT01516632|19072539|P2|STARTED|Overall Study||63
7746368|NCT01516632|19072540|P1|STARTED|Overall Study||101
7746369|NCT01516437|19072554|P4|NOT COMPLETED|Overall Study||1
7746370|NCT01516437|19072555|P3|NOT COMPLETED|Overall Study||1
7746371|NCT01516437|19072556|P2|NOT COMPLETED|Overall Study||0
7746372|NCT01516437|19072557|P1|NOT COMPLETED|Overall Study||0
7746373|NCT01516437|19072554|P4|COMPLETED|Overall Study||6
7746374|NCT01516437|19072555|P3|COMPLETED|Overall Study||14
7746375|NCT01516437|19072556|P2|COMPLETED|Overall Study||24
7746376|NCT01516437|19072557|P1|COMPLETED|Overall Study||24
7746377|NCT01516437|19072554|P4|STARTED|Overall Study||7
7746378|NCT01516437|19072555|P3|STARTED|Overall Study||15
7746379|NCT01516437|19072556|P2|STARTED|Overall Study||24
7746380|NCT01516437|19072557|P1|STARTED|Overall Study||24
7746381|NCT01516424|19072613|P2|NOT COMPLETED|Overall Study||22
7746382|NCT01516424|19072614|P1|NOT COMPLETED|Overall Study||35
7746383|NCT01516424|19072613|P2|COMPLETED|Overall Study||114
7746384|NCT01516424|19072614|P1|COMPLETED|Overall Study||96
7746385|NCT01516424|19072613|P2|STARTED|Overall Study|the patient number of randomization for Risperidone Group|136
7746386|NCT01516424|19072614|P1|STARTED|Overall Study|the patient number of randomization for Blonanserin Group|131
7746387|NCT01516268|19072622|P2|NOT COMPLETED|Overall Study||0
7746388|NCT01516268|19072623|P1|NOT COMPLETED|Overall Study||0
7746389|NCT01516268|19072622|P2|COMPLETED|Overall Study||25
7746390|NCT01516268|19072623|P1|COMPLETED|Overall Study||25
7746391|NCT01516268|19072622|P2|STARTED|Overall Study||25
7746392|NCT01516268|19072623|P1|STARTED|Overall Study||25
7746393|NCT01516034|19072629|P1|NOT COMPLETED|Overall Study||8
7746394|NCT01516034|19072629|P1|COMPLETED|Overall Study||0
7746395|NCT01516034|19072629|P1|STARTED|Overall Study||8
7746396|NCT01516008|19072636|P3|NOT COMPLETED|Overall Study||18
7746397|NCT01516008|19072637|P2|NOT COMPLETED|Overall Study||16
7746398|NCT01516008|19072638|P1|NOT COMPLETED|Overall Study||45
7746399|NCT01516008|19072636|P3|COMPLETED|Overall Study||99
7746400|NCT01516008|19072637|P2|COMPLETED|Overall Study||105
7746401|NCT01516008|19072638|P1|COMPLETED|Overall Study||69
7746402|NCT01516008|19072636|P3|STARTED|Overall Study||117
7746403|NCT01516008|19072637|P2|STARTED|Overall Study||121
7746404|NCT01516008|19072638|P1|STARTED|Overall Study||114
7746405|NCT01515995|19072672|P2|NOT COMPLETED|Overall Study||4
7746406|NCT01515995|19072673|P1|NOT COMPLETED|Overall Study||3
7746407|NCT01515995|19072672|P2|COMPLETED|Overall Study||21
7746408|NCT01515995|19072673|P1|COMPLETED|Overall Study||22
7746409|NCT01515995|19072672|P2|STARTED|Overall Study||25
7746410|NCT01515995|19072673|P1|STARTED|Overall Study||25
7746411|NCT01515956|19072679|P1|NOT COMPLETED|Overall Study||0
7746412|NCT01515956|19072679|P1|COMPLETED|Overall Study||15
7746413|NCT01515956|19072679|P1|STARTED|Overall Study||15
7746414|NCT01515943|19072688|P3|NOT COMPLETED|Overall Study||13
7746415|NCT01515943|19072689|P2|NOT COMPLETED|Overall Study||16
7746416|NCT01515943|19072690|P1|NOT COMPLETED|Overall Study||6
7746417|NCT01515943|19072688|P3|COMPLETED|Overall Study||31
7746418|NCT01515943|19072689|P2|COMPLETED|Overall Study||69
7746419|NCT01515943|19072690|P1|COMPLETED|Overall Study||69
7746420|NCT01515943|19072688|P3|STARTED|Overall Study||44
7746421|NCT01515943|19072689|P2|STARTED|Overall Study||85
7746422|NCT01515943|19072690|P1|STARTED|Overall Study||75
7746423|NCT01515891|19072736|P1|NOT COMPLETED|Overall Study||0
7746424|NCT01515891|19072736|P1|COMPLETED|Overall Study||4
7746425|NCT01515891|19072736|P1|STARTED|Overall Study||4
7746426|NCT01515865|19072743|P3|NOT COMPLETED|Part C (Randomized)||0
7746427|NCT01515865|19072744|P2|NOT COMPLETED|Part C (Randomized)||0
7746428|NCT01515865|19072745|P1|NOT COMPLETED|Part C (Randomized)||0
7746429|NCT01515865|19072743|P3|COMPLETED|Part C (Randomized)||34
7746430|NCT01515865|19072744|P2|COMPLETED|Part C (Randomized)||33
7746431|NCT01515865|19072745|P1|COMPLETED|Part C (Randomized)||0
7746432|NCT01515865|19072743|P3|STARTED|Part C (Randomized)||34
7746433|NCT01515865|19072744|P2|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33
7746434|NCT01515865|19072745|P1|STARTED|Part C (Randomized)||0
7746435|NCT01515865|19072743|P3|NOT COMPLETED|Part B (Open-label)||0
7746436|NCT01515865|19072744|P2|NOT COMPLETED|Part B (Open-label)||0
7746437|NCT01515865|19072745|P1|NOT COMPLETED|Part B (Open-label)||2
7746438|NCT01515865|19072743|P3|COMPLETED|Part B (Open-label)||0
7746439|NCT01515865|19072744|P2|COMPLETED|Part B (Open-label)||0
7746440|NCT01515865|19072745|P1|COMPLETED|Part B (Open-label)||69
7746441|NCT01515865|19072743|P3|STARTED|Part B (Open-label)||0
7746442|NCT01515865|19072744|P2|STARTED|Part B (Open-label)||0
7746443|NCT01515865|19072745|P1|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71
7746444|NCT01515865|19072743|P3|NOT COMPLETED|Part A (Open-label)||0
7746445|NCT01515865|19072744|P2|NOT COMPLETED|Part A (Open-label)||0
7746446|NCT01515865|19072745|P1|NOT COMPLETED|Part A (Open-label)||3
7746447|NCT01515865|19072743|P3|COMPLETED|Part A (Open-label)||0
7746448|NCT01515865|19072744|P2|COMPLETED|Part A (Open-label)||0
7746449|NCT01515865|19072745|P1|COMPLETED|Part A (Open-label)||95
7746450|NCT01515865|19072743|P3|STARTED|Part A (Open-label)||0
7746451|NCT01515865|19072744|P2|STARTED|Part A (Open-label)||0
7746452|NCT01515865|19072745|P1|STARTED|Part A (Open-label)||98
7746453|NCT01515748|19072755|P2|NOT COMPLETED|Overall Study||135
7746454|NCT01515748|19072756|P1|NOT COMPLETED|Overall Study||120
7746455|NCT01515748|19072755|P2|COMPLETED|Overall Study||131
7746456|NCT01515748|19072756|P1|COMPLETED|Overall Study||144
7746457|NCT01515748|19072755|P2|Treated|Overall Study||241
7746458|NCT01515748|19072756|P1|Treated|Overall Study||195
7746459|NCT01515748|19072755|P2|STARTED|Overall Study||266
7746460|NCT01515748|19072756|P1|STARTED|Overall Study||264
7746461|NCT01515696|19072779|P2|NOT COMPLETED|Overall Study||10
7746462|NCT01515696|19072780|P1|NOT COMPLETED|Overall Study||8
7746463|NCT01515696|19072779|P2|COMPLETED|Overall Study||39
7746464|NCT01515696|19072780|P1|COMPLETED|Overall Study||39
7746465|NCT01515696|19072779|P2|STARTED|Overall Study||49
7746466|NCT01515696|19072780|P1|STARTED|Overall Study||47
7746467|NCT01515657|19072790|P3|NOT COMPLETED|Third Intervention||0
7746468|NCT01515657|19072791|P2|NOT COMPLETED|Third Intervention||0
7746469|NCT01515657|19072792|P1|NOT COMPLETED|Third Intervention||1
7746470|NCT01515657|19072790|P3|COMPLETED|Third Intervention||13
7746471|NCT01515657|19072791|P2|COMPLETED|Third Intervention||11
7746472|NCT01515657|19072792|P1|COMPLETED|Third Intervention||13
7746473|NCT01515657|19072790|P3|STARTED|Third Intervention||13
7746474|NCT01515657|19072791|P2|STARTED|Third Intervention||11
7746475|NCT01515657|19072792|P1|STARTED|Third Intervention||14
7746476|NCT01515657|19072790|P3|NOT COMPLETED|Second Intervention||0
7746477|NCT01515657|19072791|P2|NOT COMPLETED|Second Intervention||1
7746478|NCT01515657|19072792|P1|NOT COMPLETED|Second Intervention||0
7746479|NCT01515657|19072790|P3|COMPLETED|Second Intervention||13
7746480|NCT01515657|19072791|P2|COMPLETED|Second Intervention||11
7746481|NCT01515657|19072792|P1|COMPLETED|Second Intervention||14
7746482|NCT01515657|19072790|P3|STARTED|Second Intervention||13
7746483|NCT01515657|19072791|P2|STARTED|Second Intervention||12
7746484|NCT01515657|19072792|P1|STARTED|Second Intervention||14
7746485|NCT01515657|19072790|P3|NOT COMPLETED|First Intervention||0
7746486|NCT01515657|19072791|P2|NOT COMPLETED|First Intervention||1
7746487|NCT01515657|19072792|P1|NOT COMPLETED|First Intervention||0
7746488|NCT01515657|19072790|P3|COMPLETED|First Intervention||13
7746489|NCT01515657|19072791|P2|COMPLETED|First Intervention||12
7746490|NCT01515657|19072792|P1|COMPLETED|First Intervention||14
7746491|NCT01515657|19072790|P3|STARTED|First Intervention||13
7746492|NCT01515657|19072791|P2|STARTED|First Intervention||13
7746493|NCT01515657|19072792|P1|STARTED|First Intervention||14
7746494|NCT01515566|19072802|P2|NOT COMPLETED|Overall Study||0
7746495|NCT01515566|19072803|P1|NOT COMPLETED|Overall Study||0
7746496|NCT01515566|19072802|P2|COMPLETED|Overall Study||10
7746497|NCT01515566|19072803|P1|COMPLETED|Overall Study||10
7746498|NCT01515566|19072802|P2|STARTED|Overall Study||10
7746499|NCT01515566|19072803|P1|STARTED|Overall Study||10
7746500|NCT01515540|19072815|P2|NOT COMPLETED|Overall Study||3
7746501|NCT01515540|19072816|P1|NOT COMPLETED|Overall Study||5
7746502|NCT01515540|19072815|P2|COMPLETED|Overall Study||15
7746503|NCT01515540|19072816|P1|COMPLETED|Overall Study||15
7746504|NCT01515540|19072815|P2|STARTED|Overall Study||18
7746505|NCT01515540|19072816|P1|STARTED|Overall Study||20
7746506|NCT01515488|19072824|P2|NOT COMPLETED|Overall Study||0
7746507|NCT01515488|19072825|P1|NOT COMPLETED|Overall Study||0
7746508|NCT01515488|19072824|P2|COMPLETED|Overall Study||200
7746509|NCT01515488|19072825|P1|COMPLETED|Overall Study||200
7746510|NCT01515488|19072824|P2|STARTED|Overall Study||200
7746511|NCT01515488|19072825|P1|STARTED|Overall Study||200
7746512|NCT01515475|19072839|P4|NOT COMPLETED|Overall Study||12
7746513|NCT01515475|19072840|P3|NOT COMPLETED|Overall Study||12
7746514|NCT01515475|19072841|P2|NOT COMPLETED|Overall Study||15
7746515|NCT01515475|19072842|P1|NOT COMPLETED|Overall Study||20
7746516|NCT01515475|19072839|P4|COMPLETED|Overall Study||53
7746517|NCT01515475|19072840|P3|COMPLETED|Overall Study||53
7746518|NCT01515475|19072841|P2|COMPLETED|Overall Study||43
7746519|NCT01515475|19072842|P1|COMPLETED|Overall Study||41
7746520|NCT01515475|19072839|P4|STARTED|Overall Study||65
7746521|NCT01515475|19072840|P3|STARTED|Overall Study||65
7746522|NCT01515475|19072841|P2|STARTED|Overall Study||58
7746523|NCT01515475|19072842|P1|STARTED|Overall Study||61
7746524|NCT01515423|19072916|P3|NOT COMPLETED|DOUBLE BLIND||92
7746525|NCT01515423|19072917|P2|NOT COMPLETED|DOUBLE BLIND||82
7746526|NCT01515423|19072918|P1|NOT COMPLETED|DOUBLE BLIND||0
7746527|NCT01515423|19072916|P3|COMPLETED|DOUBLE BLIND||420
7746528|NCT01515423|19072917|P2|COMPLETED|DOUBLE BLIND||422
7746529|NCT01515423|19072918|P1|COMPLETED|DOUBLE BLIND||0
7746530|NCT01515423|19072916|P3|STARTED|DOUBLE BLIND||512
7746531|NCT01515423|19072917|P2|STARTED|DOUBLE BLIND||504
7746532|NCT01515423|19072918|P1|STARTED|DOUBLE BLIND||0
7746533|NCT01515423|19072916|P3|NOT COMPLETED|Open Label Phase||0
7746534|NCT01515423|19072917|P2|NOT COMPLETED|Open Label Phase||0
7746535|NCT01515423|19072918|P1|NOT COMPLETED|Open Label Phase||413
7746536|NCT01515423|19072916|P3|COMPLETED|Open Label Phase||0
7746537|NCT01515423|19072917|P2|COMPLETED|Open Label Phase||0
7746538|NCT01515423|19072918|P1|COMPLETED|Open Label Phase||1016
7746539|NCT01515423|19072916|P3|STARTED|Open Label Phase||0
7746540|NCT01515423|19072917|P2|STARTED|Open Label Phase||0
7746541|NCT01515423|19072918|P1|STARTED|Open Label Phase||1429
7746542|NCT01515410|19072937|P2|NOT COMPLETED|Overall Study||0
7746543|NCT01515410|19072938|P1|NOT COMPLETED|Overall Study||0
7746544|NCT01515410|19072937|P2|COMPLETED|Overall Study||15
7746545|NCT01515410|19072938|P1|COMPLETED|Overall Study||19
7746546|NCT01515410|19072937|P2|STARTED|Overall Study||15
7746547|NCT01515410|19072938|P1|STARTED|Overall Study||19
7746548|NCT01515345|19072946|P2|NOT COMPLETED|Overall Study||0
7746549|NCT01515345|19072947|P1|NOT COMPLETED|Overall Study||1
7746550|NCT01515345|19072946|P2|COMPLETED|Overall Study||343
7746551|NCT01515345|19072947|P1|COMPLETED|Overall Study||664
7746552|NCT01515345|19072946|P2|STARTED|Overall Study||343
7746553|NCT01515345|19072947|P1|STARTED|Overall Study||665
7746554|NCT01515306|19072959|P2|NOT COMPLETED|Overall Study||14
7746555|NCT01515306|19072960|P1|NOT COMPLETED|Overall Study||12
7746556|NCT01515306|19072959|P2|COMPLETED|Overall Study||2
7746557|NCT01515306|19072960|P1|COMPLETED|Overall Study|Completed the required treatment in Cycle 1 Day 1 and Cycle 2 Day 1 and assessment.|12
7746558|NCT01515306|19072959|P2|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0
7746559|NCT01515306|19072960|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21
7746560|NCT01515306|19072959|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
7746561|NCT01515306|19072960|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
7746562|NCT01515306|19072959|P2|STARTED|Overall Study||16
7746563|NCT01515306|19072960|P1|STARTED|Overall Study||24
7746564|NCT01515189|19072973|P2|NOT COMPLETED|First Re-Induction Phase||15
7746565|NCT01515189|19072974|P1|NOT COMPLETED|First Re-Induction Phase||14
7746566|NCT01515189|19072973|P2|COMPLETED|First Re-Induction Phase||17
7746567|NCT01515189|19072974|P1|COMPLETED|First Re-Induction Phase||9
7746568|NCT01515189|19072973|P2|STARTED|First Re-Induction Phase||32
7746569|NCT01515189|19072974|P1|STARTED|First Re-Induction Phase||23
7746570|NCT01515189|19072973|P2|NOT COMPLETED|Induction||232
7746571|NCT01515189|19072974|P1|NOT COMPLETED|Induction||237
7746572|NCT01515189|19072973|P2|COMPLETED|Induction||130
7746573|NCT01515189|19072974|P1|COMPLETED|Induction||128
7746574|NCT01515189|19072973|P2|STARTED|Induction||362
7746575|NCT01515189|19072974|P1|STARTED|Induction|Includes 1 subject who was randomized but not treated due to an Adverse Event before treatment|365
7746576|NCT01515176|19072996|P2|NOT COMPLETED|Overall Study||0
7746577|NCT01515176|19072997|P1|NOT COMPLETED|Overall Study||0
7746578|NCT01515176|19072996|P2|COMPLETED|Overall Study||32
7746579|NCT01515176|19072997|P1|COMPLETED|Overall Study||4
7746580|NCT01515176|19072996|P2|STARTED|Overall Study||32
7746581|NCT01515176|19072997|P1|STARTED|Overall Study||4
7746582|NCT01515072|19073011|P2|NOT COMPLETED|Overall Study||0
7746583|NCT01515072|19073012|P1|NOT COMPLETED|Overall Study||0
7746584|NCT01515072|19073011|P2|COMPLETED|Overall Study|There were 513 total organs transplanted and 235 kidneys transplanted in the RIPC group|155
7746585|NCT01515072|19073012|P1|COMPLETED|Overall Study|There were 566 total organs transplanted and 248 kidneys transplanted in the No RIPC group.|166
7746586|NCT01515072|19073011|P2|STARTED|Overall Study||155
7746587|NCT01515072|19073012|P1|STARTED|Overall Study||166
7746588|NCT01515046|19073052|P1|NOT COMPLETED|Overall Study||0
7746589|NCT01515046|19073052|P1|COMPLETED|Overall Study||1
7746590|NCT01515046|19073052|P1|STARTED|Overall Study||1
7746591|NCT01514864|19073062|P2|NOT COMPLETED|Overall Study||5
7746592|NCT01514864|19073063|P1|NOT COMPLETED|Overall Study||9
7746593|NCT01514864|19073062|P2|COMPLETED|Overall Study||0
7746594|NCT01514864|19073063|P1|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0
7746595|NCT01514864|19073062|P2|STARTED|Overall Study||5
7746596|NCT01514864|19073063|P1|STARTED|Overall Study||9
7746597|NCT01514786|19073081|P2|NOT COMPLETED|Overall Study||0
7746598|NCT01514786|19073082|P1|NOT COMPLETED|Overall Study||0
7746599|NCT01514786|19073081|P2|COMPLETED|Overall Study||284
7746600|NCT01514786|19073082|P1|COMPLETED|Overall Study||286
7746601|NCT01514786|19073081|P2|STARTED|Overall Study||284
7746602|NCT01514786|19073082|P1|STARTED|Overall Study||286
7746603|NCT01514760|19073088|P1|NOT COMPLETED|Overall Study||2
7746604|NCT01514760|19073088|P1|COMPLETED|Overall Study||20
7746605|NCT01514760|19073088|P1|STARTED|Overall Study||22
7746606|NCT01514734|19073095|P1|NOT COMPLETED|Overall Study||0
7746607|NCT01514734|19073095|P1|COMPLETED|Overall Study||9
7746608|NCT01514734|19073095|P1|STARTED|Overall Study||9
7746609|NCT01514682|19073101|P2|NOT COMPLETED|Overall Study||6
7746610|NCT01514682|19073102|P1|NOT COMPLETED|Overall Study||6
7746611|NCT01514682|19073101|P2|COMPLETED|Overall Study||14
7746612|NCT01514682|19073102|P1|COMPLETED|Overall Study||13
7746613|NCT01514682|19073101|P2|STARTED|Overall Study||20
7746614|NCT01514682|19073102|P1|STARTED|Overall Study||19
7746615|NCT01514630|19073118|P1|NOT COMPLETED|Overall Study||3
7746616|NCT01514630|19073118|P1|COMPLETED|Overall Study||11
7746617|NCT01514630|19073118|P1|STARTED|Overall Study||14
7746618|NCT01514513|19073124|P2|NOT COMPLETED|Overall Study||1
7746619|NCT01514513|19073125|P1|NOT COMPLETED|Overall Study||1
7746620|NCT01514513|19073124|P2|COMPLETED|Overall Study||20
7746621|NCT01514513|19073125|P1|COMPLETED|Overall Study||20
7746622|NCT01514513|19073124|P2|STARTED|Overall Study||21
7746623|NCT01514513|19073125|P1|STARTED|Overall Study||21
7746624|NCT01514461|19073136|P3|NOT COMPLETED|Overall Study||4
7746625|NCT01514461|19073137|P2|NOT COMPLETED|Overall Study||3
7746626|NCT01514461|19073138|P1|NOT COMPLETED|Overall Study||5
7746627|NCT01514461|19073136|P3|COMPLETED|Overall Study||11
7746628|NCT01514461|19073137|P2|COMPLETED|Overall Study||12
7746629|NCT01514461|19073138|P1|COMPLETED|Overall Study||10
7746630|NCT01514461|19073136|P3|STARTED|Overall Study||15
7746631|NCT01514461|19073137|P2|STARTED|Overall Study||15
7746632|NCT01514461|19073138|P1|STARTED|Overall Study||15
7746633|NCT01514448|19073177|P2|NOT COMPLETED|Overall Study||8
7746634|NCT01514448|19073178|P1|NOT COMPLETED|Overall Study||12
7746635|NCT01514448|19073177|P2|COMPLETED|Overall Study||5
7746636|NCT01514448|19073178|P1|COMPLETED|Overall Study||4
7746637|NCT01514448|19073177|P2|Full Analysis Set (FAS)|Overall Study||13
7746638|NCT01514448|19073178|P1|Full Analysis Set (FAS)|Overall Study||12
7746639|NCT01514448|19073177|P2|STARTED|Overall Study||13
7746640|NCT01514448|19073178|P1|STARTED|Overall Study||16
7746641|NCT01514422|19073193|P1|NOT COMPLETED|Overall Study||1
7746642|NCT01514422|19073193|P1|COMPLETED|Overall Study||19
7746643|NCT01514422|19073193|P1|STARTED|Overall Study||20
7746644|NCT01514396|19073199|P1|NOT COMPLETED|Overall Study||0
7746645|NCT01514396|19073199|P1|COMPLETED|Overall Study||8
7746646|NCT01514396|19073199|P1|STARTED|Overall Study||8
7746647|NCT01514383|19073204|P1|NOT COMPLETED|Overall Study||0
7746648|NCT01514383|19073204|P1|COMPLETED|Overall Study||34
7746649|NCT01514383|19073204|P1|STARTED|Overall Study||34
7746650|NCT01514370|19073211|P2|NOT COMPLETED|Overall Study||16
7746651|NCT01514370|19073212|P1|NOT COMPLETED|Overall Study||11
7746652|NCT01514370|19073211|P2|COMPLETED|Overall Study||24
7746653|NCT01514370|19073212|P1|COMPLETED|Overall Study||29
7746654|NCT01514370|19073211|P2|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|40
7746655|NCT01514370|19073212|P1|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|38
7746656|NCT01514370|19073211|P2|STARTED|Overall Study||40
7746657|NCT01514370|19073212|P1|STARTED|Overall Study||40
7746658|NCT01514357|19073258|P2|NOT COMPLETED|Overall Study||0
7746659|NCT01514357|19073259|P1|NOT COMPLETED|Overall Study||4
7746660|NCT01514357|19073258|P2|COMPLETED|Overall Study||0
7746661|NCT01514357|19073259|P1|COMPLETED|Overall Study||8
7746662|NCT01514357|19073258|P2|STARTED|Overall Study||0
7746663|NCT01514357|19073259|P1|STARTED|Overall Study||12
7746664|NCT01514318|19073265|P1|NOT COMPLETED|Overall Study||0
7746665|NCT01514318|19073265|P1|COMPLETED|Overall Study||8
7746666|NCT01514318|19073265|P1|STARTED|Overall Study||8
7746667|NCT01514292|19073271|P1|NOT COMPLETED|Overall Study||0
7746668|NCT01514292|19073271|P1|COMPLETED|Overall Study||72
7746669|NCT01514292|19073271|P1|STARTED|Overall Study||72
7746670|NCT01514279|19073278|P3|NOT COMPLETED|Overall Study||5
7746671|NCT01514279|19073279|P2|NOT COMPLETED|Overall Study||13
7746672|NCT01514279|19073280|P1|NOT COMPLETED|Overall Study||11
7746673|NCT01514279|19073278|P3|COMPLETED|Overall Study||114
7746674|NCT01514279|19073279|P2|COMPLETED|Overall Study||110
7746675|NCT01514279|19073280|P1|COMPLETED|Overall Study||107
7746676|NCT01514279|19073278|P3|STARTED|Overall Study||119
7746677|NCT01514279|19073279|P2|STARTED|Overall Study||123
7746678|NCT01514279|19073280|P1|STARTED|Overall Study||118
7746679|NCT01514240|19073344|P2|NOT COMPLETED|Overall Study||11
7746680|NCT01514240|19073345|P1|NOT COMPLETED|Overall Study||6
7746681|NCT01514240|19073344|P2|COMPLETED|Overall Study||45
7746682|NCT01514240|19073345|P1|COMPLETED|Overall Study||50
7746683|NCT01514240|19073344|P2|STARTED|Overall Study||56
7746684|NCT01514240|19073345|P1|STARTED|Overall Study||56
7746685|NCT01514201|19073423|P4|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||33
7746686|NCT01514201|19073424|P3|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
7746687|NCT01514201|19073425|P2|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
7746688|NCT01514201|19073426|P1|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
7746689|NCT01514201|19073423|P4|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||2
7746690|NCT01514201|19073424|P3|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
7746691|NCT01514201|19073425|P2|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
7746692|NCT01514201|19073426|P1|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
7746693|NCT01514201|19073423|P4|STARTED|PHASE II: Maintenance With Veliparib/TMZ||35
7746694|NCT01514201|19073424|P3|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
7746695|NCT01514201|19073425|P2|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
7746696|NCT01514201|19073426|P1|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
7746697|NCT01514201|19073423|P4|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||12
7746698|NCT01514201|19073424|P3|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
7746699|NCT01514201|19073425|P2|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
7746700|NCT01514201|19073426|P1|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
7746701|NCT01514201|19073423|P4|COMPLETED|PHASE II: Veliparib + Radiation Therapy||35
7746702|NCT01514201|19073424|P3|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
7746703|NCT01514201|19073425|P2|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
7746704|NCT01514201|19073426|P1|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
7746705|NCT01514201|19073423|P4|STARTED|PHASE II: Veliparib + Radiation Therapy||47
7746706|NCT01514201|19073424|P3|STARTED|PHASE II: Veliparib + Radiation Therapy||0
7746707|NCT01514201|19073425|P2|STARTED|PHASE II: Veliparib + Radiation Therapy||0
7746708|NCT01514201|19073426|P1|STARTED|PHASE II: Veliparib + Radiation Therapy||0
7746709|NCT01514201|19073423|P4|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
7746710|NCT01514201|19073424|P3|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
7746711|NCT01514201|19073425|P2|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
7746712|NCT01514201|19073426|P1|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||5
7746713|NCT01514201|19073423|P4|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
7746714|NCT01514201|19073424|P3|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
7746715|NCT01514201|19073425|P2|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
7746716|NCT01514201|19073426|P1|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
7746717|NCT01514201|19073423|P4|STARTED|PHASE I: Maintenance With Veliparib/TMZ||0
7746718|NCT01514201|19073424|P3|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
7746719|NCT01514201|19073425|P2|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
7746720|NCT01514201|19073426|P1|STARTED|PHASE I: Maintenance With Veliparib/TMZ||5
7746721|NCT01514201|19073423|P4|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
7746722|NCT01514201|19073424|P3|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
7746723|NCT01514201|19073425|P2|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
7746724|NCT01514201|19073426|P1|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||1
7746725|NCT01514201|19073423|P4|COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
7746726|NCT01514201|19073424|P3|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
7746727|NCT01514201|19073425|P2|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
7746728|NCT01514201|19073426|P1|COMPLETED|PHASE I: Veliparib + Radiation Therapy||5
7746729|NCT01514201|19073423|P4|STARTED|PHASE I: Veliparib + Radiation Therapy||0
7746730|NCT01514201|19073424|P3|STARTED|PHASE I: Veliparib + Radiation Therapy||6
7746731|NCT01514201|19073425|P2|STARTED|PHASE I: Veliparib + Radiation Therapy||6
7746732|NCT01514201|19073426|P1|STARTED|PHASE I: Veliparib + Radiation Therapy||6
7746733|NCT01514162|19073485|P1|NOT COMPLETED|Overall Study||85
7746734|NCT01514162|19073485|P1|COMPLETED|Overall Study||160
7746735|NCT01514162|19073485|P1|STARTED|Overall Study||245
7746736|NCT01514149|19073496|P5|NOT COMPLETED|Overall Study||1
7746737|NCT01514149|19073497|P4|NOT COMPLETED|Overall Study||1
7746738|NCT01514149|19073498|P3|NOT COMPLETED|Overall Study||3
7746739|NCT01514149|19073499|P2|NOT COMPLETED|Overall Study||1
7746740|NCT01514149|19073500|P1|NOT COMPLETED|Overall Study||3
7746741|NCT01514149|19073496|P5|COMPLETED|Overall Study||14
7746742|NCT01514149|19073497|P4|COMPLETED|Overall Study||13
7746743|NCT01514149|19073498|P3|COMPLETED|Overall Study||11
7746744|NCT01514149|19073499|P2|COMPLETED|Overall Study||14
7746745|NCT01514149|19073500|P1|COMPLETED|Overall Study||12
7746746|NCT01514149|19073496|P5|STARTED|Overall Study||15
7746747|NCT01514149|19073497|P4|STARTED|Overall Study||14
7746748|NCT01514149|19073498|P3|STARTED|Overall Study||14
7746749|NCT01514149|19073499|P2|STARTED|Overall Study||15
7746750|NCT01514149|19073500|P1|STARTED|Overall Study||15
7746751|NCT01514136|19073524|P8|NOT COMPLETED|Test Period; Test D*||0
7746752|NCT01514136|19073525|P7|NOT COMPLETED|Test Period; Test D*||0
7746753|NCT01514136|19073526|P6|NOT COMPLETED|Test Period; Test D*||0
7746754|NCT01514136|19073527|P5|NOT COMPLETED|Test Period; Test D*||0
7746755|NCT01514136|19073528|P4|NOT COMPLETED|Test Period; Test D*||0
7746756|NCT01514136|19073529|P3|NOT COMPLETED|Test Period; Test D*||0
7746757|NCT01514136|19073530|P2|NOT COMPLETED|Test Period; Test D*||0
7746758|NCT01514136|19073531|P1|NOT COMPLETED|Test Period; Test D*||0
7746759|NCT01514136|19073524|P8|COMPLETED|Test Period; Test D*||23
7746760|NCT01514136|19073525|P7|COMPLETED|Test Period; Test D*||0
7746761|NCT01514136|19073526|P6|COMPLETED|Test Period; Test D*||0
7746762|NCT01514136|19073527|P5|COMPLETED|Test Period; Test D*||0
7746763|NCT01514136|19073528|P4|COMPLETED|Test Period; Test D*||0
7746764|NCT01514136|19073529|P3|COMPLETED|Test Period; Test D*||0
7746765|NCT01514136|19073530|P2|COMPLETED|Test Period; Test D*||0
7746766|NCT01514136|19073531|P1|COMPLETED|Test Period; Test D*||0
7746767|NCT01514136|19073524|P8|STARTED|Test Period; Test D*||23
7746768|NCT01514136|19073525|P7|STARTED|Test Period; Test D*||0
7746769|NCT01514136|19073526|P6|STARTED|Test Period; Test D*||0
7746770|NCT01514136|19073527|P5|STARTED|Test Period; Test D*||0
7746771|NCT01514136|19073528|P4|STARTED|Test Period; Test D*||0
7746772|NCT01514136|19073529|P3|STARTED|Test Period; Test D*||0
7746773|NCT01514136|19073530|P2|STARTED|Test Period; Test D*||0
7746774|NCT01514136|19073531|P1|STARTED|Test Period; Test D*||0
7746775|NCT01514136|19073524|P8|NOT COMPLETED|Test Period 2; Test C*||0
7746776|NCT01514136|19073525|P7|NOT COMPLETED|Test Period 2; Test C*||3
7746777|NCT01514136|19073526|P6|NOT COMPLETED|Test Period 2; Test C*||0
7746778|NCT01514136|19073527|P5|NOT COMPLETED|Test Period 2; Test C*||0
7746779|NCT01514136|19073528|P4|NOT COMPLETED|Test Period 2; Test C*||0
7746780|NCT01514136|19073529|P3|NOT COMPLETED|Test Period 2; Test C*||0
7746781|NCT01514136|19073530|P2|NOT COMPLETED|Test Period 2; Test C*||0
7746782|NCT01514136|19073531|P1|NOT COMPLETED|Test Period 2; Test C*||0
7746783|NCT01514136|19073524|P8|COMPLETED|Test Period 2; Test C*||0
7746784|NCT01514136|19073525|P7|COMPLETED|Test Period 2; Test C*||23
7746785|NCT01514136|19073526|P6|COMPLETED|Test Period 2; Test C*||0
7746786|NCT01514136|19073527|P5|COMPLETED|Test Period 2; Test C*||0
7746787|NCT01514136|19073528|P4|COMPLETED|Test Period 2; Test C*||0
7746788|NCT01514136|19073529|P3|COMPLETED|Test Period 2; Test C*||0
7746789|NCT01514136|19073530|P2|COMPLETED|Test Period 2; Test C*||0
7746790|NCT01514136|19073531|P1|COMPLETED|Test Period 2; Test C*||0
7746791|NCT01514136|19073524|P8|STARTED|Test Period 2; Test C*||0
7746792|NCT01514136|19073525|P7|STARTED|Test Period 2; Test C*||26
7746793|NCT01514136|19073526|P6|STARTED|Test Period 2; Test C*||0
7746794|NCT01514136|19073527|P5|STARTED|Test Period 2; Test C*||0
7746795|NCT01514136|19073528|P4|STARTED|Test Period 2; Test C*||0
7746796|NCT01514136|19073529|P3|STARTED|Test Period 2; Test C*||0
7746797|NCT01514136|19073530|P2|STARTED|Test Period 2; Test C*||0
7746798|NCT01514136|19073531|P1|STARTED|Test Period 2; Test C*||0
7746799|NCT01514136|19073524|P8|NOT COMPLETED|Test Period 2; Test B*||0
7746800|NCT01514136|19073525|P7|NOT COMPLETED|Test Period 2; Test B*||0
7746801|NCT01514136|19073526|P6|NOT COMPLETED|Test Period 2; Test B*||2
7746802|NCT01514136|19073527|P5|NOT COMPLETED|Test Period 2; Test B*||0
7746803|NCT01514136|19073528|P4|NOT COMPLETED|Test Period 2; Test B*||0
7746804|NCT01514136|19073529|P3|NOT COMPLETED|Test Period 2; Test B*||0
7746805|NCT01514136|19073530|P2|NOT COMPLETED|Test Period 2; Test B*||0
7746806|NCT01514136|19073531|P1|NOT COMPLETED|Test Period 2; Test B*||0
7746807|NCT01514136|19073524|P8|COMPLETED|Test Period 2; Test B*||0
7746808|NCT01514136|19073525|P7|COMPLETED|Test Period 2; Test B*||0
7746809|NCT01514136|19073526|P6|COMPLETED|Test Period 2; Test B*||26
7746810|NCT01514136|19073527|P5|COMPLETED|Test Period 2; Test B*||0
7746811|NCT01514136|19073528|P4|COMPLETED|Test Period 2; Test B*||0
7746812|NCT01514136|19073529|P3|COMPLETED|Test Period 2; Test B*||0
7746813|NCT01514136|19073530|P2|COMPLETED|Test Period 2; Test B*||0
7746814|NCT01514136|19073531|P1|COMPLETED|Test Period 2; Test B*||0
7746815|NCT01514136|19073524|P8|STARTED|Test Period 2; Test B*||0
7746816|NCT01514136|19073525|P7|STARTED|Test Period 2; Test B*||0
7746817|NCT01514136|19073526|P6|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28
7746818|NCT01514136|19073527|P5|STARTED|Test Period 2; Test B*||0
7746819|NCT01514136|19073528|P4|STARTED|Test Period 2; Test B*||0
7746820|NCT01514136|19073529|P3|STARTED|Test Period 2; Test B*||0
7746821|NCT01514136|19073530|P2|STARTED|Test Period 2; Test B*||0
7746822|NCT01514136|19073531|P1|STARTED|Test Period 2; Test B*||0
7746823|NCT01514136|19073524|P8|NOT COMPLETED|Test Period 2; Test A*||0
7746824|NCT01514136|19073525|P7|NOT COMPLETED|Test Period 2; Test A*||0
7746825|NCT01514136|19073526|P6|NOT COMPLETED|Test Period 2; Test A*||0
7746826|NCT01514136|19073527|P5|NOT COMPLETED|Test Period 2; Test A*||2
7746827|NCT01514136|19073528|P4|NOT COMPLETED|Test Period 2; Test A*||0
7746828|NCT01514136|19073529|P3|NOT COMPLETED|Test Period 2; Test A*||0
7746829|NCT01514136|19073530|P2|NOT COMPLETED|Test Period 2; Test A*||0
7746830|NCT01514136|19073531|P1|NOT COMPLETED|Test Period 2; Test A*||0
7746831|NCT01514136|19073524|P8|COMPLETED|Test Period 2; Test A*||0
7746832|NCT01514136|19073525|P7|COMPLETED|Test Period 2; Test A*||0
7746833|NCT01514136|19073526|P6|COMPLETED|Test Period 2; Test A*||0
7746834|NCT01514136|19073527|P5|COMPLETED|Test Period 2; Test A*||26
7746835|NCT01514136|19073528|P4|COMPLETED|Test Period 2; Test A*||0
7746836|NCT01514136|19073529|P3|COMPLETED|Test Period 2; Test A*||0
7746837|NCT01514136|19073530|P2|COMPLETED|Test Period 2; Test A*||0
7746838|NCT01514136|19073531|P1|COMPLETED|Test Period 2; Test A*||0
7746839|NCT01514136|19073524|P8|STARTED|Test Period 2; Test A*||0
7746840|NCT01514136|19073525|P7|STARTED|Test Period 2; Test A*||0
7746841|NCT01514136|19073526|P6|STARTED|Test Period 2; Test A*||0
7746842|NCT01514136|19073527|P5|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28
7746843|NCT01514136|19073528|P4|STARTED|Test Period 2; Test A*||0
7746844|NCT01514136|19073529|P3|STARTED|Test Period 2; Test A*||0
7746845|NCT01514136|19073530|P2|STARTED|Test Period 2; Test A*||0
7746846|NCT01514136|19073531|P1|STARTED|Test Period 2; Test A*||0
7746847|NCT01514136|19073524|P8|NOT COMPLETED|Test Period 1; Test D||0
7746848|NCT01514136|19073525|P7|NOT COMPLETED|Test Period 1; Test D||0
7746849|NCT01514136|19073526|P6|NOT COMPLETED|Test Period 1; Test D||0
7746850|NCT01514136|19073527|P5|NOT COMPLETED|Test Period 1; Test D||0
7746851|NCT01514136|19073528|P4|NOT COMPLETED|Test Period 1; Test D||2
7746852|NCT01514136|19073529|P3|NOT COMPLETED|Test Period 1; Test D||0
7746853|NCT01514136|19073530|P2|NOT COMPLETED|Test Period 1; Test D||0
7746854|NCT01514136|19073531|P1|NOT COMPLETED|Test Period 1; Test D||0
7746855|NCT01514136|19073524|P8|COMPLETED|Test Period 1; Test D||0
7746856|NCT01514136|19073525|P7|COMPLETED|Test Period 1; Test D||0
7746857|NCT01514136|19073526|P6|COMPLETED|Test Period 1; Test D||0
7746858|NCT01514136|19073527|P5|COMPLETED|Test Period 1; Test D||0
7746859|NCT01514136|19073528|P4|COMPLETED|Test Period 1; Test D||24
7746860|NCT01514136|19073529|P3|COMPLETED|Test Period 1; Test D||0
7746861|NCT01514136|19073530|P2|COMPLETED|Test Period 1; Test D||0
7746862|NCT01514136|19073531|P1|COMPLETED|Test Period 1; Test D||0
7746863|NCT01514136|19073524|P8|STARTED|Test Period 1; Test D||0
7746864|NCT01514136|19073525|P7|STARTED|Test Period 1; Test D||0
7746865|NCT01514136|19073526|P6|STARTED|Test Period 1; Test D||0
7746866|NCT01514136|19073527|P5|STARTED|Test Period 1; Test D||0
7746867|NCT01514136|19073528|P4|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26
7746868|NCT01514136|19073529|P3|STARTED|Test Period 1; Test D||0
7746869|NCT01514136|19073530|P2|STARTED|Test Period 1; Test D||0
7746870|NCT01514136|19073531|P1|STARTED|Test Period 1; Test D||0
7746871|NCT01514136|19073524|P8|NOT COMPLETED|Test Period 1; Test C||0
7746872|NCT01514136|19073525|P7|NOT COMPLETED|Test Period 1; Test C||0
7746873|NCT01514136|19073526|P6|NOT COMPLETED|Test Period 1; Test C||0
7746874|NCT01514136|19073527|P5|NOT COMPLETED|Test Period 1; Test C||0
7746875|NCT01514136|19073528|P4|NOT COMPLETED|Test Period 1; Test C||0
7746876|NCT01514136|19073529|P3|NOT COMPLETED|Test Period 1; Test C||0
7746877|NCT01514136|19073530|P2|NOT COMPLETED|Test Period 1; Test C||0
7746878|NCT01514136|19073531|P1|NOT COMPLETED|Test Period 1; Test C||0
7746879|NCT01514136|19073524|P8|COMPLETED|Test Period 1; Test C||0
7746880|NCT01514136|19073525|P7|COMPLETED|Test Period 1; Test C||0
7746881|NCT01514136|19073526|P6|COMPLETED|Test Period 1; Test C||0
7746882|NCT01514136|19073527|P5|COMPLETED|Test Period 1; Test C||0
7746883|NCT01514136|19073528|P4|COMPLETED|Test Period 1; Test C||0
7746884|NCT01514136|19073529|P3|COMPLETED|Test Period 1; Test C||24
7746885|NCT01514136|19073530|P2|COMPLETED|Test Period 1; Test C||0
7746886|NCT01514136|19073531|P1|COMPLETED|Test Period 1; Test C||0
7746887|NCT01514136|19073524|P8|STARTED|Test Period 1; Test C||0
7746888|NCT01514136|19073525|P7|STARTED|Test Period 1; Test C||0
7746889|NCT01514136|19073526|P6|STARTED|Test Period 1; Test C||0
7746890|NCT01514136|19073527|P5|STARTED|Test Period 1; Test C||0
7746891|NCT01514136|19073528|P4|STARTED|Test Period 1; Test C||0
7746892|NCT01514136|19073529|P3|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24
7746893|NCT01514136|19073530|P2|STARTED|Test Period 1; Test C||0
7746894|NCT01514136|19073531|P1|STARTED|Test Period 1; Test C||0
7746895|NCT01514136|19073524|P8|NOT COMPLETED|Test Period 1; Test B||0
7746896|NCT01514136|19073525|P7|NOT COMPLETED|Test Period 1; Test B||0
7746897|NCT01514136|19073526|P6|NOT COMPLETED|Test Period 1; Test B||0
7746898|NCT01514136|19073527|P5|NOT COMPLETED|Test Period 1; Test B||0
7746899|NCT01514136|19073528|P4|NOT COMPLETED|Test Period 1; Test B||0
7746900|NCT01514136|19073529|P3|NOT COMPLETED|Test Period 1; Test B||0
7746901|NCT01514136|19073530|P2|NOT COMPLETED|Test Period 1; Test B||1
7746902|NCT01514136|19073531|P1|NOT COMPLETED|Test Period 1; Test B||0
7746903|NCT01514136|19073524|P8|COMPLETED|Test Period 1; Test B||0
7746904|NCT01514136|19073525|P7|COMPLETED|Test Period 1; Test B||0
7746905|NCT01514136|19073526|P6|COMPLETED|Test Period 1; Test B||0
7746906|NCT01514136|19073527|P5|COMPLETED|Test Period 1; Test B||0
7746907|NCT01514136|19073528|P4|COMPLETED|Test Period 1; Test B||0
7746908|NCT01514136|19073529|P3|COMPLETED|Test Period 1; Test B||0
7746909|NCT01514136|19073530|P2|COMPLETED|Test Period 1; Test B||23
7746910|NCT01514136|19073531|P1|COMPLETED|Test Period 1; Test B||0
7746911|NCT01514136|19073524|P8|STARTED|Test Period 1; Test B||0
7746912|NCT01514136|19073525|P7|STARTED|Test Period 1; Test B||0
7746913|NCT01514136|19073526|P6|STARTED|Test Period 1; Test B||0
7746914|NCT01514136|19073527|P5|STARTED|Test Period 1; Test B||0
7746915|NCT01514136|19073528|P4|STARTED|Test Period 1; Test B||0
7746916|NCT01514136|19073529|P3|STARTED|Test Period 1; Test B||0
7746917|NCT01514136|19073530|P2|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24
7746918|NCT01514136|19073531|P1|STARTED|Test Period 1; Test B||0
7746919|NCT01514136|19073524|P8|NOT COMPLETED|Test Period 1; Test A||0
7746920|NCT01514136|19073525|P7|NOT COMPLETED|Test Period 1; Test A||0
7746921|NCT01514136|19073526|P6|NOT COMPLETED|Test Period 1; Test A||0
7746922|NCT01514136|19073527|P5|NOT COMPLETED|Test Period 1; Test A||0
7746923|NCT01514136|19073528|P4|NOT COMPLETED|Test Period 1; Test A||0
7746924|NCT01514136|19073529|P3|NOT COMPLETED|Test Period 1; Test A||0
7746925|NCT01514136|19073530|P2|NOT COMPLETED|Test Period 1; Test A||0
7746926|NCT01514136|19073531|P1|NOT COMPLETED|Test Period 1; Test A||3
7746927|NCT01514136|19073524|P8|COMPLETED|Test Period 1; Test A||0
7746928|NCT01514136|19073525|P7|COMPLETED|Test Period 1; Test A||0
7746929|NCT01514136|19073526|P6|COMPLETED|Test Period 1; Test A||0
7746930|NCT01514136|19073527|P5|COMPLETED|Test Period 1; Test A||0
7746931|NCT01514136|19073528|P4|COMPLETED|Test Period 1; Test A||0
7746932|NCT01514136|19073529|P3|COMPLETED|Test Period 1; Test A||0
7746933|NCT01514136|19073530|P2|COMPLETED|Test Period 1; Test A||0
7746934|NCT01514136|19073531|P1|COMPLETED|Test Period 1; Test A||22
7746935|NCT01514136|19073524|P8|STARTED|Test Period 1; Test A||0
7746936|NCT01514136|19073525|P7|STARTED|Test Period 1; Test A||0
7746937|NCT01514136|19073526|P6|STARTED|Test Period 1; Test A||0
7746938|NCT01514136|19073527|P5|STARTED|Test Period 1; Test A||0
7746939|NCT01514136|19073528|P4|STARTED|Test Period 1; Test A||0
7746940|NCT01514136|19073529|P3|STARTED|Test Period 1; Test A||0
7746941|NCT01514136|19073530|P2|STARTED|Test Period 1; Test A||0
7746942|NCT01514136|19073531|P1|STARTED|Test Period 1; Test A|26 subjects tested Test A|25
7746943|NCT01513967|19073565|P8|NOT COMPLETED|Overall Study||2
7746944|NCT01513967|19073566|P7|NOT COMPLETED|Overall Study||2
7746945|NCT01513967|19073567|P6|NOT COMPLETED|Overall Study||1
7746946|NCT01513967|19073568|P5|NOT COMPLETED|Overall Study||0
7746947|NCT01513967|19073569|P4|NOT COMPLETED|Overall Study||0
7746948|NCT01513967|19073570|P3|NOT COMPLETED|Overall Study||0
7746949|NCT01513967|19073571|P2|NOT COMPLETED|Overall Study||0
7746950|NCT01513967|19073572|P1|NOT COMPLETED|Overall Study||0
7746951|NCT01513967|19073565|P8|COMPLETED|Overall Study||6
7746952|NCT01513967|19073566|P7|COMPLETED|Overall Study||3
7746953|NCT01513967|19073567|P6|COMPLETED|Overall Study||3
7746954|NCT01513967|19073568|P5|COMPLETED|Overall Study||4
7746955|NCT01513967|19073569|P4|COMPLETED|Overall Study||6
7746956|NCT01513967|19073570|P3|COMPLETED|Overall Study||4
7746957|NCT01513967|19073571|P2|COMPLETED|Overall Study||4
7746958|NCT01513967|19073572|P1|COMPLETED|Overall Study||4
7746959|NCT01513967|19073565|P8|STARTED|Overall Study||8
7746960|NCT01513967|19073566|P7|STARTED|Overall Study||5
7746961|NCT01513967|19073567|P6|STARTED|Overall Study||4
7746962|NCT01513967|19073568|P5|STARTED|Overall Study||4
7746963|NCT01513967|19073569|P4|STARTED|Overall Study||6
7746964|NCT01513967|19073570|P3|STARTED|Overall Study||4
7746965|NCT01513967|19073571|P2|STARTED|Overall Study||4
7746966|NCT01513967|19073572|P1|STARTED|Overall Study||4
7746967|NCT01513902|19073593|P3|NOT COMPLETED|Overall Study||0
7746968|NCT01513902|19073594|P2|NOT COMPLETED|Overall Study||0
7746969|NCT01513902|19073595|P1|NOT COMPLETED|Overall Study||0
7746970|NCT01513902|19073593|P3|COMPLETED|Overall Study||9
7746971|NCT01513902|19073594|P2|COMPLETED|Overall Study||9
7746972|NCT01513902|19073595|P1|COMPLETED|Overall Study||8
7746973|NCT01513902|19073593|P3|STARTED|Overall Study||9
7746974|NCT01513902|19073594|P2|STARTED|Overall Study||9
7746975|NCT01513902|19073595|P1|STARTED|Overall Study||8
7746976|NCT01513759|19073630|P1|NOT COMPLETED|Overall Study||5
7746977|NCT01513759|19073630|P1|COMPLETED|Overall Study||145
7746978|NCT01513759|19073630|P1|At Least One Device Successfully Placed|Overall Study||149
7746979|NCT01513759|19073630|P1|STARTED|Overall Study||150
7746980|NCT01513590|19073641|P2|NOT COMPLETED|Overall Study||13
7746981|NCT01513590|19073642|P1|NOT COMPLETED|Overall Study||10
7746982|NCT01513590|19073641|P2|COMPLETED|Overall Study||184
7746983|NCT01513590|19073642|P1|COMPLETED|Overall Study||187
7746984|NCT01513590|19073641|P2|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195
7746985|NCT01513590|19073642|P1|Exposed|Overall Study|"One (1) subject was withdrawn prior to exposure due to non fulfilment of inclusion criteria"|196
7746986|NCT01513590|19073641|P2|STARTED|Overall Study||197
7746987|NCT01513590|19073642|P1|STARTED|Overall Study||197
7746988|NCT01513551|19073663|P3|NOT COMPLETED|Overall Study||5
7746989|NCT01513551|19073664|P2|NOT COMPLETED|Overall Study||6
7746990|NCT01513551|19073665|P1|NOT COMPLETED|Overall Study||4
7746991|NCT01513551|19073663|P3|COMPLETED|Overall Study||226
7746992|NCT01513551|19073664|P2|COMPLETED|Overall Study||225
7746993|NCT01513551|19073665|P1|COMPLETED|Overall Study||226
7746994|NCT01513551|19073663|P3|Vaccinated|Overall Study||230
7746995|NCT01513551|19073664|P2|Vaccinated|Overall Study||231
7746996|NCT01513551|19073665|P1|Vaccinated|Overall Study||230
7746997|NCT01513551|19073663|P3|STARTED|Overall Study||231
7746998|NCT01513551|19073664|P2|STARTED|Overall Study||231
7746999|NCT01513551|19073665|P1|STARTED|Overall Study||230
7747000|NCT01513538|19073691|P1|NOT COMPLETED|Overall Study||5
7747001|NCT01513538|19073691|P1|COMPLETED|Overall Study||573
7747002|NCT01513538|19073691|P1|STARTED|Overall Study||578
7747003|NCT01513473|19073697|P2|NOT COMPLETED|Extension Trial (26 Weeks)||6
7747004|NCT01513473|19073698|P1|NOT COMPLETED|Extension Trial (26 Weeks)||1
7747005|NCT01513473|19073697|P2|COMPLETED|Extension Trial (26 Weeks)||122
7747006|NCT01513473|19073698|P1|COMPLETED|Extension Trial (26 Weeks)||151
7747007|NCT01513473|19073697|P2|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128
7747008|NCT01513473|19073698|P1|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152
7747009|NCT01513473|19073697|P2|NOT COMPLETED|Main Trial (26 Weeks)||11
7747010|NCT01513473|19073698|P1|NOT COMPLETED|Main Trial (26 Weeks)||4
7747011|NCT01513473|19073697|P2|COMPLETED|Main Trial (26 Weeks)||165
7747012|NCT01513473|19073698|P1|COMPLETED|Main Trial (26 Weeks)||170
7747013|NCT01513473|19073697|P2|Exposed|Main Trial (26 Weeks)||175
7747014|NCT01513473|19073698|P1|Exposed|Main Trial (26 Weeks)||174
7747015|NCT01513473|19073697|P2|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176
7747016|NCT01513473|19073698|P1|STARTED|Main Trial (26 Weeks)||174
7747017|NCT01513460|19073725|P3|NOT COMPLETED|Overall Study||56
7747018|NCT01513460|19073726|P2|NOT COMPLETED|Overall Study||32
7747019|NCT01513460|19073727|P1|NOT COMPLETED|Overall Study||29
7747020|NCT01513460|19073725|P3|COMPLETED|Overall Study||201
7747021|NCT01513460|19073726|P2|COMPLETED|Overall Study||226
7747022|NCT01513460|19073727|P1|COMPLETED|Overall Study||229
7747023|NCT01513460|19073725|P3|Per-protocol Set|Overall Study||166
7747024|NCT01513460|19073726|P2|Per-protocol Set|Overall Study||186
7747025|NCT01513460|19073727|P1|Per-protocol Set|Overall Study||196
7747026|NCT01513460|19073725|P3|Full Analysis Set|Overall Study||257
7747027|NCT01513460|19073726|P2|Full Analysis Set|Overall Study||258
7747028|NCT01513460|19073727|P1|Full Analysis Set|Overall Study||257
7747029|NCT01513460|19073725|P3|STARTED|Overall Study||257
7747030|NCT01513460|19073726|P2|STARTED|Overall Study||258
7747031|NCT01513460|19073727|P1|STARTED|Overall Study||258
7747032|NCT01513447|19073753|P2|NOT COMPLETED|Overall Study||0
7747033|NCT01513447|19073754|P1|NOT COMPLETED|Overall Study||0
7747034|NCT01513447|19073753|P2|COMPLETED|Overall Study||5
7747035|NCT01513447|19073754|P1|COMPLETED|Overall Study||3
7747036|NCT01513447|19073753|P2|STARTED|Overall Study||5
7747037|NCT01513447|19073754|P1|STARTED|Overall Study||3
7747038|NCT01513330|19073762|P2|NOT COMPLETED|Standard Care First,||4
7747039|NCT01513330|19073763|P1|NOT COMPLETED|Standard Care First,||4
7747040|NCT01513330|19073762|P2|COMPLETED|Standard Care First,||52
7747041|NCT01513330|19073763|P1|COMPLETED|Standard Care First,||56
7747042|NCT01513330|19073762|P2|STARTED|Standard Care First,||56
7747043|NCT01513330|19073763|P1|STARTED|Standard Care First,||60
7747044|NCT01513330|19073762|P2|NOT COMPLETED|SenSura Mio First,||2
7747045|NCT01513330|19073763|P1|NOT COMPLETED|SenSura Mio First,||4
7747046|NCT01513330|19073762|P2|COMPLETED|SenSura Mio First,||56
7747047|NCT01513330|19073763|P1|COMPLETED|SenSura Mio First,||60
7747048|NCT01513330|19073762|P2|STARTED|SenSura Mio First,||58
7747049|NCT01513330|19073763|P1|STARTED|SenSura Mio First,||64
7747050|NCT01513317|19073771|P2|NOT COMPLETED|Overall Study||24
7747051|NCT01513317|19073772|P1|NOT COMPLETED|Overall Study||34
7747052|NCT01513317|19073771|P2|COMPLETED|Overall Study||2
7747053|NCT01513317|19073772|P1|COMPLETED|Overall Study||16
7747054|NCT01513317|19073771|P2|STARTED|Overall Study||26
7747055|NCT01513317|19073772|P1|STARTED|Overall Study||50
7747056|NCT01513291|19073790|P5|NOT COMPLETED|Run-out Period||0
7747057|NCT01513291|19073791|P4|NOT COMPLETED|Run-out Period||2
7747058|NCT01513291|19073792|P3|NOT COMPLETED|Run-out Period||0
7747059|NCT01513291|19073793|P2|NOT COMPLETED|Run-out Period||0
7747060|NCT01513291|19073794|P1|NOT COMPLETED|Run-out Period||0
7747061|NCT01513291|19073790|P5|COMPLETED|Run-out Period||101
7747062|NCT01513291|19073791|P4|COMPLETED|Run-out Period||45
7747063|NCT01513291|19073792|P3|COMPLETED|Run-out Period||50
7747064|NCT01513291|19073793|P2|COMPLETED|Run-out Period||0
7747065|NCT01513291|19073794|P1|COMPLETED|Run-out Period||0
7747066|NCT01513291|19073790|P5|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101
7747067|NCT01513291|19073791|P4|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47
7747068|NCT01513291|19073792|P3|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50
7747069|NCT01513291|19073793|P2|STARTED|Run-out Period||0
7747070|NCT01513291|19073794|P1|STARTED|Run-out Period||0
7747071|NCT01513291|19073790|P5|NOT COMPLETED|Treatment Period||0
7747072|NCT01513291|19073791|P4|NOT COMPLETED|Treatment Period||0
7747073|NCT01513291|19073792|P3|NOT COMPLETED|Treatment Period||0
7747074|NCT01513291|19073793|P2|NOT COMPLETED|Treatment Period||16
7747075|NCT01513291|19073794|P1|NOT COMPLETED|Treatment Period||23
7747076|NCT01513291|19073790|P5|COMPLETED|Treatment Period||0
7747077|NCT01513291|19073791|P4|COMPLETED|Treatment Period||0
7747078|NCT01513291|19073792|P3|COMPLETED|Treatment Period||0
7747079|NCT01513291|19073793|P2|COMPLETED|Treatment Period||101
7747080|NCT01513291|19073794|P1|COMPLETED|Treatment Period||97
7747081|NCT01513291|19073790|P5|Treated|Treatment Period||0
7747082|NCT01513291|19073791|P4|Treated|Treatment Period||0
7747083|NCT01513291|19073792|P3|Treated|Treatment Period||0
7747084|NCT01513291|19073793|P2|Treated|Treatment Period||115
7747085|NCT01513291|19073794|P1|Treated|Treatment Period||120
7747086|NCT01513291|19073790|P5|STARTED|Treatment Period||0
7747087|NCT01513291|19073791|P4|STARTED|Treatment Period||0
7747088|NCT01513291|19073792|P3|STARTED|Treatment Period||0
7747089|NCT01513291|19073793|P2|STARTED|Treatment Period||117
7747090|NCT01513291|19073794|P1|STARTED|Treatment Period||120
7747091|NCT01513239|19073822|P6|NOT COMPLETED|Period 2: 9 Month Extension Phase||5
7747092|NCT01513239|19073823|P5|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
7747093|NCT01513239|19073824|P4|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
7747094|NCT01513239|19073825|P3|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
7747095|NCT01513239|19073826|P2|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
7747096|NCT01513239|19073827|P1|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
7747097|NCT01513239|19073822|P6|COMPLETED|Period 2: 9 Month Extension Phase||78
7747098|NCT01513239|19073823|P5|COMPLETED|Period 2: 9 Month Extension Phase||90
7747099|NCT01513239|19073824|P4|COMPLETED|Period 2: 9 Month Extension Phase||102
7747100|NCT01513239|19073825|P3|COMPLETED|Period 2: 9 Month Extension Phase||0
7747101|NCT01513239|19073826|P2|COMPLETED|Period 2: 9 Month Extension Phase||0
7747102|NCT01513239|19073827|P1|COMPLETED|Period 2: 9 Month Extension Phase||0
7747103|NCT01513239|19073822|P6|STARTED|Period 2: 9 Month Extension Phase||83
7747104|NCT01513239|19073823|P5|STARTED|Period 2: 9 Month Extension Phase||100
7747105|NCT01513239|19073824|P4|STARTED|Period 2: 9 Month Extension Phase||112
7747106|NCT01513239|19073825|P3|STARTED|Period 2: 9 Month Extension Phase||0
7747107|NCT01513239|19073826|P2|STARTED|Period 2: 9 Month Extension Phase||0
7747108|NCT01513239|19073827|P1|STARTED|Period 2: 9 Month Extension Phase||0
7747109|NCT01513239|19073822|P6|NOT COMPLETED|Period 1: Main Phase||0
7747110|NCT01513239|19073823|P5|NOT COMPLETED|Period 1: Main Phase||0
7747111|NCT01513239|19073824|P4|NOT COMPLETED|Period 1: Main Phase||0
7747112|NCT01513239|19073825|P3|NOT COMPLETED|Period 1: Main Phase||88
7747113|NCT01513239|19073826|P2|NOT COMPLETED|Period 1: Main Phase||70
7747114|NCT01513239|19073827|P1|NOT COMPLETED|Period 1: Main Phase||75
7747115|NCT01513239|19073822|P6|COMPLETED|Period 1: Main Phase||0
7747116|NCT01513239|19073823|P5|COMPLETED|Period 1: Main Phase||0
7747117|NCT01513239|19073824|P4|COMPLETED|Period 1: Main Phase||0
7747118|NCT01513239|19073825|P3|COMPLETED|Period 1: Main Phase||311
7747119|NCT01513239|19073826|P2|COMPLETED|Period 1: Main Phase||337
7747120|NCT01513239|19073827|P1|COMPLETED|Period 1: Main Phase||322
7747121|NCT01513239|19073822|P6|All Participants as Treated|Period 1: Main Phase||0
7747122|NCT01513239|19073823|P5|All Participants as Treated|Period 1: Main Phase||0
7747123|NCT01513239|19073824|P4|All Participants as Treated|Period 1: Main Phase||0
7747124|NCT01513239|19073825|P3|All Participants as Treated|Period 1: Main Phase|Treatment actually received|381
7747125|NCT01513239|19073826|P2|All Participants as Treated|Period 1: Main Phase|Treatment actually received|396
7747126|NCT01513239|19073827|P1|All Participants as Treated|Period 1: Main Phase|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390
7747127|NCT01513239|19073822|P6|Treated|Period 1: Main Phase||0
7747128|NCT01513239|19073823|P5|Treated|Period 1: Main Phase||0
7747129|NCT01513239|19073824|P4|Treated|Period 1: Main Phase||0
7747130|NCT01513239|19073825|P3|Treated|Period 1: Main Phase|Treated participants|381
7747131|NCT01513239|19073826|P2|Treated|Period 1: Main Phase|Treated participants|396
7747132|NCT01513239|19073827|P1|Treated|Period 1: Main Phase|Treated participants|391
7747133|NCT01513239|19073822|P6|STARTED|Period 1: Main Phase||0
7747134|NCT01513239|19073823|P5|STARTED|Period 1: Main Phase||0
7747135|NCT01513239|19073824|P4|STARTED|Period 1: Main Phase||0
7747136|NCT01513239|19073825|P3|STARTED|Period 1: Main Phase|Randomized participants|399
7747137|NCT01513239|19073826|P2|STARTED|Period 1: Main Phase|Randomized participants|407
7747138|NCT01513239|19073827|P1|STARTED|Period 1: Main Phase|Randomized participants|397
7747139|NCT01513148|19073880|P2|NOT COMPLETED|Overall Study||2
7747140|NCT01513148|19073881|P1|NOT COMPLETED|Overall Study||2
7747141|NCT01513148|19073880|P2|COMPLETED|Overall Study||14
7747142|NCT01513148|19073881|P1|COMPLETED|Overall Study||14
7747143|NCT01513148|19073880|P2|STARTED|Overall Study||16
7747144|NCT01513148|19073881|P1|STARTED|Overall Study||16
7747145|NCT01513122|19073929|P2|NOT COMPLETED|Overall Study||3
7747146|NCT01513122|19073930|P1|NOT COMPLETED|Overall Study||11
7747147|NCT01513122|19073929|P2|COMPLETED|Overall Study||105
7747148|NCT01513122|19073930|P1|COMPLETED|Overall Study||91
7747149|NCT01513122|19073929|P2|STARTED|Overall Study||108
7747150|NCT01513122|19073930|P1|STARTED|Overall Study||102
7747151|NCT01512979|19073948|P2|NOT COMPLETED|Overall Study||22
7747152|NCT01512979|19073949|P1|NOT COMPLETED|Overall Study||19
7747153|NCT01512979|19073948|P2|COMPLETED|Overall Study||135
7747154|NCT01512979|19073949|P1|COMPLETED|Overall Study||140
7747155|NCT01512979|19073948|P2|STARTED|Overall Study|Randomised and treated|157
7747156|NCT01512979|19073949|P1|STARTED|Overall Study|Randomised and treated|159
7747157|NCT01512849|19073969|P4|NOT COMPLETED|Crossover Period 2||0
7747158|NCT01512849|19073970|P3|NOT COMPLETED|Crossover Period 2||0
7747159|NCT01512849|19073971|P2|NOT COMPLETED|Crossover Period 2||0
7747160|NCT01512849|19073972|P1|NOT COMPLETED|Crossover Period 2||0
7747161|NCT01512849|19073969|P4|COMPLETED|Crossover Period 2||6
7747162|NCT01512849|19073970|P3|COMPLETED|Crossover Period 2||6
7747163|NCT01512849|19073971|P2|COMPLETED|Crossover Period 2||6
7747164|NCT01512849|19073972|P1|COMPLETED|Crossover Period 2||6
7747165|NCT01512849|19073969|P4|STARTED|Crossover Period 2||6
7747166|NCT01512849|19073970|P3|STARTED|Crossover Period 2||6
7747167|NCT01512849|19073971|P2|STARTED|Crossover Period 2||6
7747168|NCT01512849|19073972|P1|STARTED|Crossover Period 2||6
7747169|NCT01512849|19073969|P4|NOT COMPLETED|Crossover Period 1||0
7747170|NCT01512849|19073970|P3|NOT COMPLETED|Crossover Period 1||0
7747171|NCT01512849|19073971|P2|NOT COMPLETED|Crossover Period 1||0
7747172|NCT01512849|19073972|P1|NOT COMPLETED|Crossover Period 1||0
7747173|NCT01512849|19073969|P4|COMPLETED|Crossover Period 1||6
7747174|NCT01512849|19073970|P3|COMPLETED|Crossover Period 1||6
7747175|NCT01512849|19073971|P2|COMPLETED|Crossover Period 1||6
7747176|NCT01512849|19073972|P1|COMPLETED|Crossover Period 1||6
7747177|NCT01512849|19073969|P4|STARTED|Crossover Period 1||6
7747178|NCT01512849|19073970|P3|STARTED|Crossover Period 1||6
7747179|NCT01512849|19073971|P2|STARTED|Crossover Period 1||6
7747180|NCT01512849|19073972|P1|STARTED|Crossover Period 1||6
7747181|NCT01512797|19073996|P2|NOT COMPLETED|Overall Study||0
7747182|NCT01512797|19073997|P1|NOT COMPLETED|Overall Study||0
7747183|NCT01512797|19073996|P2|COMPLETED|Overall Study||16
7747184|NCT01512797|19073997|P1|COMPLETED|Overall Study||16
7747185|NCT01512797|19073996|P2|STARTED|Overall Study||16
7747186|NCT01512797|19073997|P1|STARTED|Overall Study||16
7747187|NCT01512758|19074013|P2|NOT COMPLETED|Overall Study||0
7747188|NCT01512758|19074014|P1|NOT COMPLETED|Overall Study||0
7747189|NCT01512758|19074013|P2|COMPLETED|Overall Study||6
7747190|NCT01512758|19074014|P1|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|30
7747191|NCT01512758|19074013|P2|STARTED|Overall Study||6
7747192|NCT01512758|19074014|P1|STARTED|Overall Study||30
7747193|NCT01512745|19074049|P2|NOT COMPLETED|Overall Study||20
7747194|NCT01512745|19074050|P1|NOT COMPLETED|Overall Study||40
7747195|NCT01512745|19074049|P2|COMPLETED|Overall Study||71
7747196|NCT01512745|19074050|P1|COMPLETED|Overall Study||136
7747197|NCT01512745|19074049|P2|STARTED|Overall Study||91
7747198|NCT01512745|19074050|P1|STARTED|Overall Study||176
7747199|NCT01512693|19074066|P2|NOT COMPLETED|Overall Study||1
7747200|NCT01512693|19074067|P1|NOT COMPLETED|Overall Study||0
7747201|NCT01512693|19074066|P2|COMPLETED|Overall Study||8
7747202|NCT01512693|19074067|P1|COMPLETED|Overall Study||8
7747203|NCT01512693|19074066|P2|STARTED|Overall Study||9
7747204|NCT01512693|19074067|P1|STARTED|Overall Study||8
7747205|NCT01512667|19074081|P2|NOT COMPLETED|Overall Study||0
7747206|NCT01512667|19074082|P1|NOT COMPLETED|Overall Study||0
7747207|NCT01512667|19074081|P2|COMPLETED|Overall Study||12
7747208|NCT01512667|19074082|P1|COMPLETED|Overall Study||13
7747209|NCT01512667|19074081|P2|Unmatched Participants|Overall Study||0
7747210|NCT01512667|19074082|P1|Unmatched Participants|Overall Study|Participant was not matched to a healthy control participant.|1
7747211|NCT01512667|19074081|P2|Matched Participants|Overall Study||12
7747212|NCT01512667|19074082|P1|Matched Participants|Overall Study||12
7747213|NCT01512667|19074081|P2|STARTED|Overall Study||12
7747214|NCT01512667|19074082|P1|STARTED|Overall Study||13
7747215|NCT01512446|19074096|P2|NOT COMPLETED|Overall Study||215
7747216|NCT01512446|19074097|P1|NOT COMPLETED|Overall Study||221
7747217|NCT01512446|19074096|P2|COMPLETED|Overall Study||0
7747218|NCT01512446|19074097|P1|COMPLETED|Overall Study||0
7747219|NCT01512446|19074096|P2|Safety Analysis Set|Overall Study||188
7747220|NCT01512446|19074097|P1|Safety Analysis Set|Overall Study||197
7747221|NCT01512446|19074096|P2|STARTED|Overall Study||215
7747222|NCT01512446|19074097|P1|STARTED|Overall Study||221
7747223|NCT01512368|19074107|P1|NOT COMPLETED|Overall Study||3
7747224|NCT01512368|19074107|P1|COMPLETED|Overall Study||60
7747225|NCT01512368|19074107|P1|STARTED|Overall Study||63
7747226|NCT01512264|19074120|P4|NOT COMPLETED|Overall Study||1
7747227|NCT01512264|19074121|P3|NOT COMPLETED|Overall Study||0
7747228|NCT01512264|19074122|P2|NOT COMPLETED|Overall Study||0
7747229|NCT01512264|19074123|P1|NOT COMPLETED|Overall Study||0
7747230|NCT01512264|19074120|P4|COMPLETED|Overall Study||6
7747231|NCT01512264|19074121|P3|COMPLETED|Overall Study||7
7747232|NCT01512264|19074122|P2|COMPLETED|Overall Study||7
7747233|NCT01512264|19074123|P1|COMPLETED|Overall Study||7
7747234|NCT01512264|19074120|P4|STARTED|Overall Study||7
7747235|NCT01512264|19074121|P3|STARTED|Overall Study||7
7747236|NCT01512264|19074122|P2|STARTED|Overall Study||7
7747237|NCT01512264|19074123|P1|STARTED|Overall Study||7
7747238|NCT01512251|19074215|P2|NOT COMPLETED|Phase II||0
7747239|NCT01512251|19074216|P1|NOT COMPLETED|Phase II||0
7747240|NCT01512251|19074215|P2|COMPLETED|Phase II||0
7747241|NCT01512251|19074216|P1|COMPLETED|Phase II||0
7747242|NCT01512251|19074215|P2|STARTED|Phase II||0
7747243|NCT01512251|19074216|P1|STARTED|Phase II||0
7747244|NCT01512251|19074215|P2|NOT COMPLETED|Phase I, Dose 4||0
7747245|NCT01512251|19074216|P1|NOT COMPLETED|Phase I, Dose 4||0
7747246|NCT01512251|19074215|P2|COMPLETED|Phase I, Dose 4||0
7747247|NCT01512251|19074216|P1|COMPLETED|Phase I, Dose 4||0
7747248|NCT01512251|19074215|P2|STARTED|Phase I, Dose 4||0
7747249|NCT01512251|19074216|P1|STARTED|Phase I, Dose 4||0
7747250|NCT01512251|19074215|P2|NOT COMPLETED|Phase I, Dose 3||0
7747251|NCT01512251|19074216|P1|NOT COMPLETED|Phase I, Dose 3||0
7747252|NCT01512251|19074215|P2|COMPLETED|Phase I, Dose 3||0
7747253|NCT01512251|19074216|P1|COMPLETED|Phase I, Dose 3||0
7747254|NCT01512251|19074215|P2|STARTED|Phase I, Dose 3||0
7747255|NCT01512251|19074216|P1|STARTED|Phase I, Dose 3||0
7747256|NCT01512251|19074215|P2|NOT COMPLETED|Phase I, Dose 2||0
7747257|NCT01512251|19074216|P1|NOT COMPLETED|Phase I, Dose 2||0
7747258|NCT01512251|19074215|P2|COMPLETED|Phase I, Dose 2||0
7747259|NCT01512251|19074216|P1|COMPLETED|Phase I, Dose 2||0
7747260|NCT01512251|19074215|P2|STARTED|Phase I, Dose 2||0
7747261|NCT01512251|19074216|P1|STARTED|Phase I, Dose 2||0
7747262|NCT01512251|19074215|P2|NOT COMPLETED|Phase I, Dose 1||5
7747263|NCT01512251|19074216|P1|NOT COMPLETED|Phase I, Dose 1||3
7747264|NCT01512251|19074215|P2|COMPLETED|Phase I, Dose 1||0
7747265|NCT01512251|19074216|P1|COMPLETED|Phase I, Dose 1||0
7747266|NCT01512251|19074215|P2|STARTED|Phase I, Dose 1||5
7747267|NCT01512251|19074216|P1|STARTED|Phase I, Dose 1||3
7747268|NCT01512251|19074215|P2|NOT COMPLETED|Dose Level -1||0
7747269|NCT01512251|19074216|P1|NOT COMPLETED|Dose Level -1||0
7747270|NCT01512251|19074215|P2|COMPLETED|Dose Level -1||5
7747271|NCT01512251|19074216|P1|COMPLETED|Dose Level -1||3
7747272|NCT01512251|19074215|P2|STARTED|Dose Level -1||5
7747273|NCT01512251|19074216|P1|STARTED|Dose Level -1||3
7747274|NCT01512225|19074237|P2|NOT COMPLETED|Overall Study||0
7747275|NCT01512225|19074238|P1|NOT COMPLETED|Overall Study||0
7747276|NCT01512225|19074237|P2|COMPLETED|Overall Study||45
7747277|NCT01512225|19074238|P1|COMPLETED|Overall Study||45
7747278|NCT01512225|19074237|P2|Provided Day 14 Volume|Overall Study||40
7747279|NCT01512225|19074238|P1|Provided Day 14 Volume|Overall Study||45
7747280|NCT01512225|19074237|P2|STARTED|Overall Study||45
7747281|NCT01512225|19074238|P1|STARTED|Overall Study||45
7747282|NCT01512160|19074262|P4|NOT COMPLETED|Overall Study||1
7747283|NCT01512160|19074263|P3|NOT COMPLETED|Overall Study||0
7747284|NCT01512160|19074264|P2|NOT COMPLETED|Overall Study||0
7747285|NCT01512160|19074265|P1|NOT COMPLETED|Overall Study||2
7747286|NCT01512160|19074262|P4|COMPLETED|Overall Study||22
7747287|NCT01512160|19074263|P3|COMPLETED|Overall Study||22
7747288|NCT01512160|19074264|P2|COMPLETED|Overall Study||23
7747289|NCT01512160|19074265|P1|COMPLETED|Overall Study||20
7747290|NCT01512160|19074262|P4|STARTED|Overall Study||23
7747291|NCT01512160|19074263|P3|STARTED|Overall Study||22
7747292|NCT01512160|19074264|P2|STARTED|Overall Study||23
7747293|NCT01512160|19074265|P1|STARTED|Overall Study||22
7747294|NCT01512108|19074357|P2|NOT COMPLETED|Overall Study||9
7747295|NCT01512108|19074358|P1|NOT COMPLETED|Overall Study||22
7747296|NCT01512108|19074357|P2|COMPLETED|Overall Study||111
7747297|NCT01512108|19074358|P1|COMPLETED|Overall Study||221
7747298|NCT01512108|19074357|P2|Exposed|Overall Study||120
7747299|NCT01512108|19074358|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240
7747300|NCT01512108|19074357|P2|STARTED|Overall Study||120
7747301|NCT01512108|19074358|P1|STARTED|Overall Study||243
7747302|NCT01511978|19074372|P2|NOT COMPLETED|Overall Study||0
7747303|NCT01511978|19074373|P1|NOT COMPLETED|Overall Study||0
7747304|NCT01511978|19074372|P2|COMPLETED|Overall Study||18
7747305|NCT01511978|19074373|P1|COMPLETED|Overall Study||14
7747306|NCT01511978|19074372|P2|STARTED|Overall Study||18
7747307|NCT01511978|19074373|P1|STARTED|Overall Study||14
7747308|NCT01511939|19074384|P3|NOT COMPLETED|Overall Study||0
7747309|NCT01511939|19074385|P2|NOT COMPLETED|Overall Study||1
7747310|NCT01511939|19074386|P1|NOT COMPLETED|Overall Study||2
7747311|NCT01511939|19074384|P3|COMPLETED|Overall Study||8
7747312|NCT01511939|19074385|P2|COMPLETED|Overall Study||4
7747313|NCT01511939|19074386|P1|COMPLETED|Overall Study||7
7747314|NCT01511939|19074384|P3|STARTED|Overall Study||8
7747315|NCT01511939|19074385|P2|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5
7747316|NCT01511939|19074386|P1|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9
7747317|NCT01511809|19074405|P2|NOT COMPLETED|Overall Study||7
7747318|NCT01511809|19074406|P1|NOT COMPLETED|Overall Study||7
7747319|NCT01511809|19074405|P2|COMPLETED|Overall Study||52
7747320|NCT01511809|19074406|P1|COMPLETED|Overall Study||51
7747321|NCT01511809|19074405|P2|STARTED|Overall Study||59
7747322|NCT01511809|19074406|P1|STARTED|Overall Study||58
7747323|NCT01511536|19074415|P3|NOT COMPLETED|Phase 2||9
7747324|NCT01511536|19074416|P2|NOT COMPLETED|Phase 2||0
7747325|NCT01511536|19074417|P1|NOT COMPLETED|Phase 2||0
7747326|NCT01511536|19074415|P3|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18
7747327|NCT01511536|19074416|P2|COMPLETED|Phase 2||0
7747328|NCT01511536|19074417|P1|COMPLETED|Phase 2||0
7747329|NCT01511536|19074415|P3|STARTED|Phase 2||27
7747330|NCT01511536|19074416|P2|STARTED|Phase 2||0
7747331|NCT01511536|19074417|P1|STARTED|Phase 2||0
7747332|NCT01511536|19074415|P3|NOT COMPLETED|Phase 1||0
7747333|NCT01511536|19074416|P2|NOT COMPLETED|Phase 1||1
7747334|NCT01511536|19074417|P1|NOT COMPLETED|Phase 1||0
7747335|NCT01511536|19074415|P3|COMPLETED|Phase 1||0
7747336|NCT01511536|19074416|P2|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6
7747337|NCT01511536|19074417|P1|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3
7747338|NCT01511536|19074415|P3|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0
7747339|NCT01511536|19074416|P2|STARTED|Phase 1||7
7747340|NCT01511536|19074417|P1|STARTED|Phase 1||3
7747341|NCT01511445|19074439|P2|NOT COMPLETED|Overall Study||4
7747342|NCT01511445|19074440|P1|NOT COMPLETED|Overall Study||5
7747343|NCT01511445|19074439|P2|COMPLETED|Overall Study|Data analysis was completed in February, 2016|47
7747344|NCT01511445|19074440|P1|COMPLETED|Overall Study|Data analysis was completed in February, 2016|48
7747345|NCT01511445|19074439|P2|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|47
7747346|NCT01511445|19074440|P1|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|48
7747347|NCT01511445|19074439|P2|Primary Completion October, 2014|Overall Study|3 protocol violations. 1 lost to follow-up.|47
7747348|NCT01511445|19074440|P1|Primary Completion October, 2014|Overall Study|1 was excluded Bechterew's disease. 1 protocol violation. 3 were lost to follow-up.|48
7747349|NCT01511445|19074439|P2|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|51
7747350|NCT01511445|19074440|P1|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|53
7747351|NCT01511445|19074439|P2|STARTED|Overall Study|Patient enrollment started in December, 2011.|51
7747352|NCT01511445|19074440|P1|STARTED|Overall Study|Patient enrollment started in December, 2011.|53
7747353|NCT01511419|19074450|P2|NOT COMPLETED|Dose 2||0
7747354|NCT01511419|19074451|P1|NOT COMPLETED|Dose 2||1
7747355|NCT01511419|19074450|P2|COMPLETED|Dose 2||10
7747356|NCT01511419|19074451|P1|COMPLETED|Dose 2||29
7747357|NCT01511419|19074450|P2|STARTED|Dose 2||10
7747358|NCT01511419|19074451|P1|STARTED|Dose 2||30
7747359|NCT01511419|19074450|P2|NOT COMPLETED|Dose 1||0
7747360|NCT01511419|19074451|P1|NOT COMPLETED|Dose 1||0
7747361|NCT01511419|19074450|P2|COMPLETED|Dose 1||10
7747362|NCT01511419|19074451|P1|COMPLETED|Dose 1||30
7747363|NCT01511419|19074450|P2|STARTED|Dose 1||10
7747364|NCT01511419|19074451|P1|STARTED|Dose 1||30
7747365|NCT01511315|19074543|P1|NOT COMPLETED|Overall Study||4
7747366|NCT01511315|19074543|P1|COMPLETED|Overall Study||32
7747367|NCT01511315|19074543|P1|STARTED|Overall Study||36
7747368|NCT01511250|19074563|P10|NOT COMPLETED|Overall Study||5
7747369|NCT01511250|19074564|P9|NOT COMPLETED|Overall Study||14
7747370|NCT01511250|19074565|P8|NOT COMPLETED|Overall Study||4
7747371|NCT01511250|19074566|P7|NOT COMPLETED|Overall Study||2
7747372|NCT01511250|19074567|P6|NOT COMPLETED|Overall Study||0
7747373|NCT01511250|19074568|P5|NOT COMPLETED|Overall Study||0
7747374|NCT01511250|19074569|P4|NOT COMPLETED|Overall Study||3
7747375|NCT01511250|19074570|P3|NOT COMPLETED|Overall Study||4
7747376|NCT01511250|19074571|P2|NOT COMPLETED|Overall Study||5
7747377|NCT01511250|19074572|P1|NOT COMPLETED|Overall Study||9
7747378|NCT01511250|19074563|P10|COMPLETED|Overall Study||48
7747379|NCT01511250|19074564|P9|COMPLETED|Overall Study||145
7747380|NCT01511250|19074565|P8|COMPLETED|Overall Study||9
7747381|NCT01511250|19074566|P7|COMPLETED|Overall Study||21
7747382|NCT01511250|19074567|P6|COMPLETED|Overall Study||17
7747383|NCT01511250|19074568|P5|COMPLETED|Overall Study||21
7747384|NCT01511250|19074569|P4|COMPLETED|Overall Study||11
7747385|NCT01511250|19074570|P3|COMPLETED|Overall Study||18
7747386|NCT01511250|19074571|P2|COMPLETED|Overall Study||9
7747387|NCT01511250|19074572|P1|COMPLETED|Overall Study||15
7747388|NCT01511250|19074563|P10|STARTED|Overall Study||53
7747389|NCT01511250|19074564|P9|STARTED|Overall Study||159
7747390|NCT01511250|19074565|P8|STARTED|Overall Study||13
7747391|NCT01511250|19074566|P7|STARTED|Overall Study||23
7747392|NCT01511250|19074567|P6|STARTED|Overall Study||17
7747393|NCT01511250|19074568|P5|STARTED|Overall Study||21
7747394|NCT01511250|19074569|P4|STARTED|Overall Study||14
7747395|NCT01511250|19074570|P3|STARTED|Overall Study||22
7747396|NCT01511250|19074571|P2|STARTED|Overall Study||14
7747397|NCT01511250|19074572|P1|STARTED|Overall Study||24
7747398|NCT01511107|19074720|P2|NOT COMPLETED|Overall Study||41
7747399|NCT01511107|19074721|P1|NOT COMPLETED|Overall Study||22
7747400|NCT01511107|19074720|P2|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219
7747401|NCT01511107|19074721|P1|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238
7747402|NCT01511107|19074720|P2|STARTED|Overall Study|Randomized to the treatment group.|260
7747403|NCT01511107|19074721|P1|STARTED|Overall Study|Randomized to the treatment group.|260
7747404|NCT01511081|19074771|P2|NOT COMPLETED|Overall Study||0
7747405|NCT01511081|19074772|P1|NOT COMPLETED|Overall Study||0
7747406|NCT01511081|19074771|P2|COMPLETED|Overall Study||9
7747407|NCT01511081|19074772|P1|COMPLETED|Overall Study||8
7747408|NCT01511081|19074771|P2|STARTED|Overall Study||9
7747409|NCT01511081|19074772|P1|STARTED|Overall Study||8
7747410|NCT01511068|19074780|P1|NOT COMPLETED|Overall Study||0
7747411|NCT01511068|19074780|P1|COMPLETED|Overall Study||2
7747412|NCT01511068|19074780|P1|STARTED|Overall Study||2
7747413|NCT01511055|19074793|P1|NOT COMPLETED|Overall Study||6
7747414|NCT01511055|19074793|P1|COMPLETED|Overall Study||21
7747415|NCT01511055|19074793|P1|STARTED|Overall Study||27
7747416|NCT01511016|19074800|P2|NOT COMPLETED|Overall Study||2
7747417|NCT01511016|19074801|P1|NOT COMPLETED|Overall Study||2
7747418|NCT01511016|19074800|P2|COMPLETED|Overall Study||7
7747419|NCT01511016|19074801|P1|COMPLETED|Overall Study||6
7747420|NCT01511016|19074800|P2|STARTED|Overall Study||9
7747421|NCT01511016|19074801|P1|STARTED|Overall Study||8
7747422|NCT01510912|19074817|P1|NOT COMPLETED|Overall Study||242
7747423|NCT01510912|19074817|P1|COMPLETED|Overall Study||360
7747424|NCT01510912|19074817|P1|STARTED|Overall Study||602
7747425|NCT01510834|19074823|P1|NOT COMPLETED|Overall Study||33
7747426|NCT01510834|19074823|P1|COMPLETED|Overall Study||57
7747427|NCT01510834|19074823|P1|STARTED|Overall Study||90
7747428|NCT01510769|19074833|P3|NOT COMPLETED|Overall Study||22
7747429|NCT01510769|19074834|P2|NOT COMPLETED|Overall Study||25
7747430|NCT01510769|19074835|P1|NOT COMPLETED|Overall Study||27
7747431|NCT01510769|19074833|P3|COMPLETED|Overall Study||87
7747432|NCT01510769|19074834|P2|COMPLETED|Overall Study||84
7747433|NCT01510769|19074835|P1|COMPLETED|Overall Study||79
7747434|NCT01510769|19074833|P3|STARTED|Overall Study||109
7747435|NCT01510769|19074834|P2|STARTED|Overall Study||109
7747436|NCT01510769|19074835|P1|STARTED|Overall Study||106
7747437|NCT01510756|19074852|P1|NOT COMPLETED|Overall Study||4
7747438|NCT01510756|19074852|P1|COMPLETED|Overall Study||0
7747439|NCT01510756|19074852|P1|STARTED|Overall Study||4
7747440|NCT01510717|19074860|P2|NOT COMPLETED|Overall Study||5
7747441|NCT01510717|19074861|P1|NOT COMPLETED|Overall Study||2
7747442|NCT01510717|19074860|P2|COMPLETED|Overall Study||160
7747443|NCT01510717|19074861|P1|COMPLETED|Overall Study||153
7747444|NCT01510717|19074860|P2|STARTED|Overall Study||165
7747445|NCT01510717|19074861|P1|STARTED|Overall Study||155
7747446|NCT01510704|19074889|P4|NOT COMPLETED|Overall Study||0
7747447|NCT01510704|19074890|P3|NOT COMPLETED|Overall Study||0
7747448|NCT01510704|19074891|P2|NOT COMPLETED|Overall Study||0
7747449|NCT01510704|19074892|P1|NOT COMPLETED|Overall Study||0
7747450|NCT01510704|19074889|P4|COMPLETED|Overall Study||53
7747451|NCT01510704|19074890|P3|COMPLETED|Overall Study||50
7747452|NCT01510704|19074891|P2|COMPLETED|Overall Study||58
7747453|NCT01510704|19074892|P1|COMPLETED|Overall Study||54
7747454|NCT01510704|19074889|P4|STARTED|Overall Study||53
7747455|NCT01510704|19074890|P3|STARTED|Overall Study||50
7747456|NCT01510704|19074891|P2|STARTED|Overall Study||58
7747457|NCT01510704|19074892|P1|STARTED|Overall Study||54
7747458|NCT01510652|19074904|P2|NOT COMPLETED|Overall Study||67
7747459|NCT01510652|19074905|P1|NOT COMPLETED|Overall Study||92
7747460|NCT01510652|19074904|P2|COMPLETED|Overall Study||288
7747461|NCT01510652|19074905|P1|COMPLETED|Overall Study||627
7747462|NCT01510652|19074904|P2|Baseline|Overall Study||348
7747463|NCT01510652|19074905|P1|Baseline|Overall Study||718
7747464|NCT01510652|19074904|P2|STARTED|Overall Study||355
7747465|NCT01510652|19074905|P1|STARTED|Overall Study||719
7747466|NCT01510457|19074917|P2|NOT COMPLETED|Overall Study||3
7747467|NCT01510457|19074918|P1|NOT COMPLETED|Overall Study||5
7747468|NCT01510457|19074917|P2|COMPLETED|Overall Study||26
7747469|NCT01510457|19074918|P1|COMPLETED|Overall Study||12
7747470|NCT01510457|19074917|P2|STARTED|Overall Study||29
7747471|NCT01510457|19074918|P1|STARTED|Overall Study||17
7747472|NCT01510379|19074938|P2|NOT COMPLETED|Overall Study||0
7747473|NCT01510379|19074939|P1|NOT COMPLETED|Overall Study||0
7747474|NCT01510379|19074938|P2|COMPLETED|Overall Study||51
7747475|NCT01510379|19074939|P1|COMPLETED|Overall Study||49
7747476|NCT01510379|19074938|P2|STARTED|Overall Study||51
7747477|NCT01510379|19074939|P1|STARTED|Overall Study||49
7747478|NCT01510327|19074947|P1|NOT COMPLETED|Overall Study||0
7747479|NCT01510327|19074947|P1|COMPLETED|Overall Study||22
7747480|NCT01510327|19074947|P1|STARTED|Overall Study||22
7747481|NCT01510158|19074981|P3|NOT COMPLETED|Overall Study||50
7747482|NCT01510158|19074982|P2|NOT COMPLETED|Overall Study||53
7747483|NCT01510158|19074983|P1|NOT COMPLETED|Overall Study||51
7747484|NCT01510158|19074981|P3|COMPLETED|Overall Study||152
7747485|NCT01510158|19074982|P2|COMPLETED|Overall Study||150
7747486|NCT01510158|19074983|P1|COMPLETED|Overall Study||151
7747487|NCT01510158|19074981|P3|STARTED|Overall Study||202
7747488|NCT01510158|19074982|P2|STARTED|Overall Study||203
7747489|NCT01510158|19074983|P1|STARTED|Overall Study||202
7747490|NCT01510145|19074997|P1|NOT COMPLETED|Overall Study||18
7747491|NCT01510145|19074997|P1|COMPLETED|Overall Study||173
7747492|NCT01510145|19074997|P1|STARTED|Overall Study||191
7747493|NCT01510028|19075006|P4|NOT COMPLETED|Overall Study||0
7747494|NCT01510028|19075007|P3|NOT COMPLETED|Overall Study||0
7747495|NCT01510028|19075008|P2|NOT COMPLETED|Overall Study||0
7747496|NCT01510028|19075009|P1|NOT COMPLETED|Overall Study||1
7747497|NCT01510028|19075006|P4|COMPLETED|Overall Study||6
7747498|NCT01510028|19075007|P3|COMPLETED|Overall Study||6
7747499|NCT01510028|19075008|P2|COMPLETED|Overall Study||6
7747500|NCT01510028|19075009|P1|COMPLETED|Overall Study||5
7747501|NCT01510028|19075006|P4|STARTED|Overall Study||6
7747502|NCT01510028|19075007|P3|STARTED|Overall Study||6
7747503|NCT01510028|19075008|P2|STARTED|Overall Study||6
7747504|NCT01510028|19075009|P1|STARTED|Overall Study||6
7747505|NCT01509950|19075125|P3|NOT COMPLETED|Overall Study||0
7747506|NCT01509950|19075126|P2|NOT COMPLETED|Overall Study||0
7747507|NCT01509950|19075127|P1|NOT COMPLETED|Overall Study||0
7747508|NCT01509950|19075125|P3|COMPLETED|Overall Study||0
7747509|NCT01509950|19075126|P2|COMPLETED|Overall Study||8
7747510|NCT01509950|19075127|P1|COMPLETED|Overall Study||7
7747511|NCT01509950|19075125|P3|STARTED|Overall Study||0
7747512|NCT01509950|19075126|P2|STARTED|Overall Study||8
7747513|NCT01509950|19075127|P1|STARTED|Overall Study||7
7747514|NCT01509872|19075155|P2|NOT COMPLETED|Overall Study||0
7747515|NCT01509872|19075156|P1|NOT COMPLETED|Overall Study||1
7747516|NCT01509872|19075155|P2|COMPLETED|Overall Study||24
7747517|NCT01509872|19075156|P1|COMPLETED|Overall Study||25
7747518|NCT01509872|19075155|P2|Post-Intervention Assessment|Overall Study||24
7747519|NCT01509872|19075156|P1|Post-Intervention Assessment|Overall Study||26
7747520|NCT01509872|19075155|P2|STARTED|Overall Study||24
7747521|NCT01509872|19075156|P1|STARTED|Overall Study||26
7747522|NCT01509807|19075170|P2|NOT COMPLETED|Overall Study||1
7747523|NCT01509807|19075171|P1|NOT COMPLETED|Overall Study||1
7747524|NCT01509807|19075170|P2|COMPLETED|Overall Study||16
7747525|NCT01509807|19075171|P1|COMPLETED|Overall Study||15
7747526|NCT01509807|19075170|P2|STARTED|Overall Study||17
7747527|NCT01509807|19075171|P1|STARTED|Overall Study||16
7747528|NCT01509677|19075197|P2|NOT COMPLETED|Overall Study||6
7747529|NCT01509677|19075198|P1|NOT COMPLETED|Overall Study||3
7747530|NCT01509677|19075197|P2|COMPLETED|Overall Study||73
7747531|NCT01509677|19075198|P1|COMPLETED|Overall Study||76
7747532|NCT01509677|19075197|P2|STARTED|Overall Study||79
7747533|NCT01509677|19075198|P1|STARTED|Overall Study||79
7747534|NCT01509664|19075270|P2|NOT COMPLETED|Overall Study||21
7747535|NCT01509664|19075271|P1|NOT COMPLETED|Overall Study||15
7747536|NCT01509664|19075270|P2|COMPLETED|Overall Study||28
7747537|NCT01509664|19075271|P1|COMPLETED|Overall Study||34
7747538|NCT01509664|19075270|P2|T3 Follow-up|Overall Study||33
7747539|NCT01509664|19075271|P1|T3 Follow-up|Overall Study||40
7747540|NCT01509664|19075270|P2|T2 Follow-up|Overall Study||38
7747541|NCT01509664|19075271|P1|T2 Follow-up|Overall Study||45
7747542|NCT01509664|19075270|P2|STARTED|Overall Study||49
7747543|NCT01509664|19075271|P1|STARTED|Overall Study||49
7747544|NCT01509638|19075279|P2|NOT COMPLETED|Overall Study||2
7747545|NCT01509638|19075280|P1|NOT COMPLETED|Overall Study||3
7747546|NCT01509638|19075279|P2|COMPLETED|Overall Study||24
7747547|NCT01509638|19075280|P1|COMPLETED|Overall Study||20
7747548|NCT01509638|19075279|P2|STARTED|Overall Study||26
7747549|NCT01509638|19075280|P1|STARTED|Overall Study||23
7747550|NCT01509625|19075304|P1|NOT COMPLETED|Overall Study||9
7747551|NCT01509625|19075304|P1|COMPLETED|Overall Study||263
7747552|NCT01509625|19075304|P1|STARTED|Overall Study||272
7747553|NCT01509612|19075323|P3|NOT COMPLETED|Overall Study||0
7747554|NCT01509612|19075324|P2|NOT COMPLETED|Overall Study||0
7747555|NCT01509612|19075325|P1|NOT COMPLETED|Overall Study||0
7747556|NCT01509612|19075323|P3|COMPLETED|Overall Study||52
7747557|NCT01509612|19075324|P2|COMPLETED|Overall Study||51
7747558|NCT01509612|19075325|P1|COMPLETED|Overall Study||47
7747559|NCT01509612|19075323|P3|STARTED|Overall Study||52
7747560|NCT01509612|19075324|P2|STARTED|Overall Study||51
7747561|NCT01509612|19075325|P1|STARTED|Overall Study||47
7747562|NCT01509586|19075338|P2|NOT COMPLETED|Overall Study||0
7747563|NCT01509586|19075339|P1|NOT COMPLETED|Overall Study||0
7747564|NCT01509586|19075338|P2|COMPLETED|Overall Study|final intent to treat sample|610
7747565|NCT01509586|19075339|P1|COMPLETED|Overall Study|final intent to treat sample|626
7747566|NCT01509586|19075338|P2|Week 58 (Month 12)|Overall Study||499
7747567|NCT01509586|19075339|P1|Week 58 (Month 12)|Overall Study||492
7747568|NCT01509586|19075338|P2|Week 46|Overall Study||494
7747569|NCT01509586|19075339|P1|Week 46|Overall Study||483
7747570|NCT01509586|19075338|P2|Week 32 (Month 6)|Overall Study||523
7747571|NCT01509586|19075339|P1|Week 32 (Month 6)|Overall Study||504
7747572|NCT01509586|19075338|P2|Week18|Overall Study||555
7747573|NCT01509586|19075339|P1|Week18|Overall Study||529
7747574|NCT01509586|19075338|P2|Week 14|Overall Study||566
7747575|NCT01509586|19075339|P1|Week 14|Overall Study||528
7747576|NCT01509586|19075338|P2|Week 10|Overall Study||574
7747577|NCT01509586|19075339|P1|Week 10|Overall Study||537
7747578|NCT01509586|19075338|P2|Week 6|Overall Study||585
7747579|NCT01509586|19075339|P1|Week 6|Overall Study||551
7747580|NCT01509586|19075338|P2|Week 3|Overall Study||585
7747581|NCT01509586|19075339|P1|Week 3|Overall Study||574
7747582|NCT01509586|19075338|P2|STARTED|Overall Study|Week 0|610
7747583|NCT01509586|19075339|P1|STARTED|Overall Study|Week 0|626
7747584|NCT01509547|19075347|P2|NOT COMPLETED|Overall Study||39
7747585|NCT01509547|19075348|P1|NOT COMPLETED|Overall Study||35
7747586|NCT01509547|19075347|P2|COMPLETED|Overall Study||41
7747587|NCT01509547|19075348|P1|COMPLETED|Overall Study||42
7747588|NCT01509547|19075347|P2|STARTED|Overall Study||80
7747589|NCT01509547|19075348|P1|STARTED|Overall Study||77
7747590|NCT01509404|19075366|P2|NOT COMPLETED|Overall Study||0
7747591|NCT01509404|19075367|P1|NOT COMPLETED|Overall Study||0
7747592|NCT01509404|19075366|P2|COMPLETED|Overall Study||20
7747593|NCT01509404|19075367|P1|COMPLETED|Overall Study||20
7747594|NCT01509404|19075366|P2|STARTED|Overall Study||20
7747595|NCT01509404|19075367|P1|STARTED|Overall Study||20
7747596|NCT01509183|19075389|P2|NOT COMPLETED|Overall Study||111
7747597|NCT01509183|19075390|P1|NOT COMPLETED|Overall Study||109
7747598|NCT01509183|19075389|P2|COMPLETED|Overall Study||134
7747599|NCT01509183|19075390|P1|COMPLETED|Overall Study||141
7747600|NCT01509183|19075389|P2|STARTED|Overall Study||245
7747601|NCT01509183|19075390|P1|STARTED|Overall Study||250
7747602|NCT01509105|19075398|P1|NOT COMPLETED|Overall Study||0
7747603|NCT01509105|19075398|P1|COMPLETED|Overall Study||649
7747604|NCT01509105|19075398|P1|STARTED|Overall Study||649
7747605|NCT01509079|19075415|P2|NOT COMPLETED|Overall Study||3
7747606|NCT01509079|19075416|P1|NOT COMPLETED|Overall Study||0
7747607|NCT01509079|19075415|P2|COMPLETED|Overall Study||56
7747608|NCT01509079|19075416|P1|COMPLETED|Overall Study||57
7747609|NCT01509079|19075415|P2|STARTED|Overall Study||59
7747610|NCT01509079|19075416|P1|STARTED|Overall Study||57
7747611|NCT01509053|19075436|P1|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3
7747612|NCT01509053|19075436|P1|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0
7747613|NCT01509053|19075436|P1|STARTED|Aripiprazole IM Depot Extension Phase(C)||3
7747614|NCT01509053|19075436|P1|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16
7747615|NCT01509053|19075436|P1|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3
7747616|NCT01509053|19075436|P1|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19
7747617|NCT01509053|19075436|P1|NOT COMPLETED|Oral Aripirazole (Phase A)||11
7747618|NCT01509053|19075436|P1|COMPLETED|Oral Aripirazole (Phase A)||8
7747619|NCT01509053|19075436|P1|STARTED|Oral Aripirazole (Phase A)||19
7747620|NCT01509040|19075450|P3|NOT COMPLETED|Overall Study||0
7747621|NCT01509040|19075451|P2|NOT COMPLETED|Overall Study||1
7747622|NCT01509040|19075452|P1|NOT COMPLETED|Overall Study||0
7747623|NCT01509040|19075450|P3|COMPLETED|Overall Study||0
7747624|NCT01509040|19075451|P2|COMPLETED|Overall Study||1
7747625|NCT01509040|19075452|P1|COMPLETED|Overall Study||0
7747626|NCT01509040|19075450|P3|STARTED|Overall Study||0
7747627|NCT01509040|19075451|P2|STARTED|Overall Study||2
7747628|NCT01509040|19075452|P1|STARTED|Overall Study||0
7747629|NCT01508936|19075498|P2|NOT COMPLETED|Overall Study||79
7747630|NCT01508936|19075499|P1|NOT COMPLETED|Overall Study||23
7747631|NCT01508936|19075498|P2|COMPLETED|Overall Study||330
7747632|NCT01508936|19075499|P1|COMPLETED|Overall Study||79
7747633|NCT01508936|19075498|P2|FEV1 Subpopulation Analysis Set|Overall Study||346
7747634|NCT01508936|19075499|P1|FEV1 Subpopulation Analysis Set|Overall Study||91
7747635|NCT01508936|19075498|P2|Full Analysis Set|Overall Study||395
7747636|NCT01508936|19075499|P1|Full Analysis Set|Overall Study||97
7747637|NCT01508936|19075498|P2|Safety Analysis Set|Overall Study||395
7747638|NCT01508936|19075499|P1|Safety Analysis Set|Overall Study||97
7747639|NCT01508936|19075498|P2|Randomized, Not Treated|Overall Study||3
7747640|NCT01508936|19075499|P1|Randomized, Not Treated|Overall Study||1
7747641|NCT01508936|19075498|P2|Randomized|Overall Study||398
7747642|NCT01508936|19075499|P1|Randomized|Overall Study||98
7747643|NCT01508936|19075498|P2|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11
7747644|NCT01508936|19075499|P1|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4
7747645|NCT01508936|19075498|P2|STARTED|Overall Study||409
7747646|NCT01508936|19075499|P1|STARTED|Overall Study||102
7747647|NCT01508910|19075538|P4|NOT COMPLETED|Treatment||3
7747648|NCT01508910|19075539|P3|NOT COMPLETED|Treatment||10
7747649|NCT01508910|19075540|P2|NOT COMPLETED|Treatment||4
7747650|NCT01508910|19075541|P1|NOT COMPLETED|Treatment||2
7747651|NCT01508910|19075538|P4|COMPLETED|Treatment||3
7747652|NCT01508910|19075539|P3|COMPLETED|Treatment||18
7747653|NCT01508910|19075540|P2|COMPLETED|Treatment||24
7747654|NCT01508910|19075541|P1|COMPLETED|Treatment||48
7747655|NCT01508910|19075538|P4|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6
7747656|NCT01508910|19075539|P3|STARTED|Treatment||28
7747657|NCT01508910|19075540|P2|STARTED|Treatment||28
7747658|NCT01508910|19075541|P1|STARTED|Treatment||50
7747659|NCT01508910|19075538|P4|NOT COMPLETED|Randomization||0
7747660|NCT01508910|19075539|P3|NOT COMPLETED|Randomization||0
7747661|NCT01508910|19075540|P2|NOT COMPLETED|Randomization||0
7747662|NCT01508910|19075541|P1|NOT COMPLETED|Randomization||0
7747663|NCT01508910|19075538|P4|COMPLETED|Randomization||0
7747664|NCT01508910|19075539|P3|COMPLETED|Randomization||28
7747665|NCT01508910|19075540|P2|COMPLETED|Randomization||27
7747666|NCT01508910|19075541|P1|COMPLETED|Randomization||57
7747667|NCT01508910|19075538|P4|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0
7747668|NCT01508910|19075539|P3|STARTED|Randomization||28
7747669|NCT01508910|19075540|P2|STARTED|Randomization||27
7747670|NCT01508910|19075541|P1|STARTED|Randomization||57
7747671|NCT01508832|19075565|P2|NOT COMPLETED|Overall Study||0
7747672|NCT01508832|19075566|P1|NOT COMPLETED|Overall Study||0
7747673|NCT01508832|19075565|P2|COMPLETED|Overall Study||6
7747674|NCT01508832|19075566|P1|COMPLETED|Overall Study||6
7747675|NCT01508832|19075565|P2|STARTED|Overall Study||6
7747676|NCT01508832|19075566|P1|STARTED|Overall Study||6
7747677|NCT01508702|19075574|P2|NOT COMPLETED|Overall Study||13
7747678|NCT01508702|19075575|P1|NOT COMPLETED|Overall Study||23
7747679|NCT01508702|19075574|P2|COMPLETED|Overall Study||94
7747680|NCT01508702|19075575|P1|COMPLETED|Overall Study||84
7747681|NCT01508702|19075574|P2|STARTED|Overall Study||107
7747682|NCT01508702|19075575|P1|STARTED|Overall Study||107
7747683|NCT01508676|19075583|P2|NOT COMPLETED|Phase II (2 Weeks)||1
7747684|NCT01508676|19075584|P1|NOT COMPLETED|Phase II (2 Weeks)||1
7747685|NCT01508676|19075583|P2|COMPLETED|Phase II (2 Weeks)||13
7747686|NCT01508676|19075584|P1|COMPLETED|Phase II (2 Weeks)||15
7747687|NCT01508676|19075583|P2|STARTED|Phase II (2 Weeks)||14
7747688|NCT01508676|19075584|P1|STARTED|Phase II (2 Weeks)||16
7747689|NCT01508676|19075583|P2|NOT COMPLETED|Washout Period (1 Week)||0
7747690|NCT01508676|19075584|P1|NOT COMPLETED|Washout Period (1 Week)||0
7747691|NCT01508676|19075583|P2|COMPLETED|Washout Period (1 Week)||14
7747692|NCT01508676|19075584|P1|COMPLETED|Washout Period (1 Week)||16
7747693|NCT01508676|19075583|P2|STARTED|Washout Period (1 Week)||14
7747694|NCT01508676|19075584|P1|STARTED|Washout Period (1 Week)||16
7747695|NCT01508676|19075583|P2|NOT COMPLETED|Phase I (2 Weeks)||3
7747696|NCT01508676|19075584|P1|NOT COMPLETED|Phase I (2 Weeks)||2
7747697|NCT01508676|19075583|P2|COMPLETED|Phase I (2 Weeks)||14
7747698|NCT01508676|19075584|P1|COMPLETED|Phase I (2 Weeks)||16
7747699|NCT01508676|19075583|P2|STARTED|Phase I (2 Weeks)||17
7747700|NCT01508676|19075584|P1|STARTED|Phase I (2 Weeks)||18
7747701|NCT01508650|19075596|P2|NOT COMPLETED|Overall Study||3
7747702|NCT01508650|19075597|P1|NOT COMPLETED|Overall Study||0
7747703|NCT01508650|19075596|P2|COMPLETED|Overall Study||12
7747704|NCT01508650|19075597|P1|COMPLETED|Overall Study||12
7747705|NCT01508650|19075596|P2|STARTED|Overall Study||15
7747706|NCT01508650|19075597|P1|STARTED|Overall Study||12
7747707|NCT01508455|19075605|P1|NOT COMPLETED|Overall Study||0
7747708|NCT01508455|19075605|P1|COMPLETED|Overall Study||6
7747709|NCT01508455|19075605|P1|STARTED|Overall Study||6
7747710|NCT01508325|19075616|P2|NOT COMPLETED|Overall Study||21
7747711|NCT01508325|19075617|P1|NOT COMPLETED|Overall Study||18
7747712|NCT01508325|19075616|P2|COMPLETED|Overall Study||72
7747713|NCT01508325|19075617|P1|COMPLETED|Overall Study||75
7747714|NCT01508325|19075616|P2|STARTED|Overall Study||93
7747715|NCT01508325|19075617|P1|STARTED|Overall Study||93
7747716|NCT01508169|19075647|P2|NOT COMPLETED|Overall Study||2
7747717|NCT01508169|19075648|P1|NOT COMPLETED|Overall Study||3
7747718|NCT01508169|19075647|P2|COMPLETED|Overall Study||45
7747719|NCT01508169|19075648|P1|COMPLETED|Overall Study||44
7747720|NCT01508169|19075647|P2|STARTED|Overall Study||47
7747721|NCT01508169|19075648|P1|STARTED|Overall Study||47
7747722|NCT01508130|19075662|P2|NOT COMPLETED|Overall Study||69
7747723|NCT01508130|19075663|P1|NOT COMPLETED|Overall Study||227
7747724|NCT01508130|19075662|P2|COMPLETED|Overall Study||73
7747725|NCT01508130|19075663|P1|COMPLETED|Overall Study||266
7747726|NCT01508130|19075662|P2|mTRT|Overall Study||142
7747727|NCT01508130|19075663|P1|mTRT|Overall Study||493
7747728|NCT01508130|19075662|P2|STARTED|Overall Study||142
7747729|NCT01508130|19075663|P1|STARTED|Overall Study||493
7747730|NCT01508117|19075705|P1|NOT COMPLETED|Overall Study||0
7747731|NCT01508117|19075705|P1|COMPLETED|Overall Study||1
7747732|NCT01508117|19075705|P1|STARTED|Overall Study||1
7747733|NCT01508052|19075711|P2|NOT COMPLETED|Overall Study||0
7747734|NCT01508052|19075712|P1|NOT COMPLETED|Overall Study||0
7747735|NCT01508052|19075711|P2|COMPLETED|Overall Study||20
7747736|NCT01508052|19075712|P1|COMPLETED|Overall Study||20
7747737|NCT01508052|19075711|P2|STARTED|Overall Study||20
7747738|NCT01508052|19075712|P1|STARTED|Overall Study||20
7747739|NCT01508013|19075720|P2|NOT COMPLETED|Overall Study||23
7747740|NCT01508013|19075721|P1|NOT COMPLETED|Overall Study||32
7747741|NCT01508013|19075720|P2|COMPLETED|Overall Study||206
7747742|NCT01508013|19075721|P1|COMPLETED|Overall Study||182
7747743|NCT01508013|19075720|P2|STARTED|Overall Study||229
7747744|NCT01508013|19075721|P1|STARTED|Overall Study||214
7747745|NCT01507896|19075731|P1|NOT COMPLETED|Overall Study||2
7747746|NCT01507896|19075731|P1|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28
7747747|NCT01507896|19075731|P1|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30
7747748|NCT01507831|19075774|P2|NOT COMPLETED|Overall Study||440
7747749|NCT01507831|19075775|P1|NOT COMPLETED|Overall Study||193
7747750|NCT01507831|19075774|P2|COMPLETED|Overall Study||1113
7747751|NCT01507831|19075775|P1|COMPLETED|Overall Study||595
7747752|NCT01507831|19075774|P2|Treated|Overall Study||1550
7747753|NCT01507831|19075775|P1|Treated|Overall Study||788
7747754|NCT01507831|19075774|P2|STARTED|Overall Study|Randomized|1553
7747755|NCT01507831|19075775|P1|STARTED|Overall Study|Randomized|788
7747756|NCT01507779|19075845|P2|NOT COMPLETED|Overall Study||0
7747757|NCT01507779|19075846|P1|NOT COMPLETED|Overall Study||0
7747758|NCT01507779|19075845|P2|COMPLETED|Overall Study||25
7747759|NCT01507779|19075846|P1|COMPLETED|Overall Study||23
7747760|NCT01507779|19075845|P2|STARTED|Overall Study||25
7747761|NCT01507779|19075846|P1|STARTED|Overall Study||23
7747762|NCT01507688|19075886|P2|NOT COMPLETED|6 Month to 12 Month Assessment||3
7747763|NCT01507688|19075887|P1|NOT COMPLETED|6 Month to 12 Month Assessment||5
7747764|NCT01507688|19075886|P2|COMPLETED|6 Month to 12 Month Assessment||116
7747765|NCT01507688|19075887|P1|COMPLETED|6 Month to 12 Month Assessment||108
7747766|NCT01507688|19075886|P2|STARTED|6 Month to 12 Month Assessment||119
7747767|NCT01507688|19075887|P1|STARTED|6 Month to 12 Month Assessment||113
7747768|NCT01507688|19075886|P2|NOT COMPLETED|Baseline to 6 Month Assessment||10
7747769|NCT01507688|19075887|P1|NOT COMPLETED|Baseline to 6 Month Assessment||16
7747770|NCT01507688|19075886|P2|COMPLETED|Baseline to 6 Month Assessment||119
7747771|NCT01507688|19075887|P1|COMPLETED|Baseline to 6 Month Assessment||113
7747772|NCT01507688|19075886|P2|STARTED|Baseline to 6 Month Assessment||129
7747773|NCT01507688|19075887|P1|STARTED|Baseline to 6 Month Assessment||129
7747774|NCT01507662|19075895|P2|NOT COMPLETED|Overall Study||831
7747775|NCT01507662|19075896|P1|NOT COMPLETED|Overall Study||816
7747776|NCT01507662|19075895|P2|COMPLETED|Overall Study||3020
7747777|NCT01507662|19075896|P1|COMPLETED|Overall Study||3082
7747778|NCT01507662|19075895|P2|STARTED|Overall Study||3851
7747779|NCT01507662|19075896|P1|STARTED|Overall Study||3898
7747780|NCT01507584|19075902|P1|NOT COMPLETED|Overall Study||0
7747781|NCT01507584|19075902|P1|COMPLETED|Overall Study||0
7747782|NCT01507584|19075902|P1|STARTED|Overall Study||0
7747783|NCT01507493|19075910|P2|NOT COMPLETED|Overall Study||0
7747784|NCT01507493|19075911|P1|NOT COMPLETED|Overall Study||0
7747785|NCT01507493|19075910|P2|COMPLETED|Overall Study||178
7747786|NCT01507493|19075911|P1|COMPLETED|Overall Study||22
7747787|NCT01507493|19075910|P2|STARTED|Overall Study||178
7747788|NCT01507493|19075911|P1|STARTED|Overall Study||22
7747789|NCT01507350|19075925|P1|NOT COMPLETED|Overall Study||0
7747790|NCT01507350|19075925|P1|COMPLETED|Overall Study||9
7747791|NCT01507350|19075925|P1|STARTED|Overall Study||9
7747792|NCT01507298|19075931|P2|NOT COMPLETED|Overall Study||6
7747793|NCT01507298|19075932|P1|NOT COMPLETED|Overall Study||0
7747794|NCT01507298|19075931|P2|COMPLETED|Overall Study||14
7747795|NCT01507298|19075932|P1|COMPLETED|Overall Study||1
7747796|NCT01507298|19075931|P2|STARTED|Overall Study||20
7747797|NCT01507298|19075932|P1|STARTED|Overall Study||1
7747798|NCT01507246|19075942|P2|NOT COMPLETED|Overall Study||1
7747799|NCT01507246|19075943|P1|NOT COMPLETED|Overall Study||2
7747800|NCT01507246|19075942|P2|COMPLETED|Overall Study||21
7747801|NCT01507246|19075943|P1|COMPLETED|Overall Study||18
7747802|NCT01507246|19075942|P2|STARTED|Overall Study||22
7747803|NCT01507246|19075943|P1|STARTED|Overall Study||20
7747804|NCT01507233|19075957|P2|NOT COMPLETED|Overall Study||0
7747805|NCT01507233|19075958|P1|NOT COMPLETED|Overall Study||0
7747806|NCT01507233|19075957|P2|COMPLETED|Overall Study||0
7747807|NCT01507233|19075958|P1|COMPLETED|Overall Study||5
7747808|NCT01507233|19075957|P2|STARTED|Overall Study||0
7747809|NCT01507233|19075958|P1|STARTED|Overall Study||5
7747810|NCT01507220|19075970|P2|NOT COMPLETED|Overall Study||0
7747811|NCT01507220|19075971|P1|NOT COMPLETED|Overall Study||0
7747812|NCT01507220|19075970|P2|COMPLETED|Overall Study||0
7747813|NCT01507220|19075971|P1|COMPLETED|Overall Study||2
7747814|NCT01507220|19075970|P2|STARTED|Overall Study||0
7747815|NCT01507220|19075971|P1|STARTED|Overall Study||2
7747816|NCT01507181|19075985|P2|NOT COMPLETED|Overall Study||0
7747817|NCT01507181|19075986|P1|NOT COMPLETED|Overall Study||0
7747818|NCT01507181|19075985|P2|COMPLETED|Overall Study||12
7747819|NCT01507181|19075986|P1|COMPLETED|Overall Study||12
7747820|NCT01507181|19075985|P2|STARTED|Overall Study||12
7747821|NCT01507181|19075986|P1|STARTED|Overall Study||12
7747822|NCT01507155|19076006|P2|NOT COMPLETED|Overall Study||0
7747823|NCT01507155|19076007|P1|NOT COMPLETED|Overall Study||0
7747824|NCT01507155|19076006|P2|COMPLETED|Overall Study||60
7747825|NCT01507155|19076007|P1|COMPLETED|Overall Study||625
7747826|NCT01507155|19076006|P2|STARTED|Overall Study||60
7747827|NCT01507155|19076007|P1|STARTED|Overall Study||625
7747828|NCT01507103|19076016|P3|NOT COMPLETED|Overall Study||0
7747829|NCT01507103|19076017|P2|NOT COMPLETED|Overall Study||0
7747830|NCT01507103|19076018|P1|NOT COMPLETED|Overall Study||0
7747831|NCT01507103|19076016|P3|COMPLETED|Overall Study||42
7747832|NCT01507103|19076017|P2|COMPLETED|Overall Study||41
7747833|NCT01507103|19076018|P1|COMPLETED|Overall Study||41
7747834|NCT01507103|19076016|P3|STARTED|Overall Study||42
7747835|NCT01507103|19076017|P2|STARTED|Overall Study||41
7747836|NCT01507103|19076018|P1|STARTED|Overall Study||41
7747837|NCT01507090|19076041|P1|NOT COMPLETED|Overall Study||18
7747838|NCT01507090|19076041|P1|COMPLETED|Overall Study||624
7747839|NCT01507090|19076041|P1|STARTED|Overall Study||642
7747840|NCT01507051|19076080|P4|NOT COMPLETED|Overall Study||7
7747841|NCT01507051|19076081|P3|NOT COMPLETED|Overall Study||1
7747842|NCT01507051|19076082|P2|NOT COMPLETED|Overall Study||3
7747843|NCT01507051|19076083|P1|NOT COMPLETED|Overall Study||2
7747844|NCT01507051|19076080|P4|COMPLETED|Overall Study||0
7747845|NCT01507051|19076081|P3|COMPLETED|Overall Study||28
7747846|NCT01507051|19076082|P2|COMPLETED|Overall Study||28
7747847|NCT01507051|19076083|P1|COMPLETED|Overall Study||27
7747848|NCT01507051|19076080|P4|Received Placebo or Rivaroxaban|Overall Study||0
7747849|NCT01507051|19076081|P3|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28
7747850|NCT01507051|19076082|P2|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28
7747851|NCT01507051|19076083|P1|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28
7747852|NCT01507051|19076080|P4|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7
7747853|NCT01507051|19076081|P3|Warfarin run-in Phase|Overall Study||0
7747854|NCT01507051|19076082|P2|Warfarin run-in Phase|Overall Study||28
7747855|NCT01507051|19076083|P1|Warfarin run-in Phase|Overall Study||28
7747856|NCT01507051|19076080|P4|STARTED|Overall Study||7
7747857|NCT01507051|19076081|P3|STARTED|Overall Study||29
7747858|NCT01507051|19076082|P2|STARTED|Overall Study||31
7747859|NCT01507051|19076083|P1|STARTED|Overall Study||29
7747860|NCT01506960|19076201|P1|NOT COMPLETED|Overall Study||47
7747861|NCT01506960|19076201|P1|COMPLETED|Overall Study||17
7747862|NCT01506960|19076201|P1|STARTED|Overall Study||64
7747863|NCT01506947|19076207|P1|NOT COMPLETED|Overall Study||16
7747864|NCT01506947|19076207|P1|COMPLETED|Overall Study||49
7747865|NCT01506947|19076207|P1|STARTED|Overall Study||65
7747866|NCT01506908|19076225|P2|NOT COMPLETED|Overall Study||0
7747867|NCT01506908|19076226|P1|NOT COMPLETED|Overall Study||1
7747868|NCT01506908|19076225|P2|COMPLETED|Overall Study||161
7747869|NCT01506908|19076226|P1|COMPLETED|Overall Study||161
7747870|NCT01506908|19076225|P2|STARTED|Overall Study||161
7747871|NCT01506908|19076226|P1|STARTED|Overall Study||162
7747872|NCT01506882|19076244|P2|NOT COMPLETED|Overall Study||7
7747873|NCT01506882|19076245|P1|NOT COMPLETED|Overall Study||22
7747874|NCT01506882|19076244|P2|COMPLETED|Overall Study||3
7747875|NCT01506882|19076245|P1|COMPLETED|Overall Study||39
7747876|NCT01506882|19076244|P2|STARTED|Overall Study||10
7747877|NCT01506882|19076245|P1|STARTED|Overall Study||61
7747878|NCT01506726|19076259|P2|NOT COMPLETED|Overall Study||2
7747879|NCT01506726|19076260|P1|NOT COMPLETED|Overall Study||1
7747880|NCT01506726|19076259|P2|COMPLETED|Overall Study||3
7747881|NCT01506726|19076260|P1|COMPLETED|Overall Study||5
7747882|NCT01506726|19076259|P2|STARTED|Overall Study||5
7747883|NCT01506726|19076260|P1|STARTED|Overall Study||6
7747884|NCT01506596|19076300|P1|NOT COMPLETED|Overall Study||1
7747885|NCT01506596|19076300|P1|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41
7747886|NCT01506596|19076300|P1|STARTED|Overall Study||42
7747887|NCT01506479|19076311|P3|NOT COMPLETED|Overall Study||3
7747888|NCT01506479|19076312|P2|NOT COMPLETED|Overall Study||5
7747889|NCT01506479|19076313|P1|NOT COMPLETED|Overall Study||3
7747890|NCT01506479|19076311|P3|COMPLETED|Overall Study||42
7747891|NCT01506479|19076312|P2|COMPLETED|Overall Study||38
7747892|NCT01506479|19076313|P1|COMPLETED|Overall Study||37
7747893|NCT01506479|19076311|P3|STARTED|Overall Study||45
7747894|NCT01506479|19076312|P2|STARTED|Overall Study||43
7747895|NCT01506479|19076313|P1|STARTED|Overall Study||40
7747896|NCT01506453|19076327|P2|NOT COMPLETED|Overall Study||2
7747897|NCT01506453|19076328|P1|NOT COMPLETED|Overall Study||0
7747898|NCT01506453|19076327|P2|COMPLETED|Overall Study||24
7747899|NCT01506453|19076328|P1|COMPLETED|Overall Study||25
7747900|NCT01506453|19076327|P2|STARTED|Overall Study||26
7747901|NCT01506453|19076328|P1|STARTED|Overall Study||25
7747902|NCT01506362|19076338|P1|NOT COMPLETED|Overall Study||6
7747903|NCT01506362|19076338|P1|COMPLETED|Overall Study||16
7747904|NCT01506362|19076338|P1|STARTED|Overall Study||22
7747905|NCT01506323|19076344|P2|NOT COMPLETED|Overall Study||13
7747906|NCT01506323|19076345|P1|NOT COMPLETED|Overall Study||24
7747907|NCT01506323|19076344|P2|COMPLETED|Overall Study||71
7747908|NCT01506323|19076345|P1|COMPLETED|Overall Study||65
7747909|NCT01506323|19076344|P2|Post-treatment Completed CAPS|Overall Study||72
7747910|NCT01506323|19076345|P1|Post-treatment Completed CAPS|Overall Study||68
7747911|NCT01506323|19076344|P2|Post-treatment Completers|Overall Study||72
7747912|NCT01506323|19076345|P1|Post-treatment Completers|Overall Study||69
7747913|NCT01506323|19076344|P2|STARTED|Overall Study||84
7747914|NCT01506323|19076345|P1|STARTED|Overall Study||89
7747915|NCT01506271|19076374|P3|NOT COMPLETED|Overall Study||3
7747916|NCT01506271|19076375|P2|NOT COMPLETED|Overall Study||7
7747917|NCT01506271|19076376|P1|NOT COMPLETED|Overall Study||4
7747918|NCT01506271|19076374|P3|COMPLETED|Overall Study||114
7747919|NCT01506271|19076375|P2|COMPLETED|Overall Study||109
7747920|NCT01506271|19076376|P1|COMPLETED|Overall Study||114
7747921|NCT01506271|19076374|P3|Treated|Overall Study||114
7747922|NCT01506271|19076375|P2|Treated|Overall Study||116
7747923|NCT01506271|19076376|P1|Treated|Overall Study||117
7747924|NCT01506271|19076374|P3|STARTED|Overall Study||117
7747925|NCT01506271|19076375|P2|STARTED|Overall Study||116
7747926|NCT01506271|19076376|P1|STARTED|Overall Study||118
7747927|NCT01506193|19076438|P3|NOT COMPLETED|Overall Study||14
7747928|NCT01506193|19076439|P2|NOT COMPLETED|Overall Study||4
7747929|NCT01506193|19076440|P1|NOT COMPLETED|Overall Study||14
7747930|NCT01506193|19076438|P3|COMPLETED|Overall Study||168
7747931|NCT01506193|19076439|P2|COMPLETED|Overall Study||179
7747932|NCT01506193|19076440|P1|COMPLETED|Overall Study||337
7747933|NCT01506193|19076438|P3|STARTED|Overall Study||182
7747934|NCT01506193|19076439|P2|STARTED|Overall Study||183
7747935|NCT01506193|19076440|P1|STARTED|Overall Study||351
7747936|NCT01505933|19076473|P2|NOT COMPLETED|Overall Study||0
7747937|NCT01505933|19076474|P1|NOT COMPLETED|Overall Study||0
7747938|NCT01505933|19076473|P2|COMPLETED|Overall Study||14
7747939|NCT01505933|19076474|P1|COMPLETED|Overall Study||10
7747940|NCT01505933|19076473|P2|STARTED|Overall Study||14
7747941|NCT01505933|19076474|P1|STARTED|Overall Study||10
7747942|NCT01505881|19076486|P2|NOT COMPLETED|Overall Study||1
7747943|NCT01505881|19076487|P1|NOT COMPLETED|Overall Study||4
7747944|NCT01505881|19076486|P2|COMPLETED|Overall Study||58
7747945|NCT01505881|19076487|P1|COMPLETED|Overall Study||95
7747946|NCT01505881|19076486|P2|STARTED|Overall Study||59
7747947|NCT01505881|19076487|P1|STARTED|Overall Study||99
7747948|NCT01505764|19076501|P2|NOT COMPLETED|Overall Study||1
7747949|NCT01505764|19076502|P1|NOT COMPLETED|Overall Study||3
7747950|NCT01505764|19076501|P2|COMPLETED|Overall Study||2
7747951|NCT01505764|19076502|P1|COMPLETED|Overall Study||3
7747952|NCT01505764|19076501|P2|STARTED|Overall Study||3
7747953|NCT01505764|19076502|P1|STARTED|Overall Study||6
7747954|NCT01505673|19076532|P2|NOT COMPLETED|Overall Study||2
7747955|NCT01505673|19076533|P1|NOT COMPLETED|Overall Study||3
7747956|NCT01505673|19076532|P2|COMPLETED|Overall Study||34
7747957|NCT01505673|19076533|P1|COMPLETED|Overall Study||32
7747958|NCT01505673|19076532|P2|STARTED|Overall Study||36
7747959|NCT01505673|19076533|P1|STARTED|Overall Study||35
7747960|NCT01505647|19076593|P2|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3
7747961|NCT01505647|19076594|P1|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1
7747962|NCT01505647|19076593|P2|COMPLETED|Day 43 Through Day 182 Follow-up||163
7747963|NCT01505647|19076594|P1|COMPLETED|Day 43 Through Day 182 Follow-up||328
7747964|NCT01505647|19076593|P2|STARTED|Day 43 Through Day 182 Follow-up||166
7747965|NCT01505647|19076594|P1|STARTED|Day 43 Through Day 182 Follow-up||329
7747966|NCT01505647|19076593|P2|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0
7747967|NCT01505647|19076594|P1|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3
7747968|NCT01505647|19076593|P2|COMPLETED|Day 1 Through Day 42 Follow-up||166
7747969|NCT01505647|19076594|P1|COMPLETED|Day 1 Through Day 42 Follow-up||329
7747970|NCT01505647|19076593|P2|Vaccinated|Day 1 Through Day 42 Follow-up||166
7747971|NCT01505647|19076594|P1|Vaccinated|Day 1 Through Day 42 Follow-up||331
7747972|NCT01505647|19076593|P2|STARTED|Day 1 Through Day 42 Follow-up||166
7747973|NCT01505647|19076594|P1|STARTED|Day 1 Through Day 42 Follow-up||332
7747974|NCT01505634|19076611|P3|NOT COMPLETED|Overall Study||6
7747975|NCT01505634|19076612|P2|NOT COMPLETED|Overall Study||10
7747976|NCT01505634|19076613|P1|NOT COMPLETED|Overall Study||9
7747977|NCT01505634|19076611|P3|COMPLETED|Overall Study||94
7747978|NCT01505634|19076612|P2|COMPLETED|Overall Study||91
7747979|NCT01505634|19076613|P1|COMPLETED|Overall Study||92
7747980|NCT01505634|19076611|P3|Treated|Overall Study||100
7747981|NCT01505634|19076612|P2|Treated|Overall Study||99
7747982|NCT01505634|19076613|P1|Treated|Overall Study||99
7747983|NCT01505634|19076611|P3|STARTED|Overall Study||100
7747984|NCT01505634|19076612|P2|STARTED|Overall Study||101
7747985|NCT01505634|19076613|P1|STARTED|Overall Study||101
7747986|NCT01505608|19076668|P2|NOT COMPLETED|Phase II||2
7747987|NCT01505608|19076669|P1|NOT COMPLETED|Phase II||2
7747988|NCT01505608|19076668|P2|COMPLETED|Phase II||2
7747989|NCT01505608|19076669|P1|COMPLETED|Phase II||0
7747990|NCT01505608|19076668|P2|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4
7747991|NCT01505608|19076669|P1|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2
7747992|NCT01505608|19076668|P2|NOT COMPLETED|Phase I||6
7747993|NCT01505608|19076669|P1|NOT COMPLETED|Phase I||0
7747994|NCT01505608|19076668|P2|COMPLETED|Phase I||2
7747995|NCT01505608|19076669|P1|COMPLETED|Phase I||0
7747996|NCT01505608|19076668|P2|STARTED|Phase I||8
7747997|NCT01505608|19076669|P1|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0
7747998|NCT01505530|19076688|P3|NOT COMPLETED|Overall Study||41
7747999|NCT01505530|19076689|P2|NOT COMPLETED|Overall Study||43
7748000|NCT01505530|19076690|P1|NOT COMPLETED|Overall Study||41
7748001|NCT01505530|19076688|P3|COMPLETED|Overall Study||0
7748002|NCT01505530|19076689|P2|COMPLETED|Overall Study||0
7748003|NCT01505530|19076690|P1|COMPLETED|Overall Study||0
7748004|NCT01505530|19076688|P3|Completed One Cycle of Study Drug|Overall Study||31
7748005|NCT01505530|19076689|P2|Completed One Cycle of Study Drug|Overall Study||27
7748006|NCT01505530|19076690|P1|Completed One Cycle of Study Drug|Overall Study||29
7748007|NCT01505530|19076688|P3|Received At Least One Dose of Study Drug|Overall Study||41
7748008|NCT01505530|19076689|P2|Received At Least One Dose of Study Drug|Overall Study||42
7748009|NCT01505530|19076690|P1|Received At Least One Dose of Study Drug|Overall Study||41
7748010|NCT01505530|19076688|P3|STARTED|Overall Study||41
7748011|NCT01505530|19076689|P2|STARTED|Overall Study||43
7748012|NCT01505530|19076690|P1|STARTED|Overall Study||41
7748013|NCT01505491|19076734|P3|NOT COMPLETED|Overall Study||5
7748014|NCT01505491|19076735|P2|NOT COMPLETED|Overall Study||1
7748015|NCT01505491|19076736|P1|NOT COMPLETED|Overall Study||2
7748016|NCT01505491|19076734|P3|COMPLETED|Overall Study||59
7748017|NCT01505491|19076735|P2|COMPLETED|Overall Study||61
7748018|NCT01505491|19076736|P1|COMPLETED|Overall Study||65
7748019|NCT01505491|19076734|P3|STARTED|Overall Study||64
7748020|NCT01505491|19076735|P2|STARTED|Overall Study||62
7748021|NCT01505491|19076736|P1|STARTED|Overall Study||67
7748022|NCT01505465|19076758|P2|NOT COMPLETED|Overall Study||7
7748023|NCT01505465|19076759|P1|NOT COMPLETED|Overall Study||6
7748024|NCT01505465|19076758|P2|COMPLETED|Overall Study||18
7748025|NCT01505465|19076759|P1|COMPLETED|Overall Study||19
7748026|NCT01505465|19076758|P2|STARTED|Overall Study||25
7748027|NCT01505465|19076759|P1|STARTED|Overall Study||25
7748028|NCT01505387|19076775|P2|NOT COMPLETED|Overall Study||1
7748029|NCT01505387|19076776|P1|NOT COMPLETED|Overall Study||2
7748030|NCT01505387|19076775|P2|COMPLETED|Overall Study||24
7748031|NCT01505387|19076776|P1|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23
7748032|NCT01505387|19076775|P2|Treated|Overall Study||24
7748033|NCT01505387|19076776|P1|Treated|Overall Study||24
7748034|NCT01505387|19076775|P2|STARTED|Overall Study||25
7748035|NCT01505387|19076776|P1|STARTED|Overall Study||25
7748036|NCT01505374|19076782|P2|NOT COMPLETED|Overall Study||0
7748037|NCT01505374|19076783|P1|NOT COMPLETED|Overall Study||1
7748038|NCT01505374|19076782|P2|COMPLETED|Overall Study||30
7748039|NCT01505374|19076783|P1|COMPLETED|Overall Study||29
7748040|NCT01505374|19076782|P2|STARTED|Overall Study||30
7748041|NCT01505374|19076783|P1|STARTED|Overall Study||30
7748042|NCT01505179|19076799|P2|NOT COMPLETED|Overall Study||0
7748043|NCT01505179|19076800|P1|NOT COMPLETED|Overall Study||0
7748044|NCT01505179|19076799|P2|COMPLETED|Overall Study||4
7748045|NCT01505179|19076800|P1|COMPLETED|Overall Study||6
7748046|NCT01505179|19076799|P2|STARTED|Overall Study||4
7748047|NCT01505179|19076800|P1|STARTED|Overall Study||6
7748048|NCT01505166|19076815|P3|NOT COMPLETED|Overall Study||0
7748049|NCT01505166|19076816|P2|NOT COMPLETED|Overall Study||0
7748050|NCT01505166|19076817|P1|NOT COMPLETED|Overall Study||0
7748051|NCT01505166|19076815|P3|COMPLETED|Overall Study||0
7748052|NCT01505166|19076816|P2|COMPLETED|Overall Study||0
7748053|NCT01505166|19076817|P1|COMPLETED|Overall Study|"Completed means subject had successful Vigil manufacturing and had been given all the doses."|3
7748054|NCT01505166|19076815|P3|STARTED|Overall Study||0
7748055|NCT01505166|19076816|P2|STARTED|Overall Study||0
7748056|NCT01505166|19076817|P1|STARTED|Overall Study||3
7748057|NCT01505114|19076833|P4|NOT COMPLETED|Overall Study||23
7748058|NCT01505114|19076834|P3|NOT COMPLETED|Overall Study||18
7748059|NCT01505114|19076835|P2|NOT COMPLETED|Overall Study||13
7748060|NCT01505114|19076836|P1|NOT COMPLETED|Overall Study||25
7748061|NCT01505114|19076833|P4|COMPLETED|Overall Study||128
7748062|NCT01505114|19076834|P3|COMPLETED|Overall Study||129
7748063|NCT01505114|19076835|P2|COMPLETED|Overall Study||135
7748064|NCT01505114|19076836|P1|COMPLETED|Overall Study||123
7748065|NCT01505114|19076833|P4|STARTED|Overall Study||151
7748066|NCT01505114|19076834|P3|STARTED|Overall Study||147
7748067|NCT01505114|19076835|P2|STARTED|Overall Study||148
7748068|NCT01505114|19076836|P1|STARTED|Overall Study||148
7748069|NCT01505062|19076849|P3|NOT COMPLETED|Overall Study||0
7748070|NCT01505062|19076850|P2|NOT COMPLETED|Overall Study||0
7748071|NCT01505062|19076851|P1|NOT COMPLETED|Overall Study||0
7748072|NCT01505062|19076849|P3|COMPLETED|Overall Study||3
7748073|NCT01505062|19076850|P2|COMPLETED|Overall Study||3
7748074|NCT01505062|19076851|P1|COMPLETED|Overall Study||3
7748075|NCT01505062|19076849|P3|STARTED|Overall Study||3
7748076|NCT01505062|19076850|P2|STARTED|Overall Study||3
7748077|NCT01505062|19076851|P1|STARTED|Overall Study||3
7748078|NCT01505010|19076864|P2|NOT COMPLETED|Overall Study||2
7748079|NCT01505010|19076865|P1|NOT COMPLETED|Overall Study||0
7748080|NCT01505010|19076864|P2|COMPLETED|Overall Study||6
7748081|NCT01505010|19076865|P1|COMPLETED|Overall Study||9
7748082|NCT01505010|19076864|P2|STARTED|Overall Study||8
7748083|NCT01505010|19076865|P1|STARTED|Overall Study||9
7748084|NCT01504997|19076875|P1|NOT COMPLETED|Overall Study||0
7748085|NCT01504997|19076875|P1|COMPLETED|Overall Study||18
7748086|NCT01504997|19076875|P1|STARTED|Overall Study||18
7748087|NCT01504971|19076879|P1|NOT COMPLETED|Overall Study||13
7748088|NCT01504971|19076879|P1|COMPLETED|Overall Study||82
7748089|NCT01504971|19076879|P1|STARTED|Overall Study||95
7748090|NCT01504958|19076890|P3|NOT COMPLETED|Overall Study||0
7748091|NCT01504958|19076891|P2|NOT COMPLETED|Overall Study||0
7748092|NCT01504958|19076892|P1|NOT COMPLETED|Overall Study||0
7748093|NCT01504958|19076890|P3|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
7748094|NCT01504958|19076891|P2|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
7748095|NCT01504958|19076892|P1|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|10
7748096|NCT01504958|19076890|P3|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
7748097|NCT01504958|19076891|P2|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
7748098|NCT01504958|19076892|P1|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|10
7748099|NCT01504867|19076908|P2|NOT COMPLETED|Overall Study||3
7748100|NCT01504867|19076909|P1|NOT COMPLETED|Overall Study||7
7748101|NCT01504867|19076908|P2|COMPLETED|Overall Study||195
7748102|NCT01504867|19076909|P1|COMPLETED|Overall Study||195
7748103|NCT01504867|19076908|P2|STARTED|Overall Study||198
7748104|NCT01504867|19076909|P1|STARTED|Overall Study||202
7748105|NCT01504854|19076929|P2|NOT COMPLETED|Overall Study||7
7748106|NCT01504854|19076930|P1|NOT COMPLETED|Overall Study||8
7748107|NCT01504854|19076929|P2|COMPLETED|Overall Study||48
7748108|NCT01504854|19076930|P1|COMPLETED|Overall Study||56
7748109|NCT01504854|19076929|P2|STARTED|Overall Study||55
7748110|NCT01504854|19076930|P1|STARTED|Overall Study||64
7748111|NCT01504841|19076947|P3|NOT COMPLETED|Overall Study||0
7748112|NCT01504841|19076948|P2|NOT COMPLETED|Overall Study||4
7748113|NCT01504841|19076949|P1|NOT COMPLETED|Overall Study||16
7748114|NCT01504841|19076947|P3|COMPLETED|Overall Study||0
7748115|NCT01504841|19076948|P2|COMPLETED|Overall Study||2
7748116|NCT01504841|19076949|P1|COMPLETED|Overall Study||4
7748117|NCT01504841|19076947|P3|STARTED|Overall Study|No enrollments occurred into Cohort 3 during the study.|0
7748118|NCT01504841|19076948|P2|STARTED|Overall Study||6
7748119|NCT01504841|19076949|P1|STARTED|Overall Study||20
7748120|NCT01504711|19076982|P1|NOT COMPLETED|Overall Study||3
7748121|NCT01504711|19076982|P1|COMPLETED|Overall Study||27
7748122|NCT01504711|19076982|P1|STARTED|Overall Study||30
7748123|NCT01504477|19076989|P1|NOT COMPLETED|Overall Study||0
7748124|NCT01504477|19076989|P1|COMPLETED|Overall Study||6
7748125|NCT01504477|19076989|P1|STARTED|Overall Study||6
7748126|NCT01504412|19077002|P5|NOT COMPLETED|Overall Study||13
7748127|NCT01504412|19077003|P4|NOT COMPLETED|Overall Study||19
7748128|NCT01504412|19077004|P3|NOT COMPLETED|Overall Study||4
7748129|NCT01504412|19077005|P2|NOT COMPLETED|Overall Study||12
7748130|NCT01504412|19077006|P1|NOT COMPLETED|Overall Study||5
7748131|NCT01504412|19077002|P5|COMPLETED|Overall Study||77
7748132|NCT01504412|19077003|P4|COMPLETED|Overall Study||75
7748133|NCT01504412|19077004|P3|COMPLETED|Overall Study||86
7748134|NCT01504412|19077005|P2|COMPLETED|Overall Study||75
7748135|NCT01504412|19077006|P1|COMPLETED|Overall Study||84
7748136|NCT01504412|19077002|P5|STARTED|Overall Study||90
7748137|NCT01504412|19077003|P4|STARTED|Overall Study||94
7748138|NCT01504412|19077004|P3|STARTED|Overall Study||90
7748139|NCT01504412|19077005|P2|STARTED|Overall Study||87
7748140|NCT01504412|19077006|P1|STARTED|Overall Study||89
7748141|NCT01504204|19077025|P2|NOT COMPLETED|Overall Study||1
7748142|NCT01504204|19077026|P1|NOT COMPLETED|Overall Study||1
7748143|NCT01504204|19077025|P2|COMPLETED|Overall Study||9
7748144|NCT01504204|19077026|P1|COMPLETED|Overall Study||9
7748145|NCT01504204|19077025|P2|STARTED|Overall Study||10
7748146|NCT01504204|19077026|P1|STARTED|Overall Study||10
7748147|NCT01503749|19077039|P3|NOT COMPLETED|Overall Study||0
7748148|NCT01503749|19077040|P2|NOT COMPLETED|Overall Study||0
7748149|NCT01503749|19077041|P1|NOT COMPLETED|Overall Study||0
7748150|NCT01503749|19077039|P3|COMPLETED|Overall Study||3
7748151|NCT01503749|19077040|P2|COMPLETED|Overall Study||3
7748152|NCT01503749|19077041|P1|COMPLETED|Overall Study||3
7748153|NCT01503749|19077039|P3|STARTED|Overall Study||3
7748154|NCT01503749|19077040|P2|STARTED|Overall Study||3
7748155|NCT01503749|19077041|P1|STARTED|Overall Study||3
7748156|NCT01503333|19077054|P2|NOT COMPLETED|Overall Study||305
7748157|NCT01503333|19077055|P1|NOT COMPLETED|Overall Study||340
7748158|NCT01503333|19077054|P2|COMPLETED|Overall Study||461
7748159|NCT01503333|19077055|P1|COMPLETED|Overall Study||437
7748160|NCT01503333|19077054|P2|Completed Post-intervention|Overall Study||706
7748161|NCT01503333|19077055|P1|Completed Post-intervention|Overall Study||680
7748162|NCT01503333|19077054|P2|Completed Baseline|Overall Study||753
7748163|NCT01503333|19077055|P1|Completed Baseline|Overall Study||766
7748164|NCT01503333|19077054|P2|STARTED|Overall Study||766
7748165|NCT01503333|19077055|P1|STARTED|Overall Study||777
7748166|NCT01503164|19077083|P2|NOT COMPLETED|Overall Study||1
7748167|NCT01503164|19077084|P1|NOT COMPLETED|Overall Study||2
7748168|NCT01503164|19077083|P2|COMPLETED|Overall Study||55
7748169|NCT01503164|19077084|P1|COMPLETED|Overall Study||53
7748170|NCT01503164|19077083|P2|STARTED|Overall Study||56
7748171|NCT01503164|19077084|P1|STARTED|Overall Study||55
7748172|NCT01503021|19077114|P2|NOT COMPLETED|Overall Study||26
7748173|NCT01503021|19077115|P1|NOT COMPLETED|Overall Study||27
7748174|NCT01503021|19077114|P2|COMPLETED|Overall Study||332
7748175|NCT01503021|19077115|P1|COMPLETED|Overall Study||333
7748176|NCT01503021|19077114|P2|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333
7748177|NCT01503021|19077115|P1|Completed Treatment|Overall Study||333
7748178|NCT01503021|19077114|P2|Dosed|Overall Study||352
7748179|NCT01503021|19077115|P1|Dosed|Overall Study||351
7748180|NCT01503021|19077114|P2|STARTED|Overall Study||358
7748181|NCT01503021|19077115|P1|STARTED|Overall Study||360
7748182|NCT01502956|19077164|P2|NOT COMPLETED|Overall Study||26
7748183|NCT01502956|19077165|P1|NOT COMPLETED|Overall Study||24
7748184|NCT01502956|19077164|P2|COMPLETED|Overall Study||168
7748185|NCT01502956|19077165|P1|COMPLETED|Overall Study||168
7748186|NCT01502956|19077164|P2|STARTED|Overall Study||194
7748187|NCT01502956|19077165|P1|STARTED|Overall Study||192
7748188|NCT01502787|19077189|P2|NOT COMPLETED|Overall Study||0
7748189|NCT01502787|19077190|P1|NOT COMPLETED|Overall Study||0
7748190|NCT01502787|19077189|P2|COMPLETED|Overall Study||10
7748191|NCT01502787|19077190|P1|COMPLETED|Overall Study||11
7748192|NCT01502787|19077189|P2|STARTED|Overall Study||10
7748193|NCT01502787|19077190|P1|STARTED|Overall Study||11
7748194|NCT01502761|19077204|P4|NOT COMPLETED|Overall Study||0
7748195|NCT01502761|19077205|P3|NOT COMPLETED|Overall Study||0
7748196|NCT01502761|19077206|P2|NOT COMPLETED|Overall Study||0
7748197|NCT01502761|19077207|P1|NOT COMPLETED|Overall Study||0
7748198|NCT01502761|19077204|P4|COMPLETED|Overall Study||0
7748199|NCT01502761|19077205|P3|COMPLETED|Overall Study||0
7748200|NCT01502761|19077206|P2|COMPLETED|Overall Study||0
7748201|NCT01502761|19077207|P1|COMPLETED|Overall Study||4
7748202|NCT01502761|19077204|P4|STARTED|Overall Study||0
7748203|NCT01502761|19077205|P3|STARTED|Overall Study||0
7748204|NCT01502761|19077206|P2|STARTED|Overall Study||0
7748205|NCT01502761|19077207|P1|STARTED|Overall Study||4
7748206|NCT01502709|19077223|P2|NOT COMPLETED|Overall Study||0
7748207|NCT01502709|19077224|P1|NOT COMPLETED|Overall Study||4
7748208|NCT01502709|19077223|P2|COMPLETED|Overall Study||0
7748209|NCT01502709|19077224|P1|COMPLETED|Overall Study||1
7748210|NCT01502709|19077223|P2|STARTED|Overall Study||0
7748211|NCT01502709|19077224|P1|STARTED|Overall Study||5
7748212|NCT01502644|19077237|P4|NOT COMPLETED|Assigned to NA Groups||8
7748213|NCT01502644|19077238|P3|NOT COMPLETED|Assigned to NA Groups||3
7748214|NCT01502644|19077239|P2|NOT COMPLETED|Assigned to NA Groups||6
7748215|NCT01502644|19077240|P1|NOT COMPLETED|Assigned to NA Groups||0
7748216|NCT01502644|19077237|P4|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
7748217|NCT01502644|19077238|P3|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|7
7748218|NCT01502644|19077239|P2|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
7748219|NCT01502644|19077240|P1|COMPLETED|Assigned to NA Groups||0
7748220|NCT01502644|19077237|P4|STARTED|Assigned to NA Groups||32
7748221|NCT01502644|19077238|P3|STARTED|Assigned to NA Groups||10
7748222|NCT01502644|19077239|P2|STARTED|Assigned to NA Groups||30
7748223|NCT01502644|19077240|P1|STARTED|Assigned to NA Groups||0
7748224|NCT01502644|19077237|P4|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
7748225|NCT01502644|19077238|P3|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
7748226|NCT01502644|19077239|P2|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
7748227|NCT01502644|19077240|P1|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9
7748228|NCT01502644|19077237|P4|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
7748229|NCT01502644|19077238|P3|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
7748230|NCT01502644|19077239|P2|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
7748231|NCT01502644|19077240|P1|COMPLETED|Enrolled at Visit 1 After Pre-screening|Participants who completed Visit 1 were assigned to 1 of the 3 NA groups for remainder of the trial|72
7748232|NCT01502644|19077237|P4|STARTED|Enrolled at Visit 1 After Pre-screening||0
7748233|NCT01502644|19077238|P3|STARTED|Enrolled at Visit 1 After Pre-screening||0
7748234|NCT01502644|19077239|P2|STARTED|Enrolled at Visit 1 After Pre-screening||0
7748235|NCT01502644|19077240|P1|STARTED|Enrolled at Visit 1 After Pre-screening||81
7748236|NCT01502423|19077250|P2|NOT COMPLETED|Overall Study||1
7748237|NCT01502423|19077251|P1|NOT COMPLETED|Overall Study||0
7748238|NCT01502423|19077250|P2|COMPLETED|Overall Study||29
7748239|NCT01502423|19077251|P1|COMPLETED|Overall Study||31
7748240|NCT01502423|19077250|P2|STARTED|Overall Study||30
7748241|NCT01502423|19077251|P1|STARTED|Overall Study||31
7748242|NCT01502410|19077273|P4|NOT COMPLETED|Overall Study||0
7748243|NCT01502410|19077274|P3|NOT COMPLETED|Overall Study||0
7748244|NCT01502410|19077275|P2|NOT COMPLETED|Overall Study||10
7748245|NCT01502410|19077276|P1|NOT COMPLETED|Overall Study||10
7748246|NCT01502410|19077273|P4|COMPLETED|Overall Study||0
7748247|NCT01502410|19077274|P3|COMPLETED|Overall Study||0
7748248|NCT01502410|19077275|P2|COMPLETED|Overall Study||0
7748249|NCT01502410|19077276|P1|COMPLETED|Overall Study||0
7748250|NCT01502410|19077273|P4|STARTED|Overall Study||0
7748251|NCT01502410|19077274|P3|STARTED|Overall Study||0
7748252|NCT01502410|19077275|P2|STARTED|Overall Study||10
7748253|NCT01502410|19077276|P1|STARTED|Overall Study||10
7748254|NCT01502371|19077294|P5|NOT COMPLETED|Overall Study||52
7748255|NCT01502371|19077295|P4|NOT COMPLETED|Overall Study||37
7748256|NCT01502371|19077296|P3|NOT COMPLETED|Overall Study||25
7748257|NCT01502371|19077297|P2|NOT COMPLETED|Overall Study||32
7748258|NCT01502371|19077298|P1|NOT COMPLETED|Overall Study||41
7748259|NCT01502371|19077294|P5|COMPLETED|Overall Study||60
7748260|NCT01502371|19077295|P4|COMPLETED|Overall Study||88
7748261|NCT01502371|19077296|P3|COMPLETED|Overall Study||83
7748262|NCT01502371|19077297|P2|COMPLETED|Overall Study||81
7748263|NCT01502371|19077298|P1|COMPLETED|Overall Study||79
7748264|NCT01502371|19077294|P5|STARTED|Overall Study||112
7748265|NCT01502371|19077295|P4|STARTED|Overall Study||125
7748266|NCT01502371|19077296|P3|STARTED|Overall Study||108
7748267|NCT01502371|19077297|P2|STARTED|Overall Study||113
7748268|NCT01502371|19077298|P1|STARTED|Overall Study||120
7748269|NCT01502332|19077323|P2|NOT COMPLETED|Overall Study||0
7748270|NCT01502332|19077324|P1|NOT COMPLETED|Overall Study||0
7748271|NCT01502332|19077323|P2|COMPLETED|Overall Study||163
7748272|NCT01502332|19077324|P1|COMPLETED|Overall Study||157
7748273|NCT01502332|19077323|P2|STARTED|Overall Study||163
7748274|NCT01502332|19077324|P1|STARTED|Overall Study||157
7748275|NCT01502306|19077341|P3|NOT COMPLETED|Overall Study||0
7748276|NCT01502306|19077342|P2|NOT COMPLETED|Overall Study||0
7748277|NCT01502306|19077343|P1|NOT COMPLETED|Overall Study||0
7748278|NCT01502306|19077341|P3|COMPLETED|Overall Study||1407
7748279|NCT01502306|19077342|P2|COMPLETED|Overall Study||1405
7748280|NCT01502306|19077343|P1|COMPLETED|Overall Study||1004
7748281|NCT01502306|19077341|P3|STARTED|Overall Study||1407
7748282|NCT01502306|19077342|P2|STARTED|Overall Study||1405
7748283|NCT01502306|19077343|P1|STARTED|Overall Study||1004
7748284|NCT01502293|19077363|P3|NOT COMPLETED|Overall Study||4
7748285|NCT01502293|19077364|P2|NOT COMPLETED|Overall Study||17
7748286|NCT01502293|19077365|P1|NOT COMPLETED|Overall Study||25
7748287|NCT01502293|19077363|P3|COMPLETED|Overall Study||0
7748288|NCT01502293|19077364|P2|COMPLETED|Overall Study||0
7748289|NCT01502293|19077365|P1|COMPLETED|Overall Study||5
7748290|NCT01502293|19077363|P3|STARTED|Overall Study||4
7748291|NCT01502293|19077364|P2|STARTED|Overall Study||17
7748292|NCT01502293|19077365|P1|STARTED|Overall Study||30
7748293|NCT01502228|19077394|P1|NOT COMPLETED|Overall Study||1
7748294|NCT01502228|19077394|P1|COMPLETED|Overall Study||13
7748295|NCT01502228|19077394|P1|STARTED|Overall Study||14
7748296|NCT01502033|19077399|P1|NOT COMPLETED|Overall Study||3
7748297|NCT01502033|19077399|P1|COMPLETED|Overall Study|Milestone (10 participants) met|7
7748298|NCT01502033|19077399|P1|STARTED|Overall Study|Milestone (10 participants) met.|10
7748299|NCT01501955|19077407|P2|NOT COMPLETED|Overall Study||3
7748300|NCT01501955|19077408|P1|NOT COMPLETED|Overall Study||2
7748301|NCT01501955|19077407|P2|COMPLETED|Overall Study||6
7748302|NCT01501955|19077408|P1|COMPLETED|Overall Study||9
7748303|NCT01501955|19077407|P2|2 Years Postop|Overall Study|1 patient terminated due to stem revision|6
7748304|NCT01501955|19077408|P1|2 Years Postop|Overall Study||9
7748305|NCT01501955|19077407|P2|1 Year Postop|Overall Study|2 patients terminated due to stem revision|7
7748306|NCT01501955|19077408|P1|1 Year Postop|Overall Study|1 patient terminated due to stem revision|9
7748307|NCT01501955|19077407|P2|6 Weeks Postop|Overall Study||9
7748308|NCT01501955|19077408|P1|6 Weeks Postop|Overall Study|1 patient withdrew on own request|10
7748309|NCT01501955|19077407|P2|Surgery|Overall Study||9
7748310|NCT01501955|19077408|P1|Surgery|Overall Study||11
7748311|NCT01501955|19077407|P2|STARTED|Overall Study||9
7748312|NCT01501955|19077408|P1|STARTED|Overall Study||11
7748313|NCT01501929|19077450|P2|NOT COMPLETED|Second Intervention||0
7748314|NCT01501929|19077451|P1|NOT COMPLETED|Second Intervention||0
7748315|NCT01501929|19077450|P2|COMPLETED|Second Intervention||17
7748316|NCT01501929|19077451|P1|COMPLETED|Second Intervention||8
7748317|NCT01501929|19077450|P2|STARTED|Second Intervention||17
7748318|NCT01501929|19077451|P1|STARTED|Second Intervention||8
7748319|NCT01501929|19077450|P2|NOT COMPLETED|First Intervention||0
7748320|NCT01501929|19077451|P1|NOT COMPLETED|First Intervention||0
7748321|NCT01501929|19077450|P2|COMPLETED|First Intervention||17
7748322|NCT01501929|19077451|P1|COMPLETED|First Intervention||8
7748323|NCT01501929|19077450|P2|STARTED|First Intervention||17
7748324|NCT01501929|19077451|P1|STARTED|First Intervention||8
7748325|NCT01501162|19077461|P2|NOT COMPLETED|Overall Study||5
7748326|NCT01501162|19077462|P1|NOT COMPLETED|Overall Study||8
7748327|NCT01501162|19077461|P2|COMPLETED|Overall Study||60
7748328|NCT01501162|19077462|P1|COMPLETED|Overall Study||57
7748329|NCT01501162|19077461|P2|STARTED|Overall Study||65
7748330|NCT01501162|19077462|P1|STARTED|Overall Study||65
7748331|NCT01501110|19077472|P2|NOT COMPLETED|Overall Study||1
7748332|NCT01501110|19077473|P1|NOT COMPLETED|Overall Study||0
7748333|NCT01501110|19077472|P2|COMPLETED|Overall Study||33
7748334|NCT01501110|19077473|P1|COMPLETED|Overall Study||34
7748335|NCT01501110|19077472|P2|STARTED|Overall Study||34
7748336|NCT01501110|19077473|P1|STARTED|Overall Study||34
7748337|NCT01500772|19077479|P1|NOT COMPLETED|Overall Study||6
7748338|NCT01500772|19077479|P1|COMPLETED|Overall Study||0
7748339|NCT01500772|19077479|P1|STARTED|Overall Study||6
7748340|NCT01500759|19077488|P2|NOT COMPLETED|Overall Study||0
7748341|NCT01500759|19077489|P1|NOT COMPLETED|Overall Study||0
7748342|NCT01500759|19077488|P2|COMPLETED|Overall Study||3190
7748343|NCT01500759|19077489|P1|COMPLETED|Overall Study||3686
7748344|NCT01500759|19077488|P2|STARTED|Overall Study||3190
7748345|NCT01500759|19077489|P1|STARTED|Overall Study||3686
7748346|NCT01500746|19077540|P2|NOT COMPLETED|Overall Study||0
7748347|NCT01500746|19077541|P1|NOT COMPLETED|Overall Study||0
7748348|NCT01500746|19077540|P2|COMPLETED|Overall Study||4
7748349|NCT01500746|19077541|P1|COMPLETED|Overall Study||4
7748350|NCT01500746|19077540|P2|STARTED|Overall Study||4
7748351|NCT01500746|19077541|P1|STARTED|Overall Study||4
7748352|NCT01500733|19077549|P2|NOT COMPLETED|Overall Study||3
7748353|NCT01500733|19077550|P1|NOT COMPLETED|Overall Study||2
7748354|NCT01500733|19077549|P2|COMPLETED|Overall Study||48
7748355|NCT01500733|19077550|P1|COMPLETED|Overall Study||33
7748356|NCT01500733|19077549|P2|STARTED|Overall Study||51
7748357|NCT01500733|19077550|P1|STARTED|Overall Study||35
7748358|NCT01500720|19077558|P2|NOT COMPLETED|Overall Study||9
7748359|NCT01500720|19077559|P1|NOT COMPLETED|Overall Study||5
7748360|NCT01500720|19077558|P2|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80
7748361|NCT01500720|19077559|P1|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85
7748362|NCT01500720|19077558|P2|Treated|Overall Study||88
7748363|NCT01500720|19077559|P1|Treated|Overall Study||89
7748364|NCT01500720|19077558|P2|STARTED|Overall Study|Randomized|89
7748365|NCT01500720|19077559|P1|STARTED|Overall Study|Randomized|90
7748366|NCT01500694|19077573|P2|NOT COMPLETED|Overall Study||29
7748367|NCT01500694|19077574|P1|NOT COMPLETED|Overall Study||52
7748368|NCT01500694|19077573|P2|COMPLETED|Overall Study||54
7748369|NCT01500694|19077574|P1|COMPLETED|Overall Study||79
7748370|NCT01500694|19077573|P2|STARTED|Overall Study|Participants who received treatment were reported as Started.|83
7748371|NCT01500694|19077574|P1|STARTED|Overall Study||131
7748372|NCT01500629|19077600|P2|NOT COMPLETED|Period 2 (Single Dose)||0
7748373|NCT01500629|19077601|P1|NOT COMPLETED|Period 2 (Single Dose)||0
7748374|NCT01500629|19077600|P2|COMPLETED|Period 2 (Single Dose)||10
7748375|NCT01500629|19077601|P1|COMPLETED|Period 2 (Single Dose)||10
7748376|NCT01500629|19077600|P2|STARTED|Period 2 (Single Dose)||10
7748377|NCT01500629|19077601|P1|STARTED|Period 2 (Single Dose)||10
7748378|NCT01500629|19077600|P2|NOT COMPLETED|Washout Period of 14 to 30 Days||0
7748379|NCT01500629|19077601|P1|NOT COMPLETED|Washout Period of 14 to 30 Days||1
7748380|NCT01500629|19077600|P2|COMPLETED|Washout Period of 14 to 30 Days||10
7748381|NCT01500629|19077601|P1|COMPLETED|Washout Period of 14 to 30 Days||10
7748382|NCT01500629|19077600|P2|STARTED|Washout Period of 14 to 30 Days||10
7748383|NCT01500629|19077601|P1|STARTED|Washout Period of 14 to 30 Days||11
7748384|NCT01500629|19077600|P2|NOT COMPLETED|Period 1 (Single Dose)||0
7748385|NCT01500629|19077601|P1|NOT COMPLETED|Period 1 (Single Dose)||0
7748386|NCT01500629|19077600|P2|COMPLETED|Period 1 (Single Dose)||10
7748387|NCT01500629|19077601|P1|COMPLETED|Period 1 (Single Dose)||11
7748388|NCT01500629|19077600|P2|STARTED|Period 1 (Single Dose)||10
7748389|NCT01500629|19077601|P1|STARTED|Period 1 (Single Dose)||11
7748390|NCT01500434|19077685|P1|NOT COMPLETED|Overall Study||7
7748391|NCT01500434|19077685|P1|COMPLETED|Overall Study||95
7748392|NCT01500434|19077685|P1|STARTED|Overall Study||102
7748393|NCT01500382|19077718|P4|NOT COMPLETED|Treatment Period 2||0
7748394|NCT01500382|19077719|P3|NOT COMPLETED|Treatment Period 2||0
7748395|NCT01500382|19077720|P2|NOT COMPLETED|Treatment Period 2||0
7748396|NCT01500382|19077721|P1|NOT COMPLETED|Treatment Period 2||0
7748397|NCT01500382|19077718|P4|COMPLETED|Treatment Period 2||1
7748398|NCT01500382|19077719|P3|COMPLETED|Treatment Period 2||0
7748399|NCT01500382|19077720|P2|COMPLETED|Treatment Period 2||1
7748400|NCT01500382|19077721|P1|COMPLETED|Treatment Period 2||1
7748401|NCT01500382|19077718|P4|STARTED|Treatment Period 2||1
7748402|NCT01500382|19077719|P3|STARTED|Treatment Period 2||0
7748403|NCT01500382|19077720|P2|STARTED|Treatment Period 2||1
7748404|NCT01500382|19077721|P1|STARTED|Treatment Period 2||1
7748405|NCT01500382|19077718|P4|NOT COMPLETED|Washout Period||0
7748406|NCT01500382|19077719|P3|NOT COMPLETED|Washout Period||1
7748407|NCT01500382|19077720|P2|NOT COMPLETED|Washout Period||0
7748408|NCT01500382|19077721|P1|NOT COMPLETED|Washout Period||0
7748409|NCT01500382|19077718|P4|COMPLETED|Washout Period||1
7748410|NCT01500382|19077719|P3|COMPLETED|Washout Period||0
7748411|NCT01500382|19077720|P2|COMPLETED|Washout Period||1
7748412|NCT01500382|19077721|P1|COMPLETED|Washout Period||1
7748413|NCT01500382|19077718|P4|STARTED|Washout Period||1
7748414|NCT01500382|19077719|P3|STARTED|Washout Period||1
7748415|NCT01500382|19077720|P2|STARTED|Washout Period||1
7748416|NCT01500382|19077721|P1|STARTED|Washout Period||1
7748417|NCT01500382|19077718|P4|NOT COMPLETED|Treatment Period 1||0
7748418|NCT01500382|19077719|P3|NOT COMPLETED|Treatment Period 1||0
7748419|NCT01500382|19077720|P2|NOT COMPLETED|Treatment Period 1||0
7748420|NCT01500382|19077721|P1|NOT COMPLETED|Treatment Period 1||0
7748421|NCT01500382|19077718|P4|COMPLETED|Treatment Period 1||1
7748422|NCT01500382|19077719|P3|COMPLETED|Treatment Period 1||1
7748423|NCT01500382|19077720|P2|COMPLETED|Treatment Period 1||1
7748424|NCT01500382|19077721|P1|COMPLETED|Treatment Period 1||1
7748425|NCT01500382|19077718|P4|STARTED|Treatment Period 1||1
7748426|NCT01500382|19077719|P3|STARTED|Treatment Period 1||1
7748427|NCT01500382|19077720|P2|STARTED|Treatment Period 1||1
7748428|NCT01500382|19077721|P1|STARTED|Treatment Period 1||1
7748429|NCT01500317|19077746|P3|NOT COMPLETED|Overall Study||0
7748430|NCT01500317|19077747|P2|NOT COMPLETED|Overall Study||2
7748431|NCT01500317|19077748|P1|NOT COMPLETED|Overall Study||3
7748432|NCT01500317|19077746|P3|COMPLETED|Overall Study||13
7748433|NCT01500317|19077747|P2|COMPLETED|Overall Study||10
7748434|NCT01500317|19077748|P1|COMPLETED|Overall Study||10
7748435|NCT01500317|19077746|P3|STARTED|Overall Study||13
7748436|NCT01500317|19077747|P2|STARTED|Overall Study||12
7748437|NCT01500317|19077748|P1|STARTED|Overall Study||13
7748438|NCT01500278|19077770|P2|NOT COMPLETED|Week 13 - Week 104||126
7748439|NCT01500278|19077771|P1|NOT COMPLETED|Week 13 - Week 104||139
7748440|NCT01500278|19077770|P2|COMPLETED|Week 13 - Week 104||302
7748441|NCT01500278|19077771|P1|COMPLETED|Week 13 - Week 104||287
7748442|NCT01500278|19077770|P2|STARTED|Week 13 - Week 104||428
7748443|NCT01500278|19077771|P1|STARTED|Week 13 - Week 104||426
7748444|NCT01500278|19077770|P2|NOT COMPLETED|Week 0 - Week 12||30
7748445|NCT01500278|19077771|P1|NOT COMPLETED|Week 0 - Week 12||31
7748446|NCT01500278|19077770|P2|COMPLETED|Week 0 - Week 12||428
7748447|NCT01500278|19077771|P1|COMPLETED|Week 0 - Week 12||426
7748448|NCT01500278|19077770|P2|STARTED|Week 0 - Week 12||458
7748449|NCT01500278|19077771|P1|STARTED|Week 0 - Week 12||457
7748450|NCT01500252|19077795|P2|NOT COMPLETED|Overall Study||6
7748451|NCT01500252|19077796|P1|NOT COMPLETED|Overall Study||9
7748452|NCT01500252|19077795|P2|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11
7748453|NCT01500252|19077796|P1|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12
7748454|NCT01500252|19077795|P2|Ten Years|Overall Study||11
7748455|NCT01500252|19077796|P1|Ten Years|Overall Study||12
7748456|NCT01500252|19077795|P2|Five Years|Overall Study||13
7748457|NCT01500252|19077796|P1|Five Years|Overall Study||17
7748458|NCT01500252|19077795|P2|One Years|Overall Study||16
7748459|NCT01500252|19077796|P1|One Years|Overall Study||20
7748460|NCT01500252|19077795|P2|STARTED|Overall Study||17
7748461|NCT01500252|19077796|P1|STARTED|Overall Study||21
7748462|NCT01500226|19077822|P2|NOT COMPLETED|Overall Study||494
7748463|NCT01500226|19077823|P1|NOT COMPLETED|Overall Study||499
7748464|NCT01500226|19077822|P2|COMPLETED|Overall Study||191
7748465|NCT01500226|19077823|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185
7748466|NCT01500226|19077822|P2|STARTED|Overall Study||685
7748467|NCT01500226|19077823|P1|STARTED|Overall Study|Number of randomized patients|684
7748468|NCT01500213|19077835|P2|NOT COMPLETED|Overall Study||224
7748469|NCT01500213|19077836|P1|NOT COMPLETED|Overall Study||217
7748470|NCT01500213|19077835|P2|COMPLETED|Overall Study||53
7748471|NCT01500213|19077836|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61
7748472|NCT01500213|19077835|P2|STARTED|Overall Study||277
7748473|NCT01500213|19077836|P1|STARTED|Overall Study|Number of randomized patients|278
7748474|NCT01500200|19077849|P6|NOT COMPLETED|Stage 2||4
7748475|NCT01500200|19077850|P5|NOT COMPLETED|Stage 2||5
7748476|NCT01500200|19077851|P4|NOT COMPLETED|Stage 2||0
7748477|NCT01500200|19077852|P3|NOT COMPLETED|Stage 2||0
7748478|NCT01500200|19077853|P2|NOT COMPLETED|Stage 2||0
7748479|NCT01500200|19077854|P1|NOT COMPLETED|Stage 2||0
7748480|NCT01500200|19077849|P6|COMPLETED|Stage 2||18
7748481|NCT01500200|19077850|P5|COMPLETED|Stage 2||18
7748482|NCT01500200|19077851|P4|COMPLETED|Stage 2||20
7748483|NCT01500200|19077852|P3|COMPLETED|Stage 2||0
7748484|NCT01500200|19077853|P2|COMPLETED|Stage 2||0
7748485|NCT01500200|19077854|P1|COMPLETED|Stage 2||0
7748486|NCT01500200|19077849|P6|STARTED|Stage 2||22
7748487|NCT01500200|19077850|P5|STARTED|Stage 2||23
7748488|NCT01500200|19077851|P4|STARTED|Stage 2||20
7748489|NCT01500200|19077852|P3|STARTED|Stage 2||0
7748490|NCT01500200|19077853|P2|STARTED|Stage 2||0
7748491|NCT01500200|19077854|P1|STARTED|Stage 2||0
7748492|NCT01500200|19077849|P6|NOT COMPLETED|Stage 1||0
7748493|NCT01500200|19077850|P5|NOT COMPLETED|Stage 1||0
7748494|NCT01500200|19077851|P4|NOT COMPLETED|Stage 1||0
7748495|NCT01500200|19077852|P3|NOT COMPLETED|Stage 1||6
7748496|NCT01500200|19077853|P2|NOT COMPLETED|Stage 1||6
7748497|NCT01500200|19077854|P1|NOT COMPLETED|Stage 1||8
7748498|NCT01500200|19077849|P6|COMPLETED|Stage 1||0
7748499|NCT01500200|19077850|P5|COMPLETED|Stage 1||0
7748500|NCT01500200|19077851|P4|COMPLETED|Stage 1||0
7748501|NCT01500200|19077852|P3|COMPLETED|Stage 1||13
7748502|NCT01500200|19077853|P2|COMPLETED|Stage 1||18
7748503|NCT01500200|19077854|P1|COMPLETED|Stage 1||90
7748504|NCT01500200|19077849|P6|STARTED|Stage 1||0
7748505|NCT01500200|19077850|P5|STARTED|Stage 1||0
7748506|NCT01500200|19077851|P4|STARTED|Stage 1||0
7748507|NCT01500200|19077852|P3|STARTED|Stage 1||19
7748508|NCT01500200|19077853|P2|STARTED|Stage 1||24
7748509|NCT01500200|19077854|P1|STARTED|Stage 1||98
7748510|NCT01500187|19077888|P2|NOT COMPLETED|Overall Study||0
7748511|NCT01500187|19077889|P1|NOT COMPLETED|Overall Study||6
7748512|NCT01500187|19077888|P2|COMPLETED|Overall Study||15
7748513|NCT01500187|19077889|P1|COMPLETED|Overall Study||17
7748514|NCT01500187|19077888|P2|STARTED|Overall Study||15
7748515|NCT01500187|19077889|P1|STARTED|Overall Study||23
7748516|NCT01500135|19077897|P2|NOT COMPLETED|Overall Study||11
7748517|NCT01500135|19077898|P1|NOT COMPLETED|Overall Study||17
7748518|NCT01500135|19077897|P2|COMPLETED|Overall Study||39
7748519|NCT01500135|19077898|P1|COMPLETED|Overall Study||83
7748520|NCT01500135|19077897|P2|STARTED|Overall Study||50
7748521|NCT01500135|19077898|P1|STARTED|Overall Study||100
7748522|NCT01500109|19077911|P3|NOT COMPLETED|Overall Study||0
7748523|NCT01500109|19077912|P2|NOT COMPLETED|Overall Study||0
7748524|NCT01500109|19077913|P1|NOT COMPLETED|Overall Study||0
7748525|NCT01500109|19077911|P3|COMPLETED|Overall Study||16
7748526|NCT01500109|19077912|P2|COMPLETED|Overall Study||14
7748527|NCT01500109|19077913|P1|COMPLETED|Overall Study||15
7748528|NCT01500109|19077911|P3|STARTED|Overall Study||16
7748529|NCT01500109|19077912|P2|STARTED|Overall Study||14
7748530|NCT01500109|19077913|P1|STARTED|Overall Study||15
7748531|NCT01500096|19077925|P4|NOT COMPLETED|Overall Study||2
7748532|NCT01500096|19077926|P3|NOT COMPLETED|Overall Study||0
7748533|NCT01500096|19077927|P2|NOT COMPLETED|Overall Study||0
7748534|NCT01500096|19077928|P1|NOT COMPLETED|Overall Study||1
7748535|NCT01500096|19077925|P4|COMPLETED|Overall Study||14
7748536|NCT01500096|19077926|P3|COMPLETED|Overall Study||31
7748537|NCT01500096|19077927|P2|COMPLETED|Overall Study||17
7748538|NCT01500096|19077928|P1|COMPLETED|Overall Study||31
7748539|NCT01500096|19077925|P4|STARTED|Overall Study||16
7748540|NCT01500096|19077926|P3|STARTED|Overall Study||31
7748541|NCT01500096|19077927|P2|STARTED|Overall Study||17
7748542|NCT01500096|19077928|P1|STARTED|Overall Study||32
7748543|NCT01500083|19077984|P2|NOT COMPLETED|Overall Study||43
7748544|NCT01500083|19077985|P1|NOT COMPLETED|Overall Study||12
7748545|NCT01500083|19077984|P2|COMPLETED|Overall Study||31
7748546|NCT01500083|19077985|P1|COMPLETED|Overall Study||4
7748547|NCT01500083|19077984|P2|STARTED|Overall Study||74
7748548|NCT01500083|19077985|P1|STARTED|Overall Study||16
7748549|NCT01500057|19077993|P2|NOT COMPLETED|Overall Study||4
7748550|NCT01500057|19077994|P1|NOT COMPLETED|Overall Study||6
7748551|NCT01500057|19077993|P2|COMPLETED|Overall Study||31
7748552|NCT01500057|19077994|P1|COMPLETED|Overall Study||25
7748553|NCT01500057|19077993|P2|STARTED|Overall Study||35
7748554|NCT01500057|19077994|P1|STARTED|Overall Study||31
7748555|NCT01500031|19078004|P1|NOT COMPLETED|Overall Study||5
7748556|NCT01500031|19078004|P1|COMPLETED|Overall Study||87
7748557|NCT01500031|19078004|P1|STARTED|Overall Study||92
7748558|NCT01499862|19078019|P1|NOT COMPLETED|Overall Study||0
7748559|NCT01499862|19078019|P1|COMPLETED|Overall Study||3
7748560|NCT01499862|19078019|P1|STARTED|Overall Study||3
7748561|NCT01499849|19078039|P2|NOT COMPLETED|Overall Study||226
7748562|NCT01499849|19078040|P1|NOT COMPLETED|Overall Study||224
7748563|NCT01499849|19078039|P2|COMPLETED|Overall Study||40
7748564|NCT01499849|19078040|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42
7748565|NCT01499849|19078039|P2|STARTED|Overall Study||266
7748566|NCT01499849|19078040|P1|STARTED|Overall Study|Number of randomized patients|266
7748567|NCT01499810|19078050|P1|NOT COMPLETED|Overall Study||12
7748568|NCT01499810|19078050|P1|COMPLETED|Overall Study||41
7748569|NCT01499810|19078050|P1|STARTED|Overall Study||53
7748570|NCT01499667|19078100|P3|NOT COMPLETED|Overall Study||10
7748571|NCT01499667|19078101|P2|NOT COMPLETED|Overall Study||11
7748572|NCT01499667|19078102|P1|NOT COMPLETED|Overall Study||9
7748573|NCT01499667|19078100|P3|COMPLETED|Overall Study||40
7748574|NCT01499667|19078101|P2|COMPLETED|Overall Study||31
7748575|NCT01499667|19078102|P1|COMPLETED|Overall Study||41
7748576|NCT01499667|19078100|P3|Modified Full Analysis Set|Overall Study||39
7748577|NCT01499667|19078101|P2|Modified Full Analysis Set|Overall Study||29
7748578|NCT01499667|19078102|P1|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41
7748579|NCT01499667|19078100|P3|Full Analysis Set (FAS)|Overall Study||50
7748580|NCT01499667|19078101|P2|Full Analysis Set (FAS)|Overall Study||42
7748581|NCT01499667|19078102|P1|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49
7748582|NCT01499667|19078100|P3|STARTED|Overall Study||50
7748583|NCT01499667|19078101|P2|STARTED|Overall Study||42
7748584|NCT01499667|19078102|P1|STARTED|Overall Study|"Started indicates randomized as well as safety population."|50
7748585|NCT01499654|19078131|P1|NOT COMPLETED|Overall Study||0
7748586|NCT01499654|19078131|P1|COMPLETED|Overall Study||64
7748587|NCT01499654|19078131|P1|STARTED|Overall Study||64
7748588|NCT01499576|19078150|P1|NOT COMPLETED|Overall Study||21
7748589|NCT01499576|19078150|P1|COMPLETED|Overall Study||105
7748590|NCT01499576|19078150|P1|STARTED|Overall Study||126
7748591|NCT01499511|19078158|P2|NOT COMPLETED|Overall Study||0
7748592|NCT01499511|19078159|P1|NOT COMPLETED|Overall Study||1
7748593|NCT01499511|19078158|P2|COMPLETED|Overall Study||833
7748594|NCT01499511|19078159|P1|COMPLETED|Overall Study||884
7748595|NCT01499511|19078158|P2|STARTED|Overall Study||833
7748596|NCT01499511|19078159|P1|STARTED|Overall Study||885
7748597|NCT01499498|19078176|P1|NOT COMPLETED|Overall Study||0
7748598|NCT01499498|19078176|P1|COMPLETED|Overall Study||13
7748599|NCT01499498|19078176|P1|STARTED|Overall Study||13
7748600|NCT01499368|19078187|P3|NOT COMPLETED|Overall Study||21
7748601|NCT01499368|19078188|P2|NOT COMPLETED|Overall Study||18
7748602|NCT01499368|19078189|P1|NOT COMPLETED|Overall Study||27
7748603|NCT01499368|19078187|P3|COMPLETED|Overall Study||146
7748604|NCT01499368|19078188|P2|COMPLETED|Overall Study||145
7748605|NCT01499368|19078189|P1|COMPLETED|Overall Study||138
7748606|NCT01499368|19078187|P3|STARTED|Overall Study||167
7748607|NCT01499368|19078188|P2|STARTED|Overall Study||163
7748608|NCT01499368|19078189|P1|STARTED|Overall Study||165
7748609|NCT01499355|19078206|P4|NOT COMPLETED|Double-Blind Period||23
7748610|NCT01499355|19078207|P3|NOT COMPLETED|Double-Blind Period||25
7748611|NCT01499355|19078208|P2|NOT COMPLETED|Double-Blind Period||23
7748612|NCT01499355|19078209|P1|NOT COMPLETED|Double-Blind Period||0
7748613|NCT01499355|19078206|P4|COMPLETED|Double-Blind Period||39
7748614|NCT01499355|19078207|P3|COMPLETED|Double-Blind Period||38
7748615|NCT01499355|19078208|P2|COMPLETED|Double-Blind Period||40
7748616|NCT01499355|19078209|P1|COMPLETED|Double-Blind Period||0
7748617|NCT01499355|19078206|P4|STARTED|Double-Blind Period||62
7748618|NCT01499355|19078207|P3|STARTED|Double-Blind Period||63
7748619|NCT01499355|19078208|P2|STARTED|Double-Blind Period||63
7748620|NCT01499355|19078209|P1|STARTED|Double-Blind Period||0
7748621|NCT01499355|19078206|P4|NOT COMPLETED|Run-In Period||0
7748622|NCT01499355|19078207|P3|NOT COMPLETED|Run-In Period||0
7748623|NCT01499355|19078208|P2|NOT COMPLETED|Run-In Period||0
7748624|NCT01499355|19078209|P1|NOT COMPLETED|Run-In Period||31
7748625|NCT01499355|19078206|P4|COMPLETED|Run-In Period||0
7748626|NCT01499355|19078207|P3|COMPLETED|Run-In Period||0
7748627|NCT01499355|19078208|P2|COMPLETED|Run-In Period||0
7748628|NCT01499355|19078209|P1|COMPLETED|Run-In Period||245
7748629|NCT01499355|19078206|P4|STARTED|Run-In Period||0
7748630|NCT01499355|19078207|P3|STARTED|Run-In Period||0
7748631|NCT01499355|19078208|P2|STARTED|Run-In Period||0
7748632|NCT01499355|19078209|P1|STARTED|Run-In Period||276
7748633|NCT01499303|19078242|P2|NOT COMPLETED|Overall Study||7
7748634|NCT01499303|19078243|P1|NOT COMPLETED|Overall Study||3
7748635|NCT01499303|19078242|P2|COMPLETED|Overall Study||40
7748636|NCT01499303|19078243|P1|COMPLETED|Overall Study||18
7748637|NCT01499303|19078242|P2|STARTED|Overall Study||47
7748638|NCT01499303|19078243|P1|STARTED|Overall Study||21
7748639|NCT01499290|19078251|P2|NOT COMPLETED|Overall Study||35
7748640|NCT01499290|19078252|P1|NOT COMPLETED|Overall Study||55
7748641|NCT01499290|19078251|P2|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494
7748642|NCT01499290|19078252|P1|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474
7748643|NCT01499290|19078251|P2|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
7748644|NCT01499290|19078252|P1|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
7748645|NCT01499277|19078302|P2|NOT COMPLETED|Overall Study||32
7748646|NCT01499277|19078303|P1|NOT COMPLETED|Overall Study||47
7748647|NCT01499277|19078302|P2|COMPLETED|Overall Study||223
7748648|NCT01499277|19078303|P1|COMPLETED|Overall Study||459
7748649|NCT01499277|19078302|P2|STARTED|Overall Study||255
7748650|NCT01499277|19078303|P1|STARTED|Overall Study||506
7748651|NCT01499199|19078325|P1|NOT COMPLETED|Overall Study||2
7748652|NCT01499199|19078325|P1|COMPLETED|Overall Study||11
7748653|NCT01499199|19078325|P1|STARTED|Overall Study||13
7748654|NCT01499173|19078344|P1|NOT COMPLETED|Overall Study||37
7748655|NCT01499173|19078344|P1|COMPLETED|Overall Study||64
7748656|NCT01499173|19078344|P1|STARTED|Overall Study||101
7748657|NCT01499160|19078354|P1|NOT COMPLETED|Overall Study||2
7748658|NCT01499160|19078354|P1|COMPLETED|Overall Study|"1 pt-withdrew consent
~1pt-had cardiac toxicity"|5
7748659|NCT01499160|19078354|P1|STARTED|Overall Study||7
7748660|NCT01499147|19078361|P2|NOT COMPLETED|Overall Study||5
7748661|NCT01499147|19078362|P1|NOT COMPLETED|Overall Study||15
7748662|NCT01499147|19078361|P2|COMPLETED|Overall Study||12
7748663|NCT01499147|19078362|P1|COMPLETED|Overall Study||18
7748664|NCT01499147|19078361|P2|STARTED|Overall Study||17
7748665|NCT01499147|19078362|P1|STARTED|Overall Study||33
7748666|NCT01499134|19078377|P2|NOT COMPLETED|Overall Study||1
7748667|NCT01499134|19078378|P1|NOT COMPLETED|Overall Study||0
7748668|NCT01499134|19078377|P2|COMPLETED|Overall Study||7
7748669|NCT01499134|19078378|P1|COMPLETED|Overall Study||9
7748670|NCT01499134|19078377|P2|STARTED|Overall Study||8
7748671|NCT01499134|19078378|P1|STARTED|Overall Study||9
7748672|NCT01499095|19078400|P2|NOT COMPLETED|Overall Study||93
7748673|NCT01499095|19078401|P1|NOT COMPLETED|Overall Study||89
7748674|NCT01499095|19078400|P2|COMPLETED|Overall Study||314
7748675|NCT01499095|19078401|P1|COMPLETED|Overall Study||315
7748676|NCT01499095|19078400|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405
7748677|NCT01499095|19078401|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403
7748678|NCT01499095|19078400|P2|Participated in Substudy|Overall Study||0
7748679|NCT01499095|19078401|P1|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89
7748680|NCT01499095|19078400|P2|Treated|Overall Study||406
7748681|NCT01499095|19078401|P1|Treated|Overall Study||403
7748682|NCT01499095|19078400|P2|STARTED|Overall Study||407
7748683|NCT01499095|19078401|P1|STARTED|Overall Study||404
7748684|NCT01499082|19078431|P2|NOT COMPLETED|Overall Study||48
7748685|NCT01499082|19078432|P1|NOT COMPLETED|Overall Study||45
7748686|NCT01499082|19078431|P2|COMPLETED|Overall Study||355
7748687|NCT01499082|19078432|P1|COMPLETED|Overall Study||359
7748688|NCT01499082|19078431|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400
7748689|NCT01499082|19078432|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404
7748690|NCT01499082|19078431|P2|Participated in Substudy|Overall Study||0
7748691|NCT01499082|19078432|P1|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109
7748692|NCT01499082|19078431|P2|Treated|Overall Study||402
7748693|NCT01499082|19078432|P1|Treated|Overall Study||404
7748694|NCT01499082|19078431|P2|STARTED|Overall Study||403
7748695|NCT01499082|19078432|P1|STARTED|Overall Study||404
7748696|NCT01499043|19078460|P1|NOT COMPLETED|Overall Study||6
7748697|NCT01499043|19078460|P1|COMPLETED|Overall Study||0
7748698|NCT01499043|19078460|P1|STARTED|Overall Study||6
7748699|NCT01498991|19078470|P1|NOT COMPLETED|Overall Study||0
7748700|NCT01498991|19078470|P1|COMPLETED|Overall Study||2
7748701|NCT01498991|19078470|P1|STARTED|Overall Study||2
7748702|NCT01498978|19078481|P1|NOT COMPLETED|Overall Study||2
7748703|NCT01498978|19078481|P1|COMPLETED|Overall Study||8
7748704|NCT01498978|19078481|P1|STARTED|Overall Study||10
7748705|NCT01498952|19078503|P5|NOT COMPLETED|Overall Study||0
7748706|NCT01498952|19078504|P4|NOT COMPLETED|Overall Study||0
7748707|NCT01498952|19078505|P3|NOT COMPLETED|Overall Study||0
7748708|NCT01498952|19078506|P2|NOT COMPLETED|Overall Study||2
7748709|NCT01498952|19078507|P1|NOT COMPLETED|Overall Study||2
7748710|NCT01498952|19078503|P5|COMPLETED|Overall Study||0
7748711|NCT01498952|19078504|P4|COMPLETED|Overall Study||0
7748712|NCT01498952|19078505|P3|COMPLETED|Overall Study||0
7748713|NCT01498952|19078506|P2|COMPLETED|Overall Study||1
7748714|NCT01498952|19078507|P1|COMPLETED|Overall Study||1
7748715|NCT01498952|19078503|P5|STARTED|Overall Study||0
7748716|NCT01498952|19078504|P4|STARTED|Overall Study||0
7748717|NCT01498952|19078505|P3|STARTED|Overall Study||0
7748718|NCT01498952|19078506|P2|STARTED|Overall Study||3
7748719|NCT01498952|19078507|P1|STARTED|Overall Study||3
7748720|NCT01498887|19078549|P2|NOT COMPLETED|Overall Study||11
7748721|NCT01498887|19078550|P1|NOT COMPLETED|Overall Study||16
7748722|NCT01498887|19078549|P2|COMPLETED|Overall Study||136
7748723|NCT01498887|19078550|P1|COMPLETED|Overall Study||184
7748724|NCT01498887|19078549|P2|Intent-to-treat|Overall Study||135
7748725|NCT01498887|19078550|P1|Intent-to-treat|Overall Study||185
7748726|NCT01498887|19078549|P2|Safety Set|Overall Study||147
7748727|NCT01498887|19078550|P1|Safety Set|Overall Study||200
7748728|NCT01498887|19078549|P2|STARTED|Overall Study||147
7748729|NCT01498887|19078550|P1|STARTED|Overall Study||200
7748730|NCT01498822|19078571|P2|NOT COMPLETED|Overall Study||56
7748731|NCT01498822|19078572|P1|NOT COMPLETED|Overall Study||54
7748732|NCT01498822|19078571|P2|COMPLETED|Overall Study||122
7748733|NCT01498822|19078572|P1|COMPLETED|Overall Study||121
7748734|NCT01498822|19078571|P2|STARTED|Overall Study||178
7748735|NCT01498822|19078572|P1|STARTED|Overall Study||175
7748736|NCT01498744|19078586|P2|NOT COMPLETED|Overall Study||0
7748737|NCT01498744|19078587|P1|NOT COMPLETED|Overall Study||0
7748738|NCT01498744|19078586|P2|COMPLETED|Overall Study||31
7748739|NCT01498744|19078587|P1|COMPLETED|Overall Study||22
7748740|NCT01498744|19078586|P2|STARTED|Overall Study||31
7748741|NCT01498744|19078587|P1|STARTED|Overall Study||22
7748742|NCT01498692|19078599|P1|NOT COMPLETED|Overall Study||8
7748743|NCT01498692|19078599|P1|COMPLETED|Overall Study||86
7748744|NCT01498692|19078599|P1|STARTED|Overall Study||94
7748745|NCT01498679|19078630|P2|NOT COMPLETED|Overall Study||22
7748746|NCT01498679|19078631|P1|NOT COMPLETED|Overall Study||89
7748747|NCT01498679|19078630|P2|COMPLETED|Overall Study||131
7748748|NCT01498679|19078631|P1|COMPLETED|Overall Study||65
7748749|NCT01498679|19078630|P2|STARTED|Overall Study||153
7748750|NCT01498679|19078631|P1|STARTED|Overall Study||154
7748751|NCT01498653|19078647|P2|NOT COMPLETED|Overall Study||35
7748752|NCT01498653|19078648|P1|NOT COMPLETED|Overall Study||19
7748753|NCT01498653|19078647|P2|COMPLETED|Overall Study||119
7748754|NCT01498653|19078648|P1|COMPLETED|Overall Study||136
7748755|NCT01498653|19078647|P2|STARTED|Overall Study||154
7748756|NCT01498653|19078648|P1|STARTED|Overall Study||155
7748757|NCT01498640|19078662|P1|NOT COMPLETED|Overall Study||5
7748758|NCT01498640|19078662|P1|COMPLETED|Overall Study||47
7748759|NCT01498640|19078662|P1|STARTED|Overall Study||52
7748760|NCT01498601|19078678|P2|NOT COMPLETED|Overall Study||0
7748761|NCT01498601|19078679|P1|NOT COMPLETED|Overall Study||0
7748762|NCT01498601|19078678|P2|COMPLETED|Overall Study||32
7748763|NCT01498601|19078679|P1|COMPLETED|Overall Study||51
7748764|NCT01498601|19078678|P2|STARTED|Overall Study||32
7748765|NCT01498601|19078679|P1|STARTED|Overall Study||51
7748766|NCT01498588|19078685|P1|NOT COMPLETED|Overall Study||0
7748767|NCT01498588|19078685|P1|COMPLETED|Overall Study||7
7748768|NCT01498588|19078685|P1|STARTED|Overall Study||7
7748769|NCT01498575|19078692|P2|NOT COMPLETED|On the Road Driving Assessment (ODA)||24
7748770|NCT01498575|19078693|P1|NOT COMPLETED|On the Road Driving Assessment (ODA)||42
7748771|NCT01498575|19078692|P2|COMPLETED|On the Road Driving Assessment (ODA)||65
7748772|NCT01498575|19078693|P1|COMPLETED|On the Road Driving Assessment (ODA)||86
7748773|NCT01498575|19078692|P2|STARTED|On the Road Driving Assessment (ODA)||89
7748774|NCT01498575|19078693|P1|STARTED|On the Road Driving Assessment (ODA)||128
7748775|NCT01498575|19078692|P2|NOT COMPLETED|Overall Sample||14
7748776|NCT01498575|19078693|P1|NOT COMPLETED|Overall Sample||60
7748777|NCT01498575|19078692|P2|COMPLETED|Overall Sample||400
7748778|NCT01498575|19078693|P1|COMPLETED|Overall Sample||550
7748779|NCT01498575|19078692|P2|STARTED|Overall Sample||414
7748780|NCT01498575|19078693|P1|STARTED|Overall Sample||610
7748781|NCT01498549|19078699|P1|NOT COMPLETED|Overall Study||4
7748782|NCT01498549|19078699|P1|COMPLETED|Overall Study||35
7748783|NCT01498549|19078699|P1|Sugar Pill 0 mg|Overall Study||36
7748784|NCT01498549|19078699|P1|Atomoxetine 80 mg|Overall Study||37
7748785|NCT01498549|19078699|P1|Atomoxetine 40 mg|Overall Study||39
7748786|NCT01498549|19078699|P1|STARTED|Overall Study||39
7748787|NCT01498458|19078710|P1|NOT COMPLETED|Overall Study||7
7748788|NCT01498458|19078710|P1|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1
7748789|NCT01498458|19078710|P1|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8
7748790|NCT01498445|19078725|P6|NOT COMPLETED|Overall Study||1
7748791|NCT01498445|19078726|P5|NOT COMPLETED|Overall Study||1
7748792|NCT01498445|19078727|P4|NOT COMPLETED|Overall Study||2
7748793|NCT01498445|19078728|P3|NOT COMPLETED|Overall Study||1
7748794|NCT01498445|19078729|P2|NOT COMPLETED|Overall Study||0
7748795|NCT01498445|19078730|P1|NOT COMPLETED|Overall Study||0
7748796|NCT01498445|19078725|P6|COMPLETED|Overall Study||4
7748797|NCT01498445|19078726|P5|COMPLETED|Overall Study||3
7748798|NCT01498445|19078727|P4|COMPLETED|Overall Study||6
7748799|NCT01498445|19078728|P3|COMPLETED|Overall Study||7
7748800|NCT01498445|19078729|P2|COMPLETED|Overall Study||3
7748801|NCT01498445|19078730|P1|COMPLETED|Overall Study||4
7748802|NCT01498445|19078725|P6|STARTED|Overall Study||5
7748803|NCT01498445|19078726|P5|STARTED|Overall Study||4
7748804|NCT01498445|19078727|P4|STARTED|Overall Study||8
7748805|NCT01498445|19078728|P3|STARTED|Overall Study||8
7748806|NCT01498445|19078729|P2|STARTED|Overall Study||3
7748807|NCT01498445|19078730|P1|STARTED|Overall Study||4
7748808|NCT01498419|19078766|P4|NOT COMPLETED|Overall Study||19
7748809|NCT01498419|19078767|P3|NOT COMPLETED|Overall Study||18
7748810|NCT01498419|19078768|P2|NOT COMPLETED|Overall Study||23
7748811|NCT01498419|19078769|P1|NOT COMPLETED|Overall Study||18
7748812|NCT01498419|19078766|P4|COMPLETED|Overall Study||7
7748813|NCT01498419|19078767|P3|COMPLETED|Overall Study||41
7748814|NCT01498419|19078768|P2|COMPLETED|Overall Study||39
7748815|NCT01498419|19078769|P1|COMPLETED|Overall Study||42
7748816|NCT01498419|19078766|P4|STARTED|Overall Study||26
7748817|NCT01498419|19078767|P3|STARTED|Overall Study||59
7748818|NCT01498419|19078768|P2|STARTED|Overall Study||62
7748819|NCT01498419|19078769|P1|STARTED|Overall Study||60
7748820|NCT01498289|19078805|P2|NOT COMPLETED|Overall Study||104
7748821|NCT01498289|19078806|P1|NOT COMPLETED|Overall Study||98
7748822|NCT01498289|19078805|P2|COMPLETED|Overall Study||0
7748823|NCT01498289|19078806|P1|COMPLETED|Overall Study||0
7748824|NCT01498289|19078805|P2|Participants Assessed for AEs|Overall Study||98
7748825|NCT01498289|19078806|P1|Participants Assessed for AEs|Overall Study||91
7748826|NCT01498289|19078805|P2|STARTED|Overall Study||104
7748827|NCT01498289|19078806|P1|STARTED|Overall Study||98
7748828|NCT01498185|19078827|P5|NOT COMPLETED|Overall Study||3
7748829|NCT01498185|19078828|P4|NOT COMPLETED|Overall Study||3
7748830|NCT01498185|19078829|P3|NOT COMPLETED|Overall Study||0
7748831|NCT01498185|19078830|P2|NOT COMPLETED|Overall Study||1
7748832|NCT01498185|19078831|P1|NOT COMPLETED|Overall Study||1
7748833|NCT01498185|19078827|P5|COMPLETED|Overall Study||12
7748834|NCT01498185|19078828|P4|COMPLETED|Overall Study||11
7748835|NCT01498185|19078829|P3|COMPLETED|Overall Study||15
7748836|NCT01498185|19078830|P2|COMPLETED|Overall Study||12
7748837|NCT01498185|19078831|P1|COMPLETED|Overall Study||12
7748838|NCT01498185|19078827|P5|STARTED|Overall Study||15
7748839|NCT01498185|19078828|P4|STARTED|Overall Study||14
7748840|NCT01498185|19078829|P3|STARTED|Overall Study||15
7748841|NCT01498185|19078830|P2|STARTED|Overall Study||13
7748842|NCT01498185|19078831|P1|STARTED|Overall Study||13
7748843|NCT01498120|19078871|P1|NOT COMPLETED|Overall Study||13
7748844|NCT01498120|19078871|P1|COMPLETED|Overall Study||1
7748845|NCT01498120|19078871|P1|STARTED|Overall Study||14
7748846|NCT01498068|19078878|P2|NOT COMPLETED|Overall Study||1
7748847|NCT01498068|19078879|P1|NOT COMPLETED|Overall Study||1
7748848|NCT01498068|19078878|P2|COMPLETED|Overall Study||19
7748849|NCT01498068|19078879|P1|COMPLETED|Overall Study||15
7748850|NCT01498068|19078878|P2|STARTED|Overall Study||20
7748851|NCT01498068|19078879|P1|STARTED|Overall Study||16
7748852|NCT01497938|19078897|P2|NOT COMPLETED|Overall Study||2
7748853|NCT01497938|19078898|P1|NOT COMPLETED|Overall Study||5
7748854|NCT01497938|19078897|P2|COMPLETED|Overall Study||124
7748855|NCT01497938|19078898|P1|COMPLETED|Overall Study||116
7748856|NCT01497938|19078897|P2|STARTED|Overall Study||126
7748857|NCT01497938|19078898|P1|STARTED|Overall Study||121
7748858|NCT01497899|19078910|P4|NOT COMPLETED|Open-Label Extension Phase||5
7748859|NCT01497899|19078911|P3|NOT COMPLETED|Open-Label Extension Phase||9
7748860|NCT01497899|19078912|P2|NOT COMPLETED|Open-Label Extension Phase||7
7748861|NCT01497899|19078913|P1|NOT COMPLETED|Open-Label Extension Phase||19
7748862|NCT01497899|19078910|P4|COMPLETED|Open-Label Extension Phase||33
7748863|NCT01497899|19078911|P3|COMPLETED|Open-Label Extension Phase||61
7748864|NCT01497899|19078912|P2|COMPLETED|Open-Label Extension Phase||46
7748865|NCT01497899|19078913|P1|COMPLETED|Open-Label Extension Phase||86
7748866|NCT01497899|19078910|P4|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|38
7748867|NCT01497899|19078911|P3|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|70
7748868|NCT01497899|19078912|P2|STARTED|Open-Label Extension Phase||53
7748869|NCT01497899|19078913|P1|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105
7748870|NCT01497899|19078910|P4|NOT COMPLETED|Double-Blind Phase||0
7748871|NCT01497899|19078911|P3|NOT COMPLETED|Double-Blind Phase||0
7748872|NCT01497899|19078912|P2|NOT COMPLETED|Double-Blind Phase||5
7748873|NCT01497899|19078913|P1|NOT COMPLETED|Double-Blind Phase||6
7748874|NCT01497899|19078910|P4|COMPLETED|Double-Blind Phase||0
7748875|NCT01497899|19078911|P3|COMPLETED|Double-Blind Phase||0
7748876|NCT01497899|19078912|P2|COMPLETED|Double-Blind Phase||53
7748877|NCT01497899|19078913|P1|COMPLETED|Double-Blind Phase||107
7748878|NCT01497899|19078910|P4|STARTED|Double-Blind Phase||0
7748879|NCT01497899|19078911|P3|STARTED|Double-Blind Phase||0
7748880|NCT01497899|19078912|P2|STARTED|Double-Blind Phase||58
7748881|NCT01497899|19078913|P1|STARTED|Double-Blind Phase||113
7748882|NCT01497860|19078926|P1|NOT COMPLETED|Overall Study||0
7748883|NCT01497860|19078926|P1|COMPLETED|Overall Study||12
7748884|NCT01497860|19078926|P1|STARTED|Overall Study||12
7748885|NCT01497756|19078930|P1|NOT COMPLETED|Overall Study||0
7748886|NCT01497756|19078930|P1|COMPLETED|Overall Study||10
7748887|NCT01497756|19078930|P1|STARTED|Overall Study||10
7748888|NCT01497665|19078935|P1|NOT COMPLETED|Overall Study||0
7748889|NCT01497665|19078935|P1|COMPLETED|Overall Study||16
7748890|NCT01497665|19078935|P1|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10
7748891|NCT01497665|19078935|P1|STARTED|Overall Study||16
7748892|NCT01497613|19078945|P2|NOT COMPLETED|Overall Study||19
7748893|NCT01497613|19078946|P1|NOT COMPLETED|Overall Study||37
7748894|NCT01497613|19078945|P2|COMPLETED|Overall Study||131
7748895|NCT01497613|19078946|P1|COMPLETED|Overall Study||113
7748896|NCT01497613|19078945|P2|STARTED|Overall Study||150
7748897|NCT01497613|19078946|P1|STARTED|Overall Study||150
7748898|NCT01497496|19078982|P1|NOT COMPLETED|Overall Study||0
7748899|NCT01497496|19078982|P1|COMPLETED|Overall Study||29
7748900|NCT01497496|19078982|P1|STARTED|Overall Study||29
7748901|NCT01497366|19078990|P2|NOT COMPLETED|Overall Study||88
7748902|NCT01497366|19078991|P1|NOT COMPLETED|Overall Study||39
7748903|NCT01497366|19078990|P2|COMPLETED|Overall Study||176
7748904|NCT01497366|19078991|P1|COMPLETED|Overall Study||224
7748905|NCT01497366|19078990|P2|Randomized But Not Treated|Overall Study||21
7748906|NCT01497366|19078991|P1|Randomized But Not Treated|Overall Study||7
7748907|NCT01497366|19078990|P2|STARTED|Overall Study||264
7748908|NCT01497366|19078991|P1|STARTED|Overall Study||263
7748909|NCT01497275|19079009|P1|NOT COMPLETED|Overall Study||2
7748910|NCT01497275|19079009|P1|COMPLETED|Overall Study||3
7748911|NCT01497275|19079009|P1|STARTED|Overall Study||5
7748912|NCT01497262|19079016|P1|NOT COMPLETED|Overall Study||11
7748913|NCT01497262|19079016|P1|COMPLETED|Overall Study||151
7748914|NCT01497262|19079016|P1|STARTED|Overall Study||162
7748915|NCT01497197|19079023|P2|NOT COMPLETED|Overall Study||15
7748916|NCT01497197|19079024|P1|NOT COMPLETED|Overall Study||17
7748917|NCT01497197|19079023|P2|COMPLETED|Overall Study||70
7748918|NCT01497197|19079024|P1|COMPLETED|Overall Study||72
7748919|NCT01497197|19079023|P2|STARTED|Overall Study||85
7748920|NCT01497197|19079024|P1|STARTED|Overall Study||89
7748921|NCT01497171|19079052|P2|NOT COMPLETED|Overall Study||0
7748922|NCT01497171|19079053|P1|NOT COMPLETED|Overall Study||0
7748923|NCT01497171|19079052|P2|COMPLETED|Overall Study||3
7748924|NCT01497171|19079053|P1|COMPLETED|Overall Study||2
7748925|NCT01497171|19079052|P2|STARTED|Overall Study||3
7748926|NCT01497171|19079053|P1|STARTED|Overall Study||2
7748927|NCT01497067|19079059|P1|NOT COMPLETED|Overall Study||82
7748928|NCT01497067|19079059|P1|COMPLETED|Overall Study||575
7748929|NCT01497067|19079059|P1|STARTED|Overall Study||657
7748930|NCT01496846|19079070|P6|NOT COMPLETED|Supplemental Buccal Infiltration||0
7748931|NCT01496846|19079071|P5|NOT COMPLETED|Supplemental Buccal Infiltration||0
7748932|NCT01496846|19079072|P4|NOT COMPLETED|Supplemental Buccal Infiltration||0
7748933|NCT01496846|19079073|P3|NOT COMPLETED|Supplemental Buccal Infiltration||0
7748934|NCT01496846|19079074|P2|NOT COMPLETED|Supplemental Buccal Infiltration||0
7748935|NCT01496846|19079075|P1|NOT COMPLETED|Supplemental Buccal Infiltration||0
7748936|NCT01496846|19079070|P6|COMPLETED|Supplemental Buccal Infiltration||38
7748937|NCT01496846|19079071|P5|COMPLETED|Supplemental Buccal Infiltration||35
7748938|NCT01496846|19079072|P4|COMPLETED|Supplemental Buccal Infiltration||40
7748939|NCT01496846|19079073|P3|COMPLETED|Supplemental Buccal Infiltration||36
7748940|NCT01496846|19079074|P2|COMPLETED|Supplemental Buccal Infiltration||0
7748941|NCT01496846|19079075|P1|COMPLETED|Supplemental Buccal Infiltration||0
7748942|NCT01496846|19079070|P6|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|38
7748943|NCT01496846|19079071|P5|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|35
7748944|NCT01496846|19079072|P4|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|40
7748945|NCT01496846|19079073|P3|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|36
7748946|NCT01496846|19079074|P2|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
7748947|NCT01496846|19079075|P1|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
7748948|NCT01496846|19079070|P6|NOT COMPLETED|IANB Articaine (All Participants)||0
7748949|NCT01496846|19079071|P5|NOT COMPLETED|IANB Articaine (All Participants)||0
7748950|NCT01496846|19079072|P4|NOT COMPLETED|IANB Articaine (All Participants)||0
7748951|NCT01496846|19079073|P3|NOT COMPLETED|IANB Articaine (All Participants)||0
7748952|NCT01496846|19079074|P2|NOT COMPLETED|IANB Articaine (All Participants)||1
7748953|NCT01496846|19079075|P1|NOT COMPLETED|IANB Articaine (All Participants)||1
7748954|NCT01496846|19079070|P6|COMPLETED|IANB Articaine (All Participants)||38
7748955|NCT01496846|19079071|P5|COMPLETED|IANB Articaine (All Participants)||35
7748956|NCT01496846|19079072|P4|COMPLETED|IANB Articaine (All Participants)||40
7748957|NCT01496846|19079073|P3|COMPLETED|IANB Articaine (All Participants)||36
7748958|NCT01496846|19079074|P2|COMPLETED|IANB Articaine (All Participants)||23
7748959|NCT01496846|19079075|P1|COMPLETED|IANB Articaine (All Participants)||27
7748960|NCT01496846|19079070|P6|STARTED|IANB Articaine (All Participants)||38
7748961|NCT01496846|19079071|P5|STARTED|IANB Articaine (All Participants)||35
7748962|NCT01496846|19079072|P4|STARTED|IANB Articaine (All Participants)||40
7748963|NCT01496846|19079073|P3|STARTED|IANB Articaine (All Participants)||36
7748964|NCT01496846|19079074|P2|STARTED|IANB Articaine (All Participants)||24
7748965|NCT01496846|19079075|P1|STARTED|IANB Articaine (All Participants)||28
7748966|NCT01496807|19079086|P1|NOT COMPLETED|Overall Study||30
7748967|NCT01496807|19079086|P1|COMPLETED|Overall Study||1
7748968|NCT01496807|19079086|P1|STARTED|Overall Study||31
7748969|NCT01496469|19079098|P2|NOT COMPLETED|Overall Study||8
7748970|NCT01496469|19079099|P1|NOT COMPLETED|Overall Study||10
7748971|NCT01496469|19079098|P2|COMPLETED|Overall Study||53
7748972|NCT01496469|19079099|P1|COMPLETED|Overall Study||50
7748973|NCT01496469|19079098|P2|STARTED|Overall Study||61
7748974|NCT01496469|19079099|P1|STARTED|Overall Study||60
7748975|NCT01496456|19079109|P1|NOT COMPLETED|Overall Study||8
7748976|NCT01496456|19079109|P1|COMPLETED|Overall Study||9
7748977|NCT01496456|19079109|P1|3-yr Final Recall|Overall Study||9
7748978|NCT01496456|19079109|P1|2-yr Recall|Overall Study||10
7748979|NCT01496456|19079109|P1|1-yr Recall|Overall Study||12
7748980|NCT01496456|19079109|P1|Baseline|Overall Study|Baseline group started with 16 patients.|16
7748981|NCT01496456|19079109|P1|STARTED|Overall Study||17
7748982|NCT01496430|19079122|P3|NOT COMPLETED|Overall Study||10
7748983|NCT01496430|19079123|P2|NOT COMPLETED|Overall Study||5
7748984|NCT01496430|19079124|P1|NOT COMPLETED|Overall Study||6
7748985|NCT01496430|19079122|P3|COMPLETED|Overall Study||25
7748986|NCT01496430|19079123|P2|COMPLETED|Overall Study||30
7748987|NCT01496430|19079124|P1|COMPLETED|Overall Study||29
7748988|NCT01496430|19079122|P3|STARTED|Overall Study||35
7748989|NCT01496430|19079123|P2|STARTED|Overall Study||35
7748990|NCT01496430|19079124|P1|STARTED|Overall Study||35
7748991|NCT01496352|19079200|P2|NOT COMPLETED|Overall Study||0
7748992|NCT01496352|19079201|P1|NOT COMPLETED|Overall Study||0
7748993|NCT01496352|19079200|P2|COMPLETED|Overall Study||6
7748994|NCT01496352|19079201|P1|COMPLETED|Overall Study||24
7748995|NCT01496352|19079200|P2|STARTED|Overall Study||6
7748996|NCT01496352|19079201|P1|STARTED|Overall Study||24
7748997|NCT01496313|19079219|P2|NOT COMPLETED|Overall Study||15
7748998|NCT01496313|19079220|P1|NOT COMPLETED|Overall Study||5
7748999|NCT01496313|19079219|P2|COMPLETED|Overall Study||26
7749000|NCT01496313|19079220|P1|COMPLETED|Overall Study||35
7749001|NCT01496313|19079219|P2|STARTED|Overall Study||41
7749002|NCT01496313|19079220|P1|STARTED|Overall Study||40
7749003|NCT01496287|19079236|P1|NOT COMPLETED|Overall Study||6
7749004|NCT01496287|19079236|P1|COMPLETED|Overall Study||64
7749005|NCT01496287|19079236|P1|STARTED|Overall Study||70
7749006|NCT01496274|19079246|P2|NOT COMPLETED|Overall Study||5
7749007|NCT01496274|19079247|P1|NOT COMPLETED|Overall Study||3
7749008|NCT01496274|19079246|P2|COMPLETED|Overall Study||18
7749009|NCT01496274|19079247|P1|COMPLETED|Overall Study||37
7749010|NCT01496274|19079246|P2|STARTED|Overall Study||23
7749011|NCT01496274|19079247|P1|STARTED|Overall Study||40
7749012|NCT01496248|19079279|P1|NOT COMPLETED|Overall Study||10
7749013|NCT01496248|19079279|P1|COMPLETED|Overall Study||25
7749014|NCT01496248|19079279|P1|STARTED|Overall Study||35
7749015|NCT01496183|19079292|P2|NOT COMPLETED|Overall Study||2
7749016|NCT01496183|19079293|P1|NOT COMPLETED|Overall Study||3
7749017|NCT01496183|19079292|P2|COMPLETED|Overall Study||13
7749018|NCT01496183|19079293|P1|COMPLETED|Overall Study||6
7749019|NCT01496183|19079292|P2|STARTED|Overall Study||15
7749020|NCT01496183|19079293|P1|STARTED|Overall Study||9
7749021|NCT01496157|19079323|P1|NOT COMPLETED|Overall Study||0
7749022|NCT01496157|19079323|P1|COMPLETED|Overall Study||13
7749023|NCT01496157|19079323|P1|STARTED|Overall Study||13
7749024|NCT01496131|19079330|P2|NOT COMPLETED|Overall Study||0
7749025|NCT01496131|19079331|P1|NOT COMPLETED|Overall Study||0
7749026|NCT01496131|19079330|P2|COMPLETED|Overall Study||14
7749027|NCT01496131|19079331|P1|COMPLETED|Overall Study||14
7749028|NCT01496131|19079330|P2|STARTED|Overall Study||14
7749029|NCT01496131|19079331|P1|STARTED|Overall Study||14
7749030|NCT01496066|19079345|P2|NOT COMPLETED|Overall Study||9
7749031|NCT01496066|19079346|P1|NOT COMPLETED|Overall Study||12
7749032|NCT01496066|19079345|P2|COMPLETED|Overall Study||188
7749033|NCT01496066|19079346|P1|COMPLETED|Overall Study||391
7749034|NCT01496066|19079345|P2|STARTED|Overall Study||197
7749035|NCT01496066|19079346|P1|STARTED|Overall Study||403
7749036|NCT01495988|19079369|P4|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
7749037|NCT01495988|19079370|P3|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
7749038|NCT01495988|19079371|P2|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
7749039|NCT01495988|19079372|P1|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
7749040|NCT01495988|19079369|P4|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
7749041|NCT01495988|19079370|P3|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
7749042|NCT01495988|19079371|P2|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||2
7749043|NCT01495988|19079372|P1|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
7749044|NCT01495988|19079369|P4|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
7749045|NCT01495988|19079370|P3|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
7749046|NCT01495988|19079371|P2|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||2
7749047|NCT01495988|19079372|P1|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
7749048|NCT01495988|19079369|P4|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
7749049|NCT01495988|19079370|P3|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
7749050|NCT01495988|19079371|P2|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
7749051|NCT01495988|19079372|P1|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
7749052|NCT01495988|19079369|P4|COMPLETED|Vem +/- Bev (Protocol v2.0)||3
7749053|NCT01495988|19079370|P3|COMPLETED|Vem +/- Bev (Protocol v2.0)||5
7749054|NCT01495988|19079371|P2|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
7749055|NCT01495988|19079372|P1|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
7749056|NCT01495988|19079369|P4|STARTED|Vem +/- Bev (Protocol v2.0)||3
7749057|NCT01495988|19079370|P3|STARTED|Vem +/- Bev (Protocol v2.0)||5
7749058|NCT01495988|19079371|P2|STARTED|Vem +/- Bev (Protocol v2.0)||0
7749059|NCT01495988|19079372|P1|STARTED|Vem +/- Bev (Protocol v2.0)||0
7749060|NCT01495975|19079408|P2|NOT COMPLETED|Overall Study||0
7749061|NCT01495975|19079409|P1|NOT COMPLETED|Overall Study||1
7749062|NCT01495975|19079408|P2|COMPLETED|Overall Study||14
7749063|NCT01495975|19079409|P1|COMPLETED|Overall Study||14
7749064|NCT01495975|19079408|P2|STARTED|Overall Study||14
7749065|NCT01495975|19079409|P1|STARTED|Overall Study||15
7749066|NCT01495923|19079417|P2|NOT COMPLETED|Overall Study||0
7749067|NCT01495923|19079418|P1|NOT COMPLETED|Overall Study||0
7749068|NCT01495923|19079417|P2|COMPLETED|Overall Study||72
7749069|NCT01495923|19079418|P1|COMPLETED|Overall Study||73
7749070|NCT01495923|19079417|P2|STARTED|Overall Study||72
7749071|NCT01495923|19079418|P1|STARTED|Overall Study||73
7749072|NCT01495858|19079451|P3|NOT COMPLETED|Overall Study||0
7749073|NCT01495858|19079452|P2|NOT COMPLETED|Overall Study||0
7749074|NCT01495858|19079453|P1|NOT COMPLETED|Overall Study||0
7749075|NCT01495858|19079451|P3|COMPLETED|Overall Study||54
7749076|NCT01495858|19079452|P2|COMPLETED|Overall Study||106
7749077|NCT01495858|19079453|P1|COMPLETED|Overall Study||107
7749078|NCT01495858|19079451|P3|STARTED|Overall Study||54
7749079|NCT01495858|19079452|P2|STARTED|Overall Study||106
7749080|NCT01495858|19079453|P1|STARTED|Overall Study||107
7749081|NCT01495793|19079533|P1|NOT COMPLETED|Overall Study||2
7749082|NCT01495793|19079533|P1|COMPLETED|Overall Study||22
7749083|NCT01495793|19079533|P1|STARTED|Overall Study||24
7749084|NCT01495702|19079546|P2|NOT COMPLETED|Extension Phase||0
7749085|NCT01495702|19079547|P1|NOT COMPLETED|Extension Phase||0
7749086|NCT01495702|19079546|P2|COMPLETED|Extension Phase||2
7749087|NCT01495702|19079547|P1|COMPLETED|Extension Phase||26
7749088|NCT01495702|19079546|P2|STARTED|Extension Phase||2
7749089|NCT01495702|19079547|P1|STARTED|Extension Phase||26
7749090|NCT01495702|19079546|P2|NOT COMPLETED|Randomized Phase||28
7749091|NCT01495702|19079547|P1|NOT COMPLETED|Randomized Phase||26
7749092|NCT01495702|19079546|P2|COMPLETED|Randomized Phase||119
7749093|NCT01495702|19079547|P1|COMPLETED|Randomized Phase||266
7749094|NCT01495702|19079546|P2|STARTED|Randomized Phase||147
7749095|NCT01495702|19079547|P1|STARTED|Randomized Phase||292
7749096|NCT01495689|19079562|P2|NOT COMPLETED|Overall Study||7
7749097|NCT01495689|19079563|P1|NOT COMPLETED|Overall Study||10
7749098|NCT01495689|19079562|P2|COMPLETED|Overall Study||16
7749099|NCT01495689|19079563|P1|COMPLETED|Overall Study||16
7749100|NCT01495689|19079562|P2|STARTED|Overall Study||23
7749101|NCT01495689|19079563|P1|STARTED|Overall Study||26
7749102|NCT01495585|19079572|P3|NOT COMPLETED|Overall Study||0
7749103|NCT01495585|19079573|P2|NOT COMPLETED|Overall Study||0
7749104|NCT01495585|19079574|P1|NOT COMPLETED|Overall Study||0
7749105|NCT01495585|19079572|P3|COMPLETED|Overall Study||4
7749106|NCT01495585|19079573|P2|COMPLETED|Overall Study||6
7749107|NCT01495585|19079574|P1|COMPLETED|Overall Study||4
7749108|NCT01495585|19079572|P3|Open Label Lonafarnib 200 mg|Overall Study||0
7749109|NCT01495585|19079573|P2|Open Label Lonafarnib 200 mg|Overall Study||0
7749110|NCT01495585|19079574|P1|Open Label Lonafarnib 200 mg|Overall Study||2
7749111|NCT01495585|19079572|P3|STARTED|Overall Study||4
7749112|NCT01495585|19079573|P2|STARTED|Overall Study||6
7749113|NCT01495585|19079574|P1|STARTED|Overall Study||4
7749114|NCT01495572|19079587|P2|NOT COMPLETED|Overall Study||0
7749115|NCT01495572|19079588|P1|NOT COMPLETED|Overall Study||0
7749116|NCT01495572|19079587|P2|COMPLETED|Overall Study||5
7749117|NCT01495572|19079588|P1|COMPLETED|Overall Study||0
7749118|NCT01495572|19079587|P2|STARTED|Overall Study||5
7749119|NCT01495572|19079588|P1|STARTED|Overall Study||0
7749120|NCT01495481|19079596|P1|NOT COMPLETED|Dexmedetomidine||0
7749121|NCT01495481|19079596|P1|COMPLETED|Dexmedetomidine||22
7749122|NCT01495481|19079596|P1|STARTED|Dexmedetomidine||22
7749123|NCT01495481|19079596|P1|NOT COMPLETED|Washout||0
7749124|NCT01495481|19079596|P1|COMPLETED|Washout||22
7749125|NCT01495481|19079596|P1|STARTED|Washout||22
7749126|NCT01495481|19079596|P1|NOT COMPLETED|Adenosine||0
7749127|NCT01495481|19079596|P1|COMPLETED|Adenosine||22
7749128|NCT01495481|19079596|P1|STARTED|Adenosine|Patients first received adenosine and then dexmedetomidine.|22
7749129|NCT01495286|19079608|P1|NOT COMPLETED|Overall Study||0
7749130|NCT01495286|19079608|P1|COMPLETED|Overall Study||30
7749131|NCT01495286|19079608|P1|STARTED|Overall Study||30
7749132|NCT01495221|19079616|P1|NOT COMPLETED|Overall Study||0
7749133|NCT01495221|19079616|P1|COMPLETED|Overall Study|Last patient enrolled May 2012.|9
7749134|NCT01495221|19079616|P1|STARTED|Overall Study|First Patient enrolled December 2011.|9
7749135|NCT01495000|19079625|P2|NOT COMPLETED|Overall Study||12
7749136|NCT01495000|19079626|P1|NOT COMPLETED|Overall Study||13
7749137|NCT01495000|19079625|P2|COMPLETED|Overall Study||114
7749138|NCT01495000|19079626|P1|COMPLETED|Overall Study||111
7749139|NCT01495000|19079625|P2|STARTED|Overall Study||126
7749140|NCT01495000|19079626|P1|STARTED|Overall Study||124
7749141|NCT01494987|19079668|P2|NOT COMPLETED|Overall Study||28
7749142|NCT01494987|19079669|P1|NOT COMPLETED|Overall Study||28
7749143|NCT01494987|19079668|P2|COMPLETED|Overall Study||187
7749144|NCT01494987|19079669|P1|COMPLETED|Overall Study||188
7749145|NCT01494987|19079668|P2|STARTED|Overall Study||215
7749146|NCT01494987|19079669|P1|STARTED|Overall Study||216
7749147|NCT01494818|19079683|P2|NOT COMPLETED|Overall Study||2
7749148|NCT01494818|19079684|P1|NOT COMPLETED|Overall Study||2
7749149|NCT01494818|19079683|P2|COMPLETED|Overall Study||37
7749150|NCT01494818|19079684|P1|COMPLETED|Overall Study||37
7749151|NCT01494818|19079683|P2|STARTED|Overall Study||39
7749152|NCT01494818|19079684|P1|STARTED|Overall Study||39
7749153|NCT01494753|19079706|P2|NOT COMPLETED|Day42-Day84||0
7749154|NCT01494753|19079707|P1|NOT COMPLETED|Day42-Day84||0
7749155|NCT01494753|19079706|P2|COMPLETED|Day42-Day84||15
7749156|NCT01494753|19079707|P1|COMPLETED|Day42-Day84||15
7749157|NCT01494753|19079706|P2|STARTED|Day42-Day84||15
7749158|NCT01494753|19079707|P1|STARTED|Day42-Day84||15
7749159|NCT01494753|19079706|P2|NOT COMPLETED|Day0-Day42||0
7749160|NCT01494753|19079707|P1|NOT COMPLETED|Day0-Day42||0
7749161|NCT01494753|19079706|P2|COMPLETED|Day0-Day42||15
7749162|NCT01494753|19079707|P1|COMPLETED|Day0-Day42||15
7749163|NCT01494753|19079706|P2|STARTED|Day0-Day42||15
7749164|NCT01494753|19079707|P1|STARTED|Day0-Day42||15
7749165|NCT01494649|19079715|P2|NOT COMPLETED|Overall Study||1
7749166|NCT01494649|19079716|P1|NOT COMPLETED|Overall Study||0
7749167|NCT01494649|19079715|P2|COMPLETED|Overall Study||58
7749168|NCT01494649|19079716|P1|COMPLETED|Overall Study||59
7749169|NCT01494649|19079715|P2|STARTED|Overall Study||59
7749170|NCT01494649|19079716|P1|STARTED|Overall Study||59
7749171|NCT01494610|19079732|P2|NOT COMPLETED|Period 4||0
7749172|NCT01494610|19079733|P1|NOT COMPLETED|Period 4||1
7749173|NCT01494610|19079732|P2|COMPLETED|Period 4||28
7749174|NCT01494610|19079733|P1|COMPLETED|Period 4||27
7749175|NCT01494610|19079732|P2|STARTED|Period 4||28
7749176|NCT01494610|19079733|P1|STARTED|Period 4||28
7749177|NCT01494610|19079732|P2|NOT COMPLETED|Period 3||0
7749178|NCT01494610|19079733|P1|NOT COMPLETED|Period 3||2
7749179|NCT01494610|19079732|P2|COMPLETED|Period 3||28
7749180|NCT01494610|19079733|P1|COMPLETED|Period 3||28
7749181|NCT01494610|19079732|P2|STARTED|Period 3||28
7749182|NCT01494610|19079733|P1|STARTED|Period 3||30
7749183|NCT01494610|19079732|P2|NOT COMPLETED|Period 2||0
7749184|NCT01494610|19079733|P1|NOT COMPLETED|Period 2||0
7749185|NCT01494610|19079732|P2|COMPLETED|Period 2||28
7749186|NCT01494610|19079733|P1|COMPLETED|Period 2||30
7749187|NCT01494610|19079732|P2|STARTED|Period 2||28
7749188|NCT01494610|19079733|P1|STARTED|Period 2||30
7749189|NCT01494610|19079732|P2|NOT COMPLETED|Period 1||1
7749190|NCT01494610|19079733|P1|NOT COMPLETED|Period 1||1
7749191|NCT01494610|19079732|P2|COMPLETED|Period 1||28
7749192|NCT01494610|19079733|P1|COMPLETED|Period 1||30
7749193|NCT01494610|19079732|P2|STARTED|Period 1||29
7749194|NCT01494610|19079733|P1|STARTED|Period 1||31
7749195|NCT01494584|19079801|P1|NOT COMPLETED|Overall Study||1
7749196|NCT01494584|19079801|P1|COMPLETED|Overall Study||4
7749197|NCT01494584|19079801|P1|STARTED|Overall Study||5
7749198|NCT01494545|19079890|P1|NOT COMPLETED|Overall Study||10
7749199|NCT01494545|19079890|P1|COMPLETED|Overall Study||92
7749200|NCT01494545|19079890|P1|STARTED|Overall Study||102
7749201|NCT01494532|19079933|P6|NOT COMPLETED|Overall Study||0
7749202|NCT01494532|19079934|P5|NOT COMPLETED|Overall Study||12
7749203|NCT01494532|19079935|P4|NOT COMPLETED|Overall Study||15
7749204|NCT01494532|19079936|P3|NOT COMPLETED|Overall Study||17
7749205|NCT01494532|19079937|P2|NOT COMPLETED|Overall Study||4
7749206|NCT01494532|19079938|P1|NOT COMPLETED|Overall Study||10
7749207|NCT01494532|19079933|P6|COMPLETED|Overall Study||25
7749208|NCT01494532|19079934|P5|COMPLETED|Overall Study||64
7749209|NCT01494532|19079935|P4|COMPLETED|Overall Study||60
7749210|NCT01494532|19079936|P3|COMPLETED|Overall Study||59
7749211|NCT01494532|19079937|P2|COMPLETED|Overall Study||21
7749212|NCT01494532|19079938|P1|COMPLETED|Overall Study||65
7749213|NCT01494532|19079933|P6|STARTED|Overall Study||25
7749214|NCT01494532|19079934|P5|STARTED|Overall Study||76
7749215|NCT01494532|19079935|P4|STARTED|Overall Study||75
7749216|NCT01494532|19079936|P3|STARTED|Overall Study||76
7749217|NCT01494532|19079937|P2|STARTED|Overall Study||25
7749218|NCT01494532|19079938|P1|STARTED|Overall Study||75
7749219|NCT01494506|19080093|P3|NOT COMPLETED|Overall Study||103
7749220|NCT01494506|19080094|P2|NOT COMPLETED|Overall Study||143
7749221|NCT01494506|19080095|P1|NOT COMPLETED|Overall Study||148
7749222|NCT01494506|19080093|P3|COMPLETED|Overall Study||14
7749223|NCT01494506|19080094|P2|COMPLETED|Overall Study||6
7749224|NCT01494506|19080095|P1|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3
7749225|NCT01494506|19080093|P3|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117
7749226|NCT01494506|19080094|P2|Treated Population|Overall Study||134
7749227|NCT01494506|19080095|P1|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147
7749228|NCT01494506|19080093|P3|STARTED|Overall Study||117
7749229|NCT01494506|19080094|P2|STARTED|Overall Study||149
7749230|NCT01494506|19080095|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151
7749231|NCT01494467|19080132|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
7749232|NCT01494467|19080133|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
7749233|NCT01494467|19080132|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||159
7749234|NCT01494467|19080133|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||353
7749235|NCT01494467|19080132|P2|STARTED|Part C Safety Follow up (4 Weeks)||159
7749236|NCT01494467|19080133|P1|STARTED|Part C Safety Follow up (4 Weeks)||353
7749237|NCT01494467|19080132|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49
7749238|NCT01494467|19080133|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75
7749239|NCT01494467|19080132|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||159
7749240|NCT01494467|19080133|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||353
7749241|NCT01494467|19080132|P2|STARTED|Part B Long Term Active Control 40 Weeks||208
7749242|NCT01494467|19080133|P1|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428
7749243|NCT01494467|19080132|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21
7749244|NCT01494467|19080133|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30
7749245|NCT01494467|19080132|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||208
7749246|NCT01494467|19080133|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||429
7749247|NCT01494467|19080132|P2|STARTED|Part A Vehicle Control (12 Weeks)||229
7749248|NCT01494467|19080133|P1|STARTED|Part A Vehicle Control (12 Weeks)||459
7749249|NCT01494350|19080149|P1|NOT COMPLETED|Overall Study||1
7749250|NCT01494350|19080149|P1|COMPLETED|Overall Study||49
7749251|NCT01494350|19080149|P1|STARTED|Overall Study||50
7749252|NCT01494298|19080159|P2|NOT COMPLETED|Overall Study||8
7749253|NCT01494298|19080160|P1|NOT COMPLETED|Overall Study||2
7749254|NCT01494298|19080159|P2|COMPLETED|Overall Study||47
7749255|NCT01494298|19080160|P1|COMPLETED|Overall Study||54
7749256|NCT01494298|19080159|P2|STARTED|Overall Study||55
7749257|NCT01494298|19080160|P1|STARTED|Overall Study||56
7749258|NCT01494051|19080172|P2|NOT COMPLETED|Overall Study||0
7749259|NCT01494051|19080173|P1|NOT COMPLETED|Overall Study||0
7749260|NCT01494051|19080172|P2|COMPLETED|Overall Study||7
7749261|NCT01494051|19080173|P1|COMPLETED|Overall Study||6
7749262|NCT01494051|19080172|P2|STARTED|Overall Study||7
7749263|NCT01494051|19080173|P1|STARTED|Overall Study||6
7749264|NCT01494038|19080183|P2|NOT COMPLETED|Overall Study||83
7749265|NCT01494038|19080184|P1|NOT COMPLETED|Overall Study||88
7749266|NCT01494038|19080183|P2|COMPLETED|Overall Study||396
7749267|NCT01494038|19080184|P1|COMPLETED|Overall Study||389
7749268|NCT01494038|19080183|P2|STARTED|Overall Study||479
7749269|NCT01494038|19080184|P1|STARTED|Overall Study||477
7749270|NCT01493960|19080272|P2|NOT COMPLETED|Overall Study||18
7749271|NCT01493960|19080273|P1|NOT COMPLETED|Overall Study||32
7749272|NCT01493960|19080272|P2|COMPLETED|Overall Study||26
7749273|NCT01493960|19080273|P1|COMPLETED|Overall Study||55
7749274|NCT01493960|19080272|P2|Received Study Drug|Overall Study||43
7749275|NCT01493960|19080273|P1|Received Study Drug|Overall Study||87
7749276|NCT01493960|19080272|P2|STARTED|Overall Study||44
7749277|NCT01493960|19080273|P1|STARTED|Overall Study||87
7749278|NCT01493947|19080293|P2|NOT COMPLETED|Period B Extension Period||32
7749279|NCT01493947|19080294|P1|NOT COMPLETED|Period B Extension Period||33
7749280|NCT01493947|19080293|P2|COMPLETED|Period B Extension Period||326
7749281|NCT01493947|19080294|P1|COMPLETED|Period B Extension Period||366
7749282|NCT01493947|19080293|P2|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358
7749283|NCT01493947|19080294|P1|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399
7749284|NCT01493947|19080293|P2|NOT COMPLETED|Period A Efficacy and Safety Data||28
7749285|NCT01493947|19080294|P1|NOT COMPLETED|Period A Efficacy and Safety Data||32
7749286|NCT01493947|19080293|P2|COMPLETED|Period A Efficacy and Safety Data||456
7749287|NCT01493947|19080294|P1|COMPLETED|Period A Efficacy and Safety Data||446
7749288|NCT01493947|19080293|P2|STARTED|Period A Efficacy and Safety Data||484
7749289|NCT01493947|19080294|P1|STARTED|Period A Efficacy and Safety Data||478
7749290|NCT01493778|19080304|P1|NOT COMPLETED|Overall Study||8
7749291|NCT01493778|19080304|P1|COMPLETED|Overall Study||52
7749292|NCT01493778|19080304|P1|STARTED|Overall Study||60
7749293|NCT01493687|19080366|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1
7749294|NCT01493687|19080367|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
7749295|NCT01493687|19080366|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||174
7749296|NCT01493687|19080367|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||350
7749297|NCT01493687|19080366|P2|STARTED|Part C Safety Follow up (4 Weeks)||175
7749298|NCT01493687|19080367|P1|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350
7749299|NCT01493687|19080366|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35
7749300|NCT01493687|19080367|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61
7749301|NCT01493687|19080366|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||175
7749302|NCT01493687|19080367|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||351
7749303|NCT01493687|19080366|P2|STARTED|Part B Long Term Active Control 40 Weeks||210
7749304|NCT01493687|19080367|P1|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412
7749305|NCT01493687|19080366|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22
7749306|NCT01493687|19080367|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37
7749307|NCT01493687|19080366|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||210
7749308|NCT01493687|19080367|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||414
7749309|NCT01493687|19080366|P2|STARTED|Part A Vehicle Control (12 Weeks)||232
7749310|NCT01493687|19080367|P1|STARTED|Part A Vehicle Control (12 Weeks)||451
7749311|NCT01493557|19080386|P3|NOT COMPLETED|Adding the Second Strategy||0
7749312|NCT01493557|19080387|P2|NOT COMPLETED|Adding the Second Strategy||4
7749313|NCT01493557|19080388|P1|NOT COMPLETED|Adding the Second Strategy||2
7749314|NCT01493557|19080386|P3|COMPLETED|Adding the Second Strategy||0
7749315|NCT01493557|19080387|P2|COMPLETED|Adding the Second Strategy||11
7749316|NCT01493557|19080388|P1|COMPLETED|Adding the Second Strategy||12
7749317|NCT01493557|19080386|P3|STARTED|Adding the Second Strategy||0
7749318|NCT01493557|19080387|P2|STARTED|Adding the Second Strategy||15
7749319|NCT01493557|19080388|P1|STARTED|Adding the Second Strategy||14
7749320|NCT01493557|19080386|P3|NOT COMPLETED|Randomized to Management Strategies||0
7749321|NCT01493557|19080387|P2|NOT COMPLETED|Randomized to Management Strategies||11
7749322|NCT01493557|19080388|P1|NOT COMPLETED|Randomized to Management Strategies||15
7749323|NCT01493557|19080386|P3|COMPLETED|Randomized to Management Strategies||0
7749324|NCT01493557|19080387|P2|COMPLETED|Randomized to Management Strategies||47
7749325|NCT01493557|19080388|P1|COMPLETED|Randomized to Management Strategies||44
7749326|NCT01493557|19080386|P3|STARTED|Randomized to Management Strategies||0
7749327|NCT01493557|19080387|P2|STARTED|Randomized to Management Strategies||58
7749328|NCT01493557|19080388|P1|STARTED|Randomized to Management Strategies||59
7749329|NCT01493557|19080386|P3|NOT COMPLETED|Not Randomized to Management Strategies||134
7749330|NCT01493557|19080387|P2|NOT COMPLETED|Not Randomized to Management Strategies||0
7749331|NCT01493557|19080388|P1|NOT COMPLETED|Not Randomized to Management Strategies||0
7749332|NCT01493557|19080386|P3|COMPLETED|Not Randomized to Management Strategies||816
7749333|NCT01493557|19080387|P2|COMPLETED|Not Randomized to Management Strategies||0
7749334|NCT01493557|19080388|P1|COMPLETED|Not Randomized to Management Strategies||0
7749335|NCT01493557|19080386|P3|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48
7749336|NCT01493557|19080387|P2|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
7749337|NCT01493557|19080388|P1|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
7749338|NCT01493557|19080386|P3|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48
7749339|NCT01493557|19080387|P2|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
7749340|NCT01493557|19080388|P1|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
7749341|NCT01493557|19080386|P3|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854
7749342|NCT01493557|19080387|P2|Without Experiencing GIS|Not Randomized to Management Strategies||0
7749343|NCT01493557|19080388|P1|Without Experiencing GIS|Not Randomized to Management Strategies||0
7749344|NCT01493557|19080386|P3|STARTED|Not Randomized to Management Strategies||950
7749345|NCT01493557|19080387|P2|STARTED|Not Randomized to Management Strategies||0
7749346|NCT01493557|19080388|P1|STARTED|Not Randomized to Management Strategies||0
7749347|NCT01493531|19080416|P3|NOT COMPLETED|Overall Study||48
7749348|NCT01493531|19080417|P2|NOT COMPLETED|Overall Study||50
7749349|NCT01493531|19080418|P1|NOT COMPLETED|Overall Study||41
7749350|NCT01493531|19080416|P3|COMPLETED|Overall Study||158
7749351|NCT01493531|19080417|P2|COMPLETED|Overall Study||150
7749352|NCT01493531|19080418|P1|COMPLETED|Overall Study||163
7749353|NCT01493531|19080416|P3|STARTED|Overall Study||206
7749354|NCT01493531|19080417|P2|STARTED|Overall Study||200
7749355|NCT01493531|19080418|P1|STARTED|Overall Study||204
7749356|NCT01493427|19080432|P1|NOT COMPLETED|Overall Study||20
7749357|NCT01493427|19080432|P1|COMPLETED|Overall Study||179
7749358|NCT01493427|19080432|P1|STARTED|Overall Study||199
7749359|NCT01493414|19080437|P1|NOT COMPLETED|Overall Study||950
7749360|NCT01493414|19080437|P1|COMPLETED|Overall Study||1283
7749361|NCT01493414|19080437|P1|STARTED|Overall Study||2233
7749362|NCT01493284|19080450|P1|NOT COMPLETED|Overall Study||61
7749363|NCT01493284|19080450|P1|COMPLETED|Overall Study||161
7749364|NCT01493284|19080450|P1|STARTED|Overall Study||222
7749365|NCT01493180|19080459|P2|NOT COMPLETED|Overall Study||2
7749366|NCT01493180|19080460|P1|NOT COMPLETED|Overall Study||3
7749367|NCT01493180|19080459|P2|COMPLETED|Overall Study||49
7749368|NCT01493180|19080460|P1|COMPLETED|Overall Study||48
7749369|NCT01493180|19080459|P2|STARTED|Overall Study||51
7749370|NCT01493180|19080460|P1|STARTED|Overall Study||51
7749371|NCT01493167|19080466|P1|NOT COMPLETED|Overall Study||0
7749372|NCT01493167|19080466|P1|COMPLETED|Overall Study||97
7749373|NCT01493167|19080466|P1|STARTED|Overall Study||97
7749374|NCT01493089|19080472|P2|NOT COMPLETED|Overall Study||3
7749375|NCT01493089|19080473|P1|NOT COMPLETED|Overall Study||3
7749376|NCT01493089|19080472|P2|COMPLETED|Overall Study||114
7749377|NCT01493089|19080473|P1|COMPLETED|Overall Study||119
7749378|NCT01493089|19080472|P2|STARTED|Overall Study||117
7749379|NCT01493089|19080473|P1|STARTED|Overall Study||122
7749380|NCT01493024|19080493|P4|NOT COMPLETED|Overall Study||0
7749381|NCT01493024|19080494|P3|NOT COMPLETED|Overall Study||0
7749382|NCT01493024|19080495|P2|NOT COMPLETED|Overall Study||0
7749383|NCT01493024|19080496|P1|NOT COMPLETED|Overall Study||0
7749384|NCT01493024|19080493|P4|COMPLETED|Overall Study||24
7749385|NCT01493024|19080494|P3|COMPLETED|Overall Study||24
7749386|NCT01493024|19080495|P2|COMPLETED|Overall Study||12
7749387|NCT01493024|19080496|P1|COMPLETED|Overall Study||30
7749388|NCT01493024|19080493|P4|STARTED|Overall Study||24
7749389|NCT01493024|19080494|P3|STARTED|Overall Study||24
7749390|NCT01493024|19080495|P2|STARTED|Overall Study||12
7749391|NCT01493024|19080496|P1|STARTED|Overall Study||30
7749392|NCT01492686|19080572|P2|NOT COMPLETED|Open-label Phase||18
7749393|NCT01492686|19080573|P1|NOT COMPLETED|Open-label Phase||12
7749394|NCT01492686|19080572|P2|COMPLETED|Open-label Phase||40
7749395|NCT01492686|19080573|P1|COMPLETED|Open-label Phase||53
7749396|NCT01492686|19080572|P2|STARTED|Open-label Phase||58
7749397|NCT01492686|19080573|P1|STARTED|Open-label Phase||65
7749398|NCT01492686|19080572|P2|NOT COMPLETED|Double-blind Phase||8
7749399|NCT01492686|19080573|P1|NOT COMPLETED|Double-blind Phase||2
7749400|NCT01492686|19080572|P2|COMPLETED|Double-blind Phase||60
7749401|NCT01492686|19080573|P1|COMPLETED|Double-blind Phase||67
7749402|NCT01492686|19080572|P2|STARTED|Double-blind Phase||68
7749403|NCT01492686|19080573|P1|STARTED|Double-blind Phase||69
7749404|NCT01492673|19080597|P1|NOT COMPLETED|Overall Study||0
7749405|NCT01492673|19080597|P1|COMPLETED|Overall Study||9
7749406|NCT01492673|19080597|P1|STARTED|Overall Study||9
7749407|NCT01492582|19080604|P2|NOT COMPLETED|Overall Study||64
7749408|NCT01492582|19080605|P1|NOT COMPLETED|Overall Study||69
7749409|NCT01492582|19080604|P2|COMPLETED|Overall Study|Returned evaluable survey|982
7749410|NCT01492582|19080605|P1|COMPLETED|Overall Study|Received 3 vaccine doses and completed Month 7 blood draw (224 quadrivalent; 160 nonavalent)|384
7749411|NCT01492582|19080604|P2|Received First Nonavalent Vaccine Dose|Overall Study||0
7749412|NCT01492582|19080605|P1|Received First Nonavalent Vaccine Dose|Overall Study||182
7749413|NCT01492582|19080604|P2|Received First Quadrivalent Vaccine Dose|Overall Study|Does not apply|0
7749414|NCT01492582|19080605|P1|Received First Quadrivalent Vaccine Dose|Overall Study||254
7749415|NCT01492582|19080604|P2|STARTED|Overall Study|Consented to the survey arm of the study|1046
7749416|NCT01492582|19080605|P1|STARTED|Overall Study|Consented to the vaccine arm (265 quadrivalent vaccine; 188 nonavalent vaccine)|453
7749417|NCT01492439|19080630|P2|NOT COMPLETED|Overall Study||9
7749418|NCT01492439|19080631|P1|NOT COMPLETED|Overall Study||4
7749419|NCT01492439|19080630|P2|COMPLETED|Overall Study||9
7749420|NCT01492439|19080631|P1|COMPLETED|Overall Study||15
7749421|NCT01492439|19080630|P2|Post-intervention|Overall Study||13
7749422|NCT01492439|19080631|P1|Post-intervention|Overall Study||18
7749423|NCT01492439|19080630|P2|STARTED|Overall Study||18
7749424|NCT01492439|19080631|P1|STARTED|Overall Study||19
7749425|NCT01492426|19080679|P2|NOT COMPLETED|Follow-Up||10
7749426|NCT01492426|19080680|P1|NOT COMPLETED|Follow-Up||25
7749427|NCT01492426|19080679|P2|COMPLETED|Follow-Up||181
7749428|NCT01492426|19080680|P1|COMPLETED|Follow-Up||359
7749429|NCT01492426|19080679|P2|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191
7749430|NCT01492426|19080680|P1|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384
7749431|NCT01492426|19080679|P2|NOT COMPLETED|Treatment||40
7749432|NCT01492426|19080680|P1|NOT COMPLETED|Treatment||83
7749433|NCT01492426|19080679|P2|COMPLETED|Treatment||160
7749434|NCT01492426|19080680|P1|COMPLETED|Treatment||319
7749435|NCT01492426|19080679|P2|STARTED|Treatment||200
7749436|NCT01492426|19080680|P1|STARTED|Treatment||402
7749437|NCT01492400|19080698|P2|NOT COMPLETED|Overall Study||16
7749438|NCT01492400|19080699|P1|NOT COMPLETED|Overall Study||16
7749439|NCT01492400|19080698|P2|COMPLETED|Overall Study||166
7749440|NCT01492400|19080699|P1|COMPLETED|Overall Study||165
7749441|NCT01492400|19080698|P2|STARTED|Overall Study||182
7749442|NCT01492400|19080699|P1|STARTED|Overall Study||181
7749443|NCT01492309|19080711|P2|NOT COMPLETED|Overall Study||0
7749444|NCT01492309|19080712|P1|NOT COMPLETED|Overall Study||0
7749445|NCT01492309|19080711|P2|COMPLETED|Overall Study||11
7749446|NCT01492309|19080712|P1|COMPLETED|Overall Study||11
7749447|NCT01492309|19080711|P2|STARTED|Overall Study||11
7749448|NCT01492309|19080712|P1|STARTED|Overall Study||11
7749449|NCT01492088|19080723|P3|NOT COMPLETED|Overall Study||14
7749450|NCT01492088|19080724|P2|NOT COMPLETED|Overall Study||14
7749451|NCT01492088|19080725|P1|NOT COMPLETED|Overall Study||3
7749452|NCT01492088|19080723|P3|COMPLETED|Overall Study||3
7749453|NCT01492088|19080724|P2|COMPLETED|Overall Study||2
7749454|NCT01492088|19080725|P1|COMPLETED|Overall Study||0
7749455|NCT01492088|19080723|P3|STARTED|Overall Study||17
7749456|NCT01492088|19080724|P2|STARTED|Overall Study||16
7749457|NCT01492088|19080725|P1|STARTED|Overall Study||3
7749458|NCT01491984|19080785|P2|NOT COMPLETED|Overall Study||1
7749459|NCT01491984|19080786|P1|NOT COMPLETED|Overall Study||2
7749460|NCT01491984|19080785|P2|COMPLETED|Overall Study||44
7749461|NCT01491984|19080786|P1|COMPLETED|Overall Study||47
7749462|NCT01491984|19080785|P2|STARTED|Overall Study||45
7749463|NCT01491984|19080786|P1|STARTED|Overall Study||49
7749464|NCT01491958|19080794|P2|NOT COMPLETED|Overall Study||0
7749465|NCT01491958|19080795|P1|NOT COMPLETED|Overall Study||0
7749466|NCT01491958|19080794|P2|COMPLETED|Overall Study||40
7749467|NCT01491958|19080795|P1|COMPLETED|Overall Study||40
7749468|NCT01491958|19080794|P2|STARTED|Overall Study||40
7749469|NCT01491958|19080795|P1|STARTED|Overall Study||40
7749470|NCT01491919|19080806|P3|NOT COMPLETED|Overall Study||1
7749471|NCT01491919|19080807|P2|NOT COMPLETED|Overall Study||2
7749472|NCT01491919|19080808|P1|NOT COMPLETED|Overall Study||1
7749473|NCT01491919|19080806|P3|COMPLETED|Overall Study||2
7749474|NCT01491919|19080807|P2|COMPLETED|Overall Study||8
7749475|NCT01491919|19080808|P1|COMPLETED|Overall Study||12
7749476|NCT01491919|19080806|P3|STARTED|Overall Study||3
7749477|NCT01491919|19080807|P2|STARTED|Overall Study||10
7749478|NCT01491919|19080808|P1|STARTED|Overall Study||13
7749479|NCT01491893|19080854|P10|NOT COMPLETED|Overall Study||0
7749480|NCT01491893|19080855|P9|NOT COMPLETED|Overall Study||0
7749481|NCT01491893|19080856|P8|NOT COMPLETED|Overall Study||0
7749482|NCT01491893|19080857|P7|NOT COMPLETED|Overall Study||0
7749483|NCT01491893|19080858|P6|NOT COMPLETED|Overall Study||0
7749484|NCT01491893|19080859|P5|NOT COMPLETED|Overall Study||0
7749485|NCT01491893|19080860|P4|NOT COMPLETED|Overall Study||0
7749486|NCT01491893|19080861|P3|NOT COMPLETED|Overall Study||0
7749487|NCT01491893|19080862|P2|NOT COMPLETED|Overall Study||0
7749488|NCT01491893|19080863|P1|NOT COMPLETED|Overall Study||0
7749489|NCT01491893|19080854|P10|COMPLETED|Overall Study||7
7749490|NCT01491893|19080855|P9|COMPLETED|Overall Study||15
7749491|NCT01491893|19080856|P8|COMPLETED|Overall Study||24
7749492|NCT01491893|19080857|P7|COMPLETED|Overall Study||6
7749493|NCT01491893|19080858|P6|COMPLETED|Overall Study||1
7749494|NCT01491893|19080859|P5|COMPLETED|Overall Study||4
7749495|NCT01491893|19080860|P4|COMPLETED|Overall Study||1
7749496|NCT01491893|19080861|P3|COMPLETED|Overall Study||1
7749497|NCT01491893|19080862|P2|COMPLETED|Overall Study||1
7749498|NCT01491893|19080863|P1|COMPLETED|Overall Study||1
7749499|NCT01491893|19080854|P10|STARTED|Overall Study||7
7749500|NCT01491893|19080855|P9|STARTED|Overall Study||15
7749501|NCT01491893|19080856|P8|STARTED|Overall Study||24
7749502|NCT01491893|19080857|P7|STARTED|Overall Study||6
7749503|NCT01491893|19080858|P6|STARTED|Overall Study||1
7749504|NCT01491893|19080859|P5|STARTED|Overall Study||4
7749505|NCT01491893|19080860|P4|STARTED|Overall Study||1
7749506|NCT01491893|19080861|P3|STARTED|Overall Study||1
7749507|NCT01491893|19080862|P2|STARTED|Overall Study||1
7749508|NCT01491893|19080863|P1|STARTED|Overall Study||1
7749509|NCT01491854|19080879|P1|NOT COMPLETED|Overall Study||130
7749510|NCT01491854|19080879|P1|COMPLETED|Overall Study||0
7749511|NCT01491854|19080879|P1|STARTED|Overall Study||130
7749512|NCT01491841|19080890|P1|NOT COMPLETED|Overall Study||11
7749513|NCT01491841|19080890|P1|COMPLETED|Overall Study||22
7749514|NCT01491841|19080890|P1|STARTED|Overall Study||33
7749515|NCT01491802|19080904|P2|NOT COMPLETED|Overall Study||2
7749516|NCT01491802|19080905|P1|NOT COMPLETED|Overall Study||1
7749517|NCT01491802|19080904|P2|COMPLETED|Overall Study||6
7749518|NCT01491802|19080905|P1|COMPLETED|Overall Study||8
7749519|NCT01491802|19080904|P2|STARTED|Overall Study||8
7749520|NCT01491802|19080905|P1|STARTED|Overall Study||9
7749521|NCT01491737|19080932|P2|NOT COMPLETED|Overall Study||129
7749522|NCT01491737|19080933|P1|NOT COMPLETED|Overall Study||129
7749523|NCT01491737|19080932|P2|COMPLETED|Overall Study||0
7749524|NCT01491737|19080933|P1|COMPLETED|Overall Study||0
7749525|NCT01491737|19080932|P2|Entered Follow-Up (Post-Treatment)|Overall Study||116
7749526|NCT01491737|19080933|P1|Entered Follow-Up (Post-Treatment)|Overall Study||120
7749527|NCT01491737|19080932|P2|Received at Least One Dose of Study Drug|Overall Study||124
7749528|NCT01491737|19080933|P1|Received at Least One Dose of Study Drug|Overall Study||127
7749529|NCT01491737|19080932|P2|STARTED|Overall Study||129
7749530|NCT01491737|19080933|P1|STARTED|Overall Study||129
7749531|NCT01491672|19080960|P3|NOT COMPLETED|Overall Study||11
7749532|NCT01491672|19080961|P2|NOT COMPLETED|Overall Study||60
7749533|NCT01491672|19080962|P1|NOT COMPLETED|Overall Study||56
7749534|NCT01491672|19080960|P3|COMPLETED|Overall Study||3
7749535|NCT01491672|19080961|P2|COMPLETED|Overall Study||2
7749536|NCT01491672|19080962|P1|COMPLETED|Overall Study||2
7749537|NCT01491672|19080960|P3|Safety Set|Overall Study||14
7749538|NCT01491672|19080961|P2|Safety Set|Overall Study||61
7749539|NCT01491672|19080962|P1|Safety Set|Overall Study||58
7749540|NCT01491672|19080960|P3|STARTED|Overall Study||14
7749541|NCT01491672|19080961|P2|STARTED|Overall Study|1 participant died prior to treatment initiation.|62
7749542|NCT01491672|19080962|P1|STARTED|Overall Study||58
7749543|NCT01491633|19080987|P1|NOT COMPLETED|Overall Study||5
7749544|NCT01491633|19080987|P1|COMPLETED|Overall Study||0
7749545|NCT01491633|19080987|P1|STARTED|Overall Study||5
7749546|NCT01491607|19080999|P1|NOT COMPLETED|Overall Study||10
7749547|NCT01491607|19080999|P1|COMPLETED|Overall Study||190
7749548|NCT01491607|19080999|P1|STARTED|Overall Study||200
7749549|NCT01491490|19081097|P2|NOT COMPLETED|Overall Study||0
7749550|NCT01491490|19081098|P1|NOT COMPLETED|Overall Study||0
7749551|NCT01491490|19081097|P2|COMPLETED|Overall Study||1
7749552|NCT01491490|19081098|P1|COMPLETED|Overall Study||1
7749553|NCT01491490|19081097|P2|STARTED|Overall Study||1
7749554|NCT01491490|19081098|P1|STARTED|Overall Study||1
7749555|NCT01491178|19081104|P1|NOT COMPLETED|Overall Study||2794
7749556|NCT01491178|19081104|P1|COMPLETED|Overall Study|Completed is defined as 104 weeks follow-up after enrollment.|3649
7749557|NCT01491178|19081104|P1|STARTED|Overall Study|Started are the enrolled subjects who followed registration rule and for who eCRF was collected.|6443
7749558|NCT01491113|19081114|P5|NOT COMPLETED|Overall Study||0
7749559|NCT01491113|19081115|P4|NOT COMPLETED|Overall Study||0
7749560|NCT01491113|19081116|P3|NOT COMPLETED|Overall Study||0
7749561|NCT01491113|19081117|P2|NOT COMPLETED|Overall Study||0
7749562|NCT01491113|19081118|P1|NOT COMPLETED|Overall Study||0
7749563|NCT01491113|19081114|P5|COMPLETED|Overall Study||6
7749564|NCT01491113|19081115|P4|COMPLETED|Overall Study||6
7749565|NCT01491113|19081116|P3|COMPLETED|Overall Study||6
7749566|NCT01491113|19081117|P2|COMPLETED|Overall Study||6
7749567|NCT01491113|19081118|P1|COMPLETED|Overall Study||6
7749568|NCT01491113|19081114|P5|STARTED|Overall Study||6
7749569|NCT01491113|19081115|P4|STARTED|Overall Study||6
7749570|NCT01491113|19081116|P3|STARTED|Overall Study||6
7749571|NCT01491113|19081117|P2|STARTED|Overall Study||6
7749572|NCT01491113|19081118|P1|STARTED|Overall Study||6
7749573|NCT01491035|19081213|P8|NOT COMPLETED|Overall Study||0
7749574|NCT01491035|19081214|P7|NOT COMPLETED|Overall Study||0
7749575|NCT01491035|19081215|P6|NOT COMPLETED|Overall Study||0
7749576|NCT01491035|19081216|P5|NOT COMPLETED|Overall Study||1
7749577|NCT01491035|19081217|P4|NOT COMPLETED|Overall Study||0
7749578|NCT01491035|19081218|P3|NOT COMPLETED|Overall Study||0
7749579|NCT01491035|19081219|P2|NOT COMPLETED|Overall Study||0
7749580|NCT01491035|19081220|P1|NOT COMPLETED|Overall Study||0
7749581|NCT01491035|19081213|P8|COMPLETED|Overall Study||6
7749582|NCT01491035|19081214|P7|COMPLETED|Overall Study||6
7749583|NCT01491035|19081215|P6|COMPLETED|Overall Study||6
7749584|NCT01491035|19081216|P5|COMPLETED|Overall Study||5
7749585|NCT01491035|19081217|P4|COMPLETED|Overall Study||6
7749586|NCT01491035|19081218|P3|COMPLETED|Overall Study||6
7749587|NCT01491035|19081219|P2|COMPLETED|Overall Study||6
7749588|NCT01491035|19081220|P1|COMPLETED|Overall Study||6
7749589|NCT01491035|19081213|P8|STARTED|Overall Study||6
7749590|NCT01491035|19081214|P7|STARTED|Overall Study||6
7749591|NCT01491035|19081215|P6|STARTED|Overall Study||6
7749592|NCT01491035|19081216|P5|STARTED|Overall Study||6
7749593|NCT01491035|19081217|P4|STARTED|Overall Study||6
7749594|NCT01491035|19081218|P3|STARTED|Overall Study||6
7749595|NCT01491035|19081219|P2|STARTED|Overall Study||6
7749596|NCT01491035|19081220|P1|STARTED|Overall Study||6
7749597|NCT01491022|19081288|P2|NOT COMPLETED|Intervention 2||0
7749598|NCT01491022|19081289|P1|NOT COMPLETED|Intervention 2||1
7749599|NCT01491022|19081288|P2|COMPLETED|Intervention 2||11
7749600|NCT01491022|19081289|P1|COMPLETED|Intervention 2||8
7749601|NCT01491022|19081288|P2|STARTED|Intervention 2||11
7749602|NCT01491022|19081289|P1|STARTED|Intervention 2||9
7749603|NCT01491022|19081288|P2|NOT COMPLETED|2 Week Washout||0
7749604|NCT01491022|19081289|P1|NOT COMPLETED|2 Week Washout||0
7749605|NCT01491022|19081288|P2|COMPLETED|2 Week Washout||11
7749606|NCT01491022|19081289|P1|COMPLETED|2 Week Washout||9
7749607|NCT01491022|19081288|P2|STARTED|2 Week Washout||11
7749608|NCT01491022|19081289|P1|STARTED|2 Week Washout||9
7749609|NCT01491022|19081288|P2|NOT COMPLETED|Intervention 1||1
7749610|NCT01491022|19081289|P1|NOT COMPLETED|Intervention 1||1
7749611|NCT01491022|19081288|P2|COMPLETED|Intervention 1||11
7749612|NCT01491022|19081289|P1|COMPLETED|Intervention 1||9
7749613|NCT01491022|19081288|P2|STARTED|Intervention 1||12
7749614|NCT01491022|19081289|P1|STARTED|Intervention 1||10
7749615|NCT01490931|19081305|P1|NOT COMPLETED|Overall Study||0
7749616|NCT01490931|19081305|P1|COMPLETED|Overall Study||25
7749617|NCT01490931|19081305|P1|STARTED|Overall Study||25
7749618|NCT01490918|19081324|P3|NOT COMPLETED|Overall Study||12
7749619|NCT01490918|19081325|P2|NOT COMPLETED|Overall Study||14
7749620|NCT01490918|19081326|P1|NOT COMPLETED|Overall Study||13
7749621|NCT01490918|19081324|P3|COMPLETED|Overall Study||22
7749622|NCT01490918|19081325|P2|COMPLETED|Overall Study||52
7749623|NCT01490918|19081326|P1|COMPLETED|Overall Study||52
7749624|NCT01490918|19081324|P3|STARTED|Overall Study||34
7749625|NCT01490918|19081325|P2|STARTED|Overall Study||66
7749626|NCT01490918|19081326|P1|STARTED|Overall Study||65
7749627|NCT01490892|19081359|P1|NOT COMPLETED|Overall Study||0
7749628|NCT01490892|19081359|P1|COMPLETED|Overall Study||219
7749629|NCT01490892|19081359|P1|STARTED|Overall Study||219
7749630|NCT01490866|19081364|P1|NOT COMPLETED|Axitinib Maintenance Therapy||49
7749631|NCT01490866|19081364|P1|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0
7749632|NCT01490866|19081364|P1|STARTED|Axitinib Maintenance Therapy||49
7749633|NCT01490866|19081364|P1|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21
7749634|NCT01490866|19081364|P1|COMPLETED|FOLFOX/Bevacizumab Treatment||49
7749635|NCT01490866|19081364|P1|STARTED|FOLFOX/Bevacizumab Treatment||70
7749636|NCT01490840|19081375|P2|NOT COMPLETED|Phase 2||6
7749637|NCT01490840|19081376|P1|NOT COMPLETED|Phase 2||6
7749638|NCT01490840|19081375|P2|COMPLETED|Phase 2||68
7749639|NCT01490840|19081376|P1|COMPLETED|Phase 2||75
7749640|NCT01490840|19081375|P2|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74
7749641|NCT01490840|19081376|P1|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81
7749642|NCT01490840|19081375|P2|NOT COMPLETED|Phase 1||6
7749643|NCT01490840|19081376|P1|NOT COMPLETED|Phase 1||10
7749644|NCT01490840|19081375|P2|COMPLETED|Phase 1||78
7749645|NCT01490840|19081376|P1|COMPLETED|Phase 1||84
7749646|NCT01490840|19081375|P2|Modified Full Analysis Set|Phase 1||83
7749647|NCT01490840|19081376|P1|Modified Full Analysis Set|Phase 1||56
7749648|NCT01490840|19081375|P2|STARTED|Phase 1||84
7749649|NCT01490840|19081376|P1|STARTED|Phase 1||94
7749650|NCT01490814|19081400|P2|NOT COMPLETED|Overall Study||8
7749651|NCT01490814|19081401|P1|NOT COMPLETED|Overall Study||4
7749652|NCT01490814|19081400|P2|COMPLETED|Overall Study|376 received ablation|376
7749653|NCT01490814|19081401|P1|COMPLETED|Overall Study|374 received ablation|374
7749654|NCT01490814|19081400|P2|STARTED|Overall Study|384 subjects randomized to radiofrequency arm|384
7749655|NCT01490814|19081401|P1|STARTED|Overall Study|378 subjects randomized to Cryoballoon arm|378
7749656|NCT01490788|19081421|P6|NOT COMPLETED|Overall Study||0
7749657|NCT01490788|19081422|P5|NOT COMPLETED|Overall Study||0
7749658|NCT01490788|19081423|P4|NOT COMPLETED|Overall Study||0
7749659|NCT01490788|19081424|P3|NOT COMPLETED|Overall Study||0
7749660|NCT01490788|19081425|P2|NOT COMPLETED|Overall Study||0
7749661|NCT01490788|19081426|P1|NOT COMPLETED|Overall Study||1
7749662|NCT01490788|19081421|P6|COMPLETED|Overall Study||5
7749663|NCT01490788|19081422|P5|COMPLETED|Overall Study||5
7749664|NCT01490788|19081423|P4|COMPLETED|Overall Study||5
7749665|NCT01490788|19081424|P3|COMPLETED|Overall Study||5
7749666|NCT01490788|19081425|P2|COMPLETED|Overall Study||5
7749667|NCT01490788|19081426|P1|COMPLETED|Overall Study||4
7749668|NCT01490788|19081421|P6|STARTED|Overall Study||5
7749669|NCT01490788|19081422|P5|STARTED|Overall Study||5
7749670|NCT01490788|19081423|P4|STARTED|Overall Study||5
7749671|NCT01490788|19081424|P3|STARTED|Overall Study||5
7749672|NCT01490788|19081425|P2|STARTED|Overall Study||5
7749673|NCT01490788|19081426|P1|STARTED|Overall Study||5
7749674|NCT01490723|19081437|P1|NOT COMPLETED|Overall Study||0
7749675|NCT01490723|19081437|P1|COMPLETED|Overall Study||20
7749676|NCT01490723|19081437|P1|STARTED|Overall Study||20
7749677|NCT01490697|19081444|P2|NOT COMPLETED|Overall Study||2
7749678|NCT01490697|19081445|P1|NOT COMPLETED|Overall Study||1
7749679|NCT01490697|19081444|P2|COMPLETED|Overall Study||16
7749680|NCT01490697|19081445|P1|COMPLETED|Overall Study||15
7749681|NCT01490697|19081444|P2|STARTED|Overall Study||18
7749682|NCT01490697|19081445|P1|STARTED|Overall Study||16
7749683|NCT01490684|19081453|P1|NOT COMPLETED|Overall Study||0
7749684|NCT01490684|19081453|P1|COMPLETED|Overall Study||162
7749685|NCT01490684|19081453|P1|STARTED|Overall Study||162
7749686|NCT01490632|19081465|P20|NOT COMPLETED|Part D: Re-Treatment Period||7
7749687|NCT01490632|19081466|P19|NOT COMPLETED|Part D: Re-Treatment Period||7
7749688|NCT01490632|19081467|P18|NOT COMPLETED|Part D: Re-Treatment Period||5
7749689|NCT01490632|19081468|P17|NOT COMPLETED|Part D: Re-Treatment Period||0
7749690|NCT01490632|19081469|P16|NOT COMPLETED|Part D: Re-Treatment Period||0
7749691|NCT01490632|19081470|P15|NOT COMPLETED|Part D: Re-Treatment Period||0
7749692|NCT01490632|19081471|P14|NOT COMPLETED|Part D: Re-Treatment Period||0
7749693|NCT01490632|19081472|P13|NOT COMPLETED|Part D: Re-Treatment Period||0
7749694|NCT01490632|19081473|P12|NOT COMPLETED|Part D: Re-Treatment Period||0
7749695|NCT01490632|19081474|P11|NOT COMPLETED|Part D: Re-Treatment Period||0
7749696|NCT01490632|19081475|P10|NOT COMPLETED|Part D: Re-Treatment Period||0
7749697|NCT01490632|19081476|P9|NOT COMPLETED|Part D: Re-Treatment Period||0
7749698|NCT01490632|19081477|P8|NOT COMPLETED|Part D: Re-Treatment Period||0
7749699|NCT01490632|19081478|P7|NOT COMPLETED|Part D: Re-Treatment Period||0
7749700|NCT01490632|19081479|P6|NOT COMPLETED|Part D: Re-Treatment Period||0
7749701|NCT01490632|19081480|P5|NOT COMPLETED|Part D: Re-Treatment Period||0
7749702|NCT01490632|19081481|P4|NOT COMPLETED|Part D: Re-Treatment Period||0
7749703|NCT01490632|19081482|P3|NOT COMPLETED|Part D: Re-Treatment Period||0
7749704|NCT01490632|19081483|P2|NOT COMPLETED|Part D: Re-Treatment Period||0
7749705|NCT01490632|19081484|P1|NOT COMPLETED|Part D: Re-Treatment Period||0
7749706|NCT01490632|19081465|P20|COMPLETED|Part D: Re-Treatment Period||30
7749707|NCT01490632|19081466|P19|COMPLETED|Part D: Re-Treatment Period||12
7749708|NCT01490632|19081467|P18|COMPLETED|Part D: Re-Treatment Period||8
7749709|NCT01490632|19081468|P17|COMPLETED|Part D: Re-Treatment Period||3
7749710|NCT01490632|19081469|P16|COMPLETED|Part D: Re-Treatment Period||0
7749711|NCT01490632|19081470|P15|COMPLETED|Part D: Re-Treatment Period||0
7749712|NCT01490632|19081471|P14|COMPLETED|Part D: Re-Treatment Period||0
7749713|NCT01490632|19081472|P13|COMPLETED|Part D: Re-Treatment Period||0
7749714|NCT01490632|19081473|P12|COMPLETED|Part D: Re-Treatment Period||0
7749715|NCT01490632|19081474|P11|COMPLETED|Part D: Re-Treatment Period||0
7749716|NCT01490632|19081475|P10|COMPLETED|Part D: Re-Treatment Period||0
7749717|NCT01490632|19081476|P9|COMPLETED|Part D: Re-Treatment Period||0
7749718|NCT01490632|19081477|P8|COMPLETED|Part D: Re-Treatment Period||0
7749719|NCT01490632|19081478|P7|COMPLETED|Part D: Re-Treatment Period||0
7749720|NCT01490632|19081479|P6|COMPLETED|Part D: Re-Treatment Period||0
7749721|NCT01490632|19081480|P5|COMPLETED|Part D: Re-Treatment Period||0
7749722|NCT01490632|19081481|P4|COMPLETED|Part D: Re-Treatment Period||0
7749723|NCT01490632|19081482|P3|COMPLETED|Part D: Re-Treatment Period||0
7749724|NCT01490632|19081483|P2|COMPLETED|Part D: Re-Treatment Period||0
7749725|NCT01490632|19081484|P1|COMPLETED|Part D: Re-Treatment Period||0
7749726|NCT01490632|19081465|P20|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 10 mg.|37
7749727|NCT01490632|19081466|P19|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 8 mg.|19
7749728|NCT01490632|19081467|P18|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 4 mg.|13
7749729|NCT01490632|19081468|P17|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 2 mg.|3
7749730|NCT01490632|19081469|P16|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|0
7749731|NCT01490632|19081470|P15|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|0
7749732|NCT01490632|19081471|P14|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|0
7749733|NCT01490632|19081472|P13|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|0
7749734|NCT01490632|19081473|P12|STARTED|Part D: Re-Treatment Period||0
7749735|NCT01490632|19081474|P11|STARTED|Part D: Re-Treatment Period||0
7749736|NCT01490632|19081475|P10|STARTED|Part D: Re-Treatment Period||0
7749737|NCT01490632|19081476|P9|STARTED|Part D: Re-Treatment Period||0
7749738|NCT01490632|19081477|P8|STARTED|Part D: Re-Treatment Period||0
7749739|NCT01490632|19081478|P7|STARTED|Part D: Re-Treatment Period||0
7749740|NCT01490632|19081479|P6|STARTED|Part D: Re-Treatment Period||0
7749741|NCT01490632|19081480|P5|STARTED|Part D: Re-Treatment Period||0
7749742|NCT01490632|19081481|P4|STARTED|Part D: Re-Treatment Period||0
7749743|NCT01490632|19081482|P3|STARTED|Part D: Re-Treatment Period||0
7749744|NCT01490632|19081483|P2|STARTED|Part D: Re-Treatment Period||0
7749745|NCT01490632|19081484|P1|STARTED|Part D: Re-Treatment Period||0
7749746|NCT01490632|19081465|P20|NOT COMPLETED|Part C: Washout or Step-Down Period||0
7749747|NCT01490632|19081466|P19|NOT COMPLETED|Part C: Washout or Step-Down Period||0
7749748|NCT01490632|19081467|P18|NOT COMPLETED|Part C: Washout or Step-Down Period||0
7749749|NCT01490632|19081468|P17|NOT COMPLETED|Part C: Washout or Step-Down Period||0
7749750|NCT01490632|19081469|P16|NOT COMPLETED|Part C: Washout or Step-Down Period||37
7749751|NCT01490632|19081470|P15|NOT COMPLETED|Part C: Washout or Step-Down Period||18
7749752|NCT01490632|19081471|P14|NOT COMPLETED|Part C: Washout or Step-Down Period||10
7749753|NCT01490632|19081472|P13|NOT COMPLETED|Part C: Washout or Step-Down Period||5
7749754|NCT01490632|19081473|P12|NOT COMPLETED|Part C: Washout or Step-Down Period||0
7749755|NCT01490632|19081474|P11|NOT COMPLETED|Part C: Washout or Step-Down Period||0
7749756|NCT01490632|19081475|P10|NOT COMPLETED|Part C: Washout or Step-Down Period||0
7749757|NCT01490632|19081476|P9|NOT COMPLETED|Part C: Washout or Step-Down Period||0
7749758|NCT01490632|19081477|P8|NOT COMPLETED|Part C: Washout or Step-Down Period||0
7749759|NCT01490632|19081478|P7|NOT COMPLETED|Part C: Washout or Step-Down Period||0
7749760|NCT01490632|19081479|P6|NOT COMPLETED|Part C: Washout or Step-Down Period||0
7749761|NCT01490632|19081480|P5|NOT COMPLETED|Part C: Washout or Step-Down Period||0
7749762|NCT01490632|19081481|P4|NOT COMPLETED|Part C: Washout or Step-Down Period||0
7749763|NCT01490632|19081482|P3|NOT COMPLETED|Part C: Washout or Step-Down Period||0
7749764|NCT01490632|19081483|P2|NOT COMPLETED|Part C: Washout or Step-Down Period||0
7749765|NCT01490632|19081484|P1|NOT COMPLETED|Part C: Washout or Step-Down Period||0
7749766|NCT01490632|19081465|P20|COMPLETED|Part C: Washout or Step-Down Period||0
7749767|NCT01490632|19081466|P19|COMPLETED|Part C: Washout or Step-Down Period||0
7749768|NCT01490632|19081467|P18|COMPLETED|Part C: Washout or Step-Down Period||0
7749769|NCT01490632|19081468|P17|COMPLETED|Part C: Washout or Step-Down Period||0
7749770|NCT01490632|19081469|P16|COMPLETED|Part C: Washout or Step-Down Period||18
7749771|NCT01490632|19081470|P15|COMPLETED|Part C: Washout or Step-Down Period||37
7749772|NCT01490632|19081471|P14|COMPLETED|Part C: Washout or Step-Down Period||6
7749773|NCT01490632|19081472|P13|COMPLETED|Part C: Washout or Step-Down Period||10
7749774|NCT01490632|19081473|P12|COMPLETED|Part C: Washout or Step-Down Period||0
7749775|NCT01490632|19081474|P11|COMPLETED|Part C: Washout or Step-Down Period||0
7749776|NCT01490632|19081475|P10|COMPLETED|Part C: Washout or Step-Down Period||0
7749777|NCT01490632|19081476|P9|COMPLETED|Part C: Washout or Step-Down Period||0
7749778|NCT01490632|19081477|P8|COMPLETED|Part C: Washout or Step-Down Period||0
7749779|NCT01490632|19081478|P7|COMPLETED|Part C: Washout or Step-Down Period||0
7749780|NCT01490632|19081479|P6|COMPLETED|Part C: Washout or Step-Down Period||0
7749781|NCT01490632|19081480|P5|COMPLETED|Part C: Washout or Step-Down Period||0
7749782|NCT01490632|19081481|P4|COMPLETED|Part C: Washout or Step-Down Period||0
7749783|NCT01490632|19081482|P3|COMPLETED|Part C: Washout or Step-Down Period||0
7749784|NCT01490632|19081483|P2|COMPLETED|Part C: Washout or Step-Down Period||0
7749785|NCT01490632|19081484|P1|COMPLETED|Part C: Washout or Step-Down Period||0
7749786|NCT01490632|19081465|P20|STARTED|Part C: Washout or Step-Down Period||0
7749787|NCT01490632|19081466|P19|STARTED|Part C: Washout or Step-Down Period||0
7749788|NCT01490632|19081467|P18|STARTED|Part C: Washout or Step-Down Period||0
7749789|NCT01490632|19081468|P17|STARTED|Part C: Washout or Step-Down Period||0
7749790|NCT01490632|19081469|P16|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|55
7749791|NCT01490632|19081470|P15|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|55
7749792|NCT01490632|19081471|P14|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|16
7749793|NCT01490632|19081472|P13|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|15
7749794|NCT01490632|19081473|P12|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to Placebo remained on Placebo.|0
7749795|NCT01490632|19081474|P11|STARTED|Part C: Washout or Step-Down Period|Part A 10 mg non-responders were discontinued from the study.|0
7749796|NCT01490632|19081475|P10|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|0
7749797|NCT01490632|19081476|P9|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|0
7749798|NCT01490632|19081477|P8|STARTED|Part C: Washout or Step-Down Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|0
7749799|NCT01490632|19081478|P7|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|0
7749800|NCT01490632|19081479|P6|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|0
7749801|NCT01490632|19081480|P5|STARTED|Part C: Washout or Step-Down Period|One participant completed Part B but discontinued without receiving a Part C treatment assignment.|0
7749802|NCT01490632|19081481|P4|STARTED|Part C: Washout or Step-Down Period||0
7749803|NCT01490632|19081482|P3|STARTED|Part C: Washout or Step-Down Period||0
7749804|NCT01490632|19081483|P2|STARTED|Part C: Washout or Step-Down Period||0
7749805|NCT01490632|19081484|P1|STARTED|Part C: Washout or Step-Down Period||0
7749806|NCT01490632|19081465|P20|NOT COMPLETED|Part B: Extension or Step-Up Period||0
7749807|NCT01490632|19081466|P19|NOT COMPLETED|Part B: Extension or Step-Up Period||0
7749808|NCT01490632|19081467|P18|NOT COMPLETED|Part B: Extension or Step-Up Period||0
7749809|NCT01490632|19081468|P17|NOT COMPLETED|Part B: Extension or Step-Up Period||0
7749810|NCT01490632|19081469|P16|NOT COMPLETED|Part B: Extension or Step-Up Period||0
7749811|NCT01490632|19081470|P15|NOT COMPLETED|Part B: Extension or Step-Up Period||0
7749812|NCT01490632|19081471|P14|NOT COMPLETED|Part B: Extension or Step-Up Period||0
7749813|NCT01490632|19081472|P13|NOT COMPLETED|Part B: Extension or Step-Up Period||0
7749814|NCT01490632|19081473|P12|NOT COMPLETED|Part B: Extension or Step-Up Period||8
7749815|NCT01490632|19081474|P11|NOT COMPLETED|Part B: Extension or Step-Up Period||21
7749816|NCT01490632|19081475|P10|NOT COMPLETED|Part B: Extension or Step-Up Period||25
7749817|NCT01490632|19081476|P9|NOT COMPLETED|Part B: Extension or Step-Up Period||10
7749818|NCT01490632|19081477|P8|NOT COMPLETED|Part B: Extension or Step-Up Period||6
7749819|NCT01490632|19081478|P7|NOT COMPLETED|Part B: Extension or Step-Up Period||13
7749820|NCT01490632|19081479|P6|NOT COMPLETED|Part B: Extension or Step-Up Period||4
7749821|NCT01490632|19081480|P5|NOT COMPLETED|Part B: Extension or Step-Up Period||0
7749822|NCT01490632|19081481|P4|NOT COMPLETED|Part B: Extension or Step-Up Period||0
7749823|NCT01490632|19081482|P3|NOT COMPLETED|Part B: Extension or Step-Up Period||0
7749824|NCT01490632|19081483|P2|NOT COMPLETED|Part B: Extension or Step-Up Period||0
7749825|NCT01490632|19081484|P1|NOT COMPLETED|Part B: Extension or Step-Up Period||0
7749826|NCT01490632|19081465|P20|COMPLETED|Part B: Extension or Step-Up Period||0
7749827|NCT01490632|19081466|P19|COMPLETED|Part B: Extension or Step-Up Period||0
7749828|NCT01490632|19081467|P18|COMPLETED|Part B: Extension or Step-Up Period||0
7749829|NCT01490632|19081468|P17|COMPLETED|Part B: Extension or Step-Up Period||0
7749830|NCT01490632|19081469|P16|COMPLETED|Part B: Extension or Step-Up Period||0
7749831|NCT01490632|19081470|P15|COMPLETED|Part B: Extension or Step-Up Period||0
7749832|NCT01490632|19081471|P14|COMPLETED|Part B: Extension or Step-Up Period||0
7749833|NCT01490632|19081472|P13|COMPLETED|Part B: Extension or Step-Up Period||0
7749834|NCT01490632|19081473|P12|COMPLETED|Part B: Extension or Step-Up Period||0
7749835|NCT01490632|19081474|P11|COMPLETED|Part B: Extension or Step-Up Period||22
7749836|NCT01490632|19081475|P10|COMPLETED|Part B: Extension or Step-Up Period||25
7749837|NCT01490632|19081476|P9|COMPLETED|Part B: Extension or Step-Up Period||6
7749838|NCT01490632|19081477|P8|COMPLETED|Part B: Extension or Step-Up Period||13
7749839|NCT01490632|19081478|P7|COMPLETED|Part B: Extension or Step-Up Period||51
7749840|NCT01490632|19081479|P6|COMPLETED|Part B: Extension or Step-Up Period||25
7749841|NCT01490632|19081480|P5|COMPLETED|Part B: Extension or Step-Up Period||0
7749842|NCT01490632|19081481|P4|COMPLETED|Part B: Extension or Step-Up Period||0
7749843|NCT01490632|19081482|P3|COMPLETED|Part B: Extension or Step-Up Period||0
7749844|NCT01490632|19081483|P2|COMPLETED|Part B: Extension or Step-Up Period||0
7749845|NCT01490632|19081484|P1|COMPLETED|Part B: Extension or Step-Up Period||0
7749846|NCT01490632|19081465|P20|STARTED|Part B: Extension or Step-Up Period||0
7749847|NCT01490632|19081466|P19|STARTED|Part B: Extension or Step-Up Period||0
7749848|NCT01490632|19081467|P18|STARTED|Part B: Extension or Step-Up Period||0
7749849|NCT01490632|19081468|P17|STARTED|Part B: Extension or Step-Up Period||0
7749850|NCT01490632|19081469|P16|STARTED|Part B: Extension or Step-Up Period||0
7749851|NCT01490632|19081470|P15|STARTED|Part B: Extension or Step-Up Period||0
7749852|NCT01490632|19081471|P14|STARTED|Part B: Extension or Step-Up Period||0
7749853|NCT01490632|19081472|P13|STARTED|Part B: Extension or Step-Up Period||0
7749854|NCT01490632|19081473|P12|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to Placebo remained on Placebo.|8
7749855|NCT01490632|19081474|P11|STARTED|Part B: Extension or Step-Up Period|Part A 10 mg non-responders were discontinued from the study.|43
7749856|NCT01490632|19081475|P10|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|50
7749857|NCT01490632|19081476|P9|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|16
7749858|NCT01490632|19081477|P8|STARTED|Part B: Extension or Step-Up Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|19
7749859|NCT01490632|19081478|P7|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|64
7749860|NCT01490632|19081479|P6|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|29
7749861|NCT01490632|19081480|P5|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
7749862|NCT01490632|19081481|P4|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
7749863|NCT01490632|19081482|P3|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
7749864|NCT01490632|19081483|P2|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
7749865|NCT01490632|19081484|P1|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
7749866|NCT01490632|19081465|P20|NOT COMPLETED|Part A: Initial Treatment Period||0
7749867|NCT01490632|19081466|P19|NOT COMPLETED|Part A: Initial Treatment Period||0
7749868|NCT01490632|19081467|P18|NOT COMPLETED|Part A: Initial Treatment Period||0
7749869|NCT01490632|19081468|P17|NOT COMPLETED|Part A: Initial Treatment Period||0
7749870|NCT01490632|19081469|P16|NOT COMPLETED|Part A: Initial Treatment Period||0
7749871|NCT01490632|19081470|P15|NOT COMPLETED|Part A: Initial Treatment Period||0
7749872|NCT01490632|19081471|P14|NOT COMPLETED|Part A: Initial Treatment Period||0
7749873|NCT01490632|19081472|P13|NOT COMPLETED|Part A: Initial Treatment Period||0
7749874|NCT01490632|19081473|P12|NOT COMPLETED|Part A: Initial Treatment Period||0
7749875|NCT01490632|19081474|P11|NOT COMPLETED|Part A: Initial Treatment Period||0
7749876|NCT01490632|19081475|P10|NOT COMPLETED|Part A: Initial Treatment Period||0
7749877|NCT01490632|19081476|P9|NOT COMPLETED|Part A: Initial Treatment Period||0
7749878|NCT01490632|19081477|P8|NOT COMPLETED|Part A: Initial Treatment Period||0
7749879|NCT01490632|19081478|P7|NOT COMPLETED|Part A: Initial Treatment Period||0
7749880|NCT01490632|19081479|P6|NOT COMPLETED|Part A: Initial Treatment Period||0
7749881|NCT01490632|19081480|P5|NOT COMPLETED|Part A: Initial Treatment Period||17
7749882|NCT01490632|19081481|P4|NOT COMPLETED|Part A: Initial Treatment Period||9
7749883|NCT01490632|19081482|P3|NOT COMPLETED|Part A: Initial Treatment Period||5
7749884|NCT01490632|19081483|P2|NOT COMPLETED|Part A: Initial Treatment Period||4
7749885|NCT01490632|19081484|P1|NOT COMPLETED|Part A: Initial Treatment Period||7
7749886|NCT01490632|19081465|P20|COMPLETED|Part A: Initial Treatment Period||0
7749887|NCT01490632|19081466|P19|COMPLETED|Part A: Initial Treatment Period||0
7749888|NCT01490632|19081467|P18|COMPLETED|Part A: Initial Treatment Period||0
7749889|NCT01490632|19081468|P17|COMPLETED|Part A: Initial Treatment Period||0
7749890|NCT01490632|19081469|P16|COMPLETED|Part A: Initial Treatment Period||0
7749891|NCT01490632|19081470|P15|COMPLETED|Part A: Initial Treatment Period||0
7749892|NCT01490632|19081471|P14|COMPLETED|Part A: Initial Treatment Period||0
7749893|NCT01490632|19081472|P13|COMPLETED|Part A: Initial Treatment Period||0
7749894|NCT01490632|19081473|P12|COMPLETED|Part A: Initial Treatment Period||0
7749895|NCT01490632|19081474|P11|COMPLETED|Part A: Initial Treatment Period||0
7749896|NCT01490632|19081475|P10|COMPLETED|Part A: Initial Treatment Period||0
7749897|NCT01490632|19081476|P9|COMPLETED|Part A: Initial Treatment Period||0
7749898|NCT01490632|19081477|P8|COMPLETED|Part A: Initial Treatment Period||0
7749899|NCT01490632|19081478|P7|COMPLETED|Part A: Initial Treatment Period||0
7749900|NCT01490632|19081479|P6|COMPLETED|Part A: Initial Treatment Period||0
7749901|NCT01490632|19081480|P5|COMPLETED|Part A: Initial Treatment Period|Includes participants who completed Part A, but discontinued per protocol using Part A PASI score.|52
7749902|NCT01490632|19081481|P4|COMPLETED|Part A: Initial Treatment Period||55
7749903|NCT01490632|19081482|P3|COMPLETED|Part A: Initial Treatment Period||67
7749904|NCT01490632|19081483|P2|COMPLETED|Part A: Initial Treatment Period||28
7749905|NCT01490632|19081484|P1|COMPLETED|Part A: Initial Treatment Period||27
7749906|NCT01490632|19081465|P20|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
7749907|NCT01490632|19081466|P19|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
7749908|NCT01490632|19081467|P18|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
7749909|NCT01490632|19081468|P17|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
7749910|NCT01490632|19081469|P16|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
7749911|NCT01490632|19081470|P15|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
7749912|NCT01490632|19081471|P14|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
7749913|NCT01490632|19081472|P13|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
7749914|NCT01490632|19081473|P12|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
7749915|NCT01490632|19081474|P11|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
7749916|NCT01490632|19081475|P10|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
7749917|NCT01490632|19081476|P9|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
7749918|NCT01490632|19081477|P8|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
7749919|NCT01490632|19081478|P7|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
7749920|NCT01490632|19081479|P6|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
7749921|NCT01490632|19081480|P5|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||69
7749922|NCT01490632|19081481|P4|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||64
7749923|NCT01490632|19081482|P3|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||72
7749924|NCT01490632|19081483|P2|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||32
7749925|NCT01490632|19081484|P1|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||34
7749926|NCT01490632|19081465|P20|STARTED|Part A: Initial Treatment Period||0
7749927|NCT01490632|19081466|P19|STARTED|Part A: Initial Treatment Period||0
7749928|NCT01490632|19081467|P18|STARTED|Part A: Initial Treatment Period||0
7749929|NCT01490632|19081468|P17|STARTED|Part A: Initial Treatment Period||0
7749930|NCT01490632|19081469|P16|STARTED|Part A: Initial Treatment Period||0
7749931|NCT01490632|19081470|P15|STARTED|Part A: Initial Treatment Period||0
7749932|NCT01490632|19081471|P14|STARTED|Part A: Initial Treatment Period||0
7749933|NCT01490632|19081472|P13|STARTED|Part A: Initial Treatment Period||0
7749934|NCT01490632|19081473|P12|STARTED|Part A: Initial Treatment Period||0
7749935|NCT01490632|19081474|P11|STARTED|Part A: Initial Treatment Period||0
7749936|NCT01490632|19081475|P10|STARTED|Part A: Initial Treatment Period||0
7749937|NCT01490632|19081476|P9|STARTED|Part A: Initial Treatment Period||0
7749938|NCT01490632|19081477|P8|STARTED|Part A: Initial Treatment Period||0
7749939|NCT01490632|19081478|P7|STARTED|Part A: Initial Treatment Period||0
7749940|NCT01490632|19081479|P6|STARTED|Part A: Initial Treatment Period||0
7749941|NCT01490632|19081480|P5|STARTED|Part A: Initial Treatment Period||69
7749942|NCT01490632|19081481|P4|STARTED|Part A: Initial Treatment Period||64
7749943|NCT01490632|19081482|P3|STARTED|Part A: Initial Treatment Period||72
7749944|NCT01490632|19081483|P2|STARTED|Part A: Initial Treatment Period||32
7749945|NCT01490632|19081484|P1|STARTED|Part A: Initial Treatment Period||34
7749946|NCT01490580|19081614|P2|NOT COMPLETED|Overall Study||2
7749947|NCT01490580|19081615|P1|NOT COMPLETED|Overall Study||0
7749948|NCT01490580|19081614|P2|COMPLETED|Overall Study||89
7749949|NCT01490580|19081615|P1|COMPLETED|Overall Study||82
7749950|NCT01490580|19081614|P2|STARTED|Overall Study||91
7749951|NCT01490580|19081615|P1|STARTED|Overall Study||82
7749952|NCT01490359|19081637|P2|NOT COMPLETED|Overall Study||17
7749953|NCT01490359|19081638|P1|NOT COMPLETED|Overall Study||24
7749954|NCT01490359|19081637|P2|COMPLETED|Overall Study||555
7749955|NCT01490359|19081638|P1|COMPLETED|Overall Study||585
7749956|NCT01490359|19081637|P2|Followed-up at 12 mo|Overall Study||537
7749957|NCT01490359|19081638|P1|Followed-up at 12 mo|Overall Study||569
7749958|NCT01490359|19081637|P2|Followed-up at 6 mo|Overall Study||535
7749959|NCT01490359|19081638|P1|Followed-up at 6 mo|Overall Study||558
7749960|NCT01490359|19081637|P2|STARTED|Overall Study||572
7749961|NCT01490359|19081638|P1|STARTED|Overall Study||609
7749962|NCT01490294|19081662|P4|NOT COMPLETED|Overall Study||1
7749963|NCT01490294|19081663|P3|NOT COMPLETED|Overall Study||1
7749964|NCT01490294|19081664|P2|NOT COMPLETED|Overall Study||0
7749965|NCT01490294|19081665|P1|NOT COMPLETED|Overall Study||5
7749966|NCT01490294|19081662|P4|COMPLETED|Overall Study||54
7749967|NCT01490294|19081663|P3|COMPLETED|Overall Study||58
7749968|NCT01490294|19081664|P2|COMPLETED|Overall Study||60
7749969|NCT01490294|19081665|P1|COMPLETED|Overall Study||53
7749970|NCT01490294|19081662|P4|Participant Received Treatment|Overall Study||54
7749971|NCT01490294|19081663|P3|Participant Received Treatment|Overall Study||58
7749972|NCT01490294|19081664|P2|Participant Received Treatment|Overall Study||60
7749973|NCT01490294|19081665|P1|Participant Received Treatment|Overall Study||54
7749974|NCT01490294|19081662|P4|STARTED|Overall Study||55
7749975|NCT01490294|19081663|P3|STARTED|Overall Study||59
7749976|NCT01490294|19081664|P2|STARTED|Overall Study||60
7749977|NCT01490294|19081665|P1|STARTED|Overall Study||58
7749978|NCT01490190|19081899|P1|NOT COMPLETED|Overall Study||48
7749979|NCT01490190|19081899|P1|COMPLETED|Overall Study||204
7749980|NCT01490190|19081899|P1|STARTED|Overall Study||252
7749981|NCT01490151|19081920|P1|NOT COMPLETED|Overall Study||0
7749982|NCT01490151|19081920|P1|COMPLETED|Overall Study||22
7749983|NCT01490151|19081920|P1|STARTED|Overall Study||22
7749984|NCT01490125|19081926|P6|NOT COMPLETED|Period III||0
7749985|NCT01490125|19081927|P5|NOT COMPLETED|Period III||1
7749986|NCT01490125|19081928|P4|NOT COMPLETED|Period III||2
7749987|NCT01490125|19081929|P3|NOT COMPLETED|Period III||0
7749988|NCT01490125|19081930|P2|NOT COMPLETED|Period III||1
7749989|NCT01490125|19081931|P1|NOT COMPLETED|Period III||3
7749990|NCT01490125|19081926|P6|COMPLETED|Period III||35
7749991|NCT01490125|19081927|P5|COMPLETED|Period III||31
7749992|NCT01490125|19081928|P4|COMPLETED|Period III||28
7749993|NCT01490125|19081929|P3|COMPLETED|Period III||34
7749994|NCT01490125|19081930|P2|COMPLETED|Period III||32
7749995|NCT01490125|19081931|P1|COMPLETED|Period III||31
7749996|NCT01490125|19081926|P6|STARTED|Period III||35
7749997|NCT01490125|19081927|P5|STARTED|Period III||32
7749998|NCT01490125|19081928|P4|STARTED|Period III||30
7749999|NCT01490125|19081929|P3|STARTED|Period III||34
7750000|NCT01490125|19081930|P2|STARTED|Period III||33
7750001|NCT01490125|19081931|P1|STARTED|Period III||34
7750002|NCT01490125|19081926|P6|NOT COMPLETED|Period II||2
7750003|NCT01490125|19081927|P5|NOT COMPLETED|Period II||4
7750004|NCT01490125|19081928|P4|NOT COMPLETED|Period II||3
7750005|NCT01490125|19081929|P3|NOT COMPLETED|Period II||3
7750006|NCT01490125|19081930|P2|NOT COMPLETED|Period II||4
7750007|NCT01490125|19081931|P1|NOT COMPLETED|Period II||3
7750008|NCT01490125|19081926|P6|COMPLETED|Period II||35
7750009|NCT01490125|19081927|P5|COMPLETED|Period II||32
7750010|NCT01490125|19081928|P4|COMPLETED|Period II||30
7750011|NCT01490125|19081929|P3|COMPLETED|Period II||34
7750012|NCT01490125|19081930|P2|COMPLETED|Period II||33
7750013|NCT01490125|19081931|P1|COMPLETED|Period II||34
7750014|NCT01490125|19081926|P6|STARTED|Period II||37
7750015|NCT01490125|19081927|P5|STARTED|Period II||36
7750016|NCT01490125|19081928|P4|STARTED|Period II||33
7750017|NCT01490125|19081929|P3|STARTED|Period II||37
7750018|NCT01490125|19081930|P2|STARTED|Period II||37
7750019|NCT01490125|19081931|P1|STARTED|Period II||37
7750020|NCT01490125|19081926|P6|NOT COMPLETED|Period I||5
7750021|NCT01490125|19081927|P5|NOT COMPLETED|Period I||4
7750022|NCT01490125|19081928|P4|NOT COMPLETED|Period I||5
7750023|NCT01490125|19081929|P3|NOT COMPLETED|Period I||4
7750024|NCT01490125|19081930|P2|NOT COMPLETED|Period I||5
7750025|NCT01490125|19081931|P1|NOT COMPLETED|Period I||6
7750026|NCT01490125|19081926|P6|COMPLETED|Period I||37
7750027|NCT01490125|19081927|P5|COMPLETED|Period I||36
7750028|NCT01490125|19081928|P4|COMPLETED|Period I||33
7750029|NCT01490125|19081929|P3|COMPLETED|Period I||37
7750030|NCT01490125|19081930|P2|COMPLETED|Period I||37
7750031|NCT01490125|19081931|P1|COMPLETED|Period I||37
7750032|NCT01490125|19081926|P6|STARTED|Period I||42
7750033|NCT01490125|19081927|P5|STARTED|Period I||40
7750034|NCT01490125|19081928|P4|STARTED|Period I||38
7750035|NCT01490125|19081929|P3|STARTED|Period I||41
7750036|NCT01490125|19081930|P2|STARTED|Period I||42
7750037|NCT01490125|19081931|P1|STARTED|Period I||43
7750038|NCT01490086|19081959|P5|NOT COMPLETED|Overall Study||11
7750039|NCT01490086|19081960|P4|NOT COMPLETED|Overall Study||7
7750040|NCT01490086|19081961|P3|NOT COMPLETED|Overall Study||7
7750041|NCT01490086|19081962|P2|NOT COMPLETED|Overall Study||15
7750042|NCT01490086|19081963|P1|NOT COMPLETED|Overall Study||8
7750043|NCT01490086|19081959|P5|COMPLETED|Overall Study||28
7750044|NCT01490086|19081960|P4|COMPLETED|Overall Study||13
7750045|NCT01490086|19081961|P3|COMPLETED|Overall Study||51
7750046|NCT01490086|19081962|P2|COMPLETED|Overall Study||44
7750047|NCT01490086|19081963|P1|COMPLETED|Overall Study||50
7750048|NCT01490086|19081959|P5|STARTED|Overall Study||39
7750049|NCT01490086|19081960|P4|STARTED|Overall Study||20
7750050|NCT01490086|19081961|P3|STARTED|Overall Study||58
7750051|NCT01490086|19081962|P2|STARTED|Overall Study||59
7750052|NCT01490086|19081963|P1|STARTED|Overall Study||58
7750053|NCT01490073|19081997|P2|NOT COMPLETED|Overall Study||0
7750054|NCT01490073|19081998|P1|NOT COMPLETED|Overall Study||0
7750055|NCT01490073|19081997|P2|COMPLETED|Overall Study||12
7750056|NCT01490073|19081998|P1|COMPLETED|Overall Study||12
7750057|NCT01490073|19081997|P2|STARTED|Overall Study||12
7750058|NCT01490073|19081998|P1|STARTED|Overall Study||12
7750059|NCT01490060|19082008|P4|NOT COMPLETED|Cycle 2||0
7750060|NCT01490060|19082009|P3|NOT COMPLETED|Cycle 2||1
7750061|NCT01490060|19082010|P2|NOT COMPLETED|Cycle 2||1
7750062|NCT01490060|19082011|P1|NOT COMPLETED|Cycle 2||2
7750063|NCT01490060|19082008|P4|COMPLETED|Cycle 2||8
7750064|NCT01490060|19082009|P3|COMPLETED|Cycle 2||8
7750065|NCT01490060|19082010|P2|COMPLETED|Cycle 2||11
7750066|NCT01490060|19082011|P1|COMPLETED|Cycle 2||9
7750067|NCT01490060|19082008|P4|STARTED|Cycle 2||8
7750068|NCT01490060|19082009|P3|STARTED|Cycle 2||9
7750069|NCT01490060|19082010|P2|STARTED|Cycle 2||12
7750070|NCT01490060|19082011|P1|STARTED|Cycle 2||11
7750071|NCT01490060|19082008|P4|NOT COMPLETED|Cycle 1||3
7750072|NCT01490060|19082009|P3|NOT COMPLETED|Cycle 1||3
7750073|NCT01490060|19082010|P2|NOT COMPLETED|Cycle 1||1
7750074|NCT01490060|19082011|P1|NOT COMPLETED|Cycle 1||0
7750075|NCT01490060|19082008|P4|COMPLETED|Cycle 1||8
7750076|NCT01490060|19082009|P3|COMPLETED|Cycle 1||9
7750077|NCT01490060|19082010|P2|COMPLETED|Cycle 1||12
7750078|NCT01490060|19082011|P1|COMPLETED|Cycle 1||11
7750079|NCT01490060|19082008|P4|STARTED|Cycle 1||11
7750080|NCT01490060|19082009|P3|STARTED|Cycle 1||12
7750081|NCT01490060|19082010|P2|STARTED|Cycle 1||13
7750082|NCT01490060|19082011|P1|STARTED|Cycle 1||11
7750083|NCT01489969|19082022|P3|NOT COMPLETED|Overall Study||1
7750084|NCT01489969|19082023|P2|NOT COMPLETED|Overall Study||4
7750085|NCT01489969|19082024|P1|NOT COMPLETED|Overall Study||5
7750086|NCT01489969|19082022|P3|COMPLETED|Overall Study||44
7750087|NCT01489969|19082023|P2|COMPLETED|Overall Study||43
7750088|NCT01489969|19082024|P1|COMPLETED|Overall Study||40
7750089|NCT01489969|19082022|P3|STARTED|Overall Study||45
7750090|NCT01489969|19082023|P2|STARTED|Overall Study||47
7750091|NCT01489969|19082024|P1|STARTED|Overall Study||45
7750092|NCT01489956|19082040|P3|NOT COMPLETED|Overall Study||1
7750093|NCT01489956|19082041|P2|NOT COMPLETED|Overall Study||0
7750094|NCT01489956|19082042|P1|NOT COMPLETED|Overall Study||1
7750095|NCT01489956|19082040|P3|COMPLETED|Overall Study||5
7750096|NCT01489956|19082041|P2|COMPLETED|Overall Study||0
7750097|NCT01489956|19082042|P1|COMPLETED|Overall Study||12
7750098|NCT01489956|19082040|P3|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6
7750099|NCT01489956|19082041|P2|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0
7750100|NCT01489956|19082042|P1|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13
7750101|NCT01489891|19082079|P2|NOT COMPLETED|Overall Study||0
7750102|NCT01489891|19082080|P1|NOT COMPLETED|Overall Study||1
7750103|NCT01489891|19082079|P2|COMPLETED|Overall Study||60
7750104|NCT01489891|19082080|P1|COMPLETED|Overall Study||59
7750105|NCT01489891|19082079|P2|STARTED|Overall Study||60
7750106|NCT01489891|19082080|P1|STARTED|Overall Study||60
7750107|NCT01489826|19082101|P9|NOT COMPLETED|Overall Study||0
7750108|NCT01489826|19082102|P8|NOT COMPLETED|Overall Study||0
7750109|NCT01489826|19082103|P7|NOT COMPLETED|Overall Study||0
7750110|NCT01489826|19082104|P6|NOT COMPLETED|Overall Study||0
7750111|NCT01489826|19082105|P5|NOT COMPLETED|Overall Study||0
7750112|NCT01489826|19082106|P4|NOT COMPLETED|Overall Study||0
7750113|NCT01489826|19082107|P3|NOT COMPLETED|Overall Study||0
7750114|NCT01489826|19082108|P2|NOT COMPLETED|Overall Study||0
7750115|NCT01489826|19082109|P1|NOT COMPLETED|Overall Study||0
7750116|NCT01489826|19082101|P9|COMPLETED|Overall Study||6
7750117|NCT01489826|19082102|P8|COMPLETED|Overall Study||3
7750118|NCT01489826|19082103|P7|COMPLETED|Overall Study||9
7750119|NCT01489826|19082104|P6|COMPLETED|Overall Study||3
7750120|NCT01489826|19082105|P5|COMPLETED|Overall Study||3
7750121|NCT01489826|19082106|P4|COMPLETED|Overall Study||7
7750122|NCT01489826|19082107|P3|COMPLETED|Overall Study||3
7750123|NCT01489826|19082108|P2|COMPLETED|Overall Study||3
7750124|NCT01489826|19082109|P1|COMPLETED|Overall Study||3
7750125|NCT01489826|19082101|P9|STARTED|Overall Study||6
7750126|NCT01489826|19082102|P8|STARTED|Overall Study||3
7750127|NCT01489826|19082103|P7|STARTED|Overall Study||9
7750128|NCT01489826|19082104|P6|STARTED|Overall Study||3
7750129|NCT01489826|19082105|P5|STARTED|Overall Study||3
7750130|NCT01489826|19082106|P4|STARTED|Overall Study||7
7750131|NCT01489826|19082107|P3|STARTED|Overall Study||3
7750132|NCT01489826|19082108|P2|STARTED|Overall Study||3
7750133|NCT01489826|19082109|P1|STARTED|Overall Study||3
7750134|NCT01489670|19082206|P1|NOT COMPLETED|Overall Study||53
7750135|NCT01489670|19082206|P1|COMPLETED|Overall Study||334
7750136|NCT01489670|19082206|P1|STARTED|Overall Study||387
7750137|NCT01489579|19082218|P2|NOT COMPLETED|Overall Study||7
7750138|NCT01489579|19082219|P1|NOT COMPLETED|Overall Study||9
7750139|NCT01489579|19082218|P2|COMPLETED|Overall Study||57
7750140|NCT01489579|19082219|P1|COMPLETED|Overall Study||47
7750141|NCT01489579|19082218|P2|STARTED|Overall Study||64
7750142|NCT01489579|19082219|P1|STARTED|Overall Study||56
7750143|NCT01489527|19082235|P2|NOT COMPLETED|Overall Study||26
7750144|NCT01489527|19082236|P1|NOT COMPLETED|Overall Study||22
7750145|NCT01489527|19082235|P2|COMPLETED|Overall Study||175
7750146|NCT01489527|19082236|P1|COMPLETED|Overall Study||183
7750147|NCT01489527|19082235|P2|STARTED|Overall Study||201
7750148|NCT01489527|19082236|P1|STARTED|Overall Study||205
7750149|NCT01489358|19082253|P3|NOT COMPLETED|Overall Study||2
7750150|NCT01489358|19082254|P2|NOT COMPLETED|Overall Study||0
7750151|NCT01489358|19082255|P1|NOT COMPLETED|Overall Study||0
7750152|NCT01489358|19082253|P3|COMPLETED|Overall Study||8
7750153|NCT01489358|19082254|P2|COMPLETED|Overall Study||10
7750154|NCT01489358|19082255|P1|COMPLETED|Overall Study||5
7750155|NCT01489358|19082253|P3|STARTED|Overall Study||10
7750156|NCT01489358|19082254|P2|STARTED|Overall Study||10
7750157|NCT01489358|19082255|P1|STARTED|Overall Study||5
7750158|NCT01489254|19082305|P4|NOT COMPLETED|Open-label Extension Part||58
7750159|NCT01489254|19082306|P3|NOT COMPLETED|Open-label Extension Part||0
7750160|NCT01489254|19082307|P2|NOT COMPLETED|Open-label Extension Part||0
7750161|NCT01489254|19082308|P1|NOT COMPLETED|Open-label Extension Part||0
7750162|NCT01489254|19082305|P4|COMPLETED|Open-label Extension Part||670
7750163|NCT01489254|19082306|P3|COMPLETED|Open-label Extension Part||0
7750164|NCT01489254|19082307|P2|COMPLETED|Open-label Extension Part||0
7750165|NCT01489254|19082308|P1|COMPLETED|Open-label Extension Part||0
7750166|NCT01489254|19082305|P4|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728
7750167|NCT01489254|19082306|P3|STARTED|Open-label Extension Part||0
7750168|NCT01489254|19082307|P2|STARTED|Open-label Extension Part||0
7750169|NCT01489254|19082308|P1|STARTED|Open-label Extension Part||0
7750170|NCT01489254|19082305|P4|NOT COMPLETED|Double-blind Part||0
7750171|NCT01489254|19082306|P3|NOT COMPLETED|Double-blind Part||3
7750172|NCT01489254|19082307|P2|NOT COMPLETED|Double-blind Part||33
7750173|NCT01489254|19082308|P1|NOT COMPLETED|Double-blind Part||25
7750174|NCT01489254|19082305|P4|COMPLETED|Double-blind Part||0
7750175|NCT01489254|19082306|P3|COMPLETED|Double-blind Part||81
7750176|NCT01489254|19082307|P2|COMPLETED|Double-blind Part||324
7750177|NCT01489254|19082308|P1|COMPLETED|Double-blind Part||330
7750178|NCT01489254|19082305|P4|STARTED|Double-blind Part||0
7750179|NCT01489254|19082306|P3|STARTED|Double-blind Part||84
7750180|NCT01489254|19082307|P2|STARTED|Double-blind Part||357
7750181|NCT01489254|19082308|P1|STARTED|Double-blind Part||355
7750182|NCT01489189|19082319|P2|NOT COMPLETED|Overall Study||35
7750183|NCT01489189|19082320|P1|NOT COMPLETED|Overall Study||31
7750184|NCT01489189|19082319|P2|COMPLETED|Overall Study|Number of Eyes|168
7750185|NCT01489189|19082320|P1|COMPLETED|Overall Study|Number of Eyes|160
7750186|NCT01489189|19082319|P2|STARTED|Overall Study|Number of Eyes|203
7750187|NCT01489189|19082320|P1|STARTED|Overall Study|Number of Eyes|191
7750188|NCT01489111|19082345|P1|NOT COMPLETED|Overall Study||1
7750189|NCT01489111|19082345|P1|COMPLETED|Overall Study||35
7750190|NCT01489111|19082345|P1|STARTED|Overall Study||36
7750191|NCT01489020|19082366|P6|NOT COMPLETED|Overall Study||0
7750192|NCT01489020|19082367|P5|NOT COMPLETED|Overall Study||6
7750193|NCT01489020|19082368|P4|NOT COMPLETED|Overall Study||0
7750194|NCT01489020|19082369|P3|NOT COMPLETED|Overall Study||3
7750195|NCT01489020|19082370|P2|NOT COMPLETED|Overall Study||0
7750196|NCT01489020|19082371|P1|NOT COMPLETED|Overall Study||1
7750197|NCT01489020|19082366|P6|COMPLETED|Overall Study||4
7750198|NCT01489020|19082367|P5|COMPLETED|Overall Study||6
7750199|NCT01489020|19082368|P4|COMPLETED|Overall Study||4
7750200|NCT01489020|19082369|P3|COMPLETED|Overall Study||9
7750201|NCT01489020|19082370|P2|COMPLETED|Overall Study||4
7750202|NCT01489020|19082371|P1|COMPLETED|Overall Study||11
7750203|NCT01489020|19082366|P6|STARTED|Overall Study||4
7750204|NCT01489020|19082367|P5|STARTED|Overall Study||12
7750205|NCT01489020|19082368|P4|STARTED|Overall Study||4
7750206|NCT01489020|19082369|P3|STARTED|Overall Study||12
7750207|NCT01489020|19082370|P2|STARTED|Overall Study||4
7750208|NCT01489020|19082371|P1|STARTED|Overall Study||12
7750209|NCT01488994|19082405|P2|NOT COMPLETED|Overall Study||1
7750210|NCT01488994|19082406|P1|NOT COMPLETED|Overall Study||0
7750211|NCT01488994|19082405|P2|COMPLETED|Overall Study||11
7750212|NCT01488994|19082406|P1|COMPLETED|Overall Study||11
7750213|NCT01488994|19082405|P2|STARTED|Overall Study||12
7750214|NCT01488994|19082406|P1|STARTED|Overall Study||11
7750215|NCT01488890|19082497|P4|NOT COMPLETED|Overall Study||5
7750216|NCT01488890|19082498|P3|NOT COMPLETED|Overall Study||35
7750217|NCT01488890|19082499|P2|NOT COMPLETED|Overall Study||20
7750218|NCT01488890|19082500|P1|NOT COMPLETED|Overall Study||32
7750219|NCT01488890|19082497|P4|COMPLETED|Overall Study||25
7750220|NCT01488890|19082498|P3|COMPLETED|Overall Study||85
7750221|NCT01488890|19082499|P2|COMPLETED|Overall Study||100
7750222|NCT01488890|19082500|P1|COMPLETED|Overall Study||88
7750223|NCT01488890|19082497|P4|Treated|Overall Study||30
7750224|NCT01488890|19082498|P3|Treated|Overall Study||119
7750225|NCT01488890|19082499|P2|Treated|Overall Study||120
7750226|NCT01488890|19082500|P1|Treated|Overall Study||120
7750227|NCT01488890|19082497|P4|STARTED|Overall Study||30
7750228|NCT01488890|19082498|P3|STARTED|Overall Study||120
7750229|NCT01488890|19082499|P2|STARTED|Overall Study||120
7750230|NCT01488890|19082500|P1|STARTED|Overall Study||120
7750231|NCT01488877|19082538|P3|NOT COMPLETED|Re-randomization||0
7750232|NCT01488877|19082539|P2|NOT COMPLETED|Re-randomization||0
7750233|NCT01488877|19082540|P1|NOT COMPLETED|Re-randomization||0
7750234|NCT01488877|19082538|P3|COMPLETED|Re-randomization||3
7750235|NCT01488877|19082539|P2|COMPLETED|Re-randomization||0
7750236|NCT01488877|19082540|P1|COMPLETED|Re-randomization||0
7750237|NCT01488877|19082538|P3|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3
7750238|NCT01488877|19082539|P2|STARTED|Re-randomization||0
7750239|NCT01488877|19082540|P1|STARTED|Re-randomization||0
7750240|NCT01488877|19082538|P3|NOT COMPLETED|Initial Randomization||0
7750241|NCT01488877|19082539|P2|NOT COMPLETED|Initial Randomization||0
7750242|NCT01488877|19082540|P1|NOT COMPLETED|Initial Randomization||0
7750243|NCT01488877|19082538|P3|COMPLETED|Initial Randomization||0
7750244|NCT01488877|19082539|P2|COMPLETED|Initial Randomization||5
7750245|NCT01488877|19082540|P1|COMPLETED|Initial Randomization||1
7750246|NCT01488877|19082538|P3|STARTED|Initial Randomization||0
7750247|NCT01488877|19082539|P2|STARTED|Initial Randomization||5
7750248|NCT01488877|19082540|P1|STARTED|Initial Randomization||1
7750249|NCT01488708|19082557|P2|NOT COMPLETED|Overall Study||578
7750250|NCT01488708|19082558|P1|NOT COMPLETED|Overall Study||940
7750251|NCT01488708|19082557|P2|COMPLETED|Overall Study||0
7750252|NCT01488708|19082558|P1|COMPLETED|Overall Study||0
7750253|NCT01488708|19082557|P2|Participated in Follow Up|Overall Study||526
7750254|NCT01488708|19082558|P1|Participated in Follow Up|Overall Study||810
7750255|NCT01488708|19082557|P2|Received at Least 1 Dose of Study Drug|Overall Study||578
7750256|NCT01488708|19082558|P1|Received at Least 1 Dose of Study Drug|Overall Study||937
7750257|NCT01488708|19082557|P2|STARTED|Overall Study||578
7750258|NCT01488708|19082558|P1|STARTED|Overall Study||940
7750259|NCT01488578|19082578|P1|NOT COMPLETED|Overall Study||1836
7750260|NCT01488578|19082578|P1|COMPLETED|Overall Study||9321
7750261|NCT01488578|19082578|P1|STARTED|Overall Study||11157
7750262|NCT01488487|19082612|P1|NOT COMPLETED|Overall Study||9
7750263|NCT01488487|19082612|P1|COMPLETED|Overall Study||15
7750264|NCT01488487|19082612|P1|Received Treatment|Overall Study||24
7750265|NCT01488487|19082612|P1|STARTED|Overall Study||24
7750266|NCT01488448|19082621|P2|NOT COMPLETED|Overall Study||17
7750267|NCT01488448|19082622|P1|NOT COMPLETED|Overall Study||20
7750268|NCT01488448|19082621|P2|COMPLETED|Overall Study||97
7750269|NCT01488448|19082622|P1|COMPLETED|Overall Study||93
7750270|NCT01488448|19082621|P2|STARTED|Overall Study||114
7750271|NCT01488448|19082622|P1|STARTED|Overall Study||113
7750272|NCT01488409|19082646|P2|NOT COMPLETED|Overall Study||4
7750273|NCT01488409|19082647|P1|NOT COMPLETED|Overall Study||4
7750274|NCT01488409|19082646|P2|COMPLETED|Overall Study||15
7750275|NCT01488409|19082647|P1|COMPLETED|Overall Study||16
7750276|NCT01488409|19082646|P2|STARTED|Overall Study||19
7750277|NCT01488409|19082647|P1|STARTED|Overall Study||20
7750278|NCT01488370|19082664|P3|NOT COMPLETED|Overall Study||1
7750279|NCT01488370|19082665|P2|NOT COMPLETED|Overall Study||1
7750280|NCT01488370|19082666|P1|NOT COMPLETED|Overall Study||0
7750281|NCT01488370|19082664|P3|COMPLETED|Overall Study||19
7750282|NCT01488370|19082665|P2|COMPLETED|Overall Study||22
7750283|NCT01488370|19082666|P1|COMPLETED|Overall Study||22
7750284|NCT01488370|19082664|P3|STARTED|Overall Study||20
7750285|NCT01488370|19082665|P2|STARTED|Overall Study||23
7750286|NCT01488370|19082666|P1|STARTED|Overall Study||22
7750287|NCT01488318|19082686|P1|NOT COMPLETED|Overall Study||0
7750288|NCT01488318|19082686|P1|COMPLETED|Overall Study||14
7750289|NCT01488318|19082686|P1|STARTED|Overall Study||14
7750290|NCT01488279|19082695|P2|NOT COMPLETED|Overall Study||0
7750291|NCT01488279|19082696|P1|NOT COMPLETED|Overall Study||0
7750292|NCT01488279|19082695|P2|COMPLETED|Overall Study||5
7750293|NCT01488279|19082696|P1|COMPLETED|Overall Study||5
7750294|NCT01488279|19082695|P2|STARTED|Overall Study||5
7750295|NCT01488279|19082696|P1|STARTED|Overall Study||5
7750296|NCT01488188|19082712|P2|NOT COMPLETED|Overall Study||0
7750297|NCT01488188|19082713|P1|NOT COMPLETED|Overall Study||0
7750298|NCT01488188|19082712|P2|COMPLETED|Overall Study||20
7750299|NCT01488188|19082713|P1|COMPLETED|Overall Study||20
7750300|NCT01488188|19082712|P2|STARTED|Overall Study||20
7750301|NCT01488188|19082713|P1|STARTED|Overall Study||20
7750302|NCT01488097|19082725|P1|NOT COMPLETED|Overall Study||1
7750303|NCT01488097|19082725|P1|COMPLETED|Overall Study||7
7750304|NCT01488097|19082725|P1|Received Study Drug in Extension Study|Overall Study||8
7750305|NCT01488097|19082725|P1|STARTED|Overall Study||8
7750306|NCT01488071|19082738|P2|NOT COMPLETED|Overall Study||63
7750307|NCT01488071|19082739|P1|NOT COMPLETED|Overall Study||53
7750308|NCT01488071|19082738|P2|COMPLETED|Overall Study||179
7750309|NCT01488071|19082739|P1|COMPLETED|Overall Study||200
7750310|NCT01488071|19082738|P2|STARTED|Overall Study|APTS|242
7750311|NCT01488071|19082739|P1|STARTED|Overall Study|all-patients-treated set (APTS)|253
7750312|NCT01488019|19082773|P2|NOT COMPLETED|Overall Study||304
7750313|NCT01488019|19082774|P1|NOT COMPLETED|Overall Study||247
7750314|NCT01488019|19082773|P2|COMPLETED|Overall Study||226
7750315|NCT01488019|19082774|P1|COMPLETED|Overall Study||294
7750316|NCT01488019|19082773|P2|STARTED|Overall Study||530
7750317|NCT01488019|19082774|P1|STARTED|Overall Study||541
7750318|NCT01487954|19082808|P2|NOT COMPLETED|Overall Study||0
7750319|NCT01487954|19082809|P1|NOT COMPLETED|Overall Study||0
7750320|NCT01487954|19082808|P2|COMPLETED|Overall Study||16
7750321|NCT01487954|19082809|P1|COMPLETED|Overall Study||29
7750322|NCT01487954|19082808|P2|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0
7750323|NCT01487954|19082809|P1|Safety lead-in|Overall Study||10
7750324|NCT01487954|19082808|P2|STARTED|Overall Study||16
7750325|NCT01487954|19082809|P1|STARTED|Overall Study||29
7750326|NCT01487863|19082819|P2|NOT COMPLETED|Overall Study||19
7750327|NCT01487863|19082820|P1|NOT COMPLETED|Overall Study||19
7750328|NCT01487863|19082819|P2|COMPLETED|Overall Study||15
7750329|NCT01487863|19082820|P1|COMPLETED|Overall Study||16
7750330|NCT01487863|19082819|P2|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34
7750331|NCT01487863|19082820|P1|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35
7750332|NCT01487863|19082819|P2|Subjects Randomized (Efficacy Analysis)|Overall Study||34
7750333|NCT01487863|19082820|P1|Subjects Randomized (Efficacy Analysis)|Overall Study||35
7750334|NCT01487863|19082819|P2|STARTED|Overall Study||34
7750335|NCT01487863|19082820|P1|STARTED|Overall Study||35
7750336|NCT01487668|19082828|P2|NOT COMPLETED|Overall Study||17
7750337|NCT01487668|19082829|P1|NOT COMPLETED|Overall Study||25
7750338|NCT01487668|19082828|P2|COMPLETED|Overall Study||124
7750339|NCT01487668|19082829|P1|COMPLETED|Overall Study||121
7750340|NCT01487668|19082828|P2|STARTED|Overall Study||141
7750341|NCT01487668|19082829|P1|STARTED|Overall Study||146
7750342|NCT01487577|19082837|P1|NOT COMPLETED|Overall Study||1
7750343|NCT01487577|19082837|P1|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18
7750344|NCT01487577|19082837|P1|STARTED|Overall Study||19
7750345|NCT01487525|19082851|P2|NOT COMPLETED|Overall Study||1
7750346|NCT01487525|19082852|P1|NOT COMPLETED|Overall Study||0
7750347|NCT01487525|19082851|P2|COMPLETED|Overall Study||19
7750348|NCT01487525|19082852|P1|COMPLETED|Overall Study||22
7750349|NCT01487525|19082851|P2|STARTED|Overall Study||20
7750350|NCT01487525|19082852|P1|STARTED|Overall Study||22
7750351|NCT01487499|19082862|P1|NOT COMPLETED|Overall Study||0
7750352|NCT01487499|19082862|P1|COMPLETED|Overall Study||4
7750353|NCT01487499|19082862|P1|STARTED|Overall Study||4
7750354|NCT01487265|19082868|P1|NOT COMPLETED|Overall Study||37
7750355|NCT01487265|19082868|P1|COMPLETED|Overall Study||0
7750356|NCT01487265|19082868|P1|STARTED|Overall Study||37
7750357|NCT01487200|19082880|P4|NOT COMPLETED|Overall Study||0
7750358|NCT01487200|19082881|P3|NOT COMPLETED|Overall Study||0
7750359|NCT01487200|19082882|P2|NOT COMPLETED|Overall Study||1
7750360|NCT01487200|19082883|P1|NOT COMPLETED|Overall Study||0
7750361|NCT01487200|19082880|P4|COMPLETED|Overall Study||5
7750362|NCT01487200|19082881|P3|COMPLETED|Overall Study||7
7750363|NCT01487200|19082882|P2|COMPLETED|Overall Study||6
7750364|NCT01487200|19082883|P1|COMPLETED|Overall Study||5
7750365|NCT01487200|19082880|P4|STARTED|Overall Study||5
7750366|NCT01487200|19082881|P3|STARTED|Overall Study||7
7750367|NCT01487200|19082882|P2|STARTED|Overall Study||7
7750368|NCT01487200|19082883|P1|STARTED|Overall Study||5
7750369|NCT01487161|19082913|P4|NOT COMPLETED|Overall Study||2
7750370|NCT01487161|19082914|P3|NOT COMPLETED|Overall Study||1
7750371|NCT01487161|19082915|P2|NOT COMPLETED|Overall Study||2
7750372|NCT01487161|19082916|P1|NOT COMPLETED|Overall Study||2
7750373|NCT01487161|19082913|P4|COMPLETED|Overall Study||50
7750374|NCT01487161|19082914|P3|COMPLETED|Overall Study||59
7750375|NCT01487161|19082915|P2|COMPLETED|Overall Study||57
7750376|NCT01487161|19082916|P1|COMPLETED|Overall Study||56
7750377|NCT01487161|19082913|P4|STARTED|Overall Study||52
7750378|NCT01487161|19082914|P3|STARTED|Overall Study||60
7750379|NCT01487161|19082915|P2|STARTED|Overall Study||59
7750380|NCT01487161|19082916|P1|STARTED|Overall Study||58
7750381|NCT01486966|19082981|P2|NOT COMPLETED|Overall Study||2
7750382|NCT01486966|19082982|P1|NOT COMPLETED|Overall Study||0
7750383|NCT01486966|19082981|P2|COMPLETED|Overall Study||27
7750384|NCT01486966|19082982|P1|COMPLETED|Overall Study||29
7750385|NCT01486966|19082981|P2|STARTED|Overall Study||29
7750386|NCT01486966|19082982|P1|STARTED|Overall Study||29
7750387|NCT01486927|19083006|P1|NOT COMPLETED|Overall Study||13
7750388|NCT01486927|19083006|P1|COMPLETED|Overall Study||161
7750389|NCT01486927|19083006|P1|STARTED|Overall Study||174
7750390|NCT01486810|19083037|P1|NOT COMPLETED|Overall Study||8
7750391|NCT01486810|19083037|P1|COMPLETED|Overall Study||9
7750392|NCT01486810|19083037|P1|STARTED|Overall Study||17
7750393|NCT01486758|19083044|P2|NOT COMPLETED|Overall Study||1
7750394|NCT01486758|19083045|P1|NOT COMPLETED|Overall Study||0
7750395|NCT01486758|19083044|P2|COMPLETED|Overall Study||19
7750396|NCT01486758|19083045|P1|COMPLETED|Overall Study||20
7750397|NCT01486758|19083044|P2|STARTED|Overall Study||20
7750398|NCT01486758|19083045|P1|STARTED|Overall Study||20
7750399|NCT01486615|19083069|P4|NOT COMPLETED|Overall Study||2
7750400|NCT01486615|19083070|P3|NOT COMPLETED|Overall Study||2
7750401|NCT01486615|19083071|P2|NOT COMPLETED|Overall Study||1
7750402|NCT01486615|19083072|P1|NOT COMPLETED|Overall Study||0
7750403|NCT01486615|19083069|P4|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
7750404|NCT01486615|19083070|P3|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
7750405|NCT01486615|19083071|P2|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19
7750406|NCT01486615|19083072|P1|COMPLETED|Overall Study||20
7750407|NCT01486615|19083069|P4|STARTED|Overall Study||20
7750408|NCT01486615|19083070|P3|STARTED|Overall Study||20
7750409|NCT01486615|19083071|P2|STARTED|Overall Study||20
7750410|NCT01486615|19083072|P1|STARTED|Overall Study||20
7750411|NCT01486446|19083112|P2|NOT COMPLETED|Overall Study||0
7750412|NCT01486446|19083113|P1|NOT COMPLETED|Overall Study||1
7750413|NCT01486446|19083112|P2|COMPLETED|Overall Study||1
7750414|NCT01486446|19083113|P1|COMPLETED|Overall Study||6
7750415|NCT01486446|19083112|P2|STARTED|Overall Study||1
7750416|NCT01486446|19083113|P1|STARTED|Overall Study||7
7750417|NCT01486316|19083136|P4|NOT COMPLETED|Overall Study||2
7750418|NCT01486316|19083137|P3|NOT COMPLETED|Overall Study||5
7750419|NCT01486316|19083138|P2|NOT COMPLETED|Overall Study||3
7750420|NCT01486316|19083139|P1|NOT COMPLETED|Overall Study||4
7750421|NCT01486316|19083136|P4|COMPLETED|Overall Study||0
7750422|NCT01486316|19083137|P3|COMPLETED|Overall Study||0
7750423|NCT01486316|19083138|P2|COMPLETED|Overall Study||7
7750424|NCT01486316|19083139|P1|COMPLETED|Overall Study||3
7750425|NCT01486316|19083136|P4|STARTED|Overall Study|Exited prior to 6 month visit|2
7750426|NCT01486316|19083137|P3|STARTED|Overall Study|Exited prior to implant|5
7750427|NCT01486316|19083138|P2|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled with 10 being randomized to HFRS Guided Arm|10
7750428|NCT01486316|19083139|P1|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled 7 subjects randomized to Control Arm|7
7750429|NCT01486264|19083151|P2|NOT COMPLETED|Overall Study||47
7750430|NCT01486264|19083152|P1|NOT COMPLETED|Overall Study||29
7750431|NCT01486264|19083151|P2|COMPLETED|Overall Study||94
7750432|NCT01486264|19083152|P1|COMPLETED|Overall Study||113
7750433|NCT01486264|19083151|P2|Treated|Overall Study||140
7750434|NCT01486264|19083152|P1|Treated|Overall Study||142
7750435|NCT01486264|19083151|P2|STARTED|Overall Study||141
7750436|NCT01486264|19083152|P1|STARTED|Overall Study||142
7750437|NCT01486238|19083184|P2|NOT COMPLETED|Overall Study||6
7750438|NCT01486238|19083185|P1|NOT COMPLETED|Overall Study||2
7750439|NCT01486238|19083184|P2|COMPLETED|Overall Study||43
7750440|NCT01486238|19083185|P1|COMPLETED|Overall Study||21
7750441|NCT01486238|19083184|P2|STARTED|Overall Study||49
7750442|NCT01486238|19083185|P1|STARTED|Overall Study||23
7750443|NCT01486199|19083193|P2|NOT COMPLETED|Study Day at t= 2 Years||0
7750444|NCT01486199|19083194|P1|NOT COMPLETED|Study Day at t= 2 Years||0
7750445|NCT01486199|19083193|P2|COMPLETED|Study Day at t= 2 Years||0
7750446|NCT01486199|19083194|P1|COMPLETED|Study Day at t= 2 Years||9
7750447|NCT01486199|19083193|P2|STARTED|Study Day at t= 2 Years||0
7750448|NCT01486199|19083194|P1|STARTED|Study Day at t= 2 Years||9
7750449|NCT01486199|19083193|P2|NOT COMPLETED|Two Year Period Between Study Days||0
7750450|NCT01486199|19083194|P1|NOT COMPLETED|Two Year Period Between Study Days||1
7750451|NCT01486199|19083193|P2|COMPLETED|Two Year Period Between Study Days||0
7750452|NCT01486199|19083194|P1|COMPLETED|Two Year Period Between Study Days||9
7750453|NCT01486199|19083193|P2|STARTED|Two Year Period Between Study Days||0
7750454|NCT01486199|19083194|P1|STARTED|Two Year Period Between Study Days||10
7750455|NCT01486199|19083193|P2|NOT COMPLETED|Baseline Study Day||1
7750456|NCT01486199|19083194|P1|NOT COMPLETED|Baseline Study Day||0
7750457|NCT01486199|19083193|P2|COMPLETED|Baseline Study Day||9
7750458|NCT01486199|19083194|P1|COMPLETED|Baseline Study Day||10
7750459|NCT01486199|19083193|P2|STARTED|Baseline Study Day||10
7750460|NCT01486199|19083194|P1|STARTED|Baseline Study Day||10
7750461|NCT01486043|19083206|P1|NOT COMPLETED|Overall Study||2
7750462|NCT01486043|19083206|P1|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2
7750463|NCT01486043|19083206|P1|STARTED|Overall Study||4
7750464|NCT01485991|19083214|P2|NOT COMPLETED|Overall Study||36
7750465|NCT01485991|19083215|P1|NOT COMPLETED|Overall Study||32
7750466|NCT01485991|19083214|P2|COMPLETED|Overall Study||350
7750467|NCT01485991|19083215|P1|COMPLETED|Overall Study||353
7750468|NCT01485991|19083214|P2|Treated|Overall Study||384
7750469|NCT01485991|19083215|P1|Treated|Overall Study||379
7750470|NCT01485991|19083214|P2|STARTED|Overall Study||386
7750471|NCT01485991|19083215|P1|STARTED|Overall Study||385
7750472|NCT01485887|19083225|P1|NOT COMPLETED|Overall Study||12
7750473|NCT01485887|19083225|P1|COMPLETED|Overall Study||38
7750474|NCT01485887|19083225|P1|STARTED|Overall Study||50
7750475|NCT01485796|19083237|P1|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12
7750476|NCT01485796|19083237|P1|COMPLETED|Overall Trial (Incl. Safety Follow-up)|1 subject who completed Epoch 2 + 24 subjects who completed the safety follow-up|25
7750477|NCT01485796|19083237|P1|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24
7750478|NCT01485796|19083237|P1|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26
7750479|NCT01485796|19083237|P1|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1
7750480|NCT01485796|19083237|P1|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
7750481|NCT01485796|19083237|P1|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
7750482|NCT01485796|19083237|P1|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36
7750483|NCT01485796|19083237|P1|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37
7750484|NCT01485796|19083237|P1|STARTED|Overall Trial (Incl. Safety Follow-up)||37
7750485|NCT01485796|19083237|P1|NOT COMPLETED|Period 2: Epoch 2||35
7750486|NCT01485796|19083237|P1|COMPLETED|Period 2: Epoch 2||1
7750487|NCT01485796|19083237|P1|Treated in Epoch 2|Period 2: Epoch 2||36
7750488|NCT01485796|19083237|P1|STARTED|Period 2: Epoch 2||36
7750489|NCT01485796|19083237|P1|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1
7750490|NCT01485796|19083237|P1|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36
7750491|NCT01485796|19083237|P1|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37
7750492|NCT01485796|19083237|P1|STARTED|Period 1: Epoch 1 (Ramp-up)||37
7750493|NCT01485640|19083259|P1|NOT COMPLETED|Overall Study||122
7750494|NCT01485640|19083259|P1|COMPLETED|Overall Study||40
7750495|NCT01485640|19083259|P1|STARTED|Overall Study||162
7750496|NCT01485627|19083266|P2|NOT COMPLETED|Overall Study||57
7750497|NCT01485627|19083267|P1|NOT COMPLETED|Overall Study||66
7750498|NCT01485627|19083266|P2|COMPLETED|Overall Study|135 patients and 49 caregivers|184
7750499|NCT01485627|19083267|P1|COMPLETED|Overall Study|130 patients and 48 caregivers|178
7750500|NCT01485627|19083266|P2|Bereaved Caregivers: 7 Month Completed|Overall Study||49
7750501|NCT01485627|19083267|P1|Bereaved Caregivers: 7 Month Completed|Overall Study||48
7750502|NCT01485627|19083266|P2|Bereaved Caregivers: 2 Month Completed|Overall Study||52
7750503|NCT01485627|19083267|P1|Bereaved Caregivers: 2 Month Completed|Overall Study||49
7750504|NCT01485627|19083266|P2|Bereaved Caregivers: 1 Month|Overall Study||51
7750505|NCT01485627|19083267|P1|Bereaved Caregivers: 1 Month|Overall Study||51
7750506|NCT01485627|19083266|P2|Bereaved Caregivers: Total|Overall Study||64
7750507|NCT01485627|19083267|P1|Bereaved Caregivers: Total|Overall Study||63
7750508|NCT01485627|19083266|P2|Allocated Caregivers: Total|Overall Study||99
7750509|NCT01485627|19083267|P1|Allocated Caregivers: Total|Overall Study||105
7750510|NCT01485627|19083266|P2|STARTED|Overall Study|142 patients and 99 caregivers|241
7750511|NCT01485627|19083267|P1|STARTED|Overall Study|139 patients and 105 caregivers|244
7750512|NCT01485614|19083289|P4|NOT COMPLETED|Weeks 20-54||0
7750513|NCT01485614|19083290|P3|NOT COMPLETED|Weeks 20-54||2
7750514|NCT01485614|19083291|P2|NOT COMPLETED|Weeks 20-54||8
7750515|NCT01485614|19083292|P1|NOT COMPLETED|Weeks 20-54||11
7750516|NCT01485614|19083289|P4|COMPLETED|Weeks 20-54||5
7750517|NCT01485614|19083290|P3|COMPLETED|Weeks 20-54||6
7750518|NCT01485614|19083291|P2|COMPLETED|Weeks 20-54||78
7750519|NCT01485614|19083292|P1|COMPLETED|Weeks 20-54||74
7750520|NCT01485614|19083289|P4|STARTED|Weeks 20-54||5
7750521|NCT01485614|19083290|P3|STARTED|Weeks 20-54||8
7750522|NCT01485614|19083291|P2|STARTED|Weeks 20-54||86
7750523|NCT01485614|19083292|P1|STARTED|Weeks 20-54||85
7750524|NCT01485614|19083289|P4|NOT COMPLETED|Weeks 0-20||0
7750525|NCT01485614|19083290|P3|NOT COMPLETED|Weeks 0-20||1
7750526|NCT01485614|19083291|P2|NOT COMPLETED|Weeks 0-20||4
7750527|NCT01485614|19083292|P1|NOT COMPLETED|Weeks 0-20||10
7750528|NCT01485614|19083289|P4|COMPLETED|Weeks 0-20||5
7750529|NCT01485614|19083290|P3|COMPLETED|Weeks 0-20||8
7750530|NCT01485614|19083291|P2|COMPLETED|Weeks 0-20||86
7750531|NCT01485614|19083292|P1|COMPLETED|Weeks 0-20||85
7750532|NCT01485614|19083289|P4|Treated|Weeks 0-20||5
7750533|NCT01485614|19083290|P3|Treated|Weeks 0-20||9
7750534|NCT01485614|19083291|P2|Treated|Weeks 0-20||90
7750535|NCT01485614|19083292|P1|Treated|Weeks 0-20||95
7750536|NCT01485614|19083289|P4|STARTED|Weeks 0-20||5
7750537|NCT01485614|19083290|P3|STARTED|Weeks 0-20||9
7750538|NCT01485614|19083291|P2|STARTED|Weeks 0-20||90
7750539|NCT01485614|19083292|P1|STARTED|Weeks 0-20||95
7750540|NCT01485614|19083289|P4|NOT COMPLETED|Randomization||0
7750541|NCT01485614|19083290|P3|NOT COMPLETED|Randomization||0
7750542|NCT01485614|19083291|P2|NOT COMPLETED|Randomization||0
7750543|NCT01485614|19083292|P1|NOT COMPLETED|Randomization||1
7750544|NCT01485614|19083289|P4|COMPLETED|Randomization||5
7750545|NCT01485614|19083290|P3|COMPLETED|Randomization||9
7750546|NCT01485614|19083291|P2|COMPLETED|Randomization||90
7750547|NCT01485614|19083292|P1|COMPLETED|Randomization||95
7750548|NCT01485614|19083289|P4|STARTED|Randomization||5
7750549|NCT01485614|19083290|P3|STARTED|Randomization||9
7750550|NCT01485614|19083291|P2|STARTED|Randomization||90
7750551|NCT01485614|19083292|P1|STARTED|Randomization||96
7750552|NCT01485588|19083651|P3|NOT COMPLETED|Overall Study||0
7750553|NCT01485588|19083652|P2|NOT COMPLETED|Overall Study||0
7750554|NCT01485588|19083653|P1|NOT COMPLETED|Overall Study||0
7750555|NCT01485588|19083651|P3|COMPLETED|Overall Study||6
7750556|NCT01485588|19083652|P2|COMPLETED|Overall Study||6
7750557|NCT01485588|19083653|P1|COMPLETED|Overall Study||6
7750558|NCT01485588|19083651|P3|STARTED|Overall Study||6
7750559|NCT01485588|19083652|P2|STARTED|Overall Study||6
7750560|NCT01485588|19083653|P1|STARTED|Overall Study||6
7750561|NCT01485536|19083664|P1|NOT COMPLETED|Overall Study||4
7750562|NCT01485536|19083664|P1|COMPLETED|Overall Study||17
7750563|NCT01485536|19083664|P1|STARTED|Overall Study||21
7750564|NCT01485393|19083669|P2|NOT COMPLETED|Overall Study||0
7750565|NCT01485393|19083670|P1|NOT COMPLETED|Overall Study||0
7750566|NCT01485393|19083669|P2|COMPLETED|Overall Study||5
7750567|NCT01485393|19083670|P1|COMPLETED|Overall Study||5
7750568|NCT01485393|19083669|P2|STARTED|Overall Study||5
7750569|NCT01485393|19083670|P1|STARTED|Overall Study||5
7750570|NCT01485380|19083678|P1|NOT COMPLETED|Overall Study||3
7750571|NCT01485380|19083678|P1|COMPLETED|Overall Study||17
7750572|NCT01485380|19083678|P1|STARTED|Overall Study||20
7750573|NCT01485354|19083682|P1|NOT COMPLETED|Overall Study||5
7750574|NCT01485354|19083682|P1|COMPLETED|Overall Study||12
7750575|NCT01485354|19083682|P1|STARTED|Overall Study||17
7750576|NCT01485172|19083696|P6|NOT COMPLETED|Overall Study||4
7750577|NCT01485172|19083697|P5|NOT COMPLETED|Overall Study||5
7750578|NCT01485172|19083698|P4|NOT COMPLETED|Overall Study||8
7750579|NCT01485172|19083699|P3|NOT COMPLETED|Overall Study||7
7750580|NCT01485172|19083700|P2|NOT COMPLETED|Overall Study||1
7750581|NCT01485172|19083701|P1|NOT COMPLETED|Overall Study||7
7750582|NCT01485172|19083696|P6|COMPLETED|Overall Study||9
7750583|NCT01485172|19083697|P5|COMPLETED|Overall Study||34
7750584|NCT01485172|19083698|P4|COMPLETED|Overall Study||32
7750585|NCT01485172|19083699|P3|COMPLETED|Overall Study||34
7750586|NCT01485172|19083700|P2|COMPLETED|Overall Study||12
7750587|NCT01485172|19083701|P1|COMPLETED|Overall Study||33
7750588|NCT01485172|19083696|P6|STARTED|Overall Study||13
7750589|NCT01485172|19083697|P5|STARTED|Overall Study||39
7750590|NCT01485172|19083698|P4|STARTED|Overall Study||40
7750591|NCT01485172|19083699|P3|STARTED|Overall Study||41
7750592|NCT01485172|19083700|P2|STARTED|Overall Study||13
7750593|NCT01485172|19083701|P1|STARTED|Overall Study||40
7750594|NCT01485120|19083775|P1|NOT COMPLETED|Overall Study||2
7750595|NCT01485120|19083775|P1|COMPLETED|Overall Study||32
7750596|NCT01485120|19083775|P1|STARTED|Overall Study||34
7750597|NCT01485094|19083783|P3|NOT COMPLETED|Overall Study||1
7750598|NCT01485094|19083784|P2|NOT COMPLETED|Overall Study||2
7750599|NCT01485094|19083785|P1|NOT COMPLETED|Overall Study||3
7750600|NCT01485094|19083783|P3|COMPLETED|Overall Study||18
7750601|NCT01485094|19083784|P2|COMPLETED|Overall Study||18
7750602|NCT01485094|19083785|P1|COMPLETED|Overall Study||17
7750603|NCT01485094|19083783|P3|STARTED|Overall Study||19
7750604|NCT01485094|19083784|P2|STARTED|Overall Study||20
7750605|NCT01485094|19083785|P1|STARTED|Overall Study||20
7750606|NCT01485055|19083826|P1|NOT COMPLETED|Overall Study||0
7750607|NCT01485055|19083826|P1|COMPLETED|Overall Study||11
7750608|NCT01485055|19083826|P1|STARTED|Overall Study||11
7750609|NCT01484977|19083830|P1|NOT COMPLETED|Overall Study||27
7750610|NCT01484977|19083830|P1|COMPLETED|Overall Study||93
7750611|NCT01484977|19083830|P1|STARTED|Overall Study||120
7750612|NCT01484951|19083834|P1|NOT COMPLETED|Overall Study||5
7750613|NCT01484951|19083834|P1|COMPLETED|Overall Study||69
7750614|NCT01484951|19083834|P1|STARTED|Overall Study||74
7750615|NCT01484938|19083839|P1|NOT COMPLETED|Overall Study||4
7750616|NCT01484938|19083839|P1|COMPLETED|Overall Study||171
7750617|NCT01484938|19083839|P1|STARTED|Overall Study||175
7750618|NCT01484912|19083846|P2|NOT COMPLETED|Overall Study||1
7750619|NCT01484912|19083847|P1|NOT COMPLETED|Overall Study||1
7750620|NCT01484912|19083846|P2|COMPLETED|Overall Study||39
7750621|NCT01484912|19083847|P1|COMPLETED|Overall Study||38
7750622|NCT01484912|19083846|P2|STARTED|Overall Study||40
7750623|NCT01484912|19083847|P1|STARTED|Overall Study||39
7750624|NCT01484873|19083857|P1|NOT COMPLETED|Overall Study||2
7750625|NCT01484873|19083857|P1|COMPLETED|Overall Study||8
7750626|NCT01484873|19083857|P1|STARTED|Overall Study||10
7750627|NCT01484834|19083869|P4|NOT COMPLETED|Overall Study||4
7750628|NCT01484834|19083870|P3|NOT COMPLETED|Overall Study||1
7750629|NCT01484834|19083871|P2|NOT COMPLETED|Overall Study||8
7750630|NCT01484834|19083872|P1|NOT COMPLETED|Overall Study||5
7750631|NCT01484834|19083869|P4|COMPLETED|Overall Study||20
7750632|NCT01484834|19083870|P3|COMPLETED|Overall Study||38
7750633|NCT01484834|19083871|P2|COMPLETED|Overall Study||54
7750634|NCT01484834|19083872|P1|COMPLETED|Overall Study||60
7750635|NCT01484834|19083869|P4|STARTED|Overall Study||24
7750636|NCT01484834|19083870|P3|STARTED|Overall Study||39
7750637|NCT01484834|19083871|P2|STARTED|Overall Study||62
7750638|NCT01484834|19083872|P1|STARTED|Overall Study||65
7750639|NCT01484652|19083900|P2|NOT COMPLETED|Overall Study||21
7750640|NCT01484652|19083901|P1|NOT COMPLETED|Overall Study||15
7750641|NCT01484652|19083900|P2|COMPLETED|Overall Study||142
7750642|NCT01484652|19083901|P1|COMPLETED|Overall Study||151
7750643|NCT01484652|19083900|P2|STARTED|Overall Study||163
7750644|NCT01484652|19083901|P1|STARTED|Overall Study||166
7750645|NCT01484626|19083907|P1|NOT COMPLETED|Overall Study||0
7750646|NCT01484626|19083907|P1|COMPLETED|Overall Study||3
7750647|NCT01484626|19083907|P1|STARTED|Overall Study||3
7750648|NCT01484561|19083913|P2|NOT COMPLETED|Overall Study||6
7750649|NCT01484561|19083914|P1|NOT COMPLETED|Overall Study||9
7750650|NCT01484561|19083913|P2|COMPLETED|Overall Study||45
7750651|NCT01484561|19083914|P1|COMPLETED|Overall Study||88
7750652|NCT01484561|19083913|P2|STARTED|Overall Study||51
7750653|NCT01484561|19083914|P1|STARTED|Overall Study||97
7750654|NCT01484496|19084004|P4|NOT COMPLETED|Period 2||22
7750655|NCT01484496|19084005|P3|NOT COMPLETED|Period 2||15
7750656|NCT01484496|19084006|P2|NOT COMPLETED|Period 2||0
7750657|NCT01484496|19084007|P1|NOT COMPLETED|Period 2||0
7750658|NCT01484496|19084004|P4|COMPLETED|Period 2||434
7750659|NCT01484496|19084005|P3|COMPLETED|Period 2||191
7750660|NCT01484496|19084006|P2|COMPLETED|Period 2||0
7750661|NCT01484496|19084007|P1|COMPLETED|Period 2||0
7750662|NCT01484496|19084004|P4|STARTED|Period 2||456
7750663|NCT01484496|19084005|P3|STARTED|Period 2||206
7750664|NCT01484496|19084006|P2|STARTED|Period 2||0
7750665|NCT01484496|19084007|P1|STARTED|Period 2||0
7750666|NCT01484496|19084004|P4|NOT COMPLETED|Period 1||0
7750667|NCT01484496|19084005|P3|NOT COMPLETED|Period 1||0
7750668|NCT01484496|19084006|P2|NOT COMPLETED|Period 1||93
7750669|NCT01484496|19084007|P1|NOT COMPLETED|Period 1||66
7750670|NCT01484496|19084004|P4|COMPLETED|Period 1||0
7750671|NCT01484496|19084005|P3|COMPLETED|Period 1||0
7750672|NCT01484496|19084006|P2|COMPLETED|Period 1||463
7750673|NCT01484496|19084007|P1|COMPLETED|Period 1||214
7750674|NCT01484496|19084004|P4|STARTED|Period 1||0
7750675|NCT01484496|19084005|P3|STARTED|Period 1||0
7750676|NCT01484496|19084006|P2|STARTED|Period 1||556
7750677|NCT01484496|19084007|P1|STARTED|Period 1||280
7750678|NCT01484431|19084022|P3|NOT COMPLETED|Period 2||2
7750679|NCT01484431|19084023|P2|NOT COMPLETED|Period 2||1
7750680|NCT01484431|19084024|P1|NOT COMPLETED|Period 2||1
7750681|NCT01484431|19084022|P3|COMPLETED|Period 2||4
7750682|NCT01484431|19084023|P2|COMPLETED|Period 2||5
7750683|NCT01484431|19084024|P1|COMPLETED|Period 2||5
7750684|NCT01484431|19084022|P3|Received 40 mg|Period 2||1
7750685|NCT01484431|19084023|P2|Received 40 mg|Period 2||0
7750686|NCT01484431|19084024|P1|Received 40 mg|Period 2||0
7750687|NCT01484431|19084022|P3|Received 20 mg|Period 2||4
7750688|NCT01484431|19084023|P2|Received 20 mg|Period 2||1
7750689|NCT01484431|19084024|P1|Received 20 mg|Period 2||3
7750690|NCT01484431|19084022|P3|Received 15 mg|Period 2||1
7750691|NCT01484431|19084023|P2|Received 15 mg|Period 2||2
7750692|NCT01484431|19084024|P1|Received 15 mg|Period 2||1
7750693|NCT01484431|19084022|P3|Received 10 mg|Period 2||0
7750694|NCT01484431|19084023|P2|Received 10 mg|Period 2||1
7750695|NCT01484431|19084024|P1|Received 10 mg|Period 2||0
7750696|NCT01484431|19084022|P3|Received 8 mg|Period 2||0
7750697|NCT01484431|19084023|P2|Received 8 mg|Period 2||0
7750698|NCT01484431|19084024|P1|Received 8 mg|Period 2||1
7750699|NCT01484431|19084022|P3|Received 7.5 mg|Period 2||0
7750700|NCT01484431|19084023|P2|Received 7.5 mg|Period 2||2
7750701|NCT01484431|19084024|P1|Received 7.5 mg|Period 2||0
7750702|NCT01484431|19084022|P3|Received 7 mg|Period 2||0
7750703|NCT01484431|19084023|P2|Received 7 mg|Period 2||0
7750704|NCT01484431|19084024|P1|Received 7 mg|Period 2||1
7750705|NCT01484431|19084022|P3|STARTED|Period 2||6
7750706|NCT01484431|19084023|P2|STARTED|Period 2||6
7750707|NCT01484431|19084024|P1|STARTED|Period 2||6
7750708|NCT01484431|19084022|P3|NOT COMPLETED|Period 1: High Dose||0
7750709|NCT01484431|19084023|P2|NOT COMPLETED|Period 1: High Dose||1
7750710|NCT01484431|19084024|P1|NOT COMPLETED|Period 1: High Dose||0
7750711|NCT01484431|19084022|P3|COMPLETED|Period 1: High Dose||6
7750712|NCT01484431|19084023|P2|COMPLETED|Period 1: High Dose||6
7750713|NCT01484431|19084024|P1|COMPLETED|Period 1: High Dose||6
7750714|NCT01484431|19084022|P3|Received 40 mg|Period 1: High Dose||5
7750715|NCT01484431|19084023|P2|Received 40 mg|Period 1: High Dose||0
7750716|NCT01484431|19084024|P1|Received 40 mg|Period 1: High Dose||0
7750717|NCT01484431|19084022|P3|Received 20 mg|Period 1: High Dose||1
7750718|NCT01484431|19084023|P2|Received 20 mg|Period 1: High Dose||5
7750719|NCT01484431|19084024|P1|Received 20 mg|Period 1: High Dose||3
7750720|NCT01484431|19084022|P3|Received 15 mg|Period 1: High Dose||0
7750721|NCT01484431|19084023|P2|Received 15 mg|Period 1: High Dose||1
7750722|NCT01484431|19084024|P1|Received 15 mg|Period 1: High Dose||1
7750723|NCT01484431|19084022|P3|Received 10 mg|Period 1: High Dose||0
7750724|NCT01484431|19084023|P2|Received 10 mg|Period 1: High Dose||1
7750725|NCT01484431|19084024|P1|Received 10 mg|Period 1: High Dose||1
7750726|NCT01484431|19084022|P3|Received 8 mg|Period 1: High Dose||0
7750727|NCT01484431|19084023|P2|Received 8 mg|Period 1: High Dose||0
7750728|NCT01484431|19084024|P1|Received 8 mg|Period 1: High Dose||1
7750729|NCT01484431|19084022|P3|STARTED|Period 1: High Dose||6
7750730|NCT01484431|19084023|P2|STARTED|Period 1: High Dose||7
7750731|NCT01484431|19084024|P1|STARTED|Period 1: High Dose||6
7750732|NCT01484431|19084022|P3|NOT COMPLETED|Period 1: Low Dose||0
7750733|NCT01484431|19084023|P2|NOT COMPLETED|Period 1: Low Dose||0
7750734|NCT01484431|19084024|P1|NOT COMPLETED|Period 1: Low Dose||0
7750735|NCT01484431|19084022|P3|COMPLETED|Period 1: Low Dose||6
7750736|NCT01484431|19084023|P2|COMPLETED|Period 1: Low Dose||7
7750737|NCT01484431|19084024|P1|COMPLETED|Period 1: Low Dose||6
7750738|NCT01484431|19084022|P3|Received 10 mg|Period 1: Low Dose||6
7750739|NCT01484431|19084023|P2|Received 10 mg|Period 1: Low Dose||0
7750740|NCT01484431|19084024|P1|Received 10 mg|Period 1: Low Dose||0
7750741|NCT01484431|19084022|P3|Received 5 mg|Period 1: Low Dose||0
7750742|NCT01484431|19084023|P2|Received 5 mg|Period 1: Low Dose||7
7750743|NCT01484431|19084024|P1|Received 5 mg|Period 1: Low Dose||0
7750744|NCT01484431|19084022|P3|Received 4 mg|Period 1: Low Dose||0
7750745|NCT01484431|19084023|P2|Received 4 mg|Period 1: Low Dose||0
7750746|NCT01484431|19084024|P1|Received 4 mg|Period 1: Low Dose||5
7750747|NCT01484431|19084022|P3|Received 2 mg|Period 1: Low Dose||0
7750748|NCT01484431|19084023|P2|Received 2 mg|Period 1: Low Dose||0
7750749|NCT01484431|19084024|P1|Received 2 mg|Period 1: Low Dose||1
7750750|NCT01484431|19084022|P3|STARTED|Period 1: Low Dose||6
7750751|NCT01484431|19084023|P2|STARTED|Period 1: Low Dose||7
7750752|NCT01484431|19084024|P1|STARTED|Period 1: Low Dose||6
7750753|NCT01484340|19084041|P2|NOT COMPLETED|Overall Study||0
7750754|NCT01484340|19084042|P1|NOT COMPLETED|Overall Study||0
7750755|NCT01484340|19084041|P2|COMPLETED|Overall Study||279
7750756|NCT01484340|19084042|P1|COMPLETED|Overall Study||281
7750757|NCT01484340|19084041|P2|STARTED|Overall Study||279
7750758|NCT01484340|19084042|P1|STARTED|Overall Study||281
7750759|NCT01484314|19084054|P1|NOT COMPLETED|Overall Study||0
7750760|NCT01484314|19084054|P1|COMPLETED|Overall Study||1
7750761|NCT01484314|19084054|P1|STARTED|Overall Study||1
7750762|NCT01484275|19084062|P2|NOT COMPLETED|Overall Study||42
7750763|NCT01484275|19084063|P1|NOT COMPLETED|Overall Study||43
7750764|NCT01484275|19084062|P2|COMPLETED|Overall Study||0
7750765|NCT01484275|19084063|P1|COMPLETED|Overall Study||0
7750766|NCT01484275|19084062|P2|STARTED|Overall Study||42
7750767|NCT01484275|19084063|P1|STARTED|Overall Study||43
7750768|NCT01484197|19084085|P4|NOT COMPLETED|Treatment Period 4||0
7750769|NCT01484197|19084086|P3|NOT COMPLETED|Treatment Period 4||0
7750770|NCT01484197|19084087|P2|NOT COMPLETED|Treatment Period 4||0
7750771|NCT01484197|19084088|P1|NOT COMPLETED|Treatment Period 4||0
7750772|NCT01484197|19084085|P4|COMPLETED|Treatment Period 4||6
7750773|NCT01484197|19084086|P3|COMPLETED|Treatment Period 4||9
7750774|NCT01484197|19084087|P2|COMPLETED|Treatment Period 4||8
7750775|NCT01484197|19084088|P1|COMPLETED|Treatment Period 4||7
7750776|NCT01484197|19084085|P4|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6
7750777|NCT01484197|19084086|P3|STARTED|Treatment Period 4||9
7750778|NCT01484197|19084087|P2|STARTED|Treatment Period 4||8
7750779|NCT01484197|19084088|P1|STARTED|Treatment Period 4||7
7750780|NCT01484197|19084085|P4|NOT COMPLETED|Treatment Period 3||0
7750781|NCT01484197|19084086|P3|NOT COMPLETED|Treatment Period 3||0
7750782|NCT01484197|19084087|P2|NOT COMPLETED|Treatment Period 3||0
7750783|NCT01484197|19084088|P1|NOT COMPLETED|Treatment Period 3||0
7750784|NCT01484197|19084085|P4|COMPLETED|Treatment Period 3||8
7750785|NCT01484197|19084086|P3|COMPLETED|Treatment Period 3||9
7750786|NCT01484197|19084087|P2|COMPLETED|Treatment Period 3||8
7750787|NCT01484197|19084088|P1|COMPLETED|Treatment Period 3||7
7750788|NCT01484197|19084085|P4|STARTED|Treatment Period 3||8
7750789|NCT01484197|19084086|P3|STARTED|Treatment Period 3||9
7750790|NCT01484197|19084087|P2|STARTED|Treatment Period 3||8
7750791|NCT01484197|19084088|P1|STARTED|Treatment Period 3||7
7750792|NCT01484197|19084085|P4|NOT COMPLETED|Treatment Period 2||1
7750793|NCT01484197|19084086|P3|NOT COMPLETED|Treatment Period 2||0
7750794|NCT01484197|19084087|P2|NOT COMPLETED|Treatment Period 2||0
7750795|NCT01484197|19084088|P1|NOT COMPLETED|Treatment Period 2||0
7750796|NCT01484197|19084085|P4|COMPLETED|Treatment Period 2||8
7750797|NCT01484197|19084086|P3|COMPLETED|Treatment Period 2||9
7750798|NCT01484197|19084087|P2|COMPLETED|Treatment Period 2||8
7750799|NCT01484197|19084088|P1|COMPLETED|Treatment Period 2||7
7750800|NCT01484197|19084085|P4|STARTED|Treatment Period 2||9
7750801|NCT01484197|19084086|P3|STARTED|Treatment Period 2||9
7750802|NCT01484197|19084087|P2|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8
7750803|NCT01484197|19084088|P1|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7
7750804|NCT01484197|19084085|P4|NOT COMPLETED|Treatment Period 1||0
7750805|NCT01484197|19084086|P3|NOT COMPLETED|Treatment Period 1||0
7750806|NCT01484197|19084087|P2|NOT COMPLETED|Treatment Period 1||0
7750807|NCT01484197|19084088|P1|NOT COMPLETED|Treatment Period 1||1
7750808|NCT01484197|19084085|P4|COMPLETED|Treatment Period 1||9
7750809|NCT01484197|19084086|P3|COMPLETED|Treatment Period 1||9
7750810|NCT01484197|19084087|P2|COMPLETED|Treatment Period 1||9
7750811|NCT01484197|19084088|P1|COMPLETED|Treatment Period 1||8
7750812|NCT01484197|19084085|P4|STARTED|Treatment Period 1||9
7750813|NCT01484197|19084086|P3|STARTED|Treatment Period 1||9
7750814|NCT01484197|19084087|P2|STARTED|Treatment Period 1||9
7750815|NCT01484197|19084088|P1|STARTED|Treatment Period 1||9
7750816|NCT01484132|19084171|P1|NOT COMPLETED|Overall Study||22
7750817|NCT01484132|19084171|P1|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91
7750818|NCT01484132|19084171|P1|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101
7750819|NCT01484132|19084171|P1|STARTED|Overall Study||113
7750820|NCT01484054|19084179|P2|NOT COMPLETED|Period 2||0
7750821|NCT01484054|19084180|P1|NOT COMPLETED|Period 2||0
7750822|NCT01484054|19084179|P2|COMPLETED|Period 2||49
7750823|NCT01484054|19084180|P1|COMPLETED|Period 2||50
7750824|NCT01484054|19084179|P2|STARTED|Period 2||49
7750825|NCT01484054|19084180|P1|STARTED|Period 2||50
7750826|NCT01484054|19084179|P2|NOT COMPLETED|Period 1||1
7750827|NCT01484054|19084180|P1|NOT COMPLETED|Period 1||0
7750828|NCT01484054|19084179|P2|COMPLETED|Period 1||49
7750829|NCT01484054|19084180|P1|COMPLETED|Period 1||50
7750830|NCT01484054|19084179|P2|STARTED|Period 1||50
7750831|NCT01484054|19084180|P1|STARTED|Period 1||50
7750832|NCT01484041|19084190|P1|NOT COMPLETED|Overall Study||0
7750833|NCT01484041|19084190|P1|COMPLETED|Overall Study||12
7750834|NCT01484041|19084190|P1|STARTED|Overall Study||12
7750835|NCT01484028|19084198|P4|NOT COMPLETED|Period 2||0
7750836|NCT01484028|19084199|P3|NOT COMPLETED|Period 2||0
7750837|NCT01484028|19084200|P2|NOT COMPLETED|Period 2||0
7750838|NCT01484028|19084201|P1|NOT COMPLETED|Period 2||0
7750839|NCT01484028|19084198|P4|COMPLETED|Period 2||66
7750840|NCT01484028|19084199|P3|COMPLETED|Period 2||64
7750841|NCT01484028|19084200|P2|COMPLETED|Period 2||67
7750842|NCT01484028|19084201|P1|COMPLETED|Period 2||66
7750843|NCT01484028|19084198|P4|STARTED|Period 2||66
7750844|NCT01484028|19084199|P3|STARTED|Period 2||64
7750845|NCT01484028|19084200|P2|STARTED|Period 2||67
7750846|NCT01484028|19084201|P1|STARTED|Period 2||66
7750847|NCT01484028|19084198|P4|NOT COMPLETED|Period 1||1
7750848|NCT01484028|19084199|P3|NOT COMPLETED|Period 1||0
7750849|NCT01484028|19084200|P2|NOT COMPLETED|Period 1||3
7750850|NCT01484028|19084201|P1|NOT COMPLETED|Period 1||0
7750851|NCT01484028|19084198|P4|COMPLETED|Period 1||66
7750852|NCT01484028|19084199|P3|COMPLETED|Period 1||64
7750853|NCT01484028|19084200|P2|COMPLETED|Period 1||67
7750854|NCT01484028|19084201|P1|COMPLETED|Period 1||66
7750855|NCT01484028|19084198|P4|STARTED|Period 1||67
7750856|NCT01484028|19084199|P3|STARTED|Period 1||64
7750857|NCT01484028|19084200|P2|STARTED|Period 1||70
7750858|NCT01484028|19084201|P1|STARTED|Period 1||66
7750859|NCT01483963|19084216|P5|NOT COMPLETED|Overall Study||0
7750860|NCT01483963|19084217|P4|NOT COMPLETED|Overall Study||0
7750861|NCT01483963|19084218|P3|NOT COMPLETED|Overall Study||0
7750862|NCT01483963|19084219|P2|NOT COMPLETED|Overall Study||0
7750863|NCT01483963|19084220|P1|NOT COMPLETED|Overall Study||0
7750864|NCT01483963|19084216|P5|COMPLETED|Overall Study||10
7750865|NCT01483963|19084217|P4|COMPLETED|Overall Study||10
7750866|NCT01483963|19084218|P3|COMPLETED|Overall Study||10
7750867|NCT01483963|19084219|P2|COMPLETED|Overall Study||10
7750868|NCT01483963|19084220|P1|COMPLETED|Overall Study||10
7750869|NCT01483963|19084216|P5|STARTED|Overall Study||10
7750870|NCT01483963|19084217|P4|STARTED|Overall Study||10
7750871|NCT01483963|19084218|P3|STARTED|Overall Study||10
7750872|NCT01483963|19084219|P2|STARTED|Overall Study||10
7750873|NCT01483963|19084220|P1|STARTED|Overall Study||10
7750874|NCT01483937|19084294|P2|NOT COMPLETED|Overall Study||3
7750875|NCT01483937|19084295|P1|NOT COMPLETED|Overall Study||4
7750876|NCT01483937|19084294|P2|COMPLETED|Overall Study||14
7750877|NCT01483937|19084295|P1|COMPLETED|Overall Study||11
7750878|NCT01483937|19084294|P2|STARTED|Overall Study||17
7750879|NCT01483937|19084295|P1|STARTED|Overall Study||15
7750880|NCT01483924|19084322|P5|NOT COMPLETED|Overall Study||2
7750881|NCT01483924|19084323|P4|NOT COMPLETED|Overall Study||4
7750882|NCT01483924|19084324|P3|NOT COMPLETED|Overall Study||1
7750883|NCT01483924|19084325|P2|NOT COMPLETED|Overall Study||0
7750884|NCT01483924|19084326|P1|NOT COMPLETED|Overall Study||2
7750885|NCT01483924|19084322|P5|COMPLETED|Overall Study||10
7750886|NCT01483924|19084323|P4|COMPLETED|Overall Study||8
7750887|NCT01483924|19084324|P3|COMPLETED|Overall Study||11
7750888|NCT01483924|19084325|P2|COMPLETED|Overall Study||12
7750889|NCT01483924|19084326|P1|COMPLETED|Overall Study||10
7750890|NCT01483924|19084322|P5|STARTED|Overall Study||12
7750891|NCT01483924|19084323|P4|STARTED|Overall Study||12
7750892|NCT01483924|19084324|P3|STARTED|Overall Study||12
7750893|NCT01483924|19084325|P2|STARTED|Overall Study||12
7750894|NCT01483924|19084326|P1|STARTED|Overall Study||12
7750895|NCT01483872|19084374|P2|NOT COMPLETED|Overall Study||0
7750896|NCT01483872|19084375|P1|NOT COMPLETED|Overall Study||0
7750897|NCT01483872|19084374|P2|COMPLETED|Overall Study||1
7750898|NCT01483872|19084375|P1|COMPLETED|Overall Study||0
7750899|NCT01483872|19084374|P2|STARTED|Overall Study||1
7750900|NCT01483872|19084375|P1|STARTED|Overall Study||0
7750901|NCT01483820|19084379|P1|NOT COMPLETED|Overall Study||8
7750902|NCT01483820|19084379|P1|COMPLETED|Overall Study||0
7750903|NCT01483820|19084379|P1|STARTED|Overall Study||8
7750904|NCT01483807|19084388|P2|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
7750905|NCT01483807|19084389|P1|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
7750906|NCT01483807|19084388|P2|COMPLETED|Second Treatment Phase (7 Weeks)||10
7750907|NCT01483807|19084389|P1|COMPLETED|Second Treatment Phase (7 Weeks)||10
7750908|NCT01483807|19084388|P2|STARTED|Second Treatment Phase (7 Weeks)||10
7750909|NCT01483807|19084389|P1|STARTED|Second Treatment Phase (7 Weeks)||10
7750910|NCT01483807|19084388|P2|NOT COMPLETED|Washout (2 Weeks)||0
7750911|NCT01483807|19084389|P1|NOT COMPLETED|Washout (2 Weeks)||0
7750912|NCT01483807|19084388|P2|COMPLETED|Washout (2 Weeks)||10
7750913|NCT01483807|19084389|P1|COMPLETED|Washout (2 Weeks)||10
7750914|NCT01483807|19084388|P2|STARTED|Washout (2 Weeks)||10
7750915|NCT01483807|19084389|P1|STARTED|Washout (2 Weeks)||10
7750916|NCT01483807|19084388|P2|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
7750917|NCT01483807|19084389|P1|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
7750918|NCT01483807|19084388|P2|COMPLETED|First Treatment Phase (7 Weeks)||10
7750919|NCT01483807|19084389|P1|COMPLETED|First Treatment Phase (7 Weeks)||10
7750920|NCT01483807|19084388|P2|STARTED|First Treatment Phase (7 Weeks)||10
7750921|NCT01483807|19084389|P1|STARTED|First Treatment Phase (7 Weeks)||10
7750922|NCT01483690|19084402|P2|NOT COMPLETED|Overall Study||5
7750923|NCT01483690|19084403|P1|NOT COMPLETED|Overall Study||2
7750924|NCT01483690|19084402|P2|COMPLETED|Overall Study||13
7750925|NCT01483690|19084403|P1|COMPLETED|Overall Study||3
7750926|NCT01483690|19084402|P2|STARTED|Overall Study||18
7750927|NCT01483690|19084403|P1|STARTED|Overall Study||5
7750928|NCT01483651|19084411|P6|NOT COMPLETED|Overall Study||1
7750929|NCT01483651|19084412|P5|NOT COMPLETED|Overall Study||0
7750930|NCT01483651|19084413|P4|NOT COMPLETED|Overall Study||0
7750931|NCT01483651|19084414|P3|NOT COMPLETED|Overall Study||1
7750932|NCT01483651|19084415|P2|NOT COMPLETED|Overall Study||1
7750933|NCT01483651|19084416|P1|NOT COMPLETED|Overall Study||0
7750934|NCT01483651|19084411|P6|COMPLETED|Overall Study||1
7750935|NCT01483651|19084412|P5|COMPLETED|Overall Study||2
7750936|NCT01483651|19084413|P4|COMPLETED|Overall Study||1
7750937|NCT01483651|19084414|P3|COMPLETED|Overall Study||1
7750938|NCT01483651|19084415|P2|COMPLETED|Overall Study||2
7750939|NCT01483651|19084416|P1|COMPLETED|Overall Study||1
7750940|NCT01483651|19084411|P6|STARTED|Overall Study||2
7750941|NCT01483651|19084412|P5|STARTED|Overall Study||2
7750942|NCT01483651|19084413|P4|STARTED|Overall Study||1
7750943|NCT01483651|19084414|P3|STARTED|Overall Study||2
7750944|NCT01483651|19084415|P2|STARTED|Overall Study||3
7750945|NCT01483651|19084416|P1|STARTED|Overall Study||1
7750946|NCT01483625|19084426|P2|NOT COMPLETED|Overall Study||2
7750947|NCT01483625|19084427|P1|NOT COMPLETED|Overall Study||4
7750948|NCT01483625|19084426|P2|COMPLETED|Overall Study||66
7750949|NCT01483625|19084427|P1|COMPLETED|Overall Study||68
7750950|NCT01483625|19084426|P2|STARTED|Overall Study||68
7750951|NCT01483625|19084427|P1|STARTED|Overall Study||72
7750952|NCT01483599|19084450|P14|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||7
7750953|NCT01483599|19084451|P13|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||3
7750954|NCT01483599|19084452|P12|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||1
7750955|NCT01483599|19084453|P11|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
7750956|NCT01483599|19084454|P10|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||4
7750957|NCT01483599|19084455|P9|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||9
7750958|NCT01483599|19084456|P8|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
7750959|NCT01483599|19084457|P7|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
7750960|NCT01483599|19084458|P6|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
7750961|NCT01483599|19084459|P5|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
7750962|NCT01483599|19084460|P4|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
7750963|NCT01483599|19084461|P3|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
7750964|NCT01483599|19084462|P2|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
7750965|NCT01483599|19084463|P1|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
7750966|NCT01483599|19084450|P14|COMPLETED|After Controlled Period(Week 16-Week 40)||32
7750967|NCT01483599|19084451|P13|COMPLETED|After Controlled Period(Week 16-Week 40)||35
7750968|NCT01483599|19084452|P12|COMPLETED|After Controlled Period(Week 16-Week 40)||39
7750969|NCT01483599|19084453|P11|COMPLETED|After Controlled Period(Week 16-Week 40)||37
7750970|NCT01483599|19084454|P10|COMPLETED|After Controlled Period(Week 16-Week 40)||37
7750971|NCT01483599|19084455|P9|COMPLETED|After Controlled Period(Week 16-Week 40)||29
7750972|NCT01483599|19084456|P8|COMPLETED|After Controlled Period(Week 16-Week 40)||37
7750973|NCT01483599|19084457|P7|COMPLETED|After Controlled Period(Week 16-Week 40)||0
7750974|NCT01483599|19084458|P6|COMPLETED|After Controlled Period(Week 16-Week 40)||0
7750975|NCT01483599|19084459|P5|COMPLETED|After Controlled Period(Week 16-Week 40)||0
7750976|NCT01483599|19084460|P4|COMPLETED|After Controlled Period(Week 16-Week 40)||0
7750977|NCT01483599|19084461|P3|COMPLETED|After Controlled Period(Week 16-Week 40)||0
7750978|NCT01483599|19084462|P2|COMPLETED|After Controlled Period(Week 16-Week 40)||0
7750979|NCT01483599|19084463|P1|COMPLETED|After Controlled Period(Week 16-Week 40)||0
7750980|NCT01483599|19084450|P14|STARTED|After Controlled Period(Week 16-Week 40)||39
7750981|NCT01483599|19084451|P13|STARTED|After Controlled Period(Week 16-Week 40)||38
7750982|NCT01483599|19084452|P12|STARTED|After Controlled Period(Week 16-Week 40)||40
7750983|NCT01483599|19084453|P11|STARTED|After Controlled Period(Week 16-Week 40)||39
7750984|NCT01483599|19084454|P10|STARTED|After Controlled Period(Week 16-Week 40)||41
7750985|NCT01483599|19084455|P9|STARTED|After Controlled Period(Week 16-Week 40)||38
7750986|NCT01483599|19084456|P8|STARTED|After Controlled Period(Week 16-Week 40)||39
7750987|NCT01483599|19084457|P7|STARTED|After Controlled Period(Week 16-Week 40)||0
7750988|NCT01483599|19084458|P6|STARTED|After Controlled Period(Week 16-Week 40)||0
7750989|NCT01483599|19084459|P5|STARTED|After Controlled Period(Week 16-Week 40)||0
7750990|NCT01483599|19084460|P4|STARTED|After Controlled Period(Week 16-Week 40)||0
7750991|NCT01483599|19084461|P3|STARTED|After Controlled Period(Week 16-Week 40)||0
7750992|NCT01483599|19084462|P2|STARTED|After Controlled Period(Week 16-Week 40)||0
7750993|NCT01483599|19084463|P1|STARTED|After Controlled Period(Week 16-Week 40)||0
7750994|NCT01483599|19084450|P14|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
7750995|NCT01483599|19084451|P13|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
7750996|NCT01483599|19084452|P12|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
7750997|NCT01483599|19084453|P11|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
7750998|NCT01483599|19084454|P10|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
7750999|NCT01483599|19084455|P9|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
7751000|NCT01483599|19084456|P8|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
7751001|NCT01483599|19084457|P7|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
7751002|NCT01483599|19084458|P6|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
7751003|NCT01483599|19084459|P5|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||2
7751004|NCT01483599|19084460|P4|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
7751005|NCT01483599|19084461|P3|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
7751006|NCT01483599|19084462|P2|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
7751007|NCT01483599|19084463|P1|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
7751008|NCT01483599|19084450|P14|COMPLETED|Controlled Period (CP) (up to Week 16)||0
7751009|NCT01483599|19084451|P13|COMPLETED|Controlled Period (CP) (up to Week 16)||0
7751010|NCT01483599|19084452|P12|COMPLETED|Controlled Period (CP) (up to Week 16)||0
7751011|NCT01483599|19084453|P11|COMPLETED|Controlled Period (CP) (up to Week 16)||0
7751012|NCT01483599|19084454|P10|COMPLETED|Controlled Period (CP) (up to Week 16)||0
7751013|NCT01483599|19084455|P9|COMPLETED|Controlled Period (CP) (up to Week 16)||0
7751014|NCT01483599|19084456|P8|COMPLETED|Controlled Period (CP) (up to Week 16)||0
7751015|NCT01483599|19084457|P7|COMPLETED|Controlled Period (CP) (up to Week 16)||39
7751016|NCT01483599|19084458|P6|COMPLETED|Controlled Period (CP) (up to Week 16)||38
7751017|NCT01483599|19084459|P5|COMPLETED|Controlled Period (CP) (up to Week 16)||40
7751018|NCT01483599|19084460|P4|COMPLETED|Controlled Period (CP) (up to Week 16)||39
7751019|NCT01483599|19084461|P3|COMPLETED|Controlled Period (CP) (up to Week 16)||41
7751020|NCT01483599|19084462|P2|COMPLETED|Controlled Period (CP) (up to Week 16)||38
7751021|NCT01483599|19084463|P1|COMPLETED|Controlled Period (CP) (up to Week 16)||39
7751022|NCT01483599|19084450|P14|Treated|Controlled Period (CP) (up to Week 16)||0
7751023|NCT01483599|19084451|P13|Treated|Controlled Period (CP) (up to Week 16)||0
7751024|NCT01483599|19084452|P12|Treated|Controlled Period (CP) (up to Week 16)||0
7751025|NCT01483599|19084453|P11|Treated|Controlled Period (CP) (up to Week 16)||0
7751026|NCT01483599|19084454|P10|Treated|Controlled Period (CP) (up to Week 16)||0
7751027|NCT01483599|19084455|P9|Treated|Controlled Period (CP) (up to Week 16)||0
7751028|NCT01483599|19084456|P8|Treated|Controlled Period (CP) (up to Week 16)||0
7751029|NCT01483599|19084457|P7|Treated|Controlled Period (CP) (up to Week 16)||43
7751030|NCT01483599|19084458|P6|Treated|Controlled Period (CP) (up to Week 16)||41
7751031|NCT01483599|19084459|P5|Treated|Controlled Period (CP) (up to Week 16)||42
7751032|NCT01483599|19084460|P4|Treated|Controlled Period (CP) (up to Week 16)||42
7751033|NCT01483599|19084461|P3|Treated|Controlled Period (CP) (up to Week 16)||41
7751034|NCT01483599|19084462|P2|Treated|Controlled Period (CP) (up to Week 16)||41
7751035|NCT01483599|19084463|P1|Treated|Controlled Period (CP) (up to Week 16)||42
7751036|NCT01483599|19084450|P14|STARTED|Controlled Period (CP) (up to Week 16)||0
7751037|NCT01483599|19084451|P13|STARTED|Controlled Period (CP) (up to Week 16)||0
7751038|NCT01483599|19084452|P12|STARTED|Controlled Period (CP) (up to Week 16)||0
7751039|NCT01483599|19084453|P11|STARTED|Controlled Period (CP) (up to Week 16)||0
7751040|NCT01483599|19084454|P10|STARTED|Controlled Period (CP) (up to Week 16)||0
7751041|NCT01483599|19084455|P9|STARTED|Controlled Period (CP) (up to Week 16)||0
7751042|NCT01483599|19084456|P8|STARTED|Controlled Period (CP) (up to Week 16)||0
7751043|NCT01483599|19084457|P7|STARTED|Controlled Period (CP) (up to Week 16)||43
7751044|NCT01483599|19084458|P6|STARTED|Controlled Period (CP) (up to Week 16)||42
7751045|NCT01483599|19084459|P5|STARTED|Controlled Period (CP) (up to Week 16)||42
7751046|NCT01483599|19084460|P4|STARTED|Controlled Period (CP) (up to Week 16)||42
7751047|NCT01483599|19084461|P3|STARTED|Controlled Period (CP) (up to Week 16)||41
7751048|NCT01483599|19084462|P2|STARTED|Controlled Period (CP) (up to Week 16)||41
7751049|NCT01483599|19084463|P1|STARTED|Controlled Period (CP) (up to Week 16)||42
7751050|NCT01483560|19084514|P2|NOT COMPLETED|Overall Study||15
7751051|NCT01483560|19084515|P1|NOT COMPLETED|Overall Study||26
7751052|NCT01483560|19084514|P2|COMPLETED|Overall Study||194
7751053|NCT01483560|19084515|P1|COMPLETED|Overall Study||193
7751054|NCT01483560|19084514|P2|STARTED|Overall Study||209
7751055|NCT01483560|19084515|P1|STARTED|Overall Study||219
7751056|NCT01483378|19084535|P2|NOT COMPLETED|Overall Study||0
7751057|NCT01483378|19084536|P1|NOT COMPLETED|Overall Study||0
7751058|NCT01483378|19084535|P2|COMPLETED|Overall Study||66
7751059|NCT01483378|19084536|P1|COMPLETED|Overall Study||100
7751060|NCT01483378|19084535|P2|STARTED|Overall Study||66
7751061|NCT01483378|19084536|P1|STARTED|Overall Study||100
7751062|NCT01483352|19084542|P1|NOT COMPLETED|Overall Study||0
7751063|NCT01483352|19084542|P1|COMPLETED|Overall Study||12
7751064|NCT01483352|19084542|P1|STARTED|Overall Study||12
7751065|NCT01483209|19084561|P1|NOT COMPLETED|Overall Study||1
7751066|NCT01483209|19084561|P1|COMPLETED|Overall Study||1
7751067|NCT01483209|19084561|P1|STARTED|Overall Study||2
7751068|NCT01483183|19084576|P10|NOT COMPLETED|Overall Study||1
7751069|NCT01483183|19084577|P9|NOT COMPLETED|Overall Study||0
7751070|NCT01483183|19084578|P8|NOT COMPLETED|Overall Study||0
7751071|NCT01483183|19084579|P7|NOT COMPLETED|Overall Study||2
7751072|NCT01483183|19084580|P6|NOT COMPLETED|Overall Study||0
7751073|NCT01483183|19084581|P5|NOT COMPLETED|Overall Study||0
7751074|NCT01483183|19084582|P4|NOT COMPLETED|Overall Study||0
7751075|NCT01483183|19084583|P3|NOT COMPLETED|Overall Study||0
7751076|NCT01483183|19084584|P2|NOT COMPLETED|Overall Study||0
7751077|NCT01483183|19084585|P1|NOT COMPLETED|Overall Study||0
7751078|NCT01483183|19084576|P10|COMPLETED|Overall Study||4
7751079|NCT01483183|19084577|P9|COMPLETED|Overall Study||4
7751080|NCT01483183|19084578|P8|COMPLETED|Overall Study||4
7751081|NCT01483183|19084579|P7|COMPLETED|Overall Study||4
7751082|NCT01483183|19084580|P6|COMPLETED|Overall Study||4
7751083|NCT01483183|19084581|P5|COMPLETED|Overall Study||4
7751084|NCT01483183|19084582|P4|COMPLETED|Overall Study||3
7751085|NCT01483183|19084583|P3|COMPLETED|Overall Study||5
7751086|NCT01483183|19084584|P2|COMPLETED|Overall Study||1
7751087|NCT01483183|19084585|P1|COMPLETED|Overall Study||4
7751088|NCT01483183|19084576|P10|STARTED|Overall Study||5
7751089|NCT01483183|19084577|P9|STARTED|Overall Study||4
7751090|NCT01483183|19084578|P8|STARTED|Overall Study||4
7751091|NCT01483183|19084579|P7|STARTED|Overall Study||6
7751092|NCT01483183|19084580|P6|STARTED|Overall Study||4
7751093|NCT01483183|19084581|P5|STARTED|Overall Study||4
7751094|NCT01483183|19084582|P4|STARTED|Overall Study||3
7751095|NCT01483183|19084583|P3|STARTED|Overall Study||5
7751096|NCT01483183|19084584|P2|STARTED|Overall Study||1
7751097|NCT01483183|19084585|P1|STARTED|Overall Study||4
7751098|NCT01483118|19084655|P2|NOT COMPLETED|Overall Study||16
7751099|NCT01483118|19084656|P1|NOT COMPLETED|Overall Study||12
7751100|NCT01483118|19084655|P2|COMPLETED|Overall Study||6
7751101|NCT01483118|19084656|P1|COMPLETED|Overall Study||11
7751102|NCT01483118|19084655|P2|Completed 3 Months|Overall Study||11
7751103|NCT01483118|19084656|P1|Completed 3 Months|Overall Study||15
7751104|NCT01483118|19084655|P2|STARTED|Overall Study||22
7751105|NCT01483118|19084656|P1|STARTED|Overall Study||23
7751106|NCT01482962|19084668|P2|NOT COMPLETED|Overall Study||133
7751107|NCT01482962|19084669|P1|NOT COMPLETED|Overall Study||138
7751108|NCT01482962|19084668|P2|COMPLETED|Overall Study||0
7751109|NCT01482962|19084669|P1|COMPLETED|Overall Study||0
7751110|NCT01482962|19084668|P2|Safety Population: Received Study Drug|Overall Study||127
7751111|NCT01482962|19084669|P1|Safety Population: Received Study Drug|Overall Study||137
7751112|NCT01482962|19084668|P2|STARTED|Overall Study||133
7751113|NCT01482962|19084669|P1|STARTED|Overall Study||138
7751114|NCT01482910|19084702|P2|NOT COMPLETED|Overall Study||9
7751115|NCT01482910|19084703|P1|NOT COMPLETED|Overall Study||15
7751116|NCT01482910|19084702|P2|COMPLETED|Overall Study||67
7751117|NCT01482910|19084703|P1|COMPLETED|Overall Study||213
7751118|NCT01482910|19084702|P2|Completed Week 28|Overall Study||71
7751119|NCT01482910|19084703|P1|Completed Week 28|Overall Study||216
7751120|NCT01482910|19084702|P2|STARTED|Overall Study||76
7751121|NCT01482910|19084703|P1|STARTED|Overall Study||228
7751122|NCT01482884|19084715|P2|NOT COMPLETED|Overall Study||18
7751123|NCT01482884|19084716|P1|NOT COMPLETED|Overall Study||13
7751124|NCT01482884|19084715|P2|COMPLETED|Overall Study||37
7751125|NCT01482884|19084716|P1|COMPLETED|Overall Study||43
7751126|NCT01482884|19084715|P2|STARTED|Overall Study||55
7751127|NCT01482884|19084716|P1|STARTED|Overall Study|One participant did not receive study treatment|56
7751128|NCT01482819|19084742|P1|NOT COMPLETED|Overall Study||2
7751129|NCT01482819|19084742|P1|COMPLETED|Overall Study||19
7751130|NCT01482819|19084742|P1|STARTED|Overall Study||21
7751131|NCT01482767|19084762|P2|NOT COMPLETED|Overall Study||49
7751132|NCT01482767|19084763|P1|NOT COMPLETED|Overall Study||54
7751133|NCT01482767|19084762|P2|COMPLETED|Overall Study||78
7751134|NCT01482767|19084763|P1|COMPLETED|Overall Study||81
7751135|NCT01482767|19084762|P2|STARTED|Overall Study||127
7751136|NCT01482767|19084763|P1|STARTED|Overall Study||135
7751137|NCT01482715|19084796|P13|NOT COMPLETED|Overall Study||0
7751138|NCT01482715|19084797|P12|NOT COMPLETED|Overall Study||0
7751139|NCT01482715|19084798|P11|NOT COMPLETED|Overall Study||0
7751140|NCT01482715|19084799|P10|NOT COMPLETED|Overall Study||0
7751141|NCT01482715|19084800|P9|NOT COMPLETED|Overall Study||0
7751142|NCT01482715|19084801|P8|NOT COMPLETED|Overall Study||0
7751143|NCT01482715|19084802|P7|NOT COMPLETED|Overall Study||0
7751144|NCT01482715|19084803|P6|NOT COMPLETED|Overall Study||0
7751145|NCT01482715|19084804|P5|NOT COMPLETED|Overall Study||0
7751146|NCT01482715|19084805|P4|NOT COMPLETED|Overall Study||0
7751147|NCT01482715|19084806|P3|NOT COMPLETED|Overall Study||0
7751148|NCT01482715|19084807|P2|NOT COMPLETED|Overall Study||0
7751149|NCT01482715|19084808|P1|NOT COMPLETED|Overall Study||0
7751150|NCT01482715|19084796|P13|COMPLETED|Overall Study||26
7751151|NCT01482715|19084797|P12|COMPLETED|Overall Study||12
7751152|NCT01482715|19084798|P11|COMPLETED|Overall Study||42
7751153|NCT01482715|19084799|P10|COMPLETED|Overall Study||3
7751154|NCT01482715|19084800|P9|COMPLETED|Overall Study||7
7751155|NCT01482715|19084801|P8|COMPLETED|Overall Study||9
7751156|NCT01482715|19084802|P7|COMPLETED|Overall Study||8
7751157|NCT01482715|19084803|P6|COMPLETED|Overall Study||3
7751158|NCT01482715|19084804|P5|COMPLETED|Overall Study||4
7751159|NCT01482715|19084805|P4|COMPLETED|Overall Study||9
7751160|NCT01482715|19084806|P3|COMPLETED|Overall Study||4
7751161|NCT01482715|19084807|P2|COMPLETED|Overall Study||3
7751162|NCT01482715|19084808|P1|COMPLETED|Overall Study||6
7751163|NCT01482715|19084796|P13|STARTED|Overall Study||26
7751164|NCT01482715|19084797|P12|STARTED|Overall Study||12
7751165|NCT01482715|19084798|P11|STARTED|Overall Study||42
7751166|NCT01482715|19084799|P10|STARTED|Overall Study||3
7751167|NCT01482715|19084800|P9|STARTED|Overall Study||7
7751168|NCT01482715|19084801|P8|STARTED|Overall Study||9
7751169|NCT01482715|19084802|P7|STARTED|Overall Study||8
7751170|NCT01482715|19084803|P6|STARTED|Overall Study||3
7751171|NCT01482715|19084804|P5|STARTED|Overall Study||4
7751172|NCT01482715|19084805|P4|STARTED|Overall Study||9
7751173|NCT01482715|19084806|P3|STARTED|Overall Study||4
7751174|NCT01482715|19084807|P2|STARTED|Overall Study||3
7751175|NCT01482715|19084808|P1|STARTED|Overall Study||6
7751176|NCT01482598|19084891|P2|NOT COMPLETED|Overall Study||22
7751177|NCT01482598|19084892|P1|NOT COMPLETED|Overall Study||16
7751178|NCT01482598|19084891|P2|COMPLETED|Overall Study||51
7751179|NCT01482598|19084892|P1|COMPLETED|Overall Study||50
7751180|NCT01482598|19084891|P2|STARTED|Overall Study||73
7751181|NCT01482598|19084892|P1|STARTED|Overall Study||66
7751182|NCT01482429|19084900|P2|NOT COMPLETED|Protocol||0
7751183|NCT01482429|19084901|P1|NOT COMPLETED|Protocol||275
7751184|NCT01482429|19084900|P2|COMPLETED|Protocol||0
7751185|NCT01482429|19084901|P1|COMPLETED|Protocol||139
7751186|NCT01482429|19084900|P2|STARTED|Protocol||0
7751187|NCT01482429|19084901|P1|STARTED|Protocol||414
7751188|NCT01482429|19084900|P2|NOT COMPLETED|Care Usual||173
7751189|NCT01482429|19084901|P1|NOT COMPLETED|Care Usual||0
7751190|NCT01482429|19084900|P2|COMPLETED|Care Usual||96
7751191|NCT01482429|19084901|P1|COMPLETED|Care Usual||0
7751192|NCT01482429|19084900|P2|STARTED|Care Usual||269
7751193|NCT01482429|19084901|P1|STARTED|Care Usual||0
7751194|NCT01482351|19084911|P1|NOT COMPLETED|Overall Study||14
7751195|NCT01482351|19084911|P1|COMPLETED|Overall Study||54
7751196|NCT01482351|19084911|P1|12 Months|Overall Study||54
7751197|NCT01482351|19084911|P1|6 Months|Overall Study|14 dropped out|54
7751198|NCT01482351|19084911|P1|STARTED|Overall Study||68
7751199|NCT01482325|19084933|P1|NOT COMPLETED|Overall Study||0
7751200|NCT01482325|19084933|P1|COMPLETED|Overall Study||31
7751201|NCT01482325|19084933|P1|STARTED|Overall Study||31
7751202|NCT01482312|19084937|P3|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
7751203|NCT01482312|19084938|P2|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
7751204|NCT01482312|19084939|P1|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
7751205|NCT01482312|19084937|P3|COMPLETED|Period 3, 90 Minutes of Wear||9
7751206|NCT01482312|19084938|P2|COMPLETED|Period 3, 90 Minutes of Wear||9
7751207|NCT01482312|19084939|P1|COMPLETED|Period 3, 90 Minutes of Wear||8
7751208|NCT01482312|19084937|P3|STARTED|Period 3, 90 Minutes of Wear||9
7751209|NCT01482312|19084938|P2|STARTED|Period 3, 90 Minutes of Wear||9
7751210|NCT01482312|19084939|P1|STARTED|Period 3, 90 Minutes of Wear||8
7751211|NCT01482312|19084937|P3|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
7751212|NCT01482312|19084938|P2|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
7751213|NCT01482312|19084939|P1|NOT COMPLETED|Period 2, 90 Minutes of Wear||1
7751214|NCT01482312|19084937|P3|COMPLETED|Period 2, 90 Minutes of Wear||9
7751215|NCT01482312|19084938|P2|COMPLETED|Period 2, 90 Minutes of Wear||9
7751216|NCT01482312|19084939|P1|COMPLETED|Period 2, 90 Minutes of Wear||8
7751217|NCT01482312|19084937|P3|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9
7751218|NCT01482312|19084938|P2|STARTED|Period 2, 90 Minutes of Wear||9
7751219|NCT01482312|19084939|P1|STARTED|Period 2, 90 Minutes of Wear||9
7751220|NCT01482312|19084937|P3|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
7751221|NCT01482312|19084938|P2|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
7751222|NCT01482312|19084939|P1|NOT COMPLETED|Period 1, 90 Minutes of Wear||1
7751223|NCT01482312|19084937|P3|COMPLETED|Period 1, 90 Minutes of Wear||10
7751224|NCT01482312|19084938|P2|COMPLETED|Period 1, 90 Minutes of Wear||9
7751225|NCT01482312|19084939|P1|COMPLETED|Period 1, 90 Minutes of Wear||9
7751226|NCT01482312|19084937|P3|STARTED|Period 1, 90 Minutes of Wear||10
7751227|NCT01482312|19084938|P2|STARTED|Period 1, 90 Minutes of Wear||9
7751228|NCT01482312|19084939|P1|STARTED|Period 1, 90 Minutes of Wear||10
7751229|NCT01482221|19084953|P3|NOT COMPLETED|Overall Study||23
7751230|NCT01482221|19084954|P2|NOT COMPLETED|Overall Study||20
7751231|NCT01482221|19084955|P1|NOT COMPLETED|Overall Study||21
7751232|NCT01482221|19084953|P3|COMPLETED|Overall Study||77
7751233|NCT01482221|19084954|P2|COMPLETED|Overall Study||81
7751234|NCT01482221|19084955|P1|COMPLETED|Overall Study||80
7751235|NCT01482221|19084953|P3|STARTED|Overall Study||100
7751236|NCT01482221|19084954|P2|STARTED|Overall Study||101
7751237|NCT01482221|19084955|P1|STARTED|Overall Study||101
7751238|NCT01482169|19084996|P1|NOT COMPLETED|Overall Study||2
7751239|NCT01482169|19084996|P1|COMPLETED|Overall Study||46
7751240|NCT01482169|19084996|P1|STARTED|Overall Study||48
7751241|NCT01482091|19085005|P2|NOT COMPLETED|Overall Study||0
7751242|NCT01482091|19085006|P1|NOT COMPLETED|Overall Study||0
7751243|NCT01482091|19085005|P2|COMPLETED|Overall Study||24
7751244|NCT01482091|19085006|P1|COMPLETED|Overall Study||25
7751245|NCT01482091|19085005|P2|STARTED|Overall Study||24
7751246|NCT01482091|19085006|P1|STARTED|Overall Study||25
7751247|NCT01482065|19085038|P2|NOT COMPLETED|Overall Study||1
7751248|NCT01482065|19085039|P1|NOT COMPLETED|Overall Study||0
7751249|NCT01482065|19085038|P2|COMPLETED|Overall Study||4
7751250|NCT01482065|19085039|P1|COMPLETED|Overall Study||4
7751251|NCT01482065|19085038|P2|STARTED|Overall Study||5
7751252|NCT01482065|19085039|P1|STARTED|Overall Study||4
7751253|NCT01481935|19085053|P2|NOT COMPLETED|Overall Study||0
7751254|NCT01481935|19085054|P1|NOT COMPLETED|Overall Study||0
7751255|NCT01481935|19085053|P2|COMPLETED|Overall Study||93
7751256|NCT01481935|19085054|P1|COMPLETED|Overall Study||97
7751257|NCT01481935|19085053|P2|STARTED|Overall Study||93
7751258|NCT01481935|19085054|P1|STARTED|Overall Study||97
7751259|NCT01481896|19085060|P1|NOT COMPLETED|Overall Study||12
7751260|NCT01481896|19085060|P1|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114
7751261|NCT01481896|19085060|P1|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114
7751262|NCT01481896|19085060|P1|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126
7751263|NCT01481779|19085076|P2|NOT COMPLETED|Overall Study||28
7751264|NCT01481779|19085077|P1|NOT COMPLETED|Overall Study||70
7751265|NCT01481779|19085076|P2|COMPLETED|Overall Study||132
7751266|NCT01481779|19085077|P1|COMPLETED|Overall Study||225
7751267|NCT01481779|19085076|P2|Received at Least 1 Dose of Study Drug|Overall Study||159
7751268|NCT01481779|19085077|P1|Received at Least 1 Dose of Study Drug|Overall Study||294
7751269|NCT01481779|19085076|P2|STARTED|Overall Study||160
7751270|NCT01481779|19085077|P1|STARTED|Overall Study||295
7751271|NCT01481740|19085125|P2|NOT COMPLETED|Overall Study||7
7751272|NCT01481740|19085126|P1|NOT COMPLETED|Overall Study||11
7751273|NCT01481740|19085125|P2|COMPLETED|Overall Study||81
7751274|NCT01481740|19085126|P1|COMPLETED|Overall Study||79
7751275|NCT01481740|19085125|P2|STARTED|Overall Study||88
7751276|NCT01481740|19085126|P1|STARTED|Overall Study||90
7751277|NCT01481558|19085144|P2|NOT COMPLETED|Overall Study||0
7751278|NCT01481558|19085145|P1|NOT COMPLETED|Overall Study||0
7751279|NCT01481558|19085144|P2|COMPLETED|Overall Study||20
7751280|NCT01481558|19085145|P1|COMPLETED|Overall Study||20
7751281|NCT01481558|19085144|P2|STARTED|Overall Study||20
7751282|NCT01481558|19085145|P1|STARTED|Overall Study||20
7751283|NCT01481376|19085151|P1|NOT COMPLETED|Overall Study||31
7751284|NCT01481376|19085151|P1|COMPLETED|Overall Study||169
7751285|NCT01481376|19085151|P1|STARTED|Overall Study||200
7751286|NCT01481324|19085162|P3|NOT COMPLETED|Overall Study||2
7751287|NCT01481324|19085163|P2|NOT COMPLETED|Overall Study||2
7751288|NCT01481324|19085164|P1|NOT COMPLETED|Overall Study||0
7751289|NCT01481324|19085162|P3|COMPLETED|Overall Study||20
7751290|NCT01481324|19085163|P2|COMPLETED|Overall Study||22
7751291|NCT01481324|19085164|P1|COMPLETED|Overall Study||21
7751292|NCT01481324|19085162|P3|Month 3-Wear Rate Data|Overall Study||6
7751293|NCT01481324|19085163|P2|Month 3-Wear Rate Data|Overall Study||11
7751294|NCT01481324|19085164|P1|Month 3-Wear Rate Data|Overall Study||7
7751295|NCT01481324|19085162|P3|Month 2-Wear Rate Data|Overall Study||7
7751296|NCT01481324|19085163|P2|Month 2-Wear Rate Data|Overall Study||13
7751297|NCT01481324|19085164|P1|Month 2-Wear Rate Data|Overall Study||9
7751298|NCT01481324|19085162|P3|Month 1-Wear Rate Data|Overall Study||8
7751299|NCT01481324|19085163|P2|Month 1-Wear Rate Data|Overall Study||16
7751300|NCT01481324|19085164|P1|Month 1-Wear Rate Data|Overall Study||15
7751301|NCT01481324|19085162|P3|STARTED|Overall Study||22
7751302|NCT01481324|19085163|P2|STARTED|Overall Study||24
7751303|NCT01481324|19085164|P1|STARTED|Overall Study||21
7751304|NCT01481129|19085172|P1|NOT COMPLETED|Overall Study||0
7751305|NCT01481129|19085172|P1|COMPLETED|Overall Study||22
7751306|NCT01481129|19085172|P1|STARTED|Overall Study||22
7751307|NCT01481116|19085183|P3|NOT COMPLETED|Overall Study||813
7751308|NCT01481116|19085184|P2|NOT COMPLETED|Overall Study||817
7751309|NCT01481116|19085185|P1|NOT COMPLETED|Overall Study||824
7751310|NCT01481116|19085183|P3|COMPLETED|Overall Study||0
7751311|NCT01481116|19085184|P2|COMPLETED|Overall Study||0
7751312|NCT01481116|19085185|P1|COMPLETED|Overall Study||0
7751313|NCT01481116|19085183|P3|Treated|Overall Study||813
7751314|NCT01481116|19085184|P2|Treated|Overall Study||816
7751315|NCT01481116|19085185|P1|Treated|Overall Study||822
7751316|NCT01481116|19085183|P3|STARTED|Overall Study||813
7751317|NCT01481116|19085184|P2|STARTED|Overall Study||817
7751318|NCT01481116|19085185|P1|STARTED|Overall Study||824
7751319|NCT01480843|19085211|P1|NOT COMPLETED|Overall Study||5
7751320|NCT01480843|19085211|P1|COMPLETED|Overall Study||60
7751321|NCT01480843|19085211|P1|STARTED|Overall Study||65
7751322|NCT01480674|19085216|P1|NOT COMPLETED|Overall Study||35
7751323|NCT01480674|19085216|P1|COMPLETED|Overall Study||125
7751324|NCT01480674|19085216|P1|Analysed Set|Overall Study||128
7751325|NCT01480674|19085216|P1|Safety Set|Overall Study||154
7751326|NCT01480674|19085216|P1|STARTED|Overall Study||160
7751327|NCT01480596|19085230|P2|NOT COMPLETED|Overall Study||2
7751328|NCT01480596|19085231|P1|NOT COMPLETED|Overall Study||5
7751329|NCT01480596|19085230|P2|COMPLETED|Overall Study||16
7751330|NCT01480596|19085231|P1|COMPLETED|Overall Study||17
7751331|NCT01480596|19085230|P2|STARTED|Overall Study||18
7751332|NCT01480596|19085231|P1|STARTED|Overall Study||22
7751333|NCT01480297|19085273|P1|NOT COMPLETED|Overall Study||0
7751334|NCT01480297|19085273|P1|COMPLETED|Overall Study||8
7751335|NCT01480297|19085273|P1|STARTED|Overall Study||8
7751336|NCT01480284|19085279|P2|NOT COMPLETED|Overall Study||0
7751337|NCT01480284|19085280|P1|NOT COMPLETED|Overall Study||8
7751338|NCT01480284|19085279|P2|COMPLETED|Overall Study||56
7751339|NCT01480284|19085280|P1|COMPLETED|Overall Study||102
7751340|NCT01480284|19085279|P2|STARTED|Overall Study||56
7751341|NCT01480284|19085280|P1|STARTED|Overall Study||110
7751342|NCT01480258|19085310|P2|NOT COMPLETED|Toddler Dose||0
7751343|NCT01480258|19085311|P1|NOT COMPLETED|Toddler Dose||0
7751344|NCT01480258|19085310|P2|COMPLETED|Toddler Dose||642
7751345|NCT01480258|19085311|P1|COMPLETED|Toddler Dose||639
7751346|NCT01480258|19085310|P2|STARTED|Toddler Dose||642
7751347|NCT01480258|19085311|P1|STARTED|Toddler Dose||639
7751348|NCT01480258|19085310|P2|NOT COMPLETED|Interim Period||9
7751349|NCT01480258|19085311|P1|NOT COMPLETED|Interim Period||10
7751350|NCT01480258|19085310|P2|COMPLETED|Interim Period||642
7751351|NCT01480258|19085311|P1|COMPLETED|Interim Period||639
7751352|NCT01480258|19085310|P2|STARTED|Interim Period||651
7751353|NCT01480258|19085311|P1|STARTED|Interim Period||649
7751354|NCT01480258|19085310|P2|NOT COMPLETED|Infant Series||8
7751355|NCT01480258|19085311|P1|NOT COMPLETED|Infant Series||7
7751356|NCT01480258|19085310|P2|COMPLETED|Infant Series||651
7751357|NCT01480258|19085311|P1|COMPLETED|Infant Series||649
7751358|NCT01480258|19085310|P2|Vaccinated|Infant Series||659
7751359|NCT01480258|19085311|P1|Vaccinated|Infant Series||653
7751360|NCT01480258|19085310|P2|STARTED|Infant Series||659
7751361|NCT01480258|19085311|P1|STARTED|Infant Series||656
7751362|NCT01480232|19085337|P4|NOT COMPLETED|Overall Study||19
7751363|NCT01480232|19085338|P3|NOT COMPLETED|Overall Study||17
7751364|NCT01480232|19085339|P2|NOT COMPLETED|Overall Study||22
7751365|NCT01480232|19085340|P1|NOT COMPLETED|Overall Study||18
7751366|NCT01480232|19085337|P4|COMPLETED|Overall Study||22
7751367|NCT01480232|19085338|P3|COMPLETED|Overall Study||21
7751368|NCT01480232|19085339|P2|COMPLETED|Overall Study||19
7751369|NCT01480232|19085340|P1|COMPLETED|Overall Study||22
7751370|NCT01480232|19085337|P4|STARTED|Overall Study||41
7751371|NCT01480232|19085338|P3|STARTED|Overall Study||38
7751372|NCT01480232|19085339|P2|STARTED|Overall Study||41
7751373|NCT01480232|19085340|P1|STARTED|Overall Study||40
7751374|NCT01480219|19085368|P2|NOT COMPLETED|Overall Study||0
7751375|NCT01480219|19085369|P1|NOT COMPLETED|Overall Study||0
7751376|NCT01480219|19085368|P2|COMPLETED|Overall Study||142
7751377|NCT01480219|19085369|P1|COMPLETED|Overall Study||325
7751378|NCT01480219|19085368|P2|STARTED|Overall Study||142
7751379|NCT01480219|19085369|P1|STARTED|Overall Study||325
7751380|NCT01480180|19085377|P6|NOT COMPLETED|Extension Phase, Part 2||0
7751381|NCT01480180|19085378|P5|NOT COMPLETED|Extension Phase, Part 2||2
7751382|NCT01480180|19085379|P4|NOT COMPLETED|Extension Phase, Part 2||7
7751383|NCT01480180|19085380|P3|NOT COMPLETED|Extension Phase, Part 2||17
7751384|NCT01480180|19085381|P2|NOT COMPLETED|Extension Phase, Part 2||0
7751385|NCT01480180|19085382|P1|NOT COMPLETED|Extension Phase, Part 2||0
7751386|NCT01480180|19085377|P6|COMPLETED|Extension Phase, Part 2||0
7751387|NCT01480180|19085378|P5|COMPLETED|Extension Phase, Part 2||3
7751388|NCT01480180|19085379|P4|COMPLETED|Extension Phase, Part 2||33
7751389|NCT01480180|19085380|P3|COMPLETED|Extension Phase, Part 2||77
7751390|NCT01480180|19085381|P2|COMPLETED|Extension Phase, Part 2||0
7751391|NCT01480180|19085382|P1|COMPLETED|Extension Phase, Part 2||0
7751392|NCT01480180|19085377|P6|STARTED|Extension Phase, Part 2||0
7751393|NCT01480180|19085378|P5|STARTED|Extension Phase, Part 2||5
7751394|NCT01480180|19085379|P4|STARTED|Extension Phase, Part 2||40
7751395|NCT01480180|19085380|P3|STARTED|Extension Phase, Part 2||94
7751396|NCT01480180|19085381|P2|STARTED|Extension Phase, Part 2||0
7751397|NCT01480180|19085382|P1|STARTED|Extension Phase, Part 2||0
7751398|NCT01480180|19085377|P6|NOT COMPLETED|Extension Phase, Part 1||0
7751399|NCT01480180|19085378|P5|NOT COMPLETED|Extension Phase, Part 1||0
7751400|NCT01480180|19085379|P4|NOT COMPLETED|Extension Phase, Part 1||10
7751401|NCT01480180|19085380|P3|NOT COMPLETED|Extension Phase, Part 1||10
7751402|NCT01480180|19085381|P2|NOT COMPLETED|Extension Phase, Part 1||0
7751403|NCT01480180|19085382|P1|NOT COMPLETED|Extension Phase, Part 1||0
7751404|NCT01480180|19085377|P6|COMPLETED|Extension Phase, Part 1||0
7751405|NCT01480180|19085378|P5|COMPLETED|Extension Phase, Part 1||7
7751406|NCT01480180|19085379|P4|COMPLETED|Extension Phase, Part 1||28
7751407|NCT01480180|19085380|P3|COMPLETED|Extension Phase, Part 1||95
7751408|NCT01480180|19085381|P2|COMPLETED|Extension Phase, Part 1||0
7751409|NCT01480180|19085382|P1|COMPLETED|Extension Phase, Part 1||0
7751410|NCT01480180|19085377|P6|STARTED|Extension Phase, Part 1||0
7751411|NCT01480180|19085378|P5|STARTED|Extension Phase, Part 1||7
7751412|NCT01480180|19085379|P4|STARTED|Extension Phase, Part 1||38
7751413|NCT01480180|19085380|P3|STARTED|Extension Phase, Part 1||105
7751414|NCT01480180|19085381|P2|STARTED|Extension Phase, Part 1||0
7751415|NCT01480180|19085382|P1|STARTED|Extension Phase, Part 1||0
7751416|NCT01480180|19085377|P6|NOT COMPLETED|Main Phase||0
7751417|NCT01480180|19085378|P5|NOT COMPLETED|Main Phase||0
7751418|NCT01480180|19085379|P4|NOT COMPLETED|Main Phase||0
7751419|NCT01480180|19085380|P3|NOT COMPLETED|Main Phase||0
7751420|NCT01480180|19085381|P2|NOT COMPLETED|Main Phase||1
7751421|NCT01480180|19085382|P1|NOT COMPLETED|Main Phase||19
7751422|NCT01480180|19085377|P6|COMPLETED|Main Phase|Not applicable for this phase|0
7751423|NCT01480180|19085378|P5|COMPLETED|Main Phase|Not applicable for this phase|0
7751424|NCT01480180|19085379|P4|COMPLETED|Main Phase|Not applicable for this phase|0
7751425|NCT01480180|19085380|P3|COMPLETED|Main Phase|Not applicable for this phase|0
7751426|NCT01480180|19085381|P2|COMPLETED|Main Phase||11
7751427|NCT01480180|19085382|P1|COMPLETED|Main Phase||155
7751428|NCT01480180|19085377|P6|Max. Participants After Switching|Main Phase||0
7751429|NCT01480180|19085378|P5|Max. Participants After Switching|Main Phase||0
7751430|NCT01480180|19085379|P4|Max. Participants After Switching|Main Phase||0
7751431|NCT01480180|19085380|P3|Max. Participants After Switching|Main Phase||0
7751432|NCT01480180|19085381|P2|Max. Participants After Switching|Main Phase||11
7751433|NCT01480180|19085382|P1|Max. Participants After Switching|Main Phase||175
7751434|NCT01480180|19085377|P6|STARTED|Main Phase|Not applicable for this phase|0
7751435|NCT01480180|19085378|P5|STARTED|Main Phase|Not applicable for this phase|0
7751436|NCT01480180|19085379|P4|STARTED|Main Phase|Not applicable for this phase|0
7751437|NCT01480180|19085380|P3|STARTED|Main Phase|Not applicable for this phase|0
7751438|NCT01480180|19085381|P2|STARTED|Main Phase||12
7751439|NCT01480180|19085382|P1|STARTED|Main Phase||174
7751440|NCT01480089|19085539|P2|NOT COMPLETED|Overall Study||0
7751441|NCT01480089|19085540|P1|NOT COMPLETED|Overall Study||0
7751442|NCT01480089|19085539|P2|COMPLETED|Overall Study||30
7751443|NCT01480089|19085540|P1|COMPLETED|Overall Study||25
7751444|NCT01480089|19085539|P2|STARTED|Overall Study||30
7751445|NCT01480089|19085540|P1|STARTED|Overall Study||25
7751446|NCT01480076|19085550|P1|NOT COMPLETED|Overall Study||290
7751447|NCT01480076|19085550|P1|COMPLETED|Overall Study||611
7751448|NCT01480076|19085550|P1|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835
7751449|NCT01480076|19085550|P1|STARTED|Overall Study|enrolled and started run-in treatment|901
7751450|NCT01479985|19085671|P2|NOT COMPLETED|Overall Study||6
7751451|NCT01479985|19085672|P1|NOT COMPLETED|Overall Study||6
7751452|NCT01479985|19085671|P2|COMPLETED|Overall Study||80
7751453|NCT01479985|19085672|P1|COMPLETED|Overall Study||161
7751454|NCT01479985|19085671|P2|Baseline Survey|Overall Study||85
7751455|NCT01479985|19085672|P1|Baseline Survey|Overall Study||166
7751456|NCT01479985|19085671|P2|STARTED|Overall Study||86
7751457|NCT01479985|19085672|P1|STARTED|Overall Study||167
7751458|NCT01479868|19085680|P1|NOT COMPLETED|Overall Study||9
7751459|NCT01479868|19085680|P1|COMPLETED|Overall Study||97
7751460|NCT01479868|19085680|P1|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106
7751461|NCT01479777|19085695|P1|NOT COMPLETED|Overall Study||2
7751462|NCT01479777|19085695|P1|COMPLETED|Overall Study||10
7751463|NCT01479777|19085695|P1|STARTED|Overall Study||12
7751464|NCT01479764|19085707|P2|NOT COMPLETED|Treated||2
7751465|NCT01479764|19085708|P1|NOT COMPLETED|Treated||0
7751466|NCT01479764|19085707|P2|COMPLETED|Treated||75
7751467|NCT01479764|19085708|P1|COMPLETED|Treated||74
7751468|NCT01479764|19085707|P2|STARTED|Treated||77
7751469|NCT01479764|19085708|P1|STARTED|Treated||74
7751470|NCT01479764|19085707|P2|NOT COMPLETED|Randomized||1
7751471|NCT01479764|19085708|P1|NOT COMPLETED|Randomized||2
7751472|NCT01479764|19085707|P2|COMPLETED|Randomized|1 randomized participant did not receive study drug|77
7751473|NCT01479764|19085708|P1|COMPLETED|Randomized|2 randomized participants did not receive study drug|74
7751474|NCT01479764|19085707|P2|STARTED|Randomized||78
7751475|NCT01479764|19085708|P1|STARTED|Randomized||76
7751476|NCT01479725|19085718|P2|NOT COMPLETED|Overall Study||1
7751477|NCT01479725|19085719|P1|NOT COMPLETED|Overall Study||2
7751478|NCT01479725|19085718|P2|COMPLETED|Overall Study||1
7751479|NCT01479725|19085719|P1|COMPLETED|Overall Study||4
7751480|NCT01479725|19085718|P2|STARTED|Overall Study||2
7751481|NCT01479725|19085719|P1|STARTED|Overall Study||6
7751482|NCT01479621|19085731|P7|NOT COMPLETED|Treatment Period||20
7751483|NCT01479621|19085732|P6|NOT COMPLETED|Treatment Period||41
7751484|NCT01479621|19085733|P5|NOT COMPLETED|Treatment Period||21
7751485|NCT01479621|19085734|P4|NOT COMPLETED|Treatment Period||12
7751486|NCT01479621|19085735|P3|NOT COMPLETED|Treatment Period||21
7751487|NCT01479621|19085736|P2|NOT COMPLETED|Treatment Period||24
7751488|NCT01479621|19085737|P1|NOT COMPLETED|Treatment Period||0
7751489|NCT01479621|19085731|P7|COMPLETED|Treatment Period||84
7751490|NCT01479621|19085732|P6|COMPLETED|Treatment Period||63
7751491|NCT01479621|19085733|P5|COMPLETED|Treatment Period||82
7751492|NCT01479621|19085734|P4|COMPLETED|Treatment Period||92
7751493|NCT01479621|19085735|P3|COMPLETED|Treatment Period||83
7751494|NCT01479621|19085736|P2|COMPLETED|Treatment Period||79
7751495|NCT01479621|19085737|P1|COMPLETED|Treatment Period||0
7751496|NCT01479621|19085731|P7|Full Analysis Set|Treatment Period||102
7751497|NCT01479621|19085732|P6|Full Analysis Set|Treatment Period||102
7751498|NCT01479621|19085733|P5|Full Analysis Set|Treatment Period||102
7751499|NCT01479621|19085734|P4|Full Analysis Set|Treatment Period||102
7751500|NCT01479621|19085735|P3|Full Analysis Set|Treatment Period||101
7751501|NCT01479621|19085736|P2|Full Analysis Set|Treatment Period||102
7751502|NCT01479621|19085737|P1|Full Analysis Set|Treatment Period||0
7751503|NCT01479621|19085731|P7|Safety Population|Treatment Period||104
7751504|NCT01479621|19085732|P6|Safety Population|Treatment Period||104
7751505|NCT01479621|19085733|P5|Safety Population|Treatment Period||103
7751506|NCT01479621|19085734|P4|Safety Population|Treatment Period||104
7751507|NCT01479621|19085735|P3|Safety Population|Treatment Period||104
7751508|NCT01479621|19085736|P2|Safety Population|Treatment Period||103
7751509|NCT01479621|19085737|P1|Safety Population|Treatment Period||0
7751510|NCT01479621|19085731|P7|STARTED|Treatment Period||104
7751511|NCT01479621|19085732|P6|STARTED|Treatment Period||104
7751512|NCT01479621|19085733|P5|STARTED|Treatment Period||103
7751513|NCT01479621|19085734|P4|STARTED|Treatment Period||104
7751514|NCT01479621|19085735|P3|STARTED|Treatment Period||104
7751515|NCT01479621|19085736|P2|STARTED|Treatment Period||103
7751516|NCT01479621|19085737|P1|STARTED|Treatment Period||0
7751517|NCT01479621|19085731|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7751518|NCT01479621|19085732|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7751519|NCT01479621|19085733|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7751520|NCT01479621|19085734|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7751521|NCT01479621|19085735|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7751522|NCT01479621|19085736|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7751523|NCT01479621|19085737|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287
7751524|NCT01479621|19085731|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7751525|NCT01479621|19085732|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7751526|NCT01479621|19085733|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7751527|NCT01479621|19085734|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7751528|NCT01479621|19085735|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7751529|NCT01479621|19085736|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
7751530|NCT01479621|19085737|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622
7751531|NCT01479621|19085731|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
7751532|NCT01479621|19085732|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
7751533|NCT01479621|19085733|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
7751534|NCT01479621|19085734|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
7751535|NCT01479621|19085735|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
7751536|NCT01479621|19085736|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
7751537|NCT01479621|19085737|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||909
7751538|NCT01479595|19085825|P2|NOT COMPLETED|Overall Study||2
7751539|NCT01479595|19085826|P1|NOT COMPLETED|Overall Study||2
7751540|NCT01479595|19085825|P2|COMPLETED|Overall Study||19
7751541|NCT01479595|19085826|P1|COMPLETED|Overall Study||42
7751542|NCT01479595|19085825|P2|Per Protocol Analysis Set|Overall Study||20
7751543|NCT01479595|19085826|P1|Per Protocol Analysis Set|Overall Study||41
7751544|NCT01479595|19085825|P2|PK Analysis Set|Overall Study||0
7751545|NCT01479595|19085826|P1|PK Analysis Set|Overall Study||42
7751546|NCT01479595|19085825|P2|STARTED|Overall Study||21
7751547|NCT01479595|19085826|P1|STARTED|Overall Study||44
7751548|NCT01479543|19085853|P5|NOT COMPLETED|Overall Study||1
7751549|NCT01479543|19085854|P4|NOT COMPLETED|Overall Study||0
7751550|NCT01479543|19085855|P3|NOT COMPLETED|Overall Study||1
7751551|NCT01479543|19085856|P2|NOT COMPLETED|Overall Study||0
7751552|NCT01479543|19085857|P1|NOT COMPLETED|Overall Study||1
7751553|NCT01479543|19085853|P5|COMPLETED|Overall Study||20
7751554|NCT01479543|19085854|P4|COMPLETED|Overall Study||20
7751555|NCT01479543|19085855|P3|COMPLETED|Overall Study||20
7751556|NCT01479543|19085856|P2|COMPLETED|Overall Study||20
7751557|NCT01479543|19085857|P1|COMPLETED|Overall Study||20
7751558|NCT01479543|19085853|P5|STARTED|Overall Study||21
7751559|NCT01479543|19085854|P4|STARTED|Overall Study||20
7751560|NCT01479543|19085855|P3|STARTED|Overall Study||21
7751561|NCT01479543|19085856|P2|STARTED|Overall Study||20
7751562|NCT01479543|19085857|P1|STARTED|Overall Study||21
7751563|NCT01479530|19085871|P2|NOT COMPLETED|Overall Study||12
7751564|NCT01479530|19085872|P1|NOT COMPLETED|Overall Study||10
7751565|NCT01479530|19085871|P2|COMPLETED|Overall Study||151
7751566|NCT01479530|19085872|P1|COMPLETED|Overall Study||148
7751567|NCT01479530|19085871|P2|STARTED|Overall Study||163
7751568|NCT01479530|19085872|P1|STARTED|Overall Study||158
7751569|NCT01479517|19085887|P3|NOT COMPLETED|Overall Study||0
7751570|NCT01479517|19085888|P2|NOT COMPLETED|Overall Study||0
7751571|NCT01479517|19085889|P1|NOT COMPLETED|Overall Study||0
7751572|NCT01479517|19085887|P3|COMPLETED|Overall Study||10
7751573|NCT01479517|19085888|P2|COMPLETED|Overall Study||10
7751574|NCT01479517|19085889|P1|COMPLETED|Overall Study||10
7751575|NCT01479517|19085887|P3|STARTED|Overall Study||10
7751576|NCT01479517|19085888|P2|STARTED|Overall Study||10
7751577|NCT01479517|19085889|P1|STARTED|Overall Study||10
7751578|NCT01479478|19085908|P2|NOT COMPLETED|Overall Study||0
7751579|NCT01479478|19085909|P1|NOT COMPLETED|Overall Study||0
7751580|NCT01479478|19085908|P2|COMPLETED|Overall Study||126
7751581|NCT01479478|19085909|P1|COMPLETED|Overall Study||125
7751582|NCT01479478|19085908|P2|STARTED|Overall Study||126
7751583|NCT01479478|19085909|P1|STARTED|Overall Study||125
7751584|NCT01479465|19085953|P4|NOT COMPLETED|Overall Study||85
7751585|NCT01479465|19085954|P3|NOT COMPLETED|Overall Study||86
7751586|NCT01479465|19085955|P2|NOT COMPLETED|Overall Study||84
7751587|NCT01479465|19085956|P1|NOT COMPLETED|Overall Study||11
7751588|NCT01479465|19085953|P4|COMPLETED|Overall Study||0
7751589|NCT01479465|19085954|P3|COMPLETED|Overall Study||0
7751590|NCT01479465|19085955|P2|COMPLETED|Overall Study||0
7751591|NCT01479465|19085956|P1|COMPLETED|Overall Study||0
7751592|NCT01479465|19085953|P4|STARTED|Overall Study||85
7751593|NCT01479465|19085954|P3|STARTED|Overall Study||86
7751594|NCT01479465|19085955|P2|STARTED|Overall Study||84
7751595|NCT01479465|19085956|P1|STARTED|Overall Study||11
7751596|NCT01479439|19085977|P3|NOT COMPLETED|Overall Study||2
7751597|NCT01479439|19085978|P2|NOT COMPLETED|Overall Study||1
7751598|NCT01479439|19085979|P1|NOT COMPLETED|Overall Study||1
7751599|NCT01479439|19085977|P3|COMPLETED|Overall Study||6
7751600|NCT01479439|19085978|P2|COMPLETED|Overall Study||12
7751601|NCT01479439|19085979|P1|COMPLETED|Overall Study||14
7751602|NCT01479439|19085977|P3|STARTED|Overall Study||8
7751603|NCT01479439|19085978|P2|STARTED|Overall Study||13
7751604|NCT01479439|19085979|P1|STARTED|Overall Study||15
7751605|NCT01479426|19085995|P2|NOT COMPLETED|Overall Study||3
7751606|NCT01479426|19085996|P1|NOT COMPLETED|Overall Study||4
7751607|NCT01479426|19085995|P2|COMPLETED|Overall Study||37
7751608|NCT01479426|19085996|P1|COMPLETED|Overall Study||36
7751609|NCT01479426|19085995|P2|STARTED|Overall Study||40
7751610|NCT01479426|19085996|P1|STARTED|Overall Study||40
7751611|NCT01479374|19086011|P3|NOT COMPLETED|Overall Study||5
7751612|NCT01479374|19086012|P2|NOT COMPLETED|Overall Study||8
7751613|NCT01479374|19086013|P1|NOT COMPLETED|Overall Study||3
7751614|NCT01479374|19086011|P3|COMPLETED|Overall Study||63
7751615|NCT01479374|19086012|P2|COMPLETED|Overall Study||60
7751616|NCT01479374|19086013|P1|COMPLETED|Overall Study||63
7751617|NCT01479374|19086011|P3|STARTED|Overall Study||68
7751618|NCT01479374|19086012|P2|STARTED|Overall Study||68
7751619|NCT01479374|19086013|P1|STARTED|Overall Study||66
7751620|NCT01479348|19086039|P2|NOT COMPLETED|Overall Study||0
7751621|NCT01479348|19086040|P1|NOT COMPLETED|Overall Study||0
7751622|NCT01479348|19086039|P2|COMPLETED|Overall Study||0
7751623|NCT01479348|19086040|P1|COMPLETED|Overall Study||5
7751624|NCT01479348|19086039|P2|STARTED|Overall Study||0
7751625|NCT01479348|19086040|P1|STARTED|Overall Study||5
7751626|NCT01479270|19086049|P2|NOT COMPLETED|Overall Study||0
7751627|NCT01479270|19086050|P1|NOT COMPLETED|Overall Study||0
7751628|NCT01479270|19086049|P2|COMPLETED|Overall Study||28
7751629|NCT01479270|19086050|P1|COMPLETED|Overall Study||28
7751630|NCT01479270|19086049|P2|STARTED|Overall Study||28
7751631|NCT01479270|19086050|P1|STARTED|Overall Study||28
7751632|NCT01479127|19086062|P1|NOT COMPLETED|Overall Study||3
7751633|NCT01479127|19086062|P1|COMPLETED|Overall Study||5
7751634|NCT01479127|19086062|P1|Started LCIG|Overall Study||6
7751635|NCT01479127|19086062|P1|STARTED|Overall Study|started oral study drug (full safety sample)|8
7751636|NCT01479010|19086096|P1|NOT COMPLETED|Overall Study||1
7751637|NCT01479010|19086096|P1|COMPLETED|Overall Study||1
7751638|NCT01479010|19086096|P1|STARTED|Overall Study||2
7751639|NCT01478971|19086107|P1|NOT COMPLETED|Peginesatide Treatment Period||14
7751640|NCT01478971|19086107|P1|COMPLETED|Peginesatide Treatment Period||143
7751641|NCT01478971|19086107|P1|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157
7751642|NCT01478971|19086107|P1|NOT COMPLETED|Standard of Care Period||25
7751643|NCT01478971|19086107|P1|COMPLETED|Standard of Care Period||159
7751644|NCT01478971|19086107|P1|Received Treatment|Standard of Care Period||178
7751645|NCT01478971|19086107|P1|STARTED|Standard of Care Period||184
7751646|NCT01478958|19086124|P3|NOT COMPLETED|Overall Study||3
7751647|NCT01478958|19086125|P2|NOT COMPLETED|Overall Study||2
7751648|NCT01478958|19086126|P1|NOT COMPLETED|Overall Study||2
7751649|NCT01478958|19086124|P3|COMPLETED|Overall Study||66
7751650|NCT01478958|19086125|P2|COMPLETED|Overall Study||64
7751651|NCT01478958|19086126|P1|COMPLETED|Overall Study||65
7751652|NCT01478958|19086124|P3|STARTED|Overall Study||69
7751653|NCT01478958|19086125|P2|STARTED|Overall Study||66
7751654|NCT01478958|19086126|P1|STARTED|Overall Study||67
7751655|NCT01478854|19086134|P1|NOT COMPLETED|Overall Study||0
7751656|NCT01478854|19086134|P1|COMPLETED|Overall Study||30
7751657|NCT01478854|19086134|P1|STARTED|Overall Study||30
7751658|NCT01478828|19086146|P1|NOT COMPLETED|Overall Study||1
7751659|NCT01478828|19086146|P1|COMPLETED|Overall Study||1
7751660|NCT01478828|19086146|P1|STARTED|Overall Study||2
7751661|NCT01478620|19086157|P1|NOT COMPLETED|Overall Study||6
7751662|NCT01478620|19086157|P1|COMPLETED|Overall Study||119
7751663|NCT01478620|19086157|P1|STARTED|Overall Study||125
7751664|NCT01478594|19086163|P2|NOT COMPLETED|Overall Study||28
7751665|NCT01478594|19086164|P1|NOT COMPLETED|Overall Study||65
7751666|NCT01478594|19086163|P2|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60
7751667|NCT01478594|19086164|P1|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112
7751668|NCT01478594|19086163|P2|Treated|Overall Study||87
7751669|NCT01478594|19086164|P1|Treated|Overall Study||177
7751670|NCT01478594|19086163|P2|STARTED|Overall Study||88
7751671|NCT01478594|19086164|P1|STARTED|Overall Study||177
7751672|NCT01478581|19086240|P4|NOT COMPLETED|Overall Study||0
7751673|NCT01478581|19086241|P3|NOT COMPLETED|Overall Study||0
7751674|NCT01478581|19086242|P2|NOT COMPLETED|Overall Study||0
7751675|NCT01478581|19086243|P1|NOT COMPLETED|Overall Study||0
7751676|NCT01478581|19086240|P4|COMPLETED|Overall Study||43
7751677|NCT01478581|19086241|P3|COMPLETED|Overall Study||18
7751678|NCT01478581|19086242|P2|COMPLETED|Overall Study||18
7751679|NCT01478581|19086243|P1|COMPLETED|Overall Study||13
7751680|NCT01478581|19086240|P4|STARTED|Overall Study|Simon 2-stage design - cohort 4 expansion per stage 1 data (≥3 Clinical Benefit Responders observed|43
7751681|NCT01478581|19086241|P3|STARTED|Overall Study||18
7751682|NCT01478581|19086242|P2|STARTED|Overall Study||18
7751683|NCT01478581|19086243|P1|STARTED|Overall Study||13
7751684|NCT01478373|19086293|P1|NOT COMPLETED|Survival Phase||38
7751685|NCT01478373|19086293|P1|COMPLETED|Survival Phase||0
7751686|NCT01478373|19086293|P1|STARTED|Survival Phase||38
7751687|NCT01478373|19086293|P1|NOT COMPLETED|Treatment Phase||1
7751688|NCT01478373|19086293|P1|COMPLETED|Treatment Phase||38
7751689|NCT01478373|19086293|P1|STARTED|Treatment Phase||39
7751690|NCT01478360|19086306|P2|NOT COMPLETED|Overall Study||3
7751691|NCT01478360|19086307|P1|NOT COMPLETED|Overall Study||2
7751692|NCT01478360|19086306|P2|COMPLETED|Overall Study||12
7751693|NCT01478360|19086307|P1|COMPLETED|Overall Study||29
7751694|NCT01478360|19086306|P2|PK (Pharmacokinetics) Analysis Set|Overall Study||0
7751695|NCT01478360|19086307|P1|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31
7751696|NCT01478360|19086306|P2|PD (Pharmacodynamic) Analysis Set|Overall Study||15
7751697|NCT01478360|19086307|P1|PD (Pharmacodynamic) Analysis Set|Overall Study||31
7751698|NCT01478360|19086306|P2|STARTED|Overall Study||15
7751699|NCT01478360|19086307|P1|STARTED|Overall Study||31
7751700|NCT01478347|19086313|P1|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8
7751701|NCT01478347|19086313|P1|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4
7751702|NCT01478347|19086313|P1|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12
7751703|NCT01478347|19086313|P1|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1
7751704|NCT01478347|19086313|P1|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17
7751705|NCT01478347|19086313|P1|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18
7751706|NCT01478321|19086318|P1|NOT COMPLETED|Follow-up Until Death or 12.31.18 Occurs||0
7751707|NCT01478321|19086318|P1|COMPLETED|Follow-up Until Death or 12.31.18 Occurs||54
7751708|NCT01478321|19086318|P1|STARTED|Follow-up Until Death or 12.31.18 Occurs||54
7751709|NCT01478321|19086318|P1|NOT COMPLETED|Adjuvant Therapy Until PD or Toxicity||10
7751710|NCT01478321|19086318|P1|COMPLETED|Adjuvant Therapy Until PD or Toxicity||27
7751711|NCT01478321|19086318|P1|Went on to Cycle 2 +|Adjuvant Therapy Until PD or Toxicity||27
7751712|NCT01478321|19086318|P1|STARTED|Adjuvant Therapy Until PD or Toxicity||37
7751713|NCT01478321|19086318|P1|NOT COMPLETED|Started Adjuvant Therapy||1
7751714|NCT01478321|19086318|P1|COMPLETED|Started Adjuvant Therapy||37
7751715|NCT01478321|19086318|P1|Completed First Cycle|Started Adjuvant Therapy||37
7751716|NCT01478321|19086318|P1|STARTED|Started Adjuvant Therapy||38
7751717|NCT01478321|19086318|P1|NOT COMPLETED|Concurrent Therapy (5 Weeks)||16
7751718|NCT01478321|19086318|P1|COMPLETED|Concurrent Therapy (5 Weeks)||38
7751719|NCT01478321|19086318|P1|STARTED|Concurrent Therapy (5 Weeks)||54
7751720|NCT01478256|19086330|P2|NOT COMPLETED|Overall Study||0
7751721|NCT01478256|19086331|P1|NOT COMPLETED|Overall Study||0
7751722|NCT01478256|19086330|P2|COMPLETED|Overall Study||15
7751723|NCT01478256|19086331|P1|COMPLETED|Overall Study||15
7751724|NCT01478256|19086330|P2|STARTED|Overall Study||15
7751725|NCT01478256|19086331|P1|STARTED|Overall Study||15
7751726|NCT01478113|19086341|P2|NOT COMPLETED|Overall Study||1
7751727|NCT01478113|19086342|P1|NOT COMPLETED|Overall Study||1
7751728|NCT01478113|19086341|P2|COMPLETED|Overall Study||1
7751729|NCT01478113|19086342|P1|COMPLETED|Overall Study||1
7751730|NCT01478113|19086341|P2|STARTED|Overall Study||2
7751731|NCT01478113|19086342|P1|STARTED|Overall Study||2
7751732|NCT01478087|19086360|P1|NOT COMPLETED|Overall Study||1
7751733|NCT01478087|19086360|P1|COMPLETED|Overall Study||2
7751734|NCT01478087|19086360|P1|STARTED|Overall Study||3
7751735|NCT01478048|19086367|P2|NOT COMPLETED|Overall Study||75
7751736|NCT01478048|19086368|P1|NOT COMPLETED|Overall Study||77
7751737|NCT01478048|19086367|P2|COMPLETED|Overall Study||0
7751738|NCT01478048|19086368|P1|COMPLETED|Overall Study||0
7751739|NCT01478048|19086367|P2|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|74
7751740|NCT01478048|19086368|P1|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|76
7751741|NCT01478048|19086367|P2|STARTED|Overall Study||75
7751742|NCT01478048|19086368|P1|STARTED|Overall Study||77
7751743|NCT01478009|19086386|P2|NOT COMPLETED|Overall Study||1
7751744|NCT01478009|19086387|P1|NOT COMPLETED|Overall Study||1
7751745|NCT01478009|19086386|P2|COMPLETED|Overall Study||49
7751746|NCT01478009|19086387|P1|COMPLETED|Overall Study||49
7751747|NCT01478009|19086386|P2|STARTED|Overall Study||50
7751748|NCT01478009|19086387|P1|STARTED|Overall Study||50
7751749|NCT01477892|19086397|P2|NOT COMPLETED|Overall Study||2
7751750|NCT01477892|19086398|P1|NOT COMPLETED|Overall Study||0
7751751|NCT01477892|19086397|P2|COMPLETED|Overall Study||5
7751752|NCT01477892|19086398|P1|COMPLETED|Overall Study||7
7751753|NCT01477892|19086397|P2|STARTED|Overall Study||7
7751754|NCT01477892|19086398|P1|STARTED|Overall Study||7
7751755|NCT01477853|19086409|P3|NOT COMPLETED|Phase B||11
7751756|NCT01477853|19086410|P2|NOT COMPLETED|Phase B||11
7751757|NCT01477853|19086411|P1|NOT COMPLETED|Phase B||12
7751758|NCT01477853|19086409|P3|COMPLETED|Phase B||0
7751759|NCT01477853|19086410|P2|COMPLETED|Phase B||0
7751760|NCT01477853|19086411|P1|COMPLETED|Phase B||0
7751761|NCT01477853|19086409|P3|STARTED|Phase B||11
7751762|NCT01477853|19086410|P2|STARTED|Phase B||11
7751763|NCT01477853|19086411|P1|STARTED|Phase B||12
7751764|NCT01477853|19086409|P3|NOT COMPLETED|Phase A||44
7751765|NCT01477853|19086410|P2|NOT COMPLETED|Phase A||45
7751766|NCT01477853|19086411|P1|NOT COMPLETED|Phase A||43
7751767|NCT01477853|19086409|P3|COMPLETED|Phase A||11
7751768|NCT01477853|19086410|P2|COMPLETED|Phase A||11
7751769|NCT01477853|19086411|P1|COMPLETED|Phase A||12
7751770|NCT01477853|19086409|P3|STARTED|Phase A||55
7751771|NCT01477853|19086410|P2|STARTED|Phase A||56
7751772|NCT01477853|19086411|P1|STARTED|Phase A||55
7751773|NCT01477762|19086453|P4|NOT COMPLETED|Overall Study||2
7751774|NCT01477762|19086454|P3|NOT COMPLETED|Overall Study||4
7751775|NCT01477762|19086455|P2|NOT COMPLETED|Overall Study||13
7751776|NCT01477762|19086456|P1|NOT COMPLETED|Overall Study||9
7751777|NCT01477762|19086453|P4|COMPLETED|Overall Study||11
7751778|NCT01477762|19086454|P3|COMPLETED|Overall Study||16
7751779|NCT01477762|19086455|P2|COMPLETED|Overall Study||20
7751780|NCT01477762|19086456|P1|COMPLETED|Overall Study||16
7751781|NCT01477762|19086453|P4|STARTED|Overall Study||13
7751782|NCT01477762|19086454|P3|STARTED|Overall Study||20
7751783|NCT01477762|19086455|P2|STARTED|Overall Study||33
7751784|NCT01477762|19086456|P1|STARTED|Overall Study||25
7751785|NCT01477749|19086478|P1|NOT COMPLETED|Overall Study||4
7751786|NCT01477749|19086478|P1|COMPLETED|Overall Study||43
7751787|NCT01477749|19086478|P1|STARTED|Overall Study||47
7751788|NCT01477710|19086485|P1|NOT COMPLETED|Overall Study||0
7751789|NCT01477710|19086485|P1|COMPLETED|Overall Study||30
7751790|NCT01477710|19086485|P1|STARTED|Overall Study||30
7751791|NCT01477567|19086500|P7|NOT COMPLETED|Overall Study||0
7751792|NCT01477567|19086501|P6|NOT COMPLETED|Overall Study||0
7751793|NCT01477567|19086502|P5|NOT COMPLETED|Overall Study||0
7751794|NCT01477567|19086503|P4|NOT COMPLETED|Overall Study||0
7751795|NCT01477567|19086504|P3|NOT COMPLETED|Overall Study||0
7751796|NCT01477567|19086505|P2|NOT COMPLETED|Overall Study||0
7751797|NCT01477567|19086506|P1|NOT COMPLETED|Overall Study||0
7751798|NCT01477567|19086500|P7|COMPLETED|Overall Study||6
7751799|NCT01477567|19086501|P6|COMPLETED|Overall Study||5
7751800|NCT01477567|19086502|P5|COMPLETED|Overall Study||6
7751801|NCT01477567|19086503|P4|COMPLETED|Overall Study||6
7751802|NCT01477567|19086504|P3|COMPLETED|Overall Study||6
7751803|NCT01477567|19086505|P2|COMPLETED|Overall Study||6
7751804|NCT01477567|19086506|P1|COMPLETED|Overall Study||5
7751805|NCT01477567|19086500|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
7751806|NCT01477567|19086501|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
7751807|NCT01477567|19086502|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
7751808|NCT01477567|19086503|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
7751809|NCT01477567|19086504|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
7751810|NCT01477567|19086505|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
7751811|NCT01477567|19086506|P1|Received at Least 1 Dose of Study Drug|Overall Study||5
7751812|NCT01477567|19086500|P7|STARTED|Overall Study||6
7751813|NCT01477567|19086501|P6|STARTED|Overall Study||5
7751814|NCT01477567|19086502|P5|STARTED|Overall Study||6
7751815|NCT01477567|19086503|P4|STARTED|Overall Study||6
7751816|NCT01477567|19086504|P3|STARTED|Overall Study||6
7751817|NCT01477567|19086505|P2|STARTED|Overall Study||6
7751818|NCT01477567|19086506|P1|STARTED|Overall Study||5
7751819|NCT01477463|19086562|P2|NOT COMPLETED|Overall Study||0
7751820|NCT01477463|19086563|P1|NOT COMPLETED|Overall Study||0
7751821|NCT01477463|19086562|P2|COMPLETED|Overall Study||6
7751822|NCT01477463|19086563|P1|COMPLETED|Overall Study||18
7751823|NCT01477463|19086562|P2|STARTED|Overall Study||6
7751824|NCT01477463|19086563|P1|STARTED|Overall Study||18
7751825|NCT01477450|19086576|P3|NOT COMPLETED|Overall Study||0
7751826|NCT01477450|19086577|P2|NOT COMPLETED|Overall Study||0
7751827|NCT01477450|19086578|P1|NOT COMPLETED|Overall Study||0
7751828|NCT01477450|19086576|P3|COMPLETED|Overall Study||10
7751829|NCT01477450|19086577|P2|COMPLETED|Overall Study||10
7751830|NCT01477450|19086578|P1|COMPLETED|Overall Study||10
7751831|NCT01477450|19086576|P3|STARTED|Overall Study||10
7751832|NCT01477450|19086577|P2|STARTED|Overall Study||10
7751833|NCT01477450|19086578|P1|STARTED|Overall Study||10
7751834|NCT01477333|19086586|P1|NOT COMPLETED|Overall Study||3
7751835|NCT01477333|19086586|P1|COMPLETED|Overall Study||15
7751836|NCT01477333|19086586|P1|STARTED|Overall Study||18
7751837|NCT01477320|19086604|P2|NOT COMPLETED|Overall Study||15
7751838|NCT01477320|19086605|P1|NOT COMPLETED|Overall Study||7
7751839|NCT01477320|19086604|P2|COMPLETED|Overall Study||47
7751840|NCT01477320|19086605|P1|COMPLETED|Overall Study||55
7751841|NCT01477320|19086604|P2|STARTED|Overall Study||62
7751842|NCT01477320|19086605|P1|STARTED|Overall Study||62
7751843|NCT01477177|19086613|P1|NOT COMPLETED|Overall Study||0
7751844|NCT01477177|19086613|P1|COMPLETED|Overall Study||4
7751845|NCT01477177|19086613|P1|STARTED|Overall Study||4
7751846|NCT01476748|19086624|P3|NOT COMPLETED|Overall Study||0
7751847|NCT01476748|19086625|P2|NOT COMPLETED|Overall Study||0
7751848|NCT01476748|19086626|P1|NOT COMPLETED|Overall Study||0
7751849|NCT01476748|19086624|P3|COMPLETED|Overall Study||5
7751850|NCT01476748|19086625|P2|COMPLETED|Overall Study||5
7751851|NCT01476748|19086626|P1|COMPLETED|Overall Study||5
7751852|NCT01476748|19086624|P3|STARTED|Overall Study||5
7751853|NCT01476748|19086625|P2|STARTED|Overall Study||5
7751854|NCT01476748|19086626|P1|STARTED|Overall Study||5
7751855|NCT01476722|19086637|P1|NOT COMPLETED|Overall Study||1
7751856|NCT01476722|19086637|P1|COMPLETED|Overall Study||124
7751857|NCT01476722|19086637|P1|STARTED|Overall Study||125
7751858|NCT01476696|19086644|P3|NOT COMPLETED|Overall Study||0
7751859|NCT01476696|19086645|P2|NOT COMPLETED|Overall Study||1
7751860|NCT01476696|19086646|P1|NOT COMPLETED|Overall Study||3
7751861|NCT01476696|19086644|P3|COMPLETED|Overall Study||9
7751862|NCT01476696|19086645|P2|COMPLETED|Overall Study||8
7751863|NCT01476696|19086646|P1|COMPLETED|Overall Study||12
7751864|NCT01476696|19086644|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
7751865|NCT01476696|19086645|P2|Received at Least 1 Dose of Study Drug|Overall Study||9
7751866|NCT01476696|19086646|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
7751867|NCT01476696|19086644|P3|STARTED|Overall Study||9
7751868|NCT01476696|19086645|P2|STARTED|Overall Study||9
7751869|NCT01476696|19086646|P1|STARTED|Overall Study||15
7751870|NCT01476644|19086660|P1|NOT COMPLETED|Overall Study||39
7751871|NCT01476644|19086660|P1|COMPLETED|Overall Study||122
7751872|NCT01476644|19086660|P1|STARTED|Overall Study||161
7751873|NCT01476475|19086667|P2|NOT COMPLETED|Overall Study||3
7751874|NCT01476475|19086668|P1|NOT COMPLETED|Overall Study||11
7751875|NCT01476475|19086667|P2|COMPLETED|Overall Study||159
7751876|NCT01476475|19086668|P1|COMPLETED|Overall Study||150
7751877|NCT01476475|19086667|P2|STARTED|Overall Study||162
7751878|NCT01476475|19086668|P1|STARTED|Overall Study||161
7751879|NCT01476449|19086702|P2|NOT COMPLETED|Overall Study||2
7751880|NCT01476449|19086703|P1|NOT COMPLETED|Overall Study||2
7751881|NCT01476449|19086702|P2|COMPLETED|Overall Study||8
7751882|NCT01476449|19086703|P1|COMPLETED|Overall Study||8
7751883|NCT01476449|19086702|P2|STARTED|Overall Study||10
7751884|NCT01476449|19086703|P1|STARTED|Overall Study||10
7751885|NCT01476345|19086717|P2|NOT COMPLETED|Period 4||0
7751886|NCT01476345|19086718|P1|NOT COMPLETED|Period 4||0
7751887|NCT01476345|19086717|P2|COMPLETED|Period 4||39
7751888|NCT01476345|19086718|P1|COMPLETED|Period 4||39
7751889|NCT01476345|19086717|P2|STARTED|Period 4||39
7751890|NCT01476345|19086718|P1|STARTED|Period 4||39
7751891|NCT01476345|19086717|P2|NOT COMPLETED|Period 3||0
7751892|NCT01476345|19086718|P1|NOT COMPLETED|Period 3||0
7751893|NCT01476345|19086717|P2|COMPLETED|Period 3||39
7751894|NCT01476345|19086718|P1|COMPLETED|Period 3||39
7751895|NCT01476345|19086717|P2|STARTED|Period 3||39
7751896|NCT01476345|19086718|P1|STARTED|Period 3||39
7751897|NCT01476345|19086717|P2|NOT COMPLETED|Period 2||0
7751898|NCT01476345|19086718|P1|NOT COMPLETED|Period 2||0
7751899|NCT01476345|19086717|P2|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
7751900|NCT01476345|19086718|P1|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
7751901|NCT01476345|19086717|P2|STARTED|Period 2||40
7751902|NCT01476345|19086718|P1|STARTED|Period 2||40
7751903|NCT01476345|19086717|P2|NOT COMPLETED|Period 1||0
7751904|NCT01476345|19086718|P1|NOT COMPLETED|Period 1||0
7751905|NCT01476345|19086717|P2|COMPLETED|Period 1||40
7751906|NCT01476345|19086718|P1|COMPLETED|Period 1||40
7751907|NCT01476345|19086717|P2|Received at Least 1 Dose of Study Drug|Period 1||40
7751908|NCT01476345|19086718|P1|Received at Least 1 Dose of Study Drug|Period 1||40
7751909|NCT01476345|19086717|P2|STARTED|Period 1||40
7751910|NCT01476345|19086718|P1|STARTED|Period 1||40
7751911|NCT01476267|19086730|P1|NOT COMPLETED|Overall Study||0
7751912|NCT01476267|19086730|P1|COMPLETED|Overall Study||6
7751913|NCT01476267|19086730|P1|STARTED|Overall Study||6
7751914|NCT01476202|19086738|P3|NOT COMPLETED|Overall Study||0
7751915|NCT01476202|19086739|P2|NOT COMPLETED|Overall Study||0
7751916|NCT01476202|19086740|P1|NOT COMPLETED|Overall Study||0
7751917|NCT01476202|19086738|P3|COMPLETED|Overall Study||40
7751918|NCT01476202|19086739|P2|COMPLETED|Overall Study||40
7751919|NCT01476202|19086740|P1|COMPLETED|Overall Study||40
7751920|NCT01476202|19086738|P3|STARTED|Overall Study||40
7751921|NCT01476202|19086739|P2|STARTED|Overall Study||40
7751922|NCT01476202|19086740|P1|STARTED|Overall Study||40
7751923|NCT01475955|19086756|P5|NOT COMPLETED|Overall Study||0
7751924|NCT01475955|19086757|P4|NOT COMPLETED|Overall Study||0
7751925|NCT01475955|19086758|P3|NOT COMPLETED|Overall Study||3
7751926|NCT01475955|19086759|P2|NOT COMPLETED|Overall Study||0
7751927|NCT01475955|19086760|P1|NOT COMPLETED|Overall Study||1
7751928|NCT01475955|19086756|P5|COMPLETED|Overall Study||46
7751929|NCT01475955|19086757|P4|COMPLETED|Overall Study||46
7751930|NCT01475955|19086758|P3|COMPLETED|Overall Study||44
7751931|NCT01475955|19086759|P2|COMPLETED|Overall Study||48
7751932|NCT01475955|19086760|P1|COMPLETED|Overall Study||47
7751933|NCT01475955|19086756|P5|STARTED|Overall Study||46
7751934|NCT01475955|19086757|P4|STARTED|Overall Study||46
7751935|NCT01475955|19086758|P3|STARTED|Overall Study||47
7751936|NCT01475955|19086759|P2|STARTED|Overall Study||48
7751937|NCT01475955|19086760|P1|STARTED|Overall Study||48
7751938|NCT01475851|19087119|P2|NOT COMPLETED|Overall Study||0
7751939|NCT01475851|19087120|P1|NOT COMPLETED|Overall Study||1
7751940|NCT01475851|19087119|P2|COMPLETED|Overall Study||21
7751941|NCT01475851|19087120|P1|COMPLETED|Overall Study||12
7751942|NCT01475851|19087119|P2|STARTED|Overall Study||21
7751943|NCT01475851|19087120|P1|STARTED|Overall Study||13
7751944|NCT01475838|19087148|P2|NOT COMPLETED|Extension Phase||0
7751945|NCT01475838|19087149|P1|NOT COMPLETED|Extension Phase||1
7751946|NCT01475838|19087148|P2|COMPLETED|Extension Phase||20
7751947|NCT01475838|19087149|P1|COMPLETED|Extension Phase||41
7751948|NCT01475838|19087148|P2|STARTED|Extension Phase||20
7751949|NCT01475838|19087149|P1|STARTED|Extension Phase||42
7751950|NCT01475838|19087148|P2|NOT COMPLETED|Randomized Phase||36
7751951|NCT01475838|19087149|P1|NOT COMPLETED|Randomized Phase||30
7751952|NCT01475838|19087148|P2|COMPLETED|Randomized Phase||109
7751953|NCT01475838|19087149|P1|COMPLETED|Randomized Phase||263
7751954|NCT01475838|19087148|P2|STARTED|Randomized Phase||145
7751955|NCT01475838|19087149|P1|STARTED|Randomized Phase||293
7751956|NCT01475825|19087166|P4|NOT COMPLETED|Overall Study||30
7751957|NCT01475825|19087167|P3|NOT COMPLETED|Overall Study||64
7751958|NCT01475825|19087168|P2|NOT COMPLETED|Overall Study||32
7751959|NCT01475825|19087169|P1|NOT COMPLETED|Overall Study||67
7751960|NCT01475825|19087166|P4|COMPLETED|Overall Study||22
7751961|NCT01475825|19087167|P3|COMPLETED|Overall Study||38
7751962|NCT01475825|19087168|P2|COMPLETED|Overall Study||19
7751963|NCT01475825|19087169|P1|COMPLETED|Overall Study||37
7751964|NCT01475825|19087166|P4|Completed Open-Label Continuation|Overall Study||22
7751965|NCT01475825|19087167|P3|Completed Open-Label Continuation|Overall Study||38
7751966|NCT01475825|19087168|P2|Completed Open-Label Continuation|Overall Study||19
7751967|NCT01475825|19087169|P1|Completed Open-Label Continuation|Overall Study||37
7751968|NCT01475825|19087166|P4|Entered Open-Label Continuation|Overall Study||29
7751969|NCT01475825|19087167|P3|Entered Open-Label Continuation|Overall Study||44
7751970|NCT01475825|19087168|P2|Entered Open-Label Continuation|Overall Study||31
7751971|NCT01475825|19087169|P1|Entered Open-Label Continuation|Overall Study||45
7751972|NCT01475825|19087166|P4|Completed Blinded Treatment Period|Overall Study||40
7751973|NCT01475825|19087167|P3|Completed Blinded Treatment Period|Overall Study||59
7751974|NCT01475825|19087168|P2|Completed Blinded Treatment Period|Overall Study||42
7751975|NCT01475825|19087169|P1|Completed Blinded Treatment Period|Overall Study||60
7751976|NCT01475825|19087166|P4|Randomized and Treated|Overall Study||52
7751977|NCT01475825|19087167|P3|Randomized and Treated|Overall Study||102
7751978|NCT01475825|19087168|P2|Randomized and Treated|Overall Study||51
7751979|NCT01475825|19087169|P1|Randomized and Treated|Overall Study||104
7751980|NCT01475825|19087166|P4|STARTED|Overall Study||52
7751981|NCT01475825|19087167|P3|STARTED|Overall Study||102
7751982|NCT01475825|19087168|P2|STARTED|Overall Study||51
7751983|NCT01475825|19087169|P1|STARTED|Overall Study||104
7751984|NCT01475734|19087201|P2|NOT COMPLETED|Overall Study||1
7751985|NCT01475734|19087202|P1|NOT COMPLETED|Overall Study||2
7751986|NCT01475734|19087201|P2|COMPLETED|Overall Study||21
7751987|NCT01475734|19087202|P1|COMPLETED|Overall Study||20
7751988|NCT01475734|19087201|P2|STARTED|Overall Study||22
7751989|NCT01475734|19087202|P1|STARTED|Overall Study||22
7751990|NCT01475721|19087230|P2|NOT COMPLETED|Overall Study||14
7751991|NCT01475721|19087231|P1|NOT COMPLETED|Overall Study||11
7751992|NCT01475721|19087230|P2|COMPLETED|Overall Study||5831
7751993|NCT01475721|19087231|P1|COMPLETED|Overall Study||5823
7751994|NCT01475721|19087230|P2|STARTED|Overall Study||5845
7751995|NCT01475721|19087231|P1|STARTED|Overall Study||5834
7751996|NCT01475643|19087247|P2|NOT COMPLETED|Overall Study||10
7751997|NCT01475643|19087248|P1|NOT COMPLETED|Overall Study||14
7751998|NCT01475643|19087247|P2|COMPLETED|Overall Study||43
7751999|NCT01475643|19087248|P1|COMPLETED|Overall Study||40
7752000|NCT01475643|19087247|P2|STARTED|Overall Study|52 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|53
7752001|NCT01475643|19087248|P1|STARTED|Overall Study|53 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|54
7752002|NCT01475513|19087258|P2|NOT COMPLETED|Overall Study||10
7752003|NCT01475513|19087259|P1|NOT COMPLETED|Overall Study||3
7752004|NCT01475513|19087258|P2|COMPLETED|Overall Study||16
7752005|NCT01475513|19087259|P1|COMPLETED|Overall Study||17
7752006|NCT01475513|19087258|P2|STARTED|Overall Study||26
7752007|NCT01475513|19087259|P1|STARTED|Overall Study||20
7752008|NCT01475487|19087297|P2|NOT COMPLETED|Overall Study||1
7752009|NCT01475487|19087298|P1|NOT COMPLETED|Overall Study||2
7752010|NCT01475487|19087297|P2|COMPLETED|Overall Study||24
7752011|NCT01475487|19087298|P1|COMPLETED|Overall Study||23
7752012|NCT01475487|19087297|P2|STARTED|Overall Study||25
7752013|NCT01475487|19087298|P1|STARTED|Overall Study||25
7752014|NCT01475474|19087310|P1|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2
7752015|NCT01475474|19087310|P1|COMPLETED|Return to Baseline Period - 4 Weeks||71
7752016|NCT01475474|19087310|P1|STARTED|Return to Baseline Period - 4 Weeks||73
7752017|NCT01475474|19087310|P1|NOT COMPLETED|Treatment Period - 12 Weeks||18
7752018|NCT01475474|19087310|P1|COMPLETED|Treatment Period - 12 Weeks||73
7752019|NCT01475474|19087310|P1|STARTED|Treatment Period - 12 Weeks||91
7752020|NCT01475474|19087310|P1|NOT COMPLETED|Baseline Period - 4 Weeks||6
7752021|NCT01475474|19087310|P1|COMPLETED|Baseline Period - 4 Weeks||91
7752022|NCT01475474|19087310|P1|STARTED|Baseline Period - 4 Weeks||97
7752023|NCT01475461|19087321|P7|NOT COMPLETED|Treatment Period||2
7752024|NCT01475461|19087322|P6|NOT COMPLETED|Treatment Period||5
7752025|NCT01475461|19087323|P5|NOT COMPLETED|Treatment Period||4
7752026|NCT01475461|19087324|P4|NOT COMPLETED|Treatment Period||8
7752027|NCT01475461|19087325|P3|NOT COMPLETED|Treatment Period||4
7752028|NCT01475461|19087326|P2|NOT COMPLETED|Treatment Period||9
7752029|NCT01475461|19087327|P1|NOT COMPLETED|Treatment Period||0
7752030|NCT01475461|19087321|P7|COMPLETED|Treatment Period||53
7752031|NCT01475461|19087322|P6|COMPLETED|Treatment Period||51
7752032|NCT01475461|19087323|P5|COMPLETED|Treatment Period||52
7752033|NCT01475461|19087324|P4|COMPLETED|Treatment Period||46
7752034|NCT01475461|19087325|P3|COMPLETED|Treatment Period||53
7752035|NCT01475461|19087326|P2|COMPLETED|Treatment Period||48
7752036|NCT01475461|19087327|P1|COMPLETED|Treatment Period||0
7752037|NCT01475461|19087321|P7|STARTED|Treatment Period||55
7752038|NCT01475461|19087322|P6|STARTED|Treatment Period||56
7752039|NCT01475461|19087323|P5|STARTED|Treatment Period||56
7752040|NCT01475461|19087324|P4|STARTED|Treatment Period||54
7752041|NCT01475461|19087325|P3|STARTED|Treatment Period||57
7752042|NCT01475461|19087326|P2|STARTED|Treatment Period||57
7752043|NCT01475461|19087327|P1|STARTED|Treatment Period||0
7752044|NCT01475461|19087321|P7|NOT COMPLETED|Run-in Period||0
7752045|NCT01475461|19087322|P6|NOT COMPLETED|Run-in Period||0
7752046|NCT01475461|19087323|P5|NOT COMPLETED|Run-in Period||0
7752047|NCT01475461|19087324|P4|NOT COMPLETED|Run-in Period||0
7752048|NCT01475461|19087325|P3|NOT COMPLETED|Run-in Period||0
7752049|NCT01475461|19087326|P2|NOT COMPLETED|Run-in Period||0
7752050|NCT01475461|19087327|P1|NOT COMPLETED|Run-in Period||41
7752051|NCT01475461|19087321|P7|COMPLETED|Run-in Period||0
7752052|NCT01475461|19087322|P6|COMPLETED|Run-in Period||0
7752053|NCT01475461|19087323|P5|COMPLETED|Run-in Period||0
7752054|NCT01475461|19087324|P4|COMPLETED|Run-in Period||0
7752055|NCT01475461|19087325|P3|COMPLETED|Run-in Period||0
7752056|NCT01475461|19087326|P2|COMPLETED|Run-in Period||0
7752057|NCT01475461|19087327|P1|COMPLETED|Run-in Period||335
7752058|NCT01475461|19087321|P7|STARTED|Run-in Period||0
7752059|NCT01475461|19087322|P6|STARTED|Run-in Period||0
7752060|NCT01475461|19087323|P5|STARTED|Run-in Period||0
7752061|NCT01475461|19087324|P4|STARTED|Run-in Period||0
7752062|NCT01475461|19087325|P3|STARTED|Run-in Period||0
7752063|NCT01475461|19087326|P2|STARTED|Run-in Period||0
7752064|NCT01475461|19087327|P1|STARTED|Run-in Period||376
7752065|NCT01475331|19087407|P2|NOT COMPLETED|Overall Study||2
7752066|NCT01475331|19087408|P1|NOT COMPLETED|Overall Study||5
7752067|NCT01475331|19087407|P2|COMPLETED|Overall Study||21
7752068|NCT01475331|19087408|P1|COMPLETED|Overall Study||18
7752069|NCT01475331|19087407|P2|STARTED|Overall Study||23
7752070|NCT01475331|19087408|P1|STARTED|Overall Study||23
7752071|NCT01475305|19087416|P2|NOT COMPLETED|Overall Study||0
7752072|NCT01475305|19087417|P1|NOT COMPLETED|Overall Study||0
7752073|NCT01475305|19087416|P2|COMPLETED|Overall Study||3
7752074|NCT01475305|19087417|P1|COMPLETED|Overall Study||4
7752075|NCT01475305|19087416|P2|End of Quarantine, Day 15|Overall Study||3
7752076|NCT01475305|19087417|P1|End of Quarantine, Day 15|Overall Study||4
7752077|NCT01475305|19087416|P2|STARTED|Overall Study||3
7752078|NCT01475305|19087417|P1|STARTED|Overall Study||4
7752079|NCT01475253|19087460|P4|NOT COMPLETED|Open Label Extension||0
7752080|NCT01475253|19087461|P3|NOT COMPLETED|Open Label Extension||0
7752081|NCT01475253|19087462|P2|NOT COMPLETED|Open Label Extension||0
7752082|NCT01475253|19087463|P1|NOT COMPLETED|Open Label Extension||0
7752083|NCT01475253|19087460|P4|COMPLETED|Open Label Extension||56
7752084|NCT01475253|19087461|P3|COMPLETED|Open Label Extension||0
7752085|NCT01475253|19087462|P2|COMPLETED|Open Label Extension||0
7752086|NCT01475253|19087463|P1|COMPLETED|Open Label Extension||0
7752087|NCT01475253|19087460|P4|STARTED|Open Label Extension||56
7752088|NCT01475253|19087461|P3|STARTED|Open Label Extension||0
7752089|NCT01475253|19087462|P2|STARTED|Open Label Extension||0
7752090|NCT01475253|19087463|P1|STARTED|Open Label Extension||0
7752091|NCT01475253|19087460|P4|NOT COMPLETED|Randomized, Blinded Study||0
7752092|NCT01475253|19087461|P3|NOT COMPLETED|Randomized, Blinded Study||0
7752093|NCT01475253|19087462|P2|NOT COMPLETED|Randomized, Blinded Study||1
7752094|NCT01475253|19087463|P1|NOT COMPLETED|Randomized, Blinded Study||2
7752095|NCT01475253|19087460|P4|COMPLETED|Randomized, Blinded Study||0
7752096|NCT01475253|19087461|P3|COMPLETED|Randomized, Blinded Study||11
7752097|NCT01475253|19087462|P2|COMPLETED|Randomized, Blinded Study||45
7752098|NCT01475253|19087463|P1|COMPLETED|Randomized, Blinded Study||45
7752099|NCT01475253|19087460|P4|STARTED|Randomized, Blinded Study||0
7752100|NCT01475253|19087461|P3|STARTED|Randomized, Blinded Study||11
7752101|NCT01475253|19087462|P2|STARTED|Randomized, Blinded Study||46
7752102|NCT01475253|19087463|P1|STARTED|Randomized, Blinded Study||47
7752103|NCT01475214|19087492|P3|NOT COMPLETED|Overall Study||2
7752104|NCT01475214|19087493|P2|NOT COMPLETED|Overall Study||4
7752105|NCT01475214|19087494|P1|NOT COMPLETED|Overall Study||5
7752106|NCT01475214|19087492|P3|COMPLETED|Overall Study||79
7752107|NCT01475214|19087493|P2|COMPLETED|Overall Study||75
7752108|NCT01475214|19087494|P1|COMPLETED|Overall Study||79
7752109|NCT01475214|19087492|P3|STARTED|Overall Study||81
7752110|NCT01475214|19087493|P2|STARTED|Overall Study||79
7752111|NCT01475214|19087494|P1|STARTED|Overall Study||84
7752112|NCT01475175|19087505|P1|NOT COMPLETED|Overall Study||0
7752113|NCT01475175|19087505|P1|COMPLETED|Overall Study||12
7752114|NCT01475175|19087505|P1|STARTED|Overall Study||12
7752115|NCT01475162|19087517|P1|NOT COMPLETED|Overall Study||14
7752116|NCT01475162|19087517|P1|COMPLETED|Overall Study||0
7752117|NCT01475162|19087517|P1|STARTED|Overall Study||14
7752118|NCT01475097|19087530|P2|NOT COMPLETED|Overall Study||1
7752119|NCT01475097|19087531|P1|NOT COMPLETED|Overall Study||1
7752120|NCT01475097|19087530|P2|COMPLETED|Overall Study||126
7752121|NCT01475097|19087531|P1|COMPLETED|Overall Study||127
7752122|NCT01475097|19087530|P2|STARTED|Overall Study||127
7752123|NCT01475097|19087531|P1|STARTED|Overall Study||128
7752124|NCT01475071|19087539|P1|NOT COMPLETED|Overall Study||8
7752125|NCT01475071|19087539|P1|COMPLETED|Overall Study||92
7752126|NCT01475071|19087539|P1|STARTED|Overall Study||100
7752127|NCT01474993|19087549|P2|NOT COMPLETED|Overall Study||3
7752128|NCT01474993|19087550|P1|NOT COMPLETED|Overall Study||1
7752129|NCT01474993|19087549|P2|COMPLETED|Overall Study||26
7752130|NCT01474993|19087550|P1|COMPLETED|Overall Study||14
7752131|NCT01474993|19087549|P2|STARTED|Overall Study||29
7752132|NCT01474993|19087550|P1|STARTED|Overall Study||15
7752133|NCT01474915|19087580|P2|NOT COMPLETED|Overall Study||10
7752134|NCT01474915|19087581|P1|NOT COMPLETED|Overall Study||10
7752135|NCT01474915|19087580|P2|COMPLETED|Overall Study||51
7752136|NCT01474915|19087581|P1|COMPLETED|Overall Study||50
7752137|NCT01474915|19087580|P2|STARTED|Overall Study||61
7752138|NCT01474915|19087581|P1|STARTED|Overall Study||60
7752139|NCT01474876|19087592|P3|NOT COMPLETED|Overall Study||0
7752140|NCT01474876|19087593|P2|NOT COMPLETED|Overall Study||23
7752141|NCT01474876|19087594|P1|NOT COMPLETED|Overall Study||66
7752142|NCT01474876|19087592|P3|COMPLETED|Overall Study||1
7752143|NCT01474876|19087593|P2|COMPLETED|Overall Study||128
7752144|NCT01474876|19087594|P1|COMPLETED|Overall Study||337
7752145|NCT01474876|19087592|P3|STARTED|Overall Study||1
7752146|NCT01474876|19087593|P2|STARTED|Overall Study||151
7752147|NCT01474876|19087594|P1|STARTED|Overall Study||403
7752148|NCT01474863|19087628|P3|NOT COMPLETED|Overall Study||0
7752149|NCT01474863|19087629|P2|NOT COMPLETED|Overall Study||0
7752150|NCT01474863|19087630|P1|NOT COMPLETED|Overall Study||0
7752151|NCT01474863|19087628|P3|COMPLETED|Overall Study||24
7752152|NCT01474863|19087629|P2|COMPLETED|Overall Study||22
7752153|NCT01474863|19087630|P1|COMPLETED|Overall Study||26
7752154|NCT01474863|19087628|P3|STARTED|Overall Study||24
7752155|NCT01474863|19087629|P2|STARTED|Overall Study||22
7752156|NCT01474863|19087630|P1|STARTED|Overall Study||26
7752157|NCT01474772|19087640|P2|NOT COMPLETED|Follow-up||1
7752158|NCT01474772|19087641|P1|NOT COMPLETED|Follow-up||0
7752159|NCT01474772|19087640|P2|COMPLETED|Follow-up||86
7752160|NCT01474772|19087641|P1|COMPLETED|Follow-up||77
7752161|NCT01474772|19087640|P2|STARTED|Follow-up||87
7752162|NCT01474772|19087641|P1|STARTED|Follow-up||77
7752163|NCT01474772|19087640|P2|NOT COMPLETED|Period 2||10
7752164|NCT01474772|19087641|P1|NOT COMPLETED|Period 2||9
7752165|NCT01474772|19087640|P2|COMPLETED|Period 2||87
7752166|NCT01474772|19087641|P1|COMPLETED|Period 2||77
7752167|NCT01474772|19087640|P2|STARTED|Period 2||97
7752168|NCT01474772|19087641|P1|STARTED|Period 2||86
7752169|NCT01474772|19087640|P2|NOT COMPLETED|Washout||2
7752170|NCT01474772|19087641|P1|NOT COMPLETED|Washout||3
7752171|NCT01474772|19087640|P2|COMPLETED|Washout||97
7752172|NCT01474772|19087641|P1|COMPLETED|Washout||86
7752173|NCT01474772|19087640|P2|STARTED|Washout||99
7752174|NCT01474772|19087641|P1|STARTED|Washout||89
7752175|NCT01474772|19087640|P2|NOT COMPLETED|Period 1||3
7752176|NCT01474772|19087641|P1|NOT COMPLETED|Period 1||12
7752177|NCT01474772|19087640|P2|COMPLETED|Period 1||99
7752178|NCT01474772|19087641|P1|COMPLETED|Period 1||89
7752179|NCT01474772|19087640|P2|STARTED|Period 1|STARTED=treated|102
7752180|NCT01474772|19087641|P1|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101
7752181|NCT01474746|19087691|P2|NOT COMPLETED|Overall Study||2
7752182|NCT01474746|19087692|P1|NOT COMPLETED|Overall Study||3
7752183|NCT01474746|19087691|P2|COMPLETED|Overall Study||25
7752184|NCT01474746|19087692|P1|COMPLETED|Overall Study||27
7752185|NCT01474746|19087691|P2|STARTED|Overall Study||27
7752186|NCT01474746|19087692|P1|STARTED|Overall Study||30
7752187|NCT01474681|19087756|P4|NOT COMPLETED|Overall Study||6
7752188|NCT01474681|19087757|P3|NOT COMPLETED|Overall Study||2
7752189|NCT01474681|19087758|P2|NOT COMPLETED|Overall Study||3
7752190|NCT01474681|19087759|P1|NOT COMPLETED|Overall Study||0
7752191|NCT01474681|19087756|P4|COMPLETED|Overall Study||9
7752192|NCT01474681|19087757|P3|COMPLETED|Overall Study||1
7752193|NCT01474681|19087758|P2|COMPLETED|Overall Study||5
7752194|NCT01474681|19087759|P1|COMPLETED|Overall Study||1
7752195|NCT01474681|19087756|P4|STARTED|Overall Study||15
7752196|NCT01474681|19087757|P3|STARTED|Overall Study||3
7752197|NCT01474681|19087758|P2|STARTED|Overall Study||8
7752198|NCT01474681|19087759|P1|STARTED|Overall Study||1
7752199|NCT01474590|19087803|P2|NOT COMPLETED|Overall Study||17
7752200|NCT01474590|19087804|P1|NOT COMPLETED|Overall Study||28
7752201|NCT01474590|19087803|P2|COMPLETED|Overall Study||116
7752202|NCT01474590|19087804|P1|COMPLETED|Overall Study||105
7752203|NCT01474590|19087803|P2|STARTED|Overall Study||133
7752204|NCT01474590|19087804|P1|STARTED|Overall Study||133
7752205|NCT01474551|19087810|P1|NOT COMPLETED|Overall Study||1
7752206|NCT01474551|19087810|P1|COMPLETED|Overall Study||1
7752207|NCT01474551|19087810|P1|STARTED|Overall Study||2
7752208|NCT01474538|19087816|P2|NOT COMPLETED|Treatment Period 2||2
7752209|NCT01474538|19087817|P1|NOT COMPLETED|Treatment Period 2||6
7752210|NCT01474538|19087816|P2|COMPLETED|Treatment Period 2||56
7752211|NCT01474538|19087817|P1|COMPLETED|Treatment Period 2||51
7752212|NCT01474538|19087816|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||58
7752213|NCT01474538|19087817|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||57
7752214|NCT01474538|19087816|P2|STARTED|Treatment Period 2||58
7752215|NCT01474538|19087817|P1|STARTED|Treatment Period 2||57
7752216|NCT01474538|19087816|P2|NOT COMPLETED|Treatment Period 1||4
7752217|NCT01474538|19087817|P1|NOT COMPLETED|Treatment Period 1||3
7752218|NCT01474538|19087816|P2|COMPLETED|Treatment Period 1||58
7752219|NCT01474538|19087817|P1|COMPLETED|Treatment Period 1||57
7752220|NCT01474538|19087816|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||62
7752221|NCT01474538|19087817|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||60
7752222|NCT01474538|19087816|P2|STARTED|Treatment Period 1||62
7752223|NCT01474538|19087817|P1|STARTED|Treatment Period 1||60
7752224|NCT01474512|19087834|P18|NOT COMPLETED|Post-Treatment Follow-Up||46
7752225|NCT01474512|19087835|P17|NOT COMPLETED|Post-Treatment Follow-Up||156
7752226|NCT01474512|19087836|P16|NOT COMPLETED|Post-Treatment Follow-Up||8
7752227|NCT01474512|19087837|P15|NOT COMPLETED|Post-Treatment Follow-Up||18
7752228|NCT01474512|19087838|P14|NOT COMPLETED|Post-Treatment Follow-Up||0
7752229|NCT01474512|19087839|P13|NOT COMPLETED|Post-Treatment Follow-Up||0
7752230|NCT01474512|19087840|P12|NOT COMPLETED|Post-Treatment Follow-Up||0
7752231|NCT01474512|19087841|P11|NOT COMPLETED|Post-Treatment Follow-Up||0
7752232|NCT01474512|19087842|P10|NOT COMPLETED|Post-Treatment Follow-Up||0
7752233|NCT01474512|19087843|P9|NOT COMPLETED|Post-Treatment Follow-Up||0
7752234|NCT01474512|19087844|P8|NOT COMPLETED|Post-Treatment Follow-Up||0
7752235|NCT01474512|19087845|P7|NOT COMPLETED|Post-Treatment Follow-Up||0
7752236|NCT01474512|19087846|P6|NOT COMPLETED|Post-Treatment Follow-Up||0
7752237|NCT01474512|19087847|P5|NOT COMPLETED|Post-Treatment Follow-Up||0
7752238|NCT01474512|19087848|P4|NOT COMPLETED|Post-Treatment Follow-Up||0
7752239|NCT01474512|19087849|P3|NOT COMPLETED|Post-Treatment Follow-Up||0
7752240|NCT01474512|19087850|P2|NOT COMPLETED|Post-Treatment Follow-Up||0
7752241|NCT01474512|19087851|P1|NOT COMPLETED|Post-Treatment Follow-Up||0
7752242|NCT01474512|19087834|P18|COMPLETED|Post-Treatment Follow-Up||239
7752243|NCT01474512|19087835|P17|COMPLETED|Post-Treatment Follow-Up||544
7752244|NCT01474512|19087836|P16|COMPLETED|Post-Treatment Follow-Up||17
7752245|NCT01474512|19087837|P15|COMPLETED|Post-Treatment Follow-Up||0
7752246|NCT01474512|19087838|P14|COMPLETED|Post-Treatment Follow-Up||0
7752247|NCT01474512|19087839|P13|COMPLETED|Post-Treatment Follow-Up||0
7752248|NCT01474512|19087840|P12|COMPLETED|Post-Treatment Follow-Up||0
7752249|NCT01474512|19087841|P11|COMPLETED|Post-Treatment Follow-Up||0
7752250|NCT01474512|19087842|P10|COMPLETED|Post-Treatment Follow-Up||0
7752251|NCT01474512|19087843|P9|COMPLETED|Post-Treatment Follow-Up||0
7752252|NCT01474512|19087844|P8|COMPLETED|Post-Treatment Follow-Up||0
7752253|NCT01474512|19087845|P7|COMPLETED|Post-Treatment Follow-Up||0
7752254|NCT01474512|19087846|P6|COMPLETED|Post-Treatment Follow-Up||0
7752255|NCT01474512|19087847|P5|COMPLETED|Post-Treatment Follow-Up||0
7752256|NCT01474512|19087848|P4|COMPLETED|Post-Treatment Follow-Up||0
7752257|NCT01474512|19087849|P3|COMPLETED|Post-Treatment Follow-Up||0
7752258|NCT01474512|19087850|P2|COMPLETED|Post-Treatment Follow-Up||0
7752259|NCT01474512|19087851|P1|COMPLETED|Post-Treatment Follow-Up||0
7752260|NCT01474512|19087834|P18|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|285
7752261|NCT01474512|19087835|P17|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|700
7752262|NCT01474512|19087836|P16|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|25
7752263|NCT01474512|19087837|P15|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|18
7752264|NCT01474512|19087838|P14|STARTED|Post-Treatment Follow-Up||0
7752265|NCT01474512|19087839|P13|STARTED|Post-Treatment Follow-Up||0
7752266|NCT01474512|19087840|P12|STARTED|Post-Treatment Follow-Up||0
7752267|NCT01474512|19087841|P11|STARTED|Post-Treatment Follow-Up||0
7752268|NCT01474512|19087842|P10|STARTED|Post-Treatment Follow-Up||0
7752269|NCT01474512|19087843|P9|STARTED|Post-Treatment Follow-Up||0
7752270|NCT01474512|19087844|P8|STARTED|Post-Treatment Follow-Up||0
7752271|NCT01474512|19087845|P7|STARTED|Post-Treatment Follow-Up||0
7752272|NCT01474512|19087846|P6|STARTED|Post-Treatment Follow-Up||0
7752273|NCT01474512|19087847|P5|STARTED|Post-Treatment Follow-Up||0
7752274|NCT01474512|19087848|P4|STARTED|Post-Treatment Follow-Up||0
7752275|NCT01474512|19087849|P3|STARTED|Post-Treatment Follow-Up||0
7752276|NCT01474512|19087850|P2|STARTED|Post-Treatment Follow-Up||0
7752277|NCT01474512|19087851|P1|STARTED|Post-Treatment Follow-Up||0
7752278|NCT01474512|19087834|P18|NOT COMPLETED|Long-Term Extension Period||0
7752279|NCT01474512|19087835|P17|NOT COMPLETED|Long-Term Extension Period||0
7752280|NCT01474512|19087836|P16|NOT COMPLETED|Long-Term Extension Period||0
7752281|NCT01474512|19087837|P15|NOT COMPLETED|Long-Term Extension Period||0
7752282|NCT01474512|19087838|P14|NOT COMPLETED|Long-Term Extension Period||220
7752283|NCT01474512|19087839|P13|NOT COMPLETED|Long-Term Extension Period||218
7752284|NCT01474512|19087840|P12|NOT COMPLETED|Long-Term Extension Period||26
7752285|NCT01474512|19087841|P11|NOT COMPLETED|Long-Term Extension Period||0
7752286|NCT01474512|19087842|P10|NOT COMPLETED|Long-Term Extension Period||0
7752287|NCT01474512|19087843|P9|NOT COMPLETED|Long-Term Extension Period||0
7752288|NCT01474512|19087844|P8|NOT COMPLETED|Long-Term Extension Period||0
7752289|NCT01474512|19087845|P7|NOT COMPLETED|Long-Term Extension Period||0
7752290|NCT01474512|19087846|P6|NOT COMPLETED|Long-Term Extension Period||0
7752291|NCT01474512|19087847|P5|NOT COMPLETED|Long-Term Extension Period||0
7752292|NCT01474512|19087848|P4|NOT COMPLETED|Long-Term Extension Period||0
7752293|NCT01474512|19087849|P3|NOT COMPLETED|Long-Term Extension Period||0
7752294|NCT01474512|19087850|P2|NOT COMPLETED|Long-Term Extension Period||0
7752295|NCT01474512|19087851|P1|NOT COMPLETED|Long-Term Extension Period||0
7752296|NCT01474512|19087834|P18|COMPLETED|Long-Term Extension Period||0
7752297|NCT01474512|19087835|P17|COMPLETED|Long-Term Extension Period||0
7752298|NCT01474512|19087836|P16|COMPLETED|Long-Term Extension Period||0
7752299|NCT01474512|19087837|P15|COMPLETED|Long-Term Extension Period||0
7752300|NCT01474512|19087838|P14|COMPLETED|Long-Term Extension Period||855
7752301|NCT01474512|19087839|P13|COMPLETED|Long-Term Extension Period||836
7752302|NCT01474512|19087840|P12|COMPLETED|Long-Term Extension Period||0
7752303|NCT01474512|19087841|P11|COMPLETED|Long-Term Extension Period||0
7752304|NCT01474512|19087842|P10|COMPLETED|Long-Term Extension Period||0
7752305|NCT01474512|19087843|P9|COMPLETED|Long-Term Extension Period||0
7752306|NCT01474512|19087844|P8|COMPLETED|Long-Term Extension Period||0
7752307|NCT01474512|19087845|P7|COMPLETED|Long-Term Extension Period||0
7752308|NCT01474512|19087846|P6|COMPLETED|Long-Term Extension Period||0
7752309|NCT01474512|19087847|P5|COMPLETED|Long-Term Extension Period||0
7752310|NCT01474512|19087848|P4|COMPLETED|Long-Term Extension Period||0
7752311|NCT01474512|19087849|P3|COMPLETED|Long-Term Extension Period||0
7752312|NCT01474512|19087850|P2|COMPLETED|Long-Term Extension Period||0
7752313|NCT01474512|19087851|P1|COMPLETED|Long-Term Extension Period||0
7752314|NCT01474512|19087834|P18|STARTED|Long-Term Extension Period||0
7752315|NCT01474512|19087835|P17|STARTED|Long-Term Extension Period||0
7752316|NCT01474512|19087836|P16|STARTED|Long-Term Extension Period||0
7752317|NCT01474512|19087837|P15|STARTED|Long-Term Extension Period||0
7752318|NCT01474512|19087838|P14|STARTED|Long-Term Extension Period|Participants received Ixe in all dosing regimens, including participants who switched PBO to Ixe.|1075
7752319|NCT01474512|19087839|P13|STARTED|Long-Term Extension Period|Participants received Ixe alone at the start of long-term extension.|1054
7752320|NCT01474512|19087840|P12|STARTED|Long-Term Extension Period|9 participants did not start the long-term extension period.|26
7752321|NCT01474512|19087841|P11|STARTED|Long-Term Extension Period||0
7752322|NCT01474512|19087842|P10|STARTED|Long-Term Extension Period||0
7752323|NCT01474512|19087843|P9|STARTED|Long-Term Extension Period||0
7752324|NCT01474512|19087844|P8|STARTED|Long-Term Extension Period||0
7752325|NCT01474512|19087845|P7|STARTED|Long-Term Extension Period||0
7752326|NCT01474512|19087846|P6|STARTED|Long-Term Extension Period||0
7752327|NCT01474512|19087847|P5|STARTED|Long-Term Extension Period||0
7752328|NCT01474512|19087848|P4|STARTED|Long-Term Extension Period||0
7752329|NCT01474512|19087849|P3|STARTED|Long-Term Extension Period||0
7752330|NCT01474512|19087850|P2|STARTED|Long-Term Extension Period||0
7752331|NCT01474512|19087851|P1|STARTED|Long-Term Extension Period||0
7752332|NCT01474512|19087834|P18|NOT COMPLETED|Maintenance Period||0
7752333|NCT01474512|19087835|P17|NOT COMPLETED|Maintenance Period||0
7752334|NCT01474512|19087836|P16|NOT COMPLETED|Maintenance Period||0
7752335|NCT01474512|19087837|P15|NOT COMPLETED|Maintenance Period||0
7752336|NCT01474512|19087838|P14|NOT COMPLETED|Maintenance Period||0
7752337|NCT01474512|19087839|P13|NOT COMPLETED|Maintenance Period||0
7752338|NCT01474512|19087840|P12|NOT COMPLETED|Maintenance Period||0
7752339|NCT01474512|19087841|P11|NOT COMPLETED|Maintenance Period||0
7752340|NCT01474512|19087842|P10|NOT COMPLETED|Maintenance Period||18
7752341|NCT01474512|19087843|P9|NOT COMPLETED|Maintenance Period||16
7752342|NCT01474512|19087844|P8|NOT COMPLETED|Maintenance Period||41
7752343|NCT01474512|19087845|P7|NOT COMPLETED|Maintenance Period||10
7752344|NCT01474512|19087846|P6|NOT COMPLETED|Maintenance Period||52
7752345|NCT01474512|19087847|P5|NOT COMPLETED|Maintenance Period||119
7752346|NCT01474512|19087848|P4|NOT COMPLETED|Maintenance Period||202
7752347|NCT01474512|19087849|P3|NOT COMPLETED|Maintenance Period||0
7752348|NCT01474512|19087850|P2|NOT COMPLETED|Maintenance Period||0
7752349|NCT01474512|19087851|P1|NOT COMPLETED|Maintenance Period||0
7752350|NCT01474512|19087834|P18|COMPLETED|Maintenance Period||0
7752351|NCT01474512|19087835|P17|COMPLETED|Maintenance Period||0
7752352|NCT01474512|19087836|P16|COMPLETED|Maintenance Period||0
7752353|NCT01474512|19087837|P15|COMPLETED|Maintenance Period||0
7752354|NCT01474512|19087838|P14|COMPLETED|Maintenance Period||0
7752355|NCT01474512|19087839|P13|COMPLETED|Maintenance Period||0
7752356|NCT01474512|19087840|P12|COMPLETED|Maintenance Period||0
7752357|NCT01474512|19087841|P11|COMPLETED|Maintenance Period||0
7752358|NCT01474512|19087842|P10|COMPLETED|Maintenance Period||44
7752359|NCT01474512|19087843|P9|COMPLETED|Maintenance Period||62
7752360|NCT01474512|19087844|P8|COMPLETED|Maintenance Period||350
7752361|NCT01474512|19087845|P7|COMPLETED|Maintenance Period||6
7752362|NCT01474512|19087846|P6|COMPLETED|Maintenance Period||177
7752363|NCT01474512|19087847|P5|COMPLETED|Maintenance Period||108
7752364|NCT01474512|19087848|P4|COMPLETED|Maintenance Period||24
7752365|NCT01474512|19087849|P3|COMPLETED|Maintenance Period||0
7752366|NCT01474512|19087850|P2|COMPLETED|Maintenance Period||0
7752367|NCT01474512|19087851|P1|COMPLETED|Maintenance Period||0
7752368|NCT01474512|19087834|P18|Relapsed Population Completers|Maintenance Period||0
7752369|NCT01474512|19087835|P17|Relapsed Population Completers|Maintenance Period||0
7752370|NCT01474512|19087836|P16|Relapsed Population Completers|Maintenance Period||0
7752371|NCT01474512|19087837|P15|Relapsed Population Completers|Maintenance Period||0
7752372|NCT01474512|19087838|P14|Relapsed Population Completers|Maintenance Period||0
7752373|NCT01474512|19087839|P13|Relapsed Population Completers|Maintenance Period||0
7752374|NCT01474512|19087840|P12|Relapsed Population Completers|Maintenance Period||0
7752375|NCT01474512|19087841|P11|Relapsed Population Completers|Maintenance Period||321
7752376|NCT01474512|19087842|P10|Relapsed Population Completers|Maintenance Period||0
7752377|NCT01474512|19087843|P9|Relapsed Population Completers|Maintenance Period||0
7752378|NCT01474512|19087844|P8|Relapsed Population Completers|Maintenance Period||0
7752379|NCT01474512|19087845|P7|Relapsed Population Completers|Maintenance Period||0
7752380|NCT01474512|19087846|P6|Relapsed Population Completers|Maintenance Period||0
7752381|NCT01474512|19087847|P5|Relapsed Population Completers|Maintenance Period||0
7752382|NCT01474512|19087848|P4|Relapsed Population Completers|Maintenance Period||0
7752383|NCT01474512|19087849|P3|Relapsed Population Completers|Maintenance Period||0
7752384|NCT01474512|19087850|P2|Relapsed Population Completers|Maintenance Period||0
7752385|NCT01474512|19087851|P1|Relapsed Population Completers|Maintenance Period||0
7752386|NCT01474512|19087834|P18|Relapsed Population Received Drug|Maintenance Period||0
7752387|NCT01474512|19087835|P17|Relapsed Population Received Drug|Maintenance Period||0
7752388|NCT01474512|19087836|P16|Relapsed Population Received Drug|Maintenance Period||0
7752389|NCT01474512|19087837|P15|Relapsed Population Received Drug|Maintenance Period||0
7752390|NCT01474512|19087838|P14|Relapsed Population Received Drug|Maintenance Period||0
7752391|NCT01474512|19087839|P13|Relapsed Population Received Drug|Maintenance Period||0
7752392|NCT01474512|19087840|P12|Relapsed Population Received Drug|Maintenance Period||0
7752393|NCT01474512|19087841|P11|Relapsed Population Received Drug|Maintenance Period||348
7752394|NCT01474512|19087842|P10|Relapsed Population Received Drug|Maintenance Period||0
7752395|NCT01474512|19087843|P9|Relapsed Population Received Drug|Maintenance Period||0
7752396|NCT01474512|19087844|P8|Relapsed Population Received Drug|Maintenance Period||0
7752397|NCT01474512|19087845|P7|Relapsed Population Received Drug|Maintenance Period||0
7752398|NCT01474512|19087846|P6|Relapsed Population Received Drug|Maintenance Period||0
7752399|NCT01474512|19087847|P5|Relapsed Population Received Drug|Maintenance Period||0
7752400|NCT01474512|19087848|P4|Relapsed Population Received Drug|Maintenance Period||0
7752401|NCT01474512|19087849|P3|Relapsed Population Received Drug|Maintenance Period||0
7752402|NCT01474512|19087850|P2|Relapsed Population Received Drug|Maintenance Period||0
7752403|NCT01474512|19087851|P1|Relapsed Population Received Drug|Maintenance Period||0
7752404|NCT01474512|19087834|P18|Received Study Drug|Maintenance Period||0
7752405|NCT01474512|19087835|P17|Received Study Drug|Maintenance Period||0
7752406|NCT01474512|19087836|P16|Received Study Drug|Maintenance Period||0
7752407|NCT01474512|19087837|P15|Received Study Drug|Maintenance Period||0
7752408|NCT01474512|19087838|P14|Received Study Drug|Maintenance Period||0
7752409|NCT01474512|19087839|P13|Received Study Drug|Maintenance Period||0
7752410|NCT01474512|19087840|P12|Received Study Drug|Maintenance Period||0
7752411|NCT01474512|19087841|P11|Received Study Drug|Maintenance Period||0
7752412|NCT01474512|19087842|P10|Received Study Drug|Maintenance Period||62
7752413|NCT01474512|19087843|P9|Received Study Drug|Maintenance Period||78
7752414|NCT01474512|19087844|P8|Received Study Drug|Maintenance Period||391
7752415|NCT01474512|19087845|P7|Received Study Drug|Maintenance Period||16
7752416|NCT01474512|19087846|P6|Received Study Drug|Maintenance Period||229
7752417|NCT01474512|19087847|P5|Received Study Drug|Maintenance Period||227
7752418|NCT01474512|19087848|P4|Received Study Drug|Maintenance Period||226
7752419|NCT01474512|19087849|P3|Received Study Drug|Maintenance Period||0
7752420|NCT01474512|19087850|P2|Received Study Drug|Maintenance Period||0
7752421|NCT01474512|19087851|P1|Received Study Drug|Maintenance Period||0
7752422|NCT01474512|19087834|P18|STARTED|Maintenance Period||0
7752423|NCT01474512|19087835|P17|STARTED|Maintenance Period||0
7752424|NCT01474512|19087836|P16|STARTED|Maintenance Period||0
7752425|NCT01474512|19087837|P15|STARTED|Maintenance Period||0
7752426|NCT01474512|19087838|P14|STARTED|Maintenance Period||0
7752427|NCT01474512|19087839|P13|STARTED|Maintenance Period||0
7752428|NCT01474512|19087840|P12|STARTED|Maintenance Period||0
7752429|NCT01474512|19087841|P11|STARTED|Maintenance Period||0
7752430|NCT01474512|19087842|P10|STARTED|Maintenance Period||62
7752431|NCT01474512|19087843|P9|STARTED|Maintenance Period||78
7752432|NCT01474512|19087844|P8|STARTED|Maintenance Period||391
7752433|NCT01474512|19087845|P7|STARTED|Maintenance Period||16
7752434|NCT01474512|19087846|P6|STARTED|Maintenance Period||229
7752435|NCT01474512|19087847|P5|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227
7752436|NCT01474512|19087848|P4|STARTED|Maintenance Period||226
7752437|NCT01474512|19087849|P3|STARTED|Maintenance Period||0
7752438|NCT01474512|19087850|P2|STARTED|Maintenance Period||0
7752439|NCT01474512|19087851|P1|STARTED|Maintenance Period||0
7752440|NCT01474512|19087834|P18|NOT COMPLETED|Induction Period||0
7752441|NCT01474512|19087835|P17|NOT COMPLETED|Induction Period||0
7752442|NCT01474512|19087836|P16|NOT COMPLETED|Induction Period||0
7752443|NCT01474512|19087837|P15|NOT COMPLETED|Induction Period||0
7752444|NCT01474512|19087838|P14|NOT COMPLETED|Induction Period||0
7752445|NCT01474512|19087839|P13|NOT COMPLETED|Induction Period||0
7752446|NCT01474512|19087840|P12|NOT COMPLETED|Induction Period||0
7752447|NCT01474512|19087841|P11|NOT COMPLETED|Induction Period||0
7752448|NCT01474512|19087842|P10|NOT COMPLETED|Induction Period||0
7752449|NCT01474512|19087843|P9|NOT COMPLETED|Induction Period||0
7752450|NCT01474512|19087844|P8|NOT COMPLETED|Induction Period||0
7752451|NCT01474512|19087845|P7|NOT COMPLETED|Induction Period||0
7752452|NCT01474512|19087846|P6|NOT COMPLETED|Induction Period||0
7752453|NCT01474512|19087847|P5|NOT COMPLETED|Induction Period||0
7752454|NCT01474512|19087848|P4|NOT COMPLETED|Induction Period||0
7752455|NCT01474512|19087849|P3|NOT COMPLETED|Induction Period||18
7752456|NCT01474512|19087850|P2|NOT COMPLETED|Induction Period||24
7752457|NCT01474512|19087851|P1|NOT COMPLETED|Induction Period||24
7752458|NCT01474512|19087834|P18|COMPLETED|Induction Period||0
7752459|NCT01474512|19087835|P17|COMPLETED|Induction Period||0
7752460|NCT01474512|19087836|P16|COMPLETED|Induction Period||0
7752461|NCT01474512|19087837|P15|COMPLETED|Induction Period||0
7752462|NCT01474512|19087838|P14|COMPLETED|Induction Period||0
7752463|NCT01474512|19087839|P13|COMPLETED|Induction Period||0
7752464|NCT01474512|19087840|P12|COMPLETED|Induction Period||0
7752465|NCT01474512|19087841|P11|COMPLETED|Induction Period||0
7752466|NCT01474512|19087842|P10|COMPLETED|Induction Period||0
7752467|NCT01474512|19087843|P9|COMPLETED|Induction Period||0
7752468|NCT01474512|19087844|P8|COMPLETED|Induction Period||0
7752469|NCT01474512|19087845|P7|COMPLETED|Induction Period||0
7752470|NCT01474512|19087846|P6|COMPLETED|Induction Period||0
7752471|NCT01474512|19087847|P5|COMPLETED|Induction Period||0
7752472|NCT01474512|19087848|P4|COMPLETED|Induction Period||0
7752473|NCT01474512|19087849|P3|COMPLETED|Induction Period||415
7752474|NCT01474512|19087850|P2|COMPLETED|Induction Period||408
7752475|NCT01474512|19087851|P1|COMPLETED|Induction Period||407
7752476|NCT01474512|19087834|P18|Received Study Drug|Induction Period||0
7752477|NCT01474512|19087835|P17|Received Study Drug|Induction Period||0
7752478|NCT01474512|19087836|P16|Received Study Drug|Induction Period||0
7752479|NCT01474512|19087837|P15|Received Study Drug|Induction Period||0
7752480|NCT01474512|19087838|P14|Received Study Drug|Induction Period||0
7752481|NCT01474512|19087839|P13|Received Study Drug|Induction Period||0
7752482|NCT01474512|19087840|P12|Received Study Drug|Induction Period||0
7752483|NCT01474512|19087841|P11|Received Study Drug|Induction Period||0
7752484|NCT01474512|19087842|P10|Received Study Drug|Induction Period||0
7752485|NCT01474512|19087843|P9|Received Study Drug|Induction Period||0
7752486|NCT01474512|19087844|P8|Received Study Drug|Induction Period||0
7752487|NCT01474512|19087845|P7|Received Study Drug|Induction Period||0
7752488|NCT01474512|19087846|P6|Received Study Drug|Induction Period||0
7752489|NCT01474512|19087847|P5|Received Study Drug|Induction Period||0
7752490|NCT01474512|19087848|P4|Received Study Drug|Induction Period||0
7752491|NCT01474512|19087849|P3|Received Study Drug|Induction Period||433
7752492|NCT01474512|19087850|P2|Received Study Drug|Induction Period||432
7752493|NCT01474512|19087851|P1|Received Study Drug|Induction Period||431
7752494|NCT01474512|19087834|P18|STARTED|Induction Period||0
7752495|NCT01474512|19087835|P17|STARTED|Induction Period||0
7752496|NCT01474512|19087836|P16|STARTED|Induction Period||0
7752497|NCT01474512|19087837|P15|STARTED|Induction Period||0
7752498|NCT01474512|19087838|P14|STARTED|Induction Period||0
7752499|NCT01474512|19087839|P13|STARTED|Induction Period||0
7752500|NCT01474512|19087840|P12|STARTED|Induction Period||0
7752501|NCT01474512|19087841|P11|STARTED|Induction Period||0
7752502|NCT01474512|19087842|P10|STARTED|Induction Period||0
7752503|NCT01474512|19087843|P9|STARTED|Induction Period||0
7752504|NCT01474512|19087844|P8|STARTED|Induction Period||0
7752505|NCT01474512|19087845|P7|STARTED|Induction Period||0
7752506|NCT01474512|19087846|P6|STARTED|Induction Period||0
7752507|NCT01474512|19087847|P5|STARTED|Induction Period||0
7752508|NCT01474512|19087848|P4|STARTED|Induction Period||0
7752509|NCT01474512|19087849|P3|STARTED|Induction Period||433
7752510|NCT01474512|19087850|P2|STARTED|Induction Period||432
7752511|NCT01474512|19087851|P1|STARTED|Induction Period||431
7752512|NCT01474434|19087927|P4|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
7752513|NCT01474434|19087928|P3|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
7752514|NCT01474434|19087929|P2|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
7752515|NCT01474434|19087930|P1|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
7752516|NCT01474434|19087927|P4|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11
7752517|NCT01474434|19087928|P3|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10
7752518|NCT01474434|19087929|P2|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9
7752519|NCT01474434|19087930|P1|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7
7752520|NCT01474434|19087927|P4|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11
7752521|NCT01474434|19087928|P3|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10
7752522|NCT01474434|19087929|P2|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9
7752523|NCT01474434|19087930|P1|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7
7752524|NCT01474434|19087927|P4|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2
7752525|NCT01474434|19087928|P3|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
7752526|NCT01474434|19087929|P2|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0
7752527|NCT01474434|19087930|P1|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
7752528|NCT01474434|19087927|P4|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11
7752529|NCT01474434|19087928|P3|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10
7752530|NCT01474434|19087929|P2|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9
7752531|NCT01474434|19087930|P1|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7
7752532|NCT01474434|19087927|P4|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13
7752533|NCT01474434|19087928|P3|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11
7752534|NCT01474434|19087929|P2|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9
7752535|NCT01474434|19087930|P1|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8
7752536|NCT01474317|19087972|P1|NOT COMPLETED|Overall Study||2
7752537|NCT01474317|19087972|P1|COMPLETED|Overall Study||224
7752538|NCT01474317|19087972|P1|STARTED|Overall Study||226
7752539|NCT01474291|19087981|P1|NOT COMPLETED|Overall Study||220
7752540|NCT01474291|19087981|P1|COMPLETED|Overall Study||383
7752541|NCT01474291|19087981|P1|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577
7752542|NCT01474291|19087981|P1|STARTED|Overall Study||603
7752543|NCT01474239|19088025|P2|NOT COMPLETED|Overall Study||32
7752544|NCT01474239|19088026|P1|NOT COMPLETED|Overall Study||59
7752545|NCT01474239|19088025|P2|COMPLETED|Overall Study||0
7752546|NCT01474239|19088026|P1|COMPLETED|Overall Study||0
7752547|NCT01474239|19088025|P2|STARTED|Overall Study||32
7752548|NCT01474239|19088026|P1|STARTED|Overall Study||59
7752549|NCT01474213|19088064|P2|NOT COMPLETED|Overall Study||0
7752550|NCT01474213|19088065|P1|NOT COMPLETED|Overall Study||0
7752551|NCT01474213|19088064|P2|COMPLETED|Overall Study||20
7752552|NCT01474213|19088065|P1|COMPLETED|Overall Study||20
7752553|NCT01474213|19088064|P2|STARTED|Overall Study||20
7752554|NCT01474213|19088065|P1|STARTED|Overall Study||20
7752555|NCT01474200|19088089|P2|NOT COMPLETED|Overall Study||30
7752556|NCT01474200|19088090|P1|NOT COMPLETED|Overall Study||29
7752557|NCT01474200|19088089|P2|COMPLETED|Overall Study||84
7752558|NCT01474200|19088090|P1|COMPLETED|Overall Study||81
7752559|NCT01474200|19088089|P2|STARTED|Overall Study||114
7752560|NCT01474200|19088090|P1|STARTED|Overall Study||110
7752561|NCT01474122|19088143|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||15
7752562|NCT01474122|19088144|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||13
7752563|NCT01474122|19088145|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||17
7752564|NCT01474122|19088143|P3|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
7752565|NCT01474122|19088144|P2|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
7752566|NCT01474122|19088145|P1|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70
7752567|NCT01474122|19088143|P3|STARTED|Period 2: Week 16 to End of Study||88
7752568|NCT01474122|19088144|P2|STARTED|Period 2: Week 16 to End of Study||86
7752569|NCT01474122|19088145|P1|STARTED|Period 2: Week 16 to End of Study||87
7752570|NCT01474122|19088143|P3|NOT COMPLETED|Period 1: Baseline to Week 16||1
7752571|NCT01474122|19088144|P2|NOT COMPLETED|Period 1: Baseline to Week 16||2
7752572|NCT01474122|19088145|P1|NOT COMPLETED|Period 1: Baseline to Week 16||1
7752573|NCT01474122|19088143|P3|COMPLETED|Period 1: Baseline to Week 16||88
7752574|NCT01474122|19088144|P2|COMPLETED|Period 1: Baseline to Week 16||86
7752575|NCT01474122|19088145|P1|COMPLETED|Period 1: Baseline to Week 16||87
7752576|NCT01474122|19088143|P3|STARTED|Period 1: Baseline to Week 16||89
7752577|NCT01474122|19088144|P2|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88
7752578|NCT01474122|19088145|P1|STARTED|Period 1: Baseline to Week 16||88
7752579|NCT01474109|19088171|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||12
7752580|NCT01474109|19088172|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||18
7752581|NCT01474109|19088173|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||18
7752582|NCT01474109|19088171|P3|COMPLETED|Period 2: Week 16 to End of Study||83
7752583|NCT01474109|19088172|P2|COMPLETED|Period 2: Week 16 to End of Study||73
7752584|NCT01474109|19088173|P1|COMPLETED|Period 2: Week 16 to End of Study||70
7752585|NCT01474109|19088171|P3|STARTED|Period 2: Week 16 to End of Study||95
7752586|NCT01474109|19088172|P2|STARTED|Period 2: Week 16 to End of Study||91
7752587|NCT01474109|19088173|P1|STARTED|Period 2: Week 16 to End of Study||88
7752588|NCT01474109|19088171|P3|NOT COMPLETED|Period 1: Baseline to Week 16||2
7752589|NCT01474109|19088172|P2|NOT COMPLETED|Period 1: Baseline to Week 16||6
7752590|NCT01474109|19088173|P1|NOT COMPLETED|Period 1: Baseline to Week 16||7
7752591|NCT01474109|19088171|P3|COMPLETED|Period 1: Baseline to Week 16||95
7752592|NCT01474109|19088172|P2|COMPLETED|Period 1: Baseline to Week 16||91
7752593|NCT01474109|19088173|P1|COMPLETED|Period 1: Baseline to Week 16||88
7752594|NCT01474109|19088171|P3|STARTED|Period 1: Baseline to Week 16||97
7752595|NCT01474109|19088172|P2|STARTED|Period 1: Baseline to Week 16||97
7752596|NCT01474109|19088173|P1|STARTED|Period 1: Baseline to Week 16||95
7752597|NCT01474018|19088198|P2|NOT COMPLETED|Overall Study||3
7752598|NCT01474018|19088199|P1|NOT COMPLETED|Overall Study||0
7752599|NCT01474018|19088198|P2|COMPLETED|Overall Study||7
7752600|NCT01474018|19088199|P1|COMPLETED|Overall Study|Writing paper|5
7752601|NCT01474018|19088198|P2|STARTED|Overall Study||10
7752602|NCT01474018|19088199|P1|STARTED|Overall Study||5
7752603|NCT01473992|19088209|P3|NOT COMPLETED|Overall Study||0
7752604|NCT01473992|19088210|P2|NOT COMPLETED|Overall Study||0
7752605|NCT01473992|19088211|P1|NOT COMPLETED|Overall Study||0
7752606|NCT01473992|19088209|P3|COMPLETED|Overall Study||5
7752607|NCT01473992|19088210|P2|COMPLETED|Overall Study||10
7752608|NCT01473992|19088211|P1|COMPLETED|Overall Study||10
7752609|NCT01473992|19088209|P3|STARTED|Overall Study||5
7752610|NCT01473992|19088210|P2|STARTED|Overall Study||10
7752611|NCT01473992|19088211|P1|STARTED|Overall Study||10
7752612|NCT01473953|19088231|P5|NOT COMPLETED|Overall Study||0
7752613|NCT01473953|19088232|P4|NOT COMPLETED|Overall Study||0
7752614|NCT01473953|19088233|P3|NOT COMPLETED|Overall Study||0
7752615|NCT01473953|19088234|P2|NOT COMPLETED|Overall Study||0
7752616|NCT01473953|19088235|P1|NOT COMPLETED|Overall Study||1
7752617|NCT01473953|19088231|P5|COMPLETED|Overall Study||8
7752618|NCT01473953|19088232|P4|COMPLETED|Overall Study||5
7752619|NCT01473953|19088233|P3|COMPLETED|Overall Study||6
7752620|NCT01473953|19088234|P2|COMPLETED|Overall Study||6
7752621|NCT01473953|19088235|P1|COMPLETED|Overall Study||5
7752622|NCT01473953|19088231|P5|STARTED|Overall Study||8
7752623|NCT01473953|19088232|P4|STARTED|Overall Study||5
7752624|NCT01473953|19088233|P3|STARTED|Overall Study||6
7752625|NCT01473953|19088234|P2|STARTED|Overall Study||6
7752626|NCT01473953|19088235|P1|STARTED|Overall Study||6
7752627|NCT01473940|19088281|P4|NOT COMPLETED|Follow-up Until Death||0
7752628|NCT01473940|19088282|P3|NOT COMPLETED|Follow-up Until Death||0
7752629|NCT01473940|19088283|P2|NOT COMPLETED|Follow-up Until Death||0
7752630|NCT01473940|19088284|P1|NOT COMPLETED|Follow-up Until Death||0
7752631|NCT01473940|19088281|P4|COMPLETED|Follow-up Until Death||7
7752632|NCT01473940|19088282|P3|COMPLETED|Follow-up Until Death||5
7752633|NCT01473940|19088283|P2|COMPLETED|Follow-up Until Death||4
7752634|NCT01473940|19088284|P1|COMPLETED|Follow-up Until Death||3
7752635|NCT01473940|19088281|P4|STARTED|Follow-up Until Death||7
7752636|NCT01473940|19088282|P3|STARTED|Follow-up Until Death||5
7752637|NCT01473940|19088283|P2|STARTED|Follow-up Until Death||4
7752638|NCT01473940|19088284|P1|STARTED|Follow-up Until Death||3
7752639|NCT01473940|19088281|P4|NOT COMPLETED|Maintenance Therapy||4
7752640|NCT01473940|19088282|P3|NOT COMPLETED|Maintenance Therapy||1
7752641|NCT01473940|19088283|P2|NOT COMPLETED|Maintenance Therapy||2
7752642|NCT01473940|19088284|P1|NOT COMPLETED|Maintenance Therapy||1
7752643|NCT01473940|19088281|P4|COMPLETED|Maintenance Therapy||3
7752644|NCT01473940|19088282|P3|COMPLETED|Maintenance Therapy||3
7752645|NCT01473940|19088283|P2|COMPLETED|Maintenance Therapy||1
7752646|NCT01473940|19088284|P1|COMPLETED|Maintenance Therapy||2
7752647|NCT01473940|19088281|P4|Went on to Start Maintenance Therapy|Maintenance Therapy||3
7752648|NCT01473940|19088282|P3|Went on to Start Maintenance Therapy|Maintenance Therapy||3
7752649|NCT01473940|19088283|P2|Went on to Start Maintenance Therapy|Maintenance Therapy||1
7752650|NCT01473940|19088284|P1|Went on to Start Maintenance Therapy|Maintenance Therapy||2
7752651|NCT01473940|19088281|P4|Evaluated for Response|Maintenance Therapy||7
7752652|NCT01473940|19088282|P3|Evaluated for Response|Maintenance Therapy||4
7752653|NCT01473940|19088283|P2|Evaluated for Response|Maintenance Therapy||3
7752654|NCT01473940|19088284|P1|Evaluated for Response|Maintenance Therapy||3
7752655|NCT01473940|19088281|P4|STARTED|Maintenance Therapy||7
7752656|NCT01473940|19088282|P3|STARTED|Maintenance Therapy||4
7752657|NCT01473940|19088283|P2|STARTED|Maintenance Therapy||3
7752658|NCT01473940|19088284|P1|STARTED|Maintenance Therapy||3
7752659|NCT01473940|19088281|P4|NOT COMPLETED|Induction Therapy||1
7752660|NCT01473940|19088282|P3|NOT COMPLETED|Induction Therapy||2
7752661|NCT01473940|19088283|P2|NOT COMPLETED|Induction Therapy||1
7752662|NCT01473940|19088284|P1|NOT COMPLETED|Induction Therapy||0
7752663|NCT01473940|19088281|P4|COMPLETED|Induction Therapy||7
7752664|NCT01473940|19088282|P3|COMPLETED|Induction Therapy||4
7752665|NCT01473940|19088283|P2|COMPLETED|Induction Therapy||3
7752666|NCT01473940|19088284|P1|COMPLETED|Induction Therapy||3
7752667|NCT01473940|19088281|P4|Completed Induction- 12 Weeks|Induction Therapy||7
7752668|NCT01473940|19088282|P3|Completed Induction- 12 Weeks|Induction Therapy||4
7752669|NCT01473940|19088283|P2|Completed Induction- 12 Weeks|Induction Therapy||3
7752670|NCT01473940|19088284|P1|Completed Induction- 12 Weeks|Induction Therapy||3
7752671|NCT01473940|19088281|P4|Started Treatment|Induction Therapy||8
7752672|NCT01473940|19088282|P3|Started Treatment|Induction Therapy||6
7752673|NCT01473940|19088283|P2|Started Treatment|Induction Therapy||4
7752674|NCT01473940|19088284|P1|Started Treatment|Induction Therapy||3
7752675|NCT01473940|19088281|P4|STARTED|Induction Therapy||8
7752676|NCT01473940|19088282|P3|STARTED|Induction Therapy||6
7752677|NCT01473940|19088283|P2|STARTED|Induction Therapy||4
7752678|NCT01473940|19088284|P1|STARTED|Induction Therapy||3
7752679|NCT01473836|19088314|P1|NOT COMPLETED|Overall Study||6
7752680|NCT01473836|19088314|P1|COMPLETED|Overall Study||32
7752681|NCT01473836|19088314|P1|STARTED|Overall Study||38
7752682|NCT01473758|19088325|P4|NOT COMPLETED|Cycle 2||0
7752683|NCT01473758|19088326|P3|NOT COMPLETED|Cycle 2||5
7752684|NCT01473758|19088327|P2|NOT COMPLETED|Cycle 2||0
7752685|NCT01473758|19088328|P1|NOT COMPLETED|Cycle 2||0
7752686|NCT01473758|19088325|P4|COMPLETED|Cycle 2||4
7752687|NCT01473758|19088326|P3|COMPLETED|Cycle 2||5
7752688|NCT01473758|19088327|P2|COMPLETED|Cycle 2||0
7752689|NCT01473758|19088328|P1|COMPLETED|Cycle 2||0
7752690|NCT01473758|19088325|P4|STARTED|Cycle 2||4
7752691|NCT01473758|19088326|P3|STARTED|Cycle 2||10
7752692|NCT01473758|19088327|P2|STARTED|Cycle 2||0
7752693|NCT01473758|19088328|P1|STARTED|Cycle 2||0
7752694|NCT01473758|19088325|P4|NOT COMPLETED|Cycle 1||0
7752695|NCT01473758|19088326|P3|NOT COMPLETED|Cycle 1||0
7752696|NCT01473758|19088327|P2|NOT COMPLETED|Cycle 1||3
7752697|NCT01473758|19088328|P1|NOT COMPLETED|Cycle 1||11
7752698|NCT01473758|19088325|P4|COMPLETED|Cycle 1||0
7752699|NCT01473758|19088326|P3|COMPLETED|Cycle 1||0
7752700|NCT01473758|19088327|P2|COMPLETED|Cycle 1||40
7752701|NCT01473758|19088328|P1|COMPLETED|Cycle 1||27
7752702|NCT01473758|19088325|P4|STARTED|Cycle 1||0
7752703|NCT01473758|19088326|P3|STARTED|Cycle 1||0
7752704|NCT01473758|19088327|P2|STARTED|Cycle 1||43
7752705|NCT01473758|19088328|P1|STARTED|Cycle 1||38
7752706|NCT01473745|19088452|P2|NOT COMPLETED|Overall Study||0
7752707|NCT01473745|19088453|P1|NOT COMPLETED|Overall Study||0
7752708|NCT01473745|19088452|P2|COMPLETED|Overall Study||24
7752709|NCT01473745|19088453|P1|COMPLETED|Overall Study||24
7752710|NCT01473745|19088452|P2|STARTED|Overall Study||24
7752711|NCT01473745|19088453|P1|STARTED|Overall Study||24
7752712|NCT01473732|19088465|P2|NOT COMPLETED|Overall Study||0
7752713|NCT01473732|19088466|P1|NOT COMPLETED|Overall Study||2
7752714|NCT01473732|19088465|P2|COMPLETED|Overall Study||0
7752715|NCT01473732|19088466|P1|COMPLETED|Overall Study||0
7752716|NCT01473732|19088465|P2|STARTED|Overall Study||0
7752717|NCT01473732|19088466|P1|STARTED|Overall Study||2
7752718|NCT01473602|19088474|P2|NOT COMPLETED|Overall Study||8
7752719|NCT01473602|19088475|P1|NOT COMPLETED|Overall Study||8
7752720|NCT01473602|19088474|P2|COMPLETED|Overall Study||13
7752721|NCT01473602|19088475|P1|COMPLETED|Overall Study||10
7752722|NCT01473602|19088474|P2|Completed 12 Months|Overall Study||13
7752723|NCT01473602|19088475|P1|Completed 12 Months|Overall Study||10
7752724|NCT01473602|19088474|P2|Completed 6 Months|Overall Study||15
7752725|NCT01473602|19088475|P1|Completed 6 Months|Overall Study||12
7752726|NCT01473602|19088474|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
7752727|NCT01473602|19088475|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
7752728|NCT01473602|19088474|P2|STARTED|Overall Study||21
7752729|NCT01473602|19088475|P1|STARTED|Overall Study||18
7752730|NCT01473589|19088511|P2|NOT COMPLETED|Overall Study||16
7752731|NCT01473589|19088512|P1|NOT COMPLETED|Overall Study||11
7752732|NCT01473589|19088511|P2|COMPLETED|Overall Study||46
7752733|NCT01473589|19088512|P1|COMPLETED|Overall Study||49
7752734|NCT01473589|19088511|P2|Completed 12 Months|Overall Study||48
7752735|NCT01473589|19088512|P1|Completed 12 Months|Overall Study||49
7752736|NCT01473589|19088511|P2|Completed 6 Months|Overall Study||54
7752737|NCT01473589|19088512|P1|Completed 6 Months|Overall Study||51
7752738|NCT01473589|19088511|P2|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61
7752739|NCT01473589|19088512|P1|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60
7752740|NCT01473589|19088511|P2|STARTED|Overall Study||62
7752741|NCT01473589|19088512|P1|STARTED|Overall Study||60
7752742|NCT01473563|19088546|P1|NOT COMPLETED|Overall Study||1
7752743|NCT01473563|19088546|P1|COMPLETED|Overall Study||51
7752744|NCT01473563|19088546|P1|Received at Least 1 Dose of Study Drug|Overall Study||52
7752745|NCT01473563|19088546|P1|STARTED|Overall Study||52
7752746|NCT01473524|19088568|P6|NOT COMPLETED|LTSE Phase||21
7752747|NCT01473524|19088569|P5|NOT COMPLETED|LTSE Phase||17
7752748|NCT01473524|19088570|P4|NOT COMPLETED|LTSE Phase||9
7752749|NCT01473524|19088571|P3|NOT COMPLETED|LTSE Phase||0
7752750|NCT01473524|19088572|P2|NOT COMPLETED|LTSE Phase||0
7752751|NCT01473524|19088573|P1|NOT COMPLETED|LTSE Phase||0
7752752|NCT01473524|19088568|P6|COMPLETED|LTSE Phase||45
7752753|NCT01473524|19088569|P5|COMPLETED|LTSE Phase||47
7752754|NCT01473524|19088570|P4|COMPLETED|LTSE Phase||54
7752755|NCT01473524|19088571|P3|COMPLETED|LTSE Phase||0
7752756|NCT01473524|19088572|P2|COMPLETED|LTSE Phase||0
7752757|NCT01473524|19088573|P1|COMPLETED|LTSE Phase||0
7752758|NCT01473524|19088568|P6|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||66
7752759|NCT01473524|19088569|P5|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||64
7752760|NCT01473524|19088570|P4|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||63
7752761|NCT01473524|19088571|P3|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
7752762|NCT01473524|19088572|P2|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
7752763|NCT01473524|19088573|P1|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
7752764|NCT01473524|19088568|P6|STARTED|LTSE Phase|Four participants in the double-blind placebo group did not enroll in the LTSE phase.|66
7752765|NCT01473524|19088569|P5|STARTED|LTSE Phase||64
7752766|NCT01473524|19088570|P4|STARTED|LTSE Phase|One participant in the double-blind OCA 5-10 mg group did not enroll in the LTSE phase.|63
7752767|NCT01473524|19088571|P3|STARTED|LTSE Phase||0
7752768|NCT01473524|19088572|P2|STARTED|LTSE Phase||0
7752769|NCT01473524|19088573|P1|STARTED|LTSE Phase||0
7752770|NCT01473524|19088568|P6|NOT COMPLETED|DB Phase||0
7752771|NCT01473524|19088569|P5|NOT COMPLETED|DB Phase||0
7752772|NCT01473524|19088570|P4|NOT COMPLETED|DB Phase||0
7752773|NCT01473524|19088571|P3|NOT COMPLETED|DB Phase||3
7752774|NCT01473524|19088572|P2|NOT COMPLETED|DB Phase||9
7752775|NCT01473524|19088573|P1|NOT COMPLETED|DB Phase||7
7752776|NCT01473524|19088568|P6|COMPLETED|DB Phase||0
7752777|NCT01473524|19088569|P5|COMPLETED|DB Phase||0
7752778|NCT01473524|19088570|P4|COMPLETED|DB Phase||0
7752779|NCT01473524|19088571|P3|COMPLETED|DB Phase||70
7752780|NCT01473524|19088572|P2|COMPLETED|DB Phase||64
7752781|NCT01473524|19088573|P1|COMPLETED|DB Phase||64
7752782|NCT01473524|19088568|P6|Received at Least 1 Dose of Study Drug|DB Phase||0
7752783|NCT01473524|19088569|P5|Received at Least 1 Dose of Study Drug|DB Phase||0
7752784|NCT01473524|19088570|P4|Received at Least 1 Dose of Study Drug|DB Phase||0
7752785|NCT01473524|19088571|P3|Received at Least 1 Dose of Study Drug|DB Phase||73
7752786|NCT01473524|19088572|P2|Received at Least 1 Dose of Study Drug|DB Phase||73
7752787|NCT01473524|19088573|P1|Received at Least 1 Dose of Study Drug|DB Phase||70
7752788|NCT01473524|19088568|P6|STARTED|DB Phase||0
7752789|NCT01473524|19088569|P5|STARTED|DB Phase||0
7752790|NCT01473524|19088570|P4|STARTED|DB Phase||0
7752791|NCT01473524|19088571|P3|STARTED|DB Phase||73
7752792|NCT01473524|19088572|P2|STARTED|DB Phase||73
7752793|NCT01473524|19088573|P1|STARTED|DB Phase||71
7752794|NCT01473420|19088622|P2|NOT COMPLETED|Maintenance Period (16 Weeks)||17
7752795|NCT01473420|19088623|P1|NOT COMPLETED|Maintenance Period (16 Weeks)||18
7752796|NCT01473420|19088622|P2|COMPLETED|Maintenance Period (16 Weeks)||105
7752797|NCT01473420|19088623|P1|COMPLETED|Maintenance Period (16 Weeks)||106
7752798|NCT01473420|19088622|P2|STARTED|Maintenance Period (16 Weeks)||122
7752799|NCT01473420|19088623|P1|STARTED|Maintenance Period (16 Weeks)||124
7752800|NCT01473420|19088622|P2|NOT COMPLETED|Titration Period (18 Weeks)||38
7752801|NCT01473420|19088623|P1|NOT COMPLETED|Titration Period (18 Weeks)||36
7752802|NCT01473420|19088622|P2|COMPLETED|Titration Period (18 Weeks)||122
7752803|NCT01473420|19088623|P1|COMPLETED|Titration Period (18 Weeks)||124
7752804|NCT01473420|19088622|P2|Treated|Titration Period (18 Weeks)||86
7752805|NCT01473420|19088623|P1|Treated|Titration Period (18 Weeks)||80
7752806|NCT01473420|19088622|P2|STARTED|Titration Period (18 Weeks)||160
7752807|NCT01473420|19088623|P1|STARTED|Titration Period (18 Weeks)||160
7752808|NCT01473407|19088707|P2|NOT COMPLETED|Overall Study||47
7752809|NCT01473407|19088708|P1|NOT COMPLETED|Overall Study||54
7752810|NCT01473407|19088707|P2|COMPLETED|Overall Study||259
7752811|NCT01473407|19088708|P1|COMPLETED|Overall Study||252
7752812|NCT01473407|19088707|P2|STARTED|Overall Study||306
7752813|NCT01473407|19088708|P1|STARTED|Overall Study||306
7752814|NCT01473394|19088762|P2|NOT COMPLETED|Overall Study||43
7752815|NCT01473394|19088763|P1|NOT COMPLETED|Overall Study||45
7752816|NCT01473394|19088762|P2|COMPLETED|Overall Study||212
7752817|NCT01473394|19088763|P1|COMPLETED|Overall Study||208
7752818|NCT01473394|19088762|P2|STARTED|Overall Study||255
7752819|NCT01473394|19088763|P1|STARTED|Overall Study||253
7752820|NCT01473381|19088777|P4|NOT COMPLETED|Overall Study||89
7752821|NCT01473381|19088778|P3|NOT COMPLETED|Overall Study||102
7752822|NCT01473381|19088779|P2|NOT COMPLETED|Overall Study||93
7752823|NCT01473381|19088780|P1|NOT COMPLETED|Overall Study||80
7752824|NCT01473381|19088777|P4|COMPLETED|Overall Study||200
7752825|NCT01473381|19088778|P3|COMPLETED|Overall Study||189
7752826|NCT01473381|19088779|P2|COMPLETED|Overall Study||199
7752827|NCT01473381|19088780|P1|COMPLETED|Overall Study||210
7752828|NCT01473381|19088777|P4|Safety Population|Overall Study||282
7752829|NCT01473381|19088778|P3|Safety Population|Overall Study||287
7752830|NCT01473381|19088779|P2|Safety Population|Overall Study||288
7752831|NCT01473381|19088780|P1|Safety Population|Overall Study||281
7752832|NCT01473381|19088777|P4|STARTED|Overall Study||289
7752833|NCT01473381|19088778|P3|STARTED|Overall Study||291
7752834|NCT01473381|19088779|P2|STARTED|Overall Study||292
7752835|NCT01473381|19088780|P1|STARTED|Overall Study||290
7752836|NCT01473368|19088802|P4|NOT COMPLETED|Overall Study||0
7752837|NCT01473368|19088803|P3|NOT COMPLETED|Overall Study||3
7752838|NCT01473368|19088804|P2|NOT COMPLETED|Overall Study||0
7752839|NCT01473368|19088805|P1|NOT COMPLETED|Overall Study||1
7752840|NCT01473368|19088802|P4|COMPLETED|Overall Study||12
7752841|NCT01473368|19088803|P3|COMPLETED|Overall Study||12
7752842|NCT01473368|19088804|P2|COMPLETED|Overall Study||12
7752843|NCT01473368|19088805|P1|COMPLETED|Overall Study||13
7752844|NCT01473368|19088802|P4|STARTED|Overall Study||12
7752845|NCT01473368|19088803|P3|STARTED|Overall Study||15
7752846|NCT01473368|19088804|P2|STARTED|Overall Study||12
7752847|NCT01473368|19088805|P1|STARTED|Overall Study||14
7752848|NCT01473355|19088842|P1|NOT COMPLETED|Overall Study||6
7752849|NCT01473355|19088842|P1|COMPLETED|Overall Study||39
7752850|NCT01473355|19088842|P1|STARTED|Overall Study||45
7752851|NCT01473160|19088851|P1|NOT COMPLETED|Overall Study||0
7752852|NCT01473160|19088851|P1|COMPLETED|Overall Study||9
7752853|NCT01473160|19088851|P1|STARTED|Overall Study||9
7752854|NCT01472965|19088871|P2|NOT COMPLETED|Overall Study||0
7752855|NCT01472965|19088872|P1|NOT COMPLETED|Overall Study||1
7752856|NCT01472965|19088871|P2|COMPLETED|Overall Study||46
7752857|NCT01472965|19088872|P1|COMPLETED|Overall Study||48
7752858|NCT01472965|19088871|P2|STARTED|Overall Study||46
7752859|NCT01472965|19088872|P1|STARTED|Overall Study||49
7752860|NCT01472939|19088892|P4|NOT COMPLETED|Overall Study||20
7752861|NCT01472939|19088893|P3|NOT COMPLETED|Overall Study||11
7752862|NCT01472939|19088894|P2|NOT COMPLETED|Overall Study||14
7752863|NCT01472939|19088895|P1|NOT COMPLETED|Overall Study||20
7752864|NCT01472939|19088892|P4|COMPLETED|Overall Study||99
7752865|NCT01472939|19088893|P3|COMPLETED|Overall Study||108
7752866|NCT01472939|19088894|P2|COMPLETED|Overall Study||105
7752867|NCT01472939|19088895|P1|COMPLETED|Overall Study||103
7752868|NCT01472939|19088892|P4|STARTED|Overall Study||119
7752869|NCT01472939|19088893|P3|STARTED|Overall Study||119
7752870|NCT01472939|19088894|P2|STARTED|Overall Study||119
7752871|NCT01472939|19088895|P1|STARTED|Overall Study||123
7752872|NCT01472874|19088922|P1|NOT COMPLETED|Overall Study||0
7752873|NCT01472874|19088922|P1|COMPLETED|Overall Study||8
7752874|NCT01472874|19088922|P1|STARTED|Overall Study||8
7752875|NCT01472835|19088939|P2|NOT COMPLETED|Overall Study||0
7752876|NCT01472835|19088940|P1|NOT COMPLETED|Overall Study||2
7752877|NCT01472835|19088939|P2|COMPLETED|Overall Study||36
7752878|NCT01472835|19088940|P1|COMPLETED|Overall Study||35
7752879|NCT01472835|19088939|P2|STARTED|Overall Study||36
7752880|NCT01472835|19088940|P1|STARTED|Overall Study||37
7752881|NCT01472822|19088956|P2|NOT COMPLETED|Overall Study||2
7752882|NCT01472822|19088957|P1|NOT COMPLETED|Overall Study||2
7752883|NCT01472822|19088956|P2|COMPLETED|Overall Study||28
7752884|NCT01472822|19088957|P1|COMPLETED|Overall Study||28
7752885|NCT01472822|19088956|P2|STARTED|Overall Study||30
7752886|NCT01472822|19088957|P1|STARTED|Overall Study||30
7752887|NCT01472757|19088975|P4|NOT COMPLETED|Overall Study||19
7752888|NCT01472757|19088976|P3|NOT COMPLETED|Overall Study||19
7752889|NCT01472757|19088977|P2|NOT COMPLETED|Overall Study||13
7752890|NCT01472757|19088978|P1|NOT COMPLETED|Overall Study||30
7752891|NCT01472757|19088975|P4|COMPLETED|Overall Study||75
7752892|NCT01472757|19088976|P3|COMPLETED|Overall Study||76
7752893|NCT01472757|19088977|P2|COMPLETED|Overall Study||80
7752894|NCT01472757|19088978|P1|COMPLETED|Overall Study||61
7752895|NCT01472757|19088975|P4|Full Analysis Set|Overall Study||92
7752896|NCT01472757|19088976|P3|Full Analysis Set|Overall Study||92
7752897|NCT01472757|19088977|P2|Full Analysis Set|Overall Study||93
7752898|NCT01472757|19088978|P1|Full Analysis Set|Overall Study||91
7752899|NCT01472757|19088975|P4|STARTED|Overall Study||94
7752900|NCT01472757|19088976|P3|STARTED|Overall Study||95
7752901|NCT01472757|19088977|P2|STARTED|Overall Study||93
7752902|NCT01472757|19088978|P1|STARTED|Overall Study||91
7752903|NCT01472718|19089002|P2|NOT COMPLETED|Overall Study||7
7752904|NCT01472718|19089003|P1|NOT COMPLETED|Overall Study||6
7752905|NCT01472718|19089002|P2|COMPLETED|Overall Study||97
7752906|NCT01472718|19089003|P1|COMPLETED|Overall Study||98
7752907|NCT01472718|19089002|P2|STARTED|Overall Study||104
7752908|NCT01472718|19089003|P1|STARTED|Overall Study||104
7752909|NCT01472692|19089013|P2|NOT COMPLETED|Overall Study||0
7752910|NCT01472692|19089014|P1|NOT COMPLETED|Overall Study||0
7752911|NCT01472692|19089013|P2|COMPLETED|Overall Study||0
7752912|NCT01472692|19089014|P1|COMPLETED|Overall Study||0
7752913|NCT01472692|19089013|P2|STARTED|Overall Study||0
7752914|NCT01472692|19089014|P1|STARTED|Overall Study||0
7752915|NCT01472562|19089022|P1|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23
7752916|NCT01472562|19089022|P1|COMPLETED|Maintenance Phase (Week 49 to PD)||4
7752917|NCT01472562|19089022|P1|STARTED|Maintenance Phase (Week 49 to PD)||27
7752918|NCT01472562|19089022|P1|NOT COMPLETED|Induction Phase (Week 1- 48)||11
7752919|NCT01472562|19089022|P1|COMPLETED|Induction Phase (Week 1- 48)||27
7752920|NCT01472562|19089022|P1|STARTED|Induction Phase (Week 1- 48)||38
7752921|NCT01472549|19089028|P2|NOT COMPLETED|Overall Study||0
7752922|NCT01472549|19089029|P1|NOT COMPLETED|Overall Study||0
7752923|NCT01472549|19089028|P2|COMPLETED|Overall Study||575
7752924|NCT01472549|19089029|P1|COMPLETED|Overall Study||572
7752925|NCT01472549|19089028|P2|STARTED|Overall Study||575
7752926|NCT01472549|19089029|P1|STARTED|Overall Study||572
7752927|NCT01472445|19089051|P2|NOT COMPLETED|Overall Study||0
7752928|NCT01472445|19089052|P1|NOT COMPLETED|Overall Study||0
7752929|NCT01472445|19089051|P2|COMPLETED|Overall Study||16
7752930|NCT01472445|19089052|P1|COMPLETED|Overall Study||25
7752931|NCT01472445|19089051|P2|STARTED|Overall Study||16
7752932|NCT01472445|19089052|P1|STARTED|Overall Study||25
7752933|NCT01472432|19089076|P2|NOT COMPLETED|Overall Study||0
7752934|NCT01472432|19089077|P1|NOT COMPLETED|Overall Study||0
7752935|NCT01472432|19089076|P2|COMPLETED|Overall Study||53
7752936|NCT01472432|19089077|P1|COMPLETED|Overall Study||53
7752937|NCT01472432|19089076|P2|Ulcer Reduction|Overall Study||33
7752938|NCT01472432|19089077|P1|Ulcer Reduction|Overall Study||13
7752939|NCT01472432|19089076|P2|STARTED|Overall Study||53
7752940|NCT01472432|19089077|P1|STARTED|Overall Study||53
7752941|NCT01472380|19089093|P1|NOT COMPLETED|Efavirenz and FFA||0
7752942|NCT01472380|19089093|P1|COMPLETED|Efavirenz and FFA||28
7752943|NCT01472380|19089093|P1|STARTED|Efavirenz and FFA||28
7752944|NCT01472380|19089093|P1|NOT COMPLETED|1 Day Period Between Dosing||1
7752945|NCT01472380|19089093|P1|COMPLETED|1 Day Period Between Dosing||28
7752946|NCT01472380|19089093|P1|STARTED|1 Day Period Between Dosing||29
7752947|NCT01472380|19089093|P1|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0
7752948|NCT01472380|19089093|P1|COMPLETED|Fenofibric Acid (FFA) Alone||29
7752949|NCT01472380|19089093|P1|STARTED|Fenofibric Acid (FFA) Alone||29
7752950|NCT01472380|19089093|P1|NOT COMPLETED|Efavirenz Alone||1
7752951|NCT01472380|19089093|P1|COMPLETED|Efavirenz Alone||29
7752952|NCT01472380|19089093|P1|STARTED|Efavirenz Alone||30
7752953|NCT01472341|19089104|P1|NOT COMPLETED|Overall Study||272
7752954|NCT01472341|19089104|P1|COMPLETED|Overall Study||235
7752955|NCT01472341|19089104|P1|STARTED|Overall Study||507
7752956|NCT01472289|19089110|P1|NOT COMPLETED|Overall Study||2
7752957|NCT01472289|19089110|P1|COMPLETED|Overall Study||15
7752958|NCT01472289|19089110|P1|STARTED|Overall Study||17
7752959|NCT01472185|19089122|P2|NOT COMPLETED|Overall Study||34
7752960|NCT01472185|19089123|P1|NOT COMPLETED|Overall Study||34
7752961|NCT01472185|19089122|P2|COMPLETED|Overall Study||199
7752962|NCT01472185|19089123|P1|COMPLETED|Overall Study||198
7752963|NCT01472185|19089122|P2|STARTED|Overall Study||233
7752964|NCT01472185|19089123|P1|STARTED|Overall Study||232
7752965|NCT01472081|19089143|P6|NOT COMPLETED|Overall Study||6
7752966|NCT01472081|19089144|P5|NOT COMPLETED|Overall Study||47
7752967|NCT01472081|19089145|P4|NOT COMPLETED|Overall Study||46
7752968|NCT01472081|19089146|P3|NOT COMPLETED|Overall Study||20
7752969|NCT01472081|19089147|P2|NOT COMPLETED|Overall Study||26
7752970|NCT01472081|19089148|P1|NOT COMPLETED|Overall Study||7
7752971|NCT01472081|19089143|P6|COMPLETED|Overall Study||0
7752972|NCT01472081|19089144|P5|COMPLETED|Overall Study||0
7752973|NCT01472081|19089145|P4|COMPLETED|Overall Study||1
7752974|NCT01472081|19089146|P3|COMPLETED|Overall Study||0
7752975|NCT01472081|19089147|P2|COMPLETED|Overall Study||0
7752976|NCT01472081|19089148|P1|COMPLETED|Overall Study||0
7752977|NCT01472081|19089143|P6|STARTED|Overall Study||6
7752978|NCT01472081|19089144|P5|STARTED|Overall Study||47
7752979|NCT01472081|19089145|P4|STARTED|Overall Study||47
7752980|NCT01472081|19089146|P3|STARTED|Overall Study||20
7752981|NCT01472081|19089147|P2|STARTED|Overall Study||26
7752982|NCT01472081|19089148|P1|STARTED|Overall Study||7
7752983|NCT01471782|19089197|P6|NOT COMPLETED|Overall Study||41
7752984|NCT01471782|19089198|P5|NOT COMPLETED|Overall Study||26
7752985|NCT01471782|19089199|P4|NOT COMPLETED|Overall Study||5
7752986|NCT01471782|19089200|P3|NOT COMPLETED|Overall Study||5
7752987|NCT01471782|19089201|P2|NOT COMPLETED|Overall Study||6
7752988|NCT01471782|19089202|P1|NOT COMPLETED|Overall Study||5
7752989|NCT01471782|19089197|P6|COMPLETED|Overall Study|Completed 5 cycles|3
7752990|NCT01471782|19089198|P5|COMPLETED|Overall Study|Completed 5 cycles|0
7752991|NCT01471782|19089199|P4|COMPLETED|Overall Study|Completed 5 cycles|1
7752992|NCT01471782|19089200|P3|COMPLETED|Overall Study|Completed 5 cycles|0
7752993|NCT01471782|19089201|P2|COMPLETED|Overall Study|Completed 5 cycles|1
7752994|NCT01471782|19089202|P1|COMPLETED|Overall Study|Completed 5 cycles|0
7752995|NCT01471782|19089197|P6|STARTED|Overall Study||44
7752996|NCT01471782|19089198|P5|STARTED|Overall Study||26
7752997|NCT01471782|19089199|P4|STARTED|Overall Study||6
7752998|NCT01471782|19089200|P3|STARTED|Overall Study||5
7752999|NCT01471782|19089201|P2|STARTED|Overall Study||7
7753000|NCT01471782|19089202|P1|STARTED|Overall Study||5
7753001|NCT01471691|19089256|P2|NOT COMPLETED|Overall Study||1
7753002|NCT01471691|19089257|P1|NOT COMPLETED|Overall Study||0
7753003|NCT01471691|19089256|P2|COMPLETED|Overall Study||5
7753004|NCT01471691|19089257|P1|COMPLETED|Overall Study||8
7753005|NCT01471691|19089256|P2|STARTED|Overall Study||6
7753006|NCT01471691|19089257|P1|STARTED|Overall Study||8
7753007|NCT01471379|19089266|P3|NOT COMPLETED|Overall Study||0
7753008|NCT01471379|19089267|P2|NOT COMPLETED|Overall Study||1
7753009|NCT01471379|19089268|P1|NOT COMPLETED|Overall Study||1
7753010|NCT01471379|19089266|P3|COMPLETED|Overall Study||0
7753011|NCT01471379|19089267|P2|COMPLETED|Overall Study||0
7753012|NCT01471379|19089268|P1|COMPLETED|Overall Study||0
7753013|NCT01471379|19089266|P3|STARTED|Overall Study||0
7753014|NCT01471379|19089267|P2|STARTED|Overall Study||1
7753015|NCT01471379|19089268|P1|STARTED|Overall Study||1
7753016|NCT01471353|19089288|P1|NOT COMPLETED|Overall Study||3
7753017|NCT01471353|19089288|P1|COMPLETED|Overall Study||39
7753018|NCT01471353|19089288|P1|STARTED|Overall Study||42
7753019|NCT01471340|19089299|P2|NOT COMPLETED|Overall Study||6
7753020|NCT01471340|19089300|P1|NOT COMPLETED|Overall Study||6
7753021|NCT01471340|19089299|P2|COMPLETED|Overall Study||5855
7753022|NCT01471340|19089300|P1|COMPLETED|Overall Study||5862
7753023|NCT01471340|19089299|P2|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5861
7753024|NCT01471340|19089300|P1|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5868
7753025|NCT01471639|19089310|P1|NOT COMPLETED|Overall Study||0
7753026|NCT01471639|19089310|P1|COMPLETED|Overall Study||37
7753027|NCT01471639|19089310|P1|STARTED|Overall Study||37
7753028|NCT01471626|19089315|P1|NOT COMPLETED|Overall Study||0
7753029|NCT01471626|19089315|P1|COMPLETED|Overall Study||21
7753030|NCT01471626|19089315|P1|STARTED|Overall Study||21
7753031|NCT01471574|19089323|P4|NOT COMPLETED|Follow-up Period||3
7753032|NCT01471574|19089324|P3|NOT COMPLETED|Follow-up Period||7
7753033|NCT01471574|19089325|P2|NOT COMPLETED|Follow-up Period||2
7753034|NCT01471574|19089326|P1|NOT COMPLETED|Follow-up Period||7
7753035|NCT01471574|19089323|P4|COMPLETED|Follow-up Period||21
7753036|NCT01471574|19089324|P3|COMPLETED|Follow-up Period||95
7753037|NCT01471574|19089325|P2|COMPLETED|Follow-up Period||32
7753038|NCT01471574|19089326|P1|COMPLETED|Follow-up Period||114
7753039|NCT01471574|19089323|P4|STARTED|Follow-up Period||24
7753040|NCT01471574|19089324|P3|STARTED|Follow-up Period||102
7753041|NCT01471574|19089325|P2|STARTED|Follow-up Period||34
7753042|NCT01471574|19089326|P1|STARTED|Follow-up Period||121
7753043|NCT01471574|19089323|P4|NOT COMPLETED|Treatment Period||3
7753044|NCT01471574|19089324|P3|NOT COMPLETED|Treatment Period||24
7753045|NCT01471574|19089325|P2|NOT COMPLETED|Treatment Period||10
7753046|NCT01471574|19089326|P1|NOT COMPLETED|Treatment Period||31
7753047|NCT01471574|19089323|P4|COMPLETED|Treatment Period||21
7753048|NCT01471574|19089324|P3|COMPLETED|Treatment Period||82
7753049|NCT01471574|19089325|P2|COMPLETED|Treatment Period||29
7753050|NCT01471574|19089326|P1|COMPLETED|Treatment Period||101
7753051|NCT01471574|19089323|P4|STARTED|Treatment Period||24
7753052|NCT01471574|19089324|P3|STARTED|Treatment Period||106
7753053|NCT01471574|19089325|P2|STARTED|Treatment Period||39
7753054|NCT01471574|19089326|P1|STARTED|Treatment Period||132
7753055|NCT01471522|19089357|P2|NOT COMPLETED|Overall Study||48
7753056|NCT01471522|19089358|P1|NOT COMPLETED|Overall Study||64
7753057|NCT01471522|19089357|P2|COMPLETED|Overall Study||2543
7753058|NCT01471522|19089358|P1|COMPLETED|Overall Study||2524
7753059|NCT01471522|19089357|P2|STARTED|Overall Study||2591
7753060|NCT01471522|19089358|P1|STARTED|Overall Study||2588
7753061|NCT01471457|19089384|P2|NOT COMPLETED|Overall Study||18
7753062|NCT01471457|19089385|P1|NOT COMPLETED|Overall Study||19
7753063|NCT01471457|19089384|P2|COMPLETED|Overall Study||74
7753064|NCT01471457|19089385|P1|COMPLETED|Overall Study||73
7753065|NCT01471457|19089384|P2|STARTED|Overall Study||92
7753066|NCT01471457|19089385|P1|STARTED|Overall Study||92
7753067|NCT01471197|19089395|P2|NOT COMPLETED|Overall Study||2
7753068|NCT01471197|19089396|P1|NOT COMPLETED|Overall Study||6
7753069|NCT01471197|19089395|P2|COMPLETED|Overall Study||0
7753070|NCT01471197|19089396|P1|COMPLETED|Overall Study||0
7753071|NCT01471197|19089395|P2|STARTED|Overall Study||2
7753072|NCT01471197|19089396|P1|STARTED|Overall Study||6
7753073|NCT01471171|19089406|P2|NOT COMPLETED|Treatment Period 2||0
7753074|NCT01471171|19089407|P1|NOT COMPLETED|Treatment Period 2||1
7753075|NCT01471171|19089406|P2|COMPLETED|Treatment Period 2||54
7753076|NCT01471171|19089407|P1|COMPLETED|Treatment Period 2||52
7753077|NCT01471171|19089406|P2|STARTED|Treatment Period 2||54
7753078|NCT01471171|19089407|P1|STARTED|Treatment Period 2||53
7753079|NCT01471171|19089406|P2|NOT COMPLETED|Treatment Period 1||1
7753080|NCT01471171|19089407|P1|NOT COMPLETED|Treatment Period 1||4
7753081|NCT01471171|19089406|P2|COMPLETED|Treatment Period 1||54
7753082|NCT01471171|19089407|P1|COMPLETED|Treatment Period 1||53
7753083|NCT01471171|19089406|P2|STARTED|Treatment Period 1||55
7753084|NCT01471171|19089407|P1|STARTED|Treatment Period 1||57
7753085|NCT01471054|19089419|P2|NOT COMPLETED|Overall Study||0
7753086|NCT01471054|19089420|P1|NOT COMPLETED|Overall Study||4
7753087|NCT01471054|19089419|P2|COMPLETED|Overall Study||1
7753088|NCT01471054|19089420|P1|COMPLETED|Overall Study||1
7753089|NCT01471054|19089419|P2|STARTED|Overall Study||1
7753090|NCT01471054|19089420|P1|STARTED|Overall Study||5
7753091|NCT01471041|19089436|P1|NOT COMPLETED|Overall Study||7
7753092|NCT01471041|19089436|P1|COMPLETED|Overall Study||47
7753093|NCT01471041|19089436|P1|STARTED|Overall Study||54
7753094|NCT01471028|19089443|P2|NOT COMPLETED|VTI-208E||12
7753095|NCT01471028|19089444|P1|NOT COMPLETED|VTI-208E||8
7753096|NCT01471028|19089443|P2|COMPLETED|VTI-208E||51
7753097|NCT01471028|19089444|P1|COMPLETED|VTI-208E||48
7753098|NCT01471028|19089443|P2|Database Lock, 31 July 2015|VTI-208E||63
7753099|NCT01471028|19089444|P1|Database Lock, 31 July 2015|VTI-208E||56
7753100|NCT01471028|19089443|P2|STARTED|VTI-208E||63
7753101|NCT01471028|19089444|P1|STARTED|VTI-208E||56
7753102|NCT01471028|19089443|P2|NOT COMPLETED|VTI-208||44
7753103|NCT01471028|19089444|P1|NOT COMPLETED|VTI-208||40
7753104|NCT01471028|19089443|P2|COMPLETED|VTI-208||63
7753105|NCT01471028|19089444|P1|COMPLETED|VTI-208||56
7753106|NCT01471028|19089443|P2|STARTED|VTI-208||107
7753107|NCT01471028|19089444|P1|STARTED|VTI-208||96
7753108|NCT01471015|19089459|P3|NOT COMPLETED|Overall Study||1
7753109|NCT01471015|19089460|P2|NOT COMPLETED|Overall Study||1
7753110|NCT01471015|19089461|P1|NOT COMPLETED|Overall Study||0
7753111|NCT01471015|19089459|P3|COMPLETED|Overall Study||9
7753112|NCT01471015|19089460|P2|COMPLETED|Overall Study||9
7753113|NCT01471015|19089461|P1|COMPLETED|Overall Study||10
7753114|NCT01471015|19089459|P3|STARTED|Overall Study||10
7753115|NCT01471015|19089460|P2|STARTED|Overall Study||10
7753116|NCT01471015|19089461|P1|STARTED|Overall Study||10
7753117|NCT01470859|19089475|P2|NOT COMPLETED|Overall Study||0
7753118|NCT01470859|19089476|P1|NOT COMPLETED|Overall Study||1
7753119|NCT01470859|19089475|P2|COMPLETED|Overall Study||15
7753120|NCT01470859|19089476|P1|COMPLETED|Overall Study||14
7753121|NCT01470859|19089475|P2|STARTED|Overall Study||15
7753122|NCT01470859|19089476|P1|STARTED|Overall Study||15
7753123|NCT01470781|19089492|P2|NOT COMPLETED|Overall Study||12
7753124|NCT01470781|19089493|P1|NOT COMPLETED|Overall Study||18
7753125|NCT01470781|19089492|P2|COMPLETED|Overall Study||21
7753126|NCT01470781|19089493|P1|COMPLETED|Overall Study||21
7753127|NCT01470781|19089492|P2|Post-Treatment Assessment|Overall Study||23
7753128|NCT01470781|19089493|P1|Post-Treatment Assessment|Overall Study||22
7753129|NCT01470781|19089492|P2|Midpoint Assessment|Overall Study||30
7753130|NCT01470781|19089493|P1|Midpoint Assessment|Overall Study||30
7753131|NCT01470781|19089492|P2|STARTED|Overall Study||33
7753132|NCT01470781|19089493|P1|STARTED|Overall Study||39
7753133|NCT01470651|19089511|P2|NOT COMPLETED|Overall Study||3
7753134|NCT01470651|19089512|P1|NOT COMPLETED|Overall Study||7
7753135|NCT01470651|19089511|P2|COMPLETED|Overall Study||10
7753136|NCT01470651|19089512|P1|COMPLETED|Overall Study||6
7753137|NCT01470651|19089511|P2|STARTED|Overall Study||13
7753138|NCT01470651|19089512|P1|STARTED|Overall Study||13
7753139|NCT01470599|19089522|P2|NOT COMPLETED|Overall Study||43
7753140|NCT01470599|19089523|P1|NOT COMPLETED|Overall Study||19
7753141|NCT01470599|19089522|P2|COMPLETED|Overall Study||45
7753142|NCT01470599|19089523|P1|COMPLETED|Overall Study||43
7753143|NCT01470599|19089522|P2|STARTED|Overall Study||88
7753144|NCT01470599|19089523|P1|STARTED|Overall Study||62
7753145|NCT01470469|19089587|P2|NOT COMPLETED|Overall Study||24
7753146|NCT01470469|19089588|P1|NOT COMPLETED|Overall Study||10
7753147|NCT01470469|19089587|P2|COMPLETED|Overall Study||38
7753148|NCT01470469|19089588|P1|COMPLETED|Overall Study||11
7753149|NCT01470469|19089587|P2|STARTED|Overall Study||62
7753150|NCT01470469|19089588|P1|STARTED|Overall Study||21
7753151|NCT01470417|19089608|P2|NOT COMPLETED|Overall Study||2
7753152|NCT01470417|19089609|P1|NOT COMPLETED|Overall Study||0
7753153|NCT01470417|19089608|P2|COMPLETED|Overall Study||5
7753154|NCT01470417|19089609|P1|COMPLETED|Overall Study||3
7753155|NCT01470417|19089608|P2|STARTED|Overall Study||7
7753156|NCT01470417|19089609|P1|STARTED|Overall Study||3
7753157|NCT01470326|19089621|P1|NOT COMPLETED|Overall Study||153
7753158|NCT01470326|19089621|P1|COMPLETED|Overall Study||3034
7753159|NCT01470326|19089621|P1|STARTED|Overall Study||3187
7753160|NCT01470248|19089632|P1|NOT COMPLETED|Overall Study||1
7753161|NCT01470248|19089632|P1|COMPLETED|Overall Study||19
7753162|NCT01470248|19089632|P1|STARTED|Overall Study||20
7753163|NCT01470196|19089639|P1|NOT COMPLETED|Overall Study||0
7753164|NCT01470196|19089639|P1|COMPLETED|Overall Study||31
7753165|NCT01470196|19089639|P1|STARTED|Overall Study||31
7753166|NCT01470170|19089652|P5|NOT COMPLETED|Overall Study||0
7753167|NCT01470170|19089653|P4|NOT COMPLETED|Overall Study||0
7753168|NCT01470170|19089654|P3|NOT COMPLETED|Overall Study||0
7753169|NCT01470170|19089655|P2|NOT COMPLETED|Overall Study||0
7753170|NCT01470170|19089656|P1|NOT COMPLETED|Overall Study||0
7753171|NCT01470170|19089652|P5|COMPLETED|Overall Study||34
7753172|NCT01470170|19089653|P4|COMPLETED|Overall Study||36
7753173|NCT01470170|19089654|P3|COMPLETED|Overall Study||34
7753174|NCT01470170|19089655|P2|COMPLETED|Overall Study||35
7753175|NCT01470170|19089656|P1|COMPLETED|Overall Study||34
7753176|NCT01470170|19089652|P5|STARTED|Overall Study||34
7753177|NCT01470170|19089653|P4|STARTED|Overall Study||36
7753178|NCT01470170|19089654|P3|STARTED|Overall Study||34
7753179|NCT01470170|19089655|P2|STARTED|Overall Study||35
7753180|NCT01470170|19089656|P1|STARTED|Overall Study||34
7753181|NCT01470144|19089688|P1|NOT COMPLETED|Overall Study||10
7753182|NCT01470144|19089688|P1|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31
7753183|NCT01470144|19089688|P1|STARTED|Overall Study||41
7753184|NCT01470118|19089696|P3|NOT COMPLETED|Overall Study||2
7753185|NCT01470118|19089697|P2|NOT COMPLETED|Overall Study||5
7753186|NCT01470118|19089698|P1|NOT COMPLETED|Overall Study||5
7753187|NCT01470118|19089696|P3|COMPLETED|Overall Study||39
7753188|NCT01470118|19089697|P2|COMPLETED|Overall Study||38
7753189|NCT01470118|19089698|P1|COMPLETED|Overall Study||38
7753190|NCT01470118|19089696|P3|STARTED|Overall Study||41
7753191|NCT01470118|19089697|P2|STARTED|Overall Study||43
7753192|NCT01470118|19089698|P1|STARTED|Overall Study||43
7753193|NCT01470027|19089733|P3|NOT COMPLETED|Overall Study||1
7753194|NCT01470027|19089734|P2|NOT COMPLETED|Overall Study||1
7753195|NCT01470027|19089735|P1|NOT COMPLETED|Overall Study||1
7753196|NCT01470027|19089733|P3|COMPLETED|Overall Study||15
7753197|NCT01470027|19089734|P2|COMPLETED|Overall Study||14
7753198|NCT01470027|19089735|P1|COMPLETED|Overall Study||15
7753199|NCT01470027|19089733|P3|STARTED|Overall Study||16
7753200|NCT01470027|19089734|P2|STARTED|Overall Study||15
7753201|NCT01470027|19089735|P1|STARTED|Overall Study||16
7753202|NCT01470001|19089793|P2|NOT COMPLETED|Overall Study||2
7753203|NCT01470001|19089794|P1|NOT COMPLETED|Overall Study||5
7753204|NCT01470001|19089793|P2|COMPLETED|Overall Study||58
7753205|NCT01470001|19089794|P1|COMPLETED|Overall Study||53
7753206|NCT01470001|19089793|P2|STARTED|Overall Study||60
7753207|NCT01470001|19089794|P1|STARTED|Overall Study||58
7753208|NCT01469819|19089804|P1|NOT COMPLETED|Overall Study||8
7753209|NCT01469819|19089804|P1|COMPLETED|Overall Study||29
7753210|NCT01469819|19089804|P1|STARTED|Overall Study||37
7753211|NCT01469767|19089814|P1|NOT COMPLETED|Overall Study||0
7753212|NCT01469767|19089814|P1|COMPLETED|Overall Study||10
7753213|NCT01469767|19089814|P1|STARTED|Overall Study||10
7753214|NCT01469715|19089822|P1|NOT COMPLETED|Overall Study||0
7753215|NCT01469715|19089822|P1|COMPLETED|Overall Study||16
7753216|NCT01469715|19089822|P1|STARTED|Overall Study||16
7753217|NCT01469637|19089828|P2|NOT COMPLETED|Second Intervention||0
7753218|NCT01469637|19089829|P1|NOT COMPLETED|Second Intervention||1
7753219|NCT01469637|19089828|P2|COMPLETED|Second Intervention||21
7753220|NCT01469637|19089829|P1|COMPLETED|Second Intervention||21
7753221|NCT01469637|19089828|P2|STARTED|Second Intervention||21
7753222|NCT01469637|19089829|P1|STARTED|Second Intervention||22
7753223|NCT01469637|19089828|P2|NOT COMPLETED|First Intervention||1
7753224|NCT01469637|19089829|P1|NOT COMPLETED|First Intervention||0
7753225|NCT01469637|19089828|P2|COMPLETED|First Intervention||21
7753226|NCT01469637|19089829|P1|COMPLETED|First Intervention||22
7753227|NCT01469637|19089828|P2|STARTED|First Intervention||22
7753228|NCT01469637|19089829|P1|STARTED|First Intervention||22
7753229|NCT01469585|19089839|P2|NOT COMPLETED|Overall Study||3
7753230|NCT01469585|19089840|P1|NOT COMPLETED|Overall Study||7
7753231|NCT01469585|19089839|P2|COMPLETED|Overall Study||6
7753232|NCT01469585|19089840|P1|COMPLETED|Overall Study||4
7753233|NCT01469585|19089839|P2|STARTED|Overall Study||9
7753234|NCT01469585|19089840|P1|STARTED|Overall Study||11
7753235|NCT01469546|19089848|P1|NOT COMPLETED|Dose Escalation to 10 mg||0
7753236|NCT01469546|19089848|P1|COMPLETED|Dose Escalation to 10 mg||19
7753237|NCT01469546|19089848|P1|STARTED|Dose Escalation to 10 mg||19
7753238|NCT01469546|19089848|P1|NOT COMPLETED|Received 5 mg Dose||23
7753239|NCT01469546|19089848|P1|COMPLETED|Received 5 mg Dose||19
7753240|NCT01469546|19089848|P1|Completed First Cycle|Received 5 mg Dose||30
7753241|NCT01469546|19089848|P1|STARTED|Received 5 mg Dose||42
7753242|NCT01469377|19089858|P3|NOT COMPLETED|Overall Study||66
7753243|NCT01469377|19089859|P2|NOT COMPLETED|Overall Study||48
7753244|NCT01469377|19089860|P1|NOT COMPLETED|Overall Study||35
7753245|NCT01469377|19089858|P3|COMPLETED|Overall Study||210
7753246|NCT01469377|19089859|P2|COMPLETED|Overall Study||226
7753247|NCT01469377|19089860|P1|COMPLETED|Overall Study||234
7753248|NCT01469377|19089858|P3|STARTED|Overall Study||276
7753249|NCT01469377|19089859|P2|STARTED|Overall Study||274
7753250|NCT01469377|19089860|P1|STARTED|Overall Study||269
7753251|NCT01469364|19089871|P1|NOT COMPLETED|Overall Study||2
7753252|NCT01469364|19089871|P1|COMPLETED|Overall Study||28
7753253|NCT01469364|19089871|P1|STARTED|Overall Study||30
7753254|NCT01469234|19089889|P3|NOT COMPLETED|Overall Study||0
7753255|NCT01469234|19089890|P2|NOT COMPLETED|Overall Study||0
7753256|NCT01469234|19089891|P1|NOT COMPLETED|Overall Study||0
7753257|NCT01469234|19089889|P3|COMPLETED|Overall Study||85
7753258|NCT01469234|19089890|P2|COMPLETED|Overall Study||85
7753259|NCT01469234|19089891|P1|COMPLETED|Overall Study||85
7753260|NCT01469234|19089889|P3|STARTED|Overall Study||85
7753261|NCT01469234|19089890|P2|STARTED|Overall Study||85
7753262|NCT01469234|19089891|P1|STARTED|Overall Study||85
7753263|NCT01469221|19089922|P3|NOT COMPLETED|Double Blind Phase||0
7753264|NCT01469221|19089923|P2|NOT COMPLETED|Double Blind Phase||17
7753265|NCT01469221|19089924|P1|NOT COMPLETED|Double Blind Phase||14
7753266|NCT01469221|19089922|P3|COMPLETED|Double Blind Phase||0
7753267|NCT01469221|19089923|P2|COMPLETED|Double Blind Phase||0
7753268|NCT01469221|19089924|P1|COMPLETED|Double Blind Phase||0
7753269|NCT01469221|19089922|P3|STARTED|Double Blind Phase||0
7753270|NCT01469221|19089923|P2|STARTED|Double Blind Phase||17
7753271|NCT01469221|19089924|P1|STARTED|Double Blind Phase||14
7753272|NCT01469221|19089922|P3|NOT COMPLETED|Open Label Phase||3
7753273|NCT01469221|19089923|P2|NOT COMPLETED|Open Label Phase||0
7753274|NCT01469221|19089924|P1|NOT COMPLETED|Open Label Phase||0
7753275|NCT01469221|19089922|P3|COMPLETED|Open Label Phase||44
7753276|NCT01469221|19089923|P2|COMPLETED|Open Label Phase||0
7753277|NCT01469221|19089924|P1|COMPLETED|Open Label Phase||0
7753278|NCT01469221|19089922|P3|STARTED|Open Label Phase||47
7753279|NCT01469221|19089923|P2|STARTED|Open Label Phase||0
7753280|NCT01469221|19089924|P1|STARTED|Open Label Phase||0
7753281|NCT01469182|19089935|P2|NOT COMPLETED|Overall Study||6
7753282|NCT01469182|19089936|P1|NOT COMPLETED|Overall Study||35
7753283|NCT01469182|19089935|P2|COMPLETED|Overall Study||298
7753284|NCT01469182|19089936|P1|COMPLETED|Overall Study||575
7753285|NCT01469182|19089935|P2|Treated|Overall Study||304
7753286|NCT01469182|19089936|P1|Treated|Overall Study||609
7753287|NCT01469182|19089935|P2|STARTED|Overall Study||304
7753288|NCT01469182|19089936|P1|STARTED|Overall Study||610
7753289|NCT01469065|19089963|P5|NOT COMPLETED|Overall Study||1
7753290|NCT01469065|19089964|P4|NOT COMPLETED|Overall Study||0
7753291|NCT01469065|19089965|P3|NOT COMPLETED|Overall Study||0
7753292|NCT01469065|19089966|P2|NOT COMPLETED|Overall Study||1
7753293|NCT01469065|19089967|P1|NOT COMPLETED|Overall Study||0
7753294|NCT01469065|19089963|P5|COMPLETED|Overall Study||16
7753295|NCT01469065|19089964|P4|COMPLETED|Overall Study||16
7753296|NCT01469065|19089965|P3|COMPLETED|Overall Study||16
7753297|NCT01469065|19089966|P2|COMPLETED|Overall Study||16
7753298|NCT01469065|19089967|P1|COMPLETED|Overall Study||16
7753299|NCT01469065|19089963|P5|STARTED|Overall Study||17
7753300|NCT01469065|19089964|P4|STARTED|Overall Study||16
7753301|NCT01469065|19089965|P3|STARTED|Overall Study||16
7753302|NCT01469065|19089966|P2|STARTED|Overall Study||17
7753303|NCT01469065|19089967|P1|STARTED|Overall Study||16
7753304|NCT01469052|19090063|P6|NOT COMPLETED|Overall Study||6
7753305|NCT01469052|19090064|P5|NOT COMPLETED|Overall Study||8
7753306|NCT01469052|19090065|P4|NOT COMPLETED|Overall Study||5
7753307|NCT01469052|19090066|P3|NOT COMPLETED|Overall Study||6
7753308|NCT01469052|19090067|P2|NOT COMPLETED|Overall Study||4
7753309|NCT01469052|19090068|P1|NOT COMPLETED|Overall Study||6
7753310|NCT01469052|19090063|P6|COMPLETED|Overall Study||0
7753311|NCT01469052|19090064|P5|COMPLETED|Overall Study||0
7753312|NCT01469052|19090065|P4|COMPLETED|Overall Study||1
7753313|NCT01469052|19090066|P3|COMPLETED|Overall Study||0
7753314|NCT01469052|19090067|P2|COMPLETED|Overall Study||0
7753315|NCT01469052|19090068|P1|COMPLETED|Overall Study||0
7753316|NCT01469052|19090063|P6|STARTED|Overall Study||6
7753317|NCT01469052|19090064|P5|STARTED|Overall Study||8
7753318|NCT01469052|19090065|P4|STARTED|Overall Study||6
7753319|NCT01469052|19090066|P3|STARTED|Overall Study||6
7753320|NCT01469052|19090067|P2|STARTED|Overall Study||4
7753321|NCT01469052|19090068|P1|STARTED|Overall Study||6
7753322|NCT01469039|19090115|P3|NOT COMPLETED|Overall Study||113
7753323|NCT01469039|19090116|P2|NOT COMPLETED|Overall Study||73
7753324|NCT01469039|19090117|P1|NOT COMPLETED|Overall Study||77
7753325|NCT01469039|19090115|P3|COMPLETED|Overall Study||95
7753326|NCT01469039|19090116|P2|COMPLETED|Overall Study||135
7753327|NCT01469039|19090117|P1|COMPLETED|Overall Study||130
7753328|NCT01469039|19090115|P3|STARTED|Overall Study||208
7753329|NCT01469039|19090116|P2|STARTED|Overall Study||208
7753330|NCT01469039|19090117|P1|STARTED|Overall Study||207
7753331|NCT01469013|19090133|P13|NOT COMPLETED|Part B (Extension Period)||6
7753332|NCT01469013|19090134|P12|NOT COMPLETED|Part B (Extension Period)||6
7753333|NCT01469013|19090135|P11|NOT COMPLETED|Part B (Extension Period)||2
7753334|NCT01469013|19090136|P10|NOT COMPLETED|Part B (Extension Period)||3
7753335|NCT01469013|19090137|P9|NOT COMPLETED|Part B (Extension Period)||4
7753336|NCT01469013|19090138|P8|NOT COMPLETED|Part B (Extension Period)||5
7753337|NCT01469013|19090139|P7|NOT COMPLETED|Part B (Extension Period)||5
7753338|NCT01469013|19090140|P6|NOT COMPLETED|Part B (Extension Period)||2
7753339|NCT01469013|19090141|P5|NOT COMPLETED|Part B (Extension Period)||0
7753340|NCT01469013|19090142|P4|NOT COMPLETED|Part B (Extension Period)||0
7753341|NCT01469013|19090143|P3|NOT COMPLETED|Part B (Extension Period)||0
7753342|NCT01469013|19090144|P2|NOT COMPLETED|Part B (Extension Period)||0
7753343|NCT01469013|19090145|P1|NOT COMPLETED|Part B (Extension Period)||0
7753344|NCT01469013|19090133|P13|COMPLETED|Part B (Extension Period)||18
7753345|NCT01469013|19090134|P12|COMPLETED|Part B (Extension Period)||18
7753346|NCT01469013|19090135|P11|COMPLETED|Part B (Extension Period)||10
7753347|NCT01469013|19090136|P10|COMPLETED|Part B (Extension Period)||8
7753348|NCT01469013|19090137|P9|COMPLETED|Part B (Extension Period)||20
7753349|NCT01469013|19090138|P8|COMPLETED|Part B (Extension Period)||18
7753350|NCT01469013|19090139|P7|COMPLETED|Part B (Extension Period)||7
7753351|NCT01469013|19090140|P6|COMPLETED|Part B (Extension Period)||10
7753352|NCT01469013|19090141|P5|COMPLETED|Part B (Extension Period)||0
7753353|NCT01469013|19090142|P4|COMPLETED|Part B (Extension Period)||0
7753354|NCT01469013|19090143|P3|COMPLETED|Part B (Extension Period)||0
7753355|NCT01469013|19090144|P2|COMPLETED|Part B (Extension Period)||0
7753356|NCT01469013|19090145|P1|COMPLETED|Part B (Extension Period)||0
7753357|NCT01469013|19090133|P13|Received at Least 1 Dose of Study Drug|Part B (Extension Period)|1 participant discontinued prior to receiving study drug|23
7753358|NCT01469013|19090134|P12|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
7753359|NCT01469013|19090135|P11|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
7753360|NCT01469013|19090136|P10|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||11
7753361|NCT01469013|19090137|P9|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
7753362|NCT01469013|19090138|P8|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||23
7753363|NCT01469013|19090139|P7|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
7753364|NCT01469013|19090140|P6|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
7753365|NCT01469013|19090141|P5|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
7753366|NCT01469013|19090142|P4|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
7753367|NCT01469013|19090143|P3|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
7753368|NCT01469013|19090144|P2|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
7753369|NCT01469013|19090145|P1|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
7753370|NCT01469013|19090133|P13|STARTED|Part B (Extension Period)||24
7753371|NCT01469013|19090134|P12|STARTED|Part B (Extension Period)||24
7753372|NCT01469013|19090135|P11|STARTED|Part B (Extension Period)||12
7753373|NCT01469013|19090136|P10|STARTED|Part B (Extension Period)||11
7753374|NCT01469013|19090137|P9|STARTED|Part B (Extension Period)||24
7753375|NCT01469013|19090138|P8|STARTED|Part B (Extension Period)||23
7753376|NCT01469013|19090139|P7|STARTED|Part B (Extension Period)||12
7753377|NCT01469013|19090140|P6|STARTED|Part B (Extension Period)||12
7753378|NCT01469013|19090141|P5|STARTED|Part B (Extension Period)||0
7753379|NCT01469013|19090142|P4|STARTED|Part B (Extension Period)||0
7753380|NCT01469013|19090143|P3|STARTED|Part B (Extension Period)||0
7753381|NCT01469013|19090144|P2|STARTED|Part B (Extension Period)||0
7753382|NCT01469013|19090145|P1|STARTED|Part B (Extension Period)||0
7753383|NCT01469013|19090133|P13|NOT COMPLETED|Part A (Treatment Period)||0
7753384|NCT01469013|19090134|P12|NOT COMPLETED|Part A (Treatment Period)||0
7753385|NCT01469013|19090135|P11|NOT COMPLETED|Part A (Treatment Period)||0
7753386|NCT01469013|19090136|P10|NOT COMPLETED|Part A (Treatment Period)||0
7753387|NCT01469013|19090137|P9|NOT COMPLETED|Part A (Treatment Period)||0
7753388|NCT01469013|19090138|P8|NOT COMPLETED|Part A (Treatment Period)||0
7753389|NCT01469013|19090139|P7|NOT COMPLETED|Part A (Treatment Period)||0
7753390|NCT01469013|19090140|P6|NOT COMPLETED|Part A (Treatment Period)||0
7753391|NCT01469013|19090141|P5|NOT COMPLETED|Part A (Treatment Period)||1
7753392|NCT01469013|19090142|P4|NOT COMPLETED|Part A (Treatment Period)||0
7753393|NCT01469013|19090143|P3|NOT COMPLETED|Part A (Treatment Period)||1
7753394|NCT01469013|19090144|P2|NOT COMPLETED|Part A (Treatment Period)||0
7753395|NCT01469013|19090145|P1|NOT COMPLETED|Part A (Treatment Period)||1
7753396|NCT01469013|19090133|P13|COMPLETED|Part A (Treatment Period)||0
7753397|NCT01469013|19090134|P12|COMPLETED|Part A (Treatment Period)||0
7753398|NCT01469013|19090135|P11|COMPLETED|Part A (Treatment Period)||0
7753399|NCT01469013|19090136|P10|COMPLETED|Part A (Treatment Period)||0
7753400|NCT01469013|19090137|P9|COMPLETED|Part A (Treatment Period)||0
7753401|NCT01469013|19090138|P8|COMPLETED|Part A (Treatment Period)||0
7753402|NCT01469013|19090139|P7|COMPLETED|Part A (Treatment Period)||0
7753403|NCT01469013|19090140|P6|COMPLETED|Part A (Treatment Period)||0
7753404|NCT01469013|19090141|P5|COMPLETED|Part A (Treatment Period)||48
7753405|NCT01469013|19090142|P4|COMPLETED|Part A (Treatment Period)||24
7753406|NCT01469013|19090143|P3|COMPLETED|Part A (Treatment Period)||23
7753407|NCT01469013|19090144|P2|COMPLETED|Part A (Treatment Period)||24
7753408|NCT01469013|19090145|P1|COMPLETED|Part A (Treatment Period)||23
7753409|NCT01469013|19090133|P13|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
7753410|NCT01469013|19090134|P12|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
7753411|NCT01469013|19090135|P11|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
7753412|NCT01469013|19090136|P10|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
7753413|NCT01469013|19090137|P9|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
7753414|NCT01469013|19090138|P8|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
7753415|NCT01469013|19090139|P7|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
7753416|NCT01469013|19090140|P6|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
7753417|NCT01469013|19090141|P5|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||49
7753418|NCT01469013|19090142|P4|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
7753419|NCT01469013|19090143|P3|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
7753420|NCT01469013|19090144|P2|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
7753421|NCT01469013|19090145|P1|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
7753422|NCT01469013|19090133|P13|STARTED|Part A (Treatment Period)||0
7753423|NCT01469013|19090134|P12|STARTED|Part A (Treatment Period)||0
7753424|NCT01469013|19090135|P11|STARTED|Part A (Treatment Period)||0
7753425|NCT01469013|19090136|P10|STARTED|Part A (Treatment Period)||0
7753426|NCT01469013|19090137|P9|STARTED|Part A (Treatment Period)||0
7753427|NCT01469013|19090138|P8|STARTED|Part A (Treatment Period)||0
7753428|NCT01469013|19090139|P7|STARTED|Part A (Treatment Period)||0
7753429|NCT01469013|19090140|P6|STARTED|Part A (Treatment Period)||0
7753430|NCT01469013|19090141|P5|STARTED|Part A (Treatment Period)||49
7753431|NCT01469013|19090142|P4|STARTED|Part A (Treatment Period)||24
7753432|NCT01469013|19090143|P3|STARTED|Part A (Treatment Period)||24
7753433|NCT01469013|19090144|P2|STARTED|Part A (Treatment Period)||24
7753434|NCT01469013|19090145|P1|STARTED|Part A (Treatment Period)||24
7753435|NCT01469000|19090230|P2|NOT COMPLETED|Overall Study||4
7753436|NCT01469000|19090231|P1|NOT COMPLETED|Overall Study||20
7753437|NCT01469000|19090230|P2|COMPLETED|Overall Study||62
7753438|NCT01469000|19090231|P1|COMPLETED|Overall Study||109
7753439|NCT01469000|19090230|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
7753440|NCT01469000|19090231|P1|Received at Least 1 Dose of Study Drug|Overall Study||126
7753441|NCT01469000|19090230|P2|STARTED|Overall Study||66
7753442|NCT01469000|19090231|P1|STARTED|Overall Study||129
7753443|NCT01468987|19090251|P2|NOT COMPLETED|Overall Study||60
7753444|NCT01468987|19090252|P1|NOT COMPLETED|Overall Study||71
7753445|NCT01468987|19090251|P2|COMPLETED|Overall Study||618
7753446|NCT01468987|19090252|P1|COMPLETED|Overall Study||620
7753447|NCT01468987|19090251|P2|Received at Least 1 Dose of Study Drug|Overall Study||677
7753448|NCT01468987|19090252|P1|Received at Least 1 Dose of Study Drug|Overall Study||691
7753449|NCT01468987|19090251|P2|STARTED|Overall Study||678
7753450|NCT01468987|19090252|P1|STARTED|Overall Study||691
7753451|NCT01468974|19090296|P1|NOT COMPLETED|3 Years Follow-up||6
7753452|NCT01468974|19090296|P1|COMPLETED|3 Years Follow-up||26
7753453|NCT01468974|19090296|P1|STARTED|3 Years Follow-up||32
7753454|NCT01468974|19090296|P1|NOT COMPLETED|2 Years Follow-up||2
7753455|NCT01468974|19090296|P1|COMPLETED|2 Years Follow-up||32
7753456|NCT01468974|19090296|P1|STARTED|2 Years Follow-up||34
7753457|NCT01468974|19090296|P1|NOT COMPLETED|1 Year Follow-up||0
7753458|NCT01468974|19090296|P1|COMPLETED|1 Year Follow-up||34
7753459|NCT01468974|19090296|P1|STARTED|1 Year Follow-up||34
7753460|NCT01468974|19090296|P1|NOT COMPLETED|6 Months Follow-up||0
7753461|NCT01468974|19090296|P1|COMPLETED|6 Months Follow-up||34
7753462|NCT01468974|19090296|P1|STARTED|6 Months Follow-up||34
7753463|NCT01468974|19090296|P1|NOT COMPLETED|1 Month Follow-up||1
7753464|NCT01468974|19090296|P1|COMPLETED|1 Month Follow-up||34
7753465|NCT01468974|19090296|P1|STARTED|1 Month Follow-up|Intent-to-treat (ITT) population|35
7753466|NCT01468909|19090429|P2|NOT COMPLETED|Overall Study||2
7753467|NCT01468909|19090430|P1|NOT COMPLETED|Overall Study||2
7753468|NCT01468909|19090429|P2|COMPLETED|Overall Study||52
7753469|NCT01468909|19090430|P1|COMPLETED|Overall Study||50
7753470|NCT01468909|19090429|P2|STARTED|Overall Study||54
7753471|NCT01468909|19090430|P1|STARTED|Overall Study||52
7753472|NCT01468896|19090446|P2|NOT COMPLETED|Overall Study||0
7753473|NCT01468896|19090447|P1|NOT COMPLETED|Overall Study||0
7753474|NCT01468896|19090446|P2|COMPLETED|Overall Study||17
7753475|NCT01468896|19090447|P1|COMPLETED|Overall Study||6
7753476|NCT01468896|19090446|P2|STARTED|Overall Study||17
7753477|NCT01468896|19090447|P1|STARTED|Overall Study||6
7753478|NCT01468818|19090463|P1|NOT COMPLETED|Overall Study||2
7753479|NCT01468818|19090463|P1|COMPLETED|Overall Study||16
7753480|NCT01468818|19090463|P1|STARTED|Overall Study||18
7753481|NCT01468675|19090470|P2|NOT COMPLETED|Overall Study||1372
7753482|NCT01468675|19090471|P1|NOT COMPLETED|Overall Study||1000
7753483|NCT01468675|19090470|P2|COMPLETED|Overall Study||2004
7753484|NCT01468675|19090471|P1|COMPLETED|Overall Study||1699
7753485|NCT01468675|19090470|P2|STARTED|Overall Study||3376
7753486|NCT01468675|19090471|P1|STARTED|Overall Study||2699
7753487|NCT01468597|19090477|P1|NOT COMPLETED|Overall Study||35
7753488|NCT01468597|19090477|P1|COMPLETED|Overall Study||149
7753489|NCT01468597|19090477|P1|STARTED|Overall Study||184
7753490|NCT01468584|19090482|P1|NOT COMPLETED|Overall Study||0
7753491|NCT01468584|19090482|P1|COMPLETED|Overall Study||10
7753492|NCT01468584|19090482|P1|STARTED|Overall Study||10
7753493|NCT01468558|19090486|P1|NOT COMPLETED|Overall Study||2
7753494|NCT01468558|19090486|P1|COMPLETED|Overall Study||22
7753495|NCT01468558|19090486|P1|STARTED|Overall Study||24
7753496|NCT01468350|19090501|P4|NOT COMPLETED|(PART B) Day 1, Day 15||0
7753497|NCT01468350|19090502|P3|NOT COMPLETED|(PART B) Day 1, Day 15||0
7753498|NCT01468350|19090503|P2|NOT COMPLETED|(PART B) Day 1, Day 15||0
7753499|NCT01468350|19090504|P1|NOT COMPLETED|(PART B) Day 1, Day 15||0
7753500|NCT01468350|19090501|P4|COMPLETED|(PART B) Day 1, Day 15||12
7753501|NCT01468350|19090502|P3|COMPLETED|(PART B) Day 1, Day 15||12
7753502|NCT01468350|19090503|P2|COMPLETED|(PART B) Day 1, Day 15||0
7753503|NCT01468350|19090504|P1|COMPLETED|(PART B) Day 1, Day 15||0
7753504|NCT01468350|19090501|P4|STARTED|(PART B) Day 1, Day 15||12
7753505|NCT01468350|19090502|P3|STARTED|(PART B) Day 1, Day 15||12
7753506|NCT01468350|19090503|P2|STARTED|(PART B) Day 1, Day 15||0
7753507|NCT01468350|19090504|P1|STARTED|(PART B) Day 1, Day 15||0
7753508|NCT01468350|19090501|P4|NOT COMPLETED|(PART A) Day 1, Day 3||0
7753509|NCT01468350|19090502|P3|NOT COMPLETED|(PART A) Day 1, Day 3||0
7753510|NCT01468350|19090503|P2|NOT COMPLETED|(PART A) Day 1, Day 3||0
7753511|NCT01468350|19090504|P1|NOT COMPLETED|(PART A) Day 1, Day 3||0
7753512|NCT01468350|19090501|P4|COMPLETED|(PART A) Day 1, Day 3||0
7753513|NCT01468350|19090502|P3|COMPLETED|(PART A) Day 1, Day 3||0
7753514|NCT01468350|19090503|P2|COMPLETED|(PART A) Day 1, Day 3||5
7753515|NCT01468350|19090504|P1|COMPLETED|(PART A) Day 1, Day 3||6
7753516|NCT01468350|19090501|P4|STARTED|(PART A) Day 1, Day 3||0
7753517|NCT01468350|19090502|P3|STARTED|(PART A) Day 1, Day 3||0
7753518|NCT01468350|19090503|P2|STARTED|(PART A) Day 1, Day 3||5
7753519|NCT01468350|19090504|P1|STARTED|(PART A) Day 1, Day 3||6
7753520|NCT01468337|19090514|P1|NOT COMPLETED|Overall Study||0
7753521|NCT01468337|19090514|P1|COMPLETED|Overall Study||5
7753522|NCT01468337|19090514|P1|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3
7753523|NCT01468337|19090514|P1|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4
7753524|NCT01468337|19090514|P1|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2
7753525|NCT01468337|19090514|P1|Week 2|Overall Study||5
7753526|NCT01468337|19090514|P1|STARTED|Overall Study||5
7753527|NCT01468311|19090526|P1|NOT COMPLETED|Overall Study||2
7753528|NCT01468311|19090526|P1|COMPLETED|Overall Study||4
7753529|NCT01468311|19090526|P1|STARTED|Overall Study||6
7753530|NCT01468233|19090538|P6|NOT COMPLETED|Treatment Period 2||23
7753531|NCT01468233|19090539|P5|NOT COMPLETED|Treatment Period 2||28
7753532|NCT01468233|19090540|P4|NOT COMPLETED|Treatment Period 2||28
7753533|NCT01468233|19090541|P3|NOT COMPLETED|Treatment Period 2||111
7753534|NCT01468233|19090542|P2|NOT COMPLETED|Treatment Period 2||0
7753535|NCT01468233|19090543|P1|NOT COMPLETED|Treatment Period 2||0
7753536|NCT01468233|19090538|P6|COMPLETED|Treatment Period 2||28
7753537|NCT01468233|19090539|P5|COMPLETED|Treatment Period 2||25
7753538|NCT01468233|19090540|P4|COMPLETED|Treatment Period 2||23
7753539|NCT01468233|19090541|P3|COMPLETED|Treatment Period 2||40
7753540|NCT01468233|19090542|P2|COMPLETED|Treatment Period 2||0
7753541|NCT01468233|19090543|P1|COMPLETED|Treatment Period 2||0
7753542|NCT01468233|19090538|P6|STARTED|Treatment Period 2||51
7753543|NCT01468233|19090539|P5|STARTED|Treatment Period 2||53
7753544|NCT01468233|19090540|P4|STARTED|Treatment Period 2||51
7753545|NCT01468233|19090541|P3|STARTED|Treatment Period 2||151
7753546|NCT01468233|19090542|P2|STARTED|Treatment Period 2||0
7753547|NCT01468233|19090543|P1|STARTED|Treatment Period 2||0
7753548|NCT01468233|19090538|P6|NOT COMPLETED|Treatment Period 1||0
7753549|NCT01468233|19090539|P5|NOT COMPLETED|Treatment Period 1||0
7753550|NCT01468233|19090540|P4|NOT COMPLETED|Treatment Period 1||0
7753551|NCT01468233|19090541|P3|NOT COMPLETED|Treatment Period 1||0
7753552|NCT01468233|19090542|P2|NOT COMPLETED|Treatment Period 1||8
7753553|NCT01468233|19090543|P1|NOT COMPLETED|Treatment Period 1||12
7753554|NCT01468233|19090538|P6|COMPLETED|Treatment Period 1||0
7753555|NCT01468233|19090539|P5|COMPLETED|Treatment Period 1||0
7753556|NCT01468233|19090540|P4|COMPLETED|Treatment Period 1||0
7753557|NCT01468233|19090541|P3|COMPLETED|Treatment Period 1||0
7753558|NCT01468233|19090542|P2|COMPLETED|Treatment Period 1||155
7753559|NCT01468233|19090543|P1|COMPLETED|Treatment Period 1||151
7753560|NCT01468233|19090538|P6|STARTED|Treatment Period 1||0
7753561|NCT01468233|19090539|P5|STARTED|Treatment Period 1||0
7753562|NCT01468233|19090540|P4|STARTED|Treatment Period 1||0
7753563|NCT01468233|19090541|P3|STARTED|Treatment Period 1||0
7753564|NCT01468233|19090542|P2|STARTED|Treatment Period 1||163
7753565|NCT01468233|19090543|P1|STARTED|Treatment Period 1||163
7753566|NCT01468207|19090565|P6|NOT COMPLETED|Treatment Period 2||20
7753567|NCT01468207|19090566|P5|NOT COMPLETED|Treatment Period 2||21
7753568|NCT01468207|19090567|P4|NOT COMPLETED|Treatment Period 2||27
7753569|NCT01468207|19090568|P3|NOT COMPLETED|Treatment Period 2||52
7753570|NCT01468207|19090569|P2|NOT COMPLETED|Treatment Period 2||0
7753571|NCT01468207|19090570|P1|NOT COMPLETED|Treatment Period 2||0
7753572|NCT01468207|19090565|P6|COMPLETED|Treatment Period 2||28
7753573|NCT01468207|19090566|P5|COMPLETED|Treatment Period 2||27
7753574|NCT01468207|19090567|P4|COMPLETED|Treatment Period 2||22
7753575|NCT01468207|19090568|P3|COMPLETED|Treatment Period 2||93
7753576|NCT01468207|19090569|P2|COMPLETED|Treatment Period 2||0
7753577|NCT01468207|19090570|P1|COMPLETED|Treatment Period 2||0
7753578|NCT01468207|19090565|P6|STARTED|Treatment Period 2||48
7753579|NCT01468207|19090566|P5|STARTED|Treatment Period 2||48
7753580|NCT01468207|19090567|P4|STARTED|Treatment Period 2||49
7753581|NCT01468207|19090568|P3|STARTED|Treatment Period 2||145
7753582|NCT01468207|19090569|P2|STARTED|Treatment Period 2||0
7753583|NCT01468207|19090570|P1|STARTED|Treatment Period 2||0
7753584|NCT01468207|19090565|P6|NOT COMPLETED|Treatment Period 1||0
7753585|NCT01468207|19090566|P5|NOT COMPLETED|Treatment Period 1||0
7753586|NCT01468207|19090567|P4|NOT COMPLETED|Treatment Period 1||0
7753587|NCT01468207|19090568|P3|NOT COMPLETED|Treatment Period 1||0
7753588|NCT01468207|19090569|P2|NOT COMPLETED|Treatment Period 1||8
7753589|NCT01468207|19090570|P1|NOT COMPLETED|Treatment Period 1||9
7753590|NCT01468207|19090565|P6|COMPLETED|Treatment Period 1||0
7753591|NCT01468207|19090566|P5|COMPLETED|Treatment Period 1||0
7753592|NCT01468207|19090567|P4|COMPLETED|Treatment Period 1||0
7753593|NCT01468207|19090568|P3|COMPLETED|Treatment Period 1||0
7753594|NCT01468207|19090569|P2|COMPLETED|Treatment Period 1||145
7753595|NCT01468207|19090570|P1|COMPLETED|Treatment Period 1||145
7753596|NCT01468207|19090565|P6|Received Study Drug|Treatment Period 1||0
7753597|NCT01468207|19090566|P5|Received Study Drug|Treatment Period 1||0
7753598|NCT01468207|19090567|P4|Received Study Drug|Treatment Period 1||0
7753599|NCT01468207|19090568|P3|Received Study Drug|Treatment Period 1||0
7753600|NCT01468207|19090569|P2|Received Study Drug|Treatment Period 1||153
7753601|NCT01468207|19090570|P1|Received Study Drug|Treatment Period 1||152
7753602|NCT01468207|19090565|P6|STARTED|Treatment Period 1||0
7753603|NCT01468207|19090566|P5|STARTED|Treatment Period 1||0
7753604|NCT01468207|19090567|P4|STARTED|Treatment Period 1||0
7753605|NCT01468207|19090568|P3|STARTED|Treatment Period 1||0
7753606|NCT01468207|19090569|P2|STARTED|Treatment Period 1||153
7753607|NCT01468207|19090570|P1|STARTED|Treatment Period 1||154
7753608|NCT01468181|19090595|P5|NOT COMPLETED|Overall Study||5
7753609|NCT01468181|19090596|P4|NOT COMPLETED|Overall Study||3
7753610|NCT01468181|19090597|P3|NOT COMPLETED|Overall Study||8
7753611|NCT01468181|19090598|P2|NOT COMPLETED|Overall Study||2
7753612|NCT01468181|19090599|P1|NOT COMPLETED|Overall Study||10
7753613|NCT01468181|19090595|P5|COMPLETED|Overall Study||66
7753614|NCT01468181|19090596|P4|COMPLETED|Overall Study||63
7753615|NCT01468181|19090597|P3|COMPLETED|Overall Study||57
7753616|NCT01468181|19090598|P2|COMPLETED|Overall Study||59
7753617|NCT01468181|19090599|P1|COMPLETED|Overall Study||121
7753618|NCT01468181|19090595|P5|Received at Least 1 Dose of Study Drug|Overall Study||71
7753619|NCT01468181|19090596|P4|Received at Least 1 Dose of Study Drug|Overall Study||66
7753620|NCT01468181|19090597|P3|Received at Least 1 Dose of Study Drug|Overall Study||65
7753621|NCT01468181|19090598|P2|Received at Least 1 Dose of Study Drug|Overall Study||61
7753622|NCT01468181|19090599|P1|Received at Least 1 Dose of Study Drug|Overall Study||131
7753623|NCT01468181|19090595|P5|STARTED|Overall Study||71
7753624|NCT01468181|19090596|P4|STARTED|Overall Study||66
7753625|NCT01468181|19090597|P3|STARTED|Overall Study||65
7753626|NCT01468181|19090598|P2|STARTED|Overall Study||61
7753627|NCT01468181|19090599|P1|STARTED|Overall Study||131
7753628|NCT01468077|19090648|P2|NOT COMPLETED|Overall Study||3
7753629|NCT01468077|19090649|P1|NOT COMPLETED|Overall Study||4
7753630|NCT01468077|19090648|P2|COMPLETED|Overall Study||22
7753631|NCT01468077|19090649|P1|COMPLETED|Overall Study||18
7753632|NCT01468077|19090648|P2|STARTED|Overall Study||25
7753633|NCT01468077|19090649|P1|STARTED|Overall Study||22
7753634|NCT01468012|19090688|P3|NOT COMPLETED|Overall Study||4
7753635|NCT01468012|19090689|P2|NOT COMPLETED|Overall Study||1
7753636|NCT01468012|19090690|P1|NOT COMPLETED|Overall Study||2
7753637|NCT01468012|19090688|P3|COMPLETED|Overall Study||0
7753638|NCT01468012|19090689|P2|COMPLETED|Overall Study||9
7753639|NCT01468012|19090690|P1|COMPLETED|Overall Study||7
7753640|NCT01468012|19090688|P3|STARTED|Overall Study||4
7753641|NCT01468012|19090689|P2|STARTED|Overall Study||10
7753642|NCT01468012|19090690|P1|STARTED|Overall Study||9
7753643|NCT01467999|19090701|P1|NOT COMPLETED|Overall Study||13
7753644|NCT01467999|19090701|P1|COMPLETED|Overall Study||9
7753645|NCT01467999|19090701|P1|STARTED|Overall Study||22
7753646|NCT01467960|19090711|P6|NOT COMPLETED|Overall Study||30
7753647|NCT01467960|19090712|P5|NOT COMPLETED|Overall Study||30
7753648|NCT01467960|19090713|P4|NOT COMPLETED|Overall Study||30
7753649|NCT01467960|19090714|P3|NOT COMPLETED|Overall Study||0
7753650|NCT01467960|19090715|P2|NOT COMPLETED|Overall Study||0
7753651|NCT01467960|19090716|P1|NOT COMPLETED|Overall Study||0
7753652|NCT01467960|19090711|P6|COMPLETED|Overall Study||0
7753653|NCT01467960|19090712|P5|COMPLETED|Overall Study||0
7753654|NCT01467960|19090713|P4|COMPLETED|Overall Study||0
7753655|NCT01467960|19090714|P3|COMPLETED|Overall Study||30
7753656|NCT01467960|19090715|P2|COMPLETED|Overall Study||30
7753657|NCT01467960|19090716|P1|COMPLETED|Overall Study||30
7753658|NCT01467960|19090711|P6|STARTED|Overall Study||30
7753659|NCT01467960|19090712|P5|STARTED|Overall Study||30
7753660|NCT01467960|19090713|P4|STARTED|Overall Study||30
7753661|NCT01467960|19090714|P3|STARTED|Overall Study||30
7753662|NCT01467960|19090715|P2|STARTED|Overall Study||30
7753663|NCT01467960|19090716|P1|STARTED|Overall Study||30
7753664|NCT01467947|19090730|P1|NOT COMPLETED|Overall Study||0
7753665|NCT01467947|19090730|P1|COMPLETED|Overall Study||46
7753666|NCT01467947|19090730|P1|STARTED|Overall Study||46
7753667|NCT01467934|19090738|P3|NOT COMPLETED|Overall Study||0
7753668|NCT01467934|19090739|P2|NOT COMPLETED|Overall Study||0
7753669|NCT01467934|19090740|P1|NOT COMPLETED|Overall Study||0
7753670|NCT01467934|19090738|P3|COMPLETED|Overall Study||110
7753671|NCT01467934|19090739|P2|COMPLETED|Overall Study||212
7753672|NCT01467934|19090740|P1|COMPLETED|Overall Study||208
7753673|NCT01467934|19090738|P3|STARTED|Overall Study||110
7753674|NCT01467934|19090739|P2|STARTED|Overall Study||212
7753675|NCT01467934|19090740|P1|STARTED|Overall Study||208
7753676|NCT01467882|19090748|P1|NOT COMPLETED|Overall Study||0
7753677|NCT01467882|19090748|P1|COMPLETED|Overall Study||44
7753678|NCT01467882|19090748|P1|STARTED|Overall Study||44
7753679|NCT01467713|19090775|P4|NOT COMPLETED|Overall Study||109
7753680|NCT01467713|19090776|P3|NOT COMPLETED|Overall Study||102
7753681|NCT01467713|19090777|P2|NOT COMPLETED|Overall Study||104
7753682|NCT01467713|19090778|P1|NOT COMPLETED|Overall Study||102
7753683|NCT01467713|19090775|P4|COMPLETED|Overall Study||45
7753684|NCT01467713|19090776|P3|COMPLETED|Overall Study||58
7753685|NCT01467713|19090777|P2|COMPLETED|Overall Study||60
7753686|NCT01467713|19090778|P1|COMPLETED|Overall Study||62
7753687|NCT01467713|19090775|P4|Safety Analysis Set: Received Treatment|Overall Study||154
7753688|NCT01467713|19090776|P3|Safety Analysis Set: Received Treatment|Overall Study||159
7753689|NCT01467713|19090777|P2|Safety Analysis Set: Received Treatment|Overall Study||164
7753690|NCT01467713|19090778|P1|Safety Analysis Set: Received Treatment|Overall Study||163
7753691|NCT01467713|19090775|P4|STARTED|Overall Study||154
7753692|NCT01467713|19090776|P3|STARTED|Overall Study||160
7753693|NCT01467713|19090777|P2|STARTED|Overall Study||164
7753694|NCT01467713|19090778|P1|STARTED|Overall Study||164
7753695|NCT01467700|19090832|P4|NOT COMPLETED|Overall Study||27
7753696|NCT01467700|19090833|P3|NOT COMPLETED|Overall Study||27
7753697|NCT01467700|19090834|P2|NOT COMPLETED|Overall Study||28
7753698|NCT01467700|19090835|P1|NOT COMPLETED|Overall Study||29
7753699|NCT01467700|19090832|P4|COMPLETED|Overall Study||96
7753700|NCT01467700|19090833|P3|COMPLETED|Overall Study||97
7753701|NCT01467700|19090834|P2|COMPLETED|Overall Study||100
7753702|NCT01467700|19090835|P1|COMPLETED|Overall Study||86
7753703|NCT01467700|19090832|P4|Safety Set - Received Treatment|Overall Study||123
7753704|NCT01467700|19090833|P3|Safety Set - Received Treatment|Overall Study||124
7753705|NCT01467700|19090834|P2|Safety Set - Received Treatment|Overall Study||127
7753706|NCT01467700|19090835|P1|Safety Set - Received Treatment|Overall Study||115
7753707|NCT01467700|19090832|P4|STARTED|Overall Study||123
7753708|NCT01467700|19090833|P3|STARTED|Overall Study||124
7753709|NCT01467700|19090834|P2|STARTED|Overall Study||128
7753710|NCT01467700|19090835|P1|STARTED|Overall Study||115
7753711|NCT01467661|19090877|P1|NOT COMPLETED|Overall Study||21
7753712|NCT01467661|19090877|P1|COMPLETED|Overall Study||32
7753713|NCT01467661|19090877|P1|Started Post Marketing Trial|Overall Study||33
7753714|NCT01467661|19090877|P1|Started SPD422-309 (NCT01467661)|Overall Study||41
7753715|NCT01467661|19090877|P1|Completed SPD422-308 (NCT01214915)|Overall Study||42
7753716|NCT01467661|19090877|P1|STARTED|Overall Study||53
7753717|NCT01467583|19090897|P3|NOT COMPLETED|Overall Study||2
7753718|NCT01467583|19090898|P2|NOT COMPLETED|Overall Study||1
7753719|NCT01467583|19090899|P1|NOT COMPLETED|Overall Study||2
7753720|NCT01467583|19090897|P3|COMPLETED|Overall Study||10
7753721|NCT01467583|19090898|P2|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3
7753722|NCT01467583|19090899|P1|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14
7753723|NCT01467583|19090897|P3|STARTED|Overall Study||12
7753724|NCT01467583|19090898|P2|STARTED|Overall Study||4
7753725|NCT01467583|19090899|P1|STARTED|Overall Study||16
7753726|NCT01467570|19090912|P2|NOT COMPLETED|Overall Study||9
7753727|NCT01467570|19090913|P1|NOT COMPLETED|Overall Study||8
7753728|NCT01467570|19090912|P2|COMPLETED|Overall Study||63
7753729|NCT01467570|19090913|P1|COMPLETED|Overall Study||67
7753730|NCT01467570|19090912|P2|STARTED|Overall Study||72
7753731|NCT01467570|19090913|P1|STARTED|Overall Study||75
7753732|NCT01467557|19090939|P2|NOT COMPLETED|Overall Study||107
7753733|NCT01467557|19090940|P1|NOT COMPLETED|Overall Study||99
7753734|NCT01467557|19090939|P2|COMPLETED|Overall Study||463
7753735|NCT01467557|19090940|P1|COMPLETED|Overall Study||502
7753736|NCT01467557|19090939|P2|12 Month Survey Completed|Overall Study||463
7753737|NCT01467557|19090940|P1|12 Month Survey Completed|Overall Study||502
7753738|NCT01467557|19090939|P2|4 Month Survey Completed|Overall Study||493
7753739|NCT01467557|19090940|P1|4 Month Survey Completed|Overall Study||533
7753740|NCT01467557|19090939|P2|2 Week Survey Completed|Overall Study||522
7753741|NCT01467557|19090940|P1|2 Week Survey Completed|Overall Study||551
7753742|NCT01467557|19090939|P2|STARTED|Overall Study||570
7753743|NCT01467557|19090940|P1|STARTED|Overall Study||601
7753744|NCT01467505|19090950|P2|NOT COMPLETED|Overall Study||3
7753745|NCT01467505|19090951|P1|NOT COMPLETED|Overall Study||33
7753746|NCT01467505|19090950|P2|COMPLETED|Overall Study||7
7753747|NCT01467505|19090951|P1|COMPLETED|Overall Study||18
7753748|NCT01467505|19090950|P2|STARTED|Overall Study||10
7753749|NCT01467505|19090951|P1|STARTED|Overall Study||51
7753750|NCT01467492|19090983|P2|NOT COMPLETED|Overall Study||13
7753751|NCT01467492|19090984|P1|NOT COMPLETED|Overall Study||22
7753752|NCT01467492|19090983|P2|COMPLETED|Overall Study||25
7753753|NCT01467492|19090984|P1|COMPLETED|Overall Study||61
7753754|NCT01467492|19090983|P2|STARTED|Overall Study||38
7753755|NCT01467492|19090984|P1|STARTED|Overall Study||83
7753756|NCT01467479|19091008|P3|NOT COMPLETED|Overall Study||16
7753757|NCT01467479|19091009|P2|NOT COMPLETED|Overall Study||17
7753758|NCT01467479|19091010|P1|NOT COMPLETED|Overall Study||9
7753759|NCT01467479|19091008|P3|COMPLETED|Overall Study||45
7753760|NCT01467479|19091009|P2|COMPLETED|Overall Study||52
7753761|NCT01467479|19091010|P1|COMPLETED|Overall Study||46
7753762|NCT01467479|19091008|P3|Treated|Overall Study||59
7753763|NCT01467479|19091009|P2|Treated|Overall Study||69
7753764|NCT01467479|19091010|P1|Treated|Overall Study||54
7753765|NCT01467479|19091008|P3|STARTED|Overall Study||61
7753766|NCT01467479|19091009|P2|STARTED|Overall Study||69
7753767|NCT01467479|19091010|P1|STARTED|Overall Study||55
7753768|NCT01467466|19091041|P4|NOT COMPLETED|Overall Study||88
7753769|NCT01467466|19091042|P3|NOT COMPLETED|Overall Study||104
7753770|NCT01467466|19091043|P2|NOT COMPLETED|Overall Study||104
7753771|NCT01467466|19091044|P1|NOT COMPLETED|Overall Study||109
7753772|NCT01467466|19091041|P4|COMPLETED|Overall Study||1203
7753773|NCT01467466|19091042|P3|COMPLETED|Overall Study||1190
7753774|NCT01467466|19091043|P2|COMPLETED|Overall Study||1188
7753775|NCT01467466|19091044|P1|COMPLETED|Overall Study||1191
7753776|NCT01467466|19091041|P4|STARTED|Overall Study||1291
7753777|NCT01467466|19091042|P3|STARTED|Overall Study||1294
7753778|NCT01467466|19091043|P2|STARTED|Overall Study||1292
7753779|NCT01467466|19091044|P1|STARTED|Overall Study||1300
7753780|NCT01467427|19091056|P2|NOT COMPLETED|Overall Study||13
7753781|NCT01467427|19091057|P1|NOT COMPLETED|Overall Study||12
7753782|NCT01467427|19091056|P2|COMPLETED|Overall Study||0
7753783|NCT01467427|19091057|P1|COMPLETED|Overall Study||0
7753784|NCT01467427|19091056|P2|Completed Main Phase|Overall Study||13
7753785|NCT01467427|19091057|P1|Completed Main Phase|Overall Study||11
7753786|NCT01467427|19091056|P2|STARTED|Overall Study||13
7753787|NCT01467427|19091057|P1|STARTED|Overall Study||12
7753788|NCT01467271|19091075|P1|NOT COMPLETED|Overall Study||202
7753789|NCT01467271|19091075|P1|COMPLETED|Overall Study||338
7753790|NCT01467271|19091075|P1|STARTED|Overall Study||540
7753791|NCT01467076|19091082|P3|NOT COMPLETED|Overall Study||0
7753792|NCT01467076|19091083|P2|NOT COMPLETED|Overall Study||0
7753793|NCT01467076|19091084|P1|NOT COMPLETED|Overall Study||1
7753794|NCT01467076|19091082|P3|COMPLETED|Overall Study||2
7753795|NCT01467076|19091083|P2|COMPLETED|Overall Study||2
7753796|NCT01467076|19091084|P1|COMPLETED|Overall Study||2
7753797|NCT01467076|19091082|P3|STARTED|Overall Study||2
7753798|NCT01467076|19091083|P2|STARTED|Overall Study||2
7753799|NCT01467076|19091084|P1|STARTED|Overall Study||3
7753800|NCT01467037|19091121|P1|NOT COMPLETED|Overall Study||0
7753801|NCT01467037|19091121|P1|COMPLETED|Overall Study||374
7753802|NCT01467037|19091121|P1|STARTED|Overall Study||374
7753803|NCT01466985|19091131|P3|NOT COMPLETED|Overall Study||0
7753804|NCT01466985|19091132|P2|NOT COMPLETED|Overall Study||0
7753805|NCT01466985|19091133|P1|NOT COMPLETED|Overall Study||0
7753806|NCT01466985|19091131|P3|COMPLETED|Overall Study||6
7753807|NCT01466985|19091132|P2|COMPLETED|Overall Study||6
7753808|NCT01466985|19091133|P1|COMPLETED|Overall Study||6
7753809|NCT01466985|19091131|P3|STARTED|Overall Study||6
7753810|NCT01466985|19091132|P2|STARTED|Overall Study||6
7753811|NCT01466985|19091133|P1|STARTED|Overall Study||6
7753812|NCT01466972|19091150|P1|NOT COMPLETED|Overall Study||0
7753813|NCT01466972|19091150|P1|COMPLETED|Overall Study||30
7753814|NCT01466972|19091150|P1|STARTED|Overall Study||30
7753815|NCT01466881|19091156|P1|NOT COMPLETED|Overall Study||40
7753816|NCT01466881|19091156|P1|COMPLETED|Overall Study||2
7753817|NCT01466881|19091156|P1|Eligible and Treated|Overall Study||37
7753818|NCT01466881|19091156|P1|STARTED|Overall Study||42
7753819|NCT01466790|19091173|P8|NOT COMPLETED|Overall Study||1
7753820|NCT01466790|19091174|P7|NOT COMPLETED|Overall Study||1
7753821|NCT01466790|19091175|P6|NOT COMPLETED|Overall Study||0
7753822|NCT01466790|19091176|P5|NOT COMPLETED|Overall Study||3
7753823|NCT01466790|19091177|P4|NOT COMPLETED|Overall Study||0
7753824|NCT01466790|19091178|P3|NOT COMPLETED|Overall Study||0
7753825|NCT01466790|19091179|P2|NOT COMPLETED|Overall Study||1
7753826|NCT01466790|19091180|P1|NOT COMPLETED|Overall Study||4
7753827|NCT01466790|19091173|P8|COMPLETED|Overall Study||13
7753828|NCT01466790|19091174|P7|COMPLETED|Overall Study||26
7753829|NCT01466790|19091175|P6|COMPLETED|Overall Study||16
7753830|NCT01466790|19091176|P5|COMPLETED|Overall Study||27
7753831|NCT01466790|19091177|P4|COMPLETED|Overall Study||14
7753832|NCT01466790|19091178|P3|COMPLETED|Overall Study||27
7753833|NCT01466790|19091179|P2|COMPLETED|Overall Study||14
7753834|NCT01466790|19091180|P1|COMPLETED|Overall Study||20
7753835|NCT01466790|19091173|P8|STARTED|Overall Study||14
7753836|NCT01466790|19091174|P7|STARTED|Overall Study||27
7753837|NCT01466790|19091175|P6|STARTED|Overall Study||16
7753838|NCT01466790|19091176|P5|STARTED|Overall Study||30
7753839|NCT01466790|19091177|P4|STARTED|Overall Study||14
7753840|NCT01466790|19091178|P3|STARTED|Overall Study||27
7753841|NCT01466790|19091179|P2|STARTED|Overall Study||15
7753842|NCT01466790|19091180|P1|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24
7753843|NCT01466764|19091244|P2|NOT COMPLETED|Overall Study||0
7753844|NCT01466764|19091245|P1|NOT COMPLETED|Overall Study||0
7753845|NCT01466764|19091244|P2|COMPLETED|Overall Study||5
7753846|NCT01466764|19091245|P1|COMPLETED|Overall Study||5
7753847|NCT01466764|19091244|P2|STARTED|Overall Study||5
7753848|NCT01466764|19091245|P1|STARTED|Overall Study||5
7753849|NCT01466751|19091265|P2|NOT COMPLETED|Overall Study||0
7753850|NCT01466751|19091266|P1|NOT COMPLETED|Overall Study||1
7753851|NCT01466751|19091265|P2|COMPLETED|Overall Study||14
7753852|NCT01466751|19091266|P1|COMPLETED|Overall Study||13
7753853|NCT01466751|19091265|P2|STARTED|Overall Study||14
7753854|NCT01466751|19091266|P1|STARTED|Overall Study||14
7753855|NCT01466673|19091276|P2|NOT COMPLETED|Overall Study||6
7753856|NCT01466673|19091277|P1|NOT COMPLETED|Overall Study||7
7753857|NCT01466673|19091276|P2|COMPLETED|Overall Study||95
7753858|NCT01466673|19091277|P1|COMPLETED|Overall Study||93
7753859|NCT01466673|19091276|P2|STARTED|Overall Study||101
7753860|NCT01466673|19091277|P1|STARTED|Overall Study||100
7753861|NCT01466660|19091303|P2|NOT COMPLETED|Overall Study||159
7753862|NCT01466660|19091304|P1|NOT COMPLETED|Overall Study||160
7753863|NCT01466660|19091303|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
7753864|NCT01466660|19091304|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
7753865|NCT01466660|19091303|P2|STARTED|Overall Study||159
7753866|NCT01466660|19091304|P1|STARTED|Overall Study||160
7753867|NCT01466595|19091330|P2|NOT COMPLETED|Overall Study||1
7753868|NCT01466595|19091331|P1|NOT COMPLETED|Overall Study||0
7753869|NCT01466595|19091330|P2|COMPLETED|Overall Study||23
7753870|NCT01466595|19091331|P1|COMPLETED|Overall Study||49
7753871|NCT01466595|19091330|P2|STARTED|Overall Study||24
7753872|NCT01466595|19091331|P1|STARTED|Overall Study||49
7753873|NCT01466491|19091425|P4|NOT COMPLETED|Overall Study||0
7753874|NCT01466491|19091426|P3|NOT COMPLETED|Overall Study||3
7753875|NCT01466491|19091427|P2|NOT COMPLETED|Overall Study||3
7753876|NCT01466491|19091428|P1|NOT COMPLETED|Overall Study||0
7753877|NCT01466491|19091425|P4|COMPLETED|Overall Study||83
7753878|NCT01466491|19091426|P3|COMPLETED|Overall Study||80
7753879|NCT01466491|19091427|P2|COMPLETED|Overall Study||80
7753880|NCT01466491|19091428|P1|COMPLETED|Overall Study||83
7753881|NCT01466491|19091425|P4|STARTED|Overall Study||83
7753882|NCT01466491|19091426|P3|STARTED|Overall Study||83
7753883|NCT01466491|19091427|P2|STARTED|Overall Study||83
7753884|NCT01466491|19091428|P1|STARTED|Overall Study||83
7753885|NCT01466387|19091448|P6|NOT COMPLETED|Overall Study||1
7753886|NCT01466387|19091449|P5|NOT COMPLETED|Overall Study||0
7753887|NCT01466387|19091450|P4|NOT COMPLETED|Overall Study||2
7753888|NCT01466387|19091451|P3|NOT COMPLETED|Overall Study||1
7753889|NCT01466387|19091452|P2|NOT COMPLETED|Overall Study||0
7753890|NCT01466387|19091453|P1|NOT COMPLETED|Overall Study||1
7753891|NCT01466387|19091448|P6|COMPLETED|Overall Study||99
7753892|NCT01466387|19091449|P5|COMPLETED|Overall Study||51
7753893|NCT01466387|19091450|P4|COMPLETED|Overall Study||99
7753894|NCT01466387|19091451|P3|COMPLETED|Overall Study||98
7753895|NCT01466387|19091452|P2|COMPLETED|Overall Study||100
7753896|NCT01466387|19091453|P1|COMPLETED|Overall Study||100
7753897|NCT01466387|19091448|P6|STARTED|Overall Study||100
7753898|NCT01466387|19091449|P5|STARTED|Overall Study||51
7753899|NCT01466387|19091450|P4|STARTED|Overall Study||101
7753900|NCT01466387|19091451|P3|STARTED|Overall Study||99
7753901|NCT01466387|19091452|P2|STARTED|Overall Study||100
7753902|NCT01466387|19091453|P1|STARTED|Overall Study||101
7753903|NCT01466361|19091495|P4|NOT COMPLETED|Overall Study||0
7753904|NCT01466361|19091496|P3|NOT COMPLETED|Overall Study||0
7753905|NCT01466361|19091497|P2|NOT COMPLETED|Overall Study||0
7753906|NCT01466361|19091498|P1|NOT COMPLETED|Overall Study||0
7753907|NCT01466361|19091495|P4|COMPLETED|Overall Study||41
7753908|NCT01466361|19091496|P3|COMPLETED|Overall Study||60
7753909|NCT01466361|19091497|P2|COMPLETED|Overall Study||34
7753910|NCT01466361|19091498|P1|COMPLETED|Overall Study||52
7753911|NCT01466361|19091495|P4|STARTED|Overall Study||41
7753912|NCT01466361|19091496|P3|STARTED|Overall Study||60
7753913|NCT01466361|19091497|P2|STARTED|Overall Study||34
7753914|NCT01466361|19091498|P1|STARTED|Overall Study||52
7753915|NCT01466348|19091514|P2|NOT COMPLETED|Period II - Second Intervention||0
7753916|NCT01466348|19091515|P1|NOT COMPLETED|Period II - Second Intervention||0
7753917|NCT01466348|19091514|P2|COMPLETED|Period II - Second Intervention||36
7753918|NCT01466348|19091515|P1|COMPLETED|Period II - Second Intervention||35
7753919|NCT01466348|19091514|P2|STARTED|Period II - Second Intervention||36
7753920|NCT01466348|19091515|P1|STARTED|Period II - Second Intervention||35
7753921|NCT01466348|19091514|P2|NOT COMPLETED|Period I - First Intervention||1
7753922|NCT01466348|19091515|P1|NOT COMPLETED|Period I - First Intervention||0
7753923|NCT01466348|19091514|P2|COMPLETED|Period I - First Intervention||35
7753924|NCT01466348|19091515|P1|COMPLETED|Period I - First Intervention||36
7753925|NCT01466348|19091514|P2|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35
7753926|NCT01466348|19091515|P1|Intent To Treat (ITT) Population|Period I - First Intervention||36
7753927|NCT01466348|19091514|P2|STARTED|Period I - First Intervention||36
7753928|NCT01466348|19091515|P1|STARTED|Period I - First Intervention||36
7753929|NCT01466270|19091543|P2|NOT COMPLETED|Overall Study||6
7753930|NCT01466270|19091544|P1|NOT COMPLETED|Overall Study||12
7753931|NCT01466270|19091543|P2|COMPLETED|Overall Study||25
7753932|NCT01466270|19091544|P1|COMPLETED|Overall Study||19
7753933|NCT01466270|19091543|P2|STARTED|Overall Study||31
7753934|NCT01466270|19091544|P1|STARTED|Overall Study||31
7753935|NCT01466192|19091556|P1|NOT COMPLETED|Overall Study||4
7753936|NCT01466192|19091556|P1|COMPLETED|Overall Study||104
7753937|NCT01466192|19091556|P1|STARTED|Overall Study||108
7753938|NCT01466179|19091560|P1|NOT COMPLETED|Overall Study||179
7753939|NCT01466179|19091560|P1|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10
7753940|NCT01466179|19091560|P1|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189
7753941|NCT01466166|19091580|P1|NOT COMPLETED|Overall Study||163
7753942|NCT01466166|19091580|P1|COMPLETED|Overall Study||25
7753943|NCT01466166|19091580|P1|Completed 24 Weeks of Treatment|Overall Study||55
7753944|NCT01466166|19091580|P1|Received Treatment|Overall Study||188
7753945|NCT01466166|19091580|P1|STARTED|Overall Study||188
7753946|NCT01466153|19091594|P3|NOT COMPLETED|Overall Study||25
7753947|NCT01466153|19091595|P2|NOT COMPLETED|Overall Study||24
7753948|NCT01466153|19091596|P1|NOT COMPLETED|Overall Study||29
7753949|NCT01466153|19091594|P3|COMPLETED|Overall Study||36
7753950|NCT01466153|19091595|P2|COMPLETED|Overall Study||12
7753951|NCT01466153|19091596|P1|COMPLETED|Overall Study||33
7753952|NCT01466153|19091594|P3|STARTED|Overall Study||61
7753953|NCT01466153|19091595|P2|STARTED|Overall Study||36
7753954|NCT01466153|19091596|P1|STARTED|Overall Study||62
7753955|NCT01466127|19091637|P2|NOT COMPLETED|Overall Study||16
7753956|NCT01466127|19091638|P1|NOT COMPLETED|Overall Study||14
7753957|NCT01466127|19091637|P2|COMPLETED|Overall Study||14
7753958|NCT01466127|19091638|P1|COMPLETED|Overall Study||16
7753959|NCT01466127|19091637|P2|STARTED|Overall Study||30
7753960|NCT01466127|19091638|P1|STARTED|Overall Study||30
7753961|NCT01466075|19091644|P1|NOT COMPLETED|Overall Study||0
7753962|NCT01466075|19091644|P1|COMPLETED|Overall Study||207
7753963|NCT01466075|19091644|P1|STARTED|Overall Study||207
7753964|NCT01466062|19091651|P1|NOT COMPLETED|Overall Study||2
7753965|NCT01466062|19091651|P1|COMPLETED|Overall Study||26
7753966|NCT01466062|19091651|P1|STARTED|Overall Study||28
7753967|NCT01465997|19091674|P2|NOT COMPLETED|Overall Study||89
7753968|NCT01465997|19091675|P1|NOT COMPLETED|Overall Study||68
7753969|NCT01465997|19091674|P2|COMPLETED|Overall Study||180
7753970|NCT01465997|19091675|P1|COMPLETED|Overall Study||211
7753971|NCT01465997|19091674|P2|STARTED|Overall Study||269
7753972|NCT01465997|19091675|P1|STARTED|Overall Study||279
7753973|NCT01465958|19091685|P2|NOT COMPLETED|Subcutaneous (SC) Phase||1
7753974|NCT01465958|19091686|P1|NOT COMPLETED|Subcutaneous (SC) Phase||0
7753975|NCT01465958|19091685|P2|COMPLETED|Subcutaneous (SC) Phase||10
7753976|NCT01465958|19091686|P1|COMPLETED|Subcutaneous (SC) Phase||0
7753977|NCT01465958|19091685|P2|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11
7753978|NCT01465958|19091686|P1|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0
7753979|NCT01465958|19091685|P2|NOT COMPLETED|Intravenous (IV) Phase||0
7753980|NCT01465958|19091686|P1|NOT COMPLETED|Intravenous (IV) Phase||0
7753981|NCT01465958|19091685|P2|COMPLETED|Intravenous (IV) Phase||0
7753982|NCT01465958|19091686|P1|COMPLETED|Intravenous (IV) Phase||11
7753983|NCT01465958|19091685|P2|STARTED|Intravenous (IV) Phase||0
7753984|NCT01465958|19091686|P1|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11
7753985|NCT01465958|19091685|P2|NOT COMPLETED|Run-in Phase||0
7753986|NCT01465958|19091686|P1|NOT COMPLETED|Run-in Phase||1
7753987|NCT01465958|19091685|P2|COMPLETED|Run-in Phase||0
7753988|NCT01465958|19091686|P1|COMPLETED|Run-in Phase||10
7753989|NCT01465958|19091685|P2|STARTED|Run-in Phase||0
7753990|NCT01465958|19091686|P1|STARTED|Run-in Phase||11
7753991|NCT01465841|19091694|P1|NOT COMPLETED|Overall Study||68
7753992|NCT01465841|19091694|P1|COMPLETED|Overall Study||449
7753993|NCT01465841|19091694|P1|STARTED|Overall Study||517
7753994|NCT01465802|19091707|P5|NOT COMPLETED|Overall Study||12
7753995|NCT01465802|19091708|P4|NOT COMPLETED|Overall Study||29
7753996|NCT01465802|19091709|P3|NOT COMPLETED|Overall Study||0
7753997|NCT01465802|19091710|P2|NOT COMPLETED|Overall Study||24
7753998|NCT01465802|19091711|P1|NOT COMPLETED|Overall Study||33
7753999|NCT01465802|19091707|P5|COMPLETED|Overall Study||13
7754000|NCT01465802|19091708|P4|COMPLETED|Overall Study||38
7754001|NCT01465802|19091709|P3|COMPLETED|Overall Study||7
7754002|NCT01465802|19091710|P2|COMPLETED|Overall Study||42
7754003|NCT01465802|19091711|P1|COMPLETED|Overall Study||33
7754004|NCT01465802|19091707|P5|STARTED|Overall Study||25
7754005|NCT01465802|19091708|P4|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67
7754006|NCT01465802|19091709|P3|STARTED|Overall Study||7
7754007|NCT01465802|19091710|P2|STARTED|Overall Study||66
7754008|NCT01465802|19091711|P1|STARTED|Overall Study||66
7754009|NCT01465763|19091763|P3|NOT COMPLETED|Overall Study||4
7754010|NCT01465763|19091764|P2|NOT COMPLETED|Overall Study||1
7754011|NCT01465763|19091765|P1|NOT COMPLETED|Overall Study||31
7754012|NCT01465763|19091763|P3|COMPLETED|Overall Study||118
7754013|NCT01465763|19091764|P2|COMPLETED|Overall Study||15
7754014|NCT01465763|19091765|P1|COMPLETED|Overall Study||445
7754015|NCT01465763|19091763|P3|STARTED|Overall Study||122
7754016|NCT01465763|19091764|P2|STARTED|Overall Study||16
7754017|NCT01465763|19091765|P1|STARTED|Overall Study||476
7754018|NCT01465659|19091794|P4|NOT COMPLETED|Completed Follow for 1 Year||6
7754019|NCT01465659|19091795|P3|NOT COMPLETED|Completed Follow for 1 Year||2
7754020|NCT01465659|19091796|P2|NOT COMPLETED|Completed Follow for 1 Year||3
7754021|NCT01465659|19091797|P1|NOT COMPLETED|Completed Follow for 1 Year||6
7754022|NCT01465659|19091794|P4|COMPLETED|Completed Follow for 1 Year||5
7754023|NCT01465659|19091795|P3|COMPLETED|Completed Follow for 1 Year||4
7754024|NCT01465659|19091796|P2|COMPLETED|Completed Follow for 1 Year||1
7754025|NCT01465659|19091797|P1|COMPLETED|Completed Follow for 1 Year||1
7754026|NCT01465659|19091794|P4|STARTED|Completed Follow for 1 Year||11
7754027|NCT01465659|19091795|P3|STARTED|Completed Follow for 1 Year||6
7754028|NCT01465659|19091796|P2|STARTED|Completed Follow for 1 Year||4
7754029|NCT01465659|19091797|P1|STARTED|Completed Follow for 1 Year||7
7754030|NCT01465659|19091794|P4|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
7754031|NCT01465659|19091795|P3|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
7754032|NCT01465659|19091796|P2|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
7754033|NCT01465659|19091797|P1|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
7754034|NCT01465659|19091794|P4|COMPLETED|Went on to Cycle 3 and Beyond||9
7754035|NCT01465659|19091795|P3|COMPLETED|Went on to Cycle 3 and Beyond||4
7754036|NCT01465659|19091796|P2|COMPLETED|Went on to Cycle 3 and Beyond||4
7754037|NCT01465659|19091797|P1|COMPLETED|Went on to Cycle 3 and Beyond||5
7754038|NCT01465659|19091794|P4|STARTED|Went on to Cycle 3 and Beyond||9
7754039|NCT01465659|19091795|P3|STARTED|Went on to Cycle 3 and Beyond||4
7754040|NCT01465659|19091796|P2|STARTED|Went on to Cycle 3 and Beyond||4
7754041|NCT01465659|19091797|P1|STARTED|Went on to Cycle 3 and Beyond||5
7754042|NCT01465659|19091794|P4|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
7754043|NCT01465659|19091795|P3|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
7754044|NCT01465659|19091796|P2|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
7754045|NCT01465659|19091797|P1|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
7754046|NCT01465659|19091794|P4|COMPLETED|Completed 2 Cycles/Reached 1st Response||9
7754047|NCT01465659|19091795|P3|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
7754048|NCT01465659|19091796|P2|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
7754049|NCT01465659|19091797|P1|COMPLETED|Completed 2 Cycles/Reached 1st Response||5
7754050|NCT01465659|19091794|P4|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||10
7754051|NCT01465659|19091795|P3|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
7754052|NCT01465659|19091796|P2|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
7754053|NCT01465659|19091797|P1|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||7
7754054|NCT01465659|19091794|P4|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||10
7754055|NCT01465659|19091795|P3|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||6
7754056|NCT01465659|19091796|P2|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||4
7754057|NCT01465659|19091797|P1|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||7
7754058|NCT01465659|19091794|P4|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||10
7754059|NCT01465659|19091795|P3|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||6
7754060|NCT01465659|19091796|P2|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||4
7754061|NCT01465659|19091797|P1|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||7
7754062|NCT01465659|19091794|P4|STARTED|Completed 2 Cycles/Reached 1st Response||10
7754063|NCT01465659|19091795|P3|STARTED|Completed 2 Cycles/Reached 1st Response||6
7754064|NCT01465659|19091796|P2|STARTED|Completed 2 Cycles/Reached 1st Response||4
7754065|NCT01465659|19091797|P1|STARTED|Completed 2 Cycles/Reached 1st Response||7
7754066|NCT01465659|19091794|P4|NOT COMPLETED|Completed 1 Cycle of Treatment||1
7754067|NCT01465659|19091795|P3|NOT COMPLETED|Completed 1 Cycle of Treatment||0
7754068|NCT01465659|19091796|P2|NOT COMPLETED|Completed 1 Cycle of Treatment||1
7754069|NCT01465659|19091797|P1|NOT COMPLETED|Completed 1 Cycle of Treatment||0
7754070|NCT01465659|19091794|P4|COMPLETED|Completed 1 Cycle of Treatment||10
7754071|NCT01465659|19091795|P3|COMPLETED|Completed 1 Cycle of Treatment||6
7754072|NCT01465659|19091796|P2|COMPLETED|Completed 1 Cycle of Treatment||4
7754073|NCT01465659|19091797|P1|COMPLETED|Completed 1 Cycle of Treatment||7
7754074|NCT01465659|19091794|P4|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||11
7754075|NCT01465659|19091795|P3|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||6
7754076|NCT01465659|19091796|P2|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||4
7754077|NCT01465659|19091797|P1|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||7
7754078|NCT01465659|19091794|P4|STARTED|Completed 1 Cycle of Treatment||11
7754079|NCT01465659|19091795|P3|STARTED|Completed 1 Cycle of Treatment||6
7754080|NCT01465659|19091796|P2|STARTED|Completed 1 Cycle of Treatment||5
7754081|NCT01465659|19091797|P1|STARTED|Completed 1 Cycle of Treatment||7
7754082|NCT01465464|19091807|P2|NOT COMPLETED|Overall Study||444
7754083|NCT01465464|19091808|P1|NOT COMPLETED|Overall Study||444
7754084|NCT01465464|19091807|P2|COMPLETED|Overall Study||0
7754085|NCT01465464|19091808|P1|COMPLETED|Overall Study||0
7754086|NCT01465464|19091807|P2|STARTED|Overall Study||444
7754087|NCT01465464|19091808|P1|STARTED|Overall Study||444
7754088|NCT01465412|19091820|P4|NOT COMPLETED|Overall Study||0
7754089|NCT01465412|19091821|P3|NOT COMPLETED|Overall Study||0
7754090|NCT01465412|19091822|P2|NOT COMPLETED|Overall Study||0
7754091|NCT01465412|19091823|P1|NOT COMPLETED|Overall Study||0
7754092|NCT01465412|19091820|P4|COMPLETED|Overall Study||9
7754093|NCT01465412|19091821|P3|COMPLETED|Overall Study||9
7754094|NCT01465412|19091822|P2|COMPLETED|Overall Study||12
7754095|NCT01465412|19091823|P1|COMPLETED|Overall Study||12
7754096|NCT01465412|19091820|P4|STARTED|Overall Study||9
7754097|NCT01465412|19091821|P3|STARTED|Overall Study||9
7754098|NCT01465412|19091822|P2|STARTED|Overall Study||12
7754099|NCT01465412|19091823|P1|STARTED|Overall Study||12
7754100|NCT01465386|19091861|P1|NOT COMPLETED|Overall Study||4
7754101|NCT01465386|19091861|P1|COMPLETED|Overall Study||2
7754102|NCT01465386|19091861|P1|STARTED|Overall Study||6
7754103|NCT01465347|19091865|P2|NOT COMPLETED|Overall Study||3
7754104|NCT01465347|19091866|P1|NOT COMPLETED|Overall Study||1
7754105|NCT01465347|19091865|P2|COMPLETED|Overall Study||53
7754106|NCT01465347|19091866|P1|COMPLETED|Overall Study||2
7754107|NCT01465347|19091865|P2|STARTED|Overall Study||56
7754108|NCT01465347|19091866|P1|STARTED|Overall Study||3
7754109|NCT01465334|19091878|P2|NOT COMPLETED|Overall Study||6
7754110|NCT01465334|19091879|P1|NOT COMPLETED|Overall Study||2
7754111|NCT01465334|19091878|P2|COMPLETED|Overall Study||9
7754112|NCT01465334|19091879|P1|COMPLETED|Overall Study||13
7754113|NCT01465334|19091878|P2|Eligible for Allogeneic Transplant|Overall Study||9
7754114|NCT01465334|19091879|P1|Eligible for Allogeneic Transplant|Overall Study||9
7754115|NCT01465334|19091878|P2|Complete Part B Induction|Overall Study||15
7754116|NCT01465334|19091879|P1|Complete Part B Induction|Overall Study||7
7754117|NCT01465334|19091878|P2|Complete Part A Induction|Overall Study||15
7754118|NCT01465334|19091879|P1|Complete Part A Induction|Overall Study||12
7754119|NCT01465334|19091878|P2|STARTED|Overall Study||15
7754120|NCT01465334|19091879|P1|STARTED|Overall Study||15
7754121|NCT01465230|19091905|P1|NOT COMPLETED|Overall Study||2
7754122|NCT01465230|19091905|P1|COMPLETED|Overall Study||0
7754123|NCT01465230|19091905|P1|STARTED|Overall Study||2
7754124|NCT01465191|19091912|P3|NOT COMPLETED|Overall Study||7
7754125|NCT01465191|19091913|P2|NOT COMPLETED|Overall Study||9
7754126|NCT01465191|19091914|P1|NOT COMPLETED|Overall Study||9
7754127|NCT01465191|19091912|P3|COMPLETED|Overall Study||43
7754128|NCT01465191|19091913|P2|COMPLETED|Overall Study||54
7754129|NCT01465191|19091914|P1|COMPLETED|Overall Study||47
7754130|NCT01465191|19091912|P3|STARTED|Overall Study||50
7754131|NCT01465191|19091913|P2|STARTED|Overall Study||63
7754132|NCT01465191|19091914|P1|STARTED|Overall Study||56
7754133|NCT01465178|19091963|P2|NOT COMPLETED|Overall Study||0
7754134|NCT01465178|19091964|P1|NOT COMPLETED|Overall Study||1
7754135|NCT01465178|19091963|P2|COMPLETED|Overall Study||31
7754136|NCT01465178|19091964|P1|COMPLETED|Overall Study||30
7754137|NCT01465178|19091963|P2|STARTED|Overall Study||31
7754138|NCT01465178|19091964|P1|STARTED|Overall Study||31
7754139|NCT01465048|19091975|P3|NOT COMPLETED|Overall Study||0
7754140|NCT01465048|19091976|P2|NOT COMPLETED|Overall Study||0
7754141|NCT01465048|19091977|P1|NOT COMPLETED|Overall Study||0
7754142|NCT01465048|19091975|P3|COMPLETED|Overall Study||6
7754143|NCT01465048|19091976|P2|COMPLETED|Overall Study||6
7754144|NCT01465048|19091977|P1|COMPLETED|Overall Study||6
7754145|NCT01465048|19091975|P3|STARTED|Overall Study||6
7754146|NCT01465048|19091976|P2|STARTED|Overall Study||6
7754147|NCT01465048|19091977|P1|STARTED|Overall Study||6
7754148|NCT01465022|19091988|P3|NOT COMPLETED|Overall Study||70
7754149|NCT01465022|19091989|P2|NOT COMPLETED|Overall Study||23
7754150|NCT01465022|19091990|P1|NOT COMPLETED|Overall Study||23
7754151|NCT01465022|19091988|P3|COMPLETED|Overall Study||0
7754152|NCT01465022|19091989|P2|COMPLETED|Overall Study||40
7754153|NCT01465022|19091990|P1|COMPLETED|Overall Study||41
7754154|NCT01465022|19091988|P3|STARTED|Overall Study||70
7754155|NCT01465022|19091989|P2|STARTED|Overall Study||63
7754156|NCT01465022|19091990|P1|STARTED|Overall Study||64
7754157|NCT01464996|19092004|P1|NOT COMPLETED|Overall Study||0
7754158|NCT01464996|19092004|P1|COMPLETED|Overall Study||24
7754159|NCT01464996|19092004|P1|OptiBond FL|Overall Study||24
7754160|NCT01464996|19092004|P1|OptiBond XTR|Overall Study||23
7754161|NCT01464996|19092004|P1|STARTED|Overall Study||24
7754162|NCT01464931|19092024|P2|NOT COMPLETED|Overall Study||0
7754163|NCT01464931|19092025|P1|NOT COMPLETED|Overall Study||1
7754164|NCT01464931|19092024|P2|COMPLETED|Overall Study||16
7754165|NCT01464931|19092025|P1|COMPLETED|Overall Study||15
7754166|NCT01464931|19092024|P2|STARTED|Overall Study||16
7754167|NCT01464931|19092025|P1|STARTED|Overall Study||16
7754168|NCT01464879|19092062|P1|NOT COMPLETED|Overall Study||2
7754169|NCT01464879|19092062|P1|COMPLETED|Overall Study||18
7754170|NCT01464879|19092062|P1|Applicator Application (3.75 mL)|Overall Study||18
7754171|NCT01464879|19092062|P1|Applicator Application (2.50 mL)|Overall Study|One subject discontinued due to physician's decision.|18
7754172|NCT01464879|19092062|P1|Applicator Application (1.25 mL)|Overall Study|One subject discontinued due to non-compliance.|19
7754173|NCT01464879|19092062|P1|Washout Period|Overall Study||20
7754174|NCT01464879|19092062|P1|Hand Application (2.50 mL)|Overall Study||20
7754175|NCT01464879|19092062|P1|STARTED|Overall Study||20
7754176|NCT01464840|19092099|P3|NOT COMPLETED|Overall Study||0
7754177|NCT01464840|19092100|P2|NOT COMPLETED|Overall Study||0
7754178|NCT01464840|19092101|P1|NOT COMPLETED|Overall Study||0
7754179|NCT01464840|19092099|P3|COMPLETED|Overall Study||10
7754180|NCT01464840|19092100|P2|COMPLETED|Overall Study||10
7754181|NCT01464840|19092101|P1|COMPLETED|Overall Study||10
7754182|NCT01464840|19092099|P3|STARTED|Overall Study||10
7754183|NCT01464840|19092100|P2|STARTED|Overall Study||10
7754184|NCT01464840|19092101|P1|STARTED|Overall Study||10
7754185|NCT01464827|19092123|P14|NOT COMPLETED|Overall Study||3
7754186|NCT01464827|19092124|P13|NOT COMPLETED|Overall Study||2
7754187|NCT01464827|19092125|P12|NOT COMPLETED|Overall Study||2
7754188|NCT01464827|19092126|P11|NOT COMPLETED|Overall Study||2
7754189|NCT01464827|19092127|P10|NOT COMPLETED|Overall Study||3
7754190|NCT01464827|19092128|P9|NOT COMPLETED|Overall Study||3
7754191|NCT01464827|19092129|P8|NOT COMPLETED|Overall Study||3
7754192|NCT01464827|19092130|P7|NOT COMPLETED|Overall Study||4
7754193|NCT01464827|19092131|P6|NOT COMPLETED|Overall Study||1
7754194|NCT01464827|19092132|P5|NOT COMPLETED|Overall Study||8
7754195|NCT01464827|19092133|P4|NOT COMPLETED|Overall Study||4
7754196|NCT01464827|19092134|P3|NOT COMPLETED|Overall Study||0
7754197|NCT01464827|19092135|P2|NOT COMPLETED|Overall Study||7
7754198|NCT01464827|19092136|P1|NOT COMPLETED|Overall Study||3
7754199|NCT01464827|19092123|P14|COMPLETED|Overall Study||19
7754200|NCT01464827|19092124|P13|COMPLETED|Overall Study||21
7754201|NCT01464827|19092125|P12|COMPLETED|Overall Study||21
7754202|NCT01464827|19092126|P11|COMPLETED|Overall Study||21
7754203|NCT01464827|19092127|P10|COMPLETED|Overall Study||44
7754204|NCT01464827|19092128|P9|COMPLETED|Overall Study||37
7754205|NCT01464827|19092129|P8|COMPLETED|Overall Study||37
7754206|NCT01464827|19092130|P7|COMPLETED|Overall Study||37
7754207|NCT01464827|19092131|P6|COMPLETED|Overall Study||38
7754208|NCT01464827|19092132|P5|COMPLETED|Overall Study||72
7754209|NCT01464827|19092133|P4|COMPLETED|Overall Study||36
7754210|NCT01464827|19092134|P3|COMPLETED|Overall Study||39
7754211|NCT01464827|19092135|P2|COMPLETED|Overall Study||36
7754212|NCT01464827|19092136|P1|COMPLETED|Overall Study||77
7754213|NCT01464827|19092123|P14|Treated|Overall Study||20
7754214|NCT01464827|19092124|P13|Treated|Overall Study||23
7754215|NCT01464827|19092125|P12|Treated|Overall Study||22
7754216|NCT01464827|19092126|P11|Treated|Overall Study||23
7754217|NCT01464827|19092127|P10|Treated|Overall Study||45
7754218|NCT01464827|19092128|P9|Treated|Overall Study||40
7754219|NCT01464827|19092129|P8|Treated|Overall Study||40
7754220|NCT01464827|19092130|P7|Treated|Overall Study||40
7754221|NCT01464827|19092131|P6|Treated|Overall Study||39
7754222|NCT01464827|19092132|P5|Treated|Overall Study||79
7754223|NCT01464827|19092133|P4|Treated|Overall Study||40
7754224|NCT01464827|19092134|P3|Treated|Overall Study||39
7754225|NCT01464827|19092135|P2|Treated|Overall Study||41
7754226|NCT01464827|19092136|P1|Treated|Overall Study||80
7754227|NCT01464827|19092123|P14|STARTED|Overall Study||22
7754228|NCT01464827|19092124|P13|STARTED|Overall Study||23
7754229|NCT01464827|19092125|P12|STARTED|Overall Study||23
7754230|NCT01464827|19092126|P11|STARTED|Overall Study||23
7754231|NCT01464827|19092127|P10|STARTED|Overall Study||47
7754232|NCT01464827|19092128|P9|STARTED|Overall Study||40
7754233|NCT01464827|19092129|P8|STARTED|Overall Study||40
7754234|NCT01464827|19092130|P7|STARTED|Overall Study||41
7754235|NCT01464827|19092131|P6|STARTED|Overall Study||39
7754236|NCT01464827|19092132|P5|STARTED|Overall Study||80
7754237|NCT01464827|19092133|P4|STARTED|Overall Study||40
7754238|NCT01464827|19092134|P3|STARTED|Overall Study||39
7754239|NCT01464827|19092135|P2|STARTED|Overall Study||43
7754240|NCT01464827|19092136|P1|STARTED|Overall Study||80
7754241|NCT01464788|19092183|P3|NOT COMPLETED|Overall Study||0
7754242|NCT01464788|19092184|P2|NOT COMPLETED|Overall Study||2
7754243|NCT01464788|19092185|P1|NOT COMPLETED|Overall Study||0
7754244|NCT01464788|19092183|P3|COMPLETED|Overall Study||29
7754245|NCT01464788|19092184|P2|COMPLETED|Overall Study||29
7754246|NCT01464788|19092185|P1|COMPLETED|Overall Study||30
7754247|NCT01464788|19092183|P3|STARTED|Overall Study||29
7754248|NCT01464788|19092184|P2|STARTED|Overall Study||31
7754249|NCT01464788|19092185|P1|STARTED|Overall Study||30
7754250|NCT01464775|19092198|P2|NOT COMPLETED|Overall Study||6
7754251|NCT01464775|19092199|P1|NOT COMPLETED|Overall Study||11
7754252|NCT01464775|19092198|P2|COMPLETED|Overall Study||38
7754253|NCT01464775|19092199|P1|COMPLETED|Overall Study||112
7754254|NCT01464775|19092198|P2|STARTED|Overall Study||44
7754255|NCT01464775|19092199|P1|STARTED|Overall Study||123
7754256|NCT01464723|19092207|P1|NOT COMPLETED|Overall Study||0
7754257|NCT01464723|19092207|P1|COMPLETED|Overall Study||0
7754258|NCT01464723|19092207|P1|STARTED|Overall Study||0
7754259|NCT01464697|19092216|P2|NOT COMPLETED|Overall Study||10
7754260|NCT01464697|19092217|P1|NOT COMPLETED|Overall Study||3
7754261|NCT01464697|19092216|P2|COMPLETED|Overall Study||86
7754262|NCT01464697|19092217|P1|COMPLETED|Overall Study||90
7754263|NCT01464697|19092216|P2|STARTED|Overall Study||96
7754264|NCT01464697|19092217|P1|STARTED|Overall Study||93
7754265|NCT01464619|19092271|P2|NOT COMPLETED|Overall Study||4
7754266|NCT01464619|19092272|P1|NOT COMPLETED|Overall Study||3
7754267|NCT01464619|19092271|P2|COMPLETED|Overall Study||25
7754268|NCT01464619|19092272|P1|COMPLETED|Overall Study||29
7754269|NCT01464619|19092271|P2|STARTED|Overall Study||29
7754270|NCT01464619|19092272|P1|STARTED|Overall Study||32
7754271|NCT01464424|19092292|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
7754272|NCT01464424|19092293|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
7754273|NCT01464424|19092292|P2|COMPLETED|Period 2, Second 6 Weeks||41
7754274|NCT01464424|19092293|P1|COMPLETED|Period 2, Second 6 Weeks||42
7754275|NCT01464424|19092292|P2|STARTED|Period 2, Second 6 Weeks||41
7754276|NCT01464424|19092293|P1|STARTED|Period 2, Second 6 Weeks||42
7754277|NCT01464424|19092292|P2|NOT COMPLETED|Period 1, First 6 Weeks||1
7754278|NCT01464424|19092293|P1|NOT COMPLETED|Period 1, First 6 Weeks||0
7754279|NCT01464424|19092292|P2|COMPLETED|Period 1, First 6 Weeks||41
7754280|NCT01464424|19092293|P1|COMPLETED|Period 1, First 6 Weeks||42
7754281|NCT01464424|19092292|P2|STARTED|Period 1, First 6 Weeks||42
7754282|NCT01464424|19092293|P1|STARTED|Period 1, First 6 Weeks||42
7754283|NCT01464359|19092301|P1|NOT COMPLETED|Overall Study||0
7754284|NCT01464359|19092301|P1|COMPLETED|Overall Study||3
7754285|NCT01464359|19092301|P1|STARTED|Overall Study||3
7754286|NCT01464346|19092313|P3|NOT COMPLETED|Overall Study||1
7754287|NCT01464346|19092314|P2|NOT COMPLETED|Overall Study||0
7754288|NCT01464346|19092315|P1|NOT COMPLETED|Overall Study||0
7754289|NCT01464346|19092313|P3|COMPLETED|Overall Study||28
7754290|NCT01464346|19092314|P2|COMPLETED|Overall Study||32
7754291|NCT01464346|19092315|P1|COMPLETED|Overall Study||29
7754292|NCT01464346|19092313|P3|STARTED|Overall Study||29
7754293|NCT01464346|19092314|P2|STARTED|Overall Study||32
7754294|NCT01464346|19092315|P1|STARTED|Overall Study||29
7754295|NCT01464333|19092324|P1|NOT COMPLETED|Overall Study||163
7754296|NCT01464333|19092324|P1|COMPLETED|Overall Study||226
7754297|NCT01464333|19092324|P1|STARTED|Overall Study||389
7754298|NCT01464307|19092337|P2|NOT COMPLETED|Open-Label Extension Period||0
7754299|NCT01464307|19092338|P1|NOT COMPLETED|Open-Label Extension Period||51
7754300|NCT01464307|19092337|P2|COMPLETED|Open-Label Extension Period||0
7754301|NCT01464307|19092338|P1|COMPLETED|Open-Label Extension Period||218
7754302|NCT01464307|19092337|P2|Treated|Open-Label Extension Period||0
7754303|NCT01464307|19092338|P1|Treated|Open-Label Extension Period||269
7754304|NCT01464307|19092337|P2|STARTED|Open-Label Extension Period||0
7754305|NCT01464307|19092338|P1|STARTED|Open-Label Extension Period||269
7754306|NCT01464307|19092337|P2|NOT COMPLETED|Main Period||5
7754307|NCT01464307|19092338|P1|NOT COMPLETED|Main Period||15
7754308|NCT01464307|19092337|P2|COMPLETED|Main Period||140
7754309|NCT01464307|19092338|P1|COMPLETED|Main Period||129
7754310|NCT01464307|19092337|P2|Treated|Main Period||145
7754311|NCT01464307|19092338|P1|Treated|Main Period||144
7754312|NCT01464307|19092337|P2|STARTED|Main Period||145
7754313|NCT01464307|19092338|P1|STARTED|Main Period||144
7754314|NCT01464255|19092353|P2|NOT COMPLETED|Overall Study||1
7754315|NCT01464255|19092354|P1|NOT COMPLETED|Overall Study||0
7754316|NCT01464255|19092353|P2|COMPLETED|Overall Study||24
7754317|NCT01464255|19092354|P1|COMPLETED|Overall Study||25
7754318|NCT01464255|19092353|P2|STARTED|Overall Study||25
7754319|NCT01464255|19092354|P1|STARTED|Overall Study||25
7754320|NCT01464229|19092379|P2|NOT COMPLETED|Overall Study||2
7754321|NCT01464229|19092380|P1|NOT COMPLETED|Overall Study||5
7754322|NCT01464229|19092379|P2|COMPLETED|Overall Study||8
7754323|NCT01464229|19092380|P1|COMPLETED|Overall Study||5
7754324|NCT01464229|19092379|P2|STARTED|Overall Study||10
7754325|NCT01464229|19092380|P1|STARTED|Overall Study||10
7754326|NCT01464190|19092388|P2|NOT COMPLETED|Overall Study||41
7754327|NCT01464190|19092389|P1|NOT COMPLETED|Overall Study||69
7754328|NCT01464190|19092388|P2|COMPLETED|Overall Study||227
7754329|NCT01464190|19092389|P1|COMPLETED|Overall Study||322
7754330|NCT01464190|19092388|P2|STARTED|Overall Study||268
7754331|NCT01464190|19092389|P1|STARTED|Overall Study||391
7754332|NCT01464021|19092399|P1|NOT COMPLETED|Overall Study||26
7754333|NCT01464021|19092399|P1|COMPLETED|Overall Study||0
7754334|NCT01464021|19092399|P1|STARTED|Overall Study||26
7754335|NCT01463982|19092415|P4|NOT COMPLETED|Overall Study||0
7754336|NCT01463982|19092416|P3|NOT COMPLETED|Overall Study||2
7754337|NCT01463982|19092417|P2|NOT COMPLETED|Overall Study||1
7754338|NCT01463982|19092418|P1|NOT COMPLETED|Overall Study||0
7754339|NCT01463982|19092415|P4|COMPLETED|Overall Study||6
7754340|NCT01463982|19092416|P3|COMPLETED|Overall Study||2
7754341|NCT01463982|19092417|P2|COMPLETED|Overall Study||7
7754342|NCT01463982|19092418|P1|COMPLETED|Overall Study||3
7754343|NCT01463982|19092415|P4|STARTED|Overall Study||6
7754344|NCT01463982|19092416|P3|STARTED|Overall Study||4
7754345|NCT01463982|19092417|P2|STARTED|Overall Study||8
7754346|NCT01463982|19092418|P1|STARTED|Overall Study||3
7754347|NCT01463878|19092434|P2|NOT COMPLETED|Overall Study||2
7754348|NCT01463878|19092435|P1|NOT COMPLETED|Overall Study||2
7754349|NCT01463878|19092434|P2|COMPLETED|Overall Study||7
7754350|NCT01463878|19092435|P1|COMPLETED|Overall Study||7
7754351|NCT01463878|19092434|P2|STARTED|Overall Study||9
7754352|NCT01463878|19092435|P1|STARTED|Overall Study||9
7754353|NCT01463696|19092449|P8|NOT COMPLETED|Overall Study||4
7754354|NCT01463696|19092450|P7|NOT COMPLETED|Overall Study||10
7754355|NCT01463696|19092451|P6|NOT COMPLETED|Overall Study||3
7754356|NCT01463696|19092452|P5|NOT COMPLETED|Overall Study||1
7754357|NCT01463696|19092453|P4|NOT COMPLETED|Overall Study||4
7754358|NCT01463696|19092454|P3|NOT COMPLETED|Overall Study||1
7754359|NCT01463696|19092455|P2|NOT COMPLETED|Overall Study||2
7754360|NCT01463696|19092456|P1|NOT COMPLETED|Overall Study||0
7754361|NCT01463696|19092449|P8|COMPLETED|Overall Study||2
7754362|NCT01463696|19092450|P7|COMPLETED|Overall Study||6
7754363|NCT01463696|19092451|P6|COMPLETED|Overall Study||3
7754364|NCT01463696|19092452|P5|COMPLETED|Overall Study||2
7754365|NCT01463696|19092453|P4|COMPLETED|Overall Study||3
7754366|NCT01463696|19092454|P3|COMPLETED|Overall Study||2
7754367|NCT01463696|19092455|P2|COMPLETED|Overall Study||4
7754368|NCT01463696|19092456|P1|COMPLETED|Overall Study||1
7754369|NCT01463696|19092449|P8|Treated|Overall Study||6
7754370|NCT01463696|19092450|P7|Treated|Overall Study||15
7754371|NCT01463696|19092451|P6|Treated|Overall Study||6
7754372|NCT01463696|19092452|P5|Treated|Overall Study||3
7754373|NCT01463696|19092453|P4|Treated|Overall Study||7
7754374|NCT01463696|19092454|P3|Treated|Overall Study||3
7754375|NCT01463696|19092455|P2|Treated|Overall Study||6
7754376|NCT01463696|19092456|P1|Treated|Overall Study||1
7754377|NCT01463696|19092449|P8|STARTED|Overall Study||6
7754378|NCT01463696|19092450|P7|STARTED|Overall Study||16
7754379|NCT01463696|19092451|P6|STARTED|Overall Study||6
7754380|NCT01463696|19092452|P5|STARTED|Overall Study||3
7754381|NCT01463696|19092453|P4|STARTED|Overall Study||7
7754382|NCT01463696|19092454|P3|STARTED|Overall Study||3
7754383|NCT01463696|19092455|P2|STARTED|Overall Study||6
7754384|NCT01463696|19092456|P1|STARTED|Overall Study||1
7754385|NCT01463683|19092509|P3|NOT COMPLETED|Overall Study||11
7754386|NCT01463683|19092510|P2|NOT COMPLETED|Overall Study||31
7754387|NCT01463683|19092511|P1|NOT COMPLETED|Overall Study||19
7754388|NCT01463683|19092509|P3|COMPLETED|Overall Study||93
7754389|NCT01463683|19092510|P2|COMPLETED|Overall Study||278
7754390|NCT01463683|19092511|P1|COMPLETED|Overall Study||290
7754391|NCT01463683|19092509|P3|Received Vaccination 3 (Month 6)|Overall Study||93
7754392|NCT01463683|19092510|P2|Received Vaccination 3 (Month 6)|Overall Study||281
7754393|NCT01463683|19092511|P1|Received Vaccination 3 (Month 6)|Overall Study||290
7754394|NCT01463683|19092509|P3|Received Vaccination 2 (Month 1)|Overall Study||103
7754395|NCT01463683|19092510|P2|Received Vaccination 2 (Month 1)|Overall Study||300
7754396|NCT01463683|19092511|P1|Received Vaccination 2 (Month 1)|Overall Study||302
7754397|NCT01463683|19092509|P3|Received Vaccination 1 (Day 1)|Overall Study||104
7754398|NCT01463683|19092510|P2|Received Vaccination 1 (Day 1)|Overall Study||308
7754399|NCT01463683|19092511|P1|Received Vaccination 1 (Day 1)|Overall Study||309
7754400|NCT01463683|19092509|P3|STARTED|Overall Study||104
7754401|NCT01463683|19092510|P2|STARTED|Overall Study||309
7754402|NCT01463683|19092511|P1|STARTED|Overall Study||309
7754403|NCT01463631|19092528|P4|NOT COMPLETED|Overall Study||6
7754404|NCT01463631|19092529|P3|NOT COMPLETED|Overall Study||1
7754405|NCT01463631|19092530|P2|NOT COMPLETED|Overall Study||0
7754406|NCT01463631|19092531|P1|NOT COMPLETED|Overall Study||0
7754407|NCT01463631|19092528|P4|COMPLETED|Overall Study||9
7754408|NCT01463631|19092529|P3|COMPLETED|Overall Study||4
7754409|NCT01463631|19092530|P2|COMPLETED|Overall Study||4
7754410|NCT01463631|19092531|P1|COMPLETED|Overall Study||3
7754411|NCT01463631|19092528|P4|Received at Least One Dose of Study Drug|Overall Study||15
7754412|NCT01463631|19092529|P3|Received at Least One Dose of Study Drug|Overall Study||5
7754413|NCT01463631|19092530|P2|Received at Least One Dose of Study Drug|Overall Study||4
7754414|NCT01463631|19092531|P1|Received at Least One Dose of Study Drug|Overall Study||3
7754415|NCT01463631|19092528|P4|STARTED|Overall Study||15
7754416|NCT01463631|19092529|P3|STARTED|Overall Study||5
7754417|NCT01463631|19092530|P2|STARTED|Overall Study||4
7754418|NCT01463631|19092531|P1|STARTED|Overall Study||3
7754419|NCT01463527|19092553|P2|NOT COMPLETED|Overall Study||7
7754420|NCT01463527|19092554|P1|NOT COMPLETED|Overall Study||6
7754421|NCT01463527|19092553|P2|COMPLETED|Overall Study||77
7754422|NCT01463527|19092554|P1|COMPLETED|Overall Study||77
7754423|NCT01463527|19092553|P2|STARTED|Overall Study||84
7754424|NCT01463527|19092554|P1|STARTED|Overall Study||83
7754425|NCT01463384|19092562|P1|NOT COMPLETED|Overall Study||0
7754426|NCT01463384|19092562|P1|COMPLETED|Overall Study||13
7754427|NCT01463384|19092562|P1|STARTED|Overall Study||13
7754428|NCT01463306|19092577|P3|NOT COMPLETED|Overall Study||5
7754429|NCT01463306|19092578|P2|NOT COMPLETED|Overall Study||52
7754430|NCT01463306|19092579|P1|NOT COMPLETED|Overall Study||86
7754431|NCT01463306|19092577|P3|COMPLETED|Overall Study||6
7754432|NCT01463306|19092578|P2|COMPLETED|Overall Study||158
7754433|NCT01463306|19092579|P1|COMPLETED|Overall Study||298
7754434|NCT01463306|19092577|P3|STARTED|Overall Study||11
7754435|NCT01463306|19092578|P2|STARTED|Overall Study||210
7754436|NCT01463306|19092579|P1|STARTED|Overall Study||384
7754437|NCT01463293|19092650|P3|NOT COMPLETED|Overall Study||12
7754438|NCT01463293|19092651|P2|NOT COMPLETED|Overall Study||16
7754439|NCT01463293|19092652|P1|NOT COMPLETED|Overall Study||6
7754440|NCT01463293|19092650|P3|COMPLETED|Overall Study||59
7754441|NCT01463293|19092651|P2|COMPLETED|Overall Study||63
7754442|NCT01463293|19092652|P1|COMPLETED|Overall Study||68
7754443|NCT01463293|19092650|P3|STARTED|Overall Study||71
7754444|NCT01463293|19092651|P2|STARTED|Overall Study||79
7754445|NCT01463293|19092652|P1|STARTED|Overall Study||74
7754446|NCT01463267|19092664|P4|NOT COMPLETED|Overall Study||2
7754447|NCT01463267|19092665|P3|NOT COMPLETED|Overall Study||2
7754448|NCT01463267|19092666|P2|NOT COMPLETED|Overall Study||0
7754449|NCT01463267|19092667|P1|NOT COMPLETED|Overall Study||1
7754450|NCT01463267|19092664|P4|COMPLETED|Overall Study||13
7754451|NCT01463267|19092665|P3|COMPLETED|Overall Study||13
7754452|NCT01463267|19092666|P2|COMPLETED|Overall Study||15
7754453|NCT01463267|19092667|P1|COMPLETED|Overall Study||14
7754454|NCT01463267|19092664|P4|STARTED|Overall Study||15
7754455|NCT01463267|19092665|P3|STARTED|Overall Study||15
7754456|NCT01463267|19092666|P2|STARTED|Overall Study||15
7754457|NCT01463267|19092667|P1|STARTED|Overall Study||15
7754458|NCT01463202|19092683|P2|NOT COMPLETED|Overall Study||0
7754459|NCT01463202|19092684|P1|NOT COMPLETED|Overall Study||0
7754460|NCT01463202|19092683|P2|COMPLETED|Overall Study||78
7754461|NCT01463202|19092684|P1|COMPLETED|Overall Study||79
7754462|NCT01463202|19092683|P2|STARTED|Overall Study||78
7754463|NCT01463202|19092684|P1|STARTED|Overall Study||79
7754464|NCT01463111|19092696|P1|NOT COMPLETED|Overall Study||9
7754465|NCT01463111|19092696|P1|COMPLETED|Overall Study||17
7754466|NCT01463111|19092696|P1|STARTED|Overall Study||26
7754467|NCT01463098|19092718|P14|NOT COMPLETED|Part B (11 Days)||0
7754468|NCT01463098|19092719|P13|NOT COMPLETED|Part B (11 Days)||0
7754469|NCT01463098|19092720|P12|NOT COMPLETED|Part B (11 Days)||1
7754470|NCT01463098|19092721|P11|NOT COMPLETED|Part B (11 Days)||0
7754471|NCT01463098|19092722|P10|NOT COMPLETED|Part B (11 Days)||0
7754472|NCT01463098|19092723|P9|NOT COMPLETED|Part B (11 Days)||0
7754473|NCT01463098|19092724|P8|NOT COMPLETED|Part B (11 Days)||0
7754474|NCT01463098|19092725|P7|NOT COMPLETED|Part B (11 Days)||0
7754475|NCT01463098|19092726|P6|NOT COMPLETED|Part B (11 Days)||0
7754476|NCT01463098|19092727|P5|NOT COMPLETED|Part B (11 Days)||0
7754477|NCT01463098|19092728|P4|NOT COMPLETED|Part B (11 Days)||0
7754478|NCT01463098|19092729|P3|NOT COMPLETED|Part B (11 Days)||0
7754479|NCT01463098|19092730|P2|NOT COMPLETED|Part B (11 Days)||0
7754480|NCT01463098|19092731|P1|NOT COMPLETED|Part B (11 Days)||0
7754481|NCT01463098|19092718|P14|COMPLETED|Part B (11 Days)||12
7754482|NCT01463098|19092719|P13|COMPLETED|Part B (11 Days)||10
7754483|NCT01463098|19092720|P12|COMPLETED|Part B (11 Days)||12
7754484|NCT01463098|19092721|P11|COMPLETED|Part B (11 Days)||11
7754485|NCT01463098|19092722|P10|COMPLETED|Part B (11 Days)||12
7754486|NCT01463098|19092723|P9|COMPLETED|Part B (11 Days)||0
7754487|NCT01463098|19092724|P8|COMPLETED|Part B (11 Days)||0
7754488|NCT01463098|19092725|P7|COMPLETED|Part B (11 Days)||0
7754489|NCT01463098|19092726|P6|COMPLETED|Part B (11 Days)||0
7754490|NCT01463098|19092727|P5|COMPLETED|Part B (11 Days)||0
7754491|NCT01463098|19092728|P4|COMPLETED|Part B (11 Days)||0
7754492|NCT01463098|19092729|P3|COMPLETED|Part B (11 Days)||0
7754493|NCT01463098|19092730|P2|COMPLETED|Part B (11 Days)||0
7754494|NCT01463098|19092731|P1|COMPLETED|Part B (11 Days)||0
7754495|NCT01463098|19092718|P14|STARTED|Part B (11 Days)||12
7754496|NCT01463098|19092719|P13|STARTED|Part B (11 Days)||10
7754497|NCT01463098|19092720|P12|STARTED|Part B (11 Days)||13
7754498|NCT01463098|19092721|P11|STARTED|Part B (11 Days)||11
7754499|NCT01463098|19092722|P10|STARTED|Part B (11 Days)||12
7754500|NCT01463098|19092723|P9|STARTED|Part B (11 Days)||0
7754501|NCT01463098|19092724|P8|STARTED|Part B (11 Days)||0
7754502|NCT01463098|19092725|P7|STARTED|Part B (11 Days)||0
7754503|NCT01463098|19092726|P6|STARTED|Part B (11 Days)||0
7754504|NCT01463098|19092727|P5|STARTED|Part B (11 Days)||0
7754505|NCT01463098|19092728|P4|STARTED|Part B (11 Days)||0
7754506|NCT01463098|19092729|P3|STARTED|Part B (11 Days)||0
7754507|NCT01463098|19092730|P2|STARTED|Part B (11 Days)||0
7754508|NCT01463098|19092731|P1|STARTED|Part B (11 Days)||0
7754509|NCT01463098|19092718|P14|NOT COMPLETED|Part A (11 Days)||0
7754510|NCT01463098|19092719|P13|NOT COMPLETED|Part A (11 Days)||0
7754511|NCT01463098|19092720|P12|NOT COMPLETED|Part A (11 Days)||0
7754512|NCT01463098|19092721|P11|NOT COMPLETED|Part A (11 Days)||0
7754513|NCT01463098|19092722|P10|NOT COMPLETED|Part A (11 Days)||0
7754514|NCT01463098|19092723|P9|NOT COMPLETED|Part A (11 Days)||1
7754515|NCT01463098|19092724|P8|NOT COMPLETED|Part A (11 Days)||0
7754516|NCT01463098|19092725|P7|NOT COMPLETED|Part A (11 Days)||0
7754517|NCT01463098|19092726|P6|NOT COMPLETED|Part A (11 Days)||0
7754518|NCT01463098|19092727|P5|NOT COMPLETED|Part A (11 Days)||1
7754519|NCT01463098|19092728|P4|NOT COMPLETED|Part A (11 Days)||0
7754520|NCT01463098|19092729|P3|NOT COMPLETED|Part A (11 Days)||0
7754521|NCT01463098|19092730|P2|NOT COMPLETED|Part A (11 Days)||0
7754522|NCT01463098|19092731|P1|NOT COMPLETED|Part A (11 Days)||2
7754523|NCT01463098|19092718|P14|COMPLETED|Part A (11 Days)||0
7754524|NCT01463098|19092719|P13|COMPLETED|Part A (11 Days)||0
7754525|NCT01463098|19092720|P12|COMPLETED|Part A (11 Days)||0
7754526|NCT01463098|19092721|P11|COMPLETED|Part A (11 Days)||0
7754527|NCT01463098|19092722|P10|COMPLETED|Part A (11 Days)||0
7754528|NCT01463098|19092723|P9|COMPLETED|Part A (11 Days)||5
7754529|NCT01463098|19092724|P8|COMPLETED|Part A (11 Days)||6
7754530|NCT01463098|19092725|P7|COMPLETED|Part A (11 Days)||6
7754531|NCT01463098|19092726|P6|COMPLETED|Part A (11 Days)||6
7754532|NCT01463098|19092727|P5|COMPLETED|Part A (11 Days)||5
7754533|NCT01463098|19092728|P4|COMPLETED|Part A (11 Days)||6
7754534|NCT01463098|19092729|P3|COMPLETED|Part A (11 Days)||6
7754535|NCT01463098|19092730|P2|COMPLETED|Part A (11 Days)||6
7754536|NCT01463098|19092731|P1|COMPLETED|Part A (11 Days)||14
7754537|NCT01463098|19092718|P14|STARTED|Part A (11 Days)||0
7754538|NCT01463098|19092719|P13|STARTED|Part A (11 Days)||0
7754539|NCT01463098|19092720|P12|STARTED|Part A (11 Days)||0
7754540|NCT01463098|19092721|P11|STARTED|Part A (11 Days)||0
7754541|NCT01463098|19092722|P10|STARTED|Part A (11 Days)||0
7754542|NCT01463098|19092723|P9|STARTED|Part A (11 Days)||6
7754543|NCT01463098|19092724|P8|STARTED|Part A (11 Days)||6
7754544|NCT01463098|19092725|P7|STARTED|Part A (11 Days)||6
7754545|NCT01463098|19092726|P6|STARTED|Part A (11 Days)||6
7754546|NCT01463098|19092727|P5|STARTED|Part A (11 Days)||6
7754547|NCT01463098|19092728|P4|STARTED|Part A (11 Days)||6
7754548|NCT01463098|19092729|P3|STARTED|Part A (11 Days)||6
7754549|NCT01463098|19092730|P2|STARTED|Part A (11 Days)||6
7754550|NCT01463098|19092731|P1|STARTED|Part A (11 Days)||16
7754551|NCT01463033|19093054|P2|NOT COMPLETED|Overall Study||6
7754552|NCT01463033|19093055|P1|NOT COMPLETED|Overall Study||7
7754553|NCT01463033|19093054|P2|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54
7754738|NCT01462045|19093564|P3|STARTED|Overall Study||7
7754554|NCT01463033|19093055|P1|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59
7754555|NCT01463033|19093054|P2|STARTED|Overall Study||60
7754556|NCT01463033|19093055|P1|STARTED|Overall Study||66
7754557|NCT01463007|19093062|P1|NOT COMPLETED|Overall Study||1
7754558|NCT01463007|19093062|P1|COMPLETED|Overall Study||40
7754559|NCT01463007|19093062|P1|STARTED|Overall Study||41
7754560|NCT01462942|19093073|P5|NOT COMPLETED|Overall Study||45
7754561|NCT01462942|19093074|P4|NOT COMPLETED|Overall Study||50
7754562|NCT01462942|19093075|P3|NOT COMPLETED|Overall Study||40
7754563|NCT01462942|19093076|P2|NOT COMPLETED|Overall Study||34
7754564|NCT01462942|19093077|P1|NOT COMPLETED|Overall Study||34
7754565|NCT01462942|19093073|P5|COMPLETED|Overall Study||339
7754566|NCT01462942|19093074|P4|COMPLETED|Overall Study||335
7754567|NCT01462942|19093075|P3|COMPLETED|Overall Study||341
7754568|NCT01462942|19093076|P2|COMPLETED|Overall Study||351
7754569|NCT01462942|19093077|P1|COMPLETED|Overall Study||160
7754570|NCT01462942|19093073|P5|STARTED|Overall Study||384
7754571|NCT01462942|19093074|P4|STARTED|Overall Study||385
7754572|NCT01462942|19093075|P3|STARTED|Overall Study||381
7754573|NCT01462942|19093076|P2|STARTED|Overall Study||385
7754574|NCT01462942|19093077|P1|STARTED|Overall Study||194
7754575|NCT01462929|19093107|P3|NOT COMPLETED|Overall Study||5
7754576|NCT01462929|19093108|P2|NOT COMPLETED|Overall Study||4
7754577|NCT01462929|19093109|P1|NOT COMPLETED|Overall Study||5
7754578|NCT01462929|19093107|P3|COMPLETED|Overall Study||80
7754579|NCT01462929|19093108|P2|COMPLETED|Overall Study||154
7754580|NCT01462929|19093109|P1|COMPLETED|Overall Study||166
7754581|NCT01462929|19093107|P3|STARTED|Overall Study||85
7754582|NCT01462929|19093108|P2|STARTED|Overall Study||158
7754583|NCT01462929|19093109|P1|STARTED|Overall Study||171
7754584|NCT01462877|19093120|P1|NOT COMPLETED|Overall Study||71
7754585|NCT01462877|19093120|P1|COMPLETED|Overall Study||435
7754586|NCT01462877|19093120|P1|Per-protocol Set|Overall Study||364
7754587|NCT01462877|19093120|P1|Full Analysis Set|Overall Study||468
7754588|NCT01462877|19093120|P1|Safety Set|Overall Study||492
7754589|NCT01462877|19093120|P1|STARTED|Overall Study||506
7754590|NCT01462812|19093136|P2|NOT COMPLETED|Overall Study||1
7754591|NCT01462812|19093137|P1|NOT COMPLETED|Overall Study||0
7754592|NCT01462812|19093136|P2|COMPLETED|Overall Study||111
7754593|NCT01462812|19093137|P1|COMPLETED|Overall Study||111
7754594|NCT01462812|19093136|P2|STARTED|Overall Study||112
7754595|NCT01462812|19093137|P1|STARTED|Overall Study||111
7754596|NCT01462773|19093143|P1|NOT COMPLETED|Overall Study||0
7754597|NCT01462773|19093143|P1|COMPLETED|Overall Study||16
7754598|NCT01462773|19093143|P1|STARTED|Overall Study||16
7754599|NCT01462695|19093150|P2|NOT COMPLETED|Overall Study||13
7754600|NCT01462695|19093151|P1|NOT COMPLETED|Overall Study||17
7754601|NCT01462695|19093150|P2|COMPLETED|Overall Study||0
7754602|NCT01462695|19093151|P1|COMPLETED|Overall Study||0
7754603|NCT01462695|19093150|P2|STARTED|Overall Study||13
7754604|NCT01462695|19093151|P1|STARTED|Overall Study||17
7754605|NCT01462565|19093157|P1|NOT COMPLETED|Overall Study||0
7754606|NCT01462565|19093157|P1|COMPLETED|Overall Study||16
7754607|NCT01462565|19093157|P1|STARTED|Overall Study||16
7754608|NCT01462435|19093179|P4|NOT COMPLETED|Overall Study||5
7754609|NCT01462435|19093180|P3|NOT COMPLETED|Overall Study||1
7754610|NCT01462435|19093181|P2|NOT COMPLETED|Overall Study||0
7754611|NCT01462435|19093182|P1|NOT COMPLETED|Overall Study||1
7754612|NCT01462435|19093179|P4|COMPLETED|Overall Study||101
7754613|NCT01462435|19093180|P3|COMPLETED|Overall Study||106
7754614|NCT01462435|19093181|P2|COMPLETED|Overall Study||109
7754615|NCT01462435|19093182|P1|COMPLETED|Overall Study||105
7754616|NCT01462435|19093179|P4|STARTED|Overall Study||106
7754617|NCT01462435|19093180|P3|STARTED|Overall Study||107
7754618|NCT01462435|19093181|P2|STARTED|Overall Study||109
7754619|NCT01462435|19093182|P1|STARTED|Overall Study||106
7754620|NCT01462370|19093220|P2|NOT COMPLETED|Overall Study||5
7754621|NCT01462370|19093221|P1|NOT COMPLETED|Overall Study||1
7754622|NCT01462370|19093220|P2|COMPLETED|Overall Study||65
7754623|NCT01462370|19093221|P1|COMPLETED|Overall Study||68
7754624|NCT01462370|19093220|P2|STARTED|Overall Study||70
7754625|NCT01462370|19093221|P1|STARTED|Overall Study||69
7754626|NCT01462357|19093256|P3|NOT COMPLETED|Overall Study||12
7754627|NCT01462357|19093257|P2|NOT COMPLETED|Overall Study||19
7754628|NCT01462357|19093258|P1|NOT COMPLETED|Overall Study||8
7754629|NCT01462357|19093256|P3|COMPLETED|Overall Study||346
7754630|NCT01462357|19093257|P2|COMPLETED|Overall Study||339
7754631|NCT01462357|19093258|P1|COMPLETED|Overall Study||351
7754632|NCT01462357|19093256|P3|STARTED|Overall Study||358
7754633|NCT01462357|19093257|P2|STARTED|Overall Study||358
7754634|NCT01462357|19093258|P1|STARTED|Overall Study||359
7754635|NCT01462344|19093331|P2|NOT COMPLETED|Overall Study||350
7754636|NCT01462344|19093332|P1|NOT COMPLETED|Overall Study||383
7754637|NCT01462344|19093331|P2|COMPLETED|Overall Study||2751
7754638|NCT01462344|19093332|P1|COMPLETED|Overall Study||2724
7754639|NCT01462344|19093331|P2|STARTED|Overall Study||3101
7754640|NCT01462344|19093332|P1|STARTED|Overall Study||3107
7754641|NCT01462318|19093354|P3|NOT COMPLETED|Extension Phase||45
7754642|NCT01462318|19093355|P2|NOT COMPLETED|Extension Phase||0
7754643|NCT01462318|19093356|P1|NOT COMPLETED|Extension Phase||0
7754644|NCT01462318|19093354|P3|COMPLETED|Extension Phase||70
7754645|NCT01462318|19093355|P2|COMPLETED|Extension Phase||0
7754646|NCT01462318|19093356|P1|COMPLETED|Extension Phase||0
7754647|NCT01462318|19093354|P3|STARTED|Extension Phase|10 participants from the Main Study did not enter the Extension Phase.|115
7754739|NCT01462045|19093565|P2|STARTED|Overall Study||11
7754648|NCT01462318|19093355|P2|STARTED|Extension Phase|20 participants from the TP-DI Study entered the Extension Phase|0
7754649|NCT01462318|19093356|P1|STARTED|Extension Phase|95 participants from the Main Study entered the Extension Phase|0
7754650|NCT01462318|19093354|P3|NOT COMPLETED|Main Study / TP-DI Study||0
7754651|NCT01462318|19093355|P2|NOT COMPLETED|Main Study / TP-DI Study||0
7754652|NCT01462318|19093356|P1|NOT COMPLETED|Main Study / TP-DI Study||8
7754653|NCT01462318|19093354|P3|COMPLETED|Main Study / TP-DI Study||0
7754654|NCT01462318|19093355|P2|COMPLETED|Main Study / TP-DI Study||20
7754655|NCT01462318|19093356|P1|COMPLETED|Main Study / TP-DI Study||105
7754656|NCT01462318|19093354|P3|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
7754657|NCT01462318|19093355|P2|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
7754658|NCT01462318|19093356|P1|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26
7754659|NCT01462318|19093354|P3|STARTED|Main Study / TP-DI Study||0
7754660|NCT01462318|19093355|P2|STARTED|Main Study / TP-DI Study||20
7754661|NCT01462318|19093356|P1|STARTED|Main Study / TP-DI Study||113
7754662|NCT01462305|19093375|P2|NOT COMPLETED|Overall Study||4
7754663|NCT01462305|19093376|P1|NOT COMPLETED|Overall Study||2
7754664|NCT01462305|19093375|P2|COMPLETED|Overall Study||13
7754665|NCT01462305|19093376|P1|COMPLETED|Overall Study||16
7754666|NCT01462305|19093375|P2|STARTED|Overall Study||17
7754667|NCT01462305|19093376|P1|STARTED|Overall Study||18
7754668|NCT01462292|19093389|P3|NOT COMPLETED|Overall Study||0
7754669|NCT01462292|19093390|P2|NOT COMPLETED|Overall Study||0
7754670|NCT01462292|19093391|P1|NOT COMPLETED|Overall Study||0
7754671|NCT01462292|19093389|P3|COMPLETED|Overall Study||18
7754672|NCT01462292|19093390|P2|COMPLETED|Overall Study||17
7754673|NCT01462292|19093391|P1|COMPLETED|Overall Study||16
7754674|NCT01462292|19093389|P3|STARTED|Overall Study||18
7754675|NCT01462292|19093390|P2|STARTED|Overall Study||17
7754676|NCT01462292|19093391|P1|STARTED|Overall Study||16
7754677|NCT01462279|19093450|P1|NOT COMPLETED|Overall Study||3
7754678|NCT01462279|19093450|P1|COMPLETED|Overall Study||17
7754679|NCT01462279|19093450|P1|STARTED|Overall Study||20
7754680|NCT01462266|19093457|P2|NOT COMPLETED|Overall Study||27
7754681|NCT01462266|19093458|P1|NOT COMPLETED|Overall Study||35
7754682|NCT01462266|19093457|P2|COMPLETED|Overall Study||303
7754683|NCT01462266|19093458|P1|COMPLETED|Overall Study||295
7754684|NCT01462266|19093457|P2|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
7754685|NCT01462266|19093458|P1|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
7754686|NCT01462266|19093457|P2|STARTED|Overall Study||330
7754687|NCT01462266|19093458|P1|STARTED|Overall Study||330
7754688|NCT01462253|19093472|P1|NOT COMPLETED|Overall Study||8
7754689|NCT01462253|19093472|P1|COMPLETED|Overall Study||27
7754690|NCT01462253|19093472|P1|STARTED|Overall Study||35
7754691|NCT01462227|19093483|P4|NOT COMPLETED|Second Assignment||0
7754692|NCT01462227|19093484|P3|NOT COMPLETED|Second Assignment||1
7754693|NCT01462227|19093485|P2|NOT COMPLETED|Second Assignment||1
7754694|NCT01462227|19093486|P1|NOT COMPLETED|Second Assignment||1
7754695|NCT01462227|19093483|P4|COMPLETED|Second Assignment||5
7754696|NCT01462227|19093484|P3|COMPLETED|Second Assignment||5
7754697|NCT01462227|19093485|P2|COMPLETED|Second Assignment||1
7754698|NCT01462227|19093486|P1|COMPLETED|Second Assignment||3
7754699|NCT01462227|19093483|P4|STARTED|Second Assignment||5
7754700|NCT01462227|19093484|P3|STARTED|Second Assignment||6
7754701|NCT01462227|19093485|P2|STARTED|Second Assignment||2
7754702|NCT01462227|19093486|P1|STARTED|Second Assignment||4
7754703|NCT01462227|19093483|P4|NOT COMPLETED|First Assignment||0
7754704|NCT01462227|19093484|P3|NOT COMPLETED|First Assignment||0
7754705|NCT01462227|19093485|P2|NOT COMPLETED|First Assignment||0
7754706|NCT01462227|19093486|P1|NOT COMPLETED|First Assignment||0
7754707|NCT01462227|19093483|P4|COMPLETED|First Assignment||5
7754708|NCT01462227|19093484|P3|COMPLETED|First Assignment||6
7754709|NCT01462227|19093485|P2|COMPLETED|First Assignment||2
7754710|NCT01462227|19093486|P1|COMPLETED|First Assignment||4
7754711|NCT01462227|19093483|P4|STARTED|First Assignment||5
7754712|NCT01462227|19093484|P3|STARTED|First Assignment||6
7754713|NCT01462227|19093485|P2|STARTED|First Assignment||2
7754714|NCT01462227|19093486|P1|STARTED|First Assignment||4
7754715|NCT01462162|19093504|P1|NOT COMPLETED|Overall Study||12
7754716|NCT01462162|19093504|P1|COMPLETED|Overall Study||108
7754717|NCT01462162|19093504|P1|STARTED|Overall Study||120
7754718|NCT01462110|19093531|P2|NOT COMPLETED|Overall Study||0
7754719|NCT01462110|19093532|P1|NOT COMPLETED|Overall Study||1
7754720|NCT01462110|19093531|P2|COMPLETED|Overall Study||43
7754721|NCT01462110|19093532|P1|COMPLETED|Overall Study||43
7754722|NCT01462110|19093531|P2|STARTED|Overall Study||43
7754723|NCT01462110|19093532|P1|STARTED|Overall Study||44
7754724|NCT01462084|19093552|P2|NOT COMPLETED|Overall Study||1
7754725|NCT01462084|19093553|P1|NOT COMPLETED|Overall Study||2
7754726|NCT01462084|19093552|P2|COMPLETED|Overall Study||9
7754727|NCT01462084|19093553|P1|COMPLETED|Overall Study||9
7754728|NCT01462084|19093552|P2|Included for Analysis|Overall Study||9
7754729|NCT01462084|19093553|P1|Included for Analysis|Overall Study||9
7754730|NCT01462084|19093552|P2|STARTED|Overall Study||10
7754731|NCT01462084|19093553|P1|STARTED|Overall Study||11
7754732|NCT01462045|19093564|P3|NOT COMPLETED|Overall Study||0
7754733|NCT01462045|19093565|P2|NOT COMPLETED|Overall Study||1
7754734|NCT01462045|19093566|P1|NOT COMPLETED|Overall Study||0
7754735|NCT01462045|19093564|P3|COMPLETED|Overall Study||7
7754736|NCT01462045|19093565|P2|COMPLETED|Overall Study||10
7754737|NCT01462045|19093566|P1|COMPLETED|Overall Study||11
7754740|NCT01462045|19093566|P1|STARTED|Overall Study||11
7754741|NCT01461993|19093580|P3|NOT COMPLETED|Overall Study||64
7754742|NCT01461993|19093581|P2|NOT COMPLETED|Overall Study||157
7754743|NCT01461993|19093582|P1|NOT COMPLETED|Overall Study||151
7754744|NCT01461993|19093580|P3|COMPLETED|Overall Study||438
7754745|NCT01461993|19093581|P2|COMPLETED|Overall Study||841
7754746|NCT01461993|19093582|P1|COMPLETED|Overall Study||848
7754747|NCT01461993|19093580|P3|STARTED|Overall Study||502
7754748|NCT01461993|19093581|P2|STARTED|Overall Study||998
7754749|NCT01461993|19093582|P1|STARTED|Overall Study||999
7754750|NCT01461980|19093607|P3|NOT COMPLETED|Overall Study||165
7754751|NCT01461980|19093608|P2|NOT COMPLETED|Overall Study||145
7754752|NCT01461980|19093609|P1|NOT COMPLETED|Overall Study||166
7754753|NCT01461980|19093607|P3|COMPLETED|Overall Study||717
7754754|NCT01461980|19093608|P2|COMPLETED|Overall Study||733
7754755|NCT01461980|19093609|P1|COMPLETED|Overall Study||722
7754756|NCT01461980|19093607|P3|Vaccination 3|Overall Study||748
7754757|NCT01461980|19093608|P2|Vaccination 3|Overall Study||777
7754758|NCT01461980|19093609|P1|Vaccination 3|Overall Study||757
7754759|NCT01461980|19093607|P3|Vaccination 2|Overall Study||799
7754760|NCT01461980|19093608|P2|Vaccination 2|Overall Study||819
7754761|NCT01461980|19093609|P1|Vaccination 2|Overall Study||802
7754762|NCT01461980|19093607|P3|Vaccination 1|Overall Study||875
7754763|NCT01461980|19093608|P2|Vaccination 1|Overall Study||870
7754764|NCT01461980|19093609|P1|Vaccination 1|Overall Study||884
7754765|NCT01461980|19093607|P3|STARTED|Overall Study||882
7754766|NCT01461980|19093608|P2|STARTED|Overall Study||878
7754767|NCT01461980|19093609|P1|STARTED|Overall Study||888
7754768|NCT01461928|19093639|P3|NOT COMPLETED|Maintenance II (15 Months)||27
7754769|NCT01461928|19093640|P2|NOT COMPLETED|Maintenance II (15 Months)||23
7754770|NCT01461928|19093641|P1|NOT COMPLETED|Maintenance II (15 Months)||0
7754771|NCT01461928|19093639|P3|COMPLETED|Maintenance II (15 Months)||111
7754772|NCT01461928|19093640|P2|COMPLETED|Maintenance II (15 Months)|6 participants did not receive treatment|115
7754773|NCT01461928|19093641|P1|COMPLETED|Maintenance II (15 Months)||0
7754774|NCT01461928|19093639|P3|STARTED|Maintenance II (15 Months)||138
7754775|NCT01461928|19093640|P2|STARTED|Maintenance II (15 Months)||138
7754776|NCT01461928|19093641|P1|STARTED|Maintenance II (15 Months)||0
7754777|NCT01461928|19093639|P3|NOT COMPLETED|Maintenance I (24 Months)||0
7754778|NCT01461928|19093640|P2|NOT COMPLETED|Maintenance I (24 Months)||0
7754779|NCT01461928|19093641|P1|NOT COMPLETED|Maintenance I (24 Months)||218
7754780|NCT01461928|19093639|P3|COMPLETED|Maintenance I (24 Months)||0
7754781|NCT01461928|19093640|P2|COMPLETED|Maintenance I (24 Months)||0
7754782|NCT01461928|19093641|P1|COMPLETED|Maintenance I (24 Months)|Responders during 2 yrs Maint I treatment|276
7754783|NCT01461928|19093639|P3|STARTED|Maintenance I (24 Months)||0
7754784|NCT01461928|19093640|P2|STARTED|Maintenance I (24 Months)||0
7754785|NCT01461928|19093641|P1|STARTED|Maintenance I (24 Months)||494
7754786|NCT01461928|19093639|P3|NOT COMPLETED|Induction (up to 8 Months)||0
7754787|NCT01461928|19093640|P2|NOT COMPLETED|Induction (up to 8 Months)||0
7754788|NCT01461928|19093641|P1|NOT COMPLETED|Induction (up to 8 Months)||198
7754789|NCT01461928|19093639|P3|COMPLETED|Induction (up to 8 Months)||0
7754790|NCT01461928|19093640|P2|COMPLETED|Induction (up to 8 Months)||0
7754791|NCT01461928|19093641|P1|COMPLETED|Induction (up to 8 Months)||494
7754792|NCT01461928|19093639|P3|STARTED|Induction (up to 8 Months)||0
7754793|NCT01461928|19093640|P2|STARTED|Induction (up to 8 Months)||0
7754794|NCT01461928|19093641|P1|STARTED|Induction (up to 8 Months)||692
7754795|NCT01461863|19093662|P2|NOT COMPLETED|Overall Study||0
7754796|NCT01461863|19093663|P1|NOT COMPLETED|Overall Study||0
7754797|NCT01461863|19093662|P2|COMPLETED|Overall Study||48
7754798|NCT01461863|19093663|P1|COMPLETED|Overall Study||48
7754799|NCT01461863|19093662|P2|STARTED|Overall Study||48
7754800|NCT01461863|19093663|P1|STARTED|Overall Study||48
7754801|NCT01461824|19093674|P3|NOT COMPLETED|Overall Study||3
7754802|NCT01461824|19093675|P2|NOT COMPLETED|Overall Study||4
7754803|NCT01461824|19093676|P1|NOT COMPLETED|Overall Study||2
7754804|NCT01461824|19093674|P3|COMPLETED|Overall Study||8
7754805|NCT01461824|19093675|P2|COMPLETED|Overall Study||7
7754806|NCT01461824|19093676|P1|COMPLETED|Overall Study||10
7754807|NCT01461824|19093674|P3|STARTED|Overall Study||11
7754808|NCT01461824|19093675|P2|STARTED|Overall Study||11
7754809|NCT01461824|19093676|P1|STARTED|Overall Study||12
7754810|NCT01461811|19093692|P2|NOT COMPLETED|Overall Study||3
7754811|NCT01461811|19093693|P1|NOT COMPLETED|Overall Study||4
7754812|NCT01461811|19093692|P2|COMPLETED|Overall Study||46
7754813|NCT01461811|19093693|P1|COMPLETED|Overall Study||91
7754814|NCT01461811|19093692|P2|STARTED|Overall Study||49
7754815|NCT01461811|19093693|P1|STARTED|Overall Study||95
7754816|NCT01461733|19093723|P2|NOT COMPLETED|Overall Study||4
7754817|NCT01461733|19093724|P1|NOT COMPLETED|Overall Study||4
7754818|NCT01461733|19093723|P2|COMPLETED|Overall Study||8
7754819|NCT01461733|19093724|P1|COMPLETED|Overall Study||8
7754820|NCT01461733|19093723|P2|STARTED|Overall Study||12
7754821|NCT01461733|19093724|P1|STARTED|Overall Study||12
7754822|NCT01461707|19093732|P2|NOT COMPLETED|Overall Study||0
7754823|NCT01461707|19093733|P1|NOT COMPLETED|Overall Study||1
7754824|NCT01461707|19093732|P2|COMPLETED|Overall Study||15
7754825|NCT01461707|19093733|P1|COMPLETED|Overall Study||14
7754826|NCT01461707|19093732|P2|STARTED|Overall Study||15
7754827|NCT01461707|19093733|P1|STARTED|Overall Study||15
7754828|NCT01461668|19093743|P2|NOT COMPLETED|Overall Study||1
7754829|NCT01461668|19093744|P1|NOT COMPLETED|Overall Study||2
7754830|NCT01461668|19093743|P2|COMPLETED|Overall Study||25
7754831|NCT01461668|19093744|P1|COMPLETED|Overall Study||25
7754832|NCT01461668|19093743|P2|STARTED|Overall Study||26
7754833|NCT01461668|19093744|P1|STARTED|Overall Study||27
7754834|NCT01461655|19093750|P1|NOT COMPLETED|Overall Study||0
7754835|NCT01461655|19093750|P1|COMPLETED|Overall Study||40
7754836|NCT01461655|19093750|P1|STARTED|Overall Study||40
7754837|NCT01461551|19093770|P3|NOT COMPLETED|Overall Study||2
7754838|NCT01461551|19093771|P2|NOT COMPLETED|Overall Study||1
7754839|NCT01461551|19093772|P1|NOT COMPLETED|Overall Study||2
7754840|NCT01461551|19093770|P3|COMPLETED|Overall Study||33
7754841|NCT01461551|19093771|P2|COMPLETED|Overall Study||34
7754842|NCT01461551|19093772|P1|COMPLETED|Overall Study||33
7754843|NCT01461551|19093770|P3|STARTED|Overall Study||35
7754844|NCT01461551|19093771|P2|STARTED|Overall Study||35
7754845|NCT01461551|19093772|P1|STARTED|Overall Study||35
7754846|NCT01461538|19093783|P3|NOT COMPLETED|Overall Study||2
7754847|NCT01461538|19093784|P2|NOT COMPLETED|Overall Study||8
7754848|NCT01461538|19093785|P1|NOT COMPLETED|Overall Study||18
7754849|NCT01461538|19093783|P3|COMPLETED|Overall Study||7
7754850|NCT01461538|19093784|P2|COMPLETED|Overall Study||20
7754851|NCT01461538|19093785|P1|COMPLETED|Overall Study||28
7754852|NCT01461538|19093783|P3|STARTED|Overall Study||9
7754853|NCT01461538|19093784|P2|STARTED|Overall Study||28
7754854|NCT01461538|19093785|P1|STARTED|Overall Study||46
7754855|NCT01461499|19093823|P2|NOT COMPLETED|Overall Study||4
7754856|NCT01461499|19093824|P1|NOT COMPLETED|Overall Study||8
7754857|NCT01461499|19093823|P2|COMPLETED|Overall Study||114
7754858|NCT01461499|19093824|P1|COMPLETED|Overall Study||111
7754859|NCT01461499|19093823|P2|STARTED|Overall Study||118
7754860|NCT01461499|19093824|P1|STARTED|Overall Study||119
7754861|NCT01461473|19093834|P2|NOT COMPLETED|Overall Study||4
7754862|NCT01461473|19093835|P1|NOT COMPLETED|Overall Study||5
7754863|NCT01461473|19093834|P2|COMPLETED|Overall Study||55
7754864|NCT01461473|19093835|P1|COMPLETED|Overall Study||67
7754865|NCT01461473|19093834|P2|STARTED|Overall Study||59
7754866|NCT01461473|19093835|P1|STARTED|Overall Study||72
7754867|NCT01461369|19093854|P3|NOT COMPLETED|Overall Study||17
7754868|NCT01461369|19093855|P2|NOT COMPLETED|Overall Study||17
7754869|NCT01461369|19093856|P1|NOT COMPLETED|Overall Study||13
7754870|NCT01461369|19093854|P3|COMPLETED|Overall Study||86
7754871|NCT01461369|19093855|P2|COMPLETED|Overall Study||81
7754872|NCT01461369|19093856|P1|COMPLETED|Overall Study||91
7754873|NCT01461369|19093854|P3|STARTED|Overall Study||103
7754874|NCT01461369|19093855|P2|STARTED|Overall Study||98
7754875|NCT01461369|19093856|P1|STARTED|Overall Study||104
7754876|NCT01461096|19093881|P2|NOT COMPLETED|Overall Study||61
7754877|NCT01461096|19093882|P1|NOT COMPLETED|Overall Study||62
7754878|NCT01461096|19093881|P2|COMPLETED|Overall Study||226
7754879|NCT01461096|19093882|P1|COMPLETED|Overall Study||226
7754880|NCT01461096|19093881|P2|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1
7754881|NCT01461096|19093882|P1|Did Not Start Treatment|Overall Study||0
7754882|NCT01461096|19093881|P2|STARTED|Overall Study||287
7754883|NCT01461096|19093882|P1|STARTED|Overall Study||288
7754884|NCT01461057|19093898|P2|NOT COMPLETED|Overall Study||15
7754885|NCT01461057|19093899|P1|NOT COMPLETED|Overall Study||15
7754886|NCT01461057|19093898|P2|COMPLETED|Overall Study||0
7754887|NCT01461057|19093899|P1|COMPLETED|Overall Study||0
7754888|NCT01461057|19093898|P2|STARTED|Overall Study||15
7754889|NCT01461057|19093899|P1|STARTED|Overall Study||15
7754890|NCT01461044|19093909|P2|NOT COMPLETED|Overall Study||40
7754891|NCT01461044|19093910|P1|NOT COMPLETED|Overall Study||70
7754892|NCT01461044|19093909|P2|COMPLETED|Overall Study||37
7754893|NCT01461044|19093910|P1|COMPLETED|Overall Study||80
7754894|NCT01461044|19093909|P2|Participants Alive at Inclusion|Overall Study||58
7754895|NCT01461044|19093910|P1|Participants Alive at Inclusion|Overall Study||127
7754896|NCT01461044|19093909|P2|STARTED|Overall Study||77
7754897|NCT01461044|19093910|P1|STARTED|Overall Study||150
7754898|NCT01461005|19093983|P1|NOT COMPLETED|Overall Study||1
7754899|NCT01461005|19093983|P1|COMPLETED|Overall Study||0
7754900|NCT01461005|19093983|P1|STARTED|Overall Study||1
7754901|NCT01460940|19093992|P1|NOT COMPLETED|Overall Study||0
7754902|NCT01460940|19093992|P1|COMPLETED|Overall Study||24
7754903|NCT01460940|19093992|P1|STARTED|Overall Study||24
7754904|NCT01460927|19093998|P1|NOT COMPLETED|Overall Study||0
7754905|NCT01460927|19093998|P1|COMPLETED|Overall Study||25
7754906|NCT01460927|19093998|P1|STARTED|Overall Study||25
7754907|NCT01460901|19094006|P1|NOT COMPLETED|Overall Study||2
7754908|NCT01460901|19094006|P1|COMPLETED|Overall Study|Follow-up completed|3
7754909|NCT01460901|19094006|P1|tV-CTL Infusion|Overall Study||3
7754910|NCT01460901|19094006|P1|STARTED|Overall Study|First enrollment|5
7754911|NCT01460875|19094014|P1|NOT COMPLETED|Overall Study||0
7754912|NCT01460875|19094014|P1|COMPLETED|Overall Study||34
7754913|NCT01460875|19094014|P1|STARTED|Overall Study||34
7754914|NCT01460732|19094025|P1|NOT COMPLETED|Overall Study||0
7754915|NCT01460732|19094025|P1|COMPLETED|Overall Study||81
7754916|NCT01460732|19094025|P1|STARTED|Overall Study||81
7754917|NCT01460719|19094038|P1|NOT COMPLETED|Overall Study||2
7754918|NCT01460719|19094038|P1|COMPLETED|Overall Study||78
7754919|NCT01460719|19094038|P1|Vaccination 4 (~Day 90)|Overall Study||78
7754920|NCT01460719|19094038|P1|Vaccination 3 (~Day 60)|Overall Study||78
7754921|NCT01460719|19094038|P1|Vaccination 2 (~Day 30)|Overall Study||78
7754922|NCT01460719|19094038|P1|Vaccination 1 (Day 1)|Overall Study||80
7754923|NCT01460719|19094038|P1|STARTED|Overall Study||80
7754924|NCT01460628|19094048|P1|NOT COMPLETED|Overall Study||5
7754925|NCT01460628|19094048|P1|COMPLETED|Overall Study||20
7754926|NCT01460628|19094048|P1|STARTED|Overall Study||25
7754927|NCT01460446|19094060|P2|NOT COMPLETED|Overall Study||20
7754928|NCT01460446|19094061|P1|NOT COMPLETED|Overall Study||5
7754929|NCT01460446|19094060|P2|COMPLETED|Overall Study||93
7754930|NCT01460446|19094061|P1|COMPLETED|Overall Study||100
7754931|NCT01460446|19094060|P2|STARTED|Overall Study||113
7754932|NCT01460446|19094061|P1|STARTED|Overall Study||105
7754933|NCT01460407|19094088|P2|NOT COMPLETED|Period 2: Day 6 to Day 14||1
7754934|NCT01460407|19094089|P1|NOT COMPLETED|Period 2: Day 6 to Day 14||0
7754935|NCT01460407|19094088|P2|COMPLETED|Period 2: Day 6 to Day 14||13
7754936|NCT01460407|19094089|P1|COMPLETED|Period 2: Day 6 to Day 14||0
7754937|NCT01460407|19094088|P2|STARTED|Period 2: Day 6 to Day 14||14
7754938|NCT01460407|19094089|P1|STARTED|Period 2: Day 6 to Day 14||0
7754939|NCT01460407|19094088|P2|NOT COMPLETED|Period 1: Day 1 to Day 5||0
7754940|NCT01460407|19094089|P1|NOT COMPLETED|Period 1: Day 1 to Day 5||0
7754941|NCT01460407|19094088|P2|COMPLETED|Period 1: Day 1 to Day 5||0
7754942|NCT01460407|19094089|P1|COMPLETED|Period 1: Day 1 to Day 5||14
7754943|NCT01460407|19094088|P2|STARTED|Period 1: Day 1 to Day 5||0
7754944|NCT01460407|19094089|P1|STARTED|Period 1: Day 1 to Day 5||14
7754945|NCT01460381|19094102|P2|NOT COMPLETED|Period 2 (Days 8-15)||0
7754946|NCT01460381|19094103|P1|NOT COMPLETED|Period 2 (Days 8-15)||1
7754947|NCT01460381|19094102|P2|COMPLETED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2|0
7754948|NCT01460381|19094103|P1|COMPLETED|Period 2 (Days 8-15)|One participant was lost to follow-up after completing Period 2 and did not complete the study.|6
7754949|NCT01460381|19094102|P2|STARTED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2.|0
7754950|NCT01460381|19094103|P1|STARTED|Period 2 (Days 8-15)||7
7754951|NCT01460381|19094102|P2|NOT COMPLETED|Period 1 (Days 1-7)||0
7754952|NCT01460381|19094103|P1|NOT COMPLETED|Period 1 (Days 1-7)||0
7754953|NCT01460381|19094102|P2|COMPLETED|Period 1 (Days 1-7)||11
7754954|NCT01460381|19094103|P1|COMPLETED|Period 1 (Days 1-7)||7
7754955|NCT01460381|19094102|P2|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||11
7754956|NCT01460381|19094103|P1|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||7
7754957|NCT01460381|19094102|P2|STARTED|Period 1 (Days 1-7)||11
7754958|NCT01460381|19094103|P1|STARTED|Period 1 (Days 1-7)||7
7754959|NCT01460368|19094119|P7|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
7754960|NCT01460368|19094120|P6|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
7754961|NCT01460368|19094121|P5|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
7754962|NCT01460368|19094122|P4|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
7754963|NCT01460368|19094123|P3|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
7754964|NCT01460368|19094124|P2|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
7754965|NCT01460368|19094125|P1|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
7754966|NCT01460368|19094119|P7|COMPLETED|Part B: Third Interventions (Period 3)||9
7754967|NCT01460368|19094120|P6|COMPLETED|Part B: Third Interventions (Period 3)||9
7754968|NCT01460368|19094121|P5|COMPLETED|Part B: Third Interventions (Period 3)||9
7754969|NCT01460368|19094122|P4|COMPLETED|Part B: Third Interventions (Period 3)||9
7754970|NCT01460368|19094123|P3|COMPLETED|Part B: Third Interventions (Period 3)||8
7754971|NCT01460368|19094124|P2|COMPLETED|Part B: Third Interventions (Period 3)||8
7754972|NCT01460368|19094125|P1|COMPLETED|Part B: Third Interventions (Period 3)||0
7754973|NCT01460368|19094119|P7|STARTED|Part B: Third Interventions (Period 3)||9
7754974|NCT01460368|19094120|P6|STARTED|Part B: Third Interventions (Period 3)||10
7754975|NCT01460368|19094121|P5|STARTED|Part B: Third Interventions (Period 3)||9
7754976|NCT01460368|19094122|P4|STARTED|Part B: Third Interventions (Period 3)||10
7754977|NCT01460368|19094123|P3|STARTED|Part B: Third Interventions (Period 3)||9
7754978|NCT01460368|19094124|P2|STARTED|Part B: Third Interventions (Period 3)||8
7754979|NCT01460368|19094125|P1|STARTED|Part B: Third Interventions (Period 3)||0
7754980|NCT01460368|19094119|P7|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
7754981|NCT01460368|19094120|P6|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
7754982|NCT01460368|19094121|P5|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
7754983|NCT01460368|19094122|P4|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
7754984|NCT01460368|19094123|P3|NOT COMPLETED|Part B: Washout (up to 15 Days)||1
7754985|NCT01460368|19094124|P2|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
7754986|NCT01460368|19094125|P1|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
7754987|NCT01460368|19094119|P7|COMPLETED|Part B: Washout (up to 15 Days)||9
7754988|NCT01460368|19094120|P6|COMPLETED|Part B: Washout (up to 15 Days)||10
7754989|NCT01460368|19094121|P5|COMPLETED|Part B: Washout (up to 15 Days)||9
7754990|NCT01460368|19094122|P4|COMPLETED|Part B: Washout (up to 15 Days)||10
7754991|NCT01460368|19094123|P3|COMPLETED|Part B: Washout (up to 15 Days)||9
7754992|NCT01460368|19094124|P2|COMPLETED|Part B: Washout (up to 15 Days)||8
7754993|NCT01460368|19094125|P1|COMPLETED|Part B: Washout (up to 15 Days)||0
7754994|NCT01460368|19094119|P7|STARTED|Part B: Washout (up to 15 Days)||9
7754995|NCT01460368|19094120|P6|STARTED|Part B: Washout (up to 15 Days)||10
7754996|NCT01460368|19094121|P5|STARTED|Part B: Washout (up to 15 Days)||9
7754997|NCT01460368|19094122|P4|STARTED|Part B: Washout (up to 15 Days)||10
7754998|NCT01460368|19094123|P3|STARTED|Part B: Washout (up to 15 Days)||10
7754999|NCT01460368|19094124|P2|STARTED|Part B: Washout (up to 15 Days)||8
7755000|NCT01460368|19094125|P1|STARTED|Part B: Washout (up to 15 Days)||0
7755001|NCT01460368|19094119|P7|NOT COMPLETED|Part B: Second Intervention (Period 2)||1
7755002|NCT01460368|19094120|P6|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
7755003|NCT01460368|19094121|P5|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
7755004|NCT01460368|19094122|P4|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
7755005|NCT01460368|19094123|P3|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
7755006|NCT01460368|19094124|P2|NOT COMPLETED|Part B: Second Intervention (Period 2)||2
7755007|NCT01460368|19094125|P1|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
7755008|NCT01460368|19094119|P7|COMPLETED|Part B: Second Intervention (Period 2)||9
7755009|NCT01460368|19094120|P6|COMPLETED|Part B: Second Intervention (Period 2)||10
7755010|NCT01460368|19094121|P5|COMPLETED|Part B: Second Intervention (Period 2)||9
7755011|NCT01460368|19094122|P4|COMPLETED|Part B: Second Intervention (Period 2)||10
7755012|NCT01460368|19094123|P3|COMPLETED|Part B: Second Intervention (Period 2)||10
7755013|NCT01460368|19094124|P2|COMPLETED|Part B: Second Intervention (Period 2)||8
7755014|NCT01460368|19094125|P1|COMPLETED|Part B: Second Intervention (Period 2)||0
7755015|NCT01460368|19094119|P7|STARTED|Part B: Second Intervention (Period 2)||10
7755016|NCT01460368|19094120|P6|STARTED|Part B: Second Intervention (Period 2)||10
7755017|NCT01460368|19094121|P5|STARTED|Part B: Second Intervention (Period 2)||9
7755018|NCT01460368|19094122|P4|STARTED|Part B: Second Intervention (Period 2)||10
7755019|NCT01460368|19094123|P3|STARTED|Part B: Second Intervention (Period 2)||10
7755020|NCT01460368|19094124|P2|STARTED|Part B: Second Intervention (Period 2)||10
7755021|NCT01460368|19094125|P1|STARTED|Part B: Second Intervention (Period 2)||0
7755022|NCT01460368|19094119|P7|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
7755023|NCT01460368|19094120|P6|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
7755024|NCT01460368|19094121|P5|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
7755025|NCT01460368|19094122|P4|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
7755026|NCT01460368|19094123|P3|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
7755027|NCT01460368|19094124|P2|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
7755028|NCT01460368|19094125|P1|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
7755029|NCT01460368|19094119|P7|COMPLETED|Part B: Washout (up to 15 Days)||10
7755030|NCT01460368|19094120|P6|COMPLETED|Part B: Washout (up to 15 Days)||10
7755031|NCT01460368|19094121|P5|COMPLETED|Part B: Washout (up to 15 Days)||9
7755032|NCT01460368|19094122|P4|COMPLETED|Part B: Washout (up to 15 Days)||10
7755033|NCT01460368|19094123|P3|COMPLETED|Part B: Washout (up to 15 Days)||10
7755034|NCT01460368|19094124|P2|COMPLETED|Part B: Washout (up to 15 Days)||10
7755035|NCT01460368|19094125|P1|COMPLETED|Part B: Washout (up to 15 Days)||0
7755036|NCT01460368|19094119|P7|STARTED|Part B: Washout (up to 15 Days)||10
7755037|NCT01460368|19094120|P6|STARTED|Part B: Washout (up to 15 Days)||10
7755038|NCT01460368|19094121|P5|STARTED|Part B: Washout (up to 15 Days)||9
7755039|NCT01460368|19094122|P4|STARTED|Part B: Washout (up to 15 Days)||10
7755040|NCT01460368|19094123|P3|STARTED|Part B: Washout (up to 15 Days)||10
7755041|NCT01460368|19094124|P2|STARTED|Part B: Washout (up to 15 Days)||10
7755042|NCT01460368|19094125|P1|STARTED|Part B: Washout (up to 15 Days)||0
7755043|NCT01460368|19094119|P7|NOT COMPLETED|Part B: First Intervention (Period 1)||0
7755044|NCT01460368|19094120|P6|NOT COMPLETED|Part B: First Intervention (Period 1)||0
7755045|NCT01460368|19094121|P5|NOT COMPLETED|Part B: First Intervention (Period 1)||1
7755046|NCT01460368|19094122|P4|NOT COMPLETED|Part B: First Intervention (Period 1)||0
7755047|NCT01460368|19094123|P3|NOT COMPLETED|Part B: First Intervention (Period 1)||0
7755048|NCT01460368|19094124|P2|NOT COMPLETED|Part B: First Intervention (Period 1)||0
7755049|NCT01460368|19094125|P1|NOT COMPLETED|Part B: First Intervention (Period 1)||0
7755050|NCT01460368|19094119|P7|COMPLETED|Part B: First Intervention (Period 1)||10
7755051|NCT01460368|19094120|P6|COMPLETED|Part B: First Intervention (Period 1)||10
7755052|NCT01460368|19094121|P5|COMPLETED|Part B: First Intervention (Period 1)||9
7755053|NCT01460368|19094122|P4|COMPLETED|Part B: First Intervention (Period 1)||10
7755054|NCT01460368|19094123|P3|COMPLETED|Part B: First Intervention (Period 1)||10
7755055|NCT01460368|19094124|P2|COMPLETED|Part B: First Intervention (Period 1)||10
7755056|NCT01460368|19094125|P1|COMPLETED|Part B: First Intervention (Period 1)||0
7755057|NCT01460368|19094119|P7|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
7755058|NCT01460368|19094120|P6|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
7755059|NCT01460368|19094121|P5|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
7755060|NCT01460368|19094122|P4|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
7755061|NCT01460368|19094123|P3|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
7755062|NCT01460368|19094124|P2|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
7755063|NCT01460368|19094125|P1|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||0
7755064|NCT01460368|19094119|P7|STARTED|Part B: First Intervention (Period 1)||10
7755065|NCT01460368|19094120|P6|STARTED|Part B: First Intervention (Period 1)||10
7755066|NCT01460368|19094121|P5|STARTED|Part B: First Intervention (Period 1)||10
7755067|NCT01460368|19094122|P4|STARTED|Part B: First Intervention (Period 1)||10
7755068|NCT01460368|19094123|P3|STARTED|Part B: First Intervention (Period 1)||10
7755069|NCT01460368|19094124|P2|STARTED|Part B: First Intervention (Period 1)||10
7755070|NCT01460368|19094125|P1|STARTED|Part B: First Intervention (Period 1)||0
7755071|NCT01460368|19094119|P7|NOT COMPLETED|Part A||0
7755072|NCT01460368|19094120|P6|NOT COMPLETED|Part A||0
7755073|NCT01460368|19094121|P5|NOT COMPLETED|Part A||0
7755074|NCT01460368|19094122|P4|NOT COMPLETED|Part A||0
7755075|NCT01460368|19094123|P3|NOT COMPLETED|Part A||0
7755076|NCT01460368|19094124|P2|NOT COMPLETED|Part A||0
7755077|NCT01460368|19094125|P1|NOT COMPLETED|Part A||0
7755078|NCT01460368|19094119|P7|COMPLETED|Part A||0
7755079|NCT01460368|19094120|P6|COMPLETED|Part A||0
7755080|NCT01460368|19094121|P5|COMPLETED|Part A||0
7755081|NCT01460368|19094122|P4|COMPLETED|Part A||0
7755082|NCT01460368|19094123|P3|COMPLETED|Part A||0
7755083|NCT01460368|19094124|P2|COMPLETED|Part A||0
7755084|NCT01460368|19094125|P1|COMPLETED|Part A||7
7755085|NCT01460368|19094119|P7|Received at Least One Dose of Study Drug|Part A||0
7755086|NCT01460368|19094120|P6|Received at Least One Dose of Study Drug|Part A||0
7755087|NCT01460368|19094121|P5|Received at Least One Dose of Study Drug|Part A||0
7755088|NCT01460368|19094122|P4|Received at Least One Dose of Study Drug|Part A||0
7755089|NCT01460368|19094123|P3|Received at Least One Dose of Study Drug|Part A||0
7755090|NCT01460368|19094124|P2|Received at Least One Dose of Study Drug|Part A||0
7755091|NCT01460368|19094125|P1|Received at Least One Dose of Study Drug|Part A||7
7755092|NCT01460368|19094119|P7|STARTED|Part A||0
7755093|NCT01460368|19094120|P6|STARTED|Part A||0
7755094|NCT01460368|19094121|P5|STARTED|Part A||0
7755095|NCT01460368|19094122|P4|STARTED|Part A||0
7755096|NCT01460368|19094123|P3|STARTED|Part A||0
7755097|NCT01460368|19094124|P2|STARTED|Part A||0
7755098|NCT01460368|19094125|P1|STARTED|Part A||7
7755099|NCT01460342|19094137|P2|NOT COMPLETED|Overall Study||14
7755100|NCT01460342|19094138|P1|NOT COMPLETED|Overall Study||11
7755101|NCT01460342|19094137|P2|COMPLETED|Overall Study||292
7755102|NCT01460342|19094138|P1|COMPLETED|Overall Study||293
7755103|NCT01460342|19094137|P2|Received at Least 1 Dose of Study Drug|Overall Study||306
7755104|NCT01460342|19094138|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
7755105|NCT01460342|19094137|P2|STARTED|Overall Study||306
7755106|NCT01460342|19094138|P1|STARTED|Overall Study||304
7755107|NCT01460303|19094160|P2|NOT COMPLETED|Overall Study||0
7755108|NCT01460303|19094161|P1|NOT COMPLETED|Overall Study||0
7755109|NCT01460303|19094160|P2|COMPLETED|Overall Study||24
7755110|NCT01460303|19094161|P1|COMPLETED|Overall Study||25
7755111|NCT01460303|19094160|P2|STARTED|Overall Study||24
7755112|NCT01460303|19094161|P1|STARTED|Overall Study||25
7755113|NCT01460290|19094169|P1|NOT COMPLETED|Overall Study||4
7755114|NCT01460290|19094169|P1|COMPLETED|Overall Study||11
7755115|NCT01460290|19094169|P1|STARTED|Overall Study||15
7755116|NCT01460225|19094189|P1|NOT COMPLETED|Overall Study||0
7755117|NCT01460225|19094189|P1|COMPLETED|Overall Study|November 2010|19
7755118|NCT01460225|19094189|P1|STARTED|Overall Study|January 2009.|19
7755119|NCT01460160|19094196|P2|NOT COMPLETED|Follow-up||2
7755120|NCT01460160|19094197|P1|NOT COMPLETED|Follow-up||11
7755121|NCT01460160|19094196|P2|COMPLETED|Follow-up||20
7755122|NCT01460160|19094197|P1|COMPLETED|Follow-up||67
7755123|NCT01460160|19094196|P2|STARTED|Follow-up||22
7755124|NCT01460160|19094197|P1|STARTED|Follow-up||78
7755125|NCT01460160|19094196|P2|NOT COMPLETED|Treatment||5
7755126|NCT01460160|19094197|P1|NOT COMPLETED|Treatment||23
7755127|NCT01460160|19094196|P2|COMPLETED|Treatment||19
7755128|NCT01460160|19094197|P1|COMPLETED|Treatment||59
7755129|NCT01460160|19094196|P2|STARTED|Treatment||24
7755130|NCT01460160|19094197|P1|STARTED|Treatment||82
7755131|NCT01459913|19094238|P4|NOT COMPLETED|Overall Study||33
7755132|NCT01459913|19094239|P3|NOT COMPLETED|Overall Study||13
7755133|NCT01459913|19094240|P2|NOT COMPLETED|Overall Study||20
7755134|NCT01459913|19094241|P1|NOT COMPLETED|Overall Study||41
7755135|NCT01459913|19094238|P4|COMPLETED|Overall Study||29
7755136|NCT01459913|19094239|P3|COMPLETED|Overall Study||6
7755137|NCT01459913|19094240|P2|COMPLETED|Overall Study||32
7755138|NCT01459913|19094241|P1|COMPLETED|Overall Study||65
7755139|NCT01459913|19094238|P4|STARTED|Overall Study||62
7755140|NCT01459913|19094239|P3|STARTED|Overall Study||19
7755141|NCT01459913|19094240|P2|STARTED|Overall Study||52
7755142|NCT01459913|19094241|P1|STARTED|Overall Study||106
7755143|NCT01459796|19094272|P2|NOT COMPLETED|Overall Study||126
7755144|NCT01459796|19094273|P1|NOT COMPLETED|Overall Study||94
7755145|NCT01459796|19094272|P2|COMPLETED|Overall Study||0
7755146|NCT01459796|19094273|P1|COMPLETED|Overall Study||0
7755147|NCT01459796|19094272|P2|STARTED|Overall Study||126
7755148|NCT01459796|19094273|P1|STARTED|Overall Study||94
7755149|NCT01459783|19094291|P2|NOT COMPLETED|6 Months to 12 Months||30
7755150|NCT01459783|19094292|P1|NOT COMPLETED|6 Months to 12 Months||19
7755151|NCT01459783|19094291|P2|COMPLETED|6 Months to 12 Months||23
7755152|NCT01459783|19094292|P1|COMPLETED|6 Months to 12 Months||20
7755153|NCT01459783|19094291|P2|STARTED|6 Months to 12 Months||53
7755154|NCT01459783|19094292|P1|STARTED|6 Months to 12 Months||39
7755155|NCT01459783|19094291|P2|NOT COMPLETED|Baseline to 6 Months||20
7755156|NCT01459783|19094292|P1|NOT COMPLETED|Baseline to 6 Months||32
7755157|NCT01459783|19094291|P2|COMPLETED|Baseline to 6 Months||53
7755158|NCT01459783|19094292|P1|COMPLETED|Baseline to 6 Months||39
7755159|NCT01459783|19094291|P2|STARTED|Baseline to 6 Months||73
7755160|NCT01459783|19094292|P1|STARTED|Baseline to 6 Months||71
7755161|NCT01459718|19094300|P1|NOT COMPLETED|Overall Study||3
7755162|NCT01459718|19094300|P1|COMPLETED|Overall Study||10
7755163|NCT01459718|19094300|P1|Safety Analysis Set|Overall Study||13
7755164|NCT01459718|19094300|P1|STARTED|Overall Study||13
7755165|NCT01459705|19094314|P3|NOT COMPLETED|Overall Study||7
7755166|NCT01459705|19094315|P2|NOT COMPLETED|Overall Study||24
7755167|NCT01459705|19094316|P1|NOT COMPLETED|Overall Study||22
7755168|NCT01459705|19094314|P3|COMPLETED|Overall Study||47
7755169|NCT01459705|19094315|P2|COMPLETED|Overall Study||30
7755170|NCT01459705|19094316|P1|COMPLETED|Overall Study||32
7755171|NCT01459705|19094314|P3|STARTED|Overall Study||54
7755172|NCT01459705|19094315|P2|STARTED|Overall Study||54
7755173|NCT01459705|19094316|P1|STARTED|Overall Study||54
7755174|NCT01459653|19094334|P1|NOT COMPLETED|Overall Study||668
7755175|NCT01459653|19094334|P1|COMPLETED|Overall Study||828
7755176|NCT01459653|19094334|P1|STARTED|Overall Study||1496
7755177|NCT01459614|19094482|P2|NOT COMPLETED|Overall Study||0
7755178|NCT01459614|19094483|P1|NOT COMPLETED|Overall Study||1
7755179|NCT01459614|19094482|P2|COMPLETED|Overall Study||10
7755180|NCT01459614|19094483|P1|COMPLETED|Overall Study||28
7755181|NCT01459614|19094482|P2|STARTED|Overall Study||10
7755182|NCT01459614|19094483|P1|STARTED|Overall Study||29
7755183|NCT01459588|19094499|P4|NOT COMPLETED|Overall Study||1
7755184|NCT01459588|19094500|P3|NOT COMPLETED|Overall Study||1
7755185|NCT01459588|19094501|P2|NOT COMPLETED|Overall Study||2
7755186|NCT01459588|19094502|P1|NOT COMPLETED|Overall Study||1
7755187|NCT01459588|19094499|P4|COMPLETED|Overall Study||55
7755188|NCT01459588|19094500|P3|COMPLETED|Overall Study||102
7755189|NCT01459588|19094501|P2|COMPLETED|Overall Study||49
7755190|NCT01459588|19094502|P1|COMPLETED|Overall Study||104
7755191|NCT01459588|19094499|P4|STARTED|Overall Study||56
7755192|NCT01459588|19094500|P3|STARTED|Overall Study||103
7755193|NCT01459588|19094501|P2|STARTED|Overall Study||51
7755194|NCT01459588|19094502|P1|STARTED|Overall Study||105
7755195|NCT01459068|19094530|P2|NOT COMPLETED|Overall Study||34
7755196|NCT01459068|19094531|P1|NOT COMPLETED|Overall Study||39
7755197|NCT01459068|19094530|P2|COMPLETED|Overall Study||148
7755198|NCT01459068|19094531|P1|COMPLETED|Overall Study||126
7755199|NCT01459068|19094530|P2|STARTED|Overall Study||182
7755200|NCT01459068|19094531|P1|STARTED|Overall Study||165
7755201|NCT01459016|19094547|P1|NOT COMPLETED|Overall Study||15
7755202|NCT01459016|19094547|P1|COMPLETED|Overall Study||41
7755203|NCT01459016|19094547|P1|STARTED|Overall Study||56
7755204|NCT01458990|19094563|P2|NOT COMPLETED|Overall Study||0
7755205|NCT01458990|19094564|P1|NOT COMPLETED|Overall Study||0
7755206|NCT01458990|19094563|P2|COMPLETED|Overall Study||15
7755207|NCT01458990|19094564|P1|COMPLETED|Overall Study||45
7755208|NCT01458990|19094563|P2|STARTED|Overall Study||15
7755209|NCT01458990|19094564|P1|STARTED|Overall Study||45
7755210|NCT01458951|19094575|P3|NOT COMPLETED|Overall Study||15
7755211|NCT01458951|19094576|P2|NOT COMPLETED|Overall Study||1
7755212|NCT01458951|19094577|P1|NOT COMPLETED|Overall Study||32
7755213|NCT01458951|19094575|P3|COMPLETED|Overall Study||97
7755214|NCT01458951|19094576|P2|COMPLETED|Overall Study||5
7755215|NCT01458951|19094577|P1|COMPLETED|Overall Study||397
7755216|NCT01458951|19094575|P3|STARTED|Overall Study||112
7755217|NCT01458951|19094576|P2|STARTED|Overall Study||6
7755218|NCT01458951|19094577|P1|STARTED|Overall Study||429
7755219|NCT01458639|19094602|P1|NOT COMPLETED|Overall Study||6
7755220|NCT01458639|19094602|P1|COMPLETED|Overall Study||12
7755221|NCT01458639|19094602|P1|STARTED|Overall Study||18
7755222|NCT01458587|19094614|P2|NOT COMPLETED|Overall Study||0
7755223|NCT01458587|19094615|P1|NOT COMPLETED|Overall Study||1
7755224|NCT01458587|19094614|P2|COMPLETED|Overall Study||35
7755225|NCT01458587|19094615|P1|COMPLETED|Overall Study||34
7755226|NCT01458587|19094614|P2|STARTED|Overall Study||35
7755227|NCT01458587|19094615|P1|STARTED|Overall Study||35
7755228|NCT01458574|19094778|P3|NOT COMPLETED|Overall Study||145
7755229|NCT01458574|19094779|P2|NOT COMPLETED|Overall Study||71
7755230|NCT01458574|19094780|P1|NOT COMPLETED|Overall Study||87
7755231|NCT01458574|19094778|P3|COMPLETED|Overall Study||53
7755232|NCT01458574|19094779|P2|COMPLETED|Overall Study||126
7755233|NCT01458574|19094780|P1|COMPLETED|Overall Study||111
7755234|NCT01458574|19094778|P3|Treated|Overall Study||198
7755235|NCT01458574|19094779|P2|Treated|Overall Study||196
7755236|NCT01458574|19094780|P1|Treated|Overall Study||198
7755237|NCT01458574|19094778|P3|STARTED|Overall Study||198
7755238|NCT01458574|19094779|P2|STARTED|Overall Study||197
7755239|NCT01458574|19094780|P1|STARTED|Overall Study||198
7755240|NCT01458561|19094865|P2|NOT COMPLETED|Overall Study||0
7755241|NCT01458561|19094866|P1|NOT COMPLETED|Overall Study||0
7755242|NCT01458561|19094865|P2|COMPLETED|Overall Study||1
7755243|NCT01458561|19094866|P1|COMPLETED|Overall Study||0
7755244|NCT01458561|19094865|P2|STARTED|Overall Study||1
7755245|NCT01458561|19094866|P1|STARTED|Overall Study||0
7755246|NCT01458535|19094910|P6|NOT COMPLETED|Overall Study||4
7755247|NCT01458535|19094911|P5|NOT COMPLETED|Overall Study||4
7755248|NCT01458535|19094912|P4|NOT COMPLETED|Overall Study||4
7755249|NCT01458535|19094913|P3|NOT COMPLETED|Overall Study||2
7755250|NCT01458535|19094914|P2|NOT COMPLETED|Overall Study||2
7755251|NCT01458535|19094915|P1|NOT COMPLETED|Overall Study||0
7755252|NCT01458535|19094910|P6|COMPLETED|Overall Study||7
7755253|NCT01458535|19094911|P5|COMPLETED|Overall Study||6
7755254|NCT01458535|19094912|P4|COMPLETED|Overall Study||6
7755255|NCT01458535|19094913|P3|COMPLETED|Overall Study||8
7755256|NCT01458535|19094914|P2|COMPLETED|Overall Study||8
7755257|NCT01458535|19094915|P1|COMPLETED|Overall Study||10
7755258|NCT01458535|19094910|P6|STARTED|Overall Study||11
7755259|NCT01458535|19094911|P5|STARTED|Overall Study||10
7755260|NCT01458535|19094912|P4|STARTED|Overall Study||10
7755261|NCT01458535|19094913|P3|STARTED|Overall Study||10
7755262|NCT01458535|19094914|P2|STARTED|Overall Study||10
7755263|NCT01458535|19094915|P1|STARTED|Overall Study||10
7755264|NCT01458522|19094967|P2|NOT COMPLETED|Overall Study||11
7755265|NCT01458522|19094968|P1|NOT COMPLETED|Overall Study||3
7755266|NCT01458522|19094967|P2|COMPLETED|Overall Study||26
7755267|NCT01458522|19094968|P1|COMPLETED|Overall Study||34
7755268|NCT01458522|19094967|P2|Crossover to Second Drug|Overall Study||10
7755269|NCT01458522|19094968|P1|Crossover to Second Drug|Overall Study||15
7755270|NCT01458522|19094967|P2|Received First Drug|Overall Study||35
7755271|NCT01458522|19094968|P1|Received First Drug|Overall Study||35
7755272|NCT01458522|19094967|P2|STARTED|Overall Study||37
7755273|NCT01458522|19094968|P1|STARTED|Overall Study||37
7755274|NCT01458418|19094998|P4|NOT COMPLETED|Overall Study||0
7755275|NCT01458418|19094999|P3|NOT COMPLETED|Overall Study||0
7755276|NCT01458418|19095000|P2|NOT COMPLETED|Overall Study||0
7755277|NCT01458418|19095001|P1|NOT COMPLETED|Overall Study||0
7755278|NCT01458418|19094998|P4|COMPLETED|Overall Study||4
7755279|NCT01458418|19094999|P3|COMPLETED|Overall Study||0
7755280|NCT01458418|19095000|P2|COMPLETED|Overall Study||0
7755281|NCT01458418|19095001|P1|COMPLETED|Overall Study||0
7755282|NCT01458418|19094998|P4|STARTED|Overall Study||4
7755283|NCT01458418|19094999|P3|STARTED|Overall Study||0
7755284|NCT01458418|19095000|P2|STARTED|Overall Study||0
7755285|NCT01458418|19095001|P1|STARTED|Overall Study||0
7755286|NCT01458392|19095014|P3|NOT COMPLETED|Overall Study||31
7755287|NCT01458392|19095015|P2|NOT COMPLETED|Overall Study||13
7755288|NCT01458392|19095016|P1|NOT COMPLETED|Overall Study||2
7755289|NCT01458392|19095014|P3|COMPLETED|Overall Study||0
7755290|NCT01458392|19095015|P2|COMPLETED|Overall Study||0
7755291|NCT01458392|19095016|P1|COMPLETED|Overall Study||0
7755292|NCT01458392|19095014|P3|STARTED|Overall Study||31
7755293|NCT01458392|19095015|P2|STARTED|Overall Study||13
7755294|NCT01458392|19095016|P1|STARTED|Overall Study||2
7755295|NCT01458366|19095041|P5|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||1
7755296|NCT01458366|19095042|P4|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
7755297|NCT01458366|19095043|P3|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
7755298|NCT01458366|19095044|P2|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
7755299|NCT01458366|19095045|P1|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
7755300|NCT01458366|19095041|P5|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||26
7755301|NCT01458366|19095042|P4|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
7755302|NCT01458366|19095043|P3|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
7755303|NCT01458366|19095044|P2|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
7755304|NCT01458366|19095045|P1|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
7755305|NCT01458366|19095041|P5|STARTED|Period 5: Maximum Tolerated Dose (MTD)||27
7755306|NCT01458366|19095042|P4|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
7755307|NCT01458366|19095043|P3|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
7755308|NCT01458366|19095044|P2|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
7755309|NCT01458366|19095045|P1|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
7755310|NCT01458366|19095041|P5|NOT COMPLETED|Period 4: 120mg/m^2||0
7755311|NCT01458366|19095042|P4|NOT COMPLETED|Period 4: 120mg/m^2||0
7755312|NCT01458366|19095043|P3|NOT COMPLETED|Period 4: 120mg/m^2||0
7755313|NCT01458366|19095044|P2|NOT COMPLETED|Period 4: 120mg/m^2||0
7755314|NCT01458366|19095045|P1|NOT COMPLETED|Period 4: 120mg/m^2||0
7755315|NCT01458366|19095041|P5|COMPLETED|Period 4: 120mg/m^2||0
7755316|NCT01458366|19095042|P4|COMPLETED|Period 4: 120mg/m^2||3
7755317|NCT01458366|19095043|P3|COMPLETED|Period 4: 120mg/m^2||0
7755318|NCT01458366|19095044|P2|COMPLETED|Period 4: 120mg/m^2||0
7755319|NCT01458366|19095045|P1|COMPLETED|Period 4: 120mg/m^2||0
7755320|NCT01458366|19095041|P5|STARTED|Period 4: 120mg/m^2||0
7755321|NCT01458366|19095042|P4|STARTED|Period 4: 120mg/m^2||3
7755322|NCT01458366|19095043|P3|STARTED|Period 4: 120mg/m^2||0
7755323|NCT01458366|19095044|P2|STARTED|Period 4: 120mg/m^2||0
7755324|NCT01458366|19095045|P1|STARTED|Period 4: 120mg/m^2||0
7755325|NCT01458366|19095041|P5|NOT COMPLETED|Period 3: 90mg/m^2||0
7755326|NCT01458366|19095042|P4|NOT COMPLETED|Period 3: 90mg/m^2||0
7755327|NCT01458366|19095043|P3|NOT COMPLETED|Period 3: 90mg/m^2||0
7755328|NCT01458366|19095044|P2|NOT COMPLETED|Period 3: 90mg/m^2||0
7755329|NCT01458366|19095045|P1|NOT COMPLETED|Period 3: 90mg/m^2||0
7755330|NCT01458366|19095041|P5|COMPLETED|Period 3: 90mg/m^2||0
7755331|NCT01458366|19095042|P4|COMPLETED|Period 3: 90mg/m^2||0
7755332|NCT01458366|19095043|P3|COMPLETED|Period 3: 90mg/m^2||3
7755333|NCT01458366|19095044|P2|COMPLETED|Period 3: 90mg/m^2||0
7755334|NCT01458366|19095045|P1|COMPLETED|Period 3: 90mg/m^2||0
7755335|NCT01458366|19095041|P5|STARTED|Period 3: 90mg/m^2||0
7755336|NCT01458366|19095042|P4|STARTED|Period 3: 90mg/m^2||0
7755337|NCT01458366|19095043|P3|STARTED|Period 3: 90mg/m^2||3
7755338|NCT01458366|19095044|P2|STARTED|Period 3: 90mg/m^2||0
7755339|NCT01458366|19095045|P1|STARTED|Period 3: 90mg/m^2||0
7755340|NCT01458366|19095041|P5|NOT COMPLETED|Period 2: 50mg/m^2||0
7755341|NCT01458366|19095042|P4|NOT COMPLETED|Period 2: 50mg/m^2||0
7755342|NCT01458366|19095043|P3|NOT COMPLETED|Period 2: 50mg/m^2||0
7755343|NCT01458366|19095044|P2|NOT COMPLETED|Period 2: 50mg/m^2||0
7755344|NCT01458366|19095045|P1|NOT COMPLETED|Period 2: 50mg/m^2||0
7755345|NCT01458366|19095041|P5|COMPLETED|Period 2: 50mg/m^2||0
7755346|NCT01458366|19095042|P4|COMPLETED|Period 2: 50mg/m^2||0
7755347|NCT01458366|19095043|P3|COMPLETED|Period 2: 50mg/m^2||0
7755348|NCT01458366|19095044|P2|COMPLETED|Period 2: 50mg/m^2||0
7755349|NCT01458366|19095045|P1|COMPLETED|Period 2: 50mg/m^2||0
7755350|NCT01458366|19095041|P5|STARTED|Period 2: 50mg/m^2||0
7755351|NCT01458366|19095042|P4|STARTED|Period 2: 50mg/m^2||0
7755352|NCT01458366|19095043|P3|STARTED|Period 2: 50mg/m^2||0
7755353|NCT01458366|19095044|P2|STARTED|Period 2: 50mg/m^2||0
7755354|NCT01458366|19095045|P1|STARTED|Period 2: 50mg/m^2||0
7755355|NCT01458366|19095041|P5|NOT COMPLETED|Period 1: 70mg/m^2||0
7755356|NCT01458366|19095042|P4|NOT COMPLETED|Period 1: 70mg/m^2||0
7755357|NCT01458366|19095043|P3|NOT COMPLETED|Period 1: 70mg/m^2||0
7755358|NCT01458366|19095044|P2|NOT COMPLETED|Period 1: 70mg/m^2||0
7755359|NCT01458366|19095045|P1|NOT COMPLETED|Period 1: 70mg/m^2||2
7755360|NCT01458366|19095041|P5|COMPLETED|Period 1: 70mg/m^2||0
7755361|NCT01458366|19095042|P4|COMPLETED|Period 1: 70mg/m^2||0
7755362|NCT01458366|19095043|P3|COMPLETED|Period 1: 70mg/m^2||0
7755363|NCT01458366|19095044|P2|COMPLETED|Period 1: 70mg/m^2||0
7755364|NCT01458366|19095045|P1|COMPLETED|Period 1: 70mg/m^2||3
7755365|NCT01458366|19095041|P5|STARTED|Period 1: 70mg/m^2||0
7755366|NCT01458366|19095042|P4|STARTED|Period 1: 70mg/m^2||0
7755367|NCT01458366|19095043|P3|STARTED|Period 1: 70mg/m^2||0
7755368|NCT01458366|19095044|P2|STARTED|Period 1: 70mg/m^2||0
7755369|NCT01458366|19095045|P1|STARTED|Period 1: 70mg/m^2||5
7755370|NCT01458288|19095060|P1|NOT COMPLETED|Overall Study||0
7755371|NCT01458288|19095060|P1|COMPLETED|Overall Study||12
7755372|NCT01458288|19095060|P1|STARTED|Overall Study||12
7755373|NCT01458275|19095072|P3|NOT COMPLETED|Overall Study||9
7755374|NCT01458275|19095073|P2|NOT COMPLETED|Overall Study||13
7755375|NCT01458275|19095074|P1|NOT COMPLETED|Overall Study||14
7755376|NCT01458275|19095072|P3|COMPLETED|Overall Study||273
7755377|NCT01458275|19095073|P2|COMPLETED|Overall Study||269
7755378|NCT01458275|19095074|P1|COMPLETED|Overall Study||269
7755379|NCT01458275|19095072|P3|STARTED|Overall Study||282
7755380|NCT01458275|19095073|P2|STARTED|Overall Study||282
7755381|NCT01458275|19095074|P1|STARTED|Overall Study||283
7755382|NCT01458249|19095116|P1|NOT COMPLETED|Overall Study||8
7755383|NCT01458249|19095116|P1|COMPLETED|Overall Study||44
7755384|NCT01458249|19095116|P1|Participants Treated|Overall Study||51
7755385|NCT01458249|19095116|P1|STARTED|Overall Study||52
7755386|NCT01458210|19095135|P1|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3
7755387|NCT01458210|19095135|P1|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15
7755388|NCT01458210|19095135|P1|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18
7755389|NCT01458210|19095135|P1|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4
7755390|NCT01458210|19095135|P1|COMPLETED|Ortho-Cyclen Alone (Period 1)||18
7755391|NCT01458210|19095135|P1|STARTED|Ortho-Cyclen Alone (Period 1)||22
7755392|NCT01458210|19095135|P1|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0
7755393|NCT01458210|19095135|P1|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22
7755394|NCT01458210|19095135|P1|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22
7755395|NCT01458210|19095135|P1|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22
7755396|NCT01458171|19095152|P1|NOT COMPLETED|Overall Study||1
7755397|NCT01458171|19095152|P1|COMPLETED|Overall Study||22
7755398|NCT01458171|19095152|P1|STARTED|Overall Study||23
7755399|NCT01458132|19095175|P2|NOT COMPLETED|Overall Study||3
7755400|NCT01458132|19095176|P1|NOT COMPLETED|Overall Study||15
7755401|NCT01458132|19095175|P2|COMPLETED|Overall Study||1
7755402|NCT01458132|19095176|P1|COMPLETED|Overall Study||0
7755403|NCT01458132|19095175|P2|STARTED|Overall Study||4
7755404|NCT01458132|19095176|P1|STARTED|Overall Study||15
7755405|NCT01458119|19095184|P1|NOT COMPLETED|Overall Study||20
7755406|NCT01458119|19095184|P1|COMPLETED|Overall Study||65
7755407|NCT01458119|19095184|P1|ITT-Amenable Population|Overall Study||68
7755408|NCT01458119|19095184|P1|Intent to Treat (ITT) Population|Overall Study||85
7755409|NCT01458119|19095184|P1|Safety Population|Overall Study||85
7755410|NCT01458119|19095184|P1|Received at Least 1 Dose of Study Drug|Overall Study||85
7755411|NCT01458119|19095184|P1|STARTED|Overall Study||85
7755412|NCT01458106|19095191|P2|NOT COMPLETED|Overall Study||1
7755413|NCT01458106|19095192|P1|NOT COMPLETED|Overall Study||3
7755414|NCT01458106|19095191|P2|COMPLETED|Overall Study||34
7755415|NCT01458106|19095192|P1|COMPLETED|Overall Study||33
7755416|NCT01458106|19095191|P2|Non-PK Subgroup|Overall Study||0
7755417|NCT01458106|19095192|P1|Non-PK Subgroup|Overall Study||11
7755418|NCT01458106|19095191|P2|PK Subgroup|Overall Study||35
7755419|NCT01458106|19095192|P1|PK Subgroup|Overall Study||25
7755420|NCT01458106|19095191|P2|STARTED|Overall Study||35
7755421|NCT01458106|19095192|P1|STARTED|Overall Study||36
7755422|NCT01457950|19095269|P4|NOT COMPLETED|Open-Label Phase||2
7755423|NCT01457950|19095270|P3|NOT COMPLETED|Open-Label Phase||2
7755424|NCT01457950|19095271|P2|NOT COMPLETED|Open-Label Phase||0
7755425|NCT01457950|19095272|P1|NOT COMPLETED|Open-Label Phase||0
7755426|NCT01457950|19095269|P4|COMPLETED|Open-Label Phase||61
7755427|NCT01457950|19095270|P3|COMPLETED|Open-Label Phase||58
7755428|NCT01457950|19095271|P2|COMPLETED|Open-Label Phase||0
7755429|NCT01457950|19095272|P1|COMPLETED|Open-Label Phase||0
7755430|NCT01457950|19095269|P4|STARTED|Open-Label Phase||63
7755431|NCT01457950|19095270|P3|STARTED|Open-Label Phase||60
7755432|NCT01457950|19095271|P2|STARTED|Open-Label Phase||0
7755433|NCT01457950|19095272|P1|STARTED|Open-Label Phase||0
7755434|NCT01457950|19095269|P4|NOT COMPLETED|Double-Blind Phase||0
7755435|NCT01457950|19095270|P3|NOT COMPLETED|Double-Blind Phase||0
7755436|NCT01457950|19095271|P2|NOT COMPLETED|Double-Blind Phase||3
7755437|NCT01457950|19095272|P1|NOT COMPLETED|Double-Blind Phase||9
7755438|NCT01457950|19095269|P4|COMPLETED|Double-Blind Phase||0
7755439|NCT01457950|19095270|P3|COMPLETED|Double-Blind Phase||0
7755440|NCT01457950|19095271|P2|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|63
7755441|NCT01457950|19095272|P1|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|60
7755442|NCT01457950|19095269|P4|Completed the 6 Month Assessment|Double-Blind Phase||0
7755443|NCT01457950|19095270|P3|Completed the 6 Month Assessment|Double-Blind Phase||0
7755444|NCT01457950|19095271|P2|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|64
7755445|NCT01457950|19095272|P1|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|62
7755446|NCT01457950|19095269|P4|STARTED|Double-Blind Phase||0
7755447|NCT01457950|19095270|P3|STARTED|Double-Blind Phase||0
7755448|NCT01457950|19095271|P2|STARTED|Double-Blind Phase||66
7755449|NCT01457950|19095272|P1|STARTED|Double-Blind Phase||69
7755450|NCT01457924|19095351|P5|NOT COMPLETED|Individualized FUP (Weeks 48+)||6
7755451|NCT01457924|19095352|P4|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
7755452|NCT01457924|19095353|P3|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
7755453|NCT01457924|19095354|P2|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
7755454|NCT01457924|19095355|P1|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
7755455|NCT01457924|19095351|P5|COMPLETED|Individualized FUP (Weeks 48+)||36
7755456|NCT01457924|19095352|P4|COMPLETED|Individualized FUP (Weeks 48+)||15
7755457|NCT01457924|19095353|P3|COMPLETED|Individualized FUP (Weeks 48+)||12
7755458|NCT01457924|19095354|P2|COMPLETED|Individualized FUP (Weeks 48+)||14
7755459|NCT01457924|19095355|P1|COMPLETED|Individualized FUP (Weeks 48+)||11
7755460|NCT01457924|19095351|P5|STARTED|Individualized FUP (Weeks 48+)||42
7755461|NCT01457924|19095352|P4|STARTED|Individualized FUP (Weeks 48+)||20
7755462|NCT01457924|19095353|P3|STARTED|Individualized FUP (Weeks 48+)||16
7755463|NCT01457924|19095354|P2|STARTED|Individualized FUP (Weeks 48+)||18
7755464|NCT01457924|19095355|P1|STARTED|Individualized FUP (Weeks 48+)||16
7755465|NCT01457924|19095351|P5|NOT COMPLETED|FUP (Weeks 24-48)||2
7755466|NCT01457924|19095352|P4|NOT COMPLETED|FUP (Weeks 24-48)||1
7755467|NCT01457924|19095353|P3|NOT COMPLETED|FUP (Weeks 24-48)||2
7755468|NCT01457924|19095354|P2|NOT COMPLETED|FUP (Weeks 24-48)||1
7755469|NCT01457924|19095355|P1|NOT COMPLETED|FUP (Weeks 24-48)||3
7755470|NCT01457924|19095351|P5|COMPLETED|FUP (Weeks 24-48)||57
7755471|NCT01457924|19095352|P4|COMPLETED|FUP (Weeks 24-48)||32
7755472|NCT01457924|19095353|P3|COMPLETED|FUP (Weeks 24-48)||30
7755473|NCT01457924|19095354|P2|COMPLETED|FUP (Weeks 24-48)||30
7755474|NCT01457924|19095355|P1|COMPLETED|FUP (Weeks 24-48)||63
7755475|NCT01457924|19095351|P5|STARTED|FUP (Weeks 24-48)||59
7755476|NCT01457924|19095352|P4|STARTED|FUP (Weeks 24-48)||33
7755477|NCT01457924|19095353|P3|STARTED|FUP (Weeks 24-48)||32
7755478|NCT01457924|19095354|P2|STARTED|FUP (Weeks 24-48)||31
7755479|NCT01457924|19095355|P1|STARTED|FUP (Weeks 24-48)||66
7755480|NCT01457924|19095351|P5|NOT COMPLETED|Treatment Phase (Weeks 0-24)||6
7755481|NCT01457924|19095352|P4|NOT COMPLETED|Treatment Phase (Weeks 0-24)||1
7755482|NCT01457924|19095353|P3|NOT COMPLETED|Treatment Phase (Weeks 0-24)||2
7755483|NCT01457924|19095354|P2|NOT COMPLETED|Treatment Phase (Weeks 0-24)||5
7755484|NCT01457924|19095355|P1|NOT COMPLETED|Treatment Phase (Weeks 0-24)||3
7755485|NCT01457924|19095351|P5|COMPLETED|Treatment Phase (Weeks 0-24)||58
7755486|NCT01457924|19095352|P4|COMPLETED|Treatment Phase (Weeks 0-24)||33
7755487|NCT01457924|19095353|P3|COMPLETED|Treatment Phase (Weeks 0-24)||30
7755488|NCT01457924|19095354|P2|COMPLETED|Treatment Phase (Weeks 0-24)||29
7755489|NCT01457924|19095355|P1|COMPLETED|Treatment Phase (Weeks 0-24)||64
7755490|NCT01457924|19095351|P5|Completed to Week 12|Treatment Phase (Weeks 0-24)||60
7755491|NCT01457924|19095352|P4|Completed to Week 12|Treatment Phase (Weeks 0-24)||33
7755492|NCT01457924|19095353|P3|Completed to Week 12|Treatment Phase (Weeks 0-24)||30
7755493|NCT01457924|19095354|P2|Completed to Week 12|Treatment Phase (Weeks 0-24)||31
7755494|NCT01457924|19095355|P1|Completed to Week 12|Treatment Phase (Weeks 0-24)||65
7755495|NCT01457924|19095351|P5|STARTED|Treatment Phase (Weeks 0-24)||64
7755496|NCT01457924|19095352|P4|STARTED|Treatment Phase (Weeks 0-24)||34
7755497|NCT01457924|19095353|P3|STARTED|Treatment Phase (Weeks 0-24)||32
7755498|NCT01457924|19095354|P2|STARTED|Treatment Phase (Weeks 0-24)||34
7755499|NCT01457924|19095355|P1|STARTED|Treatment Phase (Weeks 0-24)||67
7755500|NCT01457885|19095417|P1|NOT COMPLETED|Overall Study||0
7755501|NCT01457885|19095417|P1|COMPLETED|Overall Study||74
7755502|NCT01457885|19095417|P1|STARTED|Overall Study||74
7755503|NCT01457846|19095425|P2|NOT COMPLETED|Overall Study||30
7755504|NCT01457846|19095426|P1|NOT COMPLETED|Overall Study||41
7755505|NCT01457846|19095425|P2|COMPLETED|Overall Study||0
7755506|NCT01457846|19095426|P1|COMPLETED|Overall Study||0
7755507|NCT01457846|19095425|P2|Ongoing Treatment at Data Cut-off|Overall Study||1
7755508|NCT01457846|19095426|P1|Ongoing Treatment at Data Cut-off|Overall Study||1
7755509|NCT01457846|19095425|P2|Did Not Receive Treatment|Overall Study||3
7755510|NCT01457846|19095426|P1|Did Not Receive Treatment|Overall Study||1
7755511|NCT01457846|19095425|P2|Received Treatment|Overall Study||27
7755512|NCT01457846|19095426|P1|Received Treatment|Overall Study||40
7755513|NCT01457846|19095425|P2|STARTED|Overall Study||30
7755514|NCT01457846|19095426|P1|STARTED|Overall Study||41
7755515|NCT01457703|19095442|P2|NOT COMPLETED|Overall Study||11
7755516|NCT01457703|19095443|P1|NOT COMPLETED|Overall Study||6
7755517|NCT01457703|19095442|P2|COMPLETED|Overall Study||22
7755518|NCT01457703|19095443|P1|COMPLETED|Overall Study||23
7755519|NCT01457703|19095442|P2|STARTED|Overall Study||33
7755520|NCT01457703|19095443|P1|STARTED|Overall Study||29
7755521|NCT01457573|19095457|P1|NOT COMPLETED|Overall Study||0
7755522|NCT01457573|19095457|P1|COMPLETED|Overall Study||10
7755523|NCT01457573|19095457|P1|STARTED|Overall Study||10
7755524|NCT01457521|19095473|P2|NOT COMPLETED|Overall Study||10
7755525|NCT01457521|19095474|P1|NOT COMPLETED|Overall Study||12
7755526|NCT01457521|19095473|P2|COMPLETED|Overall Study||117
7755527|NCT01457521|19095474|P1|COMPLETED|Overall Study||111
7755528|NCT01457521|19095473|P2|STARTED|Overall Study||127
7755529|NCT01457521|19095474|P1|STARTED|Overall Study||123
7755530|NCT01457430|19095480|P1|NOT COMPLETED|Overall Study||0
7755531|NCT01457430|19095480|P1|COMPLETED|Overall Study||19
7755532|NCT01457430|19095480|P1|STARTED|Overall Study||19
7755533|NCT01457417|19095492|P5|NOT COMPLETED|Overall Study||0
7755534|NCT01457417|19095493|P4|NOT COMPLETED|Overall Study||0
7755535|NCT01457417|19095494|P3|NOT COMPLETED|Overall Study||0
7755536|NCT01457417|19095495|P2|NOT COMPLETED|Overall Study||0
7755537|NCT01457417|19095496|P1|NOT COMPLETED|Overall Study||0
7755538|NCT01457417|19095492|P5|COMPLETED|Overall Study||19
7755539|NCT01457417|19095493|P4|COMPLETED|Overall Study||3
7755540|NCT01457417|19095494|P3|COMPLETED|Overall Study||4
7755541|NCT01457417|19095495|P2|COMPLETED|Overall Study||3
7755542|NCT01457417|19095496|P1|COMPLETED|Overall Study||3
7755543|NCT01457417|19095492|P5|STARTED|Overall Study||19
7755544|NCT01457417|19095493|P4|STARTED|Overall Study||3
7755545|NCT01457417|19095494|P3|STARTED|Overall Study||4
7755546|NCT01457417|19095495|P2|STARTED|Overall Study||3
7755547|NCT01457417|19095496|P1|STARTED|Overall Study||3
7755548|NCT01457352|19095554|P2|NOT COMPLETED|Period 3||5
7755549|NCT01457352|19095555|P1|NOT COMPLETED|Period 3||1
7755550|NCT01457352|19095554|P2|COMPLETED|Period 3||144
7755551|NCT01457352|19095555|P1|COMPLETED|Period 3||146
7755552|NCT01457352|19095554|P2|Randomization|Period 3||149
7755553|NCT01457352|19095555|P1|Randomization|Period 3||147
7755554|NCT01457352|19095554|P2|STARTED|Period 3||149
7755555|NCT01457352|19095555|P1|STARTED|Period 3||147
7755556|NCT01457352|19095554|P2|NOT COMPLETED|Period 2||0
7755557|NCT01457352|19095555|P1|NOT COMPLETED|Period 2||80
7755558|NCT01457352|19095554|P2|COMPLETED|Period 2||0
7755559|NCT01457352|19095555|P1|COMPLETED|Period 2||296
7755560|NCT01457352|19095554|P2|STARTED|Period 2||0
7755561|NCT01457352|19095555|P1|STARTED|Period 2||376
7755562|NCT01457352|19095554|P2|NOT COMPLETED|Period 1||0
7755563|NCT01457352|19095555|P1|NOT COMPLETED|Period 1||16
7755564|NCT01457352|19095554|P2|COMPLETED|Period 1||0
7755565|NCT01457352|19095555|P1|COMPLETED|Period 1||376
7755566|NCT01457352|19095554|P2|STARTED|Period 1||0
7755567|NCT01457352|19095555|P1|STARTED|Period 1||392
7755568|NCT01457339|19095567|P2|NOT COMPLETED|Period 6 (250 mg)||1
7755569|NCT01457339|19095568|P1|NOT COMPLETED|Period 6 (250 mg)||1
7755570|NCT01457339|19095567|P2|COMPLETED|Period 6 (250 mg)||21
7755571|NCT01457339|19095568|P1|COMPLETED|Period 6 (250 mg)||6
7755572|NCT01457339|19095567|P2|STARTED|Period 6 (250 mg)||22
7755573|NCT01457339|19095568|P1|STARTED|Period 6 (250 mg)||7
7755574|NCT01457339|19095567|P2|NOT COMPLETED|Period 5 (200 mg)||1
7755575|NCT01457339|19095568|P1|NOT COMPLETED|Period 5 (200 mg)||0
7755576|NCT01457339|19095567|P2|COMPLETED|Period 5 (200 mg)||22
7755577|NCT01457339|19095568|P1|COMPLETED|Period 5 (200 mg)||7
7755578|NCT01457339|19095567|P2|STARTED|Period 5 (200 mg)||23
7755579|NCT01457339|19095568|P1|STARTED|Period 5 (200 mg)||7
7755580|NCT01457339|19095567|P2|NOT COMPLETED|Period 4 (150 mg)||0
7755581|NCT01457339|19095568|P1|NOT COMPLETED|Period 4 (150 mg)||0
7755582|NCT01457339|19095567|P2|COMPLETED|Period 4 (150 mg)||23
7755583|NCT01457339|19095568|P1|COMPLETED|Period 4 (150 mg)||7
7755584|NCT01457339|19095567|P2|STARTED|Period 4 (150 mg)||23
7755585|NCT01457339|19095568|P1|STARTED|Period 4 (150 mg)||7
7755586|NCT01457339|19095567|P2|NOT COMPLETED|Period 3 (100 mg)||1
7755587|NCT01457339|19095568|P1|NOT COMPLETED|Period 3 (100 mg)||0
7755588|NCT01457339|19095567|P2|COMPLETED|Period 3 (100 mg)||23
7755589|NCT01457339|19095568|P1|COMPLETED|Period 3 (100 mg)||7
7755590|NCT01457339|19095567|P2|STARTED|Period 3 (100 mg)||24
7755591|NCT01457339|19095568|P1|STARTED|Period 3 (100 mg)||7
7755592|NCT01457339|19095567|P2|NOT COMPLETED|Period 2 (70 mg)||0
7755593|NCT01457339|19095568|P1|NOT COMPLETED|Period 2 (70 mg)||0
7755594|NCT01457339|19095567|P2|COMPLETED|Period 2 (70 mg)||24
7755595|NCT01457339|19095568|P1|COMPLETED|Period 2 (70 mg)||7
7755596|NCT01457339|19095567|P2|STARTED|Period 2 (70 mg)||24
7755597|NCT01457339|19095568|P1|STARTED|Period 2 (70 mg)||7
7755598|NCT01457339|19095567|P2|NOT COMPLETED|Period 1 (50 mg)||0
7755599|NCT01457339|19095568|P1|NOT COMPLETED|Period 1 (50 mg)||0
7755600|NCT01457339|19095567|P2|COMPLETED|Period 1 (50 mg)||24
7755601|NCT01457339|19095568|P1|COMPLETED|Period 1 (50 mg)||7
7755602|NCT01457339|19095567|P2|STARTED|Period 1 (50 mg)||24
7755603|NCT01457339|19095568|P1|STARTED|Period 1 (50 mg)||7
7755604|NCT01457196|19095734|P1|NOT COMPLETED|Overall Study||0
7755605|NCT01457196|19095734|P1|COMPLETED|Overall Study||2074
7755606|NCT01457196|19095734|P1|STARTED|Overall Study||2074
7755607|NCT01457053|19095740|P2|NOT COMPLETED|Overall Study||1
7755608|NCT01457053|19095741|P1|NOT COMPLETED|Overall Study||1
7755609|NCT01457053|19095740|P2|COMPLETED|Overall Study||1
7755610|NCT01457053|19095741|P1|COMPLETED|Overall Study||1
7755611|NCT01457053|19095740|P2|STARTED|Overall Study||2
7755612|NCT01457053|19095741|P1|STARTED|Overall Study||2
7755613|NCT01457014|19095747|P4|NOT COMPLETED|Fourth Night||0
7755614|NCT01457014|19095748|P3|NOT COMPLETED|Fourth Night||0
7755615|NCT01457014|19095749|P2|NOT COMPLETED|Fourth Night||0
7755616|NCT01457014|19095750|P1|NOT COMPLETED|Fourth Night||0
7755617|NCT01457014|19095747|P4|COMPLETED|Fourth Night||11
7755618|NCT01457014|19095748|P3|COMPLETED|Fourth Night||12
7755619|NCT01457014|19095749|P2|COMPLETED|Fourth Night||11
7755620|NCT01457014|19095750|P1|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
7755621|NCT01457014|19095747|P4|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
7755622|NCT01457014|19095748|P3|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
7755623|NCT01457014|19095749|P2|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
7755624|NCT01457014|19095750|P1|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
7755625|NCT01457014|19095747|P4|NOT COMPLETED|Third Night||0
7755626|NCT01457014|19095748|P3|NOT COMPLETED|Third Night||0
7755627|NCT01457014|19095749|P2|NOT COMPLETED|Third Night||0
7755628|NCT01457014|19095750|P1|NOT COMPLETED|Third Night||0
7755629|NCT01457014|19095747|P4|COMPLETED|Third Night||12
7755630|NCT01457014|19095748|P3|COMPLETED|Third Night||11
7755631|NCT01457014|19095749|P2|COMPLETED|Third Night||11
7755632|NCT01457014|19095750|P1|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0
7755633|NCT01457014|19095747|P4|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
7755634|NCT01457014|19095748|P3|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
7755635|NCT01457014|19095749|P2|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
7755636|NCT01457014|19095750|P1|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0
7755637|NCT01457014|19095747|P4|NOT COMPLETED|Second Night||0
7755638|NCT01457014|19095748|P3|NOT COMPLETED|Second Night||0
7755639|NCT01457014|19095749|P2|NOT COMPLETED|Second Night||0
7755640|NCT01457014|19095750|P1|NOT COMPLETED|Second Night||0
7755641|NCT01457014|19095747|P4|COMPLETED|Second Night||11
7755642|NCT01457014|19095748|P3|COMPLETED|Second Night||11
7755643|NCT01457014|19095749|P2|COMPLETED|Second Night||12
7755644|NCT01457014|19095750|P1|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0
7755645|NCT01457014|19095747|P4|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
7755646|NCT01457014|19095748|P3|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
7755647|NCT01457014|19095749|P2|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
7755648|NCT01457014|19095750|P1|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0
7755649|NCT01457014|19095747|P4|NOT COMPLETED|First Night||0
7755650|NCT01457014|19095748|P3|NOT COMPLETED|First Night||0
7755651|NCT01457014|19095749|P2|NOT COMPLETED|First Night||0
7755652|NCT01457014|19095750|P1|NOT COMPLETED|First Night||40
7755653|NCT01457014|19095747|P4|COMPLETED|First Night||0
7755654|NCT01457014|19095748|P3|COMPLETED|First Night||0
7755655|NCT01457014|19095749|P2|COMPLETED|First Night||0
7755656|NCT01457014|19095750|P1|COMPLETED|First Night||34
7755657|NCT01457014|19095747|P4|STARTED|First Night||0
7755658|NCT01457014|19095748|P3|STARTED|First Night||0
7755659|NCT01457014|19095749|P2|STARTED|First Night||0
7755660|NCT01457014|19095750|P1|STARTED|First Night||74
7755661|NCT01456962|19095767|P2|NOT COMPLETED|Overall Study||1
7755662|NCT01456962|19095768|P1|NOT COMPLETED|Overall Study||2
7755663|NCT01456962|19095767|P2|COMPLETED|Overall Study||19
7755664|NCT01456962|19095768|P1|COMPLETED|Overall Study||14
7755665|NCT01456962|19095767|P2|STARTED|Overall Study||20
7755666|NCT01456962|19095768|P1|STARTED|Overall Study||16
7755667|NCT01456949|19095774|P1|NOT COMPLETED|Study Cryoablation Procedure & Follow-up||62
7755668|NCT01456949|19095774|P1|COMPLETED|Study Cryoablation Procedure & Follow-up|5 subjects completed at least 36 months of follow-up but did not complete a 36 month follow-up visit|303
7755669|NCT01456949|19095774|P1|36-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|298
7755670|NCT01456949|19095774|P1|24-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|309
7755671|NCT01456949|19095774|P1|12-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|325
7755672|NCT01456949|19095774|P1|6-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|342
7755673|NCT01456949|19095774|P1|3-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of 354 subjects who were treated and met all I/E criteria (mITT group).|344
7755674|NCT01456949|19095774|P1|STARTED|Study Cryoablation Procedure & Follow-up||365
7755675|NCT01456949|19095774|P1|NOT COMPLETED|Enrollment||37
7755676|NCT01456949|19095774|P1|COMPLETED|Enrollment|6 rollover subjects not included in final analysis. 359 treated; 354 treated & met all I/E criteria.|365
7755677|NCT01456949|19095774|P1|Modified Intent to Treat Group (mITT)|Enrollment||354
7755678|NCT01456949|19095774|P1|Treated|Enrollment||359
7755679|NCT01456949|19095774|P1|STARTED|Enrollment||402
7755680|NCT01456936|19095785|P4|NOT COMPLETED|Overall Study||483
7755681|NCT01456936|19095786|P3|NOT COMPLETED|Overall Study||481
7755682|NCT01456936|19095787|P2|NOT COMPLETED|Overall Study||448
7755683|NCT01456936|19095788|P1|NOT COMPLETED|Overall Study||439
7755684|NCT01456936|19095785|P4|COMPLETED|Overall Study||1552
7755685|NCT01456936|19095786|P3|COMPLETED|Overall Study||1557
7755686|NCT01456936|19095787|P2|COMPLETED|Overall Study||1586
7755687|NCT01456936|19095788|P1|COMPLETED|Overall Study||1598
7755688|NCT01456936|19095785|P4|Randomized and Treated|Overall Study||2014
7755689|NCT01456936|19095786|P3|Randomized and Treated|Overall Study||2022
7755690|NCT01456936|19095787|P2|Randomized and Treated|Overall Study||2006
7755691|NCT01456936|19095788|P1|Randomized and Treated|Overall Study||2016
7755692|NCT01456936|19095785|P4|STARTED|Overall Study||2035
7755693|NCT01456936|19095786|P3|STARTED|Overall Study||2038
7755694|NCT01456936|19095787|P2|STARTED|Overall Study||2034
7755695|NCT01456936|19095788|P1|STARTED|Overall Study||2037
7755696|NCT01456897|19095896|P2|NOT COMPLETED|Overall Study||57
7755697|NCT01456897|19095897|P1|NOT COMPLETED|Overall Study||75
7755698|NCT01456897|19095896|P2|COMPLETED|Overall Study||41
7755699|NCT01456897|19095897|P1|COMPLETED|Overall Study||109
7755700|NCT01456897|19095896|P2|STARTED|Overall Study||98
7755701|NCT01456897|19095897|P1|STARTED|Overall Study||184
7755702|NCT01456780|19095916|P3|NOT COMPLETED|Overall Study||0
7755703|NCT01456780|19095917|P2|NOT COMPLETED|Overall Study||3
7755704|NCT01456780|19095918|P1|NOT COMPLETED|Overall Study||3
7755705|NCT01456780|19095916|P3|COMPLETED|Overall Study||20
7755706|NCT01456780|19095917|P2|COMPLETED|Overall Study||17
7755707|NCT01456780|19095918|P1|COMPLETED|Overall Study||17
7755708|NCT01456780|19095916|P3|STARTED|Overall Study||20
7755709|NCT01456780|19095917|P2|STARTED|Overall Study||20
7755710|NCT01456780|19095918|P1|STARTED|Overall Study||20
7755711|NCT01456494|19095937|P2|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||6
7755712|NCT01456494|19095938|P1|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||5
7755713|NCT01456494|19095937|P2|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||20
7755714|NCT01456494|19095938|P1|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||19
7755715|NCT01456494|19095937|P2|STARTED|Follow-Up Visit (Post 30-day Discharge)||26
7755716|NCT01456494|19095938|P1|STARTED|Follow-Up Visit (Post 30-day Discharge)||24
7755717|NCT01456494|19095937|P2|NOT COMPLETED|Initial Inpatient Visit||0
7755718|NCT01456494|19095938|P1|NOT COMPLETED|Initial Inpatient Visit||0
7755719|NCT01456494|19095937|P2|COMPLETED|Initial Inpatient Visit||26
7755720|NCT01456494|19095938|P1|COMPLETED|Initial Inpatient Visit||24
7755721|NCT01456494|19095937|P2|STARTED|Initial Inpatient Visit||26
7755722|NCT01456494|19095938|P1|STARTED|Initial Inpatient Visit||24
7755723|NCT01456299|19095955|P3|NOT COMPLETED|Overall Study||1
7755724|NCT01456299|19095956|P2|NOT COMPLETED|Overall Study||1
7755725|NCT01456299|19095957|P1|NOT COMPLETED|Overall Study||0
7755726|NCT01456299|19095955|P3|COMPLETED|Overall Study||33
7755727|NCT01456299|19095956|P2|COMPLETED|Overall Study||33
7755728|NCT01456299|19095957|P1|COMPLETED|Overall Study||34
7755729|NCT01456299|19095955|P3|STARTED|Overall Study||34
7755730|NCT01456299|19095956|P2|STARTED|Overall Study||34
7755731|NCT01456299|19095957|P1|STARTED|Overall Study||34
7755732|NCT01456221|19095967|P2|NOT COMPLETED|Overall Study||57
7755733|NCT01456221|19095968|P1|NOT COMPLETED|Overall Study||64
7755734|NCT01456221|19095967|P2|COMPLETED|Overall Study||126
7755735|NCT01456221|19095968|P1|COMPLETED|Overall Study||119
7755736|NCT01456221|19095967|P2|STARTED|Overall Study||183
7755737|NCT01456221|19095968|P1|STARTED|Overall Study||183
7755738|NCT01456195|19095983|P3|NOT COMPLETED|Overall Study||14
7755739|NCT01456195|19095984|P2|NOT COMPLETED|Overall Study||10
7755740|NCT01456195|19095985|P1|NOT COMPLETED|Overall Study||11
7755741|NCT01456195|19095983|P3|COMPLETED|Overall Study||127
7755742|NCT01456195|19095984|P2|COMPLETED|Overall Study||127
7755743|NCT01456195|19095985|P1|COMPLETED|Overall Study||132
7755744|NCT01456195|19095983|P3|STARTED|Overall Study||141
7755745|NCT01456195|19095984|P2|STARTED|Overall Study||137
7755746|NCT01456195|19095985|P1|STARTED|Overall Study||143
7755747|NCT01456169|19096005|P3|NOT COMPLETED|Overall Study||12
7755748|NCT01456169|19096006|P2|NOT COMPLETED|Overall Study||5
7755749|NCT01456169|19096007|P1|NOT COMPLETED|Overall Study||10
7755750|NCT01456169|19096005|P3|COMPLETED|Overall Study||123
7755751|NCT01456169|19096006|P2|COMPLETED|Overall Study||122
7755752|NCT01456169|19096007|P1|COMPLETED|Overall Study||123
7755753|NCT01456169|19096005|P3|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135
7755754|NCT01456169|19096006|P2|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127
7755755|NCT01456169|19096007|P1|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133
7755756|NCT01456143|19096058|P1|NOT COMPLETED|Overall Study||0
7755757|NCT01456143|19096058|P1|COMPLETED|Overall Study||33
7755758|NCT01456143|19096058|P1|STARTED|Overall Study||33
7755759|NCT01456130|19096067|P1|NOT COMPLETED|Overall Study||10
7755760|NCT01456130|19096067|P1|COMPLETED|Overall Study||57
7755761|NCT01456130|19096067|P1|STARTED|Overall Study||67
7755762|NCT01456052|19096077|P3|NOT COMPLETED|Overall Study||5
7755763|NCT01456052|19096078|P2|NOT COMPLETED|Overall Study||5
7755764|NCT01456052|19096079|P1|NOT COMPLETED|Overall Study||2
7755765|NCT01456052|19096077|P3|COMPLETED|Overall Study||19
7755766|NCT01456052|19096078|P2|COMPLETED|Overall Study||20
7755767|NCT01456052|19096079|P1|COMPLETED|Overall Study||8
7755768|NCT01456052|19096077|P3|STARTED|Overall Study||24
7755769|NCT01456052|19096078|P2|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25
7755770|NCT01456052|19096079|P1|STARTED|Overall Study||10
7755771|NCT01456039|19096099|P3|NOT COMPLETED|Phase 2 (Second Step)||33
7755772|NCT01456039|19096100|P2|NOT COMPLETED|Phase 2 (Second Step)||0
7755773|NCT01456039|19096101|P1|NOT COMPLETED|Phase 2 (Second Step)||0
7755774|NCT01456039|19096099|P3|COMPLETED|Phase 2 (Second Step)||7
7755775|NCT01456039|19096100|P2|COMPLETED|Phase 2 (Second Step)||0
7755776|NCT01456039|19096101|P1|COMPLETED|Phase 2 (Second Step)||0
7755777|NCT01456039|19096099|P3|STARTED|Phase 2 (Second Step)||40
7755778|NCT01456039|19096100|P2|STARTED|Phase 2 (Second Step)||0
7755779|NCT01456039|19096101|P1|STARTED|Phase 2 (Second Step)||0
7755780|NCT01456039|19096099|P3|NOT COMPLETED|Phase 1 (First Step)||0
7755781|NCT01456039|19096100|P2|NOT COMPLETED|Phase 1 (First Step)||7
7755782|NCT01456039|19096101|P1|NOT COMPLETED|Phase 1 (First Step)||2
7755783|NCT01456039|19096099|P3|COMPLETED|Phase 1 (First Step)||0
7755784|NCT01456039|19096100|P2|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
7755785|NCT01456039|19096101|P1|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
7755786|NCT01456039|19096099|P3|STARTED|Phase 1 (First Step)||0
7755787|NCT01456039|19096100|P2|STARTED|Phase 1 (First Step)||8
7755788|NCT01456039|19096101|P1|STARTED|Phase 1 (First Step)||3
7755789|NCT01456000|19096173|P2|NOT COMPLETED|Overall Study||3
7755790|NCT01456000|19096174|P1|NOT COMPLETED|Overall Study||8
7755791|NCT01456000|19096173|P2|COMPLETED|Overall Study||172
7755792|NCT01456000|19096174|P1|COMPLETED|Overall Study||170
7755793|NCT01456000|19096173|P2|STARTED|Overall Study||175
7755794|NCT01456000|19096174|P1|STARTED|Overall Study||178
7755795|NCT01455545|19096180|P2|NOT COMPLETED|Overall Study||0
7755796|NCT01455545|19096181|P1|NOT COMPLETED|Overall Study||0
7755797|NCT01455545|19096180|P2|COMPLETED|Overall Study||45
7755798|NCT01455545|19096181|P1|COMPLETED|Overall Study||55
7755799|NCT01455545|19096180|P2|STARTED|Overall Study||45
7755800|NCT01455545|19096181|P1|STARTED|Overall Study||55
7755801|NCT01455519|19096211|P2|NOT COMPLETED|Overall Study||5
7755802|NCT01455519|19096212|P1|NOT COMPLETED|Overall Study||4
7755803|NCT01455519|19096211|P2|COMPLETED|Overall Study||18
7755804|NCT01455519|19096212|P1|COMPLETED|Overall Study||8
7755805|NCT01455519|19096211|P2|STARTED|Overall Study||23
7755806|NCT01455519|19096212|P1|STARTED|Overall Study||12
7755807|NCT01455428|19096244|P2|NOT COMPLETED|Overall Study||18
7755808|NCT01455428|19096245|P1|NOT COMPLETED|Overall Study||14
7755809|NCT01455428|19096244|P2|COMPLETED|Overall Study||92
7755810|NCT01455428|19096245|P1|COMPLETED|Overall Study||98
7755811|NCT01455428|19096244|P2|Treated|Overall Study||109
7755812|NCT01455428|19096245|P1|Treated|Overall Study||111
7755813|NCT01455428|19096244|P2|STARTED|Overall Study||110
7755814|NCT01455428|19096245|P1|STARTED|Overall Study||112
7755815|NCT01455415|19096301|P2|NOT COMPLETED|Follow-up||2
7755816|NCT01455415|19096302|P1|NOT COMPLETED|Follow-up||3
7755817|NCT01455415|19096301|P2|COMPLETED|Follow-up||104
7755818|NCT01455415|19096302|P1|COMPLETED|Follow-up||111
7755819|NCT01455415|19096301|P2|STARTED|Follow-up||106
7755820|NCT01455415|19096302|P1|STARTED|Follow-up||114
7755821|NCT01455415|19096301|P2|NOT COMPLETED|Period 2||10
7755822|NCT01455415|19096302|P1|NOT COMPLETED|Period 2||13
7755823|NCT01455415|19096301|P2|COMPLETED|Period 2||106
7755824|NCT01455415|19096302|P1|COMPLETED|Period 2||114
7755825|NCT01455415|19096301|P2|STARTED|Period 2||116
7755826|NCT01455415|19096302|P1|STARTED|Period 2||127
7755827|NCT01455415|19096301|P2|NOT COMPLETED|Washout||7
7755828|NCT01455415|19096302|P1|NOT COMPLETED|Washout||8
7755829|NCT01455415|19096301|P2|COMPLETED|Washout||116
7755830|NCT01455415|19096302|P1|COMPLETED|Washout||127
7755831|NCT01455415|19096301|P2|STARTED|Washout||123
7755832|NCT01455415|19096302|P1|STARTED|Washout||135
7755833|NCT01455415|19096301|P2|NOT COMPLETED|Period 1||24
7755834|NCT01455415|19096302|P1|NOT COMPLETED|Period 1||19
7755835|NCT01455415|19096301|P2|COMPLETED|Period 1||123
7755836|NCT01455415|19096302|P1|COMPLETED|Period 1||135
7755837|NCT01455415|19096301|P2|STARTED|Period 1|Started=Treated|147
7755838|NCT01455415|19096302|P1|STARTED|Period 1|Started=Treated|154
7755839|NCT01455220|19096352|P1|NOT COMPLETED|Overall Study||30
7755840|NCT01455220|19096352|P1|COMPLETED|Overall Study||15
7755841|NCT01455220|19096352|P1|STARTED|Overall Study||45
7755842|NCT01455194|19096362|P4|NOT COMPLETED|Overall Study||28
7755843|NCT01455194|19096363|P3|NOT COMPLETED|Overall Study||30
7755844|NCT01455194|19096364|P2|NOT COMPLETED|Overall Study||31
7755845|NCT01455194|19096365|P1|NOT COMPLETED|Overall Study||153
7755846|NCT01455194|19096362|P4|COMPLETED|Overall Study||97
7755847|NCT01455194|19096363|P3|COMPLETED|Overall Study||92
7755848|NCT01455194|19096364|P2|COMPLETED|Overall Study||89
7755849|NCT01455194|19096365|P1|COMPLETED|Overall Study||0
7755850|NCT01455194|19096362|P4|STARTED|Overall Study||125
7755851|NCT01455194|19096363|P3|STARTED|Overall Study||122
7755852|NCT01455194|19096364|P2|STARTED|Overall Study||120
7755853|NCT01455194|19096365|P1|STARTED|Overall Study||153
7755854|NCT01455181|19096414|P1|NOT COMPLETED|Overall Study||0
7755855|NCT01455181|19096414|P1|COMPLETED|Overall Study||24
7755856|NCT01455181|19096414|P1|STARTED|Overall Study||24
7755857|NCT01455064|19096422|P1|NOT COMPLETED|Overall Study||1
7755858|NCT01455064|19096422|P1|COMPLETED|Overall Study||30
7755859|NCT01455064|19096422|P1|STARTED|Overall Study||31
7755860|NCT01455012|19096428|P2|NOT COMPLETED|Overall Study||4
7755861|NCT01455012|19096429|P1|NOT COMPLETED|Overall Study||11
7755862|NCT01455012|19096428|P2|COMPLETED|Overall Study||36
7755863|NCT01455012|19096429|P1|COMPLETED|Overall Study||30
7755864|NCT01455012|19096428|P2|STARTED|Overall Study||40
7755865|NCT01455012|19096429|P1|STARTED|Overall Study||41
7755866|NCT01454947|19096469|P8|NOT COMPLETED|Overall Study||5
7755867|NCT01454947|19096470|P7|NOT COMPLETED|Overall Study||1
7755868|NCT01454947|19096471|P6|NOT COMPLETED|Overall Study||3
7755869|NCT01454947|19096472|P5|NOT COMPLETED|Overall Study||1
7755870|NCT01454947|19096473|P4|NOT COMPLETED|Overall Study||1
7755871|NCT01454947|19096474|P3|NOT COMPLETED|Overall Study||3
7755872|NCT01454947|19096475|P2|NOT COMPLETED|Overall Study||4
7755873|NCT01454947|19096476|P1|NOT COMPLETED|Overall Study||3
7755874|NCT01454947|19096469|P8|COMPLETED|Overall Study||23
7755875|NCT01454947|19096470|P7|COMPLETED|Overall Study||26
7755876|NCT01454947|19096471|P6|COMPLETED|Overall Study||32
7755877|NCT01454947|19096472|P5|COMPLETED|Overall Study||33
7755878|NCT01454947|19096473|P4|COMPLETED|Overall Study||19
7755879|NCT01454947|19096474|P3|COMPLETED|Overall Study||32
7755880|NCT01454947|19096475|P2|COMPLETED|Overall Study||38
7755881|NCT01454947|19096476|P1|COMPLETED|Overall Study||24
7755882|NCT01454947|19096469|P8|STARTED|Overall Study||28
7755883|NCT01454947|19096470|P7|STARTED|Overall Study||27
7755884|NCT01454947|19096471|P6|STARTED|Overall Study||35
7755885|NCT01454947|19096472|P5|STARTED|Overall Study||34
7755886|NCT01454947|19096473|P4|STARTED|Overall Study||20
7755887|NCT01454947|19096474|P3|STARTED|Overall Study||35
7755888|NCT01454947|19096475|P2|STARTED|Overall Study||42
7755889|NCT01454947|19096476|P1|STARTED|Overall Study||27
7755890|NCT01454934|19096496|P2|NOT COMPLETED|Overall Study||270
7755891|NCT01454934|19096497|P1|NOT COMPLETED|Overall Study||270
7755892|NCT01454934|19096496|P2|COMPLETED|Overall Study||0
7755893|NCT01454934|19096497|P1|COMPLETED|Overall Study||0
7755894|NCT01454934|19096496|P2|STARTED|Overall Study||270
7755895|NCT01454934|19096497|P1|STARTED|Overall Study||270
7755896|NCT01454830|19096509|P2|NOT COMPLETED|Overall Study||27
7755897|NCT01454830|19096510|P1|NOT COMPLETED|Overall Study||31
7755898|NCT01454830|19096509|P2|COMPLETED|Overall Study||30
7755899|NCT01454830|19096510|P1|COMPLETED|Overall Study||30
7755900|NCT01454830|19096509|P2|STARTED|Overall Study||57
7755901|NCT01454830|19096510|P1|STARTED|Overall Study||61
7755902|NCT01454791|19096530|P2|NOT COMPLETED|Overall Study||0
7755903|NCT01454791|19096531|P1|NOT COMPLETED|Overall Study||0
7755904|NCT01454791|19096530|P2|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20
7755905|NCT01454791|19096531|P1|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20
7755906|NCT01454791|19096530|P2|STARTED|Overall Study||20
7755907|NCT01454791|19096531|P1|STARTED|Overall Study||20
7755908|NCT01454778|19096541|P1|NOT COMPLETED|Overall Study||3
7755909|NCT01454778|19096541|P1|COMPLETED|Overall Study||47
7755910|NCT01454778|19096541|P1|STARTED|Overall Study||50
7755911|NCT01454739|19096552|P2|NOT COMPLETED|Overall Study||21
7755912|NCT01454739|19096553|P1|NOT COMPLETED|Overall Study||7
7755913|NCT01454739|19096552|P2|COMPLETED|Overall Study||158
7755914|NCT01454739|19096553|P1|COMPLETED|Overall Study||54
7755915|NCT01454739|19096552|P2|Surgery Subgroup|Overall Study||26
7755916|NCT01454739|19096553|P1|Surgery Subgroup|Overall Study||2
7755917|NCT01454739|19096552|P2|Episodic|Overall Study||13
7755918|NCT01454739|19096553|P1|Episodic|Overall Study||0
7755919|NCT01454739|19096552|P2|Personalized Prophylaxis|Overall Study||23
7755920|NCT01454739|19096553|P1|Personalized Prophylaxis|Overall Study||3
7755921|NCT01454739|19096552|P2|Weekly Prophylaxis|Overall Study||34
7755922|NCT01454739|19096553|P1|Weekly Prophylaxis|Overall Study||0
7755923|NCT01454739|19096552|P2|Tailored Prophylaxis|Overall Study||131
7755924|NCT01454739|19096553|P1|Tailored Prophylaxis|Overall Study||59
7755925|NCT01454739|19096552|P2|STARTED|Overall Study||179
7755926|NCT01454739|19096553|P1|STARTED|Overall Study|30 participants in <6 Years Old Age Cohort and 31 participants in 6 to <12 Years Old Age Cohort.|61
7755927|NCT01454726|19096582|P2|NOT COMPLETED|Overall Study||1
7755928|NCT01454726|19096583|P1|NOT COMPLETED|Overall Study||0
7755929|NCT01454726|19096582|P2|COMPLETED|Overall Study||10
7755930|NCT01454726|19096583|P1|COMPLETED|Overall Study||16
7755931|NCT01454726|19096582|P2|STARTED|Overall Study||11
7755932|NCT01454726|19096583|P1|STARTED|Overall Study||16
7755933|NCT01454596|19096601|P12|NOT COMPLETED|Overall Study||0
7755934|NCT01454596|19096602|P11|NOT COMPLETED|Overall Study||1
7755935|NCT01454596|19096603|P10|NOT COMPLETED|Overall Study||1
7755936|NCT01454596|19096604|P9|NOT COMPLETED|Overall Study||0
7755937|NCT01454596|19096605|P8|NOT COMPLETED|Overall Study||0
7755938|NCT01454596|19096606|P7|NOT COMPLETED|Overall Study||0
7755939|NCT01454596|19096607|P6|NOT COMPLETED|Overall Study||0
7755940|NCT01454596|19096608|P5|NOT COMPLETED|Overall Study||0
7755941|NCT01454596|19096609|P4|NOT COMPLETED|Overall Study||0
7755942|NCT01454596|19096610|P3|NOT COMPLETED|Overall Study||0
7755943|NCT01454596|19096611|P2|NOT COMPLETED|Overall Study||0
7755944|NCT01454596|19096612|P1|NOT COMPLETED|Overall Study||0
7755945|NCT01454596|19096601|P12|COMPLETED|Overall Study||1
7755946|NCT01454596|19096602|P11|COMPLETED|Overall Study||0
7755947|NCT01454596|19096603|P10|COMPLETED|Overall Study||2
7755948|NCT01454596|19096604|P9|COMPLETED|Overall Study||3
7755949|NCT01454596|19096605|P8|COMPLETED|Overall Study||3
7755950|NCT01454596|19096606|P7|COMPLETED|Overall Study||1
7755951|NCT01454596|19096607|P6|COMPLETED|Overall Study||1
7755952|NCT01454596|19096608|P5|COMPLETED|Overall Study||1
7755953|NCT01454596|19096609|P4|COMPLETED|Overall Study||1
7755954|NCT01454596|19096610|P3|COMPLETED|Overall Study||1
7755955|NCT01454596|19096611|P2|COMPLETED|Overall Study||1
7755956|NCT01454596|19096612|P1|COMPLETED|Overall Study||1
7755957|NCT01454596|19096601|P12|STARTED|Overall Study||1
7755958|NCT01454596|19096602|P11|STARTED|Overall Study||1
7755959|NCT01454596|19096603|P10|STARTED|Overall Study||3
7755960|NCT01454596|19096604|P9|STARTED|Overall Study||3
7755961|NCT01454596|19096605|P8|STARTED|Overall Study||3
7755962|NCT01454596|19096606|P7|STARTED|Overall Study||1
7755963|NCT01454596|19096607|P6|STARTED|Overall Study||1
7755964|NCT01454596|19096608|P5|STARTED|Overall Study||1
7755965|NCT01454596|19096609|P4|STARTED|Overall Study||1
7755966|NCT01454596|19096610|P3|STARTED|Overall Study||1
7755967|NCT01454596|19096611|P2|STARTED|Overall Study||1
7755968|NCT01454596|19096612|P1|STARTED|Overall Study||1
7755969|NCT01454583|19096689|P3|NOT COMPLETED|3rd Year||297
7755970|NCT01454583|19096690|P2|NOT COMPLETED|3rd Year||512
7755971|NCT01454583|19096691|P1|NOT COMPLETED|3rd Year||1959
7755972|NCT01454583|19096689|P3|COMPLETED|3rd Year||285
7755973|NCT01454583|19096690|P2|COMPLETED|3rd Year||470
7755974|NCT01454583|19096691|P1|COMPLETED|3rd Year||1832
7755975|NCT01454583|19096689|P3|STARTED|3rd Year||582
7755976|NCT01454583|19096690|P2|STARTED|3rd Year||982
7755977|NCT01454583|19096691|P1|STARTED|3rd Year||3791
7755978|NCT01454583|19096689|P3|NOT COMPLETED|2nd Year||737
7755979|NCT01454583|19096690|P2|NOT COMPLETED|2nd Year||1049
7755980|NCT01454583|19096691|P1|NOT COMPLETED|2nd Year||3965
7755981|NCT01454583|19096689|P3|COMPLETED|2nd Year||1376
7755982|NCT01454583|19096690|P2|COMPLETED|2nd Year||1647
7755983|NCT01454583|19096691|P1|COMPLETED|2nd Year||6212
7755984|NCT01454583|19096689|P3|STARTED|2nd Year||2113
7755985|NCT01454583|19096690|P2|STARTED|2nd Year||2696
7755986|NCT01454583|19096691|P1|STARTED|2nd Year||10177
7755987|NCT01454583|19096689|P3|NOT COMPLETED|1st Year||180
7755988|NCT01454583|19096690|P2|NOT COMPLETED|1st Year||318
7755989|NCT01454583|19096691|P1|NOT COMPLETED|1st Year||1057
7755990|NCT01454583|19096689|P3|COMPLETED|1st Year||1933
7755991|NCT01454583|19096690|P2|COMPLETED|1st Year||2378
7755992|NCT01454583|19096691|P1|COMPLETED|1st Year||9120
7755993|NCT01454583|19096689|P3|STARTED|1st Year||2113
7755994|NCT01454583|19096690|P2|STARTED|1st Year||2696
7755995|NCT01454583|19096691|P1|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177
7755996|NCT01454570|19096759|P1|NOT COMPLETED|Overall Study||9
7755997|NCT01454570|19096759|P1|COMPLETED|Overall Study||10
7755998|NCT01454570|19096759|P1|STARTED|Overall Study||19
7755999|NCT01454531|19096763|P1|NOT COMPLETED|Overall Study||23
7756000|NCT01454531|19096763|P1|COMPLETED|Overall Study||173
7756001|NCT01454531|19096763|P1|Subjects Treated|Overall Study||192
7756002|NCT01454531|19096763|P1|STARTED|Overall Study||196
7756003|NCT01454505|19096775|P4|NOT COMPLETED|Overall Study||0
7756004|NCT01454505|19096776|P3|NOT COMPLETED|Overall Study||0
7756005|NCT01454505|19096777|P2|NOT COMPLETED|Overall Study||0
7756006|NCT01454505|19096778|P1|NOT COMPLETED|Overall Study||0
7756007|NCT01454505|19096775|P4|COMPLETED|Overall Study||20
7756008|NCT01454505|19096776|P3|COMPLETED|Overall Study||40
7756009|NCT01454505|19096777|P2|COMPLETED|Overall Study||15
7756010|NCT01454505|19096778|P1|COMPLETED|Overall Study||35
7756011|NCT01454505|19096775|P4|STARTED|Overall Study||20
7756012|NCT01454505|19096776|P3|STARTED|Overall Study||40
7756013|NCT01454505|19096777|P2|STARTED|Overall Study||15
7756014|NCT01454505|19096778|P1|STARTED|Overall Study||35
7756015|NCT01454414|19096792|P2|NOT COMPLETED|Overall Study||16
7756016|NCT01454414|19096793|P1|NOT COMPLETED|Overall Study||13
7756017|NCT01454414|19096792|P2|COMPLETED|Overall Study||64
7756018|NCT01454414|19096793|P1|COMPLETED|Overall Study||66
7756019|NCT01454414|19096792|P2|Baseline: Subjects That Sent Uniforms|Overall Study||66
7756020|NCT01454414|19096793|P1|Baseline: Subjects That Sent Uniforms|Overall Study||67
7756021|NCT01454414|19096792|P2|STARTED|Overall Study||80
7756022|NCT01454414|19096793|P1|STARTED|Overall Study||79
7756023|NCT01454401|19096799|P1|NOT COMPLETED|Overall Study||5
7756024|NCT01454401|19096799|P1|COMPLETED|Overall Study|Per Protocol (PP)|39
7756025|NCT01454401|19096799|P1|STARTED|Overall Study|ITT|44
7756026|NCT01454362|19096806|P2|NOT COMPLETED|Overall Study||0
7756027|NCT01454362|19096807|P1|NOT COMPLETED|Overall Study||0
7756028|NCT01454362|19096806|P2|COMPLETED|Overall Study||23
7756029|NCT01454362|19096807|P1|COMPLETED|Overall Study||28
7756030|NCT01454362|19096806|P2|STARTED|Overall Study||23
7756031|NCT01454362|19096807|P1|STARTED|Overall Study||28
7756032|NCT01454284|19096823|P2|NOT COMPLETED|Overall Study||73
7756033|NCT01454284|19096824|P1|NOT COMPLETED|Overall Study||116
7756034|NCT01454284|19096823|P2|COMPLETED|Overall Study||377
7756035|NCT01454284|19096824|P1|COMPLETED|Overall Study||548
7756036|NCT01454284|19096823|P2|Received at Least 1 Dose of Study Drug|Overall Study||449
7756037|NCT01454284|19096824|P1|Received at Least 1 Dose of Study Drug|Overall Study||663
7756038|NCT01454284|19096823|P2|STARTED|Overall Study||450
7756039|NCT01454284|19096824|P1|STARTED|Overall Study||664
7756040|NCT01454258|19096872|P1|NOT COMPLETED|Overall Study||997
7756041|NCT01454258|19096872|P1|COMPLETED|Overall Study||9103
7756042|NCT01454258|19096872|P1|STARTED|Overall Study||10100
7756043|NCT01454102|19096894|P16|NOT COMPLETED|Overall Study||1
7756044|NCT01454102|19096895|P15|NOT COMPLETED|Overall Study||3
7756045|NCT01454102|19096896|P14|NOT COMPLETED|Overall Study||4
7756046|NCT01454102|19096897|P13|NOT COMPLETED|Overall Study||7
7756047|NCT01454102|19096898|P12|NOT COMPLETED|Overall Study||4
7756048|NCT01454102|19096899|P11|NOT COMPLETED|Overall Study||0
7756049|NCT01454102|19096900|P10|NOT COMPLETED|Overall Study||0
7756050|NCT01454102|19096901|P9|NOT COMPLETED|Overall Study||1
7756051|NCT01454102|19096902|P8|NOT COMPLETED|Overall Study||0
7756052|NCT01454102|19096903|P7|NOT COMPLETED|Overall Study||2
7756053|NCT01454102|19096904|P6|NOT COMPLETED|Overall Study||3
7756054|NCT01454102|19096905|P5|NOT COMPLETED|Overall Study||3
7756055|NCT01454102|19096906|P4|NOT COMPLETED|Overall Study||0
7756056|NCT01454102|19096907|P3|NOT COMPLETED|Overall Study||0
7756057|NCT01454102|19096908|P2|NOT COMPLETED|Overall Study||0
7756058|NCT01454102|19096909|P1|NOT COMPLETED|Overall Study||0
7756059|NCT01454102|19096894|P16|COMPLETED|Overall Study||13
7756060|NCT01454102|19096895|P15|COMPLETED|Overall Study||36
7756061|NCT01454102|19096896|P14|COMPLETED|Overall Study||34
7756062|NCT01454102|19096897|P13|COMPLETED|Overall Study||33
7756063|NCT01454102|19096898|P12|COMPLETED|Overall Study||27
7756064|NCT01454102|19096899|P11|COMPLETED|Overall Study||12
7756065|NCT01454102|19096900|P10|COMPLETED|Overall Study||13
7756066|NCT01454102|19096901|P9|COMPLETED|Overall Study||12
7756067|NCT01454102|19096902|P8|COMPLETED|Overall Study||25
7756068|NCT01454102|19096903|P7|COMPLETED|Overall Study||22
7756069|NCT01454102|19096904|P6|COMPLETED|Overall Study||49
7756070|NCT01454102|19096905|P5|COMPLETED|Overall Study||18
7756071|NCT01454102|19096906|P4|COMPLETED|Overall Study||12
7756072|NCT01454102|19096907|P3|COMPLETED|Overall Study||15
7756073|NCT01454102|19096908|P2|COMPLETED|Overall Study||15
7756074|NCT01454102|19096909|P1|COMPLETED|Overall Study||12
7756075|NCT01454102|19096894|P16|STARTED|Overall Study||14
7756076|NCT01454102|19096895|P15|STARTED|Overall Study||39
7756077|NCT01454102|19096896|P14|STARTED|Overall Study||38
7756078|NCT01454102|19096897|P13|STARTED|Overall Study||40
7756079|NCT01454102|19096898|P12|STARTED|Overall Study||31
7756080|NCT01454102|19096899|P11|STARTED|Overall Study||12
7756081|NCT01454102|19096900|P10|STARTED|Overall Study||13
7756082|NCT01454102|19096901|P9|STARTED|Overall Study||13
7756083|NCT01454102|19096902|P8|STARTED|Overall Study||25
7756084|NCT01454102|19096903|P7|STARTED|Overall Study||24
7756085|NCT01454102|19096904|P6|STARTED|Overall Study||52
7756086|NCT01454102|19096905|P5|STARTED|Overall Study||21
7756087|NCT01454102|19096906|P4|STARTED|Overall Study||12
7756088|NCT01454102|19096907|P3|STARTED|Overall Study||15
7756089|NCT01454102|19096908|P2|STARTED|Overall Study||15
7756090|NCT01454102|19096909|P1|STARTED|Overall Study||12
7756091|NCT01454076|19097029|P5|NOT COMPLETED|Overall Study||6
7756092|NCT01454076|19097030|P4|NOT COMPLETED|Overall Study||2
7756093|NCT01454076|19097031|P3|NOT COMPLETED|Overall Study||9
7756094|NCT01454076|19097032|P2|NOT COMPLETED|Overall Study||6
7756095|NCT01454076|19097033|P1|NOT COMPLETED|Overall Study||13
7756096|NCT01454076|19097029|P5|COMPLETED|Overall Study||15
7756097|NCT01454076|19097030|P4|COMPLETED|Overall Study||16
7756098|NCT01454076|19097031|P3|COMPLETED|Overall Study||15
7756099|NCT01454076|19097032|P2|COMPLETED|Overall Study||14
7756100|NCT01454076|19097033|P1|COMPLETED|Overall Study||16
7756101|NCT01454076|19097029|P5|STARTED|Overall Study||21
7756102|NCT01454076|19097030|P4|STARTED|Overall Study||18
7756103|NCT01454076|19097031|P3|STARTED|Overall Study||24
7756104|NCT01454076|19097032|P2|STARTED|Overall Study||20
7756105|NCT01454076|19097033|P1|STARTED|Overall Study||29
7756106|NCT01454063|19097086|P2|NOT COMPLETED|Treated||0
7756107|NCT01454063|19097087|P1|NOT COMPLETED|Treated||2
7756108|NCT01454063|19097086|P2|COMPLETED|Treated||201
7756109|NCT01454063|19097087|P1|COMPLETED|Treated||199
7756110|NCT01454063|19097086|P2|STARTED|Treated||201
7756111|NCT01454063|19097087|P1|STARTED|Treated||201
7756112|NCT01454063|19097086|P2|NOT COMPLETED|Randomized||2
7756113|NCT01454063|19097087|P1|NOT COMPLETED|Randomized||1
7756114|NCT01454063|19097086|P2|COMPLETED|Randomized||201
7756115|NCT01454063|19097087|P1|COMPLETED|Randomized||201
7756116|NCT01454063|19097086|P2|STARTED|Randomized||203
7756117|NCT01454063|19097087|P1|STARTED|Randomized||202
7756118|NCT01453998|19097108|P3|NOT COMPLETED|After Protocol Amendment 2.||0
7756119|NCT01453998|19097109|P2|NOT COMPLETED|After Protocol Amendment 2.||0
7756120|NCT01453998|19097110|P1|NOT COMPLETED|After Protocol Amendment 2.||1
7756121|NCT01453998|19097108|P3|COMPLETED|After Protocol Amendment 2.||124
7756122|NCT01453998|19097109|P2|COMPLETED|After Protocol Amendment 2.||130
7756123|NCT01453998|19097110|P1|COMPLETED|After Protocol Amendment 2.||130
7756124|NCT01453998|19097108|P3|STARTED|After Protocol Amendment 2.||124
7756125|NCT01453998|19097109|P2|STARTED|After Protocol Amendment 2.||130
7756126|NCT01453998|19097110|P1|STARTED|After Protocol Amendment 2.||131
7756127|NCT01453998|19097108|P3|NOT COMPLETED|Before Protocol Amendment 2||0
7756128|NCT01453998|19097109|P2|NOT COMPLETED|Before Protocol Amendment 2||0
7756129|NCT01453998|19097110|P1|NOT COMPLETED|Before Protocol Amendment 2||0
7756130|NCT01453998|19097108|P3|COMPLETED|Before Protocol Amendment 2||99
7756131|NCT01453998|19097109|P2|COMPLETED|Before Protocol Amendment 2||88
7756132|NCT01453998|19097110|P1|COMPLETED|Before Protocol Amendment 2||85
7756133|NCT01453998|19097108|P3|STARTED|Before Protocol Amendment 2||99
7756134|NCT01453998|19097109|P2|STARTED|Before Protocol Amendment 2||88
7756135|NCT01453998|19097110|P1|STARTED|Before Protocol Amendment 2||85
7756136|NCT01453946|19097274|P1|NOT COMPLETED|Overall Study||9
7756137|NCT01453946|19097274|P1|COMPLETED|Overall Study||41
7756138|NCT01453946|19097274|P1|STARTED|Overall Study||50
7756139|NCT01453894|19097282|P2|NOT COMPLETED|Overall Study||0
7756140|NCT01453894|19097283|P1|NOT COMPLETED|Overall Study||0
7756141|NCT01453894|19097282|P2|COMPLETED|Overall Study||225
7756142|NCT01453894|19097283|P1|COMPLETED|Overall Study||225
7756143|NCT01453894|19097282|P2|STARTED|Overall Study||225
7756144|NCT01453894|19097283|P1|STARTED|Overall Study||225
7756145|NCT01453855|19097291|P2|NOT COMPLETED|Overall Study||14
7756146|NCT01453855|19097292|P1|NOT COMPLETED|Overall Study||10
7756147|NCT01453855|19097291|P2|COMPLETED|Overall Study||408
7756148|NCT01453855|19097292|P1|COMPLETED|Overall Study||432
7756149|NCT01453855|19097291|P2|STARTED|Overall Study||422
7756150|NCT01453855|19097292|P1|STARTED|Overall Study||442
7756151|NCT01453725|19097300|P2|NOT COMPLETED|Overall Study||11
7756152|NCT01453725|19097301|P1|NOT COMPLETED|Overall Study||13
7756153|NCT01453725|19097300|P2|COMPLETED|Overall Study||89
7756154|NCT01453725|19097301|P1|COMPLETED|Overall Study||85
7756155|NCT01453725|19097300|P2|STARTED|Overall Study||100
7756156|NCT01453725|19097301|P1|STARTED|Overall Study||98
7756157|NCT01453595|19097324|P3|NOT COMPLETED|Overall Study||2
7756158|NCT01453595|19097325|P2|NOT COMPLETED|Overall Study||1
7756159|NCT01453595|19097326|P1|NOT COMPLETED|Overall Study||2
7756160|NCT01453595|19097324|P3|COMPLETED|Overall Study||0
7756161|NCT01453595|19097325|P2|COMPLETED|Overall Study||5
7756162|NCT01453595|19097326|P1|COMPLETED|Overall Study||0
7756163|NCT01453595|19097324|P3|STARTED|Overall Study||2
7756164|NCT01453595|19097325|P2|STARTED|Overall Study||6
7756165|NCT01453595|19097326|P1|STARTED|Overall Study||2
7756166|NCT01453569|19097335|P3|NOT COMPLETED|Overall Study||7
7756167|NCT01453569|19097336|P2|NOT COMPLETED|Overall Study||14
7756168|NCT01453569|19097337|P1|NOT COMPLETED|Overall Study||11
7756169|NCT01453569|19097335|P3|COMPLETED|Overall Study||78
7756170|NCT01453569|19097336|P2|COMPLETED|Overall Study||70
7756171|NCT01453569|19097337|P1|COMPLETED|Overall Study||75
7756172|NCT01453569|19097335|P3|STARTED|Overall Study||85
7756173|NCT01453569|19097336|P2|STARTED|Overall Study||84
7756174|NCT01453569|19097337|P1|STARTED|Overall Study||86
7756175|NCT01453439|19097356|P2|NOT COMPLETED|Follow-up||11
7756176|NCT01453439|19097357|P1|NOT COMPLETED|Follow-up||5
7756177|NCT01453439|19097356|P2|COMPLETED|Follow-up||37
7756178|NCT01453439|19097357|P1|COMPLETED|Follow-up||39
7756179|NCT01453439|19097356|P2|STARTED|Follow-up||48
7756180|NCT01453439|19097357|P1|STARTED|Follow-up||44
7756181|NCT01453439|19097356|P2|NOT COMPLETED|Treatment Phase||11
7756182|NCT01453439|19097357|P1|NOT COMPLETED|Treatment Phase||17
7756183|NCT01453439|19097356|P2|COMPLETED|Treatment Phase||48
7756184|NCT01453439|19097357|P1|COMPLETED|Treatment Phase||44
7756185|NCT01453439|19097356|P2|STARTED|Treatment Phase||59
7756186|NCT01453439|19097357|P1|STARTED|Treatment Phase||61
7756187|NCT01453413|19097377|P1|NOT COMPLETED|Overall Study||0
7756188|NCT01453413|19097377|P1|COMPLETED|Overall Study||297
7756189|NCT01453413|19097377|P1|STARTED|Overall Study||297
7756190|NCT01453387|19097384|P2|NOT COMPLETED|Overall Study||0
7756191|NCT01453387|19097385|P1|NOT COMPLETED|Overall Study||0
7756192|NCT01453387|19097384|P2|COMPLETED|Overall Study||7
7756193|NCT01453387|19097385|P1|COMPLETED|Overall Study||21
7756194|NCT01453387|19097384|P2|STARTED|Overall Study||7
7756195|NCT01453387|19097385|P1|STARTED|Overall Study||21
7756196|NCT01453374|19097468|P1|NOT COMPLETED|Overall Study||18
7756197|NCT01453374|19097468|P1|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9
7756198|NCT01453374|19097468|P1|STARTED|Overall Study||27
7756199|NCT01453361|19097484|P1|NOT COMPLETED|Overall Study||16
7756200|NCT01453361|19097484|P1|COMPLETED|Overall Study||2
7756201|NCT01453361|19097484|P1|STARTED|Overall Study||18
7756202|NCT01453348|19097492|P3|NOT COMPLETED|Overall Study||1
7756203|NCT01453348|19097493|P2|NOT COMPLETED|Overall Study||1
7756204|NCT01453348|19097494|P1|NOT COMPLETED|Overall Study||1
7756205|NCT01453348|19097492|P3|COMPLETED|Overall Study||83
7756206|NCT01453348|19097493|P2|COMPLETED|Overall Study||83
7756207|NCT01453348|19097494|P1|COMPLETED|Overall Study||83
7756208|NCT01453348|19097492|P3|STARTED|Overall Study||84
7756209|NCT01453348|19097493|P2|STARTED|Overall Study||84
7756210|NCT01453348|19097494|P1|STARTED|Overall Study||84
7756211|NCT01453296|19097510|P2|NOT COMPLETED|Treatment Period 2||0
7756212|NCT01453296|19097511|P1|NOT COMPLETED|Treatment Period 2||2
7756213|NCT01453296|19097510|P2|COMPLETED|Treatment Period 2||13
7756214|NCT01453296|19097511|P1|COMPLETED|Treatment Period 2||11
7756215|NCT01453296|19097510|P2|STARTED|Treatment Period 2||13
7756216|NCT01453296|19097511|P1|STARTED|Treatment Period 2||13
7756217|NCT01453296|19097510|P2|NOT COMPLETED|Washout Period||0
7756218|NCT01453296|19097511|P1|NOT COMPLETED|Washout Period||0
7756219|NCT01453296|19097510|P2|COMPLETED|Washout Period||13
7756220|NCT01453296|19097511|P1|COMPLETED|Washout Period||13
7756221|NCT01453296|19097510|P2|STARTED|Washout Period||13
7756222|NCT01453296|19097511|P1|STARTED|Washout Period||13
7756223|NCT01453296|19097510|P2|NOT COMPLETED|Treatment Period 1||1
7756224|NCT01453296|19097511|P1|NOT COMPLETED|Treatment Period 1||1
7756225|NCT01453296|19097510|P2|COMPLETED|Treatment Period 1||13
7756226|NCT01453296|19097511|P1|COMPLETED|Treatment Period 1||13
7756227|NCT01453296|19097510|P2|STARTED|Treatment Period 1||14
7756228|NCT01453296|19097511|P1|STARTED|Treatment Period 1||14
7756229|NCT01453205|19097578|P3|NOT COMPLETED|Overall Study||54
7756230|NCT01453205|19097579|P2|NOT COMPLETED|Overall Study||52
7756231|NCT01453205|19097580|P1|NOT COMPLETED|Overall Study||80
7756232|NCT01453205|19097578|P3|COMPLETED|Overall Study||1
7756233|NCT01453205|19097579|P2|COMPLETED|Overall Study||0
7756234|NCT01453205|19097580|P1|COMPLETED|Overall Study||0
7756235|NCT01453205|19097578|P3|STARTED|Overall Study||55
7756236|NCT01453205|19097579|P2|STARTED|Overall Study||52
7756237|NCT01453205|19097580|P1|STARTED|Overall Study||80
7756238|NCT01453166|19097631|P3|NOT COMPLETED|Overall Study||1
7756239|NCT01453166|19097632|P2|NOT COMPLETED|Overall Study||2
7756240|NCT01453166|19097633|P1|NOT COMPLETED|Overall Study||2
7756241|NCT01453166|19097631|P3|COMPLETED|Overall Study||38
7756242|NCT01453166|19097632|P2|COMPLETED|Overall Study||39
7756243|NCT01453166|19097633|P1|COMPLETED|Overall Study||40
7756244|NCT01453166|19097631|P3|STARTED|Overall Study||39
7756245|NCT01453166|19097632|P2|STARTED|Overall Study||41
7756246|NCT01453166|19097633|P1|STARTED|Overall Study||42
7756247|NCT01453153|19097656|P3|NOT COMPLETED|Overall Study||20
7756248|NCT01453153|19097657|P2|NOT COMPLETED|Overall Study||4
7756249|NCT01453153|19097658|P1|NOT COMPLETED|Overall Study||4
7756250|NCT01453153|19097656|P3|COMPLETED|Overall Study||0
7756251|NCT01453153|19097657|P2|COMPLETED|Overall Study||0
7756252|NCT01453153|19097658|P1|COMPLETED|Overall Study||0
7756253|NCT01453153|19097656|P3|STARTED|Overall Study||20
7756254|NCT01453153|19097657|P2|STARTED|Overall Study||4
7756255|NCT01453153|19097658|P1|STARTED|Overall Study||4
7756256|NCT01453075|19097731|P2|NOT COMPLETED|Overall Study||1
7756257|NCT01453075|19097732|P1|NOT COMPLETED|Overall Study||5
7756258|NCT01453075|19097731|P2|COMPLETED|Overall Study||14
7756259|NCT01453075|19097732|P1|COMPLETED|Overall Study||11
7756260|NCT01453075|19097731|P2|STARTED|Overall Study||15
7756261|NCT01453075|19097732|P1|STARTED|Overall Study||16
7756262|NCT01453049|19097740|P2|NOT COMPLETED|Overall Study||42
7756263|NCT01453049|19097741|P1|NOT COMPLETED|Overall Study||41
7756264|NCT01453049|19097740|P2|COMPLETED|Overall Study||2
7756265|NCT01453049|19097741|P1|COMPLETED|Overall Study||1
7756266|NCT01453049|19097740|P2|STARTED|Overall Study||44
7756267|NCT01453049|19097741|P1|STARTED|Overall Study||42
7756268|NCT01453036|19097814|P3|NOT COMPLETED|Overall Study||31
7756269|NCT01453036|19097815|P2|NOT COMPLETED|Overall Study||115
7756270|NCT01453036|19097816|P1|NOT COMPLETED|Overall Study||26
7756271|NCT01453036|19097814|P3|COMPLETED|Overall Study||277
7756272|NCT01453036|19097815|P2|COMPLETED|Overall Study||193
7756273|NCT01453036|19097816|P1|COMPLETED|Overall Study||282
7756274|NCT01453036|19097814|P3|STARTED|Overall Study||308
7756275|NCT01453036|19097815|P2|STARTED|Overall Study||308
7756276|NCT01453036|19097816|P1|STARTED|Overall Study||308
7756277|NCT01453023|19097824|P2|NOT COMPLETED|Treatment Period 2||1
7756278|NCT01453023|19097825|P1|NOT COMPLETED|Treatment Period 2||0
7756279|NCT01453023|19097824|P2|COMPLETED|Treatment Period 2||11
7756280|NCT01453023|19097825|P1|COMPLETED|Treatment Period 2||12
7756281|NCT01453023|19097824|P2|STARTED|Treatment Period 2||12
7756282|NCT01453023|19097825|P1|STARTED|Treatment Period 2||12
7756283|NCT01453023|19097824|P2|NOT COMPLETED|Washout Period||0
7756284|NCT01453023|19097825|P1|NOT COMPLETED|Washout Period||0
7756285|NCT01453023|19097824|P2|COMPLETED|Washout Period||12
7756286|NCT01453023|19097825|P1|COMPLETED|Washout Period||12
7756287|NCT01453023|19097824|P2|STARTED|Washout Period||12
7756288|NCT01453023|19097825|P1|STARTED|Washout Period||12
7756289|NCT01453023|19097824|P2|NOT COMPLETED|Treatment Period (TP) 1||1
7756290|NCT01453023|19097825|P1|NOT COMPLETED|Treatment Period (TP) 1||1
7756291|NCT01453023|19097824|P2|COMPLETED|Treatment Period (TP) 1||12
7756292|NCT01453023|19097825|P1|COMPLETED|Treatment Period (TP) 1||12
7756293|NCT01453023|19097824|P2|STARTED|Treatment Period (TP) 1||13
7756294|NCT01453023|19097825|P1|STARTED|Treatment Period (TP) 1||13
7756295|NCT01452854|19097893|P1|NOT COMPLETED|Overall Study||0
7756296|NCT01452854|19097893|P1|COMPLETED|Overall Study||2
7756297|NCT01452854|19097893|P1|STARTED|Overall Study||2
7756298|NCT01452789|19097899|P2|NOT COMPLETED|Overall Study||2
7756299|NCT01452789|19097900|P1|NOT COMPLETED|Overall Study||3
7756300|NCT01452789|19097899|P2|COMPLETED|Overall Study||28
7756301|NCT01452789|19097900|P1|COMPLETED|Overall Study||30
7756302|NCT01452789|19097899|P2|STARTED|Overall Study||30
7756303|NCT01452789|19097900|P1|STARTED|Overall Study||33
7756304|NCT01452529|19097914|P3|NOT COMPLETED|Double-blind (DB) Period||82
7756305|NCT01452529|19097915|P2|NOT COMPLETED|Double-blind (DB) Period||67
7756306|NCT01452529|19097916|P1|NOT COMPLETED|Double-blind (DB) Period||0
7756307|NCT01452529|19097914|P3|COMPLETED|Double-blind (DB) Period||210
7756308|NCT01452529|19097915|P2|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229
7756309|NCT01452529|19097916|P1|COMPLETED|Double-blind (DB) Period||0
7756310|NCT01452529|19097914|P3|STARTED|Double-blind (DB) Period||292
7756311|NCT01452529|19097915|P2|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296
7756312|NCT01452529|19097916|P1|STARTED|Double-blind (DB) Period||0
7756313|NCT01452529|19097914|P3|NOT COMPLETED|Run-in Period||0
7756314|NCT01452529|19097915|P2|NOT COMPLETED|Run-in Period||0
7756315|NCT01452529|19097916|P1|NOT COMPLETED|Run-in Period||313
7756316|NCT01452529|19097914|P3|COMPLETED|Run-in Period||0
7756317|NCT01452529|19097915|P2|COMPLETED|Run-in Period||0
7756318|NCT01452529|19097916|P1|COMPLETED|Run-in Period||592
7756319|NCT01452529|19097914|P3|STARTED|Run-in Period||0
7756320|NCT01452529|19097915|P2|STARTED|Run-in Period||0
7756321|NCT01452529|19097916|P1|STARTED|Run-in Period||905
7756322|NCT01452425|19097931|P1|NOT COMPLETED|Overall Study||0
7756323|NCT01452425|19097931|P1|COMPLETED|Overall Study||10
7756324|NCT01452425|19097931|P1|STARTED|Overall Study||10
7756325|NCT01452412|19097938|P2|NOT COMPLETED|Overall Study||17
7756326|NCT01452412|19097939|P1|NOT COMPLETED|Overall Study||28
7756327|NCT01452412|19097938|P2|COMPLETED|Overall Study||58
7756328|NCT01452412|19097939|P1|COMPLETED|Overall Study||46
7756329|NCT01452412|19097938|P2|STARTED|Overall Study||75
7756330|NCT01452412|19097939|P1|STARTED|Overall Study||74
7756331|NCT01452347|19097955|P2|NOT COMPLETED|Overall Study||7
7756332|NCT01452347|19097956|P1|NOT COMPLETED|Overall Study||17
7756333|NCT01452347|19097955|P2|COMPLETED|Overall Study||77
7756334|NCT01452347|19097956|P1|COMPLETED|Overall Study||151
7756335|NCT01452347|19097955|P2|STARTED|Overall Study||84
7756336|NCT01452347|19097956|P1|STARTED|Overall Study||168
7756337|NCT01452269|19097974|P2|NOT COMPLETED|Overall Study||5
7756338|NCT01452269|19097975|P1|NOT COMPLETED|Overall Study||1
7756339|NCT01452269|19097974|P2|COMPLETED|Overall Study||51
7756340|NCT01452269|19097975|P1|COMPLETED|Overall Study||47
7756341|NCT01452269|19097974|P2|STARTED|Overall Study||56
7756342|NCT01452269|19097975|P1|STARTED|Overall Study||48
7756343|NCT01452191|19097988|P3|NOT COMPLETED|Overall Study||112
7756344|NCT01452191|19097989|P2|NOT COMPLETED|Overall Study||117
7756345|NCT01452191|19097990|P1|NOT COMPLETED|Overall Study||132
7756346|NCT01452191|19097988|P3|COMPLETED|Overall Study||258
7756347|NCT01452191|19097989|P2|COMPLETED|Overall Study||252
7756348|NCT01452191|19097990|P1|COMPLETED|Overall Study||241
7756349|NCT01452191|19097988|P3|STARTED|Overall Study||370
7756350|NCT01452191|19097989|P2|STARTED|Overall Study||369
7756351|NCT01452191|19097990|P1|STARTED|Overall Study||373
7756352|NCT01452152|19098016|P3|NOT COMPLETED|Overall Study||4
7756353|NCT01452152|19098017|P2|NOT COMPLETED|Overall Study||0
7756354|NCT01452152|19098018|P1|NOT COMPLETED|Overall Study||5
7756355|NCT01452152|19098016|P3|COMPLETED|Overall Study||0
7756356|NCT01452152|19098017|P2|COMPLETED|Overall Study||0
7756357|NCT01452152|19098018|P1|COMPLETED|Overall Study||0
7756358|NCT01452152|19098016|P3|STARTED|Overall Study||4
7756359|NCT01452152|19098017|P2|STARTED|Overall Study||0
7756360|NCT01452152|19098018|P1|STARTED|Overall Study||5
7756361|NCT01452126|19098041|P1|NOT COMPLETED|Overall Study||0
7756362|NCT01452126|19098041|P1|COMPLETED|Overall Study||49
7756363|NCT01452126|19098041|P1|STARTED|Overall Study||49
7756364|NCT01451996|19098053|P4|NOT COMPLETED|Overall Study||0
7756365|NCT01451996|19098054|P3|NOT COMPLETED|Overall Study||0
7756366|NCT01451996|19098055|P2|NOT COMPLETED|Overall Study||0
7756367|NCT01451996|19098056|P1|NOT COMPLETED|Overall Study||0
7756368|NCT01451996|19098053|P4|COMPLETED|Overall Study||85
7756369|NCT01451996|19098054|P3|COMPLETED|Overall Study||85
7756370|NCT01451996|19098055|P2|COMPLETED|Overall Study||87
7756371|NCT01451996|19098056|P1|COMPLETED|Overall Study||83
7756372|NCT01451996|19098053|P4|STARTED|Overall Study||85
7756373|NCT01451996|19098054|P3|STARTED|Overall Study||85
7756374|NCT01451996|19098055|P2|STARTED|Overall Study||87
7756375|NCT01451996|19098056|P1|STARTED|Overall Study||83
7756376|NCT01451983|19098074|P4|NOT COMPLETED|Overall Study||0
7756377|NCT01451983|19098075|P3|NOT COMPLETED|Overall Study||0
7756378|NCT01451983|19098076|P2|NOT COMPLETED|Overall Study||0
7756379|NCT01451983|19098077|P1|NOT COMPLETED|Overall Study||0
7756380|NCT01451983|19098074|P4|COMPLETED|Overall Study||24
7756381|NCT01451983|19098075|P3|COMPLETED|Overall Study||61
7756382|NCT01451983|19098076|P2|COMPLETED|Overall Study||27
7756383|NCT01451983|19098077|P1|COMPLETED|Overall Study||26
7756384|NCT01451983|19098074|P4|STARTED|Overall Study||24
7756385|NCT01451983|19098075|P3|STARTED|Overall Study||61
7756386|NCT01451983|19098076|P2|STARTED|Overall Study||27
7756387|NCT01451983|19098077|P1|STARTED|Overall Study||26
7756388|NCT01451931|19098090|P3|NOT COMPLETED|Overall Study||43
7756389|NCT01451931|19098091|P2|NOT COMPLETED|Overall Study||58
7756390|NCT01451931|19098092|P1|NOT COMPLETED|Overall Study||33
7756391|NCT01451931|19098090|P3|COMPLETED|Overall Study||923
7756392|NCT01451931|19098091|P2|COMPLETED|Overall Study||843
7756393|NCT01451931|19098092|P1|COMPLETED|Overall Study||876
7756394|NCT01451931|19098090|P3|6-month Follow up|Overall Study||923
7756395|NCT01451931|19098091|P2|6-month Follow up|Overall Study||843
7756396|NCT01451931|19098092|P1|6-month Follow up|Overall Study||876
7756397|NCT01451931|19098090|P3|Baseline Data Collection|Overall Study||958
7756398|NCT01451931|19098091|P2|Baseline Data Collection|Overall Study||893
7756399|NCT01451931|19098092|P1|Baseline Data Collection|Overall Study||908
7756400|NCT01451931|19098090|P3|STARTED|Overall Study||966
7756401|NCT01451931|19098091|P2|STARTED|Overall Study||901
7756402|NCT01451931|19098092|P1|STARTED|Overall Study||909
7756403|NCT01451827|19098116|P4|NOT COMPLETED|Overall Study||4
7756404|NCT01451827|19098117|P3|NOT COMPLETED|Overall Study||2
7756405|NCT01451827|19098118|P2|NOT COMPLETED|Overall Study||5
7756406|NCT01451827|19098119|P1|NOT COMPLETED|Overall Study||3
7756407|NCT01451827|19098116|P4|COMPLETED|Overall Study||39
7756408|NCT01451827|19098117|P3|COMPLETED|Overall Study||42
7756409|NCT01451827|19098118|P2|COMPLETED|Overall Study||40
7756410|NCT01451827|19098119|P1|COMPLETED|Overall Study||42
7756411|NCT01451827|19098116|P4|STARTED|Overall Study||43
7756412|NCT01451827|19098117|P3|STARTED|Overall Study||44
7756413|NCT01451827|19098118|P2|STARTED|Overall Study||45
7756414|NCT01451827|19098119|P1|STARTED|Overall Study||45
7756415|NCT01451814|19098139|P2|NOT COMPLETED|Overall Study||5
7756416|NCT01451814|19098140|P1|NOT COMPLETED|Overall Study||6
7756417|NCT01451814|19098139|P2|COMPLETED|Overall Study||26
7756418|NCT01451814|19098140|P1|COMPLETED|Overall Study||29
7756419|NCT01451814|19098139|P2|Attended a Session|Overall Study||31
7756420|NCT01451814|19098140|P1|Attended a Session|Overall Study||35
7756421|NCT01451814|19098139|P2|STARTED|Overall Study||31
7756422|NCT01451814|19098140|P1|STARTED|Overall Study||35
7756423|NCT01451775|19098150|P6|NOT COMPLETED|Overall Study||0
7756424|NCT01451775|19098151|P5|NOT COMPLETED|Overall Study||0
7756425|NCT01451775|19098152|P4|NOT COMPLETED|Overall Study||0
7756426|NCT01451775|19098153|P3|NOT COMPLETED|Overall Study||0
7756427|NCT01451775|19098154|P2|NOT COMPLETED|Overall Study||0
7756428|NCT01451775|19098155|P1|NOT COMPLETED|Overall Study||0
7756429|NCT01451775|19098150|P6|COMPLETED|Overall Study||3
7756430|NCT01451775|19098151|P5|COMPLETED|Overall Study||3
7756431|NCT01451775|19098152|P4|COMPLETED|Overall Study||3
7756432|NCT01451775|19098153|P3|COMPLETED|Overall Study||3
7756433|NCT01451775|19098154|P2|COMPLETED|Overall Study||3
7756434|NCT01451775|19098155|P1|COMPLETED|Overall Study||3
7756435|NCT01451775|19098150|P6|STARTED|Overall Study||3
7756436|NCT01451775|19098151|P5|STARTED|Overall Study||3
7756437|NCT01451775|19098152|P4|STARTED|Overall Study||3
7756438|NCT01451775|19098153|P3|STARTED|Overall Study||3
7756439|NCT01451775|19098154|P2|STARTED|Overall Study||3
7756440|NCT01451775|19098155|P1|STARTED|Overall Study||3
7756441|NCT01451762|19098172|P3|NOT COMPLETED|Overall Study||6
7756442|NCT01451762|19098173|P2|NOT COMPLETED|Overall Study||6
7756443|NCT01451762|19098174|P1|NOT COMPLETED|Overall Study||3
7756444|NCT01451762|19098172|P3|COMPLETED|Overall Study||24
7756445|NCT01451762|19098173|P2|COMPLETED|Overall Study||24
7756446|NCT01451762|19098174|P1|COMPLETED|Overall Study||27
7756447|NCT01451762|19098172|P3|STARTED|Overall Study||30
7756448|NCT01451762|19098173|P2|STARTED|Overall Study||30
7756449|NCT01451762|19098174|P1|STARTED|Overall Study||30
7756450|NCT01451749|19098184|P2|NOT COMPLETED|Overall Study||14
7756451|NCT01451749|19098185|P1|NOT COMPLETED|Overall Study||32
7756452|NCT01451749|19098184|P2|COMPLETED|Overall Study||94
7756453|NCT01451749|19098185|P1|COMPLETED|Overall Study||184
7756454|NCT01451749|19098184|P2|STARTED|Overall Study||108
7756455|NCT01451749|19098185|P1|STARTED|Overall Study||216
7756456|NCT01451723|19098197|P2|NOT COMPLETED|Overall Study||5
7756457|NCT01451723|19098198|P1|NOT COMPLETED|Overall Study||6
7756458|NCT01451723|19098197|P2|COMPLETED|Overall Study||0
7756459|NCT01451723|19098198|P1|COMPLETED|Overall Study||0
7756460|NCT01451723|19098197|P2|STARTED|Overall Study||5
7756461|NCT01451723|19098198|P1|STARTED|Overall Study||6
7756462|NCT01451645|19098208|P2|NOT COMPLETED|Overall Study||8
7756463|NCT01451645|19098209|P1|NOT COMPLETED|Overall Study||9
7756464|NCT01451645|19098208|P2|COMPLETED|Overall Study||33
7756465|NCT01451645|19098209|P1|COMPLETED|Overall Study||32
7756466|NCT01451645|19098208|P2|STARTED|Overall Study||41
7756467|NCT01451645|19098209|P1|STARTED|Overall Study||41
7756468|NCT01451632|19098223|P10|NOT COMPLETED|Overall Study||0
7756469|NCT01451632|19098224|P9|NOT COMPLETED|Overall Study||0
7756470|NCT01451632|19098225|P8|NOT COMPLETED|Overall Study||0
7756471|NCT01451632|19098226|P7|NOT COMPLETED|Overall Study||0
7756472|NCT01451632|19098227|P6|NOT COMPLETED|Overall Study||0
7756473|NCT01451632|19098228|P5|NOT COMPLETED|Overall Study||0
7756474|NCT01451632|19098229|P4|NOT COMPLETED|Overall Study||0
7756475|NCT01451632|19098230|P3|NOT COMPLETED|Overall Study||0
7756476|NCT01451632|19098231|P2|NOT COMPLETED|Overall Study||0
7756477|NCT01451632|19098232|P1|NOT COMPLETED|Overall Study||0
7756478|NCT01451632|19098223|P10|COMPLETED|Overall Study||4
7756479|NCT01451632|19098224|P9|COMPLETED|Overall Study||4
7756480|NCT01451632|19098225|P8|COMPLETED|Overall Study||6
7756481|NCT01451632|19098226|P7|COMPLETED|Overall Study||8
7756482|NCT01451632|19098227|P6|COMPLETED|Overall Study||4
7756483|NCT01451632|19098228|P5|COMPLETED|Overall Study||4
7756484|NCT01451632|19098229|P4|COMPLETED|Overall Study||3
7756485|NCT01451632|19098230|P3|COMPLETED|Overall Study||3
7756486|NCT01451632|19098231|P2|COMPLETED|Overall Study||4
7756487|NCT01451632|19098232|P1|COMPLETED|Overall Study||8
7756488|NCT01451632|19098223|P10|STARTED|Overall Study||4
7756489|NCT01451632|19098224|P9|STARTED|Overall Study||4
7756490|NCT01451632|19098225|P8|STARTED|Overall Study||6
7756491|NCT01451632|19098226|P7|STARTED|Overall Study||8
7756492|NCT01451632|19098227|P6|STARTED|Overall Study||4
7756493|NCT01451632|19098228|P5|STARTED|Overall Study||4
7756494|NCT01451632|19098229|P4|STARTED|Overall Study||3
7756495|NCT01451632|19098230|P3|STARTED|Overall Study||3
7756496|NCT01451632|19098231|P2|STARTED|Overall Study||4
7756497|NCT01451632|19098232|P1|STARTED|Overall Study||8
7756498|NCT01451606|19098280|P2|NOT COMPLETED|Overall Study||3
7756499|NCT01451606|19098281|P1|NOT COMPLETED|Overall Study||4
7756500|NCT01451606|19098280|P2|COMPLETED|Overall Study||15
7756501|NCT01451606|19098281|P1|COMPLETED|Overall Study||12
7756502|NCT01451606|19098280|P2|STARTED|Overall Study||18
7756503|NCT01451606|19098281|P1|STARTED|Overall Study||16
7756504|NCT01451554|19098291|P2|NOT COMPLETED|Overall Study||9
7756505|NCT01451554|19098292|P1|NOT COMPLETED|Overall Study||14
7756506|NCT01451554|19098291|P2|COMPLETED|Overall Study||23
7756507|NCT01451554|19098292|P1|COMPLETED|Overall Study||19
7756508|NCT01451554|19098291|P2|STARTED|Overall Study||32
7756509|NCT01451554|19098292|P1|STARTED|Overall Study||33
7756510|NCT01451541|19098303|P3|NOT COMPLETED|Overall Study||27
7756511|NCT01451541|19098304|P2|NOT COMPLETED|Overall Study||25
7756512|NCT01451541|19098305|P1|NOT COMPLETED|Overall Study||36
7756513|NCT01451541|19098303|P3|COMPLETED|Overall Study||254
7756514|NCT01451541|19098304|P2|COMPLETED|Overall Study||257
7756515|NCT01451541|19098305|P1|COMPLETED|Overall Study||247
7756516|NCT01451541|19098303|P3|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281
7756517|NCT01451541|19098304|P2|STARTED|Overall Study||282
7756518|NCT01451541|19098305|P1|STARTED|Overall Study||283
7756519|NCT01451463|19098345|P1|NOT COMPLETED|Overall Study||0
7756520|NCT01451463|19098345|P1|COMPLETED|Overall Study||11
7756521|NCT01451463|19098345|P1|STARTED|Overall Study||11
7756522|NCT01451437|19098363|P9|NOT COMPLETED|Overall Study||4
7756523|NCT01451437|19098364|P8|NOT COMPLETED|Overall Study||3
7756524|NCT01451437|19098365|P7|NOT COMPLETED|Overall Study||6
7756525|NCT01451437|19098366|P6|NOT COMPLETED|Overall Study||3
7756526|NCT01451437|19098367|P5|NOT COMPLETED|Overall Study||4
7756527|NCT01451437|19098368|P4|NOT COMPLETED|Overall Study||1
7756528|NCT01451437|19098369|P3|NOT COMPLETED|Overall Study||3
7756529|NCT01451437|19098370|P2|NOT COMPLETED|Overall Study||1
7756530|NCT01451437|19098371|P1|NOT COMPLETED|Overall Study||1
7756531|NCT01451437|19098363|P9|COMPLETED|Overall Study||0
7756532|NCT01451437|19098364|P8|COMPLETED|Overall Study||0
7756533|NCT01451437|19098365|P7|COMPLETED|Overall Study||0
7756534|NCT01451437|19098366|P6|COMPLETED|Overall Study||0
7756535|NCT01451437|19098367|P5|COMPLETED|Overall Study||0
7756536|NCT01451437|19098368|P4|COMPLETED|Overall Study||0
7756537|NCT01451437|19098369|P3|COMPLETED|Overall Study||0
7756538|NCT01451437|19098370|P2|COMPLETED|Overall Study||0
7756539|NCT01451437|19098371|P1|COMPLETED|Overall Study||0
7756540|NCT01451437|19098363|P9|STARTED|Overall Study||4
7756541|NCT01451437|19098364|P8|STARTED|Overall Study||3
7756542|NCT01451437|19098365|P7|STARTED|Overall Study||6
7756543|NCT01451437|19098366|P6|STARTED|Overall Study||3
7756544|NCT01451437|19098367|P5|STARTED|Overall Study||4
7756545|NCT01451437|19098368|P4|STARTED|Overall Study||1
7756546|NCT01451437|19098369|P3|STARTED|Overall Study||3
7756547|NCT01451437|19098370|P2|STARTED|Overall Study||1
7756548|NCT01451437|19098371|P1|STARTED|Overall Study||1
7756549|NCT01451424|19098503|P4|NOT COMPLETED|Overall Study||5
7756550|NCT01451424|19098504|P3|NOT COMPLETED|Overall Study||1
7756551|NCT01451424|19098505|P2|NOT COMPLETED|Overall Study||2
7756552|NCT01451424|19098506|P1|NOT COMPLETED|Overall Study||1
7756553|NCT01451424|19098503|P4|COMPLETED|Overall Study||5
7756554|NCT01451424|19098504|P3|COMPLETED|Overall Study||11
7756555|NCT01451424|19098505|P2|COMPLETED|Overall Study||7
7756556|NCT01451424|19098506|P1|COMPLETED|Overall Study||8
7756557|NCT01451424|19098503|P4|STARTED|Overall Study||10
7756558|NCT01451424|19098504|P3|STARTED|Overall Study||12
7756559|NCT01451424|19098505|P2|STARTED|Overall Study||9
7756560|NCT01451424|19098506|P1|STARTED|Overall Study||9
7756561|NCT01451411|19098539|P2|NOT COMPLETED|Overall Study||0
7756562|NCT01451411|19098540|P1|NOT COMPLETED|Overall Study||0
7756563|NCT01451411|19098539|P2|COMPLETED|Overall Study||1
7756564|NCT01451411|19098540|P1|COMPLETED|Overall Study||3
7756565|NCT01451411|19098539|P2|STARTED|Overall Study||1
7756566|NCT01451411|19098540|P1|STARTED|Overall Study||3
7756567|NCT01451398|19098564|P2|NOT COMPLETED|Overall Study||37
7756568|NCT01451398|19098565|P1|NOT COMPLETED|Overall Study||27
7756569|NCT01451398|19098564|P2|COMPLETED|Overall Study||139
7756570|NCT01451398|19098565|P1|COMPLETED|Overall Study||150
7756571|NCT01451398|19098564|P2|STARTED|Overall Study||176
7756572|NCT01451398|19098565|P1|STARTED|Overall Study||177
7756573|NCT01451385|19098597|P1|NOT COMPLETED|Overall Study||91
7756574|NCT01451385|19098597|P1|COMPLETED|Overall Study||285
7756575|NCT01451385|19098597|P1|STARTED|Overall Study||376
7756576|NCT01451372|19098609|P1|NOT COMPLETED|Overall Study||0
7756577|NCT01451372|19098609|P1|COMPLETED|Overall Study||69
7756578|NCT01451372|19098609|P1|STARTED|Overall Study||69
7756579|NCT01451203|19098616|P2|NOT COMPLETED|Post-treatment Period||34
7756580|NCT01451203|19098617|P1|NOT COMPLETED|Post-treatment Period||14
7756581|NCT01451203|19098616|P2|COMPLETED|Post-treatment Period||74
7756582|NCT01451203|19098617|P1|COMPLETED|Post-treatment Period||57
7756583|NCT01451203|19098616|P2|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28
7756584|NCT01451203|19098617|P1|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12
7756585|NCT01451203|19098616|P2|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108
7756586|NCT01451203|19098617|P1|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71
7756587|NCT01451203|19098616|P2|NOT COMPLETED|Double-blind Treatment Period||50
7756588|NCT01451203|19098617|P1|NOT COMPLETED|Double-blind Treatment Period||85
7756589|NCT01451203|19098616|P2|COMPLETED|Double-blind Treatment Period||111
7756590|NCT01451203|19098617|P1|COMPLETED|Double-blind Treatment Period||73
7756591|NCT01451203|19098616|P2|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36
7756592|NCT01451203|19098617|P1|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70
7756593|NCT01451203|19098616|P2|Received Treatment|Double-blind Treatment Period||159
7756594|NCT01451203|19098617|P1|Received Treatment|Double-blind Treatment Period||157
7756595|NCT01451203|19098616|P2|STARTED|Double-blind Treatment Period||161
7756596|NCT01451203|19098617|P1|STARTED|Double-blind Treatment Period||158
7756597|NCT01451164|19098635|P4|NOT COMPLETED|Overall Study||46
7756598|NCT01451164|19098636|P3|NOT COMPLETED|Overall Study||45
7756599|NCT01451164|19098637|P2|NOT COMPLETED|Overall Study||34
7756600|NCT01451164|19098638|P1|NOT COMPLETED|Overall Study||43
7756601|NCT01451164|19098635|P4|COMPLETED|Overall Study||70
7756602|NCT01451164|19098636|P3|COMPLETED|Overall Study||68
7756603|NCT01451164|19098637|P2|COMPLETED|Overall Study||81
7756604|NCT01451164|19098638|P1|COMPLETED|Overall Study||72
7756605|NCT01451164|19098635|P4|STARTED|Overall Study||116
7756606|NCT01451164|19098636|P3|STARTED|Overall Study||113
7756607|NCT01451164|19098637|P2|STARTED|Overall Study||115
7756608|NCT01451164|19098638|P1|STARTED|Overall Study||115
7756609|NCT01450943|19098667|P3|NOT COMPLETED|Overall Study||6
7756610|NCT01450943|19098668|P2|NOT COMPLETED|Overall Study||7
7756611|NCT01450943|19098669|P1|NOT COMPLETED|Overall Study||2
7756612|NCT01450943|19098667|P3|COMPLETED|Overall Study||42
7756613|NCT01450943|19098668|P2|COMPLETED|Overall Study||35
7756614|NCT01450943|19098669|P1|COMPLETED|Overall Study||26
7756615|NCT01450943|19098667|P3|STARTED|Overall Study||48
7756616|NCT01450943|19098668|P2|STARTED|Overall Study||42
7756617|NCT01450943|19098669|P1|STARTED|Overall Study||28
7756618|NCT01450826|19098685|P2|NOT COMPLETED|Overall Study||0
7756619|NCT01450826|19098686|P1|NOT COMPLETED|Overall Study||0
7756620|NCT01450826|19098685|P2|COMPLETED|Overall Study||66
7756621|NCT01450826|19098686|P1|COMPLETED|Overall Study||70
7756622|NCT01450826|19098685|P2|STARTED|Overall Study||66
7756623|NCT01450826|19098686|P1|STARTED|Overall Study||70
7756624|NCT01450813|19098702|P4|NOT COMPLETED|Overall Study||3
7756625|NCT01450813|19098703|P3|NOT COMPLETED|Overall Study||0
7756626|NCT01450813|19098704|P2|NOT COMPLETED|Overall Study||1
7756627|NCT01450813|19098705|P1|NOT COMPLETED|Overall Study||1
7756628|NCT01450813|19098702|P4|COMPLETED|Overall Study||17
7756629|NCT01450813|19098703|P3|COMPLETED|Overall Study||20
7756630|NCT01450813|19098704|P2|COMPLETED|Overall Study||19
7756631|NCT01450813|19098705|P1|COMPLETED|Overall Study||19
7756632|NCT01450813|19098702|P4|STARTED|Overall Study||20
7756633|NCT01450813|19098703|P3|STARTED|Overall Study||20
7756634|NCT01450813|19098704|P2|STARTED|Overall Study||20
7756635|NCT01450813|19098705|P1|STARTED|Overall Study||20
7756636|NCT01450800|19098719|P2|NOT COMPLETED|Overall Study||3
7756637|NCT01450800|19098720|P1|NOT COMPLETED|Overall Study||1
7756638|NCT01450800|19098719|P2|COMPLETED|Overall Study||78
7756639|NCT01450800|19098720|P1|COMPLETED|Overall Study||81
7756640|NCT01450800|19098719|P2|STARTED|Overall Study|81 participants were randomized to placebo|81
7756641|NCT01450800|19098720|P1|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82
7756642|NCT01450787|19098736|P2|NOT COMPLETED|Overall Study||0
7756643|NCT01450787|19098737|P1|NOT COMPLETED|Overall Study||0
7756644|NCT01450787|19098736|P2|COMPLETED|Overall Study||25
7756645|NCT01450787|19098737|P1|COMPLETED|Overall Study||38
7756646|NCT01450787|19098736|P2|STARTED|Overall Study||25
7756647|NCT01450787|19098737|P1|STARTED|Overall Study||38
7756648|NCT01450761|19098755|P2|NOT COMPLETED|Treatment With Blinded Study Therapy||476
7756649|NCT01450761|19098756|P1|NOT COMPLETED|Treatment With Blinded Study Therapy||478
7756650|NCT01450761|19098755|P2|COMPLETED|Treatment With Blinded Study Therapy||0
7756651|NCT01450761|19098756|P1|COMPLETED|Treatment With Blinded Study Therapy||0
7756652|NCT01450761|19098755|P2|STARTED|Treatment With Blinded Study Therapy||476
7756653|NCT01450761|19098756|P1|STARTED|Treatment With Blinded Study Therapy||478
7756654|NCT01450761|19098755|P2|NOT COMPLETED|Lead-in Chemotherapy||85
7756655|NCT01450761|19098756|P1|NOT COMPLETED|Lead-in Chemotherapy||84
7756656|NCT01450761|19098755|P2|COMPLETED|Lead-in Chemotherapy||476
7756657|NCT01450761|19098756|P1|COMPLETED|Lead-in Chemotherapy||478
7756658|NCT01450761|19098755|P2|STARTED|Lead-in Chemotherapy||561
7756659|NCT01450761|19098756|P1|STARTED|Lead-in Chemotherapy||562
7756660|NCT01450761|19098755|P2|NOT COMPLETED|Randomization||5
7756661|NCT01450761|19098756|P1|NOT COMPLETED|Randomization||4
7756662|NCT01450761|19098755|P2|COMPLETED|Randomization||561
7756663|NCT01450761|19098756|P1|COMPLETED|Randomization||562
7756664|NCT01450761|19098755|P2|STARTED|Randomization||566
7756665|NCT01450761|19098756|P1|STARTED|Randomization||566
7756666|NCT01450696|19098768|P2|NOT COMPLETED|Overall Study||148
7756667|NCT01450696|19098769|P1|NOT COMPLETED|Overall Study||148
7756668|NCT01450696|19098768|P2|COMPLETED|Overall Study||0
7756669|NCT01450696|19098769|P1|COMPLETED|Overall Study||0
7756670|NCT01450696|19098768|P2|Treated (Safety Population)|Overall Study||147
7756671|NCT01450696|19098769|P1|Treated (Safety Population)|Overall Study||147
7756672|NCT01450696|19098768|P2|STARTED|Overall Study||148
7756673|NCT01450696|19098769|P1|STARTED|Overall Study||148
7756674|NCT01450683|19098791|P1|NOT COMPLETED|Overall Study||2
7756675|NCT01450683|19098791|P1|COMPLETED|Overall Study||2
7756676|NCT01450683|19098791|P1|STARTED|Overall Study||4
7756677|NCT01450631|19098797|P2|NOT COMPLETED|Overall Study||4
7756678|NCT01450631|19098798|P1|NOT COMPLETED|Overall Study||3
7756679|NCT01450631|19098797|P2|COMPLETED|Overall Study||42
7756680|NCT01450631|19098798|P1|COMPLETED|Overall Study||43
7756681|NCT01450631|19098797|P2|STARTED|Overall Study||46
7756682|NCT01450631|19098798|P1|STARTED|Overall Study||46
7756683|NCT01450397|19098806|P1|NOT COMPLETED|Overall Study||0
7756684|NCT01450397|19098806|P1|COMPLETED|Overall Study||5
7756685|NCT01450397|19098806|P1|STARTED|Overall Study||5
7756686|NCT01450319|19098810|P1|NOT COMPLETED|Overall Study||0
7756687|NCT01450319|19098810|P1|COMPLETED|Overall Study||70
7756688|NCT01450319|19098810|P1|STARTED|Overall Study||70
7756689|NCT01450306|19098823|P2|NOT COMPLETED|Overall Study||0
7756690|NCT01450306|19098824|P1|NOT COMPLETED|Overall Study||0
7756691|NCT01450306|19098823|P2|COMPLETED|Overall Study||10
7756692|NCT01450306|19098824|P1|COMPLETED|Overall Study||10
7756693|NCT01450306|19098823|P2|STARTED|Overall Study||10
7756694|NCT01450306|19098824|P1|STARTED|Overall Study||10
7756695|NCT01450189|19098837|P3|NOT COMPLETED|Overall Study||0
7756696|NCT01450189|19098838|P2|NOT COMPLETED|Overall Study||0
7756697|NCT01450189|19098839|P1|NOT COMPLETED|Overall Study||0
7756698|NCT01450189|19098837|P3|COMPLETED|Overall Study||19
7756699|NCT01450189|19098838|P2|COMPLETED|Overall Study||18
7756700|NCT01450189|19098839|P1|COMPLETED|Overall Study||9
7756701|NCT01450189|19098837|P3|STARTED|Overall Study||19
7756702|NCT01450189|19098838|P2|STARTED|Overall Study||18
7756703|NCT01450189|19098839|P1|STARTED|Overall Study||9
7756704|NCT01450137|19098928|P2|NOT COMPLETED|Week 12 to Study End||2
7756705|NCT01450137|19098929|P1|NOT COMPLETED|Week 12 to Study End||0
7756706|NCT01450137|19098928|P2|COMPLETED|Week 12 to Study End||5
7756707|NCT01450137|19098929|P1|COMPLETED|Week 12 to Study End||18
7756708|NCT01450137|19098928|P2|STARTED|Week 12 to Study End||7
7756709|NCT01450137|19098929|P1|STARTED|Week 12 to Study End||18
7756710|NCT01450137|19098928|P2|NOT COMPLETED|Up to Week 12||3
7756711|NCT01450137|19098929|P1|NOT COMPLETED|Up to Week 12||2
7756712|NCT01450137|19098928|P2|COMPLETED|Up to Week 12||7
7756713|NCT01450137|19098929|P1|COMPLETED|Up to Week 12||18
7756714|NCT01450137|19098928|P2|STARTED|Up to Week 12||10
7756715|NCT01450137|19098929|P1|STARTED|Up to Week 12||20
7756716|NCT01450098|19098943|P2|NOT COMPLETED|Period 3||3
7756717|NCT01450098|19098944|P1|NOT COMPLETED|Period 3||0
7756718|NCT01450098|19098943|P2|COMPLETED|Period 3||28
7756719|NCT01450098|19098944|P1|COMPLETED|Period 3||8
7756720|NCT01450098|19098943|P2|Received at Least 1 Dose of Study Drug|Period 3||30
7756721|NCT01450098|19098944|P1|Received at Least 1 Dose of Study Drug|Period 3||8
7756722|NCT01450098|19098943|P2|STARTED|Period 3||31
7756723|NCT01450098|19098944|P1|STARTED|Period 3||8
7756724|NCT01450098|19098943|P2|NOT COMPLETED|Washout of at Least 14 Days||0
7756725|NCT01450098|19098944|P1|NOT COMPLETED|Washout of at Least 14 Days||0
7756726|NCT01450098|19098943|P2|COMPLETED|Washout of at Least 14 Days||31
7756727|NCT01450098|19098944|P1|COMPLETED|Washout of at Least 14 Days||8
7756728|NCT01450098|19098943|P2|STARTED|Washout of at Least 14 Days||31
7756729|NCT01450098|19098944|P1|STARTED|Washout of at Least 14 Days||8
7756730|NCT01450098|19098943|P2|NOT COMPLETED|Period 2||0
7756731|NCT01450098|19098944|P1|NOT COMPLETED|Period 2||0
7756732|NCT01450098|19098943|P2|COMPLETED|Period 2||31
7756733|NCT01450098|19098944|P1|COMPLETED|Period 2||8
7756734|NCT01450098|19098943|P2|Received at Least 1 Dose of Study Drug|Period 2||31
7756735|NCT01450098|19098944|P1|Received at Least 1 Dose of Study Drug|Period 2||8
7756736|NCT01450098|19098943|P2|STARTED|Period 2||31
7756737|NCT01450098|19098944|P1|STARTED|Period 2||8
7756738|NCT01450098|19098943|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
7756739|NCT01450098|19098944|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
7756740|NCT01450098|19098943|P2|COMPLETED|Washout Period of at Least 14 Days||31
7756741|NCT01450098|19098944|P1|COMPLETED|Washout Period of at Least 14 Days||8
7756742|NCT01450098|19098943|P2|STARTED|Washout Period of at Least 14 Days||31
7756743|NCT01450098|19098944|P1|STARTED|Washout Period of at Least 14 Days||8
7756744|NCT01450098|19098943|P2|NOT COMPLETED|Period 1||0
7756745|NCT01450098|19098944|P1|NOT COMPLETED|Period 1||0
7756746|NCT01450098|19098943|P2|COMPLETED|Period 1||31
7756747|NCT01450098|19098944|P1|COMPLETED|Period 1||8
7756748|NCT01450098|19098943|P2|Received at Least 1 Dose of Study Drug|Period 1||31
7756749|NCT01450098|19098944|P1|Received at Least 1 Dose of Study Drug|Period 1||8
7756750|NCT01450098|19098943|P2|STARTED|Period 1||31
7756751|NCT01450098|19098944|P1|STARTED|Period 1||8
7756752|NCT01450007|19098963|P3|NOT COMPLETED|Overall Study||3
7756753|NCT01450007|19098964|P2|NOT COMPLETED|Overall Study||5
7756754|NCT01450007|19098965|P1|NOT COMPLETED|Overall Study||2
7756755|NCT01450007|19098963|P3|COMPLETED|Overall Study||41
7756756|NCT01450007|19098964|P2|COMPLETED|Overall Study||37
7756757|NCT01450007|19098965|P1|COMPLETED|Overall Study||42
7756758|NCT01450007|19098963|P3|STARTED|Overall Study||44
7756759|NCT01450007|19098964|P2|STARTED|Overall Study||42
7756760|NCT01450007|19098965|P1|STARTED|Overall Study||44
7756761|NCT01449955|19098984|P2|NOT COMPLETED|Overall Study||2
7756762|NCT01449955|19098985|P1|NOT COMPLETED|Overall Study||1
7756763|NCT01449955|19098984|P2|COMPLETED|Overall Study||24
7756764|NCT01449955|19098985|P1|COMPLETED|Overall Study||27
7756765|NCT01449955|19098984|P2|STARTED|Overall Study||26
7756766|NCT01449955|19098985|P1|STARTED|Overall Study||28
7756767|NCT01449929|19099013|P3|NOT COMPLETED|Extension Phase Approximately 3 Years||8
7756768|NCT01449929|19099014|P2|NOT COMPLETED|Extension Phase Approximately 3 Years||0
7756769|NCT01449929|19099015|P1|NOT COMPLETED|Extension Phase Approximately 3 Years||0
7756770|NCT01449929|19099013|P3|COMPLETED|Extension Phase Approximately 3 Years||115
7756771|NCT01449929|19099014|P2|COMPLETED|Extension Phase Approximately 3 Years||0
7756772|NCT01449929|19099015|P1|COMPLETED|Extension Phase Approximately 3 Years||0
7756773|NCT01449929|19099013|P3|STARTED|Extension Phase Approximately 3 Years||123
7756774|NCT01449929|19099014|P2|STARTED|Extension Phase Approximately 3 Years||0
7756775|NCT01449929|19099015|P1|STARTED|Extension Phase Approximately 3 Years||0
7756776|NCT01449929|19099013|P3|NOT COMPLETED|Randomization Phase 96 Week||0
7756777|NCT01449929|19099014|P2|NOT COMPLETED|Randomization Phase 96 Week||53
7756778|NCT01449929|19099015|P1|NOT COMPLETED|Randomization Phase 96 Week||33
7756779|NCT01449929|19099013|P3|COMPLETED|Randomization Phase 96 Week||0
7756780|NCT01449929|19099014|P2|COMPLETED|Randomization Phase 96 Week||189
7756781|NCT01449929|19099015|P1|COMPLETED|Randomization Phase 96 Week||209
7756782|NCT01449929|19099013|P3|STARTED|Randomization Phase 96 Week||0
7756783|NCT01449929|19099014|P2|STARTED|Randomization Phase 96 Week||242
7756784|NCT01449929|19099015|P1|STARTED|Randomization Phase 96 Week||242
7756785|NCT01449864|19099052|P1|NOT COMPLETED|Overall Study||5
7756786|NCT01449864|19099052|P1|COMPLETED|Overall Study||17
7756787|NCT01449864|19099052|P1|STARTED|Overall Study||22
7756788|NCT01449812|19099060|P3|NOT COMPLETED|Overall Study||1
7756789|NCT01449812|19099061|P2|NOT COMPLETED|Overall Study||0
7756790|NCT01449812|19099062|P1|NOT COMPLETED|Overall Study||2
7756791|NCT01449812|19099060|P3|COMPLETED|Overall Study||279
7756792|NCT01449812|19099061|P2|COMPLETED|Overall Study||273
7756793|NCT01449812|19099062|P1|COMPLETED|Overall Study||270
7756794|NCT01449812|19099060|P3|STARTED|Overall Study||280
7756795|NCT01449812|19099061|P2|STARTED|Overall Study||273
7756796|NCT01449812|19099062|P1|STARTED|Overall Study||272
7756797|NCT01449747|19099156|P2|NOT COMPLETED|Overall Study||0
7756798|NCT01449747|19099157|P1|NOT COMPLETED|Overall Study||0
7756799|NCT01449747|19099156|P2|COMPLETED|Overall Study||12
7756800|NCT01449747|19099157|P1|COMPLETED|Overall Study||12
7756801|NCT01449747|19099156|P2|STARTED|Overall Study||12
7756802|NCT01449747|19099157|P1|STARTED|Overall Study||12
7756803|NCT01449734|19099171|P1|NOT COMPLETED|Overall Study||0
7756804|NCT01449734|19099171|P1|COMPLETED|Overall Study||215
7756805|NCT01449734|19099171|P1|STARTED|Overall Study||215
7756806|NCT01449721|19099177|P2|NOT COMPLETED|Overall Study||2
7756807|NCT01449721|19099178|P1|NOT COMPLETED|Overall Study||0
7756808|NCT01449721|19099177|P2|COMPLETED|Overall Study||28
7756809|NCT01449721|19099178|P1|COMPLETED|Overall Study||112
7756810|NCT01449721|19099177|P2|STARTED|Overall Study||30
7756811|NCT01449721|19099178|P1|STARTED|Overall Study||112
7756812|NCT01449708|19099190|P2|NOT COMPLETED|Overall Study||3
7756813|NCT01449708|19099191|P1|NOT COMPLETED|Overall Study||2
7756814|NCT01449708|19099190|P2|COMPLETED|Overall Study||60
7756815|NCT01449708|19099191|P1|COMPLETED|Overall Study||59
7756816|NCT01449708|19099190|P2|STARTED|Overall Study||63
7756817|NCT01449708|19099191|P1|STARTED|Overall Study||61
7756818|NCT01449682|19099202|P2|NOT COMPLETED|Overall Study||1
7756819|NCT01449682|19099203|P1|NOT COMPLETED|Overall Study||1
7756820|NCT01449682|19099202|P2|COMPLETED|Overall Study||4
7756821|NCT01449682|19099203|P1|COMPLETED|Overall Study||4
7756822|NCT01449682|19099202|P2|STARTED|Overall Study||5
7756823|NCT01449682|19099203|P1|STARTED|Overall Study||5
7756824|NCT01449630|19099224|P9|NOT COMPLETED|Period 3||0
7756825|NCT01449630|19099225|P8|NOT COMPLETED|Period 3||0
7756826|NCT01449630|19099226|P7|NOT COMPLETED|Period 3||0
7756827|NCT01449630|19099227|P6|NOT COMPLETED|Period 3||0
7756828|NCT01449630|19099228|P5|NOT COMPLETED|Period 3||0
7756829|NCT01449630|19099229|P4|NOT COMPLETED|Period 3||0
7756830|NCT01449630|19099230|P3|NOT COMPLETED|Period 3||0
7756831|NCT01449630|19099231|P2|NOT COMPLETED|Period 3||0
7756832|NCT01449630|19099232|P1|NOT COMPLETED|Period 3||0
7756833|NCT01449630|19099224|P9|COMPLETED|Period 3||2
7756834|NCT01449630|19099225|P8|COMPLETED|Period 3||6
7756835|NCT01449630|19099226|P7|COMPLETED|Period 3||1
7756836|NCT01449630|19099227|P6|COMPLETED|Period 3||1
7756837|NCT01449630|19099228|P5|COMPLETED|Period 3||5
7756838|NCT01449630|19099229|P4|COMPLETED|Period 3||1
7756839|NCT01449630|19099230|P3|COMPLETED|Period 3||2
7756840|NCT01449630|19099231|P2|COMPLETED|Period 3||6
7756841|NCT01449630|19099232|P1|COMPLETED|Period 3||1
7756842|NCT01449630|19099224|P9|STARTED|Period 3||2
7756843|NCT01449630|19099225|P8|STARTED|Period 3||6
7756844|NCT01449630|19099226|P7|STARTED|Period 3||1
7756845|NCT01449630|19099227|P6|STARTED|Period 3||1
7756846|NCT01449630|19099228|P5|STARTED|Period 3||5
7756847|NCT01449630|19099229|P4|STARTED|Period 3||1
7756848|NCT01449630|19099230|P3|STARTED|Period 3||2
7756849|NCT01449630|19099231|P2|STARTED|Period 3||6
7756850|NCT01449630|19099232|P1|STARTED|Period 3||1
7756851|NCT01449630|19099224|P9|NOT COMPLETED|Period 2||0
7756852|NCT01449630|19099225|P8|NOT COMPLETED|Period 2||0
7756853|NCT01449630|19099226|P7|NOT COMPLETED|Period 2||1
7756854|NCT01449630|19099227|P6|NOT COMPLETED|Period 2||0
7756855|NCT01449630|19099228|P5|NOT COMPLETED|Period 2||0
7756856|NCT01449630|19099229|P4|NOT COMPLETED|Period 2||0
7756857|NCT01449630|19099230|P3|NOT COMPLETED|Period 2||0
7756858|NCT01449630|19099231|P2|NOT COMPLETED|Period 2||0
7756859|NCT01449630|19099232|P1|NOT COMPLETED|Period 2||0
7756860|NCT01449630|19099224|P9|COMPLETED|Period 2||2
7756861|NCT01449630|19099225|P8|COMPLETED|Period 2||6
7756862|NCT01449630|19099226|P7|COMPLETED|Period 2||1
7756863|NCT01449630|19099227|P6|COMPLETED|Period 2||1
7756864|NCT01449630|19099228|P5|COMPLETED|Period 2||5
7756865|NCT01449630|19099229|P4|COMPLETED|Period 2||1
7756866|NCT01449630|19099230|P3|COMPLETED|Period 2||2
7756867|NCT01449630|19099231|P2|COMPLETED|Period 2||6
7756868|NCT01449630|19099232|P1|COMPLETED|Period 2||1
7756869|NCT01449630|19099224|P9|STARTED|Period 2||2
7756870|NCT01449630|19099225|P8|STARTED|Period 2||6
7756871|NCT01449630|19099226|P7|STARTED|Period 2||2
7756872|NCT01449630|19099227|P6|STARTED|Period 2||1
7756873|NCT01449630|19099228|P5|STARTED|Period 2||5
7756874|NCT01449630|19099229|P4|STARTED|Period 2||1
7756875|NCT01449630|19099230|P3|STARTED|Period 2||2
7756876|NCT01449630|19099231|P2|STARTED|Period 2||6
7756877|NCT01449630|19099232|P1|STARTED|Period 2||1
7756878|NCT01449630|19099224|P9|NOT COMPLETED|Period 1||0
7756879|NCT01449630|19099225|P8|NOT COMPLETED|Period 1||0
7756880|NCT01449630|19099226|P7|NOT COMPLETED|Period 1||0
7756881|NCT01449630|19099227|P6|NOT COMPLETED|Period 1||1
7756882|NCT01449630|19099228|P5|NOT COMPLETED|Period 1||0
7756883|NCT01449630|19099229|P4|NOT COMPLETED|Period 1||1
7756884|NCT01449630|19099230|P3|NOT COMPLETED|Period 1||0
7756885|NCT01449630|19099231|P2|NOT COMPLETED|Period 1||0
7756886|NCT01449630|19099232|P1|NOT COMPLETED|Period 1||1
7756887|NCT01449630|19099224|P9|COMPLETED|Period 1||2
7756888|NCT01449630|19099225|P8|COMPLETED|Period 1||6
7756889|NCT01449630|19099226|P7|COMPLETED|Period 1||2
7756890|NCT01449630|19099227|P6|COMPLETED|Period 1||1
7756891|NCT01449630|19099228|P5|COMPLETED|Period 1||5
7756892|NCT01449630|19099229|P4|COMPLETED|Period 1||1
7756893|NCT01449630|19099230|P3|COMPLETED|Period 1||2
7756894|NCT01449630|19099231|P2|COMPLETED|Period 1||6
7756895|NCT01449630|19099232|P1|COMPLETED|Period 1||1
7756896|NCT01449630|19099224|P9|Received at Least 1 Dose|Period 1||2
7756897|NCT01449630|19099225|P8|Received at Least 1 Dose|Period 1||6
7756898|NCT01449630|19099226|P7|Received at Least 1 Dose|Period 1||2
7756899|NCT01449630|19099227|P6|Received at Least 1 Dose|Period 1||1
7756900|NCT01449630|19099228|P5|Received at Least 1 Dose|Period 1||5
7756901|NCT01449630|19099229|P4|Received at Least 1 Dose|Period 1||2
7756902|NCT01449630|19099230|P3|Received at Least 1 Dose|Period 1||2
7756903|NCT01449630|19099231|P2|Received at Least 1 Dose|Period 1||6
7756904|NCT01449630|19099232|P1|Received at Least 1 Dose|Period 1||2
7756905|NCT01449630|19099224|P9|STARTED|Period 1||2
7756906|NCT01449630|19099225|P8|STARTED|Period 1||6
7756907|NCT01449630|19099226|P7|STARTED|Period 1||2
7756908|NCT01449630|19099227|P6|STARTED|Period 1||2
7756909|NCT01449630|19099228|P5|STARTED|Period 1||5
7756910|NCT01449630|19099229|P4|STARTED|Period 1||2
7756911|NCT01449630|19099230|P3|STARTED|Period 1||2
7756912|NCT01449630|19099231|P2|STARTED|Period 1||6
7756913|NCT01449630|19099232|P1|STARTED|Period 1||2
7756914|NCT01449539|19099302|P1|NOT COMPLETED|Overall Study||4
7756915|NCT01449539|19099302|P1|COMPLETED|Overall Study||4
7756916|NCT01449539|19099302|P1|STARTED|Overall Study||8
7756917|NCT01449526|19099308|P2|NOT COMPLETED|Overall Study||6
7756918|NCT01449526|19099309|P1|NOT COMPLETED|Overall Study||2
7756919|NCT01449526|19099308|P2|COMPLETED|Overall Study||77
7756920|NCT01449526|19099309|P1|COMPLETED|Overall Study||81
7756921|NCT01449526|19099308|P2|STARTED|Overall Study||83
7756922|NCT01449526|19099309|P1|STARTED|Overall Study||83
7756923|NCT01449513|19099319|P2|NOT COMPLETED|Overall Study||0
7756924|NCT01449513|19099320|P1|NOT COMPLETED|Overall Study||0
7756925|NCT01449513|19099319|P2|COMPLETED|Overall Study||8
7756926|NCT01449513|19099320|P1|COMPLETED|Overall Study||16
7756927|NCT01449513|19099319|P2|STARTED|Overall Study||8
7756928|NCT01449513|19099320|P1|STARTED|Overall Study||16
7756929|NCT01449461|19099378|P6|NOT COMPLETED|Overall Study||15
7756930|NCT01449461|19099379|P5|NOT COMPLETED|Overall Study||48
7756931|NCT01449461|19099380|P4|NOT COMPLETED|Overall Study||32
7756932|NCT01449461|19099381|P3|NOT COMPLETED|Overall Study||18
7756933|NCT01449461|19099382|P2|NOT COMPLETED|Overall Study||18
7756934|NCT01449461|19099383|P1|NOT COMPLETED|Overall Study||6
7756935|NCT01449461|19099378|P6|COMPLETED|Overall Study||0
7756936|NCT01449461|19099379|P5|COMPLETED|Overall Study||0
7756937|NCT01449461|19099380|P4|COMPLETED|Overall Study||0
7756938|NCT01449461|19099381|P3|COMPLETED|Overall Study||0
7756939|NCT01449461|19099382|P2|COMPLETED|Overall Study||0
7756940|NCT01449461|19099383|P1|COMPLETED|Overall Study||0
7756941|NCT01449461|19099378|P6|STARTED|Overall Study||15
7756942|NCT01449461|19099379|P5|STARTED|Overall Study||48
7756943|NCT01449461|19099380|P4|STARTED|Overall Study||32
7756944|NCT01449461|19099381|P3|STARTED|Overall Study||18
7756945|NCT01449461|19099382|P2|STARTED|Overall Study||18
7756946|NCT01449461|19099383|P1|STARTED|Overall Study||6
7756947|NCT01449370|19099520|P25|NOT COMPLETED|Overall Study||8
7756948|NCT01449370|19099521|P24|NOT COMPLETED|Overall Study||10
7756949|NCT01449370|19099522|P23|NOT COMPLETED|Overall Study||4
7756950|NCT01449370|19099523|P22|NOT COMPLETED|Overall Study||4
7756951|NCT01449370|19099524|P21|NOT COMPLETED|Overall Study||6
7756952|NCT01449370|19099525|P20|NOT COMPLETED|Overall Study||3
7756953|NCT01449370|19099526|P19|NOT COMPLETED|Overall Study||3
7756954|NCT01449370|19099527|P18|NOT COMPLETED|Overall Study||3
7756955|NCT01449370|19099528|P17|NOT COMPLETED|Overall Study||7
7756956|NCT01449370|19099529|P16|NOT COMPLETED|Overall Study||3
7756957|NCT01449370|19099530|P15|NOT COMPLETED|Overall Study||3
7756958|NCT01449370|19099531|P14|NOT COMPLETED|Overall Study||11
7756959|NCT01449370|19099532|P13|NOT COMPLETED|Overall Study||3
7756960|NCT01449370|19099533|P12|NOT COMPLETED|Overall Study||3
7756961|NCT01449370|19099534|P11|NOT COMPLETED|Overall Study||3
7756962|NCT01449370|19099535|P10|NOT COMPLETED|Overall Study||3
7756963|NCT01449370|19099536|P9|NOT COMPLETED|Overall Study||12
7756964|NCT01449370|19099537|P8|NOT COMPLETED|Overall Study||3
7756965|NCT01449370|19099538|P7|NOT COMPLETED|Overall Study||3
7756966|NCT01449370|19099539|P6|NOT COMPLETED|Overall Study||3
7756967|NCT01449370|19099540|P5|NOT COMPLETED|Overall Study||3
7756968|NCT01449370|19099541|P4|NOT COMPLETED|Overall Study||4
7756969|NCT01449370|19099542|P3|NOT COMPLETED|Overall Study||8
7756970|NCT01449370|19099543|P2|NOT COMPLETED|Overall Study||6
7756971|NCT01449370|19099544|P1|NOT COMPLETED|Overall Study||6
7756972|NCT01449370|19099520|P25|COMPLETED|Overall Study||0
7756973|NCT01449370|19099521|P24|COMPLETED|Overall Study||0
7756974|NCT01449370|19099522|P23|COMPLETED|Overall Study||0
7756975|NCT01449370|19099523|P22|COMPLETED|Overall Study||0
7756976|NCT01449370|19099524|P21|COMPLETED|Overall Study||0
7756977|NCT01449370|19099525|P20|COMPLETED|Overall Study||0
7756978|NCT01449370|19099526|P19|COMPLETED|Overall Study||0
7756979|NCT01449370|19099527|P18|COMPLETED|Overall Study||0
7756980|NCT01449370|19099528|P17|COMPLETED|Overall Study||0
7756981|NCT01449370|19099529|P16|COMPLETED|Overall Study||0
7756982|NCT01449370|19099530|P15|COMPLETED|Overall Study||0
7756983|NCT01449370|19099531|P14|COMPLETED|Overall Study||0
7756984|NCT01449370|19099532|P13|COMPLETED|Overall Study||0
7756985|NCT01449370|19099533|P12|COMPLETED|Overall Study||0
7756986|NCT01449370|19099534|P11|COMPLETED|Overall Study||0
7756987|NCT01449370|19099535|P10|COMPLETED|Overall Study||0
7756988|NCT01449370|19099536|P9|COMPLETED|Overall Study||0
7756989|NCT01449370|19099537|P8|COMPLETED|Overall Study||0
7756990|NCT01449370|19099538|P7|COMPLETED|Overall Study||0
7756991|NCT01449370|19099539|P6|COMPLETED|Overall Study||0
7756992|NCT01449370|19099540|P5|COMPLETED|Overall Study||0
7756993|NCT01449370|19099541|P4|COMPLETED|Overall Study||0
7756994|NCT01449370|19099542|P3|COMPLETED|Overall Study||0
7756995|NCT01449370|19099543|P2|COMPLETED|Overall Study||0
7756996|NCT01449370|19099544|P1|COMPLETED|Overall Study||0
7756997|NCT01449370|19099520|P25|STARTED|Overall Study||8
7756998|NCT01449370|19099521|P24|STARTED|Overall Study||10
7756999|NCT01449370|19099522|P23|STARTED|Overall Study||4
7757000|NCT01449370|19099523|P22|STARTED|Overall Study||4
7757001|NCT01449370|19099524|P21|STARTED|Overall Study||6
7757002|NCT01449370|19099525|P20|STARTED|Overall Study||3
7757003|NCT01449370|19099526|P19|STARTED|Overall Study||3
7757004|NCT01449370|19099527|P18|STARTED|Overall Study||3
7757005|NCT01449370|19099528|P17|STARTED|Overall Study||7
7757006|NCT01449370|19099529|P16|STARTED|Overall Study||3
7757007|NCT01449370|19099530|P15|STARTED|Overall Study||3
7757008|NCT01449370|19099531|P14|STARTED|Overall Study||11
7757009|NCT01449370|19099532|P13|STARTED|Overall Study||3
7757010|NCT01449370|19099533|P12|STARTED|Overall Study||3
7757011|NCT01449370|19099534|P11|STARTED|Overall Study||3
7757012|NCT01449370|19099535|P10|STARTED|Overall Study||3
7757013|NCT01449370|19099536|P9|STARTED|Overall Study||12
7757014|NCT01449370|19099537|P8|STARTED|Overall Study||3
7757015|NCT01449370|19099538|P7|STARTED|Overall Study||3
7757016|NCT01449370|19099539|P6|STARTED|Overall Study||3
7757017|NCT01449370|19099540|P5|STARTED|Overall Study||3
7757018|NCT01449370|19099541|P4|STARTED|Overall Study||4
7757019|NCT01449370|19099542|P3|STARTED|Overall Study||8
7757020|NCT01449370|19099543|P2|STARTED|Overall Study||6
7757021|NCT01449370|19099544|P1|STARTED|Overall Study||6
7757022|NCT01449305|19099917|P1|NOT COMPLETED|Overall Study||2
7757023|NCT01449305|19099917|P1|COMPLETED|Overall Study||42
7757024|NCT01449305|19099917|P1|STARTED|Overall Study||44
7757025|NCT01449279|19099922|P1|NOT COMPLETED|Overall Study||7
7757026|NCT01449279|19099922|P1|COMPLETED|Overall Study||15
7757027|NCT01449279|19099922|P1|STARTED|Overall Study||22
7757028|NCT01449266|19099933|P1|NOT COMPLETED|Overall Study||0
7757029|NCT01449266|19099933|P1|COMPLETED|Overall Study||10
7757030|NCT01449266|19099933|P1|STARTED|Overall Study||10
7757031|NCT01449240|19099940|P1|NOT COMPLETED|Overall Study||0
7757032|NCT01449240|19099940|P1|COMPLETED|Overall Study||10
7757033|NCT01449240|19099940|P1|STARTED|Overall Study||10
7757034|NCT01449006|19099947|P2|NOT COMPLETED|Overall Study||0
7757035|NCT01449006|19099948|P1|NOT COMPLETED|Overall Study||3
7757036|NCT01449006|19099947|P2|COMPLETED|Overall Study||9
7757037|NCT01449006|19099948|P1|COMPLETED|Overall Study||5
7757038|NCT01449006|19099947|P2|STARTED|Overall Study||9
7757039|NCT01449006|19099948|P1|STARTED|Overall Study||8
7757040|NCT01448850|19099962|P2|NOT COMPLETED|Overall Study||40
7757041|NCT01448850|19099963|P1|NOT COMPLETED|Overall Study||34
7757042|NCT01448850|19099962|P2|COMPLETED|Overall Study||120
7757043|NCT01448850|19099963|P1|COMPLETED|Overall Study||130
7757044|NCT01448850|19099962|P2|STARTED|Overall Study||160
7757045|NCT01448850|19099963|P1|STARTED|Overall Study||164
7757046|NCT01448824|19099994|P8|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||3
7757047|NCT01448824|19099995|P7|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
7757048|NCT01448824|19099996|P6|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
7757049|NCT01448824|19099997|P5|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
7757050|NCT01448824|19099998|P4|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
7757051|NCT01448824|19099999|P3|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
7757052|NCT01448824|19100000|P2|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
7757053|NCT01448824|19100001|P1|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
7757054|NCT01448824|19099994|P8|COMPLETED|Part 2 Period 2: Drug-drug Interaction||8
7757055|NCT01448824|19099995|P7|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
7757056|NCT01448824|19099996|P6|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
7757057|NCT01448824|19099997|P5|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
7757058|NCT01448824|19099998|P4|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
7757059|NCT01448824|19099999|P3|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
7757060|NCT01448824|19100000|P2|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
7757061|NCT01448824|19100001|P1|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
7757062|NCT01448824|19099994|P8|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||10
7757063|NCT01448824|19099995|P7|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
7757064|NCT01448824|19099996|P6|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
7757065|NCT01448824|19099997|P5|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
7757066|NCT01448824|19099998|P4|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
7757067|NCT01448824|19099999|P3|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
7757068|NCT01448824|19100000|P2|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
7757069|NCT01448824|19100001|P1|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
7757070|NCT01448824|19099994|P8|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||11
7757071|NCT01448824|19099995|P7|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
7757072|NCT01448824|19099996|P6|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
7757073|NCT01448824|19099997|P5|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
7757074|NCT01448824|19099998|P4|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
7757075|NCT01448824|19099999|P3|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
7757076|NCT01448824|19100000|P2|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
7757077|NCT01448824|19100001|P1|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
7757078|NCT01448824|19099994|P8|STARTED|Part 2 Period 2: Drug-drug Interaction||11
7757079|NCT01448824|19099995|P7|STARTED|Part 2 Period 2: Drug-drug Interaction||0
7757080|NCT01448824|19099996|P6|STARTED|Part 2 Period 2: Drug-drug Interaction||0
7757081|NCT01448824|19099997|P5|STARTED|Part 2 Period 2: Drug-drug Interaction||0
7757082|NCT01448824|19099998|P4|STARTED|Part 2 Period 2: Drug-drug Interaction||0
7757083|NCT01448824|19099999|P3|STARTED|Part 2 Period 2: Drug-drug Interaction||0
7757084|NCT01448824|19100000|P2|STARTED|Part 2 Period 2: Drug-drug Interaction||0
7757085|NCT01448824|19100001|P1|STARTED|Part 2 Period 2: Drug-drug Interaction||0
7757086|NCT01448824|19099994|P8|NOT COMPLETED|Part 2: Washout Period||0
7757087|NCT01448824|19099995|P7|NOT COMPLETED|Part 2: Washout Period||0
7757088|NCT01448824|19099996|P6|NOT COMPLETED|Part 2: Washout Period||0
7757089|NCT01448824|19099997|P5|NOT COMPLETED|Part 2: Washout Period||0
7757090|NCT01448824|19099998|P4|NOT COMPLETED|Part 2: Washout Period||0
7757091|NCT01448824|19099999|P3|NOT COMPLETED|Part 2: Washout Period||0
7757092|NCT01448824|19100000|P2|NOT COMPLETED|Part 2: Washout Period||0
7757093|NCT01448824|19100001|P1|NOT COMPLETED|Part 2: Washout Period||0
7757094|NCT01448824|19099994|P8|COMPLETED|Part 2: Washout Period||11
7757095|NCT01448824|19099995|P7|COMPLETED|Part 2: Washout Period||0
7757096|NCT01448824|19099996|P6|COMPLETED|Part 2: Washout Period||0
7757097|NCT01448824|19099997|P5|COMPLETED|Part 2: Washout Period||0
7757098|NCT01448824|19099998|P4|COMPLETED|Part 2: Washout Period||0
7757099|NCT01448824|19099999|P3|COMPLETED|Part 2: Washout Period||0
7757100|NCT01448824|19100000|P2|COMPLETED|Part 2: Washout Period||0
7757101|NCT01448824|19100001|P1|COMPLETED|Part 2: Washout Period||0
7757102|NCT01448824|19099994|P8|STARTED|Part 2: Washout Period||11
7757103|NCT01448824|19099995|P7|STARTED|Part 2: Washout Period||0
7757104|NCT01448824|19099996|P6|STARTED|Part 2: Washout Period||0
7757105|NCT01448824|19099997|P5|STARTED|Part 2: Washout Period||0
7757106|NCT01448824|19099998|P4|STARTED|Part 2: Washout Period||0
7757107|NCT01448824|19099999|P3|STARTED|Part 2: Washout Period||0
7757108|NCT01448824|19100000|P2|STARTED|Part 2: Washout Period||0
7757109|NCT01448824|19100001|P1|STARTED|Part 2: Washout Period||0
7757110|NCT01448824|19099994|P8|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||1
7757111|NCT01448824|19099995|P7|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
7757112|NCT01448824|19099996|P6|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
7757113|NCT01448824|19099997|P5|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
7757114|NCT01448824|19099998|P4|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
7757115|NCT01448824|19099999|P3|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
7757116|NCT01448824|19100000|P2|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
7757117|NCT01448824|19100001|P1|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
7757118|NCT01448824|19099994|P8|COMPLETED|Part 2 Period 1: Drug-drug Interaction||11
7757119|NCT01448824|19099995|P7|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
7757120|NCT01448824|19099996|P6|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
7757121|NCT01448824|19099997|P5|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
7757122|NCT01448824|19099998|P4|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
7757123|NCT01448824|19099999|P3|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
7757124|NCT01448824|19100000|P2|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
7757125|NCT01448824|19100001|P1|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
7757126|NCT01448824|19099994|P8|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||12
7757127|NCT01448824|19099995|P7|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
7757128|NCT01448824|19099996|P6|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
7757129|NCT01448824|19099997|P5|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
7757130|NCT01448824|19099998|P4|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
7757131|NCT01448824|19099999|P3|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
7757132|NCT01448824|19100000|P2|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
7757133|NCT01448824|19100001|P1|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
7757134|NCT01448824|19099994|P8|STARTED|Part 2 Period 1: Drug-drug Interaction||12
7757135|NCT01448824|19099995|P7|STARTED|Part 2 Period 1: Drug-drug Interaction||0
7757136|NCT01448824|19099996|P6|STARTED|Part 2 Period 1: Drug-drug Interaction||0
7757137|NCT01448824|19099997|P5|STARTED|Part 2 Period 1: Drug-drug Interaction||0
7757138|NCT01448824|19099998|P4|STARTED|Part 2 Period 1: Drug-drug Interaction||0
7757139|NCT01448824|19099999|P3|STARTED|Part 2 Period 1: Drug-drug Interaction||0
7757140|NCT01448824|19100000|P2|STARTED|Part 2 Period 1: Drug-drug Interaction||0
7757141|NCT01448824|19100001|P1|STARTED|Part 2 Period 1: Drug-drug Interaction||0
7757142|NCT01448824|19099994|P8|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
7757143|NCT01448824|19099995|P7|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
7757144|NCT01448824|19099996|P6|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
7757145|NCT01448824|19099997|P5|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
7757146|NCT01448824|19099998|P4|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
7757147|NCT01448824|19099999|P3|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
7757148|NCT01448824|19100000|P2|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
7757149|NCT01448824|19100001|P1|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
7757150|NCT01448824|19099994|P8|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
7757151|NCT01448824|19099995|P7|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
7757152|NCT01448824|19099996|P6|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
7757153|NCT01448824|19099997|P5|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
7757154|NCT01448824|19099998|P4|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
7757155|NCT01448824|19099999|P3|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
7757156|NCT01448824|19100000|P2|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
7757157|NCT01448824|19100001|P1|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||11
7757158|NCT01448824|19099994|P8|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
7757159|NCT01448824|19099995|P7|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
7757160|NCT01448824|19099996|P6|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
7757161|NCT01448824|19099997|P5|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
7757162|NCT01448824|19099998|P4|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
7757163|NCT01448824|19099999|P3|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
7757164|NCT01448824|19100000|P2|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
7757165|NCT01448824|19100001|P1|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||11
7757166|NCT01448824|19099994|P8|STARTED|Part 1 Period 2: Multiple Ascending Dose||0
7757167|NCT01448824|19099995|P7|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort D participated in Period 1 only.|0
7757168|NCT01448824|19099996|P6|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort C participated in Period 1 only.|0
7757169|NCT01448824|19099997|P5|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort B participated in Period 1 only.|0
7757170|NCT01448824|19099998|P4|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
7757171|NCT01448824|19099999|P3|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
7757172|NCT01448824|19100000|P2|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
7757173|NCT01448824|19100001|P1|STARTED|Part 1 Period 2: Multiple Ascending Dose||11
7757174|NCT01448824|19099994|P8|NOT COMPLETED|Part 1: Washout Period||0
7757175|NCT01448824|19099995|P7|NOT COMPLETED|Part 1: Washout Period||0
7757176|NCT01448824|19099996|P6|NOT COMPLETED|Part 1: Washout Period||0
7757177|NCT01448824|19099997|P5|NOT COMPLETED|Part 1: Washout Period||0
7757178|NCT01448824|19099998|P4|NOT COMPLETED|Part 1: Washout Period||0
7757179|NCT01448824|19099999|P3|NOT COMPLETED|Part 1: Washout Period||0
7757180|NCT01448824|19100000|P2|NOT COMPLETED|Part 1: Washout Period||0
7757181|NCT01448824|19100001|P1|NOT COMPLETED|Part 1: Washout Period||1
7757182|NCT01448824|19099994|P8|COMPLETED|Part 1: Washout Period||0
7757183|NCT01448824|19099995|P7|COMPLETED|Part 1: Washout Period||0
7757184|NCT01448824|19099996|P6|COMPLETED|Part 1: Washout Period||0
7757185|NCT01448824|19099997|P5|COMPLETED|Part 1: Washout Period||0
7757186|NCT01448824|19099998|P4|COMPLETED|Part 1: Washout Period||0
7757187|NCT01448824|19099999|P3|COMPLETED|Part 1: Washout Period||4
7757188|NCT01448824|19100000|P2|COMPLETED|Part 1: Washout Period||4
7757189|NCT01448824|19100001|P1|COMPLETED|Part 1: Washout Period||11
7757190|NCT01448824|19099994|P8|STARTED|Part 1: Washout Period||0
7757191|NCT01448824|19099995|P7|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort D participated in Period 1 only.|0
7757192|NCT01448824|19099996|P6|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort C participated in Period 1 only.|0
7757193|NCT01448824|19099997|P5|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort B participated in Period 1 only.|0
7757194|NCT01448824|19099998|P4|STARTED|Part 1: Washout Period|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
7757195|NCT01448824|19099999|P3|STARTED|Part 1: Washout Period||4
7757196|NCT01448824|19100000|P2|STARTED|Part 1: Washout Period||4
7757197|NCT01448824|19100001|P1|STARTED|Part 1: Washout Period||12
7757198|NCT01448824|19099994|P8|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
7757199|NCT01448824|19099995|P7|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
7757200|NCT01448824|19099996|P6|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
7757201|NCT01448824|19099997|P5|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
7757202|NCT01448824|19099998|P4|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
7757203|NCT01448824|19099999|P3|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
7757204|NCT01448824|19100000|P2|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
7757205|NCT01448824|19100001|P1|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
7757206|NCT01448824|19099994|P8|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
7757207|NCT01448824|19099995|P7|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||11
7757208|NCT01448824|19099996|P6|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||10
7757209|NCT01448824|19099997|P5|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||14
7757210|NCT01448824|19099998|P4|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||9
7757211|NCT01448824|19099999|P3|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
7757212|NCT01448824|19100000|P2|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
7757213|NCT01448824|19100001|P1|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||12
7757214|NCT01448824|19099994|P8|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||0
7757215|NCT01448824|19099995|P7|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
7757216|NCT01448824|19099996|P6|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
7757217|NCT01448824|19099997|P5|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||16
7757218|NCT01448824|19099998|P4|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||10
7757219|NCT01448824|19099999|P3|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
7757220|NCT01448824|19100000|P2|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
7757221|NCT01448824|19100001|P1|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
7757222|NCT01448824|19099994|P8|STARTED|Part 1 Period 1: Multiple Ascending Dose||0
7757223|NCT01448824|19099995|P7|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
7757224|NCT01448824|19099996|P6|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
7757225|NCT01448824|19099997|P5|STARTED|Part 1 Period 1: Multiple Ascending Dose||16
7757226|NCT01448824|19099998|P4|STARTED|Part 1 Period 1: Multiple Ascending Dose||10
7757227|NCT01448824|19099999|P3|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
7757228|NCT01448824|19100000|P2|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
7757229|NCT01448824|19100001|P1|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
7757230|NCT01448707|19100052|P2|NOT COMPLETED|Overall Study||18
7757231|NCT01448707|19100053|P1|NOT COMPLETED|Overall Study||18
7757232|NCT01448707|19100052|P2|COMPLETED|Overall Study||118
7757233|NCT01448707|19100053|P1|COMPLETED|Overall Study||119
7757234|NCT01448707|19100052|P2|STARTED|Overall Study||136
7757235|NCT01448707|19100053|P1|STARTED|Overall Study||137
7757236|NCT01448616|19100074|P4|NOT COMPLETED|Study Drug (Treatment Phase)||4
7757237|NCT01448616|19100075|P3|NOT COMPLETED|Study Drug (Treatment Phase)||4
7757238|NCT01448616|19100076|P2|NOT COMPLETED|Study Drug (Treatment Phase)||2
7757239|NCT01448616|19100077|P1|NOT COMPLETED|Study Drug (Treatment Phase)||0
7757240|NCT01448616|19100074|P4|COMPLETED|Study Drug (Treatment Phase)||9
7757241|NCT01448616|19100075|P3|COMPLETED|Study Drug (Treatment Phase)||23
7757242|NCT01448616|19100076|P2|COMPLETED|Study Drug (Treatment Phase)||22
7757243|NCT01448616|19100077|P1|COMPLETED|Study Drug (Treatment Phase)||0
7757244|NCT01448616|19100074|P4|STARTED|Study Drug (Treatment Phase)||13
7757245|NCT01448616|19100075|P3|STARTED|Study Drug (Treatment Phase)||27
7757246|NCT01448616|19100076|P2|STARTED|Study Drug (Treatment Phase)||24
7757247|NCT01448616|19100077|P1|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0
7757248|NCT01448616|19100074|P4|NOT COMPLETED|Lead-In (Observational Phase)||0
7757249|NCT01448616|19100075|P3|NOT COMPLETED|Lead-In (Observational Phase)||0
7757250|NCT01448616|19100076|P2|NOT COMPLETED|Lead-In (Observational Phase)||0
7757251|NCT01448616|19100077|P1|NOT COMPLETED|Lead-In (Observational Phase)||9
7757252|NCT01448616|19100074|P4|COMPLETED|Lead-In (Observational Phase)||0
7757253|NCT01448616|19100075|P3|COMPLETED|Lead-In (Observational Phase)||0
7757254|NCT01448616|19100076|P2|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0
7757255|NCT01448616|19100077|P1|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64
7757256|NCT01448616|19100074|P4|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
7757257|NCT01448616|19100075|P3|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
7757258|NCT01448616|19100076|P2|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
7757259|NCT01448616|19100077|P1|STARTED|Lead-In (Observational Phase)||73
7757260|NCT01448525|19100097|P2|NOT COMPLETED|Overall Study||2
7757261|NCT01448525|19100098|P1|NOT COMPLETED|Overall Study||1
7757262|NCT01448525|19100097|P2|COMPLETED|Overall Study||42
7757263|NCT01448525|19100098|P1|COMPLETED|Overall Study||43
7757264|NCT01448525|19100097|P2|STARTED|Overall Study||44
7757265|NCT01448525|19100098|P1|STARTED|Overall Study||44
7757266|NCT01448486|19100108|P2|NOT COMPLETED|Overall Study||0
7757267|NCT01448486|19100109|P1|NOT COMPLETED|Overall Study||0
7757268|NCT01448486|19100108|P2|COMPLETED|Overall Study||3
7757269|NCT01448486|19100109|P1|COMPLETED|Overall Study||3
7757270|NCT01448486|19100108|P2|STARTED|Overall Study||3
7757271|NCT01448486|19100109|P1|STARTED|Overall Study||3
7757272|NCT01448421|19100117|P1|NOT COMPLETED|Overall Study||0
7757273|NCT01448421|19100117|P1|COMPLETED|Overall Study||37
7757274|NCT01448421|19100117|P1|STARTED|Overall Study||37
7757275|NCT01448356|19100122|P1|NOT COMPLETED|Overall Study||0
7757276|NCT01448356|19100122|P1|COMPLETED|Overall Study|cross-over|10
7757277|NCT01448356|19100122|P1|STARTED|Overall Study||10
7757278|NCT01448213|19100129|P2|NOT COMPLETED|Overall Study||22
7757279|NCT01448213|19100130|P1|NOT COMPLETED|Overall Study||17
7757280|NCT01448213|19100129|P2|COMPLETED|Overall Study||112
7757281|NCT01448213|19100130|P1|COMPLETED|Overall Study||113
7757282|NCT01448213|19100129|P2|STARTED|Overall Study||134
7757283|NCT01448213|19100130|P1|STARTED|Overall Study||130
7757284|NCT01448057|19100140|P2|NOT COMPLETED|Overall Study||4
7757285|NCT01448057|19100141|P1|NOT COMPLETED|Overall Study||8
7757286|NCT01448057|19100140|P2|COMPLETED|Overall Study||167
7757287|NCT01448057|19100141|P1|COMPLETED|Overall Study||162
7757288|NCT01448057|19100140|P2|STARTED|Overall Study||171
7757289|NCT01448057|19100141|P1|STARTED|Overall Study||170
7757290|NCT01448044|19100151|P2|NOT COMPLETED|Follow Up Period||14
7757291|NCT01448044|19100152|P1|NOT COMPLETED|Follow Up Period||12
7757292|NCT01448044|19100151|P2|COMPLETED|Follow Up Period||26
7757293|NCT01448044|19100152|P1|COMPLETED|Follow Up Period||65
7757294|NCT01448044|19100151|P2|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40
7757295|NCT01448044|19100152|P1|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77
7757296|NCT01448044|19100151|P2|NOT COMPLETED|Treatment Period||16
7757297|NCT01448044|19100152|P1|NOT COMPLETED|Treatment Period||23
7757298|NCT01448044|19100151|P2|COMPLETED|Treatment Period||26
7757299|NCT01448044|19100152|P1|COMPLETED|Treatment Period||59
7757300|NCT01448044|19100151|P2|STARTED|Treatment Period||42
7757301|NCT01448044|19100152|P1|STARTED|Treatment Period||82
7757302|NCT01447927|19100168|P2|NOT COMPLETED|Overall Study||3
7757303|NCT01447927|19100169|P1|NOT COMPLETED|Overall Study||5
7757304|NCT01447927|19100168|P2|COMPLETED|Overall Study||33
7757305|NCT01447927|19100169|P1|COMPLETED|Overall Study||33
7757306|NCT01447927|19100168|P2|STARTED|Overall Study||36
7757307|NCT01447927|19100169|P1|STARTED|Overall Study||38
7757308|NCT01447914|19100177|P1|NOT COMPLETED|Overall Study||0
7757309|NCT01447914|19100177|P1|COMPLETED|Overall Study||16
7757310|NCT01447914|19100177|P1|STARTED|Overall Study||16
7757311|NCT01447888|19100188|P2|NOT COMPLETED|Overall Study||0
7757312|NCT01447888|19100189|P1|NOT COMPLETED|Overall Study||0
7757313|NCT01447888|19100188|P2|COMPLETED|Overall Study||55
7757314|NCT01447888|19100189|P1|COMPLETED|Overall Study||45
7757315|NCT01447888|19100188|P2|STARTED|Overall Study||55
7757316|NCT01447888|19100189|P1|STARTED|Overall Study||45
7757317|NCT01447849|19100201|P4|NOT COMPLETED|Second Intervention||0
7757318|NCT01447849|19100202|P3|NOT COMPLETED|Second Intervention||0
7757319|NCT01447849|19100203|P2|NOT COMPLETED|Second Intervention||0
7757320|NCT01447849|19100204|P1|NOT COMPLETED|Second Intervention||0
7757321|NCT01447849|19100201|P4|COMPLETED|Second Intervention||10
7757322|NCT01447849|19100202|P3|COMPLETED|Second Intervention||10
7757323|NCT01447849|19100203|P2|COMPLETED|Second Intervention||10
7757324|NCT01447849|19100204|P1|COMPLETED|Second Intervention||10
7757325|NCT01447849|19100201|P4|STARTED|Second Intervention||10
7757326|NCT01447849|19100202|P3|STARTED|Second Intervention||10
7757327|NCT01447849|19100203|P2|STARTED|Second Intervention||10
7757328|NCT01447849|19100204|P1|STARTED|Second Intervention||10
7757329|NCT01447849|19100201|P4|NOT COMPLETED|Washout Period for 1 Week||0
7757330|NCT01447849|19100202|P3|NOT COMPLETED|Washout Period for 1 Week||0
7757331|NCT01447849|19100203|P2|NOT COMPLETED|Washout Period for 1 Week||0
7757332|NCT01447849|19100204|P1|NOT COMPLETED|Washout Period for 1 Week||0
7757333|NCT01447849|19100201|P4|COMPLETED|Washout Period for 1 Week||10
7757334|NCT01447849|19100202|P3|COMPLETED|Washout Period for 1 Week||10
7757335|NCT01447849|19100203|P2|COMPLETED|Washout Period for 1 Week||10
7757336|NCT01447849|19100204|P1|COMPLETED|Washout Period for 1 Week||10
7757337|NCT01447849|19100201|P4|STARTED|Washout Period for 1 Week||10
7757338|NCT01447849|19100202|P3|STARTED|Washout Period for 1 Week||10
7757339|NCT01447849|19100203|P2|STARTED|Washout Period for 1 Week||10
7757340|NCT01447849|19100204|P1|STARTED|Washout Period for 1 Week||10
7757341|NCT01447849|19100201|P4|NOT COMPLETED|First Intervention||0
7757342|NCT01447849|19100202|P3|NOT COMPLETED|First Intervention||0
7757343|NCT01447849|19100203|P2|NOT COMPLETED|First Intervention||0
7757344|NCT01447849|19100204|P1|NOT COMPLETED|First Intervention||0
7757345|NCT01447849|19100201|P4|COMPLETED|First Intervention||10
7757346|NCT01447849|19100202|P3|COMPLETED|First Intervention||10
7757347|NCT01447849|19100203|P2|COMPLETED|First Intervention||10
7757348|NCT01447849|19100204|P1|COMPLETED|First Intervention||10
7757349|NCT01447849|19100201|P4|STARTED|First Intervention||10
7757350|NCT01447849|19100202|P3|STARTED|First Intervention||10
7757351|NCT01447849|19100203|P2|STARTED|First Intervention||10
7757352|NCT01447849|19100204|P1|STARTED|First Intervention||10
7757353|NCT01447719|19100214|P1|NOT COMPLETED|Overall Study||93
7757354|NCT01447719|19100214|P1|COMPLETED|Overall Study||59
7757355|NCT01447719|19100214|P1|Deceased <2 Years After AV-45 Scan|Overall Study||66
7757356|NCT01447719|19100214|P1|Valid AV-45 Scan Acquired|Overall Study||147
7757357|NCT01447719|19100214|P1|STARTED|Overall Study||152
7757358|NCT01447706|19100227|P2|NOT COMPLETED|Overall Study||3
7757359|NCT01447706|19100228|P1|NOT COMPLETED|Overall Study||0
7757360|NCT01447706|19100227|P2|COMPLETED|Overall Study||80
7757361|NCT01447706|19100228|P1|COMPLETED|Overall Study||140
7757362|NCT01447706|19100227|P2|STARTED|Overall Study|3 patients enrolled but not dosed|83
7757363|NCT01447706|19100228|P1|STARTED|Overall Study||140
7757364|NCT01447576|19100240|P1|NOT COMPLETED|Overall Study||476
7757365|NCT01447576|19100240|P1|COMPLETED|Overall Study||560
7757366|NCT01447576|19100240|P1|STARTED|Overall Study||1036
7757367|NCT01447511|19100251|P5|NOT COMPLETED|Rifampin Period||0
7757368|NCT01447511|19100252|P4|NOT COMPLETED|Rifampin Period||1
7757369|NCT01447511|19100253|P3|NOT COMPLETED|Rifampin Period||0
7757370|NCT01447511|19100254|P2|NOT COMPLETED|Rifampin Period||0
7757371|NCT01447511|19100255|P1|NOT COMPLETED|Rifampin Period||0
7757372|NCT01447511|19100251|P5|COMPLETED|Rifampin Period||4
7757373|NCT01447511|19100252|P4|COMPLETED|Rifampin Period||2
7757374|NCT01447511|19100253|P3|COMPLETED|Rifampin Period||8
7757375|NCT01447511|19100254|P2|COMPLETED|Rifampin Period||5
7757376|NCT01447511|19100255|P1|COMPLETED|Rifampin Period||8
7757377|NCT01447511|19100251|P5|STARTED|Rifampin Period||4
7757378|NCT01447511|19100252|P4|STARTED|Rifampin Period||3
7757379|NCT01447511|19100253|P3|STARTED|Rifampin Period||8
7757380|NCT01447511|19100254|P2|STARTED|Rifampin Period||5
7757381|NCT01447511|19100255|P1|STARTED|Rifampin Period||8
7757382|NCT01447511|19100251|P5|NOT COMPLETED|Fluconazole Period||0
7757383|NCT01447511|19100252|P4|NOT COMPLETED|Fluconazole Period||0
7757384|NCT01447511|19100253|P3|NOT COMPLETED|Fluconazole Period||1
7757385|NCT01447511|19100254|P2|NOT COMPLETED|Fluconazole Period||0
7757386|NCT01447511|19100255|P1|NOT COMPLETED|Fluconazole Period||0
7757387|NCT01447511|19100251|P5|COMPLETED|Fluconazole Period||4
7757388|NCT01447511|19100252|P4|COMPLETED|Fluconazole Period||3
7757389|NCT01447511|19100253|P3|COMPLETED|Fluconazole Period||8
7757390|NCT01447511|19100254|P2|COMPLETED|Fluconazole Period||0
7757391|NCT01447511|19100255|P1|COMPLETED|Fluconazole Period||8
7757392|NCT01447511|19100251|P5|STARTED|Fluconazole Period||4
7757393|NCT01447511|19100252|P4|STARTED|Fluconazole Period||3
7757394|NCT01447511|19100253|P3|STARTED|Fluconazole Period||9
7757395|NCT01447511|19100254|P2|STARTED|Fluconazole Period||0
7757396|NCT01447511|19100255|P1|STARTED|Fluconazole Period||8
7757397|NCT01447511|19100251|P5|NOT COMPLETED|Control Period||0
7757398|NCT01447511|19100252|P4|NOT COMPLETED|Control Period||0
7757399|NCT01447511|19100253|P3|NOT COMPLETED|Control Period||0
7757400|NCT01447511|19100254|P2|NOT COMPLETED|Control Period||0
7757401|NCT01447511|19100255|P1|NOT COMPLETED|Control Period||0
7757402|NCT01447511|19100251|P5|COMPLETED|Control Period||4
7757403|NCT01447511|19100252|P4|COMPLETED|Control Period||3
7757404|NCT01447511|19100253|P3|COMPLETED|Control Period||9
7757405|NCT01447511|19100254|P2|COMPLETED|Control Period||5
7757406|NCT01447511|19100255|P1|COMPLETED|Control Period||8
7757407|NCT01447511|19100251|P5|STARTED|Control Period||4
7757408|NCT01447511|19100252|P4|STARTED|Control Period||3
7757409|NCT01447511|19100253|P3|STARTED|Control Period||9
7757410|NCT01447511|19100254|P2|STARTED|Control Period||5
7757411|NCT01447511|19100255|P1|STARTED|Control Period||8
7757412|NCT01447446|19100273|P6|NOT COMPLETED|Overall Study||32
7757413|NCT01447446|19100274|P5|NOT COMPLETED|Overall Study||211
7757414|NCT01447446|19100275|P4|NOT COMPLETED|Overall Study||33
7757415|NCT01447446|19100276|P3|NOT COMPLETED|Overall Study||100
7757416|NCT01447446|19100277|P2|NOT COMPLETED|Overall Study||165
7757417|NCT01447446|19100278|P1|NOT COMPLETED|Overall Study||722
7757418|NCT01447446|19100273|P6|COMPLETED|Overall Study||54
7757419|NCT01447446|19100274|P5|COMPLETED|Overall Study||610
7757420|NCT01447446|19100275|P4|COMPLETED|Overall Study||60
7757421|NCT01447446|19100276|P3|COMPLETED|Overall Study||192
7757422|NCT01447446|19100277|P2|COMPLETED|Overall Study|Insuff.=Insufficient VR= Virological response TRT.=Treatment SVR= Sustained Virological Response|331
7757423|NCT01447446|19100278|P1|COMPLETED|Overall Study|Completed means the participants who completed the 24- weeks of follow-up period.|1590
7757424|NCT01447446|19100273|P6|STARTED|Overall Study||86
7757425|NCT01447446|19100274|P5|STARTED|Overall Study||821
7757426|NCT01447446|19100275|P4|STARTED|Overall Study||93
7757427|NCT01447446|19100276|P3|STARTED|Overall Study||292
7757428|NCT01447446|19100277|P2|STARTED|Overall Study||496
7757429|NCT01447446|19100278|P1|STARTED|Overall Study|Started means participants who started treatment and included in core population.|2312
7757430|NCT01447433|19100368|P2|NOT COMPLETED|Overall Study||6
7757431|NCT01447433|19100369|P1|NOT COMPLETED|Overall Study||4
7757432|NCT01447433|19100368|P2|COMPLETED|Overall Study||21
7757433|NCT01447433|19100369|P1|COMPLETED|Overall Study||22
7757434|NCT01447433|19100368|P2|STARTED|Overall Study||27
7757435|NCT01447433|19100369|P1|STARTED|Overall Study||26
7757436|NCT01447420|19100396|P3|NOT COMPLETED|Overall Study||10
7757437|NCT01447420|19100397|P2|NOT COMPLETED|Overall Study||27
7757438|NCT01447420|19100398|P1|NOT COMPLETED|Overall Study||10
7757439|NCT01447420|19100396|P3|COMPLETED|Overall Study||8
7757440|NCT01447420|19100397|P2|COMPLETED|Overall Study||45
7757441|NCT01447420|19100398|P1|COMPLETED|Overall Study||29
7757442|NCT01447420|19100396|P3|STARTED|Overall Study||18
7757443|NCT01447420|19100397|P2|STARTED|Overall Study||72
7757444|NCT01447420|19100398|P1|STARTED|Overall Study||39
7757445|NCT01447407|19100418|P4|NOT COMPLETED|Overall Study||2
7757446|NCT01447407|19100419|P3|NOT COMPLETED|Overall Study||1
7757447|NCT01447407|19100420|P2|NOT COMPLETED|Overall Study||0
7757448|NCT01447407|19100421|P1|NOT COMPLETED|Overall Study||2
7757449|NCT01447407|19100418|P4|COMPLETED|Overall Study||40
7757450|NCT01447407|19100419|P3|COMPLETED|Overall Study||40
7757451|NCT01447407|19100420|P2|COMPLETED|Overall Study||40
7757452|NCT01447407|19100421|P1|COMPLETED|Overall Study||39
7757453|NCT01447407|19100418|P4|STARTED|Overall Study||42
7757454|NCT01447407|19100419|P3|STARTED|Overall Study||41
7757455|NCT01447407|19100420|P2|STARTED|Overall Study||40
7757456|NCT01447407|19100421|P1|STARTED|Overall Study||41
7757457|NCT01447225|19100459|P10|NOT COMPLETED|Overall Study||0
7757458|NCT01447225|19100460|P9|NOT COMPLETED|Overall Study||0
7757459|NCT01447225|19100461|P8|NOT COMPLETED|Overall Study||0
7757460|NCT01447225|19100462|P7|NOT COMPLETED|Overall Study||0
7757461|NCT01447225|19100463|P6|NOT COMPLETED|Overall Study||0
7757462|NCT01447225|19100464|P5|NOT COMPLETED|Overall Study||0
7757463|NCT01447225|19100465|P4|NOT COMPLETED|Overall Study||0
7757464|NCT01447225|19100466|P3|NOT COMPLETED|Overall Study||0
7757465|NCT01447225|19100467|P2|NOT COMPLETED|Overall Study||0
7757466|NCT01447225|19100468|P1|NOT COMPLETED|Overall Study||0
7757467|NCT01447225|19100459|P10|COMPLETED|Overall Study||4
7757468|NCT01447225|19100460|P9|COMPLETED|Overall Study||3
7757469|NCT01447225|19100461|P8|COMPLETED|Overall Study||4
7757470|NCT01447225|19100462|P7|COMPLETED|Overall Study||7
7757471|NCT01447225|19100463|P6|COMPLETED|Overall Study||3
7757472|NCT01447225|19100464|P5|COMPLETED|Overall Study||3
7757473|NCT01447225|19100465|P4|COMPLETED|Overall Study||3
7757474|NCT01447225|19100466|P3|COMPLETED|Overall Study||5
7757475|NCT01447225|19100467|P2|COMPLETED|Overall Study||8
7757476|NCT01447225|19100468|P1|COMPLETED|Overall Study||3
7757477|NCT01447225|19100459|P10|STARTED|Overall Study||4
7757478|NCT01447225|19100460|P9|STARTED|Overall Study||3
7757479|NCT01447225|19100461|P8|STARTED|Overall Study||4
7757480|NCT01447225|19100462|P7|STARTED|Overall Study||7
7757481|NCT01447225|19100463|P6|STARTED|Overall Study||3
7757482|NCT01447225|19100464|P5|STARTED|Overall Study||3
7757483|NCT01447225|19100465|P4|STARTED|Overall Study||3
7757484|NCT01447225|19100466|P3|STARTED|Overall Study||5
7757485|NCT01447225|19100467|P2|STARTED|Overall Study||8
7757486|NCT01447225|19100468|P1|STARTED|Overall Study||3
7757487|NCT01447121|19100538|P1|NOT COMPLETED|Overall Study||0
7757488|NCT01447121|19100538|P1|COMPLETED|Overall Study||118
7757489|NCT01447121|19100538|P1|STARTED|Overall Study||118
7757490|NCT01447017|19100545|P2|NOT COMPLETED|Overall Study||10
7757491|NCT01447017|19100546|P1|NOT COMPLETED|Overall Study||10
7757492|NCT01447017|19100545|P2|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14
7757493|NCT01447017|19100546|P1|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35
7757494|NCT01447017|19100545|P2|Performed Visit 2|Overall Study||24
7757495|NCT01447017|19100546|P1|Performed Visit 2|Overall Study||43
7757496|NCT01447017|19100545|P2|STARTED|Overall Study||24
7757497|NCT01447017|19100546|P1|STARTED|Overall Study||45
7757498|NCT01446913|19100555|P3|NOT COMPLETED|Overall Study||11
7757499|NCT01446913|19100556|P2|NOT COMPLETED|Overall Study||9
7757500|NCT01446913|19100557|P1|NOT COMPLETED|Overall Study||9
7757501|NCT01446913|19100555|P3|COMPLETED|Overall Study||73
7757502|NCT01446913|19100556|P2|COMPLETED|Overall Study||73
7757503|NCT01446913|19100557|P1|COMPLETED|Overall Study||77
7757504|NCT01446913|19100555|P3|Patients With Sleep Apnea|Overall Study||21
7757505|NCT01446913|19100556|P2|Patients With Sleep Apnea|Overall Study||45
7757506|NCT01446913|19100557|P1|Patients With Sleep Apnea|Overall Study||39
7757507|NCT01446913|19100555|P3|Patients With Sleep Study|Overall Study||29
7757508|NCT01446913|19100556|P2|Patients With Sleep Study|Overall Study||56
7757509|NCT01446913|19100557|P1|Patients With Sleep Study|Overall Study||53
7757510|NCT01446913|19100555|P3|STARTED|Overall Study||84
7757511|NCT01446913|19100556|P2|STARTED|Overall Study||82
7757512|NCT01446913|19100557|P1|STARTED|Overall Study||86
7757513|NCT01446874|19100618|P3|NOT COMPLETED|Overall Study||18
7757514|NCT01446874|19100619|P2|NOT COMPLETED|Overall Study||4
7757515|NCT01446874|19100620|P1|NOT COMPLETED|Overall Study||2
7757516|NCT01446874|19100618|P3|COMPLETED|Overall Study||62
7757517|NCT01446874|19100619|P2|COMPLETED|Overall Study||46
7757518|NCT01446874|19100620|P1|COMPLETED|Overall Study||18
7757519|NCT01446874|19100618|P3|STARTED|Overall Study||80
7757520|NCT01446874|19100619|P2|STARTED|Overall Study||50
7757521|NCT01446874|19100620|P1|STARTED|Overall Study||20
7757522|NCT01446809|19100648|P3|NOT COMPLETED|Overall Study||2
7757523|NCT01446809|19100649|P2|NOT COMPLETED|Overall Study||0
7757524|NCT01446809|19100650|P1|NOT COMPLETED|Overall Study||0
7757525|NCT01446809|19100648|P3|COMPLETED|Overall Study||0
7757526|NCT01446809|19100649|P2|COMPLETED|Overall Study||7
7757527|NCT01446809|19100650|P1|COMPLETED|Overall Study||14
7757528|NCT01446809|19100648|P3|STARTED|Overall Study||2
7757529|NCT01446809|19100649|P2|STARTED|Overall Study||7
7757530|NCT01446809|19100650|P1|STARTED|Overall Study||14
7757531|NCT01446796|19100673|P2|NOT COMPLETED|Overall Study||0
7757532|NCT01446796|19100674|P1|NOT COMPLETED|Overall Study||1
7757533|NCT01446796|19100673|P2|COMPLETED|Overall Study|Study terminated early|0
7757534|NCT01446796|19100674|P1|COMPLETED|Overall Study|"Study terminated early
~One subject of three withdrew prior to randomization and did not start"|2
7757535|NCT01446796|19100673|P2|STARTED|Overall Study||0
7757536|NCT01446796|19100674|P1|STARTED|Overall Study||3
7757537|NCT01446705|19100688|P2|NOT COMPLETED|Overall Study||0
7757538|NCT01446705|19100689|P1|NOT COMPLETED|Overall Study||0
7757539|NCT01446705|19100688|P2|COMPLETED|Overall Study||6627
7757540|NCT01446705|19100689|P1|COMPLETED|Overall Study||50446
7757541|NCT01446705|19100688|P2|STARTED|Overall Study||6627
7757542|NCT01446705|19100689|P1|STARTED|Overall Study||50446
7757543|NCT01446666|19100705|P1|NOT COMPLETED|Overall Study||81
7757544|NCT01446666|19100705|P1|COMPLETED|Overall Study||326
7757545|NCT01446666|19100705|P1|STARTED|Overall Study|Among the 423 participants who consented, 15 withdrew the consent and one died.|407
7757546|NCT01446419|19100720|P2|NOT COMPLETED|Overall Study||1
7757547|NCT01446419|19100721|P1|NOT COMPLETED|Overall Study||5
7757548|NCT01446419|19100720|P2|COMPLETED|Overall Study||77
7757549|NCT01446419|19100721|P1|COMPLETED|Overall Study||142
7757550|NCT01446419|19100720|P2|12 Month Follow-up|Overall Study||77
7757551|NCT01446419|19100721|P1|12 Month Follow-up|Overall Study||142
7757552|NCT01446419|19100720|P2|6 Month Follow-up|Overall Study||77
7757553|NCT01446419|19100721|P1|6 Month Follow-up|Overall Study||144
7757554|NCT01446419|19100720|P2|3 Month Follow-up|Overall Study||77
7757555|NCT01446419|19100721|P1|3 Month Follow-up|Overall Study||146
7757556|NCT01446419|19100720|P2|STARTED|Overall Study||78
7757557|NCT01446419|19100721|P1|STARTED|Overall Study||147
7757558|NCT01446289|19100735|P4|NOT COMPLETED|Overall Study||0
7757559|NCT01446289|19100736|P3|NOT COMPLETED|Overall Study||1
7757560|NCT01446289|19100737|P2|NOT COMPLETED|Overall Study||0
7757561|NCT01446289|19100738|P1|NOT COMPLETED|Overall Study||1
7757562|NCT01446289|19100735|P4|COMPLETED|Overall Study||35
7757563|NCT01446289|19100736|P3|COMPLETED|Overall Study||50
7757564|NCT01446289|19100737|P2|COMPLETED|Overall Study||35
7757565|NCT01446289|19100738|P1|COMPLETED|Overall Study||50
7757566|NCT01446289|19100735|P4|STARTED|Overall Study||35
7757567|NCT01446289|19100736|P3|STARTED|Overall Study||51
7757568|NCT01446289|19100737|P2|STARTED|Overall Study||35
7757569|NCT01446289|19100738|P1|STARTED|Overall Study||51
7757570|NCT01446250|19100766|P4|NOT COMPLETED|Follow-up||6
7757571|NCT01446250|19100767|P3|NOT COMPLETED|Follow-up||0
7757572|NCT01446250|19100768|P2|NOT COMPLETED|Follow-up||0
7757573|NCT01446250|19100769|P1|NOT COMPLETED|Follow-up||0
7757574|NCT01446250|19100766|P4|COMPLETED|Follow-up||0
7757575|NCT01446250|19100767|P3|COMPLETED|Follow-up||0
7757576|NCT01446250|19100768|P2|COMPLETED|Follow-up||0
7757577|NCT01446250|19100769|P1|COMPLETED|Follow-up||0
7757578|NCT01446250|19100766|P4|STARTED|Follow-up||6
7757579|NCT01446250|19100767|P3|STARTED|Follow-up||0
7757580|NCT01446250|19100768|P2|STARTED|Follow-up||0
7757581|NCT01446250|19100769|P1|STARTED|Follow-up||0
7757582|NCT01446250|19100766|P4|NOT COMPLETED|Treatment Period 2||0
7757583|NCT01446250|19100767|P3|NOT COMPLETED|Treatment Period 2||0
7757584|NCT01446250|19100768|P2|NOT COMPLETED|Treatment Period 2||1
7757585|NCT01446250|19100769|P1|NOT COMPLETED|Treatment Period 2||0
7757586|NCT01446250|19100766|P4|COMPLETED|Treatment Period 2||0
7757587|NCT01446250|19100767|P3|COMPLETED|Treatment Period 2||0
7757588|NCT01446250|19100768|P2|COMPLETED|Treatment Period 2||6
7757589|NCT01446250|19100769|P1|COMPLETED|Treatment Period 2||0
7757590|NCT01446250|19100766|P4|STARTED|Treatment Period 2||0
7757591|NCT01446250|19100767|P3|STARTED|Treatment Period 2||0
7757592|NCT01446250|19100768|P2|STARTED|Treatment Period 2||7
7757593|NCT01446250|19100769|P1|STARTED|Treatment Period 2||0
7757594|NCT01446250|19100766|P4|NOT COMPLETED|Clinical Hold||0
7757595|NCT01446250|19100767|P3|NOT COMPLETED|Clinical Hold||0
7757596|NCT01446250|19100768|P2|NOT COMPLETED|Clinical Hold||0
7757597|NCT01446250|19100769|P1|NOT COMPLETED|Clinical Hold||0
7757598|NCT01446250|19100766|P4|COMPLETED|Clinical Hold||0
7757599|NCT01446250|19100767|P3|COMPLETED|Clinical Hold||5
7757600|NCT01446250|19100768|P2|COMPLETED|Clinical Hold||2
7757601|NCT01446250|19100769|P1|COMPLETED|Clinical Hold||0
7757602|NCT01446250|19100766|P4|STARTED|Clinical Hold||0
7757603|NCT01446250|19100767|P3|STARTED|Clinical Hold||5
7757604|NCT01446250|19100768|P2|STARTED|Clinical Hold||2
7757605|NCT01446250|19100769|P1|STARTED|Clinical Hold||0
7757606|NCT01446250|19100766|P4|NOT COMPLETED|Treatment Period 1||0
7757607|NCT01446250|19100767|P3|NOT COMPLETED|Treatment Period 1||0
7757608|NCT01446250|19100768|P2|NOT COMPLETED|Treatment Period 1||1
7757609|NCT01446250|19100769|P1|NOT COMPLETED|Treatment Period 1||0
7757610|NCT01446250|19100766|P4|COMPLETED|Treatment Period 1||0
7757611|NCT01446250|19100767|P3|COMPLETED|Treatment Period 1||0
7757612|NCT01446250|19100768|P2|COMPLETED|Treatment Period 1||2
7757613|NCT01446250|19100769|P1|COMPLETED|Treatment Period 1||5
7757614|NCT01446250|19100766|P4|STARTED|Treatment Period 1||0
7757615|NCT01446250|19100767|P3|STARTED|Treatment Period 1||0
7757616|NCT01446250|19100768|P2|STARTED|Treatment Period 1||3
7757617|NCT01446250|19100769|P1|STARTED|Treatment Period 1||5
7757618|NCT01446237|19100781|P1|NOT COMPLETED|Overall Study||10
7757619|NCT01446237|19100781|P1|COMPLETED|Overall Study||115
7757620|NCT01446237|19100781|P1|STARTED|Overall Study||125
7757621|NCT01446159|19100793|P4|NOT COMPLETED|Overall Study||62
7757622|NCT01446159|19100794|P3|NOT COMPLETED|Overall Study||71
7757623|NCT01446159|19100795|P2|NOT COMPLETED|Overall Study||3
7757624|NCT01446159|19100796|P1|NOT COMPLETED|Overall Study||3
7757625|NCT01446159|19100793|P4|COMPLETED|Overall Study||23
7757626|NCT01446159|19100794|P3|COMPLETED|Overall Study||21
7757627|NCT01446159|19100795|P2|COMPLETED|Overall Study||0
7757628|NCT01446159|19100796|P1|COMPLETED|Overall Study||0
7757629|NCT01446159|19100793|P4|STARTED|Overall Study||85
7757630|NCT01446159|19100794|P3|STARTED|Overall Study||92
7757631|NCT01446159|19100795|P2|STARTED|Overall Study||3
7757632|NCT01446159|19100796|P1|STARTED|Overall Study||3
7757633|NCT01446042|19100871|P3|NOT COMPLETED|Overall Study||9
7757634|NCT01446042|19100872|P2|NOT COMPLETED|Overall Study||3
7757635|NCT01446042|19100873|P1|NOT COMPLETED|Overall Study||20
7757636|NCT01446042|19100871|P3|COMPLETED|Overall Study||69
7757637|NCT01446042|19100872|P2|COMPLETED|Overall Study||83
7757638|NCT01446042|19100873|P1|COMPLETED|Overall Study||122
7757639|NCT01446042|19100871|P3|STARTED|Overall Study||78
7757640|NCT01446042|19100872|P2|STARTED|Overall Study||86
7757641|NCT01446042|19100873|P1|STARTED|Overall Study||142
7757642|NCT01446003|19100884|P2|NOT COMPLETED|Period 2||0
7757643|NCT01446003|19100885|P1|NOT COMPLETED|Period 2||1
7757644|NCT01446003|19100884|P2|COMPLETED|Period 2||15
7757645|NCT01446003|19100885|P1|COMPLETED|Period 2||13
7757646|NCT01446003|19100884|P2|STARTED|Period 2||15
7757647|NCT01446003|19100885|P1|STARTED|Period 2||14
7757648|NCT01446003|19100884|P2|NOT COMPLETED|Period 1||0
7757649|NCT01446003|19100885|P1|NOT COMPLETED|Period 1||2
7757650|NCT01446003|19100884|P2|COMPLETED|Period 1||15
7757651|NCT01446003|19100885|P1|COMPLETED|Period 1||14
7757652|NCT01446003|19100884|P2|STARTED|Period 1||15
7757653|NCT01446003|19100885|P1|STARTED|Period 1||16
7757654|NCT01445951|19100906|P3|NOT COMPLETED|Overall Study||19
7757655|NCT01445951|19100907|P2|NOT COMPLETED|Overall Study||36
7757656|NCT01445951|19100908|P1|NOT COMPLETED|Overall Study||44
7757657|NCT01445951|19100906|P3|COMPLETED|Overall Study||151
7757658|NCT01445951|19100907|P2|COMPLETED|Overall Study||138
7757659|NCT01445951|19100908|P1|COMPLETED|Overall Study||130
7757660|NCT01445951|19100906|P3|STARTED|Overall Study||170
7757661|NCT01445951|19100907|P2|STARTED|Overall Study||174
7757662|NCT01445951|19100908|P1|STARTED|Overall Study||174
7757663|NCT01445886|19100946|P1|NOT COMPLETED|Overall Study||5
7757664|NCT01445886|19100946|P1|COMPLETED|Overall Study||28
7757665|NCT01445886|19100946|P1|STARTED|Overall Study||33
7757666|NCT01445873|19100956|P1|NOT COMPLETED|Overall Study||0
7757667|NCT01445873|19100956|P1|COMPLETED|Overall Study||36
7757668|NCT01445873|19100956|P1|STARTED|Overall Study||36
7757669|NCT01445847|19100986|P2|NOT COMPLETED|Overall Study||14
7757670|NCT01445847|19100987|P1|NOT COMPLETED|Overall Study||14
7757671|NCT01445847|19100986|P2|COMPLETED|Overall Study||36
7757672|NCT01445847|19100987|P1|COMPLETED|Overall Study||36
7757673|NCT01445847|19100986|P2|STARTED|Overall Study||50
7757674|NCT01445847|19100987|P1|STARTED|Overall Study||50
7757675|NCT01445821|19100995|P2|NOT COMPLETED|Overall Study||0
7757676|NCT01445821|19100996|P1|NOT COMPLETED|Overall Study||0
7757677|NCT01445821|19100995|P2|COMPLETED|Overall Study||22
7757678|NCT01445821|19100996|P1|COMPLETED|Overall Study||22
7757679|NCT01445821|19100995|P2|STARTED|Overall Study||22
7757680|NCT01445821|19100996|P1|STARTED|Overall Study||22
7757681|NCT01445769|19101004|P1|NOT COMPLETED|Overall Study||8
7757682|NCT01445769|19101004|P1|COMPLETED|Overall Study||37
7757683|NCT01445769|19101004|P1|STARTED|Overall Study||45
7757684|NCT01445678|19101024|P2|NOT COMPLETED|Overall Study||21
7757685|NCT01445678|19101025|P1|NOT COMPLETED|Overall Study||30
7757686|NCT01445678|19101024|P2|COMPLETED|Overall Study||476
7757687|NCT01445678|19101025|P1|COMPLETED|Overall Study||452
7757688|NCT01445678|19101024|P2|STARTED|Overall Study||497
7757689|NCT01445678|19101025|P1|STARTED|Overall Study||482
7757690|NCT01445652|19101043|P2|NOT COMPLETED|Overall Study||3
7757691|NCT01445652|19101044|P1|NOT COMPLETED|Overall Study||10
7757692|NCT01445652|19101043|P2|COMPLETED|Overall Study||50
7757693|NCT01445652|19101044|P1|COMPLETED|Overall Study||47
7757694|NCT01445652|19101043|P2|STARTED|Overall Study||53
7757695|NCT01445652|19101044|P1|STARTED|Overall Study||57
7757696|NCT01445626|19101052|P1|NOT COMPLETED|Overall Study||0
7757697|NCT01445626|19101052|P1|COMPLETED|Overall Study||87
7757698|NCT01445626|19101052|P1|STARTED|Overall Study||87
7757699|NCT01445613|19101062|P1|NOT COMPLETED|1-year Follow-up||77
7757700|NCT01445613|19101062|P1|COMPLETED|1-year Follow-up||1088
7757701|NCT01445613|19101062|P1|STARTED|1-year Follow-up||1165
7757702|NCT01445613|19101062|P1|NOT COMPLETED|30-day Follow-up||35
7757703|NCT01445613|19101062|P1|COMPLETED|30-day Follow-up||1165
7757704|NCT01445613|19101062|P1|STARTED|30-day Follow-up||1200
7757705|NCT01445548|19101080|P1|NOT COMPLETED|Overall Study||1
7757706|NCT01445548|19101080|P1|COMPLETED|Overall Study||5
7757707|NCT01445548|19101080|P1|STARTED|Overall Study||6
7757708|NCT01445535|19101106|P4|NOT COMPLETED|Overall Study||2
7757709|NCT01445535|19101107|P3|NOT COMPLETED|Overall Study||1
7757710|NCT01445535|19101108|P2|NOT COMPLETED|Overall Study||0
7757711|NCT01445535|19101109|P1|NOT COMPLETED|Overall Study||1
7757712|NCT01445535|19101106|P4|COMPLETED|Overall Study||4
7757713|NCT01445535|19101107|P3|COMPLETED|Overall Study||2
7757714|NCT01445535|19101108|P2|COMPLETED|Overall Study||3
7757715|NCT01445535|19101109|P1|COMPLETED|Overall Study||2
7757716|NCT01445535|19101106|P4|STARTED|Overall Study||6
7757717|NCT01445535|19101107|P3|STARTED|Overall Study||3
7757718|NCT01445535|19101108|P2|STARTED|Overall Study||3
7757719|NCT01445535|19101109|P1|STARTED|Overall Study||3
7757720|NCT01445301|19101133|P3|NOT COMPLETED|Overall Study||9
7757721|NCT01445301|19101134|P2|NOT COMPLETED|Overall Study||35
7757722|NCT01445301|19101135|P1|NOT COMPLETED|Overall Study||21
7757723|NCT01445301|19101133|P3|COMPLETED|Overall Study||290
7757724|NCT01445301|19101134|P2|COMPLETED|Overall Study||262
7757725|NCT01445301|19101135|P1|COMPLETED|Overall Study||183
7757726|NCT01445301|19101133|P3|STARTED|Overall Study||299
7757727|NCT01445301|19101134|P2|STARTED|Overall Study||297
7757728|NCT01445301|19101135|P1|STARTED|Overall Study||204
7757729|NCT01445171|19101170|P1|NOT COMPLETED|Overall Study||95
7757730|NCT01445171|19101170|P1|COMPLETED|Overall Study||200
7757731|NCT01445171|19101170|P1|Implanted With Study Device|Overall Study||287
7757732|NCT01445171|19101170|P1|STARTED|Overall Study||295
7757733|NCT01445028|19101193|P2|NOT COMPLETED|Overall Study||3
7757734|NCT01445028|19101194|P1|NOT COMPLETED|Overall Study||0
7757735|NCT01445028|19101193|P2|COMPLETED|Overall Study||51
7757736|NCT01445028|19101194|P1|COMPLETED|Overall Study||58
7757737|NCT01445028|19101193|P2|STARTED|Overall Study||54
7757738|NCT01445028|19101194|P1|STARTED|Overall Study||58
7757739|NCT01444924|19101202|P2|NOT COMPLETED|Overall Study||0
7757740|NCT01444924|19101203|P1|NOT COMPLETED|Overall Study||0
7757741|NCT01444924|19101202|P2|COMPLETED|Overall Study||33
7757742|NCT01444924|19101203|P1|COMPLETED|Overall Study||31
7757743|NCT01444924|19101202|P2|STARTED|Overall Study||33
7757744|NCT01444924|19101203|P1|STARTED|Overall Study||31
7757745|NCT01444911|19101213|P2|NOT COMPLETED|Overall Study||0
7757746|NCT01444911|19101214|P1|NOT COMPLETED|Overall Study||8
7757747|NCT01444911|19101213|P2|COMPLETED|Overall Study||13
7757748|NCT01444911|19101214|P1|COMPLETED|Overall Study||8
7757749|NCT01444911|19101213|P2|STARTED|Overall Study||13
7757750|NCT01444911|19101214|P1|STARTED|Overall Study||16
7757751|NCT01444898|19101226|P1|NOT COMPLETED|Overall Study||1
7757752|NCT01444898|19101226|P1|COMPLETED|Overall Study||9
7757753|NCT01444898|19101226|P1|STARTED|Overall Study||10
7757754|NCT01444781|19101241|P3|NOT COMPLETED|Overall Study||3
7757755|NCT01444781|19101242|P2|NOT COMPLETED|Overall Study||4
7757756|NCT01444781|19101243|P1|NOT COMPLETED|Overall Study||3
7757757|NCT01444781|19101241|P3|COMPLETED|Overall Study||272
7757758|NCT01444781|19101242|P2|COMPLETED|Overall Study||411
7757759|NCT01444781|19101243|P1|COMPLETED|Overall Study||413
7757760|NCT01444781|19101241|P3|STARTED|Overall Study||275
7757761|NCT01444781|19101242|P2|STARTED|Overall Study||415
7757762|NCT01444781|19101243|P1|STARTED|Overall Study||416
7757763|NCT01444742|19101281|P1|NOT COMPLETED|Overall Study||1
7757764|NCT01444742|19101281|P1|COMPLETED|Overall Study||80
7757765|NCT01444742|19101281|P1|STARTED|Overall Study||81
7757766|NCT01444651|19101288|P2|NOT COMPLETED|Overall Study||9
7757767|NCT01444651|19101289|P1|NOT COMPLETED|Overall Study||11
7757768|NCT01444651|19101288|P2|COMPLETED|Overall Study||28
7757769|NCT01444651|19101289|P1|COMPLETED|Overall Study||25
7757770|NCT01444651|19101288|P2|STARTED|Overall Study||37
7757771|NCT01444651|19101289|P1|STARTED|Overall Study||36
7757772|NCT01444456|19101305|P1|NOT COMPLETED|Overall Study||285
7757773|NCT01444456|19101305|P1|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977
7757774|NCT01444456|19101305|P1|Received Darbepoetin Alfa|Overall Study||1134
7757775|NCT01444456|19101305|P1|Received Darbepoetin Alfa or Other ESA|Overall Study||1158
7757776|NCT01444456|19101305|P1|STARTED|Overall Study||1262
7757777|NCT01444430|19101316|P2|NOT COMPLETED|Overall Study||81
7757778|NCT01444430|19101317|P1|NOT COMPLETED|Overall Study||61
7757779|NCT01444430|19101316|P2|COMPLETED|Overall Study||5766
7757780|NCT01444430|19101317|P1|COMPLETED|Overall Study||5785
7757781|NCT01444430|19101316|P2|STARTED|Overall Study||5847
7757782|NCT01444430|19101317|P1|STARTED|Overall Study||5846
7757783|NCT01444417|19101339|P2|NOT COMPLETED|Overall Study||1
7757784|NCT01444417|19101340|P1|NOT COMPLETED|Overall Study||2
7757785|NCT01444417|19101339|P2|COMPLETED|Overall Study||41
7757786|NCT01444417|19101340|P1|COMPLETED|Overall Study||18
7757787|NCT01444417|19101339|P2|Received Treatment|Overall Study||42
7757788|NCT01444417|19101340|P1|Received Treatment|Overall Study||19
7757789|NCT01444417|19101339|P2|STARTED|Overall Study||42
7757790|NCT01444417|19101340|P1|STARTED|Overall Study||20
7757791|NCT01444391|19101356|P1|NOT COMPLETED|Overall Study||1
7757792|NCT01444391|19101356|P1|COMPLETED|Overall Study||41
7757793|NCT01444391|19101356|P1|STARTED|Overall Study||42
7757794|NCT01444378|19101364|P1|NOT COMPLETED|Overall Study||17
7757795|NCT01444378|19101364|P1|COMPLETED|Overall Study||124
7757796|NCT01444378|19101364|P1|STARTED|Overall Study|A total of 141 patients were enrolled into MOMENTUM|141
7757797|NCT01444300|19101476|P2|NOT COMPLETED|Overall Study||0
7757798|NCT01444300|19101477|P1|NOT COMPLETED|Overall Study||4
7757799|NCT01444300|19101476|P2|COMPLETED|Overall Study||12
7757800|NCT01444300|19101477|P1|COMPLETED|Overall Study||8
7757801|NCT01444300|19101476|P2|STARTED|Overall Study||12
7757802|NCT01444300|19101477|P1|STARTED|Overall Study||12
7757803|NCT01444287|19101487|P1|NOT COMPLETED|Period 4||0
7757804|NCT01444287|19101487|P1|COMPLETED|Period 4||22
7757805|NCT01444287|19101487|P1|STARTED|Period 4||22
7757806|NCT01444287|19101487|P1|NOT COMPLETED|Period 3||0
7757807|NCT01444287|19101487|P1|COMPLETED|Period 3||22
7757808|NCT01444287|19101487|P1|STARTED|Period 3||22
7757809|NCT01444287|19101487|P1|NOT COMPLETED|Period 2||0
7757810|NCT01444287|19101487|P1|COMPLETED|Period 2||22
7757811|NCT01444287|19101487|P1|STARTED|Period 2||22
7757812|NCT01444287|19101487|P1|NOT COMPLETED|Period 1||0
7757813|NCT01444287|19101487|P1|COMPLETED|Period 1||22
7757814|NCT01444287|19101487|P1|STARTED|Period 1||22
7757815|NCT01444092|19101509|P1|NOT COMPLETED|Overall Study||17
7757816|NCT01444092|19101509|P1|COMPLETED|Overall Study||91
7757817|NCT01444092|19101509|P1|INFORMED CONSENT OBTAINED|Overall Study||108
7757818|NCT01444092|19101509|P1|STARTED|Overall Study||108
7757819|NCT01444027|19101518|P3|NOT COMPLETED|Overall Study||38
7757820|NCT01444027|19101519|P2|NOT COMPLETED|Overall Study||30
7757821|NCT01444027|19101520|P1|NOT COMPLETED|Overall Study||30
7757822|NCT01444027|19101518|P3|COMPLETED|Overall Study||133
7757823|NCT01444027|19101519|P2|COMPLETED|Overall Study||141
7757824|NCT01444027|19101520|P1|COMPLETED|Overall Study||142
7757825|NCT01444027|19101518|P3|3 Month Follow-up|Overall Study||133
7757826|NCT01444027|19101519|P2|3 Month Follow-up|Overall Study||141
7757827|NCT01444027|19101520|P1|3 Month Follow-up|Overall Study||142
7757828|NCT01444027|19101518|P3|1 Month Follow-up|Overall Study||141
7757829|NCT01444027|19101519|P2|1 Month Follow-up|Overall Study||159
7757830|NCT01444027|19101520|P1|1 Month Follow-up|Overall Study||160
7757831|NCT01444027|19101518|P3|Received Intervention as Assigned|Overall Study||147
7757832|NCT01444027|19101519|P2|Received Intervention as Assigned|Overall Study||161
7757833|NCT01444027|19101520|P1|Received Intervention as Assigned|Overall Study||168
7757834|NCT01444027|19101518|P3|STARTED|Overall Study||171
7757835|NCT01444027|19101519|P2|STARTED|Overall Study||171
7757836|NCT01444027|19101520|P1|STARTED|Overall Study||172
7757837|NCT01443923|19101542|P2|NOT COMPLETED|Overall Study||0
7757838|NCT01443923|19101543|P1|NOT COMPLETED|Overall Study||1
7757839|NCT01443923|19101542|P2|COMPLETED|Overall Study||1
7757840|NCT01443923|19101543|P1|COMPLETED|Overall Study||2
7757841|NCT01443923|19101542|P2|STARTED|Overall Study||1
7757842|NCT01443923|19101543|P1|STARTED|Overall Study||3
7757843|NCT01443858|19101560|P3|NOT COMPLETED|Overall Study||7
7757844|NCT01443858|19101561|P2|NOT COMPLETED|Overall Study||13
7757845|NCT01443858|19101562|P1|NOT COMPLETED|Overall Study||15
7757846|NCT01443858|19101560|P3|COMPLETED|Overall Study||18
7757847|NCT01443858|19101561|P2|COMPLETED|Overall Study||12
7757848|NCT01443858|19101562|P1|COMPLETED|Overall Study||10
7757849|NCT01443858|19101560|P3|STARTED|Overall Study||25
7757850|NCT01443858|19101561|P2|STARTED|Overall Study||25
7757851|NCT01443858|19101562|P1|STARTED|Overall Study||25
7757852|NCT01443845|19101584|P2|NOT COMPLETED|Overall Study||337
7757853|NCT01443845|19101585|P1|NOT COMPLETED|Overall Study||254
7757854|NCT01443845|19101584|P2|COMPLETED|Overall Study||841
7757855|NCT01443845|19101585|P1|COMPLETED|Overall Study||922
7757856|NCT01443845|19101584|P2|STARTED|Overall Study||1178
7757857|NCT01443845|19101585|P1|STARTED|Overall Study||1176
7757858|NCT01443546|19101600|P3|NOT COMPLETED|Overall Study||0
7757859|NCT01443546|19101601|P2|NOT COMPLETED|Overall Study||0
7757860|NCT01443546|19101602|P1|NOT COMPLETED|Overall Study||0
7757861|NCT01443546|19101600|P3|COMPLETED|Overall Study||8
7757862|NCT01443546|19101601|P2|COMPLETED|Overall Study||9
7757863|NCT01443546|19101602|P1|COMPLETED|Overall Study||9
7757864|NCT01443546|19101600|P3|STARTED|Overall Study||8
7757865|NCT01443546|19101601|P2|STARTED|Overall Study||9
7757866|NCT01443546|19101602|P1|STARTED|Overall Study||9
7757867|NCT01443494|19101622|P1|NOT COMPLETED|Overall Study||0
7757868|NCT01443494|19101622|P1|COMPLETED|Overall Study||19
7757869|NCT01443494|19101622|P1|STARTED|Overall Study||19
7757870|NCT01443442|19101629|P2|NOT COMPLETED|Overall Study||0
7757871|NCT01443442|19101630|P1|NOT COMPLETED|Overall Study||0
7757872|NCT01443442|19101629|P2|COMPLETED|Overall Study||11
7757873|NCT01443442|19101630|P1|COMPLETED|Overall Study||12
7757874|NCT01443442|19101629|P2|STARTED|Overall Study||11
7757875|NCT01443442|19101630|P1|STARTED|Overall Study||12
7757876|NCT01443403|19101640|P4|NOT COMPLETED|Overall Study||9
7757877|NCT01443403|19101641|P3|NOT COMPLETED|Overall Study||7
7757878|NCT01443403|19101642|P2|NOT COMPLETED|Overall Study||6
7757879|NCT01443403|19101643|P1|NOT COMPLETED|Overall Study||6
7757880|NCT01443403|19101640|P4|COMPLETED|Overall Study||52
7757881|NCT01443403|19101641|P3|COMPLETED|Overall Study||54
7757882|NCT01443403|19101642|P2|COMPLETED|Overall Study||55
7757883|NCT01443403|19101643|P1|COMPLETED|Overall Study||55
7757884|NCT01443403|19101640|P4|Received Treatment|Overall Study||61
7757885|NCT01443403|19101641|P3|Received Treatment|Overall Study||60
7757886|NCT01443403|19101642|P2|Received Treatment|Overall Study||61
7757887|NCT01443403|19101643|P1|Received Treatment|Overall Study||61
7757888|NCT01443403|19101640|P4|STARTED|Overall Study||61
7757889|NCT01443403|19101641|P3|STARTED|Overall Study||61
7757890|NCT01443403|19101642|P2|STARTED|Overall Study||61
7757891|NCT01443403|19101643|P1|STARTED|Overall Study||61
7757892|NCT01443364|19101790|P1|NOT COMPLETED|Overall Study||41
7757893|NCT01443364|19101790|P1|COMPLETED|Overall Study||91
7757894|NCT01443364|19101790|P1|STARTED|Overall Study||132
7757895|NCT01443130|19101919|P6|NOT COMPLETED|Overall Study||34
7757896|NCT01443130|19101920|P5|NOT COMPLETED|Overall Study||44
7757897|NCT01443130|19101921|P4|NOT COMPLETED|Overall Study||39
7757898|NCT01443130|19101922|P3|NOT COMPLETED|Overall Study||77
7757899|NCT01443130|19101923|P2|NOT COMPLETED|Overall Study||69
7757900|NCT01443130|19101924|P1|NOT COMPLETED|Overall Study||68
7757901|NCT01443130|19101919|P6|COMPLETED|Overall Study||225
7757902|NCT01443130|19101920|P5|COMPLETED|Overall Study||230
7757903|NCT01443130|19101921|P4|COMPLETED|Overall Study||231
7757904|NCT01443130|19101922|P3|COMPLETED|Overall Study||223
7757905|NCT01443130|19101923|P2|COMPLETED|Overall Study||231
7757906|NCT01443130|19101924|P1|COMPLETED|Overall Study||232
7757907|NCT01443130|19101919|P6|STARTED|Overall Study||259
7757908|NCT01443130|19101920|P5|STARTED|Overall Study||274
7757909|NCT01443130|19101921|P4|STARTED|Overall Study||270
7757910|NCT01443130|19101922|P3|STARTED|Overall Study||300
7757911|NCT01443130|19101923|P2|STARTED|Overall Study||300
7757912|NCT01443130|19101924|P1|STARTED|Overall Study||300
7757913|NCT01443078|19101974|P1|NOT COMPLETED|Overall Study||29
7757914|NCT01443078|19101974|P1|COMPLETED|Overall Study||13
7757915|NCT01443078|19101974|P1|STARTED|Overall Study||42
7757916|NCT01443026|19101981|P2|NOT COMPLETED|Overall Study||5
7757917|NCT01443026|19101982|P1|NOT COMPLETED|Overall Study||3
7757918|NCT01443026|19101981|P2|COMPLETED|Overall Study||32
7757919|NCT01443026|19101982|P1|COMPLETED|Overall Study||26
7757920|NCT01443026|19101981|P2|STARTED|Overall Study||37
7757921|NCT01443026|19101982|P1|STARTED|Overall Study||29
7757922|NCT01442844|19101990|P2|NOT COMPLETED|Overall Study||0
7757923|NCT01442844|19101991|P1|NOT COMPLETED|Overall Study||0
7757924|NCT01442844|19101990|P2|COMPLETED|Overall Study||2
7757925|NCT01442844|19101991|P1|COMPLETED|Overall Study||1
7757926|NCT01442844|19101990|P2|STARTED|Overall Study||2
7757927|NCT01442844|19101991|P1|STARTED|Overall Study||1
7757928|NCT01442779|19101997|P1|NOT COMPLETED|Overall Study||7
7757929|NCT01442779|19101997|P1|COMPLETED|Overall Study||11
7757930|NCT01442779|19101997|P1|STARTED|Overall Study||18
7757931|NCT01442714|19102003|P1|NOT COMPLETED|Overall Study||12
7757932|NCT01442714|19102003|P1|COMPLETED|Overall Study||21
7757933|NCT01442714|19102003|P1|STARTED|Overall Study||33
7757934|NCT01442688|19102011|P2|NOT COMPLETED|Second Intervention||0
7757935|NCT01442688|19102012|P1|NOT COMPLETED|Second Intervention||1
7757936|NCT01442688|19102011|P2|COMPLETED|Second Intervention||31
7757937|NCT01442688|19102012|P1|COMPLETED|Second Intervention||28
7757938|NCT01442688|19102011|P2|STARTED|Second Intervention||31
7757939|NCT01442688|19102012|P1|STARTED|Second Intervention||29
7757940|NCT01442688|19102011|P2|NOT COMPLETED|First Intervention||0
7757941|NCT01442688|19102012|P1|NOT COMPLETED|First Intervention||2
7757942|NCT01442688|19102011|P2|COMPLETED|First Intervention||31
7757943|NCT01442688|19102012|P1|COMPLETED|First Intervention||29
7757944|NCT01442688|19102011|P2|STARTED|First Intervention||31
7757945|NCT01442688|19102012|P1|STARTED|First Intervention||31
7757946|NCT01442675|19102020|P1|NOT COMPLETED|Overall Study||12
7757947|NCT01442675|19102020|P1|COMPLETED|Overall Study||822
7757948|NCT01442675|19102020|P1|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781
7757949|NCT01442675|19102020|P1|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831
7757950|NCT01442675|19102020|P1|STARTED|Overall Study||834
7757951|NCT01442493|19102032|P2|NOT COMPLETED|Overall Study||2
7757952|NCT01442493|19102033|P1|NOT COMPLETED|Overall Study||3
7757953|NCT01442493|19102032|P2|COMPLETED|Overall Study||149
7757954|NCT01442493|19102033|P1|COMPLETED|Overall Study||146
7757955|NCT01442493|19102032|P2|STARTED|Overall Study||151
7757956|NCT01442493|19102033|P1|STARTED|Overall Study||149
7757957|NCT01442376|19102054|P3|NOT COMPLETED|Overall Study||5
7757958|NCT01442376|19102055|P2|NOT COMPLETED|Overall Study||9
7757959|NCT01442376|19102056|P1|NOT COMPLETED|Overall Study||3
7757960|NCT01442376|19102054|P3|COMPLETED|Overall Study||159
7757961|NCT01442376|19102055|P2|COMPLETED|Overall Study||160
7757962|NCT01442376|19102056|P1|COMPLETED|Overall Study||166
7757963|NCT01442376|19102054|P3|STARTED|Overall Study|Randomized patients|164
7757964|NCT01442376|19102055|P2|STARTED|Overall Study|Randomized patients|169
7757965|NCT01442376|19102056|P1|STARTED|Overall Study|Randomized patients|169
7757966|NCT01442181|19102069|P2|NOT COMPLETED|Overall Study||3
7757967|NCT01442181|19102070|P1|NOT COMPLETED|Overall Study||4
7757968|NCT01442181|19102069|P2|COMPLETED|Overall Study||8
7757969|NCT01442181|19102070|P1|COMPLETED|Overall Study||10
7757970|NCT01442181|19102069|P2|STARTED|Overall Study||11
7757971|NCT01442181|19102070|P1|STARTED|Overall Study||14
7757972|NCT01442155|19102094|P1|NOT COMPLETED|Overall Study||65
7757973|NCT01442155|19102094|P1|COMPLETED|Overall Study||9
7757974|NCT01442155|19102094|P1|STARTED|Overall Study||74
7757975|NCT01442129|19102101|P2|NOT COMPLETED|Overall Study||0
7757976|NCT01442129|19102102|P1|NOT COMPLETED|Overall Study||0
7757977|NCT01442129|19102101|P2|COMPLETED|Overall Study||10
7757978|NCT01442129|19102102|P1|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20
7757979|NCT01442129|19102101|P2|STARTED|Overall Study||10
7757980|NCT01442129|19102102|P1|STARTED|Overall Study||20
7757981|NCT01442103|19102110|P1|NOT COMPLETED|Overall Study||2
7757982|NCT01442103|19102110|P1|COMPLETED|Overall Study||8
7757983|NCT01442103|19102110|P1|STARTED|Overall Study||10
7757984|NCT01442064|19102120|P6|NOT COMPLETED|Overall Study||99
7757985|NCT01442064|19102121|P5|NOT COMPLETED|Overall Study||106
7757986|NCT01442064|19102122|P4|NOT COMPLETED|Overall Study||98
7757987|NCT01442064|19102123|P3|NOT COMPLETED|Overall Study||104
7757988|NCT01442064|19102124|P2|NOT COMPLETED|Overall Study||101
7757989|NCT01442064|19102125|P1|NOT COMPLETED|Overall Study||97
7757990|NCT01442064|19102120|P6|COMPLETED|Overall Study||0
7757991|NCT01442064|19102121|P5|COMPLETED|Overall Study||1
7757992|NCT01442064|19102122|P4|COMPLETED|Overall Study||0
7757993|NCT01442064|19102123|P3|COMPLETED|Overall Study||0
7757994|NCT01442064|19102124|P2|COMPLETED|Overall Study||2
7757995|NCT01442064|19102125|P1|COMPLETED|Overall Study||0
7757996|NCT01442064|19102120|P6|Received Study Drug in Extension Study|Overall Study||81
7757997|NCT01442064|19102121|P5|Received Study Drug in Extension Study|Overall Study||89
7757998|NCT01442064|19102122|P4|Received Study Drug in Extension Study|Overall Study||70
7757999|NCT01442064|19102123|P3|Received Study Drug in Extension Study|Overall Study||60
7758000|NCT01442064|19102124|P2|Received Study Drug in Extension Study|Overall Study||70
7758001|NCT01442064|19102125|P1|Received Study Drug in Extension Study|Overall Study||61
7758002|NCT01442064|19102120|P6|Ranibizumab-Treated Subjects|Overall Study||99
7758003|NCT01442064|19102121|P5|Ranibizumab-Treated Subjects|Overall Study||107
7758004|NCT01442064|19102122|P4|Ranibizumab-Treated Subjects|Overall Study||96
7758005|NCT01442064|19102123|P3|Ranibizumab-Treated Subjects|Overall Study||104
7758006|NCT01442064|19102124|P2|Ranibizumab-Treated Subjects|Overall Study||103
7758007|NCT01442064|19102125|P1|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93
7758008|NCT01442064|19102120|P6|STARTED|Overall Study||99
7758009|NCT01442064|19102121|P5|STARTED|Overall Study||107
7758010|NCT01442064|19102122|P4|STARTED|Overall Study||98
7758011|NCT01442064|19102123|P3|STARTED|Overall Study||104
7758012|NCT01442064|19102124|P2|STARTED|Overall Study||103
7758013|NCT01442064|19102125|P1|STARTED|Overall Study||97
7758014|NCT01442038|19102162|P2|NOT COMPLETED|Overall Study||279
7758015|NCT01442038|19102163|P1|NOT COMPLETED|Overall Study||303
7758016|NCT01442038|19102162|P2|COMPLETED|Overall Study||1040
7758017|NCT01442038|19102163|P1|COMPLETED|Overall Study||1029
7758018|NCT01442038|19102162|P2|STARTED|Overall Study||1319
7758019|NCT01442038|19102163|P1|STARTED|Overall Study||1332
7758020|NCT01441973|19102177|P2|NOT COMPLETED|Overall Study||16
7758021|NCT01441973|19102178|P1|NOT COMPLETED|Overall Study||15
7758022|NCT01441973|19102177|P2|COMPLETED|Overall Study|Still receiving treatment|0
7758023|NCT01441973|19102178|P1|COMPLETED|Overall Study|Still receiving treatment|0
7758024|NCT01441973|19102177|P2|STARTED|Overall Study||16
7758025|NCT01441973|19102178|P1|STARTED|Overall Study||15
7758026|NCT01441960|19102200|P2|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
7758027|NCT01441960|19102201|P1|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
7758028|NCT01441960|19102200|P2|COMPLETED|Second Neuromuscular Blocking Agent||13
7758029|NCT01441960|19102201|P1|COMPLETED|Second Neuromuscular Blocking Agent||18
7758030|NCT01441960|19102200|P2|STARTED|Second Neuromuscular Blocking Agent||13
7758031|NCT01441960|19102201|P1|STARTED|Second Neuromuscular Blocking Agent||18
7758032|NCT01441960|19102200|P2|NOT COMPLETED|First Neuromuscular Blocking Agent:||6
7758033|NCT01441960|19102201|P1|NOT COMPLETED|First Neuromuscular Blocking Agent:||8
7758034|NCT01441960|19102200|P2|COMPLETED|First Neuromuscular Blocking Agent:||13
7758035|NCT01441960|19102201|P1|COMPLETED|First Neuromuscular Blocking Agent:||18
7758036|NCT01441960|19102200|P2|STARTED|First Neuromuscular Blocking Agent:||19
7758037|NCT01441960|19102201|P1|STARTED|First Neuromuscular Blocking Agent:||26
7758038|NCT01441882|19102211|P1|NOT COMPLETED|Overall Study||6
7758039|NCT01441882|19102211|P1|COMPLETED|Overall Study||13
7758040|NCT01441882|19102211|P1|STARTED|Overall Study||19
7758041|NCT01441843|19102217|P2|NOT COMPLETED|Overall Study||5
7758042|NCT01441843|19102218|P1|NOT COMPLETED|Overall Study||12
7758043|NCT01441843|19102217|P2|COMPLETED|Overall Study||195
7758044|NCT01441843|19102218|P1|COMPLETED|Overall Study||188
7758045|NCT01441843|19102217|P2|STARTED|Overall Study||200
7758046|NCT01441843|19102218|P1|STARTED|Overall Study||200
7758047|NCT01441765|19102226|P2|NOT COMPLETED|Overall Study||0
7758048|NCT01441765|19102227|P1|NOT COMPLETED|Overall Study||1
7758049|NCT01441765|19102226|P2|COMPLETED|Overall Study|not opened|0
7758050|NCT01441765|19102227|P1|COMPLETED|Overall Study||10
7758051|NCT01441765|19102226|P2|STARTED|Overall Study|not opened|0
7758052|NCT01441765|19102227|P1|STARTED|Overall Study||11
7758053|NCT01441635|19102251|P10|NOT COMPLETED|Overall Study||2
7758054|NCT01441635|19102252|P9|NOT COMPLETED|Overall Study||2
7758055|NCT01441635|19102253|P8|NOT COMPLETED|Overall Study||4
7758056|NCT01441635|19102254|P7|NOT COMPLETED|Overall Study||6
7758057|NCT01441635|19102255|P6|NOT COMPLETED|Overall Study||5
7758058|NCT01441635|19102256|P5|NOT COMPLETED|Overall Study||2
7758059|NCT01441635|19102257|P4|NOT COMPLETED|Overall Study||7
7758060|NCT01441635|19102258|P3|NOT COMPLETED|Overall Study||3
7758061|NCT01441635|19102259|P2|NOT COMPLETED|Overall Study||6
7758062|NCT01441635|19102260|P1|NOT COMPLETED|Overall Study||6
7758063|NCT01441635|19102251|P10|COMPLETED|Overall Study||25
7758064|NCT01441635|19102252|P9|COMPLETED|Overall Study||14
7758065|NCT01441635|19102253|P8|COMPLETED|Overall Study||26
7758066|NCT01441635|19102254|P7|COMPLETED|Overall Study||24
7758067|NCT01441635|19102255|P6|COMPLETED|Overall Study||29
7758068|NCT01441635|19102256|P5|COMPLETED|Overall Study||16
7758069|NCT01441635|19102257|P4|COMPLETED|Overall Study||28
7758070|NCT01441635|19102258|P3|COMPLETED|Overall Study||13
7758071|NCT01441635|19102259|P2|COMPLETED|Overall Study||27
7758072|NCT01441635|19102260|P1|COMPLETED|Overall Study||26
7758073|NCT01441635|19102251|P10|STARTED|Overall Study||27
7758074|NCT01441635|19102252|P9|STARTED|Overall Study||16
7758075|NCT01441635|19102253|P8|STARTED|Overall Study||30
7758076|NCT01441635|19102254|P7|STARTED|Overall Study||30
7758077|NCT01441635|19102255|P6|STARTED|Overall Study||34
7758078|NCT01441635|19102256|P5|STARTED|Overall Study||18
7758079|NCT01441635|19102257|P4|STARTED|Overall Study||35
7758080|NCT01441635|19102258|P3|STARTED|Overall Study||16
7758081|NCT01441635|19102259|P2|STARTED|Overall Study||33
7758082|NCT01441635|19102260|P1|STARTED|Overall Study||32
7758083|NCT01441596|19102475|P3|NOT COMPLETED|Overall Study||4
7758084|NCT01441596|19102476|P2|NOT COMPLETED|Overall Study||3
7758085|NCT01441596|19102477|P1|NOT COMPLETED|Overall Study||4
7758086|NCT01441596|19102475|P3|COMPLETED|Overall Study||39
7758087|NCT01441596|19102476|P2|COMPLETED|Overall Study||35
7758088|NCT01441596|19102477|P1|COMPLETED|Overall Study||36
7758089|NCT01441596|19102475|P3|STARTED|Overall Study||43
7758090|NCT01441596|19102476|P2|STARTED|Overall Study||38
7758091|NCT01441596|19102477|P1|STARTED|Overall Study||40
7758092|NCT01441570|19102493|P2|NOT COMPLETED|Overall Study||0
7758093|NCT01441570|19102494|P1|NOT COMPLETED|Overall Study||0
7758094|NCT01441570|19102493|P2|COMPLETED|Overall Study||5
7758095|NCT01441570|19102494|P1|COMPLETED|Overall Study||6
7758096|NCT01441570|19102493|P2|STARTED|Overall Study||5
7758097|NCT01441570|19102494|P1|STARTED|Overall Study||6
7758098|NCT01441492|19102504|P2|NOT COMPLETED|Overall Study||28
7758099|NCT01441492|19102505|P1|NOT COMPLETED|Overall Study||27
7758100|NCT01441492|19102504|P2|COMPLETED|Overall Study||174
7758101|NCT01441492|19102505|P1|COMPLETED|Overall Study||170
7758102|NCT01441492|19102504|P2|STARTED|Overall Study||202
7758103|NCT01441492|19102505|P1|STARTED|Overall Study||197
7758104|NCT01441466|19102531|P2|NOT COMPLETED|Overall Study||0
7758105|NCT01441466|19102532|P1|NOT COMPLETED|Overall Study||0
7758106|NCT01441466|19102531|P2|COMPLETED|Overall Study||11
7758107|NCT01441466|19102532|P1|COMPLETED|Overall Study||37
7758108|NCT01441466|19102531|P2|STARTED|Overall Study||11
7758109|NCT01441466|19102532|P1|STARTED|Overall Study||37
7758110|NCT01441440|19102551|P3|NOT COMPLETED|Overall Study||22
7758111|NCT01441440|19102552|P2|NOT COMPLETED|Overall Study||23
7758112|NCT01441440|19102553|P1|NOT COMPLETED|Overall Study||17
7758113|NCT01441440|19102551|P3|COMPLETED|Overall Study||158
7758114|NCT01441440|19102552|P2|COMPLETED|Overall Study||151
7758115|NCT01441440|19102553|P1|COMPLETED|Overall Study||166
7758116|NCT01441440|19102551|P3|STARTED|Overall Study|Safety analysis set|180
7758117|NCT01441440|19102552|P2|STARTED|Overall Study|Safety analysis set|174
7758118|NCT01441440|19102553|P1|STARTED|Overall Study|Safety analysis set|183
7758119|NCT01441414|19102576|P1|NOT COMPLETED|Overall Study||15
7758120|NCT01441414|19102576|P1|COMPLETED|Overall Study||3
7758121|NCT01441414|19102576|P1|STARTED|Overall Study||18
7758122|NCT01441401|19102601|P1|NOT COMPLETED|Overall Study||0
7758123|NCT01441401|19102601|P1|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82
7758124|NCT01441401|19102601|P1|STARTED|Overall Study||82
7758125|NCT01441245|19102629|P2|NOT COMPLETED|Overall Study||0
7758126|NCT01441245|19102630|P1|NOT COMPLETED|Overall Study||0
7758127|NCT01441245|19102629|P2|COMPLETED|Overall Study||27
7758128|NCT01441245|19102630|P1|COMPLETED|Overall Study||30
7758129|NCT01441245|19102629|P2|STARTED|Overall Study||27
7758130|NCT01441245|19102630|P1|STARTED|Overall Study||30
7758131|NCT01441180|19102655|P3|NOT COMPLETED|Overall Study||3
7758132|NCT01441180|19102656|P2|NOT COMPLETED|Overall Study||1
7758133|NCT01441180|19102657|P1|NOT COMPLETED|Overall Study||1
7758134|NCT01441180|19102655|P3|COMPLETED|Overall Study||22
7758135|NCT01441180|19102656|P2|COMPLETED|Overall Study||24
7758136|NCT01441180|19102657|P1|COMPLETED|Overall Study||9
7758137|NCT01441180|19102655|P3|STARTED|Overall Study||25
7758138|NCT01441180|19102656|P2|STARTED|Overall Study||25
7758139|NCT01441180|19102657|P1|STARTED|Overall Study||10
7758140|NCT01441102|19102668|P1|NOT COMPLETED|Overall Study||3
7758141|NCT01441102|19102668|P1|COMPLETED|Overall Study||4
7758142|NCT01441102|19102668|P1|STARTED|Overall Study|Two participants withdrew prior to Month 6; therefore, two additional participants were enrolled.|7
7758143|NCT01441076|19102688|P1|NOT COMPLETED|Overall Study||2
7758144|NCT01441076|19102688|P1|COMPLETED|Overall Study||4
7758145|NCT01441076|19102688|P1|STARTED|Overall Study||6
7758146|NCT01441063|19102706|P1|NOT COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||1
7758147|NCT01441063|19102706|P1|COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||2
7758148|NCT01441063|19102706|P1|STARTED|Tocilizumab + Zidovudine /Valganciclovir||3
7758149|NCT01441063|19102706|P1|NOT COMPLETED|Tocilizumab Alone||3
7758150|NCT01441063|19102706|P1|COMPLETED|Tocilizumab Alone||5
7758151|NCT01441063|19102706|P1|STARTED|Tocilizumab Alone||8
7758152|NCT01441037|19102735|P1|NOT COMPLETED|Overall Study||0
7758153|NCT01441037|19102735|P1|COMPLETED|Overall Study||27
7758154|NCT01441037|19102735|P1|STARTED|Overall Study||27
7758155|NCT01440972|19102741|P2|NOT COMPLETED|Overall Study||2
7758156|NCT01440972|19102742|P1|NOT COMPLETED|Overall Study||3
7758157|NCT01440972|19102741|P2|COMPLETED|Overall Study||19
7758158|NCT01440972|19102742|P1|COMPLETED|Overall Study||21
7758159|NCT01440972|19102741|P2|STARTED|Overall Study||21
7758160|NCT01440972|19102742|P1|STARTED|Overall Study||24
7758161|NCT01440959|19102756|P1|NOT COMPLETED|Overall Study||0
7758162|NCT01440959|19102756|P1|COMPLETED|Overall Study||30
7758163|NCT01440959|19102756|P1|STARTED|Overall Study||30
7758164|NCT01440946|19102766|P2|NOT COMPLETED|Overall Study||1
7758165|NCT01440946|19102767|P1|NOT COMPLETED|Overall Study||2
7758166|NCT01440946|19102766|P2|COMPLETED|Overall Study||14
7758167|NCT01440946|19102767|P1|COMPLETED|Overall Study||13
7758168|NCT01440946|19102766|P2|STARTED|Overall Study||15
7758169|NCT01440946|19102767|P1|STARTED|Overall Study||15
7758170|NCT01440881|19102806|P2|NOT COMPLETED|Overall Study||1
7758171|NCT01440881|19102807|P1|NOT COMPLETED|Overall Study||0
7758172|NCT01440881|19102806|P2|COMPLETED|Overall Study||14
7758173|NCT01440881|19102807|P1|COMPLETED|Overall Study||14
7758174|NCT01440881|19102806|P2|STARTED|Overall Study||15
7758175|NCT01440881|19102807|P1|STARTED|Overall Study||14
7758176|NCT01440816|19102821|P2|NOT COMPLETED|Overall Study||11
7758177|NCT01440816|19102822|P1|NOT COMPLETED|Overall Study||1
7758178|NCT01440816|19102821|P2|COMPLETED|Overall Study||1
7758179|NCT01440816|19102822|P1|COMPLETED|Overall Study||2
7758180|NCT01440816|19102821|P2|STARTED|Overall Study||12
7758181|NCT01440816|19102822|P1|STARTED|Overall Study||3
7758182|NCT01440803|19102838|P2|NOT COMPLETED|Overall Study||4
7758183|NCT01440803|19102839|P1|NOT COMPLETED|Overall Study||2
7758184|NCT01440803|19102838|P2|COMPLETED|Overall Study||24
7758185|NCT01440803|19102839|P1|COMPLETED|Overall Study||11
7758186|NCT01440803|19102838|P2|Period 3 - Forteo Open Label|Overall Study||27
7758187|NCT01440803|19102839|P1|Period 3 - Forteo Open Label|Overall Study||13
7758188|NCT01440803|19102838|P2|Period 2 - Forteo/Forteo|Overall Study||28
7758189|NCT01440803|19102839|P1|Period 2 - Forteo/Forteo|Overall Study||13
7758190|NCT01440803|19102838|P2|Period 1 - Forteo/Placebo|Overall Study||28
7758191|NCT01440803|19102839|P1|Period 1 - Forteo/Placebo|Overall Study||13
7758192|NCT01440803|19102838|P2|STARTED|Overall Study||28
7758193|NCT01440803|19102839|P1|STARTED|Overall Study||13
7758194|NCT01440764|19102848|P7|NOT COMPLETED|Test Day 3||0
7758195|NCT01440764|19102849|P6|NOT COMPLETED|Test Day 3||0
7758196|NCT01440764|19102850|P5|NOT COMPLETED|Test Day 3||0
7758197|NCT01440764|19102851|P4|NOT COMPLETED|Test Day 3||0
7758198|NCT01440764|19102852|P3|NOT COMPLETED|Test Day 3||0
7758199|NCT01440764|19102853|P2|NOT COMPLETED|Test Day 3||0
7758200|NCT01440764|19102854|P1|NOT COMPLETED|Test Day 3||0
7758201|NCT01440764|19102848|P7|COMPLETED|Test Day 3||3
7758202|NCT01440764|19102849|P6|COMPLETED|Test Day 3||5
7758203|NCT01440764|19102850|P5|COMPLETED|Test Day 3||3
7758204|NCT01440764|19102851|P4|COMPLETED|Test Day 3||1
7758205|NCT01440764|19102852|P3|COMPLETED|Test Day 3||6
7758206|NCT01440764|19102853|P2|COMPLETED|Test Day 3||2
7758207|NCT01440764|19102854|P1|COMPLETED|Test Day 3||3
7758208|NCT01440764|19102848|P7|STARTED|Test Day 3||3
7758209|NCT01440764|19102849|P6|STARTED|Test Day 3||5
7758210|NCT01440764|19102850|P5|STARTED|Test Day 3||3
7758211|NCT01440764|19102851|P4|STARTED|Test Day 3||1
7758212|NCT01440764|19102852|P3|STARTED|Test Day 3||6
7758213|NCT01440764|19102853|P2|STARTED|Test Day 3||2
7758214|NCT01440764|19102854|P1|STARTED|Test Day 3||3
7758215|NCT01440764|19102848|P7|NOT COMPLETED|Test Day 2||0
7758216|NCT01440764|19102849|P6|NOT COMPLETED|Test Day 2||0
7758217|NCT01440764|19102850|P5|NOT COMPLETED|Test Day 2||0
7758218|NCT01440764|19102851|P4|NOT COMPLETED|Test Day 2||0
7758219|NCT01440764|19102852|P3|NOT COMPLETED|Test Day 2||0
7758220|NCT01440764|19102853|P2|NOT COMPLETED|Test Day 2||0
7758221|NCT01440764|19102854|P1|NOT COMPLETED|Test Day 2||0
7758222|NCT01440764|19102848|P7|COMPLETED|Test Day 2||3
7758223|NCT01440764|19102849|P6|COMPLETED|Test Day 2||5
7758224|NCT01440764|19102850|P5|COMPLETED|Test Day 2||3
7758225|NCT01440764|19102851|P4|COMPLETED|Test Day 2||1
7758226|NCT01440764|19102852|P3|COMPLETED|Test Day 2||6
7758227|NCT01440764|19102853|P2|COMPLETED|Test Day 2||2
7758228|NCT01440764|19102854|P1|COMPLETED|Test Day 2||3
7758229|NCT01440764|19102848|P7|STARTED|Test Day 2||3
7758230|NCT01440764|19102849|P6|STARTED|Test Day 2||5
7758231|NCT01440764|19102850|P5|STARTED|Test Day 2||3
7758232|NCT01440764|19102851|P4|STARTED|Test Day 2||1
7758233|NCT01440764|19102852|P3|STARTED|Test Day 2||6
7758234|NCT01440764|19102853|P2|STARTED|Test Day 2||2
7758235|NCT01440764|19102854|P1|STARTED|Test Day 2|Following Test Day 1, 1 subject withdrew from the study before beginning Test Day 2.|3
7758236|NCT01440764|19102848|P7|NOT COMPLETED|Test Day 1||0
7758237|NCT01440764|19102849|P6|NOT COMPLETED|Test Day 1||0
7758238|NCT01440764|19102850|P5|NOT COMPLETED|Test Day 1||0
7758239|NCT01440764|19102851|P4|NOT COMPLETED|Test Day 1||0
7758240|NCT01440764|19102852|P3|NOT COMPLETED|Test Day 1||0
7758241|NCT01440764|19102853|P2|NOT COMPLETED|Test Day 1||0
7758242|NCT01440764|19102854|P1|NOT COMPLETED|Test Day 1||0
7758243|NCT01440764|19102848|P7|COMPLETED|Test Day 1||3
7758244|NCT01440764|19102849|P6|COMPLETED|Test Day 1||5
7758245|NCT01440764|19102850|P5|COMPLETED|Test Day 1||3
7758246|NCT01440764|19102851|P4|COMPLETED|Test Day 1||1
7758247|NCT01440764|19102852|P3|COMPLETED|Test Day 1||6
7758248|NCT01440764|19102853|P2|COMPLETED|Test Day 1||2
7758249|NCT01440764|19102854|P1|COMPLETED|Test Day 1||4
7758250|NCT01440764|19102848|P7|STARTED|Test Day 1||3
7758251|NCT01440764|19102849|P6|STARTED|Test Day 1||5
7758252|NCT01440764|19102850|P5|STARTED|Test Day 1||3
7758253|NCT01440764|19102851|P4|STARTED|Test Day 1||1
7758254|NCT01440764|19102852|P3|STARTED|Test Day 1||6
7758255|NCT01440764|19102853|P2|STARTED|Test Day 1||2
7758256|NCT01440764|19102854|P1|STARTED|Test Day 1||4
7758257|NCT01440647|19102875|P2|NOT COMPLETED|Overall Study||3
7758258|NCT01440647|19102876|P1|NOT COMPLETED|Overall Study||2
7758259|NCT01440647|19102875|P2|COMPLETED|Overall Study||15
7758260|NCT01440647|19102876|P1|COMPLETED|Overall Study||14
7758261|NCT01440647|19102875|P2|STARTED|Overall Study||18
7758262|NCT01440647|19102876|P1|STARTED|Overall Study||16
7758263|NCT01440634|19102886|P2|NOT COMPLETED|Randomization Phase||10
7758264|NCT01440634|19102887|P1|NOT COMPLETED|Randomization Phase||6
7758265|NCT01440634|19102886|P2|COMPLETED|Randomization Phase||14
7758266|NCT01440634|19102887|P1|COMPLETED|Randomization Phase||24
7758267|NCT01440634|19102886|P2|STARTED|Randomization Phase||24
7758268|NCT01440634|19102887|P1|STARTED|Randomization Phase||30
7758269|NCT01440634|19102886|P2|NOT COMPLETED|Cross Sectional Phase||0
7758270|NCT01440634|19102887|P1|NOT COMPLETED|Cross Sectional Phase||0
7758271|NCT01440634|19102886|P2|COMPLETED|Cross Sectional Phase||347
7758272|NCT01440634|19102887|P1|COMPLETED|Cross Sectional Phase||0
7758273|NCT01440634|19102886|P2|STARTED|Cross Sectional Phase||347
7758274|NCT01440634|19102887|P1|STARTED|Cross Sectional Phase||0
7758275|NCT01440595|19102895|P3|NOT COMPLETED|Overall Study||1
7758276|NCT01440595|19102896|P2|NOT COMPLETED|Overall Study||3
7758277|NCT01440595|19102897|P1|NOT COMPLETED|Overall Study||1
7758278|NCT01440595|19102895|P3|COMPLETED|Overall Study||0
7758279|NCT01440595|19102896|P2|COMPLETED|Overall Study||0
7758280|NCT01440595|19102897|P1|COMPLETED|Overall Study||0
7758281|NCT01440595|19102895|P3|STARTED|Overall Study||1
7758282|NCT01440595|19102896|P2|STARTED|Overall Study||3
7758283|NCT01440595|19102897|P1|STARTED|Overall Study||1
7758284|NCT01440569|19102917|P2|NOT COMPLETED|Open-Label Rollover Phase||6
7758285|NCT01440569|19102918|P1|NOT COMPLETED|Open-Label Rollover Phase||47
7758286|NCT01440569|19102917|P2|COMPLETED|Open-Label Rollover Phase||7
7758287|NCT01440569|19102918|P1|COMPLETED|Open-Label Rollover Phase||204
7758288|NCT01440569|19102917|P2|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13
7758289|NCT01440569|19102918|P1|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251
7758290|NCT01440569|19102917|P2|NOT COMPLETED|Main Study||4
7758291|NCT01440569|19102918|P1|NOT COMPLETED|Main Study||36
7758292|NCT01440569|19102917|P2|COMPLETED|Main Study||14
7758293|NCT01440569|19102918|P1|COMPLETED|Main Study||260
7758294|NCT01440569|19102917|P2|Enrolled and Treated|Main Study||18
7758295|NCT01440569|19102918|P1|Enrolled and Treated|Main Study||295
7758296|NCT01440569|19102917|P2|STARTED|Main Study||18
7758297|NCT01440569|19102918|P1|STARTED|Main Study||296
7758298|NCT01440543|19102940|P4|NOT COMPLETED|Overall Study||6
7758299|NCT01440543|19102941|P3|NOT COMPLETED|Overall Study||2
7758300|NCT01440543|19102942|P2|NOT COMPLETED|Overall Study||4
7758301|NCT01440543|19102943|P1|NOT COMPLETED|Overall Study||4
7758302|NCT01440543|19102940|P4|COMPLETED|Overall Study||101
7758303|NCT01440543|19102941|P3|COMPLETED|Overall Study||100
7758304|NCT01440543|19102942|P2|COMPLETED|Overall Study||101
7758305|NCT01440543|19102943|P1|COMPLETED|Overall Study||102
7758306|NCT01440543|19102940|P4|STARTED|Overall Study||107
7758307|NCT01440543|19102941|P3|STARTED|Overall Study||102
7758308|NCT01440543|19102942|P2|STARTED|Overall Study||105
7758309|NCT01440543|19102943|P1|STARTED|Overall Study||106
7758310|NCT01440517|19102953|P1|NOT COMPLETED|Overall Study||1
7758311|NCT01440517|19102953|P1|COMPLETED|Overall Study||4
7758312|NCT01440517|19102953|P1|STARTED|Overall Study||5
7758313|NCT01440452|19102962|P4|NOT COMPLETED|Overall Study||0
7758314|NCT01440452|19102963|P3|NOT COMPLETED|Overall Study||0
7758315|NCT01440452|19102964|P2|NOT COMPLETED|Overall Study||0
7758316|NCT01440452|19102965|P1|NOT COMPLETED|Overall Study||0
7758317|NCT01440452|19102962|P4|COMPLETED|Overall Study||4
7758318|NCT01440452|19102963|P3|COMPLETED|Overall Study||8
7758319|NCT01440452|19102964|P2|COMPLETED|Overall Study||7
7758320|NCT01440452|19102965|P1|COMPLETED|Overall Study||6
7758321|NCT01440452|19102962|P4|STARTED|Overall Study||4
7758322|NCT01440452|19102963|P3|STARTED|Overall Study||8
7758323|NCT01440452|19102964|P2|STARTED|Overall Study||7
7758324|NCT01440452|19102965|P1|STARTED|Overall Study||6
7758325|NCT01440387|19103005|P2|NOT COMPLETED|Overall Study||0
7758326|NCT01440387|19103006|P1|NOT COMPLETED|Overall Study||0
7758327|NCT01440387|19103005|P2|COMPLETED|Overall Study||56
7758328|NCT01440387|19103006|P1|COMPLETED|Overall Study||56
7758329|NCT01440387|19103005|P2|STARTED|Overall Study||56
7758330|NCT01440387|19103006|P1|STARTED|Overall Study||56
7758331|NCT01440374|19103029|P4|NOT COMPLETED|Part 3: Extension||32
7758332|NCT01440374|19103030|P3|NOT COMPLETED|Part 3: Extension||0
7758333|NCT01440374|19103031|P2|NOT COMPLETED|Part 3: Extension||0
7758334|NCT01440374|19103032|P1|NOT COMPLETED|Part 3: Extension||0
7758335|NCT01440374|19103029|P4|COMPLETED|Part 3: Extension||27
7758336|NCT01440374|19103030|P3|COMPLETED|Part 3: Extension||0
7758337|NCT01440374|19103031|P2|COMPLETED|Part 3: Extension||0
7758338|NCT01440374|19103032|P1|COMPLETED|Part 3: Extension||0
7758339|NCT01440374|19103029|P4|STARTED|Part 3: Extension||59
7758340|NCT01440374|19103030|P3|STARTED|Part 3: Extension||0
7758341|NCT01440374|19103031|P2|STARTED|Part 3: Extension||0
7758342|NCT01440374|19103032|P1|STARTED|Part 3: Extension||0
7758343|NCT01440374|19103029|P4|NOT COMPLETED|Part 2; Double-blind Phase||0
7758344|NCT01440374|19103030|P3|NOT COMPLETED|Part 2; Double-blind Phase||55
7758345|NCT01440374|19103031|P2|NOT COMPLETED|Part 2; Double-blind Phase||20
7758346|NCT01440374|19103032|P1|NOT COMPLETED|Part 2; Double-blind Phase||0
7758347|NCT01440374|19103029|P4|COMPLETED|Part 2; Double-blind Phase||0
7758348|NCT01440374|19103030|P3|COMPLETED|Part 2; Double-blind Phase||43
7758349|NCT01440374|19103031|P2|COMPLETED|Part 2; Double-blind Phase||27
7758350|NCT01440374|19103032|P1|COMPLETED|Part 2; Double-blind Phase||0
7758351|NCT01440374|19103029|P4|STARTED|Part 2; Double-blind Phase||0
7758352|NCT01440374|19103030|P3|STARTED|Part 2; Double-blind Phase||98
7758353|NCT01440374|19103031|P2|STARTED|Part 2; Double-blind Phase||47
7758354|NCT01440374|19103032|P1|STARTED|Part 2; Double-blind Phase||0
7758355|NCT01440374|19103029|P4|NOT COMPLETED|Part 1: Open-label Phase||0
7758356|NCT01440374|19103030|P3|NOT COMPLETED|Part 1: Open-label Phase||0
7758357|NCT01440374|19103031|P2|NOT COMPLETED|Part 1: Open-label Phase||0
7758358|NCT01440374|19103032|P1|NOT COMPLETED|Part 1: Open-label Phase||6
7758359|NCT01440374|19103029|P4|COMPLETED|Part 1: Open-label Phase||0
7758360|NCT01440374|19103030|P3|COMPLETED|Part 1: Open-label Phase||0
7758361|NCT01440374|19103031|P2|COMPLETED|Part 1: Open-label Phase||0
7758362|NCT01440374|19103032|P1|COMPLETED|Part 1: Open-label Phase||11
7758363|NCT01440374|19103029|P4|STARTED|Part 1: Open-label Phase||0
7758364|NCT01440374|19103030|P3|STARTED|Part 1: Open-label Phase||0
7758365|NCT01440374|19103031|P2|STARTED|Part 1: Open-label Phase||0
7758366|NCT01440374|19103032|P1|STARTED|Part 1: Open-label Phase||17
7758367|NCT01440322|19103067|P2|NOT COMPLETED|Overall Study||1
7758368|NCT01440322|19103068|P1|NOT COMPLETED|Overall Study||7
7758369|NCT01440322|19103067|P2|COMPLETED|Overall Study||49
7758370|NCT01440322|19103068|P1|COMPLETED|Overall Study||90
7758371|NCT01440322|19103067|P2|STARTED|Overall Study||50
7758372|NCT01440322|19103068|P1|STARTED|Overall Study||97
7758373|NCT01440283|19103090|P1|NOT COMPLETED|Overall Study||10
7758374|NCT01440283|19103090|P1|COMPLETED|Overall Study||4
7758375|NCT01440283|19103090|P1|STARTED|Overall Study||14
7758376|NCT01440101|19103105|P3|NOT COMPLETED|Overall Study||1
7758377|NCT01440101|19103106|P2|NOT COMPLETED|Overall Study||4
7758378|NCT01440101|19103107|P1|NOT COMPLETED|Overall Study||2
7758379|NCT01440101|19103105|P3|COMPLETED|Overall Study||46
7758380|NCT01440101|19103106|P2|COMPLETED|Overall Study||43
7758381|NCT01440101|19103107|P1|COMPLETED|Overall Study||10
7758382|NCT01440101|19103105|P3|STARTED|Overall Study||47
7758383|NCT01440101|19103106|P2|STARTED|Overall Study||47
7758384|NCT01440101|19103107|P1|STARTED|Overall Study||12
7758385|NCT01440049|19103140|P1|NOT COMPLETED|Overall Study||5
7758386|NCT01440049|19103140|P1|COMPLETED|Overall Study||155
7758387|NCT01440049|19103140|P1|STARTED|Overall Study||160
7758388|NCT01439971|19103172|P5|NOT COMPLETED|Overall Study||1
7758389|NCT01439971|19103173|P4|NOT COMPLETED|Overall Study||0
7758390|NCT01439971|19103174|P3|NOT COMPLETED|Overall Study||2
7758391|NCT01439971|19103175|P2|NOT COMPLETED|Overall Study||1
7758392|NCT01439971|19103176|P1|NOT COMPLETED|Overall Study||0
7758393|NCT01439971|19103172|P5|COMPLETED|Overall Study||6
7758394|NCT01439971|19103173|P4|COMPLETED|Overall Study||6
7758395|NCT01439971|19103174|P3|COMPLETED|Overall Study||6
7758396|NCT01439971|19103175|P2|COMPLETED|Overall Study||6
7758397|NCT01439971|19103176|P1|COMPLETED|Overall Study||1
7758398|NCT01439971|19103172|P5|Received Treatment|Overall Study||6
7758399|NCT01439971|19103173|P4|Received Treatment|Overall Study||6
7758400|NCT01439971|19103174|P3|Received Treatment|Overall Study||6
7758401|NCT01439971|19103175|P2|Received Treatment|Overall Study||6
7758402|NCT01439971|19103176|P1|Received Treatment|Overall Study||1
7758403|NCT01439971|19103172|P5|STARTED|Overall Study||7
7758404|NCT01439971|19103173|P4|STARTED|Overall Study||6
7758405|NCT01439971|19103174|P3|STARTED|Overall Study||8
7758406|NCT01439971|19103175|P2|STARTED|Overall Study||7
7758407|NCT01439971|19103176|P1|STARTED|Overall Study||1
7758408|NCT01439945|19103356|P4|NOT COMPLETED|Optional Continuation Phase||0
7758409|NCT01439945|19103357|P3|NOT COMPLETED|Optional Continuation Phase||0
7758410|NCT01439945|19103358|P2|NOT COMPLETED|Optional Continuation Phase||0
7758411|NCT01439945|19103359|P1|NOT COMPLETED|Optional Continuation Phase||0
7758412|NCT01439945|19103356|P4|COMPLETED|Optional Continuation Phase||0
7758413|NCT01439945|19103357|P3|COMPLETED|Optional Continuation Phase||0
7758414|NCT01439945|19103358|P2|COMPLETED|Optional Continuation Phase||44
7758415|NCT01439945|19103359|P1|COMPLETED|Optional Continuation Phase||72
7758416|NCT01439945|19103356|P4|STARTED|Optional Continuation Phase||0
7758417|NCT01439945|19103357|P3|STARTED|Optional Continuation Phase||0
7758418|NCT01439945|19103358|P2|STARTED|Optional Continuation Phase||44
7758419|NCT01439945|19103359|P1|STARTED|Optional Continuation Phase||72
7758420|NCT01439945|19103356|P4|NOT COMPLETED|Double-Blind Treatment Phase||2
7758421|NCT01439945|19103357|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
7758422|NCT01439945|19103358|P2|NOT COMPLETED|Double-Blind Treatment Phase||5
7758423|NCT01439945|19103359|P1|NOT COMPLETED|Double-Blind Treatment Phase||4
7758424|NCT01439945|19103356|P4|COMPLETED|Double-Blind Treatment Phase||46
7758425|NCT01439945|19103357|P3|COMPLETED|Double-Blind Treatment Phase||45
7758426|NCT01439945|19103358|P2|COMPLETED|Double-Blind Treatment Phase||91
7758427|NCT01439945|19103359|P1|COMPLETED|Double-Blind Treatment Phase||93
7758428|NCT01439945|19103356|P4|STARTED|Double-Blind Treatment Phase||48
7758429|NCT01439945|19103357|P3|STARTED|Double-Blind Treatment Phase||48
7758430|NCT01439945|19103358|P2|STARTED|Double-Blind Treatment Phase||96
7758431|NCT01439945|19103359|P1|STARTED|Double-Blind Treatment Phase||97
7758432|NCT01439880|19103384|P2|NOT COMPLETED|All-IP Period (Years 2 to 5)||140
7758433|NCT01439880|19103385|P1|NOT COMPLETED|All-IP Period (Years 2 to 5)||70
7758434|NCT01439880|19103384|P2|COMPLETED|All-IP Period (Years 2 to 5)||682
7758435|NCT01439880|19103385|P1|COMPLETED|All-IP Period (Years 2 to 5)||328
7758436|NCT01439880|19103384|P2|Received Evolocumab|All-IP Period (Years 2 to 5)||777
7758437|NCT01439880|19103385|P1|Received Evolocumab|All-IP Period (Years 2 to 5)||374
7758438|NCT01439880|19103384|P2|STARTED|All-IP Period (Years 2 to 5)||822
7758439|NCT01439880|19103385|P1|STARTED|All-IP Period (Years 2 to 5)||398
7758440|NCT01439880|19103384|P2|NOT COMPLETED|SOC-controlled Period (Year 1)||60
7758441|NCT01439880|19103385|P1|NOT COMPLETED|SOC-controlled Period (Year 1)||44
7758442|NCT01439880|19103384|P2|COMPLETED|SOC-controlled Period (Year 1)||822
7758443|NCT01439880|19103385|P1|COMPLETED|SOC-controlled Period (Year 1)||398
7758444|NCT01439880|19103384|P2|Received Evolocumab|SOC-controlled Period (Year 1)||881
7758445|NCT01439880|19103385|P1|Received Evolocumab|SOC-controlled Period (Year 1)||0
7758446|NCT01439880|19103384|P2|STARTED|SOC-controlled Period (Year 1)||882
7758447|NCT01439880|19103385|P1|STARTED|SOC-controlled Period (Year 1)||442
7758448|NCT01439867|19103428|P2|NOT COMPLETED|Overall Study||8
7758449|NCT01439867|19103429|P1|NOT COMPLETED|Overall Study||6
7758450|NCT01439867|19103428|P2|COMPLETED|Overall Study||2
7758451|NCT01439867|19103429|P1|COMPLETED|Overall Study||2
7758452|NCT01439867|19103428|P2|Received Treatment|Overall Study||10
7758453|NCT01439867|19103429|P1|Received Treatment|Overall Study||7
7758454|NCT01439867|19103428|P2|STARTED|Overall Study||10
7758455|NCT01439867|19103429|P1|STARTED|Overall Study||8
7758456|NCT01439854|19103470|P2|NOT COMPLETED|Overall Study||0
7758457|NCT01439854|19103471|P1|NOT COMPLETED|Overall Study||0
7758458|NCT01439854|19103470|P2|COMPLETED|Overall Study||10
7758459|NCT01439854|19103471|P1|COMPLETED|Overall Study||8
7758460|NCT01439854|19103470|P2|STARTED|Overall Study||10
7758461|NCT01439854|19103471|P1|STARTED|Overall Study||8
7758462|NCT01439724|19103481|P2|NOT COMPLETED|Overall Study||8
7758463|NCT01439724|19103482|P1|NOT COMPLETED|Overall Study||9
7758464|NCT01439724|19103481|P2|COMPLETED|Overall Study||39
7758465|NCT01439724|19103482|P1|COMPLETED|Overall Study||38
7758466|NCT01439724|19103481|P2|STARTED|Overall Study||47
7758467|NCT01439724|19103482|P1|STARTED|Overall Study||47
7758468|NCT01439711|19103488|P1|NOT COMPLETED|Overall Study||40
7758469|NCT01439711|19103488|P1|COMPLETED|Overall Study||68
7758470|NCT01439711|19103488|P1|STARTED|Overall Study||108
7758471|NCT01439672|19103499|P1|NOT COMPLETED|Overall Study||24
7758472|NCT01439672|19103499|P1|COMPLETED|Overall Study||11
7758473|NCT01439672|19103499|P1|STARTED|Overall Study||35
7758474|NCT01439633|19103503|P1|NOT COMPLETED|Overall Study||0
7758475|NCT01439633|19103503|P1|COMPLETED|Overall Study||22
7758476|NCT01439633|19103503|P1|STARTED|Overall Study||22
7758477|NCT01439620|19103507|P1|NOT COMPLETED|Overall Study||0
7758478|NCT01439620|19103507|P1|COMPLETED|Overall Study||7
7758479|NCT01439620|19103507|P1|STARTED|Overall Study||7
7758480|NCT01439594|19103511|P1|NOT COMPLETED|Overall Study||0
7758481|NCT01439594|19103511|P1|COMPLETED|Overall Study||17
7758482|NCT01439594|19103511|P1|STARTED|Overall Study||17
7758483|NCT01439581|19103517|P2|NOT COMPLETED|Overall Study||0
7758484|NCT01439581|19103518|P1|NOT COMPLETED|Overall Study||0
7758485|NCT01439581|19103517|P2|COMPLETED|Overall Study||212
7758486|NCT01439581|19103518|P1|COMPLETED|Overall Study||216
7758487|NCT01439581|19103517|P2|STARTED|Overall Study||212
7758488|NCT01439581|19103518|P1|STARTED|Overall Study||216
7758489|NCT01439568|19103526|P2|NOT COMPLETED|Overall Study||2
7758490|NCT01439568|19103527|P1|NOT COMPLETED|Overall Study||3
7758491|NCT01439568|19103526|P2|COMPLETED|Overall Study||41
7758492|NCT01439568|19103527|P1|COMPLETED|Overall Study||44
7758493|NCT01439568|19103526|P2|Received at Least One Dose of Study Drug|Overall Study||43
7758494|NCT01439568|19103527|P1|Received at Least One Dose of Study Drug|Overall Study||47
7758495|NCT01439568|19103526|P2|STARTED|Overall Study||43
7758496|NCT01439568|19103527|P1|STARTED|Overall Study||47
7758497|NCT01439555|19103539|P1|NOT COMPLETED|Overall Study||1
7758498|NCT01439555|19103539|P1|COMPLETED|Overall Study||10
7758499|NCT01439555|19103539|P1|STARTED|Overall Study||11
7758500|NCT01439373|19103551|P2|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||0
7758501|NCT01439373|19103552|P1|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||2
7758502|NCT01439373|19103551|P2|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||4
7758503|NCT01439373|19103552|P1|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||9
7758504|NCT01439373|19103551|P2|STARTED|Combined With PEG and RIBA (Day 2 to 28)||4
7758505|NCT01439373|19103552|P1|STARTED|Combined With PEG and RIBA (Day 2 to 28)||11
7758506|NCT01439373|19103551|P2|NOT COMPLETED|Monotherapy (Day 1)||1
7758507|NCT01439373|19103552|P1|NOT COMPLETED|Monotherapy (Day 1)||0
7758508|NCT01439373|19103551|P2|COMPLETED|Monotherapy (Day 1)||4
7758509|NCT01439373|19103552|P1|COMPLETED|Monotherapy (Day 1)||11
7758510|NCT01439373|19103551|P2|STARTED|Monotherapy (Day 1)||5
7758511|NCT01439373|19103552|P1|STARTED|Monotherapy (Day 1)||11
7758512|NCT01439360|19103595|P2|NOT COMPLETED|Overall Study||208
7758513|NCT01439360|19103596|P1|NOT COMPLETED|Overall Study||198
7758514|NCT01439360|19103595|P2|COMPLETED|Overall Study||5804
7758515|NCT01439360|19103596|P1|COMPLETED|Overall Study||5808
7758516|NCT01439360|19103595|P2|STARTED|Overall Study||6012
7758517|NCT01439360|19103596|P1|STARTED|Overall Study||6006
7758518|NCT01439282|19103646|P2|NOT COMPLETED|Overall Study||1
7758519|NCT01439282|19103647|P1|NOT COMPLETED|Overall Study||8
7758520|NCT01439282|19103646|P2|COMPLETED|Overall Study||9
7758521|NCT01439282|19103647|P1|COMPLETED|Overall Study||59
7758522|NCT01439282|19103646|P2|STARTED|Overall Study||10
7758523|NCT01439282|19103647|P1|STARTED|Overall Study||67
7758524|NCT01439204|19103659|P2|NOT COMPLETED|Overall Study||3
7758525|NCT01439204|19103660|P1|NOT COMPLETED|Overall Study||4
7758526|NCT01439204|19103659|P2|COMPLETED|Overall Study||33
7758527|NCT01439204|19103660|P1|COMPLETED|Overall Study||32
7758528|NCT01439204|19103659|P2|STARTED|Overall Study||36
7758529|NCT01439204|19103660|P1|STARTED|Overall Study||36
7758530|NCT01439165|19103694|P2|NOT COMPLETED|Overall Study||2
7758531|NCT01439165|19103695|P1|NOT COMPLETED|Overall Study||21
7758532|NCT01439165|19103694|P2|COMPLETED|Overall Study||326
7758533|NCT01439165|19103695|P1|COMPLETED|Overall Study||981
7758534|NCT01439165|19103694|P2|STARTED|Overall Study||328
7758535|NCT01439165|19103695|P1|STARTED|Overall Study||1002
7758536|NCT01439126|19103709|P2|NOT COMPLETED|Overall Study||42
7758537|NCT01439126|19103710|P1|NOT COMPLETED|Overall Study||31
7758538|NCT01439126|19103709|P2|COMPLETED|Overall Study||25
7758539|NCT01439126|19103710|P1|COMPLETED|Overall Study||37
7758540|NCT01439126|19103709|P2|STARTED|Overall Study||67
7758541|NCT01439126|19103710|P1|STARTED|Overall Study||68
7758542|NCT01439087|19103730|P1|NOT COMPLETED|Overall Study||0
7758543|NCT01439087|19103730|P1|COMPLETED|Overall Study||2
7758544|NCT01439087|19103730|P1|STARTED|Overall Study||2
7758545|NCT01439074|19103736|P2|NOT COMPLETED|Overall Study||13
7758546|NCT01439074|19103737|P1|NOT COMPLETED|Overall Study||9
7758547|NCT01439074|19103736|P2|COMPLETED|Overall Study||74
7758548|NCT01439074|19103737|P1|COMPLETED|Overall Study||66
7758549|NCT01439074|19103736|P2|STARTED|Overall Study||87
7758550|NCT01439074|19103737|P1|STARTED|Overall Study||75
7758551|NCT01439035|19103749|P1|NOT COMPLETED|Overall Study||0
7758552|NCT01439035|19103749|P1|COMPLETED|Overall Study||6
7758553|NCT01439035|19103749|P1|STARTED|Overall Study||6
7758554|NCT01439009|19103755|P2|NOT COMPLETED|Overall Study||3
7758555|NCT01439009|19103756|P1|NOT COMPLETED|Overall Study||8
7758556|NCT01439009|19103755|P2|COMPLETED|Overall Study||47
7758557|NCT01439009|19103756|P1|COMPLETED|Overall Study||42
7758558|NCT01439009|19103755|P2|STARTED|Overall Study||50
7758559|NCT01439009|19103756|P1|STARTED|Overall Study||50
7758560|NCT01438996|19103789|P3|NOT COMPLETED|Overall Study||0
7758561|NCT01438996|19103790|P2|NOT COMPLETED|Overall Study||1
7758562|NCT01438996|19103791|P1|NOT COMPLETED|Overall Study||4
7758563|NCT01438996|19103789|P3|COMPLETED|Overall Study||20
7758564|NCT01438996|19103790|P2|COMPLETED|Overall Study||12
7758565|NCT01438996|19103791|P1|COMPLETED|Overall Study||14
7758566|NCT01438996|19103789|P3|STARTED|Overall Study||20
7758567|NCT01438996|19103790|P2|STARTED|Overall Study||13
7758568|NCT01438996|19103791|P1|STARTED|Overall Study||18
7758569|NCT01438840|19103825|P3|NOT COMPLETED|Extension Phase||10
7758570|NCT01438840|19103826|P2|NOT COMPLETED|Extension Phase||0
7758571|NCT01438840|19103827|P1|NOT COMPLETED|Extension Phase||0
7758572|NCT01438840|19103825|P3|COMPLETED|Extension Phase||29
7758573|NCT01438840|19103826|P2|COMPLETED|Extension Phase||0
7758574|NCT01438840|19103827|P1|COMPLETED|Extension Phase||0
7758575|NCT01438840|19103825|P3|STARTED|Extension Phase|39 participants met eligibility criteria for the Extension Phase.|39
7758576|NCT01438840|19103826|P2|STARTED|Extension Phase||0
7758577|NCT01438840|19103827|P1|STARTED|Extension Phase||0
7758578|NCT01438840|19103825|P3|NOT COMPLETED|Core Study||0
7758579|NCT01438840|19103826|P2|NOT COMPLETED|Core Study||10
7758580|NCT01438840|19103827|P1|NOT COMPLETED|Core Study||16
7758581|NCT01438840|19103825|P3|COMPLETED|Core Study||0
7758582|NCT01438840|19103826|P2|COMPLETED|Core Study||22
7758583|NCT01438840|19103827|P1|COMPLETED|Core Study||1
7758584|NCT01438840|19103825|P3|STARTED|Core Study||0
7758585|NCT01438840|19103826|P2|STARTED|Core Study||32
7758586|NCT01438840|19103827|P1|STARTED|Core Study||17
7758587|NCT01438814|19103840|P2|NOT COMPLETED|Overall Study||14
7758588|NCT01438814|19103841|P1|NOT COMPLETED|Overall Study||14
7758589|NCT01438814|19103840|P2|COMPLETED|Overall Study||331
7758590|NCT01438814|19103841|P1|COMPLETED|Overall Study||330
7758591|NCT01438814|19103840|P2|STARTED|Overall Study||345
7758592|NCT01438814|19103841|P1|STARTED|Overall Study||344
7758593|NCT01438710|19103871|P2|NOT COMPLETED|Second Week of Treatment||0
7758594|NCT01438710|19103872|P1|NOT COMPLETED|Second Week of Treatment||1
7758595|NCT01438710|19103871|P2|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
7758596|NCT01438710|19103872|P1|COMPLETED|Second Week of Treatment||40
7758597|NCT01438710|19103871|P2|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
7758598|NCT01438710|19103872|P1|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41
7758599|NCT01438710|19103871|P2|NOT COMPLETED|First Week of Treatment||3
7758600|NCT01438710|19103872|P1|NOT COMPLETED|First Week of Treatment||0
7758601|NCT01438710|19103871|P2|COMPLETED|First Week of Treatment||41
7758602|NCT01438710|19103872|P1|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
7758603|NCT01438710|19103871|P2|STARTED|First Week of Treatment||44
7758604|NCT01438710|19103872|P1|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
7758605|NCT01438541|19103877|P1|NOT COMPLETED|Overall Study||7
7758606|NCT01438541|19103877|P1|COMPLETED|Overall Study||22
7758607|NCT01438541|19103877|P1|STARTED|Overall Study||29
7758608|NCT01438489|19103886|P3|NOT COMPLETED|Overall Study||19
7758609|NCT01438489|19103887|P2|NOT COMPLETED|Overall Study||16
7758610|NCT01438489|19103888|P1|NOT COMPLETED|Overall Study||26
7758611|NCT01438489|19103886|P3|COMPLETED|Overall Study||85
7758612|NCT01438489|19103887|P2|COMPLETED|Overall Study||84
7758613|NCT01438489|19103888|P1|COMPLETED|Overall Study||77
7758614|NCT01438489|19103886|P3|STARTED|Overall Study||104
7758615|NCT01438489|19103887|P2|STARTED|Overall Study||100
7758616|NCT01438489|19103888|P1|STARTED|Overall Study||103
7758617|NCT01438476|19103933|P2|NOT COMPLETED|Overall Study||11
7758618|NCT01438476|19103934|P1|NOT COMPLETED|Overall Study||10
7758619|NCT01438476|19103933|P2|COMPLETED|Overall Study||34
7758620|NCT01438476|19103934|P1|COMPLETED|Overall Study||106
7758621|NCT01438476|19103933|P2|STARTED|Overall Study||45
7758622|NCT01438476|19103934|P1|STARTED|Overall Study||116
7758623|NCT01438424|19103940|P1|NOT COMPLETED|Overall Study||417
7758624|NCT01438424|19103940|P1|COMPLETED|Overall Study|Completed treatment|634
7758625|NCT01438424|19103940|P1|STARTED|Overall Study|Received treatment|1051
7758626|NCT01438411|19103976|P1|NOT COMPLETED|Overall Study||13
7758627|NCT01438411|19103976|P1|COMPLETED|Overall Study||40
7758628|NCT01438411|19103976|P1|STARTED|Overall Study||53
7758629|NCT01438307|19103991|P2|NOT COMPLETED|Overall Study||1
7758630|NCT01438307|19103992|P1|NOT COMPLETED|Overall Study||1
7758631|NCT01438307|19103991|P2|COMPLETED|Overall Study||13
7758632|NCT01438307|19103992|P1|COMPLETED|Overall Study||13
7758633|NCT01438307|19103991|P2|STARTED|Overall Study||14
7758634|NCT01438307|19103992|P1|STARTED|Overall Study||14
7758635|NCT01438294|19104006|P2|NOT COMPLETED|Overall Study||7
7758636|NCT01438294|19104007|P1|NOT COMPLETED|Overall Study||3
7758637|NCT01438294|19104006|P2|COMPLETED|Overall Study||13
7758638|NCT01438294|19104007|P1|COMPLETED|Overall Study||13
7758639|NCT01438294|19104006|P2|STARTED|Overall Study||20
7758640|NCT01438294|19104007|P1|STARTED|Overall Study||16
7758641|NCT01438229|19104017|P1|NOT COMPLETED|Overall Study||3
7758642|NCT01438229|19104017|P1|COMPLETED|Overall Study||44
7758643|NCT01438229|19104017|P1|Underwent Procedure|Overall Study||46
7758644|NCT01438229|19104017|P1|Excluded Due to Renal Artery Anatomy|Overall Study||1
7758645|NCT01438229|19104017|P1|STARTED|Overall Study||47
7758646|NCT01438177|19104050|P1|NOT COMPLETED|Overall Study||2
7758647|NCT01438177|19104050|P1|COMPLETED|Overall Study|Patients who were off due to disease progression|9
7758648|NCT01438177|19104050|P1|STARTED|Overall Study||11
7758649|NCT01438151|19104057|P1|NOT COMPLETED|Overall Study||8
7758650|NCT01438151|19104057|P1|COMPLETED|Overall Study||3
7758651|NCT01438151|19104057|P1|STARTED|Overall Study||11
7758652|NCT01438060|19104063|P2|NOT COMPLETED|On Study Beyond Week 140||8
7758653|NCT01438060|19104064|P1|NOT COMPLETED|On Study Beyond Week 140||0
7758654|NCT01438060|19104063|P2|COMPLETED|On Study Beyond Week 140||1
7758655|NCT01438060|19104064|P1|COMPLETED|On Study Beyond Week 140||0
7758656|NCT01438060|19104063|P2|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9
7758657|NCT01438060|19104064|P1|STARTED|On Study Beyond Week 140||0
7758658|NCT01438060|19104063|P2|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56
7758659|NCT01438060|19104064|P1|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58
7758660|NCT01438060|19104063|P2|COMPLETED|Extension Phase: Week 10 to Week 130||25
7758661|NCT01438060|19104064|P1|COMPLETED|Extension Phase: Week 10 to Week 130||22
7758662|NCT01438060|19104063|P2|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81
7758663|NCT01438060|19104064|P1|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80
7758664|NCT01438060|19104063|P2|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
7758665|NCT01438060|19104064|P1|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
7758666|NCT01438060|19104063|P2|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88
7758667|NCT01438060|19104064|P1|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84
7758668|NCT01438060|19104063|P2|STARTED|Acute Phase: Double-blind, 10 Weeks||106
7758669|NCT01438060|19104064|P1|STARTED|Acute Phase: Double-blind, 10 Weeks||102
7758670|NCT01438008|19104144|P2|NOT COMPLETED|Overall Study||0
7758671|NCT01438008|19104145|P1|NOT COMPLETED|Overall Study||0
7758672|NCT01438008|19104144|P2|COMPLETED|Overall Study||5
7758673|NCT01438008|19104145|P1|COMPLETED|Overall Study||4
7758674|NCT01438008|19104144|P2|STARTED|Overall Study||5
7758675|NCT01438008|19104145|P1|STARTED|Overall Study||4
7758676|NCT01437995|19104156|P3|NOT COMPLETED|Overall Study||20
7758677|NCT01437995|19104157|P2|NOT COMPLETED|Overall Study||18
7758678|NCT01437995|19104158|P1|NOT COMPLETED|Overall Study||11
7758679|NCT01437995|19104156|P3|COMPLETED|Overall Study||135
7758680|NCT01437995|19104157|P2|COMPLETED|Overall Study||131
7758681|NCT01437995|19104158|P1|COMPLETED|Overall Study||140
7758682|NCT01437995|19104156|P3|Included in Treatment Failure Analysis|Overall Study||151
7758683|NCT01437995|19104157|P2|Included in Treatment Failure Analysis|Overall Study||146
7758684|NCT01437995|19104158|P1|Included in Treatment Failure Analysis|Overall Study||150
7758685|NCT01437995|19104156|P3|STARTED|Overall Study||155
7758686|NCT01437995|19104157|P2|STARTED|Overall Study||149
7758687|NCT01437995|19104158|P1|STARTED|Overall Study||151
7758688|NCT01437943|19104180|P2|NOT COMPLETED|Overall Study||2
7758689|NCT01437943|19104181|P1|NOT COMPLETED|Overall Study||7
7758690|NCT01437943|19104180|P2|COMPLETED|Overall Study||1
7758691|NCT01437943|19104181|P1|COMPLETED|Overall Study||0
7758692|NCT01437943|19104180|P2|STARTED|Overall Study||3
7758693|NCT01437943|19104181|P1|STARTED|Overall Study||7
7758694|NCT01437878|19104189|P2|NOT COMPLETED|Overall Study||0
7758695|NCT01437878|19104190|P1|NOT COMPLETED|Overall Study||1
7758696|NCT01437878|19104189|P2|COMPLETED|Overall Study||1
7758697|NCT01437878|19104190|P1|COMPLETED|Overall Study||0
7758698|NCT01437878|19104189|P2|STARTED|Overall Study||1
7758699|NCT01437878|19104190|P1|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1
7758700|NCT01437852|19104230|P1|NOT COMPLETED|Overall Study||0
7758701|NCT01437852|19104230|P1|COMPLETED|Overall Study||30
7758702|NCT01437852|19104230|P1|Received Autograft|Overall Study||30
7758703|NCT01437852|19104230|P1|Received StrataGraft Skin Tissue|Overall Study||30
7758704|NCT01437852|19104230|P1|STARTED|Overall Study||30
7758705|NCT01437605|19104238|P2|NOT COMPLETED|Overall Study||0
7758706|NCT01437605|19104239|P1|NOT COMPLETED|Overall Study||0
7758707|NCT01437605|19104238|P2|COMPLETED|Overall Study||5
7758708|NCT01437605|19104239|P1|COMPLETED|Overall Study||9
7758709|NCT01437605|19104238|P2|STARTED|Overall Study||5
7758710|NCT01437605|19104239|P1|STARTED|Overall Study||9
7758711|NCT01437540|19104257|P2|NOT COMPLETED|Overall Study||65
7758712|NCT01437540|19104258|P1|NOT COMPLETED|Overall Study||127
7758713|NCT01437540|19104257|P2|COMPLETED|Overall Study||133
7758714|NCT01437540|19104258|P1|COMPLETED|Overall Study||265
7758715|NCT01437540|19104257|P2|STARTED|Overall Study||198
7758716|NCT01437540|19104258|P1|STARTED|Overall Study||392
7758717|NCT01437501|19104272|P2|NOT COMPLETED|Overall Study||11
7758718|NCT01437501|19104273|P1|NOT COMPLETED|Overall Study||13
7758719|NCT01437501|19104272|P2|COMPLETED|Overall Study||132
7758720|NCT01437501|19104273|P1|COMPLETED|Overall Study||135
7758721|NCT01437501|19104272|P2|STARTED|Overall Study||143
7758722|NCT01437501|19104273|P1|STARTED|Overall Study||148
7758723|NCT01437488|19104281|P1|NOT COMPLETED|Overall Study||0
7758724|NCT01437488|19104281|P1|COMPLETED|Overall Study||14
7758725|NCT01437488|19104281|P1|STARTED|Overall Study||14
7758726|NCT01437449|19104288|P1|NOT COMPLETED|Overall Study||0
7758727|NCT01437449|19104288|P1|COMPLETED|Overall Study||27
7758728|NCT01437449|19104288|P1|STARTED|Overall Study||27
7758729|NCT01437423|19104295|P1|NOT COMPLETED|Overall Study||15
7758730|NCT01437423|19104295|P1|COMPLETED|Overall Study||647
7758731|NCT01437423|19104295|P1|STARTED|Overall Study||662
7758732|NCT01437397|19104307|P5|NOT COMPLETED|Overall Study||101
7758733|NCT01437397|19104308|P4|NOT COMPLETED|Overall Study||69
7758734|NCT01437397|19104309|P3|NOT COMPLETED|Overall Study||72
7758735|NCT01437397|19104310|P2|NOT COMPLETED|Overall Study||62
7758736|NCT01437397|19104311|P1|NOT COMPLETED|Overall Study||66
7758737|NCT01437397|19104307|P5|COMPLETED|Overall Study||236
7758738|NCT01437397|19104308|P4|COMPLETED|Overall Study||270
7758739|NCT01437397|19104309|P3|COMPLETED|Overall Study||268
7758740|NCT01437397|19104310|P2|COMPLETED|Overall Study||276
7758741|NCT01437397|19104311|P1|COMPLETED|Overall Study||272
7758742|NCT01437397|19104307|P5|STARTED|Overall Study||337
7758743|NCT01437397|19104308|P4|STARTED|Overall Study||339
7758744|NCT01437397|19104309|P3|STARTED|Overall Study||340
7758745|NCT01437397|19104310|P2|STARTED|Overall Study||338
7758746|NCT01437397|19104311|P1|STARTED|Overall Study||338
7758747|NCT01437319|19104338|P3|NOT COMPLETED|Phase II||37
7758748|NCT01437319|19104339|P2|NOT COMPLETED|Phase II||44
7758749|NCT01437319|19104340|P1|NOT COMPLETED|Phase II||0
7758750|NCT01437319|19104338|P3|COMPLETED|Phase II||75
7758751|NCT01437319|19104339|P2|COMPLETED|Phase II||71
7758752|NCT01437319|19104340|P1|COMPLETED|Phase II||0
7758753|NCT01437319|19104338|P3|STARTED|Phase II||112
7758754|NCT01437319|19104339|P2|STARTED|Phase II||115
7758755|NCT01437319|19104340|P1|STARTED|Phase II||0
7758756|NCT01437319|19104338|P3|NOT COMPLETED|Phase I||0
7758757|NCT01437319|19104339|P2|NOT COMPLETED|Phase I||0
7758758|NCT01437319|19104340|P1|NOT COMPLETED|Phase I||55
7758759|NCT01437319|19104338|P3|COMPLETED|Phase I||0
7758760|NCT01437319|19104339|P2|COMPLETED|Phase I||0
7758761|NCT01437319|19104340|P1|COMPLETED|Phase I||227
7758762|NCT01437319|19104338|P3|STARTED|Phase I||0
7758763|NCT01437319|19104339|P2|STARTED|Phase I||0
7758764|NCT01437319|19104340|P1|STARTED|Phase I||282
7758765|NCT01437267|19104355|P6|NOT COMPLETED|Overall Study||0
7758766|NCT01437267|19104356|P5|NOT COMPLETED|Overall Study||0
7758767|NCT01437267|19104357|P4|NOT COMPLETED|Overall Study||1
7758768|NCT01437267|19104358|P3|NOT COMPLETED|Overall Study||0
7758769|NCT01437267|19104359|P2|NOT COMPLETED|Overall Study||1
7758770|NCT01437267|19104360|P1|NOT COMPLETED|Overall Study||0
7758771|NCT01437267|19104355|P6|COMPLETED|Overall Study||20
7758772|NCT01437267|19104356|P5|COMPLETED|Overall Study||20
7758773|NCT01437267|19104357|P4|COMPLETED|Overall Study||19
7758774|NCT01437267|19104358|P3|COMPLETED|Overall Study||20
7758775|NCT01437267|19104359|P2|COMPLETED|Overall Study||19
7758776|NCT01437267|19104360|P1|COMPLETED|Overall Study||20
7758777|NCT01437267|19104355|P6|STARTED|Overall Study||20
7758778|NCT01437267|19104356|P5|STARTED|Overall Study||20
7758779|NCT01437267|19104357|P4|STARTED|Overall Study||20
7758780|NCT01437267|19104358|P3|STARTED|Overall Study||20
7758781|NCT01437267|19104359|P2|STARTED|Overall Study||20
7758782|NCT01437267|19104360|P1|STARTED|Overall Study||20
7758783|NCT01437124|19104398|P1|NOT COMPLETED|Overall Study||0
7758784|NCT01437124|19104398|P1|COMPLETED|Overall Study||83
7758785|NCT01437124|19104398|P1|STARTED|Overall Study||83
7758786|NCT01437111|19104403|P1|NOT COMPLETED|Overall Study||18
7758787|NCT01437111|19104403|P1|COMPLETED|Overall Study||182
7758788|NCT01437111|19104403|P1|Treated Participants|Overall Study||198
7758789|NCT01437111|19104403|P1|STARTED|Overall Study||200
7758790|NCT01437098|19104414|P1|NOT COMPLETED|Overall Study||13
7758791|NCT01437098|19104414|P1|COMPLETED|Overall Study||42
7758792|NCT01437098|19104414|P1|36 Months|Overall Study||36
7758793|NCT01437098|19104414|P1|24 Months|Overall Study||42
7758794|NCT01437098|19104414|P1|12 Months|Overall Study||45
7758795|NCT01437098|19104414|P1|6 Months|Overall Study||47
7758796|NCT01437098|19104414|P1|30 Days|Overall Study||51
7758797|NCT01437098|19104414|P1|STARTED|Overall Study||55
7758798|NCT01436799|19104471|P2|NOT COMPLETED|Overall Study||0
7758799|NCT01436799|19104472|P1|NOT COMPLETED|Overall Study||0
7758800|NCT01436799|19104471|P2|COMPLETED|Overall Study||20
7758801|NCT01436799|19104472|P1|COMPLETED|Overall Study||20
7758802|NCT01436799|19104471|P2|STARTED|Overall Study||20
7758803|NCT01436799|19104472|P1|STARTED|Overall Study||20
7758804|NCT01436643|19104481|P4|NOT COMPLETED|Core Phase (16 Weeks)||0
7758805|NCT01436643|19104482|P3|NOT COMPLETED|Core Phase (16 Weeks)||3
7758806|NCT01436643|19104483|P2|NOT COMPLETED|Core Phase (16 Weeks)||4
7758807|NCT01436643|19104484|P1|NOT COMPLETED|Core Phase (16 Weeks)||1
7758808|NCT01436643|19104481|P4|COMPLETED|Core Phase (16 Weeks)||0
7758809|NCT01436643|19104482|P3|COMPLETED|Core Phase (16 Weeks)||17
7758810|NCT01436643|19104483|P2|COMPLETED|Core Phase (16 Weeks)||11
7758811|NCT01436643|19104484|P1|COMPLETED|Core Phase (16 Weeks)||16
7758812|NCT01436643|19104481|P4|STARTED|Core Phase (16 Weeks)||0
7758813|NCT01436643|19104482|P3|STARTED|Core Phase (16 Weeks)||20
7758814|NCT01436643|19104483|P2|STARTED|Core Phase (16 Weeks)||15
7758815|NCT01436643|19104484|P1|STARTED|Core Phase (16 Weeks)||17
7758816|NCT01436643|19104481|P4|NOT COMPLETED|2-week Pre-treatment||10
7758817|NCT01436643|19104482|P3|NOT COMPLETED|2-week Pre-treatment||0
7758818|NCT01436643|19104483|P2|NOT COMPLETED|2-week Pre-treatment||0
7758819|NCT01436643|19104484|P1|NOT COMPLETED|2-week Pre-treatment||0
7758820|NCT01436643|19104481|P4|COMPLETED|2-week Pre-treatment||44
7758821|NCT01436643|19104482|P3|COMPLETED|2-week Pre-treatment||0
7758822|NCT01436643|19104483|P2|COMPLETED|2-week Pre-treatment||0
7758823|NCT01436643|19104484|P1|COMPLETED|2-week Pre-treatment||0
7758824|NCT01436643|19104481|P4|STARTED|2-week Pre-treatment||54
7758825|NCT01436643|19104482|P3|STARTED|2-week Pre-treatment||0
7758826|NCT01436643|19104483|P2|STARTED|2-week Pre-treatment||0
7758827|NCT01436643|19104484|P1|STARTED|2-week Pre-treatment||0
7758828|NCT01436526|19104496|P2|NOT COMPLETED|Period 2||0
7758829|NCT01436526|19104497|P1|NOT COMPLETED|Period 2||0
7758830|NCT01436526|19104496|P2|COMPLETED|Period 2||13
7758831|NCT01436526|19104497|P1|COMPLETED|Period 2||13
7758832|NCT01436526|19104496|P2|Participants Received Treatment|Period 2||13
7758833|NCT01436526|19104497|P1|Participants Received Treatment|Period 2||13
7758834|NCT01436526|19104496|P2|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
7758835|NCT01436526|19104497|P1|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
7758836|NCT01436526|19104496|P2|NOT COMPLETED|Period 1||0
7758837|NCT01436526|19104497|P1|NOT COMPLETED|Period 1||0
7758838|NCT01436526|19104496|P2|COMPLETED|Period 1||14
7758839|NCT01436526|19104497|P1|COMPLETED|Period 1||14
7758840|NCT01436526|19104496|P2|Participants Received Treatment|Period 1||14
7758841|NCT01436526|19104497|P1|Participants Received Treatment|Period 1||14
7758842|NCT01436526|19104496|P2|STARTED|Period 1||14
7758843|NCT01436526|19104497|P1|STARTED|Period 1||14
7758844|NCT01436500|19104519|P5|NOT COMPLETED|Overall Study||4
7758845|NCT01436500|19104520|P4|NOT COMPLETED|Overall Study||1
7758846|NCT01436500|19104521|P3|NOT COMPLETED|Overall Study||5
7758847|NCT01436500|19104522|P2|NOT COMPLETED|Overall Study||3
7758848|NCT01436500|19104523|P1|NOT COMPLETED|Overall Study||3
7758849|NCT01436500|19104519|P5|COMPLETED|Overall Study||9
7758850|NCT01436500|19104520|P4|COMPLETED|Overall Study||5
7758851|NCT01436500|19104521|P3|COMPLETED|Overall Study||7
7758852|NCT01436500|19104522|P2|COMPLETED|Overall Study||9
7758853|NCT01436500|19104523|P1|COMPLETED|Overall Study||9
7758854|NCT01436500|19104519|P5|STARTED|Overall Study||13
7758855|NCT01436500|19104520|P4|STARTED|Overall Study||6
7758856|NCT01436500|19104521|P3|STARTED|Overall Study||12
7758857|NCT01436500|19104522|P2|STARTED|Overall Study||12
7758858|NCT01436500|19104523|P1|STARTED|Overall Study||12
7758859|NCT01436435|19104556|P1|NOT COMPLETED|Overall Study||64
7758860|NCT01436435|19104556|P1|COMPLETED|Overall Study||177
7758861|NCT01436435|19104556|P1|STARTED|Overall Study||241
7758862|NCT01436396|19104567|P2|NOT COMPLETED|Overall Study||42
7758863|NCT01436396|19104568|P1|NOT COMPLETED|Overall Study||32
7758864|NCT01436396|19104567|P2|COMPLETED|Overall Study||354
7758865|NCT01436396|19104568|P1|COMPLETED|Overall Study||364
7758866|NCT01436396|19104567|P2|Vaccinated|Overall Study||393
7758867|NCT01436396|19104568|P1|Vaccinated|Overall Study||394
7758868|NCT01436396|19104567|P2|STARTED|Overall Study||396
7758869|NCT01436396|19104568|P1|STARTED|Overall Study||396
7758870|NCT01436370|19104608|P8|NOT COMPLETED|Overall Study||0
7758871|NCT01436370|19104609|P7|NOT COMPLETED|Overall Study||0
7758872|NCT01436370|19104610|P6|NOT COMPLETED|Overall Study||0
7758873|NCT01436370|19104611|P5|NOT COMPLETED|Overall Study||1
7758874|NCT01436370|19104612|P4|NOT COMPLETED|Overall Study||0
7758875|NCT01436370|19104613|P3|NOT COMPLETED|Overall Study||0
7758876|NCT01436370|19104614|P2|NOT COMPLETED|Overall Study||0
7758877|NCT01436370|19104615|P1|NOT COMPLETED|Overall Study||0
7758878|NCT01436370|19104608|P8|COMPLETED|Overall Study||16
7758879|NCT01436370|19104609|P7|COMPLETED|Overall Study||16
7758880|NCT01436370|19104610|P6|COMPLETED|Overall Study||19
7758881|NCT01436370|19104611|P5|COMPLETED|Overall Study||18
7758882|NCT01436370|19104612|P4|COMPLETED|Overall Study||10
7758883|NCT01436370|19104613|P3|COMPLETED|Overall Study||10
7758884|NCT01436370|19104614|P2|COMPLETED|Overall Study||6
7758885|NCT01436370|19104615|P1|COMPLETED|Overall Study||6
7758886|NCT01436370|19104608|P8|STARTED|Overall Study||16
7758887|NCT01436370|19104609|P7|STARTED|Overall Study||16
7758888|NCT01436370|19104610|P6|STARTED|Overall Study||19
7758889|NCT01436370|19104611|P5|STARTED|Overall Study||19
7758890|NCT01436370|19104612|P4|STARTED|Overall Study||10
7758891|NCT01436370|19104613|P3|STARTED|Overall Study||10
7758892|NCT01436370|19104614|P2|STARTED|Overall Study||6
7758893|NCT01436370|19104615|P1|STARTED|Overall Study||6
7758894|NCT01436357|19104695|P2|NOT COMPLETED|Overall Study||128
7758895|NCT01436357|19104696|P1|NOT COMPLETED|Overall Study||122
7758896|NCT01436357|19104695|P2|COMPLETED|Overall Study||146
7758897|NCT01436357|19104696|P1|COMPLETED|Overall Study||152
7758898|NCT01436357|19104695|P2|Stage 2|Overall Study||226
7758899|NCT01436357|19104696|P1|Stage 2|Overall Study||225
7758900|NCT01436357|19104695|P2|Stage 1|Overall Study||48
7758901|NCT01436357|19104696|P1|Stage 1|Overall Study||49
7758902|NCT01436357|19104695|P2|STARTED|Overall Study||274
7758903|NCT01436357|19104696|P1|STARTED|Overall Study||274
7758904|NCT01436305|19104717|P3|NOT COMPLETED|Overall Study||0
7758905|NCT01436305|19104718|P2|NOT COMPLETED|Overall Study||4
7758906|NCT01436305|19104719|P1|NOT COMPLETED|Overall Study||2
7758907|NCT01436305|19104717|P3|COMPLETED|Overall Study||7
7758908|NCT01436305|19104718|P2|COMPLETED|Overall Study||2
7758909|NCT01436305|19104719|P1|COMPLETED|Overall Study||4
7758910|NCT01436305|19104717|P3|STARTED|Overall Study||7
7758911|NCT01436305|19104718|P2|STARTED|Overall Study||6
7758912|NCT01436305|19104719|P1|STARTED|Overall Study||6
7758913|NCT01436279|19104816|P2|NOT COMPLETED|Overall Study||0
7758914|NCT01436279|19104817|P1|NOT COMPLETED|Overall Study||0
7758915|NCT01436279|19104816|P2|COMPLETED|Overall Study||20
7758916|NCT01436279|19104817|P1|COMPLETED|Overall Study||30
7758917|NCT01436279|19104816|P2|STARTED|Overall Study||20
7758918|NCT01436279|19104817|P1|STARTED|Overall Study||30
7758919|NCT01436266|19104839|P2|NOT COMPLETED|Overall Study||0
7758920|NCT01436266|19104840|P1|NOT COMPLETED|Overall Study||0
7758921|NCT01436266|19104839|P2|COMPLETED|Overall Study||1
7758922|NCT01436266|19104840|P1|COMPLETED|Overall Study||1
7758923|NCT01436266|19104839|P2|STARTED|Overall Study||1
7758924|NCT01436266|19104840|P1|STARTED|Overall Study||1
7758925|NCT01436253|19104846|P1|NOT COMPLETED|Overall Study||299
7758926|NCT01436253|19104846|P1|COMPLETED|Overall Study||1897
7758927|NCT01436253|19104846|P1|STARTED|Overall Study||2196
7758928|NCT01436201|19104851|P1|NOT COMPLETED|Overall Study||4
7758929|NCT01436201|19104851|P1|COMPLETED|Overall Study||20
7758930|NCT01436201|19104851|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
7758931|NCT01436201|19104851|P1|STARTED|Overall Study||24
7758932|NCT01436175|19104861|P1|NOT COMPLETED|Overall Study||1270
7758933|NCT01436175|19104861|P1|COMPLETED|Overall Study||300
7758934|NCT01436175|19104861|P1|STARTED|Overall Study||1570
7758935|NCT01436162|19104888|P3|NOT COMPLETED|Randomized Phase||25
7758936|NCT01436162|19104889|P2|NOT COMPLETED|Randomized Phase||31
7758937|NCT01436162|19104890|P1|NOT COMPLETED|Randomized Phase||44
7758938|NCT01436162|19104888|P3|COMPLETED|Randomized Phase||189
7758939|NCT01436162|19104889|P2|COMPLETED|Randomized Phase||181
7758940|NCT01436162|19104890|P1|COMPLETED|Randomized Phase||353
7758941|NCT01436162|19104888|P3|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214
7758942|NCT01436162|19104889|P2|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212
7758943|NCT01436162|19104890|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397
7758944|NCT01436162|19104888|P3|NOT COMPLETED|Single-blind Lead-in Phase||0
7758945|NCT01436162|19104889|P2|NOT COMPLETED|Single-blind Lead-in Phase||0
7758946|NCT01436162|19104890|P1|NOT COMPLETED|Single-blind Lead-in Phase||282
7758947|NCT01436162|19104888|P3|COMPLETED|Single-blind Lead-in Phase||0
7758948|NCT01436162|19104889|P2|COMPLETED|Single-blind Lead-in Phase||0
7758949|NCT01436162|19104890|P1|COMPLETED|Single-blind Lead-in Phase||823
7758950|NCT01436162|19104888|P3|STARTED|Single-blind Lead-in Phase||0
7758951|NCT01436162|19104889|P2|STARTED|Single-blind Lead-in Phase||0
7758952|NCT01436162|19104890|P1|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105
7758953|NCT01436149|19104924|P3|NOT COMPLETED|Randomized Phase||42
7758954|NCT01436149|19104925|P2|NOT COMPLETED|Randomized Phase||38
7758955|NCT01436149|19104926|P1|NOT COMPLETED|Randomized Phase||77
7758956|NCT01436149|19104924|P3|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160
7758957|NCT01436149|19104925|P2|COMPLETED|Randomized Phase||164
7758958|NCT01436149|19104926|P1|COMPLETED|Randomized Phase||415
7758959|NCT01436149|19104924|P3|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
7758960|NCT01436149|19104925|P2|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
7758961|NCT01436149|19104926|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492
7758962|NCT01436149|19104924|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
7758963|NCT01436149|19104925|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
7758964|NCT01436149|19104926|P1|NOT COMPLETED|Antidepressant Lead-in Phase||366
7758965|NCT01436149|19104924|P3|COMPLETED|Antidepressant Lead-in Phase||0
7758966|NCT01436149|19104925|P2|COMPLETED|Antidepressant Lead-in Phase||0
7758967|NCT01436149|19104926|P1|COMPLETED|Antidepressant Lead-in Phase||896
7758968|NCT01436149|19104924|P3|STARTED|Antidepressant Lead-in Phase||0
7758969|NCT01436149|19104925|P2|STARTED|Antidepressant Lead-in Phase||0
7758970|NCT01436149|19104926|P1|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262
7758971|NCT01436110|19104957|P3|NOT COMPLETED|Overall Study||23
7758972|NCT01436110|19104958|P2|NOT COMPLETED|Overall Study||26
7758973|NCT01436110|19104959|P1|NOT COMPLETED|Overall Study||39
7758974|NCT01436110|19104957|P3|COMPLETED|Overall Study||95
7758975|NCT01436110|19104958|P2|COMPLETED|Overall Study||91
7758976|NCT01436110|19104959|P1|COMPLETED|Overall Study||77
7758977|NCT01436110|19104957|P3|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
7758978|NCT01436110|19104958|P2|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117
7758979|NCT01436110|19104959|P1|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
7758980|NCT01436110|19104957|P3|STARTED|Overall Study|These participants were randomized to trial medication.|118
7758981|NCT01436110|19104958|P2|STARTED|Overall Study|These participants were randomized to trial medication.|117
7758982|NCT01436110|19104959|P1|STARTED|Overall Study|These participants were randomized to trial medication.|116
7758983|NCT01436084|19104982|P1|NOT COMPLETED|Overall Study||4
7758984|NCT01436084|19104982|P1|COMPLETED|Overall Study||0
7758985|NCT01436084|19104982|P1|STARTED|Overall Study||4
7758986|NCT01436071|19104988|P2|NOT COMPLETED|Overall Study||14
7758987|NCT01436071|19104989|P1|NOT COMPLETED|Overall Study||26
7758988|NCT01436071|19104988|P2|COMPLETED|Overall Study||110
7758989|NCT01436071|19104989|P1|COMPLETED|Overall Study||98
7758990|NCT01436071|19104988|P2|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
7758991|NCT01436071|19104989|P1|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
7758992|NCT01436071|19104988|P2|STARTED|Overall Study|These participants were randomized to trial medication.|124
7758993|NCT01436071|19104989|P1|STARTED|Overall Study|These participants were randomized to trial medication.|124
7758994|NCT01436045|19105005|P2|NOT COMPLETED|Overall Study||0
7758995|NCT01436045|19105006|P1|NOT COMPLETED|Overall Study||0
7758996|NCT01436045|19105005|P2|COMPLETED|Overall Study||6
7758997|NCT01436045|19105006|P1|COMPLETED|Overall Study||6
7758998|NCT01436045|19105005|P2|STARTED|Overall Study||6
7758999|NCT01436045|19105006|P1|STARTED|Overall Study||6
7759000|NCT01436006|19105017|P1|NOT COMPLETED|Overall Study||37
7759001|NCT01436006|19105017|P1|COMPLETED|Overall Study||6663
7759002|NCT01436006|19105017|P1|STARTED|Overall Study||6700
7759003|NCT01435928|19105031|P3|NOT COMPLETED|Double Blind Phase - 28 Weeks||121
7759004|NCT01435928|19105032|P2|NOT COMPLETED|Double Blind Phase - 28 Weeks||116
7759005|NCT01435928|19105033|P1|NOT COMPLETED|Double Blind Phase - 28 Weeks||0
7759006|NCT01435928|19105031|P3|COMPLETED|Double Blind Phase - 28 Weeks||20
7759007|NCT01435928|19105032|P2|COMPLETED|Double Blind Phase - 28 Weeks||28
7759008|NCT01435928|19105033|P1|COMPLETED|Double Blind Phase - 28 Weeks||0
7759009|NCT01435928|19105031|P3|STARTED|Double Blind Phase - 28 Weeks||141
7759010|NCT01435928|19105032|P2|STARTED|Double Blind Phase - 28 Weeks||144
7759011|NCT01435928|19105033|P1|STARTED|Double Blind Phase - 28 Weeks||0
7759012|NCT01435928|19105031|P3|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
7759013|NCT01435928|19105032|P2|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
7759014|NCT01435928|19105033|P1|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389
7759015|NCT01435928|19105031|P3|COMPLETED|Open Label Phase - up to 24 Weeks||0
7759016|NCT01435928|19105032|P2|COMPLETED|Open Label Phase - up to 24 Weeks||0
7759017|NCT01435928|19105033|P1|COMPLETED|Open Label Phase - up to 24 Weeks||287
7759018|NCT01435928|19105031|P3|STARTED|Open Label Phase - up to 24 Weeks||0
7759019|NCT01435928|19105032|P2|STARTED|Open Label Phase - up to 24 Weeks||0
7759020|NCT01435928|19105033|P1|STARTED|Open Label Phase - up to 24 Weeks||676
7759021|NCT01435824|19105060|P2|NOT COMPLETED|Second Intervention||0
7759022|NCT01435824|19105061|P1|NOT COMPLETED|Second Intervention||0
7759023|NCT01435824|19105060|P2|COMPLETED|Second Intervention||8
7759024|NCT01435824|19105061|P1|COMPLETED|Second Intervention||8
7759025|NCT01435824|19105060|P2|STARTED|Second Intervention||8
7759026|NCT01435824|19105061|P1|STARTED|Second Intervention||8
7759027|NCT01435824|19105060|P2|NOT COMPLETED|Washout of 1-2 Weeks||0
7759028|NCT01435824|19105061|P1|NOT COMPLETED|Washout of 1-2 Weeks||0
7759029|NCT01435824|19105060|P2|COMPLETED|Washout of 1-2 Weeks||8
7759030|NCT01435824|19105061|P1|COMPLETED|Washout of 1-2 Weeks||8
7759031|NCT01435824|19105060|P2|STARTED|Washout of 1-2 Weeks||8
7759032|NCT01435824|19105061|P1|STARTED|Washout of 1-2 Weeks||8
7759033|NCT01435824|19105060|P2|NOT COMPLETED|First Intervention||0
7759034|NCT01435824|19105061|P1|NOT COMPLETED|First Intervention||0
7759035|NCT01435824|19105060|P2|COMPLETED|First Intervention||8
7759036|NCT01435824|19105061|P1|COMPLETED|First Intervention||8
7759037|NCT01435824|19105060|P2|STARTED|First Intervention||8
7759038|NCT01435824|19105061|P1|STARTED|First Intervention||8
7759039|NCT01435798|19105079|P1|NOT COMPLETED|Overall Study||1
7759040|NCT01435798|19105079|P1|COMPLETED|Overall Study|Crossover design|25
7759041|NCT01435798|19105079|P1|100% MTD|Overall Study||25
7759042|NCT01435798|19105079|P1|50% MTD|Overall Study||25
7759043|NCT01435798|19105079|P1|25% MTD|Overall Study||26
7759044|NCT01435798|19105079|P1|0% MTD|Overall Study||25
7759045|NCT01435798|19105079|P1|STARTED|Overall Study|Crossover design|26
7759046|NCT01435772|19105096|P3|NOT COMPLETED|Overall Study||15
7759047|NCT01435772|19105097|P2|NOT COMPLETED|Overall Study||3
7759048|NCT01435772|19105098|P1|NOT COMPLETED|Overall Study||3
7759049|NCT01435772|19105096|P3|COMPLETED|Overall Study||0
7759050|NCT01435772|19105097|P2|COMPLETED|Overall Study||0
7759051|NCT01435772|19105098|P1|COMPLETED|Overall Study||0
7759052|NCT01435772|19105096|P3|STARTED|Overall Study||15
7759053|NCT01435772|19105097|P2|STARTED|Overall Study||3
7759054|NCT01435772|19105098|P1|STARTED|Overall Study||3
7759055|NCT01435759|19105148|P6|NOT COMPLETED|Double-blind Phase||9
7759056|NCT01435759|19105149|P5|NOT COMPLETED|Double-blind Phase||9
7759057|NCT01435759|19105150|P4|NOT COMPLETED|Double-blind Phase||9
7759058|NCT01435759|19105151|P3|NOT COMPLETED|Double-blind Phase||7
7759059|NCT01435759|19105152|P2|NOT COMPLETED|Double-blind Phase||7
7759060|NCT01435759|19105153|P1|NOT COMPLETED|Double-blind Phase||66
7759061|NCT01435759|19105148|P6|COMPLETED|Double-blind Phase||71
7759062|NCT01435759|19105149|P5|COMPLETED|Double-blind Phase||69
7759063|NCT01435759|19105150|P4|COMPLETED|Double-blind Phase||69
7759064|NCT01435759|19105151|P3|COMPLETED|Double-blind Phase||71
7759065|NCT01435759|19105152|P2|COMPLETED|Double-blind Phase||71
7759066|NCT01435759|19105153|P1|COMPLETED|Double-blind Phase||397
7759067|NCT01435759|19105148|P6|STARTED|Double-blind Phase||80
7759068|NCT01435759|19105149|P5|STARTED|Double-blind Phase||78
7759069|NCT01435759|19105150|P4|STARTED|Double-blind Phase|Two subjects were not dosed.|78
7759070|NCT01435759|19105151|P3|STARTED|Double-blind Phase|One subject was not dosed.|78
7759071|NCT01435759|19105152|P2|STARTED|Double-blind Phase||78
7759072|NCT01435759|19105153|P1|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463
7759073|NCT01435759|19105148|P6|NOT COMPLETED|Antidepressant Lead-in Phase||0
7759074|NCT01435759|19105149|P5|NOT COMPLETED|Antidepressant Lead-in Phase||0
7759075|NCT01435759|19105150|P4|NOT COMPLETED|Antidepressant Lead-in Phase||0
7759076|NCT01435759|19105151|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
7759077|NCT01435759|19105152|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
7759078|NCT01435759|19105153|P1|NOT COMPLETED|Antidepressant Lead-in Phase||342
7759079|NCT01435759|19105148|P6|COMPLETED|Antidepressant Lead-in Phase||0
7759080|NCT01435759|19105149|P5|COMPLETED|Antidepressant Lead-in Phase||0
7759081|NCT01435759|19105150|P4|COMPLETED|Antidepressant Lead-in Phase||0
7759082|NCT01435759|19105151|P3|COMPLETED|Antidepressant Lead-in Phase||0
7759083|NCT01435759|19105152|P2|COMPLETED|Antidepressant Lead-in Phase||0
7759084|NCT01435759|19105153|P1|COMPLETED|Antidepressant Lead-in Phase||855
7759085|NCT01435759|19105148|P6|STARTED|Antidepressant Lead-in Phase||0
7759086|NCT01435759|19105149|P5|STARTED|Antidepressant Lead-in Phase||0
7759087|NCT01435759|19105150|P4|STARTED|Antidepressant Lead-in Phase||0
7759088|NCT01435759|19105151|P3|STARTED|Antidepressant Lead-in Phase||0
7759089|NCT01435759|19105152|P2|STARTED|Antidepressant Lead-in Phase||0
7759090|NCT01435759|19105153|P1|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197
7759091|NCT01435655|19105180|P1|NOT COMPLETED|Overall Study||3
7759092|NCT01435655|19105180|P1|COMPLETED|Overall Study||7
7759093|NCT01435655|19105180|P1|STARTED|Overall Study||10
7759094|NCT01435616|19105194|P2|NOT COMPLETED|Overall Study||80
7759095|NCT01435616|19105195|P1|NOT COMPLETED|Overall Study||171
7759096|NCT01435616|19105194|P2|COMPLETED|Overall Study||455
7759097|NCT01435616|19105195|P1|COMPLETED|Overall Study||832
7759098|NCT01435616|19105194|P2|Received at Least 1 Dose of Study Drug|Overall Study||535
7759099|NCT01435616|19105195|P1|Received at Least 1 Dose of Study Drug|Overall Study||1003
7759100|NCT01435616|19105194|P2|STARTED|Overall Study||535
7759101|NCT01435616|19105195|P1|STARTED|Overall Study||1003
7759102|NCT01435603|19105241|P2|NOT COMPLETED|Overall Study||35
7759103|NCT01435603|19105242|P1|NOT COMPLETED|Overall Study||39
7759104|NCT01435603|19105241|P2|COMPLETED|Overall Study||129
7759105|NCT01435603|19105242|P1|COMPLETED|Overall Study||128
7759106|NCT01435603|19105241|P2|STARTED|Overall Study||164
7759107|NCT01435603|19105242|P1|STARTED|Overall Study||167
7759108|NCT01435577|19105250|P2|NOT COMPLETED|Overall Study||52
7759109|NCT01435577|19105251|P1|NOT COMPLETED|Overall Study||17
7759110|NCT01435577|19105250|P2|COMPLETED|Overall Study||13
7759111|NCT01435577|19105251|P1|COMPLETED|Overall Study||47
7759112|NCT01435577|19105250|P2|STARTED|Overall Study||65
7759113|NCT01435577|19105251|P1|STARTED|Overall Study||64
7759114|NCT01435512|19105301|P2|NOT COMPLETED|Overall Study||0
7759115|NCT01435512|19105302|P1|NOT COMPLETED|Overall Study||0
7759116|NCT01435512|19105301|P2|COMPLETED|Overall Study||68
7759117|NCT01435512|19105302|P1|COMPLETED|Overall Study||67
7759118|NCT01435512|19105301|P2|STARTED|Overall Study||68
7759119|NCT01435512|19105302|P1|STARTED|Overall Study||67
7759120|NCT01435460|19105312|P2|NOT COMPLETED|Overall Study||6
7759121|NCT01435460|19105313|P1|NOT COMPLETED|Overall Study||11
7759122|NCT01435460|19105312|P2|COMPLETED|Overall Study||143
7759123|NCT01435460|19105313|P1|COMPLETED|Overall Study||140
7759124|NCT01435460|19105312|P2|STARTED|Overall Study||149
7759125|NCT01435460|19105313|P1|STARTED|Overall Study||151
7759126|NCT01435382|19105329|P4|NOT COMPLETED|Overall Study||1
7759127|NCT01435382|19105330|P3|NOT COMPLETED|Overall Study||1
7759128|NCT01435382|19105331|P2|NOT COMPLETED|Overall Study||2
7759129|NCT01435382|19105332|P1|NOT COMPLETED|Overall Study||1
7759130|NCT01435382|19105329|P4|COMPLETED|Overall Study||10
7759131|NCT01435382|19105330|P3|COMPLETED|Overall Study||12
7759132|NCT01435382|19105331|P2|COMPLETED|Overall Study||11
7759133|NCT01435382|19105332|P1|COMPLETED|Overall Study||11
7759134|NCT01435382|19105329|P4|STARTED|Overall Study||11
7759135|NCT01435382|19105330|P3|STARTED|Overall Study||13
7759136|NCT01435382|19105331|P2|STARTED|Overall Study||13
7759137|NCT01435382|19105332|P1|STARTED|Overall Study||12
7759138|NCT01435356|19105421|P2|NOT COMPLETED|Overall Study||24
7759139|NCT01435356|19105422|P1|NOT COMPLETED|Overall Study||32
7759140|NCT01435356|19105421|P2|COMPLETED|Overall Study||5
7759141|NCT01435356|19105422|P1|COMPLETED|Overall Study||16
7759142|NCT01435356|19105421|P2|STARTED|Overall Study||29
7759143|NCT01435356|19105422|P1|STARTED|Overall Study||48
7759144|NCT01435304|19105436|P2|NOT COMPLETED|Overall Study||0
7759145|NCT01435304|19105437|P1|NOT COMPLETED|Overall Study||0
7759146|NCT01435304|19105436|P2|COMPLETED|Overall Study||50
7759147|NCT01435304|19105437|P1|COMPLETED|Overall Study||50
7759148|NCT01435304|19105436|P2|STARTED|Overall Study||50
7759149|NCT01435304|19105437|P1|STARTED|Overall Study||50
7759150|NCT01435265|19105455|P2|NOT COMPLETED|Overall Study||1
7759151|NCT01435265|19105456|P1|NOT COMPLETED|Overall Study||0
7759152|NCT01435265|19105455|P2|COMPLETED|Overall Study||3
7759153|NCT01435265|19105456|P1|COMPLETED|Overall Study||3
7759154|NCT01435265|19105455|P2|STARTED|Overall Study||4
7759155|NCT01435265|19105456|P1|STARTED|Overall Study||3
7759156|NCT01435174|19105466|P1|NOT COMPLETED|Overall Study||9
7759157|NCT01435174|19105466|P1|COMPLETED|Overall Study||8
7759158|NCT01435174|19105466|P1|STARTED|Overall Study||17
7759159|NCT01435122|19105470|P1|NOT COMPLETED|Overall Study||8
7759160|NCT01435122|19105470|P1|COMPLETED|Overall Study||22
7759161|NCT01435122|19105470|P1|STARTED|Overall Study||30
7759162|NCT01435031|19105479|P1|NOT COMPLETED|ITT at 4 Years||7
7759163|NCT01435031|19105479|P1|COMPLETED|ITT at 4 Years||171
7759164|NCT01435031|19105479|P1|STARTED|ITT at 4 Years||178
7759165|NCT01435031|19105479|P1|NOT COMPLETED|ITT at 3 Years||11
7759166|NCT01435031|19105479|P1|COMPLETED|ITT at 3 Years||178
7759167|NCT01435031|19105479|P1|STARTED|ITT at 3 Years||189
7759168|NCT01435031|19105479|P1|NOT COMPLETED|ITT at 2 Years||13
7759169|NCT01435031|19105479|P1|COMPLETED|ITT at 2 Years||189
7759170|NCT01435031|19105479|P1|STARTED|ITT at 2 Years||202
7759171|NCT01435031|19105479|P1|NOT COMPLETED|ITT at 1 Year||9
7759172|NCT01435031|19105479|P1|COMPLETED|ITT at 1 Year||202
7759173|NCT01435031|19105479|P1|STARTED|ITT at 1 Year||211
7759174|NCT01435031|19105479|P1|NOT COMPLETED|ITT at 6 Months||5
7759175|NCT01435031|19105479|P1|COMPLETED|ITT at 6 Months||211
7759176|NCT01435031|19105479|P1|STARTED|ITT at 6 Months||216
7759177|NCT01435031|19105479|P1|NOT COMPLETED|ITT at 1 Month||6
7759178|NCT01435031|19105479|P1|COMPLETED|ITT at 1 Month||216
7759179|NCT01435031|19105479|P1|STARTED|ITT at 1 Month|ITT population|222
7759180|NCT01435018|19105580|P3|NOT COMPLETED|Overall Study||41
7759181|NCT01435018|19105581|P2|NOT COMPLETED|Overall Study||34
7759182|NCT01435018|19105582|P1|NOT COMPLETED|Overall Study||47
7759183|NCT01435018|19105580|P3|COMPLETED|Overall Study||98
7759184|NCT01435018|19105581|P2|COMPLETED|Overall Study||26
7759185|NCT01435018|19105582|P1|COMPLETED|Overall Study||88
7759186|NCT01435018|19105580|P3|STARTED|Overall Study||139
7759187|NCT01435018|19105581|P2|STARTED|Overall Study||60
7759188|NCT01435018|19105582|P1|STARTED|Overall Study||135
7759189|NCT01434823|19105675|P2|NOT COMPLETED|Overall Study||7
7759190|NCT01434823|19105676|P1|NOT COMPLETED|Overall Study||4
7759191|NCT01434823|19105675|P2|COMPLETED|Overall Study||778
7759192|NCT01434823|19105676|P1|COMPLETED|Overall Study||820
7759193|NCT01434823|19105675|P2|STARTED|Overall Study||785
7759194|NCT01434823|19105676|P1|STARTED|Overall Study||824
7759195|NCT01434810|19105694|P2|NOT COMPLETED|Overall Study||10
7759196|NCT01434810|19105695|P1|NOT COMPLETED|Overall Study||23
7759197|NCT01434810|19105694|P2|COMPLETED|Overall Study||213
7759198|NCT01434810|19105695|P1|COMPLETED|Overall Study||201
7759199|NCT01434810|19105694|P2|STARTED|Overall Study||223
7759200|NCT01434810|19105695|P1|STARTED|Overall Study||224
7759201|NCT01434745|19105707|P2|NOT COMPLETED|Overall Study||0
7759202|NCT01434745|19105708|P1|NOT COMPLETED|Overall Study||0
7759203|NCT01434745|19105707|P2|COMPLETED|Overall Study||0
7759204|NCT01434745|19105708|P1|COMPLETED|Overall Study||0
7759205|NCT01434745|19105707|P2|STARTED|Overall Study||0
7759206|NCT01434745|19105708|P1|STARTED|Overall Study||0
7759207|NCT01434693|19105730|P4|NOT COMPLETED|Overall Study||1
7759208|NCT01434693|19105731|P3|NOT COMPLETED|Overall Study||1
7759209|NCT01434693|19105732|P2|NOT COMPLETED|Overall Study||0
7759210|NCT01434693|19105733|P1|NOT COMPLETED|Overall Study||3
7759211|NCT01434693|19105730|P4|COMPLETED|Overall Study||8
7759212|NCT01434693|19105731|P3|COMPLETED|Overall Study||8
7759213|NCT01434693|19105732|P2|COMPLETED|Overall Study||9
7759214|NCT01434693|19105733|P1|COMPLETED|Overall Study||6
7759215|NCT01434693|19105730|P4|STARTED|Overall Study||9
7759216|NCT01434693|19105731|P3|STARTED|Overall Study||9
7759217|NCT01434693|19105732|P2|STARTED|Overall Study||9
7759218|NCT01434693|19105733|P1|STARTED|Overall Study||9
7759219|NCT01434680|19105747|P4|NOT COMPLETED|Overall Study||0
7759220|NCT01434680|19105748|P3|NOT COMPLETED|Overall Study||2
7759221|NCT01434680|19105749|P2|NOT COMPLETED|Overall Study||2
7759222|NCT01434680|19105750|P1|NOT COMPLETED|Overall Study||3
7759223|NCT01434680|19105747|P4|COMPLETED|Overall Study||119
7759224|NCT01434680|19105748|P3|COMPLETED|Overall Study||304
7759225|NCT01434680|19105749|P2|COMPLETED|Overall Study||266
7759226|NCT01434680|19105750|P1|COMPLETED|Overall Study||296
7759227|NCT01434680|19105747|P4|STARTED|Overall Study||119
7759228|NCT01434680|19105748|P3|STARTED|Overall Study||306
7759229|NCT01434680|19105749|P2|STARTED|Overall Study||268
7759230|NCT01434680|19105750|P1|STARTED|Overall Study||299
7759231|NCT01434667|19105767|P2|NOT COMPLETED|Overall Study||10
7759232|NCT01434667|19105768|P1|NOT COMPLETED|Overall Study||5
7759233|NCT01434667|19105767|P2|COMPLETED|Overall Study||65
7759234|NCT01434667|19105768|P1|COMPLETED|Overall Study||34
7759235|NCT01434667|19105767|P2|STARTED|Overall Study||75
7759236|NCT01434667|19105768|P1|STARTED|Overall Study||39
7759237|NCT01434654|19105794|P2|NOT COMPLETED|Overall Study||0
7759238|NCT01434654|19105795|P1|NOT COMPLETED|Overall Study||2
7759239|NCT01434654|19105794|P2|COMPLETED|Overall Study||12
7759240|NCT01434654|19105795|P1|COMPLETED|Overall Study||5
7759241|NCT01434654|19105794|P2|STARTED|Overall Study||12
7759242|NCT01434654|19105795|P1|STARTED|Overall Study||7
7759243|NCT01434641|19105807|P1|NOT COMPLETED|Overall Study||0
7759244|NCT01434641|19105807|P1|COMPLETED|Overall Study||102
7759245|NCT01434641|19105807|P1|STARTED|Overall Study||102
7759246|NCT01434511|19105812|P1|NOT COMPLETED|Overall Study||0
7759247|NCT01434511|19105812|P1|COMPLETED|Overall Study||1
7759248|NCT01434511|19105812|P1|STARTED|Overall Study||1
7759249|NCT01434342|19105831|P2|NOT COMPLETED|Overall Study||17
7759250|NCT01434342|19105832|P1|NOT COMPLETED|Overall Study||48
7759251|NCT01434342|19105831|P2|COMPLETED|Overall Study||31
7759252|NCT01434342|19105832|P1|COMPLETED|Overall Study||50
7759253|NCT01434342|19105831|P2|STARTED|Overall Study||48
7759254|NCT01434342|19105832|P1|STARTED|Overall Study||98
7759255|NCT01434290|19105842|P2|NOT COMPLETED|Overall Study||7
7759256|NCT01434290|19105843|P1|NOT COMPLETED|Overall Study||8
7759257|NCT01434290|19105842|P2|COMPLETED|Overall Study|Eligible subjects included in analysis|121
7759258|NCT01434290|19105843|P1|COMPLETED|Overall Study|Eligible subjects included in analysis|119
7759259|NCT01434290|19105842|P2|STARTED|Overall Study||128
7759260|NCT01434290|19105843|P1|STARTED|Overall Study||127
7759261|NCT01434186|19105871|P2|NOT COMPLETED|Overall Study||0
7759262|NCT01434186|19105872|P1|NOT COMPLETED|Overall Study||0
7759263|NCT01434186|19105871|P2|COMPLETED|Overall Study||4
7759264|NCT01434186|19105872|P1|COMPLETED|Overall Study||2
7759265|NCT01434186|19105871|P2|STARTED|Overall Study||4
7759266|NCT01434186|19105872|P1|STARTED|Overall Study||2
7759267|NCT01434121|19105881|P3|NOT COMPLETED|Overall Study||0
7759268|NCT01434121|19105882|P2|NOT COMPLETED|Overall Study||0
7759269|NCT01434121|19105883|P1|NOT COMPLETED|Overall Study||0
7759270|NCT01434121|19105881|P3|COMPLETED|Overall Study||8
7759271|NCT01434121|19105882|P2|COMPLETED|Overall Study||8
7759272|NCT01434121|19105883|P1|COMPLETED|Overall Study||8
7759273|NCT01434121|19105881|P3|STARTED|Overall Study||8
7759274|NCT01434121|19105882|P2|STARTED|Overall Study||8
7759275|NCT01434121|19105883|P1|STARTED|Overall Study||8
7759276|NCT01434030|19105909|P1|NOT COMPLETED|Overall Study||1
7759277|NCT01434030|19105909|P1|COMPLETED|Overall Study||56
7759278|NCT01434030|19105909|P1|STARTED|Overall Study||57
7759279|NCT01433978|19105916|P3|NOT COMPLETED|Extension Phase||6
7759280|NCT01433978|19105917|P2|NOT COMPLETED|Extension Phase||0
7759281|NCT01433978|19105918|P1|NOT COMPLETED|Extension Phase||0
7759282|NCT01433978|19105916|P3|COMPLETED|Extension Phase||0
7759283|NCT01433978|19105917|P2|COMPLETED|Extension Phase||0
7759284|NCT01433978|19105918|P1|COMPLETED|Extension Phase||0
7759285|NCT01433978|19105916|P3|STARTED|Extension Phase||6
7759286|NCT01433978|19105917|P2|STARTED|Extension Phase||0
7759287|NCT01433978|19105918|P1|STARTED|Extension Phase||0
7759288|NCT01433978|19105916|P3|NOT COMPLETED|Core Study||0
7759289|NCT01433978|19105917|P2|NOT COMPLETED|Core Study||11
7759290|NCT01433978|19105918|P1|NOT COMPLETED|Core Study||11
7759291|NCT01433978|19105916|P3|COMPLETED|Core Study||0
7759292|NCT01433978|19105917|P2|COMPLETED|Core Study||1
7759293|NCT01433978|19105918|P1|COMPLETED|Core Study||0
7759294|NCT01433978|19105916|P3|STARTED|Core Study||0
7759295|NCT01433978|19105917|P2|STARTED|Core Study||12
7759296|NCT01433978|19105918|P1|STARTED|Core Study||11
7759297|NCT01433913|19105927|P2|NOT COMPLETED|Overall Study||0
7759298|NCT01433913|19105928|P1|NOT COMPLETED|Overall Study||1
7759299|NCT01433913|19105927|P2|COMPLETED|Overall Study||10
7759300|NCT01433913|19105928|P1|COMPLETED|Overall Study||9
7759301|NCT01433913|19105927|P2|STARTED|Overall Study||10
7759302|NCT01433913|19105928|P1|STARTED|Overall Study||10
7759303|NCT01433731|19105964|P4|NOT COMPLETED|Overall Study||0
7759304|NCT01433731|19105965|P3|NOT COMPLETED|Overall Study||0
7759305|NCT01433731|19105966|P2|NOT COMPLETED|Overall Study||0
7759306|NCT01433731|19105967|P1|NOT COMPLETED|Overall Study||0
7759307|NCT01433731|19105964|P4|COMPLETED|Overall Study||5
7759308|NCT01433731|19105965|P3|COMPLETED|Overall Study||5
7759309|NCT01433731|19105966|P2|COMPLETED|Overall Study||5
7759310|NCT01433731|19105967|P1|COMPLETED|Overall Study||3
7759311|NCT01433731|19105964|P4|STARTED|Overall Study||5
7759312|NCT01433731|19105965|P3|STARTED|Overall Study||5
7759313|NCT01433731|19105966|P2|STARTED|Overall Study||5
7759314|NCT01433731|19105967|P1|STARTED|Overall Study||3
7759315|NCT01433549|19105975|P2|NOT COMPLETED|Phase 2: Second Study Product||1
7759316|NCT01433549|19105976|P1|NOT COMPLETED|Phase 2: Second Study Product||0
7759317|NCT01433549|19105975|P2|COMPLETED|Phase 2: Second Study Product||12
7759318|NCT01433549|19105976|P1|COMPLETED|Phase 2: Second Study Product||12
7759319|NCT01433549|19105975|P2|STARTED|Phase 2: Second Study Product||13
7759320|NCT01433549|19105976|P1|STARTED|Phase 2: Second Study Product||12
7759321|NCT01433549|19105975|P2|NOT COMPLETED|Phase 1: First Study Product||0
7759322|NCT01433549|19105976|P1|NOT COMPLETED|Phase 1: First Study Product||0
7759323|NCT01433549|19105975|P2|COMPLETED|Phase 1: First Study Product||13
7759324|NCT01433549|19105976|P1|COMPLETED|Phase 1: First Study Product||12
7759325|NCT01433549|19105975|P2|STARTED|Phase 1: First Study Product||13
7759326|NCT01433549|19105976|P1|STARTED|Phase 1: First Study Product||12
7759327|NCT01433471|19105986|P2|NOT COMPLETED|Overall Study||1
7759328|NCT01433471|19105987|P1|NOT COMPLETED|Overall Study||0
7759329|NCT01433471|19105986|P2|COMPLETED|Overall Study||1
7759330|NCT01433471|19105987|P1|COMPLETED|Overall Study||2
7759331|NCT01433471|19105986|P2|STARTED|Overall Study||2
7759332|NCT01433471|19105987|P1|STARTED|Overall Study||2
7759333|NCT01433354|19106003|P1|NOT COMPLETED|Overall Study||119
7759334|NCT01433354|19106003|P1|COMPLETED|Overall Study||0
7759335|NCT01433354|19106003|P1|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119
7759336|NCT01433263|19106019|P2|NOT COMPLETED|Overall Study||12
7759337|NCT01433263|19106020|P1|NOT COMPLETED|Overall Study||19
7759338|NCT01433263|19106019|P2|COMPLETED|Overall Study||16
7759339|NCT01433263|19106020|P1|COMPLETED|Overall Study||10
7759340|NCT01433263|19106019|P2|STARTED|Overall Study||28
7759341|NCT01433263|19106020|P1|STARTED|Overall Study||29
7759342|NCT01433250|19106049|P2|NOT COMPLETED|Overall Study||3
7759343|NCT01433250|19106050|P1|NOT COMPLETED|Overall Study||3
7759344|NCT01433250|19106049|P2|COMPLETED|Overall Study||14
7759345|NCT01433250|19106050|P1|COMPLETED|Overall Study||19
7759346|NCT01433250|19106049|P2|STARTED|Overall Study||17
7759347|NCT01433250|19106050|P1|STARTED|Overall Study||22
7759348|NCT01433172|19106069|P3|NOT COMPLETED|Overall Study||1
7759349|NCT01433172|19106070|P2|NOT COMPLETED|Overall Study||3
7759350|NCT01433172|19106071|P1|NOT COMPLETED|Overall Study||0
7759351|NCT01433172|19106069|P3|COMPLETED|Overall Study||32
7759352|NCT01433172|19106070|P2|COMPLETED|Overall Study||34
7759353|NCT01433172|19106071|P1|COMPLETED|Overall Study||3
7759354|NCT01433172|19106069|P3|STARTED|Overall Study||33
7759355|NCT01433172|19106070|P2|STARTED|Overall Study||37
7759356|NCT01433172|19106071|P1|STARTED|Overall Study||3
7759357|NCT01433159|19106083|P2|NOT COMPLETED|Overall Study||1
7759358|NCT01433159|19106084|P1|NOT COMPLETED|Overall Study||2
7759359|NCT01433159|19106083|P2|COMPLETED|Overall Study||9
7759360|NCT01433159|19106084|P1|COMPLETED|Overall Study||7
7759361|NCT01433159|19106083|P2|STARTED|Overall Study||10
7759362|NCT01433159|19106084|P1|STARTED|Overall Study||9
7759363|NCT01433107|19106092|P2|NOT COMPLETED|Overall Study||17
7759364|NCT01433107|19106093|P1|NOT COMPLETED|Overall Study||27
7759365|NCT01433107|19106092|P2|COMPLETED|Overall Study||128
7759366|NCT01433107|19106093|P1|COMPLETED|Overall Study||118
7759367|NCT01433107|19106092|P2|STARTED|Overall Study||145
7759368|NCT01433107|19106093|P1|STARTED|Overall Study||145
7759369|NCT01433081|19106105|P2|NOT COMPLETED|Overall Study||2
7759370|NCT01433081|19106106|P1|NOT COMPLETED|Overall Study||2
7759371|NCT01433081|19106105|P2|COMPLETED|Overall Study||23
7759372|NCT01433081|19106106|P1|COMPLETED|Overall Study||23
7759373|NCT01433081|19106105|P2|STARTED|Overall Study||25
7759374|NCT01433081|19106106|P1|STARTED|Overall Study||25
7759375|NCT01433055|19106116|P2|NOT COMPLETED|Overall Study||0
7759376|NCT01433055|19106117|P1|NOT COMPLETED|Overall Study||2
7759377|NCT01433055|19106116|P2|COMPLETED|Overall Study||23
7759378|NCT01433055|19106117|P1|COMPLETED|Overall Study||27
7759379|NCT01433055|19106116|P2|STARTED|Overall Study||23
7759380|NCT01433055|19106117|P1|STARTED|Overall Study||29
7759381|NCT01433042|19106131|P1|NOT COMPLETED|Overall Study||1
7759382|NCT01433042|19106131|P1|COMPLETED|Overall Study||224
7759383|NCT01433042|19106131|P1|STARTED|Overall Study||225
7759384|NCT01433016|19106135|P1|NOT COMPLETED|Overall Study||0
7759385|NCT01433016|19106135|P1|COMPLETED|Overall Study||20
7759386|NCT01433016|19106135|P1|STARTED|Overall Study||20
7759387|NCT01432951|19106139|P1|NOT COMPLETED|Safety Extension Day 30 to End of Study||0
7759388|NCT01432951|19106139|P1|COMPLETED|Safety Extension Day 30 to End of Study||15
7759389|NCT01432951|19106139|P1|STARTED|Safety Extension Day 30 to End of Study|Participants had the option to continue on to safety extension period.|15
7759390|NCT01432951|19106139|P1|NOT COMPLETED|Treatment Phase (Day 1 to 30)||1
7759391|NCT01432951|19106139|P1|COMPLETED|Treatment Phase (Day 1 to 30)||25
7759392|NCT01432951|19106139|P1|Progressive Disease|Treatment Phase (Day 1 to 30)||10
7759393|NCT01432951|19106139|P1|PK Sampling (no Dosing) Days 15-17|Treatment Phase (Day 1 to 30)||23
7759394|NCT01432951|19106139|P1|Received at Least One Dose of Study Drug|Treatment Phase (Day 1 to 30)||25
7759395|NCT01432951|19106139|P1|STARTED|Treatment Phase (Day 1 to 30)||26
7759396|NCT01432938|19106148|P2|NOT COMPLETED|Second Intervention||0
7759397|NCT01432938|19106149|P1|NOT COMPLETED|Second Intervention||1
7759398|NCT01432938|19106148|P2|COMPLETED|Second Intervention||14
7759399|NCT01432938|19106149|P1|COMPLETED|Second Intervention||11
7759400|NCT01432938|19106148|P2|STARTED|Second Intervention||14
7759401|NCT01432938|19106149|P1|STARTED|Second Intervention||12
7759402|NCT01432938|19106148|P2|NOT COMPLETED|Washout Period of at Least 24 Days||0
7759403|NCT01432938|19106149|P1|NOT COMPLETED|Washout Period of at Least 24 Days||0
7759404|NCT01432938|19106148|P2|COMPLETED|Washout Period of at Least 24 Days||14
7759405|NCT01432938|19106149|P1|COMPLETED|Washout Period of at Least 24 Days||12
7759406|NCT01432938|19106148|P2|STARTED|Washout Period of at Least 24 Days||14
7759407|NCT01432938|19106149|P1|STARTED|Washout Period of at Least 24 Days||12
7759408|NCT01432938|19106148|P2|NOT COMPLETED|First Intervention||0
7759409|NCT01432938|19106149|P1|NOT COMPLETED|First Intervention||2
7759410|NCT01432938|19106148|P2|COMPLETED|First Intervention||14
7759411|NCT01432938|19106149|P1|COMPLETED|First Intervention||12
7759412|NCT01432938|19106148|P2|Received at Least 1 Dose of Study Drug|First Intervention||14
7759413|NCT01432938|19106149|P1|Received at Least 1 Dose of Study Drug|First Intervention||14
7759414|NCT01432938|19106148|P2|STARTED|First Intervention||14
7759415|NCT01432938|19106149|P1|STARTED|First Intervention||14
7759416|NCT01432886|19106166|P2|NOT COMPLETED|Overall Study||0
7759417|NCT01432886|19106167|P1|NOT COMPLETED|Overall Study||0
7759418|NCT01432886|19106166|P2|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
7759419|NCT01432886|19106167|P1|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
7759420|NCT01432886|19106166|P2|STARTED|Overall Study||6
7759421|NCT01432886|19106167|P1|STARTED|Overall Study||6
7759422|NCT01432756|19106179|P4|NOT COMPLETED|Overall Study||1
7759423|NCT01432756|19106180|P3|NOT COMPLETED|Overall Study||2
7759424|NCT01432756|19106181|P2|NOT COMPLETED|Overall Study||0
7759425|NCT01432756|19106182|P1|NOT COMPLETED|Overall Study||1
7759426|NCT01432756|19106179|P4|COMPLETED|Overall Study||33
7759427|NCT01432756|19106180|P3|COMPLETED|Overall Study||30
7759428|NCT01432756|19106181|P2|COMPLETED|Overall Study||34
7759429|NCT01432756|19106182|P1|COMPLETED|Overall Study||31
7759430|NCT01432756|19106179|P4|STARTED|Overall Study||34
7759431|NCT01432756|19106180|P3|STARTED|Overall Study||32
7759432|NCT01432756|19106181|P2|STARTED|Overall Study||34
7759433|NCT01432756|19106182|P1|STARTED|Overall Study||32
7759434|NCT01432730|19106190|P2|NOT COMPLETED|Period 2||4
7759435|NCT01432730|19106191|P1|NOT COMPLETED|Period 2||0
7759436|NCT01432730|19106190|P2|COMPLETED|Period 2||8
7759437|NCT01432730|19106191|P1|COMPLETED|Period 2||10
7759438|NCT01432730|19106190|P2|STARTED|Period 2||12
7759439|NCT01432730|19106191|P1|STARTED|Period 2||10
7759440|NCT01432730|19106190|P2|NOT COMPLETED|Period 1||0
7759441|NCT01432730|19106191|P1|NOT COMPLETED|Period 1||2
7759442|NCT01432730|19106190|P2|COMPLETED|Period 1||12
7759443|NCT01432730|19106191|P1|COMPLETED|Period 1||10
7759444|NCT01432730|19106190|P2|STARTED|Period 1||12
7759445|NCT01432730|19106191|P1|STARTED|Period 1||12
7759446|NCT01432626|19106227|P1|NOT COMPLETED|Overall Study||7
7759447|NCT01432626|19106227|P1|COMPLETED|Overall Study|Completed both images|3
7759448|NCT01432626|19106227|P1|STARTED|Overall Study||10
7759449|NCT01432600|19106234|P3|NOT COMPLETED|Overall Study||1
7759450|NCT01432600|19106235|P2|NOT COMPLETED|Overall Study||1
7759451|NCT01432600|19106236|P1|NOT COMPLETED|Overall Study||0
7759452|NCT01432600|19106234|P3|COMPLETED|Overall Study||33
7759453|NCT01432600|19106235|P2|COMPLETED|Overall Study||35
7759454|NCT01432600|19106236|P1|COMPLETED|Overall Study||10
7759455|NCT01432600|19106234|P3|STARTED|Overall Study||34
7759456|NCT01432600|19106235|P2|STARTED|Overall Study||36
7759457|NCT01432600|19106236|P1|STARTED|Overall Study||10
7759458|NCT01432574|19106252|P1|NOT COMPLETED|Overall Study||3
7759459|NCT01432574|19106252|P1|COMPLETED|Overall Study||147
7759460|NCT01432574|19106252|P1|STARTED|Overall Study||150
7759461|NCT01432561|19106258|P1|NOT COMPLETED|Overall Study||0
7759462|NCT01432561|19106258|P1|COMPLETED|Overall Study||8
7759463|NCT01432561|19106258|P1|STARTED|Overall Study||8
7759464|NCT01432535|19106267|P3|NOT COMPLETED|Overall Study||0
7759465|NCT01432535|19106268|P2|NOT COMPLETED|Overall Study||0
7759466|NCT01432535|19106269|P1|NOT COMPLETED|Overall Study||0
7759467|NCT01432535|19106267|P3|COMPLETED|Overall Study||6
7759468|NCT01432535|19106268|P2|COMPLETED|Overall Study||7
7759469|NCT01432535|19106269|P1|COMPLETED|Overall Study||12
7759470|NCT01432535|19106267|P3|STARTED|Overall Study||6
7759471|NCT01432535|19106268|P2|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7
7759472|NCT01432535|19106269|P1|STARTED|Overall Study||12
7759473|NCT01432457|19106298|P3|NOT COMPLETED|Overall Study||59
7759474|NCT01432457|19106299|P2|NOT COMPLETED|Overall Study||48
7759475|NCT01432457|19106300|P1|NOT COMPLETED|Overall Study||37
7759476|NCT01432457|19106298|P3|COMPLETED|Overall Study||253
7759477|NCT01432457|19106299|P2|COMPLETED|Overall Study||258
7759478|NCT01432457|19106300|P1|COMPLETED|Overall Study||269
7759479|NCT01432457|19106298|P3|STARTED|Overall Study||312
7759480|NCT01432457|19106299|P2|STARTED|Overall Study||306
7759481|NCT01432457|19106300|P1|STARTED|Overall Study||306
7759482|NCT01432444|19106329|P3|NOT COMPLETED|Extension Phase||192
7759483|NCT01432444|19106330|P2|NOT COMPLETED|Extension Phase||0
7759484|NCT01432444|19106331|P1|NOT COMPLETED|Extension Phase||0
7759485|NCT01432444|19106329|P3|COMPLETED|Extension Phase||0
7759486|NCT01432444|19106330|P2|COMPLETED|Extension Phase||0
7759487|NCT01432444|19106331|P1|COMPLETED|Extension Phase||0
7759488|NCT01432444|19106329|P3|STARTED|Extension Phase||192
7759489|NCT01432444|19106330|P2|STARTED|Extension Phase||0
7759490|NCT01432444|19106331|P1|STARTED|Extension Phase||0
7759491|NCT01432444|19106329|P3|NOT COMPLETED|Treatment Phase||0
7759492|NCT01432444|19106330|P2|NOT COMPLETED|Treatment Phase||140
7759493|NCT01432444|19106331|P1|NOT COMPLETED|Treatment Phase||0
7759494|NCT01432444|19106329|P3|COMPLETED|Treatment Phase||0
7759495|NCT01432444|19106330|P2|COMPLETED|Treatment Phase||293
7759496|NCT01432444|19106331|P1|COMPLETED|Treatment Phase||0
7759497|NCT01432444|19106329|P3|STARTED|Treatment Phase||0
7759498|NCT01432444|19106330|P2|STARTED|Treatment Phase||433
7759499|NCT01432444|19106331|P1|STARTED|Treatment Phase||0
7759500|NCT01432444|19106329|P3|NOT COMPLETED|Tolerability/Cross-titration Phase||0
7759501|NCT01432444|19106330|P2|NOT COMPLETED|Tolerability/Cross-titration Phase||0
7759502|NCT01432444|19106331|P1|NOT COMPLETED|Tolerability/Cross-titration Phase||60
7759503|NCT01432444|19106329|P3|COMPLETED|Tolerability/Cross-titration Phase||0
7759504|NCT01432444|19106330|P2|COMPLETED|Tolerability/Cross-titration Phase||0
7759505|NCT01432444|19106331|P1|COMPLETED|Tolerability/Cross-titration Phase||265
7759506|NCT01432444|19106329|P3|STARTED|Tolerability/Cross-titration Phase||0
7759507|NCT01432444|19106330|P2|STARTED|Tolerability/Cross-titration Phase||0
7759508|NCT01432444|19106331|P1|STARTED|Tolerability/Cross-titration Phase||325
7759509|NCT01432405|19106343|P2|NOT COMPLETED|Overall Study||2
7759510|NCT01432405|19106344|P1|NOT COMPLETED|Overall Study||1
7759511|NCT01432405|19106343|P2|COMPLETED|Overall Study||10
7759512|NCT01432405|19106344|P1|COMPLETED|Overall Study||11
7759513|NCT01432405|19106343|P2|STARTED|Overall Study||12
7759514|NCT01432405|19106344|P1|STARTED|Overall Study||12
7759515|NCT01432379|19106352|P1|NOT COMPLETED|Overall Study||385
7759516|NCT01432379|19106352|P1|COMPLETED|Overall Study||783
7759517|NCT01432379|19106352|P1|STARTED|Overall Study||1168
7759518|NCT01432366|19106357|P1|NOT COMPLETED|Overall Study||68
7759519|NCT01432366|19106357|P1|COMPLETED|Overall Study||392
7759520|NCT01432366|19106357|P1|STARTED|Overall Study||460
7759521|NCT01432327|19106379|P4|NOT COMPLETED|Posttest 1 Year||23
7759522|NCT01432327|19106380|P3|NOT COMPLETED|Posttest 1 Year||20
7759523|NCT01432327|19106381|P2|NOT COMPLETED|Posttest 1 Year||28
7759524|NCT01432327|19106382|P1|NOT COMPLETED|Posttest 1 Year||24
7759525|NCT01432327|19106379|P4|COMPLETED|Posttest 1 Year||31
7759526|NCT01432327|19106380|P3|COMPLETED|Posttest 1 Year||30
7759527|NCT01432327|19106381|P2|COMPLETED|Posttest 1 Year||27
7759528|NCT01432327|19106382|P1|COMPLETED|Posttest 1 Year||28
7759529|NCT01432327|19106379|P4|STARTED|Posttest 1 Year||54
7759530|NCT01432327|19106380|P3|STARTED|Posttest 1 Year||50
7759531|NCT01432327|19106381|P2|STARTED|Posttest 1 Year||55
7759532|NCT01432327|19106382|P1|STARTED|Posttest 1 Year||52
7759533|NCT01432327|19106379|P4|NOT COMPLETED|Posttest 6 Months||2
7759534|NCT01432327|19106380|P3|NOT COMPLETED|Posttest 6 Months||5
7759535|NCT01432327|19106381|P2|NOT COMPLETED|Posttest 6 Months||0
7759536|NCT01432327|19106382|P1|NOT COMPLETED|Posttest 6 Months||0
7759537|NCT01432327|19106379|P4|COMPLETED|Posttest 6 Months||54
7759538|NCT01432327|19106380|P3|COMPLETED|Posttest 6 Months||50
7759539|NCT01432327|19106381|P2|COMPLETED|Posttest 6 Months||55
7759540|NCT01432327|19106382|P1|COMPLETED|Posttest 6 Months||52
7759541|NCT01432327|19106379|P4|STARTED|Posttest 6 Months||56
7759542|NCT01432327|19106380|P3|STARTED|Posttest 6 Months||55
7759543|NCT01432327|19106381|P2|STARTED|Posttest 6 Months||55
7759544|NCT01432327|19106382|P1|STARTED|Posttest 6 Months||52
7759545|NCT01432327|19106379|P4|NOT COMPLETED|Posttest 3 Months||1
7759546|NCT01432327|19106380|P3|NOT COMPLETED|Posttest 3 Months||2
7759547|NCT01432327|19106381|P2|NOT COMPLETED|Posttest 3 Months||2
7759548|NCT01432327|19106382|P1|NOT COMPLETED|Posttest 3 Months||4
7759549|NCT01432327|19106379|P4|COMPLETED|Posttest 3 Months||56
7759550|NCT01432327|19106380|P3|COMPLETED|Posttest 3 Months||55
7759551|NCT01432327|19106381|P2|COMPLETED|Posttest 3 Months||55
7759552|NCT01432327|19106382|P1|COMPLETED|Posttest 3 Months||52
7759553|NCT01432327|19106379|P4|STARTED|Posttest 3 Months||57
7759554|NCT01432327|19106380|P3|STARTED|Posttest 3 Months||57
7759555|NCT01432327|19106381|P2|STARTED|Posttest 3 Months||57
7759556|NCT01432327|19106382|P1|STARTED|Posttest 3 Months||56
7759557|NCT01432327|19106379|P4|NOT COMPLETED|Baseline||0
7759558|NCT01432327|19106380|P3|NOT COMPLETED|Baseline||0
7759559|NCT01432327|19106381|P2|NOT COMPLETED|Baseline||0
7759560|NCT01432327|19106382|P1|NOT COMPLETED|Baseline||0
7759561|NCT01432327|19106379|P4|COMPLETED|Baseline||57
7759562|NCT01432327|19106380|P3|COMPLETED|Baseline||57
7759563|NCT01432327|19106381|P2|COMPLETED|Baseline||57
7759564|NCT01432327|19106382|P1|COMPLETED|Baseline||56
7759565|NCT01432327|19106379|P4|STARTED|Baseline||57
7759566|NCT01432327|19106380|P3|STARTED|Baseline||57
7759567|NCT01432327|19106381|P2|STARTED|Baseline||57
7759568|NCT01432327|19106382|P1|STARTED|Baseline||56
7759569|NCT01432275|19106392|P2|NOT COMPLETED|ADC With Calculator (10 Days)||2
7759570|NCT01432275|19106393|P1|NOT COMPLETED|ADC With Calculator (10 Days)||3
7759571|NCT01432275|19106392|P2|COMPLETED|ADC With Calculator (10 Days)||79
7759572|NCT01432275|19106393|P1|COMPLETED|ADC With Calculator (10 Days)||85
7759573|NCT01432275|19106392|P2|STARTED|ADC With Calculator (10 Days)||81
7759574|NCT01432275|19106393|P1|STARTED|ADC With Calculator (10 Days)||88
7759575|NCT01432275|19106392|P2|NOT COMPLETED|Second BG Meter System (7 Days)||3
7759576|NCT01432275|19106393|P1|NOT COMPLETED|Second BG Meter System (7 Days)||2
7759577|NCT01432275|19106392|P2|COMPLETED|Second BG Meter System (7 Days)||81
7759578|NCT01432275|19106393|P1|COMPLETED|Second BG Meter System (7 Days)||88
7759579|NCT01432275|19106392|P2|STARTED|Second BG Meter System (7 Days)||84
7759580|NCT01432275|19106393|P1|STARTED|Second BG Meter System (7 Days)||90
7759581|NCT01432275|19106392|P2|NOT COMPLETED|First BG Meter System (7 Days)||3
7759582|NCT01432275|19106393|P1|NOT COMPLETED|First BG Meter System (7 Days)||0
7759583|NCT01432275|19106392|P2|COMPLETED|First BG Meter System (7 Days)||84
7759584|NCT01432275|19106393|P1|COMPLETED|First BG Meter System (7 Days)||90
7759585|NCT01432275|19106392|P2|STARTED|First BG Meter System (7 Days)||87
7759586|NCT01432275|19106393|P1|STARTED|First BG Meter System (7 Days)||90
7759587|NCT01432262|19106402|P2|NOT COMPLETED|Overall Study||1
7759588|NCT01432262|19106403|P1|NOT COMPLETED|Overall Study||2
7759589|NCT01432262|19106402|P2|COMPLETED|Overall Study||161
7759590|NCT01432262|19106403|P1|COMPLETED|Overall Study||160
7759591|NCT01432262|19106402|P2|Vaccinated|Overall Study||161
7759592|NCT01432262|19106403|P1|Vaccinated|Overall Study||162
7759593|NCT01432262|19106402|P2|STARTED|Overall Study||162
7759594|NCT01432262|19106403|P1|STARTED|Overall Study||162
7759595|NCT01432236|19106421|P2|NOT COMPLETED|Overall Study||18
7759596|NCT01432236|19106422|P1|NOT COMPLETED|Overall Study||26
7759597|NCT01432236|19106421|P2|COMPLETED|Overall Study||79
7759598|NCT01432236|19106422|P1|COMPLETED|Overall Study||70
7759599|NCT01432236|19106421|P2|STARTED|Overall Study||97
7759600|NCT01432236|19106422|P1|STARTED|Overall Study||96
7759601|NCT01432171|19106469|P2|NOT COMPLETED|Overall Study||11
7759602|NCT01432171|19106470|P1|NOT COMPLETED|Overall Study||14
7759603|NCT01432171|19106469|P2|COMPLETED|Overall Study||8
7759604|NCT01432171|19106470|P1|COMPLETED|Overall Study||4
7759605|NCT01432171|19106469|P2|STARTED|Overall Study||19
7759606|NCT01432171|19106470|P1|STARTED|Overall Study||18
7759607|NCT01432145|19106476|P1|NOT COMPLETED|Overall Study||7
7759608|NCT01432145|19106476|P1|COMPLETED|Overall Study||67
7759609|NCT01432145|19106476|P1|STARTED|Overall Study|Corrected from 75. 75 was entered in error|74
7759610|NCT01432015|19106483|P2|NOT COMPLETED|Overall Study||0
7759611|NCT01432015|19106484|P1|NOT COMPLETED|Overall Study||0
7759612|NCT01432015|19106483|P2|COMPLETED|Overall Study||10
7759613|NCT01432015|19106484|P1|COMPLETED|Overall Study||10
7759614|NCT01432015|19106483|P2|STARTED|Overall Study||10
7759615|NCT01432015|19106484|P1|STARTED|Overall Study||10
7759616|NCT01431989|19106492|P2|NOT COMPLETED|Period 2||0
7759617|NCT01431989|19106493|P1|NOT COMPLETED|Period 2||0
7759618|NCT01431989|19106492|P2|COMPLETED|Period 2||14
7759619|NCT01431989|19106493|P1|COMPLETED|Period 2||14
7759620|NCT01431989|19106492|P2|STARTED|Period 2||14
7759621|NCT01431989|19106493|P1|STARTED|Period 2||14
7759622|NCT01431989|19106492|P2|NOT COMPLETED|14-Day Washout Period||0
7759623|NCT01431989|19106493|P1|NOT COMPLETED|14-Day Washout Period||0
7759624|NCT01431989|19106492|P2|COMPLETED|14-Day Washout Period||14
7759625|NCT01431989|19106493|P1|COMPLETED|14-Day Washout Period||14
7759626|NCT01431989|19106492|P2|STARTED|14-Day Washout Period||14
7759627|NCT01431989|19106493|P1|STARTED|14-Day Washout Period||14
7759628|NCT01431989|19106492|P2|NOT COMPLETED|Period 1||0
7759629|NCT01431989|19106493|P1|NOT COMPLETED|Period 1||0
7759630|NCT01431989|19106492|P2|COMPLETED|Period 1||14
7759631|NCT01431989|19106493|P1|COMPLETED|Period 1||14
7759632|NCT01431989|19106492|P2|STARTED|Period 1||14
7759633|NCT01431989|19106493|P1|STARTED|Period 1||14
7759634|NCT01431976|19106511|P1|NOT COMPLETED|Overall Study||14
7759635|NCT01431976|19106511|P1|COMPLETED|Overall Study||6
7759636|NCT01431976|19106511|P1|STARTED|Overall Study||20
7759637|NCT01431963|19106522|P1|NOT COMPLETED|Overall Study||35
7759638|NCT01431963|19106522|P1|COMPLETED|Overall Study||32
7759639|NCT01431963|19106522|P1|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19
7759640|NCT01431963|19106522|P1|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19
7759641|NCT01431963|19106522|P1|Complete MP (24 Weeks)|Overall Study||42
7759642|NCT01431963|19106522|P1|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52
7759643|NCT01431963|19106522|P1|Complete EP (6 Weeks)|Overall Study||52
7759644|NCT01431963|19106522|P1|Received Treatment|Overall Study||65
7759645|NCT01431963|19106522|P1|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67
7759646|NCT01431963|19106522|P1|STARTED|Overall Study||67
7759647|NCT01431950|19106530|P2|NOT COMPLETED|Overall Study||15
7759648|NCT01431950|19106531|P1|NOT COMPLETED|Overall Study||19
7759649|NCT01431950|19106530|P2|COMPLETED|Overall Study||104
7759650|NCT01431950|19106531|P1|COMPLETED|Overall Study||100
7759651|NCT01431950|19106530|P2|STARTED|Overall Study||119
7759652|NCT01431950|19106531|P1|STARTED|Overall Study||119
7759653|NCT01431846|19106548|P3|NOT COMPLETED|Overall Study||0
7759654|NCT01431846|19106549|P2|NOT COMPLETED|Overall Study||0
7759655|NCT01431846|19106550|P1|NOT COMPLETED|Overall Study||0
7759656|NCT01431846|19106548|P3|COMPLETED|Overall Study||8
7759657|NCT01431846|19106549|P2|COMPLETED|Overall Study||3
7759658|NCT01431846|19106550|P1|COMPLETED|Overall Study||8
7759659|NCT01431846|19106548|P3|STARTED|Overall Study||8
7759660|NCT01431846|19106549|P2|STARTED|Overall Study||3
7759661|NCT01431846|19106550|P1|STARTED|Overall Study||8
7759662|NCT01431794|19106563|P5|NOT COMPLETED|Overall Study||0
7759663|NCT01431794|19106564|P4|NOT COMPLETED|Overall Study||0
7759664|NCT01431794|19106565|P3|NOT COMPLETED|Overall Study||0
7759665|NCT01431794|19106566|P2|NOT COMPLETED|Overall Study||0
7759666|NCT01431794|19106567|P1|NOT COMPLETED|Overall Study||0
7759667|NCT01431794|19106563|P5|COMPLETED|Overall Study|not started due to early study's termination|0
7759668|NCT01431794|19106564|P4|COMPLETED|Overall Study|not started due to early study's termination|0
7759669|NCT01431794|19106565|P3|COMPLETED|Overall Study|not started due to early study's termination|0
7759670|NCT01431794|19106566|P2|COMPLETED|Overall Study|not started due to early study's termination|0
7759671|NCT01431794|19106567|P1|COMPLETED|Overall Study||13
7759672|NCT01431794|19106563|P5|STARTED|Overall Study|not started due to early study's termination|0
7759673|NCT01431794|19106564|P4|STARTED|Overall Study|not started due to early study's termination|0
7759674|NCT01431794|19106565|P3|STARTED|Overall Study|not started due to early study's termination|0
7759675|NCT01431794|19106566|P2|STARTED|Overall Study|not started due to early study's termination|0
7759676|NCT01431794|19106567|P1|STARTED|Overall Study||13
7759677|NCT01431755|19106585|P1|NOT COMPLETED|Overall Study||5
7759678|NCT01431755|19106585|P1|COMPLETED|Overall Study||49
7759679|NCT01431755|19106585|P1|STARTED|Overall Study||54
7759680|NCT01431716|19106596|P1|NOT COMPLETED|Overall Study||1
7759681|NCT01431716|19106596|P1|COMPLETED|Overall Study||41
7759682|NCT01431716|19106596|P1|STARTED|Overall Study||42
7759683|NCT01431703|19106613|P1|NOT COMPLETED|Overall Study||0
7759684|NCT01431703|19106613|P1|COMPLETED|Overall Study||326
7759685|NCT01431703|19106613|P1|STARTED|Overall Study||326
7759686|NCT01431534|19106620|P3|NOT COMPLETED|Extension Phase||0
7759687|NCT01431534|19106621|P2|NOT COMPLETED|Extension Phase||0
7759688|NCT01431534|19106622|P1|NOT COMPLETED|Extension Phase||0
7759689|NCT01431534|19106620|P3|COMPLETED|Extension Phase||2
7759690|NCT01431534|19106621|P2|COMPLETED|Extension Phase||0
7759691|NCT01431534|19106622|P1|COMPLETED|Extension Phase||0
7759692|NCT01431534|19106620|P3|STARTED|Extension Phase|Participants from Treatment Phase who continued in Extension Phase.|2
7759693|NCT01431534|19106621|P2|STARTED|Extension Phase|No participants continued in Extension Phase.|0
7759694|NCT01431534|19106622|P1|STARTED|Extension Phase|No participants continued in Extension Phase.|0
7759695|NCT01431534|19106620|P3|NOT COMPLETED|Treatment Phase||11
7759696|NCT01431534|19106621|P2|NOT COMPLETED|Treatment Phase||3
7759697|NCT01431534|19106622|P1|NOT COMPLETED|Treatment Phase||4
7759698|NCT01431534|19106620|P3|COMPLETED|Treatment Phase|Participants completing Treatment Phase could continue in Extension Phase.|2
7759699|NCT01431534|19106621|P2|COMPLETED|Treatment Phase||0
7759700|NCT01431534|19106622|P1|COMPLETED|Treatment Phase||0
7759701|NCT01431534|19106620|P3|STARTED|Treatment Phase||13
7759702|NCT01431534|19106621|P2|STARTED|Treatment Phase||3
7759703|NCT01431534|19106622|P1|STARTED|Treatment Phase||4
7759704|NCT01431521|19106637|P4|NOT COMPLETED|Overall Study||0
7759705|NCT01431521|19106638|P3|NOT COMPLETED|Overall Study||1
7759706|NCT01431521|19106639|P2|NOT COMPLETED|Overall Study||0
7759707|NCT01431521|19106640|P1|NOT COMPLETED|Overall Study||0
7759708|NCT01431521|19106637|P4|COMPLETED|Overall Study||5
7759709|NCT01431521|19106638|P3|COMPLETED|Overall Study||10
7759710|NCT01431521|19106639|P2|COMPLETED|Overall Study||5
7759711|NCT01431521|19106640|P1|COMPLETED|Overall Study||10
7759712|NCT01431521|19106637|P4|Treated|Overall Study||5
7759713|NCT01431521|19106638|P3|Treated|Overall Study||10
7759714|NCT01431521|19106639|P2|Treated|Overall Study||5
7759715|NCT01431521|19106640|P1|Treated|Overall Study||10
7759716|NCT01431521|19106637|P4|STARTED|Overall Study||5
7759717|NCT01431521|19106638|P3|STARTED|Overall Study||11
7759718|NCT01431521|19106639|P2|STARTED|Overall Study||5
7759719|NCT01431521|19106640|P1|STARTED|Overall Study||10
7759720|NCT01431508|19106661|P1|NOT COMPLETED|Overall Study||2
7759721|NCT01431508|19106661|P1|COMPLETED|Overall Study||13
7759722|NCT01431508|19106661|P1|STARTED|Overall Study||15
7759723|NCT01431391|19106667|P2|NOT COMPLETED|Overall Study||4
7759724|NCT01431391|19106668|P1|NOT COMPLETED|Overall Study||8
7759725|NCT01431391|19106667|P2|COMPLETED|Overall Study||30
7759726|NCT01431391|19106668|P1|COMPLETED|Overall Study||26
7759727|NCT01431391|19106667|P2|Received ≥1 Leaukapheresis|Overall Study||34
7759728|NCT01431391|19106668|P1|Received ≥1 Leaukapheresis|Overall Study||34
7759729|NCT01431391|19106667|P2|STARTED|Overall Study||34
7759730|NCT01431391|19106668|P1|STARTED|Overall Study||34
7759731|NCT01431339|19106678|P2|NOT COMPLETED|Overall Study||35
7759732|NCT01431339|19106679|P1|NOT COMPLETED|Overall Study||39
7759733|NCT01431339|19106678|P2|COMPLETED|Overall Study||333
7759734|NCT01431339|19106679|P1|COMPLETED|Overall Study||332
7759735|NCT01431339|19106678|P2|Safety Population|Overall Study||367
7759736|NCT01431339|19106679|P1|Safety Population|Overall Study||368
7759737|NCT01431339|19106678|P2|STARTED|Overall Study||368
7759738|NCT01431339|19106679|P1|STARTED|Overall Study||371
7759739|NCT01431313|19106694|P3|NOT COMPLETED|Overall Study||0
7759740|NCT01431313|19106695|P2|NOT COMPLETED|Overall Study||0
7759741|NCT01431313|19106696|P1|NOT COMPLETED|Overall Study||0
7759742|NCT01431313|19106694|P3|COMPLETED|Overall Study||8
7759743|NCT01431313|19106695|P2|COMPLETED|Overall Study||20
7759744|NCT01431313|19106696|P1|COMPLETED|Overall Study||20
7759745|NCT01431313|19106694|P3|STARTED|Overall Study||8
7759746|NCT01431313|19106695|P2|STARTED|Overall Study||20
7759747|NCT01431313|19106696|P1|STARTED|Overall Study||20
7759748|NCT01431300|19106728|P3|NOT COMPLETED|Overall Study||0
7759749|NCT01431300|19106729|P2|NOT COMPLETED|Overall Study||0
7759750|NCT01431300|19106730|P1|NOT COMPLETED|Overall Study||1
7759751|NCT01431300|19106728|P3|COMPLETED|Overall Study||10
7759752|NCT01431300|19106729|P2|COMPLETED|Overall Study||10
7759753|NCT01431300|19106730|P1|COMPLETED|Overall Study||10
7759754|NCT01431300|19106728|P3|STARTED|Overall Study||10
7759755|NCT01431300|19106729|P2|STARTED|Overall Study||10
7759756|NCT01431300|19106730|P1|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11
7759757|NCT01431287|19106746|P5|NOT COMPLETED|Overall Study||77
7759758|NCT01431287|19106747|P4|NOT COMPLETED|Overall Study||63
7759759|NCT01431287|19106748|P3|NOT COMPLETED|Overall Study||97
7759760|NCT01431287|19106749|P2|NOT COMPLETED|Overall Study||98
7759761|NCT01431287|19106750|P1|NOT COMPLETED|Overall Study||98
7759762|NCT01431287|19106746|P5|COMPLETED|Overall Study||430
7759763|NCT01431287|19106747|P4|COMPLETED|Overall Study||445
7759764|NCT01431287|19106748|P3|COMPLETED|Overall Study||410
7759765|NCT01431287|19106749|P2|COMPLETED|Overall Study||409
7759766|NCT01431287|19106750|P1|COMPLETED|Overall Study||412
7759767|NCT01431287|19106746|P5|STARTED|Overall Study||507
7759768|NCT01431287|19106747|P4|STARTED|Overall Study||508
7759769|NCT01431287|19106748|P3|STARTED|Overall Study||507
7759770|NCT01431287|19106749|P2|STARTED|Overall Study||507
7759771|NCT01431287|19106750|P1|STARTED|Overall Study|started are actually the randomized|510
7759772|NCT01431274|19106912|P5|NOT COMPLETED|Overall Study||56
7759773|NCT01431274|19106913|P4|NOT COMPLETED|Overall Study||60
7759774|NCT01431274|19106914|P3|NOT COMPLETED|Overall Study||72
7759775|NCT01431274|19106915|P2|NOT COMPLETED|Overall Study||77
7759776|NCT01431274|19106916|P1|NOT COMPLETED|Overall Study||97
7759777|NCT01431274|19106912|P5|COMPLETED|Overall Study||466
7759778|NCT01431274|19106913|P4|COMPLETED|Overall Study||462
7759779|NCT01431274|19106914|P3|COMPLETED|Overall Study||455
7759780|NCT01431274|19106915|P2|COMPLETED|Overall Study||448
7759781|NCT01431274|19106916|P1|COMPLETED|Overall Study||431
7759782|NCT01431274|19106912|P5|STARTED|Overall Study||522
7759783|NCT01431274|19106913|P4|STARTED|Overall Study||522
7759784|NCT01431274|19106914|P3|STARTED|Overall Study||527
7759785|NCT01431274|19106915|P2|STARTED|Overall Study||525
7759786|NCT01431274|19106916|P1|STARTED|Overall Study||528
7759787|NCT01431170|19107075|P2|NOT COMPLETED|Overall Study||1
7759788|NCT01431170|19107076|P1|NOT COMPLETED|Overall Study||3
7759789|NCT01431170|19107075|P2|COMPLETED|Overall Study||11
7759790|NCT01431170|19107076|P1|COMPLETED|Overall Study||9
7759791|NCT01431170|19107075|P2|STARTED|Overall Study||12
7759792|NCT01431170|19107076|P1|STARTED|Overall Study||12
7759793|NCT01431144|19107094|P2|NOT COMPLETED|Overall Study||0
7759794|NCT01431144|19107095|P1|NOT COMPLETED|Overall Study||2
7759795|NCT01431144|19107094|P2|COMPLETED|Overall Study||14
7759796|NCT01431144|19107095|P1|COMPLETED|Overall Study||11
7759797|NCT01431144|19107094|P2|STARTED|Overall Study||14
7759798|NCT01431144|19107095|P1|STARTED|Overall Study||13
7759799|NCT01431131|19107103|P2|NOT COMPLETED|Overall Study||0
7759800|NCT01431131|19107104|P1|NOT COMPLETED|Overall Study||0
7759801|NCT01431131|19107103|P2|COMPLETED|Overall Study||12
7759802|NCT01431131|19107104|P1|COMPLETED|Overall Study||12
7759803|NCT01431131|19107103|P2|STARTED|Overall Study||12
7759804|NCT01431131|19107104|P1|STARTED|Overall Study||12
7759805|NCT01431105|19107112|P1|NOT COMPLETED|Overall Study||0
7759806|NCT01431105|19107112|P1|COMPLETED|Overall Study||34
7759807|NCT01431105|19107112|P1|STARTED|Overall Study||34
7759808|NCT01431079|19107118|P2|NOT COMPLETED|Overall Study||39
7759809|NCT01431079|19107119|P1|NOT COMPLETED|Overall Study||35
7759810|NCT01431079|19107118|P2|COMPLETED|Overall Study||6
7759811|NCT01431079|19107119|P1|COMPLETED|Overall Study||10
7759812|NCT01431079|19107118|P2|Post-test|Overall Study||45
7759813|NCT01431079|19107119|P1|Post-test|Overall Study||45
7759814|NCT01431079|19107118|P2|STARTED|Overall Study||45
7759815|NCT01431079|19107119|P1|STARTED|Overall Study||45
7759816|NCT01431014|19107173|P2|NOT COMPLETED|Overall Study||9
7759817|NCT01431014|19107174|P1|NOT COMPLETED|Overall Study||3
7759818|NCT01431014|19107173|P2|COMPLETED|Overall Study||25
7759819|NCT01431014|19107174|P1|COMPLETED|Overall Study||31
7759820|NCT01431014|19107173|P2|STARTED|Overall Study||34
7759821|NCT01431014|19107174|P1|STARTED|Overall Study||34
7759822|NCT01430819|19107182|P2|NOT COMPLETED|Overall Study||0
7759823|NCT01430819|19107183|P1|NOT COMPLETED|Overall Study||0
7759824|NCT01430819|19107182|P2|COMPLETED|Overall Study||150
7759825|NCT01430819|19107183|P1|COMPLETED|Overall Study||150
7759826|NCT01430819|19107182|P2|STARTED|Overall Study||150
7759827|NCT01430819|19107183|P1|STARTED|Overall Study||150
7759828|NCT01430754|19107198|P2|NOT COMPLETED|Randomized Phase||0
7759829|NCT01430754|19107199|P1|NOT COMPLETED|Randomized Phase||0
7759830|NCT01430754|19107198|P2|COMPLETED|Randomized Phase||10
7759831|NCT01430754|19107199|P1|COMPLETED|Randomized Phase||10
7759832|NCT01430754|19107198|P2|STARTED|Randomized Phase||10
7759833|NCT01430754|19107199|P1|STARTED|Randomized Phase||10
7759834|NCT01430754|19107198|P2|NOT COMPLETED|Run-In Phase||0
7759835|NCT01430754|19107199|P1|NOT COMPLETED|Run-In Phase||37
7759836|NCT01430754|19107198|P2|COMPLETED|Run-In Phase||0
7759837|NCT01430754|19107199|P1|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20
7759838|NCT01430754|19107198|P2|Entrained - After Run-In Phase|Run-In Phase||0
7759839|NCT01430754|19107199|P1|Entrained - After Run-In Phase|Run-In Phase||24
7759840|NCT01430754|19107198|P2|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0
7759841|NCT01430754|19107199|P1|STARTED|Run-In Phase||57
7759842|NCT01430741|19107221|P4|NOT COMPLETED|Overall Study||0
7759843|NCT01430741|19107222|P3|NOT COMPLETED|Overall Study||10
7759844|NCT01430741|19107223|P2|NOT COMPLETED|Overall Study||0
7759845|NCT01430741|19107224|P1|NOT COMPLETED|Overall Study||0
7759846|NCT01430741|19107221|P4|COMPLETED|Overall Study||81
7759847|NCT01430741|19107222|P3|COMPLETED|Overall Study||37
7759848|NCT01430741|19107223|P2|COMPLETED|Overall Study||87
7759849|NCT01430741|19107224|P1|COMPLETED|Overall Study||22
7759850|NCT01430741|19107221|P4|STARTED|Overall Study||81
7759851|NCT01430741|19107222|P3|STARTED|Overall Study||47
7759852|NCT01430741|19107223|P2|STARTED|Overall Study||87
7759853|NCT01430741|19107224|P1|STARTED|Overall Study||22
7759854|NCT01430624|19107257|P3|NOT COMPLETED|Overall Study||29
7759855|NCT01430624|19107258|P2|NOT COMPLETED|Overall Study||34
7759856|NCT01430624|19107259|P1|NOT COMPLETED|Overall Study||28
7759857|NCT01430624|19107257|P3|COMPLETED|Overall Study|Completed one or more follow-ups|52
7759858|NCT01430624|19107258|P2|COMPLETED|Overall Study|Completed one or more follow-ups|48
7759859|NCT01430624|19107259|P1|COMPLETED|Overall Study|Completed one or more follow-ups|54
7759860|NCT01430624|19107257|P3|Eligible Baseline Completes|Overall Study||79
7759861|NCT01430624|19107258|P2|Eligible Baseline Completes|Overall Study||77
7759862|NCT01430624|19107259|P1|Eligible Baseline Completes|Overall Study||77
7759863|NCT01430624|19107257|P3|STARTED|Overall Study||81
7759864|NCT01430624|19107258|P2|STARTED|Overall Study||82
7759865|NCT01430624|19107259|P1|STARTED|Overall Study|Initial potential eligible screened enrolled|82
7759866|NCT01430611|19107290|P2|NOT COMPLETED|Overall Study||15
7759867|NCT01430611|19107291|P1|NOT COMPLETED|Overall Study||17
7759868|NCT01430611|19107290|P2|COMPLETED|Overall Study||318
7759869|NCT01430611|19107291|P1|COMPLETED|Overall Study||315
7759870|NCT01430611|19107290|P2|STARTED|Overall Study||333
7759871|NCT01430611|19107291|P1|STARTED|Overall Study||332
7759872|NCT01430585|19107309|P1|NOT COMPLETED|Overall Study||14
7759873|NCT01430585|19107309|P1|COMPLETED|Overall Study||0
7759874|NCT01430585|19107309|P1|STARTED|Overall Study||14
7759875|NCT01430559|19107344|P2|NOT COMPLETED|Overall Study||12
7759876|NCT01430559|19107345|P1|NOT COMPLETED|Overall Study||20
7759877|NCT01430559|19107344|P2|COMPLETED|Overall Study||135
7759878|NCT01430559|19107345|P1|COMPLETED|Overall Study||126
7759879|NCT01430559|19107344|P2|Treated|Overall Study||144
7759880|NCT01430559|19107345|P1|Treated|Overall Study||143
7759881|NCT01430559|19107344|P2|STARTED|Overall Study||147
7759882|NCT01430559|19107345|P1|STARTED|Overall Study||146
7759883|NCT01430468|19107381|P2|NOT COMPLETED|Overall Study||6
7759884|NCT01430468|19107382|P1|NOT COMPLETED|Overall Study||7
7759885|NCT01430468|19107381|P2|COMPLETED|Overall Study||16
7759886|NCT01430468|19107382|P1|COMPLETED|Overall Study||15
7759887|NCT01430468|19107381|P2|STARTED|Overall Study||22
7759888|NCT01430468|19107382|P1|STARTED|Overall Study||22
7759889|NCT01430455|19107390|P1|NOT COMPLETED|Overall Study||2
7759890|NCT01430455|19107390|P1|COMPLETED|Overall Study||5
7759891|NCT01430455|19107390|P1|STARTED|Overall Study||7
7759892|NCT01430442|19107402|P8|NOT COMPLETED|Overall Study||9
7759893|NCT01430442|19107403|P7|NOT COMPLETED|Overall Study||19
7759894|NCT01430442|19107404|P6|NOT COMPLETED|Overall Study||8
7759895|NCT01430442|19107405|P5|NOT COMPLETED|Overall Study||9
7759896|NCT01430442|19107406|P4|NOT COMPLETED|Overall Study||4
7759897|NCT01430442|19107407|P3|NOT COMPLETED|Overall Study||5
7759898|NCT01430442|19107408|P2|NOT COMPLETED|Overall Study||6
7759899|NCT01430442|19107409|P1|NOT COMPLETED|Overall Study||13
7759900|NCT01430442|19107402|P8|COMPLETED|Overall Study||100
7759901|NCT01430442|19107403|P7|COMPLETED|Overall Study||210
7759902|NCT01430442|19107404|P6|COMPLETED|Overall Study||84
7759903|NCT01430442|19107405|P5|COMPLETED|Overall Study||112
7759904|NCT01430442|19107406|P4|COMPLETED|Overall Study||86
7759905|NCT01430442|19107407|P3|COMPLETED|Overall Study||86
7759906|NCT01430442|19107408|P2|COMPLETED|Overall Study||62
7759907|NCT01430442|19107409|P1|COMPLETED|Overall Study||72
7759908|NCT01430442|19107402|P8|STARTED|Overall Study||109
7759909|NCT01430442|19107403|P7|STARTED|Overall Study||229
7759910|NCT01430442|19107404|P6|STARTED|Overall Study||92
7759911|NCT01430442|19107405|P5|STARTED|Overall Study||121
7759912|NCT01430442|19107406|P4|STARTED|Overall Study||90
7759913|NCT01430442|19107407|P3|STARTED|Overall Study||91
7759914|NCT01430442|19107408|P2|STARTED|Overall Study||68
7759915|NCT01430442|19107409|P1|STARTED|Overall Study||85
7759916|NCT01430403|19107462|P3|NOT COMPLETED|Overall Study||8
7759917|NCT01430403|19107463|P2|NOT COMPLETED|Overall Study||9
7759918|NCT01430403|19107464|P1|NOT COMPLETED|Overall Study||17
7759919|NCT01430403|19107462|P3|COMPLETED|Overall Study||81
7759920|NCT01430403|19107463|P2|COMPLETED|Overall Study||121
7759921|NCT01430403|19107464|P1|COMPLETED|Overall Study||242
7759922|NCT01430403|19107462|P3|STARTED|Overall Study|Intent-to-treat|89
7759923|NCT01430403|19107463|P2|STARTED|Overall Study|Intent-to-treat|130
7759924|NCT01430403|19107464|P1|STARTED|Overall Study|Intent-to-treat|259
7759925|NCT01430325|19107517|P4|NOT COMPLETED|Overall Study||0
7759926|NCT01430325|19107518|P3|NOT COMPLETED|Overall Study||0
7759927|NCT01430325|19107519|P2|NOT COMPLETED|Overall Study||0
7759928|NCT01430325|19107520|P1|NOT COMPLETED|Overall Study||0
7759929|NCT01430325|19107517|P4|COMPLETED|Overall Study||12
7759930|NCT01430325|19107518|P3|COMPLETED|Overall Study||8
7759931|NCT01430325|19107519|P2|COMPLETED|Overall Study||12
7759932|NCT01430325|19107520|P1|COMPLETED|Overall Study||10
7759933|NCT01430325|19107517|P4|STARTED|Overall Study||12
7759934|NCT01430325|19107518|P3|STARTED|Overall Study||8
7759935|NCT01430325|19107519|P2|STARTED|Overall Study||12
7759936|NCT01430325|19107520|P1|STARTED|Overall Study||10
7759937|NCT01430299|19107540|P2|NOT COMPLETED|Overall Study||2
7759938|NCT01430299|19107541|P1|NOT COMPLETED|Overall Study||4
7759939|NCT01430299|19107540|P2|COMPLETED|Overall Study||21
7759940|NCT01430299|19107541|P1|COMPLETED|Overall Study||16
7759941|NCT01430299|19107540|P2|STARTED|Overall Study||23
7759942|NCT01430299|19107541|P1|STARTED|Overall Study||20
7759943|NCT01430182|19107549|P2|NOT COMPLETED|Overall Study||0
7759944|NCT01430182|19107550|P1|NOT COMPLETED|Overall Study||0
7759945|NCT01430182|19107549|P2|COMPLETED|Overall Study||8
7759946|NCT01430182|19107550|P1|COMPLETED|Overall Study||9
7759947|NCT01430182|19107549|P2|STARTED|Overall Study||8
7759948|NCT01430182|19107550|P1|STARTED|Overall Study||9
7759949|NCT01430169|19107556|P1|NOT COMPLETED|Overall Study||0
7759950|NCT01430169|19107556|P1|COMPLETED|Overall Study||20
7759951|NCT01430169|19107556|P1|STARTED|Overall Study||20
7759952|NCT01430130|19107571|P1|NOT COMPLETED|Overall Study||2
7759953|NCT01430130|19107571|P1|COMPLETED|Overall Study||10
7759954|NCT01430130|19107571|P1|STARTED|Overall Study||12
7759955|NCT01430104|19107577|P1|NOT COMPLETED|28-Day Teriparatide Treatment Period||1
7759956|NCT01430104|19107577|P1|COMPLETED|28-Day Teriparatide Treatment Period||28
7759957|NCT01430104|19107577|P1|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29
7759958|NCT01430104|19107577|P1|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29
7759959|NCT01430104|19107577|P1|NOT COMPLETED|14-Day Lead-In Period||0
7759960|NCT01430104|19107577|P1|COMPLETED|14-Day Lead-In Period||30
7759961|NCT01430104|19107577|P1|STARTED|14-Day Lead-In Period||30
7759962|NCT01430091|19107589|P1|NOT COMPLETED|Overall Study||0
7759963|NCT01430091|19107589|P1|COMPLETED|Overall Study||18
7759964|NCT01430091|19107589|P1|STARTED|Overall Study||18
7759965|NCT01429987|19107615|P4|NOT COMPLETED|Overall Study||66
7759966|NCT01429987|19107616|P3|NOT COMPLETED|Overall Study||36
7759967|NCT01429987|19107617|P2|NOT COMPLETED|Overall Study||62
7759968|NCT01429987|19107618|P1|NOT COMPLETED|Overall Study||49
7759969|NCT01429987|19107615|P4|COMPLETED|Overall Study||171
7759970|NCT01429987|19107616|P3|COMPLETED|Overall Study||202
7759971|NCT01429987|19107617|P2|COMPLETED|Overall Study||176
7759972|NCT01429987|19107618|P1|COMPLETED|Overall Study||189
7759973|NCT01429987|19107615|P4|STARTED|Overall Study||237
7759974|NCT01429987|19107616|P3|STARTED|Overall Study||238
7759975|NCT01429987|19107617|P2|STARTED|Overall Study||238
7759976|NCT01429987|19107618|P1|STARTED|Overall Study||238
7759977|NCT01429792|19107644|P1|NOT COMPLETED|Overall Study||406
7759978|NCT01429792|19107644|P1|COMPLETED|Overall Study||607
7759979|NCT01429792|19107644|P1|Genotype 4|Overall Study||5
7759980|NCT01429792|19107644|P1|Genotype 2 & 3|Overall Study||305
7759981|NCT01429792|19107644|P1|Genotype 1|Overall Study||687
7759982|NCT01429792|19107644|P1|STARTED|Overall Study||1013
7759983|NCT01429623|19107658|P2|NOT COMPLETED|Overall Study||59
7759984|NCT01429623|19107659|P1|NOT COMPLETED|Overall Study||51
7759985|NCT01429623|19107658|P2|COMPLETED|Overall Study||48
7759986|NCT01429623|19107659|P1|COMPLETED|Overall Study||51
7759987|NCT01429623|19107658|P2|Converted to Alzheimer's|Overall Study|21 of 103|21
7759988|NCT01429623|19107659|P1|Converted to Alzheimer's|Overall Study|14 of 99|14
7759989|NCT01429623|19107658|P2|STARTED|Overall Study|107 allocated, 4 lacked post baseline data|107
7759990|NCT01429623|19107659|P1|STARTED|Overall Study|103 allocated, 1 withdrew consent prior to first dose, 4 lacked post baseline data|102
7759991|NCT01429584|19107673|P2|NOT COMPLETED|Overall Study||1
7759992|NCT01429584|19107674|P1|NOT COMPLETED|Overall Study||1
7759993|NCT01429584|19107673|P2|COMPLETED|Overall Study||14
7759994|NCT01429584|19107674|P1|COMPLETED|Overall Study||14
7759995|NCT01429584|19107673|P2|STARTED|Overall Study||15
7759996|NCT01429584|19107674|P1|STARTED|Overall Study||15
7759997|NCT01429532|19107687|P3|NOT COMPLETED|Overall Study||0
7759998|NCT01429532|19107688|P2|NOT COMPLETED|Overall Study||0
7759999|NCT01429532|19107689|P1|NOT COMPLETED|Overall Study||0
7760000|NCT01429532|19107687|P3|COMPLETED|Overall Study||40
7760001|NCT01429532|19107688|P2|COMPLETED|Overall Study||40
7760002|NCT01429532|19107689|P1|COMPLETED|Overall Study||40
7760003|NCT01429532|19107687|P3|STARTED|Overall Study||40
7760004|NCT01429532|19107688|P2|STARTED|Overall Study||40
7760005|NCT01429532|19107689|P1|STARTED|Overall Study||40
7760006|NCT01429454|19107705|P2|NOT COMPLETED|Overall Study||30
7760007|NCT01429454|19107706|P1|NOT COMPLETED|Overall Study||27
7760008|NCT01429454|19107705|P2|COMPLETED|Overall Study||35
7760009|NCT01429454|19107706|P1|COMPLETED|Overall Study||35
7760010|NCT01429454|19107705|P2|STARTED|Overall Study||65
7760011|NCT01429454|19107706|P1|STARTED|Overall Study||62
7760012|NCT01429441|19107716|P2|NOT COMPLETED|Overall Study||23
7760013|NCT01429441|19107717|P1|NOT COMPLETED|Overall Study||38
7760014|NCT01429441|19107716|P2|COMPLETED|Overall Study||51
7760015|NCT01429441|19107717|P1|COMPLETED|Overall Study||108
7760016|NCT01429441|19107716|P2|STARTED|Overall Study||74
7760017|NCT01429441|19107717|P1|STARTED|Overall Study||146
7760018|NCT01429350|19107727|P2|NOT COMPLETED|Overall Study||5
7760019|NCT01429350|19107728|P1|NOT COMPLETED|Overall Study||7
7760020|NCT01429350|19107727|P2|COMPLETED|Overall Study||50
7760021|NCT01429350|19107728|P1|COMPLETED|Overall Study||46
7760022|NCT01429350|19107727|P2|90 Day|Overall Study||50
7760023|NCT01429350|19107728|P1|90 Day|Overall Study||46
7760024|NCT01429350|19107727|P2|Per Protocol|Overall Study||37
7760025|NCT01429350|19107728|P1|Per Protocol|Overall Study||41
7760026|NCT01429350|19107727|P2|As-Treated|Overall Study||43
7760027|NCT01429350|19107728|P1|As-Treated|Overall Study||62
7760028|NCT01429350|19107727|P2|STARTED|Overall Study||55
7760029|NCT01429350|19107728|P1|STARTED|Overall Study||53
7760030|NCT01429298|19107742|P2|NOT COMPLETED|Overall Study||6
7760031|NCT01429298|19107743|P1|NOT COMPLETED|Overall Study||4
7760032|NCT01429298|19107742|P2|COMPLETED|Overall Study||169
7760033|NCT01429298|19107743|P1|COMPLETED|Overall Study||171
7760034|NCT01429298|19107742|P2|Given IV Opioids|Overall Study|6 never given IV opioids|169
7760035|NCT01429298|19107743|P1|Given IV Opioids|Overall Study|4 never given IV opioids|171
7760036|NCT01429298|19107742|P2|STARTED|Overall Study||175
7760037|NCT01429298|19107743|P1|STARTED|Overall Study||175
7760038|NCT01429285|19107759|P2|NOT COMPLETED|Overall Study||9
7760039|NCT01429285|19107760|P1|NOT COMPLETED|Overall Study||22
7760040|NCT01429285|19107759|P2|COMPLETED|Overall Study||166
7760041|NCT01429285|19107760|P1|COMPLETED|Overall Study||153
7760042|NCT01429285|19107759|P2|Confirmation of no Duplicate Enrollment|Overall Study|2 patients were enrolled twice, at two separate ED visits, which was only noted at study conclusion|166
7760043|NCT01429285|19107760|P1|Confirmation of no Duplicate Enrollment|Overall Study|8 patients were enrolled twice at two separate ED visits, which was only noted at study conclusion.|153
7760044|NCT01429285|19107759|P2|Completed Primary Outcome Data|Overall Study|3 patients had missing data|168
7760045|NCT01429285|19107760|P1|Completed Primary Outcome Data|Overall Study|5 patients had missing data|161
7760046|NCT01429285|19107759|P2|Given IV Opioids|Overall Study|4 patients never given IV opioids|171
7760047|NCT01429285|19107760|P1|Given IV Opioids|Overall Study|9 patients never given IV opioids|166
7760048|NCT01429285|19107759|P2|STARTED|Overall Study||175
7760049|NCT01429285|19107760|P1|STARTED|Overall Study||175
7760050|NCT01429272|19107782|P4|NOT COMPLETED|Overall Study||5
7760051|NCT01429272|19107783|P3|NOT COMPLETED|Overall Study||4
7760052|NCT01429272|19107784|P2|NOT COMPLETED|Overall Study||9
7760053|NCT01429272|19107785|P1|NOT COMPLETED|Overall Study||6
7760054|NCT01429272|19107782|P4|COMPLETED|Overall Study||14
7760055|NCT01429272|19107783|P3|COMPLETED|Overall Study||15
7760056|NCT01429272|19107784|P2|COMPLETED|Overall Study||22
7760057|NCT01429272|19107785|P1|COMPLETED|Overall Study||24
7760058|NCT01429272|19107782|P4|STARTED|Overall Study||19
7760059|NCT01429272|19107783|P3|STARTED|Overall Study||19
7760060|NCT01429272|19107784|P2|STARTED|Overall Study||31
7760061|NCT01429272|19107785|P1|STARTED|Overall Study||30
7760062|NCT01429259|19107799|P1|NOT COMPLETED|Overall Study||0
7760063|NCT01429259|19107799|P1|COMPLETED|Overall Study||30
7760064|NCT01429259|19107799|P1|STARTED|Overall Study||30
7760065|NCT01429077|19107806|P2|NOT COMPLETED|Overall Study||3
7760066|NCT01429077|19107807|P1|NOT COMPLETED|Overall Study||0
7760067|NCT01429077|19107806|P2|COMPLETED|Overall Study||14
7760068|NCT01429077|19107807|P1|COMPLETED|Overall Study||19
7760069|NCT01429077|19107806|P2|Completed 6-week Intervention|Overall Study||17
7760070|NCT01429077|19107807|P1|Completed 6-week Intervention|Overall Study||19
7760071|NCT01429077|19107806|P2|STARTED|Overall Study||17
7760072|NCT01429077|19107807|P1|STARTED|Overall Study||19
7760073|NCT01429064|19107817|P4|NOT COMPLETED|Overall Study||0
7760074|NCT01429064|19107818|P3|NOT COMPLETED|Overall Study||0
7760075|NCT01429064|19107819|P2|NOT COMPLETED|Overall Study||0
7760076|NCT01429064|19107820|P1|NOT COMPLETED|Overall Study||0
7760077|NCT01429064|19107817|P4|COMPLETED|Overall Study||16
7760078|NCT01429064|19107818|P3|COMPLETED|Overall Study||19
7760079|NCT01429064|19107819|P2|COMPLETED|Overall Study||22
7760080|NCT01429064|19107820|P1|COMPLETED|Overall Study||19
7760081|NCT01429064|19107817|P4|STARTED|Overall Study||16
7760082|NCT01429064|19107818|P3|STARTED|Overall Study||19
7760083|NCT01429064|19107819|P2|STARTED|Overall Study||22
7760084|NCT01429064|19107820|P1|STARTED|Overall Study||19
7760085|NCT01429051|19107830|P1|NOT COMPLETED|Tolerability Phase||15
7760086|NCT01429051|19107830|P1|COMPLETED|Tolerability Phase||16
7760087|NCT01429051|19107830|P1|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31
7760088|NCT01429051|19107830|P1|NOT COMPLETED|Efficacy Phase||2
7760089|NCT01429051|19107830|P1|COMPLETED|Efficacy Phase||13
7760090|NCT01429051|19107830|P1|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15
7760091|NCT01429051|19107830|P1|NOT COMPLETED|Titration Phase||12
7760092|NCT01429051|19107830|P1|COMPLETED|Titration Phase||33
7760093|NCT01429051|19107830|P1|STARTED|Titration Phase||45
7760094|NCT01428882|19107853|P2|NOT COMPLETED|Overall Study||10
7760095|NCT01428882|19107854|P1|NOT COMPLETED|Overall Study||6
7760096|NCT01428882|19107853|P2|COMPLETED|Overall Study||58
7760097|NCT01428882|19107854|P1|COMPLETED|Overall Study||61
7760098|NCT01428882|19107853|P2|STARTED|Overall Study||68
7760099|NCT01428882|19107854|P1|STARTED|Overall Study||67
7760100|NCT01428765|19107866|P1|NOT COMPLETED|Overall Study||0
7760101|NCT01428765|19107866|P1|COMPLETED|Overall Study||1063
7760102|NCT01428765|19107866|P1|STARTED|Overall Study||1063
7760103|NCT01428713|19107877|P2|NOT COMPLETED|Overall Study||5
7760104|NCT01428713|19107878|P1|NOT COMPLETED|Overall Study||3
7760105|NCT01428713|19107877|P2|COMPLETED|Overall Study||3
7760106|NCT01428713|19107878|P1|COMPLETED|Overall Study||6
7760107|NCT01428713|19107877|P2|STARTED|Overall Study||8
7760108|NCT01428713|19107878|P1|STARTED|Overall Study||9
7760109|NCT01428661|19107887|P3|NOT COMPLETED|Open Label Extension||320
7760110|NCT01428661|19107888|P2|NOT COMPLETED|Open Label Extension||0
7760111|NCT01428661|19107889|P1|NOT COMPLETED|Open Label Extension||0
7760112|NCT01428661|19107887|P3|COMPLETED|Open Label Extension||19
7760113|NCT01428661|19107888|P2|COMPLETED|Open Label Extension|Does not apply.|0
7760114|NCT01428661|19107889|P1|COMPLETED|Open Label Extension|Does not apply.|0
7760115|NCT01428661|19107887|P3|STARTED|Open Label Extension||339
7760116|NCT01428661|19107888|P2|STARTED|Open Label Extension|Does not apply.|0
7760117|NCT01428661|19107889|P1|STARTED|Open Label Extension|Does not apply.|0
7760118|NCT01428661|19107887|P3|NOT COMPLETED|Double-Masked Phase||0
7760119|NCT01428661|19107888|P2|NOT COMPLETED|Double-Masked Phase||49
7760120|NCT01428661|19107889|P1|NOT COMPLETED|Double-Masked Phase||57
7760121|NCT01428661|19107887|P3|COMPLETED|Double-Masked Phase|Does not apply.|0
7760122|NCT01428661|19107888|P2|COMPLETED|Double-Masked Phase||204
7760123|NCT01428661|19107889|P1|COMPLETED|Double-Masked Phase||197
7760124|NCT01428661|19107887|P3|STARTED|Double-Masked Phase|Does not apply.|0
7760125|NCT01428661|19107888|P2|STARTED|Double-Masked Phase||253
7760126|NCT01428661|19107889|P1|STARTED|Double-Masked Phase||254
7760127|NCT01428583|19107897|P1|NOT COMPLETED|Overall Study||237
7760128|NCT01428583|19107897|P1|COMPLETED|Overall Study||158
7760129|NCT01428583|19107897|P1|STARTED|Overall Study||395
7760130|NCT01428453|19107921|P2|NOT COMPLETED|Overall Study||9
7760131|NCT01428453|19107922|P1|NOT COMPLETED|Overall Study||6
7760132|NCT01428453|19107921|P2|COMPLETED|Overall Study||52
7760133|NCT01428453|19107922|P1|COMPLETED|Overall Study||56
7760134|NCT01428453|19107921|P2|STARTED|Overall Study||61
7760135|NCT01428453|19107922|P1|STARTED|Overall Study||62
7760136|NCT01428336|19107948|P2|NOT COMPLETED|Overall Study||0
7760137|NCT01428336|19107949|P1|NOT COMPLETED|Overall Study||0
7760138|NCT01428336|19107948|P2|COMPLETED|Overall Study||12
7760139|NCT01428336|19107949|P1|COMPLETED|Overall Study||10
7760140|NCT01428336|19107948|P2|STARTED|Overall Study||12
7760141|NCT01428336|19107949|P1|STARTED|Overall Study||10
7760142|NCT01428258|19107961|P2|NOT COMPLETED|Intervention 2||0
7760143|NCT01428258|19107962|P1|NOT COMPLETED|Intervention 2||0
7760144|NCT01428258|19107961|P2|COMPLETED|Intervention 2||15
7760145|NCT01428258|19107962|P1|COMPLETED|Intervention 2||15
7760146|NCT01428258|19107961|P2|STARTED|Intervention 2||15
7760147|NCT01428258|19107962|P1|STARTED|Intervention 2||15
7760148|NCT01428258|19107961|P2|NOT COMPLETED|Intervention 1||0
7760149|NCT01428258|19107962|P1|NOT COMPLETED|Intervention 1||2
7760150|NCT01428258|19107961|P2|COMPLETED|Intervention 1||15
7760151|NCT01428258|19107962|P1|COMPLETED|Intervention 1||15
7760152|NCT01428258|19107961|P2|STARTED|Intervention 1||15
7760153|NCT01428258|19107962|P1|STARTED|Intervention 1||17
7760154|NCT01428245|19107980|P1|NOT COMPLETED|Overall Study||0
7760155|NCT01428245|19107980|P1|COMPLETED|Overall Study||1
7760156|NCT01428245|19107980|P1|STARTED|Overall Study||1
7760157|NCT01428219|19107984|P1|NOT COMPLETED|Overall Study||3
7760158|NCT01428219|19107984|P1|COMPLETED|Overall Study||22
7760159|NCT01428219|19107984|P1|STARTED|Overall Study||25
7760160|NCT01428193|19107995|P1|NOT COMPLETED|Overall Study||2
7760161|NCT01428193|19107995|P1|COMPLETED|Overall Study||2
7760162|NCT01428193|19107995|P1|STARTED|Overall Study||4
7760163|NCT01428128|19107999|P1|NOT COMPLETED|Overall Study||17
7760164|NCT01428128|19107999|P1|COMPLETED|Overall Study||33
7760165|NCT01428128|19107999|P1|STARTED|Overall Study||50
7760166|NCT01428115|19108004|P1|NOT COMPLETED|Overall Study||21
7760167|NCT01428115|19108004|P1|COMPLETED|Overall Study||62
7760168|NCT01428115|19108004|P1|STARTED|Overall Study||83
7760169|NCT01428076|19108019|P2|NOT COMPLETED|Overall Study||1
7760170|NCT01428076|19108020|P1|NOT COMPLETED|Overall Study||0
7760171|NCT01428076|19108019|P2|COMPLETED|Overall Study||11
7760172|NCT01428076|19108020|P1|COMPLETED|Overall Study||9
7760173|NCT01428076|19108019|P2|STARTED|Overall Study||12
7760174|NCT01428076|19108020|P1|STARTED|Overall Study||9
7760175|NCT01428063|19108031|P3|NOT COMPLETED|Overall Study||1
7760176|NCT01428063|19108032|P2|NOT COMPLETED|Overall Study||10
7760177|NCT01428063|19108033|P1|NOT COMPLETED|Overall Study||10
7760178|NCT01428063|19108031|P3|COMPLETED|Overall Study||5
7760179|NCT01428063|19108032|P2|COMPLETED|Overall Study||112
7760180|NCT01428063|19108033|P1|COMPLETED|Overall Study||89
7760181|NCT01428063|19108031|P3|STARTED|Overall Study||6
7760182|NCT01428063|19108032|P2|STARTED|Overall Study||122
7760183|NCT01428063|19108033|P1|STARTED|Overall Study||99
7760184|NCT01428024|19108104|P2|NOT COMPLETED|Overall Study||1
7760185|NCT01428024|19108105|P1|NOT COMPLETED|Overall Study||1
7760186|NCT01428024|19108104|P2|COMPLETED|Overall Study||29
7760187|NCT01428024|19108105|P1|COMPLETED|Overall Study||29
7760188|NCT01428024|19108104|P2|STARTED|Overall Study||30
7760189|NCT01428024|19108105|P1|STARTED|Overall Study||30
7760190|NCT01427972|19108134|P12|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7760191|NCT01427972|19108135|P11|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7760192|NCT01427972|19108136|P10|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7760193|NCT01427972|19108137|P9|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7760194|NCT01427972|19108138|P8|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7760195|NCT01427972|19108139|P7|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7760196|NCT01427972|19108140|P6|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7760197|NCT01427972|19108141|P5|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7760198|NCT01427972|19108142|P4|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7760199|NCT01427972|19108143|P3|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7760200|NCT01427972|19108144|P2|NOT COMPLETED|Treatment Period 2 (21 Days)||1
7760201|NCT01427972|19108145|P1|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7760202|NCT01427972|19108134|P12|COMPLETED|Treatment Period 2 (21 Days)||4
7760203|NCT01427972|19108135|P11|COMPLETED|Treatment Period 2 (21 Days)||3
7760204|NCT01427972|19108136|P10|COMPLETED|Treatment Period 2 (21 Days)||3
7760205|NCT01427972|19108137|P9|COMPLETED|Treatment Period 2 (21 Days)||3
7760206|NCT01427972|19108138|P8|COMPLETED|Treatment Period 2 (21 Days)||4
7760207|NCT01427972|19108139|P7|COMPLETED|Treatment Period 2 (21 Days)||3
7760208|NCT01427972|19108140|P6|COMPLETED|Treatment Period 2 (21 Days)||1
7760209|NCT01427972|19108141|P5|COMPLETED|Treatment Period 2 (21 Days)||4
7760210|NCT01427972|19108142|P4|COMPLETED|Treatment Period 2 (21 Days)||3
7760211|NCT01427972|19108143|P3|COMPLETED|Treatment Period 2 (21 Days)||4
7760212|NCT01427972|19108144|P2|COMPLETED|Treatment Period 2 (21 Days)||3
7760213|NCT01427972|19108145|P1|COMPLETED|Treatment Period 2 (21 Days)||3
7760214|NCT01427972|19108134|P12|STARTED|Treatment Period 2 (21 Days)||4
7760215|NCT01427972|19108135|P11|STARTED|Treatment Period 2 (21 Days)||3
7760216|NCT01427972|19108136|P10|STARTED|Treatment Period 2 (21 Days)||3
7760217|NCT01427972|19108137|P9|STARTED|Treatment Period 2 (21 Days)||3
7760218|NCT01427972|19108138|P8|STARTED|Treatment Period 2 (21 Days)||4
7760219|NCT01427972|19108139|P7|STARTED|Treatment Period 2 (21 Days)||3
7760220|NCT01427972|19108140|P6|STARTED|Treatment Period 2 (21 Days)||1
7760221|NCT01427972|19108141|P5|STARTED|Treatment Period 2 (21 Days)||4
7760222|NCT01427972|19108142|P4|STARTED|Treatment Period 2 (21 Days)||3
7760223|NCT01427972|19108143|P3|STARTED|Treatment Period 2 (21 Days)||4
7760224|NCT01427972|19108144|P2|STARTED|Treatment Period 2 (21 Days)||4
7760225|NCT01427972|19108145|P1|STARTED|Treatment Period 2 (21 Days)||3
7760226|NCT01427972|19108134|P12|NOT COMPLETED|Washout (at Least 28 Days)||0
7760227|NCT01427972|19108135|P11|NOT COMPLETED|Washout (at Least 28 Days)||0
7760228|NCT01427972|19108136|P10|NOT COMPLETED|Washout (at Least 28 Days)||0
7760229|NCT01427972|19108137|P9|NOT COMPLETED|Washout (at Least 28 Days)||0
7760230|NCT01427972|19108138|P8|NOT COMPLETED|Washout (at Least 28 Days)||0
7760231|NCT01427972|19108139|P7|NOT COMPLETED|Washout (at Least 28 Days)||0
7760232|NCT01427972|19108140|P6|NOT COMPLETED|Washout (at Least 28 Days)||2
7760233|NCT01427972|19108141|P5|NOT COMPLETED|Washout (at Least 28 Days)||0
7760234|NCT01427972|19108142|P4|NOT COMPLETED|Washout (at Least 28 Days)||0
7760235|NCT01427972|19108143|P3|NOT COMPLETED|Washout (at Least 28 Days)||0
7760236|NCT01427972|19108144|P2|NOT COMPLETED|Washout (at Least 28 Days)||0
7760237|NCT01427972|19108145|P1|NOT COMPLETED|Washout (at Least 28 Days)||0
7760238|NCT01427972|19108134|P12|COMPLETED|Washout (at Least 28 Days)||4
7760239|NCT01427972|19108135|P11|COMPLETED|Washout (at Least 28 Days)||3
7760240|NCT01427972|19108136|P10|COMPLETED|Washout (at Least 28 Days)||3
7760241|NCT01427972|19108137|P9|COMPLETED|Washout (at Least 28 Days)||3
7760242|NCT01427972|19108138|P8|COMPLETED|Washout (at Least 28 Days)||4
7760243|NCT01427972|19108139|P7|COMPLETED|Washout (at Least 28 Days)||3
7760244|NCT01427972|19108140|P6|COMPLETED|Washout (at Least 28 Days)||1
7760245|NCT01427972|19108141|P5|COMPLETED|Washout (at Least 28 Days)||4
7760246|NCT01427972|19108142|P4|COMPLETED|Washout (at Least 28 Days)||3
7760247|NCT01427972|19108143|P3|COMPLETED|Washout (at Least 28 Days)||4
7760248|NCT01427972|19108144|P2|COMPLETED|Washout (at Least 28 Days)||4
7760249|NCT01427972|19108145|P1|COMPLETED|Washout (at Least 28 Days)||3
7760250|NCT01427972|19108134|P12|STARTED|Washout (at Least 28 Days)||4
7760251|NCT01427972|19108135|P11|STARTED|Washout (at Least 28 Days)||3
7760252|NCT01427972|19108136|P10|STARTED|Washout (at Least 28 Days)||3
7760253|NCT01427972|19108137|P9|STARTED|Washout (at Least 28 Days)||3
7760254|NCT01427972|19108138|P8|STARTED|Washout (at Least 28 Days)||4
7760255|NCT01427972|19108139|P7|STARTED|Washout (at Least 28 Days)||3
7760256|NCT01427972|19108140|P6|STARTED|Washout (at Least 28 Days)||3
7760257|NCT01427972|19108141|P5|STARTED|Washout (at Least 28 Days)||4
7760258|NCT01427972|19108142|P4|STARTED|Washout (at Least 28 Days)||3
7760259|NCT01427972|19108143|P3|STARTED|Washout (at Least 28 Days)||4
7760260|NCT01427972|19108144|P2|STARTED|Washout (at Least 28 Days)||4
7760261|NCT01427972|19108145|P1|STARTED|Washout (at Least 28 Days)||3
7760262|NCT01427972|19108134|P12|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7760263|NCT01427972|19108135|P11|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7760264|NCT01427972|19108136|P10|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7760265|NCT01427972|19108137|P9|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7760266|NCT01427972|19108138|P8|NOT COMPLETED|Treatment Period 1 (21 Days)||1
7760267|NCT01427972|19108139|P7|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7760268|NCT01427972|19108140|P6|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7760269|NCT01427972|19108141|P5|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7760270|NCT01427972|19108142|P4|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7760271|NCT01427972|19108143|P3|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7760272|NCT01427972|19108144|P2|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7760273|NCT01427972|19108145|P1|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7760274|NCT01427972|19108134|P12|COMPLETED|Treatment Period 1 (21 Days)||4
7760275|NCT01427972|19108135|P11|COMPLETED|Treatment Period 1 (21 Days)||3
7760276|NCT01427972|19108136|P10|COMPLETED|Treatment Period 1 (21 Days)||3
7760277|NCT01427972|19108137|P9|COMPLETED|Treatment Period 1 (21 Days)||3
7760278|NCT01427972|19108138|P8|COMPLETED|Treatment Period 1 (21 Days)||4
7760279|NCT01427972|19108139|P7|COMPLETED|Treatment Period 1 (21 Days)||3
7760280|NCT01427972|19108140|P6|COMPLETED|Treatment Period 1 (21 Days)||3
7760281|NCT01427972|19108141|P5|COMPLETED|Treatment Period 1 (21 Days)||4
7760282|NCT01427972|19108142|P4|COMPLETED|Treatment Period 1 (21 Days)||3
7760283|NCT01427972|19108143|P3|COMPLETED|Treatment Period 1 (21 Days)||4
7760284|NCT01427972|19108144|P2|COMPLETED|Treatment Period 1 (21 Days)||4
7760285|NCT01427972|19108145|P1|COMPLETED|Treatment Period 1 (21 Days)||3
7760286|NCT01427972|19108134|P12|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
7760287|NCT01427972|19108135|P11|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
7760288|NCT01427972|19108136|P10|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
7760289|NCT01427972|19108137|P9|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
7760290|NCT01427972|19108138|P8|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||5
7760291|NCT01427972|19108139|P7|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
7760292|NCT01427972|19108140|P6|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
7760293|NCT01427972|19108141|P5|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
7760294|NCT01427972|19108142|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
7760295|NCT01427972|19108143|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
7760296|NCT01427972|19108144|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
7760297|NCT01427972|19108145|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
7760298|NCT01427972|19108134|P12|STARTED|Treatment Period 1 (21 Days)||4
7760299|NCT01427972|19108135|P11|STARTED|Treatment Period 1 (21 Days)||3
7760300|NCT01427972|19108136|P10|STARTED|Treatment Period 1 (21 Days)||3
7760301|NCT01427972|19108137|P9|STARTED|Treatment Period 1 (21 Days)||3
7760302|NCT01427972|19108138|P8|STARTED|Treatment Period 1 (21 Days)||5
7760303|NCT01427972|19108139|P7|STARTED|Treatment Period 1 (21 Days)||3
7760304|NCT01427972|19108140|P6|STARTED|Treatment Period 1 (21 Days)||3
7760305|NCT01427972|19108141|P5|STARTED|Treatment Period 1 (21 Days)||4
7760306|NCT01427972|19108142|P4|STARTED|Treatment Period 1 (21 Days)||3
7760307|NCT01427972|19108143|P3|STARTED|Treatment Period 1 (21 Days)||4
7760308|NCT01427972|19108144|P2|STARTED|Treatment Period 1 (21 Days)||4
7760309|NCT01427972|19108145|P1|STARTED|Treatment Period 1 (21 Days)||3
7760310|NCT01427933|19108171|P2|NOT COMPLETED|Overall Study||13
7760311|NCT01427933|19108172|P1|NOT COMPLETED|Overall Study||8
7760312|NCT01427933|19108171|P2|COMPLETED|Overall Study||57
7760313|NCT01427933|19108172|P1|COMPLETED|Overall Study||63
7760314|NCT01427933|19108171|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
7760315|NCT01427933|19108172|P1|Received at Least 1 Dose of Study Drug|Overall Study||69
7760316|NCT01427933|19108171|P2|STARTED|Overall Study||70
7760317|NCT01427933|19108172|P1|STARTED|Overall Study||71
7760318|NCT01427920|19108192|P2|NOT COMPLETED|Overall Study||17
7760319|NCT01427920|19108193|P1|NOT COMPLETED|Overall Study||9
7760320|NCT01427920|19108192|P2|COMPLETED|Overall Study||157
7760321|NCT01427920|19108193|P1|COMPLETED|Overall Study||165
7760322|NCT01427920|19108192|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173
7760323|NCT01427920|19108193|P1|Exposed|Overall Study||174
7760324|NCT01427920|19108192|P2|STARTED|Overall Study||174
7760325|NCT01427920|19108193|P1|STARTED|Overall Study||174
7760326|NCT01427907|19108213|P2|NOT COMPLETED|Overall Study||4
7760327|NCT01427907|19108214|P1|NOT COMPLETED|Overall Study||3
7760328|NCT01427907|19108213|P2|COMPLETED|Overall Study|Completed study|14
7760329|NCT01427907|19108214|P1|COMPLETED|Overall Study|Completed study|17
7760330|NCT01427907|19108213|P2|STARTED|Overall Study|Randomized|18
7760331|NCT01427907|19108214|P1|STARTED|Overall Study|Randomized|20
7760332|NCT01427881|19108220|P1|NOT COMPLETED|Overall Study||0
7760333|NCT01427881|19108220|P1|COMPLETED|Overall Study||43
7760334|NCT01427881|19108220|P1|STARTED|Overall Study||43
7760335|NCT01427803|19108235|P2|NOT COMPLETED|Overall Study||26
7760336|NCT01427803|19108236|P1|NOT COMPLETED|Overall Study||63
7760337|NCT01427803|19108235|P2|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226
7760338|NCT01427803|19108236|P1|COMPLETED|Overall Study||463
7760339|NCT01427803|19108235|P2|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237
7760340|NCT01427803|19108236|P1|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508
7760341|NCT01427803|19108235|P2|Baseline Assessment|Overall Study|only interviewed participants were assessed|130
7760342|NCT01427803|19108236|P1|Baseline Assessment|Overall Study||516
7760343|NCT01427803|19108235|P2|Purchased Product|Overall Study||252
7760344|NCT01427803|19108236|P1|Purchased Product|Overall Study|Only 516 participants used e-diary|525
7760345|NCT01427803|19108235|P2|STARTED|Overall Study||252
7760346|NCT01427803|19108236|P1|STARTED|Overall Study||526
7760347|NCT01427751|19108250|P2|NOT COMPLETED|Overall Study||14
7760348|NCT01427751|19108251|P1|NOT COMPLETED|Overall Study||42
7760349|NCT01427751|19108250|P2|COMPLETED|Overall Study||139
7760350|NCT01427751|19108251|P1|COMPLETED|Overall Study||112
7760351|NCT01427751|19108250|P2|STARTED|Overall Study||153
7760352|NCT01427751|19108251|P1|STARTED|Overall Study||154
7760353|NCT01427738|19108271|P2|NOT COMPLETED|Overall Study||21
7760354|NCT01427738|19108272|P1|NOT COMPLETED|Overall Study||19
7760355|NCT01427738|19108271|P2|COMPLETED|Overall Study||90
7760356|NCT01427738|19108272|P1|COMPLETED|Overall Study||91
7760357|NCT01427738|19108271|P2|STARTED|Overall Study||111
7760358|NCT01427738|19108272|P1|STARTED|Overall Study||110
7760359|NCT01427608|19108292|P2|NOT COMPLETED|Overall Study||38
7760360|NCT01427608|19108293|P1|NOT COMPLETED|Overall Study||21
7760361|NCT01427608|19108292|P2|COMPLETED|Overall Study||24
7760362|NCT01427608|19108293|P1|COMPLETED|Overall Study||43
7760363|NCT01427608|19108292|P2|STARTED|Overall Study||62
7760364|NCT01427608|19108293|P1|STARTED|Overall Study||64
7760365|NCT01427517|19108308|P3|NOT COMPLETED|Overall Study||0
7760366|NCT01427517|19108309|P2|NOT COMPLETED|Overall Study||0
7760367|NCT01427517|19108310|P1|NOT COMPLETED|Overall Study||0
7760368|NCT01427517|19108308|P3|COMPLETED|Overall Study||3
7760369|NCT01427517|19108309|P2|COMPLETED|Overall Study||3
7760370|NCT01427517|19108310|P1|COMPLETED|Overall Study||3
7760371|NCT01427517|19108308|P3|STARTED|Overall Study||3
7760372|NCT01427517|19108309|P2|STARTED|Overall Study||3
7760373|NCT01427517|19108310|P1|STARTED|Overall Study||3
7760374|NCT01427504|19108324|P6|NOT COMPLETED|Overall Study||2
7760375|NCT01427504|19108325|P5|NOT COMPLETED|Overall Study||1
7760376|NCT01427504|19108326|P4|NOT COMPLETED|Overall Study||1
7760377|NCT01427504|19108327|P3|NOT COMPLETED|Overall Study||1
7760378|NCT01427504|19108328|P2|NOT COMPLETED|Overall Study||1
7760379|NCT01427504|19108329|P1|NOT COMPLETED|Overall Study||0
7760380|NCT01427504|19108324|P6|COMPLETED|Overall Study||4
7760381|NCT01427504|19108325|P5|COMPLETED|Overall Study||2
7760382|NCT01427504|19108326|P4|COMPLETED|Overall Study||5
7760383|NCT01427504|19108327|P3|COMPLETED|Overall Study||3
7760384|NCT01427504|19108328|P2|COMPLETED|Overall Study||2
7760385|NCT01427504|19108329|P1|COMPLETED|Overall Study||4
7760386|NCT01427504|19108324|P6|Received Combination|Overall Study||6
7760387|NCT01427504|19108325|P5|Received Combination|Overall Study||3
7760388|NCT01427504|19108326|P4|Received Combination|Overall Study||6
7760389|NCT01427504|19108327|P3|Received Combination|Overall Study||3
7760390|NCT01427504|19108328|P2|Received Combination|Overall Study||3
7760391|NCT01427504|19108329|P1|Received Combination|Overall Study||4
7760392|NCT01427504|19108324|P6|Received Etravirine|Overall Study||4
7760393|NCT01427504|19108325|P5|Received Etravirine|Overall Study||2
7760394|NCT01427504|19108326|P4|Received Etravirine|Overall Study||6
7760395|NCT01427504|19108327|P3|Received Etravirine|Overall Study||4
7760396|NCT01427504|19108328|P2|Received Etravirine|Overall Study||2
7760397|NCT01427504|19108329|P1|Received Etravirine|Overall Study||4
7760398|NCT01427504|19108324|P6|Received Boceprevir|Overall Study||4
7760399|NCT01427504|19108325|P5|Received Boceprevir|Overall Study||2
7760400|NCT01427504|19108326|P4|Received Boceprevir|Overall Study||5
7760401|NCT01427504|19108327|P3|Received Boceprevir|Overall Study||3
7760402|NCT01427504|19108328|P2|Received Boceprevir|Overall Study||3
7760403|NCT01427504|19108329|P1|Received Boceprevir|Overall Study||4
7760404|NCT01427504|19108324|P6|STARTED|Overall Study||6
7760405|NCT01427504|19108325|P5|STARTED|Overall Study||3
7760406|NCT01427504|19108326|P4|STARTED|Overall Study||6
7760407|NCT01427504|19108327|P3|STARTED|Overall Study||4
7760408|NCT01427504|19108328|P2|STARTED|Overall Study||3
7760409|NCT01427504|19108329|P1|STARTED|Overall Study||4
7760410|NCT01427309|19108350|P4|NOT COMPLETED|Overall Study||376
7760411|NCT01427309|19108351|P3|NOT COMPLETED|Overall Study||361
7760412|NCT01427309|19108352|P2|NOT COMPLETED|Overall Study||407
7760413|NCT01427309|19108353|P1|NOT COMPLETED|Overall Study||372
7760414|NCT01427309|19108350|P4|COMPLETED|Overall Study||8373
7760415|NCT01427309|19108351|P3|COMPLETED|Overall Study||8376
7760416|NCT01427309|19108352|P2|COMPLETED|Overall Study||6837
7760417|NCT01427309|19108353|P1|COMPLETED|Overall Study||6881
7760418|NCT01427309|19108350|P4|STARTED|Overall Study||8749
7760419|NCT01427309|19108351|P3|STARTED|Overall Study||8737
7760420|NCT01427309|19108352|P2|STARTED|Overall Study||7244
7760421|NCT01427309|19108353|P1|STARTED|Overall Study||7253
7760422|NCT01427296|19108393|P2|NOT COMPLETED|Overall Study||0
7760423|NCT01427296|19108394|P1|NOT COMPLETED|Overall Study||0
7760424|NCT01427296|19108393|P2|COMPLETED|Overall Study||1051
7760425|NCT01427296|19108394|P1|COMPLETED|Overall Study||1041
7760426|NCT01427296|19108393|P2|STARTED|Overall Study||1051
7760427|NCT01427296|19108394|P1|STARTED|Overall Study||1041
7760428|NCT01426958|19108400|P1|NOT COMPLETED|Overall Study||2
7760429|NCT01426958|19108400|P1|COMPLETED|Overall Study||22
7760430|NCT01426958|19108400|P1|STARTED|Overall Study||24
7760431|NCT01426867|19108417|P3|NOT COMPLETED|Overall Study||0
7760432|NCT01426867|19108418|P2|NOT COMPLETED|Overall Study||0
7760433|NCT01426867|19108419|P1|NOT COMPLETED|Overall Study||0
7760434|NCT01426867|19108417|P3|COMPLETED|Overall Study||34
7760435|NCT01426867|19108418|P2|COMPLETED|Overall Study||34
7760436|NCT01426867|19108419|P1|COMPLETED|Overall Study||33
7760437|NCT01426867|19108417|P3|STARTED|Overall Study||34
7760438|NCT01426867|19108418|P2|STARTED|Overall Study||34
7760439|NCT01426867|19108419|P1|STARTED|Overall Study||33
7760440|NCT01426854|19108429|P2|NOT COMPLETED|Overall Study||31
7760441|NCT01426854|19108430|P1|NOT COMPLETED|Overall Study||12
7760442|NCT01426854|19108429|P2|COMPLETED|Overall Study||98
7760443|NCT01426854|19108430|P1|COMPLETED|Overall Study||119
7760444|NCT01426854|19108429|P2|STARTED|Overall Study||129
7760445|NCT01426854|19108430|P1|STARTED|Overall Study||131
7760446|NCT01426828|19108440|P2|NOT COMPLETED|Immune Response Analysis||7
7760447|NCT01426828|19108441|P1|NOT COMPLETED|Immune Response Analysis||9
7760448|NCT01426828|19108440|P2|COMPLETED|Immune Response Analysis||8
7760449|NCT01426828|19108441|P1|COMPLETED|Immune Response Analysis||8
7760450|NCT01426828|19108440|P2|STARTED|Immune Response Analysis||15
7760451|NCT01426828|19108441|P1|STARTED|Immune Response Analysis||17
7760452|NCT01426828|19108440|P2|NOT COMPLETED|Overall Study Evaluations||3
7760453|NCT01426828|19108441|P1|NOT COMPLETED|Overall Study Evaluations||5
7760454|NCT01426828|19108440|P2|COMPLETED|Overall Study Evaluations||15
7760455|NCT01426828|19108441|P1|COMPLETED|Overall Study Evaluations||17
7760456|NCT01426828|19108440|P2|STARTED|Overall Study Evaluations||18
7760457|NCT01426828|19108441|P1|STARTED|Overall Study Evaluations||22
7760458|NCT01426789|19108449|P6|NOT COMPLETED|Part 2||0
7760459|NCT01426789|19108450|P5|NOT COMPLETED|Part 2||8
7760460|NCT01426789|19108451|P4|NOT COMPLETED|Part 2||1
7760461|NCT01426789|19108452|P3|NOT COMPLETED|Part 2||15
7760462|NCT01426789|19108453|P2|NOT COMPLETED|Part 2||0
7760463|NCT01426789|19108454|P1|NOT COMPLETED|Part 2||0
7760464|NCT01426789|19108449|P6|COMPLETED|Part 2||1
7760465|NCT01426789|19108450|P5|COMPLETED|Part 2||19
7760466|NCT01426789|19108451|P4|COMPLETED|Part 2||12
7760467|NCT01426789|19108452|P3|COMPLETED|Part 2||34
7760468|NCT01426789|19108453|P2|COMPLETED|Part 2||0
7760469|NCT01426789|19108454|P1|COMPLETED|Part 2||0
7760470|NCT01426789|19108449|P6|STARTED|Part 2||1
7760471|NCT01426789|19108450|P5|STARTED|Part 2||27
7760472|NCT01426789|19108451|P4|STARTED|Part 2||13
7760473|NCT01426789|19108452|P3|STARTED|Part 2||49
7760474|NCT01426789|19108453|P2|STARTED|Part 2||0
7760475|NCT01426789|19108454|P1|STARTED|Part 2||0
7760476|NCT01426789|19108449|P6|NOT COMPLETED|Part 1||0
7760477|NCT01426789|19108450|P5|NOT COMPLETED|Part 1||0
7760478|NCT01426789|19108451|P4|NOT COMPLETED|Part 1||0
7760479|NCT01426789|19108452|P3|NOT COMPLETED|Part 1||0
7760480|NCT01426789|19108453|P2|NOT COMPLETED|Part 1||4
7760481|NCT01426789|19108454|P1|NOT COMPLETED|Part 1||6
7760482|NCT01426789|19108449|P6|COMPLETED|Part 1||0
7760483|NCT01426789|19108450|P5|COMPLETED|Part 1||0
7760484|NCT01426789|19108451|P4|COMPLETED|Part 1||0
7760485|NCT01426789|19108452|P3|COMPLETED|Part 1||0
7760486|NCT01426789|19108453|P2|COMPLETED|Part 1||28
7760487|NCT01426789|19108454|P1|COMPLETED|Part 1||62
7760488|NCT01426789|19108449|P6|STARTED|Part 1||0
7760489|NCT01426789|19108450|P5|STARTED|Part 1||0
7760490|NCT01426789|19108451|P4|STARTED|Part 1||0
7760491|NCT01426789|19108452|P3|STARTED|Part 1||0
7760492|NCT01426789|19108453|P2|STARTED|Part 1||32
7760493|NCT01426789|19108454|P1|STARTED|Part 1||68
7760494|NCT01426763|19108470|P2|NOT COMPLETED|Overall Study||0
7760495|NCT01426763|19108471|P1|NOT COMPLETED|Overall Study||0
7760496|NCT01426763|19108470|P2|COMPLETED|Overall Study||6
7760497|NCT01426763|19108471|P1|COMPLETED|Overall Study||6
7760498|NCT01426763|19108470|P2|STARTED|Overall Study||6
7760499|NCT01426763|19108471|P1|STARTED|Overall Study||6
7760500|NCT01426581|19108479|P2|NOT COMPLETED|Overall Study||0
7760501|NCT01426581|19108480|P1|NOT COMPLETED|Overall Study||0
7760502|NCT01426581|19108479|P2|COMPLETED|Overall Study||58
7760503|NCT01426581|19108480|P1|COMPLETED|Overall Study||62
7760504|NCT01426581|19108479|P2|STARTED|Overall Study||58
7760505|NCT01426581|19108480|P1|STARTED|Overall Study||62
7760506|NCT01426555|19108496|P2|NOT COMPLETED|Overall Study||15
7760507|NCT01426555|19108497|P1|NOT COMPLETED|Overall Study||18
7760508|NCT01426555|19108496|P2|COMPLETED|Overall Study||20
7760509|NCT01426555|19108497|P1|COMPLETED|Overall Study||17
7760510|NCT01426555|19108496|P2|STARTED|Overall Study||35
7760511|NCT01426555|19108497|P1|STARTED|Overall Study||35
7760512|NCT01426516|19108507|P2|NOT COMPLETED|Overall Study||0
7760513|NCT01426516|19108508|P1|NOT COMPLETED|Overall Study||0
7760514|NCT01426516|19108507|P2|COMPLETED|Overall Study||17
7760515|NCT01426516|19108508|P1|COMPLETED|Overall Study||12
7760516|NCT01426516|19108507|P2|STARTED|Overall Study||17
7760517|NCT01426516|19108508|P1|STARTED|Overall Study||12
7760518|NCT01426438|19108516|P2|NOT COMPLETED|Overall Study||10
7760519|NCT01426438|19108517|P1|NOT COMPLETED|Overall Study||15
7760520|NCT01426438|19108516|P2|COMPLETED|Overall Study||39
7760521|NCT01426438|19108517|P1|COMPLETED|Overall Study||35
7760522|NCT01426438|19108516|P2|STARTED|Overall Study||49
7760523|NCT01426438|19108517|P1|STARTED|Overall Study||50
7760524|NCT01426425|19108549|P1|NOT COMPLETED|Overall Study||175
7760525|NCT01426425|19108549|P1|COMPLETED|Overall Study|The pre-specified modified intent-to-treat analysis set was used for the primary objectives.|397
7760526|NCT01426425|19108549|P1|Intent to Treat|Overall Study|Met all inclusion and no exclusion criteria.|399
7760527|NCT01426425|19108549|P1|EP Study|Overall Study|EP study used to assess inclusion and exclusion criteria.|550
7760528|NCT01426425|19108549|P1|STARTED|Overall Study||572
7760529|NCT01426412|19108564|P9|NOT COMPLETED|Overall Study||1
7760530|NCT01426412|19108565|P8|NOT COMPLETED|Overall Study||3
7760531|NCT01426412|19108566|P7|NOT COMPLETED|Overall Study||0
7760532|NCT01426412|19108567|P6|NOT COMPLETED|Overall Study||0
7760533|NCT01426412|19108568|P5|NOT COMPLETED|Overall Study||1
7760534|NCT01426412|19108569|P4|NOT COMPLETED|Overall Study||0
7760535|NCT01426412|19108570|P3|NOT COMPLETED|Overall Study||0
7760536|NCT01426412|19108571|P2|NOT COMPLETED|Overall Study||0
7760537|NCT01426412|19108572|P1|NOT COMPLETED|Overall Study||1
7760538|NCT01426412|19108564|P9|COMPLETED|Overall Study||16
7760539|NCT01426412|19108565|P8|COMPLETED|Overall Study||7
7760540|NCT01426412|19108566|P7|COMPLETED|Overall Study||6
7760541|NCT01426412|19108567|P6|COMPLETED|Overall Study||6
7760542|NCT01426412|19108568|P5|COMPLETED|Overall Study||5
7760543|NCT01426412|19108569|P4|COMPLETED|Overall Study||6
7760544|NCT01426412|19108570|P3|COMPLETED|Overall Study||6
7760545|NCT01426412|19108571|P2|COMPLETED|Overall Study||6
7760546|NCT01426412|19108572|P1|COMPLETED|Overall Study||5
7760547|NCT01426412|19108564|P9|Received at Least 1 Dose of Study Drug|Overall Study||17
7760548|NCT01426412|19108565|P8|Received at Least 1 Dose of Study Drug|Overall Study||10
7760549|NCT01426412|19108566|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
7760550|NCT01426412|19108567|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
7760551|NCT01426412|19108568|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
7760552|NCT01426412|19108569|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
7760553|NCT01426412|19108570|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
7760554|NCT01426412|19108571|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
7760555|NCT01426412|19108572|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
7760556|NCT01426412|19108564|P9|STARTED|Overall Study||17
7760557|NCT01426412|19108565|P8|STARTED|Overall Study||10
7760558|NCT01426412|19108566|P7|STARTED|Overall Study||6
7760559|NCT01426412|19108567|P6|STARTED|Overall Study||6
7760560|NCT01426412|19108568|P5|STARTED|Overall Study||6
7760561|NCT01426412|19108569|P4|STARTED|Overall Study||6
7760562|NCT01426412|19108570|P3|STARTED|Overall Study||6
7760563|NCT01426412|19108571|P2|STARTED|Overall Study||6
7760564|NCT01426412|19108572|P1|STARTED|Overall Study||6
7760565|NCT01426386|19108635|P6|NOT COMPLETED|Overall Study||1
7760566|NCT01426386|19108636|P5|NOT COMPLETED|Overall Study||4
7760567|NCT01426386|19108637|P4|NOT COMPLETED|Overall Study||0
7760568|NCT01426386|19108638|P3|NOT COMPLETED|Overall Study||2
7760569|NCT01426386|19108639|P2|NOT COMPLETED|Overall Study||6
7760570|NCT01426386|19108640|P1|NOT COMPLETED|Overall Study||3
7760571|NCT01426386|19108635|P6|COMPLETED|Overall Study||42
7760572|NCT01426386|19108636|P5|COMPLETED|Overall Study||43
7760573|NCT01426386|19108637|P4|COMPLETED|Overall Study||44
7760574|NCT01426386|19108638|P3|COMPLETED|Overall Study||42
7760575|NCT01426386|19108639|P2|COMPLETED|Overall Study||39
7760576|NCT01426386|19108640|P1|COMPLETED|Overall Study||39
7760577|NCT01426386|19108635|P6|STARTED|Overall Study||43
7760578|NCT01426386|19108636|P5|STARTED|Overall Study||47
7760579|NCT01426386|19108637|P4|STARTED|Overall Study||44
7760580|NCT01426386|19108638|P3|STARTED|Overall Study||44
7760581|NCT01426386|19108639|P2|STARTED|Overall Study||45
7760582|NCT01426386|19108640|P1|STARTED|Overall Study||42
7760583|NCT01426373|19108696|P1|NOT COMPLETED|Overall Study||34
7760584|NCT01426373|19108696|P1|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131
7760585|NCT01426373|19108696|P1|STARTED|Overall Study||165
7760586|NCT01426360|19108714|P2|NOT COMPLETED|Overall Study||0
7760587|NCT01426360|19108715|P1|NOT COMPLETED|Overall Study||0
7760588|NCT01426360|19108714|P2|COMPLETED|Overall Study||41
7760589|NCT01426360|19108715|P1|COMPLETED|Overall Study||38
7760590|NCT01426360|19108714|P2|STARTED|Overall Study||41
7760591|NCT01426360|19108715|P1|STARTED|Overall Study||38
7760592|NCT01426347|19108729|P2|NOT COMPLETED|Overall Study||3
7760593|NCT01426347|19108730|P1|NOT COMPLETED|Overall Study||7
7760594|NCT01426347|19108729|P2|COMPLETED|Overall Study||39
7760595|NCT01426347|19108730|P1|COMPLETED|Overall Study||34
7760596|NCT01426347|19108729|P2|STARTED|Overall Study||42
7760597|NCT01426347|19108730|P1|STARTED|Overall Study||41
7760598|NCT01426269|19108738|P3|NOT COMPLETED|Period 2: 40 Weeks||47
7760599|NCT01426269|19108739|P2|NOT COMPLETED|Period 2: 40 Weeks||38
7760600|NCT01426269|19108740|P1|NOT COMPLETED|Period 2: 40 Weeks||0
7760601|NCT01426269|19108738|P3|COMPLETED|Period 2: 40 Weeks||18
7760602|NCT01426269|19108739|P2|COMPLETED|Period 2: 40 Weeks||27
7760603|NCT01426269|19108740|P1|COMPLETED|Period 2: 40 Weeks||0
7760604|NCT01426269|19108738|P3|STARTED|Period 2: 40 Weeks||65
7760605|NCT01426269|19108739|P2|STARTED|Period 2: 40 Weeks||65
7760606|NCT01426269|19108740|P1|STARTED|Period 2: 40 Weeks||0
7760607|NCT01426269|19108738|P3|NOT COMPLETED|Eligibility for Period 2, Randomization||0
7760608|NCT01426269|19108739|P2|NOT COMPLETED|Eligibility for Period 2, Randomization||0
7760609|NCT01426269|19108740|P1|NOT COMPLETED|Eligibility for Period 2, Randomization||50
7760610|NCT01426269|19108738|P3|COMPLETED|Eligibility for Period 2, Randomization||0
7760611|NCT01426269|19108739|P2|COMPLETED|Eligibility for Period 2, Randomization||0
7760612|NCT01426269|19108740|P1|COMPLETED|Eligibility for Period 2, Randomization||130
7760613|NCT01426269|19108738|P3|STARTED|Eligibility for Period 2, Randomization||0
7760614|NCT01426269|19108739|P2|STARTED|Eligibility for Period 2, Randomization||0
7760615|NCT01426269|19108740|P1|STARTED|Eligibility for Period 2, Randomization||180
7760616|NCT01426269|19108738|P3|NOT COMPLETED|Period 1: 12 Weeks||0
7760617|NCT01426269|19108739|P2|NOT COMPLETED|Period 1: 12 Weeks||0
7760618|NCT01426269|19108740|P1|NOT COMPLETED|Period 1: 12 Weeks||55
7760619|NCT01426269|19108738|P3|COMPLETED|Period 1: 12 Weeks||0
7760620|NCT01426269|19108739|P2|COMPLETED|Period 1: 12 Weeks||0
7760621|NCT01426269|19108740|P1|COMPLETED|Period 1: 12 Weeks||180
7760622|NCT01426269|19108738|P3|STARTED|Period 1: 12 Weeks||0
7760623|NCT01426269|19108739|P2|STARTED|Period 1: 12 Weeks||0
7760624|NCT01426269|19108740|P1|STARTED|Period 1: 12 Weeks||235
7760625|NCT01426230|19108767|P2|NOT COMPLETED|Overall Study||27
7760626|NCT01426230|19108768|P1|NOT COMPLETED|Overall Study||31
7760627|NCT01426230|19108767|P2|COMPLETED|Overall Study||84
7760628|NCT01426230|19108768|P1|COMPLETED|Overall Study||55
7760629|NCT01426230|19108767|P2|STARTED|Overall Study||111
7760630|NCT01426230|19108768|P1|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86
7760631|NCT01426217|19108775|P2|NOT COMPLETED|Overall Study||14
7760632|NCT01426217|19108776|P1|NOT COMPLETED|Overall Study||8
7760633|NCT01426217|19108775|P2|COMPLETED|Overall Study||266
7760634|NCT01426217|19108776|P1|COMPLETED|Overall Study||306
7760635|NCT01426217|19108775|P2|STARTED|Overall Study||280
7760636|NCT01426217|19108776|P1|STARTED|Overall Study||314
7760637|NCT01426191|19108782|P1|NOT COMPLETED|Overall Study||0
7760638|NCT01426191|19108782|P1|COMPLETED|Overall Study||2032
7760639|NCT01426191|19108782|P1|STARTED|Overall Study||2032
7760640|NCT01426113|19108789|P2|NOT COMPLETED|Overall Study||2
7760641|NCT01426113|19108790|P1|NOT COMPLETED|Overall Study||1
7760642|NCT01426113|19108789|P2|COMPLETED|Overall Study||1
7760643|NCT01426113|19108790|P1|COMPLETED|Overall Study||2
7760644|NCT01426113|19108789|P2|STARTED|Overall Study||3
7760645|NCT01426113|19108790|P1|STARTED|Overall Study||3
7760646|NCT01426009|19108796|P1|NOT COMPLETED|Washout 4||1
7760647|NCT01426009|19108796|P1|COMPLETED|Washout 4||126
7760648|NCT01426009|19108796|P1|STARTED|Washout 4||127
7760649|NCT01426009|19108796|P1|NOT COMPLETED|Period 4-Fourth Intervention (7 Days)||1
7760650|NCT01426009|19108796|P1|COMPLETED|Period 4-Fourth Intervention (7 Days)||127
7760651|NCT01426009|19108796|P1|Placebo|Period 4-Fourth Intervention (7 Days)||10
7760652|NCT01426009|19108796|P1|Tiotropium Bromide|Period 4-Fourth Intervention (7 Days)||76
7760653|NCT01426009|19108796|P1|Ipratropium Bromide|Period 4-Fourth Intervention (7 Days)||8
7760654|NCT01426009|19108796|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||9
7760655|NCT01426009|19108796|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||8
7760656|NCT01426009|19108796|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||7
7760657|NCT01426009|19108796|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||10
7760658|NCT01426009|19108796|P1|STARTED|Period 4-Fourth Intervention (7 Days)||128
7760659|NCT01426009|19108796|P1|NOT COMPLETED|Washout 3||1
7760660|NCT01426009|19108796|P1|COMPLETED|Washout 3||128
7760661|NCT01426009|19108796|P1|STARTED|Washout 3||129
7760662|NCT01426009|19108796|P1|NOT COMPLETED|Period 3-Third Intervention (7 Days)||0
7760663|NCT01426009|19108796|P1|COMPLETED|Period 3-Third Intervention (7 Days)||129
7760664|NCT01426009|19108796|P1|Placebo|Period 3-Third Intervention (7 Days)||22
7760665|NCT01426009|19108796|P1|Ipratropium Bromide|Period 3-Third Intervention (7 Days)||23
7760666|NCT01426009|19108796|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||20
7760667|NCT01426009|19108796|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||22
7760668|NCT01426009|19108796|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||23
7760669|NCT01426009|19108796|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||19
7760670|NCT01426009|19108796|P1|STARTED|Period 3-Third Intervention (7 Days)||129
7760671|NCT01426009|19108796|P1|NOT COMPLETED|Washout 2||1
7760672|NCT01426009|19108796|P1|COMPLETED|Washout 2||129
7760673|NCT01426009|19108796|P1|STARTED|Washout 2||130
7760674|NCT01426009|19108796|P1|NOT COMPLETED|Period 2-Second Intervention (7 Days)||5
7760675|NCT01426009|19108796|P1|COMPLETED|Period 2-Second Intervention (7 Days)||130
7760676|NCT01426009|19108796|P1|Placebo|Period 2-Second Intervention (7 Days)||21
7760677|NCT01426009|19108796|P1|Ipratropium Bromide|Period 2-Second Intervention (7 Days)||21
7760678|NCT01426009|19108796|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||23
7760679|NCT01426009|19108796|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
7760680|NCT01426009|19108796|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
7760681|NCT01426009|19108796|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||22
7760682|NCT01426009|19108796|P1|STARTED|Period 2-Second Intervention (7 Days)||135
7760683|NCT01426009|19108796|P1|NOT COMPLETED|Washout 1||2
7760684|NCT01426009|19108796|P1|COMPLETED|Washout 1||135
7760685|NCT01426009|19108796|P1|STARTED|Washout 1||137
7760686|NCT01426009|19108796|P1|NOT COMPLETED|Period 1-First Intervention (7 Days)||2
7760687|NCT01426009|19108796|P1|COMPLETED|Period 1-First Intervention (7 Days)||137
7760688|NCT01426009|19108796|P1|Placebo|Period 1-First Intervention (7 Days)||24
7760689|NCT01426009|19108796|P1|Ipratropium Bromide|Period 1-First Intervention (7 Days)||23
7760690|NCT01426009|19108796|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
7760691|NCT01426009|19108796|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||22
7760692|NCT01426009|19108796|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||24
7760693|NCT01426009|19108796|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
7760694|NCT01426009|19108796|P1|STARTED|Period 1-First Intervention (7 Days)||139
7760695|NCT01425879|19108852|P1|NOT COMPLETED|Overall Study||0
7760696|NCT01425879|19108852|P1|COMPLETED|Overall Study||8
7760697|NCT01425879|19108852|P1|STARTED|Overall Study||8
7760698|NCT01425853|19108861|P2|NOT COMPLETED|Overall Study||77
7760699|NCT01425853|19108862|P1|NOT COMPLETED|Overall Study||64
7760700|NCT01425853|19108861|P2|COMPLETED|Overall Study||225
7760701|NCT01425853|19108862|P1|COMPLETED|Overall Study||240
7760702|NCT01425853|19108861|P2|Per Protocol (PP)|Overall Study||258
7760703|NCT01425853|19108862|P1|Per Protocol (PP)|Overall Study||264
7760704|NCT01425853|19108861|P2|Safety Population|Overall Study||299
7760705|NCT01425853|19108862|P1|Safety Population|Overall Study||304
7760706|NCT01425853|19108861|P2|STARTED|Overall Study||302
7760707|NCT01425853|19108862|P1|STARTED|Overall Study||304
7760708|NCT01425814|19108892|P6|NOT COMPLETED|Period 5||1
7760709|NCT01425814|19108893|P5|NOT COMPLETED|Period 5||0
7760710|NCT01425814|19108894|P4|NOT COMPLETED|Period 5||0
7760711|NCT01425814|19108895|P3|NOT COMPLETED|Period 5||1
7760712|NCT01425814|19108896|P2|NOT COMPLETED|Period 5||0
7760713|NCT01425814|19108897|P1|NOT COMPLETED|Period 5||0
7760714|NCT01425814|19108892|P6|COMPLETED|Period 5||11
7760715|NCT01425814|19108893|P5|COMPLETED|Period 5||12
7760716|NCT01425814|19108894|P4|COMPLETED|Period 5||10
7760717|NCT01425814|19108895|P3|COMPLETED|Period 5||10
7760718|NCT01425814|19108896|P2|COMPLETED|Period 5||9
7760719|NCT01425814|19108897|P1|COMPLETED|Period 5||11
7760720|NCT01425814|19108892|P6|STARTED|Period 5||12
7760721|NCT01425814|19108893|P5|STARTED|Period 5||12
7760722|NCT01425814|19108894|P4|STARTED|Period 5||10
7760723|NCT01425814|19108895|P3|STARTED|Period 5||11
7760724|NCT01425814|19108896|P2|STARTED|Period 5||9
7760725|NCT01425814|19108897|P1|STARTED|Period 5||11
7760726|NCT01425814|19108892|P6|NOT COMPLETED|Period 4||0
7760727|NCT01425814|19108893|P5|NOT COMPLETED|Period 4||0
7760728|NCT01425814|19108894|P4|NOT COMPLETED|Period 4||0
7760729|NCT01425814|19108895|P3|NOT COMPLETED|Period 4||1
7760730|NCT01425814|19108896|P2|NOT COMPLETED|Period 4||0
7760731|NCT01425814|19108897|P1|NOT COMPLETED|Period 4||1
7760732|NCT01425814|19108892|P6|COMPLETED|Period 4||12
7760733|NCT01425814|19108893|P5|COMPLETED|Period 4||12
7760734|NCT01425814|19108894|P4|COMPLETED|Period 4||10
7760735|NCT01425814|19108895|P3|COMPLETED|Period 4||11
7760736|NCT01425814|19108896|P2|COMPLETED|Period 4||9
7760737|NCT01425814|19108897|P1|COMPLETED|Period 4||11
7760738|NCT01425814|19108892|P6|STARTED|Period 4||12
7760739|NCT01425814|19108893|P5|STARTED|Period 4||12
7760740|NCT01425814|19108894|P4|STARTED|Period 4||10
7760741|NCT01425814|19108895|P3|STARTED|Period 4||12
7760742|NCT01425814|19108896|P2|STARTED|Period 4||9
7760743|NCT01425814|19108897|P1|STARTED|Period 4||12
7760744|NCT01425814|19108892|P6|NOT COMPLETED|Period 3||1
7760745|NCT01425814|19108893|P5|NOT COMPLETED|Period 3||0
7760746|NCT01425814|19108894|P4|NOT COMPLETED|Period 3||0
7760747|NCT01425814|19108895|P3|NOT COMPLETED|Period 3||0
7760748|NCT01425814|19108896|P2|NOT COMPLETED|Period 3||0
7760749|NCT01425814|19108897|P1|NOT COMPLETED|Period 3||0
7760750|NCT01425814|19108892|P6|COMPLETED|Period 3||12
7760751|NCT01425814|19108893|P5|COMPLETED|Period 3||12
7760752|NCT01425814|19108894|P4|COMPLETED|Period 3||10
7760753|NCT01425814|19108895|P3|COMPLETED|Period 3||12
7760754|NCT01425814|19108896|P2|COMPLETED|Period 3||9
7760755|NCT01425814|19108897|P1|COMPLETED|Period 3||12
7760756|NCT01425814|19108892|P6|STARTED|Period 3||13
7760757|NCT01425814|19108893|P5|STARTED|Period 3||12
7760758|NCT01425814|19108894|P4|STARTED|Period 3||10
7760759|NCT01425814|19108895|P3|STARTED|Period 3||12
7760760|NCT01425814|19108896|P2|STARTED|Period 3||9
7760761|NCT01425814|19108897|P1|STARTED|Period 3||12
7760762|NCT01425814|19108892|P6|NOT COMPLETED|Period 2||0
7760763|NCT01425814|19108893|P5|NOT COMPLETED|Period 2||0
7760764|NCT01425814|19108894|P4|NOT COMPLETED|Period 2||0
7760765|NCT01425814|19108895|P3|NOT COMPLETED|Period 2||0
7760766|NCT01425814|19108896|P2|NOT COMPLETED|Period 2||1
7760767|NCT01425814|19108897|P1|NOT COMPLETED|Period 2||0
7760768|NCT01425814|19108892|P6|COMPLETED|Period 2||13
7760769|NCT01425814|19108893|P5|COMPLETED|Period 2||12
7760770|NCT01425814|19108894|P4|COMPLETED|Period 2||10
7760771|NCT01425814|19108895|P3|COMPLETED|Period 2||12
7760772|NCT01425814|19108896|P2|COMPLETED|Period 2||9
7760773|NCT01425814|19108897|P1|COMPLETED|Period 2||12
7760774|NCT01425814|19108892|P6|STARTED|Period 2||13
7760775|NCT01425814|19108893|P5|STARTED|Period 2||12
7760776|NCT01425814|19108894|P4|STARTED|Period 2||10
7760777|NCT01425814|19108895|P3|STARTED|Period 2||12
7760778|NCT01425814|19108896|P2|STARTED|Period 2||10
7760779|NCT01425814|19108897|P1|STARTED|Period 2||12
7760780|NCT01425814|19108892|P6|NOT COMPLETED|Period 1||0
7760781|NCT01425814|19108893|P5|NOT COMPLETED|Period 1||0
7760782|NCT01425814|19108894|P4|NOT COMPLETED|Period 1||0
7760783|NCT01425814|19108895|P3|NOT COMPLETED|Period 1||0
7760784|NCT01425814|19108896|P2|NOT COMPLETED|Period 1||1
7760785|NCT01425814|19108897|P1|NOT COMPLETED|Period 1||0
7760786|NCT01425814|19108892|P6|COMPLETED|Period 1||13
7760787|NCT01425814|19108893|P5|COMPLETED|Period 1||12
7760788|NCT01425814|19108894|P4|COMPLETED|Period 1||10
7760789|NCT01425814|19108895|P3|COMPLETED|Period 1||12
7760790|NCT01425814|19108896|P2|COMPLETED|Period 1||10
7760791|NCT01425814|19108897|P1|COMPLETED|Period 1||12
7760792|NCT01425814|19108892|P6|STARTED|Period 1||13
7760793|NCT01425814|19108893|P5|STARTED|Period 1||12
7760794|NCT01425814|19108894|P4|STARTED|Period 1||10
7760795|NCT01425814|19108895|P3|STARTED|Period 1||12
7760796|NCT01425814|19108896|P2|STARTED|Period 1||11
7760797|NCT01425814|19108897|P1|STARTED|Period 1||12
7760798|NCT01425801|19108989|P6|NOT COMPLETED|Period 6||0
7760799|NCT01425801|19108990|P5|NOT COMPLETED|Period 6||0
7760800|NCT01425801|19108991|P4|NOT COMPLETED|Period 6||0
7760801|NCT01425801|19108992|P3|NOT COMPLETED|Period 6||0
7760802|NCT01425801|19108993|P2|NOT COMPLETED|Period 6||0
7760803|NCT01425801|19108994|P1|NOT COMPLETED|Period 6||0
7760804|NCT01425801|19108989|P6|COMPLETED|Period 6||10
7760805|NCT01425801|19108990|P5|COMPLETED|Period 6||11
7760806|NCT01425801|19108991|P4|COMPLETED|Period 6||12
7760807|NCT01425801|19108992|P3|COMPLETED|Period 6||7
7760808|NCT01425801|19108993|P2|COMPLETED|Period 6||9
7760809|NCT01425801|19108994|P1|COMPLETED|Period 6||9
7760810|NCT01425801|19108989|P6|STARTED|Period 6||10
7760811|NCT01425801|19108990|P5|STARTED|Period 6||11
7760812|NCT01425801|19108991|P4|STARTED|Period 6||12
7760813|NCT01425801|19108992|P3|STARTED|Period 6||7
7760814|NCT01425801|19108993|P2|STARTED|Period 6||9
7760815|NCT01425801|19108994|P1|STARTED|Period 6||9
7760816|NCT01425801|19108989|P6|NOT COMPLETED|Period 5||0
7760817|NCT01425801|19108990|P5|NOT COMPLETED|Period 5||0
7760818|NCT01425801|19108991|P4|NOT COMPLETED|Period 5||0
7760819|NCT01425801|19108992|P3|NOT COMPLETED|Period 5||0
7760820|NCT01425801|19108993|P2|NOT COMPLETED|Period 5||0
7760821|NCT01425801|19108994|P1|NOT COMPLETED|Period 5||0
7760822|NCT01425801|19108989|P6|COMPLETED|Period 5||10
7760823|NCT01425801|19108990|P5|COMPLETED|Period 5||11
7760824|NCT01425801|19108991|P4|COMPLETED|Period 5||12
7760825|NCT01425801|19108992|P3|COMPLETED|Period 5||7
7760826|NCT01425801|19108993|P2|COMPLETED|Period 5||9
7760827|NCT01425801|19108994|P1|COMPLETED|Period 5||9
7760828|NCT01425801|19108989|P6|STARTED|Period 5||10
7760829|NCT01425801|19108990|P5|STARTED|Period 5||11
7760830|NCT01425801|19108991|P4|STARTED|Period 5||12
7760831|NCT01425801|19108992|P3|STARTED|Period 5||7
7760832|NCT01425801|19108993|P2|STARTED|Period 5||9
7760833|NCT01425801|19108994|P1|STARTED|Period 5||9
7760834|NCT01425801|19108989|P6|NOT COMPLETED|Period 4||0
7760835|NCT01425801|19108990|P5|NOT COMPLETED|Period 4||0
7760836|NCT01425801|19108991|P4|NOT COMPLETED|Period 4||0
7760837|NCT01425801|19108992|P3|NOT COMPLETED|Period 4||1
7760838|NCT01425801|19108993|P2|NOT COMPLETED|Period 4||0
7760839|NCT01425801|19108994|P1|NOT COMPLETED|Period 4||0
7760840|NCT01425801|19108989|P6|COMPLETED|Period 4||10
7760841|NCT01425801|19108990|P5|COMPLETED|Period 4||11
7760842|NCT01425801|19108991|P4|COMPLETED|Period 4||12
7760843|NCT01425801|19108992|P3|COMPLETED|Period 4||7
7760844|NCT01425801|19108993|P2|COMPLETED|Period 4||9
7760845|NCT01425801|19108994|P1|COMPLETED|Period 4||9
7760846|NCT01425801|19108989|P6|STARTED|Period 4||10
7760847|NCT01425801|19108990|P5|STARTED|Period 4||11
7760848|NCT01425801|19108991|P4|STARTED|Period 4||12
7760849|NCT01425801|19108992|P3|STARTED|Period 4||8
7760850|NCT01425801|19108993|P2|STARTED|Period 4||9
7760851|NCT01425801|19108994|P1|STARTED|Period 4||9
7760852|NCT01425801|19108989|P6|NOT COMPLETED|Period 3||0
7760853|NCT01425801|19108990|P5|NOT COMPLETED|Period 3||0
7760854|NCT01425801|19108991|P4|NOT COMPLETED|Period 3||0
7760855|NCT01425801|19108992|P3|NOT COMPLETED|Period 3||1
7760856|NCT01425801|19108993|P2|NOT COMPLETED|Period 3||0
7760857|NCT01425801|19108994|P1|NOT COMPLETED|Period 3||0
7760858|NCT01425801|19108989|P6|COMPLETED|Period 3||10
7760859|NCT01425801|19108990|P5|COMPLETED|Period 3||11
7760860|NCT01425801|19108991|P4|COMPLETED|Period 3||12
7760861|NCT01425801|19108992|P3|COMPLETED|Period 3||8
7760862|NCT01425801|19108993|P2|COMPLETED|Period 3||9
7760863|NCT01425801|19108994|P1|COMPLETED|Period 3||9
7760864|NCT01425801|19108989|P6|STARTED|Period 3||10
7760865|NCT01425801|19108990|P5|STARTED|Period 3||11
7760866|NCT01425801|19108991|P4|STARTED|Period 3||12
7760867|NCT01425801|19108992|P3|STARTED|Period 3||9
7760868|NCT01425801|19108993|P2|STARTED|Period 3||9
7760869|NCT01425801|19108994|P1|STARTED|Period 3||9
7760870|NCT01425801|19108989|P6|NOT COMPLETED|Period 2||0
7760871|NCT01425801|19108990|P5|NOT COMPLETED|Period 2||1
7760872|NCT01425801|19108991|P4|NOT COMPLETED|Period 2||0
7760873|NCT01425801|19108992|P3|NOT COMPLETED|Period 2||0
7760874|NCT01425801|19108993|P2|NOT COMPLETED|Period 2||0
7760875|NCT01425801|19108994|P1|NOT COMPLETED|Period 2||0
7760876|NCT01425801|19108989|P6|COMPLETED|Period 2||10
7760877|NCT01425801|19108990|P5|COMPLETED|Period 2||11
7760878|NCT01425801|19108991|P4|COMPLETED|Period 2||12
7760879|NCT01425801|19108992|P3|COMPLETED|Period 2||9
7760880|NCT01425801|19108993|P2|COMPLETED|Period 2||9
7760881|NCT01425801|19108994|P1|COMPLETED|Period 2||9
7760882|NCT01425801|19108989|P6|STARTED|Period 2||10
7760883|NCT01425801|19108990|P5|STARTED|Period 2||12
7760884|NCT01425801|19108991|P4|STARTED|Period 2||12
7760885|NCT01425801|19108992|P3|STARTED|Period 2||9
7760886|NCT01425801|19108993|P2|STARTED|Period 2||9
7760887|NCT01425801|19108994|P1|STARTED|Period 2||9
7760888|NCT01425801|19108989|P6|NOT COMPLETED|Period 1||0
7760889|NCT01425801|19108990|P5|NOT COMPLETED|Period 1||1
7760890|NCT01425801|19108991|P4|NOT COMPLETED|Period 1||0
7760891|NCT01425801|19108992|P3|NOT COMPLETED|Period 1||0
7760892|NCT01425801|19108993|P2|NOT COMPLETED|Period 1||0
7760893|NCT01425801|19108994|P1|NOT COMPLETED|Period 1||0
7760894|NCT01425801|19108989|P6|COMPLETED|Period 1||10
7760895|NCT01425801|19108990|P5|COMPLETED|Period 1||12
7760896|NCT01425801|19108991|P4|COMPLETED|Period 1||12
7760897|NCT01425801|19108992|P3|COMPLETED|Period 1||9
7760898|NCT01425801|19108993|P2|COMPLETED|Period 1||9
7760899|NCT01425801|19108994|P1|COMPLETED|Period 1||9
7760900|NCT01425801|19108989|P6|STARTED|Period 1||10
7760901|NCT01425801|19108990|P5|STARTED|Period 1||13
7760902|NCT01425801|19108991|P4|STARTED|Period 1||12
7760903|NCT01425801|19108992|P3|STARTED|Period 1||9
7760904|NCT01425801|19108993|P2|STARTED|Period 1||9
7760905|NCT01425801|19108994|P1|STARTED|Period 1||9
7760906|NCT01425749|19109100|P2|NOT COMPLETED|Overall Study||1
7760907|NCT01425749|19109101|P1|NOT COMPLETED|Overall Study||0
7760908|NCT01425749|19109100|P2|COMPLETED|Overall Study||11
7760909|NCT01425749|19109101|P1|COMPLETED|Overall Study||13
7760910|NCT01425749|19109100|P2|STARTED|Overall Study||12
7760911|NCT01425749|19109101|P1|STARTED|Overall Study||13
7760912|NCT01425723|19109118|P2|NOT COMPLETED|Overall Study||18
7760913|NCT01425723|19109119|P1|NOT COMPLETED|Overall Study||4
7760914|NCT01425723|19109118|P2|COMPLETED|Overall Study||75
7760915|NCT01425723|19109119|P1|COMPLETED|Overall Study||23
7760916|NCT01425723|19109118|P2|Surgery Subgroup|Overall Study||15
7760917|NCT01425723|19109119|P1|Surgery Subgroup|Overall Study||1
7760918|NCT01425723|19109118|P2|Episodic|Overall Study||15
7760919|NCT01425723|19109119|P1|Episodic|Overall Study||0
7760920|NCT01425723|19109118|P2|Personalized Prophylaxis|Overall Study||17
7760921|NCT01425723|19109119|P1|Personalized Prophylaxis|Overall Study||2
7760922|NCT01425723|19109118|P2|Individualized Prophylaxis|Overall Study||31
7760923|NCT01425723|19109119|P1|Individualized Prophylaxis|Overall Study||5
7760924|NCT01425723|19109118|P2|Weekly Prophylaxis|Overall Study||51
7760925|NCT01425723|19109119|P1|Weekly Prophylaxis|Overall Study||23
7760926|NCT01425723|19109118|P2|STARTED|Overall Study||93
7760927|NCT01425723|19109119|P1|STARTED|Overall Study|13 participants in <6 Years Old Age Cohort and 14 participants in 6 to <12 Years Old Age Cohort.|27
7760928|NCT01425632|19109149|P3|NOT COMPLETED|Overall Study||4
7760929|NCT01425632|19109150|P2|NOT COMPLETED|Overall Study||1
7760930|NCT01425632|19109151|P1|NOT COMPLETED|Overall Study||1
7760931|NCT01425632|19109149|P3|COMPLETED|Overall Study||159
7760932|NCT01425632|19109150|P2|COMPLETED|Overall Study||165
7760933|NCT01425632|19109151|P1|COMPLETED|Overall Study||160
7760934|NCT01425632|19109149|P3|STARTED|Overall Study||163
7760935|NCT01425632|19109150|P2|STARTED|Overall Study||166
7760936|NCT01425632|19109151|P1|STARTED|Overall Study||161
7760937|NCT01425528|19109161|P2|NOT COMPLETED|Overall Study||1
7760938|NCT01425528|19109162|P1|NOT COMPLETED|Overall Study||1
7760939|NCT01425528|19109161|P2|COMPLETED|Overall Study||5
7760940|NCT01425528|19109162|P1|COMPLETED|Overall Study||5
7760941|NCT01425528|19109161|P2|STARTED|Overall Study||6
7760942|NCT01425528|19109162|P1|STARTED|Overall Study||6
7760943|NCT01425463|19109170|P2|NOT COMPLETED|Overall Study||24
7760944|NCT01425463|19109171|P1|NOT COMPLETED|Overall Study||24
7760945|NCT01425463|19109170|P2|COMPLETED|Overall Study||102
7760946|NCT01425463|19109171|P1|COMPLETED|Overall Study||106
7760947|NCT01425463|19109170|P2|Full Analysis Set|Overall Study||116
7760948|NCT01425463|19109171|P1|Full Analysis Set|Overall Study||122
7760949|NCT01425463|19109170|P2|Safety Set|Overall Study||122
7760950|NCT01425463|19109171|P1|Safety Set|Overall Study||126
7760951|NCT01425463|19109170|P2|STARTED|Overall Study||126
7760952|NCT01425463|19109171|P1|STARTED|Overall Study||130
7760953|NCT01425359|19109187|P2|NOT COMPLETED|Overall Study||22
7760954|NCT01425359|19109188|P1|NOT COMPLETED|Overall Study||19
7760955|NCT01425359|19109187|P2|COMPLETED|Overall Study||451
7760956|NCT01425359|19109188|P1|COMPLETED|Overall Study||457
7760957|NCT01425359|19109187|P2|STARTED|Overall Study||473
7760958|NCT01425359|19109188|P1|STARTED|Overall Study||476
7760959|NCT01425307|19109206|P2|NOT COMPLETED|Overall Study||19
7760960|NCT01425307|19109207|P1|NOT COMPLETED|Overall Study||19
7760961|NCT01425307|19109206|P2|COMPLETED|Overall Study|Treatment Phase: 41; 6-Month Follow-up:59|41
7760962|NCT01425307|19109207|P1|COMPLETED|Overall Study|Treatment Phase: 42; 6-Month Follow up: 58|42
7760963|NCT01425307|19109206|P2|STARTED|Overall Study|Randomized Sample: 60; Intention-to Treat Sample:60|60
7760964|NCT01425307|19109207|P1|STARTED|Overall Study|Randomized Sample: 61; Intention-to Treat Sample:61|61
7760965|NCT01425281|19109219|P2|NOT COMPLETED|At 5-year Clinical Follow-up||11
7760966|NCT01425281|19109220|P1|NOT COMPLETED|At 5-year Clinical Follow-up||32
7760967|NCT01425281|19109219|P2|COMPLETED|At 5-year Clinical Follow-up||125
7760968|NCT01425281|19109220|P1|COMPLETED|At 5-year Clinical Follow-up||256
7760969|NCT01425281|19109219|P2|STARTED|At 5-year Clinical Follow-up||136
7760970|NCT01425281|19109220|P1|STARTED|At 5-year Clinical Follow-up||288
7760971|NCT01425281|19109219|P2|NOT COMPLETED|At 4-year Clinical Follow-up||21
7760972|NCT01425281|19109220|P1|NOT COMPLETED|At 4-year Clinical Follow-up||30
7760973|NCT01425281|19109219|P2|COMPLETED|At 4-year Clinical Follow-up||136
7760974|NCT01425281|19109220|P1|COMPLETED|At 4-year Clinical Follow-up||288
7760975|NCT01425281|19109219|P2|STARTED|At 4-year Clinical Follow-up||157
7760976|NCT01425281|19109220|P1|STARTED|At 4-year Clinical Follow-up||318
7760977|NCT01425281|19109219|P2|NOT COMPLETED|At 3-year Clinical Follow-up||6
7760978|NCT01425281|19109220|P1|NOT COMPLETED|At 3-year Clinical Follow-up||5
7760979|NCT01425281|19109219|P2|COMPLETED|At 3-year Clinical Follow-up||157
7760980|NCT01425281|19109220|P1|COMPLETED|At 3-year Clinical Follow-up||318
7760981|NCT01425281|19109219|P2|STARTED|At 3-year Clinical Follow-up||163
7760982|NCT01425281|19109220|P1|STARTED|At 3-year Clinical Follow-up||323
7760983|NCT01425281|19109219|P2|NOT COMPLETED|At 2-year Clinical Follow-up||1
7760984|NCT01425281|19109220|P1|NOT COMPLETED|At 2-year Clinical Follow-up||6
7760985|NCT01425281|19109219|P2|COMPLETED|At 2-year Clinical Follow-up||163
7760986|NCT01425281|19109220|P1|COMPLETED|At 2-year Clinical Follow-up||323
7760987|NCT01425281|19109219|P2|STARTED|At 2-year Clinical Follow-up||164
7760988|NCT01425281|19109220|P1|STARTED|At 2-year Clinical Follow-up||329
7760989|NCT01425281|19109219|P2|NOT COMPLETED|At 1-year Clinical Follow-up||1
7760990|NCT01425281|19109220|P1|NOT COMPLETED|At 1-year Clinical Follow-up||2
7760991|NCT01425281|19109219|P2|COMPLETED|At 1-year Clinical Follow-up||164
7760992|NCT01425281|19109220|P1|COMPLETED|At 1-year Clinical Follow-up||329
7760993|NCT01425281|19109219|P2|STARTED|At 1-year Clinical Follow-up||165
7760994|NCT01425281|19109220|P1|STARTED|At 1-year Clinical Follow-up||331
7760995|NCT01425281|19109219|P2|NOT COMPLETED|At 180-day Clinical Follow-up||1
7760996|NCT01425281|19109220|P1|NOT COMPLETED|At 180-day Clinical Follow-up||3
7760997|NCT01425281|19109219|P2|COMPLETED|At 180-day Clinical Follow-up||165
7760998|NCT01425281|19109220|P1|COMPLETED|At 180-day Clinical Follow-up||331
7760999|NCT01425281|19109219|P2|STARTED|At 180-day Clinical Follow-up||166
7761000|NCT01425281|19109220|P1|STARTED|At 180-day Clinical Follow-up||334
7761001|NCT01425281|19109219|P2|NOT COMPLETED|At 30-day Clinical Follow-up||0
7761002|NCT01425281|19109220|P1|NOT COMPLETED|At 30-day Clinical Follow-up||1
7761003|NCT01425281|19109219|P2|COMPLETED|At 30-day Clinical Follow-up||166
7761004|NCT01425281|19109220|P1|COMPLETED|At 30-day Clinical Follow-up||334
7761005|NCT01425281|19109219|P2|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|166
7761006|NCT01425281|19109220|P1|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|335
7761007|NCT01425268|19109438|P2|NOT COMPLETED|Overall Study||0
7761008|NCT01425268|19109439|P1|NOT COMPLETED|Overall Study||8
7761009|NCT01425268|19109438|P2|COMPLETED|Overall Study||52
7761010|NCT01425268|19109439|P1|COMPLETED|Overall Study||98
7761011|NCT01425268|19109438|P2|STARTED|Overall Study|52 Subjects Randomized to Saline Arm / 52 Subjects Treated (Implanted)|52
7761012|NCT01425268|19109439|P1|STARTED|Overall Study|106 Subjects Randomized to AeroForm Arm / 98 Subjects Treated (Implanted)|106
7761013|NCT01425229|19109447|P1|NOT COMPLETED|Bosentan During Clarithromycin||0
7761014|NCT01425229|19109447|P1|COMPLETED|Bosentan During Clarithromycin||16
7761015|NCT01425229|19109447|P1|STARTED|Bosentan During Clarithromycin||16
7761016|NCT01425229|19109447|P1|NOT COMPLETED|Bosentan Steady-state||0
7761017|NCT01425229|19109447|P1|COMPLETED|Bosentan Steady-state||16
7761018|NCT01425229|19109447|P1|STARTED|Bosentan Steady-state||16
7761019|NCT01425229|19109447|P1|NOT COMPLETED|Bosentan Single Dose||0
7761020|NCT01425229|19109447|P1|COMPLETED|Bosentan Single Dose||16
7761021|NCT01425229|19109447|P1|STARTED|Bosentan Single Dose||16
7761022|NCT01425203|19109460|P3|NOT COMPLETED|Follow-up Phase||0
7761023|NCT01425203|19109461|P2|NOT COMPLETED|Follow-up Phase||0
7761024|NCT01425203|19109462|P1|NOT COMPLETED|Follow-up Phase||0
7761025|NCT01425203|19109460|P3|COMPLETED|Follow-up Phase||27
7761026|NCT01425203|19109461|P2|COMPLETED|Follow-up Phase||49
7761027|NCT01425203|19109462|P1|COMPLETED|Follow-up Phase||153
7761028|NCT01425203|19109460|P3|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27
7761029|NCT01425203|19109461|P2|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49
7761030|NCT01425203|19109462|P1|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153
7761031|NCT01425203|19109460|P3|NOT COMPLETED|Crossover Phase||6
7761032|NCT01425203|19109461|P2|NOT COMPLETED|Crossover Phase||0
7761033|NCT01425203|19109462|P1|NOT COMPLETED|Crossover Phase||0
7761034|NCT01425203|19109460|P3|COMPLETED|Crossover Phase||21
7761035|NCT01425203|19109461|P2|COMPLETED|Crossover Phase||0
7761036|NCT01425203|19109462|P1|COMPLETED|Crossover Phase||0
7761037|NCT01425203|19109460|P3|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27
7761038|NCT01425203|19109461|P2|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
7761039|NCT01425203|19109462|P1|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
7761040|NCT01425203|19109460|P3|NOT COMPLETED|Treatment Phase||0
7761041|NCT01425203|19109461|P2|NOT COMPLETED|Treatment Phase||37
7761042|NCT01425203|19109462|P1|NOT COMPLETED|Treatment Phase||27
7761043|NCT01425203|19109460|P3|COMPLETED|Treatment Phase||0
7761044|NCT01425203|19109461|P2|COMPLETED|Treatment Phase||42
7761045|NCT01425203|19109462|P1|COMPLETED|Treatment Phase||132
7761046|NCT01425203|19109460|P3|Treated (FAS)|Treatment Phase||0
7761047|NCT01425203|19109461|P2|Treated (FAS)|Treatment Phase||78
7761048|NCT01425203|19109462|P1|Treated (FAS)|Treatment Phase||159
7761049|NCT01425203|19109460|P3|STARTED|Treatment Phase||0
7761050|NCT01425203|19109461|P2|STARTED|Treatment Phase||79
7761051|NCT01425203|19109462|P1|STARTED|Treatment Phase||159
7761052|NCT01425190|19109479|P3|NOT COMPLETED|Overall Study||0
7761053|NCT01425190|19109480|P2|NOT COMPLETED|Overall Study||0
7761054|NCT01425190|19109481|P1|NOT COMPLETED|Overall Study||1
7761055|NCT01425190|19109479|P3|COMPLETED|Overall Study||0
7761056|NCT01425190|19109480|P2|COMPLETED|Overall Study||0
7761057|NCT01425190|19109481|P1|COMPLETED|Overall Study||15
7761058|NCT01425190|19109479|P3|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0
7761059|NCT01425190|19109480|P2|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0
7761060|NCT01425190|19109481|P1|STARTED|Overall Study||16
7761061|NCT01425008|19109517|P19|NOT COMPLETED|Dose Expansion Phase||19
7761062|NCT01425008|19109518|P18|NOT COMPLETED|Dose Expansion Phase||2
7761063|NCT01425008|19109519|P17|NOT COMPLETED|Dose Expansion Phase||20
7761064|NCT01425008|19109520|P16|NOT COMPLETED|Dose Expansion Phase||11
7761065|NCT01425008|19109521|P15|NOT COMPLETED|Dose Expansion Phase||6
7761066|NCT01425008|19109522|P14|NOT COMPLETED|Dose Expansion Phase||1
7761067|NCT01425008|19109523|P13|NOT COMPLETED|Dose Expansion Phase||16
7761068|NCT01425008|19109524|P12|NOT COMPLETED|Dose Expansion Phase||8
7761069|NCT01425008|19109525|P11|NOT COMPLETED|Dose Expansion Phase||15
7761070|NCT01425008|19109526|P10|NOT COMPLETED|Dose Expansion Phase||0
7761071|NCT01425008|19109527|P9|NOT COMPLETED|Dose Expansion Phase||0
7761072|NCT01425008|19109528|P8|NOT COMPLETED|Dose Expansion Phase||0
7761073|NCT01425008|19109529|P7|NOT COMPLETED|Dose Expansion Phase||0
7761074|NCT01425008|19109530|P6|NOT COMPLETED|Dose Expansion Phase||0
7761075|NCT01425008|19109531|P5|NOT COMPLETED|Dose Expansion Phase||0
7761076|NCT01425008|19109532|P4|NOT COMPLETED|Dose Expansion Phase||0
7761077|NCT01425008|19109533|P3|NOT COMPLETED|Dose Expansion Phase||0
7761078|NCT01425008|19109534|P2|NOT COMPLETED|Dose Expansion Phase||0
7761079|NCT01425008|19109535|P1|NOT COMPLETED|Dose Expansion Phase||0
7761080|NCT01425008|19109517|P19|COMPLETED|Dose Expansion Phase||0
7761081|NCT01425008|19109518|P18|COMPLETED|Dose Expansion Phase||0
7761082|NCT01425008|19109519|P17|COMPLETED|Dose Expansion Phase||0
7761083|NCT01425008|19109520|P16|COMPLETED|Dose Expansion Phase||0
7761084|NCT01425008|19109521|P15|COMPLETED|Dose Expansion Phase||0
7761085|NCT01425008|19109522|P14|COMPLETED|Dose Expansion Phase||0
7761086|NCT01425008|19109523|P13|COMPLETED|Dose Expansion Phase||0
7761087|NCT01425008|19109524|P12|COMPLETED|Dose Expansion Phase||0
7761088|NCT01425008|19109525|P11|COMPLETED|Dose Expansion Phase||1
7761089|NCT01425008|19109526|P10|COMPLETED|Dose Expansion Phase||0
7761090|NCT01425008|19109527|P9|COMPLETED|Dose Expansion Phase||0
7761091|NCT01425008|19109528|P8|COMPLETED|Dose Expansion Phase||0
7761092|NCT01425008|19109529|P7|COMPLETED|Dose Expansion Phase||0
7761093|NCT01425008|19109530|P6|COMPLETED|Dose Expansion Phase||0
7761094|NCT01425008|19109531|P5|COMPLETED|Dose Expansion Phase||0
7761095|NCT01425008|19109532|P4|COMPLETED|Dose Expansion Phase||0
7761096|NCT01425008|19109533|P3|COMPLETED|Dose Expansion Phase||0
7761097|NCT01425008|19109534|P2|COMPLETED|Dose Expansion Phase||0
7761098|NCT01425008|19109535|P1|COMPLETED|Dose Expansion Phase||0
7761099|NCT01425008|19109517|P19|STARTED|Dose Expansion Phase||19
7761100|NCT01425008|19109518|P18|STARTED|Dose Expansion Phase||2
7761101|NCT01425008|19109519|P17|STARTED|Dose Expansion Phase||20
7761102|NCT01425008|19109520|P16|STARTED|Dose Expansion Phase||11
7761103|NCT01425008|19109521|P15|STARTED|Dose Expansion Phase||6
7761104|NCT01425008|19109522|P14|STARTED|Dose Expansion Phase||1
7761105|NCT01425008|19109523|P13|STARTED|Dose Expansion Phase||16
7761106|NCT01425008|19109524|P12|STARTED|Dose Expansion Phase||8
7761107|NCT01425008|19109525|P11|STARTED|Dose Expansion Phase||16
7761108|NCT01425008|19109526|P10|STARTED|Dose Expansion Phase||0
7761109|NCT01425008|19109527|P9|STARTED|Dose Expansion Phase||0
7761110|NCT01425008|19109528|P8|STARTED|Dose Expansion Phase||0
7761111|NCT01425008|19109529|P7|STARTED|Dose Expansion Phase||0
7761112|NCT01425008|19109530|P6|STARTED|Dose Expansion Phase||0
7761113|NCT01425008|19109531|P5|STARTED|Dose Expansion Phase||0
7761114|NCT01425008|19109532|P4|STARTED|Dose Expansion Phase||0
7761115|NCT01425008|19109533|P3|STARTED|Dose Expansion Phase||0
7761116|NCT01425008|19109534|P2|STARTED|Dose Expansion Phase||0
7761117|NCT01425008|19109535|P1|STARTED|Dose Expansion Phase||0
7761118|NCT01425008|19109517|P19|NOT COMPLETED|Dose Escalation Phase||0
7761119|NCT01425008|19109518|P18|NOT COMPLETED|Dose Escalation Phase||0
7761120|NCT01425008|19109519|P17|NOT COMPLETED|Dose Escalation Phase||0
7761121|NCT01425008|19109520|P16|NOT COMPLETED|Dose Escalation Phase||0
7761122|NCT01425008|19109521|P15|NOT COMPLETED|Dose Escalation Phase||0
7761123|NCT01425008|19109522|P14|NOT COMPLETED|Dose Escalation Phase||0
7761124|NCT01425008|19109523|P13|NOT COMPLETED|Dose Escalation Phase||0
7761125|NCT01425008|19109524|P12|NOT COMPLETED|Dose Escalation Phase||0
7761126|NCT01425008|19109525|P11|NOT COMPLETED|Dose Escalation Phase||0
7761127|NCT01425008|19109526|P10|NOT COMPLETED|Dose Escalation Phase||4
7761128|NCT01425008|19109527|P9|NOT COMPLETED|Dose Escalation Phase||13
7761129|NCT01425008|19109528|P8|NOT COMPLETED|Dose Escalation Phase||3
7761130|NCT01425008|19109529|P7|NOT COMPLETED|Dose Escalation Phase||3
7761131|NCT01425008|19109530|P6|NOT COMPLETED|Dose Escalation Phase||7
7761132|NCT01425008|19109531|P5|NOT COMPLETED|Dose Escalation Phase||7
7761133|NCT01425008|19109532|P4|NOT COMPLETED|Dose Escalation Phase||3
7761134|NCT01425008|19109533|P3|NOT COMPLETED|Dose Escalation Phase||3
7761135|NCT01425008|19109534|P2|NOT COMPLETED|Dose Escalation Phase||3
7761136|NCT01425008|19109535|P1|NOT COMPLETED|Dose Escalation Phase||4
7761137|NCT01425008|19109517|P19|COMPLETED|Dose Escalation Phase||0
7761138|NCT01425008|19109518|P18|COMPLETED|Dose Escalation Phase||0
7761139|NCT01425008|19109519|P17|COMPLETED|Dose Escalation Phase||0
7761140|NCT01425008|19109520|P16|COMPLETED|Dose Escalation Phase||0
7761141|NCT01425008|19109521|P15|COMPLETED|Dose Escalation Phase||0
7761142|NCT01425008|19109522|P14|COMPLETED|Dose Escalation Phase||0
7761143|NCT01425008|19109523|P13|COMPLETED|Dose Escalation Phase||0
7761144|NCT01425008|19109524|P12|COMPLETED|Dose Escalation Phase||0
7761145|NCT01425008|19109525|P11|COMPLETED|Dose Escalation Phase||0
7761146|NCT01425008|19109526|P10|COMPLETED|Dose Escalation Phase||0
7761147|NCT01425008|19109527|P9|COMPLETED|Dose Escalation Phase||0
7761148|NCT01425008|19109528|P8|COMPLETED|Dose Escalation Phase||0
7761149|NCT01425008|19109529|P7|COMPLETED|Dose Escalation Phase||0
7761150|NCT01425008|19109530|P6|COMPLETED|Dose Escalation Phase||0
7761151|NCT01425008|19109531|P5|COMPLETED|Dose Escalation Phase||0
7761152|NCT01425008|19109532|P4|COMPLETED|Dose Escalation Phase||0
7761153|NCT01425008|19109533|P3|COMPLETED|Dose Escalation Phase||0
7761154|NCT01425008|19109534|P2|COMPLETED|Dose Escalation Phase||0
7761155|NCT01425008|19109535|P1|COMPLETED|Dose Escalation Phase||0
7761156|NCT01425008|19109517|P19|STARTED|Dose Escalation Phase||0
7761157|NCT01425008|19109518|P18|STARTED|Dose Escalation Phase||0
7761158|NCT01425008|19109519|P17|STARTED|Dose Escalation Phase||0
7761159|NCT01425008|19109520|P16|STARTED|Dose Escalation Phase||0
7761160|NCT01425008|19109521|P15|STARTED|Dose Escalation Phase||0
7761161|NCT01425008|19109522|P14|STARTED|Dose Escalation Phase||0
7761162|NCT01425008|19109523|P13|STARTED|Dose Escalation Phase||0
7761163|NCT01425008|19109524|P12|STARTED|Dose Escalation Phase||0
7761164|NCT01425008|19109525|P11|STARTED|Dose Escalation Phase||0
7761165|NCT01425008|19109526|P10|STARTED|Dose Escalation Phase||4
7761166|NCT01425008|19109527|P9|STARTED|Dose Escalation Phase||13
7761167|NCT01425008|19109528|P8|STARTED|Dose Escalation Phase||3
7761168|NCT01425008|19109529|P7|STARTED|Dose Escalation Phase||3
7761169|NCT01425008|19109530|P6|STARTED|Dose Escalation Phase||7
7761170|NCT01425008|19109531|P5|STARTED|Dose Escalation Phase||7
7761171|NCT01425008|19109532|P4|STARTED|Dose Escalation Phase||3
7761172|NCT01425008|19109533|P3|STARTED|Dose Escalation Phase||3
7761173|NCT01425008|19109534|P2|STARTED|Dose Escalation Phase||3
7761174|NCT01425008|19109535|P1|STARTED|Dose Escalation Phase||4
7761175|NCT01424943|19109821|P2|NOT COMPLETED|Overall Study||1
7761176|NCT01424943|19109822|P1|NOT COMPLETED|Overall Study||13
7761177|NCT01424943|19109821|P2|COMPLETED|Overall Study||23
7761178|NCT01424943|19109822|P1|COMPLETED|Overall Study||12
7761179|NCT01424943|19109821|P2|STARTED|Overall Study||24
7761180|NCT01424943|19109822|P1|STARTED|Overall Study||25
7761181|NCT01424930|19109838|P2|NOT COMPLETED|Overall Study||14
7761182|NCT01424930|19109839|P1|NOT COMPLETED|Overall Study||4
7761183|NCT01424930|19109838|P2|COMPLETED|Overall Study||4
7761184|NCT01424930|19109839|P1|COMPLETED|Overall Study||3
7761185|NCT01424930|19109838|P2|Completed Food Safety Evaluation|Overall Study||18
7761186|NCT01424930|19109839|P1|Completed Food Safety Evaluation|Overall Study||6
7761187|NCT01424930|19109838|P2|STARTED|Overall Study||18
7761188|NCT01424930|19109839|P1|STARTED|Overall Study||7
7761189|NCT01424813|19109853|P2|NOT COMPLETED|Overall Study||2
7761190|NCT01424813|19109854|P1|NOT COMPLETED|Overall Study||5
7761191|NCT01424813|19109853|P2|COMPLETED|Overall Study||77
7761192|NCT01424813|19109854|P1|COMPLETED|Overall Study||74
7761193|NCT01424813|19109853|P2|Treated|Overall Study|Safety set and full analysis set|78
7761194|NCT01424813|19109854|P1|Treated|Overall Study|Safety set and full analysis set|79
7761195|NCT01424813|19109853|P2|STARTED|Overall Study||79
7761196|NCT01424813|19109854|P1|STARTED|Overall Study||79
7761197|NCT01424670|19109874|P2|NOT COMPLETED|Continuation Period||14
7761198|NCT01424670|19109875|P1|NOT COMPLETED|Continuation Period||34
7761199|NCT01424670|19109874|P2|COMPLETED|Continuation Period||142
7761200|NCT01424670|19109875|P1|COMPLETED|Continuation Period||288
7761201|NCT01424670|19109874|P2|STARTED|Continuation Period||156
7761202|NCT01424670|19109875|P1|STARTED|Continuation Period||322
7761203|NCT01424670|19109874|P2|NOT COMPLETED|6-Month Intensive Period (182 Days)||14
7761204|NCT01424670|19109875|P1|NOT COMPLETED|6-Month Intensive Period (182 Days)||19
7761205|NCT01424670|19109874|P2|COMPLETED|6-Month Intensive Period (182 Days)||156
7761206|NCT01424670|19109875|P1|COMPLETED|6-Month Intensive Period (182 Days)||322
7761207|NCT01424670|19109874|P2|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||170
7761208|NCT01424670|19109875|P1|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||341
7761209|NCT01424670|19109874|P2|STARTED|6-Month Intensive Period (182 Days)||170
7761210|NCT01424670|19109875|P1|STARTED|6-Month Intensive Period (182 Days)||341
7761211|NCT01424644|19109897|P2|NOT COMPLETED|Overall Study||27
7761212|NCT01424644|19109898|P1|NOT COMPLETED|Overall Study||33
7761213|NCT01424644|19109897|P2|COMPLETED|Overall Study||372
7761214|NCT01424644|19109898|P1|COMPLETED|Overall Study||369
7761215|NCT01424644|19109897|P2|STARTED|Overall Study||399
7761216|NCT01424644|19109898|P1|STARTED|Overall Study||402
7761217|NCT01424566|19109912|P3|NOT COMPLETED|Double-blind Treatment||15
7761218|NCT01424566|19109913|P2|NOT COMPLETED|Double-blind Treatment||25
7761219|NCT01424566|19109914|P1|NOT COMPLETED|Double-blind Treatment||0
7761220|NCT01424566|19109912|P3|COMPLETED|Double-blind Treatment||88
7761221|NCT01424566|19109913|P2|COMPLETED|Double-blind Treatment||78
7761222|NCT01424566|19109914|P1|COMPLETED|Double-blind Treatment||0
7761223|NCT01424566|19109912|P3|ITT Population|Double-blind Treatment||103
7761224|NCT01424566|19109913|P2|ITT Population|Double-blind Treatment||103
7761225|NCT01424566|19109914|P1|ITT Population|Double-blind Treatment||0
7761226|NCT01424566|19109912|P3|Randomized Safety Population|Double-blind Treatment||103
7761227|NCT01424566|19109913|P2|Randomized Safety Population|Double-blind Treatment||103
7761228|NCT01424566|19109914|P1|Randomized Safety Population|Double-blind Treatment||0
7761229|NCT01424566|19109912|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
7761230|NCT01424566|19109913|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
7761231|NCT01424566|19109914|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment||0
7761232|NCT01424566|19109912|P3|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
7761233|NCT01424566|19109913|P2|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
7761234|NCT01424566|19109914|P1|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the double-blind period.|0
7761235|NCT01424566|19109912|P3|NOT COMPLETED|Single-blind Treatment||0
7761236|NCT01424566|19109913|P2|NOT COMPLETED|Single-blind Treatment||0
7761237|NCT01424566|19109914|P1|NOT COMPLETED|Single-blind Treatment||200
7761238|NCT01424566|19109912|P3|COMPLETED|Single-blind Treatment||0
7761239|NCT01424566|19109913|P2|COMPLETED|Single-blind Treatment||0
7761240|NCT01424566|19109914|P1|COMPLETED|Single-blind Treatment||206
7761241|NCT01424566|19109912|P3|Met Randomization Criteria|Single-blind Treatment||0
7761242|NCT01424566|19109913|P2|Met Randomization Criteria|Single-blind Treatment||0
7761243|NCT01424566|19109914|P1|Met Randomization Criteria|Single-blind Treatment||206
7761244|NCT01424566|19109912|P3|Single-blind Safety Population|Single-blind Treatment||0
7761245|NCT01424566|19109913|P2|Single-blind Safety Population|Single-blind Treatment||0
7761246|NCT01424566|19109914|P1|Single-blind Safety Population|Single-blind Treatment||404
7761247|NCT01424566|19109912|P3|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
7761248|NCT01424566|19109913|P2|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
7761249|NCT01424566|19109914|P1|Received at Least 1 Dose of Study Drug|Single-blind Treatment|Two participants did not administer any study drug.|404
7761250|NCT01424566|19109912|P3|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
7761251|NCT01424566|19109913|P2|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
7761252|NCT01424566|19109914|P1|STARTED|Single-blind Treatment||406
7761253|NCT01424514|19109941|P2|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||0
7761254|NCT01424514|19109942|P1|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||1
7761255|NCT01424514|19109941|P2|COMPLETED|Period 3:Intervention Period 2 (14 Days)||19
7761256|NCT01424514|19109942|P1|COMPLETED|Period 3:Intervention Period 2 (14 Days)||18
7761257|NCT01424514|19109941|P2|STARTED|Period 3:Intervention Period 2 (14 Days)||19
7761258|NCT01424514|19109942|P1|STARTED|Period 3:Intervention Period 2 (14 Days)||19
7761259|NCT01424514|19109941|P2|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
7761260|NCT01424514|19109942|P1|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
7761261|NCT01424514|19109941|P2|COMPLETED|Period 2:Washout Period (4 Weeks)||19
7761262|NCT01424514|19109942|P1|COMPLETED|Period 2:Washout Period (4 Weeks)||19
7761263|NCT01424514|19109941|P2|STARTED|Period 2:Washout Period (4 Weeks)||19
7761264|NCT01424514|19109942|P1|STARTED|Period 2:Washout Period (4 Weeks)||19
7761265|NCT01424514|19109941|P2|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
7761266|NCT01424514|19109942|P1|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
7761267|NCT01424514|19109941|P2|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
7761268|NCT01424514|19109942|P1|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
7761269|NCT01424514|19109941|P2|STARTED|Period 1:Intervention Period 1 (14 Days)||20
7761270|NCT01424514|19109942|P1|STARTED|Period 1:Intervention Period 1 (14 Days)||20
7761271|NCT01424501|19109987|P6|NOT COMPLETED|Overall Study||0
7761272|NCT01424501|19109988|P5|NOT COMPLETED|Overall Study||0
7761273|NCT01424501|19109989|P4|NOT COMPLETED|Overall Study||0
7761274|NCT01424501|19109990|P3|NOT COMPLETED|Overall Study||2
7761275|NCT01424501|19109991|P2|NOT COMPLETED|Overall Study||1
7761276|NCT01424501|19109992|P1|NOT COMPLETED|Overall Study||1
7761277|NCT01424501|19109987|P6|COMPLETED|Overall Study||40
7761278|NCT01424501|19109988|P5|COMPLETED|Overall Study||40
7761279|NCT01424501|19109989|P4|COMPLETED|Overall Study||25
7761280|NCT01424501|19109990|P3|COMPLETED|Overall Study||22
7761281|NCT01424501|19109991|P2|COMPLETED|Overall Study||5
7761282|NCT01424501|19109992|P1|COMPLETED|Overall Study||6
7761283|NCT01424501|19109987|P6|STARTED|Overall Study||40
7761284|NCT01424501|19109988|P5|STARTED|Overall Study||40
7761285|NCT01424501|19109989|P4|STARTED|Overall Study||25
7761286|NCT01424501|19109990|P3|STARTED|Overall Study||24
7761287|NCT01424501|19109991|P2|STARTED|Overall Study||6
7761288|NCT01424501|19109992|P1|STARTED|Overall Study||7
7761289|NCT01424397|19110168|P12|NOT COMPLETED|Period-3 (8 Days)||0
7761290|NCT01424397|19110169|P11|NOT COMPLETED|Period-3 (8 Days)||0
7761291|NCT01424397|19110170|P10|NOT COMPLETED|Period-3 (8 Days)||0
7761292|NCT01424397|19110171|P9|NOT COMPLETED|Period-3 (8 Days)||0
7761293|NCT01424397|19110172|P8|NOT COMPLETED|Period-3 (8 Days)||0
7761294|NCT01424397|19110173|P7|NOT COMPLETED|Period-3 (8 Days)||0
7761295|NCT01424397|19110174|P6|NOT COMPLETED|Period-3 (8 Days)||0
7761296|NCT01424397|19110175|P5|NOT COMPLETED|Period-3 (8 Days)||0
7761297|NCT01424397|19110176|P4|NOT COMPLETED|Period-3 (8 Days)||0
7761298|NCT01424397|19110177|P3|NOT COMPLETED|Period-3 (8 Days)||0
7761299|NCT01424397|19110178|P2|NOT COMPLETED|Period-3 (8 Days)||0
7761300|NCT01424397|19110179|P1|NOT COMPLETED|Period-3 (8 Days)||0
7761301|NCT01424397|19110168|P12|COMPLETED|Period-3 (8 Days)||4
7761302|NCT01424397|19110169|P11|COMPLETED|Period-3 (8 Days)||4
7761303|NCT01424397|19110170|P10|COMPLETED|Period-3 (8 Days)||3
7761304|NCT01424397|19110171|P9|COMPLETED|Period-3 (8 Days)||4
7761305|NCT01424397|19110172|P8|COMPLETED|Period-3 (8 Days)||4
7761306|NCT01424397|19110173|P7|COMPLETED|Period-3 (8 Days)||4
7761307|NCT01424397|19110174|P6|COMPLETED|Period-3 (8 Days)||8
7761308|NCT01424397|19110175|P5|COMPLETED|Period-3 (8 Days)||8
7761309|NCT01424397|19110176|P4|COMPLETED|Period-3 (8 Days)||8
7761310|NCT01424397|19110177|P3|COMPLETED|Period-3 (8 Days)||7
7761311|NCT01424397|19110178|P2|COMPLETED|Period-3 (8 Days)||8
7761312|NCT01424397|19110179|P1|COMPLETED|Period-3 (8 Days)||7
7761313|NCT01424397|19110168|P12|STARTED|Period-3 (8 Days)||4
7761314|NCT01424397|19110169|P11|STARTED|Period-3 (8 Days)||4
7761315|NCT01424397|19110170|P10|STARTED|Period-3 (8 Days)||3
7761316|NCT01424397|19110171|P9|STARTED|Period-3 (8 Days)||4
7761317|NCT01424397|19110172|P8|STARTED|Period-3 (8 Days)||4
7761318|NCT01424397|19110173|P7|STARTED|Period-3 (8 Days)||4
7761319|NCT01424397|19110174|P6|STARTED|Period-3 (8 Days)||8
7761320|NCT01424397|19110175|P5|STARTED|Period-3 (8 Days)||8
7761321|NCT01424397|19110176|P4|STARTED|Period-3 (8 Days)||8
7761322|NCT01424397|19110177|P3|STARTED|Period-3 (8 Days)||7
7761323|NCT01424397|19110178|P2|STARTED|Period-3 (8 Days)||8
7761324|NCT01424397|19110179|P1|STARTED|Period-3 (8 Days)||7
7761325|NCT01424397|19110168|P12|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
7761326|NCT01424397|19110169|P11|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
7761327|NCT01424397|19110170|P10|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
7761328|NCT01424397|19110171|P9|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
7761329|NCT01424397|19110172|P8|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
7761330|NCT01424397|19110173|P7|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
7761331|NCT01424397|19110174|P6|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
7761332|NCT01424397|19110175|P5|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
7761333|NCT01424397|19110176|P4|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
7761334|NCT01424397|19110177|P3|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
7761335|NCT01424397|19110178|P2|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
7761336|NCT01424397|19110179|P1|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
7761337|NCT01424397|19110168|P12|COMPLETED|Washout Period-2 (14-20 Days)||4
7761338|NCT01424397|19110169|P11|COMPLETED|Washout Period-2 (14-20 Days)||4
7761339|NCT01424397|19110170|P10|COMPLETED|Washout Period-2 (14-20 Days)||3
7761340|NCT01424397|19110171|P9|COMPLETED|Washout Period-2 (14-20 Days)||4
7761341|NCT01424397|19110172|P8|COMPLETED|Washout Period-2 (14-20 Days)||4
7761342|NCT01424397|19110173|P7|COMPLETED|Washout Period-2 (14-20 Days)||4
7761343|NCT01424397|19110174|P6|COMPLETED|Washout Period-2 (14-20 Days)||8
7761344|NCT01424397|19110175|P5|COMPLETED|Washout Period-2 (14-20 Days)||8
7761345|NCT01424397|19110176|P4|COMPLETED|Washout Period-2 (14-20 Days)||8
7761346|NCT01424397|19110177|P3|COMPLETED|Washout Period-2 (14-20 Days)||7
7761347|NCT01424397|19110178|P2|COMPLETED|Washout Period-2 (14-20 Days)||8
7761348|NCT01424397|19110179|P1|COMPLETED|Washout Period-2 (14-20 Days)||7
7761349|NCT01424397|19110168|P12|STARTED|Washout Period-2 (14-20 Days)||4
7761350|NCT01424397|19110169|P11|STARTED|Washout Period-2 (14-20 Days)||4
7761351|NCT01424397|19110170|P10|STARTED|Washout Period-2 (14-20 Days)||3
7761352|NCT01424397|19110171|P9|STARTED|Washout Period-2 (14-20 Days)||4
7761353|NCT01424397|19110172|P8|STARTED|Washout Period-2 (14-20 Days)||4
7761354|NCT01424397|19110173|P7|STARTED|Washout Period-2 (14-20 Days)||4
7761355|NCT01424397|19110174|P6|STARTED|Washout Period-2 (14-20 Days)||8
7761356|NCT01424397|19110175|P5|STARTED|Washout Period-2 (14-20 Days)||8
7761357|NCT01424397|19110176|P4|STARTED|Washout Period-2 (14-20 Days)||8
7761358|NCT01424397|19110177|P3|STARTED|Washout Period-2 (14-20 Days)||7
7761359|NCT01424397|19110178|P2|STARTED|Washout Period-2 (14-20 Days)||8
7761360|NCT01424397|19110179|P1|STARTED|Washout Period-2 (14-20 Days)||7
7761361|NCT01424397|19110168|P12|NOT COMPLETED|Period-2 (8 Days)||0
7761362|NCT01424397|19110169|P11|NOT COMPLETED|Period-2 (8 Days)||0
7761363|NCT01424397|19110170|P10|NOT COMPLETED|Period-2 (8 Days)||0
7761364|NCT01424397|19110171|P9|NOT COMPLETED|Period-2 (8 Days)||0
7761365|NCT01424397|19110172|P8|NOT COMPLETED|Period-2 (8 Days)||0
7761366|NCT01424397|19110173|P7|NOT COMPLETED|Period-2 (8 Days)||0
7761367|NCT01424397|19110174|P6|NOT COMPLETED|Period-2 (8 Days)||0
7761368|NCT01424397|19110175|P5|NOT COMPLETED|Period-2 (8 Days)||0
7761369|NCT01424397|19110176|P4|NOT COMPLETED|Period-2 (8 Days)||0
7761370|NCT01424397|19110177|P3|NOT COMPLETED|Period-2 (8 Days)||1
7761371|NCT01424397|19110178|P2|NOT COMPLETED|Period-2 (8 Days)||0
7761372|NCT01424397|19110179|P1|NOT COMPLETED|Period-2 (8 Days)||0
7761373|NCT01424397|19110168|P12|COMPLETED|Period-2 (8 Days)||4
7761374|NCT01424397|19110169|P11|COMPLETED|Period-2 (8 Days)||4
7761375|NCT01424397|19110170|P10|COMPLETED|Period-2 (8 Days)||3
7761376|NCT01424397|19110171|P9|COMPLETED|Period-2 (8 Days)||4
7761377|NCT01424397|19110172|P8|COMPLETED|Period-2 (8 Days)||4
7761378|NCT01424397|19110173|P7|COMPLETED|Period-2 (8 Days)||4
7761379|NCT01424397|19110174|P6|COMPLETED|Period-2 (8 Days)||8
7761380|NCT01424397|19110175|P5|COMPLETED|Period-2 (8 Days)||8
7761381|NCT01424397|19110176|P4|COMPLETED|Period-2 (8 Days)||8
7761382|NCT01424397|19110177|P3|COMPLETED|Period-2 (8 Days)||7
7761383|NCT01424397|19110178|P2|COMPLETED|Period-2 (8 Days)||8
7761384|NCT01424397|19110179|P1|COMPLETED|Period-2 (8 Days)||7
7761385|NCT01424397|19110168|P12|STARTED|Period-2 (8 Days)||4
7761386|NCT01424397|19110169|P11|STARTED|Period-2 (8 Days)||4
7761387|NCT01424397|19110170|P10|STARTED|Period-2 (8 Days)||3
7761388|NCT01424397|19110171|P9|STARTED|Period-2 (8 Days)||4
7761389|NCT01424397|19110172|P8|STARTED|Period-2 (8 Days)||4
7761390|NCT01424397|19110173|P7|STARTED|Period-2 (8 Days)||4
7761391|NCT01424397|19110174|P6|STARTED|Period-2 (8 Days)||8
7761392|NCT01424397|19110175|P5|STARTED|Period-2 (8 Days)||8
7761393|NCT01424397|19110176|P4|STARTED|Period-2 (8 Days)||8
7761394|NCT01424397|19110177|P3|STARTED|Period-2 (8 Days)||8
7761395|NCT01424397|19110178|P2|STARTED|Period-2 (8 Days)||8
7761396|NCT01424397|19110179|P1|STARTED|Period-2 (8 Days)||7
7761397|NCT01424397|19110168|P12|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
7761398|NCT01424397|19110169|P11|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
7761399|NCT01424397|19110170|P10|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
7761400|NCT01424397|19110171|P9|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
7761401|NCT01424397|19110172|P8|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
7761402|NCT01424397|19110173|P7|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
7761403|NCT01424397|19110174|P6|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
7761404|NCT01424397|19110175|P5|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
7761405|NCT01424397|19110176|P4|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
7761406|NCT01424397|19110177|P3|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
7761407|NCT01424397|19110178|P2|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
7761408|NCT01424397|19110179|P1|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
7761409|NCT01424397|19110168|P12|COMPLETED|Washout Period-1 (14-20 Days)||4
7761410|NCT01424397|19110169|P11|COMPLETED|Washout Period-1 (14-20 Days)||4
7761411|NCT01424397|19110170|P10|COMPLETED|Washout Period-1 (14-20 Days)||3
7761412|NCT01424397|19110171|P9|COMPLETED|Washout Period-1 (14-20 Days)||4
7761413|NCT01424397|19110172|P8|COMPLETED|Washout Period-1 (14-20 Days)||4
7761414|NCT01424397|19110173|P7|COMPLETED|Washout Period-1 (14-20 Days)||4
7761415|NCT01424397|19110174|P6|COMPLETED|Washout Period-1 (14-20 Days)||8
7761416|NCT01424397|19110175|P5|COMPLETED|Washout Period-1 (14-20 Days)||8
7761417|NCT01424397|19110176|P4|COMPLETED|Washout Period-1 (14-20 Days)||8
7761418|NCT01424397|19110177|P3|COMPLETED|Washout Period-1 (14-20 Days)||8
7761419|NCT01424397|19110178|P2|COMPLETED|Washout Period-1 (14-20 Days)||8
7761420|NCT01424397|19110179|P1|COMPLETED|Washout Period-1 (14-20 Days)||7
7761421|NCT01424397|19110168|P12|STARTED|Washout Period-1 (14-20 Days)||4
7761422|NCT01424397|19110169|P11|STARTED|Washout Period-1 (14-20 Days)||4
7761423|NCT01424397|19110170|P10|STARTED|Washout Period-1 (14-20 Days)||3
7761424|NCT01424397|19110171|P9|STARTED|Washout Period-1 (14-20 Days)||4
7761425|NCT01424397|19110172|P8|STARTED|Washout Period-1 (14-20 Days)||4
7761426|NCT01424397|19110173|P7|STARTED|Washout Period-1 (14-20 Days)||4
7761427|NCT01424397|19110174|P6|STARTED|Washout Period-1 (14-20 Days)||8
7761428|NCT01424397|19110175|P5|STARTED|Washout Period-1 (14-20 Days)||8
7761429|NCT01424397|19110176|P4|STARTED|Washout Period-1 (14-20 Days)||8
7761430|NCT01424397|19110177|P3|STARTED|Washout Period-1 (14-20 Days)||8
7761431|NCT01424397|19110178|P2|STARTED|Washout Period-1 (14-20 Days)||8
7761432|NCT01424397|19110179|P1|STARTED|Washout Period-1 (14-20 Days)||7
7761433|NCT01424397|19110168|P12|NOT COMPLETED|Period-1 (8 Days)||0
7761434|NCT01424397|19110169|P11|NOT COMPLETED|Period-1 (8 Days)||0
7761435|NCT01424397|19110170|P10|NOT COMPLETED|Period-1 (8 Days)||0
7761436|NCT01424397|19110171|P9|NOT COMPLETED|Period-1 (8 Days)||0
7761437|NCT01424397|19110172|P8|NOT COMPLETED|Period-1 (8 Days)||0
7761438|NCT01424397|19110173|P7|NOT COMPLETED|Period-1 (8 Days)||0
7761439|NCT01424397|19110174|P6|NOT COMPLETED|Period-1 (8 Days)||0
7761440|NCT01424397|19110175|P5|NOT COMPLETED|Period-1 (8 Days)||0
7761441|NCT01424397|19110176|P4|NOT COMPLETED|Period-1 (8 Days)||0
7761442|NCT01424397|19110177|P3|NOT COMPLETED|Period-1 (8 Days)||0
7761443|NCT01424397|19110178|P2|NOT COMPLETED|Period-1 (8 Days)||0
7761444|NCT01424397|19110179|P1|NOT COMPLETED|Period-1 (8 Days)||0
7761445|NCT01424397|19110168|P12|COMPLETED|Period-1 (8 Days)||4
7761446|NCT01424397|19110169|P11|COMPLETED|Period-1 (8 Days)||4
7761447|NCT01424397|19110170|P10|COMPLETED|Period-1 (8 Days)||3
7761448|NCT01424397|19110171|P9|COMPLETED|Period-1 (8 Days)||4
7761449|NCT01424397|19110172|P8|COMPLETED|Period-1 (8 Days)||4
7761450|NCT01424397|19110173|P7|COMPLETED|Period-1 (8 Days)||4
7761451|NCT01424397|19110174|P6|COMPLETED|Period-1 (8 Days)||8
7761452|NCT01424397|19110175|P5|COMPLETED|Period-1 (8 Days)||8
7761453|NCT01424397|19110176|P4|COMPLETED|Period-1 (8 Days)||8
7761454|NCT01424397|19110177|P3|COMPLETED|Period-1 (8 Days)||8
7761455|NCT01424397|19110178|P2|COMPLETED|Period-1 (8 Days)||8
7761456|NCT01424397|19110179|P1|COMPLETED|Period-1 (8 Days)||7
7761457|NCT01424397|19110168|P12|STARTED|Period-1 (8 Days)||4
7761458|NCT01424397|19110169|P11|STARTED|Period-1 (8 Days)||4
7761459|NCT01424397|19110170|P10|STARTED|Period-1 (8 Days)||3
7761460|NCT01424397|19110171|P9|STARTED|Period-1 (8 Days)||4
7761461|NCT01424397|19110172|P8|STARTED|Period-1 (8 Days)||4
7761462|NCT01424397|19110173|P7|STARTED|Period-1 (8 Days)||4
7761463|NCT01424397|19110174|P6|STARTED|Period-1 (8 Days)||8
7761464|NCT01424397|19110175|P5|STARTED|Period-1 (8 Days)||8
7761465|NCT01424397|19110176|P4|STARTED|Period-1 (8 Days)||8
7761466|NCT01424397|19110177|P3|STARTED|Period-1 (8 Days)||8
7761467|NCT01424397|19110178|P2|STARTED|Period-1 (8 Days)||8
7761468|NCT01424397|19110179|P1|STARTED|Period-1 (8 Days)||7
7761469|NCT01424306|19110225|P6|NOT COMPLETED|Overall Study||0
7761470|NCT01424306|19110226|P5|NOT COMPLETED|Overall Study||1
7761471|NCT01424306|19110227|P4|NOT COMPLETED|Overall Study||0
7761472|NCT01424306|19110228|P3|NOT COMPLETED|Overall Study||0
7761473|NCT01424306|19110229|P2|NOT COMPLETED|Overall Study||0
7761474|NCT01424306|19110230|P1|NOT COMPLETED|Overall Study||0
7761475|NCT01424306|19110225|P6|COMPLETED|Overall Study||6
7761476|NCT01424306|19110226|P5|COMPLETED|Overall Study||4
7761477|NCT01424306|19110227|P4|COMPLETED|Overall Study||3
7761478|NCT01424306|19110228|P3|COMPLETED|Overall Study||3
7761479|NCT01424306|19110229|P2|COMPLETED|Overall Study||4
7761480|NCT01424306|19110230|P1|COMPLETED|Overall Study||4
7761481|NCT01424306|19110225|P6|STARTED|Overall Study||6
7761482|NCT01424306|19110226|P5|STARTED|Overall Study||5
7761483|NCT01424306|19110227|P4|STARTED|Overall Study||3
7761484|NCT01424306|19110228|P3|STARTED|Overall Study||3
7761485|NCT01424306|19110229|P2|STARTED|Overall Study||4
7761486|NCT01424306|19110230|P1|STARTED|Overall Study||4
7761487|NCT01424228|19110279|P2|NOT COMPLETED|Overall Study||47
7761488|NCT01424228|19110280|P1|NOT COMPLETED|Overall Study||56
7761489|NCT01424228|19110279|P2|COMPLETED|Overall Study||135
7761490|NCT01424228|19110280|P1|COMPLETED|Overall Study||126
7761491|NCT01424228|19110279|P2|STARTED|Overall Study||182
7761492|NCT01424228|19110280|P1|STARTED|Overall Study||182
7761493|NCT01424215|19110320|P2|NOT COMPLETED|Overall Study||0
7761494|NCT01424215|19110321|P1|NOT COMPLETED|Overall Study||0
7761495|NCT01424215|19110320|P2|COMPLETED|Overall Study||50
7761496|NCT01424215|19110321|P1|COMPLETED|Overall Study||50
7761497|NCT01424215|19110320|P2|STARTED|Overall Study||50
7761498|NCT01424215|19110321|P1|STARTED|Overall Study||50
7761499|NCT01424189|19110331|P2|NOT COMPLETED|Overall Study||6
7761500|NCT01424189|19110332|P1|NOT COMPLETED|Overall Study||13
7761501|NCT01424189|19110331|P2|COMPLETED|Overall Study||182
7761502|NCT01424189|19110332|P1|COMPLETED|Overall Study||373
7761503|NCT01424189|19110331|P2|STARTED|Overall Study||188
7761504|NCT01424189|19110332|P1|STARTED|Overall Study||386
7761505|NCT01424072|19110347|P3|NOT COMPLETED|Overall Study||0
7761506|NCT01424072|19110348|P2|NOT COMPLETED|Overall Study||0
7761507|NCT01424072|19110349|P1|NOT COMPLETED|Overall Study||0
7761508|NCT01424072|19110347|P3|COMPLETED|Overall Study||22
7761509|NCT01424072|19110348|P2|COMPLETED|Overall Study||26
7761510|NCT01424072|19110349|P1|COMPLETED|Overall Study||27
7761511|NCT01424072|19110347|P3|STARTED|Overall Study||22
7761512|NCT01424072|19110348|P2|STARTED|Overall Study||26
7761513|NCT01424072|19110349|P1|STARTED|Overall Study||27
7761514|NCT01424033|19110366|P1|NOT COMPLETED|Overall Study||5
7761515|NCT01424033|19110366|P1|COMPLETED|Overall Study||0
7761516|NCT01424033|19110366|P1|STARTED|Overall Study||5
7761517|NCT01423916|19110373|P3|NOT COMPLETED|Overall Study||7
7761518|NCT01423916|19110374|P2|NOT COMPLETED|Overall Study||20
7761519|NCT01423916|19110375|P1|NOT COMPLETED|Overall Study||11
7761520|NCT01423916|19110373|P3|COMPLETED|Overall Study||64
7761521|NCT01423916|19110374|P2|COMPLETED|Overall Study||53
7761522|NCT01423916|19110375|P1|COMPLETED|Overall Study||63
7761523|NCT01423916|19110373|P3|STARTED|Overall Study||71
7761524|NCT01423916|19110374|P2|STARTED|Overall Study||73
7761525|NCT01423916|19110375|P1|STARTED|Overall Study||74
7761526|NCT01423812|19110431|P2|NOT COMPLETED|Overall Study||4
7761527|NCT01423812|19110432|P1|NOT COMPLETED|Overall Study||3
7761528|NCT01423812|19110431|P2|COMPLETED|Overall Study||26
7761529|NCT01423812|19110432|P1|COMPLETED|Overall Study||27
7761530|NCT01423812|19110431|P2|STARTED|Overall Study||30
7761531|NCT01423812|19110432|P1|STARTED|Overall Study||30
7761532|NCT01423773|19110440|P2|NOT COMPLETED|Period 2, 2 Days||0
7761533|NCT01423773|19110441|P1|NOT COMPLETED|Period 2, 2 Days||0
7761534|NCT01423773|19110440|P2|COMPLETED|Period 2, 2 Days||10
7761535|NCT01423773|19110441|P1|COMPLETED|Period 2, 2 Days||10
7761536|NCT01423773|19110440|P2|STARTED|Period 2, 2 Days||10
7761537|NCT01423773|19110441|P1|STARTED|Period 2, 2 Days||10
7761538|NCT01423773|19110440|P2|NOT COMPLETED|Period One, 2 Days||0
7761539|NCT01423773|19110441|P1|NOT COMPLETED|Period One, 2 Days||0
7761540|NCT01423773|19110440|P2|COMPLETED|Period One, 2 Days||10
7761541|NCT01423773|19110441|P1|COMPLETED|Period One, 2 Days||10
7761542|NCT01423773|19110440|P2|STARTED|Period One, 2 Days||10
7761543|NCT01423773|19110441|P1|STARTED|Period One, 2 Days||10
7761544|NCT01423760|19110449|P2|NOT COMPLETED|Overall Study||0
7761545|NCT01423760|19110450|P1|NOT COMPLETED|Overall Study||0
7761546|NCT01423760|19110449|P2|COMPLETED|Overall Study||13
7761547|NCT01423760|19110450|P1|COMPLETED|Overall Study||14
7761548|NCT01423760|19110449|P2|Safety Analysis Set|Overall Study||8
7761549|NCT01423760|19110450|P1|Safety Analysis Set|Overall Study||12
7761550|NCT01423760|19110449|P2|Number of Non-treatment Subjects|Overall Study||5
7761551|NCT01423760|19110450|P1|Number of Non-treatment Subjects|Overall Study||2
7761552|NCT01423760|19110449|P2|Number of Tecemotide Subjects|Overall Study||8
7761553|NCT01423760|19110450|P1|Number of Tecemotide Subjects|Overall Study||12
7761554|NCT01423760|19110449|P2|STARTED|Overall Study||13
7761555|NCT01423760|19110450|P1|STARTED|Overall Study||14
7761556|NCT01423617|19110460|P2|NOT COMPLETED|Overall Study||1
7761557|NCT01423617|19110461|P1|NOT COMPLETED|Overall Study||0
7761558|NCT01423617|19110460|P2|COMPLETED|Overall Study||45
7761559|NCT01423617|19110461|P1|COMPLETED|Overall Study||46
7761560|NCT01423617|19110460|P2|STARTED|Overall Study||46
7761561|NCT01423617|19110461|P1|STARTED|Overall Study||46
7761562|NCT01423604|19110478|P2|NOT COMPLETED|Randomized||63
7761563|NCT01423604|19110479|P1|NOT COMPLETED|Randomized||63
7761564|NCT01423604|19110478|P2|COMPLETED|Randomized||0
7761565|NCT01423604|19110479|P1|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1
7761566|NCT01423604|19110478|P2|STARTED|Randomized||63
7761567|NCT01423604|19110479|P1|STARTED|Randomized||64
7761568|NCT01423604|19110478|P2|NOT COMPLETED|Safety Run-In||0
7761569|NCT01423604|19110479|P1|NOT COMPLETED|Safety Run-In||9
7761570|NCT01423604|19110478|P2|COMPLETED|Safety Run-In||0
7761571|NCT01423604|19110479|P1|COMPLETED|Safety Run-In||0
7761572|NCT01423604|19110478|P2|STARTED|Safety Run-In||0
7761573|NCT01423604|19110479|P1|STARTED|Safety Run-In||9
7761574|NCT01423253|19110494|P1|NOT COMPLETED|Overall Study||9
7761575|NCT01423253|19110494|P1|COMPLETED|Overall Study||39
7761576|NCT01423253|19110494|P1|STARTED|Overall Study||48
7761577|NCT01423162|19110507|P2|NOT COMPLETED|Overall Study||0
7761578|NCT01423162|19110508|P1|NOT COMPLETED|Overall Study||0
7761579|NCT01423162|19110507|P2|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9
7761580|NCT01423162|19110508|P1|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11
7761581|NCT01423162|19110507|P2|STARTED|Overall Study||9
7761582|NCT01423162|19110508|P1|STARTED|Overall Study||11
7761583|NCT01423084|19110516|P2|NOT COMPLETED|Overall Study||4
7761584|NCT01423084|19110517|P1|NOT COMPLETED|Overall Study||2
7761585|NCT01423084|19110516|P2|COMPLETED|Overall Study||170
7761586|NCT01423084|19110517|P1|COMPLETED|Overall Study||168
7761587|NCT01423084|19110516|P2|STARTED|Overall Study||174
7761588|NCT01423084|19110517|P1|STARTED|Overall Study||170
7761589|NCT01422915|19110547|P1|NOT COMPLETED|Overall Study||1
7761590|NCT01422915|19110547|P1|COMPLETED|Overall Study||3
7761591|NCT01422915|19110547|P1|STARTED|Overall Study|1 subject with abnormal liver chemistries removed during the first period.|4
7761592|NCT01422889|19110552|P1|NOT COMPLETED|Overall Study||9
7761593|NCT01422889|19110552|P1|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111
7761594|NCT01422889|19110552|P1|STARTED|Overall Study||1120
7761595|NCT01422876|19110567|P10|NOT COMPLETED|Week 52||17
7761596|NCT01422876|19110568|P9|NOT COMPLETED|Week 52||21
7761597|NCT01422876|19110569|P8|NOT COMPLETED|Week 52||23
7761598|NCT01422876|19110570|P7|NOT COMPLETED|Week 52||16
7761599|NCT01422876|19110571|P6|NOT COMPLETED|Week 52||17
7761600|NCT01422876|19110572|P5|NOT COMPLETED|Week 52||15
7761601|NCT01422876|19110573|P4|NOT COMPLETED|Week 52||18
7761602|NCT01422876|19110574|P3|NOT COMPLETED|Week 52||13
7761603|NCT01422876|19110575|P2|NOT COMPLETED|Week 52||10
7761604|NCT01422876|19110576|P1|NOT COMPLETED|Week 52||12
7761605|NCT01422876|19110567|P10|COMPLETED|Week 52||118
7761606|NCT01422876|19110568|P9|COMPLETED|Week 52||113
7761607|NCT01422876|19110569|P8|COMPLETED|Week 52||112
7761608|NCT01422876|19110570|P7|COMPLETED|Week 52||120
7761609|NCT01422876|19110571|P6|COMPLETED|Week 52||120
7761610|NCT01422876|19110572|P5|COMPLETED|Week 52||117
7761611|NCT01422876|19110573|P4|COMPLETED|Week 52||122
7761612|NCT01422876|19110574|P3|COMPLETED|Week 52||128
7761613|NCT01422876|19110575|P2|COMPLETED|Week 52||126
7761614|NCT01422876|19110576|P1|COMPLETED|Week 52||125
7761615|NCT01422876|19110567|P10|STARTED|Week 52||135
7761616|NCT01422876|19110568|P9|STARTED|Week 52||134
7761617|NCT01422876|19110569|P8|STARTED|Week 52||135
7761618|NCT01422876|19110570|P7|STARTED|Week 52||136
7761619|NCT01422876|19110571|P6|STARTED|Week 52||137
7761620|NCT01422876|19110572|P5|STARTED|Week 52||132
7761621|NCT01422876|19110573|P4|STARTED|Week 52||140
7761622|NCT01422876|19110574|P3|STARTED|Week 52||141
7761623|NCT01422876|19110575|P2|STARTED|Week 52||136
7761624|NCT01422876|19110576|P1|STARTED|Week 52||137
7761625|NCT01422876|19110567|P10|NOT COMPLETED|Week 24||10
7761626|NCT01422876|19110568|P9|NOT COMPLETED|Week 24||6
7761627|NCT01422876|19110569|P8|NOT COMPLETED|Week 24||7
7761628|NCT01422876|19110570|P7|NOT COMPLETED|Week 24||6
7761629|NCT01422876|19110571|P6|NOT COMPLETED|Week 24||6
7761630|NCT01422876|19110572|P5|NOT COMPLETED|Week 24||7
7761631|NCT01422876|19110573|P4|NOT COMPLETED|Week 24||8
7761632|NCT01422876|19110574|P3|NOT COMPLETED|Week 24||5
7761633|NCT01422876|19110575|P2|NOT COMPLETED|Week 24||3
7761634|NCT01422876|19110576|P1|NOT COMPLETED|Week 24||6
7761635|NCT01422876|19110567|P10|COMPLETED|Week 24||125
7761636|NCT01422876|19110568|P9|COMPLETED|Week 24||128
7761637|NCT01422876|19110569|P8|COMPLETED|Week 24||128
7761638|NCT01422876|19110570|P7|COMPLETED|Week 24||130
7761639|NCT01422876|19110571|P6|COMPLETED|Week 24||131
7761640|NCT01422876|19110572|P5|COMPLETED|Week 24||125
7761641|NCT01422876|19110573|P4|COMPLETED|Week 24||132
7761642|NCT01422876|19110574|P3|COMPLETED|Week 24||136
7761643|NCT01422876|19110575|P2|COMPLETED|Week 24||133
7761644|NCT01422876|19110576|P1|COMPLETED|Week 24||131
7761645|NCT01422876|19110567|P10|STARTED|Week 24||135
7761646|NCT01422876|19110568|P9|STARTED|Week 24||134
7761647|NCT01422876|19110569|P8|STARTED|Week 24||135
7761648|NCT01422876|19110570|P7|STARTED|Week 24||136
7761649|NCT01422876|19110571|P6|STARTED|Week 24||137
7761650|NCT01422876|19110572|P5|STARTED|Week 24||132
7761651|NCT01422876|19110573|P4|STARTED|Week 24||140
7761652|NCT01422876|19110574|P3|STARTED|Week 24||141
7761653|NCT01422876|19110575|P2|STARTED|Week 24||136
7761654|NCT01422876|19110576|P1|STARTED|Week 24||137
7761655|NCT01422850|19110623|P1|NOT COMPLETED|Overall Study||3
7761656|NCT01422850|19110623|P1|COMPLETED|Overall Study||18
7761657|NCT01422850|19110623|P1|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18
7761658|NCT01422850|19110623|P1|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19
7761659|NCT01422850|19110623|P1|Week 9 - Second Treatment|Overall Study||20
7761660|NCT01422850|19110623|P1|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20
7761661|NCT01422850|19110623|P1|Week 4 - First Treatment|Overall Study||21
7761662|NCT01422850|19110623|P1|STARTED|Overall Study||21
7761663|NCT01422824|19110629|P1|NOT COMPLETED|Overall Study||38
7761664|NCT01422824|19110629|P1|COMPLETED|Overall Study||147
7761665|NCT01422824|19110629|P1|Treated|Overall Study||184
7761666|NCT01422824|19110629|P1|STARTED|Overall Study||185
7761667|NCT01422720|19110634|P1|NOT COMPLETED|Overall Study||22
7761668|NCT01422720|19110634|P1|COMPLETED|Overall Study||50
7761669|NCT01422720|19110634|P1|Per-Protocol Set (PPS)|Overall Study||55
7761670|NCT01422720|19110634|P1|Full Analysis Set (FAS)|Overall Study||71
7761671|NCT01422720|19110634|P1|Safety Set|Overall Study||72
7761672|NCT01422720|19110634|P1|STARTED|Overall Study||72
7761673|NCT01422538|19110645|P3|NOT COMPLETED|Overall Study||2
7761674|NCT01422538|19110646|P2|NOT COMPLETED|Overall Study||2
7761675|NCT01422538|19110647|P1|NOT COMPLETED|Overall Study||0
7761676|NCT01422538|19110645|P3|COMPLETED|Overall Study||8
7761677|NCT01422538|19110646|P2|COMPLETED|Overall Study||8
7761678|NCT01422538|19110647|P1|COMPLETED|Overall Study||10
7761679|NCT01422538|19110645|P3|STARTED|Overall Study||10
7761680|NCT01422538|19110646|P2|STARTED|Overall Study||10
7761681|NCT01422538|19110647|P1|STARTED|Overall Study||10
7761682|NCT01422434|19110672|P3|NOT COMPLETED|Overall Study||6
7761683|NCT01422434|19110673|P2|NOT COMPLETED|Overall Study||5
7761684|NCT01422434|19110674|P1|NOT COMPLETED|Overall Study||11
7761685|NCT01422434|19110672|P3|COMPLETED|Overall Study||217
7761686|NCT01422434|19110673|P2|COMPLETED|Overall Study||221
7761687|NCT01422434|19110674|P1|COMPLETED|Overall Study||216
7761688|NCT01422434|19110672|P3|STARTED|Overall Study||223
7761689|NCT01422434|19110673|P2|STARTED|Overall Study||226
7761690|NCT01422434|19110674|P1|STARTED|Overall Study||227
7761691|NCT01422408|19110691|P1|NOT COMPLETED|Overall Study||4
7761692|NCT01422408|19110691|P1|COMPLETED|Overall Study||30
7761693|NCT01422408|19110691|P1|STARTED|Overall Study||34
7761694|NCT01422382|19110720|P1|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1
7761695|NCT01422382|19110720|P1|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27
7761696|NCT01422382|19110720|P1|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28
7761697|NCT01422382|19110720|P1|NOT COMPLETED|Diltiazem 240 mg QD||0
7761698|NCT01422382|19110720|P1|COMPLETED|Diltiazem 240 mg QD||28
7761699|NCT01422382|19110720|P1|STARTED|Diltiazem 240 mg QD||28
7761700|NCT01422382|19110720|P1|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0
7761701|NCT01422382|19110720|P1|COMPLETED|NK-104 4mg Once Daily (QD)||28
7761702|NCT01422382|19110720|P1|STARTED|NK-104 4mg Once Daily (QD)||28
7761703|NCT01422369|19110725|P1|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1
7761704|NCT01422369|19110725|P1|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27
7761705|NCT01422369|19110725|P1|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28
7761706|NCT01422369|19110725|P1|NOT COMPLETED|Prezista 800mg/100mg QD||0
7761707|NCT01422369|19110725|P1|COMPLETED|Prezista 800mg/100mg QD||28
7761708|NCT01422369|19110725|P1|STARTED|Prezista 800mg/100mg QD||28
7761709|NCT01422369|19110725|P1|NOT COMPLETED|NK-104 4mg QD||0
7761710|NCT01422369|19110725|P1|COMPLETED|NK-104 4mg QD||28
7761711|NCT01422369|19110725|P1|STARTED|NK-104 4mg QD||28
7761712|NCT01422356|19110730|P1|NOT COMPLETED|Overall Study||31
7761713|NCT01422356|19110730|P1|COMPLETED|Overall Study||169
7761714|NCT01422356|19110730|P1|STARTED|Overall Study||200
7761715|NCT01422304|19110736|P2|NOT COMPLETED|Overall Study||37
7761716|NCT01422304|19110737|P1|NOT COMPLETED|Overall Study||24
7761717|NCT01422304|19110736|P2|COMPLETED|Overall Study||563
7761718|NCT01422304|19110737|P1|COMPLETED|Overall Study||574
7761719|NCT01422304|19110736|P2|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589
7761720|NCT01422304|19110737|P1|Treated|Overall Study||595
7761721|NCT01422304|19110736|P2|STARTED|Overall Study|Randomized|600
7761722|NCT01422304|19110737|P1|STARTED|Overall Study|Randomized|598
7761723|NCT01422239|19110769|P2|NOT COMPLETED|Overall Study||3
7761724|NCT01422239|19110770|P1|NOT COMPLETED|Overall Study||4
7761725|NCT01422239|19110769|P2|COMPLETED|Overall Study||3
7761726|NCT01422239|19110770|P1|COMPLETED|Overall Study||10
7761727|NCT01422239|19110769|P2|STARTED|Overall Study||6
7761728|NCT01422239|19110770|P1|STARTED|Overall Study||14
7761729|NCT01422226|19110782|P2|NOT COMPLETED|Overall Study||0
7761730|NCT01422226|19110783|P1|NOT COMPLETED|Overall Study||0
7761731|NCT01422226|19110782|P2|COMPLETED|Overall Study||2
7761732|NCT01422226|19110783|P1|COMPLETED|Overall Study||1
7761733|NCT01422226|19110782|P2|STARTED|Overall Study||2
7761734|NCT01422226|19110783|P1|STARTED|Overall Study||1
7761735|NCT01422213|19110792|P3|NOT COMPLETED|Overall Study||29
7761736|NCT01422213|19110793|P2|NOT COMPLETED|Overall Study||22
7761737|NCT01422213|19110794|P1|NOT COMPLETED|Overall Study||33
7761738|NCT01422213|19110792|P3|COMPLETED|Overall Study||178
7761739|NCT01422213|19110793|P2|COMPLETED|Overall Study||173
7761740|NCT01422213|19110794|P1|COMPLETED|Overall Study||163
7761741|NCT01422213|19110792|P3|STARTED|Overall Study||207
7761742|NCT01422213|19110793|P2|STARTED|Overall Study||195
7761743|NCT01422213|19110794|P1|STARTED|Overall Study||196
7761744|NCT01422200|19110854|P2|NOT COMPLETED|Overall Study||0
7761745|NCT01422200|19110855|P1|NOT COMPLETED|Overall Study||0
7761746|NCT01422200|19110854|P2|COMPLETED|Overall Study||11
7761747|NCT01422200|19110855|P1|COMPLETED|Overall Study||11
7761748|NCT01422200|19110854|P2|STARTED|Overall Study||11
7761749|NCT01422200|19110855|P1|STARTED|Overall Study||11
7761750|NCT01422187|19110866|P3|NOT COMPLETED|Overall Study||0
7761751|NCT01422187|19110867|P2|NOT COMPLETED|Overall Study||1
7761752|NCT01422187|19110868|P1|NOT COMPLETED|Overall Study||1
7761753|NCT01422187|19110866|P3|COMPLETED|Overall Study||2
7761754|NCT01422187|19110867|P2|COMPLETED|Overall Study||8
7761755|NCT01422187|19110868|P1|COMPLETED|Overall Study||7
7761756|NCT01422187|19110866|P3|STARTED|Overall Study||2
7761757|NCT01422187|19110867|P2|STARTED|Overall Study||9
7761758|NCT01422187|19110868|P1|STARTED|Overall Study||8
7761759|NCT01422161|19110887|P2|NOT COMPLETED|Overall Study||0
7761760|NCT01422161|19110888|P1|NOT COMPLETED|Overall Study||0
7761761|NCT01422161|19110887|P2|COMPLETED|Overall Study||6
7761762|NCT01422161|19110888|P1|COMPLETED|Overall Study||10
7761763|NCT01422161|19110887|P2|STARTED|Overall Study||6
7761764|NCT01422161|19110888|P1|STARTED|Overall Study||10
7761765|NCT01422135|19110904|P6|NOT COMPLETED|Overall Study||1
7761766|NCT01422135|19110905|P5|NOT COMPLETED|Overall Study||0
7761767|NCT01422135|19110906|P4|NOT COMPLETED|Overall Study||0
7761768|NCT01422135|19110907|P3|NOT COMPLETED|Overall Study||1
7761769|NCT01422135|19110908|P2|NOT COMPLETED|Overall Study||0
7761770|NCT01422135|19110909|P1|NOT COMPLETED|Overall Study||0
7761771|NCT01422135|19110904|P6|COMPLETED|Overall Study||3
7761772|NCT01422135|19110905|P5|COMPLETED|Overall Study||4
7761773|NCT01422135|19110906|P4|COMPLETED|Overall Study||4
7761774|NCT01422135|19110907|P3|COMPLETED|Overall Study||3
7761775|NCT01422135|19110908|P2|COMPLETED|Overall Study||4
7761776|NCT01422135|19110909|P1|COMPLETED|Overall Study||4
7761777|NCT01422135|19110904|P6|STARTED|Overall Study||4
7761778|NCT01422135|19110905|P5|STARTED|Overall Study||4
7761779|NCT01422135|19110906|P4|STARTED|Overall Study||4
7761780|NCT01422135|19110907|P3|STARTED|Overall Study||4
7761781|NCT01422135|19110908|P2|STARTED|Overall Study||4
7761782|NCT01422135|19110909|P1|STARTED|Overall Study||4
7761783|NCT01422070|19110920|P2|NOT COMPLETED|Overall Study||0
7761784|NCT01422070|19110921|P1|NOT COMPLETED|Overall Study||0
7761785|NCT01422070|19110920|P2|COMPLETED|Overall Study||803
7761786|NCT01422070|19110921|P1|COMPLETED|Overall Study||5031
7761787|NCT01422070|19110920|P2|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803
7761788|NCT01422070|19110921|P1|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031
7761789|NCT01421719|19110932|P1|NOT COMPLETED|Overall Study||4
7761790|NCT01421719|19110932|P1|COMPLETED|Overall Study||16
7761791|NCT01421719|19110932|P1|STARTED|Overall Study||20
7761792|NCT01421667|19110941|P4|NOT COMPLETED|Overall Study||1
7761793|NCT01421667|19110942|P3|NOT COMPLETED|Overall Study||2
7761794|NCT01421667|19110943|P2|NOT COMPLETED|Overall Study||2
7761795|NCT01421667|19110944|P1|NOT COMPLETED|Overall Study||0
7761796|NCT01421667|19110941|P4|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15
7761797|NCT01421667|19110942|P3|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51
7761798|NCT01421667|19110943|P2|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66
7761799|NCT01421667|19110944|P1|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35
7761800|NCT01421667|19110941|P4|STARTED|Overall Study||16
7761801|NCT01421667|19110942|P3|STARTED|Overall Study||53
7761802|NCT01421667|19110943|P2|STARTED|Overall Study||68
7761803|NCT01421667|19110944|P1|STARTED|Overall Study||35
7761804|NCT01421654|19110996|P2|NOT COMPLETED|Overall Study||0
7761805|NCT01421654|19110997|P1|NOT COMPLETED|Overall Study||0
7761806|NCT01421654|19110996|P2|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9
7761807|NCT01421654|19110997|P1|COMPLETED|Overall Study||11
7761808|NCT01421654|19110996|P2|STARTED|Overall Study||9
7761809|NCT01421654|19110997|P1|STARTED|Overall Study||11
7761810|NCT01421641|19111005|P2|NOT COMPLETED|Overall Study||2
7761811|NCT01421641|19111006|P1|NOT COMPLETED|Overall Study||2
7761812|NCT01421641|19111005|P2|COMPLETED|Overall Study||35
7761813|NCT01421641|19111006|P1|COMPLETED|Overall Study||35
7761814|NCT01421641|19111005|P2|STARTED|Overall Study||37
7761815|NCT01421641|19111006|P1|STARTED|Overall Study||37
7761816|NCT01421589|19111016|P1|NOT COMPLETED|Overall Study||0
7761817|NCT01421589|19111016|P1|COMPLETED|Overall Study||15
7761818|NCT01421589|19111016|P1|STARTED|Overall Study||15
7761819|NCT01421511|19111028|P2|NOT COMPLETED|Overall Study||28
7761820|NCT01421511|19111029|P1|NOT COMPLETED|Overall Study||19
7761821|NCT01421511|19111028|P2|COMPLETED|Overall Study||306
7761822|NCT01421511|19111029|P1|COMPLETED|Overall Study||313
7761823|NCT01421511|19111028|P2|STARTED|Overall Study||334
7761824|NCT01421511|19111029|P1|STARTED|Overall Study||332
7761825|NCT01421498|19111051|P2|NOT COMPLETED|Overall Study||11
7761826|NCT01421498|19111052|P1|NOT COMPLETED|Overall Study||12
7761827|NCT01421498|19111051|P2|COMPLETED|Overall Study||284
7761828|NCT01421498|19111052|P1|COMPLETED|Overall Study||281
7761829|NCT01421498|19111051|P2|STARTED|Overall Study||295
7761830|NCT01421498|19111052|P1|STARTED|Overall Study||293
7761831|NCT01421472|19111064|P4|NOT COMPLETED|Overall Study||0
7761832|NCT01421472|19111065|P3|NOT COMPLETED|Overall Study||0
7761833|NCT01421472|19111066|P2|NOT COMPLETED|Overall Study||0
7761834|NCT01421472|19111067|P1|NOT COMPLETED|Overall Study||0
7761835|NCT01421472|19111064|P4|COMPLETED|Overall Study||32
7761836|NCT01421472|19111065|P3|COMPLETED|Overall Study||64
7761837|NCT01421472|19111066|P2|COMPLETED|Overall Study||33
7761838|NCT01421472|19111067|P1|COMPLETED|Overall Study||67
7761839|NCT01421472|19111064|P4|STARTED|Overall Study||32
7761840|NCT01421472|19111065|P3|STARTED|Overall Study||64
7761841|NCT01421472|19111066|P2|STARTED|Overall Study||33
7761842|NCT01421472|19111067|P1|STARTED|Overall Study||67
7761843|NCT01421459|19111079|P2|NOT COMPLETED|Overall Study||52
7761844|NCT01421459|19111080|P1|NOT COMPLETED|Overall Study||45
7761845|NCT01421459|19111079|P2|COMPLETED|Overall Study||328
7761846|NCT01421459|19111080|P1|COMPLETED|Overall Study||334
7761847|NCT01421459|19111079|P2|Received at Least 1 Dose of Study Drug|Overall Study||380
7761848|NCT01421459|19111080|P1|Received at Least 1 Dose of Study Drug|Overall Study||376
7761849|NCT01421459|19111079|P2|STARTED|Overall Study||380
7761850|NCT01421459|19111080|P1|STARTED|Overall Study||379
7761851|NCT01421355|19111114|P1|NOT COMPLETED|Overall Study||6
7761852|NCT01421355|19111114|P1|COMPLETED|Overall Study||15
7761853|NCT01421355|19111114|P1|STARTED|Overall Study||21
7761940|NCT01420653|19111300|P4|NOT COMPLETED|Overall Study||7
7761854|NCT01421342|19111121|P3|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||65
7761855|NCT01421342|19111122|P2|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||59
7761856|NCT01421342|19111123|P1|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||52
7761857|NCT01421342|19111121|P3|COMPLETED|Continuation of Treatment (Week 12 - 36)||203
7761858|NCT01421342|19111122|P2|COMPLETED|Continuation of Treatment (Week 12 - 36)||194
7761859|NCT01421342|19111123|P1|COMPLETED|Continuation of Treatment (Week 12 - 36)||152
7761860|NCT01421342|19111121|P3|STARTED|Continuation of Treatment (Week 12 - 36)||268
7761861|NCT01421342|19111122|P2|STARTED|Continuation of Treatment (Week 12 - 36)||253
7761862|NCT01421342|19111123|P1|STARTED|Continuation of Treatment (Week 12 - 36)||204
7761863|NCT01421342|19111121|P3|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||138
7761864|NCT01421342|19111122|P2|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||125
7761865|NCT01421342|19111123|P1|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||149
7761866|NCT01421342|19111121|P3|COMPLETED|Completed to Week 12 But Then Withdrawn||268
7761867|NCT01421342|19111122|P2|COMPLETED|Completed to Week 12 But Then Withdrawn||253
7761868|NCT01421342|19111123|P1|COMPLETED|Completed to Week 12 But Then Withdrawn||204
7761869|NCT01421342|19111121|P3|STARTED|Completed to Week 12 But Then Withdrawn||406
7761870|NCT01421342|19111122|P2|STARTED|Completed to Week 12 But Then Withdrawn||378
7761871|NCT01421342|19111123|P1|STARTED|Completed to Week 12 But Then Withdrawn||353
7761872|NCT01421342|19111121|P3|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||99
7761873|NCT01421342|19111122|P2|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||128
7761874|NCT01421342|19111123|P1|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||158
7761875|NCT01421342|19111121|P3|COMPLETED|Acute Treatment Phase (12 Weeks)||406
7761876|NCT01421342|19111122|P2|COMPLETED|Acute Treatment Phase (12 Weeks)||378
7761877|NCT01421342|19111123|P1|COMPLETED|Acute Treatment Phase (12 Weeks)||353
7761878|NCT01421342|19111121|P3|STARTED|Acute Treatment Phase (12 Weeks)||505
7761879|NCT01421342|19111122|P2|STARTED|Acute Treatment Phase (12 Weeks)||506
7761880|NCT01421342|19111123|P1|STARTED|Acute Treatment Phase (12 Weeks)||511
7761881|NCT01421303|19111140|P1|NOT COMPLETED|Overall Study||22
7761882|NCT01421303|19111140|P1|COMPLETED|Overall Study||58
7761883|NCT01421303|19111140|P1|STARTED|Overall Study||80
7761884|NCT01421277|19111167|P2|NOT COMPLETED|Overall Study||92
7761885|NCT01421277|19111168|P1|NOT COMPLETED|Overall Study||0
7761886|NCT01421277|19111167|P2|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99
7761887|NCT01421277|19111168|P1|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25
7761888|NCT01421277|19111167|P2|STARTED|Overall Study||191
7761889|NCT01421277|19111168|P1|STARTED|Overall Study||25
7761890|NCT01421225|19111180|P2|NOT COMPLETED|Overall Study||1
7761891|NCT01421225|19111181|P1|NOT COMPLETED|Overall Study||0
7761892|NCT01421225|19111180|P2|COMPLETED|Overall Study||5
7761893|NCT01421225|19111181|P1|COMPLETED|Overall Study||4
7761894|NCT01421225|19111180|P2|STARTED|Overall Study||6
7761895|NCT01421225|19111181|P1|STARTED|Overall Study||4
7761896|NCT01421147|19111195|P2|NOT COMPLETED|Extension Period||11
7761897|NCT01421147|19111196|P1|NOT COMPLETED|Extension Period||8
7761898|NCT01421147|19111195|P2|COMPLETED|Extension Period||245
7761899|NCT01421147|19111196|P1|COMPLETED|Extension Period||245
7761900|NCT01421147|19111195|P2|STARTED|Extension Period||256
7761901|NCT01421147|19111196|P1|STARTED|Extension Period||253
7761902|NCT01421147|19111195|P2|NOT COMPLETED|Treatment Period||11
7761903|NCT01421147|19111196|P1|NOT COMPLETED|Treatment Period||16
7761904|NCT01421147|19111195|P2|COMPLETED|Treatment Period||256
7761905|NCT01421147|19111196|P1|COMPLETED|Treatment Period||253
7761906|NCT01421147|19111195|P2|Received at Least 1 Dose of Study Drug|Treatment Period||267
7761907|NCT01421147|19111196|P1|Received at Least 1 Dose of Study Drug|Treatment Period||268
7761908|NCT01421147|19111195|P2|STARTED|Treatment Period||267
7761909|NCT01421147|19111196|P1|STARTED|Treatment Period||269
7761910|NCT01421134|19111228|P2|NOT COMPLETED|Overall Study||15
7761911|NCT01421134|19111229|P1|NOT COMPLETED|Overall Study||7
7761912|NCT01421134|19111228|P2|COMPLETED|Overall Study||87
7761913|NCT01421134|19111229|P1|COMPLETED|Overall Study||102
7761914|NCT01421134|19111228|P2|STARTED|Overall Study||102
7761915|NCT01421134|19111229|P1|STARTED|Overall Study||109
7761916|NCT01420965|19111250|P3|NOT COMPLETED|Overall Study||0
7761917|NCT01420965|19111251|P2|NOT COMPLETED|Overall Study||1
7761918|NCT01420965|19111252|P1|NOT COMPLETED|Overall Study||1
7761919|NCT01420965|19111250|P3|COMPLETED|Overall Study||3
7761920|NCT01420965|19111251|P2|COMPLETED|Overall Study||1
7761921|NCT01420965|19111252|P1|COMPLETED|Overall Study||1
7761922|NCT01420965|19111250|P3|STARTED|Overall Study||3
7761923|NCT01420965|19111251|P2|STARTED|Overall Study||2
7761924|NCT01420965|19111252|P1|STARTED|Overall Study||2
7761925|NCT01420926|19111265|P2|NOT COMPLETED|Overall Study||65
7761926|NCT01420926|19111266|P1|NOT COMPLETED|Overall Study||60
7761927|NCT01420926|19111265|P2|COMPLETED|Overall Study||16
7761928|NCT01420926|19111266|P1|COMPLETED|Overall Study||22
7761929|NCT01420926|19111265|P2|STARTED|Overall Study||81
7761930|NCT01420926|19111266|P1|STARTED|Overall Study||82
7761931|NCT01420848|19111283|P3|NOT COMPLETED|Overall Study||0
7761932|NCT01420848|19111284|P2|NOT COMPLETED|Overall Study||0
7761933|NCT01420848|19111285|P1|NOT COMPLETED|Overall Study||0
7761934|NCT01420848|19111283|P3|COMPLETED|Overall Study||22
7761935|NCT01420848|19111284|P2|COMPLETED|Overall Study||25
7761936|NCT01420848|19111285|P1|COMPLETED|Overall Study||24
7761937|NCT01420848|19111283|P3|STARTED|Overall Study||22
7761938|NCT01420848|19111284|P2|STARTED|Overall Study||25
7761939|NCT01420848|19111285|P1|STARTED|Overall Study||24
7761941|NCT01420653|19111301|P3|NOT COMPLETED|Overall Study||4
7761942|NCT01420653|19111302|P2|NOT COMPLETED|Overall Study||3
7761943|NCT01420653|19111303|P1|NOT COMPLETED|Overall Study||3
7761944|NCT01420653|19111300|P4|COMPLETED|Overall Study||68
7761945|NCT01420653|19111301|P3|COMPLETED|Overall Study||108
7761946|NCT01420653|19111302|P2|COMPLETED|Overall Study||108
7761947|NCT01420653|19111303|P1|COMPLETED|Overall Study||107
7761948|NCT01420653|19111300|P4|STARTED|Overall Study||75
7761949|NCT01420653|19111301|P3|STARTED|Overall Study||112
7761950|NCT01420653|19111302|P2|STARTED|Overall Study||111
7761951|NCT01420653|19111303|P1|STARTED|Overall Study||110
7761952|NCT01420627|19111313|P1|NOT COMPLETED|EZN-2279 Maintenance Period||0
7761953|NCT01420627|19111313|P1|COMPLETED|EZN-2279 Maintenance Period||6
7761954|NCT01420627|19111313|P1|STARTED|EZN-2279 Maintenance Period||6
7761955|NCT01420627|19111313|P1|NOT COMPLETED|EZN-2279 Treatment Period||1
7761956|NCT01420627|19111313|P1|COMPLETED|EZN-2279 Treatment Period||6
7761957|NCT01420627|19111313|P1|STARTED|EZN-2279 Treatment Period||7
7761958|NCT01420627|19111313|P1|NOT COMPLETED|Adagen Lead-in Period||0
7761959|NCT01420627|19111313|P1|COMPLETED|Adagen Lead-in Period||7
7761960|NCT01420627|19111313|P1|STARTED|Adagen Lead-in Period||7
7761961|NCT01420549|19111329|P2|NOT COMPLETED|Overall Study||5
7761962|NCT01420549|19111330|P1|NOT COMPLETED|Overall Study||7
7761963|NCT01420549|19111329|P2|COMPLETED|Overall Study||58
7761964|NCT01420549|19111330|P1|COMPLETED|Overall Study||59
7761965|NCT01420549|19111329|P2|STARTED|Overall Study||63
7761966|NCT01420549|19111330|P1|STARTED|Overall Study||66
7761967|NCT01420289|19111338|P2|NOT COMPLETED|Overall Study||0
7761968|NCT01420289|19111339|P1|NOT COMPLETED|Overall Study||0
7761969|NCT01420289|19111338|P2|COMPLETED|Overall Study||16
7761970|NCT01420289|19111339|P1|COMPLETED|Overall Study||18
7761971|NCT01420289|19111338|P2|STARTED|Overall Study||16
7761972|NCT01420289|19111339|P1|STARTED|Overall Study||18
7761973|NCT01420146|19111351|P1|NOT COMPLETED|Overall Study||0
7761974|NCT01420146|19111351|P1|COMPLETED|Overall Study||20
7761975|NCT01420146|19111351|P1|STARTED|Overall Study||20
7761976|NCT01420081|19111364|P9|NOT COMPLETED|Overall Study||3
7761977|NCT01420081|19111365|P8|NOT COMPLETED|Overall Study||3
7761978|NCT01420081|19111366|P7|NOT COMPLETED|Overall Study||3
7761979|NCT01420081|19111367|P6|NOT COMPLETED|Overall Study||20
7761980|NCT01420081|19111368|P5|NOT COMPLETED|Overall Study||20
7761981|NCT01420081|19111369|P4|NOT COMPLETED|Overall Study||3
7761982|NCT01420081|19111370|P3|NOT COMPLETED|Overall Study||11
7761983|NCT01420081|19111371|P2|NOT COMPLETED|Overall Study||1
7761984|NCT01420081|19111372|P1|NOT COMPLETED|Overall Study||3
7761985|NCT01420081|19111364|P9|COMPLETED|Overall Study||0
7761986|NCT01420081|19111365|P8|COMPLETED|Overall Study||0
7761987|NCT01420081|19111366|P7|COMPLETED|Overall Study||0
7761988|NCT01420081|19111367|P6|COMPLETED|Overall Study||0
7761989|NCT01420081|19111368|P5|COMPLETED|Overall Study||0
7761990|NCT01420081|19111369|P4|COMPLETED|Overall Study||0
7761991|NCT01420081|19111370|P3|COMPLETED|Overall Study||0
7761992|NCT01420081|19111371|P2|COMPLETED|Overall Study||0
7761993|NCT01420081|19111372|P1|COMPLETED|Overall Study||0
7761994|NCT01420081|19111364|P9|STARTED|Overall Study||3
7761995|NCT01420081|19111365|P8|STARTED|Overall Study||3
7761996|NCT01420081|19111366|P7|STARTED|Overall Study||3
7761997|NCT01420081|19111367|P6|STARTED|Overall Study||20
7761998|NCT01420081|19111368|P5|STARTED|Overall Study||20
7761999|NCT01420081|19111369|P4|STARTED|Overall Study||3
7762000|NCT01420081|19111370|P3|STARTED|Overall Study||11
7762001|NCT01420081|19111371|P2|STARTED|Overall Study||1
7762002|NCT01420081|19111372|P1|STARTED|Overall Study||3
7762003|NCT01420068|19111453|P2|NOT COMPLETED|Overall Study||5
7762004|NCT01420068|19111454|P1|NOT COMPLETED|Overall Study||2
7762005|NCT01420068|19111453|P2|COMPLETED|Overall Study||50
7762006|NCT01420068|19111454|P1|COMPLETED|Overall Study||49
7762007|NCT01420068|19111453|P2|STARTED|Overall Study||55
7762008|NCT01420068|19111454|P1|STARTED|Overall Study||51
7762009|NCT01420016|19111476|P4|NOT COMPLETED|Safety Analysis||0
7762010|NCT01420016|19111477|P3|NOT COMPLETED|Safety Analysis||0
7762011|NCT01420016|19111478|P2|NOT COMPLETED|Safety Analysis||0
7762012|NCT01420016|19111479|P1|NOT COMPLETED|Safety Analysis||0
7762013|NCT01420016|19111476|P4|COMPLETED|Safety Analysis||5159
7762014|NCT01420016|19111477|P3|COMPLETED|Safety Analysis||6392
7762015|NCT01420016|19111478|P2|COMPLETED|Safety Analysis||0
7762016|NCT01420016|19111479|P1|COMPLETED|Safety Analysis||0
7762017|NCT01420016|19111476|P4|STARTED|Safety Analysis||5159
7762018|NCT01420016|19111477|P3|STARTED|Safety Analysis||6392
7762019|NCT01420016|19111478|P2|STARTED|Safety Analysis||0
7762020|NCT01420016|19111479|P1|STARTED|Safety Analysis||0
7762021|NCT01420016|19111476|P4|NOT COMPLETED|Primary Analysis||0
7762022|NCT01420016|19111477|P3|NOT COMPLETED|Primary Analysis||0
7762023|NCT01420016|19111478|P2|NOT COMPLETED|Primary Analysis||2540
7762024|NCT01420016|19111479|P1|NOT COMPLETED|Primary Analysis||2927
7762025|NCT01420016|19111476|P4|COMPLETED|Primary Analysis||0
7762026|NCT01420016|19111477|P3|COMPLETED|Primary Analysis||0
7762027|NCT01420016|19111478|P2|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|3871
7762028|NCT01420016|19111479|P1|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|4043
7762029|NCT01420016|19111476|P4|STARTED|Primary Analysis||0
7762030|NCT01420016|19111477|P3|STARTED|Primary Analysis||0
7762031|NCT01420016|19111478|P2|STARTED|Primary Analysis||6411
7762032|NCT01420016|19111479|P1|STARTED|Primary Analysis||6970
7762033|NCT01419977|19111487|P2|NOT COMPLETED|Overall Study||0
7762034|NCT01419977|19111488|P1|NOT COMPLETED|Overall Study||0
7762035|NCT01419977|19111487|P2|COMPLETED|Overall Study||13
7762036|NCT01419977|19111488|P1|COMPLETED|Overall Study||16
7762037|NCT01419977|19111487|P2|STARTED|Overall Study||13
7762038|NCT01419977|19111488|P1|STARTED|Overall Study||16
7762039|NCT01419795|19111502|P2|NOT COMPLETED|Overall Study||0
7762040|NCT01419795|19111503|P1|NOT COMPLETED|Overall Study||0
7762041|NCT01419795|19111502|P2|COMPLETED|Overall Study||0
7762042|NCT01419795|19111503|P1|COMPLETED|Overall Study||3
7762043|NCT01419795|19111502|P2|STARTED|Overall Study||0
7762044|NCT01419795|19111503|P1|STARTED|Overall Study||3
7762045|NCT01419769|19111525|P1|NOT COMPLETED|Overall Study||4
7762046|NCT01419769|19111525|P1|COMPLETED|Overall Study||29
7762047|NCT01419769|19111525|P1|STARTED|Overall Study||33
7762048|NCT01419717|19111538|P1|NOT COMPLETED|Overall Study||125
7762049|NCT01419717|19111538|P1|COMPLETED|Overall Study||4
7762050|NCT01419717|19111538|P1|Received Denosumab|Overall Study||128
7762051|NCT01419717|19111538|P1|STARTED|Overall Study||129
7762052|NCT01419639|19111543|P1|NOT COMPLETED|Overall Study||1
7762053|NCT01419639|19111543|P1|COMPLETED|Overall Study||9
7762054|NCT01419639|19111543|P1|STARTED|Overall Study||10
7762055|NCT01419626|19111552|P3|NOT COMPLETED|Overall Study||3
7762056|NCT01419626|19111553|P2|NOT COMPLETED|Overall Study||3
7762057|NCT01419626|19111554|P1|NOT COMPLETED|Overall Study||4
7762058|NCT01419626|19111552|P3|COMPLETED|Overall Study||44
7762059|NCT01419626|19111553|P2|COMPLETED|Overall Study||44
7762060|NCT01419626|19111554|P1|COMPLETED|Overall Study||42
7762061|NCT01419626|19111552|P3|STARTED|Overall Study||47
7762062|NCT01419626|19111553|P2|STARTED|Overall Study||47
7762063|NCT01419626|19111554|P1|STARTED|Overall Study||46
7762064|NCT01419314|19111585|P2|NOT COMPLETED|Follow-up at Week 6 of the Trial||2
7762065|NCT01419314|19111586|P1|NOT COMPLETED|Follow-up at Week 6 of the Trial||1
7762066|NCT01419314|19111585|P2|COMPLETED|Follow-up at Week 6 of the Trial||19
7762067|NCT01419314|19111586|P1|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16
7762068|NCT01419314|19111585|P2|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21
7762069|NCT01419314|19111586|P1|STARTED|Follow-up at Week 6 of the Trial||17
7762070|NCT01419314|19111585|P2|NOT COMPLETED|Follow-up at Week 3 of the Trial||1
7762071|NCT01419314|19111586|P1|NOT COMPLETED|Follow-up at Week 3 of the Trial||6
7762072|NCT01419314|19111585|P2|COMPLETED|Follow-up at Week 3 of the Trial||21
7762073|NCT01419314|19111586|P1|COMPLETED|Follow-up at Week 3 of the Trial||17
7762074|NCT01419314|19111585|P2|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22
7762075|NCT01419314|19111586|P1|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23
7762076|NCT01419314|19111585|P2|NOT COMPLETED|Start of Study||0
7762077|NCT01419314|19111586|P1|NOT COMPLETED|Start of Study||0
7762078|NCT01419314|19111585|P2|COMPLETED|Start of Study||22
7762079|NCT01419314|19111586|P1|COMPLETED|Start of Study||23
7762080|NCT01419314|19111585|P2|STARTED|Start of Study|No comfort issues reported.|22
7762081|NCT01419314|19111586|P1|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23
7762082|NCT01419275|19111606|P1|NOT COMPLETED|Overall Study||0
7762083|NCT01419275|19111606|P1|COMPLETED|Overall Study||126
7762084|NCT01419275|19111606|P1|STARTED|Overall Study||126
7762085|NCT01419249|19111612|P2|NOT COMPLETED|Overall Study||0
7762086|NCT01419249|19111613|P1|NOT COMPLETED|Overall Study||0
7762087|NCT01419249|19111612|P2|COMPLETED|Overall Study||140
7762088|NCT01419249|19111613|P1|COMPLETED|Overall Study||318
7762089|NCT01419249|19111612|P2|STARTED|Overall Study||140
7762090|NCT01419249|19111613|P1|STARTED|Overall Study||318
7762091|NCT01419236|19111627|P2|NOT COMPLETED|Overall Study||5
7762092|NCT01419236|19111628|P1|NOT COMPLETED|Overall Study||5
7762093|NCT01419236|19111627|P2|COMPLETED|Overall Study||35
7762094|NCT01419236|19111628|P1|COMPLETED|Overall Study||31
7762095|NCT01419236|19111627|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
7762096|NCT01419236|19111628|P1|Received at Least 1 Dose of Study Drug|Overall Study||35
7762097|NCT01419236|19111627|P2|STARTED|Overall Study||40
7762098|NCT01419236|19111628|P1|STARTED|Overall Study||36
7762099|NCT01419197|19111652|P2|NOT COMPLETED|Overall Study||198
7762100|NCT01419197|19111653|P1|NOT COMPLETED|Overall Study||404
7762101|NCT01419197|19111652|P2|COMPLETED|Overall Study||0
7762102|NCT01419197|19111653|P1|COMPLETED|Overall Study||0
7762103|NCT01419197|19111652|P2|Switched to Trastuzumab Emtansine|Overall Study||94
7762104|NCT01419197|19111653|P1|Switched to Trastuzumab Emtansine|Overall Study||0
7762105|NCT01419197|19111652|P2|STARTED|Overall Study||198
7762106|NCT01419197|19111653|P1|STARTED|Overall Study||404
7762107|NCT01419184|19111678|P2|NOT COMPLETED|Overall Study||15
7762108|NCT01419184|19111679|P1|NOT COMPLETED|Overall Study||10
7762109|NCT01419184|19111678|P2|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106
7762110|NCT01419184|19111679|P1|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118
7762111|NCT01419184|19111678|P2|Received at Least 1 Dose of Study Drug|Overall Study||106
7762112|NCT01419184|19111679|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
7762113|NCT01419184|19111678|P2|STARTED|Overall Study||121
7762114|NCT01419184|19111679|P1|STARTED|Overall Study||128
7762115|NCT01419171|19111695|P1|NOT COMPLETED|Overall Study||0
7762116|NCT01419171|19111695|P1|COMPLETED|Overall Study||328
7762117|NCT01419171|19111695|P1|STARTED|Overall Study||328
7762118|NCT01419080|19111712|P1|NOT COMPLETED|Overall Study||131
7762119|NCT01419080|19111712|P1|COMPLETED|Overall Study||666
7762120|NCT01419080|19111712|P1|STARTED|Overall Study||797
7762121|NCT01419028|19111718|P1|NOT COMPLETED|Overall Study||0
7762122|NCT01419028|19111718|P1|COMPLETED|Overall Study||48
7762123|NCT01419028|19111718|P1|STARTED|Overall Study||48
7762124|NCT01419015|19111723|P1|NOT COMPLETED|Overall Study||2
7762125|NCT01419015|19111723|P1|COMPLETED|Overall Study||15
7762126|NCT01419015|19111723|P1|STARTED|Overall Study||17
7762127|NCT01418937|19111727|P1|NOT COMPLETED|Overall Study||8
7762128|NCT01418937|19111727|P1|COMPLETED|Overall Study||156
7762129|NCT01418937|19111727|P1|STARTED|Overall Study||164
7762130|NCT01418703|19111736|P4|NOT COMPLETED|Overall Study||0
7762131|NCT01418703|19111737|P3|NOT COMPLETED|Overall Study||0
7762132|NCT01418703|19111738|P2|NOT COMPLETED|Overall Study||0
7762133|NCT01418703|19111739|P1|NOT COMPLETED|Overall Study||0
7762134|NCT01418703|19111736|P4|COMPLETED|Overall Study||6
7762135|NCT01418703|19111737|P3|COMPLETED|Overall Study||6
7762136|NCT01418703|19111738|P2|COMPLETED|Overall Study||13
7762137|NCT01418703|19111739|P1|COMPLETED|Overall Study||13
7762138|NCT01418703|19111736|P4|STARTED|Overall Study||6
7762139|NCT01418703|19111737|P3|STARTED|Overall Study||6
7762140|NCT01418703|19111738|P2|STARTED|Overall Study||13
7762141|NCT01418703|19111739|P1|STARTED|Overall Study||13
7762142|NCT01418482|19111750|P1|NOT COMPLETED|Overall Study||0
7762143|NCT01418482|19111750|P1|COMPLETED|Overall Study||15
7762144|NCT01418482|19111750|P1|STARTED|Overall Study||15
7762145|NCT01418378|19111758|P2|NOT COMPLETED|Overall Study||5
7762146|NCT01418378|19111759|P1|NOT COMPLETED|Overall Study||1
7762147|NCT01418378|19111758|P2|COMPLETED|Overall Study||83
7762148|NCT01418378|19111759|P1|COMPLETED|Overall Study||89
7762149|NCT01418378|19111758|P2|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|88
7762150|NCT01418378|19111759|P1|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|90
7762151|NCT01418378|19111758|P2|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|88
7762152|NCT01418378|19111759|P1|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|90
7762153|NCT01418365|19111833|P2|NOT COMPLETED|Second Intervention||1
7762154|NCT01418365|19111834|P1|NOT COMPLETED|Second Intervention||0
7762155|NCT01418365|19111833|P2|COMPLETED|Second Intervention||13
7762156|NCT01418365|19111834|P1|COMPLETED|Second Intervention||14
7762157|NCT01418365|19111833|P2|STARTED|Second Intervention||14
7762158|NCT01418365|19111834|P1|STARTED|Second Intervention||14
7762159|NCT01418365|19111833|P2|NOT COMPLETED|First Intervention||1
7762160|NCT01418365|19111834|P1|NOT COMPLETED|First Intervention||1
7762161|NCT01418365|19111833|P2|COMPLETED|First Intervention||14
7762162|NCT01418365|19111834|P1|COMPLETED|First Intervention||14
7762163|NCT01418365|19111833|P2|STARTED|First Intervention||15
7762164|NCT01418365|19111834|P1|STARTED|First Intervention||15
7762165|NCT01418209|19111845|P3|NOT COMPLETED|Overall Study||4
7762166|NCT01418209|19111846|P2|NOT COMPLETED|Overall Study||3
7762167|NCT01418209|19111847|P1|NOT COMPLETED|Overall Study||2
7762168|NCT01418209|19111845|P3|COMPLETED|Overall Study||142
7762169|NCT01418209|19111846|P2|COMPLETED|Overall Study||93
7762170|NCT01418209|19111847|P1|COMPLETED|Overall Study||95
7762171|NCT01418209|19111845|P3|STARTED|Overall Study||146
7762172|NCT01418209|19111846|P2|STARTED|Overall Study||96
7762173|NCT01418209|19111847|P1|STARTED|Overall Study||97
7762174|NCT01418001|19111876|P1|NOT COMPLETED|Overall Study||0
7762175|NCT01418001|19111876|P1|COMPLETED|Overall Study||5
7762176|NCT01418001|19111876|P1|STARTED|Overall Study||5
7762177|NCT01417936|19111881|P1|NOT COMPLETED|Overall Study||0
7762178|NCT01417936|19111881|P1|COMPLETED|Overall Study||26
7762179|NCT01417936|19111881|P1|STARTED|Overall Study||26
7762180|NCT01417741|19111902|P2|NOT COMPLETED|Overall Study||0
7762181|NCT01417741|19111903|P1|NOT COMPLETED|Overall Study||0
7762182|NCT01417741|19111902|P2|COMPLETED|Overall Study|only 73 received the post op day phone phone call|86
7762183|NCT01417741|19111903|P1|COMPLETED|Overall Study||75
7762184|NCT01417741|19111902|P2|STARTED|Overall Study||86
7762185|NCT01417741|19111903|P1|STARTED|Overall Study||75
7762186|NCT01417481|19111911|P2|NOT COMPLETED|Second Period (8 Weeks)||0
7762187|NCT01417481|19111912|P1|NOT COMPLETED|Second Period (8 Weeks)||0
7762188|NCT01417481|19111911|P2|COMPLETED|Second Period (8 Weeks)||5
7762189|NCT01417481|19111912|P1|COMPLETED|Second Period (8 Weeks)||8
7762190|NCT01417481|19111911|P2|STARTED|Second Period (8 Weeks)||5
7762191|NCT01417481|19111912|P1|STARTED|Second Period (8 Weeks)||8
7762192|NCT01417481|19111911|P2|NOT COMPLETED|Washout (2 Weeks)||0
7762193|NCT01417481|19111912|P1|NOT COMPLETED|Washout (2 Weeks)||0
7762194|NCT01417481|19111911|P2|COMPLETED|Washout (2 Weeks)||5
7762195|NCT01417481|19111912|P1|COMPLETED|Washout (2 Weeks)||8
7762196|NCT01417481|19111911|P2|STARTED|Washout (2 Weeks)||5
7762197|NCT01417481|19111912|P1|STARTED|Washout (2 Weeks)||8
7762198|NCT01417481|19111911|P2|NOT COMPLETED|First Intervention (8 Weeks)||2
7762199|NCT01417481|19111912|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
7762200|NCT01417481|19111911|P2|COMPLETED|First Intervention (8 Weeks)||5
7762201|NCT01417481|19111912|P1|COMPLETED|First Intervention (8 Weeks)||8
7762202|NCT01417481|19111911|P2|STARTED|First Intervention (8 Weeks)||7
7762203|NCT01417481|19111912|P1|STARTED|First Intervention (8 Weeks)||8
7762204|NCT01417455|19111944|P8|NOT COMPLETED|Overall Study||0
7762205|NCT01417455|19111945|P7|NOT COMPLETED|Overall Study||0
7762206|NCT01417455|19111946|P6|NOT COMPLETED|Overall Study||0
7762207|NCT01417455|19111947|P5|NOT COMPLETED|Overall Study||0
7762208|NCT01417455|19111948|P4|NOT COMPLETED|Overall Study||0
7762209|NCT01417455|19111949|P3|NOT COMPLETED|Overall Study||0
7762210|NCT01417455|19111950|P2|NOT COMPLETED|Overall Study||0
7762211|NCT01417455|19111951|P1|NOT COMPLETED|Overall Study||0
7762212|NCT01417455|19111944|P8|COMPLETED|Overall Study||25
7762213|NCT01417455|19111945|P7|COMPLETED|Overall Study||13
7762214|NCT01417455|19111946|P6|COMPLETED|Overall Study||13
7762215|NCT01417455|19111947|P5|COMPLETED|Overall Study||30
7762216|NCT01417455|19111948|P4|COMPLETED|Overall Study||17
7762217|NCT01417455|19111949|P3|COMPLETED|Overall Study||17
7762218|NCT01417455|19111950|P2|COMPLETED|Overall Study||16
7762219|NCT01417455|19111951|P1|COMPLETED|Overall Study||16
7762220|NCT01417455|19111944|P8|STARTED|Overall Study||25
7762221|NCT01417455|19111945|P7|STARTED|Overall Study||13
7762222|NCT01417455|19111946|P6|STARTED|Overall Study||13
7762223|NCT01417455|19111947|P5|STARTED|Overall Study||30
7762224|NCT01417455|19111948|P4|STARTED|Overall Study||17
7762225|NCT01417455|19111949|P3|STARTED|Overall Study||17
7762226|NCT01417455|19111950|P2|STARTED|Overall Study||16
7762227|NCT01417455|19111951|P1|STARTED|Overall Study||16
7762228|NCT01417377|19111977|P1|NOT COMPLETED|Overall Study||13
7762229|NCT01417377|19111977|P1|COMPLETED|Overall Study||9
7762230|NCT01417377|19111977|P1|Treated|Overall Study||21
7762231|NCT01417377|19111977|P1|STARTED|Overall Study||22
7762232|NCT01417234|19111984|P1|NOT COMPLETED|Overall Study||3
7762233|NCT01417234|19111984|P1|COMPLETED|Overall Study||27
7762234|NCT01417234|19111984|P1|STARTED|Overall Study||30
7762235|NCT01417195|19111993|P2|NOT COMPLETED|Overall Study||1
7762236|NCT01417195|19111994|P1|NOT COMPLETED|Overall Study||3
7762237|NCT01417195|19111993|P2|COMPLETED|Overall Study||61
7762238|NCT01417195|19111994|P1|COMPLETED|Overall Study||57
7762239|NCT01417195|19111993|P2|STARTED|Overall Study||62
7762240|NCT01417195|19111994|P1|STARTED|Overall Study||60
7762241|NCT01417156|19112010|P1|NOT COMPLETED|Overall Study||14
7762242|NCT01417156|19112010|P1|COMPLETED|Overall Study||6
7762243|NCT01417156|19112010|P1|STARTED|Overall Study||20
7762244|NCT01417104|19112020|P2|NOT COMPLETED|Overall Study||2
7762245|NCT01417104|19112021|P1|NOT COMPLETED|Overall Study||6
7762246|NCT01417104|19112020|P2|COMPLETED|Overall Study||35
7762247|NCT01417104|19112021|P1|COMPLETED|Overall Study||28
7762248|NCT01417104|19112020|P2|STARTED|Overall Study||37
7762249|NCT01417104|19112021|P1|STARTED|Overall Study||34
7762250|NCT01417078|19112031|P1|NOT COMPLETED|Overall Study||1
7762251|NCT01417078|19112031|P1|COMPLETED|Overall Study||30
7762252|NCT01417078|19112031|P1|STARTED|Overall Study||31
7762253|NCT01417026|19112043|P2|NOT COMPLETED|Overall Study||0
7762254|NCT01417026|19112044|P1|NOT COMPLETED|Overall Study||2
7762255|NCT01417026|19112043|P2|COMPLETED|Overall Study||13
7762256|NCT01417026|19112044|P1|COMPLETED|Overall Study||14
7762257|NCT01417026|19112043|P2|STARTED|Overall Study||13
7762258|NCT01417026|19112044|P1|STARTED|Overall Study||16
7762259|NCT01417000|19112056|P2|NOT COMPLETED|Overall Study||29
7762260|NCT01417000|19112057|P1|NOT COMPLETED|Overall Study||61
7762261|NCT01417000|19112056|P2|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
7762262|NCT01417000|19112057|P1|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
7762263|NCT01417000|19112056|P2|STARTED|Overall Study|31 subjects randomized into Cy/GVAX arm; 29 subjects received ≥ 1 protocol-specified drug.|29
7762264|NCT01417000|19112057|P1|STARTED|Overall Study|62 subjects randomized into Cy/GVAX + CRS-207 arm; 61 subjects received ≥ 1 protocol-specified drug.|61
7762265|NCT01416987|19112065|P1|NOT COMPLETED|Overall Study||0
7762266|NCT01416987|19112065|P1|COMPLETED|Overall Study||600
7762267|NCT01416987|19112065|P1|STARTED|Overall Study||600
7762268|NCT01416805|19112074|P2|NOT COMPLETED|Overall Study||4
7762269|NCT01416805|19112075|P1|NOT COMPLETED|Overall Study||4
7762270|NCT01416805|19112074|P2|COMPLETED|Overall Study||47
7762271|NCT01416805|19112075|P1|COMPLETED|Overall Study||45
7762272|NCT01416805|19112074|P2|STARTED|Overall Study||51
7762273|NCT01416805|19112075|P1|STARTED|Overall Study||49
7762274|NCT01416636|19112085|P2|NOT COMPLETED|Overall Study||6
7762275|NCT01416636|19112086|P1|NOT COMPLETED|Overall Study||8
7762276|NCT01416636|19112085|P2|COMPLETED|Overall Study||46
7762277|NCT01416636|19112086|P1|COMPLETED|Overall Study||45
7762278|NCT01416636|19112085|P2|STARTED|Overall Study||52
7762279|NCT01416636|19112086|P1|STARTED|Overall Study||53
7762280|NCT01416610|19112114|P1|NOT COMPLETED|Overall Study||43
7762281|NCT01416610|19112114|P1|COMPLETED|Overall Study||45
7762282|NCT01416610|19112114|P1|Completed Follow-up|Overall Study||45
7762283|NCT01416610|19112114|P1|Completed Treatment|Overall Study||47
7762284|NCT01416610|19112114|P1|Per Protocol|Overall Study||83
7762285|NCT01416610|19112114|P1|Safety Population|Overall Study||86
7762286|NCT01416610|19112114|P1|Intention to Treat|Overall Study||88
7762287|NCT01416610|19112114|P1|STARTED|Overall Study||88
7762288|NCT01416584|19112131|P3|NOT COMPLETED|Overall Study||1
7762289|NCT01416584|19112132|P2|NOT COMPLETED|Overall Study||2
7762290|NCT01416584|19112133|P1|NOT COMPLETED|Overall Study||3
7762291|NCT01416584|19112131|P3|COMPLETED|Overall Study||32
7762292|NCT01416584|19112132|P2|COMPLETED|Overall Study||33
7762293|NCT01416584|19112133|P1|COMPLETED|Overall Study||27
7762294|NCT01416584|19112131|P3|STARTED|Overall Study||33
7762295|NCT01416584|19112132|P2|STARTED|Overall Study||35
7762296|NCT01416584|19112133|P1|STARTED|Overall Study||30
7762297|NCT01416571|19112168|P1|NOT COMPLETED|Overall Study||2
7762298|NCT01416571|19112168|P1|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76
7762299|NCT01416571|19112168|P1|STARTED|Overall Study||78
7762300|NCT01416389|19112197|P2|NOT COMPLETED|Overall Study||0
7762301|NCT01416389|19112198|P1|NOT COMPLETED|Overall Study||3
7762302|NCT01416389|19112197|P2|COMPLETED|Overall Study||13
7762303|NCT01416389|19112198|P1|COMPLETED|Overall Study||23
7762304|NCT01416389|19112197|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
7762305|NCT01416389|19112198|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
7762306|NCT01416389|19112197|P2|STARTED|Overall Study||13
7762307|NCT01416389|19112198|P1|STARTED|Overall Study||26
7762308|NCT01416272|19112215|P1|NOT COMPLETED|Overall Study||4
7762309|NCT01416272|19112215|P1|COMPLETED|Overall Study||8
7762310|NCT01416272|19112215|P1|STARTED|Overall Study||12
7762311|NCT01416194|19112224|P3|NOT COMPLETED|Overall Study||0
7762312|NCT01416194|19112225|P2|NOT COMPLETED|Overall Study||0
7762313|NCT01416194|19112226|P1|NOT COMPLETED|Overall Study||0
7762314|NCT01416194|19112224|P3|COMPLETED|Overall Study||6666
7762315|NCT01416194|19112225|P2|COMPLETED|Overall Study||2720
7762316|NCT01416194|19112226|P1|COMPLETED|Overall Study||1111
7762317|NCT01416194|19112224|P3|STARTED|Overall Study||6666
7762318|NCT01416194|19112225|P2|STARTED|Overall Study||2720
7762319|NCT01416194|19112226|P1|STARTED|Overall Study||1111
7762320|NCT01416181|19112272|P2|NOT COMPLETED|Part 2||286
7762321|NCT01416181|19112273|P1|NOT COMPLETED|Part 2||271
7762322|NCT01416181|19112272|P2|COMPLETED|Part 2||6
7762323|NCT01416181|19112273|P1|COMPLETED|Part 2||3
7762324|NCT01416181|19112272|P2|Completed Treatment for > 96 Weeks|Part 2||0
7762325|NCT01416181|19112273|P1|Completed Treatment for > 96 Weeks|Part 2||1
7762326|NCT01416181|19112272|P2|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|0
7762327|NCT01416181|19112273|P1|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|1
7762328|NCT01416181|19112272|P2|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|111
7762329|NCT01416181|19112273|P1|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|98
7762330|NCT01416181|19112272|P2|STARTED|Part 2||292
7762331|NCT01416181|19112273|P1|STARTED|Part 2||274
7762332|NCT01416181|19112272|P2|NOT COMPLETED|Part 1||114
7762333|NCT01416181|19112273|P1|NOT COMPLETED|Part 1||137
7762334|NCT01416181|19112272|P2|COMPLETED|Part 1|Completed Study through Week 108|326
7762335|NCT01416181|19112273|P1|COMPLETED|Part 1|Completed Study through Week 108|312
7762336|NCT01416181|19112272|P2|Withdrew Prior to Dosing|Part 1||1
7762337|NCT01416181|19112273|P1|Withdrew Prior to Dosing|Part 1||0
7762338|NCT01416181|19112272|P2|STARTED|Part 1||440
7762339|NCT01416181|19112273|P1|STARTED|Part 1||449
7762340|NCT01416155|19112335|P1|NOT COMPLETED|Overall Study||58
7762341|NCT01416155|19112335|P1|COMPLETED|Overall Study||39
7762342|NCT01416155|19112335|P1|STARTED|Overall Study||97
7762343|NCT01416142|19112342|P3|NOT COMPLETED|PureVision2 HD||1
7762344|NCT01416142|19112343|P2|NOT COMPLETED|PureVision2 HD||0
7762345|NCT01416142|19112344|P1|NOT COMPLETED|PureVision2 HD||0
7762346|NCT01416142|19112342|P3|COMPLETED|PureVision2 HD||62
7762347|NCT01416142|19112343|P2|COMPLETED|PureVision2 HD||0
7762348|NCT01416142|19112344|P1|COMPLETED|PureVision2 HD||0
7762349|NCT01416142|19112342|P3|STARTED|PureVision2 HD||63
7762350|NCT01416142|19112343|P2|STARTED|PureVision2 HD||0
7762351|NCT01416142|19112344|P1|STARTED|PureVision2 HD||0
7762352|NCT01416142|19112342|P3|NOT COMPLETED|Cross Over at Movie Intermission||0
7762353|NCT01416142|19112343|P2|NOT COMPLETED|Cross Over at Movie Intermission||0
7762354|NCT01416142|19112344|P1|NOT COMPLETED|Cross Over at Movie Intermission||0
7762355|NCT01416142|19112342|P3|COMPLETED|Cross Over at Movie Intermission||0
7762356|NCT01416142|19112343|P2|COMPLETED|Cross Over at Movie Intermission||31
7762357|NCT01416142|19112344|P1|COMPLETED|Cross Over at Movie Intermission||32
7762358|NCT01416142|19112342|P3|STARTED|Cross Over at Movie Intermission||0
7762359|NCT01416142|19112343|P2|STARTED|Cross Over at Movie Intermission||31
7762360|NCT01416142|19112344|P1|STARTED|Cross Over at Movie Intermission||32
7762361|NCT01416129|19112355|P2|NOT COMPLETED|Experimental Condition: Brimless||0
7762362|NCT01416129|19112356|P1|NOT COMPLETED|Experimental Condition: Brimless||0
7762363|NCT01416129|19112355|P2|COMPLETED|Experimental Condition: Brimless||5
7762364|NCT01416129|19112356|P1|COMPLETED|Experimental Condition: Brimless||5
7762365|NCT01416129|19112355|P2|STARTED|Experimental Condition: Brimless||5
7762366|NCT01416129|19112356|P1|STARTED|Experimental Condition: Brimless||5
7762367|NCT01416129|19112355|P2|NOT COMPLETED|Control Condition: Ischial Containment||0
7762368|NCT01416129|19112356|P1|NOT COMPLETED|Control Condition: Ischial Containment||0
7762369|NCT01416129|19112355|P2|COMPLETED|Control Condition: Ischial Containment||5
7762370|NCT01416129|19112356|P1|COMPLETED|Control Condition: Ischial Containment||5
7762371|NCT01416129|19112355|P2|STARTED|Control Condition: Ischial Containment||5
7762372|NCT01416129|19112356|P1|STARTED|Control Condition: Ischial Containment||5
7762373|NCT01416025|19112364|P2|NOT COMPLETED|Overall Study||0
7762374|NCT01416025|19112365|P1|NOT COMPLETED|Overall Study||0
7762375|NCT01416025|19112364|P2|COMPLETED|Overall Study||15
7762376|NCT01416025|19112365|P1|COMPLETED|Overall Study||14
7762377|NCT01416025|19112364|P2|STARTED|Overall Study||15
7762378|NCT01416025|19112365|P1|STARTED|Overall Study||14
7762379|NCT01415986|19112371|P1|NOT COMPLETED|Overall Study||1
7762380|NCT01415986|19112371|P1|COMPLETED|Overall Study|Study terminated|0
7762381|NCT01415986|19112371|P1|STARTED|Overall Study||1
7762382|NCT01415960|19112376|P1|NOT COMPLETED|Overall Study||12
7762383|NCT01415960|19112376|P1|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151
7762384|NCT01415960|19112376|P1|PK Subgroup|Overall Study||30
7762385|NCT01415960|19112376|P1|ITT|Overall Study||161
7762386|NCT01415960|19112376|P1|STARTED|Overall Study||163
7762387|NCT01415934|19112388|P2|NOT COMPLETED|Overall Study||7
7762388|NCT01415934|19112389|P1|NOT COMPLETED|Overall Study||3
7762389|NCT01415934|19112388|P2|COMPLETED|Overall Study||182
7762390|NCT01415934|19112389|P1|COMPLETED|Overall Study||189
7762391|NCT01415934|19112388|P2|STARTED|Overall Study||189
7762392|NCT01415934|19112389|P1|STARTED|Overall Study||192
7762393|NCT01415921|19112397|P2|NOT COMPLETED|Overall Study||3
7762394|NCT01415921|19112398|P1|NOT COMPLETED|Overall Study||3
7762395|NCT01415921|19112397|P2|COMPLETED|Overall Study||14
7762396|NCT01415921|19112398|P1|COMPLETED|Overall Study||13
7762397|NCT01415921|19112397|P2|STARTED|Overall Study||17
7762398|NCT01415921|19112398|P1|STARTED|Overall Study||16
7762399|NCT01415908|19112408|P2|NOT COMPLETED|Overall Study||0
7762400|NCT01415908|19112409|P1|NOT COMPLETED|Overall Study||1
7762401|NCT01415908|19112408|P2|COMPLETED|Overall Study||4
7762402|NCT01415908|19112409|P1|COMPLETED|Overall Study||10
7762403|NCT01415908|19112408|P2|STARTED|Overall Study||4
7762404|NCT01415908|19112409|P1|STARTED|Overall Study||11
7762405|NCT01415583|19112437|P2|NOT COMPLETED|Overall Study||0
7762406|NCT01415583|19112438|P1|NOT COMPLETED|Overall Study||0
7762407|NCT01415583|19112437|P2|COMPLETED|Overall Study||157
7762408|NCT01415583|19112438|P1|COMPLETED|Overall Study||157
7762409|NCT01415583|19112437|P2|STARTED|Overall Study||157
7762410|NCT01415583|19112438|P1|STARTED|Overall Study||157
7762411|NCT01415531|19112446|P2|NOT COMPLETED|Overall Study||37
7762412|NCT01415531|19112447|P1|NOT COMPLETED|Overall Study||25
7762413|NCT01415531|19112446|P2|COMPLETED|Overall Study||390
7762414|NCT01415531|19112447|P1|COMPLETED|Overall Study||189
7762415|NCT01415531|19112446|P2|STARTED|Overall Study||427
7762416|NCT01415531|19112447|P1|STARTED|Overall Study||214
7762417|NCT01415518|19112457|P2|NOT COMPLETED|Overall Study||31
7762418|NCT01415518|19112458|P1|NOT COMPLETED|Overall Study||16
7762419|NCT01415518|19112457|P2|COMPLETED|Overall Study||261
7762420|NCT01415518|19112458|P1|COMPLETED|Overall Study||276
7762421|NCT01415518|19112457|P2|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289
7762422|NCT01415518|19112458|P1|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290
7762423|NCT01415518|19112457|P2|Patients Who Received Study Treatment|Overall Study||292
7762424|NCT01415518|19112458|P1|Patients Who Received Study Treatment|Overall Study||290
7762425|NCT01415518|19112457|P2|STARTED|Overall Study||292
7762426|NCT01415518|19112458|P1|STARTED|Overall Study||292
7762427|NCT01415453|19112510|P1|NOT COMPLETED|Overall Study||0
7762428|NCT01415453|19112510|P1|COMPLETED|Overall Study||1
7762429|NCT01415453|19112510|P1|Imaging Study|Overall Study||1
7762430|NCT01415453|19112510|P1|STARTED|Overall Study||1
7762431|NCT01415440|19112517|P3|NOT COMPLETED|Overall Study||2
7762432|NCT01415440|19112518|P2|NOT COMPLETED|Overall Study||1
7762433|NCT01415440|19112519|P1|NOT COMPLETED|Overall Study||4
7762434|NCT01415440|19112517|P3|COMPLETED|Overall Study||27
7762435|NCT01415440|19112518|P2|COMPLETED|Overall Study||28
7762436|NCT01415440|19112519|P1|COMPLETED|Overall Study||37
7762437|NCT01415440|19112517|P3|STARTED|Overall Study||29
7762438|NCT01415440|19112518|P2|STARTED|Overall Study||29
7762439|NCT01415440|19112519|P1|STARTED|Overall Study||41
7762440|NCT01415427|19112530|P4|NOT COMPLETED|Overall Study||56
7762441|NCT01415427|19112531|P3|NOT COMPLETED|Overall Study||58
7762442|NCT01415427|19112532|P2|NOT COMPLETED|Overall Study||29
7762443|NCT01415427|19112533|P1|NOT COMPLETED|Overall Study||29
7762444|NCT01415427|19112530|P4|COMPLETED|Overall Study||0
7762445|NCT01415427|19112531|P3|COMPLETED|Overall Study||1
7762446|NCT01415427|19112532|P2|COMPLETED|Overall Study||0
7762447|NCT01415427|19112533|P1|COMPLETED|Overall Study||0
7762448|NCT01415427|19112530|P4|STARTED|Overall Study||56
7762449|NCT01415427|19112531|P3|STARTED|Overall Study||59
7762450|NCT01415427|19112532|P2|STARTED|Overall Study||29
7762451|NCT01415427|19112533|P1|STARTED|Overall Study||29
7762452|NCT01415401|19112570|P1|NOT COMPLETED|Overall Study||7
7762453|NCT01415401|19112570|P1|COMPLETED|Overall Study||47
7762454|NCT01415401|19112570|P1|STARTED|Overall Study||54
7762455|NCT01415349|19112575|P2|NOT COMPLETED|Treatment Period 2||0
7762456|NCT01415349|19112576|P1|NOT COMPLETED|Treatment Period 2||0
7762457|NCT01415349|19112575|P2|COMPLETED|Treatment Period 2||19
7762458|NCT01415349|19112576|P1|COMPLETED|Treatment Period 2||21
7762459|NCT01415349|19112575|P2|STARTED|Treatment Period 2||19
7762460|NCT01415349|19112576|P1|STARTED|Treatment Period 2||21
7762461|NCT01415349|19112575|P2|NOT COMPLETED|Treatment Period 1||2
7762462|NCT01415349|19112576|P1|NOT COMPLETED|Treatment Period 1||0
7762463|NCT01415349|19112575|P2|COMPLETED|Treatment Period 1||19
7762464|NCT01415349|19112576|P1|COMPLETED|Treatment Period 1||21
7762465|NCT01415349|19112575|P2|STARTED|Treatment Period 1||21
7762466|NCT01415349|19112576|P1|STARTED|Treatment Period 1||21
7762467|NCT01415232|19112584|P1|NOT COMPLETED|Overall Study||0
7762468|NCT01415232|19112584|P1|COMPLETED|Overall Study||160
7762469|NCT01415232|19112584|P1|STARTED|Overall Study||160
7762470|NCT01414855|19112588|P1|NOT COMPLETED|Overall Study||29
7762471|NCT01414855|19112588|P1|COMPLETED|Overall Study||71
7762472|NCT01414855|19112588|P1|STARTED|Overall Study||100
7762473|NCT01414634|19112604|P8|NOT COMPLETED|Overall Study||0
7762474|NCT01414634|19112605|P7|NOT COMPLETED|Overall Study||0
7762475|NCT01414634|19112606|P6|NOT COMPLETED|Overall Study||0
7762476|NCT01414634|19112607|P5|NOT COMPLETED|Overall Study||0
7762477|NCT01414634|19112608|P4|NOT COMPLETED|Overall Study||0
7762478|NCT01414634|19112609|P3|NOT COMPLETED|Overall Study||0
7762479|NCT01414634|19112610|P2|NOT COMPLETED|Overall Study||0
7762480|NCT01414634|19112611|P1|NOT COMPLETED|Overall Study||0
7762481|NCT01414634|19112604|P8|COMPLETED|Overall Study||1
7762482|NCT01414634|19112605|P7|COMPLETED|Overall Study||1
7762483|NCT01414634|19112606|P6|COMPLETED|Overall Study||2
7762484|NCT01414634|19112607|P5|COMPLETED|Overall Study||1
7762485|NCT01414634|19112608|P4|COMPLETED|Overall Study||1
7762486|NCT01414634|19112609|P3|COMPLETED|Overall Study||1
7762487|NCT01414634|19112610|P2|COMPLETED|Overall Study||1
7762488|NCT01414634|19112611|P1|COMPLETED|Overall Study||1
7762489|NCT01414634|19112604|P8|STARTED|Overall Study||1
7762490|NCT01414634|19112605|P7|STARTED|Overall Study||1
7762491|NCT01414634|19112606|P6|STARTED|Overall Study||2
7762492|NCT01414634|19112607|P5|STARTED|Overall Study||1
7762493|NCT01414634|19112608|P4|STARTED|Overall Study||1
7762494|NCT01414634|19112609|P3|STARTED|Overall Study||1
7762495|NCT01414634|19112610|P2|STARTED|Overall Study||1
7762496|NCT01414634|19112611|P1|STARTED|Overall Study||1
7762497|NCT01414413|19112624|P2|NOT COMPLETED|Overall Study||0
7762498|NCT01414413|19112625|P1|NOT COMPLETED|Overall Study||0
7762499|NCT01414413|19112624|P2|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466
7762500|NCT01414413|19112625|P1|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194
7762501|NCT01414413|19112624|P2|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466
7762502|NCT01414413|19112625|P1|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194
7762503|NCT01414257|19112637|P1|NOT COMPLETED|Overall Study||22
7762504|NCT01414257|19112637|P1|COMPLETED|Overall Study||2838
7762505|NCT01414257|19112637|P1|STARTED|Overall Study||2860
7762506|NCT01414244|19112650|P2|NOT COMPLETED|Overall Study||0
7762507|NCT01414244|19112651|P1|NOT COMPLETED|Overall Study||0
7762508|NCT01414244|19112650|P2|COMPLETED|Overall Study||52
7762509|NCT01414244|19112651|P1|COMPLETED|Overall Study||54
7762510|NCT01414244|19112650|P2|STARTED|Overall Study||52
7762511|NCT01414244|19112651|P1|STARTED|Overall Study||54
7762512|NCT01414205|19112665|P2|NOT COMPLETED|Overall Study||7
7762513|NCT01414205|19112666|P1|NOT COMPLETED|Overall Study||7
7762514|NCT01414205|19112665|P2|COMPLETED|Overall Study||32
7762515|NCT01414205|19112666|P1|COMPLETED|Overall Study||34
7762516|NCT01414205|19112665|P2|Received Study Drug|Overall Study||38
7762517|NCT01414205|19112666|P1|Received Study Drug|Overall Study||40
7762518|NCT01414205|19112665|P2|STARTED|Overall Study||39
7762519|NCT01414205|19112666|P1|STARTED|Overall Study||41
7762520|NCT01414192|19112702|P4|NOT COMPLETED|Overall Study||0
7762521|NCT01414192|19112703|P3|NOT COMPLETED|Overall Study||0
7762522|NCT01414192|19112704|P2|NOT COMPLETED|Overall Study||0
7762523|NCT01414192|19112705|P1|NOT COMPLETED|Overall Study||0
7762524|NCT01414192|19112702|P4|COMPLETED|Overall Study||1726
7762525|NCT01414192|19112703|P3|COMPLETED|Overall Study||424
7762526|NCT01414192|19112704|P2|COMPLETED|Overall Study||575
7762527|NCT01414192|19112705|P1|COMPLETED|Overall Study||490
7762528|NCT01414192|19112702|P4|STARTED|Overall Study||1726
7762529|NCT01414192|19112703|P3|STARTED|Overall Study||424
7762530|NCT01414192|19112704|P2|STARTED|Overall Study||575
7762531|NCT01414192|19112705|P1|STARTED|Overall Study||490
7762532|NCT01414166|19112735|P2|NOT COMPLETED|Overall Study||83
7762533|NCT01414166|19112736|P1|NOT COMPLETED|Overall Study||91
7762534|NCT01414166|19112735|P2|COMPLETED|Overall Study||39
7762535|NCT01414166|19112736|P1|COMPLETED|Overall Study||31
7762536|NCT01414166|19112735|P2|Treated|Overall Study||121
7762537|NCT01414166|19112736|P1|Treated|Overall Study||120
7762538|NCT01414166|19112735|P2|STARTED|Overall Study||122
7762539|NCT01414166|19112736|P1|STARTED|Overall Study||122
7762540|NCT01414153|19112762|P4|NOT COMPLETED|Overall Study||4
7762541|NCT01414153|19112763|P3|NOT COMPLETED|Overall Study||4
7762542|NCT01414153|19112764|P2|NOT COMPLETED|Overall Study||2
7762543|NCT01414153|19112765|P1|NOT COMPLETED|Overall Study||8
7762544|NCT01414153|19112762|P4|COMPLETED|Overall Study||37
7762545|NCT01414153|19112763|P3|COMPLETED|Overall Study||35
7762546|NCT01414153|19112764|P2|COMPLETED|Overall Study||38
7762547|NCT01414153|19112765|P1|COMPLETED|Overall Study||30
7762548|NCT01414153|19112762|P4|STARTED|Overall Study||41
7762549|NCT01414153|19112763|P3|STARTED|Overall Study||39
7762550|NCT01414153|19112764|P2|STARTED|Overall Study||40
7762551|NCT01414153|19112765|P1|STARTED|Overall Study||38
7762552|NCT01414114|19112799|P1|NOT COMPLETED|Overall Study||5
7762553|NCT01414114|19112799|P1|COMPLETED|Overall Study|Completed 12-week treatment period|32
7762554|NCT01414114|19112799|P1|STARTED|Overall Study||37
7762555|NCT01414036|19112819|P2|NOT COMPLETED|Completed 3 Month Survey||5
7762556|NCT01414036|19112820|P1|NOT COMPLETED|Completed 3 Month Survey||9
7762557|NCT01414036|19112819|P2|COMPLETED|Completed 3 Month Survey||19
7762558|NCT01414036|19112820|P1|COMPLETED|Completed 3 Month Survey||14
7762559|NCT01414036|19112819|P2|STARTED|Completed 3 Month Survey||24
7762560|NCT01414036|19112820|P1|STARTED|Completed 3 Month Survey||23
7762561|NCT01414036|19112819|P2|NOT COMPLETED|Received Allocated Intervention||13
7762562|NCT01414036|19112820|P1|NOT COMPLETED|Received Allocated Intervention||0
7762563|NCT01414036|19112819|P2|COMPLETED|Received Allocated Intervention||11
7762564|NCT01414036|19112820|P1|COMPLETED|Received Allocated Intervention||23
7762565|NCT01414036|19112819|P2|STARTED|Received Allocated Intervention||24
7762566|NCT01414036|19112820|P1|STARTED|Received Allocated Intervention||23
7762567|NCT01414010|19112834|P4|NOT COMPLETED|Overall Study||0
7762568|NCT01414010|19112835|P3|NOT COMPLETED|Overall Study||0
7762569|NCT01414010|19112836|P2|NOT COMPLETED|Overall Study||0
7762570|NCT01414010|19112837|P1|NOT COMPLETED|Overall Study||2
7762571|NCT01414010|19112834|P4|COMPLETED|Overall Study||8
7762572|NCT01414010|19112835|P3|COMPLETED|Overall Study||8
7762573|NCT01414010|19112836|P2|COMPLETED|Overall Study||8
7762574|NCT01414010|19112837|P1|COMPLETED|Overall Study||6
7762575|NCT01414010|19112834|P4|STARTED|Overall Study||8
7762576|NCT01414010|19112835|P3|STARTED|Overall Study||8
7762577|NCT01414010|19112836|P2|STARTED|Overall Study||8
7762578|NCT01414010|19112837|P1|STARTED|Overall Study||8
7762579|NCT01413958|19112855|P2|NOT COMPLETED|Overall Study||1
7762580|NCT01413958|19112856|P1|NOT COMPLETED|Overall Study||0
7762581|NCT01413958|19112855|P2|COMPLETED|Overall Study||286
7762582|NCT01413958|19112856|P1|COMPLETED|Overall Study||288
7762583|NCT01413958|19112855|P2|STARTED|Overall Study||287
7762584|NCT01413958|19112856|P1|STARTED|Overall Study||288
7762585|NCT01413750|19112891|P4|NOT COMPLETED|Overall Study||0
7762586|NCT01413750|19112892|P3|NOT COMPLETED|Overall Study||0
7762587|NCT01413750|19112893|P2|NOT COMPLETED|Overall Study||0
7762588|NCT01413750|19112894|P1|NOT COMPLETED|Overall Study||0
7762589|NCT01413750|19112891|P4|COMPLETED|Overall Study||7
7762590|NCT01413750|19112892|P3|COMPLETED|Overall Study||4
7762591|NCT01413750|19112893|P2|COMPLETED|Overall Study||6
7762592|NCT01413750|19112894|P1|COMPLETED|Overall Study||6
7762593|NCT01413750|19112891|P4|STARTED|Overall Study||7
7762594|NCT01413750|19112892|P3|STARTED|Overall Study||4
7762595|NCT01413750|19112893|P2|STARTED|Overall Study||6
7762596|NCT01413750|19112894|P1|STARTED|Overall Study||6
7762597|NCT01413542|19112907|P4|NOT COMPLETED|Overall Study||1
7762598|NCT01413542|19112908|P3|NOT COMPLETED|Overall Study||3
7762599|NCT01413542|19112909|P2|NOT COMPLETED|Overall Study||0
7762600|NCT01413542|19112910|P1|NOT COMPLETED|Overall Study||1
7762601|NCT01413542|19112907|P4|COMPLETED|Overall Study||7
7762602|NCT01413542|19112908|P3|COMPLETED|Overall Study||6
7762603|NCT01413542|19112909|P2|COMPLETED|Overall Study||6
7762604|NCT01413542|19112910|P1|COMPLETED|Overall Study||5
7762605|NCT01413542|19112907|P4|STARTED|Overall Study||8
7762606|NCT01413542|19112908|P3|STARTED|Overall Study||9
7762607|NCT01413542|19112909|P2|STARTED|Overall Study||6
7762608|NCT01413542|19112910|P1|STARTED|Overall Study||6
7762609|NCT01413516|19112925|P2|NOT COMPLETED|Overall Study||0
7762610|NCT01413516|19112926|P1|NOT COMPLETED|Overall Study||0
7762611|NCT01413516|19112925|P2|COMPLETED|Overall Study||9
7762612|NCT01413516|19112926|P1|COMPLETED|Overall Study||8
7762613|NCT01413516|19112925|P2|STARTED|Overall Study||9
7762614|NCT01413516|19112926|P1|STARTED|Overall Study||8
7762615|NCT01413503|19112932|P1|NOT COMPLETED|Overall Study||1
7762616|NCT01413503|19112932|P1|COMPLETED|Overall Study||49
7762617|NCT01413503|19112932|P1|STARTED|Overall Study||50
7762618|NCT01413360|19112936|P1|NOT COMPLETED|Overall Study||3
7762619|NCT01413360|19112936|P1|COMPLETED|Overall Study||7
7762620|NCT01413360|19112936|P1|STARTED|Overall Study||10
7762621|NCT01413204|19112944|P3|NOT COMPLETED|Overall Study||19
7762622|NCT01413204|19112945|P2|NOT COMPLETED|Overall Study||6
7762623|NCT01413204|19112946|P1|NOT COMPLETED|Overall Study||6
7762624|NCT01413204|19112944|P3|COMPLETED|Overall Study||74
7762625|NCT01413204|19112945|P2|COMPLETED|Overall Study||83
7762626|NCT01413204|19112946|P1|COMPLETED|Overall Study||84
7762627|NCT01413204|19112944|P3|STARTED|Overall Study||93
7762628|NCT01413204|19112945|P2|STARTED|Overall Study||89
7762629|NCT01413204|19112946|P1|STARTED|Overall Study||90
7762630|NCT01413191|19112954|P1|NOT COMPLETED|Overall Study||11
7762631|NCT01413191|19112954|P1|COMPLETED|Overall Study||7
7762632|NCT01413191|19112954|P1|STARTED|Overall Study||18
7762633|NCT01413178|19112966|P2|NOT COMPLETED|Overall Study||2
7762634|NCT01413178|19112967|P1|NOT COMPLETED|Overall Study||1
7762635|NCT01413178|19112966|P2|COMPLETED|Overall Study||98
7762636|NCT01413178|19112967|P1|COMPLETED|Overall Study||104
7762637|NCT01413178|19112966|P2|STARTED|Overall Study||100
7762638|NCT01413178|19112967|P1|STARTED|Overall Study||105
7762639|NCT01413087|19112983|P2|NOT COMPLETED|Overall Study||0
7762640|NCT01413087|19112984|P1|NOT COMPLETED|Overall Study||0
7762641|NCT01413087|19112983|P2|COMPLETED|Overall Study||6
7762642|NCT01413087|19112984|P1|COMPLETED|Overall Study||6
7762643|NCT01413087|19112983|P2|STARTED|Overall Study||6
7762644|NCT01413087|19112984|P1|STARTED|Overall Study||6
7762645|NCT01412983|19113010|P2|NOT COMPLETED|2nd Period||0
7762646|NCT01412983|19113011|P1|NOT COMPLETED|2nd Period||0
7762647|NCT01412983|19113010|P2|COMPLETED|2nd Period||46
7762648|NCT01412983|19113011|P1|COMPLETED|2nd Period||50
7762649|NCT01412983|19113010|P2|STARTED|2nd Period||46
7762650|NCT01412983|19113011|P1|STARTED|2nd Period||50
7762651|NCT01412983|19113010|P2|NOT COMPLETED|1st Period||4
7762652|NCT01412983|19113011|P1|NOT COMPLETED|1st Period||0
7762653|NCT01412983|19113010|P2|COMPLETED|1st Period||46
7762654|NCT01412983|19113011|P1|COMPLETED|1st Period||50
7762655|NCT01412983|19113010|P2|STARTED|1st Period||50
7762656|NCT01412983|19113011|P1|STARTED|1st Period||50
7762657|NCT01412957|19113021|P2|NOT COMPLETED|Overall Study||157
7762658|NCT01412957|19113022|P1|NOT COMPLETED|Overall Study||149
7762659|NCT01412957|19113021|P2|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31
7762660|NCT01412957|19113022|P1|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40
7762661|NCT01412957|19113021|P2|STARTED|Overall Study||188
7762662|NCT01412957|19113022|P1|STARTED|Overall Study||189
7762663|NCT01412944|19113044|P6|NOT COMPLETED|Follow-up||0
7762664|NCT01412944|19113045|P5|NOT COMPLETED|Follow-up||0
7762665|NCT01412944|19113046|P4|NOT COMPLETED|Follow-up||0
7762666|NCT01412944|19113047|P3|NOT COMPLETED|Follow-up||0
7762667|NCT01412944|19113048|P2|NOT COMPLETED|Follow-up||0
7762668|NCT01412944|19113049|P1|NOT COMPLETED|Follow-up||0
7762669|NCT01412944|19113044|P6|COMPLETED|Follow-up||0
7762670|NCT01412944|19113045|P5|COMPLETED|Follow-up||2
7762671|NCT01412944|19113046|P4|COMPLETED|Follow-up||1
7762672|NCT01412944|19113047|P3|COMPLETED|Follow-up||2
7762673|NCT01412944|19113048|P2|COMPLETED|Follow-up||0
7762674|NCT01412944|19113049|P1|COMPLETED|Follow-up||0
7762675|NCT01412944|19113044|P6|STARTED|Follow-up||0
7762676|NCT01412944|19113045|P5|STARTED|Follow-up||2
7762677|NCT01412944|19113046|P4|STARTED|Follow-up||1
7762678|NCT01412944|19113047|P3|STARTED|Follow-up||2
7762679|NCT01412944|19113048|P2|STARTED|Follow-up||0
7762680|NCT01412944|19113049|P1|STARTED|Follow-up||0
7762681|NCT01412944|19113044|P6|NOT COMPLETED|Entire: IV + Maintenance||0
7762682|NCT01412944|19113045|P5|NOT COMPLETED|Entire: IV + Maintenance||0
7762683|NCT01412944|19113046|P4|NOT COMPLETED|Entire: IV + Maintenance||0
7762684|NCT01412944|19113047|P3|NOT COMPLETED|Entire: IV + Maintenance||0
7762685|NCT01412944|19113048|P2|NOT COMPLETED|Entire: IV + Maintenance||5
7762686|NCT01412944|19113049|P1|NOT COMPLETED|Entire: IV + Maintenance||2
7762687|NCT01412944|19113044|P6|COMPLETED|Entire: IV + Maintenance||0
7762688|NCT01412944|19113045|P5|COMPLETED|Entire: IV + Maintenance||0
7762689|NCT01412944|19113046|P4|COMPLETED|Entire: IV + Maintenance||0
7762690|NCT01412944|19113047|P3|COMPLETED|Entire: IV + Maintenance||0
7762691|NCT01412944|19113048|P2|COMPLETED|Entire: IV + Maintenance||17
7762692|NCT01412944|19113049|P1|COMPLETED|Entire: IV + Maintenance||19
7762693|NCT01412944|19113044|P6|STARTED|Entire: IV + Maintenance||0
7762694|NCT01412944|19113045|P5|STARTED|Entire: IV + Maintenance||0
7762695|NCT01412944|19113046|P4|STARTED|Entire: IV + Maintenance||0
7762696|NCT01412944|19113047|P3|STARTED|Entire: IV + Maintenance||0
7762697|NCT01412944|19113048|P2|STARTED|Entire: IV + Maintenance||22
7762698|NCT01412944|19113049|P1|STARTED|Entire: IV + Maintenance||21
7762699|NCT01412944|19113044|P6|NOT COMPLETED|Entire: IV + Maintenance||2
7762700|NCT01412944|19113045|P5|NOT COMPLETED|Entire: IV + Maintenance||3
7762701|NCT01412944|19113046|P4|NOT COMPLETED|Entire: IV + Maintenance||1
7762702|NCT01412944|19113047|P3|NOT COMPLETED|Entire: IV + Maintenance||1
7762703|NCT01412944|19113048|P2|NOT COMPLETED|Entire: IV + Maintenance||0
7762704|NCT01412944|19113049|P1|NOT COMPLETED|Entire: IV + Maintenance||0
7762705|NCT01412944|19113044|P6|COMPLETED|Entire: IV + Maintenance||6
7762706|NCT01412944|19113045|P5|COMPLETED|Entire: IV + Maintenance||11
7762707|NCT01412944|19113046|P4|COMPLETED|Entire: IV + Maintenance||5
7762708|NCT01412944|19113047|P3|COMPLETED|Entire: IV + Maintenance||14
7762709|NCT01412944|19113048|P2|COMPLETED|Entire: IV + Maintenance||0
7762710|NCT01412944|19113049|P1|COMPLETED|Entire: IV + Maintenance||0
7762711|NCT01412944|19113044|P6|STARTED|Entire: IV + Maintenance||8
7762712|NCT01412944|19113045|P5|STARTED|Entire: IV + Maintenance||14
7762713|NCT01412944|19113046|P4|STARTED|Entire: IV + Maintenance||6
7762714|NCT01412944|19113047|P3|STARTED|Entire: IV + Maintenance||15
7762715|NCT01412944|19113048|P2|STARTED|Entire: IV + Maintenance||0
7762716|NCT01412944|19113049|P1|STARTED|Entire: IV + Maintenance||0
7762717|NCT01412944|19113044|P6|NOT COMPLETED|IV: Per CAIN457A2307||0
7762718|NCT01412944|19113045|P5|NOT COMPLETED|IV: Per CAIN457A2307||0
7762719|NCT01412944|19113046|P4|NOT COMPLETED|IV: Per CAIN457A2307||0
7762720|NCT01412944|19113047|P3|NOT COMPLETED|IV: Per CAIN457A2307||0
7762721|NCT01412944|19113048|P2|NOT COMPLETED|IV: Per CAIN457A2307||2
7762722|NCT01412944|19113049|P1|NOT COMPLETED|IV: Per CAIN457A2307||1
7762723|NCT01412944|19113044|P6|COMPLETED|IV: Per CAIN457A2307||0
7762724|NCT01412944|19113045|P5|COMPLETED|IV: Per CAIN457A2307||0
7762725|NCT01412944|19113046|P4|COMPLETED|IV: Per CAIN457A2307||0
7762726|NCT01412944|19113047|P3|COMPLETED|IV: Per CAIN457A2307||0
7762727|NCT01412944|19113048|P2|COMPLETED|IV: Per CAIN457A2307||20
7762728|NCT01412944|19113049|P1|COMPLETED|IV: Per CAIN457A2307||20
7762729|NCT01412944|19113044|P6|STARTED|IV: Per CAIN457A2307||0
7762730|NCT01412944|19113045|P5|STARTED|IV: Per CAIN457A2307||0
7762731|NCT01412944|19113046|P4|STARTED|IV: Per CAIN457A2307||0
7762732|NCT01412944|19113047|P3|STARTED|IV: Per CAIN457A2307||0
7762733|NCT01412944|19113048|P2|STARTED|IV: Per CAIN457A2307||22
7762734|NCT01412944|19113049|P1|STARTED|IV: Per CAIN457A2307||21
7762735|NCT01412944|19113044|P6|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2
7762736|NCT01412944|19113045|P5|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
7762737|NCT01412944|19113046|P4|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
7762738|NCT01412944|19113047|P3|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1
7762739|NCT01412944|19113048|P2|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
7762740|NCT01412944|19113049|P1|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
7762741|NCT01412944|19113044|P6|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
7762742|NCT01412944|19113045|P5|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
7762743|NCT01412944|19113046|P4|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
7762744|NCT01412944|19113047|P3|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
7762745|NCT01412944|19113048|P2|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
7762746|NCT01412944|19113049|P1|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
7762747|NCT01412944|19113044|P6|STARTED|IV: Per Previous CAIN457A2304 Treatment||8
7762748|NCT01412944|19113045|P5|STARTED|IV: Per Previous CAIN457A2304 Treatment||14
7762749|NCT01412944|19113046|P4|STARTED|IV: Per Previous CAIN457A2304 Treatment||6
7762750|NCT01412944|19113047|P3|STARTED|IV: Per Previous CAIN457A2304 Treatment||15
7762751|NCT01412944|19113048|P2|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
7762752|NCT01412944|19113049|P1|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
7762753|NCT01412918|19113085|P2|NOT COMPLETED|Overall Study||0
7762754|NCT01412918|19113086|P1|NOT COMPLETED|Overall Study||0
7762755|NCT01412918|19113085|P2|COMPLETED|Overall Study||1
7762756|NCT01412918|19113086|P1|COMPLETED|Overall Study||20
7762757|NCT01412918|19113085|P2|STARTED|Overall Study||1
7762758|NCT01412918|19113086|P1|STARTED|Overall Study||20
7762759|NCT01412879|19113095|P3|NOT COMPLETED|Consolidation Therapy||0
7762760|NCT01412879|19113096|P2|NOT COMPLETED|Consolidation Therapy||0
7762761|NCT01412879|19113097|P1|NOT COMPLETED|Consolidation Therapy||0
7762762|NCT01412879|19113095|P3|COMPLETED|Consolidation Therapy||26
7762763|NCT01412879|19113096|P2|COMPLETED|Consolidation Therapy||0
7762764|NCT01412879|19113097|P1|COMPLETED|Consolidation Therapy||0
7762765|NCT01412879|19113095|P3|STARTED|Consolidation Therapy|Only eligible patients who are able to have stem cell harvested receive consolidation therapy.|26
7762766|NCT01412879|19113096|P2|STARTED|Consolidation Therapy||0
7762767|NCT01412879|19113097|P1|STARTED|Consolidation Therapy||0
7762768|NCT01412879|19113095|P3|NOT COMPLETED|Initial Registration (Induction Therapy)||0
7762769|NCT01412879|19113096|P2|NOT COMPLETED|Initial Registration (Induction Therapy)||8
7762770|NCT01412879|19113097|P1|NOT COMPLETED|Initial Registration (Induction Therapy)||13
7762771|NCT01412879|19113095|P3|COMPLETED|Initial Registration (Induction Therapy)||0
7762772|NCT01412879|19113096|P2|COMPLETED|Initial Registration (Induction Therapy)||27
7762773|NCT01412879|19113097|P1|COMPLETED|Initial Registration (Induction Therapy)||5
7762774|NCT01412879|19113095|P3|Treatment Started|Initial Registration (Induction Therapy)||0
7762775|NCT01412879|19113096|P2|Treatment Started|Initial Registration (Induction Therapy)||35
7762776|NCT01412879|19113097|P1|Treatment Started|Initial Registration (Induction Therapy)||17
7762777|NCT01412879|19113095|P3|STARTED|Initial Registration (Induction Therapy)||0
7762778|NCT01412879|19113096|P2|STARTED|Initial Registration (Induction Therapy)||35
7762779|NCT01412879|19113097|P1|STARTED|Initial Registration (Induction Therapy)||18
7762780|NCT01412866|19113113|P2|NOT COMPLETED|Overall Study||2
7762781|NCT01412866|19113114|P1|NOT COMPLETED|Overall Study||1
7762782|NCT01412866|19113113|P2|COMPLETED|Overall Study||64
7762783|NCT01412866|19113114|P1|COMPLETED|Overall Study||57
7762784|NCT01412866|19113113|P2|STARTED|Overall Study||66
7762785|NCT01412866|19113114|P1|STARTED|Overall Study||58
7762786|NCT01412801|19113126|P6|NOT COMPLETED|Overall Study||3
7762787|NCT01412801|19113127|P5|NOT COMPLETED|Overall Study||3
7762788|NCT01412801|19113128|P4|NOT COMPLETED|Overall Study||4
7762789|NCT01412801|19113129|P3|NOT COMPLETED|Overall Study||7
7762790|NCT01412801|19113130|P2|NOT COMPLETED|Overall Study||5
7762791|NCT01412801|19113131|P1|NOT COMPLETED|Overall Study||4
7762792|NCT01412801|19113126|P6|COMPLETED|Overall Study||84
7762793|NCT01412801|19113127|P5|COMPLETED|Overall Study||85
7762794|NCT01412801|19113128|P4|COMPLETED|Overall Study||87
7762795|NCT01412801|19113129|P3|COMPLETED|Overall Study||83
7762796|NCT01412801|19113130|P2|COMPLETED|Overall Study||84
7762797|NCT01412801|19113131|P1|COMPLETED|Overall Study||87
7762798|NCT01412801|19113126|P6|STARTED|Overall Study||87
7762799|NCT01412801|19113127|P5|STARTED|Overall Study||88
7762800|NCT01412801|19113128|P4|STARTED|Overall Study||91
7762801|NCT01412801|19113129|P3|STARTED|Overall Study||90
7762802|NCT01412801|19113130|P2|STARTED|Overall Study||89
7762803|NCT01412801|19113131|P1|STARTED|Overall Study||91
7762804|NCT01412710|19113170|P2|NOT COMPLETED|Overall Study||5
7762805|NCT01412710|19113171|P1|NOT COMPLETED|Overall Study||4
7762806|NCT01412710|19113170|P2|COMPLETED|Overall Study||22
7762807|NCT01412710|19113171|P1|COMPLETED|Overall Study||46
7762808|NCT01412710|19113170|P2|STARTED|Overall Study||27
7762809|NCT01412710|19113171|P1|STARTED|Overall Study||50
7762810|NCT01412554|19113179|P1|NOT COMPLETED|Overall Study||0
7762811|NCT01412554|19113179|P1|COMPLETED|Overall Study||103
7762812|NCT01412554|19113179|P1|STARTED|Overall Study|103 persons re-examined in 2012-13 out of 158 persons originally examined in 1991-96.|103
7762813|NCT01412541|19113185|P2|NOT COMPLETED|Overall Study||43
7762814|NCT01412541|19113186|P1|NOT COMPLETED|Overall Study||126
7762815|NCT01412541|19113185|P2|COMPLETED|Overall Study||117
7762816|NCT01412541|19113186|P1|COMPLETED|Overall Study||246
7762817|NCT01412541|19113185|P2|STARTED|Overall Study||160
7762818|NCT01412541|19113186|P1|STARTED|Overall Study||372
7762819|NCT01412424|19113226|P1|NOT COMPLETED|Extension Treatment Period||6
7762820|NCT01412424|19113226|P1|COMPLETED|Extension Treatment Period||82
7762821|NCT01412424|19113226|P1|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88
7762822|NCT01412424|19113226|P1|NOT COMPLETED|Core Treatment Period||53
7762823|NCT01412424|19113226|P1|COMPLETED|Core Treatment Period||102
7762824|NCT01412424|19113226|P1|STARTED|Core Treatment Period||155
7762825|NCT01412372|19113244|P2|NOT COMPLETED|Overall Study||3
7762826|NCT01412372|19113245|P1|NOT COMPLETED|Overall Study||4
7762827|NCT01412372|19113244|P2|COMPLETED|Overall Study||28
7762828|NCT01412372|19113245|P1|COMPLETED|Overall Study||26
7762829|NCT01412372|19113244|P2|STARTED|Overall Study||31
7762830|NCT01412372|19113245|P1|STARTED|Overall Study||30
7762831|NCT01412333|19113263|P2|NOT COMPLETED|Overall Study||57
7762832|NCT01412333|19113264|P1|NOT COMPLETED|Overall Study||98
7762833|NCT01412333|19113263|P2|COMPLETED|Overall Study||360
7762834|NCT01412333|19113264|P1|COMPLETED|Overall Study||320
7762835|NCT01412333|19113263|P2|STARTED|Overall Study||417
7762836|NCT01412333|19113264|P1|STARTED|Overall Study||418
7762837|NCT01412281|19113299|P4|NOT COMPLETED|Overall Study||0
7762838|NCT01412281|19113300|P3|NOT COMPLETED|Overall Study||0
7762839|NCT01412281|19113301|P2|NOT COMPLETED|Overall Study||0
7762840|NCT01412281|19113302|P1|NOT COMPLETED|Overall Study||0
7762841|NCT01412281|19113299|P4|COMPLETED|Overall Study||110
7762842|NCT01412281|19113300|P3|COMPLETED|Overall Study||110
7762843|NCT01412281|19113301|P2|COMPLETED|Overall Study||110
7762844|NCT01412281|19113302|P1|COMPLETED|Overall Study||110
7762845|NCT01412281|19113299|P4|STARTED|Overall Study||110
7762846|NCT01412281|19113300|P3|STARTED|Overall Study||110
7762847|NCT01412281|19113301|P2|STARTED|Overall Study||110
7762848|NCT01412281|19113302|P1|STARTED|Overall Study||110
7762849|NCT01412229|19113324|P1|NOT COMPLETED|Overall Study||1
7762850|NCT01412229|19113324|P1|COMPLETED|Overall Study||38
7762851|NCT01412229|19113324|P1|STARTED|Overall Study||39
7762852|NCT01412164|19113336|P1|NOT COMPLETED|Overall Study||47
7762853|NCT01412164|19113336|P1|COMPLETED|Overall Study||683
7762854|NCT01412164|19113336|P1|STARTED|Overall Study||730
7762855|NCT01412151|19113347|P1|NOT COMPLETED|Week 306 - 310 - Washout Period||2
7762856|NCT01412151|19113347|P1|COMPLETED|Week 306 - 310 - Washout Period||3
7762857|NCT01412151|19113347|P1|STARTED|Week 306 - 310 - Washout Period||5
7762858|NCT01412151|19113347|P1|NOT COMPLETED|Week 0 - 306 - Treatment Period||5
7762859|NCT01412151|19113347|P1|COMPLETED|Week 0 - 306 - Treatment Period||5
7762860|NCT01412151|19113347|P1|STARTED|Week 0 - 306 - Treatment Period||10
7762861|NCT01412086|19113353|P1|NOT COMPLETED|Overall Study||0
7762862|NCT01412086|19113353|P1|COMPLETED|Overall Study||112
7762863|NCT01412086|19113353|P1|STARTED|Overall Study||112
7762864|NCT01412060|19113358|P3|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
7762865|NCT01412060|19113359|P2|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
7762866|NCT01412060|19113360|P1|NOT COMPLETED|Double-blind Treatment Phase (DBP)||0
7762867|NCT01412060|19113358|P3|COMPLETED|Double-blind Treatment Phase (DBP)||18
7762868|NCT01412060|19113359|P2|COMPLETED|Double-blind Treatment Phase (DBP)||16
7762869|NCT01412060|19113360|P1|COMPLETED|Double-blind Treatment Phase (DBP)||0
7762870|NCT01412060|19113358|P3|STARTED|Double-blind Treatment Phase (DBP)||101
7762871|NCT01412060|19113359|P2|STARTED|Double-blind Treatment Phase (DBP)||99
7762872|NCT01412060|19113360|P1|STARTED|Double-blind Treatment Phase (DBP)||0
7762873|NCT01412060|19113358|P3|NOT COMPLETED|Period Between SP and DBP||0
7762874|NCT01412060|19113359|P2|NOT COMPLETED|Period Between SP and DBP||0
7762875|NCT01412060|19113360|P1|NOT COMPLETED|Period Between SP and DBP||64
7762876|NCT01412060|19113358|P3|COMPLETED|Period Between SP and DBP||0
7762877|NCT01412060|19113359|P2|COMPLETED|Period Between SP and DBP||0
7762878|NCT01412060|19113360|P1|COMPLETED|Period Between SP and DBP||200
7762879|NCT01412060|19113358|P3|STARTED|Period Between SP and DBP||0
7762880|NCT01412060|19113359|P2|STARTED|Period Between SP and DBP||0
7762881|NCT01412060|19113360|P1|STARTED|Period Between SP and DBP||264
7762882|NCT01412060|19113358|P3|NOT COMPLETED|Open-label Stabilization Period (SP)||0
7762883|NCT01412060|19113359|P2|NOT COMPLETED|Open-label Stabilization Period (SP)||0
7762884|NCT01412060|19113360|P1|NOT COMPLETED|Open-label Stabilization Period (SP)||100
7762885|NCT01412060|19113358|P3|COMPLETED|Open-label Stabilization Period (SP)||0
7762886|NCT01412060|19113359|P2|COMPLETED|Open-label Stabilization Period (SP)||0
7762887|NCT01412060|19113360|P1|COMPLETED|Open-label Stabilization Period (SP)||264
7762888|NCT01412060|19113358|P3|STARTED|Open-label Stabilization Period (SP)||0
7762889|NCT01412060|19113359|P2|STARTED|Open-label Stabilization Period (SP)||0
7762890|NCT01412060|19113360|P1|STARTED|Open-label Stabilization Period (SP)||364
7762891|NCT01412060|19113358|P3|NOT COMPLETED|Period Between RIP and SP||0
7762892|NCT01412060|19113359|P2|NOT COMPLETED|Period Between RIP and SP||0
7762893|NCT01412060|19113360|P1|NOT COMPLETED|Period Between RIP and SP||54
7762894|NCT01412060|19113358|P3|COMPLETED|Period Between RIP and SP||0
7762895|NCT01412060|19113359|P2|COMPLETED|Period Between RIP and SP||0
7762896|NCT01412060|19113360|P1|COMPLETED|Period Between RIP and SP||364
7762897|NCT01412060|19113358|P3|STARTED|Period Between RIP and SP||0
7762898|NCT01412060|19113359|P2|STARTED|Period Between RIP and SP||0
7762899|NCT01412060|19113360|P1|STARTED|Period Between RIP and SP||418
7762900|NCT01412060|19113358|P3|NOT COMPLETED|Open-label Run-in Period (RIP)||0
7762901|NCT01412060|19113359|P2|NOT COMPLETED|Open-label Run-in Period (RIP)||0
7762902|NCT01412060|19113360|P1|NOT COMPLETED|Open-label Run-in Period (RIP)||347
7762903|NCT01412060|19113358|P3|COMPLETED|Open-label Run-in Period (RIP)||0
7762904|NCT01412060|19113359|P2|COMPLETED|Open-label Run-in Period (RIP)||0
7762905|NCT01412060|19113360|P1|COMPLETED|Open-label Run-in Period (RIP)||418
7762906|NCT01412060|19113358|P3|STARTED|Open-label Run-in Period (RIP)||0
7762907|NCT01412060|19113359|P2|STARTED|Open-label Run-in Period (RIP)||0
7762908|NCT01412060|19113360|P1|STARTED|Open-label Run-in Period (RIP)||765
7762909|NCT01412021|19113370|P1|NOT COMPLETED|Overall Study||19
7762910|NCT01412021|19113370|P1|COMPLETED|Overall Study||356
7762911|NCT01412021|19113370|P1|Case Report Forms Locked|Overall Study||368
7762912|NCT01412021|19113370|P1|STARTED|Overall Study||375
7762913|NCT01411995|19113407|P2|NOT COMPLETED|Overall Study||1
7762914|NCT01411995|19113408|P1|NOT COMPLETED|Overall Study||0
7762915|NCT01411995|19113407|P2|COMPLETED|Overall Study||99
7762916|NCT01411995|19113408|P1|COMPLETED|Overall Study||100
7762917|NCT01411995|19113407|P2|STARTED|Overall Study||100
7762918|NCT01411995|19113408|P1|STARTED|Overall Study||100
7762919|NCT01411917|19113416|P2|NOT COMPLETED|Overall Study||1
7762920|NCT01411917|19113417|P1|NOT COMPLETED|Overall Study||0
7762921|NCT01411917|19113416|P2|COMPLETED|Overall Study||36
7762922|NCT01411917|19113417|P1|COMPLETED|Overall Study||32
7762923|NCT01411917|19113416|P2|STARTED|Overall Study||37
7762924|NCT01411917|19113417|P1|STARTED|Overall Study||32
7762925|NCT01411891|19113439|P2|NOT COMPLETED|Overall Study||2
7762926|NCT01411891|19113440|P1|NOT COMPLETED|Overall Study||3
7762927|NCT01411891|19113439|P2|COMPLETED|Overall Study||48
7762928|NCT01411891|19113440|P1|COMPLETED|Overall Study||47
7762929|NCT01411891|19113439|P2|STARTED|Overall Study||50
7762930|NCT01411891|19113440|P1|STARTED|Overall Study||50
7762931|NCT01411852|19113450|P2|NOT COMPLETED|Hospital Intervention Phase||18
7762932|NCT01411852|19113451|P1|NOT COMPLETED|Hospital Intervention Phase||24
7762933|NCT01411852|19113450|P2|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71
7762934|NCT01411852|19113451|P1|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59
7762935|NCT01411852|19113450|P2|STARTED|Hospital Intervention Phase||89
7762936|NCT01411852|19113451|P1|STARTED|Hospital Intervention Phase||83
7762937|NCT01411852|19113450|P2|NOT COMPLETED|Prehospital Intervention Phase||7
7762938|NCT01411852|19113451|P1|NOT COMPLETED|Prehospital Intervention Phase||12
7762939|NCT01411852|19113450|P2|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89
7762940|NCT01411852|19113451|P1|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83
7762941|NCT01411852|19113450|P2|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96
7762942|NCT01411852|19113451|P1|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95
7762943|NCT01411839|19113496|P2|NOT COMPLETED|Overall Study||3
7762944|NCT01411839|19113497|P1|NOT COMPLETED|Overall Study||4
7762945|NCT01411839|19113496|P2|COMPLETED|Overall Study||17
7762946|NCT01411839|19113497|P1|COMPLETED|Overall Study||16
7762947|NCT01411839|19113496|P2|STARTED|Overall Study||20
7762948|NCT01411839|19113497|P1|STARTED|Overall Study||20
7762949|NCT01411774|19113509|P2|NOT COMPLETED|Overall Study||3
7762950|NCT01411774|19113510|P1|NOT COMPLETED|Overall Study||0
7762951|NCT01411774|19113509|P2|COMPLETED|Overall Study||67
7762952|NCT01411774|19113510|P1|COMPLETED|Overall Study||72
7762953|NCT01411774|19113509|P2|STARTED|Overall Study||70
7762954|NCT01411774|19113510|P1|STARTED|Overall Study||72
7762955|NCT01411696|19113518|P1|NOT COMPLETED|Overall Study||0
7762956|NCT01411696|19113518|P1|COMPLETED|Overall Study||289
7762957|NCT01411696|19113518|P1|STARTED|Overall Study||289
7762958|NCT01411592|19113527|P2|NOT COMPLETED|Overall Study||0
7762959|NCT01411592|19113528|P1|NOT COMPLETED|Overall Study||0
7762960|NCT01411592|19113527|P2|COMPLETED|Overall Study||16
7762961|NCT01411592|19113528|P1|COMPLETED|Overall Study||14
7762962|NCT01411592|19113527|P2|5-Year Time Frame|Overall Study||16
7762963|NCT01411592|19113528|P1|5-Year Time Frame|Overall Study||14
7762964|NCT01411592|19113527|P2|STARTED|Overall Study||16
7762965|NCT01411592|19113528|P1|STARTED|Overall Study||14
7762966|NCT01411527|19113538|P2|NOT COMPLETED|Overall Study||0
7762967|NCT01411527|19113539|P1|NOT COMPLETED|Overall Study||0
7762968|NCT01411527|19113538|P2|COMPLETED|Overall Study||93
7762969|NCT01411527|19113539|P1|COMPLETED|Overall Study||1864
7762970|NCT01411527|19113538|P2|STARTED|Overall Study||93
7762971|NCT01411527|19113539|P1|STARTED|Overall Study||1864
7762972|NCT01411501|19113548|P4|NOT COMPLETED|Overall Study||7
7762973|NCT01411501|19113549|P3|NOT COMPLETED|Overall Study||6
7762974|NCT01411501|19113550|P2|NOT COMPLETED|Overall Study||6
7762975|NCT01411501|19113551|P1|NOT COMPLETED|Overall Study||10
7762976|NCT01411501|19113548|P4|COMPLETED|Overall Study||163
7762977|NCT01411501|19113549|P3|COMPLETED|Overall Study||159
7762978|NCT01411501|19113550|P2|COMPLETED|Overall Study||166
7762979|NCT01411501|19113551|P1|COMPLETED|Overall Study||158
7762980|NCT01411501|19113548|P4|STARTED|Overall Study||170
7762981|NCT01411501|19113549|P3|STARTED|Overall Study||165
7762982|NCT01411501|19113550|P2|STARTED|Overall Study||172
7762983|NCT01411501|19113551|P1|STARTED|Overall Study||168
7762984|NCT01411488|19113583|P2|NOT COMPLETED|Overall Study||0
7762985|NCT01411488|19113584|P1|NOT COMPLETED|Overall Study||0
7762986|NCT01411488|19113583|P2|COMPLETED|Overall Study||38
7762987|NCT01411488|19113584|P1|COMPLETED|Overall Study||41
7762988|NCT01411488|19113583|P2|STARTED|Overall Study||38
7762989|NCT01411488|19113584|P1|STARTED|Overall Study||41
7762990|NCT01411267|19113596|P10|NOT COMPLETED|Overall Study||0
7762991|NCT01411267|19113597|P9|NOT COMPLETED|Overall Study||0
7762992|NCT01411267|19113598|P8|NOT COMPLETED|Overall Study||0
7762993|NCT01411267|19113599|P7|NOT COMPLETED|Overall Study||0
7762994|NCT01411267|19113600|P6|NOT COMPLETED|Overall Study||2
7762995|NCT01411267|19113601|P5|NOT COMPLETED|Overall Study||2
7762996|NCT01411267|19113602|P4|NOT COMPLETED|Overall Study||1
7762997|NCT01411267|19113603|P3|NOT COMPLETED|Overall Study||0
7762998|NCT01411267|19113604|P2|NOT COMPLETED|Overall Study||0
7762999|NCT01411267|19113605|P1|NOT COMPLETED|Overall Study||0
7763000|NCT01411267|19113596|P10|COMPLETED|Overall Study||0
7763001|NCT01411267|19113597|P9|COMPLETED|Overall Study||0
7763002|NCT01411267|19113598|P8|COMPLETED|Overall Study||0
7763003|NCT01411267|19113599|P7|COMPLETED|Overall Study||0
7763004|NCT01411267|19113600|P6|COMPLETED|Overall Study||10
7763005|NCT01411267|19113601|P5|COMPLETED|Overall Study||0
7763006|NCT01411267|19113602|P4|COMPLETED|Overall Study||4
7763007|NCT01411267|19113603|P3|COMPLETED|Overall Study||2
7763008|NCT01411267|19113604|P2|COMPLETED|Overall Study||3
7763009|NCT01411267|19113605|P1|COMPLETED|Overall Study||0
7763010|NCT01411267|19113596|P10|STARTED|Overall Study||0
7763011|NCT01411267|19113597|P9|STARTED|Overall Study||0
7763012|NCT01411267|19113598|P8|STARTED|Overall Study||0
7763013|NCT01411267|19113599|P7|STARTED|Overall Study||0
7763014|NCT01411267|19113600|P6|STARTED|Overall Study||12
7763015|NCT01411267|19113601|P5|STARTED|Overall Study||2
7763016|NCT01411267|19113602|P4|STARTED|Overall Study||5
7763017|NCT01411267|19113603|P3|STARTED|Overall Study||2
7763018|NCT01411267|19113604|P2|STARTED|Overall Study||3
7763019|NCT01411267|19113605|P1|STARTED|Overall Study||0
7763020|NCT01411241|19113625|P2|NOT COMPLETED|Overall Study||22
7763021|NCT01411241|19113626|P1|NOT COMPLETED|Overall Study||11
7763022|NCT01411241|19113625|P2|COMPLETED|Overall Study||293
7763023|NCT01411241|19113626|P1|COMPLETED|Overall Study||298
7763024|NCT01411241|19113625|P2|STARTED|Overall Study||315
7763025|NCT01411241|19113626|P1|STARTED|Overall Study||309
7763026|NCT01411228|19113651|P3|NOT COMPLETED|Overall Study||1
7763027|NCT01411228|19113652|P2|NOT COMPLETED|Overall Study||0
7763028|NCT01411228|19113653|P1|NOT COMPLETED|Overall Study||1
7763029|NCT01411228|19113651|P3|COMPLETED|Overall Study||4
7763030|NCT01411228|19113652|P2|COMPLETED|Overall Study||5
7763031|NCT01411228|19113653|P1|COMPLETED|Overall Study||4
7763032|NCT01411228|19113651|P3|STARTED|Overall Study||5
7763033|NCT01411228|19113652|P2|STARTED|Overall Study||5
7763034|NCT01411228|19113653|P1|STARTED|Overall Study||5
7763035|NCT01411215|19113675|P2|NOT COMPLETED|Overall Study||84
7763036|NCT01411215|19113676|P1|NOT COMPLETED|Overall Study||66
7763037|NCT01411215|19113675|P2|COMPLETED|Overall Study||7
7763038|NCT01411215|19113676|P1|COMPLETED|Overall Study||3
7763039|NCT01411215|19113675|P2|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90
7763040|NCT01411215|19113676|P1|Treated|Overall Study||69
7763041|NCT01411215|19113675|P2|STARTED|Overall Study||91
7763042|NCT01411215|19113676|P1|STARTED|Overall Study||69
7763043|NCT01411137|19113709|P1|NOT COMPLETED|Part 3: Open-Label Extension||0
7763044|NCT01411137|19113709|P1|COMPLETED|Part 3: Open-Label Extension||12
7763045|NCT01411137|19113709|P1|STARTED|Part 3: Open-Label Extension|Two sites with 11 completers of Part 2 did not participate in Part 3. Two subjects lost contact.|12
7763046|NCT01411137|19113709|P1|NOT COMPLETED|Part 2: Open-Label Extension||7
7763047|NCT01411137|19113709|P1|COMPLETED|Part 2: Open-Label Extension||25
7763048|NCT01411137|19113709|P1|STARTED|Part 2: Open-Label Extension|1 subject who completed Part 1 did not elect to continue into Part 2.|32
7763049|NCT01411137|19113709|P1|NOT COMPLETED|Part 1: Dose Conversion||10
7763050|NCT01411137|19113709|P1|COMPLETED|Part 1: Dose Conversion||33
7763051|NCT01411137|19113709|P1|STARTED|Part 1: Dose Conversion||43
7763052|NCT01411085|19113728|P1|NOT COMPLETED|Overall Study||3
7763053|NCT01411085|19113728|P1|COMPLETED|Overall Study||7
7763054|NCT01411085|19113728|P1|STARTED|Overall Study||10
7763055|NCT01410812|19113735|P3|NOT COMPLETED|Overall Study||0
7763056|NCT01410812|19113736|P2|NOT COMPLETED|Overall Study||0
7763057|NCT01410812|19113737|P1|NOT COMPLETED|Overall Study||0
7763058|NCT01410812|19113735|P3|COMPLETED|Overall Study||76
7763059|NCT01410812|19113736|P2|COMPLETED|Overall Study||75
7763060|NCT01410812|19113737|P1|COMPLETED|Overall Study||75
7763061|NCT01410812|19113735|P3|STARTED|Overall Study||76
7763062|NCT01410812|19113736|P2|STARTED|Overall Study||75
7763063|NCT01410812|19113737|P1|STARTED|Overall Study||75
7763064|NCT01410799|19113748|P1|NOT COMPLETED|Overall Study||13
7763065|NCT01410799|19113748|P1|COMPLETED|Overall Study||0
7763066|NCT01410799|19113748|P1|STARTED|Overall Study||13
7763067|NCT01410773|19113757|P1|NOT COMPLETED|Overall Study||0
7763068|NCT01410773|19113757|P1|COMPLETED|Overall Study||110
7763069|NCT01410773|19113757|P1|STARTED|Overall Study||110
7763070|NCT01410604|19113764|P2|NOT COMPLETED|Overall Study||2
7763071|NCT01410604|19113765|P1|NOT COMPLETED|Overall Study||3
7763072|NCT01410604|19113764|P2|COMPLETED|Overall Study||14
7763073|NCT01410604|19113765|P1|COMPLETED|Overall Study||12
7763074|NCT01410604|19113764|P2|STARTED|Overall Study||16
7763075|NCT01410604|19113765|P1|STARTED|Overall Study||15
7763076|NCT01410565|19113787|P3|NOT COMPLETED|Double Blind Phase||0
7763077|NCT01410565|19113788|P2|NOT COMPLETED|Double Blind Phase||15
7763078|NCT01410565|19113789|P1|NOT COMPLETED|Double Blind Phase||13
7763079|NCT01410565|19113787|P3|COMPLETED|Double Blind Phase||0
7763080|NCT01410565|19113788|P2|COMPLETED|Double Blind Phase||0
7763081|NCT01410565|19113789|P1|COMPLETED|Double Blind Phase||0
7763082|NCT01410565|19113787|P3|STARTED|Double Blind Phase||0
7763083|NCT01410565|19113788|P2|STARTED|Double Blind Phase||15
7763084|NCT01410565|19113789|P1|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13
7763085|NCT01410565|19113787|P3|NOT COMPLETED|Open Label Phase Apaziquone||8
7763086|NCT01410565|19113788|P2|NOT COMPLETED|Open Label Phase Apaziquone||0
7763087|NCT01410565|19113789|P1|NOT COMPLETED|Open Label Phase Apaziquone||0
7763088|NCT01410565|19113787|P3|COMPLETED|Open Label Phase Apaziquone||58
7763089|NCT01410565|19113788|P2|COMPLETED|Open Label Phase Apaziquone||0
7763090|NCT01410565|19113789|P1|COMPLETED|Open Label Phase Apaziquone||0
7763091|NCT01410565|19113787|P3|STARTED|Open Label Phase Apaziquone||66
7763092|NCT01410565|19113788|P2|STARTED|Open Label Phase Apaziquone||0
7763093|NCT01410565|19113789|P1|STARTED|Open Label Phase Apaziquone||0
7763094|NCT01410552|19113799|P1|NOT COMPLETED|Overall Study||136
7763095|NCT01410552|19113799|P1|COMPLETED|Overall Study||877
7763096|NCT01410552|19113799|P1|STARTED|Overall Study||1013
7763097|NCT01410474|19113806|P2|NOT COMPLETED|Overall Study||1
7763098|NCT01410474|19113807|P1|NOT COMPLETED|Overall Study||0
7763099|NCT01410474|19113806|P2|COMPLETED|Overall Study||167
7763100|NCT01410474|19113807|P1|COMPLETED|Overall Study||173
7763101|NCT01410474|19113806|P2|STARTED|Overall Study||168
7763102|NCT01410474|19113807|P1|STARTED|Overall Study||173
7763103|NCT01410448|19113830|P2|NOT COMPLETED|Overall Study||35
7763104|NCT01410448|19113831|P1|NOT COMPLETED|Overall Study||12
7763105|NCT01410448|19113830|P2|COMPLETED|Overall Study||155
7763106|NCT01410448|19113831|P1|COMPLETED|Overall Study||181
7763107|NCT01410448|19113830|P2|Modified ITT Analysis Set|Overall Study||149
7763108|NCT01410448|19113831|P1|Modified ITT Analysis Set|Overall Study||161
7763109|NCT01410448|19113830|P2|Intent-to Treat (ITT) Analysis Set|Overall Study||190
7763110|NCT01410448|19113831|P1|Intent-to Treat (ITT) Analysis Set|Overall Study||193
7763111|NCT01410448|19113830|P2|STARTED|Overall Study||190
7763112|NCT01410448|19113831|P1|STARTED|Overall Study||193
7763113|NCT01410409|19113871|P2|NOT COMPLETED|Overall Study||4
7763114|NCT01410409|19113872|P1|NOT COMPLETED|Overall Study||1
7763115|NCT01410409|19113871|P2|COMPLETED|Overall Study||46
7763116|NCT01410409|19113872|P1|COMPLETED|Overall Study||49
7763117|NCT01410409|19113871|P2|STARTED|Overall Study||50
7763118|NCT01410409|19113872|P1|STARTED|Overall Study||50
7763119|NCT01410357|19113896|P2|NOT COMPLETED|Overall Study||24
7763120|NCT01410357|19113897|P1|NOT COMPLETED|Overall Study||26
7763121|NCT01410357|19113896|P2|COMPLETED|Overall Study||76
7763122|NCT01410357|19113897|P1|COMPLETED|Overall Study||74
7763123|NCT01410357|19113896|P2|STARTED|Overall Study||100
7763124|NCT01410357|19113897|P1|STARTED|Overall Study||100
7763125|NCT01410344|19113951|P1|NOT COMPLETED|Overall Study||3
7763126|NCT01410344|19113951|P1|COMPLETED|Overall Study||17
7763127|NCT01410344|19113951|P1|STARTED|Overall Study||20
7763128|NCT01410240|19113968|P3|NOT COMPLETED|Overall Study||2
7763129|NCT01410240|19113969|P2|NOT COMPLETED|Overall Study||1
7763130|NCT01410240|19113970|P1|NOT COMPLETED|Overall Study||1
7763131|NCT01410240|19113968|P3|COMPLETED|Overall Study||10
7763132|NCT01410240|19113969|P2|COMPLETED|Overall Study||52
7763133|NCT01410240|19113970|P1|COMPLETED|Overall Study||52
7763134|NCT01410240|19113968|P3|STARTED|Overall Study||12
7763135|NCT01410240|19113969|P2|STARTED|Overall Study||53
7763136|NCT01410240|19113970|P1|STARTED|Overall Study||53
7763137|NCT01410227|19114041|P4|NOT COMPLETED|Overall Study||1
7763138|NCT01410227|19114042|P3|NOT COMPLETED|Overall Study||2
7763139|NCT01410227|19114043|P2|NOT COMPLETED|Overall Study||0
7763140|NCT01410227|19114044|P1|NOT COMPLETED|Overall Study||4
7763141|NCT01410227|19114041|P4|COMPLETED|Overall Study||5
7763142|NCT01410227|19114042|P3|COMPLETED|Overall Study||13
7763143|NCT01410227|19114043|P2|COMPLETED|Overall Study||8
7763144|NCT01410227|19114044|P1|COMPLETED|Overall Study||4
7763145|NCT01410227|19114041|P4|STARTED|Overall Study||6
7763146|NCT01410227|19114042|P3|STARTED|Overall Study||15
7763147|NCT01410227|19114043|P2|STARTED|Overall Study||8
7763148|NCT01410227|19114044|P1|STARTED|Overall Study||8
7763149|NCT01410110|19114116|P2|NOT COMPLETED|Overall Study||2
7763150|NCT01410110|19114117|P1|NOT COMPLETED|Overall Study||4
7763151|NCT01410110|19114116|P2|COMPLETED|Overall Study||22
7763152|NCT01410110|19114117|P1|COMPLETED|Overall Study||20
7763153|NCT01410110|19114116|P2|6 Month Follow-up|Overall Study||22
7763154|NCT01410110|19114117|P1|6 Month Follow-up|Overall Study||20
7763155|NCT01410110|19114116|P2|3 Months (End of Intervention)|Overall Study||22
7763156|NCT01410110|19114117|P1|3 Months (End of Intervention)|Overall Study||20
7763157|NCT01410110|19114116|P2|Randomization|Overall Study||24
7763158|NCT01410110|19114117|P1|Randomization|Overall Study||24
7763159|NCT01410110|19114116|P2|STARTED|Overall Study||24
7763160|NCT01410110|19114117|P1|STARTED|Overall Study||24
7763161|NCT01410097|19114141|P2|NOT COMPLETED|Overall Study||3
7763162|NCT01410097|19114142|P1|NOT COMPLETED|Overall Study||5
7763163|NCT01410097|19114141|P2|COMPLETED|Overall Study||530
7763164|NCT01410097|19114142|P1|COMPLETED|Overall Study||551
7763165|NCT01410097|19114141|P2|STARTED|Overall Study||533
7763166|NCT01410097|19114142|P1|STARTED|Overall Study||556
7763167|NCT01410084|19114166|P2|NOT COMPLETED|Overall Study||3
7763168|NCT01410084|19114167|P1|NOT COMPLETED|Overall Study||1
7763169|NCT01410084|19114166|P2|COMPLETED|Overall Study||27
7763170|NCT01410084|19114167|P1|COMPLETED|Overall Study||37
7763171|NCT01410084|19114166|P2|STARTED|Overall Study||30
7763172|NCT01410084|19114167|P1|STARTED|Overall Study||38
7763173|NCT01410058|19114179|P2|NOT COMPLETED|Day 35||0
7763174|NCT01410058|19114180|P1|NOT COMPLETED|Day 35||0
7763175|NCT01410058|19114179|P2|COMPLETED|Day 35||6
7763176|NCT01410058|19114180|P1|COMPLETED|Day 35||13
7763177|NCT01410058|19114179|P2|STARTED|Day 35||6
7763178|NCT01410058|19114180|P1|STARTED|Day 35||13
7763179|NCT01410058|19114179|P2|NOT COMPLETED|Baseline Day 22||0
7763180|NCT01410058|19114180|P1|NOT COMPLETED|Baseline Day 22||0
7763181|NCT01410058|19114179|P2|COMPLETED|Baseline Day 22||6
7763182|NCT01410058|19114180|P1|COMPLETED|Baseline Day 22||13
7763183|NCT01410058|19114179|P2|STARTED|Baseline Day 22||6
7763184|NCT01410058|19114180|P1|STARTED|Baseline Day 22||13
7763185|NCT01410058|19114179|P2|NOT COMPLETED|Washout Day 0||0
7763186|NCT01410058|19114180|P1|NOT COMPLETED|Washout Day 0||0
7763187|NCT01410058|19114179|P2|COMPLETED|Washout Day 0||6
7763188|NCT01410058|19114180|P1|COMPLETED|Washout Day 0||13
7763189|NCT01410058|19114179|P2|STARTED|Washout Day 0||6
7763190|NCT01410058|19114180|P1|STARTED|Washout Day 0||13
7763191|NCT01409993|19114192|P4|NOT COMPLETED|Overall Study||5
7763192|NCT01409993|19114193|P3|NOT COMPLETED|Overall Study||3
7763193|NCT01409993|19114194|P2|NOT COMPLETED|Overall Study||5
7763194|NCT01409993|19114195|P1|NOT COMPLETED|Overall Study||4
7763195|NCT01409993|19114192|P4|COMPLETED|Overall Study||8
7763196|NCT01409993|19114193|P3|COMPLETED|Overall Study||11
7763197|NCT01409993|19114194|P2|COMPLETED|Overall Study||21
7763198|NCT01409993|19114195|P1|COMPLETED|Overall Study||21
7763199|NCT01409993|19114192|P4|STARTED|Overall Study||13
7763200|NCT01409993|19114193|P3|STARTED|Overall Study||14
7763201|NCT01409993|19114194|P2|STARTED|Overall Study||26
7763202|NCT01409993|19114195|P1|STARTED|Overall Study||25
7763203|NCT01409928|19114213|P1|NOT COMPLETED|Overall Study||12
7763204|NCT01409928|19114213|P1|COMPLETED|Overall Study||4
7763205|NCT01409928|19114213|P1|STARTED|Overall Study||16
7763206|NCT01409837|19114219|P2|NOT COMPLETED|Overall Study||2
7763207|NCT01409837|19114220|P1|NOT COMPLETED|Overall Study||3
7763208|NCT01409837|19114219|P2|COMPLETED|Overall Study||14
7763209|NCT01409837|19114220|P1|COMPLETED|Overall Study||14
7763210|NCT01409837|19114219|P2|282nd Week|Overall Study||14
7763211|NCT01409837|19114220|P1|282nd Week|Overall Study||14
7763212|NCT01409837|19114219|P2|186th Week|Overall Study||14
7763213|NCT01409837|19114220|P1|186th Week|Overall Study|Moved away to another location|14
7763214|NCT01409837|19114219|P2|138th Week|Overall Study||14
7763215|NCT01409837|19114220|P1|138th Week|Overall Study||15
7763216|NCT01409837|19114219|P2|114th Week|Overall Study||14
7763217|NCT01409837|19114220|P1|114th Week|Overall Study||15
7763218|NCT01409837|19114219|P2|102nd Week|Overall Study|Married another wife|14
7763219|NCT01409837|19114220|P1|102nd Week|Overall Study||15
7763220|NCT01409837|19114219|P2|96th Week|Overall Study||15
7763221|NCT01409837|19114220|P1|96th Week|Overall Study||15
7763222|NCT01409837|19114219|P2|48th Week|Overall Study||15
7763223|NCT01409837|19114220|P1|48th Week|Overall Study|Lost to follow-up|15
7763224|NCT01409837|19114219|P2|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15
7763225|NCT01409837|19114220|P1|24th Week|Overall Study||16
7763226|NCT01409837|19114219|P2|12th Week|Overall Study||16
7763227|NCT01409837|19114220|P1|12th Week|Overall Study|Moved away to another location|16
7763228|NCT01409837|19114219|P2|6th Week|Overall Study||16
7763229|NCT01409837|19114220|P1|6th Week|Overall Study||17
7763230|NCT01409837|19114219|P2|STARTED|Overall Study||16
7763231|NCT01409837|19114220|P1|STARTED|Overall Study||17
7763232|NCT01409811|19114242|P1|NOT COMPLETED|Overall Study||1
7763233|NCT01409811|19114242|P1|COMPLETED|Overall Study||8
7763234|NCT01409811|19114242|P1|STARTED|Overall Study||9
7763235|NCT01409707|19114249|P3|NOT COMPLETED|Overall Study||16
7763236|NCT01409707|19114250|P2|NOT COMPLETED|Overall Study||17
7763237|NCT01409707|19114251|P1|NOT COMPLETED|Overall Study||5
7763238|NCT01409707|19114249|P3|COMPLETED|Overall Study||24
7763239|NCT01409707|19114250|P2|COMPLETED|Overall Study||28
7763240|NCT01409707|19114251|P1|COMPLETED|Overall Study||36
7763241|NCT01409707|19114249|P3|STARTED|Overall Study||40
7763242|NCT01409707|19114250|P2|STARTED|Overall Study||45
7763243|NCT01409707|19114251|P1|STARTED|Overall Study||41
7763244|NCT01409564|19114263|P2|NOT COMPLETED|Overall Study||5
7763245|NCT01409564|19114264|P1|NOT COMPLETED|Overall Study||5
7763246|NCT01409564|19114263|P2|COMPLETED|Overall Study||18
7763247|NCT01409564|19114264|P1|COMPLETED|Overall Study||18
7763248|NCT01409564|19114263|P2|STARTED|Overall Study||23
7763249|NCT01409564|19114264|P1|STARTED|Overall Study||23
7763250|NCT01409434|19114282|P1|NOT COMPLETED|Overall Study||4
7763251|NCT01409434|19114282|P1|COMPLETED|Overall Study||40
7763252|NCT01409434|19114282|P1|STARTED|Overall Study||44
7763253|NCT01409382|19114292|P2|NOT COMPLETED|Overall Study||80
7763254|NCT01409382|19114293|P1|NOT COMPLETED|Overall Study||81
7763255|NCT01409382|19114292|P2|COMPLETED|Overall Study||160
7763256|NCT01409382|19114293|P1|COMPLETED|Overall Study||159
7763257|NCT01409382|19114292|P2|STARTED|Overall Study||240
7763258|NCT01409382|19114293|P1|STARTED|Overall Study||240
7763259|NCT01409291|19114307|P2|NOT COMPLETED|Overall Study||9
7763260|NCT01409291|19114308|P1|NOT COMPLETED|Overall Study||7
7763261|NCT01409291|19114307|P2|COMPLETED|Overall Study||19
7763262|NCT01409291|19114308|P1|COMPLETED|Overall Study||29
7763263|NCT01409291|19114307|P2|STARTED|Overall Study||28
7763264|NCT01409291|19114308|P1|STARTED|Overall Study||36
7763265|NCT01409239|19114318|P2|NOT COMPLETED|Overall Study||0
7763266|NCT01409239|19114319|P1|NOT COMPLETED|Overall Study||0
7763267|NCT01409239|19114318|P2|COMPLETED|Overall Study||17
7763268|NCT01409239|19114319|P1|COMPLETED|Overall Study||16
7763269|NCT01409239|19114318|P2|STARTED|Overall Study||17
7763270|NCT01409239|19114319|P1|STARTED|Overall Study||16
7763271|NCT01409213|19114325|P1|NOT COMPLETED|Overall Study||0
7763272|NCT01409213|19114325|P1|COMPLETED|Overall Study||1523
7763273|NCT01409213|19114325|P1|STARTED|Overall Study||1523
7763274|NCT01409096|19114332|P2|NOT COMPLETED|Overall Study||5
7763275|NCT01409096|19114333|P1|NOT COMPLETED|Overall Study||2
7763276|NCT01409096|19114332|P2|COMPLETED|Overall Study||35
7763277|NCT01409096|19114333|P1|COMPLETED|Overall Study||38
7763278|NCT01409096|19114332|P2|STARTED|Overall Study||40
7763279|NCT01409096|19114333|P1|STARTED|Overall Study||40
7763280|NCT01409031|19114347|P2|NOT COMPLETED|Overall Study||0
7763281|NCT01409031|19114348|P1|NOT COMPLETED|Overall Study||1
7763282|NCT01409031|19114347|P2|COMPLETED|Overall Study||2
7763283|NCT01409031|19114348|P1|COMPLETED|Overall Study||0
7763284|NCT01409031|19114347|P2|STARTED|Overall Study||2
7763285|NCT01409031|19114348|P1|STARTED|Overall Study||1
7763286|NCT01408992|19114364|P1|NOT COMPLETED|Overall Study||0
7763287|NCT01408992|19114364|P1|COMPLETED|Overall Study||558
7763288|NCT01408992|19114364|P1|STARTED|Overall Study||558
7763289|NCT01408914|19114379|P3|NOT COMPLETED|Overall Study||13
7763290|NCT01408914|19114380|P2|NOT COMPLETED|Overall Study||12
7763291|NCT01408914|19114381|P1|NOT COMPLETED|Overall Study||12
7763292|NCT01408914|19114379|P3|COMPLETED|Overall Study||47
7763293|NCT01408914|19114380|P2|COMPLETED|Overall Study||48
7763294|NCT01408914|19114381|P1|COMPLETED|Overall Study||48
7763295|NCT01408914|19114379|P3|STARTED|Overall Study||60
7763296|NCT01408914|19114380|P2|STARTED|Overall Study||60
7763297|NCT01408914|19114381|P1|STARTED|Overall Study||60
7763298|NCT01408901|19114399|P4|NOT COMPLETED|26-Week Follow-Up||1
7763299|NCT01408901|19114400|P3|NOT COMPLETED|26-Week Follow-Up||0
7763300|NCT01408901|19114401|P2|NOT COMPLETED|26-Week Follow-Up||2
7763301|NCT01408901|19114402|P1|NOT COMPLETED|26-Week Follow-Up||1
7763302|NCT01408901|19114399|P4|COMPLETED|26-Week Follow-Up||46
7763303|NCT01408901|19114400|P3|COMPLETED|26-Week Follow-Up||50
7763304|NCT01408901|19114401|P2|COMPLETED|26-Week Follow-Up||50
7763305|NCT01408901|19114402|P1|COMPLETED|26-Week Follow-Up||48
7763306|NCT01408901|19114399|P4|STARTED|26-Week Follow-Up||47
7763307|NCT01408901|19114400|P3|STARTED|26-Week Follow-Up||50
7763308|NCT01408901|19114401|P2|STARTED|26-Week Follow-Up||52
7763309|NCT01408901|19114402|P1|STARTED|26-Week Follow-Up||49
7763310|NCT01408901|19114399|P4|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||3
7763311|NCT01408901|19114400|P3|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||0
7763312|NCT01408901|19114401|P2|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||2
7763313|NCT01408901|19114402|P1|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||1
7763314|NCT01408901|19114399|P4|COMPLETED|12-Week Follow-Up (Primary Endpoint)||46
7763315|NCT01408901|19114400|P3|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
7763316|NCT01408901|19114401|P2|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
7763317|NCT01408901|19114402|P1|COMPLETED|12-Week Follow-Up (Primary Endpoint)||49
7763318|NCT01408901|19114399|P4|STARTED|12-Week Follow-Up (Primary Endpoint)||49
7763319|NCT01408901|19114400|P3|STARTED|12-Week Follow-Up (Primary Endpoint)||50
7763320|NCT01408901|19114401|P2|STARTED|12-Week Follow-Up (Primary Endpoint)||52
7763321|NCT01408901|19114402|P1|STARTED|12-Week Follow-Up (Primary Endpoint)||50
7763322|NCT01408901|19114399|P4|NOT COMPLETED|6-Week Follow-Up||4
7763323|NCT01408901|19114400|P3|NOT COMPLETED|6-Week Follow-Up||3
7763324|NCT01408901|19114401|P2|NOT COMPLETED|6-Week Follow-Up||2
7763325|NCT01408901|19114402|P1|NOT COMPLETED|6-Week Follow-Up||3
7763326|NCT01408901|19114399|P4|COMPLETED|6-Week Follow-Up||47
7763327|NCT01408901|19114400|P3|COMPLETED|6-Week Follow-Up||50
7763328|NCT01408901|19114401|P2|COMPLETED|6-Week Follow-Up||51
7763329|NCT01408901|19114402|P1|COMPLETED|6-Week Follow-Up||50
7763330|NCT01408901|19114399|P4|STARTED|6-Week Follow-Up||51
7763331|NCT01408901|19114400|P3|STARTED|6-Week Follow-Up||53
7763332|NCT01408901|19114401|P2|STARTED|6-Week Follow-Up||53
7763333|NCT01408901|19114402|P1|STARTED|6-Week Follow-Up||53
7763334|NCT01408888|19114428|P2|NOT COMPLETED|Second Intervention||0
7763335|NCT01408888|19114429|P1|NOT COMPLETED|Second Intervention||2
7763336|NCT01408888|19114428|P2|COMPLETED|Second Intervention||8
7763337|NCT01408888|19114429|P1|COMPLETED|Second Intervention||16
7763338|NCT01408888|19114428|P2|STARTED|Second Intervention||8
7763339|NCT01408888|19114429|P1|STARTED|Second Intervention||18
7763340|NCT01408888|19114428|P2|NOT COMPLETED|Washout of at Least 21 Days||0
7763341|NCT01408888|19114429|P1|NOT COMPLETED|Washout of at Least 21 Days||0
7763342|NCT01408888|19114428|P2|COMPLETED|Washout of at Least 21 Days||8
7763343|NCT01408888|19114429|P1|COMPLETED|Washout of at Least 21 Days||18
7763344|NCT01408888|19114428|P2|STARTED|Washout of at Least 21 Days||8
7763345|NCT01408888|19114429|P1|STARTED|Washout of at Least 21 Days||18
7763346|NCT01408888|19114428|P2|NOT COMPLETED|First Intervention||3
7763347|NCT01408888|19114429|P1|NOT COMPLETED|First Intervention||0
7763348|NCT01408888|19114428|P2|COMPLETED|First Intervention||8
7763349|NCT01408888|19114429|P1|COMPLETED|First Intervention||18
7763350|NCT01408888|19114428|P2|Received at Least 1 Dose of Drug|First Intervention||11
7763351|NCT01408888|19114429|P1|Received at Least 1 Dose of Drug|First Intervention||18
7763352|NCT01408888|19114428|P2|STARTED|First Intervention||11
7763353|NCT01408888|19114429|P1|STARTED|First Intervention||18
7763354|NCT01408862|19114452|P1|NOT COMPLETED|Overall Study||0
7763355|NCT01408862|19114452|P1|COMPLETED|Overall Study||20
7763356|NCT01408862|19114452|P1|STARTED|Overall Study||20
7763357|NCT01408732|19114457|P2|NOT COMPLETED|Overall Study||2
7763358|NCT01408732|19114458|P1|NOT COMPLETED|Overall Study||2
7763359|NCT01408732|19114457|P2|COMPLETED|Overall Study||7
7763360|NCT01408732|19114458|P1|COMPLETED|Overall Study||7
7763361|NCT01408732|19114457|P2|STARTED|Overall Study||9
7763362|NCT01408732|19114458|P1|STARTED|Overall Study||9
7763363|NCT01408719|19114484|P20|NOT COMPLETED|Fourth Intervention (35 Days)||0
7763364|NCT01408719|19114485|P19|NOT COMPLETED|Fourth Intervention (35 Days)||0
7763365|NCT01408719|19114486|P18|NOT COMPLETED|Fourth Intervention (35 Days)||0
7763366|NCT01408719|19114487|P17|NOT COMPLETED|Fourth Intervention (35 Days)||0
7763367|NCT01408719|19114488|P16|NOT COMPLETED|Fourth Intervention (35 Days)||0
7763368|NCT01408719|19114489|P15|NOT COMPLETED|Fourth Intervention (35 Days)||0
7763369|NCT01408719|19114490|P14|NOT COMPLETED|Fourth Intervention (35 Days)||0
7763370|NCT01408719|19114491|P13|NOT COMPLETED|Fourth Intervention (35 Days)||0
7763371|NCT01408719|19114492|P12|NOT COMPLETED|Fourth Intervention (35 Days)||0
7763372|NCT01408719|19114493|P11|NOT COMPLETED|Fourth Intervention (35 Days)||0
7763373|NCT01408719|19114494|P10|NOT COMPLETED|Fourth Intervention (35 Days)||0
7763374|NCT01408719|19114495|P9|NOT COMPLETED|Fourth Intervention (35 Days)||0
7763375|NCT01408719|19114496|P8|NOT COMPLETED|Fourth Intervention (35 Days)||0
7763376|NCT01408719|19114497|P7|NOT COMPLETED|Fourth Intervention (35 Days)||0
7763377|NCT01408719|19114498|P6|NOT COMPLETED|Fourth Intervention (35 Days)||0
7763378|NCT01408719|19114499|P5|NOT COMPLETED|Fourth Intervention (35 Days)||0
7763379|NCT01408719|19114500|P4|NOT COMPLETED|Fourth Intervention (35 Days)||0
7763380|NCT01408719|19114501|P3|NOT COMPLETED|Fourth Intervention (35 Days)||0
7763381|NCT01408719|19114502|P2|NOT COMPLETED|Fourth Intervention (35 Days)||0
7763382|NCT01408719|19114503|P1|NOT COMPLETED|Fourth Intervention (35 Days)||0
7763383|NCT01408719|19114484|P20|COMPLETED|Fourth Intervention (35 Days)||1
7763384|NCT01408719|19114485|P19|COMPLETED|Fourth Intervention (35 Days)||0
7763385|NCT01408719|19114486|P18|COMPLETED|Fourth Intervention (35 Days)||2
7763386|NCT01408719|19114487|P17|COMPLETED|Fourth Intervention (35 Days)||2
7763387|NCT01408719|19114488|P16|COMPLETED|Fourth Intervention (35 Days)||1
7763388|NCT01408719|19114489|P15|COMPLETED|Fourth Intervention (35 Days)||1
7763389|NCT01408719|19114490|P14|COMPLETED|Fourth Intervention (35 Days)||3
7763390|NCT01408719|19114491|P13|COMPLETED|Fourth Intervention (35 Days)||1
7763391|NCT01408719|19114492|P12|COMPLETED|Fourth Intervention (35 Days)||2
7763392|NCT01408719|19114493|P11|COMPLETED|Fourth Intervention (35 Days)||2
7763393|NCT01408719|19114494|P10|COMPLETED|Fourth Intervention (35 Days)||1
7763394|NCT01408719|19114495|P9|COMPLETED|Fourth Intervention (35 Days)||1
7763395|NCT01408719|19114496|P8|COMPLETED|Fourth Intervention (35 Days)||2
7763396|NCT01408719|19114497|P7|COMPLETED|Fourth Intervention (35 Days)||2
7763397|NCT01408719|19114498|P6|COMPLETED|Fourth Intervention (35 Days)||3
7763398|NCT01408719|19114499|P5|COMPLETED|Fourth Intervention (35 Days)||3
7763399|NCT01408719|19114500|P4|COMPLETED|Fourth Intervention (35 Days)||2
7763400|NCT01408719|19114501|P3|COMPLETED|Fourth Intervention (35 Days)||1
7763401|NCT01408719|19114502|P2|COMPLETED|Fourth Intervention (35 Days)||3
7763402|NCT01408719|19114503|P1|COMPLETED|Fourth Intervention (35 Days)||2
7763403|NCT01408719|19114484|P20|STARTED|Fourth Intervention (35 Days)||1
7763404|NCT01408719|19114485|P19|STARTED|Fourth Intervention (35 Days)||0
7763405|NCT01408719|19114486|P18|STARTED|Fourth Intervention (35 Days)||2
7763406|NCT01408719|19114487|P17|STARTED|Fourth Intervention (35 Days)||2
7763407|NCT01408719|19114488|P16|STARTED|Fourth Intervention (35 Days)||1
7763408|NCT01408719|19114489|P15|STARTED|Fourth Intervention (35 Days)||1
7763409|NCT01408719|19114490|P14|STARTED|Fourth Intervention (35 Days)||3
7763410|NCT01408719|19114491|P13|STARTED|Fourth Intervention (35 Days)||1
7763411|NCT01408719|19114492|P12|STARTED|Fourth Intervention (35 Days)||2
7763412|NCT01408719|19114493|P11|STARTED|Fourth Intervention (35 Days)||2
7763413|NCT01408719|19114494|P10|STARTED|Fourth Intervention (35 Days)||1
7763414|NCT01408719|19114495|P9|STARTED|Fourth Intervention (35 Days)||1
7763415|NCT01408719|19114496|P8|STARTED|Fourth Intervention (35 Days)||2
7763416|NCT01408719|19114497|P7|STARTED|Fourth Intervention (35 Days)||2
7763417|NCT01408719|19114498|P6|STARTED|Fourth Intervention (35 Days)||3
7763418|NCT01408719|19114499|P5|STARTED|Fourth Intervention (35 Days)||3
7763419|NCT01408719|19114500|P4|STARTED|Fourth Intervention (35 Days)||2
7763420|NCT01408719|19114501|P3|STARTED|Fourth Intervention (35 Days)||1
7763421|NCT01408719|19114502|P2|STARTED|Fourth Intervention (35 Days)||3
7763422|NCT01408719|19114503|P1|STARTED|Fourth Intervention (35 Days)||2
7763423|NCT01408719|19114484|P20|NOT COMPLETED|Washout Period (28 Days)||0
7763424|NCT01408719|19114485|P19|NOT COMPLETED|Washout Period (28 Days)||0
7763425|NCT01408719|19114486|P18|NOT COMPLETED|Washout Period (28 Days)||0
7763426|NCT01408719|19114487|P17|NOT COMPLETED|Washout Period (28 Days)||0
7763427|NCT01408719|19114488|P16|NOT COMPLETED|Washout Period (28 Days)||0
7763428|NCT01408719|19114489|P15|NOT COMPLETED|Washout Period (28 Days)||0
7763429|NCT01408719|19114490|P14|NOT COMPLETED|Washout Period (28 Days)||0
7763430|NCT01408719|19114491|P13|NOT COMPLETED|Washout Period (28 Days)||0
7763431|NCT01408719|19114492|P12|NOT COMPLETED|Washout Period (28 Days)||0
7763432|NCT01408719|19114493|P11|NOT COMPLETED|Washout Period (28 Days)||0
7763433|NCT01408719|19114494|P10|NOT COMPLETED|Washout Period (28 Days)||0
7763434|NCT01408719|19114495|P9|NOT COMPLETED|Washout Period (28 Days)||0
7763435|NCT01408719|19114496|P8|NOT COMPLETED|Washout Period (28 Days)||0
7763436|NCT01408719|19114497|P7|NOT COMPLETED|Washout Period (28 Days)||0
7763437|NCT01408719|19114498|P6|NOT COMPLETED|Washout Period (28 Days)||0
7763438|NCT01408719|19114499|P5|NOT COMPLETED|Washout Period (28 Days)||0
7763439|NCT01408719|19114500|P4|NOT COMPLETED|Washout Period (28 Days)||0
7763440|NCT01408719|19114501|P3|NOT COMPLETED|Washout Period (28 Days)||0
7763441|NCT01408719|19114502|P2|NOT COMPLETED|Washout Period (28 Days)||0
7763442|NCT01408719|19114503|P1|NOT COMPLETED|Washout Period (28 Days)||0
7763443|NCT01408719|19114484|P20|COMPLETED|Washout Period (28 Days)||1
7763444|NCT01408719|19114485|P19|COMPLETED|Washout Period (28 Days)||0
7763445|NCT01408719|19114486|P18|COMPLETED|Washout Period (28 Days)||2
7763446|NCT01408719|19114487|P17|COMPLETED|Washout Period (28 Days)||2
7763447|NCT01408719|19114488|P16|COMPLETED|Washout Period (28 Days)||1
7763448|NCT01408719|19114489|P15|COMPLETED|Washout Period (28 Days)||1
7763449|NCT01408719|19114490|P14|COMPLETED|Washout Period (28 Days)||3
7763450|NCT01408719|19114491|P13|COMPLETED|Washout Period (28 Days)||1
7763451|NCT01408719|19114492|P12|COMPLETED|Washout Period (28 Days)||2
7763452|NCT01408719|19114493|P11|COMPLETED|Washout Period (28 Days)||2
7763453|NCT01408719|19114494|P10|COMPLETED|Washout Period (28 Days)||1
7763454|NCT01408719|19114495|P9|COMPLETED|Washout Period (28 Days)||1
7763455|NCT01408719|19114496|P8|COMPLETED|Washout Period (28 Days)||2
7763456|NCT01408719|19114497|P7|COMPLETED|Washout Period (28 Days)||2
7763457|NCT01408719|19114498|P6|COMPLETED|Washout Period (28 Days)||3
7763458|NCT01408719|19114499|P5|COMPLETED|Washout Period (28 Days)||3
7763459|NCT01408719|19114500|P4|COMPLETED|Washout Period (28 Days)||2
7763460|NCT01408719|19114501|P3|COMPLETED|Washout Period (28 Days)||1
7763461|NCT01408719|19114502|P2|COMPLETED|Washout Period (28 Days)||3
7763462|NCT01408719|19114503|P1|COMPLETED|Washout Period (28 Days)||2
7763463|NCT01408719|19114484|P20|STARTED|Washout Period (28 Days)||1
7763464|NCT01408719|19114485|P19|STARTED|Washout Period (28 Days)||0
7763465|NCT01408719|19114486|P18|STARTED|Washout Period (28 Days)||2
7763466|NCT01408719|19114487|P17|STARTED|Washout Period (28 Days)||2
7763467|NCT01408719|19114488|P16|STARTED|Washout Period (28 Days)||1
7763468|NCT01408719|19114489|P15|STARTED|Washout Period (28 Days)||1
7763469|NCT01408719|19114490|P14|STARTED|Washout Period (28 Days)||3
7763470|NCT01408719|19114491|P13|STARTED|Washout Period (28 Days)||1
7763471|NCT01408719|19114492|P12|STARTED|Washout Period (28 Days)||2
7763472|NCT01408719|19114493|P11|STARTED|Washout Period (28 Days)||2
7763473|NCT01408719|19114494|P10|STARTED|Washout Period (28 Days)||1
7763474|NCT01408719|19114495|P9|STARTED|Washout Period (28 Days)||1
7763475|NCT01408719|19114496|P8|STARTED|Washout Period (28 Days)||2
7763476|NCT01408719|19114497|P7|STARTED|Washout Period (28 Days)||2
7763477|NCT01408719|19114498|P6|STARTED|Washout Period (28 Days)||3
7763478|NCT01408719|19114499|P5|STARTED|Washout Period (28 Days)||3
7763479|NCT01408719|19114500|P4|STARTED|Washout Period (28 Days)||2
7763480|NCT01408719|19114501|P3|STARTED|Washout Period (28 Days)||1
7763481|NCT01408719|19114502|P2|STARTED|Washout Period (28 Days)||3
7763482|NCT01408719|19114503|P1|STARTED|Washout Period (28 Days)||2
7763483|NCT01408719|19114484|P20|NOT COMPLETED|Third Intervention (35 Days)||0
7763484|NCT01408719|19114485|P19|NOT COMPLETED|Third Intervention (35 Days)||0
7763485|NCT01408719|19114486|P18|NOT COMPLETED|Third Intervention (35 Days)||0
7763486|NCT01408719|19114487|P17|NOT COMPLETED|Third Intervention (35 Days)||0
7763487|NCT01408719|19114488|P16|NOT COMPLETED|Third Intervention (35 Days)||0
7763488|NCT01408719|19114489|P15|NOT COMPLETED|Third Intervention (35 Days)||0
7763489|NCT01408719|19114490|P14|NOT COMPLETED|Third Intervention (35 Days)||0
7763490|NCT01408719|19114491|P13|NOT COMPLETED|Third Intervention (35 Days)||0
7763491|NCT01408719|19114492|P12|NOT COMPLETED|Third Intervention (35 Days)||0
7763492|NCT01408719|19114493|P11|NOT COMPLETED|Third Intervention (35 Days)||0
7763493|NCT01408719|19114494|P10|NOT COMPLETED|Third Intervention (35 Days)||0
7763494|NCT01408719|19114495|P9|NOT COMPLETED|Third Intervention (35 Days)||0
7763495|NCT01408719|19114496|P8|NOT COMPLETED|Third Intervention (35 Days)||1
7763496|NCT01408719|19114497|P7|NOT COMPLETED|Third Intervention (35 Days)||0
7763497|NCT01408719|19114498|P6|NOT COMPLETED|Third Intervention (35 Days)||0
7763498|NCT01408719|19114499|P5|NOT COMPLETED|Third Intervention (35 Days)||0
7763499|NCT01408719|19114500|P4|NOT COMPLETED|Third Intervention (35 Days)||0
7763500|NCT01408719|19114501|P3|NOT COMPLETED|Third Intervention (35 Days)||0
7763501|NCT01408719|19114502|P2|NOT COMPLETED|Third Intervention (35 Days)||0
7763502|NCT01408719|19114503|P1|NOT COMPLETED|Third Intervention (35 Days)||0
7763503|NCT01408719|19114484|P20|COMPLETED|Third Intervention (35 Days)||1
7763504|NCT01408719|19114485|P19|COMPLETED|Third Intervention (35 Days)||0
7763505|NCT01408719|19114486|P18|COMPLETED|Third Intervention (35 Days)||2
7763506|NCT01408719|19114487|P17|COMPLETED|Third Intervention (35 Days)||2
7763507|NCT01408719|19114488|P16|COMPLETED|Third Intervention (35 Days)||1
7763508|NCT01408719|19114489|P15|COMPLETED|Third Intervention (35 Days)||1
7763509|NCT01408719|19114490|P14|COMPLETED|Third Intervention (35 Days)||3
7763510|NCT01408719|19114491|P13|COMPLETED|Third Intervention (35 Days)||2
7763511|NCT01408719|19114492|P12|COMPLETED|Third Intervention (35 Days)||2
7763512|NCT01408719|19114493|P11|COMPLETED|Third Intervention (35 Days)||2
7763513|NCT01408719|19114494|P10|COMPLETED|Third Intervention (35 Days)||1
7763514|NCT01408719|19114495|P9|COMPLETED|Third Intervention (35 Days)||1
7763515|NCT01408719|19114496|P8|COMPLETED|Third Intervention (35 Days)||2
7763516|NCT01408719|19114497|P7|COMPLETED|Third Intervention (35 Days)||2
7763517|NCT01408719|19114498|P6|COMPLETED|Third Intervention (35 Days)||3
7763518|NCT01408719|19114499|P5|COMPLETED|Third Intervention (35 Days)||3
7763519|NCT01408719|19114500|P4|COMPLETED|Third Intervention (35 Days)||2
7763520|NCT01408719|19114501|P3|COMPLETED|Third Intervention (35 Days)||1
7763521|NCT01408719|19114502|P2|COMPLETED|Third Intervention (35 Days)||3
7763522|NCT01408719|19114503|P1|COMPLETED|Third Intervention (35 Days)||2
7763523|NCT01408719|19114484|P20|STARTED|Third Intervention (35 Days)||1
7763524|NCT01408719|19114485|P19|STARTED|Third Intervention (35 Days)||0
7763525|NCT01408719|19114486|P18|STARTED|Third Intervention (35 Days)||2
7763526|NCT01408719|19114487|P17|STARTED|Third Intervention (35 Days)||2
7763527|NCT01408719|19114488|P16|STARTED|Third Intervention (35 Days)||1
7763528|NCT01408719|19114489|P15|STARTED|Third Intervention (35 Days)||1
7763529|NCT01408719|19114490|P14|STARTED|Third Intervention (35 Days)||3
7763530|NCT01408719|19114491|P13|STARTED|Third Intervention (35 Days)||2
7763531|NCT01408719|19114492|P12|STARTED|Third Intervention (35 Days)||2
7763532|NCT01408719|19114493|P11|STARTED|Third Intervention (35 Days)||2
7763533|NCT01408719|19114494|P10|STARTED|Third Intervention (35 Days)||1
7763534|NCT01408719|19114495|P9|STARTED|Third Intervention (35 Days)||1
7763535|NCT01408719|19114496|P8|STARTED|Third Intervention (35 Days)||3
7763536|NCT01408719|19114497|P7|STARTED|Third Intervention (35 Days)||2
7763537|NCT01408719|19114498|P6|STARTED|Third Intervention (35 Days)||3
7763538|NCT01408719|19114499|P5|STARTED|Third Intervention (35 Days)||3
7763539|NCT01408719|19114500|P4|STARTED|Third Intervention (35 Days)||2
7763540|NCT01408719|19114501|P3|STARTED|Third Intervention (35 Days)||1
7763541|NCT01408719|19114502|P2|STARTED|Third Intervention (35 Days)||3
7763542|NCT01408719|19114503|P1|STARTED|Third Intervention (35 Days)||2
7763543|NCT01408719|19114484|P20|NOT COMPLETED|Washout Period (28 Days)||0
7763544|NCT01408719|19114485|P19|NOT COMPLETED|Washout Period (28 Days)||0
7763545|NCT01408719|19114486|P18|NOT COMPLETED|Washout Period (28 Days)||0
7763546|NCT01408719|19114487|P17|NOT COMPLETED|Washout Period (28 Days)||0
7763547|NCT01408719|19114488|P16|NOT COMPLETED|Washout Period (28 Days)||0
7763548|NCT01408719|19114489|P15|NOT COMPLETED|Washout Period (28 Days)||0
7763549|NCT01408719|19114490|P14|NOT COMPLETED|Washout Period (28 Days)||0
7763550|NCT01408719|19114491|P13|NOT COMPLETED|Washout Period (28 Days)||0
7763551|NCT01408719|19114492|P12|NOT COMPLETED|Washout Period (28 Days)||0
7763552|NCT01408719|19114493|P11|NOT COMPLETED|Washout Period (28 Days)||0
7763553|NCT01408719|19114494|P10|NOT COMPLETED|Washout Period (28 Days)||0
7763554|NCT01408719|19114495|P9|NOT COMPLETED|Washout Period (28 Days)||0
7763555|NCT01408719|19114496|P8|NOT COMPLETED|Washout Period (28 Days)||0
7763556|NCT01408719|19114497|P7|NOT COMPLETED|Washout Period (28 Days)||0
7763557|NCT01408719|19114498|P6|NOT COMPLETED|Washout Period (28 Days)||0
7763558|NCT01408719|19114499|P5|NOT COMPLETED|Washout Period (28 Days)||0
7763559|NCT01408719|19114500|P4|NOT COMPLETED|Washout Period (28 Days)||0
7763560|NCT01408719|19114501|P3|NOT COMPLETED|Washout Period (28 Days)||0
7763561|NCT01408719|19114502|P2|NOT COMPLETED|Washout Period (28 Days)||0
7763562|NCT01408719|19114503|P1|NOT COMPLETED|Washout Period (28 Days)||0
7763563|NCT01408719|19114484|P20|COMPLETED|Washout Period (28 Days)||1
7763564|NCT01408719|19114485|P19|COMPLETED|Washout Period (28 Days)||0
7763565|NCT01408719|19114486|P18|COMPLETED|Washout Period (28 Days)||2
7763566|NCT01408719|19114487|P17|COMPLETED|Washout Period (28 Days)||2
7763567|NCT01408719|19114488|P16|COMPLETED|Washout Period (28 Days)||1
7763568|NCT01408719|19114489|P15|COMPLETED|Washout Period (28 Days)||1
7763569|NCT01408719|19114490|P14|COMPLETED|Washout Period (28 Days)||3
7763570|NCT01408719|19114491|P13|COMPLETED|Washout Period (28 Days)||2
7763571|NCT01408719|19114492|P12|COMPLETED|Washout Period (28 Days)||2
7763572|NCT01408719|19114493|P11|COMPLETED|Washout Period (28 Days)||2
7763573|NCT01408719|19114494|P10|COMPLETED|Washout Period (28 Days)||1
7763574|NCT01408719|19114495|P9|COMPLETED|Washout Period (28 Days)||1
7763575|NCT01408719|19114496|P8|COMPLETED|Washout Period (28 Days)||3
7763576|NCT01408719|19114497|P7|COMPLETED|Washout Period (28 Days)||2
7763577|NCT01408719|19114498|P6|COMPLETED|Washout Period (28 Days)||3
7763578|NCT01408719|19114499|P5|COMPLETED|Washout Period (28 Days)||3
7763579|NCT01408719|19114500|P4|COMPLETED|Washout Period (28 Days)||2
7763580|NCT01408719|19114501|P3|COMPLETED|Washout Period (28 Days)||1
7763581|NCT01408719|19114502|P2|COMPLETED|Washout Period (28 Days)||3
7763582|NCT01408719|19114503|P1|COMPLETED|Washout Period (28 Days)||2
7763583|NCT01408719|19114484|P20|STARTED|Washout Period (28 Days)||1
7763584|NCT01408719|19114485|P19|STARTED|Washout Period (28 Days)||0
7763585|NCT01408719|19114486|P18|STARTED|Washout Period (28 Days)||2
7763586|NCT01408719|19114487|P17|STARTED|Washout Period (28 Days)||2
7763587|NCT01408719|19114488|P16|STARTED|Washout Period (28 Days)||1
7763588|NCT01408719|19114489|P15|STARTED|Washout Period (28 Days)||1
7763589|NCT01408719|19114490|P14|STARTED|Washout Period (28 Days)||3
7763590|NCT01408719|19114491|P13|STARTED|Washout Period (28 Days)||2
7763591|NCT01408719|19114492|P12|STARTED|Washout Period (28 Days)||2
7763592|NCT01408719|19114493|P11|STARTED|Washout Period (28 Days)||2
7763593|NCT01408719|19114494|P10|STARTED|Washout Period (28 Days)||1
7763594|NCT01408719|19114495|P9|STARTED|Washout Period (28 Days)||1
7763595|NCT01408719|19114496|P8|STARTED|Washout Period (28 Days)||3
7763596|NCT01408719|19114497|P7|STARTED|Washout Period (28 Days)||2
7763597|NCT01408719|19114498|P6|STARTED|Washout Period (28 Days)||3
7763598|NCT01408719|19114499|P5|STARTED|Washout Period (28 Days)||3
7763599|NCT01408719|19114500|P4|STARTED|Washout Period (28 Days)||2
7763600|NCT01408719|19114501|P3|STARTED|Washout Period (28 Days)||1
7763601|NCT01408719|19114502|P2|STARTED|Washout Period (28 Days)||3
7763602|NCT01408719|19114503|P1|STARTED|Washout Period (28 Days)||2
7763603|NCT01408719|19114484|P20|NOT COMPLETED|Second Intervention (35 Days)||0
7763604|NCT01408719|19114485|P19|NOT COMPLETED|Second Intervention (35 Days)||0
7763605|NCT01408719|19114486|P18|NOT COMPLETED|Second Intervention (35 Days)||0
7763606|NCT01408719|19114487|P17|NOT COMPLETED|Second Intervention (35 Days)||0
7763607|NCT01408719|19114488|P16|NOT COMPLETED|Second Intervention (35 Days)||0
7763608|NCT01408719|19114489|P15|NOT COMPLETED|Second Intervention (35 Days)||0
7763609|NCT01408719|19114490|P14|NOT COMPLETED|Second Intervention (35 Days)||1
7763610|NCT01408719|19114491|P13|NOT COMPLETED|Second Intervention (35 Days)||0
7763611|NCT01408719|19114492|P12|NOT COMPLETED|Second Intervention (35 Days)||0
7763612|NCT01408719|19114493|P11|NOT COMPLETED|Second Intervention (35 Days)||0
7763613|NCT01408719|19114494|P10|NOT COMPLETED|Second Intervention (35 Days)||0
7763614|NCT01408719|19114495|P9|NOT COMPLETED|Second Intervention (35 Days)||0
7763615|NCT01408719|19114496|P8|NOT COMPLETED|Second Intervention (35 Days)||0
7763616|NCT01408719|19114497|P7|NOT COMPLETED|Second Intervention (35 Days)||0
7763617|NCT01408719|19114498|P6|NOT COMPLETED|Second Intervention (35 Days)||0
7763618|NCT01408719|19114499|P5|NOT COMPLETED|Second Intervention (35 Days)||0
7763619|NCT01408719|19114500|P4|NOT COMPLETED|Second Intervention (35 Days)||0
7763620|NCT01408719|19114501|P3|NOT COMPLETED|Second Intervention (35 Days)||0
7763621|NCT01408719|19114502|P2|NOT COMPLETED|Second Intervention (35 Days)||0
7763622|NCT01408719|19114503|P1|NOT COMPLETED|Second Intervention (35 Days)||0
7763623|NCT01408719|19114484|P20|COMPLETED|Second Intervention (35 Days)||1
7763624|NCT01408719|19114485|P19|COMPLETED|Second Intervention (35 Days)||0
7763625|NCT01408719|19114486|P18|COMPLETED|Second Intervention (35 Days)||2
7763626|NCT01408719|19114487|P17|COMPLETED|Second Intervention (35 Days)||2
7763627|NCT01408719|19114488|P16|COMPLETED|Second Intervention (35 Days)||2
7763628|NCT01408719|19114489|P15|COMPLETED|Second Intervention (35 Days)||1
7763629|NCT01408719|19114490|P14|COMPLETED|Second Intervention (35 Days)||3
7763630|NCT01408719|19114491|P13|COMPLETED|Second Intervention (35 Days)||2
7763631|NCT01408719|19114492|P12|COMPLETED|Second Intervention (35 Days)||2
7763632|NCT01408719|19114493|P11|COMPLETED|Second Intervention (35 Days)||2
7763633|NCT01408719|19114494|P10|COMPLETED|Second Intervention (35 Days)||1
7763634|NCT01408719|19114495|P9|COMPLETED|Second Intervention (35 Days)||1
7763635|NCT01408719|19114496|P8|COMPLETED|Second Intervention (35 Days)||3
7763636|NCT01408719|19114497|P7|COMPLETED|Second Intervention (35 Days)||2
7763637|NCT01408719|19114498|P6|COMPLETED|Second Intervention (35 Days)||3
7763638|NCT01408719|19114499|P5|COMPLETED|Second Intervention (35 Days)||3
7763639|NCT01408719|19114500|P4|COMPLETED|Second Intervention (35 Days)||2
7763640|NCT01408719|19114501|P3|COMPLETED|Second Intervention (35 Days)||1
7763641|NCT01408719|19114502|P2|COMPLETED|Second Intervention (35 Days)||3
7763642|NCT01408719|19114503|P1|COMPLETED|Second Intervention (35 Days)||2
7763643|NCT01408719|19114484|P20|STARTED|Second Intervention (35 Days)||1
7763644|NCT01408719|19114485|P19|STARTED|Second Intervention (35 Days)||0
7763645|NCT01408719|19114486|P18|STARTED|Second Intervention (35 Days)||2
7763646|NCT01408719|19114487|P17|STARTED|Second Intervention (35 Days)||2
7763647|NCT01408719|19114488|P16|STARTED|Second Intervention (35 Days)||2
7763648|NCT01408719|19114489|P15|STARTED|Second Intervention (35 Days)||1
7763649|NCT01408719|19114490|P14|STARTED|Second Intervention (35 Days)||4
7763650|NCT01408719|19114491|P13|STARTED|Second Intervention (35 Days)||2
7763651|NCT01408719|19114492|P12|STARTED|Second Intervention (35 Days)||2
7763652|NCT01408719|19114493|P11|STARTED|Second Intervention (35 Days)||2
7763653|NCT01408719|19114494|P10|STARTED|Second Intervention (35 Days)||1
7763654|NCT01408719|19114495|P9|STARTED|Second Intervention (35 Days)||1
7763655|NCT01408719|19114496|P8|STARTED|Second Intervention (35 Days)||3
7763656|NCT01408719|19114497|P7|STARTED|Second Intervention (35 Days)||2
7763657|NCT01408719|19114498|P6|STARTED|Second Intervention (35 Days)||3
7763658|NCT01408719|19114499|P5|STARTED|Second Intervention (35 Days)||3
7763659|NCT01408719|19114500|P4|STARTED|Second Intervention (35 Days)||2
7763660|NCT01408719|19114501|P3|STARTED|Second Intervention (35 Days)||1
7763661|NCT01408719|19114502|P2|STARTED|Second Intervention (35 Days)||3
7763662|NCT01408719|19114503|P1|STARTED|Second Intervention (35 Days)||2
7763663|NCT01408719|19114484|P20|NOT COMPLETED|Washout Period (28 Days)||0
7763664|NCT01408719|19114485|P19|NOT COMPLETED|Washout Period (28 Days)||0
7763665|NCT01408719|19114486|P18|NOT COMPLETED|Washout Period (28 Days)||0
7763666|NCT01408719|19114487|P17|NOT COMPLETED|Washout Period (28 Days)||0
7763667|NCT01408719|19114488|P16|NOT COMPLETED|Washout Period (28 Days)||0
7763668|NCT01408719|19114489|P15|NOT COMPLETED|Washout Period (28 Days)||0
7763669|NCT01408719|19114490|P14|NOT COMPLETED|Washout Period (28 Days)||0
7763670|NCT01408719|19114491|P13|NOT COMPLETED|Washout Period (28 Days)||0
7763671|NCT01408719|19114492|P12|NOT COMPLETED|Washout Period (28 Days)||0
7763672|NCT01408719|19114493|P11|NOT COMPLETED|Washout Period (28 Days)||0
7763673|NCT01408719|19114494|P10|NOT COMPLETED|Washout Period (28 Days)||0
7763674|NCT01408719|19114495|P9|NOT COMPLETED|Washout Period (28 Days)||0
7763675|NCT01408719|19114496|P8|NOT COMPLETED|Washout Period (28 Days)||0
7763676|NCT01408719|19114497|P7|NOT COMPLETED|Washout Period (28 Days)||0
7763677|NCT01408719|19114498|P6|NOT COMPLETED|Washout Period (28 Days)||0
7763678|NCT01408719|19114499|P5|NOT COMPLETED|Washout Period (28 Days)||0
7763679|NCT01408719|19114500|P4|NOT COMPLETED|Washout Period (28 Days)||0
7763680|NCT01408719|19114501|P3|NOT COMPLETED|Washout Period (28 Days)||0
7763681|NCT01408719|19114502|P2|NOT COMPLETED|Washout Period (28 Days)||0
7763682|NCT01408719|19114503|P1|NOT COMPLETED|Washout Period (28 Days)||0
7763683|NCT01408719|19114484|P20|COMPLETED|Washout Period (28 Days)||1
7763684|NCT01408719|19114485|P19|COMPLETED|Washout Period (28 Days)||0
7763685|NCT01408719|19114486|P18|COMPLETED|Washout Period (28 Days)||2
7763686|NCT01408719|19114487|P17|COMPLETED|Washout Period (28 Days)||2
7763687|NCT01408719|19114488|P16|COMPLETED|Washout Period (28 Days)||2
7763688|NCT01408719|19114489|P15|COMPLETED|Washout Period (28 Days)||1
7763689|NCT01408719|19114490|P14|COMPLETED|Washout Period (28 Days)||4
7763690|NCT01408719|19114491|P13|COMPLETED|Washout Period (28 Days)||2
7763691|NCT01408719|19114492|P12|COMPLETED|Washout Period (28 Days)||2
7763692|NCT01408719|19114493|P11|COMPLETED|Washout Period (28 Days)||2
7763693|NCT01408719|19114494|P10|COMPLETED|Washout Period (28 Days)||1
7763694|NCT01408719|19114495|P9|COMPLETED|Washout Period (28 Days)||1
7763695|NCT01408719|19114496|P8|COMPLETED|Washout Period (28 Days)||3
7763696|NCT01408719|19114497|P7|COMPLETED|Washout Period (28 Days)||2
7763697|NCT01408719|19114498|P6|COMPLETED|Washout Period (28 Days)||3
7763698|NCT01408719|19114499|P5|COMPLETED|Washout Period (28 Days)||3
7763699|NCT01408719|19114500|P4|COMPLETED|Washout Period (28 Days)||2
7763700|NCT01408719|19114501|P3|COMPLETED|Washout Period (28 Days)||1
7763701|NCT01408719|19114502|P2|COMPLETED|Washout Period (28 Days)||3
7763702|NCT01408719|19114503|P1|COMPLETED|Washout Period (28 Days)||2
7763703|NCT01408719|19114484|P20|STARTED|Washout Period (28 Days)||1
7763704|NCT01408719|19114485|P19|STARTED|Washout Period (28 Days)||0
7763705|NCT01408719|19114486|P18|STARTED|Washout Period (28 Days)||2
7763706|NCT01408719|19114487|P17|STARTED|Washout Period (28 Days)||2
7763707|NCT01408719|19114488|P16|STARTED|Washout Period (28 Days)||2
7763708|NCT01408719|19114489|P15|STARTED|Washout Period (28 Days)||1
7763709|NCT01408719|19114490|P14|STARTED|Washout Period (28 Days)||4
7763710|NCT01408719|19114491|P13|STARTED|Washout Period (28 Days)||2
7763711|NCT01408719|19114492|P12|STARTED|Washout Period (28 Days)||2
7763712|NCT01408719|19114493|P11|STARTED|Washout Period (28 Days)||2
7763713|NCT01408719|19114494|P10|STARTED|Washout Period (28 Days)||1
7763714|NCT01408719|19114495|P9|STARTED|Washout Period (28 Days)||1
7763715|NCT01408719|19114496|P8|STARTED|Washout Period (28 Days)||3
7763716|NCT01408719|19114497|P7|STARTED|Washout Period (28 Days)||2
7763717|NCT01408719|19114498|P6|STARTED|Washout Period (28 Days)||3
7763718|NCT01408719|19114499|P5|STARTED|Washout Period (28 Days)||3
7763719|NCT01408719|19114500|P4|STARTED|Washout Period (28 Days)||2
7763720|NCT01408719|19114501|P3|STARTED|Washout Period (28 Days)||1
7763721|NCT01408719|19114502|P2|STARTED|Washout Period (28 Days)||3
7763722|NCT01408719|19114503|P1|STARTED|Washout Period (28 Days)||2
7763723|NCT01408719|19114484|P20|NOT COMPLETED|First Intervention (35 Days)||0
7763724|NCT01408719|19114485|P19|NOT COMPLETED|First Intervention (35 Days)||1
7763725|NCT01408719|19114486|P18|NOT COMPLETED|First Intervention (35 Days)||0
7763726|NCT01408719|19114487|P17|NOT COMPLETED|First Intervention (35 Days)||1
7763727|NCT01408719|19114488|P16|NOT COMPLETED|First Intervention (35 Days)||0
7763728|NCT01408719|19114489|P15|NOT COMPLETED|First Intervention (35 Days)||0
7763729|NCT01408719|19114490|P14|NOT COMPLETED|First Intervention (35 Days)||1
7763730|NCT01408719|19114491|P13|NOT COMPLETED|First Intervention (35 Days)||0
7763731|NCT01408719|19114492|P12|NOT COMPLETED|First Intervention (35 Days)||0
7763732|NCT01408719|19114493|P11|NOT COMPLETED|First Intervention (35 Days)||0
7763733|NCT01408719|19114494|P10|NOT COMPLETED|First Intervention (35 Days)||0
7763734|NCT01408719|19114495|P9|NOT COMPLETED|First Intervention (35 Days)||1
7763735|NCT01408719|19114496|P8|NOT COMPLETED|First Intervention (35 Days)||0
7763736|NCT01408719|19114497|P7|NOT COMPLETED|First Intervention (35 Days)||0
7763737|NCT01408719|19114498|P6|NOT COMPLETED|First Intervention (35 Days)||0
7763738|NCT01408719|19114499|P5|NOT COMPLETED|First Intervention (35 Days)||1
7763739|NCT01408719|19114500|P4|NOT COMPLETED|First Intervention (35 Days)||0
7763740|NCT01408719|19114501|P3|NOT COMPLETED|First Intervention (35 Days)||1
7763741|NCT01408719|19114502|P2|NOT COMPLETED|First Intervention (35 Days)||0
7763742|NCT01408719|19114503|P1|NOT COMPLETED|First Intervention (35 Days)||0
7763743|NCT01408719|19114484|P20|COMPLETED|First Intervention (35 Days)||1
7763744|NCT01408719|19114485|P19|COMPLETED|First Intervention (35 Days)||0
7763745|NCT01408719|19114486|P18|COMPLETED|First Intervention (35 Days)||2
7763746|NCT01408719|19114487|P17|COMPLETED|First Intervention (35 Days)||2
7763747|NCT01408719|19114488|P16|COMPLETED|First Intervention (35 Days)||2
7763748|NCT01408719|19114489|P15|COMPLETED|First Intervention (35 Days)||1
7763749|NCT01408719|19114490|P14|COMPLETED|First Intervention (35 Days)||4
7763750|NCT01408719|19114491|P13|COMPLETED|First Intervention (35 Days)||2
7763751|NCT01408719|19114492|P12|COMPLETED|First Intervention (35 Days)||2
7763752|NCT01408719|19114493|P11|COMPLETED|First Intervention (35 Days)||2
7763753|NCT01408719|19114494|P10|COMPLETED|First Intervention (35 Days)||1
7763754|NCT01408719|19114495|P9|COMPLETED|First Intervention (35 Days)||1
7763755|NCT01408719|19114496|P8|COMPLETED|First Intervention (35 Days)||3
7763756|NCT01408719|19114497|P7|COMPLETED|First Intervention (35 Days)||2
7763757|NCT01408719|19114498|P6|COMPLETED|First Intervention (35 Days)||3
7763758|NCT01408719|19114499|P5|COMPLETED|First Intervention (35 Days)||3
7763759|NCT01408719|19114500|P4|COMPLETED|First Intervention (35 Days)||2
7763760|NCT01408719|19114501|P3|COMPLETED|First Intervention (35 Days)||1
7763761|NCT01408719|19114502|P2|COMPLETED|First Intervention (35 Days)||3
7763762|NCT01408719|19114503|P1|COMPLETED|First Intervention (35 Days)||2
7763763|NCT01408719|19114484|P20|STARTED|First Intervention (35 Days)||1
7763764|NCT01408719|19114485|P19|STARTED|First Intervention (35 Days)||1
7763765|NCT01408719|19114486|P18|STARTED|First Intervention (35 Days)||2
7763766|NCT01408719|19114487|P17|STARTED|First Intervention (35 Days)||3
7763767|NCT01408719|19114488|P16|STARTED|First Intervention (35 Days)||2
7763768|NCT01408719|19114489|P15|STARTED|First Intervention (35 Days)||1
7763769|NCT01408719|19114490|P14|STARTED|First Intervention (35 Days)||5
7763770|NCT01408719|19114491|P13|STARTED|First Intervention (35 Days)||2
7763771|NCT01408719|19114492|P12|STARTED|First Intervention (35 Days)||2
7763772|NCT01408719|19114493|P11|STARTED|First Intervention (35 Days)||2
7763773|NCT01408719|19114494|P10|STARTED|First Intervention (35 Days)||1
7763774|NCT01408719|19114495|P9|STARTED|First Intervention (35 Days)||2
7763775|NCT01408719|19114496|P8|STARTED|First Intervention (35 Days)||3
7763776|NCT01408719|19114497|P7|STARTED|First Intervention (35 Days)||2
7763777|NCT01408719|19114498|P6|STARTED|First Intervention (35 Days)||3
7763778|NCT01408719|19114499|P5|STARTED|First Intervention (35 Days)||4
7763779|NCT01408719|19114500|P4|STARTED|First Intervention (35 Days)||2
7763780|NCT01408719|19114501|P3|STARTED|First Intervention (35 Days)||2
7763781|NCT01408719|19114502|P2|STARTED|First Intervention (35 Days)||3
7763782|NCT01408719|19114503|P1|STARTED|First Intervention (35 Days)||2
7763783|NCT01408706|19114515|P2|NOT COMPLETED|Overall Study||0
7763784|NCT01408706|19114516|P1|NOT COMPLETED|Overall Study||1
7763785|NCT01408706|19114515|P2|COMPLETED|Overall Study||30
7763786|NCT01408706|19114516|P1|COMPLETED|Overall Study||29
7763787|NCT01408706|19114515|P2|STARTED|Overall Study||30
7763788|NCT01408706|19114516|P1|STARTED|Overall Study||30
7763789|NCT01408641|19114528|P2|NOT COMPLETED|Overall Study||0
7763790|NCT01408641|19114529|P1|NOT COMPLETED|Overall Study||1
7763791|NCT01408641|19114528|P2|COMPLETED|Overall Study||0
7763792|NCT01408641|19114529|P1|COMPLETED|Overall Study||0
7763793|NCT01408641|19114528|P2|STARTED|Overall Study||0
7763794|NCT01408641|19114529|P1|STARTED|Overall Study||1
7763795|NCT01408628|19114537|P1|NOT COMPLETED|Completed 6 Month Follow-Up||14
7763796|NCT01408628|19114537|P1|COMPLETED|Completed 6 Month Follow-Up||25
7763797|NCT01408628|19114537|P1|STARTED|Completed 6 Month Follow-Up||39
7763798|NCT01408628|19114537|P1|NOT COMPLETED|Started Classes/Intervention||0
7763799|NCT01408628|19114537|P1|COMPLETED|Started Classes/Intervention||39
7763800|NCT01408628|19114537|P1|STARTED|Started Classes/Intervention||39
7763801|NCT01408628|19114537|P1|NOT COMPLETED|Consented||12
7763802|NCT01408628|19114537|P1|COMPLETED|Consented||39
7763803|NCT01408628|19114537|P1|STARTED|Consented||51
7763804|NCT01408576|19114546|P3|NOT COMPLETED|Overall Study||508
7763805|NCT01408576|19114547|P2|NOT COMPLETED|Overall Study||498
7763806|NCT01408576|19114548|P1|NOT COMPLETED|Overall Study||188
7763807|NCT01408576|19114546|P3|COMPLETED|Overall Study||0
7763808|NCT01408576|19114547|P2|COMPLETED|Overall Study||0
7763809|NCT01408576|19114548|P1|COMPLETED|Overall Study||56
7763810|NCT01408576|19114546|P3|STARTED|Overall Study||508
7763811|NCT01408576|19114547|P2|STARTED|Overall Study||498
7763812|NCT01408576|19114548|P1|STARTED|Overall Study||244
7763813|NCT01408563|19114595|P1|NOT COMPLETED|Overall Study||2
7763814|NCT01408563|19114595|P1|COMPLETED|Overall Study||31
7763815|NCT01408563|19114595|P1|Received Transplant|Overall Study||31
7763816|NCT01408563|19114595|P1|STARTED|Overall Study||33
7763817|NCT01408537|19114611|P1|NOT COMPLETED|Overall Study||8
7763818|NCT01408537|19114611|P1|COMPLETED|Overall Study||144
7763819|NCT01408537|19114611|P1|STARTED|Overall Study||152
7763820|NCT01408485|19114627|P1|NOT COMPLETED|Overall Study||21
7763821|NCT01408485|19114627|P1|COMPLETED|Overall Study||179
7763822|NCT01408485|19114627|P1|STARTED|Overall Study||200
7763823|NCT01408329|19114635|P2|NOT COMPLETED|Overall Study||4
7763824|NCT01408329|19114636|P1|NOT COMPLETED|Overall Study||3
7763825|NCT01408329|19114635|P2|COMPLETED|Overall Study||11
7763826|NCT01408329|19114636|P1|COMPLETED|Overall Study||10
7763827|NCT01408329|19114635|P2|STARTED|Overall Study||15
7763828|NCT01408329|19114636|P1|STARTED|Overall Study||13
7763829|NCT01408303|19114645|P3|NOT COMPLETED|Overall Study||6
7763830|NCT01408303|19114646|P2|NOT COMPLETED|Overall Study||12
7763831|NCT01408303|19114647|P1|NOT COMPLETED|Overall Study||6
7763832|NCT01408303|19114645|P3|COMPLETED|Overall Study||210
7763833|NCT01408303|19114646|P2|COMPLETED|Overall Study||204
7763834|NCT01408303|19114647|P1|COMPLETED|Overall Study||209
7763835|NCT01408303|19114645|P3|STARTED|Overall Study||216
7763836|NCT01408303|19114646|P2|STARTED|Overall Study||216
7763837|NCT01408303|19114647|P1|STARTED|Overall Study||215
7763838|NCT01408277|19114657|P2|NOT COMPLETED|Overall Study||4
7763839|NCT01408277|19114658|P1|NOT COMPLETED|Overall Study||8
7763840|NCT01408277|19114657|P2|COMPLETED|Overall Study||23
7763841|NCT01408277|19114658|P1|COMPLETED|Overall Study||20
7763842|NCT01408277|19114657|P2|STARTED|Overall Study||27
7763843|NCT01408277|19114658|P1|STARTED|Overall Study||28
7763844|NCT01408147|19114666|P2|NOT COMPLETED|Overall Study||1
7763845|NCT01408147|19114667|P1|NOT COMPLETED|Overall Study||0
7763846|NCT01408147|19114666|P2|COMPLETED|Overall Study||196
7763847|NCT01408147|19114667|P1|COMPLETED|Overall Study|1 clinic withdrew due to low census|174
7763848|NCT01408147|19114666|P2|STARTED|Overall Study|197 participants|197
7763849|NCT01408147|19114667|P1|STARTED|Overall Study|174 participants|174
7763850|NCT01408043|19114675|P1|NOT COMPLETED|Overall Study||1
7763851|NCT01408043|19114675|P1|COMPLETED|Overall Study||24
7763852|NCT01408043|19114675|P1|STARTED|Overall Study||25
7763853|NCT01408030|19114694|P4|NOT COMPLETED|Observation Phase (Off Drug)||4
7763854|NCT01408030|19114695|P3|NOT COMPLETED|Observation Phase (Off Drug)||6
7763855|NCT01408030|19114696|P2|NOT COMPLETED|Observation Phase (Off Drug)||6
7763856|NCT01408030|19114697|P1|NOT COMPLETED|Observation Phase (Off Drug)||4
7763857|NCT01408030|19114694|P4|COMPLETED|Observation Phase (Off Drug)||21
7763858|NCT01408030|19114695|P3|COMPLETED|Observation Phase (Off Drug)||26
7763859|NCT01408030|19114696|P2|COMPLETED|Observation Phase (Off Drug)||18
7763860|NCT01408030|19114697|P1|COMPLETED|Observation Phase (Off Drug)||22
7763861|NCT01408030|19114694|P4|STARTED|Observation Phase (Off Drug)||25
7763862|NCT01408030|19114695|P3|STARTED|Observation Phase (Off Drug)||32
7763863|NCT01408030|19114696|P2|STARTED|Observation Phase (Off Drug)||24
7763864|NCT01408030|19114697|P1|STARTED|Observation Phase (Off Drug)||26
7763865|NCT01408030|19114694|P4|NOT COMPLETED|Treatment Phase (on Drug)||3
7763866|NCT01408030|19114695|P3|NOT COMPLETED|Treatment Phase (on Drug)||1
7763867|NCT01408030|19114696|P2|NOT COMPLETED|Treatment Phase (on Drug)||7
7763868|NCT01408030|19114697|P1|NOT COMPLETED|Treatment Phase (on Drug)||3
7763869|NCT01408030|19114694|P4|COMPLETED|Treatment Phase (on Drug)||25
7763870|NCT01408030|19114695|P3|COMPLETED|Treatment Phase (on Drug)||32
7763871|NCT01408030|19114696|P2|COMPLETED|Treatment Phase (on Drug)||24
7763872|NCT01408030|19114697|P1|COMPLETED|Treatment Phase (on Drug)||26
7763873|NCT01408030|19114694|P4|STARTED|Treatment Phase (on Drug)||28
7763874|NCT01408030|19114695|P3|STARTED|Treatment Phase (on Drug)||33
7763875|NCT01408030|19114696|P2|STARTED|Treatment Phase (on Drug)||31
7763876|NCT01408030|19114697|P1|STARTED|Treatment Phase (on Drug)||29
7763877|NCT01407952|19114729|P2|NOT COMPLETED|Overall Study||37
7763878|NCT01407952|19114730|P1|NOT COMPLETED|Overall Study||46
7763879|NCT01407952|19114729|P2|COMPLETED|Overall Study||266
7763880|NCT01407952|19114730|P1|COMPLETED|Overall Study||251
7763881|NCT01407952|19114729|P2|STARTED|Overall Study||303
7763882|NCT01407952|19114730|P1|STARTED|Overall Study||297
7763883|NCT01407926|19114756|P1|NOT COMPLETED|Overall Study||55
7763884|NCT01407926|19114756|P1|COMPLETED|Overall Study||87
7763885|NCT01407926|19114756|P1|STARTED|Overall Study||142
7763886|NCT01407575|19114773|P2|NOT COMPLETED|Overall Study||1
7763887|NCT01407575|19114774|P1|NOT COMPLETED|Overall Study||2
7763888|NCT01407575|19114773|P2|COMPLETED|Overall Study||5
7763889|NCT01407575|19114774|P1|COMPLETED|Overall Study||5
7763890|NCT01407575|19114773|P2|STARTED|Overall Study||6
7763891|NCT01407575|19114774|P1|STARTED|Overall Study||7
7763892|NCT01407523|19114792|P1|NOT COMPLETED|Overall Study||0
7763893|NCT01407523|19114792|P1|COMPLETED|Overall Study||16
7763894|NCT01407523|19114792|P1|STARTED|Overall Study||16
7763895|NCT01407367|19114804|P2|NOT COMPLETED|Overall Study||78
7763896|NCT01407367|19114805|P1|NOT COMPLETED|Overall Study||40
7763897|NCT01407367|19114804|P2|COMPLETED|Overall Study||164
7763898|NCT01407367|19114805|P1|COMPLETED|Overall Study||68
7763899|NCT01407367|19114804|P2|STARTED|Overall Study||242
7763900|NCT01407367|19114805|P1|STARTED|Overall Study||108
7763901|NCT01407354|19114819|P2|NOT COMPLETED|Second Intervention||2
7763902|NCT01407354|19114820|P1|NOT COMPLETED|Second Intervention||0
7763903|NCT01407354|19114819|P2|COMPLETED|Second Intervention||13
7763904|NCT01407354|19114820|P1|COMPLETED|Second Intervention||18
7763905|NCT01407354|19114819|P2|STARTED|Second Intervention||15
7763906|NCT01407354|19114820|P1|STARTED|Second Intervention||18
7763907|NCT01407354|19114819|P2|NOT COMPLETED|First Intervention||2
7763908|NCT01407354|19114820|P1|NOT COMPLETED|First Intervention||2
7763909|NCT01407354|19114819|P2|COMPLETED|First Intervention||15
7763910|NCT01407354|19114820|P1|COMPLETED|First Intervention||18
7763911|NCT01407354|19114819|P2|STARTED|First Intervention||17
7763912|NCT01407354|19114820|P1|STARTED|First Intervention||20
7763913|NCT01407276|19114836|P8|NOT COMPLETED|Overall Study||1
7763914|NCT01407276|19114837|P7|NOT COMPLETED|Overall Study||0
7763915|NCT01407276|19114838|P6|NOT COMPLETED|Overall Study||0
7763916|NCT01407276|19114839|P5|NOT COMPLETED|Overall Study||0
7763917|NCT01407276|19114840|P4|NOT COMPLETED|Overall Study||0
7763918|NCT01407276|19114841|P3|NOT COMPLETED|Overall Study||0
7763919|NCT01407276|19114842|P2|NOT COMPLETED|Overall Study||0
7763920|NCT01407276|19114843|P1|NOT COMPLETED|Overall Study||0
7763921|NCT01407276|19114836|P8|COMPLETED|Overall Study||6
7763922|NCT01407276|19114837|P7|COMPLETED|Overall Study||6
7763923|NCT01407276|19114838|P6|COMPLETED|Overall Study||6
7763924|NCT01407276|19114839|P5|COMPLETED|Overall Study||6
7763925|NCT01407276|19114840|P4|COMPLETED|Overall Study||6
7763926|NCT01407276|19114841|P3|COMPLETED|Overall Study||6
7763927|NCT01407276|19114842|P2|COMPLETED|Overall Study||6
7763928|NCT01407276|19114843|P1|COMPLETED|Overall Study||6
7763929|NCT01407276|19114836|P8|STARTED|Overall Study||7
7763930|NCT01407276|19114837|P7|STARTED|Overall Study||6
7763931|NCT01407276|19114838|P6|STARTED|Overall Study||6
7763932|NCT01407276|19114839|P5|STARTED|Overall Study||6
7763933|NCT01407276|19114840|P4|STARTED|Overall Study||6
7763934|NCT01407276|19114841|P3|STARTED|Overall Study||6
7763935|NCT01407276|19114842|P2|STARTED|Overall Study||6
7763936|NCT01407276|19114843|P1|STARTED|Overall Study||6
7763937|NCT01407094|19114970|P3|NOT COMPLETED|Stage 2||15
7763938|NCT01407094|19114971|P2|NOT COMPLETED|Stage 2||11
7763939|NCT01407094|19114972|P1|NOT COMPLETED|Stage 2||21
7763940|NCT01407094|19114970|P3|COMPLETED|Stage 2||38
7763941|NCT01407094|19114971|P2|COMPLETED|Stage 2||35
7763942|NCT01407094|19114972|P1|COMPLETED|Stage 2||113
7763943|NCT01407094|19114970|P3|STARTED|Stage 2|Stage 2 BUP includes Stage 1 SERT non-responders (n=54); 1 early exit (n=53).|53
7763944|NCT01407094|19114971|P2|STARTED|Stage 2|Stage 2 PBO includes Stage 1 PBO responders (n=47); 1 early exit (n=46).|46
7763945|NCT01407094|19114972|P1|STARTED|Stage 2|Stage 2 SERT includes Stage 1 SERT responders (n=61) and Stage 1 PBO non-responders (n=73).|134
7763946|NCT01407094|19114970|P3|NOT COMPLETED|Stage 1||0
7763947|NCT01407094|19114971|P2|NOT COMPLETED|Stage 1||27
7763948|NCT01407094|19114972|P1|NOT COMPLETED|Stage 1||34
7763949|NCT01407094|19114970|P3|COMPLETED|Stage 1||0
7763950|NCT01407094|19114971|P2|COMPLETED|Stage 1|Four participants completed Stage 1 but did not continue to Stage 2.|123
7763951|NCT01407094|19114972|P1|COMPLETED|Stage 1|One participant completed Stage 1 but did not continue to Stage 2.|112
7763952|NCT01407094|19114970|P3|STARTED|Stage 1|Bupropion (BUP) was used only in Stage 2 for non-responders to SERT.|0
7763953|NCT01407094|19114971|P2|STARTED|Stage 1|Stage 1 Placebo (PBO): 27 exited.|150
7763954|NCT01407094|19114972|P1|STARTED|Stage 1|Stage 1 Sertraline (SERT): 34 exited|146
7763955|NCT01407068|19114980|P1|NOT COMPLETED|Overall Study||0
7763956|NCT01407068|19114980|P1|COMPLETED|Overall Study||60
7763957|NCT01407068|19114980|P1|STARTED|Overall Study||60
7763958|NCT01406990|19114989|P1|NOT COMPLETED|Overall Study||0
7763959|NCT01406990|19114989|P1|COMPLETED|Overall Study||15
7763960|NCT01406990|19114989|P1|STARTED|Overall Study||15
7763961|NCT01406938|19114995|P6|NOT COMPLETED|Follow up||3
7763962|NCT01406938|19114996|P5|NOT COMPLETED|Follow up||9
7763963|NCT01406938|19114997|P4|NOT COMPLETED|Follow up||3
7763964|NCT01406938|19114998|P3|NOT COMPLETED|Follow up||8
7763965|NCT01406938|19114999|P2|NOT COMPLETED|Follow up||5
7763966|NCT01406938|19115000|P1|NOT COMPLETED|Follow up||8
7763967|NCT01406938|19114995|P6|COMPLETED|Follow up||32
7763968|NCT01406938|19114996|P5|COMPLETED|Follow up||31
7763969|NCT01406938|19114997|P4|COMPLETED|Follow up||36
7763970|NCT01406938|19114998|P3|COMPLETED|Follow up||32
7763971|NCT01406938|19114999|P2|COMPLETED|Follow up||18
7763972|NCT01406938|19115000|P1|COMPLETED|Follow up||18
7763973|NCT01406938|19114995|P6|STARTED|Follow up||35
7763974|NCT01406938|19114996|P5|STARTED|Follow up||40
7763975|NCT01406938|19114997|P4|STARTED|Follow up||39
7763976|NCT01406938|19114998|P3|STARTED|Follow up||40
7763977|NCT01406938|19114999|P2|STARTED|Follow up||23
7763978|NCT01406938|19115000|P1|STARTED|Follow up||26
7763979|NCT01406938|19114995|P6|NOT COMPLETED|Maintenance Period||16
7763980|NCT01406938|19114996|P5|NOT COMPLETED|Maintenance Period||25
7763981|NCT01406938|19114997|P4|NOT COMPLETED|Maintenance Period||18
7763982|NCT01406938|19114998|P3|NOT COMPLETED|Maintenance Period||17
7763983|NCT01406938|19114999|P2|NOT COMPLETED|Maintenance Period||0
7763984|NCT01406938|19115000|P1|NOT COMPLETED|Maintenance Period||0
7763985|NCT01406938|19114995|P6|COMPLETED|Maintenance Period||201
7763986|NCT01406938|19114996|P5|COMPLETED|Maintenance Period||181
7763987|NCT01406938|19114997|P4|COMPLETED|Maintenance Period||199
7763988|NCT01406938|19114998|P3|COMPLETED|Maintenance Period||186
7763989|NCT01406938|19114999|P2|COMPLETED|Maintenance Period||0
7763990|NCT01406938|19115000|P1|COMPLETED|Maintenance Period||0
7763991|NCT01406938|19114995|P6|FAS: Patients Assigned Treatment Drug|Maintenance Period||217
7763992|NCT01406938|19114996|P5|FAS: Patients Assigned Treatment Drug|Maintenance Period||206
7763993|NCT01406938|19114997|P4|FAS: Patients Assigned Treatment Drug|Maintenance Period||216
7763994|NCT01406938|19114998|P3|FAS: Patients Assigned Treatment Drug|Maintenance Period||203
7763995|NCT01406938|19114999|P2|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
7763996|NCT01406938|19115000|P1|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
7763997|NCT01406938|19114995|P6|STARTED|Maintenance Period||217
7763998|NCT01406938|19114996|P5|STARTED|Maintenance Period||206
7763999|NCT01406938|19114997|P4|STARTED|Maintenance Period||217
7764000|NCT01406938|19114998|P3|STARTED|Maintenance Period||203
7764001|NCT01406938|19114999|P2|STARTED|Maintenance Period||0
7764002|NCT01406938|19115000|P1|STARTED|Maintenance Period||0
7764003|NCT01406938|19114995|P6|NOT COMPLETED|Induction Period||0
7764004|NCT01406938|19114996|P5|NOT COMPLETED|Induction Period||0
7764005|NCT01406938|19114997|P4|NOT COMPLETED|Induction Period||0
7764006|NCT01406938|19114998|P3|NOT COMPLETED|Induction Period||0
7764007|NCT01406938|19114999|P2|NOT COMPLETED|Induction Period||20
7764008|NCT01406938|19115000|P1|NOT COMPLETED|Induction Period||18
7764009|NCT01406938|19114995|P6|COMPLETED|Induction Period||0
7764010|NCT01406938|19114996|P5|COMPLETED|Induction Period||0
7764011|NCT01406938|19114997|P4|COMPLETED|Induction Period||0
7764012|NCT01406938|19114998|P3|COMPLETED|Induction Period||0
7764013|NCT01406938|19114999|P2|COMPLETED|Induction Period||464
7764014|NCT01406938|19115000|P1|COMPLETED|Induction Period||464
7764015|NCT01406938|19114995|P6|FAS:Patients Assigned Study Treatment|Induction Period||0
7764016|NCT01406938|19114996|P5|FAS:Patients Assigned Study Treatment|Induction Period||0
7764017|NCT01406938|19114997|P4|FAS:Patients Assigned Study Treatment|Induction Period||0
7764018|NCT01406938|19114998|P3|FAS:Patients Assigned Study Treatment|Induction Period||0
7764019|NCT01406938|19114999|P2|FAS:Patients Assigned Study Treatment|Induction Period||483
7764020|NCT01406938|19115000|P1|FAS:Patients Assigned Study Treatment|Induction Period||482
7764021|NCT01406938|19114995|P6|STARTED|Induction Period||0
7764022|NCT01406938|19114996|P5|STARTED|Induction Period||0
7764023|NCT01406938|19114997|P4|STARTED|Induction Period||0
7764024|NCT01406938|19114998|P3|STARTED|Induction Period||0
7764025|NCT01406938|19114999|P2|STARTED|Induction Period||484
7764026|NCT01406938|19115000|P1|STARTED|Induction Period||482
7764027|NCT01406873|19115118|P2|NOT COMPLETED|Overall Study||1
7764028|NCT01406873|19115119|P1|NOT COMPLETED|Overall Study||1
7764029|NCT01406873|19115118|P2|COMPLETED|Overall Study||20
7764030|NCT01406873|19115119|P1|COMPLETED|Overall Study||20
7764031|NCT01406873|19115118|P2|STARTED|Overall Study||21
7764032|NCT01406873|19115119|P1|STARTED|Overall Study||21
7764033|NCT01406860|19115137|P2|NOT COMPLETED|Overall Study||0
7764034|NCT01406860|19115138|P1|NOT COMPLETED|Overall Study||0
7764035|NCT01406860|19115137|P2|COMPLETED|Overall Study||8
7764036|NCT01406860|19115138|P1|COMPLETED|Overall Study||11
7764037|NCT01406860|19115137|P2|STARTED|Overall Study||8
7764038|NCT01406860|19115138|P1|STARTED|Overall Study||11
7764039|NCT01406795|19115150|P1|NOT COMPLETED|Overall Study||1
7764040|NCT01406795|19115150|P1|COMPLETED|Overall Study||0
7764041|NCT01406795|19115150|P1|STARTED|Overall Study||1
7764042|NCT01406717|19115166|P2|NOT COMPLETED|Overall Study||31
7764043|NCT01406717|19115167|P1|NOT COMPLETED|Overall Study||43
7764044|NCT01406717|19115166|P2|COMPLETED|Overall Study||149
7764045|NCT01406717|19115167|P1|COMPLETED|Overall Study||137
7764046|NCT01406717|19115166|P2|STARTED|Overall Study||180
7764047|NCT01406717|19115167|P1|STARTED|Overall Study||180
7764048|NCT01406652|19115197|P2|NOT COMPLETED|Overall Study||20
7764049|NCT01406652|19115198|P1|NOT COMPLETED|Overall Study||20
7764050|NCT01406652|19115197|P2|COMPLETED|Overall Study||95
7764051|NCT01406652|19115198|P1|COMPLETED|Overall Study||89
7764052|NCT01406652|19115197|P2|STARTED|Overall Study||115
7764053|NCT01406652|19115198|P1|STARTED|Overall Study||109
7764054|NCT01406574|19115206|P4|NOT COMPLETED|Overall Study||4
7764055|NCT01406574|19115207|P3|NOT COMPLETED|Overall Study||1
7764056|NCT01406574|19115208|P2|NOT COMPLETED|Overall Study||1
7764057|NCT01406574|19115209|P1|NOT COMPLETED|Overall Study||1
7764058|NCT01406574|19115206|P4|COMPLETED|Overall Study||1
7764059|NCT01406574|19115207|P3|COMPLETED|Overall Study||6
7764060|NCT01406574|19115208|P2|COMPLETED|Overall Study||3
7764061|NCT01406574|19115209|P1|COMPLETED|Overall Study||6
7764062|NCT01406574|19115206|P4|STARTED|Overall Study||5
7764063|NCT01406574|19115207|P3|STARTED|Overall Study||7
7764064|NCT01406574|19115208|P2|STARTED|Overall Study||4
7764065|NCT01406574|19115209|P1|STARTED|Overall Study||7
7764066|NCT01406444|19115224|P3|NOT COMPLETED|Overall Study||2
7764067|NCT01406444|19115225|P2|NOT COMPLETED|Overall Study||9
7764068|NCT01406444|19115226|P1|NOT COMPLETED|Overall Study||10
7764069|NCT01406444|19115224|P3|COMPLETED|Overall Study||14
7764070|NCT01406444|19115225|P2|COMPLETED|Overall Study||24
7764071|NCT01406444|19115226|P1|COMPLETED|Overall Study||23
7764072|NCT01406444|19115224|P3|STARTED|Overall Study||16
7764073|NCT01406444|19115225|P2|STARTED|Overall Study||33
7764074|NCT01406444|19115226|P1|STARTED|Overall Study||33
7764075|NCT01406223|19115241|P4|NOT COMPLETED|Overall Study||16
7764076|NCT01406223|19115242|P3|NOT COMPLETED|Overall Study||18
7764077|NCT01406223|19115243|P2|NOT COMPLETED|Overall Study||12
7764078|NCT01406223|19115244|P1|NOT COMPLETED|Overall Study||12
7764079|NCT01406223|19115241|P4|COMPLETED|Overall Study||3
7764080|NCT01406223|19115242|P3|COMPLETED|Overall Study||2
7764081|NCT01406223|19115243|P2|COMPLETED|Overall Study||7
7764082|NCT01406223|19115244|P1|COMPLETED|Overall Study||6
7764083|NCT01406223|19115241|P4|STARTED|Overall Study||19
7764084|NCT01406223|19115242|P3|STARTED|Overall Study||20
7764085|NCT01406223|19115243|P2|STARTED|Overall Study||19
7764086|NCT01406223|19115244|P1|STARTED|Overall Study||18
7764087|NCT01406015|19115260|P2|NOT COMPLETED|Overall Study||3
7764088|NCT01406015|19115261|P1|NOT COMPLETED|Overall Study||3
7764089|NCT01406015|19115260|P2|COMPLETED|Overall Study||16
7764090|NCT01406015|19115261|P1|COMPLETED|Overall Study||16
7764091|NCT01406015|19115260|P2|STARTED|Overall Study||19
7764092|NCT01406015|19115261|P1|STARTED|Overall Study||19
7764093|NCT01405950|19115277|P4|NOT COMPLETED|Overall Study||0
7764094|NCT01405950|19115278|P3|NOT COMPLETED|Overall Study||0
7764095|NCT01405950|19115279|P2|NOT COMPLETED|Overall Study||0
7764096|NCT01405950|19115280|P1|NOT COMPLETED|Overall Study||1
7764097|NCT01405950|19115277|P4|COMPLETED|Overall Study||0
7764098|NCT01405950|19115278|P3|COMPLETED|Overall Study||0
7764099|NCT01405950|19115279|P2|COMPLETED|Overall Study||2
7764100|NCT01405950|19115280|P1|COMPLETED|Overall Study||7
7764101|NCT01405950|19115277|P4|STARTED|Overall Study||0
7764102|NCT01405950|19115278|P3|STARTED|Overall Study||0
7764103|NCT01405950|19115279|P2|STARTED|Overall Study||2
7764104|NCT01405950|19115280|P1|STARTED|Overall Study||8
7764105|NCT01405937|19115294|P2|NOT COMPLETED|Overall Study||0
7764106|NCT01405937|19115295|P1|NOT COMPLETED|Overall Study||0
7764107|NCT01405937|19115294|P2|COMPLETED|Overall Study||26
7764108|NCT01405937|19115295|P1|COMPLETED|Overall Study||25
7764109|NCT01405937|19115294|P2|STARTED|Overall Study||26
7764110|NCT01405937|19115295|P1|STARTED|Overall Study||25
7764111|NCT01405924|19115315|P1|NOT COMPLETED|Overall Study||10
7764112|NCT01405924|19115315|P1|COMPLETED|Overall Study||101
7764113|NCT01405924|19115315|P1|STARTED|Overall Study||111
7764114|NCT01405911|19115328|P3|NOT COMPLETED|Overall Study||1
7764115|NCT01405911|19115329|P2|NOT COMPLETED|Overall Study||3
7764116|NCT01405911|19115330|P1|NOT COMPLETED|Overall Study||4
7764117|NCT01405911|19115328|P3|COMPLETED|Overall Study||76
7764118|NCT01405911|19115329|P2|COMPLETED|Overall Study||79
7764119|NCT01405911|19115330|P1|COMPLETED|Overall Study||79
7764120|NCT01405911|19115328|P3|Treated|Overall Study||77
7764121|NCT01405911|19115329|P2|Treated|Overall Study|1 participant received study drug but was discontinued due to pre-treatment lab AE.|82
7764122|NCT01405911|19115330|P1|Treated|Overall Study||82
7764123|NCT01405911|19115328|P3|STARTED|Overall Study||77
7764124|NCT01405911|19115329|P2|STARTED|Overall Study||82
7764125|NCT01405911|19115330|P1|STARTED|Overall Study||83
7764126|NCT01405898|19115349|P2|NOT COMPLETED|Overall Study||2
7764127|NCT01405898|19115350|P1|NOT COMPLETED|Overall Study||2
7764128|NCT01405898|19115349|P2|COMPLETED|Overall Study||32
7764129|NCT01405898|19115350|P1|COMPLETED|Overall Study||32
7764130|NCT01405898|19115349|P2|STARTED|Overall Study||34
7764131|NCT01405898|19115350|P1|STARTED|Overall Study||34
7764132|NCT01405820|19115374|P6|NOT COMPLETED|Open-Label Treatment Period||2
7764133|NCT01405820|19115375|P5|NOT COMPLETED|Open-Label Treatment Period||2
7764134|NCT01405820|19115376|P4|NOT COMPLETED|Open-Label Treatment Period||5
7764135|NCT01405820|19115377|P3|NOT COMPLETED|Open-Label Treatment Period||3
7764136|NCT01405820|19115378|P2|NOT COMPLETED|Open-Label Treatment Period||2
7764137|NCT01405820|19115379|P1|NOT COMPLETED|Open-Label Treatment Period||4
7764138|NCT01405820|19115374|P6|COMPLETED|Open-Label Treatment Period||30
7764139|NCT01405820|19115375|P5|COMPLETED|Open-Label Treatment Period||40
7764140|NCT01405820|19115376|P4|COMPLETED|Open-Label Treatment Period||37
7764141|NCT01405820|19115377|P3|COMPLETED|Open-Label Treatment Period||39
7764142|NCT01405820|19115378|P2|COMPLETED|Open-Label Treatment Period||33
7764143|NCT01405820|19115379|P1|COMPLETED|Open-Label Treatment Period||40
7764144|NCT01405820|19115374|P6|STARTED|Open-Label Treatment Period||32
7764145|NCT01405820|19115375|P5|STARTED|Open-Label Treatment Period||42
7764146|NCT01405820|19115376|P4|STARTED|Open-Label Treatment Period||42
7764147|NCT01405820|19115377|P3|STARTED|Open-Label Treatment Period||42
7764148|NCT01405820|19115378|P2|STARTED|Open-Label Treatment Period||35
7764149|NCT01405820|19115379|P1|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44
7764150|NCT01405820|19115374|P6|NOT COMPLETED|Randomized Treatment Period||37
7764151|NCT01405820|19115375|P5|NOT COMPLETED|Randomized Treatment Period||45
7764152|NCT01405820|19115376|P4|NOT COMPLETED|Randomized Treatment Period||51
7764153|NCT01405820|19115377|P3|NOT COMPLETED|Randomized Treatment Period||43
7764154|NCT01405820|19115378|P2|NOT COMPLETED|Randomized Treatment Period||10
7764155|NCT01405820|19115379|P1|NOT COMPLETED|Randomized Treatment Period||11
7764156|NCT01405820|19115374|P6|COMPLETED|Randomized Treatment Period||1
7764157|NCT01405820|19115375|P5|COMPLETED|Randomized Treatment Period||2
7764158|NCT01405820|19115376|P4|COMPLETED|Randomized Treatment Period||3
7764159|NCT01405820|19115377|P3|COMPLETED|Randomized Treatment Period||9
7764160|NCT01405820|19115378|P2|COMPLETED|Randomized Treatment Period||35
7764161|NCT01405820|19115379|P1|COMPLETED|Randomized Treatment Period||43
7764162|NCT01405820|19115374|P6|Safety Population|Randomized Treatment Period||38
7764163|NCT01405820|19115375|P5|Safety Population|Randomized Treatment Period||47
7764164|NCT01405820|19115376|P4|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53
7764165|NCT01405820|19115377|P3|Safety Population|Randomized Treatment Period||52
7764166|NCT01405820|19115378|P2|Safety Population|Randomized Treatment Period||45
7764167|NCT01405820|19115379|P1|Safety Population|Randomized Treatment Period||54
7764168|NCT01405820|19115374|P6|STARTED|Randomized Treatment Period||38
7764169|NCT01405820|19115375|P5|STARTED|Randomized Treatment Period||47
7764170|NCT01405820|19115376|P4|STARTED|Randomized Treatment Period||54
7764171|NCT01405820|19115377|P3|STARTED|Randomized Treatment Period||52
7764172|NCT01405820|19115378|P2|STARTED|Randomized Treatment Period||45
7764173|NCT01405820|19115379|P1|STARTED|Randomized Treatment Period||54
7764174|NCT01405794|19115399|P1|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0
7764175|NCT01405794|19115399|P1|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12
7764176|NCT01405794|19115399|P1|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12
7764177|NCT01405794|19115399|P1|NOT COMPLETED|72 hr Washout||0
7764178|NCT01405794|19115399|P1|COMPLETED|72 hr Washout||12
7764179|NCT01405794|19115399|P1|STARTED|72 hr Washout||12
7764180|NCT01405794|19115399|P1|NOT COMPLETED|First Dose Placebo (14 Days)||0
7764181|NCT01405794|19115399|P1|COMPLETED|First Dose Placebo (14 Days)||12
7764182|NCT01405794|19115399|P1|STARTED|First Dose Placebo (14 Days)||12
7764183|NCT01405768|19115475|P2|NOT COMPLETED|Overall Study||0
7764184|NCT01405768|19115476|P1|NOT COMPLETED|Overall Study||4
7764185|NCT01405768|19115475|P2|COMPLETED|Overall Study||28
7764186|NCT01405768|19115476|P1|COMPLETED|Overall Study||24
7764187|NCT01405768|19115475|P2|STARTED|Overall Study||28
7764188|NCT01405768|19115476|P1|STARTED|Overall Study||28
7764189|NCT01405742|19115488|P2|NOT COMPLETED|Overall Study||0
7764190|NCT01405742|19115489|P1|NOT COMPLETED|Overall Study||1
7764191|NCT01405742|19115488|P2|COMPLETED|Overall Study||2
7764192|NCT01405742|19115489|P1|COMPLETED|Overall Study||1
7764193|NCT01405742|19115488|P2|STARTED|Overall Study||2
7764194|NCT01405742|19115489|P1|STARTED|Overall Study||2
7764195|NCT01405560|19115499|P1|NOT COMPLETED|Overall Study||1
7764196|NCT01405560|19115499|P1|COMPLETED|Overall Study||41
7764197|NCT01405560|19115499|P1|STARTED|Overall Study||42
7764198|NCT01405508|19115514|P4|NOT COMPLETED|Overall Study||0
7764199|NCT01405508|19115515|P3|NOT COMPLETED|Overall Study||0
7764200|NCT01405508|19115516|P2|NOT COMPLETED|Overall Study||1
7764201|NCT01405508|19115517|P1|NOT COMPLETED|Overall Study||1
7764202|NCT01405508|19115514|P4|COMPLETED|Overall Study||26
7764203|NCT01405508|19115515|P3|COMPLETED|Overall Study||27
7764204|NCT01405508|19115516|P2|COMPLETED|Overall Study||25
7764205|NCT01405508|19115517|P1|COMPLETED|Overall Study||25
7764206|NCT01405508|19115514|P4|STARTED|Overall Study||26
7764207|NCT01405508|19115515|P3|STARTED|Overall Study||27
7764208|NCT01405508|19115516|P2|STARTED|Overall Study||26
7764209|NCT01405508|19115517|P1|STARTED|Overall Study||26
7764210|NCT01405469|19115535|P1|NOT COMPLETED|Overall Study||0
7764211|NCT01405469|19115535|P1|COMPLETED|Overall Study||16
7764212|NCT01405469|19115535|P1|STARTED|Overall Study||16
7764213|NCT01405456|19115549|P2|NOT COMPLETED|Overall Study||1
7764214|NCT01405456|19115550|P1|NOT COMPLETED|Overall Study||3
7764215|NCT01405456|19115549|P2|COMPLETED|Overall Study||20
7764216|NCT01405456|19115550|P1|COMPLETED|Overall Study||22
7764217|NCT01405456|19115549|P2|STARTED|Overall Study||21
7764218|NCT01405456|19115550|P1|STARTED|Overall Study||25
7764219|NCT01405313|19115578|P1|NOT COMPLETED|Overall Study||0
7764220|NCT01405313|19115578|P1|COMPLETED|Overall Study||21
7764221|NCT01405313|19115578|P1|STARTED|Overall Study||21
7764222|NCT01405196|19115590|P4|NOT COMPLETED|Overall Study||9
7764223|NCT01405196|19115591|P3|NOT COMPLETED|Overall Study||23
7764224|NCT01405196|19115592|P2|NOT COMPLETED|Overall Study||12
7764225|NCT01405196|19115593|P1|NOT COMPLETED|Overall Study||11
7764226|NCT01405196|19115590|P4|COMPLETED|Overall Study||36
7764227|NCT01405196|19115591|P3|COMPLETED|Overall Study||23
7764228|NCT01405196|19115592|P2|COMPLETED|Overall Study||35
7764229|NCT01405196|19115593|P1|COMPLETED|Overall Study||34
7764230|NCT01405196|19115590|P4|STARTED|Overall Study||45
7764231|NCT01405196|19115591|P3|STARTED|Overall Study||46
7764232|NCT01405196|19115592|P2|STARTED|Overall Study||47
7764233|NCT01405196|19115593|P1|STARTED|Overall Study||45
7764234|NCT01405053|19115680|P2|NOT COMPLETED|Overall Study||8
7764235|NCT01405053|19115681|P1|NOT COMPLETED|Overall Study||10
7764236|NCT01405053|19115680|P2|COMPLETED|Overall Study||4
7764237|NCT01405053|19115681|P1|COMPLETED|Overall Study||15
7764238|NCT01405053|19115680|P2|STARTED|Overall Study||12
7764239|NCT01405053|19115681|P1|STARTED|Overall Study||25
7764240|NCT01405027|19115707|P2|NOT COMPLETED|Overall Study||51
7764241|NCT01405027|19115708|P1|NOT COMPLETED|Overall Study||32
7764242|NCT01405027|19115707|P2|COMPLETED|Overall Study||62
7764243|NCT01405027|19115708|P1|COMPLETED|Overall Study||52
7764244|NCT01405027|19115707|P2|STARTED|Overall Study||113
7764245|NCT01405027|19115708|P1|STARTED|Overall Study||84
7764246|NCT01404988|19115725|P3|NOT COMPLETED|Overall Study||3
7764247|NCT01404988|19115726|P2|NOT COMPLETED|Overall Study||4
7764248|NCT01404988|19115727|P1|NOT COMPLETED|Overall Study||6
7764249|NCT01404988|19115725|P3|COMPLETED|Overall Study||30
7764250|NCT01404988|19115726|P2|COMPLETED|Overall Study||29
7764251|NCT01404988|19115727|P1|COMPLETED|Overall Study||27
7764252|NCT01404988|19115725|P3|STARTED|Overall Study||33
7764253|NCT01404988|19115726|P2|STARTED|Overall Study||33
7764254|NCT01404988|19115727|P1|STARTED|Overall Study||33
7764255|NCT01404936|19115744|P1|NOT COMPLETED|Overall Study||0
7764256|NCT01404936|19115744|P1|COMPLETED|Overall Study||30
7764257|NCT01404936|19115744|P1|STARTED|Overall Study||30
7764258|NCT01404923|19115750|P2|NOT COMPLETED|Overall Study||17
7764259|NCT01404923|19115751|P1|NOT COMPLETED|Overall Study||23
7764260|NCT01404923|19115750|P2|COMPLETED|Overall Study||197
7764261|NCT01404923|19115751|P1|COMPLETED|Overall Study||199
7764262|NCT01404923|19115750|P2|STARTED|Overall Study||214
7764263|NCT01404923|19115751|P1|STARTED|Overall Study||222
7764264|NCT01404832|19115759|P1|NOT COMPLETED|Overall Study||0
7764265|NCT01404832|19115759|P1|COMPLETED|Overall Study||21
7764266|NCT01404832|19115759|P1|STARTED|Overall Study||21
7764267|NCT01404650|19115764|P1|NOT COMPLETED|Overall Study||0
7764268|NCT01404650|19115764|P1|COMPLETED|Overall Study||25
7764269|NCT01404650|19115764|P1|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25
7764270|NCT01404611|19115774|P3|NOT COMPLETED|Overall Study||5
7764271|NCT01404611|19115775|P2|NOT COMPLETED|Overall Study||19
7764272|NCT01404611|19115776|P1|NOT COMPLETED|Overall Study||8
7764273|NCT01404611|19115774|P3|COMPLETED|Overall Study||106
7764274|NCT01404611|19115775|P2|COMPLETED|Overall Study||89
7764275|NCT01404611|19115776|P1|COMPLETED|Overall Study||104
7764276|NCT01404611|19115774|P3|STARTED|Overall Study||111
7764277|NCT01404611|19115775|P2|STARTED|Overall Study||108
7764278|NCT01404611|19115776|P1|STARTED|Overall Study||112
7764279|NCT01404572|19115784|P3|NOT COMPLETED|Overall Study||0
7764280|NCT01404572|19115785|P2|NOT COMPLETED|Overall Study||0
7764281|NCT01404572|19115786|P1|NOT COMPLETED|Overall Study||0
7764282|NCT01404572|19115784|P3|COMPLETED|Overall Study||4
7764283|NCT01404572|19115785|P2|COMPLETED|Overall Study||4
7764284|NCT01404572|19115786|P1|COMPLETED|Overall Study||4
7764285|NCT01404572|19115784|P3|STARTED|Overall Study||4
7764286|NCT01404572|19115785|P2|STARTED|Overall Study||4
7764287|NCT01404572|19115786|P1|STARTED|Overall Study||4
7764288|NCT01404559|19115817|P4|NOT COMPLETED|Overall Study||0
7764289|NCT01404559|19115818|P3|NOT COMPLETED|Overall Study||0
7764290|NCT01404559|19115819|P2|NOT COMPLETED|Overall Study||0
7764291|NCT01404559|19115820|P1|NOT COMPLETED|Overall Study||0
7764292|NCT01404559|19115817|P4|COMPLETED|Overall Study||14
7764293|NCT01404559|19115818|P3|COMPLETED|Overall Study||4
7764294|NCT01404559|19115819|P2|COMPLETED|Overall Study||5
7764295|NCT01404559|19115820|P1|COMPLETED|Overall Study||5
7764296|NCT01404559|19115817|P4|STARTED|Overall Study||14
7764297|NCT01404559|19115818|P3|STARTED|Overall Study||4
7764298|NCT01404559|19115819|P2|STARTED|Overall Study||5
7764299|NCT01404559|19115820|P1|STARTED|Overall Study||5
7764300|NCT01404429|19115833|P2|NOT COMPLETED|Overall Study||7
7764301|NCT01404429|19115834|P1|NOT COMPLETED|Overall Study||9
7764302|NCT01404429|19115833|P2|COMPLETED|Overall Study||46
7764303|NCT01404429|19115834|P1|COMPLETED|Overall Study||38
7764304|NCT01404429|19115833|P2|STARTED|Overall Study||53
7764305|NCT01404429|19115834|P1|STARTED|Overall Study||47
7764306|NCT01404325|19115848|P2|NOT COMPLETED|Overall Study||2
7764307|NCT01404325|19115849|P1|NOT COMPLETED|Overall Study||4
7764308|NCT01404325|19115848|P2|COMPLETED|Overall Study||61
7764309|NCT01404325|19115849|P1|COMPLETED|Overall Study||63
7764310|NCT01404325|19115848|P2|STARTED|Overall Study||63
7764311|NCT01404325|19115849|P1|STARTED|Overall Study||67
7764312|NCT01404312|19115907|P2|NOT COMPLETED|Overall Study||311
7764313|NCT01404312|19115908|P1|NOT COMPLETED|Overall Study||298
7764314|NCT01404312|19115907|P2|COMPLETED|Overall Study||1193
7764315|NCT01404312|19115908|P1|COMPLETED|Overall Study||1198
7764316|NCT01404312|19115907|P2|STARTED|Overall Study||1504
7764317|NCT01404312|19115908|P1|STARTED|Overall Study||1496
7764318|NCT01404260|19115930|P2|NOT COMPLETED|Overall Study||9
7764319|NCT01404260|19115931|P1|NOT COMPLETED|Overall Study||3
7764320|NCT01404260|19115930|P2|COMPLETED|Overall Study||101
7764321|NCT01404260|19115931|P1|COMPLETED|Overall Study||106
7764322|NCT01404260|19115930|P2|STARTED|Overall Study||110
7764323|NCT01404260|19115931|P1|STARTED|Overall Study||109
7764324|NCT01404234|19115937|P1|NOT COMPLETED|Overall Study||2
7764325|NCT01404234|19115937|P1|COMPLETED|Overall Study||59
7764326|NCT01404234|19115937|P1|STARTED|Overall Study||61
7764327|NCT01404208|19115953|P2|NOT COMPLETED|Overall Study||0
7764328|NCT01404208|19115954|P1|NOT COMPLETED|Overall Study||3
7764329|NCT01404208|19115953|P2|COMPLETED|Overall Study||72
7764330|NCT01404208|19115954|P1|COMPLETED|Overall Study||67
7764331|NCT01404208|19115953|P2|STARTED|Overall Study||72
7764332|NCT01404208|19115954|P1|STARTED|Overall Study||70
7764333|NCT01404078|19115964|P2|NOT COMPLETED|Overall Study||20
7764334|NCT01404078|19115965|P1|NOT COMPLETED|Overall Study||18
7764335|NCT01404078|19115964|P2|COMPLETED|Overall Study||237
7764336|NCT01404078|19115965|P1|COMPLETED|Overall Study||243
7764337|NCT01404078|19115964|P2|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257
7764338|NCT01404078|19115965|P1|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261
7764339|NCT01404039|19115980|P13|NOT COMPLETED|Overall Study||0
7764340|NCT01404039|19115981|P12|NOT COMPLETED|Overall Study||0
7764341|NCT01404039|19115982|P11|NOT COMPLETED|Overall Study||1
7764342|NCT01404039|19115983|P10|NOT COMPLETED|Overall Study||1
7764343|NCT01404039|19115984|P9|NOT COMPLETED|Overall Study||0
7764344|NCT01404039|19115985|P8|NOT COMPLETED|Overall Study||0
7764345|NCT01404039|19115986|P7|NOT COMPLETED|Overall Study||0
7764346|NCT01404039|19115987|P6|NOT COMPLETED|Overall Study||0
7764347|NCT01404039|19115988|P5|NOT COMPLETED|Overall Study||0
7764348|NCT01404039|19115989|P4|NOT COMPLETED|Overall Study||0
7764349|NCT01404039|19115990|P3|NOT COMPLETED|Overall Study||0
7764350|NCT01404039|19115991|P2|NOT COMPLETED|Overall Study||0
7764351|NCT01404039|19115992|P1|NOT COMPLETED|Overall Study||1
7764352|NCT01404039|19115980|P13|COMPLETED|Overall Study||0
7764353|NCT01404039|19115981|P12|COMPLETED|Overall Study||0
7764354|NCT01404039|19115982|P11|COMPLETED|Overall Study||14
7764355|NCT01404039|19115983|P10|COMPLETED|Overall Study||14
7764356|NCT01404039|19115984|P9|COMPLETED|Overall Study||15
7764357|NCT01404039|19115985|P8|COMPLETED|Overall Study||15
7764358|NCT01404039|19115986|P7|COMPLETED|Overall Study||10
7764359|NCT01404039|19115987|P6|COMPLETED|Overall Study||10
7764360|NCT01404039|19115988|P5|COMPLETED|Overall Study||10
7764361|NCT01404039|19115989|P4|COMPLETED|Overall Study||10
7764362|NCT01404039|19115990|P3|COMPLETED|Overall Study||5
7764363|NCT01404039|19115991|P2|COMPLETED|Overall Study||5
7764364|NCT01404039|19115992|P1|COMPLETED|Overall Study||4
7764365|NCT01404039|19115980|P13|STARTED|Overall Study||0
7764366|NCT01404039|19115981|P12|STARTED|Overall Study||0
7764367|NCT01404039|19115982|P11|STARTED|Overall Study||15
7764368|NCT01404039|19115983|P10|STARTED|Overall Study||15
7764369|NCT01404039|19115984|P9|STARTED|Overall Study||15
7764370|NCT01404039|19115985|P8|STARTED|Overall Study||15
7764371|NCT01404039|19115986|P7|STARTED|Overall Study||10
7764372|NCT01404039|19115987|P6|STARTED|Overall Study||10
7764373|NCT01404039|19115988|P5|STARTED|Overall Study||10
7764374|NCT01404039|19115989|P4|STARTED|Overall Study||10
7764375|NCT01404039|19115990|P3|STARTED|Overall Study||5
7764376|NCT01404039|19115991|P2|STARTED|Overall Study||5
7764377|NCT01404039|19115992|P1|STARTED|Overall Study||5
7764378|NCT01403987|19116019|P3|NOT COMPLETED|Overall Study||18
7764379|NCT01403987|19116020|P2|NOT COMPLETED|Overall Study||17
7764380|NCT01403987|19116021|P1|NOT COMPLETED|Overall Study||18
7764381|NCT01403987|19116019|P3|COMPLETED|Overall Study||50
7764382|NCT01403987|19116020|P2|COMPLETED|Overall Study||17
7764383|NCT01403987|19116021|P1|COMPLETED|Overall Study||16
7764384|NCT01403987|19116019|P3|STARTED|Overall Study||68
7764385|NCT01403987|19116020|P2|STARTED|Overall Study||34
7764386|NCT01403987|19116021|P1|STARTED|Overall Study||34
7764387|NCT01403948|19116045|P10|NOT COMPLETED|Overall Study||7
7764388|NCT01403948|19116046|P9|NOT COMPLETED|Overall Study||6
7764389|NCT01403948|19116047|P8|NOT COMPLETED|Overall Study||4
7764390|NCT01403948|19116048|P7|NOT COMPLETED|Overall Study||6
7764391|NCT01403948|19116049|P6|NOT COMPLETED|Overall Study||7
7764392|NCT01403948|19116050|P5|NOT COMPLETED|Overall Study||6
7764393|NCT01403948|19116051|P4|NOT COMPLETED|Overall Study||4
7764394|NCT01403948|19116052|P3|NOT COMPLETED|Overall Study||3
7764395|NCT01403948|19116053|P2|NOT COMPLETED|Overall Study||4
7764396|NCT01403948|19116054|P1|NOT COMPLETED|Overall Study||1
7764397|NCT01403948|19116045|P10|COMPLETED|Overall Study||0
7764398|NCT01403948|19116046|P9|COMPLETED|Overall Study||0
7764399|NCT01403948|19116047|P8|COMPLETED|Overall Study||0
7764400|NCT01403948|19116048|P7|COMPLETED|Overall Study||0
7764401|NCT01403948|19116049|P6|COMPLETED|Overall Study||0
7764402|NCT01403948|19116050|P5|COMPLETED|Overall Study||0
7764403|NCT01403948|19116051|P4|COMPLETED|Overall Study||0
7764404|NCT01403948|19116052|P3|COMPLETED|Overall Study||0
7764405|NCT01403948|19116053|P2|COMPLETED|Overall Study||0
7764406|NCT01403948|19116054|P1|COMPLETED|Overall Study||0
7764407|NCT01403948|19116045|P10|STARTED|Overall Study||7
7764408|NCT01403948|19116046|P9|STARTED|Overall Study||6
7764409|NCT01403948|19116047|P8|STARTED|Overall Study||4
7764410|NCT01403948|19116048|P7|STARTED|Overall Study||6
7764411|NCT01403948|19116049|P6|STARTED|Overall Study||7
7764412|NCT01403948|19116050|P5|STARTED|Overall Study||6
7764413|NCT01403948|19116051|P4|STARTED|Overall Study||4
7764414|NCT01403948|19116052|P3|STARTED|Overall Study||3
7764415|NCT01403948|19116053|P2|STARTED|Overall Study||4
7764416|NCT01403948|19116054|P1|STARTED|Overall Study||1
7764417|NCT01403805|19116127|P2|NOT COMPLETED|Overall Study||7
7764418|NCT01403805|19116128|P1|NOT COMPLETED|Overall Study||0
7764419|NCT01403805|19116127|P2|COMPLETED|Overall Study||98
7764420|NCT01403805|19116128|P1|COMPLETED|Overall Study||94
7764421|NCT01403805|19116127|P2|Pneumonia Diagnosis|Overall Study||2
7764422|NCT01403805|19116128|P1|Pneumonia Diagnosis|Overall Study||21
7764423|NCT01403805|19116127|P2|STARTED|Overall Study||105
7764424|NCT01403805|19116128|P1|STARTED|Overall Study||94
7764425|NCT01403610|19116144|P4|NOT COMPLETED|Overall Study||0
7764426|NCT01403610|19116145|P3|NOT COMPLETED|Overall Study||0
7764427|NCT01403610|19116146|P2|NOT COMPLETED|Overall Study||3
7764428|NCT01403610|19116147|P1|NOT COMPLETED|Overall Study||2
7764429|NCT01403610|19116144|P4|COMPLETED|Overall Study||13
7764430|NCT01403610|19116145|P3|COMPLETED|Overall Study||4
7764431|NCT01403610|19116146|P2|COMPLETED|Overall Study||3
7764432|NCT01403610|19116147|P1|COMPLETED|Overall Study||3
7764433|NCT01403610|19116144|P4|STARTED|Overall Study||13
7764434|NCT01403610|19116145|P3|STARTED|Overall Study||4
7764435|NCT01403610|19116146|P2|STARTED|Overall Study||6
7764436|NCT01403610|19116147|P1|STARTED|Overall Study||5
7764437|NCT01403441|19116157|P1|NOT COMPLETED|Overall Study||0
7764438|NCT01403441|19116157|P1|COMPLETED|Overall Study||3
7764439|NCT01403441|19116157|P1|STARTED|Overall Study||3
7764440|NCT01403376|19116167|P3|NOT COMPLETED|Overall Study||0
7764441|NCT01403376|19116168|P2|NOT COMPLETED|Overall Study||0
7764442|NCT01403376|19116169|P1|NOT COMPLETED|Overall Study||0
7764443|NCT01403376|19116167|P3|COMPLETED|Overall Study||46
7764444|NCT01403376|19116168|P2|COMPLETED|Overall Study||41
7764445|NCT01403376|19116169|P1|COMPLETED|Overall Study||41
7764446|NCT01403376|19116167|P3|STARTED|Overall Study||46
7764447|NCT01403376|19116168|P2|STARTED|Overall Study||41
7764448|NCT01403376|19116169|P1|STARTED|Overall Study||41
7764449|NCT01403246|19116189|P1|NOT COMPLETED|Overall Study||0
7764450|NCT01403246|19116189|P1|COMPLETED|Overall Study||9
7764451|NCT01403246|19116189|P1|STARTED|Overall Study||9
7764452|NCT01403194|19116193|P1|NOT COMPLETED|Overall Study||10
7764453|NCT01403194|19116193|P1|COMPLETED|Overall Study||1
7764454|NCT01403194|19116193|P1|STARTED|Overall Study||11
7764455|NCT01403116|19116201|P2|NOT COMPLETED|Overall Study||27
7764456|NCT01403116|19116202|P1|NOT COMPLETED|Overall Study||32
7764457|NCT01403116|19116201|P2|COMPLETED|Overall Study||133
7764458|NCT01403116|19116202|P1|COMPLETED|Overall Study||129
7764459|NCT01403116|19116201|P2|Randomized in Error/ No Treatment Recvd|Overall Study||3
7764460|NCT01403116|19116202|P1|Randomized in Error/ No Treatment Recvd|Overall Study||1
7764461|NCT01403116|19116201|P2|Randomized|Overall Study||163
7764462|NCT01403116|19116202|P1|Randomized|Overall Study||162
7764463|NCT01403116|19116201|P2|STARTED|Overall Study||160
7764464|NCT01403116|19116202|P1|STARTED|Overall Study||161
7764465|NCT01403090|19116209|P1|NOT COMPLETED|Overall Study||0
7764466|NCT01403090|19116209|P1|COMPLETED|Overall Study||8
7764467|NCT01403090|19116209|P1|STARTED|Overall Study||8
7764468|NCT01403051|19116215|P2|NOT COMPLETED|Overall Study||6
7764469|NCT01403051|19116216|P1|NOT COMPLETED|Overall Study||10
7764470|NCT01403051|19116215|P2|COMPLETED|Overall Study||80
7764471|NCT01403051|19116216|P1|COMPLETED|Overall Study||71
7764472|NCT01403051|19116215|P2|Initiated Study Treatment|Overall Study||86
7764473|NCT01403051|19116216|P1|Initiated Study Treatment|Overall Study||81
7764474|NCT01403051|19116215|P2|STARTED|Overall Study||86
7764475|NCT01403051|19116216|P1|STARTED|Overall Study||81
7764476|NCT01402986|19116252|P4|NOT COMPLETED|Overall Study||22
7764477|NCT01402986|19116253|P3|NOT COMPLETED|Overall Study||8
7764478|NCT01402986|19116254|P2|NOT COMPLETED|Overall Study||15
7764479|NCT01402986|19116255|P1|NOT COMPLETED|Overall Study||9
7764480|NCT01402986|19116252|P4|COMPLETED|Overall Study||129
7764481|NCT01402986|19116253|P3|COMPLETED|Overall Study||67
7764482|NCT01402986|19116254|P2|COMPLETED|Overall Study||135
7764483|NCT01402986|19116255|P1|COMPLETED|Overall Study||67
7764484|NCT01402986|19116252|P4|STARTED|Overall Study||151
7764485|NCT01402986|19116253|P3|STARTED|Overall Study||75
7764486|NCT01402986|19116254|P2|STARTED|Overall Study||150
7764487|NCT01402986|19116255|P1|STARTED|Overall Study||76
7764488|NCT01402947|19116390|P2|NOT COMPLETED|Second Intervention||0
7764489|NCT01402947|19116391|P1|NOT COMPLETED|Second Intervention||0
7764490|NCT01402947|19116390|P2|COMPLETED|Second Intervention||14
7764491|NCT01402947|19116391|P1|COMPLETED|Second Intervention||15
7764492|NCT01402947|19116390|P2|STARTED|Second Intervention||14
7764493|NCT01402947|19116391|P1|STARTED|Second Intervention||15
7764494|NCT01402947|19116390|P2|NOT COMPLETED|First Intervention||1
7764495|NCT01402947|19116391|P1|NOT COMPLETED|First Intervention||0
7764496|NCT01402947|19116390|P2|COMPLETED|First Intervention||14
7764497|NCT01402947|19116391|P1|COMPLETED|First Intervention||15
7764498|NCT01402947|19116390|P2|STARTED|First Intervention||15
7764499|NCT01402947|19116391|P1|STARTED|First Intervention||15
7764500|NCT01402908|19116401|P2|NOT COMPLETED|Overall Study||18
7764501|NCT01402908|19116402|P1|NOT COMPLETED|Overall Study||34
7764502|NCT01402908|19116401|P2|COMPLETED|Overall Study||243
7764503|NCT01402908|19116402|P1|COMPLETED|Overall Study||224
7764504|NCT01402908|19116401|P2|STARTED|Overall Study||261
7764505|NCT01402908|19116402|P1|STARTED|Overall Study||258
7764506|NCT01402869|19116417|P3|NOT COMPLETED|Overall Study||1
7764507|NCT01402869|19116418|P2|NOT COMPLETED|Overall Study||0
7764508|NCT01402869|19116419|P1|NOT COMPLETED|Overall Study||0
7764509|NCT01402869|19116417|P3|COMPLETED|Overall Study||30
7764510|NCT01402869|19116418|P2|COMPLETED|Overall Study||30
7764511|NCT01402869|19116419|P1|COMPLETED|Overall Study||30
7764512|NCT01402869|19116417|P3|STARTED|Overall Study||31
7764513|NCT01402869|19116418|P2|STARTED|Overall Study||30
7764514|NCT01402869|19116419|P1|STARTED|Overall Study||30
7764515|NCT01402817|19116433|P1|NOT COMPLETED|Overall Study||11
7764516|NCT01402817|19116433|P1|COMPLETED|Overall Study||8
7764517|NCT01402817|19116433|P1|STARTED|Overall Study||19
7764518|NCT01402700|19116438|P1|NOT COMPLETED|Overall Study||7
7764519|NCT01402700|19116438|P1|COMPLETED|Overall Study||68
7764520|NCT01402700|19116438|P1|STARTED|Overall Study||75
7764521|NCT01402570|19116442|P1|NOT COMPLETED|Overall Study||1
7764522|NCT01402570|19116442|P1|COMPLETED|Overall Study||19
7764523|NCT01402570|19116442|P1|STARTED|Overall Study||20
7764524|NCT01402544|19116449|P1|NOT COMPLETED|Overall Study||6
7764525|NCT01402544|19116449|P1|COMPLETED|Overall Study||6
7764526|NCT01402544|19116449|P1|STARTED|Overall Study||12
7764527|NCT01402531|19116455|P1|NOT COMPLETED|Overall Study||0
7764528|NCT01402531|19116455|P1|COMPLETED|Overall Study||0
7764529|NCT01402531|19116455|P1|STARTED|Overall Study||0
7764530|NCT01402427|19116461|P2|NOT COMPLETED|Overall Study||0
7764531|NCT01402427|19116462|P1|NOT COMPLETED|Overall Study||0
7764532|NCT01402427|19116461|P2|COMPLETED|Overall Study||294
7764533|NCT01402427|19116462|P1|COMPLETED|Overall Study||297
7764534|NCT01402427|19116461|P2|STARTED|Overall Study||294
7764535|NCT01402427|19116462|P1|STARTED|Overall Study||297
7764536|NCT01402375|19116486|P6|NOT COMPLETED|Overall Study||0
7764537|NCT01402375|19116487|P5|NOT COMPLETED|Overall Study||0
7764538|NCT01402375|19116488|P4|NOT COMPLETED|Overall Study||0
7764539|NCT01402375|19116489|P3|NOT COMPLETED|Overall Study||0
7764540|NCT01402375|19116490|P2|NOT COMPLETED|Overall Study||0
7764541|NCT01402375|19116491|P1|NOT COMPLETED|Overall Study||0
7764542|NCT01402375|19116486|P6|COMPLETED|Overall Study||120
7764543|NCT01402375|19116487|P5|COMPLETED|Overall Study||120
7764544|NCT01402375|19116488|P4|COMPLETED|Overall Study||120
7764545|NCT01402375|19116489|P3|COMPLETED|Overall Study||120
7764546|NCT01402375|19116490|P2|COMPLETED|Overall Study||120
7764547|NCT01402375|19116491|P1|COMPLETED|Overall Study||120
7764548|NCT01402375|19116486|P6|STARTED|Overall Study||120
7764549|NCT01402375|19116487|P5|STARTED|Overall Study||120
7764550|NCT01402375|19116488|P4|STARTED|Overall Study||120
7764551|NCT01402375|19116489|P3|STARTED|Overall Study||120
7764552|NCT01402375|19116490|P2|STARTED|Overall Study||120
7764553|NCT01402375|19116491|P1|STARTED|Overall Study||120
7764554|NCT01402284|19116523|P1|NOT COMPLETED|Overall Study||14
7764555|NCT01402284|19116523|P1|COMPLETED|Overall Study||31
7764556|NCT01402284|19116523|P1|STARTED|Overall Study||45
7764557|NCT01402141|19116536|P2|NOT COMPLETED|Overall Study||2
7764558|NCT01402141|19116537|P1|NOT COMPLETED|Overall Study||1
7764559|NCT01402141|19116536|P2|COMPLETED|Overall Study||28
7764560|NCT01402141|19116537|P1|COMPLETED|Overall Study||29
7764561|NCT01402141|19116536|P2|STARTED|Overall Study||30
7764562|NCT01402141|19116537|P1|STARTED|Overall Study||30
7764563|NCT01402128|19116559|P2|NOT COMPLETED|Overall Study||0
7764564|NCT01402128|19116560|P1|NOT COMPLETED|Overall Study||1
7764565|NCT01402128|19116559|P2|COMPLETED|Overall Study||40
7764566|NCT01402128|19116560|P1|COMPLETED|Overall Study||39
7764567|NCT01402128|19116559|P2|STARTED|Overall Study||40
7764568|NCT01402128|19116560|P1|STARTED|Overall Study||40
7764569|NCT01402115|19116588|P2|NOT COMPLETED|Overall Study||1
7764570|NCT01402115|19116589|P1|NOT COMPLETED|Overall Study||1
7764571|NCT01402115|19116588|P2|COMPLETED|Overall Study||29
7764572|NCT01402115|19116589|P1|COMPLETED|Overall Study||29
7764573|NCT01402115|19116588|P2|STARTED|Overall Study||30
7764574|NCT01402115|19116589|P1|STARTED|Overall Study||30
7764575|NCT01402102|19116605|P2|NOT COMPLETED|Overall Study||3
7764576|NCT01402102|19116606|P1|NOT COMPLETED|Overall Study||2
7764577|NCT01402102|19116605|P2|COMPLETED|Overall Study||27
7764578|NCT01402102|19116606|P1|COMPLETED|Overall Study||28
7764579|NCT01402102|19116605|P2|STARTED|Overall Study||30
7764580|NCT01402102|19116606|P1|STARTED|Overall Study||30
7764581|NCT01402063|19116626|P2|NOT COMPLETED|Overall Study||3
7764582|NCT01402063|19116627|P1|NOT COMPLETED|Overall Study||3
7764583|NCT01402063|19116626|P2|COMPLETED|Overall Study||18
7764584|NCT01402063|19116627|P1|COMPLETED|Overall Study||39
7764585|NCT01402063|19116626|P2|STARTED|Overall Study||21
7764586|NCT01402063|19116627|P1|STARTED|Overall Study||42
7764587|NCT01402050|19116635|P2|NOT COMPLETED|Overall Study||0
7764588|NCT01402050|19116636|P1|NOT COMPLETED|Overall Study||0
7764589|NCT01402050|19116635|P2|COMPLETED|Overall Study||191
7764590|NCT01402050|19116636|P1|COMPLETED|Overall Study||185
7764591|NCT01402050|19116635|P2|STARTED|Overall Study||191
7764592|NCT01402050|19116636|P1|STARTED|Overall Study||185
7764593|NCT01402011|19116645|P3|NOT COMPLETED|Nine Month Follow-up||0
7764594|NCT01402011|19116646|P2|NOT COMPLETED|Nine Month Follow-up||1
7764595|NCT01402011|19116647|P1|NOT COMPLETED|Nine Month Follow-up||0
7764596|NCT01402011|19116645|P3|COMPLETED|Nine Month Follow-up||26
7764597|NCT01402011|19116646|P2|COMPLETED|Nine Month Follow-up||19
7764598|NCT01402011|19116647|P1|COMPLETED|Nine Month Follow-up||27
7764599|NCT01402011|19116645|P3|STARTED|Nine Month Follow-up||26
7764600|NCT01402011|19116646|P2|STARTED|Nine Month Follow-up||20
7764601|NCT01402011|19116647|P1|STARTED|Nine Month Follow-up||27
7764602|NCT01402011|19116645|P3|NOT COMPLETED|Active Treatment Period||0
7764603|NCT01402011|19116646|P2|NOT COMPLETED|Active Treatment Period||3
7764604|NCT01402011|19116647|P1|NOT COMPLETED|Active Treatment Period||1
7764605|NCT01402011|19116645|P3|COMPLETED|Active Treatment Period||26
7764606|NCT01402011|19116646|P2|COMPLETED|Active Treatment Period||20
7764607|NCT01402011|19116647|P1|COMPLETED|Active Treatment Period||27
7764608|NCT01402011|19116645|P3|STARTED|Active Treatment Period||26
7764609|NCT01402011|19116646|P2|STARTED|Active Treatment Period||23
7764610|NCT01402011|19116647|P1|STARTED|Active Treatment Period||28
7764611|NCT01402011|19116645|P3|NOT COMPLETED|Delayed Treatment Period||0
7764612|NCT01402011|19116646|P2|NOT COMPLETED|Delayed Treatment Period||0
7764613|NCT01402011|19116647|P1|NOT COMPLETED|Delayed Treatment Period||1
7764614|NCT01402011|19116645|P3|COMPLETED|Delayed Treatment Period||26
7764615|NCT01402011|19116646|P2|COMPLETED|Delayed Treatment Period||23
7764616|NCT01402011|19116647|P1|COMPLETED|Delayed Treatment Period|One patient with needle phobia declined to be treated before the 1st set of injections|28
7764617|NCT01402011|19116645|P3|STARTED|Delayed Treatment Period||26
7764618|NCT01402011|19116646|P2|STARTED|Delayed Treatment Period||23
7764619|NCT01402011|19116647|P1|STARTED|Delayed Treatment Period||29
7764620|NCT01401959|19116676|P3|NOT COMPLETED|Treated||5
7764621|NCT01401959|19116677|P2|NOT COMPLETED|Treated||8
7764622|NCT01401959|19116678|P1|NOT COMPLETED|Treated||7
7764623|NCT01401959|19116676|P3|COMPLETED|Treated||26
7764624|NCT01401959|19116677|P2|COMPLETED|Treated||34
7764625|NCT01401959|19116678|P1|COMPLETED|Treated||46
7764626|NCT01401959|19116676|P3|STARTED|Treated||31
7764627|NCT01401959|19116677|P2|STARTED|Treated||42
7764628|NCT01401959|19116678|P1|STARTED|Treated||53
7764629|NCT01401959|19116676|P3|NOT COMPLETED|Enrolled||0
7764630|NCT01401959|19116677|P2|NOT COMPLETED|Enrolled||0
7764631|NCT01401959|19116678|P1|NOT COMPLETED|Enrolled||1
7764632|NCT01401959|19116676|P3|COMPLETED|Enrolled||31
7764633|NCT01401959|19116677|P2|COMPLETED|Enrolled||42
7764634|NCT01401959|19116678|P1|COMPLETED|Enrolled||53
7764635|NCT01401959|19116676|P3|STARTED|Enrolled||31
7764636|NCT01401959|19116677|P2|STARTED|Enrolled||42
7764637|NCT01401959|19116678|P1|STARTED|Enrolled||54
7764638|NCT01401907|19116694|P2|NOT COMPLETED|Overall Study||51
7764639|NCT01401907|19116695|P1|NOT COMPLETED|Overall Study||57
7764640|NCT01401907|19116694|P2|COMPLETED|Overall Study||124
7764641|NCT01401907|19116695|P1|COMPLETED|Overall Study||118
7764642|NCT01401907|19116694|P2|12 Week Outcomes|Overall Study||153
7764643|NCT01401907|19116695|P1|12 Week Outcomes|Overall Study||148
7764644|NCT01401907|19116694|P2|STARTED|Overall Study||175
7764645|NCT01401907|19116695|P1|STARTED|Overall Study||175
7764646|NCT01401842|19116717|P2|NOT COMPLETED|Overall Study||67
7764647|NCT01401842|19116718|P1|NOT COMPLETED|Overall Study||68
7764648|NCT01401842|19116717|P2|COMPLETED|Overall Study||217
7764649|NCT01401842|19116718|P1|COMPLETED|Overall Study||230
7764650|NCT01401842|19116717|P2|STARTED|Overall Study||284
7764651|NCT01401842|19116718|P1|STARTED|Overall Study||298
7764652|NCT01401699|19116728|P1|NOT COMPLETED|Overall Study||0
7764653|NCT01401699|19116728|P1|COMPLETED|Overall Study||109
7764654|NCT01401699|19116728|P1|STARTED|Overall Study||109
7764655|NCT01401647|19116735|P3|NOT COMPLETED|Overall Study||3
7764656|NCT01401647|19116736|P2|NOT COMPLETED|Overall Study||8
7764657|NCT01401647|19116737|P1|NOT COMPLETED|Overall Study||4
7764658|NCT01401647|19116735|P3|COMPLETED|Overall Study||1056
7764659|NCT01401647|19116736|P2|COMPLETED|Overall Study||985
7764660|NCT01401647|19116737|P1|COMPLETED|Overall Study||968
7764661|NCT01401647|19116735|P3|STARTED|Overall Study||1059
7764662|NCT01401647|19116736|P2|STARTED|Overall Study||993
7764663|NCT01401647|19116737|P1|STARTED|Overall Study||972
7764664|NCT01401595|19116750|P2|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0
7764665|NCT01401595|19116751|P1|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14
7764666|NCT01401595|19116750|P2|COMPLETED|Imaging and Treatment (for NE Arm)||10
7764667|NCT01401595|19116751|P1|COMPLETED|Imaging and Treatment (for NE Arm)||18
7764668|NCT01401595|19116750|P2|STARTED|Imaging and Treatment (for NE Arm)||10
7764669|NCT01401595|19116751|P1|STARTED|Imaging and Treatment (for NE Arm)||32
7764670|NCT01401595|19116750|P2|NOT COMPLETED|Recruitment and Screening||2
7764671|NCT01401595|19116751|P1|NOT COMPLETED|Recruitment and Screening||43
7764672|NCT01401595|19116750|P2|COMPLETED|Recruitment and Screening|10 of the 12 remained eligible/interested after the initial screening visit.|10
7764673|NCT01401595|19116751|P1|COMPLETED|Recruitment and Screening|Of the 75, 32 remained interested/eligible after the initial screening period.|32
7764674|NCT01401595|19116750|P2|STARTED|Recruitment and Screening|Of 32 calls, 12 control subjects attended an initial screening visit.|12
7764675|NCT01401595|19116751|P1|STARTED|Recruitment and Screening|Of 345 calls, 75 potential NES subjects attended the screening visit and provided informed consent.|75
7764676|NCT01401582|19116762|P2|NOT COMPLETED|Overall Study||117
7764677|NCT01401582|19116763|P1|NOT COMPLETED|Overall Study||110
7764678|NCT01401582|19116762|P2|COMPLETED|Overall Study||291
7764679|NCT01401582|19116763|P1|COMPLETED|Overall Study||116
7764680|NCT01401582|19116762|P2|Baseline Completed|Overall Study||348
7764681|NCT01401582|19116763|P1|Baseline Completed|Overall Study||168
7764682|NCT01401582|19116762|P2|STARTED|Overall Study||408
7764683|NCT01401582|19116763|P1|STARTED|Overall Study||226
7764684|NCT01401543|19116779|P4|NOT COMPLETED|Fourth Intervention||0
7764685|NCT01401543|19116780|P3|NOT COMPLETED|Fourth Intervention||0
7764686|NCT01401543|19116781|P2|NOT COMPLETED|Fourth Intervention||0
7764687|NCT01401543|19116782|P1|NOT COMPLETED|Fourth Intervention||0
7764688|NCT01401543|19116779|P4|COMPLETED|Fourth Intervention||6
7764689|NCT01401543|19116780|P3|COMPLETED|Fourth Intervention||6
7764690|NCT01401543|19116781|P2|COMPLETED|Fourth Intervention||6
7764691|NCT01401543|19116782|P1|COMPLETED|Fourth Intervention||6
7764692|NCT01401543|19116779|P4|STARTED|Fourth Intervention||6
7764693|NCT01401543|19116780|P3|STARTED|Fourth Intervention||6
7764694|NCT01401543|19116781|P2|STARTED|Fourth Intervention||6
7764695|NCT01401543|19116782|P1|STARTED|Fourth Intervention||6
7764696|NCT01401543|19116779|P4|NOT COMPLETED|Third Washout Period of 1 Week||0
7764697|NCT01401543|19116780|P3|NOT COMPLETED|Third Washout Period of 1 Week||0
7764698|NCT01401543|19116781|P2|NOT COMPLETED|Third Washout Period of 1 Week||0
7764699|NCT01401543|19116782|P1|NOT COMPLETED|Third Washout Period of 1 Week||0
7764700|NCT01401543|19116779|P4|COMPLETED|Third Washout Period of 1 Week||6
7764701|NCT01401543|19116780|P3|COMPLETED|Third Washout Period of 1 Week||6
7764702|NCT01401543|19116781|P2|COMPLETED|Third Washout Period of 1 Week||6
7764703|NCT01401543|19116782|P1|COMPLETED|Third Washout Period of 1 Week||6
7764704|NCT01401543|19116779|P4|STARTED|Third Washout Period of 1 Week||6
7764705|NCT01401543|19116780|P3|STARTED|Third Washout Period of 1 Week||6
7764706|NCT01401543|19116781|P2|STARTED|Third Washout Period of 1 Week||6
7764707|NCT01401543|19116782|P1|STARTED|Third Washout Period of 1 Week||6
7764708|NCT01401543|19116779|P4|NOT COMPLETED|Third Intervention||0
7764709|NCT01401543|19116780|P3|NOT COMPLETED|Third Intervention||0
7764710|NCT01401543|19116781|P2|NOT COMPLETED|Third Intervention||0
7764711|NCT01401543|19116782|P1|NOT COMPLETED|Third Intervention||0
7764712|NCT01401543|19116779|P4|COMPLETED|Third Intervention||6
7764713|NCT01401543|19116780|P3|COMPLETED|Third Intervention||6
7764714|NCT01401543|19116781|P2|COMPLETED|Third Intervention||6
7764715|NCT01401543|19116782|P1|COMPLETED|Third Intervention||6
7764716|NCT01401543|19116779|P4|STARTED|Third Intervention||6
7764717|NCT01401543|19116780|P3|STARTED|Third Intervention||6
7764718|NCT01401543|19116781|P2|STARTED|Third Intervention||6
7764719|NCT01401543|19116782|P1|STARTED|Third Intervention||6
7764720|NCT01401543|19116779|P4|NOT COMPLETED|Second Washout Period of 1 Week||0
7764721|NCT01401543|19116780|P3|NOT COMPLETED|Second Washout Period of 1 Week||0
7764722|NCT01401543|19116781|P2|NOT COMPLETED|Second Washout Period of 1 Week||0
7764723|NCT01401543|19116782|P1|NOT COMPLETED|Second Washout Period of 1 Week||0
7764724|NCT01401543|19116779|P4|COMPLETED|Second Washout Period of 1 Week||6
7764725|NCT01401543|19116780|P3|COMPLETED|Second Washout Period of 1 Week||6
7764726|NCT01401543|19116781|P2|COMPLETED|Second Washout Period of 1 Week||6
7764727|NCT01401543|19116782|P1|COMPLETED|Second Washout Period of 1 Week||6
7764728|NCT01401543|19116779|P4|STARTED|Second Washout Period of 1 Week||6
7764729|NCT01401543|19116780|P3|STARTED|Second Washout Period of 1 Week||6
7764730|NCT01401543|19116781|P2|STARTED|Second Washout Period of 1 Week||6
7764731|NCT01401543|19116782|P1|STARTED|Second Washout Period of 1 Week||6
7764732|NCT01401543|19116779|P4|NOT COMPLETED|Second Intervention||0
7764733|NCT01401543|19116780|P3|NOT COMPLETED|Second Intervention||0
7764734|NCT01401543|19116781|P2|NOT COMPLETED|Second Intervention||0
7764735|NCT01401543|19116782|P1|NOT COMPLETED|Second Intervention||0
7764736|NCT01401543|19116779|P4|COMPLETED|Second Intervention||6
7764737|NCT01401543|19116780|P3|COMPLETED|Second Intervention||6
7764738|NCT01401543|19116781|P2|COMPLETED|Second Intervention||6
7764739|NCT01401543|19116782|P1|COMPLETED|Second Intervention||6
7764740|NCT01401543|19116779|P4|STARTED|Second Intervention||6
7764741|NCT01401543|19116780|P3|STARTED|Second Intervention||6
7764742|NCT01401543|19116781|P2|STARTED|Second Intervention||6
7764743|NCT01401543|19116782|P1|STARTED|Second Intervention||6
7764744|NCT01401543|19116779|P4|NOT COMPLETED|First Washout Period of 1 Week||0
7764745|NCT01401543|19116780|P3|NOT COMPLETED|First Washout Period of 1 Week||0
7764746|NCT01401543|19116781|P2|NOT COMPLETED|First Washout Period of 1 Week||0
7764747|NCT01401543|19116782|P1|NOT COMPLETED|First Washout Period of 1 Week||0
7764748|NCT01401543|19116779|P4|COMPLETED|First Washout Period of 1 Week||6
7764749|NCT01401543|19116780|P3|COMPLETED|First Washout Period of 1 Week||6
7764750|NCT01401543|19116781|P2|COMPLETED|First Washout Period of 1 Week||6
7764751|NCT01401543|19116782|P1|COMPLETED|First Washout Period of 1 Week||6
7764752|NCT01401543|19116779|P4|STARTED|First Washout Period of 1 Week||6
7764753|NCT01401543|19116780|P3|STARTED|First Washout Period of 1 Week||6
7764754|NCT01401543|19116781|P2|STARTED|First Washout Period of 1 Week||6
7764755|NCT01401543|19116782|P1|STARTED|First Washout Period of 1 Week||6
7764756|NCT01401543|19116779|P4|NOT COMPLETED|First Intervention||0
7764757|NCT01401543|19116780|P3|NOT COMPLETED|First Intervention||0
7764758|NCT01401543|19116781|P2|NOT COMPLETED|First Intervention||0
7764759|NCT01401543|19116782|P1|NOT COMPLETED|First Intervention||0
7764760|NCT01401543|19116779|P4|COMPLETED|First Intervention||6
7764761|NCT01401543|19116780|P3|COMPLETED|First Intervention||6
7764762|NCT01401543|19116781|P2|COMPLETED|First Intervention||6
7764763|NCT01401543|19116782|P1|COMPLETED|First Intervention||6
7764764|NCT01401543|19116779|P4|STARTED|First Intervention||6
7764765|NCT01401543|19116780|P3|STARTED|First Intervention||6
7764766|NCT01401543|19116781|P2|STARTED|First Intervention||6
7764767|NCT01401543|19116782|P1|STARTED|First Intervention||6
7764768|NCT01401530|19116807|P3|NOT COMPLETED|Overall Study||3
7764769|NCT01401530|19116808|P2|NOT COMPLETED|Overall Study||6
7764770|NCT01401530|19116809|P1|NOT COMPLETED|Overall Study||3
7764771|NCT01401530|19116807|P3|COMPLETED|Overall Study||0
7764772|NCT01401530|19116808|P2|COMPLETED|Overall Study||1
7764773|NCT01401530|19116809|P1|COMPLETED|Overall Study||0
7764774|NCT01401530|19116807|P3|STARTED|Overall Study||3
7764775|NCT01401530|19116808|P2|STARTED|Overall Study||7
7764776|NCT01401530|19116809|P1|STARTED|Overall Study||3
7764777|NCT01401517|19116849|P3|NOT COMPLETED|Overall Study||3
7764778|NCT01401517|19116850|P2|NOT COMPLETED|Overall Study||2
7764779|NCT01401517|19116851|P1|NOT COMPLETED|Overall Study||3
7764780|NCT01401517|19116849|P3|COMPLETED|Overall Study||15
7764781|NCT01401517|19116850|P2|COMPLETED|Overall Study||17
7764782|NCT01401517|19116851|P1|COMPLETED|Overall Study||15
7764783|NCT01401517|19116849|P3|STARTED|Overall Study||18
7764784|NCT01401517|19116850|P2|STARTED|Overall Study||19
7764785|NCT01401517|19116851|P1|STARTED|Overall Study||18
7764786|NCT01401478|19116868|P1|NOT COMPLETED|Overall Study||31
7764787|NCT01401478|19116868|P1|COMPLETED|Overall Study||55
7764788|NCT01401478|19116868|P1|STARTED|Overall Study||86
7764789|NCT01401465|19116881|P2|NOT COMPLETED|Treatment Period 2||2
7764790|NCT01401465|19116882|P1|NOT COMPLETED|Treatment Period 2||0
7764791|NCT01401465|19116881|P2|COMPLETED|Treatment Period 2||144
7764792|NCT01401465|19116882|P1|COMPLETED|Treatment Period 2||150
7764793|NCT01401465|19116881|P2|STARTED|Treatment Period 2||146
7764794|NCT01401465|19116882|P1|STARTED|Treatment Period 2||150
7764795|NCT01401465|19116881|P2|NOT COMPLETED|Washout||0
7764796|NCT01401465|19116882|P1|NOT COMPLETED|Washout||0
7764797|NCT01401465|19116881|P2|COMPLETED|Washout||146
7764798|NCT01401465|19116882|P1|COMPLETED|Washout||150
7764799|NCT01401465|19116881|P2|STARTED|Washout||146
7764800|NCT01401465|19116882|P1|STARTED|Washout||150
7764801|NCT01401465|19116881|P2|NOT COMPLETED|Treatment Period 1||16
7764802|NCT01401465|19116882|P1|NOT COMPLETED|Treatment Period 1||15
7764803|NCT01401465|19116881|P2|COMPLETED|Treatment Period 1||146
7764804|NCT01401465|19116882|P1|COMPLETED|Treatment Period 1||150
7764805|NCT01401465|19116881|P2|STARTED|Treatment Period 1||162
7764806|NCT01401465|19116882|P1|STARTED|Treatment Period 1||165
7764807|NCT01401452|19116945|P1|NOT COMPLETED|Overall Study||72
7764808|NCT01401452|19116945|P1|COMPLETED|Overall Study||174
7764809|NCT01401452|19116945|P1|Visit 5 (9 Months)|Overall Study||175
7764810|NCT01401452|19116945|P1|Visit 4 (6 Months)|Overall Study||172
7764811|NCT01401452|19116945|P1|Visit 3 (3 Months)|Overall Study||217
7764812|NCT01401452|19116945|P1|Visit 2 (1 Month)|Overall Study||225
7764813|NCT01401452|19116945|P1|Visit 1 (Baseline)|Overall Study||246
7764814|NCT01401452|19116945|P1|STARTED|Overall Study||246
7764815|NCT01401361|19116957|P1|NOT COMPLETED|Overall Study||28
7764816|NCT01401361|19116957|P1|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122
7764817|NCT01401361|19116957|P1|STARTED|Overall Study||150
7764818|NCT01401322|19116963|P1|NOT COMPLETED|Overall Study||2
7764819|NCT01401322|19116963|P1|COMPLETED|Overall Study||3
7764820|NCT01401322|19116963|P1|STARTED|Overall Study||5
7764821|NCT01401283|19116969|P2|NOT COMPLETED|Overall Study||10
7764822|NCT01401283|19116970|P1|NOT COMPLETED|Overall Study||10
7764823|NCT01401283|19116969|P2|COMPLETED|Overall Study||81
7764824|NCT01401283|19116970|P1|COMPLETED|Overall Study||79
7764825|NCT01401283|19116969|P2|STARTED|Overall Study||91
7764826|NCT01401283|19116970|P1|STARTED|Overall Study||89
7764827|NCT01401257|19116982|P4|NOT COMPLETED|Overall Study||2
7764828|NCT01401257|19116983|P3|NOT COMPLETED|Overall Study||3
7764829|NCT01401257|19116984|P2|NOT COMPLETED|Overall Study||2
7764830|NCT01401257|19116985|P1|NOT COMPLETED|Overall Study||0
7764831|NCT01401257|19116982|P4|COMPLETED|Overall Study||17
7764832|NCT01401257|19116983|P3|COMPLETED|Overall Study||16
7764833|NCT01401257|19116984|P2|COMPLETED|Overall Study||19
7764834|NCT01401257|19116985|P1|COMPLETED|Overall Study||21
7764835|NCT01401257|19116982|P4|STARTED|Overall Study||19
7764836|NCT01401257|19116983|P3|STARTED|Overall Study||19
7764837|NCT01401257|19116984|P2|STARTED|Overall Study||21
7764838|NCT01401257|19116985|P1|STARTED|Overall Study||21
7764839|NCT01401166|19116997|P4|NOT COMPLETED|Safety Follow-Up Period||19
7764840|NCT01401166|19116998|P3|NOT COMPLETED|Safety Follow-Up Period||17
7764841|NCT01401166|19116999|P2|NOT COMPLETED|Safety Follow-Up Period||18
7764842|NCT01401166|19117000|P1|NOT COMPLETED|Safety Follow-Up Period||25
7764843|NCT01401166|19116997|P4|COMPLETED|Safety Follow-Up Period||100
7764844|NCT01401166|19116998|P3|COMPLETED|Safety Follow-Up Period||104
7764845|NCT01401166|19116999|P2|COMPLETED|Safety Follow-Up Period||106
7764846|NCT01401166|19117000|P1|COMPLETED|Safety Follow-Up Period||99
7764847|NCT01401166|19116997|P4|STARTED|Safety Follow-Up Period|All 119 randomized participants entered follow-up regardless of whether they received treatment.|119
7764848|NCT01401166|19116998|P3|STARTED|Safety Follow-Up Period|All 121 randomized participants entered follow-up regardless of whether they received treatment.|121
7764849|NCT01401166|19116999|P2|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
7764850|NCT01401166|19117000|P1|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
7764851|NCT01401166|19116997|P4|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3
7764852|NCT01401166|19116998|P3|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2
7764853|NCT01401166|19116999|P2|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7
7764854|NCT01401166|19117000|P1|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4
7764855|NCT01401166|19116997|P4|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102
7764856|NCT01401166|19116998|P3|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105
7764857|NCT01401166|19116999|P2|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
7764858|NCT01401166|19117000|P1|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
7764859|NCT01401166|19116997|P4|STARTED|Continuation Treatment (Cycles 9 to 18)||105
7764860|NCT01401166|19116998|P3|STARTED|Continuation Treatment (Cycles 9 to 18)||107
7764861|NCT01401166|19116999|P2|STARTED|Continuation Treatment (Cycles 9 to 18)||116
7764862|NCT01401166|19117000|P1|STARTED|Continuation Treatment (Cycles 9 to 18)||113
7764863|NCT01401166|19116997|P4|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11
7764864|NCT01401166|19116998|P3|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12
7764865|NCT01401166|19116999|P2|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4
7764866|NCT01401166|19117000|P1|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6
7764867|NCT01401166|19116997|P4|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105
7764868|NCT01401166|19116998|P3|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107
7764869|NCT01401166|19116999|P2|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116
7764870|NCT01401166|19117000|P1|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113
7764871|NCT01401166|19116997|P4|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116
7764872|NCT01401166|19116998|P3|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
7764873|NCT01401166|19116999|P2|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120
7764874|NCT01401166|19117000|P1|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
7764875|NCT01401166|19116997|P4|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
7764876|NCT01401166|19116998|P3|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
7764877|NCT01401166|19116999|P2|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
7764878|NCT01401166|19117000|P1|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3
7764879|NCT01401166|19116997|P4|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116
7764880|NCT01401166|19116998|P3|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
7764881|NCT01401166|19116999|P2|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120
7764882|NCT01401166|19117000|P1|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
7764883|NCT01401166|19116997|P4|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 119 participants were randomized, but 1 did not receive any treatment.|118
7764884|NCT01401166|19116998|P3|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 121 participants were randomized who all received study treatment.|121
7764885|NCT01401166|19116999|P2|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
7764886|NCT01401166|19117000|P1|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
7764887|NCT01401153|19117036|P2|NOT COMPLETED|Second Test Day||5
7764888|NCT01401153|19117037|P1|NOT COMPLETED|Second Test Day||0
7764889|NCT01401153|19117036|P2|COMPLETED|Second Test Day||60
7764890|NCT01401153|19117037|P1|COMPLETED|Second Test Day||45
7764891|NCT01401153|19117036|P2|STARTED|Second Test Day||65
7764892|NCT01401153|19117037|P1|STARTED|Second Test Day||45
7764893|NCT01401153|19117036|P2|NOT COMPLETED|First Test Day||10
7764894|NCT01401153|19117037|P1|NOT COMPLETED|First Test Day||1
7764895|NCT01401153|19117036|P2|COMPLETED|First Test Day||45
7764896|NCT01401153|19117037|P1|COMPLETED|First Test Day||65
7764897|NCT01401153|19117036|P2|STARTED|First Test Day||55
7764898|NCT01401153|19117037|P1|STARTED|First Test Day||66
7764899|NCT01401101|19117071|P2|NOT COMPLETED|Overall Study||27
7764900|NCT01401101|19117072|P1|NOT COMPLETED|Overall Study||22
7764901|NCT01401101|19117071|P2|COMPLETED|Overall Study||171
7764902|NCT01401101|19117072|P1|COMPLETED|Overall Study||184
7764903|NCT01401101|19117071|P2|STARTED|Overall Study||198
7764904|NCT01401101|19117072|P1|STARTED|Overall Study||206
7764905|NCT01401062|19117084|P2|NOT COMPLETED|Overall Study||8
7764906|NCT01401062|19117085|P1|NOT COMPLETED|Overall Study||11
7764907|NCT01401062|19117084|P2|COMPLETED|Overall Study|At time of data entry, these 4 patients are still undergoing follow-up|4
7764908|NCT01401062|19117085|P1|COMPLETED|Overall Study||0
7764909|NCT01401062|19117084|P2|STARTED|Overall Study||12
7764910|NCT01401062|19117085|P1|STARTED|Overall Study||11
7764911|NCT01401049|19117093|P2|NOT COMPLETED|Overall Study||0
7764912|NCT01401049|19117094|P1|NOT COMPLETED|Overall Study||0
7764913|NCT01401049|19117093|P2|COMPLETED|Overall Study||0
7764914|NCT01401049|19117094|P1|COMPLETED|Overall Study||0
7764915|NCT01401049|19117093|P2|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
7764916|NCT01401049|19117094|P1|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
7764917|NCT01401023|19117102|P1|NOT COMPLETED|Overall Study||0
7764918|NCT01401023|19117102|P1|COMPLETED|Overall Study||10
7764919|NCT01401023|19117102|P1|STARTED|Overall Study||10
7764920|NCT01401010|19117112|P2|NOT COMPLETED|Overall Study||0
7764921|NCT01401010|19117113|P1|NOT COMPLETED|Overall Study||1
7764922|NCT01401010|19117112|P2|COMPLETED|Overall Study||6
7764923|NCT01401010|19117113|P1|COMPLETED|Overall Study||5
7764924|NCT01401010|19117112|P2|STARTED|Overall Study||6
7764925|NCT01401010|19117113|P1|STARTED|Overall Study||6
7764926|NCT01400971|19117136|P1|NOT COMPLETED|Overall Study||917
7764927|NCT01400971|19117136|P1|COMPLETED|Overall Study||3382
7764928|NCT01400971|19117136|P1|Complete Treatment Data|Overall Study||2528
7764929|NCT01400971|19117136|P1|STARTED|Overall Study||4299
7764930|NCT01400958|19117145|P2|NOT COMPLETED|Overall Study||2
7764931|NCT01400958|19117146|P1|NOT COMPLETED|Overall Study||1
7764932|NCT01400958|19117145|P2|COMPLETED|Overall Study||1
7764933|NCT01400958|19117146|P1|COMPLETED|Overall Study||2
7764934|NCT01400958|19117145|P2|STARTED|Overall Study||3
7764935|NCT01400958|19117146|P1|STARTED|Overall Study||3
7764936|NCT01400932|19117156|P2|NOT COMPLETED|Overall Study||15
7764937|NCT01400932|19117157|P1|NOT COMPLETED|Overall Study||14
7764938|NCT01400932|19117156|P2|COMPLETED|Overall Study||167
7764939|NCT01400932|19117157|P1|COMPLETED|Overall Study||164
7764940|NCT01400932|19117156|P2|STARTED|Overall Study||182
7764941|NCT01400932|19117157|P1|STARTED|Overall Study||178
7764942|NCT01400919|19117179|P1|NOT COMPLETED|Overall Study||8
7764943|NCT01400919|19117179|P1|COMPLETED|Overall Study||67
7764944|NCT01400919|19117179|P1|STARTED|Overall Study||75
7764945|NCT01400906|19117183|P6|NOT COMPLETED|Treatment Period 3||0
7764946|NCT01400906|19117184|P5|NOT COMPLETED|Treatment Period 3||0
7764947|NCT01400906|19117185|P4|NOT COMPLETED|Treatment Period 3||0
7764948|NCT01400906|19117186|P3|NOT COMPLETED|Treatment Period 3||0
7764949|NCT01400906|19117187|P2|NOT COMPLETED|Treatment Period 3||0
7764950|NCT01400906|19117188|P1|NOT COMPLETED|Treatment Period 3||0
7764951|NCT01400906|19117183|P6|COMPLETED|Treatment Period 3||5
7764952|NCT01400906|19117184|P5|COMPLETED|Treatment Period 3||6
7764953|NCT01400906|19117185|P4|COMPLETED|Treatment Period 3||6
7764954|NCT01400906|19117186|P3|COMPLETED|Treatment Period 3||6
7764955|NCT01400906|19117187|P2|COMPLETED|Treatment Period 3||6
7764956|NCT01400906|19117188|P1|COMPLETED|Treatment Period 3||6
7764957|NCT01400906|19117183|P6|STARTED|Treatment Period 3||5
7764958|NCT01400906|19117184|P5|STARTED|Treatment Period 3||6
7764959|NCT01400906|19117185|P4|STARTED|Treatment Period 3||6
7764960|NCT01400906|19117186|P3|STARTED|Treatment Period 3||6
7764961|NCT01400906|19117187|P2|STARTED|Treatment Period 3||6
7764962|NCT01400906|19117188|P1|STARTED|Treatment Period 3||6
7764963|NCT01400906|19117183|P6|NOT COMPLETED|Washout Period 2||0
7764964|NCT01400906|19117184|P5|NOT COMPLETED|Washout Period 2||0
7764965|NCT01400906|19117185|P4|NOT COMPLETED|Washout Period 2||0
7764966|NCT01400906|19117186|P3|NOT COMPLETED|Washout Period 2||0
7764967|NCT01400906|19117187|P2|NOT COMPLETED|Washout Period 2||0
7764968|NCT01400906|19117188|P1|NOT COMPLETED|Washout Period 2||0
7764969|NCT01400906|19117183|P6|COMPLETED|Washout Period 2||5
7764970|NCT01400906|19117184|P5|COMPLETED|Washout Period 2||6
7764971|NCT01400906|19117185|P4|COMPLETED|Washout Period 2||6
7764972|NCT01400906|19117186|P3|COMPLETED|Washout Period 2||6
7764973|NCT01400906|19117187|P2|COMPLETED|Washout Period 2||6
7764974|NCT01400906|19117188|P1|COMPLETED|Washout Period 2||6
7764975|NCT01400906|19117183|P6|STARTED|Washout Period 2||5
7764976|NCT01400906|19117184|P5|STARTED|Washout Period 2||6
7764977|NCT01400906|19117185|P4|STARTED|Washout Period 2||6
7764978|NCT01400906|19117186|P3|STARTED|Washout Period 2||6
7764979|NCT01400906|19117187|P2|STARTED|Washout Period 2||6
7764980|NCT01400906|19117188|P1|STARTED|Washout Period 2||6
7764981|NCT01400906|19117183|P6|NOT COMPLETED|Treatment Period 2||0
7764982|NCT01400906|19117184|P5|NOT COMPLETED|Treatment Period 2||0
7764983|NCT01400906|19117185|P4|NOT COMPLETED|Treatment Period 2||0
7764984|NCT01400906|19117186|P3|NOT COMPLETED|Treatment Period 2||0
7764985|NCT01400906|19117187|P2|NOT COMPLETED|Treatment Period 2||0
7764986|NCT01400906|19117188|P1|NOT COMPLETED|Treatment Period 2||0
7764987|NCT01400906|19117183|P6|COMPLETED|Treatment Period 2||5
7764988|NCT01400906|19117184|P5|COMPLETED|Treatment Period 2||6
7764989|NCT01400906|19117185|P4|COMPLETED|Treatment Period 2||6
7764990|NCT01400906|19117186|P3|COMPLETED|Treatment Period 2||6
7764991|NCT01400906|19117187|P2|COMPLETED|Treatment Period 2||6
7764992|NCT01400906|19117188|P1|COMPLETED|Treatment Period 2||6
7764993|NCT01400906|19117183|P6|STARTED|Treatment Period 2||5
7764994|NCT01400906|19117184|P5|STARTED|Treatment Period 2||6
7764995|NCT01400906|19117185|P4|STARTED|Treatment Period 2||6
7764996|NCT01400906|19117186|P3|STARTED|Treatment Period 2||6
7764997|NCT01400906|19117187|P2|STARTED|Treatment Period 2||6
7764998|NCT01400906|19117188|P1|STARTED|Treatment Period 2||6
7764999|NCT01400906|19117183|P6|NOT COMPLETED|Washout Period 1||0
7765000|NCT01400906|19117184|P5|NOT COMPLETED|Washout Period 1||0
7765001|NCT01400906|19117185|P4|NOT COMPLETED|Washout Period 1||0
7765002|NCT01400906|19117186|P3|NOT COMPLETED|Washout Period 1||0
7765003|NCT01400906|19117187|P2|NOT COMPLETED|Washout Period 1||0
7765004|NCT01400906|19117188|P1|NOT COMPLETED|Washout Period 1||0
7765005|NCT01400906|19117183|P6|COMPLETED|Washout Period 1||5
7765006|NCT01400906|19117184|P5|COMPLETED|Washout Period 1||6
7765007|NCT01400906|19117185|P4|COMPLETED|Washout Period 1||6
7765008|NCT01400906|19117186|P3|COMPLETED|Washout Period 1||6
7765009|NCT01400906|19117187|P2|COMPLETED|Washout Period 1||6
7765010|NCT01400906|19117188|P1|COMPLETED|Washout Period 1||6
7765011|NCT01400906|19117183|P6|STARTED|Washout Period 1||5
7765012|NCT01400906|19117184|P5|STARTED|Washout Period 1||6
7765013|NCT01400906|19117185|P4|STARTED|Washout Period 1||6
7765014|NCT01400906|19117186|P3|STARTED|Washout Period 1||6
7765015|NCT01400906|19117187|P2|STARTED|Washout Period 1||6
7765016|NCT01400906|19117188|P1|STARTED|Washout Period 1||6
7765017|NCT01400906|19117183|P6|NOT COMPLETED|Treatment Period 1||0
7765018|NCT01400906|19117184|P5|NOT COMPLETED|Treatment Period 1||0
7765019|NCT01400906|19117185|P4|NOT COMPLETED|Treatment Period 1||0
7765020|NCT01400906|19117186|P3|NOT COMPLETED|Treatment Period 1||0
7765021|NCT01400906|19117187|P2|NOT COMPLETED|Treatment Period 1||0
7765022|NCT01400906|19117188|P1|NOT COMPLETED|Treatment Period 1||0
7765023|NCT01400906|19117183|P6|COMPLETED|Treatment Period 1||5
7765024|NCT01400906|19117184|P5|COMPLETED|Treatment Period 1||6
7765025|NCT01400906|19117185|P4|COMPLETED|Treatment Period 1||6
7765026|NCT01400906|19117186|P3|COMPLETED|Treatment Period 1||6
7765027|NCT01400906|19117187|P2|COMPLETED|Treatment Period 1||6
7765028|NCT01400906|19117188|P1|COMPLETED|Treatment Period 1||6
7765029|NCT01400906|19117183|P6|STARTED|Treatment Period 1||5
7765030|NCT01400906|19117184|P5|STARTED|Treatment Period 1||6
7765031|NCT01400906|19117185|P4|STARTED|Treatment Period 1||6
7765032|NCT01400906|19117186|P3|STARTED|Treatment Period 1||6
7765033|NCT01400906|19117187|P2|STARTED|Treatment Period 1||6
7765034|NCT01400906|19117188|P1|STARTED|Treatment Period 1||6
7765035|NCT01400893|19117222|P2|NOT COMPLETED|Overall Study||27
7765036|NCT01400893|19117223|P1|NOT COMPLETED|Overall Study||27
7765037|NCT01400893|19117222|P2|COMPLETED|Overall Study||38
7765038|NCT01400893|19117223|P1|COMPLETED|Overall Study||42
7765039|NCT01400893|19117222|P2|STARTED|Overall Study||65
7765040|NCT01400893|19117223|P1|STARTED|Overall Study||69
7765041|NCT01400880|19117231|P1|NOT COMPLETED|Overall Study||2
7765042|NCT01400880|19117231|P1|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101
7765043|NCT01400880|19117231|P1|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103
7765044|NCT01400841|19117235|P1|NOT COMPLETED|Extended Study Phase (2 Years)||2
7765045|NCT01400841|19117235|P1|COMPLETED|Extended Study Phase (2 Years)||11
7765046|NCT01400841|19117235|P1|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation
~1 subject death prior to agreeing to extended follow-up"|13
7765047|NCT01400841|19117235|P1|NOT COMPLETED|Initial Study Phase (6 Months)||1
7765048|NCT01400841|19117235|P1|COMPLETED|Initial Study Phase (6 Months)||15
7765049|NCT01400841|19117235|P1|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16
7765050|NCT01400698|19117273|P6|NOT COMPLETED|Overall Study||6
7765051|NCT01400698|19117274|P5|NOT COMPLETED|Overall Study||7
7765052|NCT01400698|19117275|P4|NOT COMPLETED|Overall Study||8
7765053|NCT01400698|19117276|P3|NOT COMPLETED|Overall Study||2
7765054|NCT01400698|19117277|P2|NOT COMPLETED|Overall Study||11
7765055|NCT01400698|19117278|P1|NOT COMPLETED|Overall Study||15
7765056|NCT01400698|19117273|P6|COMPLETED|Overall Study||9
7765057|NCT01400698|19117274|P5|COMPLETED|Overall Study||7
7765058|NCT01400698|19117275|P4|COMPLETED|Overall Study||6
7765059|NCT01400698|19117276|P3|COMPLETED|Overall Study||0
7765060|NCT01400698|19117277|P2|COMPLETED|Overall Study||12
7765061|NCT01400698|19117278|P1|COMPLETED|Overall Study||8
7765062|NCT01400698|19117273|P6|STARTED|Overall Study||15
7765063|NCT01400698|19117274|P5|STARTED|Overall Study||14
7765064|NCT01400698|19117275|P4|STARTED|Overall Study||14
7765065|NCT01400698|19117276|P3|STARTED|Overall Study||2
7765066|NCT01400698|19117277|P2|STARTED|Overall Study||23
7765067|NCT01400698|19117278|P1|STARTED|Overall Study||23
7765068|NCT01400516|19117302|P2|NOT COMPLETED|Extension Trial||0
7765069|NCT01400516|19117303|P1|NOT COMPLETED|Extension Trial||0
7765070|NCT01400516|19117302|P2|COMPLETED|Extension Trial||7
7765071|NCT01400516|19117303|P1|COMPLETED|Extension Trial||6
7765072|NCT01400516|19117302|P2|STARTED|Extension Trial|Only 7 participants in the Teriparatide arm entered the Extension Trial.|7
7765073|NCT01400516|19117303|P1|STARTED|Extension Trial|Only 6 participants in the Control arm entered the Extension Trial.|6
7765074|NCT01400516|19117302|P2|NOT COMPLETED|Primary Trial||2
7765075|NCT01400516|19117303|P1|NOT COMPLETED|Primary Trial||0
7765076|NCT01400516|19117302|P2|COMPLETED|Primary Trial||12
7765077|NCT01400516|19117303|P1|COMPLETED|Primary Trial||12
7765078|NCT01400516|19117302|P2|STARTED|Primary Trial||14
7765079|NCT01400516|19117303|P1|STARTED|Primary Trial||12
7765080|NCT01400503|19117313|P1|NOT COMPLETED|Overall Study||60
7765081|NCT01400503|19117313|P1|COMPLETED|Overall Study||0
7765082|NCT01400503|19117313|P1|STARTED|Overall Study||60
7765083|NCT01400477|19117324|P2|NOT COMPLETED|Overall Study||0
7765084|NCT01400477|19117325|P1|NOT COMPLETED|Overall Study||2
7765085|NCT01400477|19117324|P2|COMPLETED|Overall Study||40
7765086|NCT01400477|19117325|P1|COMPLETED|Overall Study||38
7765087|NCT01400477|19117324|P2|STARTED|Overall Study||40
7765088|NCT01400477|19117325|P1|STARTED|Overall Study||40
7765089|NCT01400451|19117336|P3|NOT COMPLETED|Combination Treatment (or Intended)||2
7765090|NCT01400451|19117337|P2|NOT COMPLETED|Combination Treatment (or Intended)||4
7765091|NCT01400451|19117338|P1|NOT COMPLETED|Combination Treatment (or Intended)||6
7765092|NCT01400451|19117336|P3|COMPLETED|Combination Treatment (or Intended)||0
7765093|NCT01400451|19117337|P2|COMPLETED|Combination Treatment (or Intended)||0
7765094|NCT01400451|19117338|P1|COMPLETED|Combination Treatment (or Intended)||0
7765095|NCT01400451|19117336|P3|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2
7765096|NCT01400451|19117337|P2|STARTED|Combination Treatment (or Intended)||4
7765097|NCT01400451|19117338|P1|STARTED|Combination Treatment (or Intended)||6
7765098|NCT01400451|19117336|P3|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
7765099|NCT01400451|19117337|P2|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
7765100|NCT01400451|19117338|P1|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
7765101|NCT01400451|19117336|P3|COMPLETED|28 Day Lead In With Vemurafenib Alone||2
7765102|NCT01400451|19117337|P2|COMPLETED|28 Day Lead In With Vemurafenib Alone||4
7765103|NCT01400451|19117338|P1|COMPLETED|28 Day Lead In With Vemurafenib Alone||6
7765104|NCT01400451|19117336|P3|STARTED|28 Day Lead In With Vemurafenib Alone||2
7765105|NCT01400451|19117337|P2|STARTED|28 Day Lead In With Vemurafenib Alone||4
7765106|NCT01400451|19117338|P1|STARTED|28 Day Lead In With Vemurafenib Alone||6
7765107|NCT01400425|19117352|P1|NOT COMPLETED|Overall Study||10
7765108|NCT01400425|19117352|P1|COMPLETED|Overall Study||229
7765109|NCT01400425|19117352|P1|STARTED|Overall Study||239
7765110|NCT01400412|19117365|P2|NOT COMPLETED|Overall Study||17
7765111|NCT01400412|19117366|P1|NOT COMPLETED|Overall Study||10
7765112|NCT01400412|19117365|P2|COMPLETED|Overall Study||115
7765113|NCT01400412|19117366|P1|COMPLETED|Overall Study||120
7765114|NCT01400412|19117365|P2|STARTED|Overall Study||132
7765115|NCT01400412|19117366|P1|STARTED|Overall Study||130
7765116|NCT01400243|19117412|P2|NOT COMPLETED|Overall Study||11
7765117|NCT01400243|19117413|P1|NOT COMPLETED|Overall Study||8
7765118|NCT01400243|19117412|P2|COMPLETED|Overall Study||52
7765119|NCT01400243|19117413|P1|COMPLETED|Overall Study||56
7765120|NCT01400243|19117412|P2|STARTED|Overall Study||63
7765121|NCT01400243|19117413|P1|STARTED|Overall Study||64
7765122|NCT01400139|19117435|P1|NOT COMPLETED|HYD Extension Period||23
7765123|NCT01400139|19117435|P1|COMPLETED|HYD Extension Period||83
7765124|NCT01400139|19117435|P1|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106
7765125|NCT01400139|19117435|P1|NOT COMPLETED|HYD Core Study||512
7765126|NCT01400139|19117435|P1|COMPLETED|HYD Core Study||410
7765127|NCT01400139|19117435|P1|STARTED|HYD Core Study||922
7765128|NCT01400113|19117458|P2|NOT COMPLETED|Overall Study||1
7765129|NCT01400113|19117459|P1|NOT COMPLETED|Overall Study||1
7765130|NCT01400113|19117458|P2|COMPLETED|Overall Study||59
7765131|NCT01400113|19117459|P1|COMPLETED|Overall Study||59
7765132|NCT01400113|19117458|P2|STARTED|Overall Study||60
7765133|NCT01400113|19117459|P1|STARTED|Overall Study||60
7765134|NCT01399905|19117467|P2|NOT COMPLETED|Overall Study||1
7765135|NCT01399905|19117468|P1|NOT COMPLETED|Overall Study||1
7765136|NCT01399905|19117467|P2|COMPLETED|Overall Study|Subject was treated at least one dose of carbidopa before withdrawing from the study.|6
7765137|NCT01399905|19117468|P1|COMPLETED|Overall Study|Subject withdrew from the study before receiving treatment.|6
7765138|NCT01399905|19117467|P2|STARTED|Overall Study||7
7765139|NCT01399905|19117468|P1|STARTED|Overall Study||7
7765140|NCT01399866|19117482|P2|NOT COMPLETED|Overall Study||2
7765141|NCT01399866|19117483|P1|NOT COMPLETED|Overall Study||4
7765142|NCT01399866|19117482|P2|COMPLETED|Overall Study||28
7765143|NCT01399866|19117483|P1|COMPLETED|Overall Study||28
7765144|NCT01399866|19117482|P2|STARTED|Overall Study||30
7765145|NCT01399866|19117483|P1|STARTED|Overall Study||32
7765146|NCT01399827|19117501|P2|NOT COMPLETED|Overall Study||0
7765147|NCT01399827|19117502|P1|NOT COMPLETED|Overall Study||0
7765148|NCT01399827|19117501|P2|COMPLETED|Overall Study||1
7765149|NCT01399827|19117502|P1|COMPLETED|Overall Study||1
7765150|NCT01399827|19117501|P2|STARTED|Overall Study||1
7765151|NCT01399827|19117502|P1|STARTED|Overall Study||1
7765152|NCT01399788|19117516|P2|NOT COMPLETED|Second Intervention Period||0
7765153|NCT01399788|19117517|P1|NOT COMPLETED|Second Intervention Period||0
7765154|NCT01399788|19117516|P2|COMPLETED|Second Intervention Period||18
7765155|NCT01399788|19117517|P1|COMPLETED|Second Intervention Period||17
7765156|NCT01399788|19117516|P2|STARTED|Second Intervention Period||18
7765157|NCT01399788|19117517|P1|STARTED|Second Intervention Period||17
7765158|NCT01399788|19117516|P2|NOT COMPLETED|Washout Period (at Least 1 Week)||0
7765159|NCT01399788|19117517|P1|NOT COMPLETED|Washout Period (at Least 1 Week)||0
7765160|NCT01399788|19117516|P2|COMPLETED|Washout Period (at Least 1 Week)||18
7765161|NCT01399788|19117517|P1|COMPLETED|Washout Period (at Least 1 Week)||17
7765162|NCT01399788|19117516|P2|STARTED|Washout Period (at Least 1 Week)||18
7765163|NCT01399788|19117517|P1|STARTED|Washout Period (at Least 1 Week)||17
7765164|NCT01399788|19117516|P2|NOT COMPLETED|First Intervention Period||0
7765165|NCT01399788|19117517|P1|NOT COMPLETED|First Intervention Period||1
7765166|NCT01399788|19117516|P2|COMPLETED|First Intervention Period||18
7765167|NCT01399788|19117517|P1|COMPLETED|First Intervention Period||17
7765168|NCT01399788|19117516|P2|STARTED|First Intervention Period||18
7765169|NCT01399788|19117517|P1|STARTED|First Intervention Period||18
7765170|NCT01399736|19117539|P2|NOT COMPLETED|Overall Study||4
7765171|NCT01399736|19117540|P1|NOT COMPLETED|Overall Study||4
7765172|NCT01399736|19117539|P2|COMPLETED|Overall Study||586
7765173|NCT01399736|19117540|P1|COMPLETED|Overall Study||291
7765174|NCT01399736|19117539|P2|STARTED|Overall Study||590
7765175|NCT01399736|19117540|P1|STARTED|Overall Study||295
7765176|NCT01399723|19117616|P2|NOT COMPLETED|Overall Study||1
7765177|NCT01399723|19117617|P1|NOT COMPLETED|Overall Study||0
7765178|NCT01399723|19117616|P2|COMPLETED|Overall Study||263
7765179|NCT01399723|19117617|P1|COMPLETED|Overall Study||263
7765180|NCT01399723|19117616|P2|STARTED|Overall Study||264
7765181|NCT01399723|19117617|P1|STARTED|Overall Study||263
7765182|NCT01399697|19117630|P3|NOT COMPLETED|Overall Study||4
7765183|NCT01399697|19117631|P2|NOT COMPLETED|Overall Study||3
7765184|NCT01399697|19117632|P1|NOT COMPLETED|Overall Study||41
7765185|NCT01399697|19117630|P3|COMPLETED|Overall Study||78
7765186|NCT01399697|19117631|P2|COMPLETED|Overall Study||80
7765187|NCT01399697|19117632|P1|COMPLETED|Overall Study||55
7765188|NCT01399697|19117630|P3|STARTED|Overall Study||82
7765189|NCT01399697|19117631|P2|STARTED|Overall Study||83
7765190|NCT01399697|19117632|P1|STARTED|Overall Study||96
7765191|NCT01399619|19117659|P4|NOT COMPLETED|Overall Study||17
7765192|NCT01399619|19117660|P3|NOT COMPLETED|Overall Study||12
7765193|NCT01399619|19117661|P2|NOT COMPLETED|Overall Study||0
7765194|NCT01399619|19117662|P1|NOT COMPLETED|Overall Study||25
7765195|NCT01399619|19117659|P4|COMPLETED|Overall Study||0
7765196|NCT01399619|19117660|P3|COMPLETED|Overall Study||74
7765197|NCT01399619|19117661|P2|COMPLETED|Overall Study||84
7765198|NCT01399619|19117662|P1|COMPLETED|Overall Study||98
7765199|NCT01399619|19117659|P4|STARTED|Overall Study||17
7765200|NCT01399619|19117660|P3|STARTED|Overall Study||86
7765201|NCT01399619|19117661|P2|STARTED|Overall Study||84
7765202|NCT01399619|19117662|P1|STARTED|Overall Study||123
7765203|NCT01399593|19117725|P2|NOT COMPLETED|Overall Study||2
7765204|NCT01399593|19117726|P1|NOT COMPLETED|Overall Study||3
7765205|NCT01399593|19117725|P2|COMPLETED|Overall Study||49
7765206|NCT01399593|19117726|P1|COMPLETED|Overall Study||48
7765207|NCT01399593|19117725|P2|STARTED|Overall Study||51
7765208|NCT01399593|19117726|P1|STARTED|Overall Study||51
7765209|NCT01399268|19117734|P2|NOT COMPLETED|Overall Study||0
7765210|NCT01399268|19117735|P1|NOT COMPLETED|Overall Study||0
7765211|NCT01399268|19117734|P2|COMPLETED|Overall Study||15
7765212|NCT01399268|19117735|P1|COMPLETED|Overall Study||15
7765213|NCT01399268|19117734|P2|STARTED|Overall Study||15
7765214|NCT01399268|19117735|P1|STARTED|Overall Study||15
7765215|NCT01399229|19117753|P3|NOT COMPLETED|Overall Study||0
7765216|NCT01399229|19117754|P2|NOT COMPLETED|Overall Study||0
7765217|NCT01399229|19117755|P1|NOT COMPLETED|Overall Study||0
7765218|NCT01399229|19117753|P3|COMPLETED|Overall Study||5
7765219|NCT01399229|19117754|P2|COMPLETED|Overall Study||5
7765220|NCT01399229|19117755|P1|COMPLETED|Overall Study||20
7765221|NCT01399229|19117753|P3|STARTED|Overall Study||5
7765222|NCT01399229|19117754|P2|STARTED|Overall Study||5
7765223|NCT01399229|19117755|P1|STARTED|Overall Study||20
7765224|NCT01399190|19117759|P1|NOT COMPLETED|Overall Study||20
7765225|NCT01399190|19117759|P1|COMPLETED|Overall Study||48
7765226|NCT01399190|19117759|P1|Evaluable for Primary Endpoint Analysis|Overall Study||60
7765227|NCT01399190|19117759|P1|Included in Final Analysis|Overall Study||63
7765228|NCT01399190|19117759|P1|STARTED|Overall Study||68
7765229|NCT01399125|19117767|P2|NOT COMPLETED|Overall Study||60
7765230|NCT01399125|19117768|P1|NOT COMPLETED|Overall Study||51
7765231|NCT01399125|19117767|P2|COMPLETED|Overall Study||193
7765232|NCT01399125|19117768|P1|COMPLETED|Overall Study||197
7765233|NCT01399125|19117767|P2|Per Protocol (PP) Population|Overall Study||188
7765234|NCT01399125|19117768|P1|Per Protocol (PP) Population|Overall Study||192
7765235|NCT01399125|19117767|P2|STARTED|Overall Study||253
7765236|NCT01399125|19117768|P1|STARTED|Overall Study||248
7765237|NCT01399099|19117782|P1|NOT COMPLETED|Overall Study||31
7765238|NCT01399099|19117782|P1|COMPLETED|Overall Study||36
7765239|NCT01399099|19117782|P1|6 Months|Overall Study||47
7765240|NCT01399099|19117782|P1|STARTED|Overall Study||67
7765241|NCT01399047|19117789|P2|NOT COMPLETED|Overall Study||1
7765242|NCT01399047|19117790|P1|NOT COMPLETED|Overall Study||0
7765243|NCT01399047|19117789|P2|COMPLETED|Overall Study||8
7765244|NCT01399047|19117790|P1|COMPLETED|Overall Study||10
7765245|NCT01399047|19117789|P2|STARTED|Overall Study||9
7765246|NCT01399047|19117790|P1|STARTED|Overall Study||10
7765247|NCT01399008|19117807|P3|NOT COMPLETED|Overall Study||2
7765248|NCT01399008|19117808|P2|NOT COMPLETED|Overall Study||5
7765249|NCT01399008|19117809|P1|NOT COMPLETED|Overall Study||3
7765250|NCT01399008|19117807|P3|COMPLETED|Overall Study||31
7765251|NCT01399008|19117808|P2|COMPLETED|Overall Study||27
7765252|NCT01399008|19117809|P1|COMPLETED|Overall Study||32
7765253|NCT01399008|19117807|P3|STARTED|Overall Study||33
7765254|NCT01399008|19117808|P2|STARTED|Overall Study||32
7765255|NCT01399008|19117809|P1|STARTED|Overall Study||35
7765256|NCT01398982|19117819|P2|NOT COMPLETED|Overall Study||2
7765257|NCT01398982|19117820|P1|NOT COMPLETED|Overall Study||6
7765258|NCT01398982|19117819|P2|COMPLETED|Overall Study||47
7765259|NCT01398982|19117820|P1|COMPLETED|Overall Study||38
7765260|NCT01398982|19117819|P2|STARTED|Overall Study||49
7765261|NCT01398982|19117820|P1|STARTED|Overall Study||44
7765262|NCT01398956|19117826|P1|NOT COMPLETED|Overall Study||10
7765263|NCT01398956|19117826|P1|COMPLETED|Overall Study||34
7765264|NCT01398956|19117826|P1|STARTED|Overall Study||44
7765265|NCT01398943|19117834|P4|NOT COMPLETED|Second Intervention (1 Day)||0
7765266|NCT01398943|19117835|P3|NOT COMPLETED|Second Intervention (1 Day)||0
7765267|NCT01398943|19117836|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7765268|NCT01398943|19117837|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7765269|NCT01398943|19117834|P4|COMPLETED|Second Intervention (1 Day)||15
7765270|NCT01398943|19117835|P3|COMPLETED|Second Intervention (1 Day)||15
7765271|NCT01398943|19117836|P2|COMPLETED|Second Intervention (1 Day)||15
7765272|NCT01398943|19117837|P1|COMPLETED|Second Intervention (1 Day)||15
7765273|NCT01398943|19117834|P4|STARTED|Second Intervention (1 Day)||15
7765274|NCT01398943|19117835|P3|STARTED|Second Intervention (1 Day)||15
7765275|NCT01398943|19117836|P2|STARTED|Second Intervention (1 Day)||15
7765276|NCT01398943|19117837|P1|STARTED|Second Intervention (1 Day)||15
7765277|NCT01398943|19117834|P4|NOT COMPLETED|Washout (2-7 Days)||0
7765278|NCT01398943|19117835|P3|NOT COMPLETED|Washout (2-7 Days)||0
7765279|NCT01398943|19117836|P2|NOT COMPLETED|Washout (2-7 Days)||0
7765280|NCT01398943|19117837|P1|NOT COMPLETED|Washout (2-7 Days)||0
7765281|NCT01398943|19117834|P4|COMPLETED|Washout (2-7 Days)||15
7765282|NCT01398943|19117835|P3|COMPLETED|Washout (2-7 Days)||15
7765283|NCT01398943|19117836|P2|COMPLETED|Washout (2-7 Days)||15
7765284|NCT01398943|19117837|P1|COMPLETED|Washout (2-7 Days)||15
7765285|NCT01398943|19117834|P4|STARTED|Washout (2-7 Days)||15
7765286|NCT01398943|19117835|P3|STARTED|Washout (2-7 Days)||15
7765287|NCT01398943|19117836|P2|STARTED|Washout (2-7 Days)||15
7765288|NCT01398943|19117837|P1|STARTED|Washout (2-7 Days)||15
7765289|NCT01398943|19117834|P4|NOT COMPLETED|First Intervention (1 Day)||0
7765290|NCT01398943|19117835|P3|NOT COMPLETED|First Intervention (1 Day)||0
7765291|NCT01398943|19117836|P2|NOT COMPLETED|First Intervention (1 Day)||0
7765292|NCT01398943|19117837|P1|NOT COMPLETED|First Intervention (1 Day)||0
7765293|NCT01398943|19117834|P4|COMPLETED|First Intervention (1 Day)||15
7765294|NCT01398943|19117835|P3|COMPLETED|First Intervention (1 Day)||15
7765295|NCT01398943|19117836|P2|COMPLETED|First Intervention (1 Day)||15
7765296|NCT01398943|19117837|P1|COMPLETED|First Intervention (1 Day)||15
7765297|NCT01398943|19117834|P4|STARTED|First Intervention (1 Day)||15
7765298|NCT01398943|19117835|P3|STARTED|First Intervention (1 Day)||15
7765299|NCT01398943|19117836|P2|STARTED|First Intervention (1 Day)||15
7765300|NCT01398943|19117837|P1|STARTED|First Intervention (1 Day)||15
7765301|NCT01398852|19117845|P1|NOT COMPLETED|Overall Study||372
7765302|NCT01398852|19117845|P1|COMPLETED|Overall Study||0
7765303|NCT01398852|19117845|P1|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372
7765304|NCT01398839|19117851|P2|NOT COMPLETED|Overall Study||0
7765305|NCT01398839|19117852|P1|NOT COMPLETED|Overall Study||0
7765306|NCT01398839|19117851|P2|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37
7765307|NCT01398839|19117852|P1|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35
7765308|NCT01398839|19117851|P2|STARTED|Overall Study||37
7765309|NCT01398839|19117852|P1|STARTED|Overall Study||35
7765310|NCT01398787|19117858|P1|NOT COMPLETED|Overall Study||1
7765311|NCT01398787|19117858|P1|COMPLETED|Overall Study||197
7765312|NCT01398787|19117858|P1|STARTED|Overall Study||198
7765313|NCT01398514|19117876|P2|NOT COMPLETED|Overall Study||6
7765314|NCT01398514|19117877|P1|NOT COMPLETED|Overall Study||8
7765315|NCT01398514|19117876|P2|COMPLETED|Overall Study||20
7765316|NCT01398514|19117877|P1|COMPLETED|Overall Study||18
7765317|NCT01398514|19117876|P2|STARTED|Overall Study||26
7765318|NCT01398514|19117877|P1|STARTED|Overall Study||26
7765319|NCT01398475|19117889|P4|NOT COMPLETED|Overall Study||0
7765320|NCT01398475|19117890|P3|NOT COMPLETED|Overall Study||0
7765321|NCT01398475|19117891|P2|NOT COMPLETED|Overall Study||0
7765322|NCT01398475|19117892|P1|NOT COMPLETED|Overall Study||0
7765323|NCT01398475|19117889|P4|COMPLETED|Overall Study||4
7765324|NCT01398475|19117890|P3|COMPLETED|Overall Study||4
7765325|NCT01398475|19117891|P2|COMPLETED|Overall Study||3
7765326|NCT01398475|19117892|P1|COMPLETED|Overall Study||4
7765327|NCT01398475|19117889|P4|Received Fourth Intervention|Overall Study||4
7765328|NCT01398475|19117890|P3|Received Fourth Intervention|Overall Study||4
7765329|NCT01398475|19117891|P2|Received Fourth Intervention|Overall Study||3
7765330|NCT01398475|19117892|P1|Received Fourth Intervention|Overall Study||4
7765331|NCT01398475|19117889|P4|Received Third Intervention|Overall Study||4
7765332|NCT01398475|19117890|P3|Received Third Intervention|Overall Study||4
7765333|NCT01398475|19117891|P2|Received Third Intervention|Overall Study||3
7765334|NCT01398475|19117892|P1|Received Third Intervention|Overall Study||4
7765335|NCT01398475|19117889|P4|Received Second Intervention|Overall Study||4
7765336|NCT01398475|19117890|P3|Received Second Intervention|Overall Study||4
7765337|NCT01398475|19117891|P2|Received Second Intervention|Overall Study||3
7765338|NCT01398475|19117892|P1|Received Second Intervention|Overall Study||4
7765339|NCT01398475|19117889|P4|Received First Intervention|Overall Study||4
7765340|NCT01398475|19117890|P3|Received First Intervention|Overall Study||4
7765341|NCT01398475|19117891|P2|Received First Intervention|Overall Study||3
7765342|NCT01398475|19117892|P1|Received First Intervention|Overall Study||4
7765343|NCT01398475|19117889|P4|STARTED|Overall Study||4
7765344|NCT01398475|19117890|P3|STARTED|Overall Study||4
7765345|NCT01398475|19117891|P2|STARTED|Overall Study||3
7765346|NCT01398475|19117892|P1|STARTED|Overall Study||4
7765347|NCT01398410|19117912|P2|NOT COMPLETED|Overall Study||56
7765348|NCT01398410|19117913|P1|NOT COMPLETED|Overall Study||58
7765349|NCT01398410|19117912|P2|COMPLETED|Overall Study||148
7765350|NCT01398410|19117913|P1|COMPLETED|Overall Study||143
7765351|NCT01398410|19117912|P2|STARTED|Overall Study||204
7765352|NCT01398410|19117913|P1|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201
7765353|NCT01398358|19117924|P3|NOT COMPLETED|Overall Study||21
7765354|NCT01398358|19117925|P2|NOT COMPLETED|Overall Study||23
7765355|NCT01398358|19117926|P1|NOT COMPLETED|Overall Study||15
7765356|NCT01398358|19117924|P3|COMPLETED|Overall Study||234
7765357|NCT01398358|19117925|P2|COMPLETED|Overall Study||201
7765358|NCT01398358|19117926|P1|COMPLETED|Overall Study||203
7765359|NCT01398358|19117924|P3|STARTED|Overall Study||255
7765360|NCT01398358|19117925|P2|STARTED|Overall Study||224
7765361|NCT01398358|19117926|P1|STARTED|Overall Study||218
7765362|NCT01398280|19117939|P2|NOT COMPLETED|Overall Study||0
7765363|NCT01398280|19117940|P1|NOT COMPLETED|Overall Study||4
7765364|NCT01398280|19117939|P2|COMPLETED|Overall Study||4
7765365|NCT01398280|19117940|P1|COMPLETED|Overall Study||7
7765366|NCT01398280|19117939|P2|STARTED|Overall Study||4
7765367|NCT01398280|19117940|P1|STARTED|Overall Study||11
7765368|NCT01398176|19117948|P2|NOT COMPLETED|Overall Study||6
7765369|NCT01398176|19117949|P1|NOT COMPLETED|Overall Study||3
7765370|NCT01398176|19117948|P2|COMPLETED|Overall Study||19
7765371|NCT01398176|19117949|P1|COMPLETED|Overall Study||23
7765372|NCT01398176|19117948|P2|STARTED|Overall Study||25
7765373|NCT01398176|19117949|P1|STARTED|Overall Study||26
7765374|NCT01398059|19117955|P6|NOT COMPLETED|Overall Study||0
7765375|NCT01398059|19117956|P5|NOT COMPLETED|Overall Study||0
7765376|NCT01398059|19117957|P4|NOT COMPLETED|Overall Study||0
7765377|NCT01398059|19117958|P3|NOT COMPLETED|Overall Study||0
7765378|NCT01398059|19117959|P2|NOT COMPLETED|Overall Study||0
7765379|NCT01398059|19117960|P1|NOT COMPLETED|Overall Study||0
7765380|NCT01398059|19117955|P6|COMPLETED|Overall Study||2
7765381|NCT01398059|19117956|P5|COMPLETED|Overall Study||4
7765382|NCT01398059|19117957|P4|COMPLETED|Overall Study||2
7765383|NCT01398059|19117958|P3|COMPLETED|Overall Study||4
7765384|NCT01398059|19117959|P2|COMPLETED|Overall Study||3
7765385|NCT01398059|19117960|P1|COMPLETED|Overall Study||4
7765386|NCT01398059|19117955|P6|STARTED|Overall Study||2
7765387|NCT01398059|19117956|P5|STARTED|Overall Study||4
7765388|NCT01398059|19117957|P4|STARTED|Overall Study||2
7765389|NCT01398059|19117958|P3|STARTED|Overall Study||4
7765390|NCT01398059|19117959|P2|STARTED|Overall Study||3
7765391|NCT01398059|19117960|P1|STARTED|Overall Study||4
7765392|NCT01397890|19117982|P2|NOT COMPLETED|Overall Study||31
7765393|NCT01397890|19117983|P1|NOT COMPLETED|Overall Study||23
7765394|NCT01397890|19117982|P2|COMPLETED|Overall Study||260
7765395|NCT01397890|19117983|P1|COMPLETED|Overall Study||264
7765396|NCT01397890|19117982|P2|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287
7765397|NCT01397890|19117983|P1|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286
7765398|NCT01397890|19117982|P2|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290
7765399|NCT01397890|19117983|P1|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287
7765400|NCT01397890|19117982|P2|STARTED|Overall Study||291
7765401|NCT01397890|19117983|P1|STARTED|Overall Study||287
7765402|NCT01397851|19118037|P2|NOT COMPLETED|Overall Study||46
7765403|NCT01397851|19118038|P1|NOT COMPLETED|Overall Study||79
7765404|NCT01397851|19118037|P2|COMPLETED|Overall Study||39917
7765405|NCT01397851|19118038|P1|COMPLETED|Overall Study||41555
7765406|NCT01397851|19118037|P2|STARTED|Overall Study||39963
7765407|NCT01397851|19118038|P1|STARTED|Overall Study||41634
7765408|NCT01397825|19118054|P5|NOT COMPLETED|Overall Study||0
7765409|NCT01397825|19118055|P4|NOT COMPLETED|Overall Study||3
7765410|NCT01397825|19118056|P3|NOT COMPLETED|Overall Study||25
7765411|NCT01397825|19118057|P2|NOT COMPLETED|Overall Study||4
7765412|NCT01397825|19118058|P1|NOT COMPLETED|Overall Study||13
7765413|NCT01397825|19118054|P5|COMPLETED|Overall Study||0
7765414|NCT01397825|19118055|P4|COMPLETED|Overall Study||0
7765415|NCT01397825|19118056|P3|COMPLETED|Overall Study||0
7765416|NCT01397825|19118057|P2|COMPLETED|Overall Study||0
7765417|NCT01397825|19118058|P1|COMPLETED|Overall Study||0
7765418|NCT01397825|19118054|P5|STARTED|Overall Study||0
7765419|NCT01397825|19118055|P4|STARTED|Overall Study||3
7765420|NCT01397825|19118056|P3|STARTED|Overall Study||25
7765421|NCT01397825|19118057|P2|STARTED|Overall Study||4
7765422|NCT01397825|19118058|P1|STARTED|Overall Study||13
7765423|NCT01397786|19118128|P3|NOT COMPLETED|Phase B||138
7765424|NCT01397786|19118129|P2|NOT COMPLETED|Phase B||95
7765425|NCT01397786|19118130|P1|NOT COMPLETED|Phase B||303
7765426|NCT01397786|19118128|P3|COMPLETED|Phase B||91
7765427|NCT01397786|19118129|P2|COMPLETED|Phase B||109
7765428|NCT01397786|19118130|P1|COMPLETED|Phase B||308
7765429|NCT01397786|19118128|P3|STARTED|Phase B||229
7765430|NCT01397786|19118129|P2|STARTED|Phase B||204
7765431|NCT01397786|19118130|P1|STARTED|Phase B||611
7765432|NCT01397786|19118128|P3|NOT COMPLETED|Phase A||28
7765433|NCT01397786|19118129|P2|NOT COMPLETED|Phase A||0
7765434|NCT01397786|19118130|P1|NOT COMPLETED|Phase A||0
7765435|NCT01397786|19118128|P3|COMPLETED|Phase A||199
7765436|NCT01397786|19118129|P2|COMPLETED|Phase A||0
7765437|NCT01397786|19118130|P1|COMPLETED|Phase A||12
7765438|NCT01397786|19118128|P3|STARTED|Phase A||227
7765439|NCT01397786|19118129|P2|STARTED|Phase A||0
7765440|NCT01397786|19118130|P1|STARTED|Phase A|Subjects in NCT01668797 Phase A at IA-related study termination rolled over to NCT01397786 Phase A.|12
7765441|NCT01397747|19118196|P1|NOT COMPLETED|Overall Study||1027
7765442|NCT01397747|19118196|P1|COMPLETED|Overall Study||9989
7765443|NCT01397747|19118196|P1|STARTED|Overall Study||11016
7765444|NCT01397695|19118201|P1|NOT COMPLETED|Overall Study||0
7765445|NCT01397695|19118201|P1|COMPLETED|Overall Study||0
7765446|NCT01397695|19118201|P1|STARTED|Overall Study||0
7765447|NCT01397656|19118207|P2|NOT COMPLETED|Overall Study||0
7765448|NCT01397656|19118208|P1|NOT COMPLETED|Overall Study||0
7765449|NCT01397656|19118207|P2|COMPLETED|Overall Study||30
7765450|NCT01397656|19118208|P1|COMPLETED|Overall Study||33
7765451|NCT01397656|19118207|P2|STARTED|Overall Study||30
7765452|NCT01397656|19118208|P1|STARTED|Overall Study||33
7765453|NCT01397617|19118223|P3|NOT COMPLETED|Overall Study||29
7765454|NCT01397617|19118224|P2|NOT COMPLETED|Overall Study||23
7765455|NCT01397617|19118225|P1|NOT COMPLETED|Overall Study||31
7765456|NCT01397617|19118223|P3|COMPLETED|Overall Study||31
7765457|NCT01397617|19118224|P2|COMPLETED|Overall Study||30
7765458|NCT01397617|19118225|P1|COMPLETED|Overall Study||33
7765459|NCT01397617|19118223|P3|STARTED|Overall Study||60
7765460|NCT01397617|19118224|P2|STARTED|Overall Study||53
7765461|NCT01397617|19118225|P1|STARTED|Overall Study||64
7765462|NCT01397591|19118236|P1|NOT COMPLETED|Overall Study||0
7765463|NCT01397591|19118236|P1|COMPLETED|Overall Study||2
7765464|NCT01397591|19118236|P1|STARTED|Overall Study||2
7765465|NCT01397552|19118246|P2|NOT COMPLETED|Overall Study||1
7765466|NCT01397552|19118247|P1|NOT COMPLETED|Overall Study||3
7765467|NCT01397552|19118246|P2|COMPLETED|Overall Study||3
7765468|NCT01397552|19118247|P1|COMPLETED|Overall Study||1
7765469|NCT01397552|19118246|P2|STARTED|Overall Study||4
7765470|NCT01397552|19118247|P1|STARTED|Overall Study||4
7765471|NCT01397461|19118256|P3|NOT COMPLETED|Overall Study||2
7765472|NCT01397461|19118257|P2|NOT COMPLETED|Overall Study||6
7765473|NCT01397461|19118258|P1|NOT COMPLETED|Overall Study||2
7765474|NCT01397461|19118256|P3|COMPLETED|Overall Study||152
7765475|NCT01397461|19118257|P2|COMPLETED|Overall Study||150
7765476|NCT01397461|19118258|P1|COMPLETED|Overall Study||153
7765477|NCT01397461|19118256|P3|STARTED|Overall Study||154
7765478|NCT01397461|19118257|P2|STARTED|Overall Study||156
7765479|NCT01397461|19118258|P1|STARTED|Overall Study||155
7765480|NCT01397448|19118269|P3|NOT COMPLETED|Overall Study||18
7765481|NCT01397448|19118270|P2|NOT COMPLETED|Overall Study||15
7765482|NCT01397448|19118271|P1|NOT COMPLETED|Overall Study||18
7765483|NCT01397448|19118269|P3|COMPLETED|Overall Study||140
7765484|NCT01397448|19118270|P2|COMPLETED|Overall Study||142
7765485|NCT01397448|19118271|P1|COMPLETED|Overall Study||138
7765486|NCT01397448|19118269|P3|STARTED|Overall Study||158
7765487|NCT01397448|19118270|P2|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157
7765488|NCT01397448|19118271|P1|STARTED|Overall Study||156
7765489|NCT01397422|19118286|P4|NOT COMPLETED|Overall Study||8
7765490|NCT01397422|19118287|P3|NOT COMPLETED|Overall Study||3
7765491|NCT01397422|19118288|P2|NOT COMPLETED|Overall Study||3
7765492|NCT01397422|19118289|P1|NOT COMPLETED|Overall Study||2
7765493|NCT01397422|19118286|P4|COMPLETED|Overall Study||12
7765494|NCT01397422|19118287|P3|COMPLETED|Overall Study|AE = adverse event; eGFR = estimated glomerular filtration rate|18
7765495|NCT01397422|19118288|P2|COMPLETED|Overall Study||17
7765496|NCT01397422|19118289|P1|COMPLETED|Overall Study||20
7765497|NCT01397422|19118286|P4|STARTED|Overall Study||20
7765498|NCT01397422|19118287|P3|STARTED|Overall Study|Of the 3 participants who discontinued, 1 withdrew due to both an AE and an eGFR < 50 mL/min/1.73m^2|21
7765499|NCT01397422|19118288|P2|STARTED|Overall Study||20
7765500|NCT01397422|19118289|P1|STARTED|Overall Study||22
7765501|NCT01397409|19118329|P10|NOT COMPLETED|Stage 3||0
7765502|NCT01397409|19118330|P9|NOT COMPLETED|Stage 3||0
7765503|NCT01397409|19118331|P8|NOT COMPLETED|Stage 3||2
7765504|NCT01397409|19118332|P7|NOT COMPLETED|Stage 3||0
7765505|NCT01397409|19118333|P6|NOT COMPLETED|Stage 3||0
7765506|NCT01397409|19118334|P5|NOT COMPLETED|Stage 3||0
7765507|NCT01397409|19118335|P4|NOT COMPLETED|Stage 3||0
7765508|NCT01397409|19118336|P3|NOT COMPLETED|Stage 3||0
7765509|NCT01397409|19118337|P2|NOT COMPLETED|Stage 3||0
7765510|NCT01397409|19118338|P1|NOT COMPLETED|Stage 3||0
7765511|NCT01397409|19118329|P10|COMPLETED|Stage 3||16
7765512|NCT01397409|19118330|P9|COMPLETED|Stage 3||25
7765513|NCT01397409|19118331|P8|COMPLETED|Stage 3||21
7765514|NCT01397409|19118332|P7|COMPLETED|Stage 3||0
7765515|NCT01397409|19118333|P6|COMPLETED|Stage 3||0
7765516|NCT01397409|19118334|P5|COMPLETED|Stage 3||0
7765517|NCT01397409|19118335|P4|COMPLETED|Stage 3||0
7765518|NCT01397409|19118336|P3|COMPLETED|Stage 3||0
7765519|NCT01397409|19118337|P2|COMPLETED|Stage 3||0
7765520|NCT01397409|19118338|P1|COMPLETED|Stage 3||0
7765521|NCT01397409|19118329|P10|STARTED|Stage 3||16
7765522|NCT01397409|19118330|P9|STARTED|Stage 3||25
7765523|NCT01397409|19118331|P8|STARTED|Stage 3||23
7765524|NCT01397409|19118332|P7|STARTED|Stage 3||0
7765525|NCT01397409|19118333|P6|STARTED|Stage 3||0
7765526|NCT01397409|19118334|P5|STARTED|Stage 3||0
7765527|NCT01397409|19118335|P4|STARTED|Stage 3||0
7765528|NCT01397409|19118336|P3|STARTED|Stage 3||0
7765529|NCT01397409|19118337|P2|STARTED|Stage 3||0
7765530|NCT01397409|19118338|P1|STARTED|Stage 3||0
7765531|NCT01397409|19118329|P10|NOT COMPLETED|Stage 2||0
7765532|NCT01397409|19118330|P9|NOT COMPLETED|Stage 2||0
7765533|NCT01397409|19118331|P8|NOT COMPLETED|Stage 2||0
7765534|NCT01397409|19118332|P7|NOT COMPLETED|Stage 2||0
7765535|NCT01397409|19118333|P6|NOT COMPLETED|Stage 2||4
7765536|NCT01397409|19118334|P5|NOT COMPLETED|Stage 2||8
7765537|NCT01397409|19118335|P4|NOT COMPLETED|Stage 2||0
7765538|NCT01397409|19118336|P3|NOT COMPLETED|Stage 2||0
7765539|NCT01397409|19118337|P2|NOT COMPLETED|Stage 2||0
7765540|NCT01397409|19118338|P1|NOT COMPLETED|Stage 2||0
7765541|NCT01397409|19118329|P10|COMPLETED|Stage 2||0
7765542|NCT01397409|19118330|P9|COMPLETED|Stage 2||0
7765543|NCT01397409|19118331|P8|COMPLETED|Stage 2||0
7765544|NCT01397409|19118332|P7|COMPLETED|Stage 2||58
7765545|NCT01397409|19118333|P6|COMPLETED|Stage 2||54
7765546|NCT01397409|19118334|P5|COMPLETED|Stage 2||59
7765547|NCT01397409|19118335|P4|COMPLETED|Stage 2||0
7765548|NCT01397409|19118336|P3|COMPLETED|Stage 2||0
7765549|NCT01397409|19118337|P2|COMPLETED|Stage 2||0
7765550|NCT01397409|19118338|P1|COMPLETED|Stage 2||0
7765551|NCT01397409|19118329|P10|STARTED|Stage 2||0
7765552|NCT01397409|19118330|P9|STARTED|Stage 2||0
7765553|NCT01397409|19118331|P8|STARTED|Stage 2||0
7765554|NCT01397409|19118332|P7|STARTED|Stage 2||58
7765555|NCT01397409|19118333|P6|STARTED|Stage 2||58
7765556|NCT01397409|19118334|P5|STARTED|Stage 2||67
7765557|NCT01397409|19118335|P4|STARTED|Stage 2||0
7765558|NCT01397409|19118336|P3|STARTED|Stage 2||0
7765559|NCT01397409|19118337|P2|STARTED|Stage 2||0
7765560|NCT01397409|19118338|P1|STARTED|Stage 2||0
7765561|NCT01397409|19118329|P10|NOT COMPLETED|Stage 1||0
7765562|NCT01397409|19118330|P9|NOT COMPLETED|Stage 1||0
7765563|NCT01397409|19118331|P8|NOT COMPLETED|Stage 1||0
7765564|NCT01397409|19118332|P7|NOT COMPLETED|Stage 1||0
7765565|NCT01397409|19118333|P6|NOT COMPLETED|Stage 1||0
7765566|NCT01397409|19118334|P5|NOT COMPLETED|Stage 1||0
7765567|NCT01397409|19118335|P4|NOT COMPLETED|Stage 1||0
7765568|NCT01397409|19118336|P3|NOT COMPLETED|Stage 1||0
7765569|NCT01397409|19118337|P2|NOT COMPLETED|Stage 1||0
7765570|NCT01397409|19118338|P1|NOT COMPLETED|Stage 1||0
7765571|NCT01397409|19118329|P10|COMPLETED|Stage 1||0
7765572|NCT01397409|19118330|P9|COMPLETED|Stage 1||0
7765573|NCT01397409|19118331|P8|COMPLETED|Stage 1||0
7765574|NCT01397409|19118332|P7|COMPLETED|Stage 1||0
7765575|NCT01397409|19118333|P6|COMPLETED|Stage 1||0
7765576|NCT01397409|19118334|P5|COMPLETED|Stage 1||0
7765577|NCT01397409|19118335|P4|COMPLETED|Stage 1||3
7765578|NCT01397409|19118336|P3|COMPLETED|Stage 1||6
7765579|NCT01397409|19118337|P2|COMPLETED|Stage 1||6
7765580|NCT01397409|19118338|P1|COMPLETED|Stage 1||9
7765581|NCT01397409|19118329|P10|STARTED|Stage 1||0
7765582|NCT01397409|19118330|P9|STARTED|Stage 1||0
7765583|NCT01397409|19118331|P8|STARTED|Stage 1||0
7765584|NCT01397409|19118332|P7|STARTED|Stage 1||0
7765585|NCT01397409|19118333|P6|STARTED|Stage 1||0
7765586|NCT01397409|19118334|P5|STARTED|Stage 1||0
7765587|NCT01397409|19118335|P4|STARTED|Stage 1||3
7765588|NCT01397409|19118336|P3|STARTED|Stage 1||6
7765589|NCT01397409|19118337|P2|STARTED|Stage 1||6
7765590|NCT01397409|19118338|P1|STARTED|Stage 1||9
7765591|NCT01397253|19118378|P2|NOT COMPLETED|Overall Study||149
7765592|NCT01397253|19118379|P1|NOT COMPLETED|Overall Study||126
7765593|NCT01397253|19118378|P2|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243
7765594|NCT01397253|19118379|P1|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317
7765595|NCT01397253|19118378|P2|STARTED|Overall Study||392
7765596|NCT01397253|19118379|P1|STARTED|Overall Study||443
7765597|NCT01397084|19118385|P1|NOT COMPLETED|Overall Study||8
7765598|NCT01397084|19118385|P1|COMPLETED|Overall Study||100
7765599|NCT01397084|19118385|P1|STARTED|Overall Study||108
7765600|NCT01397071|19118392|P1|NOT COMPLETED|Consumption of Beef Patty With Avocado||0
7765601|NCT01397071|19118392|P1|COMPLETED|Consumption of Beef Patty With Avocado||11
7765602|NCT01397071|19118392|P1|STARTED|Consumption of Beef Patty With Avocado||11
7765603|NCT01397071|19118392|P1|NOT COMPLETED|Consumption of Beef Patty Alone||0
7765604|NCT01397071|19118392|P1|COMPLETED|Consumption of Beef Patty Alone||11
7765605|NCT01397071|19118392|P1|STARTED|Consumption of Beef Patty Alone||11
7765606|NCT01396837|19118400|P1|NOT COMPLETED|Overall Study||4
7765607|NCT01396837|19118400|P1|COMPLETED|Overall Study||16
7765608|NCT01396837|19118400|P1|STARTED|Overall Study||20
7765609|NCT01396551|19118407|P1|NOT COMPLETED|Overall Study||0
7765610|NCT01396551|19118407|P1|COMPLETED|Overall Study||69
7765611|NCT01396551|19118407|P1|STARTED|Overall Study||69
7765612|NCT01396525|19118411|P1|NOT COMPLETED|Overall Study||26
7765613|NCT01396525|19118411|P1|COMPLETED|Overall Study||127
7765614|NCT01396525|19118411|P1|STARTED|Overall Study||153
7765615|NCT01396512|19118511|P2|NOT COMPLETED|Overall Study||1
7765616|NCT01396512|19118512|P1|NOT COMPLETED|Overall Study||0
7765617|NCT01396512|19118511|P2|COMPLETED|Overall Study||136
7765618|NCT01396512|19118512|P1|COMPLETED|Overall Study||137
7765619|NCT01396512|19118511|P2|STARTED|Overall Study||137
7765620|NCT01396512|19118512|P1|STARTED|Overall Study||137
7765621|NCT01396486|19118527|P3|NOT COMPLETED|Overall Study||12
7765622|NCT01396486|19118528|P2|NOT COMPLETED|Overall Study||12
7765623|NCT01396486|19118529|P1|NOT COMPLETED|Overall Study||10
7765624|NCT01396486|19118527|P3|COMPLETED|Overall Study||10
7765625|NCT01396486|19118528|P2|COMPLETED|Overall Study||7
7765626|NCT01396486|19118529|P1|COMPLETED|Overall Study||10
7765627|NCT01396486|19118527|P3|Exposed|Overall Study||17
7765628|NCT01396486|19118528|P2|Exposed|Overall Study||16
7765629|NCT01396486|19118529|P1|Exposed|Overall Study||19
7765630|NCT01396486|19118527|P3|STARTED|Overall Study||22
7765631|NCT01396486|19118528|P2|STARTED|Overall Study||19
7765632|NCT01396486|19118529|P1|STARTED|Overall Study||20
7765633|NCT01396447|19118544|P4|NOT COMPLETED|Overall Study||52
7765634|NCT01396447|19118545|P3|NOT COMPLETED|Overall Study||30
7765635|NCT01396447|19118546|P2|NOT COMPLETED|Overall Study||40
7765636|NCT01396447|19118547|P1|NOT COMPLETED|Overall Study||43
7765637|NCT01396447|19118544|P4|COMPLETED|Overall Study||94
7765638|NCT01396447|19118545|P3|COMPLETED|Overall Study||117
7765639|NCT01396447|19118546|P2|COMPLETED|Overall Study||103
7765640|NCT01396447|19118547|P1|COMPLETED|Overall Study||105
7765641|NCT01396447|19118544|P4|Received Treatment|Overall Study||146
7765642|NCT01396447|19118545|P3|Received Treatment|Overall Study||146
7765643|NCT01396447|19118546|P2|Received Treatment|Overall Study||141
7765644|NCT01396447|19118547|P1|Received Treatment|Overall Study||145
7765645|NCT01396447|19118544|P4|STARTED|Overall Study||146
7765646|NCT01396447|19118545|P3|STARTED|Overall Study||147
7765647|NCT01396447|19118546|P2|STARTED|Overall Study||143
7765648|NCT01396447|19118547|P1|STARTED|Overall Study||148
7765649|NCT01396434|19118564|P3|NOT COMPLETED|Overall Study||0
7765650|NCT01396434|19118565|P2|NOT COMPLETED|Overall Study||0
7765651|NCT01396434|19118566|P1|NOT COMPLETED|Overall Study||11
7765652|NCT01396434|19118564|P3|COMPLETED|Overall Study||14
7765653|NCT01396434|19118565|P2|COMPLETED|Overall Study||175
7765654|NCT01396434|19118566|P1|COMPLETED|Overall Study||2806
7765655|NCT01396434|19118564|P3|STARTED|Overall Study||14
7765656|NCT01396434|19118565|P2|STARTED|Overall Study||175
7765657|NCT01396434|19118566|P1|STARTED|Overall Study||2817
7765658|NCT01396421|19118578|P4|NOT COMPLETED|Overall Study||75
7765659|NCT01396421|19118579|P3|NOT COMPLETED|Overall Study||34
7765660|NCT01396421|19118580|P2|NOT COMPLETED|Overall Study||58
7765661|NCT01396421|19118581|P1|NOT COMPLETED|Overall Study||59
7765662|NCT01396421|19118578|P4|COMPLETED|Overall Study||109
7765663|NCT01396421|19118579|P3|COMPLETED|Overall Study||56
7765664|NCT01396421|19118580|P2|COMPLETED|Overall Study||124
7765665|NCT01396421|19118581|P1|COMPLETED|Overall Study||121
7765666|NCT01396421|19118578|P4|STARTED|Overall Study||184
7765667|NCT01396421|19118579|P3|STARTED|Overall Study||90
7765668|NCT01396421|19118580|P2|STARTED|Overall Study||182
7765669|NCT01396421|19118581|P1|STARTED|Overall Study||180
7765670|NCT01396395|19118653|P2|NOT COMPLETED|Overall Study||27
7765671|NCT01396395|19118654|P1|NOT COMPLETED|Overall Study||40
7765672|NCT01396395|19118653|P2|COMPLETED|Overall Study||175
7765673|NCT01396395|19118654|P1|COMPLETED|Overall Study||160
7765674|NCT01396395|19118653|P2|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205
7765675|NCT01396395|19118654|P1|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197
7765676|NCT01396395|19118653|P2|STARTED|Overall Study||202
7765677|NCT01396395|19118654|P1|STARTED|Overall Study||200
7765678|NCT01396382|19118689|P1|NOT COMPLETED|Overall Study||0
7765679|NCT01396382|19118689|P1|COMPLETED|Overall Study||97
7765680|NCT01396382|19118689|P1|STARTED|Overall Study||97
7765681|NCT01396317|19118696|P2|NOT COMPLETED|Overall Study||0
7765682|NCT01396317|19118697|P1|NOT COMPLETED|Overall Study||1
7765683|NCT01396317|19118696|P2|COMPLETED|Overall Study||10
7765684|NCT01396317|19118697|P1|COMPLETED|Overall Study||9
7765685|NCT01396317|19118696|P2|STARTED|Overall Study||10
7765686|NCT01396317|19118697|P1|STARTED|Overall Study||10
7765687|NCT01396265|19118711|P1|NOT COMPLETED|Rifa+Afatinib||1
7765688|NCT01396265|19118711|P1|COMPLETED|Rifa+Afatinib||21
7765689|NCT01396265|19118711|P1|STARTED|Rifa+Afatinib||22
7765690|NCT01396265|19118711|P1|NOT COMPLETED|Washout||0
7765691|NCT01396265|19118711|P1|COMPLETED|Washout||22
7765692|NCT01396265|19118711|P1|STARTED|Washout||22
7765693|NCT01396265|19118711|P1|NOT COMPLETED|Afatinib||0
7765694|NCT01396265|19118711|P1|COMPLETED|Afatinib||22
7765695|NCT01396265|19118711|P1|STARTED|Afatinib||22
7765696|NCT01396239|19118738|P4|NOT COMPLETED|Overall Study||0
7765697|NCT01396239|19118739|P3|NOT COMPLETED|Overall Study||0
7765698|NCT01396239|19118740|P2|NOT COMPLETED|Overall Study||0
7765699|NCT01396239|19118741|P1|NOT COMPLETED|Overall Study||0
7765700|NCT01396239|19118738|P4|COMPLETED|Overall Study||2
7765701|NCT01396239|19118739|P3|COMPLETED|Overall Study||4
7765702|NCT01396239|19118740|P2|COMPLETED|Overall Study||2
7765703|NCT01396239|19118741|P1|COMPLETED|Overall Study||4
7765704|NCT01396239|19118738|P4|STARTED|Overall Study||2
7765705|NCT01396239|19118739|P3|STARTED|Overall Study||4
7765706|NCT01396239|19118740|P2|STARTED|Overall Study||2
7765707|NCT01396239|19118741|P1|STARTED|Overall Study||4
7765708|NCT01396226|19118764|P2|NOT COMPLETED|Overall Study||0
7765709|NCT01396226|19118765|P1|NOT COMPLETED|Overall Study||0
7765710|NCT01396226|19118764|P2|COMPLETED|Overall Study||6
7765711|NCT01396226|19118765|P1|COMPLETED|Overall Study||12
7765712|NCT01396226|19118764|P2|Patients Who Completed Treatment|Overall Study||6
7765713|NCT01396226|19118765|P1|Patients Who Completed Treatment|Overall Study||12
7765714|NCT01396226|19118764|P2|Patients Who Received Treatment|Overall Study||6
7765715|NCT01396226|19118765|P1|Patients Who Received Treatment|Overall Study||12
7765716|NCT01396226|19118764|P2|STARTED|Overall Study||6
7765717|NCT01396226|19118765|P1|STARTED|Overall Study||12
7765718|NCT01396187|19118800|P5|NOT COMPLETED|Overall Study||1
7765719|NCT01396187|19118801|P4|NOT COMPLETED|Overall Study||0
7765720|NCT01396187|19118802|P3|NOT COMPLETED|Overall Study||1
7765721|NCT01396187|19118803|P2|NOT COMPLETED|Overall Study||3
7765722|NCT01396187|19118804|P1|NOT COMPLETED|Overall Study||1
7765723|NCT01396187|19118800|P5|COMPLETED|Overall Study||9
7765724|NCT01396187|19118801|P4|COMPLETED|Overall Study||10
7765725|NCT01396187|19118802|P3|COMPLETED|Overall Study||9
7765726|NCT01396187|19118803|P2|COMPLETED|Overall Study||9
7765727|NCT01396187|19118804|P1|COMPLETED|Overall Study||7
7765728|NCT01396187|19118800|P5|STARTED|Overall Study||10
7765729|NCT01396187|19118801|P4|STARTED|Overall Study||10
7765730|NCT01396187|19118802|P3|STARTED|Overall Study||10
7765731|NCT01396187|19118803|P2|STARTED|Overall Study||12
7765732|NCT01396187|19118804|P1|STARTED|Overall Study||8
7765733|NCT01396161|19118904|P7|NOT COMPLETED|Overall Study||1
7765734|NCT01396161|19118905|P6|NOT COMPLETED|Overall Study||0
7765735|NCT01396161|19118906|P5|NOT COMPLETED|Overall Study||1
7765736|NCT01396161|19118907|P4|NOT COMPLETED|Overall Study||0
7765737|NCT01396161|19118908|P3|NOT COMPLETED|Overall Study||0
7765738|NCT01396161|19118909|P2|NOT COMPLETED|Overall Study||0
7765739|NCT01396161|19118910|P1|NOT COMPLETED|Overall Study||0
7765740|NCT01396161|19118904|P7|COMPLETED|Overall Study||10
7765741|NCT01396161|19118905|P6|COMPLETED|Overall Study||9
7765742|NCT01396161|19118906|P5|COMPLETED|Overall Study||8
7765743|NCT01396161|19118907|P4|COMPLETED|Overall Study||9
7765744|NCT01396161|19118908|P3|COMPLETED|Overall Study||9
7765745|NCT01396161|19118909|P2|COMPLETED|Overall Study||5
7765746|NCT01396161|19118910|P1|COMPLETED|Overall Study||12
7765747|NCT01396161|19118904|P7|STARTED|Overall Study||11
7765748|NCT01396161|19118905|P6|STARTED|Overall Study||9
7765749|NCT01396161|19118906|P5|STARTED|Overall Study||9
7765750|NCT01396161|19118907|P4|STARTED|Overall Study||9
7765751|NCT01396161|19118908|P3|STARTED|Overall Study||9
7765752|NCT01396161|19118909|P2|STARTED|Overall Study||5
7765753|NCT01396161|19118910|P1|STARTED|Overall Study||12
7765754|NCT01396148|19118963|P1|NOT COMPLETED|Overall Study||1
7765755|NCT01396148|19118963|P1|COMPLETED|Overall Study||5
7765756|NCT01396148|19118963|P1|STARTED|Overall Study||6
7765757|NCT01396083|19118993|P2|NOT COMPLETED|Overall Study||47
7765758|NCT01396083|19118994|P1|NOT COMPLETED|Overall Study||11
7765759|NCT01396083|19118993|P2|COMPLETED|Overall Study||72
7765760|NCT01396083|19118994|P1|COMPLETED|Overall Study||113
7765761|NCT01396083|19118993|P2|STARTED|Overall Study||119
7765762|NCT01396083|19118994|P1|STARTED|Overall Study||124
7765763|NCT01396070|19119018|P1|NOT COMPLETED|Overall Study||19
7765764|NCT01396070|19119018|P1|COMPLETED|Overall Study||17
7765765|NCT01396070|19119018|P1|STARTED|Overall Study||36
7765766|NCT01396057|19119027|P2|NOT COMPLETED|Overall Study||18
7765767|NCT01396057|19119028|P1|NOT COMPLETED|Overall Study||11
7765768|NCT01396057|19119027|P2|COMPLETED|Overall Study||100
7765769|NCT01396057|19119028|P1|COMPLETED|Overall Study||115
7765770|NCT01396057|19119027|P2|STARTED|Overall Study||118
7765771|NCT01396057|19119028|P1|STARTED|Overall Study||126
7765772|NCT01396044|19119054|P2|NOT COMPLETED|Overall Study||0
7765773|NCT01396044|19119055|P1|NOT COMPLETED|Overall Study||0
7765774|NCT01396044|19119054|P2|COMPLETED|Overall Study||171
7765775|NCT01396044|19119055|P1|COMPLETED|Overall Study||125
7765776|NCT01396044|19119054|P2|STARTED|Overall Study||171
7765777|NCT01396044|19119055|P1|STARTED|Overall Study||125
7765778|NCT01396005|19119077|P2|NOT COMPLETED|Overall Study||2
7765779|NCT01396005|19119078|P1|NOT COMPLETED|Overall Study||0
7765780|NCT01396005|19119077|P2|COMPLETED|Overall Study||9
7765781|NCT01396005|19119078|P1|COMPLETED|Overall Study||10
7765782|NCT01396005|19119077|P2|STARTED|Overall Study||11
7765783|NCT01396005|19119078|P1|STARTED|Overall Study||10
7765784|NCT01395966|19119097|P3|NOT COMPLETED|Overall Study||8
7765785|NCT01395966|19119098|P2|NOT COMPLETED|Overall Study||19
7765786|NCT01395966|19119099|P1|NOT COMPLETED|Overall Study||10
7765787|NCT01395966|19119097|P3|COMPLETED|Overall Study||104
7765788|NCT01395966|19119098|P2|COMPLETED|Overall Study||91
7765789|NCT01395966|19119099|P1|COMPLETED|Overall Study||99
7765790|NCT01395966|19119097|P3|STARTED|Overall Study||112
7765791|NCT01395966|19119098|P2|STARTED|Overall Study||110
7765792|NCT01395966|19119099|P1|STARTED|Overall Study||109
7765793|NCT01395914|19119109|P2|NOT COMPLETED|Overall Study||37
7765794|NCT01395914|19119110|P1|NOT COMPLETED|Overall Study||72
7765795|NCT01395914|19119109|P2|COMPLETED|Overall Study||131
7765796|NCT01395914|19119110|P1|COMPLETED|Overall Study||273
7765797|NCT01395914|19119109|P2|Safety Population|Overall Study||167
7765798|NCT01395914|19119110|P1|Safety Population|Overall Study||343
7765799|NCT01395914|19119109|P2|ITT Population|Overall Study||168
7765800|NCT01395914|19119110|P1|ITT Population|Overall Study||345
7765801|NCT01395914|19119109|P2|STARTED|Overall Study||168
7765802|NCT01395914|19119110|P1|STARTED|Overall Study||345
7765803|NCT01395901|19119124|P2|NOT COMPLETED|Overall Study||5
7765804|NCT01395901|19119125|P1|NOT COMPLETED|Overall Study||10
7765805|NCT01395901|19119124|P2|COMPLETED|Overall Study|Treated patients completing the study|329
7765806|NCT01395901|19119125|P1|COMPLETED|Overall Study|Treated patients completing the study|326
7765807|NCT01395901|19119124|P2|STARTED|Overall Study|Randomized Population|334
7765808|NCT01395901|19119125|P1|STARTED|Overall Study|Randomized Population|336
7765809|NCT01395888|19119141|P3|NOT COMPLETED|Treatment Period (TP)||17
7765810|NCT01395888|19119142|P2|NOT COMPLETED|Treatment Period (TP)||15
7765811|NCT01395888|19119143|P1|NOT COMPLETED|Treatment Period (TP)||0
7765812|NCT01395888|19119141|P3|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113
7765813|NCT01395888|19119142|P2|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112
7765814|NCT01395888|19119143|P1|COMPLETED|Treatment Period (TP)||0
7765815|NCT01395888|19119141|P3|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113
7765816|NCT01395888|19119142|P2|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112
7765817|NCT01395888|19119143|P1|Completed the Treatment Period|Treatment Period (TP)||0
7765818|NCT01395888|19119141|P3|STARTED|Treatment Period (TP)||130
7765819|NCT01395888|19119142|P2|STARTED|Treatment Period (TP)||127
7765820|NCT01395888|19119143|P1|STARTED|Treatment Period (TP)||0
7765821|NCT01395888|19119141|P3|NOT COMPLETED|2-week Run-in Period||0
7765822|NCT01395888|19119142|P2|NOT COMPLETED|2-week Run-in Period||0
7765823|NCT01395888|19119143|P1|NOT COMPLETED|2-week Run-in Period||22
7765824|NCT01395888|19119141|P3|COMPLETED|2-week Run-in Period||0
7765825|NCT01395888|19119142|P2|COMPLETED|2-week Run-in Period||0
7765826|NCT01395888|19119143|P1|COMPLETED|2-week Run-in Period||257
7765827|NCT01395888|19119141|P3|STARTED|2-week Run-in Period||0
7765828|NCT01395888|19119142|P2|STARTED|2-week Run-in Period||0
7765829|NCT01395888|19119143|P1|STARTED|2-week Run-in Period||279
7765830|NCT01395823|19119151|P2|NOT COMPLETED|Overall Study||9
7765831|NCT01395823|19119152|P1|NOT COMPLETED|Overall Study||15
7765832|NCT01395823|19119151|P2|COMPLETED|Overall Study||130
7765833|NCT01395823|19119152|P1|COMPLETED|Overall Study||122
7765834|NCT01395823|19119151|P2|STARTED|Overall Study||139
7765835|NCT01395823|19119152|P1|STARTED|Overall Study||137
7765836|NCT01395810|19119162|P4|NOT COMPLETED|Overall Study||0
7765837|NCT01395810|19119163|P3|NOT COMPLETED|Overall Study||0
7765838|NCT01395810|19119164|P2|NOT COMPLETED|Overall Study||4
7765839|NCT01395810|19119165|P1|NOT COMPLETED|Overall Study||2
7765840|NCT01395810|19119162|P4|COMPLETED|Overall Study||5
7765841|NCT01395810|19119163|P3|COMPLETED|Overall Study||0
7765842|NCT01395810|19119164|P2|COMPLETED|Overall Study||44
7765843|NCT01395810|19119165|P1|COMPLETED|Overall Study||16
7765844|NCT01395810|19119162|P4|After Switching the Arms|Overall Study||5
7765845|NCT01395810|19119163|P3|After Switching the Arms|Overall Study|No subjects started in this arm initially, 2 patients in 40 IU/kg arm switched to this arm.|2
7765846|NCT01395810|19119164|P2|After Switching the Arms|Overall Study|48 subjects started in this arm, 3 subjects in 10 IU/kg+1 subject in on-demand switched to this arm|52
7765847|NCT01395810|19119165|P1|After Switching the Arms|Overall Study|18 subjects started in this arm and additional 3 subjects from 40 IU/kg switched to this arm|21
7765848|NCT01395810|19119162|P4|STARTED|Overall Study||5
7765849|NCT01395810|19119163|P3|STARTED|Overall Study||0
7765850|NCT01395810|19119164|P2|STARTED|Overall Study||48
7765851|NCT01395810|19119165|P1|STARTED|Overall Study||18
7765852|NCT01395797|19119199|P6|NOT COMPLETED|Overall Study||3
7765853|NCT01395797|19119200|P5|NOT COMPLETED|Overall Study||2
7765854|NCT01395797|19119201|P4|NOT COMPLETED|Overall Study||2
7765855|NCT01395797|19119202|P3|NOT COMPLETED|Overall Study||4
7765856|NCT01395797|19119203|P2|NOT COMPLETED|Overall Study||1
7765857|NCT01395797|19119204|P1|NOT COMPLETED|Overall Study||3
7765858|NCT01395797|19119199|P6|COMPLETED|Overall Study||14
7765859|NCT01395797|19119200|P5|COMPLETED|Overall Study||7
7765860|NCT01395797|19119201|P4|COMPLETED|Overall Study||13
7765861|NCT01395797|19119202|P3|COMPLETED|Overall Study||14
7765862|NCT01395797|19119203|P2|COMPLETED|Overall Study||3
7765863|NCT01395797|19119204|P1|COMPLETED|Overall Study||16
7765864|NCT01395797|19119199|P6|STARTED|Overall Study||17
7765865|NCT01395797|19119200|P5|STARTED|Overall Study||9
7765866|NCT01395797|19119201|P4|STARTED|Overall Study||15
7765867|NCT01395797|19119202|P3|STARTED|Overall Study||18
7765868|NCT01395797|19119203|P2|STARTED|Overall Study||4
7765869|NCT01395797|19119204|P1|STARTED|Overall Study||19
7765870|NCT01395784|19119224|P1|NOT COMPLETED|Overall Study||15
7765871|NCT01395784|19119224|P1|COMPLETED|Overall Study||17
7765872|NCT01395784|19119224|P1|STARTED|Overall Study||32
7765873|NCT01395758|19119231|P3|NOT COMPLETED|Crossover Period||0
7765874|NCT01395758|19119232|P2|NOT COMPLETED|Crossover Period||0
7765875|NCT01395758|19119233|P1|NOT COMPLETED|Crossover Period||0
7765876|NCT01395758|19119231|P3|COMPLETED|Crossover Period||26
7765877|NCT01395758|19119232|P2|COMPLETED|Crossover Period||0
7765878|NCT01395758|19119233|P1|COMPLETED|Crossover Period||0
7765879|NCT01395758|19119231|P3|STARTED|Crossover Period||26
7765880|NCT01395758|19119232|P2|STARTED|Crossover Period||0
7765881|NCT01395758|19119233|P1|STARTED|Crossover Period||0
7765882|NCT01395758|19119231|P3|NOT COMPLETED|Open-label Treatment Period||0
7765883|NCT01395758|19119232|P2|NOT COMPLETED|Open-label Treatment Period||0
7765884|NCT01395758|19119233|P1|NOT COMPLETED|Open-label Treatment Period||4
7765885|NCT01395758|19119231|P3|COMPLETED|Open-label Treatment Period||0
7765886|NCT01395758|19119232|P2|COMPLETED|Open-label Treatment Period||45
7765887|NCT01395758|19119233|P1|COMPLETED|Open-label Treatment Period||47
7765888|NCT01395758|19119231|P3|STARTED|Open-label Treatment Period||0
7765889|NCT01395758|19119232|P2|STARTED|Open-label Treatment Period||45
7765890|NCT01395758|19119233|P1|STARTED|Open-label Treatment Period||51
7765891|NCT01395537|19119244|P1|NOT COMPLETED|Phase II||0
7765892|NCT01395537|19119244|P1|COMPLETED|Phase II||1
7765893|NCT01395537|19119244|P1|STARTED|Phase II||1
7765894|NCT01395537|19119244|P1|NOT COMPLETED|Phase I||0
7765895|NCT01395537|19119244|P1|COMPLETED|Phase I||13
7765896|NCT01395537|19119244|P1|STARTED|Phase I||13
7765897|NCT01395524|19119253|P3|NOT COMPLETED|Overall Study||17
7765898|NCT01395524|19119254|P2|NOT COMPLETED|Overall Study||16
7765899|NCT01395524|19119255|P1|NOT COMPLETED|Overall Study||18
7765900|NCT01395524|19119253|P3|COMPLETED|Overall Study||89
7765901|NCT01395524|19119254|P2|COMPLETED|Overall Study||83
7765902|NCT01395524|19119255|P1|COMPLETED|Overall Study||79
7765903|NCT01395524|19119253|P3|STARTED|Overall Study||106
7765904|NCT01395524|19119254|P2|STARTED|Overall Study||99
7765905|NCT01395524|19119255|P1|STARTED|Overall Study||97
7765906|NCT01395394|19119278|P3|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
7765907|NCT01395394|19119279|P2|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
7765908|NCT01395394|19119280|P1|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
7765909|NCT01395394|19119278|P3|COMPLETED|Study Visit 2 (Non-responders Only)||0
7765910|NCT01395394|19119279|P2|COMPLETED|Study Visit 2 (Non-responders Only)||0
7765911|NCT01395394|19119280|P1|COMPLETED|Study Visit 2 (Non-responders Only)||3
7765912|NCT01395394|19119278|P3|STARTED|Study Visit 2 (Non-responders Only)||0
7765913|NCT01395394|19119279|P2|STARTED|Study Visit 2 (Non-responders Only)||0
7765914|NCT01395394|19119280|P1|STARTED|Study Visit 2 (Non-responders Only)||3
7765915|NCT01395394|19119278|P3|NOT COMPLETED|Baseline Study Visit||0
7765916|NCT01395394|19119279|P2|NOT COMPLETED|Baseline Study Visit||0
7765917|NCT01395394|19119280|P1|NOT COMPLETED|Baseline Study Visit||1
7765918|NCT01395394|19119278|P3|COMPLETED|Baseline Study Visit||5
7765919|NCT01395394|19119279|P2|COMPLETED|Baseline Study Visit||3
7765920|NCT01395394|19119280|P1|COMPLETED|Baseline Study Visit||3
7765921|NCT01395394|19119278|P3|STARTED|Baseline Study Visit||5
7765922|NCT01395394|19119279|P2|STARTED|Baseline Study Visit||3
7765923|NCT01395394|19119280|P1|STARTED|Baseline Study Visit||4
7765924|NCT01395368|19119291|P1|NOT COMPLETED|Overall Study||16
7765925|NCT01395368|19119291|P1|COMPLETED|Overall Study||92
7765926|NCT01395368|19119291|P1|STARTED|Overall Study||108
7765927|NCT01395329|19119298|P3|NOT COMPLETED|Overall Study||0
7765928|NCT01395329|19119299|P2|NOT COMPLETED|Overall Study||0
7765929|NCT01395329|19119300|P1|NOT COMPLETED|Overall Study||0
7765930|NCT01395329|19119298|P3|COMPLETED|Overall Study||14
7765931|NCT01395329|19119299|P2|COMPLETED|Overall Study||14
7765932|NCT01395329|19119300|P1|COMPLETED|Overall Study||14
7765933|NCT01395329|19119298|P3|STARTED|Overall Study||14
7765934|NCT01395329|19119299|P2|STARTED|Overall Study||14
7765935|NCT01395329|19119300|P1|STARTED|Overall Study||14
7765936|NCT01395316|19119347|P1|NOT COMPLETED|Overall Study||3
7765937|NCT01395316|19119347|P1|COMPLETED|Overall Study||5
7765938|NCT01395316|19119347|P1|STARTED|Overall Study||8
7765939|NCT01395277|19119353|P2|NOT COMPLETED|Overall Study||0
7765940|NCT01395277|19119354|P1|NOT COMPLETED|Overall Study||0
7765941|NCT01395277|19119353|P2|COMPLETED|Overall Study||15
7765942|NCT01395277|19119354|P1|COMPLETED|Overall Study||15
7765943|NCT01395277|19119353|P2|STARTED|Overall Study||15
7765944|NCT01395277|19119354|P1|STARTED|Overall Study||15
7765945|NCT01395043|19119362|P1|NOT COMPLETED|Overall Study||0
7765946|NCT01395043|19119362|P1|COMPLETED|Overall Study||15
7765947|NCT01395043|19119362|P1|STARTED|Overall Study||15
7765948|NCT01395030|19119367|P1|NOT COMPLETED|Overall Study||7
7765949|NCT01395030|19119367|P1|COMPLETED|Overall Study||57
7765950|NCT01395030|19119367|P1|Adequate Tissue for Analysis|Overall Study||50
7765951|NCT01395030|19119367|P1|Complete FCH PET/CT|Overall Study||57
7765952|NCT01395030|19119367|P1|STARTED|Overall Study||64
7765953|NCT01395017|19119377|P2|NOT COMPLETED|Overall Study||102
7765954|NCT01395017|19119378|P1|NOT COMPLETED|Overall Study||100
7765955|NCT01395017|19119377|P2|COMPLETED|Overall Study||0
7765956|NCT01395017|19119378|P1|COMPLETED|Overall Study||0
7765957|NCT01395017|19119377|P2|Treated|Overall Study||101
7765958|NCT01395017|19119378|P1|Treated|Overall Study||98
7765959|NCT01395017|19119377|P2|STARTED|Overall Study||102
7765960|NCT01395017|19119378|P1|STARTED|Overall Study||100
7765961|NCT01394991|19119388|P2|NOT COMPLETED|Overall Study||72
7765962|NCT01394991|19119389|P1|NOT COMPLETED|Overall Study||59
7765963|NCT01394991|19119388|P2|COMPLETED|Overall Study||190
7765964|NCT01394991|19119389|P1|COMPLETED|Overall Study||183
7765965|NCT01394991|19119388|P2|STARTED|Overall Study||262
7765966|NCT01394991|19119389|P1|STARTED|Overall Study||242
7765967|NCT01394978|19119411|P2|NOT COMPLETED|Overall Study||31
7765968|NCT01394978|19119412|P1|NOT COMPLETED|Overall Study||21
7765969|NCT01394978|19119411|P2|COMPLETED|Overall Study||245
7765970|NCT01394978|19119412|P1|COMPLETED|Overall Study||147
7765971|NCT01394978|19119411|P2|STARTED|Overall Study||276
7765972|NCT01394978|19119412|P1|STARTED|Overall Study||168
7765973|NCT01394952|19119420|P2|NOT COMPLETED|Overall Study||17
7765974|NCT01394952|19119421|P1|NOT COMPLETED|Overall Study||17
7765975|NCT01394952|19119420|P2|COMPLETED|Overall Study||4932
7765976|NCT01394952|19119421|P1|COMPLETED|Overall Study||4935
7765977|NCT01394952|19119420|P2|Received at Least One Dose of Study Drug|Overall Study||4943
7765978|NCT01394952|19119421|P1|Received at Least One Dose of Study Drug|Overall Study||4949
7765979|NCT01394952|19119420|P2|STARTED|Overall Study||4949
7765980|NCT01394952|19119421|P1|STARTED|Overall Study||4952
7765981|NCT01394926|19119437|P1|NOT COMPLETED|Overall Study||0
7765982|NCT01394926|19119437|P1|COMPLETED|Overall Study||21
7765983|NCT01394926|19119437|P1|STARTED|Overall Study||21
7765984|NCT01394718|19119448|P2|NOT COMPLETED|Overall Study||1
7765985|NCT01394718|19119449|P1|NOT COMPLETED|Overall Study||2
7765986|NCT01394718|19119448|P2|COMPLETED|Overall Study||29
7765987|NCT01394718|19119449|P1|COMPLETED|Overall Study||28
7765988|NCT01394718|19119448|P2|STARTED|Overall Study||30
7765989|NCT01394718|19119449|P1|STARTED|Overall Study||30
7765990|NCT01394705|19119463|P2|NOT COMPLETED|Overall Study||2
7765991|NCT01394705|19119464|P1|NOT COMPLETED|Overall Study||2
7765992|NCT01394705|19119463|P2|COMPLETED|Overall Study||19
7765993|NCT01394705|19119464|P1|COMPLETED|Overall Study||19
7765994|NCT01394705|19119463|P2|STARTED|Overall Study||21
7765995|NCT01394705|19119464|P1|STARTED|Overall Study||21
7765996|NCT01394692|19119474|P2|NOT COMPLETED|Overall Study||0
7765997|NCT01394692|19119475|P1|NOT COMPLETED|Overall Study||0
7765998|NCT01394692|19119474|P2|COMPLETED|Overall Study||29
7765999|NCT01394692|19119475|P1|COMPLETED|Overall Study||29
7766000|NCT01394692|19119474|P2|STARTED|Overall Study||29
7766001|NCT01394692|19119475|P1|STARTED|Overall Study||29
7766002|NCT01394627|19119481|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7766003|NCT01394627|19119482|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7766004|NCT01394627|19119481|P2|COMPLETED|Second Intervention (1 Day)||12
7766005|NCT01394627|19119482|P1|COMPLETED|Second Intervention (1 Day)||7
7766006|NCT01394627|19119481|P2|STARTED|Second Intervention (1 Day)||12
7766007|NCT01394627|19119482|P1|STARTED|Second Intervention (1 Day)||7
7766008|NCT01394627|19119481|P2|NOT COMPLETED|Washout (1-3 Months)||0
7766009|NCT01394627|19119482|P1|NOT COMPLETED|Washout (1-3 Months)||1
7766010|NCT01394627|19119481|P2|COMPLETED|Washout (1-3 Months)||12
7766011|NCT01394627|19119482|P1|COMPLETED|Washout (1-3 Months)||7
7766012|NCT01394627|19119481|P2|STARTED|Washout (1-3 Months)||12
7766013|NCT01394627|19119482|P1|STARTED|Washout (1-3 Months)||8
7766014|NCT01394627|19119481|P2|NOT COMPLETED|First Intervention (1 Day)||1
7766015|NCT01394627|19119482|P1|NOT COMPLETED|First Intervention (1 Day)||0
7766016|NCT01394627|19119481|P2|COMPLETED|First Intervention (1 Day)||12
7766017|NCT01394627|19119482|P1|COMPLETED|First Intervention (1 Day)||8
7766018|NCT01394627|19119481|P2|STARTED|First Intervention (1 Day)||13
7766019|NCT01394627|19119482|P1|STARTED|First Intervention (1 Day)||8
7766020|NCT01394614|19119492|P2|NOT COMPLETED|Overall Study||0
7766021|NCT01394614|19119493|P1|NOT COMPLETED|Overall Study||0
7766022|NCT01394614|19119492|P2|COMPLETED|Overall Study||16
7766023|NCT01394614|19119493|P1|COMPLETED|Overall Study||8
7766024|NCT01394614|19119492|P2|STARTED|Overall Study||16
7766025|NCT01394614|19119493|P1|STARTED|Overall Study||8
7766026|NCT01394523|19119502|P3|NOT COMPLETED|Overall Study||0
7766027|NCT01394523|19119503|P2|NOT COMPLETED|Overall Study||0
7766028|NCT01394523|19119504|P1|NOT COMPLETED|Overall Study||1
7766029|NCT01394523|19119502|P3|COMPLETED|Overall Study||13
7766030|NCT01394523|19119503|P2|COMPLETED|Overall Study||13
7766031|NCT01394523|19119504|P1|COMPLETED|Overall Study||12
7766032|NCT01394523|19119502|P3|STARTED|Overall Study||13
7766033|NCT01394523|19119503|P2|STARTED|Overall Study||13
7766034|NCT01394523|19119504|P1|STARTED|Overall Study||13
7766035|NCT01394510|19119512|P1|NOT COMPLETED|Overall Study||0
7766036|NCT01394510|19119512|P1|COMPLETED|Overall Study||13
7766037|NCT01394510|19119512|P1|STARTED|Overall Study||13
7766038|NCT01394276|19119518|P1|NOT COMPLETED|Overall Study||62
7766039|NCT01394276|19119518|P1|COMPLETED|Overall Study||260
7766040|NCT01394276|19119518|P1|STARTED|Overall Study||322
7766041|NCT01394250|19119542|P2|NOT COMPLETED|Successful IV Placement & Follow-Up||11
7766042|NCT01394250|19119543|P1|NOT COMPLETED|Successful IV Placement & Follow-Up||6
7766043|NCT01394250|19119542|P2|COMPLETED|Successful IV Placement & Follow-Up||110
7766044|NCT01394250|19119543|P1|COMPLETED|Successful IV Placement & Follow-Up||114
7766045|NCT01394250|19119542|P2|STARTED|Successful IV Placement & Follow-Up||121
7766046|NCT01394250|19119543|P1|STARTED|Successful IV Placement & Follow-Up||120
7766047|NCT01394250|19119542|P2|NOT COMPLETED|Randomization and IV Placement Attempt||13
7766048|NCT01394250|19119543|P1|NOT COMPLETED|Randomization and IV Placement Attempt||14
7766049|NCT01394250|19119542|P2|COMPLETED|Randomization and IV Placement Attempt||121
7766050|NCT01394250|19119543|P1|COMPLETED|Randomization and IV Placement Attempt||120
7766051|NCT01394250|19119542|P2|STARTED|Randomization and IV Placement Attempt||134
7766052|NCT01394250|19119543|P1|STARTED|Randomization and IV Placement Attempt||134
7766053|NCT01394211|19119551|P1|NOT COMPLETED|Overall Study||2
7766054|NCT01394211|19119551|P1|COMPLETED|Overall Study||0
7766055|NCT01394211|19119551|P1|STARTED|Overall Study||2
7766056|NCT01394185|19119557|P6|NOT COMPLETED|Overall Study||1
7766057|NCT01394185|19119558|P5|NOT COMPLETED|Overall Study||4
7766058|NCT01394185|19119559|P4|NOT COMPLETED|Overall Study||1
7766059|NCT01394185|19119560|P3|NOT COMPLETED|Overall Study||0
7766060|NCT01394185|19119561|P2|NOT COMPLETED|Overall Study||0
7766061|NCT01394185|19119562|P1|NOT COMPLETED|Overall Study||6
7766062|NCT01394185|19119557|P6|COMPLETED|Overall Study||2
7766063|NCT01394185|19119558|P5|COMPLETED|Overall Study||2
7766064|NCT01394185|19119559|P4|COMPLETED|Overall Study||3
7766065|NCT01394185|19119560|P3|COMPLETED|Overall Study||2
7766066|NCT01394185|19119561|P2|COMPLETED|Overall Study||2
7766067|NCT01394185|19119562|P1|COMPLETED|Overall Study||2
7766068|NCT01394185|19119557|P6|STARTED|Overall Study||3
7766069|NCT01394185|19119558|P5|STARTED|Overall Study||6
7766070|NCT01394185|19119559|P4|STARTED|Overall Study||4
7766071|NCT01394185|19119560|P3|STARTED|Overall Study||2
7766072|NCT01394185|19119561|P2|STARTED|Overall Study||2
7766073|NCT01394185|19119562|P1|STARTED|Overall Study||8
7766074|NCT01394159|19119575|P2|NOT COMPLETED|Overall Study||0
7766075|NCT01394159|19119576|P1|NOT COMPLETED|Overall Study||0
7766076|NCT01394159|19119575|P2|COMPLETED|Overall Study||28
7766077|NCT01394159|19119576|P1|COMPLETED|Overall Study||28
7766078|NCT01394159|19119575|P2|STARTED|Overall Study||28
7766079|NCT01394159|19119576|P1|STARTED|Overall Study||28
7766080|NCT01394081|19119588|P2|NOT COMPLETED|Overall Study||0
7766081|NCT01394081|19119589|P1|NOT COMPLETED|Overall Study||0
7766082|NCT01394081|19119588|P2|COMPLETED|Overall Study||102
7766083|NCT01394081|19119589|P1|COMPLETED|Overall Study||101
7766084|NCT01394081|19119588|P2|STARTED|Overall Study||102
7766085|NCT01394081|19119589|P1|STARTED|Overall Study||101
7766086|NCT01394003|19119605|P8|NOT COMPLETED|Overall Study||0
7766087|NCT01394003|19119606|P7|NOT COMPLETED|Overall Study||0
7766088|NCT01394003|19119607|P6|NOT COMPLETED|Overall Study||0
7766089|NCT01394003|19119608|P5|NOT COMPLETED|Overall Study||0
7766090|NCT01394003|19119609|P4|NOT COMPLETED|Overall Study||0
7766091|NCT01394003|19119610|P3|NOT COMPLETED|Overall Study||0
7766092|NCT01394003|19119611|P2|NOT COMPLETED|Overall Study||0
7766093|NCT01394003|19119612|P1|NOT COMPLETED|Overall Study||0
7766094|NCT01394003|19119605|P8|COMPLETED|Overall Study||2
7766095|NCT01394003|19119606|P7|COMPLETED|Overall Study||6
7766096|NCT01394003|19119607|P6|COMPLETED|Overall Study||3
7766097|NCT01394003|19119608|P5|COMPLETED|Overall Study||3
7766098|NCT01394003|19119609|P4|COMPLETED|Overall Study||6
7766099|NCT01394003|19119610|P3|COMPLETED|Overall Study||3
7766100|NCT01394003|19119611|P2|COMPLETED|Overall Study||8
7766101|NCT01394003|19119612|P1|COMPLETED|Overall Study||3
7766102|NCT01394003|19119605|P8|Received at Least 1 Dose of Study Drug|Overall Study||2
7766103|NCT01394003|19119606|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
7766104|NCT01394003|19119607|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
7766105|NCT01394003|19119608|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
7766106|NCT01394003|19119609|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
7766107|NCT01394003|19119610|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
7766108|NCT01394003|19119611|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
7766109|NCT01394003|19119612|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
7766110|NCT01394003|19119605|P8|STARTED|Overall Study||2
7766111|NCT01394003|19119606|P7|STARTED|Overall Study||6
7766112|NCT01394003|19119607|P6|STARTED|Overall Study||3
7766113|NCT01394003|19119608|P5|STARTED|Overall Study||3
7766114|NCT01394003|19119609|P4|STARTED|Overall Study||6
7766115|NCT01394003|19119610|P3|STARTED|Overall Study||3
7766116|NCT01394003|19119611|P2|STARTED|Overall Study||8
7766117|NCT01394003|19119612|P1|STARTED|Overall Study||3
7766118|NCT01393990|19119666|P18|NOT COMPLETED|Overall Study||0
7766119|NCT01393990|19119667|P17|NOT COMPLETED|Overall Study||0
7766120|NCT01393990|19119668|P16|NOT COMPLETED|Overall Study||3
7766121|NCT01393990|19119669|P15|NOT COMPLETED|Overall Study||9
7766122|NCT01393990|19119670|P14|NOT COMPLETED|Overall Study||2
7766123|NCT01393990|19119671|P13|NOT COMPLETED|Overall Study||0
7766124|NCT01393990|19119672|P12|NOT COMPLETED|Overall Study||0
7766125|NCT01393990|19119673|P11|NOT COMPLETED|Overall Study||0
7766126|NCT01393990|19119674|P10|NOT COMPLETED|Overall Study||1
7766127|NCT01393990|19119675|P9|NOT COMPLETED|Overall Study||3
7766128|NCT01393990|19119676|P8|NOT COMPLETED|Overall Study||1
7766129|NCT01393990|19119677|P7|NOT COMPLETED|Overall Study||1
7766130|NCT01393990|19119678|P6|NOT COMPLETED|Overall Study||1
7766131|NCT01393990|19119679|P5|NOT COMPLETED|Overall Study||2
7766132|NCT01393990|19119680|P4|NOT COMPLETED|Overall Study||1
7766133|NCT01393990|19119681|P3|NOT COMPLETED|Overall Study||0
7766134|NCT01393990|19119682|P2|NOT COMPLETED|Overall Study||0
7766135|NCT01393990|19119683|P1|NOT COMPLETED|Overall Study||1
7766136|NCT01393990|19119666|P18|COMPLETED|Overall Study||6
7766137|NCT01393990|19119667|P17|COMPLETED|Overall Study||3
7766138|NCT01393990|19119668|P16|COMPLETED|Overall Study||5
7766139|NCT01393990|19119669|P15|COMPLETED|Overall Study||9
7766140|NCT01393990|19119670|P14|COMPLETED|Overall Study||3
7766141|NCT01393990|19119671|P13|COMPLETED|Overall Study||3
7766142|NCT01393990|19119672|P12|COMPLETED|Overall Study||3
7766143|NCT01393990|19119673|P11|COMPLETED|Overall Study||3
7766144|NCT01393990|19119674|P10|COMPLETED|Overall Study||2
7766145|NCT01393990|19119675|P9|COMPLETED|Overall Study||3
7766146|NCT01393990|19119676|P8|COMPLETED|Overall Study||6
7766147|NCT01393990|19119677|P7|COMPLETED|Overall Study||2
7766148|NCT01393990|19119678|P6|COMPLETED|Overall Study||2
7766149|NCT01393990|19119679|P5|COMPLETED|Overall Study||3
7766150|NCT01393990|19119680|P4|COMPLETED|Overall Study||2
7766151|NCT01393990|19119681|P3|COMPLETED|Overall Study||3
7766152|NCT01393990|19119682|P2|COMPLETED|Overall Study||3
7766153|NCT01393990|19119683|P1|COMPLETED|Overall Study||3
7766154|NCT01393990|19119666|P18|Received at Least 1 Dose of Study Drug|Overall Study||6
7766155|NCT01393990|19119667|P17|Received at Least 1 Dose of Study Drug|Overall Study||3
7766156|NCT01393990|19119668|P16|Received at Least 1 Dose of Study Drug|Overall Study||8
7766157|NCT01393990|19119669|P15|Received at Least 1 Dose of Study Drug|Overall Study||18
7766158|NCT01393990|19119670|P14|Received at Least 1 Dose of Study Drug|Overall Study||5
7766159|NCT01393990|19119671|P13|Received at Least 1 Dose of Study Drug|Overall Study||3
7766160|NCT01393990|19119672|P12|Received at Least 1 Dose of Study Drug|Overall Study||3
7766161|NCT01393990|19119673|P11|Received at Least 1 Dose of Study Drug|Overall Study||3
7766162|NCT01393990|19119674|P10|Received at Least 1 Dose of Study Drug|Overall Study||3
7766163|NCT01393990|19119675|P9|Received at Least 1 Dose of Study Drug|Overall Study||6
7766164|NCT01393990|19119676|P8|Received at Least 1 Dose of Study Drug|Overall Study||7
7766165|NCT01393990|19119677|P7|Received at Least 1 Dose of Study Drug|Overall Study||3
7766166|NCT01393990|19119678|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
7766167|NCT01393990|19119679|P5|Received at Least 1 Dose of Study Drug|Overall Study||5
7766168|NCT01393990|19119680|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
7766169|NCT01393990|19119681|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
7766170|NCT01393990|19119682|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
7766171|NCT01393990|19119683|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
7766172|NCT01393990|19119666|P18|STARTED|Overall Study||6
7766173|NCT01393990|19119667|P17|STARTED|Overall Study||3
7766174|NCT01393990|19119668|P16|STARTED|Overall Study||8
7766175|NCT01393990|19119669|P15|STARTED|Overall Study||18
7766176|NCT01393990|19119670|P14|STARTED|Overall Study||5
7766177|NCT01393990|19119671|P13|STARTED|Overall Study||3
7766178|NCT01393990|19119672|P12|STARTED|Overall Study||3
7766179|NCT01393990|19119673|P11|STARTED|Overall Study||3
7766180|NCT01393990|19119674|P10|STARTED|Overall Study||3
7766181|NCT01393990|19119675|P9|STARTED|Overall Study||6
7766182|NCT01393990|19119676|P8|STARTED|Overall Study||7
7766183|NCT01393990|19119677|P7|STARTED|Overall Study||3
7766184|NCT01393990|19119678|P6|STARTED|Overall Study||3
7766185|NCT01393990|19119679|P5|STARTED|Overall Study||5
7766186|NCT01393990|19119680|P4|STARTED|Overall Study||3
7766187|NCT01393990|19119681|P3|STARTED|Overall Study||3
7766188|NCT01393990|19119682|P2|STARTED|Overall Study||3
7766189|NCT01393990|19119683|P1|STARTED|Overall Study||4
7766190|NCT01393964|19119774|P3|NOT COMPLETED|Overall Study||9
7766191|NCT01393964|19119775|P2|NOT COMPLETED|Overall Study||9
7766192|NCT01393964|19119776|P1|NOT COMPLETED|Overall Study||8
7766193|NCT01393964|19119774|P3|COMPLETED|Overall Study|Completed=treatment on-going|0
7766194|NCT01393964|19119775|P2|COMPLETED|Overall Study|Completed=treatment on-going|0
7766195|NCT01393964|19119776|P1|COMPLETED|Overall Study|Completed=treatment on-going|0
7766196|NCT01393964|19119774|P3|STARTED|Overall Study||9
7766197|NCT01393964|19119775|P2|STARTED|Overall Study||9
7766198|NCT01393964|19119776|P1|STARTED|Overall Study||8
7766199|NCT01393899|19119817|P3|NOT COMPLETED|Overall Study||23
7766200|NCT01393899|19119818|P2|NOT COMPLETED|Overall Study||28
7766201|NCT01393899|19119819|P1|NOT COMPLETED|Overall Study||32
7766202|NCT01393899|19119817|P3|COMPLETED|Overall Study||38
7766203|NCT01393899|19119818|P2|COMPLETED|Overall Study||32
7766204|NCT01393899|19119819|P1|COMPLETED|Overall Study||27
7766205|NCT01393899|19119817|P3|STARTED|Overall Study||61
7766206|NCT01393899|19119818|P2|STARTED|Overall Study||60
7766207|NCT01393899|19119819|P1|STARTED|Overall Study||59
7766208|NCT01393821|19119873|P2|NOT COMPLETED|Overall Study||3
7766209|NCT01393821|19119874|P1|NOT COMPLETED|Overall Study||5
7766210|NCT01393821|19119873|P2|COMPLETED|Overall Study||10
7766211|NCT01393821|19119874|P1|COMPLETED|Overall Study||9
7766212|NCT01393821|19119873|P2|STARTED|Overall Study||13
7766213|NCT01393821|19119874|P1|STARTED|Overall Study||14
7766214|NCT01393743|19119888|P3|NOT COMPLETED|Extension Phase||60
7766215|NCT01393743|19119889|P2|NOT COMPLETED|Extension Phase||0
7766216|NCT01393743|19119890|P1|NOT COMPLETED|Extension Phase||0
7766217|NCT01393743|19119888|P3|COMPLETED|Extension Phase||78
7766218|NCT01393743|19119889|P2|COMPLETED|Extension Phase||0
7766219|NCT01393743|19119890|P1|COMPLETED|Extension Phase||0
7766220|NCT01393743|19119888|P3|STARTED|Extension Phase|Continuation into the Extension Phase was optional.|138
7766221|NCT01393743|19119889|P2|STARTED|Extension Phase||0
7766222|NCT01393743|19119890|P1|STARTED|Extension Phase||0
7766223|NCT01393743|19119888|P3|NOT COMPLETED|Core Study||0
7766224|NCT01393743|19119889|P2|NOT COMPLETED|Core Study||13
7766225|NCT01393743|19119890|P1|NOT COMPLETED|Core Study||10
7766226|NCT01393743|19119888|P3|COMPLETED|Core Study||0
7766227|NCT01393743|19119889|P2|COMPLETED|Core Study||68
7766228|NCT01393743|19119890|P1|COMPLETED|Core Study||72
7766229|NCT01393743|19119888|P3|STARTED|Core Study||0
7766230|NCT01393743|19119889|P2|STARTED|Core Study|Treated|81
7766231|NCT01393743|19119890|P1|STARTED|Core Study|Treated|82
7766232|NCT01393730|19119913|P1|NOT COMPLETED|Overall Study||6
7766233|NCT01393730|19119913|P1|COMPLETED|Overall Study||34
7766234|NCT01393730|19119913|P1|Evaluable AR Mutation|Overall Study||14
7766235|NCT01393730|19119913|P1|Evaluable AR Amplification|Overall Study||21
7766236|NCT01393730|19119913|P1|Treated|Overall Study||38
7766237|NCT01393730|19119913|P1|STARTED|Overall Study||40
7766238|NCT01393717|19119925|P2|NOT COMPLETED|Overall Study||0
7766239|NCT01393717|19119926|P1|NOT COMPLETED|Overall Study||0
7766240|NCT01393717|19119925|P2|COMPLETED|Overall Study||20
7766241|NCT01393717|19119926|P1|COMPLETED|Overall Study||37
7766242|NCT01393717|19119925|P2|STARTED|Overall Study||20
7766243|NCT01393717|19119926|P1|STARTED|Overall Study||37
7766244|NCT01393704|19119940|P2|NOT COMPLETED|Overall Study||0
7766245|NCT01393704|19119941|P1|NOT COMPLETED|Overall Study||0
7766246|NCT01393704|19119940|P2|COMPLETED|Overall Study||76
7766247|NCT01393704|19119941|P1|COMPLETED|Overall Study||76
7766248|NCT01393704|19119940|P2|STARTED|Overall Study||76
7766249|NCT01393704|19119941|P1|STARTED|Overall Study||76
7766250|NCT01393626|19119959|P4|NOT COMPLETED|Overall Study||1
7766251|NCT01393626|19119960|P3|NOT COMPLETED|Overall Study||12
7766252|NCT01393626|19119961|P2|NOT COMPLETED|Overall Study||12
7766253|NCT01393626|19119962|P1|NOT COMPLETED|Overall Study||18
7766254|NCT01393626|19119959|P4|COMPLETED|Overall Study||15
7766255|NCT01393626|19119960|P3|COMPLETED|Overall Study||74
7766256|NCT01393626|19119961|P2|COMPLETED|Overall Study||74
7766257|NCT01393626|19119962|P1|COMPLETED|Overall Study||73
7766258|NCT01393626|19119959|P4|STARTED|Overall Study||16
7766259|NCT01393626|19119960|P3|STARTED|Overall Study||86
7766260|NCT01393626|19119961|P2|STARTED|Overall Study||86
7766261|NCT01393626|19119962|P1|STARTED|Overall Study||91
7766262|NCT01393613|19120042|P4|NOT COMPLETED|Overall Study||66
7766263|NCT01393613|19120043|P3|NOT COMPLETED|Overall Study||54
7766264|NCT01393613|19120044|P2|NOT COMPLETED|Overall Study||57
7766265|NCT01393613|19120045|P1|NOT COMPLETED|Overall Study||39
7766266|NCT01393613|19120042|P4|COMPLETED|Overall Study||118
7766267|NCT01393613|19120043|P3|COMPLETED|Overall Study||130
7766268|NCT01393613|19120044|P2|COMPLETED|Overall Study||129
7766269|NCT01393613|19120045|P1|COMPLETED|Overall Study||81
7766270|NCT01393613|19120042|P4|STARTED|Overall Study||184
7766271|NCT01393613|19120043|P3|STARTED|Overall Study||184
7766272|NCT01393613|19120044|P2|STARTED|Overall Study||186
7766273|NCT01393613|19120045|P1|STARTED|Overall Study||120
7766274|NCT01393600|19120107|P4|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
7766275|NCT01393600|19120108|P3|NOT COMPLETED|Follow-up Period (Day 29 to 35)||1
7766276|NCT01393600|19120109|P2|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
7766277|NCT01393600|19120110|P1|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
7766278|NCT01393600|19120107|P4|COMPLETED|Follow-up Period (Day 29 to 35)||8
7766279|NCT01393600|19120108|P3|COMPLETED|Follow-up Period (Day 29 to 35)||6
7766280|NCT01393600|19120109|P2|COMPLETED|Follow-up Period (Day 29 to 35)||7
7766281|NCT01393600|19120110|P1|COMPLETED|Follow-up Period (Day 29 to 35)||9
7766282|NCT01393600|19120107|P4|STARTED|Follow-up Period (Day 29 to 35)||8
7766283|NCT01393600|19120108|P3|STARTED|Follow-up Period (Day 29 to 35)||7
7766284|NCT01393600|19120109|P2|STARTED|Follow-up Period (Day 29 to 35)||7
7766285|NCT01393600|19120110|P1|STARTED|Follow-up Period (Day 29 to 35)||9
7766286|NCT01393600|19120107|P4|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||1
7766287|NCT01393600|19120108|P3|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||2
7766288|NCT01393600|19120109|P2|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
7766289|NCT01393600|19120110|P1|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
7766290|NCT01393600|19120107|P4|COMPLETED|Treatment Period 2 (Day 15 to 28)||8
7766291|NCT01393600|19120108|P3|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
7766292|NCT01393600|19120109|P2|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
7766293|NCT01393600|19120110|P1|COMPLETED|Treatment Period 2 (Day 15 to 28)||9
7766294|NCT01393600|19120107|P4|STARTED|Treatment Period 2 (Day 15 to 28)||9
7766295|NCT01393600|19120108|P3|STARTED|Treatment Period 2 (Day 15 to 28)||9
7766296|NCT01393600|19120109|P2|STARTED|Treatment Period 2 (Day 15 to 28)||7
7766297|NCT01393600|19120110|P1|STARTED|Treatment Period 2 (Day 15 to 28)||9
7766298|NCT01393600|19120107|P4|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
7766299|NCT01393600|19120108|P3|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
7766300|NCT01393600|19120109|P2|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
7766301|NCT01393600|19120110|P1|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||0
7766302|NCT01393600|19120107|P4|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
7766303|NCT01393600|19120108|P3|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
7766304|NCT01393600|19120109|P2|COMPLETED|Treatment Period 1 (Day 1 to 14)||7
7766305|NCT01393600|19120110|P1|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
7766306|NCT01393600|19120107|P4|STARTED|Treatment Period 1 (Day 1 to 14)||10
7766307|NCT01393600|19120108|P3|STARTED|Treatment Period 1 (Day 1 to 14)||10
7766308|NCT01393600|19120109|P2|STARTED|Treatment Period 1 (Day 1 to 14)||8
7766309|NCT01393600|19120110|P1|STARTED|Treatment Period 1 (Day 1 to 14)||9
7766310|NCT01393457|19120129|P4|NOT COMPLETED|Overall Study||12
7766311|NCT01393457|19120130|P3|NOT COMPLETED|Overall Study||15
7766312|NCT01393457|19120131|P2|NOT COMPLETED|Overall Study||12
7766313|NCT01393457|19120132|P1|NOT COMPLETED|Overall Study||12
7766314|NCT01393457|19120129|P4|COMPLETED|Overall Study||15
7766315|NCT01393457|19120130|P3|COMPLETED|Overall Study||16
7766316|NCT01393457|19120131|P2|COMPLETED|Overall Study||14
7766317|NCT01393457|19120132|P1|COMPLETED|Overall Study||14
7766318|NCT01393457|19120129|P4|STARTED|Overall Study||27
7766319|NCT01393457|19120130|P3|STARTED|Overall Study||31
7766320|NCT01393457|19120131|P2|STARTED|Overall Study||26
7766321|NCT01393457|19120132|P1|STARTED|Overall Study||26
7766322|NCT01393444|19120146|P1|NOT COMPLETED|Overall Study||3
7766323|NCT01393444|19120146|P1|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3
7766324|NCT01393444|19120146|P1|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1
7766325|NCT01393444|19120146|P1|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1
7766326|NCT01393444|19120146|P1|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1
7766327|NCT01393444|19120146|P1|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1
7766328|NCT01393444|19120146|P1|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1
7766329|NCT01393444|19120146|P1|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1
7766330|NCT01393444|19120146|P1|STARTED|Overall Study||6
7766331|NCT01393405|19120151|P3|NOT COMPLETED|Maintenance Period Week||24
7766332|NCT01393405|19120152|P2|NOT COMPLETED|Maintenance Period Week||29
7766333|NCT01393405|19120153|P1|NOT COMPLETED|Maintenance Period Week||0
7766334|NCT01393405|19120151|P3|COMPLETED|Maintenance Period Week||16
7766335|NCT01393405|19120152|P2|COMPLETED|Maintenance Period Week||15
7766336|NCT01393405|19120153|P1|COMPLETED|Maintenance Period Week||0
7766337|NCT01393405|19120151|P3|STARTED|Maintenance Period Week||40
7766338|NCT01393405|19120152|P2|STARTED|Maintenance Period Week||44
7766339|NCT01393405|19120153|P1|STARTED|Maintenance Period Week||0
7766340|NCT01393405|19120151|P3|NOT COMPLETED|Induction Period (week1-16)||0
7766341|NCT01393405|19120152|P2|NOT COMPLETED|Induction Period (week1-16)||0
7766342|NCT01393405|19120153|P1|NOT COMPLETED|Induction Period (week1-16)||95
7766343|NCT01393405|19120151|P3|COMPLETED|Induction Period (week1-16)||0
7766344|NCT01393405|19120152|P2|COMPLETED|Induction Period (week1-16)||0
7766345|NCT01393405|19120153|P1|COMPLETED|Induction Period (week1-16)||84
7766346|NCT01393405|19120151|P3|STARTED|Induction Period (week1-16)||0
7766347|NCT01393405|19120152|P2|STARTED|Induction Period (week1-16)||0
7766348|NCT01393405|19120153|P1|STARTED|Induction Period (week1-16)||179
7766349|NCT01393392|19120172|P2|NOT COMPLETED|Overall Study||19
7766350|NCT01393392|19120173|P1|NOT COMPLETED|Overall Study||11
7766351|NCT01393392|19120172|P2|COMPLETED|Overall Study||24
7766352|NCT01393392|19120173|P1|COMPLETED|Overall Study||33
7766353|NCT01393392|19120172|P2|STARTED|Overall Study||43
7766354|NCT01393392|19120173|P1|STARTED|Overall Study||44
7766355|NCT01393301|19120191|P2|NOT COMPLETED|Overall Study||3
7766356|NCT01393301|19120192|P1|NOT COMPLETED|Overall Study||9
7766357|NCT01393301|19120191|P2|COMPLETED|Overall Study||24
7766358|NCT01393301|19120192|P1|COMPLETED|Overall Study||17
7766359|NCT01393301|19120191|P2|STARTED|Overall Study||27
7766360|NCT01393301|19120192|P1|STARTED|Overall Study||26
7766361|NCT01393158|19120205|P2|NOT COMPLETED|Overall Study||0
7766362|NCT01393158|19120206|P1|NOT COMPLETED|Overall Study||1
7766363|NCT01393158|19120205|P2|COMPLETED|Overall Study||10
7766364|NCT01393158|19120206|P1|COMPLETED|Overall Study||5
7766365|NCT01393158|19120205|P2|STARTED|Overall Study||10
7766366|NCT01393158|19120206|P1|STARTED|Overall Study||6
7766367|NCT01393132|19120220|P2|NOT COMPLETED|Overall Study||0
7766368|NCT01393132|19120221|P1|NOT COMPLETED|Overall Study||0
7766369|NCT01393132|19120220|P2|COMPLETED|Overall Study||3
7766370|NCT01393132|19120221|P1|COMPLETED|Overall Study||6
7766371|NCT01393132|19120220|P2|STARTED|Overall Study||3
7766372|NCT01393132|19120221|P1|STARTED|Overall Study||6
7766373|NCT01393106|19120233|P1|NOT COMPLETED|Overall Study||5
7766374|NCT01393106|19120233|P1|COMPLETED|Overall Study|Completed: Disease Progression/Death|20
7766375|NCT01393106|19120233|P1|STARTED|Overall Study||25
7766376|NCT01392989|19120250|P1|NOT COMPLETED|CIK Cell Infusion||0
7766377|NCT01392989|19120250|P1|COMPLETED|CIK Cell Infusion||31
7766378|NCT01392989|19120250|P1|STARTED|CIK Cell Infusion||31
7766379|NCT01392989|19120250|P1|NOT COMPLETED|Total Lymphoid Irradiation (TLI)||0
7766380|NCT01392989|19120250|P1|COMPLETED|Total Lymphoid Irradiation (TLI)||44
7766381|NCT01392989|19120250|P1|STARTED|Total Lymphoid Irradiation (TLI)||44
7766382|NCT01392963|19120260|P2|NOT COMPLETED|Week 24 Follow-up||0
7766383|NCT01392963|19120261|P1|NOT COMPLETED|Week 24 Follow-up||2
7766384|NCT01392963|19120260|P2|COMPLETED|Week 24 Follow-up||17
7766385|NCT01392963|19120261|P1|COMPLETED|Week 24 Follow-up||9
7766386|NCT01392963|19120260|P2|STARTED|Week 24 Follow-up||17
7766387|NCT01392963|19120261|P1|STARTED|Week 24 Follow-up||11
7766388|NCT01392963|19120260|P2|NOT COMPLETED|Week 12 (Second Intervention)||0
7766389|NCT01392963|19120261|P1|NOT COMPLETED|Week 12 (Second Intervention)||0
7766390|NCT01392963|19120260|P2|COMPLETED|Week 12 (Second Intervention)||17
7766391|NCT01392963|19120261|P1|COMPLETED|Week 12 (Second Intervention)||11
7766392|NCT01392963|19120260|P2|STARTED|Week 12 (Second Intervention)||17
7766393|NCT01392963|19120261|P1|STARTED|Week 12 (Second Intervention)||11
7766394|NCT01392963|19120260|P2|NOT COMPLETED|Week 0 (First Intervention)||2
7766395|NCT01392963|19120261|P1|NOT COMPLETED|Week 0 (First Intervention)||0
7766396|NCT01392963|19120260|P2|COMPLETED|Week 0 (First Intervention)||17
7766397|NCT01392963|19120261|P1|COMPLETED|Week 0 (First Intervention)||11
7766398|NCT01392963|19120260|P2|STARTED|Week 0 (First Intervention)||19
7766399|NCT01392963|19120261|P1|STARTED|Week 0 (First Intervention)||11
7766400|NCT01392742|19120269|P1|NOT COMPLETED|Overall Study||201
7766401|NCT01392742|19120269|P1|COMPLETED|Overall Study||242
7766402|NCT01392742|19120269|P1|STARTED|Overall Study||443
7766403|NCT01392703|19120284|P3|NOT COMPLETED|Day 9||0
7766404|NCT01392703|19120285|P2|NOT COMPLETED|Day 9||0
7766405|NCT01392703|19120286|P1|NOT COMPLETED|Day 9||0
7766406|NCT01392703|19120284|P3|COMPLETED|Day 9||25
7766407|NCT01392703|19120285|P2|COMPLETED|Day 9||26
7766408|NCT01392703|19120286|P1|COMPLETED|Day 9||26
7766409|NCT01392703|19120284|P3|STARTED|Day 9||25
7766410|NCT01392703|19120285|P2|STARTED|Day 9||26
7766411|NCT01392703|19120286|P1|STARTED|Day 9||26
7766412|NCT01392703|19120284|P3|NOT COMPLETED|Day 5||0
7766413|NCT01392703|19120285|P2|NOT COMPLETED|Day 5||0
7766414|NCT01392703|19120286|P1|NOT COMPLETED|Day 5||0
7766415|NCT01392703|19120284|P3|COMPLETED|Day 5||26
7766416|NCT01392703|19120285|P2|COMPLETED|Day 5||25
7766417|NCT01392703|19120286|P1|COMPLETED|Day 5||26
7766418|NCT01392703|19120284|P3|STARTED|Day 5||26
7766513|NCT01392378|19120409|P1|Vaccinated Dose 2|Infant Series||171
7766419|NCT01392703|19120285|P2|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25
7766420|NCT01392703|19120286|P1|STARTED|Day 5||26
7766421|NCT01392703|19120284|P3|NOT COMPLETED|Day 1||0
7766422|NCT01392703|19120285|P2|NOT COMPLETED|Day 1||0
7766423|NCT01392703|19120286|P1|NOT COMPLETED|Day 1||0
7766424|NCT01392703|19120284|P3|COMPLETED|Day 1||26
7766425|NCT01392703|19120285|P2|COMPLETED|Day 1||26
7766426|NCT01392703|19120286|P1|COMPLETED|Day 1||26
7766427|NCT01392703|19120284|P3|STARTED|Day 1||26
7766428|NCT01392703|19120285|P2|STARTED|Day 1||26
7766429|NCT01392703|19120286|P1|STARTED|Day 1||26
7766430|NCT01392677|19120315|P2|NOT COMPLETED|Overall Study||8
7766431|NCT01392677|19120316|P1|NOT COMPLETED|Overall Study||8
7766432|NCT01392677|19120315|P2|COMPLETED|Overall Study||101
7766433|NCT01392677|19120316|P1|COMPLETED|Overall Study||101
7766434|NCT01392677|19120315|P2|STARTED|Overall Study||109
7766435|NCT01392677|19120316|P1|STARTED|Overall Study||109
7766436|NCT01392625|19120332|P2|NOT COMPLETED|Overall Study||1
7766437|NCT01392625|19120333|P1|NOT COMPLETED|Overall Study||2
7766438|NCT01392625|19120332|P2|COMPLETED|Overall Study||18
7766439|NCT01392625|19120333|P1|COMPLETED|Overall Study||16
7766440|NCT01392625|19120332|P2|STARTED|Overall Study||19
7766441|NCT01392625|19120333|P1|STARTED|Overall Study||18
7766442|NCT01392573|19120351|P2|NOT COMPLETED|Overall Study||35
7766443|NCT01392573|19120352|P1|NOT COMPLETED|Overall Study||32
7766444|NCT01392573|19120351|P2|COMPLETED|Overall Study||171
7766445|NCT01392573|19120352|P1|COMPLETED|Overall Study||175
7766446|NCT01392573|19120351|P2|Exposed|Overall Study||206
7766447|NCT01392573|19120352|P1|Exposed|Overall Study||207
7766448|NCT01392573|19120351|P2|STARTED|Overall Study||206
7766449|NCT01392573|19120352|P1|STARTED|Overall Study||207
7766450|NCT01392560|19120360|P1|NOT COMPLETED|Overall Study||12
7766451|NCT01392560|19120360|P1|COMPLETED|Overall Study||40
7766452|NCT01392560|19120360|P1|STARTED|Overall Study||52
7766453|NCT01392547|19120366|P1|NOT COMPLETED|Overall Study||8
7766454|NCT01392547|19120366|P1|COMPLETED|Overall Study||64
7766455|NCT01392547|19120366|P1|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72
7766456|NCT01392495|19120380|P1|NOT COMPLETED|Overall Study||16
7766457|NCT01392495|19120380|P1|COMPLETED|Overall Study||1
7766458|NCT01392495|19120380|P1|Received 400 mg|Overall Study||13
7766459|NCT01392495|19120380|P1|Received 200 mg|Overall Study||4
7766460|NCT01392495|19120380|P1|STARTED|Overall Study||17
7766461|NCT01392443|19120392|P1|NOT COMPLETED|Overall Study||68
7766462|NCT01392443|19120392|P1|COMPLETED|Overall Study||52
7766463|NCT01392443|19120392|P1|STARTED|Overall Study||120
7766464|NCT01392378|19120405|P5|NOT COMPLETED|Toddler Dose||1
7766465|NCT01392378|19120406|P4|NOT COMPLETED|Toddler Dose||2
7766466|NCT01392378|19120407|P3|NOT COMPLETED|Toddler Dose||0
7766467|NCT01392378|19120408|P2|NOT COMPLETED|Toddler Dose||1
7766468|NCT01392378|19120409|P1|NOT COMPLETED|Toddler Dose||0
7766469|NCT01392378|19120405|P5|COMPLETED|Toddler Dose||208
7766470|NCT01392378|19120406|P4|COMPLETED|Toddler Dose||173
7766471|NCT01392378|19120407|P3|COMPLETED|Toddler Dose||170
7766472|NCT01392378|19120408|P2|COMPLETED|Toddler Dose||172
7766473|NCT01392378|19120409|P1|COMPLETED|Toddler Dose||169
7766474|NCT01392378|19120405|P5|STARTED|Toddler Dose||209
7766475|NCT01392378|19120406|P4|STARTED|Toddler Dose||175
7766476|NCT01392378|19120407|P3|STARTED|Toddler Dose||170
7766477|NCT01392378|19120408|P2|STARTED|Toddler Dose||173
7766478|NCT01392378|19120409|P1|STARTED|Toddler Dose||169
7766479|NCT01392378|19120405|P5|NOT COMPLETED|After Infant Series||1
7766480|NCT01392378|19120406|P4|NOT COMPLETED|After Infant Series||0
7766481|NCT01392378|19120407|P3|NOT COMPLETED|After Infant Series||2
7766482|NCT01392378|19120408|P2|NOT COMPLETED|After Infant Series||1
7766483|NCT01392378|19120409|P1|NOT COMPLETED|After Infant Series||0
7766484|NCT01392378|19120405|P5|COMPLETED|After Infant Series||209
7766485|NCT01392378|19120406|P4|COMPLETED|After Infant Series||175
7766486|NCT01392378|19120407|P3|COMPLETED|After Infant Series||170
7766487|NCT01392378|19120408|P2|COMPLETED|After Infant Series||173
7766488|NCT01392378|19120409|P1|COMPLETED|After Infant Series||169
7766489|NCT01392378|19120405|P5|STARTED|After Infant Series||210
7766490|NCT01392378|19120406|P4|STARTED|After Infant Series||175
7766491|NCT01392378|19120407|P3|STARTED|After Infant Series||172
7766492|NCT01392378|19120408|P2|STARTED|After Infant Series||174
7766493|NCT01392378|19120409|P1|STARTED|After Infant Series||169
7766494|NCT01392378|19120405|P5|NOT COMPLETED|Infant Series||0
7766495|NCT01392378|19120406|P4|NOT COMPLETED|Infant Series||2
7766496|NCT01392378|19120407|P3|NOT COMPLETED|Infant Series||0
7766497|NCT01392378|19120408|P2|NOT COMPLETED|Infant Series||2
7766498|NCT01392378|19120409|P1|NOT COMPLETED|Infant Series||4
7766499|NCT01392378|19120405|P5|COMPLETED|Infant Series||210
7766500|NCT01392378|19120406|P4|COMPLETED|Infant Series||175
7766501|NCT01392378|19120407|P3|COMPLETED|Infant Series||172
7766502|NCT01392378|19120408|P2|COMPLETED|Infant Series||174
7766503|NCT01392378|19120409|P1|COMPLETED|Infant Series||169
7766504|NCT01392378|19120405|P5|Vaccinated Dose 3|Infant Series||210
7766505|NCT01392378|19120406|P4|Vaccinated Dose 3|Infant Series||176
7766506|NCT01392378|19120407|P3|Vaccinated Dose 3|Infant Series||172
7766507|NCT01392378|19120408|P2|Vaccinated Dose 3|Infant Series||174
7766508|NCT01392378|19120409|P1|Vaccinated Dose 3|Infant Series||170
7766509|NCT01392378|19120405|P5|Vaccinated Dose 2|Infant Series||210
7766510|NCT01392378|19120406|P4|Vaccinated Dose 2|Infant Series||177
7766511|NCT01392378|19120407|P3|Vaccinated Dose 2|Infant Series||172
7766512|NCT01392378|19120408|P2|Vaccinated Dose 2|Infant Series||174
7766514|NCT01392378|19120405|P5|Vaccinated Dose 1|Infant Series||210
7766515|NCT01392378|19120406|P4|Vaccinated Dose 1|Infant Series||177
7766516|NCT01392378|19120407|P3|Vaccinated Dose 1|Infant Series||172
7766517|NCT01392378|19120408|P2|Vaccinated Dose 1|Infant Series||176
7766518|NCT01392378|19120409|P1|Vaccinated Dose 1|Infant Series||173
7766519|NCT01392378|19120405|P5|STARTED|Infant Series||210
7766520|NCT01392378|19120406|P4|STARTED|Infant Series||177
7766521|NCT01392378|19120407|P3|STARTED|Infant Series||172
7766522|NCT01392378|19120408|P2|STARTED|Infant Series||176
7766523|NCT01392378|19120409|P1|STARTED|Infant Series||173
7766524|NCT01392326|19120549|P3|NOT COMPLETED|Overall Study||48
7766525|NCT01392326|19120550|P2|NOT COMPLETED|Overall Study||35
7766526|NCT01392326|19120551|P1|NOT COMPLETED|Overall Study||47
7766527|NCT01392326|19120549|P3|COMPLETED|Overall Study||154
7766528|NCT01392326|19120550|P2|COMPLETED|Overall Study||167
7766529|NCT01392326|19120551|P1|COMPLETED|Overall Study||155
7766530|NCT01392326|19120549|P3|STARTED|Overall Study||202
7766531|NCT01392326|19120550|P2|STARTED|Overall Study||202
7766532|NCT01392326|19120551|P1|STARTED|Overall Study||202
7766533|NCT01392300|19120588|P3|NOT COMPLETED|Open Label Extension (OLEX) Period||51
7766534|NCT01392300|19120589|P2|NOT COMPLETED|Open Label Extension (OLEX) Period||0
7766535|NCT01392300|19120590|P1|NOT COMPLETED|Open Label Extension (OLEX) Period||0
7766536|NCT01392300|19120588|P3|COMPLETED|Open Label Extension (OLEX) Period||248
7766537|NCT01392300|19120589|P2|COMPLETED|Open Label Extension (OLEX) Period||0
7766538|NCT01392300|19120590|P1|COMPLETED|Open Label Extension (OLEX) Period||0
7766539|NCT01392300|19120588|P3|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299
7766540|NCT01392300|19120589|P2|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
7766541|NCT01392300|19120590|P1|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
7766542|NCT01392300|19120588|P3|NOT COMPLETED|Main Period (MP)||0
7766543|NCT01392300|19120589|P2|NOT COMPLETED|Main Period (MP)||7
7766544|NCT01392300|19120590|P1|NOT COMPLETED|Main Period (MP)||11
7766545|NCT01392300|19120588|P3|COMPLETED|Main Period (MP)||0
7766546|NCT01392300|19120589|P2|COMPLETED|Main Period (MP)||100
7766547|NCT01392300|19120590|P1|COMPLETED|Main Period (MP)||199
7766548|NCT01392300|19120588|P3|STARTED|Main Period (MP)||0
7766549|NCT01392300|19120589|P2|STARTED|Main Period (MP)||107
7766550|NCT01392300|19120590|P1|STARTED|Main Period (MP)||210
7766551|NCT01392170|19120695|P1|NOT COMPLETED|Overall Study||2
7766552|NCT01392170|19120695|P1|COMPLETED|Overall Study||0
7766553|NCT01392170|19120695|P1|STARTED|Overall Study||2
7766554|NCT01392053|19120701|P2|NOT COMPLETED|Overall Study||0
7766555|NCT01392053|19120702|P1|NOT COMPLETED|Overall Study||0
7766556|NCT01392053|19120701|P2|COMPLETED|Overall Study||23
7766557|NCT01392053|19120702|P1|COMPLETED|Overall Study||23
7766558|NCT01392053|19120701|P2|STARTED|Overall Study||23
7766559|NCT01392053|19120702|P1|STARTED|Overall Study||23
7766560|NCT01391858|19120722|P2|NOT COMPLETED|Overall Study||0
7766561|NCT01391858|19120723|P1|NOT COMPLETED|Overall Study||2
7766562|NCT01391858|19120722|P2|COMPLETED|Overall Study||24
7766563|NCT01391858|19120723|P1|COMPLETED|Overall Study||23
7766564|NCT01391858|19120722|P2|STARTED|Overall Study||24
7766565|NCT01391858|19120723|P1|STARTED|Overall Study||25
7766566|NCT01391832|19120745|P2|NOT COMPLETED|Overall Study||23
7766567|NCT01391832|19120746|P1|NOT COMPLETED|Overall Study||21
7766568|NCT01391832|19120745|P2|COMPLETED|Overall Study||31
7766569|NCT01391832|19120746|P1|COMPLETED|Overall Study||28
7766570|NCT01391832|19120745|P2|3 Month Follow-Up|Overall Study||29
7766571|NCT01391832|19120746|P1|3 Month Follow-Up|Overall Study||28
7766572|NCT01391832|19120745|P2|1 Month Follow-Up|Overall Study||31
7766573|NCT01391832|19120746|P1|1 Month Follow-Up|Overall Study||30
7766574|NCT01391832|19120745|P2|STARTED|Overall Study||54
7766575|NCT01391832|19120746|P1|STARTED|Overall Study||49
7766576|NCT01391819|19120754|P1|NOT COMPLETED|Overall Study||402
7766577|NCT01391819|19120754|P1|COMPLETED|Overall Study||1714
7766578|NCT01391819|19120754|P1|STARTED|Overall Study||2116
7766579|NCT01391793|19120798|P2|NOT COMPLETED|Overall Study||144
7766580|NCT01391793|19120799|P1|NOT COMPLETED|Overall Study||147
7766581|NCT01391793|19120798|P2|COMPLETED|Overall Study||131
7766582|NCT01391793|19120799|P1|COMPLETED|Overall Study||124
7766583|NCT01391793|19120798|P2|Had a Positive Urine Culture|Overall Study||188
7766584|NCT01391793|19120799|P1|Had a Positive Urine Culture|Overall Study||197
7766585|NCT01391793|19120798|P2|STARTED|Overall Study||275
7766586|NCT01391793|19120799|P1|STARTED|Overall Study||271
7766587|NCT01391663|19120813|P4|NOT COMPLETED|Overall Study||0
7766588|NCT01391663|19120814|P3|NOT COMPLETED|Overall Study||1
7766589|NCT01391663|19120815|P2|NOT COMPLETED|Overall Study||0
7766590|NCT01391663|19120816|P1|NOT COMPLETED|Overall Study||0
7766591|NCT01391663|19120813|P4|COMPLETED|Overall Study||12
7766592|NCT01391663|19120814|P3|COMPLETED|Overall Study||11
7766593|NCT01391663|19120815|P2|COMPLETED|Overall Study||12
7766594|NCT01391663|19120816|P1|COMPLETED|Overall Study||12
7766595|NCT01391663|19120813|P4|STARTED|Overall Study||12
7766596|NCT01391663|19120814|P3|STARTED|Overall Study||12
7766597|NCT01391663|19120815|P2|STARTED|Overall Study||12
7766598|NCT01391663|19120816|P1|STARTED|Overall Study||12
7766599|NCT01391611|19120846|P1|NOT COMPLETED|Overall Study||22
7766600|NCT01391611|19120846|P1|COMPLETED|Overall Study||3
7766601|NCT01391611|19120846|P1|STARTED|Overall Study||25
7766602|NCT01391559|19120851|P2|NOT COMPLETED|Second Intervention||0
7766603|NCT01391559|19120852|P1|NOT COMPLETED|Second Intervention||0
7766604|NCT01391559|19120851|P2|COMPLETED|Second Intervention||10
7766605|NCT01391559|19120852|P1|COMPLETED|Second Intervention||10
7766606|NCT01391559|19120851|P2|STARTED|Second Intervention||10
7766607|NCT01391559|19120852|P1|STARTED|Second Intervention||10
7766608|NCT01391559|19120851|P2|NOT COMPLETED|First Intervention||0
7766609|NCT01391559|19120852|P1|NOT COMPLETED|First Intervention||0
7766610|NCT01391559|19120851|P2|COMPLETED|First Intervention||10
7766611|NCT01391559|19120852|P1|COMPLETED|First Intervention||10
7766612|NCT01391559|19120851|P2|STARTED|First Intervention||10
7766613|NCT01391559|19120852|P1|STARTED|First Intervention||10
7766614|NCT01391546|19120860|P2|NOT COMPLETED|Overall Study||0
7766615|NCT01391546|19120861|P1|NOT COMPLETED|Overall Study||1
7766616|NCT01391546|19120860|P2|COMPLETED|Overall Study||177
7766617|NCT01391546|19120861|P1|COMPLETED|Overall Study||176
7766618|NCT01391546|19120860|P2|Vaccinated|Overall Study||177
7766619|NCT01391546|19120861|P1|Vaccinated|Overall Study||176
7766620|NCT01391546|19120860|P2|STARTED|Overall Study||177
7766621|NCT01391546|19120861|P1|STARTED|Overall Study||177
7766622|NCT01391507|19120883|P4|NOT COMPLETED|Overall Study||7
7766623|NCT01391507|19120884|P3|NOT COMPLETED|Overall Study||4
7766624|NCT01391507|19120885|P2|NOT COMPLETED|Overall Study||4
7766625|NCT01391507|19120886|P1|NOT COMPLETED|Overall Study||4
7766626|NCT01391507|19120883|P4|COMPLETED|Overall Study||5
7766627|NCT01391507|19120884|P3|COMPLETED|Overall Study||2
7766628|NCT01391507|19120885|P2|COMPLETED|Overall Study||4
7766629|NCT01391507|19120886|P1|COMPLETED|Overall Study||6
7766630|NCT01391507|19120883|P4|STARTED|Overall Study||12
7766631|NCT01391507|19120884|P3|STARTED|Overall Study||6
7766632|NCT01391507|19120885|P2|STARTED|Overall Study||8
7766633|NCT01391507|19120886|P1|STARTED|Overall Study||10
7766634|NCT01391468|19120934|P2|NOT COMPLETED|Overall Study||2
7766635|NCT01391468|19120935|P1|NOT COMPLETED|Overall Study||6
7766636|NCT01391468|19120934|P2|COMPLETED|Overall Study||21
7766637|NCT01391468|19120935|P1|COMPLETED|Overall Study||18
7766638|NCT01391468|19120934|P2|STARTED|Overall Study||23
7766639|NCT01391468|19120935|P1|STARTED|Overall Study||24
7766640|NCT01391364|19120949|P2|NOT COMPLETED|Overall Study||2
7766641|NCT01391364|19120950|P1|NOT COMPLETED|Overall Study||5
7766642|NCT01391364|19120949|P2|COMPLETED|Overall Study||214
7766643|NCT01391364|19120950|P1|COMPLETED|Overall Study||217
7766644|NCT01391364|19120949|P2|STARTED|Overall Study||216
7766645|NCT01391364|19120950|P1|STARTED|Overall Study||222
7766646|NCT01391325|19120960|P1|NOT COMPLETED|Overall Study||494
7766647|NCT01391325|19120960|P1|COMPLETED|Overall Study||1238
7766648|NCT01391325|19120960|P1|STARTED|Overall Study||1732
7766649|NCT01391312|19120969|P2|NOT COMPLETED|Overall Study||1
7766650|NCT01391312|19120970|P1|NOT COMPLETED|Overall Study||2
7766651|NCT01391312|19120969|P2|COMPLETED|Overall Study||19
7766652|NCT01391312|19120970|P1|COMPLETED|Overall Study||18
7766653|NCT01391312|19120969|P2|STARTED|Overall Study||20
7766654|NCT01391312|19120970|P1|STARTED|Overall Study||20
7766655|NCT01391299|19120983|P3|NOT COMPLETED|Overall Study||2
7766656|NCT01391299|19120984|P2|NOT COMPLETED|Overall Study||1
7766657|NCT01391299|19120985|P1|NOT COMPLETED|Overall Study||0
7766658|NCT01391299|19120983|P3|COMPLETED|Overall Study||56
7766659|NCT01391299|19120984|P2|COMPLETED|Overall Study||59
7766660|NCT01391299|19120985|P1|COMPLETED|Overall Study||57
7766661|NCT01391299|19120983|P3|STARTED|Overall Study||58
7766662|NCT01391299|19120984|P2|STARTED|Overall Study||60
7766663|NCT01391299|19120985|P1|STARTED|Overall Study||57
7766664|NCT01391286|19121007|P2|NOT COMPLETED|Overall Study||0
7766665|NCT01391286|19121008|P1|NOT COMPLETED|Overall Study||0
7766666|NCT01391286|19121007|P2|COMPLETED|Overall Study||18
7766667|NCT01391286|19121008|P1|COMPLETED|Overall Study||18
7766668|NCT01391286|19121007|P2|STARTED|Overall Study||18
7766669|NCT01391286|19121008|P1|STARTED|Overall Study||18
7766670|NCT01391273|19121022|P2|NOT COMPLETED|Overall Study||2
7766671|NCT01391273|19121023|P1|NOT COMPLETED|Overall Study||4
7766672|NCT01391273|19121022|P2|COMPLETED|Overall Study||83
7766673|NCT01391273|19121023|P1|COMPLETED|Overall Study||84
7766674|NCT01391273|19121022|P2|STARTED|Overall Study||85
7766675|NCT01391273|19121023|P1|STARTED|Overall Study||88
7766676|NCT01391130|19121037|P2|NOT COMPLETED|Overall Study||6
7766677|NCT01391130|19121038|P1|NOT COMPLETED|Overall Study||6
7766678|NCT01391130|19121037|P2|COMPLETED|Overall Study||31
7766679|NCT01391130|19121038|P1|COMPLETED|Overall Study||67
7766680|NCT01391130|19121037|P2|Received At Least One Dose of Study Drug|Overall Study||36
7766681|NCT01391130|19121038|P1|Received At Least One Dose of Study Drug|Overall Study||72
7766682|NCT01391130|19121037|P2|STARTED|Overall Study||37
7766683|NCT01391130|19121038|P1|STARTED|Overall Study||73
7766684|NCT01391013|19121054|P2|NOT COMPLETED|Overall Study||0
7766685|NCT01391013|19121055|P1|NOT COMPLETED|Overall Study||0
7766686|NCT01391013|19121054|P2|COMPLETED|Overall Study||15
7766687|NCT01391013|19121055|P1|COMPLETED|Overall Study||15
7766688|NCT01391013|19121054|P2|STARTED|Overall Study||15
7766689|NCT01391013|19121055|P1|STARTED|Overall Study||15
7766690|NCT01391000|19121095|P2|NOT COMPLETED|Overall Study||0
7766691|NCT01391000|19121096|P1|NOT COMPLETED|Overall Study||2
7766692|NCT01391000|19121095|P2|COMPLETED|Overall Study||35
7766693|NCT01391000|19121096|P1|COMPLETED|Overall Study||33
7766694|NCT01391000|19121095|P2|STARTED|Overall Study||35
7766695|NCT01391000|19121096|P1|STARTED|Overall Study||35
7766696|NCT01390948|19121109|P3|NOT COMPLETED|Overall Study||1
7766697|NCT01390948|19121110|P2|NOT COMPLETED|Overall Study||18
7766698|NCT01390948|19121111|P1|NOT COMPLETED|Overall Study||15
7766699|NCT01390948|19121109|P3|COMPLETED|Overall Study||2
7766700|NCT01390948|19121110|P2|COMPLETED|Overall Study||44
7766701|NCT01390948|19121111|P1|COMPLETED|Overall Study||44
7766702|NCT01390948|19121109|P3|Treated|Overall Study||3
7766703|NCT01390948|19121110|P2|Treated|Overall Study||60
7766704|NCT01390948|19121111|P1|Treated|Overall Study||56
7766705|NCT01390948|19121109|P3|STARTED|Overall Study||3
7766706|NCT01390948|19121110|P2|STARTED|Overall Study||62
7766707|NCT01390948|19121111|P1|STARTED|Overall Study||59
7766708|NCT01390909|19121152|P6|NOT COMPLETED|Overall Study||0
7766709|NCT01390909|19121153|P5|NOT COMPLETED|Overall Study||0
7766710|NCT01390909|19121154|P4|NOT COMPLETED|Overall Study||0
7766711|NCT01390909|19121155|P3|NOT COMPLETED|Overall Study||0
7766712|NCT01390909|19121156|P2|NOT COMPLETED|Overall Study||0
7766713|NCT01390909|19121157|P1|NOT COMPLETED|Overall Study||0
7766714|NCT01390909|19121152|P6|COMPLETED|Overall Study||613
7766715|NCT01390909|19121153|P5|COMPLETED|Overall Study||613
7766716|NCT01390909|19121154|P4|COMPLETED|Overall Study||602
7766717|NCT01390909|19121155|P3|COMPLETED|Overall Study||3552
7766718|NCT01390909|19121156|P2|COMPLETED|Overall Study||3552
7766719|NCT01390909|19121157|P1|COMPLETED|Overall Study||3454
7766720|NCT01390909|19121152|P6|Participants in Subgroup|Overall Study||0
7766721|NCT01390909|19121153|P5|Participants in Subgroup|Overall Study||602
7766722|NCT01390909|19121154|P4|Participants in Subgroup|Overall Study||0
7766723|NCT01390909|19121155|P3|Participants in Subgroup|Overall Study||0
7766724|NCT01390909|19121156|P2|Participants in Subgroup|Overall Study||3454
7766725|NCT01390909|19121157|P1|Participants in Subgroup|Overall Study||0
7766726|NCT01390909|19121152|P6|STARTED|Overall Study||613
7766727|NCT01390909|19121153|P5|STARTED|Overall Study||613
7766728|NCT01390909|19121154|P4|STARTED|Overall Study||602
7766729|NCT01390909|19121155|P3|STARTED|Overall Study||3552
7766730|NCT01390909|19121156|P2|STARTED|Overall Study||3552
7766731|NCT01390909|19121157|P1|STARTED|Overall Study||3454
7766732|NCT01390870|19121175|P1|NOT COMPLETED|Overall Study||0
7766733|NCT01390870|19121175|P1|COMPLETED|Overall Study||400
7766734|NCT01390870|19121175|P1|STARTED|Overall Study||400
7766735|NCT01390857|19121179|P1|NOT COMPLETED|Overall Study||10
7766736|NCT01390857|19121179|P1|COMPLETED|Overall Study||369
7766737|NCT01390857|19121179|P1|STARTED|Overall Study||379
7766738|NCT01390844|19121190|P4|NOT COMPLETED|Follow-Up Phase||0
7766739|NCT01390844|19121191|P3|NOT COMPLETED|Follow-Up Phase||1
7766740|NCT01390844|19121192|P2|NOT COMPLETED|Follow-Up Phase||1
7766741|NCT01390844|19121193|P1|NOT COMPLETED|Follow-Up Phase||1
7766742|NCT01390844|19121190|P4|COMPLETED|Follow-Up Phase||8
7766743|NCT01390844|19121191|P3|COMPLETED|Follow-Up Phase||25
7766744|NCT01390844|19121192|P2|COMPLETED|Follow-Up Phase||36
7766745|NCT01390844|19121193|P1|COMPLETED|Follow-Up Phase||92
7766746|NCT01390844|19121190|P4|STARTED|Follow-Up Phase||8
7766747|NCT01390844|19121191|P3|STARTED|Follow-Up Phase||26
7766748|NCT01390844|19121192|P2|STARTED|Follow-Up Phase||37
7766749|NCT01390844|19121193|P1|STARTED|Follow-Up Phase||93
7766750|NCT01390844|19121190|P4|NOT COMPLETED|Treatment Phase||19
7766751|NCT01390844|19121191|P3|NOT COMPLETED|Treatment Phase||31
7766752|NCT01390844|19121192|P2|NOT COMPLETED|Treatment Phase||28
7766753|NCT01390844|19121193|P1|NOT COMPLETED|Treatment Phase||40
7766754|NCT01390844|19121190|P4|COMPLETED|Treatment Phase||8
7766755|NCT01390844|19121191|P3|COMPLETED|Treatment Phase||26
7766756|NCT01390844|19121192|P2|COMPLETED|Treatment Phase||37
7766757|NCT01390844|19121193|P1|COMPLETED|Treatment Phase||93
7766758|NCT01390844|19121190|P4|Followed Good Clinical Practice (GCP)|Treatment Phase||24
7766759|NCT01390844|19121191|P3|Followed Good Clinical Practice (GCP)|Treatment Phase||47
7766760|NCT01390844|19121192|P2|Followed Good Clinical Practice (GCP)|Treatment Phase||65
7766761|NCT01390844|19121193|P1|Followed Good Clinical Practice (GCP)|Treatment Phase||133
7766762|NCT01390844|19121190|P4|STARTED|Treatment Phase||27
7766763|NCT01390844|19121191|P3|STARTED|Treatment Phase||57
7766764|NCT01390844|19121192|P2|STARTED|Treatment Phase||65
7766765|NCT01390844|19121193|P1|STARTED|Treatment Phase||133
7766766|NCT01390818|19121234|P15|NOT COMPLETED|Overall Study||0
7766767|NCT01390818|19121235|P14|NOT COMPLETED|Overall Study||0
7766768|NCT01390818|19121236|P13|NOT COMPLETED|Overall Study||0
7766769|NCT01390818|19121237|P12|NOT COMPLETED|Overall Study||0
7766770|NCT01390818|19121238|P11|NOT COMPLETED|Overall Study||0
7766771|NCT01390818|19121239|P10|NOT COMPLETED|Overall Study||0
7766772|NCT01390818|19121240|P9|NOT COMPLETED|Overall Study||0
7766773|NCT01390818|19121241|P8|NOT COMPLETED|Overall Study||0
7766774|NCT01390818|19121242|P7|NOT COMPLETED|Overall Study||0
7766775|NCT01390818|19121243|P6|NOT COMPLETED|Overall Study||0
7766776|NCT01390818|19121244|P5|NOT COMPLETED|Overall Study||0
7766777|NCT01390818|19121245|P4|NOT COMPLETED|Overall Study||0
7766778|NCT01390818|19121246|P3|NOT COMPLETED|Overall Study||0
7766779|NCT01390818|19121247|P2|NOT COMPLETED|Overall Study||0
7766780|NCT01390818|19121248|P1|NOT COMPLETED|Overall Study||0
7766781|NCT01390818|19121234|P15|COMPLETED|Overall Study||15
7766782|NCT01390818|19121235|P14|COMPLETED|Overall Study||18
7766783|NCT01390818|19121236|P13|COMPLETED|Overall Study||24
7766784|NCT01390818|19121237|P12|COMPLETED|Overall Study||26
7766785|NCT01390818|19121238|P11|COMPLETED|Overall Study||4
7766786|NCT01390818|19121239|P10|COMPLETED|Overall Study||3
7766787|NCT01390818|19121240|P9|COMPLETED|Overall Study||3
7766788|NCT01390818|19121241|P8|COMPLETED|Overall Study||14
7766789|NCT01390818|19121242|P7|COMPLETED|Overall Study||19
7766790|NCT01390818|19121243|P6|COMPLETED|Overall Study||3
7766791|NCT01390818|19121244|P5|COMPLETED|Overall Study||4
7766792|NCT01390818|19121245|P4|COMPLETED|Overall Study||4
7766793|NCT01390818|19121246|P3|COMPLETED|Overall Study||3
7766794|NCT01390818|19121247|P2|COMPLETED|Overall Study||3
7766795|NCT01390818|19121248|P1|COMPLETED|Overall Study||3
7766796|NCT01390818|19121234|P15|STARTED|Overall Study||15
7766797|NCT01390818|19121235|P14|STARTED|Overall Study||18
7766798|NCT01390818|19121236|P13|STARTED|Overall Study||24
7766799|NCT01390818|19121237|P12|STARTED|Overall Study||26
7766800|NCT01390818|19121238|P11|STARTED|Overall Study||4
7766801|NCT01390818|19121239|P10|STARTED|Overall Study||3
7766802|NCT01390818|19121240|P9|STARTED|Overall Study||3
7766803|NCT01390818|19121241|P8|STARTED|Overall Study||14
7766804|NCT01390818|19121242|P7|STARTED|Overall Study||19
7766805|NCT01390818|19121243|P6|STARTED|Overall Study||3
7766806|NCT01390818|19121244|P5|STARTED|Overall Study||4
7766807|NCT01390818|19121245|P4|STARTED|Overall Study||4
7766808|NCT01390818|19121246|P3|STARTED|Overall Study||3
7766809|NCT01390818|19121247|P2|STARTED|Overall Study||3
7766810|NCT01390818|19121248|P1|STARTED|Overall Study||3
7766811|NCT01390779|19121520|P1|NOT COMPLETED|Overall Study||1
7766812|NCT01390779|19121520|P1|COMPLETED|Overall Study||32
7766813|NCT01390779|19121520|P1|STARTED|Overall Study||33
7766814|NCT01390649|19121525|P1|NOT COMPLETED|Overall Study||1
7766815|NCT01390649|19121525|P1|COMPLETED|Overall Study||56
7766816|NCT01390649|19121525|P1|STARTED|Overall Study|Subjects treated with Privigen|57
7766817|NCT01390584|19121532|P3|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
7766818|NCT01390584|19121533|P2|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
7766819|NCT01390584|19121534|P1|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
7766820|NCT01390584|19121532|P3|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
7766821|NCT01390584|19121533|P2|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||1
7766822|NCT01390584|19121534|P1|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||4
7766823|NCT01390584|19121532|P3|STARTED|Step 2: ABVD or BEACOPP Then INRT||0
7766824|NCT01390584|19121533|P2|STARTED|Step 2: ABVD or BEACOPP Then INRT||1
7766825|NCT01390584|19121534|P1|STARTED|Step 2: ABVD or BEACOPP Then INRT||4
7766826|NCT01390584|19121532|P3|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1
7766827|NCT01390584|19121533|P2|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
7766828|NCT01390584|19121534|P1|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
7766829|NCT01390584|19121532|P3|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
7766830|NCT01390584|19121533|P2|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1
7766831|NCT01390584|19121534|P1|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||4
7766832|NCT01390584|19121532|P3|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1
7766833|NCT01390584|19121533|P2|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1
7766834|NCT01390584|19121534|P1|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||4
7766835|NCT01390441|19121556|P5|NOT COMPLETED|Extension Period||0
7766836|NCT01390441|19121557|P4|NOT COMPLETED|Extension Period||1
7766837|NCT01390441|19121558|P3|NOT COMPLETED|Extension Period||0
7766838|NCT01390441|19121559|P2|NOT COMPLETED|Extension Period||1
7766839|NCT01390441|19121560|P1|NOT COMPLETED|Extension Period||3
7766840|NCT01390441|19121556|P5|COMPLETED|Extension Period||3
7766841|NCT01390441|19121557|P4|COMPLETED|Extension Period||0
7766842|NCT01390441|19121558|P3|COMPLETED|Extension Period||1
7766843|NCT01390441|19121559|P2|COMPLETED|Extension Period||12
7766844|NCT01390441|19121560|P1|COMPLETED|Extension Period||12
7766845|NCT01390441|19121556|P5|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3
7766846|NCT01390441|19121557|P4|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
7766847|NCT01390441|19121558|P3|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
7766848|NCT01390441|19121559|P2|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13
7766849|NCT01390441|19121560|P1|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15
7766850|NCT01390441|19121556|P5|NOT COMPLETED|Treatment Period||11
7766851|NCT01390441|19121557|P4|NOT COMPLETED|Treatment Period||13
7766852|NCT01390441|19121558|P3|NOT COMPLETED|Treatment Period||10
7766853|NCT01390441|19121559|P2|NOT COMPLETED|Treatment Period||1
7766854|NCT01390441|19121560|P1|NOT COMPLETED|Treatment Period||1
7766855|NCT01390441|19121556|P5|COMPLETED|Treatment Period||7
7766856|NCT01390441|19121557|P4|COMPLETED|Treatment Period||6
7766857|NCT01390441|19121558|P3|COMPLETED|Treatment Period||8
7766858|NCT01390441|19121559|P2|COMPLETED|Treatment Period||21
7766859|NCT01390441|19121560|P1|COMPLETED|Treatment Period||22
7766860|NCT01390441|19121556|P5|STARTED|Treatment Period||18
7766861|NCT01390441|19121557|P4|STARTED|Treatment Period||19
7766862|NCT01390441|19121558|P3|STARTED|Treatment Period||18
7766863|NCT01390441|19121559|P2|STARTED|Treatment Period||22
7766864|NCT01390441|19121560|P1|STARTED|Treatment Period||23
7766865|NCT01390428|19121625|P6|NOT COMPLETED|Overall Study||0
7766866|NCT01390428|19121626|P5|NOT COMPLETED|Overall Study||1
7766867|NCT01390428|19121627|P4|NOT COMPLETED|Overall Study||0
7766868|NCT01390428|19121628|P3|NOT COMPLETED|Overall Study||1
7766869|NCT01390428|19121629|P2|NOT COMPLETED|Overall Study||0
7766870|NCT01390428|19121630|P1|NOT COMPLETED|Overall Study||0
7766871|NCT01390428|19121625|P6|COMPLETED|Overall Study||8
7766872|NCT01390428|19121626|P5|COMPLETED|Overall Study||7
7766873|NCT01390428|19121627|P4|COMPLETED|Overall Study||9
7766874|NCT01390428|19121628|P3|COMPLETED|Overall Study||8
7766875|NCT01390428|19121629|P2|COMPLETED|Overall Study||8
7766876|NCT01390428|19121630|P1|COMPLETED|Overall Study||8
7766877|NCT01390428|19121625|P6|STARTED|Overall Study||8
7766878|NCT01390428|19121626|P5|STARTED|Overall Study||8
7766879|NCT01390428|19121627|P4|STARTED|Overall Study||9
7766880|NCT01390428|19121628|P3|STARTED|Overall Study||9
7766881|NCT01390428|19121629|P2|STARTED|Overall Study||8
7766882|NCT01390428|19121630|P1|STARTED|Overall Study||8
7766883|NCT01390415|19121682|P2|NOT COMPLETED|Overall Study||0
7766884|NCT01390415|19121683|P1|NOT COMPLETED|Overall Study||0
7766885|NCT01390415|19121682|P2|COMPLETED|Overall Study||37
7766886|NCT01390415|19121683|P1|COMPLETED|Overall Study||99
7766887|NCT01390415|19121682|P2|STARTED|Overall Study||37
7766888|NCT01390415|19121683|P1|STARTED|Overall Study||99
7766889|NCT01390402|19121693|P1|NOT COMPLETED|Overall Study||5
7766890|NCT01390402|19121693|P1|COMPLETED|Overall Study||1
7766891|NCT01390402|19121693|P1|STARTED|Overall Study||6
7766892|NCT01390389|19121699|P2|NOT COMPLETED|Overall Study||1
7766893|NCT01390389|19121700|P1|NOT COMPLETED|Overall Study||4
7766894|NCT01390389|19121699|P2|COMPLETED|Overall Study||8
7766895|NCT01390389|19121700|P1|COMPLETED|Overall Study||6
7766896|NCT01390389|19121699|P2|STARTED|Overall Study||9
7766897|NCT01390389|19121700|P1|STARTED|Overall Study||10
7766898|NCT01390298|19121710|P1|NOT COMPLETED|Overall Study||24
7766899|NCT01390298|19121710|P1|COMPLETED|Overall Study||31
7766900|NCT01390298|19121710|P1|STARTED|Overall Study||55
7766901|NCT01390272|19121716|P2|NOT COMPLETED|Overall Study||15
7766902|NCT01390272|19121717|P1|NOT COMPLETED|Overall Study||17
7766903|NCT01390272|19121716|P2|COMPLETED|Overall Study||178
7766904|NCT01390272|19121717|P1|COMPLETED|Overall Study||175
7766905|NCT01390272|19121716|P2|18 Month Follow up|Overall Study|33 of 193 in the LPN control group had missing blood pressure measurement|160
7766906|NCT01390272|19121717|P1|18 Month Follow up|Overall Study|37 of 192 participants in the Titration Intervention group had missing blood pressure measurement|155
7766907|NCT01390272|19121716|P2|12 Month Follow up|Overall Study|34 of 193 in the LPN control group had missing blood pressure measurement|159
7766908|NCT01390272|19121717|P1|12 Month Follow up|Overall Study|53 of 192 participants in the Titration Intervention group had missing measurement|139
7766909|NCT01390272|19121716|P2|6 Month Follow up|Overall Study|22 of 193 in the LPN control group had missing blood pressure measurement|171
7766910|NCT01390272|19121717|P1|6 Month Follow up|Overall Study|30 of 192 participants in the Titration Intervention group had missing blood pressure measurement|162
7766911|NCT01390272|19121716|P2|STARTED|Overall Study||193
7766912|NCT01390272|19121717|P1|STARTED|Overall Study||192
7766913|NCT01390259|19121747|P2|NOT COMPLETED|Overall Study||0
7766914|NCT01390259|19121748|P1|NOT COMPLETED|Overall Study||0
7766915|NCT01390259|19121747|P2|COMPLETED|Overall Study||6
7766916|NCT01390259|19121748|P1|COMPLETED|Overall Study||5
7766917|NCT01390259|19121747|P2|STARTED|Overall Study||6
7766918|NCT01390259|19121748|P1|STARTED|Overall Study||5
7766919|NCT01390246|19121759|P2|NOT COMPLETED|Overall Study||25
7766920|NCT01390246|19121760|P1|NOT COMPLETED|Overall Study||20
7766921|NCT01390246|19121759|P2|COMPLETED|Overall Study||10
7766922|NCT01390246|19121760|P1|COMPLETED|Overall Study||10
7766923|NCT01390246|19121759|P2|Visit 7: 36-38 Weeks Gestation|Overall Study||10
7766924|NCT01390246|19121760|P1|Visit 7: 36-38 Weeks Gestation|Overall Study||10
7766925|NCT01390246|19121759|P2|Visit 6: End of Treatment|Overall Study||15
7766926|NCT01390246|19121760|P1|Visit 6: End of Treatment|Overall Study||15
7766927|NCT01390246|19121759|P2|Visit 2: Quit Day|Overall Study||24
7766928|NCT01390246|19121760|P1|Visit 2: Quit Day|Overall Study||24
7766929|NCT01390246|19121759|P2|STARTED|Overall Study||35
7766930|NCT01390246|19121760|P1|STARTED|Overall Study||30
7766931|NCT01390233|19121775|P3|NOT COMPLETED|Overall Study||6
7766932|NCT01390233|19121776|P2|NOT COMPLETED|Overall Study||2
7766933|NCT01390233|19121777|P1|NOT COMPLETED|Overall Study||5
7766934|NCT01390233|19121775|P3|COMPLETED|Overall Study||30
7766935|NCT01390233|19121776|P2|COMPLETED|Overall Study||29
7766936|NCT01390233|19121777|P1|COMPLETED|Overall Study||30
7766937|NCT01390233|19121775|P3|STARTED|Overall Study||36
7766938|NCT01390233|19121776|P2|STARTED|Overall Study||31
7766939|NCT01390233|19121777|P1|STARTED|Overall Study||35
7766940|NCT01390220|19121785|P3|NOT COMPLETED|Comparative Phase||0
7766941|NCT01390220|19121786|P2|NOT COMPLETED|Comparative Phase||1
7766942|NCT01390220|19121787|P1|NOT COMPLETED|Comparative Phase||0
7766943|NCT01390220|19121785|P3|COMPLETED|Comparative Phase||67
7766944|NCT01390220|19121786|P2|COMPLETED|Comparative Phase||133
7766945|NCT01390220|19121787|P1|COMPLETED|Comparative Phase|This arm not applicable in CP|0
7766946|NCT01390220|19121785|P3|STARTED|Comparative Phase||67
7766947|NCT01390220|19121786|P2|STARTED|Comparative Phase||134
7766948|NCT01390220|19121787|P1|STARTED|Comparative Phase|This arm not applicable in CP|0
7766949|NCT01390220|19121785|P3|NOT COMPLETED|Test Dose Phase||0
7766950|NCT01390220|19121786|P2|NOT COMPLETED|Test Dose Phase||0
7766951|NCT01390220|19121787|P1|NOT COMPLETED|Test Dose Phase||91
7766952|NCT01390220|19121785|P3|COMPLETED|Test Dose Phase||0
7766953|NCT01390220|19121786|P2|COMPLETED|Test Dose Phase||0
7766954|NCT01390220|19121787|P1|COMPLETED|Test Dose Phase||201
7766955|NCT01390220|19121785|P3|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
7766956|NCT01390220|19121786|P2|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
7766957|NCT01390220|19121787|P1|STARTED|Test Dose Phase||292
7766958|NCT01390181|19121802|P1|NOT COMPLETED|Overall Study||4
7766959|NCT01390181|19121802|P1|COMPLETED|Overall Study||0
7766960|NCT01390181|19121802|P1|STARTED|Overall Study||4
7766961|NCT01390064|19121808|P2|NOT COMPLETED|Overall Study||0
7766962|NCT01390064|19121809|P1|NOT COMPLETED|Overall Study||0
7766963|NCT01390064|19121808|P2|COMPLETED|Overall Study||3
7766964|NCT01390064|19121809|P1|COMPLETED|Overall Study||3
7766965|NCT01390064|19121808|P2|STARTED|Overall Study||3
7766966|NCT01390064|19121809|P1|STARTED|Overall Study||3
7766967|NCT01390038|19121815|P1|NOT COMPLETED|Overall Study||8
7766968|NCT01390038|19121815|P1|COMPLETED|Overall Study||149
7766969|NCT01390038|19121815|P1|STARTED|Overall Study||157
7766970|NCT01389973|19121825|P1|NOT COMPLETED|Overall Study||20
7766971|NCT01389973|19121825|P1|COMPLETED|Overall Study||0
7766972|NCT01389973|19121825|P1|STARTED|Overall Study||20
7766973|NCT01389882|19121835|P2|NOT COMPLETED|Overall Study||4
7766974|NCT01389882|19121836|P1|NOT COMPLETED|Overall Study||1
7766975|NCT01389882|19121835|P2|COMPLETED|Overall Study||7
7766976|NCT01389882|19121836|P1|COMPLETED|Overall Study||12
7766977|NCT01389882|19121835|P2|STARTED|Overall Study||11
7766978|NCT01389882|19121836|P1|STARTED|Overall Study||13
7766979|NCT01389856|19121866|P2|NOT COMPLETED|Overall Study||0
7766980|NCT01389856|19121867|P1|NOT COMPLETED|Overall Study||0
7766981|NCT01389856|19121866|P2|COMPLETED|Overall Study||8
7766982|NCT01389856|19121867|P1|COMPLETED|Overall Study||13
7766983|NCT01389856|19121866|P2|STARTED|Overall Study|Randomized and treated.|8
7766984|NCT01389856|19121867|P1|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13
7766985|NCT01389817|19121924|P2|NOT COMPLETED|Overall Study||0
7766986|NCT01389817|19121925|P1|NOT COMPLETED|Overall Study||4
7766987|NCT01389817|19121924|P2|COMPLETED|Overall Study||0
7766988|NCT01389817|19121925|P1|COMPLETED|Overall Study||0
7766989|NCT01389817|19121924|P2|STARTED|Overall Study||0
7766990|NCT01389817|19121925|P1|STARTED|Overall Study||4
7766991|NCT01389765|19121931|P2|NOT COMPLETED|Second Intervention (Day 1)||0
7766992|NCT01389765|19121932|P1|NOT COMPLETED|Second Intervention (Day 1)||0
7766993|NCT01389765|19121931|P2|COMPLETED|Second Intervention (Day 1)||12
7766994|NCT01389765|19121932|P1|COMPLETED|Second Intervention (Day 1)||12
7766995|NCT01389765|19121931|P2|STARTED|Second Intervention (Day 1)||12
7766996|NCT01389765|19121932|P1|STARTED|Second Intervention (Day 1)||12
7766997|NCT01389765|19121931|P2|NOT COMPLETED|Washout Period (7 Days)||0
7766998|NCT01389765|19121932|P1|NOT COMPLETED|Washout Period (7 Days)||0
7766999|NCT01389765|19121931|P2|COMPLETED|Washout Period (7 Days)||12
7767000|NCT01389765|19121932|P1|COMPLETED|Washout Period (7 Days)||12
7767001|NCT01389765|19121931|P2|STARTED|Washout Period (7 Days)||12
7767002|NCT01389765|19121932|P1|STARTED|Washout Period (7 Days)||12
7767003|NCT01389765|19121931|P2|NOT COMPLETED|First Intervention (Day 1)||0
7767004|NCT01389765|19121932|P1|NOT COMPLETED|First Intervention (Day 1)||0
7767005|NCT01389765|19121931|P2|COMPLETED|First Intervention (Day 1)||12
7767006|NCT01389765|19121932|P1|COMPLETED|First Intervention (Day 1)||12
7767007|NCT01389765|19121931|P2|STARTED|First Intervention (Day 1)||12
7767008|NCT01389765|19121932|P1|STARTED|First Intervention (Day 1)||12
7767009|NCT01389752|19121942|P2|NOT COMPLETED|Study Period 2||0
7767010|NCT01389752|19121943|P1|NOT COMPLETED|Study Period 2||1
7767011|NCT01389752|19121942|P2|COMPLETED|Study Period 2||9
7767012|NCT01389752|19121943|P1|COMPLETED|Study Period 2||10
7767013|NCT01389752|19121942|P2|STARTED|Study Period 2||9
7767014|NCT01389752|19121943|P1|STARTED|Study Period 2||11
7767015|NCT01389752|19121942|P2|NOT COMPLETED|Study Period 1||2
7767016|NCT01389752|19121943|P1|NOT COMPLETED|Study Period 1||0
7767017|NCT01389752|19121942|P2|COMPLETED|Study Period 1||9
7767018|NCT01389752|19121943|P1|COMPLETED|Study Period 1||11
7767019|NCT01389752|19121942|P2|STARTED|Study Period 1||11
7767020|NCT01389752|19121943|P1|STARTED|Study Period 1||11
7767021|NCT01389596|19121956|P3|NOT COMPLETED|Overall Study||10
7767022|NCT01389596|19121957|P2|NOT COMPLETED|Overall Study||16
7767023|NCT01389596|19121958|P1|NOT COMPLETED|Overall Study||10
7767024|NCT01389596|19121956|P3|COMPLETED|Overall Study||84
7767025|NCT01389596|19121957|P2|COMPLETED|Overall Study||81
7767026|NCT01389596|19121958|P1|COMPLETED|Overall Study||94
7767027|NCT01389596|19121956|P3|STARTED|Overall Study||94
7767028|NCT01389596|19121957|P2|STARTED|Overall Study||97
7767029|NCT01389596|19121958|P1|STARTED|Overall Study||104
7767030|NCT01389323|19122017|P1|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37
7767031|NCT01389323|19122017|P1|COMPLETED|Follow-up Period (up to 48 Weeks)||184
7767032|NCT01389323|19122017|P1|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221
7767033|NCT01389323|19122017|P1|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95
7767034|NCT01389323|19122017|P1|COMPLETED|Treatment Period (up to 48 Weeks)||151
7767035|NCT01389323|19122017|P1|STARTED|Treatment Period (up to 48 Weeks)||246
7767036|NCT01389284|19122040|P3|NOT COMPLETED|Overall Study||0
7767037|NCT01389284|19122041|P2|NOT COMPLETED|Overall Study||0
7767038|NCT01389284|19122042|P1|NOT COMPLETED|Overall Study||0
7767039|NCT01389284|19122040|P3|COMPLETED|Overall Study||60
7767040|NCT01389284|19122041|P2|COMPLETED|Overall Study||120
7767041|NCT01389284|19122042|P1|COMPLETED|Overall Study||120
7767042|NCT01389284|19122040|P3|STARTED|Overall Study||60
7767043|NCT01389284|19122041|P2|STARTED|Overall Study||120
7767044|NCT01389284|19122042|P1|STARTED|Overall Study||120
7767045|NCT01389258|19122074|P1|NOT COMPLETED|Overall Study||5
7767046|NCT01389258|19122074|P1|COMPLETED|Overall Study||40
7767047|NCT01389258|19122074|P1|STARTED|Overall Study||45
7767048|NCT01389245|19122084|P1|NOT COMPLETED|Overall Study||15
7767049|NCT01389245|19122084|P1|COMPLETED|Overall Study||27
7767050|NCT01389245|19122084|P1|STARTED|Overall Study||42
7767051|NCT01389128|19122094|P2|NOT COMPLETED|Overall Study||6
7767052|NCT01389128|19122095|P1|NOT COMPLETED|Overall Study||5
7767053|NCT01389128|19122094|P2|COMPLETED|Overall Study||34
7767054|NCT01389128|19122095|P1|COMPLETED|Overall Study||35
7767055|NCT01389128|19122094|P2|STARTED|Overall Study||40
7767056|NCT01389128|19122095|P1|STARTED|Overall Study||40
7767057|NCT01389102|19122119|P6|NOT COMPLETED|Overall Study||8
7767058|NCT01389102|19122120|P5|NOT COMPLETED|Overall Study||13
7767059|NCT01389102|19122121|P4|NOT COMPLETED|Overall Study||7
7767060|NCT01389102|19122122|P3|NOT COMPLETED|Overall Study||19
7767061|NCT01389102|19122123|P2|NOT COMPLETED|Overall Study||12
7767062|NCT01389102|19122124|P1|NOT COMPLETED|Overall Study||18
7767063|NCT01389102|19122119|P6|COMPLETED|Overall Study||68
7767064|NCT01389102|19122120|P5|COMPLETED|Overall Study||61
7767065|NCT01389102|19122121|P4|COMPLETED|Overall Study||69
7767066|NCT01389102|19122122|P3|COMPLETED|Overall Study||58
7767067|NCT01389102|19122123|P2|COMPLETED|Overall Study||64
7767068|NCT01389102|19122124|P1|COMPLETED|Overall Study||57
7767069|NCT01389102|19122119|P6|STARTED|Overall Study||76
7767070|NCT01389102|19122120|P5|STARTED|Overall Study||74
7767071|NCT01389102|19122121|P4|STARTED|Overall Study||76
7767072|NCT01389102|19122122|P3|STARTED|Overall Study||77
7767073|NCT01389102|19122123|P2|STARTED|Overall Study||76
7767074|NCT01389102|19122124|P1|STARTED|Overall Study||75
7767075|NCT01389076|19122144|P1|NOT COMPLETED|Overall Study||0
7767076|NCT01389076|19122144|P1|COMPLETED|Overall Study||22
7767077|NCT01389076|19122144|P1|STARTED|Overall Study||22
7767078|NCT01388985|19122154|P2|NOT COMPLETED|Overall Study||38
7767079|NCT01388985|19122155|P1|NOT COMPLETED|Overall Study||49
7767080|NCT01388985|19122154|P2|COMPLETED|Overall Study|From those 200, 28 were excluded from the per protocol analysis.|211
7767081|NCT01388985|19122155|P1|COMPLETED|Overall Study|From those 200, 15 were excluded from the per protocol analysis.|200
7767082|NCT01388985|19122154|P2|Primary Vaccination Period|Overall Study||238
7767083|NCT01388985|19122155|P1|Primary Vaccination Period|Overall Study||231
7767084|NCT01388985|19122154|P2|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
7767085|NCT01388985|19122155|P1|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
7767086|NCT01388946|19122171|P2|NOT COMPLETED|Overall Study||3
7767087|NCT01388946|19122172|P1|NOT COMPLETED|Overall Study||6
7767088|NCT01388946|19122171|P2|COMPLETED|Overall Study||52
7767089|NCT01388946|19122172|P1|COMPLETED|Overall Study||49
7767090|NCT01388946|19122171|P2|STARTED|Overall Study||55
7767091|NCT01388946|19122172|P1|STARTED|Overall Study||55
7767092|NCT01388920|19122207|P3|NOT COMPLETED|Overall Study||0
7767093|NCT01388920|19122208|P2|NOT COMPLETED|Overall Study||0
7767094|NCT01388920|19122209|P1|NOT COMPLETED|Overall Study||0
7767095|NCT01388920|19122207|P3|COMPLETED|Overall Study||0
7767096|NCT01388920|19122208|P2|COMPLETED|Overall Study||1
7767097|NCT01388920|19122209|P1|COMPLETED|Overall Study||1
7767098|NCT01388920|19122207|P3|STARTED|Overall Study||0
7767099|NCT01388920|19122208|P2|STARTED|Overall Study||1
7767100|NCT01388920|19122209|P1|STARTED|Overall Study||1
7767101|NCT01388907|19122219|P2|NOT COMPLETED|Overall Study||0
7767102|NCT01388907|19122220|P1|NOT COMPLETED|Overall Study||2
7767103|NCT01388907|19122219|P2|COMPLETED|Overall Study||28
7767104|NCT01388907|19122220|P1|COMPLETED|Overall Study||31
7767105|NCT01388907|19122219|P2|STARTED|Overall Study||28
7767106|NCT01388907|19122220|P1|STARTED|Overall Study||33
7767107|NCT01388816|19122236|P4|NOT COMPLETED|Overall Study||0
7767108|NCT01388816|19122237|P3|NOT COMPLETED|Overall Study||3
7767109|NCT01388816|19122238|P2|NOT COMPLETED|Overall Study||4
7767110|NCT01388816|19122239|P1|NOT COMPLETED|Overall Study||2
7767111|NCT01388816|19122236|P4|COMPLETED|Overall Study||44
7767112|NCT01388816|19122237|P3|COMPLETED|Overall Study||41
7767113|NCT01388816|19122238|P2|COMPLETED|Overall Study||39
7767114|NCT01388816|19122239|P1|COMPLETED|Overall Study||43
7767115|NCT01388816|19122236|P4|STARTED|Overall Study||44
7767116|NCT01388816|19122237|P3|STARTED|Overall Study||44
7767117|NCT01388816|19122238|P2|STARTED|Overall Study||43
7767118|NCT01388816|19122239|P1|STARTED|Overall Study||45
7767119|NCT01388790|19122268|P1|NOT COMPLETED|Overall Study||8
7767120|NCT01388790|19122268|P1|COMPLETED|Overall Study||32
7767121|NCT01388790|19122268|P1|STARTED|Overall Study||40
7767122|NCT01388777|19122273|P1|NOT COMPLETED|Overall Study||0
7767123|NCT01388777|19122273|P1|COMPLETED|Overall Study||1
7767124|NCT01388777|19122273|P1|Cryoablation|Overall Study||1
7767125|NCT01388777|19122273|P1|STARTED|Overall Study||1
7767126|NCT01388647|19122279|P2|NOT COMPLETED|Overall Study||2
7767127|NCT01388647|19122280|P1|NOT COMPLETED|Overall Study||1
7767128|NCT01388647|19122279|P2|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4
7767129|NCT01388647|19122280|P1|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5
7767130|NCT01388647|19122279|P2|STARTED|Overall Study||6
7767131|NCT01388647|19122280|P1|STARTED|Overall Study||6
7767132|NCT01388543|19122293|P2|NOT COMPLETED|Day 14||4
7767133|NCT01388543|19122294|P1|NOT COMPLETED|Day 14||1
7767134|NCT01388543|19122293|P2|COMPLETED|Day 14||12
7767135|NCT01388543|19122294|P1|COMPLETED|Day 14||14
7767136|NCT01388543|19122293|P2|STARTED|Day 14||16
7767137|NCT01388543|19122294|P1|STARTED|Day 14||15
7767138|NCT01388543|19122293|P2|NOT COMPLETED|Day 7, Primary End Point||0
7767139|NCT01388543|19122294|P1|NOT COMPLETED|Day 7, Primary End Point||0
7767140|NCT01388543|19122293|P2|COMPLETED|Day 7, Primary End Point||16
7767141|NCT01388543|19122294|P1|COMPLETED|Day 7, Primary End Point||15
7767142|NCT01388543|19122293|P2|STARTED|Day 7, Primary End Point||16
7767143|NCT01388543|19122294|P1|STARTED|Day 7, Primary End Point||15
7767144|NCT01388530|19122300|P1|NOT COMPLETED|Overall Study||5
7767145|NCT01388530|19122300|P1|COMPLETED|Overall Study||20
7767146|NCT01388530|19122300|P1|STARTED|Overall Study||25
7767147|NCT01388491|19122309|P2|NOT COMPLETED|Overall Study||29
7767148|NCT01388491|19122310|P1|NOT COMPLETED|Overall Study||34
7767149|NCT01388491|19122309|P2|COMPLETED|Overall Study||114
7767150|NCT01388491|19122310|P1|COMPLETED|Overall Study||116
7767151|NCT01388491|19122309|P2|Per Protocol (PP) Population|Overall Study||121
7767152|NCT01388491|19122310|P1|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125
7767153|NCT01388491|19122309|P2|Intent-to-Treat (ITT) Population|Overall Study||136
7767154|NCT01388491|19122310|P1|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140
7767155|NCT01388491|19122309|P2|Safety Population|Overall Study||142
7767156|NCT01388491|19122310|P1|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145
7767157|NCT01388491|19122309|P2|STARTED|Overall Study||143
7767158|NCT01388491|19122310|P1|STARTED|Overall Study|number randomized|150
7767159|NCT01388361|19122345|P3|NOT COMPLETED|Overall Study||14
7767160|NCT01388361|19122346|P2|NOT COMPLETED|Overall Study||12
7767161|NCT01388361|19122347|P1|NOT COMPLETED|Overall Study||12
7767162|NCT01388361|19122345|P3|COMPLETED|Overall Study||75
7767163|NCT01388361|19122346|P2|COMPLETED|Overall Study||76
7767164|NCT01388361|19122347|P1|COMPLETED|Overall Study||224
7767165|NCT01388361|19122345|P3|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86
7767166|NCT01388361|19122346|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87
7767167|NCT01388361|19122347|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234
7767168|NCT01388361|19122345|P3|STARTED|Overall Study||89
7767169|NCT01388361|19122346|P2|STARTED|Overall Study||88
7767170|NCT01388361|19122347|P1|STARTED|Overall Study||236
7767171|NCT01388335|19122364|P1|NOT COMPLETED|Safety Extension||7
7767172|NCT01388335|19122364|P1|COMPLETED|Safety Extension||0
7767173|NCT01388335|19122364|P1|STARTED|Safety Extension|Six completed Period 2 and 1 participant who discontinued Period 2 entered Safety Extension.|7
7767174|NCT01388335|19122364|P1|NOT COMPLETED|Period 2||3
7767175|NCT01388335|19122364|P1|COMPLETED|Period 2|Only 6 participants who completed Period 2 entered Safety Extension.|9
7767176|NCT01388335|19122364|P1|Received at Least 1 Dose of Study Drug|Period 2||12
7767177|NCT01388335|19122364|P1|STARTED|Period 2||12
7767178|NCT01388335|19122364|P1|NOT COMPLETED|Period 1||1
7767179|NCT01388335|19122364|P1|COMPLETED|Period 1||12
7767180|NCT01388335|19122364|P1|Received at Least 1 Dose of Study Drug|Period 1||13
7767181|NCT01388335|19122364|P1|STARTED|Period 1||13
7767182|NCT01388166|19122391|P1|NOT COMPLETED|Overall Study||59
7767183|NCT01388166|19122391|P1|COMPLETED|Overall Study||1194
7767184|NCT01388166|19122391|P1|STARTED|Overall Study||1253
7767185|NCT01387815|19122399|P2|NOT COMPLETED|Overall Study||104
7767186|NCT01387815|19122400|P1|NOT COMPLETED|Overall Study||140
7767187|NCT01387815|19122399|P2|COMPLETED|Overall Study||189
7767188|NCT01387815|19122400|P1|COMPLETED|Overall Study||162
7767189|NCT01387815|19122399|P2|STARTED|Overall Study||293
7767190|NCT01387815|19122400|P1|STARTED|Overall Study||302
7767191|NCT01387789|19122694|P1|NOT COMPLETED|Overall Study||8
7767192|NCT01387789|19122694|P1|COMPLETED|Overall Study||63
7767193|NCT01387789|19122694|P1|STARTED|Overall Study||71
7767194|NCT01387737|19122708|P2|NOT COMPLETED|Overall Study||74
7767195|NCT01387737|19122709|P1|NOT COMPLETED|Overall Study||52
7767196|NCT01387737|19122708|P2|COMPLETED|Overall Study||641
7767197|NCT01387737|19122709|P1|COMPLETED|Overall Study||532
7767198|NCT01387737|19122708|P2|STARTED|Overall Study||715
7767199|NCT01387737|19122709|P1|STARTED|Overall Study||584
7767200|NCT01387672|19122721|P6|NOT COMPLETED|Overall Study||0
7767201|NCT01387672|19122722|P5|NOT COMPLETED|Overall Study||4
7767202|NCT01387672|19122723|P4|NOT COMPLETED|Overall Study||4
7767203|NCT01387672|19122724|P3|NOT COMPLETED|Overall Study||5
7767204|NCT01387672|19122725|P2|NOT COMPLETED|Overall Study||7
7767205|NCT01387672|19122726|P1|NOT COMPLETED|Overall Study||7
7767206|NCT01387672|19122721|P6|COMPLETED|Overall Study||37
7767207|NCT01387672|19122722|P5|COMPLETED|Overall Study||34
7767208|NCT01387672|19122723|P4|COMPLETED|Overall Study||35
7767209|NCT01387672|19122724|P3|COMPLETED|Overall Study||33
7767210|NCT01387672|19122725|P2|COMPLETED|Overall Study||31
7767211|NCT01387672|19122726|P1|COMPLETED|Overall Study||32
7767212|NCT01387672|19122721|P6|STARTED|Overall Study||37
7767213|NCT01387672|19122722|P5|STARTED|Overall Study||38
7767214|NCT01387672|19122723|P4|STARTED|Overall Study||39
7767215|NCT01387672|19122724|P3|STARTED|Overall Study||38
7767216|NCT01387672|19122725|P2|STARTED|Overall Study||38
7767217|NCT01387672|19122726|P1|STARTED|Overall Study||39
7767218|NCT01387607|19122743|P2|NOT COMPLETED|Overall Study||45
7767219|NCT01387607|19122744|P1|NOT COMPLETED|Overall Study||51
7767220|NCT01387607|19122743|P2|COMPLETED|Overall Study||125
7767221|NCT01387607|19122744|P1|COMPLETED|Overall Study||122
7767222|NCT01387607|19122743|P2|Received Treatment|Overall Study||164
7767223|NCT01387607|19122744|P1|Received Treatment|Overall Study||170
7767224|NCT01387607|19122743|P2|STARTED|Overall Study||170
7767225|NCT01387607|19122744|P1|STARTED|Overall Study||173
7767226|NCT01387594|19122798|P2|NOT COMPLETED|Overall Study||3
7767227|NCT01387594|19122799|P1|NOT COMPLETED|Overall Study||0
7767228|NCT01387594|19122798|P2|COMPLETED|Overall Study||36
7767229|NCT01387594|19122799|P1|COMPLETED|Overall Study||10
7767230|NCT01387594|19122798|P2|STARTED|Overall Study||39
7767231|NCT01387594|19122799|P1|STARTED|Overall Study||10
7767232|NCT01387581|19122814|P3|NOT COMPLETED|Overall Study||3
7767233|NCT01387581|19122815|P2|NOT COMPLETED|Overall Study||6
7767234|NCT01387581|19122816|P1|NOT COMPLETED|Overall Study||7
7767235|NCT01387581|19122814|P3|COMPLETED|Overall Study||9
7767236|NCT01387581|19122815|P2|COMPLETED|Overall Study||101
7767237|NCT01387581|19122816|P1|COMPLETED|Overall Study||101
7767238|NCT01387581|19122814|P3|STARTED|Overall Study||12
7767239|NCT01387581|19122815|P2|STARTED|Overall Study||107
7767240|NCT01387581|19122816|P1|STARTED|Overall Study||108
7767241|NCT01387542|19122827|P1|NOT COMPLETED|Overall Study||8
7767242|NCT01387542|19122827|P1|COMPLETED|Overall Study||32
7767243|NCT01387542|19122827|P1|Treated|Overall Study||38
7767244|NCT01387542|19122827|P1|STARTED|Overall Study||40
7767245|NCT01387516|19122838|P4|NOT COMPLETED|Overall Study||4
7767246|NCT01387516|19122839|P3|NOT COMPLETED|Overall Study||4
7767247|NCT01387516|19122840|P2|NOT COMPLETED|Overall Study||5
7767248|NCT01387516|19122841|P1|NOT COMPLETED|Overall Study||5
7767249|NCT01387516|19122838|P4|COMPLETED|Overall Study||65
7767250|NCT01387516|19122839|P3|COMPLETED|Overall Study||75
7767251|NCT01387516|19122840|P2|COMPLETED|Overall Study||63
7767252|NCT01387516|19122841|P1|COMPLETED|Overall Study||75
7767253|NCT01387516|19122838|P4|STARTED|Overall Study||69
7767254|NCT01387516|19122839|P3|STARTED|Overall Study||79
7767255|NCT01387516|19122840|P2|STARTED|Overall Study||68
7767256|NCT01387516|19122841|P1|STARTED|Overall Study||80
7767257|NCT01387464|19122865|P2|NOT COMPLETED|Overall Study||1
7767258|NCT01387464|19122866|P1|NOT COMPLETED|Overall Study||1
7767259|NCT01387464|19122865|P2|COMPLETED|Overall Study||29
7767260|NCT01387464|19122866|P1|COMPLETED|Overall Study||29
7767261|NCT01387464|19122865|P2|Per-Protocol Population|Overall Study||29
7767262|NCT01387464|19122866|P1|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29
7767263|NCT01387464|19122865|P2|Safety Population|Overall Study||29
7767264|NCT01387464|19122866|P1|Safety Population|Overall Study||30
7767265|NCT01387464|19122865|P2|STARTED|Overall Study||30
7767266|NCT01387464|19122866|P1|STARTED|Overall Study||30
7767267|NCT01387347|19122874|P2|NOT COMPLETED|Overall Study||1
7767268|NCT01387347|19122875|P1|NOT COMPLETED|Overall Study||2
7767269|NCT01387347|19122874|P2|COMPLETED|Overall Study||35
7767270|NCT01387347|19122875|P1|COMPLETED|Overall Study||34
7767271|NCT01387347|19122874|P2|STARTED|Overall Study||36
7767272|NCT01387347|19122875|P1|STARTED|Overall Study||36
7767273|NCT01387282|19122887|P2|NOT COMPLETED|Overall Study||47
7767274|NCT01387282|19122888|P1|NOT COMPLETED|Overall Study||97
7767275|NCT01387282|19122887|P2|COMPLETED|Overall Study||118
7767276|NCT01387282|19122888|P1|COMPLETED|Overall Study||233
7767277|NCT01387282|19122887|P2|Safety Population|Overall Study||161
7767278|NCT01387282|19122888|P1|Safety Population|Overall Study||330
7767279|NCT01387282|19122887|P2|MITT Population|Overall Study||136
7767280|NCT01387282|19122888|P1|MITT Population|Overall Study||268
7767281|NCT01387282|19122887|P2|ITT Population|Overall Study||165
7767282|NCT01387282|19122888|P1|ITT Population|Overall Study||330
7767283|NCT01387282|19122887|P2|STARTED|Overall Study||165
7767284|NCT01387282|19122888|P1|STARTED|Overall Study||330
7767285|NCT01387269|19122904|P2|NOT COMPLETED|Overall Study||40
7767286|NCT01387269|19122905|P1|NOT COMPLETED|Overall Study||92
7767287|NCT01387269|19122904|P2|COMPLETED|Overall Study||121
7767288|NCT01387269|19122905|P1|COMPLETED|Overall Study||231
7767289|NCT01387269|19122904|P2|Safety Population|Overall Study||161
7767290|NCT01387269|19122905|P1|Safety Population|Overall Study||320
7767291|NCT01387269|19122904|P2|MITT Population|Overall Study||141
7767292|NCT01387269|19122905|P1|MITT Population|Overall Study||284
7767293|NCT01387269|19122904|P2|ITT Population|Overall Study||161
7767294|NCT01387269|19122905|P1|ITT Population|Overall Study||323
7767295|NCT01387269|19122904|P2|STARTED|Overall Study||161
7767296|NCT01387269|19122905|P1|STARTED|Overall Study||323
7767297|NCT01387230|19122922|P3|NOT COMPLETED|Overall Study||13
7767298|NCT01387230|19122923|P2|NOT COMPLETED|Overall Study||7
7767299|NCT01387230|19122924|P1|NOT COMPLETED|Overall Study||18
7767300|NCT01387230|19122922|P3|COMPLETED|Overall Study||56
7767301|NCT01387230|19122923|P2|COMPLETED|Overall Study||62
7767302|NCT01387230|19122924|P1|COMPLETED|Overall Study||50
7767303|NCT01387230|19122922|P3|STARTED|Overall Study||69
7767304|NCT01387230|19122923|P2|STARTED|Overall Study||69
7767305|NCT01387230|19122924|P1|STARTED|Overall Study||68
7767306|NCT01387178|19122940|P2|NOT COMPLETED|Overall Study||0
7767307|NCT01387178|19122941|P1|NOT COMPLETED|Overall Study||0
7767308|NCT01387178|19122940|P2|COMPLETED|Overall Study||10641
7767309|NCT01387178|19122941|P1|COMPLETED|Overall Study||11582
7767310|NCT01387178|19122940|P2|STARTED|Overall Study||10641
7767311|NCT01387178|19122941|P1|STARTED|Overall Study||11582
7767312|NCT01387139|19122953|P2|NOT COMPLETED|Overall Study||0
7767313|NCT01387139|19122954|P1|NOT COMPLETED|Overall Study||0
7767314|NCT01387139|19122953|P2|COMPLETED|Overall Study||84
7767315|NCT01387139|19122954|P1|COMPLETED|Overall Study||99
7767316|NCT01387139|19122953|P2|STARTED|Overall Study||84
7767317|NCT01387139|19122954|P1|STARTED|Overall Study||99
7767318|NCT01387074|19122970|P1|NOT COMPLETED|Overall Study||8
7767319|NCT01387074|19122970|P1|COMPLETED|Overall Study||100
7767320|NCT01387074|19122970|P1|STARTED|Overall Study||108
7767321|NCT01387022|19122983|P2|NOT COMPLETED|Overall Study||4
7767322|NCT01387022|19122984|P1|NOT COMPLETED|Overall Study||1
7767323|NCT01387022|19122983|P2|COMPLETED|Overall Study||26
7767324|NCT01387022|19122984|P1|COMPLETED|Overall Study||28
7767325|NCT01387022|19122983|P2|STARTED|Overall Study||30
7767326|NCT01387022|19122984|P1|STARTED|Overall Study||29
7767327|NCT01386983|19123002|P2|NOT COMPLETED|Overall Study||0
7767328|NCT01386983|19123003|P1|NOT COMPLETED|Overall Study||0
7767329|NCT01386983|19123002|P2|COMPLETED|Overall Study||68
7767330|NCT01386983|19123003|P1|COMPLETED|Overall Study||264
7767331|NCT01386983|19123002|P2|STARTED|Overall Study||68
7767332|NCT01386983|19123003|P1|STARTED|Overall Study||264
7767333|NCT01386970|19123013|P2|NOT COMPLETED|Overall Study||2
7767334|NCT01386970|19123014|P1|NOT COMPLETED|Overall Study||4
7767335|NCT01386970|19123013|P2|COMPLETED|Overall Study||21
7767336|NCT01386970|19123014|P1|COMPLETED|Overall Study||16
7767337|NCT01386970|19123013|P2|STARTED|Overall Study||23
7767338|NCT01386970|19123014|P1|STARTED|Overall Study||20
7767339|NCT01386944|19123022|P1|NOT COMPLETED|Overall Study||56
7767340|NCT01386944|19123022|P1|COMPLETED|Overall Study||46
7767341|NCT01386944|19123022|P1|STARTED|Overall Study||102
7767342|NCT01386788|19123032|P1|NOT COMPLETED|Overall Study||2
7767343|NCT01386788|19123032|P1|COMPLETED|Overall Study||100
7767344|NCT01386788|19123032|P1|STARTED|Overall Study||102
7767345|NCT01386684|19123037|P1|NOT COMPLETED|Overall Study||293
7767346|NCT01386684|19123037|P1|COMPLETED|Overall Study||259
7767347|NCT01386684|19123037|P1|STARTED|Overall Study||552
7767348|NCT01386658|19123078|P2|NOT COMPLETED|Icatibant Exposure 3||0
7767349|NCT01386658|19123079|P1|NOT COMPLETED|Icatibant Exposure 3||0
7767350|NCT01386658|19123078|P2|COMPLETED|Icatibant Exposure 3||9
7767351|NCT01386658|19123079|P1|COMPLETED|Icatibant Exposure 3||0
7767352|NCT01386658|19123078|P2|STARTED|Icatibant Exposure 3||9
7767353|NCT01386658|19123079|P1|STARTED|Icatibant Exposure 3||0
7767354|NCT01386658|19123078|P2|NOT COMPLETED|Icatibant Exposure 2||0
7767355|NCT01386658|19123079|P1|NOT COMPLETED|Icatibant Exposure 2||0
7767356|NCT01386658|19123078|P2|COMPLETED|Icatibant Exposure 2||9
7767357|NCT01386658|19123079|P1|COMPLETED|Icatibant Exposure 2||0
7767358|NCT01386658|19123078|P2|STARTED|Icatibant Exposure 2||9
7767359|NCT01386658|19123079|P1|STARTED|Icatibant Exposure 2||0
7767360|NCT01386658|19123078|P2|NOT COMPLETED|Initial Icatibant Exposure||12
7767361|NCT01386658|19123079|P1|NOT COMPLETED|Initial Icatibant Exposure||0
7767362|NCT01386658|19123078|P2|COMPLETED|Initial Icatibant Exposure||9
7767363|NCT01386658|19123079|P1|COMPLETED|Initial Icatibant Exposure||11
7767364|NCT01386658|19123078|P2|STARTED|Initial Icatibant Exposure||21
7767365|NCT01386658|19123079|P1|STARTED|Initial Icatibant Exposure||11
7767366|NCT01386645|19123145|P3|NOT COMPLETED|Overall Study||2
7767367|NCT01386645|19123146|P2|NOT COMPLETED|Overall Study||1
7767368|NCT01386645|19123147|P1|NOT COMPLETED|Overall Study||0
7767369|NCT01386645|19123145|P3|COMPLETED|Overall Study||17
7767370|NCT01386645|19123146|P2|COMPLETED|Overall Study||18
7767371|NCT01386645|19123147|P1|COMPLETED|Overall Study||18
7767372|NCT01386645|19123145|P3|STARTED|Overall Study||19
7767373|NCT01386645|19123146|P2|STARTED|Overall Study||19
7767374|NCT01386645|19123147|P1|STARTED|Overall Study||18
7767375|NCT01386632|19123163|P2|NOT COMPLETED|Overall Study||4
7767376|NCT01386632|19123164|P1|NOT COMPLETED|Overall Study||5
7767377|NCT01386632|19123163|P2|COMPLETED|Overall Study||21
7767378|NCT01386632|19123164|P1|COMPLETED|Overall Study||20
7767379|NCT01386632|19123163|P2|STARTED|Overall Study||25
7767380|NCT01386632|19123164|P1|STARTED|Overall Study||25
7767381|NCT01386606|19123176|P4|NOT COMPLETED|Overall Study||1
7767382|NCT01386606|19123177|P3|NOT COMPLETED|Overall Study||3
7767383|NCT01386606|19123178|P2|NOT COMPLETED|Overall Study||4
7767384|NCT01386606|19123179|P1|NOT COMPLETED|Overall Study||4
7767385|NCT01386606|19123176|P4|COMPLETED|Overall Study||13
7767386|NCT01386606|19123177|P3|COMPLETED|Overall Study||13
7767387|NCT01386606|19123178|P2|COMPLETED|Overall Study||10
7767388|NCT01386606|19123179|P1|COMPLETED|Overall Study||12
7767389|NCT01386606|19123176|P4|STARTED|Overall Study||14
7767390|NCT01386606|19123177|P3|STARTED|Overall Study||16
7767391|NCT01386606|19123178|P2|STARTED|Overall Study||14
7767392|NCT01386606|19123179|P1|STARTED|Overall Study||16
7767393|NCT01386554|19123210|P3|NOT COMPLETED|Overall Study||6
7767394|NCT01386554|19123211|P2|NOT COMPLETED|Overall Study||9
7767395|NCT01386554|19123212|P1|NOT COMPLETED|Overall Study||3
7767396|NCT01386554|19123210|P3|COMPLETED|Overall Study||15
7767397|NCT01386554|19123211|P2|COMPLETED|Overall Study||26
7767398|NCT01386554|19123212|P1|COMPLETED|Overall Study||1
7767399|NCT01386554|19123210|P3|STARTED|Overall Study||21
7767400|NCT01386554|19123211|P2|STARTED|Overall Study||35
7767401|NCT01386554|19123212|P1|STARTED|Overall Study||4
7767402|NCT01386528|19123223|P1|NOT COMPLETED|Overall Study||0
7767403|NCT01386528|19123223|P1|COMPLETED|Overall Study||13
7767404|NCT01386528|19123223|P1|STARTED|Overall Study||13
7767405|NCT01386125|19123235|P2|NOT COMPLETED|Overall Study||37
7767406|NCT01386125|19123236|P1|NOT COMPLETED|Overall Study||25
7767407|NCT01386125|19123235|P2|COMPLETED|Overall Study||336
7767408|NCT01386125|19123236|P1|COMPLETED|Overall Study||350
7767409|NCT01386125|19123235|P2|STARTED|Overall Study||373
7767410|NCT01386125|19123236|P1|STARTED|Overall Study||375
7767411|NCT01386008|19123244|P1|NOT COMPLETED|Overall Study||20
7767412|NCT01386008|19123244|P1|COMPLETED|Overall Study||0
7767413|NCT01386008|19123244|P1|STARTED|Overall Study||20
7767414|NCT01385995|19123253|P2|NOT COMPLETED|Period 2, 2 Months||0
7767415|NCT01385995|19123254|P1|NOT COMPLETED|Period 2, 2 Months||0
7767416|NCT01385995|19123253|P2|COMPLETED|Period 2, 2 Months||25
7767417|NCT01385995|19123254|P1|COMPLETED|Period 2, 2 Months||24
7767418|NCT01385995|19123253|P2|STARTED|Period 2, 2 Months||25
7767419|NCT01385995|19123254|P1|STARTED|Period 2, 2 Months||24
7767420|NCT01385995|19123253|P2|NOT COMPLETED|Washout Period, 1 Month||0
7767421|NCT01385995|19123254|P1|NOT COMPLETED|Washout Period, 1 Month||0
7767422|NCT01385995|19123253|P2|COMPLETED|Washout Period, 1 Month||25
7767423|NCT01385995|19123254|P1|COMPLETED|Washout Period, 1 Month||24
7767424|NCT01385995|19123253|P2|STARTED|Washout Period, 1 Month||25
7767425|NCT01385995|19123254|P1|STARTED|Washout Period, 1 Month||24
7767426|NCT01385995|19123253|P2|NOT COMPLETED|Period 1, 2 Months||0
7767427|NCT01385995|19123254|P1|NOT COMPLETED|Period 1, 2 Months||1
7767428|NCT01385995|19123253|P2|COMPLETED|Period 1, 2 Months||25
7767429|NCT01385995|19123254|P1|COMPLETED|Period 1, 2 Months||24
7767430|NCT01385995|19123253|P2|STARTED|Period 1, 2 Months||25
7767431|NCT01385995|19123254|P1|STARTED|Period 1, 2 Months||25
7767432|NCT01385748|19123271|P3|NOT COMPLETED|Overall Study||13
7767433|NCT01385748|19123272|P2|NOT COMPLETED|Overall Study||14
7767434|NCT01385748|19123273|P1|NOT COMPLETED|Overall Study||15
7767435|NCT01385748|19123271|P3|COMPLETED|Overall Study||49
7767436|NCT01385748|19123272|P2|COMPLETED|Overall Study||51
7767437|NCT01385748|19123273|P1|COMPLETED|Overall Study||41
7767438|NCT01385748|19123271|P3|STARTED|Overall Study||62
7767439|NCT01385748|19123272|P2|STARTED|Overall Study||65
7767440|NCT01385748|19123273|P1|STARTED|Overall Study||56
7767441|NCT01385696|19123318|P2|NOT COMPLETED|Overall Study||0
7767442|NCT01385696|19123319|P1|NOT COMPLETED|Overall Study||0
7767443|NCT01385696|19123318|P2|COMPLETED|Overall Study||64
7767444|NCT01385696|19123319|P1|COMPLETED|Overall Study||66
7767445|NCT01385696|19123318|P2|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64
7767446|NCT01385696|19123319|P1|STARTED|Overall Study||66
7767447|NCT01385644|19123330|P2|NOT COMPLETED|Overall Study||0
7767448|NCT01385644|19123331|P1|NOT COMPLETED|Overall Study||0
7767449|NCT01385644|19123330|P2|COMPLETED|Overall Study||4
7767450|NCT01385644|19123331|P1|COMPLETED|Overall Study||4
7767451|NCT01385644|19123330|P2|STARTED|Overall Study||4
7767452|NCT01385644|19123331|P1|STARTED|Overall Study||4
7767453|NCT01385579|19123345|P2|NOT COMPLETED|Overall Study||0
7767454|NCT01385579|19123346|P1|NOT COMPLETED|Overall Study||0
7767455|NCT01385579|19123345|P2|COMPLETED|Overall Study||104
7767456|NCT01385579|19123346|P1|COMPLETED|Overall Study||98
7767457|NCT01385579|19123345|P2|STARTED|Overall Study||104
7767458|NCT01385579|19123346|P1|STARTED|Overall Study||98
7767459|NCT01385566|19123358|P6|NOT COMPLETED|Overall Study||0
7767460|NCT01385566|19123359|P5|NOT COMPLETED|Overall Study||0
7767461|NCT01385566|19123360|P4|NOT COMPLETED|Overall Study||1
7767462|NCT01385566|19123361|P3|NOT COMPLETED|Overall Study||0
7767463|NCT01385566|19123362|P2|NOT COMPLETED|Overall Study||0
7767464|NCT01385566|19123363|P1|NOT COMPLETED|Overall Study||1
7767465|NCT01385566|19123358|P6|COMPLETED|Overall Study||34
7767466|NCT01385566|19123359|P5|COMPLETED|Overall Study||34
7767467|NCT01385566|19123360|P4|COMPLETED|Overall Study||34
7767468|NCT01385566|19123361|P3|COMPLETED|Overall Study||34
7767469|NCT01385566|19123362|P2|COMPLETED|Overall Study||34
7767470|NCT01385566|19123363|P1|COMPLETED|Overall Study||51
7767471|NCT01385566|19123358|P6|STARTED|Overall Study||34
7767472|NCT01385566|19123359|P5|STARTED|Overall Study||34
7767473|NCT01385566|19123360|P4|STARTED|Overall Study||35
7767474|NCT01385566|19123361|P3|STARTED|Overall Study||34
7767475|NCT01385566|19123362|P2|STARTED|Overall Study||34
7767476|NCT01385566|19123363|P1|STARTED|Overall Study||52
7767477|NCT01385371|19123417|P2|NOT COMPLETED|Overall Study||97
7767478|NCT01385371|19123418|P1|NOT COMPLETED|Overall Study||149
7767479|NCT01385371|19123417|P2|COMPLETED|Overall Study||652
7767480|NCT01385371|19123418|P1|COMPLETED|Overall Study||603
7767481|NCT01385371|19123417|P2|STARTED|Overall Study||749
7767482|NCT01385371|19123418|P1|STARTED|Overall Study||752
7767483|NCT01385306|19123438|P1|NOT COMPLETED|Overall Study||0
7767484|NCT01385306|19123438|P1|COMPLETED|Overall Study||6
7767485|NCT01385306|19123438|P1|STARTED|Overall Study||6
7767486|NCT01385293|19123446|P1|NOT COMPLETED|Overall Study||0
7767487|NCT01385293|19123446|P1|COMPLETED|Overall Study||30
7767488|NCT01385293|19123446|P1|STARTED|Overall Study||30
7767489|NCT01385280|19123456|P1|NOT COMPLETED|Overall Study||0
7767490|NCT01385280|19123456|P1|COMPLETED|Overall Study||13
7767491|NCT01385280|19123456|P1|STARTED|Overall Study||13
7767492|NCT01385202|19123466|P1|NOT COMPLETED|Overall Study||18
7767493|NCT01385202|19123466|P1|COMPLETED|Overall Study||154
7767494|NCT01385202|19123466|P1|Undergoing Ablation|Overall Study||160
7767495|NCT01385202|19123466|P1|Study Catheter Inserted|Overall Study||161
7767496|NCT01385202|19123466|P1|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172
7767497|NCT01385189|19123478|P5|NOT COMPLETED|Overall Study||2
7767498|NCT01385189|19123479|P4|NOT COMPLETED|Overall Study||1
7767499|NCT01385189|19123480|P3|NOT COMPLETED|Overall Study||0
7767500|NCT01385189|19123481|P2|NOT COMPLETED|Overall Study||1
7767501|NCT01385189|19123482|P1|NOT COMPLETED|Overall Study||1
7767502|NCT01385189|19123478|P5|COMPLETED|Overall Study||6
7767503|NCT01385189|19123479|P4|COMPLETED|Overall Study||3
7767504|NCT01385189|19123480|P3|COMPLETED|Overall Study||4
7767505|NCT01385189|19123481|P2|COMPLETED|Overall Study||11
7767506|NCT01385189|19123482|P1|COMPLETED|Overall Study||11
7767507|NCT01385189|19123478|P5|STARTED|Overall Study||8
7767508|NCT01385189|19123479|P4|STARTED|Overall Study||4
7767509|NCT01385189|19123480|P3|STARTED|Overall Study||4
7767510|NCT01385189|19123481|P2|STARTED|Overall Study||12
7767511|NCT01385189|19123482|P1|STARTED|Overall Study||12
7767512|NCT01385176|19123503|P2|NOT COMPLETED|6-18 Month All VNS Active||3
7767513|NCT01385176|19123504|P1|NOT COMPLETED|6-18 Month All VNS Active||4
7767514|NCT01385176|19123503|P2|COMPLETED|6-18 Month All VNS Active||27
7767515|NCT01385176|19123504|P1|COMPLETED|6-18 Month All VNS Active||58
7767516|NCT01385176|19123503|P2|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|30
7767517|NCT01385176|19123504|P1|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|62
7767518|NCT01385176|19123503|P2|NOT COMPLETED|Randomization Phase||2
7767519|NCT01385176|19123504|P1|NOT COMPLETED|Randomization Phase||1
7767520|NCT01385176|19123503|P2|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|30
7767521|NCT01385176|19123504|P1|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|62
7767522|NCT01385176|19123503|P2|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|32
7767523|NCT01385176|19123504|P1|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|63
7767524|NCT01385137|19123520|P2|NOT COMPLETED|Evaluable for Primary Endpoint||24
7767525|NCT01385137|19123521|P1|NOT COMPLETED|Evaluable for Primary Endpoint||29
7767526|NCT01385137|19123520|P2|COMPLETED|Evaluable for Primary Endpoint||107
7767527|NCT01385137|19123521|P1|COMPLETED|Evaluable for Primary Endpoint||102
7767528|NCT01385137|19123520|P2|STARTED|Evaluable for Primary Endpoint||131
7767529|NCT01385137|19123521|P1|STARTED|Evaluable for Primary Endpoint||131
7767530|NCT01385137|19123520|P2|NOT COMPLETED|Evaluable at Baseline||4
7767531|NCT01385137|19123521|P1|NOT COMPLETED|Evaluable at Baseline||9
7767532|NCT01385137|19123520|P2|COMPLETED|Evaluable at Baseline||127
7767533|NCT01385137|19123521|P1|COMPLETED|Evaluable at Baseline||122
7767534|NCT01385137|19123520|P2|STARTED|Evaluable at Baseline||131
7767535|NCT01385137|19123521|P1|STARTED|Evaluable at Baseline||131
7767536|NCT01385098|19123535|P1|NOT COMPLETED|Overall Study||14
7767537|NCT01385098|19123535|P1|COMPLETED|Overall Study|14 subjects did not complete. 4 subjects loss to follow-up & 10 subjects could not tolerate suppl.|23
7767538|NCT01385098|19123535|P1|STARTED|Overall Study||37
7767539|NCT01385033|19123543|P6|NOT COMPLETED|Part III||0
7767540|NCT01385033|19123544|P5|NOT COMPLETED|Part III||0
7767541|NCT01385033|19123545|P4|NOT COMPLETED|Part III||0
7767542|NCT01385033|19123546|P3|NOT COMPLETED|Part III||0
7767543|NCT01385033|19123547|P2|NOT COMPLETED|Part III||0
7767544|NCT01385033|19123548|P1|NOT COMPLETED|Part III||0
7767545|NCT01385033|19123543|P6|COMPLETED|Part III||0
7767546|NCT01385033|19123544|P5|COMPLETED|Part III||0
7767547|NCT01385033|19123545|P4|COMPLETED|Part III||0
7767548|NCT01385033|19123546|P3|COMPLETED|Part III||0
7767549|NCT01385033|19123547|P2|COMPLETED|Part III||0
7767550|NCT01385033|19123548|P1|COMPLETED|Part III||0
7767551|NCT01385033|19123543|P6|STARTED|Part III||0
7767552|NCT01385033|19123544|P5|STARTED|Part III||0
7767553|NCT01385033|19123545|P4|STARTED|Part III||0
7767554|NCT01385033|19123546|P3|STARTED|Part III||0
7767555|NCT01385033|19123547|P2|STARTED|Part III||0
7767556|NCT01385033|19123548|P1|STARTED|Part III||0
7767557|NCT01385033|19123543|P6|NOT COMPLETED|Part II||0
7767558|NCT01385033|19123544|P5|NOT COMPLETED|Part II||0
7767559|NCT01385033|19123545|P4|NOT COMPLETED|Part II||0
7767560|NCT01385033|19123546|P3|NOT COMPLETED|Part II||0
7767561|NCT01385033|19123547|P2|NOT COMPLETED|Part II||0
7767562|NCT01385033|19123548|P1|NOT COMPLETED|Part II||0
7767563|NCT01385033|19123543|P6|COMPLETED|Part II||0
7767564|NCT01385033|19123544|P5|COMPLETED|Part II||0
7767565|NCT01385033|19123545|P4|COMPLETED|Part II||0
7767566|NCT01385033|19123546|P3|COMPLETED|Part II||0
7767567|NCT01385033|19123547|P2|COMPLETED|Part II||0
7767568|NCT01385033|19123548|P1|COMPLETED|Part II||0
7767569|NCT01385033|19123543|P6|STARTED|Part II||0
7767570|NCT01385033|19123544|P5|STARTED|Part II||0
7767571|NCT01385033|19123545|P4|STARTED|Part II||0
7767572|NCT01385033|19123546|P3|STARTED|Part II||0
7767573|NCT01385033|19123547|P2|STARTED|Part II||0
7767574|NCT01385033|19123548|P1|STARTED|Part II||0
7767575|NCT01385033|19123543|P6|NOT COMPLETED|Part I||0
7767576|NCT01385033|19123544|P5|NOT COMPLETED|Part I||0
7767577|NCT01385033|19123545|P4|NOT COMPLETED|Part I||0
7767578|NCT01385033|19123546|P3|NOT COMPLETED|Part I||0
7767579|NCT01385033|19123547|P2|NOT COMPLETED|Part I||0
7767580|NCT01385033|19123548|P1|NOT COMPLETED|Part I||0
7767581|NCT01385033|19123543|P6|COMPLETED|Part I||0
7767582|NCT01385033|19123544|P5|COMPLETED|Part I||0
7767583|NCT01385033|19123545|P4|COMPLETED|Part I||0
7767584|NCT01385033|19123546|P3|COMPLETED|Part I||0
7767585|NCT01385033|19123547|P2|COMPLETED|Part I||14
7767586|NCT01385033|19123548|P1|COMPLETED|Part I||6
7767587|NCT01385033|19123543|P6|STARTED|Part I||0
7767588|NCT01385033|19123544|P5|STARTED|Part I||0
7767589|NCT01385033|19123545|P4|STARTED|Part I||0
7767590|NCT01385033|19123546|P3|STARTED|Part I||0
7767591|NCT01385033|19123547|P2|STARTED|Part I|These subjects did not participate in Part II or III|14
7767592|NCT01385033|19123548|P1|STARTED|Part I|These subjects did not participate in Part II or III|6
7767593|NCT01384877|19123557|P2|NOT COMPLETED|Treatment 2||2
7767594|NCT01384877|19123558|P1|NOT COMPLETED|Treatment 2||2
7767595|NCT01384877|19123557|P2|COMPLETED|Treatment 2||11
7767596|NCT01384877|19123558|P1|COMPLETED|Treatment 2||14
7767597|NCT01384877|19123557|P2|STARTED|Treatment 2|2 Patients died between treatment periods|13
7767598|NCT01384877|19123558|P1|STARTED|Treatment 2|1 Patient died between treatment periods|16
7767599|NCT01384877|19123557|P2|NOT COMPLETED|Treatment 1||0
7767600|NCT01384877|19123558|P1|NOT COMPLETED|Treatment 1||0
7767601|NCT01384877|19123557|P2|COMPLETED|Treatment 1||15
7767602|NCT01384877|19123558|P1|COMPLETED|Treatment 1||17
7767603|NCT01384877|19123557|P2|STARTED|Treatment 1||15
7767604|NCT01384877|19123558|P1|STARTED|Treatment 1||17
7767605|NCT01384760|19123584|P2|NOT COMPLETED|Overall Study||6
7767606|NCT01384760|19123585|P1|NOT COMPLETED|Overall Study||16
7767607|NCT01384760|19123584|P2|COMPLETED|Overall Study||37
7767608|NCT01384760|19123585|P1|COMPLETED|Overall Study||45
7767609|NCT01384760|19123584|P2|Randomized|Overall Study||43
7767610|NCT01384760|19123585|P1|Randomized|Overall Study||61
7767611|NCT01384760|19123584|P2|STARTED|Overall Study||43
7767612|NCT01384760|19123585|P1|STARTED|Overall Study||61
7767613|NCT01384734|19123598|P5|NOT COMPLETED|Overall Study||29
7767614|NCT01384734|19123599|P4|NOT COMPLETED|Overall Study||28
7767615|NCT01384734|19123600|P3|NOT COMPLETED|Overall Study||23
7767616|NCT01384734|19123601|P2|NOT COMPLETED|Overall Study||24
7767617|NCT01384734|19123602|P1|NOT COMPLETED|Overall Study||17
7767618|NCT01384734|19123598|P5|COMPLETED|Overall Study||22
7767619|NCT01384734|19123599|P4|COMPLETED|Overall Study||22
7767620|NCT01384734|19123600|P3|COMPLETED|Overall Study||28
7767621|NCT01384734|19123601|P2|COMPLETED|Overall Study||25
7767622|NCT01384734|19123602|P1|COMPLETED|Overall Study||33
7767623|NCT01384734|19123598|P5|STARTED|Overall Study||51
7767624|NCT01384734|19123599|P4|STARTED|Overall Study||50
7767625|NCT01384734|19123600|P3|STARTED|Overall Study||51
7767626|NCT01384734|19123601|P2|STARTED|Overall Study||49
7767627|NCT01384734|19123602|P1|STARTED|Overall Study||50
7767628|NCT01384591|19123685|P3|NOT COMPLETED|Overall Study||0
7767629|NCT01384591|19123686|P2|NOT COMPLETED|Overall Study||0
7767630|NCT01384591|19123687|P1|NOT COMPLETED|Overall Study||0
7767631|NCT01384591|19123685|P3|COMPLETED|Overall Study||2
7767632|NCT01384591|19123686|P2|COMPLETED|Overall Study||2
7767633|NCT01384591|19123687|P1|COMPLETED|Overall Study||2
7767634|NCT01384591|19123685|P3|STARTED|Overall Study||2
7767635|NCT01384591|19123686|P2|STARTED|Overall Study||2
7767636|NCT01384591|19123687|P1|STARTED|Overall Study||2
7767637|NCT01384539|19123817|P2|NOT COMPLETED|Overall Study||7
7767638|NCT01384539|19123818|P1|NOT COMPLETED|Overall Study||6
7767639|NCT01384539|19123817|P2|COMPLETED|Overall Study||57
7767640|NCT01384539|19123818|P1|COMPLETED|Overall Study||58
7767641|NCT01384539|19123817|P2|STARTED|Overall Study||64
7767642|NCT01384539|19123818|P1|STARTED|Overall Study||64
7767643|NCT01384292|19123831|P3|NOT COMPLETED|Part B||0
7767644|NCT01384292|19123832|P2|NOT COMPLETED|Part B||0
7767645|NCT01384292|19123833|P1|NOT COMPLETED|Part B||1
7767646|NCT01384292|19123831|P3|COMPLETED|Part B||0
7767647|NCT01384292|19123832|P2|COMPLETED|Part B||6
7767648|NCT01384292|19123833|P1|COMPLETED|Part B||2
7767649|NCT01384292|19123831|P3|STARTED|Part B||0
7767650|NCT01384292|19123832|P2|STARTED|Part B||6
7767651|NCT01384292|19123833|P1|STARTED|Part B||3
7767652|NCT01384292|19123831|P3|NOT COMPLETED|Part A||0
7767653|NCT01384292|19123832|P2|NOT COMPLETED|Part A||0
7767654|NCT01384292|19123833|P1|NOT COMPLETED|Part A||0
7767655|NCT01384292|19123831|P3|COMPLETED|Part A||4
7767656|NCT01384292|19123832|P2|COMPLETED|Part A||5
7767657|NCT01384292|19123833|P1|COMPLETED|Part A||5
7767658|NCT01384292|19123831|P3|STARTED|Part A||4
7767659|NCT01384292|19123832|P2|STARTED|Part A||5
7767660|NCT01384292|19123833|P1|STARTED|Part A||5
7767661|NCT01384019|19123845|P2|NOT COMPLETED|Overall Study||6
7767662|NCT01384019|19123846|P1|NOT COMPLETED|Overall Study||10
7767663|NCT01384019|19123845|P2|COMPLETED|Overall Study||55
7767664|NCT01384019|19123846|P1|COMPLETED|Overall Study||55
7767665|NCT01384019|19123845|P2|STARTED|Overall Study||61
7767666|NCT01384019|19123846|P1|STARTED|Overall Study||65
7767667|NCT01383993|19123855|P3|NOT COMPLETED|Overall Study||1
7767668|NCT01383993|19123856|P2|NOT COMPLETED|Overall Study||1
7767669|NCT01383993|19123857|P1|NOT COMPLETED|Overall Study||3
7767670|NCT01383993|19123855|P3|COMPLETED|Overall Study||1
7767671|NCT01383993|19123856|P2|COMPLETED|Overall Study||3
7767672|NCT01383993|19123857|P1|COMPLETED|Overall Study||12
7767673|NCT01383993|19123855|P3|STARTED|Overall Study||2
7767674|NCT01383993|19123856|P2|STARTED|Overall Study||4
7767675|NCT01383993|19123857|P1|STARTED|Overall Study||15
7767676|NCT01383954|19123904|P1|NOT COMPLETED|Overall Study||14
7767677|NCT01383954|19123904|P1|COMPLETED|Overall Study||38
7767678|NCT01383954|19123904|P1|Safety Population: Received Treatment|Overall Study||48
7767679|NCT01383954|19123904|P1|STARTED|Overall Study||52
7767680|NCT01383928|19123912|P3|NOT COMPLETED|Overall Study||40
7767681|NCT01383928|19123913|P2|NOT COMPLETED|Overall Study||7
7767682|NCT01383928|19123914|P1|NOT COMPLETED|Overall Study||5
7767683|NCT01383928|19123912|P3|COMPLETED|Overall Study||10
7767684|NCT01383928|19123913|P2|COMPLETED|Overall Study||0
7767685|NCT01383928|19123914|P1|COMPLETED|Overall Study||2
7767686|NCT01383928|19123912|P3|STARTED|Overall Study||50
7767687|NCT01383928|19123913|P2|STARTED|Overall Study||7
7767688|NCT01383928|19123914|P1|STARTED|Overall Study||7
7767689|NCT01383759|19123958|P2|NOT COMPLETED|Overall Study||0
7767690|NCT01383759|19123959|P1|NOT COMPLETED|Overall Study||0
7767691|NCT01383759|19123958|P2|COMPLETED|Overall Study||1
7767692|NCT01383759|19123959|P1|COMPLETED|Overall Study||19
7767693|NCT01383759|19123958|P2|STARTED|Overall Study||1
7767694|NCT01383759|19123959|P1|STARTED|Overall Study||19
7767695|NCT01383720|19123973|P1|NOT COMPLETED|Overall Study||0
7767696|NCT01383720|19123973|P1|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11
7767697|NCT01383720|19123973|P1|Primary Endpoint (Discharge/7 Days)|Overall Study||11
7767698|NCT01383720|19123973|P1|STARTED|Overall Study||11
7767699|NCT01383707|19123995|P1|NOT COMPLETED|Overall Study||72
7767700|NCT01383707|19123995|P1|COMPLETED|Overall Study||5
7767701|NCT01383707|19123995|P1|STARTED|Overall Study||77
7767702|NCT01383681|19124004|P1|NOT COMPLETED|Overall Study||46
7767703|NCT01383681|19124004|P1|COMPLETED|Overall Study||189
7767704|NCT01383681|19124004|P1|STARTED|Overall Study||235
7767705|NCT01383616|19124011|P2|NOT COMPLETED|Overall Study||23
7767706|NCT01383616|19124012|P1|NOT COMPLETED|Overall Study||17
7767707|NCT01383616|19124011|P2|COMPLETED|Overall Study||21
7767708|NCT01383616|19124012|P1|COMPLETED|Overall Study||23
7767709|NCT01383616|19124011|P2|STARTED|Overall Study||44
7767710|NCT01383616|19124012|P1|STARTED|Overall Study||40
7767711|NCT01383499|19124035|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
7767712|NCT01383499|19124036|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
7767713|NCT01383499|19124037|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
7767714|NCT01383499|19124038|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
7767715|NCT01383499|19124035|P4|COMPLETED|Period 3 (4 Weeks)||25
7767716|NCT01383499|19124036|P3|COMPLETED|Period 3 (4 Weeks)||25
7767717|NCT01383499|19124037|P2|COMPLETED|Period 3 (4 Weeks)||24
7767718|NCT01383499|19124038|P1|COMPLETED|Period 3 (4 Weeks)||26
7767719|NCT01383499|19124035|P4|STARTED|Period 3 (4 Weeks)||25
7767720|NCT01383499|19124036|P3|STARTED|Period 3 (4 Weeks)||25
7767721|NCT01383499|19124037|P2|STARTED|Period 3 (4 Weeks)||24
7767722|NCT01383499|19124038|P1|STARTED|Period 3 (4 Weeks)||26
7767723|NCT01383499|19124035|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
7767724|NCT01383499|19124036|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
7767725|NCT01383499|19124037|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
7767726|NCT01383499|19124038|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
7767727|NCT01383499|19124035|P4|COMPLETED|Period 2 (4 Weeks)||25
7767728|NCT01383499|19124036|P3|COMPLETED|Period 2 (4 Weeks)||25
7767729|NCT01383499|19124037|P2|COMPLETED|Period 2 (4 Weeks)||24
7767730|NCT01383499|19124038|P1|COMPLETED|Period 2 (4 Weeks)||26
7767731|NCT01383499|19124035|P4|STARTED|Period 2 (4 Weeks)||25
7767732|NCT01383499|19124036|P3|STARTED|Period 2 (4 Weeks)||25
7767733|NCT01383499|19124037|P2|STARTED|Period 2 (4 Weeks)||24
7767734|NCT01383499|19124038|P1|STARTED|Period 2 (4 Weeks)||26
7767735|NCT01383499|19124035|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
7767736|NCT01383499|19124036|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
7767737|NCT01383499|19124037|P2|NOT COMPLETED|Period 1 (4 Weeks)||0
7767738|NCT01383499|19124038|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
7767739|NCT01383499|19124035|P4|COMPLETED|Period 1 (4 Weeks)||25
7767740|NCT01383499|19124036|P3|COMPLETED|Period 1 (4 Weeks)||25
7767741|NCT01383499|19124037|P2|COMPLETED|Period 1 (4 Weeks)||24
7767742|NCT01383499|19124038|P1|COMPLETED|Period 1 (4 Weeks)||26
7767743|NCT01383499|19124035|P4|STARTED|Period 1 (4 Weeks)||25
7767744|NCT01383499|19124036|P3|STARTED|Period 1 (4 Weeks)||25
7767745|NCT01383499|19124037|P2|STARTED|Period 1 (4 Weeks)||24
7767746|NCT01383499|19124038|P1|STARTED|Period 1 (4 Weeks)||27
7767747|NCT01383486|19124088|P1|NOT COMPLETED|Overall Study||18
7767748|NCT01383486|19124088|P1|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235
7767749|NCT01383486|19124088|P1|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237
7767750|NCT01383486|19124088|P1|STARTED|Overall Study|Number of participants who were provided with investigational products|253
7767751|NCT01383447|19124094|P1|NOT COMPLETED|Overall Study||2
7767752|NCT01383447|19124094|P1|COMPLETED|Overall Study||0
7767753|NCT01383447|19124094|P1|STARTED|Overall Study||2
7767754|NCT01383421|19124102|P1|NOT COMPLETED|Overall Study||346
7767755|NCT01383421|19124102|P1|COMPLETED|Overall Study||679
7767756|NCT01383421|19124102|P1|STARTED|Overall Study|ITT population: all enrolled participants who received at least 1 dose of study drug.|1025
7767757|NCT01383356|19124165|P2|NOT COMPLETED|Period 2||0
7767758|NCT01383356|19124166|P1|NOT COMPLETED|Period 2||0
7767759|NCT01383356|19124165|P2|COMPLETED|Period 2|Completed period 2.|23
7767760|NCT01383356|19124166|P1|COMPLETED|Period 2|Completed period 2.|21
7767761|NCT01383356|19124165|P2|STARTED|Period 2|Entered and treated.|23
7767762|NCT01383356|19124166|P1|STARTED|Period 2|Entered and treated.|21
7767763|NCT01383356|19124165|P2|NOT COMPLETED|Washout Period (at Least 35 Days)||0
7767764|NCT01383356|19124166|P1|NOT COMPLETED|Washout Period (at Least 35 Days)||0
7767765|NCT01383356|19124165|P2|COMPLETED|Washout Period (at Least 35 Days)||23
7767766|NCT01383356|19124166|P1|COMPLETED|Washout Period (at Least 35 Days)||21
7767767|NCT01383356|19124165|P2|STARTED|Washout Period (at Least 35 Days)||23
7767768|NCT01383356|19124166|P1|STARTED|Washout Period (at Least 35 Days)||21
7767769|NCT01383356|19124165|P2|NOT COMPLETED|Period 1||6
7767770|NCT01383356|19124166|P1|NOT COMPLETED|Period 1||8
7767771|NCT01383356|19124165|P2|COMPLETED|Period 1|Completed period 1.|23
7767772|NCT01383356|19124166|P1|COMPLETED|Period 1|Completed period 1.|21
7767773|NCT01383356|19124165|P2|STARTED|Period 1|Entered and treated.|29
7767774|NCT01383356|19124166|P1|STARTED|Period 1|Entered and treated.|29
7767775|NCT01383317|19124178|P2|NOT COMPLETED|Overall Study||2
7767776|NCT01383317|19124179|P1|NOT COMPLETED|Overall Study||3
7767777|NCT01383317|19124178|P2|COMPLETED|Overall Study||33
7767778|NCT01383317|19124179|P1|COMPLETED|Overall Study||26
7767779|NCT01383317|19124178|P2|STARTED|Overall Study||35
7767780|NCT01383317|19124179|P1|STARTED|Overall Study||29
7767781|NCT01383213|19124203|P2|NOT COMPLETED|Overall Study||0
7767782|NCT01383213|19124204|P1|NOT COMPLETED|Overall Study||0
7767783|NCT01383213|19124203|P2|COMPLETED|Overall Study||41
7767784|NCT01383213|19124204|P1|COMPLETED|Overall Study||40
7767785|NCT01383213|19124203|P2|STARTED|Overall Study||41
7767786|NCT01383213|19124204|P1|STARTED|Overall Study||40
7767787|NCT01383200|19124212|P2|NOT COMPLETED|Overall Study||0
7767788|NCT01383200|19124213|P1|NOT COMPLETED|Overall Study||0
7767789|NCT01383200|19124212|P2|COMPLETED|Overall Study||6
7767790|NCT01383200|19124213|P1|COMPLETED|Overall Study||5
7767791|NCT01383200|19124212|P2|STARTED|Overall Study||6
7767792|NCT01383200|19124213|P1|STARTED|Overall Study||5
7767793|NCT01383174|19124221|P2|NOT COMPLETED|6 Month Assessment||1
7767794|NCT01383174|19124222|P1|NOT COMPLETED|6 Month Assessment||5
7767795|NCT01383174|19124221|P2|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73
7767796|NCT01383174|19124222|P1|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71
7767797|NCT01383174|19124221|P2|STARTED|6 Month Assessment||74
7767798|NCT01383174|19124222|P1|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76
7767799|NCT01383174|19124221|P2|NOT COMPLETED|3 Month Assessment||1
7767800|NCT01383174|19124222|P1|NOT COMPLETED|3 Month Assessment||6
7767801|NCT01383174|19124221|P2|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74
7767802|NCT01383174|19124222|P1|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70
7767803|NCT01383174|19124221|P2|STARTED|3 Month Assessment||75
7767804|NCT01383174|19124222|P1|STARTED|3 Month Assessment||76
7767805|NCT01383174|19124221|P2|NOT COMPLETED|Baseline Assessment||0
7767806|NCT01383174|19124222|P1|NOT COMPLETED|Baseline Assessment||0
7767807|NCT01383174|19124221|P2|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75
7767808|NCT01383174|19124222|P1|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76
7767809|NCT01383174|19124221|P2|STARTED|Baseline Assessment||75
7767810|NCT01383174|19124222|P1|STARTED|Baseline Assessment||76
7767811|NCT01383161|19124248|P2|NOT COMPLETED|Overall Study||4
7767812|NCT01383161|19124249|P1|NOT COMPLETED|Overall Study||5
7767813|NCT01383161|19124248|P2|COMPLETED|Overall Study||17
7767814|NCT01383161|19124249|P1|COMPLETED|Overall Study||20
7767815|NCT01383161|19124248|P2|STARTED|Overall Study||21
7767816|NCT01383161|19124249|P1|STARTED|Overall Study||25
7767817|NCT01383096|19124268|P3|NOT COMPLETED|Fifth Intervention (8 Days)||0
7767818|NCT01383096|19124269|P2|NOT COMPLETED|Fifth Intervention (8 Days)||0
7767819|NCT01383096|19124270|P1|NOT COMPLETED|Fifth Intervention (8 Days)||2
7767820|NCT01383096|19124268|P3|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
7767821|NCT01383096|19124269|P2|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
7767822|NCT01383096|19124270|P1|COMPLETED|Fifth Intervention (8 Days)||11
7767823|NCT01383096|19124268|P3|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
7767824|NCT01383096|19124269|P2|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
7767825|NCT01383096|19124270|P1|STARTED|Fifth Intervention (8 Days)||13
7767826|NCT01383096|19124268|P3|NOT COMPLETED|Fourth Intervention (8 Days)||0
7767827|NCT01383096|19124269|P2|NOT COMPLETED|Fourth Intervention (8 Days)||0
7767828|NCT01383096|19124270|P1|NOT COMPLETED|Fourth Intervention (8 Days)||2
7767829|NCT01383096|19124268|P3|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
7767830|NCT01383096|19124269|P2|COMPLETED|Fourth Intervention (8 Days)||12
7767831|NCT01383096|19124270|P1|COMPLETED|Fourth Intervention (8 Days)||13
7767832|NCT01383096|19124268|P3|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
7767833|NCT01383096|19124269|P2|STARTED|Fourth Intervention (8 Days)||12
7767834|NCT01383096|19124270|P1|STARTED|Fourth Intervention (8 Days)||15
7767835|NCT01383096|19124268|P3|NOT COMPLETED|Third Intervention (8 Days)||0
7767836|NCT01383096|19124269|P2|NOT COMPLETED|Third Intervention (8 Days)||4
7767837|NCT01383096|19124270|P1|NOT COMPLETED|Third Intervention (8 Days)||4
7767838|NCT01383096|19124268|P3|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
7767839|NCT01383096|19124269|P2|COMPLETED|Third Intervention (8 Days)||12
7767840|NCT01383096|19124270|P1|COMPLETED|Third Intervention (8 Days)||15
7767841|NCT01383096|19124268|P3|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
7767842|NCT01383096|19124269|P2|STARTED|Third Intervention (8 Days)||16
7767843|NCT01383096|19124270|P1|STARTED|Third Intervention (8 Days)||19
7767844|NCT01383096|19124268|P3|NOT COMPLETED|Second Intervention (8 Days)||2
7767845|NCT01383096|19124269|P2|NOT COMPLETED|Second Intervention (8 Days)||1
7767846|NCT01383096|19124270|P1|NOT COMPLETED|Second Intervention (8 Days)||0
7767847|NCT01383096|19124268|P3|COMPLETED|Second Intervention (8 Days)||14
7767848|NCT01383096|19124269|P2|COMPLETED|Second Intervention (8 Days)||16
7767849|NCT01383096|19124270|P1|COMPLETED|Second Intervention (8 Days)||19
7767850|NCT01383096|19124268|P3|STARTED|Second Intervention (8 Days)||16
7767851|NCT01383096|19124269|P2|STARTED|Second Intervention (8 Days)||17
7767852|NCT01383096|19124270|P1|STARTED|Second Intervention (8 Days)||19
7767853|NCT01383096|19124268|P3|NOT COMPLETED|First Intervention (8 Days)||0
7767854|NCT01383096|19124269|P2|NOT COMPLETED|First Intervention (8 Days)||0
7767855|NCT01383096|19124270|P1|NOT COMPLETED|First Intervention (8 Days)||0
7767856|NCT01383096|19124268|P3|COMPLETED|First Intervention (8 Days)||16
7767857|NCT01383096|19124269|P2|COMPLETED|First Intervention (8 Days)||17
7767858|NCT01383096|19124270|P1|COMPLETED|First Intervention (8 Days)||19
7767859|NCT01383096|19124268|P3|STARTED|First Intervention (8 Days)||16
7767860|NCT01383096|19124269|P2|STARTED|First Intervention (8 Days)||17
7767861|NCT01383096|19124270|P1|STARTED|First Intervention (8 Days)||19
7767862|NCT01383018|19124316|P1|NOT COMPLETED|Overall Study||375
7767863|NCT01383018|19124316|P1|COMPLETED|Overall Study||1082
7767864|NCT01383018|19124316|P1|STARTED|Overall Study||1457
7767865|NCT01383005|19124358|P2|NOT COMPLETED|Overall Study||0
7767866|NCT01383005|19124359|P1|NOT COMPLETED|Overall Study||0
7767867|NCT01383005|19124358|P2|COMPLETED|Overall Study||60
7767868|NCT01383005|19124359|P1|COMPLETED|Overall Study||34
7767869|NCT01383005|19124358|P2|STARTED|Overall Study||60
7767870|NCT01383005|19124359|P1|STARTED|Overall Study||34
7767871|NCT01382940|19124378|P1|NOT COMPLETED|Overall Study||73
7767872|NCT01382940|19124378|P1|COMPLETED|Overall Study||278
7767873|NCT01382940|19124378|P1|Received Day 182 Infusion|Overall Study||278
7767874|NCT01382940|19124378|P1|Received Day 168 Infusion|Overall Study||290
7767875|NCT01382940|19124378|P1|Received Day 15 Infusions|Overall Study||341
7767876|NCT01382940|19124378|P1|Received Day 1 Infusion|Overall Study||351
7767877|NCT01382940|19124378|P1|STARTED|Overall Study||351
7767878|NCT01382901|19124390|P2|NOT COMPLETED|Overall Study||14
7767879|NCT01382901|19124391|P1|NOT COMPLETED|Overall Study||17
7767880|NCT01382901|19124390|P2|COMPLETED|Overall Study||7
7767881|NCT01382901|19124391|P1|COMPLETED|Overall Study||7
7767882|NCT01382901|19124390|P2|STARTED|Overall Study||21
7767883|NCT01382901|19124391|P1|STARTED|Overall Study||24
7767884|NCT01382719|19124401|P4|NOT COMPLETED|Overall Study||33
7767885|NCT01382719|19124402|P3|NOT COMPLETED|Overall Study||34
7767886|NCT01382719|19124403|P2|NOT COMPLETED|Overall Study||19
7767887|NCT01382719|19124404|P1|NOT COMPLETED|Overall Study||18
7767888|NCT01382719|19124401|P4|COMPLETED|Overall Study||66
7767889|NCT01382719|19124402|P3|COMPLETED|Overall Study||66
7767890|NCT01382719|19124403|P2|COMPLETED|Overall Study||81
7767891|NCT01382719|19124404|P1|COMPLETED|Overall Study||80
7767892|NCT01382719|19124401|P4|Subjects Not Dosed|Overall Study||1
7767893|NCT01382719|19124402|P3|Subjects Not Dosed|Overall Study||1
7767894|NCT01382719|19124403|P2|Subjects Not Dosed|Overall Study||0
7767895|NCT01382719|19124404|P1|Subjects Not Dosed|Overall Study||1
7767896|NCT01382719|19124401|P4|STARTED|Overall Study||99
7767897|NCT01382719|19124402|P3|STARTED|Overall Study||100
7767898|NCT01382719|19124403|P2|STARTED|Overall Study||100
7767899|NCT01382719|19124404|P1|STARTED|Overall Study||98
7767900|NCT01382602|19124440|P2|NOT COMPLETED|Overall Study||4
7767901|NCT01382602|19124441|P1|NOT COMPLETED|Overall Study||0
7767902|NCT01382602|19124440|P2|COMPLETED|Overall Study||46
7767903|NCT01382602|19124441|P1|COMPLETED|Overall Study||93
7767904|NCT01382602|19124440|P2|STARTED|Overall Study||50
7767905|NCT01382602|19124441|P1|STARTED|Overall Study||93
7767906|NCT01382446|19124449|P2|NOT COMPLETED|Overall Study||4
7767907|NCT01382446|19124450|P1|NOT COMPLETED|Overall Study||3
7767908|NCT01382446|19124449|P2|COMPLETED|Overall Study||29
7767909|NCT01382446|19124450|P1|COMPLETED|Overall Study||30
7767910|NCT01382446|19124449|P2|STARTED|Overall Study||33
7767911|NCT01382446|19124450|P1|STARTED|Overall Study||33
7767912|NCT01382303|19124458|P2|NOT COMPLETED|Overall Study||17
7767913|NCT01382303|19124459|P1|NOT COMPLETED|Overall Study||35
7767914|NCT01382303|19124458|P2|COMPLETED|Overall Study||70
7767915|NCT01382303|19124459|P1|COMPLETED|Overall Study||52
7767916|NCT01382303|19124458|P2|STARTED|Overall Study||87
7767917|NCT01382303|19124459|P1|STARTED|Overall Study||87
7767918|NCT01382251|19124477|P2|NOT COMPLETED|Overall Study||21
7767919|NCT01382251|19124478|P1|NOT COMPLETED|Overall Study||21
7767920|NCT01382251|19124477|P2|COMPLETED|Overall Study||102
7767921|NCT01382251|19124478|P1|COMPLETED|Overall Study||102
7767922|NCT01382251|19124477|P2|STARTED|Overall Study||123
7767923|NCT01382251|19124478|P1|STARTED|Overall Study||123
7767924|NCT01382225|19124491|P2|NOT COMPLETED|Overall Study||7
7767925|NCT01382225|19124492|P1|NOT COMPLETED|Overall Study||14
7767926|NCT01382225|19124491|P2|COMPLETED|Overall Study||722
7767927|NCT01382225|19124492|P1|COMPLETED|Overall Study||711
7767928|NCT01382225|19124491|P2|STARTED|Overall Study||729
7767929|NCT01382225|19124492|P1|STARTED|Overall Study||725
7767930|NCT01382212|19124514|P1|NOT COMPLETED|Overall Study||2
7767931|NCT01382212|19124514|P1|COMPLETED|Overall Study||11
7767932|NCT01382212|19124514|P1|STARTED|Overall Study||13
7767933|NCT01382186|19124540|P2|NOT COMPLETED|Overall Study||0
7767934|NCT01382186|19124541|P1|NOT COMPLETED|Overall Study||1
7767935|NCT01382186|19124540|P2|COMPLETED|Overall Study||819
7767936|NCT01382186|19124541|P1|COMPLETED|Overall Study||32
7767937|NCT01382186|19124540|P2|STARTED|Overall Study||819
7767938|NCT01382186|19124541|P1|STARTED|Overall Study||33
7767939|NCT01382108|19124557|P2|NOT COMPLETED|Overall Study||0
7767940|NCT01382108|19124558|P1|NOT COMPLETED|Overall Study||0
7767941|NCT01382108|19124557|P2|COMPLETED|Overall Study||19
7767942|NCT01382108|19124558|P1|COMPLETED|Overall Study||20
7767943|NCT01382108|19124557|P2|STARTED|Overall Study||19
7767944|NCT01382108|19124558|P1|STARTED|Overall Study||20
7767945|NCT01381952|19124568|P1|NOT COMPLETED|Overall Study||0
7767946|NCT01381952|19124568|P1|COMPLETED|Overall Study||20
7767947|NCT01381952|19124568|P1|Collected Dose and Image Information|Overall Study||20
7767948|NCT01381952|19124568|P1|STARTED|Overall Study||20
7767949|NCT01381926|19124577|P2|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
7767950|NCT01381926|19124578|P1|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
7767951|NCT01381926|19124577|P2|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4
7767952|NCT01381926|19124578|P1|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3
7767953|NCT01381926|19124577|P2|STARTED|Low/High Dose of 2nd Treatment (2months)||4
7767954|NCT01381926|19124578|P1|STARTED|Low/High Dose of 2nd Treatment (2months)||3
7767955|NCT01381926|19124577|P2|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1
7767956|NCT01381926|19124578|P1|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2
7767957|NCT01381926|19124577|P2|COMPLETED|Low/High Dose of 1st Treatment (2months)||4
7767958|NCT01381926|19124578|P1|COMPLETED|Low/High Dose of 1st Treatment (2months)||3
7767959|NCT01381926|19124577|P2|STARTED|Low/High Dose of 1st Treatment (2months)||5
7767960|NCT01381926|19124578|P1|STARTED|Low/High Dose of 1st Treatment (2months)||5
7767961|NCT01381900|19124591|P3|NOT COMPLETED|Overall Study||12
7767962|NCT01381900|19124592|P2|NOT COMPLETED|Overall Study||9
7767963|NCT01381900|19124593|P1|NOT COMPLETED|Overall Study||9
7767964|NCT01381900|19124591|P3|COMPLETED|Overall Study||215
7767965|NCT01381900|19124592|P2|COMPLETED|Overall Study||214
7767966|NCT01381900|19124593|P1|COMPLETED|Overall Study||217
7767967|NCT01381900|19124591|P3|STARTED|Overall Study||227
7767968|NCT01381900|19124592|P2|STARTED|Overall Study||223
7767969|NCT01381900|19124593|P1|STARTED|Overall Study||226
7767970|NCT01381874|19124616|P3|NOT COMPLETED|Overall Study||76
7767971|NCT01381874|19124617|P2|NOT COMPLETED|Overall Study||63
7767972|NCT01381874|19124618|P1|NOT COMPLETED|Overall Study||77
7767973|NCT01381874|19124616|P3|COMPLETED|Overall Study||30
7767974|NCT01381874|19124617|P2|COMPLETED|Overall Study||26
7767975|NCT01381874|19124618|P1|COMPLETED|Overall Study||25
7767976|NCT01381874|19124616|P3|Treated|Overall Study||104
7767977|NCT01381874|19124617|P2|Treated|Overall Study||87
7767978|NCT01381874|19124618|P1|Treated|Overall Study||102
7767979|NCT01381874|19124616|P3|STARTED|Overall Study||106
7767980|NCT01381874|19124617|P2|STARTED|Overall Study||89
7767981|NCT01381874|19124618|P1|STARTED|Overall Study||102
7767982|NCT01381861|19124644|P1|NOT COMPLETED|Overall Study||0
7767983|NCT01381861|19124644|P1|COMPLETED|Overall Study||23
7767984|NCT01381861|19124644|P1|STARTED|Overall Study||23
7767985|NCT01381679|19124655|P1|NOT COMPLETED|Overall Study||888
7767986|NCT01381679|19124655|P1|COMPLETED|Overall Study||794
7767987|NCT01381679|19124655|P1|STARTED|Overall Study||1682
7767988|NCT01381575|19124670|P3|NOT COMPLETED|Overall Study||20
7767989|NCT01381575|19124671|P2|NOT COMPLETED|Overall Study||39
7767990|NCT01381575|19124672|P1|NOT COMPLETED|Overall Study||26
7767991|NCT01381575|19124670|P3|COMPLETED|Overall Study||395
7767992|NCT01381575|19124671|P2|COMPLETED|Overall Study||443
7767993|NCT01381575|19124672|P1|COMPLETED|Overall Study||524
7767994|NCT01381575|19124670|P3|STARTED|Overall Study||415
7767995|NCT01381575|19124671|P2|STARTED|Overall Study||482
7767996|NCT01381575|19124672|P1|STARTED|Overall Study||550
7767997|NCT01381562|19124729|P3|NOT COMPLETED|Overall Study||0
7767998|NCT01381562|19124730|P2|NOT COMPLETED|Overall Study||1
7767999|NCT01381562|19124731|P1|NOT COMPLETED|Overall Study||0
7768000|NCT01381562|19124729|P3|COMPLETED|Overall Study||5
7768001|NCT01381562|19124730|P2|COMPLETED|Overall Study||3
7768002|NCT01381562|19124731|P1|COMPLETED|Overall Study||5
7768003|NCT01381562|19124729|P3|STARTED|Overall Study||5
7768004|NCT01381562|19124730|P2|STARTED|Overall Study||4
7768005|NCT01381562|19124731|P1|STARTED|Overall Study||5
7768006|NCT01381549|19124799|P3|NOT COMPLETED|Overall Study||1
7768007|NCT01381549|19124800|P2|NOT COMPLETED|Overall Study||0
7768008|NCT01381549|19124801|P1|NOT COMPLETED|Overall Study||0
7768009|NCT01381549|19124799|P3|COMPLETED|Overall Study||5
7768010|NCT01381549|19124800|P2|COMPLETED|Overall Study||8
7768011|NCT01381549|19124801|P1|COMPLETED|Overall Study||6
7768012|NCT01381549|19124799|P3|STARTED|Overall Study||6
7768013|NCT01381549|19124800|P2|STARTED|Overall Study||8
7768014|NCT01381549|19124801|P1|STARTED|Overall Study||6
7768015|NCT01381471|19124896|P1|NOT COMPLETED|Overall Study||0
7768016|NCT01381471|19124896|P1|COMPLETED|Overall Study||11060
7768017|NCT01381471|19124896|P1|STARTED|Overall Study||11060
7768018|NCT01381406|19124903|P2|NOT COMPLETED|Overall Study||0
7768019|NCT01381406|19124904|P1|NOT COMPLETED|Overall Study||0
7768020|NCT01381406|19124903|P2|COMPLETED|Overall Study||852
7768021|NCT01381406|19124904|P1|COMPLETED|Overall Study||2481
7768022|NCT01381406|19124903|P2|STARTED|Overall Study||852
7768023|NCT01381406|19124904|P1|STARTED|Overall Study||2481
7768024|NCT01381120|19124916|P2|NOT COMPLETED|Overall Study||9
7768025|NCT01381120|19124917|P1|NOT COMPLETED|Overall Study||11
7768026|NCT01381120|19124916|P2|COMPLETED|Overall Study||18
7768027|NCT01381120|19124917|P1|COMPLETED|Overall Study||39
7768028|NCT01381120|19124916|P2|STARTED|Overall Study||27
7768029|NCT01381120|19124917|P1|STARTED|Overall Study||50
7768030|NCT01381068|19124927|P2|NOT COMPLETED|Overall Study||0
7768031|NCT01381068|19124928|P1|NOT COMPLETED|Overall Study||1
7768032|NCT01381068|19124927|P2|COMPLETED|Overall Study||24
7768033|NCT01381068|19124928|P1|COMPLETED|Overall Study||24
7768034|NCT01381068|19124927|P2|STARTED|Overall Study||24
7768035|NCT01381068|19124928|P1|STARTED|Overall Study||25
7768036|NCT01381016|19124948|P2|NOT COMPLETED|Overall Study||6
7768037|NCT01381016|19124949|P1|NOT COMPLETED|Overall Study||3
7768038|NCT01381016|19124948|P2|COMPLETED|Overall Study||11
7768039|NCT01381016|19124949|P1|COMPLETED|Overall Study||10
7768040|NCT01381016|19124948|P2|STARTED|Overall Study||17
7768041|NCT01381016|19124949|P1|STARTED|Overall Study||13
7768042|NCT01380834|19124959|P2|NOT COMPLETED|Overall Study||0
7768043|NCT01380834|19124960|P1|NOT COMPLETED|Overall Study||1
7768044|NCT01380834|19124959|P2|COMPLETED|Overall Study||42
7768045|NCT01380834|19124960|P1|COMPLETED|Overall Study||41
7768046|NCT01380834|19124959|P2|STARTED|Overall Study||42
7768047|NCT01380834|19124960|P1|STARTED|Overall Study||42
7768048|NCT01380782|19124972|P4|NOT COMPLETED|Overall Study||4
7768049|NCT01380782|19124973|P3|NOT COMPLETED|Overall Study||11
7768050|NCT01380782|19124974|P2|NOT COMPLETED|Overall Study||10
7768051|NCT01380782|19124975|P1|NOT COMPLETED|Overall Study||12
7768052|NCT01380782|19124972|P4|COMPLETED|Overall Study||0
7768053|NCT01380782|19124973|P3|COMPLETED|Overall Study||0
7768054|NCT01380782|19124974|P2|COMPLETED|Overall Study||0
7768055|NCT01380782|19124975|P1|COMPLETED|Overall Study||0
7768056|NCT01380782|19124972|P4|STARTED|Overall Study||4
7768057|NCT01380782|19124973|P3|STARTED|Overall Study||11
7768058|NCT01380782|19124974|P2|STARTED|Overall Study||10
7768059|NCT01380782|19124975|P1|STARTED|Overall Study||12
7768060|NCT01380769|19124998|P2|NOT COMPLETED|Overall Study||14
7768061|NCT01380769|19124999|P1|NOT COMPLETED|Overall Study||9
7768062|NCT01380769|19124998|P2|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|43
7768063|NCT01380769|19124999|P1|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|91
7768064|NCT01380769|19124998|P2|STARTED|Overall Study||57
7768065|NCT01380769|19124999|P1|STARTED|Overall Study||100
7768066|NCT01380743|19125011|P4|NOT COMPLETED|Overall Study||0
7768067|NCT01380743|19125012|P3|NOT COMPLETED|Overall Study||0
7768068|NCT01380743|19125013|P2|NOT COMPLETED|Overall Study||0
7768069|NCT01380743|19125014|P1|NOT COMPLETED|Overall Study||0
7768070|NCT01380743|19125011|P4|COMPLETED|Overall Study||7
7768071|NCT01380743|19125012|P3|COMPLETED|Overall Study||6
7768072|NCT01380743|19125013|P2|COMPLETED|Overall Study||6
7768073|NCT01380743|19125014|P1|COMPLETED|Overall Study||6
7768074|NCT01380743|19125011|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
7768075|NCT01380743|19125012|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
7768076|NCT01380743|19125013|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
7768077|NCT01380743|19125014|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
7768078|NCT01380743|19125011|P4|STARTED|Overall Study||7
7768079|NCT01380743|19125012|P3|STARTED|Overall Study||6
7768080|NCT01380743|19125013|P2|STARTED|Overall Study||6
7768081|NCT01380743|19125014|P1|STARTED|Overall Study||6
7768082|NCT01380730|19125060|P8|NOT COMPLETED|Overall Study||0
7768083|NCT01380730|19125061|P7|NOT COMPLETED|Overall Study||0
7768084|NCT01380730|19125062|P6|NOT COMPLETED|Overall Study||0
7768085|NCT01380730|19125063|P5|NOT COMPLETED|Overall Study||1
7768086|NCT01380730|19125064|P4|NOT COMPLETED|Overall Study||0
7768087|NCT01380730|19125065|P3|NOT COMPLETED|Overall Study||0
7768088|NCT01380730|19125066|P2|NOT COMPLETED|Overall Study||0
7768089|NCT01380730|19125067|P1|NOT COMPLETED|Overall Study||0
7768090|NCT01380730|19125060|P8|COMPLETED|Overall Study||80
7768091|NCT01380730|19125061|P7|COMPLETED|Overall Study||79
7768092|NCT01380730|19125062|P6|COMPLETED|Overall Study||79
7768093|NCT01380730|19125063|P5|COMPLETED|Overall Study||77
7768094|NCT01380730|19125064|P4|COMPLETED|Overall Study||79
7768095|NCT01380730|19125065|P3|COMPLETED|Overall Study||79
7768096|NCT01380730|19125066|P2|COMPLETED|Overall Study||79
7768097|NCT01380730|19125067|P1|COMPLETED|Overall Study||78
7768098|NCT01380730|19125060|P8|Received Treatment|Overall Study||80
7768099|NCT01380730|19125061|P7|Received Treatment|Overall Study||79
7768100|NCT01380730|19125062|P6|Received Treatment|Overall Study||79
7768101|NCT01380730|19125063|P5|Received Treatment|Overall Study||78
7768102|NCT01380730|19125064|P4|Received Treatment|Overall Study||79
7768103|NCT01380730|19125065|P3|Received Treatment|Overall Study||79
7768104|NCT01380730|19125066|P2|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77
7768105|NCT01380730|19125067|P1|Received Treatment|Overall Study||78
7768106|NCT01380730|19125060|P8|STARTED|Overall Study||80
7768107|NCT01380730|19125061|P7|STARTED|Overall Study||79
7768108|NCT01380730|19125062|P6|STARTED|Overall Study||79
7768109|NCT01380730|19125063|P5|STARTED|Overall Study||78
7768110|NCT01380730|19125064|P4|STARTED|Overall Study||79
7768111|NCT01380730|19125065|P3|STARTED|Overall Study||79
7768112|NCT01380730|19125066|P2|STARTED|Overall Study||79
7768113|NCT01380730|19125067|P1|STARTED|Overall Study||78
7768114|NCT01380691|19125125|P4|NOT COMPLETED|Period 2||0
7768115|NCT01380691|19125126|P3|NOT COMPLETED|Period 2||0
7768116|NCT01380691|19125127|P2|NOT COMPLETED|Period 2||0
7768117|NCT01380691|19125128|P1|NOT COMPLETED|Period 2||0
7768118|NCT01380691|19125125|P4|COMPLETED|Period 2||6
7768119|NCT01380691|19125126|P3|COMPLETED|Period 2||6
7768120|NCT01380691|19125127|P2|COMPLETED|Period 2||7
7768121|NCT01380691|19125128|P1|COMPLETED|Period 2||7
7768122|NCT01380691|19125125|P4|STARTED|Period 2||6
7768123|NCT01380691|19125126|P3|STARTED|Period 2||6
7768124|NCT01380691|19125127|P2|STARTED|Period 2||7
7768125|NCT01380691|19125128|P1|STARTED|Period 2||7
7768126|NCT01380691|19125125|P4|NOT COMPLETED|Washout (7 Days)||1
7768127|NCT01380691|19125126|P3|NOT COMPLETED|Washout (7 Days)||1
7768128|NCT01380691|19125127|P2|NOT COMPLETED|Washout (7 Days)||0
7768129|NCT01380691|19125128|P1|NOT COMPLETED|Washout (7 Days)||0
7768130|NCT01380691|19125125|P4|COMPLETED|Washout (7 Days)||6
7768131|NCT01380691|19125126|P3|COMPLETED|Washout (7 Days)||6
7768132|NCT01380691|19125127|P2|COMPLETED|Washout (7 Days)||7
7768133|NCT01380691|19125128|P1|COMPLETED|Washout (7 Days)||7
7768134|NCT01380691|19125125|P4|STARTED|Washout (7 Days)||7
7768135|NCT01380691|19125126|P3|STARTED|Washout (7 Days)||7
7768136|NCT01380691|19125127|P2|STARTED|Washout (7 Days)||7
7768137|NCT01380691|19125128|P1|STARTED|Washout (7 Days)||7
7768138|NCT01380691|19125125|P4|NOT COMPLETED|Period 1||0
7768139|NCT01380691|19125126|P3|NOT COMPLETED|Period 1||0
7768140|NCT01380691|19125127|P2|NOT COMPLETED|Period 1||0
7768141|NCT01380691|19125128|P1|NOT COMPLETED|Period 1||0
7768142|NCT01380691|19125125|P4|COMPLETED|Period 1||7
7768143|NCT01380691|19125126|P3|COMPLETED|Period 1||7
7768144|NCT01380691|19125127|P2|COMPLETED|Period 1||7
7768145|NCT01380691|19125128|P1|COMPLETED|Period 1||7
7768146|NCT01380691|19125125|P4|STARTED|Period 1||7
7768147|NCT01380691|19125126|P3|STARTED|Period 1||7
7768148|NCT01380691|19125127|P2|STARTED|Period 1||7
7768149|NCT01380691|19125128|P1|STARTED|Period 1||7
7768150|NCT01380639|19125180|P2|NOT COMPLETED|Overall Study||4
7768151|NCT01380639|19125181|P1|NOT COMPLETED|Overall Study||6
7768152|NCT01380639|19125180|P2|COMPLETED|Overall Study||36
7768153|NCT01380639|19125181|P1|COMPLETED|Overall Study||36
7768154|NCT01380639|19125180|P2|STARTED|Overall Study||40
7768155|NCT01380639|19125181|P1|STARTED|Overall Study||42
7768156|NCT01380535|19125189|P2|NOT COMPLETED|Overall Study||15
7768157|NCT01380535|19125190|P1|NOT COMPLETED|Overall Study||7
7768158|NCT01380535|19125189|P2|COMPLETED|Overall Study||16
7768159|NCT01380535|19125190|P1|COMPLETED|Overall Study||22
7768160|NCT01380535|19125189|P2|Intent-to-treat Population|Overall Study||24
7768161|NCT01380535|19125190|P1|Intent-to-treat Population|Overall Study||29
7768162|NCT01380535|19125189|P2|Safety Population|Overall Study||28
7768163|NCT01380535|19125190|P1|Safety Population|Overall Study||28
7768164|NCT01380535|19125189|P2|Baseline Population|Overall Study||31
7768165|NCT01380535|19125190|P1|Baseline Population|Overall Study||29
7768166|NCT01380535|19125189|P2|STARTED|Overall Study||31
7768167|NCT01380535|19125190|P1|STARTED|Overall Study||29
7768168|NCT01380379|19125196|P1|NOT COMPLETED|Overall Study||1
7768169|NCT01380379|19125196|P1|COMPLETED|Overall Study||8
7768170|NCT01380379|19125196|P1|STARTED|Overall Study||9
7768171|NCT01380366|19125201|P1|NOT COMPLETED|Overall Study||0
7768172|NCT01380366|19125201|P1|COMPLETED|Overall Study||15
7768173|NCT01380366|19125201|P1|STARTED|Overall Study||15
7768174|NCT01380327|19125209|P3|NOT COMPLETED|Overall Study||7
7768175|NCT01380327|19125210|P2|NOT COMPLETED|Overall Study||3
7768176|NCT01380327|19125211|P1|NOT COMPLETED|Overall Study||3
7768177|NCT01380327|19125209|P3|COMPLETED|Overall Study||21
7768178|NCT01380327|19125210|P2|COMPLETED|Overall Study||28
7768179|NCT01380327|19125211|P1|COMPLETED|Overall Study||27
7768180|NCT01380327|19125209|P3|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28
7768181|NCT01380327|19125210|P2|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31
7768182|NCT01380327|19125211|P1|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30
7768183|NCT01380197|19125233|P2|NOT COMPLETED|Overall Study||0
7768184|NCT01380197|19125234|P1|NOT COMPLETED|Overall Study||0
7768185|NCT01380197|19125233|P2|COMPLETED|Overall Study||20
7768186|NCT01380197|19125234|P1|COMPLETED|Overall Study||20
7768187|NCT01380197|19125233|P2|STARTED|Overall Study||20
7768188|NCT01380197|19125234|P1|STARTED|Overall Study||20
7768189|NCT01380184|19125242|P1|NOT COMPLETED|Part 2||14
7768190|NCT01380184|19125242|P1|COMPLETED|Part 2||0
7768191|NCT01380184|19125242|P1|STARTED|Part 2||14
7768192|NCT01380184|19125242|P1|NOT COMPLETED|Washout Period (≥2 Days)||0
7768193|NCT01380184|19125242|P1|COMPLETED|Washout Period (≥2 Days)||14
7768194|NCT01380184|19125242|P1|STARTED|Washout Period (≥2 Days)||14
7768195|NCT01380184|19125242|P1|NOT COMPLETED|Part 1 (19 Days)||1
7768196|NCT01380184|19125242|P1|COMPLETED|Part 1 (19 Days)||14
7768197|NCT01380184|19125242|P1|STARTED|Part 1 (19 Days)||15
7768198|NCT01380145|19125253|P1|NOT COMPLETED|Overall Study||4
7768199|NCT01380145|19125253|P1|COMPLETED|Overall Study||9
7768200|NCT01380145|19125253|P1|STARTED|Overall Study||13
7768201|NCT01380093|19125261|P9|NOT COMPLETED|Treatment Phase: Third Intervention||2
7768202|NCT01380093|19125262|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
7768203|NCT01380093|19125263|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
7768204|NCT01380093|19125264|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
7768205|NCT01380093|19125265|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
7768206|NCT01380093|19125266|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
7768207|NCT01380093|19125267|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
7768208|NCT01380093|19125268|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
7768209|NCT01380093|19125269|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
7768210|NCT01380093|19125261|P9|COMPLETED|Treatment Phase: Third Intervention||4
7768211|NCT01380093|19125262|P8|COMPLETED|Treatment Phase: Third Intervention||6
7768212|NCT01380093|19125263|P7|COMPLETED|Treatment Phase: Third Intervention||6
7768213|NCT01380093|19125264|P6|COMPLETED|Treatment Phase: Third Intervention||6
7768214|NCT01380093|19125265|P5|COMPLETED|Treatment Phase: Third Intervention||6
7768215|NCT01380093|19125266|P4|COMPLETED|Treatment Phase: Third Intervention||5
7768216|NCT01380093|19125267|P3|COMPLETED|Treatment Phase: Third Intervention||0
7768217|NCT01380093|19125268|P2|COMPLETED|Treatment Phase: Third Intervention||0
7768218|NCT01380093|19125269|P1|COMPLETED|Treatment Phase: Third Intervention||0
7768219|NCT01380093|19125261|P9|STARTED|Treatment Phase: Third Intervention||6
7768220|NCT01380093|19125262|P8|STARTED|Treatment Phase: Third Intervention||6
7768221|NCT01380093|19125263|P7|STARTED|Treatment Phase: Third Intervention||6
7768222|NCT01380093|19125264|P6|STARTED|Treatment Phase: Third Intervention||6
7768223|NCT01380093|19125265|P5|STARTED|Treatment Phase: Third Intervention||6
7768224|NCT01380093|19125266|P4|STARTED|Treatment Phase: Third Intervention||5
7768225|NCT01380093|19125267|P3|STARTED|Treatment Phase: Third Intervention||0
7768226|NCT01380093|19125268|P2|STARTED|Treatment Phase: Third Intervention||0
7768227|NCT01380093|19125269|P1|STARTED|Treatment Phase: Third Intervention||0
7768228|NCT01380093|19125261|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
7768229|NCT01380093|19125262|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
7768230|NCT01380093|19125263|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
7768231|NCT01380093|19125264|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
7768232|NCT01380093|19125265|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
7768233|NCT01380093|19125266|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
7768234|NCT01380093|19125267|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
7768235|NCT01380093|19125268|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
7768236|NCT01380093|19125269|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
7768237|NCT01380093|19125261|P9|COMPLETED|Treatment Phase: Washout Period||6
7768238|NCT01380093|19125262|P8|COMPLETED|Treatment Phase: Washout Period||6
7768239|NCT01380093|19125263|P7|COMPLETED|Treatment Phase: Washout Period||6
7768240|NCT01380093|19125264|P6|COMPLETED|Treatment Phase: Washout Period||6
7768241|NCT01380093|19125265|P5|COMPLETED|Treatment Phase: Washout Period||6
7768242|NCT01380093|19125266|P4|COMPLETED|Treatment Phase: Washout Period||5
7768243|NCT01380093|19125267|P3|COMPLETED|Treatment Phase: Washout Period||0
7768244|NCT01380093|19125268|P2|COMPLETED|Treatment Phase: Washout Period||0
7768245|NCT01380093|19125269|P1|COMPLETED|Treatment Phase: Washout Period||0
7768246|NCT01380093|19125261|P9|STARTED|Treatment Phase: Washout Period||6
7768247|NCT01380093|19125262|P8|STARTED|Treatment Phase: Washout Period||6
7768248|NCT01380093|19125263|P7|STARTED|Treatment Phase: Washout Period||6
7768249|NCT01380093|19125264|P6|STARTED|Treatment Phase: Washout Period||6
7768250|NCT01380093|19125265|P5|STARTED|Treatment Phase: Washout Period||6
7768251|NCT01380093|19125266|P4|STARTED|Treatment Phase: Washout Period||5
7768252|NCT01380093|19125267|P3|STARTED|Treatment Phase: Washout Period||0
7768253|NCT01380093|19125268|P2|STARTED|Treatment Phase: Washout Period||0
7768254|NCT01380093|19125269|P1|STARTED|Treatment Phase: Washout Period||0
7768255|NCT01380093|19125261|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
7768256|NCT01380093|19125262|P8|NOT COMPLETED|Treatment Phase: Second Intervention||0
7768257|NCT01380093|19125263|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
7768258|NCT01380093|19125264|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
7768259|NCT01380093|19125265|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
7768260|NCT01380093|19125266|P4|NOT COMPLETED|Treatment Phase: Second Intervention||1
7768261|NCT01380093|19125267|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
7768262|NCT01380093|19125268|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
7768263|NCT01380093|19125269|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
7768264|NCT01380093|19125261|P9|COMPLETED|Treatment Phase: Second Intervention||6
7768265|NCT01380093|19125262|P8|COMPLETED|Treatment Phase: Second Intervention||6
7768266|NCT01380093|19125263|P7|COMPLETED|Treatment Phase: Second Intervention||6
7768267|NCT01380093|19125264|P6|COMPLETED|Treatment Phase: Second Intervention||6
7768268|NCT01380093|19125265|P5|COMPLETED|Treatment Phase: Second Intervention||6
7768269|NCT01380093|19125266|P4|COMPLETED|Treatment Phase: Second Intervention||5
7768270|NCT01380093|19125267|P3|COMPLETED|Treatment Phase: Second Intervention||0
7768271|NCT01380093|19125268|P2|COMPLETED|Treatment Phase: Second Intervention||0
7768272|NCT01380093|19125269|P1|COMPLETED|Treatment Phase: Second Intervention||0
7768273|NCT01380093|19125261|P9|STARTED|Treatment Phase: Second Intervention||6
7768274|NCT01380093|19125262|P8|STARTED|Treatment Phase: Second Intervention||6
7768275|NCT01380093|19125263|P7|STARTED|Treatment Phase: Second Intervention||6
7768276|NCT01380093|19125264|P6|STARTED|Treatment Phase: Second Intervention||6
7768277|NCT01380093|19125265|P5|STARTED|Treatment Phase: Second Intervention||6
7768278|NCT01380093|19125266|P4|STARTED|Treatment Phase: Second Intervention||6
7768279|NCT01380093|19125267|P3|STARTED|Treatment Phase: Second Intervention||0
7768280|NCT01380093|19125268|P2|STARTED|Treatment Phase: Second Intervention||0
7768281|NCT01380093|19125269|P1|STARTED|Treatment Phase: Second Intervention||0
7768282|NCT01380093|19125261|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
7768283|NCT01380093|19125262|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
7768284|NCT01380093|19125263|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
7768285|NCT01380093|19125264|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
7768286|NCT01380093|19125265|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
7768287|NCT01380093|19125266|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
7768288|NCT01380093|19125267|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
7768289|NCT01380093|19125268|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
7768290|NCT01380093|19125269|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
7768291|NCT01380093|19125261|P9|COMPLETED|Treatment Phase: Washout Period||6
7768292|NCT01380093|19125262|P8|COMPLETED|Treatment Phase: Washout Period||6
7768293|NCT01380093|19125263|P7|COMPLETED|Treatment Phase: Washout Period||6
7768294|NCT01380093|19125264|P6|COMPLETED|Treatment Phase: Washout Period||6
7768295|NCT01380093|19125265|P5|COMPLETED|Treatment Phase: Washout Period||6
7768296|NCT01380093|19125266|P4|COMPLETED|Treatment Phase: Washout Period||6
7768297|NCT01380093|19125267|P3|COMPLETED|Treatment Phase: Washout Period||0
7768298|NCT01380093|19125268|P2|COMPLETED|Treatment Phase: Washout Period||0
7768299|NCT01380093|19125269|P1|COMPLETED|Treatment Phase: Washout Period||0
7768300|NCT01380093|19125261|P9|STARTED|Treatment Phase: Washout Period||6
7768301|NCT01380093|19125262|P8|STARTED|Treatment Phase: Washout Period||6
7768302|NCT01380093|19125263|P7|STARTED|Treatment Phase: Washout Period||6
7768303|NCT01380093|19125264|P6|STARTED|Treatment Phase: Washout Period||6
7768304|NCT01380093|19125265|P5|STARTED|Treatment Phase: Washout Period||6
7768305|NCT01380093|19125266|P4|STARTED|Treatment Phase: Washout Period||6
7768306|NCT01380093|19125267|P3|STARTED|Treatment Phase: Washout Period||0
7768307|NCT01380093|19125268|P2|STARTED|Treatment Phase: Washout Period||0
7768308|NCT01380093|19125269|P1|STARTED|Treatment Phase: Washout Period||0
7768309|NCT01380093|19125261|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
7768310|NCT01380093|19125262|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
7768311|NCT01380093|19125263|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
7768312|NCT01380093|19125264|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
7768313|NCT01380093|19125265|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
7768314|NCT01380093|19125266|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
7768315|NCT01380093|19125267|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
7768316|NCT01380093|19125268|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
7768317|NCT01380093|19125269|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
7768318|NCT01380093|19125261|P9|COMPLETED|Treatment Phase: First Intervention||6
7768319|NCT01380093|19125262|P8|COMPLETED|Treatment Phase: First Intervention||6
7768320|NCT01380093|19125263|P7|COMPLETED|Treatment Phase: First Intervention||6
7768321|NCT01380093|19125264|P6|COMPLETED|Treatment Phase: First Intervention||6
7768322|NCT01380093|19125265|P5|COMPLETED|Treatment Phase: First Intervention||6
7768323|NCT01380093|19125266|P4|COMPLETED|Treatment Phase: First Intervention||6
7768324|NCT01380093|19125267|P3|COMPLETED|Treatment Phase: First Intervention||0
7768325|NCT01380093|19125268|P2|COMPLETED|Treatment Phase: First Intervention||0
7768326|NCT01380093|19125269|P1|COMPLETED|Treatment Phase: First Intervention||0
7768327|NCT01380093|19125261|P9|STARTED|Treatment Phase: First Intervention||6
7768328|NCT01380093|19125262|P8|STARTED|Treatment Phase: First Intervention||6
7768329|NCT01380093|19125263|P7|STARTED|Treatment Phase: First Intervention||6
7768330|NCT01380093|19125264|P6|STARTED|Treatment Phase: First Intervention||6
7768331|NCT01380093|19125265|P5|STARTED|Treatment Phase: First Intervention||6
7768332|NCT01380093|19125266|P4|STARTED|Treatment Phase: First Intervention||6
7768333|NCT01380093|19125267|P3|STARTED|Treatment Phase: First Intervention||0
7768334|NCT01380093|19125268|P2|STARTED|Treatment Phase: First Intervention||0
7768335|NCT01380093|19125269|P1|STARTED|Treatment Phase: First Intervention||0
7768336|NCT01380093|19125261|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
7768337|NCT01380093|19125262|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
7768338|NCT01380093|19125263|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
7768339|NCT01380093|19125264|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
7768340|NCT01380093|19125265|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
7768341|NCT01380093|19125266|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
7768342|NCT01380093|19125267|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||13
7768343|NCT01380093|19125268|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||9
7768344|NCT01380093|19125269|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
7768345|NCT01380093|19125261|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
7768346|NCT01380093|19125262|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
7768347|NCT01380093|19125263|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
7768348|NCT01380093|19125264|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
7768349|NCT01380093|19125265|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
7768350|NCT01380093|19125266|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
7768351|NCT01380093|19125267|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
7768352|NCT01380093|19125268|P2|COMPLETED|Drug Discrimination Phase: Day 2||20
7768353|NCT01380093|19125269|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
7768354|NCT01380093|19125261|P9|STARTED|Drug Discrimination Phase: Day 2||0
7768355|NCT01380093|19125262|P8|STARTED|Drug Discrimination Phase: Day 2||0
7768356|NCT01380093|19125263|P7|STARTED|Drug Discrimination Phase: Day 2||0
7768357|NCT01380093|19125264|P6|STARTED|Drug Discrimination Phase: Day 2||0
7768358|NCT01380093|19125265|P5|STARTED|Drug Discrimination Phase: Day 2||0
7768359|NCT01380093|19125266|P4|STARTED|Drug Discrimination Phase: Day 2||0
7768360|NCT01380093|19125267|P3|STARTED|Drug Discrimination Phase: Day 2||29
7768361|NCT01380093|19125268|P2|STARTED|Drug Discrimination Phase: Day 2||29
7768362|NCT01380093|19125269|P1|STARTED|Drug Discrimination Phase: Day 2||0
7768363|NCT01380093|19125261|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7768364|NCT01380093|19125262|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7768365|NCT01380093|19125263|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7768366|NCT01380093|19125264|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7768367|NCT01380093|19125265|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7768368|NCT01380093|19125266|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7768369|NCT01380093|19125267|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7768370|NCT01380093|19125268|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||1
7768371|NCT01380093|19125269|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
7768372|NCT01380093|19125261|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
7768373|NCT01380093|19125262|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
7768374|NCT01380093|19125263|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
7768375|NCT01380093|19125264|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
7768376|NCT01380093|19125265|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
7768377|NCT01380093|19125266|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
7768378|NCT01380093|19125267|P3|COMPLETED|Drug Discrimination Phase: Day 1||29
7768379|NCT01380093|19125268|P2|COMPLETED|Drug Discrimination Phase: Day 1||29
7768380|NCT01380093|19125269|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
7768381|NCT01380093|19125261|P9|STARTED|Drug Discrimination Phase: Day 1||0
7768382|NCT01380093|19125262|P8|STARTED|Drug Discrimination Phase: Day 1||0
7768383|NCT01380093|19125263|P7|STARTED|Drug Discrimination Phase: Day 1||0
7768384|NCT01380093|19125264|P6|STARTED|Drug Discrimination Phase: Day 1||0
7768385|NCT01380093|19125265|P5|STARTED|Drug Discrimination Phase: Day 1||0
7768386|NCT01380093|19125266|P4|STARTED|Drug Discrimination Phase: Day 1||0
7768387|NCT01380093|19125267|P3|STARTED|Drug Discrimination Phase: Day 1||29
7768388|NCT01380093|19125268|P2|STARTED|Drug Discrimination Phase: Day 1||30
7768389|NCT01380093|19125269|P1|STARTED|Drug Discrimination Phase: Day 1||0
7768390|NCT01380093|19125261|P9|NOT COMPLETED|Naloxone Challenge Phase||0
7768391|NCT01380093|19125262|P8|NOT COMPLETED|Naloxone Challenge Phase||0
7768392|NCT01380093|19125263|P7|NOT COMPLETED|Naloxone Challenge Phase||0
7768393|NCT01380093|19125264|P6|NOT COMPLETED|Naloxone Challenge Phase||0
7768394|NCT01380093|19125265|P5|NOT COMPLETED|Naloxone Challenge Phase||0
7768395|NCT01380093|19125266|P4|NOT COMPLETED|Naloxone Challenge Phase||0
7768396|NCT01380093|19125267|P3|NOT COMPLETED|Naloxone Challenge Phase||0
7768397|NCT01380093|19125268|P2|NOT COMPLETED|Naloxone Challenge Phase||0
7768398|NCT01380093|19125269|P1|NOT COMPLETED|Naloxone Challenge Phase||21
7768399|NCT01380093|19125261|P9|COMPLETED|Naloxone Challenge Phase||0
7768400|NCT01380093|19125262|P8|COMPLETED|Naloxone Challenge Phase||0
7768401|NCT01380093|19125263|P7|COMPLETED|Naloxone Challenge Phase||0
7768402|NCT01380093|19125264|P6|COMPLETED|Naloxone Challenge Phase||0
7768403|NCT01380093|19125265|P5|COMPLETED|Naloxone Challenge Phase||0
7768404|NCT01380093|19125266|P4|COMPLETED|Naloxone Challenge Phase||0
7768405|NCT01380093|19125267|P3|COMPLETED|Naloxone Challenge Phase||0
7768406|NCT01380093|19125268|P2|COMPLETED|Naloxone Challenge Phase||0
7768407|NCT01380093|19125269|P1|COMPLETED|Naloxone Challenge Phase||59
7768408|NCT01380093|19125261|P9|TREATED|Naloxone Challenge Phase||0
7768409|NCT01380093|19125262|P8|TREATED|Naloxone Challenge Phase||0
7768410|NCT01380093|19125263|P7|TREATED|Naloxone Challenge Phase||0
7768411|NCT01380093|19125264|P6|TREATED|Naloxone Challenge Phase||0
7768412|NCT01380093|19125265|P5|TREATED|Naloxone Challenge Phase||0
7768413|NCT01380093|19125266|P4|TREATED|Naloxone Challenge Phase||0
7768414|NCT01380093|19125267|P3|TREATED|Naloxone Challenge Phase||0
7768415|NCT01380093|19125268|P2|TREATED|Naloxone Challenge Phase||0
7768416|NCT01380093|19125269|P1|TREATED|Naloxone Challenge Phase||59
7768417|NCT01380093|19125261|P9|STARTED|Naloxone Challenge Phase||0
7768418|NCT01380093|19125262|P8|STARTED|Naloxone Challenge Phase||0
7768419|NCT01380093|19125263|P7|STARTED|Naloxone Challenge Phase||0
7768420|NCT01380093|19125264|P6|STARTED|Naloxone Challenge Phase||0
7768421|NCT01380093|19125265|P5|STARTED|Naloxone Challenge Phase||0
7768422|NCT01380093|19125266|P4|STARTED|Naloxone Challenge Phase||0
7768423|NCT01380093|19125267|P3|STARTED|Naloxone Challenge Phase||0
7768424|NCT01380093|19125268|P2|STARTED|Naloxone Challenge Phase||0
7768425|NCT01380093|19125269|P1|STARTED|Naloxone Challenge Phase||80
7768426|NCT01380080|19125561|P2|NOT COMPLETED|Overall Study||23
7768427|NCT01380080|19125562|P1|NOT COMPLETED|Overall Study||33
7768428|NCT01380080|19125561|P2|COMPLETED|Overall Study||403
7768429|NCT01380080|19125562|P1|COMPLETED|Overall Study||391
7768430|NCT01380080|19125561|P2|STARTED|Overall Study||426
7768431|NCT01380080|19125562|P1|STARTED|Overall Study||424
7768432|NCT01379963|19125578|P1|NOT COMPLETED|Overall Study||0
7768433|NCT01379963|19125578|P1|COMPLETED|Overall Study||780
7768434|NCT01379963|19125578|P1|STARTED|Overall Study||780
7768435|NCT01379937|19125587|P4|NOT COMPLETED|Overall Study||1
7768436|NCT01379937|19125588|P3|NOT COMPLETED|Overall Study||2
7768437|NCT01379937|19125589|P2|NOT COMPLETED|Overall Study||3
7768438|NCT01379937|19125590|P1|NOT COMPLETED|Overall Study||1
7768439|NCT01379937|19125587|P4|COMPLETED|Overall Study||103
7768440|NCT01379937|19125588|P3|COMPLETED|Overall Study||102
7768441|NCT01379937|19125589|P2|COMPLETED|Overall Study||153
7768442|NCT01379937|19125590|P1|COMPLETED|Overall Study||155
7768443|NCT01379937|19125587|P4|STARTED|Overall Study||104
7768444|NCT01379937|19125588|P3|STARTED|Overall Study||104
7768445|NCT01379937|19125589|P2|STARTED|Overall Study||156
7768446|NCT01379937|19125590|P1|STARTED|Overall Study||156
7768447|NCT01379924|19125672|P2|NOT COMPLETED|36-month Assessment||4
7768448|NCT01379924|19125673|P1|NOT COMPLETED|36-month Assessment||3
7768449|NCT01379924|19125672|P2|COMPLETED|36-month Assessment||48
7768450|NCT01379924|19125673|P1|COMPLETED|36-month Assessment||52
7768451|NCT01379924|19125672|P2|STARTED|36-month Assessment||52
7768452|NCT01379924|19125673|P1|STARTED|36-month Assessment||55
7768453|NCT01379924|19125672|P2|NOT COMPLETED|24-month Assessment||3
7768454|NCT01379924|19125673|P1|NOT COMPLETED|24-month Assessment||7
7768455|NCT01379924|19125672|P2|COMPLETED|24-month Assessment||52
7768456|NCT01379924|19125673|P1|COMPLETED|24-month Assessment||55
7768457|NCT01379924|19125672|P2|STARTED|24-month Assessment||55
7768458|NCT01379924|19125673|P1|STARTED|24-month Assessment||62
7768459|NCT01379924|19125672|P2|NOT COMPLETED|12-month Assessment||13
7768460|NCT01379924|19125673|P1|NOT COMPLETED|12-month Assessment||10
7768461|NCT01379924|19125672|P2|COMPLETED|12-month Assessment||55
7768462|NCT01379924|19125673|P1|COMPLETED|12-month Assessment||62
7768463|NCT01379924|19125672|P2|STARTED|12-month Assessment||68
7768464|NCT01379924|19125673|P1|STARTED|12-month Assessment||72
7768465|NCT01379924|19125672|P2|NOT COMPLETED|Baseline||0
7768466|NCT01379924|19125673|P1|NOT COMPLETED|Baseline||0
7768467|NCT01379924|19125672|P2|COMPLETED|Baseline||68
7768468|NCT01379924|19125673|P1|COMPLETED|Baseline||72
7768469|NCT01379924|19125672|P2|STARTED|Baseline||68
7768470|NCT01379924|19125673|P1|STARTED|Baseline||72
7768471|NCT01379781|19125710|P2|NOT COMPLETED|Overall Study||8
7768472|NCT01379781|19125711|P1|NOT COMPLETED|Overall Study||11
7768473|NCT01379781|19125710|P2|COMPLETED|Overall Study||19
7768474|NCT01379781|19125711|P1|COMPLETED|Overall Study||16
7768475|NCT01379781|19125710|P2|STARTED|Overall Study||27
7768476|NCT01379781|19125711|P1|STARTED|Overall Study||27
7768477|NCT01379768|19125720|P3|NOT COMPLETED|Overall Study||0
7768478|NCT01379768|19125721|P2|NOT COMPLETED|Overall Study||1
7768479|NCT01379768|19125722|P1|NOT COMPLETED|Overall Study||3
7768480|NCT01379768|19125720|P3|COMPLETED|Overall Study||20
7768481|NCT01379768|19125721|P2|COMPLETED|Overall Study||21
7768482|NCT01379768|19125722|P1|COMPLETED|Overall Study||20
7768483|NCT01379768|19125720|P3|STARTED|Overall Study||20
7768484|NCT01379768|19125721|P2|STARTED|Overall Study||22
7768485|NCT01379768|19125722|P1|STARTED|Overall Study||23
7768486|NCT01379703|19125745|P3|NOT COMPLETED|9 Months Through 18 Months||0
7768487|NCT01379703|19125746|P2|NOT COMPLETED|9 Months Through 18 Months||230
7768488|NCT01379703|19125747|P1|NOT COMPLETED|9 Months Through 18 Months||0
7768489|NCT01379703|19125745|P3|COMPLETED|9 Months Through 18 Months||0
7768490|NCT01379703|19125746|P2|COMPLETED|9 Months Through 18 Months||854
7768491|NCT01379703|19125747|P1|COMPLETED|9 Months Through 18 Months||0
7768492|NCT01379703|19125745|P3|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
7768493|NCT01379703|19125746|P2|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
7768494|NCT01379703|19125747|P1|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
7768495|NCT01379703|19125745|P3|NOT COMPLETED|Study Start Through 9 Months||143
7768496|NCT01379703|19125746|P2|NOT COMPLETED|Study Start Through 9 Months||122
7768497|NCT01379703|19125747|P1|NOT COMPLETED|Study Start Through 9 Months||4
7768498|NCT01379703|19125745|P3|COMPLETED|Study Start Through 9 Months||873
7768499|NCT01379703|19125746|P2|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
7768500|NCT01379703|19125747|P1|COMPLETED|Study Start Through 9 Months||62
7768501|NCT01379703|19125745|P3|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016
7768502|NCT01379703|19125746|P2|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206
7768503|NCT01379703|19125747|P1|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66
7768504|NCT01379664|19125810|P2|NOT COMPLETED|Overall Study||0
7768505|NCT01379664|19125811|P1|NOT COMPLETED|Overall Study||0
7768506|NCT01379664|19125810|P2|COMPLETED|Overall Study||870
7768507|NCT01379664|19125811|P1|COMPLETED|Overall Study||714
7768508|NCT01379664|19125810|P2|STARTED|Overall Study||870
7768509|NCT01379664|19125811|P1|STARTED|Overall Study||714
7768510|NCT01379651|19125823|P2|NOT COMPLETED|Overall Study||0
7768511|NCT01379651|19125824|P1|NOT COMPLETED|Overall Study||0
7768512|NCT01379651|19125823|P2|COMPLETED|Overall Study||10
7768513|NCT01379651|19125824|P1|COMPLETED|Overall Study||10
7768514|NCT01379651|19125823|P2|STARTED|Overall Study||10
7768515|NCT01379651|19125824|P1|STARTED|Overall Study||10
7768516|NCT01379625|19125834|P2|NOT COMPLETED|Overall Study||0
7768517|NCT01379625|19125835|P1|NOT COMPLETED|Overall Study||0
7768518|NCT01379625|19125834|P2|COMPLETED|Overall Study||16
7768519|NCT01379625|19125835|P1|COMPLETED|Overall Study||16
7768520|NCT01379625|19125834|P2|STARTED|Overall Study||16
7768521|NCT01379625|19125835|P1|STARTED|Overall Study||16
7768522|NCT01379573|19125845|P1|NOT COMPLETED|Overall Study||11
7768523|NCT01379573|19125845|P1|COMPLETED|Overall Study||63
7768524|NCT01379573|19125845|P1|STARTED|Overall Study||74
7768525|NCT01379534|19125859|P2|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2
7768526|NCT01379534|19125860|P1|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4
7768527|NCT01379534|19125859|P2|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
7768528|NCT01379534|19125860|P1|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
7768529|NCT01379534|19125859|P2|STARTED|Tumor Assessment Follow-up (f/u) Phase||2
7768530|NCT01379534|19125860|P1|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4
7768531|NCT01379534|19125859|P2|NOT COMPLETED|Treatment Phase||31
7768532|NCT01379534|19125860|P1|NOT COMPLETED|Treatment Phase||22
7768533|NCT01379534|19125859|P2|COMPLETED|Treatment Phase||0
7768534|NCT01379534|19125860|P1|COMPLETED|Treatment Phase||0
7768535|NCT01379534|19125859|P2|STARTED|Treatment Phase||31
7768536|NCT01379534|19125860|P1|STARTED|Treatment Phase||22
7768537|NCT01379521|19125880|P2|NOT COMPLETED|Post-Treatment Evaluations||21
7768538|NCT01379521|19125881|P1|NOT COMPLETED|Post-Treatment Evaluations||25
7768539|NCT01379521|19125880|P2|COMPLETED|Post-Treatment Evaluations||0
7768540|NCT01379521|19125881|P1|COMPLETED|Post-Treatment Evaluations||0
7768541|NCT01379521|19125880|P2|STARTED|Post-Treatment Evaluations||21
7768542|NCT01379521|19125881|P1|STARTED|Post-Treatment Evaluations||25
7768543|NCT01379521|19125880|P2|NOT COMPLETED|Overall Study -Treatment Period||26
7768544|NCT01379521|19125881|P1|NOT COMPLETED|Overall Study -Treatment Period||33
7768545|NCT01379521|19125880|P2|COMPLETED|Overall Study -Treatment Period||0
7768546|NCT01379521|19125881|P1|COMPLETED|Overall Study -Treatment Period||0
7768547|NCT01379521|19125880|P2|STARTED|Overall Study -Treatment Period||26
7768548|NCT01379521|19125881|P1|STARTED|Overall Study -Treatment Period||33
7768549|NCT01379508|19125903|P4|NOT COMPLETED|Extension Period Weeks 109-156||0
7768550|NCT01379508|19125904|P3|NOT COMPLETED|Extension Period Weeks 109-156||14
7768551|NCT01379508|19125905|P2|NOT COMPLETED|Extension Period Weeks 109-156||3
7768552|NCT01379508|19125906|P1|NOT COMPLETED|Extension Period Weeks 109-156||19
7768553|NCT01379508|19125903|P4|COMPLETED|Extension Period Weeks 109-156||10
7768554|NCT01379508|19125904|P3|COMPLETED|Extension Period Weeks 109-156||65
7768555|NCT01379508|19125905|P2|COMPLETED|Extension Period Weeks 109-156||14
7768556|NCT01379508|19125906|P1|COMPLETED|Extension Period Weeks 109-156||45
7768557|NCT01379508|19125903|P4|STARTED|Extension Period Weeks 109-156||10
7768558|NCT01379508|19125904|P3|STARTED|Extension Period Weeks 109-156||79
7768559|NCT01379508|19125905|P2|STARTED|Extension Period Weeks 109-156||17
7768560|NCT01379508|19125906|P1|STARTED|Extension Period Weeks 109-156||64
7768561|NCT01379508|19125903|P4|NOT COMPLETED|Treatment to Week 104||0
7768562|NCT01379508|19125904|P3|NOT COMPLETED|Treatment to Week 104||13
7768563|NCT01379508|19125905|P2|NOT COMPLETED|Treatment to Week 104||3
7768564|NCT01379508|19125906|P1|NOT COMPLETED|Treatment to Week 104||19
7768565|NCT01379508|19125903|P4|COMPLETED|Treatment to Week 104||11
7768566|NCT01379508|19125904|P3|COMPLETED|Treatment to Week 104||96
7768567|NCT01379508|19125905|P2|COMPLETED|Treatment to Week 104||19
7768568|NCT01379508|19125906|P1|COMPLETED|Treatment to Week 104||80
7768569|NCT01379508|19125903|P4|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||11
7768570|NCT01379508|19125904|P3|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||105
7768571|NCT01379508|19125905|P2|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||21
7768572|NCT01379508|19125906|P1|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||91
7768573|NCT01379508|19125903|P4|Completed Wk 24|Treatment to Week 104||11
7768574|NCT01379508|19125904|P3|Completed Wk 24|Treatment to Week 104||107
7768575|NCT01379508|19125905|P2|Completed Wk 24|Treatment to Week 104||22
7768576|NCT01379508|19125906|P1|Completed Wk 24|Treatment to Week 104||93
7768577|NCT01379508|19125903|P4|STARTED|Treatment to Week 104||11
7768578|NCT01379508|19125904|P3|STARTED|Treatment to Week 104||109
7768579|NCT01379508|19125905|P2|STARTED|Treatment to Week 104||22
7768580|NCT01379508|19125906|P1|STARTED|Treatment to Week 104||99
7768581|NCT01379274|19125932|P1|NOT COMPLETED|Overall Study||1
7768582|NCT01379274|19125932|P1|COMPLETED|Overall Study||1
7768583|NCT01379274|19125932|P1|STARTED|Overall Study||2
7768584|NCT01379222|19125936|P1|NOT COMPLETED|Overall Study||73
7768585|NCT01379222|19125936|P1|COMPLETED|Overall Study||105
7768586|NCT01379222|19125936|P1|STARTED|Overall Study||178
7768587|NCT01379183|19125942|P2|NOT COMPLETED|Overall Study||0
7768588|NCT01379183|19125943|P1|NOT COMPLETED|Overall Study||0
7768589|NCT01379183|19125942|P2|COMPLETED|Overall Study||21
7768590|NCT01379183|19125943|P1|COMPLETED|Overall Study||19
7768591|NCT01379183|19125942|P2|STARTED|Overall Study||21
7768592|NCT01379183|19125943|P1|STARTED|Overall Study||19
7768593|NCT01378988|19125961|P2|NOT COMPLETED|Overall Study||0
7768594|NCT01378988|19125962|P1|NOT COMPLETED|Overall Study||0
7768595|NCT01378988|19125961|P2|COMPLETED|Overall Study||3
7768596|NCT01378988|19125962|P1|COMPLETED|Overall Study||2
7768597|NCT01378988|19125961|P2|STARTED|Overall Study||3
7768598|NCT01378988|19125962|P1|STARTED|Overall Study||2
7768599|NCT01378975|19125992|P2|NOT COMPLETED|Overall Study||50
7768600|NCT01378975|19125993|P1|NOT COMPLETED|Overall Study||86
7768601|NCT01378975|19125992|P2|COMPLETED|Overall Study||6
7768602|NCT01378975|19125993|P1|COMPLETED|Overall Study||4
7768603|NCT01378975|19125992|P2|STARTED|Overall Study||56
7768604|NCT01378975|19125993|P1|STARTED|Overall Study||90
7768605|NCT01378962|19126019|P1|NOT COMPLETED|Overall Study||17
7768606|NCT01378962|19126019|P1|COMPLETED|Overall Study||33
7768607|NCT01378962|19126019|P1|STARTED|Overall Study||50
7768608|NCT01378520|19126032|P2|NOT COMPLETED|Second Intervention (Day 4-6)||0
7768609|NCT01378520|19126033|P1|NOT COMPLETED|Second Intervention (Day 4-6)||0
7768610|NCT01378520|19126032|P2|COMPLETED|Second Intervention (Day 4-6)||10
7768611|NCT01378520|19126033|P1|COMPLETED|Second Intervention (Day 4-6)||10
7768612|NCT01378520|19126032|P2|STARTED|Second Intervention (Day 4-6)||10
7768613|NCT01378520|19126033|P1|STARTED|Second Intervention (Day 4-6)||10
7768614|NCT01378520|19126032|P2|NOT COMPLETED|First Intervention (Day 2-3)||0
7768615|NCT01378520|19126033|P1|NOT COMPLETED|First Intervention (Day 2-3)||0
7768616|NCT01378520|19126032|P2|COMPLETED|First Intervention (Day 2-3)||10
7768617|NCT01378520|19126033|P1|COMPLETED|First Intervention (Day 2-3)||10
7768618|NCT01378520|19126032|P2|STARTED|First Intervention (Day 2-3)||10
7768619|NCT01378520|19126033|P1|STARTED|First Intervention (Day 2-3)||10
7768620|NCT01378429|19126045|P2|NOT COMPLETED|Overall Study||0
7768621|NCT01378429|19126046|P1|NOT COMPLETED|Overall Study||1
7768622|NCT01378429|19126045|P2|COMPLETED|Overall Study||47
7768623|NCT01378429|19126046|P1|COMPLETED|Overall Study||41
7768624|NCT01378429|19126045|P2|STARTED|Overall Study||47
7768625|NCT01378429|19126046|P1|STARTED|Overall Study||42
7768626|NCT01378416|19126078|P1|NOT COMPLETED|Overall Study||0
7768627|NCT01378416|19126078|P1|COMPLETED|Overall Study||16
7768628|NCT01378416|19126078|P1|STARTED|Overall Study||16
7768629|NCT01378377|19126089|P3|NOT COMPLETED|Overall Study||0
7768630|NCT01378377|19126090|P2|NOT COMPLETED|Overall Study||0
7768631|NCT01378377|19126091|P1|NOT COMPLETED|Overall Study||0
7768632|NCT01378377|19126089|P3|COMPLETED|Overall Study||6
7768633|NCT01378377|19126090|P2|COMPLETED|Overall Study||23
7768634|NCT01378377|19126091|P1|COMPLETED|Overall Study||4
7768635|NCT01378377|19126089|P3|STARTED|Overall Study||6
7768636|NCT01378377|19126090|P2|STARTED|Overall Study||23
7768637|NCT01378377|19126091|P1|STARTED|Overall Study||4
7768638|NCT01378325|19126159|P2|NOT COMPLETED|Overall Study||1
7768639|NCT01378325|19126160|P1|NOT COMPLETED|Overall Study||0
7768640|NCT01378325|19126159|P2|COMPLETED|Overall Study||39
7768641|NCT01378325|19126160|P1|COMPLETED|Overall Study||40
7768642|NCT01378325|19126159|P2|STARTED|Overall Study||40
7768643|NCT01378325|19126160|P1|STARTED|Overall Study||40
7768644|NCT01378299|19126166|P1|NOT COMPLETED|Overall Study||31
7768645|NCT01378299|19126166|P1|COMPLETED|Overall Study||74
7768646|NCT01378299|19126166|P1|BMI Group 3|Overall Study||27
7768647|NCT01378299|19126166|P1|BMI Group 2|Overall Study||40
7768648|NCT01378299|19126166|P1|BMI group1|Overall Study||38
7768649|NCT01378299|19126166|P1|STARTED|Overall Study||105
7768650|NCT01378273|19126205|P2|NOT COMPLETED|Overall Study||1
7768651|NCT01378273|19126206|P1|NOT COMPLETED|Overall Study||4
7768652|NCT01378273|19126205|P2|COMPLETED|Overall Study||476
7768653|NCT01378273|19126206|P1|COMPLETED|Overall Study||460
7768654|NCT01378273|19126205|P2|STARTED|Overall Study||477
7768655|NCT01378273|19126206|P1|STARTED|Overall Study||464
7768656|NCT01378221|19126220|P2|NOT COMPLETED|Overall Study||9
7768657|NCT01378221|19126221|P1|NOT COMPLETED|Overall Study||7
7768658|NCT01378221|19126220|P2|COMPLETED|Overall Study||30
7768659|NCT01378221|19126221|P1|COMPLETED|Overall Study||29
7768660|NCT01378221|19126220|P2|STARTED|Overall Study||39
7768661|NCT01378221|19126221|P1|STARTED|Overall Study||36
7768662|NCT01378195|19126229|P2|NOT COMPLETED|Overall Study||18
7768663|NCT01378195|19126230|P1|NOT COMPLETED|Overall Study||29
7768664|NCT01378195|19126229|P2|COMPLETED|Overall Study||57
7768665|NCT01378195|19126230|P1|COMPLETED|Overall Study||46
7768666|NCT01378195|19126229|P2|STARTED|Overall Study||75
7768667|NCT01378195|19126230|P1|STARTED|Overall Study||75
7768668|NCT01378117|19126243|P3|NOT COMPLETED|Overall Study||3
7768669|NCT01378117|19126244|P2|NOT COMPLETED|Overall Study||1
7768670|NCT01378117|19126245|P1|NOT COMPLETED|Overall Study||4
7768671|NCT01378117|19126243|P3|COMPLETED|Overall Study||26
7768672|NCT01378117|19126244|P2|COMPLETED|Overall Study||29
7768673|NCT01378117|19126245|P1|COMPLETED|Overall Study||27
7768674|NCT01378117|19126243|P3|STARTED|Overall Study||29
7768675|NCT01378117|19126244|P2|STARTED|Overall Study||30
7768676|NCT01378117|19126245|P1|STARTED|Overall Study||31
7768677|NCT01378104|19126279|P2|NOT COMPLETED|Overall Study||26
7768678|NCT01378104|19126280|P1|NOT COMPLETED|Overall Study||27
7768679|NCT01378104|19126279|P2|COMPLETED|Overall Study||60
7768680|NCT01378104|19126280|P1|COMPLETED|Overall Study||65
7768681|NCT01378104|19126279|P2|STARTED|Overall Study||86
7768682|NCT01378104|19126280|P1|STARTED|Overall Study||92
7768683|NCT01378065|19126288|P1|NOT COMPLETED|Overall Study||0
7768684|NCT01378065|19126288|P1|COMPLETED|Overall Study||30
7768685|NCT01378065|19126288|P1|12 Months|Overall Study||30
7768686|NCT01378065|19126288|P1|6 Months|Overall Study||30
7768687|NCT01378065|19126288|P1|3 Months|Overall Study||30
7768688|NCT01378065|19126288|P1|6 Week|Overall Study||30
7768689|NCT01378065|19126288|P1|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30
7768690|NCT01377987|19126325|P2|NOT COMPLETED|Second Intervention (7 Days)||0
7768691|NCT01377987|19126326|P1|NOT COMPLETED|Second Intervention (7 Days)||0
7768692|NCT01377987|19126325|P2|COMPLETED|Second Intervention (7 Days)||14
7768693|NCT01377987|19126326|P1|COMPLETED|Second Intervention (7 Days)||13
7768694|NCT01377987|19126325|P2|STARTED|Second Intervention (7 Days)||14
7768695|NCT01377987|19126326|P1|STARTED|Second Intervention (7 Days)||13
7768696|NCT01377987|19126325|P2|NOT COMPLETED|Washout (7 Days)||1
7768697|NCT01377987|19126326|P1|NOT COMPLETED|Washout (7 Days)||1
7768698|NCT01377987|19126325|P2|COMPLETED|Washout (7 Days)||14
7768699|NCT01377987|19126326|P1|COMPLETED|Washout (7 Days)||13
7768700|NCT01377987|19126325|P2|STARTED|Washout (7 Days)||15
7768701|NCT01377987|19126326|P1|STARTED|Washout (7 Days)||14
7768702|NCT01377987|19126325|P2|NOT COMPLETED|First Intervention (7 Days)||0
7768703|NCT01377987|19126326|P1|NOT COMPLETED|First Intervention (7 Days)||0
7768704|NCT01377987|19126325|P2|COMPLETED|First Intervention (7 Days)||15
7768705|NCT01377987|19126326|P1|COMPLETED|First Intervention (7 Days)||14
7768706|NCT01377987|19126325|P2|STARTED|First Intervention (7 Days)||15
7768707|NCT01377987|19126326|P1|STARTED|First Intervention (7 Days)||14
7768708|NCT01377922|19126344|P2|NOT COMPLETED|Overall Study||0
7768709|NCT01377922|19126345|P1|NOT COMPLETED|Overall Study||1
7768710|NCT01377922|19126344|P2|COMPLETED|Overall Study||16
7768711|NCT01377922|19126345|P1|COMPLETED|Overall Study||21
7768712|NCT01377922|19126344|P2|STARTED|Overall Study||16
7768713|NCT01377922|19126345|P1|STARTED|Overall Study||22
7768714|NCT01377636|19126357|P1|NOT COMPLETED|Overall Study||0
7768715|NCT01377636|19126357|P1|COMPLETED|Overall Study||20
7768716|NCT01377636|19126357|P1|STARTED|Overall Study||20
7768717|NCT01377623|19126371|P2|NOT COMPLETED|Overall Study||5
7768718|NCT01377623|19126372|P1|NOT COMPLETED|Overall Study||7
7768719|NCT01377623|19126371|P2|COMPLETED|Overall Study||28
7768720|NCT01377623|19126372|P1|COMPLETED|Overall Study||26
7768721|NCT01377623|19126371|P2|STARTED|Overall Study||33
7768722|NCT01377623|19126372|P1|STARTED|Overall Study||33
7768723|NCT01377584|19126392|P6|NOT COMPLETED|Overall Study||3
7768724|NCT01377584|19126393|P5|NOT COMPLETED|Overall Study||3
7768725|NCT01377584|19126394|P4|NOT COMPLETED|Overall Study||4
7768726|NCT01377584|19126395|P3|NOT COMPLETED|Overall Study||4
7768727|NCT01377584|19126396|P2|NOT COMPLETED|Overall Study||3
7768728|NCT01377584|19126397|P1|NOT COMPLETED|Overall Study||3
7768729|NCT01377584|19126392|P6|COMPLETED|Overall Study||9
7768730|NCT01377584|19126393|P5|COMPLETED|Overall Study||9
7768731|NCT01377584|19126394|P4|COMPLETED|Overall Study||6
7768732|NCT01377584|19126395|P3|COMPLETED|Overall Study||6
7768733|NCT01377584|19126396|P2|COMPLETED|Overall Study||5
7768734|NCT01377584|19126397|P1|COMPLETED|Overall Study||5
7768735|NCT01377584|19126392|P6|STARTED|Overall Study||12
7768736|NCT01377584|19126393|P5|STARTED|Overall Study||12
7768737|NCT01377584|19126394|P4|STARTED|Overall Study||10
7768738|NCT01377584|19126395|P3|STARTED|Overall Study||10
7768739|NCT01377584|19126396|P2|STARTED|Overall Study||8
7768740|NCT01377584|19126397|P1|STARTED|Overall Study||8
7768741|NCT01377480|19126430|P4|NOT COMPLETED|Overall Study||11
7768742|NCT01377480|19126431|P3|NOT COMPLETED|Overall Study||10
7768743|NCT01377480|19126432|P2|NOT COMPLETED|Overall Study||1
7768744|NCT01377480|19126433|P1|NOT COMPLETED|Overall Study||0
7768745|NCT01377480|19126430|P4|COMPLETED|Overall Study||19
7768746|NCT01377480|19126431|P3|COMPLETED|Overall Study||18
7768747|NCT01377480|19126432|P2|COMPLETED|Overall Study||29
7768748|NCT01377480|19126433|P1|COMPLETED|Overall Study||32
7768749|NCT01377480|19126430|P4|STARTED|Overall Study||30
7768750|NCT01377480|19126431|P3|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28
7768751|NCT01377480|19126432|P2|STARTED|Overall Study||30
7768752|NCT01377480|19126433|P1|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32
7768753|NCT01377467|19126445|P2|NOT COMPLETED|Overall Study||0
7768754|NCT01377467|19126446|P1|NOT COMPLETED|Overall Study||0
7768755|NCT01377467|19126445|P2|COMPLETED|Overall Study||44
7768756|NCT01377467|19126446|P1|COMPLETED|Overall Study||46
7768757|NCT01377467|19126445|P2|STARTED|Overall Study||44
7768758|NCT01377467|19126446|P1|STARTED|Overall Study||46
7768759|NCT01377441|19126494|P2|NOT COMPLETED|Overall Study||0
7768760|NCT01377441|19126495|P1|NOT COMPLETED|Overall Study||0
7768761|NCT01377441|19126494|P2|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
7768762|NCT01377441|19126495|P1|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
7768763|NCT01377441|19126494|P2|STARTED|Overall Study||0
7768764|NCT01377441|19126495|P1|STARTED|Overall Study||0
7768765|NCT01377402|19126503|P1|NOT COMPLETED|Overall Study||0
7768766|NCT01377402|19126503|P1|COMPLETED|Overall Study||982
7768767|NCT01377402|19126503|P1|STARTED|Overall Study||982
7768768|NCT01377389|19126509|P1|NOT COMPLETED|Overall Study||3
7768769|NCT01377389|19126509|P1|COMPLETED|Overall Study||27
7768770|NCT01377389|19126509|P1|STARTED|Overall Study||30
7768771|NCT01377233|19126523|P5|NOT COMPLETED|Double-blind||2
7768772|NCT01377233|19126524|P4|NOT COMPLETED|Double-blind||4
7768773|NCT01377233|19126525|P3|NOT COMPLETED|Double-blind||2
7768774|NCT01377233|19126526|P2|NOT COMPLETED|Double-blind||1
7768775|NCT01377233|19126527|P1|NOT COMPLETED|Double-blind||0
7768776|NCT01377233|19126523|P5|COMPLETED|Double-blind||8
7768777|NCT01377233|19126524|P4|COMPLETED|Double-blind||7
7768778|NCT01377233|19126525|P3|COMPLETED|Double-blind||8
7768779|NCT01377233|19126526|P2|COMPLETED|Double-blind||10
7768780|NCT01377233|19126527|P1|COMPLETED|Double-blind||0
7768781|NCT01377233|19126523|P5|STARTED|Double-blind||10
7768782|NCT01377233|19126524|P4|STARTED|Double-blind||11
7768783|NCT01377233|19126525|P3|STARTED|Double-blind||10
7768784|NCT01377233|19126526|P2|STARTED|Double-blind||11
7768785|NCT01377233|19126527|P1|STARTED|Double-blind||0
7768786|NCT01377233|19126523|P5|NOT COMPLETED|Open-label||0
7768787|NCT01377233|19126524|P4|NOT COMPLETED|Open-label||0
7768788|NCT01377233|19126525|P3|NOT COMPLETED|Open-label||0
7768789|NCT01377233|19126526|P2|NOT COMPLETED|Open-label||0
7768790|NCT01377233|19126527|P1|NOT COMPLETED|Open-label||4
7768791|NCT01377233|19126523|P5|COMPLETED|Open-label||0
7768792|NCT01377233|19126524|P4|COMPLETED|Open-label||0
7768793|NCT01377233|19126525|P3|COMPLETED|Open-label||0
7768794|NCT01377233|19126526|P2|COMPLETED|Open-label||0
7768795|NCT01377233|19126527|P1|COMPLETED|Open-label||42
7768796|NCT01377233|19126523|P5|STARTED|Open-label||0
7768797|NCT01377233|19126524|P4|STARTED|Open-label||0
7768798|NCT01377233|19126525|P3|STARTED|Open-label||0
7768799|NCT01377233|19126526|P2|STARTED|Open-label||0
7768800|NCT01377233|19126527|P1|STARTED|Open-label||46
7768801|NCT01377194|19126554|P3|NOT COMPLETED|Overall Study||46
7768802|NCT01377194|19126555|P2|NOT COMPLETED|Overall Study||43
7768803|NCT01377194|19126556|P1|NOT COMPLETED|Overall Study||32
7768804|NCT01377194|19126554|P3|COMPLETED|Overall Study||142
7768805|NCT01377194|19126555|P2|COMPLETED|Overall Study||145
7768806|NCT01377194|19126556|P1|COMPLETED|Overall Study||154
7768807|NCT01377194|19126554|P3|STARTED|Overall Study||188
7768808|NCT01377194|19126555|P2|STARTED|Overall Study||188
7768809|NCT01377194|19126556|P1|STARTED|Overall Study||186
7768810|NCT01377012|19126570|P3|NOT COMPLETED|Extension Study, Weeks 104-260||68
7768811|NCT01377012|19126571|P2|NOT COMPLETED|Extension Study, Weeks 104-260||71
7768812|NCT01377012|19126572|P1|NOT COMPLETED|Extension Study, Weeks 104-260||57
7768813|NCT01377012|19126570|P3|COMPLETED|Extension Study, Weeks 104-260||0
7768814|NCT01377012|19126571|P2|COMPLETED|Extension Study, Weeks 104-260||0
7768815|NCT01377012|19126572|P1|COMPLETED|Extension Study, Weeks 104-260||0
7768816|NCT01377012|19126570|P3|STARTED|Extension Study, Weeks 104-260||68
7768817|NCT01377012|19126571|P2|STARTED|Extension Study, Weeks 104-260||71
7768818|NCT01377012|19126572|P1|STARTED|Extension Study, Weeks 104-260||57
7768819|NCT01377012|19126570|P3|NOT COMPLETED|Core Study||134
7768820|NCT01377012|19126571|P2|NOT COMPLETED|Core Study||132
7768821|NCT01377012|19126572|P1|NOT COMPLETED|Core Study||134
7768822|NCT01377012|19126570|P3|COMPLETED|Core Study||80
7768823|NCT01377012|19126571|P2|COMPLETED|Core Study||81
7768824|NCT01377012|19126572|P1|COMPLETED|Core Study||76
7768825|NCT01377012|19126570|P3|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34
7768826|NCT01377012|19126571|P2|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
7768827|NCT01377012|19126572|P1|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
7768828|NCT01377012|19126570|P3|wk 24 Re-randomized to AIN 75 mg Res|Core Study|Res= responder|38
7768829|NCT01377012|19126571|P2|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
7768830|NCT01377012|19126572|P1|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
7768831|NCT01377012|19126570|P3|wk16 Re-randomized to AIN 150mg NR|Core Study||53
7768832|NCT01377012|19126571|P2|wk16 Re-randomized to AIN 150mg NR|Core Study||0
7768833|NCT01377012|19126572|P1|wk16 Re-randomized to AIN 150mg NR|Core Study||0
7768834|NCT01377012|19126570|P3|wk16 Re-randomized to AIN 75mg NR|Core Study|NR=Non-responder|56
7768835|NCT01377012|19126571|P2|wk16 Re-randomized to AIN 75mg NR|Core Study||0
7768836|NCT01377012|19126572|P1|wk16 Re-randomized to AIN 75mg NR|Core Study||0
7768837|NCT01377012|19126570|P3|STARTED|Core Study||214
7768838|NCT01377012|19126571|P2|STARTED|Core Study||213
7768839|NCT01377012|19126572|P1|STARTED|Core Study||210
7768840|NCT01376908|19126609|P2|NOT COMPLETED|Overall Study||3
7768841|NCT01376908|19126610|P1|NOT COMPLETED|Overall Study||2
7768842|NCT01376908|19126609|P2|COMPLETED|Overall Study||26
7768843|NCT01376908|19126610|P1|COMPLETED|Overall Study||25
7768844|NCT01376908|19126609|P2|STARTED|Overall Study||29
7768845|NCT01376908|19126610|P1|STARTED|Overall Study||27
7768846|NCT01376804|19126643|P1|NOT COMPLETED|Follow-up Period||0
7768847|NCT01376804|19126643|P1|COMPLETED|Follow-up Period||55
7768848|NCT01376804|19126643|P1|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55
7768849|NCT01376804|19126643|P1|NOT COMPLETED|Treatment Period||8
7768850|NCT01376804|19126643|P1|COMPLETED|Treatment Period||49
7768851|NCT01376804|19126643|P1|Received Study Drug|Treatment Period||56
7768852|NCT01376804|19126643|P1|STARTED|Treatment Period||57
7768853|NCT01376700|19126654|P1|NOT COMPLETED|Overall Study||16
7768854|NCT01376700|19126654|P1|COMPLETED|Overall Study||3
7768855|NCT01376700|19126654|P1|STARTED|Overall Study||19
7768856|NCT01376557|19126675|P5|NOT COMPLETED|Overall Study||7
7768857|NCT01376557|19126676|P4|NOT COMPLETED|Overall Study||6
7768858|NCT01376557|19126677|P3|NOT COMPLETED|Overall Study||5
7768859|NCT01376557|19126678|P2|NOT COMPLETED|Overall Study||6
7768860|NCT01376557|19126679|P1|NOT COMPLETED|Overall Study||8
7768861|NCT01376557|19126675|P5|COMPLETED|Overall Study||53
7768862|NCT01376557|19126676|P4|COMPLETED|Overall Study||54
7768863|NCT01376557|19126677|P3|COMPLETED|Overall Study||55
7768864|NCT01376557|19126678|P2|COMPLETED|Overall Study||54
7768865|NCT01376557|19126679|P1|COMPLETED|Overall Study||51
7768866|NCT01376557|19126675|P5|STARTED|Overall Study||60
7768867|NCT01376557|19126676|P4|STARTED|Overall Study||60
7768868|NCT01376557|19126677|P3|STARTED|Overall Study||60
7768869|NCT01376557|19126678|P2|STARTED|Overall Study||60
7768870|NCT01376557|19126679|P1|STARTED|Overall Study||59
7768871|NCT01376388|19126716|P1|NOT COMPLETED|Overall Study||18
7768872|NCT01376388|19126716|P1|COMPLETED|Overall Study||112
7768873|NCT01376388|19126716|P1|STARTED|Overall Study||130
7768874|NCT01376362|19126731|P1|NOT COMPLETED|Overall Study||0
7768875|NCT01376362|19126731|P1|COMPLETED|Overall Study||5
7768876|NCT01376362|19126731|P1|STARTED|Overall Study||5
7768877|NCT01376349|19126754|P3|NOT COMPLETED|Optional Continuation Phase||0
7768878|NCT01376349|19126755|P2|NOT COMPLETED|Optional Continuation Phase||0
7768879|NCT01376349|19126756|P1|NOT COMPLETED|Optional Continuation Phase||0
7768880|NCT01376349|19126754|P3|COMPLETED|Optional Continuation Phase||94
7768881|NCT01376349|19126755|P2|COMPLETED|Optional Continuation Phase||0
7768882|NCT01376349|19126756|P1|COMPLETED|Optional Continuation Phase||0
7768883|NCT01376349|19126754|P3|STARTED|Optional Continuation Phase|Patients completing Arm III Placebo were offered the option of continuing High Dose DHEA|94
7768884|NCT01376349|19126755|P2|STARTED|Optional Continuation Phase||0
7768885|NCT01376349|19126756|P1|STARTED|Optional Continuation Phase||0
7768886|NCT01376349|19126754|P3|NOT COMPLETED|Raondomized Treatment||29
7768887|NCT01376349|19126755|P2|NOT COMPLETED|Raondomized Treatment||35
7768888|NCT01376349|19126756|P1|NOT COMPLETED|Raondomized Treatment||24
7768889|NCT01376349|19126754|P3|COMPLETED|Raondomized Treatment||118
7768890|NCT01376349|19126755|P2|COMPLETED|Raondomized Treatment||114
7768891|NCT01376349|19126756|P1|COMPLETED|Raondomized Treatment||123
7768892|NCT01376349|19126754|P3|STARTED|Raondomized Treatment||147
7768893|NCT01376349|19126755|P2|STARTED|Raondomized Treatment||149
7768894|NCT01376349|19126756|P1|STARTED|Raondomized Treatment||147
7768895|NCT01376323|19126770|P5|NOT COMPLETED|Overall Study||1
7768896|NCT01376323|19126771|P4|NOT COMPLETED|Overall Study||5
7768897|NCT01376323|19126772|P3|NOT COMPLETED|Overall Study||3
7768898|NCT01376323|19126773|P2|NOT COMPLETED|Overall Study||1
7768899|NCT01376323|19126774|P1|NOT COMPLETED|Overall Study||2
7768900|NCT01376323|19126770|P5|COMPLETED|Overall Study||17
7768901|NCT01376323|19126771|P4|COMPLETED|Overall Study||14
7768902|NCT01376323|19126772|P3|COMPLETED|Overall Study||16
7768903|NCT01376323|19126773|P2|COMPLETED|Overall Study||17
7768904|NCT01376323|19126774|P1|COMPLETED|Overall Study||18
7768905|NCT01376323|19126770|P5|STARTED|Overall Study||18
7768906|NCT01376323|19126771|P4|STARTED|Overall Study||19
7768907|NCT01376323|19126772|P3|STARTED|Overall Study||19
7768908|NCT01376323|19126773|P2|STARTED|Overall Study||18
7768909|NCT01376323|19126774|P1|STARTED|Overall Study||20
7768910|NCT01376310|19126858|P2|NOT COMPLETED|Overall Study||11
7768911|NCT01376310|19126859|P1|NOT COMPLETED|Overall Study||36
7768912|NCT01376310|19126858|P2|COMPLETED|Overall Study||22
7768913|NCT01376310|19126859|P1|COMPLETED|Overall Study||90
7768914|NCT01376310|19126858|P2|STARTED|Overall Study||33
7768915|NCT01376310|19126859|P1|STARTED|Overall Study||126
7768916|NCT01376297|19126867|P2|NOT COMPLETED|Overall Study||49
7768917|NCT01376297|19126868|P1|NOT COMPLETED|Overall Study||128
7768918|NCT01376297|19126867|P2|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55
7768919|NCT01376297|19126868|P1|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181
7768920|NCT01376297|19126867|P2|STARTED|Overall Study|number of randomised patients|104
7768921|NCT01376297|19126868|P1|STARTED|Overall Study|number of randomised patients|309
7768922|NCT01376245|19126878|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||26
7768923|NCT01376245|19126879|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||23
7768924|NCT01376245|19126880|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||25
7768925|NCT01376245|19126881|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||32
7768926|NCT01376245|19126882|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
7768927|NCT01376245|19126878|P5|COMPLETED|24-week, Double-blind Treatment Period||134
7768928|NCT01376245|19126879|P4|COMPLETED|24-week, Double-blind Treatment Period||138
7768929|NCT01376245|19126880|P3|COMPLETED|24-week, Double-blind Treatment Period||135
7768930|NCT01376245|19126881|P2|COMPLETED|24-week, Double-blind Treatment Period||130
7768931|NCT01376245|19126882|P1|COMPLETED|24-week, Double-blind Treatment Period||0
7768932|NCT01376245|19126878|P5|STARTED|24-week, Double-blind Treatment Period||160
7768933|NCT01376245|19126879|P4|STARTED|24-week, Double-blind Treatment Period||161
7768934|NCT01376245|19126880|P3|STARTED|24-week, Double-blind Treatment Period||160
7768935|NCT01376245|19126881|P2|STARTED|24-week, Double-blind Treatment Period||162
7768936|NCT01376245|19126882|P1|STARTED|24-week, Double-blind Treatment Period||0
7768937|NCT01376245|19126878|P5|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
7768938|NCT01376245|19126879|P4|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
7768939|NCT01376245|19126880|P3|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
7768940|NCT01376245|19126881|P2|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
7768941|NCT01376245|19126882|P1|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101
7768942|NCT01376245|19126878|P5|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
7768943|NCT01376245|19126879|P4|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
7768944|NCT01376245|19126880|P3|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
7768945|NCT01376245|19126881|P2|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
7768946|NCT01376245|19126882|P1|COMPLETED|2-wk Single-blind Placebo Run-in Period||643
7768947|NCT01376245|19126878|P5|STARTED|2-wk Single-blind Placebo Run-in Period||0
7768948|NCT01376245|19126879|P4|STARTED|2-wk Single-blind Placebo Run-in Period||0
7768949|NCT01376245|19126880|P3|STARTED|2-wk Single-blind Placebo Run-in Period||0
7768950|NCT01376245|19126881|P2|STARTED|2-wk Single-blind Placebo Run-in Period||0
7768951|NCT01376245|19126882|P1|STARTED|2-wk Single-blind Placebo Run-in Period||744
7768952|NCT01376167|19126899|P3|NOT COMPLETED|Overall Study||6
7768953|NCT01376167|19126900|P2|NOT COMPLETED|Overall Study||10
7768954|NCT01376167|19126901|P1|NOT COMPLETED|Overall Study||4
7768955|NCT01376167|19126899|P3|COMPLETED|Overall Study||123
7768956|NCT01376167|19126900|P2|COMPLETED|Overall Study||250
7768957|NCT01376167|19126901|P1|COMPLETED|Overall Study||129
7768958|NCT01376167|19126899|P3|STARTED|Overall Study||129
7768959|NCT01376167|19126900|P2|STARTED|Overall Study||260
7768960|NCT01376167|19126901|P1|STARTED|Overall Study||133
7768961|NCT01376089|19126972|P2|NOT COMPLETED|Overall Study||4
7768962|NCT01376089|19126973|P1|NOT COMPLETED|Overall Study||3
7768963|NCT01376089|19126972|P2|COMPLETED|Overall Study||144
7768964|NCT01376089|19126973|P1|COMPLETED|Overall Study||148
7768965|NCT01376089|19126972|P2|STARTED|Overall Study||148
7768966|NCT01376089|19126973|P1|STARTED|Overall Study||151
7768967|NCT01376050|19126985|P2|NOT COMPLETED|Overall Study||0
7768968|NCT01376050|19126986|P1|NOT COMPLETED|Overall Study||0
7768969|NCT01376050|19126985|P2|COMPLETED|Overall Study||11
7768970|NCT01376050|19126986|P1|COMPLETED|Overall Study||13
7768971|NCT01376050|19126985|P2|STARTED|Overall Study||11
7768972|NCT01376050|19126986|P1|STARTED|Overall Study||13
7768973|NCT01376037|19126996|P2|NOT COMPLETED|Overall Study||2
7768974|NCT01376037|19126997|P1|NOT COMPLETED|Overall Study||0
7768975|NCT01376037|19126996|P2|COMPLETED|Overall Study||29
7768976|NCT01376037|19126997|P1|COMPLETED|Overall Study||31
7768977|NCT01376037|19126996|P2|STARTED|Overall Study||31
7768978|NCT01376037|19126997|P1|STARTED|Overall Study||31
7768979|NCT01375959|19127005|P2|NOT COMPLETED|Second Intervention (6 Weeks)||3
7768980|NCT01375959|19127006|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
7768981|NCT01375959|19127005|P2|COMPLETED|Second Intervention (6 Weeks)||15
7768982|NCT01375959|19127006|P1|COMPLETED|Second Intervention (6 Weeks)||15
7768983|NCT01375959|19127005|P2|STARTED|Second Intervention (6 Weeks)||18
7768984|NCT01375959|19127006|P1|STARTED|Second Intervention (6 Weeks)||15
7768985|NCT01375959|19127005|P2|NOT COMPLETED|Wash-Out (3 Weeks)||0
7768986|NCT01375959|19127006|P1|NOT COMPLETED|Wash-Out (3 Weeks)||0
7768987|NCT01375959|19127005|P2|COMPLETED|Wash-Out (3 Weeks)||18
7768988|NCT01375959|19127006|P1|COMPLETED|Wash-Out (3 Weeks)||15
7768989|NCT01375959|19127005|P2|STARTED|Wash-Out (3 Weeks)||18
7768990|NCT01375959|19127006|P1|STARTED|Wash-Out (3 Weeks)||15
7768991|NCT01375959|19127005|P2|NOT COMPLETED|First Intervention (6 Weeks)||3
7768992|NCT01375959|19127006|P1|NOT COMPLETED|First Intervention (6 Weeks)||2
7768993|NCT01375959|19127005|P2|COMPLETED|First Intervention (6 Weeks)|Three participants were withdrawn due to adverse events.|18
7768994|NCT01375959|19127006|P1|COMPLETED|First Intervention (6 Weeks)|Two participants were withdrawn due to adverse events.|15
7768995|NCT01375959|19127005|P2|Received Invertention|First Intervention (6 Weeks)||21
7768996|NCT01375959|19127006|P1|Received Invertention|First Intervention (6 Weeks)||17
7768997|NCT01375959|19127005|P2|STARTED|First Intervention (6 Weeks)||21
7768998|NCT01375959|19127006|P1|STARTED|First Intervention (6 Weeks)||17
7768999|NCT01375946|19127012|P6|NOT COMPLETED|Overall Study||0
7769000|NCT01375946|19127013|P5|NOT COMPLETED|Overall Study||0
7769001|NCT01375946|19127014|P4|NOT COMPLETED|Overall Study||0
7769002|NCT01375946|19127015|P3|NOT COMPLETED|Overall Study||0
7769003|NCT01375946|19127016|P2|NOT COMPLETED|Overall Study||0
7769004|NCT01375946|19127017|P1|NOT COMPLETED|Overall Study||0
7769005|NCT01375946|19127012|P6|COMPLETED|Overall Study||4
7769006|NCT01375946|19127013|P5|COMPLETED|Overall Study||4
7769007|NCT01375946|19127014|P4|COMPLETED|Overall Study||4
7769008|NCT01375946|19127015|P3|COMPLETED|Overall Study||4
7769009|NCT01375946|19127016|P2|COMPLETED|Overall Study||4
7769010|NCT01375946|19127017|P1|COMPLETED|Overall Study||4
7769011|NCT01375946|19127012|P6|STARTED|Overall Study||4
7769012|NCT01375946|19127013|P5|STARTED|Overall Study||4
7769013|NCT01375946|19127014|P4|STARTED|Overall Study||4
7769014|NCT01375946|19127015|P3|STARTED|Overall Study||4
7769015|NCT01375946|19127016|P2|STARTED|Overall Study||4
7769016|NCT01375946|19127017|P1|STARTED|Overall Study||4
7769017|NCT01375777|19127034|P9|NOT COMPLETED|Overall Study||2
7769018|NCT01375777|19127035|P8|NOT COMPLETED|Overall Study||2
7769019|NCT01375777|19127036|P7|NOT COMPLETED|Overall Study||2
7769020|NCT01375777|19127037|P6|NOT COMPLETED|Overall Study||1
7769021|NCT01375777|19127038|P5|NOT COMPLETED|Overall Study||1
7769022|NCT01375777|19127039|P4|NOT COMPLETED|Overall Study||0
7769023|NCT01375777|19127040|P3|NOT COMPLETED|Overall Study||1
7769024|NCT01375777|19127041|P2|NOT COMPLETED|Overall Study||3
7769025|NCT01375777|19127042|P1|NOT COMPLETED|Overall Study||2
7769026|NCT01375777|19127034|P9|COMPLETED|Overall Study||44
7769027|NCT01375777|19127035|P8|COMPLETED|Overall Study||44
7769028|NCT01375777|19127036|P7|COMPLETED|Overall Study||44
7769029|NCT01375777|19127037|P6|COMPLETED|Overall Study||44
7769030|NCT01375777|19127038|P5|COMPLETED|Overall Study||45
7769031|NCT01375777|19127039|P4|COMPLETED|Overall Study||45
7769032|NCT01375777|19127040|P3|COMPLETED|Overall Study||45
7769033|NCT01375777|19127041|P2|COMPLETED|Overall Study||42
7769034|NCT01375777|19127042|P1|COMPLETED|Overall Study||44
7769035|NCT01375777|19127034|P9|Received Treatment|Overall Study||45
7769036|NCT01375777|19127035|P8|Received Treatment|Overall Study||45
7769037|NCT01375777|19127036|P7|Received Treatment|Overall Study||45
7769038|NCT01375777|19127037|P6|Received Treatment|Overall Study||45
7769039|NCT01375777|19127038|P5|Received Treatment|Overall Study||46
7769040|NCT01375777|19127039|P4|Received Treatment|Overall Study||45
7769041|NCT01375777|19127040|P3|Received Treatment|Overall Study||45
7769042|NCT01375777|19127041|P2|Received Treatment|Overall Study||45
7769043|NCT01375777|19127042|P1|Received Treatment|Overall Study||45
7769044|NCT01375777|19127034|P9|STARTED|Overall Study||46
7769045|NCT01375777|19127035|P8|STARTED|Overall Study||46
7769046|NCT01375777|19127036|P7|STARTED|Overall Study||46
7769047|NCT01375777|19127037|P6|STARTED|Overall Study||45
7769048|NCT01375777|19127038|P5|STARTED|Overall Study||46
7769049|NCT01375777|19127039|P4|STARTED|Overall Study||45
7769050|NCT01375777|19127040|P3|STARTED|Overall Study||46
7769051|NCT01375777|19127041|P2|STARTED|Overall Study||45
7769052|NCT01375777|19127042|P1|STARTED|Overall Study||46
7769053|NCT01375764|19127112|P5|NOT COMPLETED|Overall Study||1
7769054|NCT01375764|19127113|P4|NOT COMPLETED|Overall Study||1
7769055|NCT01375764|19127114|P3|NOT COMPLETED|Overall Study||0
7769056|NCT01375764|19127115|P2|NOT COMPLETED|Overall Study||1
7769057|NCT01375764|19127116|P1|NOT COMPLETED|Overall Study||2
7769058|NCT01375764|19127112|P5|COMPLETED|Overall Study||31
7769059|NCT01375764|19127113|P4|COMPLETED|Overall Study||31
7769060|NCT01375764|19127114|P3|COMPLETED|Overall Study||32
7769061|NCT01375764|19127115|P2|COMPLETED|Overall Study||30
7769062|NCT01375764|19127116|P1|COMPLETED|Overall Study||31
7769063|NCT01375764|19127112|P5|Received Treatment|Overall Study||32
7769064|NCT01375764|19127113|P4|Received Treatment|Overall Study||31
7769065|NCT01375764|19127114|P3|Received Treatment|Overall Study||32
7769066|NCT01375764|19127115|P2|Received Treatment|Overall Study||30
7769067|NCT01375764|19127116|P1|Received Treatment|Overall Study||32
7769068|NCT01375764|19127112|P5|STARTED|Overall Study||32
7769069|NCT01375764|19127113|P4|STARTED|Overall Study||32
7769070|NCT01375764|19127114|P3|STARTED|Overall Study||32
7769071|NCT01375764|19127115|P2|STARTED|Overall Study||31
7769072|NCT01375764|19127116|P1|STARTED|Overall Study||33
7769073|NCT01375751|19127162|P3|NOT COMPLETED|Overall Study||0
7769074|NCT01375751|19127163|P2|NOT COMPLETED|Overall Study||1
7769075|NCT01375751|19127164|P1|NOT COMPLETED|Overall Study||0
7769076|NCT01375751|19127162|P3|COMPLETED|Overall Study||56
7769077|NCT01375751|19127163|P2|COMPLETED|Overall Study||55
7769078|NCT01375751|19127164|P1|COMPLETED|Overall Study||56
7769079|NCT01375751|19127162|P3|Received Treatment|Overall Study||56
7769080|NCT01375751|19127163|P2|Received Treatment|Overall Study||55
7769081|NCT01375751|19127164|P1|Received Treatment|Overall Study||56
7769082|NCT01375751|19127162|P3|STARTED|Overall Study||56
7769083|NCT01375751|19127163|P2|STARTED|Overall Study||56
7769084|NCT01375751|19127164|P1|STARTED|Overall Study||56
7769085|NCT01375673|19127189|P2|NOT COMPLETED|Overall Study||1
7769086|NCT01375673|19127190|P1|NOT COMPLETED|Overall Study||0
7769087|NCT01375673|19127189|P2|COMPLETED|Overall Study||6
7769088|NCT01375673|19127190|P1|COMPLETED|Overall Study||7
7769089|NCT01375673|19127189|P2|STARTED|Overall Study||7
7769090|NCT01375673|19127190|P1|STARTED|Overall Study||7
7769091|NCT01375660|19127202|P2|NOT COMPLETED|Overall Study||16
7769092|NCT01375660|19127203|P1|NOT COMPLETED|Overall Study||16
7769093|NCT01375660|19127202|P2|COMPLETED|Overall Study||87
7769094|NCT01375660|19127203|P1|COMPLETED|Overall Study||86
7769095|NCT01375660|19127202|P2|STARTED|Overall Study||103
7769096|NCT01375660|19127203|P1|STARTED|Overall Study||102
7769097|NCT01375608|19127221|P1|NOT COMPLETED|Overall Study||2
7769098|NCT01375608|19127221|P1|COMPLETED|Overall Study||8
7769099|NCT01375608|19127221|P1|STARTED|Overall Study||10
7769100|NCT01375569|19127225|P1|NOT COMPLETED|Overall Study||0
7769101|NCT01375569|19127225|P1|COMPLETED|Overall Study||11
7769102|NCT01375569|19127225|P1|STARTED|Overall Study||11
7769103|NCT01375491|19127233|P3|NOT COMPLETED|Overall Study||0
7769104|NCT01375491|19127234|P2|NOT COMPLETED|Overall Study||1
7769105|NCT01375491|19127235|P1|NOT COMPLETED|Overall Study||2
7769106|NCT01375491|19127233|P3|COMPLETED|Overall Study||15
7769107|NCT01375491|19127234|P2|COMPLETED|Overall Study||12
7769108|NCT01375491|19127235|P1|COMPLETED|Overall Study||9
7769109|NCT01375491|19127233|P3|STARTED|Overall Study||15
7769110|NCT01375491|19127234|P2|STARTED|Overall Study||13
7769111|NCT01375491|19127235|P1|STARTED|Overall Study||11
7769112|NCT01375374|19127249|P1|NOT COMPLETED|Overall Study||1
7769113|NCT01375374|19127249|P1|COMPLETED|Overall Study||10
7769114|NCT01375374|19127249|P1|STARTED|Overall Study||11
7769115|NCT01375205|19127258|P2|NOT COMPLETED|Overall Study||13
7769116|NCT01375205|19127259|P1|NOT COMPLETED|Overall Study||21
7769117|NCT01375205|19127258|P2|COMPLETED|Overall Study||33
7769118|NCT01375205|19127259|P1|COMPLETED|Overall Study||33
7769119|NCT01375205|19127258|P2|STARTED|Overall Study||46
7769120|NCT01375205|19127259|P1|STARTED|Overall Study||54
7769121|NCT01375140|19127279|P1|NOT COMPLETED|Overall Study||0
7769122|NCT01375140|19127279|P1|COMPLETED|Overall Study||31
7769123|NCT01375140|19127279|P1|STARTED|Overall Study||31
7769124|NCT01375127|19127289|P6|NOT COMPLETED|Overall Study||0
7769125|NCT01375127|19127290|P5|NOT COMPLETED|Overall Study||0
7769126|NCT01375127|19127291|P4|NOT COMPLETED|Overall Study||0
7769127|NCT01375127|19127292|P3|NOT COMPLETED|Overall Study||0
7769128|NCT01375127|19127293|P2|NOT COMPLETED|Overall Study||0
7769129|NCT01375127|19127294|P1|NOT COMPLETED|Overall Study||0
7769130|NCT01375127|19127289|P6|COMPLETED|Overall Study||3
7769131|NCT01375127|19127290|P5|COMPLETED|Overall Study||5
7769132|NCT01375127|19127291|P4|COMPLETED|Overall Study||33
7769133|NCT01375127|19127292|P3|COMPLETED|Overall Study||40
7769134|NCT01375127|19127293|P2|COMPLETED|Overall Study||1
7769135|NCT01375127|19127294|P1|COMPLETED|Overall Study||1
7769136|NCT01375127|19127289|P6|STARTED|Overall Study||3
7769137|NCT01375127|19127290|P5|STARTED|Overall Study||5
7769138|NCT01375127|19127291|P4|STARTED|Overall Study||33
7769139|NCT01375127|19127292|P3|STARTED|Overall Study||40
7769140|NCT01375127|19127293|P2|STARTED|Overall Study||1
7769141|NCT01375127|19127294|P1|STARTED|Overall Study||1
7769142|NCT01375075|19127332|P6|NOT COMPLETED|Overall Study||3
7769143|NCT01375075|19127333|P5|NOT COMPLETED|Overall Study||0
7769144|NCT01375075|19127334|P4|NOT COMPLETED|Overall Study||1
7769145|NCT01375075|19127335|P3|NOT COMPLETED|Overall Study||3
7769146|NCT01375075|19127336|P2|NOT COMPLETED|Overall Study||1
7769147|NCT01375075|19127337|P1|NOT COMPLETED|Overall Study||1
7769148|NCT01375075|19127332|P6|COMPLETED|Overall Study||25
7769149|NCT01375075|19127333|P5|COMPLETED|Overall Study||27
7769150|NCT01375075|19127334|P4|COMPLETED|Overall Study||27
7769151|NCT01375075|19127335|P3|COMPLETED|Overall Study||24
7769152|NCT01375075|19127336|P2|COMPLETED|Overall Study||27
7769153|NCT01375075|19127337|P1|COMPLETED|Overall Study||26
7769154|NCT01375075|19127332|P6|Received at Least One Dose of Study Drug|Overall Study||28
7769155|NCT01375075|19127333|P5|Received at Least One Dose of Study Drug|Overall Study||27
7769156|NCT01375075|19127334|P4|Received at Least One Dose of Study Drug|Overall Study||28
7769157|NCT01375075|19127335|P3|Received at Least One Dose of Study Drug|Overall Study||27
7769158|NCT01375075|19127336|P2|Received at Least One Dose of Study Drug|Overall Study||28
7769159|NCT01375075|19127337|P1|Received at Least One Dose of Study Drug|Overall Study||27
7769160|NCT01375075|19127332|P6|STARTED|Overall Study||28
7769161|NCT01375075|19127333|P5|STARTED|Overall Study||27
7769162|NCT01375075|19127334|P4|STARTED|Overall Study||28
7769163|NCT01375075|19127335|P3|STARTED|Overall Study||27
7769164|NCT01375075|19127336|P2|STARTED|Overall Study||28
7769165|NCT01375075|19127337|P1|STARTED|Overall Study||27
7769166|NCT01375049|19127421|P1|NOT COMPLETED|Overall Study||50
7769167|NCT01375049|19127421|P1|COMPLETED|Overall Study||55
7769168|NCT01375049|19127421|P1|STARTED|Overall Study||105
7769169|NCT01375010|19127438|P2|NOT COMPLETED|Overall Study||4
7769170|NCT01375010|19127439|P1|NOT COMPLETED|Overall Study||12
7769171|NCT01375010|19127438|P2|COMPLETED|Overall Study||38
7769172|NCT01375010|19127439|P1|COMPLETED|Overall Study||31
7769173|NCT01375010|19127438|P2|STARTED|Overall Study||42
7769174|NCT01375010|19127439|P1|STARTED|Overall Study||43
7769175|NCT01374971|19127453|P1|NOT COMPLETED|Overall Study||1
7769176|NCT01374971|19127453|P1|COMPLETED|Overall Study||11
7769177|NCT01374971|19127453|P1|STARTED|Overall Study||12
7769178|NCT01374919|19127458|P1|NOT COMPLETED|Overall Study||2
7769179|NCT01374919|19127458|P1|COMPLETED|Overall Study||58
7769180|NCT01374919|19127458|P1|STARTED|Overall Study||60
7769181|NCT01374906|19127465|P2|NOT COMPLETED|Overall Study||48
7769182|NCT01374906|19127466|P1|NOT COMPLETED|Overall Study||40
7769183|NCT01374906|19127465|P2|COMPLETED|Overall Study||28
7769184|NCT01374906|19127466|P1|COMPLETED|Overall Study||34
7769185|NCT01374906|19127465|P2|Completed Extension Phase|Overall Study||15
7769186|NCT01374906|19127466|P1|Completed Extension Phase|Overall Study||24
7769187|NCT01374906|19127465|P2|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||26
7769273|NCT01374087|19127882|P1|COMPLETED|Overall Study||0
7769188|NCT01374906|19127466|P1|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||16
7769189|NCT01374906|19127465|P2|Completed Core Phase/Entered Ext. Phase|Overall Study||41
7769190|NCT01374906|19127466|P1|Completed Core Phase/Entered Ext. Phase|Overall Study||40
7769191|NCT01374906|19127465|P2|Completed Core/Did Not Enter Ext. Phase|Overall Study||13
7769192|NCT01374906|19127466|P1|Completed Core/Did Not Enter Ext. Phase|Overall Study||10
7769193|NCT01374906|19127465|P2|Completed Core Phase|Overall Study||54
7769194|NCT01374906|19127466|P1|Completed Core Phase|Overall Study||50
7769195|NCT01374906|19127465|P2|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||22
7769196|NCT01374906|19127466|P1|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||24
7769197|NCT01374906|19127465|P2|STARTED|Overall Study||76
7769198|NCT01374906|19127466|P1|STARTED|Overall Study||74
7769199|NCT01374802|19127533|P1|NOT COMPLETED|Overall Study||0
7769200|NCT01374802|19127533|P1|COMPLETED|Overall Study||14
7769201|NCT01374802|19127533|P1|STARTED|Overall Study||14
7769202|NCT01374568|19127547|P2|NOT COMPLETED|Overall Study||2
7769203|NCT01374568|19127548|P1|NOT COMPLETED|Overall Study||0
7769204|NCT01374568|19127547|P2|COMPLETED|Overall Study||1
7769205|NCT01374568|19127548|P1|COMPLETED|Overall Study||2
7769206|NCT01374568|19127547|P2|STARTED|Overall Study||3
7769207|NCT01374568|19127548|P1|STARTED|Overall Study||2
7769208|NCT01374516|19127558|P2|NOT COMPLETED|Surveillance Expansion Period||1253
7769209|NCT01374516|19127559|P1|NOT COMPLETED|Surveillance Expansion Period||2349
7769210|NCT01374516|19127558|P2|COMPLETED|Surveillance Expansion Period||5387
7769211|NCT01374516|19127559|P1|COMPLETED|Surveillance Expansion Period||10932
7769212|NCT01374516|19127558|P2|STARTED|Surveillance Expansion Period||6640
7769213|NCT01374516|19127559|P1|STARTED|Surveillance Expansion Period||13281
7769214|NCT01374516|19127558|P2|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||309
7769215|NCT01374516|19127559|P1|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||639
7769216|NCT01374516|19127558|P2|COMPLETED|Vaccination Phase (Up to 25 Months)||6640
7769217|NCT01374516|19127559|P1|COMPLETED|Vaccination Phase (Up to 25 Months)||13281
7769218|NCT01374516|19127558|P2|STARTED|Vaccination Phase (Up to 25 Months)||6949
7769219|NCT01374516|19127559|P1|STARTED|Vaccination Phase (Up to 25 Months)||13920
7769220|NCT01374490|19127591|P1|NOT COMPLETED|Overall Study||60
7769221|NCT01374490|19127591|P1|COMPLETED|Overall Study||190
7769222|NCT01374490|19127591|P1|STARTED|Overall Study||250
7769223|NCT01374451|19127597|P2|NOT COMPLETED|Overall Study||0
7769224|NCT01374451|19127598|P1|NOT COMPLETED|Overall Study||1
7769225|NCT01374451|19127597|P2|COMPLETED|Overall Study||81
7769226|NCT01374451|19127598|P1|COMPLETED|Overall Study||78
7769227|NCT01374451|19127597|P2|STARTED|Overall Study||81
7769228|NCT01374451|19127598|P1|STARTED|Overall Study||79
7769229|NCT01374438|19127627|P2|NOT COMPLETED|Overall Study||0
7769230|NCT01374438|19127628|P1|NOT COMPLETED|Overall Study||0
7769231|NCT01374438|19127627|P2|COMPLETED|Overall Study||13
7769232|NCT01374438|19127628|P1|COMPLETED|Overall Study||16
7769233|NCT01374438|19127627|P2|STARTED|Overall Study||13
7769234|NCT01374438|19127628|P1|STARTED|Overall Study||16
7769235|NCT01374425|19127644|P2|NOT COMPLETED|Overall Study||188
7769236|NCT01374425|19127645|P1|NOT COMPLETED|Overall Study||188
7769237|NCT01374425|19127644|P2|COMPLETED|Overall Study||0
7769238|NCT01374425|19127645|P1|COMPLETED|Overall Study||0
7769239|NCT01374425|19127644|P2|STARTED|Overall Study||188
7769240|NCT01374425|19127645|P1|STARTED|Overall Study||188
7769241|NCT01374269|19127725|P2|NOT COMPLETED|Overall Study||5
7769242|NCT01374269|19127726|P1|NOT COMPLETED|Overall Study||6
7769243|NCT01374269|19127725|P2|COMPLETED|Overall Study||39
7769244|NCT01374269|19127726|P1|COMPLETED|Overall Study||40
7769245|NCT01374269|19127725|P2|STARTED|Overall Study||44
7769246|NCT01374269|19127726|P1|STARTED|Overall Study||46
7769247|NCT01374217|19127854|P1|NOT COMPLETED|Overall Study||13
7769248|NCT01374217|19127854|P1|COMPLETED|Overall Study||0
7769249|NCT01374217|19127854|P1|STARTED|Overall Study||13
7769250|NCT01374178|19127862|P2|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0
7769251|NCT01374178|19127863|P1|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2
7769252|NCT01374178|19127862|P2|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5
7769253|NCT01374178|19127863|P1|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8
7769254|NCT01374178|19127862|P2|STARTED|Period 2 (up to 24 Hours After Dosing)||5
7769255|NCT01374178|19127863|P1|STARTED|Period 2 (up to 24 Hours After Dosing)||10
7769256|NCT01374178|19127862|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
7769257|NCT01374178|19127863|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
7769258|NCT01374178|19127862|P2|COMPLETED|Washout Period of at Least 7 Days||5
7769259|NCT01374178|19127863|P1|COMPLETED|Washout Period of at Least 7 Days||10
7769260|NCT01374178|19127862|P2|STARTED|Washout Period of at Least 7 Days||5
7769261|NCT01374178|19127863|P1|STARTED|Washout Period of at Least 7 Days||11
7769262|NCT01374178|19127862|P2|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
7769263|NCT01374178|19127863|P1|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
7769264|NCT01374178|19127862|P2|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5
7769265|NCT01374178|19127863|P1|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11
7769266|NCT01374178|19127862|P2|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5
7769267|NCT01374178|19127863|P1|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11
7769268|NCT01374178|19127862|P2|STARTED|Period 1 (up to 24 Hours After Dosing)||5
7769269|NCT01374178|19127863|P1|STARTED|Period 1 (up to 24 Hours After Dosing)||11
7769270|NCT01374087|19127881|P2|NOT COMPLETED|Overall Study||15
7769271|NCT01374087|19127882|P1|NOT COMPLETED|Overall Study||16
7769272|NCT01374087|19127881|P2|COMPLETED|Overall Study||0
7769274|NCT01374087|19127881|P2|STARTED|Overall Study||15
7769275|NCT01374087|19127882|P1|STARTED|Overall Study||16
7769276|NCT01373931|19127902|P2|NOT COMPLETED|Period 2||0
7769277|NCT01373931|19127903|P1|NOT COMPLETED|Period 2||0
7769278|NCT01373931|19127902|P2|COMPLETED|Period 2||8
7769279|NCT01373931|19127903|P1|COMPLETED|Period 2||6
7769280|NCT01373931|19127902|P2|STARTED|Period 2||8
7769281|NCT01373931|19127903|P1|STARTED|Period 2||6
7769282|NCT01373931|19127902|P2|NOT COMPLETED|Period 1||2
7769283|NCT01373931|19127903|P1|NOT COMPLETED|Period 1||2
7769284|NCT01373931|19127902|P2|COMPLETED|Period 1||8
7769285|NCT01373931|19127903|P1|COMPLETED|Period 1||6
7769286|NCT01373931|19127902|P2|STARTED|Period 1||10
7769287|NCT01373931|19127903|P1|STARTED|Period 1||8
7769288|NCT01373931|19127902|P2|NOT COMPLETED|Lead-in Period||0
7769289|NCT01373931|19127903|P1|NOT COMPLETED|Lead-in Period||2
7769290|NCT01373931|19127902|P2|COMPLETED|Lead-in Period||10
7769291|NCT01373931|19127903|P1|COMPLETED|Lead-in Period||8
7769292|NCT01373931|19127902|P2|Received at Least 1 Dose of Study Drug|Lead-in Period||10
7769293|NCT01373931|19127903|P1|Received at Least 1 Dose of Study Drug|Lead-in Period||8
7769294|NCT01373931|19127902|P2|STARTED|Lead-in Period||10
7769295|NCT01373931|19127903|P1|STARTED|Lead-in Period||10
7769296|NCT01373918|19127916|P2|NOT COMPLETED|Overall Study||1
7769297|NCT01373918|19127917|P1|NOT COMPLETED|Overall Study||0
7769298|NCT01373918|19127916|P2|COMPLETED|Overall Study||15
7769299|NCT01373918|19127917|P1|COMPLETED|Overall Study||20
7769300|NCT01373918|19127916|P2|STARTED|Overall Study||16
7769301|NCT01373918|19127917|P1|STARTED|Overall Study||20
7769302|NCT01373671|19127929|P1|NOT COMPLETED|Overall Study||92
7769303|NCT01373671|19127929|P1|COMPLETED|Overall Study||672
7769304|NCT01373671|19127929|P1|STARTED|Overall Study||764
7769305|NCT01373580|19127934|P1|NOT COMPLETED|Overall Study||56
7769306|NCT01373580|19127934|P1|COMPLETED|Overall Study||317
7769307|NCT01373580|19127934|P1|STARTED|Overall Study||373
7769308|NCT01373489|19127942|P2|NOT COMPLETED|Overall Study||13
7769309|NCT01373489|19127943|P1|NOT COMPLETED|Overall Study||15
7769310|NCT01373489|19127942|P2|COMPLETED|Overall Study||41
7769311|NCT01373489|19127943|P1|COMPLETED|Overall Study||44
7769312|NCT01373489|19127942|P2|STARTED|Overall Study||54
7769313|NCT01373489|19127943|P1|STARTED|Overall Study||59
7769314|NCT01373450|19127949|P6|NOT COMPLETED|Crossover Period 4||0
7769315|NCT01373450|19127950|P5|NOT COMPLETED|Crossover Period 4||0
7769316|NCT01373450|19127951|P4|NOT COMPLETED|Crossover Period 4||0
7769317|NCT01373450|19127952|P3|NOT COMPLETED|Crossover Period 4||0
7769318|NCT01373450|19127953|P2|NOT COMPLETED|Crossover Period 4||0
7769319|NCT01373450|19127954|P1|NOT COMPLETED|Crossover Period 4||0
7769320|NCT01373450|19127949|P6|COMPLETED|Crossover Period 4||2
7769321|NCT01373450|19127950|P5|COMPLETED|Crossover Period 4||2
7769322|NCT01373450|19127951|P4|COMPLETED|Crossover Period 4||2
7769323|NCT01373450|19127952|P3|COMPLETED|Crossover Period 4||2
7769324|NCT01373450|19127953|P2|COMPLETED|Crossover Period 4||2
7769325|NCT01373450|19127954|P1|COMPLETED|Crossover Period 4||2
7769326|NCT01373450|19127949|P6|STARTED|Crossover Period 4||2
7769327|NCT01373450|19127950|P5|STARTED|Crossover Period 4||2
7769328|NCT01373450|19127951|P4|STARTED|Crossover Period 4||2
7769329|NCT01373450|19127952|P3|STARTED|Crossover Period 4||2
7769330|NCT01373450|19127953|P2|STARTED|Crossover Period 4||2
7769331|NCT01373450|19127954|P1|STARTED|Crossover Period 4||2
7769332|NCT01373450|19127949|P6|NOT COMPLETED|7 Day Wash-out||0
7769333|NCT01373450|19127950|P5|NOT COMPLETED|7 Day Wash-out||0
7769334|NCT01373450|19127951|P4|NOT COMPLETED|7 Day Wash-out||0
7769335|NCT01373450|19127952|P3|NOT COMPLETED|7 Day Wash-out||0
7769336|NCT01373450|19127953|P2|NOT COMPLETED|7 Day Wash-out||0
7769337|NCT01373450|19127954|P1|NOT COMPLETED|7 Day Wash-out||0
7769338|NCT01373450|19127949|P6|COMPLETED|7 Day Wash-out||2
7769339|NCT01373450|19127950|P5|COMPLETED|7 Day Wash-out||2
7769340|NCT01373450|19127951|P4|COMPLETED|7 Day Wash-out||2
7769341|NCT01373450|19127952|P3|COMPLETED|7 Day Wash-out||2
7769342|NCT01373450|19127953|P2|COMPLETED|7 Day Wash-out||2
7769343|NCT01373450|19127954|P1|COMPLETED|7 Day Wash-out||2
7769344|NCT01373450|19127949|P6|STARTED|7 Day Wash-out||2
7769345|NCT01373450|19127950|P5|STARTED|7 Day Wash-out||2
7769346|NCT01373450|19127951|P4|STARTED|7 Day Wash-out||2
7769347|NCT01373450|19127952|P3|STARTED|7 Day Wash-out||2
7769348|NCT01373450|19127953|P2|STARTED|7 Day Wash-out||2
7769349|NCT01373450|19127954|P1|STARTED|7 Day Wash-out||2
7769350|NCT01373450|19127949|P6|NOT COMPLETED|Crossover Period 3||0
7769351|NCT01373450|19127950|P5|NOT COMPLETED|Crossover Period 3||0
7769352|NCT01373450|19127951|P4|NOT COMPLETED|Crossover Period 3||0
7769353|NCT01373450|19127952|P3|NOT COMPLETED|Crossover Period 3||0
7769354|NCT01373450|19127953|P2|NOT COMPLETED|Crossover Period 3||0
7769355|NCT01373450|19127954|P1|NOT COMPLETED|Crossover Period 3||0
7769356|NCT01373450|19127949|P6|COMPLETED|Crossover Period 3||2
7769357|NCT01373450|19127950|P5|COMPLETED|Crossover Period 3||2
7769358|NCT01373450|19127951|P4|COMPLETED|Crossover Period 3||2
7769359|NCT01373450|19127952|P3|COMPLETED|Crossover Period 3||2
7769360|NCT01373450|19127953|P2|COMPLETED|Crossover Period 3||2
7769361|NCT01373450|19127954|P1|COMPLETED|Crossover Period 3||2
7769362|NCT01373450|19127949|P6|STARTED|Crossover Period 3||2
7769363|NCT01373450|19127950|P5|STARTED|Crossover Period 3||2
7769364|NCT01373450|19127951|P4|STARTED|Crossover Period 3||2
7769365|NCT01373450|19127952|P3|STARTED|Crossover Period 3||2
7769366|NCT01373450|19127953|P2|STARTED|Crossover Period 3||2
7769367|NCT01373450|19127954|P1|STARTED|Crossover Period 3||2
7769368|NCT01373450|19127949|P6|NOT COMPLETED|7 Day Wash-out||0
7769369|NCT01373450|19127950|P5|NOT COMPLETED|7 Day Wash-out||0
7769370|NCT01373450|19127951|P4|NOT COMPLETED|7 Day Wash-out||0
7769371|NCT01373450|19127952|P3|NOT COMPLETED|7 Day Wash-out||0
7769372|NCT01373450|19127953|P2|NOT COMPLETED|7 Day Wash-out||0
7769373|NCT01373450|19127954|P1|NOT COMPLETED|7 Day Wash-out||0
7769374|NCT01373450|19127949|P6|COMPLETED|7 Day Wash-out||2
7769375|NCT01373450|19127950|P5|COMPLETED|7 Day Wash-out||2
7769376|NCT01373450|19127951|P4|COMPLETED|7 Day Wash-out||2
7769377|NCT01373450|19127952|P3|COMPLETED|7 Day Wash-out||2
7769378|NCT01373450|19127953|P2|COMPLETED|7 Day Wash-out||2
7769379|NCT01373450|19127954|P1|COMPLETED|7 Day Wash-out||2
7769380|NCT01373450|19127949|P6|STARTED|7 Day Wash-out||2
7769381|NCT01373450|19127950|P5|STARTED|7 Day Wash-out||2
7769382|NCT01373450|19127951|P4|STARTED|7 Day Wash-out||2
7769383|NCT01373450|19127952|P3|STARTED|7 Day Wash-out||2
7769384|NCT01373450|19127953|P2|STARTED|7 Day Wash-out||2
7769385|NCT01373450|19127954|P1|STARTED|7 Day Wash-out||2
7769386|NCT01373450|19127949|P6|NOT COMPLETED|Crossover Period 2||0
7769387|NCT01373450|19127950|P5|NOT COMPLETED|Crossover Period 2||0
7769388|NCT01373450|19127951|P4|NOT COMPLETED|Crossover Period 2||0
7769389|NCT01373450|19127952|P3|NOT COMPLETED|Crossover Period 2||0
7769390|NCT01373450|19127953|P2|NOT COMPLETED|Crossover Period 2||0
7769391|NCT01373450|19127954|P1|NOT COMPLETED|Crossover Period 2||0
7769392|NCT01373450|19127949|P6|COMPLETED|Crossover Period 2||2
7769393|NCT01373450|19127950|P5|COMPLETED|Crossover Period 2||2
7769394|NCT01373450|19127951|P4|COMPLETED|Crossover Period 2||2
7769395|NCT01373450|19127952|P3|COMPLETED|Crossover Period 2||2
7769396|NCT01373450|19127953|P2|COMPLETED|Crossover Period 2||2
7769397|NCT01373450|19127954|P1|COMPLETED|Crossover Period 2||2
7769398|NCT01373450|19127949|P6|STARTED|Crossover Period 2||2
7769399|NCT01373450|19127950|P5|STARTED|Crossover Period 2||2
7769400|NCT01373450|19127951|P4|STARTED|Crossover Period 2||2
7769401|NCT01373450|19127952|P3|STARTED|Crossover Period 2||2
7769402|NCT01373450|19127953|P2|STARTED|Crossover Period 2||2
7769403|NCT01373450|19127954|P1|STARTED|Crossover Period 2||2
7769404|NCT01373450|19127949|P6|NOT COMPLETED|7 Day Wash-out||0
7769405|NCT01373450|19127950|P5|NOT COMPLETED|7 Day Wash-out||0
7769406|NCT01373450|19127951|P4|NOT COMPLETED|7 Day Wash-out||0
7769407|NCT01373450|19127952|P3|NOT COMPLETED|7 Day Wash-out||0
7769408|NCT01373450|19127953|P2|NOT COMPLETED|7 Day Wash-out||0
7769409|NCT01373450|19127954|P1|NOT COMPLETED|7 Day Wash-out||0
7769410|NCT01373450|19127949|P6|COMPLETED|7 Day Wash-out||2
7769411|NCT01373450|19127950|P5|COMPLETED|7 Day Wash-out||2
7769412|NCT01373450|19127951|P4|COMPLETED|7 Day Wash-out||2
7769413|NCT01373450|19127952|P3|COMPLETED|7 Day Wash-out||2
7769414|NCT01373450|19127953|P2|COMPLETED|7 Day Wash-out||2
7769415|NCT01373450|19127954|P1|COMPLETED|7 Day Wash-out||2
7769416|NCT01373450|19127949|P6|STARTED|7 Day Wash-out||2
7769417|NCT01373450|19127950|P5|STARTED|7 Day Wash-out||2
7769418|NCT01373450|19127951|P4|STARTED|7 Day Wash-out||2
7769419|NCT01373450|19127952|P3|STARTED|7 Day Wash-out||2
7769420|NCT01373450|19127953|P2|STARTED|7 Day Wash-out||2
7769421|NCT01373450|19127954|P1|STARTED|7 Day Wash-out||2
7769422|NCT01373450|19127949|P6|NOT COMPLETED|Crossover Period 1||0
7769423|NCT01373450|19127950|P5|NOT COMPLETED|Crossover Period 1||0
7769424|NCT01373450|19127951|P4|NOT COMPLETED|Crossover Period 1||0
7769425|NCT01373450|19127952|P3|NOT COMPLETED|Crossover Period 1||0
7769426|NCT01373450|19127953|P2|NOT COMPLETED|Crossover Period 1||0
7769427|NCT01373450|19127954|P1|NOT COMPLETED|Crossover Period 1||0
7769428|NCT01373450|19127949|P6|COMPLETED|Crossover Period 1||2
7769429|NCT01373450|19127950|P5|COMPLETED|Crossover Period 1||2
7769430|NCT01373450|19127951|P4|COMPLETED|Crossover Period 1||2
7769431|NCT01373450|19127952|P3|COMPLETED|Crossover Period 1||2
7769432|NCT01373450|19127953|P2|COMPLETED|Crossover Period 1||2
7769433|NCT01373450|19127954|P1|COMPLETED|Crossover Period 1||2
7769434|NCT01373450|19127949|P6|STARTED|Crossover Period 1||2
7769435|NCT01373450|19127950|P5|STARTED|Crossover Period 1||2
7769436|NCT01373450|19127951|P4|STARTED|Crossover Period 1||2
7769437|NCT01373450|19127952|P3|STARTED|Crossover Period 1||2
7769438|NCT01373450|19127953|P2|STARTED|Crossover Period 1||2
7769439|NCT01373450|19127954|P1|STARTED|Crossover Period 1||2
7769440|NCT01373346|19127976|P1|NOT COMPLETED|Overall Study||1
7769441|NCT01373346|19127976|P1|COMPLETED|Overall Study||14
7769442|NCT01373346|19127976|P1|STARTED|Overall Study||15
7769443|NCT01373294|19127999|P2|NOT COMPLETED|Overall Study||0
7769444|NCT01373294|19128000|P1|NOT COMPLETED|Overall Study||1
7769445|NCT01373294|19127999|P2|COMPLETED|Overall Study||2
7769446|NCT01373294|19128000|P1|COMPLETED|Overall Study||14
7769447|NCT01373294|19127999|P2|STARTED|Overall Study||2
7769448|NCT01373294|19128000|P1|STARTED|Overall Study||15
7769449|NCT01373281|19128009|P2|NOT COMPLETED|Surveillance Expansion Period||118
7769450|NCT01373281|19128010|P1|NOT COMPLETED|Surveillance Expansion Period||202
7769451|NCT01373281|19128009|P2|COMPLETED|Surveillance Expansion Period||3279
7769452|NCT01373281|19128010|P1|COMPLETED|Surveillance Expansion Period||6595
7769453|NCT01373281|19128009|P2|STARTED|Surveillance Expansion Period||3397
7769454|NCT01373281|19128010|P1|STARTED|Surveillance Expansion Period||6797
7769455|NCT01373281|19128009|P2|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||27
7769456|NCT01373281|19128010|P1|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||54
7769457|NCT01373281|19128009|P2|COMPLETED|Vaccination Phase (Up to 25 Months)||3397
7769458|NCT01373281|19128010|P1|COMPLETED|Vaccination Phase (Up to 25 Months)||6797
7769459|NCT01373281|19128009|P2|STARTED|Vaccination Phase (Up to 25 Months)||3424
7769460|NCT01373281|19128010|P1|STARTED|Vaccination Phase (Up to 25 Months)||6851
7769461|NCT01373242|19128042|P1|NOT COMPLETED|Overall Study||16
7769462|NCT01373242|19128042|P1|COMPLETED|Overall Study||38
7769463|NCT01373242|19128042|P1|STARTED|Overall Study||54
7769464|NCT01373229|19128058|P1|NOT COMPLETED|Overall Study||6
7769465|NCT01373229|19128058|P1|COMPLETED|Overall Study||9
7769466|NCT01373229|19128058|P1|STARTED|Overall Study||15
7769467|NCT01373164|19128072|P5|NOT COMPLETED|Overall Study||2
7769468|NCT01373164|19128073|P4|NOT COMPLETED|Overall Study||12
7769469|NCT01373164|19128074|P3|NOT COMPLETED|Overall Study||1
7769470|NCT01373164|19128075|P2|NOT COMPLETED|Overall Study||1
7769471|NCT01373164|19128076|P1|NOT COMPLETED|Overall Study||0
7769472|NCT01373164|19128072|P5|COMPLETED|Overall Study||50
7769473|NCT01373164|19128073|P4|COMPLETED|Overall Study||92
7769474|NCT01373164|19128074|P3|COMPLETED|Overall Study||4
7769475|NCT01373164|19128075|P2|COMPLETED|Overall Study||3
7769476|NCT01373164|19128076|P1|COMPLETED|Overall Study||5
7769477|NCT01373164|19128072|P5|Received at Least One Dose|Overall Study||52
7769478|NCT01373164|19128073|P4|Received at Least One Dose|Overall Study||103
7769479|NCT01373164|19128074|P3|Received at Least One Dose|Overall Study||5
7769480|NCT01373164|19128075|P2|Received at Least One Dose|Overall Study||4
7769481|NCT01373164|19128076|P1|Received at Least One Dose|Overall Study||5
7769482|NCT01373164|19128072|P5|STARTED|Overall Study||52
7769483|NCT01373164|19128073|P4|STARTED|Overall Study||104
7769484|NCT01373164|19128074|P3|STARTED|Overall Study||5
7769485|NCT01373164|19128075|P2|STARTED|Overall Study||4
7769486|NCT01373164|19128076|P1|STARTED|Overall Study||5
7769487|NCT01372995|19128110|P3|NOT COMPLETED|Overall Study||1
7769488|NCT01372995|19128111|P2|NOT COMPLETED|Overall Study||1
7769489|NCT01372995|19128112|P1|NOT COMPLETED|Overall Study||0
7769490|NCT01372995|19128110|P3|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10
7769491|NCT01372995|19128111|P2|COMPLETED|Overall Study||9
7769492|NCT01372995|19128112|P1|COMPLETED|Overall Study||10
7769493|NCT01372995|19128110|P3|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11
7769494|NCT01372995|19128111|P2|STARTED|Overall Study||10
7769495|NCT01372995|19128112|P1|STARTED|Overall Study||10
7769496|NCT01372878|19128159|P1|NOT COMPLETED|Overall Study||184
7769497|NCT01372878|19128159|P1|COMPLETED|Overall Study||700
7769498|NCT01372878|19128159|P1|STARTED|Overall Study||884
7769499|NCT01372813|19128164|P1|NOT COMPLETED|Overall Study||0
7769500|NCT01372813|19128164|P1|COMPLETED|Overall Study||3
7769501|NCT01372813|19128164|P1|STARTED|Overall Study||3
7769502|NCT01372774|19128179|P2|NOT COMPLETED|Overall Study||5
7769503|NCT01372774|19128180|P1|NOT COMPLETED|Overall Study||4
7769504|NCT01372774|19128179|P2|COMPLETED|Overall Study||93
7769505|NCT01372774|19128180|P1|COMPLETED|Overall Study||92
7769506|NCT01372774|19128179|P2|STARTED|Overall Study||98
7769507|NCT01372774|19128180|P1|STARTED|Overall Study||96
7769508|NCT01372748|19128196|P2|NOT COMPLETED|Overall Study||39
7769509|NCT01372748|19128197|P1|NOT COMPLETED|Overall Study||23
7769510|NCT01372748|19128196|P2|COMPLETED|Overall Study|defined as having vital status|12603
7769511|NCT01372748|19128197|P1|COMPLETED|Overall Study|defined as having vital status|11022
7769512|NCT01372748|19128196|P2|STARTED|Overall Study||12642
7769513|NCT01372748|19128197|P1|STARTED|Overall Study||11045
7769514|NCT01372618|19128205|P1|NOT COMPLETED|Overall Study||9
7769515|NCT01372618|19128205|P1|COMPLETED|Overall Study||0
7769516|NCT01372618|19128205|P1|STARTED|Overall Study||9
7769517|NCT01372605|19128213|P2|NOT COMPLETED|Overall Study||10
7769518|NCT01372605|19128214|P1|NOT COMPLETED|Overall Study||12
7769519|NCT01372605|19128213|P2|COMPLETED|Overall Study||145
7769520|NCT01372605|19128214|P1|COMPLETED|Overall Study||137
7769521|NCT01372605|19128213|P2|STARTED|Overall Study||155
7769522|NCT01372605|19128214|P1|STARTED|Overall Study||149
7769523|NCT01372501|19128240|P1|NOT COMPLETED|Overall Study||5
7769524|NCT01372501|19128240|P1|COMPLETED|Overall Study||14
7769525|NCT01372501|19128240|P1|STARTED|Overall Study||19
7769526|NCT01372462|19128245|P1|NOT COMPLETED|No Treatment Control||0
7769527|NCT01372462|19128245|P1|COMPLETED|No Treatment Control||15
7769528|NCT01372462|19128245|P1|STARTED|No Treatment Control||15
7769529|NCT01372462|19128245|P1|NOT COMPLETED|Oxygen Nasal Cannula||0
7769530|NCT01372462|19128245|P1|COMPLETED|Oxygen Nasal Cannula||15
7769531|NCT01372462|19128245|P1|STARTED|Oxygen Nasal Cannula||15
7769532|NCT01372462|19128245|P1|NOT COMPLETED|NIOV - Oxygen||0
7769533|NCT01372462|19128245|P1|COMPLETED|NIOV - Oxygen||15
7769534|NCT01372462|19128245|P1|STARTED|NIOV - Oxygen||15
7769535|NCT01372462|19128245|P1|NOT COMPLETED|NIOV - Room Air||0
7769536|NCT01372462|19128245|P1|COMPLETED|NIOV - Room Air||15
7769537|NCT01372462|19128245|P1|STARTED|NIOV - Room Air||15
7769538|NCT01372410|19128263|P8|NOT COMPLETED|Treatment Period 3 (7 Days)||0
7769539|NCT01372410|19128264|P7|NOT COMPLETED|Treatment Period 3 (7 Days)||0
7769540|NCT01372410|19128265|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||1
7769541|NCT01372410|19128266|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
7769542|NCT01372410|19128267|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
7769543|NCT01372410|19128268|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||1
7769544|NCT01372410|19128269|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
7769545|NCT01372410|19128270|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
7769546|NCT01372410|19128263|P8|COMPLETED|Treatment Period 3 (7 Days)||18
7769547|NCT01372410|19128264|P7|COMPLETED|Treatment Period 3 (7 Days)||15
7769548|NCT01372410|19128265|P6|COMPLETED|Treatment Period 3 (7 Days)||18
7769549|NCT01372410|19128266|P5|COMPLETED|Treatment Period 3 (7 Days)||20
7769550|NCT01372410|19128267|P4|COMPLETED|Treatment Period 3 (7 Days)||22
7769551|NCT01372410|19128268|P3|COMPLETED|Treatment Period 3 (7 Days)||15
7769552|NCT01372410|19128269|P2|COMPLETED|Treatment Period 3 (7 Days)||18
7769553|NCT01372410|19128270|P1|COMPLETED|Treatment Period 3 (7 Days)||21
7769554|NCT01372410|19128263|P8|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
7769555|NCT01372410|19128264|P7|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15
7769556|NCT01372410|19128265|P6|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
7769557|NCT01372410|19128266|P5|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20
7769558|NCT01372410|19128267|P4|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
7769559|NCT01372410|19128268|P3|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
7769560|NCT01372410|19128269|P2|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
7769561|NCT01372410|19128270|P1|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
7769562|NCT01372410|19128263|P8|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
7769563|NCT01372410|19128264|P7|NOT COMPLETED|Washout Period 2 (10-14 Days)||1
7769564|NCT01372410|19128265|P6|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
7769565|NCT01372410|19128266|P5|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
7769566|NCT01372410|19128267|P4|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
7769567|NCT01372410|19128268|P3|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
7769568|NCT01372410|19128269|P2|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
7769569|NCT01372410|19128270|P1|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
7769570|NCT01372410|19128263|P8|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
7769571|NCT01372410|19128264|P7|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
7769572|NCT01372410|19128265|P6|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16
7769573|NCT01372410|19128266|P5|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
7769574|NCT01372410|19128267|P4|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
7769575|NCT01372410|19128268|P3|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22
7769576|NCT01372410|19128269|P2|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
7769577|NCT01372410|19128270|P1|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
7769578|NCT01372410|19128263|P8|STARTED|Washout Period 2 (10-14 Days)||19
7769579|NCT01372410|19128264|P7|STARTED|Washout Period 2 (10-14 Days)||21
7769580|NCT01372410|19128265|P6|STARTED|Washout Period 2 (10-14 Days)||16
7769581|NCT01372410|19128266|P5|STARTED|Washout Period 2 (10-14 Days)||19
7769582|NCT01372410|19128267|P4|STARTED|Washout Period 2 (10-14 Days)||17
7769583|NCT01372410|19128268|P3|STARTED|Washout Period 2 (10-14 Days)||22
7769584|NCT01372410|19128269|P2|STARTED|Washout Period 2 (10-14 Days)||21
7769585|NCT01372410|19128270|P1|STARTED|Washout Period 2 (10-14 Days)||19
7769586|NCT01372410|19128263|P8|NOT COMPLETED|Treatment Period 2 (7 Days)||0
7769587|NCT01372410|19128264|P7|NOT COMPLETED|Treatment Period 2 (7 Days)||0
7769588|NCT01372410|19128265|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||0
7769589|NCT01372410|19128266|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
7769590|NCT01372410|19128267|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
7769591|NCT01372410|19128268|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||0
7769592|NCT01372410|19128269|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
7769593|NCT01372410|19128270|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
7769594|NCT01372410|19128263|P8|COMPLETED|Treatment Period 2 (7 Days)||19
7769595|NCT01372410|19128264|P7|COMPLETED|Treatment Period 2 (7 Days)||21
7769596|NCT01372410|19128265|P6|COMPLETED|Treatment Period 2 (7 Days)||16
7769597|NCT01372410|19128266|P5|COMPLETED|Treatment Period 2 (7 Days)||19
7769598|NCT01372410|19128267|P4|COMPLETED|Treatment Period 2 (7 Days)||17
7769599|NCT01372410|19128268|P3|COMPLETED|Treatment Period 2 (7 Days)||22
7769600|NCT01372410|19128269|P2|COMPLETED|Treatment Period 2 (7 Days)||21
7769601|NCT01372410|19128270|P1|COMPLETED|Treatment Period 2 (7 Days)||19
7769602|NCT01372410|19128263|P8|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
7769603|NCT01372410|19128264|P7|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
7769604|NCT01372410|19128265|P6|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
7769605|NCT01372410|19128266|P5|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
7769606|NCT01372410|19128267|P4|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17
7769607|NCT01372410|19128268|P3|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
7769608|NCT01372410|19128269|P2|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
7769609|NCT01372410|19128270|P1|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
7769610|NCT01372410|19128263|P8|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
7769611|NCT01372410|19128264|P7|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
7769612|NCT01372410|19128265|P6|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
7769613|NCT01372410|19128266|P5|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
7769614|NCT01372410|19128267|P4|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
7769615|NCT01372410|19128268|P3|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
7769616|NCT01372410|19128269|P2|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
7769617|NCT01372410|19128270|P1|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
7769618|NCT01372410|19128263|P8|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
7769619|NCT01372410|19128264|P7|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
7769620|NCT01372410|19128265|P6|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
7769621|NCT01372410|19128266|P5|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
7769622|NCT01372410|19128267|P4|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
7769623|NCT01372410|19128268|P3|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
7769624|NCT01372410|19128269|P2|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
7769625|NCT01372410|19128270|P1|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
7769626|NCT01372410|19128263|P8|STARTED|Washout Period 1 (10-14 Days)||19
7769627|NCT01372410|19128264|P7|STARTED|Washout Period 1 (10-14 Days)||20
7769628|NCT01372410|19128265|P6|STARTED|Washout Period 1 (10-14 Days)||21
7769629|NCT01372410|19128266|P5|STARTED|Washout Period 1 (10-14 Days)||19
7769630|NCT01372410|19128267|P4|STARTED|Washout Period 1 (10-14 Days)||20
7769631|NCT01372410|19128268|P3|STARTED|Washout Period 1 (10-14 Days)||19
7769632|NCT01372410|19128269|P2|STARTED|Washout Period 1 (10-14 Days)||19
7769633|NCT01372410|19128270|P1|STARTED|Washout Period 1 (10-14 Days)||19
7769634|NCT01372410|19128263|P8|NOT COMPLETED|Treatment Period 1 (7 Days)||0
7769635|NCT01372410|19128264|P7|NOT COMPLETED|Treatment Period 1 (7 Days)||2
7769636|NCT01372410|19128265|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
7769637|NCT01372410|19128266|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||2
7769638|NCT01372410|19128267|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||0
7769639|NCT01372410|19128268|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
7769640|NCT01372410|19128269|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||2
7769641|NCT01372410|19128270|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||1
7769642|NCT01372410|19128263|P8|COMPLETED|Treatment Period 1 (7 Days)||19
7769643|NCT01372410|19128264|P7|COMPLETED|Treatment Period 1 (7 Days)||20
7769644|NCT01372410|19128265|P6|COMPLETED|Treatment Period 1 (7 Days)||21
7769645|NCT01372410|19128266|P5|COMPLETED|Treatment Period 1 (7 Days)||19
7769646|NCT01372410|19128267|P4|COMPLETED|Treatment Period 1 (7 Days)||20
7769647|NCT01372410|19128268|P3|COMPLETED|Treatment Period 1 (7 Days)||19
7769648|NCT01372410|19128269|P2|COMPLETED|Treatment Period 1 (7 Days)||19
7769649|NCT01372410|19128270|P1|COMPLETED|Treatment Period 1 (7 Days)||19
7769650|NCT01372410|19128263|P8|STARTED|Treatment Period 1 (7 Days)||19
7769651|NCT01372410|19128264|P7|STARTED|Treatment Period 1 (7 Days)||22
7769652|NCT01372410|19128265|P6|STARTED|Treatment Period 1 (7 Days)||21
7769653|NCT01372410|19128266|P5|STARTED|Treatment Period 1 (7 Days)||21
7769654|NCT01372410|19128267|P4|STARTED|Treatment Period 1 (7 Days)||20
7769655|NCT01372410|19128268|P3|STARTED|Treatment Period 1 (7 Days)||19
7769656|NCT01372410|19128269|P2|STARTED|Treatment Period 1 (7 Days)||21
7769657|NCT01372410|19128270|P1|STARTED|Treatment Period 1 (7 Days)||20
7769658|NCT01372384|19128307|P1|NOT COMPLETED|Overall Study||3
7769659|NCT01372384|19128307|P1|COMPLETED|Overall Study||3
7769660|NCT01372384|19128307|P1|STARTED|Overall Study||6
7769661|NCT01372254|19128316|P2|NOT COMPLETED|Overall Study||3
7769662|NCT01372254|19128317|P1|NOT COMPLETED|Overall Study||4
7769663|NCT01372254|19128316|P2|COMPLETED|Overall Study||46
7769664|NCT01372254|19128317|P1|COMPLETED|Overall Study||43
7769665|NCT01372254|19128316|P2|STARTED|Overall Study||49
7769666|NCT01372254|19128317|P1|STARTED|Overall Study||47
7769667|NCT01372202|19128326|P3|NOT COMPLETED|Overall Study||0
7769668|NCT01372202|19128327|P2|NOT COMPLETED|Overall Study||0
7769669|NCT01372202|19128328|P1|NOT COMPLETED|Overall Study||0
7769670|NCT01372202|19128326|P3|COMPLETED|Overall Study||9
7769671|NCT01372202|19128327|P2|COMPLETED|Overall Study||9
7769672|NCT01372202|19128328|P1|COMPLETED|Overall Study||13
7769673|NCT01372202|19128326|P3|STARTED|Overall Study||9
7769674|NCT01372202|19128327|P2|STARTED|Overall Study||9
7769675|NCT01372202|19128328|P1|STARTED|Overall Study||13
7769676|NCT01372150|19128348|P3|NOT COMPLETED|Overall Study||16
7769677|NCT01372150|19128349|P2|NOT COMPLETED|Overall Study||14
7769678|NCT01372150|19128350|P1|NOT COMPLETED|Overall Study||13
7769679|NCT01372150|19128348|P3|COMPLETED|Overall Study||99
7769680|NCT01372150|19128349|P2|COMPLETED|Overall Study||99
7769681|NCT01372150|19128350|P1|COMPLETED|Overall Study||99
7769682|NCT01372150|19128348|P3|Treated|Overall Study||115
7769683|NCT01372150|19128349|P2|Treated|Overall Study||112
7769684|NCT01372150|19128350|P1|Treated|Overall Study||112
7769685|NCT01372150|19128348|P3|STARTED|Overall Study||115
7769686|NCT01372150|19128349|P2|STARTED|Overall Study||113
7769687|NCT01372150|19128350|P1|STARTED|Overall Study||112
7769688|NCT01372085|19128377|P10|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
7769689|NCT01372085|19128378|P9|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
7769690|NCT01372085|19128379|P8|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
7769691|NCT01372085|19128380|P7|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
7769692|NCT01372085|19128381|P6|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
7769693|NCT01372085|19128382|P5|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
7769694|NCT01372085|19128383|P4|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
7769695|NCT01372085|19128384|P3|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
7769696|NCT01372085|19128385|P2|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
7769697|NCT01372085|19128386|P1|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
7769698|NCT01372085|19128377|P10|COMPLETED|Forth Intervention (Period 4a/4b)||1
7769699|NCT01372085|19128378|P9|COMPLETED|Forth Intervention (Period 4a/4b)||1
7769700|NCT01372085|19128379|P8|COMPLETED|Forth Intervention (Period 4a/4b)||1
7769701|NCT01372085|19128380|P7|COMPLETED|Forth Intervention (Period 4a/4b)||3
7769702|NCT01372085|19128381|P6|COMPLETED|Forth Intervention (Period 4a/4b)||5
7769703|NCT01372085|19128382|P5|COMPLETED|Forth Intervention (Period 4a/4b)||2
7769704|NCT01372085|19128383|P4|COMPLETED|Forth Intervention (Period 4a/4b)||1
7769705|NCT01372085|19128384|P3|COMPLETED|Forth Intervention (Period 4a/4b)||2
7769706|NCT01372085|19128385|P2|COMPLETED|Forth Intervention (Period 4a/4b)||0
7769707|NCT01372085|19128386|P1|COMPLETED|Forth Intervention (Period 4a/4b)||0
7769708|NCT01372085|19128377|P10|STARTED|Forth Intervention (Period 4a/4b)|One pt was enrolled directly into P4b to fulfill requirement for safety and tolerability assessment.|1
7769709|NCT01372085|19128378|P9|STARTED|Forth Intervention (Period 4a/4b)||1
7769710|NCT01372085|19128379|P8|STARTED|Forth Intervention (Period 4a/4b)||1
7769711|NCT01372085|19128380|P7|STARTED|Forth Intervention (Period 4a/4b)||3
7769712|NCT01372085|19128381|P6|STARTED|Forth Intervention (Period 4a/4b)||5
7769713|NCT01372085|19128382|P5|STARTED|Forth Intervention (Period 4a/4b)||2
7769714|NCT01372085|19128383|P4|STARTED|Forth Intervention (Period 4a/4b)||1
7769715|NCT01372085|19128384|P3|STARTED|Forth Intervention (Period 4a/4b)||2
7769716|NCT01372085|19128385|P2|STARTED|Forth Intervention (Period 4a/4b)||0
7769717|NCT01372085|19128386|P1|STARTED|Forth Intervention (Period 4a/4b)||0
7769718|NCT01372085|19128377|P10|NOT COMPLETED|Washout Period 3||0
7769719|NCT01372085|19128378|P9|NOT COMPLETED|Washout Period 3||0
7769720|NCT01372085|19128379|P8|NOT COMPLETED|Washout Period 3||0
7769721|NCT01372085|19128380|P7|NOT COMPLETED|Washout Period 3||0
7769722|NCT01372085|19128381|P6|NOT COMPLETED|Washout Period 3||2
7769723|NCT01372085|19128382|P5|NOT COMPLETED|Washout Period 3||0
7769724|NCT01372085|19128383|P4|NOT COMPLETED|Washout Period 3||0
7769725|NCT01372085|19128384|P3|NOT COMPLETED|Washout Period 3||0
7769726|NCT01372085|19128385|P2|NOT COMPLETED|Washout Period 3||0
7769727|NCT01372085|19128386|P1|NOT COMPLETED|Washout Period 3||0
7769728|NCT01372085|19128377|P10|COMPLETED|Washout Period 3||0
7769729|NCT01372085|19128378|P9|COMPLETED|Washout Period 3||1
7769730|NCT01372085|19128379|P8|COMPLETED|Washout Period 3||1
7769731|NCT01372085|19128380|P7|COMPLETED|Washout Period 3||3
7769732|NCT01372085|19128381|P6|COMPLETED|Washout Period 3|Two participants (pts) discontinued Washout P3 and were replaced in P3.|5
7769733|NCT01372085|19128382|P5|COMPLETED|Washout Period 3||2
7769734|NCT01372085|19128383|P4|COMPLETED|Washout Period 3||1
7769735|NCT01372085|19128384|P3|COMPLETED|Washout Period 3||2
7769736|NCT01372085|19128385|P2|COMPLETED|Washout Period 3||0
7769737|NCT01372085|19128386|P1|COMPLETED|Washout Period 3||0
7769738|NCT01372085|19128377|P10|STARTED|Washout Period 3||0
7769739|NCT01372085|19128378|P9|STARTED|Washout Period 3||1
7769740|NCT01372085|19128379|P8|STARTED|Washout Period 3||1
7769741|NCT01372085|19128380|P7|STARTED|Washout Period 3||3
7769742|NCT01372085|19128381|P6|STARTED|Washout Period 3||7
7769743|NCT01372085|19128382|P5|STARTED|Washout Period 3||2
7769744|NCT01372085|19128383|P4|STARTED|Washout Period 3||1
7769745|NCT01372085|19128384|P3|STARTED|Washout Period 3||2
7769746|NCT01372085|19128385|P2|STARTED|Washout Period 3||0
7769747|NCT01372085|19128386|P1|STARTED|Washout Period 3||0
7769748|NCT01372085|19128377|P10|NOT COMPLETED|Third Intervention (Period 3)||0
7769749|NCT01372085|19128378|P9|NOT COMPLETED|Third Intervention (Period 3)||0
7769750|NCT01372085|19128379|P8|NOT COMPLETED|Third Intervention (Period 3)||0
7769751|NCT01372085|19128380|P7|NOT COMPLETED|Third Intervention (Period 3)||0
7769752|NCT01372085|19128381|P6|NOT COMPLETED|Third Intervention (Period 3)||0
7769753|NCT01372085|19128382|P5|NOT COMPLETED|Third Intervention (Period 3)||0
7769754|NCT01372085|19128383|P4|NOT COMPLETED|Third Intervention (Period 3)||0
7769755|NCT01372085|19128384|P3|NOT COMPLETED|Third Intervention (Period 3)||0
7769756|NCT01372085|19128385|P2|NOT COMPLETED|Third Intervention (Period 3)||0
7769757|NCT01372085|19128386|P1|NOT COMPLETED|Third Intervention (Period 3)||0
7769758|NCT01372085|19128377|P10|COMPLETED|Third Intervention (Period 3)||0
7769759|NCT01372085|19128378|P9|COMPLETED|Third Intervention (Period 3)||1
7769760|NCT01372085|19128379|P8|COMPLETED|Third Intervention (Period 3)||1
7769761|NCT01372085|19128380|P7|COMPLETED|Third Intervention (Period 3)||3
7769762|NCT01372085|19128381|P6|COMPLETED|Third Intervention (Period 3)||7
7769763|NCT01372085|19128382|P5|COMPLETED|Third Intervention (Period 3)||2
7769764|NCT01372085|19128383|P4|COMPLETED|Third Intervention (Period 3)||1
7769765|NCT01372085|19128384|P3|COMPLETED|Third Intervention (Period 3)||2
7769766|NCT01372085|19128385|P2|COMPLETED|Third Intervention (Period 3)||0
7769767|NCT01372085|19128386|P1|COMPLETED|Third Intervention (Period 3)||0
7769768|NCT01372085|19128377|P10|STARTED|Third Intervention (Period 3)||0
7769769|NCT01372085|19128378|P9|STARTED|Third Intervention (Period 3)||1
7769770|NCT01372085|19128379|P8|STARTED|Third Intervention (Period 3)||1
7769771|NCT01372085|19128380|P7|STARTED|Third Intervention (Period 3)||3
7769857|NCT01372085|19128386|P1|COMPLETED|Washout Period 1||0
7769772|NCT01372085|19128381|P6|STARTED|Third Intervention (Period 3)|Replacement pts repeated Period (P) 3 to fulfill requirement for P3 versus P4a comparison.|7
7769773|NCT01372085|19128382|P5|STARTED|Third Intervention (Period 3)||2
7769774|NCT01372085|19128383|P4|STARTED|Third Intervention (Period 3)||1
7769775|NCT01372085|19128384|P3|STARTED|Third Intervention (Period 3)||2
7769776|NCT01372085|19128385|P2|STARTED|Third Intervention (Period 3)||0
7769777|NCT01372085|19128386|P1|STARTED|Third Intervention (Period 3)||0
7769778|NCT01372085|19128377|P10|NOT COMPLETED|Washout Period 2||0
7769779|NCT01372085|19128378|P9|NOT COMPLETED|Washout Period 2||0
7769780|NCT01372085|19128379|P8|NOT COMPLETED|Washout Period 2||0
7769781|NCT01372085|19128380|P7|NOT COMPLETED|Washout Period 2||0
7769782|NCT01372085|19128381|P6|NOT COMPLETED|Washout Period 2||0
7769783|NCT01372085|19128382|P5|NOT COMPLETED|Washout Period 2||1
7769784|NCT01372085|19128383|P4|NOT COMPLETED|Washout Period 2||0
7769785|NCT01372085|19128384|P3|NOT COMPLETED|Washout Period 2||0
7769786|NCT01372085|19128385|P2|NOT COMPLETED|Washout Period 2||0
7769787|NCT01372085|19128386|P1|NOT COMPLETED|Washout Period 2||0
7769788|NCT01372085|19128377|P10|COMPLETED|Washout Period 2||0
7769789|NCT01372085|19128378|P9|COMPLETED|Washout Period 2||1
7769790|NCT01372085|19128379|P8|COMPLETED|Washout Period 2||1
7769791|NCT01372085|19128380|P7|COMPLETED|Washout Period 2||3
7769792|NCT01372085|19128381|P6|COMPLETED|Washout Period 2||5
7769793|NCT01372085|19128382|P5|COMPLETED|Washout Period 2|One participant discontinued Washout Period 2 and was replaced in Period 1.|2
7769794|NCT01372085|19128383|P4|COMPLETED|Washout Period 2||1
7769795|NCT01372085|19128384|P3|COMPLETED|Washout Period 2||2
7769796|NCT01372085|19128385|P2|COMPLETED|Washout Period 2||0
7769797|NCT01372085|19128386|P1|COMPLETED|Washout Period 2||0
7769798|NCT01372085|19128377|P10|STARTED|Washout Period 2||0
7769799|NCT01372085|19128378|P9|STARTED|Washout Period 2||1
7769800|NCT01372085|19128379|P8|STARTED|Washout Period 2||1
7769801|NCT01372085|19128380|P7|STARTED|Washout Period 2||3
7769802|NCT01372085|19128381|P6|STARTED|Washout Period 2||5
7769803|NCT01372085|19128382|P5|STARTED|Washout Period 2||3
7769804|NCT01372085|19128383|P4|STARTED|Washout Period 2||1
7769805|NCT01372085|19128384|P3|STARTED|Washout Period 2||2
7769806|NCT01372085|19128385|P2|STARTED|Washout Period 2||0
7769807|NCT01372085|19128386|P1|STARTED|Washout Period 2||0
7769808|NCT01372085|19128377|P10|NOT COMPLETED|Second Intervention (Period 2)||0
7769809|NCT01372085|19128378|P9|NOT COMPLETED|Second Intervention (Period 2)||0
7769810|NCT01372085|19128379|P8|NOT COMPLETED|Second Intervention (Period 2)||0
7769811|NCT01372085|19128380|P7|NOT COMPLETED|Second Intervention (Period 2)||0
7769812|NCT01372085|19128381|P6|NOT COMPLETED|Second Intervention (Period 2)||0
7769813|NCT01372085|19128382|P5|NOT COMPLETED|Second Intervention (Period 2)||0
7769814|NCT01372085|19128383|P4|NOT COMPLETED|Second Intervention (Period 2)||0
7769815|NCT01372085|19128384|P3|NOT COMPLETED|Second Intervention (Period 2)||0
7769816|NCT01372085|19128385|P2|NOT COMPLETED|Second Intervention (Period 2)||0
7769817|NCT01372085|19128386|P1|NOT COMPLETED|Second Intervention (Period 2)||0
7769818|NCT01372085|19128377|P10|COMPLETED|Second Intervention (Period 2)||0
7769819|NCT01372085|19128378|P9|COMPLETED|Second Intervention (Period 2)||1
7769820|NCT01372085|19128379|P8|COMPLETED|Second Intervention (Period 2)||1
7769821|NCT01372085|19128380|P7|COMPLETED|Second Intervention (Period 2)||3
7769822|NCT01372085|19128381|P6|COMPLETED|Second Intervention (Period 2)||5
7769823|NCT01372085|19128382|P5|COMPLETED|Second Intervention (Period 2)||3
7769824|NCT01372085|19128383|P4|COMPLETED|Second Intervention (Period 2)||1
7769825|NCT01372085|19128384|P3|COMPLETED|Second Intervention (Period 2)||2
7769826|NCT01372085|19128385|P2|COMPLETED|Second Intervention (Period 2)||0
7769827|NCT01372085|19128386|P1|COMPLETED|Second Intervention (Period 2)||0
7769828|NCT01372085|19128377|P10|STARTED|Second Intervention (Period 2)||0
7769829|NCT01372085|19128378|P9|STARTED|Second Intervention (Period 2)||1
7769830|NCT01372085|19128379|P8|STARTED|Second Intervention (Period 2)||1
7769831|NCT01372085|19128380|P7|STARTED|Second Intervention (Period 2)||3
7769832|NCT01372085|19128381|P6|STARTED|Second Intervention (Period 2)||5
7769833|NCT01372085|19128382|P5|STARTED|Second Intervention (Period 2)||3
7769834|NCT01372085|19128383|P4|STARTED|Second Intervention (Period 2)||1
7769835|NCT01372085|19128384|P3|STARTED|Second Intervention (Period 2)||2
7769836|NCT01372085|19128385|P2|STARTED|Second Intervention (Period 2)||0
7769837|NCT01372085|19128386|P1|STARTED|Second Intervention (Period 2)||0
7769838|NCT01372085|19128377|P10|NOT COMPLETED|Washout Period 1||0
7769839|NCT01372085|19128378|P9|NOT COMPLETED|Washout Period 1||0
7769840|NCT01372085|19128379|P8|NOT COMPLETED|Washout Period 1||0
7769841|NCT01372085|19128380|P7|NOT COMPLETED|Washout Period 1||0
7769842|NCT01372085|19128381|P6|NOT COMPLETED|Washout Period 1||0
7769843|NCT01372085|19128382|P5|NOT COMPLETED|Washout Period 1||0
7769844|NCT01372085|19128383|P4|NOT COMPLETED|Washout Period 1||0
7769845|NCT01372085|19128384|P3|NOT COMPLETED|Washout Period 1||0
7769846|NCT01372085|19128385|P2|NOT COMPLETED|Washout Period 1||0
7769847|NCT01372085|19128386|P1|NOT COMPLETED|Washout Period 1||0
7769848|NCT01372085|19128377|P10|COMPLETED|Washout Period 1||0
7769849|NCT01372085|19128378|P9|COMPLETED|Washout Period 1||1
7769850|NCT01372085|19128379|P8|COMPLETED|Washout Period 1||1
7769851|NCT01372085|19128380|P7|COMPLETED|Washout Period 1||3
7769852|NCT01372085|19128381|P6|COMPLETED|Washout Period 1||5
7769853|NCT01372085|19128382|P5|COMPLETED|Washout Period 1||3
7769854|NCT01372085|19128383|P4|COMPLETED|Washout Period 1||1
7769855|NCT01372085|19128384|P3|COMPLETED|Washout Period 1||2
7769856|NCT01372085|19128385|P2|COMPLETED|Washout Period 1||0
7769858|NCT01372085|19128377|P10|STARTED|Washout Period 1||0
7769859|NCT01372085|19128378|P9|STARTED|Washout Period 1||1
7769860|NCT01372085|19128379|P8|STARTED|Washout Period 1||1
7769861|NCT01372085|19128380|P7|STARTED|Washout Period 1||3
7769862|NCT01372085|19128381|P6|STARTED|Washout Period 1||5
7769863|NCT01372085|19128382|P5|STARTED|Washout Period 1||3
7769864|NCT01372085|19128383|P4|STARTED|Washout Period 1||1
7769865|NCT01372085|19128384|P3|STARTED|Washout Period 1||2
7769866|NCT01372085|19128385|P2|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
7769867|NCT01372085|19128386|P1|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
7769868|NCT01372085|19128377|P10|NOT COMPLETED|First Intervention (Period 1)||0
7769869|NCT01372085|19128378|P9|NOT COMPLETED|First Intervention (Period 1)||0
7769870|NCT01372085|19128379|P8|NOT COMPLETED|First Intervention (Period 1)||0
7769871|NCT01372085|19128380|P7|NOT COMPLETED|First Intervention (Period 1)||0
7769872|NCT01372085|19128381|P6|NOT COMPLETED|First Intervention (Period 1)||0
7769873|NCT01372085|19128382|P5|NOT COMPLETED|First Intervention (Period 1)||0
7769874|NCT01372085|19128383|P4|NOT COMPLETED|First Intervention (Period 1)||0
7769875|NCT01372085|19128384|P3|NOT COMPLETED|First Intervention (Period 1)||0
7769876|NCT01372085|19128385|P2|NOT COMPLETED|First Intervention (Period 1)||0
7769877|NCT01372085|19128386|P1|NOT COMPLETED|First Intervention (Period 1)||0
7769878|NCT01372085|19128377|P10|COMPLETED|First Intervention (Period 1)||0
7769879|NCT01372085|19128378|P9|COMPLETED|First Intervention (Period 1)||1
7769880|NCT01372085|19128379|P8|COMPLETED|First Intervention (Period 1)||1
7769881|NCT01372085|19128380|P7|COMPLETED|First Intervention (Period 1)||3
7769882|NCT01372085|19128381|P6|COMPLETED|First Intervention (Period 1)||5
7769883|NCT01372085|19128382|P5|COMPLETED|First Intervention (Period 1)||3
7769884|NCT01372085|19128383|P4|COMPLETED|First Intervention (Period 1)||1
7769885|NCT01372085|19128384|P3|COMPLETED|First Intervention (Period 1)||2
7769886|NCT01372085|19128385|P2|COMPLETED|First Intervention (Period 1)||2
7769887|NCT01372085|19128386|P1|COMPLETED|First Intervention (Period 1)||8
7769888|NCT01372085|19128377|P10|STARTED|First Intervention (Period 1)||0
7769889|NCT01372085|19128378|P9|STARTED|First Intervention (Period 1)||1
7769890|NCT01372085|19128379|P8|STARTED|First Intervention (Period 1)||1
7769891|NCT01372085|19128380|P7|STARTED|First Intervention (Period 1)||3
7769892|NCT01372085|19128381|P6|STARTED|First Intervention (Period 1)||5
7769893|NCT01372085|19128382|P5|STARTED|First Intervention (Period 1)|Replacement participant repeated Periods 1, 2 to fulfill treatment arm comparison requirements.|3
7769894|NCT01372085|19128383|P4|STARTED|First Intervention (Period 1)||1
7769895|NCT01372085|19128384|P3|STARTED|First Intervention (Period 1)||2
7769896|NCT01372085|19128385|P2|STARTED|First Intervention (Period 1)||2
7769897|NCT01372085|19128386|P1|STARTED|First Intervention (Period 1)||8
7769898|NCT01371994|19128418|P2|NOT COMPLETED|Overall Study||42
7769899|NCT01371994|19128419|P1|NOT COMPLETED|Overall Study||57
7769900|NCT01371994|19128418|P2|COMPLETED|Overall Study||278
7769901|NCT01371994|19128419|P1|COMPLETED|Overall Study||263
7769902|NCT01371994|19128418|P2|Received Treatment|Overall Study||313
7769903|NCT01371994|19128419|P1|Received Treatment|Overall Study||310
7769904|NCT01371994|19128418|P2|STARTED|Overall Study||320
7769905|NCT01371994|19128419|P1|STARTED|Overall Study||320
7769906|NCT01371981|19128467|P6|NOT COMPLETED|Overall Study||14
7769907|NCT01371981|19128468|P5|NOT COMPLETED|Overall Study||32
7769908|NCT01371981|19128469|P4|NOT COMPLETED|Overall Study||21
7769909|NCT01371981|19128470|P3|NOT COMPLETED|Overall Study||6
7769910|NCT01371981|19128471|P2|NOT COMPLETED|Overall Study||192
7769911|NCT01371981|19128472|P1|NOT COMPLETED|Overall Study||184
7769912|NCT01371981|19128467|P6|COMPLETED|Overall Study||368
7769913|NCT01371981|19128468|P5|COMPLETED|Overall Study||15
7769914|NCT01371981|19128469|P4|COMPLETED|Overall Study||12
7769915|NCT01371981|19128470|P3|COMPLETED|Overall Study||6
7769916|NCT01371981|19128471|P2|COMPLETED|Overall Study||399
7769917|NCT01371981|19128472|P1|COMPLETED|Overall Study||396
7769918|NCT01371981|19128467|P6|STARTED|Overall Study||382
7769919|NCT01371981|19128468|P5|STARTED|Overall Study||47
7769920|NCT01371981|19128469|P4|STARTED|Overall Study||33
7769921|NCT01371981|19128470|P3|STARTED|Overall Study||12
7769922|NCT01371981|19128471|P2|STARTED|Overall Study||591
7769923|NCT01371981|19128472|P1|STARTED|Overall Study||580
7769924|NCT01371877|19128531|P2|NOT COMPLETED|Overall Study||4
7769925|NCT01371877|19128532|P1|NOT COMPLETED|Overall Study||0
7769926|NCT01371877|19128531|P2|COMPLETED|Overall Study||17
7769927|NCT01371877|19128532|P1|COMPLETED|Overall Study||21
7769928|NCT01371877|19128531|P2|STARTED|Overall Study||21
7769929|NCT01371877|19128532|P1|STARTED|Overall Study||21
7769930|NCT01371851|19128544|P2|NOT COMPLETED|Overall Study||9
7769931|NCT01371851|19128545|P1|NOT COMPLETED|Overall Study||8
7769932|NCT01371851|19128544|P2|COMPLETED|Overall Study||2
7769933|NCT01371851|19128545|P1|COMPLETED|Overall Study||3
7769934|NCT01371851|19128544|P2|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
7769935|NCT01371851|19128545|P1|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
7769936|NCT01371838|19128553|P2|NOT COMPLETED|Overall Study||66
7769937|NCT01371838|19128554|P1|NOT COMPLETED|Overall Study||49
7769938|NCT01371838|19128553|P2|COMPLETED|Overall Study||317
7769939|NCT01371838|19128554|P1|COMPLETED|Overall Study||332
7769940|NCT01371838|19128553|P2|STARTED|Overall Study||383
7769941|NCT01371838|19128554|P1|STARTED|Overall Study||381
7769942|NCT01371825|19128590|P1|NOT COMPLETED|Overall Study||4
7769943|NCT01371825|19128590|P1|COMPLETED|Overall Study||5
7769944|NCT01371825|19128590|P1|Received at Least 1 Dose of Study Drug|Overall Study||9
7769945|NCT01371825|19128590|P1|STARTED|Overall Study||9
7769946|NCT01371786|19128603|P2|NOT COMPLETED|Overall Study||0
7769947|NCT01371786|19128604|P1|NOT COMPLETED|Overall Study||0
7769948|NCT01371786|19128603|P2|COMPLETED|Overall Study||7
7769949|NCT01371786|19128604|P1|COMPLETED|Overall Study||7
7769950|NCT01371786|19128603|P2|STARTED|Overall Study||7
7769951|NCT01371786|19128604|P1|STARTED|Overall Study||7
7769952|NCT01371747|19128624|P6|NOT COMPLETED|Overall Study||14
7769953|NCT01371747|19128625|P5|NOT COMPLETED|Overall Study||7
7769954|NCT01371747|19128626|P4|NOT COMPLETED|Overall Study||9
7769955|NCT01371747|19128627|P3|NOT COMPLETED|Overall Study||24
7769956|NCT01371747|19128628|P2|NOT COMPLETED|Overall Study||23
7769957|NCT01371747|19128629|P1|NOT COMPLETED|Overall Study||18
7769958|NCT01371747|19128624|P6|COMPLETED|Overall Study||16
7769959|NCT01371747|19128625|P5|COMPLETED|Overall Study||21
7769960|NCT01371747|19128626|P4|COMPLETED|Overall Study||17
7769961|NCT01371747|19128627|P3|COMPLETED|Overall Study||50
7769962|NCT01371747|19128628|P2|COMPLETED|Overall Study||51
7769963|NCT01371747|19128629|P1|COMPLETED|Overall Study||56
7769964|NCT01371747|19128624|P6|STARTED|Overall Study||30
7769965|NCT01371747|19128625|P5|STARTED|Overall Study||28
7769966|NCT01371747|19128626|P4|STARTED|Overall Study||26
7769967|NCT01371747|19128627|P3|STARTED|Overall Study||74
7769968|NCT01371747|19128628|P2|STARTED|Overall Study||74
7769969|NCT01371747|19128629|P1|STARTED|Overall Study||74
7769970|NCT01371734|19128694|P3|NOT COMPLETED|Overall Study||17
7769971|NCT01371734|19128695|P2|NOT COMPLETED|Overall Study||19
7769972|NCT01371734|19128696|P1|NOT COMPLETED|Overall Study||23
7769973|NCT01371734|19128694|P3|COMPLETED|Overall Study||104
7769974|NCT01371734|19128695|P2|COMPLETED|Overall Study||103
7769975|NCT01371734|19128696|P1|COMPLETED|Overall Study||97
7769976|NCT01371734|19128694|P3|STARTED|Overall Study||121
7769977|NCT01371734|19128695|P2|STARTED|Overall Study||122
7769978|NCT01371734|19128696|P1|STARTED|Overall Study||120
7769979|NCT01371721|19128716|P3|NOT COMPLETED|Overall Study||30
7769980|NCT01371721|19128717|P2|NOT COMPLETED|Overall Study||24
7769981|NCT01371721|19128718|P1|NOT COMPLETED|Overall Study||29
7769982|NCT01371721|19128716|P3|COMPLETED|Overall Study||62
7769983|NCT01371721|19128717|P2|COMPLETED|Overall Study||65
7769984|NCT01371721|19128718|P1|COMPLETED|Overall Study||59
7769985|NCT01371721|19128716|P3|Treated|Overall Study||92
7769986|NCT01371721|19128717|P2|Treated|Overall Study||89
7769987|NCT01371721|19128718|P1|Treated|Overall Study||87
7769988|NCT01371721|19128716|P3|STARTED|Overall Study||92
7769989|NCT01371721|19128717|P2|STARTED|Overall Study||89
7769990|NCT01371721|19128718|P1|STARTED|Overall Study||88
7769991|NCT01371708|19128751|P3|NOT COMPLETED|Overall Study||39
7769992|NCT01371708|19128752|P2|NOT COMPLETED|Overall Study||30
7769993|NCT01371708|19128753|P1|NOT COMPLETED|Overall Study||26
7769994|NCT01371708|19128751|P3|COMPLETED|Overall Study||59
7769995|NCT01371708|19128752|P2|COMPLETED|Overall Study||63
7769996|NCT01371708|19128753|P1|COMPLETED|Overall Study||66
7769997|NCT01371708|19128751|P3|Received Treatment|Overall Study||97
7769998|NCT01371708|19128752|P2|Received Treatment|Overall Study||93
7769999|NCT01371708|19128753|P1|Received Treatment|Overall Study||91
7770000|NCT01371708|19128751|P3|STARTED|Overall Study||98
7770001|NCT01371708|19128752|P2|STARTED|Overall Study||93
7770002|NCT01371708|19128753|P1|STARTED|Overall Study||92
7770003|NCT01371656|19128785|P2|NOT COMPLETED|Overall Study||14
7770004|NCT01371656|19128786|P1|NOT COMPLETED|Overall Study||64
7770005|NCT01371656|19128785|P2|COMPLETED|Overall Study||296
7770006|NCT01371656|19128786|P1|COMPLETED|Overall Study||250
7770007|NCT01371656|19128785|P2|STARTED|Overall Study||310
7770008|NCT01371656|19128786|P1|STARTED|Overall Study||314
7770009|NCT01371643|19128806|P2|NOT COMPLETED|Overall Study||0
7770010|NCT01371643|19128807|P1|NOT COMPLETED|Overall Study||3
7770011|NCT01371643|19128806|P2|COMPLETED|Overall Study||26
7770012|NCT01371643|19128807|P1|COMPLETED|Overall Study||12
7770013|NCT01371643|19128806|P2|STARTED|Overall Study||26
7770014|NCT01371643|19128807|P1|STARTED|Overall Study||15
7770015|NCT01371565|19128817|P1|NOT COMPLETED|Overall Study||3
7770016|NCT01371565|19128817|P1|COMPLETED|Overall Study||1
7770017|NCT01371565|19128817|P1|STARTED|Overall Study||4
7770018|NCT01371552|19128821|P6|NOT COMPLETED|Part 2, One Week||0
7770019|NCT01371552|19128822|P5|NOT COMPLETED|Part 2, One Week||0
7770020|NCT01371552|19128823|P4|NOT COMPLETED|Part 2, One Week||0
7770021|NCT01371552|19128824|P3|NOT COMPLETED|Part 2, One Week||0
7770022|NCT01371552|19128825|P2|NOT COMPLETED|Part 2, One Week||0
7770023|NCT01371552|19128826|P1|NOT COMPLETED|Part 2, One Week||0
7770024|NCT01371552|19128821|P6|COMPLETED|Part 2, One Week||18
7770025|NCT01371552|19128822|P5|COMPLETED|Part 2, One Week||15
7770026|NCT01371552|19128823|P4|COMPLETED|Part 2, One Week||20
7770027|NCT01371552|19128824|P3|COMPLETED|Part 2, One Week||18
7770028|NCT01371552|19128825|P2|COMPLETED|Part 2, One Week||17
7770029|NCT01371552|19128826|P1|COMPLETED|Part 2, One Week||18
7770030|NCT01371552|19128821|P6|STARTED|Part 2, One Week||18
7770031|NCT01371552|19128822|P5|STARTED|Part 2, One Week||15
7770032|NCT01371552|19128823|P4|STARTED|Part 2, One Week||20
7770033|NCT01371552|19128824|P3|STARTED|Part 2, One Week||18
7770034|NCT01371552|19128825|P2|STARTED|Part 2, One Week||17
7770035|NCT01371552|19128826|P1|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18
7770036|NCT01371552|19128821|P6|NOT COMPLETED|Part 1, Third 3 Days||1
7770037|NCT01371552|19128822|P5|NOT COMPLETED|Part 1, Third 3 Days||1
7770038|NCT01371552|19128823|P4|NOT COMPLETED|Part 1, Third 3 Days||0
7770039|NCT01371552|19128824|P3|NOT COMPLETED|Part 1, Third 3 Days||0
7770040|NCT01371552|19128825|P2|NOT COMPLETED|Part 1, Third 3 Days||0
7770041|NCT01371552|19128826|P1|NOT COMPLETED|Part 1, Third 3 Days||0
7770042|NCT01371552|19128821|P6|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17
7770043|NCT01371552|19128822|P5|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14
7770044|NCT01371552|19128823|P4|COMPLETED|Part 1, Third 3 Days||20
7770045|NCT01371552|19128824|P3|COMPLETED|Part 1, Third 3 Days||18
7770046|NCT01371552|19128825|P2|COMPLETED|Part 1, Third 3 Days||17
7770047|NCT01371552|19128826|P1|COMPLETED|Part 1, Third 3 Days||19
7770048|NCT01371552|19128821|P6|STARTED|Part 1, Third 3 Days||18
7770049|NCT01371552|19128822|P5|STARTED|Part 1, Third 3 Days||15
7770050|NCT01371552|19128823|P4|STARTED|Part 1, Third 3 Days||20
7770051|NCT01371552|19128824|P3|STARTED|Part 1, Third 3 Days||18
7770052|NCT01371552|19128825|P2|STARTED|Part 1, Third 3 Days||17
7770053|NCT01371552|19128826|P1|STARTED|Part 1, Third 3 Days||19
7770054|NCT01371552|19128821|P6|NOT COMPLETED|Part 1, Second 3 Days||0
7770055|NCT01371552|19128822|P5|NOT COMPLETED|Part 1, Second 3 Days||0
7770056|NCT01371552|19128823|P4|NOT COMPLETED|Part 1, Second 3 Days||0
7770057|NCT01371552|19128824|P3|NOT COMPLETED|Part 1, Second 3 Days||0
7770058|NCT01371552|19128825|P2|NOT COMPLETED|Part 1, Second 3 Days||0
7770059|NCT01371552|19128826|P1|NOT COMPLETED|Part 1, Second 3 Days||1
7770060|NCT01371552|19128821|P6|COMPLETED|Part 1, Second 3 Days||18
7770061|NCT01371552|19128822|P5|COMPLETED|Part 1, Second 3 Days||15
7770062|NCT01371552|19128823|P4|COMPLETED|Part 1, Second 3 Days||20
7770063|NCT01371552|19128824|P3|COMPLETED|Part 1, Second 3 Days||18
7770064|NCT01371552|19128825|P2|COMPLETED|Part 1, Second 3 Days||17
7770065|NCT01371552|19128826|P1|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18
7770066|NCT01371552|19128821|P6|STARTED|Part 1, Second 3 Days||18
7770067|NCT01371552|19128822|P5|STARTED|Part 1, Second 3 Days||15
7770068|NCT01371552|19128823|P4|STARTED|Part 1, Second 3 Days||20
7770069|NCT01371552|19128824|P3|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18
7770070|NCT01371552|19128825|P2|STARTED|Part 1, Second 3 Days||17
7770071|NCT01371552|19128826|P1|STARTED|Part 1, Second 3 Days||19
7770072|NCT01371552|19128821|P6|NOT COMPLETED|Part 1, First 3 Days||0
7770073|NCT01371552|19128822|P5|NOT COMPLETED|Part 1, First 3 Days||0
7770074|NCT01371552|19128823|P4|NOT COMPLETED|Part 1, First 3 Days||0
7770075|NCT01371552|19128824|P3|NOT COMPLETED|Part 1, First 3 Days||1
7770076|NCT01371552|19128825|P2|NOT COMPLETED|Part 1, First 3 Days||0
7770077|NCT01371552|19128826|P1|NOT COMPLETED|Part 1, First 3 Days||0
7770078|NCT01371552|19128821|P6|COMPLETED|Part 1, First 3 Days||18
7770079|NCT01371552|19128822|P5|COMPLETED|Part 1, First 3 Days||15
7770080|NCT01371552|19128823|P4|COMPLETED|Part 1, First 3 Days||20
7770081|NCT01371552|19128824|P3|COMPLETED|Part 1, First 3 Days||19
7770082|NCT01371552|19128825|P2|COMPLETED|Part 1, First 3 Days||17
7770083|NCT01371552|19128826|P1|COMPLETED|Part 1, First 3 Days||19
7770084|NCT01371552|19128821|P6|STARTED|Part 1, First 3 Days||18
7770085|NCT01371552|19128822|P5|STARTED|Part 1, First 3 Days||15
7770086|NCT01371552|19128823|P4|STARTED|Part 1, First 3 Days||20
7770087|NCT01371552|19128824|P3|STARTED|Part 1, First 3 Days||20
7770088|NCT01371552|19128825|P2|STARTED|Part 1, First 3 Days||17
7770089|NCT01371552|19128826|P1|STARTED|Part 1, First 3 Days||19
7770090|NCT01371539|19128853|P2|NOT COMPLETED|Period Two: One Week||3
7770091|NCT01371539|19128854|P1|NOT COMPLETED|Period Two: One Week||0
7770092|NCT01371539|19128853|P2|COMPLETED|Period Two: One Week||47
7770093|NCT01371539|19128854|P1|COMPLETED|Period Two: One Week||53
7770094|NCT01371539|19128853|P2|STARTED|Period Two: One Week||50
7770095|NCT01371539|19128854|P1|STARTED|Period Two: One Week||53
7770096|NCT01371539|19128853|P2|NOT COMPLETED|Period One: One Week||1
7770097|NCT01371539|19128854|P1|NOT COMPLETED|Period One: One Week||0
7770098|NCT01371539|19128853|P2|COMPLETED|Period One: One Week||50
7770099|NCT01371539|19128854|P1|COMPLETED|Period One: One Week||53
7770100|NCT01371539|19128853|P2|STARTED|Period One: One Week||51
7770101|NCT01371539|19128854|P1|STARTED|Period One: One Week||53
7770102|NCT01371305|19128868|P6|NOT COMPLETED|Overall Study||2
7770103|NCT01371305|19128869|P5|NOT COMPLETED|Overall Study||4
7770104|NCT01371305|19128870|P4|NOT COMPLETED|Overall Study||2
7770105|NCT01371305|19128871|P3|NOT COMPLETED|Overall Study||0
7770106|NCT01371305|19128872|P2|NOT COMPLETED|Overall Study||0
7770107|NCT01371305|19128873|P1|NOT COMPLETED|Overall Study||0
7770108|NCT01371305|19128868|P6|COMPLETED|Overall Study||8
7770109|NCT01371305|19128869|P5|COMPLETED|Overall Study||2
7770110|NCT01371305|19128870|P4|COMPLETED|Overall Study||5
7770111|NCT01371305|19128871|P3|COMPLETED|Overall Study||6
7770112|NCT01371305|19128872|P2|COMPLETED|Overall Study||6
7770113|NCT01371305|19128873|P1|COMPLETED|Overall Study||6
7770114|NCT01371305|19128868|P6|STARTED|Overall Study||10
7770115|NCT01371305|19128869|P5|STARTED|Overall Study||6
7770116|NCT01371305|19128870|P4|STARTED|Overall Study||7
7770117|NCT01371305|19128871|P3|STARTED|Overall Study||6
7770118|NCT01371305|19128872|P2|STARTED|Overall Study||6
7770119|NCT01371305|19128873|P1|STARTED|Overall Study||6
7770120|NCT01371110|19128946|P2|NOT COMPLETED|Overall Study||0
7770121|NCT01371110|19128947|P1|NOT COMPLETED|Overall Study||0
7770122|NCT01371110|19128946|P2|COMPLETED|Overall Study||2
7770123|NCT01371110|19128947|P1|COMPLETED|Overall Study||1
7770124|NCT01371110|19128946|P2|STARTED|Overall Study||2
7770125|NCT01371110|19128947|P1|STARTED|Overall Study||1
7770126|NCT01371006|19128957|P2|NOT COMPLETED|Overall Study||0
7770127|NCT01371006|19128958|P1|NOT COMPLETED|Overall Study||1
7770128|NCT01371006|19128957|P2|COMPLETED|Overall Study||15
7770129|NCT01371006|19128958|P1|COMPLETED|Overall Study||13
7770130|NCT01371006|19128957|P2|STARTED|Overall Study||15
7770131|NCT01371006|19128958|P1|STARTED|Overall Study||14
7770132|NCT01370863|19128999|P2|NOT COMPLETED|Overall Study||3
7770133|NCT01370863|19129000|P1|NOT COMPLETED|Overall Study||2
7770134|NCT01370863|19128999|P2|COMPLETED|Overall Study||30
7770135|NCT01370863|19129000|P1|COMPLETED|Overall Study||32
7770136|NCT01370863|19128999|P2|STARTED|Overall Study||33
7770137|NCT01370863|19129000|P1|STARTED|Overall Study||34
7770138|NCT01370837|19129013|P3|NOT COMPLETED|Overall Study||0
7770139|NCT01370837|19129014|P2|NOT COMPLETED|Overall Study||0
7770140|NCT01370837|19129015|P1|NOT COMPLETED|Overall Study||0
7770141|NCT01370837|19129013|P3|COMPLETED|Overall Study||17
7770142|NCT01370837|19129014|P2|COMPLETED|Overall Study||12
7770143|NCT01370837|19129015|P1|COMPLETED|Overall Study||12
7770144|NCT01370837|19129013|P3|STARTED|Overall Study||17
7770145|NCT01370837|19129014|P2|STARTED|Overall Study||12
7770146|NCT01370837|19129015|P1|STARTED|Overall Study||12
7770147|NCT01370733|19129025|P2|NOT COMPLETED|Overall Study||22
7770148|NCT01370733|19129026|P1|NOT COMPLETED|Overall Study||17
7770149|NCT01370733|19129025|P2|COMPLETED|Overall Study||77
7770150|NCT01370733|19129026|P1|COMPLETED|Overall Study||86
7770151|NCT01370733|19129025|P2|STARTED|Overall Study||99
7770152|NCT01370733|19129026|P1|STARTED|Overall Study||103
7770153|NCT01370694|19129048|P1|NOT COMPLETED|Overall Study||6
7770154|NCT01370694|19129048|P1|COMPLETED|Overall Study||1
7770155|NCT01370694|19129048|P1|STARTED|Overall Study||7
7770156|NCT01370655|19129070|P12|NOT COMPLETED|Period 2||0
7770157|NCT01370655|19129071|P11|NOT COMPLETED|Period 2||1
7770158|NCT01370655|19129072|P10|NOT COMPLETED|Period 2||0
7770159|NCT01370655|19129073|P9|NOT COMPLETED|Period 2||2
7770160|NCT01370655|19129074|P8|NOT COMPLETED|Period 2||1
7770161|NCT01370655|19129075|P7|NOT COMPLETED|Period 2||1
7770162|NCT01370655|19129076|P6|NOT COMPLETED|Period 2||0
7770163|NCT01370655|19129077|P5|NOT COMPLETED|Period 2||1
7770164|NCT01370655|19129078|P4|NOT COMPLETED|Period 2||0
7770165|NCT01370655|19129079|P3|NOT COMPLETED|Period 2||2
7770166|NCT01370655|19129080|P2|NOT COMPLETED|Period 2||0
7770167|NCT01370655|19129081|P1|NOT COMPLETED|Period 2||0
7770168|NCT01370655|19129070|P12|COMPLETED|Period 2||3
7770169|NCT01370655|19129071|P11|COMPLETED|Period 2||2
7770170|NCT01370655|19129072|P10|COMPLETED|Period 2||2
7770171|NCT01370655|19129073|P9|COMPLETED|Period 2||1
7770172|NCT01370655|19129074|P8|COMPLETED|Period 2||3
7770173|NCT01370655|19129075|P7|COMPLETED|Period 2||2
7770174|NCT01370655|19129076|P6|COMPLETED|Period 2||4
7770175|NCT01370655|19129077|P5|COMPLETED|Period 2||2
7770176|NCT01370655|19129078|P4|COMPLETED|Period 2||3
7770177|NCT01370655|19129079|P3|COMPLETED|Period 2||1
7770178|NCT01370655|19129080|P2|COMPLETED|Period 2||7
7770179|NCT01370655|19129081|P1|COMPLETED|Period 2||5
7770180|NCT01370655|19129070|P12|STARTED|Period 2||3
7770181|NCT01370655|19129071|P11|STARTED|Period 2||3
7770182|NCT01370655|19129072|P10|STARTED|Period 2||2
7770183|NCT01370655|19129073|P9|STARTED|Period 2||3
7770184|NCT01370655|19129074|P8|STARTED|Period 2||4
7770185|NCT01370655|19129075|P7|STARTED|Period 2||3
7770186|NCT01370655|19129076|P6|STARTED|Period 2||4
7770187|NCT01370655|19129077|P5|STARTED|Period 2||3
7770188|NCT01370655|19129078|P4|STARTED|Period 2||3
7770189|NCT01370655|19129079|P3|STARTED|Period 2||3
7770190|NCT01370655|19129080|P2|STARTED|Period 2||7
7770191|NCT01370655|19129081|P1|STARTED|Period 2||5
7770192|NCT01370655|19129070|P12|NOT COMPLETED|Period 1||0
7770193|NCT01370655|19129071|P11|NOT COMPLETED|Period 1||0
7770194|NCT01370655|19129072|P10|NOT COMPLETED|Period 1||0
7770195|NCT01370655|19129073|P9|NOT COMPLETED|Period 1||0
7770196|NCT01370655|19129074|P8|NOT COMPLETED|Period 1||0
7770197|NCT01370655|19129075|P7|NOT COMPLETED|Period 1||1
7770198|NCT01370655|19129076|P6|NOT COMPLETED|Period 1||0
7770199|NCT01370655|19129077|P5|NOT COMPLETED|Period 1||0
7770200|NCT01370655|19129078|P4|NOT COMPLETED|Period 1||0
7770201|NCT01370655|19129079|P3|NOT COMPLETED|Period 1||0
7770202|NCT01370655|19129080|P2|NOT COMPLETED|Period 1||0
7770203|NCT01370655|19129081|P1|NOT COMPLETED|Period 1||2
7770204|NCT01370655|19129070|P12|COMPLETED|Period 1||3
7770205|NCT01370655|19129071|P11|COMPLETED|Period 1||3
7770206|NCT01370655|19129072|P10|COMPLETED|Period 1||2
7770207|NCT01370655|19129073|P9|COMPLETED|Period 1||3
7770208|NCT01370655|19129074|P8|COMPLETED|Period 1||4
7770209|NCT01370655|19129075|P7|COMPLETED|Period 1||3
7770210|NCT01370655|19129076|P6|COMPLETED|Period 1||4
7770211|NCT01370655|19129077|P5|COMPLETED|Period 1||3
7770212|NCT01370655|19129078|P4|COMPLETED|Period 1||3
7770213|NCT01370655|19129079|P3|COMPLETED|Period 1||3
7770214|NCT01370655|19129080|P2|COMPLETED|Period 1||7
7770215|NCT01370655|19129081|P1|COMPLETED|Period 1||5
7770216|NCT01370655|19129070|P12|STARTED|Period 1||3
7770217|NCT01370655|19129071|P11|STARTED|Period 1||3
7770218|NCT01370655|19129072|P10|STARTED|Period 1||2
7770219|NCT01370655|19129073|P9|STARTED|Period 1||3
7770220|NCT01370655|19129074|P8|STARTED|Period 1||4
7770221|NCT01370655|19129075|P7|STARTED|Period 1||4
7770222|NCT01370655|19129076|P6|STARTED|Period 1||4
7770223|NCT01370655|19129077|P5|STARTED|Period 1||3
7770224|NCT01370655|19129078|P4|STARTED|Period 1||3
7770225|NCT01370655|19129079|P3|STARTED|Period 1||3
7770226|NCT01370655|19129080|P2|STARTED|Period 1||7
7770227|NCT01370655|19129081|P1|STARTED|Period 1||7
7770228|NCT01370642|19129118|P3|NOT COMPLETED|Overall Study||29
7770229|NCT01370642|19129119|P2|NOT COMPLETED|Overall Study||6
7770230|NCT01370642|19129120|P1|NOT COMPLETED|Overall Study||8
7770231|NCT01370642|19129118|P3|COMPLETED|Overall Study||69
7770232|NCT01370642|19129119|P2|COMPLETED|Overall Study||92
7770233|NCT01370642|19129120|P1|COMPLETED|Overall Study||90
7770234|NCT01370642|19129118|P3|FAS Population|Overall Study||98
7770235|NCT01370642|19129119|P2|FAS Population|Overall Study||97
7770236|NCT01370642|19129120|P1|FAS Population|Overall Study||98
7770237|NCT01370642|19129118|P3|STARTED|Overall Study||98
7770238|NCT01370642|19129119|P2|STARTED|Overall Study||98
7770239|NCT01370642|19129120|P1|STARTED|Overall Study||98
7770240|NCT01370629|19129149|P1|NOT COMPLETED|Overall Study||6
7770241|NCT01370629|19129149|P1|COMPLETED|Overall Study||2009
7770242|NCT01370629|19129149|P1|STARTED|Overall Study||2015
7770243|NCT01370616|19129159|P2|NOT COMPLETED|Overall Study||67
7770244|NCT01370616|19129160|P1|NOT COMPLETED|Overall Study||62
7770245|NCT01370616|19129159|P2|COMPLETED|Overall Study||216
7770246|NCT01370616|19129160|P1|COMPLETED|Overall Study||220
7770247|NCT01370616|19129159|P2|Treated|Overall Study||275
7770248|NCT01370616|19129160|P1|Treated|Overall Study||275
7770249|NCT01370616|19129159|P2|STARTED|Overall Study|Participants randomized|283
7770250|NCT01370616|19129160|P1|STARTED|Overall Study|Participants randomized|282
7770251|NCT01370603|19129184|P2|NOT COMPLETED|Period 2||4
7770252|NCT01370603|19129185|P1|NOT COMPLETED|Period 2||3
7770253|NCT01370603|19129184|P2|COMPLETED|Period 2||146
7770254|NCT01370603|19129185|P1|COMPLETED|Period 2||138
7770255|NCT01370603|19129184|P2|STARTED|Period 2||150
7770256|NCT01370603|19129185|P1|STARTED|Period 2||141
7770257|NCT01370603|19129184|P2|NOT COMPLETED|Crossover Washout||4
7770258|NCT01370603|19129185|P1|NOT COMPLETED|Crossover Washout||9
7770259|NCT01370603|19129184|P2|COMPLETED|Crossover Washout||150
7770260|NCT01370603|19129185|P1|COMPLETED|Crossover Washout||141
7770261|NCT01370603|19129184|P2|STARTED|Crossover Washout||154
7770262|NCT01370603|19129185|P1|STARTED|Crossover Washout||150
7770263|NCT01370603|19129184|P2|NOT COMPLETED|Period 1||10
7770264|NCT01370603|19129185|P1|NOT COMPLETED|Period 1||14
7770265|NCT01370603|19129184|P2|COMPLETED|Period 1||154
7770266|NCT01370603|19129185|P1|COMPLETED|Period 1||150
7770267|NCT01370603|19129184|P2|STARTED|Period 1||164
7770268|NCT01370603|19129185|P1|STARTED|Period 1||164
7770269|NCT01370590|19129203|P2|NOT COMPLETED|Period 2||2
7770270|NCT01370590|19129204|P1|NOT COMPLETED|Period 2||1
7770271|NCT01370590|19129203|P2|COMPLETED|Period 2||184
7770272|NCT01370590|19129204|P1|COMPLETED|Period 2||180
7770273|NCT01370590|19129203|P2|STARTED|Period 2||186
7770274|NCT01370590|19129204|P1|STARTED|Period 2||181
7770275|NCT01370590|19129203|P2|NOT COMPLETED|Crossover Washout Period||6
7770276|NCT01370590|19129204|P1|NOT COMPLETED|Crossover Washout Period||6
7770277|NCT01370590|19129203|P2|COMPLETED|Crossover Washout Period||186
7770278|NCT01370590|19129204|P1|COMPLETED|Crossover Washout Period||181
7770279|NCT01370590|19129203|P2|STARTED|Crossover Washout Period||192
7770280|NCT01370590|19129204|P1|STARTED|Crossover Washout Period||187
7770281|NCT01370590|19129203|P2|NOT COMPLETED|Period 1||11
7770282|NCT01370590|19129204|P1|NOT COMPLETED|Period 1||16
7770283|NCT01370590|19129203|P2|COMPLETED|Period 1||192
7770284|NCT01370590|19129204|P1|COMPLETED|Period 1||187
7770285|NCT01370590|19129203|P2|STARTED|Period 1||203
7770286|NCT01370590|19129204|P1|STARTED|Period 1||203
7770287|NCT01370564|19129220|P1|NOT COMPLETED|Overall Study||0
7770288|NCT01370564|19129220|P1|COMPLETED|Overall Study||21
7770289|NCT01370564|19129220|P1|STARTED|Overall Study||21
7770290|NCT01370538|19129232|P2|NOT COMPLETED|Overall Study||19
7770291|NCT01370538|19129233|P1|NOT COMPLETED|Overall Study||19
7770292|NCT01370538|19129232|P2|COMPLETED|Overall Study||152
7770293|NCT01370538|19129233|P1|COMPLETED|Overall Study||151
7770294|NCT01370538|19129232|P2|Patients Who Completed Treatment|Overall Study||152
7770295|NCT01370538|19129233|P1|Patients Who Completed Treatment|Overall Study||151
7770296|NCT01370538|19129232|P2|Patients Who Received Treatment|Overall Study||161
7770297|NCT01370538|19129233|P1|Patients Who Received Treatment|Overall Study||165
7770298|NCT01370538|19129232|P2|STARTED|Overall Study||171
7770299|NCT01370538|19129233|P1|STARTED|Overall Study||170
7770300|NCT01370525|19129249|P2|NOT COMPLETED|Overall Study||11
7770301|NCT01370525|19129250|P1|NOT COMPLETED|Overall Study||8
7770302|NCT01370525|19129249|P2|COMPLETED|Overall Study||158
7770303|NCT01370525|19129250|P1|COMPLETED|Overall Study||163
7770304|NCT01370525|19129249|P2|Patients Who Completed Treatment|Overall Study||158
7770305|NCT01370525|19129250|P1|Patients Who Completed Treatment|Overall Study||163
7770306|NCT01370525|19129249|P2|Patients Who Received Treatment|Overall Study||163
7770307|NCT01370525|19129250|P1|Patients Who Received Treatment|Overall Study||168
7770308|NCT01370525|19129249|P2|STARTED|Overall Study||169
7770309|NCT01370525|19129250|P1|STARTED|Overall Study||171
7770310|NCT01370499|19129266|P2|NOT COMPLETED|Overall Study||44
7770311|NCT01370499|19129267|P1|NOT COMPLETED|Overall Study||111
7770312|NCT01370499|19129266|P2|COMPLETED|Overall Study||49
7770313|NCT01370499|19129267|P1|COMPLETED|Overall Study||84
7770314|NCT01370499|19129266|P2|Received at Least 1 Dose of Study Drug|Overall Study||92
7770315|NCT01370499|19129267|P1|Received at Least 1 Dose of Study Drug|Overall Study||195
7770316|NCT01370499|19129266|P2|Entered Abrupt Discontinuation Phase|Overall Study|One participant who entered the abrupt discontinuation phase did not receive study drug.|85
7770317|NCT01370499|19129267|P1|Entered Abrupt Discontinuation Phase|Overall Study||188
7770318|NCT01370499|19129266|P2|STARTED|Overall Study||93
7770319|NCT01370499|19129267|P1|STARTED|Overall Study||195
7770320|NCT01370460|19129301|P2|NOT COMPLETED|Overall Study||0
7770321|NCT01370460|19129302|P1|NOT COMPLETED|Overall Study||0
7770322|NCT01370460|19129301|P2|COMPLETED|Overall Study||51
7770323|NCT01370460|19129302|P1|COMPLETED|Overall Study||50
7770324|NCT01370460|19129301|P2|STARTED|Overall Study||51
7770325|NCT01370460|19129302|P1|STARTED|Overall Study||50
7770326|NCT01370408|19129309|P1|NOT COMPLETED|Overall Study||9
7770327|NCT01370408|19129309|P1|COMPLETED|Overall Study||76
7770328|NCT01370408|19129309|P1|STARTED|Overall Study||85
7770329|NCT01370369|19129320|P1|NOT COMPLETED|Overall Study||0
7770330|NCT01370369|19129320|P1|COMPLETED|Overall Study||20
7770331|NCT01370369|19129320|P1|STARTED|Overall Study||20
7770332|NCT01370356|19129369|P2|NOT COMPLETED|Overall Study||227
7770333|NCT01370356|19129370|P1|NOT COMPLETED|Overall Study||192
7770334|NCT01370356|19129369|P2|COMPLETED|Overall Study||515
7770335|NCT01370356|19129370|P1|COMPLETED|Overall Study||559
7770336|NCT01370356|19129369|P2|STARTED|Overall Study||742
7770337|NCT01370356|19129370|P1|STARTED|Overall Study||751
7770338|NCT01370317|19129386|P2|NOT COMPLETED|Overall Study||1
7770339|NCT01370317|19129387|P1|NOT COMPLETED|Overall Study||1
7770340|NCT01370317|19129386|P2|COMPLETED|Overall Study||8
7770341|NCT01370317|19129387|P1|COMPLETED|Overall Study||17
7770342|NCT01370317|19129386|P2|STARTED|Overall Study||9
7770343|NCT01370317|19129387|P1|STARTED|Overall Study||18
7770344|NCT01370265|19129398|P2|NOT COMPLETED|Second Intervention||0
7770345|NCT01370265|19129399|P1|NOT COMPLETED|Second Intervention||0
7770346|NCT01370265|19129398|P2|COMPLETED|Second Intervention||5
7770347|NCT01370265|19129399|P1|COMPLETED|Second Intervention||5
7770348|NCT01370265|19129398|P2|STARTED|Second Intervention||5
7770349|NCT01370265|19129399|P1|STARTED|Second Intervention||5
7770350|NCT01370265|19129398|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
7770351|NCT01370265|19129399|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
7770352|NCT01370265|19129398|P2|COMPLETED|Washout Period (50-minute Period Decay)||5
7770353|NCT01370265|19129399|P1|COMPLETED|Washout Period (50-minute Period Decay)||5
7770354|NCT01370265|19129398|P2|STARTED|Washout Period (50-minute Period Decay)||5
7770355|NCT01370265|19129399|P1|STARTED|Washout Period (50-minute Period Decay)||5
7770356|NCT01370265|19129398|P2|NOT COMPLETED|First Intervention||1
7770357|NCT01370265|19129399|P1|NOT COMPLETED|First Intervention||1
7770358|NCT01370265|19129398|P2|COMPLETED|First Intervention||5
7770359|NCT01370265|19129399|P1|COMPLETED|First Intervention||5
7770360|NCT01370265|19129398|P2|STARTED|First Intervention||6
7770361|NCT01370265|19129399|P1|STARTED|First Intervention||6
7770362|NCT01370265|19129398|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
7770363|NCT01370265|19129399|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
7770364|NCT01370265|19129398|P2|COMPLETED|Washout Period (50-minute Period Decay)||6
7770365|NCT01370265|19129399|P1|COMPLETED|Washout Period (50-minute Period Decay)||6
7770366|NCT01370265|19129398|P2|STARTED|Washout Period (50-minute Period Decay)||6
7770367|NCT01370265|19129399|P1|STARTED|Washout Period (50-minute Period Decay)||6
7770368|NCT01370265|19129398|P2|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
7770369|NCT01370265|19129399|P1|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
7770370|NCT01370265|19129398|P2|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
7770371|NCT01370265|19129399|P1|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
7770372|NCT01370265|19129398|P2|STARTED|Resting Myocardial Blood Flow (MBF)||6
7770373|NCT01370265|19129399|P1|STARTED|Resting Myocardial Blood Flow (MBF)||6
7770374|NCT01370213|19129419|P3|NOT COMPLETED|Overall Study||0
7770375|NCT01370213|19129420|P2|NOT COMPLETED|Overall Study||2
7770376|NCT01370213|19129421|P1|NOT COMPLETED|Overall Study||1
7770377|NCT01370213|19129419|P3|COMPLETED|Overall Study||1
7770378|NCT01370213|19129420|P2|COMPLETED|Overall Study||15
7770379|NCT01370213|19129421|P1|COMPLETED|Overall Study||6
7770380|NCT01370213|19129419|P3|STARTED|Overall Study||1
7770381|NCT01370213|19129420|P2|STARTED|Overall Study||17
7770382|NCT01370213|19129421|P1|STARTED|Overall Study||7
7770383|NCT01370083|19129441|P2|NOT COMPLETED|Overall Study||1
7770384|NCT01370083|19129442|P1|NOT COMPLETED|Overall Study||2
7770385|NCT01370083|19129441|P2|COMPLETED|Overall Study||6
7770386|NCT01370083|19129442|P1|COMPLETED|Overall Study||5
7770387|NCT01370083|19129441|P2|STARTED|Overall Study||7
7770388|NCT01370083|19129442|P1|STARTED|Overall Study||7
7770389|NCT01370005|19129455|P3|NOT COMPLETED|Overall Study||11
7770390|NCT01370005|19129456|P2|NOT COMPLETED|Overall Study||11
7770391|NCT01370005|19129457|P1|NOT COMPLETED|Overall Study||16
7770392|NCT01370005|19129455|P3|COMPLETED|Overall Study||266
7770393|NCT01370005|19129456|P2|COMPLETED|Overall Study||265
7770394|NCT01370005|19129457|P1|COMPLETED|Overall Study||256
7770395|NCT01370005|19129455|P3|STARTED|Overall Study||277
7770396|NCT01370005|19129456|P2|STARTED|Overall Study||276
7770397|NCT01370005|19129457|P1|STARTED|Overall Study||272
7770398|NCT01369888|19129514|P4|NOT COMPLETED|Overall Study||0
7770399|NCT01369888|19129515|P3|NOT COMPLETED|Overall Study||0
7770400|NCT01369888|19129516|P2|NOT COMPLETED|Overall Study||0
7770401|NCT01369888|19129517|P1|NOT COMPLETED|Overall Study||0
7770402|NCT01369888|19129514|P4|COMPLETED|Overall Study||0
7770403|NCT01369888|19129515|P3|COMPLETED|Overall Study||0
7770404|NCT01369888|19129516|P2|COMPLETED|Overall Study||2
7770405|NCT01369888|19129517|P1|COMPLETED|Overall Study||1
7770406|NCT01369888|19129514|P4|STARTED|Overall Study||0
7770407|NCT01369888|19129515|P3|STARTED|Overall Study||0
7770408|NCT01369888|19129516|P2|STARTED|Overall Study||2
7770409|NCT01369888|19129517|P1|STARTED|Overall Study||1
7770410|NCT01369875|19129527|P2|NOT COMPLETED|Overall Study||0
7770411|NCT01369875|19129528|P1|NOT COMPLETED|Overall Study||0
7770412|NCT01369875|19129527|P2|COMPLETED|Overall Study||1
7770413|NCT01369875|19129528|P1|COMPLETED|Overall Study||1
7770414|NCT01369875|19129527|P2|STARTED|Overall Study||1
7770415|NCT01369875|19129528|P1|STARTED|Overall Study||1
7770416|NCT01369849|19129539|P3|NOT COMPLETED|Overall Study||1
7770417|NCT01369849|19129540|P2|NOT COMPLETED|Overall Study||1
7770418|NCT01369849|19129541|P1|NOT COMPLETED|Overall Study||0
7770419|NCT01369849|19129539|P3|COMPLETED|Overall Study||4
7770420|NCT01369849|19129540|P2|COMPLETED|Overall Study||3
7770421|NCT01369849|19129541|P1|COMPLETED|Overall Study||6
7770422|NCT01369849|19129539|P3|STARTED|Overall Study||5
7770423|NCT01369849|19129540|P2|STARTED|Overall Study||4
7770424|NCT01369849|19129541|P1|STARTED|Overall Study||6
7770425|NCT01369784|19129563|P1|NOT COMPLETED|Overall Study||12
7770426|NCT01369784|19129563|P1|COMPLETED|Overall Study||146
7770427|NCT01369784|19129563|P1|STARTED|Overall Study||158
7770428|NCT01369758|19129588|P1|NOT COMPLETED|Overall Study||0
7770429|NCT01369758|19129588|P1|COMPLETED|Overall Study||290
7770430|NCT01369758|19129588|P1|STARTED|Overall Study||290
7770431|NCT01369745|19129598|P5|NOT COMPLETED|Overall Study||18
7770432|NCT01369745|19129599|P4|NOT COMPLETED|Overall Study||20
7770433|NCT01369745|19129600|P3|NOT COMPLETED|Overall Study||2
7770434|NCT01369745|19129601|P2|NOT COMPLETED|Overall Study||13
7770435|NCT01369745|19129602|P1|NOT COMPLETED|Overall Study||7
7770436|NCT01369745|19129598|P5|COMPLETED|Overall Study||65
7770437|NCT01369745|19129599|P4|COMPLETED|Overall Study||64
7770438|NCT01369745|19129600|P3|COMPLETED|Overall Study||16
7770439|NCT01369745|19129601|P2|COMPLETED|Overall Study||28
7770440|NCT01369745|19129602|P1|COMPLETED|Overall Study||25
7770441|NCT01369745|19129598|P5|STARTED|Overall Study||83
7770442|NCT01369745|19129599|P4|STARTED|Overall Study||84
7770443|NCT01369745|19129600|P3|STARTED|Overall Study||18
7770444|NCT01369745|19129601|P2|STARTED|Overall Study||41
7770445|NCT01369745|19129602|P1|STARTED|Overall Study||32
7770446|NCT01369732|19129636|P2|NOT COMPLETED|Overall Study||2
7770447|NCT01369732|19129637|P1|NOT COMPLETED|Overall Study||4
7770448|NCT01369732|19129636|P2|COMPLETED|Overall Study||31
7770449|NCT01369732|19129637|P1|COMPLETED|Overall Study||29
7770450|NCT01369732|19129636|P2|STARTED|Overall Study||33
7770451|NCT01369732|19129637|P1|STARTED|Overall Study||33
7770452|NCT01369706|19129643|P1|NOT COMPLETED|Overall Study||0
7770453|NCT01369706|19129643|P1|COMPLETED|Overall Study||388
7770454|NCT01369706|19129643|P1|STARTED|Overall Study||388
7770455|NCT01369680|19129651|P4|NOT COMPLETED|Overall Study||2
7770456|NCT01369680|19129652|P3|NOT COMPLETED|Overall Study||1
7770457|NCT01369680|19129653|P2|NOT COMPLETED|Overall Study||0
7770458|NCT01369680|19129654|P1|NOT COMPLETED|Overall Study||0
7770459|NCT01369680|19129651|P4|COMPLETED|Overall Study||1
7770460|NCT01369680|19129652|P3|COMPLETED|Overall Study||2
7770461|NCT01369680|19129653|P2|COMPLETED|Overall Study||3
7770462|NCT01369680|19129654|P1|COMPLETED|Overall Study||3
7770463|NCT01369680|19129651|P4|STARTED|Overall Study||3
7770464|NCT01369680|19129652|P3|STARTED|Overall Study||3
7770465|NCT01369680|19129653|P2|STARTED|Overall Study||3
7770466|NCT01369680|19129654|P1|STARTED|Overall Study||3
7770467|NCT01369641|19129675|P1|NOT COMPLETED|Overall Study||1
7770468|NCT01369641|19129675|P1|COMPLETED|Overall Study||0
7770469|NCT01369641|19129675|P1|STARTED|Overall Study||1
7770470|NCT01369615|19129681|P2|NOT COMPLETED|Overall Study||2
7770471|NCT01369615|19129682|P1|NOT COMPLETED|Overall Study||0
7770472|NCT01369615|19129681|P2|COMPLETED|Overall Study||12
7770473|NCT01369615|19129682|P1|COMPLETED|Overall Study||9
7770474|NCT01369615|19129681|P2|STARTED|Overall Study||14
7770475|NCT01369615|19129682|P1|STARTED|Overall Study||9
7770476|NCT01369511|19129692|P4|NOT COMPLETED|Overall Study||11
7770477|NCT01369511|19129693|P3|NOT COMPLETED|Overall Study||11
7770478|NCT01369511|19129694|P2|NOT COMPLETED|Overall Study||13
7770479|NCT01369511|19129695|P1|NOT COMPLETED|Overall Study||13
7770480|NCT01369511|19129692|P4|COMPLETED|Overall Study||89
7770481|NCT01369511|19129693|P3|COMPLETED|Overall Study||87
7770482|NCT01369511|19129694|P2|COMPLETED|Overall Study||91
7770483|NCT01369511|19129695|P1|COMPLETED|Overall Study||85
7770484|NCT01369511|19129692|P4|Received at Least 1 Dose of Study Drug|Overall Study||100
7770485|NCT01369511|19129693|P3|Received at Least 1 Dose of Study Drug|Overall Study||98
7770486|NCT01369511|19129694|P2|Received at Least 1 Dose of Study Drug|Overall Study|One participant was a screen failure and inadvertently randomized but did not receive study drug.|103
7770487|NCT01369511|19129695|P1|Received at Least 1 Dose of Study Drug|Overall Study||98
7770488|NCT01369511|19129692|P4|STARTED|Overall Study||100
7770489|NCT01369511|19129693|P3|STARTED|Overall Study||98
7770490|NCT01369511|19129694|P2|STARTED|Overall Study||104
7770491|NCT01369511|19129695|P1|STARTED|Overall Study||98
7770492|NCT01369498|19129713|P4|NOT COMPLETED|Overall Study||15
7770493|NCT01369498|19129714|P3|NOT COMPLETED|Overall Study||15
7770494|NCT01369498|19129715|P2|NOT COMPLETED|Overall Study||12
7770495|NCT01369498|19129716|P1|NOT COMPLETED|Overall Study||12
7770496|NCT01369498|19129713|P4|COMPLETED|Overall Study||0
7770497|NCT01369498|19129714|P3|COMPLETED|Overall Study||0
7770498|NCT01369498|19129715|P2|COMPLETED|Overall Study||0
7770499|NCT01369498|19129716|P1|COMPLETED|Overall Study||0
7770500|NCT01369498|19129713|P4|STARTED|Overall Study||15
7770501|NCT01369498|19129714|P3|STARTED|Overall Study||15
7770502|NCT01369498|19129715|P2|STARTED|Overall Study||12
7770503|NCT01369498|19129716|P1|STARTED|Overall Study||12
7770504|NCT01369485|19129748|P2|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40
7770505|NCT01369485|19129749|P1|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33
7770506|NCT01369485|19129748|P2|COMPLETED|Open Label Phase (Week 12 to Month 12)||26
7770507|NCT01369485|19129749|P1|COMPLETED|Open Label Phase (Week 12 to Month 12)||24
7770508|NCT01369485|19129748|P2|STARTED|Open Label Phase (Week 12 to Month 12)||66
7770509|NCT01369485|19129749|P1|STARTED|Open Label Phase (Week 12 to Month 12)||57
7770510|NCT01369485|19129748|P2|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17
7770511|NCT01369485|19129749|P1|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23
7770512|NCT01369485|19129748|P2|COMPLETED|Randomized Phase (Day 0 to Week 12)||66
7770513|NCT01369485|19129749|P1|COMPLETED|Randomized Phase (Day 0 to Week 12)||57
7770514|NCT01369485|19129748|P2|STARTED|Randomized Phase (Day 0 to Week 12)||83
7770515|NCT01369485|19129749|P1|STARTED|Randomized Phase (Day 0 to Week 12)||80
7770516|NCT01369433|19129791|P2|NOT COMPLETED|Overall Study||16
7770517|NCT01369433|19129792|P1|NOT COMPLETED|Overall Study||209
7770518|NCT01369433|19129791|P2|COMPLETED|Overall Study||0
7770519|NCT01369433|19129792|P1|COMPLETED|Overall Study||0
7770520|NCT01369433|19129791|P2|STARTED|Overall Study||16
7770521|NCT01369433|19129792|P1|STARTED|Overall Study||209
7770522|NCT01369355|19129804|P9|NOT COMPLETED|Long-term Extension (Week 44-272)||171
7770523|NCT01369355|19129805|P8|NOT COMPLETED|Long-term Extension (Week 44-272)||106
7770524|NCT01369355|19129806|P7|NOT COMPLETED|Long-term Extension (Week 44-272)||151
7770525|NCT01369355|19129807|P6|NOT COMPLETED|Long-term Extension (Week 44-272)||0
7770526|NCT01369355|19129808|P5|NOT COMPLETED|Long-term Extension (Week 44-272)||0
7770527|NCT01369355|19129809|P4|NOT COMPLETED|Long-term Extension (Week 44-272)||0
7770528|NCT01369355|19129810|P3|NOT COMPLETED|Long-term Extension (Week 44-272)||0
7770529|NCT01369355|19129811|P2|NOT COMPLETED|Long-term Extension (Week 44-272)||0
7770530|NCT01369355|19129812|P1|NOT COMPLETED|Long-term Extension (Week 44-272)||0
7770531|NCT01369355|19129804|P9|COMPLETED|Long-term Extension (Week 44-272)||183
7770532|NCT01369355|19129805|P8|COMPLETED|Long-term Extension (Week 44-272)||107
7770533|NCT01369355|19129806|P7|COMPLETED|Long-term Extension (Week 44-272)||0
7770534|NCT01369355|19129807|P6|COMPLETED|Long-term Extension (Week 44-272)||0
7770535|NCT01369355|19129808|P5|COMPLETED|Long-term Extension (Week 44-272)||0
7770536|NCT01369355|19129809|P4|COMPLETED|Long-term Extension (Week 44-272)||0
7770537|NCT01369355|19129810|P3|COMPLETED|Long-term Extension (Week 44-272)||0
7770538|NCT01369355|19129811|P2|COMPLETED|Long-term Extension (Week 44-272)||0
7770539|NCT01369355|19129812|P1|COMPLETED|Long-term Extension (Week 44-272)||0
7770540|NCT01369355|19129804|P9|STARTED|Long-term Extension (Week 44-272)||354
7770541|NCT01369355|19129805|P8|STARTED|Long-term Extension (Week 44-272)||213
7770542|NCT01369355|19129806|P7|STARTED|Long-term Extension (Week 44-272)||151
7770543|NCT01369355|19129807|P6|STARTED|Long-term Extension (Week 44-272)||0
7770544|NCT01369355|19129808|P5|STARTED|Long-term Extension (Week 44-272)||0
7770545|NCT01369355|19129809|P4|STARTED|Long-term Extension (Week 44-272)||0
7770546|NCT01369355|19129810|P3|STARTED|Long-term Extension (Week 44-272)||0
7770547|NCT01369355|19129811|P2|STARTED|Long-term Extension (Week 44-272)||0
7770548|NCT01369355|19129812|P1|STARTED|Long-term Extension (Week 44-272)||0
7770549|NCT01369355|19129804|P9|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
7770550|NCT01369355|19129805|P8|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
7770551|NCT01369355|19129806|P7|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
7770552|NCT01369355|19129807|P6|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||272
7770553|NCT01369355|19129808|P5|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||154
7770554|NCT01369355|19129809|P4|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||30
7770555|NCT01369355|19129810|P3|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
7770556|NCT01369355|19129811|P2|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||29
7770557|NCT01369355|19129812|P1|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
7770558|NCT01369355|19129804|P9|COMPLETED|Week 0 - Week 44 (Maintenance)||0
7770559|NCT01369355|19129805|P8|COMPLETED|Week 0 - Week 44 (Maintenance)||0
7770560|NCT01369355|19129806|P7|COMPLETED|Week 0 - Week 44 (Maintenance)||0
7770561|NCT01369355|19129807|P6|COMPLETED|Week 0 - Week 44 (Maintenance)||204
7770562|NCT01369355|19129808|P5|COMPLETED|Week 0 - Week 44 (Maintenance)||131
7770563|NCT01369355|19129809|P4|COMPLETED|Week 0 - Week 44 (Maintenance)||93
7770564|NCT01369355|19129810|P3|COMPLETED|Week 0 - Week 44 (Maintenance)||101
7770565|NCT01369355|19129811|P2|COMPLETED|Week 0 - Week 44 (Maintenance)||103
7770566|NCT01369355|19129812|P1|COMPLETED|Week 0 - Week 44 (Maintenance)||102
7770567|NCT01369355|19129804|P9|STARTED|Week 0 - Week 44 (Maintenance)||0
7770568|NCT01369355|19129805|P8|STARTED|Week 0 - Week 44 (Maintenance)||0
7770569|NCT01369355|19129806|P7|STARTED|Week 0 - Week 44 (Maintenance)||0
7770570|NCT01369355|19129807|P6|STARTED|Week 0 - Week 44 (Maintenance)||476
7770571|NCT01369355|19129808|P5|STARTED|Week 0 - Week 44 (Maintenance)||285
7770572|NCT01369355|19129809|P4|STARTED|Week 0 - Week 44 (Maintenance)||123
7770573|NCT01369355|19129810|P3|STARTED|Week 0 - Week 44 (Maintenance)||132
7770574|NCT01369355|19129811|P2|STARTED|Week 0 - Week 44 (Maintenance)||132
7770575|NCT01369355|19129812|P1|STARTED|Week 0 - Week 44 (Maintenance)||133
7770576|NCT01369342|19129844|P3|NOT COMPLETED|Overall Study||3
7770577|NCT01369342|19129845|P2|NOT COMPLETED|Overall Study||9
7770578|NCT01369342|19129846|P1|NOT COMPLETED|Overall Study||13
7770579|NCT01369342|19129844|P3|COMPLETED|Overall Study||210
7770580|NCT01369342|19129845|P2|COMPLETED|Overall Study||204
7770581|NCT01369342|19129846|P1|COMPLETED|Overall Study||201
7770582|NCT01369342|19129844|P3|STARTED|Overall Study||213
7770583|NCT01369342|19129845|P2|STARTED|Overall Study||213
7770584|NCT01369342|19129846|P1|STARTED|Overall Study||214
7770585|NCT01369329|19129869|P3|NOT COMPLETED|Overall Study||14
7770586|NCT01369329|19129870|P2|NOT COMPLETED|Overall Study||11
7770587|NCT01369329|19129871|P1|NOT COMPLETED|Overall Study||12
7770588|NCT01369329|19129869|P3|COMPLETED|Overall Study||245
7770589|NCT01369329|19129870|P2|COMPLETED|Overall Study||243
7770590|NCT01369329|19129871|P1|COMPLETED|Overall Study||244
7770591|NCT01369329|19129869|P3|STARTED|Overall Study||259
7770592|NCT01369329|19129870|P2|STARTED|Overall Study||254
7770593|NCT01369329|19129871|P1|STARTED|Overall Study||256
7770594|NCT01369225|19129897|P6|NOT COMPLETED|Overall Study||0
7770595|NCT01369225|19129898|P5|NOT COMPLETED|Overall Study||2
7770596|NCT01369225|19129899|P4|NOT COMPLETED|Overall Study||2
7770597|NCT01369225|19129900|P3|NOT COMPLETED|Overall Study||3
7770598|NCT01369225|19129901|P2|NOT COMPLETED|Overall Study||0
7770599|NCT01369225|19129902|P1|NOT COMPLETED|Overall Study||2
7770600|NCT01369225|19129897|P6|COMPLETED|Overall Study||9
7770601|NCT01369225|19129898|P5|COMPLETED|Overall Study||10
7770602|NCT01369225|19129899|P4|COMPLETED|Overall Study||8
7770603|NCT01369225|19129900|P3|COMPLETED|Overall Study||9
7770604|NCT01369225|19129901|P2|COMPLETED|Overall Study||3
7770605|NCT01369225|19129902|P1|COMPLETED|Overall Study||4
7770606|NCT01369225|19129897|P6|STARTED|Overall Study||9
7770607|NCT01369225|19129898|P5|STARTED|Overall Study||12
7770608|NCT01369225|19129899|P4|STARTED|Overall Study||10
7770609|NCT01369225|19129900|P3|STARTED|Overall Study||12
7770610|NCT01369225|19129901|P2|STARTED|Overall Study||3
7770611|NCT01369225|19129902|P1|STARTED|Overall Study||6
7770612|NCT01369199|19129994|P1|NOT COMPLETED|Overall Study||3
7770613|NCT01369199|19129994|P1|COMPLETED|Overall Study||25
7770614|NCT01369199|19129994|P1|End of Treatment (EOT)|Overall Study|1 withdrew consent before treatment,1 missed end of treatment (EOT) visit but completed follow-up.|26
7770615|NCT01369199|19129994|P1|STARTED|Overall Study||28
7770616|NCT01369108|19130017|P1|NOT COMPLETED|Overall Study||11
7770617|NCT01369108|19130017|P1|COMPLETED|Overall Study||49
7770618|NCT01369108|19130017|P1|STARTED|Overall Study|120 teeth|60
7770619|NCT01369069|19130026|P2|NOT COMPLETED|Overall Study||16
7770620|NCT01369069|19130027|P1|NOT COMPLETED|Overall Study||17
7770621|NCT01369069|19130026|P2|COMPLETED|Overall Study||554
7770622|NCT01369069|19130027|P1|COMPLETED|Overall Study||564
7770623|NCT01369069|19130026|P2|STARTED|Overall Study||570
7770624|NCT01369069|19130027|P1|STARTED|Overall Study||581
7770625|NCT01369030|19130043|P1|NOT COMPLETED|Overall Study||40
7770626|NCT01369030|19130043|P1|COMPLETED|Overall Study||554
7770627|NCT01369030|19130043|P1|STARTED|Overall Study||594
7770628|NCT01368965|19130049|P1|NOT COMPLETED|Overall Study||12
7770629|NCT01368965|19130049|P1|COMPLETED|Overall Study||40
7770630|NCT01368965|19130049|P1|Subject Withdrawal Prior to Treatment|Overall Study||2
7770631|NCT01368965|19130049|P1|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52
7770632|NCT01368900|19130058|P1|NOT COMPLETED|Overall Study||7
7770633|NCT01368900|19130058|P1|COMPLETED|Overall Study||61
7770634|NCT01368900|19130058|P1|STARTED|Overall Study||68
7770635|NCT01368874|19130071|P3|NOT COMPLETED|Overall Study||1
7770636|NCT01368874|19130072|P2|NOT COMPLETED|Overall Study||0
7770637|NCT01368874|19130073|P1|NOT COMPLETED|Overall Study||3
7770638|NCT01368874|19130071|P3|COMPLETED|Overall Study||24
7770639|NCT01368874|19130072|P2|COMPLETED|Overall Study||5
7770640|NCT01368874|19130073|P1|COMPLETED|Overall Study||31
7770641|NCT01368874|19130071|P3|STARTED|Overall Study||25
7770642|NCT01368874|19130072|P2|STARTED|Overall Study||5
7770643|NCT01368874|19130073|P1|STARTED|Overall Study||34
7770644|NCT01368835|19130133|P1|NOT COMPLETED|Overall Study||33
7770645|NCT01368835|19130133|P1|COMPLETED|Overall Study||70
7770646|NCT01368835|19130133|P1|STARTED|Overall Study|103 Subjects Enrolled|103
7770647|NCT01368809|19130142|P2|NOT COMPLETED|Overall Study||0
7770648|NCT01368809|19130143|P1|NOT COMPLETED|Overall Study||0
7770649|NCT01368809|19130142|P2|COMPLETED|Overall Study||50
7770650|NCT01368809|19130143|P1|COMPLETED|Overall Study||50
7770651|NCT01368809|19130142|P2|STARTED|Overall Study||50
7770652|NCT01368809|19130143|P1|STARTED|Overall Study||50
7770653|NCT01368653|19130155|P2|NOT COMPLETED|Overall Study||9
7770654|NCT01368653|19130156|P1|NOT COMPLETED|Overall Study||6
7770655|NCT01368653|19130155|P2|COMPLETED|Overall Study||37
7770656|NCT01368653|19130156|P1|COMPLETED|Overall Study||41
7770657|NCT01368653|19130155|P2|Randomized to Advice Only in Phase 2|Overall Study||10
7770658|NCT01368653|19130156|P1|Randomized to Advice Only in Phase 2|Overall Study||10
7770659|NCT01368653|19130155|P2|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9
7770660|NCT01368653|19130156|P1|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11
7770661|NCT01368653|19130155|P2|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19
7770662|NCT01368653|19130156|P1|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21
7770663|NCT01368653|19130155|P2|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20
7770664|NCT01368653|19130156|P1|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29
7770665|NCT01368653|19130155|P2|Completed 4-week Follow-up|Overall Study||37
7770666|NCT01368653|19130156|P1|Completed 4-week Follow-up|Overall Study||44
7770667|NCT01368653|19130155|P2|STARTED|Overall Study||46
7770668|NCT01368653|19130156|P1|STARTED|Overall Study||47
7770669|NCT01368614|19130172|P4|NOT COMPLETED|Study Period||3
7770670|NCT01368614|19130173|P3|NOT COMPLETED|Study Period||2
7770671|NCT01368614|19130174|P2|NOT COMPLETED|Study Period||1
7770672|NCT01368614|19130175|P1|NOT COMPLETED|Study Period||0
7770673|NCT01368614|19130172|P4|COMPLETED|Study Period||8
7770674|NCT01368614|19130173|P3|COMPLETED|Study Period||8
7770675|NCT01368614|19130174|P2|COMPLETED|Study Period||10
7770676|NCT01368614|19130175|P1|COMPLETED|Study Period||0
7770677|NCT01368614|19130172|P4|STARTED|Study Period||11
7770678|NCT01368614|19130173|P3|STARTED|Study Period||10
7770679|NCT01368614|19130174|P2|STARTED|Study Period||11
7770680|NCT01368614|19130175|P1|STARTED|Study Period||0
7770681|NCT01368614|19130172|P4|NOT COMPLETED|Screening Period||0
7770682|NCT01368614|19130173|P3|NOT COMPLETED|Screening Period||0
7770683|NCT01368614|19130174|P2|NOT COMPLETED|Screening Period||0
7770684|NCT01368614|19130175|P1|NOT COMPLETED|Screening Period||58
7770685|NCT01368614|19130172|P4|COMPLETED|Screening Period||0
7770686|NCT01368614|19130173|P3|COMPLETED|Screening Period||0
7770687|NCT01368614|19130174|P2|COMPLETED|Screening Period||0
7770688|NCT01368614|19130175|P1|COMPLETED|Screening Period||32
7770689|NCT01368614|19130172|P4|STARTED|Screening Period||0
7770690|NCT01368614|19130173|P3|STARTED|Screening Period||0
7770691|NCT01368614|19130174|P2|STARTED|Screening Period||0
7770692|NCT01368614|19130175|P1|STARTED|Screening Period||90
7770693|NCT01368562|19130228|P1|NOT COMPLETED|Overall Study||19
7770694|NCT01368562|19130228|P1|COMPLETED|Overall Study||7
7770695|NCT01368562|19130228|P1|Received at Least 1 Dose of Study Drug|Overall Study||25
7770696|NCT01368562|19130228|P1|STARTED|Overall Study||26
7770697|NCT01368536|19130235|P3|NOT COMPLETED|Overall Study||59
7770698|NCT01368536|19130236|P2|NOT COMPLETED|Overall Study||59
7770699|NCT01368536|19130237|P1|NOT COMPLETED|Overall Study||51
7770700|NCT01368536|19130235|P3|COMPLETED|Overall Study||83
7770701|NCT01368536|19130236|P2|COMPLETED|Overall Study||78
7770702|NCT01368536|19130237|P1|COMPLETED|Overall Study||87
7770703|NCT01368536|19130235|P3|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141
7770704|NCT01368536|19130236|P2|Full Analysis Set|Overall Study||137
7770705|NCT01368536|19130237|P1|Full Analysis Set|Overall Study||138
7770706|NCT01368536|19130235|P3|STARTED|Overall Study||142
7770707|NCT01368536|19130236|P2|STARTED|Overall Study||137
7770708|NCT01368536|19130237|P1|STARTED|Overall Study||138
7770709|NCT01368497|19130258|P1|NOT COMPLETED|Overall Study||2
7770710|NCT01368497|19130258|P1|COMPLETED|Overall Study||58
7770711|NCT01368497|19130258|P1|End of Treatment|Overall Study|Five discontinued study drugs early and completed the follow-up period per protocol.|60
7770712|NCT01368497|19130258|P1|STARTED|Overall Study||60
7770713|NCT01368432|19130287|P2|NOT COMPLETED|Overall Study||1
7770714|NCT01368432|19130288|P1|NOT COMPLETED|Overall Study||0
7770715|NCT01368432|19130287|P2|COMPLETED|Overall Study||7
7770716|NCT01368432|19130288|P1|COMPLETED|Overall Study||6
7770717|NCT01368432|19130287|P2|STARTED|Overall Study||8
7770718|NCT01368432|19130288|P1|STARTED|Overall Study||6
7770719|NCT01368406|19130322|P2|NOT COMPLETED|Overall Study||13
7770720|NCT01368406|19130323|P1|NOT COMPLETED|Overall Study||21
7770721|NCT01368406|19130322|P2|COMPLETED|Overall Study||66
7770722|NCT01368406|19130323|P1|COMPLETED|Overall Study||60
7770723|NCT01368406|19130322|P2|STARTED|Overall Study||79
7770724|NCT01368406|19130323|P1|STARTED|Overall Study||81
7770725|NCT01368276|19130331|P2|NOT COMPLETED|Overall Study||10
7770726|NCT01368276|19130332|P1|NOT COMPLETED|Overall Study||1
7770727|NCT01368276|19130331|P2|COMPLETED|Overall Study||18
7770728|NCT01368276|19130332|P1|COMPLETED|Overall Study||2
7770729|NCT01368276|19130331|P2|STARTED|Overall Study||28
7770730|NCT01368276|19130332|P1|STARTED|Overall Study||3
7770731|NCT01368263|19130345|P3|NOT COMPLETED|Overall Study||0
7770732|NCT01368263|19130346|P2|NOT COMPLETED|Overall Study||0
7770733|NCT01368263|19130347|P1|NOT COMPLETED|Overall Study||0
7770734|NCT01368263|19130345|P3|COMPLETED|Overall Study||1
7770735|NCT01368263|19130346|P2|COMPLETED|Overall Study||1
7770736|NCT01368263|19130347|P1|COMPLETED|Overall Study||6
7770737|NCT01368263|19130345|P3|STARTED|Overall Study||1
7770738|NCT01368263|19130346|P2|STARTED|Overall Study||1
7770739|NCT01368263|19130347|P1|STARTED|Overall Study||6
7770740|NCT01368211|19130369|P2|NOT COMPLETED|Second Platelets Transfusion||2
7770741|NCT01368211|19130370|P1|NOT COMPLETED|Second Platelets Transfusion||1
7770742|NCT01368211|19130369|P2|COMPLETED|Second Platelets Transfusion||5
7770743|NCT01368211|19130370|P1|COMPLETED|Second Platelets Transfusion||7
7770744|NCT01368211|19130369|P2|STARTED|Second Platelets Transfusion||7
7770745|NCT01368211|19130370|P1|STARTED|Second Platelets Transfusion||8
7770746|NCT01368211|19130369|P2|NOT COMPLETED|First Platelets Transfusion||0
7770747|NCT01368211|19130370|P1|NOT COMPLETED|First Platelets Transfusion||0
7770748|NCT01368211|19130369|P2|COMPLETED|First Platelets Transfusion||7
7770749|NCT01368211|19130370|P1|COMPLETED|First Platelets Transfusion||8
7770750|NCT01368211|19130369|P2|STARTED|First Platelets Transfusion||7
7770751|NCT01368211|19130370|P1|STARTED|First Platelets Transfusion||8
7770752|NCT01368185|19130378|P1|NOT COMPLETED|Overall Study||0
7770753|NCT01368185|19130378|P1|COMPLETED|Overall Study||1705
7770754|NCT01368185|19130378|P1|STARTED|Overall Study||1705
7770755|NCT01368081|19130398|P13|NOT COMPLETED|Overall Study||7
7770756|NCT01368081|19130399|P12|NOT COMPLETED|Overall Study||3
7770757|NCT01368081|19130400|P11|NOT COMPLETED|Overall Study||9
7770758|NCT01368081|19130401|P10|NOT COMPLETED|Overall Study||10
7770759|NCT01368081|19130402|P9|NOT COMPLETED|Overall Study||8
7770760|NCT01368081|19130403|P8|NOT COMPLETED|Overall Study||7
7770761|NCT01368081|19130404|P7|NOT COMPLETED|Overall Study||12
7770762|NCT01368081|19130405|P6|NOT COMPLETED|Overall Study||10
7770763|NCT01368081|19130406|P5|NOT COMPLETED|Overall Study||2
7770764|NCT01368081|19130407|P4|NOT COMPLETED|Overall Study||5
7770765|NCT01368081|19130408|P3|NOT COMPLETED|Overall Study||4
7770766|NCT01368081|19130409|P2|NOT COMPLETED|Overall Study||9
7770767|NCT01368081|19130410|P1|NOT COMPLETED|Overall Study||10
7770768|NCT01368081|19130398|P13|COMPLETED|Overall Study||63
7770769|NCT01368081|19130399|P12|COMPLETED|Overall Study||67
7770770|NCT01368081|19130400|P11|COMPLETED|Overall Study||62
7770771|NCT01368081|19130401|P10|COMPLETED|Overall Study||58
7770772|NCT01368081|19130402|P9|COMPLETED|Overall Study||62
7770773|NCT01368081|19130403|P8|COMPLETED|Overall Study||62
7770774|NCT01368081|19130404|P7|COMPLETED|Overall Study||124
7770775|NCT01368081|19130405|P6|COMPLETED|Overall Study||127
7770776|NCT01368081|19130406|P5|COMPLETED|Overall Study||63
7770777|NCT01368081|19130407|P4|COMPLETED|Overall Study||63
7770778|NCT01368081|19130408|P3|COMPLETED|Overall Study||59
7770779|NCT01368081|19130409|P2|COMPLETED|Overall Study||128
7770780|NCT01368081|19130410|P1|COMPLETED|Overall Study||126
7770781|NCT01368081|19130398|P13|STARTED|Overall Study||70
7770782|NCT01368081|19130399|P12|STARTED|Overall Study||70
7770783|NCT01368081|19130400|P11|STARTED|Overall Study||71
7770784|NCT01368081|19130401|P10|STARTED|Overall Study||68
7770785|NCT01368081|19130402|P9|STARTED|Overall Study||70
7770786|NCT01368081|19130403|P8|STARTED|Overall Study||69
7770787|NCT01368081|19130404|P7|STARTED|Overall Study||136
7770788|NCT01368081|19130405|P6|STARTED|Overall Study||137
7770789|NCT01368081|19130406|P5|STARTED|Overall Study||65
7770790|NCT01368081|19130407|P4|STARTED|Overall Study||68
7770791|NCT01368081|19130408|P3|STARTED|Overall Study||63
7770792|NCT01368081|19130409|P2|STARTED|Overall Study||137
7770793|NCT01368081|19130410|P1|STARTED|Overall Study||136
7770794|NCT01368042|19130464|P1|NOT COMPLETED|Overall Study||30
7770795|NCT01368042|19130464|P1|COMPLETED|Overall Study||235
7770796|NCT01368042|19130464|P1|STARTED|Overall Study||265
7770797|NCT01367886|19130484|P1|NOT COMPLETED|Overall Study||7
7770798|NCT01367886|19130484|P1|COMPLETED|Overall Study||14
7770799|NCT01367886|19130484|P1|STARTED|Overall Study||21
7770800|NCT01367860|19130493|P2|NOT COMPLETED|Overall Study||0
7770801|NCT01367860|19130494|P1|NOT COMPLETED|Overall Study||0
7770802|NCT01367860|19130493|P2|COMPLETED|Overall Study||20
7770803|NCT01367860|19130494|P1|COMPLETED|Overall Study||20
7770804|NCT01367860|19130493|P2|STARTED|Overall Study||20
7770805|NCT01367860|19130494|P1|STARTED|Overall Study||20
7770806|NCT01367847|19130534|P2|NOT COMPLETED|Overall Study||2
7770807|NCT01367847|19130535|P1|NOT COMPLETED|Overall Study||2
7770808|NCT01367847|19130534|P2|COMPLETED|Overall Study||7
7770809|NCT01367847|19130535|P1|COMPLETED|Overall Study||8
7770810|NCT01367847|19130534|P2|STARTED|Overall Study||9
7770811|NCT01367847|19130535|P1|STARTED|Overall Study||10
7770812|NCT01367834|19130551|P2|NOT COMPLETED|Overall Study||3
7770813|NCT01367834|19130552|P1|NOT COMPLETED|Overall Study||2
7770814|NCT01367834|19130551|P2|COMPLETED|Overall Study||3
7770815|NCT01367834|19130552|P1|COMPLETED|Overall Study||9
7770816|NCT01367834|19130551|P2|STARTED|Overall Study||6
7770817|NCT01367834|19130552|P1|STARTED|Overall Study||11
7770818|NCT01367704|19130576|P2|NOT COMPLETED|Overall Study||161
7770819|NCT01367704|19130577|P1|NOT COMPLETED|Overall Study||47
7770820|NCT01367704|19130576|P2|COMPLETED|Overall Study||847
7770821|NCT01367704|19130577|P1|COMPLETED|Overall Study||951
7770822|NCT01367704|19130576|P2|STARTED|Overall Study||1008
7770823|NCT01367704|19130577|P1|STARTED|Overall Study||998
7770824|NCT01367665|19130589|P2|NOT COMPLETED|Overall Study||55
7770825|NCT01367665|19130590|P1|NOT COMPLETED|Overall Study||442
7770826|NCT01367665|19130589|P2|COMPLETED|Overall Study||41
7770827|NCT01367665|19130590|P1|COMPLETED|Overall Study||677
7770828|NCT01367665|19130589|P2|STARTED|Overall Study||96
7770829|NCT01367665|19130590|P1|STARTED|Overall Study||1119
7770830|NCT01367457|19130621|P3|NOT COMPLETED|Overall Study||0
7770831|NCT01367457|19130622|P2|NOT COMPLETED|Overall Study||0
7770832|NCT01367457|19130623|P1|NOT COMPLETED|Overall Study||188
7770833|NCT01367457|19130621|P3|COMPLETED|Overall Study||26
7770834|NCT01367457|19130622|P2|COMPLETED|Overall Study||23
7770835|NCT01367457|19130623|P1|COMPLETED|Overall Study||5
7770836|NCT01367457|19130621|P3|STARTED|Overall Study||26
7770837|NCT01367457|19130622|P2|STARTED|Overall Study||23
7770838|NCT01367457|19130623|P1|STARTED|Overall Study||193
7770839|NCT01367444|19130650|P7|NOT COMPLETED|Overall Study||0
7770840|NCT01367444|19130651|P6|NOT COMPLETED|Overall Study||0
7770841|NCT01367444|19130652|P5|NOT COMPLETED|Overall Study||0
7770842|NCT01367444|19130653|P4|NOT COMPLETED|Overall Study||0
7770843|NCT01367444|19130654|P3|NOT COMPLETED|Overall Study||0
7770844|NCT01367444|19130655|P2|NOT COMPLETED|Overall Study||0
7770845|NCT01367444|19130656|P1|NOT COMPLETED|Overall Study||0
7770846|NCT01367444|19130650|P7|COMPLETED|Overall Study||1
7770847|NCT01367444|19130651|P6|COMPLETED|Overall Study||4
7770848|NCT01367444|19130652|P5|COMPLETED|Overall Study||6
7770849|NCT01367444|19130653|P4|COMPLETED|Overall Study||4
7770850|NCT01367444|19130654|P3|COMPLETED|Overall Study||4
7770851|NCT01367444|19130655|P2|COMPLETED|Overall Study||4
7770852|NCT01367444|19130656|P1|COMPLETED|Overall Study||4
7770853|NCT01367444|19130650|P7|STARTED|Overall Study||1
7770854|NCT01367444|19130651|P6|STARTED|Overall Study||4
7770855|NCT01367444|19130652|P5|STARTED|Overall Study||6
7770856|NCT01367444|19130653|P4|STARTED|Overall Study||4
7770857|NCT01367444|19130654|P3|STARTED|Overall Study||4
7770858|NCT01367444|19130655|P2|STARTED|Overall Study||4
7770859|NCT01367444|19130656|P1|STARTED|Overall Study||4
7770860|NCT01367275|19130679|P1|NOT COMPLETED|Overall Study||3
7770861|NCT01367275|19130679|P1|COMPLETED|Overall Study||5
7770862|NCT01367275|19130679|P1|STARTED|Overall Study||8
7770863|NCT01367262|19130683|P1|NOT COMPLETED|Overall Study||0
7770864|NCT01367262|19130683|P1|COMPLETED|Overall Study||6
7770865|NCT01367262|19130683|P1|STARTED|Overall Study||6
7770866|NCT01367249|19130696|P2|NOT COMPLETED|Overall Study||16
7770867|NCT01367249|19130697|P1|NOT COMPLETED|Overall Study||9
7770868|NCT01367249|19130696|P2|COMPLETED|Overall Study||202
7770869|NCT01367249|19130697|P1|COMPLETED|Overall Study||213
7770870|NCT01367249|19130696|P2|STARTED|Overall Study||218
7770871|NCT01367249|19130697|P1|STARTED|Overall Study||222
7770872|NCT01367236|19130707|P2|NOT COMPLETED|Overall Study||1
7770873|NCT01367236|19130708|P1|NOT COMPLETED|Overall Study||3
7770874|NCT01367236|19130707|P2|COMPLETED|Overall Study||29
7770875|NCT01367236|19130708|P1|COMPLETED|Overall Study||27
7770876|NCT01367236|19130707|P2|STARTED|Overall Study||30
7770877|NCT01367236|19130708|P1|STARTED|Overall Study||30
7770878|NCT01367158|19130727|P11|NOT COMPLETED|Overall Study||1
7770879|NCT01367158|19130728|P10|NOT COMPLETED|Overall Study||0
7770880|NCT01367158|19130729|P9|NOT COMPLETED|Overall Study||0
7770881|NCT01367158|19130730|P8|NOT COMPLETED|Overall Study||2
7770882|NCT01367158|19130731|P7|NOT COMPLETED|Overall Study||0
7770883|NCT01367158|19130732|P6|NOT COMPLETED|Overall Study||2
7770884|NCT01367158|19130733|P5|NOT COMPLETED|Overall Study||2
7770885|NCT01367158|19130734|P4|NOT COMPLETED|Overall Study||1
7770886|NCT01367158|19130735|P3|NOT COMPLETED|Overall Study||1
7770887|NCT01367158|19130736|P2|NOT COMPLETED|Overall Study||3
7770888|NCT01367158|19130737|P1|NOT COMPLETED|Overall Study||0
7770889|NCT01367158|19130727|P11|COMPLETED|Overall Study||72
7770890|NCT01367158|19130728|P10|COMPLETED|Overall Study||50
7770891|NCT01367158|19130729|P9|COMPLETED|Overall Study||23
7770892|NCT01367158|19130730|P8|COMPLETED|Overall Study||47
7770893|NCT01367158|19130731|P7|COMPLETED|Overall Study||25
7770894|NCT01367158|19130732|P6|COMPLETED|Overall Study||46
7770895|NCT01367158|19130733|P5|COMPLETED|Overall Study||23
7770896|NCT01367158|19130734|P4|COMPLETED|Overall Study||48
7770897|NCT01367158|19130735|P3|COMPLETED|Overall Study||23
7770898|NCT01367158|19130736|P2|COMPLETED|Overall Study||46
7770899|NCT01367158|19130737|P1|COMPLETED|Overall Study||25
7770900|NCT01367158|19130727|P11|STARTED|Overall Study||73
7770901|NCT01367158|19130728|P10|STARTED|Overall Study||50
7770902|NCT01367158|19130729|P9|STARTED|Overall Study||23
7770903|NCT01367158|19130730|P8|STARTED|Overall Study||49
7770904|NCT01367158|19130731|P7|STARTED|Overall Study||25
7770905|NCT01367158|19130732|P6|STARTED|Overall Study||48
7770906|NCT01367158|19130733|P5|STARTED|Overall Study||25
7770907|NCT01367158|19130734|P4|STARTED|Overall Study||49
7770908|NCT01367158|19130735|P3|STARTED|Overall Study||24
7770909|NCT01367158|19130736|P2|STARTED|Overall Study||49
7770910|NCT01367158|19130737|P1|STARTED|Overall Study||25
7770911|NCT01367119|19130881|P2|NOT COMPLETED|Overall Study||1
7770912|NCT01367119|19130882|P1|NOT COMPLETED|Overall Study||2
7770913|NCT01367119|19130881|P2|COMPLETED|Overall Study||16
7770914|NCT01367119|19130882|P1|COMPLETED|Overall Study||19
7770915|NCT01367119|19130881|P2|STARTED|Overall Study||17
7770916|NCT01367119|19130882|P1|STARTED|Overall Study||21
7770917|NCT01367080|19130894|P2|NOT COMPLETED|2nd Administration||0
7770918|NCT01367080|19130895|P1|NOT COMPLETED|2nd Administration||0
7770919|NCT01367080|19130894|P2|COMPLETED|2nd Administration||6
7770920|NCT01367080|19130895|P1|COMPLETED|2nd Administration||6
7770921|NCT01367080|19130894|P2|STARTED|2nd Administration||6
7770922|NCT01367080|19130895|P1|STARTED|2nd Administration||6
7770923|NCT01367080|19130894|P2|NOT COMPLETED|1st Administration||0
7770924|NCT01367080|19130895|P1|NOT COMPLETED|1st Administration||0
7770925|NCT01367080|19130894|P2|COMPLETED|1st Administration||6
7770926|NCT01367080|19130895|P1|COMPLETED|1st Administration||6
7770927|NCT01367080|19130894|P2|STARTED|1st Administration||6
7770928|NCT01367080|19130895|P1|STARTED|1st Administration||6
7770929|NCT01366976|19130909|P2|NOT COMPLETED|Overall Study||0
7770930|NCT01366976|19130910|P1|NOT COMPLETED|Overall Study||0
7770931|NCT01366976|19130909|P2|COMPLETED|Overall Study||30
7770932|NCT01366976|19130910|P1|COMPLETED|Overall Study||30
7770933|NCT01366976|19130909|P2|STARTED|Overall Study||30
7770934|NCT01366976|19130910|P1|STARTED|Overall Study||30
7770935|NCT01366885|19130922|P1|NOT COMPLETED|Overall Study||1
7770936|NCT01366885|19130922|P1|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19
7770937|NCT01366885|19130922|P1|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20
7770938|NCT01366872|19130927|P1|NOT COMPLETED|Overall Study||0
7770939|NCT01366872|19130927|P1|COMPLETED|Overall Study||50
7770940|NCT01366872|19130927|P1|STARTED|Overall Study||50
7770941|NCT01366846|19130937|P4|NOT COMPLETED|Overall Study||1
7770942|NCT01366846|19130938|P3|NOT COMPLETED|Overall Study||1
7770943|NCT01366846|19130939|P2|NOT COMPLETED|Overall Study||4
7770944|NCT01366846|19130940|P1|NOT COMPLETED|Overall Study||3
7770945|NCT01366846|19130937|P4|COMPLETED|Overall Study||45
7770946|NCT01366846|19130938|P3|COMPLETED|Overall Study||46
7770947|NCT01366846|19130939|P2|COMPLETED|Overall Study||224
7770948|NCT01366846|19130940|P1|COMPLETED|Overall Study||232
7770949|NCT01366846|19130937|P4|STARTED|Overall Study||46
7770950|NCT01366846|19130938|P3|STARTED|Overall Study||47
7770951|NCT01366846|19130939|P2|STARTED|Overall Study||228
7770952|NCT01366846|19130940|P1|STARTED|Overall Study||235
7770953|NCT01366638|19130963|P3|NOT COMPLETED|Overall Study||6
7770954|NCT01366638|19130964|P2|NOT COMPLETED|Overall Study||0
7770955|NCT01366638|19130965|P1|NOT COMPLETED|Overall Study||1
7770956|NCT01366638|19130963|P3|COMPLETED|Overall Study||20
7770957|NCT01366638|19130964|P2|COMPLETED|Overall Study||29
7770958|NCT01366638|19130965|P1|COMPLETED|Overall Study||23
7770959|NCT01366638|19130963|P3|STARTED|Overall Study||26
7770960|NCT01366638|19130964|P2|STARTED|Overall Study||29
7770961|NCT01366638|19130965|P1|STARTED|Overall Study||24
7770962|NCT01366534|19131002|P3|NOT COMPLETED|Overall Study||0
7770963|NCT01366534|19131003|P2|NOT COMPLETED|Overall Study||2
7770964|NCT01366534|19131004|P1|NOT COMPLETED|Overall Study||2
7770965|NCT01366534|19131002|P3|COMPLETED|Overall Study||12
7770966|NCT01366534|19131003|P2|COMPLETED|Overall Study||25
7770967|NCT01366534|19131004|P1|COMPLETED|Overall Study||26
7770968|NCT01366534|19131002|P3|STARTED|Overall Study||12
7770969|NCT01366534|19131003|P2|STARTED|Overall Study||27
7770970|NCT01366534|19131004|P1|STARTED|Overall Study||28
7770971|NCT01366521|19131054|P4|NOT COMPLETED|Overall Study||0
7770972|NCT01366521|19131055|P3|NOT COMPLETED|Overall Study||2
7770973|NCT01366521|19131056|P2|NOT COMPLETED|Overall Study||1
7770974|NCT01366521|19131057|P1|NOT COMPLETED|Overall Study||1
7770975|NCT01366521|19131054|P4|COMPLETED|Overall Study||11
7770976|NCT01366521|19131055|P3|COMPLETED|Overall Study||21
7770977|NCT01366521|19131056|P2|COMPLETED|Overall Study||14
7770978|NCT01366521|19131057|P1|COMPLETED|Overall Study||20
7770979|NCT01366521|19131054|P4|STARTED|Overall Study||11
7770980|NCT01366521|19131055|P3|STARTED|Overall Study||23
7770981|NCT01366521|19131056|P2|STARTED|Overall Study||15
7770982|NCT01366521|19131057|P1|STARTED|Overall Study||21
7770983|NCT01366495|19131136|P4|NOT COMPLETED|HIV Study||0
7770984|NCT01366495|19131137|P3|NOT COMPLETED|HIV Study||0
7770985|NCT01366495|19131138|P2|NOT COMPLETED|HIV Study||0
7770986|NCT01366495|19131139|P1|NOT COMPLETED|HIV Study||1
7770987|NCT01366495|19131136|P4|COMPLETED|HIV Study||0
7770988|NCT01366495|19131137|P3|COMPLETED|HIV Study||0
7770989|NCT01366495|19131138|P2|COMPLETED|HIV Study||50
7770990|NCT01366495|19131139|P1|COMPLETED|HIV Study||49
7770991|NCT01366495|19131136|P4|STARTED|HIV Study||0
7770992|NCT01366495|19131137|P3|STARTED|HIV Study||0
7770993|NCT01366495|19131138|P2|STARTED|HIV Study||50
7770994|NCT01366495|19131139|P1|STARTED|HIV Study||50
7770995|NCT01366495|19131136|P4|NOT COMPLETED|Testing Study||0
7770996|NCT01366495|19131137|P3|NOT COMPLETED|Testing Study||0
7770997|NCT01366495|19131138|P2|NOT COMPLETED|Testing Study||0
7770998|NCT01366495|19131139|P1|NOT COMPLETED|Testing Study||0
7770999|NCT01366495|19131136|P4|COMPLETED|Testing Study||348
7771000|NCT01366495|19131137|P3|COMPLETED|Testing Study||349
7771001|NCT01366495|19131138|P2|COMPLETED|Testing Study||0
7771002|NCT01366495|19131139|P1|COMPLETED|Testing Study||0
7771003|NCT01366495|19131136|P4|STARTED|Testing Study||348
7771004|NCT01366495|19131137|P3|STARTED|Testing Study||349
7771005|NCT01366495|19131138|P2|STARTED|Testing Study||0
7771006|NCT01366495|19131139|P1|STARTED|Testing Study||0
7771007|NCT01366443|19131153|P1|NOT COMPLETED|Overall Study||3
7771008|NCT01366443|19131153|P1|COMPLETED|Overall Study||285
7771009|NCT01366443|19131153|P1|STARTED|Overall Study||288
7771010|NCT01366417|19131158|P1|NOT COMPLETED|Overall Study||18
7771011|NCT01366417|19131158|P1|COMPLETED|Overall Study|25 subjects included in the analysis|25
7771012|NCT01366417|19131158|P1|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3
7771013|NCT01366417|19131158|P1|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5
7771014|NCT01366417|19131158|P1|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28
7771015|NCT01366417|19131158|P1|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28
7771016|NCT01366417|19131158|P1|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33
7771017|NCT01366417|19131158|P1|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43
7771018|NCT01366417|19131158|P1|STARTED|Overall Study||43
7771019|NCT01366209|19131167|P2|NOT COMPLETED|Overall Study||36
7771020|NCT01366209|19131168|P1|NOT COMPLETED|Overall Study||35
7771021|NCT01366209|19131167|P2|COMPLETED|Overall Study||241
7771022|NCT01366209|19131168|P1|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243
7771023|NCT01366209|19131167|P2|STARTED|Overall Study||277
7771024|NCT01366209|19131168|P1|STARTED|Overall Study||278
7771025|NCT01366196|19131176|P2|NOT COMPLETED|Overall Study||0
7771026|NCT01366196|19131177|P1|NOT COMPLETED|Overall Study||0
7771027|NCT01366196|19131176|P2|COMPLETED|Overall Study||43
7771028|NCT01366196|19131177|P1|COMPLETED|Overall Study||43
7771029|NCT01366196|19131176|P2|STARTED|Overall Study||43
7771030|NCT01366196|19131177|P1|STARTED|Overall Study||43
7771031|NCT01366092|19131191|P1|NOT COMPLETED|Overall Study||4
7771032|NCT01366092|19131191|P1|COMPLETED|Overall Study||31
7771033|NCT01366092|19131191|P1|STARTED|Overall Study||35
7771034|NCT01365910|19131200|P1|NOT COMPLETED|Overall Study||30
7771035|NCT01365910|19131200|P1|COMPLETED|Overall Study||0
7771036|NCT01365910|19131200|P1|STARTED|Overall Study||30
7771037|NCT01365845|19131207|P3|NOT COMPLETED|Treatment Phase||0
7771038|NCT01365845|19131208|P2|NOT COMPLETED|Treatment Phase||0
7771039|NCT01365845|19131209|P1|NOT COMPLETED|Treatment Phase||0
7771040|NCT01365845|19131207|P3|COMPLETED|Treatment Phase||18
7771041|NCT01365845|19131208|P2|COMPLETED|Treatment Phase||0
7771042|NCT01365845|19131209|P1|COMPLETED|Treatment Phase||0
7771043|NCT01365845|19131207|P3|STARTED|Treatment Phase||18
7771044|NCT01365845|19131208|P2|STARTED|Treatment Phase||0
7771045|NCT01365845|19131209|P1|STARTED|Treatment Phase||0
7771046|NCT01365845|19131207|P3|NOT COMPLETED|Induction Phase||0
7771047|NCT01365845|19131208|P2|NOT COMPLETED|Induction Phase||0
7771048|NCT01365845|19131209|P1|NOT COMPLETED|Induction Phase||0
7771049|NCT01365845|19131207|P3|COMPLETED|Induction Phase||0
7771050|NCT01365845|19131208|P2|COMPLETED|Induction Phase||0
7771051|NCT01365845|19131209|P1|COMPLETED|Induction Phase||18
7771052|NCT01365845|19131207|P3|STARTED|Induction Phase||0
7771053|NCT01365845|19131208|P2|STARTED|Induction Phase||0
7771054|NCT01365845|19131209|P1|STARTED|Induction Phase||18
7771055|NCT01365819|19131216|P2|NOT COMPLETED|Overall Study||13
7771056|NCT01365819|19131217|P1|NOT COMPLETED|Overall Study||13
7771057|NCT01365819|19131216|P2|COMPLETED|Overall Study||14
7771058|NCT01365819|19131217|P1|COMPLETED|Overall Study||12
7771059|NCT01365819|19131216|P2|STARTED|Overall Study||27
7771060|NCT01365819|19131217|P1|STARTED|Overall Study||25
7771061|NCT01365793|19131235|P4|NOT COMPLETED|Overall Study||2
7771062|NCT01365793|19131236|P3|NOT COMPLETED|Overall Study||7
7771063|NCT01365793|19131237|P2|NOT COMPLETED|Overall Study||7
7771064|NCT01365793|19131238|P1|NOT COMPLETED|Overall Study||2
7771065|NCT01365793|19131235|P4|COMPLETED|Overall Study||347
7771066|NCT01365793|19131236|P3|COMPLETED|Overall Study||338
7771067|NCT01365793|19131237|P2|COMPLETED|Overall Study||344
7771068|NCT01365793|19131238|P1|COMPLETED|Overall Study||342
7771069|NCT01365793|19131235|P4|STARTED|Overall Study||349
7771070|NCT01365793|19131236|P3|STARTED|Overall Study||345
7771071|NCT01365793|19131237|P2|STARTED|Overall Study||351
7771072|NCT01365793|19131238|P1|STARTED|Overall Study||344
7771073|NCT01365650|19131264|P1|NOT COMPLETED|Treatment C||0
7771074|NCT01365650|19131264|P1|COMPLETED|Treatment C||24
7771075|NCT01365650|19131264|P1|STARTED|Treatment C||24
7771076|NCT01365650|19131264|P1|NOT COMPLETED|Treatment B||0
7771077|NCT01365650|19131264|P1|COMPLETED|Treatment B||24
7771078|NCT01365650|19131264|P1|STARTED|Treatment B||24
7771079|NCT01365650|19131264|P1|NOT COMPLETED|Treatment A||0
7771080|NCT01365650|19131264|P1|COMPLETED|Treatment A||24
7771081|NCT01365650|19131264|P1|STARTED|Treatment A||24
7771082|NCT01365624|19131289|P2|NOT COMPLETED|Overall Study||0
7771083|NCT01365624|19131290|P1|NOT COMPLETED|Overall Study||0
7771084|NCT01365624|19131289|P2|COMPLETED|Overall Study||15
7771085|NCT01365624|19131290|P1|COMPLETED|Overall Study||15
7771086|NCT01365624|19131289|P2|STARTED|Overall Study||15
7771087|NCT01365624|19131290|P1|STARTED|Overall Study||15
7771088|NCT01365611|19131306|P1|NOT COMPLETED|Overall Study||0
7771089|NCT01365611|19131306|P1|COMPLETED|Overall Study||36
7771090|NCT01365611|19131306|P1|STARTED|Overall Study||36
7771091|NCT01365585|19131322|P1|NOT COMPLETED|Overall Study||0
7771092|NCT01365585|19131322|P1|COMPLETED|Overall Study||227
7771093|NCT01365585|19131322|P1|STARTED|Overall Study||227
7771094|NCT01365546|19131336|P1|NOT COMPLETED|Overall Study||11
7771095|NCT01365546|19131336|P1|COMPLETED|Overall Study||30
7771096|NCT01365546|19131336|P1|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41
7771097|NCT01365507|19131346|P2|NOT COMPLETED|Overall Study||9
7771098|NCT01365507|19131347|P1|NOT COMPLETED|Overall Study||9
7771099|NCT01365507|19131346|P2|COMPLETED|Overall Study||131
7771100|NCT01365507|19131347|P1|COMPLETED|Overall Study||127
7771101|NCT01365507|19131346|P2|Exposed|Overall Study||140
7771102|NCT01365507|19131347|P1|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134
7771103|NCT01365507|19131346|P2|STARTED|Overall Study||140
7771104|NCT01365507|19131347|P1|STARTED|Overall Study||136
7771105|NCT01365494|19131363|P2|NOT COMPLETED|Overall Study||3
7771106|NCT01365494|19131364|P1|NOT COMPLETED|Overall Study||2
7771107|NCT01365494|19131363|P2|COMPLETED|Overall Study||121
7771108|NCT01365494|19131364|P1|COMPLETED|Overall Study||124
7771109|NCT01365494|19131363|P2|STARTED|Overall Study||124
7771110|NCT01365494|19131364|P1|STARTED|Overall Study||126
7771111|NCT01365481|19131380|P4|NOT COMPLETED|Overall Study||7
7771112|NCT01365481|19131381|P3|NOT COMPLETED|Overall Study||4
7771113|NCT01365481|19131382|P2|NOT COMPLETED|Overall Study||15
7771114|NCT01365481|19131383|P1|NOT COMPLETED|Overall Study||7
7771115|NCT01365481|19131380|P4|COMPLETED|Overall Study||50
7771116|NCT01365481|19131381|P3|COMPLETED|Overall Study||14
7771117|NCT01365481|19131382|P2|COMPLETED|Overall Study||37
7771118|NCT01365481|19131383|P1|COMPLETED|Overall Study||16
7771119|NCT01365481|19131380|P4|STARTED|Overall Study||57
7771120|NCT01365481|19131381|P3|STARTED|Overall Study||18
7771121|NCT01365481|19131382|P2|STARTED|Overall Study||52
7771122|NCT01365481|19131383|P1|STARTED|Overall Study||23
7771123|NCT01365468|19131403|P2|NOT COMPLETED|Overall Study||0
7771124|NCT01365468|19131404|P1|NOT COMPLETED|Overall Study||4
7771125|NCT01365468|19131403|P2|COMPLETED|Overall Study||5
7771126|NCT01365468|19131404|P1|COMPLETED|Overall Study||0
7771127|NCT01365468|19131403|P2|STARTED|Overall Study||5
7771128|NCT01365468|19131404|P1|STARTED|Overall Study||4
7771129|NCT01365455|19131419|P5|NOT COMPLETED|Follow-up Period||0
7771130|NCT01365455|19131420|P4|NOT COMPLETED|Follow-up Period||0
7771131|NCT01365455|19131421|P3|NOT COMPLETED|Follow-up Period||0
7771132|NCT01365455|19131422|P2|NOT COMPLETED|Follow-up Period||0
7771133|NCT01365455|19131423|P1|NOT COMPLETED|Follow-up Period||0
7771134|NCT01365455|19131419|P5|COMPLETED|Follow-up Period||0
7771135|NCT01365455|19131420|P4|COMPLETED|Follow-up Period||0
7771136|NCT01365455|19131421|P3|COMPLETED|Follow-up Period||18
7771137|NCT01365455|19131422|P2|COMPLETED|Follow-up Period||47
7771138|NCT01365455|19131423|P1|COMPLETED|Follow-up Period||58
7771139|NCT01365455|19131419|P5|STARTED|Follow-up Period||0
7771140|NCT01365455|19131420|P4|STARTED|Follow-up Period||0
7771141|NCT01365455|19131421|P3|STARTED|Follow-up Period||18
7771142|NCT01365455|19131422|P2|STARTED|Follow-up Period||47
7771143|NCT01365455|19131423|P1|STARTED|Follow-up Period||58
7771144|NCT01365455|19131419|P5|NOT COMPLETED|Maintenance Period||13
7771145|NCT01365455|19131420|P4|NOT COMPLETED|Maintenance Period||9
7771146|NCT01365455|19131421|P3|NOT COMPLETED|Maintenance Period||3
7771147|NCT01365455|19131422|P2|NOT COMPLETED|Maintenance Period||23
7771148|NCT01365455|19131423|P1|NOT COMPLETED|Maintenance Period||29
7771149|NCT01365455|19131419|P5|COMPLETED|Maintenance Period||92
7771150|NCT01365455|19131420|P4|COMPLETED|Maintenance Period||100
7771151|NCT01365455|19131421|P3|COMPLETED|Maintenance Period||15
7771152|NCT01365455|19131422|P2|COMPLETED|Maintenance Period||215
7771153|NCT01365455|19131423|P1|COMPLETED|Maintenance Period||201
7771154|NCT01365455|19131419|P5|STARTED|Maintenance Period||105
7771155|NCT01365455|19131420|P4|STARTED|Maintenance Period||109
7771156|NCT01365455|19131421|P3|STARTED|Maintenance Period||18
7771157|NCT01365455|19131422|P2|STARTED|Maintenance Period||238
7771158|NCT01365455|19131423|P1|STARTED|Maintenance Period||230
7771159|NCT01365455|19131419|P5|NOT COMPLETED|Induction Period||0
7771160|NCT01365455|19131420|P4|NOT COMPLETED|Induction Period||0
7771161|NCT01365455|19131421|P3|NOT COMPLETED|Induction Period||16
7771162|NCT01365455|19131422|P2|NOT COMPLETED|Induction Period||7
7771163|NCT01365455|19131423|P1|NOT COMPLETED|Induction Period||15
7771164|NCT01365455|19131419|P5|COMPLETED|Induction Period||0
7771165|NCT01365455|19131420|P4|COMPLETED|Induction Period||0
7771166|NCT01365455|19131421|P3|COMPLETED|Induction Period||232
7771167|NCT01365455|19131422|P2|COMPLETED|Induction Period||238
7771168|NCT01365455|19131423|P1|COMPLETED|Induction Period||230
7771169|NCT01365455|19131419|P5|STARTED|Induction Period||0
7771170|NCT01365455|19131420|P4|STARTED|Induction Period||0
7771171|NCT01365455|19131421|P3|STARTED|Induction Period||248
7771172|NCT01365455|19131422|P2|STARTED|Induction Period||245
7771173|NCT01365455|19131423|P1|STARTED|Induction Period||245
7771174|NCT01365273|19131513|P2|NOT COMPLETED|Overall Study||1
7771175|NCT01365273|19131514|P1|NOT COMPLETED|Overall Study||2
7771176|NCT01365273|19131513|P2|COMPLETED|Overall Study||20
7771177|NCT01365273|19131514|P1|COMPLETED|Overall Study||20
7771178|NCT01365273|19131513|P2|Compl. Pts, Not Evaluable for Pain.|Overall Study||4
7771179|NCT01365273|19131514|P1|Compl. Pts, Not Evaluable for Pain.|Overall Study||2
7771180|NCT01365273|19131513|P2|STARTED|Overall Study||21
7771181|NCT01365273|19131514|P1|STARTED|Overall Study||22
7771182|NCT01365130|19131524|P1|NOT COMPLETED|Overall Study||2
7771183|NCT01365130|19131524|P1|COMPLETED|Overall Study||13
7771184|NCT01365130|19131524|P1|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15
7771185|NCT01365091|19131533|P4|NOT COMPLETED|Period 2||0
7771186|NCT01365091|19131534|P3|NOT COMPLETED|Period 2||1
7771187|NCT01365091|19131535|P2|NOT COMPLETED|Period 2||0
7771188|NCT01365091|19131536|P1|NOT COMPLETED|Period 2||1
7771189|NCT01365091|19131533|P4|COMPLETED|Period 2||25
7771190|NCT01365091|19131534|P3|COMPLETED|Period 2||24
7771191|NCT01365091|19131535|P2|COMPLETED|Period 2||26
7771192|NCT01365091|19131536|P1|COMPLETED|Period 2||25
7771193|NCT01365091|19131533|P4|STARTED|Period 2||25
7771194|NCT01365091|19131534|P3|STARTED|Period 2||25
7771195|NCT01365091|19131535|P2|STARTED|Period 2||26
7771196|NCT01365091|19131536|P1|STARTED|Period 2||26
7771197|NCT01365091|19131533|P4|NOT COMPLETED|Period 1||3
7771198|NCT01365091|19131534|P3|NOT COMPLETED|Period 1||3
7771199|NCT01365091|19131535|P2|NOT COMPLETED|Period 1||2
7771200|NCT01365091|19131536|P1|NOT COMPLETED|Period 1||2
7771201|NCT01365091|19131533|P4|COMPLETED|Period 1||25
7771202|NCT01365091|19131534|P3|COMPLETED|Period 1||25
7771203|NCT01365091|19131535|P2|COMPLETED|Period 1||26
7771204|NCT01365091|19131536|P1|COMPLETED|Period 1||26
7771205|NCT01365091|19131533|P4|STARTED|Period 1||28
7771206|NCT01365091|19131534|P3|STARTED|Period 1||28
7771207|NCT01365091|19131535|P2|STARTED|Period 1||28
7771208|NCT01365091|19131536|P1|STARTED|Period 1||28
7771209|NCT01365052|19131564|P2|NOT COMPLETED|Overall Study||4
7771210|NCT01365052|19131565|P1|NOT COMPLETED|Overall Study||4
7771211|NCT01365052|19131564|P2|COMPLETED|Overall Study||105
7771212|NCT01365052|19131565|P1|COMPLETED|Overall Study||213
7771213|NCT01365052|19131564|P2|STARTED|Overall Study||109
7771214|NCT01365052|19131565|P1|STARTED|Overall Study||217
7771215|NCT01365039|19131581|P2|NOT COMPLETED|Overall Study||0
7771216|NCT01365039|19131582|P1|NOT COMPLETED|Overall Study||1
7771217|NCT01365039|19131581|P2|COMPLETED|Overall Study||87
7771218|NCT01365039|19131582|P1|COMPLETED|Overall Study||85
7771219|NCT01365039|19131581|P2|STARTED|Overall Study||87
7771220|NCT01365039|19131582|P1|STARTED|Overall Study||86
7771221|NCT01364922|19131593|P3|NOT COMPLETED|Double-Blind (DB) Period||5
7771222|NCT01364922|19131594|P2|NOT COMPLETED|Double-Blind (DB) Period||5
7771223|NCT01364922|19131595|P1|NOT COMPLETED|Double-Blind (DB) Period||0
7771224|NCT01364922|19131593|P3|COMPLETED|Double-Blind (DB) Period||42
7771225|NCT01364922|19131594|P2|COMPLETED|Double-Blind (DB) Period||94
7771226|NCT01364922|19131595|P1|COMPLETED|Double-Blind (DB) Period||0
7771227|NCT01364922|19131593|P3|STARTED|Double-Blind (DB) Period||47
7771228|NCT01364922|19131594|P2|STARTED|Double-Blind (DB) Period||99
7771229|NCT01364922|19131595|P1|STARTED|Double-Blind (DB) Period||0
7771230|NCT01364922|19131593|P3|NOT COMPLETED|Open-label (OL) Period||0
7771231|NCT01364922|19131594|P2|NOT COMPLETED|Open-label (OL) Period||0
7771232|NCT01364922|19131595|P1|NOT COMPLETED|Open-label (OL) Period||22
7771233|NCT01364922|19131593|P3|COMPLETED|Open-label (OL) Period||0
7771234|NCT01364922|19131594|P2|COMPLETED|Open-label (OL) Period||0
7771235|NCT01364922|19131595|P1|COMPLETED|Open-label (OL) Period||146
7771236|NCT01364922|19131593|P3|STARTED|Open-label (OL) Period||0
7771237|NCT01364922|19131594|P2|STARTED|Open-label (OL) Period||0
7771238|NCT01364922|19131595|P1|STARTED|Open-label (OL) Period||168
7771239|NCT01364896|19131606|P1|NOT COMPLETED|Overall Study||0
7771240|NCT01364896|19131606|P1|COMPLETED|Overall Study||46
7771241|NCT01364896|19131606|P1|STARTED|Overall Study||46
7771242|NCT01364870|19131617|P3|NOT COMPLETED|Overall Study||14
7771243|NCT01364870|19131618|P2|NOT COMPLETED|Overall Study||30
7771244|NCT01364870|19131619|P1|NOT COMPLETED|Overall Study||22
7771245|NCT01364870|19131617|P3|COMPLETED|Overall Study||58
7771246|NCT01364870|19131618|P2|COMPLETED|Overall Study||93
7771247|NCT01364870|19131619|P1|COMPLETED|Overall Study||100
7771248|NCT01364870|19131617|P3|STARTED|Overall Study||72
7771249|NCT01364870|19131618|P2|STARTED|Overall Study||123
7771250|NCT01364870|19131619|P1|STARTED|Overall Study||122
7771251|NCT01364740|19131630|P1|NOT COMPLETED|Overall Study||0
7771252|NCT01364740|19131630|P1|COMPLETED|Overall Study||10
7771253|NCT01364740|19131630|P1|STARTED|Overall Study||10
7771254|NCT01364727|19131638|P1|NOT COMPLETED|Overall Study||2
7771255|NCT01364727|19131638|P1|COMPLETED|Overall Study||33
7771256|NCT01364727|19131638|P1|STARTED|Overall Study||35
7771257|NCT01364649|19131646|P2|NOT COMPLETED|Overall Study||43
7771258|NCT01364649|19131647|P1|NOT COMPLETED|Overall Study||56
7771259|NCT01364649|19131646|P2|COMPLETED|Overall Study||179
7771260|NCT01364649|19131647|P1|COMPLETED|Overall Study||169
7771261|NCT01364649|19131646|P2|STARTED|Overall Study||222
7771262|NCT01364649|19131647|P1|STARTED|Overall Study||225
7771263|NCT01364623|19131660|P4|NOT COMPLETED|Multiple Dose||0
7771264|NCT01364623|19131661|P3|NOT COMPLETED|Multiple Dose||0
7771265|NCT01364623|19131662|P2|NOT COMPLETED|Multiple Dose||0
7771266|NCT01364623|19131663|P1|NOT COMPLETED|Multiple Dose||0
7771267|NCT01364623|19131660|P4|COMPLETED|Multiple Dose||8
7771268|NCT01364623|19131661|P3|COMPLETED|Multiple Dose||0
7771269|NCT01364623|19131662|P2|COMPLETED|Multiple Dose||0
7771270|NCT01364623|19131663|P1|COMPLETED|Multiple Dose||0
7771271|NCT01364623|19131660|P4|STARTED|Multiple Dose||8
7771272|NCT01364623|19131661|P3|STARTED|Multiple Dose||0
7771273|NCT01364623|19131662|P2|STARTED|Multiple Dose||0
7771274|NCT01364623|19131663|P1|STARTED|Multiple Dose||0
7771275|NCT01364623|19131660|P4|NOT COMPLETED|Single Dose||0
7771276|NCT01364623|19131661|P3|NOT COMPLETED|Single Dose||0
7771277|NCT01364623|19131662|P2|NOT COMPLETED|Single Dose||0
7771278|NCT01364623|19131663|P1|NOT COMPLETED|Single Dose||0
7771279|NCT01364623|19131660|P4|COMPLETED|Single Dose||0
7771280|NCT01364623|19131661|P3|COMPLETED|Single Dose||8
7771281|NCT01364623|19131662|P2|COMPLETED|Single Dose||8
7771282|NCT01364623|19131663|P1|COMPLETED|Single Dose||8
7771283|NCT01364623|19131660|P4|STARTED|Single Dose||0
7771284|NCT01364623|19131661|P3|STARTED|Single Dose||8
7771285|NCT01364623|19131662|P2|STARTED|Single Dose||8
7771286|NCT01364623|19131663|P1|STARTED|Single Dose||8
7771287|NCT01364584|19131688|P2|NOT COMPLETED|Overall Study||0
7771288|NCT01364584|19131689|P1|NOT COMPLETED|Overall Study||0
7771289|NCT01364584|19131688|P2|COMPLETED|Overall Study||12
7771290|NCT01364584|19131689|P1|COMPLETED|Overall Study||11
7771291|NCT01364584|19131688|P2|STARTED|Overall Study||12
7771292|NCT01364584|19131689|P1|STARTED|Overall Study||11
7771293|NCT01364558|19131723|P3|NOT COMPLETED|Dose Three||0
7771294|NCT01364558|19131724|P2|NOT COMPLETED|Dose Three||0
7771295|NCT01364558|19131725|P1|NOT COMPLETED|Dose Three||0
7771296|NCT01364558|19131723|P3|COMPLETED|Dose Three||8
7771297|NCT01364558|19131724|P2|COMPLETED|Dose Three||8
7771298|NCT01364558|19131725|P1|COMPLETED|Dose Three||8
7771299|NCT01364558|19131723|P3|STARTED|Dose Three||8
7771300|NCT01364558|19131724|P2|STARTED|Dose Three||8
7771301|NCT01364558|19131725|P1|STARTED|Dose Three||8
7771302|NCT01364558|19131723|P3|NOT COMPLETED|Dose Two||0
7771303|NCT01364558|19131724|P2|NOT COMPLETED|Dose Two||0
7771304|NCT01364558|19131725|P1|NOT COMPLETED|Dose Two||0
7771305|NCT01364558|19131723|P3|COMPLETED|Dose Two||8
7771306|NCT01364558|19131724|P2|COMPLETED|Dose Two||8
7771307|NCT01364558|19131725|P1|COMPLETED|Dose Two||8
7771308|NCT01364558|19131723|P3|STARTED|Dose Two||8
7771309|NCT01364558|19131724|P2|STARTED|Dose Two||8
7771310|NCT01364558|19131725|P1|STARTED|Dose Two||8
7771311|NCT01364558|19131723|P3|NOT COMPLETED|Dose One||0
7771312|NCT01364558|19131724|P2|NOT COMPLETED|Dose One||0
7771313|NCT01364558|19131725|P1|NOT COMPLETED|Dose One||0
7771314|NCT01364558|19131723|P3|COMPLETED|Dose One||8
7771315|NCT01364558|19131724|P2|COMPLETED|Dose One||8
7771316|NCT01364558|19131725|P1|COMPLETED|Dose One||8
7771317|NCT01364558|19131723|P3|STARTED|Dose One||8
7771318|NCT01364558|19131724|P2|STARTED|Dose One||8
7771319|NCT01364558|19131725|P1|STARTED|Dose One||8
7771320|NCT01364467|19131735|P2|NOT COMPLETED|Overall Study||2
7771321|NCT01364467|19131736|P1|NOT COMPLETED|Overall Study||1
7771322|NCT01364467|19131735|P2|COMPLETED|Overall Study||18
7771323|NCT01364467|19131736|P1|COMPLETED|Overall Study||9
7771324|NCT01364467|19131735|P2|STARTED|Overall Study||20
7771325|NCT01364467|19131736|P1|STARTED|Overall Study||10
7771326|NCT01364428|19131748|P2|NOT COMPLETED|Overall Study||15
7771327|NCT01364428|19131749|P1|NOT COMPLETED|Overall Study||20
7771328|NCT01364428|19131748|P2|COMPLETED|Overall Study||172
7771329|NCT01364428|19131749|P1|COMPLETED|Overall Study||166
7771330|NCT01364428|19131748|P2|Exposed|Overall Study||187
7771331|NCT01364428|19131749|P1|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184
7771332|NCT01364428|19131748|P2|STARTED|Overall Study||187
7771333|NCT01364428|19131749|P1|STARTED|Overall Study||186
7771334|NCT01364389|19131766|P3|NOT COMPLETED|Overall Study||1
7771335|NCT01364389|19131767|P2|NOT COMPLETED|Overall Study||1
7771336|NCT01364389|19131768|P1|NOT COMPLETED|Overall Study||2
7771337|NCT01364389|19131766|P3|COMPLETED|Overall Study||4
7771338|NCT01364389|19131767|P2|COMPLETED|Overall Study||5
7771339|NCT01364389|19131768|P1|COMPLETED|Overall Study||3
7771340|NCT01364389|19131766|P3|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4
7771341|NCT01364389|19131767|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||6
7771342|NCT01364389|19131768|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||5
7771343|NCT01364389|19131766|P3|STARTED|Overall Study||5
7771344|NCT01364389|19131767|P2|STARTED|Overall Study||6
7771345|NCT01364389|19131768|P1|STARTED|Overall Study||5
7771346|NCT01364298|19131787|P2|NOT COMPLETED|Overall Study||23
7771347|NCT01364298|19131788|P1|NOT COMPLETED|Overall Study||14
7771348|NCT01364298|19131787|P2|COMPLETED|Overall Study||154
7771349|NCT01364298|19131788|P1|COMPLETED|Overall Study||162
7771350|NCT01364298|19131787|P2|Treated|Overall Study||174
7771351|NCT01364298|19131788|P1|Treated|Overall Study||174
7771352|NCT01364298|19131787|P2|STARTED|Overall Study||177
7771353|NCT01364298|19131788|P1|STARTED|Overall Study||176
7771354|NCT01364259|19131812|P2|NOT COMPLETED|Overall Study||0
7771355|NCT01364259|19131813|P1|NOT COMPLETED|Overall Study||0
7771356|NCT01364259|19131812|P2|COMPLETED|Overall Study||8
7771357|NCT01364259|19131813|P1|COMPLETED|Overall Study||9
7771358|NCT01364259|19131812|P2|STARTED|Overall Study||8
7771359|NCT01364259|19131813|P1|STARTED|Overall Study||9
7771360|NCT01364233|19131821|P1|NOT COMPLETED|Overall Study||1
7771361|NCT01364233|19131821|P1|COMPLETED|Overall Study||9
7771362|NCT01364233|19131821|P1|STARTED|Overall Study||10
7771363|NCT01364207|19131825|P2|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
7771364|NCT01364207|19131826|P1|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
7771365|NCT01364207|19131825|P2|COMPLETED|Second Visit (~1.5-2 Hours)||54
7771366|NCT01364207|19131826|P1|COMPLETED|Second Visit (~1.5-2 Hours)||52
7771367|NCT01364207|19131825|P2|STARTED|Second Visit (~1.5-2 Hours)||54
7771368|NCT01364207|19131826|P1|STARTED|Second Visit (~1.5-2 Hours)||52
7771369|NCT01364207|19131825|P2|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4
7771370|NCT01364207|19131826|P1|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2
7771371|NCT01364207|19131825|P2|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54
7771372|NCT01364207|19131826|P1|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52
7771373|NCT01364207|19131825|P2|STARTED|Time Between Visits (2 Days to 4 Weeks)||58
7771374|NCT01364207|19131826|P1|STARTED|Time Between Visits (2 Days to 4 Weeks)||54
7771375|NCT01364207|19131825|P2|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
7771376|NCT01364207|19131826|P1|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
7771377|NCT01364207|19131825|P2|COMPLETED|First Visit (~1.5-2 Hours)||58
7771378|NCT01364207|19131826|P1|COMPLETED|First Visit (~1.5-2 Hours)||54
7771379|NCT01364207|19131825|P2|STARTED|First Visit (~1.5-2 Hours)||58
7771380|NCT01364207|19131826|P1|STARTED|First Visit (~1.5-2 Hours)||54
7771381|NCT01364090|19131837|P3|NOT COMPLETED|Overall Study||6
7771382|NCT01364090|19131838|P2|NOT COMPLETED|Overall Study||14
7771383|NCT01364090|19131839|P1|NOT COMPLETED|Overall Study||3
7771384|NCT01364090|19131837|P3|COMPLETED|Overall Study||0
7771385|NCT01364090|19131838|P2|COMPLETED|Overall Study||12
7771386|NCT01364090|19131839|P1|COMPLETED|Overall Study||58
7771387|NCT01364090|19131837|P3|STARTED|Overall Study||6
7771388|NCT01364090|19131838|P2|STARTED|Overall Study||26
7771389|NCT01364090|19131839|P1|STARTED|Overall Study||61
7771390|NCT01363999|19131847|P1|NOT COMPLETED|D: RO4607381/ F49 Tablet||0
7771391|NCT01363999|19131847|P1|COMPLETED|D: RO4607381/ F49 Tablet||24
7771392|NCT01363999|19131847|P1|STARTED|D: RO4607381/ F49 Tablet||24
7771393|NCT01363999|19131847|P1|NOT COMPLETED|C: RO5317116/ F04 Active-coated Tablet||0
7771394|NCT01363999|19131847|P1|COMPLETED|C: RO5317116/ F04 Active-coated Tablet||24
7771395|NCT01363999|19131847|P1|STARTED|C: RO5317116/ F04 Active-coated Tablet||24
7771396|NCT01363999|19131847|P1|NOT COMPLETED|B: RO5317116/F03 Bilayer Tablet||0
7771397|NCT01363999|19131847|P1|COMPLETED|B: RO5317116/F03 Bilayer Tablet||24
7771398|NCT01363999|19131847|P1|STARTED|B: RO5317116/F03 Bilayer Tablet||24
7771399|NCT01363999|19131847|P1|NOT COMPLETED|A: RO5317116/F01 Bilayer Tablet||0
7771400|NCT01363999|19131847|P1|COMPLETED|A: RO5317116/F01 Bilayer Tablet||24
7771401|NCT01363999|19131847|P1|STARTED|A: RO5317116/F01 Bilayer Tablet||24
7771402|NCT01363986|19131866|P1|NOT COMPLETED|Overall Study||1
7771403|NCT01363986|19131866|P1|COMPLETED|Overall Study||2
7771404|NCT01363986|19131866|P1|STARTED|Overall Study||3
7771405|NCT01363908|19131876|P2|NOT COMPLETED|Chronic Dosing (CD) Phase||6
7771406|NCT01363908|19131877|P1|NOT COMPLETED|Chronic Dosing (CD) Phase||10
7771407|NCT01363908|19131876|P2|COMPLETED|Chronic Dosing (CD) Phase||10
7771408|NCT01363908|19131877|P1|COMPLETED|Chronic Dosing (CD) Phase||3
7771485|NCT01363440|19132002|P2|COMPLETED|Overall Study|Completed Week 100|125
7771409|NCT01363908|19131876|P2|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16
7771410|NCT01363908|19131877|P1|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13
7771411|NCT01363908|19131876|P2|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
7771412|NCT01363908|19131877|P1|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
7771413|NCT01363908|19131876|P2|COMPLETED|Pharmacokinetic (PK) Phase||8
7771414|NCT01363908|19131877|P1|COMPLETED|Pharmacokinetic (PK) Phase||8
7771415|NCT01363908|19131876|P2|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
7771416|NCT01363908|19131877|P1|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
7771417|NCT01363908|19131876|P2|NOT COMPLETED|Screening/Enrollment||0
7771418|NCT01363908|19131877|P1|NOT COMPLETED|Screening/Enrollment||1
7771419|NCT01363908|19131876|P2|COMPLETED|Screening/Enrollment||16
7771420|NCT01363908|19131877|P1|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13
7771421|NCT01363908|19131876|P2|STARTED|Screening/Enrollment||16
7771422|NCT01363908|19131877|P1|STARTED|Screening/Enrollment||14
7771423|NCT01363843|19131907|P1|NOT COMPLETED|Overall Study||1
7771424|NCT01363843|19131907|P1|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38
7771425|NCT01363843|19131907|P1|STARTED|Overall Study||39
7771426|NCT01363765|19131914|P2|NOT COMPLETED|Overall Study||4731
7771427|NCT01363765|19131915|P1|NOT COMPLETED|Overall Study||5800
7771428|NCT01363765|19131914|P2|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705
7771429|NCT01363765|19131915|P1|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522
7771430|NCT01363765|19131914|P2|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436
7771431|NCT01363765|19131915|P1|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322
7771432|NCT01363713|19131927|P1|NOT COMPLETED|Overall Study||6
7771433|NCT01363713|19131927|P1|COMPLETED|Overall Study|Analysed (n=130)|124
7771434|NCT01363713|19131927|P1|ALLOCATED|Overall Study||130
7771435|NCT01363713|19131927|P1|STARTED|Overall Study|Assessed for eligibility|130
7771436|NCT01363700|19131936|P5|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
7771437|NCT01363700|19131937|P4|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
7771438|NCT01363700|19131938|P3|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
7771439|NCT01363700|19131939|P2|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
7771440|NCT01363700|19131940|P1|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
7771441|NCT01363700|19131936|P5|COMPLETED|Epinastine vs Olopatadine Period2||43
7771442|NCT01363700|19131937|P4|COMPLETED|Epinastine vs Olopatadine Period2||43
7771443|NCT01363700|19131938|P3|COMPLETED|Epinastine vs Olopatadine Period2||0
7771444|NCT01363700|19131939|P2|COMPLETED|Epinastine vs Olopatadine Period2||0
7771445|NCT01363700|19131940|P1|COMPLETED|Epinastine vs Olopatadine Period2||0
7771446|NCT01363700|19131936|P5|STARTED|Epinastine vs Olopatadine Period2||43
7771447|NCT01363700|19131937|P4|STARTED|Epinastine vs Olopatadine Period2||43
7771448|NCT01363700|19131938|P3|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
7771449|NCT01363700|19131939|P2|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
7771450|NCT01363700|19131940|P1|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
7771451|NCT01363700|19131936|P5|NOT COMPLETED|Epinastine vs Placebo Period1||0
7771452|NCT01363700|19131937|P4|NOT COMPLETED|Epinastine vs Placebo Period1||0
7771453|NCT01363700|19131938|P3|NOT COMPLETED|Epinastine vs Placebo Period1||0
7771454|NCT01363700|19131939|P2|NOT COMPLETED|Epinastine vs Placebo Period1||1
7771455|NCT01363700|19131940|P1|NOT COMPLETED|Epinastine vs Placebo Period1||0
7771456|NCT01363700|19131936|P5|COMPLETED|Epinastine vs Placebo Period1||0
7771457|NCT01363700|19131937|P4|COMPLETED|Epinastine vs Placebo Period1||0
7771458|NCT01363700|19131938|P3|COMPLETED|Epinastine vs Placebo Period1||22
7771459|NCT01363700|19131939|P2|COMPLETED|Epinastine vs Placebo Period1||21
7771460|NCT01363700|19131940|P1|COMPLETED|Epinastine vs Placebo Period1||43
7771461|NCT01363700|19131936|P5|STARTED|Epinastine vs Placebo Period1|No Allocation|0
7771462|NCT01363700|19131937|P4|STARTED|Epinastine vs Placebo Period1|No Allocation|0
7771463|NCT01363700|19131938|P3|STARTED|Epinastine vs Placebo Period1||22
7771464|NCT01363700|19131939|P2|STARTED|Epinastine vs Placebo Period1||22
7771465|NCT01363700|19131940|P1|STARTED|Epinastine vs Placebo Period1||43
7771466|NCT01363661|19131959|P2|NOT COMPLETED|Overall Study||4
7771467|NCT01363661|19131960|P1|NOT COMPLETED|Overall Study||14
7771468|NCT01363661|19131959|P2|COMPLETED|Overall Study||28
7771469|NCT01363661|19131960|P1|COMPLETED|Overall Study||18
7771470|NCT01363661|19131959|P2|STARTED|Overall Study||32
7771471|NCT01363661|19131960|P1|STARTED|Overall Study||32
7771472|NCT01363492|19131976|P1|NOT COMPLETED|Overall Study||0
7771473|NCT01363492|19131976|P1|COMPLETED|Overall Study||14
7771474|NCT01363492|19131976|P1|STARTED|Overall Study||14
7771475|NCT01363479|19131991|P2|NOT COMPLETED|Overall Study||21
7771476|NCT01363479|19131992|P1|NOT COMPLETED|Overall Study||12
7771477|NCT01363479|19131991|P2|COMPLETED|Overall Study||351
7771478|NCT01363479|19131992|P1|COMPLETED|Overall Study||359
7771479|NCT01363479|19131991|P2|STARTED|Overall Study|number of randomised patients|372
7771480|NCT01363479|19131992|P1|STARTED|Overall Study|number of randomised patients|371
7771481|NCT01363440|19132001|P3|NOT COMPLETED|Overall Study||27
7771482|NCT01363440|19132002|P2|NOT COMPLETED|Overall Study||31
7771483|NCT01363440|19132003|P1|NOT COMPLETED|Overall Study||23
7771484|NCT01363440|19132001|P3|COMPLETED|Overall Study|Completed Week 100|127
7771486|NCT01363440|19132003|P1|COMPLETED|Overall Study|Completed Week 100|133
7771487|NCT01363440|19132001|P3|Completed Week 100|Overall Study||127
7771488|NCT01363440|19132002|P2|Completed Week 100|Overall Study||125
7771489|NCT01363440|19132003|P1|Completed Week 100|Overall Study||133
7771490|NCT01363440|19132001|P3|Completed Week 52|Overall Study||144
7771491|NCT01363440|19132002|P2|Completed Week 52|Overall Study||146
7771492|NCT01363440|19132003|P1|Completed Week 52|Overall Study||145
7771493|NCT01363440|19132001|P3|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152
7771494|NCT01363440|19132002|P2|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155
7771495|NCT01363440|19132003|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154
7771496|NCT01363440|19132001|P3|STARTED|Overall Study|randomized|154
7771497|NCT01363440|19132002|P2|STARTED|Overall Study|randomized|156
7771498|NCT01363440|19132003|P1|STARTED|Overall Study|randomized|156
7771499|NCT01363401|19132034|P2|NOT COMPLETED|Overall Study||4
7771500|NCT01363401|19132035|P1|NOT COMPLETED|Overall Study||2
7771501|NCT01363401|19132034|P2|COMPLETED|Overall Study||27
7771502|NCT01363401|19132035|P1|COMPLETED|Overall Study||39
7771503|NCT01363401|19132034|P2|STARTED|Overall Study||31
7771504|NCT01363401|19132035|P1|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41
7771505|NCT01363388|19132050|P3|NOT COMPLETED|Overall Study||4
7771506|NCT01363388|19132051|P2|NOT COMPLETED|Overall Study||3
7771507|NCT01363388|19132052|P1|NOT COMPLETED|Overall Study||5
7771508|NCT01363388|19132050|P3|COMPLETED|Overall Study||18
7771509|NCT01363388|19132051|P2|COMPLETED|Overall Study||19
7771510|NCT01363388|19132052|P1|COMPLETED|Overall Study||18
7771511|NCT01363388|19132050|P3|STARTED|Overall Study||22
7771512|NCT01363388|19132051|P2|STARTED|Overall Study||22
7771513|NCT01363388|19132052|P1|STARTED|Overall Study||23
7771514|NCT01363349|19132062|P2|NOT COMPLETED|Overall Study||70
7771515|NCT01363349|19132063|P1|NOT COMPLETED|Overall Study||67
7771516|NCT01363349|19132062|P2|COMPLETED|Overall Study||66
7771517|NCT01363349|19132063|P1|COMPLETED|Overall Study||66
7771518|NCT01363349|19132062|P2|Randomized|Overall Study||136
7771519|NCT01363349|19132063|P1|Randomized|Overall Study||133
7771520|NCT01363349|19132062|P2|STARTED|Overall Study||136
7771521|NCT01363349|19132063|P1|STARTED|Overall Study||133
7771522|NCT01363297|19132074|P5|NOT COMPLETED|Overall Study||31
7771523|NCT01363297|19132075|P4|NOT COMPLETED|Overall Study||10
7771524|NCT01363297|19132076|P3|NOT COMPLETED|Overall Study||6
7771525|NCT01363297|19132077|P2|NOT COMPLETED|Overall Study||6
7771526|NCT01363297|19132078|P1|NOT COMPLETED|Overall Study||3
7771527|NCT01363297|19132074|P5|COMPLETED|Overall Study||4
7771528|NCT01363297|19132075|P4|COMPLETED|Overall Study||3
7771529|NCT01363297|19132076|P3|COMPLETED|Overall Study||3
7771530|NCT01363297|19132077|P2|COMPLETED|Overall Study||6
7771531|NCT01363297|19132078|P1|COMPLETED|Overall Study||0
7771532|NCT01363297|19132074|P5|STARTED|Overall Study||35
7771533|NCT01363297|19132075|P4|STARTED|Overall Study||13
7771534|NCT01363297|19132076|P3|STARTED|Overall Study||9
7771535|NCT01363297|19132077|P2|STARTED|Overall Study||12
7771536|NCT01363297|19132078|P1|STARTED|Overall Study||3
7771537|NCT01363258|19132170|P2|NOT COMPLETED|Overall Study||0
7771538|NCT01363258|19132171|P1|NOT COMPLETED|Overall Study||0
7771539|NCT01363258|19132170|P2|COMPLETED|Overall Study||46
7771540|NCT01363258|19132171|P1|COMPLETED|Overall Study||54
7771541|NCT01363258|19132170|P2|STARTED|Overall Study||46
7771542|NCT01363258|19132171|P1|STARTED|Overall Study||54
7771543|NCT01363076|19132181|P2|NOT COMPLETED|Overall Study||1
7771544|NCT01363076|19132182|P1|NOT COMPLETED|Overall Study||0
7771545|NCT01363076|19132181|P2|COMPLETED|Overall Study||12
7771546|NCT01363076|19132182|P1|COMPLETED|Overall Study||7
7771547|NCT01363076|19132181|P2|STARTED|Overall Study||13
7771548|NCT01363076|19132182|P1|STARTED|Overall Study||7
7771549|NCT01363050|19132200|P1|NOT COMPLETED|Overall Study||0
7771550|NCT01363050|19132200|P1|COMPLETED|Overall Study||15
7771551|NCT01363050|19132200|P1|STARTED|Overall Study||15
7771552|NCT01363011|19132214|P2|NOT COMPLETED|Extension Phase||8
7771553|NCT01363011|19132215|P1|NOT COMPLETED|Extension Phase||5
7771554|NCT01363011|19132214|P2|COMPLETED|Extension Phase||41
7771555|NCT01363011|19132215|P1|COMPLETED|Extension Phase||13
7771556|NCT01363011|19132214|P2|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49
7771557|NCT01363011|19132215|P1|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18
7771558|NCT01363011|19132214|P2|NOT COMPLETED|Main Study||9
7771559|NCT01363011|19132215|P1|NOT COMPLETED|Main Study||4
7771560|NCT01363011|19132214|P2|COMPLETED|Main Study||64
7771561|NCT01363011|19132215|P1|COMPLETED|Main Study||29
7771562|NCT01363011|19132214|P2|STARTED|Main Study||73
7771563|NCT01363011|19132215|P1|STARTED|Main Study||33
7771564|NCT01362959|19132257|P2|NOT COMPLETED|Overall Study||0
7771565|NCT01362959|19132258|P1|NOT COMPLETED|Overall Study||0
7771566|NCT01362959|19132257|P2|COMPLETED|Overall Study||26
7771567|NCT01362959|19132258|P1|COMPLETED|Overall Study||21
7771568|NCT01362959|19132257|P2|STARTED|Overall Study||26
7771569|NCT01362959|19132258|P1|STARTED|Overall Study||21
7771570|NCT01362946|19132272|P2|NOT COMPLETED|Second Behavior Modification Block||0
7771571|NCT01362946|19132273|P1|NOT COMPLETED|Second Behavior Modification Block||0
7771572|NCT01362946|19132272|P2|COMPLETED|Second Behavior Modification Block||24
7771573|NCT01362946|19132273|P1|COMPLETED|Second Behavior Modification Block||23
7771574|NCT01362946|19132272|P2|STARTED|Second Behavior Modification Block||24
7771575|NCT01362946|19132273|P1|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23
7771576|NCT01362946|19132272|P2|NOT COMPLETED|First Behavior Modification Block||0
7771577|NCT01362946|19132273|P1|NOT COMPLETED|First Behavior Modification Block||0
7771578|NCT01362946|19132272|P2|COMPLETED|First Behavior Modification Block||24
7771579|NCT01362946|19132273|P1|COMPLETED|First Behavior Modification Block||24
7771580|NCT01362946|19132272|P2|STARTED|First Behavior Modification Block||24
7771581|NCT01362946|19132273|P1|STARTED|First Behavior Modification Block||24
7771582|NCT01362907|19132306|P2|NOT COMPLETED|Period 2, One Week||0
7771583|NCT01362907|19132307|P1|NOT COMPLETED|Period 2, One Week||0
7771584|NCT01362907|19132306|P2|COMPLETED|Period 2, One Week||20
7771585|NCT01362907|19132307|P1|COMPLETED|Period 2, One Week||20
7771586|NCT01362907|19132306|P2|STARTED|Period 2, One Week||20
7771587|NCT01362907|19132307|P1|STARTED|Period 2, One Week||20
7771588|NCT01362907|19132306|P2|NOT COMPLETED|Period 1, One Week||0
7771589|NCT01362907|19132307|P1|NOT COMPLETED|Period 1, One Week||0
7771590|NCT01362907|19132306|P2|COMPLETED|Period 1, One Week||20
7771591|NCT01362907|19132307|P1|COMPLETED|Period 1, One Week||20
7771592|NCT01362907|19132306|P2|STARTED|Period 1, One Week||20
7771593|NCT01362907|19132307|P1|STARTED|Period 1, One Week||20
7771594|NCT01362894|19132321|P2|NOT COMPLETED|Period Two, 1 Week||0
7771595|NCT01362894|19132322|P1|NOT COMPLETED|Period Two, 1 Week||0
7771596|NCT01362894|19132321|P2|COMPLETED|Period Two, 1 Week||115
7771597|NCT01362894|19132322|P1|COMPLETED|Period Two, 1 Week||118
7771598|NCT01362894|19132321|P2|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115
7771599|NCT01362894|19132322|P1|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118
7771600|NCT01362894|19132321|P2|NOT COMPLETED|Period One, 1 Week||0
7771601|NCT01362894|19132322|P1|NOT COMPLETED|Period One, 1 Week||0
7771602|NCT01362894|19132321|P2|COMPLETED|Period One, 1 Week||117
7771603|NCT01362894|19132322|P1|COMPLETED|Period One, 1 Week||119
7771604|NCT01362894|19132321|P2|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117
7771605|NCT01362894|19132322|P1|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119
7771606|NCT01362790|19132342|P7|NOT COMPLETED|Dose De-escalation of Regimen A||0
7771607|NCT01362790|19132343|P6|NOT COMPLETED|Dose De-escalation of Regimen A||0
7771608|NCT01362790|19132344|P5|NOT COMPLETED|Dose De-escalation of Regimen A||6
7771609|NCT01362790|19132345|P4|NOT COMPLETED|Dose De-escalation of Regimen A||0
7771610|NCT01362790|19132346|P3|NOT COMPLETED|Dose De-escalation of Regimen A||0
7771611|NCT01362790|19132347|P2|NOT COMPLETED|Dose De-escalation of Regimen A||0
7771612|NCT01362790|19132348|P1|NOT COMPLETED|Dose De-escalation of Regimen A||0
7771613|NCT01362790|19132342|P7|COMPLETED|Dose De-escalation of Regimen A||0
7771614|NCT01362790|19132343|P6|COMPLETED|Dose De-escalation of Regimen A||0
7771615|NCT01362790|19132344|P5|COMPLETED|Dose De-escalation of Regimen A||2
7771616|NCT01362790|19132345|P4|COMPLETED|Dose De-escalation of Regimen A||0
7771617|NCT01362790|19132346|P3|COMPLETED|Dose De-escalation of Regimen A||0
7771618|NCT01362790|19132347|P2|COMPLETED|Dose De-escalation of Regimen A||0
7771619|NCT01362790|19132348|P1|COMPLETED|Dose De-escalation of Regimen A||0
7771620|NCT01362790|19132342|P7|STARTED|Dose De-escalation of Regimen A||0
7771621|NCT01362790|19132343|P6|STARTED|Dose De-escalation of Regimen A||0
7771622|NCT01362790|19132344|P5|STARTED|Dose De-escalation of Regimen A||8
7771623|NCT01362790|19132345|P4|STARTED|Dose De-escalation of Regimen A||0
7771624|NCT01362790|19132346|P3|STARTED|Dose De-escalation of Regimen A||0
7771625|NCT01362790|19132347|P2|STARTED|Dose De-escalation of Regimen A||0
7771626|NCT01362790|19132348|P1|STARTED|Dose De-escalation of Regimen A||0
7771627|NCT01362790|19132342|P7|NOT COMPLETED|Pilot Phase & Phase 2||0
7771628|NCT01362790|19132343|P6|NOT COMPLETED|Pilot Phase & Phase 2||4
7771629|NCT01362790|19132344|P5|NOT COMPLETED|Pilot Phase & Phase 2||0
7771630|NCT01362790|19132345|P4|NOT COMPLETED|Pilot Phase & Phase 2||14
7771631|NCT01362790|19132346|P3|NOT COMPLETED|Pilot Phase & Phase 2||5
7771632|NCT01362790|19132347|P2|NOT COMPLETED|Pilot Phase & Phase 2||8
7771633|NCT01362790|19132348|P1|NOT COMPLETED|Pilot Phase & Phase 2||10
7771634|NCT01362790|19132342|P7|COMPLETED|Pilot Phase & Phase 2||0
7771635|NCT01362790|19132343|P6|COMPLETED|Pilot Phase & Phase 2||0
7771636|NCT01362790|19132344|P5|COMPLETED|Pilot Phase & Phase 2||0
7771637|NCT01362790|19132345|P4|COMPLETED|Pilot Phase & Phase 2||1
7771638|NCT01362790|19132346|P3|COMPLETED|Pilot Phase & Phase 2||2
7771639|NCT01362790|19132347|P2|COMPLETED|Pilot Phase & Phase 2||0
7771640|NCT01362790|19132348|P1|COMPLETED|Pilot Phase & Phase 2||1
7771641|NCT01362790|19132342|P7|STARTED|Pilot Phase & Phase 2||0
7771642|NCT01362790|19132343|P6|STARTED|Pilot Phase & Phase 2||4
7771643|NCT01362790|19132344|P5|STARTED|Pilot Phase & Phase 2||0
7771644|NCT01362790|19132345|P4|STARTED|Pilot Phase & Phase 2||15
7771645|NCT01362790|19132346|P3|STARTED|Pilot Phase & Phase 2||7
7771646|NCT01362790|19132347|P2|STARTED|Pilot Phase & Phase 2||8
7771647|NCT01362790|19132348|P1|STARTED|Pilot Phase & Phase 2||11
7771648|NCT01362686|19132398|P3|NOT COMPLETED|Overall Study||10
7771649|NCT01362686|19132399|P2|NOT COMPLETED|Overall Study||12
7771650|NCT01362686|19132400|P1|NOT COMPLETED|Overall Study||8
7771651|NCT01362686|19132398|P3|COMPLETED|Overall Study||53
7771652|NCT01362686|19132399|P2|COMPLETED|Overall Study||54
7771653|NCT01362686|19132400|P1|COMPLETED|Overall Study||59
7771654|NCT01362686|19132398|P3|STARTED|Overall Study||63
7771655|NCT01362686|19132399|P2|STARTED|Overall Study||66
7771656|NCT01362686|19132400|P1|STARTED|Overall Study||67
7771657|NCT01362608|19132416|P2|NOT COMPLETED|Overall Study||8
7771658|NCT01362608|19132417|P1|NOT COMPLETED|Overall Study||4
7771659|NCT01362608|19132416|P2|COMPLETED|Overall Study||61
7771660|NCT01362608|19132417|P1|COMPLETED|Overall Study||63
7771661|NCT01362608|19132416|P2|STARTED|Overall Study||69
7771662|NCT01362608|19132417|P1|STARTED|Overall Study||67
7771663|NCT01362530|19132455|P2|NOT COMPLETED|Optional Extension (Cycles 2-6)||0
7771664|NCT01362530|19132456|P1|NOT COMPLETED|Optional Extension (Cycles 2-6)||125
7771665|NCT01362530|19132455|P2|COMPLETED|Optional Extension (Cycles 2-6)||0
7771666|NCT01362530|19132456|P1|COMPLETED|Optional Extension (Cycles 2-6)||46
7771667|NCT01362530|19132455|P2|STARTED|Optional Extension (Cycles 2-6)||0
7771668|NCT01362530|19132456|P1|STARTED|Optional Extension (Cycles 2-6)||171
7771669|NCT01362530|19132455|P2|NOT COMPLETED|Base Study (Cycle 1)||3
7771670|NCT01362530|19132456|P1|NOT COMPLETED|Base Study (Cycle 1)||5
7771671|NCT01362530|19132455|P2|COMPLETED|Base Study (Cycle 1)||149
7771672|NCT01362530|19132456|P1|COMPLETED|Base Study (Cycle 1)||150
7771673|NCT01362530|19132455|P2|Received Study Treatment|Base Study (Cycle 1)||150
7771674|NCT01362530|19132456|P1|Received Study Treatment|Base Study (Cycle 1)||152
7771675|NCT01362530|19132455|P2|STARTED|Base Study (Cycle 1)||152
7771676|NCT01362530|19132456|P1|STARTED|Base Study (Cycle 1)||155
7771677|NCT01362517|19132469|P1|NOT COMPLETED|Overall Study||2
7771678|NCT01362517|19132469|P1|COMPLETED|Overall Study||129
7771679|NCT01362517|19132469|P1|STARTED|Overall Study||131
7771680|NCT01362491|19132480|P3|NOT COMPLETED|Overall Study||0
7771681|NCT01362491|19132481|P2|NOT COMPLETED|Overall Study||0
7771682|NCT01362491|19132482|P1|NOT COMPLETED|Overall Study||1
7771683|NCT01362491|19132480|P3|COMPLETED|Overall Study||46
7771684|NCT01362491|19132481|P2|COMPLETED|Overall Study||89
7771685|NCT01362491|19132482|P1|COMPLETED|Overall Study||90
7771686|NCT01362491|19132480|P3|STARTED|Overall Study||46
7771687|NCT01362491|19132481|P2|STARTED|Overall Study||89
7771688|NCT01362491|19132482|P1|STARTED|Overall Study||91
7771689|NCT01362439|19132530|P1|NOT COMPLETED|Overall Study||15
7771690|NCT01362439|19132530|P1|COMPLETED|Overall Study||118
7771691|NCT01362439|19132530|P1|STARTED|Overall Study||133
7771692|NCT01362348|19132545|P1|NOT COMPLETED|Overall Study||14
7771693|NCT01362348|19132545|P1|COMPLETED|Overall Study||5
7771694|NCT01362348|19132545|P1|STARTED|Overall Study||19
7771695|NCT01362322|19132564|P2|NOT COMPLETED|Overall Study||7
7771696|NCT01362322|19132565|P1|NOT COMPLETED|Overall Study||5
7771697|NCT01362322|19132564|P2|COMPLETED|Overall Study||329
7771698|NCT01362322|19132565|P1|COMPLETED|Overall Study||330
7771699|NCT01362322|19132564|P2|STARTED|Overall Study||336
7771700|NCT01362322|19132565|P1|STARTED|Overall Study||335
7771701|NCT01362296|19132597|P4|NOT COMPLETED|Crossover Phase||2
7771702|NCT01362296|19132598|P3|NOT COMPLETED|Crossover Phase||23
7771703|NCT01362296|19132599|P2|NOT COMPLETED|Crossover Phase||0
7771704|NCT01362296|19132600|P1|NOT COMPLETED|Crossover Phase||0
7771705|NCT01362296|19132597|P4|COMPLETED|Crossover Phase||0
7771706|NCT01362296|19132598|P3|COMPLETED|Crossover Phase||0
7771707|NCT01362296|19132599|P2|COMPLETED|Crossover Phase||0
7771708|NCT01362296|19132600|P1|COMPLETED|Crossover Phase||0
7771709|NCT01362296|19132597|P4|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2
7771710|NCT01362296|19132598|P3|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23
7771711|NCT01362296|19132599|P2|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
7771712|NCT01362296|19132600|P1|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
7771713|NCT01362296|19132597|P4|NOT COMPLETED|Randomized Phase (RP)||0
7771714|NCT01362296|19132598|P3|NOT COMPLETED|Randomized Phase (RP)||0
7771715|NCT01362296|19132599|P2|NOT COMPLETED|Randomized Phase (RP)||43
7771716|NCT01362296|19132600|P1|NOT COMPLETED|Randomized Phase (RP)||87
7771717|NCT01362296|19132597|P4|COMPLETED|Randomized Phase (RP)||0
7771718|NCT01362296|19132598|P3|COMPLETED|Randomized Phase (RP)||0
7771719|NCT01362296|19132599|P2|COMPLETED|Randomized Phase (RP)||0
7771720|NCT01362296|19132600|P1|COMPLETED|Randomized Phase (RP)||0
7771721|NCT01362296|19132597|P4|STARTED|Randomized Phase (RP)||0
7771722|NCT01362296|19132598|P3|STARTED|Randomized Phase (RP)||0
7771723|NCT01362296|19132599|P2|STARTED|Randomized Phase (RP)||43
7771724|NCT01362296|19132600|P1|STARTED|Randomized Phase (RP)||87
7771725|NCT01362270|19132648|P2|NOT COMPLETED|Overall Study||2
7771726|NCT01362270|19132649|P1|NOT COMPLETED|Overall Study||2
7771727|NCT01362270|19132648|P2|COMPLETED|Overall Study||6
7771728|NCT01362270|19132649|P1|COMPLETED|Overall Study||5
7771729|NCT01362270|19132648|P2|STARTED|Overall Study||8
7771730|NCT01362270|19132649|P1|STARTED|Overall Study||7
7771731|NCT01362244|19132661|P2|NOT COMPLETED|Overall Study||32
7771732|NCT01362244|19132662|P1|NOT COMPLETED|Overall Study||32
7771733|NCT01362244|19132661|P2|COMPLETED|Overall Study||19
7771734|NCT01362244|19132662|P1|COMPLETED|Overall Study||22
7771735|NCT01362244|19132661|P2|STARTED|Overall Study||51
7771736|NCT01362244|19132662|P1|STARTED|Overall Study||54
7771737|NCT01362205|19132735|P2|NOT COMPLETED|Overall Study||0
7771738|NCT01362205|19132736|P1|NOT COMPLETED|Overall Study||0
7771739|NCT01362205|19132735|P2|COMPLETED|Overall Study||27
7771740|NCT01362205|19132736|P1|COMPLETED|Overall Study||22
7771741|NCT01362205|19132735|P2|STARTED|Overall Study||27
7771742|NCT01362205|19132736|P1|STARTED|Overall Study||22
7771743|NCT01362192|19132762|P1|NOT COMPLETED|Overall Study||4
7771744|NCT01362192|19132762|P1|COMPLETED|Overall Study||16
7771745|NCT01362192|19132762|P1|STARTED|Overall Study||20
7771746|NCT01362140|19132774|P2|NOT COMPLETED|Overall Study||11
7771747|NCT01362140|19132775|P1|NOT COMPLETED|Overall Study||10
7771748|NCT01362140|19132774|P2|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87
7771749|NCT01362140|19132775|P1|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39
7771750|NCT01362140|19132774|P2|Received Treatment|Overall Study||97
7771751|NCT01362140|19132775|P1|Received Treatment|Overall Study||49
7771752|NCT01362140|19132774|P2|STARTED|Overall Study||98
7771753|NCT01362140|19132775|P1|STARTED|Overall Study||49
7771754|NCT01362127|19132799|P2|NOT COMPLETED|Overall Study||0
7771755|NCT01362127|19132800|P1|NOT COMPLETED|Overall Study||0
7771756|NCT01362127|19132799|P2|COMPLETED|Overall Study||91
7771757|NCT01362127|19132800|P1|COMPLETED|Overall Study||90
7771758|NCT01362127|19132799|P2|STARTED|Overall Study||91
7771759|NCT01362127|19132800|P1|STARTED|Overall Study||90
7771760|NCT01362062|19132812|P2|NOT COMPLETED|Overall Study||0
7771761|NCT01362062|19132813|P1|NOT COMPLETED|Overall Study||26
7771762|NCT01362062|19132812|P2|COMPLETED|Overall Study||62
7771763|NCT01362062|19132813|P1|COMPLETED|Overall Study||22
7771764|NCT01362062|19132812|P2|STARTED|Overall Study||62
7771765|NCT01362062|19132813|P1|STARTED|Overall Study||48
7771766|NCT01362049|19132834|P4|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
7771767|NCT01362049|19132835|P3|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2
7771768|NCT01362049|19132836|P2|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
7771769|NCT01362049|19132837|P1|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5
7771770|NCT01362049|19132834|P4|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21
7771771|NCT01362049|19132835|P3|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28
7771772|NCT01362049|19132836|P2|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13
7771773|NCT01362049|19132837|P1|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18
7771774|NCT01362049|19132834|P4|STARTED|Follow-Up at 52 Weeks (12 Months)||24
7771775|NCT01362049|19132835|P3|STARTED|Follow-Up at 52 Weeks (12 Months)||30
7771776|NCT01362049|19132836|P2|STARTED|Follow-Up at 52 Weeks (12 Months)||16
7771777|NCT01362049|19132837|P1|STARTED|Follow-Up at 52 Weeks (12 Months)||23
7771778|NCT01362049|19132834|P4|NOT COMPLETED|Follow-Up at 7 Weeks||1
7771779|NCT01362049|19132835|P3|NOT COMPLETED|Follow-Up at 7 Weeks||2
7771780|NCT01362049|19132836|P2|NOT COMPLETED|Follow-Up at 7 Weeks||3
7771781|NCT01362049|19132837|P1|NOT COMPLETED|Follow-Up at 7 Weeks||3
7771782|NCT01362049|19132834|P4|COMPLETED|Follow-Up at 7 Weeks||24
7771783|NCT01362049|19132835|P3|COMPLETED|Follow-Up at 7 Weeks||30
7771784|NCT01362049|19132836|P2|COMPLETED|Follow-Up at 7 Weeks||16
7771785|NCT01362049|19132837|P1|COMPLETED|Follow-Up at 7 Weeks||23
7771786|NCT01362049|19132834|P4|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25
7771787|NCT01362049|19132835|P3|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32
7771788|NCT01362049|19132836|P2|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18
7771789|NCT01362049|19132837|P1|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26
7771790|NCT01362049|19132834|P4|STARTED|Follow-Up at 7 Weeks||25
7771791|NCT01362049|19132835|P3|STARTED|Follow-Up at 7 Weeks||32
7771792|NCT01362049|19132836|P2|STARTED|Follow-Up at 7 Weeks||19
7771793|NCT01362049|19132837|P1|STARTED|Follow-Up at 7 Weeks||26
7771794|NCT01361919|19132878|P3|NOT COMPLETED|Overall Study||10
7771795|NCT01361919|19132879|P2|NOT COMPLETED|Overall Study||12
7771796|NCT01361919|19132880|P1|NOT COMPLETED|Overall Study||10
7771797|NCT01361919|19132878|P3|COMPLETED|Overall Study||88
7771798|NCT01361919|19132879|P2|COMPLETED|Overall Study||88
7771799|NCT01361919|19132880|P1|COMPLETED|Overall Study||90
7771800|NCT01361919|19132878|P3|STARTED|Overall Study||98
7771801|NCT01361919|19132879|P2|STARTED|Overall Study||100
7771802|NCT01361919|19132880|P1|STARTED|Overall Study||100
7771803|NCT01361867|19132894|P1|NOT COMPLETED|Overall Study||0
7771804|NCT01361867|19132894|P1|COMPLETED|Overall Study||15
7771805|NCT01361867|19132894|P1|STARTED|Overall Study||15
7771806|NCT01361854|19132899|P2|NOT COMPLETED|Second Intervention||0
7771807|NCT01361854|19132900|P1|NOT COMPLETED|Second Intervention||0
7771808|NCT01361854|19132899|P2|COMPLETED|Second Intervention||48
7771809|NCT01361854|19132900|P1|COMPLETED|Second Intervention||47
7771810|NCT01361854|19132899|P2|STARTED|Second Intervention||48
7771811|NCT01361854|19132900|P1|STARTED|Second Intervention||47
7771812|NCT01361854|19132899|P2|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
7771813|NCT01361854|19132900|P1|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
7771814|NCT01361854|19132899|P2|COMPLETED|Wash-out, Maximum 2 Weeks||48
7771815|NCT01361854|19132900|P1|COMPLETED|Wash-out, Maximum 2 Weeks||47
7771816|NCT01361854|19132899|P2|STARTED|Wash-out, Maximum 2 Weeks||48
7771817|NCT01361854|19132900|P1|STARTED|Wash-out, Maximum 2 Weeks||47
7771818|NCT01361854|19132899|P2|NOT COMPLETED|Day 1||3
7771819|NCT01361854|19132900|P1|NOT COMPLETED|Day 1||4
7771820|NCT01361854|19132899|P2|COMPLETED|Day 1||48
7771821|NCT01361854|19132900|P1|COMPLETED|Day 1||47
7771822|NCT01361854|19132899|P2|STARTED|Day 1||51
7771823|NCT01361854|19132900|P1|STARTED|Day 1||51
7771824|NCT01361633|19132908|P2|NOT COMPLETED|Overall Study||3
7771825|NCT01361633|19132909|P1|NOT COMPLETED|Overall Study||6
7771826|NCT01361633|19132908|P2|COMPLETED|Overall Study||23
7771827|NCT01361633|19132909|P1|COMPLETED|Overall Study||19
7771828|NCT01361633|19132908|P2|STARTED|Overall Study||26
7771829|NCT01361633|19132909|P1|STARTED|Overall Study||25
7771830|NCT01361620|19132915|P1|NOT COMPLETED|Overall Study||0
7771831|NCT01361620|19132915|P1|COMPLETED|Overall Study||132
7771832|NCT01361620|19132915|P1|STARTED|Overall Study||132
7771833|NCT01361607|19132921|P2|NOT COMPLETED|Overall Study||41
7771834|NCT01361607|19132922|P1|NOT COMPLETED|Overall Study||64
7771835|NCT01361607|19132921|P2|COMPLETED|Overall Study||158
7771836|NCT01361607|19132922|P1|COMPLETED|Overall Study||136
7771837|NCT01361607|19132921|P2|ITT Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as placebo-treated|199
7771838|NCT01361607|19132922|P1|ITT Population|Overall Study||198
7771839|NCT01361607|19132921|P2|Safety Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as nabiximols-treated|198
7771840|NCT01361607|19132922|P1|Safety Population|Overall Study|One participant randomized to nabiximols received placebo Day 22 but analyzed as nabiximols-treated|199
7771841|NCT01361607|19132921|P2|Received at Least 1 Dose of Study Drug|Overall Study||199
7771842|NCT01361607|19132922|P1|Received at Least 1 Dose of Study Drug|Overall Study||198
7771843|NCT01361607|19132921|P2|STARTED|Overall Study||199
7771844|NCT01361607|19132922|P1|STARTED|Overall Study|Two participants randomized to nabiximols did not receive any study drug|200
7771845|NCT01361594|19132950|P2|NOT COMPLETED|Overall Study||2
7771846|NCT01361594|19132951|P1|NOT COMPLETED|Overall Study||1
7771847|NCT01361594|19132950|P2|COMPLETED|Overall Study||151
7771848|NCT01361594|19132951|P1|COMPLETED|Overall Study||151
7771849|NCT01361594|19132950|P2|STARTED|Overall Study||153
7771850|NCT01361594|19132951|P1|STARTED|Overall Study||152
7771851|NCT01361568|19132965|P6|NOT COMPLETED|Overall Study||2
7771852|NCT01361568|19132966|P5|NOT COMPLETED|Overall Study||1
7771853|NCT01361568|19132967|P4|NOT COMPLETED|Overall Study||0
7771854|NCT01361568|19132968|P3|NOT COMPLETED|Overall Study||0
7771855|NCT01361568|19132969|P2|NOT COMPLETED|Overall Study||1
7771856|NCT01361568|19132970|P1|NOT COMPLETED|Overall Study||2
7771857|NCT01361568|19132965|P6|COMPLETED|Overall Study||11
7771858|NCT01361568|19132966|P5|COMPLETED|Overall Study||6
7771859|NCT01361568|19132967|P4|COMPLETED|Overall Study||21
7771860|NCT01361568|19132968|P3|COMPLETED|Overall Study||20
7771861|NCT01361568|19132969|P2|COMPLETED|Overall Study||70
7771862|NCT01361568|19132970|P1|COMPLETED|Overall Study||69
7771863|NCT01361568|19132965|P6|STARTED|Overall Study||13
7771864|NCT01361568|19132966|P5|STARTED|Overall Study||7
7771865|NCT01361568|19132967|P4|STARTED|Overall Study||21
7771866|NCT01361568|19132968|P3|STARTED|Overall Study||20
7771867|NCT01361568|19132969|P2|STARTED|Overall Study||71
7771868|NCT01361568|19132970|P1|STARTED|Overall Study||71
7771869|NCT01361464|19133000|P1|NOT COMPLETED|Overall Study||3
7771870|NCT01361464|19133000|P1|COMPLETED|Overall Study||18
7771871|NCT01361464|19133000|P1|STARTED|Overall Study||21
7771872|NCT01361308|19133009|P2|NOT COMPLETED|Overall Study||30
7771873|NCT01361308|19133010|P1|NOT COMPLETED|Overall Study||35
7771874|NCT01361308|19133009|P2|COMPLETED|Overall Study||278
7771875|NCT01361308|19133010|P1|COMPLETED|Overall Study||271
7771876|NCT01361308|19133009|P2|STARTED|Overall Study||308
7771877|NCT01361308|19133010|P1|STARTED|Overall Study||306
7771878|NCT01361217|19133050|P1|NOT COMPLETED|Overall Study||0
7771879|NCT01361217|19133050|P1|COMPLETED|Overall Study||10
7771880|NCT01361217|19133050|P1|STARTED|Overall Study||10
7771881|NCT01361178|19133058|P2|NOT COMPLETED|Overall Study||0
7771882|NCT01361178|19133059|P1|NOT COMPLETED|Overall Study||13
7771883|NCT01361178|19133058|P2|COMPLETED|Overall Study||11
7771884|NCT01361178|19133059|P1|COMPLETED|Overall Study||109
7771885|NCT01361178|19133058|P2|STARTED|Overall Study||11
7771886|NCT01361178|19133059|P1|STARTED|Overall Study||122
7771887|NCT01361126|19133067|P2|NOT COMPLETED|Overall Study||2
7771888|NCT01361126|19133068|P1|NOT COMPLETED|Overall Study||0
7771889|NCT01361126|19133067|P2|COMPLETED|Overall Study||2
7771890|NCT01361126|19133068|P1|COMPLETED|Overall Study||13
7771891|NCT01361126|19133067|P2|STARTED|Overall Study||4
7771892|NCT01361126|19133068|P1|STARTED|Overall Study||13
7771893|NCT01361113|19133083|P1|NOT COMPLETED|Overall Study||0
7771894|NCT01361113|19133083|P1|COMPLETED|Overall Study||21
7771895|NCT01361113|19133083|P1|STARTED|Overall Study||21
7771896|NCT01361048|19133094|P3|NOT COMPLETED|Overall Study||1
7771897|NCT01361048|19133095|P2|NOT COMPLETED|Overall Study||0
7771898|NCT01361048|19133096|P1|NOT COMPLETED|Overall Study||0
7771899|NCT01361048|19133094|P3|COMPLETED|Overall Study||9
7771900|NCT01361048|19133095|P2|COMPLETED|Overall Study||10
7771901|NCT01361048|19133096|P1|COMPLETED|Overall Study||20
7771902|NCT01361048|19133094|P3|STARTED|Overall Study||10
7771903|NCT01361048|19133095|P2|STARTED|Overall Study||10
7771904|NCT01361048|19133096|P1|STARTED|Overall Study||20
7771905|NCT01361009|19133107|P1|NOT COMPLETED|Overall Study||116
7771906|NCT01361009|19133107|P1|COMPLETED|Overall Study||1901
7771907|NCT01361009|19133107|P1|STARTED|Overall Study||2017
7771908|NCT01360996|19133117|P3|NOT COMPLETED|Overall Study||2
7771909|NCT01360996|19133118|P2|NOT COMPLETED|Overall Study||3
7771910|NCT01360996|19133119|P1|NOT COMPLETED|Overall Study||6
7771911|NCT01360996|19133117|P3|COMPLETED|Overall Study||21
7771912|NCT01360996|19133118|P2|COMPLETED|Overall Study||18
7771913|NCT01360996|19133119|P1|COMPLETED|Overall Study||14
7771914|NCT01360996|19133117|P3|STARTED|Overall Study||23
7771915|NCT01360996|19133118|P2|STARTED|Overall Study||21
7771916|NCT01360996|19133119|P1|STARTED|Overall Study||20
7771917|NCT01360866|19133142|P4|NOT COMPLETED|Overall Study||22
7771918|NCT01360866|19133143|P3|NOT COMPLETED|Overall Study||519
7771919|NCT01360866|19133144|P2|NOT COMPLETED|Overall Study||287
7771920|NCT01360866|19133145|P1|NOT COMPLETED|Overall Study||221
7771921|NCT01360866|19133142|P4|COMPLETED|Overall Study||54
7771922|NCT01360866|19133143|P3|COMPLETED|Overall Study||1126
7771923|NCT01360866|19133144|P2|COMPLETED|Overall Study||420
7771924|NCT01360866|19133145|P1|COMPLETED|Overall Study||295
7771925|NCT01360866|19133142|P4|STARTED|Overall Study||76
7771926|NCT01360866|19133143|P3|STARTED|Overall Study||1645
7771927|NCT01360866|19133144|P2|STARTED|Overall Study||707
7771928|NCT01360866|19133145|P1|STARTED|Overall Study||516
7771929|NCT01360840|19133174|P3|NOT COMPLETED|Overall Study||9
7771930|NCT01360840|19133175|P2|NOT COMPLETED|Overall Study||10
7771931|NCT01360840|19133176|P1|NOT COMPLETED|Overall Study||10
7771932|NCT01360840|19133174|P3|COMPLETED|Overall Study||51
7771933|NCT01360840|19133175|P2|COMPLETED|Overall Study||50
7771934|NCT01360840|19133176|P1|COMPLETED|Overall Study||50
7771935|NCT01360840|19133174|P3|STARTED|Overall Study||60
7771936|NCT01360840|19133175|P2|STARTED|Overall Study||60
7771937|NCT01360840|19133176|P1|STARTED|Overall Study||60
7771938|NCT01360762|19133226|P1|NOT COMPLETED|Whole Study Period||36
7771939|NCT01360762|19133226|P1|COMPLETED|Whole Study Period||38
7771940|NCT01360762|19133226|P1|STARTED|Whole Study Period||74
7771941|NCT01360762|19133226|P1|NOT COMPLETED|Main Study Period (12-month Treatment)||29
7771942|NCT01360762|19133226|P1|COMPLETED|Main Study Period (12-month Treatment)||45
7771943|NCT01360762|19133226|P1|STARTED|Main Study Period (12-month Treatment)||74
7771944|NCT01360645|19133236|P4|NOT COMPLETED|Phase A+||24
7771945|NCT01360645|19133237|P3|NOT COMPLETED|Phase A+||0
7771946|NCT01360645|19133238|P2|NOT COMPLETED|Phase A+||0
7771947|NCT01360645|19133239|P1|NOT COMPLETED|Phase A+||0
7771948|NCT01360645|19133236|P4|COMPLETED|Phase A+||307
7771949|NCT01360645|19133237|P3|COMPLETED|Phase A+||0
7771950|NCT01360645|19133238|P2|COMPLETED|Phase A+||0
7771951|NCT01360645|19133239|P1|COMPLETED|Phase A+||0
7771952|NCT01360645|19133236|P4|STARTED|Phase A+||331
7771953|NCT01360645|19133237|P3|STARTED|Phase A+||0
7771954|NCT01360645|19133238|P2|STARTED|Phase A+||0
7771955|NCT01360645|19133239|P1|STARTED|Phase A+||0
7771956|NCT01360645|19133236|P4|NOT COMPLETED|Phase B (6 Weeks)||0
7771957|NCT01360645|19133237|P3|NOT COMPLETED|Phase B (6 Weeks)||13
7771958|NCT01360645|19133238|P2|NOT COMPLETED|Phase B (6 Weeks)||14
7771959|NCT01360645|19133239|P1|NOT COMPLETED|Phase B (6 Weeks)||0
7771960|NCT01360645|19133236|P4|COMPLETED|Phase B (6 Weeks)||0
7771961|NCT01360645|19133237|P3|COMPLETED|Phase B (6 Weeks)||178
7771962|NCT01360645|19133238|P2|COMPLETED|Phase B (6 Weeks)||174
7771963|NCT01360645|19133239|P1|COMPLETED|Phase B (6 Weeks)||0
7771964|NCT01360645|19133236|P4|STARTED|Phase B (6 Weeks)||0
7771965|NCT01360645|19133237|P3|STARTED|Phase B (6 Weeks)||191
7771966|NCT01360645|19133238|P2|STARTED|Phase B (6 Weeks)||188
7771967|NCT01360645|19133239|P1|STARTED|Phase B (6 Weeks)||0
7771968|NCT01360645|19133236|P4|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
7771969|NCT01360645|19133237|P3|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
7771970|NCT01360645|19133238|P2|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
7771971|NCT01360645|19133239|P1|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114
7771972|NCT01360645|19133236|P4|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
7771973|NCT01360645|19133237|P3|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
7771974|NCT01360645|19133238|P2|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
7771975|NCT01360645|19133239|P1|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710
7771976|NCT01360645|19133236|P4|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
7771977|NCT01360645|19133237|P3|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
7771978|NCT01360645|19133238|P2|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
7771979|NCT01360645|19133239|P1|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824
7771980|NCT01360632|19133294|P5|NOT COMPLETED|Phase A+||25
7771981|NCT01360632|19133295|P4|NOT COMPLETED|Phase A+||0
7771982|NCT01360632|19133296|P3|NOT COMPLETED|Phase A+||0
7771983|NCT01360632|19133297|P2|NOT COMPLETED|Phase A+||0
7771984|NCT01360632|19133298|P1|NOT COMPLETED|Phase A+||0
7771985|NCT01360632|19133294|P5|COMPLETED|Phase A+||575
7771986|NCT01360632|19133295|P4|COMPLETED|Phase A+||0
7771987|NCT01360632|19133296|P3|COMPLETED|Phase A+||0
7771988|NCT01360632|19133297|P2|COMPLETED|Phase A+||0
7771989|NCT01360632|19133298|P1|COMPLETED|Phase A+||0
7771990|NCT01360632|19133294|P5|STARTED|Phase A+||600
7771991|NCT01360632|19133295|P4|STARTED|Phase A+||0
7771992|NCT01360632|19133296|P3|STARTED|Phase A+||0
7771993|NCT01360632|19133297|P2|STARTED|Phase A+||0
7771994|NCT01360632|19133298|P1|STARTED|Phase A+||0
7771995|NCT01360632|19133294|P5|NOT COMPLETED|Phase B (6 Weeks)||0
7771996|NCT01360632|19133295|P4|NOT COMPLETED|Phase B (6 Weeks)||13
7771997|NCT01360632|19133296|P3|NOT COMPLETED|Phase B (6 Weeks)||20
7771998|NCT01360632|19133297|P2|NOT COMPLETED|Phase B (6 Weeks)||10
7771999|NCT01360632|19133298|P1|NOT COMPLETED|Phase B (6 Weeks)||0
7772000|NCT01360632|19133294|P5|COMPLETED|Phase B (6 Weeks)||0
7772001|NCT01360632|19133295|P4|COMPLETED|Phase B (6 Weeks)||208
7772002|NCT01360632|19133296|P3|COMPLETED|Phase B (6 Weeks)||210
7772003|NCT01360632|19133297|P2|COMPLETED|Phase B (6 Weeks)||216
7772004|NCT01360632|19133298|P1|COMPLETED|Phase B (6 Weeks)||0
7772005|NCT01360632|19133294|P5|STARTED|Phase B (6 Weeks)||0
7772006|NCT01360632|19133295|P4|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221
7772007|NCT01360632|19133296|P3|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230
7772008|NCT01360632|19133297|P2|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226
7772009|NCT01360632|19133298|P1|STARTED|Phase B (6 Weeks)||0
7772010|NCT01360632|19133294|P5|NOT COMPLETED|Phase A (8 Weeks)||0
7772011|NCT01360632|19133295|P4|NOT COMPLETED|Phase A (8 Weeks)||0
7772012|NCT01360632|19133296|P3|NOT COMPLETED|Phase A (8 Weeks)||0
7772013|NCT01360632|19133297|P2|NOT COMPLETED|Phase A (8 Weeks)||0
7772014|NCT01360632|19133298|P1|NOT COMPLETED|Phase A (8 Weeks)||255
7772015|NCT01360632|19133294|P5|COMPLETED|Phase A (8 Weeks)||0
7772016|NCT01360632|19133295|P4|COMPLETED|Phase A (8 Weeks)||0
7772017|NCT01360632|19133296|P3|COMPLETED|Phase A (8 Weeks)||0
7772018|NCT01360632|19133297|P2|COMPLETED|Phase A (8 Weeks)||0
7772019|NCT01360632|19133298|P1|COMPLETED|Phase A (8 Weeks)||1277
7772020|NCT01360632|19133294|P5|STARTED|Phase A (8 Weeks)||0
7772021|NCT01360632|19133295|P4|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
7772022|NCT01360632|19133296|P3|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
7772023|NCT01360632|19133297|P2|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
7772024|NCT01360632|19133298|P1|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532
7772025|NCT01360554|19133377|P2|NOT COMPLETED|Overall Study||439
7772026|NCT01360554|19133378|P1|NOT COMPLETED|Overall Study||439
7772027|NCT01360554|19133377|P2|COMPLETED|Overall Study||0
7772028|NCT01360554|19133378|P1|COMPLETED|Overall Study||0
7772029|NCT01360554|19133377|P2|Treated|Overall Study||436
7772030|NCT01360554|19133378|P1|Treated|Overall Study||436
7772031|NCT01360554|19133377|P2|STARTED|Overall Study|Three participants were randomized but not treated.|439
7772032|NCT01360554|19133378|P1|STARTED|Overall Study|Three participants were randomized but not treated.|439
7772033|NCT01360450|19133416|P2|NOT COMPLETED|Overall Study||0
7772034|NCT01360450|19133417|P1|NOT COMPLETED|Overall Study||0
7772035|NCT01360450|19133416|P2|COMPLETED|Overall Study||6
7772036|NCT01360450|19133417|P1|COMPLETED|Overall Study||6
7772037|NCT01360450|19133416|P2|Completed Treatment|Overall Study||6
7772038|NCT01360450|19133417|P1|Completed Treatment|Overall Study||6
7772039|NCT01360450|19133416|P2|STARTED|Overall Study||6
7772040|NCT01360450|19133417|P1|STARTED|Overall Study||6
7772041|NCT01360398|19133427|P1|NOT COMPLETED|Overall Study||22
7772042|NCT01360398|19133427|P1|COMPLETED|Overall Study||105
7772043|NCT01360398|19133427|P1|STARTED|Overall Study||127
7772044|NCT01360229|19133451|P2|NOT COMPLETED|Overall Study||2
7772045|NCT01360229|19133452|P1|NOT COMPLETED|Overall Study||3
7772046|NCT01360229|19133451|P2|COMPLETED|Overall Study||45
7772047|NCT01360229|19133452|P1|COMPLETED|Overall Study||44
7772048|NCT01360229|19133451|P2|STARTED|Overall Study||47
7772049|NCT01360229|19133452|P1|STARTED|Overall Study||47
7772050|NCT01360021|19133461|P3|NOT COMPLETED|Overall Study||7
7772051|NCT01360021|19133462|P2|NOT COMPLETED|Overall Study||4
7772052|NCT01360021|19133463|P1|NOT COMPLETED|Overall Study||8
7772053|NCT01360021|19133461|P3|COMPLETED|Overall Study|Patients who completed study|65
7772054|NCT01360021|19133462|P2|COMPLETED|Overall Study|Patients who completed study|67
7772055|NCT01360021|19133463|P1|COMPLETED|Overall Study|Patients who completed study|63
7772056|NCT01360021|19133461|P3|STARTED|Overall Study|Patients randomized|72
7772057|NCT01360021|19133462|P2|STARTED|Overall Study|Patients randomized|71
7772058|NCT01360021|19133463|P1|STARTED|Overall Study|Patients randomized|71
7772059|NCT01359956|19133490|P4|NOT COMPLETED|Overall Study||58
7772060|NCT01359956|19133491|P3|NOT COMPLETED|Overall Study||67
7772061|NCT01359956|19133492|P2|NOT COMPLETED|Overall Study||64
7772062|NCT01359956|19133493|P1|NOT COMPLETED|Overall Study||61
7772063|NCT01359956|19133490|P4|COMPLETED|Overall Study||4
7772064|NCT01359956|19133491|P3|COMPLETED|Overall Study||4
7772065|NCT01359956|19133492|P2|COMPLETED|Overall Study||5
7772066|NCT01359956|19133493|P1|COMPLETED|Overall Study||6
7772067|NCT01359956|19133490|P4|STARTED|Overall Study||62
7772068|NCT01359956|19133491|P3|STARTED|Overall Study||71
7772069|NCT01359956|19133492|P2|STARTED|Overall Study||69
7772070|NCT01359956|19133493|P1|STARTED|Overall Study||67
7772071|NCT01359943|19133518|P3|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
7772072|NCT01359943|19133519|P2|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15
7772073|NCT01359943|19133520|P1|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
7772074|NCT01359943|19133518|P3|COMPLETED|Follow-up (Weeks 52 - 60)||36
7772075|NCT01359943|19133519|P2|COMPLETED|Follow-up (Weeks 52 - 60)||69
7772076|NCT01359943|19133520|P1|COMPLETED|Follow-up (Weeks 52 - 60)||78
7772077|NCT01359943|19133518|P3|STARTED|Follow-up (Weeks 52 - 60)||44
7772078|NCT01359943|19133519|P2|STARTED|Follow-up (Weeks 52 - 60)||84
7772079|NCT01359943|19133520|P1|STARTED|Follow-up (Weeks 52 - 60)||86
7772080|NCT01359943|19133518|P3|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
7772081|NCT01359943|19133519|P2|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13
7772082|NCT01359943|19133520|P1|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
7772083|NCT01359943|19133518|P3|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36
7772084|NCT01359943|19133519|P2|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71
7772085|NCT01359943|19133520|P1|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78
7772086|NCT01359943|19133518|P3|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44
7772087|NCT01359943|19133519|P2|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84
7772088|NCT01359943|19133520|P1|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86
7772089|NCT01359943|19133518|P3|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0
7772090|NCT01359943|19133519|P2|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4
7772091|NCT01359943|19133520|P1|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2
7772092|NCT01359943|19133518|P3|COMPLETED|Double-blind (Weeks 0 - 16)||44
7772093|NCT01359943|19133519|P2|COMPLETED|Double-blind (Weeks 0 - 16)||85
7772094|NCT01359943|19133520|P1|COMPLETED|Double-blind (Weeks 0 - 16)||86
7772095|NCT01359943|19133518|P3|STARTED|Double-blind (Weeks 0 - 16)||44
7772096|NCT01359943|19133519|P2|STARTED|Double-blind (Weeks 0 - 16)||89
7772097|NCT01359943|19133520|P1|STARTED|Double-blind (Weeks 0 - 16)||88
7772098|NCT01359904|19133568|P2|NOT COMPLETED|Overall Study||0
7772099|NCT01359904|19133569|P1|NOT COMPLETED|Overall Study||1
7772100|NCT01359904|19133568|P2|COMPLETED|Overall Study||19
7772101|NCT01359904|19133569|P1|COMPLETED|Overall Study||14
7772102|NCT01359904|19133568|P2|STARTED|Overall Study||19
7772103|NCT01359904|19133569|P1|STARTED|Overall Study||15
7772104|NCT01359748|19133585|P4|NOT COMPLETED|Overall Study||0
7772105|NCT01359748|19133586|P3|NOT COMPLETED|Overall Study||0
7772106|NCT01359748|19133587|P2|NOT COMPLETED|Overall Study||0
7772107|NCT01359748|19133588|P1|NOT COMPLETED|Overall Study||0
7772108|NCT01359748|19133585|P4|COMPLETED|Overall Study||11
7772109|NCT01359748|19133586|P3|COMPLETED|Overall Study||10
7772110|NCT01359748|19133587|P2|COMPLETED|Overall Study||20
7772111|NCT01359748|19133588|P1|COMPLETED|Overall Study||48
7772112|NCT01359748|19133585|P4|STARTED|Overall Study||11
7772113|NCT01359748|19133586|P3|STARTED|Overall Study||10
7772114|NCT01359748|19133587|P2|STARTED|Overall Study||20
7772115|NCT01359748|19133588|P1|STARTED|Overall Study||48
7772116|NCT01359735|19133598|P2|NOT COMPLETED|Overall Study||0
7772117|NCT01359735|19133599|P1|NOT COMPLETED|Overall Study||0
7772118|NCT01359735|19133598|P2|COMPLETED|Overall Study||4
7772119|NCT01359735|19133599|P1|COMPLETED|Overall Study||4
7772120|NCT01359735|19133598|P2|STARTED|Overall Study||4
7772121|NCT01359735|19133599|P1|STARTED|Overall Study||4
7772122|NCT01359644|19133623|P10|NOT COMPLETED|Follow-up Period||0
7772123|NCT01359644|19133624|P9|NOT COMPLETED|Follow-up Period||0
7772124|NCT01359644|19133625|P8|NOT COMPLETED|Follow-up Period||2
7772125|NCT01359644|19133626|P7|NOT COMPLETED|Follow-up Period||1
7772126|NCT01359644|19133627|P6|NOT COMPLETED|Follow-up Period||1
7772127|NCT01359644|19133628|P5|NOT COMPLETED|Follow-up Period||0
7772128|NCT01359644|19133629|P4|NOT COMPLETED|Follow-up Period||0
7772129|NCT01359644|19133630|P3|NOT COMPLETED|Follow-up Period||0
7772130|NCT01359644|19133631|P2|NOT COMPLETED|Follow-up Period||0
7772131|NCT01359644|19133632|P1|NOT COMPLETED|Follow-up Period||0
7772132|NCT01359644|19133623|P10|COMPLETED|Follow-up Period||20
7772133|NCT01359644|19133624|P9|COMPLETED|Follow-up Period||21
7772134|NCT01359644|19133625|P8|COMPLETED|Follow-up Period||39
7772135|NCT01359644|19133626|P7|COMPLETED|Follow-up Period||40
7772136|NCT01359644|19133627|P6|COMPLETED|Follow-up Period||12
7772137|NCT01359644|19133628|P5|COMPLETED|Follow-up Period||15
7772138|NCT01359644|19133629|P4|COMPLETED|Follow-up Period||14
7772139|NCT01359644|19133630|P3|COMPLETED|Follow-up Period||14
7772140|NCT01359644|19133631|P2|COMPLETED|Follow-up Period||16
7772141|NCT01359644|19133632|P1|COMPLETED|Follow-up Period||15
7772142|NCT01359644|19133623|P10|STARTED|Follow-up Period||20
7772143|NCT01359644|19133624|P9|STARTED|Follow-up Period||21
7772144|NCT01359644|19133625|P8|STARTED|Follow-up Period||41
7772145|NCT01359644|19133626|P7|STARTED|Follow-up Period||41
7772146|NCT01359644|19133627|P6|STARTED|Follow-up Period||13
7772147|NCT01359644|19133628|P5|STARTED|Follow-up Period||15
7772148|NCT01359644|19133629|P4|STARTED|Follow-up Period||14
7772149|NCT01359644|19133630|P3|STARTED|Follow-up Period||14
7772150|NCT01359644|19133631|P2|STARTED|Follow-up Period||16
7772151|NCT01359644|19133632|P1|STARTED|Follow-up Period||15
7772152|NCT01359644|19133623|P10|NOT COMPLETED|Treatment Period||0
7772153|NCT01359644|19133624|P9|NOT COMPLETED|Treatment Period||0
7772154|NCT01359644|19133625|P8|NOT COMPLETED|Treatment Period||0
7772155|NCT01359644|19133626|P7|NOT COMPLETED|Treatment Period||0
7772156|NCT01359644|19133627|P6|NOT COMPLETED|Treatment Period||2
7772157|NCT01359644|19133628|P5|NOT COMPLETED|Treatment Period||0
7772158|NCT01359644|19133629|P4|NOT COMPLETED|Treatment Period||0
7772159|NCT01359644|19133630|P3|NOT COMPLETED|Treatment Period||1
7772160|NCT01359644|19133631|P2|NOT COMPLETED|Treatment Period||1
7772161|NCT01359644|19133632|P1|NOT COMPLETED|Treatment Period||0
7772162|NCT01359644|19133623|P10|COMPLETED|Treatment Period||20
7772163|NCT01359644|19133624|P9|COMPLETED|Treatment Period||21
7772164|NCT01359644|19133625|P8|COMPLETED|Treatment Period||41
7772165|NCT01359644|19133626|P7|COMPLETED|Treatment Period||41
7772166|NCT01359644|19133627|P6|COMPLETED|Treatment Period||12
7772167|NCT01359644|19133628|P5|COMPLETED|Treatment Period||15
7772168|NCT01359644|19133629|P4|COMPLETED|Treatment Period||14
7772169|NCT01359644|19133630|P3|COMPLETED|Treatment Period||13
7772170|NCT01359644|19133631|P2|COMPLETED|Treatment Period||15
7772171|NCT01359644|19133632|P1|COMPLETED|Treatment Period||15
7772172|NCT01359644|19133623|P10|STARTED|Treatment Period||20
7772173|NCT01359644|19133624|P9|STARTED|Treatment Period||21
7772174|NCT01359644|19133625|P8|STARTED|Treatment Period||41
7772175|NCT01359644|19133626|P7|STARTED|Treatment Period||41
7772176|NCT01359644|19133627|P6|STARTED|Treatment Period||14
7772177|NCT01359644|19133628|P5|STARTED|Treatment Period||15
7772178|NCT01359644|19133629|P4|STARTED|Treatment Period||14
7772179|NCT01359644|19133630|P3|STARTED|Treatment Period||14
7772180|NCT01359644|19133631|P2|STARTED|Treatment Period||16
7772181|NCT01359644|19133632|P1|STARTED|Treatment Period||15
7772182|NCT01359449|19133676|P2|NOT COMPLETED|Overall Study||4
7772183|NCT01359449|19133677|P1|NOT COMPLETED|Overall Study||4
7772184|NCT01359449|19133676|P2|COMPLETED|Overall Study||58
7772185|NCT01359449|19133677|P1|COMPLETED|Overall Study||57
7772186|NCT01359449|19133676|P2|STARTED|Overall Study||62
7772187|NCT01359449|19133677|P1|STARTED|Overall Study||61
7772188|NCT01359410|19133701|P2|NOT COMPLETED|Overall Study||0
7772189|NCT01359410|19133702|P1|NOT COMPLETED|Overall Study||0
7772190|NCT01359410|19133701|P2|COMPLETED|Overall Study||46
7772191|NCT01359410|19133702|P1|COMPLETED|Overall Study||54
7772192|NCT01359410|19133701|P2|STARTED|Overall Study||46
7772193|NCT01359410|19133702|P1|STARTED|Overall Study||54
7772194|NCT01359371|19133716|P1|NOT COMPLETED|Overall Study||0
7772195|NCT01359371|19133716|P1|COMPLETED|Overall Study||131
7772196|NCT01359371|19133716|P1|STARTED|Overall Study||131
7772197|NCT01359254|19133727|P2|NOT COMPLETED|Overall Study||0
7772198|NCT01359254|19133728|P1|NOT COMPLETED|Overall Study||1
7772199|NCT01359254|19133727|P2|COMPLETED|Overall Study||0
7772200|NCT01359254|19133728|P1|COMPLETED|Overall Study||0
7772201|NCT01359254|19133727|P2|STARTED|Overall Study||0
7772202|NCT01359254|19133728|P1|STARTED|Overall Study||1
7772203|NCT01359150|19133738|P2|NOT COMPLETED|Overall Study||5
7772204|NCT01359150|19133739|P1|NOT COMPLETED|Overall Study||7
7772205|NCT01359150|19133738|P2|COMPLETED|Overall Study||106
7772206|NCT01359150|19133739|P1|COMPLETED|Overall Study||105
7772207|NCT01359150|19133738|P2|STARTED|Overall Study||111
7772208|NCT01359150|19133739|P1|STARTED|Overall Study||112
7772209|NCT01359111|19133761|P1|NOT COMPLETED|Overall Study||0
7772210|NCT01359111|19133761|P1|COMPLETED|Overall Study||20
7772211|NCT01359111|19133761|P1|STARTED|Overall Study||20
7772212|NCT01359046|19133770|P2|NOT COMPLETED|Overall Study||17
7772213|NCT01359046|19133771|P1|NOT COMPLETED|Overall Study||7
7772214|NCT01359046|19133770|P2|COMPLETED|Overall Study||127
7772215|NCT01359046|19133771|P1|COMPLETED|Overall Study||137
7772216|NCT01359046|19133770|P2|STARTED|Overall Study||144
7772217|NCT01359046|19133771|P1|STARTED|Overall Study||144
7772218|NCT01359007|19133779|P1|NOT COMPLETED|Overall Study||2
7772219|NCT01359007|19133779|P1|COMPLETED|Overall Study||3
7772220|NCT01359007|19133779|P1|STARTED|Overall Study||5
7772221|NCT01358981|19133794|P7|NOT COMPLETED|Period 4||0
7772222|NCT01358981|19133795|P6|NOT COMPLETED|Period 4||0
7772223|NCT01358981|19133796|P5|NOT COMPLETED|Period 4||0
7772224|NCT01358981|19133797|P4|NOT COMPLETED|Period 4||0
7772225|NCT01358981|19133798|P3|NOT COMPLETED|Period 4||0
7772226|NCT01358981|19133799|P2|NOT COMPLETED|Period 4||0
7772227|NCT01358981|19133800|P1|NOT COMPLETED|Period 4||0
7772228|NCT01358981|19133794|P7|COMPLETED|Period 4||0
7772229|NCT01358981|19133795|P6|COMPLETED|Period 4||0
7772230|NCT01358981|19133796|P5|COMPLETED|Period 4||0
7772231|NCT01358981|19133797|P4|COMPLETED|Period 4||2
7772232|NCT01358981|19133798|P3|COMPLETED|Period 4||2
7772233|NCT01358981|19133799|P2|COMPLETED|Period 4||2
7772234|NCT01358981|19133800|P1|COMPLETED|Period 4||2
7772235|NCT01358981|19133794|P7|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
7772236|NCT01358981|19133795|P6|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
7772237|NCT01358981|19133796|P5|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
7772238|NCT01358981|19133797|P4|STARTED|Period 4||2
7772239|NCT01358981|19133798|P3|STARTED|Period 4||2
7772240|NCT01358981|19133799|P2|STARTED|Period 4||2
7772241|NCT01358981|19133800|P1|STARTED|Period 4||2
7772242|NCT01358981|19133794|P7|NOT COMPLETED|Period 3||0
7772243|NCT01358981|19133795|P6|NOT COMPLETED|Period 3||0
7772244|NCT01358981|19133796|P5|NOT COMPLETED|Period 3||0
7772245|NCT01358981|19133797|P4|NOT COMPLETED|Period 3||0
7772246|NCT01358981|19133798|P3|NOT COMPLETED|Period 3||0
7772247|NCT01358981|19133799|P2|NOT COMPLETED|Period 3||0
7772248|NCT01358981|19133800|P1|NOT COMPLETED|Period 3||0
7772249|NCT01358981|19133794|P7|COMPLETED|Period 3||3
7772250|NCT01358981|19133795|P6|COMPLETED|Period 3||3
7772251|NCT01358981|19133796|P5|COMPLETED|Period 3||3
7772252|NCT01358981|19133797|P4|COMPLETED|Period 3||2
7772253|NCT01358981|19133798|P3|COMPLETED|Period 3||2
7772254|NCT01358981|19133799|P2|COMPLETED|Period 3||2
7772255|NCT01358981|19133800|P1|COMPLETED|Period 3||2
7772256|NCT01358981|19133794|P7|STARTED|Period 3||3
7772257|NCT01358981|19133795|P6|STARTED|Period 3||3
7772258|NCT01358981|19133796|P5|STARTED|Period 3||3
7772259|NCT01358981|19133797|P4|STARTED|Period 3||2
7772260|NCT01358981|19133798|P3|STARTED|Period 3||2
7772261|NCT01358981|19133799|P2|STARTED|Period 3||2
7772262|NCT01358981|19133800|P1|STARTED|Period 3||2
7772263|NCT01358981|19133794|P7|NOT COMPLETED|Period 2||0
7772264|NCT01358981|19133795|P6|NOT COMPLETED|Period 2||0
7772265|NCT01358981|19133796|P5|NOT COMPLETED|Period 2||0
7772266|NCT01358981|19133797|P4|NOT COMPLETED|Period 2||0
7772267|NCT01358981|19133798|P3|NOT COMPLETED|Period 2||0
7772268|NCT01358981|19133799|P2|NOT COMPLETED|Period 2||0
7772269|NCT01358981|19133800|P1|NOT COMPLETED|Period 2||0
7772270|NCT01358981|19133794|P7|COMPLETED|Period 2||3
7772271|NCT01358981|19133795|P6|COMPLETED|Period 2||3
7772272|NCT01358981|19133796|P5|COMPLETED|Period 2||3
7772273|NCT01358981|19133797|P4|COMPLETED|Period 2||2
7772274|NCT01358981|19133798|P3|COMPLETED|Period 2||2
7772275|NCT01358981|19133799|P2|COMPLETED|Period 2||2
7772276|NCT01358981|19133800|P1|COMPLETED|Period 2||2
7772277|NCT01358981|19133794|P7|STARTED|Period 2||3
7772278|NCT01358981|19133795|P6|STARTED|Period 2||3
7772279|NCT01358981|19133796|P5|STARTED|Period 2||3
7772280|NCT01358981|19133797|P4|STARTED|Period 2|One participant who withdrew in period 1 was replaced by another participant in period 2.|2
7772281|NCT01358981|19133798|P3|STARTED|Period 2||2
7772282|NCT01358981|19133799|P2|STARTED|Period 2||2
7772283|NCT01358981|19133800|P1|STARTED|Period 2||2
7772284|NCT01358981|19133794|P7|NOT COMPLETED|Period 1||0
7772285|NCT01358981|19133795|P6|NOT COMPLETED|Period 1||0
7772286|NCT01358981|19133796|P5|NOT COMPLETED|Period 1||0
7772287|NCT01358981|19133797|P4|NOT COMPLETED|Period 1||1
7772288|NCT01358981|19133798|P3|NOT COMPLETED|Period 1||0
7772289|NCT01358981|19133799|P2|NOT COMPLETED|Period 1||0
7772290|NCT01358981|19133800|P1|NOT COMPLETED|Period 1||0
7772291|NCT01358981|19133794|P7|COMPLETED|Period 1||3
7772292|NCT01358981|19133795|P6|COMPLETED|Period 1||3
7772293|NCT01358981|19133796|P5|COMPLETED|Period 1||3
7772294|NCT01358981|19133797|P4|COMPLETED|Period 1||1
7772295|NCT01358981|19133798|P3|COMPLETED|Period 1||2
7772296|NCT01358981|19133799|P2|COMPLETED|Period 1||2
7772297|NCT01358981|19133800|P1|COMPLETED|Period 1||2
7772298|NCT01358981|19133794|P7|Received at Least 1dose of Study Drug|Period 1||3
7772299|NCT01358981|19133795|P6|Received at Least 1dose of Study Drug|Period 1||3
7772300|NCT01358981|19133796|P5|Received at Least 1dose of Study Drug|Period 1||3
7772301|NCT01358981|19133797|P4|Received at Least 1dose of Study Drug|Period 1||2
7772302|NCT01358981|19133798|P3|Received at Least 1dose of Study Drug|Period 1||2
7772303|NCT01358981|19133799|P2|Received at Least 1dose of Study Drug|Period 1||2
7772304|NCT01358981|19133800|P1|Received at Least 1dose of Study Drug|Period 1||2
7772305|NCT01358981|19133794|P7|STARTED|Period 1||3
7772306|NCT01358981|19133795|P6|STARTED|Period 1||3
7772307|NCT01358981|19133796|P5|STARTED|Period 1||3
7772308|NCT01358981|19133797|P4|STARTED|Period 1||2
7772309|NCT01358981|19133798|P3|STARTED|Period 1||2
7772310|NCT01358981|19133799|P2|STARTED|Period 1||2
7772311|NCT01358981|19133800|P1|STARTED|Period 1||2
7772312|NCT01358968|19133861|P4|NOT COMPLETED|Continued Access Phase||7
7772313|NCT01358968|19133862|P3|NOT COMPLETED|Continued Access Phase||12
7772314|NCT01358968|19133863|P2|NOT COMPLETED|Continued Access Phase||0
7772315|NCT01358968|19133864|P1|NOT COMPLETED|Continued Access Phase||0
7772316|NCT01358968|19133861|P4|COMPLETED|Continued Access Phase||0
7772317|NCT01358968|19133862|P3|COMPLETED|Continued Access Phase||0
7772318|NCT01358968|19133863|P2|COMPLETED|Continued Access Phase||0
7772319|NCT01358968|19133864|P1|COMPLETED|Continued Access Phase||0
7772320|NCT01358968|19133861|P4|Received at Least 1 Dose of Study Drug|Continued Access Phase||7
7772321|NCT01358968|19133862|P3|Received at Least 1 Dose of Study Drug|Continued Access Phase||12
7772322|NCT01358968|19133863|P2|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
7772323|NCT01358968|19133864|P1|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
7772324|NCT01358968|19133861|P4|STARTED|Continued Access Phase||7
7772325|NCT01358968|19133862|P3|STARTED|Continued Access Phase||12
7772326|NCT01358968|19133863|P2|STARTED|Continued Access Phase||0
7772327|NCT01358968|19133864|P1|STARTED|Continued Access Phase||0
7772328|NCT01358968|19133861|P4|NOT COMPLETED|Period 2||0
7772329|NCT01358968|19133862|P3|NOT COMPLETED|Period 2||0
7772330|NCT01358968|19133863|P2|NOT COMPLETED|Period 2||1
7772331|NCT01358968|19133864|P1|NOT COMPLETED|Period 2||0
7772332|NCT01358968|19133861|P4|COMPLETED|Period 2||0
7772333|NCT01358968|19133862|P3|COMPLETED|Period 2||0
7772334|NCT01358968|19133863|P2|COMPLETED|Period 2||19
7772335|NCT01358968|19133864|P1|COMPLETED|Period 2||0
7772336|NCT01358968|19133861|P4|Received at Least 1 Dose of Study Drug|Period 2||0
7772337|NCT01358968|19133862|P3|Received at Least 1 Dose of Study Drug|Period 2||0
7772338|NCT01358968|19133863|P2|Received at Least 1 Dose of Study Drug|Period 2||19
7772339|NCT01358968|19133864|P1|Received at Least 1 Dose of Study Drug|Period 2||0
7772340|NCT01358968|19133861|P4|STARTED|Period 2||0
7772341|NCT01358968|19133862|P3|STARTED|Period 2||0
7772342|NCT01358968|19133863|P2|STARTED|Period 2||20
7772343|NCT01358968|19133864|P1|STARTED|Period 2||0
7772344|NCT01358968|19133861|P4|NOT COMPLETED|Period 1||0
7772345|NCT01358968|19133862|P3|NOT COMPLETED|Period 1||0
7772346|NCT01358968|19133863|P2|NOT COMPLETED|Period 1||0
7772347|NCT01358968|19133864|P1|NOT COMPLETED|Period 1||0
7772348|NCT01358968|19133861|P4|COMPLETED|Period 1||0
7772349|NCT01358968|19133862|P3|COMPLETED|Period 1||0
7772350|NCT01358968|19133863|P2|COMPLETED|Period 1||0
7772351|NCT01358968|19133864|P1|COMPLETED|Period 1||20
7772352|NCT01358968|19133861|P4|Received at Least 1 Dose of Study Drug|Period 1||0
7772353|NCT01358968|19133862|P3|Received at Least 1 Dose of Study Drug|Period 1||0
7772354|NCT01358968|19133863|P2|Received at Least 1 Dose of Study Drug|Period 1||0
7772355|NCT01358968|19133864|P1|Received at Least 1 Dose of Study Drug|Period 1||20
7772356|NCT01358968|19133861|P4|STARTED|Period 1||0
7772357|NCT01358968|19133862|P3|STARTED|Period 1||0
7772358|NCT01358968|19133863|P2|STARTED|Period 1||0
7772359|NCT01358968|19133864|P1|STARTED|Period 1||20
7772360|NCT01358877|19133880|P2|NOT COMPLETED|Overall Study||2404
7772361|NCT01358877|19133881|P1|NOT COMPLETED|Overall Study||2400
7772362|NCT01358877|19133880|P2|COMPLETED|Overall Study||0
7772363|NCT01358877|19133881|P1|COMPLETED|Overall Study||0
7772364|NCT01358877|19133880|P2|Received Study Drug (Safety Population)|Overall Study|38 pertuzumab participants did not receive pertuzumab and were included in placebo arm.|2405
7772365|NCT01358877|19133881|P1|Received Study Drug (Safety Population)|Overall Study|24 placebo participants received at least 1 dose of pertuzumab and were included in pertuzumab arm.|2364
7772366|NCT01358877|19133880|P2|Did Not Receive Study Drug|Overall Study||13
7772367|NCT01358877|19133881|P1|Did Not Receive Study Drug|Overall Study||22
7772368|NCT01358877|19133880|P2|STARTED|Overall Study||2404
7772369|NCT01358877|19133881|P1|STARTED|Overall Study||2400
7772370|NCT01358864|19133951|P8|NOT COMPLETED|Overall Study||55
7772371|NCT01358864|19133952|P7|NOT COMPLETED|Overall Study||65
7772372|NCT01358864|19133953|P6|NOT COMPLETED|Overall Study||13
7772373|NCT01358864|19133954|P5|NOT COMPLETED|Overall Study||11
7772374|NCT01358864|19133955|P4|NOT COMPLETED|Overall Study||19
7772375|NCT01358864|19133956|P3|NOT COMPLETED|Overall Study||16
7772376|NCT01358864|19133957|P2|NOT COMPLETED|Overall Study||13
7772377|NCT01358864|19133958|P1|NOT COMPLETED|Overall Study||31
7772378|NCT01358864|19133951|P8|COMPLETED|Overall Study||85
7772379|NCT01358864|19133952|P7|COMPLETED|Overall Study||81
7772380|NCT01358864|19133953|P6|COMPLETED|Overall Study||42
7772381|NCT01358864|19133954|P5|COMPLETED|Overall Study||46
7772382|NCT01358864|19133955|P4|COMPLETED|Overall Study||10
7772383|NCT01358864|19133956|P3|COMPLETED|Overall Study||87
7772384|NCT01358864|19133957|P2|COMPLETED|Overall Study||86
7772385|NCT01358864|19133958|P1|COMPLETED|Overall Study||18
7772386|NCT01358864|19133951|P8|STARTED|Overall Study||140
7772387|NCT01358864|19133952|P7|STARTED|Overall Study||146
7772388|NCT01358864|19133953|P6|STARTED|Overall Study||55
7772389|NCT01358864|19133954|P5|STARTED|Overall Study||57
7772390|NCT01358864|19133955|P4|STARTED|Overall Study||29
7772391|NCT01358864|19133956|P3|STARTED|Overall Study||103
7772392|NCT01358864|19133957|P2|STARTED|Overall Study||99
7772393|NCT01358864|19133958|P1|STARTED|Overall Study||49
7772394|NCT01358825|19134049|P2|NOT COMPLETED|Overall Study||1
7772395|NCT01358825|19134050|P1|NOT COMPLETED|Overall Study||0
7772396|NCT01358825|19134049|P2|COMPLETED|Overall Study||45
7772397|NCT01358825|19134050|P1|COMPLETED|Overall Study||12
7772398|NCT01358825|19134049|P2|STARTED|Overall Study||46
7772399|NCT01358825|19134050|P1|STARTED|Overall Study||12
7772400|NCT01358760|19134074|P3|NOT COMPLETED|Overall Study||25
7772401|NCT01358760|19134075|P2|NOT COMPLETED|Overall Study||20
7772402|NCT01358760|19134076|P1|NOT COMPLETED|Overall Study||22
7772403|NCT01358760|19134074|P3|COMPLETED|Overall Study||125
7772404|NCT01358760|19134075|P2|COMPLETED|Overall Study||128
7772405|NCT01358760|19134076|P1|COMPLETED|Overall Study||130
7772406|NCT01358760|19134074|P3|ITT Population|Overall Study||134
7772407|NCT01358760|19134075|P2|ITT Population|Overall Study||134
7772408|NCT01358760|19134076|P1|ITT Population|Overall Study||139
7772409|NCT01358760|19134074|P3|Safety Population|Overall Study||148
7772410|NCT01358760|19134075|P2|Safety Population|Overall Study||143
7772411|NCT01358760|19134076|P1|Safety Population|Overall Study||150
7772412|NCT01358760|19134074|P3|STARTED|Overall Study||150
7772413|NCT01358760|19134075|P2|STARTED|Overall Study||148
7772414|NCT01358760|19134076|P1|STARTED|Overall Study||152
7772415|NCT01358734|19134111|P3|NOT COMPLETED|Overall Study||34
7772416|NCT01358734|19134112|P2|NOT COMPLETED|Overall Study||39
7772417|NCT01358734|19134113|P1|NOT COMPLETED|Overall Study||15
7772418|NCT01358734|19134111|P3|COMPLETED|Overall Study||0
7772419|NCT01358734|19134112|P2|COMPLETED|Overall Study||0
7772420|NCT01358734|19134113|P1|COMPLETED|Overall Study||0
7772421|NCT01358734|19134111|P3|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32
7772422|NCT01358734|19134112|P2|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38
7772423|NCT01358734|19134113|P1|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14
7772424|NCT01358734|19134111|P3|STARTED|Overall Study||34
7772425|NCT01358734|19134112|P2|STARTED|Overall Study||39
7772426|NCT01358734|19134113|P1|STARTED|Overall Study||15
7772427|NCT01358721|19134161|P4|NOT COMPLETED|Overall Study||24
7772428|NCT01358721|19134162|P3|NOT COMPLETED|Overall Study||22
7772429|NCT01358721|19134163|P2|NOT COMPLETED|Overall Study||22
7772430|NCT01358721|19134164|P1|NOT COMPLETED|Overall Study||21
7772431|NCT01358721|19134161|P4|COMPLETED|Overall Study||0
7772432|NCT01358721|19134162|P3|COMPLETED|Overall Study||1
7772433|NCT01358721|19134163|P2|COMPLETED|Overall Study||0
7772434|NCT01358721|19134164|P1|COMPLETED|Overall Study||1
7772435|NCT01358721|19134161|P4|STARTED|Overall Study||24
7772436|NCT01358721|19134162|P3|STARTED|Overall Study||23
7772437|NCT01358721|19134163|P2|STARTED|Overall Study||22
7772438|NCT01358721|19134164|P1|STARTED|Overall Study||22
7772439|NCT01358708|19134216|P2|NOT COMPLETED|Open-Label Treatment Phase||0
7772440|NCT01358708|19134217|P1|NOT COMPLETED|Open-Label Treatment Phase||0
7772441|NCT01358708|19134216|P2|COMPLETED|Open-Label Treatment Phase||12
7772442|NCT01358708|19134217|P1|COMPLETED|Open-Label Treatment Phase||5
7772443|NCT01358708|19134216|P2|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12
7772444|NCT01358708|19134217|P1|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5
7772445|NCT01358708|19134216|P2|NOT COMPLETED|Double-Blind Treatment Phase||0
7772446|NCT01358708|19134217|P1|NOT COMPLETED|Double-Blind Treatment Phase||3
7772447|NCT01358708|19134216|P2|COMPLETED|Double-Blind Treatment Phase||13
7772448|NCT01358708|19134217|P1|COMPLETED|Double-Blind Treatment Phase||10
7772449|NCT01358708|19134216|P2|Received Study Medication|Double-Blind Treatment Phase||13
7772450|NCT01358708|19134217|P1|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12
7772451|NCT01358708|19134216|P2|Randomized|Double-Blind Treatment Phase||13
7772452|NCT01358708|19134217|P1|Randomized|Double-Blind Treatment Phase||13
7772453|NCT01358708|19134216|P2|STARTED|Double-Blind Treatment Phase||13
7772454|NCT01358708|19134217|P1|STARTED|Double-Blind Treatment Phase||13
7772455|NCT01358578|19134240|P6|NOT COMPLETED|Follow-up Period||0
7772456|NCT01358578|19134241|P5|NOT COMPLETED|Follow-up Period||0
7772457|NCT01358578|19134242|P4|NOT COMPLETED|Follow-up Period||19
7772458|NCT01358578|19134243|P3|NOT COMPLETED|Follow-up Period||5
7772459|NCT01358578|19134244|P2|NOT COMPLETED|Follow-up Period||6
7772460|NCT01358578|19134245|P1|NOT COMPLETED|Follow-up Period||10
7772461|NCT01358578|19134240|P6|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
7772462|NCT01358578|19134241|P5|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
7772463|NCT01358578|19134242|P4|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260
7772464|NCT01358578|19134243|P3|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21
7772465|NCT01358578|19134244|P2|COMPLETED|Follow-up Period||119
7772466|NCT01358578|19134245|P1|COMPLETED|Follow-up Period||138
7772467|NCT01358578|19134240|P6|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
7772468|NCT01358578|19134241|P5|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
7772469|NCT01358578|19134242|P4|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279
7772470|NCT01358578|19134243|P3|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26
7772471|NCT01358578|19134244|P2|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125
7772472|NCT01358578|19134245|P1|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148
7772473|NCT01358578|19134240|P6|NOT COMPLETED|Maintenance Period||11
7772474|NCT01358578|19134241|P5|NOT COMPLETED|Maintenance Period||17
7772475|NCT01358578|19134242|P4|NOT COMPLETED|Maintenance Period||42
7772476|NCT01358578|19134243|P3|NOT COMPLETED|Maintenance Period||2
7772477|NCT01358578|19134244|P2|NOT COMPLETED|Maintenance Period||22
7772478|NCT01358578|19134245|P1|NOT COMPLETED|Maintenance Period||39
7772479|NCT01358578|19134240|P6|COMPLETED|Maintenance Period||131
7772480|NCT01358578|19134241|P5|COMPLETED|Maintenance Period||125
7772481|NCT01358578|19134242|P4|COMPLETED|Maintenance Period||263
7772482|NCT01358578|19134243|P3|COMPLETED|Maintenance Period||15
7772483|NCT01358578|19134244|P2|COMPLETED|Maintenance Period||290
7772484|NCT01358578|19134245|P1|COMPLETED|Maintenance Period||276
7772485|NCT01358578|19134240|P6|STARTED|Maintenance Period||142
7772486|NCT01358578|19134241|P5|STARTED|Maintenance Period||142
7772487|NCT01358578|19134242|P4|STARTED|Maintenance Period||305
7772488|NCT01358578|19134243|P3|STARTED|Maintenance Period||17
7772489|NCT01358578|19134244|P2|STARTED|Maintenance Period||312
7772490|NCT01358578|19134245|P1|STARTED|Maintenance Period||315
7772491|NCT01358578|19134240|P6|NOT COMPLETED|Induction Period||0
7772492|NCT01358578|19134241|P5|NOT COMPLETED|Induction Period||0
7772493|NCT01358578|19134242|P4|NOT COMPLETED|Induction Period||21
7772494|NCT01358578|19134243|P3|NOT COMPLETED|Induction Period||25
7772495|NCT01358578|19134244|P2|NOT COMPLETED|Induction Period||15
7772496|NCT01358578|19134245|P1|NOT COMPLETED|Induction Period||12
7772497|NCT01358578|19134240|P6|COMPLETED|Induction Period|These groups are populated after the induction period|0
7772498|NCT01358578|19134241|P5|COMPLETED|Induction Period|These groups are populated after the induction period|0
7772499|NCT01358578|19134242|P4|COMPLETED|Induction Period||305
7772500|NCT01358578|19134243|P3|COMPLETED|Induction Period||301
7772501|NCT01358578|19134244|P2|COMPLETED|Induction Period||312
7772502|NCT01358578|19134245|P1|COMPLETED|Induction Period||315
7772503|NCT01358578|19134240|P6|STARTED|Induction Period|These groups are populated after the induction period|0
7772504|NCT01358578|19134241|P5|STARTED|Induction Period|These groups are populated after the induction period|0
7772505|NCT01358578|19134242|P4|STARTED|Induction Period||326
7772506|NCT01358578|19134243|P3|STARTED|Induction Period||326
7772507|NCT01358578|19134244|P2|STARTED|Induction Period||327
7772508|NCT01358578|19134245|P1|STARTED|Induction Period||327
7772509|NCT01358526|19134297|P3|NOT COMPLETED|Double-blind Phase||121
7772510|NCT01358526|19134298|P2|NOT COMPLETED|Double-blind Phase||80
7772511|NCT01358526|19134299|P1|NOT COMPLETED|Double-blind Phase||0
7772512|NCT01358526|19134297|P3|COMPLETED|Double-blind Phase||181
7772513|NCT01358526|19134298|P2|COMPLETED|Double-blind Phase||218
7772514|NCT01358526|19134299|P1|COMPLETED|Double-blind Phase||0
7772515|NCT01358526|19134297|P3|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302
7772516|NCT01358526|19134298|P2|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298
7772517|NCT01358526|19134299|P1|STARTED|Double-blind Phase||0
7772518|NCT01358526|19134297|P3|NOT COMPLETED|Open-label Titration Period||0
7772519|NCT01358526|19134298|P2|NOT COMPLETED|Open-label Titration Period||0
7772520|NCT01358526|19134299|P1|NOT COMPLETED|Open-label Titration Period||494
7772521|NCT01358526|19134297|P3|COMPLETED|Open-label Titration Period||0
7772522|NCT01358526|19134298|P2|COMPLETED|Open-label Titration Period||0
7772523|NCT01358526|19134299|P1|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601
7772524|NCT01358526|19134297|P3|STARTED|Open-label Titration Period||0
7772525|NCT01358526|19134298|P2|STARTED|Open-label Titration Period||0
7772526|NCT01358526|19134299|P1|STARTED|Open-label Titration Period||1095
7772527|NCT01358357|19134316|P3|NOT COMPLETED|Double-Blind Phase||0
7772528|NCT01358357|19134317|P2|NOT COMPLETED|Double-Blind Phase||100
7772529|NCT01358357|19134318|P1|NOT COMPLETED|Double-Blind Phase||80
7772530|NCT01358357|19134316|P3|COMPLETED|Double-Blind Phase||0
7772531|NCT01358357|19134317|P2|COMPLETED|Double-Blind Phase||150
7772532|NCT01358357|19134318|P1|COMPLETED|Double-Blind Phase||166
7772533|NCT01358357|19134316|P3|STARTED|Double-Blind Phase||0
7772534|NCT01358357|19134317|P2|STARTED|Double-Blind Phase||250
7772535|NCT01358357|19134318|P1|STARTED|Double-Blind Phase||246
7772536|NCT01358357|19134316|P3|NOT COMPLETED|Open Label Phase||462
7772537|NCT01358357|19134317|P2|NOT COMPLETED|Open Label Phase||0
7772538|NCT01358357|19134318|P1|NOT COMPLETED|Open Label Phase||0
7772539|NCT01358357|19134316|P3|COMPLETED|Open Label Phase||503
7772540|NCT01358357|19134317|P2|COMPLETED|Open Label Phase||0
7772541|NCT01358357|19134318|P1|COMPLETED|Open Label Phase||0
7772542|NCT01358357|19134316|P3|STARTED|Open Label Phase||965
7772543|NCT01358357|19134317|P2|STARTED|Open Label Phase||0
7772544|NCT01358357|19134318|P1|STARTED|Open Label Phase||0
7772545|NCT01358331|19134357|P6|NOT COMPLETED|Overall Study||6
7772546|NCT01358331|19134358|P5|NOT COMPLETED|Overall Study||7
7772547|NCT01358331|19134359|P4|NOT COMPLETED|Overall Study||3
7772548|NCT01358331|19134360|P3|NOT COMPLETED|Overall Study||4
7772549|NCT01358331|19134361|P2|NOT COMPLETED|Overall Study||3
7772550|NCT01358331|19134362|P1|NOT COMPLETED|Overall Study||2
7772551|NCT01358331|19134357|P6|COMPLETED|Overall Study||0
7772552|NCT01358331|19134358|P5|COMPLETED|Overall Study||0
7772553|NCT01358331|19134359|P4|COMPLETED|Overall Study||0
7772554|NCT01358331|19134360|P3|COMPLETED|Overall Study||0
7772555|NCT01358331|19134361|P2|COMPLETED|Overall Study||0
7772556|NCT01358331|19134362|P1|COMPLETED|Overall Study||0
7772557|NCT01358331|19134357|P6|STARTED|Overall Study||6
7772558|NCT01358331|19134358|P5|STARTED|Overall Study||7
7772559|NCT01358331|19134359|P4|STARTED|Overall Study||3
7772560|NCT01358331|19134360|P3|STARTED|Overall Study||4
7772561|NCT01358331|19134361|P2|STARTED|Overall Study||3
7772562|NCT01358331|19134362|P1|STARTED|Overall Study||2
7772563|NCT01358266|19134385|P3|NOT COMPLETED|Open-Label Period||70
7772564|NCT01358266|19134386|P2|NOT COMPLETED|Open-Label Period||44
7772565|NCT01358266|19134387|P1|NOT COMPLETED|Open-Label Period||56
7772566|NCT01358266|19134385|P3|COMPLETED|Open-Label Period||44
7772567|NCT01358266|19134386|P2|COMPLETED|Open-Label Period||58
7772568|NCT01358266|19134387|P1|COMPLETED|Open-Label Period||63
7772569|NCT01358266|19134385|P3|STARTED|Open-Label Period||114
7772570|NCT01358266|19134386|P2|STARTED|Open-Label Period||102
7772571|NCT01358266|19134387|P1|STARTED|Open-Label Period||119
7772572|NCT01358266|19134385|P3|NOT COMPLETED|Double-Masked Period||39
7772573|NCT01358266|19134386|P2|NOT COMPLETED|Double-Masked Period||46
7772574|NCT01358266|19134387|P1|NOT COMPLETED|Double-Masked Period||33
7772575|NCT01358266|19134385|P3|COMPLETED|Double-Masked Period||137
7772576|NCT01358266|19134386|P2|COMPLETED|Double-Masked Period||162
7772577|NCT01358266|19134387|P1|COMPLETED|Double-Masked Period||175
7772578|NCT01358266|19134385|P3|STARTED|Double-Masked Period||176
7772579|NCT01358266|19134386|P2|STARTED|Double-Masked Period||208
7772580|NCT01358266|19134387|P1|STARTED|Double-Masked Period||208
7772581|NCT01358175|19134414|P3|NOT COMPLETED|Overall Study||32
7772582|NCT01358175|19134415|P2|NOT COMPLETED|Overall Study||28
7772583|NCT01358175|19134416|P1|NOT COMPLETED|Overall Study||21
7772584|NCT01358175|19134414|P3|COMPLETED|Overall Study||90
7772585|NCT01358175|19134415|P2|COMPLETED|Overall Study||97
7772586|NCT01358175|19134416|P1|COMPLETED|Overall Study||103
7772587|NCT01358175|19134414|P3|STARTED|Overall Study||122
7772588|NCT01358175|19134415|P2|STARTED|Overall Study||125
7772589|NCT01358175|19134416|P1|STARTED|Overall Study||124
7772590|NCT01357980|19134453|P4|NOT COMPLETED|Overall Study||0
7772591|NCT01357980|19134454|P3|NOT COMPLETED|Overall Study||1
7772592|NCT01357980|19134455|P2|NOT COMPLETED|Overall Study||1
7772593|NCT01357980|19134456|P1|NOT COMPLETED|Overall Study||0
7772594|NCT01357980|19134453|P4|COMPLETED|Overall Study||7
7772595|NCT01357980|19134454|P3|COMPLETED|Overall Study||16
7772596|NCT01357980|19134455|P2|COMPLETED|Overall Study||6
7772597|NCT01357980|19134456|P1|COMPLETED|Overall Study||16
7772598|NCT01357980|19134453|P4|STARTED|Overall Study||7
7772599|NCT01357980|19134454|P3|STARTED|Overall Study||17
7772600|NCT01357980|19134455|P2|STARTED|Overall Study||7
7772601|NCT01357980|19134456|P1|STARTED|Overall Study||16
7772602|NCT01357915|19134500|P2|NOT COMPLETED|Overall Study||0
7772603|NCT01357915|19134501|P1|NOT COMPLETED|Overall Study||3
7772604|NCT01357915|19134500|P2|COMPLETED|Overall Study||17
7772605|NCT01357915|19134501|P1|COMPLETED|Overall Study||27
7772606|NCT01357915|19134500|P2|STARTED|Overall Study||17
7772607|NCT01357915|19134501|P1|STARTED|Overall Study||30
7772608|NCT01357889|19134519|P2|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4
7772609|NCT01357889|19134520|P1|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3
7772610|NCT01357889|19134519|P2|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
7772611|NCT01357889|19134520|P1|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
7772612|NCT01357889|19134519|P2|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142
7772613|NCT01357889|19134520|P1|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141
7772614|NCT01357889|19134519|P2|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
7772615|NCT01357889|19134520|P1|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
7772616|NCT01357889|19134519|P2|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126
7772617|NCT01357889|19134520|P1|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125
7772618|NCT01357889|19134519|P2|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142
7772619|NCT01357889|19134520|P1|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141
7772620|NCT01357889|19134519|P2|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2
7772621|NCT01357889|19134520|P1|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4
7772622|NCT01357889|19134519|P2|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79
7772623|NCT01357889|19134520|P1|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82
7772624|NCT01357889|19134519|P2|STARTED|Single-dose Phase (BE Phase: 28 Days)||81
7772625|NCT01357889|19134520|P1|STARTED|Single-dose Phase (BE Phase: 28 Days)||86
7772626|NCT01357850|19134564|P4|NOT COMPLETED|Overall Study||0
7772627|NCT01357850|19134565|P3|NOT COMPLETED|Overall Study||0
7772628|NCT01357850|19134566|P2|NOT COMPLETED|Overall Study||0
7772629|NCT01357850|19134567|P1|NOT COMPLETED|Overall Study||1
7772630|NCT01357850|19134564|P4|COMPLETED|Overall Study||27
7772631|NCT01357850|19134565|P3|COMPLETED|Overall Study||13
7772632|NCT01357850|19134566|P2|COMPLETED|Overall Study||12
7772633|NCT01357850|19134567|P1|COMPLETED|Overall Study||29
7772634|NCT01357850|19134564|P4|STARTED|Overall Study||27
7772635|NCT01357850|19134565|P3|STARTED|Overall Study||13
7772636|NCT01357850|19134566|P2|STARTED|Overall Study||12
7772637|NCT01357850|19134567|P1|STARTED|Overall Study||30
7772638|NCT01357720|19134641|P2|NOT COMPLETED|Overall Study||5
7772639|NCT01357720|19134642|P1|NOT COMPLETED|Overall Study||2
7772640|NCT01357720|19134641|P2|COMPLETED|Overall Study||195
7772641|NCT01357720|19134642|P1|COMPLETED|Overall Study||198
7772642|NCT01357720|19134641|P2|STARTED|Overall Study||200
7772643|NCT01357720|19134642|P1|STARTED|Overall Study||200
7772644|NCT01357655|19134658|P2|NOT COMPLETED|Overall Study||0
7772645|NCT01357655|19134659|P1|NOT COMPLETED|Overall Study||66
7772646|NCT01357655|19134658|P2|COMPLETED|Overall Study||0
7772647|NCT01357655|19134659|P1|COMPLETED|Overall Study||0
7772648|NCT01357655|19134658|P2|STARTED|Overall Study||0
7772649|NCT01357655|19134659|P1|STARTED|Overall Study||66
7772650|NCT01357616|19134676|P2|NOT COMPLETED|Overall Study||9
7772651|NCT01357616|19134677|P1|NOT COMPLETED|Overall Study||10
7772652|NCT01357616|19134676|P2|COMPLETED|Overall Study||153
7772653|NCT01357616|19134677|P1|COMPLETED|Overall Study||156
7772654|NCT01357616|19134676|P2|STARTED|Overall Study||162
7772655|NCT01357616|19134677|P1|STARTED|Overall Study||166
7772656|NCT01357577|19134691|P2|NOT COMPLETED|Overall Study||26
7772657|NCT01357577|19134692|P1|NOT COMPLETED|Overall Study||37
7772658|NCT01357577|19134691|P2|COMPLETED|Overall Study||39
7772659|NCT01357577|19134692|P1|COMPLETED|Overall Study||27
7772660|NCT01357577|19134691|P2|Post-Treatment Assessment Completed|Overall Study||39
7772661|NCT01357577|19134692|P1|Post-Treatment Assessment Completed|Overall Study||24
7772662|NCT01357577|19134691|P2|STARTED|Overall Study||65
7772663|NCT01357577|19134692|P1|STARTED|Overall Study||64
7772664|NCT01357564|19134708|P2|NOT COMPLETED|Long-term (8-month) Follow-up||16
7772665|NCT01357564|19134709|P1|NOT COMPLETED|Long-term (8-month) Follow-up||2
7772666|NCT01357564|19134708|P2|COMPLETED|Long-term (8-month) Follow-up||102
7772667|NCT01357564|19134709|P1|COMPLETED|Long-term (8-month) Follow-up||104
7772668|NCT01357564|19134708|P2|STARTED|Long-term (8-month) Follow-up||118
7772669|NCT01357564|19134709|P1|STARTED|Long-term (8-month) Follow-up||106
7772670|NCT01357564|19134708|P2|NOT COMPLETED|Short-term (4-month) Follow up||50
7772671|NCT01357564|19134709|P1|NOT COMPLETED|Short-term (4-month) Follow up||48
7772672|NCT01357564|19134708|P2|COMPLETED|Short-term (4-month) Follow up||118
7772673|NCT01357564|19134709|P1|COMPLETED|Short-term (4-month) Follow up||106
7772674|NCT01357564|19134708|P2|STARTED|Short-term (4-month) Follow up||168
7772675|NCT01357564|19134709|P1|STARTED|Short-term (4-month) Follow up||154
7772676|NCT01357551|19134719|P2|NOT COMPLETED|Overall Study||11
7772677|NCT01357551|19134720|P1|NOT COMPLETED|Overall Study||22
7772678|NCT01357551|19134719|P2|COMPLETED|Overall Study||101
7772679|NCT01357551|19134720|P1|COMPLETED|Overall Study||88
7772680|NCT01357551|19134719|P2|STARTED|Overall Study||112
7772681|NCT01357551|19134720|P1|STARTED|Overall Study||110
7772682|NCT01357512|19134734|P2|NOT COMPLETED|Overall Study||5
7772683|NCT01357512|19134735|P1|NOT COMPLETED|Overall Study||12
7772684|NCT01357512|19134734|P2|COMPLETED|Overall Study||60
7772685|NCT01357512|19134735|P1|COMPLETED|Overall Study||53
7772686|NCT01357512|19134734|P2|STARTED|Overall Study||65
7772687|NCT01357512|19134735|P1|STARTED|Overall Study||65
7772688|NCT01357356|19134747|P4|NOT COMPLETED|Overall Study||17
7772689|NCT01357356|19134748|P3|NOT COMPLETED|Overall Study||28
7772690|NCT01357356|19134749|P2|NOT COMPLETED|Overall Study||25
7772691|NCT01357356|19134750|P1|NOT COMPLETED|Overall Study||22
7772692|NCT01357356|19134747|P4|COMPLETED|Overall Study||171
7772693|NCT01357356|19134748|P3|COMPLETED|Overall Study||158
7772694|NCT01357356|19134749|P2|COMPLETED|Overall Study||163
7772695|NCT01357356|19134750|P1|COMPLETED|Overall Study||166
7772696|NCT01357356|19134747|P4|STARTED|Overall Study||188
7772697|NCT01357356|19134748|P3|STARTED|Overall Study||186
7772698|NCT01357356|19134749|P2|STARTED|Overall Study||188
7772699|NCT01357356|19134750|P1|STARTED|Overall Study||188
7772700|NCT01357239|19134768|P4|NOT COMPLETED|Stratum II: Partially-Methylated||2
7772701|NCT01357239|19134769|P3|NOT COMPLETED|Stratum II: Partially-Methylated||1
7772702|NCT01357239|19134770|P2|NOT COMPLETED|Stratum II: Partially-Methylated||0
7772703|NCT01357239|19134771|P1|NOT COMPLETED|Stratum II: Partially-Methylated||0
7772704|NCT01357239|19134768|P4|COMPLETED|Stratum II: Partially-Methylated||18
7772705|NCT01357239|19134769|P3|COMPLETED|Stratum II: Partially-Methylated||21
7772706|NCT01357239|19134770|P2|COMPLETED|Stratum II: Partially-Methylated||21
7772707|NCT01357239|19134771|P1|COMPLETED|Stratum II: Partially-Methylated||23
7772708|NCT01357239|19134768|P4|STARTED|Stratum II: Partially-Methylated||20
7772709|NCT01357239|19134769|P3|STARTED|Stratum II: Partially-Methylated||22
7772710|NCT01357239|19134770|P2|STARTED|Stratum II: Partially-Methylated||21
7772711|NCT01357239|19134771|P1|STARTED|Stratum II: Partially-Methylated||23
7772712|NCT01357239|19134768|P4|NOT COMPLETED|Stratum I: Fully-Methylated||0
7772713|NCT01357239|19134769|P3|NOT COMPLETED|Stratum I: Fully-Methylated||1
7772714|NCT01357239|19134770|P2|NOT COMPLETED|Stratum I: Fully-Methylated||0
7772715|NCT01357239|19134771|P1|NOT COMPLETED|Stratum I: Fully-Methylated||0
7772716|NCT01357239|19134768|P4|COMPLETED|Stratum I: Fully-Methylated||22
7772717|NCT01357239|19134769|P3|COMPLETED|Stratum I: Fully-Methylated||16
7772718|NCT01357239|19134770|P2|COMPLETED|Stratum I: Fully-Methylated||6
7772719|NCT01357239|19134771|P1|COMPLETED|Stratum I: Fully-Methylated||8
7772720|NCT01357239|19134768|P4|STARTED|Stratum I: Fully-Methylated||22
7772721|NCT01357239|19134769|P3|STARTED|Stratum I: Fully-Methylated||17
7772722|NCT01357239|19134770|P2|STARTED|Stratum I: Fully-Methylated||6
7772723|NCT01357239|19134771|P1|STARTED|Stratum I: Fully-Methylated||8
7772724|NCT01357239|19134768|P4|NOT COMPLETED|Stratum: All Patients||2
7772725|NCT01357239|19134769|P3|NOT COMPLETED|Stratum: All Patients||2
7772726|NCT01357239|19134770|P2|NOT COMPLETED|Stratum: All Patients||0
7772727|NCT01357239|19134771|P1|NOT COMPLETED|Stratum: All Patients||0
7772728|NCT01357239|19134768|P4|COMPLETED|Stratum: All Patients||40
7772729|NCT01357239|19134769|P3|COMPLETED|Stratum: All Patients||37
7772730|NCT01357239|19134770|P2|COMPLETED|Stratum: All Patients||27
7772731|NCT01357239|19134771|P1|COMPLETED|Stratum: All Patients||31
7772732|NCT01357239|19134768|P4|STARTED|Stratum: All Patients||42
7772733|NCT01357239|19134769|P3|STARTED|Stratum: All Patients||39
7772734|NCT01357239|19134770|P2|STARTED|Stratum: All Patients||27
7772735|NCT01357239|19134771|P1|STARTED|Stratum: All Patients||31
7772736|NCT01357161|19134829|P3|NOT COMPLETED|Part 2 (Double-Blind Comparison)||62
7772737|NCT01357161|19134830|P2|NOT COMPLETED|Part 2 (Double-Blind Comparison)||59
7772738|NCT01357161|19134831|P1|NOT COMPLETED|Part 2 (Double-Blind Comparison)||0
7772739|NCT01357161|19134829|P3|COMPLETED|Part 2 (Double-Blind Comparison)||0
7772740|NCT01357161|19134830|P2|COMPLETED|Part 2 (Double-Blind Comparison)||0
7772741|NCT01357161|19134831|P1|COMPLETED|Part 2 (Double-Blind Comparison)||0
7772742|NCT01357161|19134829|P3|Treated|Part 2 (Double-Blind Comparison)||60
7772743|NCT01357161|19134830|P2|Treated|Part 2 (Double-Blind Comparison)||59
7772744|NCT01357161|19134831|P1|Treated|Part 2 (Double-Blind Comparison)||0
7772745|NCT01357161|19134829|P3|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|62
7772746|NCT01357161|19134830|P2|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|59
7772747|NCT01357161|19134831|P1|STARTED|Part 2 (Double-Blind Comparison)||0
7772748|NCT01357161|19134829|P3|NOT COMPLETED|Part 1 (Open Label Run-in)||0
7772749|NCT01357161|19134830|P2|NOT COMPLETED|Part 1 (Open Label Run-in)||0
7772750|NCT01357161|19134831|P1|NOT COMPLETED|Part 1 (Open Label Run-in)||15
7772751|NCT01357161|19134829|P3|COMPLETED|Part 1 (Open Label Run-in)||0
7772752|NCT01357161|19134830|P2|COMPLETED|Part 1 (Open Label Run-in)||0
7772753|NCT01357161|19134831|P1|COMPLETED|Part 1 (Open Label Run-in)||0
7772754|NCT01357161|19134829|P3|STARTED|Part 1 (Open Label Run-in)||0
7772755|NCT01357161|19134830|P2|STARTED|Part 1 (Open Label Run-in)||0
7772756|NCT01357161|19134831|P1|STARTED|Part 1 (Open Label Run-in)||15
7772757|NCT01357148|19134860|P1|NOT COMPLETED|Overall Study||0
7772758|NCT01357148|19134860|P1|COMPLETED|Overall Study||143
7772759|NCT01357148|19134860|P1|STARTED|Overall Study||143
7772760|NCT01357135|19134870|P3|NOT COMPLETED|Overall Study||263
7772761|NCT01357135|19134871|P2|NOT COMPLETED|Overall Study||223
7772762|NCT01357135|19134872|P1|NOT COMPLETED|Overall Study||598
7772763|NCT01357135|19134870|P3|COMPLETED|Overall Study||583
7772764|NCT01357135|19134871|P2|COMPLETED|Overall Study||510
7772765|NCT01357135|19134872|P1|COMPLETED|Overall Study||1276
7772766|NCT01357135|19134870|P3|STARTED|Overall Study||846
7772767|NCT01357135|19134871|P2|STARTED|Overall Study||733
7772768|NCT01357135|19134872|P1|STARTED|Overall Study||1874
7772769|NCT01356966|19134883|P2|NOT COMPLETED|Overall Study||2
7772770|NCT01356966|19134884|P1|NOT COMPLETED|Overall Study||2
7772771|NCT01356966|19134883|P2|COMPLETED|Overall Study||12
7772772|NCT01356966|19134884|P1|COMPLETED|Overall Study||16
7772773|NCT01356966|19134883|P2|STARTED|Overall Study||14
7772774|NCT01356966|19134884|P1|STARTED|Overall Study||18
7772775|NCT01356940|19134896|P2|NOT COMPLETED|Second Intervention (28 Days)||0
7772776|NCT01356940|19134897|P1|NOT COMPLETED|Second Intervention (28 Days)||1
7772777|NCT01356940|19134896|P2|COMPLETED|Second Intervention (28 Days)||21
7772778|NCT01356940|19134897|P1|COMPLETED|Second Intervention (28 Days)||20
7772779|NCT01356940|19134896|P2|STARTED|Second Intervention (28 Days)||21
7772780|NCT01356940|19134897|P1|STARTED|Second Intervention (28 Days)||21
7772781|NCT01356940|19134896|P2|NOT COMPLETED|Washout (14 Days)||0
7772782|NCT01356940|19134897|P1|NOT COMPLETED|Washout (14 Days)||0
7772783|NCT01356940|19134896|P2|COMPLETED|Washout (14 Days)||21
7772784|NCT01356940|19134897|P1|COMPLETED|Washout (14 Days)||21
7772785|NCT01356940|19134896|P2|STARTED|Washout (14 Days)||21
7772786|NCT01356940|19134897|P1|STARTED|Washout (14 Days)||21
7772787|NCT01356940|19134896|P2|NOT COMPLETED|First Intervention (28 Days)||0
7772788|NCT01356940|19134897|P1|NOT COMPLETED|First Intervention (28 Days)||1
7772789|NCT01356940|19134896|P2|COMPLETED|First Intervention (28 Days)||21
7772790|NCT01356940|19134897|P1|COMPLETED|First Intervention (28 Days)||21
7772791|NCT01356940|19134896|P2|STARTED|First Intervention (28 Days)||21
7772792|NCT01356940|19134897|P1|STARTED|First Intervention (28 Days)||22
7772793|NCT01356667|19134907|P2|NOT COMPLETED|Overall Study||6
7772794|NCT01356667|19134908|P1|NOT COMPLETED|Overall Study||4
7772795|NCT01356667|19134907|P2|COMPLETED|Overall Study||0
7772796|NCT01356667|19134908|P1|COMPLETED|Overall Study||0
7772797|NCT01356667|19134907|P2|STARTED|Overall Study||6
7772798|NCT01356667|19134908|P1|STARTED|Overall Study||4
7772799|NCT01356628|19134918|P1|NOT COMPLETED|Overall Study||0
7772800|NCT01356628|19134918|P1|COMPLETED|Overall Study||23
7772801|NCT01356628|19134918|P1|STARTED|Overall Study||23
7772802|NCT01356602|19134926|P3|NOT COMPLETED|Overall Study||24
7772803|NCT01356602|19134927|P2|NOT COMPLETED|Overall Study||15
7772804|NCT01356602|19134928|P1|NOT COMPLETED|Overall Study||9
7772805|NCT01356602|19134926|P3|COMPLETED|Overall Study||108
7772806|NCT01356602|19134927|P2|COMPLETED|Overall Study||117
7772807|NCT01356602|19134928|P1|COMPLETED|Overall Study||124
7772808|NCT01356602|19134926|P3|Full Analysis Set|Overall Study||129
7772809|NCT01356602|19134927|P2|Full Analysis Set|Overall Study||129
7772810|NCT01356602|19134928|P1|Full Analysis Set|Overall Study||131
7772811|NCT01356602|19134926|P3|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
7772812|NCT01356602|19134927|P2|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
7772813|NCT01356602|19134928|P1|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133
7772814|NCT01356602|19134926|P3|STARTED|Overall Study||132
7772815|NCT01356602|19134927|P2|STARTED|Overall Study||132
7772816|NCT01356602|19134928|P1|STARTED|Overall Study||133
7772817|NCT01356589|19134987|P1|NOT COMPLETED|Overall Study||5
7772818|NCT01356589|19134987|P1|COMPLETED|Overall Study||1283
7772819|NCT01356589|19134987|P1|Treated|Overall Study||1285
7772820|NCT01356589|19134987|P1|STARTED|Overall Study||1288
7772821|NCT01356498|19134999|P6|NOT COMPLETED|Overall Study||14
7772822|NCT01356498|19135000|P5|NOT COMPLETED|Overall Study||20
7772823|NCT01356498|19135001|P4|NOT COMPLETED|Overall Study||14
7772824|NCT01356498|19135002|P3|NOT COMPLETED|Overall Study||12
7772825|NCT01356498|19135003|P2|NOT COMPLETED|Overall Study||8
7772826|NCT01356498|19135004|P1|NOT COMPLETED|Overall Study||11
7772827|NCT01356498|19134999|P6|COMPLETED|Overall Study||2
7772828|NCT01356498|19135000|P5|COMPLETED|Overall Study||8
7772829|NCT01356498|19135001|P4|COMPLETED|Overall Study||8
7772830|NCT01356498|19135002|P3|COMPLETED|Overall Study||11
7772831|NCT01356498|19135003|P2|COMPLETED|Overall Study||17
7772832|NCT01356498|19135004|P1|COMPLETED|Overall Study||24
7772833|NCT01356498|19134999|P6|STARTED|Overall Study||16
7772834|NCT01356498|19135000|P5|STARTED|Overall Study||28
7772835|NCT01356498|19135001|P4|STARTED|Overall Study||22
7772836|NCT01356498|19135002|P3|STARTED|Overall Study||23
7772837|NCT01356498|19135003|P2|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25
7772838|NCT01356498|19135004|P1|STARTED|Overall Study||35
7772839|NCT01356407|19135044|P2|NOT COMPLETED|Overall Study||4
7772840|NCT01356407|19135045|P1|NOT COMPLETED|Overall Study||6
7772841|NCT01356407|19135044|P2|COMPLETED|Overall Study||146
7772842|NCT01356407|19135045|P1|COMPLETED|Overall Study||144
7772843|NCT01356407|19135044|P2|STARTED|Overall Study||150
7772844|NCT01356407|19135045|P1|STARTED|Overall Study||150
7772845|NCT01356277|19135063|P2|NOT COMPLETED|Intervention Interval||7
7772846|NCT01356277|19135064|P1|NOT COMPLETED|Intervention Interval||10
7772847|NCT01356277|19135063|P2|COMPLETED|Intervention Interval||81
7772848|NCT01356277|19135064|P1|COMPLETED|Intervention Interval||66
7772849|NCT01356277|19135063|P2|STARTED|Intervention Interval||88
7772850|NCT01356277|19135064|P1|STARTED|Intervention Interval||76
7772851|NCT01356277|19135063|P2|NOT COMPLETED|Run-in||0
7772852|NCT01356277|19135064|P1|NOT COMPLETED|Run-in||5
7772853|NCT01356277|19135063|P2|COMPLETED|Run-in||88
7772854|NCT01356277|19135064|P1|COMPLETED|Run-in||76
7772855|NCT01356277|19135063|P2|STARTED|Run-in||88
7772856|NCT01356277|19135064|P1|STARTED|Run-in||81
7772857|NCT01356147|19135084|P2|NOT COMPLETED|Overall Study||0
7772858|NCT01356147|19135085|P1|NOT COMPLETED|Overall Study||0
7772859|NCT01356147|19135084|P2|COMPLETED|Overall Study||6
7772860|NCT01356147|19135085|P1|COMPLETED|Overall Study||5
7772861|NCT01356147|19135084|P2|STARTED|Overall Study||6
7772862|NCT01356147|19135085|P1|STARTED|Overall Study||5
7772863|NCT01355978|19135095|P1|NOT COMPLETED|Overall Study||4
7772864|NCT01355978|19135095|P1|COMPLETED|Overall Study||18
7772865|NCT01355978|19135095|P1|STARTED|Overall Study||22
7772866|NCT01355796|19135101|P2|NOT COMPLETED|Overall Study||0
7772867|NCT01355796|19135102|P1|NOT COMPLETED|Overall Study||0
7772868|NCT01355796|19135101|P2|COMPLETED|Overall Study||15
7772869|NCT01355796|19135102|P1|COMPLETED|Overall Study||15
7772870|NCT01355796|19135101|P2|Second Intervention for 14 Days|Overall Study||15
7772871|NCT01355796|19135102|P1|Second Intervention for 14 Days|Overall Study||15
7772872|NCT01355796|19135101|P2|Washout Period for 7 Days|Overall Study||15
7772873|NCT01355796|19135102|P1|Washout Period for 7 Days|Overall Study||15
7772874|NCT01355796|19135101|P2|First Intervention for 14 Days|Overall Study||15
7772875|NCT01355796|19135102|P1|First Intervention for 14 Days|Overall Study||15
7772876|NCT01355796|19135101|P2|STARTED|Overall Study||15
7772877|NCT01355796|19135102|P1|STARTED|Overall Study||15
7772878|NCT01355705|19135110|P1|NOT COMPLETED|Overall Study||0
7772879|NCT01355705|19135110|P1|COMPLETED|Overall Study||14
7772880|NCT01355705|19135110|P1|STARTED|Overall Study||14
7772881|NCT01355679|19135117|P1|NOT COMPLETED|Overall Study||2
7772882|NCT01355679|19135117|P1|COMPLETED|Overall Study||14
7772883|NCT01355679|19135117|P1|STARTED|Overall Study||16
7772884|NCT01355627|19135126|P2|NOT COMPLETED|Overall Study||38
7772885|NCT01355627|19135127|P1|NOT COMPLETED|Overall Study||33
7772886|NCT01355627|19135126|P2|COMPLETED|Overall Study||326
7772887|NCT01355627|19135127|P1|COMPLETED|Overall Study||329
7772888|NCT01355627|19135126|P2|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365
7772889|NCT01355627|19135127|P1|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361
7772890|NCT01355627|19135126|P2|Safety Analysis Set|Overall Study||364
7772891|NCT01355627|19135127|P1|Safety Analysis Set|Overall Study||362
7772892|NCT01355627|19135126|P2|STARTED|Overall Study||364
7772893|NCT01355627|19135127|P1|STARTED|Overall Study||362
7772894|NCT01355588|19135139|P4|NOT COMPLETED|Fourth Intervention (After Washout)||0
7772895|NCT01355588|19135140|P3|NOT COMPLETED|Fourth Intervention (After Washout)||0
7772896|NCT01355588|19135141|P2|NOT COMPLETED|Fourth Intervention (After Washout)||0
7772897|NCT01355588|19135142|P1|NOT COMPLETED|Fourth Intervention (After Washout)||0
7772898|NCT01355588|19135139|P4|COMPLETED|Fourth Intervention (After Washout)||4
7772899|NCT01355588|19135140|P3|COMPLETED|Fourth Intervention (After Washout)||4
7772900|NCT01355588|19135141|P2|COMPLETED|Fourth Intervention (After Washout)||4
7772901|NCT01355588|19135142|P1|COMPLETED|Fourth Intervention (After Washout)||4
7772902|NCT01355588|19135139|P4|STARTED|Fourth Intervention (After Washout)||4
7772903|NCT01355588|19135140|P3|STARTED|Fourth Intervention (After Washout)||4
7772904|NCT01355588|19135141|P2|STARTED|Fourth Intervention (After Washout)||4
7772905|NCT01355588|19135142|P1|STARTED|Fourth Intervention (After Washout)||4
7772906|NCT01355588|19135139|P4|NOT COMPLETED|Washout (3-7 Days)||0
7772907|NCT01355588|19135140|P3|NOT COMPLETED|Washout (3-7 Days)||0
7772908|NCT01355588|19135141|P2|NOT COMPLETED|Washout (3-7 Days)||0
7772909|NCT01355588|19135142|P1|NOT COMPLETED|Washout (3-7 Days)||0
7772910|NCT01355588|19135139|P4|COMPLETED|Washout (3-7 Days)||4
7772911|NCT01355588|19135140|P3|COMPLETED|Washout (3-7 Days)||4
7772912|NCT01355588|19135141|P2|COMPLETED|Washout (3-7 Days)||4
7772913|NCT01355588|19135142|P1|COMPLETED|Washout (3-7 Days)||4
7772914|NCT01355588|19135139|P4|STARTED|Washout (3-7 Days)||4
7772915|NCT01355588|19135140|P3|STARTED|Washout (3-7 Days)||4
7772916|NCT01355588|19135141|P2|STARTED|Washout (3-7 Days)||4
7772917|NCT01355588|19135142|P1|STARTED|Washout (3-7 Days)||4
7772918|NCT01355588|19135139|P4|NOT COMPLETED|Third Intervention (After Washout)||0
7772919|NCT01355588|19135140|P3|NOT COMPLETED|Third Intervention (After Washout)||0
7772920|NCT01355588|19135141|P2|NOT COMPLETED|Third Intervention (After Washout)||0
7772921|NCT01355588|19135142|P1|NOT COMPLETED|Third Intervention (After Washout)||0
7772922|NCT01355588|19135139|P4|COMPLETED|Third Intervention (After Washout)||4
7772923|NCT01355588|19135140|P3|COMPLETED|Third Intervention (After Washout)||4
7772924|NCT01355588|19135141|P2|COMPLETED|Third Intervention (After Washout)||4
7772925|NCT01355588|19135142|P1|COMPLETED|Third Intervention (After Washout)||4
7772926|NCT01355588|19135139|P4|STARTED|Third Intervention (After Washout)||4
7772927|NCT01355588|19135140|P3|STARTED|Third Intervention (After Washout)||4
7772928|NCT01355588|19135141|P2|STARTED|Third Intervention (After Washout)||4
7772929|NCT01355588|19135142|P1|STARTED|Third Intervention (After Washout)||4
7772930|NCT01355588|19135139|P4|NOT COMPLETED|Washout (3-7 Days)||0
7772931|NCT01355588|19135140|P3|NOT COMPLETED|Washout (3-7 Days)||0
7772932|NCT01355588|19135141|P2|NOT COMPLETED|Washout (3-7 Days)||0
7772933|NCT01355588|19135142|P1|NOT COMPLETED|Washout (3-7 Days)||0
7772934|NCT01355588|19135139|P4|COMPLETED|Washout (3-7 Days)||4
7772935|NCT01355588|19135140|P3|COMPLETED|Washout (3-7 Days)||4
7772936|NCT01355588|19135141|P2|COMPLETED|Washout (3-7 Days)||4
7772937|NCT01355588|19135142|P1|COMPLETED|Washout (3-7 Days)||4
7772938|NCT01355588|19135139|P4|STARTED|Washout (3-7 Days)||4
7772939|NCT01355588|19135140|P3|STARTED|Washout (3-7 Days)||4
7772940|NCT01355588|19135141|P2|STARTED|Washout (3-7 Days)||4
7772941|NCT01355588|19135142|P1|STARTED|Washout (3-7 Days)||4
7772942|NCT01355588|19135139|P4|NOT COMPLETED|Second Intervention (After Washout)||0
7772943|NCT01355588|19135140|P3|NOT COMPLETED|Second Intervention (After Washout)||0
7772944|NCT01355588|19135141|P2|NOT COMPLETED|Second Intervention (After Washout)||0
7772945|NCT01355588|19135142|P1|NOT COMPLETED|Second Intervention (After Washout)||0
7772946|NCT01355588|19135139|P4|COMPLETED|Second Intervention (After Washout)||4
7772947|NCT01355588|19135140|P3|COMPLETED|Second Intervention (After Washout)||4
7772948|NCT01355588|19135141|P2|COMPLETED|Second Intervention (After Washout)||4
7772949|NCT01355588|19135142|P1|COMPLETED|Second Intervention (After Washout)||4
7772950|NCT01355588|19135139|P4|STARTED|Second Intervention (After Washout)||4
7772951|NCT01355588|19135140|P3|STARTED|Second Intervention (After Washout)||4
7772952|NCT01355588|19135141|P2|STARTED|Second Intervention (After Washout)||4
7772953|NCT01355588|19135142|P1|STARTED|Second Intervention (After Washout)||4
7772954|NCT01355588|19135139|P4|NOT COMPLETED|Washout (3-7 Days)||0
7772955|NCT01355588|19135140|P3|NOT COMPLETED|Washout (3-7 Days)||0
7772956|NCT01355588|19135141|P2|NOT COMPLETED|Washout (3-7 Days)||0
7772957|NCT01355588|19135142|P1|NOT COMPLETED|Washout (3-7 Days)||0
7772958|NCT01355588|19135139|P4|COMPLETED|Washout (3-7 Days)||4
7772959|NCT01355588|19135140|P3|COMPLETED|Washout (3-7 Days)||4
7772960|NCT01355588|19135141|P2|COMPLETED|Washout (3-7 Days)||4
7772961|NCT01355588|19135142|P1|COMPLETED|Washout (3-7 Days)||4
7772962|NCT01355588|19135139|P4|STARTED|Washout (3-7 Days)||4
7772963|NCT01355588|19135140|P3|STARTED|Washout (3-7 Days)||4
7772964|NCT01355588|19135141|P2|STARTED|Washout (3-7 Days)||4
7772965|NCT01355588|19135142|P1|STARTED|Washout (3-7 Days)||4
7772966|NCT01355588|19135139|P4|NOT COMPLETED|First Intervention (Day 1)||0
7772967|NCT01355588|19135140|P3|NOT COMPLETED|First Intervention (Day 1)||0
7772968|NCT01355588|19135141|P2|NOT COMPLETED|First Intervention (Day 1)||0
7772969|NCT01355588|19135142|P1|NOT COMPLETED|First Intervention (Day 1)||0
7772970|NCT01355588|19135139|P4|COMPLETED|First Intervention (Day 1)||4
7772971|NCT01355588|19135140|P3|COMPLETED|First Intervention (Day 1)||4
7772972|NCT01355588|19135141|P2|COMPLETED|First Intervention (Day 1)||4
7772973|NCT01355588|19135142|P1|COMPLETED|First Intervention (Day 1)||4
7772974|NCT01355588|19135139|P4|STARTED|First Intervention (Day 1)||4
7772975|NCT01355588|19135140|P3|STARTED|First Intervention (Day 1)||4
7772976|NCT01355588|19135141|P2|STARTED|First Intervention (Day 1)||4
7772977|NCT01355588|19135142|P1|STARTED|First Intervention (Day 1)||4
7772978|NCT01355575|19135164|P1|NOT COMPLETED|Overall Study||2
7772979|NCT01355575|19135164|P1|COMPLETED|Overall Study||13
7772980|NCT01355575|19135164|P1|STARTED|Overall Study||15
7772981|NCT01355523|19135176|P2|NOT COMPLETED|Overall Study||10
7772982|NCT01355523|19135177|P1|NOT COMPLETED|Overall Study||1
7772983|NCT01355523|19135176|P2|COMPLETED|Overall Study||16
7772984|NCT01355523|19135177|P1|COMPLETED|Overall Study||27
7772985|NCT01355523|19135176|P2|STARTED|Overall Study||26
7772986|NCT01355523|19135177|P1|STARTED|Overall Study||28
7772987|NCT01355497|19135221|P2|NOT COMPLETED|Overall Study||63
7772988|NCT01355497|19135222|P1|NOT COMPLETED|Overall Study||66
7772989|NCT01355497|19135221|P2|COMPLETED|Overall Study||102
7772990|NCT01355497|19135222|P1|COMPLETED|Overall Study||99
7772991|NCT01355497|19135221|P2|STARTED|Overall Study||165
7772992|NCT01355497|19135222|P1|STARTED|Overall Study||165
7772993|NCT01355484|19135232|P2|NOT COMPLETED|Overall Study||54
7772994|NCT01355484|19135233|P1|NOT COMPLETED|Overall Study||51
7772995|NCT01355484|19135232|P2|COMPLETED|Overall Study||107
7772996|NCT01355484|19135233|P1|COMPLETED|Overall Study||109
7772997|NCT01355484|19135232|P2|STARTED|Overall Study||161
7772998|NCT01355484|19135233|P1|STARTED|Overall Study||160
7772999|NCT01355471|19135243|P2|NOT COMPLETED|Overall Study||3
7773000|NCT01355471|19135244|P1|NOT COMPLETED|Overall Study||7
7773001|NCT01355471|19135243|P2|COMPLETED|Overall Study||142
7773002|NCT01355471|19135244|P1|COMPLETED|Overall Study||141
7773003|NCT01355471|19135243|P2|STARTED|Overall Study||145
7773004|NCT01355471|19135244|P1|STARTED|Overall Study||148
7773005|NCT01355458|19135252|P2|NOT COMPLETED|Overall Study||4
7773006|NCT01355458|19135253|P1|NOT COMPLETED|Overall Study||2
7773007|NCT01355458|19135252|P2|COMPLETED|Overall Study||127
7773008|NCT01355458|19135253|P1|COMPLETED|Overall Study||127
7773009|NCT01355458|19135252|P2|STARTED|Overall Study||131
7773010|NCT01355458|19135253|P1|STARTED|Overall Study||129
7773011|NCT01355419|19135259|P1|NOT COMPLETED|Overall Study||8
7773012|NCT01355419|19135259|P1|COMPLETED|Overall Study||142
7773013|NCT01355419|19135259|P1|STARTED|Overall Study||150
7773014|NCT01355302|19135264|P3|NOT COMPLETED|Phase 2||0
7773015|NCT01355302|19135265|P2|NOT COMPLETED|Phase 2||0
7773016|NCT01355302|19135266|P1|NOT COMPLETED|Phase 2||0
7773017|NCT01355302|19135264|P3|COMPLETED|Phase 2||0
7773018|NCT01355302|19135265|P2|COMPLETED|Phase 2||0
7773019|NCT01355302|19135266|P1|COMPLETED|Phase 2||0
7773020|NCT01355302|19135264|P3|STARTED|Phase 2|The study was terminated prior to enrollment|0
7773021|NCT01355302|19135265|P2|STARTED|Phase 2|The study was terminated prior to enrollment|0
7773022|NCT01355302|19135266|P1|STARTED|Phase 2|Treatment arm not designated for phase 2.|0
7773023|NCT01355302|19135264|P3|NOT COMPLETED|Phase 1b||0
7773024|NCT01355302|19135265|P2|NOT COMPLETED|Phase 1b||0
7773025|NCT01355302|19135266|P1|NOT COMPLETED|Phase 1b||6
7773026|NCT01355302|19135264|P3|COMPLETED|Phase 1b||0
7773027|NCT01355302|19135265|P2|COMPLETED|Phase 1b||0
7773028|NCT01355302|19135266|P1|COMPLETED|Phase 1b|The subject who completed 6 cycles was withdrawn by sponsor request.|1
7773029|NCT01355302|19135264|P3|STARTED|Phase 1b||0
7773030|NCT01355302|19135265|P2|STARTED|Phase 1b||0
7773031|NCT01355302|19135266|P1|STARTED|Phase 1b|Replaced 1 subject; who discontinued study drug in first cycle|7
7773032|NCT01355289|19135281|P5|NOT COMPLETED|Open Label Extension||34
7773033|NCT01355289|19135282|P4|NOT COMPLETED|Open Label Extension||0
7773034|NCT01355289|19135283|P3|NOT COMPLETED|Open Label Extension||0
7773035|NCT01355289|19135284|P2|NOT COMPLETED|Open Label Extension||0
7773036|NCT01355289|19135285|P1|NOT COMPLETED|Open Label Extension||0
7773037|NCT01355289|19135281|P5|COMPLETED|Open Label Extension||28
7773038|NCT01355289|19135282|P4|COMPLETED|Open Label Extension||0
7773039|NCT01355289|19135283|P3|COMPLETED|Open Label Extension||0
7773040|NCT01355289|19135284|P2|COMPLETED|Open Label Extension||0
7773041|NCT01355289|19135285|P1|COMPLETED|Open Label Extension||0
7773042|NCT01355289|19135281|P5|STARTED|Open Label Extension||62
7773043|NCT01355289|19135282|P4|STARTED|Open Label Extension||0
7773044|NCT01355289|19135283|P3|STARTED|Open Label Extension||0
7773045|NCT01355289|19135284|P2|STARTED|Open Label Extension||0
7773046|NCT01355289|19135285|P1|STARTED|Open Label Extension||0
7773047|NCT01355289|19135281|P5|NOT COMPLETED|Core Study||0
7773048|NCT01355289|19135282|P4|NOT COMPLETED|Core Study||2
7773049|NCT01355289|19135283|P3|NOT COMPLETED|Core Study||0
7773050|NCT01355289|19135284|P2|NOT COMPLETED|Core Study||0
7773051|NCT01355289|19135285|P1|NOT COMPLETED|Core Study||1
7773052|NCT01355289|19135281|P5|COMPLETED|Core Study||0
7773053|NCT01355289|19135282|P4|COMPLETED|Core Study||12
7773054|NCT01355289|19135283|P3|COMPLETED|Core Study||18
7773055|NCT01355289|19135284|P2|COMPLETED|Core Study||16
7773056|NCT01355289|19135285|P1|COMPLETED|Core Study||16
7773057|NCT01355289|19135281|P5|STARTED|Core Study||0
7773058|NCT01355289|19135282|P4|STARTED|Core Study||14
7773059|NCT01355289|19135283|P3|STARTED|Core Study||18
7773060|NCT01355289|19135284|P2|STARTED|Core Study||16
7773061|NCT01355289|19135285|P1|STARTED|Core Study||17
7773062|NCT01355224|19135312|P4|NOT COMPLETED|Overall Study||29
7773063|NCT01355224|19135313|P3|NOT COMPLETED|Overall Study||19
7773064|NCT01355224|19135314|P2|NOT COMPLETED|Overall Study||23
7773065|NCT01355224|19135315|P1|NOT COMPLETED|Overall Study||31
7773066|NCT01355224|19135312|P4|COMPLETED|Overall Study||172
7773067|NCT01355224|19135313|P3|COMPLETED|Overall Study||177
7773068|NCT01355224|19135314|P2|COMPLETED|Overall Study||180
7773069|NCT01355224|19135315|P1|COMPLETED|Overall Study||167
7773070|NCT01355224|19135312|P4|Competed Baseline|Overall Study||193
7773071|NCT01355224|19135313|P3|Competed Baseline|Overall Study||193
7773072|NCT01355224|19135314|P2|Competed Baseline|Overall Study||200
7773073|NCT01355224|19135315|P1|Competed Baseline|Overall Study||191
7773074|NCT01355224|19135312|P4|STARTED|Overall Study||201
7773075|NCT01355224|19135313|P3|STARTED|Overall Study||196
7773076|NCT01355224|19135314|P2|STARTED|Overall Study||203
7773077|NCT01355224|19135315|P1|STARTED|Overall Study||198
7773078|NCT01355159|19135337|P2|NOT COMPLETED|Overall Study||79
7773079|NCT01355159|19135338|P1|NOT COMPLETED|Overall Study||84
7773080|NCT01355159|19135337|P2|COMPLETED|Overall Study||1157
7773081|NCT01355159|19135338|P1|COMPLETED|Overall Study||1144
7773082|NCT01355159|19135337|P2|STARTED|Overall Study||1236
7773083|NCT01355159|19135338|P1|STARTED|Overall Study||1228
7773084|NCT01355081|19135395|P3|NOT COMPLETED|Overall Study||11
7773085|NCT01355081|19135396|P2|NOT COMPLETED|Overall Study||10
7773086|NCT01355081|19135397|P1|NOT COMPLETED|Overall Study||7
7773087|NCT01355081|19135395|P3|COMPLETED|Overall Study||113
7773088|NCT01355081|19135396|P2|COMPLETED|Overall Study||113
7773089|NCT01355081|19135397|P1|COMPLETED|Overall Study||112
7773090|NCT01355081|19135395|P3|STARTED|Overall Study||124
7773091|NCT01355081|19135396|P2|STARTED|Overall Study||123
7773092|NCT01355081|19135397|P1|STARTED|Overall Study||119
7773093|NCT01355068|19135420|P2|NOT COMPLETED|Second Intervention Period||0
7773094|NCT01355068|19135421|P1|NOT COMPLETED|Second Intervention Period||0
7773095|NCT01355068|19135420|P2|COMPLETED|Second Intervention Period||11
7773096|NCT01355068|19135421|P1|COMPLETED|Second Intervention Period||13
7773097|NCT01355068|19135420|P2|STARTED|Second Intervention Period||11
7773098|NCT01355068|19135421|P1|STARTED|Second Intervention Period||13
7773099|NCT01355068|19135420|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7773100|NCT01355068|19135421|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7773101|NCT01355068|19135420|P2|COMPLETED|Washout Period (at Least 7 Days)||11
7773102|NCT01355068|19135421|P1|COMPLETED|Washout Period (at Least 7 Days)||13
7773103|NCT01355068|19135420|P2|STARTED|Washout Period (at Least 7 Days)||11
7773104|NCT01355068|19135421|P1|STARTED|Washout Period (at Least 7 Days)||13
7773105|NCT01355068|19135420|P2|NOT COMPLETED|First Intervention Period||2
7773106|NCT01355068|19135421|P1|NOT COMPLETED|First Intervention Period||0
7773107|NCT01355068|19135420|P2|COMPLETED|First Intervention Period||11
7773108|NCT01355068|19135421|P1|COMPLETED|First Intervention Period||13
7773109|NCT01355068|19135420|P2|STARTED|First Intervention Period||13
7773110|NCT01355068|19135421|P1|STARTED|First Intervention Period||13
7773111|NCT01354990|19135437|P1|NOT COMPLETED|Overall Study||0
7773112|NCT01354990|19135437|P1|COMPLETED|Overall Study||2974
7773113|NCT01354990|19135437|P1|STARTED|Overall Study||2974
7773114|NCT01354964|19135446|P2|NOT COMPLETED|Overall Study||1
7773115|NCT01354964|19135447|P1|NOT COMPLETED|Overall Study||4
7773116|NCT01354964|19135446|P2|COMPLETED|Overall Study||7
7773117|NCT01354964|19135447|P1|COMPLETED|Overall Study||7
7773118|NCT01354964|19135446|P2|STARTED|Overall Study||8
7773119|NCT01354964|19135447|P1|STARTED|Overall Study||11
7773120|NCT01354951|19135463|P1|NOT COMPLETED|Overall Study||2
7773121|NCT01354951|19135463|P1|COMPLETED|Overall Study||1
7773122|NCT01354951|19135463|P1|STARTED|Overall Study||3
7773123|NCT01354938|19135470|P1|NOT COMPLETED|Overall Study||1
7773124|NCT01354938|19135470|P1|COMPLETED|Overall Study||219
7773125|NCT01354938|19135470|P1|STARTED|Overall Study||220
7773126|NCT01354899|19135476|P1|NOT COMPLETED|Overall Study||3
7773127|NCT01354899|19135476|P1|COMPLETED|Overall Study||21
7773128|NCT01354899|19135476|P1|STARTED|Overall Study||24
7773129|NCT01354691|19135483|P2|NOT COMPLETED|Overall Study||22
7773130|NCT01354691|19135484|P1|NOT COMPLETED|Overall Study||21
7773131|NCT01354691|19135483|P2|COMPLETED|Overall Study||77
7773132|NCT01354691|19135484|P1|COMPLETED|Overall Study||80
7773133|NCT01354691|19135483|P2|PP|Overall Study||75
7773134|NCT01354691|19135484|P1|PP|Overall Study||79
7773135|NCT01354691|19135483|P2|ITT|Overall Study||96
7773136|NCT01354691|19135484|P1|ITT|Overall Study||99
7773137|NCT01354691|19135483|P2|STARTED|Overall Study||99
7773138|NCT01354691|19135484|P1|STARTED|Overall Study||101
7773139|NCT01354652|19135501|P3|NOT COMPLETED|Overall Study||0
7773140|NCT01354652|19135502|P2|NOT COMPLETED|Overall Study||2
7773141|NCT01354652|19135503|P1|NOT COMPLETED|Overall Study||3
7773142|NCT01354652|19135501|P3|COMPLETED|Overall Study||0
7773143|NCT01354652|19135502|P2|COMPLETED|Overall Study||0
7773144|NCT01354652|19135503|P1|COMPLETED|Overall Study||0
7773145|NCT01354652|19135501|P3|STARTED|Overall Study||0
7773146|NCT01354652|19135502|P2|STARTED|Overall Study||2
7773147|NCT01354652|19135503|P1|STARTED|Overall Study||3
7773148|NCT01354496|19135528|P6|NOT COMPLETED|Period 3||0
7773149|NCT01354496|19135529|P5|NOT COMPLETED|Period 3||0
7773150|NCT01354496|19135530|P4|NOT COMPLETED|Period 3||0
7773151|NCT01354496|19135531|P3|NOT COMPLETED|Period 3||0
7773152|NCT01354496|19135532|P2|NOT COMPLETED|Period 3||0
7773153|NCT01354496|19135533|P1|NOT COMPLETED|Period 3||0
7773154|NCT01354496|19135528|P6|COMPLETED|Period 3||6
7773155|NCT01354496|19135529|P5|COMPLETED|Period 3||5
7773156|NCT01354496|19135530|P4|COMPLETED|Period 3||4
7773157|NCT01354496|19135531|P3|COMPLETED|Period 3||4
7773158|NCT01354496|19135532|P2|COMPLETED|Period 3||5
7773159|NCT01354496|19135533|P1|COMPLETED|Period 3||6
7773160|NCT01354496|19135528|P6|STARTED|Period 3||6
7773161|NCT01354496|19135529|P5|STARTED|Period 3||5
7773162|NCT01354496|19135530|P4|STARTED|Period 3||4
7773163|NCT01354496|19135531|P3|STARTED|Period 3||4
7773164|NCT01354496|19135532|P2|STARTED|Period 3||5
7773165|NCT01354496|19135533|P1|STARTED|Period 3||6
7773166|NCT01354496|19135528|P6|NOT COMPLETED|Washout (at Least 14 Days)||0
7773167|NCT01354496|19135529|P5|NOT COMPLETED|Washout (at Least 14 Days)||0
7773168|NCT01354496|19135530|P4|NOT COMPLETED|Washout (at Least 14 Days)||1
7773169|NCT01354496|19135531|P3|NOT COMPLETED|Washout (at Least 14 Days)||0
7773170|NCT01354496|19135532|P2|NOT COMPLETED|Washout (at Least 14 Days)||1
7773171|NCT01354496|19135533|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
7773172|NCT01354496|19135528|P6|COMPLETED|Washout (at Least 14 Days)||6
7773173|NCT01354496|19135529|P5|COMPLETED|Washout (at Least 14 Days)||5
7773174|NCT01354496|19135530|P4|COMPLETED|Washout (at Least 14 Days)||4
7773175|NCT01354496|19135531|P3|COMPLETED|Washout (at Least 14 Days)||4
7773176|NCT01354496|19135532|P2|COMPLETED|Washout (at Least 14 Days)||5
7773177|NCT01354496|19135533|P1|COMPLETED|Washout (at Least 14 Days)||6
7773178|NCT01354496|19135528|P6|STARTED|Washout (at Least 14 Days)||6
7773179|NCT01354496|19135529|P5|STARTED|Washout (at Least 14 Days)||5
7773180|NCT01354496|19135530|P4|STARTED|Washout (at Least 14 Days)||5
7773181|NCT01354496|19135531|P3|STARTED|Washout (at Least 14 Days)||4
7773182|NCT01354496|19135532|P2|STARTED|Washout (at Least 14 Days)||6
7773183|NCT01354496|19135533|P1|STARTED|Washout (at Least 14 Days)||6
7773184|NCT01354496|19135528|P6|NOT COMPLETED|Period 2||0
7773185|NCT01354496|19135529|P5|NOT COMPLETED|Period 2||0
7773186|NCT01354496|19135530|P4|NOT COMPLETED|Period 2||1
7773187|NCT01354496|19135531|P3|NOT COMPLETED|Period 2||0
7773188|NCT01354496|19135532|P2|NOT COMPLETED|Period 2||0
7773189|NCT01354496|19135533|P1|NOT COMPLETED|Period 2||0
7773190|NCT01354496|19135528|P6|COMPLETED|Period 2||6
7773191|NCT01354496|19135529|P5|COMPLETED|Period 2||5
7773192|NCT01354496|19135530|P4|COMPLETED|Period 2||5
7773193|NCT01354496|19135531|P3|COMPLETED|Period 2||4
7773194|NCT01354496|19135532|P2|COMPLETED|Period 2||6
7773195|NCT01354496|19135533|P1|COMPLETED|Period 2||6
7773196|NCT01354496|19135528|P6|STARTED|Period 2||6
7773197|NCT01354496|19135529|P5|STARTED|Period 2||5
7773198|NCT01354496|19135530|P4|STARTED|Period 2||6
7773199|NCT01354496|19135531|P3|STARTED|Period 2||4
7773200|NCT01354496|19135532|P2|STARTED|Period 2||6
7773201|NCT01354496|19135533|P1|STARTED|Period 2||6
7773202|NCT01354496|19135528|P6|NOT COMPLETED|Washout (at Least 14 Days)||0
7773203|NCT01354496|19135529|P5|NOT COMPLETED|Washout (at Least 14 Days)||0
7773204|NCT01354496|19135530|P4|NOT COMPLETED|Washout (at Least 14 Days)||0
7773205|NCT01354496|19135531|P3|NOT COMPLETED|Washout (at Least 14 Days)||0
7773206|NCT01354496|19135532|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
7773207|NCT01354496|19135533|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
7773208|NCT01354496|19135528|P6|COMPLETED|Washout (at Least 14 Days)||6
7773209|NCT01354496|19135529|P5|COMPLETED|Washout (at Least 14 Days)||5
7773210|NCT01354496|19135530|P4|COMPLETED|Washout (at Least 14 Days)||6
7773211|NCT01354496|19135531|P3|COMPLETED|Washout (at Least 14 Days)||4
7773212|NCT01354496|19135532|P2|COMPLETED|Washout (at Least 14 Days)||6
7773213|NCT01354496|19135533|P1|COMPLETED|Washout (at Least 14 Days)||6
7773214|NCT01354496|19135528|P6|STARTED|Washout (at Least 14 Days)||6
7773215|NCT01354496|19135529|P5|STARTED|Washout (at Least 14 Days)||5
7773216|NCT01354496|19135530|P4|STARTED|Washout (at Least 14 Days)||6
7773217|NCT01354496|19135531|P3|STARTED|Washout (at Least 14 Days)||4
7773218|NCT01354496|19135532|P2|STARTED|Washout (at Least 14 Days)||6
7773219|NCT01354496|19135533|P1|STARTED|Washout (at Least 14 Days)||6
7773220|NCT01354496|19135528|P6|NOT COMPLETED|Period 1||0
7773221|NCT01354496|19135529|P5|NOT COMPLETED|Period 1||0
7773222|NCT01354496|19135530|P4|NOT COMPLETED|Period 1||0
7773223|NCT01354496|19135531|P3|NOT COMPLETED|Period 1||2
7773224|NCT01354496|19135532|P2|NOT COMPLETED|Period 1||0
7773225|NCT01354496|19135533|P1|NOT COMPLETED|Period 1||0
7773226|NCT01354496|19135528|P6|COMPLETED|Period 1||6
7773227|NCT01354496|19135529|P5|COMPLETED|Period 1||5
7773228|NCT01354496|19135530|P4|COMPLETED|Period 1||6
7773229|NCT01354496|19135531|P3|COMPLETED|Period 1||4
7773230|NCT01354496|19135532|P2|COMPLETED|Period 1||6
7773231|NCT01354496|19135533|P1|COMPLETED|Period 1||6
7773232|NCT01354496|19135528|P6|Received at Least 1 Dose of Study Drug|Period 1||6
7773233|NCT01354496|19135529|P5|Received at Least 1 Dose of Study Drug|Period 1||5
7773234|NCT01354496|19135530|P4|Received at Least 1 Dose of Study Drug|Period 1||6
7773235|NCT01354496|19135531|P3|Received at Least 1 Dose of Study Drug|Period 1||6
7773236|NCT01354496|19135532|P2|Received at Least 1 Dose of Study Drug|Period 1||6
7773237|NCT01354496|19135533|P1|Received at Least 1 Dose of Study Drug|Period 1||6
7773238|NCT01354496|19135528|P6|STARTED|Period 1||6
7773239|NCT01354496|19135529|P5|STARTED|Period 1||5
7773240|NCT01354496|19135530|P4|STARTED|Period 1||6
7773241|NCT01354496|19135531|P3|STARTED|Period 1||6
7773242|NCT01354496|19135532|P2|STARTED|Period 1||6
7773243|NCT01354496|19135533|P1|STARTED|Period 1||6
7773244|NCT01354444|19135562|P2|NOT COMPLETED|Overall Study||4
7773245|NCT01354444|19135563|P1|NOT COMPLETED|Overall Study||8
7773246|NCT01354444|19135562|P2|COMPLETED|Overall Study||11
7773247|NCT01354444|19135563|P1|COMPLETED|Overall Study||6
7773248|NCT01354444|19135562|P2|STARTED|Overall Study||15
7773249|NCT01354444|19135563|P1|STARTED|Overall Study||14
7773250|NCT01354431|19135576|P3|NOT COMPLETED|Participants Treated||54
7773251|NCT01354431|19135577|P2|NOT COMPLETED|Participants Treated||54
7773252|NCT01354431|19135578|P1|NOT COMPLETED|Participants Treated||59
7773253|NCT01354431|19135576|P3|COMPLETED|Participants Treated||0
7773254|NCT01354431|19135577|P2|COMPLETED|Participants Treated||0
7773255|NCT01354431|19135578|P1|COMPLETED|Participants Treated||0
7773256|NCT01354431|19135576|P3|STARTED|Participants Treated||54
7773257|NCT01354431|19135577|P2|STARTED|Participants Treated||54
7773258|NCT01354431|19135578|P1|STARTED|Participants Treated||59
7773259|NCT01354431|19135576|P3|NOT COMPLETED|Randomized to Enter Treatment Period||0
7773260|NCT01354431|19135577|P2|NOT COMPLETED|Randomized to Enter Treatment Period||0
7773261|NCT01354431|19135578|P1|NOT COMPLETED|Randomized to Enter Treatment Period||1
7773262|NCT01354431|19135576|P3|COMPLETED|Randomized to Enter Treatment Period||54
7773263|NCT01354431|19135577|P2|COMPLETED|Randomized to Enter Treatment Period||54
7773264|NCT01354431|19135578|P1|COMPLETED|Randomized to Enter Treatment Period||59
7773265|NCT01354431|19135576|P3|STARTED|Randomized to Enter Treatment Period||54
7773266|NCT01354431|19135577|P2|STARTED|Randomized to Enter Treatment Period||54
7773267|NCT01354431|19135578|P1|STARTED|Randomized to Enter Treatment Period||60
7773268|NCT01354314|19135602|P4|NOT COMPLETED|Overall Study||6
7773269|NCT01354314|19135603|P3|NOT COMPLETED|Overall Study||8
7773270|NCT01354314|19135604|P2|NOT COMPLETED|Overall Study||3
7773271|NCT01354314|19135605|P1|NOT COMPLETED|Overall Study||6
7773272|NCT01354314|19135602|P4|COMPLETED|Overall Study||5
7773273|NCT01354314|19135603|P3|COMPLETED|Overall Study||3
7773274|NCT01354314|19135604|P2|COMPLETED|Overall Study||8
7773275|NCT01354314|19135605|P1|COMPLETED|Overall Study||6
7773276|NCT01354314|19135602|P4|Completed (ITT)|Overall Study||10
7773277|NCT01354314|19135603|P3|Completed (ITT)|Overall Study||9
7773278|NCT01354314|19135604|P2|Completed (ITT)|Overall Study||11
7773279|NCT01354314|19135605|P1|Completed (ITT)|Overall Study||11
7773280|NCT01354314|19135602|P4|STARTED|Overall Study||11
7773281|NCT01354314|19135603|P3|STARTED|Overall Study||11
7773282|NCT01354314|19135604|P2|STARTED|Overall Study||11
7773283|NCT01354314|19135605|P1|STARTED|Overall Study||12
7773284|NCT01354223|19135741|P2|NOT COMPLETED|Overall Study||1
7773285|NCT01354223|19135742|P1|NOT COMPLETED|Overall Study||3
7773286|NCT01354223|19135741|P2|COMPLETED|Overall Study||29
7773287|NCT01354223|19135742|P1|COMPLETED|Overall Study||57
7773288|NCT01354223|19135741|P2|STARTED|Overall Study||30
7773289|NCT01354223|19135742|P1|STARTED|Overall Study||60
7773290|NCT01354197|19135758|P1|NOT COMPLETED|Overall Study||0
7773291|NCT01354197|19135758|P1|COMPLETED|Overall Study||4652
7773292|NCT01354197|19135758|P1|STARTED|Overall Study||4652
7773293|NCT01354145|19135766|P2|NOT COMPLETED|Overall Study||34
7773294|NCT01354145|19135767|P1|NOT COMPLETED|Overall Study||39
7773295|NCT01354145|19135766|P2|COMPLETED|Overall Study||63
7773296|NCT01354145|19135767|P1|COMPLETED|Overall Study||58
7773297|NCT01354145|19135766|P2|STARTED|Overall Study||97
7773298|NCT01354145|19135767|P1|STARTED|Overall Study||97
7773299|NCT01354132|19135801|P2|NOT COMPLETED|1 Month Post Study Medication||3
7773300|NCT01354132|19135802|P1|NOT COMPLETED|1 Month Post Study Medication||1
7773301|NCT01354132|19135801|P2|COMPLETED|1 Month Post Study Medication||16
7773302|NCT01354132|19135802|P1|COMPLETED|1 Month Post Study Medication||21
7773303|NCT01354132|19135801|P2|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16
7773304|NCT01354132|19135802|P1|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21
7773305|NCT01354132|19135801|P2|STARTED|1 Month Post Study Medication||19
7773306|NCT01354132|19135802|P1|STARTED|1 Month Post Study Medication||22
7773307|NCT01354132|19135801|P2|NOT COMPLETED|Double Blind (Visits 1-7)||11
7773308|NCT01354132|19135802|P1|NOT COMPLETED|Double Blind (Visits 1-7)||9
7773309|NCT01354132|19135801|P2|COMPLETED|Double Blind (Visits 1-7)||19
7773310|NCT01354132|19135802|P1|COMPLETED|Double Blind (Visits 1-7)||22
7773311|NCT01354132|19135801|P2|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4
7773312|NCT01354132|19135802|P1|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2
7773313|NCT01354132|19135801|P2|Stopped After First Visit|Double Blind (Visits 1-7)||2
7773314|NCT01354132|19135802|P1|Stopped After First Visit|Double Blind (Visits 1-7)||3
7773315|NCT01354132|19135801|P2|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5
7773316|NCT01354132|19135802|P1|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4
7773317|NCT01354132|19135801|P2|STARTED|Double Blind (Visits 1-7)|11 did not compete 7 study visits|30
7773318|NCT01354132|19135802|P1|STARTED|Double Blind (Visits 1-7)|9 did not compete 7 study visits|31
7773319|NCT01354132|19135801|P2|NOT COMPLETED|Randomization||1
7773320|NCT01354132|19135802|P1|NOT COMPLETED|Randomization||1
7773321|NCT01354132|19135801|P2|COMPLETED|Randomization||30
7773322|NCT01354132|19135802|P1|COMPLETED|Randomization||31
7773323|NCT01354132|19135801|P2|STARTED|Randomization|1 never took study medication due to subject withdrawal|31
7773324|NCT01354132|19135802|P1|STARTED|Randomization|1 never took study medication dropped by physician decision (White matter lesion on MRI)|32
7773325|NCT01354106|19135840|P1|NOT COMPLETED|Overall Study||2
7773326|NCT01354106|19135840|P1|COMPLETED|Overall Study||24
7773327|NCT01354106|19135840|P1|STARTED|Overall Study||26
7773328|NCT01354028|19135846|P2|NOT COMPLETED|Overall Study||5
7773329|NCT01354028|19135847|P1|NOT COMPLETED|Overall Study||2
7773330|NCT01354028|19135846|P2|COMPLETED|Overall Study||10
7773331|NCT01354028|19135847|P1|COMPLETED|Overall Study||13
7773332|NCT01354028|19135846|P2|STARTED|Overall Study||15
7773333|NCT01354028|19135847|P1|STARTED|Overall Study||15
7773334|NCT01354015|19135861|P2|NOT COMPLETED|Overall Study||5
7773335|NCT01354015|19135862|P1|NOT COMPLETED|Overall Study||6
7773336|NCT01354015|19135861|P2|COMPLETED|Overall Study||43
7773337|NCT01354015|19135862|P1|COMPLETED|Overall Study||44
7773338|NCT01354015|19135861|P2|STARTED|Overall Study||48
7773339|NCT01354015|19135862|P1|STARTED|Overall Study||50
7773340|NCT01353976|19135872|P2|NOT COMPLETED|Overall Study||51
7773341|NCT01353976|19135873|P1|NOT COMPLETED|Overall Study||48
7773342|NCT01353976|19135872|P2|COMPLETED|Overall Study||83
7773343|NCT01353976|19135873|P1|COMPLETED|Overall Study||82
7773344|NCT01353976|19135872|P2|STARTED|Overall Study||134
7773345|NCT01353976|19135873|P1|STARTED|Overall Study||130
7773346|NCT01353963|19135883|P1|NOT COMPLETED|Overall Study||2
7773347|NCT01353963|19135883|P1|COMPLETED|Overall Study||11
7773348|NCT01353963|19135883|P1|STARTED|Overall Study||13
7773349|NCT01353911|19135901|P8|NOT COMPLETED|Overall Study||15
7773350|NCT01353911|19135902|P7|NOT COMPLETED|Overall Study||6
7773351|NCT01353911|19135903|P6|NOT COMPLETED|Overall Study||7
7773352|NCT01353911|19135904|P5|NOT COMPLETED|Overall Study||6
7773353|NCT01353911|19135905|P4|NOT COMPLETED|Overall Study||2
7773354|NCT01353911|19135906|P3|NOT COMPLETED|Overall Study||9
7773355|NCT01353911|19135907|P2|NOT COMPLETED|Overall Study||9
7773356|NCT01353911|19135908|P1|NOT COMPLETED|Overall Study||8
7773357|NCT01353911|19135901|P8|COMPLETED|Overall Study||51
7773358|NCT01353911|19135902|P7|COMPLETED|Overall Study||30
7773359|NCT01353911|19135903|P6|COMPLETED|Overall Study||36
7773360|NCT01353911|19135904|P5|COMPLETED|Overall Study||23
7773361|NCT01353911|19135905|P4|COMPLETED|Overall Study||22
7773362|NCT01353911|19135906|P3|COMPLETED|Overall Study||59
7773363|NCT01353911|19135907|P2|COMPLETED|Overall Study||57
7773364|NCT01353911|19135908|P1|COMPLETED|Overall Study||28
7773365|NCT01353911|19135901|P8|STARTED|Overall Study||66
7773366|NCT01353911|19135902|P7|STARTED|Overall Study||36
7773367|NCT01353911|19135903|P6|STARTED|Overall Study||43
7773368|NCT01353911|19135904|P5|STARTED|Overall Study||29
7773369|NCT01353911|19135905|P4|STARTED|Overall Study||24
7773370|NCT01353911|19135906|P3|STARTED|Overall Study||68
7773371|NCT01353911|19135907|P2|STARTED|Overall Study||66
7773372|NCT01353911|19135908|P1|STARTED|Overall Study||36
7773373|NCT01353898|19135988|P6|NOT COMPLETED|Overall Study||1
7773374|NCT01353898|19135989|P5|NOT COMPLETED|Overall Study||0
7773375|NCT01353898|19135990|P4|NOT COMPLETED|Overall Study||0
7773376|NCT01353898|19135991|P3|NOT COMPLETED|Overall Study||0
7773377|NCT01353898|19135992|P2|NOT COMPLETED|Overall Study||0
7773378|NCT01353898|19135993|P1|NOT COMPLETED|Overall Study||0
7773379|NCT01353898|19135988|P6|COMPLETED|Overall Study||1
7773380|NCT01353898|19135989|P5|COMPLETED|Overall Study||2
7773381|NCT01353898|19135990|P4|COMPLETED|Overall Study||2
7773382|NCT01353898|19135991|P3|COMPLETED|Overall Study||2
7773383|NCT01353898|19135992|P2|COMPLETED|Overall Study||2
7773384|NCT01353898|19135993|P1|COMPLETED|Overall Study||2
7773385|NCT01353898|19135988|P6|STARTED|Overall Study||2
7773386|NCT01353898|19135989|P5|STARTED|Overall Study||2
7773387|NCT01353898|19135990|P4|STARTED|Overall Study||2
7773388|NCT01353898|19135991|P3|STARTED|Overall Study||2
7773389|NCT01353898|19135992|P2|STARTED|Overall Study||2
7773390|NCT01353898|19135993|P1|STARTED|Overall Study||2
7773391|NCT01353859|19136019|P1|NOT COMPLETED|Overall Study||4
7773392|NCT01353859|19136019|P1|COMPLETED|Overall Study||35
7773393|NCT01353859|19136019|P1|STARTED|Overall Study||39
7773394|NCT01353703|19136034|P2|NOT COMPLETED|Overall Study||0
7773395|NCT01353703|19136035|P1|NOT COMPLETED|Overall Study||1
7773396|NCT01353703|19136034|P2|COMPLETED|Overall Study||112
7773397|NCT01353703|19136035|P1|COMPLETED|Overall Study||111
7773398|NCT01353703|19136034|P2|STARTED|Overall Study||112
7773399|NCT01353703|19136035|P1|STARTED|Overall Study||112
7773400|NCT01353664|19136081|P1|NOT COMPLETED|Overall Study||19
7773401|NCT01353664|19136081|P1|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0
7773402|NCT01353664|19136081|P1|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19
7773403|NCT01353586|19136087|P2|NOT COMPLETED|Overall Study||2
7773404|NCT01353586|19136088|P1|NOT COMPLETED|Overall Study||7
7773405|NCT01353586|19136087|P2|COMPLETED|Overall Study||17
7773406|NCT01353586|19136088|P1|COMPLETED|Overall Study||160
7773407|NCT01353586|19136087|P2|Participated in SNA Substudy|Overall Study||19
7773408|NCT01353586|19136088|P1|Participated in SNA Substudy|Overall Study||19
7773409|NCT01353586|19136087|P2|Participated in Roll-in Phase|Overall Study||0
7773410|NCT01353586|19136088|P1|Participated in Roll-in Phase|Overall Study||22
7773411|NCT01353586|19136087|P2|Participated in Workflow Phase|Overall Study||0
7773412|NCT01353586|19136088|P1|Participated in Workflow Phase|Overall Study||20
7773413|NCT01353586|19136087|P2|STARTED|Overall Study||19
7773414|NCT01353586|19136088|P1|STARTED|Overall Study||167
7773415|NCT01353508|19136106|P4|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
7773416|NCT01353508|19136107|P3|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
7773417|NCT01353508|19136108|P2|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
7773418|NCT01353508|19136109|P1|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1
7773419|NCT01353508|19136106|P4|COMPLETED|Period 2 - Second Intervention (7 Days)||7
7773420|NCT01353508|19136107|P3|COMPLETED|Period 2 - Second Intervention (7 Days)||8
7773421|NCT01353508|19136108|P2|COMPLETED|Period 2 - Second Intervention (7 Days)||8
7773422|NCT01353508|19136109|P1|COMPLETED|Period 2 - Second Intervention (7 Days)||7
7773423|NCT01353508|19136106|P4|STARTED|Period 2 - Second Intervention (7 Days)||7
7773424|NCT01353508|19136107|P3|STARTED|Period 2 - Second Intervention (7 Days)||8
7773425|NCT01353508|19136108|P2|STARTED|Period 2 - Second Intervention (7 Days)||8
7773426|NCT01353508|19136109|P1|STARTED|Period 2 - Second Intervention (7 Days)||8
7773427|NCT01353508|19136106|P4|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1
7773428|NCT01353508|19136107|P3|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
7773429|NCT01353508|19136108|P2|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
7773430|NCT01353508|19136109|P1|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
7773431|NCT01353508|19136106|P4|COMPLETED|Period 1 - First Intervention (7 Days)||7
7773432|NCT01353508|19136107|P3|COMPLETED|Period 1 - First Intervention (7 Days)||8
7773433|NCT01353508|19136108|P2|COMPLETED|Period 1 - First Intervention (7 Days)||8
7773434|NCT01353508|19136109|P1|COMPLETED|Period 1 - First Intervention (7 Days)||8
7773435|NCT01353508|19136106|P4|STARTED|Period 1 - First Intervention (7 Days)||8
7773436|NCT01353508|19136107|P3|STARTED|Period 1 - First Intervention (7 Days)||8
7773437|NCT01353508|19136108|P2|STARTED|Period 1 - First Intervention (7 Days)||8
7773438|NCT01353508|19136109|P1|STARTED|Period 1 - First Intervention (7 Days)||8
7773439|NCT01353274|19136187|P1|NOT COMPLETED|Overall Study||28
7773440|NCT01353274|19136187|P1|COMPLETED|Overall Study||1129
7773441|NCT01353274|19136187|P1|STARTED|Overall Study||1157
7773442|NCT01353222|19136197|P2|NOT COMPLETED|Overall Study||72
7773443|NCT01353222|19136198|P1|NOT COMPLETED|Overall Study||70
7773444|NCT01353222|19136197|P2|COMPLETED|Overall Study||0
7773445|NCT01353222|19136198|P1|COMPLETED|Overall Study||0
7773446|NCT01353222|19136197|P2|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72
7773447|NCT01353222|19136198|P1|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0
7773448|NCT01353222|19136197|P2|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0
7773449|NCT01353222|19136198|P1|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67
7773450|NCT01353222|19136197|P2|STARTED|Overall Study||72
7773451|NCT01353222|19136198|P1|STARTED|Overall Study||70
7773452|NCT01353196|19136206|P2|NOT COMPLETED|Overall Study||11
7773453|NCT01353196|19136207|P1|NOT COMPLETED|Overall Study||29
7773454|NCT01353196|19136206|P2|COMPLETED|Overall Study||59
7773455|NCT01353196|19136207|P1|COMPLETED|Overall Study||71
7773456|NCT01353196|19136206|P2|STARTED|Overall Study||70
7773457|NCT01353196|19136207|P1|STARTED|Overall Study||100
7773458|NCT01353144|19136215|P2|NOT COMPLETED|Overall Study||8
7773459|NCT01353144|19136216|P1|NOT COMPLETED|Overall Study||9
7773460|NCT01353144|19136215|P2|COMPLETED|Overall Study||81
7773461|NCT01353144|19136216|P1|COMPLETED|Overall Study||80
7773462|NCT01353144|19136215|P2|STARTED|Overall Study||89
7773463|NCT01353144|19136216|P1|STARTED|Overall Study||89
7773464|NCT01353079|19136226|P2|NOT COMPLETED|Overall Study||21
7773465|NCT01353079|19136227|P1|NOT COMPLETED|Overall Study||27
7773466|NCT01353079|19136226|P2|COMPLETED|Overall Study||190
7773467|NCT01353079|19136227|P1|COMPLETED|Overall Study||191
7773468|NCT01353079|19136226|P2|STARTED|Overall Study||211
7773469|NCT01353079|19136227|P1|STARTED|Overall Study||218
7773470|NCT01352845|19136241|P2|NOT COMPLETED|Overall Study||203
7773471|NCT01352845|19136242|P1|NOT COMPLETED|Overall Study||671
7773472|NCT01352845|19136241|P2|COMPLETED|Overall Study||619
7773473|NCT01352845|19136242|P1|COMPLETED|Overall Study||1800
7773474|NCT01352845|19136241|P2|STARTED|Overall Study||822
7773475|NCT01352845|19136242|P1|STARTED|Overall Study||2471
7773476|NCT01352793|19136331|P2|NOT COMPLETED|Overall Study||245
7773477|NCT01352793|19136332|P1|NOT COMPLETED|Overall Study||585
7773478|NCT01352793|19136331|P2|COMPLETED|Overall Study||1663
7773479|NCT01352793|19136332|P1|COMPLETED|Overall Study||3219
7773480|NCT01352793|19136331|P2|Vaccination 3|Overall Study||1710
7773481|NCT01352793|19136332|P1|Vaccination 3|Overall Study||3314
7773482|NCT01352793|19136331|P2|Vaccination 2|Overall Study||1806
7773483|NCT01352793|19136332|P1|Vaccination 2|Overall Study||3530
7773484|NCT01352793|19136331|P2|Vaccination 1|Overall Study||1908
7773485|NCT01352793|19136332|P1|Vaccination 1|Overall Study||3796
7773486|NCT01352793|19136331|P2|STARTED|Overall Study||1908
7773487|NCT01352793|19136332|P1|STARTED|Overall Study||3804
7773488|NCT01352741|19136356|P2|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
7773489|NCT01352741|19136357|P1|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
7773490|NCT01352741|19136356|P2|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
7773491|NCT01352741|19136357|P1|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37
7773492|NCT01352741|19136356|P2|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0
7773493|NCT01352741|19136357|P1|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37
7773494|NCT01352741|19136356|P2|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0
7773495|NCT01352741|19136357|P1|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8
7773496|NCT01352741|19136356|P2|COMPLETED|Open-Label Tapentadol Continuation Arm||0
7773497|NCT01352741|19136357|P1|COMPLETED|Open-Label Tapentadol Continuation Arm||51
7773498|NCT01352741|19136356|P2|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0
7773499|NCT01352741|19136357|P1|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57
7773500|NCT01352741|19136356|P2|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0
7773501|NCT01352741|19136357|P1|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2
7773502|NCT01352741|19136356|P2|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0
7773503|NCT01352741|19136357|P1|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59
7773504|NCT01352741|19136356|P2|NOT COMPLETED|Double-blind Comparative Period||26
7773505|NCT01352741|19136357|P1|NOT COMPLETED|Double-blind Comparative Period||28
7773506|NCT01352741|19136356|P2|COMPLETED|Double-blind Comparative Period||133
7773507|NCT01352741|19136357|P1|COMPLETED|Double-blind Comparative Period||126
7773508|NCT01352741|19136356|P2|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137
7773509|NCT01352741|19136357|P1|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123
7773510|NCT01352741|19136356|P2|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137
7773511|NCT01352741|19136357|P1|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123
7773512|NCT01352741|19136356|P2|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137
7773513|NCT01352741|19136357|P1|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123
7773514|NCT01352741|19136356|P2|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137
7773515|NCT01352741|19136357|P1|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123
7773516|NCT01352741|19136356|P2|EQ-5D Per Protocol Set|Double-blind Comparative Period||143
7773517|NCT01352741|19136357|P1|EQ-5D Per Protocol Set|Double-blind Comparative Period||131
7773518|NCT01352741|19136356|P2|SF-12 Per Protocol Set|Double-blind Comparative Period||143
7773519|NCT01352741|19136357|P1|SF-12 Per Protocol Set|Double-blind Comparative Period||131
7773520|NCT01352741|19136356|P2|painDetect Per Protocol Set|Double-blind Comparative Period||127
7773521|NCT01352741|19136357|P1|painDetect Per Protocol Set|Double-blind Comparative Period||109
7773522|NCT01352741|19136356|P2|Per Protocol Set|Double-blind Comparative Period||149
7773523|NCT01352741|19136357|P1|Per Protocol Set|Double-blind Comparative Period||139
7773524|NCT01352741|19136356|P2|Major Protocol Deviations|Double-blind Comparative Period||8
7773525|NCT01352741|19136357|P1|Major Protocol Deviations|Double-blind Comparative Period||13
7773526|NCT01352741|19136356|P2|Full Analysis Set|Double-blind Comparative Period||157
7773527|NCT01352741|19136357|P1|Full Analysis Set|Double-blind Comparative Period||152
7773528|NCT01352741|19136356|P2|No Pain Assessments Available|Double-blind Comparative Period||2
7773529|NCT01352741|19136357|P1|No Pain Assessments Available|Double-blind Comparative Period||2
7773530|NCT01352741|19136356|P2|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18
7773531|NCT01352741|19136357|P1|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19
7773532|NCT01352741|19136356|P2|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159
7773533|NCT01352741|19136357|P1|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154
7773534|NCT01352741|19136356|P2|NOT COMPLETED|Open-label Tapentadol Titration Period||0
7773535|NCT01352741|19136357|P1|NOT COMPLETED|Open-label Tapentadol Titration Period||73
7773536|NCT01352741|19136356|P2|COMPLETED|Open-label Tapentadol Titration Period||0
7773537|NCT01352741|19136357|P1|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372
7773538|NCT01352741|19136356|P2|Full Analysis Set|Open-label Tapentadol Titration Period||0
7773539|NCT01352741|19136357|P1|Full Analysis Set|Open-label Tapentadol Titration Period||436
7773540|NCT01352741|19136356|P2|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0
7773541|NCT01352741|19136357|P1|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59
7773542|NCT01352741|19136356|P2|STARTED|Open-label Tapentadol Titration Period||0
7773543|NCT01352741|19136357|P1|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445
7773544|NCT01352715|19136451|P2|NOT COMPLETED|Overall Study||46
7773545|NCT01352715|19136452|P1|NOT COMPLETED|Overall Study||45
7773546|NCT01352715|19136451|P2|COMPLETED|Overall Study||209
7773547|NCT01352715|19136452|P1|COMPLETED|Overall Study||215
7773548|NCT01352715|19136451|P2|STARTED|Overall Study||255
7773549|NCT01352715|19136452|P1|STARTED|Overall Study||260
7773550|NCT01352637|19136478|P4|NOT COMPLETED|Drug||35
7773551|NCT01352637|19136479|P3|NOT COMPLETED|Drug||25
7773552|NCT01352637|19136480|P2|NOT COMPLETED|Drug||0
7773553|NCT01352637|19136481|P1|NOT COMPLETED|Drug||0
7773554|NCT01352637|19136478|P4|COMPLETED|Drug||62
7773555|NCT01352637|19136479|P3|COMPLETED|Drug||70
7773556|NCT01352637|19136480|P2|COMPLETED|Drug||0
7773557|NCT01352637|19136481|P1|COMPLETED|Drug||0
7773558|NCT01352637|19136478|P4|STARTED|Drug||97
7773559|NCT01352637|19136479|P3|STARTED|Drug||95
7773560|NCT01352637|19136480|P2|STARTED|Drug||0
7773561|NCT01352637|19136481|P1|STARTED|Drug||0
7773562|NCT01352637|19136478|P4|NOT COMPLETED|Exposure Therapy||0
7773563|NCT01352637|19136479|P3|NOT COMPLETED|Exposure Therapy||0
7773564|NCT01352637|19136480|P2|NOT COMPLETED|Exposure Therapy||33
7773565|NCT01352637|19136481|P1|NOT COMPLETED|Exposure Therapy||27
7773566|NCT01352637|19136478|P4|COMPLETED|Exposure Therapy||0
7773567|NCT01352637|19136479|P3|COMPLETED|Exposure Therapy||0
7773568|NCT01352637|19136480|P2|COMPLETED|Exposure Therapy||62
7773569|NCT01352637|19136481|P1|COMPLETED|Exposure Therapy||70
7773570|NCT01352637|19136478|P4|STARTED|Exposure Therapy||0
7773571|NCT01352637|19136479|P3|STARTED|Exposure Therapy||0
7773572|NCT01352637|19136480|P2|STARTED|Exposure Therapy||95
7773573|NCT01352637|19136481|P1|STARTED|Exposure Therapy||97
7773574|NCT01352598|19136491|P1|NOT COMPLETED|Overall Study||12
7773575|NCT01352598|19136491|P1|COMPLETED|Overall Study||72
7773576|NCT01352598|19136491|P1|STARTED|Overall Study||84
7773577|NCT01352585|19136496|P1|NOT COMPLETED|Overall Study||11
7773578|NCT01352585|19136496|P1|COMPLETED|Overall Study||36
7773579|NCT01352585|19136496|P1|STARTED|Overall Study||47
7773580|NCT01352546|19136507|P1|NOT COMPLETED|Overall Study||0
7773581|NCT01352546|19136507|P1|COMPLETED|Overall Study||31
7773582|NCT01352546|19136507|P1|STARTED|Overall Study||31
7773583|NCT01352507|19136513|P2|NOT COMPLETED|Extension Phase||0
7773584|NCT01352507|19136514|P1|NOT COMPLETED|Extension Phase||0
7773585|NCT01352507|19136513|P2|COMPLETED|Extension Phase||173
7773586|NCT01352507|19136514|P1|COMPLETED|Extension Phase||164
7773587|NCT01352507|19136513|P2|STARTED|Extension Phase||173
7773588|NCT01352507|19136514|P1|STARTED|Extension Phase||164
7773589|NCT01352507|19136513|P2|NOT COMPLETED|Treatment Period 2||3
7773590|NCT01352507|19136514|P1|NOT COMPLETED|Treatment Period 2||6
7773768|NCT01351025|19136981|P1|COMPLETED|Week 24 - 44||42
7773591|NCT01352507|19136513|P2|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180
7773592|NCT01352507|19136514|P1|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170
7773593|NCT01352507|19136513|P2|Received Treatment|Treatment Period 2||181
7773594|NCT01352507|19136514|P1|Received Treatment|Treatment Period 2||173
7773595|NCT01352507|19136513|P2|STARTED|Treatment Period 2||183
7773596|NCT01352507|19136514|P1|STARTED|Treatment Period 2||176
7773597|NCT01352507|19136513|P2|NOT COMPLETED|Washout Period||1
7773598|NCT01352507|19136514|P1|NOT COMPLETED|Washout Period||0
7773599|NCT01352507|19136513|P2|COMPLETED|Washout Period||183
7773600|NCT01352507|19136514|P1|COMPLETED|Washout Period||176
7773601|NCT01352507|19136513|P2|STARTED|Washout Period||184
7773602|NCT01352507|19136514|P1|STARTED|Washout Period||176
7773603|NCT01352507|19136513|P2|NOT COMPLETED|Treatment Period 1||9
7773604|NCT01352507|19136514|P1|NOT COMPLETED|Treatment Period 1||14
7773605|NCT01352507|19136513|P2|COMPLETED|Treatment Period 1||184
7773606|NCT01352507|19136514|P1|COMPLETED|Treatment Period 1||176
7773607|NCT01352507|19136513|P2|Received Treatment|Treatment Period 1||188
7773608|NCT01352507|19136514|P1|Received Treatment|Treatment Period 1||182
7773609|NCT01352507|19136513|P2|STARTED|Treatment Period 1||193
7773610|NCT01352507|19136514|P1|STARTED|Treatment Period 1||190
7773611|NCT01352468|19136547|P2|NOT COMPLETED|Overall Study||4
7773612|NCT01352468|19136548|P1|NOT COMPLETED|Overall Study||5
7773613|NCT01352468|19136547|P2|COMPLETED|Overall Study||18
7773614|NCT01352468|19136548|P1|COMPLETED|Overall Study||17
7773615|NCT01352468|19136547|P2|STARTED|Overall Study||22
7773616|NCT01352468|19136548|P1|STARTED|Overall Study||22
7773617|NCT01352442|19136558|P1|NOT COMPLETED|Overall Study||12
7773618|NCT01352442|19136558|P1|COMPLETED|Overall Study||139
7773619|NCT01352442|19136558|P1|STARTED|Overall Study||151
7773620|NCT01352416|19136567|P4|NOT COMPLETED|Overall Study||1
7773621|NCT01352416|19136568|P3|NOT COMPLETED|Overall Study||2
7773622|NCT01352416|19136569|P2|NOT COMPLETED|Overall Study||2
7773623|NCT01352416|19136570|P1|NOT COMPLETED|Overall Study||1
7773624|NCT01352416|19136567|P4|COMPLETED|Overall Study||1
7773625|NCT01352416|19136568|P3|COMPLETED|Overall Study||0
7773626|NCT01352416|19136569|P2|COMPLETED|Overall Study||5
7773627|NCT01352416|19136570|P1|COMPLETED|Overall Study||3
7773628|NCT01352416|19136567|P4|STARTED|Overall Study||2
7773629|NCT01352416|19136568|P3|STARTED|Overall Study||2
7773630|NCT01352416|19136569|P2|STARTED|Overall Study||7
7773631|NCT01352416|19136570|P1|STARTED|Overall Study||4
7773632|NCT01352286|19136580|P1|NOT COMPLETED|Overall Study||0
7773633|NCT01352286|19136580|P1|COMPLETED|Overall Study||25
7773634|NCT01352286|19136580|P1|Received T-cells|Overall Study||25
7773635|NCT01352286|19136580|P1|STARTED|Overall Study||25
7773636|NCT01352221|19136592|P4|NOT COMPLETED|Open-label Phase||11
7773637|NCT01352221|19136593|P3|NOT COMPLETED|Open-label Phase||13
7773638|NCT01352221|19136594|P2|NOT COMPLETED|Open-label Phase||0
7773639|NCT01352221|19136595|P1|NOT COMPLETED|Open-label Phase||0
7773640|NCT01352221|19136592|P4|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|36
7773641|NCT01352221|19136593|P3|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|37
7773642|NCT01352221|19136594|P2|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
7773643|NCT01352221|19136595|P1|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
7773644|NCT01352221|19136592|P4|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
7773645|NCT01352221|19136593|P3|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
7773646|NCT01352221|19136594|P2|STARTED|Open-label Phase|Not Applicable to open-label phase|0
7773647|NCT01352221|19136595|P1|STARTED|Open-label Phase|Not Applicable to open-label phase|0
7773648|NCT01352221|19136592|P4|NOT COMPLETED|Double-blind Phase||0
7773649|NCT01352221|19136593|P3|NOT COMPLETED|Double-blind Phase||0
7773650|NCT01352221|19136594|P2|NOT COMPLETED|Double-blind Phase||11
7773651|NCT01352221|19136595|P1|NOT COMPLETED|Double-blind Phase||9
7773652|NCT01352221|19136592|P4|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
7773653|NCT01352221|19136593|P3|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
7773654|NCT01352221|19136594|P2|COMPLETED|Double-blind Phase||53
7773655|NCT01352221|19136595|P1|COMPLETED|Double-blind Phase||55
7773656|NCT01352221|19136592|P4|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
7773657|NCT01352221|19136593|P3|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
7773658|NCT01352221|19136594|P2|STARTED|Double-blind Phase||64
7773659|NCT01352221|19136595|P1|STARTED|Double-blind Phase||64
7773660|NCT01352182|19136655|P2|NOT COMPLETED|Overall Study||0
7773661|NCT01352182|19136656|P1|NOT COMPLETED|Overall Study||0
7773662|NCT01352182|19136655|P2|COMPLETED|Overall Study||4
7773663|NCT01352182|19136656|P1|COMPLETED|Overall Study||8
7773664|NCT01352182|19136655|P2|STARTED|Overall Study||4
7773665|NCT01352182|19136656|P1|STARTED|Overall Study||8
7773666|NCT01352117|19136674|P2|NOT COMPLETED|Overall Study||24
7773667|NCT01352117|19136675|P1|NOT COMPLETED|Overall Study||21
7773668|NCT01352117|19136674|P2|COMPLETED|Overall Study||72
7773669|NCT01352117|19136675|P1|COMPLETED|Overall Study||75
7773670|NCT01352117|19136674|P2|Study Week 96 Data Potential|Overall Study||61
7773671|NCT01352117|19136675|P1|Study Week 96 Data Potential|Overall Study||58
7773672|NCT01352117|19136674|P2|Study Week 48 Data Potential|Overall Study||83
7773673|NCT01352117|19136675|P1|Study Week 48 Data Potential|Overall Study||80
7773674|NCT01352117|19136674|P2|Entered Step 2 to Initiate Delayed ET|Overall Study|Only Arm A participants could enter Step 2 to receive delayed ET.|0
7773675|NCT01352117|19136675|P1|Entered Step 2 to Initiate Delayed ET|Overall Study||32
7773676|NCT01352117|19136674|P2|STARTED|Overall Study||96
7773677|NCT01352117|19136675|P1|STARTED|Overall Study||96
7773678|NCT01351766|19136727|P1|NOT COMPLETED|Overall Study||3
7773679|NCT01351766|19136727|P1|COMPLETED|Overall Study||36
7773680|NCT01351766|19136727|P1|STARTED|Overall Study||39
7773681|NCT01351740|19136733|P2|NOT COMPLETED|Overall Study||6
7773682|NCT01351740|19136734|P1|NOT COMPLETED|Overall Study||2
7773683|NCT01351740|19136733|P2|COMPLETED|Overall Study||19
7773684|NCT01351740|19136734|P1|COMPLETED|Overall Study||23
7773685|NCT01351740|19136733|P2|STARTED|Overall Study||25
7773686|NCT01351740|19136734|P1|STARTED|Overall Study||25
7773687|NCT01351623|19136742|P1|NOT COMPLETED|Overall Study||9
7773688|NCT01351623|19136742|P1|COMPLETED|Overall Study||35
7773689|NCT01351623|19136742|P1|STARTED|Overall Study||44
7773690|NCT01351506|19136748|P1|NOT COMPLETED|Overall Study||137
7773691|NCT01351506|19136748|P1|COMPLETED|Overall Study||465
7773692|NCT01351506|19136748|P1|STARTED|Overall Study||602
7773693|NCT01351480|19136758|P1|NOT COMPLETED|Overall Study||8
7773694|NCT01351480|19136758|P1|COMPLETED|Overall Study||26
7773695|NCT01351480|19136758|P1|STARTED|Overall Study||34
7773696|NCT01351415|19136768|P2|NOT COMPLETED|Overall Study||240
7773697|NCT01351415|19136769|P1|NOT COMPLETED|Overall Study||245
7773698|NCT01351415|19136768|P2|COMPLETED|Overall Study||0
7773699|NCT01351415|19136769|P1|COMPLETED|Overall Study||0
7773700|NCT01351415|19136768|P2|Treated Participants|Overall Study||232
7773701|NCT01351415|19136769|P1|Treated Participants|Overall Study||243
7773702|NCT01351415|19136768|P2|STARTED|Overall Study||240
7773703|NCT01351415|19136769|P1|STARTED|Overall Study||245
7773704|NCT01351376|19136791|P2|NOT COMPLETED|Overall Study||0
7773705|NCT01351376|19136792|P1|NOT COMPLETED|Overall Study||0
7773706|NCT01351376|19136791|P2|COMPLETED|Overall Study||11
7773707|NCT01351376|19136792|P1|COMPLETED|Overall Study||10
7773708|NCT01351376|19136791|P2|STARTED|Overall Study||11
7773709|NCT01351376|19136792|P1|STARTED|Overall Study||10
7773710|NCT01351350|19136805|P5|NOT COMPLETED|Overall Study||7
7773711|NCT01351350|19136806|P4|NOT COMPLETED|Overall Study||13
7773712|NCT01351350|19136807|P3|NOT COMPLETED|Overall Study||11
7773713|NCT01351350|19136808|P2|NOT COMPLETED|Overall Study||29
7773714|NCT01351350|19136809|P1|NOT COMPLETED|Overall Study||8
7773715|NCT01351350|19136805|P5|COMPLETED|Overall Study||0
7773716|NCT01351350|19136806|P4|COMPLETED|Overall Study||0
7773717|NCT01351350|19136807|P3|COMPLETED|Overall Study||0
7773718|NCT01351350|19136808|P2|COMPLETED|Overall Study||0
7773719|NCT01351350|19136809|P1|COMPLETED|Overall Study||0
7773720|NCT01351350|19136805|P5|Dose-escalation Evaluable|Overall Study||0
7773721|NCT01351350|19136806|P4|Dose-escalation Evaluable|Overall Study||0
7773722|NCT01351350|19136807|P3|Dose-escalation Evaluable|Overall Study||10
7773723|NCT01351350|19136808|P2|Dose-escalation Evaluable|Overall Study||23
7773724|NCT01351350|19136809|P1|Dose-escalation Evaluable|Overall Study||7
7773725|NCT01351350|19136805|P5|Treated|Overall Study||7
7773726|NCT01351350|19136806|P4|Treated|Overall Study||13
7773727|NCT01351350|19136807|P3|Treated|Overall Study||10
7773728|NCT01351350|19136808|P2|Treated|Overall Study||29
7773729|NCT01351350|19136809|P1|Treated|Overall Study||8
7773730|NCT01351350|19136805|P5|STARTED|Overall Study||7
7773731|NCT01351350|19136806|P4|STARTED|Overall Study||13
7773732|NCT01351350|19136807|P3|STARTED|Overall Study||11
7773733|NCT01351350|19136808|P2|STARTED|Overall Study||29
7773734|NCT01351350|19136809|P1|STARTED|Overall Study||8
7773735|NCT01351337|19136922|P1|NOT COMPLETED|Overall Study||0
7773736|NCT01351337|19136922|P1|COMPLETED|Overall Study||58
7773737|NCT01351337|19136922|P1|STARTED|Overall Study||58
7773738|NCT01351090|19136931|P3|NOT COMPLETED|Overall Study||6
7773739|NCT01351090|19136932|P2|NOT COMPLETED|Overall Study||11
7773740|NCT01351090|19136933|P1|NOT COMPLETED|Overall Study||11
7773741|NCT01351090|19136931|P3|COMPLETED|Overall Study||36
7773742|NCT01351090|19136932|P2|COMPLETED|Overall Study||31
7773743|NCT01351090|19136933|P1|COMPLETED|Overall Study||32
7773744|NCT01351090|19136931|P3|STARTED|Overall Study||42
7773745|NCT01351090|19136932|P2|STARTED|Overall Study||42
7773746|NCT01351090|19136933|P1|STARTED|Overall Study||43
7773747|NCT01351077|19136952|P2|NOT COMPLETED|Overall Study||0
7773748|NCT01351077|19136953|P1|NOT COMPLETED|Overall Study||0
7773749|NCT01351077|19136952|P2|COMPLETED|Overall Study||180
7773750|NCT01351077|19136953|P1|COMPLETED|Overall Study||180
7773751|NCT01351077|19136952|P2|STARTED|Overall Study||180
7773752|NCT01351077|19136953|P1|STARTED|Overall Study||180
7773753|NCT01351064|19136969|P2|NOT COMPLETED|Overall Study||0
7773754|NCT01351064|19136970|P1|NOT COMPLETED|Overall Study||0
7773755|NCT01351064|19136969|P2|COMPLETED|Overall Study||42
7773756|NCT01351064|19136970|P1|COMPLETED|Overall Study||42
7773757|NCT01351064|19136969|P2|STARTED|Overall Study||42
7773758|NCT01351064|19136970|P1|STARTED|Overall Study||42
7773759|NCT01351025|19136980|P2|NOT COMPLETED|Week 44 - 48||0
7773760|NCT01351025|19136981|P1|NOT COMPLETED|Week 44 - 48||0
7773761|NCT01351025|19136980|P2|COMPLETED|Week 44 - 48||43
7773762|NCT01351025|19136981|P1|COMPLETED|Week 44 - 48||42
7773763|NCT01351025|19136980|P2|STARTED|Week 44 - 48||43
7773764|NCT01351025|19136981|P1|STARTED|Week 44 - 48||42
7773765|NCT01351025|19136980|P2|NOT COMPLETED|Week 24 - 44||4
7773766|NCT01351025|19136981|P1|NOT COMPLETED|Week 24 - 44||1
7773767|NCT01351025|19136980|P2|COMPLETED|Week 24 - 44||43
7773769|NCT01351025|19136980|P2|STARTED|Week 24 - 44||47
7773770|NCT01351025|19136981|P1|STARTED|Week 24 - 44||43
7773771|NCT01351025|19136980|P2|NOT COMPLETED|Week 20 - 24||0
7773772|NCT01351025|19136981|P1|NOT COMPLETED|Week 20 - 24||0
7773773|NCT01351025|19136980|P2|COMPLETED|Week 20 - 24||47
7773774|NCT01351025|19136981|P1|COMPLETED|Week 20 - 24||43
7773775|NCT01351025|19136980|P2|STARTED|Week 20 - 24||47
7773776|NCT01351025|19136981|P1|STARTED|Week 20 - 24||43
7773777|NCT01351025|19136980|P2|NOT COMPLETED|Week 0 - 20||1
7773778|NCT01351025|19136981|P1|NOT COMPLETED|Week 0 - 20||3
7773779|NCT01351025|19136980|P2|COMPLETED|Week 0 - 20||47
7773780|NCT01351025|19136981|P1|COMPLETED|Week 0 - 20||43
7773781|NCT01351025|19136980|P2|STARTED|Week 0 - 20||48
7773782|NCT01351025|19136981|P1|STARTED|Week 0 - 20||46
7773783|NCT01350999|19137014|P3|NOT COMPLETED|Overall Study||21
7773784|NCT01350999|19137015|P2|NOT COMPLETED|Overall Study||14
7773785|NCT01350999|19137016|P1|NOT COMPLETED|Overall Study||8
7773786|NCT01350999|19137014|P3|COMPLETED|Overall Study||146
7773787|NCT01350999|19137015|P2|COMPLETED|Overall Study||157
7773788|NCT01350999|19137016|P1|COMPLETED|Overall Study||157
7773789|NCT01350999|19137014|P3|Treated|Overall Study||167
7773790|NCT01350999|19137015|P2|Treated|Overall Study||171
7773791|NCT01350999|19137016|P1|Treated|Overall Study||165
7773792|NCT01350999|19137014|P3|STARTED|Overall Study||167
7773793|NCT01350999|19137015|P2|STARTED|Overall Study||171
7773794|NCT01350999|19137016|P1|STARTED|Overall Study||165
7773795|NCT01350973|19137054|P3|NOT COMPLETED|Overall Study||8
7773796|NCT01350973|19137055|P2|NOT COMPLETED|Overall Study||8
7773797|NCT01350973|19137056|P1|NOT COMPLETED|Overall Study||6
7773798|NCT01350973|19137054|P3|COMPLETED|Overall Study||187
7773799|NCT01350973|19137055|P2|COMPLETED|Overall Study||202
7773800|NCT01350973|19137056|P1|COMPLETED|Overall Study||200
7773801|NCT01350973|19137054|P3|Received Treatment|Overall Study||195
7773802|NCT01350973|19137055|P2|Received Treatment|Overall Study||210
7773803|NCT01350973|19137056|P1|Received Treatment|Overall Study||205
7773804|NCT01350973|19137054|P3|STARTED|Overall Study||195
7773805|NCT01350973|19137055|P2|STARTED|Overall Study||210
7773806|NCT01350973|19137056|P1|STARTED|Overall Study||206
7773807|NCT01350947|19137091|P1|NOT COMPLETED|Overall Study||0
7773808|NCT01350947|19137091|P1|COMPLETED|Overall Study||11
7773809|NCT01350947|19137091|P1|STARTED|Overall Study||11
7773810|NCT01350934|19137097|P2|NOT COMPLETED|Extension Study||4
7773811|NCT01350934|19137098|P1|NOT COMPLETED|Extension Study||5
7773812|NCT01350934|19137097|P2|COMPLETED|Extension Study||101
7773813|NCT01350934|19137098|P1|COMPLETED|Extension Study||95
7773814|NCT01350934|19137097|P2|STARTED|Extension Study||105
7773815|NCT01350934|19137098|P1|STARTED|Extension Study||100
7773816|NCT01350934|19137097|P2|NOT COMPLETED|Base Study||3
7773817|NCT01350934|19137098|P1|NOT COMPLETED|Base Study||11
7773818|NCT01350934|19137097|P2|COMPLETED|Base Study||105
7773819|NCT01350934|19137098|P1|COMPLETED|Base Study||100
7773820|NCT01350934|19137097|P2|STARTED|Base Study||108
7773821|NCT01350934|19137098|P1|STARTED|Base Study||111
7773822|NCT01350804|19137120|P4|NOT COMPLETED|Extension Study, Weeks 52 - 260||23
7773823|NCT01350804|19137121|P3|NOT COMPLETED|Extension Study, Weeks 52 - 260||72
7773824|NCT01350804|19137122|P2|NOT COMPLETED|Extension Study, Weeks 52 - 260||79
7773825|NCT01350804|19137123|P1|NOT COMPLETED|Extension Study, Weeks 52 - 260||80
7773826|NCT01350804|19137120|P4|COMPLETED|Extension Study, Weeks 52 - 260||0
7773827|NCT01350804|19137121|P3|COMPLETED|Extension Study, Weeks 52 - 260||0
7773828|NCT01350804|19137122|P2|COMPLETED|Extension Study, Weeks 52 - 260||0
7773829|NCT01350804|19137123|P1|COMPLETED|Extension Study, Weeks 52 - 260||0
7773830|NCT01350804|19137120|P4|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23
7773831|NCT01350804|19137121|P3|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72
7773832|NCT01350804|19137122|P2|STARTED|Extension Study, Weeks 52 - 260||79
7773833|NCT01350804|19137123|P1|STARTED|Extension Study, Weeks 52 - 260||80
7773834|NCT01350804|19137120|P4|NOT COMPLETED|Core Study||26
7773835|NCT01350804|19137121|P3|NOT COMPLETED|Core Study||47
7773836|NCT01350804|19137122|P2|NOT COMPLETED|Core Study||47
7773837|NCT01350804|19137123|P1|NOT COMPLETED|Core Study||41
7773838|NCT01350804|19137120|P4|COMPLETED|Core Study||112
7773839|NCT01350804|19137121|P3|COMPLETED|Core Study||91
7773840|NCT01350804|19137122|P2|COMPLETED|Core Study||90
7773841|NCT01350804|19137123|P1|COMPLETED|Core Study||97
7773842|NCT01350804|19137120|P4|Full Analysis Set|Core Study||138
7773843|NCT01350804|19137121|P3|Full Analysis Set|Core Study||138
7773844|NCT01350804|19137122|P2|Full Analysis Set|Core Study||137
7773845|NCT01350804|19137123|P1|Full Analysis Set|Core Study||138
7773846|NCT01350804|19137120|P4|Treatment Switch to AIN457 at Week 24|Core Study||37
7773847|NCT01350804|19137121|P3|Treatment Switch to AIN457 at Week 24|Core Study||45
7773848|NCT01350804|19137122|P2|Treatment Switch to AIN457 at Week 24|Core Study||0
7773849|NCT01350804|19137123|P1|Treatment Switch to AIN457 at Week 24|Core Study||0
7773850|NCT01350804|19137120|P4|Tratment Switch to AIN457 at Week 16|Core Study||0
7773851|NCT01350804|19137121|P3|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78
7773852|NCT01350804|19137122|P2|Tratment Switch to AIN457 at Week 16|Core Study||0
7773853|NCT01350804|19137123|P1|Tratment Switch to AIN457 at Week 16|Core Study||0
7773854|NCT01350804|19137120|P4|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137
7773855|NCT01350804|19137121|P3|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139
7773856|NCT01350804|19137122|P2|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136
7773857|NCT01350804|19137123|P1|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137
7773858|NCT01350804|19137120|P4|STARTED|Core Study||138
7773859|NCT01350804|19137121|P3|STARTED|Core Study||138
7773860|NCT01350804|19137122|P2|STARTED|Core Study||137
7773861|NCT01350804|19137123|P1|STARTED|Core Study||138
7773862|NCT01350583|19137212|P1|NOT COMPLETED|Overall Study||0
7773863|NCT01350583|19137212|P1|COMPLETED|Overall Study||2
7773864|NCT01350583|19137212|P1|STARTED|Overall Study||2
7773865|NCT01350544|19137220|P2|NOT COMPLETED|Overall Study||22
7773866|NCT01350544|19137221|P1|NOT COMPLETED|Overall Study||23
7773867|NCT01350544|19137220|P2|COMPLETED|Overall Study||86
7773868|NCT01350544|19137221|P1|COMPLETED|Overall Study||85
7773869|NCT01350544|19137220|P2|STARTED|Overall Study||108
7773870|NCT01350544|19137221|P1|STARTED|Overall Study||108
7773871|NCT01350505|19137227|P1|NOT COMPLETED|Overall Study||4
7773872|NCT01350505|19137227|P1|COMPLETED|Overall Study||17
7773873|NCT01350505|19137227|P1|STARTED|Overall Study||21
7773874|NCT01350492|19137233|P2|NOT COMPLETED|Post Intervention Follow-Up||2
7773875|NCT01350492|19137234|P1|NOT COMPLETED|Post Intervention Follow-Up||6
7773876|NCT01350492|19137233|P2|COMPLETED|Post Intervention Follow-Up||18
7773877|NCT01350492|19137234|P1|COMPLETED|Post Intervention Follow-Up||17
7773878|NCT01350492|19137233|P2|6-month MRI Scan|Post Intervention Follow-Up||20
7773879|NCT01350492|19137234|P1|6-month MRI Scan|Post Intervention Follow-Up||20
7773880|NCT01350492|19137233|P2|STARTED|Post Intervention Follow-Up||20
7773881|NCT01350492|19137234|P1|STARTED|Post Intervention Follow-Up||23
7773882|NCT01350492|19137233|P2|NOT COMPLETED|Intervention||6
7773883|NCT01350492|19137234|P1|NOT COMPLETED|Intervention||5
7773884|NCT01350492|19137233|P2|COMPLETED|Intervention||20
7773885|NCT01350492|19137234|P1|COMPLETED|Intervention||23
7773886|NCT01350492|19137233|P2|11-week MRI Scan|Intervention||21
7773887|NCT01350492|19137234|P1|11-week MRI Scan|Intervention||23
7773888|NCT01350492|19137233|P2|6-week MRI Scan|Intervention||22
7773889|NCT01350492|19137234|P1|6-week MRI Scan|Intervention||24
7773890|NCT01350492|19137233|P2|STARTED|Intervention||26
7773891|NCT01350492|19137234|P1|STARTED|Intervention||28
7773892|NCT01350479|19137252|P2|NOT COMPLETED|Overall Study||0
7773893|NCT01350479|19137253|P1|NOT COMPLETED|Overall Study||0
7773894|NCT01350479|19137252|P2|COMPLETED|Overall Study||106
7773895|NCT01350479|19137253|P1|COMPLETED|Overall Study||94
7773896|NCT01350479|19137252|P2|STARTED|Overall Study||106
7773897|NCT01350479|19137253|P1|STARTED|Overall Study||94
7773898|NCT01350453|19137261|P2|NOT COMPLETED|Overall Study||1
7773899|NCT01350453|19137262|P1|NOT COMPLETED|Overall Study||2
7773900|NCT01350453|19137261|P2|COMPLETED|Overall Study||7
7773901|NCT01350453|19137262|P1|COMPLETED|Overall Study||9
7773902|NCT01350453|19137261|P2|STARTED|Overall Study||8
7773903|NCT01350453|19137262|P1|STARTED|Overall Study||11
7773904|NCT01350414|19137276|P1|NOT COMPLETED|Overall Study||19
7773905|NCT01350414|19137276|P1|COMPLETED|Overall Study||162
7773906|NCT01350414|19137276|P1|Year 5|Overall Study||162
7773907|NCT01350414|19137276|P1|Year 4|Overall Study||159
7773908|NCT01350414|19137276|P1|Year 3|Overall Study||162
7773909|NCT01350414|19137276|P1|Year 2|Overall Study||165
7773910|NCT01350414|19137276|P1|STARTED|Overall Study||181
7773911|NCT01350401|19137293|P1|NOT COMPLETED|Overall Study||0
7773912|NCT01350401|19137293|P1|COMPLETED|Overall Study||4
7773913|NCT01350401|19137293|P1|STARTED|Overall Study||4
7773914|NCT01350388|19137305|P2|NOT COMPLETED|Overall Study||1
7773915|NCT01350388|19137306|P1|NOT COMPLETED|Overall Study||3
7773916|NCT01350388|19137305|P2|COMPLETED|Overall Study||39
7773917|NCT01350388|19137306|P1|COMPLETED|Overall Study||37
7773918|NCT01350388|19137305|P2|STARTED|Overall Study||40
7773919|NCT01350388|19137306|P1|STARTED|Overall Study||40
7773920|NCT01350271|19137325|P3|NOT COMPLETED|Overall Study||26
7773921|NCT01350271|19137326|P2|NOT COMPLETED|Overall Study||17
7773922|NCT01350271|19137327|P1|NOT COMPLETED|Overall Study||21
7773923|NCT01350271|19137325|P3|COMPLETED|Overall Study||48
7773924|NCT01350271|19137326|P2|COMPLETED|Overall Study||53
7773925|NCT01350271|19137327|P1|COMPLETED|Overall Study||49
7773926|NCT01350271|19137325|P3|STARTED|Overall Study||74
7773927|NCT01350271|19137326|P2|STARTED|Overall Study||70
7773928|NCT01350271|19137327|P1|STARTED|Overall Study||70
7773929|NCT01350258|19137341|P1|NOT COMPLETED|Overall Study||0
7773930|NCT01350258|19137341|P1|COMPLETED|Overall Study||8
7773931|NCT01350258|19137341|P1|STARTED|Overall Study||8
7773932|NCT01350245|19137350|P1|NOT COMPLETED|Overall Study||0
7773933|NCT01350245|19137350|P1|COMPLETED|Overall Study||28
7773934|NCT01350245|19137350|P1|STARTED|Overall Study||28
7773935|NCT01350232|19137355|P1|NOT COMPLETED|Overall Study||0
7773936|NCT01350232|19137355|P1|COMPLETED|Overall Study||2
7773937|NCT01350232|19137355|P1|STARTED|Overall Study||2
7773938|NCT01350141|19137369|P3|NOT COMPLETED|Overall Study||1
7773939|NCT01350141|19137370|P2|NOT COMPLETED|Overall Study||0
7773940|NCT01350141|19137371|P1|NOT COMPLETED|Overall Study||3
7773941|NCT01350141|19137369|P3|COMPLETED|Overall Study||15
7773942|NCT01350141|19137370|P2|COMPLETED|Overall Study||15
7773943|NCT01350141|19137371|P1|COMPLETED|Overall Study||12
7773944|NCT01350141|19137369|P3|Treated|Overall Study||16
7773945|NCT01350141|19137370|P2|Treated|Overall Study||15
7773946|NCT01350141|19137371|P1|Treated|Overall Study||14
7773947|NCT01350141|19137369|P3|STARTED|Overall Study||16
7773948|NCT01350141|19137370|P2|STARTED|Overall Study||15
7773949|NCT01350141|19137371|P1|STARTED|Overall Study||15
7773950|NCT01350128|19137405|P1|NOT COMPLETED|Overall Study||14
7773951|NCT01350128|19137405|P1|COMPLETED|Overall Study||89
7773952|NCT01350128|19137405|P1|Atrovent HFA 34 µg BID|Overall Study||48
7773953|NCT01350128|19137405|P1|Placebo MDI BID|Overall Study||48
7773954|NCT01350128|19137405|P1|GP MDI 4.6 µg BID|Overall Study||45
7773955|NCT01350128|19137405|P1|GP MDI 9 µg BID|Overall Study||49
7773956|NCT01350128|19137405|P1|GP MDI 18 µg BID|Overall Study||49
7773957|NCT01350128|19137405|P1|GP MDI 36 µg BID|Overall Study|Glycopyrronium Metered Dose Inhaler|49
7773958|NCT01350128|19137405|P1|STARTED|Overall Study||103
7773959|NCT01350115|19137469|P2|NOT COMPLETED|Long Term Follow-Up (All Patients)||2
7773960|NCT01350115|19137470|P1|NOT COMPLETED|Long Term Follow-Up (All Patients)||1
7773961|NCT01350115|19137469|P2|COMPLETED|Long Term Follow-Up (All Patients)||0
7773962|NCT01350115|19137470|P1|COMPLETED|Long Term Follow-Up (All Patients)||7
7773963|NCT01350115|19137469|P2|STARTED|Long Term Follow-Up (All Patients)||2
7773964|NCT01350115|19137470|P1|STARTED|Long Term Follow-Up (All Patients)||8
7773965|NCT01350115|19137469|P2|NOT COMPLETED|Core Study (All Patients)||0
7773966|NCT01350115|19137470|P1|NOT COMPLETED|Core Study (All Patients)||0
7773967|NCT01350115|19137469|P2|COMPLETED|Core Study (All Patients)||2
7773968|NCT01350115|19137470|P1|COMPLETED|Core Study (All Patients)||8
7773969|NCT01350115|19137469|P2|Pharmacodynamic Set|Core Study (All Patients)||2
7773970|NCT01350115|19137470|P1|Pharmacodynamic Set|Core Study (All Patients)||7
7773971|NCT01350115|19137469|P2|Safety Anlysis Set|Core Study (All Patients)||2
7773972|NCT01350115|19137470|P1|Safety Anlysis Set|Core Study (All Patients)||8
7773973|NCT01350115|19137469|P2|STARTED|Core Study (All Patients)||2
7773974|NCT01350115|19137470|P1|STARTED|Core Study (All Patients)||8
7773975|NCT01350102|19137486|P4|NOT COMPLETED|Overall Study||0
7773976|NCT01350102|19137487|P3|NOT COMPLETED|Overall Study||1
7773977|NCT01350102|19137488|P2|NOT COMPLETED|Overall Study||0
7773978|NCT01350102|19137489|P1|NOT COMPLETED|Overall Study||0
7773979|NCT01350102|19137486|P4|COMPLETED|Overall Study||0
7773980|NCT01350102|19137487|P3|COMPLETED|Overall Study||0
7773981|NCT01350102|19137488|P2|COMPLETED|Overall Study||1
7773982|NCT01350102|19137489|P1|COMPLETED|Overall Study||0
7773983|NCT01350102|19137486|P4|STARTED|Overall Study||0
7773984|NCT01350102|19137487|P3|STARTED|Overall Study||1
7773985|NCT01350102|19137488|P2|STARTED|Overall Study||1
7773986|NCT01350102|19137489|P1|STARTED|Overall Study||0
7773987|NCT01349972|19137509|P2|NOT COMPLETED|Overall Study||2
7773988|NCT01349972|19137510|P1|NOT COMPLETED|Overall Study||5
7773989|NCT01349972|19137509|P2|COMPLETED|Overall Study||56
7773990|NCT01349972|19137510|P1|COMPLETED|Overall Study||109
7773991|NCT01349972|19137509|P2|STARTED|Overall Study||58
7773992|NCT01349972|19137510|P1|STARTED|Overall Study||114
7773993|NCT01349959|19137526|P1|NOT COMPLETED|Overall Study||7
7773994|NCT01349959|19137526|P1|COMPLETED|Overall Study||33
7773995|NCT01349959|19137526|P1|STARTED|Overall Study||40
7773996|NCT01349933|19137537|P1|NOT COMPLETED|Overall Study||0
7773997|NCT01349933|19137537|P1|COMPLETED|Overall Study||21
7773998|NCT01349933|19137537|P1|STARTED|Overall Study||21
7773999|NCT01349920|19137547|P1|NOT COMPLETED|Overall Study||0
7774000|NCT01349920|19137547|P1|COMPLETED|Overall Study||15
7774001|NCT01349920|19137547|P1|STARTED|Overall Study||15
7774002|NCT01349907|19137567|P2|NOT COMPLETED|Overall Study||43
7774003|NCT01349907|19137568|P1|NOT COMPLETED|Overall Study||139
7774004|NCT01349907|19137567|P2|COMPLETED|Overall Study||38
7774005|NCT01349907|19137568|P1|COMPLETED|Overall Study||102
7774006|NCT01349907|19137567|P2|STARTED|Overall Study|Enrolled and Treated|81
7774007|NCT01349907|19137568|P1|STARTED|Overall Study|Enrolled and Treated|241
7774008|NCT01349829|19137606|P2|NOT COMPLETED|Overall Study||23
7774009|NCT01349829|19137607|P1|NOT COMPLETED|Overall Study||9
7774010|NCT01349829|19137606|P2|COMPLETED|Overall Study||102
7774011|NCT01349829|19137607|P1|COMPLETED|Overall Study||117
7774012|NCT01349829|19137606|P2|STARTED|Overall Study||125
7774013|NCT01349829|19137607|P1|STARTED|Overall Study||126
7774014|NCT01349816|19137625|P1|NOT COMPLETED|Overall Study||30
7774015|NCT01349816|19137625|P1|COMPLETED|Overall Study||155
7774016|NCT01349816|19137625|P1|FF MDI 9.6 µg|Overall Study||61
7774017|NCT01349816|19137625|P1|GFF MDI 9/9.6 µg|Overall Study||57
7774018|NCT01349816|19137625|P1|GFF MDI 18/9.6 µg|Overall Study||57
7774019|NCT01349816|19137625|P1|GFF MDI 36/9.6 µg|Overall Study||56
7774020|NCT01349816|19137625|P1|GFF MDI 36/7.2 µg|Overall Study||58
7774021|NCT01349816|19137625|P1|GP MDI 36 µg|Overall Study||61
7774022|NCT01349816|19137625|P1|STARTED|Overall Study||185
7774023|NCT01349803|19137691|P4|NOT COMPLETED|Overall Study||2
7774024|NCT01349803|19137692|P3|NOT COMPLETED|Overall Study||3
7774025|NCT01349803|19137693|P2|NOT COMPLETED|Overall Study||1
7774026|NCT01349803|19137694|P1|NOT COMPLETED|Overall Study||1
7774027|NCT01349803|19137691|P4|COMPLETED|Overall Study||57
7774028|NCT01349803|19137692|P3|COMPLETED|Overall Study||57
7774029|NCT01349803|19137693|P2|COMPLETED|Overall Study||57
7774030|NCT01349803|19137694|P1|COMPLETED|Overall Study||59
7774031|NCT01349803|19137691|P4|STARTED|Overall Study||59
7774032|NCT01349803|19137692|P3|STARTED|Overall Study||60
7774033|NCT01349803|19137693|P2|STARTED|Overall Study||58
7774034|NCT01349803|19137694|P1|STARTED|Overall Study||60
7774035|NCT01349790|19137764|P1|NOT COMPLETED|Overall Study||9
7774036|NCT01349790|19137764|P1|COMPLETED|Overall Study||31
7774037|NCT01349790|19137764|P1|STARTED|Overall Study||40
7774038|NCT01349673|19137783|P1|NOT COMPLETED|Overall Study||114
7774039|NCT01349673|19137783|P1|COMPLETED|Overall Study||0
7774040|NCT01349673|19137783|P1|Received At Least 1 Dose Of Study Drug|Overall Study||114
7774041|NCT01349673|19137783|P1|Participants Entered Cycle 8|Overall Study||1
7774042|NCT01349673|19137783|P1|Participants Entered Cycle 7|Overall Study||3
7774043|NCT01349673|19137783|P1|Participants Entered Cycle 6|Overall Study||5
7774044|NCT01349673|19137783|P1|Participants Entered Cycle 5|Overall Study||12
7774045|NCT01349673|19137783|P1|Participants Entered Cycle 4|Overall Study||22
7774046|NCT01349673|19137783|P1|Participants Entered Cycle 3|Overall Study||41
7774047|NCT01349673|19137783|P1|Participants Entered Cycle 2|Overall Study||65
7774048|NCT01349673|19137783|P1|Participants Entered Cycle 1|Overall Study||114
7774049|NCT01349673|19137783|P1|STARTED|Overall Study||114
7774050|NCT01349660|19137793|P3|NOT COMPLETED|Overall Study||76
7774051|NCT01349660|19137794|P2|NOT COMPLETED|Overall Study||6
7774052|NCT01349660|19137795|P1|NOT COMPLETED|Overall Study||6
7774053|NCT01349660|19137793|P3|COMPLETED|Overall Study||0
7774054|NCT01349660|19137794|P2|COMPLETED|Overall Study||0
7774055|NCT01349660|19137795|P1|COMPLETED|Overall Study||0
7774056|NCT01349660|19137793|P3|STARTED|Overall Study||76
7774057|NCT01349660|19137794|P2|STARTED|Overall Study||6
7774058|NCT01349660|19137795|P1|STARTED|Overall Study||6
7774059|NCT01349595|19137813|P2|NOT COMPLETED|Overall Study||2
7774060|NCT01349595|19137814|P1|NOT COMPLETED|Overall Study||2
7774061|NCT01349595|19137813|P2|COMPLETED|Overall Study||0
7774062|NCT01349595|19137814|P1|COMPLETED|Overall Study||0
7774063|NCT01349595|19137813|P2|STARTED|Overall Study||2
7774064|NCT01349595|19137814|P1|STARTED|Overall Study||2
7774065|NCT01349569|19137820|P1|NOT COMPLETED|Overall Study||4
7774066|NCT01349569|19137820|P1|COMPLETED|Overall Study||12
7774067|NCT01349569|19137820|P1|STARTED|Overall Study||16
7774068|NCT01349491|19137832|P2|NOT COMPLETED|Overall Study||0
7774069|NCT01349491|19137833|P1|NOT COMPLETED|Overall Study||0
7774070|NCT01349491|19137832|P2|COMPLETED|Overall Study||5
7774071|NCT01349491|19137833|P1|COMPLETED|Overall Study||5
7774072|NCT01349491|19137832|P2|STARTED|Overall Study||5
7774073|NCT01349491|19137833|P1|STARTED|Overall Study||5
7774074|NCT01349465|19137841|P2|NOT COMPLETED|Overall Study||22
7774075|NCT01349465|19137842|P1|NOT COMPLETED|Overall Study||18
7774076|NCT01349465|19137841|P2|COMPLETED|Overall Study||27
7774077|NCT01349465|19137842|P1|COMPLETED|Overall Study||182
7774078|NCT01349465|19137841|P2|STARTED|Overall Study||49
7774079|NCT01349465|19137842|P1|STARTED|Overall Study||200
7774080|NCT01349231|19137854|P1|NOT COMPLETED|Overall Study||0
7774081|NCT01349231|19137854|P1|COMPLETED|Overall Study||10
7774082|NCT01349231|19137854|P1|STARTED|Overall Study||10
7774083|NCT01349192|19137863|P2|NOT COMPLETED|Overall Study||6
7774084|NCT01349192|19137864|P1|NOT COMPLETED|Overall Study||3
7774085|NCT01349192|19137863|P2|COMPLETED|Overall Study||17
7774086|NCT01349192|19137864|P1|COMPLETED|Overall Study||21
7774087|NCT01349192|19137863|P2|Withdrawals|Overall Study||6
7774088|NCT01349192|19137864|P1|Withdrawals|Overall Study||3
7774089|NCT01349192|19137863|P2|Evaluable for Primary Endpoint|Overall Study||19
7774090|NCT01349192|19137864|P1|Evaluable for Primary Endpoint|Overall Study||22
7774091|NCT01349192|19137863|P2|STARTED|Overall Study||23
7774092|NCT01349192|19137864|P1|STARTED|Overall Study||24
7774093|NCT01349114|19137878|P2|NOT COMPLETED|Overall Study||0
7774094|NCT01349114|19137879|P1|NOT COMPLETED|Overall Study||0
7774095|NCT01349114|19137878|P2|COMPLETED|Overall Study||11
7774096|NCT01349114|19137879|P1|COMPLETED|Overall Study||10
7774097|NCT01349114|19137878|P2|STARTED|Overall Study||11
7774098|NCT01349114|19137879|P1|STARTED|Overall Study||10
7774099|NCT01349049|19137896|P9|NOT COMPLETED|Overall Study||55
7774100|NCT01349049|19137897|P8|NOT COMPLETED|Overall Study||4
7774101|NCT01349049|19137898|P7|NOT COMPLETED|Overall Study||5
7774102|NCT01349049|19137899|P6|NOT COMPLETED|Overall Study||6
7774103|NCT01349049|19137900|P5|NOT COMPLETED|Overall Study||3
7774104|NCT01349049|19137901|P4|NOT COMPLETED|Overall Study||3
7774105|NCT01349049|19137902|P3|NOT COMPLETED|Overall Study||3
7774106|NCT01349049|19137903|P2|NOT COMPLETED|Overall Study||7
7774107|NCT01349049|19137904|P1|NOT COMPLETED|Overall Study||3
7774108|NCT01349049|19137896|P9|COMPLETED|Overall Study||1
7774109|NCT01349049|19137897|P8|COMPLETED|Overall Study||0
7774110|NCT01349049|19137898|P7|COMPLETED|Overall Study||0
7774111|NCT01349049|19137899|P6|COMPLETED|Overall Study||0
7774112|NCT01349049|19137900|P5|COMPLETED|Overall Study||0
7774113|NCT01349049|19137901|P4|COMPLETED|Overall Study||0
7774114|NCT01349049|19137902|P3|COMPLETED|Overall Study||0
7774115|NCT01349049|19137903|P2|COMPLETED|Overall Study||0
7774116|NCT01349049|19137904|P1|COMPLETED|Overall Study||0
7774117|NCT01349049|19137896|P9|STARTED|Overall Study||56
7774118|NCT01349049|19137897|P8|STARTED|Overall Study||4
7774119|NCT01349049|19137898|P7|STARTED|Overall Study||5
7774120|NCT01349049|19137899|P6|STARTED|Overall Study||6
7774121|NCT01349049|19137900|P5|STARTED|Overall Study||3
7774122|NCT01349049|19137901|P4|STARTED|Overall Study||3
7774123|NCT01349049|19137902|P3|STARTED|Overall Study||3
7774124|NCT01349049|19137903|P2|STARTED|Overall Study||7
7774125|NCT01349049|19137904|P1|STARTED|Overall Study||3
7774126|NCT01349036|19137958|P2|NOT COMPLETED|Overall Study||24
7774127|NCT01349036|19137959|P1|NOT COMPLETED|Overall Study||14
7774128|NCT01349036|19137958|P2|COMPLETED|Overall Study||0
7774129|NCT01349036|19137959|P1|COMPLETED|Overall Study||0
7774130|NCT01349036|19137958|P2|STARTED|Overall Study||24
7774131|NCT01349036|19137959|P1|STARTED|Overall Study||14
7774132|NCT01348854|19137977|P2|NOT COMPLETED|Overall Study||1
7774133|NCT01348854|19137978|P1|NOT COMPLETED|Overall Study||3
7774134|NCT01348854|19137977|P2|COMPLETED|Overall Study|9 eyes of 5 participants|5
7774135|NCT01348854|19137978|P1|COMPLETED|Overall Study|47 eyes of 31 participants|31
7774136|NCT01348854|19137977|P2|STARTED|Overall Study|10 eyes of 6 participants|6
7774137|NCT01348854|19137978|P1|STARTED|Overall Study|53 eyes of 34 participants|34
7774138|NCT01348789|19137986|P1|NOT COMPLETED|Overall Study||4
7774139|NCT01348789|19137986|P1|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33
7774140|NCT01348789|19137986|P1|STARTED|Overall Study||37
7774141|NCT01348776|19137997|P1|NOT COMPLETED|Overall Study||3
7774142|NCT01348776|19137997|P1|COMPLETED|Overall Study||84
7774143|NCT01348776|19137997|P1|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87
7774144|NCT01348763|19138010|P1|NOT COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||0
7774145|NCT01348763|19138010|P1|COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||11
7774146|NCT01348763|19138010|P1|STARTED|Without Tenofovir/Emtricitabine (11 Day)||11
7774147|NCT01348763|19138010|P1|NOT COMPLETED|With Tenofovir/Emtricitabine (10 Days)||2
7774148|NCT01348763|19138010|P1|COMPLETED|With Tenofovir/Emtricitabine (10 Days)||11
7774149|NCT01348763|19138010|P1|STARTED|With Tenofovir/Emtricitabine (10 Days)||13
7774150|NCT01348698|19138015|P1|NOT COMPLETED|Overall Study||72
7774151|NCT01348698|19138015|P1|COMPLETED|Overall Study||2
7774152|NCT01348698|19138015|P1|STARTED|Overall Study||74
7774153|NCT01348607|19138025|P3|NOT COMPLETED|Overall Study||0
7774154|NCT01348607|19138026|P2|NOT COMPLETED|Overall Study||0
7774155|NCT01348607|19138027|P1|NOT COMPLETED|Overall Study||0
7774156|NCT01348607|19138025|P3|COMPLETED|Overall Study||0
7774157|NCT01348607|19138026|P2|COMPLETED|Overall Study||0
7774158|NCT01348607|19138027|P1|COMPLETED|Overall Study||1
7774159|NCT01348607|19138025|P3|STARTED|Overall Study||0
7774160|NCT01348607|19138026|P2|STARTED|Overall Study||0
7774161|NCT01348607|19138027|P1|STARTED|Overall Study||1
7774162|NCT01348542|19138040|P2|NOT COMPLETED|Overall Study||0
7774163|NCT01348542|19138041|P1|NOT COMPLETED|Overall Study||3
7774164|NCT01348542|19138040|P2|COMPLETED|Overall Study||11
7774165|NCT01348542|19138041|P1|COMPLETED|Overall Study||10
7774166|NCT01348542|19138040|P2|STARTED|Overall Study||11
7774167|NCT01348542|19138041|P1|STARTED|Overall Study||13
7774168|NCT01348490|19138057|P1|NOT COMPLETED|Overall Study||24
7774169|NCT01348490|19138057|P1|COMPLETED|Overall Study||42
7774170|NCT01348490|19138057|P1|STARTED|Overall Study||66
7774171|NCT01348425|19138115|P2|NOT COMPLETED|Overall Study||1
7774172|NCT01348425|19138116|P1|NOT COMPLETED|Overall Study||1
7774173|NCT01348425|19138115|P2|COMPLETED|Overall Study||13
7774174|NCT01348425|19138116|P1|COMPLETED|Overall Study||30
7774175|NCT01348425|19138115|P2|STARTED|Overall Study||14
7774176|NCT01348425|19138116|P1|STARTED|Overall Study||31
7774177|NCT01348347|19138124|P3|NOT COMPLETED|Overall Study||6
7774178|NCT01348347|19138125|P2|NOT COMPLETED|Overall Study||6
7774179|NCT01348347|19138126|P1|NOT COMPLETED|Overall Study||3
7774180|NCT01348347|19138124|P3|COMPLETED|Overall Study||0
7774181|NCT01348347|19138125|P2|COMPLETED|Overall Study||0
7774182|NCT01348347|19138126|P1|COMPLETED|Overall Study||0
7774183|NCT01348347|19138124|P3|STARTED|Overall Study||6
7774184|NCT01348347|19138125|P2|STARTED|Overall Study||6
7774185|NCT01348347|19138126|P1|STARTED|Overall Study||3
7774186|NCT01348165|19138157|P7|NOT COMPLETED|Overall Study||1
7774187|NCT01348165|19138158|P6|NOT COMPLETED|Overall Study||0
7774188|NCT01348165|19138159|P5|NOT COMPLETED|Overall Study||0
7774189|NCT01348165|19138160|P4|NOT COMPLETED|Overall Study||0
7774190|NCT01348165|19138161|P3|NOT COMPLETED|Overall Study||0
7774191|NCT01348165|19138162|P2|NOT COMPLETED|Overall Study||0
7774192|NCT01348165|19138163|P1|NOT COMPLETED|Overall Study||0
7774193|NCT01348165|19138157|P7|COMPLETED|Overall Study||5
7774194|NCT01348165|19138158|P6|COMPLETED|Overall Study||1
7774195|NCT01348165|19138159|P5|COMPLETED|Overall Study||6
7774196|NCT01348165|19138160|P4|COMPLETED|Overall Study||6
7774197|NCT01348165|19138161|P3|COMPLETED|Overall Study||6
7774198|NCT01348165|19138162|P2|COMPLETED|Overall Study||5
7774199|NCT01348165|19138163|P1|COMPLETED|Overall Study||10
7774200|NCT01348165|19138157|P7|STARTED|Overall Study||6
7774201|NCT01348165|19138158|P6|STARTED|Overall Study||1
7774202|NCT01348165|19138159|P5|STARTED|Overall Study||6
7774203|NCT01348165|19138160|P4|STARTED|Overall Study||6
7774204|NCT01348165|19138161|P3|STARTED|Overall Study||6
7774205|NCT01348165|19138162|P2|STARTED|Overall Study||5
7774206|NCT01348165|19138163|P1|STARTED|Overall Study||10
7774207|NCT01348139|19138292|P6|NOT COMPLETED|Period 6||0
7774208|NCT01348139|19138293|P5|NOT COMPLETED|Period 6||0
7774209|NCT01348139|19138294|P4|NOT COMPLETED|Period 6||0
7774210|NCT01348139|19138295|P3|NOT COMPLETED|Period 6||0
7774211|NCT01348139|19138296|P2|NOT COMPLETED|Period 6||0
7774212|NCT01348139|19138297|P1|NOT COMPLETED|Period 6||0
7774213|NCT01348139|19138292|P6|COMPLETED|Period 6||4
7774214|NCT01348139|19138293|P5|COMPLETED|Period 6||5
7774215|NCT01348139|19138294|P4|COMPLETED|Period 6||4
7774216|NCT01348139|19138295|P3|COMPLETED|Period 6||4
7774217|NCT01348139|19138296|P2|COMPLETED|Period 6||4
7774218|NCT01348139|19138297|P1|COMPLETED|Period 6||4
7774219|NCT01348139|19138292|P6|STARTED|Period 6||4
7774220|NCT01348139|19138293|P5|STARTED|Period 6||5
7774221|NCT01348139|19138294|P4|STARTED|Period 6||4
7774222|NCT01348139|19138295|P3|STARTED|Period 6||4
7774223|NCT01348139|19138296|P2|STARTED|Period 6||4
7774224|NCT01348139|19138297|P1|STARTED|Period 6||4
7774225|NCT01348139|19138292|P6|NOT COMPLETED|Period 5||0
7774226|NCT01348139|19138293|P5|NOT COMPLETED|Period 5||0
7774227|NCT01348139|19138294|P4|NOT COMPLETED|Period 5||0
7774228|NCT01348139|19138295|P3|NOT COMPLETED|Period 5||0
7774229|NCT01348139|19138296|P2|NOT COMPLETED|Period 5||0
7774230|NCT01348139|19138297|P1|NOT COMPLETED|Period 5||0
7774231|NCT01348139|19138292|P6|COMPLETED|Period 5||4
7774232|NCT01348139|19138293|P5|COMPLETED|Period 5||5
7774233|NCT01348139|19138294|P4|COMPLETED|Period 5||4
7774234|NCT01348139|19138295|P3|COMPLETED|Period 5||4
7774235|NCT01348139|19138296|P2|COMPLETED|Period 5||4
7774236|NCT01348139|19138297|P1|COMPLETED|Period 5||4
7774237|NCT01348139|19138292|P6|STARTED|Period 5||4
7774238|NCT01348139|19138293|P5|STARTED|Period 5||5
7774239|NCT01348139|19138294|P4|STARTED|Period 5||4
7774240|NCT01348139|19138295|P3|STARTED|Period 5||4
7774241|NCT01348139|19138296|P2|STARTED|Period 5||4
7774242|NCT01348139|19138297|P1|STARTED|Period 5||4
7774243|NCT01348139|19138292|P6|NOT COMPLETED|Period 4||0
7774244|NCT01348139|19138293|P5|NOT COMPLETED|Period 4||0
7774245|NCT01348139|19138294|P4|NOT COMPLETED|Period 4||0
7774246|NCT01348139|19138295|P3|NOT COMPLETED|Period 4||0
7774247|NCT01348139|19138296|P2|NOT COMPLETED|Period 4||0
7774248|NCT01348139|19138297|P1|NOT COMPLETED|Period 4||0
7774249|NCT01348139|19138292|P6|COMPLETED|Period 4||4
7774250|NCT01348139|19138293|P5|COMPLETED|Period 4||5
7774251|NCT01348139|19138294|P4|COMPLETED|Period 4||4
7774252|NCT01348139|19138295|P3|COMPLETED|Period 4||4
7774253|NCT01348139|19138296|P2|COMPLETED|Period 4||4
7774254|NCT01348139|19138297|P1|COMPLETED|Period 4||4
7774255|NCT01348139|19138292|P6|STARTED|Period 4||4
7774256|NCT01348139|19138293|P5|STARTED|Period 4||5
7774257|NCT01348139|19138294|P4|STARTED|Period 4||4
7774258|NCT01348139|19138295|P3|STARTED|Period 4||4
7774259|NCT01348139|19138296|P2|STARTED|Period 4||4
7774260|NCT01348139|19138297|P1|STARTED|Period 4||4
7774261|NCT01348139|19138292|P6|NOT COMPLETED|Period 3||0
7774262|NCT01348139|19138293|P5|NOT COMPLETED|Period 3||0
7774263|NCT01348139|19138294|P4|NOT COMPLETED|Period 3||0
7774264|NCT01348139|19138295|P3|NOT COMPLETED|Period 3||0
7774265|NCT01348139|19138296|P2|NOT COMPLETED|Period 3||0
7774266|NCT01348139|19138297|P1|NOT COMPLETED|Period 3||0
7774267|NCT01348139|19138292|P6|COMPLETED|Period 3||4
7774268|NCT01348139|19138293|P5|COMPLETED|Period 3||5
7774269|NCT01348139|19138294|P4|COMPLETED|Period 3||4
7774270|NCT01348139|19138295|P3|COMPLETED|Period 3||4
7774271|NCT01348139|19138296|P2|COMPLETED|Period 3||4
7774272|NCT01348139|19138297|P1|COMPLETED|Period 3||4
7774273|NCT01348139|19138292|P6|STARTED|Period 3||4
7774274|NCT01348139|19138293|P5|STARTED|Period 3||5
7774275|NCT01348139|19138294|P4|STARTED|Period 3||4
7774276|NCT01348139|19138295|P3|STARTED|Period 3||4
7774277|NCT01348139|19138296|P2|STARTED|Period 3||4
7774278|NCT01348139|19138297|P1|STARTED|Period 3||4
7774279|NCT01348139|19138292|P6|NOT COMPLETED|Period 2||0
7774280|NCT01348139|19138293|P5|NOT COMPLETED|Period 2||0
7774281|NCT01348139|19138294|P4|NOT COMPLETED|Period 2||0
7774282|NCT01348139|19138295|P3|NOT COMPLETED|Period 2||0
7774283|NCT01348139|19138296|P2|NOT COMPLETED|Period 2||0
7774284|NCT01348139|19138297|P1|NOT COMPLETED|Period 2||0
7774285|NCT01348139|19138292|P6|COMPLETED|Period 2||4
7774286|NCT01348139|19138293|P5|COMPLETED|Period 2||5
7774287|NCT01348139|19138294|P4|COMPLETED|Period 2||4
7774288|NCT01348139|19138295|P3|COMPLETED|Period 2||4
7774289|NCT01348139|19138296|P2|COMPLETED|Period 2||4
7774290|NCT01348139|19138297|P1|COMPLETED|Period 2||4
7774291|NCT01348139|19138292|P6|STARTED|Period 2||4
7774292|NCT01348139|19138293|P5|STARTED|Period 2||5
7774293|NCT01348139|19138294|P4|STARTED|Period 2||4
7774294|NCT01348139|19138295|P3|STARTED|Period 2||4
7774295|NCT01348139|19138296|P2|STARTED|Period 2||4
7774296|NCT01348139|19138297|P1|STARTED|Period 2||4
7774297|NCT01348139|19138292|P6|NOT COMPLETED|Period 1||0
7774298|NCT01348139|19138293|P5|NOT COMPLETED|Period 1||0
7774299|NCT01348139|19138294|P4|NOT COMPLETED|Period 1||0
7774300|NCT01348139|19138295|P3|NOT COMPLETED|Period 1||0
7774301|NCT01348139|19138296|P2|NOT COMPLETED|Period 1||0
7774302|NCT01348139|19138297|P1|NOT COMPLETED|Period 1||1
7774303|NCT01348139|19138292|P6|COMPLETED|Period 1||4
7774304|NCT01348139|19138293|P5|COMPLETED|Period 1||5
7774305|NCT01348139|19138294|P4|COMPLETED|Period 1||4
7774306|NCT01348139|19138295|P3|COMPLETED|Period 1||4
7774307|NCT01348139|19138296|P2|COMPLETED|Period 1||4
7774308|NCT01348139|19138297|P1|COMPLETED|Period 1||4
7774309|NCT01348139|19138292|P6|STARTED|Period 1||4
7774310|NCT01348139|19138293|P5|STARTED|Period 1||5
7774311|NCT01348139|19138294|P4|STARTED|Period 1||4
7774312|NCT01348139|19138295|P3|STARTED|Period 1||4
7774313|NCT01348139|19138296|P2|STARTED|Period 1||4
7774314|NCT01348139|19138297|P1|STARTED|Period 1||5
7774315|NCT01348100|19138378|P7|NOT COMPLETED|Overall Study||3
7774316|NCT01348100|19138379|P6|NOT COMPLETED|Overall Study||2
7774317|NCT01348100|19138380|P5|NOT COMPLETED|Overall Study||1
7774318|NCT01348100|19138381|P4|NOT COMPLETED|Overall Study||1
7774319|NCT01348100|19138382|P3|NOT COMPLETED|Overall Study||2
7774320|NCT01348100|19138383|P2|NOT COMPLETED|Overall Study||0
7774321|NCT01348100|19138384|P1|NOT COMPLETED|Overall Study||0
7774322|NCT01348100|19138378|P7|COMPLETED|Overall Study||13
7774323|NCT01348100|19138379|P6|COMPLETED|Overall Study||14
7774324|NCT01348100|19138380|P5|COMPLETED|Overall Study||14
7774325|NCT01348100|19138381|P4|COMPLETED|Overall Study||14
7774326|NCT01348100|19138382|P3|COMPLETED|Overall Study||13
7774327|NCT01348100|19138383|P2|COMPLETED|Overall Study||2
7774328|NCT01348100|19138384|P1|COMPLETED|Overall Study||2
7774329|NCT01348100|19138378|P7|STARTED|Overall Study||16
7774330|NCT01348100|19138379|P6|STARTED|Overall Study||16
7774331|NCT01348100|19138380|P5|STARTED|Overall Study||15
7774332|NCT01348100|19138381|P4|STARTED|Overall Study||15
7774333|NCT01348100|19138382|P3|STARTED|Overall Study||15
7774334|NCT01348100|19138383|P2|STARTED|Overall Study||2
7774335|NCT01348100|19138384|P1|STARTED|Overall Study||2
7774336|NCT01348087|19138429|P1|NOT COMPLETED|Overall Study||148
7774337|NCT01348087|19138429|P1|COMPLETED|Overall Study||0
7774338|NCT01348087|19138429|P1|STARTED|Overall Study||148
7774339|NCT01347931|19138443|P1|NOT COMPLETED|NIOV System||0
7774340|NCT01347931|19138443|P1|COMPLETED|NIOV System||29
7774341|NCT01347931|19138443|P1|STARTED|NIOV System||29
7774342|NCT01347931|19138443|P1|NOT COMPLETED|Standard Oxygen Therapy||1
7774343|NCT01347931|19138443|P1|COMPLETED|Standard Oxygen Therapy||29
7774344|NCT01347931|19138443|P1|STARTED|Standard Oxygen Therapy||30
7774345|NCT01347879|19138455|P2|NOT COMPLETED|Overall Study||17
7774346|NCT01347879|19138456|P1|NOT COMPLETED|Overall Study||7
7774347|NCT01347879|19138455|P2|COMPLETED|Overall Study||83
7774348|NCT01347879|19138456|P1|COMPLETED|Overall Study||46
7774349|NCT01347879|19138455|P2|STARTED|Overall Study||100
7774350|NCT01347879|19138456|P1|STARTED|Overall Study||53
7774351|NCT01347866|19138505|P17|NOT COMPLETED|Overall Study||2
7774352|NCT01347866|19138506|P16|NOT COMPLETED|Overall Study||4
7774353|NCT01347866|19138507|P15|NOT COMPLETED|Overall Study||3
7774354|NCT01347866|19138508|P14|NOT COMPLETED|Overall Study||7
7774355|NCT01347866|19138509|P13|NOT COMPLETED|Overall Study||7
7774356|NCT01347866|19138510|P12|NOT COMPLETED|Overall Study||4
7774357|NCT01347866|19138511|P11|NOT COMPLETED|Overall Study||3
7774358|NCT01347866|19138512|P10|NOT COMPLETED|Overall Study||7
7774359|NCT01347866|19138513|P9|NOT COMPLETED|Overall Study||31
7774360|NCT01347866|19138514|P8|NOT COMPLETED|Overall Study||4
7774361|NCT01347866|19138515|P7|NOT COMPLETED|Overall Study||6
7774362|NCT01347866|19138516|P6|NOT COMPLETED|Overall Study||3
7774363|NCT01347866|19138517|P5|NOT COMPLETED|Overall Study||7
7774364|NCT01347866|19138518|P4|NOT COMPLETED|Overall Study||7
7774365|NCT01347866|19138519|P3|NOT COMPLETED|Overall Study||1
7774366|NCT01347866|19138520|P2|NOT COMPLETED|Overall Study||1
7774367|NCT01347866|19138521|P1|NOT COMPLETED|Overall Study||5
7774368|NCT01347866|19138505|P17|COMPLETED|Overall Study||0
7774369|NCT01347866|19138506|P16|COMPLETED|Overall Study||0
7774370|NCT01347866|19138507|P15|COMPLETED|Overall Study||0
7774371|NCT01347866|19138508|P14|COMPLETED|Overall Study||0
7774372|NCT01347866|19138509|P13|COMPLETED|Overall Study||0
7774373|NCT01347866|19138510|P12|COMPLETED|Overall Study||0
7774374|NCT01347866|19138511|P11|COMPLETED|Overall Study||0
7774375|NCT01347866|19138512|P10|COMPLETED|Overall Study||0
7774376|NCT01347866|19138513|P9|COMPLETED|Overall Study||0
7774377|NCT01347866|19138514|P8|COMPLETED|Overall Study||0
7774378|NCT01347866|19138515|P7|COMPLETED|Overall Study||0
7774379|NCT01347866|19138516|P6|COMPLETED|Overall Study||0
7774380|NCT01347866|19138517|P5|COMPLETED|Overall Study||0
7774381|NCT01347866|19138518|P4|COMPLETED|Overall Study||0
7774382|NCT01347866|19138519|P3|COMPLETED|Overall Study||0
7774383|NCT01347866|19138520|P2|COMPLETED|Overall Study||0
7774384|NCT01347866|19138521|P1|COMPLETED|Overall Study||0
7774385|NCT01347866|19138505|P17|STARTED|Overall Study||2
7774386|NCT01347866|19138506|P16|STARTED|Overall Study||4
7774387|NCT01347866|19138507|P15|STARTED|Overall Study||3
7774388|NCT01347866|19138508|P14|STARTED|Overall Study||7
7774389|NCT01347866|19138509|P13|STARTED|Overall Study||7
7774390|NCT01347866|19138510|P12|STARTED|Overall Study||4
7774391|NCT01347866|19138511|P11|STARTED|Overall Study||3
7774392|NCT01347866|19138512|P10|STARTED|Overall Study||7
7774393|NCT01347866|19138513|P9|STARTED|Overall Study||31
7774394|NCT01347866|19138514|P8|STARTED|Overall Study||4
7774395|NCT01347866|19138515|P7|STARTED|Overall Study||6
7774396|NCT01347866|19138516|P6|STARTED|Overall Study||3
7774397|NCT01347866|19138517|P5|STARTED|Overall Study||7
7774398|NCT01347866|19138518|P4|STARTED|Overall Study||7
7774399|NCT01347866|19138519|P3|STARTED|Overall Study||1
7774400|NCT01347866|19138520|P2|STARTED|Overall Study||1
7774401|NCT01347866|19138521|P1|STARTED|Overall Study||5
7774402|NCT01347840|19138895|P1|NOT COMPLETED|Overall Study||1
7774403|NCT01347840|19138895|P1|COMPLETED|Overall Study||0
7774404|NCT01347840|19138895|P1|STARTED|Overall Study|1 subject enrolled but withdrew consent|1
7774405|NCT01347788|19138908|P3|NOT COMPLETED|Overall Study||0
7774406|NCT01347788|19138909|P2|NOT COMPLETED|Overall Study||0
7774407|NCT01347788|19138910|P1|NOT COMPLETED|Overall Study||0
7774408|NCT01347788|19138908|P3|COMPLETED|Overall Study||13
7774409|NCT01347788|19138909|P2|COMPLETED|Overall Study||10
7774410|NCT01347788|19138910|P1|COMPLETED|Overall Study||11
7774411|NCT01347788|19138908|P3|STARTED|Overall Study||13
7774412|NCT01347788|19138909|P2|STARTED|Overall Study||10
7774413|NCT01347788|19138910|P1|STARTED|Overall Study||11
7774414|NCT01347762|19138922|P4|NOT COMPLETED|Overall Study||8
7774415|NCT01347762|19138923|P3|NOT COMPLETED|Overall Study||9
7774416|NCT01347762|19138924|P2|NOT COMPLETED|Overall Study||2
7774417|NCT01347762|19138925|P1|NOT COMPLETED|Overall Study||4
7774418|NCT01347762|19138922|P4|COMPLETED|Overall Study||10
7774419|NCT01347762|19138923|P3|COMPLETED|Overall Study||7
7774420|NCT01347762|19138924|P2|COMPLETED|Overall Study||6
7774421|NCT01347762|19138925|P1|COMPLETED|Overall Study||6
7774422|NCT01347762|19138922|P4|STARTED|Overall Study||18
7774423|NCT01347762|19138923|P3|STARTED|Overall Study||16
7774424|NCT01347762|19138924|P2|STARTED|Overall Study||8
7774425|NCT01347762|19138925|P1|STARTED|Overall Study||10
7774426|NCT01347710|19138951|P1|NOT COMPLETED|Overall Study||31
7774427|NCT01347710|19138951|P1|COMPLETED|Overall Study||764
7774428|NCT01347710|19138951|P1|STARTED|Overall Study||795
7774429|NCT01347632|19138966|P1|NOT COMPLETED|Overall Study||2
7774430|NCT01347632|19138966|P1|COMPLETED|Overall Study||33
7774431|NCT01347632|19138966|P1|STARTED|Overall Study||35
7774432|NCT01347580|19138973|P2|NOT COMPLETED|Overall Study||56
7774433|NCT01347580|19138974|P1|NOT COMPLETED|Overall Study||65
7774434|NCT01347580|19138973|P2|COMPLETED|Overall Study|based on randomized treatment|897
7774435|NCT01347580|19138974|P1|COMPLETED|Overall Study|based on randomized treatment|844
7774436|NCT01347580|19138973|P2|Safety Population|Overall Study|based on actual treatment|950
7774437|NCT01347580|19138974|P1|Safety Population|Overall Study|based on actual treatment|908
7774438|NCT01347580|19138973|P2|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952
7774439|NCT01347580|19138974|P1|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906
7774440|NCT01347580|19138973|P2|STARTED|Overall Study|based on randomized treatment|953
7774441|NCT01347580|19138974|P1|STARTED|Overall Study|based on randomized treatment|909
7774442|NCT01347554|19139004|P2|NOT COMPLETED|Overall Study||11
7774443|NCT01347554|19139005|P1|NOT COMPLETED|Overall Study||7
7774444|NCT01347554|19139004|P2|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231
7774445|NCT01347554|19139005|P1|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230
7774446|NCT01347554|19139004|P2|STARTED|Overall Study||242
7774447|NCT01347554|19139005|P1|STARTED|Overall Study||237
7774448|NCT01347333|19139019|P2|NOT COMPLETED|Overall Study||0
7774449|NCT01347333|19139020|P1|NOT COMPLETED|Overall Study||0
7774450|NCT01347333|19139019|P2|COMPLETED|Overall Study||0
7774451|NCT01347333|19139020|P1|COMPLETED|Overall Study||23
7774452|NCT01347333|19139019|P2|STARTED|Overall Study|No participants were enrolled in the Primary Liver Tumor arm.|0
7774453|NCT01347333|19139020|P1|STARTED|Overall Study||23
7774454|NCT01347307|19139030|P2|NOT COMPLETED|Overall Study||5
7774455|NCT01347307|19139031|P1|NOT COMPLETED|Overall Study||0
7774456|NCT01347307|19139030|P2|COMPLETED|Overall Study||28
7774457|NCT01347307|19139031|P1|COMPLETED|Overall Study||3
7774458|NCT01347307|19139030|P2|STARTED|Overall Study||33
7774459|NCT01347307|19139031|P1|STARTED|Overall Study||3
7774460|NCT01347255|19139041|P1|NOT COMPLETED|Overall Study||0
7774461|NCT01347255|19139041|P1|COMPLETED|Overall Study||24
7774462|NCT01347255|19139041|P1|STARTED|Overall Study||24
7774463|NCT01347112|19139066|P2|NOT COMPLETED|Overall Study||12
7774464|NCT01347112|19139067|P1|NOT COMPLETED|Overall Study||4
7774465|NCT01347112|19139066|P2|COMPLETED|Overall Study||5
7774466|NCT01347112|19139067|P1|COMPLETED|Overall Study||12
7774467|NCT01347112|19139066|P2|STARTED|Overall Study||17
7774468|NCT01347112|19139067|P1|STARTED|Overall Study||16
7774469|NCT01347086|19139087|P10|NOT COMPLETED|Overall Study||1
7774470|NCT01347086|19139088|P9|NOT COMPLETED|Overall Study||0
7774471|NCT01347086|19139089|P8|NOT COMPLETED|Overall Study||1
7774472|NCT01347086|19139090|P7|NOT COMPLETED|Overall Study||1
7774473|NCT01347086|19139091|P6|NOT COMPLETED|Overall Study||0
7774474|NCT01347086|19139092|P5|NOT COMPLETED|Overall Study||0
7774475|NCT01347086|19139093|P4|NOT COMPLETED|Overall Study||0
7774476|NCT01347086|19139094|P3|NOT COMPLETED|Overall Study||1
7774477|NCT01347086|19139095|P2|NOT COMPLETED|Overall Study||0
7774478|NCT01347086|19139096|P1|NOT COMPLETED|Overall Study||0
7774479|NCT01347086|19139087|P10|COMPLETED|Overall Study||6
7774480|NCT01347086|19139088|P9|COMPLETED|Overall Study||6
7774481|NCT01347086|19139089|P8|COMPLETED|Overall Study||6
7774482|NCT01347086|19139090|P7|COMPLETED|Overall Study||6
7774483|NCT01347086|19139091|P6|COMPLETED|Overall Study||6
7774484|NCT01347086|19139092|P5|COMPLETED|Overall Study||6
7774485|NCT01347086|19139093|P4|COMPLETED|Overall Study||6
7774486|NCT01347086|19139094|P3|COMPLETED|Overall Study||6
7774487|NCT01347086|19139095|P2|COMPLETED|Overall Study||6
7774488|NCT01347086|19139096|P1|COMPLETED|Overall Study||2
7774489|NCT01347086|19139087|P10|STARTED|Overall Study|One subject was not treated.|7
7774490|NCT01347086|19139088|P9|STARTED|Overall Study||6
7774491|NCT01347086|19139089|P8|STARTED|Overall Study|One subject was not treated.|7
7774492|NCT01347086|19139090|P7|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.
~1 subject was not treated."|7
7774493|NCT01347086|19139091|P6|STARTED|Overall Study||6
7774494|NCT01347086|19139092|P5|STARTED|Overall Study||6
7774495|NCT01347086|19139093|P4|STARTED|Overall Study||6
7774496|NCT01347086|19139094|P3|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.
~1 subject was not treated."|7
7774497|NCT01347086|19139095|P2|STARTED|Overall Study||6
7774498|NCT01347086|19139096|P1|STARTED|Overall Study||2
7774499|NCT01347073|19139195|P1|NOT COMPLETED|Overall Study||2
7774500|NCT01347073|19139195|P1|COMPLETED|Overall Study||21
7774501|NCT01347073|19139195|P1|STARTED|Overall Study||23
7774502|NCT01347060|19139209|P2|NOT COMPLETED|Overall Study||0
7774503|NCT01347060|19139210|P1|NOT COMPLETED|Overall Study||0
7774504|NCT01347060|19139209|P2|COMPLETED|Overall Study||7580
7774505|NCT01347060|19139210|P1|COMPLETED|Overall Study||9868
7774506|NCT01347060|19139209|P2|STARTED|Overall Study||7580
7774507|NCT01347060|19139210|P1|STARTED|Overall Study||9868
7774508|NCT01347034|19139222|P2|NOT COMPLETED|Overall Study||0
7774509|NCT01347034|19139223|P1|NOT COMPLETED|Overall Study||0
7774510|NCT01347034|19139222|P2|COMPLETED|Overall Study||14
7774511|NCT01347034|19139223|P1|COMPLETED|Overall Study||6
7774512|NCT01347034|19139222|P2|STARTED|Overall Study||14
7774513|NCT01347034|19139223|P1|STARTED|Overall Study||6
7774514|NCT01347008|19139233|P2|NOT COMPLETED|Overall Study||0
7774515|NCT01347008|19139234|P1|NOT COMPLETED|Overall Study||0
7774516|NCT01347008|19139233|P2|COMPLETED|Overall Study||20
7774517|NCT01347008|19139234|P1|COMPLETED|Overall Study||21
7774518|NCT01347008|19139233|P2|STARTED|Overall Study||20
7774519|NCT01347008|19139234|P1|STARTED|Overall Study||21
7774520|NCT01346852|19139246|P2|NOT COMPLETED|Overall Study||0
7774521|NCT01346852|19139247|P1|NOT COMPLETED|Overall Study||0
7774522|NCT01346852|19139246|P2|COMPLETED|Overall Study||59684
7774523|NCT01346852|19139247|P1|COMPLETED|Overall Study||41753
7774524|NCT01346852|19139246|P2|STARTED|Overall Study||59684
7774525|NCT01346852|19139247|P1|STARTED|Overall Study||41753
7774526|NCT01346839|19139257|P2|NOT COMPLETED|Overall Study||209
7774527|NCT01346839|19139258|P1|NOT COMPLETED|Overall Study||314
7774528|NCT01346839|19139257|P2|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364
7774529|NCT01346839|19139258|P1|COMPLETED|Overall Study||369
7774530|NCT01346839|19139257|P2|STARTED|Overall Study||573
7774531|NCT01346839|19139258|P1|STARTED|Overall Study||683
7774532|NCT01346774|19139274|P2|NOT COMPLETED|Overall Study||17
7774533|NCT01346774|19139275|P1|NOT COMPLETED|Overall Study||13
7774534|NCT01346774|19139274|P2|COMPLETED|Overall Study||63
7774535|NCT01346774|19139275|P1|COMPLETED|Overall Study||67
7774536|NCT01346774|19139274|P2|STARTED|Overall Study||80
7774537|NCT01346774|19139275|P1|STARTED|Overall Study||80
7774538|NCT01346696|19139281|P1|NOT COMPLETED|Overall Study||1
7774539|NCT01346696|19139281|P1|COMPLETED|Overall Study||44
7774540|NCT01346696|19139281|P1|STARTED|Overall Study||45
7774541|NCT01346683|19139292|P1|NOT COMPLETED|Overall Study||0
7774542|NCT01346683|19139292|P1|COMPLETED|Overall Study||45
7774543|NCT01346683|19139292|P1|STARTED|Overall Study||45
7774544|NCT01346592|19139303|P3|NOT COMPLETED|Overall Study||78
7774545|NCT01346592|19139304|P2|NOT COMPLETED|Overall Study||89
7774546|NCT01346592|19139305|P1|NOT COMPLETED|Overall Study||153
7774547|NCT01346592|19139303|P3|COMPLETED|Overall Study||1408
7774548|NCT01346592|19139304|P2|COMPLETED|Overall Study||1389
7774549|NCT01346592|19139305|P1|COMPLETED|Overall Study||2983
7774550|NCT01346592|19139303|P3|STARTED|Overall Study||1486
7774551|NCT01346592|19139304|P2|STARTED|Overall Study||1478
7774552|NCT01346592|19139305|P1|STARTED|Overall Study||3136
7774553|NCT01346540|19139397|P2|NOT COMPLETED|Overall Study||12
7774554|NCT01346540|19139398|P1|NOT COMPLETED|Overall Study||3
7774555|NCT01346540|19139397|P2|COMPLETED|Overall Study||0
7774556|NCT01346540|19139398|P1|COMPLETED|Overall Study||1
7774557|NCT01346540|19139397|P2|STARTED|Overall Study||12
7774558|NCT01346540|19139398|P1|STARTED|Overall Study||4
7774559|NCT01346514|19139409|P2|NOT COMPLETED|Overall Study||37
7774560|NCT01346514|19139410|P1|NOT COMPLETED|Overall Study||29
7774561|NCT01346514|19139409|P2|COMPLETED|Overall Study|Number of patients completing BL-12 months.|53
7774562|NCT01346514|19139410|P1|COMPLETED|Overall Study|Number of patients completing BL-12 months|62
7774563|NCT01346514|19139409|P2|12 Month Assessment|Overall Study||53
7774564|NCT01346514|19139410|P1|12 Month Assessment|Overall Study||62
7774565|NCT01346514|19139409|P2|9 Month Assessment|Overall Study||59
7774566|NCT01346514|19139410|P1|9 Month Assessment|Overall Study||67
7774567|NCT01346514|19139409|P2|6 Month Assessment|Overall Study||61
7774568|NCT01346514|19139410|P1|6 Month Assessment|Overall Study||74
7774569|NCT01346514|19139409|P2|3 Month Assessment|Overall Study||68
7774570|NCT01346514|19139410|P1|3 Month Assessment|Overall Study||83
7774571|NCT01346514|19139409|P2|STARTED|Overall Study||90
7774572|NCT01346514|19139410|P1|STARTED|Overall Study||91
7774573|NCT01346501|19139430|P2|NOT COMPLETED|Overall Study||13
7774574|NCT01346501|19139431|P1|NOT COMPLETED|Overall Study||11
7774575|NCT01346501|19139430|P2|COMPLETED|Overall Study||80
7774576|NCT01346501|19139431|P1|COMPLETED|Overall Study||68
7774577|NCT01346501|19139430|P2|STARTED|Overall Study||93
7774578|NCT01346501|19139431|P1|STARTED|Overall Study||79
7774579|NCT01346488|19139444|P1|NOT COMPLETED|Overall Study||706
7774580|NCT01346488|19139444|P1|COMPLETED|Overall Study||1262
7774581|NCT01346488|19139444|P1|STARTED|Overall Study||1968
7774582|NCT01346475|19139464|P2|NOT COMPLETED|Second Intervention||0
7774583|NCT01346475|19139465|P1|NOT COMPLETED|Second Intervention||0
7774584|NCT01346475|19139464|P2|COMPLETED|Second Intervention||25
7774585|NCT01346475|19139465|P1|COMPLETED|Second Intervention||18
7774586|NCT01346475|19139464|P2|STARTED|Second Intervention||25
7774587|NCT01346475|19139465|P1|STARTED|Second Intervention||18
7774588|NCT01346475|19139464|P2|NOT COMPLETED|First Intervention||3
7774589|NCT01346475|19139465|P1|NOT COMPLETED|First Intervention||4
7774590|NCT01346475|19139464|P2|COMPLETED|First Intervention||25
7774591|NCT01346475|19139465|P1|COMPLETED|First Intervention||18
7774592|NCT01346475|19139464|P2|STARTED|First Intervention||28
7774593|NCT01346475|19139465|P1|STARTED|First Intervention||22
7774594|NCT01346410|19139477|P1|NOT COMPLETED|Overall Study||1
7774595|NCT01346410|19139477|P1|COMPLETED|Overall Study||0
7774596|NCT01346410|19139477|P1|STARTED|Overall Study||1
7774597|NCT01346397|19139484|P2|NOT COMPLETED|Overall Study||0
7774598|NCT01346397|19139485|P1|NOT COMPLETED|Overall Study||0
7774599|NCT01346397|19139484|P2|COMPLETED|Overall Study||85
7774600|NCT01346397|19139485|P1|COMPLETED|Overall Study||85
7774601|NCT01346397|19139484|P2|STARTED|Overall Study||85
7774602|NCT01346397|19139485|P1|STARTED|Overall Study||85
7774603|NCT01346371|19139495|P2|NOT COMPLETED|Overall Study||0
7774604|NCT01346371|19139496|P1|NOT COMPLETED|Overall Study||2
7774605|NCT01346371|19139495|P2|COMPLETED|Overall Study||20
7774606|NCT01346371|19139496|P1|COMPLETED|Overall Study||18
7774607|NCT01346371|19139495|P2|STARTED|Overall Study||20
7774608|NCT01346371|19139496|P1|STARTED|Overall Study||20
7774609|NCT01346293|19139504|P2|NOT COMPLETED|Overall Study||21
7774610|NCT01346293|19139505|P1|NOT COMPLETED|Overall Study||67
7774611|NCT01346293|19139504|P2|COMPLETED|Overall Study||608
7774612|NCT01346293|19139505|P1|COMPLETED|Overall Study||2676
7774613|NCT01346293|19139504|P2|STARTED|Overall Study||629
7774614|NCT01346293|19139505|P1|STARTED|Overall Study||2743
7774615|NCT01346189|19139535|P4|NOT COMPLETED|Overall Study||11
7774616|NCT01346189|19139536|P3|NOT COMPLETED|Overall Study||14
7774617|NCT01346189|19139537|P2|NOT COMPLETED|Overall Study||17
7774618|NCT01346189|19139538|P1|NOT COMPLETED|Overall Study||16
7774619|NCT01346189|19139535|P4|COMPLETED|Overall Study|366 patients (58 primary care physicians) included in analysis|355
7774620|NCT01346189|19139536|P3|COMPLETED|Overall Study|346 patients (58 primary care physicians) included in analysis|332
7774621|NCT01346189|19139537|P2|COMPLETED|Overall Study|358 Patients (58 primary care physicians) included in analysis|341
7774622|NCT01346189|19139538|P1|COMPLETED|Overall Study|433 patients (64 primary care physicians) included in analysis|417
7774623|NCT01346189|19139535|P4|STARTED|Overall Study||366
7774624|NCT01346189|19139536|P3|STARTED|Overall Study||346
7774625|NCT01346189|19139537|P2|STARTED|Overall Study||358
7774626|NCT01346189|19139538|P1|STARTED|Overall Study||433
7774627|NCT01346176|19139555|P3|NOT COMPLETED|Completed Satisfaction Survey||6
7774628|NCT01346176|19139556|P2|NOT COMPLETED|Completed Satisfaction Survey||4
7774629|NCT01346176|19139557|P1|NOT COMPLETED|Completed Satisfaction Survey||6
7774630|NCT01346176|19139555|P3|COMPLETED|Completed Satisfaction Survey||27
7774631|NCT01346176|19139556|P2|COMPLETED|Completed Satisfaction Survey||22
7774632|NCT01346176|19139557|P1|COMPLETED|Completed Satisfaction Survey||29
7774633|NCT01346176|19139555|P3|STARTED|Completed Satisfaction Survey||33
7774634|NCT01346176|19139556|P2|STARTED|Completed Satisfaction Survey||26
7774635|NCT01346176|19139557|P1|STARTED|Completed Satisfaction Survey||35
7774636|NCT01346176|19139555|P3|NOT COMPLETED|Completed Advance Directive||10
7774637|NCT01346176|19139556|P2|NOT COMPLETED|Completed Advance Directive||14
7774638|NCT01346176|19139557|P1|NOT COMPLETED|Completed Advance Directive||13
7774639|NCT01346176|19139555|P3|COMPLETED|Completed Advance Directive||33
7774640|NCT01346176|19139556|P2|COMPLETED|Completed Advance Directive||26
7774641|NCT01346176|19139557|P1|COMPLETED|Completed Advance Directive||35
7774642|NCT01346176|19139555|P3|STARTED|Completed Advance Directive||43
7774643|NCT01346176|19139556|P2|STARTED|Completed Advance Directive||40
7774644|NCT01346176|19139557|P1|STARTED|Completed Advance Directive||48
7774645|NCT01346176|19139555|P3|NOT COMPLETED|Recruited||0
7774646|NCT01346176|19139556|P2|NOT COMPLETED|Recruited||0
7774647|NCT01346176|19139557|P1|NOT COMPLETED|Recruited||1
7774648|NCT01346176|19139555|P3|COMPLETED|Recruited||43
7774649|NCT01346176|19139556|P2|COMPLETED|Recruited||40
7774650|NCT01346176|19139557|P1|COMPLETED|Recruited||48
7774651|NCT01346176|19139555|P3|STARTED|Recruited||43
7774652|NCT01346176|19139556|P2|STARTED|Recruited||40
7774653|NCT01346176|19139557|P1|STARTED|Recruited||49
7774654|NCT01346085|19139568|P1|NOT COMPLETED|Overall Study||0
7774655|NCT01346085|19139568|P1|COMPLETED|Overall Study||10
7774656|NCT01346085|19139568|P1|STARTED|Overall Study||10
7774657|NCT01346072|19139575|P2|NOT COMPLETED|Overall Study||0
7774658|NCT01346072|19139576|P1|NOT COMPLETED|Overall Study||0
7774659|NCT01346072|19139575|P2|COMPLETED|Overall Study||10
7774660|NCT01346072|19139576|P1|COMPLETED|Overall Study||11
7774661|NCT01346072|19139575|P2|STARTED|Overall Study||10
7774662|NCT01346072|19139576|P1|STARTED|Overall Study||11
7774663|NCT01346059|19139586|P2|NOT COMPLETED|Overall Study||0
7774664|NCT01346059|19139587|P1|NOT COMPLETED|Overall Study||1
7774665|NCT01346059|19139586|P2|COMPLETED|Overall Study||1
7774666|NCT01346059|19139587|P1|COMPLETED|Overall Study||0
7774667|NCT01346059|19139586|P2|STARTED|Overall Study||1
7774668|NCT01346059|19139587|P1|STARTED|Overall Study||1
7774669|NCT01345929|19139599|P2|NOT COMPLETED|Overall Study||19
7774670|NCT01345929|19139600|P1|NOT COMPLETED|Overall Study||21
7774671|NCT01345929|19139599|P2|COMPLETED|Overall Study||516
7774672|NCT01345929|19139600|P1|COMPLETED|Overall Study||512
7774673|NCT01345929|19139599|P2|STARTED|Overall Study||535
7774674|NCT01345929|19139600|P1|STARTED|Overall Study||533
7774675|NCT01345786|19139612|P4|NOT COMPLETED|Overall Study||3
7774676|NCT01345786|19139613|P3|NOT COMPLETED|Overall Study||5
7774677|NCT01345786|19139614|P2|NOT COMPLETED|Overall Study||8
7774678|NCT01345786|19139615|P1|NOT COMPLETED|Overall Study||6
7774679|NCT01345786|19139612|P4|COMPLETED|Overall Study||35
7774680|NCT01345786|19139613|P3|COMPLETED|Overall Study||33
7774681|NCT01345786|19139614|P2|COMPLETED|Overall Study||33
7774682|NCT01345786|19139615|P1|COMPLETED|Overall Study||35
7774683|NCT01345786|19139612|P4|Treated|Overall Study||37
7774684|NCT01345786|19139613|P3|Treated|Overall Study||37
7774685|NCT01345786|19139614|P2|Treated|Overall Study||41
7774686|NCT01345786|19139615|P1|Treated|Overall Study||41
7774687|NCT01345786|19139612|P4|STARTED|Overall Study|Number randomized|38
7774688|NCT01345786|19139613|P3|STARTED|Overall Study|Number randomized|38
7774689|NCT01345786|19139614|P2|STARTED|Overall Study|Number randomized|41
7774690|NCT01345786|19139615|P1|STARTED|Overall Study|Number randomized|41
7774691|NCT01345721|19139664|P3|NOT COMPLETED|Overall Study||0
7774692|NCT01345721|19139665|P2|NOT COMPLETED|Overall Study||0
7774693|NCT01345721|19139666|P1|NOT COMPLETED|Overall Study||0
7774694|NCT01345721|19139664|P3|COMPLETED|Overall Study||65
7774695|NCT01345721|19139665|P2|COMPLETED|Overall Study||66
7774696|NCT01345721|19139666|P1|COMPLETED|Overall Study||74
7774697|NCT01345721|19139664|P3|STARTED|Overall Study||65
7774698|NCT01345721|19139665|P2|STARTED|Overall Study||66
7774699|NCT01345721|19139666|P1|STARTED|Overall Study||74
7774700|NCT01345682|19139695|P2|NOT COMPLETED|Overall Study||161
7774701|NCT01345682|19139696|P1|NOT COMPLETED|Overall Study||322
7774702|NCT01345682|19139695|P2|COMPLETED|Overall Study||0
7774703|NCT01345682|19139696|P1|COMPLETED|Overall Study||0
7774704|NCT01345682|19139695|P2|STARTED|Overall Study|Randomised|161
7774705|NCT01345682|19139696|P1|STARTED|Overall Study|Randomised|322
7774706|NCT01345669|19139730|P2|NOT COMPLETED|Overall Study||119
7774707|NCT01345669|19139731|P1|NOT COMPLETED|Overall Study||287
7774708|NCT01345669|19139730|P2|COMPLETED|Overall Study||87
7774709|NCT01345669|19139731|P1|COMPLETED|Overall Study||124
7774710|NCT01345669|19139730|P2|STARTED|Overall Study||206
7774711|NCT01345669|19139731|P1|STARTED|Overall Study||411
7774712|NCT01345630|19139749|P2|NOT COMPLETED|Overall Study||359
7774713|NCT01345630|19139750|P1|NOT COMPLETED|Overall Study||361
7774714|NCT01345630|19139749|P2|COMPLETED|Overall Study||42
7774715|NCT01345630|19139750|P1|COMPLETED|Overall Study||35
7774716|NCT01345630|19139749|P2|STARTED|Overall Study||401
7774717|NCT01345630|19139750|P1|STARTED|Overall Study||396
7774718|NCT01345591|19139806|P1|NOT COMPLETED|Overall Study||1
7774719|NCT01345591|19139806|P1|COMPLETED|Overall Study||19
7774720|NCT01345591|19139806|P1|STARTED|Overall Study||20
7774721|NCT01345513|19139815|P1|NOT COMPLETED|Overall Study||0
7774722|NCT01345513|19139815|P1|COMPLETED|Overall Study||50
7774723|NCT01345513|19139815|P1|STARTED|Overall Study||50
7774724|NCT01345318|19139822|P1|NOT COMPLETED|Overall Study||80
7774725|NCT01345318|19139822|P1|COMPLETED|Overall Study||111
7774726|NCT01345318|19139822|P1|STARTED|Overall Study||191
7774727|NCT01345292|19139830|P3|NOT COMPLETED|Overall Study||1
7774728|NCT01345292|19139831|P2|NOT COMPLETED|Overall Study||0
7774729|NCT01345292|19139832|P1|NOT COMPLETED|Overall Study||2
7774730|NCT01345292|19139830|P3|COMPLETED|Overall Study||74
7774731|NCT01345292|19139831|P2|COMPLETED|Overall Study||76
7774732|NCT01345292|19139832|P1|COMPLETED|Overall Study||73
7774733|NCT01345292|19139830|P3|STARTED|Overall Study||75
7774734|NCT01345292|19139831|P2|STARTED|Overall Study||76
7774735|NCT01345292|19139832|P1|STARTED|Overall Study||75
7774736|NCT01345253|19139863|P2|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||144
7774737|NCT01345253|19139864|P1|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||65
7774738|NCT01345253|19139863|P2|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||146
7774739|NCT01345253|19139864|P1|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||69
7774740|NCT01345253|19139863|P2|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 16 China par. from Safety Pop|290
7774741|NCT01345253|19139864|P1|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 9 China par. from Safety Pop|134
7774742|NCT01345253|19139863|P2|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||79
7774743|NCT01345253|19139864|P1|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||56
7774744|NCT01345253|19139863|P2|COMPLETED|Double-blind (DB) Phase (52 Weeks)||372
7774745|NCT01345253|19139864|P1|COMPLETED|Double-blind (DB) Phase (52 Weeks)||170
7774746|NCT01345253|19139863|P2|STARTED|Double-blind (DB) Phase (52 Weeks)||451
7774747|NCT01345253|19139864|P1|STARTED|Double-blind (DB) Phase (52 Weeks)||226
7774748|NCT01345240|19139885|P5|NOT COMPLETED|Overall Study||10
7774749|NCT01345240|19139886|P4|NOT COMPLETED|Overall Study||9
7774750|NCT01345240|19139887|P3|NOT COMPLETED|Overall Study||18
7774751|NCT01345240|19139888|P2|NOT COMPLETED|Overall Study||14
7774752|NCT01345240|19139889|P1|NOT COMPLETED|Overall Study||11
7774753|NCT01345240|19139885|P5|COMPLETED|Overall Study||129
7774754|NCT01345240|19139886|P4|COMPLETED|Overall Study||132
7774755|NCT01345240|19139887|P3|COMPLETED|Overall Study||123
7774756|NCT01345240|19139888|P2|COMPLETED|Overall Study||128
7774757|NCT01345240|19139889|P1|COMPLETED|Overall Study||131
7774758|NCT01345240|19139885|P5|STARTED|Overall Study||139
7774759|NCT01345240|19139886|P4|STARTED|Overall Study||141
7774760|NCT01345240|19139887|P3|STARTED|Overall Study||141
7774761|NCT01345240|19139888|P2|STARTED|Overall Study||142
7774762|NCT01345240|19139889|P1|STARTED|Overall Study||142
7774763|NCT01345188|19140009|P1|NOT COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||1
7774764|NCT01345188|19140009|P1|COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||25
7774765|NCT01345188|19140009|P1|STARTED|Crossover Ranolazine/Placebo 6 Weeks||26
7774766|NCT01345188|19140009|P1|NOT COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||2
7774767|NCT01345188|19140009|P1|COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||26
7774768|NCT01345188|19140009|P1|STARTED|Randomization Ranolazine/Placebo 6 Weeks||28
7774769|NCT01345162|19140021|P2|NOT COMPLETED|Overall Study||4
7774770|NCT01345162|19140022|P1|NOT COMPLETED|Overall Study||2
7774771|NCT01345162|19140021|P2|COMPLETED|Overall Study||96
7774772|NCT01345162|19140022|P1|COMPLETED|Overall Study||98
7774773|NCT01345162|19140021|P2|STARTED|Overall Study||100
7774774|NCT01345162|19140022|P1|STARTED|Overall Study||100
7774775|NCT01345123|19140031|P3|NOT COMPLETED|Overall Study||88
7774776|NCT01345123|19140032|P2|NOT COMPLETED|Overall Study||85
7774777|NCT01345123|19140033|P1|NOT COMPLETED|Overall Study||79
7774778|NCT01345123|19140031|P3|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203
7774779|NCT01345123|19140032|P2|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226
7774780|NCT01345123|19140033|P1|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244
7774781|NCT01345123|19140031|P3|STARTED|Overall Study||3291
7774782|NCT01345123|19140032|P2|STARTED|Overall Study||3311
7774783|NCT01345123|19140033|P1|STARTED|Overall Study||3323
7774784|NCT01345058|19140055|P2|NOT COMPLETED|Overall Study||0
7774785|NCT01345058|19140056|P1|NOT COMPLETED|Overall Study||5
7774786|NCT01345058|19140055|P2|COMPLETED|Overall Study||36
7774787|NCT01345058|19140056|P1|COMPLETED|Overall Study||15
7774788|NCT01345058|19140055|P2|Received Lacosamide|Overall Study||0
7774789|NCT01345058|19140056|P1|Received Lacosamide|Overall Study||19
7774790|NCT01345058|19140055|P2|STARTED|Overall Study||36
7774791|NCT01345058|19140056|P1|STARTED|Overall Study||20
7774792|NCT01345019|19140072|P2|NOT COMPLETED|Open Label Treatment Phase||193
7774793|NCT01345019|19140073|P1|NOT COMPLETED|Open Label Treatment Phase||191
7774794|NCT01345019|19140072|P2|COMPLETED|Open Label Treatment Phase||233
7774795|NCT01345019|19140073|P1|COMPLETED|Open Label Treatment Phase||227
7774796|NCT01345019|19140072|P2|STARTED|Open Label Treatment Phase||426
7774797|NCT01345019|19140073|P1|STARTED|Open Label Treatment Phase||418
7774798|NCT01345019|19140072|P2|NOT COMPLETED|Blinded Treatment Phase||304
7774799|NCT01345019|19140073|P1|NOT COMPLETED|Blinded Treatment Phase||318
7774800|NCT01345019|19140072|P2|COMPLETED|Blinded Treatment Phase||555
7774801|NCT01345019|19140073|P1|COMPLETED|Blinded Treatment Phase||541
7774802|NCT01345019|19140072|P2|Received Treatment|Blinded Treatment Phase||850
7774803|NCT01345019|19140073|P1|Received Treatment|Blinded Treatment Phase||852
7774804|NCT01345019|19140072|P2|STARTED|Blinded Treatment Phase||859
7774805|NCT01345019|19140073|P1|STARTED|Blinded Treatment Phase||859
7774806|NCT01344876|19140095|P5|NOT COMPLETED|Overall Study||1
7774807|NCT01344876|19140096|P4|NOT COMPLETED|Overall Study||3
7774808|NCT01344876|19140097|P3|NOT COMPLETED|Overall Study||1
7774809|NCT01344876|19140098|P2|NOT COMPLETED|Overall Study||0
7774810|NCT01344876|19140099|P1|NOT COMPLETED|Overall Study||1
7774811|NCT01344876|19140095|P5|COMPLETED|Overall Study||2
7774812|NCT01344876|19140096|P4|COMPLETED|Overall Study||3
7774813|NCT01344876|19140097|P3|COMPLETED|Overall Study||3
7774814|NCT01344876|19140098|P2|COMPLETED|Overall Study||3
7774815|NCT01344876|19140099|P1|COMPLETED|Overall Study||3
7774816|NCT01344876|19140095|P5|STARTED|Overall Study||3
7774817|NCT01344876|19140096|P4|STARTED|Overall Study||6
7774818|NCT01344876|19140097|P3|STARTED|Overall Study||4
7774819|NCT01344876|19140098|P2|STARTED|Overall Study||3
7774820|NCT01344876|19140099|P1|STARTED|Overall Study||4
7774821|NCT01344824|19140113|P1|NOT COMPLETED|Overall Study||37
7774822|NCT01344824|19140113|P1|COMPLETED|Overall Study||1
7774823|NCT01344824|19140113|P1|STARTED|Overall Study||38
7774824|NCT01344759|19140121|P2|NOT COMPLETED|Overall Study||2
7774825|NCT01344759|19140122|P1|NOT COMPLETED|Overall Study||0
7774826|NCT01344759|19140121|P2|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28
7774827|NCT01344759|19140122|P1|COMPLETED|Overall Study||30
7774828|NCT01344759|19140121|P2|STARTED|Overall Study||30
7774829|NCT01344759|19140122|P1|STARTED|Overall Study||30
7774830|NCT01344629|19140154|P2|NOT COMPLETED|Crossover Period 4||0
7774831|NCT01344629|19140155|P1|NOT COMPLETED|Crossover Period 4||0
7774832|NCT01344629|19140154|P2|COMPLETED|Crossover Period 4||31
7774833|NCT01344629|19140155|P1|COMPLETED|Crossover Period 4||32
7774834|NCT01344629|19140154|P2|STARTED|Crossover Period 4||31
7774835|NCT01344629|19140155|P1|STARTED|Crossover Period 4||32
7774836|NCT01344629|19140154|P2|NOT COMPLETED|Crossover Period 3||0
7774837|NCT01344629|19140155|P1|NOT COMPLETED|Crossover Period 3||0
7774838|NCT01344629|19140154|P2|COMPLETED|Crossover Period 3||31
7774839|NCT01344629|19140155|P1|COMPLETED|Crossover Period 3||32
7774840|NCT01344629|19140154|P2|STARTED|Crossover Period 3||31
7774841|NCT01344629|19140155|P1|STARTED|Crossover Period 3||32
7774842|NCT01344629|19140154|P2|NOT COMPLETED|Crossover Period 2||1
7774843|NCT01344629|19140155|P1|NOT COMPLETED|Crossover Period 2||0
7774844|NCT01344629|19140154|P2|COMPLETED|Crossover Period 2||31
7774845|NCT01344629|19140155|P1|COMPLETED|Crossover Period 2||32
7774846|NCT01344629|19140154|P2|STARTED|Crossover Period 2||32
7774847|NCT01344629|19140155|P1|STARTED|Crossover Period 2||32
7774848|NCT01344629|19140154|P2|NOT COMPLETED|Crossover Period 1||0
7774849|NCT01344629|19140155|P1|NOT COMPLETED|Crossover Period 1||0
7774850|NCT01344629|19140154|P2|COMPLETED|Crossover Period 1||32
7774851|NCT01344629|19140155|P1|COMPLETED|Crossover Period 1||32
7774852|NCT01344629|19140154|P2|STARTED|Crossover Period 1||32
7774853|NCT01344629|19140155|P1|STARTED|Crossover Period 1||32
7774854|NCT01344616|19140175|P2|NOT COMPLETED|Overall Study||44
7774855|NCT01344616|19140176|P1|NOT COMPLETED|Overall Study||35
7774856|NCT01344616|19140175|P2|COMPLETED|Overall Study||194
7774857|NCT01344616|19140176|P1|COMPLETED|Overall Study||209
7774858|NCT01344616|19140175|P2|STARTED|Overall Study||238
7774859|NCT01344616|19140176|P1|STARTED|Overall Study||244
7774860|NCT01344538|19140184|P2|NOT COMPLETED|Overall Study||1
7774861|NCT01344538|19140185|P1|NOT COMPLETED|Overall Study||2
7774862|NCT01344538|19140184|P2|COMPLETED|Overall Study||16
7774863|NCT01344538|19140185|P1|COMPLETED|Overall Study||14
7774864|NCT01344538|19140184|P2|STARTED|Overall Study||17
7774865|NCT01344538|19140185|P1|STARTED|Overall Study||16
7774866|NCT01344460|19140191|P1|NOT COMPLETED|Overall Study||3
7774867|NCT01344460|19140191|P1|COMPLETED|Overall Study||312
7774868|NCT01344460|19140191|P1|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292
7774869|NCT01344460|19140191|P1|STARTED|Overall Study|Participants received study drug; Safety analysis set|315
7774870|NCT01344447|19140236|P1|NOT COMPLETED|Overall Study||8
7774871|NCT01344447|19140236|P1|COMPLETED|Overall Study||471
7774872|NCT01344447|19140236|P1|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457
7774873|NCT01344447|19140236|P1|STARTED|Overall Study|Participant received study drug; Safety analysis set|479
7774874|NCT01344369|19140280|P2|NOT COMPLETED|Second Intervention||1
7774875|NCT01344369|19140281|P1|NOT COMPLETED|Second Intervention||0
7774876|NCT01344369|19140280|P2|COMPLETED|Second Intervention||16
7774877|NCT01344369|19140281|P1|COMPLETED|Second Intervention||17
7774878|NCT01344369|19140280|P2|STARTED|Second Intervention||17
7774879|NCT01344369|19140281|P1|STARTED|Second Intervention||17
7774880|NCT01344369|19140280|P2|NOT COMPLETED|Washout of 28 Days||1
7774881|NCT01344369|19140281|P1|NOT COMPLETED|Washout of 28 Days||1
7774882|NCT01344369|19140280|P2|COMPLETED|Washout of 28 Days||17
7774883|NCT01344369|19140281|P1|COMPLETED|Washout of 28 Days||17
7774884|NCT01344369|19140280|P2|STARTED|Washout of 28 Days||18
7774885|NCT01344369|19140281|P1|STARTED|Washout of 28 Days||18
7774886|NCT01344369|19140280|P2|NOT COMPLETED|First Intervention||0
7774887|NCT01344369|19140281|P1|NOT COMPLETED|First Intervention||0
7774888|NCT01344369|19140280|P2|COMPLETED|First Intervention||18
7774889|NCT01344369|19140281|P1|COMPLETED|First Intervention||18
7774890|NCT01344369|19140280|P2|STARTED|First Intervention||18
7774891|NCT01344369|19140281|P1|STARTED|First Intervention||18
7774892|NCT01344356|19140299|P2|NOT COMPLETED|Overall Study||9
7774893|NCT01344356|19140300|P1|NOT COMPLETED|Overall Study||0
7774894|NCT01344356|19140299|P2|COMPLETED|Overall Study||9
7774895|NCT01344356|19140300|P1|COMPLETED|Overall Study||1
7774896|NCT01344356|19140299|P2|STARTED|Overall Study||18
7774897|NCT01344356|19140300|P1|STARTED|Overall Study||1
7774898|NCT01344226|19140312|P1|NOT COMPLETED|Overall Study||8
7774899|NCT01344226|19140312|P1|COMPLETED|Overall Study||41
7774900|NCT01344226|19140312|P1|STARTED|Overall Study||49
7774901|NCT01344161|19140321|P2|NOT COMPLETED|Overall Study||3
7774902|NCT01344161|19140322|P1|NOT COMPLETED|Overall Study||5
7774903|NCT01344161|19140321|P2|COMPLETED|Overall Study||39
7774904|NCT01344161|19140322|P1|COMPLETED|Overall Study||38
7774905|NCT01344161|19140321|P2|STARTED|Overall Study||42
7774906|NCT01344161|19140322|P1|STARTED|Overall Study||43
7774907|NCT01344057|19140334|P1|NOT COMPLETED|Overall Study||1
7774908|NCT01344057|19140334|P1|COMPLETED|Overall Study||62
7774909|NCT01344057|19140334|P1|STARTED|Overall Study||63
7774910|NCT01343901|19140341|P1|NOT COMPLETED|Overall Study||113
7774911|NCT01343901|19140341|P1|COMPLETED|Overall Study||97
7774912|NCT01343901|19140341|P1|Efficacy Population|Overall Study||205
7774913|NCT01343901|19140341|P1|STARTED|Overall Study||210
7774914|NCT01343888|19140365|P3|NOT COMPLETED|Overall Study||22
7774915|NCT01343888|19140366|P2|NOT COMPLETED|Overall Study||39
7774916|NCT01343888|19140367|P1|NOT COMPLETED|Overall Study||25
7774917|NCT01343888|19140365|P3|COMPLETED|Overall Study||110
7774918|NCT01343888|19140366|P2|COMPLETED|Overall Study||222
7774919|NCT01343888|19140367|P1|COMPLETED|Overall Study||234
7774920|NCT01343888|19140365|P3|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132
7774921|NCT01343888|19140366|P2|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261
7774922|NCT01343888|19140367|P1|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259
7774923|NCT01343823|19140409|P4|NOT COMPLETED|Overall Study||1
7774924|NCT01343823|19140410|P3|NOT COMPLETED|Overall Study||0
7774925|NCT01343823|19140411|P2|NOT COMPLETED|Overall Study||0
7774926|NCT01343823|19140412|P1|NOT COMPLETED|Overall Study||2
7774927|NCT01343823|19140409|P4|COMPLETED|Overall Study||19
7774928|NCT01343823|19140410|P3|COMPLETED|Overall Study||19
7774929|NCT01343823|19140411|P2|COMPLETED|Overall Study||20
7774930|NCT01343823|19140412|P1|COMPLETED|Overall Study||18
7774931|NCT01343823|19140409|P4|STARTED|Overall Study||20
7774932|NCT01343823|19140410|P3|STARTED|Overall Study||19
7774933|NCT01343823|19140411|P2|STARTED|Overall Study||20
7774934|NCT01343823|19140412|P1|STARTED|Overall Study||20
7774935|NCT01343693|19140426|P1|NOT COMPLETED|Overall Study||9
7774936|NCT01343693|19140426|P1|COMPLETED|Overall Study||110
7774937|NCT01343693|19140426|P1|STARTED|Overall Study||119
7774938|NCT01343667|19140433|P2|NOT COMPLETED|Overall Study||56
7774939|NCT01343667|19140434|P1|NOT COMPLETED|Overall Study||12
7774940|NCT01343667|19140433|P2|COMPLETED|Overall Study||916
7774941|NCT01343667|19140434|P1|COMPLETED|Overall Study||413
7774942|NCT01343667|19140433|P2|STARTED|Overall Study||972
7774943|NCT01343667|19140434|P1|STARTED|Overall Study||425
7774944|NCT01343485|19140442|P2|NOT COMPLETED|Overall Study||134
7774945|NCT01343485|19140443|P1|NOT COMPLETED|Overall Study||149
7774946|NCT01343485|19140442|P2|COMPLETED|Overall Study||46
7774947|NCT01343485|19140443|P1|COMPLETED|Overall Study||36
7774948|NCT01343485|19140442|P2|STARTED|Overall Study||180
7774949|NCT01343485|19140443|P1|STARTED|Overall Study||185
7774950|NCT01343407|19140449|P6|NOT COMPLETED|Third Treatment Period (Part 2)||0
7774951|NCT01343407|19140450|P5|NOT COMPLETED|Third Treatment Period (Part 2)||0
7774952|NCT01343407|19140451|P4|NOT COMPLETED|Third Treatment Period (Part 2)||0
7774953|NCT01343407|19140452|P3|NOT COMPLETED|Third Treatment Period (Part 2)||0
7774954|NCT01343407|19140453|P2|NOT COMPLETED|Third Treatment Period (Part 2)||0
7774955|NCT01343407|19140454|P1|NOT COMPLETED|Third Treatment Period (Part 2)||0
7774956|NCT01343407|19140449|P6|COMPLETED|Third Treatment Period (Part 2)||3
7774957|NCT01343407|19140450|P5|COMPLETED|Third Treatment Period (Part 2)||3
7774958|NCT01343407|19140451|P4|COMPLETED|Third Treatment Period (Part 2)||3
7774959|NCT01343407|19140452|P3|COMPLETED|Third Treatment Period (Part 2)||1
7774960|NCT01343407|19140453|P2|COMPLETED|Third Treatment Period (Part 2)||2
7774961|NCT01343407|19140454|P1|COMPLETED|Third Treatment Period (Part 2)||2
7774962|NCT01343407|19140449|P6|STARTED|Third Treatment Period (Part 2)||3
7774963|NCT01343407|19140450|P5|STARTED|Third Treatment Period (Part 2)||3
7774964|NCT01343407|19140451|P4|STARTED|Third Treatment Period (Part 2)||3
7774965|NCT01343407|19140452|P3|STARTED|Third Treatment Period (Part 2)||1
7774966|NCT01343407|19140453|P2|STARTED|Third Treatment Period (Part 2)||2
7774967|NCT01343407|19140454|P1|STARTED|Third Treatment Period (Part 2)||2
7774968|NCT01343407|19140449|P6|NOT COMPLETED|Second Washout (Part 2)||0
7774969|NCT01343407|19140450|P5|NOT COMPLETED|Second Washout (Part 2)||0
7774970|NCT01343407|19140451|P4|NOT COMPLETED|Second Washout (Part 2)||0
7774971|NCT01343407|19140452|P3|NOT COMPLETED|Second Washout (Part 2)||1
7774972|NCT01343407|19140453|P2|NOT COMPLETED|Second Washout (Part 2)||0
7774973|NCT01343407|19140454|P1|NOT COMPLETED|Second Washout (Part 2)||0
7774974|NCT01343407|19140449|P6|COMPLETED|Second Washout (Part 2)||3
7774975|NCT01343407|19140450|P5|COMPLETED|Second Washout (Part 2)||3
7774976|NCT01343407|19140451|P4|COMPLETED|Second Washout (Part 2)||3
7774977|NCT01343407|19140452|P3|COMPLETED|Second Washout (Part 2)||1
7774978|NCT01343407|19140453|P2|COMPLETED|Second Washout (Part 2)||2
7774979|NCT01343407|19140454|P1|COMPLETED|Second Washout (Part 2)||2
7774980|NCT01343407|19140449|P6|STARTED|Second Washout (Part 2)||3
7774981|NCT01343407|19140450|P5|STARTED|Second Washout (Part 2)||3
7774982|NCT01343407|19140451|P4|STARTED|Second Washout (Part 2)||3
7774983|NCT01343407|19140452|P3|STARTED|Second Washout (Part 2)||2
7774984|NCT01343407|19140453|P2|STARTED|Second Washout (Part 2)||2
7774985|NCT01343407|19140454|P1|STARTED|Second Washout (Part 2)||2
7774986|NCT01343407|19140449|P6|NOT COMPLETED|Second Treatment Period (Part 2)||0
7774987|NCT01343407|19140450|P5|NOT COMPLETED|Second Treatment Period (Part 2)||0
7774988|NCT01343407|19140451|P4|NOT COMPLETED|Second Treatment Period (Part 2)||0
7774989|NCT01343407|19140452|P3|NOT COMPLETED|Second Treatment Period (Part 2)||1
7774990|NCT01343407|19140453|P2|NOT COMPLETED|Second Treatment Period (Part 2)||0
7774991|NCT01343407|19140454|P1|NOT COMPLETED|Second Treatment Period (Part 2)||0
7774992|NCT01343407|19140449|P6|COMPLETED|Second Treatment Period (Part 2)||3
7774993|NCT01343407|19140450|P5|COMPLETED|Second Treatment Period (Part 2)||3
7774994|NCT01343407|19140451|P4|COMPLETED|Second Treatment Period (Part 2)||3
7774995|NCT01343407|19140452|P3|COMPLETED|Second Treatment Period (Part 2)||2
7774996|NCT01343407|19140453|P2|COMPLETED|Second Treatment Period (Part 2)||2
7774997|NCT01343407|19140454|P1|COMPLETED|Second Treatment Period (Part 2)||2
7774998|NCT01343407|19140449|P6|STARTED|Second Treatment Period (Part 2)||3
7774999|NCT01343407|19140450|P5|STARTED|Second Treatment Period (Part 2)||3
7775000|NCT01343407|19140451|P4|STARTED|Second Treatment Period (Part 2)||3
7775001|NCT01343407|19140452|P3|STARTED|Second Treatment Period (Part 2)||3
7775002|NCT01343407|19140453|P2|STARTED|Second Treatment Period (Part 2)||2
7775003|NCT01343407|19140454|P1|STARTED|Second Treatment Period (Part 2)||2
7775004|NCT01343407|19140449|P6|NOT COMPLETED|First Washout (Part 2)||0
7775005|NCT01343407|19140450|P5|NOT COMPLETED|First Washout (Part 2)||0
7775006|NCT01343407|19140451|P4|NOT COMPLETED|First Washout (Part 2)||0
7775007|NCT01343407|19140452|P3|NOT COMPLETED|First Washout (Part 2)||0
7775008|NCT01343407|19140453|P2|NOT COMPLETED|First Washout (Part 2)||0
7775009|NCT01343407|19140454|P1|NOT COMPLETED|First Washout (Part 2)||0
7775010|NCT01343407|19140449|P6|COMPLETED|First Washout (Part 2)||3
7775011|NCT01343407|19140450|P5|COMPLETED|First Washout (Part 2)||3
7775012|NCT01343407|19140451|P4|COMPLETED|First Washout (Part 2)||3
7775013|NCT01343407|19140452|P3|COMPLETED|First Washout (Part 2)||3
7775014|NCT01343407|19140453|P2|COMPLETED|First Washout (Part 2)||2
7775015|NCT01343407|19140454|P1|COMPLETED|First Washout (Part 2)||2
7775016|NCT01343407|19140449|P6|STARTED|First Washout (Part 2)||3
7775017|NCT01343407|19140450|P5|STARTED|First Washout (Part 2)||3
7775018|NCT01343407|19140451|P4|STARTED|First Washout (Part 2)||3
7775019|NCT01343407|19140452|P3|STARTED|First Washout (Part 2)||3
7775020|NCT01343407|19140453|P2|STARTED|First Washout (Part 2)||2
7775021|NCT01343407|19140454|P1|STARTED|First Washout (Part 2)||2
7775022|NCT01343407|19140449|P6|NOT COMPLETED|First Treatment Period (Part 2)||0
7775023|NCT01343407|19140450|P5|NOT COMPLETED|First Treatment Period (Part 2)||0
7775024|NCT01343407|19140451|P4|NOT COMPLETED|First Treatment Period (Part 2)||0
7775025|NCT01343407|19140452|P3|NOT COMPLETED|First Treatment Period (Part 2)||0
7775026|NCT01343407|19140453|P2|NOT COMPLETED|First Treatment Period (Part 2)||0
7775027|NCT01343407|19140454|P1|NOT COMPLETED|First Treatment Period (Part 2)||0
7775028|NCT01343407|19140449|P6|COMPLETED|First Treatment Period (Part 2)||3
7775029|NCT01343407|19140450|P5|COMPLETED|First Treatment Period (Part 2)||3
7775030|NCT01343407|19140451|P4|COMPLETED|First Treatment Period (Part 2)||3
7775031|NCT01343407|19140452|P3|COMPLETED|First Treatment Period (Part 2)||3
7775032|NCT01343407|19140453|P2|COMPLETED|First Treatment Period (Part 2)||2
7775033|NCT01343407|19140454|P1|COMPLETED|First Treatment Period (Part 2)||2
7775034|NCT01343407|19140449|P6|STARTED|First Treatment Period (Part 2)||3
7775035|NCT01343407|19140450|P5|STARTED|First Treatment Period (Part 2)||3
7775036|NCT01343407|19140451|P4|STARTED|First Treatment Period (Part 2)||3
7775037|NCT01343407|19140452|P3|STARTED|First Treatment Period (Part 2)||3
7775038|NCT01343407|19140453|P2|STARTED|First Treatment Period (Part 2)||2
7775039|NCT01343407|19140454|P1|STARTED|First Treatment Period (Part 2)||2
7775040|NCT01343368|19140482|P2|NOT COMPLETED|Overall Study||0
7775041|NCT01343368|19140483|P1|NOT COMPLETED|Overall Study||2
7775042|NCT01343368|19140482|P2|COMPLETED|Overall Study||10
7775043|NCT01343368|19140483|P1|COMPLETED|Overall Study||7
7775044|NCT01343368|19140482|P2|STARTED|Overall Study||10
7775045|NCT01343368|19140483|P1|STARTED|Overall Study||9
7775046|NCT01343277|19140519|P2|NOT COMPLETED|Overall Study||193
7775047|NCT01343277|19140520|P1|NOT COMPLETED|Overall Study||384
7775048|NCT01343277|19140519|P2|COMPLETED|Overall Study||0
7775049|NCT01343277|19140520|P1|COMPLETED|Overall Study||0
7775050|NCT01343277|19140519|P2|Treated|Overall Study||172
7775051|NCT01343277|19140520|P1|Treated|Overall Study||378
7775052|NCT01343277|19140519|P2|STARTED|Overall Study||193
7775053|NCT01343277|19140520|P1|STARTED|Overall Study||384
7775054|NCT01343251|19140538|P2|NOT COMPLETED|Overall Study||0
7775055|NCT01343251|19140539|P1|NOT COMPLETED|Overall Study||0
7775056|NCT01343251|19140538|P2|COMPLETED|Overall Study||17
7775057|NCT01343251|19140539|P1|COMPLETED|Overall Study||16
7775058|NCT01343251|19140538|P2|STARTED|Overall Study||17
7775059|NCT01343251|19140539|P1|STARTED|Overall Study||16
7775060|NCT01343095|19140556|P3|NOT COMPLETED|Overall Study||0
7775061|NCT01343095|19140557|P2|NOT COMPLETED|Overall Study||0
7775062|NCT01343095|19140558|P1|NOT COMPLETED|Overall Study||0
7775063|NCT01343095|19140556|P3|COMPLETED|Overall Study||3
7775064|NCT01343095|19140557|P2|COMPLETED|Overall Study||3
7775065|NCT01343095|19140558|P1|COMPLETED|Overall Study||2
7775066|NCT01343095|19140556|P3|STARTED|Overall Study||3
7775067|NCT01343095|19140557|P2|STARTED|Overall Study||3
7775068|NCT01343095|19140558|P1|STARTED|Overall Study||2
7775069|NCT01343082|19140581|P3|NOT COMPLETED|Treatment Period , Switched to DE-111||12
7775070|NCT01343082|19140582|P2|NOT COMPLETED|Treatment Period , Switched to DE-111||9
7775071|NCT01343082|19140583|P1|NOT COMPLETED|Treatment Period , Switched to DE-111||5
7775072|NCT01343082|19140581|P3|COMPLETED|Treatment Period , Switched to DE-111||31
7775073|NCT01343082|19140582|P2|COMPLETED|Treatment Period , Switched to DE-111||36
7775074|NCT01343082|19140583|P1|COMPLETED|Treatment Period , Switched to DE-111||43
7775075|NCT01343082|19140581|P3|STARTED|Treatment Period , Switched to DE-111||43
7775076|NCT01343082|19140582|P2|STARTED|Treatment Period , Switched to DE-111||45
7775077|NCT01343082|19140583|P1|STARTED|Treatment Period , Switched to DE-111||48
7775078|NCT01343082|19140581|P3|NOT COMPLETED|The run-in Period||5
7775079|NCT01343082|19140582|P2|NOT COMPLETED|The run-in Period||4
7775080|NCT01343082|19140583|P1|NOT COMPLETED|The run-in Period||3
7775081|NCT01343082|19140581|P3|COMPLETED|The run-in Period||43
7775082|NCT01343082|19140582|P2|COMPLETED|The run-in Period||45
7775083|NCT01343082|19140583|P1|COMPLETED|The run-in Period||48
7775084|NCT01343082|19140581|P3|STARTED|The run-in Period||48
7775085|NCT01343082|19140582|P2|STARTED|The run-in Period||49
7775086|NCT01343082|19140583|P1|STARTED|The run-in Period||51
7775087|NCT01343056|19140591|P4|NOT COMPLETED|Overall Study||9
7775088|NCT01343056|19140592|P3|NOT COMPLETED|Overall Study||3
7775089|NCT01343056|19140593|P2|NOT COMPLETED|Overall Study||5
7775090|NCT01343056|19140594|P1|NOT COMPLETED|Overall Study||7
7775091|NCT01343056|19140591|P4|COMPLETED|Overall Study||29
7775092|NCT01343056|19140592|P3|COMPLETED|Overall Study||29
7775093|NCT01343056|19140593|P2|COMPLETED|Overall Study||31
7775094|NCT01343056|19140594|P1|COMPLETED|Overall Study||28
7775095|NCT01343056|19140591|P4|STARTED|Overall Study||38
7775096|NCT01343056|19140592|P3|STARTED|Overall Study||32
7775097|NCT01343056|19140593|P2|STARTED|Overall Study||36
7775098|NCT01343056|19140594|P1|STARTED|Overall Study||35
7775099|NCT01343043|19140636|P4|NOT COMPLETED|Overall Study||1
7775100|NCT01343043|19140637|P3|NOT COMPLETED|Overall Study||0
7775101|NCT01343043|19140638|P2|NOT COMPLETED|Overall Study||1
7775102|NCT01343043|19140639|P1|NOT COMPLETED|Overall Study||3
7775103|NCT01343043|19140636|P4|COMPLETED|Overall Study||15
7775104|NCT01343043|19140637|P3|COMPLETED|Overall Study||5
7775105|NCT01343043|19140638|P2|COMPLETED|Overall Study||13
7775106|NCT01343043|19140639|P1|COMPLETED|Overall Study||12
7775107|NCT01343043|19140636|P4|Received T-cell Infusion|Overall Study||15
7775108|NCT01343043|19140637|P3|Received T-cell Infusion|Overall Study||5
7775109|NCT01343043|19140638|P2|Received T-cell Infusion|Overall Study||13
7775110|NCT01343043|19140639|P1|Received T-cell Infusion|Overall Study||12
7775111|NCT01343043|19140636|P4|STARTED|Overall Study||16
7775112|NCT01343043|19140637|P3|STARTED|Overall Study||5
7775113|NCT01343043|19140638|P2|STARTED|Overall Study||14
7775114|NCT01343043|19140639|P1|STARTED|Overall Study||15
7775115|NCT01343004|19140700|P3|NOT COMPLETED|Overall Study||160
7775116|NCT01343004|19140701|P2|NOT COMPLETED|Overall Study||218
7775117|NCT01343004|19140702|P1|NOT COMPLETED|Overall Study||184
7775118|NCT01343004|19140700|P3|COMPLETED|Overall Study||658
7775119|NCT01343004|19140701|P2|COMPLETED|Overall Study||606
7775120|NCT01343004|19140702|P1|COMPLETED|Overall Study||637
7775121|NCT01343004|19140700|P3|STARTED|Overall Study||818
7775122|NCT01343004|19140701|P2|STARTED|Overall Study||824
7775123|NCT01343004|19140702|P1|STARTED|Overall Study||821
7775124|NCT01342965|19140727|P2|NOT COMPLETED|Overall Study||107
7775125|NCT01342965|19140728|P1|NOT COMPLETED|Overall Study||109
7775126|NCT01342965|19140727|P2|COMPLETED|Overall Study||0
7775127|NCT01342965|19140728|P1|COMPLETED|Overall Study||1
7775128|NCT01342965|19140727|P2|Received Treatment|Overall Study||104
7775129|NCT01342965|19140728|P1|Received Treatment|Overall Study||110
7775130|NCT01342965|19140727|P2|STARTED|Overall Study||107
7775131|NCT01342965|19140728|P1|STARTED|Overall Study||110
7775132|NCT01342926|19140746|P4|NOT COMPLETED|Overall Study||12
7775133|NCT01342926|19140747|P3|NOT COMPLETED|Overall Study||14
7775134|NCT01342926|19140748|P2|NOT COMPLETED|Overall Study||15
7775135|NCT01342926|19140749|P1|NOT COMPLETED|Overall Study||9
7775136|NCT01342926|19140746|P4|COMPLETED|Overall Study||39
7775137|NCT01342926|19140747|P3|COMPLETED|Overall Study||34
7775138|NCT01342926|19140748|P2|COMPLETED|Overall Study||31
7775139|NCT01342926|19140749|P1|COMPLETED|Overall Study||37
7775140|NCT01342926|19140746|P4|STARTED|Overall Study||51
7775141|NCT01342926|19140747|P3|STARTED|Overall Study||48
7775142|NCT01342926|19140748|P2|STARTED|Overall Study||46
7775143|NCT01342926|19140749|P1|STARTED|Overall Study||46
7775144|NCT01342913|19140829|P3|NOT COMPLETED|Double-Blind Treatment Period||23
7775145|NCT01342913|19140830|P2|NOT COMPLETED|Double-Blind Treatment Period||16
7775146|NCT01342913|19140831|P1|NOT COMPLETED|Double-Blind Treatment Period||0
7775147|NCT01342913|19140829|P3|COMPLETED|Double-Blind Treatment Period||243
7775148|NCT01342913|19140830|P2|COMPLETED|Double-Blind Treatment Period||246
7775149|NCT01342913|19140831|P1|COMPLETED|Double-Blind Treatment Period||0
7775150|NCT01342913|19140829|P3|STARTED|Double-Blind Treatment Period||266
7775151|NCT01342913|19140830|P2|STARTED|Double-Blind Treatment Period||262
7775152|NCT01342913|19140831|P1|STARTED|Double-Blind Treatment Period||0
7775153|NCT01342913|19140829|P3|NOT COMPLETED|2-week Run-in Period||0
7775154|NCT01342913|19140830|P2|NOT COMPLETED|2-week Run-in Period||0
7775155|NCT01342913|19140831|P1|NOT COMPLETED|2-week Run-in Period||174
7775156|NCT01342913|19140829|P3|COMPLETED|2-week Run-in Period||0
7775157|NCT01342913|19140830|P2|COMPLETED|2-week Run-in Period||0
7775158|NCT01342913|19140831|P1|COMPLETED|2-week Run-in Period||528
7775159|NCT01342913|19140829|P3|STARTED|2-week Run-in Period||0
7775160|NCT01342913|19140830|P2|STARTED|2-week Run-in Period||0
7775161|NCT01342913|19140831|P1|STARTED|2-week Run-in Period||702
7775162|NCT01342887|19140841|P1|NOT COMPLETED|Overall Study||2
7775163|NCT01342887|19140841|P1|COMPLETED|Overall Study||4
7775164|NCT01342887|19140841|P1|STARTED|Overall Study||6
7775165|NCT01342770|19140848|P1|NOT COMPLETED|Overall Study||0
7775166|NCT01342770|19140848|P1|COMPLETED|Overall Study||6
7775167|NCT01342770|19140848|P1|STARTED|Overall Study||6
7775168|NCT01342757|19140866|P1|NOT COMPLETED|Overall Study||0
7775169|NCT01342757|19140866|P1|COMPLETED|Overall Study||12
7775170|NCT01342757|19140866|P1|STARTED|Overall Study||12
7775171|NCT01342666|19140875|P2|NOT COMPLETED|Overall Study||0
7775172|NCT01342666|19140876|P1|NOT COMPLETED|Overall Study||0
7775173|NCT01342666|19140875|P2|COMPLETED|Overall Study||24
7775174|NCT01342666|19140876|P1|COMPLETED|Overall Study||26
7775175|NCT01342666|19140875|P2|STARTED|Overall Study||24
7775176|NCT01342666|19140876|P1|STARTED|Overall Study||26
7775177|NCT01342640|19140882|P1|NOT COMPLETED|Overall Study||41
7775178|NCT01342640|19140882|P1|COMPLETED|Overall Study||29
7775179|NCT01342640|19140882|P1|STARTED|Overall Study||70
7775180|NCT01342549|19140890|P2|NOT COMPLETED|Overall Study||0
7775181|NCT01342549|19140891|P1|NOT COMPLETED|Overall Study||0
7775182|NCT01342549|19140890|P2|COMPLETED|Overall Study||31
7775183|NCT01342549|19140891|P1|COMPLETED|Overall Study||31
7775184|NCT01342549|19140890|P2|STARTED|Overall Study||31
7775185|NCT01342549|19140891|P1|STARTED|Overall Study||31
7775186|NCT01342523|19140929|P32|NOT COMPLETED|Overall Study||1
7775187|NCT01342523|19140930|P31|NOT COMPLETED|Overall Study||1
7775188|NCT01342523|19140931|P30|NOT COMPLETED|Overall Study||1
7775189|NCT01342523|19140932|P29|NOT COMPLETED|Overall Study||1
7775190|NCT01342523|19140933|P28|NOT COMPLETED|Overall Study||1
7775191|NCT01342523|19140934|P27|NOT COMPLETED|Overall Study||1
7775192|NCT01342523|19140935|P26|NOT COMPLETED|Overall Study||2
7775193|NCT01342523|19140936|P25|NOT COMPLETED|Overall Study||1
7775194|NCT01342523|19140937|P24|NOT COMPLETED|Overall Study||1
7775195|NCT01342523|19140938|P23|NOT COMPLETED|Overall Study||0
7775196|NCT01342523|19140939|P22|NOT COMPLETED|Overall Study||0
7775197|NCT01342523|19140940|P21|NOT COMPLETED|Overall Study||0
7775198|NCT01342523|19140941|P20|NOT COMPLETED|Overall Study||0
7775199|NCT01342523|19140942|P19|NOT COMPLETED|Overall Study||0
7775200|NCT01342523|19140943|P18|NOT COMPLETED|Overall Study||0
7775201|NCT01342523|19140944|P17|NOT COMPLETED|Overall Study||1
7775202|NCT01342523|19140945|P16|NOT COMPLETED|Overall Study||0
7775203|NCT01342523|19140946|P15|NOT COMPLETED|Overall Study||1
7775204|NCT01342523|19140947|P14|NOT COMPLETED|Overall Study||2
7775205|NCT01342523|19140948|P13|NOT COMPLETED|Overall Study||0
7775206|NCT01342523|19140949|P12|NOT COMPLETED|Overall Study||2
7775207|NCT01342523|19140950|P11|NOT COMPLETED|Overall Study||0
7775208|NCT01342523|19140951|P10|NOT COMPLETED|Overall Study||0
7775209|NCT01342523|19140952|P9|NOT COMPLETED|Overall Study||0
7775210|NCT01342523|19140953|P8|NOT COMPLETED|Overall Study||0
7775211|NCT01342523|19140954|P7|NOT COMPLETED|Overall Study||0
7775212|NCT01342523|19140955|P6|NOT COMPLETED|Overall Study||0
7775213|NCT01342523|19140956|P5|NOT COMPLETED|Overall Study||0
7775214|NCT01342523|19140957|P4|NOT COMPLETED|Overall Study||1
7775215|NCT01342523|19140958|P3|NOT COMPLETED|Overall Study||0
7775216|NCT01342523|19140959|P2|NOT COMPLETED|Overall Study||0
7775217|NCT01342523|19140960|P1|NOT COMPLETED|Overall Study||1
7775218|NCT01342523|19140929|P32|COMPLETED|Overall Study||27
7775219|NCT01342523|19140930|P31|COMPLETED|Overall Study||30
7775220|NCT01342523|19140931|P30|COMPLETED|Overall Study||28
7775221|NCT01342523|19140932|P29|COMPLETED|Overall Study||34
7775222|NCT01342523|19140933|P28|COMPLETED|Overall Study||30
7775223|NCT01342523|19140934|P27|COMPLETED|Overall Study||33
7775224|NCT01342523|19140935|P26|COMPLETED|Overall Study||36
7775225|NCT01342523|19140936|P25|COMPLETED|Overall Study||36
7775226|NCT01342523|19140937|P24|COMPLETED|Overall Study||35
7775227|NCT01342523|19140938|P23|COMPLETED|Overall Study||36
7775228|NCT01342523|19140939|P22|COMPLETED|Overall Study||30
7775229|NCT01342523|19140940|P21|COMPLETED|Overall Study||29
7775230|NCT01342523|19140941|P20|COMPLETED|Overall Study||27
7775231|NCT01342523|19140942|P19|COMPLETED|Overall Study||21
7775232|NCT01342523|19140943|P18|COMPLETED|Overall Study||27
7775233|NCT01342523|19140944|P17|COMPLETED|Overall Study||28
7775234|NCT01342523|19140945|P16|COMPLETED|Overall Study||32
7775235|NCT01342523|19140946|P15|COMPLETED|Overall Study||37
7775236|NCT01342523|19140947|P14|COMPLETED|Overall Study||36
7775237|NCT01342523|19140948|P13|COMPLETED|Overall Study||39
7775238|NCT01342523|19140949|P12|COMPLETED|Overall Study||36
7775239|NCT01342523|19140950|P11|COMPLETED|Overall Study||38
7775240|NCT01342523|19140951|P10|COMPLETED|Overall Study||28
7775241|NCT01342523|19140952|P9|COMPLETED|Overall Study||28
7775242|NCT01342523|19140953|P8|COMPLETED|Overall Study||27
7775243|NCT01342523|19140954|P7|COMPLETED|Overall Study||22
7775244|NCT01342523|19140955|P6|COMPLETED|Overall Study||36
7775245|NCT01342523|19140956|P5|COMPLETED|Overall Study||36
7775246|NCT01342523|19140957|P4|COMPLETED|Overall Study||32
7775247|NCT01342523|19140958|P3|COMPLETED|Overall Study||36
7775248|NCT01342523|19140959|P2|COMPLETED|Overall Study||32
7775249|NCT01342523|19140960|P1|COMPLETED|Overall Study||34
7775250|NCT01342523|19140929|P32|STARTED|Overall Study||28
7775251|NCT01342523|19140930|P31|STARTED|Overall Study||31
7775252|NCT01342523|19140931|P30|STARTED|Overall Study||29
7775253|NCT01342523|19140932|P29|STARTED|Overall Study||35
7775254|NCT01342523|19140933|P28|STARTED|Overall Study||31
7775255|NCT01342523|19140934|P27|STARTED|Overall Study||34
7775256|NCT01342523|19140935|P26|STARTED|Overall Study||38
7775257|NCT01342523|19140936|P25|STARTED|Overall Study||37
7775258|NCT01342523|19140937|P24|STARTED|Overall Study||36
7775259|NCT01342523|19140938|P23|STARTED|Overall Study||36
7775260|NCT01342523|19140939|P22|STARTED|Overall Study||30
7775261|NCT01342523|19140940|P21|STARTED|Overall Study||29
7775262|NCT01342523|19140941|P20|STARTED|Overall Study||27
7775263|NCT01342523|19140942|P19|STARTED|Overall Study||21
7775264|NCT01342523|19140943|P18|STARTED|Overall Study||27
7775265|NCT01342523|19140944|P17|STARTED|Overall Study||29
7775266|NCT01342523|19140945|P16|STARTED|Overall Study||32
7775267|NCT01342523|19140946|P15|STARTED|Overall Study||38
7775268|NCT01342523|19140947|P14|STARTED|Overall Study||38
7775269|NCT01342523|19140948|P13|STARTED|Overall Study||39
7775270|NCT01342523|19140949|P12|STARTED|Overall Study||38
7775271|NCT01342523|19140950|P11|STARTED|Overall Study||38
7775272|NCT01342523|19140951|P10|STARTED|Overall Study||28
7775273|NCT01342523|19140952|P9|STARTED|Overall Study||28
7775274|NCT01342523|19140953|P8|STARTED|Overall Study||27
7775275|NCT01342523|19140954|P7|STARTED|Overall Study||22
7775276|NCT01342523|19140955|P6|STARTED|Overall Study||36
7775277|NCT01342523|19140956|P5|STARTED|Overall Study||36
7775278|NCT01342523|19140957|P4|STARTED|Overall Study||33
7775279|NCT01342523|19140958|P3|STARTED|Overall Study||36
7775280|NCT01342523|19140959|P2|STARTED|Overall Study||32
7775281|NCT01342523|19140960|P1|STARTED|Overall Study||35
7775282|NCT01342510|19140977|P4|NOT COMPLETED|Overall Study||11
7775283|NCT01342510|19140978|P3|NOT COMPLETED|Overall Study||13
7775284|NCT01342510|19140979|P2|NOT COMPLETED|Overall Study||6
7775285|NCT01342510|19140980|P1|NOT COMPLETED|Overall Study||12
7775286|NCT01342510|19140977|P4|COMPLETED|Overall Study||39
7775287|NCT01342510|19140978|P3|COMPLETED|Overall Study||37
7775288|NCT01342510|19140979|P2|COMPLETED|Overall Study||44
7775289|NCT01342510|19140980|P1|COMPLETED|Overall Study||38
7775290|NCT01342510|19140977|P4|STARTED|Overall Study||50
7775291|NCT01342510|19140978|P3|STARTED|Overall Study||50
7775292|NCT01342510|19140979|P2|STARTED|Overall Study||50
7775293|NCT01342510|19140980|P1|STARTED|Overall Study||50
7775294|NCT01342484|19140997|P3|NOT COMPLETED|Overall Study||1
7775295|NCT01342484|19140998|P2|NOT COMPLETED|Overall Study||0
7775296|NCT01342484|19140999|P1|NOT COMPLETED|Overall Study||2
7775297|NCT01342484|19140997|P3|COMPLETED|Overall Study||13
7775298|NCT01342484|19140998|P2|COMPLETED|Overall Study||10
7775299|NCT01342484|19140999|P1|COMPLETED|Overall Study||13
7775300|NCT01342484|19140997|P3|STARTED|Overall Study||14
7775301|NCT01342484|19140998|P2|STARTED|Overall Study||10
7775302|NCT01342484|19140999|P1|STARTED|Overall Study||15
7775303|NCT01342471|19141015|P2|NOT COMPLETED|Overall Study||6
7775304|NCT01342471|19141016|P1|NOT COMPLETED|Overall Study||5
7775305|NCT01342471|19141015|P2|COMPLETED|Overall Study||23
7775306|NCT01342471|19141016|P1|COMPLETED|Overall Study||24
7775307|NCT01342471|19141015|P2|STARTED|Overall Study||29
7775308|NCT01342471|19141016|P1|STARTED|Overall Study||29
7775309|NCT01342458|19141032|P2|NOT COMPLETED|Overall Study||4
7775310|NCT01342458|19141033|P1|NOT COMPLETED|Overall Study||2
7775311|NCT01342458|19141032|P2|COMPLETED|Overall Study||24
7775312|NCT01342458|19141033|P1|COMPLETED|Overall Study||26
7775313|NCT01342458|19141032|P2|STARTED|Overall Study||28
7775314|NCT01342458|19141033|P1|STARTED|Overall Study||28
7775315|NCT01342445|19141055|P2|NOT COMPLETED|Overall Study||2
7775316|NCT01342445|19141056|P1|NOT COMPLETED|Overall Study||0
7775317|NCT01342445|19141055|P2|COMPLETED|Overall Study||22
7775318|NCT01342445|19141056|P1|COMPLETED|Overall Study||26
7775319|NCT01342445|19141055|P2|STARTED|Overall Study||24
7775320|NCT01342445|19141056|P1|STARTED|Overall Study||26
7775321|NCT01342341|19141072|P2|NOT COMPLETED|Overall Study||4
7775322|NCT01342341|19141073|P1|NOT COMPLETED|Overall Study||4
7775323|NCT01342341|19141072|P2|COMPLETED|Overall Study||20
7775324|NCT01342341|19141073|P1|COMPLETED|Overall Study||20
7775325|NCT01342341|19141072|P2|STARTED|Overall Study||24
7775326|NCT01342341|19141073|P1|STARTED|Overall Study||24
7775327|NCT01342211|19141084|P5|NOT COMPLETED|Overall Study||2
7775328|NCT01342211|19141085|P4|NOT COMPLETED|Overall Study||2
7775329|NCT01342211|19141086|P3|NOT COMPLETED|Overall Study||0
7775330|NCT01342211|19141087|P2|NOT COMPLETED|Overall Study||2
7775331|NCT01342211|19141088|P1|NOT COMPLETED|Overall Study||0
7775332|NCT01342211|19141084|P5|COMPLETED|Overall Study||16
7775333|NCT01342211|19141085|P4|COMPLETED|Overall Study||17
7775334|NCT01342211|19141086|P3|COMPLETED|Overall Study||18
7775335|NCT01342211|19141087|P2|COMPLETED|Overall Study||17
7775336|NCT01342211|19141088|P1|COMPLETED|Overall Study||19
7775337|NCT01342211|19141084|P5|Treated|Overall Study||17
7775338|NCT01342211|19141085|P4|Treated|Overall Study||19
7775339|NCT01342211|19141086|P3|Treated|Overall Study||18
7775340|NCT01342211|19141087|P2|Treated|Overall Study||17
7775341|NCT01342211|19141088|P1|Treated|Overall Study||19
7775342|NCT01342211|19141084|P5|STARTED|Overall Study||18
7775343|NCT01342211|19141085|P4|STARTED|Overall Study||19
7775344|NCT01342211|19141086|P3|STARTED|Overall Study||18
7775345|NCT01342211|19141087|P2|STARTED|Overall Study||19
7775346|NCT01342211|19141088|P1|STARTED|Overall Study||19
7775347|NCT01342172|19141154|P1|NOT COMPLETED|Overall Study||0
7775348|NCT01342172|19141154|P1|COMPLETED|Overall Study||9
7775349|NCT01342172|19141154|P1|STARTED|Overall Study||9
7775350|NCT01342107|19141167|P2|NOT COMPLETED|Overall Study||0
7775351|NCT01342107|19141168|P1|NOT COMPLETED|Overall Study||0
7775352|NCT01342107|19141167|P2|COMPLETED|Overall Study||32
7775353|NCT01342107|19141168|P1|COMPLETED|Overall Study||34
7775354|NCT01342107|19141167|P2|STARTED|Overall Study||32
7775355|NCT01342107|19141168|P1|STARTED|Overall Study||34
7775356|NCT01342094|19141176|P2|NOT COMPLETED|Overall Study||3
7775357|NCT01342094|19141177|P1|NOT COMPLETED|Overall Study||5
7775358|NCT01342094|19141176|P2|COMPLETED|Overall Study||81
7775359|NCT01342094|19141177|P1|COMPLETED|Overall Study||77
7775360|NCT01342094|19141176|P2|STARTED|Overall Study||84
7775361|NCT01342094|19141177|P1|STARTED|Overall Study||82
7775362|NCT01342081|19141186|P3|NOT COMPLETED|Overall Study||1
7775363|NCT01342081|19141187|P2|NOT COMPLETED|Overall Study||2
7775364|NCT01342081|19141188|P1|NOT COMPLETED|Overall Study||2
7775365|NCT01342081|19141186|P3|COMPLETED|Overall Study||163
7775366|NCT01342081|19141187|P2|COMPLETED|Overall Study||162
7775367|NCT01342081|19141188|P1|COMPLETED|Overall Study||159
7775368|NCT01342081|19141186|P3|STARTED|Overall Study||164
7775369|NCT01342081|19141187|P2|STARTED|Overall Study||164
7775370|NCT01342081|19141188|P1|STARTED|Overall Study||161
7775371|NCT01342029|19141196|P2|NOT COMPLETED|Period 2||0
7775372|NCT01342029|19141197|P1|NOT COMPLETED|Period 2||2
7775373|NCT01342029|19141196|P2|COMPLETED|Period 2||67
7775374|NCT01342029|19141197|P1|COMPLETED|Period 2||65
7775375|NCT01342029|19141196|P2|Dropout|Period 2||0
7775376|NCT01342029|19141197|P1|Dropout|Period 2||2
7775377|NCT01342029|19141196|P2|STARTED|Period 2||67
7775378|NCT01342029|19141197|P1|STARTED|Period 2||67
7775379|NCT01342029|19141196|P2|NOT COMPLETED|Washout||4
7775380|NCT01342029|19141197|P1|NOT COMPLETED|Washout||0
7775381|NCT01342029|19141196|P2|COMPLETED|Washout||67
7775382|NCT01342029|19141197|P1|COMPLETED|Washout||67
7775383|NCT01342029|19141196|P2|STARTED|Washout||71
7775384|NCT01342029|19141197|P1|STARTED|Washout||67
7775385|NCT01342029|19141196|P2|NOT COMPLETED|Period 1||1
7775386|NCT01342029|19141197|P1|NOT COMPLETED|Period 1||3
7775387|NCT01342029|19141196|P2|COMPLETED|Period 1||71
7775388|NCT01342029|19141197|P1|COMPLETED|Period 1||67
7775389|NCT01342029|19141196|P2|Dropout|Period 1||1
7775390|NCT01342029|19141197|P1|Dropout|Period 1||3
7775391|NCT01342029|19141196|P2|STARTED|Period 1||72
7775392|NCT01342029|19141197|P1|STARTED|Period 1||70
7775393|NCT01341990|19141207|P2|NOT COMPLETED|Overall Study||1
7775394|NCT01341990|19141208|P1|NOT COMPLETED|Overall Study||3
7775395|NCT01341990|19141207|P2|COMPLETED|Overall Study||32
7775396|NCT01341990|19141208|P1|COMPLETED|Overall Study||32
7775397|NCT01341990|19141207|P2|STARTED|Overall Study||33
7775398|NCT01341990|19141208|P1|STARTED|Overall Study||35
7775399|NCT01341977|19141218|P2|NOT COMPLETED|Overall Study||15
7775400|NCT01341977|19141219|P1|NOT COMPLETED|Overall Study||14
7775401|NCT01341977|19141218|P2|COMPLETED|Overall Study||270
7775402|NCT01341977|19141219|P1|COMPLETED|Overall Study||274
7775403|NCT01341977|19141218|P2|STARTED|Overall Study||285
7775404|NCT01341977|19141219|P1|STARTED|Overall Study||288
7775405|NCT01341912|19141225|P1|NOT COMPLETED|Overall Study||0
7775406|NCT01341912|19141225|P1|COMPLETED|Overall Study||3
7775407|NCT01341912|19141225|P1|STARTED|Overall Study||3
7775408|NCT01341782|19141232|P2|NOT COMPLETED|Overall Study||14
7775409|NCT01341782|19141233|P1|NOT COMPLETED|Overall Study||15
7775410|NCT01341782|19141232|P2|COMPLETED|Overall Study||114
7775411|NCT01341782|19141233|P1|COMPLETED|Overall Study||112
7775412|NCT01341782|19141232|P2|STARTED|Overall Study||128
7775413|NCT01341782|19141233|P1|STARTED|Overall Study||127
7775414|NCT01341730|19141251|P2|NOT COMPLETED|Overall Study||4
7775415|NCT01341730|19141252|P1|NOT COMPLETED|Overall Study||4
7775416|NCT01341730|19141251|P2|COMPLETED|Overall Study||17
7775417|NCT01341730|19141252|P1|COMPLETED|Overall Study||16
7775418|NCT01341730|19141251|P2|STARTED|Overall Study||21
7775419|NCT01341730|19141252|P1|STARTED|Overall Study||20
7775420|NCT01341652|19141262|P2|NOT COMPLETED|Overall Study||2
7775421|NCT01341652|19141263|P1|NOT COMPLETED|Overall Study||0
7775422|NCT01341652|19141262|P2|COMPLETED|Overall Study||48
7775423|NCT01341652|19141263|P1|COMPLETED|Overall Study||49
7775424|NCT01341652|19141262|P2|STARTED|Overall Study||50
7775425|NCT01341652|19141263|P1|STARTED|Overall Study||49
7775426|NCT01341639|19141279|P2|NOT COMPLETED|Post-Treatment||3
7775427|NCT01341639|19141280|P1|NOT COMPLETED|Post-Treatment||0
7775428|NCT01341639|19141279|P2|COMPLETED|Post-Treatment||545
7775429|NCT01341639|19141280|P1|COMPLETED|Post-Treatment||539
7775430|NCT01341639|19141279|P2|STARTED|Post-Treatment||548
7775431|NCT01341639|19141280|P1|STARTED|Post-Treatment||539
7775432|NCT01341639|19141279|P2|NOT COMPLETED|Toddler Dose||34
7775433|NCT01341639|19141280|P1|NOT COMPLETED|Toddler Dose||51
7775434|NCT01341639|19141279|P2|COMPLETED|Toddler Dose||548
7775435|NCT01341639|19141280|P1|COMPLETED|Toddler Dose||539
7775436|NCT01341639|19141279|P2|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|582
7775437|NCT01341639|19141280|P1|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|590
7775438|NCT01341639|19141279|P2|NOT COMPLETED|Interim Period||9
7775439|NCT01341639|19141280|P1|NOT COMPLETED|Interim Period||8
7775440|NCT01341639|19141279|P2|COMPLETED|Interim Period||581
7775441|NCT01341639|19141280|P1|COMPLETED|Interim Period||591
7775442|NCT01341639|19141279|P2|STARTED|Interim Period||590
7775443|NCT01341639|19141280|P1|STARTED|Interim Period||599
7775444|NCT01341639|19141279|P2|NOT COMPLETED|Infant Series||32
7775445|NCT01341639|19141280|P1|NOT COMPLETED|Infant Series||29
7775446|NCT01341639|19141279|P2|COMPLETED|Infant Series||590
7775447|NCT01341639|19141280|P1|COMPLETED|Infant Series||599
7775448|NCT01341639|19141279|P2|Treated|Infant Series||605
7775449|NCT01341639|19141280|P1|Treated|Infant Series||610
7775450|NCT01341639|19141279|P2|Site 0048 Excluded|Infant Series||606
7775451|NCT01341639|19141280|P1|Site 0048 Excluded|Infant Series||611
7775452|NCT01341639|19141279|P2|STARTED|Infant Series||622
7775453|NCT01341639|19141280|P1|STARTED|Infant Series||628
7775454|NCT01341600|19141304|P3|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
7775455|NCT01341600|19141305|P2|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
7775456|NCT01341600|19141306|P1|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
7775457|NCT01341600|19141304|P3|COMPLETED|Clopidogrel Plus Omeprazole||4
7775458|NCT01341600|19141305|P2|COMPLETED|Clopidogrel Plus Omeprazole||5
7775459|NCT01341600|19141306|P1|COMPLETED|Clopidogrel Plus Omeprazole||5
7775460|NCT01341600|19141304|P3|STARTED|Clopidogrel Plus Omeprazole||4
7775461|NCT01341600|19141305|P2|STARTED|Clopidogrel Plus Omeprazole||5
7775462|NCT01341600|19141306|P1|STARTED|Clopidogrel Plus Omeprazole||5
7775463|NCT01341600|19141304|P3|NOT COMPLETED|Clopidogrel 225 mg||0
7775464|NCT01341600|19141305|P2|NOT COMPLETED|Clopidogrel 225 mg||0
7775465|NCT01341600|19141306|P1|NOT COMPLETED|Clopidogrel 225 mg||0
7775466|NCT01341600|19141304|P3|COMPLETED|Clopidogrel 225 mg||6
7775467|NCT01341600|19141305|P2|COMPLETED|Clopidogrel 225 mg||6
7775468|NCT01341600|19141306|P1|COMPLETED|Clopidogrel 225 mg||6
7775469|NCT01341600|19141304|P3|STARTED|Clopidogrel 225 mg||6
7775470|NCT01341600|19141305|P2|STARTED|Clopidogrel 225 mg||6
7775471|NCT01341600|19141306|P1|STARTED|Clopidogrel 225 mg||6
7775472|NCT01341600|19141304|P3|NOT COMPLETED|Clopidogrel 150 mg||0
7775473|NCT01341600|19141305|P2|NOT COMPLETED|Clopidogrel 150 mg||0
7775474|NCT01341600|19141306|P1|NOT COMPLETED|Clopidogrel 150 mg||0
7775475|NCT01341600|19141304|P3|COMPLETED|Clopidogrel 150 mg||6
7775476|NCT01341600|19141305|P2|COMPLETED|Clopidogrel 150 mg||6
7775477|NCT01341600|19141306|P1|COMPLETED|Clopidogrel 150 mg||6
7775478|NCT01341600|19141304|P3|STARTED|Clopidogrel 150 mg||6
7775479|NCT01341600|19141305|P2|STARTED|Clopidogrel 150 mg||6
7775480|NCT01341600|19141306|P1|STARTED|Clopidogrel 150 mg||6
7775481|NCT01341600|19141304|P3|NOT COMPLETED|Clopidogrel 75 mg||0
7775482|NCT01341600|19141305|P2|NOT COMPLETED|Clopidogrel 75 mg||0
7775483|NCT01341600|19141306|P1|NOT COMPLETED|Clopidogrel 75 mg||0
7775484|NCT01341600|19141304|P3|COMPLETED|Clopidogrel 75 mg||6
7775485|NCT01341600|19141305|P2|COMPLETED|Clopidogrel 75 mg||6
7775486|NCT01341600|19141306|P1|COMPLETED|Clopidogrel 75 mg||6
7775487|NCT01341600|19141304|P3|STARTED|Clopidogrel 75 mg||6
7775488|NCT01341600|19141305|P2|STARTED|Clopidogrel 75 mg||6
7775489|NCT01341600|19141306|P1|STARTED|Clopidogrel 75 mg||6
7775490|NCT01341587|19141325|P2|NOT COMPLETED|Overall Study||10
7775491|NCT01341587|19141326|P1|NOT COMPLETED|Overall Study||4
7775492|NCT01341587|19141325|P2|COMPLETED|Overall Study||0
7775493|NCT01341587|19141326|P1|COMPLETED|Overall Study||0
7775494|NCT01341587|19141325|P2|STARTED|Overall Study||10
7775495|NCT01341587|19141326|P1|STARTED|Overall Study||4
7775496|NCT01341470|19141338|P6|NOT COMPLETED|Overall Study||1
7775497|NCT01341470|19141339|P5|NOT COMPLETED|Overall Study||0
7775498|NCT01341470|19141340|P4|NOT COMPLETED|Overall Study||1
7775499|NCT01341470|19141341|P3|NOT COMPLETED|Overall Study||1
7775500|NCT01341470|19141342|P2|NOT COMPLETED|Overall Study||0
7775501|NCT01341470|19141343|P1|NOT COMPLETED|Overall Study||0
7775502|NCT01341470|19141338|P6|COMPLETED|Overall Study||9
7775503|NCT01341470|19141339|P5|COMPLETED|Overall Study||2
7775504|NCT01341470|19141340|P4|COMPLETED|Overall Study||9
7775505|NCT01341470|19141341|P3|COMPLETED|Overall Study||9
7775506|NCT01341470|19141342|P2|COMPLETED|Overall Study||9
7775507|NCT01341470|19141343|P1|COMPLETED|Overall Study||6
7775508|NCT01341470|19141338|P6|Received at Least 1 Dose of Study Drug|Overall Study||10
7775509|NCT01341470|19141339|P5|Received at Least 1 Dose of Study Drug|Overall Study||2
7775510|NCT01341470|19141340|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
7775511|NCT01341470|19141341|P3|Received at Least 1 Dose of Study Drug|Overall Study||10
7775599|NCT01340937|19141469|P1|STARTED|Period 1: Infant Series||800
7775512|NCT01341470|19141342|P2|Received at Least 1 Dose of Study Drug|Overall Study||9
7775513|NCT01341470|19141343|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
7775514|NCT01341470|19141338|P6|STARTED|Overall Study||10
7775515|NCT01341470|19141339|P5|STARTED|Overall Study||2
7775516|NCT01341470|19141340|P4|STARTED|Overall Study||10
7775517|NCT01341470|19141341|P3|STARTED|Overall Study||10
7775518|NCT01341470|19141342|P2|STARTED|Overall Study||9
7775519|NCT01341470|19141343|P1|STARTED|Overall Study||6
7775520|NCT01341457|19141377|P2|NOT COMPLETED|Overall Study||0
7775521|NCT01341457|19141378|P1|NOT COMPLETED|Overall Study||2
7775522|NCT01341457|19141377|P2|COMPLETED|Overall Study||10
7775523|NCT01341457|19141378|P1|COMPLETED|Overall Study||5
7775524|NCT01341457|19141377|P2|Received at Least One Dose of Study Drug|Overall Study||10
7775525|NCT01341457|19141378|P1|Received at Least One Dose of Study Drug|Overall Study||7
7775526|NCT01341457|19141377|P2|STARTED|Overall Study||10
7775527|NCT01341457|19141378|P1|STARTED|Overall Study||7
7775528|NCT01341444|19141396|P2|NOT COMPLETED|Overall Study||3
7775529|NCT01341444|19141397|P1|NOT COMPLETED|Overall Study||5
7775530|NCT01341444|19141396|P2|COMPLETED|Overall Study||29
7775531|NCT01341444|19141397|P1|COMPLETED|Overall Study||26
7775532|NCT01341444|19141396|P2|STARTED|Overall Study||32
7775533|NCT01341444|19141397|P1|STARTED|Overall Study||31
7775534|NCT01341301|19141403|P1|NOT COMPLETED|Overall Study||0
7775535|NCT01341301|19141403|P1|COMPLETED|Overall Study||25
7775536|NCT01341301|19141403|P1|STARTED|Overall Study||25
7775537|NCT01341067|19141410|P1|NOT COMPLETED|Overall Study||4
7775538|NCT01341067|19141410|P1|COMPLETED|Overall Study||26
7775539|NCT01341067|19141410|P1|STARTED|Overall Study||30
7775540|NCT01340976|19141423|P6|NOT COMPLETED|Overall Study||1
7775541|NCT01340976|19141424|P5|NOT COMPLETED|Overall Study||2
7775542|NCT01340976|19141425|P4|NOT COMPLETED|Overall Study||3
7775543|NCT01340976|19141426|P3|NOT COMPLETED|Overall Study||3
7775544|NCT01340976|19141427|P2|NOT COMPLETED|Overall Study||2
7775545|NCT01340976|19141428|P1|NOT COMPLETED|Overall Study||4
7775546|NCT01340976|19141423|P6|COMPLETED|Overall Study||6
7775547|NCT01340976|19141424|P5|COMPLETED|Overall Study||5
7775548|NCT01340976|19141425|P4|COMPLETED|Overall Study||2
7775549|NCT01340976|19141426|P3|COMPLETED|Overall Study||4
7775550|NCT01340976|19141427|P2|COMPLETED|Overall Study||1
7775551|NCT01340976|19141428|P1|COMPLETED|Overall Study||0
7775552|NCT01340976|19141423|P6|Received at Least 1 Dose of Study Drug|Overall Study||7
7775553|NCT01340976|19141424|P5|Received at Least 1 Dose of Study Drug|Overall Study||7
7775554|NCT01340976|19141425|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
7775555|NCT01340976|19141426|P3|Received at Least 1 Dose of Study Drug|Overall Study||7
7775556|NCT01340976|19141427|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
7775557|NCT01340976|19141428|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
7775558|NCT01340976|19141423|P6|STARTED|Overall Study||7
7775559|NCT01340976|19141424|P5|STARTED|Overall Study||7
7775560|NCT01340976|19141425|P4|STARTED|Overall Study||5
7775561|NCT01340976|19141426|P3|STARTED|Overall Study||7
7775562|NCT01340976|19141427|P2|STARTED|Overall Study||3
7775563|NCT01340976|19141428|P1|STARTED|Overall Study||4
7775564|NCT01340937|19141466|P4|NOT COMPLETED|Period 3: Toddler Vaccinations||10
7775565|NCT01340937|19141467|P3|NOT COMPLETED|Period 3: Toddler Vaccinations||9
7775566|NCT01340937|19141468|P2|NOT COMPLETED|Period 3: Toddler Vaccinations||17
7775567|NCT01340937|19141469|P1|NOT COMPLETED|Period 3: Toddler Vaccinations||9
7775568|NCT01340937|19141466|P4|COMPLETED|Period 3: Toddler Vaccinations||319
7775569|NCT01340937|19141467|P3|COMPLETED|Period 3: Toddler Vaccinations||660
7775570|NCT01340937|19141468|P2|COMPLETED|Period 3: Toddler Vaccinations||641
7775571|NCT01340937|19141469|P1|COMPLETED|Period 3: Toddler Vaccinations||666
7775572|NCT01340937|19141466|P4|STARTED|Period 3: Toddler Vaccinations||329
7775573|NCT01340937|19141467|P3|STARTED|Period 3: Toddler Vaccinations||669
7775574|NCT01340937|19141468|P2|STARTED|Period 3: Toddler Vaccinations||658
7775575|NCT01340937|19141469|P1|STARTED|Period 3: Toddler Vaccinations||675
7775576|NCT01340937|19141466|P4|NOT COMPLETED|Period 2: Interim Period||41
7775577|NCT01340937|19141467|P3|NOT COMPLETED|Period 2: Interim Period||84
7775578|NCT01340937|19141468|P2|NOT COMPLETED|Period 2: Interim Period||79
7775579|NCT01340937|19141469|P1|NOT COMPLETED|Period 2: Interim Period||67
7775580|NCT01340937|19141466|P4|COMPLETED|Period 2: Interim Period||329
7775581|NCT01340937|19141467|P3|COMPLETED|Period 2: Interim Period||669
7775582|NCT01340937|19141468|P2|COMPLETED|Period 2: Interim Period||658
7775583|NCT01340937|19141469|P1|COMPLETED|Period 2: Interim Period||675
7775584|NCT01340937|19141466|P4|STARTED|Period 2: Interim Period||370
7775585|NCT01340937|19141467|P3|STARTED|Period 2: Interim Period||753
7775586|NCT01340937|19141468|P2|STARTED|Period 2: Interim Period||737
7775587|NCT01340937|19141469|P1|STARTED|Period 2: Interim Period||742
7775588|NCT01340937|19141466|P4|NOT COMPLETED|Period 1: Infant Series||32
7775589|NCT01340937|19141467|P3|NOT COMPLETED|Period 1: Infant Series||56
7775590|NCT01340937|19141468|P2|NOT COMPLETED|Period 1: Infant Series||60
7775591|NCT01340937|19141469|P1|NOT COMPLETED|Period 1: Infant Series||58
7775592|NCT01340937|19141466|P4|COMPLETED|Period 1: Infant Series||370
7775593|NCT01340937|19141467|P3|COMPLETED|Period 1: Infant Series||753
7775594|NCT01340937|19141468|P2|COMPLETED|Period 1: Infant Series||737
7775595|NCT01340937|19141469|P1|COMPLETED|Period 1: Infant Series||742
7775596|NCT01340937|19141466|P4|STARTED|Period 1: Infant Series||402
7775597|NCT01340937|19141467|P3|STARTED|Period 1: Infant Series||809
7775598|NCT01340937|19141468|P2|STARTED|Period 1: Infant Series||797
7775600|NCT01340898|19141629|P3|NOT COMPLETED|Booster Phase||7
7775601|NCT01340898|19141630|P2|NOT COMPLETED|Booster Phase||2
7775602|NCT01340898|19141631|P1|NOT COMPLETED|Booster Phase||10
7775603|NCT01340898|19141629|P3|COMPLETED|Booster Phase||163
7775604|NCT01340898|19141630|P2|COMPLETED|Booster Phase||164
7775605|NCT01340898|19141631|P1|COMPLETED|Booster Phase||332
7775606|NCT01340898|19141629|P3|STARTED|Booster Phase||170
7775607|NCT01340898|19141630|P2|STARTED|Booster Phase||166
7775608|NCT01340898|19141631|P1|STARTED|Booster Phase||342
7775609|NCT01340898|19141629|P3|NOT COMPLETED|Primary Phase||6
7775610|NCT01340898|19141630|P2|NOT COMPLETED|Primary Phase||9
7775611|NCT01340898|19141631|P1|NOT COMPLETED|Primary Phase||16
7775612|NCT01340898|19141629|P3|COMPLETED|Primary Phase||181
7775613|NCT01340898|19141630|P2|COMPLETED|Primary Phase||178
7775614|NCT01340898|19141631|P1|COMPLETED|Primary Phase||360
7775615|NCT01340898|19141629|P3|STARTED|Primary Phase||187
7775616|NCT01340898|19141630|P2|STARTED|Primary Phase||187
7775617|NCT01340898|19141631|P1|STARTED|Primary Phase||376
7775618|NCT01340885|19141734|P3|NOT COMPLETED|Overall Study||0
7775619|NCT01340885|19141735|P2|NOT COMPLETED|Overall Study||0
7775620|NCT01340885|19141736|P1|NOT COMPLETED|Overall Study||0
7775621|NCT01340885|19141734|P3|COMPLETED|Overall Study||0
7775622|NCT01340885|19141735|P2|COMPLETED|Overall Study||0
7775623|NCT01340885|19141736|P1|COMPLETED|Overall Study||0
7775624|NCT01340885|19141734|P3|STARTED|Overall Study||0
7775625|NCT01340885|19141735|P2|STARTED|Overall Study||0
7775626|NCT01340885|19141736|P1|STARTED|Overall Study||0
7775627|NCT01340872|19141761|P4|NOT COMPLETED|Open-label Phase||11
7775628|NCT01340872|19141762|P3|NOT COMPLETED|Open-label Phase||13
7775629|NCT01340872|19141763|P2|NOT COMPLETED|Open-label Phase||0
7775630|NCT01340872|19141764|P1|NOT COMPLETED|Open-label Phase||0
7775631|NCT01340872|19141761|P4|COMPLETED|Open-label Phase||36
7775632|NCT01340872|19141762|P3|COMPLETED|Open-label Phase||37
7775633|NCT01340872|19141763|P2|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
7775634|NCT01340872|19141764|P1|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
7775635|NCT01340872|19141761|P4|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
7775636|NCT01340872|19141762|P3|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
7775637|NCT01340872|19141763|P2|STARTED|Open-label Phase|Not Applicable to open-label phase|0
7775638|NCT01340872|19141764|P1|STARTED|Open-label Phase|Not Applicable to open-label phase|0
7775639|NCT01340872|19141761|P4|NOT COMPLETED|Double-blind Phase||0
7775640|NCT01340872|19141762|P3|NOT COMPLETED|Double-blind Phase||0
7775641|NCT01340872|19141763|P2|NOT COMPLETED|Double-blind Phase||11
7775642|NCT01340872|19141764|P1|NOT COMPLETED|Double-blind Phase||9
7775643|NCT01340872|19141761|P4|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
7775644|NCT01340872|19141762|P3|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
7775645|NCT01340872|19141763|P2|COMPLETED|Double-blind Phase||53
7775646|NCT01340872|19141764|P1|COMPLETED|Double-blind Phase||55
7775647|NCT01340872|19141761|P4|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
7775648|NCT01340872|19141762|P3|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
7775649|NCT01340872|19141763|P2|STARTED|Double-blind Phase||64
7775650|NCT01340872|19141764|P1|STARTED|Double-blind Phase||64
7775651|NCT01340794|19141824|P2|NOT COMPLETED|Overall Study||1
7775652|NCT01340794|19141825|P1|NOT COMPLETED|Overall Study||0
7775653|NCT01340794|19141824|P2|COMPLETED|Overall Study||4
7775654|NCT01340794|19141825|P1|COMPLETED|Overall Study||2
7775655|NCT01340794|19141824|P2|STARTED|Overall Study||5
7775656|NCT01340794|19141825|P1|STARTED|Overall Study||2
7775657|NCT01340768|19141841|P2|NOT COMPLETED|Overall Study||5
7775658|NCT01340768|19141842|P1|NOT COMPLETED|Overall Study||17
7775659|NCT01340768|19141841|P2|COMPLETED|Overall Study||429
7775660|NCT01340768|19141842|P1|COMPLETED|Overall Study||419
7775661|NCT01340768|19141841|P2|STARTED|Overall Study||434
7775662|NCT01340768|19141842|P1|STARTED|Overall Study||436
7775663|NCT01340664|19141853|P3|NOT COMPLETED|Overall Study||13
7775664|NCT01340664|19141854|P2|NOT COMPLETED|Overall Study||8
7775665|NCT01340664|19141855|P1|NOT COMPLETED|Overall Study||7
7775666|NCT01340664|19141853|P3|COMPLETED|Overall Study||80
7775667|NCT01340664|19141854|P2|COMPLETED|Overall Study||85
7775668|NCT01340664|19141855|P1|COMPLETED|Overall Study||86
7775669|NCT01340664|19141853|P3|STARTED|Overall Study||93
7775670|NCT01340664|19141854|P2|STARTED|Overall Study||93
7775671|NCT01340664|19141855|P1|STARTED|Overall Study||93
7775672|NCT01340651|19141872|P1|NOT COMPLETED|Overall Study||17
7775673|NCT01340651|19141872|P1|COMPLETED|Overall Study||24
7775674|NCT01340651|19141872|P1|STARTED|Overall Study||41
7775675|NCT01340625|19141888|P2|NOT COMPLETED|Second Intervention||0
7775676|NCT01340625|19141889|P1|NOT COMPLETED|Second Intervention||0
7775677|NCT01340625|19141888|P2|COMPLETED|Second Intervention||18
7775678|NCT01340625|19141889|P1|COMPLETED|Second Intervention||16
7775679|NCT01340625|19141888|P2|STARTED|Second Intervention||18
7775680|NCT01340625|19141889|P1|STARTED|Second Intervention||16
7775681|NCT01340625|19141888|P2|NOT COMPLETED|Washout Period of 28 Days||0
7775682|NCT01340625|19141889|P1|NOT COMPLETED|Washout Period of 28 Days||1
7775683|NCT01340625|19141888|P2|COMPLETED|Washout Period of 28 Days||18
7775684|NCT01340625|19141889|P1|COMPLETED|Washout Period of 28 Days||16
7775685|NCT01340625|19141888|P2|STARTED|Washout Period of 28 Days||18
7775686|NCT01340625|19141889|P1|STARTED|Washout Period of 28 Days||17
7775687|NCT01340625|19141888|P2|NOT COMPLETED|First Intervention||0
7775688|NCT01340625|19141889|P1|NOT COMPLETED|First Intervention||1
7775689|NCT01340625|19141888|P2|COMPLETED|First Intervention||18
7775690|NCT01340625|19141889|P1|COMPLETED|First Intervention||17
7775691|NCT01340625|19141888|P2|STARTED|First Intervention||18
7775692|NCT01340625|19141889|P1|STARTED|First Intervention||18
7775693|NCT01340586|19141907|P2|NOT COMPLETED|Overall Study||0
7775694|NCT01340586|19141908|P1|NOT COMPLETED|Overall Study||0
7775695|NCT01340586|19141907|P2|COMPLETED|Overall Study||8
7775696|NCT01340586|19141908|P1|COMPLETED|Overall Study||8
7775697|NCT01340586|19141907|P2|STARTED|Overall Study||8
7775698|NCT01340586|19141908|P1|STARTED|Overall Study||8
7775699|NCT01340573|19141973|P1|NOT COMPLETED|Overall Study||3
7775700|NCT01340573|19141973|P1|COMPLETED|Overall Study||0
7775701|NCT01340573|19141973|P1|STARTED|Overall Study||3
7775702|NCT01340495|19141994|P1|NOT COMPLETED|Overall Study||1
7775703|NCT01340495|19141994|P1|COMPLETED|Overall Study||69
7775704|NCT01340495|19141994|P1|STARTED|Overall Study||70
7775705|NCT01340482|19142004|P3|NOT COMPLETED|Overall Study||0
7775706|NCT01340482|19142005|P2|NOT COMPLETED|Overall Study||0
7775707|NCT01340482|19142006|P1|NOT COMPLETED|Overall Study||2
7775708|NCT01340482|19142004|P3|COMPLETED|Overall Study||1
7775709|NCT01340482|19142005|P2|COMPLETED|Overall Study||1
7775710|NCT01340482|19142006|P1|COMPLETED|Overall Study||25
7775711|NCT01340482|19142004|P3|STARTED|Overall Study||1
7775712|NCT01340482|19142005|P2|STARTED|Overall Study||1
7775713|NCT01340482|19142006|P1|STARTED|Overall Study||27
7775714|NCT01340300|19142021|P4|NOT COMPLETED|Overall Study||14
7775715|NCT01340300|19142022|P3|NOT COMPLETED|Overall Study||15
7775716|NCT01340300|19142023|P2|NOT COMPLETED|Overall Study||9
7775717|NCT01340300|19142024|P1|NOT COMPLETED|Overall Study||9
7775718|NCT01340300|19142021|P4|COMPLETED|Overall Study||20
7775719|NCT01340300|19142022|P3|COMPLETED|Overall Study||20
7775720|NCT01340300|19142023|P2|COMPLETED|Overall Study||26
7775721|NCT01340300|19142024|P1|COMPLETED|Overall Study||26
7775722|NCT01340300|19142021|P4|Follow-up Blood Sample|Overall Study||18
7775723|NCT01340300|19142022|P3|Follow-up Blood Sample|Overall Study||19
7775724|NCT01340300|19142023|P2|Follow-up Blood Sample|Overall Study||26
7775725|NCT01340300|19142024|P1|Follow-up Blood Sample|Overall Study||25
7775726|NCT01340300|19142021|P4|Baseline Blood Sample|Overall Study||29
7775727|NCT01340300|19142022|P3|Baseline Blood Sample|Overall Study||32
7775728|NCT01340300|19142023|P2|Baseline Blood Sample|Overall Study||34
7775729|NCT01340300|19142024|P1|Baseline Blood Sample|Overall Study||33
7775730|NCT01340300|19142021|P4|STARTED|Overall Study||34
7775731|NCT01340300|19142022|P3|STARTED|Overall Study||35
7775732|NCT01340300|19142023|P2|STARTED|Overall Study||35
7775733|NCT01340300|19142024|P1|STARTED|Overall Study||35
7775734|NCT01340209|19142057|P3|NOT COMPLETED|Overall Study||8
7775735|NCT01340209|19142058|P2|NOT COMPLETED|Overall Study||8
7775736|NCT01340209|19142059|P1|NOT COMPLETED|Overall Study||5
7775737|NCT01340209|19142057|P3|COMPLETED|Overall Study||106
7775738|NCT01340209|19142058|P2|COMPLETED|Overall Study||106
7775739|NCT01340209|19142059|P1|COMPLETED|Overall Study||52
7775740|NCT01340209|19142057|P3|STARTED|Overall Study||114
7775741|NCT01340209|19142058|P2|STARTED|Overall Study||114
7775742|NCT01340209|19142059|P1|STARTED|Overall Study||57
7775743|NCT01340196|19142094|P1|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2
7775744|NCT01340196|19142094|P1|COMPLETED|Treat. Period 3 (Faldaprevir)||14
7775745|NCT01340196|19142094|P1|STARTED|Treat. Period 3 (Faldaprevir)||16
7775746|NCT01340196|19142094|P1|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0
7775747|NCT01340196|19142094|P1|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
7775748|NCT01340196|19142094|P1|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
7775749|NCT01340196|19142094|P1|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0
7775750|NCT01340196|19142094|P1|COMPLETED|Treat. Period 1 (Tenofovir)||16
7775751|NCT01340196|19142094|P1|STARTED|Treat. Period 1 (Tenofovir)||16
7775752|NCT01340144|19142125|P2|NOT COMPLETED|Overall Study||58
7775753|NCT01340144|19142126|P1|NOT COMPLETED|Overall Study||72
7775754|NCT01340144|19142125|P2|COMPLETED|Overall Study||567
7775755|NCT01340144|19142126|P1|COMPLETED|Overall Study||553
7775756|NCT01340144|19142125|P2|STARTED|Overall Study||625
7775757|NCT01340144|19142126|P1|STARTED|Overall Study||625
7775758|NCT01340066|19142134|P3|NOT COMPLETED|5 Week Double Blind Randomization Period||3
7775759|NCT01340066|19142135|P2|NOT COMPLETED|5 Week Double Blind Randomization Period||5
7775760|NCT01340066|19142136|P1|NOT COMPLETED|5 Week Double Blind Randomization Period||0
7775761|NCT01340066|19142134|P3|COMPLETED|5 Week Double Blind Randomization Period||31
7775762|NCT01340066|19142135|P2|COMPLETED|5 Week Double Blind Randomization Period||28
7775763|NCT01340066|19142136|P1|COMPLETED|5 Week Double Blind Randomization Period||0
7775764|NCT01340066|19142134|P3|STARTED|5 Week Double Blind Randomization Period||34
7775765|NCT01340066|19142135|P2|STARTED|5 Week Double Blind Randomization Period||33
7775766|NCT01340066|19142136|P1|STARTED|5 Week Double Blind Randomization Period||0
7775767|NCT01340066|19142134|P3|NOT COMPLETED|Placebo Run in Period||0
7775768|NCT01340066|19142135|P2|NOT COMPLETED|Placebo Run in Period||0
7775769|NCT01340066|19142136|P1|NOT COMPLETED|Placebo Run in Period||27
7775770|NCT01340066|19142134|P3|COMPLETED|Placebo Run in Period||0
7775771|NCT01340066|19142135|P2|COMPLETED|Placebo Run in Period||0
7775772|NCT01340066|19142136|P1|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67
7775773|NCT01340066|19142134|P3|STARTED|Placebo Run in Period||0
7775774|NCT01340066|19142135|P2|STARTED|Placebo Run in Period||0
7775775|NCT01340066|19142136|P1|STARTED|Placebo Run in Period||94
7775776|NCT01340053|19142147|P4|NOT COMPLETED|Overall Study||3
7775777|NCT01340053|19142148|P3|NOT COMPLETED|Overall Study||4
7775778|NCT01340053|19142149|P2|NOT COMPLETED|Overall Study||2
7775779|NCT01340053|19142150|P1|NOT COMPLETED|Overall Study||4
7775780|NCT01340053|19142147|P4|COMPLETED|Overall Study||43
7775781|NCT01340053|19142148|P3|COMPLETED|Overall Study||43
7775782|NCT01340053|19142149|P2|COMPLETED|Overall Study||44
7775783|NCT01340053|19142150|P1|COMPLETED|Overall Study||43
7775784|NCT01340053|19142147|P4|STARTED|Overall Study||46
7775785|NCT01340053|19142148|P3|STARTED|Overall Study||47
7775786|NCT01340053|19142149|P2|STARTED|Overall Study||46
7775787|NCT01340053|19142150|P1|STARTED|Overall Study||47
7775788|NCT01340027|19142176|P12|NOT COMPLETED|Overall Study||4
7775789|NCT01340027|19142177|P11|NOT COMPLETED|Overall Study||2
7775790|NCT01340027|19142178|P10|NOT COMPLETED|Overall Study||6
7775791|NCT01340027|19142179|P9|NOT COMPLETED|Overall Study||8
7775792|NCT01340027|19142180|P8|NOT COMPLETED|Overall Study||7
7775793|NCT01340027|19142181|P7|NOT COMPLETED|Overall Study||7
7775794|NCT01340027|19142182|P6|NOT COMPLETED|Overall Study||4
7775795|NCT01340027|19142183|P5|NOT COMPLETED|Overall Study||10
7775796|NCT01340027|19142184|P4|NOT COMPLETED|Overall Study||4
7775797|NCT01340027|19142185|P3|NOT COMPLETED|Overall Study||4
7775798|NCT01340027|19142186|P2|NOT COMPLETED|Overall Study||7
7775799|NCT01340027|19142187|P1|NOT COMPLETED|Overall Study||5
7775800|NCT01340027|19142176|P12|COMPLETED|Overall Study||77
7775801|NCT01340027|19142177|P11|COMPLETED|Overall Study||79
7775802|NCT01340027|19142178|P10|COMPLETED|Overall Study||146
7775803|NCT01340027|19142179|P9|COMPLETED|Overall Study||136
7775804|NCT01340027|19142180|P8|COMPLETED|Overall Study||142
7775805|NCT01340027|19142181|P7|COMPLETED|Overall Study||142
7775806|NCT01340027|19142182|P6|COMPLETED|Overall Study||74
7775807|NCT01340027|19142183|P5|COMPLETED|Overall Study||146
7775808|NCT01340027|19142184|P4|COMPLETED|Overall Study||75
7775809|NCT01340027|19142185|P3|COMPLETED|Overall Study||75
7775810|NCT01340027|19142186|P2|COMPLETED|Overall Study||71
7775811|NCT01340027|19142187|P1|COMPLETED|Overall Study||76
7775812|NCT01340027|19142176|P12|Received Treatment|Overall Study||81
7775813|NCT01340027|19142177|P11|Received Treatment|Overall Study||81
7775814|NCT01340027|19142178|P10|Received Treatment|Overall Study||152
7775815|NCT01340027|19142179|P9|Received Treatment|Overall Study||144
7775816|NCT01340027|19142180|P8|Received Treatment|Overall Study||149
7775817|NCT01340027|19142181|P7|Received Treatment|Overall Study||149
7775818|NCT01340027|19142182|P6|Received Treatment|Overall Study||78
7775819|NCT01340027|19142183|P5|Received Treatment|Overall Study||156
7775820|NCT01340027|19142184|P4|Received Treatment|Overall Study||79
7775821|NCT01340027|19142185|P3|Received Treatment|Overall Study||78
7775822|NCT01340027|19142186|P2|Received Treatment|Overall Study||78
7775823|NCT01340027|19142187|P1|Received Treatment|Overall Study||81
7775824|NCT01340027|19142176|P12|STARTED|Overall Study||81
7775825|NCT01340027|19142177|P11|STARTED|Overall Study||81
7775826|NCT01340027|19142178|P10|STARTED|Overall Study||152
7775827|NCT01340027|19142179|P9|STARTED|Overall Study||144
7775828|NCT01340027|19142180|P8|STARTED|Overall Study||149
7775829|NCT01340027|19142181|P7|STARTED|Overall Study||149
7775830|NCT01340027|19142182|P6|STARTED|Overall Study||78
7775831|NCT01340027|19142183|P5|STARTED|Overall Study||156
7775832|NCT01340027|19142184|P4|STARTED|Overall Study||79
7775833|NCT01340027|19142185|P3|STARTED|Overall Study||79
7775834|NCT01340027|19142186|P2|STARTED|Overall Study||78
7775835|NCT01340027|19142187|P1|STARTED|Overall Study||81
7775836|NCT01340014|19142563|P2|NOT COMPLETED|Period 2, Second 7 Days||1
7775837|NCT01340014|19142564|P1|NOT COMPLETED|Period 2, Second 7 Days||0
7775838|NCT01340014|19142563|P2|COMPLETED|Period 2, Second 7 Days||56
7775839|NCT01340014|19142564|P1|COMPLETED|Period 2, Second 7 Days||53
7775840|NCT01340014|19142563|P2|STARTED|Period 2, Second 7 Days||57
7775841|NCT01340014|19142564|P1|STARTED|Period 2, Second 7 Days||53
7775842|NCT01340014|19142563|P2|NOT COMPLETED|Period 1, First 7 Days||0
7775843|NCT01340014|19142564|P1|NOT COMPLETED|Period 1, First 7 Days||2
7775844|NCT01340014|19142563|P2|COMPLETED|Period 1, First 7 Days||57
7775845|NCT01340014|19142564|P1|COMPLETED|Period 1, First 7 Days||53
7775846|NCT01340014|19142563|P2|STARTED|Period 1, First 7 Days||57
7775847|NCT01340014|19142564|P1|STARTED|Period 1, First 7 Days||55
7775848|NCT01339936|19142572|P1|NOT COMPLETED|Overall Study||2
7775849|NCT01339936|19142572|P1|COMPLETED|Overall Study|plus 1 excluded from analysis set|36
7775850|NCT01339936|19142572|P1|STARTED|Overall Study|plus 2 screen failures|38
7775851|NCT01339923|19142585|P7|NOT COMPLETED|Overall Study||14
7775852|NCT01339923|19142586|P6|NOT COMPLETED|Overall Study||9
7775853|NCT01339923|19142587|P5|NOT COMPLETED|Overall Study||5
7775854|NCT01339923|19142588|P4|NOT COMPLETED|Overall Study||4
7775855|NCT01339923|19142589|P3|NOT COMPLETED|Overall Study||8
7775856|NCT01339923|19142590|P2|NOT COMPLETED|Overall Study||16
7775857|NCT01339923|19142591|P1|NOT COMPLETED|Overall Study||14
7775858|NCT01339923|19142585|P7|COMPLETED|Overall Study||111
7775859|NCT01339923|19142586|P6|COMPLETED|Overall Study||117
7775860|NCT01339923|19142587|P5|COMPLETED|Overall Study||295
7775861|NCT01339923|19142588|P4|COMPLETED|Overall Study||100
7775862|NCT01339923|19142589|P3|COMPLETED|Overall Study||243
7775863|NCT01339923|19142590|P2|COMPLETED|Overall Study||234
7775864|NCT01339923|19142591|P1|COMPLETED|Overall Study||239
7775865|NCT01339923|19142585|P7|STARTED|Overall Study||125
7775866|NCT01339923|19142586|P6|STARTED|Overall Study||126
7775867|NCT01339923|19142587|P5|STARTED|Overall Study||300
7775868|NCT01339923|19142588|P4|STARTED|Overall Study||104
7775869|NCT01339923|19142589|P3|STARTED|Overall Study||251
7775870|NCT01339923|19142590|P2|STARTED|Overall Study||250
7775871|NCT01339923|19142591|P1|STARTED|Overall Study||253
7775872|NCT01339910|19142662|P2|NOT COMPLETED|Overall Study||4
7775873|NCT01339910|19142663|P1|NOT COMPLETED|Overall Study||3
7775874|NCT01339910|19142662|P2|COMPLETED|Overall Study||133
7775875|NCT01339910|19142663|P1|COMPLETED|Overall Study||132
7775876|NCT01339910|19142662|P2|STARTED|Overall Study||137
7775877|NCT01339910|19142663|P1|STARTED|Overall Study||135
7775878|NCT01339897|19142701|P4|NOT COMPLETED|Overall Study||1
7775879|NCT01339897|19142702|P3|NOT COMPLETED|Overall Study||0
7775880|NCT01339897|19142703|P2|NOT COMPLETED|Overall Study||0
7775881|NCT01339897|19142704|P1|NOT COMPLETED|Overall Study||1
7775882|NCT01339897|19142701|P4|COMPLETED|Overall Study||5
7775883|NCT01339897|19142702|P3|COMPLETED|Overall Study||6
7775884|NCT01339897|19142703|P2|COMPLETED|Overall Study||6
7775885|NCT01339897|19142704|P1|COMPLETED|Overall Study||6
7775886|NCT01339897|19142701|P4|STARTED|Overall Study||6
7775887|NCT01339897|19142702|P3|STARTED|Overall Study||6
7775888|NCT01339897|19142703|P2|STARTED|Overall Study||6
7775889|NCT01339897|19142704|P1|STARTED|Overall Study||7
7775890|NCT01339858|19142732|P2|NOT COMPLETED|Overall Study||12
7775891|NCT01339858|19142733|P1|NOT COMPLETED|Overall Study||16
7775892|NCT01339858|19142732|P2|COMPLETED|Overall Study||18
7775893|NCT01339858|19142733|P1|COMPLETED|Overall Study||14
7775894|NCT01339858|19142732|P2|STARTED|Overall Study||30
7775895|NCT01339858|19142733|P1|STARTED|Overall Study||30
7775896|NCT01339832|19142757|P1|NOT COMPLETED|Overall Study||14
7775897|NCT01339832|19142757|P1|COMPLETED|Overall Study||37
7775898|NCT01339832|19142757|P1|STARTED|Overall Study||51
7775899|NCT01339559|19142768|P1|NOT COMPLETED|Overall Study||398
7775900|NCT01339559|19142768|P1|COMPLETED|Overall Study||368
7775901|NCT01339559|19142768|P1|STARTED|Overall Study||766
7775902|NCT01339429|19142777|P1|NOT COMPLETED|Overall Study||4
7775903|NCT01339429|19142777|P1|COMPLETED|Overall Study||37
7775904|NCT01339429|19142777|P1|STARTED|Overall Study||41
7775905|NCT01339416|19142782|P1|NOT COMPLETED|Overall Study||0
7775906|NCT01339416|19142782|P1|COMPLETED|Overall Study||8202
7775907|NCT01339416|19142782|P1|STARTED|Overall Study||8202
7775908|NCT01339403|19142794|P2|NOT COMPLETED|Overall Study||0
7775909|NCT01339403|19142795|P1|NOT COMPLETED|Overall Study||0
7775910|NCT01339403|19142794|P2|COMPLETED|Overall Study||257600
7775911|NCT01339403|19142795|P1|COMPLETED|Overall Study||24768
7775912|NCT01339403|19142794|P2|STARTED|Overall Study||257600
7775913|NCT01339403|19142795|P1|STARTED|Overall Study||24768
7775914|NCT01339390|19142817|P2|NOT COMPLETED|Overall Study||156
7775915|NCT01339390|19142818|P1|NOT COMPLETED|Overall Study||157
7775916|NCT01339390|19142817|P2|COMPLETED|Overall Study||1442
7775917|NCT01339390|19142818|P1|COMPLETED|Overall Study||1414
7775918|NCT01339390|19142817|P2|STARTED|Overall Study||1598
7775919|NCT01339390|19142818|P1|STARTED|Overall Study||1571
7775920|NCT01339299|19142826|P2|NOT COMPLETED|Overall Study||0
7775921|NCT01339299|19142827|P1|NOT COMPLETED|Overall Study||0
7775922|NCT01339299|19142826|P2|COMPLETED|Overall Study||50
7775923|NCT01339299|19142827|P1|COMPLETED|Overall Study||50
7775924|NCT01339299|19142826|P2|STARTED|Overall Study||50
7775925|NCT01339299|19142827|P1|STARTED|Overall Study||50
7775926|NCT01339273|19142835|P2|NOT COMPLETED|Overall Study||8
7775927|NCT01339273|19142836|P1|NOT COMPLETED|Overall Study||8
7775928|NCT01339273|19142835|P2|COMPLETED|Overall Study||28
7775929|NCT01339273|19142836|P1|COMPLETED|Overall Study||28
7775930|NCT01339273|19142835|P2|STARTED|Overall Study||36
7775931|NCT01339273|19142836|P1|STARTED|Overall Study||36
7775932|NCT01339260|19142870|P2|NOT COMPLETED|Multi-cycle Extension||193
7775933|NCT01339260|19142871|P1|NOT COMPLETED|Multi-cycle Extension||186
7775934|NCT01339260|19142870|P2|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458
7775935|NCT01339260|19142871|P1|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449
7775936|NCT01339260|19142870|P2|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651
7775937|NCT01339260|19142871|P1|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635
7775938|NCT01339260|19142870|P2|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651
7775939|NCT01339260|19142871|P1|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635
7775940|NCT01339260|19142870|P2|NOT COMPLETED|Cycle 1||10
7775941|NCT01339260|19142871|P1|NOT COMPLETED|Cycle 1||7
7775942|NCT01339260|19142870|P2|COMPLETED|Cycle 1||719
7775943|NCT01339260|19142871|P1|COMPLETED|Cycle 1||719
7775944|NCT01339260|19142870|P2|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725
7775945|NCT01339260|19142871|P1|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724
7775946|NCT01339260|19142870|P2|Safety Population|Cycle 1|Patients receiving palonosetron|725
7775947|NCT01339260|19142871|P1|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725
7775948|NCT01339260|19142870|P2|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729
7775949|NCT01339260|19142871|P1|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726
7775950|NCT01339247|19142883|P2|NOT COMPLETED|Period 2||0
7775951|NCT01339247|19142884|P1|NOT COMPLETED|Period 2||0
7775952|NCT01339247|19142883|P2|COMPLETED|Period 2||30
7775953|NCT01339247|19142884|P1|COMPLETED|Period 2||30
7775954|NCT01339247|19142883|P2|STARTED|Period 2||30
7775955|NCT01339247|19142884|P1|STARTED|Period 2||30
7775956|NCT01339247|19142883|P2|NOT COMPLETED|Period 1||0
7775957|NCT01339247|19142884|P1|NOT COMPLETED|Period 1||0
7775958|NCT01339247|19142883|P2|COMPLETED|Period 1||30
7775959|NCT01339247|19142884|P1|COMPLETED|Period 1||30
7775960|NCT01339247|19142883|P2|STARTED|Period 1||30
7775961|NCT01339247|19142884|P1|STARTED|Period 1||30
7775962|NCT01339091|19142896|P2|NOT COMPLETED|Overall Study||28
7775963|NCT01339091|19142897|P1|NOT COMPLETED|Overall Study||27
7775964|NCT01339091|19142896|P2|COMPLETED|Overall Study||257
7775965|NCT01339091|19142897|P1|COMPLETED|Overall Study||261
7775966|NCT01339091|19142896|P2|Safety Population|Overall Study||284
7775967|NCT01339091|19142897|P1|Safety Population|Overall Study||284
7775968|NCT01339091|19142896|P2|STARTED|Overall Study||285
7775969|NCT01339091|19142897|P1|STARTED|Overall Study||288
7775970|NCT01339052|19142911|P2|NOT COMPLETED|Overall Study||50
7775971|NCT01339052|19142912|P1|NOT COMPLETED|Overall Study||15
7775972|NCT01339052|19142911|P2|COMPLETED|Overall Study||0
7775973|NCT01339052|19142912|P1|COMPLETED|Overall Study||0
7775974|NCT01339052|19142911|P2|Evaluable Plasma Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
7775975|NCT01339052|19142912|P1|Evaluable Plasma Sample at Surgery|Overall Study||13
7775976|NCT01339052|19142911|P2|Evaluable Tumor Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
7775977|NCT01339052|19142912|P1|Evaluable Tumor Sample at Surgery|Overall Study||14
7775978|NCT01339052|19142911|P2|Measurable Disease|Overall Study|Radiographic response evaluated on participants with measurable disease only.|40
7775979|NCT01339052|19142912|P1|Measurable Disease|Overall Study||11
7775980|NCT01339052|19142911|P2|STARTED|Overall Study||50
7775981|NCT01339052|19142912|P1|STARTED|Overall Study||15
7775982|NCT01339013|19142932|P1|NOT COMPLETED|Overall Study||0
7775983|NCT01339013|19142932|P1|COMPLETED|Overall Study||6
7775984|NCT01339013|19142932|P1|STARTED|Overall Study||6
7775985|NCT01339000|19142938|P2|NOT COMPLETED|Overall Study||0
7775986|NCT01339000|19142939|P1|NOT COMPLETED|Overall Study||1
7775987|NCT01339000|19142938|P2|COMPLETED|Overall Study||0
7775988|NCT01339000|19142939|P1|COMPLETED|Overall Study||0
7775989|NCT01339000|19142938|P2|STARTED|Overall Study||0
7775990|NCT01339000|19142939|P1|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1
7775991|NCT01338987|19142958|P5|NOT COMPLETED|Overall Study||0
7775992|NCT01338987|19142959|P4|NOT COMPLETED|Overall Study||0
7775993|NCT01338987|19142960|P3|NOT COMPLETED|Overall Study||2
7775994|NCT01338987|19142961|P2|NOT COMPLETED|Overall Study||1
7775995|NCT01338987|19142962|P1|NOT COMPLETED|Overall Study||2
7775996|NCT01338987|19142958|P5|COMPLETED|Overall Study||2
7775997|NCT01338987|19142959|P4|COMPLETED|Overall Study||31
7775998|NCT01338987|19142960|P3|COMPLETED|Overall Study||20
7775999|NCT01338987|19142961|P2|COMPLETED|Overall Study||8
7776000|NCT01338987|19142962|P1|COMPLETED|Overall Study||10
7776001|NCT01338987|19142958|P5|STARTED|Overall Study||2
7776002|NCT01338987|19142959|P4|STARTED|Overall Study||31
7776003|NCT01338987|19142960|P3|STARTED|Overall Study||22
7776004|NCT01338987|19142961|P2|STARTED|Overall Study||9
7776005|NCT01338987|19142962|P1|STARTED|Overall Study||12
7776006|NCT01338870|19142983|P6|NOT COMPLETED|Overall Study||6
7776007|NCT01338870|19142984|P5|NOT COMPLETED|Overall Study||6
7776008|NCT01338870|19142985|P4|NOT COMPLETED|Overall Study||9
7776009|NCT01338870|19142986|P3|NOT COMPLETED|Overall Study||11
7776010|NCT01338870|19142987|P2|NOT COMPLETED|Overall Study||12
7776011|NCT01338870|19142988|P1|NOT COMPLETED|Overall Study||9
7776012|NCT01338870|19142983|P6|COMPLETED|Overall Study||44
7776013|NCT01338870|19142984|P5|COMPLETED|Overall Study||46
7776014|NCT01338870|19142985|P4|COMPLETED|Overall Study||41
7776015|NCT01338870|19142986|P3|COMPLETED|Overall Study||39
7776016|NCT01338870|19142987|P2|COMPLETED|Overall Study||37
7776017|NCT01338870|19142988|P1|COMPLETED|Overall Study||41
7776018|NCT01338870|19142983|P6|STARTED|Overall Study||50
7776019|NCT01338870|19142984|P5|STARTED|Overall Study||52
7776020|NCT01338870|19142985|P4|STARTED|Overall Study||50
7776021|NCT01338870|19142986|P3|STARTED|Overall Study||50
7776022|NCT01338870|19142987|P2|STARTED|Overall Study||49
7776023|NCT01338870|19142988|P1|STARTED|Overall Study||50
7776024|NCT01338857|19143038|P1|NOT COMPLETED|Overall Study||11
7776025|NCT01338857|19143038|P1|COMPLETED|Overall Study||1
7776026|NCT01338857|19143038|P1|STARTED|Overall Study||12
7776027|NCT01338818|19143043|P1|NOT COMPLETED|Overall Study||36
7776028|NCT01338818|19143043|P1|COMPLETED|Overall Study||262
7776029|NCT01338818|19143043|P1|STARTED|Overall Study||298
7776030|NCT01338792|19143049|P1|NOT COMPLETED|Overall Study||4
7776031|NCT01338792|19143049|P1|COMPLETED|Overall Study||43
7776032|NCT01338792|19143049|P1|STARTED|Overall Study||47
7776033|NCT01338649|19143057|P2|NOT COMPLETED|Overall Study||0
7776034|NCT01338649|19143058|P1|NOT COMPLETED|Overall Study||0
7776035|NCT01338649|19143057|P2|COMPLETED|Overall Study||14
7776036|NCT01338649|19143058|P1|COMPLETED|Overall Study||13
7776037|NCT01338649|19143057|P2|STARTED|Overall Study||14
7776038|NCT01338649|19143058|P1|STARTED|Overall Study||13
7776039|NCT01338636|19143064|P1|NOT COMPLETED|Overall Study||8
7776040|NCT01338636|19143064|P1|COMPLETED|Overall Study||22
7776041|NCT01338636|19143064|P1|STARTED|Overall Study||30
7776042|NCT01338610|19143078|P3|NOT COMPLETED|Overall Study||1
7776043|NCT01338610|19143079|P2|NOT COMPLETED|Overall Study||1
7776044|NCT01338610|19143080|P1|NOT COMPLETED|Overall Study||5
7776045|NCT01338610|19143078|P3|COMPLETED|Overall Study||28
7776046|NCT01338610|19143079|P2|COMPLETED|Overall Study||55
7776047|NCT01338610|19143080|P1|COMPLETED|Overall Study||34
7776048|NCT01338610|19143078|P3|STARTED|Overall Study||29
7776049|NCT01338610|19143079|P2|STARTED|Overall Study||56
7776050|NCT01338610|19143080|P1|STARTED|Overall Study||39
7776051|NCT01338506|19143089|P2|NOT COMPLETED|Overall Study||14
7776052|NCT01338506|19143090|P1|NOT COMPLETED|Overall Study||25
7776053|NCT01338506|19143089|P2|COMPLETED|Overall Study||13
7776054|NCT01338506|19143090|P1|COMPLETED|Overall Study||29
7776055|NCT01338506|19143089|P2|STARTED|Overall Study||27
7776056|NCT01338506|19143090|P1|STARTED|Overall Study||54
7776057|NCT01338493|19143106|P1|NOT COMPLETED|24 Months Follow up||0
7776058|NCT01338493|19143106|P1|COMPLETED|24 Months Follow up||104
7776059|NCT01338493|19143106|P1|STARTED|24 Months Follow up||104
7776060|NCT01338493|19143106|P1|NOT COMPLETED|12 Months Follow up||9
7776061|NCT01338493|19143106|P1|COMPLETED|12 Months Follow up||104
7776062|NCT01338493|19143106|P1|STARTED|12 Months Follow up||113
7776063|NCT01338493|19143106|P1|NOT COMPLETED|6 Months Follow up||19
7776064|NCT01338493|19143106|P1|COMPLETED|6 Months Follow up||113
7776065|NCT01338493|19143106|P1|STARTED|6 Months Follow up||132
7776066|NCT01338493|19143106|P1|NOT COMPLETED|Discharge||2
7776067|NCT01338493|19143106|P1|COMPLETED|Discharge||132
7776068|NCT01338493|19143106|P1|STARTED|Discharge||134
7776069|NCT01338493|19143106|P1|NOT COMPLETED|Implant||0
7776070|NCT01338493|19143106|P1|COMPLETED|Implant||134
7776071|NCT01338493|19143106|P1|STARTED|Implant||134
7776072|NCT01338493|19143106|P1|NOT COMPLETED|Enrolled||5
7776073|NCT01338493|19143106|P1|COMPLETED|Enrolled||134
7776074|NCT01338493|19143106|P1|STARTED|Enrolled||139
7776075|NCT01338415|19143113|P2|NOT COMPLETED|Overall Study||9
7776076|NCT01338415|19143114|P1|NOT COMPLETED|Overall Study||10
7776077|NCT01338415|19143113|P2|COMPLETED|Overall Study||22
7776078|NCT01338415|19143114|P1|COMPLETED|Overall Study||23
7776079|NCT01338415|19143113|P2|Enrolled in FUTURE 3 Extension|Overall Study||27
7776080|NCT01338415|19143114|P1|Enrolled in FUTURE 3 Extension|Overall Study||31
7776081|NCT01338415|19143113|P2|STARTED|Overall Study||31
7776082|NCT01338415|19143114|P1|STARTED|Overall Study||33
7776083|NCT01338298|19143136|P2|NOT COMPLETED|Overall Study||3
7776084|NCT01338298|19143137|P1|NOT COMPLETED|Overall Study||4
7776085|NCT01338298|19143136|P2|COMPLETED|Overall Study||15
7776086|NCT01338298|19143137|P1|COMPLETED|Overall Study||20
7776087|NCT01338298|19143136|P2|STARTED|Overall Study||18
7776088|NCT01338298|19143137|P1|STARTED|Overall Study||24
7776089|NCT01338025|19143147|P2|NOT COMPLETED|Overall Study||11
7776090|NCT01338025|19143148|P1|NOT COMPLETED|Overall Study||11
7776091|NCT01338025|19143147|P2|COMPLETED|Overall Study||6
7776092|NCT01338025|19143148|P1|COMPLETED|Overall Study||5
7776093|NCT01338025|19143147|P2|STARTED|Overall Study||17
7776094|NCT01338025|19143148|P1|STARTED|Overall Study||16
7776095|NCT01338012|19143160|P1|NOT COMPLETED|Overall Study||8
7776096|NCT01338012|19143160|P1|COMPLETED|Overall Study||0
7776097|NCT01338012|19143160|P1|STARTED|Overall Study||8
7776098|NCT01337986|19143166|P2|NOT COMPLETED|Overall Study||5
7776099|NCT01337986|19143167|P1|NOT COMPLETED|Overall Study||3
7776100|NCT01337986|19143166|P2|COMPLETED|Overall Study||18
7776101|NCT01337986|19143167|P1|COMPLETED|Overall Study||20
7776102|NCT01337986|19143166|P2|STARTED|Overall Study||23
7776103|NCT01337986|19143167|P1|STARTED|Overall Study||23
7776104|NCT01337973|19143204|P3|NOT COMPLETED|Overall Study||11
7776105|NCT01337973|19143205|P2|NOT COMPLETED|Overall Study||15
7776106|NCT01337973|19143206|P1|NOT COMPLETED|Overall Study||16
7776107|NCT01337973|19143204|P3|COMPLETED|Overall Study||49
7776108|NCT01337973|19143205|P2|COMPLETED|Overall Study||45
7776109|NCT01337973|19143206|P1|COMPLETED|Overall Study||44
7776110|NCT01337973|19143204|P3|STARTED|Overall Study||60
7776111|NCT01337973|19143205|P2|STARTED|Overall Study||60
7776112|NCT01337973|19143206|P1|STARTED|Overall Study||60
7776113|NCT01337960|19143220|P3|NOT COMPLETED|Overall Study||0
7776114|NCT01337960|19143221|P2|NOT COMPLETED|Overall Study||0
7776115|NCT01337960|19143222|P1|NOT COMPLETED|Overall Study||2
7776116|NCT01337960|19143220|P3|COMPLETED|Overall Study||6
7776117|NCT01337960|19143221|P2|COMPLETED|Overall Study||14
7776118|NCT01337960|19143222|P1|COMPLETED|Overall Study||12
7776119|NCT01337960|19143220|P3|STARTED|Overall Study||6
7776120|NCT01337960|19143221|P2|STARTED|Overall Study||14
7776121|NCT01337960|19143222|P1|STARTED|Overall Study||14
7776122|NCT01337739|19143244|P2|NOT COMPLETED|Overall Study||0
7776123|NCT01337739|19143245|P1|NOT COMPLETED|Overall Study||0
7776124|NCT01337739|19143244|P2|COMPLETED|Overall Study||4
7776125|NCT01337739|19143245|P1|COMPLETED|Overall Study||6
7776126|NCT01337739|19143244|P2|STARTED|Overall Study||4
7776127|NCT01337739|19143245|P1|STARTED|Overall Study||6
7776128|NCT01337700|19143255|P2|NOT COMPLETED|Overall Study||0
7776129|NCT01337700|19143256|P1|NOT COMPLETED|Overall Study||0
7776130|NCT01337700|19143255|P2|COMPLETED|Overall Study||5
7776131|NCT01337700|19143256|P1|COMPLETED|Overall Study||5
7776132|NCT01337700|19143255|P2|STARTED|Overall Study||5
7776133|NCT01337700|19143256|P1|STARTED|Overall Study||5
7776134|NCT01337687|19143272|P2|NOT COMPLETED|Overall Study||0
7776135|NCT01337687|19143273|P1|NOT COMPLETED|Overall Study||0
7776136|NCT01337687|19143272|P2|COMPLETED|Overall Study||9
7776137|NCT01337687|19143273|P1|COMPLETED|Overall Study||10
7776138|NCT01337687|19143272|P2|STARTED|Overall Study||9
7776139|NCT01337687|19143273|P1|STARTED|Overall Study||10
7776140|NCT01337674|19143287|P4|NOT COMPLETED|Treatment Period 2||0
7776141|NCT01337674|19143288|P3|NOT COMPLETED|Treatment Period 2||1
7776142|NCT01337674|19143289|P2|NOT COMPLETED|Treatment Period 2||0
7776143|NCT01337674|19143290|P1|NOT COMPLETED|Treatment Period 2||0
7776144|NCT01337674|19143287|P4|COMPLETED|Treatment Period 2||6
7776145|NCT01337674|19143288|P3|COMPLETED|Treatment Period 2||5
7776146|NCT01337674|19143289|P2|COMPLETED|Treatment Period 2||6
7776147|NCT01337674|19143290|P1|COMPLETED|Treatment Period 2||6
7776148|NCT01337674|19143287|P4|STARTED|Treatment Period 2||6
7776149|NCT01337674|19143288|P3|STARTED|Treatment Period 2||6
7776150|NCT01337674|19143289|P2|STARTED|Treatment Period 2||6
7776151|NCT01337674|19143290|P1|STARTED|Treatment Period 2||6
7776152|NCT01337674|19143287|P4|NOT COMPLETED|Two-week Washout Period||0
7776153|NCT01337674|19143288|P3|NOT COMPLETED|Two-week Washout Period||0
7776154|NCT01337674|19143289|P2|NOT COMPLETED|Two-week Washout Period||0
7776155|NCT01337674|19143290|P1|NOT COMPLETED|Two-week Washout Period||0
7776156|NCT01337674|19143287|P4|COMPLETED|Two-week Washout Period||6
7776157|NCT01337674|19143288|P3|COMPLETED|Two-week Washout Period||6
7776158|NCT01337674|19143289|P2|COMPLETED|Two-week Washout Period||6
7776159|NCT01337674|19143290|P1|COMPLETED|Two-week Washout Period||6
7776160|NCT01337674|19143287|P4|STARTED|Two-week Washout Period||6
7776161|NCT01337674|19143288|P3|STARTED|Two-week Washout Period||6
7776162|NCT01337674|19143289|P2|STARTED|Two-week Washout Period||6
7776163|NCT01337674|19143290|P1|STARTED|Two-week Washout Period||6
7776164|NCT01337674|19143287|P4|NOT COMPLETED|Treatment Period 1||1
7776165|NCT01337674|19143288|P3|NOT COMPLETED|Treatment Period 1||0
7776166|NCT01337674|19143289|P2|NOT COMPLETED|Treatment Period 1||1
7776167|NCT01337674|19143290|P1|NOT COMPLETED|Treatment Period 1||0
7776168|NCT01337674|19143287|P4|COMPLETED|Treatment Period 1||6
7776169|NCT01337674|19143288|P3|COMPLETED|Treatment Period 1||6
7776170|NCT01337674|19143289|P2|COMPLETED|Treatment Period 1||6
7776171|NCT01337674|19143290|P1|COMPLETED|Treatment Period 1||6
7776172|NCT01337674|19143287|P4|STARTED|Treatment Period 1|The discontinued participant was replaced|7
7776173|NCT01337674|19143288|P3|STARTED|Treatment Period 1||6
7776174|NCT01337674|19143289|P2|STARTED|Treatment Period 1|The discontinued participant was replaced|7
7776175|NCT01337674|19143290|P1|STARTED|Treatment Period 1||6
7776176|NCT01337635|19143308|P2|NOT COMPLETED|Overall Study||1
7776177|NCT01337635|19143309|P1|NOT COMPLETED|Overall Study||0
7776178|NCT01337635|19143308|P2|COMPLETED|Overall Study||3
7776179|NCT01337635|19143309|P1|COMPLETED|Overall Study||3
7776180|NCT01337635|19143308|P2|STARTED|Overall Study||4
7776181|NCT01337635|19143309|P1|STARTED|Overall Study||3
7776182|NCT01337609|19143320|P3|NOT COMPLETED|Overall Study||0
7776183|NCT01337609|19143321|P2|NOT COMPLETED|Overall Study||0
7776184|NCT01337609|19143322|P1|NOT COMPLETED|Overall Study||1
7776185|NCT01337609|19143320|P3|COMPLETED|Overall Study||2
7776186|NCT01337609|19143321|P2|COMPLETED|Overall Study||2
7776187|NCT01337609|19143322|P1|COMPLETED|Overall Study||0
7776188|NCT01337609|19143320|P3|STARTED|Overall Study||2
7776189|NCT01337609|19143321|P2|STARTED|Overall Study||2
7776190|NCT01337609|19143322|P1|STARTED|Overall Study||1
7776191|NCT01337596|19143351|P9|NOT COMPLETED|Overall Study||0
7776192|NCT01337596|19143352|P8|NOT COMPLETED|Overall Study||0
7776193|NCT01337596|19143353|P7|NOT COMPLETED|Overall Study||0
7776194|NCT01337596|19143354|P6|NOT COMPLETED|Overall Study||0
7776195|NCT01337596|19143355|P5|NOT COMPLETED|Overall Study||2
7776196|NCT01337596|19143356|P4|NOT COMPLETED|Overall Study||0
7776197|NCT01337596|19143357|P3|NOT COMPLETED|Overall Study||0
7776198|NCT01337596|19143358|P2|NOT COMPLETED|Overall Study||0
7776199|NCT01337596|19143359|P1|NOT COMPLETED|Overall Study||0
7776200|NCT01337596|19143351|P9|COMPLETED|Overall Study||7
7776201|NCT01337596|19143352|P8|COMPLETED|Overall Study||2
7776202|NCT01337596|19143353|P7|COMPLETED|Overall Study||12
7776203|NCT01337596|19143354|P6|COMPLETED|Overall Study||7
7776204|NCT01337596|19143355|P5|COMPLETED|Overall Study||5
7776205|NCT01337596|19143356|P4|COMPLETED|Overall Study||7
7776206|NCT01337596|19143357|P3|COMPLETED|Overall Study||7
7776207|NCT01337596|19143358|P2|COMPLETED|Overall Study||7
7776208|NCT01337596|19143359|P1|COMPLETED|Overall Study||7
7776209|NCT01337596|19143351|P9|Safety Population|Overall Study||7
7776210|NCT01337596|19143352|P8|Safety Population|Overall Study||2
7776211|NCT01337596|19143353|P7|Safety Population|Overall Study||12
7776212|NCT01337596|19143354|P6|Safety Population|Overall Study||7
7776213|NCT01337596|19143355|P5|Safety Population|Overall Study||7
7776214|NCT01337596|19143356|P4|Safety Population|Overall Study||7
7776215|NCT01337596|19143357|P3|Safety Population|Overall Study||7
7776216|NCT01337596|19143358|P2|Safety Population|Overall Study||7
7776217|NCT01337596|19143359|P1|Safety Population|Overall Study||7
7776218|NCT01337596|19143351|P9|STARTED|Overall Study||7
7776219|NCT01337596|19143352|P8|STARTED|Overall Study||2
7776220|NCT01337596|19143353|P7|STARTED|Overall Study||12
7776221|NCT01337596|19143354|P6|STARTED|Overall Study||7
7776222|NCT01337596|19143355|P5|STARTED|Overall Study||7
7776223|NCT01337596|19143356|P4|STARTED|Overall Study||7
7776224|NCT01337596|19143357|P3|STARTED|Overall Study||7
7776225|NCT01337596|19143358|P2|STARTED|Overall Study||7
7776226|NCT01337596|19143359|P1|STARTED|Overall Study||7
7776227|NCT01337336|19143395|P2|NOT COMPLETED|Overall Study||0
7776228|NCT01337336|19143396|P1|NOT COMPLETED|Overall Study||0
7776229|NCT01337336|19143395|P2|COMPLETED|Overall Study||2923
7776230|NCT01337336|19143396|P1|COMPLETED|Overall Study||1078
7776231|NCT01337336|19143395|P2|STARTED|Overall Study||2923
7776232|NCT01337336|19143396|P1|STARTED|Overall Study||1078
7776233|NCT01337297|19143410|P2|NOT COMPLETED|Overall Study||6
7776234|NCT01337297|19143411|P1|NOT COMPLETED|Overall Study||5
7776235|NCT01337297|19143410|P2|COMPLETED|Overall Study||3
7776236|NCT01337297|19143411|P1|COMPLETED|Overall Study||6
7776237|NCT01337297|19143410|P2|STARTED|Overall Study||9
7776238|NCT01337297|19143411|P1|STARTED|Overall Study||11
7776239|NCT01337167|19143419|P2|NOT COMPLETED|Toddler Vaccinations||13
7776240|NCT01337167|19143420|P1|NOT COMPLETED|Toddler Vaccinations||14
7776241|NCT01337167|19143419|P2|COMPLETED|Toddler Vaccinations||407
7776242|NCT01337167|19143420|P1|COMPLETED|Toddler Vaccinations||829
7776243|NCT01337167|19143419|P2|STARTED|Toddler Vaccinations||420
7776244|NCT01337167|19143420|P1|STARTED|Toddler Vaccinations||843
7776245|NCT01337167|19143419|P2|NOT COMPLETED|Interim Period||40
7776246|NCT01337167|19143420|P1|NOT COMPLETED|Interim Period||81
7776247|NCT01337167|19143419|P2|COMPLETED|Interim Period||420
7776248|NCT01337167|19143420|P1|COMPLETED|Interim Period||843
7776249|NCT01337167|19143419|P2|STARTED|Interim Period||460
7776250|NCT01337167|19143420|P1|STARTED|Interim Period||924
7776251|NCT01337167|19143419|P2|NOT COMPLETED|Infant Series||27
7776252|NCT01337167|19143420|P1|NOT COMPLETED|Infant Series||62
7776253|NCT01337167|19143419|P2|COMPLETED|Infant Series||460
7776254|NCT01337167|19143420|P1|COMPLETED|Infant Series||924
7776255|NCT01337167|19143419|P2|STARTED|Infant Series||487
7776256|NCT01337167|19143420|P1|STARTED|Infant Series||986
7776257|NCT01337115|19143488|P2|NOT COMPLETED|Overall Study||0
7776258|NCT01337115|19143489|P1|NOT COMPLETED|Overall Study||2
7776259|NCT01337115|19143488|P2|COMPLETED|Overall Study||25
7776260|NCT01337115|19143489|P1|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23
7776261|NCT01337115|19143488|P2|STARTED|Overall Study||25
7776262|NCT01337115|19143489|P1|STARTED|Overall Study||25
7776263|NCT01337089|19143501|P1|NOT COMPLETED|Overall Study||404
7776264|NCT01337089|19143501|P1|COMPLETED|Overall Study||256
7776265|NCT01337089|19143501|P1|Efficacy Dataset|Overall Study|One participant withdrew after administering nabiximols, but no efficacy data were collected.|659
7776266|NCT01337089|19143501|P1|Safety Population|Overall Study||660
7776267|NCT01337089|19143501|P1|Received at Least 1 Dose of Study Drug|Overall Study||660
7776268|NCT01337089|19143501|P1|STARTED|Overall Study||660
7776269|NCT01337076|19143509|P1|NOT COMPLETED|Overall Study||2
7776270|NCT01337076|19143509|P1|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19
7776271|NCT01337076|19143509|P1|STARTED|Overall Study|subjects implanted|21
7776272|NCT01337050|19143516|P3|NOT COMPLETED|Overall Study||19
7776273|NCT01337050|19143517|P2|NOT COMPLETED|Overall Study||13
7776274|NCT01337050|19143518|P1|NOT COMPLETED|Overall Study||4
7776275|NCT01337050|19143516|P3|COMPLETED|Overall Study||0
7776276|NCT01337050|19143517|P2|COMPLETED|Overall Study||0
7776277|NCT01337050|19143518|P1|COMPLETED|Overall Study||0
7776278|NCT01337050|19143516|P3|STARTED|Overall Study||19
7776279|NCT01337050|19143517|P2|STARTED|Overall Study||13
7776280|NCT01337050|19143518|P1|STARTED|Overall Study||4
7776281|NCT01336972|19143579|P3|NOT COMPLETED|Overall Study||0
7776282|NCT01336972|19143580|P2|NOT COMPLETED|Overall Study||1
7776283|NCT01336972|19143581|P1|NOT COMPLETED|Overall Study||1
7776284|NCT01336972|19143579|P3|COMPLETED|Overall Study||9
7776285|NCT01336972|19143580|P2|COMPLETED|Overall Study||9
7776286|NCT01336972|19143581|P1|COMPLETED|Overall Study||9
7776287|NCT01336972|19143579|P3|STARTED|Overall Study||9
7776288|NCT01336972|19143580|P2|STARTED|Overall Study||10
7776289|NCT01336972|19143581|P1|STARTED|Overall Study||10
7776290|NCT01336959|19143619|P3|NOT COMPLETED|Overall Study||1
7776291|NCT01336959|19143620|P2|NOT COMPLETED|Overall Study||5
7776292|NCT01336959|19143621|P1|NOT COMPLETED|Overall Study||0
7776293|NCT01336959|19143619|P3|COMPLETED|Overall Study||40
7776294|NCT01336959|19143620|P2|COMPLETED|Overall Study||37
7776295|NCT01336959|19143621|P1|COMPLETED|Overall Study||8
7776296|NCT01336959|19143619|P3|STARTED|Overall Study||41
7776297|NCT01336959|19143620|P2|STARTED|Overall Study||42
7776298|NCT01336959|19143621|P1|STARTED|Overall Study||8
7776299|NCT01336933|19143632|P1|NOT COMPLETED|Overall Study||1
7776300|NCT01336933|19143632|P1|COMPLETED|Overall Study||33
7776301|NCT01336933|19143632|P1|STARTED|Overall Study||34
7776302|NCT01336894|19143643|P2|NOT COMPLETED|Follow-up||7
7776303|NCT01336894|19143644|P1|NOT COMPLETED|Follow-up||2
7776304|NCT01336894|19143643|P2|COMPLETED|Follow-up||0
7776305|NCT01336894|19143644|P1|COMPLETED|Follow-up||2
7776306|NCT01336894|19143643|P2|STARTED|Follow-up||7
7776307|NCT01336894|19143644|P1|STARTED|Follow-up||4
7776308|NCT01336894|19143643|P2|NOT COMPLETED|Protocol Interventions||0
7776309|NCT01336894|19143644|P1|NOT COMPLETED|Protocol Interventions||0
7776310|NCT01336894|19143643|P2|COMPLETED|Protocol Interventions||7
7776311|NCT01336894|19143644|P1|COMPLETED|Protocol Interventions||4
7776312|NCT01336894|19143643|P2|STARTED|Protocol Interventions||7
7776313|NCT01336894|19143644|P1|STARTED|Protocol Interventions||4
7776314|NCT01336803|19143662|P1|NOT COMPLETED|Overall Study||0
7776315|NCT01336803|19143662|P1|COMPLETED|Overall Study||21
7776316|NCT01336803|19143662|P1|Lymphoma|Overall Study||7
7776317|NCT01336803|19143662|P1|Osteomyelitis|Overall Study||4
7776318|NCT01336803|19143662|P1|Bone Sarcoma|Overall Study||10
7776319|NCT01336803|19143662|P1|STARTED|Overall Study||21
7776320|NCT01336764|19143676|P2|NOT COMPLETED|Overall Study||5
7776321|NCT01336764|19143677|P1|NOT COMPLETED|Overall Study||5
7776322|NCT01336764|19143676|P2|COMPLETED|Overall Study||5
7776323|NCT01336764|19143677|P1|COMPLETED|Overall Study||7
7776324|NCT01336764|19143676|P2|STARTED|Overall Study||10
7776325|NCT01336764|19143677|P1|STARTED|Overall Study||12
7776326|NCT01336738|19143688|P5|NOT COMPLETED|Overall Study||10
7776327|NCT01336738|19143689|P4|NOT COMPLETED|Overall Study||7
7776328|NCT01336738|19143690|P3|NOT COMPLETED|Overall Study||8
7776329|NCT01336738|19143691|P2|NOT COMPLETED|Overall Study||9
7776330|NCT01336738|19143692|P1|NOT COMPLETED|Overall Study||7
7776331|NCT01336738|19143688|P5|COMPLETED|Overall Study||43
7776332|NCT01336738|19143689|P4|COMPLETED|Overall Study||47
7776333|NCT01336738|19143690|P3|COMPLETED|Overall Study||45
7776334|NCT01336738|19143691|P2|COMPLETED|Overall Study||45
7776335|NCT01336738|19143692|P1|COMPLETED|Overall Study||45
7776336|NCT01336738|19143688|P5|STARTED|Overall Study||53
7776337|NCT01336738|19143689|P4|STARTED|Overall Study||54
7776338|NCT01336738|19143690|P3|STARTED|Overall Study||53
7776339|NCT01336738|19143691|P2|STARTED|Overall Study||54
7776340|NCT01336738|19143692|P1|STARTED|Overall Study||52
7776341|NCT01336712|19143734|P1|NOT COMPLETED|Overall Study||3
7776342|NCT01336712|19143734|P1|COMPLETED|Overall Study||27
7776343|NCT01336712|19143734|P1|STARTED|Overall Study||30
7776344|NCT01336647|19143747|P3|NOT COMPLETED|Overall Study||3
7776345|NCT01336647|19143748|P2|NOT COMPLETED|Overall Study||1
7776346|NCT01336647|19143749|P1|NOT COMPLETED|Overall Study||4
7776347|NCT01336647|19143747|P3|COMPLETED|Overall Study||44
7776348|NCT01336647|19143748|P2|COMPLETED|Overall Study||48
7776349|NCT01336647|19143749|P1|COMPLETED|Overall Study||42
7776350|NCT01336647|19143747|P3|STARTED|Overall Study||47
7776351|NCT01336647|19143748|P2|STARTED|Overall Study||49
7776352|NCT01336647|19143749|P1|STARTED|Overall Study||46
7776353|NCT01336634|19143763|P3|NOT COMPLETED|Overall Study||36
7776354|NCT01336634|19143764|P2|NOT COMPLETED|Overall Study||57
7776355|NCT01336634|19143765|P1|NOT COMPLETED|Overall Study||84
7776356|NCT01336634|19143763|P3|COMPLETED|Overall Study||0
7776357|NCT01336634|19143764|P2|COMPLETED|Overall Study||0
7776358|NCT01336634|19143765|P1|COMPLETED|Overall Study||0
7776359|NCT01336634|19143763|P3|STARTED|Overall Study||36
7776360|NCT01336634|19143764|P2|STARTED|Overall Study||57
7776361|NCT01336634|19143765|P1|STARTED|Overall Study||84
7776362|NCT01336621|19143806|P1|NOT COMPLETED|SFUCP (up to 2.6 Years)||9
7776363|NCT01336621|19143806|P1|COMPLETED|SFUCP (up to 2.6 Years)||0
7776364|NCT01336621|19143806|P1|STARTED|SFUCP (up to 2.6 Years)||9
7776365|NCT01336621|19143806|P1|NOT COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||98
7776366|NCT01336621|19143806|P1|COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||0
7776367|NCT01336621|19143806|P1|STARTED|Primary Reporting Phase (Upto 5.8 Years)||98
7776368|NCT01336608|19143856|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||24
7776369|NCT01336608|19143857|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||30
7776370|NCT01336608|19143858|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||44
7776371|NCT01336608|19143859|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
7776372|NCT01336608|19143856|P4|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111
7776373|NCT01336608|19143857|P3|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124
7776374|NCT01336608|19143858|P2|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97
7776375|NCT01336608|19143859|P1|COMPLETED|24-week, Double-blind Treatment Period||0
7776376|NCT01336608|19143856|P4|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110
7776377|NCT01336608|19143857|P3|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124
7776378|NCT01336608|19143858|P2|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96
7776379|NCT01336608|19143859|P1|Completed the Treatment Period|24-week, Double-blind Treatment Period||0
7776380|NCT01336608|19143856|P4|STARTED|24-week, Double-blind Treatment Period||135
7776381|NCT01336608|19143857|P3|STARTED|24-week, Double-blind Treatment Period||154
7776382|NCT01336608|19143858|P2|STARTED|24-week, Double-blind Treatment Period||141
7776383|NCT01336608|19143859|P1|STARTED|24-week, Double-blind Treatment Period||0
7776384|NCT01336608|19143856|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
7776385|NCT01336608|19143857|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
7776386|NCT01336608|19143858|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
7776387|NCT01336608|19143859|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||115
7776388|NCT01336608|19143856|P4|COMPLETED|2-week, Single-blind Run-In Period||0
7776389|NCT01336608|19143857|P3|COMPLETED|2-week, Single-blind Run-In Period||0
7776390|NCT01336608|19143858|P2|COMPLETED|2-week, Single-blind Run-In Period||0
7776391|NCT01336608|19143859|P1|COMPLETED|2-week, Single-blind Run-In Period||444
7776392|NCT01336608|19143856|P4|STARTED|2-week, Single-blind Run-In Period||0
7776393|NCT01336608|19143857|P3|STARTED|2-week, Single-blind Run-In Period||0
7776394|NCT01336608|19143858|P2|STARTED|2-week, Single-blind Run-In Period||0
7776395|NCT01336608|19143859|P1|STARTED|2-week, Single-blind Run-In Period||559
7776396|NCT01336569|19143873|P1|NOT COMPLETED|Overall Study||4
7776397|NCT01336569|19143873|P1|COMPLETED|Overall Study||45
7776398|NCT01336569|19143873|P1|STARTED|Overall Study||49
7776399|NCT01336413|19143879|P2|NOT COMPLETED|Overall Study||8
7776400|NCT01336413|19143880|P1|NOT COMPLETED|Overall Study||1
7776401|NCT01336413|19143879|P2|COMPLETED|Overall Study||18
7776402|NCT01336413|19143880|P1|COMPLETED|Overall Study||26
7776403|NCT01336413|19143879|P2|STARTED|Overall Study||26
7776404|NCT01336413|19143880|P1|STARTED|Overall Study||27
7776405|NCT01336296|19143904|P2|NOT COMPLETED|Overall Study||4
7776406|NCT01336296|19143905|P1|NOT COMPLETED|Overall Study||5
7776407|NCT01336296|19143904|P2|COMPLETED|Overall Study||17
7776408|NCT01336296|19143905|P1|COMPLETED|Overall Study||35
7776409|NCT01336296|19143904|P2|STARTED|Overall Study||21
7776410|NCT01336296|19143905|P1|STARTED|Overall Study||40
7776411|NCT01336205|19143921|P2|NOT COMPLETED|Overall Study||89
7776412|NCT01336205|19143922|P1|NOT COMPLETED|Overall Study||233
7776413|NCT01336205|19143921|P2|COMPLETED|Overall Study||192
7776414|NCT01336205|19143922|P1|COMPLETED|Overall Study||330
7776415|NCT01336205|19143921|P2|STARTED|Overall Study||281
7776416|NCT01336205|19143922|P1|STARTED|Overall Study||563
7776417|NCT01336140|19143934|P2|NOT COMPLETED|Overall Study||0
7776418|NCT01336140|19143935|P1|NOT COMPLETED|Overall Study||0
7776419|NCT01336140|19143934|P2|COMPLETED|Overall Study||150
7776420|NCT01336140|19143935|P1|COMPLETED|Overall Study||150
7776421|NCT01336140|19143934|P2|STARTED|Overall Study||150
7776422|NCT01336140|19143935|P1|STARTED|Overall Study||150
7776423|NCT01336023|19143950|P3|NOT COMPLETED|Week 27 to 52||28
7776424|NCT01336023|19143951|P2|NOT COMPLETED|Week 27 to 52||44
7776425|NCT01336023|19143952|P1|NOT COMPLETED|Week 27 to 52||28
7776426|NCT01336023|19143950|P3|COMPLETED|Week 27 to 52||285
7776427|NCT01336023|19143951|P2|COMPLETED|Week 27 to 52||621
7776428|NCT01336023|19143952|P1|COMPLETED|Week 27 to 52||305
7776429|NCT01336023|19143950|P3|STARTED|Week 27 to 52|From the main trial, 29 subjects were not enrolled in the extension (week 27-52).|313
7776430|NCT01336023|19143951|P2|STARTED|Week 27 to 52|From the main trial, 71 subjects were not enrolled in the extension (week 27-52).|665
7776431|NCT01336023|19143952|P1|STARTED|Week 27 to 52|From the main trial, 33 subjects were not enrolled in the extension (week 27-52).|333
7776432|NCT01336023|19143950|P3|NOT COMPLETED|Week 0 to Week 26||73
7776433|NCT01336023|19143951|P2|NOT COMPLETED|Week 0 to Week 26||98
7776434|NCT01336023|19143952|P1|NOT COMPLETED|Week 0 to Week 26||48
7776435|NCT01336023|19143950|P3|COMPLETED|Week 0 to Week 26||342
7776436|NCT01336023|19143951|P2|COMPLETED|Week 0 to Week 26||736
7776437|NCT01336023|19143952|P1|COMPLETED|Week 0 to Week 26||366
7776438|NCT01336023|19143950|P3|Exposed|Week 0 to Week 26|2 subjects withdrew before exposure to trial drug and were not included in the analysis|413
7776439|NCT01336023|19143951|P2|Exposed|Week 0 to Week 26|8 subjects withdrew before exposure to trial drug and were not included in the analysis|826
7776440|NCT01336023|19143952|P1|Exposed|Week 0 to Week 26|1 subject withdrew before exposure to trial drug and was not included in the analysis|413
7776441|NCT01336023|19143950|P3|STARTED|Week 0 to Week 26||415
7776442|NCT01336023|19143951|P2|STARTED|Week 0 to Week 26||834
7776443|NCT01336023|19143952|P1|STARTED|Week 0 to Week 26||414
7776444|NCT01335997|19143973|P2|NOT COMPLETED|Period III||79
7776445|NCT01335997|19143974|P1|NOT COMPLETED|Period III||78
7776446|NCT01335997|19143973|P2|COMPLETED|Period III||4
7776447|NCT01335997|19143974|P1|COMPLETED|Period III||6
7776448|NCT01335997|19143973|P2|STARTED|Period III||83
7776449|NCT01335997|19143974|P1|STARTED|Period III||84
7776450|NCT01335997|19143973|P2|NOT COMPLETED|Period I and II||479
7776451|NCT01335997|19143974|P1|NOT COMPLETED|Period I and II||493
7776452|NCT01335997|19143973|P2|COMPLETED|Period I and II||83
7776453|NCT01335997|19143974|P1|COMPLETED|Period I and II||84
7776454|NCT01335997|19143973|P2|STARTED|Period I and II||562
7776455|NCT01335997|19143974|P1|STARTED|Period I and II||577
7776456|NCT01335971|19143987|P3|NOT COMPLETED|Overall Study||1
7776457|NCT01335971|19143988|P2|NOT COMPLETED|Overall Study||1
7776458|NCT01335971|19143989|P1|NOT COMPLETED|Overall Study||2
7776459|NCT01335971|19143987|P3|COMPLETED|Overall Study||28
7776460|NCT01335971|19143988|P2|COMPLETED|Overall Study||28
7776461|NCT01335971|19143989|P1|COMPLETED|Overall Study||29
7776462|NCT01335971|19143987|P3|STARTED|Overall Study||29
7776463|NCT01335971|19143988|P2|STARTED|Overall Study||29
7776464|NCT01335971|19143989|P1|STARTED|Overall Study||31
7776465|NCT01335932|19144026|P2|NOT COMPLETED|Overall Study||4
7776466|NCT01335932|19144027|P1|NOT COMPLETED|Overall Study||0
7776467|NCT01335932|19144026|P2|COMPLETED|Overall Study||72
7776468|NCT01335932|19144027|P1|COMPLETED|Overall Study||84
7776469|NCT01335932|19144026|P2|STARTED|Overall Study||76
7776470|NCT01335932|19144027|P1|STARTED|Overall Study||84
7776471|NCT01335867|19144167|P2|NOT COMPLETED|Overall Study||4
7776472|NCT01335867|19144168|P1|NOT COMPLETED|Overall Study||7
7776473|NCT01335867|19144167|P2|COMPLETED|Overall Study||12
7776474|NCT01335867|19144168|P1|COMPLETED|Overall Study||9
7776475|NCT01335867|19144167|P2|STARTED|Overall Study||16
7776476|NCT01335867|19144168|P1|STARTED|Overall Study||16
7776477|NCT01335789|19144184|P2|NOT COMPLETED|Overall Study||0
7776478|NCT01335789|19144185|P1|NOT COMPLETED|Overall Study||0
7776479|NCT01335789|19144184|P2|COMPLETED|Overall Study||8
7776480|NCT01335789|19144185|P1|COMPLETED|Overall Study||8
7776481|NCT01335789|19144184|P2|STARTED|Overall Study||8
7776482|NCT01335789|19144185|P1|STARTED|Overall Study||8
7776483|NCT01335750|19144195|P1|NOT COMPLETED|Overall Study||0
7776484|NCT01335750|19144195|P1|COMPLETED|Overall Study||32
7776485|NCT01335750|19144195|P1|STARTED|Overall Study||32
7776486|NCT01335724|19144216|P2|NOT COMPLETED|Overall Study||0
7776487|NCT01335724|19144217|P1|NOT COMPLETED|Overall Study||0
7776488|NCT01335724|19144216|P2|COMPLETED|Overall Study||36
7776489|NCT01335724|19144217|P1|COMPLETED|Overall Study||36
7776490|NCT01335724|19144216|P2|STARTED|Overall Study||36
7776491|NCT01335724|19144217|P1|STARTED|Overall Study||36
7776492|NCT01335698|19144232|P5|NOT COMPLETED|Treatment Stage 2||1
7776493|NCT01335698|19144233|P4|NOT COMPLETED|Treatment Stage 2||8
7776494|NCT01335698|19144234|P3|NOT COMPLETED|Treatment Stage 2||5
7776495|NCT01335698|19144235|P2|NOT COMPLETED|Treatment Stage 2||3
7776496|NCT01335698|19144236|P1|NOT COMPLETED|Treatment Stage 2||11
7776497|NCT01335698|19144232|P5|COMPLETED|Treatment Stage 2||5
7776498|NCT01335698|19144233|P4|COMPLETED|Treatment Stage 2||18
7776499|NCT01335698|19144234|P3|COMPLETED|Treatment Stage 2||11
7776500|NCT01335698|19144235|P2|COMPLETED|Treatment Stage 2||1
7776501|NCT01335698|19144236|P1|COMPLETED|Treatment Stage 2||4
7776502|NCT01335698|19144232|P5|STARTED|Treatment Stage 2||6
7776503|NCT01335698|19144233|P4|STARTED|Treatment Stage 2||26
7776504|NCT01335698|19144234|P3|STARTED|Treatment Stage 2||16
7776505|NCT01335698|19144235|P2|STARTED|Treatment Stage 2||4
7776506|NCT01335698|19144236|P1|STARTED|Treatment Stage 2||15
7776507|NCT01335698|19144232|P5|NOT COMPLETED|Treatment Stage 1||2
7776508|NCT01335698|19144233|P4|NOT COMPLETED|Treatment Stage 1||9
7776509|NCT01335698|19144234|P3|NOT COMPLETED|Treatment Stage 1||5
7776510|NCT01335698|19144235|P2|NOT COMPLETED|Treatment Stage 1||8
7776511|NCT01335698|19144236|P1|NOT COMPLETED|Treatment Stage 1||8
7776512|NCT01335698|19144232|P5|COMPLETED|Treatment Stage 1||6
7776513|NCT01335698|19144233|P4|COMPLETED|Treatment Stage 1||26
7776514|NCT01335698|19144234|P3|COMPLETED|Treatment Stage 1||16
7776515|NCT01335698|19144235|P2|COMPLETED|Treatment Stage 1||4
7776516|NCT01335698|19144236|P1|COMPLETED|Treatment Stage 1||15
7776517|NCT01335698|19144232|P5|STARTED|Treatment Stage 1||8
7776518|NCT01335698|19144233|P4|STARTED|Treatment Stage 1||35
7776519|NCT01335698|19144234|P3|STARTED|Treatment Stage 1||21
7776520|NCT01335698|19144235|P2|STARTED|Treatment Stage 1||12
7776521|NCT01335698|19144236|P1|STARTED|Treatment Stage 1||23
7776522|NCT01335685|19144301|P8|NOT COMPLETED|Overall Study||3
7776523|NCT01335685|19144302|P7|NOT COMPLETED|Overall Study||2
7776524|NCT01335685|19144303|P6|NOT COMPLETED|Overall Study||5
7776525|NCT01335685|19144304|P5|NOT COMPLETED|Overall Study||0
7776526|NCT01335685|19144305|P4|NOT COMPLETED|Overall Study||11
7776527|NCT01335685|19144306|P3|NOT COMPLETED|Overall Study||2
7776528|NCT01335685|19144307|P2|NOT COMPLETED|Overall Study||1
7776529|NCT01335685|19144308|P1|NOT COMPLETED|Overall Study||3
7776530|NCT01335685|19144301|P8|COMPLETED|Overall Study||3
7776531|NCT01335685|19144302|P7|COMPLETED|Overall Study||2
7776532|NCT01335685|19144303|P6|COMPLETED|Overall Study||1
7776533|NCT01335685|19144304|P5|COMPLETED|Overall Study||5
7776534|NCT01335685|19144305|P4|COMPLETED|Overall Study||15
7776535|NCT01335685|19144306|P3|COMPLETED|Overall Study||1
7776536|NCT01335685|19144307|P2|COMPLETED|Overall Study||3
7776537|NCT01335685|19144308|P1|COMPLETED|Overall Study||4
7776538|NCT01335685|19144301|P8|STARTED|Overall Study||6
7776539|NCT01335685|19144302|P7|STARTED|Overall Study||4
7776540|NCT01335685|19144303|P6|STARTED|Overall Study||6
7776541|NCT01335685|19144304|P5|STARTED|Overall Study||5
7776542|NCT01335685|19144305|P4|STARTED|Overall Study||26
7776543|NCT01335685|19144306|P3|STARTED|Overall Study||3
7776544|NCT01335685|19144307|P2|STARTED|Overall Study||4
7776545|NCT01335685|19144308|P1|STARTED|Overall Study||7
7776546|NCT01335620|19144410|P1|NOT COMPLETED|Overall Study||0
7776547|NCT01335620|19144410|P1|COMPLETED|Overall Study||19
7776548|NCT01335620|19144410|P1|STARTED|Overall Study||19
7776549|NCT01335581|19144417|P1|NOT COMPLETED|Overall Study||10
7776550|NCT01335581|19144417|P1|COMPLETED|Overall Study||8
7776551|NCT01335581|19144417|P1|STARTED|Overall Study||18
7776552|NCT01335542|19144423|P2|NOT COMPLETED|Overall Study||0
7776553|NCT01335542|19144424|P1|NOT COMPLETED|Overall Study||0
7776554|NCT01335542|19144423|P2|COMPLETED|Overall Study||45
7776555|NCT01335542|19144424|P1|COMPLETED|Overall Study||45
7776556|NCT01335542|19144423|P2|STARTED|Overall Study||45
7776557|NCT01335542|19144424|P1|STARTED|Overall Study||45
7776558|NCT01335477|19144432|P2|NOT COMPLETED|Overall Study||59
7776559|NCT01335477|19144433|P1|NOT COMPLETED|Overall Study||41
7776560|NCT01335477|19144432|P2|COMPLETED|Overall Study||272
7776561|NCT01335477|19144433|P1|COMPLETED|Overall Study||179
7776562|NCT01335477|19144432|P2|STARTED|Overall Study||331
7776563|NCT01335477|19144433|P1|STARTED|Overall Study||220
7776564|NCT01335464|19144497|P2|NOT COMPLETED|Overall Study||49
7776565|NCT01335464|19144498|P1|NOT COMPLETED|Overall Study||32
7776566|NCT01335464|19144497|P2|COMPLETED|Overall Study||260
7776567|NCT01335464|19144498|P1|COMPLETED|Overall Study||174
7776568|NCT01335464|19144497|P2|STARTED|Overall Study||309
7776569|NCT01335464|19144498|P1|STARTED|Overall Study||206
7776570|NCT01335399|19144562|P2|NOT COMPLETED|Treatment Period||339
7776571|NCT01335399|19144563|P1|NOT COMPLETED|Treatment Period||333
7776572|NCT01335399|19144562|P2|COMPLETED|Treatment Period||32
7776573|NCT01335399|19144563|P1|COMPLETED|Treatment Period||38
7776574|NCT01335399|19144562|P2|STARTED|Treatment Period||371
7776575|NCT01335399|19144563|P1|STARTED|Treatment Period||371
7776576|NCT01335399|19144562|P2|NOT COMPLETED|Pre-treatment Period||3
7776577|NCT01335399|19144563|P1|NOT COMPLETED|Pre-treatment Period||3
7776578|NCT01335399|19144562|P2|COMPLETED|Pre-treatment Period||371
7776579|NCT01335399|19144563|P1|COMPLETED|Pre-treatment Period||371
7776580|NCT01335399|19144562|P2|STARTED|Pre-treatment Period||374
7776581|NCT01335399|19144563|P1|STARTED|Pre-treatment Period||374
7776582|NCT01335308|19144580|P3|NOT COMPLETED|Overall Study||81
7776583|NCT01335308|19144581|P2|NOT COMPLETED|Overall Study||67
7776584|NCT01335308|19144582|P1|NOT COMPLETED|Overall Study||40
7776585|NCT01335308|19144580|P3|COMPLETED|Overall Study||154
7776586|NCT01335308|19144581|P2|COMPLETED|Overall Study||145
7776587|NCT01335308|19144582|P1|COMPLETED|Overall Study||158
7776588|NCT01335308|19144580|P3|STARTED|Overall Study||235
7776589|NCT01335308|19144581|P2|STARTED|Overall Study||212
7776590|NCT01335308|19144582|P1|STARTED|Overall Study||198
7776591|NCT01335230|19144603|P4|NOT COMPLETED|Overall Study||0
7776592|NCT01335230|19144604|P3|NOT COMPLETED|Overall Study||0
7776593|NCT01335230|19144605|P2|NOT COMPLETED|Overall Study||0
7776594|NCT01335230|19144606|P1|NOT COMPLETED|Overall Study||0
7776595|NCT01335230|19144603|P4|COMPLETED|Overall Study|subjects|10
7776596|NCT01335230|19144604|P3|COMPLETED|Overall Study|subjects|10
7776597|NCT01335230|19144605|P2|COMPLETED|Overall Study|subjects|10
7776598|NCT01335230|19144606|P1|COMPLETED|Overall Study|subjects|10
7776599|NCT01335230|19144603|P4|STARTED|Overall Study|subjects|10
7776600|NCT01335230|19144604|P3|STARTED|Overall Study|subjects|10
7776601|NCT01335230|19144605|P2|STARTED|Overall Study|subjects|10
7776602|NCT01335230|19144606|P1|STARTED|Overall Study|subjects|10
7776603|NCT01335204|19144616|P1|NOT COMPLETED|Overall Study||0
7776604|NCT01335204|19144616|P1|COMPLETED|Overall Study||4
7776605|NCT01335204|19144616|P1|STARTED|Overall Study||4
7776606|NCT01335191|19144627|P2|NOT COMPLETED|Overall Study||0
7776607|NCT01335191|19144628|P1|NOT COMPLETED|Overall Study||0
7776608|NCT01335191|19144627|P2|COMPLETED|Overall Study||11
7776609|NCT01335191|19144628|P1|COMPLETED|Overall Study||16
7776610|NCT01335191|19144627|P2|STARTED|Overall Study||11
7776611|NCT01335191|19144628|P1|STARTED|Overall Study||16
7776612|NCT01335061|19144634|P1|NOT COMPLETED|Overall Study||0
7776613|NCT01335061|19144634|P1|COMPLETED|Overall Study||25
7776614|NCT01335061|19144634|P1|STARTED|Overall Study||25
7776615|NCT01334957|19144649|P1|NOT COMPLETED|Overall Study||0
7776616|NCT01334957|19144649|P1|COMPLETED|Overall Study||300
7776617|NCT01334957|19144649|P1|Received Multiple Doses|Overall Study||48
7776618|NCT01334957|19144649|P1|Received Single Dose|Overall Study||252
7776619|NCT01334957|19144649|P1|STARTED|Overall Study||300
7776620|NCT01334944|19144657|P2|NOT COMPLETED|Overall Study||0
7776621|NCT01334944|19144658|P1|NOT COMPLETED|Overall Study||0
7776622|NCT01334944|19144657|P2|COMPLETED|Overall Study||139
7776623|NCT01334944|19144658|P1|COMPLETED|Overall Study||11
7776624|NCT01334944|19144657|P2|Received Multiple Doses|Overall Study||43
7776625|NCT01334944|19144658|P1|Received Multiple Doses|Overall Study||10
7776626|NCT01334944|19144657|P2|Received Singel Dose|Overall Study||96
7776627|NCT01334944|19144658|P1|Received Singel Dose|Overall Study||1
7776628|NCT01334944|19144657|P2|STARTED|Overall Study||139
7776629|NCT01334944|19144658|P1|STARTED|Overall Study||11
7776630|NCT01334918|19144684|P2|NOT COMPLETED|Overall Study||1
7776631|NCT01334918|19144685|P1|NOT COMPLETED|Overall Study||8
7776632|NCT01334918|19144684|P2|COMPLETED|Overall Study||60
7776633|NCT01334918|19144685|P1|COMPLETED|Overall Study||55
7776634|NCT01334918|19144684|P2|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61
7776635|NCT01334918|19144685|P1|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57
7776636|NCT01334918|19144684|P2|STARTED|Overall Study||61
7776637|NCT01334918|19144685|P1|STARTED|Overall Study||63
7776638|NCT01334866|19144711|P1|NOT COMPLETED|Overall Study||19
7776639|NCT01334866|19144711|P1|COMPLETED|Overall Study||72
7776640|NCT01334866|19144711|P1|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91
7776641|NCT01334827|19144721|P1|NOT COMPLETED|Overall Study||0
7776642|NCT01334827|19144721|P1|COMPLETED|Overall Study||48
7776643|NCT01334827|19144721|P1|STARTED|Overall Study||48
7776644|NCT01334723|19144729|P2|NOT COMPLETED|Overall Study||0
7776645|NCT01334723|19144730|P1|NOT COMPLETED|Overall Study||0
7776646|NCT01334723|19144729|P2|COMPLETED|Overall Study||17739
7776647|NCT01334723|19144730|P1|COMPLETED|Overall Study||17293
7776648|NCT01334723|19144729|P2|STARTED|Overall Study||17739
7776649|NCT01334723|19144730|P1|STARTED|Overall Study||17293
7776650|NCT01334710|19144756|P1|NOT COMPLETED|Overall Study||3
7776651|NCT01334710|19144756|P1|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in hepatocellular cancer the trial was stopped.|0
7776652|NCT01334710|19144756|P1|STARTED|Overall Study||3
7776653|NCT01334606|19144761|P1|NOT COMPLETED|Overall Study||18
7776654|NCT01334606|19144761|P1|COMPLETED|Overall Study||3
7776655|NCT01334606|19144761|P1|STARTED|Overall Study||21
7776656|NCT01334554|19144769|P2|NOT COMPLETED|Overall Study||2
7776657|NCT01334554|19144770|P1|NOT COMPLETED|Overall Study||4
7776658|NCT01334554|19144769|P2|COMPLETED|Overall Study||21
7776659|NCT01334554|19144770|P1|COMPLETED|Overall Study||19
7776660|NCT01334554|19144769|P2|STARTED|Overall Study||23
7776661|NCT01334554|19144770|P1|STARTED|Overall Study||23
7776662|NCT01334515|19144780|P2|NOT COMPLETED|Overall Study||29
7776663|NCT01334515|19144781|P1|NOT COMPLETED|Overall Study||12
7776664|NCT01334515|19144780|P2|COMPLETED|Overall Study||7
7776665|NCT01334515|19144781|P1|COMPLETED|Overall Study||4
7776666|NCT01334515|19144780|P2|STARTED|Overall Study||36
7776667|NCT01334515|19144781|P1|STARTED|Overall Study||16
7776668|NCT01334229|19144791|P2|NOT COMPLETED|Overall Study||0
7776669|NCT01334229|19144792|P1|NOT COMPLETED|Overall Study||0
7776670|NCT01334229|19144791|P2|COMPLETED|Overall Study||11
7776671|NCT01334229|19144792|P1|COMPLETED|Overall Study||11
7776672|NCT01334229|19144791|P2|STARTED|Overall Study||11
7776673|NCT01334229|19144792|P1|STARTED|Overall Study||11
7776674|NCT01334216|19144810|P2|NOT COMPLETED|Overall Study||0
7776675|NCT01334216|19144811|P1|NOT COMPLETED|Overall Study||0
7776676|NCT01334216|19144810|P2|COMPLETED|Overall Study||194
7776677|NCT01334216|19144811|P1|COMPLETED|Overall Study||168
7776678|NCT01334216|19144810|P2|STARTED|Overall Study||194
7776679|NCT01334216|19144811|P1|STARTED|Overall Study||168
7776680|NCT01334125|19144819|P2|NOT COMPLETED|Overall Study||3
7776681|NCT01334125|19144820|P1|NOT COMPLETED|Overall Study||3
7776682|NCT01334125|19144819|P2|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10
7776683|NCT01334125|19144820|P1|COMPLETED|Overall Study|3 subjects move to another city|12
7776684|NCT01334125|19144819|P2|STARTED|Overall Study||13
7776685|NCT01334125|19144820|P1|STARTED|Overall Study||15
7776686|NCT01333956|19144836|P4|NOT COMPLETED|Overall Study||2
7776687|NCT01333956|19144837|P3|NOT COMPLETED|Overall Study||1
7776688|NCT01333956|19144838|P2|NOT COMPLETED|Overall Study||4
7776689|NCT01333956|19144839|P1|NOT COMPLETED|Overall Study||2
7776690|NCT01333956|19144836|P4|COMPLETED|Overall Study||28
7776691|NCT01333956|19144837|P3|COMPLETED|Overall Study||29
7776692|NCT01333956|19144838|P2|COMPLETED|Overall Study||26
7776693|NCT01333956|19144839|P1|COMPLETED|Overall Study||28
7776694|NCT01333956|19144836|P4|STARTED|Overall Study||30
7776695|NCT01333956|19144837|P3|STARTED|Overall Study||30
7776696|NCT01333956|19144838|P2|STARTED|Overall Study||30
7776697|NCT01333956|19144839|P1|STARTED|Overall Study||30
7776698|NCT01333943|19144875|P2|NOT COMPLETED|Overall Study||0
7776699|NCT01333943|19144876|P1|NOT COMPLETED|Overall Study||1
7776700|NCT01333943|19144875|P2|COMPLETED|Overall Study||47
7776701|NCT01333943|19144876|P1|COMPLETED|Overall Study||46
7776702|NCT01333943|19144875|P2|STARTED|Overall Study||47
7776703|NCT01333943|19144876|P1|STARTED|Overall Study||47
7776704|NCT01333865|19144892|P1|NOT COMPLETED|Overall Study||2
7776705|NCT01333865|19144892|P1|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17
7776706|NCT01333865|19144892|P1|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19
7776707|NCT01333813|19144897|P1|NOT COMPLETED|Overall Study||0
7776708|NCT01333813|19144897|P1|COMPLETED|Overall Study||297
7776709|NCT01333813|19144897|P1|STARTED|Overall Study||297
7776710|NCT01333722|19144912|P2|NOT COMPLETED|Overall Study||3
7776711|NCT01333722|19144913|P1|NOT COMPLETED|Overall Study||0
7776712|NCT01333722|19144912|P2|COMPLETED|Overall Study||46
7776713|NCT01333722|19144913|P1|COMPLETED|Overall Study||51
7776714|NCT01333722|19144912|P2|STARTED|Overall Study||49
7776715|NCT01333722|19144913|P1|STARTED|Overall Study||51
7776716|NCT01333592|19144927|P2|NOT COMPLETED|Overall Study||17
7776717|NCT01333592|19144928|P1|NOT COMPLETED|Overall Study||9
7776718|NCT01333592|19144927|P2|COMPLETED|Overall Study||52
7776719|NCT01333592|19144928|P1|COMPLETED|Overall Study||58
7776720|NCT01333592|19144927|P2|STARTED|Overall Study||69
7776721|NCT01333592|19144928|P1|STARTED|Overall Study||67
7776722|NCT01333501|19144938|P2|NOT COMPLETED|Overall Study||21
7776723|NCT01333501|19144939|P1|NOT COMPLETED|Overall Study||9
7776724|NCT01333501|19144938|P2|COMPLETED|Overall Study||30
7776725|NCT01333501|19144939|P1|COMPLETED|Overall Study||97
7776726|NCT01333501|19144938|P2|Safety Population|Overall Study||47
7776727|NCT01333501|19144939|P1|Safety Population|Overall Study||104
7776728|NCT01333501|19144938|P2|Full Analysis Set (FAS)|Overall Study||28
7776729|NCT01333501|19144939|P1|Full Analysis Set (FAS)|Overall Study||80
7776730|NCT01333501|19144938|P2|STARTED|Overall Study||51
7776731|NCT01333501|19144939|P1|STARTED|Overall Study||106
7776732|NCT01333488|19144988|P3|NOT COMPLETED|Overall Study||0
7776733|NCT01333488|19144989|P2|NOT COMPLETED|Overall Study||0
7776734|NCT01333488|19144990|P1|NOT COMPLETED|Overall Study||0
7776735|NCT01333488|19144988|P3|COMPLETED|Overall Study||3
7776736|NCT01333488|19144989|P2|COMPLETED|Overall Study||1
7776737|NCT01333488|19144990|P1|COMPLETED|Overall Study||2
7776738|NCT01333488|19144988|P3|STARTED|Overall Study||3
7776739|NCT01333488|19144989|P2|STARTED|Overall Study||1
7776740|NCT01333488|19144990|P1|STARTED|Overall Study||2
7776741|NCT01333475|19145006|P2|NOT COMPLETED|Overall Study||3
7776742|NCT01333475|19145007|P1|NOT COMPLETED|Overall Study||2
7776743|NCT01333475|19145006|P2|COMPLETED|Overall Study||6
7776744|NCT01333475|19145007|P1|COMPLETED|Overall Study||10
7776745|NCT01333475|19145006|P2|STARTED|Overall Study||9
7776746|NCT01333475|19145007|P1|STARTED|Overall Study||12
7776747|NCT01333436|19145017|P2|NOT COMPLETED|Overall Study||0
7776748|NCT01333436|19145018|P1|NOT COMPLETED|Overall Study||0
7776749|NCT01333436|19145017|P2|COMPLETED|Overall Study||50
7776750|NCT01333436|19145018|P1|COMPLETED|Overall Study||43
7776751|NCT01333436|19145017|P2|STARTED|Overall Study||50
7776752|NCT01333436|19145018|P1|STARTED|Overall Study||43
7776753|NCT01333397|19145033|P5|NOT COMPLETED|Overall Study||0
7776754|NCT01333397|19145034|P4|NOT COMPLETED|Overall Study||1
7776755|NCT01333397|19145035|P3|NOT COMPLETED|Overall Study||0
7776756|NCT01333397|19145036|P2|NOT COMPLETED|Overall Study||0
7776757|NCT01333397|19145037|P1|NOT COMPLETED|Overall Study||1
7776758|NCT01333397|19145033|P5|COMPLETED|Overall Study||35
7776759|NCT01333397|19145034|P4|COMPLETED|Overall Study||34
7776760|NCT01333397|19145035|P3|COMPLETED|Overall Study||35
7776761|NCT01333397|19145036|P2|COMPLETED|Overall Study||36
7776762|NCT01333397|19145037|P1|COMPLETED|Overall Study||34
7776763|NCT01333397|19145033|P5|STARTED|Overall Study||35
7776764|NCT01333397|19145034|P4|STARTED|Overall Study||35
7776765|NCT01333397|19145035|P3|STARTED|Overall Study||35
7776766|NCT01333397|19145036|P2|STARTED|Overall Study||36
7776767|NCT01333397|19145037|P1|STARTED|Overall Study||35
7776768|NCT01333189|19145111|P2|NOT COMPLETED|Overall Study||2
7776769|NCT01333189|19145112|P1|NOT COMPLETED|Overall Study||2
7776770|NCT01333189|19145111|P2|COMPLETED|Overall Study||11
7776771|NCT01333189|19145112|P1|COMPLETED|Overall Study||11
7776772|NCT01333189|19145111|P2|STARTED|Overall Study||13
7776773|NCT01333189|19145112|P1|STARTED|Overall Study||13
7776774|NCT01333111|19145143|P3|NOT COMPLETED|Overall Study||2
7776775|NCT01333111|19145144|P2|NOT COMPLETED|Overall Study||3
7776776|NCT01333111|19145145|P1|NOT COMPLETED|Overall Study||2
7776777|NCT01333111|19145143|P3|COMPLETED|Overall Study||13
7776778|NCT01333111|19145144|P2|COMPLETED|Overall Study||26
7776779|NCT01333111|19145145|P1|COMPLETED|Overall Study||28
7776780|NCT01333111|19145143|P3|STARTED|Overall Study||15
7776781|NCT01333111|19145144|P2|STARTED|Overall Study||29
7776782|NCT01333111|19145145|P1|STARTED|Overall Study||30
7776783|NCT01333098|19145169|P1|NOT COMPLETED|Overall Study||3
7776784|NCT01333098|19145169|P1|COMPLETED|Overall Study||12
7776785|NCT01333098|19145169|P1|STARTED|Overall Study||15
7776786|NCT01333072|19145180|P2|NOT COMPLETED|Overall Study||4
7776787|NCT01333072|19145181|P1|NOT COMPLETED|Overall Study||6
7776788|NCT01333072|19145180|P2|COMPLETED|Overall Study||27
7776789|NCT01333072|19145181|P1|COMPLETED|Overall Study||24
7776790|NCT01333072|19145180|P2|STARTED|Overall Study||31
7776791|NCT01333072|19145181|P1|STARTED|Overall Study||30
7776792|NCT01333059|19145189|P2|NOT COMPLETED|Overall Study||3
7776793|NCT01333059|19145190|P1|NOT COMPLETED|Overall Study||6
7776794|NCT01333059|19145189|P2|COMPLETED|Overall Study||8
7776795|NCT01333059|19145190|P1|COMPLETED|Overall Study||8
7776796|NCT01333059|19145189|P2|STARTED|Overall Study||11
7776797|NCT01333059|19145190|P1|STARTED|Overall Study||14
7776798|NCT01332994|19145200|P1|NOT COMPLETED|Overall Study||71
7776799|NCT01332994|19145200|P1|COMPLETED|Overall Study||448
7776800|NCT01332994|19145200|P1|Completed Week 66 (TCZ/RTX)|Overall Study||25
7776801|NCT01332994|19145200|P1|Completed Week 32 (TCZ/RTX)|Overall Study||26
7776802|NCT01332994|19145200|P1|Completed Week 32 (TCZ/TCZ)|Overall Study||200
7776803|NCT01332994|19145200|P1|Completed Week 16|Overall Study||463
7776804|NCT01332994|19145200|P1|STARTED|Overall Study||519
7776805|NCT01332981|19145256|P1|NOT COMPLETED|Overall Study||0
7776806|NCT01332981|19145256|P1|COMPLETED|Overall Study||220
7776807|NCT01332981|19145256|P1|STARTED|Overall Study||220
7776808|NCT01332968|19145269|P8|NOT COMPLETED|Follow-Up Period||531
7776809|NCT01332968|19145270|P7|NOT COMPLETED|Follow-Up Period||542
7776810|NCT01332968|19145271|P6|NOT COMPLETED|Follow-Up Period||0
7776811|NCT01332968|19145272|P5|NOT COMPLETED|Follow-Up Period||0
7776812|NCT01332968|19145273|P4|NOT COMPLETED|Follow-Up Period||0
7776813|NCT01332968|19145274|P3|NOT COMPLETED|Follow-Up Period||0
7776814|NCT01332968|19145275|P2|NOT COMPLETED|Follow-Up Period||0
7776815|NCT01332968|19145276|P1|NOT COMPLETED|Follow-Up Period||0
7776816|NCT01332968|19145269|P8|COMPLETED|Follow-Up Period||0
7776817|NCT01332968|19145270|P7|COMPLETED|Follow-Up Period||0
7776818|NCT01332968|19145271|P6|COMPLETED|Follow-Up Period||0
7776819|NCT01332968|19145272|P5|COMPLETED|Follow-Up Period||0
7776820|NCT01332968|19145273|P4|COMPLETED|Follow-Up Period||0
7776821|NCT01332968|19145274|P3|COMPLETED|Follow-Up Period||0
7776822|NCT01332968|19145275|P2|COMPLETED|Follow-Up Period||0
7776823|NCT01332968|19145276|P1|COMPLETED|Follow-Up Period||0
7776824|NCT01332968|19145269|P8|STARTED|Follow-Up Period||531
7776825|NCT01332968|19145270|P7|STARTED|Follow-Up Period||542
7776826|NCT01332968|19145271|P6|STARTED|Follow-Up Period||0
7776827|NCT01332968|19145272|P5|STARTED|Follow-Up Period||0
7776828|NCT01332968|19145273|P4|STARTED|Follow-Up Period||0
7776829|NCT01332968|19145274|P3|STARTED|Follow-Up Period||0
7776830|NCT01332968|19145275|P2|STARTED|Follow-Up Period||0
7776831|NCT01332968|19145276|P1|STARTED|Follow-Up Period||0
7776832|NCT01332968|19145269|P8|NOT COMPLETED|Maintenance/Observation Period||0
7776833|NCT01332968|19145270|P7|NOT COMPLETED|Maintenance/Observation Period||0
7776834|NCT01332968|19145271|P6|NOT COMPLETED|Maintenance/Observation Period||9
7776835|NCT01332968|19145272|P5|NOT COMPLETED|Maintenance/Observation Period||10
7776836|NCT01332968|19145273|P4|NOT COMPLETED|Maintenance/Observation Period||207
7776837|NCT01332968|19145274|P3|NOT COMPLETED|Maintenance/Observation Period||213
7776838|NCT01332968|19145275|P2|NOT COMPLETED|Maintenance/Observation Period||0
7776839|NCT01332968|19145276|P1|NOT COMPLETED|Maintenance/Observation Period||0
7776840|NCT01332968|19145269|P8|COMPLETED|Maintenance/Observation Period||0
7776841|NCT01332968|19145270|P7|COMPLETED|Maintenance/Observation Period||0
7776842|NCT01332968|19145271|P6|COMPLETED|Maintenance/Observation Period||2
7776843|NCT01332968|19145272|P5|COMPLETED|Maintenance/Observation Period||2
7776844|NCT01332968|19145273|P4|COMPLETED|Maintenance/Observation Period||417
7776845|NCT01332968|19145274|P3|COMPLETED|Maintenance/Observation Period||399
7776846|NCT01332968|19145275|P2|COMPLETED|Maintenance/Observation Period||0
7776847|NCT01332968|19145276|P1|COMPLETED|Maintenance/Observation Period||0
7776848|NCT01332968|19145269|P8|STARTED|Maintenance/Observation Period||0
7776849|NCT01332968|19145270|P7|STARTED|Maintenance/Observation Period||0
7776850|NCT01332968|19145271|P6|STARTED|Maintenance/Observation Period||11
7776851|NCT01332968|19145272|P5|STARTED|Maintenance/Observation Period||12
7776852|NCT01332968|19145273|P4|STARTED|Maintenance/Observation Period||624
7776853|NCT01332968|19145274|P3|STARTED|Maintenance/Observation Period||612
7776854|NCT01332968|19145275|P2|STARTED|Maintenance/Observation Period||0
7776855|NCT01332968|19145276|P1|STARTED|Maintenance/Observation Period||0
7776856|NCT01332968|19145269|P8|NOT COMPLETED|Induction Period||0
7776857|NCT01332968|19145270|P7|NOT COMPLETED|Induction Period||0
7776858|NCT01332968|19145271|P6|NOT COMPLETED|Induction Period||0
7776859|NCT01332968|19145272|P5|NOT COMPLETED|Induction Period||0
7776860|NCT01332968|19145273|P4|NOT COMPLETED|Induction Period||0
7776861|NCT01332968|19145274|P3|NOT COMPLETED|Induction Period||0
7776862|NCT01332968|19145275|P2|NOT COMPLETED|Induction Period||56
7776863|NCT01332968|19145276|P1|NOT COMPLETED|Induction Period||58
7776864|NCT01332968|19145269|P8|COMPLETED|Induction Period||0
7776865|NCT01332968|19145270|P7|COMPLETED|Induction Period||0
7776866|NCT01332968|19145271|P6|COMPLETED|Induction Period||0
7776867|NCT01332968|19145272|P5|COMPLETED|Induction Period||0
7776868|NCT01332968|19145273|P4|COMPLETED|Induction Period||0
7776869|NCT01332968|19145274|P3|COMPLETED|Induction Period||0
7776870|NCT01332968|19145275|P2|COMPLETED|Induction Period||646
7776871|NCT01332968|19145276|P1|COMPLETED|Induction Period||641
7776872|NCT01332968|19145269|P8|STARTED|Induction Period||0
7776873|NCT01332968|19145270|P7|STARTED|Induction Period||0
7776874|NCT01332968|19145271|P6|STARTED|Induction Period||0
7776875|NCT01332968|19145272|P5|STARTED|Induction Period||0
7776876|NCT01332968|19145273|P4|STARTED|Induction Period||0
7776877|NCT01332968|19145274|P3|STARTED|Induction Period||0
7776878|NCT01332968|19145275|P2|STARTED|Induction Period||702
7776879|NCT01332968|19145276|P1|STARTED|Induction Period||699
7776880|NCT01332851|19145342|P2|NOT COMPLETED|Overall Study||13
7776881|NCT01332851|19145343|P1|NOT COMPLETED|Overall Study||11
7776882|NCT01332851|19145342|P2|COMPLETED|Overall Study||110
7776883|NCT01332851|19145343|P1|COMPLETED|Overall Study||113
7776884|NCT01332851|19145342|P2|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|110
7776885|NCT01332851|19145343|P1|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|113
7776886|NCT01332851|19145342|P2|Completed Follow up 2|Overall Study|Includes 4 new caregivers enrolled due to initial parent no longer parenting|111
7776887|NCT01332851|19145343|P1|Completed Follow up 2|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|111
7776888|NCT01332851|19145342|P2|Completed Follow up 1|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|112
7776889|NCT01332851|19145343|P1|Completed Follow up 1|Overall Study||116
7776890|NCT01332851|19145342|P2|Completed Intervention|Overall Study|4 no intervention, 9 <full dose, 110 full dose; 4 new caregivers enrolled-initial parent dropped out|110
7776891|NCT01332851|19145343|P1|Completed Intervention|Overall Study|9 no intervention, 8 <full dose, 107 full dose; 3 new caregivers enrolled-initial parent dropped out|107
7776892|NCT01332851|19145342|P2|STARTED|Overall Study||123
7776893|NCT01332851|19145343|P1|STARTED|Overall Study||124
7776894|NCT01332799|19145377|P2|NOT COMPLETED|Overall Study||10
7776895|NCT01332799|19145378|P1|NOT COMPLETED|Overall Study||10
7776896|NCT01332799|19145377|P2|COMPLETED|Overall Study||0
7776897|NCT01332799|19145378|P1|COMPLETED|Overall Study||0
7776898|NCT01332799|19145377|P2|STARTED|Overall Study||10
7776899|NCT01332799|19145378|P1|STARTED|Overall Study||10
7776900|NCT01332721|19145388|P1|NOT COMPLETED|Overall Study||0
7776901|NCT01332721|19145388|P1|COMPLETED|Overall Study||38
7776902|NCT01332721|19145388|P1|STARTED|Overall Study||38
7776903|NCT01332630|19145394|P1|NOT COMPLETED|Overall Study||3
7776904|NCT01332630|19145394|P1|COMPLETED|Overall Study||21
7776905|NCT01332630|19145394|P1|STARTED|Overall Study||24
7776906|NCT01332578|19145398|P2|NOT COMPLETED|Period II||0
7776907|NCT01332578|19145399|P1|NOT COMPLETED|Period II||0
7776908|NCT01332578|19145398|P2|COMPLETED|Period II||13
7776909|NCT01332578|19145399|P1|COMPLETED|Period II||12
7776910|NCT01332578|19145398|P2|STARTED|Period II||13
7776911|NCT01332578|19145399|P1|STARTED|Period II||12
7776912|NCT01332578|19145398|P2|NOT COMPLETED|Washout Period||0
7776913|NCT01332578|19145399|P1|NOT COMPLETED|Washout Period||0
7776914|NCT01332578|19145398|P2|COMPLETED|Washout Period||13
7776915|NCT01332578|19145399|P1|COMPLETED|Washout Period||12
7776916|NCT01332578|19145398|P2|STARTED|Washout Period||13
7776917|NCT01332578|19145399|P1|STARTED|Washout Period||12
7776918|NCT01332578|19145398|P2|NOT COMPLETED|Period I||0
7776919|NCT01332578|19145399|P1|NOT COMPLETED|Period I||0
7776920|NCT01332578|19145398|P2|COMPLETED|Period I||13
7776921|NCT01332578|19145399|P1|COMPLETED|Period I||12
7776922|NCT01332578|19145398|P2|STARTED|Period I||13
7776923|NCT01332578|19145399|P1|STARTED|Period I||12
7776924|NCT01332500|19145422|P4|NOT COMPLETED|Overall Study||0
7776925|NCT01332500|19145423|P3|NOT COMPLETED|Overall Study||0
7776926|NCT01332500|19145424|P2|NOT COMPLETED|Overall Study||0
7776927|NCT01332500|19145425|P1|NOT COMPLETED|Overall Study||0
7776928|NCT01332500|19145422|P4|COMPLETED|Overall Study||5806
7776929|NCT01332500|19145423|P3|COMPLETED|Overall Study||2903
7776930|NCT01332500|19145424|P2|COMPLETED|Overall Study||39771
7776931|NCT01332500|19145425|P1|COMPLETED|Overall Study||13257
7776932|NCT01332500|19145422|P4|STARTED|Overall Study||5806
7776933|NCT01332500|19145423|P3|STARTED|Overall Study||2903
7776934|NCT01332500|19145424|P2|STARTED|Overall Study||39771
7776935|NCT01332500|19145425|P1|STARTED|Overall Study||13257
7776936|NCT01332487|19145445|P2|NOT COMPLETED|Overall Study||0
7776937|NCT01332487|19145446|P1|NOT COMPLETED|Overall Study||0
7776938|NCT01332487|19145445|P2|COMPLETED|Overall Study||3063
7776939|NCT01332487|19145446|P1|COMPLETED|Overall Study||5554
7776940|NCT01332487|19145445|P2|STARTED|Overall Study||3063
7776941|NCT01332487|19145446|P1|STARTED|Overall Study||5554
7776942|NCT01332461|19145456|P2|NOT COMPLETED|Overall Study||0
7776943|NCT01332461|19145457|P1|NOT COMPLETED|Overall Study||0
7776944|NCT01332461|19145456|P2|COMPLETED|Overall Study||4386
7776945|NCT01332461|19145457|P1|COMPLETED|Overall Study||1291
7776946|NCT01332461|19145456|P2|STARTED|Overall Study||4386
7776947|NCT01332461|19145457|P1|STARTED|Overall Study||1291
7776948|NCT01332435|19145471|P4|NOT COMPLETED|Overall Study||0
7776949|NCT01332435|19145472|P3|NOT COMPLETED|Overall Study||0
7776950|NCT01332435|19145473|P2|NOT COMPLETED|Overall Study||0
7776951|NCT01332435|19145474|P1|NOT COMPLETED|Overall Study||0
7776952|NCT01332435|19145471|P4|COMPLETED|Overall Study||1656
7776953|NCT01332435|19145472|P3|COMPLETED|Overall Study||2604
7776954|NCT01332435|19145473|P2|COMPLETED|Overall Study||1064
7776955|NCT01332435|19145474|P1|COMPLETED|Overall Study||1572
7776956|NCT01332435|19145471|P4|STARTED|Overall Study||1656
7776957|NCT01332435|19145472|P3|STARTED|Overall Study||2604
7776958|NCT01332435|19145473|P2|STARTED|Overall Study||1064
7776959|NCT01332435|19145474|P1|STARTED|Overall Study||1572
7776960|NCT01332357|19145504|P1|NOT COMPLETED|Overall Study||0
7776961|NCT01332357|19145504|P1|COMPLETED|Overall Study||6139
7776962|NCT01332357|19145504|P1|STARTED|Overall Study||6139
7776963|NCT01332331|19145510|P2|NOT COMPLETED|Overall Study||2
7776964|NCT01332331|19145511|P1|NOT COMPLETED|Overall Study||2
7776965|NCT01332331|19145510|P2|COMPLETED|Overall Study||18
7776966|NCT01332331|19145511|P1|COMPLETED|Overall Study||19
7776967|NCT01332331|19145510|P2|STARTED|Overall Study||20
7776968|NCT01332331|19145511|P1|STARTED|Overall Study||21
7776969|NCT01332318|19145563|P4|NOT COMPLETED|Overall Study||2
7776970|NCT01332318|19145564|P3|NOT COMPLETED|Overall Study||1
7776971|NCT01332318|19145565|P2|NOT COMPLETED|Overall Study||4
7776972|NCT01332318|19145566|P1|NOT COMPLETED|Overall Study||2
7776973|NCT01332318|19145563|P4|COMPLETED|Overall Study||28
7776974|NCT01332318|19145564|P3|COMPLETED|Overall Study||33
7776975|NCT01332318|19145565|P2|COMPLETED|Overall Study||28
7776976|NCT01332318|19145566|P1|COMPLETED|Overall Study||32
7776977|NCT01332318|19145563|P4|STARTED|Overall Study||30
7776978|NCT01332318|19145564|P3|STARTED|Overall Study||34
7776979|NCT01332318|19145565|P2|STARTED|Overall Study||32
7776980|NCT01332318|19145566|P1|STARTED|Overall Study||34
7776981|NCT01332305|19145677|P5|NOT COMPLETED|Overall Study||12
7776982|NCT01332305|19145678|P4|NOT COMPLETED|Overall Study||8
7776983|NCT01332305|19145679|P3|NOT COMPLETED|Overall Study||14
7776984|NCT01332305|19145680|P2|NOT COMPLETED|Overall Study||14
7776985|NCT01332305|19145681|P1|NOT COMPLETED|Overall Study||10
7776986|NCT01332305|19145677|P5|COMPLETED|Overall Study||33
7776987|NCT01332305|19145678|P4|COMPLETED|Overall Study||30
7776988|NCT01332305|19145679|P3|COMPLETED|Overall Study||31
7776989|NCT01332305|19145680|P2|COMPLETED|Overall Study||34
7776990|NCT01332305|19145681|P1|COMPLETED|Overall Study||31
7776991|NCT01332305|19145677|P5|STARTED|Overall Study||45
7776992|NCT01332305|19145678|P4|STARTED|Overall Study||38
7776993|NCT01332305|19145679|P3|STARTED|Overall Study||45
7776994|NCT01332305|19145680|P2|STARTED|Overall Study||48
7776995|NCT01332305|19145681|P1|STARTED|Overall Study||41
7776996|NCT01332292|19145703|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
7776997|NCT01332292|19145704|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
7776998|NCT01332292|19145703|P2|COMPLETED|Treatment Period 2 (14 Days)||11
7776999|NCT01332292|19145704|P1|COMPLETED|Treatment Period 2 (14 Days)||11
7777000|NCT01332292|19145703|P2|STARTED|Treatment Period 2 (14 Days)||12
7777001|NCT01332292|19145704|P1|STARTED|Treatment Period 2 (14 Days)||12
7777002|NCT01332292|19145703|P2|NOT COMPLETED|Washout Period (>=7 Days)||0
7777003|NCT01332292|19145704|P1|NOT COMPLETED|Washout Period (>=7 Days)||0
7777004|NCT01332292|19145703|P2|COMPLETED|Washout Period (>=7 Days)||12
7777005|NCT01332292|19145704|P1|COMPLETED|Washout Period (>=7 Days)||12
7777006|NCT01332292|19145703|P2|STARTED|Washout Period (>=7 Days)||12
7777007|NCT01332292|19145704|P1|STARTED|Washout Period (>=7 Days)||12
7777008|NCT01332292|19145703|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
7777009|NCT01332292|19145704|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
7777010|NCT01332292|19145703|P2|COMPLETED|Treatment Period 1 (14 Days)||12
7777011|NCT01332292|19145704|P1|COMPLETED|Treatment Period 1 (14 Days)||12
7777012|NCT01332292|19145703|P2|STARTED|Treatment Period 1 (14 Days)||13
7777013|NCT01332292|19145704|P1|STARTED|Treatment Period 1 (14 Days)||14
7777014|NCT01332253|19145766|P2|NOT COMPLETED|Overall Study||0
7777015|NCT01332253|19145767|P1|NOT COMPLETED|Overall Study||0
7777016|NCT01332253|19145766|P2|COMPLETED|Overall Study||79
7777017|NCT01332253|19145767|P1|COMPLETED|Overall Study||82
7777018|NCT01332253|19145766|P2|STARTED|Overall Study||79
7777019|NCT01332253|19145767|P1|STARTED|Overall Study||82
7777020|NCT01332227|19145795|P2|NOT COMPLETED|Overall Study||5
7777021|NCT01332227|19145796|P1|NOT COMPLETED|Overall Study||16
7777022|NCT01332227|19145795|P2|COMPLETED|Overall Study||32
7777023|NCT01332227|19145796|P1|COMPLETED|Overall Study||56
7777024|NCT01332227|19145795|P2|STARTED|Overall Study|Participants who received treatment|37
7777025|NCT01332227|19145796|P1|STARTED|Overall Study|Participants who received treatment|72
7777026|NCT01332188|19145818|P4|NOT COMPLETED|Overall Study||0
7777027|NCT01332188|19145819|P3|NOT COMPLETED|Overall Study||4
7777028|NCT01332188|19145820|P2|NOT COMPLETED|Overall Study||1
7777029|NCT01332188|19145821|P1|NOT COMPLETED|Overall Study||2
7777030|NCT01332188|19145818|P4|COMPLETED|Overall Study||25
7777031|NCT01332188|19145819|P3|COMPLETED|Overall Study||21
7777032|NCT01332188|19145820|P2|COMPLETED|Overall Study||25
7777033|NCT01332188|19145821|P1|COMPLETED|Overall Study||23
7777034|NCT01332188|19145818|P4|STARTED|Overall Study||25
7777035|NCT01332188|19145819|P3|STARTED|Overall Study||25
7777036|NCT01332188|19145820|P2|STARTED|Overall Study||26
7777037|NCT01332188|19145821|P1|STARTED|Overall Study||25
7777038|NCT01332149|19145977|P2|NOT COMPLETED|Overall Study||38
7777039|NCT01332149|19145978|P1|NOT COMPLETED|Overall Study||30
7777040|NCT01332149|19145977|P2|COMPLETED|Overall Study||271
7777041|NCT01332149|19145978|P1|COMPLETED|Overall Study||284
7777042|NCT01332149|19145977|P2|Treated|Overall Study||307
7777043|NCT01332149|19145978|P1|Treated|Overall Study||313
7777044|NCT01332149|19145977|P2|STARTED|Overall Study|Assigned to study treatment.|309
7777045|NCT01332149|19145978|P1|STARTED|Overall Study|Assigned to study treatment.|314
7777046|NCT01332123|19146032|P1|NOT COMPLETED|Overall Study||0
7777047|NCT01332123|19146032|P1|COMPLETED|Overall Study||10
7777048|NCT01332123|19146032|P1|STARTED|Overall Study||10
7777049|NCT01332071|19146037|P2|NOT COMPLETED|Period 2||0
7777050|NCT01332071|19146038|P1|NOT COMPLETED|Period 2||0
7777051|NCT01332071|19146037|P2|COMPLETED|Period 2||13
7777052|NCT01332071|19146038|P1|COMPLETED|Period 2||13
7777053|NCT01332071|19146037|P2|STARTED|Period 2||13
7777054|NCT01332071|19146038|P1|STARTED|Period 2||13
7777055|NCT01332071|19146037|P2|NOT COMPLETED|7-Day Washout Period||0
7777056|NCT01332071|19146038|P1|NOT COMPLETED|7-Day Washout Period||0
7777057|NCT01332071|19146037|P2|COMPLETED|7-Day Washout Period||13
7777058|NCT01332071|19146038|P1|COMPLETED|7-Day Washout Period||13
7777059|NCT01332071|19146037|P2|STARTED|7-Day Washout Period||13
7777060|NCT01332071|19146038|P1|STARTED|7-Day Washout Period||13
7777061|NCT01332071|19146037|P2|NOT COMPLETED|Period 1||0
7777062|NCT01332071|19146038|P1|NOT COMPLETED|Period 1||0
7777063|NCT01332071|19146037|P2|COMPLETED|Period 1||13
7777064|NCT01332071|19146038|P1|COMPLETED|Period 1||13
7777065|NCT01332071|19146037|P2|STARTED|Period 1||13
7777066|NCT01332071|19146038|P1|STARTED|Period 1||13
7777067|NCT01332019|19146056|P2|NOT COMPLETED|Overall Study||122
7777068|NCT01332019|19146057|P1|NOT COMPLETED|Overall Study||113
7777069|NCT01332019|19146056|P2|COMPLETED|Overall Study||425
7777070|NCT01332019|19146057|P1|COMPLETED|Overall Study||417
7777071|NCT01332019|19146056|P2|STARTED|Overall Study||547
7777072|NCT01332019|19146057|P1|STARTED|Overall Study||530
7777073|NCT01331837|19146141|P2|NOT COMPLETED|Overall Study||67
7777074|NCT01331837|19146142|P1|NOT COMPLETED|Overall Study||56
7777075|NCT01331837|19146141|P2|COMPLETED|Overall Study||1475
7777076|NCT01331837|19146142|P1|COMPLETED|Overall Study||1482
7777077|NCT01331837|19146141|P2|STARTED|Overall Study||1542
7777078|NCT01331837|19146142|P1|STARTED|Overall Study||1538
7777079|NCT01331824|19146182|P1|NOT COMPLETED|Overall Study||13
7777080|NCT01331824|19146182|P1|COMPLETED|Overall Study||9
7777081|NCT01331824|19146182|P1|STARTED|Overall Study||22
7777082|NCT01331694|19146195|P6|NOT COMPLETED|Overall Study||0
7777083|NCT01331694|19146196|P5|NOT COMPLETED|Overall Study||0
7777084|NCT01331694|19146197|P4|NOT COMPLETED|Overall Study||0
7777085|NCT01331694|19146198|P3|NOT COMPLETED|Overall Study||0
7777086|NCT01331694|19146199|P2|NOT COMPLETED|Overall Study||0
7777087|NCT01331694|19146200|P1|NOT COMPLETED|Overall Study||0
7777088|NCT01331694|19146195|P6|COMPLETED|Overall Study||9126
7777089|NCT01331694|19146196|P5|COMPLETED|Overall Study||10617
7777090|NCT01331694|19146197|P4|COMPLETED|Overall Study||12595
7777091|NCT01331694|19146198|P3|COMPLETED|Overall Study||12659
7777092|NCT01331694|19146199|P2|COMPLETED|Overall Study||14449
7777093|NCT01331694|19146200|P1|COMPLETED|Overall Study||16684
7777094|NCT01331694|19146195|P6|STARTED|Overall Study||9126
7777095|NCT01331694|19146196|P5|STARTED|Overall Study||10617
7777096|NCT01331694|19146197|P4|STARTED|Overall Study||12595
7777097|NCT01331694|19146198|P3|STARTED|Overall Study||12659
7777098|NCT01331694|19146199|P2|STARTED|Overall Study||14449
7777099|NCT01331694|19146200|P1|STARTED|Overall Study||16684
7777100|NCT01331681|19146217|P3|NOT COMPLETED|Overall Study||35
7777101|NCT01331681|19146218|P2|NOT COMPLETED|Overall Study||34
7777102|NCT01331681|19146219|P1|NOT COMPLETED|Overall Study||35
7777103|NCT01331681|19146217|P3|COMPLETED|Overall Study|Completed Week 148|100
7777104|NCT01331681|19146218|P2|COMPLETED|Overall Study|Completed Week 148|101
7777105|NCT01331681|19146219|P1|COMPLETED|Overall Study|Completed Week 148|101
7777106|NCT01331681|19146217|P3|Completed Week 148|Overall Study||100
7777107|NCT01331681|19146218|P2|Completed Week 148|Overall Study||101
7777108|NCT01331681|19146219|P1|Completed Week 148|Overall Study||101
7777109|NCT01331681|19146217|P3|Completed Week 100|Overall Study||105
7777110|NCT01331681|19146218|P2|Completed Week 100|Overall Study||110
7777111|NCT01331681|19146219|P1|Completed Week 100|Overall Study||115
7777112|NCT01331681|19146217|P3|Completed Week 52|Overall Study||115
7777113|NCT01331681|19146218|P2|Completed Week 52|Overall Study||121
7777114|NCT01331681|19146219|P1|Completed Week 52|Overall Study||125
7777115|NCT01331681|19146217|P3|Participants Received Treatment|Overall Study|safety population|133
7777116|NCT01331681|19146218|P2|Participants Received Treatment|Overall Study|safety population|135
7777117|NCT01331681|19146219|P1|Participants Received Treatment|Overall Study|safety population|136
7777118|NCT01331681|19146217|P3|STARTED|Overall Study|randomized|135
7777119|NCT01331681|19146218|P2|STARTED|Overall Study|randomized|135
7777120|NCT01331681|19146219|P1|STARTED|Overall Study|randomized|136
7777121|NCT01331408|19146245|P1|NOT COMPLETED|Overall Study||11
7777122|NCT01331408|19146245|P1|COMPLETED|Overall Study||50
7777123|NCT01331408|19146245|P1|STARTED|Overall Study||61
7777124|NCT01331304|19146253|P2|NOT COMPLETED|Overall Study||60
7777125|NCT01331304|19146254|P1|NOT COMPLETED|Overall Study||58
7777126|NCT01331304|19146253|P2|COMPLETED|Overall Study||182
7777127|NCT01331304|19146254|P1|COMPLETED|Overall Study||182
7777128|NCT01331304|19146253|P2|STARTED|Overall Study||242
7777129|NCT01331304|19146254|P1|STARTED|Overall Study||240
7777130|NCT01331291|19146268|P2|NOT COMPLETED|Overall Study||9
7777131|NCT01331291|19146269|P1|NOT COMPLETED|Overall Study||2
7777132|NCT01331291|19146268|P2|COMPLETED|Overall Study||0
7777133|NCT01331291|19146269|P1|COMPLETED|Overall Study||0
7777134|NCT01331291|19146268|P2|STARTED|Overall Study||9
7777135|NCT01331291|19146269|P1|STARTED|Overall Study||2
7777136|NCT01331213|19146282|P2|NOT COMPLETED|Overall Study||0
7777137|NCT01331213|19146283|P1|NOT COMPLETED|Overall Study||0
7777138|NCT01331213|19146282|P2|COMPLETED|Overall Study||10
7777139|NCT01331213|19146283|P1|COMPLETED|Overall Study||8
7777140|NCT01331213|19146282|P2|STARTED|Overall Study||10
7777141|NCT01331213|19146283|P1|STARTED|Overall Study||8
7777142|NCT01331161|19146303|P2|NOT COMPLETED|Overall Study||2
7777143|NCT01331161|19146304|P1|NOT COMPLETED|Overall Study||1
7777144|NCT01331161|19146303|P2|COMPLETED|Overall Study||31
7777145|NCT01331161|19146304|P1|COMPLETED|Overall Study||43
7777146|NCT01331161|19146303|P2|STARTED|Overall Study||33
7777147|NCT01331161|19146304|P1|STARTED|Overall Study||44
7777148|NCT01331109|19146312|P1|NOT COMPLETED|Overall Study||57
7777149|NCT01331109|19146312|P1|COMPLETED|Overall Study||0
7777150|NCT01331109|19146312|P1|STARTED|Overall Study||57
7777151|NCT01331083|19146324|P2|NOT COMPLETED|Overall Study||0
7777152|NCT01331083|19146325|P1|NOT COMPLETED|Overall Study||0
7777153|NCT01331083|19146324|P2|COMPLETED|Overall Study||25
7777154|NCT01331083|19146325|P1|COMPLETED|Overall Study||43
7777155|NCT01331083|19146324|P2|STARTED|Overall Study||25
7777156|NCT01331083|19146325|P1|STARTED|Overall Study||43
7777157|NCT01331005|19146339|P2|NOT COMPLETED|Overall Study||4
7777158|NCT01331005|19146340|P1|NOT COMPLETED|Overall Study||4
7777159|NCT01331005|19146339|P2|COMPLETED|Overall Study||57
7777160|NCT01331005|19146340|P1|COMPLETED|Overall Study||60
7777161|NCT01331005|19146339|P2|STARTED|Overall Study||61
7777162|NCT01331005|19146340|P1|STARTED|Overall Study||64
7777163|NCT01330966|19146350|P1|NOT COMPLETED|Overall Study||5
7777164|NCT01330966|19146350|P1|COMPLETED|Overall Study|Tumor responses evaluable in 42 of 47 pts; 5 pts discontinued prior to first tumor assessment.|42
7777165|NCT01330966|19146350|P1|STARTED|Overall Study||47
7777166|NCT01330953|19146361|P5|NOT COMPLETED|Overall Study||0
7777167|NCT01330953|19146362|P4|NOT COMPLETED|Overall Study||0
7777168|NCT01330953|19146363|P3|NOT COMPLETED|Overall Study||0
7777169|NCT01330953|19146364|P2|NOT COMPLETED|Overall Study||0
7777170|NCT01330953|19146365|P1|NOT COMPLETED|Overall Study||0
7777171|NCT01330953|19146361|P5|COMPLETED|Overall Study||6
7777172|NCT01330953|19146362|P4|COMPLETED|Overall Study||6
7777173|NCT01330953|19146363|P3|COMPLETED|Overall Study||6
7777174|NCT01330953|19146364|P2|COMPLETED|Overall Study||6
7777175|NCT01330953|19146365|P1|COMPLETED|Overall Study||8
7777176|NCT01330953|19146361|P5|STARTED|Overall Study||6
7777177|NCT01330953|19146362|P4|STARTED|Overall Study||6
7777178|NCT01330953|19146363|P3|STARTED|Overall Study||6
7777179|NCT01330953|19146364|P2|STARTED|Overall Study||6
7777180|NCT01330953|19146365|P1|STARTED|Overall Study||8
7777181|NCT01330914|19146411|P1|NOT COMPLETED|Overall Study||7
7777182|NCT01330914|19146411|P1|COMPLETED|Overall Study||48
7777183|NCT01330914|19146411|P1|STARTED|Overall Study||55
7777184|NCT01330628|19146419|P2|NOT COMPLETED|Overall Study||40
7777185|NCT01330628|19146420|P1|NOT COMPLETED|Overall Study||70
7777186|NCT01330628|19146419|P2|COMPLETED|Overall Study||42
7777187|NCT01330628|19146420|P1|COMPLETED|Overall Study||100
7777188|NCT01330628|19146419|P2|6 Month Follow-up|Overall Study||60
7777189|NCT01330628|19146420|P1|6 Month Follow-up|Overall Study||135
7777190|NCT01330628|19146419|P2|30 Day Follow-up|Overall Study||73
7777191|NCT01330628|19146420|P1|30 Day Follow-up|Overall Study||165
7777192|NCT01330628|19146419|P2|STARTED|Overall Study||82
7777193|NCT01330628|19146420|P1|STARTED|Overall Study||170
7777194|NCT01330459|19146430|P2|NOT COMPLETED|Overall Study||2
7777195|NCT01330459|19146431|P1|NOT COMPLETED|Overall Study||0
7777196|NCT01330459|19146430|P2|COMPLETED|Overall Study||58
7777197|NCT01330459|19146431|P1|COMPLETED|Overall Study||61
7777198|NCT01330459|19146430|P2|STARTED|Overall Study||60
7777199|NCT01330459|19146431|P1|STARTED|Overall Study||61
7777200|NCT01330433|19146447|P2|NOT COMPLETED|Overall Study||3
7777201|NCT01330433|19146448|P1|NOT COMPLETED|Overall Study||2
7777202|NCT01330433|19146447|P2|COMPLETED|Overall Study||16
7777203|NCT01330433|19146448|P1|COMPLETED|Overall Study||14
7777204|NCT01330433|19146447|P2|STARTED|Overall Study||19
7777205|NCT01330433|19146448|P1|STARTED|Overall Study||16
7777206|NCT01330420|19146468|P1|NOT COMPLETED|Overall Study||4
7777207|NCT01330420|19146468|P1|COMPLETED|Overall Study||24
7777208|NCT01330420|19146468|P1|STARTED|Overall Study||28
7777209|NCT01330394|19146478|P2|NOT COMPLETED|Overall Study||0
7777210|NCT01330394|19146479|P1|NOT COMPLETED|Overall Study||0
7777211|NCT01330394|19146478|P2|COMPLETED|Overall Study||16
7777212|NCT01330394|19146479|P1|COMPLETED|Overall Study||17
7777213|NCT01330394|19146478|P2|STARTED|Overall Study||16
7777214|NCT01330394|19146479|P1|STARTED|Overall Study||17
7777215|NCT01330381|19146487|P3|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18
7777216|NCT01330381|19146488|P2|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0
7777217|NCT01330381|19146489|P1|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10
7777218|NCT01330381|19146487|P3|COMPLETED|Open-label Treatment Period (16 Weeks)||81
7777219|NCT01330381|19146488|P2|COMPLETED|Open-label Treatment Period (16 Weeks)||0
7777220|NCT01330381|19146489|P1|COMPLETED|Open-label Treatment Period (16 Weeks)||88
7777221|NCT01330381|19146487|P3|STARTED|Open-label Treatment Period (16 Weeks)||99
7777222|NCT01330381|19146488|P2|STARTED|Open-label Treatment Period (16 Weeks)||0
7777223|NCT01330381|19146489|P1|STARTED|Open-label Treatment Period (16 Weeks)||98
7777224|NCT01330381|19146487|P3|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0
7777225|NCT01330381|19146488|P2|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7
7777226|NCT01330381|19146489|P1|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11
7777227|NCT01330381|19146487|P3|COMPLETED|Double-blind Treatment Period (8 Weeks)||0
7777228|NCT01330381|19146488|P2|COMPLETED|Double-blind Treatment Period (8 Weeks)||101
7777229|NCT01330381|19146489|P1|COMPLETED|Double-blind Treatment Period (8 Weeks)||96
7777230|NCT01330381|19146487|P3|Received Treatment|Double-blind Treatment Period (8 Weeks)||0
7777231|NCT01330381|19146488|P2|Received Treatment|Double-blind Treatment Period (8 Weeks)||107
7777232|NCT01330381|19146489|P1|Received Treatment|Double-blind Treatment Period (8 Weeks)||106
7777233|NCT01330381|19146487|P3|STARTED|Double-blind Treatment Period (8 Weeks)||0
7777234|NCT01330381|19146488|P2|STARTED|Double-blind Treatment Period (8 Weeks)||108
7777235|NCT01330381|19146489|P1|STARTED|Double-blind Treatment Period (8 Weeks)||107
7777236|NCT01330355|19146535|P2|NOT COMPLETED|Overall Study||0
7777237|NCT01330355|19146536|P1|NOT COMPLETED|Overall Study||0
7777238|NCT01330355|19146535|P2|COMPLETED|Overall Study||17
7777239|NCT01330355|19146536|P1|COMPLETED|Overall Study||16
7777240|NCT01330355|19146535|P2|STARTED|Overall Study||17
7777241|NCT01330355|19146536|P1|STARTED|Overall Study||16
7777242|NCT01330316|19146550|P2|NOT COMPLETED|Overall Study||15
7777243|NCT01330316|19146551|P1|NOT COMPLETED|Overall Study||2
7777244|NCT01330316|19146550|P2|COMPLETED|Overall Study||60
7777245|NCT01330316|19146551|P1|COMPLETED|Overall Study||41
7777246|NCT01330316|19146550|P2|STARTED|Overall Study||75
7777247|NCT01330316|19146551|P1|STARTED|Overall Study||43
7777248|NCT01330303|19146587|P2|NOT COMPLETED|Period 2||0
7777249|NCT01330303|19146588|P1|NOT COMPLETED|Period 2||0
7777250|NCT01330303|19146587|P2|COMPLETED|Period 2||18
7777251|NCT01330303|19146588|P1|COMPLETED|Period 2||19
7777252|NCT01330303|19146587|P2|STARTED|Period 2||18
7777253|NCT01330303|19146588|P1|STARTED|Period 2||19
7777254|NCT01330303|19146587|P2|NOT COMPLETED|7-Day Washout Period||0
7777255|NCT01330303|19146588|P1|NOT COMPLETED|7-Day Washout Period||0
7777256|NCT01330303|19146587|P2|COMPLETED|7-Day Washout Period||18
7777257|NCT01330303|19146588|P1|COMPLETED|7-Day Washout Period||19
7777258|NCT01330303|19146587|P2|STARTED|7-Day Washout Period||18
7777259|NCT01330303|19146588|P1|STARTED|7-Day Washout Period||19
7777260|NCT01330303|19146587|P2|NOT COMPLETED|Period 1||2
7777261|NCT01330303|19146588|P1|NOT COMPLETED|Period 1||1
7777262|NCT01330303|19146587|P2|COMPLETED|Period 1||18
7777263|NCT01330303|19146588|P1|COMPLETED|Period 1||19
7777264|NCT01330303|19146587|P2|STARTED|Period 1||20
7777265|NCT01330303|19146588|P1|STARTED|Period 1||20
7777266|NCT01330290|19146598|P1|NOT COMPLETED|Overall Study||0
7777267|NCT01330290|19146598|P1|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148
7777268|NCT01330290|19146598|P1|STARTED|Overall Study||148
7777269|NCT01330134|19146624|P2|NOT COMPLETED|Overall Study||0
7777270|NCT01330134|19146625|P1|NOT COMPLETED|Overall Study||0
7777271|NCT01330134|19146624|P2|COMPLETED|Overall Study||237
7777272|NCT01330134|19146625|P1|COMPLETED|Overall Study||244
7777273|NCT01330134|19146624|P2|STARTED|Overall Study||237
7777274|NCT01330134|19146625|P1|STARTED|Overall Study||244
7777275|NCT01330108|19146635|P1|NOT COMPLETED|Overall Study||4
7777276|NCT01330108|19146635|P1|COMPLETED|Overall Study||28
7777277|NCT01330108|19146635|P1|STARTED|Overall Study||32
7777278|NCT01330043|19146642|P2|NOT COMPLETED|Overall Study||4
7777279|NCT01330043|19146643|P1|NOT COMPLETED|Overall Study||0
7777280|NCT01330043|19146642|P2|COMPLETED|Overall Study||108
7777281|NCT01330043|19146643|P1|COMPLETED|Overall Study||111
7777282|NCT01330043|19146642|P2|STARTED|Overall Study||112
7777283|NCT01330043|19146643|P1|STARTED|Overall Study||111
7777284|NCT01330030|19146653|P2|NOT COMPLETED|Overall Study||17
7777285|NCT01330030|19146654|P1|NOT COMPLETED|Overall Study||16
7777286|NCT01330030|19146653|P2|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
7777287|NCT01330030|19146654|P1|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
7777288|NCT01330030|19146653|P2|STARTED|Overall Study||122
7777289|NCT01330030|19146654|P1|STARTED|Overall Study||121
7777290|NCT01330017|19146665|P5|NOT COMPLETED|Overall Study||3
7777291|NCT01330017|19146666|P4|NOT COMPLETED|Overall Study||12
7777292|NCT01330017|19146667|P3|NOT COMPLETED|Overall Study||8
7777293|NCT01330017|19146668|P2|NOT COMPLETED|Overall Study||4
7777294|NCT01330017|19146669|P1|NOT COMPLETED|Overall Study||5
7777295|NCT01330017|19146665|P5|COMPLETED|Overall Study||100
7777296|NCT01330017|19146666|P4|COMPLETED|Overall Study||100
7777297|NCT01330017|19146667|P3|COMPLETED|Overall Study||99
7777298|NCT01330017|19146668|P2|COMPLETED|Overall Study||104
7777299|NCT01330017|19146669|P1|COMPLETED|Overall Study||104
7777300|NCT01330017|19146665|P5|STARTED|Overall Study||103
7777301|NCT01330017|19146666|P4|STARTED|Overall Study||112
7777302|NCT01330017|19146667|P3|STARTED|Overall Study||107
7777303|NCT01330017|19146668|P2|STARTED|Overall Study||108
7777304|NCT01330017|19146669|P1|STARTED|Overall Study||109
7777305|NCT01329978|19146718|P5|NOT COMPLETED|Rerandomization Treatment Period||4
7777306|NCT01329978|19146719|P4|NOT COMPLETED|Rerandomization Treatment Period||5
7777307|NCT01329978|19146720|P3|NOT COMPLETED|Rerandomization Treatment Period||0
7777308|NCT01329978|19146721|P2|NOT COMPLETED|Rerandomization Treatment Period||0
7777309|NCT01329978|19146722|P1|NOT COMPLETED|Rerandomization Treatment Period||0
7777310|NCT01329978|19146718|P5|COMPLETED|Rerandomization Treatment Period||71
7777311|NCT01329978|19146719|P4|COMPLETED|Rerandomization Treatment Period||70
7777312|NCT01329978|19146720|P3|COMPLETED|Rerandomization Treatment Period||0
7777313|NCT01329978|19146721|P2|COMPLETED|Rerandomization Treatment Period||0
7777314|NCT01329978|19146722|P1|COMPLETED|Rerandomization Treatment Period||0
7777315|NCT01329978|19146718|P5|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
7777316|NCT01329978|19146719|P4|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
7777317|NCT01329978|19146720|P3|STARTED|Rerandomization Treatment Period||0
7777318|NCT01329978|19146721|P2|STARTED|Rerandomization Treatment Period||0
7777319|NCT01329978|19146722|P1|STARTED|Rerandomization Treatment Period||0
7777320|NCT01329978|19146718|P5|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
7777321|NCT01329978|19146719|P4|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
7777322|NCT01329978|19146720|P3|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5
7777323|NCT01329978|19146721|P2|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13
7777324|NCT01329978|19146722|P1|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4
7777325|NCT01329978|19146718|P5|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
7777326|NCT01329978|19146719|P4|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
7777327|NCT01329978|19146720|P3|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150
7777328|NCT01329978|19146721|P2|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112
7777329|NCT01329978|19146722|P1|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48
7777330|NCT01329978|19146718|P5|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
7777331|NCT01329978|19146719|P4|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
7777332|NCT01329978|19146720|P3|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155
7777333|NCT01329978|19146721|P2|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125
7777334|NCT01329978|19146722|P1|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52
7777335|NCT01329939|19146796|P4|NOT COMPLETED|Overall Study||5
7777336|NCT01329939|19146797|P3|NOT COMPLETED|Overall Study||1
7777337|NCT01329939|19146798|P2|NOT COMPLETED|Overall Study||1
7777338|NCT01329939|19146799|P1|NOT COMPLETED|Overall Study||3
7777339|NCT01329939|19146796|P4|COMPLETED|Overall Study||4
7777340|NCT01329939|19146797|P3|COMPLETED|Overall Study||4
7777341|NCT01329939|19146798|P2|COMPLETED|Overall Study||4
7777342|NCT01329939|19146799|P1|COMPLETED|Overall Study||4
7777343|NCT01329939|19146796|P4|STARTED|Overall Study||9
7777344|NCT01329939|19146797|P3|STARTED|Overall Study||5
7777345|NCT01329939|19146798|P2|STARTED|Overall Study||5
7777346|NCT01329939|19146799|P1|STARTED|Overall Study||7
7777347|NCT01329900|19146837|P1|NOT COMPLETED|Overall Study||1
7777348|NCT01329900|19146837|P1|COMPLETED|Overall Study||49
7777349|NCT01329900|19146837|P1|STARTED|Overall Study||50
7777350|NCT01329848|19146841|P1|NOT COMPLETED|Overall Study||29
7777351|NCT01329848|19146841|P1|COMPLETED|Overall Study||54
7777352|NCT01329848|19146841|P1|STARTED|Overall Study||83
7777353|NCT01329679|19146846|P2|NOT COMPLETED|Overall Study||0
7777354|NCT01329679|19146847|P1|NOT COMPLETED|Overall Study||0
7777355|NCT01329679|19146846|P2|COMPLETED|Overall Study||13
7777356|NCT01329679|19146847|P1|COMPLETED|Overall Study||13
7777357|NCT01329679|19146846|P2|STARTED|Overall Study||13
7777358|NCT01329679|19146847|P1|STARTED|Overall Study||13
7777359|NCT01329562|19146867|P2|NOT COMPLETED|Overall Study||7
7777360|NCT01329562|19146868|P1|NOT COMPLETED|Overall Study||9
7777361|NCT01329562|19146867|P2|COMPLETED|Overall Study||14
7777362|NCT01329562|19146868|P1|COMPLETED|Overall Study||11
7777363|NCT01329562|19146867|P2|STARTED|Overall Study||21
7777364|NCT01329562|19146868|P1|STARTED|Overall Study||20
7777365|NCT01329549|19146917|P1|NOT COMPLETED|Overall Study||2
7777366|NCT01329549|19146917|P1|COMPLETED|Overall Study||0
7777367|NCT01329549|19146917|P1|STARTED|Overall Study||2
7777368|NCT01329419|19146928|P1|NOT COMPLETED|Overall Study||235
7777369|NCT01329419|19146928|P1|COMPLETED|Overall Study||4158
7777370|NCT01329419|19146928|P1|STARTED|Overall Study||4393
7777371|NCT01329380|19146934|P1|NOT COMPLETED|Overall Study||29
7777372|NCT01329380|19146934|P1|COMPLETED|Overall Study||374
7777373|NCT01329380|19146934|P1|Safety Population|Overall Study||396
7777374|NCT01329380|19146934|P1|STARTED|Overall Study||403
7777375|NCT01329328|19146947|P3|NOT COMPLETED|Overall Study||3
7777376|NCT01329328|19146948|P2|NOT COMPLETED|Overall Study||4
7777377|NCT01329328|19146949|P1|NOT COMPLETED|Overall Study||2
7777378|NCT01329328|19146947|P3|COMPLETED|Overall Study||15
7777379|NCT01329328|19146948|P2|COMPLETED|Overall Study||13
7777380|NCT01329328|19146949|P1|COMPLETED|Overall Study||13
7777381|NCT01329328|19146947|P3|STARTED|Overall Study||18
7777382|NCT01329328|19146948|P2|STARTED|Overall Study||17
7777383|NCT01329328|19146949|P1|STARTED|Overall Study||15
7777384|NCT01329263|19146962|P2|NOT COMPLETED|Overall Study||23
7777385|NCT01329263|19146963|P1|NOT COMPLETED|Overall Study||5
7777386|NCT01329263|19146962|P2|COMPLETED|Overall Study||22
7777387|NCT01329263|19146963|P1|COMPLETED|Overall Study||10
7777388|NCT01329263|19146962|P2|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22
7777389|NCT01329263|19146963|P1|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10
7777390|NCT01329263|19146962|P2|Completed Period 2 Own or CCrush Menthol|Overall Study||30
7777391|NCT01329263|19146963|P1|Completed Period 2 Own or CCrush Menthol|Overall Study||10
7777392|NCT01329263|19146962|P2|Completed Period 1 Own Menthol|Overall Study||45
7777393|NCT01329263|19146963|P1|Completed Period 1 Own Menthol|Overall Study||15
7777394|NCT01329263|19146962|P2|STARTED|Overall Study||45
7777395|NCT01329263|19146963|P1|STARTED|Overall Study||15
7777396|NCT01329198|19146977|P2|NOT COMPLETED|Overall Study||0
7777397|NCT01329198|19146978|P1|NOT COMPLETED|Overall Study||0
7777398|NCT01329198|19146977|P2|COMPLETED|Overall Study||2
7777399|NCT01329198|19146978|P1|COMPLETED|Overall Study||3
7777400|NCT01329198|19146977|P2|STARTED|Overall Study||2
7777401|NCT01329198|19146978|P1|STARTED|Overall Study||3
7777402|NCT01329185|19146991|P2|NOT COMPLETED|Overall Study||0
7777403|NCT01329185|19146992|P1|NOT COMPLETED|Overall Study||0
7777404|NCT01329185|19146991|P2|COMPLETED|Overall Study||7
7777405|NCT01329185|19146992|P1|COMPLETED|Overall Study||10
7777406|NCT01329185|19146991|P2|PTLD|Overall Study||0
7777407|NCT01329185|19146992|P1|PTLD|Overall Study||1
7777408|NCT01329185|19146991|P2|CMV Disease|Overall Study||0
7777409|NCT01329185|19146992|P1|CMV Disease|Overall Study||1
7777410|NCT01329185|19146991|P2|STARTED|Overall Study||7
7777411|NCT01329185|19146992|P1|STARTED|Overall Study||10
7777412|NCT01329029|19147000|P2|NOT COMPLETED|Overall Study||192
7777413|NCT01329029|19147001|P1|NOT COMPLETED|Overall Study||269
7777414|NCT01329029|19147000|P2|COMPLETED|Overall Study||780
7777415|NCT01329029|19147001|P1|COMPLETED|Overall Study||704
7777416|NCT01329029|19147000|P2|Safety Population|Overall Study||967
7777417|NCT01329029|19147001|P1|Safety Population|Overall Study||968
7777418|NCT01329029|19147000|P2|Full Analysis Set (FAS)|Overall Study||966
7777419|NCT01329029|19147001|P1|Full Analysis Set (FAS)|Overall Study||969
7777420|NCT01329029|19147000|P2|STARTED|Overall Study||972
7777421|NCT01329029|19147001|P1|STARTED|Overall Study||973
7777422|NCT01328964|19147074|P3|NOT COMPLETED|Overall Study||0
7777423|NCT01328964|19147075|P2|NOT COMPLETED|Overall Study||0
7777424|NCT01328964|19147076|P1|NOT COMPLETED|Overall Study||0
7777425|NCT01328964|19147074|P3|COMPLETED|Overall Study||4424
7777426|NCT01328964|19147075|P2|COMPLETED|Overall Study||3270
7777427|NCT01328964|19147076|P1|COMPLETED|Overall Study||2212
7777428|NCT01328964|19147074|P3|STARTED|Overall Study||4424
7777429|NCT01328964|19147075|P2|STARTED|Overall Study||3270
7777430|NCT01328964|19147076|P1|STARTED|Overall Study||2212
7777431|NCT01328951|19147091|P2|NOT COMPLETED|Overall Study||322
7777432|NCT01328951|19147092|P1|NOT COMPLETED|Overall Study||321
7777433|NCT01328951|19147091|P2|COMPLETED|Overall Study||0
7777434|NCT01328951|19147092|P1|COMPLETED|Overall Study||0
7777435|NCT01328951|19147091|P2|STARTED|Overall Study||322
7777436|NCT01328951|19147092|P1|STARTED|Overall Study||321
7777437|NCT01328873|19147116|P1|NOT COMPLETED|Overall Study||0
7777438|NCT01328873|19147116|P1|COMPLETED|Overall Study||49
7777439|NCT01328873|19147116|P1|STARTED|Overall Study||49
7777440|NCT01328782|19147128|P3|NOT COMPLETED|Overall Study||0
7777441|NCT01328782|19147129|P2|NOT COMPLETED|Overall Study||0
7777442|NCT01328782|19147130|P1|NOT COMPLETED|Overall Study||0
7777443|NCT01328782|19147128|P3|COMPLETED|Overall Study||39
7777444|NCT01328782|19147129|P2|COMPLETED|Overall Study||42
7777445|NCT01328782|19147130|P1|COMPLETED|Overall Study||43
7777446|NCT01328782|19147128|P3|STARTED|Overall Study||39
7777447|NCT01328782|19147129|P2|STARTED|Overall Study||42
7777448|NCT01328782|19147130|P1|STARTED|Overall Study||43
7777449|NCT01328769|19147152|P2|NOT COMPLETED|Overall Study||1
7777450|NCT01328769|19147153|P1|NOT COMPLETED|Overall Study||0
7777451|NCT01328769|19147152|P2|COMPLETED|Overall Study||23
7777452|NCT01328769|19147153|P1|COMPLETED|Overall Study||25
7777453|NCT01328769|19147152|P2|STARTED|Overall Study||24
7777454|NCT01328769|19147153|P1|STARTED|Overall Study||25
7777455|NCT01328756|19147161|P1|NOT COMPLETED|Overall Study||123
7777456|NCT01328756|19147161|P1|COMPLETED|Overall Study||191
7777457|NCT01328756|19147161|P1|STARTED|Overall Study||314
7777458|NCT01328743|19147180|P2|NOT COMPLETED|Overall Study||10
7777459|NCT01328743|19147181|P1|NOT COMPLETED|Overall Study||9
7777460|NCT01328743|19147180|P2|COMPLETED|Overall Study||79
7777461|NCT01328743|19147181|P1|COMPLETED|Overall Study||82
7777462|NCT01328743|19147180|P2|STARTED|Overall Study||89
7777463|NCT01328743|19147181|P1|STARTED|Overall Study||91
7777464|NCT01328717|19147197|P1|NOT COMPLETED|Overall Study||1
7777465|NCT01328717|19147197|P1|COMPLETED|Overall Study||77
7777466|NCT01328717|19147197|P1|STARTED|Overall Study||78
7777467|NCT01328587|19147202|P1|NOT COMPLETED|Overall Study||0
7777468|NCT01328587|19147202|P1|COMPLETED|Overall Study||34
7777469|NCT01328587|19147202|P1|STARTED|Overall Study||34
7777470|NCT01328574|19147206|P1|NOT COMPLETED|Overall Study||1
7777471|NCT01328574|19147206|P1|COMPLETED|Overall Study||12
7777472|NCT01328574|19147206|P1|STARTED|Overall Study||13
7777473|NCT01328548|19147220|P2|NOT COMPLETED|Overall Study||0
7777474|NCT01328548|19147221|P1|NOT COMPLETED|Overall Study||4
7777475|NCT01328548|19147220|P2|COMPLETED|Overall Study||50
7777476|NCT01328548|19147221|P1|COMPLETED|Overall Study||187
7777477|NCT01328548|19147220|P2|STARTED|Overall Study||50
7777478|NCT01328548|19147221|P1|STARTED|Overall Study||191
7777479|NCT01328535|19147239|P1|NOT COMPLETED|Overall Study||1
7777480|NCT01328535|19147239|P1|COMPLETED|Overall Study||24
7777481|NCT01328535|19147239|P1|STARTED|Overall Study||25
7777482|NCT01328496|19147250|P2|NOT COMPLETED|Overall Study||0
7777483|NCT01328496|19147251|P1|NOT COMPLETED|Overall Study||1
7777484|NCT01328496|19147250|P2|COMPLETED|Overall Study||4
7777485|NCT01328496|19147251|P1|COMPLETED|Overall Study||9
7777486|NCT01328496|19147250|P2|STARTED|Overall Study||4
7777487|NCT01328496|19147251|P1|STARTED|Overall Study||10
7777488|NCT01328444|19147269|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
7777489|NCT01328444|19147270|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8
7777490|NCT01328444|19147271|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5
7777491|NCT01328444|19147272|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
7777492|NCT01328444|19147273|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
7777493|NCT01328444|19147274|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11
7777494|NCT01328444|19147269|P6|COMPLETED|Treatment Period 2 (12 Weeks)||59
7777495|NCT01328444|19147270|P5|COMPLETED|Treatment Period 2 (12 Weeks)||63
7777496|NCT01328444|19147271|P4|COMPLETED|Treatment Period 2 (12 Weeks)||30
7777497|NCT01328444|19147272|P3|COMPLETED|Treatment Period 2 (12 Weeks)||19
7777498|NCT01328444|19147273|P2|COMPLETED|Treatment Period 2 (12 Weeks)||22
7777499|NCT01328444|19147274|P1|COMPLETED|Treatment Period 2 (12 Weeks)||65
7777500|NCT01328444|19147269|P6|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66
7777501|NCT01328444|19147270|P5|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71
7777577|NCT01328379|19147351|P1|COMPLETED|Overall Study||142
7777502|NCT01328444|19147271|P4|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35
7777503|NCT01328444|19147272|P3|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22
7777504|NCT01328444|19147273|P2|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23
7777505|NCT01328444|19147274|P1|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76
7777506|NCT01328444|19147269|P6|NOT COMPLETED|Washout Period (14 Days)||4
7777507|NCT01328444|19147270|P5|NOT COMPLETED|Washout Period (14 Days)||1
7777508|NCT01328444|19147271|P4|NOT COMPLETED|Washout Period (14 Days)||1
7777509|NCT01328444|19147272|P3|NOT COMPLETED|Washout Period (14 Days)||0
7777510|NCT01328444|19147273|P2|NOT COMPLETED|Washout Period (14 Days)||1
7777511|NCT01328444|19147274|P1|NOT COMPLETED|Washout Period (14 Days)||1
7777512|NCT01328444|19147269|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68
7777513|NCT01328444|19147270|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66
7777514|NCT01328444|19147271|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32
7777515|NCT01328444|19147272|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25
7777516|NCT01328444|19147273|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
7777517|NCT01328444|19147274|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82
7777518|NCT01328444|19147269|P6|STARTED|Washout Period (14 Days)||72
7777519|NCT01328444|19147270|P5|STARTED|Washout Period (14 Days)||67
7777520|NCT01328444|19147271|P4|STARTED|Washout Period (14 Days)||33
7777521|NCT01328444|19147272|P3|STARTED|Washout Period (14 Days)||25
7777522|NCT01328444|19147273|P2|STARTED|Washout Period (14 Days)||21
7777523|NCT01328444|19147274|P1|STARTED|Washout Period (14 Days)||83
7777524|NCT01328444|19147269|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6
7777525|NCT01328444|19147270|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14
7777526|NCT01328444|19147271|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
7777527|NCT01328444|19147272|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
7777528|NCT01328444|19147273|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
7777529|NCT01328444|19147274|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
7777530|NCT01328444|19147269|P6|COMPLETED|Treatment Period 1 (12 Weeks)||72
7777531|NCT01328444|19147270|P5|COMPLETED|Treatment Period 1 (12 Weeks)||67
7777532|NCT01328444|19147271|P4|COMPLETED|Treatment Period 1 (12 Weeks)||33
7777533|NCT01328444|19147272|P3|COMPLETED|Treatment Period 1 (12 Weeks)||25
7777534|NCT01328444|19147273|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
7777535|NCT01328444|19147274|P1|COMPLETED|Treatment Period 1 (12 Weeks)||83
7777536|NCT01328444|19147269|P6|STARTED|Treatment Period 1 (12 Weeks)||78
7777537|NCT01328444|19147270|P5|STARTED|Treatment Period 1 (12 Weeks)||81
7777538|NCT01328444|19147271|P4|STARTED|Treatment Period 1 (12 Weeks)||41
7777539|NCT01328444|19147272|P3|STARTED|Treatment Period 1 (12 Weeks)||28
7777540|NCT01328444|19147273|P2|STARTED|Treatment Period 1 (12 Weeks)||26
7777541|NCT01328444|19147274|P1|STARTED|Treatment Period 1 (12 Weeks)||94
7777542|NCT01328431|19147320|P2|NOT COMPLETED|12 Month (12M)||97
7777543|NCT01328431|19147321|P1|NOT COMPLETED|12 Month (12M)||84
7777544|NCT01328431|19147320|P2|COMPLETED|12 Month (12M)||289
7777545|NCT01328431|19147321|P1|COMPLETED|12 Month (12M)||304
7777546|NCT01328431|19147320|P2|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386
7777547|NCT01328431|19147321|P1|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388
7777548|NCT01328431|19147320|P2|NOT COMPLETED|3 Month (3M)||72
7777549|NCT01328431|19147321|P1|NOT COMPLETED|3 Month (3M)||77
7777550|NCT01328431|19147320|P2|COMPLETED|3 Month (3M)||316
7777551|NCT01328431|19147321|P1|COMPLETED|3 Month (3M)||313
7777552|NCT01328431|19147320|P2|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388
7777553|NCT01328431|19147321|P1|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390
7777554|NCT01328431|19147320|P2|NOT COMPLETED|1 Month (1M)||58
7777555|NCT01328431|19147321|P1|NOT COMPLETED|1 Month (1M)||55
7777556|NCT01328431|19147320|P2|COMPLETED|1 Month (1M)||330
7777557|NCT01328431|19147321|P1|COMPLETED|1 Month (1M)||335
7777558|NCT01328431|19147320|P2|STARTED|1 Month (1M)||388
7777559|NCT01328431|19147321|P1|STARTED|1 Month (1M)||390
7777560|NCT01328431|19147320|P2|NOT COMPLETED|Baseline||2
7777561|NCT01328431|19147321|P1|NOT COMPLETED|Baseline||0
7777562|NCT01328431|19147320|P2|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388
7777563|NCT01328431|19147321|P1|COMPLETED|Baseline||390
7777564|NCT01328431|19147320|P2|STARTED|Baseline||390
7777565|NCT01328431|19147321|P1|STARTED|Baseline||390
7777566|NCT01328405|19147331|P2|NOT COMPLETED|Overall Study||0
7777567|NCT01328405|19147332|P1|NOT COMPLETED|Overall Study||0
7777568|NCT01328405|19147331|P2|COMPLETED|Overall Study||48
7777569|NCT01328405|19147332|P1|COMPLETED|Overall Study||52
7777570|NCT01328405|19147331|P2|STARTED|Overall Study||48
7777571|NCT01328405|19147332|P1|STARTED|Overall Study||52
7777572|NCT01328379|19147349|P3|NOT COMPLETED|Overall Study||0
7777573|NCT01328379|19147350|P2|NOT COMPLETED|Overall Study||0
7777574|NCT01328379|19147351|P1|NOT COMPLETED|Overall Study||1
7777575|NCT01328379|19147349|P3|COMPLETED|Overall Study||143
7777576|NCT01328379|19147350|P2|COMPLETED|Overall Study||144
7777578|NCT01328379|19147349|P3|STARTED|Overall Study||143
7777579|NCT01328379|19147350|P2|STARTED|Overall Study||144
7777580|NCT01328379|19147351|P1|STARTED|Overall Study||143
7777581|NCT01328366|19147377|P1|NOT COMPLETED|Overall Study||10
7777582|NCT01328366|19147377|P1|COMPLETED|Overall Study||143
7777583|NCT01328366|19147377|P1|STARTED|Overall Study||153
7777584|NCT01328249|19147397|P2|NOT COMPLETED|Overall Study||3
7777585|NCT01328249|19147398|P1|NOT COMPLETED|Overall Study||7
7777586|NCT01328249|19147397|P2|COMPLETED|Overall Study||23
7777587|NCT01328249|19147398|P1|COMPLETED|Overall Study||48
7777588|NCT01328249|19147397|P2|STARTED|Overall Study||26
7777589|NCT01328249|19147398|P1|STARTED|Overall Study||55
7777590|NCT01328184|19147406|P1|NOT COMPLETED|Overall Study||0
7777591|NCT01328184|19147406|P1|COMPLETED|Overall Study||18
7777592|NCT01328184|19147406|P1|STARTED|Overall Study||18
7777593|NCT01328158|19147446|P1|NOT COMPLETED|Overall Study||0
7777594|NCT01328158|19147446|P1|COMPLETED|Overall Study||220
7777595|NCT01328158|19147446|P1|STARTED|Overall Study||220
7777596|NCT01328080|19147484|P1|NOT COMPLETED|Overall Study||5
7777597|NCT01328080|19147484|P1|COMPLETED|Overall Study||6
7777598|NCT01328080|19147484|P1|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11
7777599|NCT01328054|19147488|P2|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5
7777600|NCT01328054|19147489|P1|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
7777601|NCT01328054|19147488|P2|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53
7777602|NCT01328054|19147489|P1|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
7777603|NCT01328054|19147488|P2|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58
7777604|NCT01328054|19147489|P1|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0
7777605|NCT01328054|19147488|P2|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
7777606|NCT01328054|19147489|P1|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
7777607|NCT01328054|19147488|P2|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
7777608|NCT01328054|19147489|P1|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57
7777609|NCT01328054|19147488|P2|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0
7777610|NCT01328054|19147489|P1|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57
7777611|NCT01328041|19147514|P1|NOT COMPLETED|Overall Study||57
7777612|NCT01328041|19147514|P1|COMPLETED|Overall Study||126
7777613|NCT01328041|19147514|P1|STARTED|Overall Study||183
7777614|NCT01328002|19147536|P2|NOT COMPLETED|Double-Blind Period||0
7777615|NCT01328002|19147537|P1|NOT COMPLETED|Double-Blind Period||2
7777616|NCT01328002|19147536|P2|COMPLETED|Double-Blind Period||6
7777617|NCT01328002|19147537|P1|COMPLETED|Double-Blind Period||12
7777618|NCT01328002|19147536|P2|STARTED|Double-Blind Period||6
7777619|NCT01328002|19147537|P1|STARTED|Double-Blind Period||14
7777620|NCT01328002|19147536|P2|NOT COMPLETED|Open-Label Period||0
7777621|NCT01328002|19147537|P1|NOT COMPLETED|Open-Label Period||96
7777622|NCT01328002|19147536|P2|COMPLETED|Open-Label Period||0
7777623|NCT01328002|19147537|P1|COMPLETED|Open-Label Period||20
7777624|NCT01328002|19147536|P2|STARTED|Open-Label Period||0
7777625|NCT01328002|19147537|P1|STARTED|Open-Label Period||116
7777626|NCT01327989|19147546|P1|NOT COMPLETED|Overall Study||14
7777627|NCT01327989|19147546|P1|COMPLETED|Overall Study||188
7777628|NCT01327989|19147546|P1|STARTED|Overall Study||202
7777629|NCT01327976|19147560|P2|NOT COMPLETED|Overall Study||7
7777630|NCT01327976|19147561|P1|NOT COMPLETED|Overall Study||8
7777631|NCT01327976|19147560|P2|COMPLETED|Overall Study||70
7777632|NCT01327976|19147561|P1|COMPLETED|Overall Study||154
7777633|NCT01327976|19147560|P2|STARTED|Overall Study||77
7777634|NCT01327976|19147561|P1|STARTED|Overall Study||162
7777635|NCT01327963|19147571|P1|NOT COMPLETED|Overall Study||0
7777636|NCT01327963|19147571|P1|COMPLETED|Overall Study|110 participants signed informed consent to be included in the study.|110
7777637|NCT01327963|19147571|P1|STARTED|Overall Study||110
7777638|NCT01327885|19147582|P2|NOT COMPLETED|Overall Study||224
7777639|NCT01327885|19147583|P1|NOT COMPLETED|Overall Study||228
7777640|NCT01327885|19147582|P2|COMPLETED|Overall Study||0
7777641|NCT01327885|19147583|P1|COMPLETED|Overall Study||0
7777642|NCT01327885|19147582|P2|STARTED|Overall Study||224
7777643|NCT01327885|19147583|P1|STARTED|Overall Study||228
7777644|NCT01327846|19147599|P4|NOT COMPLETED|Extension Phase||1706
7777645|NCT01327846|19147600|P3|NOT COMPLETED|Extension Phase||1092
7777646|NCT01327846|19147601|P2|NOT COMPLETED|Extension Phase||1144
7777647|NCT01327846|19147602|P1|NOT COMPLETED|Extension Phase||1099
7777648|NCT01327846|19147599|P4|COMPLETED|Extension Phase||238
7777649|NCT01327846|19147600|P3|COMPLETED|Extension Phase||187
7777650|NCT01327846|19147601|P2|COMPLETED|Extension Phase||143
7777651|NCT01327846|19147602|P1|COMPLETED|Extension Phase||168
7777652|NCT01327846|19147599|P4|Details Missing|Extension Phase||0
7777653|NCT01327846|19147600|P3|Details Missing|Extension Phase||1
7777654|NCT01327846|19147601|P2|Details Missing|Extension Phase||1
7777655|NCT01327846|19147602|P1|Details Missing|Extension Phase||0
7777656|NCT01327846|19147599|P4|Completed Treatment Period|Extension Phase||60
7777657|NCT01327846|19147600|P3|Completed Treatment Period|Extension Phase||49
7777658|NCT01327846|19147601|P2|Completed Treatment Period|Extension Phase||45
7777659|NCT01327846|19147602|P1|Completed Treatment Period|Extension Phase||41
7777660|NCT01327846|19147599|P4|Stopped/Discontinued Study at Washout|Extension Phase||178
7777661|NCT01327846|19147600|P3|Stopped/Discontinued Study at Washout|Extension Phase||137
7777662|NCT01327846|19147601|P2|Stopped/Discontinued Study at Washout|Extension Phase||97
7777663|NCT01327846|19147602|P1|Stopped/Discontinued Study at Washout|Extension Phase||127
7777664|NCT01327846|19147599|P4|STARTED|Extension Phase||1944
7777665|NCT01327846|19147600|P3|STARTED|Extension Phase||1279
7777666|NCT01327846|19147601|P2|STARTED|Extension Phase||1287
7777667|NCT01327846|19147602|P1|STARTED|Extension Phase||1267
7777668|NCT01327846|19147599|P4|NOT COMPLETED|Core Phase||33
7777669|NCT01327846|19147600|P3|NOT COMPLETED|Core Phase||26
7777670|NCT01327846|19147601|P2|NOT COMPLETED|Core Phase||32
7777671|NCT01327846|19147602|P1|NOT COMPLETED|Core Phase||28
7777672|NCT01327846|19147599|P4|COMPLETED|Core Phase||3311
7777673|NCT01327846|19147600|P3|COMPLETED|Core Phase||2144
7777674|NCT01327846|19147601|P2|COMPLETED|Core Phase||2252
7777675|NCT01327846|19147602|P1|COMPLETED|Core Phase||2235
7777676|NCT01327846|19147599|P4|STARTED|Core Phase||3344
7777677|NCT01327846|19147600|P3|STARTED|Core Phase||2170
7777678|NCT01327846|19147601|P2|STARTED|Core Phase||2284
7777679|NCT01327846|19147602|P1|STARTED|Core Phase||2263
7777680|NCT01327703|19147677|P2|NOT COMPLETED|Second Treatment Period||2
7777681|NCT01327703|19147678|P1|NOT COMPLETED|Second Treatment Period||1
7777682|NCT01327703|19147677|P2|COMPLETED|Second Treatment Period||42
7777683|NCT01327703|19147678|P1|COMPLETED|Second Treatment Period||39
7777684|NCT01327703|19147677|P2|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44
7777685|NCT01327703|19147678|P1|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40
7777686|NCT01327703|19147677|P2|NOT COMPLETED|First Treatment Period||0
7777687|NCT01327703|19147678|P1|NOT COMPLETED|First Treatment Period||0
7777688|NCT01327703|19147677|P2|COMPLETED|First Treatment Period||45
7777689|NCT01327703|19147678|P1|COMPLETED|First Treatment Period||42
7777690|NCT01327703|19147677|P2|STARTED|First Treatment Period||45
7777691|NCT01327703|19147678|P1|STARTED|First Treatment Period||42
7777692|NCT01327677|19147712|P2|NOT COMPLETED|Overall Study||13
7777693|NCT01327677|19147713|P1|NOT COMPLETED|Overall Study||20
7777694|NCT01327677|19147712|P2|COMPLETED|Overall Study||56
7777695|NCT01327677|19147713|P1|COMPLETED|Overall Study||48
7777696|NCT01327677|19147712|P2|STARTED|Overall Study||69
7777697|NCT01327677|19147713|P1|STARTED|Overall Study||68
7777698|NCT01327651|19147734|P9|NOT COMPLETED|Post Study Follow-up||2
7777699|NCT01327651|19147735|P8|NOT COMPLETED|Post Study Follow-up||1
7777700|NCT01327651|19147736|P7|NOT COMPLETED|Post Study Follow-up||4
7777701|NCT01327651|19147737|P6|NOT COMPLETED|Post Study Follow-up||0
7777702|NCT01327651|19147738|P5|NOT COMPLETED|Post Study Follow-up||0
7777703|NCT01327651|19147739|P4|NOT COMPLETED|Post Study Follow-up||0
7777704|NCT01327651|19147740|P3|NOT COMPLETED|Post Study Follow-up||1
7777705|NCT01327651|19147741|P2|NOT COMPLETED|Post Study Follow-up||1
7777706|NCT01327651|19147742|P1|NOT COMPLETED|Post Study Follow-up||0
7777707|NCT01327651|19147734|P9|COMPLETED|Post Study Follow-up||47
7777708|NCT01327651|19147735|P8|COMPLETED|Post Study Follow-up||49
7777709|NCT01327651|19147736|P7|COMPLETED|Post Study Follow-up||45
7777710|NCT01327651|19147737|P6|COMPLETED|Post Study Follow-up||59
7777711|NCT01327651|19147738|P5|COMPLETED|Post Study Follow-up||56
7777712|NCT01327651|19147739|P4|COMPLETED|Post Study Follow-up||57
7777713|NCT01327651|19147740|P3|COMPLETED|Post Study Follow-up||55
7777714|NCT01327651|19147741|P2|COMPLETED|Post Study Follow-up||55
7777715|NCT01327651|19147742|P1|COMPLETED|Post Study Follow-up||56
7777716|NCT01327651|19147734|P9|STARTED|Post Study Follow-up||49
7777717|NCT01327651|19147735|P8|STARTED|Post Study Follow-up||50
7777718|NCT01327651|19147736|P7|STARTED|Post Study Follow-up||49
7777719|NCT01327651|19147737|P6|STARTED|Post Study Follow-up||59
7777720|NCT01327651|19147738|P5|STARTED|Post Study Follow-up||56
7777721|NCT01327651|19147739|P4|STARTED|Post Study Follow-up||57
7777722|NCT01327651|19147740|P3|STARTED|Post Study Follow-up||56
7777723|NCT01327651|19147741|P2|STARTED|Post Study Follow-up||56
7777724|NCT01327651|19147742|P1|STARTED|Post Study Follow-up||56
7777725|NCT01327651|19147734|P9|NOT COMPLETED|Self-administered Dosing Period||11
7777726|NCT01327651|19147735|P8|NOT COMPLETED|Self-administered Dosing Period||10
7777727|NCT01327651|19147736|P7|NOT COMPLETED|Self-administered Dosing Period||10
7777728|NCT01327651|19147737|P6|NOT COMPLETED|Self-administered Dosing Period||0
7777729|NCT01327651|19147738|P5|NOT COMPLETED|Self-administered Dosing Period||3
7777730|NCT01327651|19147739|P4|NOT COMPLETED|Self-administered Dosing Period||3
7777731|NCT01327651|19147740|P3|NOT COMPLETED|Self-administered Dosing Period||4
7777732|NCT01327651|19147741|P2|NOT COMPLETED|Self-administered Dosing Period||3
7777733|NCT01327651|19147742|P1|NOT COMPLETED|Self-administered Dosing Period||4
7777734|NCT01327651|19147734|P9|COMPLETED|Self-administered Dosing Period||49
7777735|NCT01327651|19147735|P8|COMPLETED|Self-administered Dosing Period||50
7777736|NCT01327651|19147736|P7|COMPLETED|Self-administered Dosing Period||49
7777737|NCT01327651|19147737|P6|COMPLETED|Self-administered Dosing Period||59
7777738|NCT01327651|19147738|P5|COMPLETED|Self-administered Dosing Period||56
7777739|NCT01327651|19147739|P4|COMPLETED|Self-administered Dosing Period||57
7777740|NCT01327651|19147740|P3|COMPLETED|Self-administered Dosing Period||56
7777741|NCT01327651|19147741|P2|COMPLETED|Self-administered Dosing Period||56
7777742|NCT01327651|19147742|P1|COMPLETED|Self-administered Dosing Period||56
7777743|NCT01327651|19147734|P9|Week 26|Self-administered Dosing Period||49
7777744|NCT01327651|19147735|P8|Week 26|Self-administered Dosing Period||51
7777745|NCT01327651|19147736|P7|Week 26|Self-administered Dosing Period||50
7777746|NCT01327651|19147737|P6|Week 26|Self-administered Dosing Period||58
7777747|NCT01327651|19147738|P5|Week 26|Self-administered Dosing Period||56
7777748|NCT01327651|19147739|P4|Week 26|Self-administered Dosing Period||57
7777749|NCT01327651|19147740|P3|Week 26|Self-administered Dosing Period||53
7777750|NCT01327651|19147741|P2|Week 26|Self-administered Dosing Period||56
7777751|NCT01327651|19147742|P1|Week 26|Self-administered Dosing Period||58
7777752|NCT01327651|19147734|P9|Week 22|Self-administered Dosing Period||51
7777753|NCT01327651|19147735|P8|Week 22|Self-administered Dosing Period||50
7777754|NCT01327651|19147736|P7|Week 22|Self-administered Dosing Period||50
7777755|NCT01327651|19147737|P6|Week 22|Self-administered Dosing Period||59
7777756|NCT01327651|19147738|P5|Week 22|Self-administered Dosing Period||56
7777757|NCT01327651|19147739|P4|Week 22|Self-administered Dosing Period||58
7777758|NCT01327651|19147740|P3|Week 22|Self-administered Dosing Period||55
7777759|NCT01327651|19147741|P2|Week 22|Self-administered Dosing Period||56
7777760|NCT01327651|19147742|P1|Week 22|Self-administered Dosing Period||59
7777761|NCT01327651|19147734|P9|Week 18|Self-administered Dosing Period||53
7777762|NCT01327651|19147735|P8|Week 18|Self-administered Dosing Period||49
7777763|NCT01327651|19147736|P7|Week 18|Self-administered Dosing Period||53
7777764|NCT01327651|19147737|P6|Week 18|Self-administered Dosing Period||59
7777765|NCT01327651|19147738|P5|Week 18|Self-administered Dosing Period||57
7777766|NCT01327651|19147739|P4|Week 18|Self-administered Dosing Period||60
7777767|NCT01327651|19147740|P3|Week 18|Self-administered Dosing Period||56
7777768|NCT01327651|19147741|P2|Week 18|Self-administered Dosing Period||56
7777769|NCT01327651|19147742|P1|Week 18|Self-administered Dosing Period||57
7777770|NCT01327651|19147734|P9|Week 14|Self-administered Dosing Period||54
7777771|NCT01327651|19147735|P8|Week 14|Self-administered Dosing Period||51
7777772|NCT01327651|19147736|P7|Week 14|Self-administered Dosing Period||54
7777773|NCT01327651|19147737|P6|Week 14|Self-administered Dosing Period||59
7777774|NCT01327651|19147738|P5|Week 14|Self-administered Dosing Period||58
7777775|NCT01327651|19147739|P4|Week 14|Self-administered Dosing Period||60
7777776|NCT01327651|19147740|P3|Week 14|Self-administered Dosing Period||57
7777777|NCT01327651|19147741|P2|Week 14|Self-administered Dosing Period||55
7777778|NCT01327651|19147742|P1|Week 14|Self-administered Dosing Period||59
7777779|NCT01327651|19147734|P9|Week 10|Self-administered Dosing Period||56
7777780|NCT01327651|19147735|P8|Week 10|Self-administered Dosing Period||57
7777781|NCT01327651|19147736|P7|Week 10|Self-administered Dosing Period||57
7777782|NCT01327651|19147737|P6|Week 10|Self-administered Dosing Period||59
7777783|NCT01327651|19147738|P5|Week 10|Self-administered Dosing Period||59
7777784|NCT01327651|19147739|P4|Week 10|Self-administered Dosing Period||60
7777785|NCT01327651|19147740|P3|Week 10|Self-administered Dosing Period||60
7777786|NCT01327651|19147741|P2|Week 10|Self-administered Dosing Period||58
7777787|NCT01327651|19147742|P1|Week 10|Self-administered Dosing Period||59
7777788|NCT01327651|19147734|P9|STARTED|Self-administered Dosing Period||60
7777789|NCT01327651|19147735|P8|STARTED|Self-administered Dosing Period||60
7777790|NCT01327651|19147736|P7|STARTED|Self-administered Dosing Period||59
7777791|NCT01327651|19147737|P6|STARTED|Self-administered Dosing Period||59
7777792|NCT01327651|19147738|P5|STARTED|Self-administered Dosing Period||59
7777793|NCT01327651|19147739|P4|STARTED|Self-administered Dosing Period||60
7777794|NCT01327651|19147740|P3|STARTED|Self-administered Dosing Period||60
7777795|NCT01327651|19147741|P2|STARTED|Self-administered Dosing Period||59
7777796|NCT01327651|19147742|P1|STARTED|Self-administered Dosing Period||60
7777797|NCT01327599|19147861|P1|NOT COMPLETED|Overall Study||3
7777798|NCT01327599|19147861|P1|COMPLETED|Overall Study||57
7777799|NCT01327599|19147861|P1|STARTED|Overall Study||60
7777800|NCT01327573|19147871|P2|NOT COMPLETED|Overall Study||1
7777801|NCT01327573|19147872|P1|NOT COMPLETED|Overall Study||3
7777802|NCT01327573|19147871|P2|COMPLETED|Overall Study||4
7777803|NCT01327573|19147872|P1|COMPLETED|Overall Study||8
7777804|NCT01327573|19147871|P2|Received Treatment/Control as Allocated|Overall Study||5
7777805|NCT01327573|19147872|P1|Received Treatment/Control as Allocated|Overall Study||10
7777806|NCT01327573|19147871|P2|STARTED|Overall Study||5
7777807|NCT01327573|19147872|P1|STARTED|Overall Study||11
7777808|NCT01327547|19147883|P2|NOT COMPLETED|Overall Study||22
7777809|NCT01327547|19147884|P1|NOT COMPLETED|Overall Study||20
7777810|NCT01327547|19147883|P2|COMPLETED|Overall Study||45
7777811|NCT01327547|19147884|P1|COMPLETED|Overall Study||50
7777812|NCT01327547|19147883|P2|Randomized and Not Treated|Overall Study|Randomized but was withdrawn prior to receiving treatment due to poor venous access.|1
7777813|NCT01327547|19147884|P1|Randomized and Not Treated|Overall Study||0
7777814|NCT01327547|19147883|P2|STARTED|Overall Study||67
7777815|NCT01327547|19147884|P1|STARTED|Overall Study||70
7777816|NCT01327508|19147937|P2|NOT COMPLETED|Overall Study||0
7777817|NCT01327508|19147938|P1|NOT COMPLETED|Overall Study||0
7777818|NCT01327508|19147937|P2|COMPLETED|Overall Study||30
7777819|NCT01327508|19147938|P1|COMPLETED|Overall Study||30
7777820|NCT01327508|19147937|P2|STARTED|Overall Study||30
7777821|NCT01327508|19147938|P1|STARTED|Overall Study||30
7777822|NCT01327495|19147952|P6|NOT COMPLETED|Overall Study||2
7777823|NCT01327495|19147953|P5|NOT COMPLETED|Overall Study||3
7777824|NCT01327495|19147954|P4|NOT COMPLETED|Overall Study||0
7777825|NCT01327495|19147955|P3|NOT COMPLETED|Overall Study||2
7777826|NCT01327495|19147956|P2|NOT COMPLETED|Overall Study||2
7777827|NCT01327495|19147957|P1|NOT COMPLETED|Overall Study||2
7777828|NCT01327495|19147952|P6|COMPLETED|Overall Study|1 subject withdrawn d/t elevated LFTs, 1 dropped out d/t ski accident|9
7777829|NCT01327495|19147953|P5|COMPLETED|Overall Study|1 dropped out pre drug finish, 2 non-compliant subjects dropped|8
7777830|NCT01327495|19147954|P4|COMPLETED|Overall Study||9
7777831|NCT01327495|19147955|P3|COMPLETED|Overall Study|1 withdrawn due to injection AE. 1 drop-out (declined prostate biopsy and final visit).|8
7777922|NCT01326845|19148344|P1|STARTED|Overall Study||7
7777832|NCT01327495|19147956|P2|COMPLETED|Overall Study|1 subject declined prostate biopsy & no-showed to final visit, 1 subject dropped d/t elevated LFTs.|9
7777833|NCT01327495|19147957|P1|COMPLETED|Overall Study|1 dropped due to decreased libido & energy, 1 dropped due to too much pain with acyline injections|8
7777834|NCT01327495|19147952|P6|STARTED|Overall Study||11
7777835|NCT01327495|19147953|P5|STARTED|Overall Study||11
7777836|NCT01327495|19147954|P4|STARTED|Overall Study||9
7777837|NCT01327495|19147955|P3|STARTED|Overall Study||10
7777838|NCT01327495|19147956|P2|STARTED|Overall Study||11
7777839|NCT01327495|19147957|P1|STARTED|Overall Study||10
7777840|NCT01327482|19148049|P1|NOT COMPLETED|Overall Study||1
7777841|NCT01327482|19148049|P1|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9
7777842|NCT01327482|19148049|P1|STARTED|Overall Study||10
7777843|NCT01327339|19148054|P1|NOT COMPLETED|Overall Study||8
7777844|NCT01327339|19148054|P1|COMPLETED|Overall Study||747
7777845|NCT01327339|19148054|P1|STARTED|Overall Study||755
7777846|NCT01327313|19148064|P4|NOT COMPLETED|Overall Study||0
7777847|NCT01327313|19148065|P3|NOT COMPLETED|Overall Study||0
7777848|NCT01327313|19148066|P2|NOT COMPLETED|Overall Study||0
7777849|NCT01327313|19148067|P1|NOT COMPLETED|Overall Study||0
7777850|NCT01327313|19148064|P4|COMPLETED|Overall Study||7
7777851|NCT01327313|19148065|P3|COMPLETED|Overall Study||6
7777852|NCT01327313|19148066|P2|COMPLETED|Overall Study||6
7777853|NCT01327313|19148067|P1|COMPLETED|Overall Study||8
7777854|NCT01327313|19148064|P4|STARTED|Overall Study||7
7777855|NCT01327313|19148065|P3|STARTED|Overall Study||6
7777856|NCT01327313|19148066|P2|STARTED|Overall Study||6
7777857|NCT01327313|19148067|P1|STARTED|Overall Study||8
7777858|NCT01327300|19148189|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
7777859|NCT01327300|19148190|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
7777860|NCT01327300|19148189|P2|COMPLETED|Second Intervention (12 Weeks)||2
7777861|NCT01327300|19148190|P1|COMPLETED|Second Intervention (12 Weeks)||4
7777862|NCT01327300|19148189|P2|STARTED|Second Intervention (12 Weeks)||2
7777863|NCT01327300|19148190|P1|STARTED|Second Intervention (12 Weeks)||4
7777864|NCT01327300|19148189|P2|NOT COMPLETED|Washout (3 Weeks)||0
7777865|NCT01327300|19148190|P1|NOT COMPLETED|Washout (3 Weeks)||1
7777866|NCT01327300|19148189|P2|COMPLETED|Washout (3 Weeks)||2
7777867|NCT01327300|19148190|P1|COMPLETED|Washout (3 Weeks)||4
7777868|NCT01327300|19148189|P2|STARTED|Washout (3 Weeks)||2
7777869|NCT01327300|19148190|P1|STARTED|Washout (3 Weeks)||5
7777870|NCT01327300|19148189|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
7777871|NCT01327300|19148190|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
7777872|NCT01327300|19148189|P2|COMPLETED|First Intervention (12 Weeks)||2
7777873|NCT01327300|19148190|P1|COMPLETED|First Intervention (12 Weeks)||5
7777874|NCT01327300|19148189|P2|STARTED|First Intervention (12 Weeks)||2
7777875|NCT01327300|19148190|P1|STARTED|First Intervention (12 Weeks)||5
7777876|NCT01327274|19148206|P1|NOT COMPLETED|Overall Study||0
7777877|NCT01327274|19148206|P1|COMPLETED|Overall Study||15
7777878|NCT01327274|19148206|P1|STARTED|Overall Study||15
7777879|NCT01327157|19148215|P2|NOT COMPLETED|91-180||0
7777880|NCT01327157|19148216|P1|NOT COMPLETED|91-180||0
7777881|NCT01327157|19148215|P2|COMPLETED|91-180||0
7777882|NCT01327157|19148216|P1|COMPLETED|91-180||7
7777883|NCT01327157|19148215|P2|STARTED|91-180||0
7777884|NCT01327157|19148216|P1|STARTED|91-180||7
7777885|NCT01327157|19148215|P2|NOT COMPLETED|01-90||0
7777886|NCT01327157|19148216|P1|NOT COMPLETED|01-90||0
7777887|NCT01327157|19148215|P2|COMPLETED|01-90||7
7777888|NCT01327157|19148216|P1|COMPLETED|01-90||7
7777889|NCT01327157|19148215|P2|STARTED|01-90||7
7777890|NCT01327157|19148216|P1|STARTED|01-90||7
7777891|NCT01327053|19148230|P2|NOT COMPLETED|Overall Study||151
7777892|NCT01327053|19148231|P1|NOT COMPLETED|Overall Study||79
7777893|NCT01327053|19148230|P2|COMPLETED|Overall Study||0
7777894|NCT01327053|19148231|P1|COMPLETED|Overall Study||0
7777895|NCT01327053|19148230|P2|Post-treatment Follow-up|Overall Study||40
7777896|NCT01327053|19148231|P1|Post-treatment Follow-up|Overall Study||19
7777897|NCT01327053|19148230|P2|Survival Follow-up|Overall Study||49
7777898|NCT01327053|19148231|P1|Survival Follow-up|Overall Study||33
7777899|NCT01327053|19148230|P2|Patients Cont. to Next Phase of Trial|Overall Study||89
7777900|NCT01327053|19148231|P1|Patients Cont. to Next Phase of Trial|Overall Study||52
7777901|NCT01327053|19148230|P2|Untreated|Overall Study|one patient randomized to LDE225 (sonidegib) 800 mg did not receive study treatment|1
7777902|NCT01327053|19148231|P1|Untreated|Overall Study||0
7777903|NCT01327053|19148230|P2|STARTED|Overall Study||151
7777904|NCT01327053|19148231|P1|STARTED|Overall Study||79
7777905|NCT01326962|19148305|P1|NOT COMPLETED|Overall Study||7
7777906|NCT01326962|19148305|P1|COMPLETED|Overall Study||21
7777907|NCT01326962|19148305|P1|STARTED|Overall Study||28
7777908|NCT01326923|19148321|P1|NOT COMPLETED|Overall Study||0
7777909|NCT01326923|19148321|P1|COMPLETED|Overall Study||7
7777910|NCT01326923|19148321|P1|STARTED|Overall Study||7
7777911|NCT01326910|19148328|P2|NOT COMPLETED|Overall Study||3
7777912|NCT01326910|19148329|P1|NOT COMPLETED|Overall Study||4
7777913|NCT01326910|19148328|P2|COMPLETED|Overall Study||42
7777914|NCT01326910|19148329|P1|COMPLETED|Overall Study||41
7777915|NCT01326910|19148328|P2|STARTED|Overall Study||45
7777916|NCT01326910|19148329|P1|STARTED|Overall Study||45
7777917|NCT01326845|19148343|P2|NOT COMPLETED|Overall Study||5
7777918|NCT01326845|19148344|P1|NOT COMPLETED|Overall Study||7
7777919|NCT01326845|19148343|P2|COMPLETED|Overall Study|Study terminated early|0
7777920|NCT01326845|19148344|P1|COMPLETED|Overall Study|Study terminated early|0
7777921|NCT01326845|19148343|P2|STARTED|Overall Study||5
7777923|NCT01326780|19148370|P4|NOT COMPLETED|Overall Study||13
7777924|NCT01326780|19148371|P3|NOT COMPLETED|Overall Study||6
7777925|NCT01326780|19148372|P2|NOT COMPLETED|Overall Study||9
7777926|NCT01326780|19148373|P1|NOT COMPLETED|Overall Study||13
7777927|NCT01326780|19148370|P4|COMPLETED|Overall Study||94
7777928|NCT01326780|19148371|P3|COMPLETED|Overall Study||103
7777929|NCT01326780|19148372|P2|COMPLETED|Overall Study||100
7777930|NCT01326780|19148373|P1|COMPLETED|Overall Study||93
7777931|NCT01326780|19148370|P4|STARTED|Overall Study||107
7777932|NCT01326780|19148371|P3|STARTED|Overall Study||109
7777933|NCT01326780|19148372|P2|STARTED|Overall Study||109
7777934|NCT01326780|19148373|P1|STARTED|Overall Study||106
7777935|NCT01326728|19148405|P2|NOT COMPLETED|Overall Study||9
7777936|NCT01326728|19148406|P1|NOT COMPLETED|Overall Study||47
7777937|NCT01326728|19148405|P2|COMPLETED|Overall Study||0
7777938|NCT01326728|19148406|P1|COMPLETED|Overall Study||0
7777939|NCT01326728|19148405|P2|STARTED|Overall Study||9
7777940|NCT01326728|19148406|P1|STARTED|Overall Study||47
7777941|NCT01326702|19148430|P7|NOT COMPLETED|Overall Study||7
7777942|NCT01326702|19148431|P6|NOT COMPLETED|Overall Study||8
7777943|NCT01326702|19148432|P5|NOT COMPLETED|Overall Study||4
7777944|NCT01326702|19148433|P4|NOT COMPLETED|Overall Study||3
7777945|NCT01326702|19148434|P3|NOT COMPLETED|Overall Study||5
7777946|NCT01326702|19148435|P2|NOT COMPLETED|Overall Study||2
7777947|NCT01326702|19148436|P1|NOT COMPLETED|Overall Study||2
7777948|NCT01326702|19148430|P7|COMPLETED|Overall Study||0
7777949|NCT01326702|19148431|P6|COMPLETED|Overall Study||7
7777950|NCT01326702|19148432|P5|COMPLETED|Overall Study||1
7777951|NCT01326702|19148433|P4|COMPLETED|Overall Study||1
7777952|NCT01326702|19148434|P3|COMPLETED|Overall Study||1
7777953|NCT01326702|19148435|P2|COMPLETED|Overall Study||1
7777954|NCT01326702|19148436|P1|COMPLETED|Overall Study||1
7777955|NCT01326702|19148430|P7|STARTED|Overall Study||7
7777956|NCT01326702|19148431|P6|STARTED|Overall Study||15
7777957|NCT01326702|19148432|P5|STARTED|Overall Study||5
7777958|NCT01326702|19148433|P4|STARTED|Overall Study||4
7777959|NCT01326702|19148434|P3|STARTED|Overall Study||6
7777960|NCT01326702|19148435|P2|STARTED|Overall Study||3
7777961|NCT01326702|19148436|P1|STARTED|Overall Study||3
7777962|NCT01326546|19148492|P2|NOT COMPLETED|Overall Study||13
7777963|NCT01326546|19148493|P1|NOT COMPLETED|Overall Study||17
7777964|NCT01326546|19148492|P2|COMPLETED|Overall Study||176
7777965|NCT01326546|19148493|P1|COMPLETED|Overall Study||172
7777966|NCT01326546|19148492|P2|STARTED|Overall Study||189
7777967|NCT01326546|19148493|P1|STARTED|Overall Study||189
7777968|NCT01326533|19148501|P2|NOT COMPLETED|Overall Study||0
7777969|NCT01326533|19148502|P1|NOT COMPLETED|Overall Study||4
7777970|NCT01326533|19148501|P2|COMPLETED|Overall Study||15
7777971|NCT01326533|19148502|P1|COMPLETED|Overall Study||13
7777972|NCT01326533|19148501|P2|STARTED|Overall Study||15
7777973|NCT01326533|19148502|P1|STARTED|Overall Study||17
7777974|NCT01326481|19148510|P1|NOT COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||0
7777975|NCT01326481|19148510|P1|COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
7777976|NCT01326481|19148510|P1|STARTED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
7777977|NCT01326481|19148510|P1|NOT COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||1
7777978|NCT01326481|19148510|P1|COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||3
7777979|NCT01326481|19148510|P1|STARTED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||4
7777980|NCT01326026|19148519|P2|NOT COMPLETED|Overall Study||13
7777981|NCT01326026|19148520|P1|NOT COMPLETED|Overall Study||12
7777982|NCT01326026|19148519|P2|COMPLETED|Overall Study||98
7777983|NCT01326026|19148520|P1|COMPLETED|Overall Study||99
7777984|NCT01326026|19148519|P2|Exposed|Overall Study||111
7777985|NCT01326026|19148520|P1|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110
7777986|NCT01326026|19148519|P2|STARTED|Overall Study||111
7777987|NCT01326026|19148520|P1|STARTED|Overall Study||111
7777988|NCT01325870|19148537|P3|NOT COMPLETED|Overall Study||8
7777989|NCT01325870|19148538|P2|NOT COMPLETED|Overall Study||13
7777990|NCT01325870|19148539|P1|NOT COMPLETED|Overall Study||11
7777991|NCT01325870|19148537|P3|COMPLETED|Overall Study||6
7777992|NCT01325870|19148538|P2|COMPLETED|Overall Study||3
7777993|NCT01325870|19148539|P1|COMPLETED|Overall Study||7
7777994|NCT01325870|19148537|P3|STARTED|Overall Study||14
7777995|NCT01325870|19148538|P2|STARTED|Overall Study||16
7777996|NCT01325870|19148539|P1|STARTED|Overall Study||18
7777997|NCT01325792|19148553|P1|NOT COMPLETED|Overall Study||17
7777998|NCT01325792|19148553|P1|COMPLETED|Overall Study||87
7777999|NCT01325792|19148553|P1|STARTED|Overall Study||104
7778000|NCT01325714|19148560|P2|NOT COMPLETED|Overall Study||31
7778001|NCT01325714|19148561|P1|NOT COMPLETED|Overall Study||34
7778002|NCT01325714|19148560|P2|COMPLETED|Overall Study||71
7778003|NCT01325714|19148561|P1|COMPLETED|Overall Study||67
7778004|NCT01325714|19148560|P2|12 Month Assessment|Overall Study||71
7778005|NCT01325714|19148561|P1|12 Month Assessment|Overall Study||67
7778006|NCT01325714|19148560|P2|6 Month Asessment|Overall Study||82
7778007|NCT01325714|19148561|P1|6 Month Asessment|Overall Study||75
7778008|NCT01325714|19148560|P2|3 Month Assessment|Overall Study||86
7778009|NCT01325714|19148561|P1|3 Month Assessment|Overall Study||82
7778010|NCT01325714|19148560|P2|STARTED|Overall Study||102
7778011|NCT01325714|19148561|P1|STARTED|Overall Study||101
7778012|NCT01325701|19148585|P2|NOT COMPLETED|Overall Study||3
7778013|NCT01325701|19148586|P1|NOT COMPLETED|Overall Study||21
7778014|NCT01325701|19148585|P2|COMPLETED|Overall Study||5
7778015|NCT01325701|19148586|P1|COMPLETED|Overall Study||49
7778016|NCT01325701|19148585|P2|STARTED|Overall Study||8
7778017|NCT01325701|19148586|P1|STARTED|Overall Study||70
7778018|NCT01325623|19148596|P1|NOT COMPLETED|Overall Study||3
7778019|NCT01325623|19148596|P1|COMPLETED|Overall Study||28
7778020|NCT01325623|19148596|P1|STARTED|Overall Study||31
7778021|NCT01325584|19148638|P1|NOT COMPLETED|Overall Study||1
7778022|NCT01325584|19148638|P1|COMPLETED|Overall Study||11
7778023|NCT01325584|19148638|P1|STARTED|Overall Study||12
7778024|NCT01325532|19148648|P2|NOT COMPLETED|Overall Study||0
7778025|NCT01325532|19148649|P1|NOT COMPLETED|Overall Study||2
7778026|NCT01325532|19148648|P2|COMPLETED|Overall Study||13
7778027|NCT01325532|19148649|P1|COMPLETED|Overall Study||15
7778028|NCT01325532|19148648|P2|STARTED|Overall Study||13
7778029|NCT01325532|19148649|P1|STARTED|Overall Study||17
7778030|NCT01325493|19148661|P2|NOT COMPLETED|Overall Study||3
7778031|NCT01325493|19148662|P1|NOT COMPLETED|Overall Study||1
7778032|NCT01325493|19148661|P2|COMPLETED|Overall Study||21
7778033|NCT01325493|19148662|P1|COMPLETED|Overall Study||29
7778034|NCT01325493|19148661|P2|STARTED|Overall Study||24
7778035|NCT01325493|19148662|P1|STARTED|Overall Study||30
7778036|NCT01325428|19148674|P1|NOT COMPLETED|Part B||3
7778037|NCT01325428|19148674|P1|COMPLETED|Part B||7
7778038|NCT01325428|19148674|P1|STARTED|Part B||10
7778039|NCT01325428|19148674|P1|NOT COMPLETED|Part A||16
7778040|NCT01325428|19148674|P1|COMPLETED|Part A||10
7778041|NCT01325428|19148674|P1|STARTED|Part A||26
7778042|NCT01325350|19148694|P5|NOT COMPLETED|Overall Study||12
7778043|NCT01325350|19148695|P4|NOT COMPLETED|Overall Study||9
7778044|NCT01325350|19148696|P3|NOT COMPLETED|Overall Study||17
7778045|NCT01325350|19148697|P2|NOT COMPLETED|Overall Study||5
7778046|NCT01325350|19148698|P1|NOT COMPLETED|Overall Study||6
7778047|NCT01325350|19148694|P5|COMPLETED|Overall Study||50
7778048|NCT01325350|19148695|P4|COMPLETED|Overall Study||52
7778049|NCT01325350|19148696|P3|COMPLETED|Overall Study||44
7778050|NCT01325350|19148697|P2|COMPLETED|Overall Study||56
7778051|NCT01325350|19148698|P1|COMPLETED|Overall Study||55
7778052|NCT01325350|19148694|P5|STARTED|Overall Study||62
7778053|NCT01325350|19148695|P4|STARTED|Overall Study||61
7778054|NCT01325350|19148696|P3|STARTED|Overall Study||61
7778055|NCT01325350|19148697|P2|STARTED|Overall Study||61
7778056|NCT01325350|19148698|P1|STARTED|Overall Study||61
7778057|NCT01325337|19148740|P5|NOT COMPLETED|Overall Study||8
7778058|NCT01325337|19148741|P4|NOT COMPLETED|Overall Study||10
7778059|NCT01325337|19148742|P3|NOT COMPLETED|Overall Study||9
7778060|NCT01325337|19148743|P2|NOT COMPLETED|Overall Study||9
7778061|NCT01325337|19148744|P1|NOT COMPLETED|Overall Study||5
7778062|NCT01325337|19148740|P5|COMPLETED|Overall Study||53
7778063|NCT01325337|19148741|P4|COMPLETED|Overall Study||52
7778064|NCT01325337|19148742|P3|COMPLETED|Overall Study||53
7778065|NCT01325337|19148743|P2|COMPLETED|Overall Study||52
7778066|NCT01325337|19148744|P1|COMPLETED|Overall Study||56
7778067|NCT01325337|19148740|P5|STARTED|Overall Study||61
7778068|NCT01325337|19148741|P4|STARTED|Overall Study||62
7778069|NCT01325337|19148742|P3|STARTED|Overall Study||62
7778070|NCT01325337|19148743|P2|STARTED|Overall Study||61
7778071|NCT01325337|19148744|P1|STARTED|Overall Study||61
7778072|NCT01325311|19148783|P2|NOT COMPLETED|Overall Study||0
7778073|NCT01325311|19148784|P1|NOT COMPLETED|Overall Study||0
7778074|NCT01325311|19148783|P2|COMPLETED|Overall Study||7
7778075|NCT01325311|19148784|P1|COMPLETED|Overall Study||8
7778076|NCT01325311|19148783|P2|STARTED|Overall Study||7
7778077|NCT01325311|19148784|P1|STARTED|Overall Study||8
7778078|NCT01325207|19148824|P6|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
7778079|NCT01325207|19148825|P5|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
7778080|NCT01325207|19148826|P4|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
7778081|NCT01325207|19148827|P3|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
7778082|NCT01325207|19148828|P2|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
7778083|NCT01325207|19148829|P1|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
7778084|NCT01325207|19148824|P6|COMPLETED|Follow-up Every 3 Months Until Death||18
7778085|NCT01325207|19148825|P5|COMPLETED|Follow-up Every 3 Months Until Death||6
7778086|NCT01325207|19148826|P4|COMPLETED|Follow-up Every 3 Months Until Death||1
7778087|NCT01325207|19148827|P3|COMPLETED|Follow-up Every 3 Months Until Death||1
7778088|NCT01325207|19148828|P2|COMPLETED|Follow-up Every 3 Months Until Death||3
7778089|NCT01325207|19148829|P1|COMPLETED|Follow-up Every 3 Months Until Death||3
7778090|NCT01325207|19148824|P6|STARTED|Follow-up Every 3 Months Until Death||19
7778091|NCT01325207|19148825|P5|STARTED|Follow-up Every 3 Months Until Death||7
7778092|NCT01325207|19148826|P4|STARTED|Follow-up Every 3 Months Until Death||1
7778093|NCT01325207|19148827|P3|STARTED|Follow-up Every 3 Months Until Death||1
7778094|NCT01325207|19148828|P2|STARTED|Follow-up Every 3 Months Until Death||3
7778095|NCT01325207|19148829|P1|STARTED|Follow-up Every 3 Months Until Death||3
7778096|NCT01325207|19148824|P6|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||5
7778097|NCT01325207|19148825|P5|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
7778098|NCT01325207|19148826|P4|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
7778099|NCT01325207|19148827|P3|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
7778100|NCT01325207|19148828|P2|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||2
7778101|NCT01325207|19148829|P1|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
7778102|NCT01325207|19148824|P6|COMPLETED|Started 9th Week/Cycle 3 of Treatment||9
7778103|NCT01325207|19148825|P5|COMPLETED|Started 9th Week/Cycle 3 of Treatment||3
7778104|NCT01325207|19148826|P4|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
7778105|NCT01325207|19148827|P3|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
7778106|NCT01325207|19148828|P2|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
7778107|NCT01325207|19148829|P1|COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
7778108|NCT01325207|19148824|P6|STARTED|Started 9th Week/Cycle 3 of Treatment||14
7778109|NCT01325207|19148825|P5|STARTED|Started 9th Week/Cycle 3 of Treatment||3
7778110|NCT01325207|19148826|P4|STARTED|Started 9th Week/Cycle 3 of Treatment||1
7778111|NCT01325207|19148827|P3|STARTED|Started 9th Week/Cycle 3 of Treatment||1
7778112|NCT01325207|19148828|P2|STARTED|Started 9th Week/Cycle 3 of Treatment||2
7778113|NCT01325207|19148829|P1|STARTED|Started 9th Week/Cycle 3 of Treatment||2
7778114|NCT01325207|19148824|P6|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||5
7778115|NCT01325207|19148825|P5|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
7778116|NCT01325207|19148826|P4|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
7778117|NCT01325207|19148827|P3|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
7778118|NCT01325207|19148828|P2|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
7778119|NCT01325207|19148829|P1|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
7778120|NCT01325207|19148824|P6|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||14
7778121|NCT01325207|19148825|P5|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||3
7778122|NCT01325207|19148826|P4|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
7778123|NCT01325207|19148827|P3|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
7778124|NCT01325207|19148828|P2|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
7778125|NCT01325207|19148829|P1|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
7778126|NCT01325207|19148824|P6|STARTED|Completed 8 Weeks/2 Cycles of Treatment||19
7778127|NCT01325207|19148825|P5|STARTED|Completed 8 Weeks/2 Cycles of Treatment||5
7778128|NCT01325207|19148826|P4|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
7778129|NCT01325207|19148827|P3|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
7778130|NCT01325207|19148828|P2|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
7778131|NCT01325207|19148829|P1|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
7778132|NCT01325207|19148824|P6|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
7778133|NCT01325207|19148825|P5|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||2
7778134|NCT01325207|19148826|P4|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
7778135|NCT01325207|19148827|P3|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
7778136|NCT01325207|19148828|P2|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
7778137|NCT01325207|19148829|P1|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
7778138|NCT01325207|19148824|P6|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||19
7778139|NCT01325207|19148825|P5|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||5
7778140|NCT01325207|19148826|P4|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
7778141|NCT01325207|19148827|P3|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
7778142|NCT01325207|19148828|P2|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
7778143|NCT01325207|19148829|P1|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
7778144|NCT01325207|19148824|P6|STARTED|Completed 4 Weeks/1 Cycle of Treatment||19
7778145|NCT01325207|19148825|P5|STARTED|Completed 4 Weeks/1 Cycle of Treatment||7
7778146|NCT01325207|19148826|P4|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
7778147|NCT01325207|19148827|P3|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
7778148|NCT01325207|19148828|P2|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
7778149|NCT01325207|19148829|P1|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
7778150|NCT01325181|19148854|P2|NOT COMPLETED|Overall Study||2
7778151|NCT01325181|19148855|P1|NOT COMPLETED|Overall Study||0
7778152|NCT01325181|19148854|P2|COMPLETED|Overall Study||14
7778153|NCT01325181|19148855|P1|COMPLETED|Overall Study||18
7778154|NCT01325181|19148854|P2|STARTED|Overall Study||16
7778155|NCT01325181|19148855|P1|STARTED|Overall Study||18
7778156|NCT01324999|19148861|P1|NOT COMPLETED|Overall Study||5
7778157|NCT01324999|19148861|P1|COMPLETED|Overall Study||7
7778158|NCT01324999|19148861|P1|STARTED|Overall Study||12
7778159|NCT01324947|19148872|P1|NOT COMPLETED|Overall Study||74
7778160|NCT01324947|19148872|P1|COMPLETED|Overall Study||0
7778161|NCT01324947|19148872|P1|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64
7778162|NCT01324947|19148872|P1|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73
7778163|NCT01324947|19148872|P1|STARTED|Overall Study||74
7778164|NCT01324882|19148885|P2|NOT COMPLETED|Overall Study||0
7778165|NCT01324882|19148886|P1|NOT COMPLETED|Overall Study||0
7778166|NCT01324882|19148885|P2|COMPLETED|Overall Study|30 patients had the colonoscopy|30
7778167|NCT01324882|19148886|P1|COMPLETED|Overall Study|27 patients had the colonoscopy|27
7778168|NCT01324882|19148885|P2|STARTED|Overall Study|30 patients were randomized to this arm|30
7778169|NCT01324882|19148886|P1|STARTED|Overall Study|27 patients were randomized to this arm.|27
7778170|NCT01324830|19148913|P19|NOT COMPLETED|Overall Study||6
7778171|NCT01324830|19148914|P18|NOT COMPLETED|Overall Study||6
7778172|NCT01324830|19148915|P17|NOT COMPLETED|Overall Study||3
7778173|NCT01324830|19148916|P16|NOT COMPLETED|Overall Study||3
7778174|NCT01324830|19148917|P15|NOT COMPLETED|Overall Study||1
7778175|NCT01324830|19148918|P14|NOT COMPLETED|Overall Study||1
7778176|NCT01324830|19148919|P13|NOT COMPLETED|Overall Study||1
7778177|NCT01324830|19148920|P12|NOT COMPLETED|Overall Study||1
7778178|NCT01324830|19148921|P11|NOT COMPLETED|Overall Study||4
7778179|NCT01324830|19148922|P10|NOT COMPLETED|Overall Study||6
7778180|NCT01324830|19148923|P9|NOT COMPLETED|Overall Study||5
7778181|NCT01324830|19148924|P8|NOT COMPLETED|Overall Study||3
7778182|NCT01324830|19148925|P7|NOT COMPLETED|Overall Study||3
7778183|NCT01324830|19148926|P6|NOT COMPLETED|Overall Study||7
7778184|NCT01324830|19148927|P5|NOT COMPLETED|Overall Study||7
7778185|NCT01324830|19148928|P4|NOT COMPLETED|Overall Study||3
7778186|NCT01324830|19148929|P3|NOT COMPLETED|Overall Study||3
7778187|NCT01324830|19148930|P2|NOT COMPLETED|Overall Study||3
7778188|NCT01324830|19148931|P1|NOT COMPLETED|Overall Study||3
7778189|NCT01324830|19148913|P19|COMPLETED|Overall Study||0
7778190|NCT01324830|19148914|P18|COMPLETED|Overall Study||0
7778191|NCT01324830|19148915|P17|COMPLETED|Overall Study||0
7778192|NCT01324830|19148916|P16|COMPLETED|Overall Study||0
7778193|NCT01324830|19148917|P15|COMPLETED|Overall Study||0
7778194|NCT01324830|19148918|P14|COMPLETED|Overall Study||0
7778195|NCT01324830|19148919|P13|COMPLETED|Overall Study||0
7778196|NCT01324830|19148920|P12|COMPLETED|Overall Study||0
7778197|NCT01324830|19148921|P11|COMPLETED|Overall Study||0
7778198|NCT01324830|19148922|P10|COMPLETED|Overall Study||0
7778199|NCT01324830|19148923|P9|COMPLETED|Overall Study||0
7778200|NCT01324830|19148924|P8|COMPLETED|Overall Study||0
7778201|NCT01324830|19148925|P7|COMPLETED|Overall Study||0
7778202|NCT01324830|19148926|P6|COMPLETED|Overall Study||0
7778203|NCT01324830|19148927|P5|COMPLETED|Overall Study||0
7778204|NCT01324830|19148928|P4|COMPLETED|Overall Study||0
7778205|NCT01324830|19148929|P3|COMPLETED|Overall Study||0
7778206|NCT01324830|19148930|P2|COMPLETED|Overall Study||0
7778207|NCT01324830|19148931|P1|COMPLETED|Overall Study||0
7778208|NCT01324830|19148913|P19|STARTED|Overall Study||6
7778209|NCT01324830|19148914|P18|STARTED|Overall Study||6
7778210|NCT01324830|19148915|P17|STARTED|Overall Study||3
7778211|NCT01324830|19148916|P16|STARTED|Overall Study||3
7778212|NCT01324830|19148917|P15|STARTED|Overall Study||1
7778213|NCT01324830|19148918|P14|STARTED|Overall Study||1
7778214|NCT01324830|19148919|P13|STARTED|Overall Study||1
7778215|NCT01324830|19148920|P12|STARTED|Overall Study||1
7778216|NCT01324830|19148921|P11|STARTED|Overall Study||4
7778217|NCT01324830|19148922|P10|STARTED|Overall Study||6
7778218|NCT01324830|19148923|P9|STARTED|Overall Study||5
7778219|NCT01324830|19148924|P8|STARTED|Overall Study||3
7778220|NCT01324830|19148925|P7|STARTED|Overall Study||3
7778221|NCT01324830|19148926|P6|STARTED|Overall Study||7
7778222|NCT01324830|19148927|P5|STARTED|Overall Study||7
7778223|NCT01324830|19148928|P4|STARTED|Overall Study||3
7778224|NCT01324830|19148929|P3|STARTED|Overall Study||3
7778225|NCT01324830|19148930|P2|STARTED|Overall Study||3
7778226|NCT01324830|19148931|P1|STARTED|Overall Study||3
7778227|NCT01324700|19149047|P4|NOT COMPLETED|Overall Study||11
7778228|NCT01324700|19149048|P3|NOT COMPLETED|Overall Study||16
7778229|NCT01324700|19149049|P2|NOT COMPLETED|Overall Study||4
7778230|NCT01324700|19149050|P1|NOT COMPLETED|Overall Study||9
7778231|NCT01324700|19149047|P4|COMPLETED|Overall Study||37
7778232|NCT01324700|19149048|P3|COMPLETED|Overall Study||33
7778233|NCT01324700|19149049|P2|COMPLETED|Overall Study||16
7778234|NCT01324700|19149050|P1|COMPLETED|Overall Study||13
7778235|NCT01324700|19149047|P4|STARTED|Overall Study||48
7778236|NCT01324700|19149048|P3|STARTED|Overall Study||49
7778237|NCT01324700|19149049|P2|STARTED|Overall Study||20
7778238|NCT01324700|19149050|P1|STARTED|Overall Study||22
7778239|NCT01324687|19149066|P2|NOT COMPLETED|Overall Study||15
7778240|NCT01324687|19149067|P1|NOT COMPLETED|Overall Study||0
7778241|NCT01324687|19149066|P2|COMPLETED|Overall Study||479
7778242|NCT01324687|19149067|P1|COMPLETED|Overall Study||1058
7778243|NCT01324687|19149066|P2|STARTED|Overall Study||494
7778244|NCT01324687|19149067|P1|STARTED|Overall Study||1058
7778245|NCT01324622|19149077|P2|NOT COMPLETED|Overall Study||7
7778246|NCT01324622|19149078|P1|NOT COMPLETED|Overall Study||9
7778247|NCT01324622|19149077|P2|COMPLETED|Overall Study||4
7778248|NCT01324622|19149078|P1|COMPLETED|Overall Study||4
7778249|NCT01324622|19149077|P2|STARTED|Overall Study||11
7778250|NCT01324622|19149078|P1|STARTED|Overall Study||13
7778251|NCT01324570|19149108|P2|NOT COMPLETED|Overall Study||14
7778252|NCT01324570|19149109|P1|NOT COMPLETED|Overall Study||4
7778253|NCT01324570|19149108|P2|COMPLETED|Overall Study||21
7778254|NCT01324570|19149109|P1|COMPLETED|Overall Study||2
7778255|NCT01324570|19149108|P2|STARTED|Overall Study||35
7778256|NCT01324570|19149109|P1|STARTED|Overall Study||6
7778257|NCT01324453|19149123|P2|NOT COMPLETED|Overall Study||0
7778258|NCT01324453|19149124|P1|NOT COMPLETED|Overall Study||0
7778259|NCT01324453|19149123|P2|COMPLETED|Overall Study||49
7778260|NCT01324453|19149124|P1|COMPLETED|Overall Study||54
7778261|NCT01324453|19149123|P2|STARTED|Overall Study||49
7778262|NCT01324453|19149124|P1|STARTED|Overall Study||54
7778263|NCT01324440|19149146|P2|NOT COMPLETED|Overall Study||1
7778264|NCT01324440|19149147|P1|NOT COMPLETED|Overall Study||0
7778265|NCT01324440|19149146|P2|COMPLETED|Overall Study||31
7778266|NCT01324440|19149147|P1|COMPLETED|Overall Study||32
7778267|NCT01324440|19149146|P2|STARTED|Overall Study||32
7778268|NCT01324440|19149147|P1|STARTED|Overall Study||32
7778269|NCT01324401|19149161|P2|NOT COMPLETED|Overall Study||6
7778270|NCT01324401|19149162|P1|NOT COMPLETED|Overall Study||1
7778271|NCT01324401|19149161|P2|COMPLETED|Overall Study|three (3) unable to complete due to adverse events|20
7778272|NCT01324401|19149162|P1|COMPLETED|Overall Study|one (1) could not tolerate minimum starting dose|3
7778273|NCT01324401|19149161|P2|STARTED|Overall Study|3 excluded from ITT analysis: 1 screen fail, 2 voluntary withdrawal pre-treatment|26
7778274|NCT01324401|19149162|P1|STARTED|Overall Study||4
7778275|NCT01324388|19149173|P4|NOT COMPLETED|Part 2 of Study: Second Intervention||0
7778276|NCT01324388|19149174|P3|NOT COMPLETED|Part 2 of Study: Second Intervention||1
7778277|NCT01324388|19149175|P2|NOT COMPLETED|Part 2 of Study: Second Intervention||0
7778278|NCT01324388|19149176|P1|NOT COMPLETED|Part 2 of Study: Second Intervention||0
7778279|NCT01324388|19149173|P4|COMPLETED|Part 2 of Study: Second Intervention||9
7778280|NCT01324388|19149174|P3|COMPLETED|Part 2 of Study: Second Intervention||9
7778281|NCT01324388|19149175|P2|COMPLETED|Part 2 of Study: Second Intervention||0
7778282|NCT01324388|19149176|P1|COMPLETED|Part 2 of Study: Second Intervention||0
7778283|NCT01324388|19149173|P4|STARTED|Part 2 of Study: Second Intervention||9
7778284|NCT01324388|19149174|P3|STARTED|Part 2 of Study: Second Intervention||10
7778285|NCT01324388|19149175|P2|STARTED|Part 2 of Study: Second Intervention||0
7778286|NCT01324388|19149176|P1|STARTED|Part 2 of Study: Second Intervention||0
7778287|NCT01324388|19149173|P4|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
7778288|NCT01324388|19149174|P3|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
7778289|NCT01324388|19149175|P2|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
7778290|NCT01324388|19149176|P1|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
7778291|NCT01324388|19149173|P4|COMPLETED|Part 2: Washout of at Least 21 Days||9
7778292|NCT01324388|19149174|P3|COMPLETED|Part 2: Washout of at Least 21 Days||10
7778293|NCT01324388|19149175|P2|COMPLETED|Part 2: Washout of at Least 21 Days||0
7778294|NCT01324388|19149176|P1|COMPLETED|Part 2: Washout of at Least 21 Days||0
7778295|NCT01324388|19149173|P4|STARTED|Part 2: Washout of at Least 21 Days||9
7778296|NCT01324388|19149174|P3|STARTED|Part 2: Washout of at Least 21 Days||10
7778297|NCT01324388|19149175|P2|STARTED|Part 2: Washout of at Least 21 Days||0
7778298|NCT01324388|19149176|P1|STARTED|Part 2: Washout of at Least 21 Days||0
7778299|NCT01324388|19149173|P4|NOT COMPLETED|Part 2 of Study: First Intervention||1
7778300|NCT01324388|19149174|P3|NOT COMPLETED|Part 2 of Study: First Intervention||0
7778301|NCT01324388|19149175|P2|NOT COMPLETED|Part 2 of Study: First Intervention||0
7778302|NCT01324388|19149176|P1|NOT COMPLETED|Part 2 of Study: First Intervention||0
7778303|NCT01324388|19149173|P4|COMPLETED|Part 2 of Study: First Intervention||9
7778304|NCT01324388|19149174|P3|COMPLETED|Part 2 of Study: First Intervention||10
7778305|NCT01324388|19149175|P2|COMPLETED|Part 2 of Study: First Intervention||0
7778306|NCT01324388|19149176|P1|COMPLETED|Part 2 of Study: First Intervention||0
7778307|NCT01324388|19149173|P4|STARTED|Part 2 of Study: First Intervention||10
7778308|NCT01324388|19149174|P3|STARTED|Part 2 of Study: First Intervention||10
7778309|NCT01324388|19149175|P2|STARTED|Part 2 of Study: First Intervention||0
7778310|NCT01324388|19149176|P1|STARTED|Part 2 of Study: First Intervention||0
7778311|NCT01324388|19149173|P4|NOT COMPLETED|Part 1 of Study||0
7778312|NCT01324388|19149174|P3|NOT COMPLETED|Part 1 of Study||0
7778313|NCT01324388|19149175|P2|NOT COMPLETED|Part 1 of Study||2
7778314|NCT01324388|19149176|P1|NOT COMPLETED|Part 1 of Study||4
7778315|NCT01324388|19149173|P4|COMPLETED|Part 1 of Study||0
7778316|NCT01324388|19149174|P3|COMPLETED|Part 1 of Study||0
7778317|NCT01324388|19149175|P2|COMPLETED|Part 1 of Study||6
7778318|NCT01324388|19149176|P1|COMPLETED|Part 1 of Study||19
7778319|NCT01324388|19149173|P4|Received at Least 1 Dose|Part 1 of Study||0
7778320|NCT01324388|19149174|P3|Received at Least 1 Dose|Part 1 of Study||0
7778321|NCT01324388|19149175|P2|Received at Least 1 Dose|Part 1 of Study||8
7778322|NCT01324388|19149176|P1|Received at Least 1 Dose|Part 1 of Study||23
7778323|NCT01324388|19149173|P4|STARTED|Part 1 of Study||0
7778324|NCT01324388|19149174|P3|STARTED|Part 1 of Study||0
7778325|NCT01324388|19149175|P2|STARTED|Part 1 of Study||8
7778326|NCT01324388|19149176|P1|STARTED|Part 1 of Study||23
7778327|NCT01324349|19149197|P2|NOT COMPLETED|Overall Study||2
7778328|NCT01324349|19149198|P1|NOT COMPLETED|Overall Study||1
7778329|NCT01324349|19149197|P2|COMPLETED|Overall Study||16
7778330|NCT01324349|19149198|P1|COMPLETED|Overall Study||31
7778331|NCT01324349|19149197|P2|STARTED|Overall Study||18
7778332|NCT01324349|19149198|P1|STARTED|Overall Study||32
7778333|NCT01324323|19149208|P1|NOT COMPLETED|Overall Study||1
7778334|NCT01324323|19149208|P1|COMPLETED|Overall Study||13
7778335|NCT01324323|19149208|P1|STARTED|Overall Study||14
7778336|NCT01324310|19149228|P1|NOT COMPLETED|Overall Study||2
7778337|NCT01324310|19149228|P1|COMPLETED|Overall Study||13
7778338|NCT01324310|19149228|P1|STARTED|Overall Study||15
7778339|NCT01324271|19149248|P2|NOT COMPLETED|Overall Study||0
7778340|NCT01324271|19149249|P1|NOT COMPLETED|Overall Study||4
7778341|NCT01324271|19149248|P2|COMPLETED|Overall Study||28
7778342|NCT01324271|19149249|P1|COMPLETED|Overall Study||53
7778343|NCT01324271|19149248|P2|STARTED|Overall Study||28
7778344|NCT01324271|19149249|P1|STARTED|Overall Study||57
7778345|NCT01324128|19149257|P4|NOT COMPLETED|Stage 2||3
7778346|NCT01324128|19149258|P3|NOT COMPLETED|Stage 2||8
7778347|NCT01324128|19149259|P2|NOT COMPLETED|Stage 2||0
7778348|NCT01324128|19149260|P1|NOT COMPLETED|Stage 2||0
7778349|NCT01324128|19149257|P4|COMPLETED|Stage 2||46
7778350|NCT01324128|19149258|P3|COMPLETED|Stage 2||42
7778351|NCT01324128|19149259|P2|COMPLETED|Stage 2||0
7778352|NCT01324128|19149260|P1|COMPLETED|Stage 2||0
7778353|NCT01324128|19149257|P4|STARTED|Stage 2||49
7778354|NCT01324128|19149258|P3|STARTED|Stage 2||50
7778355|NCT01324128|19149259|P2|STARTED|Stage 2||0
7778356|NCT01324128|19149260|P1|STARTED|Stage 2||0
7778357|NCT01324128|19149257|P4|NOT COMPLETED|Stage 1||0
7778358|NCT01324128|19149258|P3|NOT COMPLETED|Stage 1||0
7778359|NCT01324128|19149259|P2|NOT COMPLETED|Stage 1||56
7778360|NCT01324128|19149260|P1|NOT COMPLETED|Stage 1||195
7778361|NCT01324128|19149257|P4|COMPLETED|Stage 1||0
7778362|NCT01324128|19149258|P3|COMPLETED|Stage 1||0
7778363|NCT01324128|19149259|P2|COMPLETED|Stage 1||293
7778364|NCT01324128|19149260|P1|COMPLETED|Stage 1||515
7778365|NCT01324128|19149257|P4|STARTED|Stage 1||0
7778366|NCT01324128|19149258|P3|STARTED|Stage 1||0
7778367|NCT01324128|19149259|P2|STARTED|Stage 1||349
7778368|NCT01324128|19149260|P1|STARTED|Stage 1||710
7778369|NCT01324102|19149272|P2|NOT COMPLETED|Overall Study||6
7778370|NCT01324102|19149273|P1|NOT COMPLETED|Overall Study||1
7778371|NCT01324102|19149272|P2|COMPLETED|Overall Study||6
7778372|NCT01324102|19149273|P1|COMPLETED|Overall Study||10
7778373|NCT01324102|19149272|P2|STARTED|Overall Study|Yoga group 4 and 6|12
7778374|NCT01324102|19149273|P1|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11
7778375|NCT01324024|19149280|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
7778376|NCT01324024|19149281|P1|NOT COMPLETED|Second Intervention (4 Weeks)||2
7778377|NCT01324024|19149280|P2|COMPLETED|Second Intervention (4 Weeks)||16
7778378|NCT01324024|19149281|P1|COMPLETED|Second Intervention (4 Weeks)||16
7778379|NCT01324024|19149280|P2|STARTED|Second Intervention (4 Weeks)||17
7778380|NCT01324024|19149281|P1|STARTED|Second Intervention (4 Weeks)||18
7778381|NCT01324024|19149280|P2|NOT COMPLETED|Washout (2 Weeks)||0
7778382|NCT01324024|19149281|P1|NOT COMPLETED|Washout (2 Weeks)||0
7778383|NCT01324024|19149280|P2|COMPLETED|Washout (2 Weeks)||17
7778384|NCT01324024|19149281|P1|COMPLETED|Washout (2 Weeks)||18
7778385|NCT01324024|19149280|P2|STARTED|Washout (2 Weeks)||17
7778386|NCT01324024|19149281|P1|STARTED|Washout (2 Weeks)||18
7778387|NCT01324024|19149280|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
7778388|NCT01324024|19149281|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
7778389|NCT01324024|19149280|P2|COMPLETED|First Intervention (4 Weeks)||17
7778390|NCT01324024|19149281|P1|COMPLETED|First Intervention (4 Weeks)||18
7778391|NCT01324024|19149280|P2|STARTED|First Intervention (4 Weeks)||17
7778392|NCT01324024|19149281|P1|STARTED|First Intervention (4 Weeks)||18
7778393|NCT01323998|19149299|P5|NOT COMPLETED|Overall Study||0
7778394|NCT01323998|19149300|P4|NOT COMPLETED|Overall Study||0
7778395|NCT01323998|19149301|P3|NOT COMPLETED|Overall Study||0
7778396|NCT01323998|19149302|P2|NOT COMPLETED|Overall Study||0
7778397|NCT01323998|19149303|P1|NOT COMPLETED|Overall Study||0
7778398|NCT01323998|19149299|P5|COMPLETED|Overall Study||6735
7778399|NCT01323998|19149300|P4|COMPLETED|Overall Study||12052
7778400|NCT01323998|19149301|P3|COMPLETED|Overall Study||10294
7778401|NCT01323998|19149302|P2|COMPLETED|Overall Study||18681
7778402|NCT01323998|19149303|P1|COMPLETED|Overall Study||200631
7778403|NCT01323998|19149299|P5|STARTED|Overall Study||6735
7778404|NCT01323998|19149300|P4|STARTED|Overall Study||12052
7778405|NCT01323998|19149301|P3|STARTED|Overall Study||10294
7778406|NCT01323998|19149302|P2|STARTED|Overall Study||18681
7778407|NCT01323998|19149303|P1|STARTED|Overall Study||200631
7778408|NCT01323972|19149319|P4|NOT COMPLETED|Overall Study||1
7778409|NCT01323972|19149320|P3|NOT COMPLETED|Overall Study||2
7778410|NCT01323972|19149321|P2|NOT COMPLETED|Overall Study||3
7778411|NCT01323972|19149322|P1|NOT COMPLETED|Overall Study||2
7778412|NCT01323972|19149319|P4|COMPLETED|Overall Study||79
7778413|NCT01323972|19149320|P3|COMPLETED|Overall Study||78
7778414|NCT01323972|19149321|P2|COMPLETED|Overall Study||76
7778415|NCT01323972|19149322|P1|COMPLETED|Overall Study||79
7778416|NCT01323972|19149319|P4|STARTED|Overall Study||80
7778417|NCT01323972|19149320|P3|STARTED|Overall Study||80
7778418|NCT01323972|19149321|P2|STARTED|Overall Study||79
7778419|NCT01323972|19149322|P1|STARTED|Overall Study||81
7778420|NCT01323959|19149357|P3|NOT COMPLETED|Overall Study||0
7778421|NCT01323959|19149358|P2|NOT COMPLETED|Overall Study||0
7778422|NCT01323959|19149359|P1|NOT COMPLETED|Overall Study||0
7778423|NCT01323959|19149357|P3|COMPLETED|Overall Study||72
7778424|NCT01323959|19149358|P2|COMPLETED|Overall Study||72
7778425|NCT01323959|19149359|P1|COMPLETED|Overall Study||67
7778426|NCT01323959|19149357|P3|STARTED|Overall Study||72
7778427|NCT01323959|19149358|P2|STARTED|Overall Study||72
7778428|NCT01323959|19149359|P1|STARTED|Overall Study||67
7778429|NCT01323946|19149418|P3|NOT COMPLETED|Overall Study||0
7778430|NCT01323946|19149419|P2|NOT COMPLETED|Overall Study||3
7778431|NCT01323946|19149420|P1|NOT COMPLETED|Overall Study||3
7778432|NCT01323946|19149418|P3|COMPLETED|Overall Study||33
7778433|NCT01323946|19149419|P2|COMPLETED|Overall Study||31
7778434|NCT01323946|19149420|P1|COMPLETED|Overall Study||43
7778435|NCT01323946|19149418|P3|STARTED|Overall Study||33
7778436|NCT01323946|19149419|P2|STARTED|Overall Study||34
7778437|NCT01323946|19149420|P1|STARTED|Overall Study||46
7778438|NCT01323920|19149541|P1|NOT COMPLETED|Overall Study||6
7778439|NCT01323920|19149541|P1|COMPLETED|Overall Study||29
7778440|NCT01323920|19149541|P1|STARTED|Overall Study||35
7778441|NCT01323855|19149553|P5|NOT COMPLETED|Overall Study||0
7778442|NCT01323855|19149554|P4|NOT COMPLETED|Overall Study||0
7778443|NCT01323855|19149555|P3|NOT COMPLETED|Overall Study||0
7778444|NCT01323855|19149556|P2|NOT COMPLETED|Overall Study||0
7778445|NCT01323855|19149557|P1|NOT COMPLETED|Overall Study||0
7778446|NCT01323855|19149553|P5|COMPLETED|Overall Study||11
7778447|NCT01323855|19149554|P4|COMPLETED|Overall Study||9
7778448|NCT01323855|19149555|P3|COMPLETED|Overall Study||8
7778449|NCT01323855|19149556|P2|COMPLETED|Overall Study||9
7778450|NCT01323855|19149557|P1|COMPLETED|Overall Study||9
7778451|NCT01323855|19149553|P5|STARTED|Overall Study||11
7778452|NCT01323855|19149554|P4|STARTED|Overall Study||9
7778453|NCT01323855|19149555|P3|STARTED|Overall Study||8
7778454|NCT01323855|19149556|P2|STARTED|Overall Study||9
7778455|NCT01323855|19149557|P1|STARTED|Overall Study||9
7778456|NCT01323790|19149582|P3|NOT COMPLETED|Overall Study||45
7778457|NCT01323790|19149583|P2|NOT COMPLETED|Overall Study||60
7778458|NCT01323790|19149584|P1|NOT COMPLETED|Overall Study||55
7778459|NCT01323790|19149582|P3|COMPLETED|Overall Study||188
7778460|NCT01323790|19149583|P2|COMPLETED|Overall Study||174
7778461|NCT01323790|19149584|P1|COMPLETED|Overall Study||178
7778462|NCT01323790|19149582|P3|STARTED|Overall Study||233
7778463|NCT01323790|19149583|P2|STARTED|Overall Study||234
7778464|NCT01323790|19149584|P1|STARTED|Overall Study||233
7778465|NCT01323777|19149622|P1|NOT COMPLETED|Overall Study||0
7778466|NCT01323777|19149622|P1|COMPLETED|Overall Study||65
7778467|NCT01323777|19149622|P1|STARTED|Overall Study||65
7778468|NCT01323673|19149635|P2|NOT COMPLETED|Overall Study||5
7778469|NCT01323673|19149636|P1|NOT COMPLETED|Overall Study||3
7778470|NCT01323673|19149635|P2|COMPLETED|Overall Study||58
7778471|NCT01323673|19149636|P1|COMPLETED|Overall Study||59
7778472|NCT01323673|19149635|P2|STARTED|Overall Study||63
7778473|NCT01323673|19149636|P1|STARTED|Overall Study||62
7778474|NCT01323660|19149656|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
7778475|NCT01323660|19149657|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4
7778476|NCT01323660|19149658|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
7778477|NCT01323660|19149659|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
7778478|NCT01323660|19149660|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
7778479|NCT01323660|19149661|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12
7778480|NCT01323660|19149656|P6|COMPLETED|Treatment Period 2 (12 Weeks)||51
7778481|NCT01323660|19149657|P5|COMPLETED|Treatment Period 2 (12 Weeks)||55
7778482|NCT01323660|19149658|P4|COMPLETED|Treatment Period 2 (12 Weeks)||25
7778483|NCT01323660|19149659|P3|COMPLETED|Treatment Period 2 (12 Weeks)||14
7778484|NCT01323660|19149660|P2|COMPLETED|Treatment Period 2 (12 Weeks)||17
7778485|NCT01323660|19149661|P1|COMPLETED|Treatment Period 2 (12 Weeks)||55
7778486|NCT01323660|19149656|P6|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|58
7778487|NCT01323660|19149657|P5|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|59
7778488|NCT01323660|19149658|P4|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|28
7778489|NCT01323660|19149659|P3|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|17
7778490|NCT01323660|19149660|P2|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|18
7778491|NCT01323660|19149661|P1|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|67
7778492|NCT01323660|19149656|P6|NOT COMPLETED|Washout Period (14 Days)||2
7778493|NCT01323660|19149657|P5|NOT COMPLETED|Washout Period (14 Days)||3
7778494|NCT01323660|19149658|P4|NOT COMPLETED|Washout Period (14 Days)||3
7778495|NCT01323660|19149659|P3|NOT COMPLETED|Washout Period (14 Days)||1
7778496|NCT01323660|19149660|P2|NOT COMPLETED|Washout Period (14 Days)||0
7778497|NCT01323660|19149661|P1|NOT COMPLETED|Washout Period (14 Days)||0
7778498|NCT01323660|19149656|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59
7778499|NCT01323660|19149657|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58
7778500|NCT01323660|19149658|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28
7778501|NCT01323660|19149659|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
7778502|NCT01323660|19149660|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
7778503|NCT01323660|19149661|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65
7778504|NCT01323660|19149656|P6|STARTED|Washout Period (14 Days)||61
7778505|NCT01323660|19149657|P5|STARTED|Washout Period (14 Days)||61
7778506|NCT01323660|19149658|P4|STARTED|Washout Period (14 Days)||31
7778507|NCT01323660|19149659|P3|STARTED|Washout Period (14 Days)||19
7778508|NCT01323660|19149660|P2|STARTED|Washout Period (14 Days)||21
7778509|NCT01323660|19149661|P1|STARTED|Washout Period (14 Days)||65
7778510|NCT01323660|19149656|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9
7778511|NCT01323660|19149657|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10
7778512|NCT01323660|19149658|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
7778513|NCT01323660|19149659|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
7778514|NCT01323660|19149660|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1
7778515|NCT01323660|19149661|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19
7778516|NCT01323660|19149656|P6|COMPLETED|Treatment Period 1 (12 Weeks)||61
7778517|NCT01323660|19149657|P5|COMPLETED|Treatment Period 1 (12 Weeks)||61
7778518|NCT01323660|19149658|P4|COMPLETED|Treatment Period 1 (12 Weeks)||31
7778519|NCT01323660|19149659|P3|COMPLETED|Treatment Period 1 (12 Weeks)||19
7778520|NCT01323660|19149660|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
7778521|NCT01323660|19149661|P1|COMPLETED|Treatment Period 1 (12 Weeks)||65
7778522|NCT01323660|19149656|P6|STARTED|Treatment Period 1 (12 Weeks)||70
7778523|NCT01323660|19149657|P5|STARTED|Treatment Period 1 (12 Weeks)||71
7778524|NCT01323660|19149658|P4|STARTED|Treatment Period 1 (12 Weeks)||36
7778525|NCT01323660|19149659|P3|STARTED|Treatment Period 1 (12 Weeks)||24
7778526|NCT01323660|19149660|P2|STARTED|Treatment Period 1 (12 Weeks)||22
7778527|NCT01323660|19149661|P1|STARTED|Treatment Period 1 (12 Weeks)||84
7778528|NCT01323647|19149707|P2|NOT COMPLETED|Overall Study||0
7778529|NCT01323647|19149708|P1|NOT COMPLETED|Overall Study||9
7778530|NCT01323647|19149707|P2|COMPLETED|Overall Study||487
7778531|NCT01323647|19149708|P1|COMPLETED|Overall Study||461
7778532|NCT01323647|19149707|P2|STARTED|Overall Study||487
7778533|NCT01323647|19149708|P1|STARTED|Overall Study||470
7778534|NCT01323634|19149725|P3|NOT COMPLETED|Double-Blind (DB) Treatment Period||22
7778535|NCT01323634|19149726|P2|NOT COMPLETED|Double-Blind (DB) Treatment Period||25
7778536|NCT01323634|19149727|P1|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
7778537|NCT01323634|19149725|P3|COMPLETED|Double-Blind (DB) Treatment Period||239
7778538|NCT01323634|19149726|P2|COMPLETED|Double-Blind (DB) Treatment Period||235
7778539|NCT01323634|19149727|P1|COMPLETED|Double-Blind (DB) Treatment Period||0
7778540|NCT01323634|19149725|P3|STARTED|Double-Blind (DB) Treatment Period||261
7778541|NCT01323634|19149726|P2|STARTED|Double-Blind (DB) Treatment Period||260
7778542|NCT01323634|19149727|P1|STARTED|Double-Blind (DB) Treatment Period||0
7778543|NCT01323634|19149725|P3|NOT COMPLETED|2-week Run-in Period||0
7778544|NCT01323634|19149726|P2|NOT COMPLETED|2-week Run-in Period||0
7778545|NCT01323634|19149727|P1|NOT COMPLETED|2-week Run-in Period||212
7778546|NCT01323634|19149725|P3|COMPLETED|2-week Run-in Period||0
7778547|NCT01323634|19149726|P2|COMPLETED|2-week Run-in Period||0
7778548|NCT01323634|19149727|P1|COMPLETED|2-week Run-in Period||521
7778549|NCT01323634|19149725|P3|STARTED|2-week Run-in Period||0
7778550|NCT01323634|19149726|P2|STARTED|2-week Run-in Period||0
7778551|NCT01323634|19149727|P1|STARTED|2-week Run-in Period||733
7778552|NCT01323621|19149737|P3|NOT COMPLETED|12-week, Double-blind Treatment Period||20
7778553|NCT01323621|19149738|P2|NOT COMPLETED|12-week, Double-blind Treatment Period||15
7778554|NCT01323621|19149739|P1|NOT COMPLETED|12-week, Double-blind Treatment Period||0
7778555|NCT01323621|19149737|P3|COMPLETED|12-week, Double-blind Treatment Period||239
7778556|NCT01323621|19149738|P2|COMPLETED|12-week, Double-blind Treatment Period||237
7778557|NCT01323621|19149739|P1|COMPLETED|12-week, Double-blind Treatment Period||0
7778558|NCT01323621|19149737|P3|STARTED|12-week, Double-blind Treatment Period||259
7778559|NCT01323621|19149738|P2|STARTED|12-week, Double-blind Treatment Period||252
7778560|NCT01323621|19149739|P1|STARTED|12-week, Double-blind Treatment Period||0
7778561|NCT01323621|19149737|P3|NOT COMPLETED|2-week, Single-blind Run In Period||0
7778562|NCT01323621|19149738|P2|NOT COMPLETED|2-week, Single-blind Run In Period||0
7778563|NCT01323621|19149739|P1|NOT COMPLETED|2-week, Single-blind Run In Period||228
7778564|NCT01323621|19149737|P3|COMPLETED|2-week, Single-blind Run In Period||0
7778565|NCT01323621|19149738|P2|COMPLETED|2-week, Single-blind Run In Period||0
7778566|NCT01323621|19149739|P1|COMPLETED|2-week, Single-blind Run In Period||511
7778567|NCT01323621|19149737|P3|STARTED|2-week, Single-blind Run In Period||0
7778568|NCT01323621|19149738|P2|STARTED|2-week, Single-blind Run In Period||0
7778569|NCT01323621|19149739|P1|STARTED|2-week, Single-blind Run In Period||739
7778570|NCT01323595|19149749|P2|NOT COMPLETED|Overall Study||21
7778571|NCT01323595|19149750|P1|NOT COMPLETED|Overall Study||23
7778572|NCT01323595|19149749|P2|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18
7778573|NCT01323595|19149750|P1|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16
7778574|NCT01323595|19149749|P2|STARTED|Overall Study||39
7778575|NCT01323595|19149750|P1|STARTED|Overall Study||39
7778576|NCT01323582|19149760|P2|NOT COMPLETED|Weeks 8-11 (Period 2)||1
7778577|NCT01323582|19149761|P1|NOT COMPLETED|Weeks 8-11 (Period 2)||0
7778578|NCT01323582|19149760|P2|COMPLETED|Weeks 8-11 (Period 2)||10
7778579|NCT01323582|19149761|P1|COMPLETED|Weeks 8-11 (Period 2)||10
7778580|NCT01323582|19149760|P2|STARTED|Weeks 8-11 (Period 2)||11
7778581|NCT01323582|19149761|P1|STARTED|Weeks 8-11 (Period 2)||10
7778582|NCT01323582|19149760|P2|NOT COMPLETED|Weeks 5-7 (Washout)||1
7778583|NCT01323582|19149761|P1|NOT COMPLETED|Weeks 5-7 (Washout)||0
7778584|NCT01323582|19149760|P2|COMPLETED|Weeks 5-7 (Washout)||11
7778585|NCT01323582|19149761|P1|COMPLETED|Weeks 5-7 (Washout)||10
7778586|NCT01323582|19149760|P2|STARTED|Weeks 5-7 (Washout)||12
7778587|NCT01323582|19149761|P1|STARTED|Weeks 5-7 (Washout)||10
7778588|NCT01323582|19149760|P2|NOT COMPLETED|Weeks 1-4 (First Period)||2
7778589|NCT01323582|19149761|P1|NOT COMPLETED|Weeks 1-4 (First Period)||2
7778590|NCT01323582|19149760|P2|COMPLETED|Weeks 1-4 (First Period)||12
7778591|NCT01323582|19149761|P1|COMPLETED|Weeks 1-4 (First Period)||10
7778592|NCT01323582|19149760|P2|STARTED|Weeks 1-4 (First Period)||14
7778593|NCT01323582|19149761|P1|STARTED|Weeks 1-4 (First Period)||12
7778594|NCT01323517|19149777|P1|NOT COMPLETED|Overall Study||0
7778595|NCT01323517|19149777|P1|COMPLETED|Overall Study||26
7778596|NCT01323517|19149777|P1|STARTED|Overall Study||26
7778597|NCT01323478|19149784|P1|NOT COMPLETED|Overall Study||24
7778598|NCT01323478|19149784|P1|COMPLETED|Overall Study||47
7778599|NCT01323478|19149784|P1|STARTED|Overall Study||71
7778600|NCT01323387|19149797|P1|NOT COMPLETED|Overall Study||84
7778601|NCT01323387|19149797|P1|COMPLETED|Overall Study||94
7778602|NCT01323387|19149797|P1|STARTED|Overall Study||178
7778603|NCT01323270|19149810|P2|NOT COMPLETED|Overall Study||29
7778604|NCT01323270|19149811|P1|NOT COMPLETED|Overall Study||43
7778605|NCT01323270|19149810|P2|COMPLETED|Overall Study||347
7778606|NCT01323270|19149811|P1|COMPLETED|Overall Study||330
7778607|NCT01323270|19149810|P2|STARTED|Overall Study||376
7778608|NCT01323270|19149811|P1|STARTED|Overall Study||373
7778609|NCT01323192|19149833|P2|NOT COMPLETED|Overall Study||6
7778610|NCT01323192|19149834|P1|NOT COMPLETED|Overall Study||9
7778611|NCT01323192|19149833|P2|COMPLETED|Overall Study||135
7778612|NCT01323192|19149834|P1|COMPLETED|Overall Study||134
7778613|NCT01323192|19149833|P2|STARTED|Overall Study||141
7778614|NCT01323192|19149834|P1|STARTED|Overall Study||143
7778615|NCT01323153|19149852|P2|NOT COMPLETED|Overall Study||8
7778616|NCT01323153|19149853|P1|NOT COMPLETED|Overall Study||17
7778617|NCT01323153|19149852|P2|COMPLETED|Overall Study||142
7778618|NCT01323153|19149853|P1|COMPLETED|Overall Study||133
7778619|NCT01323153|19149852|P2|STARTED|Overall Study||150
7778620|NCT01323153|19149853|P1|STARTED|Overall Study||150
7778621|NCT01323140|19149859|P1|NOT COMPLETED|Overall Study||2
7778622|NCT01323140|19149859|P1|COMPLETED|Overall Study||38
7778623|NCT01323140|19149859|P1|STARTED|Overall Study||40
7778624|NCT01323010|19149865|P2|NOT COMPLETED|Overall Study||0
7778625|NCT01323010|19149866|P1|NOT COMPLETED|Overall Study||0
7778626|NCT01323010|19149865|P2|COMPLETED|Overall Study||59
7778627|NCT01323010|19149866|P1|COMPLETED|Overall Study||60
7778628|NCT01323010|19149865|P2|STARTED|Overall Study||59
7778629|NCT01323010|19149866|P1|STARTED|Overall Study||60
7778630|NCT01322971|19149917|P2|NOT COMPLETED|Overall Study||1
7778631|NCT01322971|19149918|P1|NOT COMPLETED|Overall Study||1
7778632|NCT01322971|19149917|P2|COMPLETED|Overall Study||0
7778633|NCT01322971|19149918|P1|COMPLETED|Overall Study||0
7778634|NCT01322971|19149917|P2|STARTED|Overall Study||1
7778635|NCT01322971|19149918|P1|STARTED|Overall Study||1
7778636|NCT01322945|19149932|P2|NOT COMPLETED|Overall Study||0
7778637|NCT01322945|19149933|P1|NOT COMPLETED|Overall Study||0
7778638|NCT01322945|19149932|P2|COMPLETED|Overall Study||42
7778639|NCT01322945|19149933|P1|COMPLETED|Overall Study||52
7778640|NCT01322945|19149932|P2|STARTED|Overall Study||42
7778641|NCT01322945|19149933|P1|STARTED|Overall Study||52
7778642|NCT01322841|19149943|P2|NOT COMPLETED|Overall Study||0
7778643|NCT01322841|19149944|P1|NOT COMPLETED|Overall Study||0
7778644|NCT01322841|19149943|P2|COMPLETED|Overall Study||1123
7778645|NCT01322841|19149944|P1|COMPLETED|Overall Study||1116
7778646|NCT01322841|19149943|P2|STARTED|Overall Study||1123
7778647|NCT01322841|19149944|P1|STARTED|Overall Study||1116
7778648|NCT01322815|19149954|P2|NOT COMPLETED|Overall Study||0
7778649|NCT01322815|19149955|P1|NOT COMPLETED|Overall Study||0
7778650|NCT01322815|19149954|P2|COMPLETED|Overall Study||4
7778651|NCT01322815|19149955|P1|COMPLETED|Overall Study||7
7778652|NCT01322815|19149954|P2|STARTED|Overall Study||4
7778653|NCT01322815|19149955|P1|STARTED|Overall Study||7
7778654|NCT01322633|19149963|P2|NOT COMPLETED|Overall Study||0
7778655|NCT01322633|19149964|P1|NOT COMPLETED|Overall Study||0
7778656|NCT01322633|19149963|P2|COMPLETED|Overall Study||27686
7778657|NCT01322633|19149964|P1|COMPLETED|Overall Study||34178
7778658|NCT01322633|19149963|P2|STARTED|Overall Study||27686
7778659|NCT01322633|19149964|P1|STARTED|Overall Study||34178
7778660|NCT01322607|19149976|P2|NOT COMPLETED|Overall Study||0
7778661|NCT01322607|19149977|P1|NOT COMPLETED|Overall Study||1
7778662|NCT01322607|19149976|P2|COMPLETED|Overall Study||9
7778663|NCT01322607|19149977|P1|COMPLETED|Overall Study||10
7778664|NCT01322607|19149976|P2|STARTED|Overall Study||9
7778665|NCT01322607|19149977|P1|STARTED|Overall Study||11
7778666|NCT01322594|19149995|P6|NOT COMPLETED|Overall Study||0
7778667|NCT01322594|19149996|P5|NOT COMPLETED|Overall Study||0
7778668|NCT01322594|19149997|P4|NOT COMPLETED|Overall Study||0
7778669|NCT01322594|19149998|P3|NOT COMPLETED|Overall Study||0
7778670|NCT01322594|19149999|P2|NOT COMPLETED|Overall Study||0
7778671|NCT01322594|19150000|P1|NOT COMPLETED|Overall Study||0
7778672|NCT01322594|19149995|P6|COMPLETED|Overall Study||6
7778673|NCT01322594|19149996|P5|COMPLETED|Overall Study||7
7778674|NCT01322594|19149997|P4|COMPLETED|Overall Study||6
7778675|NCT01322594|19149998|P3|COMPLETED|Overall Study||3
7778676|NCT01322594|19149999|P2|COMPLETED|Overall Study||3
7778677|NCT01322594|19150000|P1|COMPLETED|Overall Study||6
7778678|NCT01322594|19149995|P6|STARTED|Overall Study||6
7778679|NCT01322594|19149996|P5|STARTED|Overall Study||7
7778680|NCT01322594|19149997|P4|STARTED|Overall Study||6
7778681|NCT01322594|19149998|P3|STARTED|Overall Study||3
7778682|NCT01322594|19149999|P2|STARTED|Overall Study||3
7778683|NCT01322594|19150000|P1|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6
7778684|NCT01322490|19150083|P3|NOT COMPLETED|Long Term Follow-up Period||413
7778685|NCT01322490|19150084|P2|NOT COMPLETED|Long Term Follow-up Period||408
7778686|NCT01322490|19150085|P1|NOT COMPLETED|Long Term Follow-up Period||409
7778687|NCT01322490|19150083|P3|COMPLETED|Long Term Follow-up Period||0
7778688|NCT01322490|19150084|P2|COMPLETED|Long Term Follow-up Period||0
7778689|NCT01322490|19150085|P1|COMPLETED|Long Term Follow-up Period||0
7778690|NCT01322490|19150083|P3|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|413
7778691|NCT01322490|19150084|P2|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|408
7778692|NCT01322490|19150085|P1|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|409
7778693|NCT01322490|19150083|P3|NOT COMPLETED|Treatment Period||153
7778694|NCT01322490|19150084|P2|NOT COMPLETED|Treatment Period||153
7778695|NCT01322490|19150085|P1|NOT COMPLETED|Treatment Period||132
7778696|NCT01322490|19150083|P3|COMPLETED|Treatment Period||280
7778697|NCT01322490|19150084|P2|COMPLETED|Treatment Period||279
7778698|NCT01322490|19150085|P1|COMPLETED|Treatment Period||300
7778699|NCT01322490|19150083|P3|Treated|Treatment Period||428
7778700|NCT01322490|19150084|P2|Treated|Treatment Period||429
7778701|NCT01322490|19150085|P1|Treated|Treatment Period||429
7778702|NCT01322490|19150083|P3|STARTED|Treatment Period||433
7778703|NCT01322490|19150084|P2|STARTED|Treatment Period||432
7778704|NCT01322490|19150085|P1|STARTED|Treatment Period||432
7778705|NCT01322386|19150098|P2|NOT COMPLETED|Overall Study||2
7778706|NCT01322386|19150099|P1|NOT COMPLETED|Overall Study||0
7778707|NCT01322386|19150098|P2|COMPLETED|Overall Study||9
7778708|NCT01322386|19150099|P1|COMPLETED|Overall Study||10
7778709|NCT01322386|19150098|P2|STARTED|Overall Study||11
7778710|NCT01322386|19150099|P1|STARTED|Overall Study||10
7778711|NCT01322360|19150107|P1|NOT COMPLETED|Overall Study||0
7778712|NCT01322360|19150107|P1|COMPLETED|Overall Study||50
7778713|NCT01322360|19150107|P1|STARTED|Overall Study||50
7778714|NCT01322347|19150114|P2|NOT COMPLETED|Overall Study||35
7778715|NCT01322347|19150115|P1|NOT COMPLETED|Overall Study||51
7778716|NCT01322347|19150114|P2|COMPLETED|Overall Study||112
7778717|NCT01322347|19150115|P1|COMPLETED|Overall Study||96
7778718|NCT01322347|19150114|P2|Completed St 3|Overall Study||86
7778719|NCT01322347|19150115|P1|Completed St 3|Overall Study||82
7778720|NCT01322347|19150114|P2|Enrolled in St 3|Overall Study||113
7778721|NCT01322347|19150115|P1|Enrolled in St 3|Overall Study||101
7778722|NCT01322347|19150114|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90
7778723|NCT01322347|19150115|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68
7778724|NCT01322347|19150114|P2|Completed 48 Wks in St 2|Overall Study||22
7778725|NCT01322347|19150115|P1|Completed 48 Wks in St 2|Overall Study||28
7778726|NCT01322347|19150114|P2|STARTED|Overall Study||147
7778727|NCT01322347|19150115|P1|STARTED|Overall Study||147
7778728|NCT01322048|19150152|P2|NOT COMPLETED|Overall Study||0
7778729|NCT01322048|19150153|P1|NOT COMPLETED|Overall Study||0
7778730|NCT01322048|19150152|P2|COMPLETED|Overall Study||26
7778731|NCT01322048|19150153|P1|COMPLETED|Overall Study||21
7778732|NCT01322048|19150152|P2|STARTED|Overall Study||26
7778733|NCT01322048|19150153|P1|STARTED|Overall Study||21
7778734|NCT01322022|19150163|P2|NOT COMPLETED|Overall Study||2
7778735|NCT01322022|19150164|P1|NOT COMPLETED|Overall Study||5
7778736|NCT01322022|19150163|P2|COMPLETED|Overall Study||18
7778737|NCT01322022|19150164|P1|COMPLETED|Overall Study||15
7778738|NCT01322022|19150163|P2|Week 4|Overall Study||18
7778739|NCT01322022|19150164|P1|Week 4|Overall Study||15
7778740|NCT01322022|19150163|P2|STARTED|Overall Study||20
7778741|NCT01322022|19150164|P1|STARTED|Overall Study||20
7778742|NCT01322009|19150178|P2|NOT COMPLETED|Overall Study||3
7778743|NCT01322009|19150179|P1|NOT COMPLETED|Overall Study||0
7778744|NCT01322009|19150178|P2|COMPLETED|Overall Study||4
7778745|NCT01322009|19150179|P1|COMPLETED|Overall Study||7
7778746|NCT01322009|19150178|P2|STARTED|Overall Study||7
7778747|NCT01322009|19150179|P1|STARTED|Overall Study||7
7778748|NCT01321879|19150187|P1|NOT COMPLETED|Overall Study||14
7778749|NCT01321879|19150187|P1|COMPLETED|Overall Study||25
7778750|NCT01321879|19150187|P1|STARTED|Overall Study||39
7778751|NCT01321749|19150193|P2|NOT COMPLETED|Overall Study||22
7778752|NCT01321749|19150194|P1|NOT COMPLETED|Overall Study||13
7778753|NCT01321749|19150193|P2|COMPLETED|Overall Study||30
7778754|NCT01321749|19150194|P1|COMPLETED|Overall Study||38
7778755|NCT01321749|19150193|P2|STARTED|Overall Study||52
7778756|NCT01321749|19150194|P1|STARTED|Overall Study||51
7778757|NCT01321723|19150203|P3|NOT COMPLETED|Overall Study||4
7778758|NCT01321723|19150204|P2|NOT COMPLETED|Overall Study||5
7778759|NCT01321723|19150205|P1|NOT COMPLETED|Overall Study||5
7778760|NCT01321723|19150203|P3|COMPLETED|Overall Study||28
7778761|NCT01321723|19150204|P2|COMPLETED|Overall Study||28
7778762|NCT01321723|19150205|P1|COMPLETED|Overall Study||27
7778763|NCT01321723|19150203|P3|STARTED|Overall Study||32
7778764|NCT01321723|19150204|P2|STARTED|Overall Study||33
7778765|NCT01321723|19150205|P1|STARTED|Overall Study||32
7778766|NCT01321710|19150227|P3|NOT COMPLETED|Overall Study||0
7778767|NCT01321710|19150228|P2|NOT COMPLETED|Overall Study||5
7778768|NCT01321710|19150229|P1|NOT COMPLETED|Overall Study||4
7778769|NCT01321710|19150227|P3|COMPLETED|Overall Study||44
7778770|NCT01321710|19150228|P2|COMPLETED|Overall Study||53
7778771|NCT01321710|19150229|P1|COMPLETED|Overall Study||46
7778772|NCT01321710|19150227|P3|STARTED|Overall Study||44
7778773|NCT01321710|19150228|P2|STARTED|Overall Study||58
7778774|NCT01321710|19150229|P1|STARTED|Overall Study||50
7778775|NCT01321697|19150244|P1|NOT COMPLETED|Overall Study||7
7778776|NCT01321697|19150244|P1|COMPLETED|Overall Study||0
7778777|NCT01321697|19150244|P1|STARTED|Overall Study||7
7778778|NCT01321606|19150250|P4|NOT COMPLETED|Overall Study||1
7778779|NCT01321606|19150251|P3|NOT COMPLETED|Overall Study||0
7778780|NCT01321606|19150252|P2|NOT COMPLETED|Overall Study||0
7778781|NCT01321606|19150253|P1|NOT COMPLETED|Overall Study||0
7778782|NCT01321606|19150250|P4|COMPLETED|Overall Study||28
7778783|NCT01321606|19150251|P3|COMPLETED|Overall Study||34
7778784|NCT01321606|19150252|P2|COMPLETED|Overall Study||32
7778785|NCT01321606|19150253|P1|COMPLETED|Overall Study||18
7778786|NCT01321606|19150250|P4|STARTED|Overall Study||29
7778787|NCT01321606|19150251|P3|STARTED|Overall Study||34
7778788|NCT01321606|19150252|P2|STARTED|Overall Study||32
7778789|NCT01321606|19150253|P1|STARTED|Overall Study||18
7778790|NCT01321554|19150273|P4|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
7778791|NCT01321554|19150274|P3|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
7778792|NCT01321554|19150275|P2|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
7778793|NCT01321554|19150276|P1|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
7778794|NCT01321554|19150273|P4|COMPLETED|OOL Lenvatinib Treatment Period||30
7778795|NCT01321554|19150274|P3|COMPLETED|OOL Lenvatinib Treatment Period||85
7778796|NCT01321554|19150275|P2|COMPLETED|OOL Lenvatinib Treatment Period||0
7778797|NCT01321554|19150276|P1|COMPLETED|OOL Lenvatinib Treatment Period||0
7778798|NCT01321554|19150273|P4|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|30
7778799|NCT01321554|19150274|P3|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|85
7778800|NCT01321554|19150275|P2|STARTED|OOL Lenvatinib Treatment Period||0
7778801|NCT01321554|19150276|P1|STARTED|OOL Lenvatinib Treatment Period||0
7778802|NCT01321554|19150273|P4|NOT COMPLETED|Randomization Phase||0
7778803|NCT01321554|19150274|P3|NOT COMPLETED|Randomization Phase||0
7778804|NCT01321554|19150275|P2|NOT COMPLETED|Randomization Phase||0
7778805|NCT01321554|19150276|P1|NOT COMPLETED|Randomization Phase||0
7778806|NCT01321554|19150273|P4|COMPLETED|Randomization Phase||0
7778807|NCT01321554|19150274|P3|COMPLETED|Randomization Phase||0
7778808|NCT01321554|19150275|P2|COMPLETED|Randomization Phase||131
7778809|NCT01321554|19150276|P1|COMPLETED|Randomization Phase||261
7778810|NCT01321554|19150273|P4|STARTED|Randomization Phase||0
7778811|NCT01321554|19150274|P3|STARTED|Randomization Phase||0
7778812|NCT01321554|19150275|P2|STARTED|Randomization Phase||131
7778813|NCT01321554|19150276|P1|STARTED|Randomization Phase||261
7778814|NCT01321073|19150289|P1|NOT COMPLETED|Overall Study||7
7778815|NCT01321073|19150289|P1|COMPLETED|Overall Study||57
7778816|NCT01321073|19150289|P1|STARTED|Overall Study||64
7778817|NCT01321008|19150293|P1|NOT COMPLETED|Overall Study||1
7778818|NCT01321008|19150293|P1|COMPLETED|Overall Study||0
7778819|NCT01321008|19150293|P1|STARTED|Overall Study||1
7778820|NCT01320943|19150299|P2|NOT COMPLETED|Overall Study||2
7778821|NCT01320943|19150300|P1|NOT COMPLETED|Overall Study||1
7778822|NCT01320943|19150299|P2|COMPLETED|Overall Study||20
7778823|NCT01320943|19150300|P1|COMPLETED|Overall Study||20
7778824|NCT01320943|19150299|P2|STARTED|Overall Study||22
7778825|NCT01320943|19150300|P1|STARTED|Overall Study|13 participants did not restart TDF; 8 participants restarted TDF during the study.|21
7778826|NCT01320826|19150319|P1|NOT COMPLETED|Overall Study||0
7778827|NCT01320826|19150319|P1|COMPLETED|Overall Study||577
7778828|NCT01320826|19150319|P1|STARTED|Overall Study||577
7778829|NCT01320735|19150334|P1|NOT COMPLETED|Overall Study||106
7778830|NCT01320735|19150334|P1|COMPLETED|Overall Study||194
7778831|NCT01320735|19150334|P1|STARTED|Overall Study||300
7778832|NCT01320722|19150356|P5|NOT COMPLETED|Overall Study||8
7778833|NCT01320722|19150357|P4|NOT COMPLETED|Overall Study||14
7778834|NCT01320722|19150358|P3|NOT COMPLETED|Overall Study||7
7778835|NCT01320722|19150359|P2|NOT COMPLETED|Overall Study||6
7778836|NCT01320722|19150360|P1|NOT COMPLETED|Overall Study||3
7778837|NCT01320722|19150356|P5|COMPLETED|Overall Study||45
7778838|NCT01320722|19150357|P4|COMPLETED|Overall Study||35
7778839|NCT01320722|19150358|P3|COMPLETED|Overall Study||40
7778840|NCT01320722|19150359|P2|COMPLETED|Overall Study||41
7778841|NCT01320722|19150360|P1|COMPLETED|Overall Study||43
7778842|NCT01320722|19150356|P5|Received Intervention|Overall Study||51
7778843|NCT01320722|19150357|P4|Received Intervention|Overall Study||48
7778844|NCT01320722|19150358|P3|Received Intervention|Overall Study||46
7778845|NCT01320722|19150359|P2|Received Intervention|Overall Study||45
7778846|NCT01320722|19150360|P1|Received Intervention|Overall Study||43
7778847|NCT01320722|19150356|P5|STARTED|Overall Study||53
7778848|NCT01320722|19150357|P4|STARTED|Overall Study||49
7778849|NCT01320722|19150358|P3|STARTED|Overall Study||47
7778850|NCT01320722|19150359|P2|STARTED|Overall Study||47
7778851|NCT01320722|19150360|P1|STARTED|Overall Study||46
7778852|NCT01320683|19150397|P1|NOT COMPLETED|Overall Study||1
7778853|NCT01320683|19150397|P1|COMPLETED|Overall Study||0
7778854|NCT01320683|19150397|P1|STARTED|Overall Study||1
7778855|NCT01320553|19150406|P4|NOT COMPLETED|Overall Study||1
7778856|NCT01320553|19150407|P3|NOT COMPLETED|Overall Study||2
7778857|NCT01320553|19150408|P2|NOT COMPLETED|Overall Study||4
7778858|NCT01320553|19150409|P1|NOT COMPLETED|Overall Study||1
7778859|NCT01320553|19150406|P4|COMPLETED|Overall Study||29
7778860|NCT01320553|19150407|P3|COMPLETED|Overall Study||29
7778861|NCT01320553|19150408|P2|COMPLETED|Overall Study||26
7778862|NCT01320553|19150409|P1|COMPLETED|Overall Study||30
7778863|NCT01320553|19150406|P4|STARTED|Overall Study||30
7778864|NCT01320553|19150407|P3|STARTED|Overall Study||31
7778865|NCT01320553|19150408|P2|STARTED|Overall Study||30
7778866|NCT01320553|19150409|P1|STARTED|Overall Study||31
7778867|NCT01320293|19150423|P1|NOT COMPLETED|Overall Study||2
7778868|NCT01320293|19150423|P1|COMPLETED|Overall Study||16
7778869|NCT01320293|19150423|P1|STARTED|Overall Study||18
7778870|NCT01320202|19150431|P2|NOT COMPLETED|Overall Study||44
7778871|NCT01320202|19150432|P1|NOT COMPLETED|Overall Study||56
7778872|NCT01320202|19150431|P2|COMPLETED|Overall Study||109
7778873|NCT01320202|19150432|P1|COMPLETED|Overall Study||96
7778874|NCT01320202|19150431|P2|Completed St 3|Overall Study||82
7778875|NCT01320202|19150432|P1|Completed St 3|Overall Study||79
7778876|NCT01320202|19150431|P2|Enrolled in St 3|Overall Study||109
7778877|NCT01320202|19150432|P1|Enrolled in St 3|Overall Study||98
7778878|NCT01320202|19150431|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82
7778879|NCT01320202|19150432|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69
7778880|NCT01320202|19150431|P2|Comp 48 Wks in St 2|Overall Study||27
7778881|NCT01320202|19150432|P1|Comp 48 Wks in St 2|Overall Study||27
7778882|NCT01320202|19150431|P2|STARTED|Overall Study||153
7778883|NCT01320202|19150432|P1|STARTED|Overall Study||152
7778884|NCT01320150|19150469|P1|NOT COMPLETED|Overall Study||66
7778885|NCT01320150|19150469|P1|COMPLETED|Overall Study||245
7778886|NCT01320150|19150469|P1|Non-PPP|Overall Study||211
7778887|NCT01320150|19150469|P1|PPP|Overall Study||34
7778888|NCT01320150|19150469|P1|STARTED|Overall Study||311
7778889|NCT01320137|19150475|P2|NOT COMPLETED|Overall Study||0
7778890|NCT01320137|19150476|P1|NOT COMPLETED|Overall Study||0
7778891|NCT01320137|19150475|P2|COMPLETED|Overall Study||40
7778892|NCT01320137|19150476|P1|COMPLETED|Overall Study||40
7778893|NCT01320137|19150475|P2|STARTED|Overall Study||40
7778894|NCT01320137|19150476|P1|STARTED|Overall Study||40
7778895|NCT01320072|19150490|P2|NOT COMPLETED|Overall Study||0
7778896|NCT01320072|19150491|P1|NOT COMPLETED|Overall Study||0
7778897|NCT01320072|19150490|P2|COMPLETED|Overall Study||13
7778898|NCT01320072|19150491|P1|COMPLETED|Overall Study||16
7778899|NCT01320072|19150490|P2|STARTED|Overall Study||13
7778900|NCT01320072|19150491|P1|STARTED|Overall Study||16
7778901|NCT01320033|19150503|P3|NOT COMPLETED|Overall Study||53
7778902|NCT01320033|19150504|P2|NOT COMPLETED|Overall Study||64
7778903|NCT01320033|19150505|P1|NOT COMPLETED|Overall Study||58
7778904|NCT01320033|19150503|P3|COMPLETED|Overall Study||169
7778905|NCT01320033|19150504|P2|COMPLETED|Overall Study||160
7778906|NCT01320033|19150505|P1|COMPLETED|Overall Study||158
7778907|NCT01320033|19150503|P3|STARTED|Overall Study||222
7778908|NCT01320033|19150504|P2|STARTED|Overall Study||224
7778909|NCT01320033|19150505|P1|STARTED|Overall Study||216
7778910|NCT01319994|19150533|P2|NOT COMPLETED|Overall Study||6
7778911|NCT01319994|19150534|P1|NOT COMPLETED|Overall Study||7
7778912|NCT01319994|19150533|P2|COMPLETED|Overall Study||21
7778913|NCT01319994|19150534|P1|COMPLETED|Overall Study||19
7778914|NCT01319994|19150533|P2|Did Not Develop Overt Diabetes|Overall Study||21
7778915|NCT01319994|19150534|P1|Did Not Develop Overt Diabetes|Overall Study||19
7778916|NCT01319994|19150533|P2|Glucocorticoid Dose as Inc Cri|Overall Study||22
7778917|NCT01319994|19150534|P1|Glucocorticoid Dose as Inc Cri|Overall Study||19
7778918|NCT01319994|19150533|P2|Tolerated at Least 1.7g/Day Dose|Overall Study||24
7778919|NCT01319994|19150534|P1|Tolerated at Least 1.7g/Day Dose|Overall Study||19
7778920|NCT01319994|19150533|P2|Abto Keep Appoinment Shedule|Overall Study||24
7778921|NCT01319994|19150534|P1|Abto Keep Appoinment Shedule|Overall Study||23
7778922|NCT01319994|19150533|P2|STARTED|Overall Study||27
7778923|NCT01319994|19150534|P1|STARTED|Overall Study||26
7778924|NCT01319929|19150544|P2|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
7778925|NCT01319929|19150545|P1|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
7778926|NCT01319929|19150544|P2|COMPLETED|Second Treatment Period (4 Weeks)||16
7778927|NCT01319929|19150545|P1|COMPLETED|Second Treatment Period (4 Weeks)||16
7778928|NCT01319929|19150544|P2|STARTED|Second Treatment Period (4 Weeks)||17
7778929|NCT01319929|19150545|P1|STARTED|Second Treatment Period (4 Weeks)||17
7778930|NCT01319929|19150544|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
7778931|NCT01319929|19150545|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
7778932|NCT01319929|19150544|P2|COMPLETED|Washout Period (3 Weeks)||17
7778933|NCT01319929|19150545|P1|COMPLETED|Washout Period (3 Weeks)||17
7778934|NCT01319929|19150544|P2|STARTED|Washout Period (3 Weeks)||17
7778935|NCT01319929|19150545|P1|STARTED|Washout Period (3 Weeks)||17
7778936|NCT01319929|19150544|P2|NOT COMPLETED|First Treatment Period (4 Weeks)||2
7778937|NCT01319929|19150545|P1|NOT COMPLETED|First Treatment Period (4 Weeks)||3
7778938|NCT01319929|19150544|P2|COMPLETED|First Treatment Period (4 Weeks)||17
7778939|NCT01319929|19150545|P1|COMPLETED|First Treatment Period (4 Weeks)||17
7778940|NCT01319929|19150544|P2|STARTED|First Treatment Period (4 Weeks)||19
7778941|NCT01319929|19150545|P1|STARTED|First Treatment Period (4 Weeks)||20
7778942|NCT01319877|19150577|P2|NOT COMPLETED|Overall Study||45
7778943|NCT01319877|19150578|P1|NOT COMPLETED|Overall Study||108
7778944|NCT01319877|19150577|P2|COMPLETED|Overall Study||108
7778945|NCT01319877|19150578|P1|COMPLETED|Overall Study||345
7778946|NCT01319877|19150577|P2|STARTED|Overall Study||153
7778947|NCT01319877|19150578|P1|STARTED|Overall Study||453
7778948|NCT01319851|19150613|P1|NOT COMPLETED|Overall Study||0
7778949|NCT01319851|19150613|P1|COMPLETED|Overall Study||3
7778950|NCT01319851|19150613|P1|STARTED|Overall Study||3
7778951|NCT01319812|19150625|P2|NOT COMPLETED|Overall Study||22
7778952|NCT01319812|19150626|P1|NOT COMPLETED|Overall Study||16
7778953|NCT01319812|19150625|P2|COMPLETED|Overall Study||280
7778954|NCT01319812|19150626|P1|COMPLETED|Overall Study||145
7778955|NCT01319812|19150625|P2|STARTED|Overall Study||302
7778956|NCT01319812|19150626|P1|STARTED|Overall Study||161
7778957|NCT01319799|19150707|P1|NOT COMPLETED|Overall Study||0
7778958|NCT01319799|19150707|P1|COMPLETED|Overall Study||10
7778959|NCT01319799|19150707|P1|STARTED|Overall Study||10
7778960|NCT01319773|19150717|P5|NOT COMPLETED|Overall Study||0
7778961|NCT01319773|19150718|P4|NOT COMPLETED|Overall Study||0
7778962|NCT01319773|19150719|P3|NOT COMPLETED|Overall Study||0
7778963|NCT01319773|19150720|P2|NOT COMPLETED|Overall Study||0
7778964|NCT01319773|19150721|P1|NOT COMPLETED|Overall Study||0
7778965|NCT01319773|19150717|P5|COMPLETED|Overall Study||8
7778966|NCT01319773|19150718|P4|COMPLETED|Overall Study||8
7778967|NCT01319773|19150719|P3|COMPLETED|Overall Study||8
7778968|NCT01319773|19150720|P2|COMPLETED|Overall Study||10
7778969|NCT01319773|19150721|P1|COMPLETED|Overall Study||10
7778970|NCT01319773|19150717|P5|STARTED|Overall Study||8
7778971|NCT01319773|19150718|P4|STARTED|Overall Study||8
7778972|NCT01319773|19150719|P3|STARTED|Overall Study||8
7778973|NCT01319773|19150720|P2|STARTED|Overall Study||10
7778974|NCT01319773|19150721|P1|STARTED|Overall Study||10
7778975|NCT01319760|19150737|P2|NOT COMPLETED|Overall Study||0
7778976|NCT01319760|19150738|P1|NOT COMPLETED|Overall Study||0
7778977|NCT01319760|19150737|P2|COMPLETED|Overall Study||5
7778978|NCT01319760|19150738|P1|COMPLETED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
7778979|NCT01319760|19150737|P2|STARTED|Overall Study||5
7778980|NCT01319760|19150738|P1|STARTED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
7778981|NCT01319721|19150746|P2|NOT COMPLETED|Overall Study||6
7778982|NCT01319721|19150747|P1|NOT COMPLETED|Overall Study||1
7778983|NCT01319721|19150746|P2|COMPLETED|Overall Study|The unit of measure is eyes.|42
7778984|NCT01319721|19150747|P1|COMPLETED|Overall Study|The unit of measure is eyes.|47
7778985|NCT01319721|19150746|P2|STARTED|Overall Study|The unit of measure is eyes.|48
7778986|NCT01319721|19150747|P1|STARTED|Overall Study|The unit of measure is eyes.|48
7778987|NCT01319617|19150761|P1|NOT COMPLETED|Overall Study||1
7778988|NCT01319617|19150761|P1|COMPLETED|Overall Study||40
7778989|NCT01319617|19150761|P1|STARTED|Overall Study||41
7778990|NCT01319552|19150765|P1|NOT COMPLETED|Overall Study||0
7778991|NCT01319552|19150765|P1|COMPLETED|Overall Study||14
7778992|NCT01319552|19150765|P1|STARTED|Overall Study||14
7778993|NCT01319539|19150770|P1|NOT COMPLETED|Overall Study||0
7778994|NCT01319539|19150770|P1|COMPLETED|Overall Study||12
7778995|NCT01319539|19150770|P1|STARTED|Overall Study||12
7778996|NCT01319500|19150780|P2|NOT COMPLETED|Overall Study||0
7778997|NCT01319500|19150781|P1|NOT COMPLETED|Overall Study||0
7778998|NCT01319500|19150780|P2|COMPLETED|Overall Study||2589
7778999|NCT01319500|19150781|P1|COMPLETED|Overall Study||1187
7779000|NCT01319500|19150780|P2|STARTED|Overall Study||2589
7779001|NCT01319500|19150781|P1|STARTED|Overall Study||1187
7779002|NCT01319422|19150800|P2|NOT COMPLETED|Overall Study||0
7779003|NCT01319422|19150801|P1|NOT COMPLETED|Overall Study||1
7779004|NCT01319422|19150800|P2|COMPLETED|Overall Study||20
7779005|NCT01319422|19150801|P1|COMPLETED|Overall Study||19
7779006|NCT01319422|19150800|P2|STARTED|Overall Study||20
7779007|NCT01319422|19150801|P1|STARTED|Overall Study||20
7779008|NCT01319396|19150815|P1|NOT COMPLETED|Overall Study||0
7779009|NCT01319396|19150815|P1|COMPLETED|Overall Study||24
7779010|NCT01319396|19150815|P1|STARTED|Overall Study||24
7779011|NCT01319383|19150819|P2|NOT COMPLETED|Overall Study||10
7779012|NCT01319383|19150820|P1|NOT COMPLETED|Overall Study||12
7779013|NCT01319383|19150819|P2|COMPLETED|Overall Study||3
7779014|NCT01319383|19150820|P1|COMPLETED|Overall Study||0
7779015|NCT01319383|19150819|P2|Step 4|Overall Study|Only 3/6 completed the study.|3
7779016|NCT01319383|19150820|P1|Step 4|Overall Study|Arm 1 did not have a Step 4|0
7779017|NCT01319383|19150819|P2|Step 3|Overall Study|3 Arm 1 participants enrolled here; 6/7 had in vivo response to 2 VOR doses given 72 hours apart.|6
7779018|NCT01319383|19150820|P1|Step 3|Overall Study|None who qualified for the 2 series of 11 doses of VOR (taken M-T-W & off for 4 days for 4 wks).|0
7779019|NCT01319383|19150819|P2|Step 2|Overall Study||0
7779020|NCT01319383|19150820|P1|Step 2|Overall Study|The 4 without ex vivo response (Step 1) took a single dose to see if in vivo response would occur|4
7779021|NCT01319383|19150819|P2|Step 2|Overall Study|The 7 participants without an in vivo response to single dose of VOR 400 mg PO were terminated.|4
7779022|NCT01319383|19150820|P1|Step 2|Overall Study|These participants demonstrated an ex vivo response in Step 1|8
7779023|NCT01319383|19150819|P2|Step 1|Overall Study|The 2 participants without an ex vivo response were terminated from the study.|11
7779024|NCT01319383|19150820|P1|Step 1|Overall Study||8
7779025|NCT01319383|19150819|P2|STARTED|Overall Study||13
7779026|NCT01319383|19150820|P1|STARTED|Overall Study||12
7779027|NCT01319318|19150837|P1|NOT COMPLETED|Overall Study||0
7779028|NCT01319318|19150837|P1|COMPLETED|Overall Study||25
7779029|NCT01319318|19150837|P1|STARTED|Overall Study||25
7779030|NCT01319110|19150843|P2|NOT COMPLETED|Overall Study||0
7779031|NCT01319110|19150844|P1|NOT COMPLETED|Overall Study||0
7779032|NCT01319110|19150843|P2|COMPLETED|Overall Study||5
7779033|NCT01319110|19150844|P1|COMPLETED|Overall Study||5
7779034|NCT01319110|19150843|P2|STARTED|Overall Study||5
7779035|NCT01319110|19150844|P1|STARTED|Overall Study||5
7779036|NCT01319045|19150852|P1|NOT COMPLETED|Overall Study||2
7779037|NCT01319045|19150852|P1|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3
7779038|NCT01319045|19150852|P1|STARTED|Overall Study||5
7779039|NCT01318993|19150859|P1|NOT COMPLETED|Overall Study||398
7779040|NCT01318993|19150859|P1|COMPLETED|Overall Study||0
7779041|NCT01318993|19150859|P1|STARTED|Overall Study||398
7779042|NCT01318967|19150875|P1|NOT COMPLETED|Overall Study||0
7779043|NCT01318967|19150875|P1|COMPLETED|Overall Study||10
7779044|NCT01318967|19150875|P1|STARTED|Overall Study||10
7779045|NCT01318915|19150880|P1|NOT COMPLETED|Overall Study||1
7779046|NCT01318915|19150880|P1|COMPLETED|Overall Study||9
7779047|NCT01318915|19150880|P1|STARTED|Overall Study||10
7779048|NCT01318902|19150909|P4|NOT COMPLETED|Overall Study||6
7779049|NCT01318902|19150910|P3|NOT COMPLETED|Overall Study||2
7779050|NCT01318902|19150911|P2|NOT COMPLETED|Overall Study||3
7779051|NCT01318902|19150912|P1|NOT COMPLETED|Overall Study||1
7779052|NCT01318902|19150909|P4|COMPLETED|Overall Study||5
7779053|NCT01318902|19150910|P3|COMPLETED|Overall Study||3
7779054|NCT01318902|19150911|P2|COMPLETED|Overall Study||2
7779055|NCT01318902|19150912|P1|COMPLETED|Overall Study||5
7779056|NCT01318902|19150909|P4|STARTED|Overall Study||11
7779057|NCT01318902|19150910|P3|STARTED|Overall Study||5
7779058|NCT01318902|19150911|P2|STARTED|Overall Study||5
7779059|NCT01318902|19150912|P1|STARTED|Overall Study||6
7779060|NCT01318876|19150989|P1|NOT COMPLETED|Day 29 Survey||1825
7779061|NCT01318876|19150989|P1|COMPLETED|Day 29 Survey||5724
7779062|NCT01318876|19150989|P1|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549
7779063|NCT01318876|19150989|P1|NOT COMPLETED|Day 8 Survey||1820
7779064|NCT01318876|19150989|P1|COMPLETED|Day 8 Survey||5825
7779065|NCT01318876|19150989|P1|STARTED|Day 8 Survey||7645
7779066|NCT01318811|19150996|P2|NOT COMPLETED|Overall Study||4
7779067|NCT01318811|19150997|P1|NOT COMPLETED|Overall Study||1
7779068|NCT01318811|19150996|P2|COMPLETED|Overall Study||4
7779069|NCT01318811|19150997|P1|COMPLETED|Overall Study||3
7779070|NCT01318811|19150996|P2|STARTED|Overall Study||8
7779071|NCT01318811|19150997|P1|STARTED|Overall Study||4
7779072|NCT01318733|19151005|P1|NOT COMPLETED|Overall Study||170
7779073|NCT01318733|19151005|P1|COMPLETED|Overall Study||279
7779074|NCT01318733|19151005|P1|STARTED|Overall Study||449
7779075|NCT01318694|19151013|P4|NOT COMPLETED|Overall Study||68
7779076|NCT01318694|19151014|P3|NOT COMPLETED|Overall Study||43
7779077|NCT01318694|19151015|P2|NOT COMPLETED|Overall Study||58
7779078|NCT01318694|19151016|P1|NOT COMPLETED|Overall Study||52
7779079|NCT01318694|19151013|P4|COMPLETED|Overall Study||200
7779080|NCT01318694|19151014|P3|COMPLETED|Overall Study||225
7779081|NCT01318694|19151015|P2|COMPLETED|Overall Study||212
7779082|NCT01318694|19151016|P1|COMPLETED|Overall Study||223
7779083|NCT01318694|19151013|P4|Safety Set|Overall Study||265
7779084|NCT01318694|19151014|P3|Safety Set|Overall Study||265
7779085|NCT01318694|19151015|P2|Safety Set|Overall Study||268
7779086|NCT01318694|19151016|P1|Safety Set|Overall Study||273
7779087|NCT01318694|19151013|P4|Full Analysis Set|Overall Study||268
7779088|NCT01318694|19151014|P3|Full Analysis Set|Overall Study||265
7779089|NCT01318694|19151015|P2|Full Analysis Set|Overall Study||270
7779090|NCT01318694|19151016|P1|Full Analysis Set|Overall Study||274
7779091|NCT01318694|19151013|P4|STARTED|Overall Study||268
7779092|NCT01318694|19151014|P3|STARTED|Overall Study||268
7779093|NCT01318694|19151015|P2|STARTED|Overall Study||270
7779094|NCT01318694|19151016|P1|STARTED|Overall Study||275
7779095|NCT01318577|19151072|P2|NOT COMPLETED|Overall Study||8
7779096|NCT01318577|19151073|P1|NOT COMPLETED|Overall Study||13
7779097|NCT01318577|19151072|P2|COMPLETED|Overall Study||212
7779098|NCT01318577|19151073|P1|COMPLETED|Overall Study||211
7779099|NCT01318577|19151072|P2|STARTED|Overall Study||220
7779100|NCT01318577|19151073|P1|STARTED|Overall Study||224
7779101|NCT01318538|19151081|P3|NOT COMPLETED|Overall Study||0
7779102|NCT01318538|19151082|P2|NOT COMPLETED|Overall Study||0
7779103|NCT01318538|19151083|P1|NOT COMPLETED|Overall Study||0
7779104|NCT01318538|19151081|P3|COMPLETED|Overall Study||8
7779105|NCT01318538|19151082|P2|COMPLETED|Overall Study||106
7779106|NCT01318538|19151083|P1|COMPLETED|Overall Study||52
7779107|NCT01318538|19151081|P3|STARTED|Overall Study||8
7779108|NCT01318538|19151082|P2|STARTED|Overall Study||106
7779109|NCT01318538|19151083|P1|STARTED|Overall Study||52
7779110|NCT01318512|19151107|P1|NOT COMPLETED|Maintenance Period (6 Months)||11
7779111|NCT01318512|19151107|P1|COMPLETED|Maintenance Period (6 Months)||329
7779112|NCT01318512|19151107|P1|STARTED|Maintenance Period (6 Months)||340
7779113|NCT01318512|19151107|P1|NOT COMPLETED|Titration Period (4 Months)||0
7779114|NCT01318512|19151107|P1|COMPLETED|Titration Period (4 Months)||340
7779115|NCT01318512|19151107|P1|STARTED|Titration Period (4 Months)||340
7779116|NCT01318499|19151126|P3|NOT COMPLETED|Overall Study||147
7779117|NCT01318499|19151127|P2|NOT COMPLETED|Overall Study||76
7779118|NCT01318499|19151128|P1|NOT COMPLETED|Overall Study||65
7779119|NCT01318499|19151126|P3|COMPLETED|Overall Study||121
7779120|NCT01318499|19151127|P2|COMPLETED|Overall Study||458
7779121|NCT01318499|19151128|P1|COMPLETED|Overall Study||475
7779122|NCT01318499|19151126|P3|STARTED|Overall Study||268
7779123|NCT01318499|19151127|P2|STARTED|Overall Study||534
7779124|NCT01318499|19151128|P1|STARTED|Overall Study||540
7779125|NCT01318408|19151146|P1|NOT COMPLETED|Overall Study||8
7779126|NCT01318408|19151146|P1|COMPLETED|Overall Study||16
7779127|NCT01318408|19151146|P1|STARTED|Overall Study||24
7779128|NCT01318382|19151151|P1|NOT COMPLETED|Overall Study||13
7779129|NCT01318382|19151151|P1|COMPLETED|Overall Study||289
7779130|NCT01318382|19151151|P1|STARTED|Overall Study||302
7779131|NCT01318278|19151161|P3|NOT COMPLETED|Overall Study||0
7779132|NCT01318278|19151162|P2|NOT COMPLETED|Overall Study||0
7779133|NCT01318278|19151163|P1|NOT COMPLETED|Overall Study||0
7779134|NCT01318278|19151161|P3|COMPLETED|Overall Study||50
7779135|NCT01318278|19151162|P2|COMPLETED|Overall Study||10
7779136|NCT01318278|19151163|P1|COMPLETED|Overall Study||10
7779137|NCT01318278|19151161|P3|STARTED|Overall Study||50
7779138|NCT01318278|19151162|P2|STARTED|Overall Study||10
7779139|NCT01318278|19151163|P1|STARTED|Overall Study||10
7779140|NCT01318135|19151209|P8|NOT COMPLETED|Entered - Long-Term Extension Study||3
7779141|NCT01318135|19151210|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
7779142|NCT01318135|19151211|P6|NOT COMPLETED|Entered - Long-Term Extension Study||4
7779143|NCT01318135|19151212|P5|NOT COMPLETED|Entered - Long-Term Extension Study||9
7779144|NCT01318135|19151213|P4|NOT COMPLETED|Entered - Long-Term Extension Study||7
7779145|NCT01318135|19151214|P3|NOT COMPLETED|Entered - Long-Term Extension Study||8
7779146|NCT01318135|19151215|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
7779147|NCT01318135|19151216|P1|NOT COMPLETED|Entered - Long-Term Extension Study||17
7779148|NCT01318135|19151209|P8|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46
7779149|NCT01318135|19151210|P7|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49
7779150|NCT01318135|19151211|P6|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83
7779151|NCT01318135|19151212|P5|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81
7779152|NCT01318135|19151213|P4|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42
7779153|NCT01318135|19151214|P3|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38
7779154|NCT01318135|19151215|P2|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89
7779155|NCT01318135|19151216|P1|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80
7779156|NCT01318135|19151209|P8|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49
7779157|NCT01318135|19151210|P7|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50
7779158|NCT01318135|19151211|P6|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87
7779159|NCT01318135|19151212|P5|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90
7779160|NCT01318135|19151213|P4|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49
7779161|NCT01318135|19151214|P3|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46
7779162|NCT01318135|19151215|P2|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102
7779163|NCT01318135|19151216|P1|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97
7779164|NCT01318135|19151209|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
7779165|NCT01318135|19151210|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
7779166|NCT01318135|19151211|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
7779167|NCT01318135|19151212|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
7779168|NCT01318135|19151213|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
7779169|NCT01318135|19151214|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
7779170|NCT01318135|19151215|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
7779171|NCT01318135|19151216|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
7779172|NCT01318135|19151209|P8|COMPLETED|Enrolled - Long-Term Extension Study||49
7779173|NCT01318135|19151210|P7|COMPLETED|Enrolled - Long-Term Extension Study||50
7779174|NCT01318135|19151211|P6|COMPLETED|Enrolled - Long-Term Extension Study||90
7779175|NCT01318135|19151212|P5|COMPLETED|Enrolled - Long-Term Extension Study||91
7779176|NCT01318135|19151213|P4|COMPLETED|Enrolled - Long-Term Extension Study||49
7779177|NCT01318135|19151214|P3|COMPLETED|Enrolled - Long-Term Extension Study||46
7779178|NCT01318135|19151215|P2|COMPLETED|Enrolled - Long-Term Extension Study||102
7779179|NCT01318135|19151216|P1|COMPLETED|Enrolled - Long-Term Extension Study||97
7779180|NCT01318135|19151209|P8|STARTED|Enrolled - Long-Term Extension Study||49
7779181|NCT01318135|19151210|P7|STARTED|Enrolled - Long-Term Extension Study||50
7779182|NCT01318135|19151211|P6|STARTED|Enrolled - Long-Term Extension Study||90
7779183|NCT01318135|19151212|P5|STARTED|Enrolled - Long-Term Extension Study||91
7779184|NCT01318135|19151213|P4|STARTED|Enrolled - Long-Term Extension Study||49
7779185|NCT01318135|19151214|P3|STARTED|Enrolled - Long-Term Extension Study||46
7779186|NCT01318135|19151215|P2|STARTED|Enrolled - Long-Term Extension Study||102
7779187|NCT01318135|19151216|P1|STARTED|Enrolled - Long-Term Extension Study||99
7779188|NCT01318122|19151348|P4|NOT COMPLETED|Entered - Long-Term Extension Study||4
7779189|NCT01318122|19151349|P3|NOT COMPLETED|Entered - Long-Term Extension Study||6
7779190|NCT01318122|19151350|P2|NOT COMPLETED|Entered - Long-Term Extension Study||11
7779191|NCT01318122|19151351|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
7779192|NCT01318122|19151348|P4|COMPLETED|Entered - Long-Term Extension Study||48
7779193|NCT01318122|19151349|P3|COMPLETED|Entered - Long-Term Extension Study||49
7779194|NCT01318122|19151350|P2|COMPLETED|Entered - Long-Term Extension Study||99
7779195|NCT01318122|19151351|P1|COMPLETED|Entered - Long-Term Extension Study||96
7779196|NCT01318122|19151348|P4|STARTED|Entered - Long-Term Extension Study||52
7779197|NCT01318122|19151349|P3|STARTED|Entered - Long-Term Extension Study||55
7779198|NCT01318122|19151350|P2|STARTED|Entered - Long-Term Extension Study||110
7779199|NCT01318122|19151351|P1|STARTED|Entered - Long-Term Extension Study||105
7779200|NCT01318122|19151348|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
7779201|NCT01318122|19151349|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
7779202|NCT01318122|19151350|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
7779203|NCT01318122|19151351|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
7779204|NCT01318122|19151348|P4|COMPLETED|Enrolled - Long-Term Extension Study||52
7779205|NCT01318122|19151349|P3|COMPLETED|Enrolled - Long-Term Extension Study||55
7779206|NCT01318122|19151350|P2|COMPLETED|Enrolled - Long-Term Extension Study||110
7779207|NCT01318122|19151351|P1|COMPLETED|Enrolled - Long-Term Extension Study||105
7779208|NCT01318122|19151348|P4|STARTED|Enrolled - Long-Term Extension Study||53
7779209|NCT01318122|19151349|P3|STARTED|Enrolled - Long-Term Extension Study||57
7779210|NCT01318122|19151350|P2|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110
7779211|NCT01318122|19151351|P1|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106
7779212|NCT01318109|19151420|P3|NOT COMPLETED|Overall Study||0
7779213|NCT01318109|19151421|P2|NOT COMPLETED|Overall Study||3
7779214|NCT01318109|19151422|P1|NOT COMPLETED|Overall Study||1
7779215|NCT01318109|19151420|P3|COMPLETED|Overall Study||100
7779216|NCT01318109|19151421|P2|COMPLETED|Overall Study||93
7779217|NCT01318109|19151422|P1|COMPLETED|Overall Study||91
7779218|NCT01318109|19151420|P3|STARTED|Overall Study||100
7779219|NCT01318109|19151421|P2|STARTED|Overall Study||96
7779220|NCT01318109|19151422|P1|STARTED|Overall Study||92
7779221|NCT01318083|19151457|P3|NOT COMPLETED|Overall Study||5
7779222|NCT01318083|19151458|P2|NOT COMPLETED|Overall Study||2
7779223|NCT01318083|19151459|P1|NOT COMPLETED|Overall Study||6
7779224|NCT01318083|19151457|P3|COMPLETED|Overall Study||98
7779225|NCT01318083|19151458|P2|COMPLETED|Overall Study||102
7779226|NCT01318083|19151459|P1|COMPLETED|Overall Study||99
7779227|NCT01318083|19151457|P3|STARTED|Overall Study||103
7779228|NCT01318083|19151458|P2|STARTED|Overall Study||104
7779229|NCT01318083|19151459|P1|STARTED|Overall Study||105
7779230|NCT01318070|19151494|P3|NOT COMPLETED|Overall Study||7
7779231|NCT01318070|19151495|P2|NOT COMPLETED|Overall Study||2
7779232|NCT01318070|19151496|P1|NOT COMPLETED|Overall Study||2
7779233|NCT01318070|19151494|P3|COMPLETED|Overall Study||108
7779234|NCT01318070|19151495|P2|COMPLETED|Overall Study||111
7779235|NCT01318070|19151496|P1|COMPLETED|Overall Study||109
7779236|NCT01318070|19151494|P3|STARTED|Overall Study||115
7779237|NCT01318070|19151495|P2|STARTED|Overall Study||113
7779238|NCT01318070|19151496|P1|STARTED|Overall Study||111
7779239|NCT01318018|19151530|P2|NOT COMPLETED|Overall Study||0
7779240|NCT01318018|19151531|P1|NOT COMPLETED|Overall Study||0
7779241|NCT01318018|19151530|P2|COMPLETED|Overall Study||10
7779242|NCT01318018|19151531|P1|COMPLETED|Overall Study||10
7779243|NCT01318018|19151530|P2|STARTED|Overall Study||10
7779244|NCT01318018|19151531|P1|STARTED|Overall Study||10
7779245|NCT01317940|19151543|P6|NOT COMPLETED|Overall Study||0
7779246|NCT01317940|19151544|P5|NOT COMPLETED|Overall Study||1
7779247|NCT01317940|19151545|P4|NOT COMPLETED|Overall Study||1
7779248|NCT01317940|19151546|P3|NOT COMPLETED|Overall Study||5
7779249|NCT01317940|19151547|P2|NOT COMPLETED|Overall Study||0
7779250|NCT01317940|19151548|P1|NOT COMPLETED|Overall Study||1
7779251|NCT01317940|19151543|P6|COMPLETED|Overall Study||4
7779252|NCT01317940|19151544|P5|COMPLETED|Overall Study||12
7779253|NCT01317940|19151545|P4|COMPLETED|Overall Study||5
7779254|NCT01317940|19151546|P3|COMPLETED|Overall Study||15
7779255|NCT01317940|19151547|P2|COMPLETED|Overall Study||10
7779256|NCT01317940|19151548|P1|COMPLETED|Overall Study||18
7779257|NCT01317940|19151543|P6|STARTED|Overall Study||4
7779258|NCT01317940|19151544|P5|STARTED|Overall Study||13
7779259|NCT01317940|19151545|P4|STARTED|Overall Study||6
7779260|NCT01317940|19151546|P3|STARTED|Overall Study||20
7779261|NCT01317940|19151547|P2|STARTED|Overall Study||10
7779262|NCT01317940|19151548|P1|STARTED|Overall Study||19
7779263|NCT01317901|19151569|P2|NOT COMPLETED|Overall Study||0
7779264|NCT01317901|19151570|P1|NOT COMPLETED|Overall Study||0
7779265|NCT01317901|19151569|P2|COMPLETED|Overall Study||6
7779266|NCT01317901|19151570|P1|COMPLETED|Overall Study||6
7779267|NCT01317901|19151569|P2|STARTED|Overall Study||6
7779268|NCT01317901|19151570|P1|STARTED|Overall Study||6
7779269|NCT01317797|19151579|P3|NOT COMPLETED|Overall Study||1
7779270|NCT01317797|19151580|P2|NOT COMPLETED|Overall Study||1
7779271|NCT01317797|19151581|P1|NOT COMPLETED|Overall Study||0
7779272|NCT01317797|19151579|P3|COMPLETED|Overall Study||8
7779273|NCT01317797|19151580|P2|COMPLETED|Overall Study||6
7779274|NCT01317797|19151581|P1|COMPLETED|Overall Study||8
7779275|NCT01317797|19151579|P3|STARTED|Overall Study||9
7779276|NCT01317797|19151580|P2|STARTED|Overall Study||7
7779277|NCT01317797|19151581|P1|STARTED|Overall Study||8
7779278|NCT01317667|19151636|P3|NOT COMPLETED|Overall Study||0
7779279|NCT01317667|19151637|P2|NOT COMPLETED|Overall Study||0
7779280|NCT01317667|19151638|P1|NOT COMPLETED|Overall Study||0
7779281|NCT01317667|19151636|P3|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10
7779282|NCT01317667|19151637|P2|COMPLETED|Overall Study||10
7779283|NCT01317667|19151638|P1|COMPLETED|Overall Study||10
7779284|NCT01317667|19151636|P3|STARTED|Overall Study||10
7779285|NCT01317667|19151637|P2|STARTED|Overall Study||10
7779286|NCT01317667|19151638|P1|STARTED|Overall Study||10
7779287|NCT01317641|19151658|P9|NOT COMPLETED|Overall Study||5
7779288|NCT01317641|19151659|P8|NOT COMPLETED|Overall Study||5
7779289|NCT01317641|19151660|P7|NOT COMPLETED|Overall Study||3
7779290|NCT01317641|19151661|P6|NOT COMPLETED|Overall Study||0
7779291|NCT01317641|19151662|P5|NOT COMPLETED|Overall Study||0
7779292|NCT01317641|19151663|P4|NOT COMPLETED|Overall Study||1
7779293|NCT01317641|19151664|P3|NOT COMPLETED|Overall Study||0
7779294|NCT01317641|19151665|P2|NOT COMPLETED|Overall Study||1
7779295|NCT01317641|19151666|P1|NOT COMPLETED|Overall Study||1
7779296|NCT01317641|19151658|P9|COMPLETED|Overall Study||31
7779297|NCT01317641|19151659|P8|COMPLETED|Overall Study||33
7779298|NCT01317641|19151660|P7|COMPLETED|Overall Study||35
7779299|NCT01317641|19151661|P6|COMPLETED|Overall Study||3
7779300|NCT01317641|19151662|P5|COMPLETED|Overall Study||3
7779301|NCT01317641|19151663|P4|COMPLETED|Overall Study||3
7779302|NCT01317641|19151664|P3|COMPLETED|Overall Study||3
7779303|NCT01317641|19151665|P2|COMPLETED|Overall Study||6
7779304|NCT01317641|19151666|P1|COMPLETED|Overall Study||3
7779305|NCT01317641|19151658|P9|STARTED|Overall Study||36
7779306|NCT01317641|19151659|P8|STARTED|Overall Study||38
7779307|NCT01317641|19151660|P7|STARTED|Overall Study||38
7779308|NCT01317641|19151661|P6|STARTED|Overall Study||3
7779309|NCT01317641|19151662|P5|STARTED|Overall Study||3
7779310|NCT01317641|19151663|P4|STARTED|Overall Study||4
7779311|NCT01317641|19151664|P3|STARTED|Overall Study||3
7779312|NCT01317641|19151665|P2|STARTED|Overall Study||7
7779313|NCT01317641|19151666|P1|STARTED|Overall Study||4
7779314|NCT01317615|19151768|P1|NOT COMPLETED|Overall Study||49
7779315|NCT01317615|19151768|P1|COMPLETED|Overall Study||0
7779316|NCT01317615|19151768|P1|STARTED|Overall Study||49
7779317|NCT01317550|19151781|P4|NOT COMPLETED|Overall Study||0
7779318|NCT01317550|19151782|P3|NOT COMPLETED|Overall Study||0
7779319|NCT01317550|19151783|P2|NOT COMPLETED|Overall Study||0
7779320|NCT01317550|19151784|P1|NOT COMPLETED|Overall Study||2
7779321|NCT01317550|19151781|P4|COMPLETED|Overall Study||3
7779322|NCT01317550|19151782|P3|COMPLETED|Overall Study||3
7779323|NCT01317550|19151783|P2|COMPLETED|Overall Study||3
7779324|NCT01317550|19151784|P1|COMPLETED|Overall Study||3
7779325|NCT01317550|19151781|P4|STARTED|Overall Study||3
7779326|NCT01317550|19151782|P3|STARTED|Overall Study||3
7779327|NCT01317550|19151783|P2|STARTED|Overall Study||3
7779328|NCT01317550|19151784|P1|STARTED|Overall Study||5
7779329|NCT01317472|19151796|P2|NOT COMPLETED|Overall Study||0
7779330|NCT01317472|19151797|P1|NOT COMPLETED|Overall Study||2
7779331|NCT01317472|19151796|P2|COMPLETED|Overall Study||2
7779332|NCT01317472|19151797|P1|COMPLETED|Overall Study||7
7779333|NCT01317472|19151796|P2|STARTED|Overall Study||2
7779334|NCT01317472|19151797|P1|STARTED|Overall Study||9
7779335|NCT01317199|19151807|P4|NOT COMPLETED|Randomized Phase 2||17
7779336|NCT01317199|19151808|P3|NOT COMPLETED|Randomized Phase 2||21
7779337|NCT01317199|19151809|P2|NOT COMPLETED|Randomized Phase 2||11
7779338|NCT01317199|19151810|P1|NOT COMPLETED|Randomized Phase 2||0
7779339|NCT01317199|19151807|P4|COMPLETED|Randomized Phase 2||32
7779340|NCT01317199|19151808|P3|COMPLETED|Randomized Phase 2||35
7779341|NCT01317199|19151809|P2|COMPLETED|Randomized Phase 2||13
7779342|NCT01317199|19151810|P1|COMPLETED|Randomized Phase 2||0
7779343|NCT01317199|19151807|P4|STARTED|Randomized Phase 2||49
7779344|NCT01317199|19151808|P3|STARTED|Randomized Phase 2||56
7779345|NCT01317199|19151809|P2|STARTED|Randomized Phase 2||24
7779346|NCT01317199|19151810|P1|STARTED|Randomized Phase 2||0
7779347|NCT01317199|19151807|P4|NOT COMPLETED|Dose-escalation Phase 1||0
7779348|NCT01317199|19151808|P3|NOT COMPLETED|Dose-escalation Phase 1||0
7779349|NCT01317199|19151809|P2|NOT COMPLETED|Dose-escalation Phase 1||0
7779350|NCT01317199|19151810|P1|NOT COMPLETED|Dose-escalation Phase 1||7
7779351|NCT01317199|19151807|P4|COMPLETED|Dose-escalation Phase 1||0
7779352|NCT01317199|19151808|P3|COMPLETED|Dose-escalation Phase 1||0
7779353|NCT01317199|19151809|P2|COMPLETED|Dose-escalation Phase 1||0
7779354|NCT01317199|19151810|P1|COMPLETED|Dose-escalation Phase 1||7
7779355|NCT01317199|19151807|P4|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
7779356|NCT01317199|19151808|P3|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
7779357|NCT01317199|19151809|P2|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
7779358|NCT01317199|19151810|P1|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||6
7779359|NCT01317199|19151807|P4|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
7779360|NCT01317199|19151808|P3|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
7779361|NCT01317199|19151809|P2|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
7779362|NCT01317199|19151810|P1|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
7779363|NCT01317199|19151807|P4|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
7779364|NCT01317199|19151808|P3|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
7779365|NCT01317199|19151809|P2|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
7779366|NCT01317199|19151810|P1|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
7779367|NCT01317199|19151807|P4|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
7779368|NCT01317199|19151808|P3|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
7779369|NCT01317199|19151809|P2|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
7779370|NCT01317199|19151810|P1|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
7779371|NCT01317199|19151807|P4|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
7779372|NCT01317199|19151808|P3|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
7779373|NCT01317199|19151809|P2|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
7779374|NCT01317199|19151810|P1|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||2
7779375|NCT01317199|19151807|P4|STARTED|Dose-escalation Phase 1||0
7779376|NCT01317199|19151808|P3|STARTED|Dose-escalation Phase 1||0
7779377|NCT01317199|19151809|P2|STARTED|Dose-escalation Phase 1||0
7779378|NCT01317199|19151810|P1|STARTED|Dose-escalation Phase 1||14
7779379|NCT01317160|19151839|P2|NOT COMPLETED|Overall Study||6
7779380|NCT01317160|19151840|P1|NOT COMPLETED|Overall Study||4
7779381|NCT01317160|19151839|P2|COMPLETED|Overall Study||69
7779382|NCT01317160|19151840|P1|COMPLETED|Overall Study||71
7779383|NCT01317160|19151839|P2|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
7779384|NCT01317160|19151840|P1|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
7779385|NCT01317160|19151839|P2|STARTED|Overall Study||75
7779386|NCT01317160|19151840|P1|STARTED|Overall Study||75
7779387|NCT01317095|19151850|P2|NOT COMPLETED|Overall Study||0
7779388|NCT01317095|19151851|P1|NOT COMPLETED|Overall Study||0
7779389|NCT01317095|19151850|P2|COMPLETED|Overall Study||41
7779390|NCT01317095|19151851|P1|COMPLETED|Overall Study||39
7779391|NCT01317095|19151850|P2|STARTED|Overall Study||41
7779392|NCT01317095|19151851|P1|STARTED|Overall Study||39
7779393|NCT01317030|19151865|P2|NOT COMPLETED|Overall Study||0
7779394|NCT01317030|19151866|P1|NOT COMPLETED|Overall Study||0
7779395|NCT01317030|19151865|P2|COMPLETED|Overall Study||13
7779396|NCT01317030|19151866|P1|COMPLETED|Overall Study||12
7779397|NCT01317030|19151865|P2|STARTED|Overall Study||13
7779398|NCT01317030|19151866|P1|STARTED|Overall Study||12
7779399|NCT01317004|19151874|P2|NOT COMPLETED|Overall Study||9
7779400|NCT01317004|19151875|P1|NOT COMPLETED|Overall Study||4
7779401|NCT01317004|19151874|P2|COMPLETED|Overall Study||5
7779402|NCT01317004|19151875|P1|COMPLETED|Overall Study||47
7779403|NCT01317004|19151874|P2|Safety Set|Overall Study||11
7779404|NCT01317004|19151875|P1|Safety Set|Overall Study||50
7779405|NCT01317004|19151874|P2|STARTED|Overall Study||14
7779406|NCT01317004|19151875|P1|STARTED|Overall Study||51
7779407|NCT01316939|19151896|P3|NOT COMPLETED|Overall Study||69
7779408|NCT01316939|19151897|P2|NOT COMPLETED|Overall Study||68
7779409|NCT01316939|19151898|P1|NOT COMPLETED|Overall Study||63
7779410|NCT01316939|19151896|P3|COMPLETED|Overall Study||7
7779411|NCT01316939|19151897|P2|COMPLETED|Overall Study||9
7779412|NCT01316939|19151898|P1|COMPLETED|Overall Study||13
7779413|NCT01316939|19151896|P3|STARTED|Overall Study||76
7779414|NCT01316939|19151897|P2|STARTED|Overall Study||77
7779415|NCT01316939|19151898|P1|STARTED|Overall Study||76
7779416|NCT01316926|19151978|P2|NOT COMPLETED|Period 2||0
7779417|NCT01316926|19151979|P1|NOT COMPLETED|Period 2||0
7779418|NCT01316926|19151978|P2|COMPLETED|Period 2||30
7779419|NCT01316926|19151979|P1|COMPLETED|Period 2||29
7779420|NCT01316926|19151978|P2|STARTED|Period 2||30
7779421|NCT01316926|19151979|P1|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29
7779422|NCT01316926|19151978|P2|NOT COMPLETED|Period 1||0
7779423|NCT01316926|19151979|P1|NOT COMPLETED|Period 1||0
7779424|NCT01316926|19151978|P2|COMPLETED|Period 1||30
7779425|NCT01316926|19151979|P1|COMPLETED|Period 1||30
7779426|NCT01316926|19151978|P2|STARTED|Period 1||30
7779427|NCT01316926|19151979|P1|STARTED|Period 1||30
7779428|NCT01316913|19151993|P4|NOT COMPLETED|Overall Study||39
7779429|NCT01316913|19151994|P3|NOT COMPLETED|Overall Study||49
7779430|NCT01316913|19151995|P2|NOT COMPLETED|Overall Study||54
7779431|NCT01316913|19151996|P1|NOT COMPLETED|Overall Study||57
7779432|NCT01316913|19151993|P4|COMPLETED|Overall Study||176
7779433|NCT01316913|19151994|P3|COMPLETED|Overall Study||166
7779434|NCT01316913|19151995|P2|COMPLETED|Overall Study||163
7779435|NCT01316913|19151996|P1|COMPLETED|Overall Study||165
7779436|NCT01316913|19151993|P4|STARTED|Overall Study||215
7779437|NCT01316913|19151994|P3|STARTED|Overall Study||215
7779438|NCT01316913|19151995|P2|STARTED|Overall Study||217
7779439|NCT01316913|19151996|P1|STARTED|Overall Study||222
7779440|NCT01316900|19152018|P4|NOT COMPLETED|Overall Study||31
7779441|NCT01316900|19152019|P3|NOT COMPLETED|Overall Study||41
7779442|NCT01316900|19152020|P2|NOT COMPLETED|Overall Study||31
7779443|NCT01316900|19152021|P1|NOT COMPLETED|Overall Study||44
7779444|NCT01316900|19152018|P4|COMPLETED|Overall Study||177
7779445|NCT01316900|19152019|P3|COMPLETED|Overall Study||173
7779446|NCT01316900|19152020|P2|COMPLETED|Overall Study||181
7779447|NCT01316900|19152021|P1|COMPLETED|Overall Study||165
7779448|NCT01316900|19152018|P4|STARTED|Overall Study||208
7779449|NCT01316900|19152019|P3|STARTED|Overall Study||214
7779450|NCT01316900|19152020|P2|STARTED|Overall Study||212
7779451|NCT01316900|19152021|P1|STARTED|Overall Study||209
7779452|NCT01316887|19152042|P3|NOT COMPLETED|Overall Study||83
7779453|NCT01316887|19152043|P2|NOT COMPLETED|Overall Study||94
7779454|NCT01316887|19152044|P1|NOT COMPLETED|Overall Study||43
7779455|NCT01316887|19152042|P3|COMPLETED|Overall Study||143
7779456|NCT01316887|19152043|P2|COMPLETED|Overall Study||133
7779457|NCT01316887|19152044|P1|COMPLETED|Overall Study||66
7779458|NCT01316887|19152042|P3|STARTED|Overall Study||226
7779459|NCT01316887|19152043|P2|STARTED|Overall Study||227
7779460|NCT01316887|19152044|P1|STARTED|Overall Study||109
7779461|NCT01316770|19152106|P2|NOT COMPLETED|Overall Study||0
7779462|NCT01316770|19152107|P1|NOT COMPLETED|Overall Study||0
7779463|NCT01316770|19152106|P2|COMPLETED|Overall Study||9
7779464|NCT01316770|19152107|P1|COMPLETED|Overall Study||9
7779465|NCT01316770|19152106|P2|STARTED|Overall Study|Each study participant received the placebo parotid irrigation on the other side of mouth.|9
7779466|NCT01316770|19152107|P1|STARTED|Overall Study|Each study participant received the dexamethasone parotid irrigation on one side of mouth.|9
7779467|NCT01316692|19152169|P1|NOT COMPLETED|Overall Study||12
7779468|NCT01316692|19152169|P1|COMPLETED|Overall Study||0
7779469|NCT01316692|19152169|P1|STARTED|Overall Study||12
7779470|NCT01316614|19152178|P1|NOT COMPLETED|Overall Study||37
7779471|NCT01316614|19152178|P1|COMPLETED|Overall Study||100
7779472|NCT01316614|19152178|P1|STARTED|Overall Study||137
7779473|NCT01316575|19152195|P2|NOT COMPLETED|Overall Study||1
7779474|NCT01316575|19152196|P1|NOT COMPLETED|Overall Study||2
7779475|NCT01316575|19152195|P2|COMPLETED|Overall Study||19
7779476|NCT01316575|19152196|P1|COMPLETED|Overall Study||18
7779477|NCT01316575|19152195|P2|STARTED|Overall Study||20
7779478|NCT01316575|19152196|P1|STARTED|Overall Study||20
7779479|NCT01316510|19152210|P2|NOT COMPLETED|Overall Study||0
7779480|NCT01316510|19152211|P1|NOT COMPLETED|Overall Study||0
7779481|NCT01316510|19152210|P2|COMPLETED|Overall Study||12
7779482|NCT01316510|19152211|P1|COMPLETED|Overall Study||12
7779483|NCT01316510|19152210|P2|STARTED|Overall Study||12
7779484|NCT01316510|19152211|P1|STARTED|Overall Study||12
7779485|NCT01316419|19152219|P1|NOT COMPLETED|Overall Study||265
7779486|NCT01316419|19152219|P1|COMPLETED|Overall Study||1824
7779487|NCT01316419|19152219|P1|STARTED|Overall Study||2089
7779488|NCT01316380|19152245|P3|NOT COMPLETED|Overall Study||3
7779489|NCT01316380|19152246|P2|NOT COMPLETED|Overall Study||5
7779490|NCT01316380|19152247|P1|NOT COMPLETED|Overall Study||2
7779491|NCT01316380|19152245|P3|COMPLETED|Overall Study||152
7779492|NCT01316380|19152246|P2|COMPLETED|Overall Study||149
7779493|NCT01316380|19152247|P1|COMPLETED|Overall Study||154
7779494|NCT01316380|19152245|P3|STARTED|Overall Study||155
7779495|NCT01316380|19152246|P2|STARTED|Overall Study||154
7779496|NCT01316380|19152247|P1|STARTED|Overall Study||156
7779497|NCT01316341|19152288|P3|NOT COMPLETED|Overall Study||0
7779498|NCT01316341|19152289|P2|NOT COMPLETED|Overall Study||0
7779499|NCT01316341|19152290|P1|NOT COMPLETED|Overall Study||0
7779500|NCT01316341|19152288|P3|COMPLETED|Overall Study||9
7779501|NCT01316341|19152289|P2|COMPLETED|Overall Study||9
7779502|NCT01316341|19152290|P1|COMPLETED|Overall Study||6
7779503|NCT01316341|19152288|P3|STARTED|Overall Study||9
7779504|NCT01316341|19152289|P2|STARTED|Overall Study||9
7779505|NCT01316341|19152290|P1|STARTED|Overall Study||6
7779506|NCT01316315|19152358|P2|NOT COMPLETED|Sequence 2||0
7779507|NCT01316315|19152359|P1|NOT COMPLETED|Sequence 2||0
7779508|NCT01316315|19152358|P2|COMPLETED|Sequence 2||7
7779509|NCT01316315|19152359|P1|COMPLETED|Sequence 2||7
7779510|NCT01316315|19152358|P2|STARTED|Sequence 2||7
7779511|NCT01316315|19152359|P1|STARTED|Sequence 2||7
7779512|NCT01316315|19152358|P2|NOT COMPLETED|Sequence 1||0
7779513|NCT01316315|19152359|P1|NOT COMPLETED|Sequence 1||0
7779514|NCT01316315|19152358|P2|COMPLETED|Sequence 1||7
7779515|NCT01316315|19152359|P1|COMPLETED|Sequence 1||7
7779516|NCT01316315|19152358|P2|STARTED|Sequence 1||7
7779517|NCT01316315|19152359|P1|STARTED|Sequence 1||7
7779518|NCT01316302|19152373|P2|NOT COMPLETED|Overall Study||11
7779519|NCT01316302|19152374|P1|NOT COMPLETED|Overall Study||10
7779520|NCT01316302|19152373|P2|COMPLETED|Overall Study||22
7779521|NCT01316302|19152374|P1|COMPLETED|Overall Study||20
7779522|NCT01316302|19152373|P2|STARTED|Overall Study||33
7779523|NCT01316302|19152374|P1|STARTED|Overall Study||30
7779524|NCT01316276|19152384|P1|NOT COMPLETED|Overall Study||67
7779525|NCT01316276|19152384|P1|COMPLETED|Overall Study||139
7779526|NCT01316276|19152384|P1|STARTED|Overall Study||206
7779527|NCT01316263|19152405|P2|NOT COMPLETED|Overall Study||0
7779528|NCT01316263|19152406|P1|NOT COMPLETED|Overall Study||0
7779529|NCT01316263|19152405|P2|COMPLETED|Overall Study||14
7779530|NCT01316263|19152406|P1|COMPLETED|Overall Study||7
7779531|NCT01316263|19152405|P2|Received Any Study Drug|Overall Study||14
7779532|NCT01316263|19152406|P1|Received Any Study Drug|Overall Study||7
7779533|NCT01316263|19152405|P2|STARTED|Overall Study||14
7779534|NCT01316263|19152406|P1|STARTED|Overall Study||7
7779535|NCT01316224|19152432|P1|NOT COMPLETED|Overall Study||10
7779536|NCT01316224|19152432|P1|COMPLETED|Overall Study||42
7779537|NCT01316224|19152432|P1|Completed Visit 4 to Rheumatologist|Overall Study||28
7779538|NCT01316224|19152432|P1|Completed Visit 4 to Dermatologist|Overall Study||42
7779539|NCT01316224|19152432|P1|Completed Visit 3 to Rheumatologist|Overall Study||39
7779540|NCT01316224|19152432|P1|Completed Visit 3 to Dermatologist|Overall Study||48
7779541|NCT01316224|19152432|P1|Completed Visit 2 to Dermatologist|Overall Study||51
7779542|NCT01316224|19152432|P1|Completed Visit 1 to Rheumatologist|Overall Study||49
7779543|NCT01316224|19152432|P1|Completed Visit 1 to Dermatologist|Overall Study||52
7779544|NCT01316224|19152432|P1|STARTED|Overall Study||52
7779545|NCT01316211|19152448|P2|NOT COMPLETED|Overall Study||12
7779546|NCT01316211|19152449|P1|NOT COMPLETED|Overall Study||11
7779547|NCT01316211|19152448|P2|COMPLETED|Overall Study||111
7779548|NCT01316211|19152449|P1|COMPLETED|Overall Study||105
7779549|NCT01316211|19152448|P2|STARTED|Overall Study||123
7779550|NCT01316211|19152449|P1|STARTED|Overall Study||116
7779551|NCT01316055|19152485|P3|NOT COMPLETED|Overall Study||0
7779552|NCT01316055|19152486|P2|NOT COMPLETED|Overall Study||0
7779553|NCT01316055|19152487|P1|NOT COMPLETED|Overall Study||1
7779554|NCT01316055|19152485|P3|COMPLETED|Overall Study||12
7779555|NCT01316055|19152486|P2|COMPLETED|Overall Study||17
7779556|NCT01316055|19152487|P1|COMPLETED|Overall Study||12
7779557|NCT01316055|19152485|P3|STARTED|Overall Study||12
7779558|NCT01316055|19152486|P2|STARTED|Overall Study||17
7779559|NCT01316055|19152487|P1|STARTED|Overall Study||13
7779560|NCT01316042|19152503|P2|NOT COMPLETED|Overall Study||1
7779561|NCT01316042|19152504|P1|NOT COMPLETED|Overall Study||0
7779562|NCT01316042|19152503|P2|COMPLETED|Overall Study||1
7779563|NCT01316042|19152504|P1|COMPLETED|Overall Study||2
7779564|NCT01316042|19152503|P2|STARTED|Overall Study||2
7779565|NCT01316042|19152504|P1|STARTED|Overall Study||2
7779566|NCT01315873|19152510|P1|NOT COMPLETED|Overall Study||0
7779567|NCT01315873|19152510|P1|COMPLETED|Overall Study||24
7779568|NCT01315873|19152510|P1|STARTED|Overall Study||24
7779569|NCT01315847|19152518|P2|NOT COMPLETED|Part III, Period 2||0
7779570|NCT01315847|19152519|P1|NOT COMPLETED|Part III, Period 2||0
7779571|NCT01315847|19152518|P2|COMPLETED|Part III, Period 2||3
7779572|NCT01315847|19152519|P1|COMPLETED|Part III, Period 2||0
7779573|NCT01315847|19152518|P2|Received [11C]MK-4232|Part III, Period 2||3
7779574|NCT01315847|19152519|P1|Received [11C]MK-4232|Part III, Period 2||0
7779575|NCT01315847|19152518|P2|Received Telcagepant|Part III, Period 2||3
7779576|NCT01315847|19152519|P1|Received Telcagepant|Part III, Period 2||0
7779577|NCT01315847|19152518|P2|STARTED|Part III, Period 2||3
7779578|NCT01315847|19152519|P1|STARTED|Part III, Period 2||0
7779579|NCT01315847|19152518|P2|NOT COMPLETED|Part III, Period 1||1
7779580|NCT01315847|19152519|P1|NOT COMPLETED|Part III, Period 1||0
7779581|NCT01315847|19152518|P2|COMPLETED|Part III, Period 1||3
7779582|NCT01315847|19152519|P1|COMPLETED|Part III, Period 1||0
7779583|NCT01315847|19152518|P2|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4
7779584|NCT01315847|19152519|P1|Received [11C]MK-4232|Part III, Period 1||0
7779585|NCT01315847|19152518|P2|Received Telcagepant|Part III, Period 1||4
7779586|NCT01315847|19152519|P1|Received Telcagepant|Part III, Period 1||0
7779587|NCT01315847|19152518|P2|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4
7779588|NCT01315847|19152519|P1|STARTED|Part III, Period 1||0
7779589|NCT01315847|19152518|P2|NOT COMPLETED|Part I, Period 2||0
7779590|NCT01315847|19152519|P1|NOT COMPLETED|Part I, Period 2||0
7779591|NCT01315847|19152518|P2|COMPLETED|Part I, Period 2||0
7779592|NCT01315847|19152519|P1|COMPLETED|Part I, Period 2||3
7779593|NCT01315847|19152518|P2|Received [11C]MK-4232|Part I, Period 2||0
7779594|NCT01315847|19152519|P1|Received [11C]MK-4232|Part I, Period 2||3
7779595|NCT01315847|19152518|P2|Received Telcagepant|Part I, Period 2||0
7779596|NCT01315847|19152519|P1|Received Telcagepant|Part I, Period 2||3
7779597|NCT01315847|19152518|P2|STARTED|Part I, Period 2||0
7779598|NCT01315847|19152519|P1|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3
7779599|NCT01315847|19152518|P2|NOT COMPLETED|Part I, Period 1||0
7779600|NCT01315847|19152519|P1|NOT COMPLETED|Part I, Period 1||3
7779601|NCT01315847|19152518|P2|COMPLETED|Part I, Period 1||0
7779602|NCT01315847|19152519|P1|COMPLETED|Part I, Period 1||2
7779603|NCT01315847|19152518|P2|Received [11C]MK-4232|Part I, Period 1||0
7779604|NCT01315847|19152519|P1|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5
7779605|NCT01315847|19152518|P2|Received Telcagepant|Part I, Period 1||0
7779606|NCT01315847|19152519|P1|Received Telcagepant|Part I, Period 1||5
7779607|NCT01315847|19152518|P2|STARTED|Part I, Period 1||0
7779608|NCT01315847|19152519|P1|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5
7779609|NCT01315678|19152533|P2|NOT COMPLETED|Overall Study||6
7779610|NCT01315678|19152534|P1|NOT COMPLETED|Overall Study||14
7779611|NCT01315678|19152533|P2|COMPLETED|Overall Study||140
7779612|NCT01315678|19152534|P1|COMPLETED|Overall Study||134
7779613|NCT01315678|19152533|P2|STARTED|Overall Study||146
7779614|NCT01315678|19152534|P1|STARTED|Overall Study||148
7779615|NCT01315665|19152554|P2|NOT COMPLETED|Overall Study||0
7779616|NCT01315665|19152555|P1|NOT COMPLETED|Overall Study||0
7779617|NCT01315665|19152554|P2|COMPLETED|Overall Study||5
7779618|NCT01315665|19152555|P1|COMPLETED|Overall Study||10
7779619|NCT01315665|19152554|P2|STARTED|Overall Study||5
7779620|NCT01315665|19152555|P1|STARTED|Overall Study||10
7779621|NCT01315574|19152571|P2|NOT COMPLETED|Overall Study||0
7779622|NCT01315574|19152572|P1|NOT COMPLETED|Overall Study||0
7779623|NCT01315574|19152571|P2|COMPLETED|Overall Study||7
7779624|NCT01315574|19152572|P1|COMPLETED|Overall Study||7
7779625|NCT01315574|19152571|P2|STARTED|Overall Study||7
7779626|NCT01315574|19152572|P1|STARTED|Overall Study||7
7779627|NCT01315353|19152585|P3|NOT COMPLETED|Overall Study||13
7779628|NCT01315353|19152586|P2|NOT COMPLETED|Overall Study||23
7779629|NCT01315353|19152587|P1|NOT COMPLETED|Overall Study||29
7779630|NCT01315353|19152585|P3|COMPLETED|Overall Study||166
7779631|NCT01315353|19152586|P2|COMPLETED|Overall Study||120
7779632|NCT01315353|19152587|P1|COMPLETED|Overall Study||116
7779633|NCT01315353|19152585|P3|STARTED|Overall Study||179
7779634|NCT01315353|19152586|P2|STARTED|Overall Study||143
7779635|NCT01315353|19152587|P1|STARTED|Overall Study||145
7779636|NCT01315249|19152614|P2|NOT COMPLETED|Overall Study||47
7779637|NCT01315249|19152615|P1|NOT COMPLETED|Overall Study||44
7779638|NCT01315249|19152614|P2|COMPLETED|Overall Study||217
7779639|NCT01315249|19152615|P1|COMPLETED|Overall Study||215
7779640|NCT01315249|19152614|P2|STARTED|Overall Study||264
7779641|NCT01315249|19152615|P1|STARTED|Overall Study||259
7779642|NCT01315236|19152643|P2|NOT COMPLETED|12-Month Follow-up Period||1
7779643|NCT01315236|19152644|P1|NOT COMPLETED|12-Month Follow-up Period||1
7779644|NCT01315236|19152643|P2|COMPLETED|12-Month Follow-up Period||31
7779645|NCT01315236|19152644|P1|COMPLETED|12-Month Follow-up Period||26
7779646|NCT01315236|19152643|P2|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|32
7779647|NCT01315236|19152644|P1|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|27
7779648|NCT01315236|19152643|P2|NOT COMPLETED|Open-label Phase||2
7779649|NCT01315236|19152644|P1|NOT COMPLETED|Open-label Phase||1
7779650|NCT01315236|19152643|P2|COMPLETED|Open-label Phase||41
7779651|NCT01315236|19152644|P1|COMPLETED|Open-label Phase||34
7779652|NCT01315236|19152643|P2|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|43
7779653|NCT01315236|19152644|P1|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|35
7779654|NCT01315236|19152643|P2|NOT COMPLETED|Double-blind Phase||0
7779655|NCT01315236|19152644|P1|NOT COMPLETED|Double-blind Phase||4
7779656|NCT01315236|19152643|P2|COMPLETED|Double-blind Phase||45
7779657|NCT01315236|19152644|P1|COMPLETED|Double-blind Phase||40
7779658|NCT01315236|19152643|P2|STARTED|Double-blind Phase||45
7779659|NCT01315236|19152644|P1|STARTED|Double-blind Phase||44
7779660|NCT01315158|19152668|P2|NOT COMPLETED|Overall Study||0
7779661|NCT01315158|19152669|P1|NOT COMPLETED|Overall Study||0
7779662|NCT01315158|19152668|P2|COMPLETED|Overall Study||19
7779663|NCT01315158|19152669|P1|COMPLETED|Overall Study||17
7779664|NCT01315158|19152668|P2|STARTED|Overall Study||19
7779665|NCT01315158|19152669|P1|STARTED|Overall Study||17
7779666|NCT01315145|19152693|P2|NOT COMPLETED|Overall Study||5
7779667|NCT01315145|19152694|P1|NOT COMPLETED|Overall Study||17
7779668|NCT01315145|19152693|P2|COMPLETED|Overall Study||11
7779669|NCT01315145|19152694|P1|COMPLETED|Overall Study||105
7779670|NCT01315145|19152693|P2|STARTED|Overall Study||16
7779671|NCT01315145|19152694|P1|STARTED|Overall Study||122
7779672|NCT01315132|19152700|P1|NOT COMPLETED|Overall Study||1
7779673|NCT01315132|19152700|P1|COMPLETED|Overall Study||46
7779674|NCT01315132|19152700|P1|STARTED|Overall Study||47
7779675|NCT01315028|19152707|P2|NOT COMPLETED|Overall Study||1
7779676|NCT01315028|19152708|P1|NOT COMPLETED|Overall Study||1
7779677|NCT01315028|19152707|P2|COMPLETED|Overall Study||9
7779678|NCT01315028|19152708|P1|COMPLETED|Overall Study||9
7779679|NCT01315028|19152707|P2|STARTED|Overall Study||10
7779680|NCT01315028|19152708|P1|STARTED|Overall Study||10
7779681|NCT01315002|19152720|P2|NOT COMPLETED|Overall Study||5
7779682|NCT01315002|19152721|P1|NOT COMPLETED|Overall Study||5
7779683|NCT01315002|19152720|P2|COMPLETED|Overall Study||55
7779684|NCT01315002|19152721|P1|COMPLETED|Overall Study||56
7779685|NCT01315002|19152720|P2|STARTED|Overall Study||60
7779686|NCT01315002|19152721|P1|STARTED|Overall Study||61
7779687|NCT01314963|19152727|P1|NOT COMPLETED|Overall Study||0
7779688|NCT01314963|19152727|P1|COMPLETED|Overall Study||50
7779689|NCT01314963|19152727|P1|STARTED|Overall Study||50
7779690|NCT01314911|19152735|P2|NOT COMPLETED|Overall Study||6
7779691|NCT01314911|19152736|P1|NOT COMPLETED|Overall Study||5
7779692|NCT01314911|19152735|P2|COMPLETED|Overall Study||274
7779693|NCT01314911|19152736|P1|COMPLETED|Overall Study||273
7779694|NCT01314911|19152735|P2|STARTED|Overall Study||280
7779695|NCT01314911|19152736|P1|STARTED|Overall Study||278
7779696|NCT01314872|19152787|P15|NOT COMPLETED|Period 2||24
7779697|NCT01314872|19152788|P14|NOT COMPLETED|Period 2||53
7779698|NCT01314872|19152789|P13|NOT COMPLETED|Period 2||60
7779699|NCT01314872|19152790|P12|NOT COMPLETED|Period 2||48
7779700|NCT01314872|19152791|P11|NOT COMPLETED|Period 2||0
7779701|NCT01314872|19152792|P10|NOT COMPLETED|Period 2||0
7779702|NCT01314872|19152793|P9|NOT COMPLETED|Period 2||0
7779703|NCT01314872|19152794|P8|NOT COMPLETED|Period 2||0
7779704|NCT01314872|19152795|P7|NOT COMPLETED|Period 2||0
7779705|NCT01314872|19152796|P6|NOT COMPLETED|Period 2||0
7779706|NCT01314872|19152797|P5|NOT COMPLETED|Period 2||0
7779707|NCT01314872|19152798|P4|NOT COMPLETED|Period 2||0
7779708|NCT01314872|19152799|P3|NOT COMPLETED|Period 2||0
7779709|NCT01314872|19152800|P2|NOT COMPLETED|Period 2||0
7779710|NCT01314872|19152801|P1|NOT COMPLETED|Period 2||0
7779711|NCT01314872|19152787|P15|COMPLETED|Period 2||110
7779712|NCT01314872|19152788|P14|COMPLETED|Period 2||187
7779713|NCT01314872|19152789|P13|COMPLETED|Period 2||188
7779714|NCT01314872|19152790|P12|COMPLETED|Period 2||175
7779715|NCT01314872|19152791|P11|COMPLETED|Period 2||0
7779716|NCT01314872|19152792|P10|COMPLETED|Period 2||0
7779717|NCT01314872|19152793|P9|COMPLETED|Period 2||0
7779718|NCT01314872|19152794|P8|COMPLETED|Period 2||0
7779719|NCT01314872|19152795|P7|COMPLETED|Period 2||0
7779720|NCT01314872|19152796|P6|COMPLETED|Period 2||0
7779721|NCT01314872|19152797|P5|COMPLETED|Period 2||0
7779722|NCT01314872|19152798|P4|COMPLETED|Period 2||0
7779723|NCT01314872|19152799|P3|COMPLETED|Period 2||0
7779724|NCT01314872|19152800|P2|COMPLETED|Period 2||0
7779725|NCT01314872|19152801|P1|COMPLETED|Period 2||0
7779726|NCT01314872|19152787|P15|STARTED|Period 2||134
7779727|NCT01314872|19152788|P14|STARTED|Period 2||240
7779728|NCT01314872|19152789|P13|STARTED|Period 2||248
7779729|NCT01314872|19152790|P12|STARTED|Period 2||223
7779730|NCT01314872|19152791|P11|STARTED|Period 2||0
7779731|NCT01314872|19152792|P10|STARTED|Period 2||0
7779732|NCT01314872|19152793|P9|STARTED|Period 2||0
7779733|NCT01314872|19152794|P8|STARTED|Period 2||0
7779734|NCT01314872|19152795|P7|STARTED|Period 2||0
7779735|NCT01314872|19152796|P6|STARTED|Period 2||0
7779736|NCT01314872|19152797|P5|STARTED|Period 2||0
7779737|NCT01314872|19152798|P4|STARTED|Period 2||0
7779738|NCT01314872|19152799|P3|STARTED|Period 2||0
7779739|NCT01314872|19152800|P2|STARTED|Period 2||0
7779740|NCT01314872|19152801|P1|STARTED|Period 2||0
7779741|NCT01314872|19152787|P15|NOT COMPLETED|Treatment Period 1||0
7779742|NCT01314872|19152788|P14|NOT COMPLETED|Treatment Period 1||0
7779743|NCT01314872|19152789|P13|NOT COMPLETED|Treatment Period 1||0
7779744|NCT01314872|19152790|P12|NOT COMPLETED|Treatment Period 1||0
7779745|NCT01314872|19152791|P11|NOT COMPLETED|Treatment Period 1||3
7779746|NCT01314872|19152792|P10|NOT COMPLETED|Treatment Period 1||4
7779747|NCT01314872|19152793|P9|NOT COMPLETED|Treatment Period 1||6
7779748|NCT01314872|19152794|P8|NOT COMPLETED|Treatment Period 1||7
7779749|NCT01314872|19152795|P7|NOT COMPLETED|Treatment Period 1||8
7779750|NCT01314872|19152796|P6|NOT COMPLETED|Treatment Period 1||7
7779751|NCT01314872|19152797|P5|NOT COMPLETED|Treatment Period 1||7
7779752|NCT01314872|19152798|P4|NOT COMPLETED|Treatment Period 1||7
7779753|NCT01314872|19152799|P3|NOT COMPLETED|Treatment Period 1||6
7779754|NCT01314872|19152800|P2|NOT COMPLETED|Treatment Period 1||6
7779755|NCT01314872|19152801|P1|NOT COMPLETED|Treatment Period 1||10
7779756|NCT01314872|19152787|P15|COMPLETED|Treatment Period 1||0
7779757|NCT01314872|19152788|P14|COMPLETED|Treatment Period 1||0
7779758|NCT01314872|19152789|P13|COMPLETED|Treatment Period 1||0
7779759|NCT01314872|19152790|P12|COMPLETED|Treatment Period 1||0
7779760|NCT01314872|19152791|P11|COMPLETED|Treatment Period 1||107
7779761|NCT01314872|19152792|P10|COMPLETED|Treatment Period 1||118
7779762|NCT01314872|19152793|P9|COMPLETED|Treatment Period 1||106
7779763|NCT01314872|19152794|P8|COMPLETED|Treatment Period 1||57
7779764|NCT01314872|19152795|P7|COMPLETED|Treatment Period 1||126
7779765|NCT01314872|19152796|P6|COMPLETED|Treatment Period 1||128
7779766|NCT01314872|19152797|P5|COMPLETED|Treatment Period 1||142
7779767|NCT01314872|19152798|P4|COMPLETED|Treatment Period 1||143
7779768|NCT01314872|19152799|P3|COMPLETED|Treatment Period 1||128
7779769|NCT01314872|19152800|P2|COMPLETED|Treatment Period 1||138
7779770|NCT01314872|19152801|P1|COMPLETED|Treatment Period 1||131
7779771|NCT01314872|19152787|P15|STARTED|Treatment Period 1||0
7779772|NCT01314872|19152788|P14|STARTED|Treatment Period 1||0
7779773|NCT01314872|19152789|P13|STARTED|Treatment Period 1||0
7779774|NCT01314872|19152790|P12|STARTED|Treatment Period 1||0
7779775|NCT01314872|19152791|P11|STARTED|Treatment Period 1||110
7779776|NCT01314872|19152792|P10|STARTED|Treatment Period 1||122
7779777|NCT01314872|19152793|P9|STARTED|Treatment Period 1||112
7779778|NCT01314872|19152794|P8|STARTED|Treatment Period 1||64
7779779|NCT01314872|19152795|P7|STARTED|Treatment Period 1||134
7779780|NCT01314872|19152796|P6|STARTED|Treatment Period 1||135
7779781|NCT01314872|19152797|P5|STARTED|Treatment Period 1||149
7779782|NCT01314872|19152798|P4|STARTED|Treatment Period 1||150
7779783|NCT01314872|19152799|P3|STARTED|Treatment Period 1||134
7779784|NCT01314872|19152800|P2|STARTED|Treatment Period 1||144
7779785|NCT01314872|19152801|P1|STARTED|Treatment Period 1||141
7779786|NCT01314742|19152894|P2|NOT COMPLETED|Overall Study||0
7779787|NCT01314742|19152895|P1|NOT COMPLETED|Overall Study||0
7779788|NCT01314742|19152894|P2|COMPLETED|Overall Study||21
7779789|NCT01314742|19152895|P1|COMPLETED|Overall Study||20
7779790|NCT01314742|19152894|P2|STARTED|Overall Study||21
7779791|NCT01314742|19152895|P1|STARTED|Overall Study||20
7779792|NCT01314716|19152905|P2|NOT COMPLETED|Open-Label Phase||12
7779793|NCT01314716|19152906|P1|NOT COMPLETED|Open-Label Phase||10
7779794|NCT01314716|19152905|P2|COMPLETED|Open-Label Phase||98
7779795|NCT01314716|19152906|P1|COMPLETED|Open-Label Phase||102
7779796|NCT01314716|19152905|P2|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110
7779797|NCT01314716|19152906|P1|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112
7779798|NCT01314716|19152905|P2|NOT COMPLETED|Double-Blind Phase||15
7779799|NCT01314716|19152906|P1|NOT COMPLETED|Double-Blind Phase||17
7779800|NCT01314716|19152905|P2|COMPLETED|Double-Blind Phase||123
7779801|NCT01314716|19152906|P1|COMPLETED|Double-Blind Phase||119
7779802|NCT01314716|19152905|P2|Randomized and Treated|Double-Blind Phase||137
7779803|NCT01314716|19152906|P1|Randomized and Treated|Double-Blind Phase||135
7779804|NCT01314716|19152905|P2|STARTED|Double-Blind Phase||138
7779805|NCT01314716|19152906|P1|STARTED|Double-Blind Phase||136
7779806|NCT01314703|19152918|P1|NOT COMPLETED|Overall Study||8
7779807|NCT01314703|19152918|P1|COMPLETED|Overall Study||27
7779808|NCT01314703|19152918|P1|Discontinued When Enrollment Completed|Overall Study||3
7779809|NCT01314703|19152918|P1|Non Qualified Bacterial Screening Counts|Overall Study||3
7779810|NCT01314703|19152918|P1|Excluded Prior to Screening Baseline|Overall Study||2
7779811|NCT01314703|19152918|P1|Completed Study|Overall Study||27
7779812|NCT01314703|19152918|P1|Completed Treatment Visit|Overall Study||27
7779813|NCT01314703|19152918|P1|Completed Screen Visit|Overall Study||33
7779814|NCT01314703|19152918|P1|Signed Informed Consent|Overall Study||35
7779815|NCT01314703|19152918|P1|STARTED|Overall Study||35
7779816|NCT01314443|19152927|P4|NOT COMPLETED|Overall Study||2
7779817|NCT01314443|19152928|P3|NOT COMPLETED|Overall Study||2
7779818|NCT01314443|19152929|P2|NOT COMPLETED|Overall Study||3
7779819|NCT01314443|19152930|P1|NOT COMPLETED|Overall Study||4
7779820|NCT01314443|19152927|P4|COMPLETED|Overall Study||13
7779821|NCT01314443|19152928|P3|COMPLETED|Overall Study||13
7779822|NCT01314443|19152929|P2|COMPLETED|Overall Study||16
7779823|NCT01314443|19152930|P1|COMPLETED|Overall Study||14
7779824|NCT01314443|19152927|P4|STARTED|Overall Study||15
7779825|NCT01314443|19152928|P3|STARTED|Overall Study||15
7779826|NCT01314443|19152929|P2|STARTED|Overall Study||19
7779827|NCT01314443|19152930|P1|STARTED|Overall Study||18
7779828|NCT01314417|19152948|P1|NOT COMPLETED|Overall Study||0
7779829|NCT01314417|19152948|P1|COMPLETED|Overall Study||2
7779830|NCT01314417|19152948|P1|STARTED|Overall Study||2
7779831|NCT01314313|19152979|P2|NOT COMPLETED|Overall Study||311
7779832|NCT01314313|19152980|P1|NOT COMPLETED|Overall Study||227
7779833|NCT01314313|19152979|P2|COMPLETED|Overall Study||710
7779834|NCT01314313|19152980|P1|COMPLETED|Overall Study||784
7779835|NCT01314313|19152979|P2|Valve Implanted|Overall Study||936
7779836|NCT01314313|19152980|P1|Valve Implanted|Overall Study||974
7779837|NCT01314313|19152979|P2|As Treated|Overall Study||944
7779838|NCT01314313|19152980|P1|As Treated|Overall Study||994
7779839|NCT01314313|19152979|P2|STARTED|Overall Study||1021
7779840|NCT01314313|19152980|P1|STARTED|Overall Study||1011
7779841|NCT01314261|19153000|P4|NOT COMPLETED|Overall Study||3
7779842|NCT01314261|19153001|P3|NOT COMPLETED|Overall Study||3
7779843|NCT01314261|19153002|P2|NOT COMPLETED|Overall Study||4
7779844|NCT01314261|19153003|P1|NOT COMPLETED|Overall Study||2
7779845|NCT01314261|19153000|P4|COMPLETED|Overall Study||6
7779846|NCT01314261|19153001|P3|COMPLETED|Overall Study||7
7779847|NCT01314261|19153002|P2|COMPLETED|Overall Study||5
7779848|NCT01314261|19153003|P1|COMPLETED|Overall Study||7
7779849|NCT01314261|19153000|P4|Discontinued pegIFN/RBV|Overall Study||1
7779850|NCT01314261|19153001|P3|Discontinued pegIFN/RBV|Overall Study||5
7779851|NCT01314261|19153002|P2|Discontinued pegIFN/RBV|Overall Study||4
7779852|NCT01314261|19153003|P1|Discontinued pegIFN/RBV|Overall Study||1
7779853|NCT01314261|19153000|P4|Discontinued ABT-267 or Placebo|Overall Study||0
7779854|NCT01314261|19153001|P3|Discontinued ABT-267 or Placebo|Overall Study||1
7779855|NCT01314261|19153002|P2|Discontinued ABT-267 or Placebo|Overall Study||0
7779856|NCT01314261|19153003|P1|Discontinued ABT-267 or Placebo|Overall Study||1
7779857|NCT01314261|19153000|P4|STARTED|Overall Study||9
7779858|NCT01314261|19153001|P3|STARTED|Overall Study||10
7779859|NCT01314261|19153002|P2|STARTED|Overall Study||9
7779860|NCT01314261|19153003|P1|STARTED|Overall Study||9
7779861|NCT01314118|19153054|P1|NOT COMPLETED|Overall Study||131
7779862|NCT01314118|19153054|P1|COMPLETED|Overall Study||0
7779863|NCT01314118|19153054|P1|STARTED|Overall Study||131
7779864|NCT01314105|19153063|P2|NOT COMPLETED|Overall Study||12
7779865|NCT01314105|19153064|P1|NOT COMPLETED|Overall Study||7
7779866|NCT01314105|19153063|P2|COMPLETED|Overall Study||0
7779867|NCT01314105|19153064|P1|COMPLETED|Overall Study||0
7779868|NCT01314105|19153063|P2|STARTED|Overall Study||12
7779869|NCT01314105|19153064|P1|STARTED|Overall Study||7
7779870|NCT01314014|19153106|P1|NOT COMPLETED|Overall Study||0
7779871|NCT01314014|19153106|P1|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22
7779872|NCT01314014|19153106|P1|STARTED|Overall Study||22
7779873|NCT01314001|19153117|P6|NOT COMPLETED|Overall Study||71
7779874|NCT01314001|19153118|P5|NOT COMPLETED|Overall Study||72
7779875|NCT01314001|19153119|P4|NOT COMPLETED|Overall Study||69
7779876|NCT01314001|19153120|P3|NOT COMPLETED|Overall Study||69
7779877|NCT01314001|19153121|P2|NOT COMPLETED|Overall Study||69
7779878|NCT01314001|19153122|P1|NOT COMPLETED|Overall Study||75
7779879|NCT01314001|19153117|P6|COMPLETED|Overall Study||129
7779880|NCT01314001|19153118|P5|COMPLETED|Overall Study||148
7779881|NCT01314001|19153119|P4|COMPLETED|Overall Study||122
7779882|NCT01314001|19153120|P3|COMPLETED|Overall Study||158
7779883|NCT01314001|19153121|P2|COMPLETED|Overall Study||124
7779884|NCT01314001|19153122|P1|COMPLETED|Overall Study||140
7779885|NCT01314001|19153117|P6|6-Month Follow Up Survey|Overall Study||139
7779886|NCT01314001|19153118|P5|6-Month Follow Up Survey|Overall Study||157
7779887|NCT01314001|19153119|P4|6-Month Follow Up Survey|Overall Study||135
7779888|NCT01314001|19153120|P3|6-Month Follow Up Survey|Overall Study||165
7779889|NCT01314001|19153121|P2|6-Month Follow Up Survey|Overall Study||137
7779890|NCT01314001|19153122|P1|6-Month Follow Up Survey|Overall Study||146
7779891|NCT01314001|19153117|P6|End-of-Treatment Visit|Overall Study||160
7779892|NCT01314001|19153118|P5|End-of-Treatment Visit|Overall Study||174
7779893|NCT01314001|19153119|P4|End-of-Treatment Visit|Overall Study||146
7779894|NCT01314001|19153120|P3|End-of-Treatment Visit|Overall Study||179
7779895|NCT01314001|19153121|P2|End-of-Treatment Visit|Overall Study||141
7779896|NCT01314001|19153122|P1|End-of-Treatment Visit|Overall Study||156
7779897|NCT01314001|19153117|P6|STARTED|Overall Study||200
7779898|NCT01314001|19153118|P5|STARTED|Overall Study||220
7779899|NCT01314001|19153119|P4|STARTED|Overall Study||191
7779900|NCT01314001|19153120|P3|STARTED|Overall Study||227
7779901|NCT01314001|19153121|P2|STARTED|Overall Study||193
7779902|NCT01314001|19153122|P1|STARTED|Overall Study||215
7779903|NCT01313936|19153168|P2|NOT COMPLETED|Overall Study||0
7779904|NCT01313936|19153169|P1|NOT COMPLETED|Overall Study||0
7779905|NCT01313936|19153168|P2|COMPLETED|Overall Study||26
7779906|NCT01313936|19153169|P1|COMPLETED|Overall Study||6
7779907|NCT01313936|19153168|P2|STARTED|Overall Study||26
7779908|NCT01313936|19153169|P1|STARTED|Overall Study||6
7779909|NCT01313923|19153182|P1|NOT COMPLETED|Overall Study||3
7779910|NCT01313923|19153182|P1|COMPLETED|Overall Study||0
7779911|NCT01313923|19153182|P1|STARTED|Overall Study||3
7779912|NCT01313910|19153186|P1|NOT COMPLETED|Overall Study||0
7779913|NCT01313910|19153186|P1|COMPLETED|Overall Study||8
7779914|NCT01313910|19153186|P1|STARTED|Overall Study||8
7779915|NCT01313897|19153194|P1|NOT COMPLETED|Overall Study||2
7779916|NCT01313897|19153194|P1|COMPLETED|Overall Study||8
7779917|NCT01313897|19153194|P1|STARTED|Overall Study||10
7779918|NCT01313884|19153198|P1|NOT COMPLETED|Overall Study||1
7779919|NCT01313884|19153198|P1|COMPLETED|Overall Study||2
7779920|NCT01313884|19153198|P1|STARTED|Overall Study||3
7779921|NCT01313858|19153206|P3|NOT COMPLETED|Overall Study||238
7779922|NCT01313858|19153207|P2|NOT COMPLETED|Overall Study||270
7779923|NCT01313858|19153208|P1|NOT COMPLETED|Overall Study||286
7779924|NCT01313858|19153206|P3|COMPLETED|Overall Study||305
7779925|NCT01313858|19153207|P2|COMPLETED|Overall Study||276
7779926|NCT01313858|19153208|P1|COMPLETED|Overall Study||238
7779927|NCT01313858|19153206|P3|STARTED|Overall Study||543
7779928|NCT01313858|19153207|P2|STARTED|Overall Study||546
7779929|NCT01313858|19153208|P1|STARTED|Overall Study||524
7779930|NCT01313780|19153231|P2|NOT COMPLETED|Overall Study||28
7779931|NCT01313780|19153232|P1|NOT COMPLETED|Overall Study||25
7779932|NCT01313780|19153231|P2|COMPLETED|Overall Study|PPS|31
7779933|NCT01313780|19153232|P1|COMPLETED|Overall Study|PPS|33
7779934|NCT01313780|19153231|P2|STARTED|Overall Study|FAS|59
7779935|NCT01313780|19153232|P1|STARTED|Overall Study|FAS|58
7779936|NCT01313767|19153242|P2|NOT COMPLETED|Overall Study||2
7779937|NCT01313767|19153243|P1|NOT COMPLETED|Overall Study||7
7779938|NCT01313767|19153242|P2|COMPLETED|Overall Study||96
7779939|NCT01313767|19153243|P1|COMPLETED|Overall Study||91
7779940|NCT01313767|19153242|P2|STARTED|Overall Study||98
7779941|NCT01313767|19153243|P1|STARTED|Overall Study||98
7779942|NCT01313728|19153285|P1|NOT COMPLETED|Baseline to Completion||0
7779943|NCT01313728|19153285|P1|COMPLETED|Baseline to Completion||25
7779944|NCT01313728|19153285|P1|STARTED|Baseline to Completion||25
7779945|NCT01313728|19153285|P1|NOT COMPLETED|Informed Consent to Baseline||1
7779946|NCT01313728|19153285|P1|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25
7779947|NCT01313728|19153285|P1|STARTED|Informed Consent to Baseline||26
7779948|NCT01313689|19153305|P5|NOT COMPLETED|24-Week Randomization 2||15
7779949|NCT01313689|19153306|P4|NOT COMPLETED|24-Week Randomization 2||1
7779950|NCT01313689|19153307|P3|NOT COMPLETED|24-Week Randomization 2||3
7779951|NCT01313689|19153308|P2|NOT COMPLETED|24-Week Randomization 2||0
7779952|NCT01313689|19153309|P1|NOT COMPLETED|24-Week Randomization 2||0
7779953|NCT01313689|19153305|P5|COMPLETED|24-Week Randomization 2||27
7779954|NCT01313689|19153306|P4|COMPLETED|24-Week Randomization 2||12
7779955|NCT01313689|19153307|P3|COMPLETED|24-Week Randomization 2||21
7779956|NCT01313689|19153308|P2|COMPLETED|24-Week Randomization 2||0
7779957|NCT01313689|19153309|P1|COMPLETED|24-Week Randomization 2||0
7779958|NCT01313689|19153305|P5|STARTED|24-Week Randomization 2|OFA Participants who did not enter Randomization 2.|42
7779959|NCT01313689|19153306|P4|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13
7779960|NCT01313689|19153307|P3|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24
7779961|NCT01313689|19153308|P2|STARTED|24-Week Randomization 2||0
7779962|NCT01313689|19153309|P1|STARTED|24-Week Randomization 2||0
7779963|NCT01313689|19153305|P5|NOT COMPLETED|24-Week Randomization 1||0
7779964|NCT01313689|19153306|P4|NOT COMPLETED|24-Week Randomization 1||0
7779965|NCT01313689|19153307|P3|NOT COMPLETED|24-Week Randomization 1||0
7779966|NCT01313689|19153308|P2|NOT COMPLETED|24-Week Randomization 1||10
7779967|NCT01313689|19153309|P1|NOT COMPLETED|24-Week Randomization 1||19
7779968|NCT01313689|19153305|P5|COMPLETED|24-Week Randomization 1||0
7779969|NCT01313689|19153306|P4|COMPLETED|24-Week Randomization 1||0
7779970|NCT01313689|19153307|P3|COMPLETED|24-Week Randomization 1||0
7779971|NCT01313689|19153308|P2|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33
7779972|NCT01313689|19153309|P1|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60
7779973|NCT01313689|19153305|P5|STARTED|24-Week Randomization 1||0
7779974|NCT01313689|19153306|P4|STARTED|24-Week Randomization 1||0
7779975|NCT01313689|19153307|P3|STARTED|24-Week Randomization 1||0
7779976|NCT01313689|19153308|P2|STARTED|24-Week Randomization 1|Of the 43 participants in the PC arm, 22 entered the OFA Salvage arm.|43
7779977|NCT01313689|19153309|P1|STARTED|24-Week Randomization 1||79
7779978|NCT01313676|19153388|P4|NOT COMPLETED|Overall Study||994
7779979|NCT01313676|19153389|P3|NOT COMPLETED|Overall Study||1088
7779980|NCT01313676|19153390|P2|NOT COMPLETED|Overall Study||1113
7779981|NCT01313676|19153391|P1|NOT COMPLETED|Overall Study||1250
7779982|NCT01313676|19153388|P4|COMPLETED|Overall Study||3146
7779983|NCT01313676|19153389|P3|COMPLETED|Overall Study||3052
7779984|NCT01313676|19153390|P2|COMPLETED|Overall Study||3044
7779985|NCT01313676|19153391|P1|COMPLETED|Overall Study||2881
7779986|NCT01313676|19153388|P4|STARTED|Overall Study||4140
7779987|NCT01313676|19153389|P3|STARTED|Overall Study||4140
7779988|NCT01313676|19153390|P2|STARTED|Overall Study||4157
7779989|NCT01313676|19153391|P1|STARTED|Overall Study||4131
7779990|NCT01313663|19153411|P2|NOT COMPLETED|Overall Study||8
7779991|NCT01313663|19153412|P1|NOT COMPLETED|Overall Study||4
7779992|NCT01313663|19153411|P2|COMPLETED|Overall Study||3
7779993|NCT01313663|19153412|P1|COMPLETED|Overall Study||5
7779994|NCT01313663|19153411|P2|STARTED|Overall Study||11
7779995|NCT01313663|19153412|P1|STARTED|Overall Study||9
7779996|NCT01313650|19153450|P4|NOT COMPLETED|Overall Study||81
7779997|NCT01313650|19153451|P3|NOT COMPLETED|Overall Study||103
7779998|NCT01313650|19153452|P2|NOT COMPLETED|Overall Study||94
7779999|NCT01313650|19153453|P1|NOT COMPLETED|Overall Study||76
7780000|NCT01313650|19153450|P4|COMPLETED|Overall Study||332
7780001|NCT01313650|19153451|P3|COMPLETED|Overall Study||318
7780002|NCT01313650|19153452|P2|COMPLETED|Overall Study||324
7780003|NCT01313650|19153453|P1|COMPLETED|Overall Study||204
7780004|NCT01313650|19153450|P4|STARTED|Overall Study||413
7780005|NCT01313650|19153451|P3|STARTED|Overall Study||421
7780006|NCT01313650|19153452|P2|STARTED|Overall Study||418
7780007|NCT01313650|19153453|P1|STARTED|Overall Study||280
7780008|NCT01313637|19153479|P4|NOT COMPLETED|Overall Study||78
7780009|NCT01313637|19153480|P3|NOT COMPLETED|Overall Study||106
7780010|NCT01313637|19153481|P2|NOT COMPLETED|Overall Study||95
7780011|NCT01313637|19153482|P1|NOT COMPLETED|Overall Study||92
7780012|NCT01313637|19153479|P4|COMPLETED|Overall Study||325
7780013|NCT01313637|19153480|P3|COMPLETED|Overall Study||298
7780014|NCT01313637|19153481|P2|COMPLETED|Overall Study||312
7780015|NCT01313637|19153482|P1|COMPLETED|Overall Study||183
7780016|NCT01313637|19153479|P4|STARTED|Overall Study||403
7780017|NCT01313637|19153480|P3|STARTED|Overall Study||404
7780018|NCT01313637|19153481|P2|STARTED|Overall Study||407
7780019|NCT01313637|19153482|P1|STARTED|Overall Study||275
7780020|NCT01313624|19153506|P2|NOT COMPLETED|Open-Label Phase||13
7780021|NCT01313624|19153507|P1|NOT COMPLETED|Open-Label Phase||4
7780022|NCT01313624|19153506|P2|COMPLETED|Open-Label Phase||109
7780023|NCT01313624|19153507|P1|COMPLETED|Open-Label Phase||92
7780024|NCT01313624|19153506|P2|STARTED|Open-Label Phase||122
7780025|NCT01313624|19153507|P1|STARTED|Open-Label Phase||96
7780026|NCT01313624|19153506|P2|NOT COMPLETED|Double-Blind Phase||10
7780027|NCT01313624|19153507|P1|NOT COMPLETED|Double-Blind Phase||38
7780028|NCT01313624|19153506|P2|COMPLETED|Double-Blind Phase||122
7780029|NCT01313624|19153507|P1|COMPLETED|Double-Blind Phase||96
7780030|NCT01313624|19153506|P2|STARTED|Double-Blind Phase||132
7780031|NCT01313624|19153507|P1|STARTED|Double-Blind Phase||134
7780032|NCT01313559|19153521|P2|NOT COMPLETED|Overall Study||2
7780033|NCT01313559|19153522|P1|NOT COMPLETED|Overall Study||4
7780034|NCT01313559|19153521|P2|COMPLETED|Overall Study||0
7780035|NCT01313559|19153522|P1|COMPLETED|Overall Study||0
7780036|NCT01313559|19153521|P2|STARTED|Overall Study||2
7780037|NCT01313559|19153522|P1|STARTED|Overall Study||4
7780038|NCT01313520|19153536|P2|NOT COMPLETED|Overall Study||0
7780039|NCT01313520|19153537|P1|NOT COMPLETED|Overall Study||0
7780040|NCT01313520|19153536|P2|COMPLETED|Overall Study||31
7780041|NCT01313520|19153537|P1|COMPLETED|Overall Study||30
7780042|NCT01313520|19153536|P2|STARTED|Overall Study||31
7780043|NCT01313520|19153537|P1|STARTED|Overall Study||30
7780044|NCT01313507|19153557|P1|NOT COMPLETED|Overall Study||0
7780045|NCT01313507|19153557|P1|COMPLETED|Overall Study||21
7780046|NCT01313507|19153557|P1|STARTED|Overall Study||21
7780047|NCT01313494|19153565|P2|NOT COMPLETED|Overall Study||50
7780048|NCT01313494|19153566|P1|NOT COMPLETED|Overall Study||67
7780049|NCT01313494|19153565|P2|COMPLETED|Overall Study||263
7780050|NCT01313494|19153566|P1|COMPLETED|Overall Study||246
7780051|NCT01313494|19153565|P2|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311
7780052|NCT01313494|19153566|P1|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315
7780053|NCT01313494|19153565|P2|STARTED|Overall Study||313
7780054|NCT01313494|19153566|P1|STARTED|Overall Study||313
7780055|NCT01313416|19153618|P1|NOT COMPLETED|Overall Study||0
7780056|NCT01313416|19153618|P1|COMPLETED|Overall Study||2
7780057|NCT01313416|19153618|P1|STARTED|Overall Study||2
7780058|NCT01313312|19153623|P1|NOT COMPLETED|Overall Study||36
7780059|NCT01313312|19153623|P1|COMPLETED|Overall Study||222
7780060|NCT01313312|19153623|P1|Cycle 5|Overall Study||11
7780061|NCT01313312|19153623|P1|Cycle 4|Overall Study||81
7780062|NCT01313312|19153623|P1|Cycle 3|Overall Study||175
7780063|NCT01313312|19153623|P1|Cycle 2|Overall Study||229
7780064|NCT01313312|19153623|P1|Cycle 1|Overall Study||254
7780065|NCT01313312|19153623|P1|STARTED|Overall Study||258
7780066|NCT01313299|19153670|P3|NOT COMPLETED|Overall Study||4
7780067|NCT01313299|19153671|P2|NOT COMPLETED|Overall Study||3
7780068|NCT01313299|19153672|P1|NOT COMPLETED|Overall Study||7
7780069|NCT01313299|19153670|P3|COMPLETED|Overall Study||77
7780070|NCT01313299|19153671|P2|COMPLETED|Overall Study||78
7780071|NCT01313299|19153672|P1|COMPLETED|Overall Study||74
7780072|NCT01313299|19153670|P3|STARTED|Overall Study||81
7780073|NCT01313299|19153671|P2|STARTED|Overall Study||81
7780074|NCT01313299|19153672|P1|STARTED|Overall Study||81
7780075|NCT01313286|19153686|P2|NOT COMPLETED|Period 2||0
7780076|NCT01313286|19153687|P1|NOT COMPLETED|Period 2||0
7780077|NCT01313286|19153686|P2|COMPLETED|Period 2||8
7780078|NCT01313286|19153687|P1|COMPLETED|Period 2||6
7780079|NCT01313286|19153686|P2|STARTED|Period 2||8
7780080|NCT01313286|19153687|P1|STARTED|Period 2||6
7780081|NCT01313286|19153686|P2|NOT COMPLETED|Period 1||0
7780082|NCT01313286|19153687|P1|NOT COMPLETED|Period 1||2
7780083|NCT01313286|19153686|P2|COMPLETED|Period 1||8
7780084|NCT01313286|19153687|P1|COMPLETED|Period 1||6
7780085|NCT01313286|19153686|P2|STARTED|Period 1||8
7780086|NCT01313286|19153687|P1|STARTED|Period 1||8
7780087|NCT01313273|19153697|P2|NOT COMPLETED|Overall Study||1
7780088|NCT01313273|19153698|P1|NOT COMPLETED|Overall Study||2
7780089|NCT01313273|19153697|P2|COMPLETED|Overall Study||0
7780090|NCT01313273|19153698|P1|COMPLETED|Overall Study||0
7780091|NCT01313273|19153697|P2|STARTED|Overall Study||1
7780092|NCT01313273|19153698|P1|STARTED|Overall Study||2
7780093|NCT01313221|19153713|P3|NOT COMPLETED|Overall Study||23
7780094|NCT01313221|19153714|P2|NOT COMPLETED|Overall Study||8
7780095|NCT01313221|19153715|P1|NOT COMPLETED|Overall Study||12
7780096|NCT01313221|19153713|P3|COMPLETED|Overall Study||0
7780097|NCT01313221|19153714|P2|COMPLETED|Overall Study||135
7780098|NCT01313221|19153715|P1|COMPLETED|Overall Study||132
7780099|NCT01313221|19153713|P3|Randomized|Overall Study||0
7780100|NCT01313221|19153714|P2|Randomized|Overall Study||143
7780101|NCT01313221|19153715|P1|Randomized|Overall Study||144
7780102|NCT01313221|19153713|P3|STARTED|Overall Study||23
7780103|NCT01313221|19153714|P2|STARTED|Overall Study||143
7780104|NCT01313221|19153715|P1|STARTED|Overall Study||144
7780105|NCT01313208|19153767|P2|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3
7780106|NCT01313208|19153768|P1|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6
7780107|NCT01313208|19153767|P2|COMPLETED|Open-label Phase (Weeks 13 - 24)||98
7780108|NCT01313208|19153768|P1|COMPLETED|Open-label Phase (Weeks 13 - 24)||92
7780109|NCT01313208|19153767|P2|STARTED|Open-label Phase (Weeks 13 - 24)||101
7780110|NCT01313208|19153768|P1|STARTED|Open-label Phase (Weeks 13 - 24)||98
7780111|NCT01313208|19153767|P2|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5
7780112|NCT01313208|19153768|P1|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6
7780113|NCT01313208|19153767|P2|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101
7780114|NCT01313208|19153768|P1|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98
7780115|NCT01313208|19153767|P2|STARTED|Double-blind Phase (Weeks 1 - 12)||106
7780116|NCT01313208|19153768|P1|STARTED|Double-blind Phase (Weeks 1 - 12)||104
7780117|NCT01313182|19153858|P2|NOT COMPLETED|Overall Study||92
7780118|NCT01313182|19153859|P1|NOT COMPLETED|Overall Study||66
7780119|NCT01313182|19153858|P2|COMPLETED|Overall Study||763
7780120|NCT01313182|19153859|P1|COMPLETED|Overall Study||776
7780121|NCT01313182|19153858|P2|STARTED|Overall Study||855
7780122|NCT01313182|19153859|P1|STARTED|Overall Study||842
7780123|NCT01313117|19153871|P1|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
7780124|NCT01313117|19153871|P1|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0
7780125|NCT01313117|19153871|P1|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
7780126|NCT01313117|19153871|P1|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0
7780127|NCT01313117|19153871|P1|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
7780128|NCT01313117|19153871|P1|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
7780129|NCT01313117|19153871|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0
7780130|NCT01313117|19153871|P1|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
7780131|NCT01313117|19153871|P1|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
7780132|NCT01313117|19153871|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
7780133|NCT01313117|19153871|P1|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
7780134|NCT01313117|19153871|P1|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2
7780135|NCT01313117|19153871|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0
7780136|NCT01313117|19153871|P1|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
7780137|NCT01313117|19153871|P1|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
7780138|NCT01313078|19153878|P1|NOT COMPLETED|Overall Study||3
7780139|NCT01313078|19153878|P1|COMPLETED|Overall Study||1
7780140|NCT01313078|19153878|P1|STARTED|Overall Study||4
7780141|NCT01313039|19153883|P1|NOT COMPLETED|Overall Study||2
7780142|NCT01313039|19153883|P1|COMPLETED|Overall Study||2
7780143|NCT01313039|19153883|P1|STARTED|Overall Study||4
7780144|NCT01312961|19153889|P2|NOT COMPLETED|Overall Study||7
7780145|NCT01312961|19153890|P1|NOT COMPLETED|Overall Study||17
7780146|NCT01312961|19153889|P2|COMPLETED|Overall Study||45
7780147|NCT01312961|19153890|P1|COMPLETED|Overall Study||35
7780148|NCT01312961|19153889|P2|Treated|Overall Study||52
7780149|NCT01312961|19153890|P1|Treated|Overall Study||52
7780150|NCT01312961|19153889|P2|STARTED|Overall Study||52
7780151|NCT01312961|19153890|P1|STARTED|Overall Study||52
7780152|NCT01312948|19153916|P1|NOT COMPLETED|Overall Study||0
7780153|NCT01312948|19153916|P1|COMPLETED|Overall Study||6
7780154|NCT01312948|19153916|P1|STARTED|Overall Study||6
7780155|NCT01312909|19153926|P3|NOT COMPLETED|Overall Study||47
7780156|NCT01312909|19153927|P2|NOT COMPLETED|Overall Study||36
7780157|NCT01312909|19153928|P1|NOT COMPLETED|Overall Study||42
7780158|NCT01312909|19153926|P3|COMPLETED|Overall Study||53
7780159|NCT01312909|19153927|P2|COMPLETED|Overall Study||67
7780160|NCT01312909|19153928|P1|COMPLETED|Overall Study||67
7780161|NCT01312909|19153926|P3|Treated|Overall Study||99
7780162|NCT01312909|19153927|P2|Treated|Overall Study||100
7780163|NCT01312909|19153928|P1|Treated|Overall Study||108
7780164|NCT01312909|19153926|P3|STARTED|Overall Study||100
7780165|NCT01312909|19153927|P2|STARTED|Overall Study||103
7780166|NCT01312909|19153928|P1|STARTED|Overall Study||109
7780167|NCT01312844|19153977|P2|NOT COMPLETED|Overall Study||0
7780168|NCT01312844|19153978|P1|NOT COMPLETED|Overall Study||0
7780169|NCT01312844|19153977|P2|COMPLETED|Overall Study||3
7780170|NCT01312844|19153978|P1|COMPLETED|Overall Study||4
7780171|NCT01312844|19153977|P2|STARTED|Overall Study||3
7780172|NCT01312844|19153978|P1|STARTED|Overall Study||4
7780173|NCT01312818|19154000|P1|NOT COMPLETED|Overall Study||0
7780174|NCT01312818|19154000|P1|COMPLETED|Overall Study||2
7780175|NCT01312818|19154000|P1|STARTED|Overall Study||2
7780176|NCT01312805|19154008|P2|NOT COMPLETED|Overall Study||0
7780177|NCT01312805|19154009|P1|NOT COMPLETED|Overall Study||0
7780178|NCT01312805|19154008|P2|COMPLETED|Overall Study||1082
7780179|NCT01312805|19154009|P1|COMPLETED|Overall Study||1016
7780180|NCT01312805|19154008|P2|STARTED|Overall Study||1082
7780181|NCT01312805|19154009|P1|STARTED|Overall Study||1016
7780182|NCT01312779|19154015|P1|NOT COMPLETED|Overall Study||32
7780183|NCT01312779|19154015|P1|COMPLETED|Overall Study||7
7780184|NCT01312779|19154015|P1|Implanted With Device|Overall Study||12
7780185|NCT01312779|19154015|P1|STARTED|Overall Study||39
7780186|NCT01312766|19154047|P2|NOT COMPLETED|Overall Study||5
7780187|NCT01312766|19154048|P1|NOT COMPLETED|Overall Study||6
7780188|NCT01312766|19154047|P2|COMPLETED|Overall Study||130
7780189|NCT01312766|19154048|P1|COMPLETED|Overall Study||129
7780190|NCT01312766|19154047|P2|STARTED|Overall Study||135
7780191|NCT01312766|19154048|P1|STARTED|Overall Study||135
7780192|NCT01312675|19154080|P2|NOT COMPLETED|Overall Study||0
7780193|NCT01312675|19154081|P1|NOT COMPLETED|Overall Study||0
7780194|NCT01312675|19154080|P2|COMPLETED|Overall Study||7
7780195|NCT01312675|19154081|P1|COMPLETED|Overall Study||9
7780196|NCT01312675|19154080|P2|STARTED|Overall Study||7
7780197|NCT01312675|19154081|P1|STARTED|Overall Study||9
7780198|NCT01312519|19154089|P2|NOT COMPLETED|Overall Study||0
7780199|NCT01312519|19154090|P1|NOT COMPLETED|Overall Study||0
7780200|NCT01312519|19154089|P2|COMPLETED|Overall Study||24
7780201|NCT01312519|19154090|P1|COMPLETED|Overall Study||26
7780202|NCT01312519|19154089|P2|STARTED|Overall Study||24
7780203|NCT01312519|19154090|P1|STARTED|Overall Study||26
7780204|NCT01312467|19154098|P1|NOT COMPLETED|Overall Study||13
7780205|NCT01312467|19154098|P1|COMPLETED|Overall Study||32
7780206|NCT01312467|19154098|P1|STARTED|Overall Study||45
7780207|NCT01312428|19154107|P2|NOT COMPLETED|Overall Study||4
7780208|NCT01312428|19154108|P1|NOT COMPLETED|Overall Study||3
7780209|NCT01312428|19154107|P2|COMPLETED|Overall Study||0
7780210|NCT01312428|19154108|P1|COMPLETED|Overall Study||0
7780211|NCT01312428|19154107|P2|STARTED|Overall Study||4
7780212|NCT01312428|19154108|P1|STARTED|Overall Study||3
7780213|NCT01312272|19154118|P2|NOT COMPLETED|Overall Study||1
7780214|NCT01312272|19154119|P1|NOT COMPLETED|Overall Study||0
7780215|NCT01312272|19154118|P2|COMPLETED|Overall Study||11
7780216|NCT01312272|19154119|P1|COMPLETED|Overall Study||12
7780217|NCT01312272|19154118|P2|STARTED|Overall Study||12
7780218|NCT01312272|19154119|P1|STARTED|Overall Study||12
7780219|NCT01312233|19154138|P3|NOT COMPLETED|Overall Study||7
7780220|NCT01312233|19154139|P2|NOT COMPLETED|Overall Study||0
7780221|NCT01312233|19154140|P1|NOT COMPLETED|Overall Study||2
7780222|NCT01312233|19154138|P3|COMPLETED|Overall Study||36
7780223|NCT01312233|19154139|P2|COMPLETED|Overall Study||44
7780224|NCT01312233|19154140|P1|COMPLETED|Overall Study||42
7780225|NCT01312233|19154138|P3|STARTED|Overall Study||43
7780226|NCT01312233|19154139|P2|STARTED|Overall Study||44
7780227|NCT01312233|19154140|P1|STARTED|Overall Study||44
7780228|NCT01312181|19154163|P3|NOT COMPLETED|Overall Study||8
7780229|NCT01312181|19154164|P2|NOT COMPLETED|Overall Study||6
7780230|NCT01312181|19154165|P1|NOT COMPLETED|Overall Study||2
7780231|NCT01312181|19154163|P3|COMPLETED|Overall Study||75
7780232|NCT01312181|19154164|P2|COMPLETED|Overall Study||71
7780233|NCT01312181|19154165|P1|COMPLETED|Overall Study||78
7780234|NCT01312181|19154163|P3|STARTED|Overall Study||83
7780235|NCT01312181|19154164|P2|STARTED|Overall Study||77
7780236|NCT01312181|19154165|P1|STARTED|Overall Study||80
7780237|NCT01312129|19154178|P2|NOT COMPLETED|Second Intervention (24 Hours)||1
7780238|NCT01312129|19154179|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
7780239|NCT01312129|19154178|P2|COMPLETED|Second Intervention (24 Hours)||6
7780240|NCT01312129|19154179|P1|COMPLETED|Second Intervention (24 Hours)||6
7780241|NCT01312129|19154178|P2|Alcohol Cue|Second Intervention (24 Hours)||6
7780242|NCT01312129|19154179|P1|Alcohol Cue|Second Intervention (24 Hours)||6
7780243|NCT01312129|19154178|P2|Control Cue|Second Intervention (24 Hours)||6
7780244|NCT01312129|19154179|P1|Control Cue|Second Intervention (24 Hours)||6
7780245|NCT01312129|19154178|P2|STARTED|Second Intervention (24 Hours)||7
7780246|NCT01312129|19154179|P1|STARTED|Second Intervention (24 Hours)||6
7780247|NCT01312129|19154178|P2|NOT COMPLETED|Washout (1 Week)||0
7780248|NCT01312129|19154179|P1|NOT COMPLETED|Washout (1 Week)||0
7780249|NCT01312129|19154178|P2|COMPLETED|Washout (1 Week)||7
7780250|NCT01312129|19154179|P1|COMPLETED|Washout (1 Week)||6
7780251|NCT01312129|19154178|P2|STARTED|Washout (1 Week)||7
7780252|NCT01312129|19154179|P1|STARTED|Washout (1 Week)||6
7780253|NCT01312129|19154178|P2|NOT COMPLETED|First Intervention (24 Hours)||0
7780254|NCT01312129|19154179|P1|NOT COMPLETED|First Intervention (24 Hours)||0
7780255|NCT01312129|19154178|P2|COMPLETED|First Intervention (24 Hours)||7
7780256|NCT01312129|19154179|P1|COMPLETED|First Intervention (24 Hours)||6
7780257|NCT01312129|19154178|P2|Alcohol Cue|First Intervention (24 Hours)||7
7780258|NCT01312129|19154179|P1|Alcohol Cue|First Intervention (24 Hours)||6
7780259|NCT01312129|19154178|P2|Control Cue|First Intervention (24 Hours)||7
7780260|NCT01312129|19154179|P1|Control Cue|First Intervention (24 Hours)||6
7780261|NCT01312129|19154178|P2|STARTED|First Intervention (24 Hours)||7
7780262|NCT01312129|19154179|P1|STARTED|First Intervention (24 Hours)||6
7780263|NCT01312038|19154187|P2|NOT COMPLETED|Overall Study||0
7780264|NCT01312038|19154188|P1|NOT COMPLETED|Overall Study||0
7780265|NCT01312038|19154187|P2|COMPLETED|Overall Study||12
7780266|NCT01312038|19154188|P1|COMPLETED|Overall Study||13
7780267|NCT01312038|19154187|P2|STARTED|Overall Study||12
7780268|NCT01312038|19154188|P1|STARTED|Overall Study||13
7780269|NCT01311895|19154196|P2|NOT COMPLETED|Overall Study||0
7780270|NCT01311895|19154197|P1|NOT COMPLETED|Overall Study||0
7780271|NCT01311895|19154196|P2|COMPLETED|Overall Study||175
7780272|NCT01311895|19154197|P1|COMPLETED|Overall Study||175
7780273|NCT01311895|19154196|P2|STARTED|Overall Study||175
7780274|NCT01311895|19154197|P1|STARTED|Overall Study||175
7780275|NCT01311687|19154209|P2|NOT COMPLETED|PFS Follow-up Phase||0
7780276|NCT01311687|19154210|P1|NOT COMPLETED|PFS Follow-up Phase||0
7780277|NCT01311687|19154209|P2|COMPLETED|PFS Follow-up Phase||8
7780278|NCT01311687|19154210|P1|COMPLETED|PFS Follow-up Phase||11
7780279|NCT01311687|19154209|P2|Crossed-over to Pomalidomide|PFS Follow-up Phase||0
7780280|NCT01311687|19154210|P1|Crossed-over to Pomalidomide|PFS Follow-up Phase||11
7780281|NCT01311687|19154209|P2|STARTED|PFS Follow-up Phase||8
7780282|NCT01311687|19154210|P1|STARTED|PFS Follow-up Phase||11
7780283|NCT01311687|19154209|P2|NOT COMPLETED|Treatment Phase||0
7780284|NCT01311687|19154210|P1|NOT COMPLETED|Treatment Phase||0
7780285|NCT01311687|19154209|P2|COMPLETED|Treatment Phase||153
7780286|NCT01311687|19154210|P1|COMPLETED|Treatment Phase||302
7780287|NCT01311687|19154209|P2|Crossed-over to Pomalidomide|Treatment Phase|After Amendment 4 participants still on HD-Dex treatment were permitted to crossover to pomalidomide|11
7780288|NCT01311687|19154210|P1|Crossed-over to Pomalidomide|Treatment Phase|Not applicable to participants initially randomized to receive pomalidomide|0
7780289|NCT01311687|19154209|P2|Received Study Drug|Treatment Phase||150
7780290|NCT01311687|19154210|P1|Received Study Drug|Treatment Phase||300
7780291|NCT01311687|19154209|P2|STARTED|Treatment Phase||153
7780292|NCT01311687|19154210|P1|STARTED|Treatment Phase||302
7780293|NCT01311661|19154264|P1|NOT COMPLETED|Overall Study||7
7780294|NCT01311661|19154264|P1|COMPLETED|Overall Study||199
7780295|NCT01311661|19154264|P1|Received Olo 10 mcg qd|Overall Study||102
7780296|NCT01311661|19154264|P1|Received Olo 5 mcg Bid|Overall Study||101
7780297|NCT01311661|19154264|P1|Received Olo 5 mcg qd|Overall Study||101
7780298|NCT01311661|19154264|P1|Received Olo 2.5 mcg Bid|Overall Study||101
7780299|NCT01311661|19154264|P1|Received Placebo|Overall Study||201
7780300|NCT01311661|19154264|P1|STARTED|Overall Study|Entered and treated|206
7780301|NCT01311648|19154409|P3|NOT COMPLETED|Overall Study||21
7780302|NCT01311648|19154410|P2|NOT COMPLETED|Overall Study||0
7780303|NCT01311648|19154411|P1|NOT COMPLETED|Overall Study||0
7780304|NCT01311648|19154409|P3|COMPLETED|Overall Study||22
7780305|NCT01311648|19154410|P2|COMPLETED|Overall Study||26
7780306|NCT01311648|19154411|P1|COMPLETED|Overall Study||25
7780307|NCT01311648|19154409|P3|STARTED|Overall Study||43
7780308|NCT01311648|19154410|P2|STARTED|Overall Study||26
7780309|NCT01311648|19154411|P1|STARTED|Overall Study||25
7780310|NCT01311557|19154456|P2|NOT COMPLETED|Overall Study||6
7780311|NCT01311557|19154457|P1|NOT COMPLETED|Overall Study||5
7780312|NCT01311557|19154456|P2|COMPLETED|Overall Study||645
7780313|NCT01311557|19154457|P1|COMPLETED|Overall Study||646
7780314|NCT01311557|19154456|P2|STARTED|Overall Study||651
7780315|NCT01311557|19154457|P1|STARTED|Overall Study||651
7780316|NCT01311505|19154473|P2|NOT COMPLETED|Second Intervention Period||0
7780317|NCT01311505|19154474|P1|NOT COMPLETED|Second Intervention Period||0
7780318|NCT01311505|19154473|P2|COMPLETED|Second Intervention Period||10
7780319|NCT01311505|19154474|P1|COMPLETED|Second Intervention Period||10
7780320|NCT01311505|19154473|P2|STARTED|Second Intervention Period||10
7780321|NCT01311505|19154474|P1|STARTED|Second Intervention Period||10
7780322|NCT01311505|19154473|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7780323|NCT01311505|19154474|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7780324|NCT01311505|19154473|P2|COMPLETED|Washout Period (at Least 7 Days)||10
7780325|NCT01311505|19154474|P1|COMPLETED|Washout Period (at Least 7 Days)||10
7780326|NCT01311505|19154473|P2|STARTED|Washout Period (at Least 7 Days)||10
7780327|NCT01311505|19154474|P1|STARTED|Washout Period (at Least 7 Days)||10
7780328|NCT01311505|19154473|P2|NOT COMPLETED|First Intervention Period||1
7780329|NCT01311505|19154474|P1|NOT COMPLETED|First Intervention Period||0
7780330|NCT01311505|19154473|P2|COMPLETED|First Intervention Period||10
7780331|NCT01311505|19154474|P1|COMPLETED|First Intervention Period||10
7780332|NCT01311505|19154473|P2|STARTED|First Intervention Period||11
7780333|NCT01311505|19154474|P1|STARTED|First Intervention Period||10
7780334|NCT01311362|19154502|P1|NOT COMPLETED|Ambrisentan and SJW||0
7780335|NCT01311362|19154502|P1|COMPLETED|Ambrisentan and SJW||20
7780336|NCT01311362|19154502|P1|STARTED|Ambrisentan and SJW||20
7780337|NCT01311362|19154502|P1|NOT COMPLETED|Ambrisentan Steady-state||0
7780338|NCT01311362|19154502|P1|COMPLETED|Ambrisentan Steady-state||20
7780339|NCT01311362|19154502|P1|STARTED|Ambrisentan Steady-state||20
7780340|NCT01311362|19154502|P1|NOT COMPLETED|Ambrisentan Single Dose||0
7780341|NCT01311362|19154502|P1|COMPLETED|Ambrisentan Single Dose||20
7780342|NCT01311362|19154502|P1|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20
7780343|NCT01311102|19154515|P2|NOT COMPLETED|Overall Study||0
7780344|NCT01311102|19154516|P1|NOT COMPLETED|Overall Study||0
7780345|NCT01311102|19154515|P2|COMPLETED|Overall Study||20
7780346|NCT01311102|19154516|P1|COMPLETED|Overall Study||20
7780347|NCT01311102|19154515|P2|STARTED|Overall Study||20
7780348|NCT01311102|19154516|P1|STARTED|Overall Study||20
7780349|NCT01311024|19154530|P2|NOT COMPLETED|Overall Study||22
7780350|NCT01311024|19154531|P1|NOT COMPLETED|Overall Study||35
7780351|NCT01311024|19154530|P2|COMPLETED|Overall Study||789
7780352|NCT01311024|19154531|P1|COMPLETED|Overall Study||1495
7780353|NCT01311024|19154530|P2|STARTED|Overall Study||811
7780354|NCT01311024|19154531|P1|STARTED|Overall Study||1530
7780355|NCT01310868|19154537|P1|NOT COMPLETED|Overall Study||13
7780356|NCT01310868|19154537|P1|COMPLETED|Overall Study||59
7780357|NCT01310868|19154537|P1|STARTED|Overall Study||72
7780358|NCT01310855|19154545|P2|NOT COMPLETED|Overall Study||0
7780359|NCT01310855|19154546|P1|NOT COMPLETED|Overall Study||0
7780360|NCT01310855|19154545|P2|COMPLETED|Overall Study||19
7780361|NCT01310855|19154546|P1|COMPLETED|Overall Study||19
7780362|NCT01310855|19154545|P2|STARTED|Overall Study||19
7780363|NCT01310855|19154546|P1|STARTED|Overall Study||19
7780364|NCT01310803|19154554|P2|NOT COMPLETED|Overall Study||0
7780365|NCT01310803|19154555|P1|NOT COMPLETED|Overall Study||1
7780366|NCT01310803|19154554|P2|COMPLETED|Overall Study||0
7780367|NCT01310803|19154555|P1|COMPLETED|Overall Study||0
7780368|NCT01310803|19154554|P2|STARTED|Overall Study||0
7780369|NCT01310803|19154555|P1|STARTED|Overall Study||1
7780370|NCT01310777|19154566|P3|NOT COMPLETED|Overall Study||30
7780371|NCT01310777|19154567|P2|NOT COMPLETED|Overall Study||14
7780372|NCT01310777|19154568|P1|NOT COMPLETED|Overall Study||33
7780373|NCT01310777|19154566|P3|COMPLETED|Overall Study||145
7780374|NCT01310777|19154567|P2|COMPLETED|Overall Study||178
7780375|NCT01310777|19154568|P1|COMPLETED|Overall Study||160
7780376|NCT01310777|19154566|P3|STARTED|Overall Study||175
7780377|NCT01310777|19154567|P2|STARTED|Overall Study||192
7780378|NCT01310777|19154568|P1|STARTED|Overall Study||193
7780379|NCT01310699|19154578|P2|NOT COMPLETED|Overall Study||6
7780380|NCT01310699|19154579|P1|NOT COMPLETED|Overall Study||4
7780381|NCT01310699|19154578|P2|COMPLETED|Overall Study||143
7780382|NCT01310699|19154579|P1|COMPLETED|Overall Study||128
7780383|NCT01310699|19154578|P2|STARTED|Overall Study||149
7780384|NCT01310699|19154579|P1|STARTED|Overall Study||132
7780385|NCT01310582|19154591|P2|NOT COMPLETED|Overall Study||0
7780386|NCT01310582|19154592|P1|NOT COMPLETED|Overall Study||0
7780387|NCT01310582|19154591|P2|COMPLETED|Overall Study||26
7780388|NCT01310582|19154592|P1|COMPLETED|Overall Study||31
7780389|NCT01310582|19154591|P2|STARTED|Overall Study||26
7780390|NCT01310582|19154592|P1|STARTED|Overall Study||31
7780391|NCT01310413|19154606|P7|NOT COMPLETED|From Day U0 to Day U385||3
7780392|NCT01310413|19154607|P6|NOT COMPLETED|From Day U0 to Day U385||0
7780393|NCT01310413|19154608|P5|NOT COMPLETED|From Day U0 to Day U385||0
7780394|NCT01310413|19154609|P4|NOT COMPLETED|From Day U0 to Day U385||0
7780395|NCT01310413|19154610|P3|NOT COMPLETED|From Day U0 to Day U385||0
7780396|NCT01310413|19154611|P2|NOT COMPLETED|From Day U0 to Day U385||0
7780397|NCT01310413|19154612|P1|NOT COMPLETED|From Day U0 to Day U385||0
7780398|NCT01310413|19154606|P7|COMPLETED|From Day U0 to Day U385|Upto Day U42|152
7780399|NCT01310413|19154607|P6|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
7780400|NCT01310413|19154608|P5|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
7780401|NCT01310413|19154609|P4|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
7780483|NCT01309893|19154879|P1|NOT COMPLETED|Week 2 - Crossover Intervention||1
7780402|NCT01310413|19154610|P3|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
7780403|NCT01310413|19154611|P2|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
7780404|NCT01310413|19154612|P1|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
7780405|NCT01310413|19154606|P7|STARTED|From Day U0 to Day U385|Upto Day U42|155
7780406|NCT01310413|19154607|P6|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
7780407|NCT01310413|19154608|P5|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
7780408|NCT01310413|19154609|P4|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
7780409|NCT01310413|19154610|P3|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
7780410|NCT01310413|19154611|P2|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
7780411|NCT01310413|19154612|P1|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
7780412|NCT01310413|19154606|P7|NOT COMPLETED|Day 0 to Day 385||0
7780413|NCT01310413|19154607|P6|NOT COMPLETED|Day 0 to Day 385||3
7780414|NCT01310413|19154608|P5|NOT COMPLETED|Day 0 to Day 385||3
7780415|NCT01310413|19154609|P4|NOT COMPLETED|Day 0 to Day 385||8
7780416|NCT01310413|19154610|P3|NOT COMPLETED|Day 0 to Day 385||7
7780417|NCT01310413|19154611|P2|NOT COMPLETED|Day 0 to Day 385||8
7780418|NCT01310413|19154612|P1|NOT COMPLETED|Day 0 to Day 385||27
7780419|NCT01310413|19154606|P7|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
7780420|NCT01310413|19154607|P6|COMPLETED|Day 0 to Day 385||77
7780421|NCT01310413|19154608|P5|COMPLETED|Day 0 to Day 385||73
7780422|NCT01310413|19154609|P4|COMPLETED|Day 0 to Day 385||67
7780423|NCT01310413|19154610|P3|COMPLETED|Day 0 to Day 385||203
7780424|NCT01310413|19154611|P2|COMPLETED|Day 0 to Day 385||190
7780425|NCT01310413|19154612|P1|COMPLETED|Day 0 to Day 385||172
7780426|NCT01310413|19154606|P7|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
7780427|NCT01310413|19154607|P6|STARTED|Day 0 to Day 385||80
7780428|NCT01310413|19154608|P5|STARTED|Day 0 to Day 385||76
7780429|NCT01310413|19154609|P4|STARTED|Day 0 to Day 385||75
7780430|NCT01310413|19154610|P3|STARTED|Day 0 to Day 385||210
7780431|NCT01310413|19154611|P2|STARTED|Day 0 to Day 385||198
7780432|NCT01310413|19154612|P1|STARTED|Day 0 to Day 385||199
7780433|NCT01310400|19154768|P3|NOT COMPLETED|Overall Study||30
7780434|NCT01310400|19154769|P2|NOT COMPLETED|Overall Study||32
7780435|NCT01310400|19154770|P1|NOT COMPLETED|Overall Study||28
7780436|NCT01310400|19154768|P3|COMPLETED|Overall Study||422
7780437|NCT01310400|19154769|P2|COMPLETED|Overall Study||420
7780438|NCT01310400|19154770|P1|COMPLETED|Overall Study||424
7780439|NCT01310400|19154768|P3|STARTED|Overall Study||452
7780440|NCT01310400|19154769|P2|STARTED|Overall Study||452
7780441|NCT01310400|19154770|P1|STARTED|Overall Study||452
7780442|NCT01310179|19154787|P1|NOT COMPLETED|Overall Study||0
7780443|NCT01310179|19154787|P1|COMPLETED|Overall Study||12
7780444|NCT01310179|19154787|P1|STARTED|Overall Study||12
7780445|NCT01310127|19154794|P2|NOT COMPLETED|Overall Study||1
7780446|NCT01310127|19154795|P1|NOT COMPLETED|Overall Study||2
7780447|NCT01310127|19154794|P2|COMPLETED|Overall Study||10
7780448|NCT01310127|19154795|P1|COMPLETED|Overall Study||10
7780449|NCT01310127|19154794|P2|STARTED|Overall Study||11
7780450|NCT01310127|19154795|P1|STARTED|Overall Study||12
7780451|NCT01310075|19154809|P2|NOT COMPLETED|Overall Study||10
7780452|NCT01310075|19154810|P1|NOT COMPLETED|Overall Study||14
7780453|NCT01310075|19154809|P2|COMPLETED|Overall Study||35
7780454|NCT01310075|19154810|P1|COMPLETED|Overall Study||31
7780455|NCT01310075|19154809|P2|STARTED|Overall Study||45
7780456|NCT01310075|19154810|P1|STARTED|Overall Study||45
7780457|NCT01310036|19154816|P1|NOT COMPLETED|Overall Study||202
7780458|NCT01310036|19154816|P1|COMPLETED|Overall Study||6
7780459|NCT01310036|19154816|P1|STARTED|Overall Study||208
7780460|NCT01309997|19154829|P2|NOT COMPLETED|Overall Study||6
7780461|NCT01309997|19154830|P1|NOT COMPLETED|Overall Study||5
7780462|NCT01309997|19154829|P2|COMPLETED|Overall Study||31
7780463|NCT01309997|19154830|P1|COMPLETED|Overall Study||30
7780464|NCT01309997|19154829|P2|Crossed Over to Second Arm|Overall Study||23
7780465|NCT01309997|19154830|P1|Crossed Over to Second Arm|Overall Study||19
7780466|NCT01309997|19154829|P2|Remained on First Arm Only|Overall Study||14
7780467|NCT01309997|19154830|P1|Remained on First Arm Only|Overall Study||16
7780468|NCT01309997|19154829|P2|STARTED|Overall Study||37
7780469|NCT01309997|19154830|P1|STARTED|Overall Study||35
7780470|NCT01309919|19154854|P2|NOT COMPLETED|Overall Study||48
7780471|NCT01309919|19154855|P1|NOT COMPLETED|Overall Study||17
7780472|NCT01309919|19154854|P2|COMPLETED|Overall Study||27
7780473|NCT01309919|19154855|P1|COMPLETED|Overall Study||58
7780474|NCT01309919|19154854|P2|STARTED|Overall Study||75
7780475|NCT01309919|19154855|P1|STARTED|Overall Study||75
7780476|NCT01309906|19154867|P2|NOT COMPLETED|Overall Study||1
7780477|NCT01309906|19154868|P1|NOT COMPLETED|Overall Study||1
7780478|NCT01309906|19154867|P2|COMPLETED|Overall Study||32
7780479|NCT01309906|19154868|P1|COMPLETED|Overall Study||32
7780480|NCT01309906|19154867|P2|STARTED|Overall Study||33
7780481|NCT01309906|19154868|P1|STARTED|Overall Study||33
7780482|NCT01309893|19154878|P2|NOT COMPLETED|Week 2 - Crossover Intervention||1
7780484|NCT01309893|19154878|P2|COMPLETED|Week 2 - Crossover Intervention||32
7780485|NCT01309893|19154879|P1|COMPLETED|Week 2 - Crossover Intervention||32
7780486|NCT01309893|19154878|P2|STARTED|Week 2 - Crossover Intervention||33
7780487|NCT01309893|19154879|P1|STARTED|Week 2 - Crossover Intervention||33
7780488|NCT01309893|19154878|P2|NOT COMPLETED|Week 1 - First Intervention||0
7780489|NCT01309893|19154879|P1|NOT COMPLETED|Week 1 - First Intervention||0
7780490|NCT01309893|19154878|P2|COMPLETED|Week 1 - First Intervention||33
7780491|NCT01309893|19154879|P1|COMPLETED|Week 1 - First Intervention||33
7780492|NCT01309893|19154878|P2|STARTED|Week 1 - First Intervention||33
7780493|NCT01309893|19154879|P1|STARTED|Week 1 - First Intervention||33
7780494|NCT01309880|19154889|P2|NOT COMPLETED|Overall Study||0
7780495|NCT01309880|19154890|P1|NOT COMPLETED|Overall Study||0
7780496|NCT01309880|19154889|P2|COMPLETED|Overall Study||33
7780497|NCT01309880|19154890|P1|COMPLETED|Overall Study||33
7780498|NCT01309880|19154889|P2|STARTED|Overall Study||33
7780499|NCT01309880|19154890|P1|STARTED|Overall Study||33
7780500|NCT01309867|19154900|P2|NOT COMPLETED|Overall Study||12
7780501|NCT01309867|19154901|P1|NOT COMPLETED|Overall Study||3
7780502|NCT01309867|19154900|P2|COMPLETED|Overall Study||139
7780503|NCT01309867|19154901|P1|COMPLETED|Overall Study||148
7780504|NCT01309867|19154900|P2|STARTED|Overall Study||151
7780505|NCT01309867|19154901|P1|STARTED|Overall Study||151
7780506|NCT01309841|19154916|P3|NOT COMPLETED|Overall Study||37
7780507|NCT01309841|19154917|P2|NOT COMPLETED|Overall Study||41
7780508|NCT01309841|19154918|P1|NOT COMPLETED|Overall Study||39
7780509|NCT01309841|19154916|P3|COMPLETED|Overall Study||180
7780510|NCT01309841|19154917|P2|COMPLETED|Overall Study||177
7780511|NCT01309841|19154918|P1|COMPLETED|Overall Study||178
7780512|NCT01309841|19154916|P3|STARTED|Overall Study||217
7780513|NCT01309841|19154917|P2|STARTED|Overall Study||218
7780514|NCT01309841|19154918|P1|STARTED|Overall Study||217
7780515|NCT01309828|19154958|P2|NOT COMPLETED|Overall Study||16
7780516|NCT01309828|19154959|P1|NOT COMPLETED|Overall Study||16
7780517|NCT01309828|19154958|P2|COMPLETED|Overall Study||60
7780518|NCT01309828|19154959|P1|COMPLETED|Overall Study||61
7780519|NCT01309828|19154958|P2|STARTED|Overall Study||76
7780520|NCT01309828|19154959|P1|STARTED|Overall Study||77
7780521|NCT01309802|19154973|P2|NOT COMPLETED|Overall Study||9
7780522|NCT01309802|19154974|P1|NOT COMPLETED|Overall Study||12
7780523|NCT01309802|19154973|P2|COMPLETED|Overall Study||14
7780524|NCT01309802|19154974|P1|COMPLETED|Overall Study||13
7780525|NCT01309802|19154973|P2|STARTED|Overall Study||23
7780526|NCT01309802|19154974|P1|STARTED|Overall Study||25
7780527|NCT01309737|19154993|P5|NOT COMPLETED|Week 16 to 52||33
7780528|NCT01309737|19154994|P4|NOT COMPLETED|Week 16 to 52||34
7780529|NCT01309737|19154995|P3|NOT COMPLETED|Week 16 to 52||0
7780530|NCT01309737|19154996|P2|NOT COMPLETED|Week 16 to 52||103
7780531|NCT01309737|19154997|P1|NOT COMPLETED|Week 16 to 52||133
7780532|NCT01309737|19154993|P5|COMPLETED|Week 16 to 52||44
7780533|NCT01309737|19154994|P4|COMPLETED|Week 16 to 52||41
7780534|NCT01309737|19154995|P3|COMPLETED|Week 16 to 52||0
7780535|NCT01309737|19154996|P2|COMPLETED|Week 16 to 52||238
7780536|NCT01309737|19154997|P1|COMPLETED|Week 16 to 52||198
7780537|NCT01309737|19154993|P5|STARTED|Week 16 to 52||77
7780538|NCT01309737|19154994|P4|STARTED|Week 16 to 52||75
7780539|NCT01309737|19154995|P3|STARTED|Week 16 to 52||0
7780540|NCT01309737|19154996|P2|STARTED|Week 16 to 52||341
7780541|NCT01309737|19154997|P1|STARTED|Week 16 to 52||331
7780542|NCT01309737|19154993|P5|NOT COMPLETED|Week 0 to 16||0
7780543|NCT01309737|19154994|P4|NOT COMPLETED|Week 0 to 16||0
7780544|NCT01309737|19154995|P3|NOT COMPLETED|Week 0 to 16||44
7780545|NCT01309737|19154996|P2|NOT COMPLETED|Week 0 to 16||40
7780546|NCT01309737|19154997|P1|NOT COMPLETED|Week 0 to 16||52
7780547|NCT01309737|19154993|P5|COMPLETED|Week 0 to 16||0
7780548|NCT01309737|19154994|P4|COMPLETED|Week 0 to 16||0
7780549|NCT01309737|19154995|P3|COMPLETED|Week 0 to 16||152
7780550|NCT01309737|19154996|P2|COMPLETED|Week 0 to 16||341
7780551|NCT01309737|19154997|P1|COMPLETED|Week 0 to 16||331
7780552|NCT01309737|19154993|P5|Treated|Week 0 to 16||0
7780553|NCT01309737|19154994|P4|Treated|Week 0 to 16||0
7780554|NCT01309737|19154995|P3|Treated|Week 0 to 16||196
7780555|NCT01309737|19154996|P2|Treated|Week 0 to 16||381
7780556|NCT01309737|19154997|P1|Treated|Week 0 to 16||382
7780557|NCT01309737|19154993|P5|STARTED|Week 0 to 16||0
7780558|NCT01309737|19154994|P4|STARTED|Week 0 to 16||0
7780559|NCT01309737|19154995|P3|STARTED|Week 0 to 16||196
7780560|NCT01309737|19154996|P2|STARTED|Week 0 to 16||381
7780561|NCT01309737|19154997|P1|STARTED|Week 0 to 16||383
7780562|NCT01309672|19155192|P1|NOT COMPLETED|Overall Study||37
7780563|NCT01309672|19155192|P1|COMPLETED|Overall Study||4
7780564|NCT01309672|19155192|P1|Received Protocol Treatment|Overall Study||40
7780565|NCT01309672|19155192|P1|STARTED|Overall Study||41
7780566|NCT01309659|19155202|P2|NOT COMPLETED|Overall Study||1
7780567|NCT01309659|19155203|P1|NOT COMPLETED|Overall Study||0
7780568|NCT01309659|19155202|P2|COMPLETED|Overall Study||9
7780569|NCT01309659|19155203|P1|COMPLETED|Overall Study||9
7780570|NCT01309659|19155202|P2|STARTED|Overall Study||10
7780571|NCT01309659|19155203|P1|STARTED|Overall Study||9
7780572|NCT01309646|19155245|P2|NOT COMPLETED|Overall Study||0
7780573|NCT01309646|19155246|P1|NOT COMPLETED|Overall Study||0
7780574|NCT01309646|19155245|P2|COMPLETED|Overall Study||227
7780575|NCT01309646|19155246|P1|COMPLETED|Overall Study||224
7780576|NCT01309646|19155245|P2|STARTED|Overall Study||227
7780577|NCT01309646|19155246|P1|STARTED|Overall Study||224
7780578|NCT01309581|19155286|P2|NOT COMPLETED|Overall Study||0
7780579|NCT01309581|19155287|P1|NOT COMPLETED|Overall Study||0
7780580|NCT01309581|19155286|P2|COMPLETED|Overall Study||1
7780581|NCT01309581|19155287|P1|COMPLETED|Overall Study||2
7780582|NCT01309581|19155286|P2|STARTED|Overall Study||1
7780583|NCT01309581|19155287|P1|STARTED|Overall Study||2
7780584|NCT01309451|19155297|P2|NOT COMPLETED|Overall Study||3
7780585|NCT01309451|19155298|P1|NOT COMPLETED|Overall Study||2
7780586|NCT01309451|19155297|P2|COMPLETED|Overall Study|unit of measure is number of eyes|18
7780587|NCT01309451|19155298|P1|COMPLETED|Overall Study|unit of measure is number of eyes|17
7780588|NCT01309451|19155297|P2|STARTED|Overall Study|unit of measure is number of eyes|21
7780589|NCT01309451|19155298|P1|STARTED|Overall Study|unit of measure is number of eyes|19
7780590|NCT01309386|19155308|P2|NOT COMPLETED|Overall Study||21
7780591|NCT01309386|19155309|P1|NOT COMPLETED|Overall Study||22
7780592|NCT01309386|19155308|P2|COMPLETED|Overall Study||29
7780593|NCT01309386|19155309|P1|COMPLETED|Overall Study||28
7780594|NCT01309386|19155308|P2|STARTED|Overall Study||50
7780595|NCT01309386|19155309|P1|STARTED|Overall Study||50
7780596|NCT01309360|19155330|P3|NOT COMPLETED|Overall Study||0
7780597|NCT01309360|19155331|P2|NOT COMPLETED|Overall Study||0
7780598|NCT01309360|19155332|P1|NOT COMPLETED|Overall Study||0
7780599|NCT01309360|19155330|P3|COMPLETED|Overall Study||40
7780600|NCT01309360|19155331|P2|COMPLETED|Overall Study||40
7780601|NCT01309360|19155332|P1|COMPLETED|Overall Study||40
7780602|NCT01309360|19155330|P3|STARTED|Overall Study||40
7780603|NCT01309360|19155331|P2|STARTED|Overall Study||40
7780604|NCT01309360|19155332|P1|STARTED|Overall Study||40
7780605|NCT01309308|19155357|P2|NOT COMPLETED|Overall Study||4
7780606|NCT01309308|19155358|P1|NOT COMPLETED|Overall Study||6
7780607|NCT01309308|19155357|P2|COMPLETED|Overall Study||71
7780608|NCT01309308|19155358|P1|COMPLETED|Overall Study||69
7780609|NCT01309308|19155357|P2|STARTED|Overall Study||75
7780610|NCT01309308|19155358|P1|STARTED|Overall Study||75
7780611|NCT01309282|19155366|P1|NOT COMPLETED|Overall Study||1
7780612|NCT01309282|19155366|P1|COMPLETED|Overall Study||8
7780613|NCT01309282|19155366|P1|STARTED|Overall Study||9
7780614|NCT01309269|19155383|P1|NOT COMPLETED|Overall Study||840
7780615|NCT01309269|19155383|P1|COMPLETED|Overall Study||245
7780616|NCT01309269|19155383|P1|Treated|Overall Study||978
7780617|NCT01309269|19155383|P1|STARTED|Overall Study||1085
7780618|NCT01309243|19155391|P2|NOT COMPLETED|Extension Phase||0
7780619|NCT01309243|19155392|P1|NOT COMPLETED|Extension Phase||6
7780620|NCT01309243|19155391|P2|COMPLETED|Extension Phase||117
7780621|NCT01309243|19155392|P1|COMPLETED|Extension Phase||34
7780622|NCT01309243|19155391|P2|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117
7780623|NCT01309243|19155392|P1|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40
7780624|NCT01309243|19155391|P2|NOT COMPLETED|Randomized Phase Through Week 96||109
7780625|NCT01309243|19155392|P1|NOT COMPLETED|Randomized Phase Through Week 96||84
7780626|NCT01309243|19155391|P2|COMPLETED|Randomized Phase Through Week 96||290
7780627|NCT01309243|19155392|P1|COMPLETED|Randomized Phase Through Week 96||316
7780628|NCT01309243|19155391|P2|Randomized and Treated|Randomized Phase Through Week 96||392
7780629|NCT01309243|19155392|P1|Randomized and Treated|Randomized Phase Through Week 96||394
7780630|NCT01309243|19155391|P2|STARTED|Randomized Phase Through Week 96||399
7780631|NCT01309243|19155392|P1|STARTED|Randomized Phase Through Week 96||400
7780632|NCT01309204|19155418|P2|NOT COMPLETED|Overall Study||75
7780633|NCT01309204|19155419|P1|NOT COMPLETED|Overall Study||67
7780634|NCT01309204|19155418|P2|COMPLETED|Overall Study||361
7780635|NCT01309204|19155419|P1|COMPLETED|Overall Study||385
7780636|NCT01309204|19155418|P2|STARTED|Overall Study||436
7780637|NCT01309204|19155419|P1|STARTED|Overall Study||452
7780638|NCT01309165|19155427|P2|NOT COMPLETED|Overall Study||7
7780639|NCT01309165|19155428|P1|NOT COMPLETED|Overall Study||6
7780640|NCT01309165|19155427|P2|COMPLETED|Overall Study||9
7780641|NCT01309165|19155428|P1|COMPLETED|Overall Study||13
7780642|NCT01309165|19155427|P2|Included in Primary Analysis|Overall Study||12
7780643|NCT01309165|19155428|P1|Included in Primary Analysis|Overall Study||14
7780644|NCT01309165|19155427|P2|Received Allocated Intervention|Overall Study||14
7780645|NCT01309165|19155428|P1|Received Allocated Intervention|Overall Study||16
7780646|NCT01309165|19155427|P2|STARTED|Overall Study||16
7780647|NCT01309165|19155428|P1|STARTED|Overall Study||19
7780648|NCT01309100|19155440|P1|NOT COMPLETED|Overall Study||2
7780649|NCT01309100|19155440|P1|COMPLETED|Overall Study||142
7780650|NCT01309100|19155440|P1|STARTED|Overall Study||144
7780651|NCT01308918|19155451|P1|NOT COMPLETED|Overall Study||0
7780652|NCT01308918|19155451|P1|COMPLETED|Overall Study||50
7780653|NCT01308918|19155451|P1|STARTED|Overall Study||50
7780654|NCT01308853|19155458|P1|NOT COMPLETED|Overall Study||4
7780655|NCT01308853|19155458|P1|COMPLETED|Overall Study||20
7780656|NCT01308853|19155458|P1|STARTED|Overall Study||24
7780657|NCT01308840|19155463|P1|NOT COMPLETED|Overall Study||0
7780658|NCT01308840|19155463|P1|COMPLETED|Overall Study||31
7780659|NCT01308840|19155463|P1|STARTED|Overall Study||31
7780660|NCT01308814|19155472|P2|NOT COMPLETED|Overall Study||23
7780661|NCT01308814|19155473|P1|NOT COMPLETED|Overall Study||17
7780662|NCT01308814|19155472|P2|COMPLETED|Overall Study||63
7780663|NCT01308814|19155473|P1|COMPLETED|Overall Study||69
7780664|NCT01308814|19155472|P2|STARTED|Overall Study||86
7780665|NCT01308814|19155473|P1|STARTED|Overall Study||86
7780666|NCT01308788|19155493|P2|NOT COMPLETED|2-year Treatment||11
7780667|NCT01308788|19155494|P1|NOT COMPLETED|2-year Treatment||4
7780668|NCT01308788|19155493|P2|COMPLETED|2-year Treatment||10
7780669|NCT01308788|19155494|P1|COMPLETED|2-year Treatment||10
7780670|NCT01308788|19155493|P2|STARTED|2-year Treatment||21
7780671|NCT01308788|19155494|P1|STARTED|2-year Treatment||14
7780672|NCT01308788|19155493|P2|NOT COMPLETED|6-month Treatment||0
7780673|NCT01308788|19155494|P1|NOT COMPLETED|6-month Treatment||0
7780674|NCT01308788|19155493|P2|COMPLETED|6-month Treatment||21
7780675|NCT01308788|19155494|P1|COMPLETED|6-month Treatment||14
7780676|NCT01308788|19155493|P2|STARTED|6-month Treatment||21
7780677|NCT01308788|19155494|P1|STARTED|6-month Treatment||14
7780678|NCT01308762|19155529|P3|NOT COMPLETED|Overall Study||0
7780679|NCT01308762|19155530|P2|NOT COMPLETED|Overall Study||1
7780680|NCT01308762|19155531|P1|NOT COMPLETED|Overall Study||0
7780681|NCT01308762|19155529|P3|COMPLETED|Overall Study||6
7780682|NCT01308762|19155530|P2|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6
7780683|NCT01308762|19155531|P1|COMPLETED|Overall Study||6
7780684|NCT01308762|19155529|P3|STARTED|Overall Study||6
7780685|NCT01308762|19155530|P2|STARTED|Overall Study||7
7780686|NCT01308762|19155531|P1|STARTED|Overall Study||6
7780687|NCT01308749|19155544|P2|NOT COMPLETED|Period 2: Open Label Treatment||2
7780688|NCT01308749|19155545|P1|NOT COMPLETED|Period 2: Open Label Treatment||0
7780689|NCT01308749|19155544|P2|COMPLETED|Period 2: Open Label Treatment||11
7780690|NCT01308749|19155545|P1|COMPLETED|Period 2: Open Label Treatment||11
7780691|NCT01308749|19155544|P2|STARTED|Period 2: Open Label Treatment||13
7780692|NCT01308749|19155545|P1|STARTED|Period 2: Open Label Treatment||11
7780693|NCT01308749|19155544|P2|NOT COMPLETED|Period 1: Double Blind Treatment||0
7780694|NCT01308749|19155545|P1|NOT COMPLETED|Period 1: Double Blind Treatment||1
7780695|NCT01308749|19155544|P2|COMPLETED|Period 1: Double Blind Treatment||13
7780696|NCT01308749|19155545|P1|COMPLETED|Period 1: Double Blind Treatment||11
7780697|NCT01308749|19155544|P2|STARTED|Period 1: Double Blind Treatment||13
7780698|NCT01308749|19155545|P1|STARTED|Period 1: Double Blind Treatment||12
7780699|NCT01308736|19155575|P2|NOT COMPLETED|Overall Study||5
7780700|NCT01308736|19155576|P1|NOT COMPLETED|Overall Study||6
7780701|NCT01308736|19155575|P2|COMPLETED|Overall Study||27
7780702|NCT01308736|19155576|P1|COMPLETED|Overall Study||25
7780703|NCT01308736|19155575|P2|STARTED|Overall Study||32
7780704|NCT01308736|19155576|P1|STARTED|Overall Study||31
7780705|NCT01308619|19155584|P2|NOT COMPLETED|Overall Study||3
7780706|NCT01308619|19155585|P1|NOT COMPLETED|Overall Study||7
7780707|NCT01308619|19155584|P2|COMPLETED|Overall Study||83
7780708|NCT01308619|19155585|P1|COMPLETED|Overall Study||77
7780709|NCT01308619|19155584|P2|STARTED|Overall Study||86
7780710|NCT01308619|19155585|P1|STARTED|Overall Study||84
7780711|NCT01308580|19155599|P2|NOT COMPLETED|Overall Study||7
7780712|NCT01308580|19155600|P1|NOT COMPLETED|Overall Study||12
7780713|NCT01308580|19155599|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595
7780714|NCT01308580|19155600|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586
7780715|NCT01308580|19155599|P2|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588
7780716|NCT01308580|19155600|P1|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587
7780717|NCT01308580|19155599|P2|STARTED|Overall Study||602
7780718|NCT01308580|19155600|P1|STARTED|Overall Study||598
7780719|NCT01308567|19155643|P3|NOT COMPLETED|Overall Study||4
7780720|NCT01308567|19155644|P2|NOT COMPLETED|Overall Study||4
7780721|NCT01308567|19155645|P1|NOT COMPLETED|Overall Study||2
7780722|NCT01308567|19155643|P3|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|384
7780723|NCT01308567|19155644|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|385
7780724|NCT01308567|19155645|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|389
7780725|NCT01308567|19155643|P3|Treated|Overall Study|For 2 participants, actual treatment received was Cabazitaxel 20 mg/m^2.|377
7780726|NCT01308567|19155644|P2|Treated|Overall Study|For 15 participants, actual treatment received was Cabazitaxel 25 mg/m^2.|382
7780727|NCT01308567|19155645|P1|Treated|Overall Study|For 1 participant, actual treatment received was Cabazitaxel 25 mg/m^2.|388
7780728|NCT01308567|19155643|P3|STARTED|Overall Study|Randomized|388
7780729|NCT01308567|19155644|P2|STARTED|Overall Study|Randomized|389
7780730|NCT01308567|19155645|P1|STARTED|Overall Study|Randomized|391
7780731|NCT01308476|19155685|P2|NOT COMPLETED|Overall Study||2
7780732|NCT01308476|19155686|P1|NOT COMPLETED|Overall Study||3
7780733|NCT01308476|19155685|P2|COMPLETED|Overall Study||45
7780734|NCT01308476|19155686|P1|COMPLETED|Overall Study||45
7780735|NCT01308476|19155685|P2|STARTED|Overall Study|Entered and treated.|47
7780736|NCT01308476|19155686|P1|STARTED|Overall Study|Entered and treated.|48
7780737|NCT01308463|19155706|P1|NOT COMPLETED|Overall Study||29
7780738|NCT01308463|19155706|P1|COMPLETED|Overall Study||0
7780739|NCT01308463|19155706|P1|12 Years|Overall Study||2
7780740|NCT01308463|19155706|P1|11 Years|Overall Study||8
7780741|NCT01308463|19155706|P1|10 Years|Overall Study||8
7780742|NCT01308463|19155706|P1|9 Years|Overall Study||11
7780743|NCT01308463|19155706|P1|8 Years|Overall Study||14
7780744|NCT01308463|19155706|P1|7 Years|Overall Study||12
7780745|NCT01308463|19155706|P1|6 Years|Overall Study||11
7780746|NCT01308463|19155706|P1|5 Years|Overall Study||20
7780747|NCT01308463|19155706|P1|4 Years|Overall Study||20
7780748|NCT01308463|19155706|P1|3 Years|Overall Study||17
7780749|NCT01308463|19155706|P1|2 Years|Overall Study||18
7780750|NCT01308463|19155706|P1|1 Year|Overall Study||21
7780751|NCT01308463|19155706|P1|6 Months|Overall Study||23
7780752|NCT01308463|19155706|P1|STARTED|Overall Study||29
7780753|NCT01308450|19155713|P1|NOT COMPLETED|Overall Study||2
7780754|NCT01308450|19155713|P1|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300
7780755|NCT01308450|19155713|P1|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302
7780756|NCT01308424|19155719|P3|NOT COMPLETED|Randomization||2
7780757|NCT01308424|19155720|P2|NOT COMPLETED|Randomization||3
7780758|NCT01308424|19155721|P1|NOT COMPLETED|Randomization||0
7780759|NCT01308424|19155719|P3|COMPLETED|Randomization||82
7780760|NCT01308424|19155720|P2|COMPLETED|Randomization||84
7780761|NCT01308424|19155721|P1|COMPLETED|Randomization||0
7780762|NCT01308424|19155719|P3|STARTED|Randomization||84
7780763|NCT01308424|19155720|P2|STARTED|Randomization||87
7780764|NCT01308424|19155721|P1|STARTED|Randomization||0
7780765|NCT01308424|19155719|P3|NOT COMPLETED|Baseline Eligibility||0
7780766|NCT01308424|19155720|P2|NOT COMPLETED|Baseline Eligibility||0
7780767|NCT01308424|19155721|P1|NOT COMPLETED|Baseline Eligibility||71
7780768|NCT01308424|19155719|P3|COMPLETED|Baseline Eligibility||0
7780769|NCT01308424|19155720|P2|COMPLETED|Baseline Eligibility||0
7780770|NCT01308424|19155721|P1|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171
7780771|NCT01308424|19155719|P3|STARTED|Baseline Eligibility||0
7780772|NCT01308424|19155720|P2|STARTED|Baseline Eligibility||0
7780773|NCT01308424|19155721|P1|STARTED|Baseline Eligibility||242
7780774|NCT01308294|19155731|P3|NOT COMPLETED|Cycle 3||0
7780775|NCT01308294|19155732|P2|NOT COMPLETED|Cycle 3||1
7780776|NCT01308294|19155733|P1|NOT COMPLETED|Cycle 3||0
7780777|NCT01308294|19155731|P3|COMPLETED|Cycle 3||0
7780778|NCT01308294|19155732|P2|COMPLETED|Cycle 3||4
7780779|NCT01308294|19155733|P1|COMPLETED|Cycle 3||10
7780780|NCT01308294|19155731|P3|STARTED|Cycle 3||0
7780781|NCT01308294|19155732|P2|STARTED|Cycle 3||5
7780782|NCT01308294|19155733|P1|STARTED|Cycle 3||10
7780783|NCT01308294|19155731|P3|NOT COMPLETED|Cycle 2||0
7780784|NCT01308294|19155732|P2|NOT COMPLETED|Cycle 2||1
7780785|NCT01308294|19155733|P1|NOT COMPLETED|Cycle 2||0
7780786|NCT01308294|19155731|P3|COMPLETED|Cycle 2||0
7780787|NCT01308294|19155732|P2|COMPLETED|Cycle 2||5
7780788|NCT01308294|19155733|P1|COMPLETED|Cycle 2||10
7780789|NCT01308294|19155731|P3|STARTED|Cycle 2||0
7780790|NCT01308294|19155732|P2|STARTED|Cycle 2||6
7780791|NCT01308294|19155733|P1|STARTED|Cycle 2||10
7780792|NCT01308294|19155731|P3|NOT COMPLETED|Cycle 1||0
7780793|NCT01308294|19155732|P2|NOT COMPLETED|Cycle 1||0
7780794|NCT01308294|19155733|P1|NOT COMPLETED|Cycle 1||0
7780795|NCT01308294|19155731|P3|COMPLETED|Cycle 1||0
7780796|NCT01308294|19155732|P2|COMPLETED|Cycle 1||6
7780797|NCT01308294|19155733|P1|COMPLETED|Cycle 1||10
7780798|NCT01308294|19155731|P3|STARTED|Cycle 1||0
7780799|NCT01308294|19155732|P2|STARTED|Cycle 1||6
7780800|NCT01308294|19155733|P1|STARTED|Cycle 1||10
7780801|NCT01308060|19155761|P2|NOT COMPLETED|Part B||8
7780802|NCT01308060|19155762|P1|NOT COMPLETED|Part B||19
7780803|NCT01308060|19155761|P2|COMPLETED|Part B||69
7780804|NCT01308060|19155762|P1|COMPLETED|Part B||219
7780805|NCT01308060|19155761|P2|STARTED|Part B||77
7780806|NCT01308060|19155762|P1|STARTED|Part B||238
7780807|NCT01308060|19155761|P2|NOT COMPLETED|Part A||6
7780808|NCT01308060|19155762|P1|NOT COMPLETED|Part A||14
7780809|NCT01308060|19155761|P2|COMPLETED|Part A||77
7780810|NCT01308060|19155762|P1|COMPLETED|Part A||238
7780811|NCT01308060|19155761|P2|STARTED|Part A||83
7780812|NCT01308060|19155762|P1|STARTED|Part A||252
7780813|NCT01308008|19155773|P2|NOT COMPLETED|12 Months||4
7780814|NCT01308008|19155774|P1|NOT COMPLETED|12 Months||8
7780815|NCT01308008|19155773|P2|COMPLETED|12 Months||58
7780816|NCT01308008|19155774|P1|COMPLETED|12 Months||46
7780817|NCT01308008|19155773|P2|STARTED|12 Months||62
7780818|NCT01308008|19155774|P1|STARTED|12 Months||54
7780819|NCT01308008|19155773|P2|NOT COMPLETED|6 Months||9
7780820|NCT01308008|19155774|P1|NOT COMPLETED|6 Months||8
7780821|NCT01308008|19155773|P2|COMPLETED|6 Months||62
7780822|NCT01308008|19155774|P1|COMPLETED|6 Months||54
7780823|NCT01308008|19155773|P2|STARTED|6 Months||71
7780824|NCT01308008|19155774|P1|STARTED|6 Months||62
7780825|NCT01308008|19155773|P2|NOT COMPLETED|4 Weeks||2
7780826|NCT01308008|19155774|P1|NOT COMPLETED|4 Weeks||9
7780827|NCT01308008|19155773|P2|COMPLETED|4 Weeks||71
7780828|NCT01308008|19155774|P1|COMPLETED|4 Weeks||62
7780829|NCT01308008|19155773|P2|STARTED|4 Weeks||73
7780830|NCT01308008|19155774|P1|STARTED|4 Weeks||71
7780831|NCT01307956|19155784|P1|NOT COMPLETED|Overall Study||0
7780832|NCT01307956|19155784|P1|COMPLETED|Overall Study||11
7780833|NCT01307956|19155784|P1|STARTED|Overall Study||11
7780834|NCT01307930|19155791|P1|NOT COMPLETED|Overall Study||2
7780835|NCT01307930|19155791|P1|COMPLETED|Overall Study||18
7780836|NCT01307930|19155791|P1|STARTED|Overall Study||20
7780837|NCT01307891|19155797|P2|NOT COMPLETED|Overall Study||1
7780838|NCT01307891|19155798|P1|NOT COMPLETED|Overall Study||3
7780839|NCT01307891|19155797|P2|COMPLETED|Overall Study||21
7780840|NCT01307891|19155798|P1|COMPLETED|Overall Study||39
7780841|NCT01307891|19155797|P2|STARTED|Overall Study||22
7780842|NCT01307891|19155798|P1|STARTED|Overall Study||42
7780843|NCT01307787|19155810|P2|NOT COMPLETED|Overall Study||0
7780844|NCT01307787|19155811|P1|NOT COMPLETED|Overall Study||2
7780845|NCT01307787|19155810|P2|COMPLETED|Overall Study||15
7780846|NCT01307787|19155811|P1|COMPLETED|Overall Study||17
7780847|NCT01307787|19155810|P2|T2= After 22 Weeks at Follow-up|Overall Study||15
7780848|NCT01307787|19155811|P1|T2= After 22 Weeks at Follow-up|Overall Study||17
7780849|NCT01307787|19155810|P2|T1= After 9 Weeks Post Intervention|Overall Study||15
7780850|NCT01307787|19155811|P1|T1= After 9 Weeks Post Intervention|Overall Study||18
7780851|NCT01307787|19155810|P2|STARTED|Overall Study||15
7780852|NCT01307787|19155811|P1|STARTED|Overall Study||19
7780853|NCT01307748|19155834|P3|NOT COMPLETED|Overall Study||0
7780854|NCT01307748|19155835|P2|NOT COMPLETED|Overall Study||0
7780855|NCT01307748|19155836|P1|NOT COMPLETED|Overall Study||0
7780856|NCT01307748|19155834|P3|COMPLETED|Overall Study||30
7780857|NCT01307748|19155835|P2|COMPLETED|Overall Study||31
7780858|NCT01307748|19155836|P1|COMPLETED|Overall Study||31
7780859|NCT01307748|19155834|P3|STARTED|Overall Study||30
7780860|NCT01307748|19155835|P2|STARTED|Overall Study||31
7780861|NCT01307748|19155836|P1|STARTED|Overall Study||31
7780862|NCT01307631|19155850|P2|NOT COMPLETED|Overall Study||0
7780863|NCT01307631|19155851|P1|NOT COMPLETED|Overall Study||0
7780864|NCT01307631|19155850|P2|COMPLETED|Overall Study||28
7780865|NCT01307631|19155851|P1|COMPLETED|Overall Study||9
7780866|NCT01307631|19155850|P2|STARTED|Overall Study||28
7780867|NCT01307631|19155851|P1|STARTED|Overall Study||9
7780868|NCT01307618|19155861|P2|NOT COMPLETED|Overall Study||0
7780869|NCT01307618|19155862|P1|NOT COMPLETED|Overall Study||0
7780870|NCT01307618|19155861|P2|COMPLETED|Overall Study||5
7780871|NCT01307618|19155862|P1|COMPLETED|Overall Study||5
7780872|NCT01307618|19155861|P2|STARTED|Overall Study||5
7780873|NCT01307618|19155862|P1|STARTED|Overall Study||5
7780874|NCT01307579|19155880|P2|NOT COMPLETED|Overall Study||145
7780875|NCT01307579|19155881|P1|NOT COMPLETED|Overall Study||140
7780876|NCT01307579|19155880|P2|COMPLETED|Overall Study||115
7780877|NCT01307579|19155881|P1|COMPLETED|Overall Study||117
7780878|NCT01307579|19155880|P2|STARTED|Overall Study||260
7780879|NCT01307579|19155881|P1|STARTED|Overall Study||257
7780880|NCT01307501|19155893|P1|NOT COMPLETED|Overall Study||23
7780881|NCT01307501|19155893|P1|COMPLETED|Overall Study||17
7780882|NCT01307501|19155893|P1|Intent-to-Treat (ITT) Population|Overall Study||40
7780883|NCT01307501|19155893|P1|STARTED|Overall Study||40
7780884|NCT01307462|19155906|P1|NOT COMPLETED|Overall Study||1
7780885|NCT01307462|19155906|P1|COMPLETED|Overall Study||35
7780886|NCT01307462|19155906|P1|STARTED|Overall Study||36
7780887|NCT01307449|19155923|P4|NOT COMPLETED|Overall Study||0
7780888|NCT01307449|19155924|P3|NOT COMPLETED|Overall Study||0
7780889|NCT01307449|19155925|P2|NOT COMPLETED|Overall Study||0
7780890|NCT01307449|19155926|P1|NOT COMPLETED|Overall Study||1
7780891|NCT01307449|19155923|P4|COMPLETED|Overall Study||11
7780892|NCT01307449|19155924|P3|COMPLETED|Overall Study||11
7780893|NCT01307449|19155925|P2|COMPLETED|Overall Study||33
7780894|NCT01307449|19155926|P1|COMPLETED|Overall Study||32
7780895|NCT01307449|19155923|P4|STARTED|Overall Study||11
7780896|NCT01307449|19155924|P3|STARTED|Overall Study||11
7780897|NCT01307449|19155925|P2|STARTED|Overall Study||33
7780898|NCT01307449|19155926|P1|STARTED|Overall Study||33
7780899|NCT01307423|19155959|P9|NOT COMPLETED|Long-term Safety Phase (Year 5)||3
7780900|NCT01307423|19155960|P8|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
7780901|NCT01307423|19155961|P7|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
7780902|NCT01307423|19155962|P6|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
7780903|NCT01307423|19155963|P5|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
7780904|NCT01307423|19155964|P4|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
7780905|NCT01307423|19155965|P3|NOT COMPLETED|Long-term Safety Phase (Year 5)||6
7780906|NCT01307423|19155966|P2|NOT COMPLETED|Long-term Safety Phase (Year 5)||10
7780907|NCT01307423|19155967|P1|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
7780908|NCT01307423|19155959|P9|COMPLETED|Long-term Safety Phase (Year 5)||41
7780909|NCT01307423|19155960|P8|COMPLETED|Long-term Safety Phase (Year 5)||37
7780910|NCT01307423|19155961|P7|COMPLETED|Long-term Safety Phase (Year 5)||0
7780911|NCT01307423|19155962|P6|COMPLETED|Long-term Safety Phase (Year 5)||0
7780912|NCT01307423|19155963|P5|COMPLETED|Long-term Safety Phase (Year 5)||0
7780913|NCT01307423|19155964|P4|COMPLETED|Long-term Safety Phase (Year 5)||0
7780914|NCT01307423|19155965|P3|COMPLETED|Long-term Safety Phase (Year 5)||80
7780915|NCT01307423|19155966|P2|COMPLETED|Long-term Safety Phase (Year 5)||71
7780916|NCT01307423|19155967|P1|COMPLETED|Long-term Safety Phase (Year 5)||0
7780917|NCT01307423|19155959|P9|STARTED|Long-term Safety Phase (Year 5)||44
7780918|NCT01307423|19155960|P8|STARTED|Long-term Safety Phase (Year 5)||38
7780919|NCT01307423|19155961|P7|STARTED|Long-term Safety Phase (Year 5)||0
7780920|NCT01307423|19155962|P6|STARTED|Long-term Safety Phase (Year 5)||0
7780921|NCT01307423|19155963|P5|STARTED|Long-term Safety Phase (Year 5)||0
7780922|NCT01307423|19155964|P4|STARTED|Long-term Safety Phase (Year 5)||0
7780923|NCT01307423|19155965|P3|STARTED|Long-term Safety Phase (Year 5)||86
7780924|NCT01307423|19155966|P2|STARTED|Long-term Safety Phase (Year 5)||81
7780925|NCT01307423|19155967|P1|STARTED|Long-term Safety Phase (Year 5)||0
7780926|NCT01307423|19155959|P9|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
7780927|NCT01307423|19155960|P8|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
7780928|NCT01307423|19155961|P7|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
7780929|NCT01307423|19155962|P6|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
7780930|NCT01307423|19155963|P5|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
7780931|NCT01307423|19155964|P4|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
7780932|NCT01307423|19155965|P3|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
7780933|NCT01307423|19155966|P2|NOT COMPLETED|Long-term Safety Phase (Year 4)||8
7780934|NCT01307423|19155967|P1|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
7780935|NCT01307423|19155959|P9|COMPLETED|Long-term Safety Phase (Year 4)||44
7780936|NCT01307423|19155960|P8|COMPLETED|Long-term Safety Phase (Year 4)||38
7780937|NCT01307423|19155961|P7|COMPLETED|Long-term Safety Phase (Year 4)||0
7780938|NCT01307423|19155962|P6|COMPLETED|Long-term Safety Phase (Year 4)||0
7780939|NCT01307423|19155963|P5|COMPLETED|Long-term Safety Phase (Year 4)||0
7780940|NCT01307423|19155964|P4|COMPLETED|Long-term Safety Phase (Year 4)||0
7780941|NCT01307423|19155965|P3|COMPLETED|Long-term Safety Phase (Year 4)||86
7780942|NCT01307423|19155966|P2|COMPLETED|Long-term Safety Phase (Year 4)||81
7780943|NCT01307423|19155967|P1|COMPLETED|Long-term Safety Phase (Year 4)||0
7780944|NCT01307423|19155959|P9|STARTED|Long-term Safety Phase (Year 4)||49
7780945|NCT01307423|19155960|P8|STARTED|Long-term Safety Phase (Year 4)||40
7780946|NCT01307423|19155961|P7|STARTED|Long-term Safety Phase (Year 4)||0
7780947|NCT01307423|19155962|P6|STARTED|Long-term Safety Phase (Year 4)||0
7780948|NCT01307423|19155963|P5|STARTED|Long-term Safety Phase (Year 4)||0
7780949|NCT01307423|19155964|P4|STARTED|Long-term Safety Phase (Year 4)||0
7780950|NCT01307423|19155965|P3|STARTED|Long-term Safety Phase (Year 4)||91
7780951|NCT01307423|19155966|P2|STARTED|Long-term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|89
7780952|NCT01307423|19155967|P1|STARTED|Long-term Safety Phase (Year 4)||0
7780953|NCT01307423|19155959|P9|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
7780954|NCT01307423|19155960|P8|NOT COMPLETED|Long-term Safety Phase (Year 3)||8
7780955|NCT01307423|19155961|P7|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
7780956|NCT01307423|19155962|P6|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
7780957|NCT01307423|19155963|P5|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
7780958|NCT01307423|19155964|P4|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
7780959|NCT01307423|19155965|P3|NOT COMPLETED|Long-term Safety Phase (Year 3)||18
7780960|NCT01307423|19155966|P2|NOT COMPLETED|Long-term Safety Phase (Year 3)||9
7780961|NCT01307423|19155967|P1|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
7780962|NCT01307423|19155959|P9|COMPLETED|Long-term Safety Phase (Year 3)||49
7780963|NCT01307423|19155960|P8|COMPLETED|Long-term Safety Phase (Year 3)||40
7780964|NCT01307423|19155961|P7|COMPLETED|Long-term Safety Phase (Year 3)||0
7780965|NCT01307423|19155962|P6|COMPLETED|Long-term Safety Phase (Year 3)||0
7780966|NCT01307423|19155963|P5|COMPLETED|Long-term Safety Phase (Year 3)||0
7780967|NCT01307423|19155964|P4|COMPLETED|Long-term Safety Phase (Year 3)||0
7780968|NCT01307423|19155965|P3|COMPLETED|Long-term Safety Phase (Year 3)||91
7780969|NCT01307423|19155966|P2|COMPLETED|Long-term Safety Phase (Year 3)||90
7780970|NCT01307423|19155967|P1|COMPLETED|Long-term Safety Phase (Year 3)||0
7780971|NCT01307423|19155959|P9|STARTED|Long-term Safety Phase (Year 3)||60
7780972|NCT01307423|19155960|P8|STARTED|Long-term Safety Phase (Year 3)||48
7780973|NCT01307423|19155961|P7|STARTED|Long-term Safety Phase (Year 3)||0
7780974|NCT01307423|19155962|P6|STARTED|Long-term Safety Phase (Year 3)||0
7780975|NCT01307423|19155963|P5|STARTED|Long-term Safety Phase (Year 3)||0
7780976|NCT01307423|19155964|P4|STARTED|Long-term Safety Phase (Year 3)||0
7780977|NCT01307423|19155965|P3|STARTED|Long-term Safety Phase (Year 3)||109
7780978|NCT01307423|19155966|P2|STARTED|Long-term Safety Phase (Year 3)||99
7780979|NCT01307423|19155967|P1|STARTED|Long-term Safety Phase (Year 3)||0
7780980|NCT01307423|19155959|P9|NOT COMPLETED|Long-term Safety Phase (Year 2)||7
7780981|NCT01307423|19155960|P8|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
7780982|NCT01307423|19155961|P7|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
7780983|NCT01307423|19155962|P6|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
7780984|NCT01307423|19155963|P5|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
7780985|NCT01307423|19155964|P4|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
7780986|NCT01307423|19155965|P3|NOT COMPLETED|Long-term Safety Phase (Year 2)||25
7780987|NCT01307423|19155966|P2|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
7780988|NCT01307423|19155967|P1|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
7780989|NCT01307423|19155959|P9|COMPLETED|Long-term Safety Phase (Year 2)||60
7780990|NCT01307423|19155960|P8|COMPLETED|Long-term Safety Phase (Year 2)||48
7780991|NCT01307423|19155961|P7|COMPLETED|Long-term Safety Phase (Year 2)||0
7780992|NCT01307423|19155962|P6|COMPLETED|Long-term Safety Phase (Year 2)||0
7780993|NCT01307423|19155963|P5|COMPLETED|Long-term Safety Phase (Year 2)||0
7780994|NCT01307423|19155964|P4|COMPLETED|Long-term Safety Phase (Year 2)||0
7780995|NCT01307423|19155965|P3|COMPLETED|Long-term Safety Phase (Year 2)||109
7780996|NCT01307423|19155966|P2|COMPLETED|Long-term Safety Phase (Year 2)||99
7780997|NCT01307423|19155967|P1|COMPLETED|Long-term Safety Phase (Year 2)||0
7780998|NCT01307423|19155959|P9|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|67
7780999|NCT01307423|19155960|P8|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;15 patients finished Wk 52;no entry into LTSP|57
7781000|NCT01307423|19155961|P7|STARTED|Long-term Safety Phase (Year 2)||0
7781001|NCT01307423|19155962|P6|STARTED|Long-term Safety Phase (Year 2)||0
7781002|NCT01307423|19155963|P5|STARTED|Long-term Safety Phase (Year 2)||0
7781003|NCT01307423|19155964|P4|STARTED|Long-term Safety Phase (Year 2)||0
7781004|NCT01307423|19155965|P3|STARTED|Long-term Safety Phase (Year 2)|7 participants who completed Week 52 did not enter the long-term safety phase|134
7781005|NCT01307423|19155966|P2|STARTED|Long-term Safety Phase (Year 2)|10 participants who completed Week 52 did not enter the long-term safety phase|122
7781006|NCT01307423|19155967|P1|STARTED|Long-term Safety Phase (Year 2)||0
7781007|NCT01307423|19155959|P9|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
7781008|NCT01307423|19155960|P8|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
7781009|NCT01307423|19155961|P7|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1
7781010|NCT01307423|19155962|P6|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
7781011|NCT01307423|19155963|P5|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
7781012|NCT01307423|19155964|P4|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8
7781013|NCT01307423|19155965|P3|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9
7781014|NCT01307423|19155966|P2|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19
7781015|NCT01307423|19155967|P1|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
7781016|NCT01307423|19155959|P9|COMPLETED|Active Treatment Phase (Week 25-52)||0
7781017|NCT01307423|19155960|P8|COMPLETED|Active Treatment Phase (Week 25-52)||0
7781018|NCT01307423|19155961|P7|COMPLETED|Active Treatment Phase (Week 25-52)||25
7781019|NCT01307423|19155962|P6|COMPLETED|Active Treatment Phase (Week 25-52)||43
7781020|NCT01307423|19155963|P5|COMPLETED|Active Treatment Phase (Week 25-52)||23
7781021|NCT01307423|19155964|P4|COMPLETED|Active Treatment Phase (Week 25-52)||38
7781022|NCT01307423|19155965|P3|COMPLETED|Active Treatment Phase (Week 25-52)||141
7781023|NCT01307423|19155966|P2|COMPLETED|Active Treatment Phase (Week 25-52)||132
7781024|NCT01307423|19155967|P1|COMPLETED|Active Treatment Phase (Week 25-52)||0
7781025|NCT01307423|19155959|P9|STARTED|Active Treatment Phase (Week 25-52)||0
7781026|NCT01307423|19155960|P8|STARTED|Active Treatment Phase (Week 25-52)||0
7781027|NCT01307423|19155961|P7|STARTED|Active Treatment Phase (Week 25-52)||26
7781028|NCT01307423|19155962|P6|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46
7781029|NCT01307423|19155963|P5|STARTED|Active Treatment Phase (Week 25-52)||26
7781030|NCT01307423|19155964|P4|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46
7781031|NCT01307423|19155965|P3|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150
7781032|NCT01307423|19155966|P2|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151
7781033|NCT01307423|19155967|P1|STARTED|Active Treatment Phase (Week 25-52)||0
7781034|NCT01307423|19155959|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7781035|NCT01307423|19155960|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7781036|NCT01307423|19155961|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7781037|NCT01307423|19155962|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7781038|NCT01307423|19155963|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7781039|NCT01307423|19155964|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7781040|NCT01307423|19155965|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
7781041|NCT01307423|19155966|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15
7781042|NCT01307423|19155967|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
7781043|NCT01307423|19155959|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7781044|NCT01307423|19155960|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7781045|NCT01307423|19155961|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7781046|NCT01307423|19155962|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7781047|NCT01307423|19155963|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7781048|NCT01307423|19155964|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7781049|NCT01307423|19155965|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155
7781050|NCT01307423|19155966|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160
7781051|NCT01307423|19155967|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156
7781052|NCT01307423|19155959|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7781053|NCT01307423|19155960|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7781054|NCT01307423|19155961|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7781055|NCT01307423|19155962|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7781056|NCT01307423|19155963|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7781057|NCT01307423|19155964|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7781058|NCT01307423|19155965|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79
7781059|NCT01307423|19155966|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73
7781060|NCT01307423|19155967|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103
7781061|NCT01307423|19155959|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7781062|NCT01307423|19155960|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7781063|NCT01307423|19155961|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7781064|NCT01307423|19155962|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7781065|NCT01307423|19155963|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7781066|NCT01307423|19155964|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7781067|NCT01307423|19155965|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
7781068|NCT01307423|19155966|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168
7781069|NCT01307423|19155967|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
7781070|NCT01307423|19155959|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
7781071|NCT01307423|19155960|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
7781072|NCT01307423|19155961|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
7781073|NCT01307423|19155962|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
7781074|NCT01307423|19155963|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
7781075|NCT01307423|19155964|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
7781076|NCT01307423|19155965|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
7781077|NCT01307423|19155966|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
7781078|NCT01307423|19155967|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176
7781079|NCT01307423|19155959|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
7781080|NCT01307423|19155960|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
7781081|NCT01307423|19155961|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
7781082|NCT01307423|19155962|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
7781083|NCT01307423|19155963|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
7781084|NCT01307423|19155964|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
7781085|NCT01307423|19155965|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||177
7781086|NCT01307423|19155966|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||175
7781087|NCT01307423|19155967|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||176
7781088|NCT01307397|19156151|P1|NOT COMPLETED|Overall Study||0
7781089|NCT01307397|19156151|P1|COMPLETED|Overall Study|A participant completed study in case of progressive disease, adverse events or consent withdrawn|3219
7781090|NCT01307397|19156151|P1|STARTED|Overall Study||3219
7781091|NCT01307319|19156173|P3|NOT COMPLETED|Overall Study||7
7781092|NCT01307319|19156174|P2|NOT COMPLETED|Overall Study||8
7781093|NCT01307319|19156175|P1|NOT COMPLETED|Overall Study||4
7781094|NCT01307319|19156173|P3|COMPLETED|Overall Study||227
7781095|NCT01307319|19156174|P2|COMPLETED|Overall Study||234
7781096|NCT01307319|19156175|P1|COMPLETED|Overall Study||235
7781097|NCT01307319|19156173|P3|ITT Population|Overall Study||234
7781098|NCT01307319|19156174|P2|ITT Population|Overall Study||241
7781099|NCT01307319|19156175|P1|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238
7781100|NCT01307319|19156173|P3|Safety Population|Overall Study||234
7781101|NCT01307319|19156174|P2|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241
7781102|NCT01307319|19156175|P1|Safety Population|Overall Study||239
7781103|NCT01307319|19156173|P3|STARTED|Overall Study|Randomized|234
7781104|NCT01307319|19156174|P2|STARTED|Overall Study|Randomized|242
7781105|NCT01307319|19156175|P1|STARTED|Overall Study|Randomized|239
7781106|NCT01307267|19156209|P23|NOT COMPLETED|Overall Study||4
7781107|NCT01307267|19156210|P22|NOT COMPLETED|Overall Study||5
7781108|NCT01307267|19156211|P21|NOT COMPLETED|Overall Study||3
7781109|NCT01307267|19156212|P20|NOT COMPLETED|Overall Study||32
7781110|NCT01307267|19156213|P19|NOT COMPLETED|Overall Study||2
7781111|NCT01307267|19156214|P18|NOT COMPLETED|Overall Study||1
7781112|NCT01307267|19156215|P17|NOT COMPLETED|Overall Study||1
7781113|NCT01307267|19156216|P16|NOT COMPLETED|Overall Study||1
7781114|NCT01307267|19156217|P15|NOT COMPLETED|Overall Study||2
7781115|NCT01307267|19156218|P14|NOT COMPLETED|Overall Study||0
7781116|NCT01307267|19156219|P13|NOT COMPLETED|Overall Study||1
7781117|NCT01307267|19156220|P12|NOT COMPLETED|Overall Study||11
7781118|NCT01307267|19156221|P11|NOT COMPLETED|Overall Study||6
7781119|NCT01307267|19156222|P10|NOT COMPLETED|Overall Study||5
7781120|NCT01307267|19156223|P9|NOT COMPLETED|Overall Study||30
7781121|NCT01307267|19156224|P8|NOT COMPLETED|Overall Study||4
7781122|NCT01307267|19156225|P7|NOT COMPLETED|Overall Study||2
7781123|NCT01307267|19156226|P6|NOT COMPLETED|Overall Study||41
7781124|NCT01307267|19156227|P5|NOT COMPLETED|Overall Study||1
7781125|NCT01307267|19156228|P4|NOT COMPLETED|Overall Study||3
7781126|NCT01307267|19156229|P3|NOT COMPLETED|Overall Study||5
7781127|NCT01307267|19156230|P2|NOT COMPLETED|Overall Study||3
7781128|NCT01307267|19156231|P1|NOT COMPLETED|Overall Study||4
7781129|NCT01307267|19156209|P23|COMPLETED|Overall Study||0
7781130|NCT01307267|19156210|P22|COMPLETED|Overall Study||0
7781131|NCT01307267|19156211|P21|COMPLETED|Overall Study||0
7781132|NCT01307267|19156212|P20|COMPLETED|Overall Study||0
7781133|NCT01307267|19156213|P19|COMPLETED|Overall Study||2
7781134|NCT01307267|19156214|P18|COMPLETED|Overall Study||2
7781135|NCT01307267|19156215|P17|COMPLETED|Overall Study||2
7781136|NCT01307267|19156216|P16|COMPLETED|Overall Study||2
7781137|NCT01307267|19156217|P15|COMPLETED|Overall Study||2
7781138|NCT01307267|19156218|P14|COMPLETED|Overall Study||3
7781139|NCT01307267|19156219|P13|COMPLETED|Overall Study||2
7781140|NCT01307267|19156220|P12|COMPLETED|Overall Study||0
7781141|NCT01307267|19156221|P11|COMPLETED|Overall Study||0
7781142|NCT01307267|19156222|P10|COMPLETED|Overall Study||0
7781143|NCT01307267|19156223|P9|COMPLETED|Overall Study||1
7781144|NCT01307267|19156224|P8|COMPLETED|Overall Study||0
7781145|NCT01307267|19156225|P7|COMPLETED|Overall Study||1
7781146|NCT01307267|19156226|P6|COMPLETED|Overall Study||1
7781147|NCT01307267|19156227|P5|COMPLETED|Overall Study||2
7781148|NCT01307267|19156228|P4|COMPLETED|Overall Study||1
7781149|NCT01307267|19156229|P3|COMPLETED|Overall Study||1
7781150|NCT01307267|19156230|P2|COMPLETED|Overall Study||0
7781151|NCT01307267|19156231|P1|COMPLETED|Overall Study||0
7781152|NCT01307267|19156209|P23|STARTED|Overall Study||4
7781153|NCT01307267|19156210|P22|STARTED|Overall Study||5
7781154|NCT01307267|19156211|P21|STARTED|Overall Study||3
7781155|NCT01307267|19156212|P20|STARTED|Overall Study||32
7781156|NCT01307267|19156213|P19|STARTED|Overall Study||4
7781157|NCT01307267|19156214|P18|STARTED|Overall Study||3
7781158|NCT01307267|19156215|P17|STARTED|Overall Study||3
7781159|NCT01307267|19156216|P16|STARTED|Overall Study||3
7781160|NCT01307267|19156217|P15|STARTED|Overall Study||4
7781161|NCT01307267|19156218|P14|STARTED|Overall Study||3
7781162|NCT01307267|19156219|P13|STARTED|Overall Study||3
7781163|NCT01307267|19156220|P12|STARTED|Overall Study||11
7781164|NCT01307267|19156221|P11|STARTED|Overall Study||6
7781165|NCT01307267|19156222|P10|STARTED|Overall Study||5
7781166|NCT01307267|19156223|P9|STARTED|Overall Study||31
7781167|NCT01307267|19156224|P8|STARTED|Overall Study||4
7781168|NCT01307267|19156225|P7|STARTED|Overall Study||3
7781169|NCT01307267|19156226|P6|STARTED|Overall Study||42
7781170|NCT01307267|19156227|P5|STARTED|Overall Study||3
7781171|NCT01307267|19156228|P4|STARTED|Overall Study||4
7781172|NCT01307267|19156229|P3|STARTED|Overall Study||6
7781173|NCT01307267|19156230|P2|STARTED|Overall Study||3
7781174|NCT01307267|19156231|P1|STARTED|Overall Study||4
7781175|NCT01307111|19156822|P2|NOT COMPLETED|1-2 Week IUD Check up||2
7781176|NCT01307111|19156823|P1|NOT COMPLETED|1-2 Week IUD Check up||2
7781177|NCT01307111|19156822|P2|COMPLETED|1-2 Week IUD Check up||38
7781178|NCT01307111|19156823|P1|COMPLETED|1-2 Week IUD Check up||38
7781179|NCT01307111|19156822|P2|STARTED|1-2 Week IUD Check up||40
7781180|NCT01307111|19156823|P1|STARTED|1-2 Week IUD Check up||40
7781181|NCT01307111|19156822|P2|NOT COMPLETED|IUD Insertion||0
7781182|NCT01307111|19156823|P1|NOT COMPLETED|IUD Insertion||2
7781183|NCT01307111|19156822|P2|COMPLETED|IUD Insertion||40
7781184|NCT01307111|19156823|P1|COMPLETED|IUD Insertion||40
7781185|NCT01307111|19156822|P2|STARTED|IUD Insertion||40
7781186|NCT01307111|19156823|P1|STARTED|IUD Insertion||42
7781187|NCT01307098|19156834|P3|NOT COMPLETED|Overall Study||0
7781188|NCT01307098|19156835|P2|NOT COMPLETED|Overall Study||0
7781189|NCT01307098|19156836|P1|NOT COMPLETED|Overall Study||0
7781190|NCT01307098|19156834|P3|COMPLETED|Overall Study||3
7781191|NCT01307098|19156835|P2|COMPLETED|Overall Study||3
7781192|NCT01307098|19156836|P1|COMPLETED|Overall Study||3
7781193|NCT01307098|19156834|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
7781194|NCT01307098|19156835|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
7781195|NCT01307098|19156836|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
7781196|NCT01307098|19156834|P3|STARTED|Overall Study||3
7781197|NCT01307098|19156835|P2|STARTED|Overall Study||3
7781198|NCT01307098|19156836|P1|STARTED|Overall Study||3
7781199|NCT01307046|19156846|P2|NOT COMPLETED|Overall Study||11
7781200|NCT01307046|19156847|P1|NOT COMPLETED|Overall Study||12
7781201|NCT01307046|19156846|P2|COMPLETED|Overall Study||159
7781202|NCT01307046|19156847|P1|COMPLETED|Overall Study||154
7781203|NCT01307046|19156846|P2|STARTED|Overall Study||170
7781204|NCT01307046|19156847|P1|STARTED|Overall Study||166
7781205|NCT01307033|19156859|P4|NOT COMPLETED|44-week Open-label Extension||12
7781206|NCT01307033|19156860|P3|NOT COMPLETED|44-week Open-label Extension||11
7781207|NCT01307033|19156861|P2|NOT COMPLETED|44-week Open-label Extension||0
7781208|NCT01307033|19156862|P1|NOT COMPLETED|44-week Open-label Extension||0
7781209|NCT01307033|19156859|P4|COMPLETED|44-week Open-label Extension||115
7781210|NCT01307033|19156860|P3|COMPLETED|44-week Open-label Extension||120
7781211|NCT01307033|19156861|P2|COMPLETED|44-week Open-label Extension||0
7781212|NCT01307033|19156862|P1|COMPLETED|44-week Open-label Extension||0
7781213|NCT01307033|19156859|P4|STARTED|44-week Open-label Extension||127
7781214|NCT01307033|19156860|P3|STARTED|44-week Open-label Extension||131
7781215|NCT01307033|19156861|P2|STARTED|44-week Open-label Extension||0
7781216|NCT01307033|19156862|P1|STARTED|44-week Open-label Extension||0
7781217|NCT01307033|19156859|P4|NOT COMPLETED|8-week Double-blind Period||0
7781218|NCT01307033|19156860|P3|NOT COMPLETED|8-week Double-blind Period||0
7781219|NCT01307033|19156861|P2|NOT COMPLETED|8-week Double-blind Period||7
7781220|NCT01307033|19156862|P1|NOT COMPLETED|8-week Double-blind Period||13
7781221|NCT01307033|19156859|P4|COMPLETED|8-week Double-blind Period||0
7781222|NCT01307033|19156860|P3|COMPLETED|8-week Double-blind Period||0
7781223|NCT01307033|19156861|P2|COMPLETED|8-week Double-blind Period||127
7781224|NCT01307033|19156862|P1|COMPLETED|8-week Double-blind Period||131
7781225|NCT01307033|19156859|P4|STARTED|8-week Double-blind Period||0
7781226|NCT01307033|19156860|P3|STARTED|8-week Double-blind Period||0
7781227|NCT01307033|19156861|P2|STARTED|8-week Double-blind Period||134
7781228|NCT01307033|19156862|P1|STARTED|8-week Double-blind Period||144
7781229|NCT01307020|19156884|P10|NOT COMPLETED|Overall Study||0
7781230|NCT01307020|19156885|P9|NOT COMPLETED|Overall Study||0
7781231|NCT01307020|19156886|P8|NOT COMPLETED|Overall Study||0
7781232|NCT01307020|19156887|P7|NOT COMPLETED|Overall Study||1
7781233|NCT01307020|19156888|P6|NOT COMPLETED|Overall Study||0
7781234|NCT01307020|19156889|P5|NOT COMPLETED|Overall Study||0
7781235|NCT01307020|19156890|P4|NOT COMPLETED|Overall Study||1
7781236|NCT01307020|19156891|P3|NOT COMPLETED|Overall Study||1
7781237|NCT01307020|19156892|P2|NOT COMPLETED|Overall Study||1
7781238|NCT01307020|19156893|P1|NOT COMPLETED|Overall Study||0
7781239|NCT01307020|19156884|P10|COMPLETED|Overall Study||62
7781240|NCT01307020|19156885|P9|COMPLETED|Overall Study||61
7781241|NCT01307020|19156886|P8|COMPLETED|Overall Study||60
7781242|NCT01307020|19156887|P7|COMPLETED|Overall Study||58
7781243|NCT01307020|19156888|P6|COMPLETED|Overall Study||61
7781244|NCT01307020|19156889|P5|COMPLETED|Overall Study||60
7781245|NCT01307020|19156890|P4|COMPLETED|Overall Study||60
7781246|NCT01307020|19156891|P3|COMPLETED|Overall Study||62
7781247|NCT01307020|19156892|P2|COMPLETED|Overall Study||62
7781248|NCT01307020|19156893|P1|COMPLETED|Overall Study||61
7781249|NCT01307020|19156884|P10|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
7781250|NCT01307020|19156885|P9|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
7781251|NCT01307020|19156886|P8|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
7781252|NCT01307020|19156887|P7|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
7781253|NCT01307020|19156888|P6|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
7781254|NCT01307020|19156889|P5|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
7781255|NCT01307020|19156890|P4|ITT (>= 1 Assessment Post Randomization)|Overall Study||61
7781256|NCT01307020|19156891|P3|ITT (>= 1 Assessment Post Randomization)|Overall Study||63
7781257|NCT01307020|19156892|P2|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
7781258|NCT01307020|19156893|P1|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
7781259|NCT01307020|19156884|P10|Safety Population|Overall Study||62
7781260|NCT01307020|19156885|P9|Safety Population|Overall Study||61
7781261|NCT01307020|19156886|P8|Safety Population|Overall Study||60
7781262|NCT01307020|19156887|P7|Safety Population|Overall Study||59
7781263|NCT01307020|19156888|P6|Safety Population|Overall Study||61
7781264|NCT01307020|19156889|P5|Safety Population|Overall Study||60
7781265|NCT01307020|19156890|P4|Safety Population|Overall Study||61
7781266|NCT01307020|19156891|P3|Safety Population|Overall Study||63
7781267|NCT01307020|19156892|P2|Safety Population|Overall Study||63
7781268|NCT01307020|19156893|P1|Safety Population|Overall Study||61
7781269|NCT01307020|19156884|P10|STARTED|Overall Study||62
7781270|NCT01307020|19156885|P9|STARTED|Overall Study||61
7781271|NCT01307020|19156886|P8|STARTED|Overall Study||60
7781272|NCT01307020|19156887|P7|STARTED|Overall Study||59
7781273|NCT01307020|19156888|P6|STARTED|Overall Study||61
7781274|NCT01307020|19156889|P5|STARTED|Overall Study||60
7781275|NCT01307020|19156890|P4|STARTED|Overall Study||61
7781276|NCT01307020|19156891|P3|STARTED|Overall Study||63
7781277|NCT01307020|19156892|P2|STARTED|Overall Study||63
7781278|NCT01307020|19156893|P1|STARTED|Overall Study||61
7781279|NCT01307007|19156937|P2|NOT COMPLETED|Overall Study||0
7781280|NCT01307007|19156938|P1|NOT COMPLETED|Overall Study||0
7781281|NCT01307007|19156937|P2|COMPLETED|Overall Study||30
7781282|NCT01307007|19156938|P1|COMPLETED|Overall Study||25
7781283|NCT01307007|19156937|P2|STARTED|Overall Study||30
7781284|NCT01307007|19156938|P1|STARTED|Overall Study||25
7781285|NCT01306968|19156948|P4|NOT COMPLETED|Overall Study||4
7781286|NCT01306968|19156949|P3|NOT COMPLETED|Overall Study||1
7781287|NCT01306968|19156950|P2|NOT COMPLETED|Overall Study||3
7781288|NCT01306968|19156951|P1|NOT COMPLETED|Overall Study||1
7781289|NCT01306968|19156948|P4|COMPLETED|Overall Study||21
7781290|NCT01306968|19156949|P3|COMPLETED|Overall Study||23
7781291|NCT01306968|19156950|P2|COMPLETED|Overall Study||20
7781292|NCT01306968|19156951|P1|COMPLETED|Overall Study||6
7781293|NCT01306968|19156948|P4|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25
7781294|NCT01306968|19156949|P3|STARTED|Overall Study||24
7781295|NCT01306968|19156950|P2|STARTED|Overall Study||23
7781296|NCT01306968|19156951|P1|STARTED|Overall Study||7
7781297|NCT01306942|19156976|P4|NOT COMPLETED|Phase II||16
7781298|NCT01306942|19156977|P3|NOT COMPLETED|Phase II||0
7781299|NCT01306942|19156978|P2|NOT COMPLETED|Phase II||0
7781300|NCT01306942|19156979|P1|NOT COMPLETED|Phase II||2
7781301|NCT01306942|19156976|P4|COMPLETED|Phase II||11
7781302|NCT01306942|19156977|P3|COMPLETED|Phase II||0
7781303|NCT01306942|19156978|P2|COMPLETED|Phase II||0
7781304|NCT01306942|19156979|P1|COMPLETED|Phase II||0
7781305|NCT01306942|19156976|P4|STARTED|Phase II||27
7781306|NCT01306942|19156977|P3|STARTED|Phase II||0
7781307|NCT01306942|19156978|P2|STARTED|Phase II|Dasatinib 140mg was not the RP2D, so these patients were not included in the phase II analyses.|0
7781308|NCT01306942|19156979|P1|STARTED|Phase II|Two patients from phase I with measurable disease and RP2D were included in the phase II analyses.|2
7781309|NCT01306942|19156976|P4|NOT COMPLETED|Phase I||0
7781310|NCT01306942|19156977|P3|NOT COMPLETED|Phase I||0
7781311|NCT01306942|19156978|P2|NOT COMPLETED|Phase I||3
7781312|NCT01306942|19156979|P1|NOT COMPLETED|Phase I||5
7781313|NCT01306942|19156976|P4|COMPLETED|Phase I||0
7781314|NCT01306942|19156977|P3|COMPLETED|Phase I||0
7781315|NCT01306942|19156978|P2|COMPLETED|Phase I||1
7781316|NCT01306942|19156979|P1|COMPLETED|Phase I||1
7781317|NCT01306942|19156976|P4|STARTED|Phase I||0
7781318|NCT01306942|19156977|P3|STARTED|Phase I||0
7781319|NCT01306942|19156978|P2|STARTED|Phase I||4
7781320|NCT01306942|19156979|P1|STARTED|Phase I||6
7781321|NCT01306890|19157011|P1|NOT COMPLETED|Overall Study||1519
7781322|NCT01306890|19157011|P1|COMPLETED|Overall Study|Subjects were alive at the end of the study and had completed at least 3 years of follow up.|457
7781323|NCT01306890|19157011|P1|STARTED|Overall Study||1976
7781324|NCT01306877|19157018|P2|NOT COMPLETED|Overall Study||4
7781325|NCT01306877|19157019|P1|NOT COMPLETED|Overall Study||3
7781326|NCT01306877|19157018|P2|COMPLETED|Overall Study||67
7781327|NCT01306877|19157019|P1|COMPLETED|Overall Study||75
7781328|NCT01306877|19157018|P2|STARTED|Overall Study||71
7781329|NCT01306877|19157019|P1|STARTED|Overall Study||78
7781330|NCT01306656|19157039|P2|NOT COMPLETED|Overall Study||0
7781331|NCT01306656|19157040|P1|NOT COMPLETED|Overall Study||1
7781332|NCT01306656|19157039|P2|COMPLETED|Overall Study||2
7781333|NCT01306656|19157040|P1|COMPLETED|Overall Study||6
7781334|NCT01306656|19157039|P2|STARTED|Overall Study||2
7781335|NCT01306656|19157040|P1|STARTED|Overall Study||7
7781336|NCT01306643|19157052|P1|NOT COMPLETED|Overall Study||13
7781337|NCT01306643|19157052|P1|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5
7781338|NCT01306643|19157052|P1|STARTED|Overall Study||18
7781339|NCT01306617|19157064|P3|NOT COMPLETED|Overall Study||5
7781340|NCT01306617|19157065|P2|NOT COMPLETED|Overall Study||1
7781341|NCT01306617|19157066|P1|NOT COMPLETED|Overall Study||1
7781342|NCT01306617|19157064|P3|COMPLETED|Overall Study|The number of participants who completed study drug|12
7781343|NCT01306617|19157065|P2|COMPLETED|Overall Study|The number of participants who completed study drug|13
7781344|NCT01306617|19157066|P1|COMPLETED|Overall Study|The number of participants who completed study drug|18
7781345|NCT01306617|19157064|P3|STARTED|Overall Study||17
7781346|NCT01306617|19157065|P2|STARTED|Overall Study||14
7781347|NCT01306617|19157066|P1|STARTED|Overall Study||19
7781348|NCT01306331|19157109|P2|NOT COMPLETED|Overall Study||877
7781349|NCT01306331|19157110|P1|NOT COMPLETED|Overall Study||901
7781350|NCT01306331|19157109|P2|COMPLETED|Overall Study||788
7781351|NCT01306331|19157110|P1|COMPLETED|Overall Study||758
7781352|NCT01306331|19157109|P2|STARTED|Overall Study||1665
7781353|NCT01306331|19157110|P1|STARTED|Overall Study||1659
7781354|NCT01306305|19157120|P2|NOT COMPLETED|Overall Study||0
7781355|NCT01306305|19157121|P1|NOT COMPLETED|Overall Study||2
7781356|NCT01306305|19157120|P2|COMPLETED|Overall Study||55
7781357|NCT01306305|19157121|P1|COMPLETED|Overall Study||53
7781358|NCT01306305|19157120|P2|STARTED|Overall Study||55
7781359|NCT01306305|19157121|P1|STARTED|Overall Study||55
7781360|NCT01306292|19157137|P4|NOT COMPLETED|Second Injection||0
7781361|NCT01306292|19157138|P3|NOT COMPLETED|Second Injection||1
7781362|NCT01306292|19157139|P2|NOT COMPLETED|Second Injection||0
7781363|NCT01306292|19157140|P1|NOT COMPLETED|Second Injection||0
7781364|NCT01306292|19157137|P4|COMPLETED|Second Injection||10
7781365|NCT01306292|19157138|P3|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7
7781366|NCT01306292|19157139|P2|COMPLETED|Second Injection||8
7781367|NCT01306292|19157140|P1|COMPLETED|Second Injection||10
7781368|NCT01306292|19157137|P4|STARTED|Second Injection||10
7781369|NCT01306292|19157138|P3|STARTED|Second Injection||8
7781370|NCT01306292|19157139|P2|STARTED|Second Injection||8
7781371|NCT01306292|19157140|P1|STARTED|Second Injection||10
7781372|NCT01306292|19157137|P4|NOT COMPLETED|Washout (at Least 10 Minutes)||0
7781373|NCT01306292|19157138|P3|NOT COMPLETED|Washout (at Least 10 Minutes)||0
7781374|NCT01306292|19157139|P2|NOT COMPLETED|Washout (at Least 10 Minutes)||0
7781375|NCT01306292|19157140|P1|NOT COMPLETED|Washout (at Least 10 Minutes)||0
7781376|NCT01306292|19157137|P4|COMPLETED|Washout (at Least 10 Minutes)||10
7781377|NCT01306292|19157138|P3|COMPLETED|Washout (at Least 10 Minutes)||8
7781378|NCT01306292|19157139|P2|COMPLETED|Washout (at Least 10 Minutes)||8
7781379|NCT01306292|19157140|P1|COMPLETED|Washout (at Least 10 Minutes)||10
7781380|NCT01306292|19157137|P4|STARTED|Washout (at Least 10 Minutes)||10
7781381|NCT01306292|19157138|P3|STARTED|Washout (at Least 10 Minutes)||8
7781382|NCT01306292|19157139|P2|STARTED|Washout (at Least 10 Minutes)||8
7781383|NCT01306292|19157140|P1|STARTED|Washout (at Least 10 Minutes)||10
7781384|NCT01306292|19157137|P4|NOT COMPLETED|First Injection||0
7781385|NCT01306292|19157138|P3|NOT COMPLETED|First Injection||0
7781386|NCT01306292|19157139|P2|NOT COMPLETED|First Injection||0
7781387|NCT01306292|19157140|P1|NOT COMPLETED|First Injection||0
7781388|NCT01306292|19157137|P4|COMPLETED|First Injection||10
7781389|NCT01306292|19157138|P3|COMPLETED|First Injection||8
7781390|NCT01306292|19157139|P2|COMPLETED|First Injection||8
7781391|NCT01306292|19157140|P1|COMPLETED|First Injection||10
7781392|NCT01306292|19157137|P4|STARTED|First Injection||10
7781393|NCT01306292|19157138|P3|STARTED|First Injection||8
7781394|NCT01306292|19157139|P2|STARTED|First Injection||8
7781395|NCT01306292|19157140|P1|STARTED|First Injection||10
7781396|NCT01306253|19157158|P2|NOT COMPLETED|Overall Study||1
7781397|NCT01306253|19157159|P1|NOT COMPLETED|Overall Study||1
7781398|NCT01306253|19157158|P2|COMPLETED|Overall Study||56
7781399|NCT01306253|19157159|P1|COMPLETED|Overall Study||56
7781400|NCT01306253|19157158|P2|STARTED|Overall Study||57
7781401|NCT01306253|19157159|P1|STARTED|Overall Study||57
7781402|NCT01306214|19157176|P3|NOT COMPLETED|Overall Study||22
7781403|NCT01306214|19157177|P2|NOT COMPLETED|Overall Study||28
7781404|NCT01306214|19157178|P1|NOT COMPLETED|Overall Study||28
7781405|NCT01306214|19157176|P3|COMPLETED|Overall Study||168
7781406|NCT01306214|19157177|P2|COMPLETED|Overall Study||159
7781407|NCT01306214|19157178|P1|COMPLETED|Overall Study||161
7781408|NCT01306214|19157176|P3|STARTED|Overall Study||190
7781409|NCT01306214|19157177|P2|STARTED|Overall Study||187
7781410|NCT01306214|19157178|P1|STARTED|Overall Study||189
7781411|NCT01306201|19157195|P1|NOT COMPLETED|Overall Study||10
7781412|NCT01306201|19157195|P1|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53
7781413|NCT01306201|19157195|P1|STARTED|Overall Study||63
7781414|NCT01306175|19157203|P1|NOT COMPLETED|Second Intervention||0
7781415|NCT01306175|19157203|P1|COMPLETED|Second Intervention||20
7781416|NCT01306175|19157203|P1|STARTED|Second Intervention||20
7781417|NCT01306175|19157203|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
7781418|NCT01306175|19157203|P1|COMPLETED|Washout Period of at Least 14 Days||20
7781419|NCT01306175|19157203|P1|STARTED|Washout Period of at Least 14 Days||20
7781420|NCT01306175|19157203|P1|NOT COMPLETED|First Intervention||0
7781421|NCT01306175|19157203|P1|COMPLETED|First Intervention||20
7781422|NCT01306175|19157203|P1|STARTED|First Intervention||20
7781423|NCT01306162|19157217|P4|NOT COMPLETED|Period 4||0
7781424|NCT01306162|19157218|P3|NOT COMPLETED|Period 4||0
7781425|NCT01306162|19157219|P2|NOT COMPLETED|Period 4||0
7781426|NCT01306162|19157220|P1|NOT COMPLETED|Period 4||0
7781427|NCT01306162|19157217|P4|COMPLETED|Period 4||8
7781428|NCT01306162|19157218|P3|COMPLETED|Period 4||9
7781429|NCT01306162|19157219|P2|COMPLETED|Period 4||8
7781430|NCT01306162|19157220|P1|COMPLETED|Period 4||9
7781431|NCT01306162|19157217|P4|STARTED|Period 4||8
7781432|NCT01306162|19157218|P3|STARTED|Period 4||9
7781433|NCT01306162|19157219|P2|STARTED|Period 4||8
7781434|NCT01306162|19157220|P1|STARTED|Period 4||9
7781435|NCT01306162|19157217|P4|NOT COMPLETED|Washout 2||0
7781436|NCT01306162|19157218|P3|NOT COMPLETED|Washout 2||0
7781437|NCT01306162|19157219|P2|NOT COMPLETED|Washout 2||0
7781438|NCT01306162|19157220|P1|NOT COMPLETED|Washout 2||0
7781439|NCT01306162|19157217|P4|COMPLETED|Washout 2||8
7781440|NCT01306162|19157218|P3|COMPLETED|Washout 2||9
7781441|NCT01306162|19157219|P2|COMPLETED|Washout 2||8
7781442|NCT01306162|19157220|P1|COMPLETED|Washout 2||9
7781443|NCT01306162|19157217|P4|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8
7781444|NCT01306162|19157218|P3|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9
7781445|NCT01306162|19157219|P2|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8
7781446|NCT01306162|19157220|P1|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9
7781447|NCT01306162|19157217|P4|NOT COMPLETED|Period 3||0
7781448|NCT01306162|19157218|P3|NOT COMPLETED|Period 3||0
7781449|NCT01306162|19157219|P2|NOT COMPLETED|Period 3||0
7781450|NCT01306162|19157220|P1|NOT COMPLETED|Period 3||0
7781451|NCT01306162|19157217|P4|COMPLETED|Period 3||8
7781452|NCT01306162|19157218|P3|COMPLETED|Period 3||9
7781453|NCT01306162|19157219|P2|COMPLETED|Period 3||8
7781454|NCT01306162|19157220|P1|COMPLETED|Period 3||9
7781455|NCT01306162|19157217|P4|STARTED|Period 3||8
7781456|NCT01306162|19157218|P3|STARTED|Period 3||9
7781457|NCT01306162|19157219|P2|STARTED|Period 3||8
7781458|NCT01306162|19157220|P1|STARTED|Period 3||9
7781459|NCT01306162|19157217|P4|NOT COMPLETED|Period 2||0
7781460|NCT01306162|19157218|P3|NOT COMPLETED|Period 2||0
7781461|NCT01306162|19157219|P2|NOT COMPLETED|Period 2||0
7781462|NCT01306162|19157220|P1|NOT COMPLETED|Period 2||0
7781463|NCT01306162|19157217|P4|COMPLETED|Period 2||8
7781464|NCT01306162|19157218|P3|COMPLETED|Period 2||9
7781465|NCT01306162|19157219|P2|COMPLETED|Period 2||8
7781466|NCT01306162|19157220|P1|COMPLETED|Period 2||9
7781467|NCT01306162|19157217|P4|STARTED|Period 2|No washout phase after Period 2.|8
7781468|NCT01306162|19157218|P3|STARTED|Period 2|No washout phase after Period 2.|9
7781469|NCT01306162|19157219|P2|STARTED|Period 2|No washout phase after Period 2.|8
7781470|NCT01306162|19157220|P1|STARTED|Period 2|No washout phase after Period 2.|9
7781471|NCT01306162|19157217|P4|NOT COMPLETED|Washout 1||0
7781472|NCT01306162|19157218|P3|NOT COMPLETED|Washout 1||0
7781473|NCT01306162|19157219|P2|NOT COMPLETED|Washout 1||1
7781474|NCT01306162|19157220|P1|NOT COMPLETED|Washout 1||0
7781475|NCT01306162|19157217|P4|COMPLETED|Washout 1||8
7781476|NCT01306162|19157218|P3|COMPLETED|Washout 1||9
7781477|NCT01306162|19157219|P2|COMPLETED|Washout 1||8
7781478|NCT01306162|19157220|P1|COMPLETED|Washout 1||9
7781479|NCT01306162|19157217|P4|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8
7781480|NCT01306162|19157218|P3|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9
7781481|NCT01306162|19157219|P2|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
7781482|NCT01306162|19157220|P1|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
7781483|NCT01306162|19157217|P4|NOT COMPLETED|Period 1||1
7781484|NCT01306162|19157218|P3|NOT COMPLETED|Period 1||0
7781485|NCT01306162|19157219|P2|NOT COMPLETED|Period 1||0
7781486|NCT01306162|19157220|P1|NOT COMPLETED|Period 1||0
7781487|NCT01306162|19157217|P4|COMPLETED|Period 1||8
7781488|NCT01306162|19157218|P3|COMPLETED|Period 1||9
7781489|NCT01306162|19157219|P2|COMPLETED|Period 1||9
7781490|NCT01306162|19157220|P1|COMPLETED|Period 1||9
7781491|NCT01306162|19157217|P4|STARTED|Period 1||9
7781492|NCT01306162|19157218|P3|STARTED|Period 1||9
7781493|NCT01306162|19157219|P2|STARTED|Period 1||9
7781494|NCT01306162|19157220|P1|STARTED|Period 1||9
7781495|NCT01306058|19157248|P1|NOT COMPLETED|Overall Study||2
7781496|NCT01306058|19157248|P1|COMPLETED|Overall Study||25
7781497|NCT01306058|19157248|P1|STARTED|Overall Study||27
7781498|NCT01306032|19157275|P6|NOT COMPLETED|Disease Progression/Crossover||0
7781499|NCT01306032|19157276|P5|NOT COMPLETED|Disease Progression/Crossover||0
7781500|NCT01306032|19157277|P4|NOT COMPLETED|Disease Progression/Crossover||3
7781501|NCT01306032|19157278|P3|NOT COMPLETED|Disease Progression/Crossover||0
7781502|NCT01306032|19157279|P2|NOT COMPLETED|Disease Progression/Crossover||2
7781503|NCT01306032|19157280|P1|NOT COMPLETED|Disease Progression/Crossover||0
7781504|NCT01306032|19157275|P6|COMPLETED|Disease Progression/Crossover||0
7781505|NCT01306032|19157276|P5|COMPLETED|Disease Progression/Crossover||0
7781506|NCT01306032|19157277|P4|COMPLETED|Disease Progression/Crossover||26
7781507|NCT01306032|19157278|P3|COMPLETED|Disease Progression/Crossover||0
7781508|NCT01306032|19157279|P2|COMPLETED|Disease Progression/Crossover||14
7781509|NCT01306032|19157280|P1|COMPLETED|Disease Progression/Crossover||0
7781510|NCT01306032|19157275|P6|STARTED|Disease Progression/Crossover||0
7781511|NCT01306032|19157276|P5|STARTED|Disease Progression/Crossover||0
7781512|NCT01306032|19157277|P4|STARTED|Disease Progression/Crossover||29
7781513|NCT01306032|19157278|P3|STARTED|Disease Progression/Crossover||0
7781514|NCT01306032|19157279|P2|STARTED|Disease Progression/Crossover||16
7781515|NCT01306032|19157280|P1|STARTED|Disease Progression/Crossover||0
7781516|NCT01306032|19157275|P6|NOT COMPLETED|First Intervention||2
7781517|NCT01306032|19157276|P5|NOT COMPLETED|First Intervention||2
7781518|NCT01306032|19157277|P4|NOT COMPLETED|First Intervention||1
7781519|NCT01306032|19157278|P3|NOT COMPLETED|First Intervention||2
7781520|NCT01306032|19157279|P2|NOT COMPLETED|First Intervention||2
7781521|NCT01306032|19157280|P1|NOT COMPLETED|First Intervention||1
7781522|NCT01306032|19157275|P6|COMPLETED|First Intervention||0
7781523|NCT01306032|19157276|P5|COMPLETED|First Intervention||0
7781524|NCT01306032|19157277|P4|COMPLETED|First Intervention||37
7781525|NCT01306032|19157278|P3|COMPLETED|First Intervention||35
7781526|NCT01306032|19157279|P2|COMPLETED|First Intervention||18
7781527|NCT01306032|19157280|P1|COMPLETED|First Intervention||21
7781528|NCT01306032|19157275|P6|STARTED|First Intervention||2
7781529|NCT01306032|19157276|P5|STARTED|First Intervention||2
7781530|NCT01306032|19157277|P4|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38
7781531|NCT01306032|19157278|P3|STARTED|First Intervention||37
7781532|NCT01306032|19157279|P2|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20
7781533|NCT01306032|19157280|P1|STARTED|First Intervention||22
7781534|NCT01305941|19157332|P1|NOT COMPLETED|Overall Study||10
7781535|NCT01305941|19157332|P1|COMPLETED|Overall Study||22
7781536|NCT01305941|19157332|P1|STARTED|Overall Study||32
7781537|NCT01305811|19157346|P2|NOT COMPLETED|Overall Study||11
7781538|NCT01305811|19157347|P1|NOT COMPLETED|Overall Study||8
7781539|NCT01305811|19157346|P2|COMPLETED|Overall Study||41
7781540|NCT01305811|19157347|P1|COMPLETED|Overall Study||44
7781541|NCT01305811|19157346|P2|STARTED|Overall Study||52
7781542|NCT01305811|19157347|P1|STARTED|Overall Study||52
7781543|NCT01305772|19157357|P2|NOT COMPLETED|Overall Study||0
7781544|NCT01305772|19157358|P1|NOT COMPLETED|Overall Study||0
7781545|NCT01305772|19157357|P2|COMPLETED|Overall Study||1
7781546|NCT01305772|19157358|P1|COMPLETED|Overall Study||5
7781547|NCT01305772|19157357|P2|RT + Panitumumab Dose #2 / #3|Overall Study||1
7781548|NCT01305772|19157358|P1|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5
7781549|NCT01305772|19157357|P2|Surgery/Biopsy #2|Overall Study||1
7781550|NCT01305772|19157358|P1|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1
7781551|NCT01305772|19157357|P2|Research PET/CT #2|Overall Study||1
7781552|NCT01305772|19157358|P1|Research PET/CT #2|Overall Study||5
7781553|NCT01305772|19157357|P2|Panitumumab Dose #1|Overall Study||1
7781554|NCT01305772|19157358|P1|Panitumumab Dose #1|Overall Study||5
7781555|NCT01305772|19157357|P2|Research PET/CT #1|Overall Study||1
7781556|NCT01305772|19157358|P1|Research PET/CT #1|Overall Study||5
7781557|NCT01305772|19157357|P2|Genomic Screening + Biopsy #1|Overall Study||1
7781558|NCT01305772|19157358|P1|Genomic Screening + Biopsy #1|Overall Study||5
7781559|NCT01305772|19157357|P2|STARTED|Overall Study||1
7781560|NCT01305772|19157358|P1|STARTED|Overall Study||5
7781561|NCT01305655|19157365|P1|NOT COMPLETED|Overall Study||0
7781562|NCT01305655|19157365|P1|COMPLETED|Overall Study|December 31, 2014|47
7781563|NCT01305655|19157365|P1|STARTED|Overall Study|July 2008|47
7781564|NCT01305577|19157372|P3|NOT COMPLETED|Overall Study||10
7781565|NCT01305577|19157373|P2|NOT COMPLETED|Overall Study||11
7781566|NCT01305577|19157374|P1|NOT COMPLETED|Overall Study||13
7781567|NCT01305577|19157372|P3|COMPLETED|Overall Study||112
7781568|NCT01305577|19157373|P2|COMPLETED|Overall Study||110
7781569|NCT01305577|19157374|P1|COMPLETED|Overall Study||107
7781570|NCT01305577|19157372|P3|Received Treatment|Overall Study||122
7781571|NCT01305577|19157373|P2|Received Treatment|Overall Study||121
7781572|NCT01305577|19157374|P1|Received Treatment|Overall Study||119
7781573|NCT01305577|19157372|P3|STARTED|Overall Study||122
7781574|NCT01305577|19157373|P2|STARTED|Overall Study||121
7781575|NCT01305577|19157374|P1|STARTED|Overall Study||120
7781576|NCT01305564|19157403|P1|NOT COMPLETED|Overall Study||37
7781577|NCT01305564|19157403|P1|COMPLETED|Overall Study||163
7781578|NCT01305564|19157403|P1|STARTED|Overall Study||200
7781579|NCT01305473|19157418|P1|NOT COMPLETED|Overall Study||0
7781580|NCT01305473|19157418|P1|COMPLETED|Overall Study||90
7781581|NCT01305473|19157418|P1|STARTED|Overall Study||90
7781582|NCT01305408|19157430|P2|NOT COMPLETED|Overall Study||31
7781583|NCT01305408|19157431|P1|NOT COMPLETED|Overall Study||32
7781584|NCT01305408|19157430|P2|COMPLETED|Overall Study||169
7781585|NCT01305408|19157431|P1|COMPLETED|Overall Study||167
7781586|NCT01305408|19157430|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
7781587|NCT01305408|19157431|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
7781588|NCT01305408|19157430|P2|Safety Population|Overall Study|Treated participants.|200
7781589|NCT01305408|19157431|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198
7781590|NCT01305408|19157430|P2|STARTED|Overall Study||200
7781591|NCT01305408|19157431|P1|STARTED|Overall Study||199
7781592|NCT01305356|19157483|P2|NOT COMPLETED|Overall Study||0
7781593|NCT01305356|19157484|P1|NOT COMPLETED|Overall Study||0
7781594|NCT01305356|19157483|P2|COMPLETED|Overall Study||167
7781595|NCT01305356|19157484|P1|COMPLETED|Overall Study||132
7781596|NCT01305356|19157483|P2|STARTED|Overall Study||167
7781597|NCT01305356|19157484|P1|STARTED|Overall Study||132
7781598|NCT01305265|19157500|P2|NOT COMPLETED|Overall Study||6
7781599|NCT01305265|19157501|P1|NOT COMPLETED|Overall Study||2
7781600|NCT01305265|19157500|P2|COMPLETED|Overall Study||64
7781601|NCT01305265|19157501|P1|COMPLETED|Overall Study||69
7781602|NCT01305265|19157500|P2|STARTED|Overall Study||70
7781603|NCT01305265|19157501|P1|STARTED|Overall Study||71
7781604|NCT01305252|19157509|P2|NOT COMPLETED|Overall Study||0
7781605|NCT01305252|19157510|P1|NOT COMPLETED|Overall Study||1
7781606|NCT01305252|19157509|P2|COMPLETED|Overall Study||11
7781607|NCT01305252|19157510|P1|COMPLETED|Overall Study||9
7781608|NCT01305252|19157509|P2|STARTED|Overall Study||11
7781609|NCT01305252|19157510|P1|STARTED|Overall Study||10
7781610|NCT01305239|19157524|P1|NOT COMPLETED|Overall Study||23
7781611|NCT01305239|19157524|P1|COMPLETED|Overall Study||375
7781612|NCT01305239|19157524|P1|Intent to Treat Population|Overall Study||287
7781613|NCT01305239|19157524|P1|Safety Set|Overall Study||397
7781614|NCT01305239|19157524|P1|STARTED|Overall Study||398
7781615|NCT01305213|19157534|P2|NOT COMPLETED|Overall Study||0
7781616|NCT01305213|19157535|P1|NOT COMPLETED|Overall Study||0
7781617|NCT01305213|19157534|P2|COMPLETED|Overall Study||54
7781618|NCT01305213|19157535|P1|COMPLETED|Overall Study||53
7781619|NCT01305213|19157534|P2|STARTED|Overall Study||54
7781620|NCT01305213|19157535|P1|STARTED|Overall Study||53
7781621|NCT01305200|19157554|P3|NOT COMPLETED|Overall Study||3
7781622|NCT01305200|19157555|P2|NOT COMPLETED|Overall Study||31
7781623|NCT01305200|19157556|P1|NOT COMPLETED|Overall Study||29
7781624|NCT01305200|19157554|P3|COMPLETED|Overall Study||0
7781625|NCT01305200|19157555|P2|COMPLETED|Overall Study||81
7781626|NCT01305200|19157556|P1|COMPLETED|Overall Study||82
7781627|NCT01305200|19157554|P3|STARTED|Overall Study||3
7781628|NCT01305200|19157555|P2|STARTED|Overall Study||112
7781629|NCT01305200|19157556|P1|STARTED|Overall Study||111
7781630|NCT01305044|19157586|P2|NOT COMPLETED|Overall Study||6
7781631|NCT01305044|19157587|P1|NOT COMPLETED|Overall Study||3
7781632|NCT01305044|19157586|P2|COMPLETED|Overall Study||25
7781633|NCT01305044|19157587|P1|COMPLETED|Overall Study||29
7781634|NCT01305044|19157586|P2|STARTED|Overall Study||31
7781635|NCT01305044|19157587|P1|STARTED|Overall Study||32
7781636|NCT01304966|19157611|P1|NOT COMPLETED|Overall Study||0
7781637|NCT01304966|19157611|P1|COMPLETED|Overall Study||15
7781638|NCT01304966|19157611|P1|STARTED|Overall Study||15
7781639|NCT01304940|19157619|P2|NOT COMPLETED|Overall Study||0
7781640|NCT01304940|19157620|P1|NOT COMPLETED|Overall Study||3
7781641|NCT01304940|19157619|P2|COMPLETED|Overall Study||25
7781642|NCT01304940|19157620|P1|COMPLETED|Overall Study|these participants met severity requirement and were included in study analyses|22
7781643|NCT01304940|19157619|P2|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
7781644|NCT01304940|19157620|P1|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
7781645|NCT01304940|19157619|P2|STARTED|Overall Study||25
7781646|NCT01304940|19157620|P1|STARTED|Overall Study||25
7781647|NCT01304706|19157626|P1|NOT COMPLETED|Overall Study||17
7781648|NCT01304706|19157626|P1|COMPLETED|Overall Study||104
7781649|NCT01304706|19157626|P1|STARTED|Overall Study||121
7781650|NCT01304693|19157635|P5|NOT COMPLETED|Overall Study||1
7781651|NCT01304693|19157636|P4|NOT COMPLETED|Overall Study||1
7781652|NCT01304693|19157637|P3|NOT COMPLETED|Overall Study||1
7781653|NCT01304693|19157638|P2|NOT COMPLETED|Overall Study||0
7781654|NCT01304693|19157639|P1|NOT COMPLETED|Overall Study||0
7781655|NCT01304693|19157635|P5|COMPLETED|Overall Study||60
7781656|NCT01304693|19157636|P4|COMPLETED|Overall Study||39
7781657|NCT01304693|19157637|P3|COMPLETED|Overall Study||47
7781658|NCT01304693|19157638|P2|COMPLETED|Overall Study||35
7781659|NCT01304693|19157639|P1|COMPLETED|Overall Study||10
7781660|NCT01304693|19157635|P5|STARTED|Overall Study||61
7781661|NCT01304693|19157636|P4|STARTED|Overall Study||40
7781662|NCT01304693|19157637|P3|STARTED|Overall Study||48
7781663|NCT01304693|19157638|P2|STARTED|Overall Study||35
7781664|NCT01304693|19157639|P1|STARTED|Overall Study||10
7781665|NCT01304641|19157658|P2|NOT COMPLETED|Overall Study||0
7781666|NCT01304641|19157659|P1|NOT COMPLETED|Overall Study||0
7781667|NCT01304641|19157658|P2|COMPLETED|Overall Study||20132
7781668|NCT01304641|19157659|P1|COMPLETED|Overall Study||11470
7781669|NCT01304641|19157658|P2|STARTED|Overall Study||20132
7781670|NCT01304641|19157659|P1|STARTED|Overall Study||11470
7781671|NCT01304589|19157677|P1|NOT COMPLETED|Overall Study||13
7781672|NCT01304589|19157677|P1|COMPLETED|Overall Study||18
7781673|NCT01304589|19157677|P1|STARTED|Overall Study||31
7781674|NCT01304498|19157686|P2|NOT COMPLETED|Overall Study||5
7781675|NCT01304498|19157687|P1|NOT COMPLETED|Overall Study||6
7781676|NCT01304498|19157686|P2|COMPLETED|Overall Study||295
7781677|NCT01304498|19157687|P1|COMPLETED|Overall Study||294
7781678|NCT01304498|19157686|P2|Received ≥1 Dose|Overall Study||300
7781679|NCT01304498|19157687|P1|Received ≥1 Dose|Overall Study||300
7781680|NCT01304498|19157686|P2|STARTED|Overall Study||300
7781681|NCT01304498|19157687|P1|STARTED|Overall Study||300
7781682|NCT01304407|19157707|P1|NOT COMPLETED|Overall Study||0
7781683|NCT01304407|19157707|P1|COMPLETED|Overall Study||29
7781684|NCT01304407|19157707|P1|STARTED|Overall Study||29
7781685|NCT01304329|19157711|P6|NOT COMPLETED|Third Intervention (3 Days)||0
7781686|NCT01304329|19157712|P5|NOT COMPLETED|Third Intervention (3 Days)||0
7781687|NCT01304329|19157713|P4|NOT COMPLETED|Third Intervention (3 Days)||0
7781688|NCT01304329|19157714|P3|NOT COMPLETED|Third Intervention (3 Days)||0
7781689|NCT01304329|19157715|P2|NOT COMPLETED|Third Intervention (3 Days)||1
7781690|NCT01304329|19157716|P1|NOT COMPLETED|Third Intervention (3 Days)||0
7781691|NCT01304329|19157711|P6|COMPLETED|Third Intervention (3 Days)||3
7781692|NCT01304329|19157712|P5|COMPLETED|Third Intervention (3 Days)||3
7781693|NCT01304329|19157713|P4|COMPLETED|Third Intervention (3 Days)||3
7781694|NCT01304329|19157714|P3|COMPLETED|Third Intervention (3 Days)||3
7781695|NCT01304329|19157715|P2|COMPLETED|Third Intervention (3 Days)||2
7781696|NCT01304329|19157716|P1|COMPLETED|Third Intervention (3 Days)||3
7781697|NCT01304329|19157711|P6|STARTED|Third Intervention (3 Days)||3
7781698|NCT01304329|19157712|P5|STARTED|Third Intervention (3 Days)||3
7781699|NCT01304329|19157713|P4|STARTED|Third Intervention (3 Days)||3
7781700|NCT01304329|19157714|P3|STARTED|Third Intervention (3 Days)||3
7781701|NCT01304329|19157715|P2|STARTED|Third Intervention (3 Days)||3
7781702|NCT01304329|19157716|P1|STARTED|Third Intervention (3 Days)||3
7781703|NCT01304329|19157711|P6|NOT COMPLETED|Second Intervention (3 Days)||0
7781704|NCT01304329|19157712|P5|NOT COMPLETED|Second Intervention (3 Days)||0
7781705|NCT01304329|19157713|P4|NOT COMPLETED|Second Intervention (3 Days)||0
7781706|NCT01304329|19157714|P3|NOT COMPLETED|Second Intervention (3 Days)||0
7781707|NCT01304329|19157715|P2|NOT COMPLETED|Second Intervention (3 Days)||0
7781708|NCT01304329|19157716|P1|NOT COMPLETED|Second Intervention (3 Days)||0
7781709|NCT01304329|19157711|P6|COMPLETED|Second Intervention (3 Days)||3
7781710|NCT01304329|19157712|P5|COMPLETED|Second Intervention (3 Days)||3
7781711|NCT01304329|19157713|P4|COMPLETED|Second Intervention (3 Days)||3
7781712|NCT01304329|19157714|P3|COMPLETED|Second Intervention (3 Days)||3
7781713|NCT01304329|19157715|P2|COMPLETED|Second Intervention (3 Days)||3
7781714|NCT01304329|19157716|P1|COMPLETED|Second Intervention (3 Days)||3
7781715|NCT01304329|19157711|P6|STARTED|Second Intervention (3 Days)||3
7781716|NCT01304329|19157712|P5|STARTED|Second Intervention (3 Days)||3
7781717|NCT01304329|19157713|P4|STARTED|Second Intervention (3 Days)||3
7781718|NCT01304329|19157714|P3|STARTED|Second Intervention (3 Days)||3
7781719|NCT01304329|19157715|P2|STARTED|Second Intervention (3 Days)||3
7781720|NCT01304329|19157716|P1|STARTED|Second Intervention (3 Days)||3
7781721|NCT01304329|19157711|P6|NOT COMPLETED|First Intervention (3 Days)||0
7781722|NCT01304329|19157712|P5|NOT COMPLETED|First Intervention (3 Days)||0
7781723|NCT01304329|19157713|P4|NOT COMPLETED|First Intervention (3 Days)||0
7781724|NCT01304329|19157714|P3|NOT COMPLETED|First Intervention (3 Days)||0
7781725|NCT01304329|19157715|P2|NOT COMPLETED|First Intervention (3 Days)||0
7781726|NCT01304329|19157716|P1|NOT COMPLETED|First Intervention (3 Days)||0
7781727|NCT01304329|19157711|P6|COMPLETED|First Intervention (3 Days)||3
7781728|NCT01304329|19157712|P5|COMPLETED|First Intervention (3 Days)||3
7781729|NCT01304329|19157713|P4|COMPLETED|First Intervention (3 Days)||3
7781730|NCT01304329|19157714|P3|COMPLETED|First Intervention (3 Days)||3
7781731|NCT01304329|19157715|P2|COMPLETED|First Intervention (3 Days)||3
7781732|NCT01304329|19157716|P1|COMPLETED|First Intervention (3 Days)||3
7781733|NCT01304329|19157711|P6|STARTED|First Intervention (3 Days)||3
7781734|NCT01304329|19157712|P5|STARTED|First Intervention (3 Days)||3
7781735|NCT01304329|19157713|P4|STARTED|First Intervention (3 Days)||3
7781736|NCT01304329|19157714|P3|STARTED|First Intervention (3 Days)||3
7781737|NCT01304329|19157715|P2|STARTED|First Intervention (3 Days)||3
7781738|NCT01304329|19157716|P1|STARTED|First Intervention (3 Days)||3
7781739|NCT01304316|19157733|P1|NOT COMPLETED|Overall Study||0
7781740|NCT01304316|19157733|P1|COMPLETED|Overall Study||12
7781741|NCT01304316|19157733|P1|STARTED|Overall Study||12
7781742|NCT01304277|19157747|P1|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0
7781743|NCT01304277|19157747|P1|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17
7781744|NCT01304277|19157747|P1|STARTED|Treatment (Replagal AF, Week 2- EOS)||17
7781745|NCT01304277|19157747|P1|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0
7781746|NCT01304277|19157747|P1|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17
7781747|NCT01304277|19157747|P1|STARTED|Screening (Replagal RB, Week 0- Week 2)||17
7781748|NCT01304238|19157769|P10|NOT COMPLETED|Overall Study||0
7781749|NCT01304238|19157770|P9|NOT COMPLETED|Overall Study||0
7781750|NCT01304238|19157771|P8|NOT COMPLETED|Overall Study||0
7781751|NCT01304238|19157772|P7|NOT COMPLETED|Overall Study||0
7781752|NCT01304238|19157773|P6|NOT COMPLETED|Overall Study||0
7781753|NCT01304238|19157774|P5|NOT COMPLETED|Overall Study||0
7781754|NCT01304238|19157775|P4|NOT COMPLETED|Overall Study||0
7781755|NCT01304238|19157776|P3|NOT COMPLETED|Overall Study||0
7781756|NCT01304238|19157777|P2|NOT COMPLETED|Overall Study||0
7781757|NCT01304238|19157778|P1|NOT COMPLETED|Overall Study||0
7781758|NCT01304238|19157769|P10|COMPLETED|Overall Study||3
7781759|NCT01304238|19157770|P9|COMPLETED|Overall Study||1
7781760|NCT01304238|19157771|P8|COMPLETED|Overall Study||4
7781761|NCT01304238|19157772|P7|COMPLETED|Overall Study||5
7781762|NCT01304238|19157773|P6|COMPLETED|Overall Study||11
7781763|NCT01304238|19157774|P5|COMPLETED|Overall Study||11
7781764|NCT01304238|19157775|P4|COMPLETED|Overall Study||78
7781765|NCT01304238|19157776|P3|COMPLETED|Overall Study||46
7781766|NCT01304238|19157777|P2|COMPLETED|Overall Study||4
7781767|NCT01304238|19157778|P1|COMPLETED|Overall Study||32
7781768|NCT01304238|19157769|P10|STARTED|Overall Study||3
7781769|NCT01304238|19157770|P9|STARTED|Overall Study||1
7781770|NCT01304238|19157771|P8|STARTED|Overall Study||4
7781771|NCT01304238|19157772|P7|STARTED|Overall Study||5
7781772|NCT01304238|19157773|P6|STARTED|Overall Study||11
7781773|NCT01304238|19157774|P5|STARTED|Overall Study||11
7781774|NCT01304238|19157775|P4|STARTED|Overall Study||78
7781775|NCT01304238|19157776|P3|STARTED|Overall Study||46
7781776|NCT01304238|19157777|P2|STARTED|Overall Study||4
7781777|NCT01304238|19157778|P1|STARTED|Overall Study||32
7781778|NCT01304147|19157850|P2|NOT COMPLETED|Second Intervention (7days)||1
7781779|NCT01304147|19157851|P1|NOT COMPLETED|Second Intervention (7days)||1
7781780|NCT01304147|19157850|P2|COMPLETED|Second Intervention (7days)||9
7781781|NCT01304147|19157851|P1|COMPLETED|Second Intervention (7days)||9
7781782|NCT01304147|19157850|P2|STARTED|Second Intervention (7days)||10
7781783|NCT01304147|19157851|P1|STARTED|Second Intervention (7days)||10
7781784|NCT01304147|19157850|P2|NOT COMPLETED|Washout (1 Day)||0
7781785|NCT01304147|19157851|P1|NOT COMPLETED|Washout (1 Day)||0
7781786|NCT01304147|19157850|P2|COMPLETED|Washout (1 Day)||10
7781787|NCT01304147|19157851|P1|COMPLETED|Washout (1 Day)||10
7781788|NCT01304147|19157850|P2|STARTED|Washout (1 Day)||10
7781789|NCT01304147|19157851|P1|STARTED|Washout (1 Day)||10
7781790|NCT01304147|19157850|P2|NOT COMPLETED|First Intervention (7days)||0
7781791|NCT01304147|19157851|P1|NOT COMPLETED|First Intervention (7days)||0
7781792|NCT01304147|19157850|P2|COMPLETED|First Intervention (7days)||10
7781793|NCT01304147|19157851|P1|COMPLETED|First Intervention (7days)||10
7781794|NCT01304147|19157850|P2|STARTED|First Intervention (7days)||10
7781795|NCT01304147|19157851|P1|STARTED|First Intervention (7days)||10
7781796|NCT01304082|19157859|P5|NOT COMPLETED|Overall Study||0
7781797|NCT01304082|19157860|P4|NOT COMPLETED|Overall Study||0
7781798|NCT01304082|19157861|P3|NOT COMPLETED|Overall Study||0
7781799|NCT01304082|19157862|P2|NOT COMPLETED|Overall Study||0
7781800|NCT01304082|19157863|P1|NOT COMPLETED|Overall Study||0
7781801|NCT01304082|19157859|P5|COMPLETED|Overall Study||5
7781802|NCT01304082|19157860|P4|COMPLETED|Overall Study||8
7781803|NCT01304082|19157861|P3|COMPLETED|Overall Study||11
7781804|NCT01304082|19157862|P2|COMPLETED|Overall Study||2
7781805|NCT01304082|19157863|P1|COMPLETED|Overall Study||3
7781806|NCT01304082|19157859|P5|Third Intervention|Overall Study||5
7781807|NCT01304082|19157860|P4|Third Intervention|Overall Study||8
7781808|NCT01304082|19157861|P3|Third Intervention|Overall Study||11
7781809|NCT01304082|19157862|P2|Third Intervention|Overall Study||2
7781810|NCT01304082|19157863|P1|Third Intervention|Overall Study||3
7781811|NCT01304082|19157859|P5|Second Intervention|Overall Study||5
7781812|NCT01304082|19157860|P4|Second Intervention|Overall Study||8
7781813|NCT01304082|19157861|P3|Second Intervention|Overall Study||11
7781814|NCT01304082|19157862|P2|Second Intervention|Overall Study||2
7781815|NCT01304082|19157863|P1|Second Intervention|Overall Study||3
7781816|NCT01304082|19157859|P5|First Intervention|Overall Study||5
7781817|NCT01304082|19157860|P4|First Intervention|Overall Study||8
7781818|NCT01304082|19157861|P3|First Intervention|Overall Study||11
7781819|NCT01304082|19157862|P2|First Intervention|Overall Study||2
7781820|NCT01304082|19157863|P1|First Intervention|Overall Study||3
7781821|NCT01304082|19157859|P5|STARTED|Overall Study||5
7781822|NCT01304082|19157860|P4|STARTED|Overall Study||8
7781823|NCT01304082|19157861|P3|STARTED|Overall Study||11
7781824|NCT01304082|19157862|P2|STARTED|Overall Study||2
7781825|NCT01304082|19157863|P1|STARTED|Overall Study||3
7781826|NCT01303965|19157882|P2|NOT COMPLETED|Overall Study||10
7781827|NCT01303965|19157883|P1|NOT COMPLETED|Overall Study||3
7781828|NCT01303965|19157882|P2|COMPLETED|Overall Study||1
7781829|NCT01303965|19157883|P1|COMPLETED|Overall Study||0
7781830|NCT01303965|19157882|P2|STARTED|Overall Study||11
7781831|NCT01303965|19157883|P1|STARTED|Overall Study||3
7781832|NCT01303939|19157897|P2|NOT COMPLETED|Overall Study||0
7781833|NCT01303939|19157898|P1|NOT COMPLETED|Overall Study||7
7781834|NCT01303939|19157897|P2|COMPLETED|Overall Study||15
7781835|NCT01303939|19157898|P1|COMPLETED|Overall Study|Matched controls not found for comparisons. Only best matched glaucoma patients were included.|15
7781836|NCT01303939|19157897|P2|STARTED|Overall Study||15
7781837|NCT01303939|19157898|P1|STARTED|Overall Study||22
7781838|NCT01303861|19157911|P4|NOT COMPLETED|Overall Study||59
7781839|NCT01303861|19157912|P3|NOT COMPLETED|Overall Study||36
7781840|NCT01303861|19157913|P2|NOT COMPLETED|Overall Study||25
7781841|NCT01303861|19157914|P1|NOT COMPLETED|Overall Study||58
7781842|NCT01303861|19157911|P4|COMPLETED|Overall Study||54
7781843|NCT01303861|19157912|P3|COMPLETED|Overall Study||19
7781844|NCT01303861|19157913|P2|COMPLETED|Overall Study||25
7781845|NCT01303861|19157914|P1|COMPLETED|Overall Study||51
7781846|NCT01303861|19157911|P4|Finished Treatment Phase|Overall Study||72
7781847|NCT01303861|19157912|P3|Finished Treatment Phase|Overall Study||39
7781848|NCT01303861|19157913|P2|Finished Treatment Phase|Overall Study||34
7781849|NCT01303861|19157914|P1|Finished Treatment Phase|Overall Study||71
7781850|NCT01303861|19157911|P4|STARTED|Overall Study||113
7781851|NCT01303861|19157912|P3|STARTED|Overall Study||55
7781852|NCT01303861|19157913|P2|STARTED|Overall Study||50
7781853|NCT01303861|19157914|P1|STARTED|Overall Study||109
7781854|NCT01303835|19157935|P2|NOT COMPLETED|Overall Study||25
7781855|NCT01303835|19157936|P1|NOT COMPLETED|Overall Study||19
7781856|NCT01303835|19157935|P2|COMPLETED|Overall Study||31
7781857|NCT01303835|19157936|P1|COMPLETED|Overall Study||35
7781858|NCT01303835|19157935|P2|STARTED|Overall Study||56
7781859|NCT01303835|19157936|P1|STARTED|Overall Study||54
7781860|NCT01303744|19157950|P4|NOT COMPLETED|Overall Study||0
7781861|NCT01303744|19157951|P3|NOT COMPLETED|Overall Study||0
7781862|NCT01303744|19157952|P2|NOT COMPLETED|Overall Study||0
7781863|NCT01303744|19157953|P1|NOT COMPLETED|Overall Study||0
7781864|NCT01303744|19157950|P4|COMPLETED|Overall Study||24
7781865|NCT01303744|19157951|P3|COMPLETED|Overall Study||24
7781866|NCT01303744|19157952|P2|COMPLETED|Overall Study||24
7781867|NCT01303744|19157953|P1|COMPLETED|Overall Study||24
7781868|NCT01303744|19157950|P4|STARTED|Overall Study||24
7781869|NCT01303744|19157951|P3|STARTED|Overall Study||24
7781870|NCT01303744|19157952|P2|STARTED|Overall Study||24
7781871|NCT01303744|19157953|P1|STARTED|Overall Study||24
7781872|NCT01303627|19157973|P2|NOT COMPLETED|Overall Study||1
7781873|NCT01303627|19157974|P1|NOT COMPLETED|Overall Study||0
7781874|NCT01303627|19157973|P2|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20
7781875|NCT01303627|19157974|P1|COMPLETED|Overall Study||21
7781876|NCT01303627|19157973|P2|STARTED|Overall Study||21
7781877|NCT01303627|19157974|P1|STARTED|Overall Study||21
7781878|NCT01303510|19157982|P2|NOT COMPLETED|Overall Study||0
7781879|NCT01303510|19157983|P1|NOT COMPLETED|Overall Study||1
7781880|NCT01303510|19157982|P2|COMPLETED|Overall Study||56
7781881|NCT01303510|19157983|P1|COMPLETED|Overall Study||54
7781882|NCT01303510|19157982|P2|STARTED|Overall Study||56
7781883|NCT01303510|19157983|P1|STARTED|Overall Study||55
7781884|NCT01303445|19157997|P2|NOT COMPLETED|Follow-up Period (14 Days)||1
7781885|NCT01303445|19157998|P1|NOT COMPLETED|Follow-up Period (14 Days)||0
7781886|NCT01303445|19157997|P2|COMPLETED|Follow-up Period (14 Days)||25
7781887|NCT01303445|19157998|P1|COMPLETED|Follow-up Period (14 Days)||26
7781888|NCT01303445|19157997|P2|STARTED|Follow-up Period (14 Days)||26
7781889|NCT01303445|19157998|P1|STARTED|Follow-up Period (14 Days)||26
7781890|NCT01303445|19157997|P2|NOT COMPLETED|Fourth Intervention (7 Days)||0
7781891|NCT01303445|19157998|P1|NOT COMPLETED|Fourth Intervention (7 Days)||1
7781892|NCT01303445|19157997|P2|COMPLETED|Fourth Intervention (7 Days)||26
7781893|NCT01303445|19157998|P1|COMPLETED|Fourth Intervention (7 Days)||26
7781894|NCT01303445|19157997|P2|STARTED|Fourth Intervention (7 Days)||26
7781895|NCT01303445|19157998|P1|STARTED|Fourth Intervention (7 Days)||27
7781896|NCT01303445|19157997|P2|NOT COMPLETED|Third Intervention (7 Days)||0
7781897|NCT01303445|19157998|P1|NOT COMPLETED|Third Intervention (7 Days)||0
7781898|NCT01303445|19157997|P2|COMPLETED|Third Intervention (7 Days)||26
7781899|NCT01303445|19157998|P1|COMPLETED|Third Intervention (7 Days)||27
7781900|NCT01303445|19157997|P2|STARTED|Third Intervention (7 Days)||26
7781901|NCT01303445|19157998|P1|STARTED|Third Intervention (7 Days)||27
7781902|NCT01303445|19157997|P2|NOT COMPLETED|Washout (14 Days)||2
7781903|NCT01303445|19157998|P1|NOT COMPLETED|Washout (14 Days)||1
7781904|NCT01303445|19157997|P2|COMPLETED|Washout (14 Days)||26
7781905|NCT01303445|19157998|P1|COMPLETED|Washout (14 Days)||27
7781906|NCT01303445|19157997|P2|STARTED|Washout (14 Days)||28
7781907|NCT01303445|19157998|P1|STARTED|Washout (14 Days)||28
7781908|NCT01303445|19157997|P2|NOT COMPLETED|Second Intervention (7 Days)||2
7781909|NCT01303445|19157998|P1|NOT COMPLETED|Second Intervention (7 Days)||1
7781910|NCT01303445|19157997|P2|COMPLETED|Second Intervention (7 Days)||28
7781911|NCT01303445|19157998|P1|COMPLETED|Second Intervention (7 Days)||28
7781912|NCT01303445|19157997|P2|STARTED|Second Intervention (7 Days)||30
7781913|NCT01303445|19157998|P1|STARTED|Second Intervention (7 Days)||29
7781914|NCT01303445|19157997|P2|NOT COMPLETED|First Intervention (7 Days)||0
7781915|NCT01303445|19157998|P1|NOT COMPLETED|First Intervention (7 Days)||1
7781916|NCT01303445|19157997|P2|COMPLETED|First Intervention (7 Days)||30
7781917|NCT01303445|19157998|P1|COMPLETED|First Intervention (7 Days)||29
7781918|NCT01303445|19157997|P2|STARTED|First Intervention (7 Days)||30
7781919|NCT01303445|19157998|P1|STARTED|First Intervention (7 Days)||30
7781920|NCT01303419|19158028|P1|NOT COMPLETED|Overall Study||96
7781921|NCT01303419|19158028|P1|COMPLETED|Overall Study||128
7781922|NCT01303419|19158028|P1|STARTED|Overall Study|Subjects who met all Inclusion and none of the Exclusion criteria|224
7781923|NCT01303406|19158038|P2|NOT COMPLETED|Overall Study||1
7781924|NCT01303406|19158039|P1|NOT COMPLETED|Overall Study||0
7781925|NCT01303406|19158038|P2|COMPLETED|Overall Study||15
7781926|NCT01303406|19158039|P1|COMPLETED|Overall Study||13
7781927|NCT01303406|19158038|P2|STARTED|Overall Study||16
7781928|NCT01303406|19158039|P1|STARTED|Overall Study||13
7781929|NCT01303380|19158047|P1|NOT COMPLETED|Overall Study||1
7781930|NCT01303380|19158047|P1|COMPLETED|Overall Study||8
7781931|NCT01303380|19158047|P1|STARTED|Overall Study||9
7781932|NCT01303224|19158077|P4|NOT COMPLETED|Overall Study||10
7781933|NCT01303224|19158078|P3|NOT COMPLETED|Overall Study||6
7781934|NCT01303224|19158079|P2|NOT COMPLETED|Overall Study||11
7781935|NCT01303224|19158080|P1|NOT COMPLETED|Overall Study||11
7781936|NCT01303224|19158077|P4|COMPLETED|Overall Study||133
7781937|NCT01303224|19158078|P3|COMPLETED|Overall Study||133
7781938|NCT01303224|19158079|P2|COMPLETED|Overall Study||131
7781939|NCT01303224|19158080|P1|COMPLETED|Overall Study||130
7781940|NCT01303224|19158077|P4|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142
7781941|NCT01303224|19158078|P3|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139
7781942|NCT01303224|19158079|P2|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138
7781943|NCT01303224|19158080|P1|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140
7781944|NCT01303224|19158077|P4|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143
7781945|NCT01303224|19158078|P3|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139
7781946|NCT01303224|19158079|P2|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142
7781947|NCT01303224|19158080|P1|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141
7781948|NCT01303159|19158106|P1|NOT COMPLETED|Overall Study||23
7781949|NCT01303159|19158106|P1|COMPLETED|Overall Study||6
7781950|NCT01303159|19158106|P1|STARTED|Overall Study||29
7781951|NCT01303003|19158113|P2|NOT COMPLETED|Overall Study||0
7781952|NCT01303003|19158114|P1|NOT COMPLETED|Overall Study||0
7781953|NCT01303003|19158113|P2|COMPLETED|Overall Study||0
7781954|NCT01303003|19158114|P1|COMPLETED|Overall Study||0
7781955|NCT01303003|19158113|P2|STARTED|Overall Study||0
7781956|NCT01303003|19158114|P1|STARTED|Overall Study||0
7781957|NCT01302964|19158124|P2|NOT COMPLETED|Overall Study||0
7781958|NCT01302964|19158125|P1|NOT COMPLETED|Overall Study||1
7781959|NCT01302964|19158124|P2|COMPLETED|Overall Study||10
7781960|NCT01302964|19158125|P1|COMPLETED|Overall Study||19
7781961|NCT01302964|19158124|P2|STARTED|Overall Study||10
7781962|NCT01302964|19158125|P1|STARTED|Overall Study||20
7781963|NCT01302938|19158135|P2|NOT COMPLETED|Overall Study||0
7781964|NCT01302938|19158136|P1|NOT COMPLETED|Overall Study||2
7781965|NCT01302938|19158135|P2|COMPLETED|Overall Study||6
7781966|NCT01302938|19158136|P1|COMPLETED|Overall Study||10
7781967|NCT01302938|19158135|P2|STARTED|Overall Study||6
7781968|NCT01302938|19158136|P1|STARTED|Overall Study||12
7781969|NCT01302899|19158181|P2|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
7781970|NCT01302899|19158182|P1|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
7781971|NCT01302899|19158181|P2|COMPLETED|Period 4 (Weeks 19 to 26)||3
7781972|NCT01302899|19158182|P1|COMPLETED|Period 4 (Weeks 19 to 26)||3
7781973|NCT01302899|19158181|P2|STARTED|Period 4 (Weeks 19 to 26)||3
7781974|NCT01302899|19158182|P1|STARTED|Period 4 (Weeks 19 to 26)||3
7781975|NCT01302899|19158181|P2|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
7781976|NCT01302899|19158182|P1|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
7781977|NCT01302899|19158181|P2|COMPLETED|Period 3 (Weeks 13 to 18)||3
7781978|NCT01302899|19158182|P1|COMPLETED|Period 3 (Weeks 13 to 18)||3
7781979|NCT01302899|19158181|P2|STARTED|Period 3 (Weeks 13 to 18)||3
7781980|NCT01302899|19158182|P1|STARTED|Period 3 (Weeks 13 to 18)||3
7781981|NCT01302899|19158181|P2|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
7781982|NCT01302899|19158182|P1|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
7781983|NCT01302899|19158181|P2|COMPLETED|Period 2 (Weeks 7 to 12)||3
7781984|NCT01302899|19158182|P1|COMPLETED|Period 2 (Weeks 7 to 12)||3
7781985|NCT01302899|19158181|P2|STARTED|Period 2 (Weeks 7 to 12)||4
7781986|NCT01302899|19158182|P1|STARTED|Period 2 (Weeks 7 to 12)||4
7781987|NCT01302899|19158181|P2|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
7781988|NCT01302899|19158182|P1|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
7781989|NCT01302899|19158181|P2|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
7781990|NCT01302899|19158182|P1|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
7781991|NCT01302899|19158181|P2|STARTED|Period 1 (Day 1 to End of Week 6)||4
7781992|NCT01302899|19158182|P1|STARTED|Period 1 (Day 1 to End of Week 6)||4
7781993|NCT01302860|19158232|P1|NOT COMPLETED|Overall Study||0
7781994|NCT01302860|19158232|P1|COMPLETED|Overall Study||17
7781995|NCT01302860|19158232|P1|STARTED|Overall Study||17
7781996|NCT01302834|19158246|P2|NOT COMPLETED|Overall Study||26
7781997|NCT01302834|19158247|P1|NOT COMPLETED|Overall Study||18
7781998|NCT01302834|19158246|P2|COMPLETED|Overall Study||399
7781999|NCT01302834|19158247|P1|COMPLETED|Overall Study||406
7782000|NCT01302834|19158246|P2|Progressed|Overall Study||122
7782001|NCT01302834|19158247|P1|Progressed|Overall Study||76
7782002|NCT01302834|19158246|P2|Feeding Tube Assessed|Overall Study||356
7782003|NCT01302834|19158247|P1|Feeding Tube Assessed|Overall Study||368
7782004|NCT01302834|19158246|P2|Dental Health Assessed 5 Years PT|Overall Study||43
7782005|NCT01302834|19158247|P1|Dental Health Assessed 5 Years PT|Overall Study||44
7782006|NCT01302834|19158246|P2|Dental Health Assessed 2 Years PT|Overall Study||201
7782007|NCT01302834|19158247|P1|Dental Health Assessed 2 Years PT|Overall Study||208
7782008|NCT01302834|19158246|P2|Dental Health Assessed 1 Year PT|Overall Study||267
7782009|NCT01302834|19158247|P1|Dental Health Assessed 1 Year PT|Overall Study||267
7782010|NCT01302834|19158246|P2|AE Assessed 5 Years PT|Overall Study||86
7782011|NCT01302834|19158247|P1|AE Assessed 5 Years PT|Overall Study||92
7782012|NCT01302834|19158246|P2|AE Assessed 2 Years PT|Overall Study||303
7782013|NCT01302834|19158247|P1|AE Assessed 2 Years PT|Overall Study||311
7782014|NCT01302834|19158246|P2|AE Assessment 1 Year PT|Overall Study||351
7782015|NCT01302834|19158247|P1|AE Assessment 1 Year PT|Overall Study||360
7782016|NCT01302834|19158246|P2|AE Assessed 6 Months PT|Overall Study||352
7782017|NCT01302834|19158247|P1|AE Assessed 6 Months PT|Overall Study||361
7782018|NCT01302834|19158246|P2|AE Assessed 3 Months PT|Overall Study||367
7782019|NCT01302834|19158247|P1|AE Assessed 3 Months PT|Overall Study||359
7782020|NCT01302834|19158246|P2|AE Assessed 1 Month Post-treatment (PT)|Overall Study||363
7782021|NCT01302834|19158247|P1|AE Assessed 1 Month Post-treatment (PT)|Overall Study||369
7782022|NCT01302834|19158246|P2|Started Treatment|Overall Study||394
7782023|NCT01302834|19158247|P1|Started Treatment|Overall Study||398
7782024|NCT01302834|19158246|P2|Eligible|Overall Study||399
7782025|NCT01302834|19158247|P1|Eligible|Overall Study||406
7782026|NCT01302834|19158246|P2|STARTED|Overall Study||425
7782027|NCT01302834|19158247|P1|STARTED|Overall Study||424
7782028|NCT01302743|19158292|P3|NOT COMPLETED|Overall Study||2
7782029|NCT01302743|19158293|P2|NOT COMPLETED|Overall Study||1
7782030|NCT01302743|19158294|P1|NOT COMPLETED|Overall Study||1
7782031|NCT01302743|19158292|P3|COMPLETED|Overall Study||8
7782032|NCT01302743|19158293|P2|COMPLETED|Overall Study||7
7782033|NCT01302743|19158294|P1|COMPLETED|Overall Study||6
7782034|NCT01302743|19158292|P3|STARTED|Overall Study||10
7782035|NCT01302743|19158293|P2|STARTED|Overall Study||8
7782036|NCT01302743|19158294|P1|STARTED|Overall Study||7
7782037|NCT01302691|19158307|P2|NOT COMPLETED|Overall Study||6
7782038|NCT01302691|19158308|P1|NOT COMPLETED|Overall Study||10
7782039|NCT01302691|19158307|P2|COMPLETED|Overall Study||157
7782040|NCT01302691|19158308|P1|COMPLETED|Overall Study||154
7782041|NCT01302691|19158307|P2|STARTED|Overall Study||163
7782042|NCT01302691|19158308|P1|STARTED|Overall Study||164
7782043|NCT01302548|19158328|P2|NOT COMPLETED|Overall Study||1
7782044|NCT01302548|19158329|P1|NOT COMPLETED|Overall Study||2
7782045|NCT01302548|19158328|P2|COMPLETED|Overall Study||18
7782046|NCT01302548|19158329|P1|COMPLETED|Overall Study||12
7782047|NCT01302548|19158328|P2|STARTED|Overall Study||19
7782048|NCT01302548|19158329|P1|STARTED|Overall Study||14
7782049|NCT01302483|19158341|P2|NOT COMPLETED|Overall Study||0
7782050|NCT01302483|19158342|P1|NOT COMPLETED|Overall Study||0
7782051|NCT01302483|19158341|P2|COMPLETED|Overall Study||15
7782052|NCT01302483|19158342|P1|COMPLETED|Overall Study||30
7782053|NCT01302483|19158341|P2|STARTED|Overall Study||15
7782054|NCT01302483|19158342|P1|STARTED|Overall Study||30
7782055|NCT01302444|19158358|P2|NOT COMPLETED|Overall Study||0
7782056|NCT01302444|19158359|P1|NOT COMPLETED|Overall Study||0
7782057|NCT01302444|19158358|P2|COMPLETED|Overall Study||0
7782058|NCT01302444|19158359|P1|COMPLETED|Overall Study||1
7782059|NCT01302444|19158358|P2|STARTED|Overall Study||0
7782060|NCT01302444|19158359|P1|STARTED|Overall Study||1
7782061|NCT01302418|19158379|P1|NOT COMPLETED|Overall Study||18
7782062|NCT01302418|19158379|P1|COMPLETED|Overall Study||254
7782063|NCT01302418|19158379|P1|STARTED|Overall Study||272
7782064|NCT01302392|19158385|P2|NOT COMPLETED|Overall Study||1
7782065|NCT01302392|19158386|P1|NOT COMPLETED|Overall Study||7
7782066|NCT01302392|19158385|P2|COMPLETED|Overall Study||156
7782067|NCT01302392|19158386|P1|COMPLETED|Overall Study||151
7782068|NCT01302392|19158385|P2|Treated|Overall Study||157
7782069|NCT01302392|19158386|P1|Treated|Overall Study||153
7782070|NCT01302392|19158385|P2|STARTED|Overall Study||157
7782071|NCT01302392|19158386|P1|STARTED|Overall Study||158
7782072|NCT01302379|19158410|P4|NOT COMPLETED|Overall Study||4
7782073|NCT01302379|19158411|P3|NOT COMPLETED|Overall Study||4
7782074|NCT01302379|19158412|P2|NOT COMPLETED|Overall Study||5
7782075|NCT01302379|19158413|P1|NOT COMPLETED|Overall Study||7
7782076|NCT01302379|19158410|P4|COMPLETED|Overall Study||79
7782077|NCT01302379|19158411|P3|COMPLETED|Overall Study||80
7782078|NCT01302379|19158412|P2|COMPLETED|Overall Study||78
7782079|NCT01302379|19158413|P1|COMPLETED|Overall Study||76
7782080|NCT01302379|19158410|P4|STARTED|Overall Study||83
7782081|NCT01302379|19158411|P3|STARTED|Overall Study||84
7782082|NCT01302379|19158412|P2|STARTED|Overall Study||83
7782083|NCT01302379|19158413|P1|STARTED|Overall Study||83
7782084|NCT01302366|19158437|P1|NOT COMPLETED|Overall Study||5
7782085|NCT01302366|19158437|P1|COMPLETED|Overall Study||15
7782086|NCT01302366|19158437|P1|STARTED|Overall Study||20
7782087|NCT01302119|19158445|P2|NOT COMPLETED|Overall Study||28
7782088|NCT01302119|19158446|P1|NOT COMPLETED|Overall Study||50
7782089|NCT01302119|19158445|P2|COMPLETED|Overall Study||177
7782090|NCT01302119|19158446|P1|COMPLETED|Overall Study||349
7782091|NCT01302119|19158445|P2|STARTED|Overall Study||205
7782092|NCT01302119|19158446|P1|STARTED|Overall Study||399
7782093|NCT01302067|19158461|P3|NOT COMPLETED|Overall Study||98
7782094|NCT01302067|19158462|P2|NOT COMPLETED|Overall Study||34
7782095|NCT01302067|19158463|P1|NOT COMPLETED|Overall Study||78
7782096|NCT01302067|19158461|P3|COMPLETED|Overall Study||681
7782097|NCT01302067|19158462|P2|COMPLETED|Overall Study||352
7782098|NCT01302067|19158463|P1|COMPLETED|Overall Study||712
7782099|NCT01302067|19158461|P3|STARTED|Overall Study||779
7782100|NCT01302067|19158462|P2|STARTED|Overall Study||386
7782101|NCT01302067|19158463|P1|STARTED|Overall Study||790
7782102|NCT01302054|19158534|P3|NOT COMPLETED|Double-Blind Treatment Phase||46
7782103|NCT01302054|19158535|P2|NOT COMPLETED|Double-Blind Treatment Phase||27
7782104|NCT01302054|19158536|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
7782105|NCT01302054|19158534|P3|COMPLETED|Double-Blind Treatment Phase||255
7782106|NCT01302054|19158535|P2|COMPLETED|Double-Blind Treatment Phase||281
7782107|NCT01302054|19158536|P1|COMPLETED|Double-Blind Treatment Phase||0
7782108|NCT01302054|19158534|P3|STARTED|Double-Blind Treatment Phase||301
7782109|NCT01302054|19158535|P2|STARTED|Double-Blind Treatment Phase||308
7782110|NCT01302054|19158536|P1|STARTED|Double-Blind Treatment Phase||0
7782111|NCT01302054|19158534|P3|NOT COMPLETED|Between Open-Label and Double Blind||0
7782112|NCT01302054|19158535|P2|NOT COMPLETED|Between Open-Label and Double Blind||0
7782113|NCT01302054|19158536|P1|NOT COMPLETED|Between Open-Label and Double Blind||2
7782114|NCT01302054|19158534|P3|COMPLETED|Between Open-Label and Double Blind||0
7782115|NCT01302054|19158535|P2|COMPLETED|Between Open-Label and Double Blind||0
7782116|NCT01302054|19158536|P1|COMPLETED|Between Open-Label and Double Blind||609
7782117|NCT01302054|19158534|P3|STARTED|Between Open-Label and Double Blind||0
7782118|NCT01302054|19158535|P2|STARTED|Between Open-Label and Double Blind||0
7782119|NCT01302054|19158536|P1|STARTED|Between Open-Label and Double Blind||611
7782120|NCT01302054|19158534|P3|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
7782121|NCT01302054|19158535|P2|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
7782122|NCT01302054|19158536|P1|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379
7782123|NCT01302054|19158534|P3|COMPLETED|Tolterodine Open-Label Run-In Phase||0
7782124|NCT01302054|19158535|P2|COMPLETED|Tolterodine Open-Label Run-In Phase||0
7782125|NCT01302054|19158536|P1|COMPLETED|Tolterodine Open-Label Run-In Phase||611
7782126|NCT01302054|19158534|P3|STARTED|Tolterodine Open-Label Run-In Phase||0
7782127|NCT01302054|19158535|P2|STARTED|Tolterodine Open-Label Run-In Phase||0
7782128|NCT01302054|19158536|P1|STARTED|Tolterodine Open-Label Run-In Phase||990
7782129|NCT01302041|19158563|P1|NOT COMPLETED|Overall Study||40
7782130|NCT01302041|19158563|P1|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|27
7782131|NCT01302041|19158563|P1|Treatment Received|Overall Study||67
7782132|NCT01302041|19158563|P1|STARTED|Overall Study||67
7782133|NCT01301963|19158594|P2|NOT COMPLETED|Overall Study||0
7782134|NCT01301963|19158595|P1|NOT COMPLETED|Overall Study||0
7782135|NCT01301963|19158594|P2|COMPLETED|Overall Study||4
7782136|NCT01301963|19158595|P1|COMPLETED|Overall Study||5
7782137|NCT01301963|19158594|P2|STARTED|Overall Study||4
7782138|NCT01301963|19158595|P1|STARTED|Overall Study||5
7782139|NCT01301950|19158605|P2|NOT COMPLETED|Overall Study||1
7782140|NCT01301950|19158606|P1|NOT COMPLETED|Overall Study||0
7782141|NCT01301950|19158605|P2|COMPLETED|Overall Study||14
7782142|NCT01301950|19158606|P1|COMPLETED|Overall Study||15
7782143|NCT01301950|19158605|P2|STARTED|Overall Study||15
7782144|NCT01301950|19158606|P1|STARTED|Overall Study||15
7782145|NCT01301833|19158624|P4|NOT COMPLETED|Overall Study||7
7782146|NCT01301833|19158625|P3|NOT COMPLETED|Overall Study||7
7782147|NCT01301833|19158626|P2|NOT COMPLETED|Overall Study||8
7782148|NCT01301833|19158627|P1|NOT COMPLETED|Overall Study||15
7782149|NCT01301833|19158624|P4|COMPLETED|Overall Study||68
7782150|NCT01301833|19158625|P3|COMPLETED|Overall Study||88
7782151|NCT01301833|19158626|P2|COMPLETED|Overall Study||72
7782152|NCT01301833|19158627|P1|COMPLETED|Overall Study||197
7782153|NCT01301833|19158624|P4|STARTED|Overall Study||75
7782154|NCT01301833|19158625|P3|STARTED|Overall Study||95
7782155|NCT01301833|19158626|P2|STARTED|Overall Study||80
7782156|NCT01301833|19158627|P1|STARTED|Overall Study||212
7782157|NCT01301742|19158653|P2|NOT COMPLETED|Second Intervention||0
7782158|NCT01301742|19158654|P1|NOT COMPLETED|Second Intervention||0
7782159|NCT01301742|19158653|P2|COMPLETED|Second Intervention||9
7782160|NCT01301742|19158654|P1|COMPLETED|Second Intervention||9
7782161|NCT01301742|19158653|P2|STARTED|Second Intervention||9
7782162|NCT01301742|19158654|P1|STARTED|Second Intervention||9
7782163|NCT01301742|19158653|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
7782164|NCT01301742|19158654|P1|NOT COMPLETED|Washout Period of at Least 7 Days||0
7782165|NCT01301742|19158653|P2|COMPLETED|Washout Period of at Least 7 Days||9
7782166|NCT01301742|19158654|P1|COMPLETED|Washout Period of at Least 7 Days||9
7782167|NCT01301742|19158653|P2|STARTED|Washout Period of at Least 7 Days||9
7782168|NCT01301742|19158654|P1|STARTED|Washout Period of at Least 7 Days||9
7782169|NCT01301742|19158653|P2|NOT COMPLETED|First Intervention||0
7782170|NCT01301742|19158654|P1|NOT COMPLETED|First Intervention||0
7782171|NCT01301742|19158653|P2|COMPLETED|First Intervention||9
7782172|NCT01301742|19158654|P1|COMPLETED|First Intervention||9
7782173|NCT01301742|19158653|P2|STARTED|First Intervention||9
7782174|NCT01301742|19158654|P1|STARTED|First Intervention||9
7782175|NCT01301729|19158665|P1|NOT COMPLETED|Overall Study||4
7782176|NCT01301729|19158665|P1|COMPLETED|Overall Study||28
7782177|NCT01301729|19158665|P1|STARTED|Overall Study||32
7782178|NCT01301625|19158676|P1|NOT COMPLETED|Overall Study||35
7782179|NCT01301625|19158676|P1|COMPLETED|Overall Study||43
7782180|NCT01301625|19158676|P1|STARTED|Overall Study||78
7782181|NCT01301508|19158748|P2|NOT COMPLETED|Overall Study||3
7782182|NCT01301508|19158749|P1|NOT COMPLETED|Overall Study||1
7782183|NCT01301508|19158748|P2|COMPLETED|Overall Study||22
7782184|NCT01301508|19158749|P1|COMPLETED|Overall Study||20
7782185|NCT01301508|19158748|P2|STARTED|Overall Study||25
7782186|NCT01301508|19158749|P1|STARTED|Overall Study||21
7782187|NCT01301456|19158779|P12|NOT COMPLETED|Stage 2||0
7782188|NCT01301456|19158780|P11|NOT COMPLETED|Stage 2||1
7782189|NCT01301456|19158781|P10|NOT COMPLETED|Stage 2||0
7782190|NCT01301456|19158782|P9|NOT COMPLETED|Stage 2||0
7782191|NCT01301456|19158783|P8|NOT COMPLETED|Stage 2||0
7782192|NCT01301456|19158784|P7|NOT COMPLETED|Stage 2||0
7782193|NCT01301456|19158785|P6|NOT COMPLETED|Stage 2||0
7782194|NCT01301456|19158786|P5|NOT COMPLETED|Stage 2||0
7782195|NCT01301456|19158787|P4|NOT COMPLETED|Stage 2||0
7782196|NCT01301456|19158788|P3|NOT COMPLETED|Stage 2||0
7782197|NCT01301456|19158789|P2|NOT COMPLETED|Stage 2||0
7782198|NCT01301456|19158790|P1|NOT COMPLETED|Stage 2||0
7782199|NCT01301456|19158779|P12|COMPLETED|Stage 2||6
7782200|NCT01301456|19158780|P11|COMPLETED|Stage 2||6
7782201|NCT01301456|19158781|P10|COMPLETED|Stage 2||7
7782202|NCT01301456|19158782|P9|COMPLETED|Stage 2||5
7782203|NCT01301456|19158783|P8|COMPLETED|Stage 2||7
7782204|NCT01301456|19158784|P7|COMPLETED|Stage 2||0
7782205|NCT01301456|19158785|P6|COMPLETED|Stage 2||0
7782206|NCT01301456|19158786|P5|COMPLETED|Stage 2||0
7782207|NCT01301456|19158787|P4|COMPLETED|Stage 2||0
7782208|NCT01301456|19158788|P3|COMPLETED|Stage 2||0
7782209|NCT01301456|19158789|P2|COMPLETED|Stage 2||0
7782210|NCT01301456|19158790|P1|COMPLETED|Stage 2||0
7782211|NCT01301456|19158779|P12|Received Treatment|Stage 2||6
7782212|NCT01301456|19158780|P11|Received Treatment|Stage 2||7
7782213|NCT01301456|19158781|P10|Received Treatment|Stage 2||7
7782214|NCT01301456|19158782|P9|Received Treatment|Stage 2||5
7782215|NCT01301456|19158783|P8|Received Treatment|Stage 2||7
7782216|NCT01301456|19158784|P7|Received Treatment|Stage 2||0
7782217|NCT01301456|19158785|P6|Received Treatment|Stage 2||0
7782218|NCT01301456|19158786|P5|Received Treatment|Stage 2||0
7782219|NCT01301456|19158787|P4|Received Treatment|Stage 2||0
7782220|NCT01301456|19158788|P3|Received Treatment|Stage 2||0
7782221|NCT01301456|19158789|P2|Received Treatment|Stage 2||0
7782222|NCT01301456|19158790|P1|Received Treatment|Stage 2||0
7782223|NCT01301456|19158779|P12|STARTED|Stage 2||6
7782224|NCT01301456|19158780|P11|STARTED|Stage 2||7
7782225|NCT01301456|19158781|P10|STARTED|Stage 2||7
7782226|NCT01301456|19158782|P9|STARTED|Stage 2||5
7782227|NCT01301456|19158783|P8|STARTED|Stage 2||7
7782228|NCT01301456|19158784|P7|STARTED|Stage 2||0
7782229|NCT01301456|19158785|P6|STARTED|Stage 2||0
7782230|NCT01301456|19158786|P5|STARTED|Stage 2||0
7782231|NCT01301456|19158787|P4|STARTED|Stage 2||0
7782232|NCT01301456|19158788|P3|STARTED|Stage 2||0
7782233|NCT01301456|19158789|P2|STARTED|Stage 2||0
7782234|NCT01301456|19158790|P1|STARTED|Stage 2||0
7782235|NCT01301456|19158779|P12|NOT COMPLETED|Stage 1||0
7782236|NCT01301456|19158780|P11|NOT COMPLETED|Stage 1||0
7782237|NCT01301456|19158781|P10|NOT COMPLETED|Stage 1||0
7782238|NCT01301456|19158782|P9|NOT COMPLETED|Stage 1||0
7782239|NCT01301456|19158783|P8|NOT COMPLETED|Stage 1||0
7782240|NCT01301456|19158784|P7|NOT COMPLETED|Stage 1||1
7782241|NCT01301456|19158785|P6|NOT COMPLETED|Stage 1||0
7782242|NCT01301456|19158786|P5|NOT COMPLETED|Stage 1||1
7782243|NCT01301456|19158787|P4|NOT COMPLETED|Stage 1||0
7782244|NCT01301456|19158788|P3|NOT COMPLETED|Stage 1||1
7782245|NCT01301456|19158789|P2|NOT COMPLETED|Stage 1||0
7782246|NCT01301456|19158790|P1|NOT COMPLETED|Stage 1||0
7782247|NCT01301456|19158779|P12|COMPLETED|Stage 1||0
7782248|NCT01301456|19158780|P11|COMPLETED|Stage 1||0
7782249|NCT01301456|19158781|P10|COMPLETED|Stage 1||0
7782250|NCT01301456|19158782|P9|COMPLETED|Stage 1||0
7782251|NCT01301456|19158783|P8|COMPLETED|Stage 1||0
7782252|NCT01301456|19158784|P7|COMPLETED|Stage 1||7
7782253|NCT01301456|19158785|P6|COMPLETED|Stage 1||5
7782254|NCT01301456|19158786|P5|COMPLETED|Stage 1||6
7782255|NCT01301456|19158787|P4|COMPLETED|Stage 1||6
7782256|NCT01301456|19158788|P3|COMPLETED|Stage 1||5
7782257|NCT01301456|19158789|P2|COMPLETED|Stage 1||5
7782258|NCT01301456|19158790|P1|COMPLETED|Stage 1||15
7782259|NCT01301456|19158779|P12|Received Treatment|Stage 1||0
7782260|NCT01301456|19158780|P11|Received Treatment|Stage 1||0
7782261|NCT01301456|19158781|P10|Received Treatment|Stage 1||0
7782262|NCT01301456|19158782|P9|Received Treatment|Stage 1||0
7782263|NCT01301456|19158783|P8|Received Treatment|Stage 1||0
7782264|NCT01301456|19158784|P7|Received Treatment|Stage 1||7
7782265|NCT01301456|19158785|P6|Received Treatment|Stage 1||5
7782266|NCT01301456|19158786|P5|Received Treatment|Stage 1||7
7782267|NCT01301456|19158787|P4|Received Treatment|Stage 1||6
7782268|NCT01301456|19158788|P3|Received Treatment|Stage 1||6
7782269|NCT01301456|19158789|P2|Received Treatment|Stage 1||5
7782270|NCT01301456|19158790|P1|Received Treatment|Stage 1||15
7782271|NCT01301456|19158779|P12|STARTED|Stage 1||0
7782272|NCT01301456|19158780|P11|STARTED|Stage 1||0
7782273|NCT01301456|19158781|P10|STARTED|Stage 1||0
7782274|NCT01301456|19158782|P9|STARTED|Stage 1||0
7782275|NCT01301456|19158783|P8|STARTED|Stage 1||0
7782276|NCT01301456|19158784|P7|STARTED|Stage 1||8
7782277|NCT01301456|19158785|P6|STARTED|Stage 1||5
7782278|NCT01301456|19158786|P5|STARTED|Stage 1||7
7782279|NCT01301456|19158787|P4|STARTED|Stage 1||6
7782280|NCT01301456|19158788|P3|STARTED|Stage 1||6
7782281|NCT01301456|19158789|P2|STARTED|Stage 1||5
7782282|NCT01301456|19158790|P1|STARTED|Stage 1||15
7782283|NCT01301391|19159016|P1|NOT COMPLETED|Overall Study||26
7782284|NCT01301391|19159016|P1|COMPLETED|Overall Study||4
7782285|NCT01301391|19159016|P1|STARTED|Overall Study|On treatment until disease progression, patient withdrawal of consent, or unacceptable toxicity.|30
7782286|NCT01301274|19159028|P2|NOT COMPLETED|Overall Study||1
7782287|NCT01301274|19159029|P1|NOT COMPLETED|Overall Study||2
7782288|NCT01301274|19159028|P2|COMPLETED|Overall Study||31
7782289|NCT01301274|19159029|P1|COMPLETED|Overall Study||32
7782290|NCT01301274|19159028|P2|STARTED|Overall Study||32
7782291|NCT01301274|19159029|P1|STARTED|Overall Study||34
7782292|NCT01301092|19159044|P3|NOT COMPLETED|Overall Study||1
7782293|NCT01301092|19159045|P2|NOT COMPLETED|Overall Study||0
7782294|NCT01301092|19159046|P1|NOT COMPLETED|Overall Study||0
7782295|NCT01301092|19159044|P3|COMPLETED|Overall Study||7
7782296|NCT01301092|19159045|P2|COMPLETED|Overall Study||16
7782297|NCT01301092|19159046|P1|COMPLETED|Overall Study||6
7782298|NCT01301092|19159044|P3|STARTED|Overall Study||8
7782299|NCT01301092|19159045|P2|STARTED|Overall Study||16
7782300|NCT01301092|19159046|P1|STARTED|Overall Study||6
7782301|NCT01301079|19159063|P2|NOT COMPLETED|Overall Study||2
7782302|NCT01301079|19159064|P1|NOT COMPLETED|Overall Study||2
7782303|NCT01301079|19159063|P2|COMPLETED|Overall Study||28
7782304|NCT01301079|19159064|P1|COMPLETED|Overall Study||28
7782305|NCT01301079|19159063|P2|STARTED|Overall Study||30
7782306|NCT01301079|19159064|P1|STARTED|Overall Study||30
7782307|NCT01301066|19159142|P2|NOT COMPLETED|Overall Study||35
7782308|NCT01301066|19159143|P1|NOT COMPLETED|Overall Study||27
7782309|NCT01301066|19159142|P2|COMPLETED|Overall Study||91
7782310|NCT01301066|19159143|P1|COMPLETED|Overall Study||99
7782311|NCT01301066|19159142|P2|STARTED|Overall Study||126
7782312|NCT01301066|19159143|P1|STARTED|Overall Study||126
7782313|NCT01301027|19159151|P2|NOT COMPLETED|Overall Study||10
7782314|NCT01301027|19159152|P1|NOT COMPLETED|Overall Study||8
7782315|NCT01301027|19159151|P2|COMPLETED|Overall Study||37
7782316|NCT01301027|19159152|P1|COMPLETED|Overall Study||40
7782317|NCT01301027|19159151|P2|STARTED|Overall Study||47
7782318|NCT01301027|19159152|P1|STARTED|Overall Study||48
7782319|NCT01301001|19159164|P2|NOT COMPLETED|Second Intervention||0
7782320|NCT01301001|19159165|P1|NOT COMPLETED|Second Intervention||4
7782321|NCT01301001|19159164|P2|COMPLETED|Second Intervention||36
7782322|NCT01301001|19159165|P1|COMPLETED|Second Intervention||30
7782323|NCT01301001|19159164|P2|STARTED|Second Intervention||36
7782324|NCT01301001|19159165|P1|STARTED|Second Intervention||34
7782325|NCT01301001|19159164|P2|NOT COMPLETED|Washout (2 Weeks)||0
7782326|NCT01301001|19159165|P1|NOT COMPLETED|Washout (2 Weeks)||0
7782327|NCT01301001|19159164|P2|COMPLETED|Washout (2 Weeks)||36
7782328|NCT01301001|19159165|P1|COMPLETED|Washout (2 Weeks)||34
7782329|NCT01301001|19159164|P2|STARTED|Washout (2 Weeks)||36
7782330|NCT01301001|19159165|P1|STARTED|Washout (2 Weeks)||34
7782331|NCT01301001|19159164|P2|NOT COMPLETED|First Intervention||9
7782332|NCT01301001|19159165|P1|NOT COMPLETED|First Intervention||10
7782333|NCT01301001|19159164|P2|COMPLETED|First Intervention||36
7782334|NCT01301001|19159165|P1|COMPLETED|First Intervention||34
7782335|NCT01301001|19159164|P2|STARTED|First Intervention||45
7782336|NCT01301001|19159165|P1|STARTED|First Intervention||44
7782337|NCT01300949|19159178|P3|NOT COMPLETED|Overall Study||0
7782338|NCT01300949|19159179|P2|NOT COMPLETED|Overall Study||0
7782339|NCT01300949|19159180|P1|NOT COMPLETED|Overall Study||0
7782340|NCT01300949|19159178|P3|COMPLETED|Overall Study||35
7782341|NCT01300949|19159179|P2|COMPLETED|Overall Study||125
7782342|NCT01300949|19159180|P1|COMPLETED|Overall Study||154
7782343|NCT01300949|19159178|P3|STARTED|Overall Study||35
7782344|NCT01300949|19159179|P2|STARTED|Overall Study||125
7782345|NCT01300949|19159180|P1|STARTED|Overall Study||154
7782346|NCT01300923|19159188|P2|NOT COMPLETED|Overall Study||2
7782347|NCT01300923|19159189|P1|NOT COMPLETED|Overall Study||0
7782348|NCT01300923|19159188|P2|COMPLETED|Overall Study||0
7782349|NCT01300923|19159189|P1|COMPLETED|Overall Study||12
7782350|NCT01300923|19159188|P2|STARTED|Overall Study||2
7782351|NCT01300923|19159189|P1|STARTED|Overall Study||12
7782352|NCT01300819|19159202|P2|NOT COMPLETED|Overall Study||44
7782353|NCT01300819|19159203|P1|NOT COMPLETED|Overall Study||22
7782354|NCT01300819|19159202|P2|COMPLETED|Overall Study||180
7782355|NCT01300819|19159203|P1|COMPLETED|Overall Study||103
7782356|NCT01300819|19159202|P2|STARTED|Overall Study||224
7782357|NCT01300819|19159203|P1|STARTED|Overall Study||125
7782358|NCT01300767|19159231|P1|NOT COMPLETED|Overall Study||4
7782359|NCT01300767|19159231|P1|COMPLETED|Overall Study||70
7782360|NCT01300767|19159231|P1|STARTED|Overall Study||74
7782361|NCT01300741|19159259|P1|NOT COMPLETED|Overall Study||3
7782362|NCT01300741|19159259|P1|COMPLETED|Overall Study||72
7782363|NCT01300741|19159259|P1|STARTED|Overall Study||75
7782364|NCT01300728|19159289|P2|NOT COMPLETED|Overall Study||1
7782365|NCT01300728|19159290|P1|NOT COMPLETED|Overall Study||2
7782366|NCT01300728|19159289|P2|COMPLETED|Overall Study||25
7782367|NCT01300728|19159290|P1|COMPLETED|Overall Study||24
7782368|NCT01300728|19159289|P2|STARTED|Overall Study||26
7782369|NCT01300728|19159290|P1|STARTED|Overall Study||26
7782370|NCT01300650|19159304|P1|NOT COMPLETED|Overall Study||1
7782371|NCT01300650|19159304|P1|COMPLETED|Overall Study||7
7782372|NCT01300650|19159304|P1|STARTED|Overall Study||8
7782373|NCT01300624|19159310|P1|NOT COMPLETED|Overall Study||0
7782374|NCT01300624|19159310|P1|COMPLETED|Overall Study||11
7782375|NCT01300624|19159310|P1|STARTED|Overall Study||11
7782376|NCT01300572|19159320|P1|NOT COMPLETED|Overall Study||1
7782377|NCT01300572|19159320|P1|COMPLETED|Overall Study||15
7782378|NCT01300572|19159320|P1|STARTED|Overall Study||16
7782379|NCT01300559|19159335|P2|NOT COMPLETED|Overall Study||0
7782380|NCT01300559|19159336|P1|NOT COMPLETED|Overall Study||0
7782381|NCT01300559|19159335|P2|COMPLETED|Overall Study||30
7782382|NCT01300559|19159336|P1|COMPLETED|Overall Study||30
7782383|NCT01300559|19159335|P2|STARTED|Overall Study||30
7782384|NCT01300559|19159336|P1|STARTED|Overall Study||30
7782385|NCT01300546|19159344|P2|NOT COMPLETED|Overall Study||6
7782386|NCT01300546|19159345|P1|NOT COMPLETED|Overall Study||1
7782387|NCT01300546|19159344|P2|COMPLETED|Overall Study||14
7782388|NCT01300546|19159345|P1|COMPLETED|Overall Study||18
7782389|NCT01300546|19159344|P2|STARTED|Overall Study||20
7782390|NCT01300546|19159345|P1|STARTED|Overall Study||19
7782391|NCT01300455|19159375|P2|NOT COMPLETED|Period 2||0
7782392|NCT01300455|19159376|P1|NOT COMPLETED|Period 2||0
7782393|NCT01300455|19159375|P2|COMPLETED|Period 2||13
7782394|NCT01300455|19159376|P1|COMPLETED|Period 2||12
7782395|NCT01300455|19159375|P2|STARTED|Period 2||13
7782396|NCT01300455|19159376|P1|STARTED|Period 2||12
7782397|NCT01300455|19159375|P2|NOT COMPLETED|Washout||0
7782398|NCT01300455|19159376|P1|NOT COMPLETED|Washout||1
7782399|NCT01300455|19159375|P2|COMPLETED|Washout||13
7782400|NCT01300455|19159376|P1|COMPLETED|Washout||12
7782401|NCT01300455|19159375|P2|STARTED|Washout||13
7782402|NCT01300455|19159376|P1|STARTED|Washout||13
7782403|NCT01300455|19159375|P2|NOT COMPLETED|Period 1||0
7782404|NCT01300455|19159376|P1|NOT COMPLETED|Period 1||0
7782405|NCT01300455|19159375|P2|COMPLETED|Period 1||13
7782406|NCT01300455|19159376|P1|COMPLETED|Period 1||13
7782407|NCT01300455|19159375|P2|STARTED|Period 1||13
7782408|NCT01300455|19159376|P1|STARTED|Period 1||13
7782409|NCT01300351|19159396|P2|NOT COMPLETED|Overall Study||38
7782410|NCT01300351|19159397|P1|NOT COMPLETED|Overall Study||36
7782411|NCT01300351|19159396|P2|COMPLETED|Overall Study||72
7782412|NCT01300351|19159397|P1|COMPLETED|Overall Study||75
7782413|NCT01300351|19159396|P2|Received Study Treatment|Overall Study||110
7782414|NCT01300351|19159397|P1|Received Study Treatment|Overall Study||109
7782415|NCT01300351|19159396|P2|STARTED|Overall Study||110
7782416|NCT01300351|19159397|P1|STARTED|Overall Study||111
7782417|NCT01300338|19159413|P2|NOT COMPLETED|Overall Study||0
7782418|NCT01300338|19159414|P1|NOT COMPLETED|Overall Study||5
7782419|NCT01300338|19159413|P2|COMPLETED|Overall Study||25
7782420|NCT01300338|19159414|P1|COMPLETED|Overall Study||20
7782421|NCT01300338|19159413|P2|STARTED|Overall Study||25
7782422|NCT01300338|19159414|P1|STARTED|Overall Study||25
7782423|NCT01300286|19159422|P1|NOT COMPLETED|Overall Study||1
7782424|NCT01300286|19159422|P1|COMPLETED|Overall Study||22
7782425|NCT01300286|19159422|P1|STARTED|Overall Study||23
7782426|NCT01300260|19159432|P2|NOT COMPLETED|Period 2 of Study: Second Intervention||1
7782427|NCT01300260|19159433|P1|NOT COMPLETED|Period 2 of Study: Second Intervention||0
7782428|NCT01300260|19159432|P2|COMPLETED|Period 2 of Study: Second Intervention||15
7782429|NCT01300260|19159433|P1|COMPLETED|Period 2 of Study: Second Intervention||14
7782430|NCT01300260|19159432|P2|STARTED|Period 2 of Study: Second Intervention||16
7782431|NCT01300260|19159433|P1|STARTED|Period 2 of Study: Second Intervention||14
7782432|NCT01300260|19159432|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
7782433|NCT01300260|19159433|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
7782434|NCT01300260|19159432|P2|COMPLETED|Washout Period of at Least 28 Days||16
7782435|NCT01300260|19159433|P1|COMPLETED|Washout Period of at Least 28 Days||14
7782436|NCT01300260|19159432|P2|STARTED|Washout Period of at Least 28 Days||16
7782437|NCT01300260|19159433|P1|STARTED|Washout Period of at Least 28 Days||14
7782438|NCT01300260|19159432|P2|NOT COMPLETED|Period 1 of Study: First Intervention||1
7782439|NCT01300260|19159433|P1|NOT COMPLETED|Period 1 of Study: First Intervention||1
7782440|NCT01300260|19159432|P2|COMPLETED|Period 1 of Study: First Intervention||16
7782441|NCT01300260|19159433|P1|COMPLETED|Period 1 of Study: First Intervention||14
7782442|NCT01300260|19159432|P2|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17
7782443|NCT01300260|19159433|P1|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15
7782444|NCT01300260|19159432|P2|STARTED|Period 1 of Study: First Intervention||17
7782445|NCT01300260|19159433|P1|STARTED|Period 1 of Study: First Intervention||15
7782446|NCT01300247|19159465|P2|NOT COMPLETED|Overall Study||2
7782447|NCT01300247|19159466|P1|NOT COMPLETED|Overall Study||4
7782448|NCT01300247|19159465|P2|COMPLETED|Overall Study||18
7782449|NCT01300247|19159466|P1|COMPLETED|Overall Study||17
7782450|NCT01300247|19159465|P2|STARTED|Overall Study||20
7782451|NCT01300247|19159466|P1|STARTED|Overall Study||21
7782452|NCT01300234|19159498|P2|NOT COMPLETED|Overall Study||27
7782453|NCT01300234|19159499|P1|NOT COMPLETED|Overall Study||28
7782454|NCT01300234|19159498|P2|COMPLETED|Overall Study||228
7782455|NCT01300234|19159499|P1|COMPLETED|Overall Study||229
7782456|NCT01300234|19159498|P2|STARTED|Overall Study||255
7782457|NCT01300234|19159499|P1|STARTED|Overall Study||257
7782458|NCT01300065|19159535|P2|NOT COMPLETED|Overall Study||3
7782459|NCT01300065|19159536|P1|NOT COMPLETED|Overall Study||6
7782460|NCT01300065|19159535|P2|COMPLETED|Overall Study||217
7782461|NCT01300065|19159536|P1|COMPLETED|Overall Study||215
7782462|NCT01300065|19159535|P2|STARTED|Overall Study||220
7782463|NCT01300065|19159536|P1|STARTED|Overall Study||221
7782464|NCT01300052|19159546|P2|NOT COMPLETED|Overall Study||3
7782465|NCT01300052|19159547|P1|NOT COMPLETED|Overall Study||6
7782466|NCT01300052|19159546|P2|COMPLETED|Overall Study||19
7782467|NCT01300052|19159547|P1|COMPLETED|Overall Study||40
7782468|NCT01300052|19159546|P2|STARTED|Overall Study||22
7782469|NCT01300052|19159547|P1|STARTED|Overall Study||46
7782470|NCT01299961|19159565|P1|NOT COMPLETED|Overall Study||6
7782471|NCT01299961|19159565|P1|COMPLETED|Overall Study||19
7782472|NCT01299961|19159565|P1|STARTED|Overall Study||25
7782473|NCT01299909|19159574|P3|NOT COMPLETED|Overall Study||17
7782474|NCT01299909|19159575|P2|NOT COMPLETED|Overall Study||18
7782475|NCT01299909|19159576|P1|NOT COMPLETED|Overall Study||22
7782476|NCT01299909|19159574|P3|COMPLETED|Overall Study||23
7782477|NCT01299909|19159575|P2|COMPLETED|Overall Study||49
7782478|NCT01299909|19159576|P1|COMPLETED|Overall Study||46
7782479|NCT01299909|19159574|P3|STARTED|Overall Study||40
7782480|NCT01299909|19159575|P2|STARTED|Overall Study||67
7782481|NCT01299909|19159576|P1|STARTED|Overall Study||68
7782482|NCT01299896|19159591|P2|NOT COMPLETED|Overall Study||18
7782483|NCT01299896|19159592|P1|NOT COMPLETED|Overall Study||1
7782484|NCT01299896|19159591|P2|COMPLETED|Overall Study||296
7782485|NCT01299896|19159592|P1|COMPLETED|Overall Study||318
7782486|NCT01299896|19159591|P2|STARTED|Overall Study||314
7782487|NCT01299896|19159592|P1|STARTED|Overall Study||319
7782488|NCT01299805|19159600|P2|NOT COMPLETED|Overall Study||0
7782489|NCT01299805|19159601|P1|NOT COMPLETED|Overall Study||2
7782490|NCT01299805|19159600|P2|COMPLETED|Overall Study||5
7782491|NCT01299805|19159601|P1|COMPLETED|Overall Study||10
7782492|NCT01299805|19159600|P2|STARTED|Overall Study||5
7782493|NCT01299805|19159601|P1|STARTED|Overall Study||12
7782494|NCT01299766|19159631|P2|NOT COMPLETED|Overall Study||23
7782495|NCT01299766|19159632|P1|NOT COMPLETED|Overall Study||34
7782496|NCT01299766|19159631|P2|COMPLETED|Overall Study||87
7782497|NCT01299766|19159632|P1|COMPLETED|Overall Study||77
7782498|NCT01299766|19159631|P2|STARTED|Overall Study||110
7782499|NCT01299766|19159632|P1|STARTED|Overall Study||111
7782500|NCT01299727|19159643|P3|NOT COMPLETED|Overall Study||4
7782501|NCT01299727|19159644|P2|NOT COMPLETED|Overall Study||4
7782502|NCT01299727|19159645|P1|NOT COMPLETED|Overall Study||4
7782503|NCT01299727|19159643|P3|COMPLETED|Overall Study||0
7782504|NCT01299727|19159644|P2|COMPLETED|Overall Study||0
7782505|NCT01299727|19159645|P1|COMPLETED|Overall Study||0
7782506|NCT01299727|19159643|P3|STARTED|Overall Study||4
7782507|NCT01299727|19159644|P2|STARTED|Overall Study||4
7782508|NCT01299727|19159645|P1|STARTED|Overall Study||4
7782509|NCT01299610|19159692|P3|NOT COMPLETED|Overall Study||0
7782510|NCT01299610|19159693|P2|NOT COMPLETED|Overall Study||0
7782511|NCT01299610|19159694|P1|NOT COMPLETED|Overall Study||0
7782512|NCT01299610|19159692|P3|COMPLETED|Overall Study||10
7782513|NCT01299610|19159693|P2|COMPLETED|Overall Study||5
7782514|NCT01299610|19159694|P1|COMPLETED|Overall Study||10
7782515|NCT01299610|19159692|P3|STARTED|Overall Study||10
7782516|NCT01299610|19159693|P2|STARTED|Overall Study||5
7782517|NCT01299610|19159694|P1|STARTED|Overall Study||10
7782518|NCT01299584|19159739|P1|NOT COMPLETED|Overall Study||9
7782519|NCT01299584|19159739|P1|COMPLETED|Overall Study||766
7782520|NCT01299584|19159739|P1|STARTED|Overall Study||775
7782521|NCT01299571|19159746|P1|NOT COMPLETED|Overall Study||107
7782522|NCT01299571|19159746|P1|COMPLETED|Overall Study||3870
7782523|NCT01299571|19159746|P1|STARTED|Overall Study||3977
7782524|NCT01299480|19159757|P5|NOT COMPLETED|Overall Study||20
7782525|NCT01299480|19159758|P4|NOT COMPLETED|Overall Study||25
7782526|NCT01299480|19159759|P3|NOT COMPLETED|Overall Study||41
7782527|NCT01299480|19159760|P2|NOT COMPLETED|Overall Study||35
7782528|NCT01299480|19159761|P1|NOT COMPLETED|Overall Study||42
7782529|NCT01299480|19159757|P5|COMPLETED|Overall Study||123
7782530|NCT01299480|19159758|P4|COMPLETED|Overall Study||261
7782531|NCT01299480|19159759|P3|COMPLETED|Overall Study||386
7782532|NCT01299480|19159760|P2|COMPLETED|Overall Study||395
7782533|NCT01299480|19159761|P1|COMPLETED|Overall Study||385
7782534|NCT01299480|19159757|P5|STARTED|Overall Study||143
7782535|NCT01299480|19159758|P4|STARTED|Overall Study||286
7782536|NCT01299480|19159759|P3|STARTED|Overall Study||427
7782537|NCT01299480|19159760|P2|STARTED|Overall Study||430
7782538|NCT01299480|19159761|P1|STARTED|Overall Study||427
7782539|NCT01299454|19159800|P4|NOT COMPLETED|Overall Study||0
7782540|NCT01299454|19159801|P3|NOT COMPLETED|Overall Study||0
7782541|NCT01299454|19159802|P2|NOT COMPLETED|Overall Study||0
7782542|NCT01299454|19159803|P1|NOT COMPLETED|Overall Study||0
7782543|NCT01299454|19159800|P4|COMPLETED|Overall Study||23
7782544|NCT01299454|19159801|P3|COMPLETED|Overall Study||6
7782545|NCT01299454|19159802|P2|COMPLETED|Overall Study||8
7782546|NCT01299454|19159803|P1|COMPLETED|Overall Study||8
7782547|NCT01299454|19159800|P4|STARTED|Overall Study||23
7782548|NCT01299454|19159801|P3|STARTED|Overall Study||6
7782549|NCT01299454|19159802|P2|STARTED|Overall Study||8
7782550|NCT01299454|19159803|P1|STARTED|Overall Study||8
7782551|NCT01299389|19159963|P4|NOT COMPLETED|Post-observational||6
7782552|NCT01299389|19159964|P3|NOT COMPLETED|Post-observational||12
7782553|NCT01299389|19159965|P2|NOT COMPLETED|Post-observational||0
7782554|NCT01299389|19159966|P1|NOT COMPLETED|Post-observational||0
7782555|NCT01299389|19159963|P4|COMPLETED|Post-observational||149
7782556|NCT01299389|19159964|P3|COMPLETED|Post-observational||144
7782557|NCT01299389|19159965|P2|COMPLETED|Post-observational||0
7782558|NCT01299389|19159966|P1|COMPLETED|Post-observational||0
7782559|NCT01299389|19159963|P4|STARTED|Post-observational||155
7782560|NCT01299389|19159964|P3|STARTED|Post-observational||156
7782561|NCT01299389|19159965|P2|STARTED|Post-observational||0
7782562|NCT01299389|19159966|P1|STARTED|Post-observational||0
7782563|NCT01299389|19159963|P4|NOT COMPLETED|Double-blind||0
7782564|NCT01299389|19159964|P3|NOT COMPLETED|Double-blind||0
7782565|NCT01299389|19159965|P2|NOT COMPLETED|Double-blind||64
7782566|NCT01299389|19159966|P1|NOT COMPLETED|Double-blind||109
7782567|NCT01299389|19159963|P4|COMPLETED|Double-blind||0
7782568|NCT01299389|19159964|P3|COMPLETED|Double-blind||0
7782569|NCT01299389|19159965|P2|COMPLETED|Double-blind||95
7782570|NCT01299389|19159966|P1|COMPLETED|Double-blind||55
7782571|NCT01299389|19159963|P4|STARTED|Double-blind||0
7782572|NCT01299389|19159964|P3|STARTED|Double-blind||0
7782573|NCT01299389|19159965|P2|STARTED|Double-blind||159
7782574|NCT01299389|19159966|P1|STARTED|Double-blind||164
7782575|NCT01299376|19159988|P2|NOT COMPLETED|Extension (Weeks 9 to 52)||15
7782576|NCT01299376|19159989|P1|NOT COMPLETED|Extension (Weeks 9 to 52)||10
7782577|NCT01299376|19159988|P2|COMPLETED|Extension (Weeks 9 to 52)||118
7782578|NCT01299376|19159989|P1|COMPLETED|Extension (Weeks 9 to 52)||124
7782579|NCT01299376|19159988|P2|STARTED|Extension (Weeks 9 to 52)||133
7782580|NCT01299376|19159989|P1|STARTED|Extension (Weeks 9 to 52)||134
7782581|NCT01299376|19159988|P2|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12
7782582|NCT01299376|19159989|P1|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7
7782583|NCT01299376|19159988|P2|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133
7782584|NCT01299376|19159989|P1|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134
7782585|NCT01299376|19159988|P2|STARTED|Double-blind Treatment (Weeks 1 to 8)||145
7782586|NCT01299376|19159989|P1|STARTED|Double-blind Treatment (Weeks 1 to 8)||141
7782587|NCT01299285|19160019|P1|NOT COMPLETED|Overall Study||0
7782588|NCT01299285|19160019|P1|COMPLETED|Overall Study||6
7782589|NCT01299285|19160019|P1|STARTED|Overall Study||6
7782590|NCT01299272|19160032|P4|NOT COMPLETED|Double-blind (DB) Randomized Period||58
7782591|NCT01299272|19160033|P3|NOT COMPLETED|Double-blind (DB) Randomized Period||70
7782592|NCT01299272|19160034|P2|NOT COMPLETED|Double-blind (DB) Randomized Period||0
7782593|NCT01299272|19160035|P1|NOT COMPLETED|Double-blind (DB) Randomized Period||0
7782594|NCT01299272|19160032|P4|COMPLETED|Double-blind (DB) Randomized Period||234
7782595|NCT01299272|19160033|P3|COMPLETED|Double-blind (DB) Randomized Period||224
7782596|NCT01299272|19160034|P2|COMPLETED|Double-blind (DB) Randomized Period||0
7782597|NCT01299272|19160035|P1|COMPLETED|Double-blind (DB) Randomized Period||0
7782598|NCT01299272|19160032|P4|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period entered the DC Period.|268
7782599|NCT01299272|19160033|P3|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the abrupt DC Period.|132
7782600|NCT01299272|19160034|P2|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
7782601|NCT01299272|19160035|P1|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
7782602|NCT01299272|19160032|P4|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
7782603|NCT01299272|19160033|P3|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the taper DC Period.|129
7782604|NCT01299272|19160034|P2|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
7782605|NCT01299272|19160035|P1|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
7782606|NCT01299272|19160032|P4|STARTED|Double-blind (DB) Randomized Period||292
7782607|NCT01299272|19160033|P3|STARTED|Double-blind (DB) Randomized Period||294
7782608|NCT01299272|19160034|P2|STARTED|Double-blind (DB) Randomized Period||0
7782609|NCT01299272|19160035|P1|STARTED|Double-blind (DB) Randomized Period||0
7782610|NCT01299272|19160032|P4|NOT COMPLETED|Stabilization Open-label (OL) Period||0
7782611|NCT01299272|19160033|P3|NOT COMPLETED|Stabilization Open-label (OL) Period||0
7782612|NCT01299272|19160034|P2|NOT COMPLETED|Stabilization Open-label (OL) Period||249
7782613|NCT01299272|19160035|P1|NOT COMPLETED|Stabilization Open-label (OL) Period||0
7782614|NCT01299272|19160032|P4|COMPLETED|Stabilization Open-label (OL) Period||0
7782615|NCT01299272|19160033|P3|COMPLETED|Stabilization Open-label (OL) Period||0
7782616|NCT01299272|19160034|P2|COMPLETED|Stabilization Open-label (OL) Period|Participants who completed the Stabilization OL Period were randomized to the DB Period.|586
7782617|NCT01299272|19160035|P1|COMPLETED|Stabilization Open-label (OL) Period||0
7782618|NCT01299272|19160032|P4|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
7782619|NCT01299272|19160033|P3|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
7782620|NCT01299272|19160034|P2|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period|Participants who discontinued the Stabilization OL Period had the option to enter the DC Period.|164
7782621|NCT01299272|19160035|P1|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
7782622|NCT01299272|19160032|P4|STARTED|Stabilization Open-label (OL) Period||0
7782623|NCT01299272|19160033|P3|STARTED|Stabilization Open-label (OL) Period||0
7782624|NCT01299272|19160034|P2|STARTED|Stabilization Open-label (OL) Period||835
7782625|NCT01299272|19160035|P1|STARTED|Stabilization Open-label (OL) Period||0
7782626|NCT01299272|19160032|P4|NOT COMPLETED|Acute Open-label (OL) Period||0
7782627|NCT01299272|19160033|P3|NOT COMPLETED|Acute Open-label (OL) Period||0
7782628|NCT01299272|19160034|P2|NOT COMPLETED|Acute Open-label (OL) Period||0
7782629|NCT01299272|19160035|P1|NOT COMPLETED|Acute Open-label (OL) Period||414
7782630|NCT01299272|19160032|P4|COMPLETED|Acute Open-label (OL) Period||0
7782631|NCT01299272|19160033|P3|COMPLETED|Acute Open-label (OL) Period||0
7782632|NCT01299272|19160034|P2|COMPLETED|Acute Open-label (OL) Period||0
7782633|NCT01299272|19160035|P1|COMPLETED|Acute Open-label (OL) Period|Participants who completed the Acute OL Period entered the Stabilization OL Period.|835
7782634|NCT01299272|19160032|P4|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
7782635|NCT01299272|19160033|P3|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
7782636|NCT01299272|19160034|P2|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
7782637|NCT01299272|19160035|P1|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period|Participants who discontinued the Acute OL Period had the option to enter the DC Period.|271
7782638|NCT01299272|19160032|P4|STARTED|Acute Open-label (OL) Period||0
7782639|NCT01299272|19160033|P3|STARTED|Acute Open-label (OL) Period||0
7782640|NCT01299272|19160034|P2|STARTED|Acute Open-label (OL) Period||0
7782641|NCT01299272|19160035|P1|STARTED|Acute Open-label (OL) Period||1249
7782642|NCT01299116|19160090|P3|NOT COMPLETED|Overall Study||11
7782643|NCT01299116|19160091|P2|NOT COMPLETED|Overall Study||9
7782644|NCT01299116|19160092|P1|NOT COMPLETED|Overall Study||65
7782645|NCT01299116|19160090|P3|COMPLETED|Overall Study||184
7782646|NCT01299116|19160091|P2|COMPLETED|Overall Study||168
7782647|NCT01299116|19160092|P1|COMPLETED|Overall Study||457
7782648|NCT01299116|19160090|P3|STARTED|Overall Study||195
7782649|NCT01299116|19160091|P2|STARTED|Overall Study||177
7782650|NCT01299116|19160092|P1|STARTED|Overall Study||522
7782651|NCT01299103|19160109|P3|NOT COMPLETED|Overall Study||2
7782652|NCT01299103|19160110|P2|NOT COMPLETED|Overall Study||2
7782653|NCT01299103|19160111|P1|NOT COMPLETED|Overall Study||0
7782654|NCT01299103|19160109|P3|COMPLETED|Overall Study||8
7782655|NCT01299103|19160110|P2|COMPLETED|Overall Study||13
7782656|NCT01299103|19160111|P1|COMPLETED|Overall Study||15
7782657|NCT01299103|19160109|P3|STARTED|Overall Study||10
7782658|NCT01299103|19160110|P2|STARTED|Overall Study||15
7782659|NCT01299103|19160111|P1|STARTED|Overall Study||15
7782660|NCT01299090|19160122|P1|NOT COMPLETED|Overall Study||0
7782661|NCT01299090|19160122|P1|COMPLETED|Overall Study||49
7782662|NCT01299090|19160122|P1|STARTED|Overall Study||49
7782663|NCT01299077|19160127|P1|NOT COMPLETED|Overall Study||0
7782664|NCT01299077|19160127|P1|COMPLETED|Overall Study||478
7782665|NCT01299077|19160127|P1|STARTED|Overall Study||478
7782666|NCT01299038|19160137|P2|NOT COMPLETED|Overall Study||0
7782667|NCT01299038|19160138|P1|NOT COMPLETED|Overall Study||1
7782668|NCT01299038|19160137|P2|COMPLETED|Overall Study|Evaluable|10
7782669|NCT01299038|19160138|P1|COMPLETED|Overall Study|Evaluable|9
7782670|NCT01299038|19160137|P2|STARTED|Overall Study|Consented|10
7782671|NCT01299038|19160138|P1|STARTED|Overall Study|Consented|10
7782672|NCT01299025|19160146|P2|NOT COMPLETED|Overall Study||1
7782673|NCT01299025|19160147|P1|NOT COMPLETED|Overall Study||3
7782674|NCT01299025|19160146|P2|COMPLETED|Overall Study||41
7782675|NCT01299025|19160147|P1|COMPLETED|Overall Study||39
7782676|NCT01299025|19160146|P2|STARTED|Overall Study||42
7782677|NCT01299025|19160147|P1|STARTED|Overall Study||42
7782678|NCT01298921|19160161|P2|NOT COMPLETED|Overall Study||0
7782679|NCT01298921|19160162|P1|NOT COMPLETED|Overall Study||0
7782680|NCT01298921|19160161|P2|COMPLETED|Overall Study||0
7782681|NCT01298921|19160162|P1|COMPLETED|Overall Study||0
7782682|NCT01298921|19160161|P2|STARTED|Overall Study||0
7782683|NCT01298921|19160162|P1|STARTED|Overall Study||0
7782684|NCT01298778|19160172|P2|NOT COMPLETED|Overall Study||6
7782685|NCT01298778|19160173|P1|NOT COMPLETED|Overall Study||3
7782686|NCT01298778|19160172|P2|COMPLETED|Overall Study||30
7782687|NCT01298778|19160173|P1|COMPLETED|Overall Study||30
7782688|NCT01298778|19160172|P2|STARTED|Overall Study||36
7782689|NCT01298778|19160173|P1|STARTED|Overall Study||33
7782690|NCT01298765|19160193|P1|NOT COMPLETED|Long-Term Treatment Period||99
7782691|NCT01298765|19160193|P1|COMPLETED|Long-Term Treatment Period||127
7782692|NCT01298765|19160193|P1|STARTED|Long-Term Treatment Period||226
7782693|NCT01298765|19160193|P1|NOT COMPLETED|Titration Period||76
7782694|NCT01298765|19160193|P1|COMPLETED|Titration Period||226
7782695|NCT01298765|19160193|P1|STARTED|Titration Period||302
7782696|NCT01298752|19160203|P2|NOT COMPLETED|Overall Study||26
7782697|NCT01298752|19160204|P1|NOT COMPLETED|Overall Study||43
7782698|NCT01298752|19160203|P2|COMPLETED|Overall Study||31
7782699|NCT01298752|19160204|P1|COMPLETED|Overall Study||77
7782700|NCT01298752|19160203|P2|STARTED|Overall Study||57
7782701|NCT01298752|19160204|P1|STARTED|Overall Study||120
7782702|NCT01298700|19160214|P2|NOT COMPLETED|Overall Study||100
7782703|NCT01298700|19160215|P1|NOT COMPLETED|Overall Study||101
7782704|NCT01298700|19160214|P2|COMPLETED|Overall Study||303
7782705|NCT01298700|19160215|P1|COMPLETED|Overall Study||302
7782706|NCT01298700|19160214|P2|Safety Population: Received Study Drug|Overall Study||398
7782707|NCT01298700|19160215|P1|Safety Population: Received Study Drug|Overall Study||400
7782708|NCT01298700|19160214|P2|STARTED|Overall Study||403
7782709|NCT01298700|19160215|P1|STARTED|Overall Study||403
7782710|NCT01298661|19160226|P3|NOT COMPLETED|Overall Study||2
7782711|NCT01298661|19160227|P2|NOT COMPLETED|Overall Study||0
7782712|NCT01298661|19160228|P1|NOT COMPLETED|Overall Study||2
7782713|NCT01298661|19160226|P3|COMPLETED|Overall Study||32
7782714|NCT01298661|19160227|P2|COMPLETED|Overall Study||24
7782715|NCT01298661|19160228|P1|COMPLETED|Overall Study||31
7782716|NCT01298661|19160226|P3|STARTED|Overall Study||34
7782717|NCT01298661|19160227|P2|STARTED|Overall Study||24
7782718|NCT01298661|19160228|P1|STARTED|Overall Study||33
7782719|NCT01298648|19160306|P1|NOT COMPLETED|Overall Study||23
7782720|NCT01298648|19160306|P1|COMPLETED|Overall Study||1693
7782721|NCT01298648|19160306|P1|STARTED|Overall Study||1716
7782722|NCT01298596|19160317|P2|NOT COMPLETED|Overall Study||33
7782723|NCT01298596|19160318|P1|NOT COMPLETED|Overall Study||28
7782724|NCT01298596|19160317|P2|COMPLETED|Overall Study||167
7782725|NCT01298596|19160318|P1|COMPLETED|Overall Study||172
7782726|NCT01298596|19160317|P2|STARTED|Overall Study||200
7782727|NCT01298596|19160318|P1|STARTED|Overall Study||200
7782728|NCT01298570|19160328|P2|NOT COMPLETED|Overall Study||61
7782729|NCT01298570|19160329|P1|NOT COMPLETED|Overall Study||120
7782730|NCT01298570|19160328|P2|COMPLETED|Overall Study||0
7782731|NCT01298570|19160329|P1|COMPLETED|Overall Study||0
7782732|NCT01298570|19160328|P2|STARTED|Overall Study||61
7782733|NCT01298570|19160329|P1|STARTED|Overall Study||120
7782734|NCT01298544|19160345|P1|NOT COMPLETED|Overall Study||0
7782735|NCT01298544|19160345|P1|COMPLETED|Overall Study||335
7782736|NCT01298544|19160345|P1|STARTED|Overall Study||335
7782737|NCT01298531|19160356|P2|NOT COMPLETED|Overall Study||7
7782738|NCT01298531|19160357|P1|NOT COMPLETED|Overall Study||9
7782739|NCT01298531|19160356|P2|COMPLETED|Overall Study||41
7782740|NCT01298531|19160357|P1|COMPLETED|Overall Study||33
7782741|NCT01298531|19160356|P2|STARTED|Overall Study||48
7782742|NCT01298531|19160357|P1|STARTED|Overall Study||42
7782743|NCT01298518|19160486|P3|NOT COMPLETED|Overall Study||1
7782744|NCT01298518|19160487|P2|NOT COMPLETED|Overall Study||0
7782745|NCT01298518|19160488|P1|NOT COMPLETED|Overall Study||0
7782746|NCT01298518|19160486|P3|COMPLETED|Overall Study||15
7782747|NCT01298518|19160487|P2|COMPLETED|Overall Study||16
7782748|NCT01298518|19160488|P1|COMPLETED|Overall Study||16
7782749|NCT01298518|19160486|P3|STARTED|Overall Study||16
7782750|NCT01298518|19160487|P2|STARTED|Overall Study||16
7782751|NCT01298518|19160488|P1|STARTED|Overall Study||16
7782752|NCT01298492|19160540|P1|NOT COMPLETED|Overall Study||119
7782753|NCT01298492|19160540|P1|COMPLETED|Overall Study||149
7782754|NCT01298492|19160540|P1|STARTED|Overall Study||268
7782755|NCT01298362|19160548|P2|NOT COMPLETED|Overall Study||43
7782756|NCT01298362|19160549|P1|NOT COMPLETED|Overall Study||38
7782757|NCT01298362|19160548|P2|COMPLETED|Overall Study||123
7782758|NCT01298362|19160549|P1|COMPLETED|Overall Study||86
7782759|NCT01298362|19160548|P2|STARTED|Overall Study||166
7782760|NCT01298362|19160549|P1|STARTED|Overall Study||124
7782761|NCT01298323|19160569|P2|NOT COMPLETED|Overall Study||88
7782762|NCT01298323|19160570|P1|NOT COMPLETED|Overall Study||86
7782763|NCT01298323|19160569|P2|COMPLETED|Overall Study||15
7782764|NCT01298323|19160570|P1|COMPLETED|Overall Study||16
7782765|NCT01298323|19160569|P2|Ongoing|Overall Study||55
7782766|NCT01298323|19160570|P1|Ongoing|Overall Study||55
7782767|NCT01298323|19160569|P2|STARTED|Overall Study||103
7782768|NCT01298323|19160570|P1|STARTED|Overall Study||102
7782769|NCT01298219|19160578|P2|NOT COMPLETED|Overall Study||36
7782770|NCT01298219|19160579|P1|NOT COMPLETED|Overall Study||50
7782771|NCT01298219|19160578|P2|COMPLETED|Overall Study||184
7782772|NCT01298219|19160579|P1|COMPLETED|Overall Study||169
7782773|NCT01298219|19160578|P2|Safety Analysis Set|Overall Study||220
7782774|NCT01298219|19160579|P1|Safety Analysis Set|Overall Study||219
7782775|NCT01298219|19160578|P2|Intention to Treat (ITT)|Overall Study||220
7782776|NCT01298219|19160579|P1|Intention to Treat (ITT)|Overall Study||219
7782777|NCT01298219|19160578|P2|STARTED|Overall Study||220
7782778|NCT01298219|19160579|P1|STARTED|Overall Study||219
7782779|NCT01298193|19160593|P1|NOT COMPLETED|Efficacy Phase (Second Cycle)||1
7782780|NCT01298193|19160593|P1|COMPLETED|Efficacy Phase (Second Cycle)||23
7782781|NCT01298193|19160593|P1|STARTED|Efficacy Phase (Second Cycle)||24
7782782|NCT01298193|19160593|P1|NOT COMPLETED|Observational Phase (First Cycle)||27
7782783|NCT01298193|19160593|P1|COMPLETED|Observational Phase (First Cycle)|From these 185 completed patients, only 24 experiment emesis on Cycle 1 (NCR) (efficacy phase).|185
7782784|NCT01298193|19160593|P1|STARTED|Observational Phase (First Cycle)||212
7782785|NCT01298167|19160608|P2|NOT COMPLETED|Overall Study||0
7782786|NCT01298167|19160609|P1|NOT COMPLETED|Overall Study||1
7782787|NCT01298167|19160608|P2|COMPLETED|Overall Study||8
7782788|NCT01298167|19160609|P1|COMPLETED|Overall Study||5
7782789|NCT01298167|19160608|P2|STARTED|Overall Study||8
7782790|NCT01298167|19160609|P1|STARTED|Overall Study||6
7782791|NCT01298141|19160615|P1|NOT COMPLETED|Overall Study||31
7782792|NCT01298141|19160615|P1|COMPLETED|Overall Study||140
7782793|NCT01298141|19160615|P1|Treated|Overall Study||167
7782794|NCT01298141|19160615|P1|STARTED|Overall Study||171
7782795|NCT01298128|19160627|P2|NOT COMPLETED|Overall Study||8
7782796|NCT01298128|19160628|P1|NOT COMPLETED|Overall Study||9
7782797|NCT01298128|19160627|P2|COMPLETED|Overall Study||27
7782798|NCT01298128|19160628|P1|COMPLETED|Overall Study||26
7782799|NCT01298128|19160627|P2|STARTED|Overall Study||35
7782800|NCT01298128|19160628|P1|STARTED|Overall Study||35
7782801|NCT01298063|19160639|P5|NOT COMPLETED|Overall Study||0
7782802|NCT01298063|19160640|P4|NOT COMPLETED|Overall Study||0
7782803|NCT01298063|19160641|P3|NOT COMPLETED|Overall Study||0
7782804|NCT01298063|19160642|P2|NOT COMPLETED|Overall Study||0
7782805|NCT01298063|19160643|P1|NOT COMPLETED|Overall Study||0
7782806|NCT01298063|19160639|P5|COMPLETED|Overall Study||8
7782807|NCT01298063|19160640|P4|COMPLETED|Overall Study||8
7782808|NCT01298063|19160641|P3|COMPLETED|Overall Study||8
7782809|NCT01298063|19160642|P2|COMPLETED|Overall Study||3
7782810|NCT01298063|19160643|P1|COMPLETED|Overall Study||8
7782811|NCT01298063|19160639|P5|STARTED|Overall Study||8
7782812|NCT01298063|19160640|P4|STARTED|Overall Study||8
7782813|NCT01298063|19160641|P3|STARTED|Overall Study||8
7782814|NCT01298063|19160642|P2|STARTED|Overall Study||3
7782815|NCT01298063|19160643|P1|STARTED|Overall Study||8
7782816|NCT01297985|19160672|P2|NOT COMPLETED|Overall Study||53
7782817|NCT01297985|19160673|P1|NOT COMPLETED|Overall Study||55
7782818|NCT01297985|19160672|P2|COMPLETED|Overall Study||163
7782819|NCT01297985|19160673|P1|COMPLETED|Overall Study||157
7782820|NCT01297985|19160672|P2|STARTED|Overall Study||216
7782821|NCT01297985|19160673|P1|STARTED|Overall Study||212
7782822|NCT01297920|19160690|P3|NOT COMPLETED|Overall Study||57
7782823|NCT01297920|19160691|P2|NOT COMPLETED|Overall Study||27
7782824|NCT01297920|19160692|P1|NOT COMPLETED|Overall Study||58
7782825|NCT01297920|19160690|P3|COMPLETED|Overall Study||178
7782826|NCT01297920|19160691|P2|COMPLETED|Overall Study||207
7782827|NCT01297920|19160692|P1|COMPLETED|Overall Study||163
7782828|NCT01297920|19160690|P3|STARTED|Overall Study||235
7782829|NCT01297920|19160691|P2|STARTED|Overall Study||234
7782830|NCT01297920|19160692|P1|STARTED|Overall Study||221
7782831|NCT01297595|19160700|P2|NOT COMPLETED|Second Intervention Period||0
7782832|NCT01297595|19160701|P1|NOT COMPLETED|Second Intervention Period||0
7782833|NCT01297595|19160700|P2|COMPLETED|Second Intervention Period||11
7782834|NCT01297595|19160701|P1|COMPLETED|Second Intervention Period||11
7782835|NCT01297595|19160700|P2|STARTED|Second Intervention Period||11
7782836|NCT01297595|19160701|P1|STARTED|Second Intervention Period||11
7782837|NCT01297595|19160700|P2|NOT COMPLETED|Washout Period (At Least 14 Days)||0
7782838|NCT01297595|19160701|P1|NOT COMPLETED|Washout Period (At Least 14 Days)||0
7782839|NCT01297595|19160700|P2|COMPLETED|Washout Period (At Least 14 Days)||11
7782840|NCT01297595|19160701|P1|COMPLETED|Washout Period (At Least 14 Days)||11
7782841|NCT01297595|19160700|P2|STARTED|Washout Period (At Least 14 Days)||11
7782842|NCT01297595|19160701|P1|STARTED|Washout Period (At Least 14 Days)||11
7782843|NCT01297595|19160700|P2|NOT COMPLETED|First Intervention Period||0
7782844|NCT01297595|19160701|P1|NOT COMPLETED|First Intervention Period||0
7782845|NCT01297595|19160700|P2|COMPLETED|First Intervention Period||11
7782846|NCT01297595|19160701|P1|COMPLETED|First Intervention Period||11
7782847|NCT01297595|19160700|P2|STARTED|First Intervention Period||11
7782848|NCT01297595|19160701|P1|STARTED|First Intervention Period||11
7782849|NCT01297517|19160736|P3|NOT COMPLETED|Overall Study||27
7782850|NCT01297517|19160737|P2|NOT COMPLETED|Overall Study||12
7782851|NCT01297517|19160738|P1|NOT COMPLETED|Overall Study||27
7782852|NCT01297517|19160736|P3|COMPLETED|Overall Study||193
7782853|NCT01297517|19160737|P2|COMPLETED|Overall Study||214
7782854|NCT01297517|19160738|P1|COMPLETED|Overall Study||187
7782855|NCT01297517|19160736|P3|STARTED|Overall Study||220
7782856|NCT01297517|19160737|P2|STARTED|Overall Study||226
7782857|NCT01297517|19160738|P1|STARTED|Overall Study||214
7782858|NCT01297504|19160746|P1|NOT COMPLETED|Overall Study||67
7782859|NCT01297504|19160746|P1|COMPLETED|Overall Study||397
7782860|NCT01297504|19160746|P1|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458
7782861|NCT01297504|19160746|P1|STARTED|Overall Study||464
7782862|NCT01297491|19160760|P2|NOT COMPLETED|Overall Study||33
7782863|NCT01297491|19160761|P1|NOT COMPLETED|Overall Study||30
7782864|NCT01297491|19160760|P2|COMPLETED|Overall Study||0
7782865|NCT01297491|19160761|P1|COMPLETED|Overall Study||0
7782866|NCT01297491|19160760|P2|STARTED|Overall Study||33
7782867|NCT01297491|19160761|P1|STARTED|Overall Study||30
7782868|NCT01297465|19160779|P2|NOT COMPLETED|Overall Study||10
7782869|NCT01297465|19160780|P1|NOT COMPLETED|Overall Study||8
7782870|NCT01297465|19160779|P2|COMPLETED|Overall Study||93
7782871|NCT01297465|19160780|P1|COMPLETED|Overall Study||91
7782872|NCT01297465|19160779|P2|STARTED|Overall Study||103
7782873|NCT01297465|19160780|P1|STARTED|Overall Study||99
7782874|NCT01297348|19160814|P2|NOT COMPLETED|Overall Study||0
7782875|NCT01297348|19160815|P1|NOT COMPLETED|Overall Study||0
7782876|NCT01297348|19160814|P2|COMPLETED|Overall Study||586401
7782877|NCT01297348|19160815|P1|COMPLETED|Overall Study||12281
7782878|NCT01297348|19160814|P2|STARTED|Overall Study||586401
7782879|NCT01297348|19160815|P1|STARTED|Overall Study||12281
7782880|NCT01297335|19160825|P1|NOT COMPLETED|Overall Study||0
7782881|NCT01297335|19160825|P1|COMPLETED|Overall Study||10
7782882|NCT01297335|19160825|P1|STARTED|Overall Study||10
7782883|NCT01297322|19160833|P2|NOT COMPLETED|Overall Study||4
7782884|NCT01297322|19160834|P1|NOT COMPLETED|Overall Study||1
7782885|NCT01297322|19160833|P2|COMPLETED|Overall Study||274
7782886|NCT01297322|19160834|P1|COMPLETED|Overall Study||141
7782887|NCT01297322|19160833|P2|STARTED|Overall Study||278
7782888|NCT01297322|19160834|P1|STARTED|Overall Study||142
7782889|NCT01297309|19160853|P1|NOT COMPLETED|Overall Study||14
7782890|NCT01297309|19160853|P1|COMPLETED|Overall Study||37
7782891|NCT01297309|19160853|P1|Started Extension Period|Overall Study||46
7782892|NCT01297309|19160853|P1|Treated|Overall Study||49
7782893|NCT01297309|19160853|P1|STARTED|Overall Study||51
7782894|NCT01297283|19160870|P1|NOT COMPLETED|Overall Study||19
7782895|NCT01297283|19160870|P1|COMPLETED|Overall Study||176
7782896|NCT01297283|19160870|P1|STARTED|Overall Study||195
7782897|NCT01297270|19160878|P3|NOT COMPLETED|Overall Study||29
7782898|NCT01297270|19160879|P2|NOT COMPLETED|Overall Study||72
7782899|NCT01297270|19160880|P1|NOT COMPLETED|Overall Study||45
7782900|NCT01297270|19160878|P3|COMPLETED|Overall Study||103
7782901|NCT01297270|19160879|P2|COMPLETED|Overall Study||192
7782902|NCT01297270|19160880|P1|COMPLETED|Overall Study||217
7782903|NCT01297270|19160878|P3|STARTED|Overall Study||132
7782904|NCT01297270|19160879|P2|STARTED|Overall Study||264
7782905|NCT01297270|19160880|P1|STARTED|Overall Study||262
7782906|NCT01297257|19160918|P1|NOT COMPLETED|Overall Study||0
7782907|NCT01297257|19160918|P1|COMPLETED|Overall Study||7740
7782908|NCT01297257|19160918|P1|STARTED|Overall Study||7740
7782909|NCT01297244|19160925|P2|NOT COMPLETED|Overall Study||6
7782910|NCT01297244|19160926|P1|NOT COMPLETED|Overall Study||35
7782911|NCT01297244|19160925|P2|COMPLETED|Overall Study||9
7782912|NCT01297244|19160926|P1|COMPLETED|Overall Study||55
7782913|NCT01297244|19160925|P2|STARTED|Overall Study||15
7782914|NCT01297244|19160926|P1|STARTED|Overall Study||90
7782915|NCT01297062|19160946|P7|NOT COMPLETED|Overall Study||8
7782916|NCT01297062|19160947|P6|NOT COMPLETED|Overall Study||1
7782917|NCT01297062|19160948|P5|NOT COMPLETED|Overall Study||2
7782918|NCT01297062|19160949|P4|NOT COMPLETED|Overall Study||1
7782919|NCT01297062|19160950|P3|NOT COMPLETED|Overall Study||2
7782920|NCT01297062|19160951|P2|NOT COMPLETED|Overall Study||1
7782921|NCT01297062|19160952|P1|NOT COMPLETED|Overall Study||4
7782922|NCT01297062|19160946|P7|COMPLETED|Overall Study||0
7782923|NCT01297062|19160947|P6|COMPLETED|Overall Study||13
7782924|NCT01297062|19160948|P5|COMPLETED|Overall Study||13
7782925|NCT01297062|19160949|P4|COMPLETED|Overall Study||13
7782926|NCT01297062|19160950|P3|COMPLETED|Overall Study||12
7782927|NCT01297062|19160951|P2|COMPLETED|Overall Study||13
7782928|NCT01297062|19160952|P1|COMPLETED|Overall Study||11
7782929|NCT01297062|19160946|P7|Evaluable Population|Overall Study||0
7782930|NCT01297062|19160947|P6|Evaluable Population|Overall Study||13
7782931|NCT01297062|19160948|P5|Evaluable Population|Overall Study||13
7782932|NCT01297062|19160949|P4|Evaluable Population|Overall Study||13
7782933|NCT01297062|19160950|P3|Evaluable Population|Overall Study||12
7782934|NCT01297062|19160951|P2|Evaluable Population|Overall Study||12
7782935|NCT01297062|19160952|P1|Evaluable Population|Overall Study||11
7782936|NCT01297062|19160946|P7|Intent to Treat (ITT)|Overall Study||0
7782937|NCT01297062|19160947|P6|Intent to Treat (ITT)|Overall Study||14
7782938|NCT01297062|19160948|P5|Intent to Treat (ITT)|Overall Study||15
7782939|NCT01297062|19160949|P4|Intent to Treat (ITT)|Overall Study||14
7782940|NCT01297062|19160950|P3|Intent to Treat (ITT)|Overall Study||14
7782941|NCT01297062|19160951|P2|Intent to Treat (ITT)|Overall Study||14
7782942|NCT01297062|19160952|P1|Intent to Treat (ITT)|Overall Study||15
7782943|NCT01297062|19160946|P7|STARTED|Overall Study||8
7782944|NCT01297062|19160947|P6|STARTED|Overall Study||14
7782945|NCT01297062|19160948|P5|STARTED|Overall Study||15
7782946|NCT01297062|19160949|P4|STARTED|Overall Study||14
7782947|NCT01297062|19160950|P3|STARTED|Overall Study||14
7782948|NCT01297062|19160951|P2|STARTED|Overall Study||14
7782949|NCT01297062|19160952|P1|STARTED|Overall Study||15
7782950|NCT01296932|19160983|P9|NOT COMPLETED|Overall Study||4
7782951|NCT01296932|19160984|P8|NOT COMPLETED|Overall Study||2
7782952|NCT01296932|19160985|P7|NOT COMPLETED|Overall Study||6
7782953|NCT01296932|19160986|P6|NOT COMPLETED|Overall Study||3
7782954|NCT01296932|19160987|P5|NOT COMPLETED|Overall Study||3
7782955|NCT01296932|19160988|P4|NOT COMPLETED|Overall Study||6
7782956|NCT01296932|19160989|P3|NOT COMPLETED|Overall Study||6
7782957|NCT01296932|19160990|P2|NOT COMPLETED|Overall Study||3
7782958|NCT01296932|19160991|P1|NOT COMPLETED|Overall Study||3
7782959|NCT01296932|19160983|P9|COMPLETED|Overall Study||0
7782960|NCT01296932|19160984|P8|COMPLETED|Overall Study||1
7782961|NCT01296932|19160985|P7|COMPLETED|Overall Study||0
7782962|NCT01296932|19160986|P6|COMPLETED|Overall Study||0
7782963|NCT01296932|19160987|P5|COMPLETED|Overall Study||0
7782964|NCT01296932|19160988|P4|COMPLETED|Overall Study||0
7782965|NCT01296932|19160989|P3|COMPLETED|Overall Study||0
7782966|NCT01296932|19160990|P2|COMPLETED|Overall Study||0
7782967|NCT01296932|19160991|P1|COMPLETED|Overall Study||0
7782968|NCT01296932|19160983|P9|STARTED|Overall Study||4
7782969|NCT01296932|19160984|P8|STARTED|Overall Study||3
7782970|NCT01296932|19160985|P7|STARTED|Overall Study||6
7782971|NCT01296932|19160986|P6|STARTED|Overall Study||3
7782972|NCT01296932|19160987|P5|STARTED|Overall Study||3
7782973|NCT01296932|19160988|P4|STARTED|Overall Study||6
7782974|NCT01296932|19160989|P3|STARTED|Overall Study||6
7782975|NCT01296932|19160990|P2|STARTED|Overall Study||3
7782976|NCT01296932|19160991|P1|STARTED|Overall Study||3
7782977|NCT01296841|19161077|P2|NOT COMPLETED|Overall Study||0
7782978|NCT01296841|19161078|P1|NOT COMPLETED|Overall Study||0
7782979|NCT01296841|19161077|P2|COMPLETED|Overall Study||15
7782980|NCT01296841|19161078|P1|COMPLETED|Overall Study||19
7782981|NCT01296841|19161077|P2|STARTED|Overall Study||15
7782982|NCT01296841|19161078|P1|STARTED|Overall Study||19
7782983|NCT01296815|19161090|P2|NOT COMPLETED|Overall Study||0
7782984|NCT01296815|19161091|P1|NOT COMPLETED|Overall Study||0
7782985|NCT01296815|19161090|P2|COMPLETED|Overall Study||7
7782986|NCT01296815|19161091|P1|COMPLETED|Overall Study||7
7782987|NCT01296815|19161090|P2|STARTED|Overall Study||7
7782988|NCT01296815|19161091|P1|STARTED|Overall Study||7
7782989|NCT01296763|19161100|P3|NOT COMPLETED|Overall Study||0
7782990|NCT01296763|19161101|P2|NOT COMPLETED|Overall Study||0
7782991|NCT01296763|19161102|P1|NOT COMPLETED|Overall Study||0
7782992|NCT01296763|19161100|P3|COMPLETED|Overall Study||6
7782993|NCT01296763|19161101|P2|COMPLETED|Overall Study||5
7782994|NCT01296763|19161102|P1|COMPLETED|Overall Study||7
7782995|NCT01296763|19161100|P3|STARTED|Overall Study||6
7782996|NCT01296763|19161101|P2|STARTED|Overall Study||5
7782997|NCT01296763|19161102|P1|STARTED|Overall Study||7
7782998|NCT01296698|19161115|P2|NOT COMPLETED|Overall Study||13
7782999|NCT01296698|19161116|P1|NOT COMPLETED|Overall Study||244
7783000|NCT01296698|19161115|P2|COMPLETED|Overall Study||0
7783001|NCT01296698|19161116|P1|COMPLETED|Overall Study||0
7783002|NCT01296698|19161115|P2|STARTED|Overall Study||13
7783003|NCT01296698|19161116|P1|STARTED|Overall Study||244
7783004|NCT01296672|19161170|P2|NOT COMPLETED|Overall Study||18
7783005|NCT01296672|19161171|P1|NOT COMPLETED|Overall Study||73
7783006|NCT01296672|19161170|P2|COMPLETED|Overall Study||59
7783007|NCT01296672|19161171|P1|COMPLETED|Overall Study||233
7783008|NCT01296672|19161170|P2|STARTED|Overall Study||77
7783009|NCT01296672|19161171|P1|STARTED|Overall Study||306
7783010|NCT01296646|19161183|P2|NOT COMPLETED|Overall Study||11
7783011|NCT01296646|19161184|P1|NOT COMPLETED|Overall Study||11
7783012|NCT01296646|19161183|P2|COMPLETED|Overall Study||29
7783013|NCT01296646|19161184|P1|COMPLETED|Overall Study||29
7783014|NCT01296646|19161183|P2|STARTED|Overall Study||40
7783015|NCT01296646|19161184|P1|STARTED|Overall Study||40
7783016|NCT01296568|19161192|P1|NOT COMPLETED|Continued Access Phase||3
7783017|NCT01296568|19161192|P1|COMPLETED|Continued Access Phase|After study discontinuation participants assessed for disease progression (21-day safety follow-up).|0
7783018|NCT01296568|19161192|P1|STARTED|Continued Access Phase||3
7783019|NCT01296568|19161192|P1|NOT COMPLETED|[^14C]LY2603618 Single Dose and Washout||0
7783020|NCT01296568|19161192|P1|COMPLETED|[^14C]LY2603618 Single Dose and Washout||3
7783021|NCT01296568|19161192|P1|STARTED|[^14C]LY2603618 Single Dose and Washout||3
7783022|NCT01296542|19161208|P2|NOT COMPLETED|Overall Study||2
7783023|NCT01296542|19161209|P1|NOT COMPLETED|Overall Study||0
7783024|NCT01296542|19161208|P2|COMPLETED|Overall Study||28
7783025|NCT01296542|19161209|P1|COMPLETED|Overall Study||30
7783026|NCT01296542|19161208|P2|STARTED|Overall Study||30
7783027|NCT01296542|19161209|P1|STARTED|Overall Study||30
7783028|NCT01296412|19161217|P2|NOT COMPLETED|Overall Study||70
7783029|NCT01296412|19161218|P1|NOT COMPLETED|Overall Study||51
7783030|NCT01296412|19161217|P2|COMPLETED|Overall Study||257
7783031|NCT01296412|19161218|P1|COMPLETED|Overall Study||275
7783032|NCT01296412|19161217|P2|STARTED|Overall Study||327
7783033|NCT01296412|19161218|P1|STARTED|Overall Study||326
7783034|NCT01296360|19161232|P2|NOT COMPLETED|Overall Study||8
7783035|NCT01296360|19161233|P1|NOT COMPLETED|Overall Study||6
7783036|NCT01296360|19161232|P2|COMPLETED|Overall Study||142
7783037|NCT01296360|19161233|P1|COMPLETED|Overall Study||144
7783038|NCT01296360|19161232|P2|Visit 2a (Month 13)|Overall Study||0
7783039|NCT01296360|19161233|P1|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148
7783040|NCT01296360|19161232|P2|Visit 2 (Month 12)|Overall Study||149
7783041|NCT01296360|19161233|P1|Visit 2 (Month 12)|Overall Study|booster was administered|148
7783042|NCT01296360|19161232|P2|STARTED|Overall Study||150
7783043|NCT01296360|19161233|P1|STARTED|Overall Study||150
7783044|NCT01296347|19161241|P2|NOT COMPLETED|12 Month Follow up||3
7783045|NCT01296347|19161242|P1|NOT COMPLETED|12 Month Follow up||4
7783046|NCT01296347|19161241|P2|COMPLETED|12 Month Follow up||28
7783047|NCT01296347|19161242|P1|COMPLETED|12 Month Follow up||28
7783048|NCT01296347|19161241|P2|STARTED|12 Month Follow up||31
7783049|NCT01296347|19161242|P1|STARTED|12 Month Follow up||32
7783050|NCT01296347|19161241|P2|NOT COMPLETED|6 Month Follow up||2
7783051|NCT01296347|19161242|P1|NOT COMPLETED|6 Month Follow up||2
7783052|NCT01296347|19161241|P2|COMPLETED|6 Month Follow up||31
7783053|NCT01296347|19161242|P1|COMPLETED|6 Month Follow up||32
7783054|NCT01296347|19161241|P2|STARTED|6 Month Follow up||33
7783055|NCT01296347|19161242|P1|STARTED|6 Month Follow up||34
7783056|NCT01296347|19161241|P2|NOT COMPLETED|3 Month Follow up||1
7783057|NCT01296347|19161242|P1|NOT COMPLETED|3 Month Follow up||1
7783058|NCT01296347|19161241|P2|COMPLETED|3 Month Follow up||33
7783059|NCT01296347|19161242|P1|COMPLETED|3 Month Follow up||34
7783060|NCT01296347|19161241|P2|STARTED|3 Month Follow up||34
7783061|NCT01296347|19161242|P1|STARTED|3 Month Follow up||35
7783062|NCT01296347|19161241|P2|NOT COMPLETED|6 Week Follow up||1
7783063|NCT01296347|19161242|P1|NOT COMPLETED|6 Week Follow up||0
7783064|NCT01296347|19161241|P2|COMPLETED|6 Week Follow up||34
7783065|NCT01296347|19161242|P1|COMPLETED|6 Week Follow up||35
7783066|NCT01296347|19161241|P2|STARTED|6 Week Follow up||35
7783067|NCT01296347|19161242|P1|STARTED|6 Week Follow up||35
7783068|NCT01296347|19161241|P2|NOT COMPLETED|Allocation||4
7783069|NCT01296347|19161242|P1|NOT COMPLETED|Allocation||3
7783070|NCT01296347|19161241|P2|COMPLETED|Allocation||35
7783071|NCT01296347|19161242|P1|COMPLETED|Allocation||35
7783072|NCT01296347|19161241|P2|STARTED|Allocation||39
7783073|NCT01296347|19161242|P1|STARTED|Allocation||38
7783074|NCT01296191|19161260|P2|NOT COMPLETED|Overall Study||1
7783075|NCT01296191|19161261|P1|NOT COMPLETED|Overall Study||3
7783076|NCT01296191|19161260|P2|COMPLETED|Overall Study||59
7783077|NCT01296191|19161261|P1|COMPLETED|Overall Study||57
7783078|NCT01296191|19161260|P2|STARTED|Overall Study||60
7783079|NCT01296191|19161261|P1|STARTED|Overall Study||60
7783080|NCT01296152|19161267|P1|NOT COMPLETED|Overall Study||1
7783081|NCT01296152|19161267|P1|COMPLETED|Overall Study||24
7783082|NCT01296152|19161267|P1|STARTED|Overall Study||25
7783083|NCT01296035|19161294|P1|NOT COMPLETED|Overall Study||1
7783084|NCT01296035|19161294|P1|COMPLETED|Overall Study||7
7783085|NCT01296035|19161294|P1|STARTED|Overall Study||8
7783086|NCT01295905|19161301|P2|NOT COMPLETED|Overall Study||0
7783087|NCT01295905|19161302|P1|NOT COMPLETED|Overall Study||2
7783088|NCT01295905|19161301|P2|COMPLETED|Overall Study||30
7783089|NCT01295905|19161302|P1|COMPLETED|Overall Study||58
7783090|NCT01295905|19161301|P2|STARTED|Overall Study||30
7783091|NCT01295905|19161302|P1|STARTED|Overall Study||60
7783092|NCT01295879|19161314|P1|NOT COMPLETED|Overall Study||0
7783093|NCT01295879|19161314|P1|COMPLETED|Overall Study||29
7783094|NCT01295879|19161314|P1|STARTED|Overall Study||29
7783095|NCT01295840|19161320|P1|NOT COMPLETED|Overall Study||1
7783096|NCT01295840|19161320|P1|COMPLETED|Overall Study||50
7783097|NCT01295840|19161320|P1|STARTED|Overall Study||51
7783098|NCT01295827|19161346|P15|NOT COMPLETED|Overall Study||0
7783099|NCT01295827|19161347|P14|NOT COMPLETED|Overall Study||0
7783100|NCT01295827|19161348|P13|NOT COMPLETED|Overall Study||0
7783101|NCT01295827|19161349|P12|NOT COMPLETED|Overall Study||186
7783102|NCT01295827|19161350|P11|NOT COMPLETED|Overall Study||276
7783103|NCT01295827|19161351|P10|NOT COMPLETED|Overall Study||55
7783104|NCT01295827|19161352|P9|NOT COMPLETED|Overall Study||169
7783105|NCT01295827|19161353|P8|NOT COMPLETED|Overall Study||297
7783106|NCT01295827|19161354|P7|NOT COMPLETED|Overall Study||146
7783107|NCT01295827|19161355|P6|NOT COMPLETED|Overall Study||6
7783108|NCT01295827|19161356|P5|NOT COMPLETED|Overall Study||2
7783109|NCT01295827|19161357|P4|NOT COMPLETED|Overall Study||4
7783110|NCT01295827|19161358|P3|NOT COMPLETED|Overall Study||12
7783111|NCT01295827|19161359|P2|NOT COMPLETED|Overall Study||3
7783112|NCT01295827|19161360|P1|NOT COMPLETED|Overall Study||4
7783113|NCT01295827|19161346|P15|COMPLETED|Overall Study||0
7783114|NCT01295827|19161347|P14|COMPLETED|Overall Study||0
7783115|NCT01295827|19161348|P13|COMPLETED|Overall Study||0
7783116|NCT01295827|19161349|P12|COMPLETED|Overall Study||17
7783117|NCT01295827|19161350|P11|COMPLETED|Overall Study||20
7783118|NCT01295827|19161351|P10|COMPLETED|Overall Study||6
7783119|NCT01295827|19161352|P9|COMPLETED|Overall Study||14
7783120|NCT01295827|19161353|P8|COMPLETED|Overall Study||24
7783121|NCT01295827|19161354|P7|COMPLETED|Overall Study||18
7783122|NCT01295827|19161355|P6|COMPLETED|Overall Study||0
7783123|NCT01295827|19161356|P5|COMPLETED|Overall Study||1
7783124|NCT01295827|19161357|P4|COMPLETED|Overall Study||0
7783125|NCT01295827|19161358|P3|COMPLETED|Overall Study||0
7783126|NCT01295827|19161359|P2|COMPLETED|Overall Study||0
7783127|NCT01295827|19161360|P1|COMPLETED|Overall Study||0
7783128|NCT01295827|19161346|P15|Treated (All Treated Population)|Overall Study||0
7783129|NCT01295827|19161347|P14|Treated (All Treated Population)|Overall Study||0
7783130|NCT01295827|19161348|P13|Treated (All Treated Population)|Overall Study||0
7783131|NCT01295827|19161349|P12|Treated (All Treated Population)|Overall Study||202
7783132|NCT01295827|19161350|P11|Treated (All Treated Population)|Overall Study||287
7783133|NCT01295827|19161351|P10|Treated (All Treated Population)|Overall Study||61
7783134|NCT01295827|19161352|P9|Treated (All Treated Population)|Overall Study||180
7783135|NCT01295827|19161353|P8|Treated (All Treated Population)|Overall Study||313
7783136|NCT01295827|19161354|P7|Treated (All Treated Population)|Overall Study||162
7783137|NCT01295827|19161355|P6|Treated (All Treated Population)|Overall Study||6
7783138|NCT01295827|19161356|P5|Treated (All Treated Population)|Overall Study||3
7783139|NCT01295827|19161357|P4|Treated (All Treated Population)|Overall Study||4
7783140|NCT01295827|19161358|P3|Treated (All Treated Population)|Overall Study||10
7783141|NCT01295827|19161359|P2|Treated (All Treated Population)|Overall Study||3
7783142|NCT01295827|19161360|P1|Treated (All Treated Population)|Overall Study||4
7783143|NCT01295827|19161346|P15|STARTED|Overall Study||0
7783144|NCT01295827|19161347|P14|STARTED|Overall Study||0
7783145|NCT01295827|19161348|P13|STARTED|Overall Study||0
7783146|NCT01295827|19161349|P12|STARTED|Overall Study||203
7783147|NCT01295827|19161350|P11|STARTED|Overall Study||296
7783148|NCT01295827|19161351|P10|STARTED|Overall Study||61
7783149|NCT01295827|19161352|P9|STARTED|Overall Study||183
7783150|NCT01295827|19161353|P8|STARTED|Overall Study||321
7783151|NCT01295827|19161354|P7|STARTED|Overall Study||164
7783152|NCT01295827|19161355|P6|STARTED|Overall Study||6
7783153|NCT01295827|19161356|P5|STARTED|Overall Study||3
7783154|NCT01295827|19161357|P4|STARTED|Overall Study||4
7783155|NCT01295827|19161358|P3|STARTED|Overall Study||12
7783156|NCT01295827|19161359|P2|STARTED|Overall Study||3
7783157|NCT01295827|19161360|P1|STARTED|Overall Study||4
7783158|NCT01295814|19161733|P2|NOT COMPLETED|Overall Study||2
7783159|NCT01295814|19161734|P1|NOT COMPLETED|Overall Study||2
7783160|NCT01295814|19161733|P2|COMPLETED|Overall Study||19
7783161|NCT01295814|19161734|P1|COMPLETED|Overall Study||20
7783162|NCT01295814|19161733|P2|STARTED|Overall Study||21
7783163|NCT01295814|19161734|P1|STARTED|Overall Study||22
7783164|NCT01295710|19161750|P2|NOT COMPLETED|Overall Study||50
7783165|NCT01295710|19161751|P1|NOT COMPLETED|Overall Study||78
7783166|NCT01295710|19161750|P2|COMPLETED|Overall Study||78
7783167|NCT01295710|19161751|P1|COMPLETED|Overall Study||48
7783168|NCT01295710|19161750|P2|STARTED|Overall Study|Randomized and treated|128
7783169|NCT01295710|19161751|P1|STARTED|Overall Study|Randomized and treated|126
7783170|NCT01295671|19161814|P3|NOT COMPLETED|Overall Study||3
7783171|NCT01295671|19161815|P2|NOT COMPLETED|Overall Study||7
7783172|NCT01295671|19161816|P1|NOT COMPLETED|Overall Study||7
7783173|NCT01295671|19161814|P3|COMPLETED|Overall Study||66
7783174|NCT01295671|19161815|P2|COMPLETED|Overall Study||60
7783175|NCT01295671|19161816|P1|COMPLETED|Overall Study||60
7783176|NCT01295671|19161814|P3|STARTED|Overall Study||69
7783177|NCT01295671|19161815|P2|STARTED|Overall Study||67
7783178|NCT01295671|19161816|P1|STARTED|Overall Study||67
7783179|NCT01295515|19161854|P1|NOT COMPLETED|Overall Study||0
7783180|NCT01295515|19161854|P1|COMPLETED|Overall Study||7
7783181|NCT01295515|19161854|P1|STARTED|Overall Study||7
7783182|NCT01295320|19161862|P1|NOT COMPLETED|Overall Study||10
7783183|NCT01295320|19161862|P1|COMPLETED|Overall Study||119
7783184|NCT01295320|19161862|P1|STARTED|Overall Study||129
7783185|NCT01295281|19161879|P2|NOT COMPLETED|Second Intervention (7days)||0
7783186|NCT01295281|19161880|P1|NOT COMPLETED|Second Intervention (7days)||0
7783187|NCT01295281|19161879|P2|COMPLETED|Second Intervention (7days)||51
7783188|NCT01295281|19161880|P1|COMPLETED|Second Intervention (7days)||53
7783189|NCT01295281|19161879|P2|STARTED|Second Intervention (7days)||51
7783190|NCT01295281|19161880|P1|STARTED|Second Intervention (7days)||53
7783191|NCT01295281|19161879|P2|NOT COMPLETED|First Intervention (7 Days)||1
7783192|NCT01295281|19161880|P1|NOT COMPLETED|First Intervention (7 Days)||0
7783193|NCT01295281|19161879|P2|COMPLETED|First Intervention (7 Days)||51
7783194|NCT01295281|19161880|P1|COMPLETED|First Intervention (7 Days)||53
7783195|NCT01295281|19161879|P2|STARTED|First Intervention (7 Days)||52
7783196|NCT01295281|19161880|P1|STARTED|First Intervention (7 Days)||53
7783197|NCT01295216|19161888|P2|NOT COMPLETED|Overall Study||34
7783198|NCT01295216|19161889|P1|NOT COMPLETED|Overall Study||50
7783199|NCT01295216|19161888|P2|COMPLETED|Overall Study||287
7783200|NCT01295216|19161889|P1|COMPLETED|Overall Study||266
7783201|NCT01295216|19161888|P2|STARTED|Overall Study||321
7783202|NCT01295216|19161889|P1|STARTED|Overall Study||316
7783203|NCT01295112|19161907|P2|NOT COMPLETED|Overall Study||0
7783204|NCT01295112|19161908|P1|NOT COMPLETED|Overall Study||0
7783205|NCT01295112|19161907|P2|COMPLETED|Overall Study||33
7783206|NCT01295112|19161908|P1|COMPLETED|Overall Study||35
7783207|NCT01295112|19161907|P2|STARTED|Overall Study||33
7783208|NCT01295112|19161908|P1|STARTED|Overall Study||35
7783209|NCT01295034|19161918|P2|NOT COMPLETED|Overall Study||5
7783210|NCT01295034|19161919|P1|NOT COMPLETED|Overall Study||5
7783211|NCT01295034|19161918|P2|COMPLETED|Overall Study||25
7783212|NCT01295034|19161919|P1|COMPLETED|Overall Study||27
7783213|NCT01295034|19161918|P2|STARTED|Overall Study||30
7783214|NCT01295034|19161919|P1|STARTED|Overall Study||32
7783215|NCT01294917|19161927|P1|NOT COMPLETED|Overall Study||6
7783216|NCT01294917|19161927|P1|COMPLETED|Overall Study||36
7783217|NCT01294917|19161927|P1|Received OptiFree RepleniSH MPS|Overall Study||36
7783218|NCT01294917|19161927|P1|Received Clear Care|Overall Study||36
7783219|NCT01294917|19161927|P1|Received Investigational MPS|Overall Study||36
7783220|NCT01294917|19161927|P1|STARTED|Overall Study||42
7783221|NCT01294800|19161937|P4|NOT COMPLETED|Overall Study||16
7783222|NCT01294800|19161938|P3|NOT COMPLETED|Overall Study||17
7783223|NCT01294800|19161939|P2|NOT COMPLETED|Overall Study||10
7783224|NCT01294800|19161940|P1|NOT COMPLETED|Overall Study||11
7783225|NCT01294800|19161937|P4|COMPLETED|Overall Study||97
7783226|NCT01294800|19161938|P3|COMPLETED|Overall Study||96
7783227|NCT01294800|19161939|P2|COMPLETED|Overall Study||103
7783228|NCT01294800|19161940|P1|COMPLETED|Overall Study||100
7783229|NCT01294800|19161937|P4|STARTED|Overall Study||113
7783230|NCT01294800|19161938|P3|STARTED|Overall Study||113
7783231|NCT01294800|19161939|P2|STARTED|Overall Study||113
7783232|NCT01294800|19161940|P1|STARTED|Overall Study||111
7783233|NCT01294787|19161966|P6|NOT COMPLETED|Period 3||0
7783234|NCT01294787|19161967|P5|NOT COMPLETED|Period 3||1
7783235|NCT01294787|19161968|P4|NOT COMPLETED|Period 3||0
7783236|NCT01294787|19161969|P3|NOT COMPLETED|Period 3||0
7783237|NCT01294787|19161970|P2|NOT COMPLETED|Period 3||0
7783238|NCT01294787|19161971|P1|NOT COMPLETED|Period 3||0
7783239|NCT01294787|19161966|P6|COMPLETED|Period 3||13
7783240|NCT01294787|19161967|P5|COMPLETED|Period 3||13
7783241|NCT01294787|19161968|P4|COMPLETED|Period 3||9
7783242|NCT01294787|19161969|P3|COMPLETED|Period 3||13
7783243|NCT01294787|19161970|P2|COMPLETED|Period 3||13
7783244|NCT01294787|19161971|P1|COMPLETED|Period 3||12
7783245|NCT01294787|19161966|P6|STARTED|Period 3||13
7783246|NCT01294787|19161967|P5|STARTED|Period 3||14
7783247|NCT01294787|19161968|P4|STARTED|Period 3||9
7783248|NCT01294787|19161969|P3|STARTED|Period 3||13
7783249|NCT01294787|19161970|P2|STARTED|Period 3||13
7783250|NCT01294787|19161971|P1|STARTED|Period 3||12
7783251|NCT01294787|19161966|P6|NOT COMPLETED|Period 2||0
7783252|NCT01294787|19161967|P5|NOT COMPLETED|Period 2||0
7783253|NCT01294787|19161968|P4|NOT COMPLETED|Period 2||2
7783254|NCT01294787|19161969|P3|NOT COMPLETED|Period 2||0
7783255|NCT01294787|19161970|P2|NOT COMPLETED|Period 2||3
7783256|NCT01294787|19161971|P1|NOT COMPLETED|Period 2||0
7783257|NCT01294787|19161966|P6|COMPLETED|Period 2||13
7783258|NCT01294787|19161967|P5|COMPLETED|Period 2||14
7783259|NCT01294787|19161968|P4|COMPLETED|Period 2||9
7783260|NCT01294787|19161969|P3|COMPLETED|Period 2||13
7783261|NCT01294787|19161970|P2|COMPLETED|Period 2||13
7783262|NCT01294787|19161971|P1|COMPLETED|Period 2||12
7783263|NCT01294787|19161966|P6|STARTED|Period 2||13
7783264|NCT01294787|19161967|P5|STARTED|Period 2||14
7783265|NCT01294787|19161968|P4|STARTED|Period 2||11
7783266|NCT01294787|19161969|P3|STARTED|Period 2||13
7783267|NCT01294787|19161970|P2|STARTED|Period 2||16
7783268|NCT01294787|19161971|P1|STARTED|Period 2||12
7783269|NCT01294787|19161966|P6|NOT COMPLETED|Period 1||2
7783270|NCT01294787|19161967|P5|NOT COMPLETED|Period 1||2
7783271|NCT01294787|19161968|P4|NOT COMPLETED|Period 1||1
7783272|NCT01294787|19161969|P3|NOT COMPLETED|Period 1||1
7783273|NCT01294787|19161970|P2|NOT COMPLETED|Period 1||0
7783274|NCT01294787|19161971|P1|NOT COMPLETED|Period 1||0
7783275|NCT01294787|19161966|P6|COMPLETED|Period 1||13
7783276|NCT01294787|19161967|P5|COMPLETED|Period 1||14
7783277|NCT01294787|19161968|P4|COMPLETED|Period 1||11
7783278|NCT01294787|19161969|P3|COMPLETED|Period 1||13
7783279|NCT01294787|19161970|P2|COMPLETED|Period 1||16
7783280|NCT01294787|19161971|P1|COMPLETED|Period 1||12
7783281|NCT01294787|19161966|P6|STARTED|Period 1|One randomized participant did not receive study drug|15
7783282|NCT01294787|19161967|P5|STARTED|Period 1||16
7783283|NCT01294787|19161968|P4|STARTED|Period 1||12
7783284|NCT01294787|19161969|P3|STARTED|Period 1||14
7783285|NCT01294787|19161970|P2|STARTED|Period 1||16
7783286|NCT01294787|19161971|P1|STARTED|Period 1||12
7783287|NCT01294748|19162015|P2|NOT COMPLETED|Overall Study||2
7783288|NCT01294748|19162016|P1|NOT COMPLETED|Overall Study||5
7783289|NCT01294748|19162015|P2|COMPLETED|Overall Study|At 270 days|59
7783290|NCT01294748|19162016|P1|COMPLETED|Overall Study|At 270 days|118
7783291|NCT01294748|19162015|P2|STARTED|Overall Study||61
7783292|NCT01294748|19162016|P1|STARTED|Overall Study||123
7783293|NCT01294709|19162042|P2|NOT COMPLETED|Period 2||0
7783294|NCT01294709|19162043|P1|NOT COMPLETED|Period 2||1
7783295|NCT01294709|19162042|P2|COMPLETED|Period 2||31
7783296|NCT01294709|19162043|P1|COMPLETED|Period 2||28
7783297|NCT01294709|19162042|P2|STARTED|Period 2||31
7783298|NCT01294709|19162043|P1|STARTED|Period 2||29
7783299|NCT01294709|19162042|P2|NOT COMPLETED|Washout Period||1
7783300|NCT01294709|19162043|P1|NOT COMPLETED|Washout Period||1
7783301|NCT01294709|19162042|P2|COMPLETED|Washout Period||31
7783302|NCT01294709|19162043|P1|COMPLETED|Washout Period||29
7783303|NCT01294709|19162042|P2|STARTED|Washout Period||32
7783304|NCT01294709|19162043|P1|STARTED|Washout Period||30
7783305|NCT01294709|19162042|P2|NOT COMPLETED|Period 1||1
7783306|NCT01294709|19162043|P1|NOT COMPLETED|Period 1||1
7783307|NCT01294709|19162042|P2|COMPLETED|Period 1||32
7783308|NCT01294709|19162043|P1|COMPLETED|Period 1||30
7783309|NCT01294709|19162042|P2|STARTED|Period 1||33
7783310|NCT01294709|19162043|P1|STARTED|Period 1||31
7783311|NCT01294696|19162062|P1|NOT COMPLETED|Overall Study||74
7783312|NCT01294696|19162062|P1|COMPLETED|Overall Study||1187
7783313|NCT01294696|19162062|P1|STARTED|Overall Study||1261
7783314|NCT01294683|19162076|P2|NOT COMPLETED|Post Crossover (Period III)||32
7783315|NCT01294683|19162077|P1|NOT COMPLETED|Post Crossover (Period III)||33
7783316|NCT01294683|19162076|P2|COMPLETED|Post Crossover (Period III)||190
7783317|NCT01294683|19162077|P1|COMPLETED|Post Crossover (Period III)||199
7783318|NCT01294683|19162076|P2|STARTED|Post Crossover (Period III)||222
7783319|NCT01294683|19162077|P1|STARTED|Post Crossover (Period III)||232
7783320|NCT01294683|19162076|P2|NOT COMPLETED|Precrossover (Periods I/II)||266
7783321|NCT01294683|19162077|P1|NOT COMPLETED|Precrossover (Periods I/II)||257
7783322|NCT01294683|19162076|P2|COMPLETED|Precrossover (Periods I/II)||222
7783323|NCT01294683|19162077|P1|COMPLETED|Precrossover (Periods I/II)||232
7783324|NCT01294683|19162076|P2|Treated|Precrossover (Periods I/II)||486
7783325|NCT01294683|19162077|P1|Treated|Precrossover (Periods I/II)||486
7783326|NCT01294683|19162076|P2|STARTED|Precrossover (Periods I/II)||488
7783327|NCT01294683|19162077|P1|STARTED|Precrossover (Periods I/II)||489
7783328|NCT01294644|19162130|P3|NOT COMPLETED|Overall Study||14
7783329|NCT01294644|19162131|P2|NOT COMPLETED|Overall Study||10
7783330|NCT01294644|19162132|P1|NOT COMPLETED|Overall Study||10
7783331|NCT01294644|19162130|P3|COMPLETED|Overall Study||103
7783332|NCT01294644|19162131|P2|COMPLETED|Overall Study||112
7783333|NCT01294644|19162132|P1|COMPLETED|Overall Study||111
7783334|NCT01294644|19162130|P3|Received Treatment|Overall Study||114
7783335|NCT01294644|19162131|P2|Received Treatment|Overall Study||122
7783336|NCT01294644|19162132|P1|Received Treatment|Overall Study||118
7783337|NCT01294644|19162130|P3|STARTED|Overall Study||117
7783338|NCT01294644|19162131|P2|STARTED|Overall Study||122
7783339|NCT01294644|19162132|P1|STARTED|Overall Study||121
7783340|NCT01294592|19162163|P2|NOT COMPLETED|Overall Study||73
7783341|NCT01294592|19162164|P1|NOT COMPLETED|Overall Study||77
7783342|NCT01294592|19162163|P2|COMPLETED|Overall Study||300
7783343|NCT01294592|19162164|P1|COMPLETED|Overall Study||292
7783344|NCT01294592|19162163|P2|STARTED|Overall Study||373
7783345|NCT01294592|19162164|P1|STARTED|Overall Study||369
7783346|NCT01294579|19162192|P1|NOT COMPLETED|Overall Study||35
7783347|NCT01294579|19162192|P1|COMPLETED|Overall Study||14
7783348|NCT01294579|19162192|P1|STARTED|Overall Study||49
7783349|NCT01294553|19162202|P1|NOT COMPLETED|Overall Study||269
7783350|NCT01294553|19162202|P1|COMPLETED|Overall Study||713
7783351|NCT01294553|19162202|P1|STARTED|Overall Study||982
7783352|NCT01294514|19162208|P1|NOT COMPLETED|Overall Study||1
7783353|NCT01294514|19162208|P1|COMPLETED|Overall Study||26
7783354|NCT01294514|19162208|P1|STARTED|Overall Study||27
7783355|NCT01294462|19162218|P2|NOT COMPLETED|Overall Study||63
7783356|NCT01294462|19162219|P1|NOT COMPLETED|Overall Study||66
7783357|NCT01294462|19162218|P2|COMPLETED|Overall Study||337
7783358|NCT01294462|19162219|P1|COMPLETED|Overall Study||335
7783359|NCT01294462|19162218|P2|Received Randomized Treatment|Overall Study||380
7783360|NCT01294462|19162219|P1|Received Randomized Treatment|Overall Study||387
7783361|NCT01294462|19162218|P2|STARTED|Overall Study||400
7783362|NCT01294462|19162219|P1|STARTED|Overall Study||401
7783363|NCT01294449|19162233|P2|NOT COMPLETED|Overall Study||15
7783364|NCT01294449|19162234|P1|NOT COMPLETED|Overall Study||12
7783365|NCT01294449|19162233|P2|COMPLETED|Overall Study||237
7783366|NCT01294449|19162234|P1|COMPLETED|Overall Study||144
7783367|NCT01294449|19162233|P2|Consent to Registry|Overall Study||245
7783368|NCT01294449|19162234|P1|Consent to Registry|Overall Study||149
7783369|NCT01294449|19162233|P2|STARTED|Overall Study||252
7783370|NCT01294449|19162234|P1|STARTED|Overall Study||156
7783371|NCT01294436|19162242|P2|NOT COMPLETED|Overall Study||70
7783372|NCT01294436|19162243|P1|NOT COMPLETED|Overall Study||28
7783373|NCT01294436|19162242|P2|COMPLETED|Overall Study||409
7783374|NCT01294436|19162243|P1|COMPLETED|Overall Study||221
7783375|NCT01294436|19162242|P2|STARTED|Overall Study||479
7783376|NCT01294436|19162243|P1|STARTED|Overall Study||249
7783377|NCT01294423|19162278|P3|NOT COMPLETED|Overall Study||8
7783378|NCT01294423|19162279|P2|NOT COMPLETED|Overall Study||9
7783379|NCT01294423|19162280|P1|NOT COMPLETED|Overall Study||5
7783380|NCT01294423|19162278|P3|COMPLETED|Overall Study||79
7783381|NCT01294423|19162279|P2|COMPLETED|Overall Study||79
7783382|NCT01294423|19162280|P1|COMPLETED|Overall Study||81
7783383|NCT01294423|19162278|P3|STARTED|Overall Study||87
7783384|NCT01294423|19162279|P2|STARTED|Overall Study||88
7783385|NCT01294423|19162280|P1|STARTED|Overall Study||86
7783386|NCT01294397|19162294|P1|NOT COMPLETED|Overall Study||2
7783387|NCT01294397|19162294|P1|COMPLETED|Overall Study||17
7783388|NCT01294397|19162294|P1|STARTED|Overall Study||19
7783389|NCT01294384|19162307|P3|NOT COMPLETED|Overall Study||9
7783390|NCT01294384|19162308|P2|NOT COMPLETED|Overall Study||6
7783391|NCT01294384|19162309|P1|NOT COMPLETED|Overall Study||4
7783392|NCT01294384|19162307|P3|COMPLETED|Overall Study||95
7783393|NCT01294384|19162308|P2|COMPLETED|Overall Study||94
7783394|NCT01294384|19162309|P1|COMPLETED|Overall Study||97
7783395|NCT01294384|19162307|P3|STARTED|Overall Study||104
7783396|NCT01294384|19162308|P2|STARTED|Overall Study||100
7783397|NCT01294384|19162309|P1|STARTED|Overall Study||101
7783398|NCT01294371|19162338|P1|NOT COMPLETED|Overall Study||34
7783399|NCT01294371|19162338|P1|COMPLETED|Overall Study||357
7783400|NCT01294371|19162338|P1|Treated|Overall Study||390
7783401|NCT01294371|19162338|P1|STARTED|Overall Study||391
7783402|NCT01294358|19162346|P5|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||1
7783403|NCT01294358|19162347|P4|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
7783404|NCT01294358|19162348|P3|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
7783405|NCT01294358|19162349|P2|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
7783406|NCT01294358|19162350|P1|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
7783407|NCT01294358|19162346|P5|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
7783408|NCT01294358|19162347|P4|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
7783409|NCT01294358|19162348|P3|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
7783410|NCT01294358|19162349|P2|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
7783411|NCT01294358|19162350|P1|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
7783412|NCT01294358|19162346|P5|STARTED|Cohort 5: 3/8/12-3/9/12|1 participant from 96mg move to 115mg.|1
7783413|NCT01294358|19162347|P4|STARTED|Cohort 5: 3/8/12-3/9/12||0
7783414|NCT01294358|19162348|P3|STARTED|Cohort 5: 3/8/12-3/9/12||0
7783415|NCT01294358|19162349|P2|STARTED|Cohort 5: 3/8/12-3/9/12||0
7783416|NCT01294358|19162350|P1|STARTED|Cohort 5: 3/8/12-3/9/12||0
7783417|NCT01294358|19162346|P5|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
7783418|NCT01294358|19162347|P4|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||1
7783419|NCT01294358|19162348|P3|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
7783420|NCT01294358|19162349|P2|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
7783421|NCT01294358|19162350|P1|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
7783422|NCT01294358|19162346|P5|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
7783423|NCT01294358|19162347|P4|COMPLETED|Cohort 4: 12/30/11-2/17/17||1
7783424|NCT01294358|19162348|P3|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
7783425|NCT01294358|19162349|P2|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
7783426|NCT01294358|19162350|P1|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
7783427|NCT01294358|19162346|P5|STARTED|Cohort 4: 12/30/11-2/17/17||0
7783428|NCT01294358|19162347|P4|STARTED|Cohort 4: 12/30/11-2/17/17|2 participants from 72mg move to 96mg.|2
7783429|NCT01294358|19162348|P3|STARTED|Cohort 4: 12/30/11-2/17/17||0
7783430|NCT01294358|19162349|P2|STARTED|Cohort 4: 12/30/11-2/17/17||0
7783431|NCT01294358|19162350|P1|STARTED|Cohort 4: 12/30/11-2/17/17||0
7783432|NCT01294358|19162346|P5|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
7783433|NCT01294358|19162347|P4|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
7783434|NCT01294358|19162348|P3|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||2
7783435|NCT01294358|19162349|P2|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
7783436|NCT01294358|19162350|P1|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
7783437|NCT01294358|19162346|P5|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
7783438|NCT01294358|19162347|P4|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
7783439|NCT01294358|19162348|P3|COMPLETED|Cohort 3: 12/1/11-10/6/12||2
7783440|NCT01294358|19162349|P2|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
7783441|NCT01294358|19162350|P1|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
7783442|NCT01294358|19162346|P5|STARTED|Cohort 3: 12/1/11-10/6/12||0
7783443|NCT01294358|19162347|P4|STARTED|Cohort 3: 12/1/11-10/6/12||0
7783444|NCT01294358|19162348|P3|STARTED|Cohort 3: 12/1/11-10/6/12|4 participants from 36mg move to 72mg.|4
7783445|NCT01294358|19162349|P2|STARTED|Cohort 3: 12/1/11-10/6/12||0
7783446|NCT01294358|19162350|P1|STARTED|Cohort 3: 12/1/11-10/6/12||0
7783447|NCT01294358|19162346|P5|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
7783448|NCT01294358|19162347|P4|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
7783449|NCT01294358|19162348|P3|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
7783450|NCT01294358|19162349|P2|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||2
7783451|NCT01294358|19162350|P1|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
7783452|NCT01294358|19162346|P5|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
7783453|NCT01294358|19162347|P4|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
7783454|NCT01294358|19162348|P3|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
7783455|NCT01294358|19162349|P2|COMPLETED|Cohort 2: 6/9/11-9/17/12||4
7783456|NCT01294358|19162350|P1|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
7783457|NCT01294358|19162346|P5|STARTED|Cohort 2: 6/9/11-9/17/12||0
7783458|NCT01294358|19162347|P4|STARTED|Cohort 2: 6/9/11-9/17/12||0
7783459|NCT01294358|19162348|P3|STARTED|Cohort 2: 6/9/11-9/17/12||0
7783460|NCT01294358|19162349|P2|STARTED|Cohort 2: 6/9/11-9/17/12|4 participants from 18mg move to 36mg and 2 additional participants were enrolled at this dose.|6
7783461|NCT01294358|19162350|P1|STARTED|Cohort 2: 6/9/11-9/17/12||0
7783462|NCT01294358|19162346|P5|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
7783463|NCT01294358|19162347|P4|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
7783464|NCT01294358|19162348|P3|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
7783465|NCT01294358|19162349|P2|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
7783466|NCT01294358|19162350|P1|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
7783467|NCT01294358|19162346|P5|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
7783468|NCT01294358|19162347|P4|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
7783469|NCT01294358|19162348|P3|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
7783470|NCT01294358|19162349|P2|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
7783471|NCT01294358|19162350|P1|COMPLETED|Cohort 1: 5/11/11-11/9/11||4
7783472|NCT01294358|19162346|P5|STARTED|Cohort 1: 5/11/11-11/9/11||0
7783473|NCT01294358|19162347|P4|STARTED|Cohort 1: 5/11/11-11/9/11||0
7783474|NCT01294358|19162348|P3|STARTED|Cohort 1: 5/11/11-11/9/11||0
7783475|NCT01294358|19162349|P2|STARTED|Cohort 1: 5/11/11-11/9/11||0
7783476|NCT01294358|19162350|P1|STARTED|Cohort 1: 5/11/11-11/9/11||4
7783477|NCT01294319|19162412|P8|NOT COMPLETED|Overall Study||0
7783478|NCT01294319|19162413|P7|NOT COMPLETED|Overall Study||0
7783479|NCT01294319|19162414|P6|NOT COMPLETED|Overall Study||0
7783480|NCT01294319|19162415|P5|NOT COMPLETED|Overall Study||0
7783481|NCT01294319|19162416|P4|NOT COMPLETED|Overall Study||0
7783482|NCT01294319|19162417|P3|NOT COMPLETED|Overall Study||0
7783483|NCT01294319|19162418|P2|NOT COMPLETED|Overall Study||0
7783484|NCT01294319|19162419|P1|NOT COMPLETED|Overall Study||0
7783485|NCT01294319|19162412|P8|COMPLETED|Overall Study||5
7783486|NCT01294319|19162413|P7|COMPLETED|Overall Study||5
7783487|NCT01294319|19162414|P6|COMPLETED|Overall Study||4
7783488|NCT01294319|19162415|P5|COMPLETED|Overall Study||5
7783489|NCT01294319|19162416|P4|COMPLETED|Overall Study||5
7783490|NCT01294319|19162417|P3|COMPLETED|Overall Study||5
7783491|NCT01294319|19162418|P2|COMPLETED|Overall Study||6
7783492|NCT01294319|19162419|P1|COMPLETED|Overall Study||4
7783493|NCT01294319|19162412|P8|STARTED|Overall Study||5
7783494|NCT01294319|19162413|P7|STARTED|Overall Study||5
7783495|NCT01294319|19162414|P6|STARTED|Overall Study||4
7783496|NCT01294319|19162415|P5|STARTED|Overall Study||5
7783497|NCT01294319|19162416|P4|STARTED|Overall Study||5
7783498|NCT01294319|19162417|P3|STARTED|Overall Study||5
7783499|NCT01294319|19162418|P2|STARTED|Overall Study||6
7783500|NCT01294319|19162419|P1|STARTED|Overall Study||4
7783501|NCT01294306|19162429|P2|NOT COMPLETED|Overall Study||0
7783502|NCT01294306|19162430|P1|NOT COMPLETED|Overall Study||0
7783503|NCT01294306|19162429|P2|COMPLETED|Overall Study||35
7783504|NCT01294306|19162430|P1|COMPLETED|Overall Study||45
7783505|NCT01294306|19162429|P2|STARTED|Overall Study||35
7783506|NCT01294306|19162430|P1|STARTED|Overall Study||45
7783507|NCT01294267|19162444|P1|NOT COMPLETED|Overall Study||0
7783508|NCT01294267|19162444|P1|COMPLETED|Overall Study||20
7783509|NCT01294267|19162444|P1|STARTED|Overall Study||20
7783510|NCT01294241|19162450|P1|NOT COMPLETED|Overall Study||0
7783511|NCT01294241|19162450|P1|COMPLETED|Overall Study||10
7783512|NCT01294241|19162450|P1|STARTED|Overall Study||10
7783513|NCT01294228|19162458|P1|NOT COMPLETED|Overall Study||0
7783514|NCT01294228|19162458|P1|COMPLETED|Overall Study||1001
7783515|NCT01294228|19162458|P1|STARTED|Overall Study||1001
7783516|NCT01294163|19162465|P3|NOT COMPLETED|Overall Study||3
7783517|NCT01294163|19162466|P2|NOT COMPLETED|Overall Study||0
7783518|NCT01294163|19162467|P1|NOT COMPLETED|Overall Study||1
7783519|NCT01294163|19162465|P3|COMPLETED|Overall Study||163
7783520|NCT01294163|19162466|P2|COMPLETED|Overall Study||165
7783521|NCT01294163|19162467|P1|COMPLETED|Overall Study||177
7783522|NCT01294163|19162465|P3|STARTED|Overall Study||166
7783523|NCT01294163|19162466|P2|STARTED|Overall Study||165
7783524|NCT01294163|19162467|P1|STARTED|Overall Study||178
7783525|NCT01294150|19162478|P2|NOT COMPLETED|Overall Study||2
7783526|NCT01294150|19162479|P1|NOT COMPLETED|Overall Study||2
7783527|NCT01294150|19162478|P2|COMPLETED|Overall Study||64
7783528|NCT01294150|19162479|P1|COMPLETED|Overall Study||138
7783529|NCT01294150|19162478|P2|STARTED|Overall Study||66
7783530|NCT01294150|19162479|P1|STARTED|Overall Study||140
7783531|NCT01294098|19162492|P3|NOT COMPLETED|Overall Study||1
7783532|NCT01294098|19162493|P2|NOT COMPLETED|Overall Study||1
7783533|NCT01294098|19162494|P1|NOT COMPLETED|Overall Study||0
7783534|NCT01294098|19162492|P3|COMPLETED|Overall Study||0
7783535|NCT01294098|19162493|P2|COMPLETED|Overall Study||0
7783536|NCT01294098|19162494|P1|COMPLETED|Overall Study||0
7783537|NCT01294098|19162492|P3|STARTED|Overall Study||1
7783538|NCT01294098|19162493|P2|STARTED|Overall Study||1
7783539|NCT01294098|19162494|P1|STARTED|Overall Study||0
7783540|NCT01294046|19162508|P1|NOT COMPLETED|Overall Study||3
7783541|NCT01294046|19162508|P1|COMPLETED|Overall Study||0
7783542|NCT01294046|19162508|P1|STARTED|Overall Study||3
7783543|NCT01293968|19162523|P2|NOT COMPLETED|Overall Study||3
7783544|NCT01293968|19162524|P1|NOT COMPLETED|Overall Study||3
7783545|NCT01293968|19162523|P2|COMPLETED|Overall Study||14
7783546|NCT01293968|19162524|P1|COMPLETED|Overall Study||17
7783547|NCT01293968|19162523|P2|STARTED|Overall Study||17
7783548|NCT01293968|19162524|P1|STARTED|Overall Study||20
7783549|NCT01293825|19162530|P1|NOT COMPLETED|Overall Study||10
7783550|NCT01293825|19162530|P1|COMPLETED|Overall Study||20
7783551|NCT01293825|19162530|P1|STARTED|Overall Study||30
7783552|NCT01293695|19162544|P2|NOT COMPLETED|Overall Study||7
7783553|NCT01293695|19162545|P1|NOT COMPLETED|Overall Study||15
7783554|NCT01293695|19162544|P2|COMPLETED|Overall Study||87
7783555|NCT01293695|19162545|P1|COMPLETED|Overall Study||78
7783556|NCT01293695|19162544|P2|STARTED|Overall Study||94
7783557|NCT01293695|19162545|P1|STARTED|Overall Study||93
7783558|NCT01293682|19162559|P1|NOT COMPLETED|Overall Study||0
7783559|NCT01293682|19162559|P1|COMPLETED|Overall Study||12
7783560|NCT01293682|19162559|P1|STARTED|Overall Study||12
7783561|NCT01293539|19162564|P1|NOT COMPLETED|Overall Study||1
7783562|NCT01293539|19162564|P1|COMPLETED|Overall Study||9
7783563|NCT01293539|19162564|P1|STARTED|Overall Study||10
7783564|NCT01293240|19162568|P1|NOT COMPLETED|Overall Study||2
7783565|NCT01293240|19162568|P1|COMPLETED|Overall Study||115
7783566|NCT01293240|19162568|P1|STARTED|Overall Study||117
7783567|NCT01293123|19162585|P2|NOT COMPLETED|Overall Study||1
7783568|NCT01293123|19162586|P1|NOT COMPLETED|Overall Study||0
7783569|NCT01293123|19162585|P2|COMPLETED|Overall Study||0
7783570|NCT01293123|19162586|P1|COMPLETED|Overall Study||1
7783571|NCT01293123|19162585|P2|STARTED|Overall Study||1
7783572|NCT01293123|19162586|P1|STARTED|Overall Study||1
7783573|NCT01293084|19162600|P1|NOT COMPLETED|Overall Study||5
7783574|NCT01293084|19162600|P1|COMPLETED|Overall Study||12
7783575|NCT01293084|19162600|P1|STARTED|Overall Study||17
7783576|NCT01293032|19162612|P4|NOT COMPLETED|Treatment||1
7783577|NCT01293032|19162613|P3|NOT COMPLETED|Treatment||1
7783578|NCT01293032|19162614|P2|NOT COMPLETED|Treatment||5
7783579|NCT01293032|19162615|P1|NOT COMPLETED|Treatment||2
7783580|NCT01293032|19162612|P4|COMPLETED|Treatment||13
7783581|NCT01293032|19162613|P3|COMPLETED|Treatment||10
7783582|NCT01293032|19162614|P2|COMPLETED|Treatment||14
7783583|NCT01293032|19162615|P1|COMPLETED|Treatment||10
7783584|NCT01293032|19162612|P4|STARTED|Treatment||14
7783585|NCT01293032|19162613|P3|STARTED|Treatment||11
7783586|NCT01293032|19162614|P2|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19
7783587|NCT01293032|19162615|P1|STARTED|Treatment||12
7783588|NCT01293032|19162612|P4|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
7783589|NCT01293032|19162613|P3|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5
7783590|NCT01293032|19162614|P2|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
7783591|NCT01293032|19162615|P1|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
7783592|NCT01293032|19162612|P4|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14
7783593|NCT01293032|19162613|P3|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11
7783594|NCT01293032|19162614|P2|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17
7783595|NCT01293032|19162615|P1|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12
7783596|NCT01293032|19162612|P4|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14
7783597|NCT01293032|19162613|P3|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16
7783598|NCT01293032|19162614|P2|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17
7783599|NCT01293032|19162615|P1|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12
7783600|NCT01293032|19162612|P4|STARTED|Recurrence Score(RS)Assigned/Randomized||14
7783601|NCT01293032|19162613|P3|STARTED|Recurrence Score(RS)Assigned/Randomized||16
7783602|NCT01293032|19162614|P2|STARTED|Recurrence Score(RS)Assigned/Randomized||17
7783603|NCT01293032|19162615|P1|STARTED|Recurrence Score(RS)Assigned/Randomized||12
7783604|NCT01293006|19162626|P4|NOT COMPLETED|Period 2||0
7783605|NCT01293006|19162627|P3|NOT COMPLETED|Period 2||0
7783606|NCT01293006|19162628|P2|NOT COMPLETED|Period 2||0
7783607|NCT01293006|19162629|P1|NOT COMPLETED|Period 2||1
7783608|NCT01293006|19162626|P4|COMPLETED|Period 2||3
7783609|NCT01293006|19162627|P3|COMPLETED|Period 2||9
7783610|NCT01293006|19162628|P2|COMPLETED|Period 2||2
7783611|NCT01293006|19162629|P1|COMPLETED|Period 2||10
7783612|NCT01293006|19162626|P4|STARTED|Period 2||3
7783613|NCT01293006|19162627|P3|STARTED|Period 2||9
7783614|NCT01293006|19162628|P2|STARTED|Period 2||2
7783615|NCT01293006|19162629|P1|STARTED|Period 2||11
7783616|NCT01293006|19162626|P4|NOT COMPLETED|Washout||0
7783617|NCT01293006|19162627|P3|NOT COMPLETED|Washout||0
7783618|NCT01293006|19162628|P2|NOT COMPLETED|Washout||0
7783619|NCT01293006|19162629|P1|NOT COMPLETED|Washout||0
7783620|NCT01293006|19162626|P4|COMPLETED|Washout||3
7783621|NCT01293006|19162627|P3|COMPLETED|Washout||9
7783622|NCT01293006|19162628|P2|COMPLETED|Washout||2
7783623|NCT01293006|19162629|P1|COMPLETED|Washout||11
7783624|NCT01293006|19162626|P4|STARTED|Washout||3
7783625|NCT01293006|19162627|P3|STARTED|Washout||9
7783626|NCT01293006|19162628|P2|STARTED|Washout||2
7783627|NCT01293006|19162629|P1|STARTED|Washout||11
7783628|NCT01293006|19162626|P4|NOT COMPLETED|Period 1||0
7783629|NCT01293006|19162627|P3|NOT COMPLETED|Period 1||0
7783630|NCT01293006|19162628|P2|NOT COMPLETED|Period 1||0
7783631|NCT01293006|19162629|P1|NOT COMPLETED|Period 1||0
7783632|NCT01293006|19162626|P4|COMPLETED|Period 1||3
7783633|NCT01293006|19162627|P3|COMPLETED|Period 1||9
7783634|NCT01293006|19162628|P2|COMPLETED|Period 1||2
7783635|NCT01293006|19162629|P1|COMPLETED|Period 1||11
7783636|NCT01293006|19162626|P4|STARTED|Period 1||3
7783637|NCT01293006|19162627|P3|STARTED|Period 1||9
7783638|NCT01293006|19162628|P2|STARTED|Period 1||2
7783639|NCT01293006|19162629|P1|STARTED|Period 1||11
7783640|NCT01292928|19162650|P1|NOT COMPLETED|Overall Study||24
7783641|NCT01292928|19162650|P1|COMPLETED|Overall Study||275
7783642|NCT01292928|19162650|P1|Completed 12-Month Clinical Follow-up|Overall Study||266
7783643|NCT01292928|19162650|P1|STARTED|Overall Study||299
7783644|NCT01292876|19162667|P1|NOT COMPLETED|Overall Study||4
7783645|NCT01292876|19162667|P1|COMPLETED|Overall Study||13
7783646|NCT01292876|19162667|P1|STARTED|Overall Study||17
7783647|NCT01292837|19162673|P1|NOT COMPLETED|Overall Study||2
7783648|NCT01292837|19162673|P1|COMPLETED|Overall Study||11
7783649|NCT01292837|19162673|P1|STARTED|Overall Study||13
7783650|NCT01292798|19162682|P1|NOT COMPLETED|Overall Study||0
7783651|NCT01292798|19162682|P1|COMPLETED|Overall Study||43
7783652|NCT01292798|19162682|P1|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29
7783653|NCT01292798|19162682|P1|STARTED|Overall Study||43
7783654|NCT01292746|19162688|P1|NOT COMPLETED|Overall Study||0
7783655|NCT01292746|19162688|P1|COMPLETED|Overall Study||14
7783656|NCT01292746|19162688|P1|STARTED|Overall Study||14
7783657|NCT01292642|19162692|P1|NOT COMPLETED|Overall Study||5
7783658|NCT01292642|19162692|P1|COMPLETED|Overall Study||7
7783659|NCT01292642|19162692|P1|STARTED|Overall Study||12
7783660|NCT01292629|19162700|P1|NOT COMPLETED|Overall Study||0
7783661|NCT01292629|19162700|P1|COMPLETED|Overall Study||125
7783662|NCT01292629|19162700|P1|STARTED|Overall Study||125
7783663|NCT01292603|19162710|P6|NOT COMPLETED|Overall Survival Status||10
7783664|NCT01292603|19162711|P5|NOT COMPLETED|Overall Survival Status||16
7783665|NCT01292603|19162712|P4|NOT COMPLETED|Overall Survival Status||1
7783666|NCT01292603|19162713|P3|NOT COMPLETED|Overall Survival Status||3
7783667|NCT01292603|19162714|P2|NOT COMPLETED|Overall Survival Status||1
7783668|NCT01292603|19162715|P1|NOT COMPLETED|Overall Survival Status||3
7783669|NCT01292603|19162710|P6|COMPLETED|Overall Survival Status||78
7783670|NCT01292603|19162711|P5|COMPLETED|Overall Survival Status||72
7783671|NCT01292603|19162712|P4|COMPLETED|Overall Survival Status||7
7783672|NCT01292603|19162713|P3|COMPLETED|Overall Survival Status||20
7783673|NCT01292603|19162714|P2|COMPLETED|Overall Survival Status||16
7783674|NCT01292603|19162715|P1|COMPLETED|Overall Survival Status||13
7783675|NCT01292603|19162710|P6|STARTED|Overall Survival Status||88
7783676|NCT01292603|19162711|P5|STARTED|Overall Survival Status||88
7783677|NCT01292603|19162712|P4|STARTED|Overall Survival Status||8
7783678|NCT01292603|19162713|P3|STARTED|Overall Survival Status||23
7783679|NCT01292603|19162714|P2|STARTED|Overall Survival Status||17
7783680|NCT01292603|19162715|P1|STARTED|Overall Survival Status||16
7783681|NCT01292603|19162710|P6|NOT COMPLETED|Part 2: Regular Follow-Up||12
7783682|NCT01292603|19162711|P5|NOT COMPLETED|Part 2: Regular Follow-Up||19
7783683|NCT01292603|19162712|P4|NOT COMPLETED|Part 2: Regular Follow-Up||0
7783684|NCT01292603|19162713|P3|NOT COMPLETED|Part 2: Regular Follow-Up||0
7783685|NCT01292603|19162714|P2|NOT COMPLETED|Part 2: Regular Follow-Up||0
7783686|NCT01292603|19162715|P1|NOT COMPLETED|Part 2: Regular Follow-Up||0
7783687|NCT01292603|19162710|P6|COMPLETED|Part 2: Regular Follow-Up||75
7783688|NCT01292603|19162711|P5|COMPLETED|Part 2: Regular Follow-Up||68
7783689|NCT01292603|19162712|P4|COMPLETED|Part 2: Regular Follow-Up||0
7783690|NCT01292603|19162713|P3|COMPLETED|Part 2: Regular Follow-Up||0
7783691|NCT01292603|19162714|P2|COMPLETED|Part 2: Regular Follow-Up||0
7783692|NCT01292603|19162715|P1|COMPLETED|Part 2: Regular Follow-Up||0
7783693|NCT01292603|19162710|P6|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
7783694|NCT01292603|19162711|P5|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
7783695|NCT01292603|19162712|P4|STARTED|Part 2: Regular Follow-Up||0
7783696|NCT01292603|19162713|P3|STARTED|Part 2: Regular Follow-Up||0
7783697|NCT01292603|19162714|P2|STARTED|Part 2: Regular Follow-Up||0
7783698|NCT01292603|19162715|P1|STARTED|Part 2: Regular Follow-Up||0
7783699|NCT01292603|19162710|P6|NOT COMPLETED|Part 2: Dose Confirmation Period||15
7783700|NCT01292603|19162711|P5|NOT COMPLETED|Part 2: Dose Confirmation Period||16
7783701|NCT01292603|19162712|P4|NOT COMPLETED|Part 2: Dose Confirmation Period||0
7783702|NCT01292603|19162713|P3|NOT COMPLETED|Part 2: Dose Confirmation Period||0
7783703|NCT01292603|19162714|P2|NOT COMPLETED|Part 2: Dose Confirmation Period||0
7783704|NCT01292603|19162715|P1|NOT COMPLETED|Part 2: Dose Confirmation Period||0
7783705|NCT01292603|19162710|P6|COMPLETED|Part 2: Dose Confirmation Period||73
7783706|NCT01292603|19162711|P5|COMPLETED|Part 2: Dose Confirmation Period||72
7783707|NCT01292603|19162712|P4|COMPLETED|Part 2: Dose Confirmation Period||0
7783708|NCT01292603|19162713|P3|COMPLETED|Part 2: Dose Confirmation Period||0
7783709|NCT01292603|19162714|P2|COMPLETED|Part 2: Dose Confirmation Period||0
7783710|NCT01292603|19162715|P1|COMPLETED|Part 2: Dose Confirmation Period||0
7783711|NCT01292603|19162710|P6|STARTED|Part 2: Dose Confirmation Period||88
7783712|NCT01292603|19162711|P5|STARTED|Part 2: Dose Confirmation Period||88
7783713|NCT01292603|19162712|P4|STARTED|Part 2: Dose Confirmation Period||0
7783714|NCT01292603|19162713|P3|STARTED|Part 2: Dose Confirmation Period||0
7783715|NCT01292603|19162714|P2|STARTED|Part 2: Dose Confirmation Period||0
7783716|NCT01292603|19162715|P1|STARTED|Part 2: Dose Confirmation Period||0
7783717|NCT01292603|19162710|P6|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
7783718|NCT01292603|19162711|P5|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
7783719|NCT01292603|19162712|P4|NOT COMPLETED|Part 1: Regular Follow-Up Period||1
7783720|NCT01292603|19162713|P3|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
7783721|NCT01292603|19162714|P2|NOT COMPLETED|Part 1: Regular Follow-Up Period||7
7783722|NCT01292603|19162715|P1|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
7783723|NCT01292603|19162710|P6|COMPLETED|Part 1: Regular Follow-Up Period||0
7783724|NCT01292603|19162711|P5|COMPLETED|Part 1: Regular Follow-Up Period||0
7783725|NCT01292603|19162712|P4|COMPLETED|Part 1: Regular Follow-Up Period||7
7783726|NCT01292603|19162713|P3|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|17
7783727|NCT01292603|19162714|P2|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
7783728|NCT01292603|19162715|P1|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
7783729|NCT01292603|19162710|P6|STARTED|Part 1: Regular Follow-Up Period||0
7783730|NCT01292603|19162711|P5|STARTED|Part 1: Regular Follow-Up Period||0
7783731|NCT01292603|19162712|P4|STARTED|Part 1: Regular Follow-Up Period||8
7783732|NCT01292603|19162713|P3|STARTED|Part 1: Regular Follow-Up Period||23
7783733|NCT01292603|19162714|P2|STARTED|Part 1: Regular Follow-Up Period||17
7783734|NCT01292603|19162715|P1|STARTED|Part 1: Regular Follow-Up Period||16
7783735|NCT01292603|19162710|P6|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
7783736|NCT01292603|19162711|P5|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
7783737|NCT01292603|19162712|P4|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8
7783738|NCT01292603|19162713|P3|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
7783739|NCT01292603|19162714|P2|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
7783740|NCT01292603|19162715|P1|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
7783741|NCT01292603|19162710|P6|COMPLETED|Part 1: Pilot Dose Selection Period||0
7783742|NCT01292603|19162711|P5|COMPLETED|Part 1: Pilot Dose Selection Period||0
7783743|NCT01292603|19162712|P4|COMPLETED|Part 1: Pilot Dose Selection Period||0
7783744|NCT01292603|19162713|P3|COMPLETED|Part 1: Pilot Dose Selection Period||23
7783745|NCT01292603|19162714|P2|COMPLETED|Part 1: Pilot Dose Selection Period||17
7783746|NCT01292603|19162715|P1|COMPLETED|Part 1: Pilot Dose Selection Period||16
7783747|NCT01292603|19162710|P6|STARTED|Part 1: Pilot Dose Selection Period||0
7783748|NCT01292603|19162711|P5|STARTED|Part 1: Pilot Dose Selection Period||0
7783749|NCT01292603|19162712|P4|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8
7783750|NCT01292603|19162713|P3|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23
7783751|NCT01292603|19162714|P2|STARTED|Part 1: Pilot Dose Selection Period||17
7783752|NCT01292603|19162715|P1|STARTED|Part 1: Pilot Dose Selection Period||16
7783753|NCT01292538|19162761|P2|NOT COMPLETED|Overall Study||0
7783754|NCT01292538|19162762|P1|NOT COMPLETED|Overall Study||0
7783755|NCT01292538|19162761|P2|COMPLETED|Overall Study||32
7783756|NCT01292538|19162762|P1|COMPLETED|Overall Study||35
7783757|NCT01292538|19162761|P2|STARTED|Overall Study||32
7783758|NCT01292538|19162762|P1|STARTED|Overall Study||35
7783759|NCT01292486|19162768|P1|NOT COMPLETED|Overall Study||6
7783760|NCT01292486|19162768|P1|COMPLETED|Overall Study||26
7783761|NCT01292486|19162768|P1|STARTED|Overall Study||32
7783762|NCT01292473|19162782|P4|NOT COMPLETED|Overall Study||12
7783763|NCT01292473|19162783|P3|NOT COMPLETED|Overall Study||9
7783764|NCT01292473|19162784|P2|NOT COMPLETED|Overall Study||7
7783765|NCT01292473|19162785|P1|NOT COMPLETED|Overall Study||5
7783766|NCT01292473|19162782|P4|COMPLETED|Overall Study||67
7783767|NCT01292473|19162783|P3|COMPLETED|Overall Study||74
7783768|NCT01292473|19162784|P2|COMPLETED|Overall Study||75
7783769|NCT01292473|19162785|P1|COMPLETED|Overall Study||74
7783770|NCT01292473|19162782|P4|STARTED|Overall Study||79
7783771|NCT01292473|19162783|P3|STARTED|Overall Study||83
7783772|NCT01292473|19162784|P2|STARTED|Overall Study||82
7783773|NCT01292473|19162785|P1|STARTED|Overall Study||79
7783774|NCT01292447|19162829|P2|NOT COMPLETED|Overall Study||3
7783775|NCT01292447|19162830|P1|NOT COMPLETED|Overall Study||2
7783776|NCT01292447|19162829|P2|COMPLETED|Overall Study||72
7783777|NCT01292447|19162830|P1|COMPLETED|Overall Study||73
7783778|NCT01292447|19162829|P2|STARTED|Overall Study||75
7783779|NCT01292447|19162830|P1|STARTED|Overall Study||75
7783780|NCT01292304|19162836|P1|NOT COMPLETED|Overall Study||0
7783781|NCT01292304|19162836|P1|COMPLETED|Overall Study||10
7783782|NCT01292304|19162836|P1|STARTED|Overall Study||10
7783783|NCT01292265|19162844|P1|NOT COMPLETED|Overall Study||0
7783784|NCT01292265|19162844|P1|COMPLETED|Overall Study||3
7783785|NCT01292265|19162844|P1|STARTED|Overall Study||3
7783786|NCT01292239|19162853|P2|NOT COMPLETED|Overall Study||7
7783787|NCT01292239|19162854|P1|NOT COMPLETED|Overall Study||4
7783788|NCT01292239|19162853|P2|COMPLETED|Overall Study||53
7783789|NCT01292239|19162854|P1|COMPLETED|Overall Study||119
7783790|NCT01292239|19162853|P2|STARTED|Overall Study||60
7783791|NCT01292239|19162854|P1|STARTED|Overall Study||123
7783792|NCT01292226|19162875|P1|NOT COMPLETED|Overall Study||13
7783793|NCT01292226|19162875|P1|COMPLETED|Overall Study||32
7783794|NCT01292226|19162875|P1|STARTED|Overall Study||45
7783795|NCT01292187|19162908|P2|NOT COMPLETED|Overall Study||13
7783796|NCT01292187|19162909|P1|NOT COMPLETED|Overall Study||17
7783797|NCT01292187|19162908|P2|COMPLETED|Overall Study||30
7783798|NCT01292187|19162909|P1|COMPLETED|Overall Study||69
7783799|NCT01292187|19162908|P2|STARTED|Overall Study||43
7783800|NCT01292187|19162909|P1|STARTED|Overall Study||86
7783801|NCT01292135|19162919|P2|NOT COMPLETED|Overall Study||9
7783802|NCT01292135|19162920|P1|NOT COMPLETED|Overall Study||0
7783803|NCT01292135|19162919|P2|COMPLETED|Overall Study||21
7783804|NCT01292135|19162920|P1|COMPLETED|Overall Study||3
7783805|NCT01292135|19162919|P2|STARTED|Overall Study||30
7783806|NCT01292135|19162920|P1|STARTED|Overall Study||3
7783807|NCT01292070|19162938|P1|NOT COMPLETED|Overall Study||0
7783808|NCT01292070|19162938|P1|COMPLETED|Overall Study||4
7783809|NCT01292070|19162938|P1|STARTED|Overall Study||4
7783810|NCT01292057|19162944|P2|NOT COMPLETED|Overall Study||2
7783811|NCT01292057|19162945|P1|NOT COMPLETED|Overall Study||2
7783812|NCT01292057|19162944|P2|COMPLETED|Overall Study||48
7783813|NCT01292057|19162945|P1|COMPLETED|Overall Study||47
7783814|NCT01292057|19162944|P2|STARTED|Overall Study||50
7783815|NCT01292057|19162945|P1|STARTED|Overall Study||49
7783816|NCT01292005|19162955|P2|NOT COMPLETED|Overall Study||0
7783817|NCT01292005|19162956|P1|NOT COMPLETED|Overall Study||0
7783818|NCT01292005|19162955|P2|COMPLETED|Overall Study||14
7783819|NCT01292005|19162956|P1|COMPLETED|Overall Study||14
7783820|NCT01292005|19162955|P2|STARTED|Overall Study||14
7783821|NCT01292005|19162956|P1|STARTED|Overall Study||14
7783822|NCT01291836|19162980|P2|NOT COMPLETED|Overall Study||0
7783823|NCT01291836|19162981|P1|NOT COMPLETED|Overall Study||0
7783824|NCT01291836|19162980|P2|COMPLETED|Overall Study||71
7783825|NCT01291836|19162981|P1|COMPLETED|Overall Study||930
7783826|NCT01291836|19162980|P2|STARTED|Overall Study||71
7783827|NCT01291836|19162981|P1|STARTED|Overall Study||930
7783828|NCT01291784|19162987|P3|NOT COMPLETED|Overall Study||0
7783829|NCT01291784|19162988|P2|NOT COMPLETED|Overall Study||1
7783830|NCT01291784|19162989|P1|NOT COMPLETED|Overall Study||0
7783831|NCT01291784|19162987|P3|COMPLETED|Overall Study||1
7783832|NCT01291784|19162988|P2|COMPLETED|Overall Study||0
7783833|NCT01291784|19162989|P1|COMPLETED|Overall Study||1
7783834|NCT01291784|19162987|P3|STARTED|Overall Study||1
7783835|NCT01291784|19162988|P2|STARTED|Overall Study||1
7783836|NCT01291784|19162989|P1|STARTED|Overall Study||1
7783837|NCT01291498|19163009|P1|NOT COMPLETED|Overall Study||1
7783838|NCT01291498|19163009|P1|COMPLETED|Overall Study||0
7783839|NCT01291498|19163009|P1|STARTED|Overall Study||1
7783840|NCT01291277|19163017|P2|NOT COMPLETED|Overall Study||3
7783841|NCT01291277|19163018|P1|NOT COMPLETED|Overall Study||5
7783842|NCT01291277|19163017|P2|COMPLETED|Overall Study||42
7783843|NCT01291277|19163018|P1|COMPLETED|Overall Study||40
7783844|NCT01291277|19163017|P2|STARTED|Overall Study||45
7783845|NCT01291277|19163018|P1|STARTED|Overall Study||45
7783846|NCT01291264|19163024|P1|NOT COMPLETED|Overall Study||0
7783847|NCT01291264|19163024|P1|COMPLETED|Overall Study||260
7783848|NCT01291264|19163024|P1|STARTED|Overall Study||260
7783849|NCT01291225|19163030|P2|NOT COMPLETED|Overall Study||39
7783850|NCT01291225|19163031|P1|NOT COMPLETED|Overall Study||85
7783851|NCT01291225|19163030|P2|COMPLETED|Overall Study||121
7783852|NCT01291225|19163031|P1|COMPLETED|Overall Study||66
7783853|NCT01291225|19163030|P2|STARTED|Overall Study||160
7783854|NCT01291225|19163031|P1|STARTED|Overall Study||151
7783855|NCT01291173|19163045|P4|NOT COMPLETED|Overall Study||13
7783856|NCT01291173|19163046|P3|NOT COMPLETED|Overall Study||13
7783857|NCT01291173|19163047|P2|NOT COMPLETED|Overall Study||15
7783858|NCT01291173|19163048|P1|NOT COMPLETED|Overall Study||17
7783859|NCT01291173|19163045|P4|COMPLETED|Overall Study||52
7783860|NCT01291173|19163046|P3|COMPLETED|Overall Study||52
7783861|NCT01291173|19163047|P2|COMPLETED|Overall Study||51
7783862|NCT01291173|19163048|P1|COMPLETED|Overall Study||47
7783863|NCT01291173|19163045|P4|STARTED|Overall Study||65
7783864|NCT01291173|19163046|P3|STARTED|Overall Study||65
7783865|NCT01291173|19163047|P2|STARTED|Overall Study||66
7783866|NCT01291173|19163048|P1|STARTED|Overall Study||64
7783867|NCT01291160|19163112|P2|NOT COMPLETED|Overall Study||16
7783868|NCT01291160|19163113|P1|NOT COMPLETED|Overall Study||18
7783869|NCT01291160|19163112|P2|COMPLETED|Overall Study||48
7783870|NCT01291160|19163113|P1|COMPLETED|Overall Study||48
7783871|NCT01291160|19163112|P2|STARTED|Overall Study||64
7783872|NCT01291160|19163113|P1|STARTED|Overall Study||66
7783873|NCT01291108|19163123|P6|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1
7783874|NCT01291108|19163124|P5|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
7783875|NCT01291108|19163125|P4|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
7783876|NCT01291108|19163126|P3|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
7783877|NCT01291108|19163127|P2|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2
7783878|NCT01291108|19163128|P1|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
7783879|NCT01291108|19163123|P6|COMPLETED|Month 2 (Adjunctive Therapy)||25
7783880|NCT01291108|19163124|P5|COMPLETED|Month 2 (Adjunctive Therapy)||34
7783881|NCT01291108|19163125|P4|COMPLETED|Month 2 (Adjunctive Therapy)||0
7783882|NCT01291108|19163126|P3|COMPLETED|Month 2 (Adjunctive Therapy)||24
7783883|NCT01291108|19163127|P2|COMPLETED|Month 2 (Adjunctive Therapy)||38
7783884|NCT01291108|19163128|P1|COMPLETED|Month 2 (Adjunctive Therapy)||0
7783885|NCT01291108|19163123|P6|STARTED|Month 2 (Adjunctive Therapy)||26
7783886|NCT01291108|19163124|P5|STARTED|Month 2 (Adjunctive Therapy)||34
7783887|NCT01291108|19163125|P4|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
7783888|NCT01291108|19163126|P3|STARTED|Month 2 (Adjunctive Therapy)||24
7783889|NCT01291108|19163127|P2|STARTED|Month 2 (Adjunctive Therapy)||40
7783890|NCT01291108|19163128|P1|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
7783891|NCT01291108|19163123|P6|NOT COMPLETED|Month 1 (Monotherapy)||0
7783892|NCT01291108|19163124|P5|NOT COMPLETED|Month 1 (Monotherapy)||0
7783893|NCT01291108|19163125|P4|NOT COMPLETED|Month 1 (Monotherapy)||0
7783894|NCT01291108|19163126|P3|NOT COMPLETED|Month 1 (Monotherapy)||0
7783895|NCT01291108|19163127|P2|NOT COMPLETED|Month 1 (Monotherapy)||0
7783896|NCT01291108|19163128|P1|NOT COMPLETED|Month 1 (Monotherapy)||1
7783897|NCT01291108|19163123|P6|COMPLETED|Month 1 (Monotherapy)||0
7783898|NCT01291108|19163124|P5|COMPLETED|Month 1 (Monotherapy)||0
7783899|NCT01291108|19163125|P4|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60
7783900|NCT01291108|19163126|P3|COMPLETED|Month 1 (Monotherapy)||0
7783901|NCT01291108|19163127|P2|COMPLETED|Month 1 (Monotherapy)||0
7783902|NCT01291108|19163128|P1|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64
7783903|NCT01291108|19163123|P6|STARTED|Month 1 (Monotherapy)||0
7783904|NCT01291108|19163124|P5|STARTED|Month 1 (Monotherapy)||0
7783905|NCT01291108|19163125|P4|STARTED|Month 1 (Monotherapy)||60
7783906|NCT01291108|19163126|P3|STARTED|Month 1 (Monotherapy)||0
7783907|NCT01291108|19163127|P2|STARTED|Month 1 (Monotherapy)||0
7783908|NCT01291108|19163128|P1|STARTED|Month 1 (Monotherapy)||65
7783909|NCT01291056|19163144|P2|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
7783910|NCT01291056|19163145|P1|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
7783911|NCT01291056|19163144|P2|COMPLETED|Intervention Two (Menstration Days 3-7)||10
7783912|NCT01291056|19163145|P1|COMPLETED|Intervention Two (Menstration Days 3-7)||10
7783913|NCT01291056|19163144|P2|STARTED|Intervention Two (Menstration Days 3-7)||10
7783914|NCT01291056|19163145|P1|STARTED|Intervention Two (Menstration Days 3-7)||10
7783915|NCT01291056|19163144|P2|NOT COMPLETED|Washout||0
7783916|NCT01291056|19163145|P1|NOT COMPLETED|Washout||0
7783917|NCT01291056|19163144|P2|COMPLETED|Washout||10
7783918|NCT01291056|19163145|P1|COMPLETED|Washout||10
7783919|NCT01291056|19163144|P2|STARTED|Washout||10
7783920|NCT01291056|19163145|P1|STARTED|Washout||10
7783921|NCT01291056|19163144|P2|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
7783922|NCT01291056|19163145|P1|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
7783923|NCT01291056|19163144|P2|COMPLETED|Intervention One (Menstraution Day 3-7)||10
7783924|NCT01291056|19163145|P1|COMPLETED|Intervention One (Menstraution Day 3-7)||10
7783925|NCT01291056|19163144|P2|STARTED|Intervention One (Menstraution Day 3-7)||10
7783926|NCT01291056|19163145|P1|STARTED|Intervention One (Menstraution Day 3-7)||10
7783927|NCT01291017|19163157|P1|NOT COMPLETED|Overall Study||5
7783928|NCT01291017|19163157|P1|COMPLETED|Overall Study||14
7783929|NCT01291017|19163157|P1|STARTED|Overall Study||19
7783930|NCT01290978|19163165|P1|NOT COMPLETED|Overall Study||0
7783931|NCT01290978|19163165|P1|COMPLETED|Overall Study||22
7783932|NCT01290978|19163165|P1|STARTED|Overall Study||22
7783933|NCT01290952|19163174|P2|NOT COMPLETED|Overall Study||14
7783934|NCT01290952|19163175|P1|NOT COMPLETED|Overall Study||12
7783935|NCT01290952|19163174|P2|COMPLETED|Overall Study||193
7783936|NCT01290952|19163175|P1|COMPLETED|Overall Study||192
7783937|NCT01290952|19163174|P2|STARTED|Overall Study||207
7783938|NCT01290952|19163175|P1|STARTED|Overall Study||204
7783939|NCT01290913|19163183|P1|NOT COMPLETED|Overall Study||1
7783940|NCT01290913|19163183|P1|COMPLETED|Overall Study||12
7783941|NCT01290913|19163183|P1|STARTED|Overall Study||13
7783942|NCT01290887|19163190|P2|NOT COMPLETED|Overall Study||536
7783943|NCT01290887|19163191|P1|NOT COMPLETED|Overall Study||466
7783944|NCT01290887|19163190|P2|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35
7783945|NCT01290887|19163191|P1|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15
7783946|NCT01290887|19163190|P2|Safety Analysis Set|Overall Study||571
7783947|NCT01290887|19163191|P1|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480
7783948|NCT01290887|19163190|P2|STARTED|Overall Study||571
7783949|NCT01290887|19163191|P1|STARTED|Overall Study||481
7783950|NCT01290874|19163231|P2|NOT COMPLETED|Overall Study||404
7783951|NCT01290874|19163232|P1|NOT COMPLETED|Overall Study||410
7783952|NCT01290874|19163231|P2|COMPLETED|Overall Study||134
7783953|NCT01290874|19163232|P1|COMPLETED|Overall Study||122
7783954|NCT01290874|19163231|P2|STARTED|Overall Study||538
7783955|NCT01290874|19163232|P1|STARTED|Overall Study||532
7783956|NCT01290822|19163252|P1|NOT COMPLETED|Overall Study||11
7783957|NCT01290822|19163252|P1|COMPLETED|Overall Study||1
7783958|NCT01290822|19163252|P1|STARTED|Overall Study||12
7783959|NCT01290796|19163261|P1|NOT COMPLETED|Overall Study||30
7783960|NCT01290796|19163261|P1|COMPLETED|Overall Study||123
7783961|NCT01290796|19163261|P1|STARTED|Overall Study||153
7783962|NCT01290757|19163277|P2|NOT COMPLETED|Overall Study||2
7783963|NCT01290757|19163278|P1|NOT COMPLETED|Overall Study||2
7783964|NCT01290757|19163277|P2|COMPLETED|Overall Study||88
7783965|NCT01290757|19163278|P1|COMPLETED|Overall Study||88
7783966|NCT01290757|19163277|P2|STARTED|Overall Study||90
7783967|NCT01290757|19163278|P1|STARTED|Overall Study||90
7783968|NCT01290731|19163294|P1|NOT COMPLETED|Overall Study||1
7783969|NCT01290731|19163294|P1|COMPLETED|Overall Study||48
7783970|NCT01290731|19163294|P1|STARTED|Overall Study||49
7783971|NCT01290718|19163306|P1|NOT COMPLETED|Overall Study||4
7783972|NCT01290718|19163306|P1|COMPLETED|Overall Study||0
7783973|NCT01290718|19163306|P1|STARTED|Overall Study||4
7783974|NCT01290679|19163315|P2|NOT COMPLETED|Overall Study||21
7783975|NCT01290679|19163316|P1|NOT COMPLETED|Overall Study||16
7783976|NCT01290679|19163315|P2|COMPLETED|Overall Study||113
7783977|NCT01290679|19163316|P1|COMPLETED|Overall Study||241
7783978|NCT01290679|19163315|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134
7783979|NCT01290679|19163316|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257
7783980|NCT01290666|19163385|P1|NOT COMPLETED|Overall Study||38
7783981|NCT01290666|19163385|P1|COMPLETED|Overall Study||55
7783982|NCT01290666|19163385|P1|STARTED|Overall Study||93
7783983|NCT01290640|19163391|P2|NOT COMPLETED|Overall Study||0
7783984|NCT01290640|19163392|P1|NOT COMPLETED|Overall Study||0
7783985|NCT01290640|19163391|P2|COMPLETED|Overall Study||10
7783986|NCT01290640|19163392|P1|COMPLETED|Overall Study||12
7783987|NCT01290640|19163391|P2|STARTED|Overall Study||10
7783988|NCT01290640|19163392|P1|STARTED|Overall Study||12
7783989|NCT01290627|19163403|P3|NOT COMPLETED|Overall Study||0
7783990|NCT01290627|19163404|P2|NOT COMPLETED|Overall Study||0
7783991|NCT01290627|19163405|P1|NOT COMPLETED|Overall Study||0
7783992|NCT01290627|19163403|P3|COMPLETED|Overall Study||10
7783993|NCT01290627|19163404|P2|COMPLETED|Overall Study||10
7783994|NCT01290627|19163405|P1|COMPLETED|Overall Study||10
7783995|NCT01290627|19163403|P3|STARTED|Overall Study||10
7783996|NCT01290627|19163404|P2|STARTED|Overall Study||10
7783997|NCT01290627|19163405|P1|STARTED|Overall Study||10
7783998|NCT01290614|19163427|P2|NOT COMPLETED|Overall Study||0
7783999|NCT01290614|19163428|P1|NOT COMPLETED|Overall Study||552
7784000|NCT01290614|19163427|P2|COMPLETED|Overall Study||1129
7784001|NCT01290614|19163428|P1|COMPLETED|Overall Study||518
7784002|NCT01290614|19163427|P2|STARTED|Overall Study||1129
7784003|NCT01290614|19163428|P1|STARTED|Overall Study||1070
7784004|NCT01290601|19163438|P4|NOT COMPLETED|Overall Study||0
7784005|NCT01290601|19163439|P3|NOT COMPLETED|Overall Study||0
7784006|NCT01290601|19163440|P2|NOT COMPLETED|Overall Study||5
7784007|NCT01290601|19163441|P1|NOT COMPLETED|Overall Study||11
7784008|NCT01290601|19163438|P4|COMPLETED|Overall Study||0
7784009|NCT01290601|19163439|P3|COMPLETED|Overall Study||0
7784010|NCT01290601|19163440|P2|COMPLETED|Overall Study||19
7784011|NCT01290601|19163441|P1|COMPLETED|Overall Study||35
7784012|NCT01290601|19163438|P4|STARTED|Overall Study||0
7784013|NCT01290601|19163439|P3|STARTED|Overall Study||0
7784014|NCT01290601|19163440|P2|STARTED|Overall Study||24
7784015|NCT01290601|19163441|P1|STARTED|Overall Study||46
7784016|NCT01290536|19163455|P1|NOT COMPLETED|Overall Study||0
7784017|NCT01290536|19163455|P1|COMPLETED|Overall Study||42
7784018|NCT01290536|19163455|P1|STARTED|Overall Study||42
7784019|NCT01290523|19163462|P1|NOT COMPLETED|Overall Study||3
7784020|NCT01290523|19163462|P1|COMPLETED|Overall Study||11
7784021|NCT01290523|19163462|P1|STARTED|Overall Study||14
7784022|NCT01290484|19163467|P1|NOT COMPLETED|Overall Study||0
7784023|NCT01290484|19163467|P1|COMPLETED|Overall Study||7
7784024|NCT01290484|19163467|P1|STARTED|Overall Study||7
7784025|NCT01290445|19163474|P3|NOT COMPLETED|Overall Study||0
7784026|NCT01290445|19163475|P2|NOT COMPLETED|Overall Study||0
7784027|NCT01290445|19163476|P1|NOT COMPLETED|Overall Study||0
7784028|NCT01290445|19163474|P3|COMPLETED|Overall Study||806438
7784029|NCT01290445|19163475|P2|COMPLETED|Overall Study||78412
7784030|NCT01290445|19163476|P1|COMPLETED|Overall Study||335
7784031|NCT01290445|19163474|P3|STARTED|Overall Study||806438
7784032|NCT01290445|19163475|P2|STARTED|Overall Study||78412
7784033|NCT01290445|19163476|P1|STARTED|Overall Study||335
7784034|NCT01290341|19163501|P2|NOT COMPLETED|Overall Study||29
7784035|NCT01290341|19163502|P1|NOT COMPLETED|Overall Study||92
7784036|NCT01290341|19163501|P2|COMPLETED|Overall Study||258
7784037|NCT01290341|19163502|P1|COMPLETED|Overall Study||481
7784038|NCT01290341|19163501|P2|STARTED|Overall Study||287
7784039|NCT01290341|19163502|P1|STARTED|Overall Study||573
7784040|NCT01290315|19163514|P4|NOT COMPLETED|Overall Study||5
7784041|NCT01290315|19163515|P3|NOT COMPLETED|Overall Study||0
7784042|NCT01290315|19163516|P2|NOT COMPLETED|Overall Study||3
7784043|NCT01290315|19163517|P1|NOT COMPLETED|Overall Study||3
7784044|NCT01290315|19163514|P4|COMPLETED|Overall Study||8
7784045|NCT01290315|19163515|P3|COMPLETED|Overall Study||10
7784046|NCT01290315|19163516|P2|COMPLETED|Overall Study||9
7784047|NCT01290315|19163517|P1|COMPLETED|Overall Study||11
7784048|NCT01290315|19163514|P4|STARTED|Overall Study||13
7784049|NCT01290315|19163515|P3|STARTED|Overall Study||10
7784050|NCT01290315|19163516|P2|STARTED|Overall Study||12
7784051|NCT01290315|19163517|P1|STARTED|Overall Study||14
7784052|NCT01290263|19163539|P5|NOT COMPLETED|Overall Study||37
7784053|NCT01290263|19163540|P4|NOT COMPLETED|Overall Study||27
7784054|NCT01290263|19163541|P3|NOT COMPLETED|Overall Study||7
7784055|NCT01290263|19163542|P2|NOT COMPLETED|Overall Study||3
7784056|NCT01290263|19163543|P1|NOT COMPLETED|Overall Study||11
7784057|NCT01290263|19163539|P5|COMPLETED|Overall Study||0
7784058|NCT01290263|19163540|P4|COMPLETED|Overall Study||0
7784059|NCT01290263|19163541|P3|COMPLETED|Overall Study||0
7784060|NCT01290263|19163542|P2|COMPLETED|Overall Study||0
7784061|NCT01290263|19163543|P1|COMPLETED|Overall Study||0
7784062|NCT01290263|19163539|P5|STARTED|Overall Study||37
7784063|NCT01290263|19163540|P4|STARTED|Overall Study||27
7784064|NCT01290263|19163541|P3|STARTED|Overall Study||7
7784065|NCT01290263|19163542|P2|STARTED|Overall Study||3
7784066|NCT01290263|19163543|P1|STARTED|Overall Study||11
7784067|NCT01290237|19163561|P2|NOT COMPLETED|Overall Study||2
7784068|NCT01290237|19163562|P1|NOT COMPLETED|Overall Study||11
7784069|NCT01290237|19163561|P2|COMPLETED|Overall Study||27
7784070|NCT01290237|19163562|P1|COMPLETED|Overall Study||19
7784071|NCT01290237|19163561|P2|STARTED|Overall Study||29
7784072|NCT01290237|19163562|P1|STARTED|Overall Study||30
7784073|NCT01290224|19163570|P1|NOT COMPLETED|Overall Study||5
7784074|NCT01290224|19163570|P1|COMPLETED|Overall Study||5
7784075|NCT01290224|19163570|P1|STARTED|Overall Study||10
7784076|NCT01290094|19163581|P1|NOT COMPLETED|Overall Study||6
7784077|NCT01290094|19163581|P1|COMPLETED|Overall Study||35
7784078|NCT01290094|19163581|P1|STARTED|Overall Study||41
7784079|NCT01290068|19163594|P2|NOT COMPLETED|Overall Study||6
7784080|NCT01290068|19163595|P1|NOT COMPLETED|Overall Study||7
7784081|NCT01290068|19163594|P2|COMPLETED|Overall Study||94
7784082|NCT01290068|19163595|P1|COMPLETED|Overall Study||101
7784083|NCT01290068|19163594|P2|Implanted|Overall Study||98
7784084|NCT01290068|19163595|P1|Implanted|Overall Study||108
7784085|NCT01290068|19163594|P2|STARTED|Overall Study||100
7784086|NCT01290068|19163595|P1|STARTED|Overall Study||108
7784087|NCT01290029|19163607|P1|NOT COMPLETED|Overall Study||2
7784088|NCT01290029|19163607|P1|COMPLETED|Overall Study||12
7784089|NCT01290029|19163607|P1|Received Study Treatment|Overall Study||12
7784090|NCT01290029|19163607|P1|STARTED|Overall Study||14
7784091|NCT01289990|19163633|P13|NOT COMPLETED|Overall Study||98
7784092|NCT01289990|19163634|P12|NOT COMPLETED|Overall Study||68
7784093|NCT01289990|19163635|P11|NOT COMPLETED|Overall Study||76
7784094|NCT01289990|19163636|P10|NOT COMPLETED|Overall Study||86
7784095|NCT01289990|19163637|P9|NOT COMPLETED|Overall Study||75
7784096|NCT01289990|19163638|P8|NOT COMPLETED|Overall Study||55
7784097|NCT01289990|19163639|P7|NOT COMPLETED|Overall Study||88
7784098|NCT01289990|19163640|P6|NOT COMPLETED|Overall Study||74
7784099|NCT01289990|19163641|P5|NOT COMPLETED|Overall Study||72
7784100|NCT01289990|19163642|P4|NOT COMPLETED|Overall Study||87
7784101|NCT01289990|19163643|P3|NOT COMPLETED|Overall Study||109
7784102|NCT01289990|19163644|P2|NOT COMPLETED|Overall Study||81
7784103|NCT01289990|19163645|P1|NOT COMPLETED|Overall Study||77
7784104|NCT01289990|19163633|P13|COMPLETED|Overall Study||127
7784105|NCT01289990|19163634|P12|COMPLETED|Overall Study||150
7784106|NCT01289990|19163635|P11|COMPLETED|Overall Study||150
7784107|NCT01289990|19163636|P10|COMPLETED|Overall Study||121
7784108|NCT01289990|19163637|P9|COMPLETED|Overall Study||139
7784109|NCT01289990|19163638|P8|COMPLETED|Overall Study||162
7784110|NCT01289990|19163639|P7|COMPLETED|Overall Study||78
7784111|NCT01289990|19163640|P6|COMPLETED|Overall Study||94
7784112|NCT01289990|19163641|P5|COMPLETED|Overall Study||93
7784113|NCT01289990|19163642|P4|COMPLETED|Overall Study||136
7784114|NCT01289990|19163643|P3|COMPLETED|Overall Study||119
7784115|NCT01289990|19163644|P2|COMPLETED|Overall Study||143
7784116|NCT01289990|19163645|P1|COMPLETED|Overall Study||147
7784117|NCT01289990|19163633|P13|STARTED|Overall Study||225
7784118|NCT01289990|19163634|P12|STARTED|Overall Study||218
7784119|NCT01289990|19163635|P11|STARTED|Overall Study||226
7784120|NCT01289990|19163636|P10|STARTED|Overall Study||207
7784121|NCT01289990|19163637|P9|STARTED|Overall Study||214
7784122|NCT01289990|19163638|P8|STARTED|Overall Study||217
7784123|NCT01289990|19163639|P7|STARTED|Overall Study||166
7784124|NCT01289990|19163640|P6|STARTED|Overall Study||168
7784125|NCT01289990|19163641|P5|STARTED|Overall Study||165
7784126|NCT01289990|19163642|P4|STARTED|Overall Study||223
7784127|NCT01289990|19163643|P3|STARTED|Overall Study||228
7784128|NCT01289990|19163644|P2|STARTED|Overall Study||224
7784129|NCT01289990|19163645|P1|STARTED|Overall Study||224
7784130|NCT01289912|19163831|P2|NOT COMPLETED|Overall Study||2
7784131|NCT01289912|19163832|P1|NOT COMPLETED|Overall Study||3
7784132|NCT01289912|19163831|P2|COMPLETED|Overall Study||13
7784133|NCT01289912|19163832|P1|COMPLETED|Overall Study||29
7784134|NCT01289912|19163831|P2|STARTED|Overall Study||15
7784135|NCT01289912|19163832|P1|STARTED|Overall Study||32
7784136|NCT01289847|19163862|P1|NOT COMPLETED|Overall Study||1
7784137|NCT01289847|19163862|P1|COMPLETED|Overall Study||24
7784138|NCT01289847|19163862|P1|STARTED|Overall Study||25
7784139|NCT01289821|19163871|P1|NOT COMPLETED|Survival Follow-up Period||18
7784140|NCT01289821|19163871|P1|COMPLETED|Survival Follow-up Period|34 participants died and completed survival follow-up period.|34
7784141|NCT01289821|19163871|P1|STARTED|Survival Follow-up Period||52
7784142|NCT01289821|19163871|P1|NOT COMPLETED|Safety Follow-up Period||5
7784143|NCT01289821|19163871|P1|COMPLETED|Safety Follow-up Period||49
7784144|NCT01289821|19163871|P1|STARTED|Safety Follow-up Period||54
7784145|NCT01289821|19163871|P1|NOT COMPLETED|Treatment Period||54
7784146|NCT01289821|19163871|P1|COMPLETED|Treatment Period||0
7784147|NCT01289821|19163871|P1|Participants Received Regorafenib|Treatment Period||54
7784148|NCT01289821|19163871|P1|STARTED|Treatment Period||54
7784149|NCT01289782|19163882|P2|NOT COMPLETED|Overall Study||12
7784150|NCT01289782|19163883|P1|NOT COMPLETED|Overall Study||25
7784151|NCT01289782|19163882|P2|COMPLETED|Overall Study||118
7784152|NCT01289782|19163883|P1|COMPLETED|Overall Study||239
7784153|NCT01289782|19163882|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130
7784154|NCT01289782|19163883|P1|STARTED|Overall Study||264
7784155|NCT01289678|19163952|P1|NOT COMPLETED|Overall Study||6
7784156|NCT01289678|19163952|P1|COMPLETED|Overall Study||12
7784157|NCT01289678|19163952|P1|STARTED|Overall Study||18
7784158|NCT01289665|19163958|P2|NOT COMPLETED|Overall Study||0
7784159|NCT01289665|19163959|P1|NOT COMPLETED|Overall Study||1
7784160|NCT01289665|19163958|P2|COMPLETED|Overall Study||60
7784161|NCT01289665|19163959|P1|COMPLETED|Overall Study||59
7784162|NCT01289665|19163958|P2|STARTED|Overall Study||60
7784163|NCT01289665|19163959|P1|STARTED|Overall Study||60
7784164|NCT01289639|19163968|P3|NOT COMPLETED|Overall Study||0
7784165|NCT01289639|19163969|P2|NOT COMPLETED|Overall Study||0
7784166|NCT01289639|19163970|P1|NOT COMPLETED|Overall Study||1
7784167|NCT01289639|19163968|P3|COMPLETED|Overall Study||0
7784168|NCT01289639|19163969|P2|COMPLETED|Overall Study||6
7784169|NCT01289639|19163970|P1|COMPLETED|Overall Study||4
7784170|NCT01289639|19163968|P3|STARTED|Overall Study||0
7784171|NCT01289639|19163969|P2|STARTED|Overall Study||6
7784172|NCT01289639|19163970|P1|STARTED|Overall Study||5
7784173|NCT01289574|19163996|P3|NOT COMPLETED|Overall Study||3
7784174|NCT01289574|19163997|P2|NOT COMPLETED|Overall Study||3
7784175|NCT01289574|19163998|P1|NOT COMPLETED|Overall Study||7
7784176|NCT01289574|19163996|P3|COMPLETED|Overall Study||60
7784177|NCT01289574|19163997|P2|COMPLETED|Overall Study||57
7784178|NCT01289574|19163998|P1|COMPLETED|Overall Study||51
7784179|NCT01289574|19163996|P3|STARTED|Overall Study||63
7784180|NCT01289574|19163997|P2|STARTED|Overall Study||60
7784181|NCT01289574|19163998|P1|STARTED|Overall Study||58
7784182|NCT01289548|19164015|P3|NOT COMPLETED|Overall Study||0
7784183|NCT01289548|19164016|P2|NOT COMPLETED|Overall Study||0
7784184|NCT01289548|19164017|P1|NOT COMPLETED|Overall Study||0
7784185|NCT01289548|19164015|P3|COMPLETED|Overall Study||40
7784186|NCT01289548|19164016|P2|COMPLETED|Overall Study||40
7784187|NCT01289548|19164017|P1|COMPLETED|Overall Study||40
7784188|NCT01289548|19164015|P3|Recipients|Overall Study||20
7784189|NCT01289548|19164016|P2|Recipients|Overall Study||20
7784190|NCT01289548|19164017|P1|Recipients|Overall Study||20
7784191|NCT01289548|19164015|P3|Donors|Overall Study||20
7784192|NCT01289548|19164016|P2|Donors|Overall Study||20
7784193|NCT01289548|19164017|P1|Donors|Overall Study||20
7784194|NCT01289548|19164015|P3|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
7784195|NCT01289548|19164016|P2|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
7784196|NCT01289548|19164017|P1|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
7784197|NCT01289522|19164061|P1|NOT COMPLETED|Overall Study||11
7784198|NCT01289522|19164061|P1|COMPLETED|Overall Study||43
7784199|NCT01289522|19164061|P1|STARTED|Overall Study||54
7784200|NCT01289457|19164070|P3|NOT COMPLETED|Overall Study||0
7784201|NCT01289457|19164071|P2|NOT COMPLETED|Overall Study||0
7784202|NCT01289457|19164072|P1|NOT COMPLETED|Overall Study||0
7784203|NCT01289457|19164070|P3|COMPLETED|Overall Study||113
7784204|NCT01289457|19164071|P2|COMPLETED|Overall Study||157
7784205|NCT01289457|19164072|P1|COMPLETED|Overall Study||12
7784206|NCT01289457|19164070|P3|STARTED|Overall Study||113
7784207|NCT01289457|19164071|P2|STARTED|Overall Study||157
7784208|NCT01289457|19164072|P1|STARTED|Overall Study||12
7784209|NCT01289431|19164096|P7|NOT COMPLETED|Overall Study||1
7784210|NCT01289431|19164097|P6|NOT COMPLETED|Overall Study||2
7784211|NCT01289431|19164098|P5|NOT COMPLETED|Overall Study||2
7784212|NCT01289431|19164099|P4|NOT COMPLETED|Overall Study||5
7784213|NCT01289431|19164100|P3|NOT COMPLETED|Overall Study||4
7784214|NCT01289431|19164101|P2|NOT COMPLETED|Overall Study||2
7784215|NCT01289431|19164102|P1|NOT COMPLETED|Overall Study||5
7784216|NCT01289431|19164096|P7|COMPLETED|Overall Study||33
7784217|NCT01289431|19164097|P6|COMPLETED|Overall Study||31
7784218|NCT01289431|19164098|P5|COMPLETED|Overall Study||32
7784219|NCT01289431|19164099|P4|COMPLETED|Overall Study||28
7784220|NCT01289431|19164100|P3|COMPLETED|Overall Study||30
7784221|NCT01289431|19164101|P2|COMPLETED|Overall Study||32
7784222|NCT01289431|19164102|P1|COMPLETED|Overall Study||29
7784223|NCT01289431|19164096|P7|STARTED|Overall Study||34
7784224|NCT01289431|19164097|P6|STARTED|Overall Study||33
7784225|NCT01289431|19164098|P5|STARTED|Overall Study||34
7784226|NCT01289431|19164099|P4|STARTED|Overall Study||33
7784227|NCT01289431|19164100|P3|STARTED|Overall Study||34
7784228|NCT01289431|19164101|P2|STARTED|Overall Study||34
7784229|NCT01289431|19164102|P1|STARTED|Overall Study||34
7784230|NCT01289418|19164142|P1|NOT COMPLETED|Day 29 Survey||2468
7784231|NCT01289418|19164142|P1|COMPLETED|Day 29 Survey||4057
7784232|NCT01289418|19164142|P1|STARTED|Day 29 Survey||6525
7784233|NCT01289418|19164142|P1|NOT COMPLETED|Day 8 Survey||2218
7784234|NCT01289418|19164142|P1|COMPLETED|Day 8 Survey||4307
7784235|NCT01289418|19164142|P1|STARTED|Day 8 Survey||6525
7784236|NCT01289392|19164151|P3|NOT COMPLETED|Overall Study||0
7784237|NCT01289392|19164152|P2|NOT COMPLETED|Overall Study||0
7784238|NCT01289392|19164153|P1|NOT COMPLETED|Overall Study||0
7784239|NCT01289392|19164151|P3|COMPLETED|Overall Study||7
7784240|NCT01289392|19164152|P2|COMPLETED|Overall Study||9
7784241|NCT01289392|19164153|P1|COMPLETED|Overall Study||9
7784242|NCT01289392|19164151|P3|STARTED|Overall Study||7
7784243|NCT01289392|19164152|P2|STARTED|Overall Study||9
7784244|NCT01289392|19164153|P1|STARTED|Overall Study||9
7784245|NCT01289275|19164165|P4|NOT COMPLETED|Overall Study||0
7784246|NCT01289275|19164166|P3|NOT COMPLETED|Overall Study||0
7784247|NCT01289275|19164167|P2|NOT COMPLETED|Overall Study||0
7784248|NCT01289275|19164168|P1|NOT COMPLETED|Overall Study||0
7784249|NCT01289275|19164165|P4|COMPLETED|Overall Study||316
7784250|NCT01289275|19164166|P3|COMPLETED|Overall Study||317
7784251|NCT01289275|19164167|P2|COMPLETED|Overall Study||320
7784252|NCT01289275|19164168|P1|COMPLETED|Overall Study||317
7784253|NCT01289275|19164165|P4|STARTED|Overall Study||316
7784254|NCT01289275|19164166|P3|STARTED|Overall Study||317
7784255|NCT01289275|19164167|P2|STARTED|Overall Study||320
7784256|NCT01289275|19164168|P1|STARTED|Overall Study||317
7784257|NCT01289210|19164190|P1|NOT COMPLETED|Overall Study||1
7784258|NCT01289210|19164190|P1|COMPLETED|Overall Study||1
7784259|NCT01289210|19164190|P1|STARTED|Overall Study||2
7784260|NCT01289119|19164200|P6|NOT COMPLETED|Overall Study||4
7784261|NCT01289119|19164201|P5|NOT COMPLETED|Overall Study||5
7784262|NCT01289119|19164202|P4|NOT COMPLETED|Overall Study||6
7784263|NCT01289119|19164203|P3|NOT COMPLETED|Overall Study||9
7784264|NCT01289119|19164204|P2|NOT COMPLETED|Overall Study||9
7784265|NCT01289119|19164205|P1|NOT COMPLETED|Overall Study||9
7784266|NCT01289119|19164200|P6|COMPLETED|Overall Study||57
7784267|NCT01289119|19164201|P5|COMPLETED|Overall Study||58
7784268|NCT01289119|19164202|P4|COMPLETED|Overall Study||93
7784269|NCT01289119|19164203|P3|COMPLETED|Overall Study||89
7784270|NCT01289119|19164204|P2|COMPLETED|Overall Study||83
7784271|NCT01289119|19164205|P1|COMPLETED|Overall Study||84
7784272|NCT01289119|19164200|P6|Treated|Overall Study||61
7784273|NCT01289119|19164201|P5|Treated|Overall Study||63
7784274|NCT01289119|19164202|P4|Treated|Overall Study||99
7784275|NCT01289119|19164203|P3|Treated|Overall Study||98
7784276|NCT01289119|19164204|P2|Treated|Overall Study||92
7784277|NCT01289119|19164205|P1|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92
7784278|NCT01289119|19164200|P6|STARTED|Overall Study||61
7784279|NCT01289119|19164201|P5|STARTED|Overall Study||63
7784280|NCT01289119|19164202|P4|STARTED|Overall Study||99
7784281|NCT01289119|19164203|P3|STARTED|Overall Study||98
7784282|NCT01289119|19164204|P2|STARTED|Overall Study||92
7784283|NCT01289119|19164205|P1|STARTED|Overall Study||93
7784284|NCT01289080|19164287|P2|NOT COMPLETED|Overall Study||0
7784285|NCT01289080|19164288|P1|NOT COMPLETED|Overall Study||0
7784286|NCT01289080|19164287|P2|COMPLETED|Overall Study||10
7784287|NCT01289080|19164288|P1|COMPLETED|Overall Study||9
7784288|NCT01289080|19164287|P2|STARTED|Overall Study||10
7784289|NCT01289080|19164288|P1|STARTED|Overall Study||9
7784290|NCT01289067|19164319|P1|NOT COMPLETED|Overall Study||0
7784291|NCT01289067|19164319|P1|COMPLETED|Overall Study||13
7784292|NCT01289067|19164319|P1|STARTED|Overall Study||13
7784293|NCT01289041|19164326|P1|NOT COMPLETED|Overall Study||70
7784294|NCT01289041|19164326|P1|COMPLETED|Overall Study||0
7784295|NCT01289041|19164326|P1|STARTED|Overall Study||70
7784296|NCT01289028|19164338|P1|NOT COMPLETED|Overall Study||83
7784297|NCT01289028|19164338|P1|COMPLETED|Overall Study||42
7784298|NCT01289028|19164338|P1|STARTED|Overall Study||125
7784299|NCT01289015|19164352|P2|NOT COMPLETED|Overall Study||54
7784300|NCT01289015|19164353|P1|NOT COMPLETED|Overall Study||99
7784301|NCT01289015|19164352|P2|COMPLETED|Overall Study||230
7784302|NCT01289015|19164353|P1|COMPLETED|Overall Study||472
7784303|NCT01289015|19164352|P2|STARTED|Overall Study||284
7784304|NCT01289015|19164353|P1|STARTED|Overall Study||571
7784305|NCT01288989|19164366|P5|NOT COMPLETED|Overall Study||6
7784306|NCT01288989|19164367|P4|NOT COMPLETED|Overall Study||1
7784307|NCT01288989|19164368|P3|NOT COMPLETED|Overall Study||0
7784308|NCT01288989|19164369|P2|NOT COMPLETED|Overall Study||0
7784309|NCT01288989|19164370|P1|NOT COMPLETED|Overall Study||1
7784310|NCT01288989|19164366|P5|COMPLETED|Overall Study||15
7784311|NCT01288989|19164367|P4|COMPLETED|Overall Study||10
7784312|NCT01288989|19164368|P3|COMPLETED|Overall Study||3
7784313|NCT01288989|19164369|P2|COMPLETED|Overall Study||3
7784314|NCT01288989|19164370|P1|COMPLETED|Overall Study||5
7784315|NCT01288989|19164366|P5|Received at Least 1 Dose of Study Drug|Overall Study||21
7784316|NCT01288989|19164367|P4|Received at Least 1 Dose of Study Drug|Overall Study||11
7784317|NCT01288989|19164368|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
7784318|NCT01288989|19164369|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
7784319|NCT01288989|19164370|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
7784320|NCT01288989|19164366|P5|STARTED|Overall Study||21
7784321|NCT01288989|19164367|P4|STARTED|Overall Study||11
7784322|NCT01288989|19164368|P3|STARTED|Overall Study||3
7784323|NCT01288989|19164369|P2|STARTED|Overall Study||3
7784324|NCT01288989|19164370|P1|STARTED|Overall Study||6
7784325|NCT01288976|19164431|P3|NOT COMPLETED|Overall Study||20
7784326|NCT01288976|19164432|P2|NOT COMPLETED|Overall Study||27
7784327|NCT01288976|19164433|P1|NOT COMPLETED|Overall Study||178
7784328|NCT01288976|19164431|P3|COMPLETED|Overall Study||85
7784329|NCT01288976|19164432|P2|COMPLETED|Overall Study||22
7784330|NCT01288976|19164433|P1|COMPLETED|Overall Study||389
7784331|NCT01288976|19164431|P3|STARTED|Overall Study||105
7784332|NCT01288976|19164432|P2|STARTED|Overall Study||49
7784333|NCT01288976|19164433|P1|STARTED|Overall Study||567
7784334|NCT01288937|19164462|P2|NOT COMPLETED|Overall Study||0
7784335|NCT01288937|19164463|P1|NOT COMPLETED|Overall Study||1
7784336|NCT01288937|19164462|P2|COMPLETED|Overall Study||2
7784337|NCT01288937|19164463|P1|COMPLETED|Overall Study||3
7784338|NCT01288937|19164462|P2|STARTED|Overall Study||2
7784339|NCT01288937|19164463|P1|STARTED|Overall Study||4
7784340|NCT01288911|19164471|P2|NOT COMPLETED|Open-label Period (All Enzalutamide)||9
7784341|NCT01288911|19164472|P1|NOT COMPLETED|Open-label Period (All Enzalutamide)||42
7784342|NCT01288911|19164471|P2|COMPLETED|Open-label Period (All Enzalutamide)||0
7784343|NCT01288911|19164472|P1|COMPLETED|Open-label Period (All Enzalutamide)||0
7784344|NCT01288911|19164471|P2|Received Treatment|Open-label Period (All Enzalutamide)||9
7784345|NCT01288911|19164472|P1|Received Treatment|Open-label Period (All Enzalutamide)||42
7784346|NCT01288911|19164471|P2|STARTED|Open-label Period (All Enzalutamide)||9
7784347|NCT01288911|19164472|P1|STARTED|Open-label Period (All Enzalutamide)||42
7784348|NCT01288911|19164471|P2|NOT COMPLETED|Double-blind Period||182
7784349|NCT01288911|19164472|P1|NOT COMPLETED|Double-blind Period||142
7784350|NCT01288911|19164471|P2|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|9
7784351|NCT01288911|19164472|P1|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|42
7784352|NCT01288911|19164471|P2|Received Treatment|Double-blind Period||189
7784353|NCT01288911|19164472|P1|Received Treatment|Double-blind Period||183
7784354|NCT01288911|19164471|P2|STARTED|Double-blind Period||191
7784355|NCT01288911|19164472|P1|STARTED|Double-blind Period||184
7784356|NCT01288859|19164503|P6|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
7784357|NCT01288859|19164504|P5|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
7784358|NCT01288859|19164505|P4|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
7784359|NCT01288859|19164506|P3|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
7784360|NCT01288859|19164507|P2|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
7784361|NCT01288859|19164508|P1|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
7784362|NCT01288859|19164503|P6|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
7784363|NCT01288859|19164504|P5|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
7784364|NCT01288859|19164505|P4|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
7784365|NCT01288859|19164506|P3|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
7784366|NCT01288859|19164507|P2|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
7784367|NCT01288859|19164508|P1|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
7784368|NCT01288859|19164503|P6|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
7784369|NCT01288859|19164504|P5|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
7784370|NCT01288859|19164505|P4|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
7784371|NCT01288859|19164506|P3|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
7784372|NCT01288859|19164507|P2|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
7784373|NCT01288859|19164508|P1|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
7784374|NCT01288859|19164503|P6|NOT COMPLETED|Washout Period of 1 Week||0
7784375|NCT01288859|19164504|P5|NOT COMPLETED|Washout Period of 1 Week||0
7784376|NCT01288859|19164505|P4|NOT COMPLETED|Washout Period of 1 Week||0
7784377|NCT01288859|19164506|P3|NOT COMPLETED|Washout Period of 1 Week||0
7784378|NCT01288859|19164507|P2|NOT COMPLETED|Washout Period of 1 Week||0
7784379|NCT01288859|19164508|P1|NOT COMPLETED|Washout Period of 1 Week||0
7784380|NCT01288859|19164503|P6|COMPLETED|Washout Period of 1 Week||0
7784381|NCT01288859|19164504|P5|COMPLETED|Washout Period of 1 Week||5
7784382|NCT01288859|19164505|P4|COMPLETED|Washout Period of 1 Week||5
7784383|NCT01288859|19164506|P3|COMPLETED|Washout Period of 1 Week||0
7784384|NCT01288859|19164507|P2|COMPLETED|Washout Period of 1 Week||0
7784385|NCT01288859|19164508|P1|COMPLETED|Washout Period of 1 Week||0
7784386|NCT01288859|19164503|P6|STARTED|Washout Period of 1 Week||0
7784387|NCT01288859|19164504|P5|STARTED|Washout Period of 1 Week||5
7784388|NCT01288859|19164505|P4|STARTED|Washout Period of 1 Week||5
7784389|NCT01288859|19164506|P3|STARTED|Washout Period of 1 Week||0
7784390|NCT01288859|19164507|P2|STARTED|Washout Period of 1 Week||0
7784391|NCT01288859|19164508|P1|STARTED|Washout Period of 1 Week||0
7784392|NCT01288859|19164503|P6|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
7784393|NCT01288859|19164504|P5|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
7784394|NCT01288859|19164505|P4|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
7784395|NCT01288859|19164506|P3|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
7784396|NCT01288859|19164507|P2|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
7784397|NCT01288859|19164508|P1|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
7784398|NCT01288859|19164503|P6|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
7784399|NCT01288859|19164504|P5|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
7784400|NCT01288859|19164505|P4|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
7784401|NCT01288859|19164506|P3|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
7784402|NCT01288859|19164507|P2|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
7784403|NCT01288859|19164508|P1|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
7784404|NCT01288859|19164503|P6|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
7784405|NCT01288859|19164504|P5|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
7784406|NCT01288859|19164505|P4|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
7784407|NCT01288859|19164506|P3|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
7784408|NCT01288859|19164507|P2|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
7784409|NCT01288859|19164508|P1|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
7784410|NCT01288859|19164503|P6|NOT COMPLETED|Washout Period of 1 Week||0
7784411|NCT01288859|19164504|P5|NOT COMPLETED|Washout Period of 1 Week||0
7784412|NCT01288859|19164505|P4|NOT COMPLETED|Washout Period of 1 Week||0
7784413|NCT01288859|19164506|P3|NOT COMPLETED|Washout Period of 1 Week||0
7784414|NCT01288859|19164507|P2|NOT COMPLETED|Washout Period of 1 Week||0
7784415|NCT01288859|19164508|P1|NOT COMPLETED|Washout Period of 1 Week||0
7784416|NCT01288859|19164503|P6|COMPLETED|Washout Period of 1 Week||0
7784417|NCT01288859|19164504|P5|COMPLETED|Washout Period of 1 Week||5
7784418|NCT01288859|19164505|P4|COMPLETED|Washout Period of 1 Week||5
7784419|NCT01288859|19164506|P3|COMPLETED|Washout Period of 1 Week||0
7784420|NCT01288859|19164507|P2|COMPLETED|Washout Period of 1 Week||0
7784421|NCT01288859|19164508|P1|COMPLETED|Washout Period of 1 Week||0
7784422|NCT01288859|19164503|P6|STARTED|Washout Period of 1 Week||0
7784423|NCT01288859|19164504|P5|STARTED|Washout Period of 1 Week||5
7784424|NCT01288859|19164505|P4|STARTED|Washout Period of 1 Week||5
7784425|NCT01288859|19164506|P3|STARTED|Washout Period of 1 Week||0
7784426|NCT01288859|19164507|P2|STARTED|Washout Period of 1 Week||0
7784427|NCT01288859|19164508|P1|STARTED|Washout Period of 1 Week||0
7784428|NCT01288859|19164503|P6|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
7784429|NCT01288859|19164504|P5|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
7784430|NCT01288859|19164505|P4|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
7784431|NCT01288859|19164506|P3|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
7784432|NCT01288859|19164507|P2|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
7784433|NCT01288859|19164508|P1|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
7784434|NCT01288859|19164503|P6|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
7784435|NCT01288859|19164504|P5|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
7784436|NCT01288859|19164505|P4|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
7784437|NCT01288859|19164506|P3|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
7784438|NCT01288859|19164507|P2|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
7784439|NCT01288859|19164508|P1|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
7784440|NCT01288859|19164503|P6|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
7784441|NCT01288859|19164504|P5|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
7784442|NCT01288859|19164505|P4|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
7784443|NCT01288859|19164506|P3|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
7784444|NCT01288859|19164507|P2|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
7784445|NCT01288859|19164508|P1|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
7784446|NCT01288859|19164503|P6|NOT COMPLETED|Washout Period of 1 Week||0
7784447|NCT01288859|19164504|P5|NOT COMPLETED|Washout Period of 1 Week||0
7784448|NCT01288859|19164505|P4|NOT COMPLETED|Washout Period of 1 Week||0
7784449|NCT01288859|19164506|P3|NOT COMPLETED|Washout Period of 1 Week||0
7784450|NCT01288859|19164507|P2|NOT COMPLETED|Washout Period of 1 Week||0
7784451|NCT01288859|19164508|P1|NOT COMPLETED|Washout Period of 1 Week||0
7784452|NCT01288859|19164503|P6|COMPLETED|Washout Period of 1 Week||0
7784453|NCT01288859|19164504|P5|COMPLETED|Washout Period of 1 Week||0
7784454|NCT01288859|19164505|P4|COMPLETED|Washout Period of 1 Week||0
7784455|NCT01288859|19164506|P3|COMPLETED|Washout Period of 1 Week||5
7784456|NCT01288859|19164507|P2|COMPLETED|Washout Period of 1 Week||5
7784457|NCT01288859|19164508|P1|COMPLETED|Washout Period of 1 Week||0
7784458|NCT01288859|19164503|P6|STARTED|Washout Period of 1 Week||0
7784459|NCT01288859|19164504|P5|STARTED|Washout Period of 1 Week||0
7784460|NCT01288859|19164505|P4|STARTED|Washout Period of 1 Week||0
7784461|NCT01288859|19164506|P3|STARTED|Washout Period of 1 Week||5
7784462|NCT01288859|19164507|P2|STARTED|Washout Period of 1 Week||5
7784463|NCT01288859|19164508|P1|STARTED|Washout Period of 1 Week||0
7784464|NCT01288859|19164503|P6|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
7784465|NCT01288859|19164504|P5|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
7784466|NCT01288859|19164505|P4|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
7784467|NCT01288859|19164506|P3|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
7784468|NCT01288859|19164507|P2|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
7784469|NCT01288859|19164508|P1|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
7784470|NCT01288859|19164503|P6|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
7784471|NCT01288859|19164504|P5|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
7784472|NCT01288859|19164505|P4|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
7784473|NCT01288859|19164506|P3|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
7784474|NCT01288859|19164507|P2|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
7784475|NCT01288859|19164508|P1|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
7784476|NCT01288859|19164503|P6|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
7784477|NCT01288859|19164504|P5|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
7784478|NCT01288859|19164505|P4|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
7784479|NCT01288859|19164506|P3|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
7784480|NCT01288859|19164507|P2|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
7784481|NCT01288859|19164508|P1|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
7784482|NCT01288859|19164503|P6|NOT COMPLETED|Washout Period of 1 Week||0
7784483|NCT01288859|19164504|P5|NOT COMPLETED|Washout Period of 1 Week||0
7784484|NCT01288859|19164505|P4|NOT COMPLETED|Washout Period of 1 Week||0
7784485|NCT01288859|19164506|P3|NOT COMPLETED|Washout Period of 1 Week||0
7784486|NCT01288859|19164507|P2|NOT COMPLETED|Washout Period of 1 Week||0
7784487|NCT01288859|19164508|P1|NOT COMPLETED|Washout Period of 1 Week||0
7784488|NCT01288859|19164503|P6|COMPLETED|Washout Period of 1 Week||5
7784489|NCT01288859|19164504|P5|COMPLETED|Washout Period of 1 Week||0
7784490|NCT01288859|19164505|P4|COMPLETED|Washout Period of 1 Week||0
7784491|NCT01288859|19164506|P3|COMPLETED|Washout Period of 1 Week||0
7784492|NCT01288859|19164507|P2|COMPLETED|Washout Period of 1 Week||0
7784493|NCT01288859|19164508|P1|COMPLETED|Washout Period of 1 Week||5
7784494|NCT01288859|19164503|P6|STARTED|Washout Period of 1 Week||5
7784495|NCT01288859|19164504|P5|STARTED|Washout Period of 1 Week||0
7784496|NCT01288859|19164505|P4|STARTED|Washout Period of 1 Week||0
7784497|NCT01288859|19164506|P3|STARTED|Washout Period of 1 Week||0
7784498|NCT01288859|19164507|P2|STARTED|Washout Period of 1 Week||0
7784499|NCT01288859|19164508|P1|STARTED|Washout Period of 1 Week||5
7784500|NCT01288859|19164503|P6|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
7784501|NCT01288859|19164504|P5|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
7784502|NCT01288859|19164505|P4|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
7784503|NCT01288859|19164506|P3|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
7784504|NCT01288859|19164507|P2|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
7784505|NCT01288859|19164508|P1|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
7784506|NCT01288859|19164503|P6|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
7784507|NCT01288859|19164504|P5|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
7784508|NCT01288859|19164505|P4|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
7784509|NCT01288859|19164506|P3|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
7784510|NCT01288859|19164507|P2|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
7784511|NCT01288859|19164508|P1|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
7784512|NCT01288859|19164503|P6|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
7784513|NCT01288859|19164504|P5|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
7784514|NCT01288859|19164505|P4|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
7784515|NCT01288859|19164506|P3|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
7784516|NCT01288859|19164507|P2|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
7784517|NCT01288859|19164508|P1|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
7784518|NCT01288859|19164503|P6|NOT COMPLETED|Washout Period of 1 Week||0
7784519|NCT01288859|19164504|P5|NOT COMPLETED|Washout Period of 1 Week||0
7784520|NCT01288859|19164505|P4|NOT COMPLETED|Washout Period of 1 Week||0
7784521|NCT01288859|19164506|P3|NOT COMPLETED|Washout Period of 1 Week||0
7784522|NCT01288859|19164507|P2|NOT COMPLETED|Washout Period of 1 Week||0
7784523|NCT01288859|19164508|P1|NOT COMPLETED|Washout Period of 1 Week||0
7784524|NCT01288859|19164503|P6|COMPLETED|Washout Period of 1 Week||5
7784525|NCT01288859|19164504|P5|COMPLETED|Washout Period of 1 Week||0
7784526|NCT01288859|19164505|P4|COMPLETED|Washout Period of 1 Week||0
7784527|NCT01288859|19164506|P3|COMPLETED|Washout Period of 1 Week||0
7784528|NCT01288859|19164507|P2|COMPLETED|Washout Period of 1 Week||0
7784529|NCT01288859|19164508|P1|COMPLETED|Washout Period of 1 Week||5
7784530|NCT01288859|19164503|P6|STARTED|Washout Period of 1 Week||5
7784531|NCT01288859|19164504|P5|STARTED|Washout Period of 1 Week||0
7784532|NCT01288859|19164505|P4|STARTED|Washout Period of 1 Week||0
7784533|NCT01288859|19164506|P3|STARTED|Washout Period of 1 Week||0
7784534|NCT01288859|19164507|P2|STARTED|Washout Period of 1 Week||0
7784535|NCT01288859|19164508|P1|STARTED|Washout Period of 1 Week||5
7784536|NCT01288859|19164503|P6|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
7784537|NCT01288859|19164504|P5|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
7784538|NCT01288859|19164505|P4|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
7784539|NCT01288859|19164506|P3|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
7784540|NCT01288859|19164507|P2|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
7784541|NCT01288859|19164508|P1|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
7784542|NCT01288859|19164503|P6|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
7784543|NCT01288859|19164504|P5|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
7784544|NCT01288859|19164505|P4|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
7784545|NCT01288859|19164506|P3|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
7784546|NCT01288859|19164507|P2|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
7784547|NCT01288859|19164508|P1|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
7784548|NCT01288859|19164503|P6|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
7784549|NCT01288859|19164504|P5|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
7784550|NCT01288859|19164505|P4|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
7784551|NCT01288859|19164506|P3|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
7784552|NCT01288859|19164507|P2|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
7784553|NCT01288859|19164508|P1|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
7784554|NCT01288833|19164536|P2|NOT COMPLETED|Overall Study||0
7784555|NCT01288833|19164537|P1|NOT COMPLETED|Overall Study||0
7784556|NCT01288833|19164536|P2|COMPLETED|Overall Study||281
7784557|NCT01288833|19164537|P1|COMPLETED|Overall Study||277
7784558|NCT01288833|19164536|P2|STARTED|Overall Study||281
7784559|NCT01288833|19164537|P1|STARTED|Overall Study||277
7784560|NCT01288807|19164551|P1|NOT COMPLETED|Overall Study||0
7784561|NCT01288807|19164551|P1|COMPLETED|Overall Study||8
7784562|NCT01288807|19164551|P1|STARTED|Overall Study||8
7784563|NCT01288781|19164561|P2|NOT COMPLETED|Overall Study||0
7784564|NCT01288781|19164562|P1|NOT COMPLETED|Overall Study||0
7784565|NCT01288781|19164561|P2|COMPLETED|Overall Study||12
7784566|NCT01288781|19164562|P1|COMPLETED|Overall Study||11
7784567|NCT01288781|19164561|P2|STARTED|Overall Study||12
7784568|NCT01288781|19164562|P1|STARTED|Overall Study||11
7784569|NCT01288729|19164582|P2|NOT COMPLETED|Overall Study||0
7784570|NCT01288729|19164583|P1|NOT COMPLETED|Overall Study||1
7784571|NCT01288729|19164582|P2|COMPLETED|Overall Study||10
7784572|NCT01288729|19164583|P1|COMPLETED|Overall Study||9
7784573|NCT01288729|19164582|P2|STARTED|Overall Study||10
7784574|NCT01288729|19164583|P1|STARTED|Overall Study||10
7784575|NCT01288612|19164592|P3|NOT COMPLETED|Overall Study||82
7784576|NCT01288612|19164593|P2|NOT COMPLETED|Overall Study||82
7784577|NCT01288612|19164594|P1|NOT COMPLETED|Overall Study||89
7784578|NCT01288612|19164592|P3|COMPLETED|Overall Study||76
7784579|NCT01288612|19164593|P2|COMPLETED|Overall Study||69
7784580|NCT01288612|19164594|P1|COMPLETED|Overall Study||61
7784581|NCT01288612|19164592|P3|Agreed to Take Part|Overall Study||76
7784582|NCT01288612|19164593|P2|Agreed to Take Part|Overall Study||72
7784583|NCT01288612|19164594|P1|Agreed to Take Part|Overall Study||61
7784584|NCT01288612|19164592|P3|Contacted|Overall Study||138
7784585|NCT01288612|19164593|P2|Contacted|Overall Study||135
7784586|NCT01288612|19164594|P1|Contacted|Overall Study||139
7784587|NCT01288612|19164592|P3|STARTED|Overall Study||158
7784588|NCT01288612|19164593|P2|STARTED|Overall Study||151
7784589|NCT01288612|19164594|P1|STARTED|Overall Study||150
7784590|NCT01288534|19164623|P1|NOT COMPLETED|Overall Study||0
7784591|NCT01288534|19164623|P1|COMPLETED|Overall Study||68
7784592|NCT01288534|19164623|P1|STARTED|Overall Study||68
7784593|NCT01288521|19164633|P2|NOT COMPLETED|Overall Study||0
7784594|NCT01288521|19164634|P1|NOT COMPLETED|Overall Study||0
7784595|NCT01288521|19164633|P2|COMPLETED|Overall Study||5
7784596|NCT01288521|19164634|P1|COMPLETED|Overall Study||3
7784597|NCT01288521|19164633|P2|STARTED|Overall Study||5
7784598|NCT01288521|19164634|P1|STARTED|Overall Study||3
7784599|NCT01288469|19164643|P3|NOT COMPLETED|Overall Study||2
7784600|NCT01288469|19164644|P2|NOT COMPLETED|Overall Study||3
7784601|NCT01288469|19164645|P1|NOT COMPLETED|Overall Study||7
7784602|NCT01288469|19164643|P3|COMPLETED|Overall Study||28
7784603|NCT01288469|19164644|P2|COMPLETED|Overall Study||28
7784604|NCT01288469|19164645|P1|COMPLETED|Overall Study||24
7784605|NCT01288469|19164643|P3|Treated|Overall Study||30
7784606|NCT01288469|19164644|P2|Treated|Overall Study||31
7784607|NCT01288469|19164645|P1|Treated|Overall Study||31
7784608|NCT01288469|19164643|P3|STARTED|Overall Study|Randomized|30
7784609|NCT01288469|19164644|P2|STARTED|Overall Study|Randomized|31
7784610|NCT01288469|19164645|P1|STARTED|Overall Study|Randomized|31
7784611|NCT01288443|19164677|P6|NOT COMPLETED|Overall Study||5
7784612|NCT01288443|19164678|P5|NOT COMPLETED|Overall Study||7
7784613|NCT01288443|19164679|P4|NOT COMPLETED|Overall Study||4
7784614|NCT01288443|19164680|P3|NOT COMPLETED|Overall Study||1
7784615|NCT01288443|19164681|P2|NOT COMPLETED|Overall Study||1
7784616|NCT01288443|19164682|P1|NOT COMPLETED|Overall Study||0
7784617|NCT01288443|19164677|P6|COMPLETED|Overall Study||25
7784618|NCT01288443|19164678|P5|COMPLETED|Overall Study||23
7784619|NCT01288443|19164679|P4|COMPLETED|Overall Study||27
7784620|NCT01288443|19164680|P3|COMPLETED|Overall Study||30
7784621|NCT01288443|19164681|P2|COMPLETED|Overall Study||29
7784622|NCT01288443|19164682|P1|COMPLETED|Overall Study||31
7784623|NCT01288443|19164677|P6|Treated|Overall Study||30
7784624|NCT01288443|19164678|P5|Treated|Overall Study||29
7784625|NCT01288443|19164679|P4|Treated|Overall Study||31
7784626|NCT01288443|19164680|P3|Treated|Overall Study||31
7784627|NCT01288443|19164681|P2|Treated|Overall Study||30
7784628|NCT01288443|19164682|P1|Treated|Overall Study||31
7784629|NCT01288443|19164677|P6|STARTED|Overall Study|Randomized|30
7784630|NCT01288443|19164678|P5|STARTED|Overall Study|Randomized|30
7784631|NCT01288443|19164679|P4|STARTED|Overall Study|Randomized|31
7784632|NCT01288443|19164680|P3|STARTED|Overall Study|Randomized|31
7784633|NCT01288443|19164681|P2|STARTED|Overall Study|Randomized|30
7784634|NCT01288443|19164682|P1|STARTED|Overall Study|Randomized|31
7784635|NCT01288430|19164742|P10|NOT COMPLETED|Part 2||3
7784636|NCT01288430|19164743|P9|NOT COMPLETED|Part 2||12
7784637|NCT01288430|19164744|P8|NOT COMPLETED|Part 2||12
7784638|NCT01288430|19164745|P7|NOT COMPLETED|Part 2||0
7784639|NCT01288430|19164746|P6|NOT COMPLETED|Part 2||0
7784640|NCT01288430|19164747|P5|NOT COMPLETED|Part 2||0
7784641|NCT01288430|19164748|P4|NOT COMPLETED|Part 2||0
7784642|NCT01288430|19164749|P3|NOT COMPLETED|Part 2||0
7784643|NCT01288430|19164750|P2|NOT COMPLETED|Part 2||0
7784644|NCT01288430|19164751|P1|NOT COMPLETED|Part 2||0
7784645|NCT01288430|19164742|P10|COMPLETED|Part 2||0
7784646|NCT01288430|19164743|P9|COMPLETED|Part 2||0
7784647|NCT01288430|19164744|P8|COMPLETED|Part 2||0
7784648|NCT01288430|19164745|P7|COMPLETED|Part 2||0
7784649|NCT01288430|19164746|P6|COMPLETED|Part 2||0
7784650|NCT01288430|19164747|P5|COMPLETED|Part 2||0
7784651|NCT01288430|19164748|P4|COMPLETED|Part 2||0
7784652|NCT01288430|19164749|P3|COMPLETED|Part 2||0
7784653|NCT01288430|19164750|P2|COMPLETED|Part 2||0
7784654|NCT01288430|19164751|P1|COMPLETED|Part 2||0
7784655|NCT01288430|19164742|P10|STARTED|Part 2||3
7784656|NCT01288430|19164743|P9|STARTED|Part 2||12
7784657|NCT01288430|19164744|P8|STARTED|Part 2||12
7784658|NCT01288430|19164745|P7|STARTED|Part 2||0
7784659|NCT01288430|19164746|P6|STARTED|Part 2||0
7784660|NCT01288430|19164747|P5|STARTED|Part 2||0
7784661|NCT01288430|19164748|P4|STARTED|Part 2||0
7784662|NCT01288430|19164749|P3|STARTED|Part 2||0
7784663|NCT01288430|19164750|P2|STARTED|Part 2||0
7784664|NCT01288430|19164751|P1|STARTED|Part 2||0
7784665|NCT01288430|19164742|P10|NOT COMPLETED|Part 1||0
7784666|NCT01288430|19164743|P9|NOT COMPLETED|Part 1||0
7784667|NCT01288430|19164744|P8|NOT COMPLETED|Part 1||0
7784668|NCT01288430|19164745|P7|NOT COMPLETED|Part 1||7
7784669|NCT01288430|19164746|P6|NOT COMPLETED|Part 1||6
7784670|NCT01288430|19164747|P5|NOT COMPLETED|Part 1||3
7784671|NCT01288430|19164748|P4|NOT COMPLETED|Part 1||7
7784672|NCT01288430|19164749|P3|NOT COMPLETED|Part 1||5
7784673|NCT01288430|19164750|P2|NOT COMPLETED|Part 1||3
7784674|NCT01288430|19164751|P1|NOT COMPLETED|Part 1||2
7784675|NCT01288430|19164742|P10|COMPLETED|Part 1||0
7784676|NCT01288430|19164743|P9|COMPLETED|Part 1||0
7784677|NCT01288430|19164744|P8|COMPLETED|Part 1||0
7784678|NCT01288430|19164745|P7|COMPLETED|Part 1||0
7784679|NCT01288430|19164746|P6|COMPLETED|Part 1||0
7784680|NCT01288430|19164747|P5|COMPLETED|Part 1||0
7784681|NCT01288430|19164748|P4|COMPLETED|Part 1||0
7784682|NCT01288430|19164749|P3|COMPLETED|Part 1||0
7784683|NCT01288430|19164750|P2|COMPLETED|Part 1||0
7784684|NCT01288430|19164751|P1|COMPLETED|Part 1||0
7784685|NCT01288430|19164742|P10|STARTED|Part 1||0
7784686|NCT01288430|19164743|P9|STARTED|Part 1||0
7784687|NCT01288430|19164744|P8|STARTED|Part 1||0
7784688|NCT01288430|19164745|P7|STARTED|Part 1||7
7784689|NCT01288430|19164746|P6|STARTED|Part 1||6
7784690|NCT01288430|19164747|P5|STARTED|Part 1||3
7784691|NCT01288430|19164748|P4|STARTED|Part 1||7
7784692|NCT01288430|19164749|P3|STARTED|Part 1||5
7784693|NCT01288430|19164750|P2|STARTED|Part 1||3
7784694|NCT01288430|19164751|P1|STARTED|Part 1||2
7784695|NCT01288287|19164875|P1|NOT COMPLETED|Overall Study||46
7784696|NCT01288287|19164875|P1|COMPLETED|Overall Study||103
7784697|NCT01288287|19164875|P1|Full Analysis Set|Overall Study||111
7784698|NCT01288287|19164875|P1|Safety Set|Overall Study||147
7784699|NCT01288287|19164875|P1|STARTED|Overall Study||149
7784700|NCT01288209|19164890|P2|NOT COMPLETED|Overall Study||3
7784701|NCT01288209|19164891|P1|NOT COMPLETED|Overall Study||2
7784702|NCT01288209|19164890|P2|COMPLETED|Overall Study||50
7784703|NCT01288209|19164891|P1|COMPLETED|Overall Study||51
7784704|NCT01288209|19164890|P2|STARTED|Overall Study||53
7784705|NCT01288209|19164891|P1|STARTED|Overall Study||53
7784706|NCT01288079|19164921|P4|NOT COMPLETED|Overall Study||17
7784707|NCT01288079|19164922|P3|NOT COMPLETED|Overall Study||19
7784708|NCT01288079|19164923|P2|NOT COMPLETED|Overall Study||27
7784709|NCT01288079|19164924|P1|NOT COMPLETED|Overall Study||20
7784710|NCT01288079|19164921|P4|COMPLETED|Overall Study||18
7784711|NCT01288079|19164922|P3|COMPLETED|Overall Study||18
7784712|NCT01288079|19164923|P2|COMPLETED|Overall Study||9
7784713|NCT01288079|19164924|P1|COMPLETED|Overall Study||17
7784714|NCT01288079|19164921|P4|STARTED|Overall Study||35
7784715|NCT01288079|19164922|P3|STARTED|Overall Study||37
7784716|NCT01288079|19164923|P2|STARTED|Overall Study||36
7784717|NCT01288079|19164924|P1|STARTED|Overall Study||37
7784718|NCT01288053|19164934|P1|NOT COMPLETED|Overall Study||1
7784719|NCT01288053|19164934|P1|COMPLETED|Overall Study||8
7784720|NCT01288053|19164934|P1|STARTED|Overall Study||9
7784721|NCT01288027|19164938|P1|NOT COMPLETED|Overall Study||0
7784722|NCT01288027|19164938|P1|COMPLETED|Overall Study||16
7784723|NCT01288027|19164938|P1|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16
7784724|NCT01288027|19164938|P1|STARTED|Overall Study||16
7784725|NCT01287897|19164952|P4|NOT COMPLETED|Overall Study||7
7784726|NCT01287897|19164953|P3|NOT COMPLETED|Overall Study||12
7784727|NCT01287897|19164954|P2|NOT COMPLETED|Overall Study||11
7784728|NCT01287897|19164955|P1|NOT COMPLETED|Overall Study||11
7784729|NCT01287897|19164952|P4|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33
7784730|NCT01287897|19164953|P3|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
7784731|NCT01287897|19164954|P2|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58
7784732|NCT01287897|19164955|P1|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
7784733|NCT01287897|19164952|P4|Enrolled in NCT01345318|Overall Study||29
7784734|NCT01287897|19164953|P3|Enrolled in NCT01345318|Overall Study||56
7784735|NCT01287897|19164954|P2|Enrolled in NCT01345318|Overall Study||50
7784736|NCT01287897|19164955|P1|Enrolled in NCT01345318|Overall Study||56
7784737|NCT01287897|19164952|P4|Completed Follow-up Period|Overall Study||4
7784738|NCT01287897|19164953|P3|Completed Follow-up Period|Overall Study||3
7784739|NCT01287897|19164954|P2|Completed Follow-up Period|Overall Study||8
7784740|NCT01287897|19164955|P1|Completed Follow-up Period|Overall Study||3
7784741|NCT01287897|19164952|P4|Completed Treatment Period|Overall Study||29
7784742|NCT01287897|19164953|P3|Completed Treatment Period|Overall Study||58
7784743|NCT01287897|19164954|P2|Completed Treatment Period|Overall Study||52
7784744|NCT01287897|19164955|P1|Completed Treatment Period|Overall Study||58
7784745|NCT01287897|19164952|P4|Treated|Overall Study||40
7784746|NCT01287897|19164953|P3|Treated|Overall Study||71
7784747|NCT01287897|19164954|P2|Treated|Overall Study||67
7784748|NCT01287897|19164955|P1|Treated|Overall Study||69
7784749|NCT01287897|19164952|P4|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40
7784750|NCT01287897|19164953|P3|STARTED|Overall Study||71
7784751|NCT01287897|19164954|P2|STARTED|Overall Study||69
7784752|NCT01287897|19164955|P1|STARTED|Overall Study||70
7784753|NCT01287832|19165006|P2|NOT COMPLETED|Overall Study||1
7784754|NCT01287832|19165007|P1|NOT COMPLETED|Overall Study||1
7784755|NCT01287832|19165006|P2|COMPLETED|Overall Study||4
7784756|NCT01287832|19165007|P1|COMPLETED|Overall Study||5
7784757|NCT01287832|19165006|P2|STARTED|Overall Study||5
7784758|NCT01287832|19165007|P1|STARTED|Overall Study||6
7784759|NCT01287754|19165015|P2|NOT COMPLETED|Overall Study||21
7784760|NCT01287754|19165016|P1|NOT COMPLETED|Overall Study||3
7784761|NCT01287754|19165015|P2|COMPLETED|Overall Study||0
7784762|NCT01287754|19165016|P1|COMPLETED|Overall Study||0
7784763|NCT01287754|19165015|P2|STARTED|Overall Study||21
7784764|NCT01287754|19165016|P1|STARTED|Overall Study||3
7784765|NCT01287741|19165028|P2|NOT COMPLETED|Overall Study||615
7784766|NCT01287741|19165029|P1|NOT COMPLETED|Overall Study||626
7784767|NCT01287741|19165028|P2|COMPLETED|Overall Study||91
7784768|NCT01287741|19165029|P1|COMPLETED|Overall Study||86
7784769|NCT01287741|19165028|P2|STARTED|Overall Study||706
7784770|NCT01287741|19165029|P1|STARTED|Overall Study||712
7784771|NCT01287611|19165065|P2|NOT COMPLETED|Overall Study||19
7784772|NCT01287611|19165066|P1|NOT COMPLETED|Overall Study||33
7784773|NCT01287611|19165065|P2|COMPLETED|Overall Study||65
7784774|NCT01287611|19165066|P1|COMPLETED|Overall Study||51
7784775|NCT01287611|19165065|P2|The Number of Patients Who Underwent C/S|Overall Study||84
7784776|NCT01287611|19165066|P1|The Number of Patients Who Underwent C/S|Overall Study||84
7784777|NCT01287611|19165065|P2|STARTED|Overall Study||84
7784778|NCT01287611|19165066|P1|STARTED|Overall Study||84
7784779|NCT01287520|19165083|P9|NOT COMPLETED|Overall Study||5
7784780|NCT01287520|19165084|P8|NOT COMPLETED|Overall Study||5
7784781|NCT01287520|19165085|P7|NOT COMPLETED|Overall Study||2
7784782|NCT01287520|19165086|P6|NOT COMPLETED|Overall Study||4
7784783|NCT01287520|19165087|P5|NOT COMPLETED|Overall Study||3
7784784|NCT01287520|19165088|P4|NOT COMPLETED|Overall Study||7
7784785|NCT01287520|19165089|P3|NOT COMPLETED|Overall Study||5
7784786|NCT01287520|19165090|P2|NOT COMPLETED|Overall Study||7
7784787|NCT01287520|19165091|P1|NOT COMPLETED|Overall Study||3
7784788|NCT01287520|19165083|P9|COMPLETED|Overall Study||0
7784789|NCT01287520|19165084|P8|COMPLETED|Overall Study||0
7784790|NCT01287520|19165085|P7|COMPLETED|Overall Study||0
7784791|NCT01287520|19165086|P6|COMPLETED|Overall Study||0
7784792|NCT01287520|19165087|P5|COMPLETED|Overall Study||0
7784793|NCT01287520|19165088|P4|COMPLETED|Overall Study||0
7784794|NCT01287520|19165089|P3|COMPLETED|Overall Study||0
7784795|NCT01287520|19165090|P2|COMPLETED|Overall Study||0
7784796|NCT01287520|19165091|P1|COMPLETED|Overall Study||0
7784797|NCT01287520|19165083|P9|STARTED|Overall Study||5
7784798|NCT01287520|19165084|P8|STARTED|Overall Study||5
7784799|NCT01287520|19165085|P7|STARTED|Overall Study||2
7784800|NCT01287520|19165086|P6|STARTED|Overall Study||4
7784801|NCT01287520|19165087|P5|STARTED|Overall Study||3
7784802|NCT01287520|19165088|P4|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
7784803|NCT01287520|19165089|P3|STARTED|Overall Study||5
7784804|NCT01287520|19165090|P2|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
7784805|NCT01287520|19165091|P1|STARTED|Overall Study||3
7784806|NCT01287416|19165155|P2|NOT COMPLETED|6 Month Follow-up||2
7784807|NCT01287416|19165156|P1|NOT COMPLETED|6 Month Follow-up||3
7784808|NCT01287416|19165155|P2|COMPLETED|6 Month Follow-up||22
7784809|NCT01287416|19165156|P1|COMPLETED|6 Month Follow-up||28
7784810|NCT01287416|19165155|P2|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24
7784811|NCT01287416|19165156|P1|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31
7784812|NCT01287416|19165155|P2|NOT COMPLETED|Pre-post Training||25
7784813|NCT01287416|19165156|P1|NOT COMPLETED|Pre-post Training||22
7784814|NCT01287416|19165155|P2|COMPLETED|Pre-post Training||23
7784815|NCT01287416|19165156|P1|COMPLETED|Pre-post Training||26
7784816|NCT01287416|19165155|P2|Post Training Questionnaire|Pre-post Training||23
7784817|NCT01287416|19165156|P1|Post Training Questionnaire|Pre-post Training||26
7784818|NCT01287416|19165155|P2|Training Workshop|Pre-post Training|number of people that showed up for the training session|24
7784819|NCT01287416|19165156|P1|Training Workshop|Pre-post Training|number of people that showed up for the training session|31
7784820|NCT01287416|19165155|P2|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
7784821|NCT01287416|19165156|P1|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
7784822|NCT01287403|19165192|P1|NOT COMPLETED|6th and Last Intervention (1 Day)||0
7784823|NCT01287403|19165192|P1|COMPLETED|6th and Last Intervention (1 Day)||13
7784824|NCT01287403|19165192|P1|STARTED|6th and Last Intervention (1 Day)||13
7784825|NCT01287403|19165192|P1|NOT COMPLETED|Washout (7 Days)||0
7784826|NCT01287403|19165192|P1|COMPLETED|Washout (7 Days)||13
7784827|NCT01287403|19165192|P1|STARTED|Washout (7 Days)||13
7784828|NCT01287403|19165192|P1|NOT COMPLETED|5th Intervention (1 Day)||0
7784829|NCT01287403|19165192|P1|COMPLETED|5th Intervention (1 Day)||13
7784830|NCT01287403|19165192|P1|STARTED|5th Intervention (1 Day)||13
7784831|NCT01287403|19165192|P1|NOT COMPLETED|Washout (7 Days)||0
7784832|NCT01287403|19165192|P1|COMPLETED|Washout (7 Days)||13
7784833|NCT01287403|19165192|P1|STARTED|Washout (7 Days)||13
7784834|NCT01287403|19165192|P1|NOT COMPLETED|4th Intervention (1 Day)||0
7784835|NCT01287403|19165192|P1|COMPLETED|4th Intervention (1 Day)||13
7784836|NCT01287403|19165192|P1|STARTED|4th Intervention (1 Day)||13
7784837|NCT01287403|19165192|P1|NOT COMPLETED|Washout (7 Days)||0
7784838|NCT01287403|19165192|P1|COMPLETED|Washout (7 Days)||13
7784839|NCT01287403|19165192|P1|STARTED|Washout (7 Days)||13
7784840|NCT01287403|19165192|P1|NOT COMPLETED|3rd Intervention (1 Day)||0
7784841|NCT01287403|19165192|P1|COMPLETED|3rd Intervention (1 Day)||13
7784842|NCT01287403|19165192|P1|STARTED|3rd Intervention (1 Day)||13
7784843|NCT01287403|19165192|P1|NOT COMPLETED|Washout (7 Days)||0
7784844|NCT01287403|19165192|P1|COMPLETED|Washout (7 Days)||13
7784845|NCT01287403|19165192|P1|STARTED|Washout (7 Days)||13
7784846|NCT01287403|19165192|P1|NOT COMPLETED|2nd Intervention (1 Day)||0
7784847|NCT01287403|19165192|P1|COMPLETED|2nd Intervention (1 Day)||13
7784848|NCT01287403|19165192|P1|STARTED|2nd Intervention (1 Day)||13
7784849|NCT01287403|19165192|P1|NOT COMPLETED|Washout 7 Days||0
7784850|NCT01287403|19165192|P1|COMPLETED|Washout 7 Days||13
7784851|NCT01287403|19165192|P1|STARTED|Washout 7 Days||13
7784852|NCT01287403|19165192|P1|NOT COMPLETED|1st Intervention (1 Day)||1
7784853|NCT01287403|19165192|P1|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13
7784854|NCT01287403|19165192|P1|STARTED|1st Intervention (1 Day)||14
7784855|NCT01287403|19165192|P1|NOT COMPLETED|Diet Restriction (7 Days)||0
7784856|NCT01287403|19165192|P1|COMPLETED|Diet Restriction (7 Days)||14
7784857|NCT01287403|19165192|P1|STARTED|Diet Restriction (7 Days)||14
7784858|NCT01287377|19165209|P3|NOT COMPLETED|Overall Study||0
7784859|NCT01287377|19165210|P2|NOT COMPLETED|Overall Study||0
7784860|NCT01287377|19165211|P1|NOT COMPLETED|Overall Study||0
7784861|NCT01287377|19165209|P3|COMPLETED|Overall Study|Study Complete|82
7784862|NCT01287377|19165210|P2|COMPLETED|Overall Study|Study Complete|81
7784863|NCT01287377|19165211|P1|COMPLETED|Overall Study|Study Complete|80
7784864|NCT01287377|19165209|P3|STARTED|Overall Study||82
7784865|NCT01287377|19165210|P2|STARTED|Overall Study||81
7784866|NCT01287377|19165211|P1|STARTED|Overall Study||80
7784867|NCT01287364|19165224|P2|NOT COMPLETED|Overall Study||10
7784868|NCT01287364|19165225|P1|NOT COMPLETED|Overall Study||9
7784869|NCT01287364|19165224|P2|COMPLETED|Overall Study||81
7784870|NCT01287364|19165225|P1|COMPLETED|Overall Study||85
7784871|NCT01287364|19165224|P2|STARTED|Overall Study||91
7784872|NCT01287364|19165225|P1|STARTED|Overall Study||94
7784873|NCT01287221|19165247|P2|NOT COMPLETED|Overall Study||5
7784874|NCT01287221|19165248|P1|NOT COMPLETED|Overall Study||4
7784875|NCT01287221|19165247|P2|COMPLETED|Overall Study||45
7784876|NCT01287221|19165248|P1|COMPLETED|Overall Study||46
7784877|NCT01287221|19165247|P2|Completed 12 Months Follow-up|Overall Study||39
7784878|NCT01287221|19165248|P1|Completed 12 Months Follow-up|Overall Study||40
7784879|NCT01287221|19165247|P2|Completed 9 Months Follow-up|Overall Study||40
7784880|NCT01287221|19165248|P1|Completed 9 Months Follow-up|Overall Study||42
7784881|NCT01287221|19165247|P2|Completed 6 Months Follow-up|Overall Study||43
7784882|NCT01287221|19165248|P1|Completed 6 Months Follow-up|Overall Study||47
7784883|NCT01287221|19165247|P2|Completed 3 Months Follow-up|Overall Study||50
7784884|NCT01287221|19165248|P1|Completed 3 Months Follow-up|Overall Study||49
7784885|NCT01287221|19165247|P2|STARTED|Overall Study||50
7784886|NCT01287221|19165248|P1|STARTED|Overall Study||50
7784887|NCT01287208|19165268|P2|NOT COMPLETED|Phase 2: Team Competition||0
7784888|NCT01287208|19165269|P1|NOT COMPLETED|Phase 2: Team Competition||0
7784889|NCT01287208|19165268|P2|COMPLETED|Phase 2: Team Competition||49
7784890|NCT01287208|19165269|P1|COMPLETED|Phase 2: Team Competition||50
7784891|NCT01287208|19165268|P2|STARTED|Phase 2: Team Competition||49
7784892|NCT01287208|19165269|P1|STARTED|Phase 2: Team Competition||50
7784893|NCT01287208|19165268|P2|NOT COMPLETED|Phase 1: Randomized Phase||3
7784894|NCT01287208|19165269|P1|NOT COMPLETED|Phase 1: Randomized Phase||2
7784895|NCT01287208|19165268|P2|COMPLETED|Phase 1: Randomized Phase||49
7784896|NCT01287208|19165269|P1|COMPLETED|Phase 1: Randomized Phase||50
7784897|NCT01287208|19165268|P2|STARTED|Phase 1: Randomized Phase||52
7784898|NCT01287208|19165269|P1|STARTED|Phase 1: Randomized Phase||52
7784899|NCT01287195|19165283|P1|NOT COMPLETED|Overall Study||2
7784900|NCT01287195|19165283|P1|COMPLETED|Overall Study||4
7784901|NCT01287195|19165283|P1|STARTED|Overall Study||6
7784902|NCT01287117|19165298|P4|NOT COMPLETED|Overall Study||12
7784903|NCT01287117|19165299|P3|NOT COMPLETED|Overall Study||16
7784904|NCT01287117|19165300|P2|NOT COMPLETED|Overall Study||14
7784905|NCT01287117|19165301|P1|NOT COMPLETED|Overall Study||15
7784906|NCT01287117|19165298|P4|COMPLETED|Overall Study||69
7784907|NCT01287117|19165299|P3|COMPLETED|Overall Study||64
7784908|NCT01287117|19165300|P2|COMPLETED|Overall Study||64
7784909|NCT01287117|19165301|P1|COMPLETED|Overall Study||65
7784910|NCT01287117|19165298|P4|Received Treatment|Overall Study||81
7784911|NCT01287117|19165299|P3|Received Treatment|Overall Study||80
7784912|NCT01287117|19165300|P2|Received Treatment|Overall Study||77
7784913|NCT01287117|19165301|P1|Received Treatment|Overall Study||80
7784914|NCT01287117|19165298|P4|STARTED|Overall Study||81
7784915|NCT01287117|19165299|P3|STARTED|Overall Study||80
7784916|NCT01287117|19165300|P2|STARTED|Overall Study||78
7784917|NCT01287117|19165301|P1|STARTED|Overall Study||80
7784918|NCT01287104|19165351|P4|NOT COMPLETED|Overall Study||3
7784919|NCT01287104|19165352|P3|NOT COMPLETED|Overall Study||7
7784920|NCT01287104|19165353|P2|NOT COMPLETED|Overall Study||5
7784921|NCT01287104|19165354|P1|NOT COMPLETED|Overall Study||1
7784922|NCT01287104|19165351|P4|COMPLETED|Overall Study||8
7784923|NCT01287104|19165352|P3|COMPLETED|Overall Study||5
7784924|NCT01287104|19165353|P2|COMPLETED|Overall Study||2
7784925|NCT01287104|19165354|P1|COMPLETED|Overall Study||3
7784926|NCT01287104|19165351|P4|STARTED|Overall Study||11
7784927|NCT01287104|19165352|P3|STARTED|Overall Study||12
7784928|NCT01287104|19165353|P2|STARTED|Overall Study||7
7784929|NCT01287104|19165354|P1|STARTED|Overall Study||4
7784930|NCT01287078|19165389|P2|NOT COMPLETED|Overall Study||2
7784931|NCT01287078|19165390|P1|NOT COMPLETED|Overall Study||10
7784932|NCT01287078|19165389|P2|COMPLETED|Overall Study||1
7784933|NCT01287078|19165390|P1|COMPLETED|Overall Study||10
7784934|NCT01287078|19165389|P2|STARTED|Overall Study||3
7784935|NCT01287078|19165390|P1|STARTED|Overall Study||20
7784936|NCT01287065|19165410|P6|NOT COMPLETED|Treatment Period 3||0
7784937|NCT01287065|19165411|P5|NOT COMPLETED|Treatment Period 3||0
7784938|NCT01287065|19165412|P4|NOT COMPLETED|Treatment Period 3||0
7784939|NCT01287065|19165413|P3|NOT COMPLETED|Treatment Period 3||0
7784940|NCT01287065|19165414|P2|NOT COMPLETED|Treatment Period 3||0
7784941|NCT01287065|19165415|P1|NOT COMPLETED|Treatment Period 3||0
7784942|NCT01287065|19165410|P6|COMPLETED|Treatment Period 3||4
7784943|NCT01287065|19165411|P5|COMPLETED|Treatment Period 3||4
7784944|NCT01287065|19165412|P4|COMPLETED|Treatment Period 3||4
7784945|NCT01287065|19165413|P3|COMPLETED|Treatment Period 3||4
7784946|NCT01287065|19165414|P2|COMPLETED|Treatment Period 3||4
7784947|NCT01287065|19165415|P1|COMPLETED|Treatment Period 3||4
7784948|NCT01287065|19165410|P6|STARTED|Treatment Period 3||4
7784949|NCT01287065|19165411|P5|STARTED|Treatment Period 3||4
7784950|NCT01287065|19165412|P4|STARTED|Treatment Period 3||4
7784951|NCT01287065|19165413|P3|STARTED|Treatment Period 3||4
7784952|NCT01287065|19165414|P2|STARTED|Treatment Period 3||4
7784953|NCT01287065|19165415|P1|STARTED|Treatment Period 3||4
7784954|NCT01287065|19165410|P6|NOT COMPLETED|Washout Period 2||0
7784955|NCT01287065|19165411|P5|NOT COMPLETED|Washout Period 2||0
7784956|NCT01287065|19165412|P4|NOT COMPLETED|Washout Period 2||0
7784957|NCT01287065|19165413|P3|NOT COMPLETED|Washout Period 2||0
7784958|NCT01287065|19165414|P2|NOT COMPLETED|Washout Period 2||0
7784959|NCT01287065|19165415|P1|NOT COMPLETED|Washout Period 2||0
7784960|NCT01287065|19165410|P6|COMPLETED|Washout Period 2||4
7784961|NCT01287065|19165411|P5|COMPLETED|Washout Period 2||4
7784962|NCT01287065|19165412|P4|COMPLETED|Washout Period 2||4
7784963|NCT01287065|19165413|P3|COMPLETED|Washout Period 2||4
7784964|NCT01287065|19165414|P2|COMPLETED|Washout Period 2||4
7784965|NCT01287065|19165415|P1|COMPLETED|Washout Period 2||4
7784966|NCT01287065|19165410|P6|STARTED|Washout Period 2||4
7784967|NCT01287065|19165411|P5|STARTED|Washout Period 2||4
7784968|NCT01287065|19165412|P4|STARTED|Washout Period 2||4
7784969|NCT01287065|19165413|P3|STARTED|Washout Period 2||4
7784970|NCT01287065|19165414|P2|STARTED|Washout Period 2||4
7784971|NCT01287065|19165415|P1|STARTED|Washout Period 2||4
7784972|NCT01287065|19165410|P6|NOT COMPLETED|Treatment Period 2||0
7784973|NCT01287065|19165411|P5|NOT COMPLETED|Treatment Period 2||0
7784974|NCT01287065|19165412|P4|NOT COMPLETED|Treatment Period 2||0
7784975|NCT01287065|19165413|P3|NOT COMPLETED|Treatment Period 2||0
7784976|NCT01287065|19165414|P2|NOT COMPLETED|Treatment Period 2||0
7784977|NCT01287065|19165415|P1|NOT COMPLETED|Treatment Period 2||0
7784978|NCT01287065|19165410|P6|COMPLETED|Treatment Period 2||4
7784979|NCT01287065|19165411|P5|COMPLETED|Treatment Period 2||4
7784980|NCT01287065|19165412|P4|COMPLETED|Treatment Period 2||4
7784981|NCT01287065|19165413|P3|COMPLETED|Treatment Period 2||4
7784982|NCT01287065|19165414|P2|COMPLETED|Treatment Period 2||4
7784983|NCT01287065|19165415|P1|COMPLETED|Treatment Period 2||4
7784984|NCT01287065|19165410|P6|STARTED|Treatment Period 2||4
7784985|NCT01287065|19165411|P5|STARTED|Treatment Period 2||4
7784986|NCT01287065|19165412|P4|STARTED|Treatment Period 2||4
7784987|NCT01287065|19165413|P3|STARTED|Treatment Period 2||4
7784988|NCT01287065|19165414|P2|STARTED|Treatment Period 2||4
7784989|NCT01287065|19165415|P1|STARTED|Treatment Period 2||4
7784990|NCT01287065|19165410|P6|NOT COMPLETED|Washout Period 1||0
7784991|NCT01287065|19165411|P5|NOT COMPLETED|Washout Period 1||0
7784992|NCT01287065|19165412|P4|NOT COMPLETED|Washout Period 1||0
7784993|NCT01287065|19165413|P3|NOT COMPLETED|Washout Period 1||0
7784994|NCT01287065|19165414|P2|NOT COMPLETED|Washout Period 1||0
7784995|NCT01287065|19165415|P1|NOT COMPLETED|Washout Period 1||0
7784996|NCT01287065|19165410|P6|COMPLETED|Washout Period 1||4
7784997|NCT01287065|19165411|P5|COMPLETED|Washout Period 1||4
7784998|NCT01287065|19165412|P4|COMPLETED|Washout Period 1||4
7784999|NCT01287065|19165413|P3|COMPLETED|Washout Period 1||4
7785000|NCT01287065|19165414|P2|COMPLETED|Washout Period 1||4
7785001|NCT01287065|19165415|P1|COMPLETED|Washout Period 1||4
7785002|NCT01287065|19165410|P6|STARTED|Washout Period 1||4
7785003|NCT01287065|19165411|P5|STARTED|Washout Period 1||4
7785004|NCT01287065|19165412|P4|STARTED|Washout Period 1||4
7785005|NCT01287065|19165413|P3|STARTED|Washout Period 1||4
7785006|NCT01287065|19165414|P2|STARTED|Washout Period 1||4
7785007|NCT01287065|19165415|P1|STARTED|Washout Period 1||4
7785008|NCT01287065|19165410|P6|NOT COMPLETED|Treatment Period 1||1
7785009|NCT01287065|19165411|P5|NOT COMPLETED|Treatment Period 1||1
7785010|NCT01287065|19165412|P4|NOT COMPLETED|Treatment Period 1||0
7785011|NCT01287065|19165413|P3|NOT COMPLETED|Treatment Period 1||0
7785012|NCT01287065|19165414|P2|NOT COMPLETED|Treatment Period 1||0
7785013|NCT01287065|19165415|P1|NOT COMPLETED|Treatment Period 1||0
7785014|NCT01287065|19165410|P6|COMPLETED|Treatment Period 1||4
7785015|NCT01287065|19165411|P5|COMPLETED|Treatment Period 1||4
7785016|NCT01287065|19165412|P4|COMPLETED|Treatment Period 1||4
7785017|NCT01287065|19165413|P3|COMPLETED|Treatment Period 1||4
7785018|NCT01287065|19165414|P2|COMPLETED|Treatment Period 1||4
7785019|NCT01287065|19165415|P1|COMPLETED|Treatment Period 1||4
7785020|NCT01287065|19165410|P6|STARTED|Treatment Period 1||5
7785021|NCT01287065|19165411|P5|STARTED|Treatment Period 1||5
7785022|NCT01287065|19165412|P4|STARTED|Treatment Period 1||4
7785023|NCT01287065|19165413|P3|STARTED|Treatment Period 1||4
7785024|NCT01287065|19165414|P2|STARTED|Treatment Period 1||4
7785025|NCT01287065|19165415|P1|STARTED|Treatment Period 1||4
7785026|NCT01287039|19165434|P2|NOT COMPLETED|Overall Study||27
7785027|NCT01287039|19165435|P1|NOT COMPLETED|Overall Study||29
7785028|NCT01287039|19165434|P2|COMPLETED|Overall Study||218
7785029|NCT01287039|19165435|P1|COMPLETED|Overall Study||215
7785030|NCT01287039|19165434|P2|STARTED|Overall Study||245
7785031|NCT01287039|19165435|P1|STARTED|Overall Study||244
7785032|NCT01287013|19165468|P3|NOT COMPLETED|Overall Study||21
7785033|NCT01287013|19165469|P2|NOT COMPLETED|Overall Study||5
7785034|NCT01287013|19165470|P1|NOT COMPLETED|Overall Study||3
7785035|NCT01287013|19165468|P3|COMPLETED|Overall Study||0
7785036|NCT01287013|19165469|P2|COMPLETED|Overall Study||29
7785037|NCT01287013|19165470|P1|COMPLETED|Overall Study||29
7785038|NCT01287013|19165468|P3|STARTED|Overall Study||21
7785039|NCT01287013|19165469|P2|STARTED|Overall Study||34
7785040|NCT01287013|19165470|P1|STARTED|Overall Study||32
7785041|NCT01286987|19165500|P15|NOT COMPLETED|Part 2: Dose Expansion||2
7785042|NCT01286987|19165501|P14|NOT COMPLETED|Part 2: Dose Expansion||24
7785043|NCT01286987|19165502|P13|NOT COMPLETED|Part 2: Dose Expansion||12
7785044|NCT01286987|19165503|P12|NOT COMPLETED|Part 2: Dose Expansion||10
7785045|NCT01286987|19165504|P11|NOT COMPLETED|Part 2: Dose Expansion||10
7785046|NCT01286987|19165505|P10|NOT COMPLETED|Part 2: Dose Expansion||11
7785047|NCT01286987|19165506|P9|NOT COMPLETED|Part 2: Dose Expansion||0
7785048|NCT01286987|19165507|P8|NOT COMPLETED|Part 2: Dose Expansion||0
7785049|NCT01286987|19165508|P7|NOT COMPLETED|Part 2: Dose Expansion||0
7785050|NCT01286987|19165509|P6|NOT COMPLETED|Part 2: Dose Expansion||0
7785051|NCT01286987|19165510|P5|NOT COMPLETED|Part 2: Dose Expansion||0
7785052|NCT01286987|19165511|P4|NOT COMPLETED|Part 2: Dose Expansion||0
7785053|NCT01286987|19165512|P3|NOT COMPLETED|Part 2: Dose Expansion||0
7785054|NCT01286987|19165513|P2|NOT COMPLETED|Part 2: Dose Expansion||0
7785055|NCT01286987|19165514|P1|NOT COMPLETED|Part 2: Dose Expansion||0
7785056|NCT01286987|19165500|P15|COMPLETED|Part 2: Dose Expansion||1
7785057|NCT01286987|19165501|P14|COMPLETED|Part 2: Dose Expansion||0
7785058|NCT01286987|19165502|P13|COMPLETED|Part 2: Dose Expansion||0
7785059|NCT01286987|19165503|P12|COMPLETED|Part 2: Dose Expansion||1
7785060|NCT01286987|19165504|P11|COMPLETED|Part 2: Dose Expansion||2
7785061|NCT01286987|19165505|P10|COMPLETED|Part 2: Dose Expansion||1
7785062|NCT01286987|19165506|P9|COMPLETED|Part 2: Dose Expansion||0
7785063|NCT01286987|19165507|P8|COMPLETED|Part 2: Dose Expansion||0
7785064|NCT01286987|19165508|P7|COMPLETED|Part 2: Dose Expansion||0
7785065|NCT01286987|19165509|P6|COMPLETED|Part 2: Dose Expansion||0
7785066|NCT01286987|19165510|P5|COMPLETED|Part 2: Dose Expansion||0
7785067|NCT01286987|19165511|P4|COMPLETED|Part 2: Dose Expansion||0
7785068|NCT01286987|19165512|P3|COMPLETED|Part 2: Dose Expansion||0
7785069|NCT01286987|19165513|P2|COMPLETED|Part 2: Dose Expansion||0
7785070|NCT01286987|19165514|P1|COMPLETED|Part 2: Dose Expansion||0
7785071|NCT01286987|19165500|P15|Treated|Part 2: Dose Expansion||3
7785072|NCT01286987|19165501|P14|Treated|Part 2: Dose Expansion||23
7785073|NCT01286987|19165502|P13|Treated|Part 2: Dose Expansion||12
7785074|NCT01286987|19165503|P12|Treated|Part 2: Dose Expansion||10
7785075|NCT01286987|19165504|P11|Treated|Part 2: Dose Expansion||11
7785076|NCT01286987|19165505|P10|Treated|Part 2: Dose Expansion||12
7785077|NCT01286987|19165506|P9|Treated|Part 2: Dose Expansion||0
7785078|NCT01286987|19165507|P8|Treated|Part 2: Dose Expansion||0
7785079|NCT01286987|19165508|P7|Treated|Part 2: Dose Expansion||0
7785080|NCT01286987|19165509|P6|Treated|Part 2: Dose Expansion||0
7785081|NCT01286987|19165510|P5|Treated|Part 2: Dose Expansion||0
7785082|NCT01286987|19165511|P4|Treated|Part 2: Dose Expansion||0
7785083|NCT01286987|19165512|P3|Treated|Part 2: Dose Expansion||0
7785084|NCT01286987|19165513|P2|Treated|Part 2: Dose Expansion||0
7785085|NCT01286987|19165514|P1|Treated|Part 2: Dose Expansion||0
7785086|NCT01286987|19165500|P15|STARTED|Part 2: Dose Expansion||3
7785087|NCT01286987|19165501|P14|STARTED|Part 2: Dose Expansion||24
7785088|NCT01286987|19165502|P13|STARTED|Part 2: Dose Expansion||12
7785089|NCT01286987|19165503|P12|STARTED|Part 2: Dose Expansion||11
7785090|NCT01286987|19165504|P11|STARTED|Part 2: Dose Expansion||12
7785091|NCT01286987|19165505|P10|STARTED|Part 2: Dose Expansion||12
7785092|NCT01286987|19165506|P9|STARTED|Part 2: Dose Expansion||0
7785093|NCT01286987|19165507|P8|STARTED|Part 2: Dose Expansion||0
7785094|NCT01286987|19165508|P7|STARTED|Part 2: Dose Expansion||0
7785095|NCT01286987|19165509|P6|STARTED|Part 2: Dose Expansion||0
7785096|NCT01286987|19165510|P5|STARTED|Part 2: Dose Expansion||0
7785097|NCT01286987|19165511|P4|STARTED|Part 2: Dose Expansion||0
7785098|NCT01286987|19165512|P3|STARTED|Part 2: Dose Expansion||0
7785099|NCT01286987|19165513|P2|STARTED|Part 2: Dose Expansion||0
7785100|NCT01286987|19165514|P1|STARTED|Part 2: Dose Expansion||0
7785101|NCT01286987|19165500|P15|NOT COMPLETED|Part 1: Dose Escalation||0
7785102|NCT01286987|19165501|P14|NOT COMPLETED|Part 1: Dose Escalation||0
7785103|NCT01286987|19165502|P13|NOT COMPLETED|Part 1: Dose Escalation||0
7785104|NCT01286987|19165503|P12|NOT COMPLETED|Part 1: Dose Escalation||0
7785105|NCT01286987|19165504|P11|NOT COMPLETED|Part 1: Dose Escalation||0
7785106|NCT01286987|19165505|P10|NOT COMPLETED|Part 1: Dose Escalation||0
7785107|NCT01286987|19165506|P9|NOT COMPLETED|Part 1: Dose Escalation||6
7785108|NCT01286987|19165507|P8|NOT COMPLETED|Part 1: Dose Escalation||5
7785109|NCT01286987|19165508|P7|NOT COMPLETED|Part 1: Dose Escalation||5
7785110|NCT01286987|19165509|P6|NOT COMPLETED|Part 1: Dose Escalation||6
7785111|NCT01286987|19165510|P5|NOT COMPLETED|Part 1: Dose Escalation||3
7785112|NCT01286987|19165511|P4|NOT COMPLETED|Part 1: Dose Escalation||3
7785113|NCT01286987|19165512|P3|NOT COMPLETED|Part 1: Dose Escalation||3
7785114|NCT01286987|19165513|P2|NOT COMPLETED|Part 1: Dose Escalation||3
7785115|NCT01286987|19165514|P1|NOT COMPLETED|Part 1: Dose Escalation||3
7785116|NCT01286987|19165500|P15|COMPLETED|Part 1: Dose Escalation||0
7785117|NCT01286987|19165501|P14|COMPLETED|Part 1: Dose Escalation||0
7785118|NCT01286987|19165502|P13|COMPLETED|Part 1: Dose Escalation||0
7785119|NCT01286987|19165503|P12|COMPLETED|Part 1: Dose Escalation||0
7785120|NCT01286987|19165504|P11|COMPLETED|Part 1: Dose Escalation||0
7785121|NCT01286987|19165505|P10|COMPLETED|Part 1: Dose Escalation||0
7785122|NCT01286987|19165506|P9|COMPLETED|Part 1: Dose Escalation||0
7785123|NCT01286987|19165507|P8|COMPLETED|Part 1: Dose Escalation||1
7785124|NCT01286987|19165508|P7|COMPLETED|Part 1: Dose Escalation||1
7785125|NCT01286987|19165509|P6|COMPLETED|Part 1: Dose Escalation||0
7785126|NCT01286987|19165510|P5|COMPLETED|Part 1: Dose Escalation||0
7785127|NCT01286987|19165511|P4|COMPLETED|Part 1: Dose Escalation||0
7785128|NCT01286987|19165512|P3|COMPLETED|Part 1: Dose Escalation||0
7785129|NCT01286987|19165513|P2|COMPLETED|Part 1: Dose Escalation||0
7785130|NCT01286987|19165514|P1|COMPLETED|Part 1: Dose Escalation||0
7785131|NCT01286987|19165500|P15|Breast Cancer|Part 1: Dose Escalation||0
7785132|NCT01286987|19165501|P14|Breast Cancer|Part 1: Dose Escalation||0
7785133|NCT01286987|19165502|P13|Breast Cancer|Part 1: Dose Escalation||0
7785134|NCT01286987|19165503|P12|Breast Cancer|Part 1: Dose Escalation||0
7785135|NCT01286987|19165504|P11|Breast Cancer|Part 1: Dose Escalation||0
7785136|NCT01286987|19165505|P10|Breast Cancer|Part 1: Dose Escalation||0
7785137|NCT01286987|19165506|P9|Breast Cancer|Part 1: Dose Escalation||3
7785138|NCT01286987|19165507|P8|Breast Cancer|Part 1: Dose Escalation||2
7785139|NCT01286987|19165508|P7|Breast Cancer|Part 1: Dose Escalation||2
7785140|NCT01286987|19165509|P6|Breast Cancer|Part 1: Dose Escalation||1
7785141|NCT01286987|19165510|P5|Breast Cancer|Part 1: Dose Escalation||0
7785142|NCT01286987|19165511|P4|Breast Cancer|Part 1: Dose Escalation||0
7785143|NCT01286987|19165512|P3|Breast Cancer|Part 1: Dose Escalation||0
7785144|NCT01286987|19165513|P2|Breast Cancer|Part 1: Dose Escalation||0
7785145|NCT01286987|19165514|P1|Breast Cancer|Part 1: Dose Escalation||0
7785146|NCT01286987|19165500|P15|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
7785147|NCT01286987|19165501|P14|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
7785148|NCT01286987|19165502|P13|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
7785149|NCT01286987|19165503|P12|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
7785150|NCT01286987|19165504|P11|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
7785151|NCT01286987|19165505|P10|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
7785152|NCT01286987|19165506|P9|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
7785153|NCT01286987|19165507|P8|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
7785154|NCT01286987|19165508|P7|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
7785155|NCT01286987|19165509|P6|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
7785156|NCT01286987|19165510|P5|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
7785157|NCT01286987|19165511|P4|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
7785158|NCT01286987|19165512|P3|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
7785159|NCT01286987|19165513|P2|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
7785160|NCT01286987|19165514|P1|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
7785161|NCT01286987|19165500|P15|Pancreatic Cancer|Part 1: Dose Escalation||0
7785162|NCT01286987|19165501|P14|Pancreatic Cancer|Part 1: Dose Escalation||0
7785163|NCT01286987|19165502|P13|Pancreatic Cancer|Part 1: Dose Escalation||0
7785164|NCT01286987|19165503|P12|Pancreatic Cancer|Part 1: Dose Escalation||0
7785165|NCT01286987|19165504|P11|Pancreatic Cancer|Part 1: Dose Escalation||0
7785166|NCT01286987|19165505|P10|Pancreatic Cancer|Part 1: Dose Escalation||0
7785167|NCT01286987|19165506|P9|Pancreatic Cancer|Part 1: Dose Escalation||0
7785168|NCT01286987|19165507|P8|Pancreatic Cancer|Part 1: Dose Escalation||0
7785169|NCT01286987|19165508|P7|Pancreatic Cancer|Part 1: Dose Escalation||0
7785170|NCT01286987|19165509|P6|Pancreatic Cancer|Part 1: Dose Escalation||0
7785171|NCT01286987|19165510|P5|Pancreatic Cancer|Part 1: Dose Escalation||0
7785172|NCT01286987|19165511|P4|Pancreatic Cancer|Part 1: Dose Escalation||0
7785173|NCT01286987|19165512|P3|Pancreatic Cancer|Part 1: Dose Escalation||0
7785174|NCT01286987|19165513|P2|Pancreatic Cancer|Part 1: Dose Escalation||2
7785175|NCT01286987|19165514|P1|Pancreatic Cancer|Part 1: Dose Escalation||1
7785176|NCT01286987|19165500|P15|Ewing Cancer|Part 1: Dose Escalation||0
7785177|NCT01286987|19165501|P14|Ewing Cancer|Part 1: Dose Escalation||0
7785178|NCT01286987|19165502|P13|Ewing Cancer|Part 1: Dose Escalation||0
7785179|NCT01286987|19165503|P12|Ewing Cancer|Part 1: Dose Escalation||0
7785180|NCT01286987|19165504|P11|Ewing Cancer|Part 1: Dose Escalation||0
7785181|NCT01286987|19165505|P10|Ewing Cancer|Part 1: Dose Escalation||0
7785182|NCT01286987|19165506|P9|Ewing Cancer|Part 1: Dose Escalation||1
7785183|NCT01286987|19165507|P8|Ewing Cancer|Part 1: Dose Escalation||1
7785184|NCT01286987|19165508|P7|Ewing Cancer|Part 1: Dose Escalation||0
7785185|NCT01286987|19165509|P6|Ewing Cancer|Part 1: Dose Escalation||0
7785186|NCT01286987|19165510|P5|Ewing Cancer|Part 1: Dose Escalation||0
7785187|NCT01286987|19165511|P4|Ewing Cancer|Part 1: Dose Escalation||0
7785188|NCT01286987|19165512|P3|Ewing Cancer|Part 1: Dose Escalation||0
7785189|NCT01286987|19165513|P2|Ewing Cancer|Part 1: Dose Escalation||0
7785190|NCT01286987|19165514|P1|Ewing Cancer|Part 1: Dose Escalation||0
7785191|NCT01286987|19165500|P15|Prostate Cancer|Part 1: Dose Escalation||0
7785192|NCT01286987|19165501|P14|Prostate Cancer|Part 1: Dose Escalation||0
7785193|NCT01286987|19165502|P13|Prostate Cancer|Part 1: Dose Escalation||0
7785194|NCT01286987|19165503|P12|Prostate Cancer|Part 1: Dose Escalation||0
7785195|NCT01286987|19165504|P11|Prostate Cancer|Part 1: Dose Escalation||0
7785196|NCT01286987|19165505|P10|Prostate Cancer|Part 1: Dose Escalation||0
7785197|NCT01286987|19165506|P9|Prostate Cancer|Part 1: Dose Escalation||0
7785198|NCT01286987|19165507|P8|Prostate Cancer|Part 1: Dose Escalation||0
7785199|NCT01286987|19165508|P7|Prostate Cancer|Part 1: Dose Escalation||0
7785200|NCT01286987|19165509|P6|Prostate Cancer|Part 1: Dose Escalation||1
7785201|NCT01286987|19165510|P5|Prostate Cancer|Part 1: Dose Escalation||0
7785202|NCT01286987|19165511|P4|Prostate Cancer|Part 1: Dose Escalation||0
7785203|NCT01286987|19165512|P3|Prostate Cancer|Part 1: Dose Escalation||0
7785204|NCT01286987|19165513|P2|Prostate Cancer|Part 1: Dose Escalation||0
7785205|NCT01286987|19165514|P1|Prostate Cancer|Part 1: Dose Escalation||0
7785206|NCT01286987|19165500|P15|Colorectal Cancer|Part 1: Dose Escalation||0
7785207|NCT01286987|19165501|P14|Colorectal Cancer|Part 1: Dose Escalation||0
7785208|NCT01286987|19165502|P13|Colorectal Cancer|Part 1: Dose Escalation||0
7785209|NCT01286987|19165503|P12|Colorectal Cancer|Part 1: Dose Escalation||0
7785210|NCT01286987|19165504|P11|Colorectal Cancer|Part 1: Dose Escalation||0
7785211|NCT01286987|19165505|P10|Colorectal Cancer|Part 1: Dose Escalation||0
7785212|NCT01286987|19165506|P9|Colorectal Cancer|Part 1: Dose Escalation||0
7785213|NCT01286987|19165507|P8|Colorectal Cancer|Part 1: Dose Escalation||0
7785214|NCT01286987|19165508|P7|Colorectal Cancer|Part 1: Dose Escalation||0
7785215|NCT01286987|19165509|P6|Colorectal Cancer|Part 1: Dose Escalation||0
7785216|NCT01286987|19165510|P5|Colorectal Cancer|Part 1: Dose Escalation||0
7785217|NCT01286987|19165511|P4|Colorectal Cancer|Part 1: Dose Escalation||0
7785218|NCT01286987|19165512|P3|Colorectal Cancer|Part 1: Dose Escalation||1
7785219|NCT01286987|19165513|P2|Colorectal Cancer|Part 1: Dose Escalation||0
7785220|NCT01286987|19165514|P1|Colorectal Cancer|Part 1: Dose Escalation||1
7785221|NCT01286987|19165500|P15|STARTED|Part 1: Dose Escalation||0
7785222|NCT01286987|19165501|P14|STARTED|Part 1: Dose Escalation||0
7785223|NCT01286987|19165502|P13|STARTED|Part 1: Dose Escalation||0
7785224|NCT01286987|19165503|P12|STARTED|Part 1: Dose Escalation||0
7785225|NCT01286987|19165504|P11|STARTED|Part 1: Dose Escalation||0
7785226|NCT01286987|19165505|P10|STARTED|Part 1: Dose Escalation||0
7785227|NCT01286987|19165506|P9|STARTED|Part 1: Dose Escalation||6
7785228|NCT01286987|19165507|P8|STARTED|Part 1: Dose Escalation||6
7785229|NCT01286987|19165508|P7|STARTED|Part 1: Dose Escalation||6
7785230|NCT01286987|19165509|P6|STARTED|Part 1: Dose Escalation||6
7785231|NCT01286987|19165510|P5|STARTED|Part 1: Dose Escalation||3
7785232|NCT01286987|19165511|P4|STARTED|Part 1: Dose Escalation||3
7785233|NCT01286987|19165512|P3|STARTED|Part 1: Dose Escalation||3
7785234|NCT01286987|19165513|P2|STARTED|Part 1: Dose Escalation||3
7785235|NCT01286987|19165514|P1|STARTED|Part 1: Dose Escalation||3
7785236|NCT01286870|19165655|P1|NOT COMPLETED|Overall Study||0
7785237|NCT01286870|19165655|P1|COMPLETED|Overall Study||11
7785238|NCT01286870|19165655|P1|STARTED|Overall Study||11
7785239|NCT01286818|19165660|P1|NOT COMPLETED|Overall Study||0
7785240|NCT01286818|19165660|P1|COMPLETED|Overall Study||6
7785241|NCT01286818|19165660|P1|Completed DLT Assessment Period|Overall Study||5
7785242|NCT01286818|19165660|P1|STARTED|Overall Study||6
7785243|NCT01286805|19165674|P2|NOT COMPLETED|Overall Study||1
7785244|NCT01286805|19165675|P1|NOT COMPLETED|Overall Study||0
7785245|NCT01286805|19165674|P2|COMPLETED|Overall Study||41
7785246|NCT01286805|19165675|P1|COMPLETED|Overall Study||41
7785247|NCT01286805|19165674|P2|STARTED|Overall Study||42
7785248|NCT01286805|19165675|P1|STARTED|Overall Study||41
7785249|NCT01286779|19165695|P1|NOT COMPLETED|Overall Study||19
7785250|NCT01286779|19165695|P1|COMPLETED|Overall Study||96
7785251|NCT01286779|19165695|P1|STARTED|Overall Study||115
7785252|NCT01286753|19165747|P2|NOT COMPLETED|Overall Study||25
7785253|NCT01286753|19165748|P1|NOT COMPLETED|Overall Study||26
7785254|NCT01286753|19165747|P2|COMPLETED|Overall Study||0
7785255|NCT01286753|19165748|P1|COMPLETED|Overall Study||0
7785256|NCT01286753|19165747|P2|STARTED|Overall Study||25
7785257|NCT01286753|19165748|P1|STARTED|Overall Study||26
7785258|NCT01286740|19165766|P1|NOT COMPLETED|Overall Study||2
7785259|NCT01286740|19165766|P1|COMPLETED|Overall Study||48
7785260|NCT01286740|19165766|P1|Week 12 (Primary Endpoint)|Overall Study||49
7785261|NCT01286740|19165766|P1|Enrolled and Treated|Overall Study||49
7785262|NCT01286740|19165766|P1|STARTED|Overall Study||50
7785263|NCT01286558|19165784|P2|NOT COMPLETED|Overall Study||2
7785264|NCT01286558|19165785|P1|NOT COMPLETED|Overall Study||1
7785265|NCT01286558|19165784|P2|COMPLETED|Overall Study||111
7785266|NCT01286558|19165785|P1|COMPLETED|Overall Study||111
7785267|NCT01286558|19165784|P2|STARTED|Overall Study||113
7785268|NCT01286558|19165785|P1|STARTED|Overall Study||112
7785269|NCT01286493|19165815|P1|NOT COMPLETED|Overall Study||3
7785270|NCT01286493|19165815|P1|COMPLETED|Overall Study||30
7785271|NCT01286493|19165815|P1|STARTED|Overall Study||33
7785272|NCT01286480|19165821|P2|NOT COMPLETED|Overall Study||3
7785273|NCT01286480|19165822|P1|NOT COMPLETED|Overall Study||5
7785274|NCT01286480|19165821|P2|COMPLETED|Overall Study||31
7785275|NCT01286480|19165822|P1|COMPLETED|Overall Study||27
7785276|NCT01286480|19165821|P2|STARTED|Overall Study||34
7785277|NCT01286480|19165822|P1|STARTED|Overall Study||32
7785278|NCT01286454|19165830|P11|NOT COMPLETED|Part II- Sixth Intervention Period||0
7785279|NCT01286454|19165831|P10|NOT COMPLETED|Part II- Sixth Intervention Period||0
7785280|NCT01286454|19165832|P9|NOT COMPLETED|Part II- Sixth Intervention Period||0
7785281|NCT01286454|19165833|P8|NOT COMPLETED|Part II- Sixth Intervention Period||0
7785282|NCT01286454|19165834|P7|NOT COMPLETED|Part II- Sixth Intervention Period||0
7785283|NCT01286454|19165835|P6|NOT COMPLETED|Part II- Sixth Intervention Period||0
7785284|NCT01286454|19165836|P5|NOT COMPLETED|Part II- Sixth Intervention Period||0
7785285|NCT01286454|19165837|P4|NOT COMPLETED|Part II- Sixth Intervention Period||0
7785286|NCT01286454|19165838|P3|NOT COMPLETED|Part II- Sixth Intervention Period||0
7785287|NCT01286454|19165839|P2|NOT COMPLETED|Part II- Sixth Intervention Period||0
7785288|NCT01286454|19165840|P1|NOT COMPLETED|Part II- Sixth Intervention Period||0
7785289|NCT01286454|19165830|P11|COMPLETED|Part II- Sixth Intervention Period||20
7785290|NCT01286454|19165831|P10|COMPLETED|Part II- Sixth Intervention Period||0
7785291|NCT01286454|19165832|P9|COMPLETED|Part II- Sixth Intervention Period||0
7785292|NCT01286454|19165833|P8|COMPLETED|Part II- Sixth Intervention Period||0
7785293|NCT01286454|19165834|P7|COMPLETED|Part II- Sixth Intervention Period||0
7785294|NCT01286454|19165835|P6|COMPLETED|Part II- Sixth Intervention Period||0
7785295|NCT01286454|19165836|P5|COMPLETED|Part II- Sixth Intervention Period||0
7785296|NCT01286454|19165837|P4|COMPLETED|Part II- Sixth Intervention Period||0
7785297|NCT01286454|19165838|P3|COMPLETED|Part II- Sixth Intervention Period||0
7785298|NCT01286454|19165839|P2|COMPLETED|Part II- Sixth Intervention Period||0
7785299|NCT01286454|19165840|P1|COMPLETED|Part II- Sixth Intervention Period||0
7785300|NCT01286454|19165830|P11|STARTED|Part II- Sixth Intervention Period||20
7785301|NCT01286454|19165831|P10|STARTED|Part II- Sixth Intervention Period||0
7785302|NCT01286454|19165832|P9|STARTED|Part II- Sixth Intervention Period||0
7785303|NCT01286454|19165833|P8|STARTED|Part II- Sixth Intervention Period||0
7785304|NCT01286454|19165834|P7|STARTED|Part II- Sixth Intervention Period||0
7785305|NCT01286454|19165835|P6|STARTED|Part II- Sixth Intervention Period||0
7785306|NCT01286454|19165836|P5|STARTED|Part II- Sixth Intervention Period||0
7785307|NCT01286454|19165837|P4|STARTED|Part II- Sixth Intervention Period||0
7785308|NCT01286454|19165838|P3|STARTED|Part II- Sixth Intervention Period||0
7785309|NCT01286454|19165839|P2|STARTED|Part II- Sixth Intervention Period||0
7785310|NCT01286454|19165840|P1|STARTED|Part II- Sixth Intervention Period||0
7785311|NCT01286454|19165830|P11|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
7785312|NCT01286454|19165831|P10|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
7785313|NCT01286454|19165832|P9|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
7785314|NCT01286454|19165833|P8|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
7785315|NCT01286454|19165834|P7|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
7785316|NCT01286454|19165835|P6|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
7785317|NCT01286454|19165836|P5|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
7785318|NCT01286454|19165837|P4|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
7785319|NCT01286454|19165838|P3|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
7785320|NCT01286454|19165839|P2|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
7785321|NCT01286454|19165840|P1|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
7785322|NCT01286454|19165830|P11|COMPLETED|Washout Period (Approximately 2 Weeks)||0
7785323|NCT01286454|19165831|P10|COMPLETED|Washout Period (Approximately 2 Weeks)||2
7785324|NCT01286454|19165832|P9|COMPLETED|Washout Period (Approximately 2 Weeks)||2
7785325|NCT01286454|19165833|P8|COMPLETED|Washout Period (Approximately 2 Weeks)||2
7785326|NCT01286454|19165834|P7|COMPLETED|Washout Period (Approximately 2 Weeks)||2
7785327|NCT01286454|19165835|P6|COMPLETED|Washout Period (Approximately 2 Weeks)||2
7785328|NCT01286454|19165836|P5|COMPLETED|Washout Period (Approximately 2 Weeks)||2
7785329|NCT01286454|19165837|P4|COMPLETED|Washout Period (Approximately 2 Weeks)||2
7785330|NCT01286454|19165838|P3|COMPLETED|Washout Period (Approximately 2 Weeks)||2
7785331|NCT01286454|19165839|P2|COMPLETED|Washout Period (Approximately 2 Weeks)||2
7785332|NCT01286454|19165840|P1|COMPLETED|Washout Period (Approximately 2 Weeks)||2
7785333|NCT01286454|19165830|P11|STARTED|Washout Period (Approximately 2 Weeks)||0
7785334|NCT01286454|19165831|P10|STARTED|Washout Period (Approximately 2 Weeks)||2
7785335|NCT01286454|19165832|P9|STARTED|Washout Period (Approximately 2 Weeks)||2
7785336|NCT01286454|19165833|P8|STARTED|Washout Period (Approximately 2 Weeks)||2
7785337|NCT01286454|19165834|P7|STARTED|Washout Period (Approximately 2 Weeks)||2
7785338|NCT01286454|19165835|P6|STARTED|Washout Period (Approximately 2 Weeks)||2
7785339|NCT01286454|19165836|P5|STARTED|Washout Period (Approximately 2 Weeks)||2
7785340|NCT01286454|19165837|P4|STARTED|Washout Period (Approximately 2 Weeks)||2
7785341|NCT01286454|19165838|P3|STARTED|Washout Period (Approximately 2 Weeks)||2
7785342|NCT01286454|19165839|P2|STARTED|Washout Period (Approximately 2 Weeks)||2
7785343|NCT01286454|19165840|P1|STARTED|Washout Period (Approximately 2 Weeks)||2
7785344|NCT01286454|19165830|P11|NOT COMPLETED|Fifth Intervention Period||0
7785345|NCT01286454|19165831|P10|NOT COMPLETED|Fifth Intervention Period||0
7785346|NCT01286454|19165832|P9|NOT COMPLETED|Fifth Intervention Period||0
7785347|NCT01286454|19165833|P8|NOT COMPLETED|Fifth Intervention Period||0
7785348|NCT01286454|19165834|P7|NOT COMPLETED|Fifth Intervention Period||0
7785349|NCT01286454|19165835|P6|NOT COMPLETED|Fifth Intervention Period||0
7785350|NCT01286454|19165836|P5|NOT COMPLETED|Fifth Intervention Period||0
7785351|NCT01286454|19165837|P4|NOT COMPLETED|Fifth Intervention Period||0
7785352|NCT01286454|19165838|P3|NOT COMPLETED|Fifth Intervention Period||0
7785353|NCT01286454|19165839|P2|NOT COMPLETED|Fifth Intervention Period||0
7785354|NCT01286454|19165840|P1|NOT COMPLETED|Fifth Intervention Period||0
7785355|NCT01286454|19165830|P11|COMPLETED|Fifth Intervention Period||0
7785356|NCT01286454|19165831|P10|COMPLETED|Fifth Intervention Period||2
7785357|NCT01286454|19165832|P9|COMPLETED|Fifth Intervention Period||2
7785358|NCT01286454|19165833|P8|COMPLETED|Fifth Intervention Period||2
7785359|NCT01286454|19165834|P7|COMPLETED|Fifth Intervention Period||2
7785360|NCT01286454|19165835|P6|COMPLETED|Fifth Intervention Period||2
7785361|NCT01286454|19165836|P5|COMPLETED|Fifth Intervention Period||2
7785362|NCT01286454|19165837|P4|COMPLETED|Fifth Intervention Period||2
7785363|NCT01286454|19165838|P3|COMPLETED|Fifth Intervention Period||2
7785364|NCT01286454|19165839|P2|COMPLETED|Fifth Intervention Period||2
7785365|NCT01286454|19165840|P1|COMPLETED|Fifth Intervention Period||2
7785366|NCT01286454|19165830|P11|STARTED|Fifth Intervention Period||0
7785367|NCT01286454|19165831|P10|STARTED|Fifth Intervention Period||2
7785368|NCT01286454|19165832|P9|STARTED|Fifth Intervention Period||2
7785369|NCT01286454|19165833|P8|STARTED|Fifth Intervention Period||2
7785370|NCT01286454|19165834|P7|STARTED|Fifth Intervention Period||2
7785371|NCT01286454|19165835|P6|STARTED|Fifth Intervention Period||2
7785372|NCT01286454|19165836|P5|STARTED|Fifth Intervention Period||2
7785373|NCT01286454|19165837|P4|STARTED|Fifth Intervention Period||2
7785374|NCT01286454|19165838|P3|STARTED|Fifth Intervention Period||2
7785375|NCT01286454|19165839|P2|STARTED|Fifth Intervention Period||2
7785376|NCT01286454|19165840|P1|STARTED|Fifth Intervention Period||2
7785377|NCT01286454|19165830|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785378|NCT01286454|19165831|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785379|NCT01286454|19165832|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785380|NCT01286454|19165833|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785381|NCT01286454|19165834|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785382|NCT01286454|19165835|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785383|NCT01286454|19165836|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785384|NCT01286454|19165837|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785385|NCT01286454|19165838|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785386|NCT01286454|19165839|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785387|NCT01286454|19165840|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785388|NCT01286454|19165830|P11|COMPLETED|Washout Period (At Least 3 Days)||0
7785389|NCT01286454|19165831|P10|COMPLETED|Washout Period (At Least 3 Days)||2
7785390|NCT01286454|19165832|P9|COMPLETED|Washout Period (At Least 3 Days)||2
7785391|NCT01286454|19165833|P8|COMPLETED|Washout Period (At Least 3 Days)||2
7785392|NCT01286454|19165834|P7|COMPLETED|Washout Period (At Least 3 Days)||2
7785393|NCT01286454|19165835|P6|COMPLETED|Washout Period (At Least 3 Days)||2
7785394|NCT01286454|19165836|P5|COMPLETED|Washout Period (At Least 3 Days)||2
7785395|NCT01286454|19165837|P4|COMPLETED|Washout Period (At Least 3 Days)||2
7785396|NCT01286454|19165838|P3|COMPLETED|Washout Period (At Least 3 Days)||2
7785397|NCT01286454|19165839|P2|COMPLETED|Washout Period (At Least 3 Days)||2
7785398|NCT01286454|19165840|P1|COMPLETED|Washout Period (At Least 3 Days)||2
7785399|NCT01286454|19165830|P11|STARTED|Washout Period (At Least 3 Days)||0
7785400|NCT01286454|19165831|P10|STARTED|Washout Period (At Least 3 Days)||2
7785401|NCT01286454|19165832|P9|STARTED|Washout Period (At Least 3 Days)||2
7785402|NCT01286454|19165833|P8|STARTED|Washout Period (At Least 3 Days)||2
7785403|NCT01286454|19165834|P7|STARTED|Washout Period (At Least 3 Days)||2
7785404|NCT01286454|19165835|P6|STARTED|Washout Period (At Least 3 Days)||2
7785405|NCT01286454|19165836|P5|STARTED|Washout Period (At Least 3 Days)||2
7785406|NCT01286454|19165837|P4|STARTED|Washout Period (At Least 3 Days)||2
7785407|NCT01286454|19165838|P3|STARTED|Washout Period (At Least 3 Days)||2
7785408|NCT01286454|19165839|P2|STARTED|Washout Period (At Least 3 Days)||2
7785409|NCT01286454|19165840|P1|STARTED|Washout Period (At Least 3 Days)||2
7785410|NCT01286454|19165830|P11|NOT COMPLETED|Fourth Intervention Period||0
7785411|NCT01286454|19165831|P10|NOT COMPLETED|Fourth Intervention Period||0
7785412|NCT01286454|19165832|P9|NOT COMPLETED|Fourth Intervention Period||0
7785413|NCT01286454|19165833|P8|NOT COMPLETED|Fourth Intervention Period||0
7785414|NCT01286454|19165834|P7|NOT COMPLETED|Fourth Intervention Period||0
7785415|NCT01286454|19165835|P6|NOT COMPLETED|Fourth Intervention Period||0
7785416|NCT01286454|19165836|P5|NOT COMPLETED|Fourth Intervention Period||0
7785417|NCT01286454|19165837|P4|NOT COMPLETED|Fourth Intervention Period||0
7785418|NCT01286454|19165838|P3|NOT COMPLETED|Fourth Intervention Period||0
7785419|NCT01286454|19165839|P2|NOT COMPLETED|Fourth Intervention Period||0
7785420|NCT01286454|19165840|P1|NOT COMPLETED|Fourth Intervention Period||0
7785421|NCT01286454|19165830|P11|COMPLETED|Fourth Intervention Period||0
7785422|NCT01286454|19165831|P10|COMPLETED|Fourth Intervention Period||2
7785423|NCT01286454|19165832|P9|COMPLETED|Fourth Intervention Period||2
7785424|NCT01286454|19165833|P8|COMPLETED|Fourth Intervention Period||2
7785425|NCT01286454|19165834|P7|COMPLETED|Fourth Intervention Period||2
7785426|NCT01286454|19165835|P6|COMPLETED|Fourth Intervention Period||2
7785427|NCT01286454|19165836|P5|COMPLETED|Fourth Intervention Period||2
7785428|NCT01286454|19165837|P4|COMPLETED|Fourth Intervention Period||2
7785429|NCT01286454|19165838|P3|COMPLETED|Fourth Intervention Period||2
7785430|NCT01286454|19165839|P2|COMPLETED|Fourth Intervention Period||2
7785431|NCT01286454|19165840|P1|COMPLETED|Fourth Intervention Period||2
7785432|NCT01286454|19165830|P11|STARTED|Fourth Intervention Period||0
7785433|NCT01286454|19165831|P10|STARTED|Fourth Intervention Period||2
7785434|NCT01286454|19165832|P9|STARTED|Fourth Intervention Period||2
7785435|NCT01286454|19165833|P8|STARTED|Fourth Intervention Period||2
7785436|NCT01286454|19165834|P7|STARTED|Fourth Intervention Period||2
7785437|NCT01286454|19165835|P6|STARTED|Fourth Intervention Period||2
7785438|NCT01286454|19165836|P5|STARTED|Fourth Intervention Period||2
7785439|NCT01286454|19165837|P4|STARTED|Fourth Intervention Period||2
7785440|NCT01286454|19165838|P3|STARTED|Fourth Intervention Period||2
7785441|NCT01286454|19165839|P2|STARTED|Fourth Intervention Period||2
7785442|NCT01286454|19165840|P1|STARTED|Fourth Intervention Period||2
7785443|NCT01286454|19165830|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785444|NCT01286454|19165831|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785445|NCT01286454|19165832|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785446|NCT01286454|19165833|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785447|NCT01286454|19165834|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785448|NCT01286454|19165835|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785449|NCT01286454|19165836|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785450|NCT01286454|19165837|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785451|NCT01286454|19165838|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785452|NCT01286454|19165839|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785453|NCT01286454|19165840|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785454|NCT01286454|19165830|P11|COMPLETED|Washout Period (At Least 3 Days)||0
7785455|NCT01286454|19165831|P10|COMPLETED|Washout Period (At Least 3 Days)||2
7785456|NCT01286454|19165832|P9|COMPLETED|Washout Period (At Least 3 Days)||2
7785457|NCT01286454|19165833|P8|COMPLETED|Washout Period (At Least 3 Days)||2
7785458|NCT01286454|19165834|P7|COMPLETED|Washout Period (At Least 3 Days)||2
7785459|NCT01286454|19165835|P6|COMPLETED|Washout Period (At Least 3 Days)||2
7785460|NCT01286454|19165836|P5|COMPLETED|Washout Period (At Least 3 Days)||2
7785461|NCT01286454|19165837|P4|COMPLETED|Washout Period (At Least 3 Days)||2
7785462|NCT01286454|19165838|P3|COMPLETED|Washout Period (At Least 3 Days)||2
7785463|NCT01286454|19165839|P2|COMPLETED|Washout Period (At Least 3 Days)||2
7785464|NCT01286454|19165840|P1|COMPLETED|Washout Period (At Least 3 Days)||2
7785465|NCT01286454|19165830|P11|STARTED|Washout Period (At Least 3 Days)||0
7785466|NCT01286454|19165831|P10|STARTED|Washout Period (At Least 3 Days)||2
7785467|NCT01286454|19165832|P9|STARTED|Washout Period (At Least 3 Days)||2
7785468|NCT01286454|19165833|P8|STARTED|Washout Period (At Least 3 Days)||2
7785469|NCT01286454|19165834|P7|STARTED|Washout Period (At Least 3 Days)||2
7785470|NCT01286454|19165835|P6|STARTED|Washout Period (At Least 3 Days)||2
7785471|NCT01286454|19165836|P5|STARTED|Washout Period (At Least 3 Days)||2
7785472|NCT01286454|19165837|P4|STARTED|Washout Period (At Least 3 Days)||2
7785473|NCT01286454|19165838|P3|STARTED|Washout Period (At Least 3 Days)||2
7785474|NCT01286454|19165839|P2|STARTED|Washout Period (At Least 3 Days)||2
7785475|NCT01286454|19165840|P1|STARTED|Washout Period (At Least 3 Days)||2
7785476|NCT01286454|19165830|P11|NOT COMPLETED|Third Intervention Period||0
7785477|NCT01286454|19165831|P10|NOT COMPLETED|Third Intervention Period||0
7785478|NCT01286454|19165832|P9|NOT COMPLETED|Third Intervention Period||0
7785479|NCT01286454|19165833|P8|NOT COMPLETED|Third Intervention Period||0
7785480|NCT01286454|19165834|P7|NOT COMPLETED|Third Intervention Period||0
7785481|NCT01286454|19165835|P6|NOT COMPLETED|Third Intervention Period||0
7785482|NCT01286454|19165836|P5|NOT COMPLETED|Third Intervention Period||0
7785483|NCT01286454|19165837|P4|NOT COMPLETED|Third Intervention Period||0
7785484|NCT01286454|19165838|P3|NOT COMPLETED|Third Intervention Period||0
7785485|NCT01286454|19165839|P2|NOT COMPLETED|Third Intervention Period||0
7785486|NCT01286454|19165840|P1|NOT COMPLETED|Third Intervention Period||0
7785487|NCT01286454|19165830|P11|COMPLETED|Third Intervention Period||0
7785488|NCT01286454|19165831|P10|COMPLETED|Third Intervention Period||2
7785489|NCT01286454|19165832|P9|COMPLETED|Third Intervention Period||2
7785490|NCT01286454|19165833|P8|COMPLETED|Third Intervention Period||2
7785491|NCT01286454|19165834|P7|COMPLETED|Third Intervention Period||2
7785492|NCT01286454|19165835|P6|COMPLETED|Third Intervention Period||2
7785493|NCT01286454|19165836|P5|COMPLETED|Third Intervention Period||2
7785494|NCT01286454|19165837|P4|COMPLETED|Third Intervention Period||2
7785495|NCT01286454|19165838|P3|COMPLETED|Third Intervention Period||2
7785496|NCT01286454|19165839|P2|COMPLETED|Third Intervention Period||2
7785497|NCT01286454|19165840|P1|COMPLETED|Third Intervention Period||2
7785498|NCT01286454|19165830|P11|STARTED|Third Intervention Period||0
7785499|NCT01286454|19165831|P10|STARTED|Third Intervention Period||2
7785500|NCT01286454|19165832|P9|STARTED|Third Intervention Period||2
7785501|NCT01286454|19165833|P8|STARTED|Third Intervention Period||2
7785502|NCT01286454|19165834|P7|STARTED|Third Intervention Period||2
7785503|NCT01286454|19165835|P6|STARTED|Third Intervention Period||2
7785504|NCT01286454|19165836|P5|STARTED|Third Intervention Period||2
7785505|NCT01286454|19165837|P4|STARTED|Third Intervention Period||2
7785506|NCT01286454|19165838|P3|STARTED|Third Intervention Period||2
7785507|NCT01286454|19165839|P2|STARTED|Third Intervention Period||2
7785508|NCT01286454|19165840|P1|STARTED|Third Intervention Period||2
7785509|NCT01286454|19165830|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785510|NCT01286454|19165831|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785511|NCT01286454|19165832|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785512|NCT01286454|19165833|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785513|NCT01286454|19165834|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785514|NCT01286454|19165835|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785515|NCT01286454|19165836|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785516|NCT01286454|19165837|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785517|NCT01286454|19165838|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785518|NCT01286454|19165839|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785519|NCT01286454|19165840|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785520|NCT01286454|19165830|P11|COMPLETED|Washout Period (At Least 3 Days)||0
7785521|NCT01286454|19165831|P10|COMPLETED|Washout Period (At Least 3 Days)||2
7785522|NCT01286454|19165832|P9|COMPLETED|Washout Period (At Least 3 Days)||2
7785523|NCT01286454|19165833|P8|COMPLETED|Washout Period (At Least 3 Days)||2
7785524|NCT01286454|19165834|P7|COMPLETED|Washout Period (At Least 3 Days)||2
7785525|NCT01286454|19165835|P6|COMPLETED|Washout Period (At Least 3 Days)||2
7785526|NCT01286454|19165836|P5|COMPLETED|Washout Period (At Least 3 Days)||2
7785527|NCT01286454|19165837|P4|COMPLETED|Washout Period (At Least 3 Days)||2
7785528|NCT01286454|19165838|P3|COMPLETED|Washout Period (At Least 3 Days)||2
7785529|NCT01286454|19165839|P2|COMPLETED|Washout Period (At Least 3 Days)||2
7785530|NCT01286454|19165840|P1|COMPLETED|Washout Period (At Least 3 Days)||2
7785531|NCT01286454|19165830|P11|STARTED|Washout Period (At Least 3 Days)||0
7785532|NCT01286454|19165831|P10|STARTED|Washout Period (At Least 3 Days)||2
7785533|NCT01286454|19165832|P9|STARTED|Washout Period (At Least 3 Days)||2
7785534|NCT01286454|19165833|P8|STARTED|Washout Period (At Least 3 Days)||2
7785535|NCT01286454|19165834|P7|STARTED|Washout Period (At Least 3 Days)||2
7785536|NCT01286454|19165835|P6|STARTED|Washout Period (At Least 3 Days)||2
7785537|NCT01286454|19165836|P5|STARTED|Washout Period (At Least 3 Days)||2
7785538|NCT01286454|19165837|P4|STARTED|Washout Period (At Least 3 Days)||2
7785539|NCT01286454|19165838|P3|STARTED|Washout Period (At Least 3 Days)||2
7785540|NCT01286454|19165839|P2|STARTED|Washout Period (At Least 3 Days)||2
7785541|NCT01286454|19165840|P1|STARTED|Washout Period (At Least 3 Days)||2
7785542|NCT01286454|19165830|P11|NOT COMPLETED|Second Intervention Period||0
7785543|NCT01286454|19165831|P10|NOT COMPLETED|Second Intervention Period||0
7785544|NCT01286454|19165832|P9|NOT COMPLETED|Second Intervention Period||0
7785545|NCT01286454|19165833|P8|NOT COMPLETED|Second Intervention Period||0
7785546|NCT01286454|19165834|P7|NOT COMPLETED|Second Intervention Period||0
7785547|NCT01286454|19165835|P6|NOT COMPLETED|Second Intervention Period||0
7785548|NCT01286454|19165836|P5|NOT COMPLETED|Second Intervention Period||0
7785549|NCT01286454|19165837|P4|NOT COMPLETED|Second Intervention Period||0
7785550|NCT01286454|19165838|P3|NOT COMPLETED|Second Intervention Period||0
7785551|NCT01286454|19165839|P2|NOT COMPLETED|Second Intervention Period||0
7785552|NCT01286454|19165840|P1|NOT COMPLETED|Second Intervention Period||0
7785553|NCT01286454|19165830|P11|COMPLETED|Second Intervention Period||0
7785554|NCT01286454|19165831|P10|COMPLETED|Second Intervention Period||2
7785555|NCT01286454|19165832|P9|COMPLETED|Second Intervention Period||2
7785556|NCT01286454|19165833|P8|COMPLETED|Second Intervention Period||2
7785557|NCT01286454|19165834|P7|COMPLETED|Second Intervention Period||2
7785558|NCT01286454|19165835|P6|COMPLETED|Second Intervention Period||2
7785559|NCT01286454|19165836|P5|COMPLETED|Second Intervention Period||2
7785560|NCT01286454|19165837|P4|COMPLETED|Second Intervention Period||2
7785561|NCT01286454|19165838|P3|COMPLETED|Second Intervention Period||2
7785562|NCT01286454|19165839|P2|COMPLETED|Second Intervention Period||2
7785563|NCT01286454|19165840|P1|COMPLETED|Second Intervention Period||2
7785564|NCT01286454|19165830|P11|STARTED|Second Intervention Period||0
7785565|NCT01286454|19165831|P10|STARTED|Second Intervention Period||2
7785566|NCT01286454|19165832|P9|STARTED|Second Intervention Period||2
7785567|NCT01286454|19165833|P8|STARTED|Second Intervention Period||2
7785568|NCT01286454|19165834|P7|STARTED|Second Intervention Period||2
7785569|NCT01286454|19165835|P6|STARTED|Second Intervention Period||2
7785570|NCT01286454|19165836|P5|STARTED|Second Intervention Period||2
7785571|NCT01286454|19165837|P4|STARTED|Second Intervention Period||2
7785572|NCT01286454|19165838|P3|STARTED|Second Intervention Period||2
7785573|NCT01286454|19165839|P2|STARTED|Second Intervention Period||2
7785574|NCT01286454|19165840|P1|STARTED|Second Intervention Period||2
7785575|NCT01286454|19165830|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785576|NCT01286454|19165831|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785577|NCT01286454|19165832|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785578|NCT01286454|19165833|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785579|NCT01286454|19165834|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785580|NCT01286454|19165835|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785581|NCT01286454|19165836|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785582|NCT01286454|19165837|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785583|NCT01286454|19165838|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785584|NCT01286454|19165839|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785585|NCT01286454|19165840|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
7785586|NCT01286454|19165830|P11|COMPLETED|Washout Period (At Least 3 Days)||0
7785587|NCT01286454|19165831|P10|COMPLETED|Washout Period (At Least 3 Days)||2
7785588|NCT01286454|19165832|P9|COMPLETED|Washout Period (At Least 3 Days)||2
7785589|NCT01286454|19165833|P8|COMPLETED|Washout Period (At Least 3 Days)||2
7785590|NCT01286454|19165834|P7|COMPLETED|Washout Period (At Least 3 Days)||2
7785591|NCT01286454|19165835|P6|COMPLETED|Washout Period (At Least 3 Days)||2
7785592|NCT01286454|19165836|P5|COMPLETED|Washout Period (At Least 3 Days)||2
7785593|NCT01286454|19165837|P4|COMPLETED|Washout Period (At Least 3 Days)||2
7785594|NCT01286454|19165838|P3|COMPLETED|Washout Period (At Least 3 Days)||2
7785595|NCT01286454|19165839|P2|COMPLETED|Washout Period (At Least 3 Days)||2
7785596|NCT01286454|19165840|P1|COMPLETED|Washout Period (At Least 3 Days)||2
7785597|NCT01286454|19165830|P11|STARTED|Washout Period (At Least 3 Days)||0
7785598|NCT01286454|19165831|P10|STARTED|Washout Period (At Least 3 Days)||2
7785599|NCT01286454|19165832|P9|STARTED|Washout Period (At Least 3 Days)||2
7785600|NCT01286454|19165833|P8|STARTED|Washout Period (At Least 3 Days)||2
7785601|NCT01286454|19165834|P7|STARTED|Washout Period (At Least 3 Days)||2
7785602|NCT01286454|19165835|P6|STARTED|Washout Period (At Least 3 Days)||2
7785603|NCT01286454|19165836|P5|STARTED|Washout Period (At Least 3 Days)||2
7785604|NCT01286454|19165837|P4|STARTED|Washout Period (At Least 3 Days)||2
7785605|NCT01286454|19165838|P3|STARTED|Washout Period (At Least 3 Days)||2
7785606|NCT01286454|19165839|P2|STARTED|Washout Period (At Least 3 Days)||2
7785607|NCT01286454|19165840|P1|STARTED|Washout Period (At Least 3 Days)||2
7785608|NCT01286454|19165830|P11|NOT COMPLETED|Part I- First Intervention Period||0
7785609|NCT01286454|19165831|P10|NOT COMPLETED|Part I- First Intervention Period||0
7785610|NCT01286454|19165832|P9|NOT COMPLETED|Part I- First Intervention Period||0
7785611|NCT01286454|19165833|P8|NOT COMPLETED|Part I- First Intervention Period||0
7785612|NCT01286454|19165834|P7|NOT COMPLETED|Part I- First Intervention Period||0
7785613|NCT01286454|19165835|P6|NOT COMPLETED|Part I- First Intervention Period||0
7785614|NCT01286454|19165836|P5|NOT COMPLETED|Part I- First Intervention Period||0
7785615|NCT01286454|19165837|P4|NOT COMPLETED|Part I- First Intervention Period||0
7785616|NCT01286454|19165838|P3|NOT COMPLETED|Part I- First Intervention Period||0
7785617|NCT01286454|19165839|P2|NOT COMPLETED|Part I- First Intervention Period||0
7785618|NCT01286454|19165840|P1|NOT COMPLETED|Part I- First Intervention Period||0
7785619|NCT01286454|19165830|P11|COMPLETED|Part I- First Intervention Period||0
7785620|NCT01286454|19165831|P10|COMPLETED|Part I- First Intervention Period||2
7785621|NCT01286454|19165832|P9|COMPLETED|Part I- First Intervention Period||2
7785622|NCT01286454|19165833|P8|COMPLETED|Part I- First Intervention Period||2
7785623|NCT01286454|19165834|P7|COMPLETED|Part I- First Intervention Period||2
7785624|NCT01286454|19165835|P6|COMPLETED|Part I- First Intervention Period||2
7785625|NCT01286454|19165836|P5|COMPLETED|Part I- First Intervention Period||2
7785626|NCT01286454|19165837|P4|COMPLETED|Part I- First Intervention Period||2
7785627|NCT01286454|19165838|P3|COMPLETED|Part I- First Intervention Period||2
7785628|NCT01286454|19165839|P2|COMPLETED|Part I- First Intervention Period||2
7785629|NCT01286454|19165840|P1|COMPLETED|Part I- First Intervention Period||2
7785630|NCT01286454|19165830|P11|STARTED|Part I- First Intervention Period||0
7785631|NCT01286454|19165831|P10|STARTED|Part I- First Intervention Period||2
7785632|NCT01286454|19165832|P9|STARTED|Part I- First Intervention Period||2
7785633|NCT01286454|19165833|P8|STARTED|Part I- First Intervention Period||2
7785634|NCT01286454|19165834|P7|STARTED|Part I- First Intervention Period||2
7785635|NCT01286454|19165835|P6|STARTED|Part I- First Intervention Period||2
7785636|NCT01286454|19165836|P5|STARTED|Part I- First Intervention Period||2
7785637|NCT01286454|19165837|P4|STARTED|Part I- First Intervention Period||2
7785638|NCT01286454|19165838|P3|STARTED|Part I- First Intervention Period||2
7785639|NCT01286454|19165839|P2|STARTED|Part I- First Intervention Period||2
7785640|NCT01286454|19165840|P1|STARTED|Part I- First Intervention Period||2
7785641|NCT01286441|19165882|P4|NOT COMPLETED|Overall Study||11
7785642|NCT01286441|19165883|P3|NOT COMPLETED|Overall Study||7
7785643|NCT01286441|19165884|P2|NOT COMPLETED|Overall Study||7
7785644|NCT01286441|19165885|P1|NOT COMPLETED|Overall Study||7
7785645|NCT01286441|19165882|P4|COMPLETED|Overall Study||37
7785646|NCT01286441|19165883|P3|COMPLETED|Overall Study||39
7785647|NCT01286441|19165884|P2|COMPLETED|Overall Study||37
7785648|NCT01286441|19165885|P1|COMPLETED|Overall Study||38
7785649|NCT01286441|19165882|P4|STARTED|Overall Study||48
7785650|NCT01286441|19165883|P3|STARTED|Overall Study||46
7785651|NCT01286441|19165884|P2|STARTED|Overall Study||44
7785652|NCT01286441|19165885|P1|STARTED|Overall Study||45
7785653|NCT01286402|19165901|P2|NOT COMPLETED|Overall Study||0
7785654|NCT01286402|19165902|P1|NOT COMPLETED|Overall Study||0
7785655|NCT01286402|19165901|P2|COMPLETED|Overall Study||6
7785656|NCT01286402|19165902|P1|COMPLETED|Overall Study||5
7785657|NCT01286402|19165901|P2|STARTED|Overall Study||6
7785658|NCT01286402|19165902|P1|STARTED|Overall Study||5
7785659|NCT01286324|19165910|P2|NOT COMPLETED|Overall Study||0
7785660|NCT01286324|19165911|P1|NOT COMPLETED|Overall Study||0
7785661|NCT01286324|19165910|P2|COMPLETED|Overall Study||17
7785662|NCT01286324|19165911|P1|COMPLETED|Overall Study||17
7785663|NCT01286324|19165910|P2|STARTED|Overall Study||17
7785664|NCT01286324|19165911|P1|STARTED|Overall Study||17
7785665|NCT01286311|19165929|P2|NOT COMPLETED|Overall Study||0
7785666|NCT01286311|19165930|P1|NOT COMPLETED|Overall Study||14
7785667|NCT01286311|19165929|P2|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232
7785668|NCT01286311|19165930|P1|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218
7785669|NCT01286311|19165929|P2|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232
7785670|NCT01286311|19165930|P1|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232
7785671|NCT01286272|19165946|P2|NOT COMPLETED|Overall Study||3
7785672|NCT01286272|19165947|P1|NOT COMPLETED|Overall Study||1
7785673|NCT01286272|19165946|P2|COMPLETED|Overall Study||62
7785674|NCT01286272|19165947|P1|COMPLETED|Overall Study||66
7785675|NCT01286272|19165946|P2|STARTED|Overall Study||65
7785676|NCT01286272|19165947|P1|STARTED|Overall Study||67
7785677|NCT01286259|19165957|P1|NOT COMPLETED|Overall Study||0
7785678|NCT01286259|19165957|P1|COMPLETED|Overall Study||16
7785679|NCT01286259|19165957|P1|STARTED|Overall Study||16
7785680|NCT01286207|19165967|P3|NOT COMPLETED|Overall Study||90
7785681|NCT01286207|19165968|P2|NOT COMPLETED|Overall Study||248
7785682|NCT01286207|19165969|P1|NOT COMPLETED|Overall Study||298
7785683|NCT01286207|19165967|P3|COMPLETED|Overall Study||261
7785684|NCT01286207|19165968|P2|COMPLETED|Overall Study||609
7785685|NCT01286207|19165969|P1|COMPLETED|Overall Study||453
7785686|NCT01286207|19165967|P3|STARTED|Overall Study||351
7785687|NCT01286207|19165968|P2|STARTED|Overall Study||857
7785688|NCT01286207|19165969|P1|STARTED|Overall Study||751
7785689|NCT01286168|19165989|P1|NOT COMPLETED|Overall Study||3
7785690|NCT01286168|19165989|P1|COMPLETED|Overall Study||101
7785691|NCT01286168|19165989|P1|STARTED|Overall Study||104
7785692|NCT01286129|19166003|P2|NOT COMPLETED|Overall Study||5
7785693|NCT01286129|19166004|P1|NOT COMPLETED|Overall Study||8
7785694|NCT01286129|19166003|P2|COMPLETED|Overall Study||13
7785695|NCT01286129|19166004|P1|COMPLETED|Overall Study||19
7785696|NCT01286129|19166003|P2|STARTED|Overall Study||18
7785697|NCT01286129|19166004|P1|STARTED|Overall Study||27
7785698|NCT01286077|19166014|P2|NOT COMPLETED|Overall Study||7
7785699|NCT01286077|19166015|P1|NOT COMPLETED|Overall Study||10
7785700|NCT01286077|19166014|P2|COMPLETED|Overall Study||46
7785701|NCT01286077|19166015|P1|COMPLETED|Overall Study||41
7785702|NCT01286077|19166014|P2|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53
7785703|NCT01286077|19166015|P1|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51
7785704|NCT01286012|19166051|P2|NOT COMPLETED|Overall Study||14
7785705|NCT01286012|19166052|P1|NOT COMPLETED|Overall Study||13
7785706|NCT01286012|19166051|P2|COMPLETED|Overall Study||40
7785707|NCT01286012|19166052|P1|COMPLETED|Overall Study||41
7785708|NCT01286012|19166051|P2|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54
7785709|NCT01286012|19166052|P1|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54
7785710|NCT01285960|19166066|P1|NOT COMPLETED|Overall Study||6
7785711|NCT01285960|19166066|P1|COMPLETED|Overall Study|An additional 2 subjects receiving fewer than 10 sonications were included in the safety population|102
7785712|NCT01285960|19166066|P1|STARTED|Overall Study|2 subjects receiving fewer than 10 sonications were added to the 106 for safety population of 108|108
7785713|NCT01285947|19166072|P2|NOT COMPLETED|Overall Study||0
7785714|NCT01285947|19166073|P1|NOT COMPLETED|Overall Study||0
7785715|NCT01285947|19166072|P2|COMPLETED|Overall Study||10
7785716|NCT01285947|19166073|P1|COMPLETED|Overall Study||10
7785717|NCT01285947|19166072|P2|STARTED|Overall Study||10
7785718|NCT01285947|19166073|P1|STARTED|Overall Study||10
7785719|NCT01285908|19166079|P3|NOT COMPLETED|Treatment Crossover||0
7785720|NCT01285908|19166080|P2|NOT COMPLETED|Treatment Crossover||0
7785721|NCT01285908|19166081|P1|NOT COMPLETED|Treatment Crossover||0
7785722|NCT01285908|19166079|P3|COMPLETED|Treatment Crossover||2
7785723|NCT01285908|19166080|P2|COMPLETED|Treatment Crossover||2
7785724|NCT01285908|19166081|P1|COMPLETED|Treatment Crossover||0
7785725|NCT01285908|19166079|P3|STARTED|Treatment Crossover||2
7785726|NCT01285908|19166080|P2|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2
7785727|NCT01285908|19166081|P1|STARTED|Treatment Crossover||0
7785728|NCT01285908|19166079|P3|NOT COMPLETED|Baseline Measurement||0
7785729|NCT01285908|19166080|P2|NOT COMPLETED|Baseline Measurement||0
7785730|NCT01285908|19166081|P1|NOT COMPLETED|Baseline Measurement||3
7785731|NCT01285908|19166079|P3|COMPLETED|Baseline Measurement||0
7785732|NCT01285908|19166080|P2|COMPLETED|Baseline Measurement||0
7785733|NCT01285908|19166081|P1|COMPLETED|Baseline Measurement||3
7785734|NCT01285908|19166079|P3|STARTED|Baseline Measurement||0
7785735|NCT01285908|19166080|P2|STARTED|Baseline Measurement||0
7785736|NCT01285908|19166081|P1|STARTED|Baseline Measurement||6
7785737|NCT01285843|19166115|P2|NOT COMPLETED|Overall Study||2
7785738|NCT01285843|19166116|P1|NOT COMPLETED|Overall Study||2
7785739|NCT01285843|19166115|P2|COMPLETED|Overall Study||18
7785740|NCT01285843|19166116|P1|COMPLETED|Overall Study||18
7785741|NCT01285843|19166115|P2|STARTED|Overall Study||20
7785742|NCT01285843|19166116|P1|STARTED|Overall Study||20
7785743|NCT01285791|19166131|P3|NOT COMPLETED|Overall Study||0
7785744|NCT01285791|19166132|P2|NOT COMPLETED|Overall Study||0
7785745|NCT01285791|19166133|P1|NOT COMPLETED|Overall Study||0
7785746|NCT01285791|19166131|P3|COMPLETED|Overall Study||13
7785747|NCT01285791|19166132|P2|COMPLETED|Overall Study||15
7785748|NCT01285791|19166133|P1|COMPLETED|Overall Study||11
7785749|NCT01285791|19166131|P3|STARTED|Overall Study||13
7785750|NCT01285791|19166132|P2|STARTED|Overall Study||15
7785751|NCT01285791|19166133|P1|STARTED|Overall Study||11
7785752|NCT01285713|19166143|P2|NOT COMPLETED|Overall Study||0
7785753|NCT01285713|19166144|P1|NOT COMPLETED|Overall Study||0
7785754|NCT01285713|19166143|P2|COMPLETED|Overall Study||41
7785755|NCT01285713|19166144|P1|COMPLETED|Overall Study||42
7785756|NCT01285713|19166143|P2|STARTED|Overall Study||41
7785757|NCT01285713|19166144|P1|STARTED|Overall Study||42
7785758|NCT01285635|19166153|P3|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
7785759|NCT01285635|19166154|P2|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
7785760|NCT01285635|19166155|P1|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
7785761|NCT01285635|19166153|P3|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
7785762|NCT01285635|19166154|P2|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
7785763|NCT01285635|19166155|P1|COMPLETED|Second Intervention (10, 3 Week Cycles)||13
7785764|NCT01285635|19166153|P3|STARTED|Second Intervention (10, 3 Week Cycles)||11
7785765|NCT01285635|19166154|P2|STARTED|Second Intervention (10, 3 Week Cycles)||11
7785766|NCT01285635|19166155|P1|STARTED|Second Intervention (10, 3 Week Cycles)||13
7785767|NCT01285635|19166153|P3|NOT COMPLETED|First Intervention (2 Weeks)||0
7785768|NCT01285635|19166154|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
7785769|NCT01285635|19166155|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
7785770|NCT01285635|19166153|P3|COMPLETED|First Intervention (2 Weeks)||11
7785771|NCT01285635|19166154|P2|COMPLETED|First Intervention (2 Weeks)||11
7785772|NCT01285635|19166155|P1|COMPLETED|First Intervention (2 Weeks)||13
7785773|NCT01285635|19166153|P3|STARTED|First Intervention (2 Weeks)||11
7785774|NCT01285635|19166154|P2|STARTED|First Intervention (2 Weeks)||11
7785775|NCT01285635|19166155|P1|STARTED|First Intervention (2 Weeks)||13
7785776|NCT01285609|19166175|P2|NOT COMPLETED|Treated With Blinded Therapy||359
7785777|NCT01285609|19166176|P1|NOT COMPLETED|Treated With Blinded Therapy||387
7785778|NCT01285609|19166175|P2|COMPLETED|Treated With Blinded Therapy||2
7785779|NCT01285609|19166176|P1|COMPLETED|Treated With Blinded Therapy||1
7785780|NCT01285609|19166175|P2|STARTED|Treated With Blinded Therapy||361
7785781|NCT01285609|19166176|P1|STARTED|Treated With Blinded Therapy||388
7785782|NCT01285609|19166175|P2|NOT COMPLETED|Randomized||116
7785783|NCT01285609|19166176|P1|NOT COMPLETED|Randomized||91
7785784|NCT01285609|19166175|P2|COMPLETED|Randomized||361
7785785|NCT01285609|19166176|P1|COMPLETED|Randomized||388
7785786|NCT01285609|19166175|P2|Treated With Chemotherapy (1st Dose)|Randomized||473
7785787|NCT01285609|19166176|P1|Treated With Chemotherapy (1st Dose)|Randomized||475
7785788|NCT01285609|19166175|P2|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477
7785789|NCT01285609|19166176|P1|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479
7785790|NCT01285518|19166194|P8|NOT COMPLETED|Overall Study||0
7785791|NCT01285518|19166195|P7|NOT COMPLETED|Overall Study||0
7785792|NCT01285518|19166196|P6|NOT COMPLETED|Overall Study||1
7785793|NCT01285518|19166197|P5|NOT COMPLETED|Overall Study||0
7785794|NCT01285518|19166198|P4|NOT COMPLETED|Overall Study||0
7785795|NCT01285518|19166199|P3|NOT COMPLETED|Overall Study||0
7785796|NCT01285518|19166200|P2|NOT COMPLETED|Overall Study||0
7785797|NCT01285518|19166201|P1|NOT COMPLETED|Overall Study||0
7785798|NCT01285518|19166194|P8|COMPLETED|Overall Study||14
7785799|NCT01285518|19166195|P7|COMPLETED|Overall Study||10
7785800|NCT01285518|19166196|P6|COMPLETED|Overall Study||9
7785801|NCT01285518|19166197|P5|COMPLETED|Overall Study||10
7785802|NCT01285518|19166198|P4|COMPLETED|Overall Study||10
7785803|NCT01285518|19166199|P3|COMPLETED|Overall Study||10
7785804|NCT01285518|19166200|P2|COMPLETED|Overall Study||10
7785805|NCT01285518|19166201|P1|COMPLETED|Overall Study||10
7785806|NCT01285518|19166194|P8|STARTED|Overall Study||14
7785807|NCT01285518|19166195|P7|STARTED|Overall Study||10
7785808|NCT01285518|19166196|P6|STARTED|Overall Study||10
7785809|NCT01285518|19166197|P5|STARTED|Overall Study||10
7785810|NCT01285518|19166198|P4|STARTED|Overall Study||10
7785811|NCT01285518|19166199|P3|STARTED|Overall Study||10
7785812|NCT01285518|19166200|P2|STARTED|Overall Study||10
7785813|NCT01285518|19166201|P1|STARTED|Overall Study||10
7785814|NCT01285492|19166461|P2|NOT COMPLETED|Overall Study||1
7785815|NCT01285492|19166462|P1|NOT COMPLETED|Overall Study||17
7785816|NCT01285492|19166461|P2|COMPLETED|Overall Study||38
7785817|NCT01285492|19166462|P1|COMPLETED|Overall Study||104
7785818|NCT01285492|19166461|P2|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39
7785819|NCT01285492|19166462|P1|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119
7785820|NCT01285492|19166461|P2|STARTED|Overall Study|All patients randomized to this group|39
7785821|NCT01285492|19166462|P1|STARTED|Overall Study|All patients randomized to this group|121
7785822|NCT01285427|19166480|P1|NOT COMPLETED|Overall Study||1
7785823|NCT01285427|19166480|P1|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299
7785824|NCT01285427|19166480|P1|STARTED|Overall Study||300
7785825|NCT01285401|19166494|P2|NOT COMPLETED|Overall Study||29
7785826|NCT01285401|19166495|P1|NOT COMPLETED|Overall Study||17
7785827|NCT01285401|19166494|P2|COMPLETED|Overall Study||88
7785828|NCT01285401|19166495|P1|COMPLETED|Overall Study||98
7785829|NCT01285401|19166494|P2|Treated|Overall Study||116
7785830|NCT01285401|19166495|P1|Treated|Overall Study||113
7785831|NCT01285401|19166494|P2|STARTED|Overall Study||117
7785832|NCT01285401|19166495|P1|STARTED|Overall Study||115
7785833|NCT01285349|19166536|P3|NOT COMPLETED|Overall Study||27
7785834|NCT01285349|19166537|P2|NOT COMPLETED|Overall Study||20
7785835|NCT01285349|19166538|P1|NOT COMPLETED|Overall Study||27
7785836|NCT01285349|19166536|P3|COMPLETED|Overall Study||157
7785837|NCT01285349|19166537|P2|COMPLETED|Overall Study||170
7785838|NCT01285349|19166538|P1|COMPLETED|Overall Study||163
7785839|NCT01285349|19166536|P3|STARTED|Overall Study||184
7785840|NCT01285349|19166537|P2|STARTED|Overall Study||190
7785841|NCT01285349|19166538|P1|STARTED|Overall Study||190
7785842|NCT01285323|19166551|P2|NOT COMPLETED|Overall Study||30
7785843|NCT01285323|19166552|P1|NOT COMPLETED|Overall Study||33
7785844|NCT01285323|19166551|P2|COMPLETED|Overall Study||202
7785845|NCT01285323|19166552|P1|COMPLETED|Overall Study||199
7785846|NCT01285323|19166551|P2|Safety Analysis Set|Overall Study||232
7785847|NCT01285323|19166552|P1|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232
7785848|NCT01285323|19166551|P2|Full Analysis Set|Overall Study||232
7785849|NCT01285323|19166552|P1|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232
7785850|NCT01285323|19166551|P2|STARTED|Overall Study||232
7785851|NCT01285323|19166552|P1|STARTED|Overall Study||232
7785852|NCT01285310|19166587|P5|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19
7785853|NCT01285310|19166588|P4|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10
7785854|NCT01285310|19166589|P3|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26
7785855|NCT01285310|19166590|P2|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32
7785856|NCT01285310|19166591|P1|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0
7785857|NCT01285310|19166587|P5|COMPLETED|Active Treatment Phase: Weeks 25-52||23
7785858|NCT01285310|19166588|P4|COMPLETED|Active Treatment Phase: Weeks 25-52||17
7785859|NCT01285310|19166589|P3|COMPLETED|Active Treatment Phase: Weeks 25-52||34
7785860|NCT01285310|19166590|P2|COMPLETED|Active Treatment Phase: Weeks 25-52||31
7785861|NCT01285310|19166591|P1|COMPLETED|Active Treatment Phase: Weeks 25-52||0
7785862|NCT01285310|19166587|P5|STARTED|Active Treatment Phase: Weeks 25-52||42
7785863|NCT01285310|19166588|P4|STARTED|Active Treatment Phase: Weeks 25-52||27
7785864|NCT01285310|19166589|P3|STARTED|Active Treatment Phase: Weeks 25-52||60
7785865|NCT01285310|19166590|P2|STARTED|Active Treatment Phase: Weeks 25-52||63
7785866|NCT01285310|19166591|P1|STARTED|Active Treatment Phase: Weeks 25-52||0
7785867|NCT01285310|19166587|P5|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
7785868|NCT01285310|19166588|P4|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
7785869|NCT01285310|19166589|P3|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
7785870|NCT01285310|19166590|P2|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
7785871|NCT01285310|19166591|P1|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9
7785872|NCT01285310|19166587|P5|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
7785873|NCT01285310|19166588|P4|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
7785874|NCT01285310|19166589|P3|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61
7785875|NCT01285310|19166590|P2|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67
7785876|NCT01285310|19166591|P1|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70
7785877|NCT01285310|19166587|P5|STARTED|Placebo Controlled Phase: Weeks 0-24||0
7785878|NCT01285310|19166588|P4|STARTED|Placebo Controlled Phase: Weeks 0-24||0
7785879|NCT01285310|19166589|P3|STARTED|Placebo Controlled Phase: Weeks 0-24||76
7785880|NCT01285310|19166590|P2|STARTED|Placebo Controlled Phase: Weeks 0-24||82
7785881|NCT01285310|19166591|P1|STARTED|Placebo Controlled Phase: Weeks 0-24||79
7785882|NCT01285076|19166824|P1|NOT COMPLETED|Overall Study||0
7785883|NCT01285076|19166824|P1|COMPLETED|Overall Study||834
7785884|NCT01285076|19166824|P1|STARTED|Overall Study||834
7785885|NCT01285050|19166837|P1|NOT COMPLETED|Overall Study||1
7785886|NCT01285050|19166837|P1|COMPLETED|Overall Study||19
7785887|NCT01285050|19166837|P1|STARTED|Overall Study||20
7785888|NCT01285024|19166844|P2|NOT COMPLETED|Overall Study||0
7785889|NCT01285024|19166845|P1|NOT COMPLETED|Overall Study||0
7785890|NCT01285024|19166844|P2|COMPLETED|Overall Study||60
7785891|NCT01285024|19166845|P1|COMPLETED|Overall Study||49
7785892|NCT01285024|19166844|P2|STARTED|Overall Study||60
7785893|NCT01285024|19166845|P1|STARTED|Overall Study||49
7785894|NCT01284959|19166856|P3|NOT COMPLETED|Overall Study||1
7785895|NCT01284959|19166857|P2|NOT COMPLETED|Overall Study||0
7785896|NCT01284959|19166858|P1|NOT COMPLETED|Overall Study||1
7785897|NCT01284959|19166856|P3|COMPLETED|Overall Study||10
7785898|NCT01284959|19166857|P2|COMPLETED|Overall Study||12
7785899|NCT01284959|19166858|P1|COMPLETED|Overall Study||10
7785900|NCT01284959|19166856|P3|STARTED|Overall Study||11
7785901|NCT01284959|19166857|P2|STARTED|Overall Study||12
7785902|NCT01284959|19166858|P1|STARTED|Overall Study||11
7785903|NCT01284634|19166888|P4|NOT COMPLETED|Overall Study||1
7785904|NCT01284634|19166889|P3|NOT COMPLETED|Overall Study||2
7785905|NCT01284634|19166890|P2|NOT COMPLETED|Overall Study||0
7785906|NCT01284634|19166891|P1|NOT COMPLETED|Overall Study||1
7785907|NCT01284634|19166888|P4|COMPLETED|Overall Study||4
7785908|NCT01284634|19166889|P3|COMPLETED|Overall Study||5
7785909|NCT01284634|19166890|P2|COMPLETED|Overall Study||6
7785910|NCT01284634|19166891|P1|COMPLETED|Overall Study||6
7785911|NCT01284634|19166888|P4|Intent to Treat (ITT) Analysis Set|Overall Study||5
7785912|NCT01284634|19166889|P3|Intent to Treat (ITT) Analysis Set|Overall Study||7
7785913|NCT01284634|19166890|P2|Intent to Treat (ITT) Analysis Set|Overall Study||6
7785914|NCT01284634|19166891|P1|Intent to Treat (ITT) Analysis Set|Overall Study||7
7785915|NCT01284634|19166888|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
7785916|NCT01284634|19166889|P3|Received at Least 1 Dose of Study Drug|Overall Study||7
7785917|NCT01284634|19166890|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
7785918|NCT01284634|19166891|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
7785919|NCT01284634|19166888|P4|STARTED|Overall Study||5
7785920|NCT01284634|19166889|P3|STARTED|Overall Study||7
7785921|NCT01284634|19166890|P2|STARTED|Overall Study||6
7785922|NCT01284634|19166891|P1|STARTED|Overall Study||7
7785923|NCT01284621|19166921|P6|NOT COMPLETED|Third Intervention (8 Days)||0
7785924|NCT01284621|19166922|P5|NOT COMPLETED|Third Intervention (8 Days)||0
7785925|NCT01284621|19166923|P4|NOT COMPLETED|Third Intervention (8 Days)||0
7785926|NCT01284621|19166924|P3|NOT COMPLETED|Third Intervention (8 Days)||0
7785927|NCT01284621|19166925|P2|NOT COMPLETED|Third Intervention (8 Days)||0
7785928|NCT01284621|19166926|P1|NOT COMPLETED|Third Intervention (8 Days)||0
7785929|NCT01284621|19166921|P6|COMPLETED|Third Intervention (8 Days)||4
7785930|NCT01284621|19166922|P5|COMPLETED|Third Intervention (8 Days)||3
7785931|NCT01284621|19166923|P4|COMPLETED|Third Intervention (8 Days)||4
7785932|NCT01284621|19166924|P3|COMPLETED|Third Intervention (8 Days)||4
7785933|NCT01284621|19166925|P2|COMPLETED|Third Intervention (8 Days)||4
7785934|NCT01284621|19166926|P1|COMPLETED|Third Intervention (8 Days)||3
7785935|NCT01284621|19166921|P6|STARTED|Third Intervention (8 Days)||4
7785936|NCT01284621|19166922|P5|STARTED|Third Intervention (8 Days)||3
7785937|NCT01284621|19166923|P4|STARTED|Third Intervention (8 Days)||4
7785938|NCT01284621|19166924|P3|STARTED|Third Intervention (8 Days)||4
7785939|NCT01284621|19166925|P2|STARTED|Third Intervention (8 Days)||4
7785940|NCT01284621|19166926|P1|STARTED|Third Intervention (8 Days)||3
7785941|NCT01284621|19166921|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
7785942|NCT01284621|19166922|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
7785943|NCT01284621|19166923|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
7785944|NCT01284621|19166924|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
7785945|NCT01284621|19166925|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
7785946|NCT01284621|19166926|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
7785947|NCT01284621|19166921|P6|COMPLETED|Washout Period 2 (7 Days)||4
7785948|NCT01284621|19166922|P5|COMPLETED|Washout Period 2 (7 Days)||3
7785949|NCT01284621|19166923|P4|COMPLETED|Washout Period 2 (7 Days)||4
7785950|NCT01284621|19166924|P3|COMPLETED|Washout Period 2 (7 Days)||4
7785951|NCT01284621|19166925|P2|COMPLETED|Washout Period 2 (7 Days)||4
7785952|NCT01284621|19166926|P1|COMPLETED|Washout Period 2 (7 Days)||3
7785953|NCT01284621|19166921|P6|STARTED|Washout Period 2 (7 Days)||4
7785954|NCT01284621|19166922|P5|STARTED|Washout Period 2 (7 Days)||3
7785955|NCT01284621|19166923|P4|STARTED|Washout Period 2 (7 Days)||4
7785956|NCT01284621|19166924|P3|STARTED|Washout Period 2 (7 Days)||4
7785957|NCT01284621|19166925|P2|STARTED|Washout Period 2 (7 Days)||4
7785958|NCT01284621|19166926|P1|STARTED|Washout Period 2 (7 Days)||3
7785959|NCT01284621|19166921|P6|NOT COMPLETED|Second Intervention (8 Days)||0
7785960|NCT01284621|19166922|P5|NOT COMPLETED|Second Intervention (8 Days)||0
7785961|NCT01284621|19166923|P4|NOT COMPLETED|Second Intervention (8 Days)||0
7785962|NCT01284621|19166924|P3|NOT COMPLETED|Second Intervention (8 Days)||0
7785963|NCT01284621|19166925|P2|NOT COMPLETED|Second Intervention (8 Days)||0
7785964|NCT01284621|19166926|P1|NOT COMPLETED|Second Intervention (8 Days)||0
7785965|NCT01284621|19166921|P6|COMPLETED|Second Intervention (8 Days)||4
7785966|NCT01284621|19166922|P5|COMPLETED|Second Intervention (8 Days)||3
7785967|NCT01284621|19166923|P4|COMPLETED|Second Intervention (8 Days)||4
7785968|NCT01284621|19166924|P3|COMPLETED|Second Intervention (8 Days)||4
7785969|NCT01284621|19166925|P2|COMPLETED|Second Intervention (8 Days)||4
7785970|NCT01284621|19166926|P1|COMPLETED|Second Intervention (8 Days)||3
7785971|NCT01284621|19166921|P6|STARTED|Second Intervention (8 Days)||4
7785972|NCT01284621|19166922|P5|STARTED|Second Intervention (8 Days)||3
7785973|NCT01284621|19166923|P4|STARTED|Second Intervention (8 Days)||4
7785974|NCT01284621|19166924|P3|STARTED|Second Intervention (8 Days)||4
7785975|NCT01284621|19166925|P2|STARTED|Second Intervention (8 Days)||4
7785976|NCT01284621|19166926|P1|STARTED|Second Intervention (8 Days)||3
7785977|NCT01284621|19166921|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
7785978|NCT01284621|19166922|P5|NOT COMPLETED|Washout Period 1 (7 Days)||1
7785979|NCT01284621|19166923|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
7785980|NCT01284621|19166924|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
7785981|NCT01284621|19166925|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
7785982|NCT01284621|19166926|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
7785983|NCT01284621|19166921|P6|COMPLETED|Washout Period 1 (7 Days)||4
7785984|NCT01284621|19166922|P5|COMPLETED|Washout Period 1 (7 Days)||3
7785985|NCT01284621|19166923|P4|COMPLETED|Washout Period 1 (7 Days)||4
7785986|NCT01284621|19166924|P3|COMPLETED|Washout Period 1 (7 Days)||4
7785987|NCT01284621|19166925|P2|COMPLETED|Washout Period 1 (7 Days)||4
7785988|NCT01284621|19166926|P1|COMPLETED|Washout Period 1 (7 Days)||3
7785989|NCT01284621|19166921|P6|STARTED|Washout Period 1 (7 Days)||4
7785990|NCT01284621|19166922|P5|STARTED|Washout Period 1 (7 Days)||4
7785991|NCT01284621|19166923|P4|STARTED|Washout Period 1 (7 Days)||4
7785992|NCT01284621|19166924|P3|STARTED|Washout Period 1 (7 Days)||4
7785993|NCT01284621|19166925|P2|STARTED|Washout Period 1 (7 Days)||4
7785994|NCT01284621|19166926|P1|STARTED|Washout Period 1 (7 Days)||3
7785995|NCT01284621|19166921|P6|NOT COMPLETED|First Intervention (8 Days)||0
7785996|NCT01284621|19166922|P5|NOT COMPLETED|First Intervention (8 Days)||0
7785997|NCT01284621|19166923|P4|NOT COMPLETED|First Intervention (8 Days)||0
7785998|NCT01284621|19166924|P3|NOT COMPLETED|First Intervention (8 Days)||0
7785999|NCT01284621|19166925|P2|NOT COMPLETED|First Intervention (8 Days)||0
7786000|NCT01284621|19166926|P1|NOT COMPLETED|First Intervention (8 Days)||0
7786001|NCT01284621|19166921|P6|COMPLETED|First Intervention (8 Days)||4
7786002|NCT01284621|19166922|P5|COMPLETED|First Intervention (8 Days)||4
7786003|NCT01284621|19166923|P4|COMPLETED|First Intervention (8 Days)||4
7786004|NCT01284621|19166924|P3|COMPLETED|First Intervention (8 Days)||4
7786005|NCT01284621|19166925|P2|COMPLETED|First Intervention (8 Days)||4
7786006|NCT01284621|19166926|P1|COMPLETED|First Intervention (8 Days)||3
7786007|NCT01284621|19166921|P6|STARTED|First Intervention (8 Days)||4
7786008|NCT01284621|19166922|P5|STARTED|First Intervention (8 Days)||4
7786009|NCT01284621|19166923|P4|STARTED|First Intervention (8 Days)||4
7786010|NCT01284621|19166924|P3|STARTED|First Intervention (8 Days)||4
7786011|NCT01284621|19166925|P2|STARTED|First Intervention (8 Days)||4
7786012|NCT01284621|19166926|P1|STARTED|First Intervention (8 Days)||3
7786013|NCT01284517|19166970|P2|NOT COMPLETED|Overall Study||36
7786014|NCT01284517|19166971|P1|NOT COMPLETED|Overall Study||32
7786015|NCT01284517|19166970|P2|COMPLETED|Overall Study||140
7786016|NCT01284517|19166971|P1|COMPLETED|Overall Study||148
7786017|NCT01284517|19166970|P2|STARTED|Overall Study||176
7786018|NCT01284517|19166971|P1|STARTED|Overall Study||180
7786019|NCT01284504|19166983|P2|NOT COMPLETED|Overall Study||0
7786020|NCT01284504|19166984|P1|NOT COMPLETED|Overall Study||0
7786021|NCT01284504|19166983|P2|COMPLETED|Overall Study||0
7786022|NCT01284504|19166984|P1|COMPLETED|Overall Study||0
7786023|NCT01284504|19166983|P2|STARTED|Overall Study||0
7786024|NCT01284504|19166984|P1|STARTED|Overall Study||0
7786025|NCT01284491|19166994|P1|NOT COMPLETED|Overall Study||13
7786026|NCT01284491|19166994|P1|COMPLETED|Overall Study||0
7786027|NCT01284491|19166994|P1|STARTED|Overall Study||13
7786028|NCT01284426|19167000|P1|NOT COMPLETED|Overall Study||2
7786029|NCT01284426|19167000|P1|COMPLETED|Overall Study||92
7786030|NCT01284426|19167000|P1|STARTED|Overall Study||94
7786031|NCT01284361|19167004|P1|NOT COMPLETED|Overall Study||9
7786032|NCT01284361|19167004|P1|COMPLETED|Overall Study||82
7786033|NCT01284361|19167004|P1|STARTED|Overall Study||91
7786034|NCT01284335|19167024|P13|NOT COMPLETED|Overall Study||0
7786035|NCT01284335|19167025|P12|NOT COMPLETED|Overall Study||0
7786036|NCT01284335|19167026|P11|NOT COMPLETED|Overall Study||0
7786037|NCT01284335|19167027|P10|NOT COMPLETED|Overall Study||0
7786038|NCT01284335|19167028|P9|NOT COMPLETED|Overall Study||0
7786039|NCT01284335|19167029|P8|NOT COMPLETED|Overall Study||0
7786040|NCT01284335|19167030|P7|NOT COMPLETED|Overall Study||0
7786041|NCT01284335|19167031|P6|NOT COMPLETED|Overall Study||0
7786042|NCT01284335|19167032|P5|NOT COMPLETED|Overall Study||0
7786043|NCT01284335|19167033|P4|NOT COMPLETED|Overall Study||0
7786044|NCT01284335|19167034|P3|NOT COMPLETED|Overall Study||0
7786045|NCT01284335|19167035|P2|NOT COMPLETED|Overall Study||0
7786046|NCT01284335|19167036|P1|NOT COMPLETED|Overall Study||0
7786047|NCT01284335|19167024|P13|COMPLETED|Overall Study||12
7786048|NCT01284335|19167025|P12|COMPLETED|Overall Study||16
7786049|NCT01284335|19167026|P11|COMPLETED|Overall Study||45
7786050|NCT01284335|19167027|P10|COMPLETED|Overall Study||14
7786051|NCT01284335|19167028|P9|COMPLETED|Overall Study||4
7786052|NCT01284335|19167029|P8|COMPLETED|Overall Study||6
7786053|NCT01284335|19167030|P7|COMPLETED|Overall Study||19
7786054|NCT01284335|19167031|P6|COMPLETED|Overall Study||26
7786055|NCT01284335|19167032|P5|COMPLETED|Overall Study||24
7786056|NCT01284335|19167033|P4|COMPLETED|Overall Study||5
7786057|NCT01284335|19167034|P3|COMPLETED|Overall Study||5
7786058|NCT01284335|19167035|P2|COMPLETED|Overall Study||33
7786059|NCT01284335|19167036|P1|COMPLETED|Overall Study||25
7786060|NCT01284335|19167024|P13|Received at Least One Dose of Study Drug|Overall Study||12
7786061|NCT01284335|19167025|P12|Received at Least One Dose of Study Drug|Overall Study||16
7786062|NCT01284335|19167026|P11|Received at Least One Dose of Study Drug|Overall Study||45
7786063|NCT01284335|19167027|P10|Received at Least One Dose of Study Drug|Overall Study||14
7786064|NCT01284335|19167028|P9|Received at Least One Dose of Study Drug|Overall Study||4
7786065|NCT01284335|19167029|P8|Received at Least One Dose of Study Drug|Overall Study||6
7786066|NCT01284335|19167030|P7|Received at Least One Dose of Study Drug|Overall Study||19
7786067|NCT01284335|19167031|P6|Received at Least One Dose of Study Drug|Overall Study||26
7786068|NCT01284335|19167032|P5|Received at Least One Dose of Study Drug|Overall Study||24
7786069|NCT01284335|19167033|P4|Received at Least One Dose of Study Drug|Overall Study||5
7786070|NCT01284335|19167034|P3|Received at Least One Dose of Study Drug|Overall Study||5
7786071|NCT01284335|19167035|P2|Received at Least One Dose of Study Drug|Overall Study||33
7786072|NCT01284335|19167036|P1|Received at Least One Dose of Study Drug|Overall Study||25
7786073|NCT01284335|19167024|P13|STARTED|Overall Study||12
7786074|NCT01284335|19167025|P12|STARTED|Overall Study||16
7786075|NCT01284335|19167026|P11|STARTED|Overall Study||45
7786076|NCT01284335|19167027|P10|STARTED|Overall Study||14
7786077|NCT01284335|19167028|P9|STARTED|Overall Study||4
7786078|NCT01284335|19167029|P8|STARTED|Overall Study||6
7786079|NCT01284335|19167030|P7|STARTED|Overall Study||19
7786080|NCT01284335|19167031|P6|STARTED|Overall Study||26
7786081|NCT01284335|19167032|P5|STARTED|Overall Study||24
7786082|NCT01284335|19167033|P4|STARTED|Overall Study||5
7786083|NCT01284335|19167034|P3|STARTED|Overall Study||5
7786084|NCT01284335|19167035|P2|STARTED|Overall Study||33
7786085|NCT01284335|19167036|P1|STARTED|Overall Study||25
7786086|NCT01284296|19167084|P1|NOT COMPLETED|Overall Study||0
7786087|NCT01284296|19167084|P1|COMPLETED|Overall Study||20
7786088|NCT01284296|19167084|P1|STARTED|Overall Study||20
7786089|NCT01284244|19167091|P2|NOT COMPLETED|Overall Study||0
7786090|NCT01284244|19167092|P1|NOT COMPLETED|Overall Study||0
7786091|NCT01284244|19167091|P2|COMPLETED|Overall Study||18
7786092|NCT01284244|19167092|P1|COMPLETED|Overall Study||18
7786093|NCT01284244|19167091|P2|STARTED|Overall Study||18
7786094|NCT01284244|19167092|P1|STARTED|Overall Study||18
7786095|NCT01284140|19167100|P2|NOT COMPLETED|Subjects With Paired 24hr Collections||6
7786096|NCT01284140|19167101|P1|NOT COMPLETED|Subjects With Paired 24hr Collections||5
7786097|NCT01284140|19167100|P2|COMPLETED|Subjects With Paired 24hr Collections||5
7786098|NCT01284140|19167101|P1|COMPLETED|Subjects With Paired 24hr Collections||6
7786099|NCT01284140|19167100|P2|STARTED|Subjects With Paired 24hr Collections||11
7786100|NCT01284140|19167101|P1|STARTED|Subjects With Paired 24hr Collections||11
7786101|NCT01284140|19167100|P2|NOT COMPLETED|Randomization and Intervention||0
7786102|NCT01284140|19167101|P1|NOT COMPLETED|Randomization and Intervention||0
7786103|NCT01284140|19167100|P2|COMPLETED|Randomization and Intervention||11
7786104|NCT01284140|19167101|P1|COMPLETED|Randomization and Intervention||11
7786105|NCT01284140|19167100|P2|STARTED|Randomization and Intervention||11
7786106|NCT01284140|19167101|P1|STARTED|Randomization and Intervention||11
7786107|NCT01284127|19167115|P1|NOT COMPLETED|Overall Study||7
7786108|NCT01284127|19167115|P1|COMPLETED|Overall Study||31
7786109|NCT01284127|19167115|P1|STARTED|Overall Study||38
7786110|NCT01284114|19167124|P1|NOT COMPLETED|Overall Study||4
7786111|NCT01284114|19167124|P1|COMPLETED|Overall Study||19
7786112|NCT01284114|19167124|P1|STARTED|Overall Study||23
7786113|NCT01284062|19167136|P4|NOT COMPLETED|Overall Study||14
7786114|NCT01284062|19167137|P3|NOT COMPLETED|Overall Study||6
7786115|NCT01284062|19167138|P2|NOT COMPLETED|Overall Study||8
7786116|NCT01284062|19167139|P1|NOT COMPLETED|Overall Study||11
7786117|NCT01284062|19167136|P4|COMPLETED|Overall Study||7
7786118|NCT01284062|19167137|P3|COMPLETED|Overall Study||15
7786119|NCT01284062|19167138|P2|COMPLETED|Overall Study||13
7786120|NCT01284062|19167139|P1|COMPLETED|Overall Study||10
7786121|NCT01284062|19167136|P4|STARTED|Overall Study||21
7786122|NCT01284062|19167137|P3|STARTED|Overall Study||21
7786123|NCT01284062|19167138|P2|STARTED|Overall Study||21
7786124|NCT01284062|19167139|P1|STARTED|Overall Study||21
7786125|NCT01283971|19167213|P2|NOT COMPLETED|Overall Study||12
7786126|NCT01283971|19167214|P1|NOT COMPLETED|Overall Study||15
7786127|NCT01283971|19167213|P2|COMPLETED|Overall Study||36
7786128|NCT01283971|19167214|P1|COMPLETED|Overall Study||33
7786129|NCT01283971|19167213|P2|Intent to Treat Population|Overall Study||48
7786130|NCT01283971|19167214|P1|Intent to Treat Population|Overall Study||46
7786131|NCT01283971|19167213|P2|STARTED|Overall Study||48
7786132|NCT01283971|19167214|P1|STARTED|Overall Study||48
7786133|NCT01283581|19167261|P3|NOT COMPLETED|Overall Study||20
7786134|NCT01283581|19167262|P2|NOT COMPLETED|Overall Study||14
7786135|NCT01283581|19167263|P1|NOT COMPLETED|Overall Study||12
7786136|NCT01283581|19167261|P3|COMPLETED|Overall Study||78
7786137|NCT01283581|19167262|P2|COMPLETED|Overall Study||63
7786138|NCT01283581|19167263|P1|COMPLETED|Overall Study||69
7786139|NCT01283581|19167261|P3|STARTED|Overall Study||98
7786140|NCT01283581|19167262|P2|STARTED|Overall Study||77
7786141|NCT01283581|19167263|P1|STARTED|Overall Study||81
7786142|NCT01283555|19167289|P2|NOT COMPLETED|Second Intervention||0
7786143|NCT01283555|19167290|P1|NOT COMPLETED|Second Intervention||0
7786144|NCT01283555|19167289|P2|COMPLETED|Second Intervention||12
7786145|NCT01283555|19167290|P1|COMPLETED|Second Intervention||13
7786146|NCT01283555|19167289|P2|STARTED|Second Intervention||12
7786147|NCT01283555|19167290|P1|STARTED|Second Intervention||13
7786148|NCT01283555|19167289|P2|NOT COMPLETED|Washout Period of at Least 21 Days||0
7786149|NCT01283555|19167290|P1|NOT COMPLETED|Washout Period of at Least 21 Days||0
7786150|NCT01283555|19167289|P2|COMPLETED|Washout Period of at Least 21 Days||12
7786151|NCT01283555|19167290|P1|COMPLETED|Washout Period of at Least 21 Days||13
7786152|NCT01283555|19167289|P2|STARTED|Washout Period of at Least 21 Days||12
7786153|NCT01283555|19167290|P1|STARTED|Washout Period of at Least 21 Days||13
7786154|NCT01283555|19167289|P2|NOT COMPLETED|First Intervention||0
7786155|NCT01283555|19167290|P1|NOT COMPLETED|First Intervention||0
7786156|NCT01283555|19167289|P2|COMPLETED|First Intervention||12
7786157|NCT01283555|19167290|P1|COMPLETED|First Intervention||13
7786158|NCT01283555|19167289|P2|STARTED|First Intervention||12
7786159|NCT01283555|19167290|P1|STARTED|First Intervention||13
7786160|NCT01283542|19167333|P1|NOT COMPLETED|Extension Phase||3
7786161|NCT01283542|19167333|P1|COMPLETED|Extension Phase||10
7786162|NCT01283542|19167333|P1|Safety Analysis Set|Extension Phase||13
7786163|NCT01283542|19167333|P1|Full Analysis Set (FAS)|Extension Phase||13
7786164|NCT01283542|19167333|P1|STARTED|Extension Phase||13
7786165|NCT01283542|19167333|P1|NOT COMPLETED|Main Phase||7
7786166|NCT01283542|19167333|P1|COMPLETED|Main Phase||13
7786167|NCT01283542|19167333|P1|Safety Analysis Set|Main Phase||20
7786168|NCT01283542|19167333|P1|Full Analysis Set (FAS)|Main Phase||20
7786169|NCT01283542|19167333|P1|STARTED|Main Phase||20
7786170|NCT01283516|19167398|P9|NOT COMPLETED|Overall Study||255
7786171|NCT01283516|19167399|P8|NOT COMPLETED|Overall Study||5
7786172|NCT01283516|19167400|P7|NOT COMPLETED|Overall Study||10
7786173|NCT01283516|19167401|P6|NOT COMPLETED|Overall Study||10
7786174|NCT01283516|19167402|P5|NOT COMPLETED|Overall Study||14
7786175|NCT01283516|19167403|P4|NOT COMPLETED|Overall Study||3
7786176|NCT01283516|19167404|P3|NOT COMPLETED|Overall Study||3
7786177|NCT01283516|19167405|P2|NOT COMPLETED|Overall Study||2
7786178|NCT01283516|19167406|P1|NOT COMPLETED|Overall Study||2
7786179|NCT01283516|19167398|P9|COMPLETED|Overall Study||0
7786180|NCT01283516|19167399|P8|COMPLETED|Overall Study||0
7786181|NCT01283516|19167400|P7|COMPLETED|Overall Study||0
7786182|NCT01283516|19167401|P6|COMPLETED|Overall Study||0
7786183|NCT01283516|19167402|P5|COMPLETED|Overall Study||0
7786184|NCT01283516|19167403|P4|COMPLETED|Overall Study||0
7786185|NCT01283516|19167404|P3|COMPLETED|Overall Study||0
7786186|NCT01283516|19167405|P2|COMPLETED|Overall Study||0
7786187|NCT01283516|19167406|P1|COMPLETED|Overall Study|Completed - see explanation in Recruitment Details.|0
7786188|NCT01283516|19167398|P9|Non-NSCLC|Overall Study|Small number of patients at 750 mg - non-NSCLC, assessment limited, not included in efficacy tables|9
7786189|NCT01283516|19167399|P8|Non-NSCLC|Overall Study||0
7786190|NCT01283516|19167400|P7|Non-NSCLC|Overall Study||1
7786191|NCT01283516|19167401|P6|Non-NSCLC|Overall Study||0
7786192|NCT01283516|19167402|P5|Non-NSCLC|Overall Study||2
7786193|NCT01283516|19167403|P4|Non-NSCLC|Overall Study||0
7786194|NCT01283516|19167404|P3|Non-NSCLC|Overall Study||1
7786195|NCT01283516|19167405|P2|Non-NSCLC|Overall Study||1
7786196|NCT01283516|19167406|P1|Non-NSCLC|Overall Study||0
7786197|NCT01283516|19167398|P9|Dose-Determining Set (DDS)|Overall Study||8
7786198|NCT01283516|19167399|P8|Dose-Determining Set (DDS)|Overall Study||5
7786199|NCT01283516|19167400|P7|Dose-Determining Set (DDS)|Overall Study||10
7786200|NCT01283516|19167401|P6|Dose-Determining Set (DDS)|Overall Study||8
7786201|NCT01283516|19167402|P5|Dose-Determining Set (DDS)|Overall Study||14
7786202|NCT01283516|19167403|P4|Dose-Determining Set (DDS)|Overall Study||3
7786203|NCT01283516|19167404|P3|Dose-Determining Set (DDS)|Overall Study||3
7786204|NCT01283516|19167405|P2|Dose-Determining Set (DDS)|Overall Study||1
7786205|NCT01283516|19167406|P1|Dose-Determining Set (DDS)|Overall Study||2
7786206|NCT01283516|19167398|P9|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246
7786207|NCT01283516|19167399|P8|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5
7786208|NCT01283516|19167400|P7|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9
7786209|NCT01283516|19167401|P6|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10
7786210|NCT01283516|19167402|P5|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12
7786211|NCT01283516|19167403|P4|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3
7786212|NCT01283516|19167404|P3|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
7786213|NCT01283516|19167405|P2|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1
7786214|NCT01283516|19167406|P1|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
7786215|NCT01283516|19167398|P9|STARTED|Overall Study||255
7786216|NCT01283516|19167399|P8|STARTED|Overall Study||5
7786217|NCT01283516|19167400|P7|STARTED|Overall Study||10
7786218|NCT01283516|19167401|P6|STARTED|Overall Study||10
7786219|NCT01283516|19167402|P5|STARTED|Overall Study||14
7786220|NCT01283516|19167403|P4|STARTED|Overall Study||3
7786221|NCT01283516|19167404|P3|STARTED|Overall Study||3
7786222|NCT01283516|19167405|P2|STARTED|Overall Study||2
7786223|NCT01283516|19167406|P1|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2
7786224|NCT01283464|19167528|P2|NOT COMPLETED|Overall Study||1
7786225|NCT01283464|19167529|P1|NOT COMPLETED|Overall Study||2
7786226|NCT01283464|19167528|P2|COMPLETED|Overall Study||11
7786227|NCT01283464|19167529|P1|COMPLETED|Overall Study||10
7786228|NCT01283464|19167528|P2|STARTED|Overall Study||12
7786229|NCT01283464|19167529|P1|STARTED|Overall Study||12
7786230|NCT01283386|19167537|P2|NOT COMPLETED|Overall Study||12
7786231|NCT01283386|19167538|P1|NOT COMPLETED|Overall Study||8
7786232|NCT01283386|19167537|P2|COMPLETED|Overall Study||4
7786233|NCT01283386|19167538|P1|COMPLETED|Overall Study||2
7786234|NCT01283386|19167537|P2|STARTED|Overall Study||16
7786235|NCT01283386|19167538|P1|STARTED|Overall Study||10
7786236|NCT01283334|19167562|P1|NOT COMPLETED|Overall Study||7
7786237|NCT01283334|19167562|P1|COMPLETED|Overall Study||13
7786238|NCT01283334|19167562|P1|STARTED|Overall Study||20
7786239|NCT01283321|19167570|P2|NOT COMPLETED|Overall Study||0
7786240|NCT01283321|19167571|P1|NOT COMPLETED|Overall Study||0
7786241|NCT01283321|19167570|P2|COMPLETED|Overall Study||10
7786242|NCT01283321|19167571|P1|COMPLETED|Overall Study||10
7786243|NCT01283321|19167570|P2|STARTED|Overall Study||10
7786244|NCT01283321|19167571|P1|STARTED|Overall Study||10
7786245|NCT01283282|19167585|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
7786246|NCT01283282|19167586|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
7786247|NCT01283282|19167585|P2|COMPLETED|Second Intervention (6 Weeks)||19
7786248|NCT01283282|19167586|P1|COMPLETED|Second Intervention (6 Weeks)||22
7786249|NCT01283282|19167585|P2|STARTED|Second Intervention (6 Weeks)||19
7786250|NCT01283282|19167586|P1|STARTED|Second Intervention (6 Weeks)||22
7786251|NCT01283282|19167585|P2|NOT COMPLETED|First Intervention (6 Weeks)||4
7786252|NCT01283282|19167586|P1|NOT COMPLETED|First Intervention (6 Weeks)||3
7786253|NCT01283282|19167585|P2|COMPLETED|First Intervention (6 Weeks)||19
7786254|NCT01283282|19167586|P1|COMPLETED|First Intervention (6 Weeks)||22
7786255|NCT01283282|19167585|P2|STARTED|First Intervention (6 Weeks)||23
7786256|NCT01283282|19167586|P1|STARTED|First Intervention (6 Weeks)||25
7786257|NCT01283152|19167606|P2|NOT COMPLETED|Overall Study||0
7786258|NCT01283152|19167607|P1|NOT COMPLETED|Overall Study||2
7786259|NCT01283152|19167606|P2|COMPLETED|Overall Study||25
7786260|NCT01283152|19167607|P1|COMPLETED|Overall Study||23
7786261|NCT01283152|19167606|P2|24-hr HESA Attempted|Overall Study||25
7786262|NCT01283152|19167607|P1|24-hr HESA Attempted|Overall Study||25
7786263|NCT01283152|19167606|P2|Study Treatment Received|Overall Study||25
7786264|NCT01283152|19167607|P1|Study Treatment Received|Overall Study||25
7786265|NCT01283152|19167606|P2|ITT Population|Overall Study||25
7786266|NCT01283152|19167607|P1|ITT Population|Overall Study||25
7786267|NCT01283152|19167606|P2|STARTED|Overall Study||25
7786268|NCT01283152|19167607|P1|STARTED|Overall Study||25
7786269|NCT01283139|19167621|P4|NOT COMPLETED|Overall Study||15
7786270|NCT01283139|19167622|P3|NOT COMPLETED|Overall Study||18
7786271|NCT01283139|19167623|P2|NOT COMPLETED|Overall Study||18
7786272|NCT01283139|19167624|P1|NOT COMPLETED|Overall Study||17
7786273|NCT01283139|19167621|P4|COMPLETED|Overall Study||92
7786274|NCT01283139|19167622|P3|COMPLETED|Overall Study||91
7786275|NCT01283139|19167623|P2|COMPLETED|Overall Study||90
7786276|NCT01283139|19167624|P1|COMPLETED|Overall Study||91
7786277|NCT01283139|19167621|P4|STARTED|Overall Study||107
7786278|NCT01283139|19167622|P3|STARTED|Overall Study||109
7786279|NCT01283139|19167623|P2|STARTED|Overall Study||108
7786280|NCT01283139|19167624|P1|STARTED|Overall Study||108
7786281|NCT01283035|19167666|P1|NOT COMPLETED|Overall Study||1
7786282|NCT01283035|19167666|P1|COMPLETED|Overall Study||5
7786283|NCT01283035|19167666|P1|STARTED|Overall Study||6
7786284|NCT01283022|19167675|P1|NOT COMPLETED|Overall Study||0
7786285|NCT01283022|19167675|P1|COMPLETED|Overall Study||24
7786286|NCT01283022|19167675|P1|STARTED|Overall Study||24
7786287|NCT01283009|19167683|P2|NOT COMPLETED|Overall Study||117
7786288|NCT01283009|19167684|P1|NOT COMPLETED|Overall Study||118
7786289|NCT01283009|19167683|P2|COMPLETED|Overall Study||180
7786290|NCT01283009|19167684|P1|COMPLETED|Overall Study||169
7786291|NCT01283009|19167683|P2|STARTED|Overall Study||297
7786292|NCT01283009|19167684|P1|STARTED|Overall Study||287
7786293|NCT01282866|19167690|P1|NOT COMPLETED|Overall Study||1
7786294|NCT01282866|19167690|P1|COMPLETED|Overall Study||34
7786295|NCT01282866|19167690|P1|STARTED|Overall Study||35
7786296|NCT01282814|19167698|P2|NOT COMPLETED|Second Intervention||0
7786297|NCT01282814|19167699|P1|NOT COMPLETED|Second Intervention||0
7786298|NCT01282814|19167698|P2|COMPLETED|Second Intervention||9
7786299|NCT01282814|19167699|P1|COMPLETED|Second Intervention||10
7786300|NCT01282814|19167698|P2|STARTED|Second Intervention||9
7786301|NCT01282814|19167699|P1|STARTED|Second Intervention||10
7786302|NCT01282814|19167698|P2|NOT COMPLETED|Washout of 7 Days||0
7786303|NCT01282814|19167699|P1|NOT COMPLETED|Washout of 7 Days||2
7786304|NCT01282814|19167698|P2|COMPLETED|Washout of 7 Days||9
7786305|NCT01282814|19167699|P1|COMPLETED|Washout of 7 Days||10
7786306|NCT01282814|19167698|P2|STARTED|Washout of 7 Days||9
7786307|NCT01282814|19167699|P1|STARTED|Washout of 7 Days||12
7786308|NCT01282814|19167698|P2|NOT COMPLETED|First Intervention||3
7786309|NCT01282814|19167699|P1|NOT COMPLETED|First Intervention||0
7786310|NCT01282814|19167698|P2|COMPLETED|First Intervention||9
7786311|NCT01282814|19167699|P1|COMPLETED|First Intervention||12
7786312|NCT01282814|19167698|P2|STARTED|First Intervention||12
7786313|NCT01282814|19167699|P1|STARTED|First Intervention||12
7786314|NCT01282801|19167711|P2|NOT COMPLETED|Second Intervention||1
7786315|NCT01282801|19167712|P1|NOT COMPLETED|Second Intervention||0
7786316|NCT01282801|19167711|P2|COMPLETED|Second Intervention||8
7786317|NCT01282801|19167712|P1|COMPLETED|Second Intervention||9
7786318|NCT01282801|19167711|P2|STARTED|Second Intervention||9
7786319|NCT01282801|19167712|P1|STARTED|Second Intervention||9
7786320|NCT01282801|19167711|P2|NOT COMPLETED|Washout of 7 Days||0
7786321|NCT01282801|19167712|P1|NOT COMPLETED|Washout of 7 Days||0
7786322|NCT01282801|19167711|P2|COMPLETED|Washout of 7 Days||9
7786323|NCT01282801|19167712|P1|COMPLETED|Washout of 7 Days||9
7786324|NCT01282801|19167711|P2|STARTED|Washout of 7 Days||9
7786325|NCT01282801|19167712|P1|STARTED|Washout of 7 Days||9
7786326|NCT01282801|19167711|P2|NOT COMPLETED|First Intervention||0
7786327|NCT01282801|19167712|P1|NOT COMPLETED|First Intervention||0
7786328|NCT01282801|19167711|P2|COMPLETED|First Intervention||9
7786329|NCT01282801|19167712|P1|COMPLETED|First Intervention||9
7786330|NCT01282801|19167711|P2|STARTED|First Intervention||9
7786331|NCT01282801|19167712|P1|STARTED|First Intervention||9
7786332|NCT01282723|19167728|P1|NOT COMPLETED|Overall Study||0
7786333|NCT01282723|19167728|P1|COMPLETED|Overall Study||20
7786334|NCT01282723|19167728|P1|STARTED|Overall Study||20
7786335|NCT01282710|19167732|P1|NOT COMPLETED|Overall Study||0
7786336|NCT01282710|19167732|P1|COMPLETED|Overall Study||20
7786337|NCT01282710|19167732|P1|STARTED|Overall Study||20
7786338|NCT01282476|19167736|P1|NOT COMPLETED|Overall Study||11
7786339|NCT01282476|19167736|P1|COMPLETED|Overall Study||7
7786340|NCT01282476|19167736|P1|STARTED|Overall Study||18
7786341|NCT01282463|19167745|P3|NOT COMPLETED|Overall Study||4
7786342|NCT01282463|19167746|P2|NOT COMPLETED|Overall Study||4
7786343|NCT01282463|19167747|P1|NOT COMPLETED|Overall Study||8
7786344|NCT01282463|19167745|P3|COMPLETED|Overall Study||46
7786345|NCT01282463|19167746|P2|COMPLETED|Overall Study||45
7786346|NCT01282463|19167747|P1|COMPLETED|Overall Study||41
7786347|NCT01282463|19167745|P3|Received at Least 1 Dose of Study Drug|Overall Study||49
7786348|NCT01282463|19167746|P2|Received at Least 1 Dose of Study Drug|Overall Study||46
7786349|NCT01282463|19167747|P1|Received at Least 1 Dose of Study Drug|Overall Study||45
7786350|NCT01282463|19167745|P3|STARTED|Overall Study||50
7786351|NCT01282463|19167746|P2|STARTED|Overall Study||49
7786352|NCT01282463|19167747|P1|STARTED|Overall Study||49
7786353|NCT01282424|19167785|P1|NOT COMPLETED|Long-term Follow-up Period (5 Years)||64
7786354|NCT01282424|19167785|P1|COMPLETED|Long-term Follow-up Period (5 Years)||20
7786355|NCT01282424|19167785|P1|STARTED|Long-term Follow-up Period (5 Years)|Participants did not have to complete the TP in order to enter the Long-term Follow-up Period.|84
7786356|NCT01282424|19167785|P1|NOT COMPLETED|Treatment Period (TP) (81 Months)||46
7786357|NCT01282424|19167785|P1|COMPLETED|Treatment Period (TP) (81 Months)||79
7786358|NCT01282424|19167785|P1|Completed: Death|Treatment Period (TP) (81 Months)||9
7786359|NCT01282424|19167785|P1|Completed: Disease Progression|Treatment Period (TP) (81 Months)||70
7786360|NCT01282424|19167785|P1|STARTED|Treatment Period (TP) (81 Months)||125
7786361|NCT01282372|19167802|P1|NOT COMPLETED|Overall Study||79
7786362|NCT01282372|19167802|P1|COMPLETED|Overall Study||421
7786363|NCT01282372|19167802|P1|STARTED|Overall Study||500
7786364|NCT01282294|19167830|P1|NOT COMPLETED|Overall Study||19
7786365|NCT01282294|19167830|P1|COMPLETED|Overall Study||81
7786366|NCT01282294|19167830|P1|12 Months|Overall Study||86
7786367|NCT01282294|19167830|P1|6 Months|Overall Study||94
7786368|NCT01282294|19167830|P1|3 Months|Overall Study||95
7786369|NCT01282294|19167830|P1|6 Weeks|Overall Study||95
7786370|NCT01282294|19167830|P1|Post-operative|Overall Study||99
7786371|NCT01282294|19167830|P1|Intra-operative|Overall Study||99
7786372|NCT01282294|19167830|P1|STARTED|Overall Study||100
7786373|NCT01282242|19167850|P2|NOT COMPLETED|Overall Study||0
7786374|NCT01282242|19167851|P1|NOT COMPLETED|Overall Study||0
7786375|NCT01282242|19167850|P2|COMPLETED|Overall Study||8
7786376|NCT01282242|19167851|P1|COMPLETED|Overall Study||80
7786377|NCT01282242|19167850|P2|STARTED|Overall Study||8
7786378|NCT01282242|19167851|P1|STARTED|Overall Study||80
7786379|NCT01282229|19167859|P1|NOT COMPLETED|Overall Study||2
7786380|NCT01282229|19167859|P1|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57
7786381|NCT01282229|19167859|P1|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59
7786382|NCT01282216|19167891|P4|NOT COMPLETED|Overall Study||8
7786383|NCT01282216|19167892|P3|NOT COMPLETED|Overall Study||33
7786384|NCT01282216|19167893|P2|NOT COMPLETED|Overall Study||0
7786385|NCT01282216|19167894|P1|NOT COMPLETED|Overall Study||0
7786386|NCT01282216|19167891|P4|COMPLETED|Overall Study||0
7786387|NCT01282216|19167892|P3|COMPLETED|Overall Study||19
7786388|NCT01282216|19167893|P2|COMPLETED|Overall Study||26
7786389|NCT01282216|19167894|P1|COMPLETED|Overall Study||18
7786390|NCT01282216|19167891|P4|STARTED|Overall Study||8
7786391|NCT01282216|19167892|P3|STARTED|Overall Study||52
7786392|NCT01282216|19167893|P2|STARTED|Overall Study||26
7786393|NCT01282216|19167894|P1|STARTED|Overall Study||18
7786394|NCT01282203|19167904|P1|NOT COMPLETED|Overall Study||1
7786395|NCT01282203|19167904|P1|COMPLETED|Overall Study||1121
7786396|NCT01282203|19167904|P1|STARTED|Overall Study||1122
7786397|NCT01282164|19167926|P2|NOT COMPLETED|Overall Study||0
7786398|NCT01282164|19167927|P1|NOT COMPLETED|Overall Study||1
7786399|NCT01282164|19167926|P2|COMPLETED|Overall Study||14
7786400|NCT01282164|19167927|P1|COMPLETED|Overall Study||28
7786401|NCT01282164|19167926|P2|STARTED|Overall Study||14
7786402|NCT01282164|19167927|P1|STARTED|Overall Study||29
7786403|NCT01282138|19167952|P2|NOT COMPLETED|CAPT||0
7786404|NCT01282138|19167953|P1|NOT COMPLETED|CAPT||0
7786405|NCT01282138|19167952|P2|COMPLETED|CAPT||7
7786406|NCT01282138|19167953|P1|COMPLETED|CAPT||6
7786407|NCT01282138|19167952|P2|STARTED|CAPT||7
7786408|NCT01282138|19167953|P1|STARTED|CAPT||6
7786409|NCT01282138|19167952|P2|NOT COMPLETED|EEC||0
7786410|NCT01282138|19167953|P1|NOT COMPLETED|EEC||0
7786411|NCT01282138|19167952|P2|COMPLETED|EEC||7
7786412|NCT01282138|19167953|P1|COMPLETED|EEC||6
7786413|NCT01282138|19167952|P2|STARTED|EEC||7
7786414|NCT01282138|19167953|P1|STARTED|EEC||6
7786415|NCT01282086|19167961|P1|NOT COMPLETED|Overall Study||0
7786416|NCT01282086|19167961|P1|COMPLETED|Overall Study||1365
7786417|NCT01282086|19167961|P1|STARTED|Overall Study||1365
7786418|NCT01281969|19167980|P3|NOT COMPLETED|Overall Study||12
7786419|NCT01281969|19167981|P2|NOT COMPLETED|Overall Study||0
7786420|NCT01281969|19167982|P1|NOT COMPLETED|Overall Study||1
7786421|NCT01281969|19167980|P3|COMPLETED|Overall Study||0
7786422|NCT01281969|19167981|P2|COMPLETED|Overall Study||18
7786423|NCT01281969|19167982|P1|COMPLETED|Overall Study||17
7786424|NCT01281969|19167980|P3|STARTED|Overall Study||12
7786425|NCT01281969|19167981|P2|STARTED|Overall Study||18
7786426|NCT01281969|19167982|P1|STARTED|Overall Study||18
7786427|NCT01281956|19167994|P2|NOT COMPLETED|2nd Intervention (3 Months)||0
7786428|NCT01281956|19167995|P1|NOT COMPLETED|2nd Intervention (3 Months)||1
7786429|NCT01281956|19167994|P2|COMPLETED|2nd Intervention (3 Months)||5
7786430|NCT01281956|19167995|P1|COMPLETED|2nd Intervention (3 Months)||4
7786431|NCT01281956|19167994|P2|STARTED|2nd Intervention (3 Months)||5
7786432|NCT01281956|19167995|P1|STARTED|2nd Intervention (3 Months)||5
7786433|NCT01281956|19167994|P2|NOT COMPLETED|1st Intervention (3 Months)||0
7786434|NCT01281956|19167995|P1|NOT COMPLETED|1st Intervention (3 Months)||0
7786435|NCT01281956|19167994|P2|COMPLETED|1st Intervention (3 Months)||5
7786436|NCT01281956|19167995|P1|COMPLETED|1st Intervention (3 Months)||5
7786437|NCT01281956|19167994|P2|STARTED|1st Intervention (3 Months)||5
7786438|NCT01281956|19167995|P1|STARTED|1st Intervention (3 Months)||5
7786439|NCT01281917|19168026|P1|NOT COMPLETED|Overall Study||1
7786440|NCT01281917|19168026|P1|COMPLETED|Overall Study||39
7786441|NCT01281917|19168026|P1|STARTED|Overall Study||40
7786442|NCT01281865|19168038|P2|NOT COMPLETED|Overall Study||1
7786443|NCT01281865|19168039|P1|NOT COMPLETED|Overall Study||3
7786444|NCT01281865|19168038|P2|COMPLETED|Overall Study||1
7786445|NCT01281865|19168039|P1|COMPLETED|Overall Study||9
7786446|NCT01281865|19168038|P2|STARTED|Overall Study||2
7786447|NCT01281865|19168039|P1|STARTED|Overall Study||12
7786448|NCT01281839|19168047|P2|NOT COMPLETED|Overall Study||14
7786449|NCT01281839|19168048|P1|NOT COMPLETED|Overall Study||10
7786450|NCT01281839|19168047|P2|COMPLETED|Overall Study||119
7786451|NCT01281839|19168048|P1|COMPLETED|Overall Study||250
7786452|NCT01281839|19168047|P2|STARTED|Overall Study||133
7786453|NCT01281839|19168048|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260
7786454|NCT01281644|19168109|P1|NOT COMPLETED|Overall Study||5
7786455|NCT01281644|19168109|P1|COMPLETED|Overall Study||18
7786456|NCT01281644|19168109|P1|STARTED|Overall Study||23
7786457|NCT01281501|19168119|P2|NOT COMPLETED|Overall Study||0
7786458|NCT01281501|19168120|P1|NOT COMPLETED|Overall Study||0
7786459|NCT01281501|19168119|P2|COMPLETED|Overall Study||43
7786460|NCT01281501|19168120|P1|COMPLETED|Overall Study||44
7786461|NCT01281501|19168119|P2|STARTED|Overall Study||43
7786462|NCT01281501|19168120|P1|STARTED|Overall Study||44
7786463|NCT01281475|19168134|P2|NOT COMPLETED|Overall Study||8
7786464|NCT01281475|19168135|P1|NOT COMPLETED|Overall Study||4
7786465|NCT01281475|19168134|P2|COMPLETED|Overall Study||26
7786466|NCT01281475|19168135|P1|COMPLETED|Overall Study||29
7786467|NCT01281475|19168134|P2|STARTED|Overall Study||34
7786468|NCT01281475|19168135|P1|STARTED|Overall Study||33
7786469|NCT01281306|19168150|P7|NOT COMPLETED|Overall Study||7
7786470|NCT01281306|19168151|P6|NOT COMPLETED|Overall Study||7
7786471|NCT01281306|19168152|P5|NOT COMPLETED|Overall Study||9
7786472|NCT01281306|19168153|P4|NOT COMPLETED|Overall Study||11
7786473|NCT01281306|19168154|P3|NOT COMPLETED|Overall Study||8
7786474|NCT01281306|19168155|P2|NOT COMPLETED|Overall Study||4
7786475|NCT01281306|19168156|P1|NOT COMPLETED|Overall Study||8
7786476|NCT01281306|19168150|P7|COMPLETED|Overall Study||51
7786477|NCT01281306|19168151|P6|COMPLETED|Overall Study||135
7786478|NCT01281306|19168152|P5|COMPLETED|Overall Study||134
7786479|NCT01281306|19168153|P4|COMPLETED|Overall Study||123
7786480|NCT01281306|19168154|P3|COMPLETED|Overall Study||133
7786481|NCT01281306|19168155|P2|COMPLETED|Overall Study||141
7786482|NCT01281306|19168156|P1|COMPLETED|Overall Study||136
7786483|NCT01281306|19168150|P7|Ambulatory Blood Pressure Monitoring Set|Overall Study||35
7786484|NCT01281306|19168151|P6|Ambulatory Blood Pressure Monitoring Set|Overall Study||91
7786485|NCT01281306|19168152|P5|Ambulatory Blood Pressure Monitoring Set|Overall Study||93
7786486|NCT01281306|19168153|P4|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
7786487|NCT01281306|19168154|P3|Ambulatory Blood Pressure Monitoring Set|Overall Study||92
7786488|NCT01281306|19168155|P2|Ambulatory Blood Pressure Monitoring Set|Overall Study||99
7786489|NCT01281306|19168156|P1|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
7786490|NCT01281306|19168150|P7|Safety Set|Overall Study||58
7786491|NCT01281306|19168151|P6|Safety Set|Overall Study||142
7786492|NCT01281306|19168152|P5|Safety Set|Overall Study||143
7786493|NCT01281306|19168153|P4|Safety Set|Overall Study||133
7786494|NCT01281306|19168154|P3|Safety Set|Overall Study||141
7786495|NCT01281306|19168155|P2|Safety Set|Overall Study||145
7786496|NCT01281306|19168156|P1|Safety Set|Overall Study||143
7786497|NCT01281306|19168150|P7|Full Analysis Set|Overall Study||58
7786498|NCT01281306|19168151|P6|Full Analysis Set|Overall Study||142
7786499|NCT01281306|19168152|P5|Full Analysis Set|Overall Study||143
7786500|NCT01281306|19168153|P4|Full Analysis Set|Overall Study||133
7786501|NCT01281306|19168154|P3|Full Analysis Set|Overall Study||141
7786502|NCT01281306|19168155|P2|Full Analysis Set|Overall Study||145
7786503|NCT01281306|19168156|P1|Full Analysis Set|Overall Study||143
7786504|NCT01281306|19168150|P7|STARTED|Overall Study||58
7786505|NCT01281306|19168151|P6|STARTED|Overall Study||142
7786506|NCT01281306|19168152|P5|STARTED|Overall Study||143
7786507|NCT01281306|19168153|P4|STARTED|Overall Study||134
7786508|NCT01281306|19168154|P3|STARTED|Overall Study||141
7786509|NCT01281306|19168155|P2|STARTED|Overall Study||145
7786510|NCT01281306|19168156|P1|STARTED|Overall Study||144
7786511|NCT01281202|19168272|P2|NOT COMPLETED|Overall Study||36
7786512|NCT01281202|19168273|P1|NOT COMPLETED|Overall Study||28
7786513|NCT01281202|19168272|P2|COMPLETED|Overall Study||68
7786514|NCT01281202|19168273|P1|COMPLETED|Overall Study||75
7786515|NCT01281202|19168272|P2|STARTED|Overall Study||104
7786516|NCT01281202|19168273|P1|STARTED|Overall Study||103
7786517|NCT01281124|19168281|P1|NOT COMPLETED|Overall Study||1
7786518|NCT01281124|19168281|P1|COMPLETED|Overall Study||0
7786519|NCT01281124|19168281|P1|STARTED|Overall Study||1
7786520|NCT01281007|19168289|P2|NOT COMPLETED|Overall Study||8
7786521|NCT01281007|19168290|P1|NOT COMPLETED|Overall Study||4
7786522|NCT01281007|19168289|P2|COMPLETED|Overall Study||67
7786523|NCT01281007|19168290|P1|COMPLETED|Overall Study||71
7786524|NCT01281007|19168289|P2|STARTED|Overall Study||75
7786525|NCT01281007|19168290|P1|STARTED|Overall Study||75
7786526|NCT01280981|19168296|P1|NOT COMPLETED|Overall Study||92
7786527|NCT01280981|19168296|P1|COMPLETED|Overall Study||196
7786528|NCT01280981|19168296|P1|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260
7786529|NCT01280981|19168296|P1|STARTED|Overall Study||288
7786530|NCT01280968|19168307|P2|NOT COMPLETED|Overall Study||3
7786531|NCT01280968|19168308|P1|NOT COMPLETED|Overall Study||18
7786532|NCT01280968|19168307|P2|COMPLETED|Overall Study||4
7786533|NCT01280968|19168308|P1|COMPLETED|Overall Study||27
7786534|NCT01280968|19168307|P2|STARTED|Overall Study||7
7786535|NCT01280968|19168308|P1|STARTED|Overall Study||45
7786536|NCT01280955|19168324|P1|NOT COMPLETED|Overall Study||3
7786537|NCT01280955|19168324|P1|COMPLETED|Overall Study||27
7786538|NCT01280955|19168324|P1|STARTED|Overall Study||30
7786539|NCT01280942|19168357|P2|NOT COMPLETED|Overall Study||0
7786540|NCT01280942|19168358|P1|NOT COMPLETED|Overall Study||0
7786541|NCT01280942|19168357|P2|COMPLETED|Overall Study||9911
7786542|NCT01280942|19168358|P1|COMPLETED|Overall Study||10120
7786543|NCT01280942|19168357|P2|STARTED|Overall Study||9911
7786544|NCT01280942|19168358|P1|STARTED|Overall Study||10120
7786545|NCT01280903|19168368|P2|NOT COMPLETED|Overall Study||16
7786546|NCT01280903|19168369|P1|NOT COMPLETED|Overall Study||23
7786547|NCT01280903|19168368|P2|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|75
7786548|NCT01280903|19168369|P1|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|68
7786549|NCT01280903|19168368|P2|STARTED|Overall Study||91
7786550|NCT01280903|19168369|P1|STARTED|Overall Study||91
7786551|NCT01280812|19168436|P3|NOT COMPLETED|Overall Study||1
7786552|NCT01280812|19168437|P2|NOT COMPLETED|Overall Study||2
7786553|NCT01280812|19168438|P1|NOT COMPLETED|Overall Study||3
7786554|NCT01280812|19168436|P3|COMPLETED|Overall Study||68
7786555|NCT01280812|19168437|P2|COMPLETED|Overall Study||69
7786556|NCT01280812|19168438|P1|COMPLETED|Overall Study||67
7786557|NCT01280812|19168436|P3|STARTED|Overall Study||69
7786558|NCT01280812|19168437|P2|STARTED|Overall Study||71
7786559|NCT01280812|19168438|P1|STARTED|Overall Study||70
7786560|NCT01280721|19168461|P1|NOT COMPLETED|Overall Study||22
7786561|NCT01280721|19168461|P1|COMPLETED|Overall Study||113
7786562|NCT01280721|19168461|P1|STARTED|Overall Study||135
7786563|NCT01280695|19168481|P5|NOT COMPLETED|Overall Study||2
7786564|NCT01280695|19168482|P4|NOT COMPLETED|Overall Study||4
7786565|NCT01280695|19168483|P3|NOT COMPLETED|Overall Study||5
7786566|NCT01280695|19168484|P2|NOT COMPLETED|Overall Study||1
7786567|NCT01280695|19168485|P1|NOT COMPLETED|Overall Study||0
7786568|NCT01280695|19168481|P5|COMPLETED|Overall Study||24
7786569|NCT01280695|19168482|P4|COMPLETED|Overall Study||22
7786570|NCT01280695|19168483|P3|COMPLETED|Overall Study||21
7786571|NCT01280695|19168484|P2|COMPLETED|Overall Study||24
7786572|NCT01280695|19168485|P1|COMPLETED|Overall Study||26
7786573|NCT01280695|19168481|P5|STARTED|Overall Study||26
7786574|NCT01280695|19168482|P4|STARTED|Overall Study||26
7786575|NCT01280695|19168483|P3|STARTED|Overall Study||26
7786576|NCT01280695|19168484|P2|STARTED|Overall Study||25
7786577|NCT01280695|19168485|P1|STARTED|Overall Study||26
7786578|NCT01280656|19168525|P3|NOT COMPLETED|Overall Study||63
7786579|NCT01280656|19168526|P2|NOT COMPLETED|Overall Study||47
7786580|NCT01280656|19168527|P1|NOT COMPLETED|Overall Study||3
7786581|NCT01280656|19168525|P3|COMPLETED|Overall Study||223
7786582|NCT01280656|19168526|P2|COMPLETED|Overall Study||265
7786583|NCT01280656|19168527|P1|COMPLETED|Overall Study||59
7786584|NCT01280656|19168525|P3|STARTED|Overall Study||286
7786585|NCT01280656|19168526|P2|STARTED|Overall Study||312
7786586|NCT01280656|19168527|P1|STARTED|Overall Study||62
7786587|NCT01280604|19168573|P2|NOT COMPLETED|Overall Study||5
7786588|NCT01280604|19168574|P1|NOT COMPLETED|Overall Study||9
7786589|NCT01280604|19168573|P2|COMPLETED|Overall Study||28
7786590|NCT01280604|19168574|P1|COMPLETED|Overall Study||24
7786591|NCT01280604|19168573|P2|Subjects Meeting All Inclusion Criteria|Overall Study||29
7786592|NCT01280604|19168574|P1|Subjects Meeting All Inclusion Criteria|Overall Study||25
7786593|NCT01280604|19168573|P2|STARTED|Overall Study||33
7786594|NCT01280604|19168574|P1|STARTED|Overall Study||33
7786595|NCT01280591|19168594|P4|NOT COMPLETED|Overall Study||3
7786596|NCT01280591|19168595|P3|NOT COMPLETED|Overall Study||0
7786597|NCT01280591|19168596|P2|NOT COMPLETED|Overall Study||0
7786598|NCT01280591|19168597|P1|NOT COMPLETED|Overall Study||0
7786599|NCT01280591|19168594|P4|COMPLETED|Overall Study||99
7786600|NCT01280591|19168595|P3|COMPLETED|Overall Study||203
7786601|NCT01280591|19168596|P2|COMPLETED|Overall Study||204
7786602|NCT01280591|19168597|P1|COMPLETED|Overall Study||203
7786603|NCT01280591|19168594|P4|STARTED|Overall Study||102
7786604|NCT01280591|19168595|P3|STARTED|Overall Study||203
7786605|NCT01280591|19168596|P2|STARTED|Overall Study||204
7786606|NCT01280591|19168597|P1|STARTED|Overall Study||203
7786607|NCT01280552|19168689|P2|NOT COMPLETED|Overall Study||1
7786608|NCT01280552|19168690|P1|NOT COMPLETED|Overall Study||6
7786609|NCT01280552|19168689|P2|COMPLETED|Overall Study||42
7786610|NCT01280552|19168690|P1|COMPLETED|Overall Study|Survival is still being assessed|75
7786611|NCT01280552|19168689|P2|STARTED|Overall Study||43
7786612|NCT01280552|19168690|P1|STARTED|Overall Study||81
7786613|NCT01280409|19168704|P2|NOT COMPLETED|Overall Study||19
7786614|NCT01280409|19168705|P1|NOT COMPLETED|Overall Study||16
7786615|NCT01280409|19168704|P2|COMPLETED|Overall Study||36
7786616|NCT01280409|19168705|P1|COMPLETED|Overall Study||43
7786617|NCT01280409|19168704|P2|STARTED|Overall Study||55
7786618|NCT01280409|19168705|P1|STARTED|Overall Study||59
7786619|NCT01280357|19168735|P1|NOT COMPLETED|Overall Study||26
7786620|NCT01280357|19168735|P1|COMPLETED|Overall Study||34
7786621|NCT01280357|19168735|P1|STARTED|Overall Study||60
7786622|NCT01280266|19168744|P2|NOT COMPLETED|Second Intervention (Week 5-9)||0
7786623|NCT01280266|19168745|P1|NOT COMPLETED|Second Intervention (Week 5-9)||0
7786624|NCT01280266|19168744|P2|COMPLETED|Second Intervention (Week 5-9)||12
7786625|NCT01280266|19168745|P1|COMPLETED|Second Intervention (Week 5-9)||14
7786626|NCT01280266|19168744|P2|STARTED|Second Intervention (Week 5-9)||12
7786627|NCT01280266|19168745|P1|STARTED|Second Intervention (Week 5-9)||14
7786628|NCT01280266|19168744|P2|NOT COMPLETED|Washout Period (Week 4-5)||0
7786629|NCT01280266|19168745|P1|NOT COMPLETED|Washout Period (Week 4-5)||0
7786630|NCT01280266|19168744|P2|COMPLETED|Washout Period (Week 4-5)||12
7786631|NCT01280266|19168745|P1|COMPLETED|Washout Period (Week 4-5)||14
7786632|NCT01280266|19168744|P2|STARTED|Washout Period (Week 4-5)||12
7786633|NCT01280266|19168745|P1|STARTED|Washout Period (Week 4-5)||14
7786634|NCT01280266|19168744|P2|NOT COMPLETED|First Intervention (Week 1-4)||2
7786635|NCT01280266|19168745|P1|NOT COMPLETED|First Intervention (Week 1-4)||1
7786636|NCT01280266|19168744|P2|COMPLETED|First Intervention (Week 1-4)||12
7786637|NCT01280266|19168745|P1|COMPLETED|First Intervention (Week 1-4)||14
7786638|NCT01280266|19168744|P2|STARTED|First Intervention (Week 1-4)||14
7786639|NCT01280266|19168745|P1|STARTED|First Intervention (Week 1-4)||15
7786640|NCT01280201|19168767|P1|NOT COMPLETED|Overall Study||0
7786641|NCT01280201|19168767|P1|COMPLETED|Overall Study||44
7786642|NCT01280201|19168767|P1|STARTED|Overall Study||44
7786643|NCT01280123|19168779|P3|NOT COMPLETED|Overall Study||1
7786644|NCT01280123|19168780|P2|NOT COMPLETED|Overall Study||4
7786645|NCT01280123|19168781|P1|NOT COMPLETED|Overall Study||1
7786646|NCT01280123|19168779|P3|COMPLETED|Overall Study||70
7786647|NCT01280123|19168780|P2|COMPLETED|Overall Study||63
7786648|NCT01280123|19168781|P1|COMPLETED|Overall Study||71
7786649|NCT01280123|19168779|P3|STARTED|Overall Study||71
7786650|NCT01280123|19168780|P2|STARTED|Overall Study||67
7786651|NCT01280123|19168781|P1|STARTED|Overall Study||72
7786652|NCT01280110|19168806|P2|NOT COMPLETED|Overall Study||0
7786653|NCT01280110|19168807|P1|NOT COMPLETED|Overall Study||0
7786654|NCT01280110|19168806|P2|COMPLETED|Overall Study||22
7786655|NCT01280110|19168807|P1|COMPLETED|Overall Study||22
7786656|NCT01280110|19168806|P2|STARTED|Overall Study||22
7786657|NCT01280110|19168807|P1|STARTED|Overall Study||22
7786658|NCT01280058|19168817|P2|NOT COMPLETED|Overall Study||0
7786659|NCT01280058|19168818|P1|NOT COMPLETED|Overall Study||0
7786660|NCT01280058|19168817|P2|COMPLETED|Overall Study||37
7786661|NCT01280058|19168818|P1|COMPLETED|Overall Study||36
7786662|NCT01280058|19168817|P2|STARTED|Overall Study||37
7786663|NCT01280058|19168818|P1|STARTED|Overall Study||36
7786664|NCT01279954|19168836|P2|NOT COMPLETED|Overall Study||4
7786665|NCT01279954|19168837|P1|NOT COMPLETED|Overall Study||3
7786666|NCT01279954|19168836|P2|COMPLETED|Overall Study||1
7786667|NCT01279954|19168837|P1|COMPLETED|Overall Study||2
7786668|NCT01279954|19168836|P2|STARTED|Overall Study||5
7786669|NCT01279954|19168837|P1|STARTED|Overall Study||5
7786670|NCT01279850|19168848|P1|NOT COMPLETED|Overall Study||91
7786671|NCT01279850|19168848|P1|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|800
7786672|NCT01279850|19168848|P1|STARTED|Overall Study||891
7786673|NCT01279681|19168864|P2|NOT COMPLETED|Overall Study||17
7786674|NCT01279681|19168865|P1|NOT COMPLETED|Overall Study||15
7786675|NCT01279681|19168864|P2|COMPLETED|Overall Study||0
7786676|NCT01279681|19168865|P1|COMPLETED|Overall Study||0
7786677|NCT01279681|19168864|P2|STARTED|Overall Study||17
7786678|NCT01279681|19168865|P1|STARTED|Overall Study||15
7786679|NCT01279616|19168877|P1|NOT COMPLETED|Overall Study||7
7786680|NCT01279616|19168877|P1|COMPLETED|Overall Study||1
7786681|NCT01279616|19168877|P1|STARTED|Overall Study||8
7786682|NCT01279564|19168883|P2|NOT COMPLETED|Overall Study||0
7786683|NCT01279564|19168884|P1|NOT COMPLETED|Overall Study||0
7786684|NCT01279564|19168883|P2|COMPLETED|Overall Study||32
7786685|NCT01279564|19168884|P1|COMPLETED|Overall Study||40
7786686|NCT01279564|19168883|P2|STARTED|Overall Study||32
7786687|NCT01279564|19168884|P1|STARTED|Overall Study||40
7786688|NCT01279486|19168890|P1|NOT COMPLETED|Overall Study||1
7786689|NCT01279486|19168890|P1|COMPLETED|Overall Study|1 result questionnaire was not returned so 119 volunteers results were used for consumer accuracy.|119
7786690|NCT01279486|19168890|P1|STARTED|Overall Study||120
7786691|NCT01279447|19168896|P2|NOT COMPLETED|Overall Study||1
7786692|NCT01279447|19168897|P1|NOT COMPLETED|Overall Study||3
7786693|NCT01279447|19168896|P2|COMPLETED|Overall Study||33
7786694|NCT01279447|19168897|P1|COMPLETED|Overall Study||31
7786695|NCT01279447|19168896|P2|STARTED|Overall Study||34
7786696|NCT01279447|19168897|P1|STARTED|Overall Study||34
7786697|NCT01279343|19168905|P2|NOT COMPLETED|Overall Study||6
7786698|NCT01279343|19168906|P1|NOT COMPLETED|Overall Study||2
7786699|NCT01279343|19168905|P2|COMPLETED|Overall Study||58
7786700|NCT01279343|19168906|P1|COMPLETED|Overall Study||57
7786701|NCT01279343|19168905|P2|STARTED|Overall Study||64
7786702|NCT01279343|19168906|P1|STARTED|Overall Study||59
7786703|NCT01279317|19168930|P2|NOT COMPLETED|Period 2||0
7786704|NCT01279317|19168931|P1|NOT COMPLETED|Period 2||0
7786705|NCT01279317|19168930|P2|COMPLETED|Period 2||6
7786706|NCT01279317|19168931|P1|COMPLETED|Period 2||6
7786707|NCT01279317|19168930|P2|STARTED|Period 2||6
7786708|NCT01279317|19168931|P1|STARTED|Period 2||6
7786709|NCT01279317|19168930|P2|NOT COMPLETED|Washout||0
7786710|NCT01279317|19168931|P1|NOT COMPLETED|Washout||0
7786711|NCT01279317|19168930|P2|COMPLETED|Washout||6
7786712|NCT01279317|19168931|P1|COMPLETED|Washout||6
7786713|NCT01279317|19168930|P2|STARTED|Washout||6
7786714|NCT01279317|19168931|P1|STARTED|Washout||6
7786715|NCT01279317|19168930|P2|NOT COMPLETED|Period 1||0
7786716|NCT01279317|19168931|P1|NOT COMPLETED|Period 1||0
7786717|NCT01279317|19168930|P2|COMPLETED|Period 1||6
7786718|NCT01279317|19168931|P1|COMPLETED|Period 1||6
7786719|NCT01279317|19168930|P2|STARTED|Period 1||6
7786720|NCT01279317|19168931|P1|STARTED|Period 1||6
7786721|NCT01279265|19168938|P2|NOT COMPLETED|Overall Study||6
7786722|NCT01279265|19168939|P1|NOT COMPLETED|Overall Study||4
7786723|NCT01279265|19168938|P2|COMPLETED|Overall Study||11
7786724|NCT01279265|19168939|P1|COMPLETED|Overall Study||9
7786725|NCT01279265|19168938|P2|STARTED|Overall Study||17
7786726|NCT01279265|19168939|P1|STARTED|Overall Study||13
7786727|NCT01279200|19168951|P2|NOT COMPLETED|Overall Study||7
7786728|NCT01279200|19168952|P1|NOT COMPLETED|Overall Study||2
7786729|NCT01279200|19168951|P2|COMPLETED|Overall Study||4
7786730|NCT01279200|19168952|P1|COMPLETED|Overall Study||8
7786731|NCT01279200|19168951|P2|STARTED|Overall Study||11
7786732|NCT01279200|19168952|P1|STARTED|Overall Study||10
7786733|NCT01279187|19168962|P2|NOT COMPLETED|Overall Study||0
7786734|NCT01279187|19168963|P1|NOT COMPLETED|Overall Study||0
7786735|NCT01279187|19168962|P2|COMPLETED|Overall Study||13
7786736|NCT01279187|19168963|P1|COMPLETED|Overall Study||14
7786737|NCT01279187|19168962|P2|STARTED|Overall Study||13
7786738|NCT01279187|19168963|P1|STARTED|Overall Study||14
7786739|NCT01279109|19168979|P2|NOT COMPLETED|Overall Study||12
7786740|NCT01279109|19168980|P1|NOT COMPLETED|Overall Study||13
7786741|NCT01279109|19168979|P2|COMPLETED|Overall Study||55
7786742|NCT01279109|19168980|P1|COMPLETED|Overall Study||55
7786743|NCT01279109|19168979|P2|STARTED|Overall Study||67
7786744|NCT01279109|19168980|P1|STARTED|Overall Study||68
7786745|NCT01279070|19168990|P2|NOT COMPLETED|Overall Study||4
7786746|NCT01279070|19168991|P1|NOT COMPLETED|Overall Study||5
7786747|NCT01279070|19168990|P2|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24
7786748|NCT01279070|19168991|P1|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29
7786749|NCT01279070|19168990|P2|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28
7786750|NCT01279070|19168991|P1|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34
7786751|NCT01279044|19169010|P3|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3
7786752|NCT01279044|19169011|P2|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11
7786753|NCT01279044|19169012|P1|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0
7786754|NCT01279044|19169010|P3|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161
7786755|NCT01279044|19169011|P2|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151
7786756|NCT01279044|19169012|P1|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
7786757|NCT01279044|19169010|P3|STARTED|PHASE 2 - Randmonized Controlled Trial||164
7786758|NCT01279044|19169011|P2|STARTED|PHASE 2 - Randmonized Controlled Trial||162
7786759|NCT01279044|19169012|P1|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
7786760|NCT01279044|19169010|P3|NOT COMPLETED|PHASE 1 - Formative||0
7786761|NCT01279044|19169011|P2|NOT COMPLETED|PHASE 1 - Formative||0
7786762|NCT01279044|19169012|P1|NOT COMPLETED|PHASE 1 - Formative||0
7786763|NCT01279044|19169010|P3|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
7786764|NCT01279044|19169011|P2|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
7786765|NCT01279044|19169012|P1|COMPLETED|PHASE 1 - Formative||59
7786766|NCT01279044|19169010|P3|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
7786767|NCT01279044|19169011|P2|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
7786768|NCT01279044|19169012|P1|STARTED|PHASE 1 - Formative||59
7786769|NCT01278953|19169032|P2|NOT COMPLETED|Overall Study||11
7786770|NCT01278953|19169033|P1|NOT COMPLETED|Overall Study||9
7786771|NCT01278953|19169032|P2|COMPLETED|Overall Study||134
7786772|NCT01278953|19169033|P1|COMPLETED|Overall Study||146
7786773|NCT01278953|19169032|P2|STARTED|Overall Study||145
7786774|NCT01278953|19169033|P1|STARTED|Overall Study||155
7786775|NCT01278927|19169045|P4|NOT COMPLETED|Overall Study||0
7786776|NCT01278927|19169046|P3|NOT COMPLETED|Overall Study||0
7786777|NCT01278927|19169047|P2|NOT COMPLETED|Overall Study||0
7786778|NCT01278927|19169048|P1|NOT COMPLETED|Overall Study||0
7786779|NCT01278927|19169045|P4|COMPLETED|Overall Study||175
7786780|NCT01278927|19169046|P3|COMPLETED|Overall Study||178
7786781|NCT01278927|19169047|P2|COMPLETED|Overall Study||178
7786782|NCT01278927|19169048|P1|COMPLETED|Overall Study||180
7786783|NCT01278927|19169045|P4|STARTED|Overall Study||175
7786784|NCT01278927|19169046|P3|STARTED|Overall Study||178
7786785|NCT01278927|19169047|P2|STARTED|Overall Study||178
7786786|NCT01278927|19169048|P1|STARTED|Overall Study||180
7786787|NCT01278862|19169088|P2|NOT COMPLETED|Overall Study||1
7786788|NCT01278862|19169089|P1|NOT COMPLETED|Overall Study||1
7786789|NCT01278862|19169088|P2|COMPLETED|Overall Study||42
7786790|NCT01278862|19169089|P1|COMPLETED|Overall Study||44
7786791|NCT01278862|19169088|P2|STARTED|Overall Study||43
7786792|NCT01278862|19169089|P1|STARTED|Overall Study||45
7786793|NCT01278797|19169097|P2|NOT COMPLETED|Period 2||0
7786794|NCT01278797|19169098|P1|NOT COMPLETED|Period 2||0
7786795|NCT01278797|19169097|P2|COMPLETED|Period 2||13
7786796|NCT01278797|19169098|P1|COMPLETED|Period 2||13
7786797|NCT01278797|19169097|P2|STARTED|Period 2||13
7786798|NCT01278797|19169098|P1|STARTED|Period 2||13
7786799|NCT01278797|19169097|P2|NOT COMPLETED|Washout Period of 21 Days||0
7786800|NCT01278797|19169098|P1|NOT COMPLETED|Washout Period of 21 Days||0
7786801|NCT01278797|19169097|P2|COMPLETED|Washout Period of 21 Days||13
7786802|NCT01278797|19169098|P1|COMPLETED|Washout Period of 21 Days||13
7786803|NCT01278797|19169097|P2|STARTED|Washout Period of 21 Days||13
7786804|NCT01278797|19169098|P1|STARTED|Washout Period of 21 Days||13
7786805|NCT01278797|19169097|P2|NOT COMPLETED|Period 1||1
7786806|NCT01278797|19169098|P1|NOT COMPLETED|Period 1||1
7786807|NCT01278797|19169097|P2|COMPLETED|Period 1||13
7786808|NCT01278797|19169098|P1|COMPLETED|Period 1||13
7786809|NCT01278797|19169097|P2|STARTED|Period 1||14
7786810|NCT01278797|19169098|P1|STARTED|Period 1||14
7786811|NCT01278745|19169110|P4|NOT COMPLETED|Overall Study||78
7786812|NCT01278745|19169111|P3|NOT COMPLETED|Overall Study||121
7786813|NCT01278745|19169112|P2|NOT COMPLETED|Overall Study||6
7786814|NCT01278745|19169113|P1|NOT COMPLETED|Overall Study||5
7786815|NCT01278745|19169110|P4|COMPLETED|Overall Study||0
7786816|NCT01278745|19169111|P3|COMPLETED|Overall Study||0
7786817|NCT01278745|19169112|P2|COMPLETED|Overall Study||68
7786818|NCT01278745|19169113|P1|COMPLETED|Overall Study||84
7786819|NCT01278745|19169110|P4|STARTED|Overall Study||78
7786820|NCT01278745|19169111|P3|STARTED|Overall Study||121
7786821|NCT01278745|19169112|P2|STARTED|Overall Study||74
7786822|NCT01278745|19169113|P1|STARTED|Overall Study||89
7786823|NCT01278615|19169145|P1|NOT COMPLETED|Overall Study||2
7786824|NCT01278615|19169145|P1|COMPLETED|Overall Study||14
7786825|NCT01278615|19169145|P1|STARTED|Overall Study||16
7786826|NCT01278485|19169155|P1|NOT COMPLETED|Overall Study||0
7786827|NCT01278485|19169155|P1|COMPLETED|Overall Study||719
7786828|NCT01278485|19169155|P1|STARTED|Overall Study||719
7786829|NCT01278407|19169171|P5|NOT COMPLETED|Extension Phase||30
7786830|NCT01278407|19169172|P4|NOT COMPLETED|Extension Phase||12
7786831|NCT01278407|19169173|P3|NOT COMPLETED|Extension Phase||0
7786832|NCT01278407|19169174|P2|NOT COMPLETED|Extension Phase||0
7786833|NCT01278407|19169175|P1|NOT COMPLETED|Extension Phase||0
7786834|NCT01278407|19169171|P5|COMPLETED|Extension Phase||66
7786835|NCT01278407|19169172|P4|COMPLETED|Extension Phase||34
7786836|NCT01278407|19169173|P3|COMPLETED|Extension Phase||0
7786837|NCT01278407|19169174|P2|COMPLETED|Extension Phase||0
7786838|NCT01278407|19169175|P1|COMPLETED|Extension Phase||0
7786839|NCT01278407|19169171|P5|STARTED|Extension Phase||96
7786840|NCT01278407|19169172|P4|STARTED|Extension Phase||46
7786841|NCT01278407|19169173|P3|STARTED|Extension Phase||0
7786842|NCT01278407|19169174|P2|STARTED|Extension Phase||0
7786843|NCT01278407|19169175|P1|STARTED|Extension Phase||0
7786844|NCT01278407|19169171|P5|NOT COMPLETED|Confirmatory Phase||0
7786845|NCT01278407|19169172|P4|NOT COMPLETED|Confirmatory Phase||0
7786846|NCT01278407|19169173|P3|NOT COMPLETED|Confirmatory Phase||6
7786847|NCT01278407|19169174|P2|NOT COMPLETED|Confirmatory Phase||16
7786848|NCT01278407|19169175|P1|NOT COMPLETED|Confirmatory Phase||9
7786849|NCT01278407|19169171|P5|COMPLETED|Confirmatory Phase||0
7786850|NCT01278407|19169172|P4|COMPLETED|Confirmatory Phase||0
7786851|NCT01278407|19169173|P3|COMPLETED|Confirmatory Phase||43
7786852|NCT01278407|19169174|P2|COMPLETED|Confirmatory Phase||31
7786853|NCT01278407|19169175|P1|COMPLETED|Confirmatory Phase||37
7786854|NCT01278407|19169171|P5|STARTED|Confirmatory Phase||0
7786855|NCT01278407|19169172|P4|STARTED|Confirmatory Phase||0
7786856|NCT01278407|19169173|P3|STARTED|Confirmatory Phase||49
7786857|NCT01278407|19169174|P2|STARTED|Confirmatory Phase||47
7786858|NCT01278407|19169175|P1|STARTED|Confirmatory Phase||46
7786859|NCT01278394|19169188|P1|NOT COMPLETED|Overall Study||1
7786860|NCT01278394|19169188|P1|COMPLETED|Overall Study||28
7786861|NCT01278394|19169188|P1|STARTED|Overall Study||29
7786862|NCT01278342|19169201|P3|NOT COMPLETED|Overall Study||0
7786863|NCT01278342|19169202|P2|NOT COMPLETED|Overall Study||1
7786864|NCT01278342|19169203|P1|NOT COMPLETED|Overall Study||4
7786865|NCT01278342|19169201|P3|COMPLETED|Overall Study||32
7786866|NCT01278342|19169202|P2|COMPLETED|Overall Study||30
7786867|NCT01278342|19169203|P1|COMPLETED|Overall Study||3
7786868|NCT01278342|19169201|P3|STARTED|Overall Study||32
7786869|NCT01278342|19169202|P2|STARTED|Overall Study||31
7786870|NCT01278342|19169203|P1|STARTED|Overall Study||7
7786871|NCT01278303|19169217|P1|NOT COMPLETED|Overall Study||0
7786872|NCT01278303|19169217|P1|COMPLETED|Overall Study||82
7786873|NCT01278303|19169217|P1|STARTED|Overall Study||82
7786874|NCT01278173|19169223|P1|NOT COMPLETED|Overall Study||27
7786875|NCT01278173|19169223|P1|COMPLETED|Overall Study||38
7786876|NCT01278173|19169223|P1|STARTED|Overall Study||65
7786877|NCT01278160|19169230|P2|NOT COMPLETED|Overall Study||6
7786878|NCT01278160|19169231|P1|NOT COMPLETED|Overall Study||5
7786879|NCT01278160|19169230|P2|COMPLETED|Overall Study||84
7786880|NCT01278160|19169231|P1|COMPLETED|Overall Study||84
7786881|NCT01278160|19169230|P2|STARTED|Overall Study||90
7786882|NCT01278160|19169231|P1|STARTED|Overall Study||89
7786883|NCT01278030|19169247|P2|NOT COMPLETED|Overall Study||4
7786884|NCT01278030|19169248|P1|NOT COMPLETED|Overall Study||8
7786885|NCT01278030|19169247|P2|COMPLETED|Overall Study||31
7786886|NCT01278030|19169248|P1|COMPLETED|Overall Study||35
7786887|NCT01278030|19169247|P2|STARTED|Overall Study||35
7786888|NCT01278030|19169248|P1|STARTED|Overall Study||43
7786889|NCT01277887|19169256|P2|NOT COMPLETED|Post-Quit Treatment Phase||5
7786890|NCT01277887|19169257|P1|NOT COMPLETED|Post-Quit Treatment Phase||3
7786891|NCT01277887|19169256|P2|COMPLETED|Post-Quit Treatment Phase||5
7786892|NCT01277887|19169257|P1|COMPLETED|Post-Quit Treatment Phase||3
7786893|NCT01277887|19169256|P2|STARTED|Post-Quit Treatment Phase||10
7786894|NCT01277887|19169257|P1|STARTED|Post-Quit Treatment Phase||6
7786895|NCT01277887|19169256|P2|NOT COMPLETED|Pre-Quit Treatment Phase||0
7786896|NCT01277887|19169257|P1|NOT COMPLETED|Pre-Quit Treatment Phase||3
7786897|NCT01277887|19169256|P2|COMPLETED|Pre-Quit Treatment Phase||10
7786898|NCT01277887|19169257|P1|COMPLETED|Pre-Quit Treatment Phase||6
7786899|NCT01277887|19169256|P2|Entered Study|Pre-Quit Treatment Phase||10
7786900|NCT01277887|19169257|P1|Entered Study|Pre-Quit Treatment Phase||7
7786901|NCT01277887|19169256|P2|STARTED|Pre-Quit Treatment Phase||10
7786902|NCT01277887|19169257|P1|STARTED|Pre-Quit Treatment Phase||9
7786903|NCT01277861|19169269|P2|NOT COMPLETED|Overall Study||2
7786904|NCT01277861|19169270|P1|NOT COMPLETED|Overall Study||2
7786905|NCT01277861|19169269|P2|COMPLETED|Overall Study||47
7786906|NCT01277861|19169270|P1|COMPLETED|Overall Study||49
7786907|NCT01277861|19169269|P2|STARTED|Overall Study||49
7786908|NCT01277861|19169270|P1|STARTED|Overall Study||51
7786909|NCT01277822|19169282|P2|NOT COMPLETED|Overall Study||11
7786910|NCT01277822|19169283|P1|NOT COMPLETED|Overall Study||15
7786911|NCT01277822|19169282|P2|COMPLETED|Overall Study||155
7786912|NCT01277822|19169283|P1|COMPLETED|Overall Study||153
7786913|NCT01277822|19169282|P2|STARTED|Overall Study||166
7786914|NCT01277822|19169283|P1|STARTED|Overall Study||168
7786915|NCT01277783|19169303|P1|NOT COMPLETED|Overall Study||0
7786916|NCT01277783|19169303|P1|COMPLETED|Overall Study||138
7786917|NCT01277783|19169303|P1|STARTED|Overall Study||138
7786918|NCT01277757|19169319|P1|NOT COMPLETED|Overall Study||2
7786919|NCT01277757|19169319|P1|COMPLETED|Overall Study||28
7786920|NCT01277757|19169319|P1|STARTED|Overall Study||30
7786921|NCT01277744|19169326|P1|NOT COMPLETED|Overall Study||2
7786922|NCT01277744|19169326|P1|COMPLETED|Overall Study||20
7786923|NCT01277744|19169326|P1|STARTED|Overall Study||22
7786924|NCT01277718|19169331|P2|NOT COMPLETED|Period 3 - Third Intervention||0
7786925|NCT01277718|19169332|P1|NOT COMPLETED|Period 3 - Third Intervention||0
7786926|NCT01277718|19169331|P2|COMPLETED|Period 3 - Third Intervention||7
7786927|NCT01277718|19169332|P1|COMPLETED|Period 3 - Third Intervention||10
7786928|NCT01277718|19169331|P2|STARTED|Period 3 - Third Intervention||7
7786929|NCT01277718|19169332|P1|STARTED|Period 3 - Third Intervention||10
7786930|NCT01277718|19169331|P2|NOT COMPLETED|Washout Period of 13 Days||0
7786931|NCT01277718|19169332|P1|NOT COMPLETED|Washout Period of 13 Days||0
7786932|NCT01277718|19169331|P2|COMPLETED|Washout Period of 13 Days||7
7786933|NCT01277718|19169332|P1|COMPLETED|Washout Period of 13 Days||10
7786934|NCT01277718|19169331|P2|STARTED|Washout Period of 13 Days||7
7786935|NCT01277718|19169332|P1|STARTED|Washout Period of 13 Days||10
7786936|NCT01277718|19169331|P2|NOT COMPLETED|Period 2 - Second Intervention||3
7786937|NCT01277718|19169332|P1|NOT COMPLETED|Period 2 - Second Intervention||0
7786938|NCT01277718|19169331|P2|COMPLETED|Period 2 - Second Intervention||7
7786939|NCT01277718|19169332|P1|COMPLETED|Period 2 - Second Intervention||10
7786940|NCT01277718|19169331|P2|STARTED|Period 2 - Second Intervention||10
7786941|NCT01277718|19169332|P1|STARTED|Period 2 - Second Intervention||10
7786942|NCT01277718|19169331|P2|NOT COMPLETED|Washout Period of 13 Days||0
7786943|NCT01277718|19169332|P1|NOT COMPLETED|Washout Period of 13 Days||0
7786944|NCT01277718|19169331|P2|COMPLETED|Washout Period of 13 Days||10
7786945|NCT01277718|19169332|P1|COMPLETED|Washout Period of 13 Days||10
7786946|NCT01277718|19169331|P2|STARTED|Washout Period of 13 Days||10
7786947|NCT01277718|19169332|P1|STARTED|Washout Period of 13 Days||10
7786948|NCT01277718|19169331|P2|NOT COMPLETED|Period 1 - First Intervention||0
7786949|NCT01277718|19169332|P1|NOT COMPLETED|Period 1 - First Intervention||0
7786950|NCT01277718|19169331|P2|COMPLETED|Period 1 - First Intervention||10
7786951|NCT01277718|19169332|P1|COMPLETED|Period 1 - First Intervention||10
7786952|NCT01277718|19169331|P2|STARTED|Period 1 - First Intervention||10
7786953|NCT01277718|19169332|P1|STARTED|Period 1 - First Intervention||10
7786954|NCT01277666|19169346|P3|NOT COMPLETED|Overall Study||49
7786955|NCT01277666|19169347|P2|NOT COMPLETED|Overall Study||59
7786956|NCT01277666|19169348|P1|NOT COMPLETED|Overall Study||45
7786957|NCT01277666|19169346|P3|COMPLETED|Overall Study||153
7786958|NCT01277666|19169347|P2|COMPLETED|Overall Study||144
7786959|NCT01277666|19169348|P1|COMPLETED|Overall Study||158
7786960|NCT01277666|19169346|P3|STARTED|Overall Study||202
7786961|NCT01277666|19169347|P2|STARTED|Overall Study||203
7786962|NCT01277666|19169348|P1|STARTED|Overall Study||203
7786963|NCT01277601|19169381|P4|NOT COMPLETED|Overall Study||36
7786964|NCT01277601|19169382|P3|NOT COMPLETED|Overall Study||27
7786965|NCT01277601|19169383|P2|NOT COMPLETED|Overall Study||48
7786966|NCT01277601|19169384|P1|NOT COMPLETED|Overall Study||37
7786967|NCT01277601|19169381|P4|COMPLETED|Overall Study||150
7786968|NCT01277601|19169382|P3|COMPLETED|Overall Study||163
7786969|NCT01277601|19169383|P2|COMPLETED|Overall Study||139
7786970|NCT01277601|19169384|P1|COMPLETED|Overall Study||151
7786971|NCT01277601|19169381|P4|STARTED|Overall Study||186
7786972|NCT01277601|19169382|P3|STARTED|Overall Study||190
7786973|NCT01277601|19169383|P2|STARTED|Overall Study||187
7786974|NCT01277601|19169384|P1|STARTED|Overall Study||188
7786975|NCT01277549|19169475|P2|NOT COMPLETED|Overall Study||14
7786976|NCT01277549|19169476|P1|NOT COMPLETED|Overall Study||26
7786977|NCT01277549|19169475|P2|COMPLETED|Overall Study||15
7786978|NCT01277549|19169476|P1|COMPLETED|Overall Study||15
7786979|NCT01277549|19169475|P2|STARTED|Overall Study||29
7786980|NCT01277549|19169476|P1|STARTED|Overall Study||41
7786981|NCT01277523|19169493|P3|NOT COMPLETED|Overall Study||0
7786982|NCT01277523|19169494|P2|NOT COMPLETED|Overall Study||1
7786983|NCT01277523|19169495|P1|NOT COMPLETED|Overall Study||3
7786984|NCT01277523|19169493|P3|COMPLETED|Overall Study||130
7786985|NCT01277523|19169494|P2|COMPLETED|Overall Study||126
7786986|NCT01277523|19169495|P1|COMPLETED|Overall Study||132
7786987|NCT01277523|19169493|P3|STARTED|Overall Study||130
7786988|NCT01277523|19169494|P2|STARTED|Overall Study||127
7786989|NCT01277523|19169495|P1|STARTED|Overall Study||135
7786990|NCT01277510|19169547|P2|NOT COMPLETED|Open-label Phase||3
7786991|NCT01277510|19169548|P1|NOT COMPLETED|Open-label Phase||7
7786992|NCT01277510|19169547|P2|COMPLETED|Open-label Phase|Completed investigational product|1
7786993|NCT01277510|19169548|P1|COMPLETED|Open-label Phase|Completed investigational product|1
7786994|NCT01277510|19169547|P2|Received Investigational Product|Open-label Phase||4
7786995|NCT01277510|19169548|P1|Received Investigational Product|Open-label Phase||6
7786996|NCT01277510|19169547|P2|STARTED|Open-label Phase||4
7786997|NCT01277510|19169548|P1|STARTED|Open-label Phase||8
7786998|NCT01277510|19169547|P2|NOT COMPLETED|Double-blind Phase||18
7786999|NCT01277510|19169548|P1|NOT COMPLETED|Double-blind Phase||13
7787000|NCT01277510|19169547|P2|COMPLETED|Double-blind Phase|Completed investigational product|4
7787001|NCT01277510|19169548|P1|COMPLETED|Double-blind Phase|Completed investigational product|8
7787002|NCT01277510|19169547|P2|Received Investigational Product|Double-blind Phase||22
7787003|NCT01277510|19169548|P1|Received Investigational Product|Double-blind Phase||21
7787004|NCT01277510|19169547|P2|STARTED|Double-blind Phase||22
7787005|NCT01277510|19169548|P1|STARTED|Double-blind Phase||21
7787006|NCT01277354|19169572|P2|NOT COMPLETED|Overall Study||0
7787007|NCT01277354|19169573|P1|NOT COMPLETED|Overall Study||0
7787008|NCT01277354|19169572|P2|COMPLETED|Overall Study||1
7787009|NCT01277354|19169573|P1|COMPLETED|Overall Study||1
7787010|NCT01277354|19169572|P2|STARTED|Overall Study||1
7787011|NCT01277354|19169573|P1|STARTED|Overall Study||1
7787012|NCT01277341|19169583|P4|NOT COMPLETED|Overall Study||6
7787013|NCT01277341|19169584|P3|NOT COMPLETED|Overall Study||4
7787014|NCT01277341|19169585|P2|NOT COMPLETED|Overall Study||5
7787015|NCT01277341|19169586|P1|NOT COMPLETED|Overall Study||4
7787016|NCT01277341|19169583|P4|COMPLETED|Overall Study||146
7787017|NCT01277341|19169584|P3|COMPLETED|Overall Study||145
7787018|NCT01277341|19169585|P2|COMPLETED|Overall Study||145
7787019|NCT01277341|19169586|P1|COMPLETED|Overall Study||146
7787020|NCT01277341|19169583|P4|STARTED|Overall Study||152
7787021|NCT01277341|19169584|P3|STARTED|Overall Study||149
7787022|NCT01277341|19169585|P2|STARTED|Overall Study||150
7787023|NCT01277341|19169586|P1|STARTED|Overall Study||150
7787024|NCT01277302|19169599|P3|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6
7787025|NCT01277302|19169600|P2|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4
7787026|NCT01277302|19169601|P1|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5
7787027|NCT01277302|19169599|P3|COMPLETED|8-Month Alternate Dose Regimen Period||13
7787028|NCT01277302|19169600|P2|COMPLETED|8-Month Alternate Dose Regimen Period||82
7787029|NCT01277302|19169601|P1|COMPLETED|8-Month Alternate Dose Regimen Period||80
7787030|NCT01277302|19169599|P3|STARTED|8-Month Alternate Dose Regimen Period||19
7787031|NCT01277302|19169600|P2|STARTED|8-Month Alternate Dose Regimen Period||86
7787032|NCT01277302|19169601|P1|STARTED|8-Month Alternate Dose Regimen Period||85
7787033|NCT01277302|19169599|P3|NOT COMPLETED|7-Month Fixed Treatment Period||12
7787034|NCT01277302|19169600|P2|NOT COMPLETED|7-Month Fixed Treatment Period||0
7787035|NCT01277302|19169601|P1|NOT COMPLETED|7-Month Fixed Treatment Period||0
7787036|NCT01277302|19169599|P3|COMPLETED|7-Month Fixed Treatment Period||19
7787037|NCT01277302|19169600|P2|COMPLETED|7-Month Fixed Treatment Period||86
7787038|NCT01277302|19169601|P1|COMPLETED|7-Month Fixed Treatment Period||85
7787039|NCT01277302|19169599|P3|STARTED|7-Month Fixed Treatment Period||31
7787040|NCT01277302|19169600|P2|STARTED|7-Month Fixed Treatment Period||86
7787041|NCT01277302|19169601|P1|STARTED|7-Month Fixed Treatment Period||85
7787042|NCT01277211|19169633|P2|NOT COMPLETED|Overall Study||63
7787043|NCT01277211|19169634|P1|NOT COMPLETED|Overall Study||150
7787044|NCT01277211|19169633|P2|COMPLETED|Overall Study||182
7787045|NCT01277211|19169634|P1|COMPLETED|Overall Study||588
7787046|NCT01277211|19169633|P2|Treated|Overall Study||232
7787047|NCT01277211|19169634|P1|Treated|Overall Study||714
7787048|NCT01277211|19169633|P2|STARTED|Overall Study||245
7787049|NCT01277211|19169634|P1|STARTED|Overall Study||738
7787050|NCT01277159|19169649|P5|NOT COMPLETED|Overall Study||5
7787051|NCT01277159|19169650|P4|NOT COMPLETED|Overall Study||3
7787052|NCT01277159|19169651|P3|NOT COMPLETED|Overall Study||3
7787053|NCT01277159|19169652|P2|NOT COMPLETED|Overall Study||1
7787054|NCT01277159|19169653|P1|NOT COMPLETED|Overall Study||4
7787055|NCT01277159|19169649|P5|COMPLETED|Overall Study||16
7787056|NCT01277159|19169650|P4|COMPLETED|Overall Study||19
7787057|NCT01277159|19169651|P3|COMPLETED|Overall Study||19
7787058|NCT01277159|19169652|P2|COMPLETED|Overall Study||21
7787059|NCT01277159|19169653|P1|COMPLETED|Overall Study||17
7787060|NCT01277159|19169649|P5|STARTED|Overall Study||21
7787061|NCT01277159|19169650|P4|STARTED|Overall Study||22
7787062|NCT01277159|19169651|P3|STARTED|Overall Study||22
7787063|NCT01277159|19169652|P2|STARTED|Overall Study||22
7787064|NCT01277159|19169653|P1|STARTED|Overall Study||21
7787065|NCT01277081|19169667|P2|NOT COMPLETED|Overall Study||0
7787066|NCT01277081|19169668|P1|NOT COMPLETED|Overall Study||0
7787067|NCT01277081|19169667|P2|COMPLETED|Overall Study||100
7787068|NCT01277081|19169668|P1|COMPLETED|Overall Study||100
7787069|NCT01277081|19169667|P2|STARTED|Overall Study||100
7787070|NCT01277081|19169668|P1|STARTED|Overall Study||100
7787071|NCT01277042|19169686|P2|NOT COMPLETED|Overall Study||5
7787072|NCT01277042|19169687|P1|NOT COMPLETED|Overall Study||8
7787073|NCT01277042|19169686|P2|COMPLETED|Overall Study||601
7787074|NCT01277042|19169687|P1|COMPLETED|Overall Study||598
7787075|NCT01277042|19169686|P2|STARTED|Overall Study||606
7787076|NCT01277042|19169687|P1|STARTED|Overall Study||606
7787077|NCT01276860|19169711|P2|NOT COMPLETED|Overall Study||0
7787078|NCT01276860|19169712|P1|NOT COMPLETED|Overall Study||0
7787079|NCT01276860|19169711|P2|COMPLETED|Overall Study||2
7787080|NCT01276860|19169712|P1|COMPLETED|Overall Study||5
7787081|NCT01276860|19169711|P2|STARTED|Overall Study||2
7787082|NCT01276860|19169712|P1|STARTED|Overall Study||5
7787083|NCT01276847|19169723|P3|NOT COMPLETED|Overall Study||0
7787084|NCT01276847|19169724|P2|NOT COMPLETED|Overall Study||0
7787085|NCT01276847|19169725|P1|NOT COMPLETED|Overall Study||1
7787086|NCT01276847|19169723|P3|COMPLETED|Overall Study||20
7787087|NCT01276847|19169724|P2|COMPLETED|Overall Study||10
7787088|NCT01276847|19169725|P1|COMPLETED|Overall Study||9
7787089|NCT01276847|19169723|P3|STARTED|Overall Study||20
7787090|NCT01276847|19169724|P2|STARTED|Overall Study||10
7787091|NCT01276847|19169725|P1|STARTED|Overall Study||10
7787092|NCT01276821|19169735|P2|NOT COMPLETED|Overall Study||1
7787093|NCT01276821|19169736|P1|NOT COMPLETED|Overall Study||0
7787094|NCT01276821|19169735|P2|COMPLETED|Overall Study||49
7787095|NCT01276821|19169736|P1|COMPLETED|Overall Study||50
7787096|NCT01276821|19169735|P2|STARTED|Overall Study||50
7787097|NCT01276821|19169736|P1|STARTED|Overall Study||50
7787098|NCT01276756|19169756|P2|NOT COMPLETED|Overall Study||2
7787099|NCT01276756|19169757|P1|NOT COMPLETED|Overall Study||5
7787100|NCT01276756|19169756|P2|COMPLETED|Overall Study||48
7787101|NCT01276756|19169757|P1|COMPLETED|Overall Study||45
7787102|NCT01276756|19169756|P2|STARTED|Overall Study||50
7787103|NCT01276756|19169757|P1|STARTED|Overall Study||50
7787104|NCT01276652|19169774|P3|NOT COMPLETED|Period 2: Observational||0
7787105|NCT01276652|19169775|P2|NOT COMPLETED|Period 2: Observational||0
7787106|NCT01276652|19169776|P1|NOT COMPLETED|Period 2: Observational||0
7787107|NCT01276652|19169774|P3|COMPLETED|Period 2: Observational||5
7787108|NCT01276652|19169775|P2|COMPLETED|Period 2: Observational||8
7787109|NCT01276652|19169776|P1|COMPLETED|Period 2: Observational||9
7787110|NCT01276652|19169774|P3|STARTED|Period 2: Observational|Subjects were only enrolled in the Observational arm during Period 2.|5
7787111|NCT01276652|19169775|P2|STARTED|Period 2: Observational||8
7787112|NCT01276652|19169776|P1|STARTED|Period 2: Observational||9
7787113|NCT01276652|19169774|P3|NOT COMPLETED|Period 1: Randomization||0
7787114|NCT01276652|19169775|P2|NOT COMPLETED|Period 1: Randomization||0
7787115|NCT01276652|19169776|P1|NOT COMPLETED|Period 1: Randomization||0
7787116|NCT01276652|19169774|P3|COMPLETED|Period 1: Randomization||0
7787117|NCT01276652|19169775|P2|COMPLETED|Period 1: Randomization||8
7787118|NCT01276652|19169776|P1|COMPLETED|Period 1: Randomization||9
7787119|NCT01276652|19169774|P3|STARTED|Period 1: Randomization|No subjects were enrolled in this arm during Period 1.|0
7787120|NCT01276652|19169775|P2|STARTED|Period 1: Randomization||8
7787121|NCT01276652|19169776|P1|STARTED|Period 1: Randomization||9
7787122|NCT01276639|19169802|P5|NOT COMPLETED|Week 16 to 52||21
7787123|NCT01276639|19169803|P4|NOT COMPLETED|Week 16 to 52||16
7787124|NCT01276639|19169804|P3|NOT COMPLETED|Week 16 to 52||0
7787125|NCT01276639|19169805|P2|NOT COMPLETED|Week 16 to 52||101
7787126|NCT01276639|19169806|P1|NOT COMPLETED|Week 16 to 52||127
7787127|NCT01276639|19169802|P5|COMPLETED|Week 16 to 52||45
7787128|NCT01276639|19169803|P4|COMPLETED|Week 16 to 52||50
7787129|NCT01276639|19169804|P3|COMPLETED|Week 16 to 52||0
7787130|NCT01276639|19169805|P2|COMPLETED|Week 16 to 52||219
7787131|NCT01276639|19169806|P1|COMPLETED|Week 16 to 52||186
7787132|NCT01276639|19169802|P5|STARTED|Week 16 to 52||66
7787133|NCT01276639|19169803|P4|STARTED|Week 16 to 52||66
7787134|NCT01276639|19169804|P3|STARTED|Week 16 to 52||0
7787135|NCT01276639|19169805|P2|STARTED|Week 16 to 52||320
7787136|NCT01276639|19169806|P1|STARTED|Week 16 to 52||313
7787137|NCT01276639|19169802|P5|NOT COMPLETED|Week 0 to 16||0
7787138|NCT01276639|19169803|P4|NOT COMPLETED|Week 0 to 16||0
7787139|NCT01276639|19169804|P3|NOT COMPLETED|Week 0 to 16||45
7787140|NCT01276639|19169805|P2|NOT COMPLETED|Week 0 to 16||41
7787141|NCT01276639|19169806|P1|NOT COMPLETED|Week 0 to 16||50
7787142|NCT01276639|19169802|P5|COMPLETED|Week 0 to 16||0
7787143|NCT01276639|19169803|P4|COMPLETED|Week 0 to 16||0
7787144|NCT01276639|19169804|P3|COMPLETED|Week 0 to 16||132
7787145|NCT01276639|19169805|P2|COMPLETED|Week 0 to 16||320
7787146|NCT01276639|19169806|P1|COMPLETED|Week 0 to 16||313
7787147|NCT01276639|19169802|P5|Treated|Week 0 to 16||0
7787148|NCT01276639|19169803|P4|Treated|Week 0 to 16||0
7787149|NCT01276639|19169804|P3|Treated|Week 0 to 16||177
7787150|NCT01276639|19169805|P2|Treated|Week 0 to 16||360
7787151|NCT01276639|19169806|P1|Treated|Week 0 to 16||363
7787152|NCT01276639|19169802|P5|STARTED|Week 0 to 16||0
7787153|NCT01276639|19169803|P4|STARTED|Week 0 to 16||0
7787154|NCT01276639|19169804|P3|STARTED|Week 0 to 16||177
7787155|NCT01276639|19169805|P2|STARTED|Week 0 to 16||361
7787156|NCT01276639|19169806|P1|STARTED|Week 0 to 16||363
7787157|NCT01276535|19170001|P1|NOT COMPLETED|Overall Study||0
7787158|NCT01276535|19170001|P1|COMPLETED|Overall Study||12
7787159|NCT01276535|19170001|P1|STARTED|Overall Study||12
7787160|NCT01276509|19170011|P4|NOT COMPLETED|Overall Study||5
7787161|NCT01276509|19170012|P3|NOT COMPLETED|Overall Study||5
7787162|NCT01276509|19170013|P2|NOT COMPLETED|Overall Study||12
7787163|NCT01276509|19170014|P1|NOT COMPLETED|Overall Study||13
7787164|NCT01276509|19170011|P4|COMPLETED|Overall Study||58
7787165|NCT01276509|19170012|P3|COMPLETED|Overall Study||63
7787166|NCT01276509|19170013|P2|COMPLETED|Overall Study||53
7787167|NCT01276509|19170014|P1|COMPLETED|Overall Study||53
7787168|NCT01276509|19170011|P4|STARTED|Overall Study||63
7787169|NCT01276509|19170012|P3|STARTED|Overall Study||68
7787170|NCT01276509|19170013|P2|STARTED|Overall Study||65
7787171|NCT01276509|19170014|P1|STARTED|Overall Study||66
7787172|NCT01276457|19170067|P2|NOT COMPLETED|Extension Study||2
7787173|NCT01276457|19170068|P1|NOT COMPLETED|Extension Study||6
7787174|NCT01276457|19170067|P2|COMPLETED|Extension Study||110
7787175|NCT01276457|19170068|P1|COMPLETED|Extension Study||105
7787176|NCT01276457|19170067|P2|STARTED|Extension Study||112
7787177|NCT01276457|19170068|P1|STARTED|Extension Study||111
7787178|NCT01276457|19170067|P2|NOT COMPLETED|Core Study||20
7787179|NCT01276457|19170068|P1|NOT COMPLETED|Core Study||13
7787180|NCT01276457|19170067|P2|COMPLETED|Core Study||123
7787181|NCT01276457|19170068|P1|COMPLETED|Core Study||129
7787182|NCT01276457|19170067|P2|STARTED|Core Study||143
7787183|NCT01276457|19170068|P1|STARTED|Core Study||142
7787184|NCT01276353|19170082|P2|NOT COMPLETED|Extension||9
7787185|NCT01276353|19170083|P1|NOT COMPLETED|Extension||7
7787186|NCT01276353|19170082|P2|COMPLETED|Extension||14
7787187|NCT01276353|19170083|P1|COMPLETED|Extension||12
7787188|NCT01276353|19170082|P2|STARTED|Extension||23
7787189|NCT01276353|19170083|P1|STARTED|Extension||19
7787190|NCT01276353|19170082|P2|NOT COMPLETED|Double-blind||0
7787191|NCT01276353|19170083|P1|NOT COMPLETED|Double-blind||3
7787192|NCT01276353|19170082|P2|COMPLETED|Double-blind||23
7787193|NCT01276353|19170083|P1|COMPLETED|Double-blind||19
7787194|NCT01276353|19170082|P2|STARTED|Double-blind||23
7787195|NCT01276353|19170083|P1|STARTED|Double-blind||22
7787196|NCT01276327|19170095|P2|NOT COMPLETED|Overall Study||3
7787197|NCT01276327|19170096|P1|NOT COMPLETED|Overall Study||2
7787198|NCT01276327|19170095|P2|COMPLETED|Overall Study||29
7787199|NCT01276327|19170096|P1|COMPLETED|Overall Study||30
7787200|NCT01276327|19170095|P2|STARTED|Overall Study||32
7787201|NCT01276327|19170096|P1|STARTED|Overall Study||32
7787202|NCT01276314|19170122|P4|NOT COMPLETED|Overall Study||5
7787203|NCT01276314|19170123|P3|NOT COMPLETED|Overall Study||4
7787204|NCT01276314|19170124|P2|NOT COMPLETED|Overall Study||10
7787205|NCT01276314|19170125|P1|NOT COMPLETED|Overall Study||10
7787206|NCT01276314|19170122|P4|COMPLETED|Overall Study||17
7787207|NCT01276314|19170123|P3|COMPLETED|Overall Study||18
7787208|NCT01276314|19170124|P2|COMPLETED|Overall Study||33
7787209|NCT01276314|19170125|P1|COMPLETED|Overall Study||38
7787210|NCT01276314|19170122|P4|STARTED|Overall Study||22
7787211|NCT01276314|19170123|P3|STARTED|Overall Study||22
7787212|NCT01276314|19170124|P2|STARTED|Overall Study||43
7787213|NCT01276314|19170125|P1|STARTED|Overall Study||48
7787214|NCT01276301|19170135|P2|NOT COMPLETED|Second Intervention||0
7787215|NCT01276301|19170136|P1|NOT COMPLETED|Second Intervention||0
7787216|NCT01276301|19170135|P2|COMPLETED|Second Intervention||8
7787217|NCT01276301|19170136|P1|COMPLETED|Second Intervention||8
7787218|NCT01276301|19170135|P2|STARTED|Second Intervention||8
7787219|NCT01276301|19170136|P1|STARTED|Second Intervention||8
7787220|NCT01276301|19170135|P2|NOT COMPLETED|Washout Period of 7 Days||0
7787221|NCT01276301|19170136|P1|NOT COMPLETED|Washout Period of 7 Days||0
7787222|NCT01276301|19170135|P2|COMPLETED|Washout Period of 7 Days||8
7787223|NCT01276301|19170136|P1|COMPLETED|Washout Period of 7 Days||8
7787224|NCT01276301|19170135|P2|STARTED|Washout Period of 7 Days||8
7787225|NCT01276301|19170136|P1|STARTED|Washout Period of 7 Days||8
7787226|NCT01276301|19170135|P2|NOT COMPLETED|First Intervention||0
7787227|NCT01276301|19170136|P1|NOT COMPLETED|First Intervention||0
7787228|NCT01276301|19170135|P2|COMPLETED|First Intervention||8
7787229|NCT01276301|19170136|P1|COMPLETED|First Intervention||8
7787230|NCT01276301|19170135|P2|STARTED|First Intervention||8
7787231|NCT01276301|19170136|P1|STARTED|First Intervention||8
7787232|NCT01276288|19170163|P4|NOT COMPLETED|Overall Study||0
7787233|NCT01276288|19170164|P3|NOT COMPLETED|Overall Study||0
7787234|NCT01276288|19170165|P2|NOT COMPLETED|Overall Study||1
7787235|NCT01276288|19170166|P1|NOT COMPLETED|Overall Study||2
7787236|NCT01276288|19170163|P4|COMPLETED|Overall Study||5
7787237|NCT01276288|19170164|P3|COMPLETED|Overall Study||5
7787238|NCT01276288|19170165|P2|COMPLETED|Overall Study||5
7787239|NCT01276288|19170166|P1|COMPLETED|Overall Study||5
7787240|NCT01276288|19170163|P4|Received EMPA+TOR|Overall Study||5
7787241|NCT01276288|19170164|P3|Received EMPA+TOR|Overall Study||5
7787242|NCT01276288|19170165|P2|Received EMPA+TOR|Overall Study||0
7787243|NCT01276288|19170166|P1|Received EMPA+TOR|Overall Study||0
7787244|NCT01276288|19170163|P4|Received EMPA+HCT|Overall Study||0
7787245|NCT01276288|19170164|P3|Received EMPA+HCT|Overall Study||0
7787246|NCT01276288|19170165|P2|Received EMPA+HCT|Overall Study||5
7787247|NCT01276288|19170166|P1|Received EMPA+HCT|Overall Study||5
7787248|NCT01276288|19170163|P4|Received EMPA|Overall Study||5
7787249|NCT01276288|19170164|P3|Received EMPA|Overall Study||5
7787250|NCT01276288|19170165|P2|Received EMPA|Overall Study||5
7787251|NCT01276288|19170166|P1|Received EMPA|Overall Study||6
7787252|NCT01276288|19170163|P4|STARTED|Overall Study||5
7787253|NCT01276288|19170164|P3|STARTED|Overall Study||5
7787254|NCT01276288|19170165|P2|STARTED|Overall Study||6
7787255|NCT01276288|19170166|P1|STARTED|Overall Study||7
7787256|NCT01276223|19170293|P3|NOT COMPLETED|Overall Study||3
7787257|NCT01276223|19170294|P2|NOT COMPLETED|Overall Study||4
7787258|NCT01276223|19170295|P1|NOT COMPLETED|Overall Study||11
7787259|NCT01276223|19170293|P3|COMPLETED|Overall Study||101
7787260|NCT01276223|19170294|P2|COMPLETED|Overall Study||103
7787261|NCT01276223|19170295|P1|COMPLETED|Overall Study||67
7787262|NCT01276223|19170293|P3|STARTED|Overall Study||104
7787263|NCT01276223|19170294|P2|STARTED|Overall Study||107
7787264|NCT01276223|19170295|P1|STARTED|Overall Study||78
7787265|NCT01276197|19170304|P2|NOT COMPLETED|Overall Study||110
7787266|NCT01276197|19170305|P1|NOT COMPLETED|Overall Study||108
7787267|NCT01276197|19170304|P2|COMPLETED|Overall Study||200
7787268|NCT01276197|19170305|P1|COMPLETED|Overall Study||200
7787269|NCT01276197|19170304|P2|STARTED|Overall Study||310
7787270|NCT01276197|19170305|P1|STARTED|Overall Study||308
7787271|NCT01276171|19170316|P3|NOT COMPLETED|Overall Study||0
7787272|NCT01276171|19170317|P2|NOT COMPLETED|Overall Study||0
7787273|NCT01276171|19170318|P1|NOT COMPLETED|Overall Study||0
7787274|NCT01276171|19170316|P3|COMPLETED|Overall Study||256
7787275|NCT01276171|19170317|P2|COMPLETED|Overall Study||244
7787276|NCT01276171|19170318|P1|COMPLETED|Overall Study||249
7787277|NCT01276171|19170316|P3|STARTED|Overall Study||256
7787278|NCT01276171|19170317|P2|STARTED|Overall Study||244
7787279|NCT01276171|19170318|P1|STARTED|Overall Study||249
7787280|NCT01276106|19170336|P4|NOT COMPLETED|Overall Study||13
7787281|NCT01276106|19170337|P3|NOT COMPLETED|Overall Study||16
7787282|NCT01276106|19170338|P2|NOT COMPLETED|Overall Study||9
7787283|NCT01276106|19170339|P1|NOT COMPLETED|Overall Study||12
7787284|NCT01276106|19170336|P4|COMPLETED|Overall Study||52
7787285|NCT01276106|19170337|P3|COMPLETED|Overall Study||49
7787286|NCT01276106|19170338|P2|COMPLETED|Overall Study||55
7787287|NCT01276106|19170339|P1|COMPLETED|Overall Study||53
7787288|NCT01276106|19170336|P4|STARTED|Overall Study||65
7787289|NCT01276106|19170337|P3|STARTED|Overall Study||65
7787290|NCT01276106|19170338|P2|STARTED|Overall Study||64
7787291|NCT01276106|19170339|P1|STARTED|Overall Study||65
7787292|NCT01276054|19170351|P2|NOT COMPLETED|Overall Study||2
7787293|NCT01276054|19170352|P1|NOT COMPLETED|Overall Study||2
7787294|NCT01276054|19170351|P2|COMPLETED|Overall Study||0
7787295|NCT01276054|19170352|P1|COMPLETED|Overall Study||0
7787296|NCT01276054|19170351|P2|STARTED|Overall Study||2
7787297|NCT01276054|19170352|P1|STARTED|Overall Study||2
7787298|NCT01276041|19170358|P1|NOT COMPLETED|Overall Study||3
7787299|NCT01276041|19170358|P1|COMPLETED|Overall Study||67
7787300|NCT01276041|19170358|P1|STARTED|Overall Study||70
7787301|NCT01275833|19170367|P2|NOT COMPLETED|Overall Study||1
7787302|NCT01275833|19170368|P1|NOT COMPLETED|Overall Study||1
7787303|NCT01275833|19170367|P2|COMPLETED|Overall Study||0
7787304|NCT01275833|19170368|P1|COMPLETED|Overall Study||0
7787305|NCT01275833|19170367|P2|STARTED|Overall Study||1
7787306|NCT01275833|19170368|P1|STARTED|Overall Study||1
7787307|NCT01275755|19170376|P2|NOT COMPLETED|Run-out Placebo Period||0
7787308|NCT01275755|19170377|P1|NOT COMPLETED|Run-out Placebo Period||1
7787309|NCT01275755|19170376|P2|COMPLETED|Run-out Placebo Period||37
7787310|NCT01275755|19170377|P1|COMPLETED|Run-out Placebo Period||38
7787311|NCT01275755|19170376|P2|STARTED|Run-out Placebo Period||37
7787312|NCT01275755|19170377|P1|STARTED|Run-out Placebo Period||39
7787313|NCT01275755|19170376|P2|NOT COMPLETED|Double-blind Treatment Period||3
7787314|NCT01275755|19170377|P1|NOT COMPLETED|Double-blind Treatment Period||2
7787315|NCT01275755|19170376|P2|COMPLETED|Double-blind Treatment Period||37
7787316|NCT01275755|19170377|P1|COMPLETED|Double-blind Treatment Period||39
7787317|NCT01275755|19170376|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40
7787318|NCT01275755|19170377|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41
7787319|NCT01275755|19170376|P2|STARTED|Double-blind Treatment Period||40
7787320|NCT01275755|19170377|P1|STARTED|Double-blind Treatment Period||41
7787321|NCT01275755|19170376|P2|NOT COMPLETED|Run-in Placebo Period||0
7787322|NCT01275755|19170377|P1|NOT COMPLETED|Run-in Placebo Period||0
7787323|NCT01275755|19170376|P2|COMPLETED|Run-in Placebo Period||40
7787324|NCT01275755|19170377|P1|COMPLETED|Run-in Placebo Period||41
7787325|NCT01275755|19170376|P2|STARTED|Run-in Placebo Period||40
7787326|NCT01275755|19170377|P1|STARTED|Run-in Placebo Period||41
7787327|NCT01275677|19170385|P2|NOT COMPLETED|Overall Study||42
7787328|NCT01275677|19170386|P1|NOT COMPLETED|Overall Study||28
7787329|NCT01275677|19170385|P2|COMPLETED|Overall Study||1598
7787330|NCT01275677|19170386|P1|COMPLETED|Overall Study||1602
7787331|NCT01275677|19170385|P2|STARTED|Overall Study||1640
7787332|NCT01275677|19170386|P1|STARTED|Overall Study||1630
7787333|NCT01275664|19170404|P1|NOT COMPLETED|Overall Study||0
7787334|NCT01275664|19170404|P1|COMPLETED|Overall Study||4
7787335|NCT01275664|19170404|P1|STARTED|Overall Study||4
7787336|NCT01275625|19170412|P1|NOT COMPLETED|Overall Study||13
7787337|NCT01275625|19170412|P1|COMPLETED|Overall Study||64
7787338|NCT01275625|19170412|P1|Treated|Overall Study||77
7787339|NCT01275625|19170412|P1|STARTED|Overall Study||77
7787340|NCT01275586|19170426|P1|NOT COMPLETED|Overall Study||3
7787341|NCT01275586|19170426|P1|COMPLETED|Overall Study||3
7787342|NCT01275586|19170426|P1|STARTED|Overall Study||6
7787343|NCT01275430|19170430|P1|NOT COMPLETED|Overall Study||9
7787344|NCT01275430|19170430|P1|COMPLETED|Overall Study||18
7787345|NCT01275430|19170430|P1|STARTED|Overall Study||27
7787346|NCT01275365|19170442|P4|NOT COMPLETED|Overall Study||3
7787347|NCT01275365|19170443|P3|NOT COMPLETED|Overall Study||5
7787348|NCT01275365|19170444|P2|NOT COMPLETED|Overall Study||3
7787349|NCT01275365|19170445|P1|NOT COMPLETED|Overall Study||3
7787350|NCT01275365|19170442|P4|COMPLETED|Overall Study||19
7787351|NCT01275365|19170443|P3|COMPLETED|Overall Study||17
7787352|NCT01275365|19170444|P2|COMPLETED|Overall Study||21
7787353|NCT01275365|19170445|P1|COMPLETED|Overall Study||21
7787354|NCT01275365|19170442|P4|STARTED|Overall Study||22
7787355|NCT01275365|19170443|P3|STARTED|Overall Study||22
7787356|NCT01275365|19170444|P2|STARTED|Overall Study||24
7787357|NCT01275365|19170445|P1|STARTED|Overall Study||24
7787358|NCT01275339|19170495|P4|NOT COMPLETED|Overall Study||0
7787359|NCT01275339|19170496|P3|NOT COMPLETED|Overall Study||1
7787360|NCT01275339|19170497|P2|NOT COMPLETED|Overall Study||0
7787361|NCT01275339|19170498|P1|NOT COMPLETED|Overall Study||1
7787362|NCT01275339|19170495|P4|COMPLETED|Overall Study||4
7787363|NCT01275339|19170496|P3|COMPLETED|Overall Study||3
7787364|NCT01275339|19170497|P2|COMPLETED|Overall Study||0
7787365|NCT01275339|19170498|P1|COMPLETED|Overall Study||1
7787366|NCT01275339|19170495|P4|STARTED|Overall Study||4
7787367|NCT01275339|19170496|P3|STARTED|Overall Study||4
7787368|NCT01275339|19170497|P2|STARTED|Overall Study||0
7787369|NCT01275339|19170498|P1|STARTED|Overall Study||2
7787370|NCT01275313|19170510|P2|NOT COMPLETED|Overall Study||52
7787371|NCT01275313|19170511|P1|NOT COMPLETED|Overall Study||25
7787372|NCT01275313|19170510|P2|COMPLETED|Overall Study||79
7787373|NCT01275313|19170511|P1|COMPLETED|Overall Study||102
7787374|NCT01275313|19170510|P2|STARTED|Overall Study||131
7787375|NCT01275313|19170511|P1|STARTED|Overall Study||127
7787376|NCT01275300|19170517|P2|NOT COMPLETED|Phase 2: Open-label 6days)||0
7787377|NCT01275300|19170518|P1|NOT COMPLETED|Phase 2: Open-label 6days)||0
7787378|NCT01275300|19170517|P2|COMPLETED|Phase 2: Open-label 6days)||4
7787379|NCT01275300|19170518|P1|COMPLETED|Phase 2: Open-label 6days)||5
7787380|NCT01275300|19170517|P2|STARTED|Phase 2: Open-label 6days)||4
7787381|NCT01275300|19170518|P1|STARTED|Phase 2: Open-label 6days)||5
7787382|NCT01275300|19170517|P2|NOT COMPLETED|Washout (14 Days)||0
7787383|NCT01275300|19170518|P1|NOT COMPLETED|Washout (14 Days)||0
7787384|NCT01275300|19170517|P2|COMPLETED|Washout (14 Days)||4
7787385|NCT01275300|19170518|P1|COMPLETED|Washout (14 Days)||5
7787386|NCT01275300|19170517|P2|STARTED|Washout (14 Days)||4
7787387|NCT01275300|19170518|P1|STARTED|Washout (14 Days)||5
7787388|NCT01275300|19170517|P2|NOT COMPLETED|2nd Intervention(5 Days)||0
7787389|NCT01275300|19170518|P1|NOT COMPLETED|2nd Intervention(5 Days)||0
7787390|NCT01275300|19170517|P2|COMPLETED|2nd Intervention(5 Days)||4
7787391|NCT01275300|19170518|P1|COMPLETED|2nd Intervention(5 Days)||5
7787392|NCT01275300|19170517|P2|STARTED|2nd Intervention(5 Days)||4
7787393|NCT01275300|19170518|P1|STARTED|2nd Intervention(5 Days)||5
7787394|NCT01275300|19170517|P2|NOT COMPLETED|Washout (14 Days)||0
7787395|NCT01275300|19170518|P1|NOT COMPLETED|Washout (14 Days)||0
7787396|NCT01275300|19170517|P2|COMPLETED|Washout (14 Days)||4
7787397|NCT01275300|19170518|P1|COMPLETED|Washout (14 Days)||5
7787398|NCT01275300|19170517|P2|STARTED|Washout (14 Days)||4
7787399|NCT01275300|19170518|P1|STARTED|Washout (14 Days)||5
7787400|NCT01275300|19170517|P2|NOT COMPLETED|1st Intervention (5 Days)||0
7787401|NCT01275300|19170518|P1|NOT COMPLETED|1st Intervention (5 Days)||0
7787402|NCT01275300|19170517|P2|COMPLETED|1st Intervention (5 Days)||4
7787403|NCT01275300|19170518|P1|COMPLETED|1st Intervention (5 Days)||5
7787404|NCT01275300|19170517|P2|STARTED|1st Intervention (5 Days)||4
7787405|NCT01275300|19170518|P1|STARTED|1st Intervention (5 Days)||5
7787406|NCT01275196|19170526|P2|NOT COMPLETED|Overall Study||21
7787407|NCT01275196|19170527|P1|NOT COMPLETED|Overall Study||20
7787408|NCT01275196|19170526|P2|COMPLETED|Overall Study||113
7787409|NCT01275196|19170527|P1|COMPLETED|Overall Study||113
7787410|NCT01275196|19170526|P2|Intended to Continue Into Extension|Overall Study||113
7787411|NCT01275196|19170527|P1|Intended to Continue Into Extension|Overall Study||112
7787412|NCT01275196|19170526|P2|STARTED|Overall Study||134
7787413|NCT01275196|19170527|P1|STARTED|Overall Study||133
7787414|NCT01275170|19170574|P8|NOT COMPLETED|Part 2: Period 2||0
7787415|NCT01275170|19170575|P7|NOT COMPLETED|Part 2: Period 2||0
7787416|NCT01275170|19170576|P6|NOT COMPLETED|Part 2: Period 2||0
7787417|NCT01275170|19170577|P5|NOT COMPLETED|Part 2: Period 2||0
7787418|NCT01275170|19170578|P4|NOT COMPLETED|Part 2: Period 2||0
7787419|NCT01275170|19170579|P3|NOT COMPLETED|Part 2: Period 2||0
7787420|NCT01275170|19170580|P2|NOT COMPLETED|Part 2: Period 2||0
7787421|NCT01275170|19170581|P1|NOT COMPLETED|Part 2: Period 2||0
7787422|NCT01275170|19170574|P8|COMPLETED|Part 2: Period 2||6
7787423|NCT01275170|19170575|P7|COMPLETED|Part 2: Period 2||6
7787424|NCT01275170|19170576|P6|COMPLETED|Part 2: Period 2||0
7787425|NCT01275170|19170577|P5|COMPLETED|Part 2: Period 2||0
7787426|NCT01275170|19170578|P4|COMPLETED|Part 2: Period 2||0
7787427|NCT01275170|19170579|P3|COMPLETED|Part 2: Period 2||0
7787428|NCT01275170|19170580|P2|COMPLETED|Part 2: Period 2||0
7787429|NCT01275170|19170581|P1|COMPLETED|Part 2: Period 2||0
7787430|NCT01275170|19170574|P8|STARTED|Part 2: Period 2||6
7787431|NCT01275170|19170575|P7|STARTED|Part 2: Period 2||6
7787432|NCT01275170|19170576|P6|STARTED|Part 2: Period 2|Panel F participated in Part 1, Period 1 and Part 2, Period 1.|0
7787433|NCT01275170|19170577|P5|STARTED|Part 2: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
7787434|NCT01275170|19170578|P4|STARTED|Part 2: Period 2||0
7787435|NCT01275170|19170579|P3|STARTED|Part 2: Period 2||0
7787436|NCT01275170|19170580|P2|STARTED|Part 2: Period 2||0
7787437|NCT01275170|19170581|P1|STARTED|Part 2: Period 2||0
7787438|NCT01275170|19170574|P8|NOT COMPLETED|Part 2: Period 1||0
7787439|NCT01275170|19170575|P7|NOT COMPLETED|Part 2: Period 1||0
7787440|NCT01275170|19170576|P6|NOT COMPLETED|Part 2: Period 1||0
7787441|NCT01275170|19170577|P5|NOT COMPLETED|Part 2: Period 1||0
7787442|NCT01275170|19170578|P4|NOT COMPLETED|Part 2: Period 1||0
7787443|NCT01275170|19170579|P3|NOT COMPLETED|Part 2: Period 1||0
7787444|NCT01275170|19170580|P2|NOT COMPLETED|Part 2: Period 1||0
7787445|NCT01275170|19170581|P1|NOT COMPLETED|Part 2: Period 1||0
7787446|NCT01275170|19170574|P8|COMPLETED|Part 2: Period 1||6
7787447|NCT01275170|19170575|P7|COMPLETED|Part 2: Period 1||6
7787448|NCT01275170|19170576|P6|COMPLETED|Part 2: Period 1||6
7787449|NCT01275170|19170577|P5|COMPLETED|Part 2: Period 1||6
7787450|NCT01275170|19170578|P4|COMPLETED|Part 2: Period 1||0
7787451|NCT01275170|19170579|P3|COMPLETED|Part 2: Period 1||0
7787452|NCT01275170|19170580|P2|COMPLETED|Part 2: Period 1||0
7787453|NCT01275170|19170581|P1|COMPLETED|Part 2: Period 1||0
7787454|NCT01275170|19170574|P8|STARTED|Part 2: Period 1||6
7787455|NCT01275170|19170575|P7|STARTED|Part 2: Period 1||6
7787456|NCT01275170|19170576|P6|STARTED|Part 2: Period 1||6
7787457|NCT01275170|19170577|P5|STARTED|Part 2: Period 1||6
7787458|NCT01275170|19170578|P4|STARTED|Part 2: Period 1||0
7787459|NCT01275170|19170579|P3|STARTED|Part 2: Period 1||0
7787460|NCT01275170|19170580|P2|STARTED|Part 2: Period 1||0
7787461|NCT01275170|19170581|P1|STARTED|Part 2: Period 1||0
7787462|NCT01275170|19170574|P8|NOT COMPLETED|Part 1: Period 2||0
7787463|NCT01275170|19170575|P7|NOT COMPLETED|Part 1: Period 2||0
7787464|NCT01275170|19170576|P6|NOT COMPLETED|Part 1: Period 2||0
7787465|NCT01275170|19170577|P5|NOT COMPLETED|Part 1: Period 2||0
7787466|NCT01275170|19170578|P4|NOT COMPLETED|Part 1: Period 2||0
7787467|NCT01275170|19170579|P3|NOT COMPLETED|Part 1: Period 2||0
7787468|NCT01275170|19170580|P2|NOT COMPLETED|Part 1: Period 2||0
7787469|NCT01275170|19170581|P1|NOT COMPLETED|Part 1: Period 2||0
7787470|NCT01275170|19170574|P8|COMPLETED|Part 1: Period 2||6
7787471|NCT01275170|19170575|P7|COMPLETED|Part 1: Period 2||6
7787472|NCT01275170|19170576|P6|COMPLETED|Part 1: Period 2||0
7787473|NCT01275170|19170577|P5|COMPLETED|Part 1: Period 2||0
7787474|NCT01275170|19170578|P4|COMPLETED|Part 1: Period 2||0
7787475|NCT01275170|19170579|P3|COMPLETED|Part 1: Period 2||0
7787476|NCT01275170|19170580|P2|COMPLETED|Part 1: Period 2||0
7787477|NCT01275170|19170581|P1|COMPLETED|Part 1: Period 2||0
7787478|NCT01275170|19170574|P8|STARTED|Part 1: Period 2||6
7787479|NCT01275170|19170575|P7|STARTED|Part 1: Period 2||6
7787480|NCT01275170|19170576|P6|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
7787481|NCT01275170|19170577|P5|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
7787482|NCT01275170|19170578|P4|STARTED|Part 1: Period 2|Panel D participated in Part 1, Period 1 only.|0
7787483|NCT01275170|19170579|P3|STARTED|Part 1: Period 2|Panel C participated in Part 1, Period 1 only.|0
7787668|NCT01273883|19171134|P1|COMPLETED|Washout Period of 2 Weeks||17
7787484|NCT01275170|19170580|P2|STARTED|Part 1: Period 2|Panel B participated in Part 1, Period 1 only.|0
7787485|NCT01275170|19170581|P1|STARTED|Part 1: Period 2|Panel A participated in Part 1, Period 1 only.|0
7787486|NCT01275170|19170574|P8|NOT COMPLETED|Part 1: Period 1||0
7787487|NCT01275170|19170575|P7|NOT COMPLETED|Part 1: Period 1||0
7787488|NCT01275170|19170576|P6|NOT COMPLETED|Part 1: Period 1||0
7787489|NCT01275170|19170577|P5|NOT COMPLETED|Part 1: Period 1||0
7787490|NCT01275170|19170578|P4|NOT COMPLETED|Part 1: Period 1||0
7787491|NCT01275170|19170579|P3|NOT COMPLETED|Part 1: Period 1||0
7787492|NCT01275170|19170580|P2|NOT COMPLETED|Part 1: Period 1||0
7787493|NCT01275170|19170581|P1|NOT COMPLETED|Part 1: Period 1||1
7787494|NCT01275170|19170574|P8|COMPLETED|Part 1: Period 1||6
7787495|NCT01275170|19170575|P7|COMPLETED|Part 1: Period 1||6
7787496|NCT01275170|19170576|P6|COMPLETED|Part 1: Period 1||6
7787497|NCT01275170|19170577|P5|COMPLETED|Part 1: Period 1||6
7787498|NCT01275170|19170578|P4|COMPLETED|Part 1: Period 1||6
7787499|NCT01275170|19170579|P3|COMPLETED|Part 1: Period 1||6
7787500|NCT01275170|19170580|P2|COMPLETED|Part 1: Period 1||6
7787501|NCT01275170|19170581|P1|COMPLETED|Part 1: Period 1||6
7787502|NCT01275170|19170574|P8|Treated|Part 1: Period 1||6
7787503|NCT01275170|19170575|P7|Treated|Part 1: Period 1||6
7787504|NCT01275170|19170576|P6|Treated|Part 1: Period 1||6
7787505|NCT01275170|19170577|P5|Treated|Part 1: Period 1||6
7787506|NCT01275170|19170578|P4|Treated|Part 1: Period 1||6
7787507|NCT01275170|19170579|P3|Treated|Part 1: Period 1||6
7787508|NCT01275170|19170580|P2|Treated|Part 1: Period 1||6
7787509|NCT01275170|19170581|P1|Treated|Part 1: Period 1||6
7787510|NCT01275170|19170574|P8|STARTED|Part 1: Period 1||6
7787511|NCT01275170|19170575|P7|STARTED|Part 1: Period 1||6
7787512|NCT01275170|19170576|P6|STARTED|Part 1: Period 1||6
7787513|NCT01275170|19170577|P5|STARTED|Part 1: Period 1||6
7787514|NCT01275170|19170578|P4|STARTED|Part 1: Period 1||6
7787515|NCT01275170|19170579|P3|STARTED|Part 1: Period 1||6
7787516|NCT01275170|19170580|P2|STARTED|Part 1: Period 1||6
7787517|NCT01275170|19170581|P1|STARTED|Part 1: Period 1||7
7787518|NCT01275144|19170799|P2|NOT COMPLETED|Second Intervention (6 Days)||0
7787519|NCT01275144|19170800|P1|NOT COMPLETED|Second Intervention (6 Days)||1
7787520|NCT01275144|19170799|P2|COMPLETED|Second Intervention (6 Days)||14
7787521|NCT01275144|19170800|P1|COMPLETED|Second Intervention (6 Days)||13
7787522|NCT01275144|19170799|P2|STARTED|Second Intervention (6 Days)||14
7787523|NCT01275144|19170800|P1|STARTED|Second Intervention (6 Days)||14
7787524|NCT01275144|19170799|P2|NOT COMPLETED|Washout (7 Days)||0
7787525|NCT01275144|19170800|P1|NOT COMPLETED|Washout (7 Days)||0
7787526|NCT01275144|19170799|P2|COMPLETED|Washout (7 Days)||14
7787527|NCT01275144|19170800|P1|COMPLETED|Washout (7 Days)||14
7787528|NCT01275144|19170799|P2|STARTED|Washout (7 Days)||14
7787529|NCT01275144|19170800|P1|STARTED|Washout (7 Days)||14
7787530|NCT01275144|19170799|P2|NOT COMPLETED|First Intervention (6 Days)||0
7787531|NCT01275144|19170800|P1|NOT COMPLETED|First Intervention (6 Days)||0
7787532|NCT01275144|19170799|P2|COMPLETED|First Intervention (6 Days)||14
7787533|NCT01275144|19170800|P1|COMPLETED|First Intervention (6 Days)||14
7787534|NCT01275144|19170799|P2|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
7787535|NCT01275144|19170800|P1|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
7787536|NCT01275144|19170799|P2|STARTED|First Intervention (6 Days)||14
7787537|NCT01275144|19170800|P1|STARTED|First Intervention (6 Days)||14
7787538|NCT01275131|19170858|P4|NOT COMPLETED|Period 2 (Crossover)||2
7787539|NCT01275131|19170859|P3|NOT COMPLETED|Period 2 (Crossover)||1
7787540|NCT01275131|19170860|P2|NOT COMPLETED|Period 2 (Crossover)||1
7787541|NCT01275131|19170861|P1|NOT COMPLETED|Period 2 (Crossover)||1
7787542|NCT01275131|19170858|P4|COMPLETED|Period 2 (Crossover)||8
7787543|NCT01275131|19170859|P3|COMPLETED|Period 2 (Crossover)||9
7787544|NCT01275131|19170860|P2|COMPLETED|Period 2 (Crossover)||8
7787545|NCT01275131|19170861|P1|COMPLETED|Period 2 (Crossover)||8
7787546|NCT01275131|19170858|P4|STARTED|Period 2 (Crossover)||10
7787547|NCT01275131|19170859|P3|STARTED|Period 2 (Crossover)||10
7787548|NCT01275131|19170860|P2|STARTED|Period 2 (Crossover)||9
7787549|NCT01275131|19170861|P1|STARTED|Period 2 (Crossover)||9
7787550|NCT01275131|19170858|P4|NOT COMPLETED|5- to 14-Day Washout Period||0
7787551|NCT01275131|19170859|P3|NOT COMPLETED|5- to 14-Day Washout Period||0
7787552|NCT01275131|19170860|P2|NOT COMPLETED|5- to 14-Day Washout Period||0
7787553|NCT01275131|19170861|P1|NOT COMPLETED|5- to 14-Day Washout Period||0
7787554|NCT01275131|19170858|P4|COMPLETED|5- to 14-Day Washout Period||10
7787555|NCT01275131|19170859|P3|COMPLETED|5- to 14-Day Washout Period||10
7787556|NCT01275131|19170860|P2|COMPLETED|5- to 14-Day Washout Period||9
7787557|NCT01275131|19170861|P1|COMPLETED|5- to 14-Day Washout Period||9
7787558|NCT01275131|19170858|P4|STARTED|5- to 14-Day Washout Period||10
7787559|NCT01275131|19170859|P3|STARTED|5- to 14-Day Washout Period||10
7787560|NCT01275131|19170860|P2|STARTED|5- to 14-Day Washout Period||9
7787561|NCT01275131|19170861|P1|STARTED|5- to 14-Day Washout Period||9
7787562|NCT01275131|19170858|P4|NOT COMPLETED|Period 1||2
7787563|NCT01275131|19170859|P3|NOT COMPLETED|Period 1||3
7787564|NCT01275131|19170860|P2|NOT COMPLETED|Period 1||0
7787565|NCT01275131|19170861|P1|NOT COMPLETED|Period 1||2
7787566|NCT01275131|19170858|P4|COMPLETED|Period 1||10
7787567|NCT01275131|19170859|P3|COMPLETED|Period 1||10
7787568|NCT01275131|19170860|P2|COMPLETED|Period 1||9
7787569|NCT01275131|19170861|P1|COMPLETED|Period 1||9
7787570|NCT01275131|19170858|P4|Received at Least One Dose of Study Drug|Period 1||12
7787571|NCT01275131|19170859|P3|Received at Least One Dose of Study Drug|Period 1||13
7787572|NCT01275131|19170860|P2|Received at Least One Dose of Study Drug|Period 1||9
7787573|NCT01275131|19170861|P1|Received at Least One Dose of Study Drug|Period 1||11
7787574|NCT01275131|19170858|P4|STARTED|Period 1||12
7787575|NCT01275131|19170859|P3|STARTED|Period 1||13
7787576|NCT01275131|19170860|P2|STARTED|Period 1||9
7787577|NCT01275131|19170861|P1|STARTED|Period 1||11
7787578|NCT01275092|19170895|P1|NOT COMPLETED|Overall Study||0
7787579|NCT01275092|19170895|P1|COMPLETED|Overall Study||164
7787580|NCT01275092|19170895|P1|STARTED|Overall Study||164
7787581|NCT01275066|19170904|P3|NOT COMPLETED|Overall Study||1
7787582|NCT01275066|19170905|P2|NOT COMPLETED|Overall Study||0
7787583|NCT01275066|19170906|P1|NOT COMPLETED|Overall Study||1
7787584|NCT01275066|19170904|P3|COMPLETED|Overall Study||57
7787585|NCT01275066|19170905|P2|COMPLETED|Overall Study||59
7787586|NCT01275066|19170906|P1|COMPLETED|Overall Study||59
7787587|NCT01275066|19170904|P3|Treated|Overall Study||58
7787588|NCT01275066|19170905|P2|Treated|Overall Study||59
7787589|NCT01275066|19170906|P1|Treated|Overall Study||59
7787590|NCT01275066|19170904|P3|STARTED|Overall Study||58
7787591|NCT01275066|19170905|P2|STARTED|Overall Study||59
7787592|NCT01275066|19170906|P1|STARTED|Overall Study||60
7787593|NCT01275053|19170920|P1|NOT COMPLETED|Overall Study||0
7787594|NCT01275053|19170920|P1|COMPLETED|Overall Study||12
7787595|NCT01275053|19170920|P1|STARTED|Overall Study||12
7787596|NCT01274897|19170926|P2|NOT COMPLETED|Overall Study||0
7787597|NCT01274897|19170927|P1|NOT COMPLETED|Overall Study||0
7787598|NCT01274897|19170926|P2|COMPLETED|Overall Study||153
7787599|NCT01274897|19170927|P1|COMPLETED|Overall Study||297
7787600|NCT01274897|19170926|P2|STARTED|Overall Study||153
7787601|NCT01274897|19170927|P1|STARTED|Overall Study||297
7787602|NCT01274715|19170939|P1|NOT COMPLETED|Overall Study||4
7787603|NCT01274715|19170939|P1|COMPLETED|Overall Study||8
7787604|NCT01274715|19170939|P1|Screened Out at Baseline|Overall Study||3
7787605|NCT01274715|19170939|P1|STARTED|Overall Study||12
7787606|NCT01274637|19170946|P2|NOT COMPLETED|Overall Study||2
7787607|NCT01274637|19170947|P1|NOT COMPLETED|Overall Study||0
7787608|NCT01274637|19170946|P2|COMPLETED|Overall Study||30
7787609|NCT01274637|19170947|P1|COMPLETED|Overall Study||30
7787610|NCT01274637|19170946|P2|STARTED|Overall Study||32
7787611|NCT01274637|19170947|P1|STARTED|Overall Study||30
7787612|NCT01274611|19170963|P1|NOT COMPLETED|Overall Study||0
7787613|NCT01274611|19170963|P1|COMPLETED|Overall Study||20
7787614|NCT01274611|19170963|P1|STARTED|Overall Study||20
7787615|NCT01274585|19170973|P2|NOT COMPLETED|Overall Study||0
7787616|NCT01274585|19170974|P1|NOT COMPLETED|Overall Study||0
7787617|NCT01274585|19170973|P2|COMPLETED|Overall Study||3
7787618|NCT01274585|19170974|P1|COMPLETED|Overall Study||2
7787619|NCT01274585|19170973|P2|STARTED|Overall Study||3
7787620|NCT01274585|19170974|P1|STARTED|Overall Study||2
7787621|NCT01274559|19170986|P2|NOT COMPLETED|Overall Study||145
7787622|NCT01274559|19170987|P1|NOT COMPLETED|Overall Study||197
7787623|NCT01274559|19170986|P2|COMPLETED|Overall Study||441
7787624|NCT01274559|19170987|P1|COMPLETED|Overall Study||390
7787625|NCT01274559|19170986|P2|Treated|Overall Study||572
7787626|NCT01274559|19170987|P1|Treated|Overall Study||572
7787627|NCT01274559|19170986|P2|STARTED|Overall Study||586
7787628|NCT01274559|19170987|P1|STARTED|Overall Study||587
7787629|NCT01274533|19171037|P1|NOT COMPLETED|Overall Study||4
7787630|NCT01274533|19171037|P1|COMPLETED|Overall Study||0
7787631|NCT01274533|19171037|P1|STARTED|Overall Study||4
7787632|NCT01274520|19171044|P2|NOT COMPLETED|Overall Study||0
7787633|NCT01274520|19171045|P1|NOT COMPLETED|Overall Study||0
7787634|NCT01274520|19171044|P2|COMPLETED|Overall Study||24
7787635|NCT01274520|19171045|P1|COMPLETED|Overall Study||25
7787636|NCT01274520|19171044|P2|STARTED|Overall Study||24
7787637|NCT01274520|19171045|P1|STARTED|Overall Study||25
7787638|NCT01274429|19171073|P1|NOT COMPLETED|Overall Study||5
7787639|NCT01274429|19171073|P1|COMPLETED|Overall Study||0
7787640|NCT01274429|19171073|P1|STARTED|Overall Study||5
7787641|NCT01274351|19171078|P1|NOT COMPLETED|Overall Study||20
7787642|NCT01274351|19171078|P1|COMPLETED|Overall Study||92
7787643|NCT01274351|19171078|P1|STARTED|Overall Study||112
7787644|NCT01274182|19171090|P3|NOT COMPLETED|Overall Study||12
7787645|NCT01274182|19171091|P2|NOT COMPLETED|Overall Study||18
7787646|NCT01274182|19171092|P1|NOT COMPLETED|Overall Study||21
7787647|NCT01274182|19171090|P3|COMPLETED|Overall Study||80
7787648|NCT01274182|19171091|P2|COMPLETED|Overall Study||69
7787649|NCT01274182|19171092|P1|COMPLETED|Overall Study||112
7787650|NCT01274182|19171090|P3|24 Weeks|Overall Study||84
7787651|NCT01274182|19171091|P2|24 Weeks|Overall Study||83
7787652|NCT01274182|19171092|P1|24 Weeks|Overall Study||123
7787653|NCT01274182|19171090|P3|STARTED|Overall Study||92
7787654|NCT01274182|19171091|P2|STARTED|Overall Study||87
7787655|NCT01274182|19171092|P1|STARTED|Overall Study||133
7787656|NCT01273896|19171129|P1|NOT COMPLETED|Overall Study||0
7787657|NCT01273896|19171129|P1|COMPLETED|Overall Study||22
7787658|NCT01273896|19171129|P1|STARTED|Overall Study||22
7787659|NCT01273883|19171133|P2|NOT COMPLETED|Second Intervention||1
7787660|NCT01273883|19171134|P1|NOT COMPLETED|Second Intervention||2
7787661|NCT01273883|19171133|P2|COMPLETED|Second Intervention||17
7787662|NCT01273883|19171134|P1|COMPLETED|Second Intervention||15
7787663|NCT01273883|19171133|P2|STARTED|Second Intervention||18
7787664|NCT01273883|19171134|P1|STARTED|Second Intervention||17
7787665|NCT01273883|19171133|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
7787666|NCT01273883|19171134|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
7787667|NCT01273883|19171133|P2|COMPLETED|Washout Period of 2 Weeks||18
7787669|NCT01273883|19171133|P2|STARTED|Washout Period of 2 Weeks||18
7787670|NCT01273883|19171134|P1|STARTED|Washout Period of 2 Weeks||17
7787671|NCT01273883|19171133|P2|NOT COMPLETED|First Intervention||1
7787672|NCT01273883|19171134|P1|NOT COMPLETED|First Intervention||2
7787673|NCT01273883|19171133|P2|COMPLETED|First Intervention||18
7787674|NCT01273883|19171134|P1|COMPLETED|First Intervention||17
7787675|NCT01273883|19171133|P2|STARTED|First Intervention|Received at least 1 dose of study drug.|19
7787676|NCT01273883|19171134|P1|STARTED|First Intervention|Received at least 1 dose of study drug.|19
7787677|NCT01273857|19171148|P2|NOT COMPLETED|Overall Study||0
7787678|NCT01273857|19171149|P1|NOT COMPLETED|Overall Study||0
7787679|NCT01273857|19171148|P2|COMPLETED|Overall Study||7
7787680|NCT01273857|19171149|P1|COMPLETED|Overall Study||7
7787681|NCT01273857|19171148|P2|STARTED|Overall Study||7
7787682|NCT01273857|19171149|P1|STARTED|Overall Study||7
7787683|NCT01273818|19171160|P3|NOT COMPLETED|Overall Study||9
7787684|NCT01273818|19171161|P2|NOT COMPLETED|Overall Study||2
7787685|NCT01273818|19171162|P1|NOT COMPLETED|Overall Study||13
7787686|NCT01273818|19171160|P3|COMPLETED|Overall Study||91
7787687|NCT01273818|19171161|P2|COMPLETED|Overall Study||98
7787688|NCT01273818|19171162|P1|COMPLETED|Overall Study||87
7787689|NCT01273818|19171160|P3|STARTED|Overall Study||100
7787690|NCT01273818|19171161|P2|STARTED|Overall Study||100
7787691|NCT01273818|19171162|P1|STARTED|Overall Study||100
7787692|NCT01273805|19171172|P2|NOT COMPLETED|Overall Study||10
7787693|NCT01273805|19171173|P1|NOT COMPLETED|Overall Study||10
7787694|NCT01273805|19171172|P2|COMPLETED|Overall Study||0
7787695|NCT01273805|19171173|P1|COMPLETED|Overall Study||0
7787696|NCT01273805|19171172|P2|STARTED|Overall Study||10
7787697|NCT01273805|19171173|P1|STARTED|Overall Study||10
7787698|NCT01273766|19171192|P3|NOT COMPLETED|Overall Study||0
7787699|NCT01273766|19171193|P2|NOT COMPLETED|Overall Study||0
7787700|NCT01273766|19171194|P1|NOT COMPLETED|Overall Study||0
7787701|NCT01273766|19171192|P3|COMPLETED|Overall Study||5
7787702|NCT01273766|19171193|P2|COMPLETED|Overall Study||7
7787703|NCT01273766|19171194|P1|COMPLETED|Overall Study||4
7787704|NCT01273766|19171192|P3|STARTED|Overall Study||5
7787705|NCT01273766|19171193|P2|STARTED|Overall Study||7
7787706|NCT01273766|19171194|P1|STARTED|Overall Study||4
7787707|NCT01273623|19171204|P1|NOT COMPLETED|Overall Study||29
7787708|NCT01273623|19171204|P1|COMPLETED|Overall Study|met IVUS criteria|26
7787709|NCT01273623|19171204|P1|STARTED|Overall Study|met angiographic criteria|55
7787710|NCT01273597|19171211|P1|NOT COMPLETED|Overall Study||8
7787711|NCT01273597|19171211|P1|COMPLETED|Overall Study||52
7787712|NCT01273597|19171211|P1|STARTED|Overall Study||60
7787713|NCT01273519|19171226|P3|NOT COMPLETED|Overall Study||8
7787714|NCT01273519|19171227|P2|NOT COMPLETED|Overall Study||5
7787715|NCT01273519|19171228|P1|NOT COMPLETED|Overall Study||19
7787716|NCT01273519|19171226|P3|COMPLETED|Overall Study||39
7787717|NCT01273519|19171227|P2|COMPLETED|Overall Study||25
7787718|NCT01273519|19171228|P1|COMPLETED|Overall Study||59
7787719|NCT01273519|19171226|P3|STARTED|Overall Study||47
7787720|NCT01273519|19171227|P2|STARTED|Overall Study||30
7787721|NCT01273519|19171228|P1|STARTED|Overall Study||78
7787722|NCT01273207|19171261|P1|NOT COMPLETED|Overall Study||5
7787723|NCT01273207|19171261|P1|COMPLETED|Overall Study||2
7787724|NCT01273207|19171261|P1|STARTED|Overall Study||7
7787725|NCT01273181|19171271|P4|NOT COMPLETED|Phase 2, Dose 2||1
7787726|NCT01273181|19171272|P3|NOT COMPLETED|Phase 2, Dose 2||0
7787727|NCT01273181|19171273|P2|NOT COMPLETED|Phase 2, Dose 2||0
7787728|NCT01273181|19171274|P1|NOT COMPLETED|Phase 2, Dose 2||0
7787729|NCT01273181|19171271|P4|COMPLETED|Phase 2, Dose 2||0
7787730|NCT01273181|19171272|P3|COMPLETED|Phase 2, Dose 2||0
7787731|NCT01273181|19171273|P2|COMPLETED|Phase 2, Dose 2||0
7787732|NCT01273181|19171274|P1|COMPLETED|Phase 2, Dose 2||0
7787733|NCT01273181|19171271|P4|STARTED|Phase 2, Dose 2||1
7787734|NCT01273181|19171272|P3|STARTED|Phase 2, Dose 2||0
7787735|NCT01273181|19171273|P2|STARTED|Phase 2, Dose 2||0
7787736|NCT01273181|19171274|P1|STARTED|Phase 2, Dose 2||0
7787737|NCT01273181|19171271|P4|NOT COMPLETED|Phase 2, Dose 1||0
7787738|NCT01273181|19171272|P3|NOT COMPLETED|Phase 2, Dose 1||1
7787739|NCT01273181|19171273|P2|NOT COMPLETED|Phase 2, Dose 1||0
7787740|NCT01273181|19171274|P1|NOT COMPLETED|Phase 2, Dose 1||0
7787741|NCT01273181|19171271|P4|COMPLETED|Phase 2, Dose 1||0
7787742|NCT01273181|19171272|P3|COMPLETED|Phase 2, Dose 1||1
7787743|NCT01273181|19171273|P2|COMPLETED|Phase 2, Dose 1||0
7787744|NCT01273181|19171274|P1|COMPLETED|Phase 2, Dose 1||0
7787745|NCT01273181|19171271|P4|STARTED|Phase 2, Dose 1||0
7787746|NCT01273181|19171272|P3|STARTED|Phase 2, Dose 1||2
7787747|NCT01273181|19171273|P2|STARTED|Phase 2, Dose 1||0
7787748|NCT01273181|19171274|P1|STARTED|Phase 2, Dose 1||0
7787749|NCT01273181|19171271|P4|NOT COMPLETED|Phase I, Dose 2||0
7787750|NCT01273181|19171272|P3|NOT COMPLETED|Phase I, Dose 2||0
7787751|NCT01273181|19171273|P2|NOT COMPLETED|Phase I, Dose 2||1
7787752|NCT01273181|19171274|P1|NOT COMPLETED|Phase I, Dose 2||0
7787753|NCT01273181|19171271|P4|COMPLETED|Phase I, Dose 2||0
7787754|NCT01273181|19171272|P3|COMPLETED|Phase I, Dose 2||0
7787755|NCT01273181|19171273|P2|COMPLETED|Phase I, Dose 2||2
7787756|NCT01273181|19171274|P1|COMPLETED|Phase I, Dose 2||0
7787757|NCT01273181|19171271|P4|STARTED|Phase I, Dose 2||0
7787758|NCT01273181|19171272|P3|STARTED|Phase I, Dose 2||0
7787759|NCT01273181|19171273|P2|STARTED|Phase I, Dose 2||3
7787760|NCT01273181|19171274|P1|STARTED|Phase I, Dose 2||0
7787761|NCT01273181|19171271|P4|NOT COMPLETED|Phase I, Dose 1||0
7787762|NCT01273181|19171272|P3|NOT COMPLETED|Phase I, Dose 1||0
7787763|NCT01273181|19171273|P2|NOT COMPLETED|Phase I, Dose 1||0
7787764|NCT01273181|19171274|P1|NOT COMPLETED|Phase I, Dose 1||1
7787765|NCT01273181|19171271|P4|COMPLETED|Phase I, Dose 1||0
7787766|NCT01273181|19171272|P3|COMPLETED|Phase I, Dose 1||0
7787767|NCT01273181|19171273|P2|COMPLETED|Phase I, Dose 1||0
7787768|NCT01273181|19171274|P1|COMPLETED|Phase I, Dose 1||2
7787769|NCT01273181|19171271|P4|STARTED|Phase I, Dose 1||0
7787770|NCT01273181|19171272|P3|STARTED|Phase I, Dose 1||0
7787771|NCT01273181|19171273|P2|STARTED|Phase I, Dose 1||0
7787772|NCT01273181|19171274|P1|STARTED|Phase I, Dose 1||3
7787773|NCT01273155|19171292|P7|NOT COMPLETED|Overall Study||6
7787774|NCT01273155|19171293|P6|NOT COMPLETED|Overall Study||5
7787775|NCT01273155|19171294|P5|NOT COMPLETED|Overall Study||2
7787776|NCT01273155|19171295|P4|NOT COMPLETED|Overall Study||1
7787777|NCT01273155|19171296|P3|NOT COMPLETED|Overall Study||12
7787778|NCT01273155|19171297|P2|NOT COMPLETED|Overall Study||4
7787779|NCT01273155|19171298|P1|NOT COMPLETED|Overall Study||2
7787780|NCT01273155|19171292|P7|COMPLETED|Overall Study||2
7787781|NCT01273155|19171293|P6|COMPLETED|Overall Study||5
7787782|NCT01273155|19171294|P5|COMPLETED|Overall Study||3
7787783|NCT01273155|19171295|P4|COMPLETED|Overall Study||4
7787784|NCT01273155|19171296|P3|COMPLETED|Overall Study||6
7787785|NCT01273155|19171297|P2|COMPLETED|Overall Study||8
7787786|NCT01273155|19171298|P1|COMPLETED|Overall Study||12
7787787|NCT01273155|19171292|P7|STARTED|Overall Study||8
7787788|NCT01273155|19171293|P6|STARTED|Overall Study||10
7787789|NCT01273155|19171294|P5|STARTED|Overall Study||5
7787790|NCT01273155|19171295|P4|STARTED|Overall Study||5
7787791|NCT01273155|19171296|P3|STARTED|Overall Study||18
7787792|NCT01273155|19171297|P2|STARTED|Overall Study||12
7787793|NCT01273155|19171298|P1|STARTED|Overall Study||14
7787794|NCT01273064|19171375|P5|NOT COMPLETED|Overall Study||10
7787795|NCT01273064|19171376|P4|NOT COMPLETED|Overall Study||20
7787796|NCT01273064|19171377|P3|NOT COMPLETED|Overall Study||31
7787797|NCT01273064|19171378|P2|NOT COMPLETED|Overall Study||30
7787798|NCT01273064|19171379|P1|NOT COMPLETED|Overall Study||23
7787799|NCT01273064|19171375|P5|COMPLETED|Overall Study||0
7787800|NCT01273064|19171376|P4|COMPLETED|Overall Study||0
7787801|NCT01273064|19171377|P3|COMPLETED|Overall Study||0
7787802|NCT01273064|19171378|P2|COMPLETED|Overall Study||0
7787803|NCT01273064|19171379|P1|COMPLETED|Overall Study||0
7787804|NCT01273064|19171375|P5|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10
7787805|NCT01273064|19171376|P4|STARTED|Overall Study||20
7787806|NCT01273064|19171377|P3|STARTED|Overall Study||31
7787807|NCT01273064|19171378|P2|STARTED|Overall Study||30
7787808|NCT01273064|19171379|P1|STARTED|Overall Study||23
7787809|NCT01273038|19171398|P2|NOT COMPLETED|Second Intervention (14 Days)||2
7787810|NCT01273038|19171399|P1|NOT COMPLETED|Second Intervention (14 Days)||0
7787811|NCT01273038|19171398|P2|COMPLETED|Second Intervention (14 Days)||8
7787812|NCT01273038|19171399|P1|COMPLETED|Second Intervention (14 Days)||10
7787813|NCT01273038|19171398|P2|STARTED|Second Intervention (14 Days)||10
7787814|NCT01273038|19171399|P1|STARTED|Second Intervention (14 Days)||10
7787815|NCT01273038|19171398|P2|NOT COMPLETED|First Intervention (14 Days)||0
7787816|NCT01273038|19171399|P1|NOT COMPLETED|First Intervention (14 Days)||0
7787817|NCT01273038|19171398|P2|COMPLETED|First Intervention (14 Days)||10
7787818|NCT01273038|19171399|P1|COMPLETED|First Intervention (14 Days)||10
7787819|NCT01273038|19171398|P2|STARTED|First Intervention (14 Days)||10
7787820|NCT01273038|19171399|P1|STARTED|First Intervention (14 Days)||10
7787821|NCT01272999|19171407|P2|NOT COMPLETED|Overall Study||0
7787822|NCT01272999|19171408|P1|NOT COMPLETED|Overall Study||0
7787823|NCT01272999|19171407|P2|COMPLETED|Overall Study||34
7787824|NCT01272999|19171408|P1|COMPLETED|Overall Study||357
7787825|NCT01272999|19171407|P2|STARTED|Overall Study||34
7787826|NCT01272999|19171408|P1|STARTED|Overall Study||357
7787827|NCT01272960|19171434|P2|NOT COMPLETED|Overall Study||0
7787828|NCT01272960|19171435|P1|NOT COMPLETED|Overall Study||0
7787829|NCT01272960|19171434|P2|COMPLETED|Overall Study||15
7787830|NCT01272960|19171435|P1|COMPLETED|Overall Study||14
7787831|NCT01272960|19171434|P2|STARTED|Overall Study||15
7787832|NCT01272960|19171435|P1|STARTED|Overall Study||14
7787833|NCT01272947|19171449|P2|NOT COMPLETED|Overall Study||2
7787834|NCT01272947|19171450|P1|NOT COMPLETED|Overall Study||2
7787835|NCT01272947|19171449|P2|COMPLETED|Overall Study||98
7787836|NCT01272947|19171450|P1|COMPLETED|Overall Study||102
7787837|NCT01272947|19171449|P2|STARTED|Overall Study||100
7787838|NCT01272947|19171450|P1|STARTED|Overall Study||104
7787839|NCT01272934|19171460|P2|NOT COMPLETED|Overall Study||2
7787840|NCT01272934|19171461|P1|NOT COMPLETED|Overall Study||0
7787841|NCT01272934|19171460|P2|COMPLETED|Overall Study||101
7787842|NCT01272934|19171461|P1|COMPLETED|Overall Study||102
7787843|NCT01272934|19171460|P2|STARTED|Overall Study||103
7787844|NCT01272934|19171461|P1|STARTED|Overall Study||102
7787845|NCT01272921|19171471|P2|NOT COMPLETED|Overall Study||1
7787846|NCT01272921|19171472|P1|NOT COMPLETED|Overall Study||2
7787847|NCT01272921|19171471|P2|COMPLETED|Overall Study||70
7787848|NCT01272921|19171472|P1|COMPLETED|Overall Study||69
7787849|NCT01272921|19171471|P2|STARTED|Overall Study||71
7787850|NCT01272921|19171472|P1|STARTED|Overall Study||71
7787851|NCT01272908|19171480|P1|NOT COMPLETED|Re-Treatment Period||6
7787852|NCT01272908|19171480|P1|COMPLETED|Re-Treatment Period||71
7787853|NCT01272908|19171480|P1|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77
7787854|NCT01272908|19171480|P1|NOT COMPLETED|Initial Treatment Period||8
7787855|NCT01272908|19171480|P1|COMPLETED|Initial Treatment Period||112
7787856|NCT01272908|19171480|P1|STARTED|Initial Treatment Period||120
7787857|NCT01272882|19171514|P1|NOT COMPLETED|Overall Study||0
7787858|NCT01272882|19171514|P1|COMPLETED|Overall Study||13
7787859|NCT01272882|19171514|P1|STARTED|Overall Study||13
7787860|NCT01272869|19171520|P2|NOT COMPLETED|Period 2 (14 Days)||0
7787861|NCT01272869|19171521|P1|NOT COMPLETED|Period 2 (14 Days)||1
7787862|NCT01272869|19171520|P2|COMPLETED|Period 2 (14 Days)||10
7787863|NCT01272869|19171521|P1|COMPLETED|Period 2 (14 Days)||9
7787864|NCT01272869|19171520|P2|STARTED|Period 2 (14 Days)||10
7787865|NCT01272869|19171521|P1|STARTED|Period 2 (14 Days)||10
7787866|NCT01272869|19171520|P2|NOT COMPLETED|Period 1 (14 Days)||0
7787867|NCT01272869|19171521|P1|NOT COMPLETED|Period 1 (14 Days)||0
7787868|NCT01272869|19171520|P2|COMPLETED|Period 1 (14 Days)||10
7787869|NCT01272869|19171521|P1|COMPLETED|Period 1 (14 Days)||10
7787870|NCT01272869|19171520|P2|STARTED|Period 1 (14 Days)||10
7787871|NCT01272869|19171521|P1|STARTED|Period 1 (14 Days)||10
7787872|NCT01272830|19171529|P2|NOT COMPLETED|Overall Study||5
7787873|NCT01272830|19171530|P1|NOT COMPLETED|Overall Study||8
7787874|NCT01272830|19171529|P2|COMPLETED|Overall Study||21
7787875|NCT01272830|19171530|P1|COMPLETED|Overall Study||17
7787876|NCT01272830|19171529|P2|STARTED|Overall Study||26
7787877|NCT01272830|19171530|P1|STARTED|Overall Study||25
7787878|NCT01272804|19171548|P6|NOT COMPLETED|Overall Study||1
7787879|NCT01272804|19171549|P5|NOT COMPLETED|Overall Study||2
7787880|NCT01272804|19171550|P4|NOT COMPLETED|Overall Study||0
7787881|NCT01272804|19171551|P3|NOT COMPLETED|Overall Study||0
7787882|NCT01272804|19171552|P2|NOT COMPLETED|Overall Study||0
7787883|NCT01272804|19171553|P1|NOT COMPLETED|Overall Study||1
7787884|NCT01272804|19171548|P6|COMPLETED|Overall Study||15
7787885|NCT01272804|19171549|P5|COMPLETED|Overall Study||7
7787886|NCT01272804|19171550|P4|COMPLETED|Overall Study||9
7787887|NCT01272804|19171551|P3|COMPLETED|Overall Study||9
7787888|NCT01272804|19171552|P2|COMPLETED|Overall Study||9
7787889|NCT01272804|19171553|P1|COMPLETED|Overall Study||8
7787890|NCT01272804|19171548|P6|STARTED|Overall Study||16
7787891|NCT01272804|19171549|P5|STARTED|Overall Study||9
7787892|NCT01272804|19171550|P4|STARTED|Overall Study||9
7787893|NCT01272804|19171551|P3|STARTED|Overall Study||9
7787894|NCT01272804|19171552|P2|STARTED|Overall Study||9
7787895|NCT01272804|19171553|P1|STARTED|Overall Study||9
7787896|NCT01272661|19171711|P3|NOT COMPLETED|Overall Study||72
7787897|NCT01272661|19171712|P2|NOT COMPLETED|Overall Study||209
7787898|NCT01272661|19171713|P1|NOT COMPLETED|Overall Study||126
7787899|NCT01272661|19171711|P3|COMPLETED|Overall Study||314
7787900|NCT01272661|19171712|P2|COMPLETED|Overall Study||288
7787901|NCT01272661|19171713|P1|COMPLETED|Overall Study||287
7787902|NCT01272661|19171711|P3|STARTED|Overall Study||386
7787903|NCT01272661|19171712|P2|STARTED|Overall Study||497
7787904|NCT01272661|19171713|P1|STARTED|Overall Study||413
7787905|NCT01272635|19171738|P4|NOT COMPLETED|Overall Study||23
7787906|NCT01272635|19171739|P3|NOT COMPLETED|Overall Study||31
7787907|NCT01272635|19171740|P2|NOT COMPLETED|Overall Study||20
7787908|NCT01272635|19171741|P1|NOT COMPLETED|Overall Study||31
7787909|NCT01272635|19171738|P4|COMPLETED|Overall Study||129
7787910|NCT01272635|19171739|P3|COMPLETED|Overall Study||117
7787911|NCT01272635|19171740|P2|COMPLETED|Overall Study||134
7787912|NCT01272635|19171741|P1|COMPLETED|Overall Study||122
7787913|NCT01272635|19171738|P4|STARTED|Overall Study||152
7787914|NCT01272635|19171739|P3|STARTED|Overall Study||148
7787915|NCT01272635|19171740|P2|STARTED|Overall Study||154
7787916|NCT01272635|19171741|P1|STARTED|Overall Study||153
7787917|NCT01272583|19171759|P2|NOT COMPLETED|Overall Study||0
7787918|NCT01272583|19171760|P1|NOT COMPLETED|Overall Study||0
7787919|NCT01272583|19171759|P2|COMPLETED|Overall Study||8
7787920|NCT01272583|19171760|P1|COMPLETED|Overall Study||8
7787921|NCT01272583|19171759|P2|STARTED|Overall Study||8
7787922|NCT01272583|19171760|P1|STARTED|Overall Study||8
7787923|NCT01272388|19171791|P2|NOT COMPLETED|Overall Study||0
7787924|NCT01272388|19171792|P1|NOT COMPLETED|Overall Study||0
7787925|NCT01272388|19171791|P2|COMPLETED|Overall Study||0
7787926|NCT01272388|19171792|P1|COMPLETED|Overall Study||1
7787927|NCT01272388|19171791|P2|STARTED|Overall Study||0
7787928|NCT01272388|19171792|P1|STARTED|Overall Study||1
7787929|NCT01272284|19171800|P1|NOT COMPLETED|12-month Follow-up Visit||4
7787930|NCT01272284|19171800|P1|COMPLETED|12-month Follow-up Visit||105
7787931|NCT01272284|19171800|P1|STARTED|12-month Follow-up Visit||109
7787932|NCT01272284|19171800|P1|NOT COMPLETED|6-month Follow-up Visit||3
7787933|NCT01272284|19171800|P1|COMPLETED|6-month Follow-up Visit||109
7787934|NCT01272284|19171800|P1|STARTED|6-month Follow-up Visit||112
7787935|NCT01272284|19171800|P1|NOT COMPLETED|3-month Follow-up Visit||1
7787936|NCT01272284|19171800|P1|COMPLETED|3-month Follow-up Visit||112
7787937|NCT01272284|19171800|P1|STARTED|3-month Follow-up Visit||113
7787938|NCT01272245|19171814|P1|NOT COMPLETED|Overall Study||0
7787939|NCT01272245|19171814|P1|COMPLETED|Overall Study||36
7787940|NCT01272245|19171814|P1|STARTED|Overall Study||36
7787941|NCT01272232|19171825|P3|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5
7787942|NCT01272232|19171826|P2|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10
7787943|NCT01272232|19171827|P1|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14
7787944|NCT01272232|19171825|P3|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135
7787945|NCT01272232|19171826|P2|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154
7788013|NCT01272219|19171875|P3|COMPLETED|Main Period: Week 0 to Week 56||0
7787946|NCT01272232|19171827|P1|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310
7787947|NCT01272232|19171825|P3|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140
7787948|NCT01272232|19171826|P2|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164
7787949|NCT01272232|19171827|P1|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324
7787950|NCT01272232|19171825|P3|NOT COMPLETED|Weeks 0-56||72
7787951|NCT01272232|19171826|P2|NOT COMPLETED|Weeks 0-56||47
7787952|NCT01272232|19171827|P1|NOT COMPLETED|Weeks 0-56||99
7787953|NCT01272232|19171825|P3|COMPLETED|Weeks 0-56||140
7787954|NCT01272232|19171826|P2|COMPLETED|Weeks 0-56||164
7787955|NCT01272232|19171827|P1|COMPLETED|Weeks 0-56||324
7787956|NCT01272232|19171825|P3|Exposed|Weeks 0-56||212
7787957|NCT01272232|19171826|P2|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210
7787958|NCT01272232|19171827|P1|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422
7787959|NCT01272232|19171825|P3|STARTED|Weeks 0-56||212
7787960|NCT01272232|19171826|P2|STARTED|Weeks 0-56||211
7787961|NCT01272232|19171827|P1|STARTED|Weeks 0-56||423
7787962|NCT01272219|19171872|P6|NOT COMPLETED|Main + Extension Period: Week 0-172||422
7787963|NCT01272219|19171873|P5|NOT COMPLETED|Main + Extension Period: Week 0-172||722
7787964|NCT01272219|19171874|P4|NOT COMPLETED|Main + Extension Period: Week 0-172||0
7787965|NCT01272219|19171875|P3|NOT COMPLETED|Main + Extension Period: Week 0-172||0
7787966|NCT01272219|19171876|P2|NOT COMPLETED|Main + Extension Period: Week 0-172||0
7787967|NCT01272219|19171877|P1|NOT COMPLETED|Main + Extension Period: Week 0-172||0
7787968|NCT01272219|19171872|P6|COMPLETED|Main + Extension Period: Week 0-172||327
7787969|NCT01272219|19171873|P5|COMPLETED|Main + Extension Period: Week 0-172||783
7787970|NCT01272219|19171874|P4|COMPLETED|Main + Extension Period: Week 0-172||0
7787971|NCT01272219|19171875|P3|COMPLETED|Main + Extension Period: Week 0-172||0
7787972|NCT01272219|19171876|P2|COMPLETED|Main + Extension Period: Week 0-172||0
7787973|NCT01272219|19171877|P1|COMPLETED|Main + Extension Period: Week 0-172||0
7787974|NCT01272219|19171872|P6|Exposed|Main + Extension Period: Week 0-172||747
7787975|NCT01272219|19171873|P5|Exposed|Main + Extension Period: Week 0-172||1501
7787976|NCT01272219|19171874|P4|Exposed|Main + Extension Period: Week 0-172||0
7787977|NCT01272219|19171875|P3|Exposed|Main + Extension Period: Week 0-172||0
7787978|NCT01272219|19171876|P2|Exposed|Main + Extension Period: Week 0-172||0
7787979|NCT01272219|19171877|P1|Exposed|Main + Extension Period: Week 0-172||0
7787980|NCT01272219|19171872|P6|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749
7787981|NCT01272219|19171873|P5|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505
7787982|NCT01272219|19171874|P4|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0
7787983|NCT01272219|19171875|P3|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
7787984|NCT01272219|19171876|P2|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
7787985|NCT01272219|19171877|P1|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0
7787986|NCT01272219|19171872|P6|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
7787987|NCT01272219|19171873|P5|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
7787988|NCT01272219|19171874|P4|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15
7787989|NCT01272219|19171875|P3|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7
7787990|NCT01272219|19171876|P2|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9
7787991|NCT01272219|19171877|P1|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
7787992|NCT01272219|19171872|P6|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
7787993|NCT01272219|19171873|P5|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
7787994|NCT01272219|19171874|P4|COMPLETED|Re-randomised Period: Week 56 to Week 68||289
7787995|NCT01272219|19171875|P3|COMPLETED|Re-randomised Period: Week 56 to Week 68||343
7787996|NCT01272219|19171876|P2|COMPLETED|Re-randomised Period: Week 56 to Week 68||342
7787997|NCT01272219|19171877|P1|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
7787998|NCT01272219|19171872|P6|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
7787999|NCT01272219|19171873|P5|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
7788000|NCT01272219|19171874|P4|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304
7788001|NCT01272219|19171875|P3|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350
7788002|NCT01272219|19171876|P2|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351
7788003|NCT01272219|19171877|P1|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
7788004|NCT01272219|19171872|P6|NOT COMPLETED|Main Period: Week 0 to Week 56||252
7788005|NCT01272219|19171873|P5|NOT COMPLETED|Main Period: Week 0 to Week 56||418
7788006|NCT01272219|19171874|P4|NOT COMPLETED|Main Period: Week 0 to Week 56||191
7788007|NCT01272219|19171875|P3|NOT COMPLETED|Main Period: Week 0 to Week 56||0
7788008|NCT01272219|19171876|P2|NOT COMPLETED|Main Period: Week 0 to Week 56||0
7788009|NCT01272219|19171877|P1|NOT COMPLETED|Main Period: Week 0 to Week 56||280
7788010|NCT01272219|19171872|P6|COMPLETED|Main Period: Week 0 to Week 56||505
7788011|NCT01272219|19171873|P5|COMPLETED|Main Period: Week 0 to Week 56||1110
7788012|NCT01272219|19171874|P4|COMPLETED|Main Period: Week 0 to Week 56||296
7788014|NCT01272219|19171876|P2|COMPLETED|Main Period: Week 0 to Week 56||0
7788015|NCT01272219|19171877|P1|COMPLETED|Main Period: Week 0 to Week 56||679
7788016|NCT01272219|19171872|P6|Exposed|Main Period: Week 0 to Week 56||755
7788017|NCT01272219|19171873|P5|Exposed|Main Period: Week 0 to Week 56||1524
7788018|NCT01272219|19171874|P4|Exposed|Main Period: Week 0 to Week 56||487
7788019|NCT01272219|19171875|P3|Exposed|Main Period: Week 0 to Week 56||0
7788020|NCT01272219|19171876|P2|Exposed|Main Period: Week 0 to Week 56||0
7788021|NCT01272219|19171877|P1|Exposed|Main Period: Week 0 to Week 56||957
7788022|NCT01272219|19171872|P6|STARTED|Main Period: Week 0 to Week 56||757
7788023|NCT01272219|19171873|P5|STARTED|Main Period: Week 0 to Week 56||1528
7788024|NCT01272219|19171874|P4|STARTED|Main Period: Week 0 to Week 56||487
7788025|NCT01272219|19171875|P3|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
7788026|NCT01272219|19171876|P2|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
7788027|NCT01272219|19171877|P1|STARTED|Main Period: Week 0 to Week 56||959
7788028|NCT01272193|19171911|P2|NOT COMPLETED|Overall Study||12
7788029|NCT01272193|19171912|P1|NOT COMPLETED|Overall Study||10
7788030|NCT01272193|19171911|P2|COMPLETED|Overall Study||137
7788031|NCT01272193|19171912|P1|COMPLETED|Overall Study||137
7788032|NCT01272193|19171911|P2|STARTED|Overall Study||149
7788033|NCT01272193|19171912|P1|STARTED|Overall Study||147
7788034|NCT01272180|19171932|P4|NOT COMPLETED|Overall Study||14
7788035|NCT01272180|19171933|P3|NOT COMPLETED|Overall Study||13
7788036|NCT01272180|19171934|P2|NOT COMPLETED|Overall Study||21
7788037|NCT01272180|19171935|P1|NOT COMPLETED|Overall Study||17
7788038|NCT01272180|19171932|P4|COMPLETED|Overall Study||107
7788039|NCT01272180|19171933|P3|COMPLETED|Overall Study||109
7788040|NCT01272180|19171934|P2|COMPLETED|Overall Study||100
7788041|NCT01272180|19171935|P1|COMPLETED|Overall Study||103
7788042|NCT01272180|19171932|P4|STARTED|Overall Study||121
7788043|NCT01272180|19171933|P3|STARTED|Overall Study||122
7788044|NCT01272180|19171934|P2|STARTED|Overall Study||121
7788045|NCT01272180|19171935|P1|STARTED|Overall Study||120
7788046|NCT01272141|19171975|P1|NOT COMPLETED|Overall Study||0
7788047|NCT01272141|19171975|P1|COMPLETED|Overall Study||5
7788048|NCT01272141|19171975|P1|STARTED|Overall Study||5
7788049|NCT01272076|19171980|P1|NOT COMPLETED|Overall Study||0
7788050|NCT01272076|19171980|P1|COMPLETED|Overall Study||52
7788051|NCT01272076|19171980|P1|STARTED|Overall Study||52
7788052|NCT01272011|19171987|P3|NOT COMPLETED|Overall Study||0
7788053|NCT01272011|19171988|P2|NOT COMPLETED|Overall Study||2
7788054|NCT01272011|19171989|P1|NOT COMPLETED|Overall Study||0
7788055|NCT01272011|19171987|P3|COMPLETED|Overall Study||3
7788056|NCT01272011|19171988|P2|COMPLETED|Overall Study||8
7788057|NCT01272011|19171989|P1|COMPLETED|Overall Study||3
7788058|NCT01272011|19171987|P3|STARTED|Overall Study||3
7788059|NCT01272011|19171988|P2|STARTED|Overall Study||10
7788060|NCT01272011|19171989|P1|STARTED|Overall Study||3
7788061|NCT01271946|19172002|P2|NOT COMPLETED|Overall Study||0
7788062|NCT01271946|19172003|P1|NOT COMPLETED|Overall Study||0
7788063|NCT01271946|19172002|P2|COMPLETED|Overall Study||5
7788064|NCT01271946|19172003|P1|COMPLETED|Overall Study||346
7788065|NCT01271946|19172002|P2|STARTED|Overall Study||5
7788066|NCT01271946|19172003|P1|STARTED|Overall Study||346
7788067|NCT01271933|19172025|P3|NOT COMPLETED|Double-Blind Phase||12
7788068|NCT01271933|19172026|P2|NOT COMPLETED|Double-Blind Phase||17
7788069|NCT01271933|19172027|P1|NOT COMPLETED|Double-Blind Phase||0
7788070|NCT01271933|19172025|P3|COMPLETED|Double-Blind Phase||47
7788071|NCT01271933|19172026|P2|COMPLETED|Double-Blind Phase||46
7788072|NCT01271933|19172027|P1|COMPLETED|Double-Blind Phase||0
7788073|NCT01271933|19172025|P3|Treated|Double-Blind Phase||58
7788074|NCT01271933|19172026|P2|Treated|Double-Blind Phase||63
7788075|NCT01271933|19172027|P1|Treated|Double-Blind Phase||0
7788076|NCT01271933|19172025|P3|STARTED|Double-Blind Phase||59
7788077|NCT01271933|19172026|P2|STARTED|Double-Blind Phase||63
7788078|NCT01271933|19172027|P1|STARTED|Double-Blind Phase||0
7788079|NCT01271933|19172025|P3|NOT COMPLETED|Single-Blind Phase||0
7788080|NCT01271933|19172026|P2|NOT COMPLETED|Single-Blind Phase||0
7788081|NCT01271933|19172027|P1|NOT COMPLETED|Single-Blind Phase||121
7788082|NCT01271933|19172025|P3|COMPLETED|Single-Blind Phase||0
7788083|NCT01271933|19172026|P2|COMPLETED|Single-Blind Phase||0
7788084|NCT01271933|19172027|P1|COMPLETED|Single-Blind Phase||320
7788085|NCT01271933|19172025|P3|STARTED|Single-Blind Phase||0
7788086|NCT01271933|19172026|P2|STARTED|Single-Blind Phase||0
7788087|NCT01271933|19172027|P1|STARTED|Single-Blind Phase||441
7788088|NCT01271907|19172127|P3|NOT COMPLETED|Overall Study||0
7788089|NCT01271907|19172128|P2|NOT COMPLETED|Overall Study||0
7788090|NCT01271907|19172129|P1|NOT COMPLETED|Overall Study||0
7788091|NCT01271907|19172127|P3|COMPLETED|Overall Study||0
7788092|NCT01271907|19172128|P2|COMPLETED|Overall Study||0
7788093|NCT01271907|19172129|P1|COMPLETED|Overall Study||3
7788094|NCT01271907|19172127|P3|STARTED|Overall Study||0
7788095|NCT01271907|19172128|P2|STARTED|Overall Study||0
7788096|NCT01271907|19172129|P1|STARTED|Overall Study||3
7788097|NCT01271868|19172143|P1|NOT COMPLETED|Treatment Study||0
7788098|NCT01271868|19172143|P1|COMPLETED|Treatment Study||9
7788099|NCT01271868|19172143|P1|STARTED|Treatment Study||9
7788100|NCT01271868|19172143|P1|NOT COMPLETED|Pharmacokinetic Study||0
7788101|NCT01271868|19172143|P1|COMPLETED|Pharmacokinetic Study||9
7788102|NCT01271868|19172143|P1|STARTED|Pharmacokinetic Study||9
7788103|NCT01271855|19172156|P2|NOT COMPLETED|Overall Study||0
7788104|NCT01271855|19172157|P1|NOT COMPLETED|Overall Study||0
7788105|NCT01271855|19172156|P2|COMPLETED|Overall Study||52
7788106|NCT01271855|19172157|P1|COMPLETED|Overall Study||48
7788107|NCT01271855|19172156|P2|STARTED|Overall Study||52
7788108|NCT01271855|19172157|P1|STARTED|Overall Study||48
7788109|NCT01271803|19172170|P3|NOT COMPLETED|Overall Study||2
7788110|NCT01271803|19172171|P2|NOT COMPLETED|Overall Study||39
7788111|NCT01271803|19172172|P1|NOT COMPLETED|Overall Study||55
7788112|NCT01271803|19172170|P3|COMPLETED|Overall Study||0
7788113|NCT01271803|19172171|P2|COMPLETED|Overall Study||24
7788114|NCT01271803|19172172|P1|COMPLETED|Overall Study||11
7788115|NCT01271803|19172170|P3|STARTED|Overall Study||2
7788116|NCT01271803|19172171|P2|STARTED|Overall Study||63
7788117|NCT01271803|19172172|P1|STARTED|Overall Study||66
7788118|NCT01271725|19172334|P2|NOT COMPLETED|Part B||12
7788119|NCT01271725|19172335|P1|NOT COMPLETED|Part B||0
7788120|NCT01271725|19172334|P2|COMPLETED|Part B|Patient deemed to have completed the trial once they showed progressive disease according to RECIST|27
7788121|NCT01271725|19172335|P1|COMPLETED|Part B||0
7788122|NCT01271725|19172334|P2|STARTED|Part B||39
7788123|NCT01271725|19172335|P1|STARTED|Part B||0
7788124|NCT01271725|19172334|P2|NOT COMPLETED|Part A||0
7788125|NCT01271725|19172335|P1|NOT COMPLETED|Part A||35
7788126|NCT01271725|19172334|P2|COMPLETED|Part A||0
7788127|NCT01271725|19172335|P1|COMPLETED|Part A||39
7788128|NCT01271725|19172334|P2|STARTED|Part A||0
7788129|NCT01271725|19172335|P1|STARTED|Part A|Started are the treated patients|74
7788130|NCT01271712|19172364|P2|NOT COMPLETED|Survival Follow-up||6
7788131|NCT01271712|19172365|P1|NOT COMPLETED|Survival Follow-up||15
7788132|NCT01271712|19172364|P2|COMPLETED|Survival Follow-up|33 participants died and completed survival follow-up.|33
7788133|NCT01271712|19172365|P1|COMPLETED|Survival Follow-up|85 participants died and completed survival follow-up.|85
7788134|NCT01271712|19172364|P2|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|39
7788135|NCT01271712|19172365|P1|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|100
7788136|NCT01271712|19172364|P2|NOT COMPLETED|Safety Follow-up||15
7788137|NCT01271712|19172365|P1|NOT COMPLETED|Safety Follow-up||21
7788138|NCT01271712|19172364|P2|COMPLETED|Safety Follow-up||37
7788139|NCT01271712|19172365|P1|COMPLETED|Safety Follow-up||97
7788140|NCT01271712|19172364|P2|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|52
7788141|NCT01271712|19172365|P1|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|118
7788142|NCT01271712|19172364|P2|NOT COMPLETED|Open Label Treatment||58
7788143|NCT01271712|19172365|P1|NOT COMPLETED|Open Label Treatment||91
7788144|NCT01271712|19172364|P2|COMPLETED|Open Label Treatment||0
7788145|NCT01271712|19172365|P1|COMPLETED|Open Label Treatment||0
7788146|NCT01271712|19172364|P2|STARTED|Open Label Treatment||58
7788147|NCT01271712|19172365|P1|STARTED|Open Label Treatment||91
7788148|NCT01271712|19172364|P2|NOT COMPLETED|Double Blind Treatment||8
7788149|NCT01271712|19172365|P1|NOT COMPLETED|Double Blind Treatment||42
7788150|NCT01271712|19172364|P2|COMPLETED|Double Blind Treatment|58 participants started open-label treatment with regorafenib|58
7788151|NCT01271712|19172365|P1|COMPLETED|Double Blind Treatment|91 participants started open-label treatment with regorafenib|91
7788152|NCT01271712|19172364|P2|Participants Received Treatment|Double Blind Treatment||66
7788153|NCT01271712|19172365|P1|Participants Received Treatment|Double Blind Treatment||132
7788154|NCT01271712|19172364|P2|STARTED|Double Blind Treatment||66
7788155|NCT01271712|19172365|P1|STARTED|Double Blind Treatment||133
7788156|NCT01271686|19172386|P1|NOT COMPLETED|Overall Study||0
7788157|NCT01271686|19172386|P1|COMPLETED|Overall Study||16
7788158|NCT01271686|19172386|P1|STARTED|Overall Study||16
7788159|NCT01271543|19172392|P2|NOT COMPLETED|Overall Study||1
7788160|NCT01271543|19172393|P1|NOT COMPLETED|Overall Study||1
7788161|NCT01271543|19172392|P2|COMPLETED|Overall Study||29
7788162|NCT01271543|19172393|P1|COMPLETED|Overall Study||29
7788163|NCT01271543|19172392|P2|STARTED|Overall Study||30
7788164|NCT01271543|19172393|P1|STARTED|Overall Study||30
7788165|NCT01271452|19172403|P2|NOT COMPLETED|Overall Study||8
7788166|NCT01271452|19172404|P1|NOT COMPLETED|Overall Study||7
7788167|NCT01271452|19172403|P2|COMPLETED|Overall Study||104
7788168|NCT01271452|19172404|P1|COMPLETED|Overall Study||105
7788169|NCT01271452|19172403|P2|STARTED|Overall Study||112
7788170|NCT01271452|19172404|P1|STARTED|Overall Study||112
7788171|NCT01271413|19172426|P2|NOT COMPLETED|Overall Study||8
7788172|NCT01271413|19172427|P1|NOT COMPLETED|Overall Study||9
7788173|NCT01271413|19172426|P2|COMPLETED|Overall Study||28
7788174|NCT01271413|19172427|P1|COMPLETED|Overall Study||28
7788175|NCT01271413|19172426|P2|STARTED|Overall Study||36
7788176|NCT01271413|19172427|P1|STARTED|Overall Study||37
7788177|NCT01271244|19172435|P2|NOT COMPLETED|Overall Study||3
7788178|NCT01271244|19172436|P1|NOT COMPLETED|Overall Study||7
7788179|NCT01271244|19172435|P2|COMPLETED|Overall Study||5
7788180|NCT01271244|19172436|P1|COMPLETED|Overall Study||11
7788181|NCT01271244|19172435|P2|STARTED|Overall Study||8
7788182|NCT01271244|19172436|P1|STARTED|Overall Study||18
7788183|NCT01271036|19172446|P2|NOT COMPLETED|Overall Study||0
7788184|NCT01271036|19172447|P1|NOT COMPLETED|Overall Study||0
7788185|NCT01271036|19172446|P2|COMPLETED|Overall Study||62
7788186|NCT01271036|19172447|P1|COMPLETED|Overall Study||62
7788187|NCT01271036|19172446|P2|STARTED|Overall Study||62
7788188|NCT01271036|19172447|P1|STARTED|Overall Study||62
7788189|NCT01271010|19172461|P1|NOT COMPLETED|Overall Study||61
7788190|NCT01271010|19172461|P1|COMPLETED|Overall Study||28
7788191|NCT01271010|19172461|P1|STARTED|Overall Study||89
7788192|NCT01270971|19172476|P2|NOT COMPLETED|Overall Study||23
7788193|NCT01270971|19172477|P1|NOT COMPLETED|Overall Study||52
7788194|NCT01270971|19172476|P2|COMPLETED|Overall Study||171
7788195|NCT01270971|19172477|P1|COMPLETED|Overall Study||348
7788196|NCT01270971|19172476|P2|STARTED|Overall Study||194
7788197|NCT01270971|19172477|P1|STARTED|Overall Study||400
7788198|NCT01270958|19172489|P1|NOT COMPLETED|Overall Study||4
7788199|NCT01270958|19172489|P1|COMPLETED|Overall Study||56
7788200|NCT01270958|19172489|P1|STARTED|Overall Study||60
7788201|NCT01270919|19172513|P1|NOT COMPLETED|Overall Study||0
7788202|NCT01270919|19172513|P1|COMPLETED|Overall Study||0
7788203|NCT01270919|19172513|P1|STARTED|Overall Study|One participant was enrolled but was censored.|0
7788204|NCT01270880|19172518|P1|NOT COMPLETED|Overall Study||1
7788205|NCT01270880|19172518|P1|COMPLETED|Overall Study||17
7788206|NCT01270880|19172518|P1|STARTED|Overall Study||18
7788207|NCT01270867|19172529|P2|NOT COMPLETED|Overall Study||0
7788208|NCT01270867|19172530|P1|NOT COMPLETED|Overall Study||1
7788209|NCT01270867|19172529|P2|COMPLETED|Overall Study||88
7788210|NCT01270867|19172530|P1|COMPLETED|Overall Study||89
7788211|NCT01270867|19172529|P2|STARTED|Overall Study||88
7788212|NCT01270867|19172530|P1|STARTED|Overall Study||90
7788213|NCT01270841|19172548|P4|NOT COMPLETED|Overall Study||13
7788214|NCT01270841|19172549|P3|NOT COMPLETED|Overall Study||11
7788215|NCT01270841|19172550|P2|NOT COMPLETED|Overall Study||14
7788216|NCT01270841|19172551|P1|NOT COMPLETED|Overall Study||13
7788217|NCT01270841|19172548|P4|COMPLETED|Overall Study||20
7788218|NCT01270841|19172549|P3|COMPLETED|Overall Study||18
7788219|NCT01270841|19172550|P2|COMPLETED|Overall Study||19
7788220|NCT01270841|19172551|P1|COMPLETED|Overall Study||16
7788221|NCT01270841|19172548|P4|STARTED|Overall Study||33
7788222|NCT01270841|19172549|P3|STARTED|Overall Study||29
7788223|NCT01270841|19172550|P2|STARTED|Overall Study||33
7788224|NCT01270841|19172551|P1|STARTED|Overall Study||29
7788225|NCT01270828|19172575|P3|NOT COMPLETED|Double Blind Phase||0
7788226|NCT01270828|19172576|P2|NOT COMPLETED|Double Blind Phase||45
7788227|NCT01270828|19172577|P1|NOT COMPLETED|Double Blind Phase||26
7788228|NCT01270828|19172575|P3|COMPLETED|Double Blind Phase||0
7788229|NCT01270828|19172576|P2|COMPLETED|Double Blind Phase||160
7788230|NCT01270828|19172577|P1|COMPLETED|Double Blind Phase||182
7788231|NCT01270828|19172575|P3|STARTED|Double Blind Phase||0
7788232|NCT01270828|19172576|P2|STARTED|Double Blind Phase||205
7788233|NCT01270828|19172577|P1|STARTED|Double Blind Phase||208
7788234|NCT01270828|19172575|P3|NOT COMPLETED|Pregabalin CR SB||146
7788235|NCT01270828|19172576|P2|NOT COMPLETED|Pregabalin CR SB||0
7788236|NCT01270828|19172577|P1|NOT COMPLETED|Pregabalin CR SB||0
7788237|NCT01270828|19172575|P3|COMPLETED|Pregabalin CR SB||660
7788238|NCT01270828|19172576|P2|COMPLETED|Pregabalin CR SB||0
7788239|NCT01270828|19172577|P1|COMPLETED|Pregabalin CR SB||0
7788240|NCT01270828|19172575|P3|STARTED|Pregabalin CR SB||806
7788241|NCT01270828|19172576|P2|STARTED|Pregabalin CR SB||0
7788242|NCT01270828|19172577|P1|STARTED|Pregabalin CR SB||0
7788243|NCT01270802|19172619|P2|NOT COMPLETED|Overall Study||1
7788244|NCT01270802|19172620|P1|NOT COMPLETED|Overall Study||2
7788245|NCT01270802|19172619|P2|COMPLETED|Overall Study||14
7788246|NCT01270802|19172620|P1|COMPLETED|Overall Study||13
7788247|NCT01270802|19172619|P2|STARTED|Overall Study||15
7788248|NCT01270802|19172620|P1|STARTED|Overall Study||15
7788249|NCT01270711|19172636|P8|NOT COMPLETED|Part 2: Effectiveness||0
7788250|NCT01270711|19172637|P7|NOT COMPLETED|Part 2: Effectiveness||0
7788251|NCT01270711|19172638|P6|NOT COMPLETED|Part 2: Effectiveness||0
7788252|NCT01270711|19172639|P5|NOT COMPLETED|Part 2: Effectiveness||0
7788253|NCT01270711|19172640|P4|NOT COMPLETED|Part 2: Effectiveness||0
7788254|NCT01270711|19172641|P3|NOT COMPLETED|Part 2: Effectiveness||0
7788255|NCT01270711|19172642|P2|NOT COMPLETED|Part 2: Effectiveness||0
7788256|NCT01270711|19172643|P1|NOT COMPLETED|Part 2: Effectiveness||0
7788257|NCT01270711|19172636|P8|COMPLETED|Part 2: Effectiveness||48
7788258|NCT01270711|19172637|P7|COMPLETED|Part 2: Effectiveness||2
7788259|NCT01270711|19172638|P6|COMPLETED|Part 2: Effectiveness||11
7788260|NCT01270711|19172639|P5|COMPLETED|Part 2: Effectiveness||0
7788261|NCT01270711|19172640|P4|COMPLETED|Part 2: Effectiveness||0
7788262|NCT01270711|19172641|P3|COMPLETED|Part 2: Effectiveness||0
7788263|NCT01270711|19172642|P2|COMPLETED|Part 2: Effectiveness||0
7788264|NCT01270711|19172643|P1|COMPLETED|Part 2: Effectiveness||0
7788265|NCT01270711|19172636|P8|STARTED|Part 2: Effectiveness||48
7788266|NCT01270711|19172637|P7|STARTED|Part 2: Effectiveness||2
7788267|NCT01270711|19172638|P6|STARTED|Part 2: Effectiveness||11
7788268|NCT01270711|19172639|P5|STARTED|Part 2: Effectiveness||0
7788269|NCT01270711|19172640|P4|STARTED|Part 2: Effectiveness||0
7788270|NCT01270711|19172641|P3|STARTED|Part 2: Effectiveness||0
7788271|NCT01270711|19172642|P2|STARTED|Part 2: Effectiveness||0
7788272|NCT01270711|19172643|P1|STARTED|Part 2: Effectiveness||0
7788273|NCT01270711|19172636|P8|NOT COMPLETED|Part 1: Compliance||0
7788274|NCT01270711|19172637|P7|NOT COMPLETED|Part 1: Compliance||0
7788275|NCT01270711|19172638|P6|NOT COMPLETED|Part 1: Compliance||0
7788276|NCT01270711|19172639|P5|NOT COMPLETED|Part 1: Compliance||0
7788277|NCT01270711|19172640|P4|NOT COMPLETED|Part 1: Compliance||0
7788278|NCT01270711|19172641|P3|NOT COMPLETED|Part 1: Compliance||0
7788279|NCT01270711|19172642|P2|NOT COMPLETED|Part 1: Compliance||0
7788280|NCT01270711|19172643|P1|NOT COMPLETED|Part 1: Compliance||0
7788281|NCT01270711|19172636|P8|COMPLETED|Part 1: Compliance||0
7788282|NCT01270711|19172637|P7|COMPLETED|Part 1: Compliance||0
7788283|NCT01270711|19172638|P6|COMPLETED|Part 1: Compliance||0
7788284|NCT01270711|19172639|P5|COMPLETED|Part 1: Compliance||2024
7788285|NCT01270711|19172640|P4|COMPLETED|Part 1: Compliance||5486
7788286|NCT01270711|19172641|P3|COMPLETED|Part 1: Compliance||326
7788287|NCT01270711|19172642|P2|COMPLETED|Part 1: Compliance||6580
7788288|NCT01270711|19172643|P1|COMPLETED|Part 1: Compliance||7537
7788289|NCT01270711|19172636|P8|STARTED|Part 1: Compliance||0
7788290|NCT01270711|19172637|P7|STARTED|Part 1: Compliance||0
7788291|NCT01270711|19172638|P6|STARTED|Part 1: Compliance||0
7788292|NCT01270711|19172639|P5|STARTED|Part 1: Compliance||2024
7788293|NCT01270711|19172640|P4|STARTED|Part 1: Compliance||5486
7788294|NCT01270711|19172641|P3|STARTED|Part 1: Compliance||326
7788295|NCT01270711|19172642|P2|STARTED|Part 1: Compliance||6580
7788296|NCT01270711|19172643|P1|STARTED|Part 1: Compliance||7537
7788297|NCT01270659|19172744|P4|NOT COMPLETED|Overall Study||0
7788298|NCT01270659|19172745|P3|NOT COMPLETED|Overall Study||0
7788299|NCT01270659|19172746|P2|NOT COMPLETED|Overall Study||0
7788300|NCT01270659|19172747|P1|NOT COMPLETED|Overall Study||0
7788301|NCT01270659|19172744|P4|COMPLETED|Overall Study||25
7788302|NCT01270659|19172745|P3|COMPLETED|Overall Study||4
7788303|NCT01270659|19172746|P2|COMPLETED|Overall Study||25
7788304|NCT01270659|19172747|P1|COMPLETED|Overall Study||6
7788305|NCT01270659|19172744|P4|STARTED|Overall Study||25
7788306|NCT01270659|19172745|P3|STARTED|Overall Study||4
7788307|NCT01270659|19172746|P2|STARTED|Overall Study||25
7788308|NCT01270659|19172747|P1|STARTED|Overall Study||6
7788309|NCT01270620|19172767|P2|NOT COMPLETED|Overall Study||3
7788310|NCT01270620|19172768|P1|NOT COMPLETED|Overall Study||1
7788311|NCT01270620|19172767|P2|COMPLETED|Overall Study||47
7788312|NCT01270620|19172768|P1|COMPLETED|Overall Study||49
7788313|NCT01270620|19172767|P2|STARTED|Overall Study||50
7788314|NCT01270620|19172768|P1|STARTED|Overall Study||50
7788315|NCT01270581|19172820|P2|NOT COMPLETED|Overall Study||0
7788316|NCT01270581|19172821|P1|NOT COMPLETED|Overall Study||1
7788317|NCT01270581|19172820|P2|COMPLETED|Overall Study||3
7788318|NCT01270581|19172821|P1|COMPLETED|Overall Study||3
7788319|NCT01270581|19172820|P2|STARTED|Overall Study||3
7788320|NCT01270581|19172821|P1|STARTED|Overall Study||4
7788321|NCT01270555|19172827|P1|NOT COMPLETED|Overall Study||13
7788322|NCT01270555|19172827|P1|COMPLETED|Overall Study||19
7788323|NCT01270555|19172827|P1|STARTED|Overall Study||32
7788324|NCT01270542|19172839|P2|NOT COMPLETED|Overall Study||1
7788325|NCT01270542|19172840|P1|NOT COMPLETED|Overall Study||1
7788326|NCT01270542|19172839|P2|COMPLETED|Overall Study||8
7788327|NCT01270542|19172840|P1|COMPLETED|Overall Study||9
7788328|NCT01270542|19172839|P2|STARTED|Overall Study||9
7788329|NCT01270542|19172840|P1|STARTED|Overall Study||10
7788330|NCT01270529|19172853|P3|NOT COMPLETED|Overall Study||0
7788331|NCT01270529|19172854|P2|NOT COMPLETED|Overall Study||0
7788332|NCT01270529|19172855|P1|NOT COMPLETED|Overall Study||0
7788333|NCT01270529|19172853|P3|COMPLETED|Overall Study||25
7788334|NCT01270529|19172854|P2|COMPLETED|Overall Study||7
7788335|NCT01270529|19172855|P1|COMPLETED|Overall Study||12
7788336|NCT01270529|19172853|P3|STARTED|Overall Study||25
7788337|NCT01270529|19172854|P2|STARTED|Overall Study||7
7788338|NCT01270529|19172855|P1|STARTED|Overall Study||12
7788339|NCT01270503|19172863|P1|NOT COMPLETED|Overall Study||1
7788340|NCT01270503|19172863|P1|COMPLETED|Overall Study||537
7788341|NCT01270503|19172863|P1|STARTED|Overall Study||538
7788342|NCT01270464|19172871|P3|NOT COMPLETED|Overall Study||18
7788343|NCT01270464|19172872|P2|NOT COMPLETED|Overall Study||12
7788344|NCT01270464|19172873|P1|NOT COMPLETED|Overall Study||20
7788345|NCT01270464|19172871|P3|COMPLETED|Overall Study||88
7788346|NCT01270464|19172872|P2|COMPLETED|Overall Study||92
7788347|NCT01270464|19172873|P1|COMPLETED|Overall Study||85
7788348|NCT01270464|19172871|P3|Pharmacokinetic Analysis Set|Overall Study||103
7788349|NCT01270464|19172872|P2|Pharmacokinetic Analysis Set|Overall Study||103
7788350|NCT01270464|19172873|P1|Pharmacokinetic Analysis Set|Overall Study||105
7788351|NCT01270464|19172871|P3|Full Analysis Set|Overall Study||103
7788352|NCT01270464|19172872|P2|Full Analysis Set|Overall Study||103
7788353|NCT01270464|19172873|P1|Full Analysis Set|Overall Study||105
7788354|NCT01270464|19172871|P3|Safety Analysis Set|Overall Study||103
7788355|NCT01270464|19172872|P2|Safety Analysis Set|Overall Study||103
7788356|NCT01270464|19172873|P1|Safety Analysis Set|Overall Study||105
7788357|NCT01270464|19172871|P3|STARTED|Overall Study||106
7788358|NCT01270464|19172872|P2|STARTED|Overall Study||104
7788359|NCT01270464|19172873|P1|STARTED|Overall Study||105
7788360|NCT01270321|19172923|P3|NOT COMPLETED|Overall Study||9
7788361|NCT01270321|19172924|P2|NOT COMPLETED|Overall Study||10
7788362|NCT01270321|19172925|P1|NOT COMPLETED|Overall Study||10
7788363|NCT01270321|19172923|P3|COMPLETED|Overall Study||3
7788364|NCT01270321|19172924|P2|COMPLETED|Overall Study||1
7788365|NCT01270321|19172925|P1|COMPLETED|Overall Study||9
7788366|NCT01270321|19172923|P3|STARTED|Overall Study||12
7788367|NCT01270321|19172924|P2|STARTED|Overall Study||11
7788368|NCT01270321|19172925|P1|STARTED|Overall Study||19
7788369|NCT01270256|19172938|P2|NOT COMPLETED|Overall Study||0
7788370|NCT01270256|19172939|P1|NOT COMPLETED|Overall Study||1
7788371|NCT01270256|19172938|P2|COMPLETED|Overall Study||20
7788372|NCT01270256|19172939|P1|COMPLETED|Overall Study||20
7788373|NCT01270256|19172938|P2|STARTED|Overall Study||20
7788374|NCT01270256|19172939|P1|STARTED|Overall Study||21
7788375|NCT01270139|19172948|P3|NOT COMPLETED|Overall Study||20
7788376|NCT01270139|19172949|P2|NOT COMPLETED|Overall Study||26
7788377|NCT01270139|19172950|P1|NOT COMPLETED|Overall Study||18
7788378|NCT01270139|19172948|P3|COMPLETED|Overall Study|Pre-treatment evaluable population|40
7788379|NCT01270139|19172949|P2|COMPLETED|Overall Study|Pre-treatment evaluable population|34
7788380|NCT01270139|19172950|P1|COMPLETED|Overall Study|Pre-treatment evaluable population|42
7788381|NCT01270139|19172948|P3|STARTED|Overall Study|Intention-to-treat population|60
7788382|NCT01270139|19172949|P2|STARTED|Overall Study|Intention-to-treat population|60
7788383|NCT01270139|19172950|P1|STARTED|Overall Study|Intention-to-treat population|60
7788384|NCT01270126|19173010|P2|NOT COMPLETED|Overall Study||0
7788385|NCT01270126|19173011|P1|NOT COMPLETED|Overall Study||0
7788386|NCT01270126|19173010|P2|COMPLETED|Overall Study||10
7788387|NCT01270126|19173011|P1|COMPLETED|Overall Study||12
7788388|NCT01270126|19173010|P2|STARTED|Overall Study||10
7788389|NCT01270126|19173011|P1|STARTED|Overall Study||12
7788390|NCT01269918|19173019|P2|NOT COMPLETED|Overall Study||3
7788391|NCT01269918|19173020|P1|NOT COMPLETED|Overall Study||0
7788392|NCT01269918|19173019|P2|COMPLETED|Overall Study||68
7788393|NCT01269918|19173020|P1|COMPLETED|Overall Study||71
7788394|NCT01269918|19173019|P2|STARTED|Overall Study||71
7788395|NCT01269918|19173020|P1|STARTED|Overall Study||71
7788396|NCT01269801|19173054|P2|NOT COMPLETED|Overall Study||3
7788397|NCT01269801|19173055|P1|NOT COMPLETED|Overall Study||0
7788398|NCT01269801|19173054|P2|COMPLETED|Overall Study||77
7788399|NCT01269801|19173055|P1|COMPLETED|Overall Study||74
7788400|NCT01269801|19173054|P2|STARTED|Overall Study||80
7788401|NCT01269801|19173055|P1|STARTED|Overall Study||74
7788402|NCT01269749|19173063|P2|NOT COMPLETED|Overall Study||0
7788403|NCT01269749|19173064|P1|NOT COMPLETED|Overall Study||0
7788404|NCT01269749|19173063|P2|COMPLETED|Overall Study||3
7788405|NCT01269749|19173064|P1|COMPLETED|Overall Study||16
7788406|NCT01269749|19173063|P2|STARTED|Overall Study||3
7788407|NCT01269749|19173064|P1|STARTED|Overall Study||16
7788408|NCT01269736|19173074|P2|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
7788409|NCT01269736|19173075|P1|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
7788410|NCT01269736|19173074|P2|COMPLETED|Patient Outcomes (Hospital Admissions)|43799 unique patients assessed overall (at any time point) by end of study.|43799
7788411|NCT01269736|19173075|P1|COMPLETED|Patient Outcomes (Hospital Admissions)|52085 unique patients assessed overall (at any time point) by end of study.|52085
7788412|NCT01269736|19173074|P2|30 Months Assessment|Patient Outcomes (Hospital Admissions)|13265 unique patients, assessed at 6 hospitals.|13265
7788413|NCT01269736|19173075|P1|30 Months Assessment|Patient Outcomes (Hospital Admissions)|16702 unique patients, assessed at 7 hospitals.|16702
7788414|NCT01269736|19173074|P2|15 Months Assessment|Patient Outcomes (Hospital Admissions)|14075 unique patients, assessed at 6 hospitals.|14075
7788415|NCT01269736|19173075|P1|15 Months Assessment|Patient Outcomes (Hospital Admissions)|18031 unique patients, assessed at 7 hospitals.|18031
7788416|NCT01269736|19173074|P2|Baseline Assessment|Patient Outcomes (Hospital Admissions)|16549 unique patients, assessed at 6 hospitals.|16549
7788417|NCT01269736|19173075|P1|Baseline Assessment|Patient Outcomes (Hospital Admissions)|17352 unique patients, assessed at 7 hospitals.|17352
7788418|NCT01269736|19173074|P2|STARTED|Patient Outcomes (Hospital Admissions)|16459 unique patients were assessed at 6 hospitals at the initiation of the study.|43799
7788419|NCT01269736|19173075|P1|STARTED|Patient Outcomes (Hospital Admissions)|17352 unique patients were assessed at 7 hospitals at the initiation of the study.|52085
7788420|NCT01269736|19173074|P2|NOT COMPLETED|Patient Quality of Care Assessments||0
7788421|NCT01269736|19173075|P1|NOT COMPLETED|Patient Quality of Care Assessments||0
7788422|NCT01269736|19173074|P2|COMPLETED|Patient Quality of Care Assessments|2288 unique patients assessed overall (at any time point) by end of study.|2288
7788423|NCT01269736|19173075|P1|COMPLETED|Patient Quality of Care Assessments|2299 unique patients assessed overall (at any time point) by end of study.|2299
7788424|NCT01269736|19173074|P2|30 Months Assessment|Patient Quality of Care Assessments|626 unique patients, assessed at 7 hospitals.|626
7788425|NCT01269736|19173075|P1|30 Months Assessment|Patient Quality of Care Assessments|697 unique patients, assessed at 8 hospitals.|697
7788426|NCT01269736|19173074|P2|15 Months Assessment|Patient Quality of Care Assessments|773 unique patients, assessed at 8 hospitals.|773
7788427|NCT01269736|19173075|P1|15 Months Assessment|Patient Quality of Care Assessments|687 unique patients, assessed at 8 hospitals.|687
7788428|NCT01269736|19173074|P2|Baseline Assessment|Patient Quality of Care Assessments|889 unique patients, assessed at 8 hospitals.|889
7788429|NCT01269736|19173075|P1|Baseline Assessment|Patient Quality of Care Assessments|915 unique patients, assessed at 9 hospitals.|915
7788430|NCT01269736|19173074|P2|STARTED|Patient Quality of Care Assessments|889 unique patients were assessed at 8 hospitals at the initiation of the study.|2288
7788431|NCT01269736|19173075|P1|STARTED|Patient Quality of Care Assessments|915 unique patients were assessed at 9 hospitals at the initiation of the study.|2299
7788432|NCT01269736|19173074|P2|NOT COMPLETED|Nurses' Knowledge Assessments||0
7788433|NCT01269736|19173075|P1|NOT COMPLETED|Nurses' Knowledge Assessments||0
7788434|NCT01269736|19173074|P2|COMPLETED|Nurses' Knowledge Assessments|1428 unique nurses assessed overall (at any time point) by end of study.|1428
7788435|NCT01269736|19173075|P1|COMPLETED|Nurses' Knowledge Assessments|1585 unique nurses assessed overall (at any time point) by end of study.|1585
7788436|NCT01269736|19173074|P2|30 Months Assessment|Nurses' Knowledge Assessments|926 unique nurses, assessed at 8 hospitals.|926
7788437|NCT01269736|19173075|P1|30 Months Assessment|Nurses' Knowledge Assessments|741 unique nurses, assessed at 8 hospitals.|741
7788438|NCT01269736|19173074|P2|15 Months Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|782
7788439|NCT01269736|19173075|P1|15 Months Assessment|Nurses' Knowledge Assessments|1108 unique nurses, assessed at 9 hospitals.|1108
7788440|NCT01269736|19173074|P2|Baseline Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|866
7788441|NCT01269736|19173075|P1|Baseline Assessment|Nurses' Knowledge Assessments|873 unique nurses, assessed at 9 hospitals.|873
7788616|NCT01267864|19173430|P2|STARTED|Overall Study||110
7788442|NCT01269736|19173074|P2|STARTED|Nurses' Knowledge Assessments|866 unique nurses were assessed at 8 hospitals at the initiation of the study.|1428
7788443|NCT01269736|19173075|P1|STARTED|Nurses' Knowledge Assessments|873 unique nurses were assessed at 9 hospitals at the initiation of the study.|1585
7788444|NCT01269710|19173087|P1|NOT COMPLETED|Overall Study||3
7788445|NCT01269710|19173087|P1|COMPLETED|Overall Study|This refers to Week 52.|1
7788446|NCT01269710|19173087|P1|Week 36|Overall Study||2
7788447|NCT01269710|19173087|P1|Week 12|Overall Study||3
7788448|NCT01269710|19173087|P1|STARTED|Overall Study||4
7788449|NCT01269385|19173095|P4|NOT COMPLETED|Overall Study||0
7788450|NCT01269385|19173096|P3|NOT COMPLETED|Overall Study||0
7788451|NCT01269385|19173097|P2|NOT COMPLETED|Overall Study||1
7788452|NCT01269385|19173098|P1|NOT COMPLETED|Overall Study||1
7788453|NCT01269385|19173095|P4|COMPLETED|Overall Study||8
7788454|NCT01269385|19173096|P3|COMPLETED|Overall Study||6
7788455|NCT01269385|19173097|P2|COMPLETED|Overall Study||3
7788456|NCT01269385|19173098|P1|COMPLETED|Overall Study||3
7788457|NCT01269385|19173095|P4|STARTED|Overall Study||8
7788458|NCT01269385|19173096|P3|STARTED|Overall Study||6
7788459|NCT01269385|19173097|P2|STARTED|Overall Study||4
7788460|NCT01269385|19173098|P1|STARTED|Overall Study||4
7788461|NCT01269372|19173112|P1|NOT COMPLETED|Overall Study||0
7788462|NCT01269372|19173112|P1|COMPLETED|Overall Study||30
7788463|NCT01269372|19173112|P1|STARTED|Overall Study||30
7788464|NCT01269346|19173123|P1|NOT COMPLETED|Extension Phase||43
7788465|NCT01269346|19173123|P1|COMPLETED|Extension Phase||0
7788466|NCT01269346|19173123|P1|STARTED|Extension Phase|Out of 52 participants randomized, only 43 continued into the Extension Phase of the study.|43
7788467|NCT01269346|19173123|P1|NOT COMPLETED|Treatment Phase||9
7788468|NCT01269346|19173123|P1|COMPLETED|Treatment Phase||43
7788469|NCT01269346|19173123|P1|Completed 6 Cycles|Treatment Phase||45
7788470|NCT01269346|19173123|P1|STARTED|Treatment Phase||52
7788471|NCT01269125|19173134|P3|NOT COMPLETED|Overall Study||0
7788472|NCT01269125|19173135|P2|NOT COMPLETED|Overall Study||5
7788473|NCT01269125|19173136|P1|NOT COMPLETED|Overall Study||7
7788474|NCT01269125|19173134|P3|COMPLETED|Overall Study||60
7788475|NCT01269125|19173135|P2|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55
7788476|NCT01269125|19173136|P1|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53
7788477|NCT01269125|19173134|P3|STARTED|Overall Study||60
7788478|NCT01269125|19173135|P2|STARTED|Overall Study||60
7788479|NCT01269125|19173136|P1|STARTED|Overall Study||60
7788480|NCT01269047|19173159|P3|NOT COMPLETED|Overall Study||1
7788481|NCT01269047|19173160|P2|NOT COMPLETED|Overall Study||2
7788482|NCT01269047|19173161|P1|NOT COMPLETED|Overall Study||1
7788483|NCT01269047|19173159|P3|COMPLETED|Overall Study||10
7788484|NCT01269047|19173160|P2|COMPLETED|Overall Study||11
7788485|NCT01269047|19173161|P1|COMPLETED|Overall Study||12
7788486|NCT01269047|19173159|P3|STARTED|Overall Study||11
7788487|NCT01269047|19173160|P2|STARTED|Overall Study||13
7788488|NCT01269047|19173161|P1|STARTED|Overall Study||13
7788489|NCT01268943|19173180|P4|NOT COMPLETED|Overall Study||0
7788490|NCT01268943|19173181|P3|NOT COMPLETED|Overall Study||0
7788491|NCT01268943|19173182|P2|NOT COMPLETED|Overall Study||0
7788492|NCT01268943|19173183|P1|NOT COMPLETED|Overall Study||0
7788493|NCT01268943|19173180|P4|COMPLETED|Overall Study||6
7788494|NCT01268943|19173181|P3|COMPLETED|Overall Study||3
7788495|NCT01268943|19173182|P2|COMPLETED|Overall Study||3
7788496|NCT01268943|19173183|P1|COMPLETED|Overall Study||6
7788497|NCT01268943|19173180|P4|STARTED|Overall Study||6
7788498|NCT01268943|19173181|P3|STARTED|Overall Study||3
7788499|NCT01268943|19173182|P2|STARTED|Overall Study||3
7788500|NCT01268943|19173183|P1|STARTED|Overall Study||6
7788501|NCT01268891|19173195|P2|NOT COMPLETED|Overall Study||8
7788502|NCT01268891|19173196|P1|NOT COMPLETED|Overall Study||8
7788503|NCT01268891|19173195|P2|COMPLETED|Overall Study||58
7788504|NCT01268891|19173196|P1|COMPLETED|Overall Study||58
7788505|NCT01268891|19173195|P2|STARTED|Overall Study||66
7788506|NCT01268891|19173196|P1|STARTED|Overall Study||66
7788507|NCT01268683|19173208|P1|NOT COMPLETED|Overall Study||0
7788508|NCT01268683|19173208|P1|COMPLETED|Overall Study||10
7788509|NCT01268683|19173208|P1|STARTED|Overall Study||10
7788510|NCT01268644|19173215|P1|NOT COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||0
7788511|NCT01268644|19173215|P1|COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||7
7788512|NCT01268644|19173215|P1|STARTED|Phase C (Weeks 20-24) Off Leptin Therapy||7
7788513|NCT01268644|19173215|P1|NOT COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||0
7788514|NCT01268644|19173215|P1|COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||7
7788515|NCT01268644|19173215|P1|STARTED|Phase B (Weeks 12-20) Leptin Therapy|One subject withdrew after 12 weeks .|7
7788516|NCT01268644|19173215|P1|NOT COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||0
7788517|NCT01268644|19173215|P1|COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||8
7788518|NCT01268644|19173215|P1|STARTED|Phase A (Weeks 0-12) Leptin Therapy||8
7788519|NCT01268644|19173215|P1|NOT COMPLETED|Baseline Period (Week 0)||0
7788520|NCT01268644|19173215|P1|COMPLETED|Baseline Period (Week 0)||8
7788521|NCT01268644|19173215|P1|STARTED|Baseline Period (Week 0)||8
7788522|NCT01268566|19173222|P1|NOT COMPLETED|Overall Study||43
7788523|NCT01268566|19173222|P1|COMPLETED|Overall Study||13
7788524|NCT01268566|19173222|P1|STARTED|Overall Study||56
7788525|NCT01268553|19173240|P1|NOT COMPLETED|Overall Study||0
7788526|NCT01268553|19173240|P1|COMPLETED|Overall Study||6
7788527|NCT01268553|19173240|P1|STARTED|Overall Study||6
7788528|NCT01268514|19173249|P1|NOT COMPLETED|Overall Study||41
7788529|NCT01268514|19173249|P1|COMPLETED|Overall Study||74
7788530|NCT01268514|19173249|P1|Participants Who Received the Device|Overall Study||114
7788531|NCT01268514|19173249|P1|STARTED|Overall Study||115
7788532|NCT01268501|19173258|P1|NOT COMPLETED|Overall Study||9
7788533|NCT01268501|19173258|P1|COMPLETED|Overall Study||87
7788534|NCT01268501|19173258|P1|STARTED|Overall Study||96
7788535|NCT01268488|19173262|P1|NOT COMPLETED|Overall Study||5
7788536|NCT01268488|19173262|P1|COMPLETED|Overall Study||93
7788537|NCT01268488|19173262|P1|STARTED|Overall Study||98
7788538|NCT01268306|19173269|P1|NOT COMPLETED|Overall Study||1
7788539|NCT01268306|19173269|P1|COMPLETED|Overall Study||7
7788540|NCT01268306|19173269|P1|STARTED|Overall Study||8
7788541|NCT01268293|19173273|P1|NOT COMPLETED|Overall Study||9
7788542|NCT01268293|19173273|P1|COMPLETED|Overall Study||0
7788543|NCT01268293|19173273|P1|Completed Cycle 1|Overall Study||9
7788544|NCT01268293|19173273|P1|STARTED|Overall Study||9
7788545|NCT01268267|19173278|P1|NOT COMPLETED|Overall Study||1
7788546|NCT01268267|19173278|P1|COMPLETED|Overall Study||93
7788547|NCT01268267|19173278|P1|STARTED|Overall Study||94
7788548|NCT01268189|19173285|P1|NOT COMPLETED|Overall Study||3
7788549|NCT01268189|19173285|P1|COMPLETED|Overall Study||17
7788550|NCT01268189|19173285|P1|STARTED|Overall Study||20
7788551|NCT01268150|19173299|P1|NOT COMPLETED|Extension Phase||27
7788552|NCT01268150|19173299|P1|COMPLETED|Extension Phase||1
7788553|NCT01268150|19173299|P1|Treatment Ongoing at Data Cutoff Date|Extension Phase||1
7788554|NCT01268150|19173299|P1|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28
7788555|NCT01268150|19173299|P1|NOT COMPLETED|Treatment Phase||28
7788556|NCT01268150|19173299|P1|COMPLETED|Treatment Phase||28
7788557|NCT01268150|19173299|P1|STARTED|Treatment Phase||56
7788558|NCT01268111|19173309|P2|NOT COMPLETED|Overall Study||0
7788559|NCT01268111|19173310|P1|NOT COMPLETED|Overall Study||0
7788560|NCT01268111|19173309|P2|COMPLETED|Overall Study||6
7788561|NCT01268111|19173310|P1|COMPLETED|Overall Study||6
7788562|NCT01268111|19173309|P2|STARTED|Overall Study||6
7788563|NCT01268111|19173310|P1|STARTED|Overall Study||6
7788564|NCT01268098|19173318|P2|NOT COMPLETED|Overall Study||0
7788565|NCT01268098|19173319|P1|NOT COMPLETED|Overall Study||1
7788566|NCT01268098|19173318|P2|COMPLETED|Overall Study||23
7788567|NCT01268098|19173319|P1|COMPLETED|Overall Study||18
7788568|NCT01268098|19173318|P2|STARTED|Overall Study||23
7788569|NCT01268098|19173319|P1|STARTED|Overall Study||19
7788570|NCT01268059|19173331|P4|NOT COMPLETED|Overall Study||5
7788571|NCT01268059|19173332|P3|NOT COMPLETED|Overall Study||3
7788572|NCT01268059|19173333|P2|NOT COMPLETED|Overall Study||35
7788573|NCT01268059|19173334|P1|NOT COMPLETED|Overall Study||28
7788574|NCT01268059|19173331|P4|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3
7788575|NCT01268059|19173332|P3|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3
7788576|NCT01268059|19173333|P2|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|10
7788577|NCT01268059|19173334|P1|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|12
7788578|NCT01268059|19173331|P4|STARTED|Overall Study||8
7788579|NCT01268059|19173332|P3|STARTED|Overall Study||6
7788580|NCT01268059|19173333|P2|STARTED|Overall Study|Arm applicable for both dose-determination (Phase 1b) and randomization phase (Phase 2) of study.|45
7788581|NCT01268059|19173334|P1|STARTED|Overall Study||40
7788582|NCT01268046|19173395|P4|NOT COMPLETED|Overall Study||1
7788583|NCT01268046|19173396|P3|NOT COMPLETED|Overall Study||1
7788584|NCT01268046|19173397|P2|NOT COMPLETED|Overall Study||0
7788585|NCT01268046|19173398|P1|NOT COMPLETED|Overall Study||1
7788586|NCT01268046|19173395|P4|COMPLETED|Overall Study||7
7788587|NCT01268046|19173396|P3|COMPLETED|Overall Study||7
7788588|NCT01268046|19173397|P2|COMPLETED|Overall Study||9
7788589|NCT01268046|19173398|P1|COMPLETED|Overall Study||12
7788590|NCT01268046|19173395|P4|STARTED|Overall Study||8
7788591|NCT01268046|19173396|P3|STARTED|Overall Study||8
7788592|NCT01268046|19173397|P2|STARTED|Overall Study||9
7788593|NCT01268046|19173398|P1|STARTED|Overall Study||13
7788594|NCT01267994|19173408|P1|NOT COMPLETED|Overall Study||2
7788595|NCT01267994|19173408|P1|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10
7788596|NCT01267994|19173408|P1|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12
7788597|NCT01267955|19173413|P1|NOT COMPLETED|Stage 2 (6 Months)||6
7788598|NCT01267955|19173413|P1|COMPLETED|Stage 2 (6 Months)||39
7788599|NCT01267955|19173413|P1|STARTED|Stage 2 (6 Months)||45
7788600|NCT01267955|19173413|P1|NOT COMPLETED|Stage 1 (6 Months)||3
7788601|NCT01267955|19173413|P1|COMPLETED|Stage 1 (6 Months)||17
7788602|NCT01267955|19173413|P1|STARTED|Stage 1 (6 Months)||20
7788603|NCT01267929|19173419|P2|NOT COMPLETED|Overall Study||0
7788604|NCT01267929|19173420|P1|NOT COMPLETED|Overall Study||0
7788605|NCT01267929|19173419|P2|COMPLETED|Overall Study||15
7788606|NCT01267929|19173420|P1|COMPLETED|Overall Study||15
7788607|NCT01267929|19173419|P2|STARTED|Overall Study||15
7788608|NCT01267929|19173420|P1|STARTED|Overall Study||15
7788609|NCT01267864|19173429|P3|NOT COMPLETED|Overall Study||0
7788610|NCT01267864|19173430|P2|NOT COMPLETED|Overall Study||0
7788611|NCT01267864|19173431|P1|NOT COMPLETED|Overall Study||0
7788612|NCT01267864|19173429|P3|COMPLETED|Overall Study||110
7788613|NCT01267864|19173430|P2|COMPLETED|Overall Study||110
7788614|NCT01267864|19173431|P1|COMPLETED|Overall Study||110
7788615|NCT01267864|19173429|P3|STARTED|Overall Study||110
7788617|NCT01267864|19173431|P1|STARTED|Overall Study||110
7788618|NCT01267825|19173450|P2|NOT COMPLETED|Overall Study||0
7788619|NCT01267825|19173451|P1|NOT COMPLETED|Overall Study||1
7788620|NCT01267825|19173450|P2|COMPLETED|Overall Study||0
7788621|NCT01267825|19173451|P1|COMPLETED|Overall Study||0
7788622|NCT01267825|19173450|P2|STARTED|Overall Study||0
7788623|NCT01267825|19173451|P1|STARTED|Overall Study||1
7788624|NCT01267656|19173461|P2|NOT COMPLETED|Overall Study||1
7788625|NCT01267656|19173462|P1|NOT COMPLETED|Overall Study||1
7788626|NCT01267656|19173461|P2|COMPLETED|Overall Study||82
7788627|NCT01267656|19173462|P1|COMPLETED|Overall Study||82
7788628|NCT01267656|19173461|P2|STARTED|Overall Study||83
7788629|NCT01267656|19173462|P1|STARTED|Overall Study||83
7788630|NCT01267422|19173468|P2|NOT COMPLETED|Safety and Efficacy Study||0
7788631|NCT01267422|19173469|P1|NOT COMPLETED|Safety and Efficacy Study||0
7788632|NCT01267422|19173468|P2|COMPLETED|Safety and Efficacy Study||4
7788633|NCT01267422|19173469|P1|COMPLETED|Safety and Efficacy Study||5
7788634|NCT01267422|19173468|P2|STARTED|Safety and Efficacy Study||4
7788635|NCT01267422|19173469|P1|STARTED|Safety and Efficacy Study||5
7788636|NCT01267422|19173468|P2|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
7788637|NCT01267422|19173469|P1|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
7788638|NCT01267422|19173468|P2|COMPLETED|Intravitreal rAAV2-ND4 Injection||4
7788639|NCT01267422|19173469|P1|COMPLETED|Intravitreal rAAV2-ND4 Injection||5
7788640|NCT01267422|19173468|P2|STARTED|Intravitreal rAAV2-ND4 Injection||4
7788641|NCT01267422|19173469|P1|STARTED|Intravitreal rAAV2-ND4 Injection||5
7788642|NCT01267292|19173489|P2|NOT COMPLETED|Overall Study||6
7788643|NCT01267292|19173490|P1|NOT COMPLETED|Overall Study||4
7788644|NCT01267292|19173489|P2|COMPLETED|Overall Study||20
7788645|NCT01267292|19173490|P1|COMPLETED|Overall Study||20
7788646|NCT01267292|19173489|P2|STARTED|Overall Study||26
7788647|NCT01267292|19173490|P1|STARTED|Overall Study||24
7788648|NCT01267279|19173526|P2|NOT COMPLETED|Overall Study||6
7788649|NCT01267279|19173527|P1|NOT COMPLETED|Overall Study||2
7788650|NCT01267279|19173526|P2|COMPLETED|Overall Study||21
7788651|NCT01267279|19173527|P1|COMPLETED|Overall Study||22
7788652|NCT01267279|19173526|P2|STARTED|Overall Study||27
7788653|NCT01267279|19173527|P1|STARTED|Overall Study||24
7788654|NCT01267266|19173533|P2|NOT COMPLETED|Randomized Phase||0
7788655|NCT01267266|19173534|P1|NOT COMPLETED|Randomized Phase||0
7788656|NCT01267266|19173533|P2|COMPLETED|Randomized Phase||5
7788657|NCT01267266|19173534|P1|COMPLETED|Randomized Phase||3
7788658|NCT01267266|19173533|P2|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5
7788659|NCT01267266|19173534|P1|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3
7788660|NCT01267266|19173533|P2|NOT COMPLETED|Lead-in Phase||0
7788661|NCT01267266|19173534|P1|NOT COMPLETED|Lead-in Phase||23
7788662|NCT01267266|19173533|P2|COMPLETED|Lead-in Phase||0
7788663|NCT01267266|19173534|P1|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8
7788664|NCT01267266|19173533|P2|STARTED|Lead-in Phase||0
7788665|NCT01267266|19173534|P1|STARTED|Lead-in Phase||31
7788666|NCT01267266|19173533|P2|NOT COMPLETED|Enrollment Phase||0
7788667|NCT01267266|19173534|P1|NOT COMPLETED|Enrollment Phase||2
7788668|NCT01267266|19173533|P2|COMPLETED|Enrollment Phase||0
7788669|NCT01267266|19173534|P1|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31
7788670|NCT01267266|19173533|P2|STARTED|Enrollment Phase||0
7788671|NCT01267266|19173534|P1|STARTED|Enrollment Phase||33
7788672|NCT01267253|19173547|P1|NOT COMPLETED|Overall Study||3
7788673|NCT01267253|19173547|P1|COMPLETED|Overall Study|Eligible and treated patients|28
7788674|NCT01267253|19173547|P1|STARTED|Overall Study||31
7788675|NCT01267240|19173555|P1|NOT COMPLETED|Overall Study||0
7788676|NCT01267240|19173555|P1|COMPLETED|Overall Study||25
7788677|NCT01267240|19173555|P1|STARTED|Overall Study||25
7788678|NCT01267227|19173565|P4|NOT COMPLETED|Overall Study||3
7788679|NCT01267227|19173566|P3|NOT COMPLETED|Overall Study||2
7788680|NCT01267227|19173567|P2|NOT COMPLETED|Overall Study||1
7788681|NCT01267227|19173568|P1|NOT COMPLETED|Overall Study||1
7788682|NCT01267227|19173565|P4|COMPLETED|Overall Study||17
7788683|NCT01267227|19173566|P3|COMPLETED|Overall Study||18
7788684|NCT01267227|19173567|P2|COMPLETED|Overall Study||19
7788685|NCT01267227|19173568|P1|COMPLETED|Overall Study||19
7788686|NCT01267227|19173565|P4|STARTED|Overall Study||20
7788687|NCT01267227|19173566|P3|STARTED|Overall Study||20
7788688|NCT01267227|19173567|P2|STARTED|Overall Study||20
7788689|NCT01267227|19173568|P1|STARTED|Overall Study||20
7788690|NCT01267201|19173586|P6|NOT COMPLETED|Third Intervention Period||0
7788691|NCT01267201|19173587|P5|NOT COMPLETED|Third Intervention Period||0
7788692|NCT01267201|19173588|P4|NOT COMPLETED|Third Intervention Period||0
7788693|NCT01267201|19173589|P3|NOT COMPLETED|Third Intervention Period||0
7788694|NCT01267201|19173590|P2|NOT COMPLETED|Third Intervention Period||0
7788695|NCT01267201|19173591|P1|NOT COMPLETED|Third Intervention Period||0
7788696|NCT01267201|19173586|P6|COMPLETED|Third Intervention Period||4
7788697|NCT01267201|19173587|P5|COMPLETED|Third Intervention Period||4
7788698|NCT01267201|19173588|P4|COMPLETED|Third Intervention Period||4
7788699|NCT01267201|19173589|P3|COMPLETED|Third Intervention Period||4
7788700|NCT01267201|19173590|P2|COMPLETED|Third Intervention Period||3
7788701|NCT01267201|19173591|P1|COMPLETED|Third Intervention Period||3
7788702|NCT01267201|19173586|P6|STARTED|Third Intervention Period||4
7788703|NCT01267201|19173587|P5|STARTED|Third Intervention Period||4
7788704|NCT01267201|19173588|P4|STARTED|Third Intervention Period||4
7788705|NCT01267201|19173589|P3|STARTED|Third Intervention Period||4
7788706|NCT01267201|19173590|P2|STARTED|Third Intervention Period||3
7788707|NCT01267201|19173591|P1|STARTED|Third Intervention Period||3
7788708|NCT01267201|19173586|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
7788709|NCT01267201|19173587|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
7788710|NCT01267201|19173588|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
7788711|NCT01267201|19173589|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
7788712|NCT01267201|19173590|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
7788713|NCT01267201|19173591|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
7788714|NCT01267201|19173586|P6|COMPLETED|Washout Period (At Least 2 Days)||4
7788715|NCT01267201|19173587|P5|COMPLETED|Washout Period (At Least 2 Days)||4
7788716|NCT01267201|19173588|P4|COMPLETED|Washout Period (At Least 2 Days)||4
7788717|NCT01267201|19173589|P3|COMPLETED|Washout Period (At Least 2 Days)||4
7788718|NCT01267201|19173590|P2|COMPLETED|Washout Period (At Least 2 Days)||3
7788719|NCT01267201|19173591|P1|COMPLETED|Washout Period (At Least 2 Days)||3
7788720|NCT01267201|19173586|P6|STARTED|Washout Period (At Least 2 Days)||4
7788721|NCT01267201|19173587|P5|STARTED|Washout Period (At Least 2 Days)||4
7788722|NCT01267201|19173588|P4|STARTED|Washout Period (At Least 2 Days)||4
7788723|NCT01267201|19173589|P3|STARTED|Washout Period (At Least 2 Days)||4
7788724|NCT01267201|19173590|P2|STARTED|Washout Period (At Least 2 Days)||3
7788725|NCT01267201|19173591|P1|STARTED|Washout Period (At Least 2 Days)||3
7788726|NCT01267201|19173586|P6|NOT COMPLETED|Second Intervention Period||0
7788727|NCT01267201|19173587|P5|NOT COMPLETED|Second Intervention Period||0
7788728|NCT01267201|19173588|P4|NOT COMPLETED|Second Intervention Period||0
7788729|NCT01267201|19173589|P3|NOT COMPLETED|Second Intervention Period||0
7788730|NCT01267201|19173590|P2|NOT COMPLETED|Second Intervention Period||1
7788731|NCT01267201|19173591|P1|NOT COMPLETED|Second Intervention Period||0
7788732|NCT01267201|19173586|P6|COMPLETED|Second Intervention Period||4
7788733|NCT01267201|19173587|P5|COMPLETED|Second Intervention Period||4
7788734|NCT01267201|19173588|P4|COMPLETED|Second Intervention Period||4
7788735|NCT01267201|19173589|P3|COMPLETED|Second Intervention Period||4
7788736|NCT01267201|19173590|P2|COMPLETED|Second Intervention Period||3
7788737|NCT01267201|19173591|P1|COMPLETED|Second Intervention Period||3
7788738|NCT01267201|19173586|P6|STARTED|Second Intervention Period||4
7788739|NCT01267201|19173587|P5|STARTED|Second Intervention Period||4
7788740|NCT01267201|19173588|P4|STARTED|Second Intervention Period||4
7788741|NCT01267201|19173589|P3|STARTED|Second Intervention Period||4
7788742|NCT01267201|19173590|P2|STARTED|Second Intervention Period||4
7788743|NCT01267201|19173591|P1|STARTED|Second Intervention Period||3
7788744|NCT01267201|19173586|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
7788745|NCT01267201|19173587|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
7788746|NCT01267201|19173588|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
7788747|NCT01267201|19173589|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
7788748|NCT01267201|19173590|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
7788749|NCT01267201|19173591|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
7788750|NCT01267201|19173586|P6|COMPLETED|Washout Period (At Least 2 Days)||4
7788751|NCT01267201|19173587|P5|COMPLETED|Washout Period (At Least 2 Days)||4
7788752|NCT01267201|19173588|P4|COMPLETED|Washout Period (At Least 2 Days)||4
7788753|NCT01267201|19173589|P3|COMPLETED|Washout Period (At Least 2 Days)||4
7788754|NCT01267201|19173590|P2|COMPLETED|Washout Period (At Least 2 Days)||4
7788755|NCT01267201|19173591|P1|COMPLETED|Washout Period (At Least 2 Days)||3
7788756|NCT01267201|19173586|P6|STARTED|Washout Period (At Least 2 Days)||4
7788757|NCT01267201|19173587|P5|STARTED|Washout Period (At Least 2 Days)||4
7788758|NCT01267201|19173588|P4|STARTED|Washout Period (At Least 2 Days)||4
7788759|NCT01267201|19173589|P3|STARTED|Washout Period (At Least 2 Days)||4
7788760|NCT01267201|19173590|P2|STARTED|Washout Period (At Least 2 Days)||4
7788761|NCT01267201|19173591|P1|STARTED|Washout Period (At Least 2 Days)||3
7788762|NCT01267201|19173586|P6|NOT COMPLETED|First Intervention Period||0
7788763|NCT01267201|19173587|P5|NOT COMPLETED|First Intervention Period||0
7788764|NCT01267201|19173588|P4|NOT COMPLETED|First Intervention Period||0
7788765|NCT01267201|19173589|P3|NOT COMPLETED|First Intervention Period||0
7788766|NCT01267201|19173590|P2|NOT COMPLETED|First Intervention Period||0
7788767|NCT01267201|19173591|P1|NOT COMPLETED|First Intervention Period||1
7788768|NCT01267201|19173586|P6|COMPLETED|First Intervention Period||4
7788769|NCT01267201|19173587|P5|COMPLETED|First Intervention Period||4
7788770|NCT01267201|19173588|P4|COMPLETED|First Intervention Period||4
7788771|NCT01267201|19173589|P3|COMPLETED|First Intervention Period||4
7788772|NCT01267201|19173590|P2|COMPLETED|First Intervention Period||4
7788773|NCT01267201|19173591|P1|COMPLETED|First Intervention Period||3
7788774|NCT01267201|19173586|P6|STARTED|First Intervention Period||4
7788775|NCT01267201|19173587|P5|STARTED|First Intervention Period||4
7788776|NCT01267201|19173588|P4|STARTED|First Intervention Period||4
7788777|NCT01267201|19173589|P3|STARTED|First Intervention Period||4
7788778|NCT01267201|19173590|P2|STARTED|First Intervention Period||4
7788779|NCT01267201|19173591|P1|STARTED|First Intervention Period||4
7788780|NCT01267175|19173608|P1|NOT COMPLETED|Overall Study||2
7788781|NCT01267175|19173608|P1|COMPLETED|Overall Study||29
7788782|NCT01267175|19173608|P1|STARTED|Overall Study||31
7788783|NCT01267136|19173615|P2|NOT COMPLETED|Overall Study||6
7788784|NCT01267136|19173616|P1|NOT COMPLETED|Overall Study||4
7788785|NCT01267136|19173615|P2|COMPLETED|Overall Study||36
7788786|NCT01267136|19173616|P1|COMPLETED|Overall Study||38
7788787|NCT01267136|19173615|P2|STARTED|Overall Study||42
7788788|NCT01267136|19173616|P1|STARTED|Overall Study||42
7788789|NCT01267045|19173626|P2|NOT COMPLETED|6-month Outcome||3
7788790|NCT01267045|19173627|P1|NOT COMPLETED|6-month Outcome||0
7788791|NCT01267045|19173626|P2|COMPLETED|6-month Outcome||23
7788792|NCT01267045|19173627|P1|COMPLETED|6-month Outcome||22
7788793|NCT01267045|19173626|P2|STARTED|6-month Outcome||26
7788794|NCT01267045|19173627|P1|STARTED|6-month Outcome||22
7788795|NCT01267045|19173626|P2|NOT COMPLETED|2-month Outcomes||3
7788796|NCT01267045|19173627|P1|NOT COMPLETED|2-month Outcomes||4
7788797|NCT01267045|19173626|P2|COMPLETED|2-month Outcomes||26
7788798|NCT01267045|19173627|P1|COMPLETED|2-month Outcomes||22
7788799|NCT01267045|19173626|P2|STARTED|2-month Outcomes||29
7788800|NCT01267045|19173627|P1|STARTED|2-month Outcomes||26
7788801|NCT01267019|19173662|P3|NOT COMPLETED|Overall Study||6
7788802|NCT01267019|19173663|P2|NOT COMPLETED|Overall Study||6
7788803|NCT01267019|19173664|P1|NOT COMPLETED|Overall Study||6
7788804|NCT01267019|19173662|P3|COMPLETED|Overall Study||47
7788805|NCT01267019|19173663|P2|COMPLETED|Overall Study||47
7788806|NCT01267019|19173664|P1|COMPLETED|Overall Study||41
7788807|NCT01267019|19173662|P3|STARTED|Overall Study||53
7788808|NCT01267019|19173663|P2|STARTED|Overall Study||53
7788809|NCT01267019|19173664|P1|STARTED|Overall Study||47
7788810|NCT01266993|19173680|P2|NOT COMPLETED|Booster Phase (Month 68-69)||2
7788811|NCT01266993|19173681|P1|NOT COMPLETED|Booster Phase (Month 68-69)||5
7788812|NCT01266993|19173680|P2|COMPLETED|Booster Phase (Month 68-69)||60
7788813|NCT01266993|19173681|P1|COMPLETED|Booster Phase (Month 68-69)||174
7788814|NCT01266993|19173680|P2|STARTED|Booster Phase (Month 68-69)||62
7788815|NCT01266993|19173681|P1|STARTED|Booster Phase (Month 68-69)||179
7788816|NCT01266993|19173680|P2|NOT COMPLETED|Persistence Phase (Month 56-68)||0
7788817|NCT01266993|19173681|P1|NOT COMPLETED|Persistence Phase (Month 56-68)||0
7788818|NCT01266993|19173680|P2|COMPLETED|Persistence Phase (Month 56-68)||67
7788819|NCT01266993|19173681|P1|COMPLETED|Persistence Phase (Month 56-68)||193
7788820|NCT01266993|19173680|P2|STARTED|Persistence Phase (Month 56-68)||67
7788821|NCT01266993|19173681|P1|STARTED|Persistence Phase (Month 56-68)||193
7788822|NCT01266993|19173680|P2|NOT COMPLETED|Persistence Phase (Month 44-56)||0
7788823|NCT01266993|19173681|P1|NOT COMPLETED|Persistence Phase (Month 44-56)||0
7788824|NCT01266993|19173680|P2|COMPLETED|Persistence Phase (Month 44-56)||68
7788825|NCT01266993|19173681|P1|COMPLETED|Persistence Phase (Month 44-56)||193
7788826|NCT01266993|19173680|P2|STARTED|Persistence Phase (Month 44-56)||68
7788827|NCT01266993|19173681|P1|STARTED|Persistence Phase (Month 44-56)||193
7788828|NCT01266993|19173680|P2|NOT COMPLETED|Persistence Phase (Month 32-44)||0
7788829|NCT01266993|19173681|P1|NOT COMPLETED|Persistence Phase (Month 32-44)||0
7788830|NCT01266993|19173680|P2|COMPLETED|Persistence Phase (Month 32-44)||72
7788831|NCT01266993|19173681|P1|COMPLETED|Persistence Phase (Month 32-44)||199
7788832|NCT01266993|19173680|P2|STARTED|Persistence Phase (Month 32-44)||72
7788833|NCT01266993|19173681|P1|STARTED|Persistence Phase (Month 32-44)||199
7788834|NCT01266967|19173751|P2|NOT COMPLETED|Overall Study||83
7788835|NCT01266967|19173752|P1|NOT COMPLETED|Overall Study||89
7788836|NCT01266967|19173751|P2|COMPLETED|Overall Study||0
7788837|NCT01266967|19173752|P1|COMPLETED|Overall Study||0
7788838|NCT01266967|19173751|P2|STARTED|Overall Study||83
7788839|NCT01266967|19173752|P1|STARTED|Overall Study||89
7788840|NCT01266876|19173804|P5|NOT COMPLETED|Overall Study||0
7788841|NCT01266876|19173805|P4|NOT COMPLETED|Overall Study||1
7788842|NCT01266876|19173806|P3|NOT COMPLETED|Overall Study||0
7788843|NCT01266876|19173807|P2|NOT COMPLETED|Overall Study||0
7788844|NCT01266876|19173808|P1|NOT COMPLETED|Overall Study||0
7788845|NCT01266876|19173804|P5|COMPLETED|Overall Study||16
7788846|NCT01266876|19173805|P4|COMPLETED|Overall Study||14
7788847|NCT01266876|19173806|P3|COMPLETED|Overall Study||16
7788848|NCT01266876|19173807|P2|COMPLETED|Overall Study||15
7788849|NCT01266876|19173808|P1|COMPLETED|Overall Study||15
7788850|NCT01266876|19173804|P5|STARTED|Overall Study||16
7788851|NCT01266876|19173805|P4|STARTED|Overall Study||15
7788852|NCT01266876|19173806|P3|STARTED|Overall Study||16
7788853|NCT01266876|19173807|P2|STARTED|Overall Study||15
7788854|NCT01266876|19173808|P1|STARTED|Overall Study||15
7788855|NCT01266850|19173915|P5|NOT COMPLETED|Overall Study||30
7788856|NCT01266850|19173916|P4|NOT COMPLETED|Overall Study||28
7788857|NCT01266850|19173917|P3|NOT COMPLETED|Overall Study||24
7788858|NCT01266850|19173918|P2|NOT COMPLETED|Overall Study||36
7788859|NCT01266850|19173919|P1|NOT COMPLETED|Overall Study||30
7788860|NCT01266850|19173915|P5|COMPLETED|Overall Study||297
7788861|NCT01266850|19173916|P4|COMPLETED|Overall Study||301
7788862|NCT01266850|19173917|P3|COMPLETED|Overall Study||214
7788863|NCT01266850|19173918|P2|COMPLETED|Overall Study||212
7788864|NCT01266850|19173919|P1|COMPLETED|Overall Study||212
7788865|NCT01266850|19173915|P5|Received Third Vaccine|Overall Study||299
7788866|NCT01266850|19173916|P4|Received Third Vaccine|Overall Study||0
7788867|NCT01266850|19173917|P3|Received Third Vaccine|Overall Study||217
7788868|NCT01266850|19173918|P2|Received Third Vaccine|Overall Study||221
7788869|NCT01266850|19173919|P1|Received Third Vaccine|Overall Study||221
7788870|NCT01266850|19173915|P5|Received Second Vaccine|Overall Study||307
7788871|NCT01266850|19173916|P4|Received Second Vaccine|Overall Study||311
7788872|NCT01266850|19173917|P3|Received Second Vaccine|Overall Study||227
7788873|NCT01266850|19173918|P2|Received Second Vaccine|Overall Study||233
7788874|NCT01266850|19173919|P1|Received Second Vaccine|Overall Study||231
7788875|NCT01266850|19173915|P5|STARTED|Overall Study||327
7788876|NCT01266850|19173916|P4|STARTED|Overall Study||329
7788877|NCT01266850|19173917|P3|STARTED|Overall Study||238
7788878|NCT01266850|19173918|P2|STARTED|Overall Study||248
7788879|NCT01266850|19173919|P1|STARTED|Overall Study||242
7788880|NCT01266824|19173973|P2|NOT COMPLETED|Overall Study||3
7788881|NCT01266824|19173974|P1|NOT COMPLETED|Overall Study||2
7788882|NCT01266824|19173973|P2|COMPLETED|Overall Study||0
7788883|NCT01266824|19173974|P1|COMPLETED|Overall Study||0
7788884|NCT01266824|19173973|P2|STARTED|Overall Study||3
7788885|NCT01266824|19173974|P1|STARTED|Overall Study||2
7788886|NCT01266603|19173986|P1|NOT COMPLETED|Overall Study||42
7788887|NCT01266603|19173986|P1|COMPLETED|Overall Study||2
7788888|NCT01266603|19173986|P1|Maintenance Completion|Overall Study||2
7788889|NCT01266603|19173986|P1|Continued to Maintenance- MAGE-A3|Overall Study||4
7788890|NCT01266603|19173986|P1|Patients Evaluable for Response|Overall Study||16
7788891|NCT01266603|19173986|P1|Patients Evaluable for Safety|Overall Study||17
7788892|NCT01266603|19173986|P1|MAGE-A3 Positive Tumor|Overall Study||18
7788893|NCT01266603|19173986|P1|STARTED|Overall Study||44
7788894|NCT01266590|19173992|P1|NOT COMPLETED|Overall Study||6
7788895|NCT01266590|19173992|P1|COMPLETED|Overall Study||24
7788896|NCT01266590|19173992|P1|STARTED|Overall Study||30
7788897|NCT01266460|19174003|P1|NOT COMPLETED|Overall Study||34
7788898|NCT01266460|19174003|P1|COMPLETED|Overall Study||16
7788899|NCT01266460|19174003|P1|STARTED|Overall Study||50
7788900|NCT01266447|19174012|P1|NOT COMPLETED|Overall Study||0
7788901|NCT01266447|19174012|P1|COMPLETED|Overall Study|Eligible and treated patients|27
7788902|NCT01266447|19174012|P1|STARTED|Overall Study||27
7788903|NCT01266317|19174021|P1|NOT COMPLETED|Overall Study||2
7788904|NCT01266317|19174021|P1|COMPLETED|Overall Study||7
7788905|NCT01266317|19174021|P1|STARTED|Overall Study|One additional patient was a protocol violation post consent when autoantibodies returned positive|9
7788906|NCT01266291|19174026|P1|NOT COMPLETED|Overall Study||1
7788907|NCT01266291|19174026|P1|COMPLETED|Overall Study||0
7788908|NCT01266291|19174026|P1|STARTED|Overall Study||1
7788909|NCT01266265|19174033|P2|NOT COMPLETED|Overall Study||190
7788910|NCT01266265|19174034|P1|NOT COMPLETED|Overall Study||205
7788911|NCT01266265|19174033|P2|COMPLETED|Overall Study||477
7788912|NCT01266265|19174034|P1|COMPLETED|Overall Study||461
7788913|NCT01266265|19174033|P2|STARTED|Overall Study||667
7788914|NCT01266265|19174034|P1|STARTED|Overall Study||666
7788915|NCT01266161|19174042|P2|NOT COMPLETED|Overall Study||1
7788916|NCT01266161|19174043|P1|NOT COMPLETED|Overall Study||4
7788917|NCT01266161|19174042|P2|COMPLETED|Overall Study||53
7788918|NCT01266161|19174043|P1|COMPLETED|Overall Study||48
7788919|NCT01266161|19174042|P2|STARTED|Overall Study||54
7788920|NCT01266161|19174043|P1|STARTED|Overall Study||52
7788921|NCT01266148|19174075|P2|NOT COMPLETED|Overall Study||3
7788922|NCT01266148|19174076|P1|NOT COMPLETED|Overall Study||7
7788923|NCT01266148|19174075|P2|COMPLETED|Overall Study||56
7788924|NCT01266148|19174076|P1|COMPLETED|Overall Study||49
7788925|NCT01266148|19174075|P2|STARTED|Overall Study||59
7788926|NCT01266148|19174076|P1|STARTED|Overall Study||56
7788927|NCT01266122|19174104|P2|NOT COMPLETED|Overall Study||6
7788928|NCT01266122|19174105|P1|NOT COMPLETED|Overall Study||6
7788929|NCT01266122|19174104|P2|COMPLETED|Overall Study||42
7788930|NCT01266122|19174105|P1|COMPLETED|Overall Study||42
7788931|NCT01266122|19174104|P2|STARTED|Overall Study||48
7788932|NCT01266122|19174105|P1|STARTED|Overall Study||48
7788933|NCT01266070|19174113|P1|NOT COMPLETED|Overall Study||4
7788934|NCT01266070|19174113|P1|COMPLETED|Overall Study||2
7788935|NCT01266070|19174113|P1|STARTED|Overall Study||6
7788936|NCT01266031|19174121|P3|NOT COMPLETED|Overall Study||2
7788937|NCT01266031|19174122|P2|NOT COMPLETED|Overall Study||3
7788938|NCT01266031|19174123|P1|NOT COMPLETED|Overall Study||0
7788939|NCT01266031|19174121|P3|COMPLETED|Overall Study||47
7788940|NCT01266031|19174122|P2|COMPLETED|Overall Study||38
7788941|NCT01266031|19174123|P1|COMPLETED|Overall Study||6
7788942|NCT01266031|19174121|P3|STARTED|Overall Study||49
7788943|NCT01266031|19174122|P2|STARTED|Overall Study||41
7788944|NCT01266031|19174123|P1|STARTED|Overall Study||6
7788945|NCT01266018|19174150|P2|NOT COMPLETED|Overall Study||1
7788946|NCT01266018|19174151|P1|NOT COMPLETED|Overall Study||1
7788947|NCT01266018|19174150|P2|COMPLETED|Overall Study||12
7788948|NCT01266018|19174151|P1|COMPLETED|Overall Study|Defined as evaluable for the primary endpoint|8
7788949|NCT01266018|19174150|P2|STARTED|Overall Study||13
7788950|NCT01266018|19174151|P1|STARTED|Overall Study||9
7788951|NCT01265992|19174162|P1|NOT COMPLETED|Overall Study||9
7788952|NCT01265992|19174162|P1|COMPLETED|Overall Study||41
7788953|NCT01265992|19174162|P1|Received Treatment|Overall Study||49
7788954|NCT01265992|19174162|P1|STARTED|Overall Study||50
7788955|NCT01265966|19174178|P3|NOT COMPLETED|Overall Study||2
7788956|NCT01265966|19174179|P2|NOT COMPLETED|Overall Study||2
7788957|NCT01265966|19174180|P1|NOT COMPLETED|Overall Study||3
7788958|NCT01265966|19174178|P3|COMPLETED|Overall Study||27
7788959|NCT01265966|19174179|P2|COMPLETED|Overall Study||39
7788960|NCT01265966|19174180|P1|COMPLETED|Overall Study||44
7788961|NCT01265966|19174178|P3|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
7788962|NCT01265966|19174179|P2|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
7788963|NCT01265966|19174180|P1|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3
7788964|NCT01265966|19174178|P3|STARTED|Overall Study||29
7788965|NCT01265966|19174179|P2|STARTED|Overall Study||41
7788966|NCT01265966|19174180|P1|STARTED|Overall Study||47
7788967|NCT01265953|19174190|P2|NOT COMPLETED|Overall Study||3
7788968|NCT01265953|19174191|P1|NOT COMPLETED|Overall Study||5
7788969|NCT01265953|19174190|P2|COMPLETED|Overall Study||45
7788970|NCT01265953|19174191|P1|COMPLETED|Overall Study||45
7788971|NCT01265953|19174190|P2|STARTED|Overall Study||48
7788972|NCT01265953|19174191|P1|STARTED|Overall Study||50
7788973|NCT01265875|19174203|P1|NOT COMPLETED|Overall Study||1
7788974|NCT01265875|19174203|P1|COMPLETED|Overall Study||11
7788975|NCT01265875|19174203|P1|STARTED|Overall Study||12
7788976|NCT01265823|19174211|P1|NOT COMPLETED|Overall Study||7
7788977|NCT01265823|19174211|P1|COMPLETED|Overall Study||143
7788978|NCT01265823|19174211|P1|STARTED|Overall Study||150
7788979|NCT01265797|19174240|P2|NOT COMPLETED|Open Label Month||1
7788980|NCT01265797|19174241|P1|NOT COMPLETED|Open Label Month||0
7788981|NCT01265797|19174240|P2|COMPLETED|Open Label Month||26
7788982|NCT01265797|19174241|P1|COMPLETED|Open Label Month||24
7788983|NCT01265797|19174240|P2|STARTED|Open Label Month||27
7788984|NCT01265797|19174241|P1|STARTED|Open Label Month||24
7788985|NCT01265797|19174240|P2|NOT COMPLETED|Blinded Month||2
7788986|NCT01265797|19174241|P1|NOT COMPLETED|Blinded Month||10
7788987|NCT01265797|19174240|P2|COMPLETED|Blinded Month||27
7788988|NCT01265797|19174241|P1|COMPLETED|Blinded Month||24
7788989|NCT01265797|19174240|P2|STARTED|Blinded Month||29
7788990|NCT01265797|19174241|P1|STARTED|Blinded Month||34
7788991|NCT01265797|19174240|P2|NOT COMPLETED|Run-in Month||5
7788992|NCT01265797|19174241|P1|NOT COMPLETED|Run-in Month||0
7788993|NCT01265797|19174240|P2|COMPLETED|Run-in Month||29
7788994|NCT01265797|19174241|P1|COMPLETED|Run-in Month||34
7788995|NCT01265797|19174240|P2|STARTED|Run-in Month||34
7788996|NCT01265797|19174241|P1|STARTED|Run-in Month||34
7788997|NCT01265784|19174272|P3|NOT COMPLETED|Overall Study||4
7788998|NCT01265784|19174273|P2|NOT COMPLETED|Overall Study||8
7788999|NCT01265784|19174274|P1|NOT COMPLETED|Overall Study||12
7789000|NCT01265784|19174272|P3|COMPLETED|Overall Study||26
7789001|NCT01265784|19174273|P2|COMPLETED|Overall Study||49
7789002|NCT01265784|19174274|P1|COMPLETED|Overall Study||44
7789003|NCT01265784|19174272|P3|Received at Least 1 Dose of Study Drug|Overall Study||29
7789004|NCT01265784|19174273|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
7789005|NCT01265784|19174274|P1|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54
7789006|NCT01265784|19174272|P3|STARTED|Overall Study||30
7789007|NCT01265784|19174273|P2|STARTED|Overall Study||57
7789008|NCT01265784|19174274|P1|STARTED|Overall Study||56
7789009|NCT01265719|19174342|P2|NOT COMPLETED|Overall Study||13
7789010|NCT01265719|19174343|P1|NOT COMPLETED|Overall Study||14
7789011|NCT01265719|19174342|P2|COMPLETED|Overall Study||60
7789012|NCT01265719|19174343|P1|COMPLETED|Overall Study||88
7789013|NCT01265719|19174342|P2|STARTED|Overall Study||73
7789014|NCT01265719|19174343|P1|STARTED|Overall Study||102
7789015|NCT01265667|19174377|P2|NOT COMPLETED|Overall Study||13
7789016|NCT01265667|19174378|P1|NOT COMPLETED|Overall Study||20
7789017|NCT01265667|19174377|P2|COMPLETED|Overall Study||135
7789018|NCT01265667|19174378|P1|COMPLETED|Overall Study||125
7789019|NCT01265667|19174377|P2|STARTED|Overall Study||148
7789020|NCT01265667|19174378|P1|STARTED|Overall Study||145
7789021|NCT01265615|19174394|P4|NOT COMPLETED|Overall Study||3
7789022|NCT01265615|19174395|P3|NOT COMPLETED|Overall Study||4
7789023|NCT01265615|19174396|P2|NOT COMPLETED|Overall Study||2
7789024|NCT01265615|19174397|P1|NOT COMPLETED|Overall Study||2
7789025|NCT01265615|19174394|P4|COMPLETED|Overall Study||27
7789026|NCT01265615|19174395|P3|COMPLETED|Overall Study||26
7789027|NCT01265615|19174396|P2|COMPLETED|Overall Study||28
7789028|NCT01265615|19174397|P1|COMPLETED|Overall Study||28
7789029|NCT01265615|19174394|P4|STARTED|Overall Study||30
7789030|NCT01265615|19174395|P3|STARTED|Overall Study||30
7789031|NCT01265615|19174396|P2|STARTED|Overall Study||30
7789032|NCT01265615|19174397|P1|STARTED|Overall Study||30
7789033|NCT01265563|19174448|P5|NOT COMPLETED|Overall Study||2
7789034|NCT01265563|19174449|P4|NOT COMPLETED|Overall Study||0
7789035|NCT01265563|19174450|P3|NOT COMPLETED|Overall Study||1
7789036|NCT01265563|19174451|P2|NOT COMPLETED|Overall Study||1
7789037|NCT01265563|19174452|P1|NOT COMPLETED|Overall Study||0
7789038|NCT01265563|19174448|P5|COMPLETED|Overall Study||14
7789039|NCT01265563|19174449|P4|COMPLETED|Overall Study||16
7789040|NCT01265563|19174450|P3|COMPLETED|Overall Study||16
7789041|NCT01265563|19174451|P2|COMPLETED|Overall Study||12
7789042|NCT01265563|19174452|P1|COMPLETED|Overall Study||16
7789043|NCT01265563|19174448|P5|STARTED|Overall Study||16
7789044|NCT01265563|19174449|P4|STARTED|Overall Study||16
7789045|NCT01265563|19174450|P3|STARTED|Overall Study||17
7789046|NCT01265563|19174451|P2|STARTED|Overall Study||13
7789047|NCT01265563|19174452|P1|STARTED|Overall Study||16
7789048|NCT01265550|19174478|P4|NOT COMPLETED|Post Randomization||0
7789049|NCT01265550|19174479|P3|NOT COMPLETED|Post Randomization||20
7789050|NCT01265550|19174480|P2|NOT COMPLETED|Post Randomization||8
7789051|NCT01265550|19174481|P1|NOT COMPLETED|Post Randomization||15
7789052|NCT01265550|19174478|P4|COMPLETED|Post Randomization||0
7789053|NCT01265550|19174479|P3|COMPLETED|Post Randomization||6
7789054|NCT01265550|19174480|P2|COMPLETED|Post Randomization||19
7789055|NCT01265550|19174481|P1|COMPLETED|Post Randomization||10
7789056|NCT01265550|19174478|P4|STARTED|Post Randomization||0
7789057|NCT01265550|19174479|P3|STARTED|Post Randomization||26
7789058|NCT01265550|19174480|P2|STARTED|Post Randomization||27
7789059|NCT01265550|19174481|P1|STARTED|Post Randomization||25
7789060|NCT01265550|19174478|P4|NOT COMPLETED|Pre Randomization||288
7789061|NCT01265550|19174479|P3|NOT COMPLETED|Pre Randomization||0
7789062|NCT01265550|19174480|P2|NOT COMPLETED|Pre Randomization||0
7789063|NCT01265550|19174481|P1|NOT COMPLETED|Pre Randomization||0
7789064|NCT01265550|19174478|P4|COMPLETED|Pre Randomization||78
7789065|NCT01265550|19174479|P3|COMPLETED|Pre Randomization||0
7789066|NCT01265550|19174480|P2|COMPLETED|Pre Randomization||0
7789067|NCT01265550|19174481|P1|COMPLETED|Pre Randomization||0
7789068|NCT01265550|19174478|P4|STARTED|Pre Randomization||366
7789069|NCT01265550|19174479|P3|STARTED|Pre Randomization||0
7789070|NCT01265550|19174480|P2|STARTED|Pre Randomization||0
7789071|NCT01265550|19174481|P1|STARTED|Pre Randomization||0
7789072|NCT01265537|19174573|P2|NOT COMPLETED|Overall Study||2
7789073|NCT01265537|19174574|P1|NOT COMPLETED|Overall Study||2
7789074|NCT01265537|19174573|P2|COMPLETED|Overall Study||13
7789075|NCT01265537|19174574|P1|COMPLETED|Overall Study||13
7789076|NCT01265537|19174573|P2|STARTED|Overall Study||15
7789077|NCT01265537|19174574|P1|STARTED|Overall Study||15
7789078|NCT01265524|19174604|P2|NOT COMPLETED|Overall Study||6
7789079|NCT01265524|19174605|P1|NOT COMPLETED|Overall Study||18
7789080|NCT01265524|19174604|P2|COMPLETED|Overall Study||46
7789081|NCT01265524|19174605|P1|COMPLETED|Overall Study||41
7789082|NCT01265524|19174604|P2|STARTED|Overall Study||52
7789083|NCT01265524|19174605|P1|STARTED|Overall Study||59
7789084|NCT01265511|19174625|P2|NOT COMPLETED|Overall Study||3
7789085|NCT01265511|19174626|P1|NOT COMPLETED|Overall Study||2
7789086|NCT01265511|19174625|P2|COMPLETED|Overall Study||5
7789087|NCT01265511|19174626|P1|COMPLETED|Overall Study||0
7789088|NCT01265511|19174625|P2|STARTED|Overall Study||8
7789089|NCT01265511|19174626|P1|STARTED|Overall Study||2
7789090|NCT01265498|19174640|P2|NOT COMPLETED|Overall Study||33
7789091|NCT01265498|19174641|P1|NOT COMPLETED|Overall Study||31
7789092|NCT01265498|19174640|P2|COMPLETED|Overall Study||109
7789093|NCT01265498|19174641|P1|COMPLETED|Overall Study||110
7789094|NCT01265498|19174640|P2|Both Baseline and Week 72 Biopsy|Overall Study||98
7789095|NCT01265498|19174641|P1|Both Baseline and Week 72 Biopsy|Overall Study||102
7789096|NCT01265498|19174640|P2|STARTED|Overall Study||142
7789097|NCT01265498|19174641|P1|STARTED|Overall Study||141
7789098|NCT01265459|19174744|P3|NOT COMPLETED|Overall Study||2
7789099|NCT01265459|19174745|P2|NOT COMPLETED|Overall Study||0
7789100|NCT01265459|19174746|P1|NOT COMPLETED|Overall Study||0
7789101|NCT01265459|19174744|P3|COMPLETED|Overall Study||20
7789102|NCT01265459|19174745|P2|COMPLETED|Overall Study||23
7789103|NCT01265459|19174746|P1|COMPLETED|Overall Study||23
7789104|NCT01265459|19174744|P3|STARTED|Overall Study||22
7789105|NCT01265459|19174745|P2|STARTED|Overall Study||23
7789106|NCT01265459|19174746|P1|STARTED|Overall Study||23
7789107|NCT01265446|19174768|P2|NOT COMPLETED|Overall Study||0
7789108|NCT01265446|19174769|P1|NOT COMPLETED|Overall Study||1
7789109|NCT01265446|19174768|P2|COMPLETED|Overall Study||125
7789110|NCT01265446|19174769|P1|COMPLETED|Overall Study||124
7789111|NCT01265446|19174768|P2|STARTED|Overall Study||125
7789112|NCT01265446|19174769|P1|STARTED|Overall Study||125
7789113|NCT01265420|19174777|P1|NOT COMPLETED|Overall Study||1
7789114|NCT01265420|19174777|P1|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6
7789115|NCT01265420|19174777|P1|STARTED|Overall Study||7
7789116|NCT01265394|19174781|P1|NOT COMPLETED|Overall Study||37
7789117|NCT01265394|19174781|P1|COMPLETED|Overall Study||181
7789118|NCT01265394|19174781|P1|STARTED|Overall Study||218
7789119|NCT01265056|19174788|P2|NOT COMPLETED|Follow up||3
7789120|NCT01265056|19174789|P1|NOT COMPLETED|Follow up||7
7789121|NCT01265056|19174788|P2|COMPLETED|Follow up||24
7789122|NCT01265056|19174789|P1|COMPLETED|Follow up||19
7789123|NCT01265056|19174788|P2|STARTED|Follow up||27
7789124|NCT01265056|19174789|P1|STARTED|Follow up||26
7789125|NCT01265056|19174788|P2|NOT COMPLETED|Initial Study Period||2
7789126|NCT01265056|19174789|P1|NOT COMPLETED|Initial Study Period||2
7789127|NCT01265056|19174788|P2|COMPLETED|Initial Study Period||25
7789128|NCT01265056|19174789|P1|COMPLETED|Initial Study Period||24
7789129|NCT01265056|19174788|P2|STARTED|Initial Study Period||27
7789130|NCT01265056|19174789|P1|STARTED|Initial Study Period||26
7789131|NCT01264965|19174799|P1|NOT COMPLETED|Overall Study||10
7789132|NCT01264965|19174799|P1|COMPLETED|Overall Study||15
7789133|NCT01264965|19174799|P1|STARTED|Overall Study||25
7789134|NCT01264952|19174807|P3|NOT COMPLETED|Overall Study||0
7789135|NCT01264952|19174808|P2|NOT COMPLETED|Overall Study||0
7789136|NCT01264952|19174809|P1|NOT COMPLETED|Overall Study||0
7789137|NCT01264952|19174807|P3|COMPLETED|Overall Study||8
7789138|NCT01264952|19174808|P2|COMPLETED|Overall Study||2
7789139|NCT01264952|19174809|P1|COMPLETED|Overall Study||6
7789140|NCT01264952|19174807|P3|STARTED|Overall Study||8
7789141|NCT01264952|19174808|P2|STARTED|Overall Study||2
7789142|NCT01264952|19174809|P1|STARTED|Overall Study||6
7789143|NCT01264939|19174825|P2|NOT COMPLETED|Overall Study||28
7789144|NCT01264939|19174826|P1|NOT COMPLETED|Overall Study||18
7789145|NCT01264939|19174825|P2|COMPLETED|Overall Study||224
7789146|NCT01264939|19174826|P1|COMPLETED|Overall Study||66
7789147|NCT01264939|19174825|P2|STARTED|Overall Study||252
7789148|NCT01264939|19174826|P1|STARTED|Overall Study||84
7789149|NCT01264887|19174852|P1|NOT COMPLETED|Overall Study||31
7789150|NCT01264887|19174852|P1|COMPLETED|Overall Study||0
7789151|NCT01264887|19174852|P1|STARTED|Overall Study||31
7789152|NCT01264835|19174863|P1|NOT COMPLETED|Overall Study||1
7789153|NCT01264835|19174863|P1|COMPLETED|Overall Study||1
7789154|NCT01264835|19174863|P1|STARTED|Overall Study||2
7789155|NCT01264770|19174873|P6|NOT COMPLETED|Overall Study||6
7789156|NCT01264770|19174874|P5|NOT COMPLETED|Overall Study||8
7789157|NCT01264770|19174875|P4|NOT COMPLETED|Overall Study||6
7789158|NCT01264770|19174876|P3|NOT COMPLETED|Overall Study||16
7789159|NCT01264770|19174877|P2|NOT COMPLETED|Overall Study||10
7789160|NCT01264770|19174878|P1|NOT COMPLETED|Overall Study||18
7789161|NCT01264770|19174873|P6|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
7789162|NCT01264770|19174874|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
7789163|NCT01264770|19174875|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48
7789164|NCT01264770|19174876|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41
7789165|NCT01264770|19174877|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38
7789166|NCT01264770|19174878|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36
7789167|NCT01264770|19174873|P6|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0
7789168|NCT01264770|19174874|P5|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
7789169|NCT01264770|19174875|P4|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3
7789170|NCT01264770|19174876|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
7789171|NCT01264770|19174877|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5
7789172|NCT01264770|19174878|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
7789173|NCT01264770|19174873|P6|STARTED|Overall Study|Patients who received treatment|25
7789174|NCT01264770|19174874|P5|STARTED|Overall Study|Patients who received treatment|27
7789175|NCT01264770|19174875|P4|STARTED|Overall Study|Patients who received treatment|54
7789176|NCT01264770|19174876|P3|STARTED|Overall Study|Patients who received treatment|57
7789177|NCT01264770|19174877|P2|STARTED|Overall Study|Patients who received treatment|48
7789178|NCT01264770|19174878|P1|STARTED|Overall Study|Patients who received treatment|54
7789179|NCT01264718|19174964|P2|NOT COMPLETED|Overall Study||43
7789180|NCT01264718|19174965|P1|NOT COMPLETED|Overall Study||49
7789181|NCT01264718|19174964|P2|COMPLETED|Overall Study||114
7789182|NCT01264718|19174965|P1|COMPLETED|Overall Study||123
7789183|NCT01264718|19174964|P2|STARTED|Overall Study||157
7789184|NCT01264718|19174965|P1|STARTED|Overall Study||172
7789185|NCT01264705|19174980|P3|NOT COMPLETED|Overall Study||0
7789186|NCT01264705|19174981|P2|NOT COMPLETED|Overall Study||0
7789187|NCT01264705|19174982|P1|NOT COMPLETED|Overall Study||0
7789188|NCT01264705|19174980|P3|COMPLETED|Overall Study||41
7789189|NCT01264705|19174981|P2|COMPLETED|Overall Study||3
7789190|NCT01264705|19174982|P1|COMPLETED|Overall Study||3
7789191|NCT01264705|19174980|P3|STARTED|Overall Study||41
7789192|NCT01264705|19174981|P2|STARTED|Overall Study||3
7789193|NCT01264705|19174982|P1|STARTED|Overall Study||3
7789194|NCT01264679|19175002|P1|NOT COMPLETED|Overall Study||5
7789195|NCT01264679|19175002|P1|COMPLETED|Overall Study||3
7789196|NCT01264679|19175002|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
7789197|NCT01264679|19175002|P1|STARTED|Overall Study||8
7789198|NCT01264614|19175010|P2|NOT COMPLETED|Overall Study||2
7789199|NCT01264614|19175011|P1|NOT COMPLETED|Overall Study||1
7789200|NCT01264614|19175010|P2|COMPLETED|Overall Study||7
7789201|NCT01264614|19175011|P1|COMPLETED|Overall Study||12
7789202|NCT01264614|19175010|P2|STARTED|Overall Study||9
7789203|NCT01264614|19175011|P1|STARTED|Overall Study||13
7789204|NCT01264601|19175027|P2|NOT COMPLETED|Overall Study||0
7789205|NCT01264601|19175028|P1|NOT COMPLETED|Overall Study||0
7789206|NCT01264601|19175027|P2|COMPLETED|Overall Study||14
7789207|NCT01264601|19175028|P1|COMPLETED|Overall Study||17
7789208|NCT01264601|19175027|P2|STARTED|Overall Study||14
7789209|NCT01264601|19175028|P1|STARTED|Overall Study||17
7789210|NCT01264419|19175036|P1|NOT COMPLETED|Overall Study||3
7789211|NCT01264419|19175036|P1|COMPLETED|Overall Study||72
7789212|NCT01264419|19175036|P1|STARTED|Overall Study||75
7789213|NCT01264380|19175041|P3|NOT COMPLETED|Period C||14
7789214|NCT01264380|19175042|P2|NOT COMPLETED|Period C||0
7789215|NCT01264380|19175043|P1|NOT COMPLETED|Period C||0
7789216|NCT01264380|19175041|P3|COMPLETED|Period C||2
7789217|NCT01264380|19175042|P2|COMPLETED|Period C||0
7789218|NCT01264380|19175043|P1|COMPLETED|Period C||0
7789219|NCT01264380|19175041|P3|STARTED|Period C||16
7789220|NCT01264380|19175042|P2|STARTED|Period C||0
7789221|NCT01264380|19175043|P1|STARTED|Period C||0
7789222|NCT01264380|19175041|P3|NOT COMPLETED|Period B||0
7789223|NCT01264380|19175042|P2|NOT COMPLETED|Period B||0
7789224|NCT01264380|19175043|P1|NOT COMPLETED|Period B||0
7789225|NCT01264380|19175041|P3|COMPLETED|Period B||0
7789226|NCT01264380|19175042|P2|COMPLETED|Period B||8
7789227|NCT01264380|19175043|P1|COMPLETED|Period B||8
7789228|NCT01264380|19175041|P3|STARTED|Period B||0
7789229|NCT01264380|19175042|P2|STARTED|Period B||8
7789230|NCT01264380|19175043|P1|STARTED|Period B||8
7789231|NCT01264380|19175041|P3|NOT COMPLETED|Period A||0
7789232|NCT01264380|19175042|P2|NOT COMPLETED|Period A||0
7789233|NCT01264380|19175043|P1|NOT COMPLETED|Period A||0
7789234|NCT01264380|19175041|P3|COMPLETED|Period A||0
7789235|NCT01264380|19175042|P2|COMPLETED|Period A||8
7789236|NCT01264380|19175043|P1|COMPLETED|Period A||8
7789237|NCT01264380|19175041|P3|STARTED|Period A||0
7789238|NCT01264380|19175042|P2|STARTED|Period A||8
7789239|NCT01264380|19175043|P1|STARTED|Period A||8
7789240|NCT01264081|19175064|P1|NOT COMPLETED|Analysis||0
7789241|NCT01264081|19175064|P1|COMPLETED|Analysis||2
7789242|NCT01264081|19175064|P1|STARTED|Analysis||2
7789243|NCT01264081|19175064|P1|NOT COMPLETED|Started Treatment||2
7789244|NCT01264081|19175064|P1|COMPLETED|Started Treatment||2
7789245|NCT01264081|19175064|P1|STARTED|Started Treatment||4
7789246|NCT01264081|19175064|P1|NOT COMPLETED|Participants Screened||30
7789247|NCT01264081|19175064|P1|COMPLETED|Participants Screened||4
7789248|NCT01264081|19175064|P1|STARTED|Participants Screened||34
7789249|NCT01264016|19175069|P1|NOT COMPLETED|Overall Study||2
7789250|NCT01264016|19175069|P1|COMPLETED|Overall Study||94
7789251|NCT01264016|19175069|P1|STARTED|Overall Study||96
7789252|NCT01263938|19175075|P1|NOT COMPLETED|Overall Study||0
7789253|NCT01263938|19175075|P1|COMPLETED|Overall Study||5
7789254|NCT01263938|19175075|P1|STARTED|Overall Study||5
7789255|NCT01263925|19175084|P2|NOT COMPLETED|Overall Study||52
7789256|NCT01263925|19175085|P1|NOT COMPLETED|Overall Study||51
7789257|NCT01263925|19175084|P2|COMPLETED|Overall Study||233
7789258|NCT01263925|19175085|P1|COMPLETED|Overall Study||225
7789259|NCT01263925|19175084|P2|Full Analysis Set|Overall Study||272
7789260|NCT01263925|19175085|P1|Full Analysis Set|Overall Study||269
7789261|NCT01263925|19175084|P2|STARTED|Overall Study||285
7789262|NCT01263925|19175085|P1|STARTED|Overall Study||276
7789263|NCT01263873|19175119|P2|NOT COMPLETED|Overall Study||1
7789264|NCT01263873|19175120|P1|NOT COMPLETED|Overall Study||1
7789265|NCT01263873|19175119|P2|COMPLETED|Overall Study||29
7789266|NCT01263873|19175120|P1|COMPLETED|Overall Study||29
7789267|NCT01263873|19175119|P2|STARTED|Overall Study||30
7789268|NCT01263873|19175120|P1|STARTED|Overall Study||30
7789269|NCT01263782|19175134|P4|NOT COMPLETED|Overall Study||1
7789270|NCT01263782|19175135|P3|NOT COMPLETED|Overall Study||3
7789271|NCT01263782|19175136|P2|NOT COMPLETED|Overall Study||0
7789272|NCT01263782|19175137|P1|NOT COMPLETED|Overall Study||0
7789273|NCT01263782|19175134|P4|COMPLETED|Overall Study||5
7789274|NCT01263782|19175135|P3|COMPLETED|Overall Study||3
7789275|NCT01263782|19175136|P2|COMPLETED|Overall Study||6
7789276|NCT01263782|19175137|P1|COMPLETED|Overall Study||6
7789277|NCT01263782|19175134|P4|STARTED|Overall Study||6
7789278|NCT01263782|19175135|P3|STARTED|Overall Study||6
7789279|NCT01263782|19175136|P2|STARTED|Overall Study||6
7789280|NCT01263782|19175137|P1|STARTED|Overall Study||6
7789281|NCT01263717|19175153|P2|NOT COMPLETED|Overall Study||6
7789282|NCT01263717|19175154|P1|NOT COMPLETED|Overall Study||5
7789283|NCT01263717|19175153|P2|COMPLETED|Overall Study||20
7789284|NCT01263717|19175154|P1|COMPLETED|Overall Study||23
7789285|NCT01263717|19175153|P2|Baseline Visit|Overall Study||22
7789286|NCT01263717|19175154|P1|Baseline Visit|Overall Study||28
7789287|NCT01263717|19175153|P2|STARTED|Overall Study||26
7789288|NCT01263717|19175154|P1|STARTED|Overall Study||28
7789289|NCT01263704|19175182|P1|NOT COMPLETED|Overall Study||29
7789290|NCT01263704|19175182|P1|COMPLETED|Overall Study||13
7789291|NCT01263704|19175182|P1|STARTED|Overall Study||42
7789292|NCT01263691|19175197|P6|NOT COMPLETED|Overall Study||0
7789293|NCT01263691|19175198|P5|NOT COMPLETED|Overall Study||0
7789294|NCT01263691|19175199|P4|NOT COMPLETED|Overall Study||1
7789295|NCT01263691|19175200|P3|NOT COMPLETED|Overall Study||1
7789296|NCT01263691|19175201|P2|NOT COMPLETED|Overall Study||0
7789297|NCT01263691|19175202|P1|NOT COMPLETED|Overall Study||3
7789298|NCT01263691|19175197|P6|COMPLETED|Overall Study||15
7789299|NCT01263691|19175198|P5|COMPLETED|Overall Study||18
7789300|NCT01263691|19175199|P4|COMPLETED|Overall Study||18
7789301|NCT01263691|19175200|P3|COMPLETED|Overall Study||16
7789302|NCT01263691|19175201|P2|COMPLETED|Overall Study||18
7789303|NCT01263691|19175202|P1|COMPLETED|Overall Study||15
7789304|NCT01263691|19175197|P6|STARTED|Overall Study||15
7789305|NCT01263691|19175198|P5|STARTED|Overall Study||18
7789306|NCT01263691|19175199|P4|STARTED|Overall Study||19
7789307|NCT01263691|19175200|P3|STARTED|Overall Study||17
7789308|NCT01263691|19175201|P2|STARTED|Overall Study||18
7789309|NCT01263691|19175202|P1|STARTED|Overall Study||18
7789310|NCT01263665|19175312|P1|NOT COMPLETED|Overall Study||9
7789311|NCT01263665|19175312|P1|COMPLETED|Overall Study||62
7789312|NCT01263665|19175312|P1|STARTED|Overall Study||71
7789313|NCT01263639|19175319|P2|NOT COMPLETED|Overall Study||79
7789314|NCT01263639|19175320|P1|NOT COMPLETED|Overall Study||73
7789315|NCT01263639|19175319|P2|COMPLETED|Overall Study||42
7789316|NCT01263639|19175320|P1|COMPLETED|Overall Study||34
7789317|NCT01263639|19175319|P2|STARTED|Overall Study||121
7789318|NCT01263639|19175320|P1|STARTED|Overall Study||107
7789319|NCT01263561|19175328|P2|NOT COMPLETED|Overall Study||2
7789320|NCT01263561|19175329|P1|NOT COMPLETED|Overall Study||1
7789321|NCT01263561|19175328|P2|COMPLETED|Overall Study||31
7789322|NCT01263561|19175329|P1|COMPLETED|Overall Study||30
7789323|NCT01263561|19175328|P2|STARTED|Overall Study||33
7789324|NCT01263561|19175329|P1|STARTED|Overall Study||31
7789325|NCT01263509|19175341|P4|NOT COMPLETED|Entered - Long-Term Extension Study||2
7789326|NCT01263509|19175342|P3|NOT COMPLETED|Entered - Long-Term Extension Study||5
7789327|NCT01263509|19175343|P2|NOT COMPLETED|Entered - Long-Term Extension Study||12
7789328|NCT01263509|19175344|P1|NOT COMPLETED|Entered - Long-Term Extension Study||8
7789329|NCT01263509|19175341|P4|COMPLETED|Entered - Long-Term Extension Study||24
7789330|NCT01263509|19175342|P3|COMPLETED|Entered - Long-Term Extension Study||27
7789331|NCT01263509|19175343|P2|COMPLETED|Entered - Long-Term Extension Study||48
7789332|NCT01263509|19175344|P1|COMPLETED|Entered - Long-Term Extension Study||53
7789333|NCT01263509|19175341|P4|STARTED|Entered - Long-Term Extension Study||26
7789334|NCT01263509|19175342|P3|STARTED|Entered - Long-Term Extension Study||32
7789335|NCT01263509|19175343|P2|STARTED|Entered - Long-Term Extension Study||60
7789336|NCT01263509|19175344|P1|STARTED|Entered - Long-Term Extension Study||61
7789337|NCT01263509|19175341|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
7789338|NCT01263509|19175342|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
7789339|NCT01263509|19175343|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
7789340|NCT01263509|19175344|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
7789341|NCT01263509|19175341|P4|COMPLETED|Enrolled - Long-Term Extension Study||26
7789342|NCT01263509|19175342|P3|COMPLETED|Enrolled - Long-Term Extension Study||32
7789343|NCT01263509|19175343|P2|COMPLETED|Enrolled - Long-Term Extension Study||60
7789344|NCT01263509|19175344|P1|COMPLETED|Enrolled - Long-Term Extension Study||61
7789345|NCT01263509|19175341|P4|STARTED|Enrolled - Long-Term Extension Study||26
7789346|NCT01263509|19175342|P3|STARTED|Enrolled - Long-Term Extension Study||32
7789347|NCT01263509|19175343|P2|STARTED|Enrolled - Long-Term Extension Study||60
7789348|NCT01263509|19175344|P1|STARTED|Enrolled - Long-Term Extension Study||61
7789349|NCT01263496|19175473|P9|NOT COMPLETED|Entered - Long-Term Extension Study||3
7789350|NCT01263496|19175474|P8|NOT COMPLETED|Entered - Long-Term Extension Study||1
7789351|NCT01263496|19175475|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
7789352|NCT01263496|19175476|P6|NOT COMPLETED|Entered - Long-Term Extension Study||1
7789353|NCT01263496|19175477|P5|NOT COMPLETED|Entered - Long-Term Extension Study||10
7789354|NCT01263496|19175478|P4|NOT COMPLETED|Entered - Long-Term Extension Study||6
7789355|NCT01263496|19175479|P3|NOT COMPLETED|Entered - Long-Term Extension Study||10
7789356|NCT01263496|19175480|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
7789357|NCT01263496|19175481|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
7789358|NCT01263496|19175473|P9|COMPLETED|Entered - Long-Term Extension Study||15
7789359|NCT01263496|19175474|P8|COMPLETED|Entered - Long-Term Extension Study||16
7789360|NCT01263496|19175475|P7|COMPLETED|Entered - Long-Term Extension Study||16
7789361|NCT01263496|19175476|P6|COMPLETED|Entered - Long-Term Extension Study||16
7789362|NCT01263496|19175477|P5|COMPLETED|Entered - Long-Term Extension Study||61
7789363|NCT01263496|19175478|P4|COMPLETED|Entered - Long-Term Extension Study||68
7789364|NCT01263496|19175479|P3|COMPLETED|Entered - Long-Term Extension Study||62
7789365|NCT01263496|19175480|P2|COMPLETED|Entered - Long-Term Extension Study||59
7789366|NCT01263496|19175481|P1|COMPLETED|Entered - Long-Term Extension Study||62
7789367|NCT01263496|19175473|P9|STARTED|Entered - Long-Term Extension Study||18
7789368|NCT01263496|19175474|P8|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17
7789369|NCT01263496|19175475|P7|STARTED|Entered - Long-Term Extension Study||17
7789370|NCT01263496|19175476|P6|STARTED|Entered - Long-Term Extension Study||17
7789371|NCT01263496|19175477|P5|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71
7789372|NCT01263496|19175478|P4|STARTED|Entered - Long-Term Extension Study||74
7789373|NCT01263496|19175479|P3|STARTED|Entered - Long-Term Extension Study||72
7789374|NCT01263496|19175480|P2|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72
7789375|NCT01263496|19175481|P1|STARTED|Entered - Long-Term Extension Study||71
7789376|NCT01263496|19175473|P9|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
7789377|NCT01263496|19175474|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
7789378|NCT01263496|19175475|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
7789379|NCT01263496|19175476|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
7789380|NCT01263496|19175477|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
7789381|NCT01263496|19175478|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
7789382|NCT01263496|19175479|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
7789383|NCT01263496|19175480|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
7789384|NCT01263496|19175481|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
7789385|NCT01263496|19175473|P9|COMPLETED|Enrolled - Long-Term Extension Study||18
7789386|NCT01263496|19175474|P8|COMPLETED|Enrolled - Long-Term Extension Study||18
7789387|NCT01263496|19175475|P7|COMPLETED|Enrolled - Long-Term Extension Study||17
7789388|NCT01263496|19175476|P6|COMPLETED|Enrolled - Long-Term Extension Study||17
7789389|NCT01263496|19175477|P5|COMPLETED|Enrolled - Long-Term Extension Study||72
7789390|NCT01263496|19175478|P4|COMPLETED|Enrolled - Long-Term Extension Study||74
7789391|NCT01263496|19175479|P3|COMPLETED|Enrolled - Long-Term Extension Study||72
7789392|NCT01263496|19175480|P2|COMPLETED|Enrolled - Long-Term Extension Study||75
7789393|NCT01263496|19175481|P1|COMPLETED|Enrolled - Long-Term Extension Study||71
7789394|NCT01263496|19175473|P9|STARTED|Enrolled - Long-Term Extension Study||18
7789395|NCT01263496|19175474|P8|STARTED|Enrolled - Long-Term Extension Study||18
7789396|NCT01263496|19175475|P7|STARTED|Enrolled - Long-Term Extension Study||17
7789397|NCT01263496|19175476|P6|STARTED|Enrolled - Long-Term Extension Study||17
7789398|NCT01263496|19175477|P5|STARTED|Enrolled - Long-Term Extension Study||74
7789399|NCT01263496|19175478|P4|STARTED|Enrolled - Long-Term Extension Study||75
7789400|NCT01263496|19175479|P3|STARTED|Enrolled - Long-Term Extension Study||72
7789401|NCT01263496|19175480|P2|STARTED|Enrolled - Long-Term Extension Study||75
7789402|NCT01263496|19175481|P1|STARTED|Enrolled - Long-Term Extension Study||72
7789403|NCT01263483|19175776|P3|NOT COMPLETED|Overall Study||5
7789404|NCT01263483|19175777|P2|NOT COMPLETED|Overall Study||2
7789405|NCT01263483|19175778|P1|NOT COMPLETED|Overall Study||7
7789406|NCT01263483|19175776|P3|COMPLETED|Overall Study||74
7789407|NCT01263483|19175777|P2|COMPLETED|Overall Study||74
7789408|NCT01263483|19175778|P1|COMPLETED|Overall Study||68
7789409|NCT01263483|19175776|P3|STARTED|Overall Study||79
7789410|NCT01263483|19175777|P2|STARTED|Overall Study||76
7789411|NCT01263483|19175778|P1|STARTED|Overall Study||75
7789412|NCT01263470|19175840|P6|NOT COMPLETED|Overall Study||5
7789413|NCT01263470|19175841|P5|NOT COMPLETED|Overall Study||3
7789414|NCT01263470|19175842|P4|NOT COMPLETED|Overall Study||3
7789415|NCT01263470|19175843|P3|NOT COMPLETED|Overall Study||4
7789416|NCT01263470|19175844|P2|NOT COMPLETED|Overall Study||5
7789417|NCT01263470|19175845|P1|NOT COMPLETED|Overall Study||2
7789418|NCT01263470|19175840|P6|COMPLETED|Overall Study||78
7789419|NCT01263470|19175841|P5|COMPLETED|Overall Study||76
7789420|NCT01263470|19175842|P4|COMPLETED|Overall Study||77
7789421|NCT01263470|19175843|P3|COMPLETED|Overall Study||80
7789422|NCT01263470|19175844|P2|COMPLETED|Overall Study||74
7789423|NCT01263470|19175845|P1|COMPLETED|Overall Study||73
7789424|NCT01263470|19175840|P6|STARTED|Overall Study||83
7789425|NCT01263470|19175841|P5|STARTED|Overall Study||79
7789426|NCT01263470|19175842|P4|STARTED|Overall Study||80
7789427|NCT01263470|19175843|P3|STARTED|Overall Study||84
7789428|NCT01263470|19175844|P2|STARTED|Overall Study||79
7789429|NCT01263470|19175845|P1|STARTED|Overall Study||75
7789430|NCT01263444|19175955|P1|NOT COMPLETED|Overall Study||10
7789431|NCT01263444|19175955|P1|COMPLETED|Overall Study||37
7789432|NCT01263444|19175955|P1|STARTED|Overall Study||47
7789433|NCT01263314|19175964|P8|NOT COMPLETED|Period 3||0
7789434|NCT01263314|19175965|P7|NOT COMPLETED|Period 3||0
7789435|NCT01263314|19175966|P6|NOT COMPLETED|Period 3||0
7789436|NCT01263314|19175967|P5|NOT COMPLETED|Period 3||0
7789437|NCT01263314|19175968|P4|NOT COMPLETED|Period 3||0
7789438|NCT01263314|19175969|P3|NOT COMPLETED|Period 3||0
7789439|NCT01263314|19175970|P2|NOT COMPLETED|Period 3||0
7789440|NCT01263314|19175971|P1|NOT COMPLETED|Period 3||0
7789441|NCT01263314|19175964|P8|COMPLETED|Period 3||2
7789442|NCT01263314|19175965|P7|COMPLETED|Period 3||2
7789443|NCT01263314|19175966|P6|COMPLETED|Period 3||2
7789444|NCT01263314|19175967|P5|COMPLETED|Period 3||2
7789445|NCT01263314|19175968|P4|COMPLETED|Period 3||2
7789446|NCT01263314|19175969|P3|COMPLETED|Period 3||2
7789447|NCT01263314|19175970|P2|COMPLETED|Period 3||2
7789448|NCT01263314|19175971|P1|COMPLETED|Period 3||2
7789449|NCT01263314|19175964|P8|STARTED|Period 3||2
7789450|NCT01263314|19175965|P7|STARTED|Period 3||2
7789451|NCT01263314|19175966|P6|STARTED|Period 3||2
7789452|NCT01263314|19175967|P5|STARTED|Period 3||2
7789453|NCT01263314|19175968|P4|STARTED|Period 3||2
7789454|NCT01263314|19175969|P3|STARTED|Period 3||2
7789455|NCT01263314|19175970|P2|STARTED|Period 3||2
7789456|NCT01263314|19175971|P1|STARTED|Period 3||2
7789457|NCT01263314|19175964|P8|NOT COMPLETED|Period 2||0
7789458|NCT01263314|19175965|P7|NOT COMPLETED|Period 2||0
7789459|NCT01263314|19175966|P6|NOT COMPLETED|Period 2||0
7789460|NCT01263314|19175967|P5|NOT COMPLETED|Period 2||0
7789461|NCT01263314|19175968|P4|NOT COMPLETED|Period 2||0
7789462|NCT01263314|19175969|P3|NOT COMPLETED|Period 2||0
7789463|NCT01263314|19175970|P2|NOT COMPLETED|Period 2||0
7789464|NCT01263314|19175971|P1|NOT COMPLETED|Period 2||0
7789465|NCT01263314|19175964|P8|COMPLETED|Period 2||2
7789466|NCT01263314|19175965|P7|COMPLETED|Period 2||2
7789467|NCT01263314|19175966|P6|COMPLETED|Period 2||2
7789468|NCT01263314|19175967|P5|COMPLETED|Period 2||2
7789469|NCT01263314|19175968|P4|COMPLETED|Period 2||2
7789470|NCT01263314|19175969|P3|COMPLETED|Period 2||2
7789471|NCT01263314|19175970|P2|COMPLETED|Period 2||2
7789472|NCT01263314|19175971|P1|COMPLETED|Period 2||2
7789473|NCT01263314|19175964|P8|STARTED|Period 2||2
7789474|NCT01263314|19175965|P7|STARTED|Period 2||2
7789475|NCT01263314|19175966|P6|STARTED|Period 2||2
7789476|NCT01263314|19175967|P5|STARTED|Period 2||2
7789477|NCT01263314|19175968|P4|STARTED|Period 2||2
7789478|NCT01263314|19175969|P3|STARTED|Period 2||2
7789479|NCT01263314|19175970|P2|STARTED|Period 2||2
7789480|NCT01263314|19175971|P1|STARTED|Period 2||2
7789481|NCT01263314|19175964|P8|NOT COMPLETED|Period 1||0
7789482|NCT01263314|19175965|P7|NOT COMPLETED|Period 1||0
7789483|NCT01263314|19175966|P6|NOT COMPLETED|Period 1||0
7789484|NCT01263314|19175967|P5|NOT COMPLETED|Period 1||0
7789485|NCT01263314|19175968|P4|NOT COMPLETED|Period 1||0
7789486|NCT01263314|19175969|P3|NOT COMPLETED|Period 1||0
7789487|NCT01263314|19175970|P2|NOT COMPLETED|Period 1||0
7789488|NCT01263314|19175971|P1|NOT COMPLETED|Period 1||0
7789489|NCT01263314|19175964|P8|COMPLETED|Period 1||2
7789490|NCT01263314|19175965|P7|COMPLETED|Period 1||2
7789491|NCT01263314|19175966|P6|COMPLETED|Period 1||2
7789492|NCT01263314|19175967|P5|COMPLETED|Period 1||2
7789493|NCT01263314|19175968|P4|COMPLETED|Period 1||2
7789494|NCT01263314|19175969|P3|COMPLETED|Period 1||2
7789495|NCT01263314|19175970|P2|COMPLETED|Period 1||2
7789496|NCT01263314|19175971|P1|COMPLETED|Period 1||2
7789497|NCT01263314|19175964|P8|STARTED|Period 1||2
7789498|NCT01263314|19175965|P7|STARTED|Period 1||2
7789499|NCT01263314|19175966|P6|STARTED|Period 1||2
7789500|NCT01263314|19175967|P5|STARTED|Period 1||2
7789501|NCT01263314|19175968|P4|STARTED|Period 1||2
7789502|NCT01263314|19175969|P3|STARTED|Period 1||2
7789503|NCT01263314|19175970|P2|STARTED|Period 1||2
7789504|NCT01263314|19175971|P1|STARTED|Period 1||2
7789505|NCT01263301|19176079|P2|NOT COMPLETED|Overall Study||0
7789506|NCT01263301|19176080|P1|NOT COMPLETED|Overall Study||0
7789507|NCT01263301|19176079|P2|COMPLETED|Overall Study||11
7789508|NCT01263301|19176080|P1|COMPLETED|Overall Study||5
7789509|NCT01263301|19176079|P2|STARTED|Overall Study||11
7789510|NCT01263301|19176080|P1|STARTED|Overall Study||5
7789511|NCT01263223|19176092|P2|NOT COMPLETED|7-day Follow-up||1
7789512|NCT01263223|19176093|P1|NOT COMPLETED|7-day Follow-up||1
7789513|NCT01263223|19176092|P2|COMPLETED|7-day Follow-up|One participant who did not complete received 36-mg LY2216684 in Period 3.|10
7789514|NCT01263223|19176093|P1|COMPLETED|7-day Follow-up|One participant who did not complete received Placebo in Period 3.|11
7789515|NCT01263223|19176092|P2|STARTED|7-day Follow-up||11
7789516|NCT01263223|19176093|P1|STARTED|7-day Follow-up||12
7789517|NCT01263223|19176092|P2|NOT COMPLETED|Period 3||0
7789518|NCT01263223|19176093|P1|NOT COMPLETED|Period 3||0
7789519|NCT01263223|19176092|P2|COMPLETED|Period 3||11
7789520|NCT01263223|19176093|P1|COMPLETED|Period 3||12
7789521|NCT01263223|19176092|P2|STARTED|Period 3||11
7789522|NCT01263223|19176093|P1|STARTED|Period 3||12
7789523|NCT01263223|19176092|P2|NOT COMPLETED|Period 2||1
7789524|NCT01263223|19176093|P1|NOT COMPLETED|Period 2||0
7789525|NCT01263223|19176092|P2|COMPLETED|Period 2||11
7789526|NCT01263223|19176093|P1|COMPLETED|Period 2||12
7789527|NCT01263223|19176092|P2|STARTED|Period 2||12
7789528|NCT01263223|19176093|P1|STARTED|Period 2||12
7789529|NCT01263223|19176092|P2|NOT COMPLETED|3-Day Washout||0
7789530|NCT01263223|19176093|P1|NOT COMPLETED|3-Day Washout||0
7789531|NCT01263223|19176092|P2|COMPLETED|3-Day Washout||12
7789532|NCT01263223|19176093|P1|COMPLETED|3-Day Washout||12
7789533|NCT01263223|19176092|P2|STARTED|3-Day Washout||12
7789534|NCT01263223|19176093|P1|STARTED|3-Day Washout||12
7789535|NCT01263223|19176092|P2|NOT COMPLETED|Period 1||0
7789536|NCT01263223|19176093|P1|NOT COMPLETED|Period 1||0
7789537|NCT01263223|19176092|P2|COMPLETED|Period 1||12
7789538|NCT01263223|19176093|P1|COMPLETED|Period 1||12
7789539|NCT01263223|19176092|P2|STARTED|Period 1||12
7789540|NCT01263223|19176093|P1|STARTED|Period 1||12
7789541|NCT01263197|19176116|P6|NOT COMPLETED|Third Intervention (Period 3)||0
7789542|NCT01263197|19176117|P5|NOT COMPLETED|Third Intervention (Period 3)||0
7789543|NCT01263197|19176118|P4|NOT COMPLETED|Third Intervention (Period 3)||0
7789544|NCT01263197|19176119|P3|NOT COMPLETED|Third Intervention (Period 3)||0
7789545|NCT01263197|19176120|P2|NOT COMPLETED|Third Intervention (Period 3)||1
7789546|NCT01263197|19176121|P1|NOT COMPLETED|Third Intervention (Period 3)||0
7789547|NCT01263197|19176116|P6|COMPLETED|Third Intervention (Period 3)||6
7789548|NCT01263197|19176117|P5|COMPLETED|Third Intervention (Period 3)||7
7789549|NCT01263197|19176118|P4|COMPLETED|Third Intervention (Period 3)||7
7789550|NCT01263197|19176119|P3|COMPLETED|Third Intervention (Period 3)||8
7789551|NCT01263197|19176120|P2|COMPLETED|Third Intervention (Period 3)||7
7789552|NCT01263197|19176121|P1|COMPLETED|Third Intervention (Period 3)||8
7789553|NCT01263197|19176116|P6|STARTED|Third Intervention (Period 3)||6
7789554|NCT01263197|19176117|P5|STARTED|Third Intervention (Period 3)||7
7789555|NCT01263197|19176118|P4|STARTED|Third Intervention (Period 3)||7
7789556|NCT01263197|19176119|P3|STARTED|Third Intervention (Period 3)||8
7789557|NCT01263197|19176120|P2|STARTED|Third Intervention (Period 3)||8
7789558|NCT01263197|19176121|P1|STARTED|Third Intervention (Period 3)||8
7789559|NCT01263197|19176116|P6|NOT COMPLETED|Washout Period 2||1
7789560|NCT01263197|19176117|P5|NOT COMPLETED|Washout Period 2||0
7789561|NCT01263197|19176118|P4|NOT COMPLETED|Washout Period 2||1
7789562|NCT01263197|19176119|P3|NOT COMPLETED|Washout Period 2||0
7789563|NCT01263197|19176120|P2|NOT COMPLETED|Washout Period 2||0
7789564|NCT01263197|19176121|P1|NOT COMPLETED|Washout Period 2||0
7789565|NCT01263197|19176116|P6|COMPLETED|Washout Period 2||6
7789566|NCT01263197|19176117|P5|COMPLETED|Washout Period 2||7
7789567|NCT01263197|19176118|P4|COMPLETED|Washout Period 2||7
7789568|NCT01263197|19176119|P3|COMPLETED|Washout Period 2||8
7789569|NCT01263197|19176120|P2|COMPLETED|Washout Period 2||8
7789570|NCT01263197|19176121|P1|COMPLETED|Washout Period 2||8
7789571|NCT01263197|19176116|P6|STARTED|Washout Period 2||7
7789572|NCT01263197|19176117|P5|STARTED|Washout Period 2||7
7789573|NCT01263197|19176118|P4|STARTED|Washout Period 2||8
7789574|NCT01263197|19176119|P3|STARTED|Washout Period 2||8
7789575|NCT01263197|19176120|P2|STARTED|Washout Period 2||8
7789576|NCT01263197|19176121|P1|STARTED|Washout Period 2||8
7789577|NCT01263197|19176116|P6|NOT COMPLETED|Second Intervention (Period 2)||0
7789578|NCT01263197|19176117|P5|NOT COMPLETED|Second Intervention (Period 2)||0
7789579|NCT01263197|19176118|P4|NOT COMPLETED|Second Intervention (Period 2)||0
7789580|NCT01263197|19176119|P3|NOT COMPLETED|Second Intervention (Period 2)||0
7789581|NCT01263197|19176120|P2|NOT COMPLETED|Second Intervention (Period 2)||0
7789582|NCT01263197|19176121|P1|NOT COMPLETED|Second Intervention (Period 2)||0
7789583|NCT01263197|19176116|P6|COMPLETED|Second Intervention (Period 2)||7
7789584|NCT01263197|19176117|P5|COMPLETED|Second Intervention (Period 2)||7
7789585|NCT01263197|19176118|P4|COMPLETED|Second Intervention (Period 2)||8
7789586|NCT01263197|19176119|P3|COMPLETED|Second Intervention (Period 2)||8
7789587|NCT01263197|19176120|P2|COMPLETED|Second Intervention (Period 2)||8
7789588|NCT01263197|19176121|P1|COMPLETED|Second Intervention (Period 2)||8
7789589|NCT01263197|19176116|P6|STARTED|Second Intervention (Period 2)||7
7789590|NCT01263197|19176117|P5|STARTED|Second Intervention (Period 2)||7
7789591|NCT01263197|19176118|P4|STARTED|Second Intervention (Period 2)||8
7789592|NCT01263197|19176119|P3|STARTED|Second Intervention (Period 2)||8
7789593|NCT01263197|19176120|P2|STARTED|Second Intervention (Period 2)||8
7789594|NCT01263197|19176121|P1|STARTED|Second Intervention (Period 2)||8
7789595|NCT01263197|19176116|P6|NOT COMPLETED|Washout Period 1||0
7789596|NCT01263197|19176117|P5|NOT COMPLETED|Washout Period 1||1
7789597|NCT01263197|19176118|P4|NOT COMPLETED|Washout Period 1||0
7789598|NCT01263197|19176119|P3|NOT COMPLETED|Washout Period 1||0
7789599|NCT01263197|19176120|P2|NOT COMPLETED|Washout Period 1||0
7789600|NCT01263197|19176121|P1|NOT COMPLETED|Washout Period 1||0
7789601|NCT01263197|19176116|P6|COMPLETED|Washout Period 1||7
7789602|NCT01263197|19176117|P5|COMPLETED|Washout Period 1||7
7789603|NCT01263197|19176118|P4|COMPLETED|Washout Period 1||8
7789604|NCT01263197|19176119|P3|COMPLETED|Washout Period 1||8
7789605|NCT01263197|19176120|P2|COMPLETED|Washout Period 1||8
7789606|NCT01263197|19176121|P1|COMPLETED|Washout Period 1||8
7789607|NCT01263197|19176116|P6|STARTED|Washout Period 1||7
7789608|NCT01263197|19176117|P5|STARTED|Washout Period 1||8
7789609|NCT01263197|19176118|P4|STARTED|Washout Period 1||8
7789610|NCT01263197|19176119|P3|STARTED|Washout Period 1||8
7789611|NCT01263197|19176120|P2|STARTED|Washout Period 1||8
7789612|NCT01263197|19176121|P1|STARTED|Washout Period 1||8
7789613|NCT01263197|19176116|P6|NOT COMPLETED|First Intervention (Period 1)||1
7789614|NCT01263197|19176117|P5|NOT COMPLETED|First Intervention (Period 1)||0
7789615|NCT01263197|19176118|P4|NOT COMPLETED|First Intervention (Period 1)||0
7789616|NCT01263197|19176119|P3|NOT COMPLETED|First Intervention (Period 1)||0
7789617|NCT01263197|19176120|P2|NOT COMPLETED|First Intervention (Period 1)||0
7789618|NCT01263197|19176121|P1|NOT COMPLETED|First Intervention (Period 1)||0
7789619|NCT01263197|19176116|P6|COMPLETED|First Intervention (Period 1)||7
7789620|NCT01263197|19176117|P5|COMPLETED|First Intervention (Period 1)||8
7789621|NCT01263197|19176118|P4|COMPLETED|First Intervention (Period 1)||8
7789622|NCT01263197|19176119|P3|COMPLETED|First Intervention (Period 1)||8
7789623|NCT01263197|19176120|P2|COMPLETED|First Intervention (Period 1)||8
7789624|NCT01263197|19176121|P1|COMPLETED|First Intervention (Period 1)||8
7789625|NCT01263197|19176116|P6|STARTED|First Intervention (Period 1)||8
7789626|NCT01263197|19176117|P5|STARTED|First Intervention (Period 1)||8
7789627|NCT01263197|19176118|P4|STARTED|First Intervention (Period 1)||8
7789628|NCT01263197|19176119|P3|STARTED|First Intervention (Period 1)||8
7789629|NCT01263197|19176120|P2|STARTED|First Intervention (Period 1)||8
7789630|NCT01263197|19176121|P1|STARTED|First Intervention (Period 1)||8
7789631|NCT01263132|19176149|P2|NOT COMPLETED|Overall Study||0
7789632|NCT01263132|19176150|P1|NOT COMPLETED|Overall Study||0
7789633|NCT01263132|19176149|P2|COMPLETED|Overall Study||37
7789634|NCT01263132|19176150|P1|COMPLETED|Overall Study||38
7789635|NCT01263132|19176149|P2|STARTED|Overall Study||37
7789636|NCT01263132|19176150|P1|STARTED|Overall Study||38
7789637|NCT01263119|19176164|P1|NOT COMPLETED|Period 2||2
7789638|NCT01263119|19176164|P1|COMPLETED|Period 2||14
7789639|NCT01263119|19176164|P1|STARTED|Period 2||16
7789640|NCT01263119|19176164|P1|NOT COMPLETED|Period 1||2
7789641|NCT01263119|19176164|P1|COMPLETED|Period 1||16
7789642|NCT01263119|19176164|P1|STARTED|Period 1||18
7789643|NCT01263106|19176185|P2|NOT COMPLETED|Period 2 (7 Days)||0
7789644|NCT01263106|19176186|P1|NOT COMPLETED|Period 2 (7 Days)||0
7789645|NCT01263106|19176185|P2|COMPLETED|Period 2 (7 Days)||9
7789646|NCT01263106|19176186|P1|COMPLETED|Period 2 (7 Days)||10
7789647|NCT01263106|19176185|P2|STARTED|Period 2 (7 Days)||9
7789648|NCT01263106|19176186|P1|STARTED|Period 2 (7 Days)||10
7789649|NCT01263106|19176185|P2|NOT COMPLETED|Washout (at Least 7 Days)||1
7789650|NCT01263106|19176186|P1|NOT COMPLETED|Washout (at Least 7 Days)||1
7789651|NCT01263106|19176185|P2|COMPLETED|Washout (at Least 7 Days)||9
7789652|NCT01263106|19176186|P1|COMPLETED|Washout (at Least 7 Days)||10
7789653|NCT01263106|19176185|P2|STARTED|Washout (at Least 7 Days)||10
7789654|NCT01263106|19176186|P1|STARTED|Washout (at Least 7 Days)||11
7789655|NCT01263106|19176185|P2|NOT COMPLETED|Period 1 (7 Days)||0
7789656|NCT01263106|19176186|P1|NOT COMPLETED|Period 1 (7 Days)||0
7789657|NCT01263106|19176185|P2|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took LY + theophylline but was not given theophylline alone.|10
7789658|NCT01263106|19176186|P1|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took theophylline alone but was not given LY + theophylline.|11
7789659|NCT01263106|19176185|P2|STARTED|Period 1 (7 Days)||10
7789660|NCT01263106|19176186|P1|STARTED|Period 1 (7 Days)||11
7789661|NCT01263093|19176201|P2|NOT COMPLETED|Period 2||0
7789662|NCT01263093|19176202|P1|NOT COMPLETED|Period 2||1
7789663|NCT01263093|19176201|P2|COMPLETED|Period 2||23
7789664|NCT01263093|19176202|P1|COMPLETED|Period 2||22
7789665|NCT01263093|19176201|P2|STARTED|Period 2||23
7789666|NCT01263093|19176202|P1|STARTED|Period 2||23
7789667|NCT01263093|19176201|P2|NOT COMPLETED|Washout||0
7789668|NCT01263093|19176202|P1|NOT COMPLETED|Washout||1
7789669|NCT01263093|19176201|P2|COMPLETED|Washout||23
7789670|NCT01263093|19176202|P1|COMPLETED|Washout||23
7789671|NCT01263093|19176201|P2|STARTED|Washout||23
7789672|NCT01263093|19176202|P1|STARTED|Washout||24
7789673|NCT01263093|19176201|P2|NOT COMPLETED|Period 1||0
7789674|NCT01263093|19176202|P1|NOT COMPLETED|Period 1||0
7789675|NCT01263093|19176201|P2|COMPLETED|Period 1||23
7789676|NCT01263093|19176202|P1|COMPLETED|Period 1||24
7789677|NCT01263093|19176201|P2|STARTED|Period 1||23
7789678|NCT01263093|19176202|P1|STARTED|Period 1||24
7789679|NCT01263054|19176219|P2|NOT COMPLETED|Overall Study||6
7789680|NCT01263054|19176220|P1|NOT COMPLETED|Overall Study||5
7789681|NCT01263054|19176219|P2|COMPLETED|Overall Study||28
7789682|NCT01263054|19176220|P1|COMPLETED|Overall Study||24
7789683|NCT01263054|19176219|P2|STARTED|Overall Study||34
7789684|NCT01263054|19176220|P1|STARTED|Overall Study||29
7789685|NCT01263028|19176238|P1|NOT COMPLETED|Overall Study||6
7789686|NCT01263028|19176238|P1|COMPLETED|Overall Study||0
7789687|NCT01263028|19176238|P1|STARTED|Overall Study||6
7789688|NCT01263015|19176248|P2|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31
7789689|NCT01263015|19176249|P1|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24
7789690|NCT01263015|19176248|P2|COMPLETED|Open-label Phase: 48 Weeks Duration||278
7789691|NCT01263015|19176249|P1|COMPLETED|Open-label Phase: 48 Weeks Duration||317
7789692|NCT01263015|19176248|P2|STARTED|Open-label Phase: 48 Weeks Duration||309
7789693|NCT01263015|19176249|P1|STARTED|Open-label Phase: 48 Weeks Duration||341
7789694|NCT01263015|19176248|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109
7789695|NCT01263015|19176249|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72
7789696|NCT01263015|19176248|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||310
7789697|NCT01263015|19176249|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||342
7789698|NCT01263015|19176248|P2|STARTED|Double-blind Phase: 96 Weeks Duration||419
7789699|NCT01263015|19176249|P1|STARTED|Double-blind Phase: 96 Weeks Duration||414
7789700|NCT01262989|19176275|P2|NOT COMPLETED|Period 2||1
7789701|NCT01262989|19176276|P1|NOT COMPLETED|Period 2||0
7789702|NCT01262989|19176275|P2|COMPLETED|Period 2||16
7789703|NCT01262989|19176276|P1|COMPLETED|Period 2||19
7789704|NCT01262989|19176275|P2|STARTED|Period 2||17
7789705|NCT01262989|19176276|P1|STARTED|Period 2||19
7789706|NCT01262989|19176275|P2|NOT COMPLETED|7-Day Washout Period||0
7789707|NCT01262989|19176276|P1|NOT COMPLETED|7-Day Washout Period||0
7789708|NCT01262989|19176275|P2|COMPLETED|7-Day Washout Period||17
7789709|NCT01262989|19176276|P1|COMPLETED|7-Day Washout Period||19
7789710|NCT01262989|19176275|P2|STARTED|7-Day Washout Period||17
7789711|NCT01262989|19176276|P1|STARTED|7-Day Washout Period||19
7789712|NCT01262989|19176275|P2|NOT COMPLETED|Period 1||3
7789713|NCT01262989|19176276|P1|NOT COMPLETED|Period 1||1
7789714|NCT01262989|19176275|P2|COMPLETED|Period 1||17
7789715|NCT01262989|19176276|P1|COMPLETED|Period 1||19
7789716|NCT01262989|19176275|P2|STARTED|Period 1||20
7789717|NCT01262989|19176276|P1|STARTED|Period 1||20
7789718|NCT01262976|19176292|P6|NOT COMPLETED|Up to Year 3||4
7789719|NCT01262976|19176293|P5|NOT COMPLETED|Up to Year 3||2
7789720|NCT01262976|19176294|P4|NOT COMPLETED|Up to Year 3||5
7789721|NCT01262976|19176295|P3|NOT COMPLETED|Up to Year 3||7
7789722|NCT01262976|19176296|P2|NOT COMPLETED|Up to Year 3||2
7789723|NCT01262976|19176297|P1|NOT COMPLETED|Up to Year 3||6
7789724|NCT01262976|19176292|P6|COMPLETED|Up to Year 3||36
7789725|NCT01262976|19176293|P5|COMPLETED|Up to Year 3||38
7789726|NCT01262976|19176294|P4|COMPLETED|Up to Year 3||35
7789727|NCT01262976|19176295|P3|COMPLETED|Up to Year 3||33
7789728|NCT01262976|19176296|P2|COMPLETED|Up to Year 3||38
7789729|NCT01262976|19176297|P1|COMPLETED|Up to Year 3||34
7789730|NCT01262976|19176292|P6|STARTED|Up to Year 3||40
7789731|NCT01262976|19176293|P5|STARTED|Up to Year 3||40
7789732|NCT01262976|19176294|P4|STARTED|Up to Year 3||40
7789733|NCT01262976|19176295|P3|STARTED|Up to Year 3||40
7789734|NCT01262976|19176296|P2|STARTED|Up to Year 3||40
7789735|NCT01262976|19176297|P1|STARTED|Up to Year 3||40
7789736|NCT01262976|19176292|P6|NOT COMPLETED|Up to Year 2||5
7789737|NCT01262976|19176293|P5|NOT COMPLETED|Up to Year 2||4
7789738|NCT01262976|19176294|P4|NOT COMPLETED|Up to Year 2||4
7789739|NCT01262976|19176295|P3|NOT COMPLETED|Up to Year 2||5
7789740|NCT01262976|19176296|P2|NOT COMPLETED|Up to Year 2||1
7789741|NCT01262976|19176297|P1|NOT COMPLETED|Up to Year 2||5
7789742|NCT01262976|19176292|P6|COMPLETED|Up to Year 2||35
7789743|NCT01262976|19176293|P5|COMPLETED|Up to Year 2||36
7789744|NCT01262976|19176294|P4|COMPLETED|Up to Year 2||36
7789745|NCT01262976|19176295|P3|COMPLETED|Up to Year 2||35
7789746|NCT01262976|19176296|P2|COMPLETED|Up to Year 2||39
7789747|NCT01262976|19176297|P1|COMPLETED|Up to Year 2||35
7789748|NCT01262976|19176292|P6|STARTED|Up to Year 2||40
7789749|NCT01262976|19176293|P5|STARTED|Up to Year 2||40
7789750|NCT01262976|19176294|P4|STARTED|Up to Year 2||40
7789751|NCT01262976|19176295|P3|STARTED|Up to Year 2||40
7789752|NCT01262976|19176296|P2|STARTED|Up to Year 2||40
7789753|NCT01262976|19176297|P1|STARTED|Up to Year 2||40
7789754|NCT01262976|19176292|P6|NOT COMPLETED|Up to Year 1||9
7789755|NCT01262976|19176293|P5|NOT COMPLETED|Up to Year 1||11
7789756|NCT01262976|19176294|P4|NOT COMPLETED|Up to Year 1||4
7789757|NCT01262976|19176295|P3|NOT COMPLETED|Up to Year 1||3
7789758|NCT01262976|19176296|P2|NOT COMPLETED|Up to Year 1||1
7789759|NCT01262976|19176297|P1|NOT COMPLETED|Up to Year 1||9
7789760|NCT01262976|19176292|P6|COMPLETED|Up to Year 1||31
7789761|NCT01262976|19176293|P5|COMPLETED|Up to Year 1||29
7789762|NCT01262976|19176294|P4|COMPLETED|Up to Year 1||36
7789763|NCT01262976|19176295|P3|COMPLETED|Up to Year 1||37
7789764|NCT01262976|19176296|P2|COMPLETED|Up to Year 1||39
7789765|NCT01262976|19176297|P1|COMPLETED|Up to Year 1||31
7789766|NCT01262976|19176292|P6|STARTED|Up to Year 1||40
7789767|NCT01262976|19176293|P5|STARTED|Up to Year 1||40
7789768|NCT01262976|19176294|P4|STARTED|Up to Year 1||40
7789769|NCT01262976|19176295|P3|STARTED|Up to Year 1||40
7789770|NCT01262976|19176296|P2|STARTED|Up to Year 1||40
7789771|NCT01262976|19176297|P1|STARTED|Up to Year 1||40
7789772|NCT01262976|19176292|P6|NOT COMPLETED|Up to Month 7||4
7789773|NCT01262976|19176293|P5|NOT COMPLETED|Up to Month 7||2
7789774|NCT01262976|19176294|P4|NOT COMPLETED|Up to Month 7||6
7789775|NCT01262976|19176295|P3|NOT COMPLETED|Up to Month 7||6
7789776|NCT01262976|19176296|P2|NOT COMPLETED|Up to Month 7||0
7789777|NCT01262976|19176297|P1|NOT COMPLETED|Up to Month 7||5
7789778|NCT01262976|19176292|P6|COMPLETED|Up to Month 7||36
7789779|NCT01262976|19176293|P5|COMPLETED|Up to Month 7||38
7789780|NCT01262976|19176294|P4|COMPLETED|Up to Month 7||34
7789781|NCT01262976|19176295|P3|COMPLETED|Up to Month 7||34
7789782|NCT01262976|19176296|P2|COMPLETED|Up to Month 7||40
7789783|NCT01262976|19176297|P1|COMPLETED|Up to Month 7||35
7789784|NCT01262976|19176292|P6|STARTED|Up to Month 7||40
7789785|NCT01262976|19176293|P5|STARTED|Up to Month 7||40
7789786|NCT01262976|19176294|P4|STARTED|Up to Month 7||40
7789787|NCT01262976|19176295|P3|STARTED|Up to Month 7||40
7789788|NCT01262976|19176296|P2|STARTED|Up to Month 7||40
7789789|NCT01262976|19176297|P1|STARTED|Up to Month 7||40
7789790|NCT01262976|19176292|P6|NOT COMPLETED|Up to Month 2||4
7789791|NCT01262976|19176293|P5|NOT COMPLETED|Up to Month 2||2
7789792|NCT01262976|19176294|P4|NOT COMPLETED|Up to Month 2||2
7789793|NCT01262976|19176295|P3|NOT COMPLETED|Up to Month 2||1
7789794|NCT01262976|19176296|P2|NOT COMPLETED|Up to Month 2||1
7789795|NCT01262976|19176297|P1|NOT COMPLETED|Up to Month 2||3
7789796|NCT01262976|19176292|P6|COMPLETED|Up to Month 2||36
7789797|NCT01262976|19176293|P5|COMPLETED|Up to Month 2||38
7789798|NCT01262976|19176294|P4|COMPLETED|Up to Month 2||38
7789799|NCT01262976|19176295|P3|COMPLETED|Up to Month 2||39
7789800|NCT01262976|19176296|P2|COMPLETED|Up to Month 2||39
7789801|NCT01262976|19176297|P1|COMPLETED|Up to Month 2||37
7789802|NCT01262976|19176292|P6|STARTED|Up to Month 2||40
7789803|NCT01262976|19176293|P5|STARTED|Up to Month 2||40
7789804|NCT01262976|19176294|P4|STARTED|Up to Month 2||40
7789805|NCT01262976|19176295|P3|STARTED|Up to Month 2||40
7789806|NCT01262976|19176296|P2|STARTED|Up to Month 2||40
7789807|NCT01262976|19176297|P1|STARTED|Up to Month 2||40
7789808|NCT01262898|19176453|P4|NOT COMPLETED|Overall Study||0
7789809|NCT01262898|19176454|P3|NOT COMPLETED|Overall Study||0
7789810|NCT01262898|19176455|P2|NOT COMPLETED|Overall Study||2
7789811|NCT01262898|19176456|P1|NOT COMPLETED|Overall Study||3
7789812|NCT01262898|19176453|P4|COMPLETED|Overall Study||22
7789813|NCT01262898|19176454|P3|COMPLETED|Overall Study||18
7789814|NCT01262898|19176455|P2|COMPLETED|Overall Study||16
7789815|NCT01262898|19176456|P1|COMPLETED|Overall Study||18
7789816|NCT01262898|19176453|P4|STARTED|Overall Study||22
7789817|NCT01262898|19176454|P3|STARTED|Overall Study||18
7789818|NCT01262898|19176455|P2|STARTED|Overall Study||18
7789819|NCT01262898|19176456|P1|STARTED|Overall Study||21
7789820|NCT01262872|19176584|P8|NOT COMPLETED|Step 2||6
7789821|NCT01262872|19176585|P7|NOT COMPLETED|Step 2||9
7789822|NCT01262872|19176586|P6|NOT COMPLETED|Step 2||9
7789823|NCT01262872|19176587|P5|NOT COMPLETED|Step 2||5
7789824|NCT01262872|19176588|P4|NOT COMPLETED|Step 2||10
7789825|NCT01262872|19176589|P3|NOT COMPLETED|Step 2||9
7789826|NCT01262872|19176590|P2|NOT COMPLETED|Step 2||0
7789827|NCT01262872|19176591|P1|NOT COMPLETED|Step 2||0
7789828|NCT01262872|19176584|P8|COMPLETED|Step 2||194
7789829|NCT01262872|19176585|P7|COMPLETED|Step 2||191
7789830|NCT01262872|19176586|P6|COMPLETED|Step 2||191
7789831|NCT01262872|19176587|P5|COMPLETED|Step 2||195
7789832|NCT01262872|19176588|P4|COMPLETED|Step 2||190
7789833|NCT01262872|19176589|P3|COMPLETED|Step 2||191
7789834|NCT01262872|19176590|P2|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
7789835|NCT01262872|19176591|P1|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
7789836|NCT01262872|19176584|P8|STARTED|Step 2||200
7789837|NCT01262872|19176585|P7|STARTED|Step 2||200
7789838|NCT01262872|19176586|P6|STARTED|Step 2||200
7789839|NCT01262872|19176587|P5|STARTED|Step 2||200
7789840|NCT01262872|19176588|P4|STARTED|Step 2||200
7789841|NCT01262872|19176589|P3|STARTED|Step 2||200
7789842|NCT01262872|19176590|P2|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
7789843|NCT01262872|19176591|P1|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
7789844|NCT01262872|19176584|P8|NOT COMPLETED|Step 1||0
7789845|NCT01262872|19176585|P7|NOT COMPLETED|Step 1||0
7789846|NCT01262872|19176586|P6|NOT COMPLETED|Step 1||0
7789847|NCT01262872|19176587|P5|NOT COMPLETED|Step 1||0
7789848|NCT01262872|19176588|P4|NOT COMPLETED|Step 1||0
7789849|NCT01262872|19176589|P3|NOT COMPLETED|Step 1||0
7789850|NCT01262872|19176590|P2|NOT COMPLETED|Step 1||0
7789851|NCT01262872|19176591|P1|NOT COMPLETED|Step 1||0
7789852|NCT01262872|19176584|P8|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
7789853|NCT01262872|19176585|P7|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
7789854|NCT01262872|19176586|P6|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
7789855|NCT01262872|19176587|P5|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
7789856|NCT01262872|19176588|P4|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0
7789857|NCT01262872|19176589|P3|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
7789858|NCT01262872|19176590|P2|COMPLETED|Step 1||60
7789859|NCT01262872|19176591|P1|COMPLETED|Step 1||60
7789860|NCT01262872|19176584|P8|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
7789861|NCT01262872|19176585|P7|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
7789862|NCT01262872|19176586|P6|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
7789863|NCT01262872|19176587|P5|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
7789864|NCT01262872|19176588|P4|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
7789865|NCT01262872|19176589|P3|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
7789866|NCT01262872|19176590|P2|STARTED|Step 1||60
7789867|NCT01262872|19176591|P1|STARTED|Step 1||60
7789868|NCT01262846|19176858|P2|NOT COMPLETED|Overall Study||3
7789869|NCT01262846|19176859|P1|NOT COMPLETED|Overall Study||2
7789870|NCT01262846|19176858|P2|COMPLETED|Overall Study||97
7789871|NCT01262846|19176859|P1|COMPLETED|Overall Study||93
7789872|NCT01262846|19176858|P2|STARTED|Overall Study||100
7789873|NCT01262846|19176859|P1|STARTED|Overall Study||95
7789874|NCT01262820|19176865|P1|NOT COMPLETED|Overall Study||15
7789875|NCT01262820|19176865|P1|COMPLETED|Overall Study||0
7789876|NCT01262820|19176865|P1|STARTED|Overall Study||15
7789877|NCT01262755|19176872|P1|NOT COMPLETED|Overall Study||0
7789878|NCT01262755|19176872|P1|COMPLETED|Overall Study||450
7789879|NCT01262755|19176872|P1|STARTED|Overall Study||450
7789880|NCT01262677|19176879|P3|NOT COMPLETED|Overall Study||12
7789881|NCT01262677|19176880|P2|NOT COMPLETED|Overall Study||15
7789882|NCT01262677|19176881|P1|NOT COMPLETED|Overall Study||9
7789883|NCT01262677|19176879|P3|COMPLETED|Overall Study||98
7789884|NCT01262677|19176880|P2|COMPLETED|Overall Study||98
7789885|NCT01262677|19176881|P1|COMPLETED|Overall Study||91
7789886|NCT01262677|19176879|P3|STARTED|Overall Study||110
7789887|NCT01262677|19176880|P2|STARTED|Overall Study||113
7789888|NCT01262677|19176881|P1|STARTED|Overall Study||100
7789889|NCT01262651|19176972|P2|NOT COMPLETED|Overall Study||48
7789890|NCT01262651|19176973|P1|NOT COMPLETED|Overall Study||58
7789891|NCT01262651|19176972|P2|COMPLETED|Overall Study||150
7789892|NCT01262651|19176973|P1|COMPLETED|Overall Study||141
7789893|NCT01262651|19176972|P2|ITT Population|Overall Study||198
7789894|NCT01262651|19176973|P1|ITT Population|Overall Study||199
7789895|NCT01262651|19176972|P2|Safety Population|Overall Study||198
7789896|NCT01262651|19176973|P1|Safety Population|Overall Study||199
7789897|NCT01262651|19176972|P2|Received at Least 1 Dose of Study Drug|Overall Study||198
7789898|NCT01262651|19176973|P1|Received at Least 1 Dose of Study Drug|Overall Study||199
7789899|NCT01262651|19176972|P2|STARTED|Overall Study||198
7789900|NCT01262651|19176973|P1|STARTED|Overall Study||199
7789901|NCT01262599|19177001|P2|NOT COMPLETED|Overall Study||0
7789902|NCT01262599|19177002|P1|NOT COMPLETED|Overall Study||0
7789903|NCT01262599|19177001|P2|COMPLETED|Overall Study||16
7789904|NCT01262599|19177002|P1|COMPLETED|Overall Study||16
7789905|NCT01262599|19177001|P2|STARTED|Overall Study||16
7789906|NCT01262599|19177002|P1|STARTED|Overall Study||16
7789907|NCT01262573|19177014|P2|NOT COMPLETED|Overall Study||1
7789908|NCT01262573|19177015|P1|NOT COMPLETED|Overall Study||0
7789909|NCT01262573|19177014|P2|COMPLETED|Overall Study||31
7789910|NCT01262573|19177015|P1|COMPLETED|Overall Study||32
7789911|NCT01262573|19177014|P2|STARTED|Overall Study||32
7789912|NCT01262573|19177015|P1|STARTED|Overall Study||32
7789913|NCT01262560|19177026|P3|NOT COMPLETED|Overall Study||2
7789914|NCT01262560|19177027|P2|NOT COMPLETED|Overall Study||1
7789915|NCT01262560|19177028|P1|NOT COMPLETED|Overall Study||0
7789916|NCT01262560|19177026|P3|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|54
7789917|NCT01262560|19177027|P2|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
7789918|NCT01262560|19177028|P1|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
7789919|NCT01262560|19177026|P3|STARTED|Overall Study||56
7789920|NCT01262560|19177027|P2|STARTED|Overall Study||54
7789921|NCT01262560|19177028|P1|STARTED|Overall Study||53
7789922|NCT01262547|19177063|P1|NOT COMPLETED|Overall Study||0
7789923|NCT01262547|19177063|P1|COMPLETED|Overall Study||3
7789924|NCT01262547|19177063|P1|STARTED|Overall Study||3
7789925|NCT01262456|19177077|P3|NOT COMPLETED|1-Month Open-Label Extension Period||5
7789926|NCT01262456|19177078|P2|NOT COMPLETED|1-Month Open-Label Extension Period||3
7789927|NCT01262456|19177079|P1|NOT COMPLETED|1-Month Open-Label Extension Period||4
7789928|NCT01262456|19177077|P3|COMPLETED|1-Month Open-Label Extension Period||98
7789929|NCT01262456|19177078|P2|COMPLETED|1-Month Open-Label Extension Period||97
7789930|NCT01262456|19177079|P1|COMPLETED|1-Month Open-Label Extension Period||120
7789931|NCT01262456|19177077|P3|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102
7789932|NCT01262456|19177078|P2|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101
7789933|NCT01262456|19177079|P1|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124
7789934|NCT01262456|19177077|P3|STARTED|1-Month Open-Label Extension Period||103
7789935|NCT01262456|19177078|P2|STARTED|1-Month Open-Label Extension Period||100
7789936|NCT01262456|19177079|P1|STARTED|1-Month Open-Label Extension Period||124
7789937|NCT01262456|19177077|P3|NOT COMPLETED|3-Month Double-Blind Period||26
7789938|NCT01262456|19177078|P2|NOT COMPLETED|3-Month Double-Blind Period||23
7789939|NCT01262456|19177079|P1|NOT COMPLETED|3-Month Double-Blind Period||19
7789940|NCT01262456|19177077|P3|COMPLETED|3-Month Double-Blind Period||103
7789941|NCT01262456|19177078|P2|COMPLETED|3-Month Double-Blind Period||100
7789942|NCT01262456|19177079|P1|COMPLETED|3-Month Double-Blind Period||124
7789943|NCT01262456|19177077|P3|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122
7789944|NCT01262456|19177078|P2|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119
7789945|NCT01262456|19177079|P1|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143
7790120|NCT01261611|19177335|P1|STARTED|Treatment Cycle 1||156
7789946|NCT01262456|19177077|P3|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124
7789947|NCT01262456|19177078|P2|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119
7789948|NCT01262456|19177079|P1|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142
7789949|NCT01262456|19177077|P3|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129
7789950|NCT01262456|19177078|P2|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123
7789951|NCT01262456|19177079|P1|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143
7789952|NCT01262365|19177123|P3|NOT COMPLETED|Overall Study||94
7789953|NCT01262365|19177124|P2|NOT COMPLETED|Overall Study||81
7789954|NCT01262365|19177125|P1|NOT COMPLETED|Overall Study||90
7789955|NCT01262365|19177123|P3|COMPLETED|Overall Study||171
7789956|NCT01262365|19177124|P2|COMPLETED|Overall Study||181
7789957|NCT01262365|19177125|P1|COMPLETED|Overall Study||176
7789958|NCT01262365|19177123|P3|STARTED|Overall Study||265
7789959|NCT01262365|19177124|P2|STARTED|Overall Study||262
7789960|NCT01262365|19177125|P1|STARTED|Overall Study||266
7789961|NCT01262352|19177150|P2|NOT COMPLETED|Period 2||0
7789962|NCT01262352|19177151|P1|NOT COMPLETED|Period 2||0
7789963|NCT01262352|19177150|P2|COMPLETED|Period 2||8
7789964|NCT01262352|19177151|P1|COMPLETED|Period 2||9
7789965|NCT01262352|19177150|P2|Dosed|Period 2||8
7789966|NCT01262352|19177151|P1|Dosed|Period 2||9
7789967|NCT01262352|19177150|P2|STARTED|Period 2||8
7789968|NCT01262352|19177151|P1|STARTED|Period 2||9
7789969|NCT01262352|19177150|P2|NOT COMPLETED|Washout||2
7789970|NCT01262352|19177151|P1|NOT COMPLETED|Washout||1
7789971|NCT01262352|19177150|P2|COMPLETED|Washout||8
7789972|NCT01262352|19177151|P1|COMPLETED|Washout||9
7789973|NCT01262352|19177150|P2|STARTED|Washout||10
7789974|NCT01262352|19177151|P1|STARTED|Washout||10
7789975|NCT01262352|19177150|P2|NOT COMPLETED|Period 1||0
7789976|NCT01262352|19177151|P1|NOT COMPLETED|Period 1||1
7789977|NCT01262352|19177150|P2|COMPLETED|Period 1||10
7789978|NCT01262352|19177151|P1|COMPLETED|Period 1||10
7789979|NCT01262352|19177150|P2|Dosed|Period 1||10
7789980|NCT01262352|19177151|P1|Dosed|Period 1||10
7789981|NCT01262352|19177150|P2|STARTED|Period 1||10
7789982|NCT01262352|19177151|P1|STARTED|Period 1||11
7789983|NCT01262339|19177163|P1|NOT COMPLETED|Overall Study||0
7789984|NCT01262339|19177163|P1|COMPLETED|Overall Study||2
7789985|NCT01262339|19177163|P1|STARTED|Overall Study||2
7789986|NCT01262287|19177169|P2|NOT COMPLETED|Overall Study||1
7789987|NCT01262287|19177170|P1|NOT COMPLETED|Overall Study||2
7789988|NCT01262287|19177169|P2|COMPLETED|Overall Study||18
7789989|NCT01262287|19177170|P1|COMPLETED|Overall Study||18
7789990|NCT01262287|19177169|P2|STARTED|Overall Study||19
7789991|NCT01262287|19177170|P1|STARTED|Overall Study||20
7789992|NCT01262131|19177183|P3|NOT COMPLETED|Overall Study||0
7789993|NCT01262131|19177184|P2|NOT COMPLETED|Overall Study||0
7789994|NCT01262131|19177185|P1|NOT COMPLETED|Overall Study||0
7789995|NCT01262131|19177183|P3|COMPLETED|Overall Study||4
7789996|NCT01262131|19177184|P2|COMPLETED|Overall Study||4
7789997|NCT01262131|19177185|P1|COMPLETED|Overall Study||5
7789998|NCT01262131|19177183|P3|STARTED|Overall Study||4
7789999|NCT01262131|19177184|P2|STARTED|Overall Study||4
7790000|NCT01262131|19177185|P1|STARTED|Overall Study||5
7790001|NCT01262118|19177195|P2|NOT COMPLETED|Treatment Period (6 Weeks)||0
7790002|NCT01262118|19177196|P1|NOT COMPLETED|Treatment Period (6 Weeks)||0
7790003|NCT01262118|19177195|P2|COMPLETED|Treatment Period (6 Weeks)||0
7790004|NCT01262118|19177196|P1|COMPLETED|Treatment Period (6 Weeks)||36
7790005|NCT01262118|19177195|P2|STARTED|Treatment Period (6 Weeks)||0
7790006|NCT01262118|19177196|P1|STARTED|Treatment Period (6 Weeks)||36
7790007|NCT01262118|19177195|P2|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
7790008|NCT01262118|19177196|P1|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
7790009|NCT01262118|19177195|P2|COMPLETED|Baseline Assessment Period (3 Days)||33
7790010|NCT01262118|19177196|P1|COMPLETED|Baseline Assessment Period (3 Days)||36
7790011|NCT01262118|19177195|P2|STARTED|Baseline Assessment Period (3 Days)||33
7790012|NCT01262118|19177196|P1|STARTED|Baseline Assessment Period (3 Days)||36
7790013|NCT01262105|19177222|P2|NOT COMPLETED|Overall Study||0
7790014|NCT01262105|19177223|P1|NOT COMPLETED|Overall Study||0
7790015|NCT01262105|19177222|P2|COMPLETED|Overall Study||10
7790016|NCT01262105|19177223|P1|COMPLETED|Overall Study||13
7790017|NCT01262105|19177222|P2|STARTED|Overall Study||10
7790018|NCT01262105|19177223|P1|STARTED|Overall Study||13
7790019|NCT01262092|19177231|P2|NOT COMPLETED|Gabapentin Taper||0
7790020|NCT01262092|19177232|P1|NOT COMPLETED|Gabapentin Taper||1
7790021|NCT01262092|19177231|P2|COMPLETED|Gabapentin Taper||11
7790022|NCT01262092|19177232|P1|COMPLETED|Gabapentin Taper||9
7790023|NCT01262092|19177231|P2|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11
7790024|NCT01262092|19177232|P1|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10
7790025|NCT01262092|19177231|P2|NOT COMPLETED|Buprenorphine Taper||1
7790026|NCT01262092|19177232|P1|NOT COMPLETED|Buprenorphine Taper||1
7790027|NCT01262092|19177231|P2|COMPLETED|Buprenorphine Taper||12
7790028|NCT01262092|19177232|P1|COMPLETED|Buprenorphine Taper||11
7790029|NCT01262092|19177231|P2|STARTED|Buprenorphine Taper||13
7790030|NCT01262092|19177232|P1|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12
7790031|NCT01262092|19177231|P2|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1
7790032|NCT01262092|19177232|P1|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3
7790033|NCT01262092|19177231|P2|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
7790034|NCT01262092|19177232|P1|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
7790035|NCT01262092|19177231|P2|STARTED|Buprenorphine+Gabapentin/Plac Induction||14
7790036|NCT01262092|19177232|P1|STARTED|Buprenorphine+Gabapentin/Plac Induction||16
7790037|NCT01262027|19177238|P1|NOT COMPLETED|Overall Study||5
7790038|NCT01262027|19177238|P1|COMPLETED|Overall Study||17
7790039|NCT01262027|19177238|P1|STARTED|Overall Study||22
7790040|NCT01261975|19177243|P1|NOT COMPLETED|Overall Study||1
7790041|NCT01261975|19177243|P1|COMPLETED|Overall Study|35 Participants 70 eyes completed|35
7790042|NCT01261975|19177243|P1|STARTED|Overall Study|36 Participants 72 eyes started|36
7790043|NCT01261819|19177264|P2|NOT COMPLETED|Overall Study||0
7790044|NCT01261819|19177265|P1|NOT COMPLETED|Overall Study||0
7790045|NCT01261819|19177264|P2|COMPLETED|Overall Study||33
7790046|NCT01261819|19177265|P1|COMPLETED|Overall Study||33
7790047|NCT01261819|19177264|P2|STARTED|Overall Study||33
7790048|NCT01261819|19177265|P1|STARTED|Overall Study||33
7790049|NCT01261793|19177274|P3|NOT COMPLETED|Overall Study||82
7790050|NCT01261793|19177275|P2|NOT COMPLETED|Overall Study||91
7790051|NCT01261793|19177276|P1|NOT COMPLETED|Overall Study||85
7790052|NCT01261793|19177274|P3|COMPLETED|Overall Study||184
7790053|NCT01261793|19177275|P2|COMPLETED|Overall Study||171
7790054|NCT01261793|19177276|P1|COMPLETED|Overall Study||178
7790055|NCT01261793|19177274|P3|STARTED|Overall Study||266
7790056|NCT01261793|19177275|P2|STARTED|Overall Study||262
7790057|NCT01261793|19177276|P1|STARTED|Overall Study||263
7790058|NCT01261780|19177301|P2|NOT COMPLETED|Overall Study||2
7790059|NCT01261780|19177302|P1|NOT COMPLETED|Overall Study||2
7790060|NCT01261780|19177301|P2|COMPLETED|Overall Study||5
7790061|NCT01261780|19177302|P1|COMPLETED|Overall Study||5
7790062|NCT01261780|19177301|P2|STARTED|Overall Study||7
7790063|NCT01261780|19177302|P1|STARTED|Overall Study||7
7790064|NCT01261624|19177312|P2|NOT COMPLETED|Week 13 to Week 24||1
7790065|NCT01261624|19177313|P1|NOT COMPLETED|Week 13 to Week 24||0
7790066|NCT01261624|19177312|P2|COMPLETED|Week 13 to Week 24||10
7790067|NCT01261624|19177313|P1|COMPLETED|Week 13 to Week 24||1
7790068|NCT01261624|19177312|P2|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11
7790069|NCT01261624|19177313|P1|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1
7790070|NCT01261624|19177312|P2|NOT COMPLETED|Week 0 to Week 12||3
7790071|NCT01261624|19177313|P1|NOT COMPLETED|Week 0 to Week 12||1
7790072|NCT01261624|19177312|P2|COMPLETED|Week 0 to Week 12||3
7790073|NCT01261624|19177313|P1|COMPLETED|Week 0 to Week 12||9
7790074|NCT01261624|19177312|P2|STARTED|Week 0 to Week 12||6
7790075|NCT01261624|19177313|P1|STARTED|Week 0 to Week 12||10
7790076|NCT01261611|19177333|P3|NOT COMPLETED|Treatment Cycle 5||0
7790077|NCT01261611|19177334|P2|NOT COMPLETED|Treatment Cycle 5||0
7790078|NCT01261611|19177335|P1|NOT COMPLETED|Treatment Cycle 5||3
7790079|NCT01261611|19177333|P3|COMPLETED|Treatment Cycle 5||0
7790080|NCT01261611|19177334|P2|COMPLETED|Treatment Cycle 5||0
7790081|NCT01261611|19177335|P1|COMPLETED|Treatment Cycle 5||217
7790082|NCT01261611|19177333|P3|STARTED|Treatment Cycle 5||0
7790083|NCT01261611|19177334|P2|STARTED|Treatment Cycle 5||0
7790084|NCT01261611|19177335|P1|STARTED|Treatment Cycle 5||220
7790085|NCT01261611|19177333|P3|NOT COMPLETED|Treatment Cycle 4||0
7790086|NCT01261611|19177334|P2|NOT COMPLETED|Treatment Cycle 4||0
7790087|NCT01261611|19177335|P1|NOT COMPLETED|Treatment Cycle 4||96
7790088|NCT01261611|19177333|P3|COMPLETED|Treatment Cycle 4||0
7790089|NCT01261611|19177334|P2|COMPLETED|Treatment Cycle 4||0
7790090|NCT01261611|19177335|P1|COMPLETED|Treatment Cycle 4||220
7790091|NCT01261611|19177333|P3|STARTED|Treatment Cycle 4||0
7790092|NCT01261611|19177334|P2|STARTED|Treatment Cycle 4||0
7790093|NCT01261611|19177335|P1|STARTED|Treatment Cycle 4||316
7790094|NCT01261611|19177333|P3|NOT COMPLETED|Treatment Cycle 3||0
7790095|NCT01261611|19177334|P2|NOT COMPLETED|Treatment Cycle 3||0
7790096|NCT01261611|19177335|P1|NOT COMPLETED|Treatment Cycle 3||30
7790097|NCT01261611|19177333|P3|COMPLETED|Treatment Cycle 3||0
7790098|NCT01261611|19177334|P2|COMPLETED|Treatment Cycle 3||0
7790099|NCT01261611|19177335|P1|COMPLETED|Treatment Cycle 3||316
7790100|NCT01261611|19177333|P3|STARTED|Treatment Cycle 3||0
7790101|NCT01261611|19177334|P2|STARTED|Treatment Cycle 3||0
7790102|NCT01261611|19177335|P1|STARTED|Treatment Cycle 3||346
7790103|NCT01261611|19177333|P3|NOT COMPLETED|Treatment Cycle 2||0
7790104|NCT01261611|19177334|P2|NOT COMPLETED|Treatment Cycle 2||0
7790105|NCT01261611|19177335|P1|NOT COMPLETED|Treatment Cycle 2||13
7790106|NCT01261611|19177333|P3|COMPLETED|Treatment Cycle 2||0
7790107|NCT01261611|19177334|P2|COMPLETED|Treatment Cycle 2||0
7790108|NCT01261611|19177335|P1|COMPLETED|Treatment Cycle 2||346
7790109|NCT01261611|19177333|P3|STARTED|Treatment Cycle 2||0
7790110|NCT01261611|19177334|P2|STARTED|Treatment Cycle 2||0
7790111|NCT01261611|19177335|P1|STARTED|Treatment Cycle 2|All but 1 who completed DB period entered the open label period. This subject remained at Cycle 1.|359
7790112|NCT01261611|19177333|P3|NOT COMPLETED|Treatment Cycle 1||2
7790113|NCT01261611|19177334|P2|NOT COMPLETED|Treatment Cycle 1||3
7790114|NCT01261611|19177335|P1|NOT COMPLETED|Treatment Cycle 1||4
7790115|NCT01261611|19177333|P3|COMPLETED|Treatment Cycle 1||52
7790116|NCT01261611|19177334|P2|COMPLETED|Treatment Cycle 1||156
7790117|NCT01261611|19177335|P1|COMPLETED|Treatment Cycle 1||152
7790118|NCT01261611|19177333|P3|STARTED|Treatment Cycle 1||54
7790119|NCT01261611|19177334|P2|STARTED|Treatment Cycle 1||159
7790121|NCT01261559|19177373|P2|NOT COMPLETED|Overall Study||0
7790122|NCT01261559|19177374|P1|NOT COMPLETED|Overall Study||0
7790123|NCT01261559|19177373|P2|COMPLETED|Overall Study||36
7790124|NCT01261559|19177374|P1|COMPLETED|Overall Study||36
7790125|NCT01261559|19177373|P2|STARTED|Overall Study||36
7790126|NCT01261559|19177374|P1|STARTED|Overall Study||36
7790127|NCT01261507|19177386|P1|NOT COMPLETED|Overall Study||0
7790128|NCT01261507|19177386|P1|COMPLETED|Overall Study||15
7790129|NCT01261507|19177386|P1|STARTED|Overall Study||15
7790130|NCT01261390|19177399|P4|NOT COMPLETED|Overall Study||8
7790131|NCT01261390|19177400|P3|NOT COMPLETED|Overall Study||7
7790132|NCT01261390|19177401|P2|NOT COMPLETED|Overall Study||9
7790133|NCT01261390|19177402|P1|NOT COMPLETED|Overall Study||7
7790134|NCT01261390|19177399|P4|COMPLETED|Overall Study|14 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
7790135|NCT01261390|19177400|P3|COMPLETED|Overall Study|16 of the 35 participants that completed the study in this arm were under the 6-Month protocol.|35
7790136|NCT01261390|19177401|P2|COMPLETED|Overall Study|12 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
7790137|NCT01261390|19177402|P1|COMPLETED|Overall Study|14 of the 37 participants that completed the study in this arm were under the 6-Month protocol.|37
7790138|NCT01261390|19177399|P4|12-Month Visit|Overall Study||19
7790139|NCT01261390|19177400|P3|12-Month Visit|Overall Study||19
7790140|NCT01261390|19177401|P2|12-Month Visit|Overall Study||21
7790141|NCT01261390|19177402|P1|12-Month Visit|Overall Study||23
7790142|NCT01261390|19177399|P4|6-Month Visit|Overall Study|For 14 of the 32 participants in this arm, this was their final visit.|32
7790143|NCT01261390|19177400|P3|6-Month Visit|Overall Study|For 16 of the 34 participants in this arm, this was their final visit.|34
7790144|NCT01261390|19177401|P2|6-Month Visit|Overall Study|For 12 of the 34 participants in this arm, this was their final visit.|34
7790145|NCT01261390|19177402|P1|6-Month Visit|Overall Study|For 14 of the 30 participants in this arm, this was their final visit.|37
7790146|NCT01261390|19177399|P4|STARTED|Overall Study|15 of the 41 participants only had to complete a 6-month follow-up assessment.|41
7790147|NCT01261390|19177400|P3|STARTED|Overall Study|16 of the 42 participants only had to complete a 6-month follow-up assessment.|42
7790148|NCT01261390|19177401|P2|STARTED|Overall Study|15 of the 42 participants only had to complete a 6-month follow-up assessment.|42
7790149|NCT01261390|19177402|P1|STARTED|Overall Study|15 of the 44 participants only had to complete a 6-month follow-up assessment.|44
7790150|NCT01261338|19177566|P2|NOT COMPLETED|Overall Study||2
7790151|NCT01261338|19177567|P1|NOT COMPLETED|Overall Study||3
7790152|NCT01261338|19177566|P2|COMPLETED|Overall Study||12
7790153|NCT01261338|19177567|P1|COMPLETED|Overall Study||11
7790154|NCT01261338|19177566|P2|STARTED|Overall Study||14
7790155|NCT01261338|19177567|P1|STARTED|Overall Study|One person in the olestra group started 4 months after the trial began.|14
7790156|NCT01261325|19177578|P3|NOT COMPLETED|Overall Study||26
7790157|NCT01261325|19177579|P2|NOT COMPLETED|Overall Study||29
7790158|NCT01261325|19177580|P1|NOT COMPLETED|Overall Study||17
7790159|NCT01261325|19177578|P3|COMPLETED|Overall Study||225
7790160|NCT01261325|19177579|P2|COMPLETED|Overall Study||225
7790161|NCT01261325|19177580|P1|COMPLETED|Overall Study||246
7790162|NCT01261325|19177578|P3|STARTED|Overall Study||251
7790163|NCT01261325|19177579|P2|STARTED|Overall Study||254
7790164|NCT01261325|19177580|P1|STARTED|Overall Study||263
7790165|NCT01261247|19177612|P1|NOT COMPLETED|Overall Study||2
7790166|NCT01261247|19177612|P1|COMPLETED|Overall Study||39
7790167|NCT01261247|19177612|P1|STARTED|Overall Study||41
7790168|NCT01261052|19177619|P1|NOT COMPLETED|APD Only Intervention (33 Hours)||0
7790169|NCT01261052|19177619|P1|COMPLETED|APD Only Intervention (33 Hours)||14
7790170|NCT01261052|19177619|P1|STARTED|APD Only Intervention (33 Hours)||14
7790171|NCT01261052|19177619|P1|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0
7790172|NCT01261052|19177619|P1|COMPLETED|FMPD/APD Intervention (33 Hours)||14
7790173|NCT01261052|19177619|P1|STARTED|FMPD/APD Intervention (33 Hours)||14
7790174|NCT01261000|19177625|P1|NOT COMPLETED|Overall Study||1
7790175|NCT01261000|19177625|P1|COMPLETED|Overall Study||7
7790176|NCT01261000|19177625|P1|STARTED|Overall Study||8
7790177|NCT01260948|19177631|P2|NOT COMPLETED|Second Intervention||1
7790178|NCT01260948|19177632|P1|NOT COMPLETED|Second Intervention||0
7790179|NCT01260948|19177631|P2|COMPLETED|Second Intervention||9
7790180|NCT01260948|19177632|P1|COMPLETED|Second Intervention||12
7790181|NCT01260948|19177631|P2|STARTED|Second Intervention||10
7790182|NCT01260948|19177632|P1|STARTED|Second Intervention||12
7790183|NCT01260948|19177631|P2|NOT COMPLETED|Washout of 28 Days||3
7790184|NCT01260948|19177632|P1|NOT COMPLETED|Washout of 28 Days||1
7790185|NCT01260948|19177631|P2|COMPLETED|Washout of 28 Days||10
7790186|NCT01260948|19177632|P1|COMPLETED|Washout of 28 Days||12
7790187|NCT01260948|19177631|P2|STARTED|Washout of 28 Days||13
7790188|NCT01260948|19177632|P1|STARTED|Washout of 28 Days||13
7790189|NCT01260948|19177631|P2|NOT COMPLETED|First Intervention||0
7790190|NCT01260948|19177632|P1|NOT COMPLETED|First Intervention||0
7790191|NCT01260948|19177631|P2|COMPLETED|First Intervention||13
7790192|NCT01260948|19177632|P1|COMPLETED|First Intervention||13
7790193|NCT01260948|19177631|P2|STARTED|First Intervention||13
7790194|NCT01260948|19177632|P1|STARTED|First Intervention||13
7790195|NCT01260922|19177642|P2|NOT COMPLETED|Second Intervention||2
7790196|NCT01260922|19177643|P1|NOT COMPLETED|Second Intervention||0
7790197|NCT01260922|19177642|P2|COMPLETED|Second Intervention||8
7790198|NCT01260922|19177643|P1|COMPLETED|Second Intervention||9
7790199|NCT01260922|19177642|P2|STARTED|Second Intervention||10
7790200|NCT01260922|19177643|P1|STARTED|Second Intervention||9
7790201|NCT01260922|19177642|P2|NOT COMPLETED|Washout of 28 Days||2
7790202|NCT01260922|19177643|P1|NOT COMPLETED|Washout of 28 Days||4
7790203|NCT01260922|19177642|P2|COMPLETED|Washout of 28 Days||10
7790204|NCT01260922|19177643|P1|COMPLETED|Washout of 28 Days||9
7790205|NCT01260922|19177642|P2|STARTED|Washout of 28 Days||12
7790206|NCT01260922|19177643|P1|STARTED|Washout of 28 Days||13
7790207|NCT01260922|19177642|P2|NOT COMPLETED|First Intervention||1
7790208|NCT01260922|19177643|P1|NOT COMPLETED|First Intervention||0
7790209|NCT01260922|19177642|P2|COMPLETED|First Intervention||12
7790210|NCT01260922|19177643|P1|COMPLETED|First Intervention||13
7790211|NCT01260922|19177642|P2|STARTED|First Intervention||13
7790212|NCT01260922|19177643|P1|STARTED|First Intervention||13
7790213|NCT01260896|19177653|P2|NOT COMPLETED|Second Intervention||0
7790214|NCT01260896|19177654|P1|NOT COMPLETED|Second Intervention||0
7790215|NCT01260896|19177653|P2|COMPLETED|Second Intervention||12
7790216|NCT01260896|19177654|P1|COMPLETED|Second Intervention||10
7790217|NCT01260896|19177653|P2|STARTED|Second Intervention||12
7790218|NCT01260896|19177654|P1|STARTED|Second Intervention||10
7790219|NCT01260896|19177653|P2|NOT COMPLETED|Washout of 7 Days||0
7790220|NCT01260896|19177654|P1|NOT COMPLETED|Washout of 7 Days||0
7790221|NCT01260896|19177653|P2|COMPLETED|Washout of 7 Days||12
7790222|NCT01260896|19177654|P1|COMPLETED|Washout of 7 Days||10
7790223|NCT01260896|19177653|P2|STARTED|Washout of 7 Days||12
7790224|NCT01260896|19177654|P1|STARTED|Washout of 7 Days||10
7790225|NCT01260896|19177653|P2|NOT COMPLETED|First Intervention||0
7790226|NCT01260896|19177654|P1|NOT COMPLETED|First Intervention||2
7790227|NCT01260896|19177653|P2|COMPLETED|First Intervention||12
7790228|NCT01260896|19177654|P1|COMPLETED|First Intervention||10
7790229|NCT01260896|19177653|P2|STARTED|First Intervention||12
7790230|NCT01260896|19177654|P1|STARTED|First Intervention||12
7790231|NCT01260883|19177673|P3|NOT COMPLETED|Overall Study||0
7790232|NCT01260883|19177674|P2|NOT COMPLETED|Overall Study||0
7790233|NCT01260883|19177675|P1|NOT COMPLETED|Overall Study||0
7790234|NCT01260883|19177673|P3|COMPLETED|Overall Study||18
7790235|NCT01260883|19177674|P2|COMPLETED|Overall Study||11
7790236|NCT01260883|19177675|P1|COMPLETED|Overall Study||22
7790237|NCT01260883|19177673|P3|STARTED|Overall Study||18
7790238|NCT01260883|19177674|P2|STARTED|Overall Study||11
7790239|NCT01260883|19177675|P1|STARTED|Overall Study||22
7790240|NCT01260701|19177712|P1|NOT COMPLETED|Overall Study||75
7790241|NCT01260701|19177712|P1|COMPLETED|Overall Study||0
7790242|NCT01260701|19177712|P1|Eligible and Began Protocol Therapy|Overall Study||70
7790243|NCT01260701|19177712|P1|Eligible|Overall Study||71
7790244|NCT01260701|19177712|P1|STARTED|Overall Study||75
7790245|NCT01260688|19177721|P2|NOT COMPLETED|Overall Study||0
7790246|NCT01260688|19177722|P1|NOT COMPLETED|Overall Study||0
7790247|NCT01260688|19177721|P2|COMPLETED|Overall Study||11
7790248|NCT01260688|19177722|P1|COMPLETED|Overall Study||11
7790249|NCT01260688|19177721|P2|STARTED|Overall Study||11
7790250|NCT01260688|19177722|P1|STARTED|Overall Study||11
7790251|NCT01260662|19177759|P3|NOT COMPLETED|Overall Study||0
7790252|NCT01260662|19177760|P2|NOT COMPLETED|Overall Study||0
7790253|NCT01260662|19177761|P1|NOT COMPLETED|Overall Study||0
7790254|NCT01260662|19177759|P3|COMPLETED|Overall Study||96
7790255|NCT01260662|19177760|P2|COMPLETED|Overall Study||85
7790256|NCT01260662|19177761|P1|COMPLETED|Overall Study||90
7790257|NCT01260662|19177759|P3|STARTED|Overall Study||96
7790258|NCT01260662|19177760|P2|STARTED|Overall Study||85
7790259|NCT01260662|19177761|P1|STARTED|Overall Study||90
7790260|NCT01260649|19177780|P2|NOT COMPLETED|Overall Study||1
7790261|NCT01260649|19177781|P1|NOT COMPLETED|Overall Study||2
7790262|NCT01260649|19177780|P2|COMPLETED|Overall Study||8
7790263|NCT01260649|19177781|P1|COMPLETED|Overall Study||6
7790264|NCT01260649|19177780|P2|STARTED|Overall Study||9
7790265|NCT01260649|19177781|P1|STARTED|Overall Study||8
7790266|NCT01260584|19177793|P4|NOT COMPLETED|Period 2||1
7790267|NCT01260584|19177794|P3|NOT COMPLETED|Period 2||5
7790268|NCT01260584|19177795|P2|NOT COMPLETED|Period 2||3
7790269|NCT01260584|19177796|P1|NOT COMPLETED|Period 2||1
7790270|NCT01260584|19177793|P4|COMPLETED|Period 2||26
7790271|NCT01260584|19177794|P3|COMPLETED|Period 2||20
7790272|NCT01260584|19177795|P2|COMPLETED|Period 2||25
7790273|NCT01260584|19177796|P1|COMPLETED|Period 2||26
7790274|NCT01260584|19177793|P4|STARTED|Period 2||27
7790275|NCT01260584|19177794|P3|STARTED|Period 2||25
7790276|NCT01260584|19177795|P2|STARTED|Period 2||28
7790277|NCT01260584|19177796|P1|STARTED|Period 2||27
7790278|NCT01260584|19177793|P4|NOT COMPLETED|Period 1||1
7790279|NCT01260584|19177794|P3|NOT COMPLETED|Period 1||2
7790280|NCT01260584|19177795|P2|NOT COMPLETED|Period 1||0
7790281|NCT01260584|19177796|P1|NOT COMPLETED|Period 1||0
7790282|NCT01260584|19177793|P4|COMPLETED|Period 1||27
7790283|NCT01260584|19177794|P3|COMPLETED|Period 1||25
7790284|NCT01260584|19177795|P2|COMPLETED|Period 1||28
7790285|NCT01260584|19177796|P1|COMPLETED|Period 1||27
7790286|NCT01260584|19177793|P4|STARTED|Period 1||28
7790287|NCT01260584|19177794|P3|STARTED|Period 1||27
7790288|NCT01260584|19177795|P2|STARTED|Period 1||28
7790289|NCT01260584|19177796|P1|STARTED|Period 1||27
7790290|NCT01260493|19177832|P2|NOT COMPLETED|Overall Study||4
7790291|NCT01260493|19177833|P1|NOT COMPLETED|Overall Study||16
7790292|NCT01260493|19177832|P2|COMPLETED|Overall Study||85
7790293|NCT01260493|19177833|P1|COMPLETED|Overall Study||76
7790294|NCT01260493|19177832|P2|STARTED|Overall Study||89
7790295|NCT01260493|19177833|P1|STARTED|Overall Study||92
7790296|NCT01260467|19177839|P1|NOT COMPLETED|Overall Study||2
7790297|NCT01260467|19177839|P1|COMPLETED|Overall Study||2
7790298|NCT01260467|19177839|P1|STARTED|Overall Study||4
7790299|NCT01260454|19177845|P1|NOT COMPLETED|Overall Study||0
7790300|NCT01260454|19177845|P1|COMPLETED|Overall Study||6
7790301|NCT01260454|19177845|P1|STARTED|Overall Study||6
7790302|NCT01260350|19177871|P22|NOT COMPLETED|Overall Study||0
7790303|NCT01260350|19177872|P21|NOT COMPLETED|Overall Study||3
7790304|NCT01260350|19177873|P20|NOT COMPLETED|Overall Study||0
7790305|NCT01260350|19177874|P19|NOT COMPLETED|Overall Study||0
7790306|NCT01260350|19177875|P18|NOT COMPLETED|Overall Study||1
7790307|NCT01260350|19177876|P17|NOT COMPLETED|Overall Study||0
7790308|NCT01260350|19177877|P16|NOT COMPLETED|Overall Study||0
7790309|NCT01260350|19177878|P15|NOT COMPLETED|Overall Study||0
7790310|NCT01260350|19177879|P14|NOT COMPLETED|Overall Study||0
7790311|NCT01260350|19177880|P13|NOT COMPLETED|Overall Study||0
7790312|NCT01260350|19177881|P12|NOT COMPLETED|Overall Study||0
7790313|NCT01260350|19177882|P11|NOT COMPLETED|Overall Study||0
7790314|NCT01260350|19177883|P10|NOT COMPLETED|Overall Study||0
7790315|NCT01260350|19177884|P9|NOT COMPLETED|Overall Study||1
7790316|NCT01260350|19177885|P8|NOT COMPLETED|Overall Study||0
7790317|NCT01260350|19177886|P7|NOT COMPLETED|Overall Study||0
7790318|NCT01260350|19177887|P6|NOT COMPLETED|Overall Study||0
7790319|NCT01260350|19177888|P5|NOT COMPLETED|Overall Study||0
7790320|NCT01260350|19177889|P4|NOT COMPLETED|Overall Study||0
7790321|NCT01260350|19177890|P3|NOT COMPLETED|Overall Study||0
7790322|NCT01260350|19177891|P2|NOT COMPLETED|Overall Study||0
7790323|NCT01260350|19177892|P1|NOT COMPLETED|Overall Study||0
7790324|NCT01260350|19177871|P22|COMPLETED|Overall Study||0
7790325|NCT01260350|19177872|P21|COMPLETED|Overall Study||22
7790326|NCT01260350|19177873|P20|COMPLETED|Overall Study||14
7790327|NCT01260350|19177874|P19|COMPLETED|Overall Study||0
7790328|NCT01260350|19177875|P18|COMPLETED|Overall Study||9
7790329|NCT01260350|19177876|P17|COMPLETED|Overall Study||9
7790330|NCT01260350|19177877|P16|COMPLETED|Overall Study||10
7790331|NCT01260350|19177878|P15|COMPLETED|Overall Study||25
7790332|NCT01260350|19177879|P14|COMPLETED|Overall Study||10
7790333|NCT01260350|19177880|P13|COMPLETED|Overall Study||25
7790334|NCT01260350|19177881|P12|COMPLETED|Overall Study||9
7790335|NCT01260350|19177882|P11|COMPLETED|Overall Study||10
7790336|NCT01260350|19177883|P10|COMPLETED|Overall Study||25
7790337|NCT01260350|19177884|P9|COMPLETED|Overall Study||24
7790338|NCT01260350|19177885|P8|COMPLETED|Overall Study||25
7790339|NCT01260350|19177886|P7|COMPLETED|Overall Study||10
7790340|NCT01260350|19177887|P6|COMPLETED|Overall Study||10
7790341|NCT01260350|19177888|P5|COMPLETED|Overall Study||10
7790342|NCT01260350|19177889|P4|COMPLETED|Overall Study||11
7790343|NCT01260350|19177890|P3|COMPLETED|Overall Study||10
7790344|NCT01260350|19177891|P2|COMPLETED|Overall Study||9
7790345|NCT01260350|19177892|P1|COMPLETED|Overall Study||10
7790346|NCT01260350|19177871|P22|STARTED|Overall Study||0
7790347|NCT01260350|19177872|P21|STARTED|Overall Study||25
7790348|NCT01260350|19177873|P20|STARTED|Overall Study||14
7790349|NCT01260350|19177874|P19|STARTED|Overall Study||0
7790350|NCT01260350|19177875|P18|STARTED|Overall Study||10
7790351|NCT01260350|19177876|P17|STARTED|Overall Study||9
7790352|NCT01260350|19177877|P16|STARTED|Overall Study||10
7790353|NCT01260350|19177878|P15|STARTED|Overall Study||25
7790354|NCT01260350|19177879|P14|STARTED|Overall Study||10
7790355|NCT01260350|19177880|P13|STARTED|Overall Study||25
7790356|NCT01260350|19177881|P12|STARTED|Overall Study||9
7790357|NCT01260350|19177882|P11|STARTED|Overall Study||10
7790358|NCT01260350|19177883|P10|STARTED|Overall Study||25
7790359|NCT01260350|19177884|P9|STARTED|Overall Study||25
7790360|NCT01260350|19177885|P8|STARTED|Overall Study||25
7790361|NCT01260350|19177886|P7|STARTED|Overall Study||10
7790362|NCT01260350|19177887|P6|STARTED|Overall Study||10
7790363|NCT01260350|19177888|P5|STARTED|Overall Study||10
7790364|NCT01260350|19177889|P4|STARTED|Overall Study||11
7790365|NCT01260350|19177890|P3|STARTED|Overall Study||10
7790366|NCT01260350|19177891|P2|STARTED|Overall Study||9
7790367|NCT01260350|19177892|P1|STARTED|Overall Study||10
7790368|NCT01260324|19178084|P2|NOT COMPLETED|Overall Study||0
7790369|NCT01260324|19178085|P1|NOT COMPLETED|Overall Study||0
7790370|NCT01260324|19178084|P2|COMPLETED|Overall Study||20000
7790371|NCT01260324|19178085|P1|COMPLETED|Overall Study||1283
7790372|NCT01260324|19178084|P2|STARTED|Overall Study||20000
7790373|NCT01260324|19178085|P1|STARTED|Overall Study||1283
7790374|NCT01260311|19178099|P1|NOT COMPLETED|Overall Study||127
7790375|NCT01260311|19178099|P1|COMPLETED|Overall Study||381
7790376|NCT01260311|19178099|P1|STARTED|Overall Study||508
7790377|NCT01260272|19178109|P2|NOT COMPLETED|Overall Study||2
7790378|NCT01260272|19178110|P1|NOT COMPLETED|Overall Study||2
7790379|NCT01260272|19178109|P2|COMPLETED|Overall Study||30
7790380|NCT01260272|19178110|P1|COMPLETED|Overall Study||15
7790381|NCT01260272|19178109|P2|STARTED|Overall Study||32
7790382|NCT01260272|19178110|P1|STARTED|Overall Study||17
7790383|NCT01260194|19178130|P1|NOT COMPLETED|Overall Study||1
7790384|NCT01260194|19178130|P1|COMPLETED|Overall Study||3
7790385|NCT01260194|19178130|P1|STARTED|Overall Study||4
7790386|NCT01260181|19178142|P1|NOT COMPLETED|Overall Study||1
7790387|NCT01260181|19178142|P1|COMPLETED|Overall Study||29
7790388|NCT01260181|19178142|P1|STARTED|Overall Study||30
7790389|NCT01260142|19178157|P6|NOT COMPLETED|Treatment Period 2||0
7790390|NCT01260142|19178158|P5|NOT COMPLETED|Treatment Period 2||0
7790391|NCT01260142|19178159|P4|NOT COMPLETED|Treatment Period 2||0
7790392|NCT01260142|19178160|P3|NOT COMPLETED|Treatment Period 2||0
7790393|NCT01260142|19178161|P2|NOT COMPLETED|Treatment Period 2||0
7790394|NCT01260142|19178162|P1|NOT COMPLETED|Treatment Period 2||0
7790395|NCT01260142|19178157|P6|COMPLETED|Treatment Period 2||3
7790396|NCT01260142|19178158|P5|COMPLETED|Treatment Period 2||4
7790397|NCT01260142|19178159|P4|COMPLETED|Treatment Period 2||6
7790398|NCT01260142|19178160|P3|COMPLETED|Treatment Period 2||6
7790399|NCT01260142|19178161|P2|COMPLETED|Treatment Period 2||5
7790400|NCT01260142|19178162|P1|COMPLETED|Treatment Period 2||5
7790401|NCT01260142|19178157|P6|STARTED|Treatment Period 2||3
7790402|NCT01260142|19178158|P5|STARTED|Treatment Period 2||4
7790403|NCT01260142|19178159|P4|STARTED|Treatment Period 2||6
7790404|NCT01260142|19178160|P3|STARTED|Treatment Period 2||6
7790405|NCT01260142|19178161|P2|STARTED|Treatment Period 2||5
7790406|NCT01260142|19178162|P1|STARTED|Treatment Period 2||5
7790407|NCT01260142|19178157|P6|NOT COMPLETED|Treatment Period 1||3
7790408|NCT01260142|19178158|P5|NOT COMPLETED|Treatment Period 1||2
7790409|NCT01260142|19178159|P4|NOT COMPLETED|Treatment Period 1||0
7790410|NCT01260142|19178160|P3|NOT COMPLETED|Treatment Period 1||0
7790411|NCT01260142|19178161|P2|NOT COMPLETED|Treatment Period 1||1
7790412|NCT01260142|19178162|P1|NOT COMPLETED|Treatment Period 1||1
7790413|NCT01260142|19178157|P6|COMPLETED|Treatment Period 1||3
7790414|NCT01260142|19178158|P5|COMPLETED|Treatment Period 1||4
7790415|NCT01260142|19178159|P4|COMPLETED|Treatment Period 1||6
7790416|NCT01260142|19178160|P3|COMPLETED|Treatment Period 1||6
7790417|NCT01260142|19178161|P2|COMPLETED|Treatment Period 1||5
7790418|NCT01260142|19178162|P1|COMPLETED|Treatment Period 1||5
7790419|NCT01260142|19178157|P6|STARTED|Treatment Period 1||6
7790420|NCT01260142|19178158|P5|STARTED|Treatment Period 1||6
7790421|NCT01260142|19178159|P4|STARTED|Treatment Period 1||6
7790422|NCT01260142|19178160|P3|STARTED|Treatment Period 1||6
7790423|NCT01260142|19178161|P2|STARTED|Treatment Period 1||6
7790424|NCT01260142|19178162|P1|STARTED|Treatment Period 1||6
7790425|NCT01259869|19178212|P1|NOT COMPLETED|Overall Study||1
7790426|NCT01259869|19178212|P1|COMPLETED|Overall Study||33
7790427|NCT01259869|19178212|P1|STARTED|Overall Study||34
7790428|NCT01259856|19178218|P2|NOT COMPLETED|Overall Study||74
7790429|NCT01259856|19178219|P1|NOT COMPLETED|Overall Study||69
7790430|NCT01259856|19178218|P2|COMPLETED|Overall Study||12
7790431|NCT01259856|19178219|P1|COMPLETED|Overall Study||13
7790432|NCT01259856|19178218|P2|STARTED|Overall Study||86
7790433|NCT01259856|19178219|P1|STARTED|Overall Study||82
7790434|NCT01259726|19178243|P4|NOT COMPLETED|Overall Study||5
7790435|NCT01259726|19178244|P3|NOT COMPLETED|Overall Study||4
7790436|NCT01259726|19178245|P2|NOT COMPLETED|Overall Study||4
7790437|NCT01259726|19178246|P1|NOT COMPLETED|Overall Study||5
7790438|NCT01259726|19178243|P4|COMPLETED|Overall Study||36
7790439|NCT01259726|19178244|P3|COMPLETED|Overall Study||39
7790440|NCT01259726|19178245|P2|COMPLETED|Overall Study||37
7790441|NCT01259726|19178246|P1|COMPLETED|Overall Study||38
7790442|NCT01259726|19178243|P4|Treated|Overall Study||39
7790443|NCT01259726|19178244|P3|Treated|Overall Study||41
7790444|NCT01259726|19178245|P2|Treated|Overall Study||37
7790445|NCT01259726|19178246|P1|Treated|Overall Study||40
7790446|NCT01259726|19178243|P4|STARTED|Overall Study||41
7790447|NCT01259726|19178244|P3|STARTED|Overall Study||43
7790448|NCT01259726|19178245|P2|STARTED|Overall Study||41
7790449|NCT01259726|19178246|P1|STARTED|Overall Study||43
7790450|NCT01259713|19178278|P2|NOT COMPLETED|Overall Study||41
7790451|NCT01259713|19178279|P1|NOT COMPLETED|Overall Study||95
7790452|NCT01259713|19178278|P2|COMPLETED|Overall Study||77
7790453|NCT01259713|19178279|P1|COMPLETED|Overall Study||142
7790454|NCT01259713|19178278|P2|STARTED|Overall Study||118
7790455|NCT01259713|19178279|P1|STARTED|Overall Study||237
7790456|NCT01259596|19178303|P2|NOT COMPLETED|Overall Study||6
7790457|NCT01259596|19178304|P1|NOT COMPLETED|Overall Study||4
7790458|NCT01259596|19178303|P2|COMPLETED|Overall Study||65
7790459|NCT01259596|19178304|P1|COMPLETED|Overall Study||66
7790460|NCT01259596|19178303|P2|STARTED|Overall Study||71
7790461|NCT01259596|19178304|P1|STARTED|Overall Study||70
7790462|NCT01259492|19178326|P4|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81
7790463|NCT01259492|19178327|P3|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50
7790464|NCT01259492|19178328|P2|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69
7790465|NCT01259492|19178329|P1|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54
7790466|NCT01259492|19178326|P4|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42
7790467|NCT01259492|19178327|P3|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70
7790468|NCT01259492|19178328|P2|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63
7790469|NCT01259492|19178329|P1|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60
7790470|NCT01259492|19178326|P4|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115
7790471|NCT01259492|19178327|P3|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114
7790472|NCT01259492|19178328|P2|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128
7790473|NCT01259492|19178329|P1|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110
7790474|NCT01259492|19178326|P4|STARTED|Period 3 (Week 15 to End of Week 40)||123
7790475|NCT01259492|19178327|P3|STARTED|Period 3 (Week 15 to End of Week 40)||120
7790476|NCT01259492|19178328|P2|STARTED|Period 3 (Week 15 to End of Week 40)||132
7790477|NCT01259492|19178329|P1|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114
7790478|NCT01259492|19178326|P4|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28
7790479|NCT01259492|19178327|P3|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24
7790480|NCT01259492|19178328|P2|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18
7790481|NCT01259492|19178329|P1|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25
7790482|NCT01259492|19178326|P4|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125
7790483|NCT01259492|19178327|P3|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114
7790484|NCT01259492|19178328|P2|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123
7790485|NCT01259492|19178329|P1|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127
7790486|NCT01259492|19178326|P4|STARTED|Period 2 (Week 10 to Week 14)||153
7790487|NCT01259492|19178327|P3|STARTED|Period 2 (Week 10 to Week 14)||138
7790488|NCT01259492|19178328|P2|STARTED|Period 2 (Week 10 to Week 14)||141
7790489|NCT01259492|19178329|P1|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152
7790490|NCT01259492|19178326|P4|NOT COMPLETED|Period 1 (9 Weeks)||28
7790491|NCT01259492|19178327|P3|NOT COMPLETED|Period 1 (9 Weeks)||43
7790492|NCT01259492|19178328|P2|NOT COMPLETED|Period 1 (9 Weeks)||41
7790493|NCT01259492|19178329|P1|NOT COMPLETED|Period 1 (9 Weeks)||29
7790494|NCT01259492|19178326|P4|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153
7790495|NCT01259492|19178327|P3|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138
7790496|NCT01259492|19178328|P2|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141
7790497|NCT01259492|19178329|P1|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152
7790498|NCT01259492|19178326|P4|Full Analysis Set|Period 1 (9 Weeks)||172
7790499|NCT01259492|19178327|P3|Full Analysis Set|Period 1 (9 Weeks)||179
7790500|NCT01259492|19178328|P2|Full Analysis Set|Period 1 (9 Weeks)||175
7790501|NCT01259492|19178329|P1|Full Analysis Set|Period 1 (9 Weeks)||174
7790502|NCT01259492|19178326|P4|STARTED|Period 1 (9 Weeks)||181
7790503|NCT01259492|19178327|P3|STARTED|Period 1 (9 Weeks)||181
7790504|NCT01259492|19178328|P2|STARTED|Period 1 (9 Weeks)||182
7790505|NCT01259492|19178329|P1|STARTED|Period 1 (9 Weeks)||181
7790506|NCT01259466|19178378|P2|NOT COMPLETED|Overall Study||9
7790507|NCT01259466|19178379|P1|NOT COMPLETED|Overall Study||1
7790508|NCT01259466|19178378|P2|COMPLETED|Overall Study||18
7790509|NCT01259466|19178379|P1|COMPLETED|Overall Study||26
7790510|NCT01259466|19178378|P2|STARTED|Overall Study||27
7790511|NCT01259466|19178379|P1|STARTED|Overall Study||27
7790512|NCT01259440|19178389|P2|NOT COMPLETED|Overall Study||0
7790513|NCT01259440|19178390|P1|NOT COMPLETED|Overall Study||0
7790514|NCT01259440|19178389|P2|COMPLETED|Overall Study||10
7790515|NCT01259440|19178390|P1|COMPLETED|Overall Study||13
7790516|NCT01259440|19178389|P2|STARTED|Overall Study||10
7790517|NCT01259440|19178390|P1|STARTED|Overall Study||13
7790518|NCT01259427|19178398|P2|NOT COMPLETED|Overall Study||14
7790519|NCT01259427|19178399|P1|NOT COMPLETED|Overall Study||18
7790520|NCT01259427|19178398|P2|COMPLETED|Overall Study||110
7790521|NCT01259427|19178399|P1|COMPLETED|Overall Study||106
7790522|NCT01259427|19178398|P2|STARTED|Overall Study||124
7790523|NCT01259427|19178399|P1|STARTED|Overall Study||124
7790524|NCT01259401|19178417|P2|NOT COMPLETED|4-month Follow-up||2
7790525|NCT01259401|19178418|P1|NOT COMPLETED|4-month Follow-up||0
7790526|NCT01259401|19178417|P2|COMPLETED|4-month Follow-up||19
7790527|NCT01259401|19178418|P1|COMPLETED|4-month Follow-up||21
7790528|NCT01259401|19178417|P2|STARTED|4-month Follow-up||21
7790529|NCT01259401|19178418|P1|STARTED|4-month Follow-up||21
7790530|NCT01259401|19178417|P2|NOT COMPLETED|End of 4-week Intervention||0
7790531|NCT01259401|19178418|P1|NOT COMPLETED|End of 4-week Intervention||0
7790532|NCT01259401|19178417|P2|COMPLETED|End of 4-week Intervention||21
7790533|NCT01259401|19178418|P1|COMPLETED|End of 4-week Intervention||21
7790534|NCT01259401|19178417|P2|STARTED|End of 4-week Intervention||21
7790535|NCT01259401|19178418|P1|STARTED|End of 4-week Intervention||21
7790536|NCT01259388|19178428|P2|NOT COMPLETED|Overall Study||1
7790537|NCT01259388|19178429|P1|NOT COMPLETED|Overall Study||5
7790538|NCT01259388|19178428|P2|COMPLETED|Overall Study||11
7790539|NCT01259388|19178429|P1|COMPLETED|Overall Study||6
7790540|NCT01259388|19178428|P2|STARTED|Overall Study||12
7790541|NCT01259388|19178429|P1|STARTED|Overall Study||11
7790542|NCT01259375|19178439|P1|NOT COMPLETED|Overall Study||1
7790543|NCT01259375|19178439|P1|COMPLETED|Overall Study||23
7790544|NCT01259375|19178439|P1|STARTED|Overall Study||24
7790545|NCT01259297|19178456|P8|NOT COMPLETED|Double Blind Randomized Period||3
7790546|NCT01259297|19178457|P7|NOT COMPLETED|Double Blind Randomized Period||6
7790547|NCT01259297|19178458|P6|NOT COMPLETED|Double Blind Randomized Period||8
7790548|NCT01259297|19178459|P5|NOT COMPLETED|Double Blind Randomized Period||4
7790549|NCT01259297|19178460|P4|NOT COMPLETED|Double Blind Randomized Period||4
7790550|NCT01259297|19178461|P3|NOT COMPLETED|Double Blind Randomized Period||1
7790551|NCT01259297|19178462|P2|NOT COMPLETED|Double Blind Randomized Period||3
7790552|NCT01259297|19178463|P1|NOT COMPLETED|Double Blind Randomized Period||2
7790553|NCT01259297|19178456|P8|COMPLETED|Double Blind Randomized Period||196
7790554|NCT01259297|19178457|P7|COMPLETED|Double Blind Randomized Period||190
7790555|NCT01259297|19178458|P6|COMPLETED|Double Blind Randomized Period||245
7790556|NCT01259297|19178459|P5|COMPLETED|Double Blind Randomized Period||247
7790557|NCT01259297|19178460|P4|COMPLETED|Double Blind Randomized Period||191
7790558|NCT01259297|19178461|P3|COMPLETED|Double Blind Randomized Period||188
7790559|NCT01259297|19178462|P2|COMPLETED|Double Blind Randomized Period||229
7790560|NCT01259297|19178463|P1|COMPLETED|Double Blind Randomized Period||242
7790561|NCT01259297|19178456|P8|STARTED|Double Blind Randomized Period||199
7790562|NCT01259297|19178457|P7|STARTED|Double Blind Randomized Period||196
7790563|NCT01259297|19178458|P6|STARTED|Double Blind Randomized Period||253
7790564|NCT01259297|19178459|P5|STARTED|Double Blind Randomized Period||251
7790565|NCT01259297|19178460|P4|STARTED|Double Blind Randomized Period||195
7790566|NCT01259297|19178461|P3|STARTED|Double Blind Randomized Period||189
7790567|NCT01259297|19178462|P2|STARTED|Double Blind Randomized Period||232
7790568|NCT01259297|19178463|P1|STARTED|Double Blind Randomized Period||244
7790569|NCT01259297|19178456|P8|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
7790570|NCT01259297|19178457|P7|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
7790571|NCT01259297|19178458|P6|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
7790572|NCT01259297|19178459|P5|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
7790573|NCT01259297|19178460|P4|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
7790574|NCT01259297|19178461|P3|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222
7790575|NCT01259297|19178462|P2|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
7790576|NCT01259297|19178463|P1|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355
7790577|NCT01259297|19178456|P8|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
7790578|NCT01259297|19178457|P7|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
7790579|NCT01259297|19178458|P6|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
7790580|NCT01259297|19178459|P5|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
7790581|NCT01259297|19178460|P4|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
7790582|NCT01259297|19178461|P3|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779
7790583|NCT01259297|19178462|P2|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
7790584|NCT01259297|19178463|P1|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980
7790585|NCT01259297|19178456|P8|STARTED|Run-in Open Label Period (4-5 Weeks)||0
7790586|NCT01259297|19178457|P7|STARTED|Run-in Open Label Period (4-5 Weeks)||0
7790587|NCT01259297|19178458|P6|STARTED|Run-in Open Label Period (4-5 Weeks)||0
7790588|NCT01259297|19178459|P5|STARTED|Run-in Open Label Period (4-5 Weeks)||0
7790589|NCT01259297|19178460|P4|STARTED|Run-in Open Label Period (4-5 Weeks)||0
7790590|NCT01259297|19178461|P3|STARTED|Run-in Open Label Period (4-5 Weeks)||1001
7790591|NCT01259297|19178462|P2|STARTED|Run-in Open Label Period (4-5 Weeks)||0
7790592|NCT01259297|19178463|P1|STARTED|Run-in Open Label Period (4-5 Weeks)||1335
7790593|NCT01259284|19178494|P3|NOT COMPLETED|Overall Study||0
7790594|NCT01259284|19178495|P2|NOT COMPLETED|Overall Study||0
7790595|NCT01259284|19178496|P1|NOT COMPLETED|Overall Study||2
7790596|NCT01259284|19178494|P3|COMPLETED|Overall Study||0
7790597|NCT01259284|19178495|P2|COMPLETED|Overall Study||0
7790598|NCT01259284|19178496|P1|COMPLETED|Overall Study||0
7790599|NCT01259284|19178494|P3|STARTED|Overall Study||0
7790600|NCT01259284|19178495|P2|STARTED|Overall Study||0
7790601|NCT01259284|19178496|P1|STARTED|Overall Study||2
7790602|NCT01259245|19178506|P2|NOT COMPLETED|Overall Study||26
7790603|NCT01259245|19178507|P1|NOT COMPLETED|Overall Study||28
7790604|NCT01259245|19178506|P2|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68
7790605|NCT01259245|19178507|P1|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70
7790606|NCT01259245|19178506|P2|STARTED|Overall Study||94
7790607|NCT01259245|19178507|P1|STARTED|Overall Study||98
7790608|NCT01259128|19178533|P2|NOT COMPLETED|Overall Study||2
7790609|NCT01259128|19178534|P1|NOT COMPLETED|Overall Study||0
7790610|NCT01259128|19178533|P2|COMPLETED|Overall Study||15
7790611|NCT01259128|19178534|P1|COMPLETED|Overall Study||15
7790612|NCT01259128|19178533|P2|STARTED|Overall Study||17
7790613|NCT01259128|19178534|P1|STARTED|Overall Study||15
7790614|NCT01259115|19178544|P2|NOT COMPLETED|Period 2||0
7790615|NCT01259115|19178545|P1|NOT COMPLETED|Period 2||1
7790616|NCT01259115|19178544|P2|COMPLETED|Period 2||9
7790617|NCT01259115|19178545|P1|COMPLETED|Period 2||6
7790618|NCT01259115|19178544|P2|STARTED|Period 2||9
7790619|NCT01259115|19178545|P1|STARTED|Period 2||7
7790620|NCT01259115|19178544|P2|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
7790621|NCT01259115|19178545|P1|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
7790622|NCT01259115|19178544|P2|COMPLETED|Period: Washout Period of 4 to 18 Days||9
7790623|NCT01259115|19178545|P1|COMPLETED|Period: Washout Period of 4 to 18 Days||7
7790624|NCT01259115|19178544|P2|STARTED|Period: Washout Period of 4 to 18 Days||9
7790625|NCT01259115|19178545|P1|STARTED|Period: Washout Period of 4 to 18 Days||7
7790626|NCT01259115|19178544|P2|NOT COMPLETED|Period 1||1
7790627|NCT01259115|19178545|P1|NOT COMPLETED|Period 1||3
7790628|NCT01259115|19178544|P2|COMPLETED|Period 1||9
7790629|NCT01259115|19178545|P1|COMPLETED|Period 1||7
7790630|NCT01259115|19178544|P2|STARTED|Period 1||10
7790631|NCT01259115|19178545|P1|STARTED|Period 1||10
7790632|NCT01259102|19178581|P5|NOT COMPLETED|Overall Study||1
7790633|NCT01259102|19178582|P4|NOT COMPLETED|Overall Study||2
7790634|NCT01259102|19178583|P3|NOT COMPLETED|Overall Study||2
7790635|NCT01259102|19178584|P2|NOT COMPLETED|Overall Study||0
7790636|NCT01259102|19178585|P1|NOT COMPLETED|Overall Study||1
7790637|NCT01259102|19178581|P5|COMPLETED|Overall Study||13
7790638|NCT01259102|19178582|P4|COMPLETED|Overall Study||12
7790639|NCT01259102|19178583|P3|COMPLETED|Overall Study||13
7790640|NCT01259102|19178584|P2|COMPLETED|Overall Study||14
7790641|NCT01259102|19178585|P1|COMPLETED|Overall Study||12
7790642|NCT01259102|19178581|P5|STARTED|Overall Study||14
7790643|NCT01259102|19178582|P4|STARTED|Overall Study||14
7790644|NCT01259102|19178583|P3|STARTED|Overall Study||15
7790645|NCT01259102|19178584|P2|STARTED|Overall Study||14
7790646|NCT01259102|19178585|P1|STARTED|Overall Study||13
7790647|NCT01259089|19178642|P6|NOT COMPLETED|Survival Follow up for Two Years||19
7790648|NCT01259089|19178643|P5|NOT COMPLETED|Survival Follow up for Two Years||6
7790649|NCT01259089|19178644|P4|NOT COMPLETED|Survival Follow up for Two Years||3
7790650|NCT01259089|19178645|P3|NOT COMPLETED|Survival Follow up for Two Years||2
7790651|NCT01259089|19178646|P2|NOT COMPLETED|Survival Follow up for Two Years||2
7790652|NCT01259089|19178647|P1|NOT COMPLETED|Survival Follow up for Two Years||3
7790653|NCT01259089|19178642|P6|COMPLETED|Survival Follow up for Two Years||0
7790654|NCT01259089|19178643|P5|COMPLETED|Survival Follow up for Two Years||0
7790655|NCT01259089|19178644|P4|COMPLETED|Survival Follow up for Two Years||0
7790656|NCT01259089|19178645|P3|COMPLETED|Survival Follow up for Two Years||1
7790657|NCT01259089|19178646|P2|COMPLETED|Survival Follow up for Two Years||1
7790658|NCT01259089|19178647|P1|COMPLETED|Survival Follow up for Two Years||0
7790659|NCT01259089|19178642|P6|STARTED|Survival Follow up for Two Years||19
7790660|NCT01259089|19178643|P5|STARTED|Survival Follow up for Two Years||6
7790661|NCT01259089|19178644|P4|STARTED|Survival Follow up for Two Years||3
7790662|NCT01259089|19178645|P3|STARTED|Survival Follow up for Two Years||3
7790663|NCT01259089|19178646|P2|STARTED|Survival Follow up for Two Years||3
7790664|NCT01259089|19178647|P1|STARTED|Survival Follow up for Two Years||3
7790665|NCT01259089|19178642|P6|NOT COMPLETED|Continued Treatment After 8 Weeks||1
7790666|NCT01259089|19178643|P5|NOT COMPLETED|Continued Treatment After 8 Weeks||2
7790667|NCT01259089|19178644|P4|NOT COMPLETED|Continued Treatment After 8 Weeks||1
7790668|NCT01259089|19178645|P3|NOT COMPLETED|Continued Treatment After 8 Weeks||1
7790669|NCT01259089|19178646|P2|NOT COMPLETED|Continued Treatment After 8 Weeks||1
7790670|NCT01259089|19178647|P1|NOT COMPLETED|Continued Treatment After 8 Weeks||2
7790671|NCT01259089|19178642|P6|COMPLETED|Continued Treatment After 8 Weeks||7
7790672|NCT01259089|19178643|P5|COMPLETED|Continued Treatment After 8 Weeks||0
7790673|NCT01259089|19178644|P4|COMPLETED|Continued Treatment After 8 Weeks||1
7790674|NCT01259089|19178645|P3|COMPLETED|Continued Treatment After 8 Weeks||1
7790675|NCT01259089|19178646|P2|COMPLETED|Continued Treatment After 8 Weeks||2
7790676|NCT01259089|19178647|P1|COMPLETED|Continued Treatment After 8 Weeks||1
7790677|NCT01259089|19178642|P6|STARTED|Continued Treatment After 8 Weeks||8
7790678|NCT01259089|19178643|P5|STARTED|Continued Treatment After 8 Weeks||2
7790679|NCT01259089|19178644|P4|STARTED|Continued Treatment After 8 Weeks||2
7790680|NCT01259089|19178645|P3|STARTED|Continued Treatment After 8 Weeks||2
7790681|NCT01259089|19178646|P2|STARTED|Continued Treatment After 8 Weeks||3
7790682|NCT01259089|19178647|P1|STARTED|Continued Treatment After 8 Weeks||3
7790683|NCT01259089|19178642|P6|NOT COMPLETED|Confirmed Response at 8 Weeks||10
7790684|NCT01259089|19178643|P5|NOT COMPLETED|Confirmed Response at 8 Weeks||4
7790685|NCT01259089|19178644|P4|NOT COMPLETED|Confirmed Response at 8 Weeks||1
7790686|NCT01259089|19178645|P3|NOT COMPLETED|Confirmed Response at 8 Weeks||1
7790687|NCT01259089|19178646|P2|NOT COMPLETED|Confirmed Response at 8 Weeks||0
7790688|NCT01259089|19178647|P1|NOT COMPLETED|Confirmed Response at 8 Weeks||0
7790689|NCT01259089|19178642|P6|COMPLETED|Confirmed Response at 8 Weeks||8
7790690|NCT01259089|19178643|P5|COMPLETED|Confirmed Response at 8 Weeks||2
7790691|NCT01259089|19178644|P4|COMPLETED|Confirmed Response at 8 Weeks||2
7790692|NCT01259089|19178645|P3|COMPLETED|Confirmed Response at 8 Weeks||2
7790693|NCT01259089|19178646|P2|COMPLETED|Confirmed Response at 8 Weeks||3
7790694|NCT01259089|19178647|P1|COMPLETED|Confirmed Response at 8 Weeks||3
7790695|NCT01259089|19178642|P6|STARTED|Confirmed Response at 8 Weeks||18
7790696|NCT01259089|19178643|P5|STARTED|Confirmed Response at 8 Weeks||6
7790697|NCT01259089|19178644|P4|STARTED|Confirmed Response at 8 Weeks||3
7790698|NCT01259089|19178645|P3|STARTED|Confirmed Response at 8 Weeks||3
7790699|NCT01259089|19178646|P2|STARTED|Confirmed Response at 8 Weeks||3
7790700|NCT01259089|19178647|P1|STARTED|Confirmed Response at 8 Weeks||3
7790701|NCT01259089|19178642|P6|NOT COMPLETED|Reached First Response at 4 Weeks||2
7790702|NCT01259089|19178643|P5|NOT COMPLETED|Reached First Response at 4 Weeks||0
7790703|NCT01259089|19178644|P4|NOT COMPLETED|Reached First Response at 4 Weeks||0
7790704|NCT01259089|19178645|P3|NOT COMPLETED|Reached First Response at 4 Weeks||0
7790705|NCT01259089|19178646|P2|NOT COMPLETED|Reached First Response at 4 Weeks||0
7790706|NCT01259089|19178647|P1|NOT COMPLETED|Reached First Response at 4 Weeks||0
7790707|NCT01259089|19178642|P6|COMPLETED|Reached First Response at 4 Weeks||18
7790708|NCT01259089|19178643|P5|COMPLETED|Reached First Response at 4 Weeks||6
7790709|NCT01259089|19178644|P4|COMPLETED|Reached First Response at 4 Weeks||3
7790710|NCT01259089|19178645|P3|COMPLETED|Reached First Response at 4 Weeks||3
7790711|NCT01259089|19178646|P2|COMPLETED|Reached First Response at 4 Weeks||3
7790712|NCT01259089|19178647|P1|COMPLETED|Reached First Response at 4 Weeks||3
7790713|NCT01259089|19178642|P6|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||18
7790714|NCT01259089|19178643|P5|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||6
7790715|NCT01259089|19178644|P4|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
7790716|NCT01259089|19178645|P3|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
7790717|NCT01259089|19178646|P2|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
7790718|NCT01259089|19178647|P1|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
7790719|NCT01259089|19178642|P6|Started Treatment on Study|Reached First Response at 4 Weeks||19
7790720|NCT01259089|19178643|P5|Started Treatment on Study|Reached First Response at 4 Weeks||6
7790721|NCT01259089|19178644|P4|Started Treatment on Study|Reached First Response at 4 Weeks||3
7790722|NCT01259089|19178645|P3|Started Treatment on Study|Reached First Response at 4 Weeks||3
7790723|NCT01259089|19178646|P2|Started Treatment on Study|Reached First Response at 4 Weeks||3
7790724|NCT01259089|19178647|P1|Started Treatment on Study|Reached First Response at 4 Weeks||3
7790725|NCT01259089|19178642|P6|STARTED|Reached First Response at 4 Weeks||20
7790726|NCT01259089|19178643|P5|STARTED|Reached First Response at 4 Weeks||6
7790727|NCT01259089|19178644|P4|STARTED|Reached First Response at 4 Weeks||3
7790728|NCT01259089|19178645|P3|STARTED|Reached First Response at 4 Weeks||3
7790729|NCT01259089|19178646|P2|STARTED|Reached First Response at 4 Weeks||3
7790730|NCT01259089|19178647|P1|STARTED|Reached First Response at 4 Weeks||3
7790731|NCT01259063|19178666|P1|NOT COMPLETED|Overall Study||0
7790732|NCT01259063|19178666|P1|COMPLETED|Overall Study||33
7790733|NCT01259063|19178666|P1|STARTED|Overall Study||33
7790734|NCT01259024|19178675|P1|NOT COMPLETED|Overall Study||1
7790735|NCT01259024|19178675|P1|COMPLETED|Overall Study||0
7790736|NCT01259024|19178675|P1|STARTED|Overall Study||1
7790737|NCT01259011|19178684|P2|NOT COMPLETED|After Patient Death||0
7790738|NCT01259011|19178685|P1|NOT COMPLETED|After Patient Death||0
7790739|NCT01259011|19178684|P2|COMPLETED|After Patient Death||28
7790740|NCT01259011|19178685|P1|COMPLETED|After Patient Death||17
7790741|NCT01259011|19178684|P2|STARTED|After Patient Death|of 109 patient-surrogate dyads/pairs randomized, 28 surrogates of patients who died|28
7790742|NCT01259011|19178685|P1|STARTED|After Patient Death|of 101 patient-surrogate dyads/pairs randomized, 17 surrogates of patients who died|17
7790743|NCT01259011|19178684|P2|NOT COMPLETED|Main Study Period||0
7790744|NCT01259011|19178685|P1|NOT COMPLETED|Main Study Period||0
7790745|NCT01259011|19178684|P2|COMPLETED|Main Study Period||109
7790746|NCT01259011|19178685|P1|COMPLETED|Main Study Period||101
7790747|NCT01259011|19178684|P2|STARTED|Main Study Period|109 dyads (=218 individuals)|109
7790748|NCT01259011|19178685|P1|STARTED|Main Study Period|101 dyads (=202 individuals)|101
7790749|NCT01258998|19178695|P1|NOT COMPLETED|Overall Study||1
7790750|NCT01258998|19178695|P1|COMPLETED|Overall Study||59
7790751|NCT01258998|19178695|P1|STARTED|Overall Study||60
7790752|NCT01258985|19178708|P2|NOT COMPLETED|Overall Study||0
7790753|NCT01258985|19178709|P1|NOT COMPLETED|Overall Study||0
7790754|NCT01258985|19178708|P2|COMPLETED|Overall Study||98
7790755|NCT01258985|19178709|P1|COMPLETED|Overall Study||106
7790756|NCT01258985|19178708|P2|STARTED|Overall Study||98
7790757|NCT01258985|19178709|P1|STARTED|Overall Study||106
7790758|NCT01258855|19178737|P2|NOT COMPLETED|Overall Study||0
7790759|NCT01258855|19178738|P1|NOT COMPLETED|Overall Study||0
7790760|NCT01258855|19178737|P2|COMPLETED|Overall Study||29
7790761|NCT01258855|19178738|P1|COMPLETED|Overall Study||55
7790762|NCT01258855|19178737|P2|STARTED|Overall Study||29
7790763|NCT01258855|19178738|P1|STARTED|Overall Study||55
7790764|NCT01258803|19178756|P6|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
7790765|NCT01258803|19178757|P5|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
7790766|NCT01258803|19178758|P4|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
7790767|NCT01258803|19178759|P3|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
7790768|NCT01258803|19178760|P2|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
7790769|NCT01258803|19178761|P1|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
7790770|NCT01258803|19178756|P6|COMPLETED|Treatment Period 4 (1 Dose)||15
7790771|NCT01258803|19178757|P5|COMPLETED|Treatment Period 4 (1 Dose)||15
7790772|NCT01258803|19178758|P4|COMPLETED|Treatment Period 4 (1 Dose)||15
7790773|NCT01258803|19178759|P3|COMPLETED|Treatment Period 4 (1 Dose)||14
7790774|NCT01258803|19178760|P2|COMPLETED|Treatment Period 4 (1 Dose)||14
7790775|NCT01258803|19178761|P1|COMPLETED|Treatment Period 4 (1 Dose)||14
7790776|NCT01258803|19178756|P6|STARTED|Treatment Period 4 (1 Dose)||15
7790777|NCT01258803|19178757|P5|STARTED|Treatment Period 4 (1 Dose)||15
7790778|NCT01258803|19178758|P4|STARTED|Treatment Period 4 (1 Dose)||15
7790779|NCT01258803|19178759|P3|STARTED|Treatment Period 4 (1 Dose)||14
7790780|NCT01258803|19178760|P2|STARTED|Treatment Period 4 (1 Dose)||14
7790781|NCT01258803|19178761|P1|STARTED|Treatment Period 4 (1 Dose)||14
7790782|NCT01258803|19178756|P6|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
7790783|NCT01258803|19178757|P5|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
7790784|NCT01258803|19178758|P4|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
7790785|NCT01258803|19178759|P3|NOT COMPLETED|Treatment Period 3 (1 Dose)||1
7790786|NCT01258803|19178760|P2|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
7790787|NCT01258803|19178761|P1|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
7790788|NCT01258803|19178756|P6|COMPLETED|Treatment Period 3 (1 Dose)||15
7790789|NCT01258803|19178757|P5|COMPLETED|Treatment Period 3 (1 Dose)||15
7790790|NCT01258803|19178758|P4|COMPLETED|Treatment Period 3 (1 Dose)||15
7790791|NCT01258803|19178759|P3|COMPLETED|Treatment Period 3 (1 Dose)||14
7790792|NCT01258803|19178760|P2|COMPLETED|Treatment Period 3 (1 Dose)||14
7790793|NCT01258803|19178761|P1|COMPLETED|Treatment Period 3 (1 Dose)||14
7790794|NCT01258803|19178756|P6|STARTED|Treatment Period 3 (1 Dose)||15
7790795|NCT01258803|19178757|P5|STARTED|Treatment Period 3 (1 Dose)||15
7790796|NCT01258803|19178758|P4|STARTED|Treatment Period 3 (1 Dose)||15
7790797|NCT01258803|19178759|P3|STARTED|Treatment Period 3 (1 Dose)||15
7790798|NCT01258803|19178760|P2|STARTED|Treatment Period 3 (1 Dose)||14
7790799|NCT01258803|19178761|P1|STARTED|Treatment Period 3 (1 Dose)||14
7790800|NCT01258803|19178756|P6|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
7790801|NCT01258803|19178757|P5|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
7790802|NCT01258803|19178758|P4|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
7790803|NCT01258803|19178759|P3|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
7790804|NCT01258803|19178760|P2|NOT COMPLETED|Treatment Period 2 (1 Dose)||2
7790805|NCT01258803|19178761|P1|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
7790806|NCT01258803|19178756|P6|COMPLETED|Treatment Period 2 (1 Dose)||15
7790807|NCT01258803|19178757|P5|COMPLETED|Treatment Period 2 (1 Dose)||15
7790808|NCT01258803|19178758|P4|COMPLETED|Treatment Period 2 (1 Dose)||15
7790809|NCT01258803|19178759|P3|COMPLETED|Treatment Period 2 (1 Dose)||15
7790810|NCT01258803|19178760|P2|COMPLETED|Treatment Period 2 (1 Dose)||14
7790811|NCT01258803|19178761|P1|COMPLETED|Treatment Period 2 (1 Dose)||14
7790812|NCT01258803|19178756|P6|STARTED|Treatment Period 2 (1 Dose)||16
7790813|NCT01258803|19178757|P5|STARTED|Treatment Period 2 (1 Dose)||15
7790814|NCT01258803|19178758|P4|STARTED|Treatment Period 2 (1 Dose)||15
7790815|NCT01258803|19178759|P3|STARTED|Treatment Period 2 (1 Dose)||15
7790816|NCT01258803|19178760|P2|STARTED|Treatment Period 2 (1 Dose)||16
7790817|NCT01258803|19178761|P1|STARTED|Treatment Period 2 (1 Dose)||15
7790818|NCT01258803|19178756|P6|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
7790819|NCT01258803|19178757|P5|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
7790820|NCT01258803|19178758|P4|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
7790821|NCT01258803|19178759|P3|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
7790822|NCT01258803|19178760|P2|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
7790823|NCT01258803|19178761|P1|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
7790824|NCT01258803|19178756|P6|COMPLETED|Treatment Period 1 (1 Dose)||16
7790825|NCT01258803|19178757|P5|COMPLETED|Treatment Period 1 (1 Dose)||15
7790826|NCT01258803|19178758|P4|COMPLETED|Treatment Period 1 (1 Dose)||15
7790827|NCT01258803|19178759|P3|COMPLETED|Treatment Period 1 (1 Dose)||15
7790828|NCT01258803|19178760|P2|COMPLETED|Treatment Period 1 (1 Dose)||16
7790829|NCT01258803|19178761|P1|COMPLETED|Treatment Period 1 (1 Dose)||15
7790830|NCT01258803|19178756|P6|STARTED|Treatment Period 1 (1 Dose)||16
7790831|NCT01258803|19178757|P5|STARTED|Treatment Period 1 (1 Dose)||15
7790832|NCT01258803|19178758|P4|STARTED|Treatment Period 1 (1 Dose)||15
7790833|NCT01258803|19178759|P3|STARTED|Treatment Period 1 (1 Dose)||15
7790834|NCT01258803|19178760|P2|STARTED|Treatment Period 1 (1 Dose)||16
7790835|NCT01258803|19178761|P1|STARTED|Treatment Period 1 (1 Dose)||15
7790836|NCT01258790|19178789|P2|NOT COMPLETED|Overall Study||0
7790837|NCT01258790|19178790|P1|NOT COMPLETED|Overall Study||0
7790838|NCT01258790|19178789|P2|COMPLETED|Overall Study||6
7790839|NCT01258790|19178790|P1|COMPLETED|Overall Study||6
7790840|NCT01258790|19178789|P2|STARTED|Overall Study||6
7790841|NCT01258790|19178790|P1|STARTED|Overall Study||6
7790842|NCT01258738|19178798|P2|NOT COMPLETED|Open-label Period||21
7790843|NCT01258738|19178799|P1|NOT COMPLETED|Open-label Period||17
7790844|NCT01258738|19178798|P2|COMPLETED|Open-label Period||85
7790845|NCT01258738|19178799|P1|COMPLETED|Open-label Period||85
7790846|NCT01258738|19178798|P2|STARTED|Open-label Period||106
7790847|NCT01258738|19178799|P1|STARTED|Open-label Period||102
7790848|NCT01258738|19178798|P2|NOT COMPLETED|Double-blind Period||7
7790849|NCT01258738|19178799|P1|NOT COMPLETED|Double-blind Period||9
7790850|NCT01258738|19178798|P2|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107
7790851|NCT01258738|19178799|P1|COMPLETED|Double-blind Period||102
7790852|NCT01258738|19178798|P2|Treated|Double-blind Period||113
7790853|NCT01258738|19178799|P1|Treated|Double-blind Period||111
7790854|NCT01258738|19178798|P2|STARTED|Double-blind Period||114
7790855|NCT01258738|19178799|P1|STARTED|Double-blind Period||111
7790856|NCT01258660|19178937|P2|NOT COMPLETED|Overall Study||11
7790857|NCT01258660|19178938|P1|NOT COMPLETED|Overall Study||11
7790858|NCT01258660|19178937|P2|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
7790859|NCT01258660|19178938|P1|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
7790860|NCT01258660|19178937|P2|Completed Treatment|Overall Study||81
7790861|NCT01258660|19178938|P1|Completed Treatment|Overall Study||79
7790862|NCT01258660|19178937|P2|Received Treatment|Overall Study||82
7790863|NCT01258660|19178938|P1|Received Treatment|Overall Study||79
7790864|NCT01258660|19178937|P2|STARTED|Overall Study|randomized and received at least one dose of treatment|86
7790865|NCT01258660|19178938|P1|STARTED|Overall Study|randomized and received at least one dose of treatment|86
7790866|NCT01258608|19178957|P2|NOT COMPLETED|Overall Study||19
7790867|NCT01258608|19178958|P1|NOT COMPLETED|Overall Study||21
7790868|NCT01258608|19178957|P2|COMPLETED|Overall Study||31
7790869|NCT01258608|19178958|P1|COMPLETED|Overall Study||30
7790870|NCT01258608|19178957|P2|STARTED|Overall Study||50
7790871|NCT01258608|19178958|P1|STARTED|Overall Study||51
7790872|NCT01258595|19179006|P2|NOT COMPLETED|Overall Study||1
7790873|NCT01258595|19179007|P1|NOT COMPLETED|Overall Study||1
7790874|NCT01258595|19179006|P2|COMPLETED|Overall Study||151
7790875|NCT01258595|19179007|P1|COMPLETED|Overall Study||147
7790876|NCT01258595|19179006|P2|STARTED|Overall Study||152
7790877|NCT01258595|19179007|P1|STARTED|Overall Study||148
7790878|NCT01258582|19179023|P2|NOT COMPLETED|Overall Study||258
7790879|NCT01258582|19179024|P1|NOT COMPLETED|Overall Study||282
7790880|NCT01258582|19179023|P2|COMPLETED|Overall Study||563
7790881|NCT01258582|19179024|P1|COMPLETED|Overall Study||548
7790882|NCT01258582|19179023|P2|STARTED|Overall Study||821
7790883|NCT01258582|19179024|P1|STARTED|Overall Study||830
7790884|NCT01258504|19179030|P1|NOT COMPLETED|Bosentan and SJW||0
7790885|NCT01258504|19179030|P1|COMPLETED|Bosentan and SJW||13
7790886|NCT01258504|19179030|P1|STARTED|Bosentan and SJW||13
7790887|NCT01258504|19179030|P1|NOT COMPLETED|Bosentan Steady-state||0
7790888|NCT01258504|19179030|P1|COMPLETED|Bosentan Steady-state||13
7790889|NCT01258504|19179030|P1|STARTED|Bosentan Steady-state||13
7790890|NCT01258504|19179030|P1|NOT COMPLETED|Bosentan Single Dose||0
7790891|NCT01258504|19179030|P1|COMPLETED|Bosentan Single Dose||13
7790892|NCT01258504|19179030|P1|STARTED|Bosentan Single Dose||13
7790893|NCT01258387|19179049|P7|NOT COMPLETED|Overall Study||0
7790894|NCT01258387|19179050|P6|NOT COMPLETED|Overall Study||0
7790895|NCT01258387|19179051|P5|NOT COMPLETED|Overall Study||0
7790896|NCT01258387|19179052|P4|NOT COMPLETED|Overall Study||0
7790897|NCT01258387|19179053|P3|NOT COMPLETED|Overall Study||0
7790898|NCT01258387|19179054|P2|NOT COMPLETED|Overall Study||0
7790899|NCT01258387|19179055|P1|NOT COMPLETED|Overall Study||0
7790900|NCT01258387|19179049|P7|COMPLETED|Overall Study||4
7790901|NCT01258387|19179050|P6|COMPLETED|Overall Study||6
7790902|NCT01258387|19179051|P5|COMPLETED|Overall Study||6
7790903|NCT01258387|19179052|P4|COMPLETED|Overall Study||6
7790904|NCT01258387|19179053|P3|COMPLETED|Overall Study||6
7790905|NCT01258387|19179054|P2|COMPLETED|Overall Study||6
7790906|NCT01258387|19179055|P1|COMPLETED|Overall Study||6
7790907|NCT01258387|19179049|P7|Patients Randomized to Placebo|Overall Study||1
7790908|NCT01258387|19179050|P6|Patients Randomized to Placebo|Overall Study||2
7790909|NCT01258387|19179051|P5|Patients Randomized to Placebo|Overall Study||2
7790910|NCT01258387|19179052|P4|Patients Randomized to Placebo|Overall Study||2
7790911|NCT01258387|19179053|P3|Patients Randomized to Placebo|Overall Study||2
7790912|NCT01258387|19179054|P2|Patients Randomized to Placebo|Overall Study||2
7790913|NCT01258387|19179055|P1|Patients Randomized to Placebo|Overall Study||2
7790914|NCT01258387|19179049|P7|Patients Randomized to GGF2|Overall Study||3
7790915|NCT01258387|19179050|P6|Patients Randomized to GGF2|Overall Study||4
7790916|NCT01258387|19179051|P5|Patients Randomized to GGF2|Overall Study||4
7790917|NCT01258387|19179052|P4|Patients Randomized to GGF2|Overall Study||4
7790918|NCT01258387|19179053|P3|Patients Randomized to GGF2|Overall Study||4
7790919|NCT01258387|19179054|P2|Patients Randomized to GGF2|Overall Study||4
7790920|NCT01258387|19179055|P1|Patients Randomized to GGF2|Overall Study||4
7790921|NCT01258387|19179049|P7|STARTED|Overall Study||4
7790922|NCT01258387|19179050|P6|STARTED|Overall Study||6
7790923|NCT01258387|19179051|P5|STARTED|Overall Study||6
7790924|NCT01258387|19179052|P4|STARTED|Overall Study||6
7790925|NCT01258387|19179053|P3|STARTED|Overall Study||6
7790926|NCT01258387|19179054|P2|STARTED|Overall Study||6
7790927|NCT01258387|19179055|P1|STARTED|Overall Study||6
7790928|NCT01258374|19179097|P1|NOT COMPLETED|Overall Study||0
7790929|NCT01258374|19179097|P1|COMPLETED|Overall Study||15
7790930|NCT01258374|19179097|P1|STARTED|Overall Study||15
7790931|NCT01258348|19179104|P5|NOT COMPLETED|Overall Study||6
7790932|NCT01258348|19179105|P4|NOT COMPLETED|Overall Study||6
7790933|NCT01258348|19179106|P3|NOT COMPLETED|Overall Study||3
7790934|NCT01258348|19179107|P2|NOT COMPLETED|Overall Study||5
7790935|NCT01258348|19179108|P1|NOT COMPLETED|Overall Study||1
7790936|NCT01258348|19179104|P5|COMPLETED|Overall Study||0
7790937|NCT01258348|19179105|P4|COMPLETED|Overall Study||0
7790938|NCT01258348|19179106|P3|COMPLETED|Overall Study||0
7790939|NCT01258348|19179107|P2|COMPLETED|Overall Study||0
7790940|NCT01258348|19179108|P1|COMPLETED|Overall Study||0
7790941|NCT01258348|19179104|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
7790942|NCT01258348|19179105|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
7790943|NCT01258348|19179106|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
7790944|NCT01258348|19179107|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
7790945|NCT01258348|19179108|P1|Received at Least 1 Dose of Study Drug|Overall Study||1
7790946|NCT01258348|19179104|P5|STARTED|Overall Study||6
7790947|NCT01258348|19179105|P4|STARTED|Overall Study||6
7790948|NCT01258348|19179106|P3|STARTED|Overall Study||3
7790949|NCT01258348|19179107|P2|STARTED|Overall Study||5
7790950|NCT01258348|19179108|P1|STARTED|Overall Study||1
7790951|NCT01258153|19179136|P3|NOT COMPLETED|Overall Study||1
7790952|NCT01258153|19179137|P2|NOT COMPLETED|Overall Study||1
7790953|NCT01258153|19179138|P1|NOT COMPLETED|Overall Study||1
7790954|NCT01258153|19179136|P3|COMPLETED|Overall Study||36
7790955|NCT01258153|19179137|P2|COMPLETED|Overall Study||37
7790956|NCT01258153|19179138|P1|COMPLETED|Overall Study||39
7790957|NCT01258153|19179136|P3|STARTED|Overall Study||37
7790958|NCT01258153|19179137|P2|STARTED|Overall Study||38
7790959|NCT01258153|19179138|P1|STARTED|Overall Study||40
7790960|NCT01258101|19179165|P4|NOT COMPLETED|Overall Study||25
7790961|NCT01258101|19179166|P3|NOT COMPLETED|Overall Study||11
7790962|NCT01258101|19179167|P2|NOT COMPLETED|Overall Study||34
7790963|NCT01258101|19179168|P1|NOT COMPLETED|Overall Study||33
7790964|NCT01258101|19179165|P4|COMPLETED|Overall Study||27
7790965|NCT01258101|19179166|P3|COMPLETED|Overall Study||22
7790966|NCT01258101|19179167|P2|COMPLETED|Overall Study||110
7790967|NCT01258101|19179168|P1|COMPLETED|Overall Study||118
7790968|NCT01258101|19179165|P4|Standard Analysis Population|Overall Study||26
7790969|NCT01258101|19179166|P3|Standard Analysis Population|Overall Study||21
7790970|NCT01258101|19179167|P2|Standard Analysis Population|Overall Study||110
7790971|NCT01258101|19179168|P1|Standard Analysis Population|Overall Study||115
7790972|NCT01258101|19179165|P4|Safety Analysis Population|Overall Study||48
7790973|NCT01258101|19179166|P3|Safety Analysis Population|Overall Study||30
7790974|NCT01258101|19179167|P2|Safety Analysis Population|Overall Study||141
7790975|NCT01258101|19179168|P1|Safety Analysis Population|Overall Study||144
7790976|NCT01258101|19179165|P4|STARTED|Overall Study||52
7790977|NCT01258101|19179166|P3|STARTED|Overall Study||33
7790978|NCT01258101|19179167|P2|STARTED|Overall Study||144
7790979|NCT01258101|19179168|P1|STARTED|Overall Study||151
7790980|NCT01258075|19179220|P2|NOT COMPLETED|Overall Study||23
7790981|NCT01258075|19179221|P1|NOT COMPLETED|Overall Study||42
7790982|NCT01258075|19179220|P2|COMPLETED|Overall Study||72
7790983|NCT01258075|19179221|P1|COMPLETED|Overall Study||99
7790984|NCT01258075|19179220|P2|STARTED|Overall Study||95
7790985|NCT01258075|19179221|P1|STARTED|Overall Study||141
7790986|NCT01258049|19179229|P2|NOT COMPLETED|Overall Study||2
7790987|NCT01258049|19179230|P1|NOT COMPLETED|Overall Study||2
7790988|NCT01258049|19179229|P2|COMPLETED|Overall Study||72
7790989|NCT01258049|19179230|P1|COMPLETED|Overall Study||75
7790990|NCT01258049|19179229|P2|STARTED|Overall Study||74
7790991|NCT01258049|19179230|P1|STARTED|Overall Study||77
7790992|NCT01257880|19179268|P2|NOT COMPLETED|Overall Study||0
7790993|NCT01257880|19179269|P1|NOT COMPLETED|Overall Study||0
7790994|NCT01257880|19179268|P2|COMPLETED|Overall Study||19
7790995|NCT01257880|19179269|P1|COMPLETED|Overall Study||12
7790996|NCT01257880|19179268|P2|STARTED|Overall Study||19
7790997|NCT01257880|19179269|P1|STARTED|Overall Study||12
7790998|NCT01257802|19179279|P2|NOT COMPLETED|Overall Study||6
7790999|NCT01257802|19179280|P1|NOT COMPLETED|Overall Study||1
7791000|NCT01257802|19179279|P2|COMPLETED|Overall Study||2
7791001|NCT01257802|19179280|P1|COMPLETED|Overall Study||5
7791002|NCT01257802|19179279|P2|6 Month / 24 Week Visit|Overall Study||2
7791003|NCT01257802|19179280|P1|6 Month / 24 Week Visit|Overall Study||5
7791004|NCT01257802|19179279|P2|STARTED|Overall Study||8
7791005|NCT01257802|19179280|P1|STARTED|Overall Study||6
7791006|NCT01257750|19179294|P1|NOT COMPLETED|Overall Study||0
7791007|NCT01257750|19179294|P1|COMPLETED|Overall Study||20
7791008|NCT01257750|19179294|P1|STARTED|Overall Study||20
7791009|NCT01257737|19179307|P2|NOT COMPLETED|Overall Study||4
7791010|NCT01257737|19179308|P1|NOT COMPLETED|Overall Study||2
7791011|NCT01257737|19179307|P2|COMPLETED|Overall Study||39
7791012|NCT01257737|19179308|P1|COMPLETED|Overall Study||43
7791013|NCT01257737|19179307|P2|STARTED|Overall Study||43
7791014|NCT01257737|19179308|P1|STARTED|Overall Study||45
7791015|NCT01257698|19179328|P2|NOT COMPLETED|Overall Study||0
7791016|NCT01257698|19179329|P1|NOT COMPLETED|Overall Study||4
7791017|NCT01257698|19179328|P2|COMPLETED|Overall Study||9
7791018|NCT01257698|19179329|P1|COMPLETED|Overall Study||8
7791019|NCT01257698|19179328|P2|STARTED|Overall Study||9
7791020|NCT01257698|19179329|P1|STARTED|Overall Study||12
7791021|NCT01257581|19179338|P3|NOT COMPLETED|Overall Study||6
7791022|NCT01257581|19179339|P2|NOT COMPLETED|Overall Study||3
7791023|NCT01257581|19179340|P1|NOT COMPLETED|Overall Study||5
7791024|NCT01257581|19179338|P3|COMPLETED|Overall Study||11
7791025|NCT01257581|19179339|P2|COMPLETED|Overall Study||18
7791026|NCT01257581|19179340|P1|COMPLETED|Overall Study||17
7791027|NCT01257581|19179338|P3|STARTED|Overall Study||17
7791028|NCT01257581|19179339|P2|STARTED|Overall Study||21
7791029|NCT01257581|19179340|P1|STARTED|Overall Study||22
7791030|NCT01257568|19179378|P1|NOT COMPLETED|Overall Study||33
7791031|NCT01257568|19179378|P1|COMPLETED|Overall Study||7
7791032|NCT01257568|19179378|P1|STARTED|Overall Study||40
7791033|NCT01257542|19179392|P2|NOT COMPLETED|Overall Study||7
7791034|NCT01257542|19179393|P1|NOT COMPLETED|Overall Study||3
7791035|NCT01257542|19179392|P2|COMPLETED|Overall Study||45
7791036|NCT01257542|19179393|P1|COMPLETED|Overall Study||52
7791037|NCT01257542|19179392|P2|STARTED|Overall Study||52
7791038|NCT01257542|19179393|P1|STARTED|Overall Study||55
7791039|NCT01257503|19179413|P2|NOT COMPLETED|Overall Study||11
7791040|NCT01257503|19179414|P1|NOT COMPLETED|Overall Study||8
7791041|NCT01257503|19179413|P2|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119
7791042|NCT01257503|19179414|P1|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125
7791043|NCT01257503|19179413|P2|Returned Dosage Logbooks|Overall Study||80
7791044|NCT01257503|19179414|P1|Returned Dosage Logbooks|Overall Study||75
7791045|NCT01257503|19179413|P2|Returned Symptom Diaries|Overall Study||83
7791046|NCT01257503|19179414|P1|Returned Symptom Diaries|Overall Study||80
7791047|NCT01257503|19179413|P2|STARTED|Overall Study||130
7791048|NCT01257503|19179414|P1|STARTED|Overall Study||133
7791049|NCT01257438|19179430|P2|NOT COMPLETED|Overall Study||46
7791050|NCT01257438|19179431|P1|NOT COMPLETED|Overall Study||30
7791051|NCT01257438|19179430|P2|COMPLETED|Overall Study||97
7791052|NCT01257438|19179431|P1|COMPLETED|Overall Study||102
7791053|NCT01257438|19179430|P2|STARTED|Overall Study||143
7791054|NCT01257438|19179431|P1|STARTED|Overall Study||132
7791055|NCT01257425|19179443|P2|NOT COMPLETED|Overall Study||6
7791056|NCT01257425|19179444|P1|NOT COMPLETED|Overall Study||6
7791057|NCT01257425|19179443|P2|COMPLETED|Overall Study||45
7791058|NCT01257425|19179444|P1|COMPLETED|Overall Study||46
7791059|NCT01257425|19179443|P2|STARTED|Overall Study||51
7791060|NCT01257425|19179444|P1|STARTED|Overall Study||52
7791061|NCT01257347|19179466|P4|NOT COMPLETED|Overall Study||0
7791062|NCT01257347|19179467|P3|NOT COMPLETED|Overall Study||0
7791063|NCT01257347|19179468|P2|NOT COMPLETED|Overall Study||0
7791064|NCT01257347|19179469|P1|NOT COMPLETED|Overall Study||0
7791065|NCT01257347|19179466|P4|COMPLETED|Overall Study||65
7791066|NCT01257347|19179467|P3|COMPLETED|Overall Study||35
7791067|NCT01257347|19179468|P2|COMPLETED|Overall Study||12
7791068|NCT01257347|19179469|P1|COMPLETED|Overall Study||12
7791069|NCT01257347|19179466|P4|STARTED|Overall Study||65
7791070|NCT01257347|19179467|P3|STARTED|Overall Study||35
7791071|NCT01257347|19179468|P2|STARTED|Overall Study|Median patients per provider = 4; range 1-13 (65 patients)|12
7791072|NCT01257347|19179469|P1|STARTED|Overall Study|Median patients per provider = 3; range 1-10 (35 patients)|12
7791073|NCT01257230|19179486|P3|NOT COMPLETED|Overall Study||6
7791074|NCT01257230|19179487|P2|NOT COMPLETED|Overall Study||10
7791075|NCT01257230|19179488|P1|NOT COMPLETED|Overall Study||6
7791076|NCT01257230|19179486|P3|COMPLETED|Overall Study||129
7791077|NCT01257230|19179487|P2|COMPLETED|Overall Study||115
7791078|NCT01257230|19179488|P1|COMPLETED|Overall Study||132
7791079|NCT01257230|19179486|P3|STARTED|Overall Study||135
7791080|NCT01257230|19179487|P2|STARTED|Overall Study||125
7791081|NCT01257230|19179488|P1|STARTED|Overall Study||138
7791082|NCT01257217|19179543|P2|NOT COMPLETED|Overall Study||0
7791083|NCT01257217|19179544|P1|NOT COMPLETED|Overall Study||2
7791084|NCT01257217|19179543|P2|COMPLETED|Overall Study||10
7791085|NCT01257217|19179544|P1|COMPLETED|Overall Study||13
7791086|NCT01257217|19179543|P2|STARTED|Overall Study||10
7791087|NCT01257217|19179544|P1|STARTED|Overall Study||15
7791088|NCT01257204|19179565|P3|NOT COMPLETED|Follow-up Period (up to Week 48)||10
7791089|NCT01257204|19179566|P2|NOT COMPLETED|Follow-up Period (up to Week 48)||6
7791090|NCT01257204|19179567|P1|NOT COMPLETED|Follow-up Period (up to Week 48)||1
7791091|NCT01257204|19179565|P3|COMPLETED|Follow-up Period (up to Week 48)||39
7791092|NCT01257204|19179566|P2|COMPLETED|Follow-up Period (up to Week 48)||41
7791093|NCT01257204|19179567|P1|COMPLETED|Follow-up Period (up to Week 48)||48
7791094|NCT01257204|19179565|P3|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
7791095|NCT01257204|19179566|P2|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47
7791096|NCT01257204|19179567|P1|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
7791097|NCT01257204|19179565|P3|NOT COMPLETED|Treatment Period (up to Week 24)||9
7791098|NCT01257204|19179566|P2|NOT COMPLETED|Treatment Period (up to Week 24)||6
7791099|NCT01257204|19179567|P1|NOT COMPLETED|Treatment Period (up to Week 24)||5
7791100|NCT01257204|19179565|P3|COMPLETED|Treatment Period (up to Week 24)||42
7791101|NCT01257204|19179566|P2|COMPLETED|Treatment Period (up to Week 24)||44
7791102|NCT01257204|19179567|P1|COMPLETED|Treatment Period (up to Week 24)||45
7791103|NCT01257204|19179565|P3|STARTED|Treatment Period (up to Week 24)||51
7791104|NCT01257204|19179566|P2|STARTED|Treatment Period (up to Week 24)||50
7791105|NCT01257204|19179567|P1|STARTED|Treatment Period (up to Week 24)||50
7791106|NCT01257087|19179613|P2|NOT COMPLETED|Overall Study||0
7791107|NCT01257087|19179614|P1|NOT COMPLETED|Overall Study||0
7791108|NCT01257087|19179613|P2|COMPLETED|Overall Study||17
7791109|NCT01257087|19179614|P1|COMPLETED|Overall Study||18
7791110|NCT01257087|19179613|P2|STARTED|Overall Study||17
7791111|NCT01257087|19179614|P1|STARTED|Overall Study||18
7791112|NCT01256983|19179626|P2|NOT COMPLETED|Overall Study||3
7791113|NCT01256983|19179627|P1|NOT COMPLETED|Overall Study||1
7791114|NCT01256983|19179626|P2|COMPLETED|Overall Study||12
7791115|NCT01256983|19179627|P1|COMPLETED|Overall Study||14
7791116|NCT01256983|19179626|P2|STARTED|Overall Study||15
7791117|NCT01256983|19179627|P1|STARTED|Overall Study||15
7791118|NCT01256944|19179635|P2|NOT COMPLETED|Overall Study||0
7791119|NCT01256944|19179636|P1|NOT COMPLETED|Overall Study||0
7791120|NCT01256944|19179635|P2|COMPLETED|Overall Study||220
7791121|NCT01256944|19179636|P1|COMPLETED|Overall Study||70
7791122|NCT01256944|19179635|P2|STARTED|Overall Study||220
7791123|NCT01256944|19179636|P1|STARTED|Overall Study||70
7791124|NCT01256918|19179664|P1|NOT COMPLETED|Overall Study||0
7791125|NCT01256918|19179664|P1|COMPLETED|Overall Study||200
7791126|NCT01256918|19179664|P1|Full Thickness Nuclear Crack Achieved|Overall Study||200
7791127|NCT01256918|19179664|P1|STARTED|Overall Study||200
7791128|NCT01256879|19179675|P1|NOT COMPLETED|Overall Study||1
7791129|NCT01256879|19179675|P1|COMPLETED|Overall Study||24
7791130|NCT01256879|19179675|P1|Commercial Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
7791131|NCT01256879|19179675|P1|Sorbitol-free Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
7791132|NCT01256879|19179675|P1|CimTest-B|Overall Study|24 started this intervention and 24 completed|24
7791133|NCT01256879|19179675|P1|CimTest-A|Overall Study|25 started this intervention but only 24 completed|25
7791134|NCT01256879|19179675|P1|STARTED|Overall Study|25 started in this cross-over study but only 24 completed|25
7791135|NCT01256840|19179688|P3|NOT COMPLETED|Overall Study||0
7791136|NCT01256840|19179689|P2|NOT COMPLETED|Overall Study||0
7791137|NCT01256840|19179690|P1|NOT COMPLETED|Overall Study||0
7791138|NCT01256840|19179688|P3|COMPLETED|Overall Study||25
7791139|NCT01256840|19179689|P2|COMPLETED|Overall Study||16
7791140|NCT01256840|19179690|P1|COMPLETED|Overall Study||30
7791141|NCT01256840|19179688|P3|STARTED|Overall Study||25
7791142|NCT01256840|19179689|P2|STARTED|Overall Study||16
7791143|NCT01256840|19179690|P1|STARTED|Overall Study||30
7791144|NCT01256788|19179701|P3|NOT COMPLETED|Overall Study||3
7791145|NCT01256788|19179702|P2|NOT COMPLETED|Overall Study||8
7791146|NCT01256788|19179703|P1|NOT COMPLETED|Overall Study||5
7791147|NCT01256788|19179701|P3|COMPLETED|Overall Study||5
7791148|NCT01256788|19179702|P2|COMPLETED|Overall Study||6
7791149|NCT01256788|19179703|P1|COMPLETED|Overall Study||7
7791150|NCT01256788|19179701|P3|STARTED|Overall Study||8
7791151|NCT01256788|19179702|P2|STARTED|Overall Study||14
7791152|NCT01256788|19179703|P1|STARTED|Overall Study||12
7791153|NCT01256684|19179714|P3|NOT COMPLETED|Overall Study||11
7791154|NCT01256684|19179715|P2|NOT COMPLETED|Overall Study||13
7791155|NCT01256684|19179716|P1|NOT COMPLETED|Overall Study||9
7791156|NCT01256684|19179714|P3|COMPLETED|Overall Study||76
7791157|NCT01256684|19179715|P2|COMPLETED|Overall Study||74
7791158|NCT01256684|19179716|P1|COMPLETED|Overall Study||72
7791159|NCT01256684|19179714|P3|ITT Population|Overall Study||81
7791160|NCT01256684|19179715|P2|ITT Population|Overall Study||79
7791161|NCT01256684|19179716|P1|ITT Population|Overall Study||77
7791162|NCT01256684|19179714|P3|Safety Population|Overall Study||87
7791163|NCT01256684|19179715|P2|Safety Population|Overall Study||86
7791164|NCT01256684|19179716|P1|Safety Population|Overall Study||80
7791165|NCT01256684|19179714|P3|STARTED|Overall Study||87
7791166|NCT01256684|19179715|P2|STARTED|Overall Study||87
7791167|NCT01256684|19179716|P1|STARTED|Overall Study||81
7791168|NCT01256671|19179748|P1|NOT COMPLETED|Overall Study||95
7791169|NCT01256671|19179748|P1|COMPLETED|Overall Study||435
7791170|NCT01256671|19179748|P1|Safety Population|Overall Study||521
7791171|NCT01256671|19179748|P1|STARTED|Overall Study||530
7791172|NCT01256658|19179761|P2|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372
7791173|NCT01256658|19179762|P1|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854
7791174|NCT01256658|19179761|P2|COMPLETED|Period 2 - Follow up Only - No Treatment||0
7791175|NCT01256658|19179762|P1|COMPLETED|Period 2 - Follow up Only - No Treatment||0
7791176|NCT01256658|19179761|P2|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287
7791177|NCT01256658|19179762|P1|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777
7791178|NCT01256658|19179761|P2|Death|Period 2 - Follow up Only - No Treatment||8
7791179|NCT01256658|19179762|P1|Death|Period 2 - Follow up Only - No Treatment||6
7791180|NCT01256658|19179761|P2|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77
7791181|NCT01256658|19179762|P1|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71
7791182|NCT01256658|19179761|P2|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372
7791183|NCT01256658|19179762|P1|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854
7791184|NCT01256658|19179761|P2|NOT COMPLETED|Period 1||748
7791185|NCT01256658|19179762|P1|NOT COMPLETED|Period 1||920
7791186|NCT01256658|19179761|P2|COMPLETED|Period 1||6510
7791187|NCT01256658|19179762|P1|COMPLETED|Period 1||5897
7791188|NCT01256658|19179761|P2|STARTED|Period 1||7258
7791189|NCT01256658|19179762|P1|STARTED|Period 1||6817
7791190|NCT01256593|19179812|P1|NOT COMPLETED|Overall Study||214
7791191|NCT01256593|19179812|P1|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|3613
7791192|NCT01256593|19179812|P1|STARTED|Overall Study||3827
7791193|NCT01256567|19179826|P1|NOT COMPLETED|Overall Study||1
7791194|NCT01256567|19179826|P1|COMPLETED|Overall Study||6
7791195|NCT01256567|19179826|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
7791196|NCT01256567|19179826|P1|STARTED|Overall Study||7
7791197|NCT01256502|19179836|P1|NOT COMPLETED|Overall Study||10
7791198|NCT01256502|19179836|P1|COMPLETED|Overall Study||129
7791199|NCT01256502|19179836|P1|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139
7791200|NCT01256476|19179848|P2|NOT COMPLETED|Overall Study||7
7791201|NCT01256476|19179849|P1|NOT COMPLETED|Overall Study||6
7791202|NCT01256476|19179848|P2|COMPLETED|Overall Study||157
7791203|NCT01256476|19179849|P1|COMPLETED|Overall Study||158
7791204|NCT01256476|19179848|P2|STARTED|Overall Study||164
7791205|NCT01256476|19179849|P1|STARTED|Overall Study||164
7791206|NCT01256450|19179857|P3|NOT COMPLETED|Double-blind Treatment||37
7791207|NCT01256450|19179858|P2|NOT COMPLETED|Double-blind Treatment||28
7791208|NCT01256450|19179859|P1|NOT COMPLETED|Double-blind Treatment||0
7791209|NCT01256450|19179857|P3|COMPLETED|Double-blind Treatment||81
7791210|NCT01256450|19179858|P2|COMPLETED|Double-blind Treatment||89
7791211|NCT01256450|19179859|P1|COMPLETED|Double-blind Treatment||0
7791212|NCT01256450|19179857|P3|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118
7791213|NCT01256450|19179858|P2|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117
7791214|NCT01256450|19179859|P1|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
7791215|NCT01256450|19179857|P3|NOT COMPLETED|Open-label Titration||0
7791216|NCT01256450|19179858|P2|NOT COMPLETED|Open-label Titration||0
7791217|NCT01256450|19179859|P1|NOT COMPLETED|Open-label Titration||99
7791218|NCT01256450|19179857|P3|COMPLETED|Open-label Titration||0
7791219|NCT01256450|19179858|P2|COMPLETED|Open-label Titration||0
7791220|NCT01256450|19179859|P1|COMPLETED|Open-label Titration||235
7791221|NCT01256450|19179857|P3|STARTED|Open-label Titration||0
7791222|NCT01256450|19179858|P2|STARTED|Open-label Titration||0
7791223|NCT01256450|19179859|P1|STARTED|Open-label Titration||334
7791224|NCT01256424|19179888|P4|NOT COMPLETED|Overall Study||7
7791225|NCT01256424|19179889|P3|NOT COMPLETED|Overall Study||7
7791226|NCT01256424|19179890|P2|NOT COMPLETED|Overall Study||8
7791227|NCT01256424|19179891|P1|NOT COMPLETED|Overall Study||9
7791228|NCT01256424|19179888|P4|COMPLETED|Overall Study||61
7791229|NCT01256424|19179889|P3|COMPLETED|Overall Study||55
7791230|NCT01256424|19179890|P2|COMPLETED|Overall Study||59
7791231|NCT01256424|19179891|P1|COMPLETED|Overall Study||56
7791232|NCT01256424|19179888|P4|STARTED|Overall Study||68
7791233|NCT01256424|19179889|P3|STARTED|Overall Study||62
7791234|NCT01256424|19179890|P2|STARTED|Overall Study||67
7791235|NCT01256424|19179891|P1|STARTED|Overall Study||65
7791236|NCT01256411|19179917|P6|NOT COMPLETED|Extension by Mono or Combination Therapy||4
7791237|NCT01256411|19179918|P5|NOT COMPLETED|Extension by Mono or Combination Therapy||17
7791238|NCT01256411|19179919|P4|NOT COMPLETED|Extension by Mono or Combination Therapy||0
7791239|NCT01256411|19179920|P3|NOT COMPLETED|Extension by Mono or Combination Therapy||0
7791240|NCT01256411|19179921|P2|NOT COMPLETED|Extension by Mono or Combination Therapy||0
7791241|NCT01256411|19179922|P1|NOT COMPLETED|Extension by Mono or Combination Therapy||0
7791242|NCT01256411|19179917|P6|COMPLETED|Extension by Mono or Combination Therapy||109
7791243|NCT01256411|19179918|P5|COMPLETED|Extension by Mono or Combination Therapy||211
7791244|NCT01256411|19179919|P4|COMPLETED|Extension by Mono or Combination Therapy||0
7791245|NCT01256411|19179920|P3|COMPLETED|Extension by Mono or Combination Therapy||0
7791246|NCT01256411|19179921|P2|COMPLETED|Extension by Mono or Combination Therapy||0
7791247|NCT01256411|19179922|P1|COMPLETED|Extension by Mono or Combination Therapy||0
7791248|NCT01256411|19179917|P6|STARTED|Extension by Mono or Combination Therapy||113
7791249|NCT01256411|19179918|P5|STARTED|Extension by Mono or Combination Therapy||228
7791250|NCT01256411|19179919|P4|STARTED|Extension by Mono or Combination Therapy||0
7791251|NCT01256411|19179920|P3|STARTED|Extension by Mono or Combination Therapy||0
7791252|NCT01256411|19179921|P2|STARTED|Extension by Mono or Combination Therapy||0
7791253|NCT01256411|19179922|P1|STARTED|Extension by Mono or Combination Therapy||0
7791254|NCT01256411|19179917|P6|NOT COMPLETED|Extension by Maximum Treatment||0
7791255|NCT01256411|19179918|P5|NOT COMPLETED|Extension by Maximum Treatment||0
7791256|NCT01256411|19179919|P4|NOT COMPLETED|Extension by Maximum Treatment||0
7791257|NCT01256411|19179920|P3|NOT COMPLETED|Extension by Maximum Treatment||4
7791258|NCT01256411|19179921|P2|NOT COMPLETED|Extension by Maximum Treatment||10
7791259|NCT01256411|19179922|P1|NOT COMPLETED|Extension by Maximum Treatment||7
7791260|NCT01256411|19179917|P6|COMPLETED|Extension by Maximum Treatment||0
7791261|NCT01256411|19179918|P5|COMPLETED|Extension by Maximum Treatment||0
7791262|NCT01256411|19179919|P4|COMPLETED|Extension by Maximum Treatment||4
7791263|NCT01256411|19179920|P3|COMPLETED|Extension by Maximum Treatment||105
7791264|NCT01256411|19179921|P2|COMPLETED|Extension by Maximum Treatment||79
7791265|NCT01256411|19179922|P1|COMPLETED|Extension by Maximum Treatment||132
7791266|NCT01256411|19179917|P6|Down Titrated to 100 mg|Extension by Maximum Treatment||0
7791267|NCT01256411|19179918|P5|Down Titrated to 100 mg|Extension by Maximum Treatment||0
7791268|NCT01256411|19179919|P4|Down Titrated to 100 mg|Extension by Maximum Treatment||0
7791269|NCT01256411|19179920|P3|Down Titrated to 100 mg|Extension by Maximum Treatment||0
7791270|NCT01256411|19179921|P2|Down Titrated to 100 mg|Extension by Maximum Treatment||0
7791271|NCT01256411|19179922|P1|Down Titrated to 100 mg|Extension by Maximum Treatment||12
7791272|NCT01256411|19179917|P6|STARTED|Extension by Maximum Treatment||0
7791273|NCT01256411|19179918|P5|STARTED|Extension by Maximum Treatment||0
7791274|NCT01256411|19179919|P4|STARTED|Extension by Maximum Treatment||4
7791275|NCT01256411|19179920|P3|STARTED|Extension by Maximum Treatment||109
7791276|NCT01256411|19179921|P2|STARTED|Extension by Maximum Treatment||89
7791277|NCT01256411|19179922|P1|STARTED|Extension by Maximum Treatment||139
7791278|NCT01256398|19179946|P1|NOT COMPLETED|Overall Study||1
7791279|NCT01256398|19179946|P1|COMPLETED|Overall Study||65
7791280|NCT01256398|19179946|P1|STARTED|Overall Study||66
7791281|NCT01256385|19179952|P2|NOT COMPLETED|Overall Study||3
7791282|NCT01256385|19179953|P1|NOT COMPLETED|Overall Study||3
7791283|NCT01256385|19179952|P2|COMPLETED|Overall Study||40
7791284|NCT01256385|19179953|P1|COMPLETED|Overall Study||40
7791285|NCT01256385|19179952|P2|Crossover From Arm B to Arm A|Overall Study||15
7791286|NCT01256385|19179953|P1|Crossover From Arm B to Arm A|Overall Study||0
7791287|NCT01256385|19179952|P2|STARTED|Overall Study||43
7791288|NCT01256385|19179953|P1|STARTED|Overall Study||43
7791289|NCT01256294|19179973|P2|NOT COMPLETED|Overall Study||2
7791290|NCT01256294|19179974|P1|NOT COMPLETED|Overall Study||4
7791291|NCT01256294|19179973|P2|COMPLETED|Overall Study||33
7791292|NCT01256294|19179974|P1|COMPLETED|Overall Study||32
7791293|NCT01256294|19179973|P2|STARTED|Overall Study||35
7791294|NCT01256294|19179974|P1|STARTED|Overall Study||36
7791295|NCT01256281|19179990|P1|NOT COMPLETED|Overall Study||0
7791296|NCT01256281|19179990|P1|COMPLETED|Overall Study||2
7791297|NCT01256281|19179990|P1|STARTED|Overall Study||2
7791298|NCT01256190|19179996|P2|NOT COMPLETED|Overall Study||0
7791299|NCT01256190|19179997|P1|NOT COMPLETED|Overall Study||2
7791300|NCT01256190|19179996|P2|COMPLETED|Overall Study||17
7791301|NCT01256190|19179997|P1|COMPLETED|Overall Study||37
7791302|NCT01256190|19179996|P2|STARTED|Overall Study||17
7791303|NCT01256190|19179997|P1|STARTED|Overall Study||39
7791304|NCT01256177|19180013|P2|NOT COMPLETED|Overall Study||37
7791305|NCT01256177|19180014|P1|NOT COMPLETED|Overall Study||50
7791306|NCT01256177|19180013|P2|COMPLETED|Overall Study||111
7791307|NCT01256177|19180014|P1|COMPLETED|Overall Study||98
7791308|NCT01256177|19180013|P2|STARTED|Overall Study||148
7791309|NCT01256177|19180014|P1|STARTED|Overall Study||148
7791310|NCT01256164|19180038|P2|NOT COMPLETED|Overall Study||0
7791311|NCT01256164|19180039|P1|NOT COMPLETED|Overall Study||0
7791312|NCT01256164|19180038|P2|COMPLETED|Overall Study||23
7791313|NCT01256164|19180039|P1|COMPLETED|Overall Study||47
7791314|NCT01256164|19180038|P2|STARTED|Overall Study||23
7791315|NCT01256164|19180039|P1|STARTED|Overall Study||47
7791316|NCT01256086|19180057|P4|NOT COMPLETED|Treatment Day 4||0
7791317|NCT01256086|19180058|P3|NOT COMPLETED|Treatment Day 4||0
7791318|NCT01256086|19180059|P2|NOT COMPLETED|Treatment Day 4||0
7791319|NCT01256086|19180060|P1|NOT COMPLETED|Treatment Day 4||0
7791320|NCT01256086|19180057|P4|COMPLETED|Treatment Day 4||11
7791321|NCT01256086|19180058|P3|COMPLETED|Treatment Day 4||9
7791322|NCT01256086|19180059|P2|COMPLETED|Treatment Day 4||10
7791323|NCT01256086|19180060|P1|COMPLETED|Treatment Day 4||11
7791324|NCT01256086|19180057|P4|STARTED|Treatment Day 4||11
7791325|NCT01256086|19180058|P3|STARTED|Treatment Day 4||9
7791326|NCT01256086|19180059|P2|STARTED|Treatment Day 4||10
7791327|NCT01256086|19180060|P1|STARTED|Treatment Day 4||11
7791328|NCT01256086|19180057|P4|NOT COMPLETED|Treatment Day 3||0
7791329|NCT01256086|19180058|P3|NOT COMPLETED|Treatment Day 3||0
7791330|NCT01256086|19180059|P2|NOT COMPLETED|Treatment Day 3||0
7791331|NCT01256086|19180060|P1|NOT COMPLETED|Treatment Day 3||0
7791332|NCT01256086|19180057|P4|COMPLETED|Treatment Day 3||11
7791333|NCT01256086|19180058|P3|COMPLETED|Treatment Day 3||9
7791334|NCT01256086|19180059|P2|COMPLETED|Treatment Day 3||10
7791335|NCT01256086|19180060|P1|COMPLETED|Treatment Day 3||11
7791336|NCT01256086|19180057|P4|STARTED|Treatment Day 3||11
7791337|NCT01256086|19180058|P3|STARTED|Treatment Day 3||9
7791338|NCT01256086|19180059|P2|STARTED|Treatment Day 3||10
7791339|NCT01256086|19180060|P1|STARTED|Treatment Day 3||11
7791340|NCT01256086|19180057|P4|NOT COMPLETED|Treatment Day 2||0
7791341|NCT01256086|19180058|P3|NOT COMPLETED|Treatment Day 2||0
7791342|NCT01256086|19180059|P2|NOT COMPLETED|Treatment Day 2||0
7791343|NCT01256086|19180060|P1|NOT COMPLETED|Treatment Day 2||0
7791344|NCT01256086|19180057|P4|COMPLETED|Treatment Day 2||11
7791345|NCT01256086|19180058|P3|COMPLETED|Treatment Day 2||9
7791346|NCT01256086|19180059|P2|COMPLETED|Treatment Day 2||10
7791347|NCT01256086|19180060|P1|COMPLETED|Treatment Day 2||11
7791348|NCT01256086|19180057|P4|STARTED|Treatment Day 2||11
7791349|NCT01256086|19180058|P3|STARTED|Treatment Day 2||9
7791350|NCT01256086|19180059|P2|STARTED|Treatment Day 2||10
7791351|NCT01256086|19180060|P1|STARTED|Treatment Day 2||11
7791352|NCT01256086|19180057|P4|NOT COMPLETED|Treatment Day 1||0
7791353|NCT01256086|19180058|P3|NOT COMPLETED|Treatment Day 1||0
7791354|NCT01256086|19180059|P2|NOT COMPLETED|Treatment Day 1||0
7791355|NCT01256086|19180060|P1|NOT COMPLETED|Treatment Day 1||0
7791356|NCT01256086|19180057|P4|COMPLETED|Treatment Day 1||11
7791357|NCT01256086|19180058|P3|COMPLETED|Treatment Day 1||11
7791358|NCT01256086|19180059|P2|COMPLETED|Treatment Day 1||11
7791359|NCT01256086|19180060|P1|COMPLETED|Treatment Day 1||11
7791360|NCT01256086|19180057|P4|STARTED|Treatment Day 1||11
7791361|NCT01256086|19180058|P3|STARTED|Treatment Day 1||11
7791362|NCT01256086|19180059|P2|STARTED|Treatment Day 1||11
7791363|NCT01256086|19180060|P1|STARTED|Treatment Day 1||11
7791364|NCT01256060|19180070|P4|NOT COMPLETED|Overall Study||0
7791365|NCT01256060|19180071|P3|NOT COMPLETED|Overall Study||0
7791366|NCT01256060|19180072|P2|NOT COMPLETED|Overall Study||1
7791367|NCT01256060|19180073|P1|NOT COMPLETED|Overall Study||0
7791368|NCT01256060|19180070|P4|COMPLETED|Overall Study||6
7791369|NCT01256060|19180071|P3|COMPLETED|Overall Study||3
7791370|NCT01256060|19180072|P2|COMPLETED|Overall Study||2
7791371|NCT01256060|19180073|P1|COMPLETED|Overall Study||3
7791372|NCT01256060|19180070|P4|STARTED|Overall Study||6
7791373|NCT01256060|19180071|P3|STARTED|Overall Study||3
7791374|NCT01256060|19180072|P2|STARTED|Overall Study||3
7791375|NCT01256060|19180073|P1|STARTED|Overall Study||3
7791376|NCT01256034|19180082|P2|NOT COMPLETED|Overall Study||25
7791377|NCT01256034|19180083|P1|NOT COMPLETED|Overall Study||25
7791378|NCT01256034|19180082|P2|COMPLETED|Overall Study||0
7791379|NCT01256034|19180083|P1|COMPLETED|Overall Study||0
7791380|NCT01256034|19180082|P2|STARTED|Overall Study||25
7791381|NCT01256034|19180083|P1|STARTED|Overall Study||25
7791382|NCT01256008|19180092|P3|NOT COMPLETED|Overall Study||21
7791383|NCT01256008|19180093|P2|NOT COMPLETED|Overall Study||7
7791384|NCT01256008|19180094|P1|NOT COMPLETED|Overall Study||8
7791385|NCT01256008|19180092|P3|COMPLETED|Overall Study||175
7791386|NCT01256008|19180093|P2|COMPLETED|Overall Study||91
7791387|NCT01256008|19180094|P1|COMPLETED|Overall Study||90
7791388|NCT01256008|19180092|P3|STARTED|Overall Study||196
7791389|NCT01256008|19180093|P2|STARTED|Overall Study||98
7791390|NCT01256008|19180094|P1|STARTED|Overall Study||98
7791391|NCT01255904|19180116|P2|NOT COMPLETED|Overall Study||4
7791392|NCT01255904|19180117|P1|NOT COMPLETED|Overall Study||1
7791393|NCT01255904|19180116|P2|COMPLETED|Overall Study||41
7791394|NCT01255904|19180117|P1|COMPLETED|Overall Study||44
7791395|NCT01255904|19180116|P2|STARTED|Overall Study||45
7791396|NCT01255904|19180117|P1|STARTED|Overall Study||45
7791397|NCT01255865|19180130|P7|NOT COMPLETED|Overall Study||0
7791398|NCT01255865|19180131|P6|NOT COMPLETED|Overall Study||0
7791399|NCT01255865|19180132|P5|NOT COMPLETED|Overall Study||0
7791400|NCT01255865|19180133|P4|NOT COMPLETED|Overall Study||0
7791401|NCT01255865|19180134|P3|NOT COMPLETED|Overall Study||0
7791402|NCT01255865|19180135|P2|NOT COMPLETED|Overall Study||0
7791403|NCT01255865|19180136|P1|NOT COMPLETED|Overall Study||0
7791404|NCT01255865|19180130|P7|COMPLETED|Overall Study||20
7791405|NCT01255865|19180131|P6|COMPLETED|Overall Study||20
7791406|NCT01255865|19180132|P5|COMPLETED|Overall Study||20
7791407|NCT01255865|19180133|P4|COMPLETED|Overall Study||30
7791408|NCT01255865|19180134|P3|COMPLETED|Overall Study||10
7791409|NCT01255865|19180135|P2|COMPLETED|Overall Study||10
7791410|NCT01255865|19180136|P1|COMPLETED|Overall Study||1
7791411|NCT01255865|19180130|P7|STARTED|Overall Study||20
7791412|NCT01255865|19180131|P6|STARTED|Overall Study||20
7791413|NCT01255865|19180132|P5|STARTED|Overall Study||20
7791414|NCT01255865|19180133|P4|STARTED|Overall Study||30
7791415|NCT01255865|19180134|P3|STARTED|Overall Study||10
7791416|NCT01255865|19180135|P2|STARTED|Overall Study||10
7791417|NCT01255865|19180136|P1|STARTED|Overall Study||1
7791418|NCT01255787|19180156|P4|NOT COMPLETED|Overall Study||22
7791419|NCT01255787|19180157|P3|NOT COMPLETED|Overall Study||18
7791420|NCT01255787|19180158|P2|NOT COMPLETED|Overall Study||17
7791421|NCT01255787|19180159|P1|NOT COMPLETED|Overall Study||16
7791422|NCT01255787|19180156|P4|COMPLETED|Overall Study||132
7791423|NCT01255787|19180157|P3|COMPLETED|Overall Study||132
7791424|NCT01255787|19180158|P2|COMPLETED|Overall Study||127
7791425|NCT01255787|19180159|P1|COMPLETED|Overall Study||136
7791426|NCT01255787|19180156|P4|Treated|Overall Study||150
7791427|NCT01255787|19180157|P3|Treated|Overall Study||148
7791428|NCT01255787|19180158|P2|Treated|Overall Study||144
7791429|NCT01255787|19180159|P1|Treated|Overall Study||152
7791430|NCT01255787|19180156|P4|STARTED|Overall Study||154
7791431|NCT01255787|19180157|P3|STARTED|Overall Study||150
7791432|NCT01255787|19180158|P2|STARTED|Overall Study||144
7791433|NCT01255787|19180159|P1|STARTED|Overall Study||152
7791434|NCT01255761|19180187|P2|NOT COMPLETED|Overall Study||175
7791435|NCT01255761|19180188|P1|NOT COMPLETED|Overall Study||182
7791436|NCT01255761|19180187|P2|COMPLETED|Overall Study||192
7791437|NCT01255761|19180188|P1|COMPLETED|Overall Study||187
7791438|NCT01255761|19180187|P2|STARTED|Overall Study||367
7791439|NCT01255761|19180188|P1|STARTED|Overall Study||369
7791440|NCT01255722|19180273|P3|NOT COMPLETED|Overall Study||1
7791441|NCT01255722|19180274|P2|NOT COMPLETED|Overall Study||1
7791442|NCT01255722|19180275|P1|NOT COMPLETED|Overall Study||3
7791443|NCT01255722|19180273|P3|COMPLETED|Overall Study||152
7791444|NCT01255722|19180274|P2|COMPLETED|Overall Study||159
7791445|NCT01255722|19180275|P1|COMPLETED|Overall Study||152
7791446|NCT01255722|19180273|P3|STARTED|Overall Study||153
7791447|NCT01255722|19180274|P2|STARTED|Overall Study||160
7791448|NCT01255722|19180275|P1|STARTED|Overall Study||155
7791449|NCT01255631|19180300|P2|NOT COMPLETED|Overall Study||6
7791450|NCT01255631|19180301|P1|NOT COMPLETED|Overall Study||9
7791451|NCT01255631|19180300|P2|COMPLETED|Overall Study|study terminated due to poor enrollment|3
7791452|NCT01255631|19180301|P1|COMPLETED|Overall Study|study terminated due to poor enrollment|4
7791453|NCT01255631|19180300|P2|STARTED|Overall Study||9
7791454|NCT01255631|19180301|P1|STARTED|Overall Study||13
7791455|NCT01255592|19180319|P2|NOT COMPLETED|Overall Study||1
7791456|NCT01255592|19180320|P1|NOT COMPLETED|Overall Study||6
7791457|NCT01255592|19180319|P2|COMPLETED|Overall Study||25
7791458|NCT01255592|19180320|P1|COMPLETED|Overall Study||20
7791459|NCT01255592|19180319|P2|STARTED|Overall Study||26
7791460|NCT01255592|19180320|P1|STARTED|Overall Study||26
7791461|NCT01255449|19180376|P1|NOT COMPLETED|Overall Study||0
7791462|NCT01255449|19180376|P1|COMPLETED|Overall Study||26
7791463|NCT01255449|19180376|P1|STARTED|Overall Study||26
7791464|NCT01255436|19180383|P2|NOT COMPLETED|Overall Study||194
7791465|NCT01255436|19180384|P1|NOT COMPLETED|Overall Study||182
7791466|NCT01255436|19180383|P2|COMPLETED|Overall Study||135
7791467|NCT01255436|19180384|P1|COMPLETED|Overall Study||151
7791468|NCT01255436|19180383|P2|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329
7791469|NCT01255436|19180384|P1|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333
7791470|NCT01255423|19180398|P2|NOT COMPLETED|Overall Study||3
7791471|NCT01255423|19180399|P1|NOT COMPLETED|Overall Study||3
7791472|NCT01255423|19180398|P2|COMPLETED|Overall Study||99
7791473|NCT01255423|19180399|P1|COMPLETED|Overall Study||101
7791474|NCT01255423|19180398|P2|STARTED|Overall Study||102
7791475|NCT01255423|19180399|P1|STARTED|Overall Study||104
7791476|NCT01255306|19180415|P2|NOT COMPLETED|Overall Study||1
7791477|NCT01255306|19180416|P1|NOT COMPLETED|Overall Study||1
7791478|NCT01255306|19180415|P2|COMPLETED|Overall Study||32
7791479|NCT01255306|19180416|P1|COMPLETED|Overall Study||25
7791480|NCT01255306|19180415|P2|STARTED|Overall Study||33
7791481|NCT01255306|19180416|P1|STARTED|Overall Study||26
7791482|NCT01255163|19180427|P2|NOT COMPLETED|Overall Study||5
7791483|NCT01255163|19180428|P1|NOT COMPLETED|Overall Study||4
7791484|NCT01255163|19180427|P2|COMPLETED|Overall Study||9
7791485|NCT01255163|19180428|P1|COMPLETED|Overall Study||9
7791486|NCT01255163|19180427|P2|STARTED|Overall Study||14
7791487|NCT01255163|19180428|P1|STARTED|Overall Study||13
7791488|NCT01255137|19180450|P1|NOT COMPLETED|Overall Study||0
7791489|NCT01255137|19180450|P1|COMPLETED|Overall Study||13
7791490|NCT01255137|19180450|P1|STARTED|Overall Study||13
7791491|NCT01254890|19180457|P2|NOT COMPLETED|Overall Study||10
7791492|NCT01254890|19180458|P1|NOT COMPLETED|Overall Study||1
7791493|NCT01254890|19180457|P2|COMPLETED|Overall Study||47
7791494|NCT01254890|19180458|P1|COMPLETED|Overall Study||2
7791495|NCT01254890|19180457|P2|STARTED|Overall Study||57
7791496|NCT01254890|19180458|P1|STARTED|Overall Study||3
7791497|NCT01254877|19180467|P3|NOT COMPLETED|Overall Study||5
7791498|NCT01254877|19180468|P2|NOT COMPLETED|Overall Study||11
7791499|NCT01254877|19180469|P1|NOT COMPLETED|Overall Study||10
7791500|NCT01254877|19180467|P3|COMPLETED|Overall Study||64
7791501|NCT01254877|19180468|P2|COMPLETED|Overall Study||58
7791502|NCT01254877|19180469|P1|COMPLETED|Overall Study||57
7791503|NCT01254877|19180467|P3|STARTED|Overall Study||69
7791504|NCT01254877|19180468|P2|STARTED|Overall Study||69
7791505|NCT01254877|19180469|P1|STARTED|Overall Study||67
7791506|NCT01254851|19180494|P2|NOT COMPLETED|Overall Study||9
7791507|NCT01254851|19180495|P1|NOT COMPLETED|Overall Study||8
7791508|NCT01254851|19180494|P2|COMPLETED|Overall Study||68
7791509|NCT01254851|19180495|P1|COMPLETED|Overall Study||61
7791510|NCT01254851|19180494|P2|STARTED|Overall Study||77
7791511|NCT01254851|19180495|P1|STARTED|Overall Study||69
7791512|NCT01254760|19180501|P2|NOT COMPLETED|Second Period, 5 Days of Wear||0
7791513|NCT01254760|19180502|P1|NOT COMPLETED|Second Period, 5 Days of Wear||0
7791514|NCT01254760|19180501|P2|COMPLETED|Second Period, 5 Days of Wear||38
7791515|NCT01254760|19180502|P1|COMPLETED|Second Period, 5 Days of Wear||34
7791516|NCT01254760|19180501|P2|STARTED|Second Period, 5 Days of Wear||38
7791517|NCT01254760|19180502|P1|STARTED|Second Period, 5 Days of Wear||34
7791518|NCT01254760|19180501|P2|NOT COMPLETED|First Period, 5 Days of Wear||0
7791519|NCT01254760|19180502|P1|NOT COMPLETED|First Period, 5 Days of Wear||0
7791520|NCT01254760|19180501|P2|COMPLETED|First Period, 5 Days of Wear||38
7791521|NCT01254760|19180502|P1|COMPLETED|First Period, 5 Days of Wear||34
7791522|NCT01254760|19180501|P2|STARTED|First Period, 5 Days of Wear||38
7791523|NCT01254760|19180502|P1|STARTED|First Period, 5 Days of Wear||34
7791524|NCT01254747|19180520|P4|NOT COMPLETED|Overall Study||2
7791525|NCT01254747|19180521|P3|NOT COMPLETED|Overall Study||4
7791526|NCT01254747|19180522|P2|NOT COMPLETED|Overall Study||6
7791527|NCT01254747|19180523|P1|NOT COMPLETED|Overall Study||0
7791528|NCT01254747|19180520|P4|COMPLETED|Overall Study||28
7791529|NCT01254747|19180521|P3|COMPLETED|Overall Study||26
7791530|NCT01254747|19180522|P2|COMPLETED|Overall Study||23
7791531|NCT01254747|19180523|P1|COMPLETED|Overall Study||40
7791532|NCT01254747|19180520|P4|STARTED|Overall Study||30
7791533|NCT01254747|19180521|P3|STARTED|Overall Study||30
7791534|NCT01254747|19180522|P2|STARTED|Overall Study||29
7791535|NCT01254747|19180523|P1|STARTED|Overall Study||40
7791536|NCT01254721|19180563|P2|NOT COMPLETED|Overall Study||22
7791537|NCT01254721|19180564|P1|NOT COMPLETED|Overall Study||15
7791538|NCT01254721|19180563|P2|COMPLETED|Overall Study||42
7791539|NCT01254721|19180564|P1|COMPLETED|Overall Study||52
7791540|NCT01254721|19180563|P2|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64
7791541|NCT01254721|19180564|P1|STARTED|Overall Study|Seroquel XR: 300mg|67
7791542|NCT01254669|19180574|P2|NOT COMPLETED|Overall Study||4
7791543|NCT01254669|19180575|P1|NOT COMPLETED|Overall Study||3
7791544|NCT01254669|19180574|P2|COMPLETED|Overall Study||96
7791545|NCT01254669|19180575|P1|COMPLETED|Overall Study||97
7791546|NCT01254669|19180574|P2|STARTED|Overall Study||100
7791547|NCT01254669|19180575|P1|STARTED|Overall Study||100
7791548|NCT01254656|19180586|P3|NOT COMPLETED|Overall Study||18
7791549|NCT01254656|19180587|P2|NOT COMPLETED|Overall Study||43
7791550|NCT01254656|19180588|P1|NOT COMPLETED|Overall Study||47
7791551|NCT01254656|19180586|P3|COMPLETED|Overall Study||0
7791552|NCT01254656|19180587|P2|COMPLETED|Overall Study||0
7791553|NCT01254656|19180588|P1|COMPLETED|Overall Study||0
7791554|NCT01254656|19180586|P3|Treated|Overall Study||18
7791555|NCT01254656|19180587|P2|Treated|Overall Study||43
7791556|NCT01254656|19180588|P1|Treated|Overall Study||47
7791557|NCT01254656|19180586|P3|STARTED|Overall Study||18
7791558|NCT01254656|19180587|P2|STARTED|Overall Study||43
7791559|NCT01254656|19180588|P1|STARTED|Overall Study||47
7791560|NCT01254643|19180614|P1|NOT COMPLETED|Overall Study||1
7791561|NCT01254643|19180614|P1|COMPLETED|Overall Study||99
7791562|NCT01254643|19180614|P1|Vaccination 3|Overall Study||99
7791563|NCT01254643|19180614|P1|Vaccination 2|Overall Study||99
7791564|NCT01254643|19180614|P1|Vaccination 1|Overall Study||100
7791565|NCT01254643|19180614|P1|STARTED|Overall Study||100
7791566|NCT01254630|19180626|P4|NOT COMPLETED|Overall Study||1285
7791567|NCT01254630|19180627|P3|NOT COMPLETED|Overall Study||812
7791568|NCT01254630|19180628|P2|NOT COMPLETED|Overall Study||1288
7791569|NCT01254630|19180629|P1|NOT COMPLETED|Overall Study||802
7791570|NCT01254630|19180626|P4|COMPLETED|Overall Study||0
7791571|NCT01254630|19180627|P3|COMPLETED|Overall Study||552
7791572|NCT01254630|19180628|P2|COMPLETED|Overall Study||0
7791573|NCT01254630|19180629|P1|COMPLETED|Overall Study||546
7791574|NCT01254630|19180626|P4|Received Vaccination 4|Overall Study||1160
7791575|NCT01254630|19180627|P3|Received Vaccination 4|Overall Study||1212
7791576|NCT01254630|19180628|P2|Received Vaccination 4|Overall Study||1145
7791577|NCT01254630|19180629|P1|Received Vaccination 4|Overall Study||1155
7791578|NCT01254630|19180626|P4|Received Vaccination 3|Overall Study||1194
7791579|NCT01254630|19180627|P3|Received Vaccination 3|Overall Study||1247
7791580|NCT01254630|19180628|P2|Received Vaccination 3|Overall Study||1178
7791581|NCT01254630|19180629|P1|Received Vaccination 3|Overall Study||1198
7791582|NCT01254630|19180626|P4|Received Vaccination 2|Overall Study||1226
7791583|NCT01254630|19180627|P3|Received Vaccination 2|Overall Study||1286
7791584|NCT01254630|19180628|P2|Received Vaccination 2|Overall Study||1217
7791585|NCT01254630|19180629|P1|Received Vaccination 2|Overall Study||1255
7791586|NCT01254630|19180626|P4|Received Vaccination 1|Overall Study||1275
7791587|NCT01254630|19180627|P3|Received Vaccination 1|Overall Study||1350
7791588|NCT01254630|19180628|P2|Received Vaccination 1|Overall Study||1277
7791589|NCT01254630|19180629|P1|Received Vaccination 1|Overall Study||1328
7791590|NCT01254630|19180626|P4|STARTED|Overall Study||1285
7791591|NCT01254630|19180627|P3|STARTED|Overall Study||1364
7791592|NCT01254630|19180628|P2|STARTED|Overall Study||1288
7791593|NCT01254630|19180629|P1|STARTED|Overall Study||1348
7791594|NCT01254604|19180649|P2|NOT COMPLETED|Overall Study||9
7791595|NCT01254604|19180650|P1|NOT COMPLETED|Overall Study||8
7791596|NCT01254604|19180649|P2|COMPLETED|Overall Study||86
7791597|NCT01254604|19180650|P1|COMPLETED|Overall Study||87
7791598|NCT01254604|19180649|P2|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94
7791599|NCT01254604|19180650|P1|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93
7791600|NCT01254604|19180649|P2|STARTED|Overall Study||95
7791601|NCT01254604|19180650|P1|STARTED|Overall Study||95
7791602|NCT01254565|19180668|P6|NOT COMPLETED|Overall Study||4
7791603|NCT01254565|19180669|P5|NOT COMPLETED|Overall Study||4
7791604|NCT01254565|19180670|P4|NOT COMPLETED|Overall Study||1
7791605|NCT01254565|19180671|P3|NOT COMPLETED|Overall Study||0
7791606|NCT01254565|19180672|P2|NOT COMPLETED|Overall Study||1
7791607|NCT01254565|19180673|P1|NOT COMPLETED|Overall Study||1
7791608|NCT01254565|19180668|P6|COMPLETED|Overall Study||13
7791609|NCT01254565|19180669|P5|COMPLETED|Overall Study||12
7791610|NCT01254565|19180670|P4|COMPLETED|Overall Study||20
7791611|NCT01254565|19180671|P3|COMPLETED|Overall Study||21
7791612|NCT01254565|19180672|P2|COMPLETED|Overall Study||6
7791613|NCT01254565|19180673|P1|COMPLETED|Overall Study||4
7791614|NCT01254565|19180668|P6|Received Treatment|Overall Study||13
7791615|NCT01254565|19180669|P5|Received Treatment|Overall Study||13
7791616|NCT01254565|19180670|P4|Received Treatment|Overall Study||21
7791617|NCT01254565|19180671|P3|Received Treatment|Overall Study||21
7791618|NCT01254565|19180672|P2|Received Treatment|Overall Study||6
7791619|NCT01254565|19180673|P1|Received Treatment|Overall Study||4
7791620|NCT01254565|19180668|P6|STARTED|Overall Study||17
7791621|NCT01254565|19180669|P5|STARTED|Overall Study||16
7791622|NCT01254565|19180670|P4|STARTED|Overall Study||21
7791623|NCT01254565|19180671|P3|STARTED|Overall Study||21
7791624|NCT01254565|19180672|P2|STARTED|Overall Study||7
7791625|NCT01254565|19180673|P1|STARTED|Overall Study||5
7791626|NCT01254552|19180723|P1|NOT COMPLETED|CCTA With Xenetix 350||6
7791627|NCT01254552|19180723|P1|COMPLETED|CCTA With Xenetix 350||322
7791628|NCT01254552|19180723|P1|STARTED|CCTA With Xenetix 350||328
7791629|NCT01254552|19180723|P1|NOT COMPLETED|Delayed-enhanced MRI With Dotarem||20
7791630|NCT01254552|19180723|P1|COMPLETED|Delayed-enhanced MRI With Dotarem||328
7791631|NCT01254552|19180723|P1|STARTED|Delayed-enhanced MRI With Dotarem||348
7791632|NCT01254552|19180723|P1|NOT COMPLETED|Screening Visit||3
7791633|NCT01254552|19180723|P1|COMPLETED|Screening Visit||348
7791634|NCT01254552|19180723|P1|STARTED|Screening Visit||351
7791635|NCT01254422|19180733|P2|NOT COMPLETED|Overall Study||1
7791636|NCT01254422|19180734|P1|NOT COMPLETED|Overall Study||3
7791637|NCT01254422|19180733|P2|COMPLETED|Overall Study||50
7791638|NCT01254422|19180734|P1|COMPLETED|Overall Study||196
7791639|NCT01254422|19180733|P2|STARTED|Overall Study||51
7791640|NCT01254422|19180734|P1|STARTED|Overall Study||199
7791641|NCT01254409|19180762|P4|NOT COMPLETED|Overall Study||0
7791642|NCT01254409|19180763|P3|NOT COMPLETED|Overall Study||0
7791643|NCT01254409|19180764|P2|NOT COMPLETED|Overall Study||1
7791644|NCT01254409|19180765|P1|NOT COMPLETED|Overall Study||0
7791645|NCT01254409|19180762|P4|COMPLETED|Overall Study||4
7791646|NCT01254409|19180763|P3|COMPLETED|Overall Study||5
7791647|NCT01254409|19180764|P2|COMPLETED|Overall Study||5
7791648|NCT01254409|19180765|P1|COMPLETED|Overall Study||6
7791649|NCT01254409|19180762|P4|STARTED|Overall Study||4
7791650|NCT01254409|19180763|P3|STARTED|Overall Study||5
7791651|NCT01254409|19180764|P2|STARTED|Overall Study||6
7791652|NCT01254409|19180765|P1|STARTED|Overall Study||6
7791653|NCT01254396|19180817|P2|NOT COMPLETED|Second Intervention Period||0
7791654|NCT01254396|19180818|P1|NOT COMPLETED|Second Intervention Period||0
7791655|NCT01254396|19180817|P2|COMPLETED|Second Intervention Period||6
7791656|NCT01254396|19180818|P1|COMPLETED|Second Intervention Period||6
7791657|NCT01254396|19180817|P2|STARTED|Second Intervention Period||6
7791658|NCT01254396|19180818|P1|STARTED|Second Intervention Period||6
7791659|NCT01254396|19180817|P2|NOT COMPLETED|Washout Period (at Least 1 Day)||0
7791660|NCT01254396|19180818|P1|NOT COMPLETED|Washout Period (at Least 1 Day)||0
7791661|NCT01254396|19180817|P2|COMPLETED|Washout Period (at Least 1 Day)||6
7791662|NCT01254396|19180818|P1|COMPLETED|Washout Period (at Least 1 Day)||6
7791663|NCT01254396|19180817|P2|STARTED|Washout Period (at Least 1 Day)||6
7791664|NCT01254396|19180818|P1|STARTED|Washout Period (at Least 1 Day)||6
7791665|NCT01254396|19180817|P2|NOT COMPLETED|First Intervention Period||0
7791666|NCT01254396|19180818|P1|NOT COMPLETED|First Intervention Period||0
7791667|NCT01254396|19180817|P2|COMPLETED|First Intervention Period||6
7791668|NCT01254396|19180818|P1|COMPLETED|First Intervention Period||6
7791669|NCT01254396|19180817|P2|STARTED|First Intervention Period||6
7791670|NCT01254396|19180818|P1|STARTED|First Intervention Period||6
7791671|NCT01254344|19180834|P2|NOT COMPLETED|Overall Study||19
7791672|NCT01254344|19180835|P1|NOT COMPLETED|Overall Study||13
7791673|NCT01254344|19180834|P2|COMPLETED|Overall Study||281
7791674|NCT01254344|19180835|P1|COMPLETED|Overall Study||286
7791675|NCT01254344|19180834|P2|Treated|Overall Study||297
7791676|NCT01254344|19180835|P1|Treated|Overall Study||290
7791677|NCT01254344|19180834|P2|STARTED|Overall Study||300
7791678|NCT01254344|19180835|P1|STARTED|Overall Study||299
7791679|NCT01254331|19180843|P1|NOT COMPLETED|Extension Phase||4
7791680|NCT01254331|19180843|P1|COMPLETED|Extension Phase||41
7791681|NCT01254331|19180843|P1|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45
7791682|NCT01254331|19180843|P1|NOT COMPLETED|Initial Phase||5
7791683|NCT01254331|19180843|P1|COMPLETED|Initial Phase||46
7791684|NCT01254331|19180843|P1|STARTED|Initial Phase||51
7791685|NCT01254318|19180861|P1|NOT COMPLETED|Overall Study||52
7791686|NCT01254318|19180861|P1|COMPLETED|Overall Study|Alive at end of study|78
7791687|NCT01254318|19180861|P1|STARTED|Overall Study|Alive at start of study|130
7791688|NCT01254305|19180870|P3|NOT COMPLETED|Overall Study||17
7791689|NCT01254305|19180871|P2|NOT COMPLETED|Overall Study||18
7791690|NCT01254305|19180872|P1|NOT COMPLETED|Overall Study||22
7791691|NCT01254305|19180870|P3|COMPLETED|Overall Study||62
7791692|NCT01254305|19180871|P2|COMPLETED|Overall Study||72
7791693|NCT01254305|19180872|P1|COMPLETED|Overall Study||71
7791694|NCT01254305|19180870|P3|Safety Population|Overall Study||77
7791695|NCT01254305|19180871|P2|Safety Population|Overall Study||85
7791696|NCT01254305|19180872|P1|Safety Population|Overall Study||89
7791697|NCT01254305|19180870|P3|STARTED|Overall Study||79
7791698|NCT01254305|19180871|P2|STARTED|Overall Study||90
7791699|NCT01254305|19180872|P1|STARTED|Overall Study||93
7791700|NCT01254292|19180888|P2|NOT COMPLETED|LCS12 Extension Phase||0
7791701|NCT01254292|19180889|P1|NOT COMPLETED|LCS12 Extension Phase||37
7791702|NCT01254292|19180888|P2|COMPLETED|LCS12 Extension Phase||0
7791703|NCT01254292|19180889|P1|COMPLETED|LCS12 Extension Phase||163
7791704|NCT01254292|19180888|P2|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0
7791705|NCT01254292|19180889|P1|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200
7791706|NCT01254292|19180888|P2|NOT COMPLETED|Comparative Phase||81
7791707|NCT01254292|19180889|P1|NOT COMPLETED|Comparative Phase||55
7791708|NCT01254292|19180888|P2|COMPLETED|Comparative Phase||204
7791709|NCT01254292|19180889|P1|COMPLETED|Comparative Phase||227
7791710|NCT01254292|19180888|P2|Participants Received Treatment|Comparative Phase|safety population|281
7791711|NCT01254292|19180889|P1|Participants Received Treatment|Comparative Phase|safety population|279
7791712|NCT01254292|19180888|P2|STARTED|Comparative Phase||285
7791713|NCT01254292|19180889|P1|STARTED|Comparative Phase||282
7791714|NCT01254214|19180951|P2|NOT COMPLETED|Overall Study||1
7791715|NCT01254214|19180952|P1|NOT COMPLETED|Overall Study||3
7791716|NCT01254214|19180951|P2|COMPLETED|Overall Study||27
7791717|NCT01254214|19180952|P1|COMPLETED|Overall Study||24
7791718|NCT01254214|19180951|P2|STARTED|Overall Study||28
7791719|NCT01254214|19180952|P1|STARTED|Overall Study||27
7791720|NCT01254188|19180966|P1|NOT COMPLETED|Overall Study||93
7791721|NCT01254188|19180966|P1|COMPLETED|Overall Study||328
7791722|NCT01254188|19180966|P1|STARTED|Overall Study||421
7791723|NCT01254045|19180977|P6|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
7791724|NCT01254045|19180978|P5|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
7791725|NCT01254045|19180979|P4|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
7791726|NCT01254045|19180980|P3|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
7791727|NCT01254045|19180981|P2|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
7791728|NCT01254045|19180982|P1|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
7791729|NCT01254045|19180977|P6|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
7791730|NCT01254045|19180978|P5|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
7791731|NCT01254045|19180979|P4|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
7791732|NCT01254045|19180980|P3|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
7791733|NCT01254045|19180981|P2|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
7791734|NCT01254045|19180982|P1|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
7791735|NCT01254045|19180977|P6|STARTED|Third/Time 3 (1 Day at Week 3)||1
7791736|NCT01254045|19180978|P5|STARTED|Third/Time 3 (1 Day at Week 3)||1
7791737|NCT01254045|19180979|P4|STARTED|Third/Time 3 (1 Day at Week 3)||1
7791738|NCT01254045|19180980|P3|STARTED|Third/Time 3 (1 Day at Week 3)||2
7791739|NCT01254045|19180981|P2|STARTED|Third/Time 3 (1 Day at Week 3)||2
7791740|NCT01254045|19180982|P1|STARTED|Third/Time 3 (1 Day at Week 3)||1
7791741|NCT01254045|19180977|P6|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
7791742|NCT01254045|19180978|P5|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
7791743|NCT01254045|19180979|P4|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
7791744|NCT01254045|19180980|P3|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
7791745|NCT01254045|19180981|P2|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
7791746|NCT01254045|19180982|P1|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
7791747|NCT01254045|19180977|P6|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
7791748|NCT01254045|19180978|P5|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
7791749|NCT01254045|19180979|P4|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
7791750|NCT01254045|19180980|P3|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
7791751|NCT01254045|19180981|P2|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
7791752|NCT01254045|19180982|P1|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
7791753|NCT01254045|19180977|P6|STARTED|Second/Time 2 (1 Day at Week 2)||1
7791754|NCT01254045|19180978|P5|STARTED|Second/Time 2 (1 Day at Week 2)||1
7791755|NCT01254045|19180979|P4|STARTED|Second/Time 2 (1 Day at Week 2)||1
7791756|NCT01254045|19180980|P3|STARTED|Second/Time 2 (1 Day at Week 2)||2
7791757|NCT01254045|19180981|P2|STARTED|Second/Time 2 (1 Day at Week 2)||2
7791758|NCT01254045|19180982|P1|STARTED|Second/Time 2 (1 Day at Week 2)||1
7791759|NCT01254045|19180977|P6|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
7791760|NCT01254045|19180978|P5|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
7791761|NCT01254045|19180979|P4|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
7791762|NCT01254045|19180980|P3|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
7791763|NCT01254045|19180981|P2|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
7791764|NCT01254045|19180982|P1|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1
7791765|NCT01254045|19180977|P6|COMPLETED|First/Baseline (1 Day at Week 1 )||1
7791766|NCT01254045|19180978|P5|COMPLETED|First/Baseline (1 Day at Week 1 )||1
7791767|NCT01254045|19180979|P4|COMPLETED|First/Baseline (1 Day at Week 1 )||1
7791768|NCT01254045|19180980|P3|COMPLETED|First/Baseline (1 Day at Week 1 )||2
7791769|NCT01254045|19180981|P2|COMPLETED|First/Baseline (1 Day at Week 1 )||2
7791770|NCT01254045|19180982|P1|COMPLETED|First/Baseline (1 Day at Week 1 )||1
7791771|NCT01254045|19180977|P6|STARTED|First/Baseline (1 Day at Week 1 )||1
7791772|NCT01254045|19180978|P5|STARTED|First/Baseline (1 Day at Week 1 )||1
7791773|NCT01254045|19180979|P4|STARTED|First/Baseline (1 Day at Week 1 )||1
7791774|NCT01254045|19180980|P3|STARTED|First/Baseline (1 Day at Week 1 )||2
7791775|NCT01254045|19180981|P2|STARTED|First/Baseline (1 Day at Week 1 )||2
7791776|NCT01254045|19180982|P1|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2
7791777|NCT01254019|19180995|P2|NOT COMPLETED|Overall Study||4
7791778|NCT01254019|19180996|P1|NOT COMPLETED|Overall Study||1
7791779|NCT01254019|19180995|P2|COMPLETED|Overall Study||121
7791780|NCT01254019|19180996|P1|COMPLETED|Overall Study||60
7791781|NCT01254019|19180995|P2|STARTED|Overall Study||125
7791782|NCT01254019|19180996|P1|STARTED|Overall Study||61
7791783|NCT01253980|19181049|P2|NOT COMPLETED|Overall Study||0
7791784|NCT01253980|19181050|P1|NOT COMPLETED|Overall Study||0
7791785|NCT01253980|19181049|P2|COMPLETED|Overall Study||39
7791786|NCT01253980|19181050|P1|COMPLETED|Overall Study||35
7791787|NCT01253980|19181049|P2|STARTED|Overall Study||39
7791788|NCT01253980|19181050|P1|STARTED|Overall Study||35
7791789|NCT01253902|19181059|P3|NOT COMPLETED|Overall Study||4
7791790|NCT01253902|19181060|P2|NOT COMPLETED|Overall Study||2
7791791|NCT01253902|19181061|P1|NOT COMPLETED|Overall Study||5
7791792|NCT01253902|19181059|P3|COMPLETED|Overall Study||51
7791793|NCT01253902|19181060|P2|COMPLETED|Overall Study||51
7791794|NCT01253902|19181061|P1|COMPLETED|Overall Study||51
7791795|NCT01253902|19181059|P3|STARTED|Overall Study||55
7791796|NCT01253902|19181060|P2|STARTED|Overall Study||53
7791797|NCT01253902|19181061|P1|STARTED|Overall Study||56
7791798|NCT01253824|19181077|P2|NOT COMPLETED|Overall Study||0
7791799|NCT01253824|19181078|P1|NOT COMPLETED|Overall Study||0
7791800|NCT01253824|19181077|P2|COMPLETED|Overall Study||7
7791801|NCT01253824|19181078|P1|COMPLETED|Overall Study||7
7791802|NCT01253824|19181077|P2|STARTED|Overall Study||7
7791803|NCT01253824|19181078|P1|STARTED|Overall Study||7
7791804|NCT01253811|19181090|P1|NOT COMPLETED|Overall Study||1
7791805|NCT01253811|19181090|P1|COMPLETED|Overall Study||5
7791806|NCT01253811|19181090|P1|Exposed|Overall Study||6
7791807|NCT01253811|19181090|P1|STARTED|Overall Study||6
7791808|NCT01253642|19181109|P1|NOT COMPLETED|Overall Study||5
7791809|NCT01253642|19181109|P1|COMPLETED|Overall Study||6
7791810|NCT01253642|19181109|P1|STARTED|Overall Study||11
7791811|NCT01253577|19181121|P1|NOT COMPLETED|Overall Study||3
7791812|NCT01253577|19181121|P1|COMPLETED|Overall Study||102
7791813|NCT01253577|19181121|P1|STARTED|Overall Study||105
7791814|NCT01253564|19181129|P1|NOT COMPLETED|Overall Study||24
7791815|NCT01253564|19181129|P1|COMPLETED|Overall Study||0
7791816|NCT01253564|19181129|P1|STARTED|Overall Study||24
7791817|NCT01253525|19181146|P1|NOT COMPLETED|Overall Study||0
7791818|NCT01253525|19181146|P1|COMPLETED|Overall Study||6
7791819|NCT01253525|19181146|P1|Received Any Quantity of Study Drug|Overall Study||6
7791820|NCT01253525|19181146|P1|STARTED|Overall Study||6
7791821|NCT01253460|19181173|P1|NOT COMPLETED|Overall Study||0
7791822|NCT01253460|19181173|P1|COMPLETED|Overall Study||18
7791823|NCT01253460|19181173|P1|STARTED|Overall Study||18
7791824|NCT01253447|19181178|P1|NOT COMPLETED|Overall Study||2
7791825|NCT01253447|19181178|P1|COMPLETED|Overall Study||17
7791826|NCT01253447|19181178|P1|STARTED|Overall Study||19
7791827|NCT01253421|19181188|P5|NOT COMPLETED|Drug+Scanning Visit||1
7791828|NCT01253421|19181189|P4|NOT COMPLETED|Drug+Scanning Visit||0
7791829|NCT01253421|19181190|P3|NOT COMPLETED|Drug+Scanning Visit||0
7791830|NCT01253421|19181191|P2|NOT COMPLETED|Drug+Scanning Visit||0
7791831|NCT01253421|19181192|P1|NOT COMPLETED|Drug+Scanning Visit||0
7791832|NCT01253421|19181188|P5|COMPLETED|Drug+Scanning Visit||14
7791833|NCT01253421|19181189|P4|COMPLETED|Drug+Scanning Visit||16
7791834|NCT01253421|19181190|P3|COMPLETED|Drug+Scanning Visit||14
7791835|NCT01253421|19181191|P2|COMPLETED|Drug+Scanning Visit||15
7791836|NCT01253421|19181192|P1|COMPLETED|Drug+Scanning Visit||0
7791837|NCT01253421|19181188|P5|Received Drug Challenge|Drug+Scanning Visit||15
7791838|NCT01253421|19181189|P4|Received Drug Challenge|Drug+Scanning Visit||16
7791839|NCT01253421|19181190|P3|Received Drug Challenge|Drug+Scanning Visit||14
7791840|NCT01253421|19181191|P2|Received Drug Challenge|Drug+Scanning Visit||15
7791841|NCT01253421|19181192|P1|Received Drug Challenge|Drug+Scanning Visit||0
7791842|NCT01253421|19181188|P5|STARTED|Drug+Scanning Visit||15
7791843|NCT01253421|19181189|P4|STARTED|Drug+Scanning Visit||16
7791844|NCT01253421|19181190|P3|STARTED|Drug+Scanning Visit||14
7791845|NCT01253421|19181191|P2|STARTED|Drug+Scanning Visit||15
7791846|NCT01253421|19181192|P1|STARTED|Drug+Scanning Visit|Arm has no participants once randomization has occurred.|0
7791847|NCT01253421|19181188|P5|NOT COMPLETED|Assessment and Scheduling||0
7791848|NCT01253421|19181189|P4|NOT COMPLETED|Assessment and Scheduling||0
7791849|NCT01253421|19181190|P3|NOT COMPLETED|Assessment and Scheduling||0
7791850|NCT01253421|19181191|P2|NOT COMPLETED|Assessment and Scheduling||0
7791851|NCT01253421|19181192|P1|NOT COMPLETED|Assessment and Scheduling||99
7791852|NCT01253421|19181188|P5|COMPLETED|Assessment and Scheduling||0
7791853|NCT01253421|19181189|P4|COMPLETED|Assessment and Scheduling||0
7791854|NCT01253421|19181190|P3|COMPLETED|Assessment and Scheduling||0
7791855|NCT01253421|19181191|P2|COMPLETED|Assessment and Scheduling||0
7791856|NCT01253421|19181192|P1|COMPLETED|Assessment and Scheduling||60
7791857|NCT01253421|19181188|P5|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
7791858|NCT01253421|19181189|P4|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
7791859|NCT01253421|19181190|P3|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
7791860|NCT01253421|19181191|P2|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
7791861|NCT01253421|19181192|P1|Returned for Drug+Scanning Visit|Assessment and Scheduling||60
7791862|NCT01253421|19181188|P5|Eligible After Screening Visit|Assessment and Scheduling||0
7791863|NCT01253421|19181189|P4|Eligible After Screening Visit|Assessment and Scheduling||0
7791864|NCT01253421|19181190|P3|Eligible After Screening Visit|Assessment and Scheduling||0
7791865|NCT01253421|19181191|P2|Eligible After Screening Visit|Assessment and Scheduling||0
7791866|NCT01253421|19181192|P1|Eligible After Screening Visit|Assessment and Scheduling||85
7791867|NCT01253421|19181188|P5|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
7791868|NCT01253421|19181189|P4|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
7791869|NCT01253421|19181190|P3|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
7791870|NCT01253421|19181191|P2|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
7791871|NCT01253421|19181192|P1|STARTED|Assessment and Scheduling||159
7791872|NCT01253408|19181241|P3|NOT COMPLETED|Overall Study||0
7791873|NCT01253408|19181242|P2|NOT COMPLETED|Overall Study||1
7791874|NCT01253408|19181243|P1|NOT COMPLETED|Overall Study||0
7791875|NCT01253408|19181241|P3|COMPLETED|Overall Study||13
7791876|NCT01253408|19181242|P2|COMPLETED|Overall Study||12
7791877|NCT01253408|19181243|P1|COMPLETED|Overall Study||10
7791878|NCT01253408|19181241|P3|STARTED|Overall Study||13
7791879|NCT01253408|19181242|P2|STARTED|Overall Study||13
7791880|NCT01253408|19181243|P1|STARTED|Overall Study||10
7791881|NCT01253369|19181266|P1|NOT COMPLETED|Overall Study||33
7791882|NCT01253369|19181266|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
7791883|NCT01253369|19181266|P1|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30
7791884|NCT01253369|19181266|P1|STARTED|Overall Study||33
7791885|NCT01253343|19181273|P2|NOT COMPLETED|Overall Study||0
7791886|NCT01253343|19181274|P1|NOT COMPLETED|Overall Study||0
7791887|NCT01253343|19181273|P2|COMPLETED|Overall Study||8
7791888|NCT01253343|19181274|P1|COMPLETED|Overall Study||9
7791889|NCT01253343|19181273|P2|STARTED|Overall Study||8
7791890|NCT01253343|19181274|P1|STARTED|Overall Study||9
7791891|NCT01253317|19181296|P1|NOT COMPLETED|Overall Study||2
7791892|NCT01253317|19181296|P1|COMPLETED|Overall Study||10
7791893|NCT01253317|19181296|P1|STARTED|Overall Study||12
7791894|NCT01253304|19181308|P4|NOT COMPLETED|Overall Study||1
7791895|NCT01253304|19181309|P3|NOT COMPLETED|Overall Study||0
7791896|NCT01253304|19181310|P2|NOT COMPLETED|Overall Study||0
7791897|NCT01253304|19181311|P1|NOT COMPLETED|Overall Study||0
7791898|NCT01253304|19181308|P4|COMPLETED|Overall Study||2
7791899|NCT01253304|19181309|P3|COMPLETED|Overall Study||6
7791900|NCT01253304|19181310|P2|COMPLETED|Overall Study||6
7791901|NCT01253304|19181311|P1|COMPLETED|Overall Study||11
7791902|NCT01253304|19181308|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
7791903|NCT01253304|19181309|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
7791904|NCT01253304|19181310|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
7791905|NCT01253304|19181311|P1|Received at Least 1 Dose of Study Drug|Overall Study||11
7791906|NCT01253304|19181308|P4|STARTED|Overall Study||3
7791907|NCT01253304|19181309|P3|STARTED|Overall Study||6
7791908|NCT01253304|19181310|P2|STARTED|Overall Study||6
7791909|NCT01253304|19181311|P1|STARTED|Overall Study||11
7791910|NCT01253291|19181350|P5|NOT COMPLETED|Overall Study||2
7791911|NCT01253291|19181351|P4|NOT COMPLETED|Overall Study||0
7791912|NCT01253291|19181352|P3|NOT COMPLETED|Overall Study||0
7791913|NCT01253291|19181353|P2|NOT COMPLETED|Overall Study||2
7791914|NCT01253291|19181354|P1|NOT COMPLETED|Overall Study||4
7791915|NCT01253291|19181350|P5|COMPLETED|Overall Study||3
7791916|NCT01253291|19181351|P4|COMPLETED|Overall Study||5
7791917|NCT01253291|19181352|P3|COMPLETED|Overall Study||4
7791918|NCT01253291|19181353|P2|COMPLETED|Overall Study||4
7791919|NCT01253291|19181354|P1|COMPLETED|Overall Study||2
7791920|NCT01253291|19181350|P5|Received Study Drug During BCDL|Overall Study||5
7791921|NCT01253291|19181351|P4|Received Study Drug During BCDL|Overall Study||5
7791922|NCT01253291|19181352|P3|Received Study Drug During BCDL|Overall Study||4
7791923|NCT01253291|19181353|P2|Received Study Drug During BCDL|Overall Study||6
7791924|NCT01253291|19181354|P1|Received Study Drug During BCDL|Overall Study||6
7791925|NCT01253291|19181350|P5|STARTED|Overall Study||5
7791926|NCT01253291|19181351|P4|STARTED|Overall Study||5
7791927|NCT01253291|19181352|P3|STARTED|Overall Study||4
7791928|NCT01253291|19181353|P2|STARTED|Overall Study||6
7791929|NCT01253291|19181354|P1|STARTED|Overall Study||6
7791930|NCT01253265|19181378|P5|NOT COMPLETED|Overall Study||1
7791931|NCT01253265|19181379|P4|NOT COMPLETED|Overall Study||0
7791932|NCT01253265|19181380|P3|NOT COMPLETED|Overall Study||0
7791933|NCT01253265|19181381|P2|NOT COMPLETED|Overall Study||0
7791934|NCT01253265|19181382|P1|NOT COMPLETED|Overall Study||1
7791935|NCT01253265|19181378|P5|COMPLETED|Overall Study||7
7791936|NCT01253265|19181379|P4|COMPLETED|Overall Study||6
7791937|NCT01253265|19181380|P3|COMPLETED|Overall Study||6
7791938|NCT01253265|19181381|P2|COMPLETED|Overall Study||6
7791939|NCT01253265|19181382|P1|COMPLETED|Overall Study||5
7791940|NCT01253265|19181378|P5|STARTED|Overall Study||8
7791941|NCT01253265|19181379|P4|STARTED|Overall Study||6
7791942|NCT01253265|19181380|P3|STARTED|Overall Study||6
7791943|NCT01253265|19181381|P2|STARTED|Overall Study||6
7791944|NCT01253265|19181382|P1|STARTED|Overall Study||6
7791945|NCT01253226|19181431|P5|NOT COMPLETED|Overall Study||2
7791946|NCT01253226|19181432|P4|NOT COMPLETED|Overall Study||1
7791947|NCT01253226|19181433|P3|NOT COMPLETED|Overall Study||1
7791948|NCT01253226|19181434|P2|NOT COMPLETED|Overall Study||1
7791949|NCT01253226|19181435|P1|NOT COMPLETED|Overall Study||0
7791950|NCT01253226|19181431|P5|COMPLETED|Overall Study||6
7791951|NCT01253226|19181432|P4|COMPLETED|Overall Study||5
7791952|NCT01253226|19181433|P3|COMPLETED|Overall Study||5
7791953|NCT01253226|19181434|P2|COMPLETED|Overall Study||5
7791954|NCT01253226|19181435|P1|COMPLETED|Overall Study||6
7791955|NCT01253226|19181431|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
7791956|NCT01253226|19181432|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
7791957|NCT01253226|19181433|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
7791958|NCT01253226|19181434|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
7791959|NCT01253226|19181435|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
7791960|NCT01253226|19181431|P5|STARTED|Overall Study||8
7791961|NCT01253226|19181432|P4|STARTED|Overall Study||6
7791962|NCT01253226|19181433|P3|STARTED|Overall Study||6
7791963|NCT01253226|19181434|P2|STARTED|Overall Study||6
7791964|NCT01253226|19181435|P1|STARTED|Overall Study||6
7791965|NCT01253200|19181495|P5|NOT COMPLETED|Overall Study||5
7791966|NCT01253200|19181496|P4|NOT COMPLETED|Overall Study||5
7791967|NCT01253200|19181497|P3|NOT COMPLETED|Overall Study||2
7791968|NCT01253200|19181498|P2|NOT COMPLETED|Overall Study||19
7791969|NCT01253200|19181499|P1|NOT COMPLETED|Overall Study||21
7791970|NCT01253200|19181495|P5|COMPLETED|Overall Study||0
7791971|NCT01253200|19181496|P4|COMPLETED|Overall Study||12
7791972|NCT01253200|19181497|P3|COMPLETED|Overall Study||28
7791973|NCT01253200|19181498|P2|COMPLETED|Overall Study||106
7791974|NCT01253200|19181499|P1|COMPLETED|Overall Study||104
7791975|NCT01253200|19181495|P5|3 Month Follow-up|Overall Study||0
7791976|NCT01253200|19181496|P4|3 Month Follow-up|Overall Study||12
7791977|NCT01253200|19181497|P3|3 Month Follow-up|Overall Study||28
7791978|NCT01253200|19181498|P2|3 Month Follow-up|Overall Study||106
7791979|NCT01253200|19181499|P1|3 Month Follow-up|Overall Study||104
7791980|NCT01253200|19181495|P5|10 Day Follow-up|Overall Study||0
7791981|NCT01253200|19181496|P4|10 Day Follow-up|Overall Study||12
7791982|NCT01253200|19181497|P3|10 Day Follow-up|Overall Study||28
7791983|NCT01253200|19181498|P2|10 Day Follow-up|Overall Study||111
7791984|NCT01253200|19181499|P1|10 Day Follow-up|Overall Study||106
7791985|NCT01253200|19181495|P5|Procedure|Overall Study||0
7791986|NCT01253200|19181496|P4|Procedure|Overall Study||12
7791987|NCT01253200|19181497|P3|Procedure|Overall Study||28
7791988|NCT01253200|19181498|P2|Procedure|Overall Study||111
7791989|NCT01253200|19181499|P1|Procedure|Overall Study||109
7791990|NCT01253200|19181495|P5|STARTED|Overall Study||5
7791991|NCT01253200|19181496|P4|STARTED|Overall Study||17
7791992|NCT01253200|19181497|P3|STARTED|Overall Study||30
7791993|NCT01253200|19181498|P2|STARTED|Overall Study||125
7791994|NCT01253200|19181499|P1|STARTED|Overall Study||125
7791995|NCT01253187|19181514|P6|NOT COMPLETED|Period 3||0
7791996|NCT01253187|19181515|P5|NOT COMPLETED|Period 3||1
7791997|NCT01253187|19181516|P4|NOT COMPLETED|Period 3||0
7791998|NCT01253187|19181517|P3|NOT COMPLETED|Period 3||0
7791999|NCT01253187|19181518|P2|NOT COMPLETED|Period 3||1
7792000|NCT01253187|19181519|P1|NOT COMPLETED|Period 3||1
7792001|NCT01253187|19181514|P6|COMPLETED|Period 3||6
7792002|NCT01253187|19181515|P5|COMPLETED|Period 3||7
7792003|NCT01253187|19181516|P4|COMPLETED|Period 3||7
7792004|NCT01253187|19181517|P3|COMPLETED|Period 3||7
7792005|NCT01253187|19181518|P2|COMPLETED|Period 3||7
7792006|NCT01253187|19181519|P1|COMPLETED|Period 3||6
7792007|NCT01253187|19181514|P6|STARTED|Period 3||6
7792008|NCT01253187|19181515|P5|STARTED|Period 3||8
7792009|NCT01253187|19181516|P4|STARTED|Period 3||7
7792010|NCT01253187|19181517|P3|STARTED|Period 3||7
7792011|NCT01253187|19181518|P2|STARTED|Period 3||8
7792012|NCT01253187|19181519|P1|STARTED|Period 3||7
7792013|NCT01253187|19181514|P6|NOT COMPLETED|Period 2||0
7792014|NCT01253187|19181515|P5|NOT COMPLETED|Period 2||1
7792015|NCT01253187|19181516|P4|NOT COMPLETED|Period 2||0
7792016|NCT01253187|19181517|P3|NOT COMPLETED|Period 2||0
7792017|NCT01253187|19181518|P2|NOT COMPLETED|Period 2||0
7792018|NCT01253187|19181519|P1|NOT COMPLETED|Period 2||0
7792019|NCT01253187|19181514|P6|COMPLETED|Period 2||6
7792020|NCT01253187|19181515|P5|COMPLETED|Period 2||8
7792021|NCT01253187|19181516|P4|COMPLETED|Period 2||7
7792022|NCT01253187|19181517|P3|COMPLETED|Period 2||7
7792023|NCT01253187|19181518|P2|COMPLETED|Period 2||8
7792024|NCT01253187|19181519|P1|COMPLETED|Period 2||7
7792025|NCT01253187|19181514|P6|STARTED|Period 2||6
7792026|NCT01253187|19181515|P5|STARTED|Period 2||9
7792027|NCT01253187|19181516|P4|STARTED|Period 2||7
7792028|NCT01253187|19181517|P3|STARTED|Period 2||7
7792029|NCT01253187|19181518|P2|STARTED|Period 2||8
7792030|NCT01253187|19181519|P1|STARTED|Period 2||7
7792031|NCT01253187|19181514|P6|NOT COMPLETED|Period 1||0
7792032|NCT01253187|19181515|P5|NOT COMPLETED|Period 1||0
7792033|NCT01253187|19181516|P4|NOT COMPLETED|Period 1||0
7792034|NCT01253187|19181517|P3|NOT COMPLETED|Period 1||0
7792035|NCT01253187|19181518|P2|NOT COMPLETED|Period 1||0
7792036|NCT01253187|19181519|P1|NOT COMPLETED|Period 1||0
7792037|NCT01253187|19181514|P6|COMPLETED|Period 1||6
7792038|NCT01253187|19181515|P5|COMPLETED|Period 1||9
7792039|NCT01253187|19181516|P4|COMPLETED|Period 1||7
7792040|NCT01253187|19181517|P3|COMPLETED|Period 1||7
7792041|NCT01253187|19181518|P2|COMPLETED|Period 1||8
7792042|NCT01253187|19181519|P1|COMPLETED|Period 1||7
7792043|NCT01253187|19181514|P6|STARTED|Period 1||6
7792044|NCT01253187|19181515|P5|STARTED|Period 1||9
7792045|NCT01253187|19181516|P4|STARTED|Period 1||7
7792046|NCT01253187|19181517|P3|STARTED|Period 1||7
7792047|NCT01253187|19181518|P2|STARTED|Period 1||8
7792048|NCT01253187|19181519|P1|STARTED|Period 1||7
7792049|NCT01253174|19181548|P6|NOT COMPLETED|Period 3||0
7792050|NCT01253174|19181549|P5|NOT COMPLETED|Period 3||1
7792051|NCT01253174|19181550|P4|NOT COMPLETED|Period 3||0
7792052|NCT01253174|19181551|P3|NOT COMPLETED|Period 3||1
7792053|NCT01253174|19181552|P2|NOT COMPLETED|Period 3||1
7792054|NCT01253174|19181553|P1|NOT COMPLETED|Period 3||0
7792055|NCT01253174|19181548|P6|COMPLETED|Period 3||7
7792056|NCT01253174|19181549|P5|COMPLETED|Period 3||7
7792057|NCT01253174|19181550|P4|COMPLETED|Period 3||7
7792058|NCT01253174|19181551|P3|COMPLETED|Period 3||6
7792059|NCT01253174|19181552|P2|COMPLETED|Period 3||8
7792060|NCT01253174|19181553|P1|COMPLETED|Period 3||6
7792061|NCT01253174|19181548|P6|STARTED|Period 3||7
7792062|NCT01253174|19181549|P5|STARTED|Period 3||8
7792063|NCT01253174|19181550|P4|STARTED|Period 3||7
7792064|NCT01253174|19181551|P3|STARTED|Period 3||7
7792065|NCT01253174|19181552|P2|STARTED|Period 3||9
7792066|NCT01253174|19181553|P1|STARTED|Period 3||6
7792067|NCT01253174|19181548|P6|NOT COMPLETED|Period 2||0
7792068|NCT01253174|19181549|P5|NOT COMPLETED|Period 2||0
7792069|NCT01253174|19181550|P4|NOT COMPLETED|Period 2||0
7792070|NCT01253174|19181551|P3|NOT COMPLETED|Period 2||1
7792071|NCT01253174|19181552|P2|NOT COMPLETED|Period 2||0
7792072|NCT01253174|19181553|P1|NOT COMPLETED|Period 2||0
7792073|NCT01253174|19181548|P6|COMPLETED|Period 2||7
7792074|NCT01253174|19181549|P5|COMPLETED|Period 2||8
7792075|NCT01253174|19181550|P4|COMPLETED|Period 2||7
7792076|NCT01253174|19181551|P3|COMPLETED|Period 2||7
7792077|NCT01253174|19181552|P2|COMPLETED|Period 2||9
7792078|NCT01253174|19181553|P1|COMPLETED|Period 2||6
7792079|NCT01253174|19181548|P6|STARTED|Period 2||7
7792080|NCT01253174|19181549|P5|STARTED|Period 2||8
7792081|NCT01253174|19181550|P4|STARTED|Period 2||7
7792082|NCT01253174|19181551|P3|STARTED|Period 2||8
7792083|NCT01253174|19181552|P2|STARTED|Period 2||9
7792084|NCT01253174|19181553|P1|STARTED|Period 2||6
7792085|NCT01253174|19181548|P6|NOT COMPLETED|Period 1||0
7792086|NCT01253174|19181549|P5|NOT COMPLETED|Period 1||1
7792087|NCT01253174|19181550|P4|NOT COMPLETED|Period 1||0
7792088|NCT01253174|19181551|P3|NOT COMPLETED|Period 1||1
7792089|NCT01253174|19181552|P2|NOT COMPLETED|Period 1||1
7792090|NCT01253174|19181553|P1|NOT COMPLETED|Period 1||0
7792091|NCT01253174|19181548|P6|COMPLETED|Period 1||7
7792092|NCT01253174|19181549|P5|COMPLETED|Period 1||8
7792093|NCT01253174|19181550|P4|COMPLETED|Period 1||7
7792094|NCT01253174|19181551|P3|COMPLETED|Period 1||8
7792095|NCT01253174|19181552|P2|COMPLETED|Period 1||9
7792096|NCT01253174|19181553|P1|COMPLETED|Period 1||6
7792097|NCT01253174|19181548|P6|STARTED|Period 1||7
7792098|NCT01253174|19181549|P5|STARTED|Period 1||9
7792099|NCT01253174|19181550|P4|STARTED|Period 1||7
7792100|NCT01253174|19181551|P3|STARTED|Period 1||9
7792101|NCT01253174|19181552|P2|STARTED|Period 1||10
7792102|NCT01253174|19181553|P1|STARTED|Period 1||6
7792103|NCT01253148|19181582|P1|NOT COMPLETED|Overall Study||0
7792104|NCT01253148|19181582|P1|COMPLETED|Overall Study||25
7792105|NCT01253148|19181582|P1|STARTED|Overall Study||25
7792106|NCT01253135|19181588|P1|NOT COMPLETED|Amended Protocol||1
7792107|NCT01253135|19181588|P1|COMPLETED|Amended Protocol||24
7792108|NCT01253135|19181588|P1|STARTED|Amended Protocol||25
7792109|NCT01253135|19181588|P1|NOT COMPLETED|Original Protocol||15
7792110|NCT01253135|19181588|P1|COMPLETED|Original Protocol||0
7792111|NCT01253135|19181588|P1|STARTED|Original Protocol||15
7792112|NCT01253070|19181596|P1|NOT COMPLETED|Overall Study||0
7792113|NCT01253070|19181596|P1|COMPLETED|Overall Study||54
7792114|NCT01253070|19181596|P1|STARTED|Overall Study||54
7792115|NCT01253044|19181607|P2|NOT COMPLETED|Overall Study||29
7792116|NCT01253044|19181608|P1|NOT COMPLETED|Overall Study||38
7792117|NCT01253044|19181607|P2|COMPLETED|Overall Study||51
7792118|NCT01253044|19181608|P1|COMPLETED|Overall Study||42
7792119|NCT01253044|19181607|P2|STARTED|Overall Study||80
7792120|NCT01253044|19181608|P1|STARTED|Overall Study||80
7792121|NCT01253018|19181618|P2|NOT COMPLETED|Overall Study||2
7792122|NCT01253018|19181619|P1|NOT COMPLETED|Overall Study||4
7792123|NCT01253018|19181618|P2|COMPLETED|Overall Study||21
7792124|NCT01253018|19181619|P1|COMPLETED|Overall Study||18
7792125|NCT01253018|19181618|P2|STARTED|Overall Study||23
7792126|NCT01253018|19181619|P1|STARTED|Overall Study||22
7792127|NCT01252966|19181633|P2|NOT COMPLETED|Overall Study||13
7792128|NCT01252966|19181634|P1|NOT COMPLETED|Overall Study||23
7792129|NCT01252966|19181633|P2|COMPLETED|Overall Study||92
7792130|NCT01252966|19181634|P1|COMPLETED|Overall Study||85
7792131|NCT01252966|19181633|P2|STARTED|Overall Study||105
7792132|NCT01252966|19181634|P1|STARTED|Overall Study||108
7792133|NCT01252953|19181650|P2|NOT COMPLETED|Overall Study||38
7792134|NCT01252953|19181651|P1|NOT COMPLETED|Overall Study||38
7792135|NCT01252953|19181650|P2|COMPLETED|Overall Study||15186
7792136|NCT01252953|19181651|P1|COMPLETED|Overall Study||15187
7792137|NCT01252953|19181650|P2|STARTED|Overall Study||15224
7792138|NCT01252953|19181651|P1|STARTED|Overall Study||15225
7792139|NCT01252940|19181665|P2|NOT COMPLETED|Extension Phase||3
7792140|NCT01252940|19181666|P1|NOT COMPLETED|Extension Phase||10
7792141|NCT01252940|19181665|P2|COMPLETED|Extension Phase||46
7792142|NCT01252940|19181666|P1|COMPLETED|Extension Phase||100
7792143|NCT01252940|19181665|P2|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49
7792144|NCT01252940|19181666|P1|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110
7792145|NCT01252940|19181665|P2|NOT COMPLETED|Main Study Phase||12
7792146|NCT01252940|19181666|P1|NOT COMPLETED|Main Study Phase||26
7792147|NCT01252940|19181665|P2|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149
7792148|NCT01252940|19181666|P1|COMPLETED|Main Study Phase||295
7792149|NCT01252940|19181665|P2|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153
7792150|NCT01252940|19181666|P1|Completed 24 Weeks|Main Study Phase||0
7792151|NCT01252940|19181665|P2|STARTED|Main Study Phase||161
7792152|NCT01252940|19181666|P1|STARTED|Main Study Phase||321
7792153|NCT01252810|19181697|P2|NOT COMPLETED|Overall Study||3
7792154|NCT01252810|19181698|P1|NOT COMPLETED|Overall Study||14
7792155|NCT01252810|19181697|P2|COMPLETED|Overall Study||139
7792156|NCT01252810|19181698|P1|COMPLETED|Overall Study||128
7792157|NCT01252810|19181697|P2|STARTED|Overall Study||142
7792158|NCT01252810|19181698|P1|STARTED|Overall Study||142
7792159|NCT01252745|19181711|P3|NOT COMPLETED|Overall Study||0
7792160|NCT01252745|19181712|P2|NOT COMPLETED|Overall Study||0
7792161|NCT01252745|19181713|P1|NOT COMPLETED|Overall Study||0
7792162|NCT01252745|19181711|P3|COMPLETED|Overall Study||7
7792163|NCT01252745|19181712|P2|COMPLETED|Overall Study||7
7792164|NCT01252745|19181713|P1|COMPLETED|Overall Study||8
7792165|NCT01252745|19181711|P3|STARTED|Overall Study||7
7792166|NCT01252745|19181712|P2|STARTED|Overall Study||7
7792167|NCT01252745|19181713|P1|STARTED|Overall Study||8
7792168|NCT01252667|19181733|P6|NOT COMPLETED|Overall Study||1
7792169|NCT01252667|19181734|P5|NOT COMPLETED|Overall Study||0
7792170|NCT01252667|19181735|P4|NOT COMPLETED|Overall Study||0
7792171|NCT01252667|19181736|P3|NOT COMPLETED|Overall Study||0
7792172|NCT01252667|19181737|P2|NOT COMPLETED|Overall Study||0
7792173|NCT01252667|19181738|P1|NOT COMPLETED|Overall Study||0
7792174|NCT01252667|19181733|P6|COMPLETED|Overall Study||34
7792175|NCT01252667|19181734|P5|COMPLETED|Overall Study||0
7792176|NCT01252667|19181735|P4|COMPLETED|Overall Study||0
7792177|NCT01252667|19181736|P3|COMPLETED|Overall Study||3
7792178|NCT01252667|19181737|P2|COMPLETED|Overall Study||3
7792179|NCT01252667|19181738|P1|COMPLETED|Overall Study||3
7792180|NCT01252667|19181733|P6|STARTED|Overall Study||35
7792181|NCT01252667|19181734|P5|STARTED|Overall Study||0
7792182|NCT01252667|19181735|P4|STARTED|Overall Study||0
7792183|NCT01252667|19181736|P3|STARTED|Overall Study||3
7792184|NCT01252667|19181737|P2|STARTED|Overall Study||3
7792185|NCT01252667|19181738|P1|STARTED|Overall Study||3
7792186|NCT01252563|19181800|P1|NOT COMPLETED|Overall Study||432
7792187|NCT01252563|19181800|P1|COMPLETED|Overall Study||13343
7792188|NCT01252563|19181800|P1|STARTED|Overall Study||13775
7792189|NCT01252355|19181840|P3|NOT COMPLETED|Overall Study||179
7792190|NCT01252355|19181841|P2|NOT COMPLETED|Overall Study||178
7792191|NCT01252355|19181842|P1|NOT COMPLETED|Overall Study||177
7792192|NCT01252355|19181840|P3|COMPLETED|Overall Study||0
7792193|NCT01252355|19181841|P2|COMPLETED|Overall Study||0
7792194|NCT01252355|19181842|P1|COMPLETED|Overall Study||0
7792195|NCT01252355|19181840|P3|Treated|Overall Study|One participant received teriflunomide 7 mg.|179
7792196|NCT01252355|19181841|P2|Treated|Overall Study||178
7792197|NCT01252355|19181842|P1|Treated|Overall Study||175
7792198|NCT01252355|19181840|P3|STARTED|Overall Study|Randomized.|179
7792199|NCT01252355|19181841|P2|STARTED|Overall Study|Randomized.|178
7792200|NCT01252355|19181842|P1|STARTED|Overall Study|Randomized.|177
7792201|NCT01252290|19181880|P1|NOT COMPLETED|Overall Study||1
7792202|NCT01252290|19181880|P1|COMPLETED|Overall Study||34
7792203|NCT01252290|19181880|P1|STARTED|Overall Study||35
7792204|NCT01252277|19181888|P1|NOT COMPLETED|Overall Study||2
7792205|NCT01252277|19181888|P1|COMPLETED|Overall Study||34
7792206|NCT01252277|19181888|P1|STARTED|Overall Study||36
7792207|NCT01252251|19181896|P1|NOT COMPLETED|Overall Study||1
7792208|NCT01252251|19181896|P1|COMPLETED|Overall Study||13
7792209|NCT01252251|19181896|P1|STARTED|Overall Study||14
7792210|NCT01252238|19181908|P3|NOT COMPLETED|Overall Study||4
7792211|NCT01252238|19181909|P2|NOT COMPLETED|Overall Study||4
7792212|NCT01252238|19181910|P1|NOT COMPLETED|Overall Study||4
7792213|NCT01252238|19181908|P3|COMPLETED|Overall Study|sponsor terminated study|4
7792214|NCT01252238|19181909|P2|COMPLETED|Overall Study|sponsor terminated study|4
7792215|NCT01252238|19181910|P1|COMPLETED|Overall Study|sponsor terminated study|4
7792216|NCT01252238|19181908|P3|STARTED|Overall Study||8
7792217|NCT01252238|19181909|P2|STARTED|Overall Study||8
7792218|NCT01252238|19181910|P1|STARTED|Overall Study||8
7792219|NCT01252186|19181927|P3|NOT COMPLETED|Overall Study||34
7792220|NCT01252186|19181928|P2|NOT COMPLETED|Overall Study||32
7792221|NCT01252186|19181929|P1|NOT COMPLETED|Overall Study||30
7792222|NCT01252186|19181927|P3|COMPLETED|Overall Study||53
7792223|NCT01252186|19181928|P2|COMPLETED|Overall Study||59
7792224|NCT01252186|19181929|P1|COMPLETED|Overall Study||57
7792225|NCT01252186|19181927|P3|Received Study Drug|Overall Study||80
7792226|NCT01252186|19181928|P2|Received Study Drug|Overall Study||89
7792227|NCT01252186|19181929|P1|Received Study Drug|Overall Study||83
7792228|NCT01252186|19181927|P3|STARTED|Overall Study||87
7792229|NCT01252186|19181928|P2|STARTED|Overall Study||91
7792230|NCT01252186|19181929|P1|STARTED|Overall Study||87
7792231|NCT01252147|19181997|P1|NOT COMPLETED|Overall Study||0
7792232|NCT01252147|19181997|P1|COMPLETED|Overall Study||68
7792233|NCT01252147|19181997|P1|STARTED|Overall Study||68
7792234|NCT01252134|19182002|P6|NOT COMPLETED|Period 3, 8 Hours||0
7792235|NCT01252134|19182003|P5|NOT COMPLETED|Period 3, 8 Hours||0
7792236|NCT01252134|19182004|P4|NOT COMPLETED|Period 3, 8 Hours||0
7792237|NCT01252134|19182005|P3|NOT COMPLETED|Period 3, 8 Hours||0
7792238|NCT01252134|19182006|P2|NOT COMPLETED|Period 3, 8 Hours||0
7792239|NCT01252134|19182007|P1|NOT COMPLETED|Period 3, 8 Hours||0
7792240|NCT01252134|19182002|P6|COMPLETED|Period 3, 8 Hours||4
7792241|NCT01252134|19182003|P5|COMPLETED|Period 3, 8 Hours||3
7792242|NCT01252134|19182004|P4|COMPLETED|Period 3, 8 Hours||5
7792243|NCT01252134|19182005|P3|COMPLETED|Period 3, 8 Hours||2
7792244|NCT01252134|19182006|P2|COMPLETED|Period 3, 8 Hours||3
7792245|NCT01252134|19182007|P1|COMPLETED|Period 3, 8 Hours||3
7792246|NCT01252134|19182002|P6|STARTED|Period 3, 8 Hours||4
7792247|NCT01252134|19182003|P5|STARTED|Period 3, 8 Hours||3
7792248|NCT01252134|19182004|P4|STARTED|Period 3, 8 Hours||5
7792249|NCT01252134|19182005|P3|STARTED|Period 3, 8 Hours||2
7792250|NCT01252134|19182006|P2|STARTED|Period 3, 8 Hours||3
7792251|NCT01252134|19182007|P1|STARTED|Period 3, 8 Hours||3
7792252|NCT01252134|19182002|P6|NOT COMPLETED|Period 2, 8 Hours||0
7792253|NCT01252134|19182003|P5|NOT COMPLETED|Period 2, 8 Hours||0
7792254|NCT01252134|19182004|P4|NOT COMPLETED|Period 2, 8 Hours||0
7792255|NCT01252134|19182005|P3|NOT COMPLETED|Period 2, 8 Hours||0
7792256|NCT01252134|19182006|P2|NOT COMPLETED|Period 2, 8 Hours||0
7792257|NCT01252134|19182007|P1|NOT COMPLETED|Period 2, 8 Hours||0
7792258|NCT01252134|19182002|P6|COMPLETED|Period 2, 8 Hours||4
7792259|NCT01252134|19182003|P5|COMPLETED|Period 2, 8 Hours||3
7792260|NCT01252134|19182004|P4|COMPLETED|Period 2, 8 Hours||5
7792261|NCT01252134|19182005|P3|COMPLETED|Period 2, 8 Hours||2
7792262|NCT01252134|19182006|P2|COMPLETED|Period 2, 8 Hours||3
7792263|NCT01252134|19182007|P1|COMPLETED|Period 2, 8 Hours||3
7792264|NCT01252134|19182002|P6|STARTED|Period 2, 8 Hours||4
7792265|NCT01252134|19182003|P5|STARTED|Period 2, 8 Hours||3
7792266|NCT01252134|19182004|P4|STARTED|Period 2, 8 Hours||5
7792267|NCT01252134|19182005|P3|STARTED|Period 2, 8 Hours||2
7792268|NCT01252134|19182006|P2|STARTED|Period 2, 8 Hours||3
7792269|NCT01252134|19182007|P1|STARTED|Period 2, 8 Hours||3
7792270|NCT01252134|19182002|P6|NOT COMPLETED|Period 1, 8 Hours||0
7792271|NCT01252134|19182003|P5|NOT COMPLETED|Period 1, 8 Hours||0
7792272|NCT01252134|19182004|P4|NOT COMPLETED|Period 1, 8 Hours||0
7792273|NCT01252134|19182005|P3|NOT COMPLETED|Period 1, 8 Hours||1
7792274|NCT01252134|19182006|P2|NOT COMPLETED|Period 1, 8 Hours||1
7792275|NCT01252134|19182007|P1|NOT COMPLETED|Period 1, 8 Hours||0
7792276|NCT01252134|19182002|P6|COMPLETED|Period 1, 8 Hours||4
7792277|NCT01252134|19182003|P5|COMPLETED|Period 1, 8 Hours||3
7792278|NCT01252134|19182004|P4|COMPLETED|Period 1, 8 Hours||5
7792279|NCT01252134|19182005|P3|COMPLETED|Period 1, 8 Hours||2
7792280|NCT01252134|19182006|P2|COMPLETED|Period 1, 8 Hours||3
7792281|NCT01252134|19182007|P1|COMPLETED|Period 1, 8 Hours||3
7792282|NCT01252134|19182002|P6|STARTED|Period 1, 8 Hours||4
7792283|NCT01252134|19182003|P5|STARTED|Period 1, 8 Hours||3
7792284|NCT01252134|19182004|P4|STARTED|Period 1, 8 Hours||5
7792285|NCT01252134|19182005|P3|STARTED|Period 1, 8 Hours||3
7792286|NCT01252134|19182006|P2|STARTED|Period 1, 8 Hours||4
7792287|NCT01252134|19182007|P1|STARTED|Period 1, 8 Hours||3
7792288|NCT01252095|19182026|P2|NOT COMPLETED|Overall Study||0
7792289|NCT01252095|19182027|P1|NOT COMPLETED|Overall Study||1
7792290|NCT01252095|19182026|P2|COMPLETED|Overall Study||1
7792291|NCT01252095|19182027|P1|COMPLETED|Overall Study||2
7792292|NCT01252095|19182026|P2|STARTED|Overall Study||1
7792293|NCT01252095|19182027|P1|STARTED|Overall Study||3
7792294|NCT01251978|19182035|P2|NOT COMPLETED|Overall Study||0
7792295|NCT01251978|19182036|P1|NOT COMPLETED|Overall Study||0
7792296|NCT01251978|19182035|P2|COMPLETED|Overall Study||3
7792297|NCT01251978|19182036|P1|COMPLETED|Overall Study||5
7792298|NCT01251978|19182035|P2|STARTED|Overall Study||3
7792299|NCT01251978|19182036|P1|STARTED|Overall Study||5
7792300|NCT01251965|19182048|P3|NOT COMPLETED|Overall Study||11
7792301|NCT01251965|19182049|P2|NOT COMPLETED|Overall Study||2
7792302|NCT01251965|19182050|P1|NOT COMPLETED|Overall Study||1
7792303|NCT01251965|19182048|P3|COMPLETED|Overall Study||7
7792304|NCT01251965|19182049|P2|COMPLETED|Overall Study||3
7792305|NCT01251965|19182050|P1|COMPLETED|Overall Study||3
7792306|NCT01251965|19182048|P3|STARTED|Overall Study||18
7792307|NCT01251965|19182049|P2|STARTED|Overall Study||5
7792308|NCT01251965|19182050|P1|STARTED|Overall Study||4
7792309|NCT01251952|19182062|P1|NOT COMPLETED|Overall Study||1
7792310|NCT01251952|19182062|P1|COMPLETED|Overall Study||1
7792311|NCT01251952|19182062|P1|STARTED|Overall Study||2
7792312|NCT01251861|19182068|P2|NOT COMPLETED|Overall Study||28
7792313|NCT01251861|19182069|P1|NOT COMPLETED|Overall Study||18
7792314|NCT01251861|19182068|P2|COMPLETED|Overall Study||26
7792315|NCT01251861|19182069|P1|COMPLETED|Overall Study||36
7792316|NCT01251861|19182068|P2|Pts With PSA Response|Overall Study||36
7792317|NCT01251861|19182069|P1|Pts With PSA Response|Overall Study||44
7792318|NCT01251861|19182068|P2|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||47
7792319|NCT01251861|19182069|P1|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||49
7792320|NCT01251861|19182068|P2|Pts Who Received Protocol Therapy|Overall Study||53
7792321|NCT01251861|19182069|P1|Pts Who Received Protocol Therapy|Overall Study||50
7792322|NCT01251861|19182068|P2|STARTED|Overall Study||54
7792323|NCT01251861|19182069|P1|STARTED|Overall Study||54
7792324|NCT01251770|19182097|P2|NOT COMPLETED|Overall Study||7
7792325|NCT01251770|19182098|P1|NOT COMPLETED|Overall Study||13
7792326|NCT01251770|19182097|P2|COMPLETED|Overall Study||29
7792327|NCT01251770|19182098|P1|COMPLETED|Overall Study||29
7792328|NCT01251770|19182097|P2|STARTED|Overall Study||36
7792329|NCT01251770|19182098|P1|STARTED|Overall Study||42
7792330|NCT01251757|19182109|P3|NOT COMPLETED|Overall Study||0
7792331|NCT01251757|19182110|P2|NOT COMPLETED|Overall Study||0
7792332|NCT01251757|19182111|P1|NOT COMPLETED|Overall Study||0
7792333|NCT01251757|19182109|P3|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250
7792334|NCT01251757|19182110|P2|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247
7792335|NCT01251757|19182111|P1|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255
7792336|NCT01251757|19182109|P3|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250
7792337|NCT01251757|19182110|P2|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247
7792338|NCT01251757|19182111|P1|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255
7792339|NCT01251744|19182142|P2|NOT COMPLETED|Overall Study||0
7792340|NCT01251744|19182143|P1|NOT COMPLETED|Overall Study||1
7792341|NCT01251744|19182142|P2|COMPLETED|Overall Study||78
7792342|NCT01251744|19182143|P1|COMPLETED|Overall Study||76
7792343|NCT01251744|19182142|P2|STARTED|Overall Study||78
7792344|NCT01251744|19182143|P1|STARTED|Overall Study||77
7792345|NCT01251653|19182201|P9|NOT COMPLETED|Overall Study||6
7792346|NCT01251653|19182202|P8|NOT COMPLETED|Overall Study||12
7792347|NCT01251653|19182203|P7|NOT COMPLETED|Overall Study||18
7792348|NCT01251653|19182204|P6|NOT COMPLETED|Overall Study||18
7792349|NCT01251653|19182205|P5|NOT COMPLETED|Overall Study||2
7792350|NCT01251653|19182206|P4|NOT COMPLETED|Overall Study||6
7792351|NCT01251653|19182207|P3|NOT COMPLETED|Overall Study||20
7792352|NCT01251653|19182208|P2|NOT COMPLETED|Overall Study||8
7792353|NCT01251653|19182209|P1|NOT COMPLETED|Overall Study||3
7792354|NCT01251653|19182201|P9|COMPLETED|Overall Study||0
7792355|NCT01251653|19182202|P8|COMPLETED|Overall Study||0
7792356|NCT01251653|19182203|P7|COMPLETED|Overall Study||0
7792357|NCT01251653|19182204|P6|COMPLETED|Overall Study||0
7792358|NCT01251653|19182205|P5|COMPLETED|Overall Study||0
7792359|NCT01251653|19182206|P4|COMPLETED|Overall Study||0
7792360|NCT01251653|19182207|P3|COMPLETED|Overall Study||0
7792361|NCT01251653|19182208|P2|COMPLETED|Overall Study||0
7792362|NCT01251653|19182209|P1|COMPLETED|Overall Study||0
7792363|NCT01251653|19182201|P9|STARTED|Overall Study||6
7792364|NCT01251653|19182202|P8|STARTED|Overall Study||12
7792365|NCT01251653|19182203|P7|STARTED|Overall Study||18
7792366|NCT01251653|19182204|P6|STARTED|Overall Study||18
7792367|NCT01251653|19182205|P5|STARTED|Overall Study||2
7792368|NCT01251653|19182206|P4|STARTED|Overall Study||6
7792369|NCT01251653|19182207|P3|STARTED|Overall Study||20
7792370|NCT01251653|19182208|P2|STARTED|Overall Study||8
7792371|NCT01251653|19182209|P1|STARTED|Overall Study||3
7792372|NCT01251614|19182337|P3|NOT COMPLETED|Overall Study||8
7792373|NCT01251614|19182338|P2|NOT COMPLETED|Overall Study||13
7792374|NCT01251614|19182339|P1|NOT COMPLETED|Overall Study||3
7792375|NCT01251614|19182337|P3|COMPLETED|Overall Study||30
7792376|NCT01251614|19182338|P2|COMPLETED|Overall Study||26
7792377|NCT01251614|19182339|P1|COMPLETED|Overall Study||34
7792378|NCT01251614|19182337|P3|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
7792379|NCT01251614|19182338|P2|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
7792380|NCT01251614|19182339|P1|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
7792381|NCT01251614|19182337|P3|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|19
7792382|NCT01251614|19182338|P2|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|11
7792383|NCT01251614|19182339|P1|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|8
7792384|NCT01251614|19182337|P3|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|23
7792385|NCT01251614|19182338|P2|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|18
7792386|NCT01251614|19182339|P1|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|13
7792387|NCT01251614|19182337|P3|STARTED|Overall Study||38
7792388|NCT01251614|19182338|P2|STARTED|Overall Study||39
7792389|NCT01251614|19182339|P1|STARTED|Overall Study||37
7792390|NCT01251588|19182413|P2|NOT COMPLETED|Overall Study||4
7792391|NCT01251588|19182414|P1|NOT COMPLETED|Overall Study||0
7792392|NCT01251588|19182413|P2|COMPLETED|Overall Study||59
7792393|NCT01251588|19182414|P1|COMPLETED|Overall Study||65
7792394|NCT01251588|19182413|P2|STARTED|Overall Study||63
7792395|NCT01251588|19182414|P1|STARTED|Overall Study||65
7792396|NCT01251575|19182446|P1|NOT COMPLETED|Overall Study||1
7792397|NCT01251575|19182446|P1|COMPLETED|Overall Study||76
7792398|NCT01251575|19182446|P1|STARTED|Overall Study||77
7792399|NCT01251536|19182456|P3|NOT COMPLETED|Overall Study||0
7792400|NCT01251536|19182457|P2|NOT COMPLETED|Overall Study||0
7792401|NCT01251536|19182458|P1|NOT COMPLETED|Overall Study||0
7792402|NCT01251536|19182456|P3|COMPLETED|Overall Study||7
7792403|NCT01251536|19182457|P2|COMPLETED|Overall Study||93
7792404|NCT01251536|19182458|P1|COMPLETED|Overall Study||8
7792405|NCT01251536|19182456|P3|STARTED|Overall Study||7
7792406|NCT01251536|19182457|P2|STARTED|Overall Study||93
7792407|NCT01251536|19182458|P1|STARTED|Overall Study||8
7792408|NCT01251393|19182530|P2|NOT COMPLETED|Overall Study||44
7792409|NCT01251393|19182531|P1|NOT COMPLETED|Overall Study||32
7792410|NCT01251393|19182530|P2|COMPLETED|Overall Study||11
7792411|NCT01251393|19182531|P1|COMPLETED|Overall Study||24
7792412|NCT01251393|19182530|P2|STARTED|Overall Study||55
7792413|NCT01251393|19182531|P1|STARTED|Overall Study||56
7792414|NCT01251380|19182537|P1|NOT COMPLETED|Overall Study||22
7792415|NCT01251380|19182537|P1|COMPLETED|Overall Study||194
7792416|NCT01251380|19182537|P1|Cycle 4|Overall Study||11
7792417|NCT01251380|19182537|P1|Cycle 3|Overall Study||86
7792418|NCT01251380|19182537|P1|Cycle 2|Overall Study||175
7792419|NCT01251380|19182537|P1|Cycle 1|Overall Study||207
7792420|NCT01251380|19182537|P1|STARTED|Overall Study|Safety population.|216
7792421|NCT01251367|19182561|P1|NOT COMPLETED|Overall Study||76
7792422|NCT01251367|19182561|P1|COMPLETED|Overall Study||269
7792423|NCT01251367|19182561|P1|Cycle 4|Overall Study||139
7792424|NCT01251367|19182561|P1|Cycle 3|Overall Study||224
7792425|NCT01251367|19182561|P1|Cycle 2|Overall Study||297
7792426|NCT01251367|19182561|P1|Cycle 1|Overall Study||345
7792427|NCT01251367|19182561|P1|STARTED|Overall Study||345
7792428|NCT01251354|19182596|P1|NOT COMPLETED|Overall Study||6
7792429|NCT01251354|19182596|P1|COMPLETED|Overall Study||0
7792430|NCT01251354|19182596|P1|STARTED|Overall Study||6
7792431|NCT01251315|19182612|P6|NOT COMPLETED|Overall Study||0
7792432|NCT01251315|19182613|P5|NOT COMPLETED|Overall Study||0
7792433|NCT01251315|19182614|P4|NOT COMPLETED|Overall Study||0
7792434|NCT01251315|19182615|P3|NOT COMPLETED|Overall Study||0
7792435|NCT01251315|19182616|P2|NOT COMPLETED|Overall Study||0
7792436|NCT01251315|19182617|P1|NOT COMPLETED|Overall Study||0
7792437|NCT01251315|19182612|P6|COMPLETED|Overall Study||4
7792438|NCT01251315|19182613|P5|COMPLETED|Overall Study||4
7792439|NCT01251315|19182614|P4|COMPLETED|Overall Study||4
7792440|NCT01251315|19182615|P3|COMPLETED|Overall Study||4
7792441|NCT01251315|19182616|P2|COMPLETED|Overall Study||4
7792442|NCT01251315|19182617|P1|COMPLETED|Overall Study||4
7792443|NCT01251315|19182612|P6|STARTED|Overall Study||4
7792444|NCT01251315|19182613|P5|STARTED|Overall Study||4
7792445|NCT01251315|19182614|P4|STARTED|Overall Study||4
7792446|NCT01251315|19182615|P3|STARTED|Overall Study||4
7792447|NCT01251315|19182616|P2|STARTED|Overall Study||4
7792448|NCT01251315|19182617|P1|STARTED|Overall Study||4
7792449|NCT01251276|19182639|P2|NOT COMPLETED|Overall Study||1
7792450|NCT01251276|19182640|P1|NOT COMPLETED|Overall Study||1
7792451|NCT01251276|19182639|P2|COMPLETED|Overall Study||107
7792452|NCT01251276|19182640|P1|COMPLETED|Overall Study||95
7792453|NCT01251276|19182639|P2|Vaccinated|Overall Study||108
7792454|NCT01251276|19182640|P1|Vaccinated|Overall Study||96
7792455|NCT01251276|19182639|P2|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|108
7792456|NCT01251276|19182640|P1|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|96
7792457|NCT01251146|19182658|P2|NOT COMPLETED|Overall Study||10
7792458|NCT01251146|19182659|P1|NOT COMPLETED|Overall Study||3
7792459|NCT01251146|19182658|P2|COMPLETED|Overall Study||81
7792460|NCT01251146|19182659|P1|COMPLETED|Overall Study||83
7792461|NCT01251146|19182658|P2|STARTED|Overall Study||91
7792462|NCT01251146|19182659|P1|STARTED|Overall Study||86
7792463|NCT01251120|19182681|P2|NOT COMPLETED|Overall Study||1
7792464|NCT01251120|19182682|P1|NOT COMPLETED|Overall Study||0
7792465|NCT01251120|19182681|P2|COMPLETED|Overall Study||0
7792466|NCT01251120|19182682|P1|COMPLETED|Overall Study||1
7792467|NCT01251120|19182681|P2|STARTED|Overall Study||1
7792468|NCT01251120|19182682|P1|STARTED|Overall Study||1
7792469|NCT01251042|19182704|P2|NOT COMPLETED|Overall Study||0
7792470|NCT01251042|19182705|P1|NOT COMPLETED|Overall Study||0
7792471|NCT01251042|19182704|P2|COMPLETED|Overall Study||23
7792472|NCT01251042|19182705|P1|COMPLETED|Overall Study||26
7792473|NCT01251042|19182704|P2|STARTED|Overall Study||23
7792474|NCT01251042|19182705|P1|STARTED|Overall Study||26
7792475|NCT01250990|19182737|P2|NOT COMPLETED|Overall Study||2
7792476|NCT01250990|19182738|P1|NOT COMPLETED|Overall Study||4
7792477|NCT01250990|19182737|P2|COMPLETED|Overall Study||9
7792478|NCT01250990|19182738|P1|COMPLETED|Overall Study||7
7792479|NCT01250990|19182737|P2|STARTED|Overall Study||11
7792480|NCT01250990|19182738|P1|STARTED|Overall Study||11
7792481|NCT01250977|19182746|P2|NOT COMPLETED|Overall Study||2
7792482|NCT01250977|19182747|P1|NOT COMPLETED|Overall Study||0
7792483|NCT01250977|19182746|P2|COMPLETED|Overall Study||12
7792484|NCT01250977|19182747|P1|COMPLETED|Overall Study||6
7792485|NCT01250977|19182746|P2|STARTED|Overall Study||14
7792486|NCT01250977|19182747|P1|STARTED|Overall Study||6
7792487|NCT01250925|19182762|P3|NOT COMPLETED|Overall Study||2
7792488|NCT01250925|19182763|P2|NOT COMPLETED|Overall Study||3
7792489|NCT01250925|19182764|P1|NOT COMPLETED|Overall Study||5
7792490|NCT01250925|19182762|P3|COMPLETED|Overall Study||30
7792491|NCT01250925|19182763|P2|COMPLETED|Overall Study||28
7792492|NCT01250925|19182764|P1|COMPLETED|Overall Study||26
7792493|NCT01250925|19182762|P3|STARTED|Overall Study||32
7792494|NCT01250925|19182763|P2|STARTED|Overall Study||31
7792495|NCT01250925|19182764|P1|STARTED|Overall Study||31
7792496|NCT01250899|19182804|P2|NOT COMPLETED|Overall Study||0
7792497|NCT01250899|19182805|P1|NOT COMPLETED|Overall Study||0
7792498|NCT01250899|19182804|P2|COMPLETED|Overall Study||82
7792499|NCT01250899|19182805|P1|COMPLETED|Overall Study||40
7792500|NCT01250899|19182804|P2|STARTED|Overall Study||82
7792501|NCT01250899|19182805|P1|STARTED|Overall Study||40
7792502|NCT01250873|19182809|P1|NOT COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||1
7792503|NCT01250873|19182809|P1|COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||17
7792504|NCT01250873|19182809|P1|STARTED|Period 3:LY2216684+Sertraline(Days11-13)||18
7792505|NCT01250873|19182809|P1|NOT COMPLETED|Period 2: Sertraline (Day 4, 5-10)||0
7792506|NCT01250873|19182809|P1|COMPLETED|Period 2: Sertraline (Day 4, 5-10)||18
7792507|NCT01250873|19182809|P1|STARTED|Period 2: Sertraline (Day 4, 5-10)||18
7792508|NCT01250873|19182809|P1|NOT COMPLETED|Period 1: LY2216684 (Days 1-3)||2
7792509|NCT01250873|19182809|P1|COMPLETED|Period 1: LY2216684 (Days 1-3)||18
7792510|NCT01250873|19182809|P1|STARTED|Period 1: LY2216684 (Days 1-3)||20
7792511|NCT01250834|19182820|P1|NOT COMPLETED|Overall Study||0
7792512|NCT01250834|19182820|P1|COMPLETED|Overall Study||27
7792513|NCT01250834|19182820|P1|STARTED|Overall Study||27
7792514|NCT01250769|19182841|P4|NOT COMPLETED|Overall Study||0
7792515|NCT01250769|19182842|P3|NOT COMPLETED|Overall Study||2
7792516|NCT01250769|19182843|P2|NOT COMPLETED|Overall Study||1
7792517|NCT01250769|19182844|P1|NOT COMPLETED|Overall Study||0
7792518|NCT01250769|19182841|P4|COMPLETED|Overall Study||11
7792519|NCT01250769|19182842|P3|COMPLETED|Overall Study||73
7792520|NCT01250769|19182843|P2|COMPLETED|Overall Study||72
7792521|NCT01250769|19182844|P1|COMPLETED|Overall Study||11
7792522|NCT01250769|19182841|P4|Day 14|Overall Study||11
7792523|NCT01250769|19182842|P3|Day 14|Overall Study||74
7792524|NCT01250769|19182843|P2|Day 14|Overall Study||72
7792525|NCT01250769|19182844|P1|Day 14|Overall Study||11
7792526|NCT01250769|19182841|P4|STARTED|Overall Study||11
7792527|NCT01250769|19182842|P3|STARTED|Overall Study||75
7792528|NCT01250769|19182843|P2|STARTED|Overall Study||73
7792529|NCT01250769|19182844|P1|STARTED|Overall Study||11
7792530|NCT01250756|19182876|P2|NOT COMPLETED|After Toddler Dose||1
7792531|NCT01250756|19182877|P1|NOT COMPLETED|After Toddler Dose||0
7792532|NCT01250756|19182876|P2|COMPLETED|After Toddler Dose||147
7792533|NCT01250756|19182877|P1|COMPLETED|After Toddler Dose||0
7792534|NCT01250756|19182876|P2|STARTED|After Toddler Dose||148
7792535|NCT01250756|19182877|P1|STARTED|After Toddler Dose||0
7792536|NCT01250756|19182876|P2|NOT COMPLETED|Toddler Dose||1
7792537|NCT01250756|19182877|P1|NOT COMPLETED|Toddler Dose||0
7792538|NCT01250756|19182876|P2|COMPLETED|Toddler Dose||148
7792539|NCT01250756|19182877|P1|COMPLETED|Toddler Dose||122
7792540|NCT01250756|19182876|P2|STARTED|Toddler Dose||149
7792541|NCT01250756|19182877|P1|STARTED|Toddler Dose||122
7792542|NCT01250756|19182876|P2|NOT COMPLETED|After Infant Series||4
7792543|NCT01250756|19182877|P1|NOT COMPLETED|After Infant Series||11
7792544|NCT01250756|19182876|P2|COMPLETED|After Infant Series||149
7792545|NCT01250756|19182877|P1|COMPLETED|After Infant Series||122
7792546|NCT01250756|19182876|P2|STARTED|After Infant Series||153
7792547|NCT01250756|19182877|P1|STARTED|After Infant Series||133
7792548|NCT01250756|19182876|P2|NOT COMPLETED|Infant Series||7
7792549|NCT01250756|19182877|P1|NOT COMPLETED|Infant Series||28
7792550|NCT01250756|19182876|P2|COMPLETED|Infant Series||153
7792551|NCT01250756|19182877|P1|COMPLETED|Infant Series||133
7792552|NCT01250756|19182876|P2|Vaccinated Dose 3|Infant Series||155
7792553|NCT01250756|19182877|P1|Vaccinated Dose 3|Infant Series||133
7792554|NCT01250756|19182876|P2|Vaccinated Dose 2|Infant Series||157
7792555|NCT01250756|19182877|P1|Vaccinated Dose 2|Infant Series||147
7792556|NCT01250756|19182876|P2|Vaccinated Dose 1|Infant Series||158
7792557|NCT01250756|19182877|P1|Vaccinated Dose 1|Infant Series||159
7792558|NCT01250756|19182876|P2|STARTED|Infant Series||160
7792559|NCT01250756|19182877|P1|STARTED|Infant Series||161
7792560|NCT01250730|19182930|P3|NOT COMPLETED|Overall Study||0
7792561|NCT01250730|19182931|P2|NOT COMPLETED|Overall Study||0
7792562|NCT01250730|19182932|P1|NOT COMPLETED|Overall Study||0
7792563|NCT01250730|19182930|P3|COMPLETED|Overall Study||6
7792564|NCT01250730|19182931|P2|COMPLETED|Overall Study||6
7792565|NCT01250730|19182932|P1|COMPLETED|Overall Study||6
7792566|NCT01250730|19182930|P3|STARTED|Overall Study||6
7792567|NCT01250730|19182931|P2|STARTED|Overall Study||6
7792568|NCT01250730|19182932|P1|STARTED|Overall Study||6
7792569|NCT01250717|19182988|P1|NOT COMPLETED|Overall Study||0
7792570|NCT01250717|19182988|P1|COMPLETED|Overall Study||28
7792571|NCT01250717|19182988|P1|STARTED|Overall Study||28
7792572|NCT01250509|19182994|P2|NOT COMPLETED|Overall Study||2
7792573|NCT01250509|19182995|P1|NOT COMPLETED|Overall Study||5
7792574|NCT01250509|19182994|P2|COMPLETED|Overall Study||21
7792575|NCT01250509|19182995|P1|COMPLETED|Overall Study||19
7792576|NCT01250509|19182994|P2|STARTED|Overall Study||23
7792577|NCT01250509|19182995|P1|STARTED|Overall Study||24
7792578|NCT01250418|19183009|P2|NOT COMPLETED|Overall Study||1
7792579|NCT01250418|19183010|P1|NOT COMPLETED|Overall Study||1
7792580|NCT01250418|19183009|P2|COMPLETED|Overall Study||15
7792581|NCT01250418|19183010|P1|COMPLETED|Overall Study||8
7792582|NCT01250418|19183009|P2|STARTED|Overall Study||16
7792583|NCT01250418|19183010|P1|STARTED|Overall Study||9
7792584|NCT01250379|19183018|P2|NOT COMPLETED|Overall Study||193
7792585|NCT01250379|19183019|P1|NOT COMPLETED|Overall Study||202
7792586|NCT01250379|19183018|P2|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54
7792587|NCT01250379|19183019|P1|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45
7792588|NCT01250379|19183018|P2|STARTED|Overall Study||247
7792589|NCT01250379|19183019|P1|STARTED|Overall Study||247
7792590|NCT01250210|19183080|P3|NOT COMPLETED|Overall Study||8
7792591|NCT01250210|19183081|P2|NOT COMPLETED|Overall Study||4
7792592|NCT01250210|19183082|P1|NOT COMPLETED|Overall Study||4
7792593|NCT01250210|19183080|P3|COMPLETED|Overall Study||25
7792594|NCT01250210|19183081|P2|COMPLETED|Overall Study||41
7792595|NCT01250210|19183082|P1|COMPLETED|Overall Study||41
7792596|NCT01250210|19183080|P3|STARTED|Overall Study||33
7792597|NCT01250210|19183081|P2|STARTED|Overall Study||45
7792598|NCT01250210|19183082|P1|STARTED|Overall Study||45
7792599|NCT01250184|19183096|P3|NOT COMPLETED|Overall Study||0
7792600|NCT01250184|19183097|P2|NOT COMPLETED|Overall Study||0
7792601|NCT01250184|19183098|P1|NOT COMPLETED|Overall Study||0
7792602|NCT01250184|19183096|P3|COMPLETED|Overall Study||43
7792603|NCT01250184|19183097|P2|COMPLETED|Overall Study||41
7792604|NCT01250184|19183098|P1|COMPLETED|Overall Study||43
7792605|NCT01250184|19183096|P3|STARTED|Overall Study||43
7792606|NCT01250184|19183097|P2|STARTED|Overall Study||41
7792607|NCT01250184|19183098|P1|STARTED|Overall Study||43
7792608|NCT01250171|19183124|P3|NOT COMPLETED|Overall Study||0
7792609|NCT01250171|19183125|P2|NOT COMPLETED|Overall Study||0
7792610|NCT01250171|19183126|P1|NOT COMPLETED|Overall Study||1
7792611|NCT01250171|19183124|P3|COMPLETED|Overall Study||24
7792612|NCT01250171|19183125|P2|COMPLETED|Overall Study||22
7792613|NCT01250171|19183126|P1|COMPLETED|Overall Study||25
7792614|NCT01250171|19183124|P3|STARTED|Overall Study||24
7792615|NCT01250171|19183125|P2|STARTED|Overall Study||22
7792616|NCT01250171|19183126|P1|STARTED|Overall Study||26
7792617|NCT01250145|19183157|P2|NOT COMPLETED|Overall Study||5
7792618|NCT01250145|19183158|P1|NOT COMPLETED|Overall Study||2
7792619|NCT01250145|19183157|P2|COMPLETED|Overall Study||205
7792620|NCT01250145|19183158|P1|COMPLETED|Overall Study||39
7792621|NCT01250145|19183157|P2|STARTED|Overall Study||210
7792622|NCT01250145|19183158|P1|STARTED|Overall Study||41
7792623|NCT01250119|19183178|P2|NOT COMPLETED|Treatment Phase||41
7792624|NCT01250119|19183179|P1|NOT COMPLETED|Treatment Phase||0
7792625|NCT01250119|19183178|P2|COMPLETED|Treatment Phase||0
7792626|NCT01250119|19183179|P1|COMPLETED|Treatment Phase||0
7792627|NCT01250119|19183178|P2|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41
7792628|NCT01250119|19183179|P1|STARTED|Treatment Phase||0
7792629|NCT01250119|19183178|P2|NOT COMPLETED|Diagnostic Phase||0
7792630|NCT01250119|19183179|P1|NOT COMPLETED|Diagnostic Phase||113
7792631|NCT01250119|19183178|P2|COMPLETED|Diagnostic Phase||0
7792632|NCT01250119|19183179|P1|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575
7792633|NCT01250119|19183178|P2|STARTED|Diagnostic Phase||0
7792634|NCT01250119|19183179|P1|STARTED|Diagnostic Phase||688
7792635|NCT01250054|19183194|P2|NOT COMPLETED|Period 2, One Week of Wear||0
7792636|NCT01250054|19183195|P1|NOT COMPLETED|Period 2, One Week of Wear||1
7792637|NCT01250054|19183194|P2|COMPLETED|Period 2, One Week of Wear||8
7792638|NCT01250054|19183195|P1|COMPLETED|Period 2, One Week of Wear||6
7792639|NCT01250054|19183194|P2|STARTED|Period 2, One Week of Wear||8
7792640|NCT01250054|19183195|P1|STARTED|Period 2, One Week of Wear||7
7792641|NCT01250054|19183194|P2|NOT COMPLETED|Period 1, One Week of Wear||0
7792642|NCT01250054|19183195|P1|NOT COMPLETED|Period 1, One Week of Wear||0
7792643|NCT01250054|19183194|P2|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8
7792644|NCT01250054|19183195|P1|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8
7792645|NCT01250054|19183194|P2|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8
7792646|NCT01250054|19183195|P1|STARTED|Period 1, One Week of Wear||8
7792647|NCT01250002|19183203|P2|NOT COMPLETED|Overall Study||3
7792648|NCT01250002|19183204|P1|NOT COMPLETED|Overall Study||4
7792649|NCT01250002|19183203|P2|COMPLETED|Overall Study||32
7792650|NCT01250002|19183204|P1|COMPLETED|Overall Study||31
7792651|NCT01250002|19183203|P2|STARTED|Overall Study||35
7792652|NCT01250002|19183204|P1|STARTED|Overall Study||35
7792653|NCT01249872|19183218|P6|NOT COMPLETED|Overall Study||0
7792654|NCT01249872|19183219|P5|NOT COMPLETED|Overall Study||0
7792655|NCT01249872|19183220|P4|NOT COMPLETED|Overall Study||0
7792656|NCT01249872|19183221|P3|NOT COMPLETED|Overall Study||0
7792657|NCT01249872|19183222|P2|NOT COMPLETED|Overall Study||0
7792658|NCT01249872|19183223|P1|NOT COMPLETED|Overall Study||0
7792659|NCT01249872|19183218|P6|COMPLETED|Overall Study||16
7792660|NCT01249872|19183219|P5|COMPLETED|Overall Study||16
7792661|NCT01249872|19183220|P4|COMPLETED|Overall Study||16
7792662|NCT01249872|19183221|P3|COMPLETED|Overall Study||16
7792663|NCT01249872|19183222|P2|COMPLETED|Overall Study||16
7792664|NCT01249872|19183223|P1|COMPLETED|Overall Study||16
7792665|NCT01249872|19183218|P6|STARTED|Overall Study||16
7792666|NCT01249872|19183219|P5|STARTED|Overall Study||16
7792667|NCT01249872|19183220|P4|STARTED|Overall Study||16
7792668|NCT01249872|19183221|P3|STARTED|Overall Study||16
7792669|NCT01249872|19183222|P2|STARTED|Overall Study||16
7792670|NCT01249872|19183223|P1|STARTED|Overall Study||16
7792671|NCT01249833|19183269|P2|NOT COMPLETED|Overall Study||1
7792672|NCT01249833|19183270|P1|NOT COMPLETED|Overall Study||0
7792673|NCT01249833|19183269|P2|COMPLETED|Overall Study||62
7792674|NCT01249833|19183270|P1|COMPLETED|Overall Study||59
7792675|NCT01249833|19183269|P2|STARTED|Overall Study||63
7792676|NCT01249833|19183270|P1|STARTED|Overall Study||59
7792677|NCT01249664|19183284|P2|NOT COMPLETED|Overall Study||0
7792678|NCT01249664|19183285|P1|NOT COMPLETED|Overall Study||6
7792679|NCT01249664|19183284|P2|COMPLETED|Overall Study|Completers of study visits up to week 48|31
7792680|NCT01249664|19183285|P1|COMPLETED|Overall Study|Completers of study visits up to week 48|85
7792681|NCT01249664|19183284|P2|Completed 48 Weeks Treatment|Overall Study||24
7792682|NCT01249664|19183285|P1|Completed 48 Weeks Treatment|Overall Study||78
7792683|NCT01249664|19183284|P2|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25
7792684|NCT01249664|19183285|P1|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83
7792685|NCT01249664|19183284|P2|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31
7792686|NCT01249664|19183285|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90
7792687|NCT01249664|19183284|P2|Participants Received Treatment|Overall Study|Safety population|31
7792688|NCT01249664|19183285|P1|Participants Received Treatment|Overall Study|Safety population|91
7792689|NCT01249664|19183284|P2|STARTED|Overall Study||31
7792690|NCT01249664|19183285|P1|STARTED|Overall Study||91
7792691|NCT01249651|19183335|P1|NOT COMPLETED|Overall Study||7
7792692|NCT01249651|19183335|P1|COMPLETED|Overall Study|Completed the 8-week treatment period|94
7792693|NCT01249651|19183335|P1|STARTED|Overall Study|Enrolled|101
7792694|NCT01249625|19183344|P2|NOT COMPLETED|Overall Study||0
7792695|NCT01249625|19183345|P1|NOT COMPLETED|Overall Study||0
7792696|NCT01249625|19183344|P2|COMPLETED|Overall Study||1488
7792697|NCT01249625|19183345|P1|COMPLETED|Overall Study||1374
7792698|NCT01249625|19183344|P2|STARTED|Overall Study||1488
7792699|NCT01249625|19183345|P1|STARTED|Overall Study||1374
7792700|NCT01249417|19183364|P3|NOT COMPLETED|Treatment Phase - ITT Population||4
7792701|NCT01249417|19183365|P2|NOT COMPLETED|Treatment Phase - ITT Population||4
7792702|NCT01249417|19183366|P1|NOT COMPLETED|Treatment Phase - ITT Population||1
7792703|NCT01249417|19183364|P3|COMPLETED|Treatment Phase - ITT Population||73
7792704|NCT01249417|19183365|P2|COMPLETED|Treatment Phase - ITT Population||75
7792705|NCT01249417|19183366|P1|COMPLETED|Treatment Phase - ITT Population||78
7792706|NCT01249417|19183364|P3|STARTED|Treatment Phase - ITT Population||77
7792707|NCT01249417|19183365|P2|STARTED|Treatment Phase - ITT Population||79
7792708|NCT01249417|19183366|P1|STARTED|Treatment Phase - ITT Population||79
7792709|NCT01249417|19183364|P3|NOT COMPLETED|Randomised Population||4
7792710|NCT01249417|19183365|P2|NOT COMPLETED|Randomised Population||1
7792711|NCT01249417|19183366|P1|NOT COMPLETED|Randomised Population||1
7792712|NCT01249417|19183364|P3|COMPLETED|Randomised Population||77
7792713|NCT01249417|19183365|P2|COMPLETED|Randomised Population||79
7792714|NCT01249417|19183366|P1|COMPLETED|Randomised Population||79
7792715|NCT01249417|19183364|P3|Treated|Randomised Population||79
7792716|NCT01249417|19183365|P2|Treated|Randomised Population||80
7792717|NCT01249417|19183366|P1|Treated|Randomised Population||80
7792718|NCT01249417|19183364|P3|STARTED|Randomised Population||81
7792719|NCT01249417|19183365|P2|STARTED|Randomised Population||80
7792720|NCT01249417|19183366|P1|STARTED|Randomised Population||80
7792721|NCT01249404|19183383|P3|NOT COMPLETED|Overall Study||7
7792722|NCT01249404|19183384|P2|NOT COMPLETED|Overall Study||8
7792723|NCT01249404|19183385|P1|NOT COMPLETED|Overall Study||7
7792724|NCT01249404|19183383|P3|COMPLETED|Overall Study||125
7792725|NCT01249404|19183384|P2|COMPLETED|Overall Study||121
7792726|NCT01249404|19183385|P1|COMPLETED|Overall Study||120
7792727|NCT01249404|19183383|P3|STARTED|Overall Study||132
7792728|NCT01249404|19183384|P2|STARTED|Overall Study||129
7792729|NCT01249404|19183385|P1|STARTED|Overall Study||127
7792730|NCT01249365|19183462|P1|NOT COMPLETED|Overall Study||1
7792731|NCT01249365|19183462|P1|COMPLETED|Overall Study||198
7792732|NCT01249365|19183462|P1|STARTED|Overall Study||199
7792733|NCT01249274|19183470|P2|NOT COMPLETED|Overall Study||6
7792734|NCT01249274|19183471|P1|NOT COMPLETED|Overall Study||4
7792735|NCT01249274|19183470|P2|COMPLETED|Overall Study||19
7792736|NCT01249274|19183471|P1|COMPLETED|Overall Study||21
7792737|NCT01249274|19183470|P2|Completed Post Trial Visit But Not tx|Overall Study||2
7792738|NCT01249274|19183471|P1|Completed Post Trial Visit But Not tx|Overall Study||1
7792739|NCT01249274|19183470|P2|Completed Treatment & Post Trial Visit|Overall Study||17
7792740|NCT01249274|19183471|P1|Completed Treatment & Post Trial Visit|Overall Study||20
7792741|NCT01249274|19183470|P2|Completed Treatment|Overall Study||19
7792742|NCT01249274|19183471|P1|Completed Treatment|Overall Study||21
7792743|NCT01249274|19183470|P2|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
7792744|NCT01249274|19183471|P1|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
7792745|NCT01249261|19183497|P2|NOT COMPLETED|Overall Study||0
7792746|NCT01249261|19183498|P1|NOT COMPLETED|Overall Study||1
7792747|NCT01249261|19183497|P2|COMPLETED|Overall Study||31
7792748|NCT01249261|19183498|P1|COMPLETED|Overall Study||29
7792749|NCT01249261|19183497|P2|STARTED|Overall Study||31
7792750|NCT01249261|19183498|P1|STARTED|Overall Study||30
7792751|NCT01249157|19183526|P1|NOT COMPLETED|Overall Study||1
7792752|NCT01249157|19183526|P1|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0
7792753|NCT01249157|19183526|P1|STARTED|Overall Study||1
7792754|NCT01249131|19183530|P6|NOT COMPLETED|Third Intervention||0
7792755|NCT01249131|19183531|P5|NOT COMPLETED|Third Intervention||0
7792756|NCT01249131|19183532|P4|NOT COMPLETED|Third Intervention||0
7792757|NCT01249131|19183533|P3|NOT COMPLETED|Third Intervention||0
7792758|NCT01249131|19183534|P2|NOT COMPLETED|Third Intervention||0
7792759|NCT01249131|19183535|P1|NOT COMPLETED|Third Intervention||0
7792760|NCT01249131|19183530|P6|COMPLETED|Third Intervention||4
7792761|NCT01249131|19183531|P5|COMPLETED|Third Intervention||2
7792762|NCT01249131|19183532|P4|COMPLETED|Third Intervention||3
7792763|NCT01249131|19183533|P3|COMPLETED|Third Intervention||4
7792764|NCT01249131|19183534|P2|COMPLETED|Third Intervention||3
7792765|NCT01249131|19183535|P1|COMPLETED|Third Intervention||3
7792766|NCT01249131|19183530|P6|STARTED|Third Intervention||4
7792767|NCT01249131|19183531|P5|STARTED|Third Intervention||2
7792768|NCT01249131|19183532|P4|STARTED|Third Intervention||3
7792769|NCT01249131|19183533|P3|STARTED|Third Intervention||4
7792770|NCT01249131|19183534|P2|STARTED|Third Intervention||3
7792771|NCT01249131|19183535|P1|STARTED|Third Intervention||3
7792772|NCT01249131|19183530|P6|NOT COMPLETED|Washout Period of 10 Days||0
7792773|NCT01249131|19183531|P5|NOT COMPLETED|Washout Period of 10 Days||0
7792774|NCT01249131|19183532|P4|NOT COMPLETED|Washout Period of 10 Days||0
7792775|NCT01249131|19183533|P3|NOT COMPLETED|Washout Period of 10 Days||0
7792776|NCT01249131|19183534|P2|NOT COMPLETED|Washout Period of 10 Days||0
7792777|NCT01249131|19183535|P1|NOT COMPLETED|Washout Period of 10 Days||0
7792778|NCT01249131|19183530|P6|COMPLETED|Washout Period of 10 Days||4
7792779|NCT01249131|19183531|P5|COMPLETED|Washout Period of 10 Days||2
7792780|NCT01249131|19183532|P4|COMPLETED|Washout Period of 10 Days||3
7792781|NCT01249131|19183533|P3|COMPLETED|Washout Period of 10 Days||4
7792782|NCT01249131|19183534|P2|COMPLETED|Washout Period of 10 Days||3
7792783|NCT01249131|19183535|P1|COMPLETED|Washout Period of 10 Days||3
7792784|NCT01249131|19183530|P6|STARTED|Washout Period of 10 Days||4
7792785|NCT01249131|19183531|P5|STARTED|Washout Period of 10 Days||2
7792786|NCT01249131|19183532|P4|STARTED|Washout Period of 10 Days||3
7792787|NCT01249131|19183533|P3|STARTED|Washout Period of 10 Days||4
7792788|NCT01249131|19183534|P2|STARTED|Washout Period of 10 Days||3
7792789|NCT01249131|19183535|P1|STARTED|Washout Period of 10 Days||3
7792790|NCT01249131|19183530|P6|NOT COMPLETED|Second Intervention||0
7792791|NCT01249131|19183531|P5|NOT COMPLETED|Second Intervention||0
7792792|NCT01249131|19183532|P4|NOT COMPLETED|Second Intervention||0
7792793|NCT01249131|19183533|P3|NOT COMPLETED|Second Intervention||0
7792794|NCT01249131|19183534|P2|NOT COMPLETED|Second Intervention||0
7792795|NCT01249131|19183535|P1|NOT COMPLETED|Second Intervention||0
7792796|NCT01249131|19183530|P6|COMPLETED|Second Intervention||4
7792797|NCT01249131|19183531|P5|COMPLETED|Second Intervention||2
7792798|NCT01249131|19183532|P4|COMPLETED|Second Intervention||3
7792799|NCT01249131|19183533|P3|COMPLETED|Second Intervention||4
7792800|NCT01249131|19183534|P2|COMPLETED|Second Intervention||3
7792801|NCT01249131|19183535|P1|COMPLETED|Second Intervention||3
7792802|NCT01249131|19183530|P6|STARTED|Second Intervention||4
7792803|NCT01249131|19183531|P5|STARTED|Second Intervention||2
7792804|NCT01249131|19183532|P4|STARTED|Second Intervention||3
7792805|NCT01249131|19183533|P3|STARTED|Second Intervention||4
7792806|NCT01249131|19183534|P2|STARTED|Second Intervention||3
7792807|NCT01249131|19183535|P1|STARTED|Second Intervention||3
7792808|NCT01249131|19183530|P6|NOT COMPLETED|Washout Period of 10 Days||0
7792809|NCT01249131|19183531|P5|NOT COMPLETED|Washout Period of 10 Days||1
7792810|NCT01249131|19183532|P4|NOT COMPLETED|Washout Period of 10 Days||0
7792811|NCT01249131|19183533|P3|NOT COMPLETED|Washout Period of 10 Days||0
7792812|NCT01249131|19183534|P2|NOT COMPLETED|Washout Period of 10 Days||0
7792813|NCT01249131|19183535|P1|NOT COMPLETED|Washout Period of 10 Days||0
7792814|NCT01249131|19183530|P6|COMPLETED|Washout Period of 10 Days||4
7792815|NCT01249131|19183531|P5|COMPLETED|Washout Period of 10 Days||2
7792816|NCT01249131|19183532|P4|COMPLETED|Washout Period of 10 Days||3
7792817|NCT01249131|19183533|P3|COMPLETED|Washout Period of 10 Days||4
7792818|NCT01249131|19183534|P2|COMPLETED|Washout Period of 10 Days||3
7792819|NCT01249131|19183535|P1|COMPLETED|Washout Period of 10 Days||3
7792820|NCT01249131|19183530|P6|STARTED|Washout Period of 10 Days||4
7792821|NCT01249131|19183531|P5|STARTED|Washout Period of 10 Days||3
7792822|NCT01249131|19183532|P4|STARTED|Washout Period of 10 Days||3
7792823|NCT01249131|19183533|P3|STARTED|Washout Period of 10 Days||4
7792824|NCT01249131|19183534|P2|STARTED|Washout Period of 10 Days||3
7792825|NCT01249131|19183535|P1|STARTED|Washout Period of 10 Days||3
7792826|NCT01249131|19183530|P6|NOT COMPLETED|First Intervention||0
7792827|NCT01249131|19183531|P5|NOT COMPLETED|First Intervention||0
7792828|NCT01249131|19183532|P4|NOT COMPLETED|First Intervention||0
7792829|NCT01249131|19183533|P3|NOT COMPLETED|First Intervention||0
7792830|NCT01249131|19183534|P2|NOT COMPLETED|First Intervention||0
7792831|NCT01249131|19183535|P1|NOT COMPLETED|First Intervention||0
7792832|NCT01249131|19183530|P6|COMPLETED|First Intervention||4
7792833|NCT01249131|19183531|P5|COMPLETED|First Intervention||3
7792834|NCT01249131|19183532|P4|COMPLETED|First Intervention||3
7792835|NCT01249131|19183533|P3|COMPLETED|First Intervention||4
7792836|NCT01249131|19183534|P2|COMPLETED|First Intervention||3
7792837|NCT01249131|19183535|P1|COMPLETED|First Intervention||3
7792838|NCT01249131|19183530|P6|STARTED|First Intervention||4
7792839|NCT01249131|19183531|P5|STARTED|First Intervention||3
7792840|NCT01249131|19183532|P4|STARTED|First Intervention||3
7792841|NCT01249131|19183533|P3|STARTED|First Intervention||4
7792842|NCT01249131|19183534|P2|STARTED|First Intervention||3
7792843|NCT01249131|19183535|P1|STARTED|First Intervention||3
7792844|NCT01249118|19183555|P3|NOT COMPLETED|Second Washout Period||0
7792845|NCT01249118|19183556|P2|NOT COMPLETED|Second Washout Period||0
7792846|NCT01249118|19183557|P1|NOT COMPLETED|Second Washout Period||0
7792847|NCT01249118|19183555|P3|COMPLETED|Second Washout Period||5
7792848|NCT01249118|19183556|P2|COMPLETED|Second Washout Period||5
7792849|NCT01249118|19183557|P1|COMPLETED|Second Washout Period||2
7792850|NCT01249118|19183555|P3|STARTED|Second Washout Period||5
7792851|NCT01249118|19183556|P2|STARTED|Second Washout Period||5
7792852|NCT01249118|19183557|P1|STARTED|Second Washout Period||2
7792853|NCT01249118|19183555|P3|NOT COMPLETED|Second Intervention Period||0
7792854|NCT01249118|19183556|P2|NOT COMPLETED|Second Intervention Period||0
7792855|NCT01249118|19183557|P1|NOT COMPLETED|Second Intervention Period||0
7792856|NCT01249118|19183555|P3|COMPLETED|Second Intervention Period||5
7792857|NCT01249118|19183556|P2|COMPLETED|Second Intervention Period||5
7792858|NCT01249118|19183557|P1|COMPLETED|Second Intervention Period||2
7792859|NCT01249118|19183555|P3|STARTED|Second Intervention Period||5
7792860|NCT01249118|19183556|P2|STARTED|Second Intervention Period||5
7792861|NCT01249118|19183557|P1|STARTED|Second Intervention Period||2
7792862|NCT01249118|19183555|P3|NOT COMPLETED|First Washout Period||0
7792863|NCT01249118|19183556|P2|NOT COMPLETED|First Washout Period||1
7792864|NCT01249118|19183557|P1|NOT COMPLETED|First Washout Period||0
7792865|NCT01249118|19183555|P3|COMPLETED|First Washout Period||5
7792866|NCT01249118|19183556|P2|COMPLETED|First Washout Period||5
7792867|NCT01249118|19183557|P1|COMPLETED|First Washout Period||2
7792868|NCT01249118|19183555|P3|STARTED|First Washout Period||5
7792869|NCT01249118|19183556|P2|STARTED|First Washout Period||6
7792870|NCT01249118|19183557|P1|STARTED|First Washout Period||2
7792871|NCT01249118|19183555|P3|NOT COMPLETED|First Intervention Period||0
7792872|NCT01249118|19183556|P2|NOT COMPLETED|First Intervention Period||0
7792873|NCT01249118|19183557|P1|NOT COMPLETED|First Intervention Period||0
7792874|NCT01249118|19183555|P3|COMPLETED|First Intervention Period||5
7792875|NCT01249118|19183556|P2|COMPLETED|First Intervention Period||6
7792876|NCT01249118|19183557|P1|COMPLETED|First Intervention Period||2
7792877|NCT01249118|19183555|P3|STARTED|First Intervention Period||5
7792878|NCT01249118|19183556|P2|STARTED|First Intervention Period||6
7792879|NCT01249118|19183557|P1|STARTED|First Intervention Period||2
7792880|NCT01249092|19183591|P1|NOT COMPLETED|Overall Study||2
7792881|NCT01249092|19183591|P1|COMPLETED|Overall Study||18
7792882|NCT01249092|19183591|P1|STARTED|Overall Study||20
7792883|NCT01249027|19183597|P1|NOT COMPLETED|5 Years Clinical Follow up||68
7792884|NCT01249027|19183597|P1|COMPLETED|5 Years Clinical Follow up||2142
7792885|NCT01249027|19183597|P1|STARTED|5 Years Clinical Follow up||2210
7792886|NCT01249027|19183597|P1|NOT COMPLETED|4 Years Clinical Follow up||13
7792887|NCT01249027|19183597|P1|COMPLETED|4 Years Clinical Follow up||2210
7792888|NCT01249027|19183597|P1|STARTED|4 Years Clinical Follow up||2223
7792889|NCT01249027|19183597|P1|NOT COMPLETED|3 Years Clinical Follow up||31
7792890|NCT01249027|19183597|P1|COMPLETED|3 Years Clinical Follow up||2223
7792891|NCT01249027|19183597|P1|STARTED|3 Years Clinical Follow up||2254
7792892|NCT01249027|19183597|P1|NOT COMPLETED|2 Years Clinical Follow up||137
7792893|NCT01249027|19183597|P1|COMPLETED|2 Years Clinical Follow up||2254
7792894|NCT01249027|19183597|P1|STARTED|2 Years Clinical Follow up||2391
7792895|NCT01249027|19183597|P1|NOT COMPLETED|1 Year Clinical Follow up||91
7792896|NCT01249027|19183597|P1|COMPLETED|1 Year Clinical Follow up||2391
7792897|NCT01249027|19183597|P1|STARTED|1 Year Clinical Follow up||2482
7792898|NCT01248962|19183668|P2|NOT COMPLETED|Overall Study||16
7792899|NCT01248962|19183669|P1|NOT COMPLETED|Overall Study||16
7792900|NCT01248962|19183668|P2|COMPLETED|Overall Study||56
7792901|NCT01248962|19183669|P1|COMPLETED|Overall Study||58
7792902|NCT01248962|19183668|P2|STARTED|Overall Study||72
7792903|NCT01248962|19183669|P1|STARTED|Overall Study||74
7792904|NCT01248949|19183685|P5|NOT COMPLETED|Overall Study||4
7792905|NCT01248949|19183686|P4|NOT COMPLETED|Overall Study||10
7792906|NCT01248949|19183687|P3|NOT COMPLETED|Overall Study||37
7792907|NCT01248949|19183688|P2|NOT COMPLETED|Overall Study||13
7792908|NCT01248949|19183689|P1|NOT COMPLETED|Overall Study||33
7792909|NCT01248949|19183685|P5|COMPLETED|Overall Study||3
7792910|NCT01248949|19183686|P4|COMPLETED|Overall Study||3
7792911|NCT01248949|19183687|P3|COMPLETED|Overall Study||1
7792912|NCT01248949|19183688|P2|COMPLETED|Overall Study||3
7792913|NCT01248949|19183689|P1|COMPLETED|Overall Study||9
7792914|NCT01248949|19183685|P5|STARTED|Overall Study||7
7792915|NCT01248949|19183686|P4|STARTED|Overall Study||13
7792916|NCT01248949|19183687|P3|STARTED|Overall Study||38
7792917|NCT01248949|19183688|P2|STARTED|Overall Study||16
7792918|NCT01248949|19183689|P1|STARTED|Overall Study||42
7792919|NCT01248936|19183801|P1|NOT COMPLETED|Overall Study||374
7792920|NCT01248936|19183801|P1|COMPLETED|Overall Study||0
7792921|NCT01248936|19183801|P1|STARTED|Overall Study||374
7792922|NCT01248884|19183814|P3|NOT COMPLETED|Overall Study||1
7792923|NCT01248884|19183815|P2|NOT COMPLETED|Overall Study||3
7792924|NCT01248884|19183816|P1|NOT COMPLETED|Overall Study||2
7792925|NCT01248884|19183814|P3|COMPLETED|Overall Study||238
7792926|NCT01248884|19183815|P2|COMPLETED|Overall Study||239
7792927|NCT01248884|19183816|P1|COMPLETED|Overall Study||238
7792928|NCT01248884|19183814|P3|STARTED|Overall Study||239
7792929|NCT01248884|19183815|P2|STARTED|Overall Study||242
7792930|NCT01248884|19183816|P1|STARTED|Overall Study||240
7792931|NCT01248793|19183874|P2|NOT COMPLETED|Overall Study||6
7792932|NCT01248793|19183875|P1|NOT COMPLETED|Overall Study||4
7792933|NCT01248793|19183874|P2|COMPLETED|Overall Study||102
7792934|NCT01248793|19183875|P1|COMPLETED|Overall Study||101
7792935|NCT01248793|19183874|P2|STARTED|Overall Study||108
7792936|NCT01248793|19183875|P1|STARTED|Overall Study||105
7792937|NCT01248780|19183889|P2|NOT COMPLETED|Overall Study||15
7792938|NCT01248780|19183890|P1|NOT COMPLETED|Overall Study||9
7792939|NCT01248780|19183889|P2|COMPLETED|Overall Study||117
7792940|NCT01248780|19183890|P1|COMPLETED|Overall Study||123
7792941|NCT01248780|19183889|P2|STARTED|Overall Study||132
7792942|NCT01248780|19183890|P1|STARTED|Overall Study||132
7792943|NCT01248741|19183902|P1|NOT COMPLETED|Overall Study||0
7792944|NCT01248741|19183902|P1|COMPLETED|Overall Study||20
7792945|NCT01248741|19183902|P1|STARTED|Overall Study||20
7792946|NCT01248728|19183908|P2|NOT COMPLETED|Overall Study||2
7792947|NCT01248728|19183909|P1|NOT COMPLETED|Overall Study||4
7792948|NCT01248728|19183908|P2|COMPLETED|Overall Study||17
7792949|NCT01248728|19183909|P1|COMPLETED|Overall Study||15
7792950|NCT01248728|19183908|P2|STARTED|Overall Study||19
7792951|NCT01248728|19183909|P1|STARTED|Overall Study||19
7792952|NCT01248715|19183925|P2|NOT COMPLETED|Overall Study||510
7792953|NCT01248715|19183926|P1|NOT COMPLETED|Overall Study||501
7792954|NCT01248715|19183925|P2|COMPLETED|Overall Study||41
7792955|NCT01248715|19183926|P1|COMPLETED|Overall Study||55
7792956|NCT01248715|19183925|P2|STARTED|Overall Study||551
7792957|NCT01248715|19183926|P1|STARTED|Overall Study||556
7792958|NCT01248585|19183946|P2|NOT COMPLETED|Overall Study||0
7792959|NCT01248585|19183947|P1|NOT COMPLETED|Overall Study||0
7792960|NCT01248585|19183946|P2|COMPLETED|Overall Study||150
7792961|NCT01248585|19183947|P1|COMPLETED|Overall Study||148
7792962|NCT01248585|19183946|P2|STARTED|Overall Study||150
7792963|NCT01248585|19183947|P1|STARTED|Overall Study||148
7792964|NCT01248468|19183964|P3|NOT COMPLETED|Overall Study||4
7792965|NCT01248468|19183965|P2|NOT COMPLETED|Overall Study||14
7792966|NCT01248468|19183966|P1|NOT COMPLETED|Overall Study||15
7792967|NCT01248468|19183964|P3|COMPLETED|Overall Study||145
7792968|NCT01248468|19183965|P2|COMPLETED|Overall Study||290
7792969|NCT01248468|19183966|P1|COMPLETED|Overall Study||284
7792970|NCT01248468|19183964|P3|ITT Population|Overall Study||125
7792971|NCT01248468|19183965|P2|ITT Population|Overall Study||261
7792972|NCT01248468|19183966|P1|ITT Population|Overall Study||256
7792973|NCT01248468|19183964|P3|Safety Population|Overall Study||133
7792974|NCT01248468|19183965|P2|Safety Population|Overall Study||271
7792975|NCT01248468|19183966|P1|Safety Population|Overall Study||266
7792976|NCT01248468|19183964|P3|STARTED|Overall Study||149
7792977|NCT01248468|19183965|P2|STARTED|Overall Study||304
7792978|NCT01248468|19183966|P1|STARTED|Overall Study||299
7792979|NCT01248455|19183983|P1|NOT COMPLETED|Overall Study||1
7792980|NCT01248455|19183983|P1|COMPLETED|Overall Study||8
7792981|NCT01248455|19183983|P1|STARTED|Overall Study||9
7792982|NCT01248416|19183991|P3|NOT COMPLETED|Overall Study||1
7792983|NCT01248416|19183992|P2|NOT COMPLETED|Overall Study||0
7792984|NCT01248416|19183993|P1|NOT COMPLETED|Overall Study||4
7792985|NCT01248416|19183991|P3|COMPLETED|Overall Study||25
7792986|NCT01248416|19183992|P2|COMPLETED|Overall Study||25
7792987|NCT01248416|19183993|P1|COMPLETED|Overall Study||21
7792988|NCT01248416|19183991|P3|STARTED|Overall Study||26
7792989|NCT01248416|19183992|P2|STARTED|Overall Study||25
7792990|NCT01248416|19183993|P1|STARTED|Overall Study||25
7792991|NCT01248364|19184028|P4|NOT COMPLETED|Overall Study||0
7792992|NCT01248364|19184029|P3|NOT COMPLETED|Overall Study||0
7792993|NCT01248364|19184030|P2|NOT COMPLETED|Overall Study||1
7792994|NCT01248364|19184031|P1|NOT COMPLETED|Overall Study||0
7792995|NCT01248364|19184028|P4|COMPLETED|Overall Study||12
7792996|NCT01248364|19184029|P3|COMPLETED|Overall Study||13
7792997|NCT01248364|19184030|P2|COMPLETED|Overall Study||33
7792998|NCT01248364|19184031|P1|COMPLETED|Overall Study||32
7792999|NCT01248364|19184028|P4|Completed Chronic Phase:28-day Treatment|Overall Study||0
7793000|NCT01248364|19184029|P3|Completed Chronic Phase:28-day Treatment|Overall Study||13
7793001|NCT01248364|19184030|P2|Completed Chronic Phase:28-day Treatment|Overall Study||33
7793002|NCT01248364|19184031|P1|Completed Chronic Phase:28-day Treatment|Overall Study||32
7793003|NCT01248364|19184028|P4|Completed Acute Phase:Single Dose, Day 1|Overall Study||12
7793004|NCT01248364|19184029|P3|Completed Acute Phase:Single Dose, Day 1|Overall Study||13
7793005|NCT01248364|19184030|P2|Completed Acute Phase:Single Dose, Day 1|Overall Study||34
7793006|NCT01248364|19184031|P1|Completed Acute Phase:Single Dose, Day 1|Overall Study||32
7793007|NCT01248364|19184028|P4|STARTED|Overall Study||12
7793008|NCT01248364|19184029|P3|STARTED|Overall Study||13
7793009|NCT01248364|19184030|P2|STARTED|Overall Study||34
7793010|NCT01248364|19184031|P1|STARTED|Overall Study||32
7793011|NCT01248221|19184079|P2|NOT COMPLETED|Overall Study||0
7793012|NCT01248221|19184080|P1|NOT COMPLETED|Overall Study||0
7793013|NCT01248221|19184079|P2|COMPLETED|Overall Study||15
7793014|NCT01248221|19184080|P1|COMPLETED|Overall Study||15
7793015|NCT01248221|19184079|P2|STARTED|Overall Study||15
7793016|NCT01248221|19184080|P1|STARTED|Overall Study||15
7793017|NCT01248130|19184094|P2|NOT COMPLETED|Overall Study||0
7793018|NCT01248130|19184095|P1|NOT COMPLETED|Overall Study||2
7793019|NCT01248130|19184094|P2|COMPLETED|Overall Study||4
7793020|NCT01248130|19184095|P1|COMPLETED|Overall Study||1
7793021|NCT01248130|19184094|P2|STARTED|Overall Study||4
7793022|NCT01248130|19184095|P1|STARTED|Overall Study||3
7793023|NCT01248104|19184105|P2|NOT COMPLETED|Overall Study||8
7793024|NCT01248104|19184106|P1|NOT COMPLETED|Overall Study||10
7793025|NCT01248104|19184105|P2|COMPLETED|Overall Study||42
7793026|NCT01248104|19184106|P1|COMPLETED|Overall Study||40
7793027|NCT01248104|19184105|P2|STARTED|Overall Study||50
7793028|NCT01248104|19184106|P1|STARTED|Overall Study||50
7793029|NCT01248065|19184114|P2|NOT COMPLETED|Overall Study||22
7793030|NCT01248065|19184115|P1|NOT COMPLETED|Overall Study||26
7793031|NCT01248065|19184114|P2|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179
7793032|NCT01248065|19184115|P1|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181
7793033|NCT01248065|19184114|P2|STARTED|Overall Study||201
7793034|NCT01248065|19184115|P1|STARTED|Overall Study||207
7793035|NCT01248013|19184125|P1|NOT COMPLETED|Overall Study||14
7793036|NCT01248013|19184125|P1|COMPLETED|Overall Study||75
7793037|NCT01248013|19184125|P1|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75
7793038|NCT01248013|19184125|P1|STARTED|Overall Study||89
7793039|NCT01247974|19184131|P2|NOT COMPLETED|Overall Study||19
7793040|NCT01247974|19184132|P1|NOT COMPLETED|Overall Study||26
7793041|NCT01247974|19184131|P2|COMPLETED|Overall Study||203
7793042|NCT01247974|19184132|P1|COMPLETED|Overall Study||191
7793043|NCT01247974|19184131|P2|STARTED|Overall Study||222
7793044|NCT01247974|19184132|P1|STARTED|Overall Study||217
7793045|NCT01247922|19184140|P1|NOT COMPLETED|Overall Study||4
7793046|NCT01247922|19184140|P1|COMPLETED|Overall Study||0
7793047|NCT01247922|19184140|P1|Treated|Overall Study||4
7793048|NCT01247922|19184140|P1|STARTED|Overall Study||4
7793049|NCT01247675|19184150|P4|NOT COMPLETED|Overall Study||0
7793050|NCT01247675|19184151|P3|NOT COMPLETED|Overall Study||0
7793051|NCT01247675|19184152|P2|NOT COMPLETED|Overall Study||2
7793052|NCT01247675|19184153|P1|NOT COMPLETED|Overall Study||2
7793053|NCT01247675|19184150|P4|COMPLETED|Overall Study||8
7793054|NCT01247675|19184151|P3|COMPLETED|Overall Study||9
7793055|NCT01247675|19184152|P2|COMPLETED|Overall Study||8
7793056|NCT01247675|19184153|P1|COMPLETED|Overall Study||8
7793057|NCT01247675|19184150|P4|STARTED|Overall Study||8
7793058|NCT01247675|19184151|P3|STARTED|Overall Study||9
7793059|NCT01247675|19184152|P2|STARTED|Overall Study||10
7793060|NCT01247675|19184153|P1|STARTED|Overall Study||10
7793061|NCT01247571|19184175|P1|NOT COMPLETED|Overall Study||3
7793062|NCT01247571|19184175|P1|COMPLETED|Overall Study||19
7793063|NCT01247571|19184175|P1|STARTED|Overall Study||22
7793064|NCT01247428|19184183|P1|NOT COMPLETED|Overall Study||0
7793065|NCT01247428|19184183|P1|COMPLETED|Overall Study||30
7793066|NCT01247428|19184183|P1|STARTED|Overall Study||30
7793067|NCT01247363|19184204|P1|NOT COMPLETED|Overall Study||0
7793068|NCT01247363|19184204|P1|COMPLETED|Overall Study||20
7793069|NCT01247363|19184204|P1|STARTED|Overall Study||20
7793070|NCT01247350|19184238|P5|NOT COMPLETED|Overall Study||1
7793071|NCT01247350|19184239|P4|NOT COMPLETED|Overall Study||1
7793072|NCT01247350|19184240|P3|NOT COMPLETED|Overall Study||1
7793073|NCT01247350|19184241|P2|NOT COMPLETED|Overall Study||0
7793074|NCT01247350|19184242|P1|NOT COMPLETED|Overall Study||0
7793075|NCT01247350|19184238|P5|COMPLETED|Overall Study||8
7793076|NCT01247350|19184239|P4|COMPLETED|Overall Study||6
7793077|NCT01247350|19184240|P3|COMPLETED|Overall Study||5
7793078|NCT01247350|19184241|P2|COMPLETED|Overall Study||6
7793079|NCT01247350|19184242|P1|COMPLETED|Overall Study||6
7793080|NCT01247350|19184238|P5|Received Multiple Doses of Study Drug|Overall Study||5
7793081|NCT01247350|19184239|P4|Received Multiple Doses of Study Drug|Overall Study||6
7793082|NCT01247350|19184240|P3|Received Multiple Doses of Study Drug|Overall Study||6
7793083|NCT01247350|19184241|P2|Received Multiple Doses of Study Drug|Overall Study||0
7793084|NCT01247350|19184242|P1|Received Multiple Doses of Study Drug|Overall Study||0
7793085|NCT01247350|19184238|P5|STARTED|Overall Study||9
7793086|NCT01247350|19184239|P4|STARTED|Overall Study||7
7793087|NCT01247350|19184240|P3|STARTED|Overall Study||6
7793088|NCT01247350|19184241|P2|STARTED|Overall Study||6
7793089|NCT01247350|19184242|P1|STARTED|Overall Study||6
7793090|NCT01247324|19184300|P2|NOT COMPLETED|Overall Study||44
7793091|NCT01247324|19184301|P1|NOT COMPLETED|Overall Study||71
7793092|NCT01247324|19184300|P2|COMPLETED|Overall Study||366
7793093|NCT01247324|19184301|P1|COMPLETED|Overall Study||340
7793094|NCT01247324|19184300|P2|STARTED|Overall Study||410
7793095|NCT01247324|19184301|P1|STARTED|Overall Study||411
7793096|NCT01247298|19184332|P1|NOT COMPLETED|Overall Study||0
7793097|NCT01247298|19184332|P1|COMPLETED|Overall Study||17
7793098|NCT01247298|19184332|P1|STARTED|Overall Study||17
7793099|NCT01247285|19184342|P2|NOT COMPLETED|Second Intervention||0
7793100|NCT01247285|19184343|P1|NOT COMPLETED|Second Intervention||0
7793101|NCT01247285|19184342|P2|COMPLETED|Second Intervention||13
7793102|NCT01247285|19184343|P1|COMPLETED|Second Intervention||13
7793103|NCT01247285|19184342|P2|STARTED|Second Intervention||13
7793104|NCT01247285|19184343|P1|STARTED|Second Intervention||13
7793105|NCT01247285|19184342|P2|NOT COMPLETED|Washout of 28 Days||0
7793106|NCT01247285|19184343|P1|NOT COMPLETED|Washout of 28 Days||0
7793107|NCT01247285|19184342|P2|COMPLETED|Washout of 28 Days||13
7793108|NCT01247285|19184343|P1|COMPLETED|Washout of 28 Days||13
7793109|NCT01247285|19184342|P2|STARTED|Washout of 28 Days||13
7793110|NCT01247285|19184343|P1|STARTED|Washout of 28 Days||13
7793111|NCT01247285|19184342|P2|NOT COMPLETED|First Intervention||0
7793112|NCT01247285|19184343|P1|NOT COMPLETED|First Intervention||0
7793113|NCT01247285|19184342|P2|COMPLETED|First Intervention||13
7793114|NCT01247285|19184343|P1|COMPLETED|First Intervention||13
7793115|NCT01247285|19184342|P2|STARTED|First Intervention||13
7793116|NCT01247285|19184343|P1|STARTED|First Intervention||13
7793117|NCT01247272|19184361|P2|NOT COMPLETED|Second Intervention||0
7793118|NCT01247272|19184362|P1|NOT COMPLETED|Second Intervention||0
7793119|NCT01247272|19184361|P2|COMPLETED|Second Intervention||13
7793120|NCT01247272|19184362|P1|COMPLETED|Second Intervention||13
7793121|NCT01247272|19184361|P2|STARTED|Second Intervention||13
7793122|NCT01247272|19184362|P1|STARTED|Second Intervention||13
7793123|NCT01247272|19184361|P2|NOT COMPLETED|Washout of 28 Days||0
7793124|NCT01247272|19184362|P1|NOT COMPLETED|Washout of 28 Days||0
7793125|NCT01247272|19184361|P2|COMPLETED|Washout of 28 Days||13
7793126|NCT01247272|19184362|P1|COMPLETED|Washout of 28 Days||13
7793127|NCT01247272|19184361|P2|STARTED|Washout of 28 Days||13
7793128|NCT01247272|19184362|P1|STARTED|Washout of 28 Days||13
7793129|NCT01247272|19184361|P2|NOT COMPLETED|First Intervention||0
7793130|NCT01247272|19184362|P1|NOT COMPLETED|First Intervention||0
7793131|NCT01247272|19184361|P2|COMPLETED|First Intervention||13
7793132|NCT01247272|19184362|P1|COMPLETED|First Intervention||13
7793133|NCT01247272|19184361|P2|STARTED|First Intervention||13
7793134|NCT01247272|19184362|P1|STARTED|First Intervention||13
7793135|NCT01247220|19184380|P2|NOT COMPLETED|Overall Study||0
7793136|NCT01247220|19184381|P1|NOT COMPLETED|Overall Study||0
7793137|NCT01247220|19184380|P2|COMPLETED|Overall Study||6
7793138|NCT01247220|19184381|P1|COMPLETED|Overall Study||6
7793139|NCT01247220|19184380|P2|STARTED|Overall Study||6
7793140|NCT01247220|19184381|P1|STARTED|Overall Study||6
7793141|NCT01247090|19184394|P3|NOT COMPLETED|Overall Study||0
7793142|NCT01247090|19184395|P2|NOT COMPLETED|Overall Study||1
7793143|NCT01247090|19184396|P1|NOT COMPLETED|Overall Study||1
7793144|NCT01247090|19184394|P3|COMPLETED|Overall Study||4
7793145|NCT01247090|19184395|P2|COMPLETED|Overall Study||3
7793146|NCT01247090|19184396|P1|COMPLETED|Overall Study||3
7793147|NCT01247090|19184394|P3|STARTED|Overall Study||4
7793148|NCT01247090|19184395|P2|STARTED|Overall Study||4
7793149|NCT01247090|19184396|P1|STARTED|Overall Study||4
7793150|NCT01247064|19184406|P2|NOT COMPLETED|Overall Study||0
7793151|NCT01247064|19184407|P1|NOT COMPLETED|Overall Study||0
7793152|NCT01247064|19184406|P2|COMPLETED|Overall Study||31
7793153|NCT01247064|19184407|P1|COMPLETED|Overall Study||31
7793154|NCT01247064|19184406|P2|STARTED|Overall Study||31
7793155|NCT01247064|19184407|P1|STARTED|Overall Study||31
7793156|NCT01246999|19184425|P4|NOT COMPLETED|Overall Study||2
7793157|NCT01246999|19184426|P3|NOT COMPLETED|Overall Study||0
7793158|NCT01246999|19184427|P2|NOT COMPLETED|Overall Study||1
7793159|NCT01246999|19184428|P1|NOT COMPLETED|Overall Study||0
7793160|NCT01246999|19184425|P4|COMPLETED|Overall Study||15
7793161|NCT01246999|19184426|P3|COMPLETED|Overall Study||2
7793162|NCT01246999|19184427|P2|COMPLETED|Overall Study||3
7793163|NCT01246999|19184428|P1|COMPLETED|Overall Study||11
7793164|NCT01246999|19184425|P4|STARTED|Overall Study||17
7793165|NCT01246999|19184426|P3|STARTED|Overall Study||2
7793166|NCT01246999|19184427|P2|STARTED|Overall Study||4
7793167|NCT01246999|19184428|P1|STARTED|Overall Study||11
7793168|NCT01246986|19184468|P7|NOT COMPLETED|Overall Study||0
7793169|NCT01246986|19184469|P6|NOT COMPLETED|Overall Study||1
7793170|NCT01246986|19184470|P5|NOT COMPLETED|Overall Study||5
7793171|NCT01246986|19184471|P4|NOT COMPLETED|Overall Study||0
7793172|NCT01246986|19184472|P3|NOT COMPLETED|Overall Study||6
7793173|NCT01246986|19184473|P2|NOT COMPLETED|Overall Study||5
7793174|NCT01246986|19184474|P1|NOT COMPLETED|Overall Study||3
7793175|NCT01246986|19184468|P7|COMPLETED|Overall Study||5
7793176|NCT01246986|19184469|P6|COMPLETED|Overall Study||2
7793177|NCT01246986|19184470|P5|COMPLETED|Overall Study||39
7793178|NCT01246986|19184471|P4|COMPLETED|Overall Study||3
7793179|NCT01246986|19184472|P3|COMPLETED|Overall Study||34
7793180|NCT01246986|19184473|P2|COMPLETED|Overall Study||67
7793181|NCT01246986|19184474|P1|COMPLETED|Overall Study||34
7793182|NCT01246986|19184468|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
7793183|NCT01246986|19184469|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
7793184|NCT01246986|19184470|P5|Received at Least 1 Dose of Study Drug|Overall Study||44
7793185|NCT01246986|19184471|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
7793186|NCT01246986|19184472|P3|Received at Least 1 Dose of Study Drug|Overall Study||40
7793187|NCT01246986|19184473|P2|Received at Least 1 Dose of Study Drug|Overall Study||72
7793188|NCT01246986|19184474|P1|Received at Least 1 Dose of Study Drug|Overall Study||37
7793189|NCT01246986|19184468|P7|STARTED|Overall Study||5
7793190|NCT01246986|19184469|P6|STARTED|Overall Study||3
7793191|NCT01246986|19184470|P5|STARTED|Overall Study||44
7793192|NCT01246986|19184471|P4|STARTED|Overall Study||3
7793193|NCT01246986|19184472|P3|STARTED|Overall Study||40
7793194|NCT01246986|19184473|P2|STARTED|Overall Study||72
7793195|NCT01246986|19184474|P1|STARTED|Overall Study||37
7793196|NCT01246973|19184534|P2|NOT COMPLETED|Overall Study||47
7793197|NCT01246973|19184535|P1|NOT COMPLETED|Overall Study||61
7793198|NCT01246973|19184534|P2|COMPLETED|Overall Study||295
7793199|NCT01246973|19184535|P1|COMPLETED|Overall Study||283
7793200|NCT01246973|19184534|P2|STARTED|Overall Study||342
7793201|NCT01246973|19184535|P1|STARTED|Overall Study||344
7793202|NCT01246960|19184545|P2|NOT COMPLETED|Overall Study||4
7793203|NCT01246960|19184546|P1|NOT COMPLETED|Overall Study||6
7793204|NCT01246960|19184545|P2|COMPLETED|Overall Study||80
7793205|NCT01246960|19184546|P1|COMPLETED|Overall Study||78
7793206|NCT01246960|19184545|P2|Received Any Quantity of Study Drug|Overall Study||80
7793207|NCT01246960|19184546|P1|Received Any Quantity of Study Drug|Overall Study||82
7793208|NCT01246960|19184545|P2|STARTED|Overall Study||84
7793209|NCT01246960|19184546|P1|STARTED|Overall Study||84
7793210|NCT01246895|19184566|P2|NOT COMPLETED|Overall Study||4
7793211|NCT01246895|19184567|P1|NOT COMPLETED|Overall Study||3
7793212|NCT01246895|19184566|P2|COMPLETED|Overall Study||26
7793213|NCT01246895|19184567|P1|COMPLETED|Overall Study||34
7793214|NCT01246895|19184566|P2|STARTED|Overall Study||30
7793215|NCT01246895|19184567|P1|STARTED|Overall Study||37
7793216|NCT01246791|19184581|P1|NOT COMPLETED|Overall Study||0
7793217|NCT01246791|19184581|P1|COMPLETED|Overall Study||12
7793218|NCT01246791|19184581|P1|STARTED|Overall Study||12
7793219|NCT01246713|19184596|P2|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
7793220|NCT01246713|19184597|P1|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
7793221|NCT01246713|19184596|P2|COMPLETED|Second Acetaminophen Dosing (1 Day)||9
7793222|NCT01246713|19184597|P1|COMPLETED|Second Acetaminophen Dosing (1 Day)||6
7793223|NCT01246713|19184596|P2|STARTED|Second Acetaminophen Dosing (1 Day)||9
7793224|NCT01246713|19184597|P1|STARTED|Second Acetaminophen Dosing (1 Day)||6
7793225|NCT01246713|19184596|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
7793226|NCT01246713|19184597|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
7793227|NCT01246713|19184596|P2|COMPLETED|Washout (at Least 14 Days)||9
7793228|NCT01246713|19184597|P1|COMPLETED|Washout (at Least 14 Days)||6
7793229|NCT01246713|19184596|P2|STARTED|Washout (at Least 14 Days)||9
7793230|NCT01246713|19184597|P1|STARTED|Washout (at Least 14 Days)||6
7793231|NCT01246713|19184596|P2|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
7793232|NCT01246713|19184597|P1|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
7793233|NCT01246713|19184596|P2|COMPLETED|First Acetaminophen Dosing (1 Day)||9
7793234|NCT01246713|19184597|P1|COMPLETED|First Acetaminophen Dosing (1 Day)||6
7793235|NCT01246713|19184596|P2|STARTED|First Acetaminophen Dosing (1 Day)||9
7793236|NCT01246713|19184597|P1|STARTED|First Acetaminophen Dosing (1 Day)||6
7793237|NCT01246479|19184603|P1|NOT COMPLETED|Overall Study||5
7793238|NCT01246479|19184603|P1|COMPLETED|Overall Study|primary endpoint at Month 12|18
7793239|NCT01246479|19184603|P1|STARTED|Overall Study||23
7793240|NCT01246401|19184613|P2|NOT COMPLETED|Overall Study||0
7793241|NCT01246401|19184614|P1|NOT COMPLETED|Overall Study||0
7793242|NCT01246401|19184613|P2|COMPLETED|Overall Study||27
7793243|NCT01246401|19184614|P1|COMPLETED|Overall Study||66
7793244|NCT01246401|19184613|P2|STARTED|Overall Study||27
7793245|NCT01246401|19184614|P1|STARTED|Overall Study||66
7793246|NCT01246349|19184640|P2|NOT COMPLETED|Overall Study||0
7793247|NCT01246349|19184641|P1|NOT COMPLETED|Overall Study||0
7793248|NCT01246349|19184640|P2|COMPLETED|Overall Study||20
7793249|NCT01246349|19184641|P1|COMPLETED|Overall Study||20
7793250|NCT01246349|19184640|P2|STARTED|Overall Study||20
7793251|NCT01246349|19184641|P1|STARTED|Overall Study||20
7793252|NCT01246258|19184653|P1|NOT COMPLETED|Overall Study||0
7793253|NCT01246258|19184653|P1|COMPLETED|Overall Study||5
7793254|NCT01246258|19184653|P1|STARTED|Overall Study||5
7793255|NCT01246206|19184658|P1|NOT COMPLETED|Overall Study||1
7793256|NCT01246206|19184658|P1|COMPLETED|Overall Study||20
7793257|NCT01246206|19184658|P1|STARTED|Overall Study||21
7793258|NCT01246076|19184669|P1|NOT COMPLETED|Overall Study||0
7793259|NCT01246076|19184669|P1|COMPLETED|Overall Study||24
7793260|NCT01246076|19184669|P1|STARTED|Overall Study||24
7793261|NCT01246063|19184684|P6|NOT COMPLETED|Overall Study||0
7793262|NCT01246063|19184685|P5|NOT COMPLETED|Overall Study||0
7793263|NCT01246063|19184686|P4|NOT COMPLETED|Overall Study||0
7793264|NCT01246063|19184687|P3|NOT COMPLETED|Overall Study||0
7793265|NCT01246063|19184688|P2|NOT COMPLETED|Overall Study||0
7793266|NCT01246063|19184689|P1|NOT COMPLETED|Overall Study||0
7793267|NCT01246063|19184684|P6|COMPLETED|Overall Study||17
7793268|NCT01246063|19184685|P5|COMPLETED|Overall Study||7
7793269|NCT01246063|19184686|P4|COMPLETED|Overall Study||5
7793270|NCT01246063|19184687|P3|COMPLETED|Overall Study||4
7793271|NCT01246063|19184688|P2|COMPLETED|Overall Study||4
7793272|NCT01246063|19184689|P1|COMPLETED|Overall Study||3
7793273|NCT01246063|19184684|P6|STARTED|Overall Study||17
7793274|NCT01246063|19184685|P5|STARTED|Overall Study||7
7793275|NCT01246063|19184686|P4|STARTED|Overall Study||5
7793276|NCT01246063|19184687|P3|STARTED|Overall Study||4
7793277|NCT01246063|19184688|P2|STARTED|Overall Study||4
7793278|NCT01246063|19184689|P1|STARTED|Overall Study||3
7793279|NCT01246050|19184726|P2|NOT COMPLETED|Overall Study||0
7793280|NCT01246050|19184727|P1|NOT COMPLETED|Overall Study||0
7793281|NCT01246050|19184726|P2|COMPLETED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
7793282|NCT01246050|19184727|P1|COMPLETED|Overall Study||6
7793283|NCT01246050|19184726|P2|STARTED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
7793284|NCT01246050|19184727|P1|STARTED|Overall Study||6
7793285|NCT01246011|19184736|P3|NOT COMPLETED|Overall Study||4
7793286|NCT01246011|19184737|P2|NOT COMPLETED|Overall Study||0
7793287|NCT01246011|19184738|P1|NOT COMPLETED|Overall Study||0
7793288|NCT01246011|19184736|P3|COMPLETED|Overall Study||5
7793289|NCT01246011|19184737|P2|COMPLETED|Overall Study||0
7793290|NCT01246011|19184738|P1|COMPLETED|Overall Study||0
7793291|NCT01246011|19184736|P3|STARTED|Overall Study||9
7793292|NCT01246011|19184737|P2|STARTED|Overall Study||0
7793293|NCT01246011|19184738|P1|STARTED|Overall Study||0
7793294|NCT01245972|19184752|P3|NOT COMPLETED|Overall Study||0
7793295|NCT01245972|19184753|P2|NOT COMPLETED|Overall Study||0
7793296|NCT01245972|19184754|P1|NOT COMPLETED|Overall Study||0
7793297|NCT01245972|19184752|P3|COMPLETED|Overall Study||8
7793298|NCT01245972|19184753|P2|COMPLETED|Overall Study||8
7793299|NCT01245972|19184754|P1|COMPLETED|Overall Study||7
7793300|NCT01245972|19184752|P3|STARTED|Overall Study||8
7793301|NCT01245972|19184753|P2|STARTED|Overall Study||8
7793302|NCT01245972|19184754|P1|STARTED|Overall Study||7
7793303|NCT01245764|19184766|P4|NOT COMPLETED|Study Phase B||0
7793304|NCT01245764|19184767|P3|NOT COMPLETED|Study Phase B||0
7793305|NCT01245764|19184768|P2|NOT COMPLETED|Study Phase B||0
7793306|NCT01245764|19184769|P1|NOT COMPLETED|Study Phase B||0
7793307|NCT01245764|19184766|P4|COMPLETED|Study Phase B||17
7793308|NCT01245764|19184767|P3|COMPLETED|Study Phase B||0
7793309|NCT01245764|19184768|P2|COMPLETED|Study Phase B||0
7793310|NCT01245764|19184769|P1|COMPLETED|Study Phase B||0
7793311|NCT01245764|19184766|P4|Completed Vaccinations in Study Phase B|Study Phase B||17
7793312|NCT01245764|19184767|P3|Completed Vaccinations in Study Phase B|Study Phase B||0
7793313|NCT01245764|19184768|P2|Completed Vaccinations in Study Phase B|Study Phase B||0
7793314|NCT01245764|19184769|P1|Completed Vaccinations in Study Phase B|Study Phase B||0
7793315|NCT01245764|19184766|P4|STARTED|Study Phase B||17
7793316|NCT01245764|19184767|P3|STARTED|Study Phase B||0
7793317|NCT01245764|19184768|P2|STARTED|Study Phase B||0
7793318|NCT01245764|19184769|P1|STARTED|Study Phase B||0
7793319|NCT01245764|19184766|P4|NOT COMPLETED|Study Phase A||3
7793320|NCT01245764|19184767|P3|NOT COMPLETED|Study Phase A||10
7793321|NCT01245764|19184768|P2|NOT COMPLETED|Study Phase A||5
7793322|NCT01245764|19184769|P1|NOT COMPLETED|Study Phase A||9
7793323|NCT01245764|19184766|P4|COMPLETED|Study Phase A||17
7793324|NCT01245764|19184767|P3|COMPLETED|Study Phase A||110
7793325|NCT01245764|19184768|P2|COMPLETED|Study Phase A||25
7793326|NCT01245764|19184769|P1|COMPLETED|Study Phase A||71
7793327|NCT01245764|19184766|P4|Completed Vaccinations in Study Phase A|Study Phase A||19
7793328|NCT01245764|19184767|P3|Completed Vaccinations in Study Phase A|Study Phase A||117
7793329|NCT01245764|19184768|P2|Completed Vaccinations in Study Phase A|Study Phase A||28
7793330|NCT01245764|19184769|P1|Completed Vaccinations in Study Phase A|Study Phase A||77
7793331|NCT01245764|19184766|P4|STARTED|Study Phase A||20
7793332|NCT01245764|19184767|P3|STARTED|Study Phase A||120
7793333|NCT01245764|19184768|P2|STARTED|Study Phase A||30
7793334|NCT01245764|19184769|P1|STARTED|Study Phase A||80
7793335|NCT01245751|19184807|P4|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
7793336|NCT01245751|19184808|P3|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
7793337|NCT01245751|19184809|P2|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
7793338|NCT01245751|19184810|P1|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
7793339|NCT01245751|19184807|P4|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
7793340|NCT01245751|19184808|P3|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
7793341|NCT01245751|19184809|P2|COMPLETED|Part 2: Week 156 (3 Year) Visit||139
7793342|NCT01245751|19184810|P1|COMPLETED|Part 2: Week 156 (3 Year) Visit||161
7793343|NCT01245751|19184807|P4|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
7793344|NCT01245751|19184808|P3|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
7793345|NCT01245751|19184809|P2|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139
7793346|NCT01245751|19184810|P1|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161
7793347|NCT01245751|19184807|P4|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
7793348|NCT01245751|19184808|P3|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0
7793349|NCT01245751|19184809|P2|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5
7793350|NCT01245751|19184810|P1|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
7793351|NCT01245751|19184807|P4|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98
7793352|NCT01245751|19184808|P3|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100
7793353|NCT01245751|19184809|P2|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194
7793354|NCT01245751|19184810|P1|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199
7793355|NCT01245751|19184807|P4|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
7793356|NCT01245751|19184808|P3|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
7793357|NCT01245751|19184809|P2|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199
7793358|NCT01245751|19184810|P1|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201
7793359|NCT01245751|19184807|P4|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
7793360|NCT01245751|19184808|P3|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
7793361|NCT01245751|19184809|P2|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199
7793362|NCT01245751|19184810|P1|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201
7793363|NCT01245738|19184823|P1|NOT COMPLETED|Overall Study||40
7793364|NCT01245738|19184823|P1|COMPLETED|Overall Study||474
7793365|NCT01245738|19184823|P1|STARTED|Overall Study||514
7793366|NCT01245699|19184842|P2|NOT COMPLETED|Overall Study||5
7793367|NCT01245699|19184843|P1|NOT COMPLETED|Overall Study||9
7793368|NCT01245699|19184842|P2|COMPLETED|Overall Study||49
7793369|NCT01245699|19184843|P1|COMPLETED|Overall Study||52
7793370|NCT01245699|19184842|P2|STARTED|Overall Study||54
7793371|NCT01245699|19184843|P1|STARTED|Overall Study||61
7793372|NCT01245673|19184859|P1|NOT COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||0
7793373|NCT01245673|19184859|P1|COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||26
7793374|NCT01245673|19184859|P1|STARTED|Maintenance: MAGE-A3, PVC After T Cells||26
7793375|NCT01245673|19184859|P1|NOT COMPLETED|Start Lenalidomide||0
7793376|NCT01245673|19184859|P1|COMPLETED|Start Lenalidomide||26
7793377|NCT01245673|19184859|P1|STARTED|Start Lenalidomide||26
7793378|NCT01245673|19184859|P1|NOT COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||1
7793379|NCT01245673|19184859|P1|COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||26
7793380|NCT01245673|19184859|P1|STARTED|MAGE-A3, Hiltonol®, PVC After T Cells||27
7793381|NCT01245673|19184859|P1|NOT COMPLETED|Activated/Costimulated Autologous T Cell||0
7793382|NCT01245673|19184859|P1|COMPLETED|Activated/Costimulated Autologous T Cell||27
7793383|NCT01245673|19184859|P1|STARTED|Activated/Costimulated Autologous T Cell||27
7793384|NCT01245673|19184859|P1|NOT COMPLETED|Pre Transplant Vaccinations||0
7793385|NCT01245673|19184859|P1|COMPLETED|Pre Transplant Vaccinations||27
7793386|NCT01245673|19184859|P1|Pre Transplant Vaccinations 1-3|Pre Transplant Vaccinations||27
7793387|NCT01245673|19184859|P1|STARTED|Pre Transplant Vaccinations||27
7793388|NCT01245673|19184859|P1|NOT COMPLETED|Enrollment||1
7793389|NCT01245673|19184859|P1|COMPLETED|Enrollment|One subject failed to meet screening criteria for the trial.|27
7793390|NCT01245673|19184859|P1|STARTED|Enrollment||28
7793391|NCT01245647|19184865|P2|NOT COMPLETED|Overall Study||4
7793392|NCT01245647|19184866|P1|NOT COMPLETED|Overall Study||0
7793393|NCT01245647|19184865|P2|COMPLETED|Overall Study||8
7793394|NCT01245647|19184866|P1|COMPLETED|Overall Study||7
7793395|NCT01245647|19184865|P2|STARTED|Overall Study||12
7793396|NCT01245647|19184866|P1|STARTED|Overall Study||7
7793397|NCT01245595|19184882|P2|NOT COMPLETED|Overall Study||0
7793398|NCT01245595|19184883|P1|NOT COMPLETED|Overall Study||0
7793399|NCT01245595|19184882|P2|COMPLETED|Overall Study||72
7793400|NCT01245595|19184883|P1|COMPLETED|Overall Study||72
7793401|NCT01245595|19184882|P2|Completed Full Course of Study Drug|Overall Study||61
7793402|NCT01245595|19184883|P1|Completed Full Course of Study Drug|Overall Study||57
7793403|NCT01245595|19184882|P2|STARTED|Overall Study||72
7793404|NCT01245595|19184883|P1|STARTED|Overall Study||72
7793405|NCT01245439|19184889|P1|NOT COMPLETED|Overall Study||0
7793406|NCT01245439|19184889|P1|COMPLETED|Overall Study||65
7793407|NCT01245439|19184889|P1|STARTED|Overall Study||65
7793408|NCT01245413|19184920|P2|NOT COMPLETED|Athena First,||0
7793409|NCT01245413|19184921|P1|NOT COMPLETED|Athena First,||0
7793410|NCT01245413|19184920|P2|COMPLETED|Athena First,||16
7793411|NCT01245413|19184921|P1|COMPLETED|Athena First,||16
7793412|NCT01245413|19184920|P2|STARTED|Athena First,||16
7793413|NCT01245413|19184921|P1|STARTED|Athena First,||16
7793414|NCT01245413|19184920|P2|NOT COMPLETED|Sensura First,||0
7793415|NCT01245413|19184921|P1|NOT COMPLETED|Sensura First,||0
7793416|NCT01245413|19184920|P2|COMPLETED|Sensura First,||16
7793417|NCT01245413|19184921|P1|COMPLETED|Sensura First,||16
7793418|NCT01245413|19184920|P2|STARTED|Sensura First,||16
7793419|NCT01245413|19184921|P1|STARTED|Sensura First,||16
7793420|NCT01245387|19184927|P1|NOT COMPLETED|Overall Study||813
7793421|NCT01245387|19184927|P1|COMPLETED|Overall Study||188
7793422|NCT01245387|19184927|P1|STARTED|Overall Study||1001
7793423|NCT01245374|19184976|P1|NOT COMPLETED|Overall Study||4
7793424|NCT01245374|19184976|P1|COMPLETED|Overall Study||99
7793425|NCT01245374|19184976|P1|STARTED|Overall Study||103
7793426|NCT01245283|19184999|P3|NOT COMPLETED|Overall Study||11
7793427|NCT01245283|19185000|P2|NOT COMPLETED|Overall Study||11
7793428|NCT01245283|19185001|P1|NOT COMPLETED|Overall Study||14
7793429|NCT01245283|19184999|P3|COMPLETED|Overall Study||19
7793430|NCT01245283|19185000|P2|COMPLETED|Overall Study||17
7793431|NCT01245283|19185001|P1|COMPLETED|Overall Study||18
7793432|NCT01245283|19184999|P3|STARTED|Overall Study||30
7793433|NCT01245283|19185000|P2|STARTED|Overall Study||28
7793434|NCT01245283|19185001|P1|STARTED|Overall Study||32
7793435|NCT01245270|19185035|P2|NOT COMPLETED|Overall Study||0
7793436|NCT01245270|19185036|P1|NOT COMPLETED|Overall Study||0
7793437|NCT01245270|19185035|P2|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
7793438|NCT01245270|19185036|P1|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
7793439|NCT01245270|19185035|P2|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
7793440|NCT01245270|19185036|P1|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
7793441|NCT01245140|19185046|P2|NOT COMPLETED|Overall Study||10
7793442|NCT01245140|19185047|P1|NOT COMPLETED|Overall Study||3
7793443|NCT01245140|19185046|P2|COMPLETED|Overall Study||14
7793444|NCT01245140|19185047|P1|COMPLETED|Overall Study||6
7793445|NCT01245140|19185046|P2|STARTED|Overall Study||24
7793446|NCT01245140|19185047|P1|STARTED|Overall Study||9
7793447|NCT01245101|19185103|P2|NOT COMPLETED|Period 3 (Treatment)||0
7793448|NCT01245101|19185104|P1|NOT COMPLETED|Period 3 (Treatment)||1
7793449|NCT01245101|19185103|P2|COMPLETED|Period 3 (Treatment)||0
7793450|NCT01245101|19185104|P1|COMPLETED|Period 3 (Treatment)||11
7793451|NCT01245101|19185103|P2|STARTED|Period 3 (Treatment)||0
7793452|NCT01245101|19185104|P1|STARTED|Period 3 (Treatment)||12
7793453|NCT01245101|19185103|P2|NOT COMPLETED|Period 2 (Washout)||0
7793454|NCT01245101|19185104|P1|NOT COMPLETED|Period 2 (Washout)||1
7793455|NCT01245101|19185103|P2|COMPLETED|Period 2 (Washout)||0
7793456|NCT01245101|19185104|P1|COMPLETED|Period 2 (Washout)||12
7793457|NCT01245101|19185103|P2|STARTED|Period 2 (Washout)||0
7793458|NCT01245101|19185104|P1|STARTED|Period 2 (Washout)||13
7793459|NCT01245101|19185103|P2|NOT COMPLETED|Period 1 (Treatment)||0
7793460|NCT01245101|19185104|P1|NOT COMPLETED|Period 1 (Treatment)||2
7793461|NCT01245101|19185103|P2|COMPLETED|Period 1 (Treatment)||0
7793462|NCT01245101|19185104|P1|COMPLETED|Period 1 (Treatment)||13
7793463|NCT01245101|19185103|P2|STARTED|Period 1 (Treatment)||0
7793464|NCT01245101|19185104|P1|STARTED|Period 1 (Treatment)||15
7793465|NCT01245062|19185114|P3|NOT COMPLETED|Cross-over Phase||17
7793466|NCT01245062|19185115|P2|NOT COMPLETED|Cross-over Phase||0
7793467|NCT01245062|19185116|P1|NOT COMPLETED|Cross-over Phase||0
7793468|NCT01245062|19185114|P3|COMPLETED|Cross-over Phase||53
7793469|NCT01245062|19185115|P2|COMPLETED|Cross-over Phase||0
7793470|NCT01245062|19185116|P1|COMPLETED|Cross-over Phase||0
7793471|NCT01245062|19185114|P3|STARTED|Cross-over Phase|As of the data cut on December 16, 2016, 70 of 108 participants crossed over from CT to trametinib.|70
7793472|NCT01245062|19185115|P2|STARTED|Cross-over Phase||0
7793473|NCT01245062|19185116|P1|STARTED|Cross-over Phase||0
7793474|NCT01245062|19185114|P3|NOT COMPLETED|Randomization and Crossover Phase||0
7793475|NCT01245062|19185115|P2|NOT COMPLETED|Randomization and Crossover Phase||31
7793476|NCT01245062|19185116|P1|NOT COMPLETED|Randomization and Crossover Phase||41
7793477|NCT01245062|19185114|P3|COMPLETED|Randomization and Crossover Phase||0
7793478|NCT01245062|19185115|P2|COMPLETED|Randomization and Crossover Phase||77
7793479|NCT01245062|19185116|P1|COMPLETED|Randomization and Crossover Phase||173
7793480|NCT01245062|19185114|P3|STARTED|Randomization and Crossover Phase||0
7793481|NCT01245062|19185115|P2|STARTED|Randomization and Crossover Phase||108
7793482|NCT01245062|19185116|P1|STARTED|Randomization and Crossover Phase||214
7793483|NCT01245049|19185154|P2|NOT COMPLETED|Overall Study||4
7793484|NCT01245049|19185155|P1|NOT COMPLETED|Overall Study||1
7793485|NCT01245049|19185154|P2|COMPLETED|Overall Study||126
7793486|NCT01245049|19185155|P1|COMPLETED|Overall Study||254
7793487|NCT01245049|19185154|P2|STARTED|Overall Study||130
7793488|NCT01245049|19185155|P1|STARTED|Overall Study||255
7793489|NCT01244984|19185208|P3|NOT COMPLETED|Overall Study||4
7793490|NCT01244984|19185209|P2|NOT COMPLETED|Overall Study||14
7793491|NCT01244984|19185210|P1|NOT COMPLETED|Overall Study||5
7793492|NCT01244984|19185208|P3|COMPLETED|Overall Study||86
7793493|NCT01244984|19185209|P2|COMPLETED|Overall Study||79
7793494|NCT01244984|19185210|P1|COMPLETED|Overall Study||55
7793495|NCT01244984|19185208|P3|STARTED|Overall Study||90
7793496|NCT01244984|19185209|P2|STARTED|Overall Study||93
7793497|NCT01244984|19185210|P1|STARTED|Overall Study||60
7793498|NCT01244906|19185284|P1|NOT COMPLETED|Overall Study||8
7793499|NCT01244906|19185284|P1|COMPLETED|Overall Study||18
7793500|NCT01244906|19185284|P1|STARTED|Overall Study||26
7793501|NCT01244893|19185293|P2|NOT COMPLETED|Final Visit||0
7793502|NCT01244893|19185294|P1|NOT COMPLETED|Final Visit||0
7793503|NCT01244893|19185293|P2|COMPLETED|Final Visit||21
7793504|NCT01244893|19185294|P1|COMPLETED|Final Visit||21
7793505|NCT01244893|19185293|P2|STARTED|Final Visit||21
7793506|NCT01244893|19185294|P1|STARTED|Final Visit||21
7793507|NCT01244893|19185293|P2|NOT COMPLETED|1-Week Follow Up||0
7793508|NCT01244893|19185294|P1|NOT COMPLETED|1-Week Follow Up||1
7793509|NCT01244893|19185293|P2|COMPLETED|1-Week Follow Up||21
7793510|NCT01244893|19185294|P1|COMPLETED|1-Week Follow Up||21
7793511|NCT01244893|19185293|P2|STARTED|1-Week Follow Up||21
7793512|NCT01244893|19185294|P1|STARTED|1-Week Follow Up||22
7793513|NCT01244893|19185293|P2|NOT COMPLETED|Baseline||1
7793514|NCT01244893|19185294|P1|NOT COMPLETED|Baseline||0
7793515|NCT01244893|19185293|P2|COMPLETED|Baseline||21
7793516|NCT01244893|19185294|P1|COMPLETED|Baseline||22
7793517|NCT01244893|19185293|P2|STARTED|Baseline||22
7793518|NCT01244893|19185294|P1|STARTED|Baseline||22
7793519|NCT01244828|19185306|P1|NOT COMPLETED|Overall Study||78
7793520|NCT01244828|19185306|P1|COMPLETED|Overall Study||79
7793521|NCT01244828|19185306|P1|STARTED|Overall Study|Received study drug|157
7793522|NCT01244815|19185322|P4|NOT COMPLETED|Overall Study||12
7793523|NCT01244815|19185323|P3|NOT COMPLETED|Overall Study||11
7793524|NCT01244815|19185324|P2|NOT COMPLETED|Overall Study||17
7793525|NCT01244815|19185325|P1|NOT COMPLETED|Overall Study||14
7793526|NCT01244815|19185322|P4|COMPLETED|Overall Study||87
7793527|NCT01244815|19185323|P3|COMPLETED|Overall Study||88
7793528|NCT01244815|19185324|P2|COMPLETED|Overall Study||88
7793529|NCT01244815|19185325|P1|COMPLETED|Overall Study||87
7793530|NCT01244815|19185322|P4|Treated|Overall Study||99
7793531|NCT01244815|19185323|P3|Treated|Overall Study||99
7793532|NCT01244815|19185324|P2|Treated|Overall Study||104
7793533|NCT01244815|19185325|P1|Treated|Overall Study||101
7793534|NCT01244815|19185322|P4|STARTED|Overall Study|Randomized|99
7793535|NCT01244815|19185323|P3|STARTED|Overall Study|Randomized|99
7793536|NCT01244815|19185324|P2|STARTED|Overall Study|Randomized|105
7793537|NCT01244815|19185325|P1|STARTED|Overall Study|Randomized|101
7793538|NCT01244724|19185399|P1|NOT COMPLETED|Overall Study||8
7793539|NCT01244724|19185399|P1|COMPLETED|Overall Study||9
7793540|NCT01244724|19185399|P1|Week 2 Visit|Overall Study||15
7793541|NCT01244724|19185399|P1|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17
7793542|NCT01244711|19185404|P1|NOT COMPLETED|Overall Study||0
7793543|NCT01244711|19185404|P1|COMPLETED|Overall Study||1
7793544|NCT01244711|19185404|P1|STARTED|Overall Study||1
7793545|NCT01244633|19185408|P1|NOT COMPLETED|Overall Study||3
7793546|NCT01244633|19185408|P1|COMPLETED|Overall Study||15
7793547|NCT01244633|19185408|P1|STARTED|Overall Study||18
7793548|NCT01244620|19185412|P4|NOT COMPLETED|Overall Study||4
7793549|NCT01244620|19185413|P3|NOT COMPLETED|Overall Study||4
7793550|NCT01244620|19185414|P2|NOT COMPLETED|Overall Study||4
7793551|NCT01244620|19185415|P1|NOT COMPLETED|Overall Study||4
7793552|NCT01244620|19185412|P4|COMPLETED|Overall Study||0
7793553|NCT01244620|19185413|P3|COMPLETED|Overall Study||0
7793554|NCT01244620|19185414|P2|COMPLETED|Overall Study||0
7793555|NCT01244620|19185415|P1|COMPLETED|Overall Study||0
7793556|NCT01244620|19185412|P4|STARTED|Overall Study||4
7793557|NCT01244620|19185413|P3|STARTED|Overall Study||4
7793558|NCT01244620|19185414|P2|STARTED|Overall Study||4
7793559|NCT01244620|19185415|P1|STARTED|Overall Study||4
7793560|NCT01244529|19185449|P1|NOT COMPLETED|Overall Study||0
7793561|NCT01244529|19185449|P1|COMPLETED|Overall Study||41
7793562|NCT01244529|19185449|P1|STARTED|Overall Study||41
7793563|NCT01244516|19185474|P3|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2
7793564|NCT01244516|19185475|P2|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1
7793565|NCT01244516|19185476|P1|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3
7793566|NCT01244516|19185474|P3|COMPLETED|Period 2 (1-week to 2-week Visit)||168
7793567|NCT01244516|19185475|P2|COMPLETED|Period 2 (1-week to 2-week Visit)||170
7793568|NCT01244516|19185476|P1|COMPLETED|Period 2 (1-week to 2-week Visit)||163
7793569|NCT01244516|19185474|P3|STARTED|Period 2 (1-week to 2-week Visit)||170
7793570|NCT01244516|19185475|P2|STARTED|Period 2 (1-week to 2-week Visit)||171
7793571|NCT01244516|19185476|P1|STARTED|Period 2 (1-week to 2-week Visit)||166
7793572|NCT01244516|19185474|P3|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3
7793573|NCT01244516|19185475|P2|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6
7793574|NCT01244516|19185476|P1|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4
7793575|NCT01244516|19185474|P3|COMPLETED|Period 1 (Baseline to 1-week Visit)||170
7793576|NCT01244516|19185475|P2|COMPLETED|Period 1 (Baseline to 1-week Visit)||171
7793577|NCT01244516|19185476|P1|COMPLETED|Period 1 (Baseline to 1-week Visit)||166
7793578|NCT01244516|19185474|P3|STARTED|Period 1 (Baseline to 1-week Visit)||173
7793579|NCT01244516|19185475|P2|STARTED|Period 1 (Baseline to 1-week Visit)||177
7793580|NCT01244516|19185476|P1|STARTED|Period 1 (Baseline to 1-week Visit)||170
7793581|NCT01244503|19185489|P1|NOT COMPLETED|Overall Study||0
7793582|NCT01244503|19185489|P1|COMPLETED|Overall Study||61
7793583|NCT01244503|19185489|P1|STARTED|Overall Study||61
7793584|NCT01244490|19185497|P3|NOT COMPLETED|Overall Study||23
7793585|NCT01244490|19185498|P2|NOT COMPLETED|Overall Study||24
7793586|NCT01244490|19185499|P1|NOT COMPLETED|Overall Study||19
7793587|NCT01244490|19185497|P3|COMPLETED|Overall Study||89
7793588|NCT01244490|19185498|P2|COMPLETED|Overall Study||91
7793589|NCT01244490|19185499|P1|COMPLETED|Overall Study||92
7793590|NCT01244490|19185497|P3|STARTED|Overall Study||112
7793591|NCT01244490|19185498|P2|STARTED|Overall Study||115
7793592|NCT01244490|19185499|P1|STARTED|Overall Study||111
7793593|NCT01244477|19185554|P2|NOT COMPLETED|Overall Study||3
7793594|NCT01244477|19185555|P1|NOT COMPLETED|Overall Study||20
7793595|NCT01244477|19185554|P2|COMPLETED|Overall Study||20
7793596|NCT01244477|19185555|P1|COMPLETED|Overall Study||18
7793597|NCT01244477|19185554|P2|STARTED|Overall Study||23
7793598|NCT01244477|19185555|P1|STARTED|Overall Study||38
7793599|NCT01244451|19185567|P1|NOT COMPLETED|Overall Study||13
7793600|NCT01244451|19185567|P1|COMPLETED|Overall Study||36
7793601|NCT01244451|19185567|P1|STARTED|Overall Study||49
7793602|NCT01244425|19185576|P2|NOT COMPLETED|Overall Study||3
7793603|NCT01244425|19185577|P1|NOT COMPLETED|Overall Study||3
7793604|NCT01244425|19185576|P2|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32
7793605|NCT01244425|19185577|P1|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32
7793606|NCT01244425|19185576|P2|STARTED|Overall Study||35
7793607|NCT01244425|19185577|P1|STARTED|Overall Study||35
7793608|NCT01244412|19185597|P1|NOT COMPLETED|Overall Study||0
7793609|NCT01244412|19185597|P1|COMPLETED|Overall Study||1
7793610|NCT01244412|19185597|P1|STARTED|Overall Study||1
7793611|NCT01244243|19185601|P1|NOT COMPLETED|Overall Study||0
7793612|NCT01244243|19185601|P1|COMPLETED|Overall Study||41
7793613|NCT01244243|19185601|P1|STARTED|Overall Study||41
7793614|NCT01244191|19185608|P2|NOT COMPLETED|Overall Study||498
7793615|NCT01244191|19185609|P1|NOT COMPLETED|Overall Study||480
7793616|NCT01244191|19185608|P2|COMPLETED|Overall Study||24
7793617|NCT01244191|19185609|P1|COMPLETED|Overall Study||46
7793618|NCT01244191|19185608|P2|Did Not Receive Treatment|Overall Study||5
7793619|NCT01244191|19185609|P1|Did Not Receive Treatment|Overall Study||6
7793620|NCT01244191|19185608|P2|STARTED|Overall Study||522
7793621|NCT01244191|19185609|P1|STARTED|Overall Study||526
7793622|NCT01244126|19185632|P3|NOT COMPLETED|Overall Study||9
7793623|NCT01244126|19185633|P2|NOT COMPLETED|Overall Study||3
7793624|NCT01244126|19185634|P1|NOT COMPLETED|Overall Study||3
7793625|NCT01244126|19185632|P3|COMPLETED|Overall Study||48
7793626|NCT01244126|19185633|P2|COMPLETED|Overall Study||52
7793627|NCT01244126|19185634|P1|COMPLETED|Overall Study||56
7793628|NCT01244126|19185632|P3|STARTED|Overall Study||57
7793629|NCT01244126|19185633|P2|STARTED|Overall Study||55
7793630|NCT01244126|19185634|P1|STARTED|Overall Study||59
7793631|NCT01244061|19185647|P2|NOT COMPLETED|Overall Study||103
7793632|NCT01244061|19185648|P1|NOT COMPLETED|Overall Study||82
7793633|NCT01244061|19185647|P2|COMPLETED|Overall Study||144
7793634|NCT01244061|19185648|P1|COMPLETED|Overall Study||169
7793635|NCT01244061|19185647|P2|STARTED|Overall Study||247
7793636|NCT01244061|19185648|P1|STARTED|Overall Study||251
7793637|NCT01244035|19185660|P6|NOT COMPLETED|Part 1: Period 3||1
7793638|NCT01244035|19185661|P5|NOT COMPLETED|Part 1: Period 3||1
7793639|NCT01244035|19185662|P4|NOT COMPLETED|Part 1: Period 3||0
7793640|NCT01244035|19185663|P3|NOT COMPLETED|Part 1: Period 3||0
7793641|NCT01244035|19185664|P2|NOT COMPLETED|Part 1: Period 3||1
7793642|NCT01244035|19185665|P1|NOT COMPLETED|Part 1: Period 3||0
7793643|NCT01244035|19185660|P6|COMPLETED|Part 1: Period 3||2
7793644|NCT01244035|19185661|P5|COMPLETED|Part 1: Period 3||3
7793645|NCT01244035|19185662|P4|COMPLETED|Part 1: Period 3||5
7793646|NCT01244035|19185663|P3|COMPLETED|Part 1: Period 3||3
7793647|NCT01244035|19185664|P2|COMPLETED|Part 1: Period 3||2
7793648|NCT01244035|19185665|P1|COMPLETED|Part 1: Period 3||4
7793649|NCT01244035|19185660|P6|STARTED|Part 1: Period 3||3
7793650|NCT01244035|19185661|P5|STARTED|Part 1: Period 3||4
7793651|NCT01244035|19185662|P4|STARTED|Part 1: Period 3||5
7793652|NCT01244035|19185663|P3|STARTED|Part 1: Period 3||3
7793653|NCT01244035|19185664|P2|STARTED|Part 1: Period 3||3
7793654|NCT01244035|19185665|P1|STARTED|Part 1: Period 3||4
7793655|NCT01244035|19185660|P6|NOT COMPLETED|Part 1: Period 2||0
7793656|NCT01244035|19185661|P5|NOT COMPLETED|Part 1: Period 2||0
7793657|NCT01244035|19185662|P4|NOT COMPLETED|Part 1: Period 2||0
7793658|NCT01244035|19185663|P3|NOT COMPLETED|Part 1: Period 2||1
7793659|NCT01244035|19185664|P2|NOT COMPLETED|Part 1: Period 2||0
7793660|NCT01244035|19185665|P1|NOT COMPLETED|Part 1: Period 2||0
7793661|NCT01244035|19185660|P6|COMPLETED|Part 1: Period 2||3
7793662|NCT01244035|19185661|P5|COMPLETED|Part 1: Period 2||4
7793663|NCT01244035|19185662|P4|COMPLETED|Part 1: Period 2||5
7793664|NCT01244035|19185663|P3|COMPLETED|Part 1: Period 2||3
7793665|NCT01244035|19185664|P2|COMPLETED|Part 1: Period 2||3
7793666|NCT01244035|19185665|P1|COMPLETED|Part 1: Period 2||4
7793667|NCT01244035|19185660|P6|STARTED|Part 1: Period 2||3
7793668|NCT01244035|19185661|P5|STARTED|Part 1: Period 2||4
7793669|NCT01244035|19185662|P4|STARTED|Part 1: Period 2||5
7793670|NCT01244035|19185663|P3|STARTED|Part 1: Period 2||4
7793671|NCT01244035|19185664|P2|STARTED|Part 1: Period 2||3
7793672|NCT01244035|19185665|P1|STARTED|Part 1: Period 2||4
7793673|NCT01244035|19185660|P6|NOT COMPLETED|Part 1: Period 1||2
7793674|NCT01244035|19185661|P5|NOT COMPLETED|Part 1: Period 1||1
7793675|NCT01244035|19185662|P4|NOT COMPLETED|Part 1: Period 1||0
7793676|NCT01244035|19185663|P3|NOT COMPLETED|Part 1: Period 1||2
7793677|NCT01244035|19185664|P2|NOT COMPLETED|Part 1: Period 1||2
7793678|NCT01244035|19185665|P1|NOT COMPLETED|Part 1: Period 1||1
7793679|NCT01244035|19185660|P6|COMPLETED|Part 1: Period 1||3
7793680|NCT01244035|19185661|P5|COMPLETED|Part 1: Period 1||4
7793681|NCT01244035|19185662|P4|COMPLETED|Part 1: Period 1||5
7793682|NCT01244035|19185663|P3|COMPLETED|Part 1: Period 1||4
7793683|NCT01244035|19185664|P2|COMPLETED|Part 1: Period 1||3
7793684|NCT01244035|19185665|P1|COMPLETED|Part 1: Period 1||4
7793685|NCT01244035|19185660|P6|STARTED|Part 1: Period 1||5
7793686|NCT01244035|19185661|P5|STARTED|Part 1: Period 1||5
7793687|NCT01244035|19185662|P4|STARTED|Part 1: Period 1||5
7793688|NCT01244035|19185663|P3|STARTED|Part 1: Period 1||6
7793689|NCT01244035|19185664|P2|STARTED|Part 1: Period 1||5
7793690|NCT01244035|19185665|P1|STARTED|Part 1: Period 1||5
7793691|NCT01243957|19185693|P1|NOT COMPLETED|Overall Study||0
7793692|NCT01243957|19185693|P1|COMPLETED|Overall Study||20
7793693|NCT01243957|19185693|P1|STARTED|Overall Study||20
7793694|NCT01243944|19185706|P2|NOT COMPLETED|Overall Study||51
7793695|NCT01243944|19185707|P1|NOT COMPLETED|Overall Study||45
7793696|NCT01243944|19185706|P2|COMPLETED|Overall Study|Study evaluation completion is reported for participants that were treated & those never treatment.|61
7793697|NCT01243944|19185707|P1|COMPLETED|Overall Study||65
7793698|NCT01243944|19185706|P2|Followed for Survival|Overall Study||21
7793699|NCT01243944|19185707|P1|Followed for Survival|Overall Study||22
7793700|NCT01243944|19185706|P2|Treated|Overall Study||111
7793701|NCT01243944|19185707|P1|Treated|Overall Study||110
7793702|NCT01243944|19185706|P2|STARTED|Overall Study|One participant withdrew consent 5 days after randomization to BAT & wasn't treated while on study.|112
7793703|NCT01243944|19185707|P1|STARTED|Overall Study||110
7793704|NCT01243892|19185735|P2|NOT COMPLETED|Overall Study||0
7793705|NCT01243892|19185736|P1|NOT COMPLETED|Overall Study||2
7793706|NCT01243892|19185735|P2|COMPLETED|Overall Study||3
7793707|NCT01243892|19185736|P1|COMPLETED|Overall Study||13
7793708|NCT01243892|19185735|P2|STARTED|Overall Study||3
7793709|NCT01243892|19185736|P1|STARTED|Overall Study||15
7793710|NCT01243775|19185746|P1|NOT COMPLETED|Overall Study||2
7793711|NCT01243775|19185746|P1|COMPLETED|Overall Study||31
7793712|NCT01243775|19185746|P1|STARTED|Overall Study||33
7793713|NCT01243762|19185760|P7|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||6
7793714|NCT01243762|19185761|P6|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
7793715|NCT01243762|19185762|P5|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||4
7793716|NCT01243762|19185763|P4|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||2
7793717|NCT01243762|19185764|P3|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
7793718|NCT01243762|19185765|P2|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||5
7793719|NCT01243762|19185766|P1|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||1
7793720|NCT01243762|19185760|P7|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
7793721|NCT01243762|19185761|P6|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
7793722|NCT01243762|19185762|P5|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
7793723|NCT01243762|19185763|P4|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
7793724|NCT01243762|19185764|P3|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
7793725|NCT01243762|19185765|P2|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
7793726|NCT01243762|19185766|P1|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
7793727|NCT01243762|19185760|P7|STARTED|Part 2 (Dose Confirmation/Efficacy)|New participants were enrolled in Part 2 of the study that did not participate in Part 1|6
7793728|NCT01243762|19185761|P6|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
7793729|NCT01243762|19185762|P5|STARTED|Part 2 (Dose Confirmation/Efficacy)||4
7793730|NCT01243762|19185763|P4|STARTED|Part 2 (Dose Confirmation/Efficacy)||2
7793731|NCT01243762|19185764|P3|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
7793732|NCT01243762|19185765|P2|STARTED|Part 2 (Dose Confirmation/Efficacy)||5
7793733|NCT01243762|19185766|P1|STARTED|Part 2 (Dose Confirmation/Efficacy)||1
7793734|NCT01243762|19185760|P7|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||0
7793735|NCT01243762|19185761|P6|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
7793736|NCT01243762|19185762|P5|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
7793737|NCT01243762|19185763|P4|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
7793738|NCT01243762|19185764|P3|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
7793739|NCT01243762|19185765|P2|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||8
7793740|NCT01243762|19185766|P1|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
7793741|NCT01243762|19185760|P7|COMPLETED|Part 1 (Dose Escalation/MTD)||0
7793742|NCT01243762|19185761|P6|COMPLETED|Part 1 (Dose Escalation/MTD)||0
7793743|NCT01243762|19185762|P5|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|4
7793744|NCT01243762|19185763|P4|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|2
7793745|NCT01243762|19185764|P3|COMPLETED|Part 1 (Dose Escalation/MTD)||0
7793746|NCT01243762|19185765|P2|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|5
7793747|NCT01243762|19185766|P1|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|1
7793748|NCT01243762|19185760|P7|STARTED|Part 1 (Dose Escalation/MTD)||0
7793749|NCT01243762|19185761|P6|STARTED|Part 1 (Dose Escalation/MTD)||3
7793750|NCT01243762|19185762|P5|STARTED|Part 1 (Dose Escalation/MTD)||10
7793751|NCT01243762|19185763|P4|STARTED|Part 1 (Dose Escalation/MTD)||8
7793752|NCT01243762|19185764|P3|STARTED|Part 1 (Dose Escalation/MTD)||3
7793753|NCT01243762|19185765|P2|STARTED|Part 1 (Dose Escalation/MTD)||13
7793754|NCT01243762|19185766|P1|STARTED|Part 1 (Dose Escalation/MTD)||4
7793755|NCT01243671|19185785|P1|NOT COMPLETED|Overall Study||5
7793756|NCT01243671|19185785|P1|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15
7793757|NCT01243671|19185785|P1|Completed 52 Weeks of Treatment|Overall Study||17
7793758|NCT01243671|19185785|P1|Completed 24 Weeks of Treatment|Overall Study||18
7793759|NCT01243671|19185785|P1|STARTED|Overall Study||20
7793760|NCT01243619|19185798|P1|NOT COMPLETED|Overall Study||0
7793761|NCT01243619|19185798|P1|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5
7793762|NCT01243619|19185798|P1|STARTED|Overall Study||5
7793763|NCT01243580|19185804|P2|NOT COMPLETED|Overall Study||2
7793764|NCT01243580|19185805|P1|NOT COMPLETED|Overall Study||0
7793765|NCT01243580|19185804|P2|COMPLETED|Overall Study||16
7793766|NCT01243580|19185805|P1|COMPLETED|Overall Study||18
7793767|NCT01243580|19185804|P2|STARTED|Overall Study||18
7793768|NCT01243580|19185805|P1|STARTED|Overall Study||18
7793769|NCT01243567|19185834|P2|NOT COMPLETED|Overall Study||0
7793770|NCT01243567|19185835|P1|NOT COMPLETED|Overall Study||1
7793771|NCT01243567|19185834|P2|COMPLETED|Overall Study||38
7793772|NCT01243567|19185835|P1|COMPLETED|Overall Study||42
7793773|NCT01243567|19185834|P2|STARTED|Overall Study||38
7793774|NCT01243567|19185835|P1|STARTED|Overall Study||43
7793775|NCT01243450|19185852|P3|NOT COMPLETED|Overall Study||67
7793776|NCT01243450|19185853|P2|NOT COMPLETED|Overall Study||25
7793777|NCT01243450|19185854|P1|NOT COMPLETED|Overall Study||83
7793778|NCT01243450|19185852|P3|COMPLETED|Overall Study||337
7793779|NCT01243450|19185853|P2|COMPLETED|Overall Study||110
7793780|NCT01243450|19185854|P1|COMPLETED|Overall Study||318
7793781|NCT01243450|19185852|P3|STARTED|Overall Study||404
7793782|NCT01243450|19185853|P2|STARTED|Overall Study||135
7793783|NCT01243450|19185854|P1|STARTED|Overall Study||401
7793784|NCT01243424|19185864|P2|NOT COMPLETED|Discontinuation From Treatment||1182
7793785|NCT01243424|19185865|P1|NOT COMPLETED|Discontinuation From Treatment||1132
7793786|NCT01243424|19185864|P2|COMPLETED|Discontinuation From Treatment||1832
7793787|NCT01243424|19185865|P1|COMPLETED|Discontinuation From Treatment||1896
7793788|NCT01243424|19185864|P2|Treated|Discontinuation From Treatment||3010
7793789|NCT01243424|19185865|P1|Treated|Discontinuation From Treatment||3023
7793790|NCT01243424|19185864|P2|STARTED|Discontinuation From Treatment||3014
7793791|NCT01243424|19185865|P1|STARTED|Discontinuation From Treatment||3028
7793792|NCT01243424|19185864|P2|NOT COMPLETED|Discontinuation From Study (Treated Set)||119
7793793|NCT01243424|19185865|P1|NOT COMPLETED|Discontinuation From Study (Treated Set)||129
7793794|NCT01243424|19185864|P2|COMPLETED|Discontinuation From Study (Treated Set)||2895
7793795|NCT01243424|19185865|P1|COMPLETED|Discontinuation From Study (Treated Set)||2899
7793796|NCT01243424|19185864|P2|Treated|Discontinuation From Study (Treated Set)||3010
7793797|NCT01243424|19185865|P1|Treated|Discontinuation From Study (Treated Set)||3023
7793798|NCT01243424|19185864|P2|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||146
7793799|NCT01243424|19185865|P1|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||123
7793800|NCT01243424|19185864|P2|STARTED|Discontinuation From Study (Treated Set)||3014
7793801|NCT01243424|19185865|P1|STARTED|Discontinuation From Study (Treated Set)||3028
7793802|NCT01243411|19185907|P1|NOT COMPLETED|Overall Study||41
7793803|NCT01243411|19185907|P1|COMPLETED|Overall Study||306
7793804|NCT01243411|19185907|P1|STARTED|Overall Study||347
7793805|NCT01243333|19185919|P1|NOT COMPLETED|Overall Study||8
7793806|NCT01243333|19185919|P1|COMPLETED|Overall Study||18
7793807|NCT01243333|19185919|P1|STARTED|Overall Study||26
7793808|NCT01243320|19185925|P1|NOT COMPLETED|32ppm Oral Silver (14 Days)||0
7793809|NCT01243320|19185925|P1|COMPLETED|32ppm Oral Silver (14 Days)||24
7793810|NCT01243320|19185925|P1|STARTED|32ppm Oral Silver (14 Days)||24
7793811|NCT01243320|19185925|P1|NOT COMPLETED|Washout (3 Days)||0
7793812|NCT01243320|19185925|P1|COMPLETED|Washout (3 Days)||36
7793813|NCT01243320|19185925|P1|STARTED|Washout (3 Days)||36
7793814|NCT01243320|19185925|P1|NOT COMPLETED|10ppm Oral Silver (14 Days)||0
7793815|NCT01243320|19185925|P1|COMPLETED|10ppm Oral Silver (14 Days)||36
7793816|NCT01243320|19185925|P1|STARTED|10ppm Oral Silver (14 Days)||36
7793817|NCT01243320|19185925|P1|NOT COMPLETED|10ppm Oral Silver (7 Days)||0
7793818|NCT01243320|19185925|P1|COMPLETED|10ppm Oral Silver (7 Days)||36
7793819|NCT01243320|19185925|P1|STARTED|10ppm Oral Silver (7 Days)||36
7793820|NCT01243320|19185925|P1|NOT COMPLETED|10ppm Oral Silver (3 Days)||0
7793821|NCT01243320|19185925|P1|COMPLETED|10ppm Oral Silver (3 Days)||36
7793822|NCT01243320|19185925|P1|STARTED|10ppm Oral Silver (3 Days)||36
7793823|NCT01243294|19186001|P2|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
7793824|NCT01243294|19186002|P1|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
7793825|NCT01243294|19186001|P2|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26
7793826|NCT01243294|19186002|P1|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28
7793827|NCT01243294|19186001|P2|STARTED|Second Intervention (10 Days +/- 2 Days)||26
7793828|NCT01243294|19186002|P1|STARTED|Second Intervention (10 Days +/- 2 Days)||28
7793829|NCT01243294|19186001|P2|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
7793830|NCT01243294|19186002|P1|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
7793831|NCT01243294|19186001|P2|COMPLETED|First Intervention (10 Days +/- 2 Days)||26
7793832|NCT01243294|19186002|P1|COMPLETED|First Intervention (10 Days +/- 2 Days)||28
7793833|NCT01243294|19186001|P2|STARTED|First Intervention (10 Days +/- 2 Days)||26
7793834|NCT01243294|19186002|P1|STARTED|First Intervention (10 Days +/- 2 Days)||28
7793835|NCT01243268|19186018|P1|NOT COMPLETED|Overall Study||64
7793836|NCT01243268|19186018|P1|COMPLETED|Overall Study||610
7793837|NCT01243268|19186018|P1|STARTED|Overall Study||674
7793838|NCT01243242|19186028|P2|NOT COMPLETED|Overall Study||4
7793839|NCT01243242|19186029|P1|NOT COMPLETED|Overall Study||3
7793840|NCT01243242|19186028|P2|COMPLETED|Overall Study||56
7793841|NCT01243242|19186029|P1|COMPLETED|Overall Study||57
7793842|NCT01243242|19186028|P2|STARTED|Overall Study||60
7793843|NCT01243242|19186029|P1|STARTED|Overall Study||60
7793844|NCT01243177|19186043|P2|NOT COMPLETED|Overall Study||178
7793845|NCT01243177|19186044|P1|NOT COMPLETED|Overall Study||178
7793846|NCT01243177|19186043|P2|COMPLETED|Overall Study||264
7793847|NCT01243177|19186044|P1|COMPLETED|Overall Study||266
7793848|NCT01243177|19186043|P2|STARTED|Overall Study||442
7793849|NCT01243177|19186044|P1|STARTED|Overall Study||444
7793850|NCT01243151|19186065|P5|NOT COMPLETED|Overall Study||0
7793851|NCT01243151|19186066|P4|NOT COMPLETED|Overall Study||2
7793852|NCT01243151|19186067|P3|NOT COMPLETED|Overall Study||1
7793853|NCT01243151|19186068|P2|NOT COMPLETED|Overall Study||1
7793854|NCT01243151|19186069|P1|NOT COMPLETED|Overall Study||0
7793855|NCT01243151|19186065|P5|COMPLETED|Overall Study||14
7793856|NCT01243151|19186066|P4|COMPLETED|Overall Study||12
7793857|NCT01243151|19186067|P3|COMPLETED|Overall Study||13
7793858|NCT01243151|19186068|P2|COMPLETED|Overall Study||13
7793859|NCT01243151|19186069|P1|COMPLETED|Overall Study||12
7793860|NCT01243151|19186065|P5|Treated|Overall Study||14
7793861|NCT01243151|19186066|P4|Treated|Overall Study||13
7793862|NCT01243151|19186067|P3|Treated|Overall Study||14
7793863|NCT01243151|19186068|P2|Treated|Overall Study||14
7793864|NCT01243151|19186069|P1|Treated|Overall Study||12
7793865|NCT01243151|19186065|P5|STARTED|Overall Study||14
7793866|NCT01243151|19186066|P4|STARTED|Overall Study||14
7793867|NCT01243151|19186067|P3|STARTED|Overall Study||14
7793868|NCT01243151|19186068|P2|STARTED|Overall Study||14
7793869|NCT01243151|19186069|P1|STARTED|Overall Study||12
7793870|NCT01243112|19186308|P1|NOT COMPLETED|Overall Study||0
7793871|NCT01243112|19186308|P1|COMPLETED|Overall Study||25
7793872|NCT01243112|19186308|P1|STARTED|Overall Study||25
7793873|NCT01242813|19186313|P1|NOT COMPLETED|Overall Study||2
7793874|NCT01242813|19186313|P1|COMPLETED|Overall Study||18
7793875|NCT01242813|19186313|P1|STARTED|Overall Study||20
7793876|NCT01242748|19186335|P2|NOT COMPLETED|Overall Study||14
7793877|NCT01242748|19186336|P1|NOT COMPLETED|Overall Study||38
7793878|NCT01242748|19186335|P2|COMPLETED|Overall Study||80
7793879|NCT01242748|19186336|P1|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156
7793880|NCT01242748|19186335|P2|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282
7793881|NCT01242748|19186336|P1|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565
7793882|NCT01242748|19186335|P2|CS35/CS35A Safety Analysis Set|Overall Study||283
7793883|NCT01242748|19186336|P1|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565
7793884|NCT01242748|19186335|P2|STARTED|Overall Study||94
7793885|NCT01242748|19186336|P1|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194
7793886|NCT01242644|19186359|P3|NOT COMPLETED|Overall Study||0
7793887|NCT01242644|19186360|P2|NOT COMPLETED|Overall Study||0
7793888|NCT01242644|19186361|P1|NOT COMPLETED|Overall Study||0
7793889|NCT01242644|19186359|P3|COMPLETED|Overall Study||15
7793890|NCT01242644|19186360|P2|COMPLETED|Overall Study||17
7793891|NCT01242644|19186361|P1|COMPLETED|Overall Study||16
7793892|NCT01242644|19186359|P3|STARTED|Overall Study||15
7793893|NCT01242644|19186360|P2|STARTED|Overall Study||17
7793894|NCT01242644|19186361|P1|STARTED|Overall Study||16
7793895|NCT01242527|19186394|P4|NOT COMPLETED|Overall Study||9
7793896|NCT01242527|19186395|P3|NOT COMPLETED|Overall Study||14
7793897|NCT01242527|19186396|P2|NOT COMPLETED|Overall Study||7
7793898|NCT01242527|19186397|P1|NOT COMPLETED|Overall Study||5
7793899|NCT01242527|19186394|P4|COMPLETED|Overall Study||90
7793900|NCT01242527|19186395|P3|COMPLETED|Overall Study||87
7793901|NCT01242527|19186396|P2|COMPLETED|Overall Study||93
7793902|NCT01242527|19186397|P1|COMPLETED|Overall Study||94
7793903|NCT01242527|19186394|P4|STARTED|Overall Study||99
7793904|NCT01242527|19186395|P3|STARTED|Overall Study||101
7793905|NCT01242527|19186396|P2|STARTED|Overall Study||100
7793906|NCT01242527|19186397|P1|STARTED|Overall Study||99
7793907|NCT01242514|19186410|P3|NOT COMPLETED|Overall Study||212
7793908|NCT01242514|19186411|P2|NOT COMPLETED|Overall Study||357
7793909|NCT01242514|19186412|P1|NOT COMPLETED|Overall Study||1343
7793910|NCT01242514|19186410|P3|COMPLETED|Overall Study|Due to project closure.|0
7793911|NCT01242514|19186411|P2|COMPLETED|Overall Study|Due to project closure.|0
7793912|NCT01242514|19186412|P1|COMPLETED|Overall Study|Due to project closure.|0
7793913|NCT01242514|19186410|P3|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2
7793914|NCT01242514|19186411|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
7793915|NCT01242514|19186412|P1|Enrolled But Did Not Receive Treatment|Overall Study|Other|3
7793916|NCT01242514|19186410|P3|STARTED|Overall Study|Patients who received treatment|212
7793917|NCT01242514|19186411|P2|STARTED|Overall Study|Patients who received treatment|357
7793918|NCT01242514|19186412|P1|STARTED|Overall Study|Patients who received treatment|1343
7793919|NCT01242371|19186431|P2|NOT COMPLETED|Overall Study||5
7793920|NCT01242371|19186432|P1|NOT COMPLETED|Overall Study||2
7793921|NCT01242371|19186431|P2|COMPLETED|Overall Study||27
7793922|NCT01242371|19186432|P1|COMPLETED|Overall Study||31
7793923|NCT01242371|19186431|P2|STARTED|Overall Study||32
7793924|NCT01242371|19186432|P1|STARTED|Overall Study||33
7793925|NCT01242241|19186440|P2|NOT COMPLETED|Overall Study||0
7793926|NCT01242241|19186441|P1|NOT COMPLETED|Overall Study||0
7793927|NCT01242241|19186440|P2|COMPLETED|Overall Study||40
7793928|NCT01242241|19186441|P1|COMPLETED|Overall Study||40
7793929|NCT01242241|19186440|P2|STARTED|Overall Study||40
7793930|NCT01242241|19186441|P1|STARTED|Overall Study||40
7793931|NCT01242176|19186449|P2|NOT COMPLETED|Second Intervention||0
7793932|NCT01242176|19186450|P1|NOT COMPLETED|Second Intervention||0
7793933|NCT01242176|19186449|P2|COMPLETED|Second Intervention||10
7793934|NCT01242176|19186450|P1|COMPLETED|Second Intervention||11
7793935|NCT01242176|19186449|P2|STARTED|Second Intervention||10
7793936|NCT01242176|19186450|P1|STARTED|Second Intervention||11
7793937|NCT01242176|19186449|P2|NOT COMPLETED|Washout Period of 7 Days||2
7793938|NCT01242176|19186450|P1|NOT COMPLETED|Washout Period of 7 Days||1
7793939|NCT01242176|19186449|P2|COMPLETED|Washout Period of 7 Days||10
7793940|NCT01242176|19186450|P1|COMPLETED|Washout Period of 7 Days||11
7793941|NCT01242176|19186449|P2|STARTED|Washout Period of 7 Days||12
7793942|NCT01242176|19186450|P1|STARTED|Washout Period of 7 Days||12
7793943|NCT01242176|19186449|P2|NOT COMPLETED|First Intervention||0
7793944|NCT01242176|19186450|P1|NOT COMPLETED|First Intervention||0
7793945|NCT01242176|19186449|P2|COMPLETED|First Intervention||12
7793946|NCT01242176|19186450|P1|COMPLETED|First Intervention||12
7793947|NCT01242176|19186449|P2|STARTED|First Intervention||12
7793948|NCT01242176|19186450|P1|STARTED|First Intervention||12
7793949|NCT01242111|19186460|P1|NOT COMPLETED|Overall Study||3
7793950|NCT01242111|19186460|P1|COMPLETED|Overall Study||17
7793951|NCT01242111|19186460|P1|STARTED|Overall Study||20
7793952|NCT01242085|19186472|P3|NOT COMPLETED|Overall Study||0
7793953|NCT01242085|19186473|P2|NOT COMPLETED|Overall Study||7
7793954|NCT01242085|19186474|P1|NOT COMPLETED|Overall Study||8
7793955|NCT01242085|19186472|P3|COMPLETED|Overall Study||1
7793956|NCT01242085|19186473|P2|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26
7793957|NCT01242085|19186474|P1|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22
7793958|NCT01242085|19186472|P3|STARTED|Overall Study||1
7793959|NCT01242085|19186473|P2|STARTED|Overall Study||33
7793960|NCT01242085|19186474|P1|STARTED|Overall Study||30
7793961|NCT01242020|19186484|P2|NOT COMPLETED|Overall Study||0
7793962|NCT01242020|19186485|P1|NOT COMPLETED|Overall Study||3
7793963|NCT01242020|19186484|P2|COMPLETED|Overall Study||0
7793964|NCT01242020|19186485|P1|COMPLETED|Overall Study||3
7793965|NCT01242020|19186484|P2|STARTED|Overall Study||0
7793966|NCT01242020|19186485|P1|STARTED|Overall Study||6
7793967|NCT01241916|19186495|P2|NOT COMPLETED|Overall Study||10
7793968|NCT01241916|19186496|P1|NOT COMPLETED|Overall Study||7
7793969|NCT01241916|19186495|P2|COMPLETED|Overall Study||21
7793970|NCT01241916|19186496|P1|COMPLETED|Overall Study||28
7793971|NCT01241916|19186495|P2|STARTED|Overall Study||31
7793972|NCT01241916|19186496|P1|STARTED|Overall Study||35
7793973|NCT01241903|19186506|P2|NOT COMPLETED|Overall Study||0
7793974|NCT01241903|19186507|P1|NOT COMPLETED|Overall Study||1
7793975|NCT01241903|19186506|P2|COMPLETED|Overall Study||27
7793976|NCT01241903|19186507|P1|COMPLETED|Overall Study||26
7793977|NCT01241903|19186506|P2|STARTED|Overall Study||27
7793978|NCT01241903|19186507|P1|STARTED|Overall Study||27
7793979|NCT01241760|19186515|P2|NOT COMPLETED|Overall Study||40
7793980|NCT01241760|19186516|P1|NOT COMPLETED|Overall Study||34
7793981|NCT01241760|19186515|P2|COMPLETED|Overall Study||329
7793982|NCT01241760|19186516|P1|COMPLETED|Overall Study||337
7793983|NCT01241760|19186515|P2|STARTED|Overall Study||369
7793984|NCT01241760|19186516|P1|STARTED|Overall Study||371
7793985|NCT01241604|19186535|P3|NOT COMPLETED|Study Period||0
7793986|NCT01241604|19186536|P2|NOT COMPLETED|Study Period||0
7793987|NCT01241604|19186537|P1|NOT COMPLETED|Study Period||0
7793988|NCT01241604|19186535|P3|COMPLETED|Study Period||3
7793989|NCT01241604|19186536|P2|COMPLETED|Study Period||5
7793990|NCT01241604|19186537|P1|COMPLETED|Study Period||0
7793991|NCT01241604|19186535|P3|STARTED|Study Period||3
7793992|NCT01241604|19186536|P2|STARTED|Study Period||5
7793993|NCT01241604|19186537|P1|STARTED|Study Period||0
7793994|NCT01241604|19186535|P3|NOT COMPLETED|Screening Period||0
7793995|NCT01241604|19186536|P2|NOT COMPLETED|Screening Period||0
7793996|NCT01241604|19186537|P1|NOT COMPLETED|Screening Period||3
7793997|NCT01241604|19186535|P3|COMPLETED|Screening Period||0
7793998|NCT01241604|19186536|P2|COMPLETED|Screening Period||0
7793999|NCT01241604|19186537|P1|COMPLETED|Screening Period||8
7794000|NCT01241604|19186535|P3|STARTED|Screening Period||0
7794001|NCT01241604|19186536|P2|STARTED|Screening Period||0
7794002|NCT01241604|19186537|P1|STARTED|Screening Period||11
7794003|NCT01241591|19186582|P4|NOT COMPLETED|Overall Study||12
7794004|NCT01241591|19186583|P3|NOT COMPLETED|Overall Study||22
7794005|NCT01241591|19186584|P2|NOT COMPLETED|Overall Study||24
7794006|NCT01241591|19186585|P1|NOT COMPLETED|Overall Study||23
7794007|NCT01241591|19186582|P4|COMPLETED|Overall Study||95
7794008|NCT01241591|19186583|P3|COMPLETED|Overall Study||313
7794009|NCT01241591|19186584|P2|COMPLETED|Overall Study||306
7794010|NCT01241591|19186585|P1|COMPLETED|Overall Study||306
7794011|NCT01241591|19186582|P4|STARTED|Overall Study||107
7794012|NCT01241591|19186583|P3|STARTED|Overall Study||335
7794013|NCT01241591|19186584|P2|STARTED|Overall Study||330
7794014|NCT01241591|19186585|P1|STARTED|Overall Study||329
7794015|NCT01241565|19186775|P1|NOT COMPLETED|Overall Study||0
7794016|NCT01241565|19186775|P1|COMPLETED|Overall Study||50
7794017|NCT01241565|19186775|P1|STARTED|Overall Study||50
7794018|NCT01241552|19186788|P4|NOT COMPLETED|Overall Study||64
7794019|NCT01241552|19186789|P3|NOT COMPLETED|Overall Study||60
7794020|NCT01241552|19186790|P2|NOT COMPLETED|Overall Study||63
7794021|NCT01241552|19186791|P1|NOT COMPLETED|Overall Study||41
7794022|NCT01241552|19186788|P4|COMPLETED|Overall Study||340
7794023|NCT01241552|19186789|P3|COMPLETED|Overall Study||343
7794024|NCT01241552|19186790|P2|COMPLETED|Overall Study||340
7794025|NCT01241552|19186791|P1|COMPLETED|Overall Study||201
7794026|NCT01241552|19186788|P4|Treated|Overall Study||397
7794027|NCT01241552|19186789|P3|Treated|Overall Study||388
7794028|NCT01241552|19186790|P2|Treated|Overall Study||392
7794029|NCT01241552|19186791|P1|Treated|Overall Study||235
7794030|NCT01241552|19186788|P4|STARTED|Overall Study||404
7794031|NCT01241552|19186789|P3|STARTED|Overall Study||403
7794032|NCT01241552|19186790|P2|STARTED|Overall Study||403
7794033|NCT01241552|19186791|P1|STARTED|Overall Study||242
7794034|NCT01241539|19186857|P1|NOT COMPLETED|Period 2||0
7794035|NCT01241539|19186857|P1|COMPLETED|Period 2||7
7794036|NCT01241539|19186857|P1|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7
7794037|NCT01241539|19186857|P1|NOT COMPLETED|Period 1||0
7794038|NCT01241539|19186857|P1|COMPLETED|Period 1||7
7794039|NCT01241539|19186857|P1|STARTED|Period 1||7
7794040|NCT01241513|19186878|P2|NOT COMPLETED|Overall Study||0
7794041|NCT01241513|19186879|P1|NOT COMPLETED|Overall Study||0
7794042|NCT01241513|19186878|P2|COMPLETED|Overall Study||9
7794043|NCT01241513|19186879|P1|COMPLETED|Overall Study|Study has been completed|10
7794044|NCT01241513|19186878|P2|STARTED|Overall Study||9
7794045|NCT01241513|19186879|P1|STARTED|Overall Study||10
7794046|NCT01241461|19186886|P2|NOT COMPLETED|Overall Study||6
7794047|NCT01241461|19186887|P1|NOT COMPLETED|Overall Study||3
7794048|NCT01241461|19186886|P2|COMPLETED|Overall Study||0
7794049|NCT01241461|19186887|P1|COMPLETED|Overall Study||0
7794050|NCT01241461|19186886|P2|STARTED|Overall Study||6
7794051|NCT01241461|19186887|P1|STARTED|Overall Study||3
7794052|NCT01241448|19186907|P4|NOT COMPLETED|Overall Study||23
7794053|NCT01241448|19186908|P3|NOT COMPLETED|Overall Study||23
7794054|NCT01241448|19186909|P2|NOT COMPLETED|Overall Study||29
7794055|NCT01241448|19186910|P1|NOT COMPLETED|Overall Study||37
7794056|NCT01241448|19186907|P4|COMPLETED|Overall Study||43
7794057|NCT01241448|19186908|P3|COMPLETED|Overall Study||43
7794058|NCT01241448|19186909|P2|COMPLETED|Overall Study||36
7794059|NCT01241448|19186910|P1|COMPLETED|Overall Study||29
7794060|NCT01241448|19186907|P4|ITT With ≥1 Post-Baseline Measure|Overall Study||62
7794061|NCT01241448|19186908|P3|ITT With ≥1 Post-Baseline Measure|Overall Study||64
7794062|NCT01241448|19186909|P2|ITT With ≥1 Post-Baseline Measure|Overall Study||61
7794063|NCT01241448|19186910|P1|ITT With ≥1 Post-Baseline Measure|Overall Study||61
7794064|NCT01241448|19186907|P4|Intent-to-Treat Population (ITT)|Overall Study||64
7794065|NCT01241448|19186908|P3|Intent-to-Treat Population (ITT)|Overall Study||64
7794066|NCT01241448|19186909|P2|Intent-to-Treat Population (ITT)|Overall Study||63
7794067|NCT01241448|19186910|P1|Intent-to-Treat Population (ITT)|Overall Study||63
7794068|NCT01241448|19186907|P4|STARTED|Overall Study||66
7794069|NCT01241448|19186908|P3|STARTED|Overall Study||66
7794070|NCT01241448|19186909|P2|STARTED|Overall Study||65
7794071|NCT01241448|19186910|P1|STARTED|Overall Study||66
7794072|NCT01241435|19186978|P4|NOT COMPLETED|Overall Study||0
7794073|NCT01241435|19186979|P3|NOT COMPLETED|Overall Study||0
7794074|NCT01241435|19186980|P2|NOT COMPLETED|Overall Study||0
7794075|NCT01241435|19186981|P1|NOT COMPLETED|Overall Study||0
7794076|NCT01241435|19186978|P4|COMPLETED|Overall Study||8
7794077|NCT01241435|19186979|P3|COMPLETED|Overall Study||8
7794078|NCT01241435|19186980|P2|COMPLETED|Overall Study||8
7794079|NCT01241435|19186981|P1|COMPLETED|Overall Study||12
7794080|NCT01241435|19186978|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
7794081|NCT01241435|19186979|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
7794082|NCT01241435|19186980|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
7794083|NCT01241435|19186981|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
7794084|NCT01241435|19186978|P4|STARTED|Overall Study||8
7794085|NCT01241435|19186979|P3|STARTED|Overall Study||8
7794086|NCT01241435|19186980|P2|STARTED|Overall Study||8
7794087|NCT01241435|19186981|P1|STARTED|Overall Study||12
7794088|NCT01241318|19187001|P2|NOT COMPLETED|Overall Study||742
7794089|NCT01241318|19187002|P1|NOT COMPLETED|Overall Study||1179
7794090|NCT01241318|19187001|P2|COMPLETED|Overall Study|Infants|19308
7794091|NCT01241318|19187002|P1|COMPLETED|Overall Study|Infants|18450
7794092|NCT01241318|19187001|P2|Liveborn Infant|Overall Study|Infants|19346
7794093|NCT01241318|19187002|P1|Liveborn Infant|Overall Study|Infants|18510
7794094|NCT01241318|19187001|P2|STARTED|Overall Study|Women enrolled|20050
7794095|NCT01241318|19187002|P1|STARTED|Overall Study|Women enrolled|19629
7794096|NCT01241292|19187019|P2|NOT COMPLETED|Overall Study||3
7794097|NCT01241292|19187020|P1|NOT COMPLETED|Overall Study||3
7794098|NCT01241292|19187019|P2|COMPLETED|Overall Study|completed=treatment on-going|0
7794099|NCT01241292|19187020|P1|COMPLETED|Overall Study|completed=treatment on-going|0
7794100|NCT01241292|19187019|P2|Entered Treatment Period|Overall Study||3
7794101|NCT01241292|19187020|P1|Entered Treatment Period|Overall Study||3
7794102|NCT01241292|19187019|P2|STARTED|Overall Study||3
7794103|NCT01241292|19187020|P1|STARTED|Overall Study||3
7794104|NCT01241279|19187044|P2|NOT COMPLETED|Overall Study||1
7794105|NCT01241279|19187045|P1|NOT COMPLETED|Overall Study||0
7794106|NCT01241279|19187044|P2|COMPLETED|Overall Study||1
7794107|NCT01241279|19187045|P1|COMPLETED|Overall Study||4
7794108|NCT01241279|19187044|P2|STARTED|Overall Study||2
7794109|NCT01241279|19187045|P1|STARTED|Overall Study||4
7794110|NCT01241240|19187055|P2|NOT COMPLETED|Overall Study||9
7794111|NCT01241240|19187056|P1|NOT COMPLETED|Overall Study||8
7794112|NCT01241240|19187055|P2|COMPLETED|Overall Study||89
7794113|NCT01241240|19187056|P1|COMPLETED|Overall Study||86
7794114|NCT01241240|19187055|P2|STARTED|Overall Study||98
7794115|NCT01241240|19187056|P1|STARTED|Overall Study||94
7794116|NCT01240915|19187074|P9|NOT COMPLETED|Overall Study||8
7794117|NCT01240915|19187075|P8|NOT COMPLETED|Overall Study||4
7794118|NCT01240915|19187076|P7|NOT COMPLETED|Overall Study||8
7794119|NCT01240915|19187077|P6|NOT COMPLETED|Overall Study||10
7794120|NCT01240915|19187078|P5|NOT COMPLETED|Overall Study||4
7794121|NCT01240915|19187079|P4|NOT COMPLETED|Overall Study||3
7794122|NCT01240915|19187080|P3|NOT COMPLETED|Overall Study||0
7794123|NCT01240915|19187081|P2|NOT COMPLETED|Overall Study||1
7794124|NCT01240915|19187082|P1|NOT COMPLETED|Overall Study||2
7794125|NCT01240915|19187074|P9|COMPLETED|Overall Study||13
7794126|NCT01240915|19187075|P8|COMPLETED|Overall Study||15
7794127|NCT01240915|19187076|P7|COMPLETED|Overall Study||17
7794128|NCT01240915|19187077|P6|COMPLETED|Overall Study||13
7794129|NCT01240915|19187078|P5|COMPLETED|Overall Study||2
7794130|NCT01240915|19187079|P4|COMPLETED|Overall Study||1
7794131|NCT01240915|19187080|P3|COMPLETED|Overall Study||2
7794132|NCT01240915|19187081|P2|COMPLETED|Overall Study||2
7794133|NCT01240915|19187082|P1|COMPLETED|Overall Study||0
7794134|NCT01240915|19187074|P9|STARTED|Overall Study||21
7794135|NCT01240915|19187075|P8|STARTED|Overall Study||19
7794136|NCT01240915|19187076|P7|STARTED|Overall Study||25
7794137|NCT01240915|19187077|P6|STARTED|Overall Study||23
7794138|NCT01240915|19187078|P5|STARTED|Overall Study||6
7794139|NCT01240915|19187079|P4|STARTED|Overall Study||4
7794140|NCT01240915|19187080|P3|STARTED|Overall Study||2
7794141|NCT01240915|19187081|P2|STARTED|Overall Study||3
7794142|NCT01240915|19187082|P1|STARTED|Overall Study||2
7794143|NCT01240902|19187265|P4|NOT COMPLETED|Overall Study||165
7794144|NCT01240902|19187266|P3|NOT COMPLETED|Overall Study||100
7794145|NCT01240902|19187267|P2|NOT COMPLETED|Overall Study||79
7794146|NCT01240902|19187268|P1|NOT COMPLETED|Overall Study||211
7794147|NCT01240902|19187265|P4|COMPLETED|Overall Study||237
7794148|NCT01240902|19187266|P3|COMPLETED|Overall Study||295
7794149|NCT01240902|19187267|P2|COMPLETED|Overall Study||77
7794150|NCT01240902|19187268|P1|COMPLETED|Overall Study||289
7794151|NCT01240902|19187265|P4|STARTED|Overall Study||402
7794152|NCT01240902|19187266|P3|STARTED|Overall Study||395
7794153|NCT01240902|19187267|P2|STARTED|Overall Study||156
7794154|NCT01240902|19187268|P1|STARTED|Overall Study||500
7794155|NCT01240863|19187356|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52
7794156|NCT01240863|19187357|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46
7794157|NCT01240863|19187358|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
7794158|NCT01240863|19187356|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||94
7794159|NCT01240863|19187357|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||102
7794160|NCT01240863|19187358|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
7794161|NCT01240863|19187356|P3|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146
7794162|NCT01240863|19187357|P2|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147
7794163|NCT01240863|19187358|P1|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0
7794164|NCT01240863|19187356|P3|STARTED|Double-blind Treatment Period (12 Weeks)||146
7794165|NCT01240863|19187357|P2|STARTED|Double-blind Treatment Period (12 Weeks)||148
7794166|NCT01240863|19187358|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
7794167|NCT01240863|19187356|P3|NOT COMPLETED|Open-label Titration Period||0
7794168|NCT01240863|19187357|P2|NOT COMPLETED|Open-label Titration Period||0
7794169|NCT01240863|19187358|P1|NOT COMPLETED|Open-label Titration Period||97
7794170|NCT01240863|19187356|P3|COMPLETED|Open-label Titration Period||0
7794171|NCT01240863|19187357|P2|COMPLETED|Open-label Titration Period||0
7794172|NCT01240863|19187358|P1|COMPLETED|Open-label Titration Period||294
7794173|NCT01240863|19187356|P3|Safety Analysis Set|Open-label Titration Period||0
7794174|NCT01240863|19187357|P2|Safety Analysis Set|Open-label Titration Period||0
7794175|NCT01240863|19187358|P1|Safety Analysis Set|Open-label Titration Period||389
7794176|NCT01240863|19187356|P3|STARTED|Open-label Titration Period||0
7794177|NCT01240863|19187357|P2|STARTED|Open-label Titration Period||0
7794178|NCT01240863|19187358|P1|STARTED|Open-label Titration Period||391
7794179|NCT01240811|19187420|P3|NOT COMPLETED|Overall Study||1
7794180|NCT01240811|19187421|P2|NOT COMPLETED|Overall Study||1
7794181|NCT01240811|19187422|P1|NOT COMPLETED|Overall Study||0
7794182|NCT01240811|19187420|P3|COMPLETED|Overall Study||16
7794183|NCT01240811|19187421|P2|COMPLETED|Overall Study||16
7794184|NCT01240811|19187422|P1|COMPLETED|Overall Study||8
7794185|NCT01240811|19187420|P3|STARTED|Overall Study||17
7794186|NCT01240811|19187421|P2|STARTED|Overall Study||17
7794187|NCT01240811|19187422|P1|STARTED|Overall Study||8
7794188|NCT01240785|19187438|P2|NOT COMPLETED|Overall Study||3
7794189|NCT01240785|19187439|P1|NOT COMPLETED|Overall Study||1
7794190|NCT01240785|19187438|P2|COMPLETED|Overall Study||107
7794191|NCT01240785|19187439|P1|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110
7794192|NCT01240785|19187438|P2|STARTED|Overall Study||110
7794193|NCT01240785|19187439|P1|STARTED|Overall Study||111
7794194|NCT01240746|19187470|P3|NOT COMPLETED|Overall Study||243
7794195|NCT01240746|19187471|P2|NOT COMPLETED|Overall Study||48
7794196|NCT01240746|19187472|P1|NOT COMPLETED|Overall Study||59
7794197|NCT01240746|19187470|P3|COMPLETED|Overall Study||2659
7794198|NCT01240746|19187471|P2|COMPLETED|Overall Study||677
7794199|NCT01240746|19187472|P1|COMPLETED|Overall Study||677
7794200|NCT01240746|19187470|P3|STARTED|Overall Study||2902
7794201|NCT01240746|19187471|P2|STARTED|Overall Study||725
7794202|NCT01240746|19187472|P1|STARTED|Overall Study||736
7794203|NCT01240590|19187527|P5|NOT COMPLETED|Phase II||1
7794204|NCT01240590|19187528|P4|NOT COMPLETED|Phase II||2
7794205|NCT01240590|19187529|P3|NOT COMPLETED|Phase II||0
7794206|NCT01240590|19187530|P2|NOT COMPLETED|Phase II||0
7794207|NCT01240590|19187531|P1|NOT COMPLETED|Phase II||0
7794208|NCT01240590|19187527|P5|COMPLETED|Phase II||0
7794209|NCT01240590|19187528|P4|COMPLETED|Phase II||15
7794210|NCT01240590|19187529|P3|COMPLETED|Phase II||0
7794211|NCT01240590|19187530|P2|COMPLETED|Phase II||0
7794212|NCT01240590|19187531|P1|COMPLETED|Phase II||0
7794213|NCT01240590|19187527|P5|STARTED|Phase II||1
7794214|NCT01240590|19187528|P4|STARTED|Phase II||17
7794215|NCT01240590|19187529|P3|STARTED|Phase II||0
7794216|NCT01240590|19187530|P2|STARTED|Phase II||0
7794217|NCT01240590|19187531|P1|STARTED|Phase II||0
7794218|NCT01240590|19187527|P5|NOT COMPLETED|Phase I||0
7794219|NCT01240590|19187528|P4|NOT COMPLETED|Phase I||0
7794220|NCT01240590|19187529|P3|NOT COMPLETED|Phase I||3
7794221|NCT01240590|19187530|P2|NOT COMPLETED|Phase I||0
7794222|NCT01240590|19187531|P1|NOT COMPLETED|Phase I||0
7794223|NCT01240590|19187527|P5|COMPLETED|Phase I||0
7794224|NCT01240590|19187528|P4|COMPLETED|Phase I||0
7794225|NCT01240590|19187529|P3|COMPLETED|Phase I||0
7794226|NCT01240590|19187530|P2|COMPLETED|Phase I||6
7794227|NCT01240590|19187531|P1|COMPLETED|Phase I||0
7794228|NCT01240590|19187527|P5|STARTED|Phase I||0
7794229|NCT01240590|19187528|P4|STARTED|Phase I||0
7794230|NCT01240590|19187529|P3|STARTED|Phase I||3
7794231|NCT01240590|19187530|P2|STARTED|Phase I||6
7794232|NCT01240590|19187531|P1|STARTED|Phase I||0
7794233|NCT01240551|19187559|P2|NOT COMPLETED|Overall Study||3
7794234|NCT01240551|19187560|P1|NOT COMPLETED|Overall Study||4
7794235|NCT01240551|19187559|P2|COMPLETED|Overall Study||27
7794236|NCT01240551|19187560|P1|COMPLETED|Overall Study||26
7794237|NCT01240551|19187559|P2|STARTED|Overall Study||30
7794238|NCT01240551|19187560|P1|STARTED|Overall Study||30
7794239|NCT01240382|19187570|P2|NOT COMPLETED|Overall Study||4
7794240|NCT01240382|19187571|P1|NOT COMPLETED|Overall Study||2
7794241|NCT01240382|19187570|P2|COMPLETED|Overall Study||139
7794242|NCT01240382|19187571|P1|COMPLETED|Overall Study||142
7794243|NCT01240382|19187570|P2|STARTED|Overall Study||143
7794244|NCT01240382|19187571|P1|STARTED|Overall Study||144
7794245|NCT01240356|19187581|P2|NOT COMPLETED|Overall Study||0
7794246|NCT01240356|19187582|P1|NOT COMPLETED|Overall Study||3
7794247|NCT01240356|19187581|P2|COMPLETED|Overall Study||20
7794248|NCT01240356|19187582|P1|COMPLETED|Overall Study||15
7794249|NCT01240356|19187581|P2|STARTED|Overall Study||20
7794250|NCT01240356|19187582|P1|STARTED|Overall Study||18
7794251|NCT01240330|19187593|P1|NOT COMPLETED|Overall Study||0
7794252|NCT01240330|19187593|P1|COMPLETED|Overall Study||33
7794253|NCT01240330|19187593|P1|STARTED|Overall Study||33
7794254|NCT01240304|19187599|P1|NOT COMPLETED|Overall Study||10
7794255|NCT01240304|19187599|P1|COMPLETED|Overall Study||0
7794256|NCT01240304|19187599|P1|STARTED|Overall Study||10
7794257|NCT01240200|19187605|P2|NOT COMPLETED|12-week Crossover Phase - Period 2||0
7794258|NCT01240200|19187606|P1|NOT COMPLETED|12-week Crossover Phase - Period 2||0
7794259|NCT01240200|19187605|P2|COMPLETED|12-week Crossover Phase - Period 2||23
7794260|NCT01240200|19187606|P1|COMPLETED|12-week Crossover Phase - Period 2||23
7794261|NCT01240200|19187605|P2|STARTED|12-week Crossover Phase - Period 2||23
7794262|NCT01240200|19187606|P1|STARTED|12-week Crossover Phase - Period 2||23
7794263|NCT01240200|19187605|P2|NOT COMPLETED|12-week Crossover Phase - Period 1||1
7794264|NCT01240200|19187606|P1|NOT COMPLETED|12-week Crossover Phase - Period 1||2
7794265|NCT01240200|19187605|P2|COMPLETED|12-week Crossover Phase - Period 1||23
7794266|NCT01240200|19187606|P1|COMPLETED|12-week Crossover Phase - Period 1||23
7794267|NCT01240200|19187605|P2|STARTED|12-week Crossover Phase - Period 1||24
7794268|NCT01240200|19187606|P1|STARTED|12-week Crossover Phase - Period 1||25
7794269|NCT01240135|19187624|P2|NOT COMPLETED|Period Two, 14 Days of Wear||2
7794270|NCT01240135|19187625|P1|NOT COMPLETED|Period Two, 14 Days of Wear||1
7794271|NCT01240135|19187624|P2|COMPLETED|Period Two, 14 Days of Wear||43
7794272|NCT01240135|19187625|P1|COMPLETED|Period Two, 14 Days of Wear||43
7794273|NCT01240135|19187624|P2|STARTED|Period Two, 14 Days of Wear||45
7794274|NCT01240135|19187625|P1|STARTED|Period Two, 14 Days of Wear||44
7794275|NCT01240135|19187624|P2|NOT COMPLETED|Period One, 14 Days of Wear||0
7794276|NCT01240135|19187625|P1|NOT COMPLETED|Period One, 14 Days of Wear||0
7794277|NCT01240135|19187624|P2|COMPLETED|Period One, 14 Days of Wear||45
7794278|NCT01240135|19187625|P1|COMPLETED|Period One, 14 Days of Wear||44
7794279|NCT01240135|19187624|P2|STARTED|Period One, 14 Days of Wear||45
7794280|NCT01240135|19187625|P1|STARTED|Period One, 14 Days of Wear||44
7794281|NCT01240122|19187633|P1|NOT COMPLETED|Overall Study||0
7794282|NCT01240122|19187633|P1|COMPLETED|Overall Study||29
7794283|NCT01240122|19187633|P1|STARTED|Overall Study||29
7794284|NCT01239992|19187642|P1|NOT COMPLETED|Overall Study||2
7794285|NCT01239992|19187642|P1|COMPLETED|Overall Study||10
7794286|NCT01239992|19187642|P1|STARTED|Overall Study||12
7794287|NCT01239797|19187651|P2|NOT COMPLETED|Treated Participants||274
7794288|NCT01239797|19187652|P1|NOT COMPLETED|Treated Participants||235
7794289|NCT01239797|19187651|P2|COMPLETED|Treated Participants|Completed = Still on Treatment|43
7794290|NCT01239797|19187652|P1|COMPLETED|Treated Participants|Completed = Still on Treatment|83
7794291|NCT01239797|19187651|P2|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317
7794292|NCT01239797|19187652|P1|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318
7794293|NCT01239797|19187651|P2|NOT COMPLETED|Randomized Participants||9
7794294|NCT01239797|19187652|P1|NOT COMPLETED|Randomized Participants||2
7794295|NCT01239797|19187651|P2|COMPLETED|Randomized Participants||316
7794296|NCT01239797|19187652|P1|COMPLETED|Randomized Participants||319
7794297|NCT01239797|19187651|P2|STARTED|Randomized Participants||325
7794298|NCT01239797|19187652|P1|STARTED|Randomized Participants||321
7794299|NCT01239745|19187660|P1|NOT COMPLETED|Overall Study||46
7794300|NCT01239745|19187660|P1|COMPLETED|Overall Study||0
7794301|NCT01239745|19187660|P1|STARTED|Overall Study||46
7794302|NCT01239732|19187671|P1|NOT COMPLETED|Overall Study||1021
7794303|NCT01239732|19187671|P1|COMPLETED|Overall Study||0
7794304|NCT01239732|19187671|P1|STARTED|Overall Study||1021
7794305|NCT01239680|19187684|P2|NOT COMPLETED|Overall Study||0
7794306|NCT01239680|19187685|P1|NOT COMPLETED|Overall Study||2
7794307|NCT01239680|19187684|P2|COMPLETED|Overall Study||2
7794308|NCT01239680|19187685|P1|COMPLETED|Overall Study||1
7794309|NCT01239680|19187684|P2|STARTED|Overall Study||2
7794310|NCT01239680|19187685|P1|STARTED|Overall Study||3
7794311|NCT01239511|19187695|P4|NOT COMPLETED|Overall Study||9
7794312|NCT01239511|19187696|P3|NOT COMPLETED|Overall Study||4
7794313|NCT01239511|19187697|P2|NOT COMPLETED|Overall Study||5
7794314|NCT01239511|19187698|P1|NOT COMPLETED|Overall Study||1
7794315|NCT01239511|19187695|P4|COMPLETED|Overall Study||38
7794316|NCT01239511|19187696|P3|COMPLETED|Overall Study||43
7794317|NCT01239511|19187697|P2|COMPLETED|Overall Study||40
7794318|NCT01239511|19187698|P1|COMPLETED|Overall Study||46
7794319|NCT01239511|19187695|P4|STARTED|Overall Study||47
7794320|NCT01239511|19187696|P3|STARTED|Overall Study||47
7794321|NCT01239511|19187697|P2|STARTED|Overall Study||45
7794322|NCT01239511|19187698|P1|STARTED|Overall Study||47
7794323|NCT01239472|19187710|P2|NOT COMPLETED|Overall Study||3
7794324|NCT01239472|19187711|P1|NOT COMPLETED|Overall Study||5
7794325|NCT01239472|19187710|P2|COMPLETED|Overall Study||12
7794326|NCT01239472|19187711|P1|COMPLETED|Overall Study||10
7794327|NCT01239472|19187710|P2|STARTED|Overall Study||15
7794328|NCT01239472|19187711|P1|STARTED|Overall Study||15
7794329|NCT01239394|19187719|P1|NOT COMPLETED|Overall Study||1
7794330|NCT01239394|19187719|P1|COMPLETED|Overall Study||41
7794331|NCT01239394|19187719|P1|STARTED|Overall Study||42
7794332|NCT01239381|19187726|P1|NOT COMPLETED|Overall Study||2
7794333|NCT01239381|19187726|P1|COMPLETED|Overall Study||90
7794334|NCT01239381|19187726|P1|STARTED|Overall Study||92
7794335|NCT01239368|19187746|P10|NOT COMPLETED|Overall Study||4
7794336|NCT01239368|19187747|P9|NOT COMPLETED|Overall Study||0
7794337|NCT01239368|19187748|P8|NOT COMPLETED|Overall Study||0
7794338|NCT01239368|19187749|P7|NOT COMPLETED|Overall Study||6
7794339|NCT01239368|19187750|P6|NOT COMPLETED|Overall Study||4
7794340|NCT01239368|19187751|P5|NOT COMPLETED|Overall Study||5
7794341|NCT01239368|19187752|P4|NOT COMPLETED|Overall Study||1
7794342|NCT01239368|19187753|P3|NOT COMPLETED|Overall Study||1
7794343|NCT01239368|19187754|P2|NOT COMPLETED|Overall Study||1
7794344|NCT01239368|19187755|P1|NOT COMPLETED|Overall Study||2
7794345|NCT01239368|19187746|P10|COMPLETED|Overall Study||1
7794346|NCT01239368|19187747|P9|COMPLETED|Overall Study||1
7794347|NCT01239368|19187748|P8|COMPLETED|Overall Study||0
7794348|NCT01239368|19187749|P7|COMPLETED|Overall Study||1
7794349|NCT01239368|19187750|P6|COMPLETED|Overall Study||1
7794350|NCT01239368|19187751|P5|COMPLETED|Overall Study||2
7794351|NCT01239368|19187752|P4|COMPLETED|Overall Study||1
7794352|NCT01239368|19187753|P3|COMPLETED|Overall Study||0
7794353|NCT01239368|19187754|P2|COMPLETED|Overall Study||0
7794354|NCT01239368|19187755|P1|COMPLETED|Overall Study||0
7794355|NCT01239368|19187746|P10|STARTED|Overall Study||5
7794356|NCT01239368|19187747|P9|STARTED|Overall Study||1
7794357|NCT01239368|19187748|P8|STARTED|Overall Study||0
7794358|NCT01239368|19187749|P7|STARTED|Overall Study||7
7794359|NCT01239368|19187750|P6|STARTED|Overall Study||5
7794360|NCT01239368|19187751|P5|STARTED|Overall Study||7
7794361|NCT01239368|19187752|P4|STARTED|Overall Study||2
7794362|NCT01239368|19187753|P3|STARTED|Overall Study||1
7794363|NCT01239368|19187754|P2|STARTED|Overall Study||1
7794364|NCT01239368|19187755|P1|STARTED|Overall Study||2
7794365|NCT01239355|19187799|P1|NOT COMPLETED|Overall Study||0
7794366|NCT01239355|19187799|P1|COMPLETED|Overall Study||15
7794367|NCT01239355|19187799|P1|STARTED|Overall Study||15
7794368|NCT01239342|19187807|P2|NOT COMPLETED|Overall Study||6
7794369|NCT01239342|19187808|P1|NOT COMPLETED|Overall Study||3
7794370|NCT01239342|19187807|P2|COMPLETED|Overall Study||8
7794371|NCT01239342|19187808|P1|COMPLETED|Overall Study||26
7794372|NCT01239342|19187807|P2|STARTED|Overall Study||14
7794373|NCT01239342|19187808|P1|STARTED|Overall Study||29
7794374|NCT01239316|19187824|P1|NOT COMPLETED|Overall Study||12
7794375|NCT01239316|19187824|P1|COMPLETED|Overall Study||0
7794376|NCT01239316|19187824|P1|STARTED|Overall Study||12
7794377|NCT01239212|19187832|P1|NOT COMPLETED|Overall Study||0
7794378|NCT01239212|19187832|P1|COMPLETED|Overall Study||7
7794379|NCT01239212|19187832|P1|STARTED|Overall Study||7
7794380|NCT01239160|19187838|P3|NOT COMPLETED|Overall Study||10
7794381|NCT01239160|19187839|P2|NOT COMPLETED|Overall Study||19
7794382|NCT01239160|19187840|P1|NOT COMPLETED|Overall Study||25
7794383|NCT01239160|19187838|P3|COMPLETED|Overall Study||0
7794384|NCT01239160|19187839|P2|COMPLETED|Overall Study||95
7794385|NCT01239160|19187840|P1|COMPLETED|Overall Study||89
7794386|NCT01239160|19187838|P3|STARTED|Overall Study||10
7794387|NCT01239160|19187839|P2|STARTED|Overall Study||114
7794388|NCT01239160|19187840|P1|STARTED|Overall Study||114
7794389|NCT01239121|19187853|P3|NOT COMPLETED|Overall Study||0
7794390|NCT01239121|19187854|P2|NOT COMPLETED|Overall Study||4
7794391|NCT01239121|19187855|P1|NOT COMPLETED|Overall Study||2
7794392|NCT01239121|19187853|P3|COMPLETED|Overall Study||15
7794393|NCT01239121|19187854|P2|COMPLETED|Overall Study||195
7794394|NCT01239121|19187855|P1|COMPLETED|Overall Study||186
7794395|NCT01239121|19187853|P3|STARTED|Overall Study||15
7794396|NCT01239121|19187854|P2|STARTED|Overall Study||199
7794397|NCT01239121|19187855|P1|STARTED|Overall Study||188
7794398|NCT01239056|19187869|P1|NOT COMPLETED|Overall Study||0
7794399|NCT01239056|19187869|P1|COMPLETED|Overall Study||20
7794400|NCT01239056|19187869|P1|STARTED|Overall Study||20
7794401|NCT01239043|19187877|P2|NOT COMPLETED|Overall Study||1
7794402|NCT01239043|19187878|P1|NOT COMPLETED|Overall Study||2
7794403|NCT01239043|19187877|P2|COMPLETED|Overall Study||102
7794404|NCT01239043|19187878|P1|COMPLETED|Overall Study||34
7794405|NCT01239043|19187877|P2|STARTED|Overall Study||103
7794406|NCT01239043|19187878|P1|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36
7794407|NCT01238991|19187906|P10|NOT COMPLETED|Overall Study||2
7794408|NCT01238991|19187907|P9|NOT COMPLETED|Overall Study||4
7794409|NCT01238991|19187908|P8|NOT COMPLETED|Overall Study||5
7794410|NCT01238991|19187909|P7|NOT COMPLETED|Overall Study||8
7794411|NCT01238991|19187910|P6|NOT COMPLETED|Overall Study||0
7794412|NCT01238991|19187911|P5|NOT COMPLETED|Overall Study||2
7794413|NCT01238991|19187912|P4|NOT COMPLETED|Overall Study||2
7794414|NCT01238991|19187913|P3|NOT COMPLETED|Overall Study||6
7794415|NCT01238991|19187914|P2|NOT COMPLETED|Overall Study||0
7794416|NCT01238991|19187915|P1|NOT COMPLETED|Overall Study||2
7794417|NCT01238991|19187906|P10|COMPLETED|Overall Study||0
7794418|NCT01238991|19187907|P9|COMPLETED|Overall Study||0
7794419|NCT01238991|19187908|P8|COMPLETED|Overall Study||0
7794420|NCT01238991|19187909|P7|COMPLETED|Overall Study||0
7794421|NCT01238991|19187910|P6|COMPLETED|Overall Study||2
7794422|NCT01238991|19187911|P5|COMPLETED|Overall Study||3
7794423|NCT01238991|19187912|P4|COMPLETED|Overall Study||4
7794424|NCT01238991|19187913|P3|COMPLETED|Overall Study||5
7794425|NCT01238991|19187914|P2|COMPLETED|Overall Study||3
7794426|NCT01238991|19187915|P1|COMPLETED|Overall Study||5
7794427|NCT01238991|19187906|P10|Received Treatment|Overall Study||2
7794428|NCT01238991|19187907|P9|Received Treatment|Overall Study||4
7794429|NCT01238991|19187908|P8|Received Treatment|Overall Study||5
7794430|NCT01238991|19187909|P7|Received Treatment|Overall Study||8
7794431|NCT01238991|19187910|P6|Received Treatment|Overall Study||2
7794432|NCT01238991|19187911|P5|Received Treatment|Overall Study||5
7794433|NCT01238991|19187912|P4|Received Treatment|Overall Study||6
7794434|NCT01238991|19187913|P3|Received Treatment|Overall Study||11
7794435|NCT01238991|19187914|P2|Received Treatment|Overall Study||3
7794436|NCT01238991|19187915|P1|Received Treatment|Overall Study||7
7794437|NCT01238991|19187906|P10|STARTED|Overall Study||2
7794438|NCT01238991|19187907|P9|STARTED|Overall Study||4
7794439|NCT01238991|19187908|P8|STARTED|Overall Study||5
7794440|NCT01238991|19187909|P7|STARTED|Overall Study||8
7794441|NCT01238991|19187910|P6|STARTED|Overall Study||2
7794442|NCT01238991|19187911|P5|STARTED|Overall Study||5
7794443|NCT01238991|19187912|P4|STARTED|Overall Study||6
7794444|NCT01238991|19187913|P3|STARTED|Overall Study||11
7794445|NCT01238991|19187914|P2|STARTED|Overall Study||3
7794446|NCT01238991|19187915|P1|STARTED|Overall Study||7
7794447|NCT01238900|19188002|P1|NOT COMPLETED|<12 Months Post Stent Removal||5
7794448|NCT01238900|19188002|P1|COMPLETED|<12 Months Post Stent Removal||18
7794449|NCT01238900|19188002|P1|STARTED|<12 Months Post Stent Removal||23
7794450|NCT01238900|19188002|P1|NOT COMPLETED|6 Months Post Stent Placement||0
7794451|NCT01238900|19188002|P1|COMPLETED|6 Months Post Stent Placement||23
7794452|NCT01238900|19188002|P1|STARTED|6 Months Post Stent Placement||23
7794453|NCT01238861|19188016|P6|NOT COMPLETED|Overall Study||15
7794454|NCT01238861|19188017|P5|NOT COMPLETED|Overall Study||13
7794455|NCT01238861|19188018|P4|NOT COMPLETED|Overall Study||13
7794456|NCT01238861|19188019|P3|NOT COMPLETED|Overall Study||11
7794457|NCT01238861|19188020|P2|NOT COMPLETED|Overall Study||8
7794458|NCT01238861|19188021|P1|NOT COMPLETED|Overall Study||11
7794459|NCT01238861|19188016|P6|COMPLETED|Overall Study||125
7794460|NCT01238861|19188017|P5|COMPLETED|Overall Study||129
7794461|NCT01238861|19188018|P4|COMPLETED|Overall Study||69
7794462|NCT01238861|19188019|P3|COMPLETED|Overall Study||70
7794463|NCT01238861|19188020|P2|COMPLETED|Overall Study||73
7794464|NCT01238861|19188021|P1|COMPLETED|Overall Study||69
7794465|NCT01238861|19188016|P6|STARTED|Overall Study||140
7794466|NCT01238861|19188017|P5|STARTED|Overall Study||142
7794467|NCT01238861|19188018|P4|STARTED|Overall Study||82
7794468|NCT01238861|19188019|P3|STARTED|Overall Study||81
7794469|NCT01238861|19188020|P2|STARTED|Overall Study||81
7794470|NCT01238861|19188021|P1|STARTED|Overall Study||80
7794471|NCT01238848|19188101|P2|NOT COMPLETED|Overall Study||5
7794472|NCT01238848|19188102|P1|NOT COMPLETED|Overall Study||13
7794473|NCT01238848|19188101|P2|COMPLETED|Overall Study||45
7794474|NCT01238848|19188102|P1|COMPLETED|Overall Study||37
7794475|NCT01238848|19188101|P2|STARTED|Overall Study||50
7794476|NCT01238848|19188102|P1|STARTED|Overall Study||50
7794477|NCT01238835|19188110|P1|NOT COMPLETED|Overall Study||136
7794478|NCT01238835|19188110|P1|COMPLETED|Overall Study||82
7794479|NCT01238835|19188110|P1|STARTED|Overall Study||218
7794480|NCT01238822|19188115|P1|NOT COMPLETED|Overall Study||3
7794481|NCT01238822|19188115|P1|COMPLETED|Overall Study||93
7794482|NCT01238822|19188115|P1|Received High Dosage|Overall Study||93
7794483|NCT01238822|19188115|P1|Received Medium Dosage|Overall Study||93
7794484|NCT01238822|19188115|P1|Received Low Dosage|Overall Study||93
7794485|NCT01238822|19188115|P1|Received Placebo|Overall Study||93
7794486|NCT01238822|19188115|P1|STARTED|Overall Study||96
7794487|NCT01238640|19188125|P1|NOT COMPLETED|Overall Study||0
7794488|NCT01238640|19188125|P1|COMPLETED|Overall Study||84
7794489|NCT01238640|19188125|P1|STARTED|Overall Study||84
7794490|NCT01238588|19188142|P1|NOT COMPLETED|Overall Study||3
7794491|NCT01238588|19188142|P1|COMPLETED|Overall Study||9
7794492|NCT01238588|19188142|P1|STARTED|Overall Study||12
7794493|NCT01238575|19188155|P2|NOT COMPLETED|Overall Study||4
7794494|NCT01238575|19188156|P1|NOT COMPLETED|Overall Study||4
7794495|NCT01238575|19188155|P2|COMPLETED|Overall Study||28
7794496|NCT01238575|19188156|P1|COMPLETED|Overall Study||26
7794497|NCT01238575|19188155|P2|STARTED|Overall Study||32
7794498|NCT01238575|19188156|P1|STARTED|Overall Study||30
7794499|NCT01238549|19188192|P1|NOT COMPLETED|Overall Study||36
7794500|NCT01238549|19188192|P1|COMPLETED|Overall Study||248
7794501|NCT01238549|19188192|P1|STARTED|Overall Study||284
7794502|NCT01238536|19188211|P2|NOT COMPLETED|Overall Study||50
7794503|NCT01238536|19188212|P1|NOT COMPLETED|Overall Study||47
7794504|NCT01238536|19188211|P2|COMPLETED|Overall Study||150
7794505|NCT01238536|19188212|P1|COMPLETED|Overall Study||153
7794506|NCT01238536|19188211|P2|STARTED|Overall Study||200
7794507|NCT01238536|19188212|P1|STARTED|Overall Study||200
7794508|NCT01238471|19188226|P2|NOT COMPLETED|Overall Study||0
7794509|NCT01238471|19188227|P1|NOT COMPLETED|Overall Study||0
7794510|NCT01238471|19188226|P2|COMPLETED|Overall Study||10
7794511|NCT01238471|19188227|P1|COMPLETED|Overall Study||10
7794512|NCT01238471|19188226|P2|STARTED|Overall Study||10
7794513|NCT01238471|19188227|P1|STARTED|Overall Study||10
7794514|NCT01238341|19188233|P1|NOT COMPLETED|Overall Study||0
7794515|NCT01238341|19188233|P1|COMPLETED|Overall Study||7
7794516|NCT01238341|19188233|P1|STARTED|Overall Study||7
7794517|NCT01238211|19188240|P1|NOT COMPLETED|Overall Study||58
7794518|NCT01238211|19188240|P1|COMPLETED|Overall Study||3
7794519|NCT01238211|19188240|P1|STARTED|Overall Study||61
7794520|NCT01238172|19188246|P2|NOT COMPLETED|Overall Study||24
7794521|NCT01238172|19188247|P1|NOT COMPLETED|Overall Study||11
7794522|NCT01238172|19188246|P2|COMPLETED|Overall Study||217
7794523|NCT01238172|19188247|P1|COMPLETED|Overall Study||226
7794524|NCT01238172|19188246|P2|STARTED|Overall Study||241
7794525|NCT01238172|19188247|P1|STARTED|Overall Study||237
7794526|NCT01237951|19188259|P1|NOT COMPLETED|Overall Study||1
7794527|NCT01237951|19188259|P1|COMPLETED|Overall Study||74
7794528|NCT01237951|19188259|P1|STARTED|Overall Study||75
7794529|NCT01237899|19188277|P11|NOT COMPLETED|Second Dosing Period||0
7794530|NCT01237899|19188278|P10|NOT COMPLETED|Second Dosing Period||0
7794531|NCT01237899|19188279|P9|NOT COMPLETED|Second Dosing Period||0
7794532|NCT01237899|19188280|P8|NOT COMPLETED|Second Dosing Period||0
7794533|NCT01237899|19188281|P7|NOT COMPLETED|Second Dosing Period||0
7794534|NCT01237899|19188282|P6|NOT COMPLETED|Second Dosing Period||0
7794535|NCT01237899|19188283|P5|NOT COMPLETED|Second Dosing Period||0
7794536|NCT01237899|19188284|P4|NOT COMPLETED|Second Dosing Period||0
7794537|NCT01237899|19188285|P3|NOT COMPLETED|Second Dosing Period||0
7794538|NCT01237899|19188286|P2|NOT COMPLETED|Second Dosing Period||0
7794539|NCT01237899|19188287|P1|NOT COMPLETED|Second Dosing Period||0
7794540|NCT01237899|19188277|P11|COMPLETED|Second Dosing Period||4
7794541|NCT01237899|19188278|P10|COMPLETED|Second Dosing Period||3
7794542|NCT01237899|19188279|P9|COMPLETED|Second Dosing Period||4
7794543|NCT01237899|19188280|P8|COMPLETED|Second Dosing Period||3
7794544|NCT01237899|19188281|P7|COMPLETED|Second Dosing Period||1
7794545|NCT01237899|19188282|P6|COMPLETED|Second Dosing Period||4
7794546|NCT01237899|19188283|P5|COMPLETED|Second Dosing Period||2
7794547|NCT01237899|19188284|P4|COMPLETED|Second Dosing Period||3
7794548|NCT01237899|19188285|P3|COMPLETED|Second Dosing Period||3
7794549|NCT01237899|19188286|P2|COMPLETED|Second Dosing Period||3
7794550|NCT01237899|19188287|P1|COMPLETED|Second Dosing Period||1
7794551|NCT01237899|19188277|P11|STARTED|Second Dosing Period||4
7794552|NCT01237899|19188278|P10|STARTED|Second Dosing Period||3
7794553|NCT01237899|19188279|P9|STARTED|Second Dosing Period||4
7794554|NCT01237899|19188280|P8|STARTED|Second Dosing Period||3
7794555|NCT01237899|19188281|P7|STARTED|Second Dosing Period||1
7794556|NCT01237899|19188282|P6|STARTED|Second Dosing Period||4
7794557|NCT01237899|19188283|P5|STARTED|Second Dosing Period||2
7794558|NCT01237899|19188284|P4|STARTED|Second Dosing Period||3
7794559|NCT01237899|19188285|P3|STARTED|Second Dosing Period||3
7794560|NCT01237899|19188286|P2|STARTED|Second Dosing Period||3
7794561|NCT01237899|19188287|P1|STARTED|Second Dosing Period||1
7794562|NCT01237899|19188277|P11|NOT COMPLETED|Washout Period of at Least 7 Days||0
7794563|NCT01237899|19188278|P10|NOT COMPLETED|Washout Period of at Least 7 Days||0
7794564|NCT01237899|19188279|P9|NOT COMPLETED|Washout Period of at Least 7 Days||0
7794565|NCT01237899|19188280|P8|NOT COMPLETED|Washout Period of at Least 7 Days||0
7794566|NCT01237899|19188281|P7|NOT COMPLETED|Washout Period of at Least 7 Days||0
7794567|NCT01237899|19188282|P6|NOT COMPLETED|Washout Period of at Least 7 Days||0
7794568|NCT01237899|19188283|P5|NOT COMPLETED|Washout Period of at Least 7 Days||0
7794569|NCT01237899|19188284|P4|NOT COMPLETED|Washout Period of at Least 7 Days||0
7794570|NCT01237899|19188285|P3|NOT COMPLETED|Washout Period of at Least 7 Days||1
7794571|NCT01237899|19188286|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
7794572|NCT01237899|19188287|P1|NOT COMPLETED|Washout Period of at Least 7 Days||0
7794573|NCT01237899|19188277|P11|COMPLETED|Washout Period of at Least 7 Days||4
7794574|NCT01237899|19188278|P10|COMPLETED|Washout Period of at Least 7 Days||3
7794575|NCT01237899|19188279|P9|COMPLETED|Washout Period of at Least 7 Days||4
7794576|NCT01237899|19188280|P8|COMPLETED|Washout Period of at Least 7 Days||3
7794577|NCT01237899|19188281|P7|COMPLETED|Washout Period of at Least 7 Days||1
7794578|NCT01237899|19188282|P6|COMPLETED|Washout Period of at Least 7 Days||4
7794579|NCT01237899|19188283|P5|COMPLETED|Washout Period of at Least 7 Days||2
7794580|NCT01237899|19188284|P4|COMPLETED|Washout Period of at Least 7 Days||3
7794581|NCT01237899|19188285|P3|COMPLETED|Washout Period of at Least 7 Days||3
7794582|NCT01237899|19188286|P2|COMPLETED|Washout Period of at Least 7 Days||3
7794583|NCT01237899|19188287|P1|COMPLETED|Washout Period of at Least 7 Days||1
7794584|NCT01237899|19188277|P11|STARTED|Washout Period of at Least 7 Days||4
7794585|NCT01237899|19188278|P10|STARTED|Washout Period of at Least 7 Days||3
7794586|NCT01237899|19188279|P9|STARTED|Washout Period of at Least 7 Days||4
7794587|NCT01237899|19188280|P8|STARTED|Washout Period of at Least 7 Days||3
7794588|NCT01237899|19188281|P7|STARTED|Washout Period of at Least 7 Days||1
7794589|NCT01237899|19188282|P6|STARTED|Washout Period of at Least 7 Days||4
7794590|NCT01237899|19188283|P5|STARTED|Washout Period of at Least 7 Days||2
7794591|NCT01237899|19188284|P4|STARTED|Washout Period of at Least 7 Days||3
7794592|NCT01237899|19188285|P3|STARTED|Washout Period of at Least 7 Days||4
7794593|NCT01237899|19188286|P2|STARTED|Washout Period of at Least 7 Days||3
7794594|NCT01237899|19188287|P1|STARTED|Washout Period of at Least 7 Days||1
7794595|NCT01237899|19188277|P11|NOT COMPLETED|First Dosing Period||0
7794596|NCT01237899|19188278|P10|NOT COMPLETED|First Dosing Period||0
7794597|NCT01237899|19188279|P9|NOT COMPLETED|First Dosing Period||0
7794598|NCT01237899|19188280|P8|NOT COMPLETED|First Dosing Period||0
7794599|NCT01237899|19188281|P7|NOT COMPLETED|First Dosing Period||0
7794600|NCT01237899|19188282|P6|NOT COMPLETED|First Dosing Period||0
7794601|NCT01237899|19188283|P5|NOT COMPLETED|First Dosing Period||0
7794602|NCT01237899|19188284|P4|NOT COMPLETED|First Dosing Period||0
7794603|NCT01237899|19188285|P3|NOT COMPLETED|First Dosing Period||0
7794604|NCT01237899|19188286|P2|NOT COMPLETED|First Dosing Period||0
7794605|NCT01237899|19188287|P1|NOT COMPLETED|First Dosing Period||0
7794606|NCT01237899|19188277|P11|COMPLETED|First Dosing Period||4
7794607|NCT01237899|19188278|P10|COMPLETED|First Dosing Period||3
7794608|NCT01237899|19188279|P9|COMPLETED|First Dosing Period||4
7794609|NCT01237899|19188280|P8|COMPLETED|First Dosing Period||3
7794610|NCT01237899|19188281|P7|COMPLETED|First Dosing Period||1
7794611|NCT01237899|19188282|P6|COMPLETED|First Dosing Period||4
7794612|NCT01237899|19188283|P5|COMPLETED|First Dosing Period||2
7794613|NCT01237899|19188284|P4|COMPLETED|First Dosing Period||3
7794614|NCT01237899|19188285|P3|COMPLETED|First Dosing Period||4
7794615|NCT01237899|19188286|P2|COMPLETED|First Dosing Period||3
7794616|NCT01237899|19188287|P1|COMPLETED|First Dosing Period||1
7794617|NCT01237899|19188277|P11|STARTED|First Dosing Period||4
7794618|NCT01237899|19188278|P10|STARTED|First Dosing Period||3
7794619|NCT01237899|19188279|P9|STARTED|First Dosing Period||4
7794620|NCT01237899|19188280|P8|STARTED|First Dosing Period||3
7794621|NCT01237899|19188281|P7|STARTED|First Dosing Period||1
7794622|NCT01237899|19188282|P6|STARTED|First Dosing Period||4
7794623|NCT01237899|19188283|P5|STARTED|First Dosing Period||2
7794624|NCT01237899|19188284|P4|STARTED|First Dosing Period||3
7794625|NCT01237899|19188285|P3|STARTED|First Dosing Period||4
7794626|NCT01237899|19188286|P2|STARTED|First Dosing Period||3
7794627|NCT01237899|19188287|P1|STARTED|First Dosing Period||1
7794628|NCT01237821|19188317|P2|NOT COMPLETED|Overall Study||0
7794629|NCT01237821|19188318|P1|NOT COMPLETED|Overall Study||6
7794630|NCT01237821|19188317|P2|COMPLETED|Overall Study||34
7794631|NCT01237821|19188318|P1|COMPLETED|Overall Study||26
7794632|NCT01237821|19188317|P2|STARTED|Overall Study||34
7794633|NCT01237821|19188318|P1|STARTED|Overall Study||32
7794634|NCT01237678|19188367|P3|NOT COMPLETED|Phase II||50
7794635|NCT01237678|19188368|P2|NOT COMPLETED|Phase II||98
7794636|NCT01237678|19188369|P1|NOT COMPLETED|Phase II||0
7794637|NCT01237678|19188367|P3|COMPLETED|Phase II||0
7794638|NCT01237678|19188368|P2|COMPLETED|Phase II||0
7794639|NCT01237678|19188369|P1|COMPLETED|Phase II||0
7794640|NCT01237678|19188367|P3|Received Intervention|Phase II||47
7794641|NCT01237678|19188368|P2|Received Intervention|Phase II||94
7794642|NCT01237678|19188369|P1|Received Intervention|Phase II||0
7794643|NCT01237678|19188367|P3|STARTED|Phase II|50 subjects were randomized, 47 subjects treated|50
7794644|NCT01237678|19188368|P2|STARTED|Phase II|98 subjects were randomized, 94 subjects treated|98
7794645|NCT01237678|19188369|P1|STARTED|Phase II||0
7794646|NCT01237678|19188367|P3|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
7794647|NCT01237678|19188368|P2|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
7794648|NCT01237678|19188369|P1|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||33
7794649|NCT01237678|19188367|P3|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
7794650|NCT01237678|19188368|P2|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
7794651|NCT01237678|19188369|P1|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
7794652|NCT01237678|19188367|P3|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
7794653|NCT01237678|19188368|P2|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
7794654|NCT01237678|19188369|P1|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||33
7794655|NCT01237678|19188367|P3|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
7794656|NCT01237678|19188368|P2|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
7794657|NCT01237678|19188369|P1|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||33
7794658|NCT01237613|19188388|P1|NOT COMPLETED|Overall Study||0
7794659|NCT01237613|19188388|P1|COMPLETED|Overall Study||4
7794660|NCT01237613|19188388|P1|STARTED|Overall Study||4
7794661|NCT01237587|19188414|P2|NOT COMPLETED|Taper Phase||10
7794662|NCT01237587|19188415|P1|NOT COMPLETED|Taper Phase||5
7794663|NCT01237587|19188414|P2|COMPLETED|Taper Phase||34
7794664|NCT01237587|19188415|P1|COMPLETED|Taper Phase||31
7794665|NCT01237587|19188414|P2|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|44
7794666|NCT01237587|19188415|P1|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|36
7794667|NCT01237587|19188414|P2|NOT COMPLETED|Open Label Treatment (Extension Phase)||25
7794668|NCT01237587|19188415|P1|NOT COMPLETED|Open Label Treatment (Extension Phase)||18
7794669|NCT01237587|19188414|P2|COMPLETED|Open Label Treatment (Extension Phase)||50
7794670|NCT01237587|19188415|P1|COMPLETED|Open Label Treatment (Extension Phase)||56
7794671|NCT01237587|19188414|P2|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||75
7794672|NCT01237587|19188415|P1|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||74
7794673|NCT01237587|19188414|P2|STARTED|Open Label Treatment (Extension Phase)||75
7794674|NCT01237587|19188415|P1|STARTED|Open Label Treatment (Extension Phase)||74
7794675|NCT01237587|19188414|P2|NOT COMPLETED|Double Blind Treatment (Acute Phase)||18
7794676|NCT01237587|19188415|P1|NOT COMPLETED|Double Blind Treatment (Acute Phase)||17
7794677|NCT01237587|19188414|P2|COMPLETED|Double Blind Treatment (Acute Phase)||75
7794678|NCT01237587|19188415|P1|COMPLETED|Double Blind Treatment (Acute Phase)||74
7794679|NCT01237587|19188414|P2|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||93
7794680|NCT01237587|19188415|P1|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||91
7794681|NCT01237587|19188414|P2|STARTED|Double Blind Treatment (Acute Phase)||93
7794682|NCT01237587|19188415|P1|STARTED|Double Blind Treatment (Acute Phase)||91
7794683|NCT01237353|19188462|P1|NOT COMPLETED|Overall Study||0
7794684|NCT01237353|19188462|P1|COMPLETED|Overall Study||6
7794685|NCT01237353|19188462|P1|STARTED|Overall Study||6
7794686|NCT01237340|19188467|P1|NOT COMPLETED|Overall Study||40
7794687|NCT01237340|19188467|P1|COMPLETED|Overall Study||19
7794688|NCT01237340|19188467|P1|STARTED|Overall Study||59
7794689|NCT01237327|19188481|P2|NOT COMPLETED|Overall Study||40
7794690|NCT01237327|19188482|P1|NOT COMPLETED|Overall Study||42
7794691|NCT01237327|19188481|P2|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
7794692|NCT01237327|19188482|P1|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
7794693|NCT01237327|19188481|P2|Continued Treatment in Extension Study|Overall Study||17
7794694|NCT01237327|19188482|P1|Continued Treatment in Extension Study|Overall Study||21
7794695|NCT01237327|19188481|P2|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2
7794696|NCT01237327|19188482|P1|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3
7794697|NCT01237327|19188481|P2|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24
7794698|NCT01237327|19188482|P1|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22
7794699|NCT01237327|19188481|P2|STARTED|Overall Study||41
7794700|NCT01237327|19188482|P1|STARTED|Overall Study||43
7794701|NCT01237301|19188498|P2|NOT COMPLETED|Overall Study||4
7794702|NCT01237301|19188499|P1|NOT COMPLETED|Overall Study||5
7794703|NCT01237301|19188498|P2|COMPLETED|Overall Study||55
7794704|NCT01237301|19188499|P1|COMPLETED|Overall Study||60
7794705|NCT01237301|19188498|P2|STARTED|Overall Study||59
7794706|NCT01237301|19188499|P1|STARTED|Overall Study||65
7794707|NCT01237223|19188517|P6|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
7794708|NCT01237223|19188518|P5|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4
7794709|NCT01237223|19188519|P4|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
7794710|NCT01237223|19188520|P3|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
7794711|NCT01237223|19188521|P2|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
7794712|NCT01237223|19188522|P1|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33
7794713|NCT01237223|19188517|P6|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154
7794714|NCT01237223|19188518|P5|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155
7794715|NCT01237223|19188519|P4|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153
7794716|NCT01237223|19188520|P3|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143
7794717|NCT01237223|19188521|P2|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142
7794718|NCT01237223|19188522|P1|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120
7794719|NCT01237223|19188517|P6|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
7794720|NCT01237223|19188518|P5|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
7794721|NCT01237223|19188519|P4|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
7794722|NCT01237223|19188520|P3|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
7794723|NCT01237223|19188521|P2|STARTED|Double Blind (Treatment Period, 8 Weeks)||157
7794724|NCT01237223|19188522|P1|STARTED|Double Blind (Treatment Period, 8 Weeks)||153
7794725|NCT01237223|19188517|P6|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
7794726|NCT01237223|19188518|P5|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
7794727|NCT01237223|19188519|P4|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
7794728|NCT01237223|19188520|P3|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
7794729|NCT01237223|19188521|P2|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
7794730|NCT01237223|19188522|P1|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398
7794731|NCT01237223|19188517|P6|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
7794732|NCT01237223|19188518|P5|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
7794733|NCT01237223|19188519|P4|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
7794734|NCT01237223|19188520|P3|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
7794735|NCT01237223|19188521|P2|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
7794736|NCT01237223|19188522|P1|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944
7794737|NCT01237223|19188517|P6|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
7794738|NCT01237223|19188518|P5|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
7794739|NCT01237223|19188519|P4|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
7794740|NCT01237223|19188520|P3|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
7794741|NCT01237223|19188521|P2|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
7794742|NCT01237223|19188522|P1|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342
7794743|NCT01237197|19188563|P2|NOT COMPLETED|Open Label Period||0
7794744|NCT01237197|19188564|P1|NOT COMPLETED|Open Label Period||0
7794745|NCT01237197|19188563|P2|COMPLETED|Open Label Period||10
7794746|NCT01237197|19188564|P1|COMPLETED|Open Label Period||12
7794747|NCT01237197|19188563|P2|STARTED|Open Label Period||10
7794748|NCT01237197|19188564|P1|STARTED|Open Label Period||12
7794749|NCT01237197|19188563|P2|NOT COMPLETED|Randomization Period||3
7794750|NCT01237197|19188564|P1|NOT COMPLETED|Randomization Period||1
7794751|NCT01237197|19188563|P2|COMPLETED|Randomization Period||10
7794752|NCT01237197|19188564|P1|COMPLETED|Randomization Period||12
7794753|NCT01237197|19188563|P2|STARTED|Randomization Period||13
7794754|NCT01237197|19188564|P1|STARTED|Randomization Period||13
7794755|NCT01237080|19188572|P2|NOT COMPLETED|Overall Study||0
7794756|NCT01237080|19188573|P1|NOT COMPLETED|Overall Study||0
7794757|NCT01237080|19188572|P2|COMPLETED|Overall Study||50
7794758|NCT01237080|19188573|P1|COMPLETED|Overall Study||50
7794759|NCT01237080|19188572|P2|STARTED|Overall Study||50
7794760|NCT01237080|19188573|P1|STARTED|Overall Study||50
7794761|NCT01237054|19188581|P1|NOT COMPLETED|Overall Study||1
7794762|NCT01237054|19188581|P1|COMPLETED|Overall Study||30
7794763|NCT01237054|19188581|P1|STARTED|Overall Study||31
7794764|NCT01237041|19188607|P5|NOT COMPLETED|Overall Study||0
7794765|NCT01237041|19188608|P4|NOT COMPLETED|Overall Study||0
7794766|NCT01237041|19188609|P3|NOT COMPLETED|Overall Study||0
7794767|NCT01237041|19188610|P2|NOT COMPLETED|Overall Study||0
7794768|NCT01237041|19188611|P1|NOT COMPLETED|Overall Study||0
7794769|NCT01237041|19188607|P5|COMPLETED|Overall Study||5
7794770|NCT01237041|19188608|P4|COMPLETED|Overall Study||5
7794771|NCT01237041|19188609|P3|COMPLETED|Overall Study||2
7794772|NCT01237041|19188610|P2|COMPLETED|Overall Study||3
7794773|NCT01237041|19188611|P1|COMPLETED|Overall Study||2
7794774|NCT01237041|19188607|P5|STARTED|Overall Study||5
7794775|NCT01237041|19188608|P4|STARTED|Overall Study||5
7794776|NCT01237041|19188609|P3|STARTED|Overall Study||2
7794777|NCT01237041|19188610|P2|STARTED|Overall Study||3
7794778|NCT01237041|19188611|P1|STARTED|Overall Study||2
7794779|NCT01236768|19188635|P2|NOT COMPLETED|Overall Study||61
7794780|NCT01236768|19188636|P1|NOT COMPLETED|Overall Study||89
7794781|NCT01236768|19188635|P2|COMPLETED|Overall Study||145
7794782|NCT01236768|19188636|P1|COMPLETED|Overall Study||112
7794783|NCT01236768|19188635|P2|STARTED|Overall Study||206
7794784|NCT01236768|19188636|P1|STARTED|Overall Study||201
7794785|NCT01236755|19188650|P1|NOT COMPLETED|Orthokeratology Wearing Phase||8
7794786|NCT01236755|19188650|P1|COMPLETED|Orthokeratology Wearing Phase||66
7794787|NCT01236755|19188650|P1|STARTED|Orthokeratology Wearing Phase||74
7794788|NCT01236755|19188650|P1|NOT COMPLETED|Spectacles Wearing Phase||17
7794789|NCT01236755|19188650|P1|COMPLETED|Spectacles Wearing Phase||74
7794790|NCT01236755|19188650|P1|STARTED|Spectacles Wearing Phase||91
7794791|NCT01236742|19188658|P3|NOT COMPLETED|Overall Study||3
7794792|NCT01236742|19188659|P2|NOT COMPLETED|Overall Study||3
7794793|NCT01236742|19188660|P1|NOT COMPLETED|Overall Study||3
7794794|NCT01236742|19188658|P3|COMPLETED|Overall Study||13
7794795|NCT01236742|19188659|P2|COMPLETED|Overall Study||16
7794796|NCT01236742|19188660|P1|COMPLETED|Overall Study||15
7794797|NCT01236742|19188658|P3|STARTED|Overall Study||16
7794798|NCT01236742|19188659|P2|STARTED|Overall Study||19
7794799|NCT01236742|19188660|P1|STARTED|Overall Study||18
7794800|NCT01236534|19188673|P2|NOT COMPLETED|Overall Study||0
7794801|NCT01236534|19188674|P1|NOT COMPLETED|Overall Study||3
7794802|NCT01236534|19188673|P2|COMPLETED|Overall Study||10
7794803|NCT01236534|19188674|P1|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8
7794804|NCT01236534|19188673|P2|STARTED|Overall Study||10
7794805|NCT01236534|19188674|P1|STARTED|Overall Study||11
7794806|NCT01236391|19188682|P1|NOT COMPLETED|Overall Study||16
7794807|NCT01236391|19188682|P1|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95
7794808|NCT01236391|19188682|P1|STARTED|Overall Study|Participants who received study treatment|111
7794809|NCT01236365|19188692|P2|NOT COMPLETED|Overall Study||2
7794810|NCT01236365|19188693|P1|NOT COMPLETED|Overall Study||2
7794811|NCT01236365|19188692|P2|COMPLETED|Overall Study||19
7794812|NCT01236365|19188693|P1|COMPLETED|Overall Study||19
7794813|NCT01236365|19188692|P2|STARTED|Overall Study||21
7794814|NCT01236365|19188693|P1|STARTED|Overall Study||21
7794815|NCT01236339|19188717|P2|NOT COMPLETED|Overall Study||13
7794816|NCT01236339|19188718|P1|NOT COMPLETED|Overall Study||11
7794817|NCT01236339|19188717|P2|COMPLETED|Overall Study||0
7794818|NCT01236339|19188718|P1|COMPLETED|Overall Study||2
7794819|NCT01236339|19188717|P2|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4
7794820|NCT01236339|19188718|P1|LVP Crossover to TIPS|Overall Study||0
7794821|NCT01236339|19188717|P2|STARTED|Overall Study||13
7794822|NCT01236339|19188718|P1|STARTED|Overall Study||13
7794823|NCT01235923|19188738|P2|NOT COMPLETED|Overall Study||0
7794824|NCT01235923|19188739|P1|NOT COMPLETED|Overall Study||0
7794825|NCT01235923|19188738|P2|COMPLETED|Overall Study||10
7794826|NCT01235923|19188739|P1|COMPLETED|Overall Study||10
7794827|NCT01235923|19188738|P2|STARTED|Overall Study||10
7794828|NCT01235923|19188739|P1|STARTED|Overall Study||10
7794829|NCT01235793|19188747|P1|NOT COMPLETED|Overall Study||6
7794830|NCT01235793|19188747|P1|COMPLETED|Overall Study||5
7794831|NCT01235793|19188747|P1|STARTED|Overall Study||11
7794832|NCT01236573|19188763|P11|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1
7794833|NCT01236573|19188764|P10|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794834|NCT01236573|19188765|P9|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794835|NCT01236573|19188766|P8|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794836|NCT01236573|19188767|P7|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794837|NCT01236573|19188768|P6|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794838|NCT01236573|19188769|P5|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794839|NCT01236573|19188770|P4|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794840|NCT01236573|19188771|P3|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794841|NCT01236573|19188772|P2|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794842|NCT01236573|19188773|P1|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794843|NCT01236573|19188763|P11|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5
7794844|NCT01236573|19188764|P10|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794845|NCT01236573|19188765|P9|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794846|NCT01236573|19188766|P8|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794847|NCT01236573|19188767|P7|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794848|NCT01236573|19188768|P6|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794849|NCT01236573|19188769|P5|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794850|NCT01236573|19188770|P4|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794851|NCT01236573|19188771|P3|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794852|NCT01236573|19188772|P2|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794853|NCT01236573|19188773|P1|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794854|NCT01236573|19188763|P11|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6
7794855|NCT01236573|19188764|P10|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794856|NCT01236573|19188765|P9|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794857|NCT01236573|19188766|P8|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794858|NCT01236573|19188767|P7|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794859|NCT01236573|19188768|P6|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794860|NCT01236573|19188769|P5|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794861|NCT01236573|19188770|P4|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794862|NCT01236573|19188771|P3|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794863|NCT01236573|19188772|P2|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794864|NCT01236573|19188773|P1|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
7794865|NCT01236573|19188763|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
7794866|NCT01236573|19188764|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
7794867|NCT01236573|19188765|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
7794868|NCT01236573|19188766|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
7794869|NCT01236573|19188767|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
7794870|NCT01236573|19188768|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
7794871|NCT01236573|19188769|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
7794872|NCT01236573|19188770|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
7794873|NCT01236573|19188771|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
7794874|NCT01236573|19188772|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
7794875|NCT01236573|19188773|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
7794876|NCT01236573|19188763|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
7794877|NCT01236573|19188764|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
7794878|NCT01236573|19188765|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
7794879|NCT01236573|19188766|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
7794880|NCT01236573|19188767|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
7794881|NCT01236573|19188768|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4
7794882|NCT01236573|19188769|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
7794883|NCT01236573|19188770|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
7794884|NCT01236573|19188771|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
7794885|NCT01236573|19188772|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
7794886|NCT01236573|19188773|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
7794887|NCT01236573|19188763|P11|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
7794888|NCT01236573|19188764|P10|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
7794889|NCT01236573|19188765|P9|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
7794890|NCT01236573|19188766|P8|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
7794891|NCT01236573|19188767|P7|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
7794892|NCT01236573|19188768|P6|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
7794893|NCT01236573|19188769|P5|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1
7794894|NCT01236573|19188770|P4|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
7794895|NCT01236573|19188771|P3|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
7794896|NCT01236573|19188772|P2|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
7794897|NCT01236573|19188773|P1|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
7794898|NCT01236573|19188763|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794899|NCT01236573|19188764|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794900|NCT01236573|19188765|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794901|NCT01236573|19188766|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794902|NCT01236573|19188767|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794903|NCT01236573|19188768|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794904|NCT01236573|19188769|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794905|NCT01236573|19188770|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794906|NCT01236573|19188771|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794907|NCT01236573|19188772|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794908|NCT01236573|19188773|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794909|NCT01236573|19188763|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794910|NCT01236573|19188764|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794911|NCT01236573|19188765|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794912|NCT01236573|19188766|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794913|NCT01236573|19188767|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794914|NCT01236573|19188768|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794915|NCT01236573|19188769|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794916|NCT01236573|19188770|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
7794917|NCT01236573|19188771|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6
7794918|NCT01236573|19188772|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
7794919|NCT01236573|19188773|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
7794920|NCT01236573|19188763|P11|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794921|NCT01236573|19188764|P10|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794922|NCT01236573|19188765|P9|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794923|NCT01236573|19188766|P8|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794924|NCT01236573|19188767|P7|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794925|NCT01236573|19188768|P6|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794926|NCT01236573|19188769|P5|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
7794927|NCT01236573|19188770|P4|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
7794928|NCT01236573|19188771|P3|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6
7794929|NCT01236573|19188772|P2|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
7794930|NCT01236573|19188773|P1|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
7794931|NCT01236560|19188815|P6|NOT COMPLETED|Overall Study||0
7794932|NCT01236560|19188816|P5|NOT COMPLETED|Overall Study||0
7794933|NCT01236560|19188817|P4|NOT COMPLETED|Overall Study||22
7794934|NCT01236560|19188818|P3|NOT COMPLETED|Overall Study||20
7794935|NCT01236560|19188819|P2|NOT COMPLETED|Overall Study||24
7794936|NCT01236560|19188820|P1|NOT COMPLETED|Overall Study||5
7794937|NCT01236560|19188815|P6|COMPLETED|Overall Study||0
7794938|NCT01236560|19188816|P5|COMPLETED|Overall Study||0
7794939|NCT01236560|19188817|P4|COMPLETED|Overall Study||10
7794940|NCT01236560|19188818|P3|COMPLETED|Overall Study||11
7794941|NCT01236560|19188819|P2|COMPLETED|Overall Study||8
7794942|NCT01236560|19188820|P1|COMPLETED|Overall Study||1
7794943|NCT01236560|19188815|P6|STARTED|Overall Study||0
7794944|NCT01236560|19188816|P5|STARTED|Overall Study||0
7794945|NCT01236560|19188817|P4|STARTED|Overall Study||32
7794946|NCT01236560|19188818|P3|STARTED|Overall Study||31
7794947|NCT01236560|19188819|P2|STARTED|Overall Study||32
7794948|NCT01236560|19188820|P1|STARTED|Overall Study||6
7794949|NCT01236521|19188841|P2|NOT COMPLETED|Overall Study||25
7794950|NCT01236521|19188842|P1|NOT COMPLETED|Overall Study||21
7794951|NCT01236521|19188841|P2|COMPLETED|Overall Study||105
7794952|NCT01236521|19188842|P1|COMPLETED|Overall Study||110
7794953|NCT01236521|19188841|P2|12-moth Completed|Overall Study||105
7794954|NCT01236521|19188842|P1|12-moth Completed|Overall Study||110
7794955|NCT01236521|19188841|P2|9-month Completed|Overall Study||101
7794956|NCT01236521|19188842|P1|9-month Completed|Overall Study||115
7794957|NCT01236521|19188841|P2|6-month Completed|Overall Study||116
7794958|NCT01236521|19188842|P1|6-month Completed|Overall Study||122
7794959|NCT01236521|19188841|P2|3-month Completed|Overall Study||119
7794960|NCT01236521|19188842|P1|3-month Completed|Overall Study||122
7794961|NCT01236521|19188841|P2|STARTED|Overall Study||130
7794962|NCT01236521|19188842|P1|STARTED|Overall Study||131
7794963|NCT01236378|19188870|P1|NOT COMPLETED|Overall Study||0
7794964|NCT01236378|19188870|P1|COMPLETED|Overall Study||24
7794965|NCT01236378|19188870|P1|STARTED|Overall Study||24
7794966|NCT01236352|19188893|P11|NOT COMPLETED|Overall Study||20
7794967|NCT01236352|19188894|P10|NOT COMPLETED|Overall Study||22
7794968|NCT01236352|19188895|P9|NOT COMPLETED|Overall Study||3
7794969|NCT01236352|19188896|P8|NOT COMPLETED|Overall Study||7
7794970|NCT01236352|19188897|P7|NOT COMPLETED|Overall Study||8
7794971|NCT01236352|19188898|P6|NOT COMPLETED|Overall Study||4
7794972|NCT01236352|19188899|P5|NOT COMPLETED|Overall Study||4
7794973|NCT01236352|19188900|P4|NOT COMPLETED|Overall Study||3
7794974|NCT01236352|19188901|P3|NOT COMPLETED|Overall Study||4
7794975|NCT01236352|19188902|P2|NOT COMPLETED|Overall Study||4
7794976|NCT01236352|19188903|P1|NOT COMPLETED|Overall Study||4
7794977|NCT01236352|19188893|P11|COMPLETED|Overall Study||0
7794978|NCT01236352|19188894|P10|COMPLETED|Overall Study||0
7794979|NCT01236352|19188895|P9|COMPLETED|Overall Study||0
7794980|NCT01236352|19188896|P8|COMPLETED|Overall Study||0
7794981|NCT01236352|19188897|P7|COMPLETED|Overall Study||0
7794982|NCT01236352|19188898|P6|COMPLETED|Overall Study||0
7794983|NCT01236352|19188899|P5|COMPLETED|Overall Study||0
7794984|NCT01236352|19188900|P4|COMPLETED|Overall Study||1
7794985|NCT01236352|19188901|P3|COMPLETED|Overall Study||0
7794986|NCT01236352|19188902|P2|COMPLETED|Overall Study||0
7794987|NCT01236352|19188903|P1|COMPLETED|Overall Study||0
7794988|NCT01236352|19188893|P11|STARTED|Overall Study||20
7794989|NCT01236352|19188894|P10|STARTED|Overall Study||22
7794990|NCT01236352|19188895|P9|STARTED|Overall Study||3
7794991|NCT01236352|19188896|P8|STARTED|Overall Study||7
7794992|NCT01236352|19188897|P7|STARTED|Overall Study||8
7794993|NCT01236352|19188898|P6|STARTED|Overall Study||4
7794994|NCT01236352|19188899|P5|STARTED|Overall Study||4
7794995|NCT01236352|19188900|P4|STARTED|Overall Study||4
7794996|NCT01236352|19188901|P3|STARTED|Overall Study||4
7794997|NCT01236352|19188902|P2|STARTED|Overall Study||4
7794998|NCT01236352|19188903|P1|STARTED|Overall Study||4
7794999|NCT01236326|19189072|P2|NOT COMPLETED|Overall Study||4
7795000|NCT01236326|19189073|P1|NOT COMPLETED|Overall Study||1
7795001|NCT01236326|19189072|P2|COMPLETED|Overall Study||51
7795002|NCT01236326|19189073|P1|COMPLETED|Overall Study||49
7795003|NCT01236326|19189072|P2|STARTED|Overall Study||55
7795004|NCT01236326|19189073|P1|STARTED|Overall Study||50
7795005|NCT01236300|19189087|P1|NOT COMPLETED|Overall Study||0
7795006|NCT01236300|19189087|P1|COMPLETED|Overall Study||66
7795007|NCT01236300|19189087|P1|STARTED|Overall Study||66
7795008|NCT01236196|19189097|P2|NOT COMPLETED|Overall Study||8
7795009|NCT01236196|19189098|P1|NOT COMPLETED|Overall Study||1
7795010|NCT01236196|19189097|P2|COMPLETED|Overall Study||13
7795011|NCT01236196|19189098|P1|COMPLETED|Overall Study||17
7795012|NCT01236196|19189097|P2|STARTED|Overall Study||21
7795013|NCT01236196|19189098|P1|STARTED|Overall Study||18
7795014|NCT01236170|19189110|P1|NOT COMPLETED|Overall Study||15
7795015|NCT01236170|19189110|P1|COMPLETED|Overall Study||482
7795016|NCT01236170|19189110|P1|STARTED|Overall Study||497
7795017|NCT01236118|19189121|P3|NOT COMPLETED|Overall Study||3
7795018|NCT01236118|19189122|P2|NOT COMPLETED|Overall Study||1
7795019|NCT01236118|19189123|P1|NOT COMPLETED|Overall Study||2
7795020|NCT01236118|19189121|P3|COMPLETED|Overall Study||14
7795021|NCT01236118|19189122|P2|COMPLETED|Overall Study||4
7795022|NCT01236118|19189123|P1|COMPLETED|Overall Study||4
7795023|NCT01236118|19189121|P3|STARTED|Overall Study||17
7795024|NCT01236118|19189122|P2|STARTED|Overall Study||5
7795025|NCT01236118|19189123|P1|STARTED|Overall Study||6
7795026|NCT01236105|19189131|P1|NOT COMPLETED|Overall Study||0
7795027|NCT01236105|19189131|P1|COMPLETED|Overall Study||21
7795028|NCT01236105|19189131|P1|STARTED|Overall Study||21
7795029|NCT01236053|19189167|P22|NOT COMPLETED|Overall Study||0
7795030|NCT01236053|19189168|P21|NOT COMPLETED|Overall Study||0
7795031|NCT01236053|19189169|P20|NOT COMPLETED|Overall Study||0
7795032|NCT01236053|19189170|P19|NOT COMPLETED|Overall Study||0
7795033|NCT01236053|19189171|P18|NOT COMPLETED|Overall Study||0
7795034|NCT01236053|19189172|P17|NOT COMPLETED|Overall Study||0
7795035|NCT01236053|19189173|P16|NOT COMPLETED|Overall Study||0
7795036|NCT01236053|19189174|P15|NOT COMPLETED|Overall Study||0
7795037|NCT01236053|19189175|P14|NOT COMPLETED|Overall Study||0
7795038|NCT01236053|19189176|P13|NOT COMPLETED|Overall Study||0
7795039|NCT01236053|19189177|P12|NOT COMPLETED|Overall Study||0
7795040|NCT01236053|19189178|P11|NOT COMPLETED|Overall Study||0
7795041|NCT01236053|19189179|P10|NOT COMPLETED|Overall Study||0
7795042|NCT01236053|19189180|P9|NOT COMPLETED|Overall Study||0
7795043|NCT01236053|19189181|P8|NOT COMPLETED|Overall Study||0
7795044|NCT01236053|19189182|P7|NOT COMPLETED|Overall Study||0
7795045|NCT01236053|19189183|P6|NOT COMPLETED|Overall Study||0
7795046|NCT01236053|19189184|P5|NOT COMPLETED|Overall Study||0
7795047|NCT01236053|19189185|P4|NOT COMPLETED|Overall Study||0
7795048|NCT01236053|19189186|P3|NOT COMPLETED|Overall Study||0
7795049|NCT01236053|19189187|P2|NOT COMPLETED|Overall Study||0
7795050|NCT01236053|19189188|P1|NOT COMPLETED|Overall Study||0
7795051|NCT01236053|19189167|P22|COMPLETED|Overall Study||12167
7795052|NCT01236053|19189168|P21|COMPLETED|Overall Study||1272
7795053|NCT01236053|19189169|P20|COMPLETED|Overall Study||20382
7795054|NCT01236053|19189170|P19|COMPLETED|Overall Study||2155
7795055|NCT01236053|19189171|P18|COMPLETED|Overall Study||380
7795056|NCT01236053|19189172|P17|COMPLETED|Overall Study||38
7795057|NCT01236053|19189173|P16|COMPLETED|Overall Study||43559
7795058|NCT01236053|19189174|P15|COMPLETED|Overall Study||4600
7795059|NCT01236053|19189175|P14|COMPLETED|Overall Study||1396
7795060|NCT01236053|19189176|P13|COMPLETED|Overall Study||148
7795061|NCT01236053|19189177|P12|COMPLETED|Overall Study||188924
7795062|NCT01236053|19189178|P11|COMPLETED|Overall Study||19564
7795063|NCT01236053|19189179|P10|COMPLETED|Overall Study||2935
7795064|NCT01236053|19189180|P9|COMPLETED|Overall Study||300
7795065|NCT01236053|19189181|P8|COMPLETED|Overall Study||102836
7795066|NCT01236053|19189182|P7|COMPLETED|Overall Study||10855
7795067|NCT01236053|19189183|P6|COMPLETED|Overall Study||2067
7795068|NCT01236053|19189184|P5|COMPLETED|Overall Study||212
7795069|NCT01236053|19189185|P4|COMPLETED|Overall Study||17853
7795070|NCT01236053|19189186|P3|COMPLETED|Overall Study||1877
7795071|NCT01236053|19189187|P2|COMPLETED|Overall Study||1710950
7795072|NCT01236053|19189188|P1|COMPLETED|Overall Study||179138
7795073|NCT01236053|19189167|P22|STARTED|Overall Study||12167
7795074|NCT01236053|19189168|P21|STARTED|Overall Study||1272
7795075|NCT01236053|19189169|P20|STARTED|Overall Study||20382
7795076|NCT01236053|19189170|P19|STARTED|Overall Study||2155
7795077|NCT01236053|19189171|P18|STARTED|Overall Study||380
7795078|NCT01236053|19189172|P17|STARTED|Overall Study||38
7795079|NCT01236053|19189173|P16|STARTED|Overall Study||43559
7795080|NCT01236053|19189174|P15|STARTED|Overall Study||4600
7795081|NCT01236053|19189175|P14|STARTED|Overall Study||1396
7795082|NCT01236053|19189176|P13|STARTED|Overall Study||148
7795083|NCT01236053|19189177|P12|STARTED|Overall Study||188924
7795084|NCT01236053|19189178|P11|STARTED|Overall Study||19564
7795085|NCT01236053|19189179|P10|STARTED|Overall Study||2935
7795086|NCT01236053|19189180|P9|STARTED|Overall Study||300
7795087|NCT01236053|19189181|P8|STARTED|Overall Study||102836
7795088|NCT01236053|19189182|P7|STARTED|Overall Study||10855
7795089|NCT01236053|19189183|P6|STARTED|Overall Study||2067
7795090|NCT01236053|19189184|P5|STARTED|Overall Study||212
7795091|NCT01236053|19189185|P4|STARTED|Overall Study||17853
7795092|NCT01236053|19189186|P3|STARTED|Overall Study||1877
7795093|NCT01236053|19189187|P2|STARTED|Overall Study||1710950
7795094|NCT01236053|19189188|P1|STARTED|Overall Study||179138
7795095|NCT01236001|19189324|P2|NOT COMPLETED|Overall Study||22
7795096|NCT01236001|19189325|P1|NOT COMPLETED|Overall Study||18
7795097|NCT01236001|19189324|P2|COMPLETED|Overall Study||65
7795098|NCT01236001|19189325|P1|COMPLETED|Overall Study||87
7795099|NCT01236001|19189324|P2|STARTED|Overall Study||87
7795100|NCT01236001|19189325|P1|STARTED|Overall Study||105
7795101|NCT01235975|19189357|P2|NOT COMPLETED|Overall Study||7
7795102|NCT01235975|19189358|P1|NOT COMPLETED|Overall Study||17
7795103|NCT01235975|19189357|P2|COMPLETED|Overall Study||88
7795104|NCT01235975|19189358|P1|COMPLETED|Overall Study||257
7795105|NCT01235975|19189357|P2|STARTED|Overall Study||95
7795106|NCT01235975|19189358|P1|STARTED|Overall Study||274
7795107|NCT01235962|19189394|P4|NOT COMPLETED|Overall Study||86
7795108|NCT01235962|19189395|P3|NOT COMPLETED|Overall Study||118
7795109|NCT01235962|19189396|P2|NOT COMPLETED|Overall Study||35
7795110|NCT01235962|19189397|P1|NOT COMPLETED|Overall Study||46
7795111|NCT01235962|19189394|P4|COMPLETED|Overall Study||478
7795112|NCT01235962|19189395|P3|COMPLETED|Overall Study||453
7795113|NCT01235962|19189396|P2|COMPLETED|Overall Study||170
7795114|NCT01235962|19189397|P1|COMPLETED|Overall Study||152
7795115|NCT01235962|19189394|P4|All Deaths|Overall Study||104
7795116|NCT01235962|19189395|P3|All Deaths|Overall Study||102
7795117|NCT01235962|19189396|P2|All Deaths|Overall Study||46
7795118|NCT01235962|19189397|P1|All Deaths|Overall Study||43
7795119|NCT01235962|19189394|P4|Prem. Withdrawn = Did Not Complete Study|Overall Study||86
7795120|NCT01235962|19189395|P3|Prem. Withdrawn = Did Not Complete Study|Overall Study||118
7795121|NCT01235962|19189396|P2|Prem. Withdrawn = Did Not Complete Study|Overall Study||35
7795122|NCT01235962|19189397|P1|Prem. Withdrawn = Did Not Complete Study|Overall Study||46
7795123|NCT01235962|19189394|P4|STARTED|Overall Study||564
7795124|NCT01235962|19189395|P3|STARTED|Overall Study||571
7795125|NCT01235962|19189396|P2|STARTED|Overall Study||205
7795126|NCT01235962|19189397|P1|STARTED|Overall Study||198
7795127|NCT01235949|19189467|P18|NOT COMPLETED|Booster Phase||2
7795128|NCT01235949|19189468|P17|NOT COMPLETED|Booster Phase||0
7795129|NCT01235949|19189469|P16|NOT COMPLETED|Booster Phase||1
7795130|NCT01235949|19189470|P15|NOT COMPLETED|Booster Phase||2
7795131|NCT01235949|19189471|P14|NOT COMPLETED|Booster Phase||0
7795132|NCT01235949|19189472|P13|NOT COMPLETED|Booster Phase||3
7795133|NCT01235949|19189473|P12|NOT COMPLETED|Booster Phase||3
7795134|NCT01235949|19189474|P11|NOT COMPLETED|Booster Phase||2
7795135|NCT01235949|19189475|P10|NOT COMPLETED|Booster Phase||1
7795136|NCT01235949|19189476|P9|NOT COMPLETED|Booster Phase||2
7795137|NCT01235949|19189477|P8|NOT COMPLETED|Booster Phase||1
7795138|NCT01235949|19189478|P7|NOT COMPLETED|Booster Phase||0
7795139|NCT01235949|19189479|P6|NOT COMPLETED|Booster Phase||0
7795140|NCT01235949|19189480|P5|NOT COMPLETED|Booster Phase||0
7795141|NCT01235949|19189481|P4|NOT COMPLETED|Booster Phase||0
7795142|NCT01235949|19189482|P3|NOT COMPLETED|Booster Phase||0
7795143|NCT01235949|19189483|P2|NOT COMPLETED|Booster Phase||0
7795144|NCT01235949|19189484|P1|NOT COMPLETED|Booster Phase||0
7795145|NCT01235949|19189467|P18|COMPLETED|Booster Phase||65
7795146|NCT01235949|19189468|P17|COMPLETED|Booster Phase||68
7795147|NCT01235949|19189469|P16|COMPLETED|Booster Phase||66
7795148|NCT01235949|19189470|P15|COMPLETED|Booster Phase||60
7795149|NCT01235949|19189471|P14|COMPLETED|Booster Phase||65
7795150|NCT01235949|19189472|P13|COMPLETED|Booster Phase||60
7795151|NCT01235949|19189473|P12|COMPLETED|Booster Phase||60
7795152|NCT01235949|19189474|P11|COMPLETED|Booster Phase||61
7795153|NCT01235949|19189475|P10|COMPLETED|Booster Phase||62
7795154|NCT01235949|19189476|P9|COMPLETED|Booster Phase||61
7795155|NCT01235949|19189477|P8|COMPLETED|Booster Phase||59
7795156|NCT01235949|19189478|P7|COMPLETED|Booster Phase||64
7795157|NCT01235949|19189479|P6|COMPLETED|Booster Phase||0
7795158|NCT01235949|19189480|P5|COMPLETED|Booster Phase||0
7795159|NCT01235949|19189481|P4|COMPLETED|Booster Phase||0
7795160|NCT01235949|19189482|P3|COMPLETED|Booster Phase||0
7795161|NCT01235949|19189483|P2|COMPLETED|Booster Phase||0
7795162|NCT01235949|19189484|P1|COMPLETED|Booster Phase||0
7795163|NCT01235949|19189467|P18|STARTED|Booster Phase|subjects from the primary NPARA group continuing in booster phase with different treatment|67
7795164|NCT01235949|19189468|P17|STARTED|Booster Phase|subjects from the primary DPARA group continuing in booster phase with different treatment|68
7795165|NCT01235949|19189469|P16|STARTED|Booster Phase|subjects from the primary IPARA group continuing in booster phase with different treatment|67
7795166|NCT01235949|19189470|P15|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|62
7795167|NCT01235949|19189471|P14|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|65
7795168|NCT01235949|19189472|P13|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|63
7795169|NCT01235949|19189473|P12|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
7795170|NCT01235949|19189474|P11|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
7795171|NCT01235949|19189475|P10|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
7795172|NCT01235949|19189476|P9|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|63
7795173|NCT01235949|19189477|P8|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|60
7795174|NCT01235949|19189478|P7|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|64
7795175|NCT01235949|19189479|P6|STARTED|Booster Phase|subjects re-randomized to NPARA-IPARA Group in booster phase|0
7795176|NCT01235949|19189480|P5|STARTED|Booster Phase|subjects re-randomized to DPARA-IPARA Group in booster phase|0
7795177|NCT01235949|19189481|P4|STARTED|Booster Phase|subjects re-randomized to IPARA-NPARA Group in booster phase|0
7795178|NCT01235949|19189482|P3|STARTED|Booster Phase|re-randomized to diverse treatments (NIBU-IIBU, NIBU-DIBU and NIBU-NIBU Groups) in booster phase|0
7795179|NCT01235949|19189483|P2|STARTED|Booster Phase|re-randomized to diverse treatments (DIBU-IIBU, DIBU-DIBU and DIBU-NIBU Groups) in booster phase|0
7795180|NCT01235949|19189484|P1|STARTED|Booster Phase|re-randomized to diverse treatments (IIBU-IIBU, IIBU-DIBU and IIBU-NIBU Groups) in booster phase|0
7795181|NCT01235949|19189467|P18|NOT COMPLETED|Primary Phase||0
7795182|NCT01235949|19189468|P17|NOT COMPLETED|Primary Phase||0
7795183|NCT01235949|19189469|P16|NOT COMPLETED|Primary Phase||0
7795184|NCT01235949|19189470|P15|NOT COMPLETED|Primary Phase||0
7795185|NCT01235949|19189471|P14|NOT COMPLETED|Primary Phase||0
7795186|NCT01235949|19189472|P13|NOT COMPLETED|Primary Phase||0
7795187|NCT01235949|19189473|P12|NOT COMPLETED|Primary Phase||0
7795188|NCT01235949|19189474|P11|NOT COMPLETED|Primary Phase||0
7795189|NCT01235949|19189475|P10|NOT COMPLETED|Primary Phase||0
7795190|NCT01235949|19189476|P9|NOT COMPLETED|Primary Phase||0
7795191|NCT01235949|19189477|P8|NOT COMPLETED|Primary Phase||0
7795192|NCT01235949|19189478|P7|NOT COMPLETED|Primary Phase||0
7795193|NCT01235949|19189479|P6|NOT COMPLETED|Primary Phase||7
7795194|NCT01235949|19189480|P5|NOT COMPLETED|Primary Phase||1
7795195|NCT01235949|19189481|P4|NOT COMPLETED|Primary Phase||2
7795196|NCT01235949|19189482|P3|NOT COMPLETED|Primary Phase||3
7795197|NCT01235949|19189483|P2|NOT COMPLETED|Primary Phase||3
7795198|NCT01235949|19189484|P1|NOT COMPLETED|Primary Phase||4
7795199|NCT01235949|19189467|P18|COMPLETED|Primary Phase||0
7795200|NCT01235949|19189468|P17|COMPLETED|Primary Phase||0
7795201|NCT01235949|19189469|P16|COMPLETED|Primary Phase||0
7795202|NCT01235949|19189470|P15|COMPLETED|Primary Phase||0
7795203|NCT01235949|19189471|P14|COMPLETED|Primary Phase||0
7795204|NCT01235949|19189472|P13|COMPLETED|Primary Phase||0
7795205|NCT01235949|19189473|P12|COMPLETED|Primary Phase||0
7795206|NCT01235949|19189474|P11|COMPLETED|Primary Phase||0
7795207|NCT01235949|19189475|P10|COMPLETED|Primary Phase||0
7795208|NCT01235949|19189476|P9|COMPLETED|Primary Phase||0
7795209|NCT01235949|19189477|P8|COMPLETED|Primary Phase||0
7795210|NCT01235949|19189478|P7|COMPLETED|Primary Phase||0
7795211|NCT01235949|19189479|P6|COMPLETED|Primary Phase|After Primary Phase completion, all subjects were willing to participate in the Booster Phase|67
7795212|NCT01235949|19189480|P5|COMPLETED|Primary Phase|After Primary Phase completion, 3 subjects were not willing to participate in the Booster Phase|71
7795213|NCT01235949|19189481|P4|COMPLETED|Primary Phase|After Primary Phase completion, 2 subjects were not willing to participate in the Booster Phase|69
7795214|NCT01235949|19189482|P3|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|196
7795215|NCT01235949|19189483|P2|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|195
7795216|NCT01235949|19189484|P1|COMPLETED|Primary Phase|After Primary Phase completion, 7 subjects were not willing to participate in the Booster Phase|194
7795217|NCT01235949|19189467|P18|STARTED|Primary Phase||0
7795218|NCT01235949|19189468|P17|STARTED|Primary Phase||0
7795219|NCT01235949|19189469|P16|STARTED|Primary Phase||0
7795220|NCT01235949|19189470|P15|STARTED|Primary Phase||0
7795221|NCT01235949|19189471|P14|STARTED|Primary Phase||0
7795222|NCT01235949|19189472|P13|STARTED|Primary Phase||0
7795223|NCT01235949|19189473|P12|STARTED|Primary Phase||0
7795224|NCT01235949|19189474|P11|STARTED|Primary Phase||0
7795225|NCT01235949|19189475|P10|STARTED|Primary Phase||0
7795226|NCT01235949|19189476|P9|STARTED|Primary Phase||0
7795227|NCT01235949|19189477|P8|STARTED|Primary Phase||0
7795228|NCT01235949|19189478|P7|STARTED|Primary Phase||0
7795229|NCT01235949|19189479|P6|STARTED|Primary Phase||74
7795230|NCT01235949|19189480|P5|STARTED|Primary Phase||72
7795231|NCT01235949|19189481|P4|STARTED|Primary Phase||71
7795232|NCT01235949|19189482|P3|STARTED|Primary Phase||199
7795233|NCT01235949|19189483|P2|STARTED|Primary Phase||198
7795234|NCT01235949|19189484|P1|STARTED|Primary Phase||198
7795235|NCT01235910|19189720|P1|NOT COMPLETED|Overall Study||0
7795236|NCT01235910|19189720|P1|COMPLETED|Overall Study||1
7795237|NCT01235910|19189720|P1|STARTED|Overall Study||1
7795238|NCT01235897|19189726|P1|NOT COMPLETED|Overall Study||0
7795239|NCT01235897|19189726|P1|COMPLETED|Overall Study||16
7795240|NCT01235897|19189726|P1|STARTED|Overall Study||16
7795241|NCT01235741|19189734|P3|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7
7795242|NCT01235741|19189735|P2|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9
7795243|NCT01235741|19189736|P1|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0
7795244|NCT01235741|19189734|P3|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29
7795326|NCT01235442|19189980|P1|COMPLETED|Overall Study||253
7795245|NCT01235741|19189735|P2|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27
7795246|NCT01235741|19189736|P1|COMPLETED|Follow-Up Post Treatment up to Month 6||0
7795247|NCT01235741|19189734|P3|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36
7795248|NCT01235741|19189735|P2|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36
7795249|NCT01235741|19189736|P1|STARTED|Follow-Up Post Treatment up to Month 6||0
7795250|NCT01235741|19189734|P3|NOT COMPLETED|Randomized to Treatment||36
7795251|NCT01235741|19189735|P2|NOT COMPLETED|Randomized to Treatment||36
7795252|NCT01235741|19189736|P1|NOT COMPLETED|Randomized to Treatment||0
7795253|NCT01235741|19189734|P3|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
7795254|NCT01235741|19189735|P2|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
7795255|NCT01235741|19189736|P1|COMPLETED|Randomized to Treatment||0
7795256|NCT01235741|19189734|P3|STARTED|Randomized to Treatment||36
7795257|NCT01235741|19189735|P2|STARTED|Randomized to Treatment||36
7795258|NCT01235741|19189736|P1|STARTED|Randomized to Treatment||0
7795259|NCT01235741|19189734|P3|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
7795260|NCT01235741|19189735|P2|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
7795261|NCT01235741|19189736|P1|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141
7795262|NCT01235741|19189734|P3|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
7795263|NCT01235741|19189735|P2|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
7795264|NCT01235741|19189736|P1|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72
7795265|NCT01235741|19189734|P3|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
7795266|NCT01235741|19189735|P2|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
7795267|NCT01235741|19189736|P1|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213
7795268|NCT01235728|19189763|P8|NOT COMPLETED|Overall Study||0
7795269|NCT01235728|19189764|P7|NOT COMPLETED|Overall Study||0
7795270|NCT01235728|19189765|P6|NOT COMPLETED|Overall Study||0
7795271|NCT01235728|19189766|P5|NOT COMPLETED|Overall Study||0
7795272|NCT01235728|19189767|P4|NOT COMPLETED|Overall Study||1
7795273|NCT01235728|19189768|P3|NOT COMPLETED|Overall Study||0
7795274|NCT01235728|19189769|P2|NOT COMPLETED|Overall Study||0
7795275|NCT01235728|19189770|P1|NOT COMPLETED|Overall Study||0
7795276|NCT01235728|19189763|P8|COMPLETED|Overall Study||3
7795277|NCT01235728|19189764|P7|COMPLETED|Overall Study||3
7795278|NCT01235728|19189765|P6|COMPLETED|Overall Study||3
7795279|NCT01235728|19189766|P5|COMPLETED|Overall Study||3
7795280|NCT01235728|19189767|P4|COMPLETED|Overall Study||2
7795281|NCT01235728|19189768|P3|COMPLETED|Overall Study||3
7795282|NCT01235728|19189769|P2|COMPLETED|Overall Study||3
7795283|NCT01235728|19189770|P1|COMPLETED|Overall Study||3
7795284|NCT01235728|19189763|P8|STARTED|Overall Study||3
7795285|NCT01235728|19189764|P7|STARTED|Overall Study||3
7795286|NCT01235728|19189765|P6|STARTED|Overall Study||3
7795287|NCT01235728|19189766|P5|STARTED|Overall Study||3
7795288|NCT01235728|19189767|P4|STARTED|Overall Study||3
7795289|NCT01235728|19189768|P3|STARTED|Overall Study||3
7795290|NCT01235728|19189769|P2|STARTED|Overall Study||3
7795291|NCT01235728|19189770|P1|STARTED|Overall Study||3
7795292|NCT01235715|19189780|P2|NOT COMPLETED|Overall Study||2
7795293|NCT01235715|19189781|P1|NOT COMPLETED|Overall Study||0
7795294|NCT01235715|19189780|P2|COMPLETED|Overall Study||100
7795295|NCT01235715|19189781|P1|COMPLETED|Overall Study||98
7795296|NCT01235715|19189780|P2|STARTED|Overall Study||102
7795297|NCT01235715|19189781|P1|STARTED|Overall Study||98
7795298|NCT01235689|19189821|P2|NOT COMPLETED|Overall Study||32
7795299|NCT01235689|19189822|P1|NOT COMPLETED|Overall Study||29
7795300|NCT01235689|19189821|P2|COMPLETED|Overall Study||90
7795301|NCT01235689|19189822|P1|COMPLETED|Overall Study||93
7795302|NCT01235689|19189821|P2|Randomized at Week 9|Overall Study||53
7795303|NCT01235689|19189822|P1|Randomized at Week 9|Overall Study||59
7795304|NCT01235689|19189821|P2|Early Randomized (Baseline to Week 9)|Overall Study||69
7795305|NCT01235689|19189822|P1|Early Randomized (Baseline to Week 9)|Overall Study||63
7795306|NCT01235689|19189821|P2|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
7795307|NCT01235689|19189822|P1|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
7795308|NCT01235598|19189894|P2|NOT COMPLETED|Overall Study||4
7795309|NCT01235598|19189895|P1|NOT COMPLETED|Overall Study||1
7795310|NCT01235598|19189894|P2|COMPLETED|Overall Study||24
7795311|NCT01235598|19189895|P1|COMPLETED|Overall Study||12
7795312|NCT01235598|19189894|P2|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28
7795313|NCT01235598|19189895|P1|STARTED|Overall Study||13
7795314|NCT01235546|19189940|P2|NOT COMPLETED|Overall Study||1
7795315|NCT01235546|19189941|P1|NOT COMPLETED|Overall Study||2
7795316|NCT01235546|19189940|P2|COMPLETED|Overall Study||1018
7795317|NCT01235546|19189941|P1|COMPLETED|Overall Study||992
7795318|NCT01235546|19189940|P2|STARTED|Overall Study||1019
7795319|NCT01235546|19189941|P1|STARTED|Overall Study||994
7795320|NCT01235507|19189965|P1|NOT COMPLETED|Overall Study||2
7795321|NCT01235507|19189965|P1|COMPLETED|Overall Study||69
7795322|NCT01235507|19189965|P1|STARTED|Overall Study||71
7795323|NCT01235442|19189979|P2|NOT COMPLETED|Overall Study||44
7795324|NCT01235442|19189980|P1|NOT COMPLETED|Overall Study||44
7795325|NCT01235442|19189979|P2|COMPLETED|Overall Study||251
7795327|NCT01235442|19189979|P2|STARTED|Overall Study||295
7795328|NCT01235442|19189980|P1|STARTED|Overall Study||297
7795329|NCT01235403|19189998|P1|NOT COMPLETED|Overall Study||26
7795330|NCT01235403|19189998|P1|COMPLETED|Overall Study||74
7795331|NCT01235403|19189998|P1|STARTED|Overall Study||100
7795332|NCT01235377|19190006|P2|NOT COMPLETED|Overall Study||1
7795333|NCT01235377|19190007|P1|NOT COMPLETED|Overall Study||1
7795334|NCT01235377|19190006|P2|COMPLETED|Overall Study||8
7795335|NCT01235377|19190007|P1|COMPLETED|Overall Study||10
7795336|NCT01235377|19190006|P2|STARTED|Overall Study||9
7795337|NCT01235377|19190007|P1|STARTED|Overall Study||11
7795338|NCT01235351|19190015|P2|NOT COMPLETED|Treatment With Different Dose Sequences||0
7795339|NCT01235351|19190016|P1|NOT COMPLETED|Treatment With Different Dose Sequences||0
7795340|NCT01235351|19190015|P2|COMPLETED|Treatment With Different Dose Sequences||82
7795341|NCT01235351|19190016|P1|COMPLETED|Treatment With Different Dose Sequences||233
7795342|NCT01235351|19190015|P2|300 mg First Then 225 mg|Treatment With Different Dose Sequences||41
7795343|NCT01235351|19190016|P1|300 mg First Then 225 mg|Treatment With Different Dose Sequences||0
7795344|NCT01235351|19190015|P2|225 mg First Then 300 mg|Treatment With Different Dose Sequences||41
7795345|NCT01235351|19190016|P1|225 mg First Then 300 mg|Treatment With Different Dose Sequences||0
7795346|NCT01235351|19190015|P2|150 mg First Then 75 mg|Treatment With Different Dose Sequences||0
7795347|NCT01235351|19190016|P1|150 mg First Then 75 mg|Treatment With Different Dose Sequences||117
7795348|NCT01235351|19190015|P2|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||0
7795349|NCT01235351|19190016|P1|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||116
7795350|NCT01235351|19190015|P2|STARTED|Treatment With Different Dose Sequences||82
7795351|NCT01235351|19190016|P1|STARTED|Treatment With Different Dose Sequences||233
7795352|NCT01235351|19190015|P2|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||4
7795353|NCT01235351|19190016|P1|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||10
7795354|NCT01235351|19190015|P2|COMPLETED|Initial Treatment With 75 mg and 150 mg||82
7795355|NCT01235351|19190016|P1|COMPLETED|Initial Treatment With 75 mg and 150 mg|4 allocated to initial treatment included in primary analysis|237
7795356|NCT01235351|19190015|P2|STARTED|Initial Treatment With 75 mg and 150 mg||86
7795357|NCT01235351|19190016|P1|STARTED|Initial Treatment With 75 mg and 150 mg||247
7795358|NCT01235338|19190028|P2|NOT COMPLETED|Overall Study||5
7795359|NCT01235338|19190029|P1|NOT COMPLETED|Overall Study||11
7795360|NCT01235338|19190028|P2|COMPLETED|Overall Study||33
7795361|NCT01235338|19190029|P1|COMPLETED|Overall Study||31
7795362|NCT01235338|19190028|P2|STARTED|Overall Study||38
7795363|NCT01235338|19190029|P1|STARTED|Overall Study||42
7795364|NCT01235234|19190074|P3|NOT COMPLETED|Overall Study||1
7795365|NCT01235234|19190075|P2|NOT COMPLETED|Overall Study||2
7795366|NCT01235234|19190076|P1|NOT COMPLETED|Overall Study||2
7795367|NCT01235234|19190074|P3|COMPLETED|Overall Study||80
7795368|NCT01235234|19190075|P2|COMPLETED|Overall Study||76
7795369|NCT01235234|19190076|P1|COMPLETED|Overall Study||75
7795370|NCT01235234|19190074|P3|STARTED|Overall Study||81
7795371|NCT01235234|19190075|P2|STARTED|Overall Study||78
7795372|NCT01235234|19190076|P1|STARTED|Overall Study||77
7795373|NCT01235195|19190084|P2|NOT COMPLETED|Second Intervention||0
7795374|NCT01235195|19190085|P1|NOT COMPLETED|Second Intervention||0
7795375|NCT01235195|19190084|P2|COMPLETED|Second Intervention||15
7795376|NCT01235195|19190085|P1|COMPLETED|Second Intervention||15
7795377|NCT01235195|19190084|P2|STARTED|Second Intervention||15
7795378|NCT01235195|19190085|P1|STARTED|Second Intervention||15
7795379|NCT01235195|19190084|P2|NOT COMPLETED|Washout Period of At Least 8 Days||0
7795380|NCT01235195|19190085|P1|NOT COMPLETED|Washout Period of At Least 8 Days||0
7795381|NCT01235195|19190084|P2|COMPLETED|Washout Period of At Least 8 Days||15
7795382|NCT01235195|19190085|P1|COMPLETED|Washout Period of At Least 8 Days||15
7795383|NCT01235195|19190084|P2|STARTED|Washout Period of At Least 8 Days||15
7795384|NCT01235195|19190085|P1|STARTED|Washout Period of At Least 8 Days||15
7795385|NCT01235195|19190084|P2|NOT COMPLETED|First Intervention||0
7795386|NCT01235195|19190085|P1|NOT COMPLETED|First Intervention||0
7795387|NCT01235195|19190084|P2|COMPLETED|First Intervention||15
7795388|NCT01235195|19190085|P1|COMPLETED|First Intervention||15
7795389|NCT01235195|19190084|P2|STARTED|First Intervention||15
7795390|NCT01235195|19190085|P1|STARTED|First Intervention||15
7795391|NCT01234922|19190105|P4|NOT COMPLETED|Overall Study||0
7795392|NCT01234922|19190106|P3|NOT COMPLETED|Overall Study||0
7795393|NCT01234922|19190107|P2|NOT COMPLETED|Overall Study||0
7795394|NCT01234922|19190108|P1|NOT COMPLETED|Overall Study||0
7795395|NCT01234922|19190105|P4|COMPLETED|Overall Study||2
7795396|NCT01234922|19190106|P3|COMPLETED|Overall Study||2
7795397|NCT01234922|19190107|P2|COMPLETED|Overall Study||1
7795398|NCT01234922|19190108|P1|COMPLETED|Overall Study||1
7795399|NCT01234922|19190105|P4|STARTED|Overall Study||2
7795400|NCT01234922|19190106|P3|STARTED|Overall Study||2
7795401|NCT01234922|19190107|P2|STARTED|Overall Study||1
7795402|NCT01234922|19190108|P1|STARTED|Overall Study||1
7795403|NCT01234883|19190124|P2|NOT COMPLETED|Overall Study||13
7795404|NCT01234883|19190125|P1|NOT COMPLETED|Overall Study||10
7795405|NCT01234883|19190124|P2|COMPLETED|Overall Study||36
7795406|NCT01234883|19190125|P1|COMPLETED|Overall Study||41
7795407|NCT01234883|19190124|P2|STARTED|Overall Study||49
7795408|NCT01234883|19190125|P1|STARTED|Overall Study||51
7795409|NCT01234870|19190131|P1|NOT COMPLETED|Overall Study||0
7795410|NCT01234870|19190131|P1|COMPLETED|Overall Study||40
7795411|NCT01234870|19190131|P1|STARTED|Overall Study||40
7795412|NCT01234831|19190138|P2|NOT COMPLETED|Overall Study||4
7795413|NCT01234831|19190139|P1|NOT COMPLETED|Overall Study||2
7795414|NCT01234831|19190138|P2|COMPLETED|Overall Study||198
7795415|NCT01234831|19190139|P1|COMPLETED|Overall Study||259
7795416|NCT01234831|19190138|P2|STARTED|Overall Study||202
7795417|NCT01234831|19190139|P1|STARTED|Overall Study||261
7795418|NCT01234766|19190151|P1|NOT COMPLETED|Overall Study||4
7795419|NCT01234766|19190151|P1|COMPLETED|Overall Study||35
7795420|NCT01234766|19190151|P1|STARTED|Overall Study||39
7795421|NCT01234714|19190155|P1|NOT COMPLETED|Overall Study||0
7795422|NCT01234714|19190155|P1|COMPLETED|Overall Study||84
7795423|NCT01234714|19190155|P1|STARTED|Overall Study||84
7795424|NCT01234675|19190172|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
7795425|NCT01234675|19190173|P1|NOT COMPLETED|Second Intervention (6 Weeks)||2
7795426|NCT01234675|19190172|P2|COMPLETED|Second Intervention (6 Weeks)||8
7795427|NCT01234675|19190173|P1|COMPLETED|Second Intervention (6 Weeks)||7
7795428|NCT01234675|19190172|P2|STARTED|Second Intervention (6 Weeks)||8
7795429|NCT01234675|19190173|P1|STARTED|Second Intervention (6 Weeks)||9
7795430|NCT01234675|19190172|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
7795431|NCT01234675|19190173|P1|NOT COMPLETED|First Intervention (6 Weeks)||1
7795432|NCT01234675|19190172|P2|COMPLETED|First Intervention (6 Weeks)||8
7795433|NCT01234675|19190173|P1|COMPLETED|First Intervention (6 Weeks)||9
7795434|NCT01234675|19190172|P2|STARTED|First Intervention (6 Weeks)||9
7795435|NCT01234675|19190173|P1|STARTED|First Intervention (6 Weeks)||10
7795436|NCT01234649|19190205|P2|NOT COMPLETED|Overall Study||38
7795437|NCT01234649|19190206|P1|NOT COMPLETED|Overall Study||43
7795438|NCT01234649|19190205|P2|COMPLETED|Overall Study||37
7795439|NCT01234649|19190206|P1|COMPLETED|Overall Study||35
7795440|NCT01234649|19190205|P2|STARTED|Overall Study||75
7795441|NCT01234649|19190206|P1|STARTED|Overall Study||78
7795442|NCT01234467|19190254|P1|NOT COMPLETED|Overall Study||12
7795443|NCT01234467|19190254|P1|COMPLETED|Overall Study||11
7795444|NCT01234467|19190254|P1|STARTED|Overall Study||23
7795445|NCT01234402|19190266|P3|NOT COMPLETED|Overall Study||8
7795446|NCT01234402|19190267|P2|NOT COMPLETED|Overall Study||6
7795447|NCT01234402|19190268|P1|NOT COMPLETED|Overall Study||1
7795448|NCT01234402|19190266|P3|COMPLETED|Overall Study||42
7795449|NCT01234402|19190267|P2|COMPLETED|Overall Study||45
7795450|NCT01234402|19190268|P1|COMPLETED|Overall Study||51
7795451|NCT01234402|19190266|P3|Capecitabine Crossover to Icrucumab|Overall Study||1
7795452|NCT01234402|19190267|P2|Capecitabine Crossover to Icrucumab|Overall Study||0
7795453|NCT01234402|19190268|P1|Capecitabine Crossover to Icrucumab|Overall Study||0
7795454|NCT01234402|19190266|P3|Capecitabine Crossover to Ramucirumab|Overall Study||29
7795455|NCT01234402|19190267|P2|Capecitabine Crossover to Ramucirumab|Overall Study||0
7795456|NCT01234402|19190268|P1|Capecitabine Crossover to Ramucirumab|Overall Study||0
7795457|NCT01234402|19190266|P3|Received at Least One Dose of Study Drug|Overall Study||49
7795458|NCT01234402|19190267|P2|Received at Least One Dose of Study Drug|Overall Study||49
7795459|NCT01234402|19190268|P1|Received at Least One Dose of Study Drug|Overall Study||52
7795460|NCT01234402|19190266|P3|STARTED|Overall Study||50
7795461|NCT01234402|19190267|P2|STARTED|Overall Study||51
7795462|NCT01234402|19190268|P1|STARTED|Overall Study||52
7795463|NCT01234350|19190309|P2|NOT COMPLETED|Overall Study||267
7795464|NCT01234350|19190310|P1|NOT COMPLETED|Overall Study||687
7795465|NCT01234350|19190309|P2|COMPLETED|Overall Study||226
7795466|NCT01234350|19190310|P1|COMPLETED|Overall Study||313
7795467|NCT01234350|19190309|P2|STARTED|Overall Study||493
7795468|NCT01234350|19190310|P1|STARTED|Overall Study||1000
7795469|NCT01234337|19190336|P2|NOT COMPLETED|Overall Study||271
7795470|NCT01234337|19190337|P1|NOT COMPLETED|Overall Study||266
7795471|NCT01234337|19190336|P2|COMPLETED|Overall Study||0
7795472|NCT01234337|19190337|P1|COMPLETED|Overall Study||0
7795473|NCT01234337|19190336|P2|Participants Received Treatment|Overall Study||267
7795474|NCT01234337|19190337|P1|Participants Received Treatment|Overall Study||260
7795475|NCT01234337|19190336|P2|STARTED|Overall Study||271
7795476|NCT01234337|19190337|P1|STARTED|Overall Study||266
7795477|NCT01234207|19190365|P2|NOT COMPLETED|Second Intervention||0
7795478|NCT01234207|19190366|P1|NOT COMPLETED|Second Intervention||0
7795479|NCT01234207|19190365|P2|COMPLETED|Second Intervention||48
7795480|NCT01234207|19190366|P1|COMPLETED|Second Intervention||47
7795481|NCT01234207|19190365|P2|STARTED|Second Intervention||48
7795482|NCT01234207|19190366|P1|STARTED|Second Intervention||47
7795483|NCT01234207|19190365|P2|NOT COMPLETED|1-Week Washout Period||0
7795484|NCT01234207|19190366|P1|NOT COMPLETED|1-Week Washout Period||0
7795485|NCT01234207|19190365|P2|COMPLETED|1-Week Washout Period||48
7795486|NCT01234207|19190366|P1|COMPLETED|1-Week Washout Period||47
7795487|NCT01234207|19190365|P2|STARTED|1-Week Washout Period||48
7795488|NCT01234207|19190366|P1|STARTED|1-Week Washout Period||47
7795489|NCT01234207|19190365|P2|NOT COMPLETED|First Intervention||0
7795490|NCT01234207|19190366|P1|NOT COMPLETED|First Intervention||0
7795491|NCT01234207|19190365|P2|COMPLETED|First Intervention||48
7795492|NCT01234207|19190366|P1|COMPLETED|First Intervention||47
7795493|NCT01234207|19190365|P2|STARTED|First Intervention||48
7795494|NCT01234207|19190366|P1|STARTED|First Intervention||47
7795495|NCT01234103|19190388|P2|NOT COMPLETED|Overall Study||0
7795496|NCT01234103|19190389|P1|NOT COMPLETED|Overall Study||0
7795497|NCT01234103|19190388|P2|COMPLETED|Overall Study||391
7795498|NCT01234103|19190389|P1|COMPLETED|Overall Study||542
7795499|NCT01234103|19190388|P2|STARTED|Overall Study||391
7795500|NCT01234103|19190389|P1|STARTED|Overall Study||542
7795501|NCT01233999|19190397|P1|NOT COMPLETED|Overall Study||2
7795502|NCT01233999|19190397|P1|COMPLETED|Overall Study||8
7795503|NCT01233999|19190397|P1|STARTED|Overall Study||10
7795504|NCT01233921|19190403|P2|NOT COMPLETED|Overall Study||0
7795505|NCT01233921|19190404|P1|NOT COMPLETED|Overall Study||0
7795506|NCT01233921|19190403|P2|COMPLETED|Overall Study||3
7795507|NCT01233921|19190404|P1|COMPLETED|Overall Study||3
7795508|NCT01233921|19190403|P2|STARTED|Overall Study||3
7795509|NCT01233921|19190404|P1|STARTED|Overall Study||3
7795510|NCT01233869|19190416|P4|NOT COMPLETED|Extended Treatment Period (46 Months)||16
7795511|NCT01233869|19190417|P3|NOT COMPLETED|Extended Treatment Period (46 Months)||5
7795512|NCT01233869|19190418|P2|NOT COMPLETED|Extended Treatment Period (46 Months)||3
7795513|NCT01233869|19190419|P1|NOT COMPLETED|Extended Treatment Period (46 Months)||14
7795514|NCT01233869|19190416|P4|COMPLETED|Extended Treatment Period (46 Months)||18
7795515|NCT01233869|19190417|P3|COMPLETED|Extended Treatment Period (46 Months)||17
7795516|NCT01233869|19190418|P2|COMPLETED|Extended Treatment Period (46 Months)||0
7795517|NCT01233869|19190419|P1|COMPLETED|Extended Treatment Period (46 Months)||20
7795518|NCT01233869|19190416|P4|STARTED|Extended Treatment Period (46 Months)||34
7795519|NCT01233869|19190417|P3|STARTED|Extended Treatment Period (46 Months)||22
7795520|NCT01233869|19190418|P2|STARTED|Extended Treatment Period (46 Months)||3
7795521|NCT01233869|19190419|P1|STARTED|Extended Treatment Period (46 Months)||34
7795522|NCT01233869|19190416|P4|NOT COMPLETED|Washout Period 30 Days||0
7795523|NCT01233869|19190417|P3|NOT COMPLETED|Washout Period 30 Days||0
7795524|NCT01233869|19190418|P2|NOT COMPLETED|Washout Period 30 Days||0
7795525|NCT01233869|19190419|P1|NOT COMPLETED|Washout Period 30 Days||0
7795526|NCT01233869|19190416|P4|COMPLETED|Washout Period 30 Days||34
7795527|NCT01233869|19190417|P3|COMPLETED|Washout Period 30 Days||22
7795528|NCT01233869|19190418|P2|COMPLETED|Washout Period 30 Days||3
7795529|NCT01233869|19190419|P1|COMPLETED|Washout Period 30 Days||34
7795530|NCT01233869|19190416|P4|STARTED|Washout Period 30 Days||34
7795531|NCT01233869|19190417|P3|STARTED|Washout Period 30 Days||22
7795532|NCT01233869|19190418|P2|STARTED|Washout Period 30 Days||3
7795533|NCT01233869|19190419|P1|STARTED|Washout Period 30 Days||34
7795534|NCT01233869|19190416|P4|NOT COMPLETED|Initial Treatment Period (24 Months)||22
7795535|NCT01233869|19190417|P3|NOT COMPLETED|Initial Treatment Period (24 Months)||2
7795536|NCT01233869|19190418|P2|NOT COMPLETED|Initial Treatment Period (24 Months)||28
7795537|NCT01233869|19190419|P1|NOT COMPLETED|Initial Treatment Period (24 Months)||24
7795538|NCT01233869|19190416|P4|COMPLETED|Initial Treatment Period (24 Months)||34
7795539|NCT01233869|19190417|P3|COMPLETED|Initial Treatment Period (24 Months)||22
7795540|NCT01233869|19190418|P2|COMPLETED|Initial Treatment Period (24 Months)||3
7795541|NCT01233869|19190419|P1|COMPLETED|Initial Treatment Period (24 Months)||34
7795542|NCT01233869|19190416|P4|STARTED|Initial Treatment Period (24 Months)||56
7795543|NCT01233869|19190417|P3|STARTED|Initial Treatment Period (24 Months)||24
7795544|NCT01233869|19190418|P2|STARTED|Initial Treatment Period (24 Months)||31
7795545|NCT01233869|19190419|P1|STARTED|Initial Treatment Period (24 Months)||58
7795546|NCT01233817|19190505|P1|NOT COMPLETED|Overall Study||3
7795547|NCT01233817|19190505|P1|COMPLETED|Overall Study||9
7795548|NCT01233817|19190505|P1|STARTED|Overall Study||12
7795549|NCT01233726|19190512|P3|NOT COMPLETED|Overall Study||1
7795550|NCT01233726|19190513|P2|NOT COMPLETED|Overall Study||0
7795551|NCT01233726|19190514|P1|NOT COMPLETED|Overall Study||1
7795552|NCT01233726|19190512|P3|COMPLETED|Overall Study||52
7795553|NCT01233726|19190513|P2|COMPLETED|Overall Study||53
7795554|NCT01233726|19190514|P1|COMPLETED|Overall Study||52
7795555|NCT01233726|19190512|P3|STARTED|Overall Study||53
7795556|NCT01233726|19190513|P2|STARTED|Overall Study||53
7795557|NCT01233726|19190514|P1|STARTED|Overall Study||53
7795558|NCT01233687|19190552|P1|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4
7795559|NCT01233687|19190552|P1|COMPLETED|Phase II AMG 102 + Erlotinib||45
7795560|NCT01233687|19190552|P1|Response-Evaluable|Phase II AMG 102 + Erlotinib||45
7795561|NCT01233687|19190552|P1|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49
7795562|NCT01233687|19190552|P1|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0
7795563|NCT01233687|19190552|P1|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7
7795564|NCT01233687|19190552|P1|STARTED|Phase I RP2D AMG 102 + Erlotinib||7
7795565|NCT01233609|19190562|P2|NOT COMPLETED|Overall Study||2
7795566|NCT01233609|19190563|P1|NOT COMPLETED|Overall Study||9
7795567|NCT01233609|19190562|P2|COMPLETED|Overall Study||42
7795568|NCT01233609|19190563|P1|COMPLETED|Overall Study||37
7795569|NCT01233609|19190562|P2|STARTED|Overall Study||44
7795570|NCT01233609|19190563|P1|STARTED|Overall Study||46
7795571|NCT01233284|19190587|P5|NOT COMPLETED|Period 4 (4 Weeks)||0
7795572|NCT01233284|19190588|P4|NOT COMPLETED|Period 4 (4 Weeks)||1
7795573|NCT01233284|19190589|P3|NOT COMPLETED|Period 4 (4 Weeks)||0
7795574|NCT01233284|19190590|P2|NOT COMPLETED|Period 4 (4 Weeks)||1
7795575|NCT01233284|19190591|P1|NOT COMPLETED|Period 4 (4 Weeks)||0
7795576|NCT01233284|19190587|P5|COMPLETED|Period 4 (4 Weeks)||1
7795577|NCT01233284|19190588|P4|COMPLETED|Period 4 (4 Weeks)||33
7795578|NCT01233284|19190589|P3|COMPLETED|Period 4 (4 Weeks)||35
7795579|NCT01233284|19190590|P2|COMPLETED|Period 4 (4 Weeks)||36
7795580|NCT01233284|19190591|P1|COMPLETED|Period 4 (4 Weeks)||36
7795581|NCT01233284|19190587|P5|STARTED|Period 4 (4 Weeks)||1
7795582|NCT01233284|19190588|P4|STARTED|Period 4 (4 Weeks)||34
7795583|NCT01233284|19190589|P3|STARTED|Period 4 (4 Weeks)||35
7795584|NCT01233284|19190590|P2|STARTED|Period 4 (4 Weeks)||37
7795585|NCT01233284|19190591|P1|STARTED|Period 4 (4 Weeks)||36
7795586|NCT01233284|19190587|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
7795587|NCT01233284|19190588|P4|NOT COMPLETED|Period 3 (4 Weeks)||1
7795588|NCT01233284|19190589|P3|NOT COMPLETED|Period 3 (4 Weeks)||1
7795589|NCT01233284|19190590|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
7795590|NCT01233284|19190591|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
7795591|NCT01233284|19190587|P5|COMPLETED|Period 3 (4 Weeks)||1
7795592|NCT01233284|19190588|P4|COMPLETED|Period 3 (4 Weeks)||34
7795593|NCT01233284|19190589|P3|COMPLETED|Period 3 (4 Weeks)||35
7795594|NCT01233284|19190590|P2|COMPLETED|Period 3 (4 Weeks)||37
7795595|NCT01233284|19190591|P1|COMPLETED|Period 3 (4 Weeks)||36
7795596|NCT01233284|19190587|P5|STARTED|Period 3 (4 Weeks)||1
7795597|NCT01233284|19190588|P4|STARTED|Period 3 (4 Weeks)||35
7795598|NCT01233284|19190589|P3|STARTED|Period 3 (4 Weeks)||36
7795599|NCT01233284|19190590|P2|STARTED|Period 3 (4 Weeks)||37
7795600|NCT01233284|19190591|P1|STARTED|Period 3 (4 Weeks)||36
7795601|NCT01233284|19190587|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
7795602|NCT01233284|19190588|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
7795603|NCT01233284|19190589|P3|NOT COMPLETED|Period 2 (4 Weeks)||1
7795604|NCT01233284|19190590|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
7795605|NCT01233284|19190591|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
7795606|NCT01233284|19190587|P5|COMPLETED|Period 2 (4 Weeks)||1
7795607|NCT01233284|19190588|P4|COMPLETED|Period 2 (4 Weeks)||35
7795608|NCT01233284|19190589|P3|COMPLETED|Period 2 (4 Weeks)||36
7795609|NCT01233284|19190590|P2|COMPLETED|Period 2 (4 Weeks)||37
7795610|NCT01233284|19190591|P1|COMPLETED|Period 2 (4 Weeks)||36
7795611|NCT01233284|19190587|P5|STARTED|Period 2 (4 Weeks)||1
7795612|NCT01233284|19190588|P4|STARTED|Period 2 (4 Weeks)||35
7795613|NCT01233284|19190589|P3|STARTED|Period 2 (4 Weeks)||37
7795614|NCT01233284|19190590|P2|STARTED|Period 2 (4 Weeks)||37
7795615|NCT01233284|19190591|P1|STARTED|Period 2 (4 Weeks)||36
7795616|NCT01233284|19190587|P5|NOT COMPLETED|Period 1 (4 Weeks)||0
7795617|NCT01233284|19190588|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
7795618|NCT01233284|19190589|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
7795619|NCT01233284|19190590|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
7795620|NCT01233284|19190591|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
7795621|NCT01233284|19190587|P5|COMPLETED|Period 1 (4 Weeks)||1
7795622|NCT01233284|19190588|P4|COMPLETED|Period 1 (4 Weeks)||35
7795623|NCT01233284|19190589|P3|COMPLETED|Period 1 (4 Weeks)||37
7795624|NCT01233284|19190590|P2|COMPLETED|Period 1 (4 Weeks)||37
7795625|NCT01233284|19190591|P1|COMPLETED|Period 1 (4 Weeks)||36
7795626|NCT01233284|19190587|P5|STARTED|Period 1 (4 Weeks)||1
7795627|NCT01233284|19190588|P4|STARTED|Period 1 (4 Weeks)||35
7795628|NCT01233284|19190589|P3|STARTED|Period 1 (4 Weeks)||38
7795629|NCT01233284|19190590|P2|STARTED|Period 1 (4 Weeks)||38
7795630|NCT01233284|19190591|P1|STARTED|Period 1 (4 Weeks)||37
7795631|NCT01233258|19190672|P6|NOT COMPLETED|Second Intervention (6 Months)||0
7795632|NCT01233258|19190673|P5|NOT COMPLETED|Second Intervention (6 Months)||0
7795633|NCT01233258|19190674|P4|NOT COMPLETED|Second Intervention (6 Months)||0
7795634|NCT01233258|19190675|P3|NOT COMPLETED|Second Intervention (6 Months)||0
7795635|NCT01233258|19190676|P2|NOT COMPLETED|Second Intervention (6 Months)||0
7795636|NCT01233258|19190677|P1|NOT COMPLETED|Second Intervention (6 Months)||0
7795637|NCT01233258|19190672|P6|COMPLETED|Second Intervention (6 Months)||15
7795638|NCT01233258|19190673|P5|COMPLETED|Second Intervention (6 Months)||16
7795639|NCT01233258|19190674|P4|COMPLETED|Second Intervention (6 Months)||15
7795640|NCT01233258|19190675|P3|COMPLETED|Second Intervention (6 Months)||13
7795641|NCT01233258|19190676|P2|COMPLETED|Second Intervention (6 Months)||10
7795642|NCT01233258|19190677|P1|COMPLETED|Second Intervention (6 Months)||10
7795643|NCT01233258|19190672|P6|STARTED|Second Intervention (6 Months)||15
7795644|NCT01233258|19190673|P5|STARTED|Second Intervention (6 Months)||16
7795645|NCT01233258|19190674|P4|STARTED|Second Intervention (6 Months)||15
7795646|NCT01233258|19190675|P3|STARTED|Second Intervention (6 Months)||13
7795647|NCT01233258|19190676|P2|STARTED|Second Intervention (6 Months)||10
7795648|NCT01233258|19190677|P1|STARTED|Second Intervention (6 Months)||10
7795649|NCT01233258|19190672|P6|NOT COMPLETED|Washout (2-3 Days)||0
7795650|NCT01233258|19190673|P5|NOT COMPLETED|Washout (2-3 Days)||0
7795651|NCT01233258|19190674|P4|NOT COMPLETED|Washout (2-3 Days)||0
7795652|NCT01233258|19190675|P3|NOT COMPLETED|Washout (2-3 Days)||0
7795653|NCT01233258|19190676|P2|NOT COMPLETED|Washout (2-3 Days)||0
7795654|NCT01233258|19190677|P1|NOT COMPLETED|Washout (2-3 Days)||0
7795655|NCT01233258|19190672|P6|COMPLETED|Washout (2-3 Days)||15
7795656|NCT01233258|19190673|P5|COMPLETED|Washout (2-3 Days)||16
7795657|NCT01233258|19190674|P4|COMPLETED|Washout (2-3 Days)||15
7795658|NCT01233258|19190675|P3|COMPLETED|Washout (2-3 Days)||13
7795659|NCT01233258|19190676|P2|COMPLETED|Washout (2-3 Days)||10
7795660|NCT01233258|19190677|P1|COMPLETED|Washout (2-3 Days)||10
7795661|NCT01233258|19190672|P6|STARTED|Washout (2-3 Days)||15
7795662|NCT01233258|19190673|P5|STARTED|Washout (2-3 Days)||16
7795663|NCT01233258|19190674|P4|STARTED|Washout (2-3 Days)||15
7795664|NCT01233258|19190675|P3|STARTED|Washout (2-3 Days)||13
7795665|NCT01233258|19190676|P2|STARTED|Washout (2-3 Days)||10
7795666|NCT01233258|19190677|P1|STARTED|Washout (2-3 Days)||10
7795667|NCT01233258|19190672|P6|NOT COMPLETED|First Intervention (6 Months)||1
7795668|NCT01233258|19190673|P5|NOT COMPLETED|First Intervention (6 Months)||0
7795669|NCT01233258|19190674|P4|NOT COMPLETED|First Intervention (6 Months)||1
7795670|NCT01233258|19190675|P3|NOT COMPLETED|First Intervention (6 Months)||1
7795671|NCT01233258|19190676|P2|NOT COMPLETED|First Intervention (6 Months)||0
7795672|NCT01233258|19190677|P1|NOT COMPLETED|First Intervention (6 Months)||1
7795673|NCT01233258|19190672|P6|COMPLETED|First Intervention (6 Months)||15
7795674|NCT01233258|19190673|P5|COMPLETED|First Intervention (6 Months)||16
7795675|NCT01233258|19190674|P4|COMPLETED|First Intervention (6 Months)||15
7795676|NCT01233258|19190675|P3|COMPLETED|First Intervention (6 Months)||13
7795677|NCT01233258|19190676|P2|COMPLETED|First Intervention (6 Months)||10
7795678|NCT01233258|19190677|P1|COMPLETED|First Intervention (6 Months)||10
7795679|NCT01233258|19190672|P6|Participants Received Treatment|First Intervention (6 Months)||15
7795680|NCT01233258|19190673|P5|Participants Received Treatment|First Intervention (6 Months)||16
7795681|NCT01233258|19190674|P4|Participants Received Treatment|First Intervention (6 Months)||15
7795682|NCT01233258|19190675|P3|Participants Received Treatment|First Intervention (6 Months)||13
7795683|NCT01233258|19190676|P2|Participants Received Treatment|First Intervention (6 Months)||10
7795684|NCT01233258|19190677|P1|Participants Received Treatment|First Intervention (6 Months)||11
7795685|NCT01233258|19190672|P6|STARTED|First Intervention (6 Months)||16
7795686|NCT01233258|19190673|P5|STARTED|First Intervention (6 Months)||16
7795687|NCT01233258|19190674|P4|STARTED|First Intervention (6 Months)||16
7795688|NCT01233258|19190675|P3|STARTED|First Intervention (6 Months)||14
7795689|NCT01233258|19190676|P2|STARTED|First Intervention (6 Months)||10
7795690|NCT01233258|19190677|P1|STARTED|First Intervention (6 Months)||11
7795691|NCT01233232|19190697|P3|NOT COMPLETED|Overall Study||0
7795692|NCT01233232|19190698|P2|NOT COMPLETED|Overall Study||0
7795693|NCT01233232|19190699|P1|NOT COMPLETED|Overall Study||1
7795694|NCT01233232|19190697|P3|COMPLETED|Overall Study||28
7795695|NCT01233232|19190698|P2|COMPLETED|Overall Study||30
7795696|NCT01233232|19190699|P1|COMPLETED|Overall Study||28
7795697|NCT01233232|19190697|P3|STARTED|Overall Study||28
7795698|NCT01233232|19190698|P2|STARTED|Overall Study||30
7795699|NCT01233232|19190699|P1|STARTED|Overall Study||29
7795700|NCT01233076|19190752|P2|NOT COMPLETED|Period 2, One Week||0
7795701|NCT01233076|19190753|P1|NOT COMPLETED|Period 2, One Week||1
7795702|NCT01233076|19190752|P2|COMPLETED|Period 2, One Week||30
7795703|NCT01233076|19190753|P1|COMPLETED|Period 2, One Week||29
7795704|NCT01233076|19190752|P2|STARTED|Period 2, One Week||30
7795705|NCT01233076|19190753|P1|STARTED|Period 2, One Week||30
7795706|NCT01233076|19190752|P2|NOT COMPLETED|Period 1, One Week||0
7795707|NCT01233076|19190753|P1|NOT COMPLETED|Period 1, One Week||0
7795708|NCT01233076|19190752|P2|COMPLETED|Period 1, One Week||30
7795709|NCT01233076|19190753|P1|COMPLETED|Period 1, One Week||30
7795710|NCT01233076|19190752|P2|STARTED|Period 1, One Week||30
7795711|NCT01233076|19190753|P1|STARTED|Period 1, One Week||30
7795712|NCT01233050|19190761|P2|NOT COMPLETED|Overall Study||6
7795713|NCT01233050|19190762|P1|NOT COMPLETED|Overall Study||8
7795714|NCT01233050|19190761|P2|COMPLETED|Overall Study|6 participants were excluded after treatment administered due to inclusion/exclusion criteria|396
7795715|NCT01233050|19190762|P1|COMPLETED|Overall Study|8 participants were excluded after treatment administered due to inclusion/exclusion criteria|392
7795716|NCT01233050|19190761|P2|STARTED|Overall Study||402
7795717|NCT01233050|19190762|P1|STARTED|Overall Study||400
7795718|NCT01232946|19190781|P3|NOT COMPLETED|Overall Study||2
7795719|NCT01232946|19190782|P2|NOT COMPLETED|Overall Study||1
7795720|NCT01232946|19190783|P1|NOT COMPLETED|Overall Study||0
7795721|NCT01232946|19190781|P3|COMPLETED|Overall Study|2 withdrew after baseline measurements|9
7795722|NCT01232946|19190782|P2|COMPLETED|Overall Study|1 participant died unrelated to study|9
7795723|NCT01232946|19190783|P1|COMPLETED|Overall Study||9
7795724|NCT01232946|19190781|P3|STARTED|Overall Study||11
7795725|NCT01232946|19190782|P2|STARTED|Overall Study||10
7795726|NCT01232946|19190783|P1|STARTED|Overall Study||9
7795727|NCT01232920|19190799|P2|NOT COMPLETED|Overall Study||7
7795728|NCT01232920|19190800|P1|NOT COMPLETED|Overall Study||6
7795729|NCT01232920|19190799|P2|COMPLETED|Overall Study||32
7795730|NCT01232920|19190800|P1|COMPLETED|Overall Study||35
7795731|NCT01232920|19190799|P2|STARTED|Overall Study||39
7795732|NCT01232920|19190800|P1|STARTED|Overall Study||41
7795733|NCT01232894|19190814|P2|NOT COMPLETED|Overall Study||8
7795734|NCT01232894|19190815|P1|NOT COMPLETED|Overall Study||12
7795735|NCT01232894|19190814|P2|COMPLETED|Overall Study||22
7795736|NCT01232894|19190815|P1|COMPLETED|Overall Study||48
7795737|NCT01232894|19190814|P2|Received Study Drug|Overall Study||28
7795738|NCT01232894|19190815|P1|Received Study Drug|Overall Study||59
7795739|NCT01232894|19190814|P2|STARTED|Overall Study||30
7795740|NCT01232894|19190815|P1|STARTED|Overall Study||60
7795741|NCT01232868|19190823|P2|NOT COMPLETED|Overall Study||4
7795742|NCT01232868|19190824|P1|NOT COMPLETED|Overall Study||2
7795743|NCT01232868|19190823|P2|COMPLETED|Overall Study||40
7795744|NCT01232868|19190824|P1|COMPLETED|Overall Study||20
7795745|NCT01232868|19190823|P2|STARTED|Overall Study||44
7795746|NCT01232868|19190824|P1|STARTED|Overall Study||22
7795747|NCT01232829|19190832|P1|NOT COMPLETED|Overall Study||0
7795748|NCT01232829|19190832|P1|COMPLETED|Overall Study||18
7795749|NCT01232829|19190832|P1|STARTED|Overall Study||18
7795750|NCT01232790|19190838|P2|NOT COMPLETED|Second Crossover||2
7795751|NCT01232790|19190839|P1|NOT COMPLETED|Second Crossover||1
7795752|NCT01232790|19190838|P2|COMPLETED|Second Crossover||9
7795753|NCT01232790|19190839|P1|COMPLETED|Second Crossover||10
7795754|NCT01232790|19190838|P2|STARTED|Second Crossover||11
7795755|NCT01232790|19190839|P1|STARTED|Second Crossover||11
7795756|NCT01232790|19190838|P2|NOT COMPLETED|First Crossover||0
7795757|NCT01232790|19190839|P1|NOT COMPLETED|First Crossover||1
7795758|NCT01232790|19190838|P2|COMPLETED|First Crossover||11
7795759|NCT01232790|19190839|P1|COMPLETED|First Crossover||11
7795760|NCT01232790|19190838|P2|STARTED|First Crossover||11
7795761|NCT01232790|19190839|P1|STARTED|First Crossover||12
7795762|NCT01232790|19190838|P2|NOT COMPLETED|Initial Assessment||1
7795763|NCT01232790|19190839|P1|NOT COMPLETED|Initial Assessment||0
7795764|NCT01232790|19190838|P2|COMPLETED|Initial Assessment||11
7795765|NCT01232790|19190839|P1|COMPLETED|Initial Assessment||12
7795766|NCT01232790|19190838|P2|STARTED|Initial Assessment||12
7795767|NCT01232790|19190839|P1|STARTED|Initial Assessment||12
7795768|NCT01232790|19190838|P2|NOT COMPLETED|Randomization||2
7795769|NCT01232790|19190839|P1|NOT COMPLETED|Randomization||2
7795770|NCT01232790|19190838|P2|COMPLETED|Randomization||12
7795771|NCT01232790|19190839|P1|COMPLETED|Randomization||12
7795772|NCT01232790|19190838|P2|STARTED|Randomization||14
7795773|NCT01232790|19190839|P1|STARTED|Randomization||14
7795774|NCT01232738|19190893|P1|NOT COMPLETED|Overall Study||13
7795775|NCT01232738|19190893|P1|COMPLETED|Overall Study||23
7795776|NCT01232738|19190893|P1|STARTED|Overall Study||36
7795777|NCT01232569|19190909|P4|NOT COMPLETED|Open-label Extension Period||27
7795778|NCT01232569|19190910|P3|NOT COMPLETED|Open-label Extension Period||27
7795779|NCT01232569|19190911|P2|NOT COMPLETED|Open-label Extension Period||0
7795780|NCT01232569|19190912|P1|NOT COMPLETED|Open-label Extension Period||0
7795781|NCT01232569|19190909|P4|COMPLETED|Open-label Extension Period||200
7795782|NCT01232569|19190910|P3|COMPLETED|Open-label Extension Period||203
7795783|NCT01232569|19190911|P2|COMPLETED|Open-label Extension Period||0
7795784|NCT01232569|19190912|P1|COMPLETED|Open-label Extension Period||0
7795785|NCT01232569|19190909|P4|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227
7795786|NCT01232569|19190910|P3|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230
7795787|NCT01232569|19190911|P2|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
7795788|NCT01232569|19190912|P1|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
7795789|NCT01232569|19190909|P4|NOT COMPLETED|Double-blind Treatment Period||0
7795790|NCT01232569|19190910|P3|NOT COMPLETED|Double-blind Treatment Period||0
7795791|NCT01232569|19190911|P2|NOT COMPLETED|Double-blind Treatment Period||9
7795792|NCT01232569|19190912|P1|NOT COMPLETED|Double-blind Treatment Period||28
7795793|NCT01232569|19190909|P4|COMPLETED|Double-blind Treatment Period||0
7795794|NCT01232569|19190910|P3|COMPLETED|Double-blind Treatment Period||0
7795795|NCT01232569|19190911|P2|COMPLETED|Double-blind Treatment Period||209
7795796|NCT01232569|19190912|P1|COMPLETED|Double-blind Treatment Period||410
7795797|NCT01232569|19190909|P4|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
7795798|NCT01232569|19190910|P3|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
7795799|NCT01232569|19190911|P2|STARTED|Double-blind Treatment Period||218
7795800|NCT01232569|19190912|P1|STARTED|Double-blind Treatment Period||438
7795801|NCT01232556|19190955|P2|NOT COMPLETED|Overall Study||171
7795802|NCT01232556|19190956|P1|NOT COMPLETED|Overall Study||159
7795803|NCT01232556|19190955|P2|COMPLETED|Overall Study||1
7795804|NCT01232556|19190956|P1|COMPLETED|Overall Study||7
7795805|NCT01232556|19190955|P2|Treated|Overall Study||167
7795806|NCT01232556|19190956|P1|Treated|Overall Study|One subject in this arm received rituximab only and was excluded from the safety population.|165
7795807|NCT01232556|19190955|P2|STARTED|Overall Study||172
7795808|NCT01232556|19190956|P1|STARTED|Overall Study||166
7795809|NCT01232504|19190979|P3|NOT COMPLETED|Overall Study||8
7795810|NCT01232504|19190980|P2|NOT COMPLETED|Overall Study||2
7795811|NCT01232504|19190981|P1|NOT COMPLETED|Overall Study||9
7795812|NCT01232504|19190979|P3|COMPLETED|Overall Study||61
7795813|NCT01232504|19190980|P2|COMPLETED|Overall Study||67
7795814|NCT01232504|19190981|P1|COMPLETED|Overall Study||59
7795815|NCT01232504|19190979|P3|STARTED|Overall Study||69
7795816|NCT01232504|19190980|P2|STARTED|Overall Study||69
7795817|NCT01232504|19190981|P1|STARTED|Overall Study||68
7795818|NCT01232491|19191015|P2|NOT COMPLETED|Overall Study||63
7795819|NCT01232491|19191016|P1|NOT COMPLETED|Overall Study||60
7795820|NCT01232491|19191015|P2|COMPLETED|Overall Study||242
7795821|NCT01232491|19191016|P1|COMPLETED|Overall Study||246
7795822|NCT01232491|19191015|P2|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301
7795823|NCT01232491|19191016|P1|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305
7795824|NCT01232491|19191015|P2|STARTED|Overall Study||305
7795825|NCT01232491|19191016|P1|STARTED|Overall Study||306
7795826|NCT01232465|19191036|P2|NOT COMPLETED|Overall Study||0
7795827|NCT01232465|19191037|P1|NOT COMPLETED|Overall Study||0
7795828|NCT01232465|19191036|P2|COMPLETED|Overall Study||402
7795829|NCT01232465|19191037|P1|COMPLETED|Overall Study||337
7795830|NCT01232465|19191036|P2|STARTED|Overall Study||402
7795831|NCT01232465|19191037|P1|STARTED|Overall Study||337
7795832|NCT01232452|19191045|P2|NOT COMPLETED|Overall Study||39
7795833|NCT01232452|19191046|P1|NOT COMPLETED|Overall Study||39
7795834|NCT01232452|19191045|P2|COMPLETED|Overall Study||46
7795835|NCT01232452|19191046|P1|COMPLETED|Overall Study||48
7795836|NCT01232452|19191045|P2|Received at Least One Dose of Study Drug|Overall Study||81
7795837|NCT01232452|19191046|P1|Received at Least One Dose of Study Drug|Overall Study||85
7795838|NCT01232452|19191045|P2|STARTED|Overall Study||85
7795839|NCT01232452|19191046|P1|STARTED|Overall Study||87
7795840|NCT01232296|19191072|P2|NOT COMPLETED|Overall Study||83
7795841|NCT01232296|19191073|P1|NOT COMPLETED|Overall Study||82
7795842|NCT01232296|19191072|P2|COMPLETED|Overall Study||0
7795843|NCT01232296|19191073|P1|COMPLETED|Overall Study||0
7795844|NCT01232296|19191072|P2|Safety Set|Overall Study||83
7795845|NCT01232296|19191073|P1|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79
7795846|NCT01232296|19191072|P2|Full Analysis Set|Overall Study||83
7795847|NCT01232296|19191073|P1|Full Analysis Set|Overall Study||82
7795848|NCT01232296|19191072|P2|STARTED|Overall Study||83
7795849|NCT01232296|19191073|P1|STARTED|Overall Study||82
7795850|NCT01232283|19191090|P10|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||61
7795851|NCT01232283|19191091|P9|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||108
7795852|NCT01232283|19191092|P8|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
7795853|NCT01232283|19191093|P7|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
7795854|NCT01232283|19191094|P6|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
7795855|NCT01232283|19191095|P5|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
7795856|NCT01232283|19191096|P4|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
7795857|NCT01232283|19191097|P3|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
7795858|NCT01232283|19191098|P2|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
7795859|NCT01232283|19191099|P1|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
7795860|NCT01232283|19191090|P10|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||19
7795861|NCT01232283|19191091|P9|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||29
7795862|NCT01232283|19191092|P8|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
7795863|NCT01232283|19191093|P7|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
7795864|NCT01232283|19191094|P6|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
7795865|NCT01232283|19191095|P5|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
7795866|NCT01232283|19191096|P4|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
7795867|NCT01232283|19191097|P3|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
7795868|NCT01232283|19191098|P2|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
7795869|NCT01232283|19191099|P1|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
7795870|NCT01232283|19191090|P10|STARTED|Long-Term Extension Phase (Weeks 52-260)||80
7795871|NCT01232283|19191091|P9|STARTED|Long-Term Extension Phase (Weeks 52-260)||137
7795872|NCT01232283|19191092|P8|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
7795873|NCT01232283|19191093|P7|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
7795874|NCT01232283|19191094|P6|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
7795875|NCT01232283|19191095|P5|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
7795876|NCT01232283|19191096|P4|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
7795877|NCT01232283|19191097|P3|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
7795878|NCT01232283|19191098|P2|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
7795879|NCT01232283|19191099|P1|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
7795880|NCT01232283|19191090|P10|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
7795881|NCT01232283|19191091|P9|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
7795882|NCT01232283|19191092|P8|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
7795883|NCT01232283|19191093|P7|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17
7795884|NCT01232283|19191094|P6|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5
7795885|NCT01232283|19191095|P5|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
7795886|NCT01232283|19191096|P4|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
7795887|NCT01232283|19191097|P3|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
7795888|NCT01232283|19191098|P2|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
7795889|NCT01232283|19191099|P1|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
7795890|NCT01232283|19191090|P10|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
7795891|NCT01232283|19191091|P9|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
7795892|NCT01232283|19191092|P8|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84
7795893|NCT01232283|19191093|P7|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41
7795894|NCT01232283|19191094|P6|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56
7795895|NCT01232283|19191095|P5|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50
7795896|NCT01232283|19191096|P4|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
7795897|NCT01232283|19191097|P3|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
7795898|NCT01232283|19191098|P2|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
7795899|NCT01232283|19191099|P1|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
7795900|NCT01232283|19191090|P10|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
7795901|NCT01232283|19191091|P9|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
7795902|NCT01232283|19191092|P8|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17
7795903|NCT01232283|19191093|P7|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28
7795904|NCT01232283|19191094|P6|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
7795905|NCT01232283|19191095|P5|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
7795906|NCT01232283|19191096|P4|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
7795907|NCT01232283|19191097|P3|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
7795908|NCT01232283|19191098|P2|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
7795909|NCT01232283|19191099|P1|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
7795910|NCT01232283|19191090|P10|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
7795911|NCT01232283|19191091|P9|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
7795912|NCT01232283|19191092|P8|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96
7795913|NCT01232283|19191093|P7|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58
7795914|NCT01232283|19191094|P6|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61
7795915|NCT01232283|19191095|P5|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62
7795916|NCT01232283|19191096|P4|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
7795917|NCT01232283|19191097|P3|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
7795918|NCT01232283|19191098|P2|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
7795919|NCT01232283|19191099|P1|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
7795920|NCT01232283|19191090|P10|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
7795921|NCT01232283|19191091|P9|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
7795922|NCT01232283|19191092|P8|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
7795923|NCT01232283|19191093|P7|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
7795924|NCT01232283|19191094|P6|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
7795925|NCT01232283|19191095|P5|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
7795926|NCT01232283|19191096|P4|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8
7795927|NCT01232283|19191097|P3|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40
7795928|NCT01232283|19191098|P2|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
7795929|NCT01232283|19191099|P1|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
7795930|NCT01232283|19191090|P10|COMPLETED|Maintenance Phase (Weeks16-32)||0
7795931|NCT01232283|19191091|P9|COMPLETED|Maintenance Phase (Weeks16-32)||0
7795932|NCT01232283|19191092|P8|COMPLETED|Maintenance Phase (Weeks16-32)||0
7795933|NCT01232283|19191093|P7|COMPLETED|Maintenance Phase (Weeks16-32)||0
7795934|NCT01232283|19191094|P6|COMPLETED|Maintenance Phase (Weeks16-32)||0
7795935|NCT01232283|19191095|P5|COMPLETED|Maintenance Phase (Weeks16-32)||0
7795936|NCT01232283|19191096|P4|COMPLETED|Maintenance Phase (Weeks16-32)||100
7795937|NCT01232283|19191097|P3|COMPLETED|Maintenance Phase (Weeks16-32)||194
7795938|NCT01232283|19191098|P2|COMPLETED|Maintenance Phase (Weeks16-32)||0
7795939|NCT01232283|19191099|P1|COMPLETED|Maintenance Phase (Weeks16-32)||0
7795940|NCT01232283|19191090|P10|STARTED|Maintenance Phase (Weeks16-32)||0
7795941|NCT01232283|19191091|P9|STARTED|Maintenance Phase (Weeks16-32)||0
7795942|NCT01232283|19191092|P8|STARTED|Maintenance Phase (Weeks16-32)||0
7795943|NCT01232283|19191093|P7|STARTED|Maintenance Phase (Weeks16-32)||0
7795944|NCT01232283|19191094|P6|STARTED|Maintenance Phase (Weeks16-32)||0
7795945|NCT01232283|19191095|P5|STARTED|Maintenance Phase (Weeks16-32)||0
7795946|NCT01232283|19191096|P4|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108
7795947|NCT01232283|19191097|P3|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234
7795948|NCT01232283|19191098|P2|STARTED|Maintenance Phase (Weeks16-32)||0
7795949|NCT01232283|19191099|P1|STARTED|Maintenance Phase (Weeks16-32)||0
7795950|NCT01232283|19191090|P10|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
7795951|NCT01232283|19191091|P9|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
7795952|NCT01232283|19191092|P8|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
7795953|NCT01232283|19191093|P7|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
7795954|NCT01232283|19191094|P6|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
7795955|NCT01232283|19191095|P5|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
7795956|NCT01232283|19191096|P4|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
7795957|NCT01232283|19191097|P3|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
7795958|NCT01232283|19191098|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26
7795959|NCT01232283|19191099|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36
7795960|NCT01232283|19191090|P10|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
7795961|NCT01232283|19191091|P9|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
7795962|NCT01232283|19191092|P8|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
7795963|NCT01232283|19191093|P7|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
7795964|NCT01232283|19191094|P6|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
7795965|NCT01232283|19191095|P5|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
7795966|NCT01232283|19191096|P4|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
7795967|NCT01232283|19191097|P3|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
7795968|NCT01232283|19191098|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112
7795969|NCT01232283|19191099|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239
7795970|NCT01232283|19191090|P10|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
7795971|NCT01232283|19191091|P9|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
7795972|NCT01232283|19191092|P8|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
7795973|NCT01232283|19191093|P7|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
7795974|NCT01232283|19191094|P6|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
7795975|NCT01232283|19191095|P5|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
7795976|NCT01232283|19191096|P4|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
7795977|NCT01232283|19191097|P3|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
7795978|NCT01232283|19191098|P2|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136
7795979|NCT01232283|19191099|P1|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272
7795980|NCT01232283|19191090|P10|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
7795981|NCT01232283|19191091|P9|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
7795982|NCT01232283|19191092|P8|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
7795983|NCT01232283|19191093|P7|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
7795984|NCT01232283|19191094|P6|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
7795985|NCT01232283|19191095|P5|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
7795986|NCT01232283|19191096|P4|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
7795987|NCT01232283|19191097|P3|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
7795988|NCT01232283|19191098|P2|STARTED|Placebo Controlled Phase (Weeks 0-16)||138
7795989|NCT01232283|19191099|P1|STARTED|Placebo Controlled Phase (Weeks 0-16)||275
7795990|NCT01232205|19191133|P2|NOT COMPLETED|Overall Study||3
7795991|NCT01232205|19191134|P1|NOT COMPLETED|Overall Study||3
7795992|NCT01232205|19191133|P2|COMPLETED|Overall Study||55
7795993|NCT01232205|19191134|P1|COMPLETED|Overall Study||49
7795994|NCT01232205|19191133|P2|STARTED|Overall Study||58
7795995|NCT01232205|19191134|P1|STARTED|Overall Study||52
7795996|NCT01232127|19191140|P3|NOT COMPLETED|Period 3: Days 18-24||0
7795997|NCT01232127|19191141|P2|NOT COMPLETED|Period 3: Days 18-24||0
7795998|NCT01232127|19191142|P1|NOT COMPLETED|Period 3: Days 18-24||0
7795999|NCT01232127|19191140|P3|COMPLETED|Period 3: Days 18-24||24
7796000|NCT01232127|19191141|P2|COMPLETED|Period 3: Days 18-24||0
7796001|NCT01232127|19191142|P1|COMPLETED|Period 3: Days 18-24||0
7796002|NCT01232127|19191140|P3|STARTED|Period 3: Days 18-24|Participants who received treatment.|24
7796003|NCT01232127|19191141|P2|STARTED|Period 3: Days 18-24||0
7796004|NCT01232127|19191142|P1|STARTED|Period 3: Days 18-24||0
7796005|NCT01232127|19191140|P3|NOT COMPLETED|Period 2: Days 11-17||0
7796006|NCT01232127|19191141|P2|NOT COMPLETED|Period 2: Days 11-17||0
7796007|NCT01232127|19191142|P1|NOT COMPLETED|Period 2: Days 11-17||0
7796008|NCT01232127|19191140|P3|COMPLETED|Period 2: Days 11-17||0
7796009|NCT01232127|19191141|P2|COMPLETED|Period 2: Days 11-17||24
7796010|NCT01232127|19191142|P1|COMPLETED|Period 2: Days 11-17||0
7796011|NCT01232127|19191140|P3|STARTED|Period 2: Days 11-17||0
7796012|NCT01232127|19191141|P2|STARTED|Period 2: Days 11-17|Participants who received treatment.|24
7796013|NCT01232127|19191142|P1|STARTED|Period 2: Days 11-17||0
7796014|NCT01232127|19191140|P3|NOT COMPLETED|Period 1: Days 1-10||0
7796015|NCT01232127|19191141|P2|NOT COMPLETED|Period 1: Days 1-10||0
7796016|NCT01232127|19191142|P1|NOT COMPLETED|Period 1: Days 1-10||1
7796017|NCT01232127|19191140|P3|COMPLETED|Period 1: Days 1-10||0
7796018|NCT01232127|19191141|P2|COMPLETED|Period 1: Days 1-10||0
7796019|NCT01232127|19191142|P1|COMPLETED|Period 1: Days 1-10||24
7796020|NCT01232127|19191140|P3|STARTED|Period 1: Days 1-10||0
7796021|NCT01232127|19191141|P2|STARTED|Period 1: Days 1-10||0
7796022|NCT01232127|19191142|P1|STARTED|Period 1: Days 1-10|Participants who received treatment.|25
7796023|NCT01231984|19191166|P4|NOT COMPLETED|Study Period 2||4
7796024|NCT01231984|19191167|P3|NOT COMPLETED|Study Period 2||0
7796025|NCT01231984|19191168|P2|NOT COMPLETED|Study Period 2||2
7796026|NCT01231984|19191169|P1|NOT COMPLETED|Study Period 2||3
7796027|NCT01231984|19191166|P4|COMPLETED|Study Period 2||56
7796028|NCT01231984|19191167|P3|COMPLETED|Study Period 2||59
7796029|NCT01231984|19191168|P2|COMPLETED|Study Period 2||61
7796030|NCT01231984|19191169|P1|COMPLETED|Study Period 2||54
7796031|NCT01231984|19191166|P4|STARTED|Study Period 2||60
7796032|NCT01231984|19191167|P3|STARTED|Study Period 2||59
7796033|NCT01231984|19191168|P2|STARTED|Study Period 2||63
7796034|NCT01231984|19191169|P1|STARTED|Study Period 2||57
7796035|NCT01231984|19191166|P4|NOT COMPLETED|Study Period 1||9
7796036|NCT01231984|19191167|P3|NOT COMPLETED|Study Period 1||7
7796037|NCT01231984|19191168|P2|NOT COMPLETED|Study Period 1||7
7796038|NCT01231984|19191169|P1|NOT COMPLETED|Study Period 1||12
7796039|NCT01231984|19191166|P4|COMPLETED|Study Period 1||60
7796040|NCT01231984|19191167|P3|COMPLETED|Study Period 1||59
7796041|NCT01231984|19191168|P2|COMPLETED|Study Period 1||63
7796042|NCT01231984|19191169|P1|COMPLETED|Study Period 1||57
7796043|NCT01231984|19191166|P4|STARTED|Study Period 1||69
7796044|NCT01231984|19191167|P3|STARTED|Study Period 1||66
7796045|NCT01231984|19191168|P2|STARTED|Study Period 1||70
7796046|NCT01231984|19191169|P1|STARTED|Study Period 1||69
7796047|NCT01231841|19191190|P1|NOT COMPLETED|Overall Study||0
7796048|NCT01231841|19191190|P1|COMPLETED|Overall Study||20
7796049|NCT01231841|19191190|P1|STARTED|Overall Study||20
7796050|NCT01231750|19191196|P2|NOT COMPLETED|Overall Study||0
7796051|NCT01231750|19191197|P1|NOT COMPLETED|Overall Study||0
7796052|NCT01231750|19191196|P2|COMPLETED|Overall Study||4
7796053|NCT01231750|19191197|P1|COMPLETED|Overall Study||3
7796054|NCT01231750|19191196|P2|STARTED|Overall Study||4
7796055|NCT01231750|19191197|P1|STARTED|Overall Study||3
7796056|NCT01231646|19191215|P2|NOT COMPLETED|Overall Study||0
7796057|NCT01231646|19191216|P1|NOT COMPLETED|Overall Study||0
7796058|NCT01231646|19191215|P2|COMPLETED|Overall Study||10
7796059|NCT01231646|19191216|P1|COMPLETED|Overall Study||28
7796060|NCT01231646|19191215|P2|STARTED|Overall Study||10
7796061|NCT01231646|19191216|P1|STARTED|Overall Study||28
7796062|NCT01231633|19191224|P2|NOT COMPLETED|Overall Study||0
7796063|NCT01231633|19191225|P1|NOT COMPLETED|Overall Study||0
7796064|NCT01231633|19191224|P2|COMPLETED|Overall Study||13
7796065|NCT01231633|19191225|P1|COMPLETED|Overall Study||14
7796066|NCT01231633|19191224|P2|STARTED|Overall Study||13
7796067|NCT01231633|19191225|P1|STARTED|Overall Study||14
7796068|NCT01231620|19191238|P3|NOT COMPLETED|Overall Study||39
7796069|NCT01231620|19191239|P2|NOT COMPLETED|Overall Study||31
7796070|NCT01231620|19191240|P1|NOT COMPLETED|Overall Study||26
7796071|NCT01231620|19191238|P3|COMPLETED|Overall Study||166
7796072|NCT01231620|19191239|P2|COMPLETED|Overall Study||178
7796073|NCT01231620|19191240|P1|COMPLETED|Overall Study||175
7796074|NCT01231620|19191238|P3|STARTED|Overall Study||205
7796075|NCT01231620|19191239|P2|STARTED|Overall Study||209
7796076|NCT01231620|19191240|P1|STARTED|Overall Study||201
7796077|NCT01231607|19191346|P5|NOT COMPLETED|Overall Study||24
7796078|NCT01231607|19191347|P4|NOT COMPLETED|Overall Study||38
7796079|NCT01231607|19191348|P3|NOT COMPLETED|Overall Study||31
7796080|NCT01231607|19191349|P2|NOT COMPLETED|Overall Study||34
7796081|NCT01231607|19191350|P1|NOT COMPLETED|Overall Study||29
7796082|NCT01231607|19191346|P5|COMPLETED|Overall Study||157
7796083|NCT01231607|19191347|P4|COMPLETED|Overall Study||141
7796084|NCT01231607|19191348|P3|COMPLETED|Overall Study||153
7796085|NCT01231607|19191349|P2|COMPLETED|Overall Study||154
7796086|NCT01231607|19191350|P1|COMPLETED|Overall Study||156
7796087|NCT01231607|19191346|P5|STARTED|Overall Study||181
7796088|NCT01231607|19191347|P4|STARTED|Overall Study||179
7796089|NCT01231607|19191348|P3|STARTED|Overall Study||184
7796090|NCT01231607|19191349|P2|STARTED|Overall Study||188
7796091|NCT01231607|19191350|P1|STARTED|Overall Study||185
7796092|NCT01231581|19191442|P2|NOT COMPLETED|Overall Study||80
7796093|NCT01231581|19191443|P1|NOT COMPLETED|Overall Study||80
7796094|NCT01231581|19191442|P2|COMPLETED|Overall Study||0
7796095|NCT01231581|19191443|P1|COMPLETED|Overall Study||0
7796096|NCT01231581|19191442|P2|Ongoing|Overall Study||0
7796097|NCT01231581|19191443|P1|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1
7796098|NCT01231581|19191442|P2|STARTED|Overall Study||80
7796099|NCT01231581|19191443|P1|STARTED|Overall Study||80
7796100|NCT01231555|19191464|P3|NOT COMPLETED|Overall Study||8
7796101|NCT01231555|19191465|P2|NOT COMPLETED|Overall Study||7
7796102|NCT01231555|19191466|P1|NOT COMPLETED|Overall Study||8
7796103|NCT01231555|19191464|P3|COMPLETED|Overall Study||0
7796104|NCT01231555|19191465|P2|COMPLETED|Overall Study||0
7796105|NCT01231555|19191466|P1|COMPLETED|Overall Study||0
7796106|NCT01231555|19191464|P3|STARTED|Overall Study||8
7796107|NCT01231555|19191465|P2|STARTED|Overall Study||7
7796108|NCT01231555|19191466|P1|STARTED|Overall Study||8
7796109|NCT01231516|19191497|P2|NOT COMPLETED|Open-label Phase||26
7796110|NCT01231516|19191498|P1|NOT COMPLETED|Open-label Phase||295
7796111|NCT01231516|19191497|P2|COMPLETED|Open-label Phase||1
7796112|NCT01231516|19191498|P1|COMPLETED|Open-label Phase||0
7796113|NCT01231516|19191497|P2|Ongoing at the Time of Analysis|Open-label Phase||23
7796114|NCT01231516|19191498|P1|Ongoing at the Time of Analysis|Open-label Phase||282
7796115|NCT01231516|19191497|P2|STARTED|Open-label Phase|256 participants completed the Double-blind Phase but did not enter the Open-label Phase.|27
7796116|NCT01231516|19191498|P1|STARTED|Open-label Phase|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295
7796117|NCT01231516|19191497|P2|NOT COMPLETED|48 Week Double-blind Phase||79
7796118|NCT01231516|19191498|P1|NOT COMPLETED|48 Week Double-blind Phase||58
7796119|NCT01231516|19191497|P2|COMPLETED|48 Week Double-blind Phase||283
7796120|NCT01231516|19191498|P1|COMPLETED|48 Week Double-blind Phase||299
7796121|NCT01231516|19191497|P2|STARTED|48 Week Double-blind Phase||362
7796122|NCT01231516|19191498|P1|STARTED|48 Week Double-blind Phase||357
7796123|NCT01231503|19191528|P8|NOT COMPLETED|Overall Study||8
7796124|NCT01231503|19191529|P7|NOT COMPLETED|Overall Study||7
7796125|NCT01231503|19191530|P6|NOT COMPLETED|Overall Study||16
7796126|NCT01231503|19191531|P5|NOT COMPLETED|Overall Study||10
7796127|NCT01231503|19191532|P4|NOT COMPLETED|Overall Study||8
7796128|NCT01231503|19191533|P3|NOT COMPLETED|Overall Study||12
7796129|NCT01231503|19191534|P2|NOT COMPLETED|Overall Study||13
7796130|NCT01231503|19191535|P1|NOT COMPLETED|Overall Study||14
7796131|NCT01231503|19191528|P8|COMPLETED|Overall Study||52
7796132|NCT01231503|19191529|P7|COMPLETED|Overall Study||53
7796133|NCT01231503|19191530|P6|COMPLETED|Overall Study||44
7796134|NCT01231503|19191531|P5|COMPLETED|Overall Study||50
7796135|NCT01231503|19191532|P4|COMPLETED|Overall Study||52
7796136|NCT01231503|19191533|P3|COMPLETED|Overall Study||48
7796137|NCT01231503|19191534|P2|COMPLETED|Overall Study||46
7796138|NCT01231503|19191535|P1|COMPLETED|Overall Study||46
7796139|NCT01231503|19191528|P8|STARTED|Overall Study||60
7796140|NCT01231503|19191529|P7|STARTED|Overall Study||60
7796141|NCT01231503|19191530|P6|STARTED|Overall Study||60
7796142|NCT01231503|19191531|P5|STARTED|Overall Study||60
7796143|NCT01231503|19191532|P4|STARTED|Overall Study||60
7796144|NCT01231503|19191533|P3|STARTED|Overall Study||60
7796145|NCT01231503|19191534|P2|STARTED|Overall Study||59
7796146|NCT01231503|19191535|P1|STARTED|Overall Study||60
7796147|NCT01231464|19191775|P2|NOT COMPLETED|Overall Study||7
7796148|NCT01231464|19191776|P1|NOT COMPLETED|Overall Study||5
7796149|NCT01231464|19191775|P2|COMPLETED|Overall Study||176
7796150|NCT01231464|19191776|P1|COMPLETED|Overall Study||177
7796151|NCT01231464|19191775|P2|STARTED|Overall Study||183
7796152|NCT01231464|19191776|P1|STARTED|Overall Study||182
7796153|NCT01231412|19191789|P3|NOT COMPLETED|Overall Study||0
7796154|NCT01231412|19191790|P2|NOT COMPLETED|Overall Study||1
7796155|NCT01231412|19191791|P1|NOT COMPLETED|Overall Study||0
7796156|NCT01231412|19191789|P3|COMPLETED|Overall Study||6
7796157|NCT01231412|19191790|P2|COMPLETED|Overall Study||90
7796158|NCT01231412|19191791|P1|COMPLETED|Overall Study||77
7796159|NCT01231412|19191789|P3|STARTED|Overall Study||6
7796160|NCT01231412|19191790|P2|STARTED|Overall Study||91
7796161|NCT01231412|19191791|P1|STARTED|Overall Study||77
7796162|NCT01231399|19191814|P1|NOT COMPLETED|Overall Study||0
7796163|NCT01231399|19191814|P1|COMPLETED|Overall Study||6
7796164|NCT01231399|19191814|P1|STARTED|Overall Study||6
7796165|NCT01231373|19191825|P4|NOT COMPLETED|Overall Study||1
7796166|NCT01231373|19191826|P3|NOT COMPLETED|Overall Study||0
7796167|NCT01231373|19191827|P2|NOT COMPLETED|Overall Study||1
7796168|NCT01231373|19191828|P1|NOT COMPLETED|Overall Study||3
7796169|NCT01231373|19191825|P4|COMPLETED|Overall Study||57
7796170|NCT01231373|19191826|P3|COMPLETED|Overall Study||60
7796171|NCT01231373|19191827|P2|COMPLETED|Overall Study||57
7796172|NCT01231373|19191828|P1|COMPLETED|Overall Study||56
7796173|NCT01231373|19191825|P4|Patients Receiving Blinded Treatment|Overall Study||58
7796174|NCT01231373|19191826|P3|Patients Receiving Blinded Treatment|Overall Study||60
7796175|NCT01231373|19191827|P2|Patients Receiving Blinded Treatment|Overall Study||57
7796176|NCT01231373|19191828|P1|Patients Receiving Blinded Treatment|Overall Study||57
7796177|NCT01231373|19191825|P4|STARTED|Overall Study||58
7796178|NCT01231373|19191826|P3|STARTED|Overall Study||60
7796179|NCT01231373|19191827|P2|STARTED|Overall Study||58
7796180|NCT01231373|19191828|P1|STARTED|Overall Study||59
7796181|NCT01231334|19191848|P2|NOT COMPLETED|Overall Study||21
7796182|NCT01231334|19191849|P1|NOT COMPLETED|Overall Study||19
7796183|NCT01231334|19191848|P2|COMPLETED|Overall Study||120
7796184|NCT01231334|19191849|P1|COMPLETED|Overall Study||126
7796185|NCT01231334|19191848|P2|STARTED|Overall Study||141
7796186|NCT01231334|19191849|P1|STARTED|Overall Study||145
7796187|NCT01231321|19191867|P1|NOT COMPLETED|Overall Study||5
7796188|NCT01231321|19191867|P1|COMPLETED|Overall Study||95
7796189|NCT01231321|19191867|P1|STARTED|Overall Study||100
7796190|NCT01231230|19191878|P1|NOT COMPLETED|Overall Study||0
7796191|NCT01231230|19191878|P1|COMPLETED|Overall Study||14
7796192|NCT01231230|19191878|P1|Placebo|Overall Study||14
7796193|NCT01231230|19191878|P1|Fluticasone/Salmeterol|Overall Study||14
7796194|NCT01231230|19191878|P1|Salmeterol|Overall Study||14
7796195|NCT01231230|19191878|P1|Fluticasone|Overall Study||14
7796196|NCT01231230|19191878|P1|STARTED|Overall Study||14
7796197|NCT01230931|19191890|P2|NOT COMPLETED|Overall Study||0
7796198|NCT01230931|19191891|P1|NOT COMPLETED|Overall Study||0
7796199|NCT01230931|19191890|P2|COMPLETED|Overall Study||10
7796200|NCT01230931|19191891|P1|COMPLETED|Overall Study||10
7796201|NCT01230931|19191890|P2|STARTED|Overall Study||10
7796202|NCT01230931|19191891|P1|STARTED|Overall Study||10
7796203|NCT01230892|19191915|P2|NOT COMPLETED|Overall Study||1
7796204|NCT01230892|19191916|P1|NOT COMPLETED|Overall Study||3
7796205|NCT01230892|19191915|P2|COMPLETED|Overall Study||13
7796206|NCT01230892|19191916|P1|COMPLETED|Overall Study||12
7796207|NCT01230892|19191915|P2|STARTED|Overall Study||14
7796208|NCT01230892|19191916|P1|STARTED|Overall Study||15
7796209|NCT01230827|19191926|P4|NOT COMPLETED|Overall Study||78
7796210|NCT01230827|19191927|P3|NOT COMPLETED|Overall Study||65
7796211|NCT01230827|19191928|P2|NOT COMPLETED|Overall Study||11
7796212|NCT01230827|19191929|P1|NOT COMPLETED|Overall Study||19
7796213|NCT01230827|19191926|P4|COMPLETED|Overall Study||0
7796214|NCT01230827|19191927|P3|COMPLETED|Overall Study||0
7796215|NCT01230827|19191928|P2|COMPLETED|Overall Study||0
7796216|NCT01230827|19191929|P1|COMPLETED|Overall Study||0
7796217|NCT01230827|19191926|P4|STARTED|Overall Study||78
7796218|NCT01230827|19191927|P3|STARTED|Overall Study||65
7796219|NCT01230827|19191928|P2|STARTED|Overall Study||11
7796220|NCT01230827|19191929|P1|STARTED|Overall Study||19
7796221|NCT01230814|19191945|P2|NOT COMPLETED|Overall Study||4
7796222|NCT01230814|19191946|P1|NOT COMPLETED|Overall Study||13
7796223|NCT01230814|19191945|P2|COMPLETED|Overall Study||112
7796224|NCT01230814|19191946|P1|COMPLETED|Overall Study||105
7796225|NCT01230814|19191945|P2|STARTED|Overall Study||116
7796226|NCT01230814|19191946|P1|STARTED|Overall Study||118
7796227|NCT01230801|19191961|P3|NOT COMPLETED|Overall Study||1
7796228|NCT01230801|19191962|P2|NOT COMPLETED|Overall Study||0
7796229|NCT01230801|19191963|P1|NOT COMPLETED|Overall Study||0
7796230|NCT01230801|19191961|P3|COMPLETED|Overall Study||15
7796231|NCT01230801|19191962|P2|COMPLETED|Overall Study||3
7796232|NCT01230801|19191963|P1|COMPLETED|Overall Study||3
7796233|NCT01230801|19191961|P3|STARTED|Overall Study||16
7796234|NCT01230801|19191962|P2|STARTED|Overall Study||3
7796235|NCT01230801|19191963|P1|STARTED|Overall Study||3
7796236|NCT01230788|19191996|P1|NOT COMPLETED|Overall Study||1
7796237|NCT01230788|19191996|P1|COMPLETED|Overall Study||0
7796238|NCT01230788|19191996|P1|STARTED|Overall Study||1
7796239|NCT01230749|19192008|P4|NOT COMPLETED|Overall Study||2
7796240|NCT01230749|19192009|P3|NOT COMPLETED|Overall Study||2
7796241|NCT01230749|19192010|P2|NOT COMPLETED|Overall Study||2
7796242|NCT01230749|19192011|P1|NOT COMPLETED|Overall Study||0
7796243|NCT01230749|19192008|P4|COMPLETED|Overall Study||20
7796244|NCT01230749|19192009|P3|COMPLETED|Overall Study||21
7796245|NCT01230749|19192010|P2|COMPLETED|Overall Study||20
7796246|NCT01230749|19192011|P1|COMPLETED|Overall Study||22
7796247|NCT01230749|19192008|P4|STARTED|Overall Study||22
7796248|NCT01230749|19192009|P3|STARTED|Overall Study||23
7796249|NCT01230749|19192010|P2|STARTED|Overall Study||22
7796250|NCT01230749|19192011|P1|STARTED|Overall Study||22
7796251|NCT01230710|19192046|P1|NOT COMPLETED|Overall Study||49
7796252|NCT01230710|19192046|P1|COMPLETED|Overall Study||2
7796253|NCT01230710|19192046|P1|STARTED|Overall Study||51
7796254|NCT01230593|19192057|P3|NOT COMPLETED|Overall Study||12
7796255|NCT01230593|19192058|P2|NOT COMPLETED|Overall Study||18
7796256|NCT01230593|19192059|P1|NOT COMPLETED|Overall Study||15
7796257|NCT01230593|19192057|P3|COMPLETED|Overall Study||38
7796258|NCT01230593|19192058|P2|COMPLETED|Overall Study||32
7796259|NCT01230593|19192059|P1|COMPLETED|Overall Study||35
7796260|NCT01230593|19192057|P3|STARTED|Overall Study||50
7796261|NCT01230593|19192058|P2|STARTED|Overall Study||50
7796262|NCT01230593|19192059|P1|STARTED|Overall Study||50
7796263|NCT01230554|19192070|P1|NOT COMPLETED|Overall Study||3
7796264|NCT01230554|19192070|P1|COMPLETED|Overall Study||209
7796265|NCT01230554|19192070|P1|STARTED|Overall Study||212
7796266|NCT01230502|19192080|P3|NOT COMPLETED|Overall Study||0
7796267|NCT01230502|19192081|P2|NOT COMPLETED|Overall Study||0
7796268|NCT01230502|19192082|P1|NOT COMPLETED|Overall Study||0
7796269|NCT01230502|19192080|P3|COMPLETED|Overall Study||0
7796270|NCT01230502|19192081|P2|COMPLETED|Overall Study||0
7796271|NCT01230502|19192082|P1|COMPLETED|Overall Study||9
7796272|NCT01230502|19192080|P3|STARTED|Overall Study||0
7796273|NCT01230502|19192081|P2|STARTED|Overall Study||0
7796274|NCT01230502|19192082|P1|STARTED|Overall Study||9
7796275|NCT01230489|19192093|P1|NOT COMPLETED|Overall Study||5
7796276|NCT01230489|19192093|P1|COMPLETED|Overall Study||8
7796277|NCT01230489|19192093|P1|STARTED|Overall Study||13
7796278|NCT01230424|19192099|P2|NOT COMPLETED|Overall Study||0
7796279|NCT01230424|19192100|P1|NOT COMPLETED|Overall Study||0
7796280|NCT01230424|19192099|P2|COMPLETED|Overall Study||70
7796281|NCT01230424|19192100|P1|COMPLETED|Overall Study||70
7796282|NCT01230424|19192099|P2|STARTED|Overall Study||70
7796283|NCT01230424|19192100|P1|STARTED|Overall Study||70
7796284|NCT01230307|19192128|P2|NOT COMPLETED|Overall Study||2
7796285|NCT01230307|19192129|P1|NOT COMPLETED|Overall Study||0
7796286|NCT01230307|19192128|P2|COMPLETED|Overall Study||4
7796287|NCT01230307|19192129|P1|COMPLETED|Overall Study||6
7796288|NCT01230307|19192128|P2|STARTED|Overall Study||6
7796289|NCT01230307|19192129|P1|STARTED|Overall Study||6
7796290|NCT01230177|19192141|P1|NOT COMPLETED|Overall Study||0
7796291|NCT01230177|19192141|P1|COMPLETED|Overall Study||3
7796292|NCT01230177|19192141|P1|STARTED|Overall Study||3
7796293|NCT01230125|19192151|P2|NOT COMPLETED|Overall Study||50
7796294|NCT01230125|19192152|P1|NOT COMPLETED|Overall Study||73
7796295|NCT01230125|19192151|P2|COMPLETED|Overall Study||54
7796296|NCT01230125|19192152|P1|COMPLETED|Overall Study||134
7796297|NCT01230125|19192151|P2|STARTED|Overall Study||104
7796298|NCT01230125|19192152|P1|STARTED|Overall Study||207
7796299|NCT01230060|19192162|P1|NOT COMPLETED|Overall Study||1
7796300|NCT01230060|19192162|P1|COMPLETED|Overall Study||121
7796301|NCT01230060|19192162|P1|STARTED|Overall Study||122
7796302|NCT01230021|19192166|P1|NOT COMPLETED|Overall Study||0
7796303|NCT01230021|19192166|P1|COMPLETED|Overall Study||6
7796304|NCT01230021|19192166|P1|STARTED|Overall Study||6
7796305|NCT01229943|19192188|P2|NOT COMPLETED|Overall Study||17
7796306|NCT01229943|19192189|P1|NOT COMPLETED|Overall Study||18
7796307|NCT01229943|19192188|P2|COMPLETED|Overall Study||58
7796308|NCT01229943|19192189|P1|COMPLETED|Overall Study||57
7796309|NCT01229943|19192188|P2|STARTED|Overall Study||75
7796310|NCT01229943|19192189|P1|STARTED|Overall Study||75
7796311|NCT01229891|19192202|P3|NOT COMPLETED|Overall Study||0
7796312|NCT01229891|19192203|P2|NOT COMPLETED|Overall Study||0
7796313|NCT01229891|19192204|P1|NOT COMPLETED|Overall Study||0
7796314|NCT01229891|19192202|P3|COMPLETED|Overall Study||30
7796315|NCT01229891|19192203|P2|COMPLETED|Overall Study||30
7796316|NCT01229891|19192204|P1|COMPLETED|Overall Study||30
7796317|NCT01229891|19192202|P3|STARTED|Overall Study||30
7796318|NCT01229891|19192203|P2|STARTED|Overall Study||30
7796319|NCT01229891|19192204|P1|STARTED|Overall Study||30
7796320|NCT01229735|19192235|P2|NOT COMPLETED|Overall Study||66
7796321|NCT01229735|19192236|P1|NOT COMPLETED|Overall Study||66
7796322|NCT01229735|19192235|P2|COMPLETED|Overall Study||100
7796323|NCT01229735|19192236|P1|COMPLETED|Overall Study||111
7796324|NCT01229735|19192235|P2|STARTED|Overall Study||166
7796325|NCT01229735|19192236|P1|STARTED|Overall Study||177
7796326|NCT01229722|19192252|P2|NOT COMPLETED|Overall Study||4
7796327|NCT01229722|19192253|P1|NOT COMPLETED|Overall Study||0
7796328|NCT01229722|19192252|P2|COMPLETED|Overall Study||30
7796329|NCT01229722|19192253|P1|COMPLETED|Overall Study||36
7796330|NCT01229722|19192252|P2|STARTED|Overall Study||34
7796331|NCT01229722|19192253|P1|STARTED|Overall Study||36
7796332|NCT01229527|19192266|P3|NOT COMPLETED|Overall Study||0
7796333|NCT01229527|19192267|P2|NOT COMPLETED|Overall Study||0
7796334|NCT01229527|19192268|P1|NOT COMPLETED|Overall Study||0
7796335|NCT01229527|19192266|P3|COMPLETED|Overall Study||30
7796336|NCT01229527|19192267|P2|COMPLETED|Overall Study||30
7796337|NCT01229527|19192268|P1|COMPLETED|Overall Study||30
7796338|NCT01229527|19192266|P3|STARTED|Overall Study||30
7796339|NCT01229527|19192267|P2|STARTED|Overall Study||30
7796340|NCT01229527|19192268|P1|STARTED|Overall Study||30
7796341|NCT01229462|19192281|P2|NOT COMPLETED|Overall Study||9
7796342|NCT01229462|19192282|P1|NOT COMPLETED|Overall Study||5
7796343|NCT01229462|19192281|P2|COMPLETED|Overall Study||109
7796344|NCT01229462|19192282|P1|COMPLETED|Overall Study||115
7796345|NCT01229462|19192281|P2|STARTED|Overall Study||118
7796346|NCT01229462|19192282|P1|STARTED|Overall Study||120
7796347|NCT01229449|19192293|P5|NOT COMPLETED|Overall Study||1
7796348|NCT01229449|19192294|P4|NOT COMPLETED|Overall Study||1
7796349|NCT01229449|19192295|P3|NOT COMPLETED|Overall Study||2
7796350|NCT01229449|19192296|P2|NOT COMPLETED|Overall Study||4
7796351|NCT01229449|19192297|P1|NOT COMPLETED|Overall Study||1
7796352|NCT01229449|19192293|P5|COMPLETED|Overall Study||54
7796353|NCT01229449|19192294|P4|COMPLETED|Overall Study||112
7796354|NCT01229449|19192295|P3|COMPLETED|Overall Study||167
7796355|NCT01229449|19192296|P2|COMPLETED|Overall Study||164
7796356|NCT01229449|19192297|P1|COMPLETED|Overall Study||172
7796357|NCT01229449|19192293|P5|STARTED|Overall Study||55
7796358|NCT01229449|19192294|P4|STARTED|Overall Study||113
7796359|NCT01229449|19192295|P3|STARTED|Overall Study||169
7796360|NCT01229449|19192296|P2|STARTED|Overall Study||168
7796361|NCT01229449|19192297|P1|STARTED|Overall Study||173
7796362|NCT01229436|19192354|P1|NOT COMPLETED|Overall Study||5
7796363|NCT01229436|19192354|P1|COMPLETED|Overall Study||249
7796364|NCT01229436|19192354|P1|STARTED|Overall Study||254
7796365|NCT01229423|19192392|P1|NOT COMPLETED|Overall Study||15
7796366|NCT01229423|19192392|P1|COMPLETED|Overall Study||47
7796367|NCT01229423|19192392|P1|STARTED|Overall Study||62
7796368|NCT01229410|19192403|P2|NOT COMPLETED|Overall Study||3
7796369|NCT01229410|19192404|P1|NOT COMPLETED|Overall Study||5
7796370|NCT01229410|19192403|P2|COMPLETED|Overall Study||9
7796371|NCT01229410|19192404|P1|COMPLETED|Overall Study||7
7796372|NCT01229410|19192403|P2|STARTED|Overall Study||12
7796373|NCT01229410|19192404|P1|STARTED|Overall Study||12
7796374|NCT01229397|19192416|P2|NOT COMPLETED|Overall Study||9
7796375|NCT01229397|19192417|P1|NOT COMPLETED|Overall Study||11
7796376|NCT01229397|19192416|P2|COMPLETED|Overall Study||93
7796377|NCT01229397|19192417|P1|COMPLETED|Overall Study||92
7796378|NCT01229397|19192416|P2|STARTED|Overall Study||102
7796379|NCT01229397|19192417|P1|STARTED|Overall Study||103
7796380|NCT01229371|19192435|P4|NOT COMPLETED|Overall Study||0
7796381|NCT01229371|19192436|P3|NOT COMPLETED|Overall Study||0
7796382|NCT01229371|19192437|P2|NOT COMPLETED|Overall Study||1
7796383|NCT01229371|19192438|P1|NOT COMPLETED|Overall Study||0
7796384|NCT01229371|19192435|P4|COMPLETED|Overall Study||110
7796385|NCT01229371|19192436|P3|COMPLETED|Overall Study||110
7796386|NCT01229371|19192437|P2|COMPLETED|Overall Study||110
7796387|NCT01229371|19192438|P1|COMPLETED|Overall Study||109
7796388|NCT01229371|19192435|P4|STARTED|Overall Study||110
7796389|NCT01229371|19192436|P3|STARTED|Overall Study||110
7796390|NCT01229371|19192437|P2|STARTED|Overall Study||111
7796391|NCT01229371|19192438|P1|STARTED|Overall Study||109
7796392|NCT01229267|19192465|P5|NOT COMPLETED|Overall Study||220
7796393|NCT01229267|19192466|P4|NOT COMPLETED|Overall Study||35
7796394|NCT01229267|19192467|P3|NOT COMPLETED|Overall Study||86
7796395|NCT01229267|19192468|P2|NOT COMPLETED|Overall Study||82
7796396|NCT01229267|19192469|P1|NOT COMPLETED|Overall Study||81
7796397|NCT01229267|19192465|P5|COMPLETED|Overall Study||344
7796398|NCT01229267|19192466|P4|COMPLETED|Overall Study||71
7796399|NCT01229267|19192467|P3|COMPLETED|Overall Study||101
7796400|NCT01229267|19192468|P2|COMPLETED|Overall Study||102
7796401|NCT01229267|19192469|P1|COMPLETED|Overall Study||108
7796402|NCT01229267|19192465|P5|Received Vaccination 4|Overall Study||477
7796403|NCT01229267|19192466|P4|Received Vaccination 4|Overall Study||87
7796404|NCT01229267|19192467|P3|Received Vaccination 4|Overall Study||149
7796405|NCT01229267|19192468|P2|Received Vaccination 4|Overall Study||149
7796406|NCT01229267|19192469|P1|Received Vaccination 4|Overall Study||155
7796407|NCT01229267|19192465|P5|Received Vaccination 3|Overall Study||491
7796408|NCT01229267|19192466|P4|Received Vaccination 3|Overall Study||89
7796409|NCT01229267|19192467|P3|Received Vaccination 3|Overall Study||160
7796410|NCT01229267|19192468|P2|Received Vaccination 3|Overall Study||155
7796411|NCT01229267|19192469|P1|Received Vaccination 3|Overall Study||163
7796412|NCT01229267|19192465|P5|Received Vaccination 2|Overall Study||511
7796413|NCT01229267|19192466|P4|Received Vaccination 2|Overall Study||94
7796414|NCT01229267|19192467|P3|Received Vaccination 2|Overall Study||168
7796415|NCT01229267|19192468|P2|Received Vaccination 2|Overall Study||163
7796416|NCT01229267|19192469|P1|Received Vaccination 2|Overall Study||171
7796417|NCT01229267|19192465|P5|Received Vaccination 1|Overall Study||556
7796418|NCT01229267|19192466|P4|Received Vaccination 1|Overall Study||104
7796419|NCT01229267|19192467|P3|Received Vaccination 1|Overall Study||186
7796420|NCT01229267|19192468|P2|Received Vaccination 1|Overall Study||180
7796421|NCT01229267|19192469|P1|Received Vaccination 1|Overall Study||188
7796422|NCT01229267|19192465|P5|STARTED|Overall Study||564
7796423|NCT01229267|19192466|P4|STARTED|Overall Study||106
7796424|NCT01229267|19192467|P3|STARTED|Overall Study||187
7796425|NCT01229267|19192468|P2|STARTED|Overall Study||184
7796426|NCT01229267|19192469|P1|STARTED|Overall Study||189
7796427|NCT01229254|19192488|P3|NOT COMPLETED|Overall Study||12
7796428|NCT01229254|19192489|P2|NOT COMPLETED|Overall Study||16
7796429|NCT01229254|19192490|P1|NOT COMPLETED|Overall Study||15
7796430|NCT01229254|19192488|P3|COMPLETED|Overall Study||61
7796431|NCT01229254|19192489|P2|COMPLETED|Overall Study||58
7796432|NCT01229254|19192490|P1|COMPLETED|Overall Study||27
7796433|NCT01229254|19192488|P3|STARTED|Overall Study||73
7796434|NCT01229254|19192489|P2|STARTED|Overall Study||74
7796435|NCT01229254|19192490|P1|STARTED|Overall Study||42
7796436|NCT01229228|19192504|P5|NOT COMPLETED|Overall Study||1
7796437|NCT01229228|19192505|P4|NOT COMPLETED|Overall Study||0
7796438|NCT01229228|19192506|P3|NOT COMPLETED|Overall Study||1
7796439|NCT01229228|19192507|P2|NOT COMPLETED|Overall Study||0
7796440|NCT01229228|19192508|P1|NOT COMPLETED|Overall Study||1
7796441|NCT01229228|19192504|P5|COMPLETED|Overall Study||50
7796442|NCT01229228|19192505|P4|COMPLETED|Overall Study||51
7796443|NCT01229228|19192506|P3|COMPLETED|Overall Study||49
7796444|NCT01229228|19192507|P2|COMPLETED|Overall Study||51
7796445|NCT01229228|19192508|P1|COMPLETED|Overall Study||50
7796446|NCT01229228|19192504|P5|STARTED|Overall Study||51
7796447|NCT01229228|19192505|P4|STARTED|Overall Study||51
7796448|NCT01229228|19192506|P3|STARTED|Overall Study||50
7796449|NCT01229228|19192507|P2|STARTED|Overall Study||51
7796450|NCT01229228|19192508|P1|STARTED|Overall Study||51
7796451|NCT01229176|19192528|P8|NOT COMPLETED|Overall Study||3
7796452|NCT01229176|19192529|P7|NOT COMPLETED|Overall Study||0
7796453|NCT01229176|19192530|P6|NOT COMPLETED|Overall Study||2
7796454|NCT01229176|19192531|P5|NOT COMPLETED|Overall Study||2
7796455|NCT01229176|19192532|P4|NOT COMPLETED|Overall Study||1
7796456|NCT01229176|19192533|P3|NOT COMPLETED|Overall Study||0
7796457|NCT01229176|19192534|P2|NOT COMPLETED|Overall Study||3
7796458|NCT01229176|19192535|P1|NOT COMPLETED|Overall Study||0
7796459|NCT01229176|19192528|P8|COMPLETED|Overall Study||17
7796460|NCT01229176|19192529|P7|COMPLETED|Overall Study||20
7796461|NCT01229176|19192530|P6|COMPLETED|Overall Study||18
7796462|NCT01229176|19192531|P5|COMPLETED|Overall Study||18
7796463|NCT01229176|19192532|P4|COMPLETED|Overall Study||19
7796464|NCT01229176|19192533|P3|COMPLETED|Overall Study||20
7796465|NCT01229176|19192534|P2|COMPLETED|Overall Study||37
7796466|NCT01229176|19192535|P1|COMPLETED|Overall Study||40
7796467|NCT01229176|19192528|P8|STARTED|Overall Study||20
7796468|NCT01229176|19192529|P7|STARTED|Overall Study||20
7796469|NCT01229176|19192530|P6|STARTED|Overall Study||20
7796470|NCT01229176|19192531|P5|STARTED|Overall Study||20
7796471|NCT01229176|19192532|P4|STARTED|Overall Study||20
7796472|NCT01229176|19192533|P3|STARTED|Overall Study||20
7796473|NCT01229176|19192534|P2|STARTED|Overall Study||40
7796474|NCT01229176|19192535|P1|STARTED|Overall Study||40
7796475|NCT01229150|19192589|P4|NOT COMPLETED|Overall Study||0
7796476|NCT01229150|19192590|P3|NOT COMPLETED|Overall Study||0
7796477|NCT01229150|19192591|P2|NOT COMPLETED|Overall Study||2
7796478|NCT01229150|19192592|P1|NOT COMPLETED|Overall Study||2
7796479|NCT01229150|19192589|P4|COMPLETED|Overall Study||19
7796480|NCT01229150|19192590|P3|COMPLETED|Overall Study||19
7796481|NCT01229150|19192591|P2|COMPLETED|Overall Study||9
7796482|NCT01229150|19192592|P1|COMPLETED|Overall Study||28
7796483|NCT01229150|19192589|P4|STARTED|Overall Study||19
7796484|NCT01229150|19192590|P3|STARTED|Overall Study||19
7796485|NCT01229150|19192591|P2|STARTED|Overall Study||11
7796486|NCT01229150|19192592|P1|STARTED|Overall Study||30
7796487|NCT01229111|19192649|P1|NOT COMPLETED|Overall Study||1
7796488|NCT01229111|19192649|P1|COMPLETED|Overall Study||13
7796489|NCT01229111|19192649|P1|STARTED|Overall Study||14
7796490|NCT01228968|19192657|P1|NOT COMPLETED|Overall Study||0
7796491|NCT01228968|19192657|P1|COMPLETED|Overall Study||9
7796492|NCT01228968|19192657|P1|STARTED|Overall Study||9
7796493|NCT01228929|19192667|P3|NOT COMPLETED|High Temperature Condition||0
7796494|NCT01228929|19192668|P2|NOT COMPLETED|High Temperature Condition||0
7796495|NCT01228929|19192669|P1|NOT COMPLETED|High Temperature Condition||0
7796496|NCT01228929|19192667|P3|COMPLETED|High Temperature Condition||6
7796497|NCT01228929|19192668|P2|COMPLETED|High Temperature Condition||6
7796498|NCT01228929|19192669|P1|COMPLETED|High Temperature Condition||6
7796499|NCT01228929|19192667|P3|STARTED|High Temperature Condition||6
7796500|NCT01228929|19192668|P2|STARTED|High Temperature Condition||6
7796501|NCT01228929|19192669|P1|STARTED|High Temperature Condition||6
7796502|NCT01228929|19192667|P3|NOT COMPLETED|Low Humidity Condition||0
7796503|NCT01228929|19192668|P2|NOT COMPLETED|Low Humidity Condition||0
7796504|NCT01228929|19192669|P1|NOT COMPLETED|Low Humidity Condition||0
7796505|NCT01228929|19192667|P3|COMPLETED|Low Humidity Condition||6
7796506|NCT01228929|19192668|P2|COMPLETED|Low Humidity Condition||6
7796507|NCT01228929|19192669|P1|COMPLETED|Low Humidity Condition||6
7796508|NCT01228929|19192667|P3|STARTED|Low Humidity Condition||6
7796509|NCT01228929|19192668|P2|STARTED|Low Humidity Condition||6
7796510|NCT01228929|19192669|P1|STARTED|Low Humidity Condition||6
7796511|NCT01228929|19192667|P3|NOT COMPLETED|Nominal Condition||0
7796512|NCT01228929|19192668|P2|NOT COMPLETED|Nominal Condition||0
7796513|NCT01228929|19192669|P1|NOT COMPLETED|Nominal Condition||0
7796514|NCT01228929|19192667|P3|COMPLETED|Nominal Condition||6
7796515|NCT01228929|19192668|P2|COMPLETED|Nominal Condition||6
7796516|NCT01228929|19192669|P1|COMPLETED|Nominal Condition||6
7796517|NCT01228929|19192667|P3|STARTED|Nominal Condition||6
7796518|NCT01228929|19192668|P2|STARTED|Nominal Condition||6
7796519|NCT01228929|19192669|P1|STARTED|Nominal Condition||6
7796520|NCT01228903|19192679|P2|NOT COMPLETED|Overall Study||5
7796521|NCT01228903|19192680|P1|NOT COMPLETED|Overall Study||5
7796522|NCT01228903|19192679|P2|COMPLETED|Overall Study||34
7796523|NCT01228903|19192680|P1|COMPLETED|Overall Study||36
7796524|NCT01228903|19192679|P2|STARTED|Overall Study||39
7796525|NCT01228903|19192680|P1|STARTED|Overall Study||41
7796526|NCT01228747|19192698|P2|NOT COMPLETED|Overall Study||45
7796527|NCT01228747|19192699|P1|NOT COMPLETED|Overall Study||65
7796528|NCT01228747|19192698|P2|COMPLETED|Overall Study||81
7796529|NCT01228747|19192699|P1|COMPLETED|Overall Study||60
7796530|NCT01228747|19192698|P2|STARTED|Overall Study||126
7796531|NCT01228747|19192699|P1|STARTED|Overall Study||125
7796532|NCT01228734|19192715|P2|NOT COMPLETED|Overall Study||4
7796533|NCT01228734|19192716|P1|NOT COMPLETED|Overall Study||0
7796534|NCT01228734|19192715|P2|COMPLETED|Overall Study||200
7796535|NCT01228734|19192716|P1|COMPLETED|Overall Study||193
7796536|NCT01228734|19192715|P2|Modified Safety Population|Overall Study||199
7796537|NCT01228734|19192716|P1|Modified Safety Population|Overall Study|One subject was randomized to FOLFOX-4 group but received cetuximab + FOLFOX-4 treatment instead|194
7796538|NCT01228734|19192715|P2|Modified Intent-to-treat Population|Overall Study||200
7796539|NCT01228734|19192716|P1|Modified Intent-to-treat Population|Overall Study||193
7796540|NCT01228734|19192715|P2|STARTED|Overall Study||204
7796541|NCT01228734|19192716|P1|STARTED|Overall Study||193
7796542|NCT01228591|19192730|P2|NOT COMPLETED|Final Visit||0
7796543|NCT01228591|19192731|P1|NOT COMPLETED|Final Visit||0
7796544|NCT01228591|19192730|P2|COMPLETED|Final Visit||16
7796545|NCT01228591|19192731|P1|COMPLETED|Final Visit||17
7796546|NCT01228591|19192730|P2|STARTED|Final Visit||16
7796547|NCT01228591|19192731|P1|STARTED|Final Visit||17
7796548|NCT01228591|19192730|P2|NOT COMPLETED|1-Week Follow-Up||0
7796549|NCT01228591|19192731|P1|NOT COMPLETED|1-Week Follow-Up||0
7796550|NCT01228591|19192730|P2|COMPLETED|1-Week Follow-Up||16
7796551|NCT01228591|19192731|P1|COMPLETED|1-Week Follow-Up||17
7796552|NCT01228591|19192730|P2|STARTED|1-Week Follow-Up||16
7796553|NCT01228591|19192731|P1|STARTED|1-Week Follow-Up||17
7796554|NCT01228591|19192730|P2|NOT COMPLETED|Baseline||2
7796555|NCT01228591|19192731|P1|NOT COMPLETED|Baseline||1
7796556|NCT01228591|19192730|P2|COMPLETED|Baseline||16
7796557|NCT01228591|19192731|P1|COMPLETED|Baseline||17
7796558|NCT01228591|19192730|P2|STARTED|Baseline||18
7796559|NCT01228591|19192731|P1|STARTED|Baseline||18
7796560|NCT01228435|19192749|P2|NOT COMPLETED|Overall Study||0
7796561|NCT01228435|19192750|P1|NOT COMPLETED|Overall Study||0
7796562|NCT01228435|19192749|P2|COMPLETED|Overall Study||2
7796563|NCT01228435|19192750|P1|COMPLETED|Overall Study||1
7796564|NCT01228435|19192749|P2|STARTED|Overall Study||2
7796565|NCT01228435|19192750|P1|STARTED|Overall Study||1
7796566|NCT01228318|19192760|P2|NOT COMPLETED|Overall Study||7
7796567|NCT01228318|19192761|P1|NOT COMPLETED|Overall Study||4
7796568|NCT01228318|19192760|P2|COMPLETED|Overall Study||22
7796569|NCT01228318|19192761|P1|COMPLETED|Overall Study||30
7796570|NCT01228318|19192760|P2|STARTED|Overall Study||29
7796571|NCT01228318|19192761|P1|STARTED|Overall Study||34
7796572|NCT01228175|19192777|P2|NOT COMPLETED|Overall Study||53
7796573|NCT01228175|19192778|P1|NOT COMPLETED|Overall Study||66
7796574|NCT01228175|19192777|P2|COMPLETED|Overall Study||46
7796575|NCT01228175|19192778|P1|COMPLETED|Overall Study||53
7796576|NCT01228175|19192777|P2|STARTED|Overall Study||99
7796577|NCT01228175|19192778|P1|STARTED|Overall Study||119
7796578|NCT01228149|19192786|P2|NOT COMPLETED|Overall Study||4
7796579|NCT01228149|19192787|P1|NOT COMPLETED|Overall Study||5
7796580|NCT01228149|19192786|P2|COMPLETED|Overall Study||26
7796581|NCT01228149|19192787|P1|COMPLETED|Overall Study||27
7796582|NCT01228149|19192786|P2|STARTED|Overall Study||30
7796583|NCT01228149|19192787|P1|STARTED|Overall Study||32
7796584|NCT01228084|19192809|P1|NOT COMPLETED|Overall Study||4
7796585|NCT01228084|19192809|P1|COMPLETED|Overall Study||16
7796586|NCT01228084|19192809|P1|STARTED|Overall Study||20
7796587|NCT01228071|19192820|P1|NOT COMPLETED|Overall Study||2
7796588|NCT01228071|19192820|P1|COMPLETED|Overall Study||32
7796589|NCT01228071|19192820|P1|STARTED|Overall Study||34
7796590|NCT01228019|19192826|P1|NOT COMPLETED|Overall Study||304
7796591|NCT01228019|19192826|P1|COMPLETED|Overall Study||862
7796592|NCT01228019|19192826|P1|STARTED|Overall Study||1166
7796593|NCT01227993|19192841|P1|NOT COMPLETED|Overall Study||0
7796594|NCT01227993|19192841|P1|COMPLETED|Overall Study||3
7796595|NCT01227993|19192841|P1|STARTED|Overall Study||3
7796596|NCT01227980|19192853|P2|NOT COMPLETED|Overall Study||5
7796597|NCT01227980|19192854|P1|NOT COMPLETED|Overall Study||2
7796598|NCT01227980|19192853|P2|COMPLETED|Overall Study||25
7796599|NCT01227980|19192854|P1|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38
7796600|NCT01227980|19192853|P2|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0
7796601|NCT01227980|19192854|P1|Measure Drug Level Concentration|Overall Study||10
7796602|NCT01227980|19192853|P2|Scripts Challenge Sessions|Overall Study||25
7796603|NCT01227980|19192854|P1|Scripts Challenge Sessions|Overall Study||26
7796604|NCT01227980|19192853|P2|STARTED|Overall Study||30
7796605|NCT01227980|19192854|P1|STARTED|Overall Study||40
7796606|NCT01227967|19192892|P2|NOT COMPLETED|Overall Study||13
7796607|NCT01227967|19192893|P1|NOT COMPLETED|Overall Study||16
7796608|NCT01227967|19192892|P2|COMPLETED|Overall Study||303
7796609|NCT01227967|19192893|P1|COMPLETED|Overall Study||298
7796610|NCT01227967|19192892|P2|STARTED|Overall Study||316
7796611|NCT01227967|19192893|P1|STARTED|Overall Study||314
7796612|NCT01227954|19192927|P1|NOT COMPLETED|Overall Study||13
7796613|NCT01227954|19192927|P1|COMPLETED|Overall Study|Eligible subjects available for analysis|100
7796614|NCT01227954|19192927|P1|STARTED|Overall Study||113
7796615|NCT01227928|19192941|P2|NOT COMPLETED|Overall Study||17
7796616|NCT01227928|19192942|P1|NOT COMPLETED|Overall Study||22
7796617|NCT01227928|19192941|P2|COMPLETED|Overall Study||56
7796618|NCT01227928|19192942|P1|COMPLETED|Overall Study||50
7796619|NCT01227928|19192941|P2|STARTED|Overall Study||73
7796620|NCT01227928|19192942|P1|STARTED|Overall Study||72
7796621|NCT01227902|19192980|P4|NOT COMPLETED|Overall Study||10
7796622|NCT01227902|19192981|P3|NOT COMPLETED|Overall Study||19
7796623|NCT01227902|19192982|P2|NOT COMPLETED|Overall Study||13
7796624|NCT01227902|19192983|P1|NOT COMPLETED|Overall Study||18
7796625|NCT01227902|19192980|P4|COMPLETED|Overall Study||42
7796626|NCT01227902|19192981|P3|COMPLETED|Overall Study||25
7796627|NCT01227902|19192982|P2|COMPLETED|Overall Study||38
7796628|NCT01227902|19192983|P1|COMPLETED|Overall Study||38
7796629|NCT01227902|19192980|P4|STARTED|Overall Study||52
7796630|NCT01227902|19192981|P3|STARTED|Overall Study||44
7796631|NCT01227902|19192982|P2|STARTED|Overall Study||51
7796632|NCT01227902|19192983|P1|STARTED|Overall Study||56
7796633|NCT01227889|19193076|P2|NOT COMPLETED|Crossover Phase||37
7796634|NCT01227889|19193077|P1|NOT COMPLETED|Crossover Phase||0
7796635|NCT01227889|19193076|P2|COMPLETED|Crossover Phase||0
7796636|NCT01227889|19193077|P1|COMPLETED|Crossover Phase||0
7796637|NCT01227889|19193076|P2|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|37
7796638|NCT01227889|19193077|P1|STARTED|Crossover Phase||0
7796639|NCT01227889|19193076|P2|NOT COMPLETED|Randomized Phase (RP)||63
7796640|NCT01227889|19193077|P1|NOT COMPLETED|Randomized Phase (RP)||187
7796641|NCT01227889|19193076|P2|COMPLETED|Randomized Phase (RP)||0
7796642|NCT01227889|19193077|P1|COMPLETED|Randomized Phase (RP)||0
7796643|NCT01227889|19193076|P2|STARTED|Randomized Phase (RP)||63
7796644|NCT01227889|19193077|P1|STARTED|Randomized Phase (RP)||187
7796645|NCT01227824|19193104|P3|NOT COMPLETED|Open-label Phase: Median of 1267 Days||44
7796646|NCT01227824|19193105|P2|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
7796647|NCT01227824|19193106|P1|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
7796648|NCT01227824|19193104|P3|COMPLETED|Open-label Phase: Median of 1267 Days||294
7796649|NCT01227824|19193105|P2|COMPLETED|Open-label Phase: Median of 1267 Days||0
7796650|NCT01227824|19193106|P1|COMPLETED|Open-label Phase: Median of 1267 Days||0
7796651|NCT01227824|19193104|P3|STARTED|Open-label Phase: Median of 1267 Days|338 participants continued into the Open-label phase on completing the Double-blind Phase|338
7796652|NCT01227824|19193105|P2|STARTED|Open-label Phase: Median of 1267 Days||0
7796653|NCT01227824|19193106|P1|STARTED|Open-label Phase: Median of 1267 Days||0
7796654|NCT01227824|19193104|P3|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||0
7796655|NCT01227824|19193105|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||79
7796656|NCT01227824|19193106|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||107
7796657|NCT01227824|19193104|P3|COMPLETED|Double-blind Phase: 96 Weeks Duration||0
7796658|NCT01227824|19193105|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||332
7796659|NCT01227824|19193106|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||304
7796660|NCT01227824|19193104|P3|STARTED|Double-blind Phase: 96 Weeks Duration||0
7796661|NCT01227824|19193105|P2|STARTED|Double-blind Phase: 96 Weeks Duration||411
7796662|NCT01227824|19193106|P1|STARTED|Double-blind Phase: 96 Weeks Duration||411
7796663|NCT01227785|19193135|P1|NOT COMPLETED|Overall Study||12
7796664|NCT01227785|19193135|P1|COMPLETED|Overall Study||108
7796665|NCT01227785|19193135|P1|STARTED|Overall Study||120
7796666|NCT01227707|19193201|P1|NOT COMPLETED|Overall Study||24
7796667|NCT01227707|19193201|P1|COMPLETED|Overall Study||19
7796668|NCT01227707|19193201|P1|STARTED|Overall Study||43
7796669|NCT01227681|19193220|P3|NOT COMPLETED|Overall Study||0
7796670|NCT01227681|19193221|P2|NOT COMPLETED|Overall Study||0
7796671|NCT01227681|19193222|P1|NOT COMPLETED|Overall Study||0
7796672|NCT01227681|19193220|P3|COMPLETED|Overall Study||0
7796673|NCT01227681|19193221|P2|COMPLETED|Overall Study||0
7796674|NCT01227681|19193222|P1|COMPLETED|Overall Study||4
7796675|NCT01227681|19193220|P3|STARTED|Overall Study||0
7796676|NCT01227681|19193221|P2|STARTED|Overall Study||0
7796677|NCT01227681|19193222|P1|STARTED|Overall Study||4
7796678|NCT01227668|19193228|P2|NOT COMPLETED|Phase 2 (Randomization Phase)||25
7796679|NCT01227668|19193229|P1|NOT COMPLETED|Phase 2 (Randomization Phase)||19
7796680|NCT01227668|19193228|P2|COMPLETED|Phase 2 (Randomization Phase)||19
7796681|NCT01227668|19193229|P1|COMPLETED|Phase 2 (Randomization Phase)||22
7796682|NCT01227668|19193228|P2|Received Treatment|Phase 2 (Randomization Phase)||43
7796683|NCT01227668|19193229|P1|Received Treatment|Phase 2 (Randomization Phase)||39
7796684|NCT01227668|19193228|P2|STARTED|Phase 2 (Randomization Phase)|Randomized|44
7796685|NCT01227668|19193229|P1|STARTED|Phase 2 (Randomization Phase)|Randomized|41
7796686|NCT01227668|19193228|P2|NOT COMPLETED|Phase 1 (Stabilization Phase)||0
7796687|NCT01227668|19193229|P1|NOT COMPLETED|Phase 1 (Stabilization Phase)||72
7796688|NCT01227668|19193228|P2|COMPLETED|Phase 1 (Stabilization Phase)||0
7796689|NCT01227668|19193229|P1|COMPLETED|Phase 1 (Stabilization Phase)||85
7796690|NCT01227668|19193228|P2|Received Treatment|Phase 1 (Stabilization Phase)||0
7796691|NCT01227668|19193229|P1|Received Treatment|Phase 1 (Stabilization Phase)||155
7796692|NCT01227668|19193228|P2|STARTED|Phase 1 (Stabilization Phase)||0
7796693|NCT01227668|19193229|P1|STARTED|Phase 1 (Stabilization Phase)|Randomized|157
7796694|NCT01227655|19193246|P3|NOT COMPLETED|Overall Study||14
7796695|NCT01227655|19193247|P2|NOT COMPLETED|Overall Study||26
7796696|NCT01227655|19193248|P1|NOT COMPLETED|Overall Study||11
7796697|NCT01227655|19193246|P3|COMPLETED|Overall Study||130
7796698|NCT01227655|19193247|P2|COMPLETED|Overall Study||128
7796699|NCT01227655|19193248|P1|COMPLETED|Overall Study||118
7796700|NCT01227655|19193246|P3|Full Analysis Set|Overall Study||135
7796701|NCT01227655|19193247|P2|Full Analysis Set|Overall Study||147
7796702|NCT01227655|19193248|P1|Full Analysis Set|Overall Study||125
7796703|NCT01227655|19193246|P3|Safety Set|Overall Study||136
7796704|NCT01227655|19193247|P2|Safety Set|Overall Study||150
7796705|NCT01227655|19193248|P1|Safety Set|Overall Study||125
7796706|NCT01227655|19193246|P3|STARTED|Overall Study||144
7796707|NCT01227655|19193247|P2|STARTED|Overall Study||154
7796708|NCT01227655|19193248|P1|STARTED|Overall Study||129
7796709|NCT01227629|19193275|P10|NOT COMPLETED|Overall Study||2
7796710|NCT01227629|19193276|P9|NOT COMPLETED|Overall Study||6
7796711|NCT01227629|19193277|P8|NOT COMPLETED|Overall Study||6
7796712|NCT01227629|19193278|P7|NOT COMPLETED|Overall Study||8
7796713|NCT01227629|19193279|P6|NOT COMPLETED|Overall Study||1
7796714|NCT01227629|19193280|P5|NOT COMPLETED|Overall Study||2
7796715|NCT01227629|19193281|P4|NOT COMPLETED|Overall Study||8
7796716|NCT01227629|19193282|P3|NOT COMPLETED|Overall Study||1
7796717|NCT01227629|19193283|P2|NOT COMPLETED|Overall Study||2
7796718|NCT01227629|19193284|P1|NOT COMPLETED|Overall Study||2
7796719|NCT01227629|19193275|P10|COMPLETED|Overall Study||68
7796720|NCT01227629|19193276|P9|COMPLETED|Overall Study||24
7796721|NCT01227629|19193277|P8|COMPLETED|Overall Study||27
7796722|NCT01227629|19193278|P7|COMPLETED|Overall Study||90
7796723|NCT01227629|19193279|P6|COMPLETED|Overall Study||32
7796724|NCT01227629|19193280|P5|COMPLETED|Overall Study||32
7796725|NCT01227629|19193281|P4|COMPLETED|Overall Study||91
7796726|NCT01227629|19193282|P3|COMPLETED|Overall Study||26
7796727|NCT01227629|19193283|P2|COMPLETED|Overall Study||18
7796728|NCT01227629|19193284|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56
7796729|NCT01227629|19193275|P10|STARTED|Overall Study||70
7796730|NCT01227629|19193276|P9|STARTED|Overall Study||30
7796731|NCT01227629|19193277|P8|STARTED|Overall Study||33
7796732|NCT01227629|19193278|P7|STARTED|Overall Study||98
7796733|NCT01227629|19193279|P6|STARTED|Overall Study||33
7796734|NCT01227629|19193280|P5|STARTED|Overall Study||34
7796735|NCT01227629|19193281|P4|STARTED|Overall Study||99
7796736|NCT01227629|19193282|P3|STARTED|Overall Study||27
7796737|NCT01227629|19193283|P2|STARTED|Overall Study||20
7796738|NCT01227629|19193284|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58
7796739|NCT01227616|19193522|P2|NOT COMPLETED|Overall Study||23
7796740|NCT01227616|19193523|P1|NOT COMPLETED|Overall Study||54
7796741|NCT01227616|19193522|P2|COMPLETED|Overall Study||74
7796742|NCT01227616|19193523|P1|COMPLETED|Overall Study||142
7796743|NCT01227616|19193522|P2|STARTED|Overall Study||97
7796744|NCT01227616|19193523|P1|STARTED|Overall Study||196
7796745|NCT01227577|19193533|P1|NOT COMPLETED|Overall Study||35
7796746|NCT01227577|19193533|P1|COMPLETED|Overall Study||93
7796747|NCT01227577|19193533|P1|STARTED|Overall Study||128
7796748|NCT01227564|19193548|P3|NOT COMPLETED|Overall Study||6
7796749|NCT01227564|19193549|P2|NOT COMPLETED|Overall Study||2
7796750|NCT01227564|19193550|P1|NOT COMPLETED|Overall Study||4
7796751|NCT01227564|19193548|P3|COMPLETED|Overall Study|Completed study|15
7796752|NCT01227564|19193549|P2|COMPLETED|Overall Study|Completed study|18
7796753|NCT01227564|19193550|P1|COMPLETED|Overall Study|Completed study|18
7796754|NCT01227564|19193548|P3|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17
7796755|NCT01227564|19193549|P2|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18
7796756|NCT01227564|19193550|P1|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21
7796757|NCT01227564|19193548|P3|Treated|Overall Study||21
7796758|NCT01227564|19193549|P2|Treated|Overall Study||20
7796759|NCT01227564|19193550|P1|Treated|Overall Study||22
7796760|NCT01227564|19193548|P3|STARTED|Overall Study||21
7796761|NCT01227564|19193549|P2|STARTED|Overall Study||20
7796762|NCT01227564|19193550|P1|STARTED|Overall Study||22
7796763|NCT01227551|19193681|P1|NOT COMPLETED|Overall Study||34
7796764|NCT01227551|19193681|P1|COMPLETED|Overall Study||23
7796765|NCT01227551|19193681|P1|STARTED|Overall Study||57
7796766|NCT01227512|19193688|P2|NOT COMPLETED|Overall Study||10
7796767|NCT01227512|19193689|P1|NOT COMPLETED|Overall Study||13
7796768|NCT01227512|19193688|P2|COMPLETED|Overall Study||48
7796769|NCT01227512|19193689|P1|COMPLETED|Overall Study||53
7796770|NCT01227512|19193688|P2|STARTED|Overall Study||58
7796771|NCT01227512|19193689|P1|STARTED|Overall Study||66
7796772|NCT01227434|19193711|P2|NOT COMPLETED|Overall Study||0
7796773|NCT01227434|19193712|P1|NOT COMPLETED|Overall Study||0
7796774|NCT01227434|19193711|P2|COMPLETED|Overall Study||16
7796775|NCT01227434|19193712|P1|COMPLETED|Overall Study||6
7796776|NCT01227434|19193711|P2|STARTED|Overall Study||16
7796777|NCT01227434|19193712|P1|STARTED|Overall Study||6
7796778|NCT01227421|19193723|P3|NOT COMPLETED|Overall Study||10
7796779|NCT01227421|19193724|P2|NOT COMPLETED|Overall Study||18
7796780|NCT01227421|19193725|P1|NOT COMPLETED|Overall Study||11
7796781|NCT01227421|19193723|P3|COMPLETED|Overall Study||201
7796782|NCT01227421|19193724|P2|COMPLETED|Overall Study||194
7796783|NCT01227421|19193725|P1|COMPLETED|Overall Study||190
7796784|NCT01227421|19193723|P3|STARTED|Overall Study||211
7796785|NCT01227421|19193724|P2|STARTED|Overall Study||212
7796786|NCT01227421|19193725|P1|STARTED|Overall Study||201
7796787|NCT01227395|19193777|P2|NOT COMPLETED|Overall Study||1
7796788|NCT01227395|19193778|P1|NOT COMPLETED|Overall Study||0
7796789|NCT01227395|19193777|P2|COMPLETED|Overall Study||84
7796790|NCT01227395|19193778|P1|COMPLETED|Overall Study||391
7796791|NCT01227395|19193777|P2|STARTED|Overall Study||85
7796792|NCT01227395|19193778|P1|STARTED|Overall Study||391
7796793|NCT01227382|19193806|P1|NOT COMPLETED|Overall Study||0
7796794|NCT01227382|19193806|P1|COMPLETED|Overall Study||26
7796795|NCT01227382|19193806|P1|STARTED|Overall Study||26
7796796|NCT01227278|19193818|P2|NOT COMPLETED|Overall Study||8
7796797|NCT01227278|19193819|P1|NOT COMPLETED|Overall Study||5
7796798|NCT01227278|19193818|P2|COMPLETED|Overall Study||43
7796799|NCT01227278|19193819|P1|COMPLETED|Overall Study||45
7796800|NCT01227278|19193818|P2|STARTED|Overall Study||51
7796801|NCT01227278|19193819|P1|STARTED|Overall Study||50
7796802|NCT01227265|19193846|P3|NOT COMPLETED|Overall Study||14
7796803|NCT01227265|19193847|P2|NOT COMPLETED|Overall Study||20
7796804|NCT01227265|19193848|P1|NOT COMPLETED|Overall Study||19
7796805|NCT01227265|19193846|P3|COMPLETED|Overall Study||145
7796806|NCT01227265|19193847|P2|COMPLETED|Overall Study||139
7796807|NCT01227265|19193848|P1|COMPLETED|Overall Study||139
7796808|NCT01227265|19193846|P3|Treated|Overall Study||159
7796809|NCT01227265|19193847|P2|Treated|Overall Study||157
7796810|NCT01227265|19193848|P1|Treated|Overall Study||157
7796811|NCT01227265|19193846|P3|STARTED|Overall Study||159
7796812|NCT01227265|19193847|P2|STARTED|Overall Study||159
7796813|NCT01227265|19193848|P1|STARTED|Overall Study||158
7796814|NCT01227252|19193878|P4|NOT COMPLETED|Overall Study||0
7796815|NCT01227252|19193879|P3|NOT COMPLETED|Overall Study||0
7796816|NCT01227252|19193880|P2|NOT COMPLETED|Overall Study||3
7796817|NCT01227252|19193881|P1|NOT COMPLETED|Overall Study||0
7796818|NCT01227252|19193878|P4|COMPLETED|Overall Study||10
7796819|NCT01227252|19193879|P3|COMPLETED|Overall Study||10
7796820|NCT01227252|19193880|P2|COMPLETED|Overall Study||7
7796821|NCT01227252|19193881|P1|COMPLETED|Overall Study||12
7796822|NCT01227252|19193878|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
7796823|NCT01227252|19193879|P3|Received at Least 1 Dose of Study Drug|Overall Study||10
7796824|NCT01227252|19193880|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
7796825|NCT01227252|19193881|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
7796826|NCT01227252|19193878|P4|STARTED|Overall Study||10
7796827|NCT01227252|19193879|P3|STARTED|Overall Study||10
7796828|NCT01227252|19193880|P2|STARTED|Overall Study||10
7796829|NCT01227252|19193881|P1|STARTED|Overall Study||12
7796830|NCT01227057|19193910|P2|NOT COMPLETED|Overall Study||8
7796831|NCT01227057|19193911|P1|NOT COMPLETED|Overall Study||6
7796832|NCT01227057|19193910|P2|COMPLETED|Overall Study||19
7796833|NCT01227057|19193911|P1|COMPLETED|Overall Study||25
7796834|NCT01227057|19193910|P2|STARTED|Overall Study||27
7796835|NCT01227057|19193911|P1|STARTED|Overall Study||31
7796836|NCT01227044|19193923|P2|NOT COMPLETED|Overall Study||9
7796837|NCT01227044|19193924|P1|NOT COMPLETED|Overall Study||6
7796838|NCT01227044|19193923|P2|COMPLETED|Overall Study||17
7796839|NCT01227044|19193924|P1|COMPLETED|Overall Study||19
7796840|NCT01227044|19193923|P2|STARTED|Overall Study||26
7796841|NCT01227044|19193924|P1|STARTED|Overall Study||25
7796842|NCT01227018|19193932|P1|NOT COMPLETED|Overall Study||15
7796843|NCT01227018|19193932|P1|COMPLETED|Overall Study||0
7796844|NCT01227018|19193932|P1|STARTED|Overall Study||15
7796845|NCT01227005|19193942|P2|NOT COMPLETED|Overall Study||1
7796846|NCT01227005|19193943|P1|NOT COMPLETED|Overall Study||5
7796847|NCT01227005|19193942|P2|COMPLETED|Overall Study||51
7796848|NCT01227005|19193943|P1|COMPLETED|Overall Study||50
7796849|NCT01227005|19193942|P2|STARTED|Overall Study||52
7796850|NCT01227005|19193943|P1|STARTED|Overall Study||55
7796851|NCT01226979|19193953|P1|NOT COMPLETED|Overall Study||0
7796852|NCT01226979|19193953|P1|COMPLETED|Overall Study||16
7796853|NCT01226979|19193953|P1|STARTED|Overall Study||16
7796854|NCT01226914|19193964|P2|NOT COMPLETED|Overall Study||0
7796855|NCT01226914|19193965|P1|NOT COMPLETED|Overall Study||0
7796856|NCT01226914|19193964|P2|COMPLETED|Overall Study||27
7796857|NCT01226914|19193965|P1|COMPLETED|Overall Study||28
7796858|NCT01226914|19193964|P2|STARTED|Overall Study||27
7796859|NCT01226914|19193965|P1|STARTED|Overall Study||28
7796860|NCT01226745|19193977|P6|NOT COMPLETED|Overall Study||5
7796861|NCT01226745|19193978|P5|NOT COMPLETED|Overall Study||4
7796862|NCT01226745|19193979|P4|NOT COMPLETED|Overall Study||5
7796863|NCT01226745|19193980|P3|NOT COMPLETED|Overall Study||20
7796864|NCT01226745|19193981|P2|NOT COMPLETED|Overall Study||16
7796865|NCT01226745|19193982|P1|NOT COMPLETED|Overall Study||17
7796866|NCT01226745|19193977|P6|COMPLETED|Overall Study||24
7796867|NCT01226745|19193978|P5|COMPLETED|Overall Study||22
7796868|NCT01226745|19193979|P4|COMPLETED|Overall Study||24
7796869|NCT01226745|19193980|P3|COMPLETED|Overall Study||69
7796870|NCT01226745|19193981|P2|COMPLETED|Overall Study||71
7796871|NCT01226745|19193982|P1|COMPLETED|Overall Study||63
7796872|NCT01226745|19193977|P6|STARTED|Overall Study||29
7796873|NCT01226745|19193978|P5|STARTED|Overall Study||26
7796874|NCT01226745|19193979|P4|STARTED|Overall Study||29
7796875|NCT01226745|19193980|P3|STARTED|Overall Study||89
7796876|NCT01226745|19193981|P2|STARTED|Overall Study||87
7796877|NCT01226745|19193982|P1|STARTED|Overall Study||80
7796878|NCT01226732|19194062|P6|NOT COMPLETED|Overall Study||6
7796879|NCT01226732|19194063|P5|NOT COMPLETED|Overall Study||3
7796880|NCT01226732|19194064|P4|NOT COMPLETED|Overall Study||5
7796881|NCT01226732|19194065|P3|NOT COMPLETED|Overall Study||3
7796882|NCT01226732|19194066|P2|NOT COMPLETED|Overall Study||3
7796883|NCT01226732|19194067|P1|NOT COMPLETED|Overall Study||3
7796884|NCT01226732|19194062|P6|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
7796885|NCT01226732|19194063|P5|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
7796886|NCT01226732|19194064|P4|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
7796887|NCT01226732|19194065|P3|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
7796888|NCT01226732|19194066|P2|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
7796889|NCT01226732|19194067|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
7796890|NCT01226732|19194062|P6|STARTED|Overall Study||6
7796891|NCT01226732|19194063|P5|STARTED|Overall Study||3
7796892|NCT01226732|19194064|P4|STARTED|Overall Study||5
7796893|NCT01226732|19194065|P3|STARTED|Overall Study||3
7796894|NCT01226732|19194066|P2|STARTED|Overall Study||3
7796895|NCT01226732|19194067|P1|STARTED|Overall Study||3
7796896|NCT01226719|19194083|P1|NOT COMPLETED|Overall Study||13
7796897|NCT01226719|19194083|P1|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2
7796898|NCT01226719|19194083|P1|STARTED|Overall Study||15
7796899|NCT01226706|19194093|P2|NOT COMPLETED|Overall Study||0
7796900|NCT01226706|19194094|P1|NOT COMPLETED|Overall Study||0
7796901|NCT01226706|19194093|P2|COMPLETED|Overall Study||11
7796902|NCT01226706|19194094|P1|COMPLETED|Overall Study||10
7796903|NCT01226706|19194093|P2|STARTED|Overall Study||11
7796904|NCT01226706|19194094|P1|STARTED|Overall Study||10
7796905|NCT01226511|19194178|P2|NOT COMPLETED|Taper Period||3
7796906|NCT01226511|19194179|P1|NOT COMPLETED|Taper Period||5
7796907|NCT01226511|19194178|P2|COMPLETED|Taper Period||54
7796908|NCT01226511|19194179|P1|COMPLETED|Taper Period||46
7796909|NCT01226511|19194178|P2|STARTED|Taper Period||57
7796910|NCT01226511|19194179|P1|STARTED|Taper Period||51
7796911|NCT01226511|19194178|P2|NOT COMPLETED|Extension Treatment Period||27
7796912|NCT01226511|19194179|P1|NOT COMPLETED|Extension Treatment Period||27
7796913|NCT01226511|19194178|P2|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83
7796914|NCT01226511|19194179|P1|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81
7796915|NCT01226511|19194178|P2|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110
7796916|NCT01226511|19194179|P1|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108
7796917|NCT01226511|19194178|P2|NOT COMPLETED|Acute Treatment Period||31
7796918|NCT01226511|19194179|P1|NOT COMPLETED|Acute Treatment Period||32
7796919|NCT01226511|19194178|P2|COMPLETED|Acute Treatment Period||110
7796920|NCT01226511|19194179|P1|COMPLETED|Acute Treatment Period||108
7796921|NCT01226511|19194178|P2|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141
7796922|NCT01226511|19194179|P1|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140
7796923|NCT01226485|19194222|P7|NOT COMPLETED|Overall Study||0
7796924|NCT01226485|19194223|P6|NOT COMPLETED|Overall Study||0
7796925|NCT01226485|19194224|P5|NOT COMPLETED|Overall Study||0
7796926|NCT01226485|19194225|P4|NOT COMPLETED|Overall Study||0
7796927|NCT01226485|19194226|P3|NOT COMPLETED|Overall Study||0
7796928|NCT01226485|19194227|P2|NOT COMPLETED|Overall Study||0
7796929|NCT01226485|19194228|P1|NOT COMPLETED|Overall Study||0
7796930|NCT01226485|19194222|P7|COMPLETED|Overall Study||40
7796931|NCT01226485|19194223|P6|COMPLETED|Overall Study||19
7796932|NCT01226485|19194224|P5|COMPLETED|Overall Study||7
7796933|NCT01226485|19194225|P4|COMPLETED|Overall Study||6
7796934|NCT01226485|19194226|P3|COMPLETED|Overall Study||3
7796935|NCT01226485|19194227|P2|COMPLETED|Overall Study||6
7796936|NCT01226485|19194228|P1|COMPLETED|Overall Study||3
7796937|NCT01226485|19194222|P7|Received at Least One Dose of Drug|Overall Study||40
7796938|NCT01226485|19194223|P6|Received at Least One Dose of Drug|Overall Study||19
7796939|NCT01226485|19194224|P5|Received at Least One Dose of Drug|Overall Study||7
7796940|NCT01226485|19194225|P4|Received at Least One Dose of Drug|Overall Study||6
7796941|NCT01226485|19194226|P3|Received at Least One Dose of Drug|Overall Study||3
7796942|NCT01226485|19194227|P2|Received at Least One Dose of Drug|Overall Study||6
7796943|NCT01226485|19194228|P1|Received at Least One Dose of Drug|Overall Study||3
7796944|NCT01226485|19194222|P7|STARTED|Overall Study||40
7796945|NCT01226485|19194223|P6|STARTED|Overall Study||19
7796946|NCT01226485|19194224|P5|STARTED|Overall Study||7
7796947|NCT01226485|19194225|P4|STARTED|Overall Study||6
7796948|NCT01226485|19194226|P3|STARTED|Overall Study||3
7796949|NCT01226485|19194227|P2|STARTED|Overall Study||6
7796950|NCT01226485|19194228|P1|STARTED|Overall Study||3
7796951|NCT01226472|19194277|P1|NOT COMPLETED|Overall Study||1
7796952|NCT01226472|19194277|P1|COMPLETED|Overall Study||0
7796953|NCT01226472|19194277|P1|STARTED|Overall Study||1
7796954|NCT01226459|19194284|P2|NOT COMPLETED|Overall Study||32
7796955|NCT01226459|19194285|P1|NOT COMPLETED|Overall Study||21
7796956|NCT01226459|19194284|P2|COMPLETED|Overall Study||171
7796957|NCT01226459|19194285|P1|COMPLETED|Overall Study||180
7796958|NCT01226459|19194284|P2|STARTED|Overall Study||203
7796959|NCT01226459|19194285|P1|STARTED|Overall Study||201
7796960|NCT01226420|19194295|P1|NOT COMPLETED|Overall Study||0
7796961|NCT01226420|19194295|P1|COMPLETED|Overall Study||6
7796962|NCT01226420|19194295|P1|STARTED|Overall Study||6
7796963|NCT01226121|19194303|P3|NOT COMPLETED|Overall Study||1
7796964|NCT01226121|19194304|P2|NOT COMPLETED|Overall Study||0
7796965|NCT01226121|19194305|P1|NOT COMPLETED|Overall Study||2
7796966|NCT01226121|19194303|P3|COMPLETED|Overall Study||12
7796967|NCT01226121|19194304|P2|COMPLETED|Overall Study||11
7796968|NCT01226121|19194305|P1|COMPLETED|Overall Study||11
7796969|NCT01226121|19194303|P3|30 Day Evaluation|Overall Study||13
7796970|NCT01226121|19194304|P2|30 Day Evaluation|Overall Study||11
7796971|NCT01226121|19194305|P1|30 Day Evaluation|Overall Study||12
7796972|NCT01226121|19194303|P3|STARTED|Overall Study||13
7796973|NCT01226121|19194304|P2|STARTED|Overall Study||11
7796974|NCT01226121|19194305|P1|STARTED|Overall Study||13
7796975|NCT01226095|19194316|P1|NOT COMPLETED|Overall Study||1
7796976|NCT01226095|19194316|P1|COMPLETED|Overall Study||518
7796977|NCT01226095|19194316|P1|STARTED|Overall Study||519
7796978|NCT01226043|19194341|P4|NOT COMPLETED|30-week Observational Phase||13
7796979|NCT01226043|19194342|P3|NOT COMPLETED|30-week Observational Phase||6
7796980|NCT01226043|19194343|P2|NOT COMPLETED|30-week Observational Phase||0
7796981|NCT01226043|19194344|P1|NOT COMPLETED|30-week Observational Phase||0
7796982|NCT01226043|19194341|P4|COMPLETED|30-week Observational Phase||140
7796983|NCT01226043|19194342|P3|COMPLETED|30-week Observational Phase||153
7796984|NCT01226043|19194343|P2|COMPLETED|30-week Observational Phase||0
7796985|NCT01226043|19194344|P1|COMPLETED|30-week Observational Phase||0
7796986|NCT01226043|19194341|P4|TREATED|30-week Observational Phase||153
7796987|NCT01226043|19194342|P3|TREATED|30-week Observational Phase||159
7796988|NCT01226043|19194343|P2|TREATED|30-week Observational Phase||0
7796989|NCT01226043|19194344|P1|TREATED|30-week Observational Phase||0
7796990|NCT01226043|19194341|P4|STARTED|30-week Observational Phase||153
7796991|NCT01226043|19194342|P3|STARTED|30-week Observational Phase||159
7796992|NCT01226043|19194343|P2|STARTED|30-week Observational Phase||0
7796993|NCT01226043|19194344|P1|STARTED|30-week Observational Phase||0
7796994|NCT01226043|19194341|P4|NOT COMPLETED|6-week Re-randomization Phase||11
7796995|NCT01226043|19194342|P3|NOT COMPLETED|6-week Re-randomization Phase||7
7796996|NCT01226043|19194343|P2|NOT COMPLETED|6-week Re-randomization Phase||0
7796997|NCT01226043|19194344|P1|NOT COMPLETED|6-week Re-randomization Phase||0
7796998|NCT01226043|19194341|P4|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156
7796999|NCT01226043|19194342|P3|COMPLETED|6-week Re-randomization Phase||159
7797000|NCT01226043|19194343|P2|COMPLETED|6-week Re-randomization Phase||0
7797001|NCT01226043|19194344|P1|COMPLETED|6-week Re-randomization Phase||0
7797002|NCT01226043|19194341|P4|TREATED|6-week Re-randomization Phase||165
7797003|NCT01226043|19194342|P3|TREATED|6-week Re-randomization Phase||165
7797004|NCT01226043|19194343|P2|TREATED|6-week Re-randomization Phase||0
7797005|NCT01226043|19194344|P1|TREATED|6-week Re-randomization Phase||0
7797006|NCT01226043|19194341|P4|STARTED|6-week Re-randomization Phase||167
7797007|NCT01226043|19194342|P3|STARTED|6-week Re-randomization Phase||166
7797008|NCT01226043|19194343|P2|STARTED|6-week Re-randomization Phase||0
7797009|NCT01226043|19194344|P1|STARTED|6-week Re-randomization Phase||0
7797010|NCT01226043|19194341|P4|NOT COMPLETED|4-week Crossover Phase - Period 2||0
7797011|NCT01226043|19194342|P3|NOT COMPLETED|4-week Crossover Phase - Period 2||0
7797012|NCT01226043|19194343|P2|NOT COMPLETED|4-week Crossover Phase - Period 2||6
7797013|NCT01226043|19194344|P1|NOT COMPLETED|4-week Crossover Phase - Period 2||4
7797014|NCT01226043|19194341|P4|COMPLETED|4-week Crossover Phase - Period 2||0
7797015|NCT01226043|19194342|P3|COMPLETED|4-week Crossover Phase - Period 2||0
7797016|NCT01226043|19194343|P2|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188
7797017|NCT01226043|19194344|P1|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195
7797018|NCT01226043|19194341|P4|TREATED|4-week Crossover Phase - Period 2||0
7797019|NCT01226043|19194342|P3|TREATED|4-week Crossover Phase - Period 2||0
7797020|NCT01226043|19194343|P2|TREATED|4-week Crossover Phase - Period 2||194
7797021|NCT01226043|19194344|P1|TREATED|4-week Crossover Phase - Period 2||199
7797022|NCT01226043|19194341|P4|STARTED|4-week Crossover Phase - Period 2||0
7797023|NCT01226043|19194342|P3|STARTED|4-week Crossover Phase - Period 2||0
7797024|NCT01226043|19194343|P2|STARTED|4-week Crossover Phase - Period 2||194
7797025|NCT01226043|19194344|P1|STARTED|4-week Crossover Phase - Period 2||199
7797026|NCT01226043|19194341|P4|NOT COMPLETED|4-week Crossover Phase - Period 1||0
7797027|NCT01226043|19194342|P3|NOT COMPLETED|4-week Crossover Phase - Period 1||0
7797028|NCT01226043|19194343|P2|NOT COMPLETED|4-week Crossover Phase - Period 1||9
7797029|NCT01226043|19194344|P1|NOT COMPLETED|4-week Crossover Phase - Period 1||3
7797030|NCT01226043|19194341|P4|COMPLETED|4-week Crossover Phase - Period 1||0
7797031|NCT01226043|19194342|P3|COMPLETED|4-week Crossover Phase - Period 1||0
7797032|NCT01226043|19194343|P2|COMPLETED|4-week Crossover Phase - Period 1||194
7797033|NCT01226043|19194344|P1|COMPLETED|4-week Crossover Phase - Period 1||199
7797034|NCT01226043|19194341|P4|TREATED|4-week Crossover Phase - Period 1||0
7797035|NCT01226043|19194342|P3|TREATED|4-week Crossover Phase - Period 1||0
7797036|NCT01226043|19194343|P2|TREATED|4-week Crossover Phase - Period 1||200
7797037|NCT01226043|19194344|P1|TREATED|4-week Crossover Phase - Period 1||202
7797038|NCT01226043|19194341|P4|STARTED|4-week Crossover Phase - Period 1||0
7797039|NCT01226043|19194342|P3|STARTED|4-week Crossover Phase - Period 1||0
7797040|NCT01226043|19194343|P2|STARTED|4-week Crossover Phase - Period 1||203
7797041|NCT01226043|19194344|P1|STARTED|4-week Crossover Phase - Period 1||202
7797042|NCT01225991|19194382|P1|NOT COMPLETED|Overall Study||6
7797043|NCT01225991|19194382|P1|COMPLETED|Overall Study||12
7797044|NCT01225991|19194382|P1|STARTED|Overall Study||18
7797045|NCT01225952|19194393|P3|NOT COMPLETED|Overall Study||6
7797046|NCT01225952|19194394|P2|NOT COMPLETED|Overall Study||4
7797047|NCT01225952|19194395|P1|NOT COMPLETED|Overall Study||6
7797048|NCT01225952|19194393|P3|COMPLETED|Overall Study||25
7797049|NCT01225952|19194394|P2|COMPLETED|Overall Study||27
7797050|NCT01225952|19194395|P1|COMPLETED|Overall Study||25
7797051|NCT01225952|19194393|P3|STARTED|Overall Study||31
7797052|NCT01225952|19194394|P2|STARTED|Overall Study||31
7797053|NCT01225952|19194395|P1|STARTED|Overall Study||31
7797054|NCT01225926|19194480|P2|NOT COMPLETED|Overall Study||0
7797055|NCT01225926|19194481|P1|NOT COMPLETED|Overall Study||0
7797056|NCT01225926|19194480|P2|COMPLETED|Overall Study||12
7797057|NCT01225926|19194481|P1|COMPLETED|Overall Study||12
7797058|NCT01225926|19194480|P2|STARTED|Overall Study||12
7797059|NCT01225926|19194481|P1|STARTED|Overall Study||12
7797060|NCT01225887|19194487|P1|NOT COMPLETED|Overall Study||5
7797061|NCT01225887|19194487|P1|COMPLETED|Overall Study||32
7797062|NCT01225887|19194487|P1|STARTED|Overall Study||37
7797063|NCT01225835|19194497|P2|NOT COMPLETED|Overall Study||3
7797064|NCT01225835|19194498|P1|NOT COMPLETED|Overall Study||7
7797065|NCT01225835|19194497|P2|COMPLETED|Overall Study|hCG criterion met|59
7797066|NCT01225835|19194498|P1|COMPLETED|Overall Study|hCG criterion met|55
7797067|NCT01225835|19194497|P2|Per Protocol Population|Overall Study||58
7797068|NCT01225835|19194498|P1|Per Protocol Population|Overall Study||48
7797069|NCT01225835|19194497|P2|STARTED|Overall Study||62
7797070|NCT01225835|19194498|P1|STARTED|Overall Study||62
7797071|NCT01225822|19194546|P5|NOT COMPLETED|Overall Study||31
7797072|NCT01225822|19194547|P4|NOT COMPLETED|Overall Study||52
7797073|NCT01225822|19194548|P3|NOT COMPLETED|Overall Study||38
7797074|NCT01225822|19194549|P2|NOT COMPLETED|Overall Study||56
7797075|NCT01225822|19194550|P1|NOT COMPLETED|Overall Study||38
7797076|NCT01225822|19194546|P5|COMPLETED|Overall Study||361
7797077|NCT01225822|19194547|P4|COMPLETED|Overall Study||333
7797078|NCT01225822|19194548|P3|COMPLETED|Overall Study||355
7797079|NCT01225822|19194549|P2|COMPLETED|Overall Study||334
7797080|NCT01225822|19194550|P1|COMPLETED|Overall Study||351
7797081|NCT01225822|19194546|P5|STARTED|Overall Study||392
7797082|NCT01225822|19194547|P4|STARTED|Overall Study||385
7797083|NCT01225822|19194548|P3|STARTED|Overall Study||393
7797084|NCT01225822|19194549|P2|STARTED|Overall Study||390
7797085|NCT01225822|19194550|P1|STARTED|Overall Study||389
7797086|NCT01225731|19194617|P13|NOT COMPLETED|Part 3||7
7797087|NCT01225731|19194618|P12|NOT COMPLETED|Part 3||10
7797088|NCT01225731|19194619|P11|NOT COMPLETED|Part 3||6
7797089|NCT01225731|19194620|P10|NOT COMPLETED|Part 3||0
7797090|NCT01225731|19194621|P9|NOT COMPLETED|Part 3||0
7797091|NCT01225731|19194622|P8|NOT COMPLETED|Part 3||0
7797092|NCT01225731|19194623|P7|NOT COMPLETED|Part 3||0
7797093|NCT01225731|19194624|P6|NOT COMPLETED|Part 3||0
7797094|NCT01225731|19194625|P5|NOT COMPLETED|Part 3||0
7797095|NCT01225731|19194626|P4|NOT COMPLETED|Part 3||0
7797096|NCT01225731|19194627|P3|NOT COMPLETED|Part 3||0
7797097|NCT01225731|19194628|P2|NOT COMPLETED|Part 3||0
7797098|NCT01225731|19194629|P1|NOT COMPLETED|Part 3||0
7797099|NCT01225731|19194617|P13|COMPLETED|Part 3||60
7797100|NCT01225731|19194618|P12|COMPLETED|Part 3||116
7797101|NCT01225731|19194619|P11|COMPLETED|Part 3||80
7797102|NCT01225731|19194620|P10|COMPLETED|Part 3||10
7797103|NCT01225731|19194621|P9|COMPLETED|Part 3||0
7797104|NCT01225731|19194622|P8|COMPLETED|Part 3||0
7797105|NCT01225731|19194623|P7|COMPLETED|Part 3||0
7797106|NCT01225731|19194624|P6|COMPLETED|Part 3||0
7797107|NCT01225731|19194625|P5|COMPLETED|Part 3||0
7797108|NCT01225731|19194626|P4|COMPLETED|Part 3||0
7797109|NCT01225731|19194627|P3|COMPLETED|Part 3||0
7797110|NCT01225731|19194628|P2|COMPLETED|Part 3||0
7797111|NCT01225731|19194629|P1|COMPLETED|Part 3||0
7797112|NCT01225731|19194617|P13|STARTED|Part 3|Not all participants entered follow-up|67
7797113|NCT01225731|19194618|P12|STARTED|Part 3|Not all participants entered follow-up|126
7797114|NCT01225731|19194619|P11|STARTED|Part 3|Not all participants entered follow-up|86
7797115|NCT01225731|19194620|P10|STARTED|Part 3|Not all participants entered follow-up|10
7797116|NCT01225731|19194621|P9|STARTED|Part 3|Participants could enter the follow-up period|0
7797117|NCT01225731|19194622|P8|STARTED|Part 3|Participants could enter the follow-up period|0
7797118|NCT01225731|19194623|P7|STARTED|Part 3|Participants could enter the follow-up period|0
7797119|NCT01225731|19194624|P6|STARTED|Part 3|Participants could enter the follow-up period|0
7797120|NCT01225731|19194625|P5|STARTED|Part 3||0
7797121|NCT01225731|19194626|P4|STARTED|Part 3||0
7797122|NCT01225731|19194627|P3|STARTED|Part 3||0
7797123|NCT01225731|19194628|P2|STARTED|Part 3||0
7797124|NCT01225731|19194629|P1|STARTED|Part 3||0
7797125|NCT01225731|19194617|P13|NOT COMPLETED|Part 2||0
7797126|NCT01225731|19194618|P12|NOT COMPLETED|Part 2||0
7797127|NCT01225731|19194619|P11|NOT COMPLETED|Part 2||0
7797128|NCT01225731|19194620|P10|NOT COMPLETED|Part 2||0
7797129|NCT01225731|19194621|P9|NOT COMPLETED|Part 2||11
7797130|NCT01225731|19194622|P8|NOT COMPLETED|Part 2||25
7797131|NCT01225731|19194623|P7|NOT COMPLETED|Part 2||8
7797132|NCT01225731|19194624|P6|NOT COMPLETED|Part 2||3
7797133|NCT01225731|19194625|P5|NOT COMPLETED|Part 2||0
7797134|NCT01225731|19194626|P4|NOT COMPLETED|Part 2||0
7797135|NCT01225731|19194627|P3|NOT COMPLETED|Part 2||0
7797136|NCT01225731|19194628|P2|NOT COMPLETED|Part 2||0
7797137|NCT01225731|19194629|P1|NOT COMPLETED|Part 2||0
7797138|NCT01225731|19194617|P13|COMPLETED|Part 2||0
7797139|NCT01225731|19194618|P12|COMPLETED|Part 2||0
7797140|NCT01225731|19194619|P11|COMPLETED|Part 2||0
7797141|NCT01225731|19194620|P10|COMPLETED|Part 2||0
7797142|NCT01225731|19194621|P9|COMPLETED|Part 2||68
7797143|NCT01225731|19194622|P8|COMPLETED|Part 2||128
7797144|NCT01225731|19194623|P7|COMPLETED|Part 2||86
7797145|NCT01225731|19194624|P6|COMPLETED|Part 2||10
7797146|NCT01225731|19194625|P5|COMPLETED|Part 2||0
7797147|NCT01225731|19194626|P4|COMPLETED|Part 2||0
7797148|NCT01225731|19194627|P3|COMPLETED|Part 2||0
7797149|NCT01225731|19194628|P2|COMPLETED|Part 2||0
7797150|NCT01225731|19194629|P1|COMPLETED|Part 2||0
7797151|NCT01225731|19194617|P13|STARTED|Part 2||0
7797152|NCT01225731|19194618|P12|STARTED|Part 2||0
7797153|NCT01225731|19194619|P11|STARTED|Part 2||0
7797154|NCT01225731|19194620|P10|STARTED|Part 2||0
7797155|NCT01225731|19194621|P9|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79
7797156|NCT01225731|19194622|P8|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153
7797157|NCT01225731|19194623|P7|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94
7797158|NCT01225731|19194624|P6|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13
7797159|NCT01225731|19194625|P5|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0
7797160|NCT01225731|19194626|P4|STARTED|Part 2|Participants could progress into Part 2|0
7797161|NCT01225731|19194627|P3|STARTED|Part 2|Participants could progress into Part 2|0
7797162|NCT01225731|19194628|P2|STARTED|Part 2|Participants could progress into Part 2|0
7797163|NCT01225731|19194629|P1|STARTED|Part 2|Participants could progress into Part 2|0
7797164|NCT01225731|19194617|P13|NOT COMPLETED|Part 1||0
7797165|NCT01225731|19194618|P12|NOT COMPLETED|Part 1||0
7797166|NCT01225731|19194619|P11|NOT COMPLETED|Part 1||0
7797167|NCT01225731|19194620|P10|NOT COMPLETED|Part 1||0
7797168|NCT01225731|19194621|P9|NOT COMPLETED|Part 1||0
7797169|NCT01225731|19194622|P8|NOT COMPLETED|Part 1||0
7797170|NCT01225731|19194623|P7|NOT COMPLETED|Part 1||0
7797171|NCT01225731|19194624|P6|NOT COMPLETED|Part 1||0
7797172|NCT01225731|19194625|P5|NOT COMPLETED|Part 1||6
7797173|NCT01225731|19194626|P4|NOT COMPLETED|Part 1||2
7797174|NCT01225731|19194627|P3|NOT COMPLETED|Part 1||1
7797175|NCT01225731|19194628|P2|NOT COMPLETED|Part 1||5
7797176|NCT01225731|19194629|P1|NOT COMPLETED|Part 1||2
7797177|NCT01225731|19194617|P13|COMPLETED|Part 1||0
7797178|NCT01225731|19194618|P12|COMPLETED|Part 1||0
7797179|NCT01225731|19194619|P11|COMPLETED|Part 1||0
7797180|NCT01225731|19194620|P10|COMPLETED|Part 1||0
7797181|NCT01225731|19194621|P9|COMPLETED|Part 1||0
7797182|NCT01225731|19194622|P8|COMPLETED|Part 1||0
7797183|NCT01225731|19194623|P7|COMPLETED|Part 1||0
7797184|NCT01225731|19194624|P6|COMPLETED|Part 1||0
7797185|NCT01225731|19194625|P5|COMPLETED|Part 1||40
7797186|NCT01225731|19194626|P4|COMPLETED|Part 1||84
7797187|NCT01225731|19194627|P3|COMPLETED|Part 1||88
7797188|NCT01225731|19194628|P2|COMPLETED|Part 1||87
7797189|NCT01225731|19194629|P1|COMPLETED|Part 1||40
7797190|NCT01225731|19194617|P13|STARTED|Part 1||0
7797191|NCT01225731|19194618|P12|STARTED|Part 1||0
7797192|NCT01225731|19194619|P11|STARTED|Part 1||0
7797193|NCT01225731|19194620|P10|STARTED|Part 1||0
7797194|NCT01225731|19194621|P9|STARTED|Part 1||0
7797195|NCT01225731|19194622|P8|STARTED|Part 1||0
7797196|NCT01225731|19194623|P7|STARTED|Part 1||0
7797197|NCT01225731|19194624|P6|STARTED|Part 1||0
7797198|NCT01225731|19194625|P5|STARTED|Part 1||46
7797199|NCT01225731|19194626|P4|STARTED|Part 1||86
7797200|NCT01225731|19194627|P3|STARTED|Part 1||89
7797201|NCT01225731|19194628|P2|STARTED|Part 1||92
7797202|NCT01225731|19194629|P1|STARTED|Part 1||42
7797203|NCT01225562|19194724|P3|NOT COMPLETED|Overall Study||53
7797204|NCT01225562|19194725|P2|NOT COMPLETED|Overall Study||56
7797205|NCT01225562|19194726|P1|NOT COMPLETED|Overall Study||55
7797206|NCT01225562|19194724|P3|COMPLETED|Overall Study||7014
7797207|NCT01225562|19194725|P2|COMPLETED|Overall Study||6989
7797208|NCT01225562|19194726|P1|COMPLETED|Overall Study||6995
7797209|NCT01225562|19194724|P3|STARTED|Overall Study||7067
7797210|NCT01225562|19194725|P2|STARTED|Overall Study||7045
7797211|NCT01225562|19194726|P1|STARTED|Overall Study||7050
7797212|NCT01225549|19194743|P10|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
7797213|NCT01225549|19194744|P9|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
7797214|NCT01225549|19194745|P8|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
7797215|NCT01225549|19194746|P7|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
7797216|NCT01225549|19194747|P6|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
7797217|NCT01225549|19194748|P5|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
7797218|NCT01225549|19194749|P4|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
7797219|NCT01225549|19194750|P3|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
7797220|NCT01225549|19194751|P2|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
7797221|NCT01225549|19194752|P1|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
7797222|NCT01225549|19194743|P10|COMPLETED|Period 7 - Fourth Treatment Period||1
7797223|NCT01225549|19194744|P9|COMPLETED|Period 7 - Fourth Treatment Period||4
7797224|NCT01225549|19194745|P8|COMPLETED|Period 7 - Fourth Treatment Period||1
7797225|NCT01225549|19194746|P7|COMPLETED|Period 7 - Fourth Treatment Period||3
7797226|NCT01225549|19194747|P6|COMPLETED|Period 7 - Fourth Treatment Period||1
7797227|NCT01225549|19194748|P5|COMPLETED|Period 7 - Fourth Treatment Period||1
7797228|NCT01225549|19194749|P4|COMPLETED|Period 7 - Fourth Treatment Period||0
7797229|NCT01225549|19194750|P3|COMPLETED|Period 7 - Fourth Treatment Period||3
7797230|NCT01225549|19194751|P2|COMPLETED|Period 7 - Fourth Treatment Period||3
7797231|NCT01225549|19194752|P1|COMPLETED|Period 7 - Fourth Treatment Period||1
7797232|NCT01225549|19194743|P10|STARTED|Period 7 - Fourth Treatment Period||1
7797233|NCT01225549|19194744|P9|STARTED|Period 7 - Fourth Treatment Period||4
7797234|NCT01225549|19194745|P8|STARTED|Period 7 - Fourth Treatment Period||1
7797235|NCT01225549|19194746|P7|STARTED|Period 7 - Fourth Treatment Period||3
7797236|NCT01225549|19194747|P6|STARTED|Period 7 - Fourth Treatment Period||1
7797237|NCT01225549|19194748|P5|STARTED|Period 7 - Fourth Treatment Period||1
7797238|NCT01225549|19194749|P4|STARTED|Period 7 - Fourth Treatment Period||0
7797239|NCT01225549|19194750|P3|STARTED|Period 7 - Fourth Treatment Period||3
7797240|NCT01225549|19194751|P2|STARTED|Period 7 - Fourth Treatment Period||3
7797241|NCT01225549|19194752|P1|STARTED|Period 7 - Fourth Treatment Period||1
7797242|NCT01225549|19194743|P10|NOT COMPLETED|Period 6 - Washout||0
7797243|NCT01225549|19194744|P9|NOT COMPLETED|Period 6 - Washout||0
7797244|NCT01225549|19194745|P8|NOT COMPLETED|Period 6 - Washout||0
7797245|NCT01225549|19194746|P7|NOT COMPLETED|Period 6 - Washout||0
7797246|NCT01225549|19194747|P6|NOT COMPLETED|Period 6 - Washout||0
7797247|NCT01225549|19194748|P5|NOT COMPLETED|Period 6 - Washout||0
7797248|NCT01225549|19194749|P4|NOT COMPLETED|Period 6 - Washout||1
7797249|NCT01225549|19194750|P3|NOT COMPLETED|Period 6 - Washout||0
7797250|NCT01225549|19194751|P2|NOT COMPLETED|Period 6 - Washout||0
7797251|NCT01225549|19194752|P1|NOT COMPLETED|Period 6 - Washout||0
7797252|NCT01225549|19194743|P10|COMPLETED|Period 6 - Washout||1
7797253|NCT01225549|19194744|P9|COMPLETED|Period 6 - Washout||4
7797254|NCT01225549|19194745|P8|COMPLETED|Period 6 - Washout||1
7797255|NCT01225549|19194746|P7|COMPLETED|Period 6 - Washout||3
7797256|NCT01225549|19194747|P6|COMPLETED|Period 6 - Washout||1
7797257|NCT01225549|19194748|P5|COMPLETED|Period 6 - Washout||1
7797258|NCT01225549|19194749|P4|COMPLETED|Period 6 - Washout||0
7797259|NCT01225549|19194750|P3|COMPLETED|Period 6 - Washout||3
7797260|NCT01225549|19194751|P2|COMPLETED|Period 6 - Washout||3
7797261|NCT01225549|19194752|P1|COMPLETED|Period 6 - Washout||1
7797262|NCT01225549|19194743|P10|STARTED|Period 6 - Washout||1
7797263|NCT01225549|19194744|P9|STARTED|Period 6 - Washout||4
7797264|NCT01225549|19194745|P8|STARTED|Period 6 - Washout||1
7797265|NCT01225549|19194746|P7|STARTED|Period 6 - Washout||3
7797266|NCT01225549|19194747|P6|STARTED|Period 6 - Washout||1
7797267|NCT01225549|19194748|P5|STARTED|Period 6 - Washout||1
7797268|NCT01225549|19194749|P4|STARTED|Period 6 - Washout||1
7797269|NCT01225549|19194750|P3|STARTED|Period 6 - Washout||3
7797270|NCT01225549|19194751|P2|STARTED|Period 6 - Washout||3
7797271|NCT01225549|19194752|P1|STARTED|Period 6 - Washout||1
7797272|NCT01225549|19194743|P10|NOT COMPLETED|Period 5 - Third Treatment Period||0
7797273|NCT01225549|19194744|P9|NOT COMPLETED|Period 5 - Third Treatment Period||0
7797274|NCT01225549|19194745|P8|NOT COMPLETED|Period 5 - Third Treatment Period||0
7797275|NCT01225549|19194746|P7|NOT COMPLETED|Period 5 - Third Treatment Period||0
7797276|NCT01225549|19194747|P6|NOT COMPLETED|Period 5 - Third Treatment Period||0
7797277|NCT01225549|19194748|P5|NOT COMPLETED|Period 5 - Third Treatment Period||0
7797278|NCT01225549|19194749|P4|NOT COMPLETED|Period 5 - Third Treatment Period||0
7797279|NCT01225549|19194750|P3|NOT COMPLETED|Period 5 - Third Treatment Period||0
7797280|NCT01225549|19194751|P2|NOT COMPLETED|Period 5 - Third Treatment Period||0
7797281|NCT01225549|19194752|P1|NOT COMPLETED|Period 5 - Third Treatment Period||0
7797282|NCT01225549|19194743|P10|COMPLETED|Period 5 - Third Treatment Period||1
7797283|NCT01225549|19194744|P9|COMPLETED|Period 5 - Third Treatment Period||4
7797284|NCT01225549|19194745|P8|COMPLETED|Period 5 - Third Treatment Period||1
7797285|NCT01225549|19194746|P7|COMPLETED|Period 5 - Third Treatment Period||3
7797286|NCT01225549|19194747|P6|COMPLETED|Period 5 - Third Treatment Period||1
7797287|NCT01225549|19194748|P5|COMPLETED|Period 5 - Third Treatment Period||1
7797288|NCT01225549|19194749|P4|COMPLETED|Period 5 - Third Treatment Period||1
7797289|NCT01225549|19194750|P3|COMPLETED|Period 5 - Third Treatment Period||3
7797290|NCT01225549|19194751|P2|COMPLETED|Period 5 - Third Treatment Period||3
7797291|NCT01225549|19194752|P1|COMPLETED|Period 5 - Third Treatment Period||1
7797292|NCT01225549|19194743|P10|STARTED|Period 5 - Third Treatment Period||1
7797293|NCT01225549|19194744|P9|STARTED|Period 5 - Third Treatment Period||4
7797294|NCT01225549|19194745|P8|STARTED|Period 5 - Third Treatment Period||1
7797295|NCT01225549|19194746|P7|STARTED|Period 5 - Third Treatment Period||3
7797296|NCT01225549|19194747|P6|STARTED|Period 5 - Third Treatment Period||1
7797297|NCT01225549|19194748|P5|STARTED|Period 5 - Third Treatment Period||1
7797298|NCT01225549|19194749|P4|STARTED|Period 5 - Third Treatment Period||1
7797299|NCT01225549|19194750|P3|STARTED|Period 5 - Third Treatment Period||3
7797300|NCT01225549|19194751|P2|STARTED|Period 5 - Third Treatment Period||3
7797301|NCT01225549|19194752|P1|STARTED|Period 5 - Third Treatment Period||1
7797302|NCT01225549|19194743|P10|NOT COMPLETED|Period 4 - Washout||0
7797303|NCT01225549|19194744|P9|NOT COMPLETED|Period 4 - Washout||0
7797304|NCT01225549|19194745|P8|NOT COMPLETED|Period 4 - Washout||0
7797305|NCT01225549|19194746|P7|NOT COMPLETED|Period 4 - Washout||0
7797306|NCT01225549|19194747|P6|NOT COMPLETED|Period 4 - Washout||0
7797307|NCT01225549|19194748|P5|NOT COMPLETED|Period 4 - Washout||0
7797308|NCT01225549|19194749|P4|NOT COMPLETED|Period 4 - Washout||0
7797309|NCT01225549|19194750|P3|NOT COMPLETED|Period 4 - Washout||0
7797310|NCT01225549|19194751|P2|NOT COMPLETED|Period 4 - Washout||1
7797311|NCT01225549|19194752|P1|NOT COMPLETED|Period 4 - Washout||0
7797312|NCT01225549|19194743|P10|COMPLETED|Period 4 - Washout||1
7797313|NCT01225549|19194744|P9|COMPLETED|Period 4 - Washout||4
7797314|NCT01225549|19194745|P8|COMPLETED|Period 4 - Washout||1
7797315|NCT01225549|19194746|P7|COMPLETED|Period 4 - Washout||3
7797316|NCT01225549|19194747|P6|COMPLETED|Period 4 - Washout||1
7797317|NCT01225549|19194748|P5|COMPLETED|Period 4 - Washout||1
7797318|NCT01225549|19194749|P4|COMPLETED|Period 4 - Washout||1
7797319|NCT01225549|19194750|P3|COMPLETED|Period 4 - Washout||3
7797320|NCT01225549|19194751|P2|COMPLETED|Period 4 - Washout||3
7797321|NCT01225549|19194752|P1|COMPLETED|Period 4 - Washout||1
7797322|NCT01225549|19194743|P10|STARTED|Period 4 - Washout||1
7797323|NCT01225549|19194744|P9|STARTED|Period 4 - Washout||4
7797324|NCT01225549|19194745|P8|STARTED|Period 4 - Washout||1
7797325|NCT01225549|19194746|P7|STARTED|Period 4 - Washout||3
7797326|NCT01225549|19194747|P6|STARTED|Period 4 - Washout||1
7797327|NCT01225549|19194748|P5|STARTED|Period 4 - Washout||1
7797328|NCT01225549|19194749|P4|STARTED|Period 4 - Washout||1
7797329|NCT01225549|19194750|P3|STARTED|Period 4 - Washout||3
7797330|NCT01225549|19194751|P2|STARTED|Period 4 - Washout||4
7797331|NCT01225549|19194752|P1|STARTED|Period 4 - Washout||1
7797332|NCT01225549|19194743|P10|NOT COMPLETED|Period 3 - Second Treatment Period||0
7797333|NCT01225549|19194744|P9|NOT COMPLETED|Period 3 - Second Treatment Period||0
7797334|NCT01225549|19194745|P8|NOT COMPLETED|Period 3 - Second Treatment Period||0
7797335|NCT01225549|19194746|P7|NOT COMPLETED|Period 3 - Second Treatment Period||0
7797336|NCT01225549|19194747|P6|NOT COMPLETED|Period 3 - Second Treatment Period||0
7797337|NCT01225549|19194748|P5|NOT COMPLETED|Period 3 - Second Treatment Period||0
7797338|NCT01225549|19194749|P4|NOT COMPLETED|Period 3 - Second Treatment Period||0
7797339|NCT01225549|19194750|P3|NOT COMPLETED|Period 3 - Second Treatment Period||0
7797340|NCT01225549|19194751|P2|NOT COMPLETED|Period 3 - Second Treatment Period||0
7797341|NCT01225549|19194752|P1|NOT COMPLETED|Period 3 - Second Treatment Period||0
7797342|NCT01225549|19194743|P10|COMPLETED|Period 3 - Second Treatment Period||1
7797343|NCT01225549|19194744|P9|COMPLETED|Period 3 - Second Treatment Period||4
7797344|NCT01225549|19194745|P8|COMPLETED|Period 3 - Second Treatment Period||1
7797345|NCT01225549|19194746|P7|COMPLETED|Period 3 - Second Treatment Period||3
7797346|NCT01225549|19194747|P6|COMPLETED|Period 3 - Second Treatment Period||1
7797347|NCT01225549|19194748|P5|COMPLETED|Period 3 - Second Treatment Period||1
7797348|NCT01225549|19194749|P4|COMPLETED|Period 3 - Second Treatment Period||1
7797349|NCT01225549|19194750|P3|COMPLETED|Period 3 - Second Treatment Period||3
7797350|NCT01225549|19194751|P2|COMPLETED|Period 3 - Second Treatment Period||4
7797351|NCT01225549|19194752|P1|COMPLETED|Period 3 - Second Treatment Period||1
7797352|NCT01225549|19194743|P10|STARTED|Period 3 - Second Treatment Period||1
7797353|NCT01225549|19194744|P9|STARTED|Period 3 - Second Treatment Period||4
7797354|NCT01225549|19194745|P8|STARTED|Period 3 - Second Treatment Period||1
7797355|NCT01225549|19194746|P7|STARTED|Period 3 - Second Treatment Period||3
7797356|NCT01225549|19194747|P6|STARTED|Period 3 - Second Treatment Period||1
7797357|NCT01225549|19194748|P5|STARTED|Period 3 - Second Treatment Period||1
7797358|NCT01225549|19194749|P4|STARTED|Period 3 - Second Treatment Period||1
7797359|NCT01225549|19194750|P3|STARTED|Period 3 - Second Treatment Period||3
7797360|NCT01225549|19194751|P2|STARTED|Period 3 - Second Treatment Period||4
7797361|NCT01225549|19194752|P1|STARTED|Period 3 - Second Treatment Period||1
7797362|NCT01225549|19194743|P10|NOT COMPLETED|Period 2 - Washout||0
7797363|NCT01225549|19194744|P9|NOT COMPLETED|Period 2 - Washout||0
7797364|NCT01225549|19194745|P8|NOT COMPLETED|Period 2 - Washout||0
7797365|NCT01225549|19194746|P7|NOT COMPLETED|Period 2 - Washout||0
7797366|NCT01225549|19194747|P6|NOT COMPLETED|Period 2 - Washout||0
7797367|NCT01225549|19194748|P5|NOT COMPLETED|Period 2 - Washout||0
7797368|NCT01225549|19194749|P4|NOT COMPLETED|Period 2 - Washout||0
7797369|NCT01225549|19194750|P3|NOT COMPLETED|Period 2 - Washout||0
7797370|NCT01225549|19194751|P2|NOT COMPLETED|Period 2 - Washout||0
7797371|NCT01225549|19194752|P1|NOT COMPLETED|Period 2 - Washout||0
7797372|NCT01225549|19194743|P10|COMPLETED|Period 2 - Washout||1
7797373|NCT01225549|19194744|P9|COMPLETED|Period 2 - Washout||4
7797374|NCT01225549|19194745|P8|COMPLETED|Period 2 - Washout||1
7797375|NCT01225549|19194746|P7|COMPLETED|Period 2 - Washout||3
7797376|NCT01225549|19194747|P6|COMPLETED|Period 2 - Washout||1
7797377|NCT01225549|19194748|P5|COMPLETED|Period 2 - Washout||1
7797378|NCT01225549|19194749|P4|COMPLETED|Period 2 - Washout||1
7797379|NCT01225549|19194750|P3|COMPLETED|Period 2 - Washout||3
7797380|NCT01225549|19194751|P2|COMPLETED|Period 2 - Washout||4
7797381|NCT01225549|19194752|P1|COMPLETED|Period 2 - Washout||1
7797382|NCT01225549|19194743|P10|STARTED|Period 2 - Washout||1
7797383|NCT01225549|19194744|P9|STARTED|Period 2 - Washout||4
7797384|NCT01225549|19194745|P8|STARTED|Period 2 - Washout||1
7797385|NCT01225549|19194746|P7|STARTED|Period 2 - Washout||3
7797386|NCT01225549|19194747|P6|STARTED|Period 2 - Washout||1
7797387|NCT01225549|19194748|P5|STARTED|Period 2 - Washout||1
7797388|NCT01225549|19194749|P4|STARTED|Period 2 - Washout||1
7797389|NCT01225549|19194750|P3|STARTED|Period 2 - Washout||3
7797390|NCT01225549|19194751|P2|STARTED|Period 2 - Washout||4
7797391|NCT01225549|19194752|P1|STARTED|Period 2 - Washout||1
7797392|NCT01225549|19194743|P10|NOT COMPLETED|Period 1 - First Treatment Period||0
7797393|NCT01225549|19194744|P9|NOT COMPLETED|Period 1 - First Treatment Period||0
7797394|NCT01225549|19194745|P8|NOT COMPLETED|Period 1 - First Treatment Period||0
7797395|NCT01225549|19194746|P7|NOT COMPLETED|Period 1 - First Treatment Period||0
7797396|NCT01225549|19194747|P6|NOT COMPLETED|Period 1 - First Treatment Period||0
7797397|NCT01225549|19194748|P5|NOT COMPLETED|Period 1 - First Treatment Period||0
7797398|NCT01225549|19194749|P4|NOT COMPLETED|Period 1 - First Treatment Period||0
7797399|NCT01225549|19194750|P3|NOT COMPLETED|Period 1 - First Treatment Period||0
7797400|NCT01225549|19194751|P2|NOT COMPLETED|Period 1 - First Treatment Period||0
7797401|NCT01225549|19194752|P1|NOT COMPLETED|Period 1 - First Treatment Period||0
7797402|NCT01225549|19194743|P10|COMPLETED|Period 1 - First Treatment Period||1
7797403|NCT01225549|19194744|P9|COMPLETED|Period 1 - First Treatment Period||4
7797404|NCT01225549|19194745|P8|COMPLETED|Period 1 - First Treatment Period||1
7797405|NCT01225549|19194746|P7|COMPLETED|Period 1 - First Treatment Period||3
7797406|NCT01225549|19194747|P6|COMPLETED|Period 1 - First Treatment Period||1
7797407|NCT01225549|19194748|P5|COMPLETED|Period 1 - First Treatment Period||1
7797408|NCT01225549|19194749|P4|COMPLETED|Period 1 - First Treatment Period||1
7797409|NCT01225549|19194750|P3|COMPLETED|Period 1 - First Treatment Period||3
7797410|NCT01225549|19194751|P2|COMPLETED|Period 1 - First Treatment Period||4
7797411|NCT01225549|19194752|P1|COMPLETED|Period 1 - First Treatment Period||1
7797412|NCT01225549|19194743|P10|STARTED|Period 1 - First Treatment Period||1
7797413|NCT01225549|19194744|P9|STARTED|Period 1 - First Treatment Period||4
7797414|NCT01225549|19194745|P8|STARTED|Period 1 - First Treatment Period||1
7797415|NCT01225549|19194746|P7|STARTED|Period 1 - First Treatment Period||3
7797416|NCT01225549|19194747|P6|STARTED|Period 1 - First Treatment Period||1
7797417|NCT01225549|19194748|P5|STARTED|Period 1 - First Treatment Period||1
7797418|NCT01225549|19194749|P4|STARTED|Period 1 - First Treatment Period||1
7797419|NCT01225549|19194750|P3|STARTED|Period 1 - First Treatment Period||3
7797420|NCT01225549|19194751|P2|STARTED|Period 1 - First Treatment Period||4
7797421|NCT01225549|19194752|P1|STARTED|Period 1 - First Treatment Period||1
7797422|NCT01225354|19194794|P1|NOT COMPLETED|Overall Study||1
7797423|NCT01225354|19194794|P1|COMPLETED|Overall Study||19
7797424|NCT01225354|19194794|P1|STARTED|Overall Study||20
7797425|NCT01225341|19194805|P2|NOT COMPLETED|Overall Study||0
7797426|NCT01225341|19194806|P1|NOT COMPLETED|Overall Study||0
7797427|NCT01225341|19194805|P2|COMPLETED|Overall Study||0
7797428|NCT01225341|19194806|P1|COMPLETED|Overall Study||0
7797429|NCT01225341|19194805|P2|STARTED|Overall Study||0
7797430|NCT01225341|19194806|P1|STARTED|Overall Study||0
7797431|NCT01225289|19194820|P2|NOT COMPLETED|Overall Study||1
7797432|NCT01225289|19194821|P1|NOT COMPLETED|Overall Study||0
7797433|NCT01225289|19194820|P2|COMPLETED|Overall Study||17
7797434|NCT01225289|19194821|P1|COMPLETED|Overall Study||18
7797435|NCT01225289|19194820|P2|STARTED|Overall Study||18
7797436|NCT01225289|19194821|P1|STARTED|Overall Study||18
7797437|NCT01225263|19194835|P2|NOT COMPLETED|Weeks 13 to 24||1
7797438|NCT01225263|19194836|P1|NOT COMPLETED|Weeks 13 to 24||4
7797439|NCT01225263|19194835|P2|COMPLETED|Weeks 13 to 24||28
7797440|NCT01225263|19194836|P1|COMPLETED|Weeks 13 to 24||24
7797441|NCT01225263|19194835|P2|STARTED|Weeks 13 to 24||29
7797442|NCT01225263|19194836|P1|STARTED|Weeks 13 to 24||28
7797443|NCT01225263|19194835|P2|NOT COMPLETED|Weeks 1 to 12||0
7797444|NCT01225263|19194836|P1|NOT COMPLETED|Weeks 1 to 12||0
7797445|NCT01225263|19194835|P2|COMPLETED|Weeks 1 to 12||29
7797446|NCT01225263|19194836|P1|COMPLETED|Weeks 1 to 12||28
7797447|NCT01225263|19194835|P2|STARTED|Weeks 1 to 12||29
7797448|NCT01225263|19194836|P1|STARTED|Weeks 1 to 12||28
7797449|NCT01225250|19194846|P2|NOT COMPLETED|Overall Study||5
7797450|NCT01225250|19194847|P1|NOT COMPLETED|Overall Study||5
7797451|NCT01225250|19194846|P2|COMPLETED|Overall Study||10
7797452|NCT01225250|19194847|P1|COMPLETED|Overall Study||10
7797453|NCT01225250|19194846|P2|STARTED|Overall Study||15
7797454|NCT01225250|19194847|P1|STARTED|Overall Study||15
7797455|NCT01225211|19194873|P10|NOT COMPLETED|Overall Study||5
7797456|NCT01225211|19194874|P9|NOT COMPLETED|Overall Study||1
7797457|NCT01225211|19194875|P8|NOT COMPLETED|Overall Study||0
7797458|NCT01225211|19194876|P7|NOT COMPLETED|Overall Study||1
7797459|NCT01225211|19194877|P6|NOT COMPLETED|Overall Study||0
7797460|NCT01225211|19194878|P5|NOT COMPLETED|Overall Study||0
7797461|NCT01225211|19194879|P4|NOT COMPLETED|Overall Study||0
7797462|NCT01225211|19194880|P3|NOT COMPLETED|Overall Study||1
7797463|NCT01225211|19194881|P2|NOT COMPLETED|Overall Study||0
7797464|NCT01225211|19194882|P1|NOT COMPLETED|Overall Study||0
7797465|NCT01225211|19194873|P10|COMPLETED|Overall Study||57
7797466|NCT01225211|19194874|P9|COMPLETED|Overall Study||62
7797467|NCT01225211|19194875|P8|COMPLETED|Overall Study||11
7797468|NCT01225211|19194876|P7|COMPLETED|Overall Study||41
7797469|NCT01225211|19194877|P6|COMPLETED|Overall Study||21
7797470|NCT01225211|19194878|P5|COMPLETED|Overall Study||23
7797471|NCT01225211|19194879|P4|COMPLETED|Overall Study||27
7797472|NCT01225211|19194880|P3|COMPLETED|Overall Study||20
7797473|NCT01225211|19194881|P2|COMPLETED|Overall Study||20
7797474|NCT01225211|19194882|P1|COMPLETED|Overall Study||21
7797475|NCT01225211|19194873|P10|STARTED|Overall Study||62
7797476|NCT01225211|19194874|P9|STARTED|Overall Study||63
7797477|NCT01225211|19194875|P8|STARTED|Overall Study||11
7797478|NCT01225211|19194876|P7|STARTED|Overall Study||42
7797479|NCT01225211|19194877|P6|STARTED|Overall Study||21
7797480|NCT01225211|19194878|P5|STARTED|Overall Study||23
7797481|NCT01225211|19194879|P4|STARTED|Overall Study||27
7797482|NCT01225211|19194880|P3|STARTED|Overall Study||21
7797483|NCT01225211|19194881|P2|STARTED|Overall Study||20
7797484|NCT01225211|19194882|P1|STARTED|Overall Study||21
7797485|NCT01225172|19194985|P2|NOT COMPLETED|Overall Study||1
7797486|NCT01225172|19194986|P1|NOT COMPLETED|Overall Study||6
7797487|NCT01225172|19194985|P2|COMPLETED|Overall Study||6
7797488|NCT01225172|19194986|P1|COMPLETED|Overall Study||46
7797489|NCT01225172|19194985|P2|STARTED|Overall Study||7
7797490|NCT01225172|19194986|P1|STARTED|Overall Study||52
7797491|NCT01225159|19195008|P2|NOT COMPLETED|Overall Study||0
7797492|NCT01225159|19195009|P1|NOT COMPLETED|Overall Study||1
7797493|NCT01225159|19195008|P2|COMPLETED|Overall Study||100
7797494|NCT01225159|19195009|P1|COMPLETED|Overall Study||99
7797495|NCT01225159|19195008|P2|STARTED|Overall Study||100
7797496|NCT01225159|19195009|P1|STARTED|Overall Study||100
7797497|NCT01225146|19195019|P2|NOT COMPLETED|Overall Study||2
7797498|NCT01225146|19195020|P1|NOT COMPLETED|Overall Study||0
7797499|NCT01225146|19195019|P2|COMPLETED|Overall Study||0
7797500|NCT01225146|19195020|P1|COMPLETED|Overall Study||6
7797501|NCT01225146|19195019|P2|STARTED|Overall Study||2
7797502|NCT01225146|19195020|P1|STARTED|Overall Study||6
7797503|NCT01225068|19195038|P2|NOT COMPLETED|Overall Study||1
7797504|NCT01225068|19195039|P1|NOT COMPLETED|Overall Study||4
7797505|NCT01225068|19195038|P2|COMPLETED|Overall Study||19
7797506|NCT01225068|19195039|P1|COMPLETED|Overall Study||16
7797507|NCT01225068|19195038|P2|STARTED|Overall Study||20
7797508|NCT01225068|19195039|P1|STARTED|Overall Study||20
7797509|NCT01225055|19195048|P3|NOT COMPLETED|Overall Study||3
7797510|NCT01225055|19195049|P2|NOT COMPLETED|Overall Study||2
7797511|NCT01225055|19195050|P1|NOT COMPLETED|Overall Study||0
7797512|NCT01225055|19195048|P3|COMPLETED|Overall Study||18
7797513|NCT01225055|19195049|P2|COMPLETED|Overall Study||18
7797514|NCT01225055|19195050|P1|COMPLETED|Overall Study||20
7797515|NCT01225055|19195048|P3|STARTED|Overall Study||21
7797516|NCT01225055|19195049|P2|STARTED|Overall Study||20
7797517|NCT01225055|19195050|P1|STARTED|Overall Study||20
7797518|NCT01225029|19195075|P2|NOT COMPLETED|Overall Study||0
7797519|NCT01225029|19195076|P1|NOT COMPLETED|Overall Study||0
7797520|NCT01225029|19195075|P2|COMPLETED|Overall Study||32
7797521|NCT01225029|19195076|P1|COMPLETED|Overall Study||32
7797522|NCT01225029|19195075|P2|STARTED|Overall Study||32
7797523|NCT01225029|19195076|P1|STARTED|Overall Study||32
7797524|NCT01224925|19195088|P2|NOT COMPLETED|Overall Study||2
7797525|NCT01224925|19195089|P1|NOT COMPLETED|Overall Study||3
7797526|NCT01224925|19195088|P2|COMPLETED|Overall Study||31
7797527|NCT01224925|19195089|P1|COMPLETED|Overall Study||34
7797528|NCT01224925|19195088|P2|STARTED|Overall Study||33
7797529|NCT01224925|19195089|P1|STARTED|Overall Study||37
7797530|NCT01224821|19195097|P1|NOT COMPLETED|Long-Term Follow-Up||11
7797531|NCT01224821|19195097|P1|COMPLETED|Long-Term Follow-Up||0
7797532|NCT01224821|19195097|P1|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11
7797533|NCT01224821|19195097|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46
7797534|NCT01224821|19195097|P1|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1
7797535|NCT01224821|19195097|P1|STARTED|Dosimetric and Therapeutic Treatment||47
7797536|NCT01224782|19195116|P1|NOT COMPLETED|Overall Study||264
7797537|NCT01224782|19195116|P1|COMPLETED|Overall Study||730
7797538|NCT01224782|19195116|P1|STARTED|Overall Study||994
7797539|NCT01224678|19195127|P2|NOT COMPLETED|Overall Study||0
7797540|NCT01224678|19195128|P1|NOT COMPLETED|Overall Study||0
7797541|NCT01224678|19195127|P2|COMPLETED|Overall Study||150
7797542|NCT01224678|19195128|P1|COMPLETED|Overall Study||150
7797543|NCT01224678|19195127|P2|STARTED|Overall Study||150
7797544|NCT01224678|19195128|P1|STARTED|Overall Study||150
7797545|NCT01224639|19195142|P8|NOT COMPLETED|Overall Study||2
7797546|NCT01224639|19195143|P7|NOT COMPLETED|Overall Study||1
7797547|NCT01224639|19195144|P6|NOT COMPLETED|Overall Study||0
7797548|NCT01224639|19195145|P5|NOT COMPLETED|Overall Study||2
7797549|NCT01224639|19195146|P4|NOT COMPLETED|Overall Study||0
7797550|NCT01224639|19195147|P3|NOT COMPLETED|Overall Study||0
7797551|NCT01224639|19195148|P2|NOT COMPLETED|Overall Study||0
7797552|NCT01224639|19195149|P1|NOT COMPLETED|Overall Study||0
7797553|NCT01224639|19195142|P8|COMPLETED|Overall Study||3
7797554|NCT01224639|19195143|P7|COMPLETED|Overall Study||17
7797555|NCT01224639|19195144|P6|COMPLETED|Overall Study||4
7797556|NCT01224639|19195145|P5|COMPLETED|Overall Study||19
7797557|NCT01224639|19195146|P4|COMPLETED|Overall Study||3
7797558|NCT01224639|19195147|P3|COMPLETED|Overall Study||21
7797559|NCT01224639|19195148|P2|COMPLETED|Overall Study||5
7797560|NCT01224639|19195149|P1|COMPLETED|Overall Study||19
7797561|NCT01224639|19195142|P8|STARTED|Overall Study||5
7797562|NCT01224639|19195143|P7|STARTED|Overall Study||18
7797563|NCT01224639|19195144|P6|STARTED|Overall Study||4
7797564|NCT01224639|19195145|P5|STARTED|Overall Study||21
7797565|NCT01224639|19195146|P4|STARTED|Overall Study||3
7797566|NCT01224639|19195147|P3|STARTED|Overall Study||21
7797567|NCT01224639|19195148|P2|STARTED|Overall Study||5
7797568|NCT01224639|19195149|P1|STARTED|Overall Study||19
7797569|NCT01224626|19195255|P1|NOT COMPLETED|Overall Study||1
7797570|NCT01224626|19195255|P1|COMPLETED|Overall Study||41
7797571|NCT01224626|19195255|P1|STARTED|Overall Study||42
7797572|NCT01224444|19195261|P1|NOT COMPLETED|Overall Study||0
7797573|NCT01224444|19195261|P1|COMPLETED|Overall Study||269
7797574|NCT01224444|19195261|P1|STARTED|Overall Study||269
7797575|NCT01224431|19195267|P2|NOT COMPLETED|Overall Study||5
7797576|NCT01224431|19195268|P1|NOT COMPLETED|Overall Study||0
7797577|NCT01224431|19195267|P2|COMPLETED|Overall Study||25
7797578|NCT01224431|19195268|P1|COMPLETED|Overall Study||30
7797579|NCT01224431|19195267|P2|STARTED|Overall Study||30
7797580|NCT01224431|19195268|P1|STARTED|Overall Study||30
7797581|NCT01224236|19195278|P2|NOT COMPLETED|Overall Study||1
7797582|NCT01224236|19195279|P1|NOT COMPLETED|Overall Study||1
7797583|NCT01224236|19195278|P2|COMPLETED|Overall Study||73
7797584|NCT01224236|19195279|P1|COMPLETED|Overall Study||75
7797585|NCT01224236|19195278|P2|STARTED|Overall Study||74
7797586|NCT01224236|19195279|P1|STARTED|Overall Study||76
7797587|NCT01224171|19195289|P2|NOT COMPLETED|Overall Study||13
7797588|NCT01224171|19195290|P1|NOT COMPLETED|Overall Study||15
7797589|NCT01224171|19195289|P2|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196
7797590|NCT01224171|19195290|P1|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192
7797591|NCT01224171|19195289|P2|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158
7797592|NCT01224171|19195290|P1|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157
7797593|NCT01224171|19195289|P2|STARTED|Overall Study||209
7797594|NCT01224171|19195290|P1|STARTED|Overall Study||207
7797595|NCT01224158|19195312|P2|NOT COMPLETED|Overall Study||0
7797596|NCT01224158|19195313|P1|NOT COMPLETED|Overall Study||1
7797597|NCT01224158|19195312|P2|COMPLETED|Overall Study||77
7797598|NCT01224158|19195313|P1|COMPLETED|Overall Study||75
7797599|NCT01224158|19195312|P2|STARTED|Overall Study||77
7797600|NCT01224158|19195313|P1|STARTED|Overall Study||76
7797601|NCT01224145|19195329|P1|NOT COMPLETED|Overall Study||0
7797602|NCT01224145|19195329|P1|COMPLETED|Overall Study||10
7797603|NCT01224145|19195329|P1|STARTED|Overall Study||10
7797604|NCT01224015|19195340|P3|NOT COMPLETED|Overall Study||13
7797605|NCT01224015|19195341|P2|NOT COMPLETED|Overall Study||16
7797606|NCT01224015|19195342|P1|NOT COMPLETED|Overall Study||14
7797607|NCT01224015|19195340|P3|COMPLETED|Overall Study||83
7797608|NCT01224015|19195341|P2|COMPLETED|Overall Study||211
7797609|NCT01224015|19195342|P1|COMPLETED|Overall Study||347
7797610|NCT01224015|19195340|P3|STARTED|Overall Study||96
7797611|NCT01224015|19195341|P2|STARTED|Overall Study||227
7797612|NCT01224015|19195342|P1|STARTED|Overall Study||361
7797613|NCT01223963|19195350|P1|NOT COMPLETED|Overall Study||0
7797614|NCT01223963|19195350|P1|COMPLETED|Overall Study||93
7797615|NCT01223963|19195350|P1|STARTED|Overall Study|All subjects treated between May 1 2008 and Dec 31 2009 in selected clinics were to be asked.|93
7797616|NCT01223937|19195357|P2|NOT COMPLETED|Overall Study||18
7797617|NCT01223937|19195358|P1|NOT COMPLETED|Overall Study||17
7797618|NCT01223937|19195357|P2|COMPLETED|Overall Study||119
7797619|NCT01223937|19195358|P1|COMPLETED|Overall Study||114
7797620|NCT01223937|19195357|P2|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135
7797621|NCT01223937|19195358|P1|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126
7797622|NCT01223937|19195357|P2|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133
7797623|NCT01223937|19195358|P1|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128
7797624|NCT01223937|19195357|P2|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137
7797625|NCT01223937|19195358|P1|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131
7797626|NCT01223703|19195382|P2|NOT COMPLETED|Overall Study||0
7797627|NCT01223703|19195383|P1|NOT COMPLETED|Overall Study||0
7797628|NCT01223703|19195382|P2|COMPLETED|Overall Study||66
7797629|NCT01223703|19195383|P1|COMPLETED|Overall Study||67
7797630|NCT01223703|19195382|P2|STARTED|Overall Study||66
7797631|NCT01223703|19195383|P1|STARTED|Overall Study||67
7797632|NCT01223469|19195397|P2|NOT COMPLETED|Overall Study||0
7797633|NCT01223469|19195398|P1|NOT COMPLETED|Overall Study||0
7797634|NCT01223469|19195397|P2|COMPLETED|Overall Study||43
7797635|NCT01223469|19195398|P1|COMPLETED|Overall Study||34
7797636|NCT01223469|19195397|P2|STARTED|Overall Study||43
7797637|NCT01223469|19195398|P1|STARTED|Overall Study||34
7797638|NCT01223404|19195404|P6|NOT COMPLETED|Third Intervention (1 Day)||0
7797639|NCT01223404|19195405|P5|NOT COMPLETED|Third Intervention (1 Day)||0
7797640|NCT01223404|19195406|P4|NOT COMPLETED|Third Intervention (1 Day)||1
7797641|NCT01223404|19195407|P3|NOT COMPLETED|Third Intervention (1 Day)||0
7797642|NCT01223404|19195408|P2|NOT COMPLETED|Third Intervention (1 Day)||0
7797643|NCT01223404|19195409|P1|NOT COMPLETED|Third Intervention (1 Day)||0
7797644|NCT01223404|19195404|P6|COMPLETED|Third Intervention (1 Day)||3
7797645|NCT01223404|19195405|P5|COMPLETED|Third Intervention (1 Day)||2
7797646|NCT01223404|19195406|P4|COMPLETED|Third Intervention (1 Day)||3
7797647|NCT01223404|19195407|P3|COMPLETED|Third Intervention (1 Day)||4
7797648|NCT01223404|19195408|P2|COMPLETED|Third Intervention (1 Day)||3
7797649|NCT01223404|19195409|P1|COMPLETED|Third Intervention (1 Day)||3
7797650|NCT01223404|19195404|P6|STARTED|Third Intervention (1 Day)||3
7797651|NCT01223404|19195405|P5|STARTED|Third Intervention (1 Day)||2
7797652|NCT01223404|19195406|P4|STARTED|Third Intervention (1 Day)||4
7797653|NCT01223404|19195407|P3|STARTED|Third Intervention (1 Day)||4
7797654|NCT01223404|19195408|P2|STARTED|Third Intervention (1 Day)||3
7797655|NCT01223404|19195409|P1|STARTED|Third Intervention (1 Day)||3
7797656|NCT01223404|19195404|P6|NOT COMPLETED|Second Intervention (1 Day)||0
7797657|NCT01223404|19195405|P5|NOT COMPLETED|Second Intervention (1 Day)||0
7797658|NCT01223404|19195406|P4|NOT COMPLETED|Second Intervention (1 Day)||0
7797659|NCT01223404|19195407|P3|NOT COMPLETED|Second Intervention (1 Day)||0
7797660|NCT01223404|19195408|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7797661|NCT01223404|19195409|P1|NOT COMPLETED|Second Intervention (1 Day)||1
7797662|NCT01223404|19195404|P6|COMPLETED|Second Intervention (1 Day)||3
7797663|NCT01223404|19195405|P5|COMPLETED|Second Intervention (1 Day)||2
7797664|NCT01223404|19195406|P4|COMPLETED|Second Intervention (1 Day)||4
7797665|NCT01223404|19195407|P3|COMPLETED|Second Intervention (1 Day)||4
7797666|NCT01223404|19195408|P2|COMPLETED|Second Intervention (1 Day)||3
7797667|NCT01223404|19195409|P1|COMPLETED|Second Intervention (1 Day)||3
7797668|NCT01223404|19195404|P6|STARTED|Second Intervention (1 Day)||3
7797669|NCT01223404|19195405|P5|STARTED|Second Intervention (1 Day)||2
7797670|NCT01223404|19195406|P4|STARTED|Second Intervention (1 Day)||4
7797671|NCT01223404|19195407|P3|STARTED|Second Intervention (1 Day)||4
7797672|NCT01223404|19195408|P2|STARTED|Second Intervention (1 Day)||3
7797673|NCT01223404|19195409|P1|STARTED|Second Intervention (1 Day)||4
7797674|NCT01223404|19195404|P6|NOT COMPLETED|First Intervention (1 Day)||0
7797675|NCT01223404|19195405|P5|NOT COMPLETED|First Intervention (1 Day)||0
7797676|NCT01223404|19195406|P4|NOT COMPLETED|First Intervention (1 Day)||1
7797677|NCT01223404|19195407|P3|NOT COMPLETED|First Intervention (1 Day)||0
7797678|NCT01223404|19195408|P2|NOT COMPLETED|First Intervention (1 Day)||0
7797679|NCT01223404|19195409|P1|NOT COMPLETED|First Intervention (1 Day)||0
7797680|NCT01223404|19195404|P6|COMPLETED|First Intervention (1 Day)||3
7797681|NCT01223404|19195405|P5|COMPLETED|First Intervention (1 Day)||2
7797682|NCT01223404|19195406|P4|COMPLETED|First Intervention (1 Day)||4
7797683|NCT01223404|19195407|P3|COMPLETED|First Intervention (1 Day)||4
7797684|NCT01223404|19195408|P2|COMPLETED|First Intervention (1 Day)||3
7797685|NCT01223404|19195409|P1|COMPLETED|First Intervention (1 Day)||4
7797686|NCT01223404|19195404|P6|STARTED|First Intervention (1 Day)||3
7797687|NCT01223404|19195405|P5|STARTED|First Intervention (1 Day)||2
7797688|NCT01223404|19195406|P4|STARTED|First Intervention (1 Day)||5
7797689|NCT01223404|19195407|P3|STARTED|First Intervention (1 Day)||4
7797690|NCT01223404|19195408|P2|STARTED|First Intervention (1 Day)||3
7797691|NCT01223404|19195409|P1|STARTED|First Intervention (1 Day)||4
7797692|NCT01223378|19195437|P5|NOT COMPLETED|Overall Study||3
7797693|NCT01223378|19195438|P4|NOT COMPLETED|Overall Study||1
7797694|NCT01223378|19195439|P3|NOT COMPLETED|Overall Study||3
7797695|NCT01223378|19195440|P2|NOT COMPLETED|Overall Study||4
7797696|NCT01223378|19195441|P1|NOT COMPLETED|Overall Study||6
7797697|NCT01223378|19195437|P5|COMPLETED|Overall Study||79
7797698|NCT01223378|19195438|P4|COMPLETED|Overall Study||80
7797699|NCT01223378|19195439|P3|COMPLETED|Overall Study||80
7797700|NCT01223378|19195440|P2|COMPLETED|Overall Study||81
7797701|NCT01223378|19195441|P1|COMPLETED|Overall Study||76
7797702|NCT01223378|19195437|P5|STARTED|Overall Study||82
7797703|NCT01223378|19195438|P4|STARTED|Overall Study||81
7797704|NCT01223378|19195439|P3|STARTED|Overall Study||83
7797705|NCT01223378|19195440|P2|STARTED|Overall Study||85
7797706|NCT01223378|19195441|P1|STARTED|Overall Study||82
7797707|NCT01223365|19195473|P1|NOT COMPLETED|Open-label Treatment Period||102
7797708|NCT01223365|19195473|P1|COMPLETED|Open-label Treatment Period||189
7797709|NCT01223365|19195473|P1|STARTED|Open-label Treatment Period||291
7797710|NCT01223365|19195473|P1|NOT COMPLETED|Open-label Titration Period||39
7797711|NCT01223365|19195473|P1|COMPLETED|Open-label Titration Period||291
7797712|NCT01223365|19195473|P1|Achieved Stable Pain Relief|Open-label Titration Period||294
7797713|NCT01223365|19195473|P1|Safety Analysis Set|Open-label Titration Period||329
7797714|NCT01223365|19195473|P1|STARTED|Open-label Titration Period||330
7797715|NCT01223352|19195516|P2|NOT COMPLETED|Overall Study||0
7797716|NCT01223352|19195517|P1|NOT COMPLETED|Overall Study||0
7797717|NCT01223352|19195516|P2|COMPLETED|Overall Study||33
7797718|NCT01223352|19195517|P1|COMPLETED|Overall Study||31
7797719|NCT01223352|19195516|P2|STARTED|Overall Study||33
7797720|NCT01223352|19195517|P1|STARTED|Overall Study||31
7797721|NCT01223235|19195537|P1|NOT COMPLETED|Overall Study||1
7797722|NCT01223235|19195537|P1|COMPLETED|Overall Study||21
7797723|NCT01223235|19195537|P1|STARTED|Overall Study||22
7797724|NCT01223196|19195545|P2|NOT COMPLETED|Overall Study||0
7797725|NCT01223196|19195546|P1|NOT COMPLETED|Overall Study||4
7797726|NCT01223196|19195545|P2|COMPLETED|Overall Study||11
7797727|NCT01223196|19195546|P1|COMPLETED|Overall Study||9
7797728|NCT01223196|19195545|P2|STARTED|Overall Study||11
7797729|NCT01223196|19195546|P1|STARTED|Overall Study||13
7797730|NCT01223183|19195558|P2|NOT COMPLETED|Imaging Day 2||0
7797731|NCT01223183|19195559|P1|NOT COMPLETED|Imaging Day 2||0
7797732|NCT01223183|19195558|P2|COMPLETED|Imaging Day 2||9
7797733|NCT01223183|19195559|P1|COMPLETED|Imaging Day 2||8
7797734|NCT01223183|19195558|P2|STARTED|Imaging Day 2||9
7797735|NCT01223183|19195559|P1|STARTED|Imaging Day 2||8
7797736|NCT01223183|19195558|P2|NOT COMPLETED|Washout Period (5-24 Days)||0
7797737|NCT01223183|19195559|P1|NOT COMPLETED|Washout Period (5-24 Days)||2
7797738|NCT01223183|19195558|P2|COMPLETED|Washout Period (5-24 Days)||9
7797739|NCT01223183|19195559|P1|COMPLETED|Washout Period (5-24 Days)||8
7797740|NCT01223183|19195558|P2|STARTED|Washout Period (5-24 Days)||9
7797741|NCT01223183|19195559|P1|STARTED|Washout Period (5-24 Days)||10
7797742|NCT01223183|19195558|P2|NOT COMPLETED|Imaging Day 1||1
7797743|NCT01223183|19195559|P1|NOT COMPLETED|Imaging Day 1||0
7797744|NCT01223183|19195558|P2|COMPLETED|Imaging Day 1||9
7797745|NCT01223183|19195559|P1|COMPLETED|Imaging Day 1||10
7797746|NCT01223183|19195558|P2|STARTED|Imaging Day 1||10
7797747|NCT01223183|19195559|P1|STARTED|Imaging Day 1||10
7797748|NCT01223027|19195569|P2|NOT COMPLETED|Overall Study||277
7797749|NCT01223027|19195570|P1|NOT COMPLETED|Overall Study||274
7797750|NCT01223027|19195569|P2|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9
7797751|NCT01223027|19195570|P1|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10
7797752|NCT01223027|19195569|P2|STARTED|Overall Study||286
7797753|NCT01223027|19195570|P1|STARTED|Overall Study||284
7797754|NCT01223001|19195593|P2|NOT COMPLETED|Overall Study||4
7797755|NCT01223001|19195594|P1|NOT COMPLETED|Overall Study||4
7797756|NCT01223001|19195593|P2|COMPLETED|Overall Study||0
7797757|NCT01223001|19195594|P1|COMPLETED|Overall Study||0
7797758|NCT01223001|19195593|P2|STARTED|Overall Study||4
7797759|NCT01223001|19195594|P1|STARTED|Overall Study||4
7797760|NCT01222884|19195602|P2|NOT COMPLETED|Overall Study||4
7797761|NCT01222884|19195603|P1|NOT COMPLETED|Overall Study||24
7797762|NCT01222884|19195602|P2|COMPLETED|Overall Study||113
7797763|NCT01222884|19195603|P1|COMPLETED|Overall Study||210
7797764|NCT01222884|19195602|P2|STARTED|Overall Study||117
7797765|NCT01222884|19195603|P1|STARTED|Overall Study||234
7797766|NCT01222871|19195613|P2|NOT COMPLETED|Overall Study||0
7797767|NCT01222871|19195614|P1|NOT COMPLETED|Overall Study||0
7797768|NCT01222871|19195613|P2|COMPLETED|Overall Study||0
7797769|NCT01222871|19195614|P1|COMPLETED|Overall Study||0
7797770|NCT01222871|19195613|P2|STARTED|Overall Study||0
7797771|NCT01222871|19195614|P1|STARTED|Overall Study||0
7797772|NCT01222832|19195623|P2|NOT COMPLETED|Overall Study||1
7797773|NCT01222832|19195624|P1|NOT COMPLETED|Overall Study||0
7797774|NCT01222832|19195623|P2|COMPLETED|Overall Study||112
7797775|NCT01222832|19195624|P1|COMPLETED|Overall Study||113
7797776|NCT01222832|19195623|P2|STARTED|Overall Study||113
7797777|NCT01222832|19195624|P1|STARTED|Overall Study||113
7797778|NCT01222715|19195632|P2|NOT COMPLETED|Overall Study||27
7797779|NCT01222715|19195633|P1|NOT COMPLETED|Overall Study||36
7797780|NCT01222715|19195632|P2|COMPLETED|Overall Study||16
7797781|NCT01222715|19195633|P1|COMPLETED|Overall Study||8
7797782|NCT01222715|19195632|P2|STARTED|Overall Study||43
7797783|NCT01222715|19195633|P1|STARTED|Overall Study||44
7797784|NCT01222689|19195643|P1|NOT COMPLETED|Overall Study||0
7797785|NCT01222689|19195643|P1|COMPLETED|Overall Study||46
7797786|NCT01222689|19195643|P1|STARTED|Overall Study||46
7797787|NCT01222585|19195656|P1|NOT COMPLETED|Overall Study||0
7797788|NCT01222585|19195656|P1|COMPLETED|Overall Study||24
7797789|NCT01222585|19195656|P1|STARTED|Overall Study||24
7797790|NCT01222572|19195666|P3|NOT COMPLETED|Overall Study||0
7797791|NCT01222572|19195667|P2|NOT COMPLETED|Overall Study||0
7797792|NCT01222572|19195668|P1|NOT COMPLETED|Overall Study||0
7797793|NCT01222572|19195666|P3|COMPLETED|Overall Study||0
7797794|NCT01222572|19195667|P2|COMPLETED|Overall Study||0
7797795|NCT01222572|19195668|P1|COMPLETED|Overall Study||1
7797796|NCT01222572|19195666|P3|STARTED|Overall Study||0
7797797|NCT01222572|19195667|P2|STARTED|Overall Study||0
7797798|NCT01222572|19195668|P1|STARTED|Overall Study||1
7797799|NCT01222533|19195672|P1|NOT COMPLETED|Overall Study||14
7797800|NCT01222533|19195672|P1|COMPLETED|Overall Study|Completed planned observation time (week 21)|140
7797801|NCT01222533|19195672|P1|Received Tio HH18|Overall Study||146
7797802|NCT01222533|19195672|P1|Received Tio R5|Overall Study||150
7797803|NCT01222533|19195672|P1|Received Tio R2.5|Overall Study||145
7797804|NCT01222533|19195672|P1|Received Tio R1.25|Overall Study||147
7797805|NCT01222533|19195672|P1|Received Placebo|Overall Study||147
7797806|NCT01222533|19195672|P1|STARTED|Overall Study|Entered and treated.|154
7797807|NCT01222520|19195811|P2|NOT COMPLETED|Double-blind Period||2
7797808|NCT01222520|19195812|P1|NOT COMPLETED|Double-blind Period||1
7797809|NCT01222520|19195811|P2|COMPLETED|Double-blind Period||85
7797810|NCT01222520|19195812|P1|COMPLETED|Double-blind Period||86
7797811|NCT01222520|19195811|P2|STARTED|Double-blind Period||87
7797812|NCT01222520|19195812|P1|STARTED|Double-blind Period||87
7797813|NCT01222520|19195811|P2|NOT COMPLETED|Open-label run-in Period||23
7797814|NCT01222520|19195812|P1|NOT COMPLETED|Open-label run-in Period||0
7797815|NCT01222520|19195811|P2|COMPLETED|Open-label run-in Period||174
7797816|NCT01222520|19195812|P1|COMPLETED|Open-label run-in Period||0
7797817|NCT01222520|19195811|P2|STARTED|Open-label run-in Period||197
7797818|NCT01222520|19195812|P1|STARTED|Open-label run-in Period||0
7797819|NCT01222507|19195830|P1|NOT COMPLETED|Overall Study||2
7797820|NCT01222507|19195830|P1|COMPLETED|Overall Study||60
7797821|NCT01222507|19195830|P1|STARTED|Overall Study||62
7797822|NCT01222494|19195837|P3|NOT COMPLETED|Overall Study||4
7797823|NCT01222494|19195838|P2|NOT COMPLETED|Overall Study||4
7797824|NCT01222494|19195839|P1|NOT COMPLETED|Overall Study||1
7797825|NCT01222494|19195837|P3|COMPLETED|Overall Study||17
7797826|NCT01222494|19195838|P2|COMPLETED|Overall Study||15
7797827|NCT01222494|19195839|P1|COMPLETED|Overall Study||6
7797828|NCT01222494|19195837|P3|STARTED|Overall Study||21
7797829|NCT01222494|19195838|P2|STARTED|Overall Study||19
7797830|NCT01222494|19195839|P1|STARTED|Overall Study||7
7797831|NCT01222416|19195858|P2|NOT COMPLETED|Overall Study||0
7797832|NCT01222416|19195859|P1|NOT COMPLETED|Overall Study||20
7797833|NCT01222416|19195858|P2|COMPLETED|Overall Study||0
7797834|NCT01222416|19195859|P1|COMPLETED|Overall Study||30
7797835|NCT01222416|19195858|P2|STARTED|Overall Study||0
7797836|NCT01222416|19195859|P1|STARTED|Overall Study||50
7797837|NCT01222403|19195869|P2|NOT COMPLETED|Overall Study||2
7797838|NCT01222403|19195870|P1|NOT COMPLETED|Overall Study||0
7797839|NCT01222403|19195869|P2|COMPLETED|Overall Study||379
7797840|NCT01222403|19195870|P1|COMPLETED|Overall Study||386
7797841|NCT01222403|19195869|P2|STARTED|Overall Study||381
7797842|NCT01222403|19195870|P1|STARTED|Overall Study||386
7797843|NCT01222390|19195880|P1|NOT COMPLETED|Overall Study||0
7797844|NCT01222390|19195880|P1|COMPLETED|Overall Study||12
7797845|NCT01222390|19195880|P1|STARTED|Overall Study||12
7797846|NCT01222299|19195888|P4|NOT COMPLETED|Overall Study||5
7797847|NCT01222299|19195889|P3|NOT COMPLETED|Overall Study||2
7797848|NCT01222299|19195890|P2|NOT COMPLETED|Overall Study||2
7797849|NCT01222299|19195891|P1|NOT COMPLETED|Overall Study||0
7797850|NCT01222299|19195888|P4|COMPLETED|Overall Study||18
7797851|NCT01222299|19195889|P3|COMPLETED|Overall Study||20
7797852|NCT01222299|19195890|P2|COMPLETED|Overall Study||21
7797853|NCT01222299|19195891|P1|COMPLETED|Overall Study||21
7797854|NCT01222299|19195888|P4|STARTED|Overall Study||23
7797855|NCT01222299|19195889|P3|STARTED|Overall Study||22
7797856|NCT01222299|19195890|P2|STARTED|Overall Study||23
7797857|NCT01222299|19195891|P1|STARTED|Overall Study||21
7797858|NCT01222286|19195903|P2|NOT COMPLETED|Overall Study||0
7797859|NCT01222286|19195904|P1|NOT COMPLETED|Overall Study||0
7797860|NCT01222286|19195903|P2|COMPLETED|Overall Study||14
7797861|NCT01222286|19195904|P1|COMPLETED|Overall Study||16
7797862|NCT01222286|19195903|P2|STARTED|Overall Study||14
7797863|NCT01222286|19195904|P1|STARTED|Overall Study||16
7797864|NCT01222273|19195916|P1|NOT COMPLETED|Overall Study||0
7797865|NCT01222273|19195916|P1|COMPLETED|Overall Study||7
7797866|NCT01222273|19195916|P1|STARTED|Overall Study||7
7797867|NCT01222260|19195922|P1|NOT COMPLETED|Overall Study||2
7797868|NCT01222260|19195922|P1|COMPLETED|Overall Study||29
7797869|NCT01222260|19195922|P1|STARTED|Overall Study||31
7797870|NCT01222247|19195931|P2|NOT COMPLETED|Overall Study||2
7797871|NCT01222247|19195932|P1|NOT COMPLETED|Overall Study||2
7797872|NCT01222247|19195931|P2|COMPLETED|Overall Study||1400
7797873|NCT01222247|19195932|P1|COMPLETED|Overall Study||1427
7797874|NCT01222247|19195931|P2|Did Not Receive Assigned Medication|Overall Study||5
7797875|NCT01222247|19195932|P1|Did Not Receive Assigned Medication|Overall Study||1
7797876|NCT01222247|19195931|P2|Received 1 Dose|Overall Study||571
7797877|NCT01222247|19195932|P1|Received 1 Dose|Overall Study||568
7797878|NCT01222247|19195931|P2|Received 2 Doses|Overall Study||826
7797879|NCT01222247|19195932|P1|Received 2 Doses|Overall Study||860
7797880|NCT01222247|19195931|P2|STARTED|Overall Study||1402
7797881|NCT01222247|19195932|P1|STARTED|Overall Study||1429
7797882|NCT01222234|19195997|P3|NOT COMPLETED|Overall Study||2
7797883|NCT01222234|19195998|P2|NOT COMPLETED|Overall Study||2
7797884|NCT01222234|19195999|P1|NOT COMPLETED|Overall Study||0
7797885|NCT01222234|19195997|P3|COMPLETED|Overall Study||22
7797886|NCT01222234|19195998|P2|COMPLETED|Overall Study||15
7797887|NCT01222234|19195999|P1|COMPLETED|Overall Study||15
7797888|NCT01222234|19195997|P3|STARTED|Overall Study||24
7797889|NCT01222234|19195998|P2|STARTED|Overall Study||17
7797890|NCT01222234|19195999|P1|STARTED|Overall Study||15
7797891|NCT01222195|19196008|P1|NOT COMPLETED|Overall Study||0
7797892|NCT01222195|19196008|P1|COMPLETED|Overall Study||1
7797893|NCT01222195|19196008|P1|STARTED|Overall Study||1
7797894|NCT01222117|19196023|P11|NOT COMPLETED|Overall Study||0
7797895|NCT01222117|19196024|P10|NOT COMPLETED|Overall Study||2
7797896|NCT01222117|19196025|P9|NOT COMPLETED|Overall Study||3
7797897|NCT01222117|19196026|P8|NOT COMPLETED|Overall Study||0
7797898|NCT01222117|19196027|P7|NOT COMPLETED|Overall Study||0
7797899|NCT01222117|19196028|P6|NOT COMPLETED|Overall Study||1
7797900|NCT01222117|19196029|P5|NOT COMPLETED|Overall Study||1
7797901|NCT01222117|19196030|P4|NOT COMPLETED|Overall Study||1
7797902|NCT01222117|19196031|P3|NOT COMPLETED|Overall Study||0
7797903|NCT01222117|19196032|P2|NOT COMPLETED|Overall Study||1
7797904|NCT01222117|19196033|P1|NOT COMPLETED|Overall Study||3
7797905|NCT01222117|19196023|P11|COMPLETED|Overall Study||6
7797906|NCT01222117|19196024|P10|COMPLETED|Overall Study||17
7797907|NCT01222117|19196025|P9|COMPLETED|Overall Study||20
7797908|NCT01222117|19196026|P8|COMPLETED|Overall Study||12
7797909|NCT01222117|19196027|P7|COMPLETED|Overall Study||13
7797910|NCT01222117|19196028|P6|COMPLETED|Overall Study||9
7797911|NCT01222117|19196029|P5|COMPLETED|Overall Study||8
7797912|NCT01222117|19196030|P4|COMPLETED|Overall Study||19
7797913|NCT01222117|19196031|P3|COMPLETED|Overall Study||22
7797914|NCT01222117|19196032|P2|COMPLETED|Overall Study||19
7797915|NCT01222117|19196033|P1|COMPLETED|Overall Study||17
7797916|NCT01222117|19196023|P11|STARTED|Overall Study||6
7797917|NCT01222117|19196024|P10|STARTED|Overall Study||19
7797918|NCT01222117|19196025|P9|STARTED|Overall Study||23
7797919|NCT01222117|19196026|P8|STARTED|Overall Study||12
7797920|NCT01222117|19196027|P7|STARTED|Overall Study||13
7797921|NCT01222117|19196028|P6|STARTED|Overall Study||10
7797922|NCT01222117|19196029|P5|STARTED|Overall Study||9
7797923|NCT01222117|19196030|P4|STARTED|Overall Study||20
7797924|NCT01222117|19196031|P3|STARTED|Overall Study||22
7797925|NCT01222117|19196032|P2|STARTED|Overall Study||20
7797926|NCT01222117|19196033|P1|STARTED|Overall Study||20
7797927|NCT01222104|19196068|P1|NOT COMPLETED|Overall Study||47
7797928|NCT01222104|19196068|P1|COMPLETED|Overall Study||587
7797929|NCT01222104|19196068|P1|Completed 30-day Visit-No Angio-Seal|Overall Study||90
7797930|NCT01222104|19196068|P1|Completed 30-day Visit-Angio-Seal|Overall Study||497
7797931|NCT01222104|19196068|P1|Successful Deployment and Hemostasis|Overall Study||524
7797932|NCT01222104|19196068|P1|Successful Deployment|Overall Study||529
7797933|NCT01222104|19196068|P1|Angio-Seal Deployment Attempted|Overall Study||534
7797934|NCT01222104|19196068|P1|STARTED|Overall Study||634
7797935|NCT01222091|19196082|P2|NOT COMPLETED|Overall Study||0
7797936|NCT01222091|19196083|P1|NOT COMPLETED|Overall Study||0
7797937|NCT01222091|19196082|P2|COMPLETED|Overall Study||5
7797938|NCT01222091|19196083|P1|COMPLETED|Overall Study||5
7797939|NCT01222091|19196082|P2|STARTED|Overall Study||5
7797940|NCT01222091|19196083|P1|STARTED|Overall Study||5
7797941|NCT01222078|19196091|P1|NOT COMPLETED|Overall Study||1
7797942|NCT01222078|19196091|P1|COMPLETED|Overall Study||0
7797943|NCT01222078|19196091|P1|STARTED|Overall Study||1
7797944|NCT01221948|19196125|P1|NOT COMPLETED|Overall Study||14
7797945|NCT01221948|19196125|P1|COMPLETED|Overall Study||39
7797946|NCT01221948|19196125|P1|STARTED|Overall Study||53
7797947|NCT01221857|19196136|P1|NOT COMPLETED|Overall Study||0
7797948|NCT01221857|19196136|P1|COMPLETED|Overall Study||12
7797949|NCT01221857|19196136|P1|STARTED|Overall Study||12
7797950|NCT01221753|19196144|P1|NOT COMPLETED|Overall Study||1
7797951|NCT01221753|19196144|P1|COMPLETED|Overall Study||6
7797952|NCT01221753|19196144|P1|STARTED|Overall Study||7
7797953|NCT01221727|19196151|P2|NOT COMPLETED|Overall Study||1
7797954|NCT01221727|19196152|P1|NOT COMPLETED|Overall Study||3
7797955|NCT01221727|19196151|P2|COMPLETED|Overall Study||8
7797956|NCT01221727|19196152|P1|COMPLETED|Overall Study||18
7797957|NCT01221727|19196151|P2|Treated|Overall Study|Number of subjects received investigational product|8
7797958|NCT01221727|19196152|P1|Treated|Overall Study|Number of subjects received investigational product|19
7797959|NCT01221727|19196151|P2|STARTED|Overall Study|Number of subjects randomized into the study|9
7797960|NCT01221727|19196152|P1|STARTED|Overall Study|Number of subjects randomized into the study|21
7797961|NCT01221623|19196173|P2|NOT COMPLETED|Overall Study||14
7797962|NCT01221623|19196174|P1|NOT COMPLETED|Overall Study||38
7797963|NCT01221623|19196173|P2|COMPLETED|Overall Study||127
7797964|NCT01221623|19196174|P1|COMPLETED|Overall Study||236
7797965|NCT01221623|19196173|P2|STARTED|Overall Study||141
7797966|NCT01221623|19196174|P1|STARTED|Overall Study||274
7797967|NCT01221597|19196198|P2|NOT COMPLETED|Overall Study||16
7797968|NCT01221597|19196199|P1|NOT COMPLETED|Overall Study||36
7797969|NCT01221597|19196198|P2|COMPLETED|Overall Study||124
7797970|NCT01221597|19196199|P1|COMPLETED|Overall Study||241
7797971|NCT01221597|19196198|P2|STARTED|Overall Study||140
7797972|NCT01221597|19196199|P1|STARTED|Overall Study||277
7797973|NCT01221441|19196223|P2|NOT COMPLETED|Overall Study||12
7797974|NCT01221441|19196224|P1|NOT COMPLETED|Overall Study||22
7797975|NCT01221441|19196223|P2|COMPLETED|Overall Study||23
7797976|NCT01221441|19196224|P1|COMPLETED|Overall Study||45
7797977|NCT01221441|19196223|P2|STARTED|Overall Study||35
7797978|NCT01221441|19196224|P1|STARTED|Overall Study||67
7797979|NCT01221363|19196256|P2|NOT COMPLETED|Overall Study||5
7797980|NCT01221363|19196257|P1|NOT COMPLETED|Overall Study||12
7797981|NCT01221363|19196256|P2|COMPLETED|Overall Study||68
7797982|NCT01221363|19196257|P1|COMPLETED|Overall Study||81
7797983|NCT01221363|19196256|P2|STARTED|Overall Study||73
7797984|NCT01221363|19196257|P1|STARTED|Overall Study||93
7797985|NCT01221350|19196267|P2|NOT COMPLETED|Overall Study||3
7797986|NCT01221350|19196268|P1|NOT COMPLETED|Overall Study||5
7797987|NCT01221350|19196267|P2|COMPLETED|Overall Study||24
7797988|NCT01221350|19196268|P1|COMPLETED|Overall Study||23
7797989|NCT01221350|19196267|P2|Analysis Population|Overall Study||24
7797990|NCT01221350|19196268|P1|Analysis Population|Overall Study||23
7797991|NCT01221350|19196267|P2|Received Intervention|Overall Study||27
7797992|NCT01221350|19196268|P1|Received Intervention|Overall Study||28
7797993|NCT01221350|19196267|P2|STARTED|Overall Study||27
7797994|NCT01221350|19196268|P1|STARTED|Overall Study||28
7797995|NCT01221311|19196310|P2|NOT COMPLETED|Overall Study||0
7797996|NCT01221311|19196311|P1|NOT COMPLETED|Overall Study||0
7797997|NCT01221311|19196310|P2|COMPLETED|Overall Study||55
7797998|NCT01221311|19196311|P1|COMPLETED|Overall Study||57
7797999|NCT01221311|19196310|P2|STARTED|Overall Study||55
7798000|NCT01221311|19196311|P1|STARTED|Overall Study||57
7798001|NCT01221298|19196317|P1|NOT COMPLETED|Overall Study||0
7798002|NCT01221298|19196317|P1|COMPLETED|Overall Study|The number of participants who completed study drug|11
7798003|NCT01221298|19196317|P1|STARTED|Overall Study||11
7798004|NCT01221285|19196327|P1|NOT COMPLETED|Overall Study||1
7798005|NCT01221285|19196327|P1|COMPLETED|Overall Study||10
7798006|NCT01221285|19196327|P1|STARTED|Overall Study||11
7798007|NCT01221272|19196336|P2|NOT COMPLETED|Period 2||2
7798008|NCT01221272|19196337|P1|NOT COMPLETED|Period 2||0
7798009|NCT01221272|19196336|P2|COMPLETED|Period 2||37
7798010|NCT01221272|19196337|P1|COMPLETED|Period 2||39
7798011|NCT01221272|19196336|P2|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39
7798012|NCT01221272|19196337|P1|STARTED|Period 2||39
7798013|NCT01221272|19196336|P2|NOT COMPLETED|Period 1||2
7798014|NCT01221272|19196337|P1|NOT COMPLETED|Period 1||2
7798015|NCT01221272|19196336|P2|COMPLETED|Period 1||38
7798016|NCT01221272|19196337|P1|COMPLETED|Period 1||39
7798017|NCT01221272|19196336|P2|STARTED|Period 1||40
7798018|NCT01221272|19196337|P1|STARTED|Period 1||41
7798019|NCT01221233|19196354|P2|NOT COMPLETED|Overall Study||1
7798020|NCT01221233|19196355|P1|NOT COMPLETED|Overall Study||3
7798021|NCT01221233|19196354|P2|COMPLETED|Overall Study||19
7798022|NCT01221233|19196355|P1|COMPLETED|Overall Study||15
7798023|NCT01221233|19196354|P2|STARTED|Overall Study||20
7798024|NCT01221233|19196355|P1|STARTED|Overall Study||18
7798025|NCT01221207|19196364|P3|NOT COMPLETED|Overall Study||21
7798026|NCT01221207|19196365|P2|NOT COMPLETED|Overall Study||9
7798027|NCT01221207|19196366|P1|NOT COMPLETED|Overall Study||32
7798028|NCT01221207|19196364|P3|COMPLETED|Overall Study||54
7798029|NCT01221207|19196365|P2|COMPLETED|Overall Study||66
7798030|NCT01221207|19196366|P1|COMPLETED|Overall Study||43
7798031|NCT01221207|19196364|P3|STARTED|Overall Study||75
7798032|NCT01221207|19196365|P2|STARTED|Overall Study||75
7798033|NCT01221207|19196366|P1|STARTED|Overall Study||75
7798034|NCT01221194|19196376|P2|NOT COMPLETED|Overall Study||0
7798035|NCT01221194|19196377|P1|NOT COMPLETED|Overall Study||0
7798036|NCT01221194|19196376|P2|COMPLETED|Overall Study||186
7798037|NCT01221194|19196377|P1|COMPLETED|Overall Study||195
7798038|NCT01221194|19196376|P2|STARTED|Overall Study||186
7798039|NCT01221194|19196377|P1|STARTED|Overall Study||195
7798040|NCT01221181|19196383|P1|NOT COMPLETED|Overall Study||1
7798041|NCT01221181|19196383|P1|COMPLETED|Overall Study||5
7798042|NCT01221181|19196383|P1|STARTED|Overall Study||6
7798043|NCT01221090|19196391|P4|NOT COMPLETED|Overall Study||22
7798044|NCT01221090|19196392|P3|NOT COMPLETED|Overall Study||42
7798045|NCT01221090|19196393|P2|NOT COMPLETED|Overall Study||34
7798046|NCT01221090|19196394|P1|NOT COMPLETED|Overall Study||15
7798047|NCT01221090|19196391|P4|COMPLETED|Overall Study||73
7798048|NCT01221090|19196392|P3|COMPLETED|Overall Study||57
7798049|NCT01221090|19196393|P2|COMPLETED|Overall Study||47
7798050|NCT01221090|19196394|P1|COMPLETED|Overall Study||86
7798051|NCT01221090|19196391|P4|STARTED|Overall Study||95
7798052|NCT01221090|19196392|P3|STARTED|Overall Study||99
7798053|NCT01221090|19196393|P2|STARTED|Overall Study||81
7798054|NCT01221090|19196394|P1|STARTED|Overall Study||101
7798055|NCT01220999|19196425|P5|NOT COMPLETED|Overall Study||0
7798056|NCT01220999|19196426|P4|NOT COMPLETED|Overall Study||0
7798057|NCT01220999|19196427|P3|NOT COMPLETED|Overall Study||1
7798058|NCT01220999|19196428|P2|NOT COMPLETED|Overall Study||0
7798059|NCT01220999|19196429|P1|NOT COMPLETED|Overall Study||0
7798060|NCT01220999|19196425|P5|COMPLETED|Overall Study||5
7798061|NCT01220999|19196426|P4|COMPLETED|Overall Study||3
7798062|NCT01220999|19196427|P3|COMPLETED|Overall Study||4
7798063|NCT01220999|19196428|P2|COMPLETED|Overall Study||4
7798064|NCT01220999|19196429|P1|COMPLETED|Overall Study||2
7798065|NCT01220999|19196425|P5|STARTED|Overall Study||5
7798066|NCT01220999|19196426|P4|STARTED|Overall Study||3
7798067|NCT01220999|19196427|P3|STARTED|Overall Study||5
7798068|NCT01220999|19196428|P2|STARTED|Overall Study||4
7798069|NCT01220999|19196429|P1|STARTED|Overall Study||2
7798070|NCT01220973|19196506|P1|NOT COMPLETED|Overall Study||4
7798071|NCT01220973|19196506|P1|COMPLETED|Overall Study||23
7798072|NCT01220973|19196506|P1|STARTED|Overall Study||27
7798073|NCT01220869|19196510|P1|NOT COMPLETED|Overall Study||6
7798074|NCT01220869|19196510|P1|COMPLETED|Overall Study||104
7798075|NCT01220869|19196510|P1|STARTED|Overall Study||110
7798076|NCT01220739|19196520|P2|NOT COMPLETED|Overall Study||0
7798077|NCT01220739|19196521|P1|NOT COMPLETED|Overall Study||0
7798078|NCT01220739|19196520|P2|COMPLETED|Overall Study||5
7798079|NCT01220739|19196521|P1|COMPLETED|Overall Study||7
7798080|NCT01220739|19196520|P2|STARTED|Overall Study||5
7798081|NCT01220739|19196521|P1|STARTED|Overall Study||7
7798082|NCT01220726|19196531|P2|NOT COMPLETED|Overall Study||2
7798083|NCT01220726|19196532|P1|NOT COMPLETED|Overall Study||0
7798084|NCT01220726|19196531|P2|COMPLETED|Overall Study||13
7798085|NCT01220726|19196532|P1|COMPLETED|Overall Study||15
7798086|NCT01220726|19196531|P2|STARTED|Overall Study||15
7798087|NCT01220726|19196532|P1|STARTED|Overall Study||15
7798088|NCT01220687|19196552|P2|NOT COMPLETED|Overall Study||1
7798089|NCT01220687|19196553|P1|NOT COMPLETED|Overall Study||2
7798090|NCT01220687|19196552|P2|COMPLETED|Overall Study||14
7798091|NCT01220687|19196553|P1|COMPLETED|Overall Study||14
7798092|NCT01220687|19196552|P2|STARTED|Overall Study||15
7798093|NCT01220687|19196553|P1|STARTED|Overall Study||16
7798094|NCT01220609|19196579|P1|NOT COMPLETED|Overall Study||3
7798095|NCT01220609|19196579|P1|COMPLETED|Overall Study|Eligible and treated patients|23
7798096|NCT01220609|19196579|P1|STARTED|Overall Study||26
7798097|NCT01220557|19196593|P2|NOT COMPLETED|Overall Study||5
7798098|NCT01220557|19196594|P1|NOT COMPLETED|Overall Study||6
7798099|NCT01220557|19196593|P2|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74
7798100|NCT01220557|19196594|P1|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75
7798101|NCT01220557|19196593|P2|STARTED|Overall Study||79
7798102|NCT01220557|19196594|P1|STARTED|Overall Study||81
7798103|NCT01220466|19196603|P3|NOT COMPLETED|Overall Study||0
7798104|NCT01220466|19196604|P2|NOT COMPLETED|Overall Study||0
7798105|NCT01220466|19196605|P1|NOT COMPLETED|Overall Study||0
7798106|NCT01220466|19196603|P3|COMPLETED|Overall Study|16 eyes|10
7798107|NCT01220466|19196604|P2|COMPLETED|Overall Study|108 eyes|56
7798108|NCT01220466|19196605|P1|COMPLETED|Overall Study|19 eyes|11
7798109|NCT01220466|19196603|P3|STARTED|Overall Study|16 eyes|10
7798110|NCT01220466|19196604|P2|STARTED|Overall Study|108 eyes|56
7798111|NCT01220466|19196605|P1|STARTED|Overall Study|19 eyes|11
7798112|NCT01220414|19196627|P4|NOT COMPLETED|Overall Study||1
7798113|NCT01220414|19196628|P3|NOT COMPLETED|Overall Study||0
7798114|NCT01220414|19196629|P2|NOT COMPLETED|Overall Study||0
7798115|NCT01220414|19196630|P1|NOT COMPLETED|Overall Study||1
7798116|NCT01220414|19196627|P4|COMPLETED|Overall Study||14
7798117|NCT01220414|19196628|P3|COMPLETED|Overall Study||14
7798118|NCT01220414|19196629|P2|COMPLETED|Overall Study||14
7798119|NCT01220414|19196630|P1|COMPLETED|Overall Study||14
7798120|NCT01220414|19196627|P4|STARTED|Overall Study||15
7798121|NCT01220414|19196628|P3|STARTED|Overall Study||14
7798122|NCT01220414|19196629|P2|STARTED|Overall Study||14
7798123|NCT01220414|19196630|P1|STARTED|Overall Study||15
7798124|NCT01220401|19196637|P1|NOT COMPLETED|Overall Study||3
7798125|NCT01220401|19196637|P1|COMPLETED|Overall Study||18
7798126|NCT01220401|19196637|P1|STARTED|Overall Study||21
7798127|NCT01220297|19196646|P1|NOT COMPLETED|Overall Study||3
7798128|NCT01220297|19196646|P1|COMPLETED|Overall Study||0
7798129|NCT01220297|19196646|P1|STARTED|Overall Study||3
7798130|NCT01220180|19196663|P1|NOT COMPLETED|Overall Study||207
7798131|NCT01220180|19196663|P1|COMPLETED|Overall Study||3968
7798132|NCT01220180|19196663|P1|Treated|Overall Study||4174
7798133|NCT01220180|19196663|P1|STARTED|Overall Study||4175
7798134|NCT01220167|19196689|P3|NOT COMPLETED|Period 3||0
7798135|NCT01220167|19196690|P2|NOT COMPLETED|Period 3||1
7798136|NCT01220167|19196691|P1|NOT COMPLETED|Period 3||0
7798137|NCT01220167|19196689|P3|COMPLETED|Period 3||6
7798138|NCT01220167|19196690|P2|COMPLETED|Period 3||5
7798139|NCT01220167|19196691|P1|COMPLETED|Period 3||6
7798140|NCT01220167|19196689|P3|STARTED|Period 3||6
7798141|NCT01220167|19196690|P2|STARTED|Period 3||6
7798142|NCT01220167|19196691|P1|STARTED|Period 3||6
7798143|NCT01220167|19196689|P3|NOT COMPLETED|Period 2||0
7798144|NCT01220167|19196690|P2|NOT COMPLETED|Period 2||0
7798145|NCT01220167|19196691|P1|NOT COMPLETED|Period 2||0
7798146|NCT01220167|19196689|P3|COMPLETED|Period 2||6
7798147|NCT01220167|19196690|P2|COMPLETED|Period 2||6
7798148|NCT01220167|19196691|P1|COMPLETED|Period 2||6
7798149|NCT01220167|19196689|P3|STARTED|Period 2||6
7798150|NCT01220167|19196690|P2|STARTED|Period 2||6
7798151|NCT01220167|19196691|P1|STARTED|Period 2||6
7798152|NCT01220167|19196689|P3|NOT COMPLETED|Period 1||0
7798153|NCT01220167|19196690|P2|NOT COMPLETED|Period 1||0
7798154|NCT01220167|19196691|P1|NOT COMPLETED|Period 1||0
7798155|NCT01220167|19196689|P3|COMPLETED|Period 1||6
7798156|NCT01220167|19196690|P2|COMPLETED|Period 1||6
7798157|NCT01220167|19196691|P1|COMPLETED|Period 1||6
7798158|NCT01220167|19196689|P3|STARTED|Period 1||6
7798159|NCT01220167|19196690|P2|STARTED|Period 1||6
7798160|NCT01220167|19196691|P1|STARTED|Period 1||6
7798161|NCT01220128|19196704|P7|NOT COMPLETED|Overall Study||5
7798162|NCT01220128|19196705|P6|NOT COMPLETED|Overall Study||0
7798163|NCT01220128|19196706|P5|NOT COMPLETED|Overall Study||0
7798164|NCT01220128|19196707|P4|NOT COMPLETED|Overall Study||0
7798165|NCT01220128|19196708|P3|NOT COMPLETED|Overall Study||3
7798166|NCT01220128|19196709|P2|NOT COMPLETED|Overall Study||1
7798167|NCT01220128|19196710|P1|NOT COMPLETED|Overall Study||4
7798168|NCT01220128|19196704|P7|COMPLETED|Overall Study||3
7798169|NCT01220128|19196705|P6|COMPLETED|Overall Study||4
7798170|NCT01220128|19196706|P5|COMPLETED|Overall Study||11
7798171|NCT01220128|19196707|P4|COMPLETED|Overall Study||6
7798172|NCT01220128|19196708|P3|COMPLETED|Overall Study||6
7798173|NCT01220128|19196709|P2|COMPLETED|Overall Study||6
7798174|NCT01220128|19196710|P1|COMPLETED|Overall Study||11
7798175|NCT01220128|19196704|P7|STARTED|Overall Study||8
7798176|NCT01220128|19196705|P6|STARTED|Overall Study||4
7798177|NCT01220128|19196706|P5|STARTED|Overall Study||11
7798178|NCT01220128|19196707|P4|STARTED|Overall Study||6
7798179|NCT01220128|19196708|P3|STARTED|Overall Study||9
7798180|NCT01220128|19196709|P2|STARTED|Overall Study||7
7798181|NCT01220128|19196710|P1|STARTED|Overall Study||15
7798182|NCT01219985|19196915|P1|NOT COMPLETED|Overall Study||20
7798183|NCT01219985|19196915|P1|COMPLETED|Overall Study||30
7798184|NCT01219985|19196915|P1|STARTED|Overall Study||50
7798185|NCT01219959|19196923|P2|NOT COMPLETED|Overall Study||23
7798186|NCT01219959|19196924|P1|NOT COMPLETED|Overall Study||7
7798187|NCT01219959|19196923|P2|COMPLETED|Overall Study||101
7798188|NCT01219959|19196924|P1|COMPLETED|Overall Study||120
7798189|NCT01219959|19196923|P2|STARTED|Overall Study||124
7798190|NCT01219959|19196924|P1|STARTED|Overall Study||127
7798191|NCT01219933|19196972|P1|NOT COMPLETED|Overall Study||38
7798192|NCT01219933|19196972|P1|COMPLETED|Overall Study||30
7798193|NCT01219933|19196972|P1|STARTED|Overall Study||68
7798194|NCT01219881|19197011|P2|NOT COMPLETED|Overall Study||5
7798195|NCT01219881|19197012|P1|NOT COMPLETED|Overall Study||4
7798196|NCT01219881|19197011|P2|COMPLETED|Overall Study||32
7798197|NCT01219881|19197012|P1|COMPLETED|Overall Study||34
7798198|NCT01219881|19197011|P2|STARTED|Overall Study||37
7798199|NCT01219881|19197012|P1|STARTED|Overall Study||38
7798200|NCT01219855|19197029|P5|NOT COMPLETED|Overall Study||1
7798201|NCT01219855|19197030|P4|NOT COMPLETED|Overall Study||1
7798202|NCT01219855|19197031|P3|NOT COMPLETED|Overall Study||1
7798203|NCT01219855|19197032|P2|NOT COMPLETED|Overall Study||5
7798204|NCT01219855|19197033|P1|NOT COMPLETED|Overall Study||1
7798205|NCT01219855|19197029|P5|COMPLETED|Overall Study||13
7798206|NCT01219855|19197030|P4|COMPLETED|Overall Study||12
7798207|NCT01219855|19197031|P3|COMPLETED|Overall Study||16
7798208|NCT01219855|19197032|P2|COMPLETED|Overall Study||12
7798209|NCT01219855|19197033|P1|COMPLETED|Overall Study||16
7798210|NCT01219855|19197029|P5|STARTED|Overall Study||14
7798211|NCT01219855|19197030|P4|STARTED|Overall Study||13
7798212|NCT01219855|19197031|P3|STARTED|Overall Study||17
7798213|NCT01219855|19197032|P2|STARTED|Overall Study||17
7798214|NCT01219855|19197033|P1|STARTED|Overall Study||17
7798215|NCT01219777|19197069|P1|NOT COMPLETED|Overall Study||0
7798216|NCT01219777|19197069|P1|COMPLETED|Overall Study||9
7798217|NCT01219777|19197069|P1|STARTED|Overall Study||9
7798218|NCT01219738|19197074|P1|NOT COMPLETED|Overall Study||0
7798219|NCT01219738|19197074|P1|COMPLETED|Overall Study||20
7798220|NCT01219738|19197074|P1|Budesonide 720- 4 Times|Overall Study||20
7798221|NCT01219738|19197074|P1|Budesonide 1440|Overall Study||20
7798222|NCT01219738|19197074|P1|Budesonide 720|Overall Study||20
7798223|NCT01219738|19197074|P1|Budesonide 360|Overall Study||20
7798224|NCT01219738|19197074|P1|STARTED|Overall Study||20
7798225|NCT01219673|19197095|P8|NOT COMPLETED|Overall Study||0
7798226|NCT01219673|19197096|P7|NOT COMPLETED|Overall Study||0
7798227|NCT01219673|19197097|P6|NOT COMPLETED|Overall Study||0
7798228|NCT01219673|19197098|P5|NOT COMPLETED|Overall Study||0
7798229|NCT01219673|19197099|P4|NOT COMPLETED|Overall Study||0
7798230|NCT01219673|19197100|P3|NOT COMPLETED|Overall Study||0
7798231|NCT01219673|19197101|P2|NOT COMPLETED|Overall Study||0
7798232|NCT01219673|19197102|P1|NOT COMPLETED|Overall Study||0
7798233|NCT01219673|19197095|P8|COMPLETED|Overall Study||0
7798234|NCT01219673|19197096|P7|COMPLETED|Overall Study||0
7798235|NCT01219673|19197097|P6|COMPLETED|Overall Study||0
7798236|NCT01219673|19197098|P5|COMPLETED|Overall Study||0
7798237|NCT01219673|19197099|P4|COMPLETED|Overall Study||0
7798238|NCT01219673|19197100|P3|COMPLETED|Overall Study||1
7798239|NCT01219673|19197101|P2|COMPLETED|Overall Study||0
7798240|NCT01219673|19197102|P1|COMPLETED|Overall Study||0
7798241|NCT01219673|19197095|P8|STARTED|Overall Study||0
7798242|NCT01219673|19197096|P7|STARTED|Overall Study||0
7798243|NCT01219673|19197097|P6|STARTED|Overall Study||0
7798244|NCT01219673|19197098|P5|STARTED|Overall Study||0
7798245|NCT01219673|19197099|P4|STARTED|Overall Study||0
7798246|NCT01219673|19197100|P3|STARTED|Overall Study||1
7798247|NCT01219673|19197101|P2|STARTED|Overall Study||0
7798248|NCT01219673|19197102|P1|STARTED|Overall Study||0
7798249|NCT01218997|19197122|P2|NOT COMPLETED|Overall Study||41
7798250|NCT01218997|19197123|P1|NOT COMPLETED|Overall Study||245
7798251|NCT01218997|19197122|P2|COMPLETED|Overall Study||24
7798252|NCT01218997|19197123|P1|COMPLETED|Overall Study||126
7798253|NCT01218997|19197122|P2|STARTED|Overall Study||65
7798254|NCT01218997|19197123|P1|STARTED|Overall Study||371
7798255|NCT01218984|19197132|P3|NOT COMPLETED|Overall Study||3
7798256|NCT01218984|19197133|P2|NOT COMPLETED|Overall Study||2
7798257|NCT01218984|19197134|P1|NOT COMPLETED|Overall Study||1
7798258|NCT01218984|19197132|P3|COMPLETED|Overall Study||7
7798259|NCT01218984|19197133|P2|COMPLETED|Overall Study||6
7798260|NCT01218984|19197134|P1|COMPLETED|Overall Study||8
7798261|NCT01218984|19197132|P3|STARTED|Overall Study||10
7798262|NCT01218984|19197133|P2|STARTED|Overall Study||8
7798263|NCT01218984|19197134|P1|STARTED|Overall Study||9
7798264|NCT01218971|19197144|P2|NOT COMPLETED|Overall Study||80
7798265|NCT01218971|19197145|P1|NOT COMPLETED|Overall Study||104
7798266|NCT01218971|19197144|P2|COMPLETED|Overall Study||77
7798267|NCT01218971|19197145|P1|COMPLETED|Overall Study||71
7798268|NCT01218971|19197144|P2|STARTED|Overall Study||157
7798269|NCT01218971|19197145|P1|STARTED|Overall Study||175
7798270|NCT01218958|19197158|P3|NOT COMPLETED|Overall Study||81
7798271|NCT01218958|19197159|P2|NOT COMPLETED|Overall Study||81
7798272|NCT01218958|19197160|P1|NOT COMPLETED|Overall Study||84
7798273|NCT01218958|19197158|P3|COMPLETED|Overall Study||128
7798274|NCT01218958|19197159|P2|COMPLETED|Overall Study||124
7798275|NCT01218958|19197160|P1|COMPLETED|Overall Study||126
7798276|NCT01218958|19197158|P3|STARTED|Overall Study||209
7798277|NCT01218958|19197159|P2|STARTED|Overall Study||205
7798278|NCT01218958|19197160|P1|STARTED|Overall Study||210
7798279|NCT01218867|19197182|P11|NOT COMPLETED|Overall Study||0
7798280|NCT01218867|19197183|P10|NOT COMPLETED|Overall Study||0
7798281|NCT01218867|19197184|P9|NOT COMPLETED|Overall Study||0
7798282|NCT01218867|19197185|P8|NOT COMPLETED|Overall Study||0
7798283|NCT01218867|19197186|P7|NOT COMPLETED|Overall Study||1
7798284|NCT01218867|19197187|P6|NOT COMPLETED|Overall Study||0
7798285|NCT01218867|19197188|P5|NOT COMPLETED|Overall Study||0
7798286|NCT01218867|19197189|P4|NOT COMPLETED|Overall Study||0
7798287|NCT01218867|19197190|P3|NOT COMPLETED|Overall Study||0
7798288|NCT01218867|19197191|P2|NOT COMPLETED|Overall Study||0
7798289|NCT01218867|19197192|P1|NOT COMPLETED|Overall Study||0
7798290|NCT01218867|19197182|P11|COMPLETED|Overall Study||2
7798291|NCT01218867|19197183|P10|COMPLETED|Overall Study||4
7798292|NCT01218867|19197184|P9|COMPLETED|Overall Study||3
7798293|NCT01218867|19197185|P8|COMPLETED|Overall Study||3
7798294|NCT01218867|19197186|P7|COMPLETED|Overall Study||3
7798295|NCT01218867|19197187|P6|COMPLETED|Overall Study||1
7798296|NCT01218867|19197188|P5|COMPLETED|Overall Study||1
7798297|NCT01218867|19197189|P4|COMPLETED|Overall Study||1
7798298|NCT01218867|19197190|P3|COMPLETED|Overall Study||3
7798299|NCT01218867|19197191|P2|COMPLETED|Overall Study||1
7798300|NCT01218867|19197192|P1|COMPLETED|Overall Study||1
7798301|NCT01218867|19197182|P11|STARTED|Overall Study||2
7798302|NCT01218867|19197183|P10|STARTED|Overall Study||4
7798303|NCT01218867|19197184|P9|STARTED|Overall Study||3
7798304|NCT01218867|19197185|P8|STARTED|Overall Study||3
7798305|NCT01218867|19197186|P7|STARTED|Overall Study||4
7798306|NCT01218867|19197187|P6|STARTED|Overall Study||1
7798307|NCT01218867|19197188|P5|STARTED|Overall Study||1
7798308|NCT01218867|19197189|P4|STARTED|Overall Study||1
7798309|NCT01218867|19197190|P3|STARTED|Overall Study||3
7798310|NCT01218867|19197191|P2|STARTED|Overall Study||1
7798311|NCT01218867|19197192|P1|STARTED|Overall Study||1
7798312|NCT01218802|19197240|P2|NOT COMPLETED|Overall Study||18
7798313|NCT01218802|19197241|P1|NOT COMPLETED|Overall Study||10
7798314|NCT01218802|19197240|P2|COMPLETED|Overall Study||57
7798315|NCT01218802|19197241|P1|COMPLETED|Overall Study||62
7798316|NCT01218802|19197240|P2|STARTED|Overall Study||75
7798317|NCT01218802|19197241|P1|STARTED|Overall Study||72
7798318|NCT01218672|19197251|P2|NOT COMPLETED|Overall Study||21
7798319|NCT01218672|19197252|P1|NOT COMPLETED|Overall Study||11
7798320|NCT01218672|19197251|P2|COMPLETED|Overall Study||121
7798321|NCT01218672|19197252|P1|COMPLETED|Overall Study||128
7798322|NCT01218672|19197251|P2|Treated|Overall Study||133
7798323|NCT01218672|19197252|P1|Treated|Overall Study||136
7798324|NCT01218672|19197251|P2|STARTED|Overall Study||142
7798325|NCT01218672|19197252|P1|STARTED|Overall Study||139
7798326|NCT01218659|19197278|P3|NOT COMPLETED|12-Month OLE||10
7798327|NCT01218659|19197279|P2|NOT COMPLETED|12-Month OLE||0
7798328|NCT01218659|19197280|P1|NOT COMPLETED|12-Month OLE||0
7798329|NCT01218659|19197278|P3|COMPLETED|12-Month OLE||42
7798330|NCT01218659|19197279|P2|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
7798331|NCT01218659|19197280|P1|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
7798332|NCT01218659|19197278|P3|Modified Intent-to-Treat (mITT)|12-Month OLE||46
7798333|NCT01218659|19197279|P2|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
7798334|NCT01218659|19197280|P1|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
7798335|NCT01218659|19197278|P3|Safety Population|12-Month OLE||51
7798336|NCT01218659|19197279|P2|Safety Population|12-Month OLE||0
7798337|NCT01218659|19197280|P1|Safety Population|12-Month OLE||0
7798338|NCT01218659|19197278|P3|STARTED|12-Month OLE|Fifty-two participants completed the 18-mo. randomized treatment period.|52
7798339|NCT01218659|19197279|P2|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
7798340|NCT01218659|19197280|P1|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
7798341|NCT01218659|19197278|P3|NOT COMPLETED|18-Month Randomized Period||0
7798342|NCT01218659|19197279|P2|NOT COMPLETED|18-Month Randomized Period||6
7798343|NCT01218659|19197280|P1|NOT COMPLETED|18-Month Randomized Period||2
7798344|NCT01218659|19197278|P3|COMPLETED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
7798345|NCT01218659|19197279|P2|COMPLETED|18-Month Randomized Period||18
7798346|NCT01218659|19197280|P1|COMPLETED|18-Month Randomized Period||34
7798347|NCT01218659|19197278|P3|Safety Population|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
7798348|NCT01218659|19197279|P2|Safety Population|18-Month Randomized Period||21
7798349|NCT01218659|19197280|P1|Safety Population|18-Month Randomized Period||36
7798350|NCT01218659|19197278|P3|STARTED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
7798351|NCT01218659|19197279|P2|STARTED|18-Month Randomized Period||24
7798352|NCT01218659|19197280|P1|STARTED|18-Month Randomized Period||36
7798353|NCT01218646|19197295|P4|NOT COMPLETED|Overall Study||1
7798354|NCT01218646|19197296|P3|NOT COMPLETED|Overall Study||2
7798355|NCT01218646|19197297|P2|NOT COMPLETED|Overall Study||0
7798356|NCT01218646|19197298|P1|NOT COMPLETED|Overall Study||1
7798357|NCT01218646|19197295|P4|COMPLETED|Overall Study||63
7798358|NCT01218646|19197296|P3|COMPLETED|Overall Study||223
7798359|NCT01218646|19197297|P2|COMPLETED|Overall Study||225
7798360|NCT01218646|19197298|P1|COMPLETED|Overall Study||224
7798361|NCT01218646|19197295|P4|STARTED|Overall Study||64
7798362|NCT01218646|19197296|P3|STARTED|Overall Study||225
7798363|NCT01218646|19197297|P2|STARTED|Overall Study||225
7798364|NCT01218646|19197298|P1|STARTED|Overall Study||225
7798365|NCT01218594|19197336|P1|NOT COMPLETED|Overall Study||12
7798366|NCT01218594|19197336|P1|COMPLETED|Overall Study||36
7798367|NCT01218594|19197336|P1|STARTED|Overall Study||48
7798368|NCT01218516|19197342|P4|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
7798369|NCT01218516|19197343|P3|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
7798370|NCT01218516|19197344|P2|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
7798371|NCT01218516|19197345|P1|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
7798372|NCT01218516|19197342|P4|COMPLETED|Monotherapy (up to 23.5 Months)||28
7798373|NCT01218516|19197343|P3|COMPLETED|Monotherapy (up to 23.5 Months)||38
7798374|NCT01218516|19197344|P2|COMPLETED|Monotherapy (up to 23.5 Months)||0
7798375|NCT01218516|19197345|P1|COMPLETED|Monotherapy (up to 23.5 Months)||0
7798376|NCT01218516|19197342|P4|Safety Analysis Set|Monotherapy (up to 23.5 Months)|Three participants were randomized to placebo but actually received Farletuzumab.|31
7798377|NCT01218516|19197343|P3|Safety Analysis Set|Monotherapy (up to 23.5 Months)||35
7798378|NCT01218516|19197344|P2|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
7798379|NCT01218516|19197345|P1|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
7798380|NCT01218516|19197342|P4|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|28
7798381|NCT01218516|19197343|P3|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|38
7798382|NCT01218516|19197344|P2|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
7798383|NCT01218516|19197345|P1|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
7798384|NCT01218516|19197342|P4|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
7798385|NCT01218516|19197343|P3|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
7798386|NCT01218516|19197344|P2|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||35
7798387|NCT01218516|19197345|P1|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||29
7798388|NCT01218516|19197342|P4|COMPLETED|Combination Therapy (up to 4.5 Months)||0
7798389|NCT01218516|19197343|P3|COMPLETED|Combination Therapy (up to 4.5 Months)||0
7798390|NCT01218516|19197344|P2|COMPLETED|Combination Therapy (up to 4.5 Months)||28
7798391|NCT01218516|19197345|P1|COMPLETED|Combination Therapy (up to 4.5 Months)||38
7798392|NCT01218516|19197342|P4|STARTED|Combination Therapy (up to 4.5 Months)||0
7798393|NCT01218516|19197343|P3|STARTED|Combination Therapy (up to 4.5 Months)||0
7798394|NCT01218516|19197344|P2|STARTED|Combination Therapy (up to 4.5 Months)||63
7798395|NCT01218516|19197345|P1|STARTED|Combination Therapy (up to 4.5 Months)||67
7798396|NCT01218477|19197367|P4|NOT COMPLETED|Overall Study||2
7798397|NCT01218477|19197368|P3|NOT COMPLETED|Overall Study||14
7798398|NCT01218477|19197369|P2|NOT COMPLETED|Overall Study||8
7798399|NCT01218477|19197370|P1|NOT COMPLETED|Overall Study||3
7798400|NCT01218477|19197367|P4|COMPLETED|Overall Study|Still receiving study drug|0
7798401|NCT01218477|19197368|P3|COMPLETED|Overall Study|Still receiving study drug|0
7798402|NCT01218477|19197369|P2|COMPLETED|Overall Study|Still receiving study drug|0
7798403|NCT01218477|19197370|P1|COMPLETED|Overall Study|Still receiving study drug|0
7798404|NCT01218477|19197367|P4|STARTED|Overall Study|Participants who received treatment|2
7798405|NCT01218477|19197368|P3|STARTED|Overall Study|Participants who received treatment|14
7798406|NCT01218477|19197369|P2|STARTED|Overall Study|Participants who received treatment|8
7798407|NCT01218477|19197370|P1|STARTED|Overall Study|Participants who received treatment|3
7798408|NCT01218438|19197387|P1|NOT COMPLETED|Epoch 4||3
7798409|NCT01218438|19197387|P1|COMPLETED|Epoch 4||67
7798410|NCT01218438|19197387|P1|STARTED|Epoch 4||70
7798411|NCT01218438|19197387|P1|NOT COMPLETED|Epoch 3||4
7798412|NCT01218438|19197387|P1|COMPLETED|Epoch 3||70
7798413|NCT01218438|19197387|P1|STARTED|Epoch 3||74
7798414|NCT01218438|19197387|P1|NOT COMPLETED|Epoch 2||0
7798415|NCT01218438|19197387|P1|COMPLETED|Epoch 2||45
7798416|NCT01218438|19197387|P1|STARTED|Epoch 2||45
7798417|NCT01218438|19197387|P1|NOT COMPLETED|Epoch 1||3
7798418|NCT01218438|19197387|P1|COMPLETED|Epoch 1||74
7798419|NCT01218438|19197387|P1|STARTED|Epoch 1||77
7798420|NCT01218399|19197542|P2|NOT COMPLETED|Overall Study||0
7798421|NCT01218399|19197543|P1|NOT COMPLETED|Overall Study||0
7798422|NCT01218399|19197542|P2|COMPLETED|Overall Study||5
7798423|NCT01218399|19197543|P1|COMPLETED|Overall Study||5
7798424|NCT01218399|19197542|P2|STARTED|Overall Study||5
7798425|NCT01218399|19197543|P1|STARTED|Overall Study||5
7798426|NCT01218308|19197553|P2|NOT COMPLETED|Overall Study||120
7798427|NCT01218308|19197554|P1|NOT COMPLETED|Overall Study||103
7798428|NCT01218308|19197553|P2|COMPLETED|Overall Study||2464
7798429|NCT01218308|19197554|P1|COMPLETED|Overall Study||2481
7798430|NCT01218308|19197553|P2|STARTED|Overall Study||2584
7798431|NCT01218308|19197554|P1|STARTED|Overall Study||2584
7798432|NCT01218243|19197598|P2|NOT COMPLETED|Overall Study||14
7798433|NCT01218243|19197599|P1|NOT COMPLETED|Overall Study||9
7798434|NCT01218243|19197598|P2|COMPLETED|Overall Study||36
7798435|NCT01218243|19197599|P1|COMPLETED|Overall Study||41
7798436|NCT01218243|19197598|P2|Treatment Completed|Overall Study||42
7798437|NCT01218243|19197599|P1|Treatment Completed|Overall Study||45
7798438|NCT01218243|19197598|P2|STARTED|Overall Study||50
7798439|NCT01218243|19197599|P1|STARTED|Overall Study||50
7798440|NCT01218204|19197615|P4|NOT COMPLETED|Part B Pooled Treatment Arm||3
7798441|NCT01218204|19197616|P3|NOT COMPLETED|Part B Pooled Treatment Arm||0
7798442|NCT01218204|19197617|P2|NOT COMPLETED|Part B Pooled Treatment Arm||0
7798443|NCT01218204|19197618|P1|NOT COMPLETED|Part B Pooled Treatment Arm||0
7798444|NCT01218204|19197615|P4|COMPLETED|Part B Pooled Treatment Arm||127
7798445|NCT01218204|19197616|P3|COMPLETED|Part B Pooled Treatment Arm||0
7798446|NCT01218204|19197617|P2|COMPLETED|Part B Pooled Treatment Arm||0
7798447|NCT01218204|19197618|P1|COMPLETED|Part B Pooled Treatment Arm||0
7798448|NCT01218204|19197615|P4|STARTED|Part B Pooled Treatment Arm||130
7798449|NCT01218204|19197616|P3|STARTED|Part B Pooled Treatment Arm||0
7798450|NCT01218204|19197617|P2|STARTED|Part B Pooled Treatment Arm||0
7798451|NCT01218204|19197618|P1|STARTED|Part B Pooled Treatment Arm||0
7798452|NCT01218204|19197615|P4|NOT COMPLETED|Part B Run-in||0
7798453|NCT01218204|19197616|P3|NOT COMPLETED|Part B Run-in||6
7798454|NCT01218204|19197617|P2|NOT COMPLETED|Part B Run-in||0
7798455|NCT01218204|19197618|P1|NOT COMPLETED|Part B Run-in||0
7798456|NCT01218204|19197615|P4|COMPLETED|Part B Run-in||0
7798457|NCT01218204|19197616|P3|COMPLETED|Part B Run-in||83
7798458|NCT01218204|19197617|P2|COMPLETED|Part B Run-in||0
7798459|NCT01218204|19197618|P1|COMPLETED|Part B Run-in||0
7798460|NCT01218204|19197615|P4|STARTED|Part B Run-in||0
7798461|NCT01218204|19197616|P3|STARTED|Part B Run-in||89
7798462|NCT01218204|19197617|P2|STARTED|Part B Run-in||0
7798463|NCT01218204|19197618|P1|STARTED|Part B Run-in||0
7798464|NCT01218204|19197615|P4|NOT COMPLETED|Part B Washout||0
7798465|NCT01218204|19197616|P3|NOT COMPLETED|Part B Washout||0
7798466|NCT01218204|19197617|P2|NOT COMPLETED|Part B Washout||145
7798467|NCT01218204|19197618|P1|NOT COMPLETED|Part B Washout||0
7798468|NCT01218204|19197615|P4|COMPLETED|Part B Washout||0
7798469|NCT01218204|19197616|P3|COMPLETED|Part B Washout||0
7798470|NCT01218204|19197617|P2|COMPLETED|Part B Washout||136
7798471|NCT01218204|19197618|P1|COMPLETED|Part B Washout||0
7798472|NCT01218204|19197615|P4|STARTED|Part B Washout||0
7798473|NCT01218204|19197616|P3|STARTED|Part B Washout||0
7798474|NCT01218204|19197617|P2|STARTED|Part B Washout||281
7798475|NCT01218204|19197618|P1|STARTED|Part B Washout||0
7798476|NCT01218204|19197615|P4|NOT COMPLETED|Part A||0
7798477|NCT01218204|19197616|P3|NOT COMPLETED|Part A||0
7798478|NCT01218204|19197617|P2|NOT COMPLETED|Part A||0
7798479|NCT01218204|19197618|P1|NOT COMPLETED|Part A||0
7798480|NCT01218204|19197615|P4|COMPLETED|Part A||0
7798481|NCT01218204|19197616|P3|COMPLETED|Part A||0
7798482|NCT01218204|19197617|P2|COMPLETED|Part A||0
7798483|NCT01218204|19197618|P1|COMPLETED|Part A||6
7798484|NCT01218204|19197615|P4|STARTED|Part A||0
7798485|NCT01218204|19197616|P3|STARTED|Part A||0
7798486|NCT01218204|19197617|P2|STARTED|Part A||0
7798487|NCT01218204|19197618|P1|STARTED|Part A||6
7798488|NCT01218126|19197882|P4|NOT COMPLETED|Overall Study||35
7798489|NCT01218126|19197883|P3|NOT COMPLETED|Overall Study||24
7798490|NCT01218126|19197884|P2|NOT COMPLETED|Overall Study||22
7798491|NCT01218126|19197885|P1|NOT COMPLETED|Overall Study||24
7798492|NCT01218126|19197882|P4|COMPLETED|Overall Study||114
7798493|NCT01218126|19197883|P3|COMPLETED|Overall Study||127
7798494|NCT01218126|19197884|P2|COMPLETED|Overall Study||127
7798495|NCT01218126|19197885|P1|COMPLETED|Overall Study||129
7798496|NCT01218126|19197882|P4|STARTED|Overall Study||149
7798497|NCT01218126|19197883|P3|STARTED|Overall Study||151
7798498|NCT01218126|19197884|P2|STARTED|Overall Study||149
7798499|NCT01218126|19197885|P1|STARTED|Overall Study||153
7798500|NCT01218113|19197926|P3|NOT COMPLETED|Overall Study||6
7798501|NCT01218113|19197927|P2|NOT COMPLETED|Overall Study||1
7798502|NCT01218113|19197928|P1|NOT COMPLETED|Overall Study||5
7798503|NCT01218113|19197926|P3|COMPLETED|Overall Study||58
7798504|NCT01218113|19197927|P2|COMPLETED|Overall Study||63
7798505|NCT01218113|19197928|P1|COMPLETED|Overall Study||57
7798506|NCT01218113|19197926|P3|STARTED|Overall Study||64
7798507|NCT01218113|19197927|P2|STARTED|Overall Study||64
7798508|NCT01218113|19197928|P1|STARTED|Overall Study||62
7798509|NCT01218100|19198109|P4|NOT COMPLETED|Overall Study||34
7798510|NCT01218100|19198110|P3|NOT COMPLETED|Overall Study||27
7798511|NCT01218100|19198111|P2|NOT COMPLETED|Overall Study||25
7798512|NCT01218100|19198112|P1|NOT COMPLETED|Overall Study||24
7798513|NCT01218100|19198109|P4|COMPLETED|Overall Study||156
7798514|NCT01218100|19198110|P3|COMPLETED|Overall Study||162
7798515|NCT01218100|19198111|P2|COMPLETED|Overall Study||165
7798516|NCT01218100|19198112|P1|COMPLETED|Overall Study||71
7798517|NCT01218100|19198109|P4|STARTED|Overall Study||190
7798518|NCT01218100|19198110|P3|STARTED|Overall Study||189
7798519|NCT01218100|19198111|P2|STARTED|Overall Study||190
7798520|NCT01218100|19198112|P1|STARTED|Overall Study||95
7798521|NCT01218087|19198128|P2|NOT COMPLETED|Overall Study||6
7798522|NCT01218087|19198129|P1|NOT COMPLETED|Overall Study||15
7798523|NCT01218087|19198128|P2|COMPLETED|Overall Study||35
7798524|NCT01218087|19198129|P1|COMPLETED|Overall Study||27
7798525|NCT01218087|19198128|P2|STARTED|Overall Study||41
7798526|NCT01218087|19198129|P1|STARTED|Overall Study||42
7798527|NCT01218048|19198137|P1|NOT COMPLETED|Overall Study||0
7798528|NCT01218048|19198137|P1|COMPLETED|Overall Study||40
7798529|NCT01218048|19198137|P1|STARTED|Overall Study||40
7798530|NCT01218009|19198151|P2|NOT COMPLETED|Overall Study||165
7798531|NCT01218009|19198152|P1|NOT COMPLETED|Overall Study||166
7798532|NCT01218009|19198151|P2|COMPLETED|Overall Study||0
7798533|NCT01218009|19198152|P1|COMPLETED|Overall Study||0
7798534|NCT01218009|19198151|P2|STARTED|Overall Study||165
7798535|NCT01218009|19198152|P1|STARTED|Overall Study||166
7798536|NCT01217957|19198175|P5|NOT COMPLETED|Phase 2||1
7798537|NCT01217957|19198176|P4|NOT COMPLETED|Phase 2||0
7798538|NCT01217957|19198177|P3|NOT COMPLETED|Phase 2||0
7798539|NCT01217957|19198178|P2|NOT COMPLETED|Phase 2||0
7798540|NCT01217957|19198179|P1|NOT COMPLETED|Phase 2||0
7798541|NCT01217957|19198175|P5|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49
7798542|NCT01217957|19198176|P4|COMPLETED|Phase 2||0
7798543|NCT01217957|19198177|P3|COMPLETED|Phase 2||0
7798544|NCT01217957|19198178|P2|COMPLETED|Phase 2||0
7798545|NCT01217957|19198179|P1|COMPLETED|Phase 2||0
7798546|NCT01217957|19198175|P5|STARTED|Phase 2||50
7798547|NCT01217957|19198176|P4|STARTED|Phase 2||0
7798548|NCT01217957|19198177|P3|STARTED|Phase 2||0
7798549|NCT01217957|19198178|P2|STARTED|Phase 2||0
7798550|NCT01217957|19198179|P1|STARTED|Phase 2||0
7798551|NCT01217957|19198175|P5|NOT COMPLETED|Phase 1||0
7798552|NCT01217957|19198176|P4|NOT COMPLETED|Phase 1||1
7798553|NCT01217957|19198177|P3|NOT COMPLETED|Phase 1||1
7798554|NCT01217957|19198178|P2|NOT COMPLETED|Phase 1||0
7798555|NCT01217957|19198179|P1|NOT COMPLETED|Phase 1||1
7798556|NCT01217957|19198175|P5|COMPLETED|Phase 1||0
7798557|NCT01217957|19198176|P4|COMPLETED|Phase 1||2
7798558|NCT01217957|19198177|P3|COMPLETED|Phase 1||5
7798559|NCT01217957|19198178|P2|COMPLETED|Phase 1||3
7798560|NCT01217957|19198179|P1|COMPLETED|Phase 1||2
7798561|NCT01217957|19198175|P5|STARTED|Phase 1||0
7798562|NCT01217957|19198176|P4|STARTED|Phase 1||3
7798563|NCT01217957|19198177|P3|STARTED|Phase 1||6
7798564|NCT01217957|19198178|P2|STARTED|Phase 1||3
7798565|NCT01217957|19198179|P1|STARTED|Phase 1||3
7798566|NCT01217944|19198238|P3|NOT COMPLETED|Overall Study||0
7798567|NCT01217944|19198239|P2|NOT COMPLETED|Overall Study||4
7798568|NCT01217944|19198240|P1|NOT COMPLETED|Overall Study||6
7798569|NCT01217944|19198238|P3|COMPLETED|Overall Study||55
7798570|NCT01217944|19198239|P2|COMPLETED|Overall Study||112
7798571|NCT01217944|19198240|P1|COMPLETED|Overall Study||100
7798572|NCT01217944|19198238|P3|Completed 6 Months|Overall Study||55
7798573|NCT01217944|19198239|P2|Completed 6 Months|Overall Study||116
7798574|NCT01217944|19198240|P1|Completed 6 Months|Overall Study||103
7798575|NCT01217944|19198238|P3|Completed 3 Months|Overall Study||55
7798576|NCT01217944|19198239|P2|Completed 3 Months|Overall Study||116
7798577|NCT01217944|19198240|P1|Completed 3 Months|Overall Study||105
7798578|NCT01217944|19198238|P3|STARTED|Overall Study||55
7798579|NCT01217944|19198239|P2|STARTED|Overall Study||116
7798580|NCT01217944|19198240|P1|STARTED|Overall Study||106
7798581|NCT01217892|19198283|P4|NOT COMPLETED|Overall Study||8
7798582|NCT01217892|19198284|P3|NOT COMPLETED|Overall Study||9
7798583|NCT01217892|19198285|P2|NOT COMPLETED|Overall Study||6
7798584|NCT01217892|19198286|P1|NOT COMPLETED|Overall Study||7
7798585|NCT01217892|19198283|P4|COMPLETED|Overall Study||93
7798586|NCT01217892|19198284|P3|COMPLETED|Overall Study||90
7798587|NCT01217892|19198285|P2|COMPLETED|Overall Study||94
7798588|NCT01217892|19198286|P1|COMPLETED|Overall Study||93
7798589|NCT01217892|19198283|P4|STARTED|Overall Study||101
7798590|NCT01217892|19198284|P3|STARTED|Overall Study||99
7798591|NCT01217892|19198285|P2|STARTED|Overall Study||100
7798592|NCT01217892|19198286|P1|STARTED|Overall Study||100
7798593|NCT01217840|19198314|P2|NOT COMPLETED|Overall Study||3
7798594|NCT01217840|19198315|P1|NOT COMPLETED|Overall Study||6
7798595|NCT01217840|19198314|P2|COMPLETED|Overall Study||17
7798596|NCT01217840|19198315|P1|COMPLETED|Overall Study||14
7798597|NCT01217840|19198314|P2|STARTED|Overall Study||20
7798598|NCT01217840|19198315|P1|STARTED|Overall Study||20
7798599|NCT01217827|19198339|P2|NOT COMPLETED|Overall Study||0
7798600|NCT01217827|19198340|P1|NOT COMPLETED|Overall Study||0
7798601|NCT01217827|19198339|P2|COMPLETED|Overall Study||43
7798602|NCT01217827|19198340|P1|COMPLETED|Overall Study||46
7798603|NCT01217827|19198339|P2|STARTED|Overall Study||43
7798604|NCT01217827|19198340|P1|STARTED|Overall Study||46
7798605|NCT01217814|19198349|P3|NOT COMPLETED|Overall Study||1
7798606|NCT01217814|19198350|P2|NOT COMPLETED|Overall Study||1
7798607|NCT01217814|19198351|P1|NOT COMPLETED|Overall Study||1
7798608|NCT01217814|19198349|P3|COMPLETED|Overall Study||6
7798609|NCT01217814|19198350|P2|COMPLETED|Overall Study||4
7798610|NCT01217814|19198351|P1|COMPLETED|Overall Study||3
7798611|NCT01217814|19198349|P3|STARTED|Overall Study||7
7798612|NCT01217814|19198350|P2|STARTED|Overall Study||5
7798613|NCT01217814|19198351|P1|STARTED|Overall Study||4
7798614|NCT01217801|19198377|P2|NOT COMPLETED|Period 2||0
7798615|NCT01217801|19198378|P1|NOT COMPLETED|Period 2||0
7798616|NCT01217801|19198377|P2|COMPLETED|Period 2||22
7798617|NCT01217801|19198378|P1|COMPLETED|Period 2||23
7798618|NCT01217801|19198377|P2|STARTED|Period 2||22
7798619|NCT01217801|19198378|P1|STARTED|Period 2||23
7798620|NCT01217801|19198377|P2|NOT COMPLETED|Period 1||2
7798621|NCT01217801|19198378|P1|NOT COMPLETED|Period 1||1
7798622|NCT01217801|19198377|P2|COMPLETED|Period 1||22
7798623|NCT01217801|19198378|P1|COMPLETED|Period 1||23
7798624|NCT01217801|19198377|P2|STARTED|Period 1||24
7798625|NCT01217801|19198378|P1|STARTED|Period 1||24
7798626|NCT01217749|19198387|P3|NOT COMPLETED|Overall Study||2
7798627|NCT01217749|19198388|P2|NOT COMPLETED|Overall Study||3
7798628|NCT01217749|19198389|P1|NOT COMPLETED|Overall Study||3
7798629|NCT01217749|19198387|P3|COMPLETED|Overall Study||22
7798630|NCT01217749|19198388|P2|COMPLETED|Overall Study||17
7798631|NCT01217749|19198389|P1|COMPLETED|Overall Study||24
7798632|NCT01217749|19198387|P3|STARTED|Overall Study||24
7798633|NCT01217749|19198388|P2|STARTED|Overall Study||20
7798634|NCT01217749|19198389|P1|STARTED|Overall Study||27
7798635|NCT01217606|19198407|P2|NOT COMPLETED|9-Month Masked Extension||11
7798636|NCT01217606|19198408|P1|NOT COMPLETED|9-Month Masked Extension||13
7798637|NCT01217606|19198407|P2|COMPLETED|9-Month Masked Extension||62
7798638|NCT01217606|19198408|P1|COMPLETED|9-Month Masked Extension||54
7798639|NCT01217606|19198407|P2|Not Enrolled in Masked Extension|9-Month Masked Extension||10
7798640|NCT01217606|19198408|P1|Not Enrolled in Masked Extension|9-Month Masked Extension||9
7798641|NCT01217606|19198407|P2|STARTED|9-Month Masked Extension||73
7798642|NCT01217606|19198408|P1|STARTED|9-Month Masked Extension||67
7798643|NCT01217606|19198407|P2|NOT COMPLETED|Initial Treatment Phase||12
7798644|NCT01217606|19198408|P1|NOT COMPLETED|Initial Treatment Phase||14
7798645|NCT01217606|19198407|P2|COMPLETED|Initial Treatment Phase||83
7798646|NCT01217606|19198408|P1|COMPLETED|Initial Treatment Phase||76
7798647|NCT01217606|19198407|P2|STARTED|Initial Treatment Phase||95
7798648|NCT01217606|19198408|P1|STARTED|Initial Treatment Phase||90
7798649|NCT01217515|19198421|P3|NOT COMPLETED|Overall Study||10
7798650|NCT01217515|19198422|P2|NOT COMPLETED|Overall Study||8
7798651|NCT01217515|19198423|P1|NOT COMPLETED|Overall Study||7
7798652|NCT01217515|19198421|P3|COMPLETED|Overall Study||145
7798653|NCT01217515|19198422|P2|COMPLETED|Overall Study||148
7798654|NCT01217515|19198423|P1|COMPLETED|Overall Study||147
7798655|NCT01217515|19198421|P3|STARTED|Overall Study||155
7798656|NCT01217515|19198422|P2|STARTED|Overall Study||156
7798657|NCT01217515|19198423|P1|STARTED|Overall Study||154
7798658|NCT01217476|19198439|P2|NOT COMPLETED|Overall Study||7
7798659|NCT01217476|19198440|P1|NOT COMPLETED|Overall Study||12
7798660|NCT01217476|19198439|P2|COMPLETED|Overall Study||95
7798661|NCT01217476|19198440|P1|COMPLETED|Overall Study||93
7798662|NCT01217476|19198439|P2|STARTED|Overall Study||102
7798663|NCT01217476|19198440|P1|STARTED|Overall Study||105
7798664|NCT01217463|19198450|P2|NOT COMPLETED|Overall Study||8
7798665|NCT01217463|19198451|P1|NOT COMPLETED|Overall Study||13
7798666|NCT01217463|19198450|P2|COMPLETED|Overall Study||94
7798667|NCT01217463|19198451|P1|COMPLETED|Overall Study||86
7798668|NCT01217463|19198450|P2|STARTED|Overall Study||102
7798669|NCT01217463|19198451|P1|STARTED|Overall Study||99
7798670|NCT01217437|19198461|P2|NOT COMPLETED|Overall Study||41
7798671|NCT01217437|19198462|P1|NOT COMPLETED|Overall Study||43
7798672|NCT01217437|19198461|P2|COMPLETED|Overall Study||12
7798673|NCT01217437|19198462|P1|COMPLETED|Overall Study||12
7798674|NCT01217437|19198461|P2|STARTED|Overall Study||53
7798675|NCT01217437|19198462|P1|STARTED|Overall Study||55
7798676|NCT01217411|19198474|P2|NOT COMPLETED|Overall Study||2
7798677|NCT01217411|19198475|P1|NOT COMPLETED|Overall Study||3
7798678|NCT01217411|19198474|P2|COMPLETED|Overall Study||0
7798679|NCT01217411|19198475|P1|COMPLETED|Overall Study||0
7798680|NCT01217411|19198474|P2|20mg|Overall Study||0
7798681|NCT01217411|19198475|P1|20mg|Overall Study||0
7798682|NCT01217411|19198474|P2|10mg|Overall Study||0
7798683|NCT01217411|19198475|P1|10mg|Overall Study||0
7798684|NCT01217411|19198474|P2|5mg|Overall Study||2
7798685|NCT01217411|19198475|P1|5mg|Overall Study||3
7798686|NCT01217411|19198474|P2|STARTED|Overall Study||2
7798687|NCT01217411|19198475|P1|STARTED|Overall Study||3
7798688|NCT01217385|19198483|P1|NOT COMPLETED|Overall Study||26
7798689|NCT01217385|19198483|P1|COMPLETED|Overall Study||34
7798690|NCT01217385|19198483|P1|STARTED|Overall Study||60
7798691|NCT01217307|19198495|P2|NOT COMPLETED|Overall Study||1
7798692|NCT01217307|19198496|P1|NOT COMPLETED|Overall Study||0
7798693|NCT01217307|19198495|P2|COMPLETED|Overall Study||188
7798694|NCT01217307|19198496|P1|COMPLETED|Overall Study||191
7798695|NCT01217307|19198495|P2|STARTED|Overall Study||189
7798696|NCT01217307|19198496|P1|STARTED|Overall Study||191
7798697|NCT01217229|19198502|P1|NOT COMPLETED|Overall Study||20
7798698|NCT01217229|19198502|P1|COMPLETED|Overall Study||0
7798699|NCT01217229|19198502|P1|STARTED|Overall Study||20
7798700|NCT01217190|19198511|P2|NOT COMPLETED|Second Dosing||2
7798701|NCT01217190|19198512|P1|NOT COMPLETED|Second Dosing||0
7798702|NCT01217190|19198511|P2|COMPLETED|Second Dosing|Two subjects withdrew for personal reasons (other than adverse event).|22
7798703|NCT01217190|19198512|P1|COMPLETED|Second Dosing||24
7798704|NCT01217190|19198511|P2|STARTED|Second Dosing||24
7798705|NCT01217190|19198512|P1|STARTED|Second Dosing||24
7798706|NCT01217190|19198511|P2|NOT COMPLETED|First Dosing||0
7798707|NCT01217190|19198512|P1|NOT COMPLETED|First Dosing||0
7798708|NCT01217190|19198511|P2|COMPLETED|First Dosing||24
7798709|NCT01217190|19198512|P1|COMPLETED|First Dosing||24
7798710|NCT01217190|19198511|P2|STARTED|First Dosing||24
7798711|NCT01217190|19198512|P1|STARTED|First Dosing||24
7798712|NCT01217112|19198527|P5|NOT COMPLETED|Overall Study||1
7798713|NCT01217112|19198528|P4|NOT COMPLETED|Overall Study||2
7798714|NCT01217112|19198529|P3|NOT COMPLETED|Overall Study||1
7798715|NCT01217112|19198530|P2|NOT COMPLETED|Overall Study||2
7798716|NCT01217112|19198531|P1|NOT COMPLETED|Overall Study||0
7798717|NCT01217112|19198527|P5|COMPLETED|Overall Study||13
7798718|NCT01217112|19198528|P4|COMPLETED|Overall Study||10
7798719|NCT01217112|19198529|P3|COMPLETED|Overall Study||12
7798720|NCT01217112|19198530|P2|COMPLETED|Overall Study||10
7798721|NCT01217112|19198531|P1|COMPLETED|Overall Study||11
7798722|NCT01217112|19198527|P5|STARTED|Overall Study||14
7798723|NCT01217112|19198528|P4|STARTED|Overall Study||12
7798724|NCT01217112|19198529|P3|STARTED|Overall Study||13
7798725|NCT01217112|19198530|P2|STARTED|Overall Study||12
7798726|NCT01217112|19198531|P1|STARTED|Overall Study||11
7798727|NCT01217073|19198764|P8|NOT COMPLETED|Extension Period||20
7798728|NCT01217073|19198765|P7|NOT COMPLETED|Extension Period||91
7798729|NCT01217073|19198766|P6|NOT COMPLETED|Extension Period||0
7798730|NCT01217073|19198767|P5|NOT COMPLETED|Extension Period||0
7798731|NCT01217073|19198768|P4|NOT COMPLETED|Extension Period||0
7798732|NCT01217073|19198769|P3|NOT COMPLETED|Extension Period||0
7798733|NCT01217073|19198770|P2|NOT COMPLETED|Extension Period||0
7798734|NCT01217073|19198771|P1|NOT COMPLETED|Extension Period||0
7798735|NCT01217073|19198764|P8|COMPLETED|Extension Period||60
7798736|NCT01217073|19198765|P7|COMPLETED|Extension Period||314
7798737|NCT01217073|19198766|P6|COMPLETED|Extension Period||0
7798738|NCT01217073|19198767|P5|COMPLETED|Extension Period||0
7798739|NCT01217073|19198768|P4|COMPLETED|Extension Period||0
7798740|NCT01217073|19198769|P3|COMPLETED|Extension Period||0
7798741|NCT01217073|19198770|P2|COMPLETED|Extension Period||0
7798742|NCT01217073|19198771|P1|COMPLETED|Extension Period||0
7798743|NCT01217073|19198764|P8|STARTED|Extension Period||80
7798744|NCT01217073|19198765|P7|STARTED|Extension Period||405
7798745|NCT01217073|19198766|P6|STARTED|Extension Period||0
7798746|NCT01217073|19198767|P5|STARTED|Extension Period||0
7798747|NCT01217073|19198768|P4|STARTED|Extension Period||0
7798748|NCT01217073|19198769|P3|STARTED|Extension Period||0
7798749|NCT01217073|19198770|P2|STARTED|Extension Period||0
7798750|NCT01217073|19198771|P1|STARTED|Extension Period||0
7798751|NCT01217073|19198764|P8|NOT COMPLETED|Base Period||0
7798752|NCT01217073|19198765|P7|NOT COMPLETED|Base Period||0
7798753|NCT01217073|19198766|P6|NOT COMPLETED|Base Period||9
7798754|NCT01217073|19198767|P5|NOT COMPLETED|Base Period||15
7798755|NCT01217073|19198768|P4|NOT COMPLETED|Base Period||2
7798756|NCT01217073|19198769|P3|NOT COMPLETED|Base Period||7
7798757|NCT01217073|19198770|P2|NOT COMPLETED|Base Period||5
7798758|NCT01217073|19198771|P1|NOT COMPLETED|Base Period||7
7798759|NCT01217073|19198764|P8|COMPLETED|Base Period||0
7798760|NCT01217073|19198765|P7|COMPLETED|Base Period||0
7798761|NCT01217073|19198766|P6|COMPLETED|Base Period||105
7798762|NCT01217073|19198767|P5|COMPLETED|Base Period||99
7798763|NCT01217073|19198768|P4|COMPLETED|Base Period||113
7798764|NCT01217073|19198769|P3|COMPLETED|Base Period||107
7798765|NCT01217073|19198770|P2|COMPLETED|Base Period||110
7798766|NCT01217073|19198771|P1|COMPLETED|Base Period||106
7798767|NCT01217073|19198764|P8|STARTED|Base Period||0
7798768|NCT01217073|19198765|P7|STARTED|Base Period||0
7798769|NCT01217073|19198766|P6|STARTED|Base Period||114
7798770|NCT01217073|19198767|P5|STARTED|Base Period||114
7798771|NCT01217073|19198768|P4|STARTED|Base Period||115
7798772|NCT01217073|19198769|P3|STARTED|Base Period||114
7798773|NCT01217073|19198770|P2|STARTED|Base Period||115
7798774|NCT01217073|19198771|P1|STARTED|Base Period||113
7798775|NCT01216943|19198839|P1|NOT COMPLETED|Overall Study||13
7798776|NCT01216943|19198839|P1|COMPLETED|Overall Study||113
7798777|NCT01216943|19198839|P1|STARTED|Overall Study||126
7798778|NCT01216761|19198843|P3|NOT COMPLETED|Overall Study||0
7798779|NCT01216761|19198844|P2|NOT COMPLETED|Overall Study||0
7798780|NCT01216761|19198845|P1|NOT COMPLETED|Overall Study||0
7798781|NCT01216761|19198843|P3|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
7798782|NCT01216761|19198844|P2|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
7798783|NCT01216761|19198845|P1|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
7798784|NCT01216761|19198843|P3|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
7798785|NCT01216761|19198844|P2|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
7798786|NCT01216761|19198845|P1|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
7798787|NCT01216748|19198853|P1|NOT COMPLETED|Overall Study||0
7798788|NCT01216748|19198853|P1|COMPLETED|Overall Study||10
7798789|NCT01216748|19198853|P1|Eucapnic Hyperventilation|Overall Study||10
7798790|NCT01216748|19198853|P1|Hypercapnic Hyperventilation|Overall Study||10
7798791|NCT01216748|19198853|P1|Hypocapnic Hyperventilation|Overall Study||10
7798792|NCT01216748|19198853|P1|Quiet Breathing|Overall Study||10
7798793|NCT01216748|19198853|P1|STARTED|Overall Study||10
7798794|NCT01216735|19198860|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
7798795|NCT01216735|19198861|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
7798796|NCT01216735|19198860|P2|COMPLETED|Second Intervention (3 Weeks)||7
7798797|NCT01216735|19198861|P1|COMPLETED|Second Intervention (3 Weeks)||8
7798798|NCT01216735|19198860|P2|STARTED|Second Intervention (3 Weeks)||7
7798799|NCT01216735|19198861|P1|STARTED|Second Intervention (3 Weeks)||8
7798800|NCT01216735|19198860|P2|NOT COMPLETED|Washout (3 Weeks)||0
7798801|NCT01216735|19198861|P1|NOT COMPLETED|Washout (3 Weeks)||0
7798802|NCT01216735|19198860|P2|COMPLETED|Washout (3 Weeks)||7
7798803|NCT01216735|19198861|P1|COMPLETED|Washout (3 Weeks)||8
7798804|NCT01216735|19198860|P2|STARTED|Washout (3 Weeks)||7
7798805|NCT01216735|19198861|P1|STARTED|Washout (3 Weeks)||8
7798806|NCT01216735|19198860|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
7798807|NCT01216735|19198861|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
7798808|NCT01216735|19198860|P2|COMPLETED|First Intervention (3 Weeks)||7
7798809|NCT01216735|19198861|P1|COMPLETED|First Intervention (3 Weeks)||8
7798810|NCT01216735|19198860|P2|STARTED|First Intervention (3 Weeks)||7
7798811|NCT01216735|19198861|P1|STARTED|First Intervention (3 Weeks)||8
7798812|NCT01216631|19198872|P3|NOT COMPLETED|Overall Study||0
7798813|NCT01216631|19198873|P2|NOT COMPLETED|Overall Study||0
7798814|NCT01216631|19198874|P1|NOT COMPLETED|Overall Study||0
7798815|NCT01216631|19198872|P3|COMPLETED|Overall Study||1
7798816|NCT01216631|19198873|P2|COMPLETED|Overall Study||0
7798817|NCT01216631|19198874|P1|COMPLETED|Overall Study||0
7798818|NCT01216631|19198872|P3|STARTED|Overall Study||1
7798819|NCT01216631|19198873|P2|STARTED|Overall Study||0
7798820|NCT01216631|19198874|P1|STARTED|Overall Study||0
7798821|NCT01216410|19198885|P3|NOT COMPLETED|Overall Study||3
7798822|NCT01216410|19198886|P2|NOT COMPLETED|Overall Study||1
7798823|NCT01216410|19198887|P1|NOT COMPLETED|Overall Study||2
7798824|NCT01216410|19198885|P3|COMPLETED|Overall Study||100
7798825|NCT01216410|19198886|P2|COMPLETED|Overall Study||99
7798826|NCT01216410|19198887|P1|COMPLETED|Overall Study||101
7798827|NCT01216410|19198885|P3|STARTED|Overall Study||103
7798828|NCT01216410|19198886|P2|STARTED|Overall Study||100
7798829|NCT01216410|19198887|P1|STARTED|Overall Study||103
7798830|NCT01216397|19198907|P2|NOT COMPLETED|Period 2||0
7798831|NCT01216397|19198908|P1|NOT COMPLETED|Period 2||0
7798832|NCT01216397|19198907|P2|COMPLETED|Period 2||20
7798833|NCT01216397|19198908|P1|COMPLETED|Period 2||20
7798834|NCT01216397|19198907|P2|STARTED|Period 2||20
7798835|NCT01216397|19198908|P1|STARTED|Period 2||20
7798836|NCT01216397|19198907|P2|NOT COMPLETED|Washout (35 Days)||0
7798837|NCT01216397|19198908|P1|NOT COMPLETED|Washout (35 Days)||0
7798838|NCT01216397|19198907|P2|COMPLETED|Washout (35 Days)||20
7798839|NCT01216397|19198908|P1|COMPLETED|Washout (35 Days)||20
7798840|NCT01216397|19198907|P2|STARTED|Washout (35 Days)||20
7798841|NCT01216397|19198908|P1|STARTED|Washout (35 Days)||20
7798842|NCT01216397|19198907|P2|NOT COMPLETED|Period 1||0
7798843|NCT01216397|19198908|P1|NOT COMPLETED|Period 1||0
7798844|NCT01216397|19198907|P2|COMPLETED|Period 1||20
7798845|NCT01216397|19198908|P1|COMPLETED|Period 1||20
7798846|NCT01216397|19198907|P2|STARTED|Period 1||20
7798847|NCT01216397|19198908|P1|STARTED|Period 1||20
7798848|NCT01216332|19198962|P2|NOT COMPLETED|Overall Study||0
7798849|NCT01216332|19198963|P1|NOT COMPLETED|Overall Study||4
7798850|NCT01216332|19198962|P2|COMPLETED|Overall Study||16
7798851|NCT01216332|19198963|P1|COMPLETED|Overall Study||30
7798852|NCT01216332|19198962|P2|STARTED|Overall Study||16
7798853|NCT01216332|19198963|P1|STARTED|Overall Study||34
7798854|NCT01216319|19198981|P1|NOT COMPLETED|Overall Study||4
7798855|NCT01216319|19198981|P1|COMPLETED|Overall Study||46
7798856|NCT01216319|19198981|P1|STARTED|Overall Study||50
7798857|NCT01216241|19198988|P2|NOT COMPLETED|Overall Study||0
7798858|NCT01216241|19198989|P1|NOT COMPLETED|Overall Study||0
7798859|NCT01216241|19198988|P2|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
7798860|NCT01216241|19198989|P1|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
7798861|NCT01216241|19198988|P2|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
7798862|NCT01216241|19198989|P1|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
7798863|NCT01216176|19198998|P3|NOT COMPLETED|Overall Study||1
7798864|NCT01216176|19198999|P2|NOT COMPLETED|Overall Study||8
7798865|NCT01216176|19199000|P1|NOT COMPLETED|Overall Study||0
7798866|NCT01216176|19198998|P3|COMPLETED|Overall Study||19
7798867|NCT01216176|19198999|P2|COMPLETED|Overall Study||31
7798868|NCT01216176|19199000|P1|COMPLETED|Overall Study||12
7798869|NCT01216176|19198998|P3|STARTED|Overall Study||20
7798870|NCT01216176|19198999|P2|STARTED|Overall Study||39
7798871|NCT01216176|19199000|P1|STARTED|Overall Study||12
7798872|NCT01216163|19199023|P3|NOT COMPLETED|Overall Study||0
7798873|NCT01216163|19199024|P2|NOT COMPLETED|Overall Study||1
7798874|NCT01216163|19199025|P1|NOT COMPLETED|Overall Study||1
7798875|NCT01216163|19199023|P3|COMPLETED|Overall Study||85
7798876|NCT01216163|19199024|P2|COMPLETED|Overall Study||87
7798877|NCT01216163|19199025|P1|COMPLETED|Overall Study||44
7798878|NCT01216163|19199023|P3|STARTED|Overall Study||85
7798879|NCT01216163|19199024|P2|STARTED|Overall Study||88
7798880|NCT01216163|19199025|P1|STARTED|Overall Study||45
7798881|NCT01216072|19199077|P2|NOT COMPLETED|Open-Label Extension Period (3 Months)||14
7798882|NCT01216072|19199078|P1|NOT COMPLETED|Open-Label Extension Period (3 Months)||0
7798883|NCT01216072|19199077|P2|COMPLETED|Open-Label Extension Period (3 Months)||181
7798884|NCT01216072|19199078|P1|COMPLETED|Open-Label Extension Period (3 Months)||0
7798885|NCT01216072|19199077|P2|Safety Set|Open-Label Extension Period (3 Months)||193
7798886|NCT01216072|19199078|P1|Safety Set|Open-Label Extension Period (3 Months)||0
7798887|NCT01216072|19199077|P2|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195
7798888|NCT01216072|19199078|P1|STARTED|Open-Label Extension Period (3 Months)||0
7798889|NCT01216072|19199077|P2|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34
7798890|NCT01216072|19199078|P1|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76
7798891|NCT01216072|19199077|P2|COMPLETED|Open-Label Core Period ( 6 Months)||229
7798892|NCT01216072|19199078|P1|COMPLETED|Open-Label Core Period ( 6 Months)||714
7798893|NCT01216072|19199077|P2|Safety Set|Open-Label Core Period ( 6 Months)||245
7798894|NCT01216072|19199078|P1|Safety Set|Open-Label Core Period ( 6 Months)||783
7798895|NCT01216072|19199077|P2|Full Analysis Set|Open-Label Core Period ( 6 Months)||263
7798896|NCT01216072|19199078|P1|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789
7798897|NCT01216072|19199077|P2|STARTED|Open-Label Core Period ( 6 Months)||263
7798898|NCT01216072|19199078|P1|STARTED|Open-Label Core Period ( 6 Months)||790
7798899|NCT01215981|19199106|P2|NOT COMPLETED|Overall Study||1
7798900|NCT01215981|19199107|P1|NOT COMPLETED|Overall Study||2
7798901|NCT01215981|19199106|P2|COMPLETED|Overall Study||32
7798902|NCT01215981|19199107|P1|COMPLETED|Overall Study||33
7798903|NCT01215981|19199106|P2|STARTED|Overall Study||33
7798904|NCT01215981|19199107|P1|STARTED|Overall Study||35
7798905|NCT01215968|19199117|P2|NOT COMPLETED|Overall Study||7
7798906|NCT01215968|19199118|P1|NOT COMPLETED|Overall Study||2
7798907|NCT01215968|19199117|P2|COMPLETED|Overall Study||18
7798908|NCT01215968|19199118|P1|COMPLETED|Overall Study||11
7798909|NCT01215968|19199117|P2|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24
7798910|NCT01215968|19199118|P1|Received at Least 1 Dose of Study Drug|Overall Study||13
7798911|NCT01215968|19199117|P2|STARTED|Overall Study||25
7798912|NCT01215968|19199118|P1|STARTED|Overall Study||13
7798913|NCT01215955|19199138|P4|NOT COMPLETED|Overall Study||53
7798914|NCT01215955|19199139|P3|NOT COMPLETED|Overall Study||48
7798915|NCT01215955|19199140|P2|NOT COMPLETED|Overall Study||53
7798916|NCT01215955|19199141|P1|NOT COMPLETED|Overall Study||45
7798917|NCT01215955|19199138|P4|COMPLETED|Overall Study||241
7798918|NCT01215955|19199139|P3|COMPLETED|Overall Study||244
7798919|NCT01215955|19199140|P2|COMPLETED|Overall Study||210
7798920|NCT01215955|19199141|P1|COMPLETED|Overall Study||223
7798921|NCT01215955|19199138|P4|Received at Least 1 Dose of Study Drug|Overall Study||290
7798922|NCT01215955|19199139|P3|Received at Least 1 Dose of Study Drug|Overall Study||288
7798923|NCT01215955|19199140|P2|Received at Least 1 Dose of Study Drug|Overall Study||261
7798924|NCT01215955|19199141|P1|Received at Least 1 Dose of Study Drug|Overall Study||267
7798925|NCT01215955|19199138|P4|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294
7798926|NCT01215955|19199139|P3|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292
7798927|NCT01215955|19199140|P2|STARTED|Overall Study||263
7798928|NCT01215955|19199141|P1|STARTED|Overall Study||268
7798929|NCT01215942|19199209|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||146
7798930|NCT01215942|19199210|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||85
7798931|NCT01215942|19199209|P2|COMPLETED|Post-Treatment Follow-Up Period||445
7798932|NCT01215942|19199210|P1|COMPLETED|Post-Treatment Follow-Up Period||283
7798933|NCT01215942|19199209|P2|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|591
7798934|NCT01215942|19199210|P1|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|368
7798935|NCT01215942|19199209|P2|NOT COMPLETED|Treatment Period||672
7798936|NCT01215942|19199210|P1|NOT COMPLETED|Treatment Period||414
7798937|NCT01215942|19199209|P2|COMPLETED|Treatment Period||0
7798938|NCT01215942|19199210|P1|COMPLETED|Treatment Period||0
7798939|NCT01215942|19199209|P2|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|672
7798940|NCT01215942|19199210|P1|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|414
7798941|NCT01215929|19199327|P2|NOT COMPLETED|Overall Study||5
7798942|NCT01215929|19199328|P1|NOT COMPLETED|Overall Study||6
7798943|NCT01215929|19199327|P2|COMPLETED|Overall Study||12
7798944|NCT01215929|19199328|P1|COMPLETED|Overall Study||12
7798945|NCT01215929|19199327|P2|STARTED|Overall Study||17
7798946|NCT01215929|19199328|P1|STARTED|Overall Study||18
7798947|NCT01215916|19199343|P9|NOT COMPLETED|Overall Study||2
7798948|NCT01215916|19199344|P8|NOT COMPLETED|Overall Study||3
7798949|NCT01215916|19199345|P7|NOT COMPLETED|Overall Study||9
7798950|NCT01215916|19199346|P6|NOT COMPLETED|Overall Study||4
7798951|NCT01215916|19199347|P5|NOT COMPLETED|Overall Study||6
7798952|NCT01215916|19199348|P4|NOT COMPLETED|Overall Study||6
7798953|NCT01215916|19199349|P3|NOT COMPLETED|Overall Study||3
7798954|NCT01215916|19199350|P2|NOT COMPLETED|Overall Study||5
7798955|NCT01215916|19199351|P1|NOT COMPLETED|Overall Study||1
7798956|NCT01215916|19199343|P9|COMPLETED|Overall Study||0
7798957|NCT01215916|19199344|P8|COMPLETED|Overall Study||0
7798958|NCT01215916|19199345|P7|COMPLETED|Overall Study||0
7798959|NCT01215916|19199346|P6|COMPLETED|Overall Study||0
7798960|NCT01215916|19199347|P5|COMPLETED|Overall Study||0
7798961|NCT01215916|19199348|P4|COMPLETED|Overall Study||0
7798962|NCT01215916|19199349|P3|COMPLETED|Overall Study||0
7798963|NCT01215916|19199350|P2|COMPLETED|Overall Study||0
7798964|NCT01215916|19199351|P1|COMPLETED|Overall Study||0
7798965|NCT01215916|19199343|P9|Received at Least 1 Dose of Either Drug|Overall Study||2
7798966|NCT01215916|19199344|P8|Received at Least 1 Dose of Either Drug|Overall Study||3
7798967|NCT01215916|19199345|P7|Received at Least 1 Dose of Either Drug|Overall Study||9
7798968|NCT01215916|19199346|P6|Received at Least 1 Dose of Either Drug|Overall Study||4
7798969|NCT01215916|19199347|P5|Received at Least 1 Dose of Either Drug|Overall Study||6
7798970|NCT01215916|19199348|P4|Received at Least 1 Dose of Either Drug|Overall Study||6
7798971|NCT01215916|19199349|P3|Received at Least 1 Dose of Either Drug|Overall Study||3
7798972|NCT01215916|19199350|P2|Received at Least 1 Dose of Either Drug|Overall Study||5
7798973|NCT01215916|19199351|P1|Received at Least 1 Dose of Either Drug|Overall Study||1
7798974|NCT01215916|19199343|P9|STARTED|Overall Study||2
7798975|NCT01215916|19199344|P8|STARTED|Overall Study||3
7798976|NCT01215916|19199345|P7|STARTED|Overall Study||9
7798977|NCT01215916|19199346|P6|STARTED|Overall Study||4
7798978|NCT01215916|19199347|P5|STARTED|Overall Study||6
7798979|NCT01215916|19199348|P4|STARTED|Overall Study||6
7798980|NCT01215916|19199349|P3|STARTED|Overall Study||3
7798981|NCT01215916|19199350|P2|STARTED|Overall Study||5
7798982|NCT01215916|19199351|P1|STARTED|Overall Study||1
7798983|NCT01215851|19199385|P6|NOT COMPLETED|Follow up Period||1
7798984|NCT01215851|19199386|P5|NOT COMPLETED|Follow up Period||0
7798985|NCT01215851|19199387|P4|NOT COMPLETED|Follow up Period||0
7798986|NCT01215851|19199388|P3|NOT COMPLETED|Follow up Period||0
7798987|NCT01215851|19199389|P2|NOT COMPLETED|Follow up Period||0
7798988|NCT01215851|19199390|P1|NOT COMPLETED|Follow up Period||0
7798989|NCT01215851|19199385|P6|COMPLETED|Follow up Period||13
7798990|NCT01215851|19199386|P5|COMPLETED|Follow up Period||10
7798991|NCT01215851|19199387|P4|COMPLETED|Follow up Period||12
7798992|NCT01215851|19199388|P3|COMPLETED|Follow up Period||14
7798993|NCT01215851|19199389|P2|COMPLETED|Follow up Period||14
7798994|NCT01215851|19199390|P1|COMPLETED|Follow up Period||14
7798995|NCT01215851|19199385|P6|STARTED|Follow up Period||14
7798996|NCT01215851|19199386|P5|STARTED|Follow up Period||10
7798997|NCT01215851|19199387|P4|STARTED|Follow up Period||12
7798998|NCT01215851|19199388|P3|STARTED|Follow up Period||14
7798999|NCT01215851|19199389|P2|STARTED|Follow up Period||14
7799000|NCT01215851|19199390|P1|STARTED|Follow up Period||14
7799001|NCT01215851|19199385|P6|NOT COMPLETED|Treatment Period||1
7799002|NCT01215851|19199386|P5|NOT COMPLETED|Treatment Period||0
7799003|NCT01215851|19199387|P4|NOT COMPLETED|Treatment Period||3
7799004|NCT01215851|19199388|P3|NOT COMPLETED|Treatment Period||1
7799005|NCT01215851|19199389|P2|NOT COMPLETED|Treatment Period||1
7799006|NCT01215851|19199390|P1|NOT COMPLETED|Treatment Period||1
7799007|NCT01215851|19199385|P6|COMPLETED|Treatment Period||14
7799008|NCT01215851|19199386|P5|COMPLETED|Treatment Period||10
7799009|NCT01215851|19199387|P4|COMPLETED|Treatment Period||12
7799010|NCT01215851|19199388|P3|COMPLETED|Treatment Period||14
7799011|NCT01215851|19199389|P2|COMPLETED|Treatment Period||14
7799012|NCT01215851|19199390|P1|COMPLETED|Treatment Period||14
7799013|NCT01215851|19199385|P6|STARTED|Treatment Period||15
7799014|NCT01215851|19199386|P5|STARTED|Treatment Period||10
7799015|NCT01215851|19199387|P4|STARTED|Treatment Period||15
7799016|NCT01215851|19199388|P3|STARTED|Treatment Period||15
7799017|NCT01215851|19199389|P2|STARTED|Treatment Period||15
7799018|NCT01215851|19199390|P1|STARTED|Treatment Period||15
7799019|NCT01215786|19199431|P3|NOT COMPLETED|Overall Study||0
7799020|NCT01215786|19199432|P2|NOT COMPLETED|Overall Study||0
7799021|NCT01215786|19199433|P1|NOT COMPLETED|Overall Study||0
7799022|NCT01215786|19199431|P3|COMPLETED|Overall Study||10
7799023|NCT01215786|19199432|P2|COMPLETED|Overall Study||19
7799024|NCT01215786|19199433|P1|COMPLETED|Overall Study||21
7799025|NCT01215786|19199431|P3|STARTED|Overall Study||10
7799026|NCT01215786|19199432|P2|STARTED|Overall Study||19
7799027|NCT01215786|19199433|P1|STARTED|Overall Study||21
7799028|NCT01215734|19199449|P2|NOT COMPLETED|Overall Study||1
7799029|NCT01215734|19199450|P1|NOT COMPLETED|Overall Study||0
7799030|NCT01215734|19199449|P2|COMPLETED|Overall Study||14
7799031|NCT01215734|19199450|P1|COMPLETED|Overall Study||29
7799032|NCT01215734|19199449|P2|STARTED|Overall Study||15
7799033|NCT01215734|19199450|P1|STARTED|Overall Study||29
7799034|NCT01215721|19199458|P1|NOT COMPLETED|Overall Study||2
7799035|NCT01215721|19199458|P1|COMPLETED|Overall Study||38
7799036|NCT01215721|19199458|P1|STARTED|Overall Study||40
7799037|NCT01215695|19199464|P2|NOT COMPLETED|Overall Study||0
7799038|NCT01215695|19199465|P1|NOT COMPLETED|Overall Study||0
7799039|NCT01215695|19199464|P2|COMPLETED|Overall Study||70
7799040|NCT01215695|19199465|P1|COMPLETED|Overall Study||70
7799041|NCT01215695|19199464|P2|STARTED|Overall Study||70
7799042|NCT01215695|19199465|P1|STARTED|Overall Study||70
7799043|NCT01215643|19199484|P5|NOT COMPLETED|Overall Study||11
7799044|NCT01215643|19199485|P4|NOT COMPLETED|Overall Study||4
7799045|NCT01215643|19199486|P3|NOT COMPLETED|Overall Study||12
7799046|NCT01215643|19199487|P2|NOT COMPLETED|Overall Study||4
7799047|NCT01215643|19199488|P1|NOT COMPLETED|Overall Study||9
7799048|NCT01215643|19199484|P5|COMPLETED|Overall Study||29
7799049|NCT01215643|19199485|P4|COMPLETED|Overall Study||35
7799050|NCT01215643|19199486|P3|COMPLETED|Overall Study||82
7799051|NCT01215643|19199487|P2|COMPLETED|Overall Study||80
7799052|NCT01215643|19199488|P1|COMPLETED|Overall Study||74
7799053|NCT01215643|19199484|P5|STARTED|Overall Study||40
7799054|NCT01215643|19199485|P4|STARTED|Overall Study||39
7799055|NCT01215643|19199486|P3|STARTED|Overall Study||94
7799056|NCT01215643|19199487|P2|STARTED|Overall Study||84
7799057|NCT01215643|19199488|P1|STARTED|Overall Study||83
7799058|NCT01215513|19199590|P1|NOT COMPLETED|Overall Study||45
7799059|NCT01215513|19199590|P1|COMPLETED|Overall Study||112
7799060|NCT01215513|19199590|P1|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127
7799061|NCT01215513|19199590|P1|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155
7799062|NCT01215513|19199590|P1|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156
7799063|NCT01215513|19199590|P1|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157
7799064|NCT01215435|19199599|P2|NOT COMPLETED|Overall Study||16
7799065|NCT01215435|19199600|P1|NOT COMPLETED|Overall Study||19
7799066|NCT01215435|19199599|P2|COMPLETED|Overall Study||107
7799067|NCT01215435|19199600|P1|COMPLETED|Overall Study||103
7799068|NCT01215435|19199599|P2|STARTED|Overall Study||123
7799069|NCT01215435|19199600|P1|STARTED|Overall Study||122
7799070|NCT01215422|19199614|P4|NOT COMPLETED|Overall Study||8
7799071|NCT01215422|19199615|P3|NOT COMPLETED|Overall Study||3
7799072|NCT01215422|19199616|P2|NOT COMPLETED|Overall Study||0
7799073|NCT01215422|19199617|P1|NOT COMPLETED|Overall Study||8
7799074|NCT01215422|19199614|P4|COMPLETED|Overall Study||193
7799075|NCT01215422|19199615|P3|COMPLETED|Overall Study||193
7799076|NCT01215422|19199616|P2|COMPLETED|Overall Study||249
7799077|NCT01215422|19199617|P1|COMPLETED|Overall Study||6
7799078|NCT01215422|19199614|P4|STARTED|Overall Study||201
7799079|NCT01215422|19199615|P3|STARTED|Overall Study||196
7799080|NCT01215422|19199616|P2|STARTED|Overall Study||249
7799081|NCT01215422|19199617|P1|STARTED|Overall Study||14
7799082|NCT01215357|19199639|P1|NOT COMPLETED|Overall Study||12
7799083|NCT01215357|19199639|P1|COMPLETED|Overall Study||22
7799084|NCT01215357|19199639|P1|STARTED|Overall Study||34
7799085|NCT01215344|19199645|P2|NOT COMPLETED|Overall Study||0
7799086|NCT01215344|19199646|P1|NOT COMPLETED|Overall Study||10
7799087|NCT01215344|19199645|P2|COMPLETED|Overall Study||3
7799088|NCT01215344|19199646|P1|COMPLETED|Overall Study||23
7799089|NCT01215344|19199645|P2|STARTED|Overall Study||3
7799090|NCT01215344|19199646|P1|STARTED|Overall Study||33
7799091|NCT01215318|19199656|P2|NOT COMPLETED|Overall Study||0
7799092|NCT01215318|19199657|P1|NOT COMPLETED|Overall Study||0
7799093|NCT01215318|19199656|P2|COMPLETED|Overall Study||24
7799094|NCT01215318|19199657|P1|COMPLETED|Overall Study||20
7799095|NCT01215318|19199656|P2|STARTED|Overall Study||24
7799096|NCT01215318|19199657|P1|STARTED|Overall Study||20
7799097|NCT01215292|19199670|P5|NOT COMPLETED|Overall Study||0
7799098|NCT01215292|19199671|P4|NOT COMPLETED|Overall Study||0
7799099|NCT01215292|19199672|P3|NOT COMPLETED|Overall Study||0
7799100|NCT01215292|19199673|P2|NOT COMPLETED|Overall Study||0
7799101|NCT01215292|19199674|P1|NOT COMPLETED|Overall Study||0
7799102|NCT01215292|19199670|P5|COMPLETED|Overall Study||8
7799103|NCT01215292|19199671|P4|COMPLETED|Overall Study||8
7799104|NCT01215292|19199672|P3|COMPLETED|Overall Study||8
7799105|NCT01215292|19199673|P2|COMPLETED|Overall Study||8
7799106|NCT01215292|19199674|P1|COMPLETED|Overall Study||8
7799107|NCT01215292|19199670|P5|STARTED|Overall Study||8
7799108|NCT01215292|19199671|P4|STARTED|Overall Study||8
7799109|NCT01215292|19199672|P3|STARTED|Overall Study||8
7799110|NCT01215292|19199673|P2|STARTED|Overall Study||8
7799111|NCT01215292|19199674|P1|STARTED|Overall Study||8
7799112|NCT01215279|19199698|P2|NOT COMPLETED|Overall Study||0
7799113|NCT01215279|19199699|P1|NOT COMPLETED|Overall Study||0
7799114|NCT01215279|19199698|P2|COMPLETED|Overall Study||32
7799115|NCT01215279|19199699|P1|COMPLETED|Overall Study||31
7799116|NCT01215279|19199698|P2|STARTED|Overall Study||32
7799117|NCT01215279|19199699|P1|STARTED|Overall Study||31
7799118|NCT01215253|19199765|P2|NOT COMPLETED|Overall Study||63
7799119|NCT01215253|19199766|P1|NOT COMPLETED|Overall Study||86
7799120|NCT01215253|19199765|P2|COMPLETED|Overall Study||439
7799121|NCT01215253|19199766|P1|COMPLETED|Overall Study||424
7799122|NCT01215253|19199765|P2|STARTED|Overall Study||502
7799123|NCT01215253|19199766|P1|STARTED|Overall Study||510
7799124|NCT01215240|19199796|P2|NOT COMPLETED|Overall Study||0
7799125|NCT01215240|19199797|P1|NOT COMPLETED|Overall Study||0
7799126|NCT01215240|19199796|P2|COMPLETED|Overall Study||12
7799127|NCT01215240|19199797|P1|COMPLETED|Overall Study||10
7799128|NCT01215240|19199796|P2|STARTED|Overall Study||12
7799129|NCT01215240|19199797|P1|STARTED|Overall Study||10
7799130|NCT01215227|19199819|P6|NOT COMPLETED|Overall Study||58
7799131|NCT01215227|19199820|P5|NOT COMPLETED|Overall Study||48
7799132|NCT01215227|19199821|P4|NOT COMPLETED|Overall Study||49
7799133|NCT01215227|19199822|P3|NOT COMPLETED|Overall Study||57
7799134|NCT01215227|19199823|P2|NOT COMPLETED|Overall Study||119
7799135|NCT01215227|19199824|P1|NOT COMPLETED|Overall Study||121
7799136|NCT01215227|19199819|P6|COMPLETED|Overall Study||51
7799137|NCT01215227|19199820|P5|COMPLETED|Overall Study||45
7799138|NCT01215227|19199821|P4|COMPLETED|Overall Study||48
7799139|NCT01215227|19199822|P3|COMPLETED|Overall Study||50
7799140|NCT01215227|19199823|P2|COMPLETED|Overall Study||96
7799141|NCT01215227|19199824|P1|COMPLETED|Overall Study||97
7799142|NCT01215227|19199819|P6|Treated|Overall Study||108
7799143|NCT01215227|19199820|P5|Treated|Overall Study||93
7799144|NCT01215227|19199821|P4|Treated|Overall Study||96
7799145|NCT01215227|19199822|P3|Treated|Overall Study||106
7799146|NCT01215227|19199823|P2|Treated|Overall Study||215
7799147|NCT01215227|19199824|P1|Treated|Overall Study||218
7799148|NCT01215227|19199819|P6|STARTED|Overall Study||109
7799149|NCT01215227|19199820|P5|STARTED|Overall Study||93
7799150|NCT01215227|19199821|P4|STARTED|Overall Study||97
7799151|NCT01215227|19199822|P3|STARTED|Overall Study||107
7799152|NCT01215227|19199823|P2|STARTED|Overall Study||215
7799153|NCT01215227|19199824|P1|STARTED|Overall Study||218
7799154|NCT01215188|19199871|P3|NOT COMPLETED|Overall Study||52
7799155|NCT01215188|19199872|P2|NOT COMPLETED|Overall Study||59
7799156|NCT01215188|19199873|P1|NOT COMPLETED|Overall Study||58
7799157|NCT01215188|19199871|P3|COMPLETED|Overall Study||326
7799158|NCT01215188|19199872|P2|COMPLETED|Overall Study||327
7799159|NCT01215188|19199873|P1|COMPLETED|Overall Study||320
7799160|NCT01215188|19199871|P3|STARTED|Overall Study||378
7799161|NCT01215188|19199872|P2|STARTED|Overall Study||386
7799162|NCT01215188|19199873|P1|STARTED|Overall Study||378
7799163|NCT01215175|19199925|P5|NOT COMPLETED|Overall Study||0
7799164|NCT01215175|19199926|P4|NOT COMPLETED|Overall Study||1
7799165|NCT01215175|19199927|P3|NOT COMPLETED|Overall Study||0
7799166|NCT01215175|19199928|P2|NOT COMPLETED|Overall Study||1
7799167|NCT01215175|19199929|P1|NOT COMPLETED|Overall Study||0
7799168|NCT01215175|19199925|P5|COMPLETED|Overall Study||28
7799169|NCT01215175|19199926|P4|COMPLETED|Overall Study||28
7799170|NCT01215175|19199927|P3|COMPLETED|Overall Study||33
7799171|NCT01215175|19199928|P2|COMPLETED|Overall Study||29
7799172|NCT01215175|19199929|P1|COMPLETED|Overall Study||30
7799173|NCT01215175|19199925|P5|Treated|Overall Study||28
7799174|NCT01215175|19199926|P4|Treated|Overall Study||29
7799175|NCT01215175|19199927|P3|Treated|Overall Study||33
7799176|NCT01215175|19199928|P2|Treated|Overall Study||30
7799177|NCT01215175|19199929|P1|Treated|Overall Study||30
7799178|NCT01215175|19199925|P5|STARTED|Overall Study||28
7799179|NCT01215175|19199926|P4|STARTED|Overall Study||29
7799180|NCT01215175|19199927|P3|STARTED|Overall Study||33
7799181|NCT01215175|19199928|P2|STARTED|Overall Study||30
7799182|NCT01215175|19199929|P1|STARTED|Overall Study||30
7799183|NCT01215123|19199971|P1|NOT COMPLETED|Overall Study||0
7799184|NCT01215123|19199971|P1|COMPLETED|Overall Study||28
7799185|NCT01215123|19199971|P1|STARTED|Overall Study||28
7799186|NCT01215110|19199981|P5|NOT COMPLETED|Overall Study||0
7799187|NCT01215110|19199982|P4|NOT COMPLETED|Overall Study||1
7799188|NCT01215110|19199983|P3|NOT COMPLETED|Overall Study||2
7799189|NCT01215110|19199984|P2|NOT COMPLETED|Overall Study||0
7799190|NCT01215110|19199985|P1|NOT COMPLETED|Overall Study||0
7799191|NCT01215110|19199981|P5|COMPLETED|Overall Study||8
7799192|NCT01215110|19199982|P4|COMPLETED|Overall Study||14
7799193|NCT01215110|19199983|P3|COMPLETED|Overall Study||13
7799194|NCT01215110|19199984|P2|COMPLETED|Overall Study||15
7799195|NCT01215110|19199985|P1|COMPLETED|Overall Study||15
7799196|NCT01215110|19199981|P5|STARTED|Overall Study||8
7799197|NCT01215110|19199982|P4|STARTED|Overall Study||15
7799198|NCT01215110|19199983|P3|STARTED|Overall Study||15
7799199|NCT01215110|19199984|P2|STARTED|Overall Study||15
7799200|NCT01215110|19199985|P1|STARTED|Overall Study||15
7799201|NCT01215097|19200046|P2|NOT COMPLETED|Overall Study||14
7799202|NCT01215097|19200047|P1|NOT COMPLETED|Overall Study||12
7799203|NCT01215097|19200046|P2|COMPLETED|Overall Study||191
7799204|NCT01215097|19200047|P1|COMPLETED|Overall Study||88
7799205|NCT01215097|19200046|P2|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205
7799206|NCT01215097|19200047|P1|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100
7799207|NCT01215032|19200079|P1|NOT COMPLETED|Overall Study||20
7799208|NCT01215032|19200079|P1|COMPLETED|Overall Study||1
7799209|NCT01215032|19200079|P1|STARTED|Overall Study||21
7799210|NCT01214980|19200089|P2|NOT COMPLETED|Overall Study||2
7799211|NCT01214980|19200090|P1|NOT COMPLETED|Overall Study||3
7799212|NCT01214980|19200089|P2|COMPLETED|Overall Study||14
7799213|NCT01214980|19200090|P1|COMPLETED|Overall Study||13
7799214|NCT01214980|19200089|P2|STARTED|Overall Study||16
7799215|NCT01214980|19200090|P1|STARTED|Overall Study||16
7799216|NCT01214915|19200104|P1|NOT COMPLETED|Overall Study||11
7799217|NCT01214915|19200104|P1|COMPLETED|Overall Study||42
7799218|NCT01214915|19200104|P1|STARTED|Overall Study||53
7799219|NCT01214850|19200115|P3|NOT COMPLETED|Overall Study||161
7799220|NCT01214850|19200116|P2|NOT COMPLETED|Overall Study||144
7799221|NCT01214850|19200117|P1|NOT COMPLETED|Overall Study||183
7799222|NCT01214850|19200115|P3|COMPLETED|Overall Study||826
7799223|NCT01214850|19200116|P2|COMPLETED|Overall Study||844
7799224|NCT01214850|19200117|P1|COMPLETED|Overall Study||796
7799225|NCT01214850|19200115|P3|STARTED|Overall Study||987
7799226|NCT01214850|19200116|P2|STARTED|Overall Study||988
7799227|NCT01214850|19200117|P1|STARTED|Overall Study||979
7799228|NCT01214837|19200201|P3|NOT COMPLETED|Overall Study||62
7799229|NCT01214837|19200202|P2|NOT COMPLETED|Overall Study||64
7799230|NCT01214837|19200203|P1|NOT COMPLETED|Overall Study||54
7799231|NCT01214837|19200201|P3|COMPLETED|Overall Study||184
7799232|NCT01214837|19200202|P2|COMPLETED|Overall Study||192
7799233|NCT01214837|19200203|P1|COMPLETED|Overall Study||195
7799234|NCT01214837|19200201|P3|STARTED|Overall Study||246
7799235|NCT01214837|19200202|P2|STARTED|Overall Study||256
7799236|NCT01214837|19200203|P1|STARTED|Overall Study||249
7799237|NCT01214824|19200240|P1|NOT COMPLETED|Overall Study||3
7799238|NCT01214824|19200240|P1|COMPLETED|Overall Study||29
7799239|NCT01214824|19200240|P1|STARTED|Overall Study||32
7799240|NCT01214811|19200247|P1|NOT COMPLETED|Overall Study||3
7799241|NCT01214811|19200247|P1|COMPLETED|Overall Study||24
7799242|NCT01214811|19200247|P1|STARTED|Overall Study||27
7799243|NCT01214759|19200251|P1|NOT COMPLETED|Overall Study||48
7799244|NCT01214759|19200251|P1|COMPLETED|Overall Study||55
7799245|NCT01214759|19200251|P1|28 Days nPEP Completion|Overall Study||85
7799246|NCT01214759|19200251|P1|STARTED|Overall Study||103
7799247|NCT01214720|19200259|P2|NOT COMPLETED|Overall Study||68
7799248|NCT01214720|19200260|P1|NOT COMPLETED|Overall Study||85
7799249|NCT01214720|19200259|P2|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233
7799250|NCT01214720|19200260|P1|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221
7799251|NCT01214720|19200259|P2|STARTED|Overall Study||301
7799252|NCT01214720|19200260|P1|STARTED|Overall Study||306
7799253|NCT01214668|19200283|P6|NOT COMPLETED|Overall Study||6
7799254|NCT01214668|19200284|P5|NOT COMPLETED|Overall Study||6
7799255|NCT01214668|19200285|P4|NOT COMPLETED|Overall Study||6
7799256|NCT01214668|19200286|P3|NOT COMPLETED|Overall Study||6
7799257|NCT01214668|19200287|P2|NOT COMPLETED|Overall Study||3
7799258|NCT01214668|19200288|P1|NOT COMPLETED|Overall Study||4
7799259|NCT01214668|19200283|P6|COMPLETED|Overall Study||0
7799260|NCT01214668|19200284|P5|COMPLETED|Overall Study||0
7799261|NCT01214668|19200285|P4|COMPLETED|Overall Study||0
7799262|NCT01214668|19200286|P3|COMPLETED|Overall Study||0
7799263|NCT01214668|19200287|P2|COMPLETED|Overall Study||0
7799264|NCT01214668|19200288|P1|COMPLETED|Overall Study||0
7799265|NCT01214668|19200283|P6|Received at Least One Dose of Study Drug|Overall Study||6
7799266|NCT01214668|19200284|P5|Received at Least One Dose of Study Drug|Overall Study||6
7799267|NCT01214668|19200285|P4|Received at Least One Dose of Study Drug|Overall Study||6
7799268|NCT01214668|19200286|P3|Received at Least One Dose of Study Drug|Overall Study||6
7799269|NCT01214668|19200287|P2|Received at Least One Dose of Study Drug|Overall Study||3
7799270|NCT01214668|19200288|P1|Received at Least One Dose of Study Drug|Overall Study||4
7799271|NCT01214668|19200283|P6|STARTED|Overall Study||6
7799272|NCT01214668|19200284|P5|STARTED|Overall Study||6
7799273|NCT01214668|19200285|P4|STARTED|Overall Study||6
7799274|NCT01214668|19200286|P3|STARTED|Overall Study||6
7799275|NCT01214668|19200287|P2|STARTED|Overall Study||3
7799276|NCT01214668|19200288|P1|STARTED|Overall Study||4
7799277|NCT01214655|19200325|P3|NOT COMPLETED|Part C||7
7799278|NCT01214655|19200326|P2|NOT COMPLETED|Part C||0
7799279|NCT01214655|19200327|P1|NOT COMPLETED|Part C||0
7799280|NCT01214655|19200325|P3|COMPLETED|Part C||1
7799281|NCT01214655|19200326|P2|COMPLETED|Part C||0
7799282|NCT01214655|19200327|P1|COMPLETED|Part C||0
7799283|NCT01214655|19200325|P3|Received at Least 1 Dose of 5 mg/m²/Day|Part C||8
7799284|NCT01214655|19200326|P2|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
7799285|NCT01214655|19200327|P1|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
7799286|NCT01214655|19200325|P3|STARTED|Part C|Total on Schedule C, dose days 1,2,3|8
7799287|NCT01214655|19200326|P2|STARTED|Part C||0
7799288|NCT01214655|19200327|P1|STARTED|Part C||0
7799289|NCT01214655|19200325|P3|NOT COMPLETED|Part B||0
7799290|NCT01214655|19200326|P2|NOT COMPLETED|Part B||13
7799291|NCT01214655|19200327|P1|NOT COMPLETED|Part B||0
7799292|NCT01214655|19200325|P3|COMPLETED|Part B||0
7799293|NCT01214655|19200326|P2|COMPLETED|Part B||2
7799294|NCT01214655|19200327|P1|COMPLETED|Part B||0
7799295|NCT01214655|19200325|P3|Joined 14 mg/m²/Day|Part B||0
7799296|NCT01214655|19200326|P2|Joined 14 mg/m²/Day|Part B||3
7799297|NCT01214655|19200327|P1|Joined 14 mg/m²/Day|Part B||0
7799298|NCT01214655|19200325|P3|Escalated From 12 to 14 mg/m²/Day|Part B||0
7799299|NCT01214655|19200326|P2|Escalated From 12 to 14 mg/m²/Day|Part B||1
7799300|NCT01214655|19200327|P1|Escalated From 12 to 14 mg/m²/Day|Part B||0
7799301|NCT01214655|19200325|P3|Joined 12 mg/m²/Day|Part B||0
7799302|NCT01214655|19200326|P2|Joined 12 mg/m²/Day|Part B||5
7799303|NCT01214655|19200327|P1|Joined 12 mg/m²/Day|Part B||0
7799304|NCT01214655|19200325|P3|Escalated to 12 mg/m²/Day|Part B||0
7799305|NCT01214655|19200326|P2|Escalated to 12 mg/m²/Day|Part B||2
7799306|NCT01214655|19200327|P1|Escalated to 12 mg/m²/Day|Part B||0
7799307|NCT01214655|19200325|P3|Joined 10 mg/m²/Day Study D|Part B||0
7799308|NCT01214655|19200326|P2|Joined 10 mg/m²/Day Study D|Part B||3
7799309|NCT01214655|19200327|P1|Joined 10 mg/m²/Day Study D|Part B||0
7799310|NCT01214655|19200325|P3|Escalated From 8 to 10 mg/m²/Day|Part B||0
7799311|NCT01214655|19200326|P2|Escalated From 8 to 10 mg/m²/Day|Part B||2
7799312|NCT01214655|19200327|P1|Escalated From 8 to 10 mg/m²/Day|Part B||0
7799313|NCT01214655|19200325|P3|Recieved 8 mg/m²/Day Study Drug|Part B||0
7799314|NCT01214655|19200326|P2|Recieved 8 mg/m²/Day Study Drug|Part B||4
7799315|NCT01214655|19200327|P1|Recieved 8 mg/m²/Day Study Drug|Part B||0
7799316|NCT01214655|19200325|P3|Received at Least 1 Dose of Study Drug|Part B||0
7799317|NCT01214655|19200326|P2|Received at Least 1 Dose of Study Drug|Part B||15
7799318|NCT01214655|19200327|P1|Received at Least 1 Dose of Study Drug|Part B||0
7799319|NCT01214655|19200325|P3|STARTED|Part B||0
7799320|NCT01214655|19200326|P2|STARTED|Part B|Total on Schedule B, dose days 1,5,9|15
7799321|NCT01214655|19200327|P1|STARTED|Part B|Part A participants did not enroll in Part B. Participants in A, B, C are considered Cohorts.|0
7799322|NCT01214655|19200325|P3|NOT COMPLETED|Part A||0
7799323|NCT01214655|19200326|P2|NOT COMPLETED|Part A||0
7799324|NCT01214655|19200327|P1|NOT COMPLETED|Part A||8
7799325|NCT01214655|19200325|P3|COMPLETED|Part A||0
7799326|NCT01214655|19200326|P2|COMPLETED|Part A||0
7799327|NCT01214655|19200327|P1|COMPLETED|Part A||2
7799328|NCT01214655|19200325|P3|Received 6 mg Study Drug|Part A||0
7799329|NCT01214655|19200326|P2|Received 6 mg Study Drug|Part A||0
7799330|NCT01214655|19200327|P1|Received 6 mg Study Drug|Part A||5
7799331|NCT01214655|19200325|P3|Joined 6 mg Group|Part A||0
7799332|NCT01214655|19200326|P2|Joined 6 mg Group|Part A||0
7799333|NCT01214655|19200327|P1|Joined 6 mg Group|Part A||4
7799334|NCT01214655|19200325|P3|Escalated From 5 mg Study Drug|Part A||0
7799335|NCT01214655|19200326|P2|Escalated From 5 mg Study Drug|Part A||0
7799336|NCT01214655|19200327|P1|Escalated From 5 mg Study Drug|Part A||1
7799337|NCT01214655|19200325|P3|Joined 5 mg Study Drug|Part A||0
7799338|NCT01214655|19200326|P2|Joined 5 mg Study Drug|Part A||0
7799339|NCT01214655|19200327|P1|Joined 5 mg Study Drug|Part A||2
7799340|NCT01214655|19200325|P3|Escalated From 4 mg Study Drug|Part A||0
7799341|NCT01214655|19200326|P2|Escalated From 4 mg Study Drug|Part A||0
7799342|NCT01214655|19200327|P1|Escalated From 4 mg Study Drug|Part A||0
7799343|NCT01214655|19200325|P3|Joined 4 mg Group|Part A||0
7799344|NCT01214655|19200326|P2|Joined 4 mg Group|Part A||0
7799345|NCT01214655|19200327|P1|Joined 4 mg Group|Part A||1
7799346|NCT01214655|19200325|P3|Escalated From 2 to 4 mg/m²/Day|Part A||0
7799347|NCT01214655|19200326|P2|Escalated From 2 to 4 mg/m²/Day|Part A||0
7799348|NCT01214655|19200327|P1|Escalated From 2 to 4 mg/m²/Day|Part A||3
7799349|NCT01214655|19200325|P3|Received 2 mg Study Drug|Part A||0
7799350|NCT01214655|19200326|P2|Received 2 mg Study Drug|Part A||0
7799351|NCT01214655|19200327|P1|Received 2 mg Study Drug|Part A||3
7799352|NCT01214655|19200325|P3|STARTED|Part A||0
7799353|NCT01214655|19200326|P2|STARTED|Part A||0
7799354|NCT01214655|19200327|P1|STARTED|Part A|Total on Schedule A, dose days 1,2,3|10
7799355|NCT01214642|19200400|P12|NOT COMPLETED|Overall Study||6
7799356|NCT01214642|19200401|P11|NOT COMPLETED|Overall Study||4
7799357|NCT01214642|19200402|P10|NOT COMPLETED|Overall Study||4
7799358|NCT01214642|19200403|P9|NOT COMPLETED|Overall Study||13
7799359|NCT01214642|19200404|P8|NOT COMPLETED|Overall Study||3
7799360|NCT01214642|19200405|P7|NOT COMPLETED|Overall Study||6
7799361|NCT01214642|19200406|P6|NOT COMPLETED|Overall Study||3
7799362|NCT01214642|19200407|P5|NOT COMPLETED|Overall Study||6
7799363|NCT01214642|19200408|P4|NOT COMPLETED|Overall Study||6
7799364|NCT01214642|19200409|P3|NOT COMPLETED|Overall Study||6
7799365|NCT01214642|19200410|P2|NOT COMPLETED|Overall Study||3
7799366|NCT01214642|19200411|P1|NOT COMPLETED|Overall Study||3
7799367|NCT01214642|19200400|P12|COMPLETED|Overall Study||0
7799368|NCT01214642|19200401|P11|COMPLETED|Overall Study||0
7799369|NCT01214642|19200402|P10|COMPLETED|Overall Study||0
7799370|NCT01214642|19200403|P9|COMPLETED|Overall Study||0
7799371|NCT01214642|19200404|P8|COMPLETED|Overall Study||0
7799372|NCT01214642|19200405|P7|COMPLETED|Overall Study||0
7799373|NCT01214642|19200406|P6|COMPLETED|Overall Study||0
7799374|NCT01214642|19200407|P5|COMPLETED|Overall Study||0
7799375|NCT01214642|19200408|P4|COMPLETED|Overall Study||0
7799376|NCT01214642|19200409|P3|COMPLETED|Overall Study||0
7799377|NCT01214642|19200410|P2|COMPLETED|Overall Study||0
7799378|NCT01214642|19200411|P1|COMPLETED|Overall Study||0
7799379|NCT01214642|19200400|P12|Complete at Least 2 Cycles of Study Drug|Overall Study||5
7799380|NCT01214642|19200401|P11|Complete at Least 2 Cycles of Study Drug|Overall Study||2
7799381|NCT01214642|19200402|P10|Complete at Least 2 Cycles of Study Drug|Overall Study||2
7799382|NCT01214642|19200403|P9|Complete at Least 2 Cycles of Study Drug|Overall Study||12
7799383|NCT01214642|19200404|P8|Complete at Least 2 Cycles of Study Drug|Overall Study||3
7799384|NCT01214642|19200405|P7|Complete at Least 2 Cycles of Study Drug|Overall Study||6
7799385|NCT01214642|19200406|P6|Complete at Least 2 Cycles of Study Drug|Overall Study||1
7799386|NCT01214642|19200407|P5|Complete at Least 2 Cycles of Study Drug|Overall Study||6
7799387|NCT01214642|19200408|P4|Complete at Least 2 Cycles of Study Drug|Overall Study||4
7799388|NCT01214642|19200409|P3|Complete at Least 2 Cycles of Study Drug|Overall Study||5
7799389|NCT01214642|19200410|P2|Complete at Least 2 Cycles of Study Drug|Overall Study||1
7799390|NCT01214642|19200411|P1|Complete at Least 2 Cycles of Study Drug|Overall Study||3
7799391|NCT01214642|19200400|P12|Received at Least 1 Dose of Study Drug|Overall Study||6
7799392|NCT01214642|19200401|P11|Received at Least 1 Dose of Study Drug|Overall Study||4
7799393|NCT01214642|19200402|P10|Received at Least 1 Dose of Study Drug|Overall Study||4
7799394|NCT01214642|19200403|P9|Received at Least 1 Dose of Study Drug|Overall Study||13
7799395|NCT01214642|19200404|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
7799396|NCT01214642|19200405|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
7799397|NCT01214642|19200406|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
7799398|NCT01214642|19200407|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
7799399|NCT01214642|19200408|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
7799400|NCT01214642|19200409|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
7799401|NCT01214642|19200410|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
7799402|NCT01214642|19200411|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
7799403|NCT01214642|19200400|P12|STARTED|Overall Study||6
7799404|NCT01214642|19200401|P11|STARTED|Overall Study||4
7799405|NCT01214642|19200402|P10|STARTED|Overall Study||4
7799406|NCT01214642|19200403|P9|STARTED|Overall Study|All participants who received 12 mg/m2/day on Days 1 and 5 plus PEG in Part A and Part B.|13
7799407|NCT01214642|19200404|P8|STARTED|Overall Study||3
7799408|NCT01214642|19200405|P7|STARTED|Overall Study||6
7799409|NCT01214642|19200406|P6|STARTED|Overall Study||3
7799410|NCT01214642|19200407|P5|STARTED|Overall Study||6
7799411|NCT01214642|19200408|P4|STARTED|Overall Study||6
7799412|NCT01214642|19200409|P3|STARTED|Overall Study||6
7799413|NCT01214642|19200410|P2|STARTED|Overall Study||3
7799414|NCT01214642|19200411|P1|STARTED|Overall Study||3
7799415|NCT01214629|19200491|P11|NOT COMPLETED|Overall Study||2
7799416|NCT01214629|19200492|P10|NOT COMPLETED|Overall Study||7
7799417|NCT01214629|19200493|P9|NOT COMPLETED|Overall Study||1
7799418|NCT01214629|19200494|P8|NOT COMPLETED|Overall Study||1
7799419|NCT01214629|19200495|P7|NOT COMPLETED|Overall Study||1
7799420|NCT01214629|19200496|P6|NOT COMPLETED|Overall Study||4
7799421|NCT01214629|19200497|P5|NOT COMPLETED|Overall Study||2
7799422|NCT01214629|19200498|P4|NOT COMPLETED|Overall Study||2
7799423|NCT01214629|19200499|P3|NOT COMPLETED|Overall Study||0
7799424|NCT01214629|19200500|P2|NOT COMPLETED|Overall Study||1
7799425|NCT01214629|19200501|P1|NOT COMPLETED|Overall Study||1
7799426|NCT01214629|19200491|P11|COMPLETED|Overall Study||1
7799427|NCT01214629|19200492|P10|COMPLETED|Overall Study||11
7799428|NCT01214629|19200493|P9|COMPLETED|Overall Study||2
7799429|NCT01214629|19200494|P8|COMPLETED|Overall Study||2
7799430|NCT01214629|19200495|P7|COMPLETED|Overall Study||4
7799431|NCT01214629|19200496|P6|COMPLETED|Overall Study||9
7799432|NCT01214629|19200497|P5|COMPLETED|Overall Study||1
7799433|NCT01214629|19200498|P4|COMPLETED|Overall Study||1
7799434|NCT01214629|19200499|P3|COMPLETED|Overall Study||1
7799435|NCT01214629|19200500|P2|COMPLETED|Overall Study||0
7799436|NCT01214629|19200501|P1|COMPLETED|Overall Study||0
7799437|NCT01214629|19200491|P11|Received at Least 1 Dose of Study Drug|Overall Study||3
7799438|NCT01214629|19200492|P10|Received at Least 1 Dose of Study Drug|Overall Study||18
7799439|NCT01214629|19200493|P9|Received at Least 1 Dose of Study Drug|Overall Study||3
7799440|NCT01214629|19200494|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
7799441|NCT01214629|19200495|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
7799442|NCT01214629|19200496|P6|Received at Least 1 Dose of Study Drug|Overall Study||13
7799443|NCT01214629|19200497|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
7799444|NCT01214629|19200498|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
7799445|NCT01214629|19200499|P3|Received at Least 1 Dose of Study Drug|Overall Study||1
7799446|NCT01214629|19200500|P2|Received at Least 1 Dose of Study Drug|Overall Study||1
7799447|NCT01214629|19200501|P1|Received at Least 1 Dose of Study Drug|Overall Study||1
7799448|NCT01214629|19200491|P11|STARTED|Overall Study||3
7799449|NCT01214629|19200492|P10|STARTED|Overall Study||18
7799450|NCT01214629|19200493|P9|STARTED|Overall Study||3
7799451|NCT01214629|19200494|P8|STARTED|Overall Study||3
7799452|NCT01214629|19200495|P7|STARTED|Overall Study||5
7799453|NCT01214629|19200496|P6|STARTED|Overall Study||13
7799454|NCT01214629|19200497|P5|STARTED|Overall Study||3
7799455|NCT01214629|19200498|P4|STARTED|Overall Study||3
7799456|NCT01214629|19200499|P3|STARTED|Overall Study||1
7799457|NCT01214629|19200500|P2|STARTED|Overall Study||1
7799458|NCT01214629|19200501|P1|STARTED|Overall Study||1
7799459|NCT01214616|19200566|P4|NOT COMPLETED|Overall Study||6
7799460|NCT01214616|19200567|P3|NOT COMPLETED|Overall Study||3
7799461|NCT01214616|19200568|P2|NOT COMPLETED|Overall Study||5
7799462|NCT01214616|19200569|P1|NOT COMPLETED|Overall Study||3
7799463|NCT01214616|19200566|P4|COMPLETED|Overall Study||0
7799464|NCT01214616|19200567|P3|COMPLETED|Overall Study||0
7799465|NCT01214616|19200568|P2|COMPLETED|Overall Study||0
7799466|NCT01214616|19200569|P1|COMPLETED|Overall Study||0
7799467|NCT01214616|19200566|P4|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6
7799468|NCT01214616|19200567|P3|STARTED|Overall Study||3
7799469|NCT01214616|19200568|P2|STARTED|Overall Study||5
7799470|NCT01214616|19200569|P1|STARTED|Overall Study||3
7799471|NCT01214603|19200606|P3|NOT COMPLETED|Overall Study||4
7799472|NCT01214603|19200607|P2|NOT COMPLETED|Overall Study||1
7799473|NCT01214603|19200608|P1|NOT COMPLETED|Overall Study||5
7799474|NCT01214603|19200606|P3|COMPLETED|Overall Study||3
7799475|NCT01214603|19200607|P2|COMPLETED|Overall Study||5
7799476|NCT01214603|19200608|P1|COMPLETED|Overall Study||2
7799477|NCT01214603|19200606|P3|Received at Least 1 Dose of LY2090314|Overall Study||7
7799478|NCT01214603|19200607|P2|Received at Least 1 Dose of LY2090314|Overall Study||6
7799479|NCT01214603|19200608|P1|Received at Least 1 Dose of LY2090314|Overall Study||7
7799480|NCT01214603|19200606|P3|STARTED|Overall Study||7
7799481|NCT01214603|19200607|P2|STARTED|Overall Study||6
7799482|NCT01214603|19200608|P1|STARTED|Overall Study||7
7799483|NCT01214434|19200631|P2|NOT COMPLETED|Overall Study||2
7799484|NCT01214434|19200632|P1|NOT COMPLETED|Overall Study||4
7799485|NCT01214434|19200631|P2|COMPLETED|Overall Study||25
7799486|NCT01214434|19200632|P1|COMPLETED|Overall Study||11
7799487|NCT01214434|19200631|P2|STARTED|Overall Study||27
7799488|NCT01214434|19200632|P1|STARTED|Overall Study||15
7799489|NCT01214395|19200648|P1|NOT COMPLETED|Overall Study||5
7799490|NCT01214395|19200648|P1|COMPLETED|Overall Study||0
7799491|NCT01214395|19200648|P1|STARTED|Overall Study||5
7799492|NCT01214356|19200655|P2|NOT COMPLETED|Overall Study||14
7799493|NCT01214356|19200656|P1|NOT COMPLETED|Overall Study||17
7799494|NCT01214356|19200655|P2|COMPLETED|Overall Study||13
7799495|NCT01214356|19200656|P1|COMPLETED|Overall Study||10
7799496|NCT01214356|19200655|P2|STARTED|Overall Study||27
7799497|NCT01214356|19200656|P1|STARTED|Overall Study||27
7799498|NCT01214330|19200662|P1|NOT COMPLETED|Overall Study||48
7799499|NCT01214330|19200662|P1|COMPLETED|Overall Study||102
7799500|NCT01214330|19200662|P1|STARTED|Overall Study||150
7799501|NCT01214317|19200668|P2|NOT COMPLETED|Overall Study||0
7799502|NCT01214317|19200669|P1|NOT COMPLETED|Overall Study||0
7799503|NCT01214317|19200668|P2|COMPLETED|Overall Study||22
7799504|NCT01214317|19200669|P1|COMPLETED|Overall Study||18
7799505|NCT01214317|19200668|P2|STARTED|Overall Study||22
7799506|NCT01214317|19200669|P1|STARTED|Overall Study||18
7799507|NCT01214252|19200677|P1|NOT COMPLETED|Overall Study||82
7799508|NCT01214252|19200677|P1|COMPLETED|Overall Study||343
7799509|NCT01214252|19200677|P1|STARTED|Overall Study||425
7799510|NCT01214239|19200685|P2|NOT COMPLETED|Overall Study||18
7799511|NCT01214239|19200686|P1|NOT COMPLETED|Overall Study||12
7799512|NCT01214239|19200685|P2|COMPLETED|Overall Study||182
7799513|NCT01214239|19200686|P1|COMPLETED|Overall Study||87
7799514|NCT01214239|19200685|P2|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200
7799515|NCT01214239|19200686|P1|STARTED|Overall Study|patients who were randomised and treated with placebo|99
7799516|NCT01214200|19200718|P1|NOT COMPLETED|Overall Study||11
7799517|NCT01214200|19200718|P1|COMPLETED|Overall Study||9
7799518|NCT01214200|19200718|P1|STARTED|Overall Study||20
7799519|NCT01214187|19200732|P2|NOT COMPLETED|Overall Study||6
7799520|NCT01214187|19200733|P1|NOT COMPLETED|Overall Study||7
7799521|NCT01214187|19200732|P2|COMPLETED|Overall Study||23
7799522|NCT01214187|19200733|P1|COMPLETED|Overall Study||22
7799523|NCT01214187|19200732|P2|STARTED|Overall Study||29
7799524|NCT01214187|19200733|P1|STARTED|Overall Study||29
7799525|NCT01214174|19200750|P3|NOT COMPLETED|Overall Study||1
7799526|NCT01214174|19200751|P2|NOT COMPLETED|Overall Study||0
7799527|NCT01214174|19200752|P1|NOT COMPLETED|Overall Study||0
7799528|NCT01214174|19200750|P3|COMPLETED|Overall Study||13
7799529|NCT01214174|19200751|P2|COMPLETED|Overall Study||16
7799530|NCT01214174|19200752|P1|COMPLETED|Overall Study||13
7799531|NCT01214174|19200750|P3|STARTED|Overall Study||14
7799532|NCT01214174|19200751|P2|STARTED|Overall Study||16
7799533|NCT01214174|19200752|P1|STARTED|Overall Study||13
7799534|NCT01214161|19200762|P2|NOT COMPLETED|Overall Study||0
7799535|NCT01214161|19200763|P1|NOT COMPLETED|Overall Study||0
7799536|NCT01214161|19200762|P2|COMPLETED|Overall Study||100
7799537|NCT01214161|19200763|P1|COMPLETED|Overall Study||100
7799538|NCT01214161|19200762|P2|STARTED|Overall Study||100
7799539|NCT01214161|19200763|P1|STARTED|Overall Study||100
7799540|NCT01214109|19200773|P4|NOT COMPLETED|Overall Study||0
7799541|NCT01214109|19200774|P3|NOT COMPLETED|Overall Study||0
7799542|NCT01214109|19200775|P2|NOT COMPLETED|Overall Study||0
7799543|NCT01214109|19200776|P1|NOT COMPLETED|Overall Study||0
7799544|NCT01214109|19200773|P4|COMPLETED|Overall Study||24
7799545|NCT01214109|19200774|P3|COMPLETED|Overall Study||24
7799546|NCT01214109|19200775|P2|COMPLETED|Overall Study||24
7799547|NCT01214109|19200776|P1|COMPLETED|Overall Study||24
7799548|NCT01214109|19200773|P4|STARTED|Overall Study||24
7799549|NCT01214109|19200774|P3|STARTED|Overall Study||24
7799550|NCT01214109|19200775|P2|STARTED|Overall Study||24
7799551|NCT01214109|19200776|P1|STARTED|Overall Study||24
7799552|NCT01214083|19200868|P3|NOT COMPLETED|Overall Study||10
7799553|NCT01214083|19200869|P2|NOT COMPLETED|Overall Study||10
7799554|NCT01214083|19200870|P1|NOT COMPLETED|Overall Study||12
7799555|NCT01214083|19200868|P3|COMPLETED|Overall Study||21
7799556|NCT01214083|19200869|P2|COMPLETED|Overall Study||23
7799557|NCT01214083|19200870|P1|COMPLETED|Overall Study||19
7799558|NCT01214083|19200868|P3|STARTED|Overall Study||31
7799559|NCT01214083|19200869|P2|STARTED|Overall Study||33
7799560|NCT01214083|19200870|P1|STARTED|Overall Study||31
7799561|NCT01214044|19200902|P1|NOT COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||4
7799562|NCT01214044|19200902|P1|COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||10
7799563|NCT01214044|19200902|P1|STARTED|Visits 6-11: Escitalopram 20 mg Daily||14
7799564|NCT01214044|19200902|P1|NOT COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||3
7799565|NCT01214044|19200902|P1|COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||14
7799566|NCT01214044|19200902|P1|STARTED|Visits 3-5: Escitalopram 10 mg Daily||17
7799567|NCT01214044|19200902|P1|NOT COMPLETED|Visit 2: End Washout & Start Placebo||2
7799568|NCT01214044|19200902|P1|COMPLETED|Visit 2: End Washout & Start Placebo|2 subjects dropped out during the placebo week (between study visits 2 & 3)|17
7799569|NCT01214044|19200902|P1|STARTED|Visit 2: End Washout & Start Placebo||19
7799570|NCT01214044|19200902|P1|NOT COMPLETED|Visit 1: Screening and Consent, Washout||12
7799571|NCT01214044|19200902|P1|COMPLETED|Visit 1: Screening and Consent, Washout||19
7799572|NCT01214044|19200902|P1|STARTED|Visit 1: Screening and Consent, Washout||31
7799573|NCT01213966|19200916|P4|NOT COMPLETED|Overall Study||1
7799574|NCT01213966|19200917|P3|NOT COMPLETED|Overall Study||3
7799575|NCT01213966|19200918|P2|NOT COMPLETED|Overall Study||0
7799576|NCT01213966|19200919|P1|NOT COMPLETED|Overall Study||1
7799577|NCT01213966|19200916|P4|COMPLETED|Overall Study||20
7799578|NCT01213966|19200917|P3|COMPLETED|Overall Study||17
7799579|NCT01213966|19200918|P2|COMPLETED|Overall Study||20
7799580|NCT01213966|19200919|P1|COMPLETED|Overall Study||19
7799581|NCT01213966|19200916|P4|STARTED|Overall Study||21
7799582|NCT01213966|19200917|P3|STARTED|Overall Study||20
7799583|NCT01213966|19200918|P2|STARTED|Overall Study||20
7799584|NCT01213966|19200919|P1|STARTED|Overall Study||20
7799585|NCT01213940|19200931|P2|NOT COMPLETED|Overall Study||0
7799586|NCT01213940|19200932|P1|NOT COMPLETED|Overall Study||0
7799587|NCT01213940|19200931|P2|COMPLETED|Overall Study||6
7799588|NCT01213940|19200932|P1|COMPLETED|Overall Study||14
7799589|NCT01213940|19200931|P2|STARTED|Overall Study||6
7799590|NCT01213940|19200932|P1|STARTED|Overall Study||14
7799591|NCT01213836|19200940|P2|NOT COMPLETED|Period 2, Second Intervention||0
7799592|NCT01213836|19200941|P1|NOT COMPLETED|Period 2, Second Intervention||0
7799593|NCT01213836|19200940|P2|COMPLETED|Period 2, Second Intervention||29
7799594|NCT01213836|19200941|P1|COMPLETED|Period 2, Second Intervention||31
7799595|NCT01213836|19200940|P2|STARTED|Period 2, Second Intervention||29
7799596|NCT01213836|19200941|P1|STARTED|Period 2, Second Intervention||31
7799597|NCT01213836|19200940|P2|NOT COMPLETED|Period 1, First Intervention||3
7799598|NCT01213836|19200941|P1|NOT COMPLETED|Period 1, First Intervention||3
7799599|NCT01213836|19200940|P2|COMPLETED|Period 1, First Intervention||29
7799600|NCT01213836|19200941|P1|COMPLETED|Period 1, First Intervention||31
7799601|NCT01213836|19200940|P2|STARTED|Period 1, First Intervention||32
7799602|NCT01213836|19200941|P1|STARTED|Period 1, First Intervention||34
7799603|NCT01213823|19200961|P2|NOT COMPLETED|Overall Study||0
7799604|NCT01213823|19200962|P1|NOT COMPLETED|Overall Study||0
7799605|NCT01213823|19200961|P2|COMPLETED|Overall Study||467
7799606|NCT01213823|19200962|P1|COMPLETED|Overall Study||69
7799607|NCT01213823|19200961|P2|STARTED|Overall Study||467
7799608|NCT01213823|19200962|P1|STARTED|Overall Study||69
7799609|NCT01213706|19200968|P1|NOT COMPLETED|WBPA||0
7799610|NCT01213706|19200968|P1|COMPLETED|WBPA||45
7799611|NCT01213706|19200968|P1|STARTED|WBPA||45
7799612|NCT01213706|19200968|P1|NOT COMPLETED|Washout (1 Hour)||0
7799613|NCT01213706|19200968|P1|COMPLETED|Washout (1 Hour)||45
7799614|NCT01213706|19200968|P1|STARTED|Washout (1 Hour)||45
7799615|NCT01213706|19200968|P1|NOT COMPLETED|Sham WBPA||0
7799616|NCT01213706|19200968|P1|COMPLETED|Sham WBPA||45
7799617|NCT01213706|19200968|P1|STARTED|Sham WBPA||45
7799618|NCT01213589|19200977|P3|NOT COMPLETED|Overall Study||8
7799619|NCT01213589|19200978|P2|NOT COMPLETED|Overall Study||5
7799620|NCT01213589|19200979|P1|NOT COMPLETED|Overall Study||13
7799621|NCT01213589|19200977|P3|COMPLETED|Overall Study||18
7799622|NCT01213589|19200978|P2|COMPLETED|Overall Study||19
7799623|NCT01213589|19200979|P1|COMPLETED|Overall Study||37
7799624|NCT01213589|19200977|P3|STARTED|Overall Study||26
7799625|NCT01213589|19200978|P2|STARTED|Overall Study||24
7799626|NCT01213589|19200979|P1|STARTED|Overall Study||50
7799627|NCT01213576|19201009|P4|NOT COMPLETED|Overall Study||4
7799628|NCT01213576|19201010|P3|NOT COMPLETED|Overall Study||5
7799629|NCT01213576|19201011|P2|NOT COMPLETED|Overall Study||4
7799630|NCT01213576|19201012|P1|NOT COMPLETED|Overall Study||3
7799631|NCT01213576|19201009|P4|COMPLETED|Overall Study||13
7799632|NCT01213576|19201010|P3|COMPLETED|Overall Study||13
7799633|NCT01213576|19201011|P2|COMPLETED|Overall Study||13
7799634|NCT01213576|19201012|P1|COMPLETED|Overall Study||15
7799635|NCT01213576|19201009|P4|STARTED|Overall Study||17
7799636|NCT01213576|19201010|P3|STARTED|Overall Study||18
7799637|NCT01213576|19201011|P2|STARTED|Overall Study||17
7799638|NCT01213576|19201012|P1|STARTED|Overall Study||18
7799639|NCT01213524|19201028|P1|NOT COMPLETED|Session 7||0
7799640|NCT01213524|19201028|P1|COMPLETED|Session 7||56
7799641|NCT01213524|19201028|P1|STARTED|Session 7||56
7799642|NCT01213524|19201028|P1|NOT COMPLETED|Session 6||0
7799643|NCT01213524|19201028|P1|COMPLETED|Session 6|Number who continued in the study to the next session|56
7799644|NCT01213524|19201028|P1|STARTED|Session 6||56
7799645|NCT01213524|19201028|P1|NOT COMPLETED|Session 5||0
7799646|NCT01213524|19201028|P1|COMPLETED|Session 5|Number who continued in the study to the next session|56
7799647|NCT01213524|19201028|P1|STARTED|Session 5||56
7799648|NCT01213524|19201028|P1|NOT COMPLETED|Session 4||3
7799649|NCT01213524|19201028|P1|COMPLETED|Session 4|Number who continued in the study to the next session|56
7799650|NCT01213524|19201028|P1|STARTED|Session 4||59
7799651|NCT01213524|19201028|P1|NOT COMPLETED|Session 3||4
7799652|NCT01213524|19201028|P1|COMPLETED|Session 3|Number who continued in study to next session|59
7799653|NCT01213524|19201028|P1|STARTED|Session 3||63
7799654|NCT01213524|19201028|P1|NOT COMPLETED|Session 2||5
7799655|NCT01213524|19201028|P1|COMPLETED|Session 2|Number who continued in the study to the next session|63
7799656|NCT01213524|19201028|P1|STARTED|Session 2||68
7799657|NCT01213524|19201028|P1|NOT COMPLETED|Baseline||7
7799658|NCT01213524|19201028|P1|COMPLETED|Baseline|Number of participants who continued in the study past baseline|68
7799659|NCT01213524|19201028|P1|STARTED|Baseline|Total number who signed informed consent.|75
7799660|NCT01213472|19201042|P1|NOT COMPLETED|Overall Study||27
7799661|NCT01213472|19201042|P1|COMPLETED|Overall Study||6
7799662|NCT01213472|19201042|P1|STARTED|Overall Study||33
7799663|NCT01213329|19201065|P2|NOT COMPLETED|Phase 2||0
7799664|NCT01213329|19201066|P1|NOT COMPLETED|Phase 2||0
7799665|NCT01213329|19201065|P2|COMPLETED|Phase 2||0
7799666|NCT01213329|19201066|P1|COMPLETED|Phase 2||0
7799667|NCT01213329|19201065|P2|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
7799668|NCT01213329|19201066|P1|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
7799669|NCT01213329|19201065|P2|NOT COMPLETED|Screening||0
7799670|NCT01213329|19201066|P1|NOT COMPLETED|Screening||0
7799671|NCT01213329|19201065|P2|COMPLETED|Screening||25
7799672|NCT01213329|19201066|P1|COMPLETED|Screening||25
7799673|NCT01213329|19201065|P2|STARTED|Screening||25
7799674|NCT01213329|19201066|P1|STARTED|Screening||25
7799675|NCT01213316|19201072|P1|NOT COMPLETED|Overall Study||0
7799676|NCT01213316|19201072|P1|COMPLETED|Overall Study||451
7799677|NCT01213316|19201072|P1|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272
7799678|NCT01213316|19201072|P1|Discontinued Treatment Before 48 Weeks|Overall Study||67
7799679|NCT01213316|19201072|P1|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179
7799680|NCT01213316|19201072|P1|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48
7799681|NCT01213316|19201072|P1|STARTED|Overall Study|Participants in the initial and amendment cohorts|451
7799682|NCT01213264|19201091|P3|NOT COMPLETED|Overall Study||6
7799683|NCT01213264|19201092|P2|NOT COMPLETED|Overall Study||2
7799684|NCT01213264|19201093|P1|NOT COMPLETED|Overall Study||2
7799685|NCT01213264|19201091|P3|COMPLETED|Overall Study||321
7799686|NCT01213264|19201092|P2|COMPLETED|Overall Study||175
7799687|NCT01213264|19201093|P1|COMPLETED|Overall Study||153
7799688|NCT01213264|19201091|P3|STARTED|Overall Study||327
7799689|NCT01213264|19201092|P2|STARTED|Overall Study||177
7799690|NCT01213264|19201093|P1|STARTED|Overall Study||155
7799691|NCT01213251|19201113|P3|NOT COMPLETED|Overall Study||11
7799692|NCT01213251|19201114|P2|NOT COMPLETED|Overall Study||4
7799693|NCT01213251|19201115|P1|NOT COMPLETED|Overall Study||6
7799694|NCT01213251|19201113|P3|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
7799695|NCT01213251|19201114|P2|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37
7799696|NCT01213251|19201115|P1|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
7799697|NCT01213251|19201113|P3|STARTED|Overall Study||45
7799698|NCT01213251|19201114|P2|STARTED|Overall Study||41
7799699|NCT01213251|19201115|P1|STARTED|Overall Study||40
7799700|NCT01213199|19201136|P1|NOT COMPLETED|Overall Study||4
7799701|NCT01213199|19201136|P1|COMPLETED|Overall Study||16
7799702|NCT01213199|19201136|P1|STARTED|Overall Study||20
7799703|NCT01213173|19201142|P2|NOT COMPLETED|Overall Study||16
7799704|NCT01213173|19201143|P1|NOT COMPLETED|Overall Study||12
7799705|NCT01213173|19201142|P2|COMPLETED|Overall Study|Patients who completed the study|110
7799706|NCT01213173|19201143|P1|COMPLETED|Overall Study|Patients who completed the study|113
7799707|NCT01213173|19201142|P2|Patients Included in PP Population|Overall Study||89
7799708|NCT01213173|19201143|P1|Patients Included in PP Population|Overall Study||102
7799709|NCT01213173|19201142|P2|Patients Included in ITT Population|Overall Study||115
7799710|NCT01213173|19201143|P1|Patients Included in ITT Population|Overall Study||116
7799711|NCT01213173|19201142|P2|Patients Included in Safety Population|Overall Study||112
7799712|NCT01213173|19201143|P1|Patients Included in Safety Population|Overall Study||139
7799713|NCT01213173|19201142|P2|STARTED|Overall Study|Patients who were randomized and received treatment|126
7799714|NCT01213173|19201143|P1|STARTED|Overall Study|Patients who were randomized and received treatment|125
7799715|NCT01213082|19201176|P3|NOT COMPLETED|Overall Study||5
7799716|NCT01213082|19201177|P2|NOT COMPLETED|Overall Study||7
7799717|NCT01213082|19201178|P1|NOT COMPLETED|Overall Study||6
7799718|NCT01213082|19201176|P3|COMPLETED|Overall Study||6
7799719|NCT01213082|19201177|P2|COMPLETED|Overall Study||4
7799720|NCT01213082|19201178|P1|COMPLETED|Overall Study||6
7799721|NCT01213082|19201176|P3|STARTED|Overall Study||11
7799722|NCT01213082|19201177|P2|STARTED|Overall Study||11
7799723|NCT01213082|19201178|P1|STARTED|Overall Study||12
7799724|NCT01213043|19201191|P2|NOT COMPLETED|Follow-up||0
7799725|NCT01213043|19201192|P1|NOT COMPLETED|Follow-up||0
7799726|NCT01213043|19201191|P2|COMPLETED|Follow-up||15
7799727|NCT01213043|19201192|P1|COMPLETED|Follow-up||15
7799728|NCT01213043|19201191|P2|STARTED|Follow-up||15
7799729|NCT01213043|19201192|P1|STARTED|Follow-up||15
7799730|NCT01213043|19201191|P2|NOT COMPLETED|Treatment Period 2||0
7799731|NCT01213043|19201192|P1|NOT COMPLETED|Treatment Period 2||0
7799732|NCT01213043|19201191|P2|COMPLETED|Treatment Period 2||15
7799733|NCT01213043|19201192|P1|COMPLETED|Treatment Period 2||15
7799734|NCT01213043|19201191|P2|STARTED|Treatment Period 2||15
7799735|NCT01213043|19201192|P1|STARTED|Treatment Period 2||15
7799736|NCT01213043|19201191|P2|NOT COMPLETED|Washout Period||0
7799737|NCT01213043|19201192|P1|NOT COMPLETED|Washout Period||0
7799738|NCT01213043|19201191|P2|COMPLETED|Washout Period||15
7799739|NCT01213043|19201192|P1|COMPLETED|Washout Period||15
7799740|NCT01213043|19201191|P2|STARTED|Washout Period||15
7799741|NCT01213043|19201192|P1|STARTED|Washout Period||15
7799742|NCT01213043|19201191|P2|NOT COMPLETED|Treatment Period 1||0
7799743|NCT01213043|19201192|P1|NOT COMPLETED|Treatment Period 1||0
7799744|NCT01213043|19201191|P2|COMPLETED|Treatment Period 1||15
7799745|NCT01213043|19201192|P1|COMPLETED|Treatment Period 1||15
7799746|NCT01213043|19201191|P2|STARTED|Treatment Period 1||15
7799747|NCT01213043|19201192|P1|STARTED|Treatment Period 1||15
7799748|NCT01212991|19201220|P3|NOT COMPLETED|Open-label||234
7799749|NCT01212991|19201221|P2|NOT COMPLETED|Open-label||0
7799750|NCT01212991|19201222|P1|NOT COMPLETED|Open-label||0
7799751|NCT01212991|19201220|P3|COMPLETED|Open-label||0
7799752|NCT01212991|19201221|P2|COMPLETED|Open-label||0
7799753|NCT01212991|19201222|P1|COMPLETED|Open-label||0
7799754|NCT01212991|19201220|P3|STARTED|Open-label|previous placebo treated participants were given the opportunity to receive enzalutamide|234
7799755|NCT01212991|19201221|P2|STARTED|Open-label|participants were given the opportunity to receive open-label access to enzalutamide|0
7799756|NCT01212991|19201222|P1|STARTED|Open-label||0
7799757|NCT01212991|19201220|P3|NOT COMPLETED|Double-blind||0
7799758|NCT01212991|19201221|P2|NOT COMPLETED|Double-blind||611
7799759|NCT01212991|19201222|P1|NOT COMPLETED|Double-blind||872
7799760|NCT01212991|19201220|P3|COMPLETED|Double-blind||0
7799761|NCT01212991|19201221|P2|COMPLETED|Double-blind||234
7799762|NCT01212991|19201222|P1|COMPLETED|Double-blind||0
7799763|NCT01212991|19201220|P3|Safety Population|Double-blind||0
7799764|NCT01212991|19201221|P2|Safety Population|Double-blind||844
7799765|NCT01212991|19201222|P1|Safety Population|Double-blind||871
7799766|NCT01212991|19201220|P3|STARTED|Double-blind||0
7799767|NCT01212991|19201221|P2|STARTED|Double-blind||845
7799768|NCT01212991|19201222|P1|STARTED|Double-blind||872
7799769|NCT01212952|19201253|P3|NOT COMPLETED|Overall Study||0
7799770|NCT01212952|19201254|P2|NOT COMPLETED|Overall Study||0
7799771|NCT01212952|19201255|P1|NOT COMPLETED|Overall Study||0
7799772|NCT01212952|19201253|P3|COMPLETED|Overall Study||41
7799773|NCT01212952|19201254|P2|COMPLETED|Overall Study||6
7799774|NCT01212952|19201255|P1|COMPLETED|Overall Study||3
7799775|NCT01212952|19201253|P3|STARTED|Overall Study||41
7799776|NCT01212952|19201254|P2|STARTED|Overall Study||6
7799777|NCT01212952|19201255|P1|STARTED|Overall Study||3
7799778|NCT01212900|19201273|P2|NOT COMPLETED|Overall Study||7
7799779|NCT01212900|19201274|P1|NOT COMPLETED|Overall Study||12
7799780|NCT01212900|19201273|P2|COMPLETED|Overall Study||107
7799781|NCT01212900|19201274|P1|COMPLETED|Overall Study||104
7799782|NCT01212900|19201273|P2|STARTED|Overall Study||114
7799783|NCT01212900|19201274|P1|STARTED|Overall Study||116
7799784|NCT01212874|19201282|P2|NOT COMPLETED|Overall Study||23
7799785|NCT01212874|19201283|P1|NOT COMPLETED|Overall Study||22
7799786|NCT01212874|19201282|P2|COMPLETED|Overall Study||12
7799787|NCT01212874|19201283|P1|COMPLETED|Overall Study||13
7799788|NCT01212874|19201282|P2|Received Allocated Intervention|Overall Study||12
7799789|NCT01212874|19201283|P1|Received Allocated Intervention|Overall Study||13
7799790|NCT01212874|19201282|P2|STARTED|Overall Study||35
7799791|NCT01212874|19201283|P1|STARTED|Overall Study||35
7799792|NCT01212770|19201294|P9|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
7799793|NCT01212770|19201295|P8|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
7799794|NCT01212770|19201296|P7|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
7799795|NCT01212770|19201297|P6|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
7799796|NCT01212770|19201298|P5|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
7799797|NCT01212770|19201299|P4|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
7799798|NCT01212770|19201300|P3|NOT COMPLETED|Long-term Safety Phase (Year 5)||11
7799799|NCT01212770|19201301|P2|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
7799800|NCT01212770|19201302|P1|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
7799801|NCT01212770|19201294|P9|COMPLETED|Long-term Safety Phase (Year 5)||41
7799802|NCT01212770|19201295|P8|COMPLETED|Long-term Safety Phase (Year 5)||30
7799803|NCT01212770|19201296|P7|COMPLETED|Long-term Safety Phase (Year 5)||0
7799804|NCT01212770|19201297|P6|COMPLETED|Long-term Safety Phase (Year 5)||0
7799805|NCT01212770|19201298|P5|COMPLETED|Long-term Safety Phase (Year 5)||0
7799806|NCT01212770|19201299|P4|COMPLETED|Long-term Safety Phase (Year 5)||0
7799807|NCT01212770|19201300|P3|COMPLETED|Long-term Safety Phase (Year 5)||72
7799808|NCT01212770|19201301|P2|COMPLETED|Long-term Safety Phase (Year 5)||68
7799809|NCT01212770|19201302|P1|COMPLETED|Long-term Safety Phase (Year 5)||0
7799810|NCT01212770|19201294|P9|STARTED|Long-term Safety Phase (Year 5)||42
7799811|NCT01212770|19201295|P8|STARTED|Long-term Safety Phase (Year 5)||32
7799812|NCT01212770|19201296|P7|STARTED|Long-term Safety Phase (Year 5)||0
7799813|NCT01212770|19201297|P6|STARTED|Long-term Safety Phase (Year 5)||0
7799814|NCT01212770|19201298|P5|STARTED|Long-term Safety Phase (Year 5)||0
7799815|NCT01212770|19201299|P4|STARTED|Long-term Safety Phase (Year 5)||0
7799816|NCT01212770|19201300|P3|STARTED|Long-term Safety Phase (Year 5)||83
7799817|NCT01212770|19201301|P2|STARTED|Long-term Safety Phase (Year 5)|1 participant who completed Year 4 did not continue treatment in Year 5|70
7799818|NCT01212770|19201302|P1|STARTED|Long-term Safety Phase (Year 5)||0
7799819|NCT01212770|19201294|P9|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
7799820|NCT01212770|19201295|P8|NOT COMPLETED|Long-term Safety Phase (Year 4)||3
7799821|NCT01212770|19201296|P7|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
7799822|NCT01212770|19201297|P6|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
7799823|NCT01212770|19201298|P5|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
7799824|NCT01212770|19201299|P4|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
7799825|NCT01212770|19201300|P3|NOT COMPLETED|Long-term Safety Phase (Year 4)||11
7799826|NCT01212770|19201301|P2|NOT COMPLETED|Long-term Safety Phase (Year 4)||6
7799827|NCT01212770|19201302|P1|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
7799828|NCT01212770|19201294|P9|COMPLETED|Long-term Safety Phase (Year 4)||42
7799829|NCT01212770|19201295|P8|COMPLETED|Long-term Safety Phase (Year 4)||32
7799830|NCT01212770|19201296|P7|COMPLETED|Long-term Safety Phase (Year 4)||0
7799831|NCT01212770|19201297|P6|COMPLETED|Long-term Safety Phase (Year 4)||0
7799832|NCT01212770|19201298|P5|COMPLETED|Long-term Safety Phase (Year 4)||0
7799833|NCT01212770|19201299|P4|COMPLETED|Long-term Safety Phase (Year 4)||0
7799834|NCT01212770|19201300|P3|COMPLETED|Long-term Safety Phase (Year 4)||83
7799835|NCT01212770|19201301|P2|COMPLETED|Long-term Safety Phase (Year 4)||71
7799836|NCT01212770|19201302|P1|COMPLETED|Long-term Safety Phase (Year 4)||0
7799837|NCT01212770|19201294|P9|STARTED|Long-term Safety Phase (Year 4)||44
7799838|NCT01212770|19201295|P8|STARTED|Long-term Safety Phase (Year 4)||35
7799839|NCT01212770|19201296|P7|STARTED|Long-term Safety Phase (Year 4)||0
7799840|NCT01212770|19201297|P6|STARTED|Long-term Safety Phase (Year 4)||0
7799841|NCT01212770|19201298|P5|STARTED|Long-term Safety Phase (Year 4)||0
7799842|NCT01212770|19201299|P4|STARTED|Long-term Safety Phase (Year 4)||0
7799843|NCT01212770|19201300|P3|STARTED|Long-term Safety Phase (Year 4)||94
7799844|NCT01212770|19201301|P2|STARTED|Long-term Safety Phase (Year 4)|1 participant was counted in Year 4 but not in year 3 due to late APR dispensing|77
7799845|NCT01212770|19201302|P1|STARTED|Long-term Safety Phase (Year 4)||0
7799846|NCT01212770|19201294|P9|NOT COMPLETED|Long-term Safety Phase (Year 3)||5
7799847|NCT01212770|19201295|P8|NOT COMPLETED|Long-term Safety Phase (Year 3)||7
7799848|NCT01212770|19201296|P7|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
7799849|NCT01212770|19201297|P6|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
7799850|NCT01212770|19201298|P5|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
7799851|NCT01212770|19201299|P4|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
7799852|NCT01212770|19201300|P3|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
7799853|NCT01212770|19201301|P2|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
7799854|NCT01212770|19201302|P1|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
7799855|NCT01212770|19201294|P9|COMPLETED|Long-term Safety Phase (Year 3)||44
7799856|NCT01212770|19201295|P8|COMPLETED|Long-term Safety Phase (Year 3)||35
7799857|NCT01212770|19201296|P7|COMPLETED|Long-term Safety Phase (Year 3)||0
7799858|NCT01212770|19201297|P6|COMPLETED|Long-term Safety Phase (Year 3)||0
7799859|NCT01212770|19201298|P5|COMPLETED|Long-term Safety Phase (Year 3)||0
7799860|NCT01212770|19201299|P4|COMPLETED|Long-term Safety Phase (Year 3)||0
7799861|NCT01212770|19201300|P3|COMPLETED|Long-term Safety Phase (Year 3)||94
7799862|NCT01212770|19201301|P2|COMPLETED|Long-term Safety Phase (Year 3)|1 participant missed due to APR dispensed late|76
7799863|NCT01212770|19201302|P1|COMPLETED|Long-term Safety Phase (Year 3)||0
7799864|NCT01212770|19201294|P9|STARTED|Long-term Safety Phase (Year 3)|Patients from the PBO/APR 30 mg EE and XO are combined;1 patient finished Wk 52;no entry into LTSP|49
7799865|NCT01212770|19201295|P8|STARTED|Long-term Safety Phase (Year 3)|The PBO/APR 20 mg EE and XO participants from week 24-52 are combined within the LTSP.|42
7799866|NCT01212770|19201296|P7|STARTED|Long-term Safety Phase (Year 3)||0
7799867|NCT01212770|19201297|P6|STARTED|Long-term Safety Phase (Year 3)||0
7799868|NCT01212770|19201298|P5|STARTED|Long-term Safety Phase (Year 3)||0
7799869|NCT01212770|19201299|P4|STARTED|Long-term Safety Phase (Year 3)||0
7799870|NCT01212770|19201300|P3|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|105
7799871|NCT01212770|19201301|P2|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|87
7799872|NCT01212770|19201302|P1|STARTED|Long-term Safety Phase (Year 3)||0
7799873|NCT01212770|19201294|P9|NOT COMPLETED|Long-term Safety Phase (Year 2)||14
7799874|NCT01212770|19201295|P8|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
7799875|NCT01212770|19201296|P7|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
7799876|NCT01212770|19201297|P6|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
7799877|NCT01212770|19201298|P5|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
7799878|NCT01212770|19201299|P4|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
7799879|NCT01212770|19201300|P3|NOT COMPLETED|Long-term Safety Phase (Year 2)||15
7799880|NCT01212770|19201301|P2|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
7799881|NCT01212770|19201302|P1|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
7799882|NCT01212770|19201294|P9|COMPLETED|Long-term Safety Phase (Year 2)||50
7799883|NCT01212770|19201295|P8|COMPLETED|Long-term Safety Phase (Year 2)||42
7799884|NCT01212770|19201296|P7|COMPLETED|Long-term Safety Phase (Year 2)||0
7799885|NCT01212770|19201297|P6|COMPLETED|Long-term Safety Phase (Year 2)||0
7799886|NCT01212770|19201298|P5|COMPLETED|Long-term Safety Phase (Year 2)||0
7799887|NCT01212770|19201299|P4|COMPLETED|Long-term Safety Phase (Year 2)||0
7799888|NCT01212770|19201300|P3|COMPLETED|Long-term Safety Phase (Year 2)||106
7799889|NCT01212770|19201301|P2|COMPLETED|Long-term Safety Phase (Year 2)||88
7799890|NCT01212770|19201302|P1|COMPLETED|Long-term Safety Phase (Year 2)||0
7799891|NCT01212770|19201294|P9|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;3 patients finished Wk 52;no entry into LTSP|64
7799892|NCT01212770|19201295|P8|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|51
7799893|NCT01212770|19201296|P7|STARTED|Long-term Safety Phase (Year 2)||0
7799894|NCT01212770|19201297|P6|STARTED|Long-term Safety Phase (Year 2)||0
7799895|NCT01212770|19201298|P5|STARTED|Long-term Safety Phase (Year 2)||0
7799896|NCT01212770|19201299|P4|STARTED|Long-term Safety Phase (Year 2)||0
7799897|NCT01212770|19201300|P3|STARTED|Long-term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|121
7799898|NCT01212770|19201301|P2|STARTED|Long-term Safety Phase (Year 2)|9 participants who completed Week 52 did not enter the long-term safety phase (LTSP)|111
7799899|NCT01212770|19201302|P1|STARTED|Long-term Safety Phase (Year 2)||0
7799900|NCT01212770|19201294|P9|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
7799901|NCT01212770|19201295|P8|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
7799902|NCT01212770|19201296|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
7799903|NCT01212770|19201297|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3
7799904|NCT01212770|19201298|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
7799905|NCT01212770|19201299|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11
7799906|NCT01212770|19201300|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
7799907|NCT01212770|19201301|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
7799908|NCT01212770|19201302|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
7799909|NCT01212770|19201294|P9|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
7799910|NCT01212770|19201295|P8|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
7799911|NCT01212770|19201296|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
7799912|NCT01212770|19201297|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
7799913|NCT01212770|19201298|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
7799914|NCT01212770|19201299|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32
7799915|NCT01212770|19201300|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126
7799916|NCT01212770|19201301|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120
7799917|NCT01212770|19201302|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
7799918|NCT01212770|19201294|P9|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
7799919|NCT01212770|19201295|P8|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
7799920|NCT01212770|19201296|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
7799921|NCT01212770|19201297|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|47
7799922|NCT01212770|19201298|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
7799923|NCT01212770|19201299|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|43
7799993|NCT01212757|19201502|P6|COMPLETED|Long-Term Safety Phase (Year 5)||0
7799924|NCT01212770|19201300|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|7 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|138
7799925|NCT01212770|19201301|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|139
7799926|NCT01212770|19201302|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
7799927|NCT01212770|19201294|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7799928|NCT01212770|19201295|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7799929|NCT01212770|19201296|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7799930|NCT01212770|19201297|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7799931|NCT01212770|19201298|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7799932|NCT01212770|19201299|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7799933|NCT01212770|19201300|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
7799934|NCT01212770|19201301|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
7799935|NCT01212770|19201302|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
7799936|NCT01212770|19201294|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7799937|NCT01212770|19201295|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7799938|NCT01212770|19201296|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7799939|NCT01212770|19201297|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7799940|NCT01212770|19201298|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7799941|NCT01212770|19201299|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7799942|NCT01212770|19201300|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145
7799943|NCT01212770|19201301|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147
7799944|NCT01212770|19201302|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
7799945|NCT01212770|19201294|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7799946|NCT01212770|19201295|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7799947|NCT01212770|19201296|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7799948|NCT01212770|19201297|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7799949|NCT01212770|19201298|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7799950|NCT01212770|19201299|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7799951|NCT01212770|19201300|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week 24|53
7799952|NCT01212770|19201301|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76
7799953|NCT01212770|19201302|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week (Wk) 24|97
7799954|NCT01212770|19201294|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7799955|NCT01212770|19201295|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7799956|NCT01212770|19201296|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7799957|NCT01212770|19201297|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7799958|NCT01212770|19201298|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7799959|NCT01212770|19201299|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7799960|NCT01212770|19201300|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
7799961|NCT01212770|19201301|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157
7799962|NCT01212770|19201302|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
7799963|NCT01212770|19201294|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
7799964|NCT01212770|19201295|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
7799965|NCT01212770|19201296|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
7799966|NCT01212770|19201297|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
7799967|NCT01212770|19201298|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
7799968|NCT01212770|19201299|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
7799969|NCT01212770|19201300|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167
7799970|NCT01212770|19201301|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
7799971|NCT01212770|19201302|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
7799972|NCT01212770|19201294|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
7799973|NCT01212770|19201295|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
7799974|NCT01212770|19201296|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
7799975|NCT01212770|19201297|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
7799976|NCT01212770|19201298|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
7799977|NCT01212770|19201299|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
7799978|NCT01212770|19201300|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||167
7799979|NCT01212770|19201301|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
7799980|NCT01212770|19201302|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
7799981|NCT01212757|19201499|P9|NOT COMPLETED|Long-Term Safety Phase (Year 5)||2
7799982|NCT01212757|19201500|P8|NOT COMPLETED|Long-Term Safety Phase (Year 5)||5
7799983|NCT01212757|19201501|P7|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
7799984|NCT01212757|19201502|P6|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
7799985|NCT01212757|19201503|P5|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
7799986|NCT01212757|19201504|P4|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
7799987|NCT01212757|19201505|P3|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
7799988|NCT01212757|19201506|P2|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
7799989|NCT01212757|19201507|P1|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
7799990|NCT01212757|19201499|P9|COMPLETED|Long-Term Safety Phase (Year 5)||37
7799991|NCT01212757|19201500|P8|COMPLETED|Long-Term Safety Phase (Year 5)||33
7799992|NCT01212757|19201501|P7|COMPLETED|Long-Term Safety Phase (Year 5)||0
7799994|NCT01212757|19201503|P5|COMPLETED|Long-Term Safety Phase (Year 5)||0
7799995|NCT01212757|19201504|P4|COMPLETED|Long-Term Safety Phase (Year 5)||0
7799996|NCT01212757|19201505|P3|COMPLETED|Long-Term Safety Phase (Year 5)||69
7799997|NCT01212757|19201506|P2|COMPLETED|Long-Term Safety Phase (Year 5)||72
7799998|NCT01212757|19201507|P1|COMPLETED|Long-Term Safety Phase (Year 5)||0
7799999|NCT01212757|19201499|P9|STARTED|Long-Term Safety Phase (Year 5)||39
7800000|NCT01212757|19201500|P8|STARTED|Long-Term Safety Phase (Year 5)|1 participant was only counted in year 5 but not in 4 year due to late APR dispensing|38
7800001|NCT01212757|19201501|P7|STARTED|Long-Term Safety Phase (Year 5)||0
7800002|NCT01212757|19201502|P6|STARTED|Long-Term Safety Phase (Year 5)||0
7800003|NCT01212757|19201503|P5|STARTED|Long-Term Safety Phase (Year 5)||0
7800004|NCT01212757|19201504|P4|STARTED|Long-Term Safety Phase (Year 5)||0
7800005|NCT01212757|19201505|P3|STARTED|Long-Term Safety Phase (Year 5)||77
7800006|NCT01212757|19201506|P2|STARTED|Long-Term Safety Phase (Year 5)||80
7800007|NCT01212757|19201507|P1|STARTED|Long-Term Safety Phase (Year 5)||0
7800008|NCT01212757|19201499|P9|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
7800009|NCT01212757|19201500|P8|NOT COMPLETED|Long-Term Safety Phase (Year 4)||4
7800010|NCT01212757|19201501|P7|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
7800011|NCT01212757|19201502|P6|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
7800012|NCT01212757|19201503|P5|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
7800013|NCT01212757|19201504|P4|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
7800014|NCT01212757|19201505|P3|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
7800015|NCT01212757|19201506|P2|NOT COMPLETED|Long-Term Safety Phase (Year 4)||9
7800016|NCT01212757|19201507|P1|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
7800017|NCT01212757|19201499|P9|COMPLETED|Long-Term Safety Phase (Year 4)||39
7800018|NCT01212757|19201500|P8|COMPLETED|Long-Term Safety Phase (Year 4)||37
7800019|NCT01212757|19201501|P7|COMPLETED|Long-Term Safety Phase (Year 4)||0
7800020|NCT01212757|19201502|P6|COMPLETED|Long-Term Safety Phase (Year 4)||0
7800021|NCT01212757|19201503|P5|COMPLETED|Long-Term Safety Phase (Year 4)||0
7800022|NCT01212757|19201504|P4|COMPLETED|Long-Term Safety Phase (Year 4)||0
7800023|NCT01212757|19201505|P3|COMPLETED|Long-Term Safety Phase (Year 4)||77
7800024|NCT01212757|19201506|P2|COMPLETED|Long-Term Safety Phase (Year 4)||80
7800025|NCT01212757|19201507|P1|COMPLETED|Long-Term Safety Phase (Year 4)||0
7800026|NCT01212757|19201499|P9|STARTED|Long-Term Safety Phase (Year 4)||46
7800027|NCT01212757|19201500|P8|STARTED|Long-Term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|41
7800028|NCT01212757|19201501|P7|STARTED|Long-Term Safety Phase (Year 4)||0
7800029|NCT01212757|19201502|P6|STARTED|Long-Term Safety Phase (Year 4)||0
7800030|NCT01212757|19201503|P5|STARTED|Long-Term Safety Phase (Year 4)||0
7800031|NCT01212757|19201504|P4|STARTED|Long-Term Safety Phase (Year 4)||0
7800032|NCT01212757|19201505|P3|STARTED|Long-Term Safety Phase (Year 4)||84
7800033|NCT01212757|19201506|P2|STARTED|Long-Term Safety Phase (Year 4)||89
7800034|NCT01212757|19201507|P1|STARTED|Long-Term Safety Phase (Year 4)||0
7800035|NCT01212757|19201499|P9|NOT COMPLETED|Long-Term Safety Phase (Year 3)||5
7800036|NCT01212757|19201500|P8|NOT COMPLETED|Long-Term Safety Phase (Year 3)||6
7800037|NCT01212757|19201501|P7|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
7800038|NCT01212757|19201502|P6|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
7800039|NCT01212757|19201503|P5|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
7800040|NCT01212757|19201504|P4|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
7800041|NCT01212757|19201505|P3|NOT COMPLETED|Long-Term Safety Phase (Year 3)||11
7800042|NCT01212757|19201506|P2|NOT COMPLETED|Long-Term Safety Phase (Year 3)||18
7800043|NCT01212757|19201507|P1|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
7800044|NCT01212757|19201499|P9|COMPLETED|Long-Term Safety Phase (Year 3)||46
7800045|NCT01212757|19201500|P8|COMPLETED|Long-Term Safety Phase (Year 3)||42
7800046|NCT01212757|19201501|P7|COMPLETED|Long-Term Safety Phase (Year 3)||0
7800047|NCT01212757|19201502|P6|COMPLETED|Long-Term Safety Phase (Year 3)||0
7800048|NCT01212757|19201503|P5|COMPLETED|Long-Term Safety Phase (Year 3)||0
7800049|NCT01212757|19201504|P4|COMPLETED|Long-Term Safety Phase (Year 3)||0
7800050|NCT01212757|19201505|P3|COMPLETED|Long-Term Safety Phase (Year 3)||84
7800051|NCT01212757|19201506|P2|COMPLETED|Long-Term Safety Phase (Year 3)||89
7800052|NCT01212757|19201507|P1|COMPLETED|Long-Term Safety Phase (Year 3)||0
7800053|NCT01212757|19201499|P9|STARTED|Long-Term Safety Phase (Year 3)||51
7800054|NCT01212757|19201500|P8|STARTED|Long-Term Safety Phase (Year 3)||48
7800055|NCT01212757|19201501|P7|STARTED|Long-Term Safety Phase (Year 3)||0
7800056|NCT01212757|19201502|P6|STARTED|Long-Term Safety Phase (Year 3)||0
7800057|NCT01212757|19201503|P5|STARTED|Long-Term Safety Phase (Year 3)||0
7800058|NCT01212757|19201504|P4|STARTED|Long-Term Safety Phase (Year 3)||0
7800059|NCT01212757|19201505|P3|STARTED|Long-Term Safety Phase (Year 3)||95
7800060|NCT01212757|19201506|P2|STARTED|Long-Term Safety Phase (Year 3)||107
7800061|NCT01212757|19201507|P1|STARTED|Long-Term Safety Phase (Year 3)||0
7800062|NCT01212757|19201499|P9|NOT COMPLETED|Long-Term Safety Phase (Year 2)||9
7800063|NCT01212757|19201500|P8|NOT COMPLETED|Long-Term Safety Phase (Year 2)||10
7800064|NCT01212757|19201501|P7|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
7800065|NCT01212757|19201502|P6|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
7800066|NCT01212757|19201503|P5|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
7800067|NCT01212757|19201504|P4|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
7800068|NCT01212757|19201505|P3|NOT COMPLETED|Long-Term Safety Phase (Year 2)||14
7800069|NCT01212757|19201506|P2|NOT COMPLETED|Long-Term Safety Phase (Year 2)||12
7800070|NCT01212757|19201507|P1|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
7800071|NCT01212757|19201499|P9|COMPLETED|Long-Term Safety Phase (Year 2)||51
7800072|NCT01212757|19201500|P8|COMPLETED|Long-Term Safety Phase (Year 2)||48
7800073|NCT01212757|19201501|P7|COMPLETED|Long-Term Safety Phase (Year 2)||0
7800074|NCT01212757|19201502|P6|COMPLETED|Long-Term Safety Phase (Year 2)||0
7800075|NCT01212757|19201503|P5|COMPLETED|Long-Term Safety Phase (Year 2)||0
7800076|NCT01212757|19201504|P4|COMPLETED|Long-Term Safety Phase (Year 2)||0
7800077|NCT01212757|19201505|P3|COMPLETED|Long-Term Safety Phase (Year 2)||95
7800078|NCT01212757|19201506|P2|COMPLETED|Long-Term Safety Phase (Year 2)||107
7800079|NCT01212757|19201507|P1|COMPLETED|Long-Term Safety Phase (Year 2)||0
7800080|NCT01212757|19201499|P9|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 30EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|60
7800081|NCT01212757|19201500|P8|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 20EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|58
7800082|NCT01212757|19201501|P7|STARTED|Long-Term Safety Phase (Year 2)||0
7800083|NCT01212757|19201502|P6|STARTED|Long-Term Safety Phase (Year 2)||0
7800084|NCT01212757|19201503|P5|STARTED|Long-Term Safety Phase (Year 2)||0
7800085|NCT01212757|19201504|P4|STARTED|Long-Term Safety Phase (Year 2)||0
7800086|NCT01212757|19201505|P3|STARTED|Long-Term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|109
7800087|NCT01212757|19201506|P2|STARTED|Long-Term Safety Phase (Year 2)|6 participants who completed Week 52 did not enter the long-term safety phase|119
7800088|NCT01212757|19201507|P1|STARTED|Long-Term Safety Phase (Year 2)||0
7800089|NCT01212757|19201499|P9|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
7800090|NCT01212757|19201500|P8|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
7800091|NCT01212757|19201501|P7|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
7800092|NCT01212757|19201502|P6|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||7
7800093|NCT01212757|19201503|P5|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||2
7800094|NCT01212757|19201504|P4|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||8
7800095|NCT01212757|19201505|P3|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||20
7800096|NCT01212757|19201506|P2|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
7800097|NCT01212757|19201507|P1|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
7800098|NCT01212757|19201499|P9|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
7800099|NCT01212757|19201500|P8|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
7800100|NCT01212757|19201501|P7|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||28
7800101|NCT01212757|19201502|P6|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||34
7800102|NCT01212757|19201503|P5|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||25
7800103|NCT01212757|19201504|P4|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||35
7800104|NCT01212757|19201505|P3|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||114
7800105|NCT01212757|19201506|P2|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||125
7800106|NCT01212757|19201507|P1|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
7800107|NCT01212757|19201499|P9|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
7800108|NCT01212757|19201500|P8|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
7800109|NCT01212757|19201501|P7|STARTED|Active Treatment Phase (Weeks 24 - 52)||28
7800110|NCT01212757|19201502|P6|STARTED|Active Treatment Phase (Weeks 24 - 52)|2 participants who EE and completed Week 24 did not enter the Week 24-52 active treatment phase|41
7800111|NCT01212757|19201503|P5|STARTED|Active Treatment Phase (Weeks 24 - 52)||27
7800112|NCT01212757|19201504|P4|STARTED|Active Treatment Phase (Weeks 24 - 52)||43
7800113|NCT01212757|19201505|P3|STARTED|Active Treatment Phase (Weeks 24 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|134
7800114|NCT01212757|19201506|P2|STARTED|Active Treatment Phase (Weeks 24 - 52)|6 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|137
7800115|NCT01212757|19201507|P1|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
7800116|NCT01212757|19201499|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7800117|NCT01212757|19201500|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7800118|NCT01212757|19201501|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7800119|NCT01212757|19201502|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7800120|NCT01212757|19201503|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7800121|NCT01212757|19201504|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7800122|NCT01212757|19201505|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21
7800123|NCT01212757|19201506|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
7800124|NCT01212757|19201507|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19
7800125|NCT01212757|19201499|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7800126|NCT01212757|19201500|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7800127|NCT01212757|19201501|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7800128|NCT01212757|19201502|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7800129|NCT01212757|19201503|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7800130|NCT01212757|19201504|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
7800131|NCT01212757|19201505|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142
7800132|NCT01212757|19201506|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143
7800133|NCT01212757|19201507|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143
7800134|NCT01212757|19201499|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7800135|NCT01212757|19201500|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7800136|NCT01212757|19201501|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7800137|NCT01212757|19201502|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7800138|NCT01212757|19201503|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7800139|NCT01212757|19201504|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7800140|NCT01212757|19201505|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64
7800141|NCT01212757|19201506|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59
7800142|NCT01212757|19201507|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88
7800143|NCT01212757|19201499|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7800144|NCT01212757|19201500|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7800145|NCT01212757|19201501|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7800146|NCT01212757|19201502|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7800147|NCT01212757|19201503|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7800148|NCT01212757|19201504|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
7800149|NCT01212757|19201505|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149
7800150|NCT01212757|19201506|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151
7800151|NCT01212757|19201507|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148
7800152|NCT01212757|19201499|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
7800153|NCT01212757|19201500|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
7800154|NCT01212757|19201501|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
7800155|NCT01212757|19201502|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
7800156|NCT01212757|19201503|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
7800157|NCT01212757|19201504|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
7800158|NCT01212757|19201505|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162
7800159|NCT01212757|19201506|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163
7800160|NCT01212757|19201507|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159
7800161|NCT01212757|19201499|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
7800162|NCT01212757|19201500|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
7800163|NCT01212757|19201501|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
7800164|NCT01212757|19201502|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
7800165|NCT01212757|19201503|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
7800166|NCT01212757|19201504|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
7800167|NCT01212757|19201505|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
7800168|NCT01212757|19201506|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
7800169|NCT01212757|19201507|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||162
7800170|NCT01212744|19201691|P1|NOT COMPLETED|Overall Study||1
7800171|NCT01212744|19201691|P1|COMPLETED|Overall Study||15
7800172|NCT01212744|19201691|P1|STARTED|Overall Study||16
7800173|NCT01212627|19201704|P1|NOT COMPLETED|Overall Study||0
7800174|NCT01212627|19201704|P1|COMPLETED|Overall Study||12
7800175|NCT01212627|19201704|P1|STARTED|Overall Study||12
7800176|NCT01212588|19201710|P2|NOT COMPLETED|Overall Study||2
7800177|NCT01212588|19201711|P1|NOT COMPLETED|Overall Study||1
7800178|NCT01212588|19201710|P2|COMPLETED|Overall Study||10
7800179|NCT01212588|19201711|P1|COMPLETED|Overall Study||9
7800180|NCT01212588|19201710|P2|STARTED|Overall Study||12
7800181|NCT01212588|19201711|P1|STARTED|Overall Study||10
7800182|NCT01212484|19201745|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
7800183|NCT01212484|19201746|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
7800184|NCT01212484|19201745|P2|COMPLETED|Second Intervention (4 Weeks)||3
7800185|NCT01212484|19201746|P1|COMPLETED|Second Intervention (4 Weeks)||5
7800186|NCT01212484|19201745|P2|STARTED|Second Intervention (4 Weeks)||4
7800187|NCT01212484|19201746|P1|STARTED|Second Intervention (4 Weeks)||5
7800188|NCT01212484|19201745|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
7800189|NCT01212484|19201746|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
7800190|NCT01212484|19201745|P2|COMPLETED|First Intervention (4 Weeks)||4
7800191|NCT01212484|19201746|P1|COMPLETED|First Intervention (4 Weeks)||5
7800192|NCT01212484|19201745|P2|STARTED|First Intervention (4 Weeks)||6
7800193|NCT01212484|19201746|P1|STARTED|First Intervention (4 Weeks)||5
7800194|NCT01212484|19201745|P2|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0
7800195|NCT01212484|19201746|P1|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1
7800196|NCT01212484|19201745|P2|COMPLETED|Carbidopa Titration Period (4 Weeks)||6
7800197|NCT01212484|19201746|P1|COMPLETED|Carbidopa Titration Period (4 Weeks)||5
7800198|NCT01212484|19201745|P2|STARTED|Carbidopa Titration Period (4 Weeks)||6
7800199|NCT01212484|19201746|P1|STARTED|Carbidopa Titration Period (4 Weeks)||6
7800200|NCT01212471|19201759|P3|NOT COMPLETED|Overall Study||7
7800201|NCT01212471|19201760|P2|NOT COMPLETED|Overall Study||3
7800202|NCT01212471|19201761|P1|NOT COMPLETED|Overall Study||2
7800203|NCT01212471|19201759|P3|COMPLETED|Overall Study||132
7800204|NCT01212471|19201760|P2|COMPLETED|Overall Study||137
7800205|NCT01212471|19201761|P1|COMPLETED|Overall Study||139
7800206|NCT01212471|19201759|P3|STARTED|Overall Study||139
7800207|NCT01212471|19201760|P2|STARTED|Overall Study||140
7800208|NCT01212471|19201761|P1|STARTED|Overall Study||141
7800209|NCT01212445|19201772|P3|NOT COMPLETED|Overall Study||0
7800210|NCT01212445|19201773|P2|NOT COMPLETED|Overall Study||0
7800211|NCT01212445|19201774|P1|NOT COMPLETED|Overall Study||0
7800212|NCT01212445|19201772|P3|COMPLETED|Overall Study||51
7800213|NCT01212445|19201773|P2|COMPLETED|Overall Study||51
7800214|NCT01212445|19201774|P1|COMPLETED|Overall Study||52
7800215|NCT01212445|19201772|P3|STARTED|Overall Study||51
7800216|NCT01212445|19201773|P2|STARTED|Overall Study||51
7800217|NCT01212445|19201774|P1|STARTED|Overall Study||52
7800218|NCT01212302|19201803|P1|NOT COMPLETED|Overall Study||0
7800219|NCT01212302|19201803|P1|COMPLETED|Overall Study||504
7800220|NCT01212302|19201803|P1|STARTED|Overall Study||504
7800221|NCT01212185|19201809|P2|NOT COMPLETED|Overall Study||1
7800222|NCT01212185|19201810|P1|NOT COMPLETED|Overall Study||2
7800223|NCT01212185|19201809|P2|COMPLETED|Overall Study||7
7800224|NCT01212185|19201810|P1|COMPLETED|Overall Study||4
7800225|NCT01212185|19201809|P2|STARTED|Overall Study||8
7800226|NCT01212185|19201810|P1|STARTED|Overall Study||6
7800227|NCT01212172|19201818|P2|NOT COMPLETED|Overall Study||1
7800228|NCT01212172|19201819|P1|NOT COMPLETED|Overall Study||1
7800229|NCT01212172|19201818|P2|COMPLETED|Overall Study||9
7800230|NCT01212172|19201819|P1|COMPLETED|Overall Study||9
7800231|NCT01212172|19201818|P2|STARTED|Overall Study||10
7800232|NCT01212172|19201819|P1|STARTED|Overall Study||10
7800233|NCT01212159|19201829|P2|NOT COMPLETED|Overall Study||12
7800234|NCT01212159|19201830|P1|NOT COMPLETED|Overall Study||12
7800235|NCT01212159|19201829|P2|COMPLETED|Overall Study||32
7800236|NCT01212159|19201830|P1|COMPLETED|Overall Study||14
7800237|NCT01212159|19201829|P2|STARTED|Overall Study||44
7800238|NCT01212159|19201830|P1|STARTED|Overall Study||26
7800239|NCT01212107|19201852|P12|NOT COMPLETED|Overall Study||32
7800240|NCT01212107|19201853|P11|NOT COMPLETED|Overall Study||1
7800241|NCT01212107|19201854|P10|NOT COMPLETED|Overall Study||2
7800242|NCT01212107|19201855|P9|NOT COMPLETED|Overall Study||2
7800243|NCT01212107|19201856|P8|NOT COMPLETED|Overall Study||1
7800244|NCT01212107|19201857|P7|NOT COMPLETED|Overall Study||0
7800245|NCT01212107|19201858|P6|NOT COMPLETED|Overall Study||1
7800246|NCT01212107|19201859|P5|NOT COMPLETED|Overall Study||1
7800247|NCT01212107|19201860|P4|NOT COMPLETED|Overall Study||0
7800248|NCT01212107|19201861|P3|NOT COMPLETED|Overall Study||3
7800249|NCT01212107|19201862|P2|NOT COMPLETED|Overall Study||1
7800250|NCT01212107|19201863|P1|NOT COMPLETED|Overall Study||1
7800251|NCT01212107|19201852|P12|COMPLETED|Overall Study||26
7800252|NCT01212107|19201853|P11|COMPLETED|Overall Study||2
7800253|NCT01212107|19201854|P10|COMPLETED|Overall Study||1
7800254|NCT01212107|19201855|P9|COMPLETED|Overall Study||1
7800255|NCT01212107|19201856|P8|COMPLETED|Overall Study||2
7800256|NCT01212107|19201857|P7|COMPLETED|Overall Study||3
7800257|NCT01212107|19201858|P6|COMPLETED|Overall Study||2
7800258|NCT01212107|19201859|P5|COMPLETED|Overall Study||2
7800259|NCT01212107|19201860|P4|COMPLETED|Overall Study||3
7800260|NCT01212107|19201861|P3|COMPLETED|Overall Study||3
7800261|NCT01212107|19201862|P2|COMPLETED|Overall Study||2
7800262|NCT01212107|19201863|P1|COMPLETED|Overall Study||2
7800263|NCT01212107|19201852|P12|STARTED|Overall Study||58
7800264|NCT01212107|19201853|P11|STARTED|Overall Study||3
7800265|NCT01212107|19201854|P10|STARTED|Overall Study||3
7800266|NCT01212107|19201855|P9|STARTED|Overall Study||3
7800267|NCT01212107|19201856|P8|STARTED|Overall Study||3
7800268|NCT01212107|19201857|P7|STARTED|Overall Study||3
7800269|NCT01212107|19201858|P6|STARTED|Overall Study||3
7800270|NCT01212107|19201859|P5|STARTED|Overall Study||3
7800271|NCT01212107|19201860|P4|STARTED|Overall Study||3
7800272|NCT01212107|19201861|P3|STARTED|Overall Study||6
7800273|NCT01212107|19201862|P2|STARTED|Overall Study||3
7800274|NCT01212107|19201863|P1|STARTED|Overall Study||3
7800275|NCT01212094|19201929|P3|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11
7800276|NCT01212094|19201930|P2|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4
7800277|NCT01212094|19201931|P1|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0
7800278|NCT01212094|19201929|P3|COMPLETED|Years 2 & 3: Treatment Randomization||7
7800279|NCT01212094|19201930|P2|COMPLETED|Years 2 & 3: Treatment Randomization||5
7800280|NCT01212094|19201931|P1|COMPLETED|Years 2 & 3: Treatment Randomization||0
7800281|NCT01212094|19201929|P3|STARTED|Years 2 & 3: Treatment Randomization||18
7800282|NCT01212094|19201930|P2|STARTED|Years 2 & 3: Treatment Randomization||9
7800283|NCT01212094|19201931|P1|STARTED|Years 2 & 3: Treatment Randomization||0
7800284|NCT01212094|19201929|P3|NOT COMPLETED|Year 1: Baseline Monitoring||0
7800285|NCT01212094|19201930|P2|NOT COMPLETED|Year 1: Baseline Monitoring||0
7800286|NCT01212094|19201931|P1|NOT COMPLETED|Year 1: Baseline Monitoring||16
7800287|NCT01212094|19201929|P3|COMPLETED|Year 1: Baseline Monitoring||0
7800288|NCT01212094|19201930|P2|COMPLETED|Year 1: Baseline Monitoring||0
7800289|NCT01212094|19201931|P1|COMPLETED|Year 1: Baseline Monitoring||27
7800290|NCT01212094|19201929|P3|STARTED|Year 1: Baseline Monitoring||0
7800291|NCT01212094|19201930|P2|STARTED|Year 1: Baseline Monitoring||0
7800292|NCT01212094|19201931|P1|STARTED|Year 1: Baseline Monitoring||43
7800293|NCT01211873|19201965|P3|NOT COMPLETED|Overall Study||2
7800294|NCT01211873|19201966|P2|NOT COMPLETED|Overall Study||2
7800295|NCT01211873|19201967|P1|NOT COMPLETED|Overall Study||5
7800296|NCT01211873|19201965|P3|COMPLETED|Overall Study||36
7800297|NCT01211873|19201966|P2|COMPLETED|Overall Study||117
7800298|NCT01211873|19201967|P1|COMPLETED|Overall Study||240
7800299|NCT01211873|19201965|P3|STARTED|Overall Study||38
7800300|NCT01211873|19201966|P2|STARTED|Overall Study||119
7800301|NCT01211873|19201967|P1|STARTED|Overall Study||245
7800302|NCT01211769|19201990|P4|NOT COMPLETED|Overall Study||11
7800303|NCT01211769|19201991|P3|NOT COMPLETED|Overall Study||8
7800304|NCT01211769|19201992|P2|NOT COMPLETED|Overall Study||10
7800305|NCT01211769|19201993|P1|NOT COMPLETED|Overall Study||9
7800306|NCT01211769|19201990|P4|COMPLETED|Overall Study||9
7800307|NCT01211769|19201991|P3|COMPLETED|Overall Study||12
7800308|NCT01211769|19201992|P2|COMPLETED|Overall Study||10
7800309|NCT01211769|19201993|P1|COMPLETED|Overall Study||11
7800310|NCT01211769|19201990|P4|Participants/Group|Overall Study||20
7800311|NCT01211769|19201991|P3|Participants/Group|Overall Study||20
7800312|NCT01211769|19201992|P2|Participants/Group|Overall Study||20
7800313|NCT01211769|19201993|P1|Participants/Group|Overall Study||20
7800314|NCT01211769|19201990|P4|STARTED|Overall Study||20
7800315|NCT01211769|19201991|P3|STARTED|Overall Study||20
7800316|NCT01211769|19201992|P2|STARTED|Overall Study||20
7800317|NCT01211769|19201993|P1|STARTED|Overall Study||20
7800318|NCT01211756|19202011|P1|NOT COMPLETED|Overall Study||0
7800319|NCT01211756|19202011|P1|COMPLETED|Overall Study||1
7800320|NCT01211756|19202011|P1|STARTED|Overall Study||1
7800321|NCT01211730|19202029|P2|NOT COMPLETED|Overall Study||0
7800322|NCT01211730|19202030|P1|NOT COMPLETED|Overall Study||0
7800323|NCT01211730|19202029|P2|COMPLETED|Overall Study||82
7800324|NCT01211730|19202030|P1|COMPLETED|Overall Study||82
7800325|NCT01211730|19202029|P2|STARTED|Overall Study||82
7800326|NCT01211730|19202030|P1|STARTED|Overall Study||82
7800327|NCT01211665|19202048|P2|NOT COMPLETED|Overall Study||0
7800328|NCT01211665|19202049|P1|NOT COMPLETED|Overall Study||2
7800329|NCT01211665|19202048|P2|COMPLETED|Overall Study|completed treatment with study drug|1
7800330|NCT01211665|19202049|P1|COMPLETED|Overall Study||0
7800331|NCT01211665|19202048|P2|STARTED|Overall Study||1
7800332|NCT01211665|19202049|P1|STARTED|Overall Study||2
7800333|NCT01211613|19202076|P3|NOT COMPLETED|Overall Study||2
7800334|NCT01211613|19202077|P2|NOT COMPLETED|Overall Study||2
7800335|NCT01211613|19202078|P1|NOT COMPLETED|Overall Study||3
7800336|NCT01211613|19202076|P3|COMPLETED|Overall Study||33
7800337|NCT01211613|19202077|P2|COMPLETED|Overall Study||33
7800338|NCT01211613|19202078|P1|COMPLETED|Overall Study||34
7800339|NCT01211613|19202076|P3|STARTED|Overall Study||35
7800340|NCT01211613|19202077|P2|STARTED|Overall Study||35
7800341|NCT01211613|19202078|P1|STARTED|Overall Study||37
7800342|NCT01211600|19202091|P2|NOT COMPLETED|Overall Study||0
7800343|NCT01211600|19202092|P1|NOT COMPLETED|Overall Study||0
7800344|NCT01211600|19202091|P2|COMPLETED|Overall Study||376
7800345|NCT01211600|19202092|P1|COMPLETED|Overall Study||370
7800346|NCT01211600|19202091|P2|STARTED|Overall Study||376
7800347|NCT01211600|19202092|P1|STARTED|Overall Study||370
7800348|NCT01211535|19202124|P2|NOT COMPLETED|Overall Study||1
7800349|NCT01211535|19202125|P1|NOT COMPLETED|Overall Study||0
7800350|NCT01211535|19202124|P2|COMPLETED|Overall Study||51
7800351|NCT01211535|19202125|P1|COMPLETED|Overall Study||52
7800352|NCT01211535|19202124|P2|STARTED|Overall Study||52
7800353|NCT01211535|19202125|P1|STARTED|Overall Study||52
7800354|NCT01211522|19202134|P3|NOT COMPLETED|Overall Study||5
7800355|NCT01211522|19202135|P2|NOT COMPLETED|Overall Study||7
7800356|NCT01211522|19202136|P1|NOT COMPLETED|Overall Study||3
7800357|NCT01211522|19202134|P3|COMPLETED|Overall Study||179
7800358|NCT01211522|19202135|P2|COMPLETED|Overall Study||183
7800359|NCT01211522|19202136|P1|COMPLETED|Overall Study||189
7800360|NCT01211522|19202134|P3|STARTED|Overall Study||184
7800361|NCT01211522|19202135|P2|STARTED|Overall Study||190
7800362|NCT01211522|19202136|P1|STARTED|Overall Study||192
7800363|NCT01211340|19202173|P2|NOT COMPLETED|Overall Study||0
7800364|NCT01211340|19202174|P1|NOT COMPLETED|Overall Study||0
7800365|NCT01211340|19202173|P2|COMPLETED|Overall Study||223
7800366|NCT01211340|19202174|P1|COMPLETED|Overall Study||223
7800367|NCT01211340|19202173|P2|STARTED|Overall Study||223
7800368|NCT01211340|19202174|P1|STARTED|Overall Study||223
7800369|NCT01211288|19202186|P2|NOT COMPLETED|Overall Study||1
7800370|NCT01211288|19202187|P1|NOT COMPLETED|Overall Study||1
7800371|NCT01211288|19202186|P2|COMPLETED|Overall Study||19
7800372|NCT01211288|19202187|P1|COMPLETED|Overall Study||20
7800373|NCT01211288|19202186|P2|STARTED|Overall Study||20
7800374|NCT01211288|19202187|P1|STARTED|Overall Study||21
7800375|NCT01211262|19202205|P2|NOT COMPLETED|Overall Study||10
7800376|NCT01211262|19202206|P1|NOT COMPLETED|Overall Study||23
7800377|NCT01211262|19202205|P2|COMPLETED|Overall Study||8
7800378|NCT01211262|19202206|P1|COMPLETED|Overall Study||43
7800379|NCT01211262|19202205|P2|STARTED|Overall Study||18
7800380|NCT01211262|19202206|P1|STARTED|Overall Study||66
7800381|NCT01211197|19202246|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7800382|NCT01211197|19202247|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7800383|NCT01211197|19202248|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7800384|NCT01211197|19202249|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7800385|NCT01211197|19202250|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7800386|NCT01211197|19202251|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
7800387|NCT01211197|19202246|P6|COMPLETED|Treatment Period 3 (1 Day)||2
7800388|NCT01211197|19202247|P5|COMPLETED|Treatment Period 3 (1 Day)||2
7800389|NCT01211197|19202248|P4|COMPLETED|Treatment Period 3 (1 Day)||3
7800390|NCT01211197|19202249|P3|COMPLETED|Treatment Period 3 (1 Day)||2
7800391|NCT01211197|19202250|P2|COMPLETED|Treatment Period 3 (1 Day)||3
7800392|NCT01211197|19202251|P1|COMPLETED|Treatment Period 3 (1 Day)||2
7800393|NCT01211197|19202246|P6|STARTED|Treatment Period 3 (1 Day)||2
7800394|NCT01211197|19202247|P5|STARTED|Treatment Period 3 (1 Day)||2
7800395|NCT01211197|19202248|P4|STARTED|Treatment Period 3 (1 Day)||3
7800396|NCT01211197|19202249|P3|STARTED|Treatment Period 3 (1 Day)||2
7800397|NCT01211197|19202250|P2|STARTED|Treatment Period 3 (1 Day)||3
7800398|NCT01211197|19202251|P1|STARTED|Treatment Period 3 (1 Day)||2
7800399|NCT01211197|19202246|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
7800400|NCT01211197|19202247|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
7800401|NCT01211197|19202248|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
7800402|NCT01211197|19202249|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
7800403|NCT01211197|19202250|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
7800404|NCT01211197|19202251|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
7800405|NCT01211197|19202246|P6|COMPLETED|Washout Period 2 (7 Days)||2
7800406|NCT01211197|19202247|P5|COMPLETED|Washout Period 2 (7 Days)||2
7800407|NCT01211197|19202248|P4|COMPLETED|Washout Period 2 (7 Days)||3
7800408|NCT01211197|19202249|P3|COMPLETED|Washout Period 2 (7 Days)||2
7800409|NCT01211197|19202250|P2|COMPLETED|Washout Period 2 (7 Days)||3
7800410|NCT01211197|19202251|P1|COMPLETED|Washout Period 2 (7 Days)||2
7800411|NCT01211197|19202246|P6|STARTED|Washout Period 2 (7 Days)||2
7800412|NCT01211197|19202247|P5|STARTED|Washout Period 2 (7 Days)||2
7800413|NCT01211197|19202248|P4|STARTED|Washout Period 2 (7 Days)||3
7800414|NCT01211197|19202249|P3|STARTED|Washout Period 2 (7 Days)||2
7800415|NCT01211197|19202250|P2|STARTED|Washout Period 2 (7 Days)||3
7800416|NCT01211197|19202251|P1|STARTED|Washout Period 2 (7 Days)||3
7800417|NCT01211197|19202246|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7800418|NCT01211197|19202247|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7800419|NCT01211197|19202248|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7800420|NCT01211197|19202249|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7800421|NCT01211197|19202250|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7800422|NCT01211197|19202251|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7800423|NCT01211197|19202246|P6|COMPLETED|Treatment Period 2 (1 Day)||2
7800424|NCT01211197|19202247|P5|COMPLETED|Treatment Period 2 (1 Day)||2
7800425|NCT01211197|19202248|P4|COMPLETED|Treatment Period 2 (1 Day)||3
7800426|NCT01211197|19202249|P3|COMPLETED|Treatment Period 2 (1 Day)||2
7800427|NCT01211197|19202250|P2|COMPLETED|Treatment Period 2 (1 Day)||3
7800428|NCT01211197|19202251|P1|COMPLETED|Treatment Period 2 (1 Day)||3
7800429|NCT01211197|19202246|P6|STARTED|Treatment Period 2 (1 Day)||2
7800430|NCT01211197|19202247|P5|STARTED|Treatment Period 2 (1 Day)||2
7800431|NCT01211197|19202248|P4|STARTED|Treatment Period 2 (1 Day)||3
7800432|NCT01211197|19202249|P3|STARTED|Treatment Period 2 (1 Day)||2
7800433|NCT01211197|19202250|P2|STARTED|Treatment Period 2 (1 Day)||3
7800434|NCT01211197|19202251|P1|STARTED|Treatment Period 2 (1 Day)||3
7800435|NCT01211197|19202246|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
7800436|NCT01211197|19202247|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
7800437|NCT01211197|19202248|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
7800438|NCT01211197|19202249|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
7800439|NCT01211197|19202250|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
7800440|NCT01211197|19202251|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
7800441|NCT01211197|19202246|P6|COMPLETED|Washout Period 1 (7 Days)||2
7800442|NCT01211197|19202247|P5|COMPLETED|Washout Period 1 (7 Days)||2
7800443|NCT01211197|19202248|P4|COMPLETED|Washout Period 1 (7 Days)||3
7800444|NCT01211197|19202249|P3|COMPLETED|Washout Period 1 (7 Days)||2
7800445|NCT01211197|19202250|P2|COMPLETED|Washout Period 1 (7 Days)||3
7800446|NCT01211197|19202251|P1|COMPLETED|Washout Period 1 (7 Days)||3
7800447|NCT01211197|19202246|P6|STARTED|Washout Period 1 (7 Days)||2
7800448|NCT01211197|19202247|P5|STARTED|Washout Period 1 (7 Days)||2
7800449|NCT01211197|19202248|P4|STARTED|Washout Period 1 (7 Days)||3
7800450|NCT01211197|19202249|P3|STARTED|Washout Period 1 (7 Days)||3
7800451|NCT01211197|19202250|P2|STARTED|Washout Period 1 (7 Days)||3
7800452|NCT01211197|19202251|P1|STARTED|Washout Period 1 (7 Days)||3
7800453|NCT01211197|19202246|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7800454|NCT01211197|19202247|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7800455|NCT01211197|19202248|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7800456|NCT01211197|19202249|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7800457|NCT01211197|19202250|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7800458|NCT01211197|19202251|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7800459|NCT01211197|19202246|P6|COMPLETED|Treatment Period 1 (1 Day)||2
7800460|NCT01211197|19202247|P5|COMPLETED|Treatment Period 1 (1 Day)||2
7800461|NCT01211197|19202248|P4|COMPLETED|Treatment Period 1 (1 Day)||3
7800462|NCT01211197|19202249|P3|COMPLETED|Treatment Period 1 (1 Day)||3
7800463|NCT01211197|19202250|P2|COMPLETED|Treatment Period 1 (1 Day)||3
7800464|NCT01211197|19202251|P1|COMPLETED|Treatment Period 1 (1 Day)||3
7800465|NCT01211197|19202246|P6|STARTED|Treatment Period 1 (1 Day)||2
7800466|NCT01211197|19202247|P5|STARTED|Treatment Period 1 (1 Day)||2
7800467|NCT01211197|19202248|P4|STARTED|Treatment Period 1 (1 Day)||3
7800468|NCT01211197|19202249|P3|STARTED|Treatment Period 1 (1 Day)||3
7800469|NCT01211197|19202250|P2|STARTED|Treatment Period 1 (1 Day)||3
7800470|NCT01211197|19202251|P1|STARTED|Treatment Period 1 (1 Day)||3
7800471|NCT01211184|19202298|P3|NOT COMPLETED|Overall Study||1
7800472|NCT01211184|19202299|P2|NOT COMPLETED|Overall Study||2
7800473|NCT01211184|19202300|P1|NOT COMPLETED|Overall Study||0
7800474|NCT01211184|19202298|P3|COMPLETED|Overall Study||19
7800475|NCT01211184|19202299|P2|COMPLETED|Overall Study||18
7800476|NCT01211184|19202300|P1|COMPLETED|Overall Study||20
7800477|NCT01211184|19202298|P3|STARTED|Overall Study||20
7800478|NCT01211184|19202299|P2|STARTED|Overall Study||20
7800479|NCT01211184|19202300|P1|STARTED|Overall Study||20
7800480|NCT01211145|19202315|P4|NOT COMPLETED|Overall Study||20
7800481|NCT01211145|19202316|P3|NOT COMPLETED|Overall Study||13
7800482|NCT01211145|19202317|P2|NOT COMPLETED|Overall Study||17
7800483|NCT01211145|19202318|P1|NOT COMPLETED|Overall Study||26
7800484|NCT01211145|19202315|P4|COMPLETED|Overall Study||268
7800485|NCT01211145|19202316|P3|COMPLETED|Overall Study||86
7800486|NCT01211145|19202317|P2|COMPLETED|Overall Study||98
7800487|NCT01211145|19202318|P1|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270
7800488|NCT01211145|19202315|P4|STARTED|Overall Study||288
7800489|NCT01211145|19202316|P3|STARTED|Overall Study||99
7800490|NCT01211145|19202317|P2|STARTED|Overall Study||115
7800491|NCT01211145|19202318|P1|STARTED|Overall Study||296
7800492|NCT01211106|19202350|P2|NOT COMPLETED|Overall Study||11
7800493|NCT01211106|19202351|P1|NOT COMPLETED|Overall Study||13
7800494|NCT01211106|19202350|P2|COMPLETED|Overall Study||77
7800495|NCT01211106|19202351|P1|COMPLETED|Overall Study||82
7800496|NCT01211106|19202350|P2|STARTED|Overall Study||88
7800497|NCT01211106|19202351|P1|STARTED|Overall Study||95
7800498|NCT01210820|19202361|P2|NOT COMPLETED|Overall Study||0
7800499|NCT01210820|19202362|P1|NOT COMPLETED|Overall Study||0
7800500|NCT01210820|19202361|P2|COMPLETED|Overall Study||4
7800501|NCT01210820|19202362|P1|COMPLETED|Overall Study||17
7800502|NCT01210820|19202361|P2|STARTED|Overall Study||4
7800503|NCT01210820|19202362|P1|STARTED|Overall Study||17
7800504|NCT01210807|19202372|P2|NOT COMPLETED|Overall Study||3
7800505|NCT01210807|19202373|P1|NOT COMPLETED|Overall Study||3
7800506|NCT01210807|19202372|P2|COMPLETED|Overall Study||31
7800507|NCT01210807|19202373|P1|COMPLETED|Overall Study||33
7800508|NCT01210807|19202372|P2|STARTED|Overall Study||34
7800509|NCT01210807|19202373|P1|STARTED|Overall Study||36
7800510|NCT01210716|19202381|P2|NOT COMPLETED|Second TPE Procedure||0
7800511|NCT01210716|19202382|P1|NOT COMPLETED|Second TPE Procedure||3
7800512|NCT01210716|19202381|P2|COMPLETED|Second TPE Procedure||15
7800513|NCT01210716|19202382|P1|COMPLETED|Second TPE Procedure||15
7800514|NCT01210716|19202381|P2|STARTED|Second TPE Procedure||15
7800515|NCT01210716|19202382|P1|STARTED|Second TPE Procedure||18
7800516|NCT01210716|19202381|P2|NOT COMPLETED|First TPE Procedure||2
7800517|NCT01210716|19202382|P1|NOT COMPLETED|First TPE Procedure||2
7800518|NCT01210716|19202381|P2|COMPLETED|First TPE Procedure||15
7800519|NCT01210716|19202382|P1|COMPLETED|First TPE Procedure||18
7800520|NCT01210716|19202381|P2|STARTED|First TPE Procedure||17
7800521|NCT01210716|19202382|P1|STARTED|First TPE Procedure||20
7800522|NCT01210690|19202388|P1|NOT COMPLETED|Overall Study||26
7800523|NCT01210690|19202388|P1|COMPLETED|Overall Study||75
7800524|NCT01210690|19202388|P1|STARTED|Overall Study||101
7800525|NCT01210664|19202401|P4|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||1
7800526|NCT01210664|19202402|P3|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
7800527|NCT01210664|19202403|P2|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
7800528|NCT01210664|19202404|P1|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
7800529|NCT01210664|19202401|P4|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||4
7800530|NCT01210664|19202402|P3|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
7800531|NCT01210664|19202403|P2|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
7800532|NCT01210664|19202404|P1|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
7800533|NCT01210664|19202401|P4|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||4
7800534|NCT01210664|19202402|P3|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
7800535|NCT01210664|19202403|P2|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
7800536|NCT01210664|19202404|P1|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
7800537|NCT01210664|19202401|P4|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||5
7800538|NCT01210664|19202402|P3|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
7800539|NCT01210664|19202403|P2|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
7800540|NCT01210664|19202404|P1|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
7800541|NCT01210664|19202401|P4|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
7800542|NCT01210664|19202402|P3|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||2
7800543|NCT01210664|19202403|P2|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
7800544|NCT01210664|19202404|P1|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
7800545|NCT01210664|19202401|P4|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
7800546|NCT01210664|19202402|P3|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||3
7800547|NCT01210664|19202403|P2|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
7800548|NCT01210664|19202404|P1|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
7800549|NCT01210664|19202401|P4|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
7800550|NCT01210664|19202402|P3|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||4
7800551|NCT01210664|19202403|P2|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
7800552|NCT01210664|19202404|P1|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
7800553|NCT01210664|19202401|P4|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
7800554|NCT01210664|19202402|P3|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||5
7800555|NCT01210664|19202403|P2|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
7800556|NCT01210664|19202404|P1|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
7800557|NCT01210664|19202401|P4|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
7800558|NCT01210664|19202402|P3|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
7800559|NCT01210664|19202403|P2|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
7800560|NCT01210664|19202404|P1|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
7800561|NCT01210664|19202401|P4|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
7800562|NCT01210664|19202402|P3|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
7800563|NCT01210664|19202403|P2|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
7800564|NCT01210664|19202404|P1|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
7800565|NCT01210664|19202401|P4|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
7800566|NCT01210664|19202402|P3|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
7800567|NCT01210664|19202403|P2|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
7800568|NCT01210664|19202404|P1|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
7800569|NCT01210664|19202401|P4|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
7800570|NCT01210664|19202402|P3|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
7800571|NCT01210664|19202403|P2|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
7800572|NCT01210664|19202404|P1|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
7800573|NCT01210664|19202401|P4|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
7800574|NCT01210664|19202402|P3|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
7800575|NCT01210664|19202403|P2|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
7800576|NCT01210664|19202404|P1|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
7800577|NCT01210664|19202401|P4|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
7800578|NCT01210664|19202402|P3|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
7800579|NCT01210664|19202403|P2|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
7800580|NCT01210664|19202404|P1|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
7800581|NCT01210664|19202401|P4|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
7800582|NCT01210664|19202402|P3|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
7800583|NCT01210664|19202403|P2|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
7800584|NCT01210664|19202404|P1|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
7800585|NCT01210664|19202401|P4|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
7800586|NCT01210664|19202402|P3|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
7800587|NCT01210664|19202403|P2|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
7800588|NCT01210664|19202404|P1|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
7800589|NCT01210651|19202432|P2|NOT COMPLETED|Overall Study||8
7800590|NCT01210651|19202433|P1|NOT COMPLETED|Overall Study||5
7800591|NCT01210651|19202432|P2|COMPLETED|Overall Study||10
7800592|NCT01210651|19202433|P1|COMPLETED|Overall Study||15
7800593|NCT01210651|19202432|P2|Number Attending 1st Assigned Session|Overall Study||12
7800594|NCT01210651|19202433|P1|Number Attending 1st Assigned Session|Overall Study||18
7800595|NCT01210651|19202432|P2|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18
7800596|NCT01210651|19202433|P1|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20
7800597|NCT01210560|19202449|P9|NOT COMPLETED|Intervention 3 (7 Days)||0
7800598|NCT01210560|19202450|P8|NOT COMPLETED|Intervention 3 (7 Days)||0
7800599|NCT01210560|19202451|P7|NOT COMPLETED|Intervention 3 (7 Days)||0
7800600|NCT01210560|19202452|P6|NOT COMPLETED|Intervention 3 (7 Days)||0
7800601|NCT01210560|19202453|P5|NOT COMPLETED|Intervention 3 (7 Days)||0
7800602|NCT01210560|19202454|P4|NOT COMPLETED|Intervention 3 (7 Days)||0
7800603|NCT01210560|19202455|P3|NOT COMPLETED|Intervention 3 (7 Days)||0
7800604|NCT01210560|19202456|P2|NOT COMPLETED|Intervention 3 (7 Days)||0
7800605|NCT01210560|19202457|P1|NOT COMPLETED|Intervention 3 (7 Days)||0
7800606|NCT01210560|19202449|P9|COMPLETED|Intervention 3 (7 Days)||5
7800607|NCT01210560|19202450|P8|COMPLETED|Intervention 3 (7 Days)||4
7800608|NCT01210560|19202451|P7|COMPLETED|Intervention 3 (7 Days)||4
7800609|NCT01210560|19202452|P6|COMPLETED|Intervention 3 (7 Days)||2
7800610|NCT01210560|19202453|P5|COMPLETED|Intervention 3 (7 Days)||2
7800611|NCT01210560|19202454|P4|COMPLETED|Intervention 3 (7 Days)||2
7800612|NCT01210560|19202455|P3|COMPLETED|Intervention 3 (7 Days)||2
7800613|NCT01210560|19202456|P2|COMPLETED|Intervention 3 (7 Days)||2
7800614|NCT01210560|19202457|P1|COMPLETED|Intervention 3 (7 Days)||2
7800615|NCT01210560|19202449|P9|STARTED|Intervention 3 (7 Days)||5
7800616|NCT01210560|19202450|P8|STARTED|Intervention 3 (7 Days)||4
7800617|NCT01210560|19202451|P7|STARTED|Intervention 3 (7 Days)||4
7800618|NCT01210560|19202452|P6|STARTED|Intervention 3 (7 Days)||2
7800619|NCT01210560|19202453|P5|STARTED|Intervention 3 (7 Days)||2
7800620|NCT01210560|19202454|P4|STARTED|Intervention 3 (7 Days)||2
7800621|NCT01210560|19202455|P3|STARTED|Intervention 3 (7 Days)||2
7800622|NCT01210560|19202456|P2|STARTED|Intervention 3 (7 Days)||2
7800623|NCT01210560|19202457|P1|STARTED|Intervention 3 (7 Days)||2
7800624|NCT01210560|19202449|P9|NOT COMPLETED|Intervention 2 (7 Days)||0
7800625|NCT01210560|19202450|P8|NOT COMPLETED|Intervention 2 (7 Days)||0
7800626|NCT01210560|19202451|P7|NOT COMPLETED|Intervention 2 (7 Days)||0
7800627|NCT01210560|19202452|P6|NOT COMPLETED|Intervention 2 (7 Days)||0
7800628|NCT01210560|19202453|P5|NOT COMPLETED|Intervention 2 (7 Days)||0
7800629|NCT01210560|19202454|P4|NOT COMPLETED|Intervention 2 (7 Days)||0
7800630|NCT01210560|19202455|P3|NOT COMPLETED|Intervention 2 (7 Days)||0
7800631|NCT01210560|19202456|P2|NOT COMPLETED|Intervention 2 (7 Days)||0
7800632|NCT01210560|19202457|P1|NOT COMPLETED|Intervention 2 (7 Days)||0
7800633|NCT01210560|19202449|P9|COMPLETED|Intervention 2 (7 Days)||5
7800634|NCT01210560|19202450|P8|COMPLETED|Intervention 2 (7 Days)||4
7800635|NCT01210560|19202451|P7|COMPLETED|Intervention 2 (7 Days)||4
7800636|NCT01210560|19202452|P6|COMPLETED|Intervention 2 (7 Days)||2
7800637|NCT01210560|19202453|P5|COMPLETED|Intervention 2 (7 Days)||2
7800638|NCT01210560|19202454|P4|COMPLETED|Intervention 2 (7 Days)||2
7800639|NCT01210560|19202455|P3|COMPLETED|Intervention 2 (7 Days)||2
7800640|NCT01210560|19202456|P2|COMPLETED|Intervention 2 (7 Days)||2
7800641|NCT01210560|19202457|P1|COMPLETED|Intervention 2 (7 Days)||2
7800642|NCT01210560|19202449|P9|STARTED|Intervention 2 (7 Days)||5
7800643|NCT01210560|19202450|P8|STARTED|Intervention 2 (7 Days)||4
7800644|NCT01210560|19202451|P7|STARTED|Intervention 2 (7 Days)||4
7800645|NCT01210560|19202452|P6|STARTED|Intervention 2 (7 Days)||2
7800646|NCT01210560|19202453|P5|STARTED|Intervention 2 (7 Days)||2
7800647|NCT01210560|19202454|P4|STARTED|Intervention 2 (7 Days)||2
7800648|NCT01210560|19202455|P3|STARTED|Intervention 2 (7 Days)||2
7800649|NCT01210560|19202456|P2|STARTED|Intervention 2 (7 Days)||2
7800650|NCT01210560|19202457|P1|STARTED|Intervention 2 (7 Days)||2
7800651|NCT01210560|19202449|P9|NOT COMPLETED|Intervention 1 (7 Days)||0
7800652|NCT01210560|19202450|P8|NOT COMPLETED|Intervention 1 (7 Days)||0
7800653|NCT01210560|19202451|P7|NOT COMPLETED|Intervention 1 (7 Days)||0
7800654|NCT01210560|19202452|P6|NOT COMPLETED|Intervention 1 (7 Days)||0
7800655|NCT01210560|19202453|P5|NOT COMPLETED|Intervention 1 (7 Days)||0
7800656|NCT01210560|19202454|P4|NOT COMPLETED|Intervention 1 (7 Days)||0
7800657|NCT01210560|19202455|P3|NOT COMPLETED|Intervention 1 (7 Days)||0
7800658|NCT01210560|19202456|P2|NOT COMPLETED|Intervention 1 (7 Days)||0
7800659|NCT01210560|19202457|P1|NOT COMPLETED|Intervention 1 (7 Days)||0
7800660|NCT01210560|19202449|P9|COMPLETED|Intervention 1 (7 Days)||5
7800661|NCT01210560|19202450|P8|COMPLETED|Intervention 1 (7 Days)||4
7800662|NCT01210560|19202451|P7|COMPLETED|Intervention 1 (7 Days)||4
7800663|NCT01210560|19202452|P6|COMPLETED|Intervention 1 (7 Days)||2
7800664|NCT01210560|19202453|P5|COMPLETED|Intervention 1 (7 Days)||2
7800665|NCT01210560|19202454|P4|COMPLETED|Intervention 1 (7 Days)||2
7800666|NCT01210560|19202455|P3|COMPLETED|Intervention 1 (7 Days)||2
7800667|NCT01210560|19202456|P2|COMPLETED|Intervention 1 (7 Days)||2
7800668|NCT01210560|19202457|P1|COMPLETED|Intervention 1 (7 Days)||2
7800669|NCT01210560|19202449|P9|STARTED|Intervention 1 (7 Days)||5
7800670|NCT01210560|19202450|P8|STARTED|Intervention 1 (7 Days)||4
7800671|NCT01210560|19202451|P7|STARTED|Intervention 1 (7 Days)||4
7800672|NCT01210560|19202452|P6|STARTED|Intervention 1 (7 Days)||2
7800673|NCT01210560|19202453|P5|STARTED|Intervention 1 (7 Days)||2
7800674|NCT01210560|19202454|P4|STARTED|Intervention 1 (7 Days)||2
7800675|NCT01210560|19202455|P3|STARTED|Intervention 1 (7 Days)||2
7800676|NCT01210560|19202456|P2|STARTED|Intervention 1 (7 Days)||2
7800677|NCT01210560|19202457|P1|STARTED|Intervention 1 (7 Days)||2
7800678|NCT01210495|19202553|P4|NOT COMPLETED|Overall Study||68
7800679|NCT01210495|19202554|P3|NOT COMPLETED|Overall Study||134
7800680|NCT01210495|19202555|P2|NOT COMPLETED|Overall Study||7
7800681|NCT01210495|19202556|P1|NOT COMPLETED|Overall Study||15
7800682|NCT01210495|19202553|P4|COMPLETED|Overall Study||0
7800683|NCT01210495|19202554|P3|COMPLETED|Overall Study||0
7800684|NCT01210495|19202555|P2|COMPLETED|Overall Study||0
7800685|NCT01210495|19202556|P1|COMPLETED|Overall Study||0
7800686|NCT01210495|19202553|P4|STARTED|Overall Study||68
7800687|NCT01210495|19202554|P3|STARTED|Overall Study||134
7800688|NCT01210495|19202555|P2|STARTED|Overall Study||7
7800689|NCT01210495|19202556|P1|STARTED|Overall Study||15
7800690|NCT01210443|19202618|P1|NOT COMPLETED|Overall Study||2
7800691|NCT01210443|19202618|P1|COMPLETED|Overall Study||0
7800692|NCT01210443|19202618|P1|STARTED|Overall Study||2
7800693|NCT01210352|19202635|P9|NOT COMPLETED|Overall Study||4
7800694|NCT01210352|19202636|P8|NOT COMPLETED|Overall Study||3
7800695|NCT01210352|19202637|P7|NOT COMPLETED|Overall Study||2
7800696|NCT01210352|19202638|P6|NOT COMPLETED|Overall Study||0
7800697|NCT01210352|19202639|P5|NOT COMPLETED|Overall Study||0
7800698|NCT01210352|19202640|P4|NOT COMPLETED|Overall Study||0
7800699|NCT01210352|19202641|P3|NOT COMPLETED|Overall Study||2
7800700|NCT01210352|19202642|P2|NOT COMPLETED|Overall Study||0
7800701|NCT01210352|19202643|P1|NOT COMPLETED|Overall Study||0
7800702|NCT01210352|19202635|P9|COMPLETED|Overall Study||2
7800703|NCT01210352|19202636|P8|COMPLETED|Overall Study||7
7800704|NCT01210352|19202637|P7|COMPLETED|Overall Study||5
7800705|NCT01210352|19202638|P6|COMPLETED|Overall Study||6
7800706|NCT01210352|19202639|P5|COMPLETED|Overall Study||6
7800707|NCT01210352|19202640|P4|COMPLETED|Overall Study||7
7800708|NCT01210352|19202641|P3|COMPLETED|Overall Study||5
7800709|NCT01210352|19202642|P2|COMPLETED|Overall Study||6
7800710|NCT01210352|19202643|P1|COMPLETED|Overall Study||6
7800711|NCT01210352|19202635|P9|STARTED|Overall Study||6
7800712|NCT01210352|19202636|P8|STARTED|Overall Study||10
7800713|NCT01210352|19202637|P7|STARTED|Overall Study||7
7800714|NCT01210352|19202638|P6|STARTED|Overall Study||6
7800715|NCT01210352|19202639|P5|STARTED|Overall Study||6
7800716|NCT01210352|19202640|P4|STARTED|Overall Study||7
7800717|NCT01210352|19202641|P3|STARTED|Overall Study||7
7800718|NCT01210352|19202642|P2|STARTED|Overall Study||6
7800719|NCT01210352|19202643|P1|STARTED|Overall Study||6
7800720|NCT01210222|19202834|P1|NOT COMPLETED|Overall Study||3
7800721|NCT01210222|19202834|P1|COMPLETED|Overall Study||32
7800722|NCT01210222|19202834|P1|STARTED|Overall Study||35
7800723|NCT01210170|19202847|P1|NOT COMPLETED|Overall Study||7
7800724|NCT01210170|19202847|P1|COMPLETED|Overall Study||15
7800725|NCT01210170|19202847|P1|STARTED|Overall Study||22
7800726|NCT01210144|19202870|P2|NOT COMPLETED|Overall Study||0
7800727|NCT01210144|19202871|P1|NOT COMPLETED|Overall Study||3
7800728|NCT01210144|19202870|P2|COMPLETED|Overall Study||11
7800729|NCT01210144|19202871|P1|COMPLETED|Overall Study||10
7800730|NCT01210144|19202870|P2|STARTED|Overall Study||11
7800731|NCT01210144|19202871|P1|STARTED|Overall Study||13
7800732|NCT01210118|19202893|P2|NOT COMPLETED|Overall Study||5
7800733|NCT01210118|19202894|P1|NOT COMPLETED|Overall Study||3
7800734|NCT01210118|19202893|P2|COMPLETED|Overall Study||42
7800735|NCT01210118|19202894|P1|COMPLETED|Overall Study||42
7800736|NCT01210118|19202893|P2|STARTED|Overall Study||47
7800737|NCT01210118|19202894|P1|STARTED|Overall Study||45
7800738|NCT01210079|19202908|P2|NOT COMPLETED|Overall Study||0
7800739|NCT01210079|19202909|P1|NOT COMPLETED|Overall Study||0
7800740|NCT01210079|19202908|P2|COMPLETED|Overall Study||16
7800741|NCT01210079|19202909|P1|COMPLETED|Overall Study||10
7800742|NCT01210079|19202908|P2|STARTED|Overall Study||16
7800743|NCT01210079|19202909|P1|STARTED|Overall Study||10
7800744|NCT01210001|19202918|P3|NOT COMPLETED|Overall Study||12
7800745|NCT01210001|19202919|P2|NOT COMPLETED|Overall Study||11
7800746|NCT01210001|19202920|P1|NOT COMPLETED|Overall Study||19
7800747|NCT01210001|19202918|P3|COMPLETED|Overall Study||156
7800748|NCT01210001|19202919|P2|COMPLETED|Overall Study||154
7800749|NCT01210001|19202920|P1|COMPLETED|Overall Study||147
7800750|NCT01210001|19202918|P3|STARTED|Overall Study||168
7800751|NCT01210001|19202919|P2|STARTED|Overall Study||165
7800752|NCT01210001|19202920|P1|STARTED|Overall Study||166
7800753|NCT01209949|19202940|P1|NOT COMPLETED|Overall Study||3
7800754|NCT01209949|19202940|P1|COMPLETED|Overall Study||27
7800755|NCT01209949|19202940|P1|STARTED|Overall Study||30
7800756|NCT01209832|19202946|P1|NOT COMPLETED|Maintenance Period 2 (M1)||0
7800757|NCT01209832|19202946|P1|COMPLETED|Maintenance Period 2 (M1)||3
7800758|NCT01209832|19202946|P1|STARTED|Maintenance Period 2 (M1)|One participant who completed maintenance period 1 did not enter maintenance period 2.|3
7800759|NCT01209832|19202946|P1|NOT COMPLETED|Maintenance Period 1 (M1)||0
7800760|NCT01209832|19202946|P1|COMPLETED|Maintenance Period 1 (M1)||4
7800761|NCT01209832|19202946|P1|STARTED|Maintenance Period 1 (M1)|Five participants who completed Period 2 did not enroll into Maintenance Period.|4
7800762|NCT01209832|19202946|P1|NOT COMPLETED|Period 2||1
7800763|NCT01209832|19202946|P1|COMPLETED|Period 2||9
7800764|NCT01209832|19202946|P1|STARTED|Period 2||10
7800765|NCT01209832|19202946|P1|NOT COMPLETED|Period 1||1
7800766|NCT01209832|19202946|P1|COMPLETED|Period 1||10
7800767|NCT01209832|19202946|P1|Received At Least 1 Dose of Study Drug|Period 1||10
7800768|NCT01209832|19202946|P1|STARTED|Period 1||11
7800769|NCT01209780|19202965|P5|NOT COMPLETED|Overall Study||5
7800770|NCT01209780|19202966|P4|NOT COMPLETED|Overall Study||10
7800771|NCT01209780|19202967|P3|NOT COMPLETED|Overall Study||4
7800772|NCT01209780|19202968|P2|NOT COMPLETED|Overall Study||18
7800773|NCT01209780|19202969|P1|NOT COMPLETED|Overall Study||26
7800774|NCT01209780|19202965|P5|COMPLETED|Overall Study||407
7800775|NCT01209780|19202966|P4|COMPLETED|Overall Study||807
7800776|NCT01209780|19202967|P3|COMPLETED|Overall Study||44
7800777|NCT01209780|19202968|P2|COMPLETED|Overall Study||467
7800778|NCT01209780|19202969|P1|COMPLETED|Overall Study||1016
7800779|NCT01209780|19202965|P5|STARTED|Overall Study||412
7800780|NCT01209780|19202966|P4|STARTED|Overall Study||817
7800781|NCT01209780|19202967|P3|STARTED|Overall Study||48
7800782|NCT01209780|19202968|P2|STARTED|Overall Study||485
7800783|NCT01209780|19202969|P1|STARTED|Overall Study||1042
7800784|NCT01209767|19202995|P1|NOT COMPLETED|Overall Study||4
7800785|NCT01209767|19202995|P1|COMPLETED|Overall Study||18
7800786|NCT01209767|19202995|P1|STARTED|Overall Study||22
7800787|NCT01209702|19203005|P4|NOT COMPLETED|Overall Study||153
7800788|NCT01209702|19203006|P3|NOT COMPLETED|Overall Study||51
7800789|NCT01209702|19203007|P2|NOT COMPLETED|Overall Study||51
7800790|NCT01209702|19203008|P1|NOT COMPLETED|Overall Study||51
7800791|NCT01209702|19203005|P4|COMPLETED|Overall Study||0
7800792|NCT01209702|19203006|P3|COMPLETED|Overall Study||0
7800793|NCT01209702|19203007|P2|COMPLETED|Overall Study||0
7800794|NCT01209702|19203008|P1|COMPLETED|Overall Study||0
7800795|NCT01209702|19203005|P4|Completed 24 Weeks Treatment|Overall Study||10
7800796|NCT01209702|19203006|P3|Completed 24 Weeks Treatment|Overall Study||3
7800797|NCT01209702|19203007|P2|Completed 24 Weeks Treatment|Overall Study||28
7800798|NCT01209702|19203008|P1|Completed 24 Weeks Treatment|Overall Study||19
7800799|NCT01209702|19203005|P4|Completed 12 Weeks Treatment|Overall Study||59
7800800|NCT01209702|19203006|P3|Completed 12 Weeks Treatment|Overall Study||12
7800801|NCT01209702|19203007|P2|Completed 12 Weeks Treatment|Overall Study||48
7800802|NCT01209702|19203008|P1|Completed 12 Weeks Treatment|Overall Study||50
7800803|NCT01209702|19203005|P4|Escape or Switched to Tocilizumab|Overall Study||0
7800804|NCT01209702|19203006|P3|Escape or Switched to Tocilizumab|Overall Study||6
7800805|NCT01209702|19203007|P2|Escape or Switched to Tocilizumab|Overall Study||0
7800806|NCT01209702|19203008|P1|Escape or Switched to Tocilizumab|Overall Study||51
7800807|NCT01209702|19203005|P4|Treated|Overall Study||152
7800808|NCT01209702|19203006|P3|Treated|Overall Study||51
7800809|NCT01209702|19203007|P2|Treated|Overall Study||51
7800810|NCT01209702|19203008|P1|Treated|Overall Study||51
7800811|NCT01209702|19203005|P4|STARTED|Overall Study||153
7800812|NCT01209702|19203006|P3|STARTED|Overall Study||51
7800813|NCT01209702|19203007|P2|STARTED|Overall Study||51
7800814|NCT01209702|19203008|P1|STARTED|Overall Study||51
7800815|NCT01209689|19203064|P2|NOT COMPLETED|Overall Study||22
7800816|NCT01209689|19203065|P1|NOT COMPLETED|Overall Study||91
7800817|NCT01209689|19203064|P2|COMPLETED|Overall Study||0
7800818|NCT01209689|19203065|P1|COMPLETED|Overall Study||0
7800819|NCT01209689|19203064|P2|STARTED|Overall Study||22
7800820|NCT01209689|19203065|P1|STARTED|Overall Study||91
7800821|NCT01209624|19203071|P1|NOT COMPLETED|Overall Study||326
7800822|NCT01209624|19203071|P1|COMPLETED|Overall Study||576
7800823|NCT01209624|19203071|P1|Per Protocol Population|Overall Study||469
7800824|NCT01209624|19203071|P1|STARTED|Overall Study||902
7800825|NCT01209598|19203104|P2|NOT COMPLETED|Overall Study||0
7800826|NCT01209598|19203105|P1|NOT COMPLETED|Overall Study||1
7800827|NCT01209598|19203104|P2|COMPLETED|Overall Study||60
7800828|NCT01209598|19203105|P1|COMPLETED|Overall Study||29
7800829|NCT01209598|19203104|P2|STARTED|Overall Study||60
7800830|NCT01209598|19203105|P1|STARTED|Overall Study||30
7800831|NCT01209520|19203113|P1|NOT COMPLETED|Overall Study||3
7800832|NCT01209520|19203113|P1|COMPLETED|Overall Study||3
7800833|NCT01209520|19203113|P1|STARTED|Overall Study||6
7800834|NCT01209442|19203118|P1|NOT COMPLETED|Overall Study||0
7800835|NCT01209442|19203118|P1|COMPLETED|Overall Study||30
7800836|NCT01209442|19203118|P1|STARTED|Overall Study||30
7800837|NCT01209325|19203123|P1|NOT COMPLETED|Overall Study||43
7800838|NCT01209325|19203123|P1|COMPLETED|Overall Study||106
7800839|NCT01209325|19203123|P1|Returned After Week 28|Overall Study||124
7800840|NCT01209325|19203123|P1|Received Third Vaccine Infjection|Overall Study||138
7800841|NCT01209325|19203123|P1|Received Second Vaccine Injection|Overall Study||141
7800842|NCT01209325|19203123|P1|Received First Vaccine Injection|Overall Study||144
7800843|NCT01209325|19203123|P1|Eligible|Overall Study||145
7800844|NCT01209325|19203123|P1|STARTED|Overall Study||149
7800845|NCT01209286|19203178|P3|NOT COMPLETED|Overall Study||3
7800846|NCT01209286|19203179|P2|NOT COMPLETED|Overall Study||10
7800847|NCT01209286|19203180|P1|NOT COMPLETED|Overall Study||5
7800848|NCT01209286|19203178|P3|COMPLETED|Overall Study||3
7800849|NCT01209286|19203179|P2|COMPLETED|Overall Study||13
7800850|NCT01209286|19203180|P1|COMPLETED|Overall Study||2
7800851|NCT01209286|19203178|P3|STARTED|Overall Study||6
7800852|NCT01209286|19203179|P2|STARTED|Overall Study||23
7800853|NCT01209286|19203180|P1|STARTED|Overall Study||7
7800854|NCT01209260|19203233|P2|NOT COMPLETED|Overall Study||0
7800855|NCT01209260|19203234|P1|NOT COMPLETED|Overall Study||0
7800856|NCT01209260|19203233|P2|COMPLETED|Overall Study||36
7800857|NCT01209260|19203234|P1|COMPLETED|Overall Study||36
7800858|NCT01209260|19203233|P2|STARTED|Overall Study||36
7800859|NCT01209260|19203234|P1|STARTED|Overall Study||36
7800860|NCT01209234|19203248|P2|NOT COMPLETED|Overall Study||7
7800861|NCT01209234|19203249|P1|NOT COMPLETED|Overall Study||12
7800862|NCT01209234|19203248|P2|COMPLETED|Overall Study||1063
7800863|NCT01209234|19203249|P1|COMPLETED|Overall Study||1058
7800864|NCT01209234|19203248|P2|STARTED|Overall Study||1070
7800865|NCT01209234|19203249|P1|STARTED|Overall Study||1070
7800866|NCT01209195|19203259|P6|NOT COMPLETED|Overall Study||0
7800867|NCT01209195|19203260|P5|NOT COMPLETED|Overall Study||0
7800868|NCT01209195|19203261|P4|NOT COMPLETED|Overall Study||0
7800869|NCT01209195|19203262|P3|NOT COMPLETED|Overall Study||0
7800870|NCT01209195|19203263|P2|NOT COMPLETED|Overall Study||0
7800871|NCT01209195|19203264|P1|NOT COMPLETED|Overall Study||0
7800872|NCT01209195|19203259|P6|COMPLETED|Overall Study||13
7800873|NCT01209195|19203260|P5|COMPLETED|Overall Study||6
7800874|NCT01209195|19203261|P4|COMPLETED|Overall Study||6
7800875|NCT01209195|19203262|P3|COMPLETED|Overall Study||6
7800876|NCT01209195|19203263|P2|COMPLETED|Overall Study||3
7800877|NCT01209195|19203264|P1|COMPLETED|Overall Study||7
7800878|NCT01209195|19203259|P6|STARTED|Overall Study||13
7800879|NCT01209195|19203260|P5|STARTED|Overall Study||6
7800880|NCT01209195|19203261|P4|STARTED|Overall Study||6
7800881|NCT01209195|19203262|P3|STARTED|Overall Study||6
7800882|NCT01209195|19203263|P2|STARTED|Overall Study||3
7800883|NCT01209195|19203264|P1|STARTED|Overall Study||7
7800884|NCT01209143|19203300|P2|NOT COMPLETED|Overall Study||20
7800885|NCT01209143|19203301|P1|NOT COMPLETED|Overall Study||19
7800886|NCT01209143|19203300|P2|COMPLETED|Overall Study||8
7800887|NCT01209143|19203301|P1|COMPLETED|Overall Study||5
7800888|NCT01209143|19203300|P2|STARTED|Overall Study||28
7800889|NCT01209143|19203301|P1|STARTED|Overall Study||24
7800890|NCT01209078|19203311|P2|NOT COMPLETED|Overall Study||3
7800891|NCT01209078|19203312|P1|NOT COMPLETED|Overall Study||16
7800892|NCT01209078|19203311|P2|COMPLETED|Overall Study||24
7800893|NCT01209078|19203312|P1|COMPLETED|Overall Study||41
7800894|NCT01209078|19203311|P2|STARTED|Overall Study||27
7800895|NCT01209078|19203312|P1|STARTED|Overall Study||57
7800896|NCT01208961|19203387|P2|NOT COMPLETED|High-Fat Period IV||0
7800897|NCT01208961|19203388|P1|NOT COMPLETED|High-Fat Period IV||0
7800898|NCT01208961|19203387|P2|COMPLETED|High-Fat Period IV||26
7800899|NCT01208961|19203388|P1|COMPLETED|High-Fat Period IV||25
7800900|NCT01208961|19203387|P2|STARTED|High-Fat Period IV||26
7800901|NCT01208961|19203388|P1|STARTED|High-Fat Period IV||25
7800902|NCT01208961|19203387|P2|NOT COMPLETED|High-Fat Period III||0
7800903|NCT01208961|19203388|P1|NOT COMPLETED|High-Fat Period III||1
7800904|NCT01208961|19203387|P2|COMPLETED|High-Fat Period III||26
7800905|NCT01208961|19203388|P1|COMPLETED|High-Fat Period III||25
7800906|NCT01208961|19203387|P2|STARTED|High-Fat Period III||26
7800907|NCT01208961|19203388|P1|STARTED|High-Fat Period III||26
7800908|NCT01208961|19203387|P2|NOT COMPLETED|Low-Fat Period II||0
7800909|NCT01208961|19203388|P1|NOT COMPLETED|Low-Fat Period II||0
7800910|NCT01208961|19203387|P2|COMPLETED|Low-Fat Period II||27
7800911|NCT01208961|19203388|P1|COMPLETED|Low-Fat Period II||26
7800912|NCT01208961|19203387|P2|STARTED|Low-Fat Period II||27
7800913|NCT01208961|19203388|P1|STARTED|Low-Fat Period II||26
7800914|NCT01208961|19203387|P2|NOT COMPLETED|Low-Fat Period I||0
7800915|NCT01208961|19203388|P1|NOT COMPLETED|Low-Fat Period I||0
7800916|NCT01208961|19203387|P2|COMPLETED|Low-Fat Period I||27
7800917|NCT01208961|19203388|P1|COMPLETED|Low-Fat Period I||27
7800918|NCT01208961|19203387|P2|STARTED|Low-Fat Period I||27
7800919|NCT01208961|19203388|P1|STARTED|Low-Fat Period I||27
7800920|NCT01208922|19203399|P2|NOT COMPLETED|Overall Study||10
7800921|NCT01208922|19203400|P1|NOT COMPLETED|Overall Study||11
7800922|NCT01208922|19203399|P2|COMPLETED|Overall Study||405
7800923|NCT01208922|19203400|P1|COMPLETED|Overall Study||409
7800924|NCT01208922|19203399|P2|STARTED|Overall Study||415
7800925|NCT01208922|19203400|P1|STARTED|Overall Study||420
7800926|NCT01208870|19203410|P2|NOT COMPLETED|Overall Study||8
7800927|NCT01208870|19203411|P1|NOT COMPLETED|Overall Study||2
7800928|NCT01208870|19203410|P2|COMPLETED|Overall Study||36
7800929|NCT01208870|19203411|P1|COMPLETED|Overall Study||44
7800930|NCT01208870|19203410|P2|Pilot 2|Overall Study||22
7800931|NCT01208870|19203411|P1|Pilot 2|Overall Study||26
7800932|NCT01208870|19203410|P2|Pilot 1|Overall Study||22
7800933|NCT01208870|19203411|P1|Pilot 1|Overall Study||20
7800934|NCT01208870|19203410|P2|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013.|44
7800935|NCT01208870|19203411|P1|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013|46
7800936|NCT01208415|19203427|P1|NOT COMPLETED|Overall Study||40
7800937|NCT01208415|19203427|P1|COMPLETED|Overall Study||0
7800938|NCT01208415|19203427|P1|6 Months|Overall Study||37
7800939|NCT01208415|19203427|P1|STARTED|Overall Study||40
7800940|NCT01208402|19203433|P2|NOT COMPLETED|Overall Study||0
7800941|NCT01208402|19203434|P1|NOT COMPLETED|Overall Study||1
7800942|NCT01208402|19203433|P2|COMPLETED|Overall Study||28
7800943|NCT01208402|19203434|P1|COMPLETED|Overall Study||30
7800944|NCT01208402|19203433|P2|STARTED|Overall Study||28
7800945|NCT01208402|19203434|P1|STARTED|Overall Study||31
7800946|NCT01208337|19203450|P1|NOT COMPLETED|Overall Study||3
7800947|NCT01208337|19203450|P1|COMPLETED|Overall Study||20
7800948|NCT01208337|19203450|P1|Five-year Follow-up|Overall Study||20
7800949|NCT01208337|19203450|P1|One-year Follow-up|Overall Study||23
7800950|NCT01208337|19203450|P1|STARTED|Overall Study||23
7800951|NCT01208233|19203464|P6|NOT COMPLETED|Overall Study||21
7800952|NCT01208233|19203465|P5|NOT COMPLETED|Overall Study||24
7800953|NCT01208233|19203466|P4|NOT COMPLETED|Overall Study||1
7800954|NCT01208233|19203467|P3|NOT COMPLETED|Overall Study||4
7800955|NCT01208233|19203468|P2|NOT COMPLETED|Overall Study||3
7800956|NCT01208233|19203469|P1|NOT COMPLETED|Overall Study||5
7800957|NCT01208233|19203464|P6|COMPLETED|Overall Study||46
7800958|NCT01208233|19203465|P5|COMPLETED|Overall Study||46
7800959|NCT01208233|19203466|P4|COMPLETED|Overall Study||9
7800960|NCT01208233|19203467|P3|COMPLETED|Overall Study||7
7800961|NCT01208233|19203468|P2|COMPLETED|Overall Study||6
7800962|NCT01208233|19203469|P1|COMPLETED|Overall Study||6
7800963|NCT01208233|19203464|P6|STARTED|Overall Study||67
7800964|NCT01208233|19203465|P5|STARTED|Overall Study||70
7800965|NCT01208233|19203466|P4|STARTED|Overall Study||10
7800966|NCT01208233|19203467|P3|STARTED|Overall Study||11
7800967|NCT01208233|19203468|P2|STARTED|Overall Study||9
7800968|NCT01208233|19203469|P1|STARTED|Overall Study||11
7800969|NCT01208220|19203582|P2|NOT COMPLETED|Overall Study||0
7800970|NCT01208220|19203583|P1|NOT COMPLETED|Overall Study||0
7800971|NCT01208220|19203582|P2|COMPLETED|Overall Study||1
7800972|NCT01208220|19203583|P1|COMPLETED|Overall Study||1
7800973|NCT01208220|19203582|P2|STARTED|Overall Study||1
7800974|NCT01208220|19203583|P1|STARTED|Overall Study||1
7800975|NCT01208207|19203594|P7|NOT COMPLETED|Part II||11
7800976|NCT01208207|19203595|P6|NOT COMPLETED|Part II||16
7800977|NCT01208207|19203596|P5|NOT COMPLETED|Part II||23
7800978|NCT01208207|19203597|P4|NOT COMPLETED|Part II||32
7800979|NCT01208207|19203598|P3|NOT COMPLETED|Part II||0
7800980|NCT01208207|19203599|P2|NOT COMPLETED|Part II||0
7800981|NCT01208207|19203600|P1|NOT COMPLETED|Part II||0
7800982|NCT01208207|19203594|P7|COMPLETED|Part II||131
7800983|NCT01208207|19203595|P6|COMPLETED|Part II||129
7800984|NCT01208207|19203596|P5|COMPLETED|Part II||295
7800985|NCT01208207|19203597|P4|COMPLETED|Part II||282
7800986|NCT01208207|19203598|P3|COMPLETED|Part II||0
7800987|NCT01208207|19203599|P2|COMPLETED|Part II||0
7800988|NCT01208207|19203600|P1|COMPLETED|Part II||0
7800989|NCT01208207|19203594|P7|STARTED|Part II||142
7800990|NCT01208207|19203595|P6|STARTED|Part II||145
7800991|NCT01208207|19203596|P5|STARTED|Part II||318
7800992|NCT01208207|19203597|P4|STARTED|Part II||314
7800993|NCT01208207|19203598|P3|STARTED|Part II||0
7800994|NCT01208207|19203599|P2|STARTED|Part II||0
7800995|NCT01208207|19203600|P1|STARTED|Part II||0
7800996|NCT01208207|19203594|P7|NOT COMPLETED|Part I||0
7800997|NCT01208207|19203595|P6|NOT COMPLETED|Part I||0
7800998|NCT01208207|19203596|P5|NOT COMPLETED|Part I||0
7800999|NCT01208207|19203597|P4|NOT COMPLETED|Part I||0
7801000|NCT01208207|19203598|P3|NOT COMPLETED|Part I||15
7801001|NCT01208207|19203599|P2|NOT COMPLETED|Part I||11
7801002|NCT01208207|19203600|P1|NOT COMPLETED|Part I||70
7801003|NCT01208207|19203594|P7|COMPLETED|Part I||0
7801004|NCT01208207|19203595|P6|COMPLETED|Part I||0
7801005|NCT01208207|19203596|P5|COMPLETED|Part I||0
7801006|NCT01208207|19203597|P4|COMPLETED|Part I||0
7801007|NCT01208207|19203598|P3|COMPLETED|Part I||142
7801008|NCT01208207|19203599|P2|COMPLETED|Part I||145
7801009|NCT01208207|19203600|P1|COMPLETED|Part I||632
7801010|NCT01208207|19203594|P7|STARTED|Part I||0
7801011|NCT01208207|19203595|P6|STARTED|Part I||0
7801012|NCT01208207|19203596|P5|STARTED|Part I||0
7801013|NCT01208207|19203597|P4|STARTED|Part I||0
7801014|NCT01208207|19203598|P3|STARTED|Part I||157
7801015|NCT01208207|19203599|P2|STARTED|Part I||156
7801016|NCT01208207|19203600|P1|STARTED|Part I||702
7801017|NCT01208181|19203627|P5|NOT COMPLETED|Part 2||0
7801018|NCT01208181|19203628|P4|NOT COMPLETED|Part 2||20
7801019|NCT01208181|19203629|P3|NOT COMPLETED|Part 2||16
7801020|NCT01208181|19203630|P2|NOT COMPLETED|Part 2||0
7801021|NCT01208181|19203631|P1|NOT COMPLETED|Part 2||0
7801022|NCT01208181|19203627|P5|COMPLETED|Part 2||0
7801023|NCT01208181|19203628|P4|COMPLETED|Part 2||343
7801024|NCT01208181|19203629|P3|COMPLETED|Part 2||334
7801025|NCT01208181|19203630|P2|COMPLETED|Part 2||0
7801026|NCT01208181|19203631|P1|COMPLETED|Part 2||0
7801114|NCT01207492|19203830|P1|COMPLETED|Overall Study||2
7801027|NCT01208181|19203627|P5|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0
7801028|NCT01208181|19203628|P4|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363
7801029|NCT01208181|19203629|P3|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350
7801030|NCT01208181|19203630|P2|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
7801031|NCT01208181|19203631|P1|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
7801032|NCT01208181|19203627|P5|NOT COMPLETED|Part 1||22
7801033|NCT01208181|19203628|P4|NOT COMPLETED|Part 1||0
7801034|NCT01208181|19203629|P3|NOT COMPLETED|Part 1||0
7801035|NCT01208181|19203630|P2|NOT COMPLETED|Part 1||55
7801036|NCT01208181|19203631|P1|NOT COMPLETED|Part 1||99
7801037|NCT01208181|19203627|P5|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96
7801038|NCT01208181|19203628|P4|COMPLETED|Part 1||0
7801039|NCT01208181|19203629|P3|COMPLETED|Part 1||0
7801040|NCT01208181|19203630|P2|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413
7801041|NCT01208181|19203631|P1|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719
7801042|NCT01208181|19203627|P5|STARTED|Part 1||118
7801043|NCT01208181|19203628|P4|STARTED|Part 1||0
7801044|NCT01208181|19203629|P3|STARTED|Part 1||0
7801045|NCT01208181|19203630|P2|STARTED|Part 1||468
7801046|NCT01208181|19203631|P1|STARTED|Part 1||818
7801047|NCT01208103|19203660|P1|NOT COMPLETED|Overall Study||2
7801048|NCT01208103|19203660|P1|COMPLETED|Overall Study||28
7801049|NCT01208103|19203660|P1|STARTED|Overall Study||30
7801050|NCT01208038|19203668|P1|NOT COMPLETED|Overall Study||1
7801051|NCT01208038|19203668|P1|COMPLETED|Overall Study|Patient withdrew before commencing study drug|21
7801052|NCT01208038|19203668|P1|STARTED|Overall Study||22
7801053|NCT01207934|19203678|P3|NOT COMPLETED|Overall Study||0
7801054|NCT01207934|19203679|P2|NOT COMPLETED|Overall Study||0
7801055|NCT01207934|19203680|P1|NOT COMPLETED|Overall Study||0
7801056|NCT01207934|19203678|P3|COMPLETED|Overall Study||6
7801057|NCT01207934|19203679|P2|COMPLETED|Overall Study||6
7801058|NCT01207934|19203680|P1|COMPLETED|Overall Study||6
7801059|NCT01207934|19203678|P3|STARTED|Overall Study||6
7801060|NCT01207934|19203679|P2|STARTED|Overall Study||6
7801061|NCT01207934|19203680|P1|STARTED|Overall Study||6
7801062|NCT01207765|19203697|P1|NOT COMPLETED|Overall Study||0
7801063|NCT01207765|19203697|P1|COMPLETED|Overall Study||8
7801064|NCT01207765|19203697|P1|STARTED|Overall Study||8
7801065|NCT01207726|19203705|P2|NOT COMPLETED|Overall Study||0
7801066|NCT01207726|19203706|P1|NOT COMPLETED|Overall Study||0
7801067|NCT01207726|19203705|P2|COMPLETED|Overall Study||6
7801068|NCT01207726|19203706|P1|COMPLETED|Overall Study||7
7801069|NCT01207726|19203705|P2|STARTED|Overall Study||6
7801070|NCT01207726|19203706|P1|STARTED|Overall Study||7
7801071|NCT01207687|19203724|P1|NOT COMPLETED|Overall Study||2
7801072|NCT01207687|19203724|P1|COMPLETED|Overall Study||12
7801073|NCT01207687|19203724|P1|STARTED|Overall Study||14
7801074|NCT01207648|19203754|P1|NOT COMPLETED|Overall Study||0
7801075|NCT01207648|19203754|P1|COMPLETED|Overall Study||307
7801076|NCT01207648|19203754|P1|STARTED|Overall Study||307
7801077|NCT01207596|19203762|P1|NOT COMPLETED|Overall Study||9
7801078|NCT01207596|19203762|P1|COMPLETED|Overall Study||21
7801079|NCT01207596|19203762|P1|STARTED|Overall Study||30
7801080|NCT01207583|19203775|P3|NOT COMPLETED|Overall Study||1
7801081|NCT01207583|19203776|P2|NOT COMPLETED|Overall Study||5
7801082|NCT01207583|19203777|P1|NOT COMPLETED|Overall Study||1
7801083|NCT01207583|19203775|P3|COMPLETED|Overall Study||54
7801084|NCT01207583|19203776|P2|COMPLETED|Overall Study||26
7801085|NCT01207583|19203777|P1|COMPLETED|Overall Study||13
7801086|NCT01207583|19203775|P3|Dose 4|Overall Study||0
7801087|NCT01207583|19203776|P2|Dose 4|Overall Study||0
7801088|NCT01207583|19203777|P1|Dose 4|Overall Study||7
7801089|NCT01207583|19203775|P3|Dose 3|Overall Study||0
7801090|NCT01207583|19203776|P2|Dose 3|Overall Study||27
7801091|NCT01207583|19203777|P1|Dose 3|Overall Study||13
7801092|NCT01207583|19203775|P3|Dose 2|Overall Study||54
7801093|NCT01207583|19203776|P2|Dose 2|Overall Study||29
7801094|NCT01207583|19203777|P1|Dose 2|Overall Study||13
7801095|NCT01207583|19203775|P3|Dose 1|Overall Study||55
7801096|NCT01207583|19203776|P2|Dose 1|Overall Study||31
7801097|NCT01207583|19203777|P1|Dose 1|Overall Study||14
7801098|NCT01207583|19203775|P3|STARTED|Overall Study||55
7801099|NCT01207583|19203776|P2|STARTED|Overall Study||31
7801100|NCT01207583|19203777|P1|STARTED|Overall Study||14
7801101|NCT01207570|19203817|P2|NOT COMPLETED|The Second Stage (After Crossover)||0
7801102|NCT01207570|19203818|P1|NOT COMPLETED|The Second Stage (After Crossover)||0
7801103|NCT01207570|19203817|P2|COMPLETED|The Second Stage (After Crossover)||23
7801104|NCT01207570|19203818|P1|COMPLETED|The Second Stage (After Crossover)||31
7801105|NCT01207570|19203817|P2|STARTED|The Second Stage (After Crossover)||23
7801106|NCT01207570|19203818|P1|STARTED|The Second Stage (After Crossover)||31
7801107|NCT01207570|19203817|P2|NOT COMPLETED|The First Stage (Before Crossover)||0
7801108|NCT01207570|19203818|P1|NOT COMPLETED|The First Stage (Before Crossover)||0
7801109|NCT01207570|19203817|P2|COMPLETED|The First Stage (Before Crossover)||31
7801110|NCT01207570|19203818|P1|COMPLETED|The First Stage (Before Crossover)||23
7801111|NCT01207570|19203817|P2|STARTED|The First Stage (Before Crossover)||31
7801112|NCT01207570|19203818|P1|STARTED|The First Stage (Before Crossover)||23
7801113|NCT01207492|19203830|P1|NOT COMPLETED|Overall Study||15
7801115|NCT01207492|19203830|P1|STARTED|Overall Study||17
7801116|NCT01207466|19203836|P2|NOT COMPLETED|Period 2, One Week of Wear||0
7801117|NCT01207466|19203837|P1|NOT COMPLETED|Period 2, One Week of Wear||0
7801118|NCT01207466|19203836|P2|COMPLETED|Period 2, One Week of Wear||48
7801119|NCT01207466|19203837|P1|COMPLETED|Period 2, One Week of Wear||45
7801120|NCT01207466|19203836|P2|STARTED|Period 2, One Week of Wear||48
7801121|NCT01207466|19203837|P1|STARTED|Period 2, One Week of Wear||45
7801122|NCT01207466|19203836|P2|NOT COMPLETED|Period 1, One Week of Wear||0
7801123|NCT01207466|19203837|P1|NOT COMPLETED|Period 1, One Week of Wear||0
7801124|NCT01207466|19203836|P2|COMPLETED|Period 1, One Week of Wear||48
7801125|NCT01207466|19203837|P1|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46
7801126|NCT01207466|19203836|P2|STARTED|Period 1, One Week of Wear||48
7801127|NCT01207466|19203837|P1|STARTED|Period 1, One Week of Wear||46
7801128|NCT01207453|19203845|P2|NOT COMPLETED|2nd Intervention||2
7801129|NCT01207453|19203846|P1|NOT COMPLETED|2nd Intervention||2
7801130|NCT01207453|19203845|P2|COMPLETED|2nd Intervention||15
7801131|NCT01207453|19203846|P1|COMPLETED|2nd Intervention||17
7801132|NCT01207453|19203845|P2|STARTED|2nd Intervention||17
7801133|NCT01207453|19203846|P1|STARTED|2nd Intervention||19
7801134|NCT01207453|19203845|P2|NOT COMPLETED|Washout||0
7801135|NCT01207453|19203846|P1|NOT COMPLETED|Washout||2
7801136|NCT01207453|19203845|P2|COMPLETED|Washout||17
7801137|NCT01207453|19203846|P1|COMPLETED|Washout||19
7801138|NCT01207453|19203845|P2|STARTED|Washout||17
7801139|NCT01207453|19203846|P1|STARTED|Washout||21
7801140|NCT01207453|19203845|P2|NOT COMPLETED|First Intervention||1
7801141|NCT01207453|19203846|P1|NOT COMPLETED|First Intervention||2
7801142|NCT01207453|19203845|P2|COMPLETED|First Intervention||17
7801143|NCT01207453|19203846|P1|COMPLETED|First Intervention||21
7801144|NCT01207453|19203845|P2|STARTED|First Intervention||18
7801145|NCT01207453|19203846|P1|STARTED|First Intervention||23
7801146|NCT01207440|19203872|P7|NOT COMPLETED|Overall Study||5
7801147|NCT01207440|19203873|P6|NOT COMPLETED|Overall Study||46
7801148|NCT01207440|19203874|P5|NOT COMPLETED|Overall Study||48
7801149|NCT01207440|19203875|P4|NOT COMPLETED|Overall Study||18
7801150|NCT01207440|19203876|P3|NOT COMPLETED|Overall Study||65
7801151|NCT01207440|19203877|P2|NOT COMPLETED|Overall Study||64
7801152|NCT01207440|19203878|P1|NOT COMPLETED|Overall Study||203
7801153|NCT01207440|19203872|P7|COMPLETED|Overall Study||0
7801154|NCT01207440|19203873|P6|COMPLETED|Overall Study||0
7801155|NCT01207440|19203874|P5|COMPLETED|Overall Study||0
7801156|NCT01207440|19203875|P4|COMPLETED|Overall Study||0
7801157|NCT01207440|19203876|P3|COMPLETED|Overall Study||0
7801158|NCT01207440|19203877|P2|COMPLETED|Overall Study||0
7801159|NCT01207440|19203878|P1|COMPLETED|Overall Study||0
7801160|NCT01207440|19203872|P7|STARTED|Overall Study||5
7801161|NCT01207440|19203873|P6|STARTED|Overall Study||46
7801162|NCT01207440|19203874|P5|STARTED|Overall Study||48
7801163|NCT01207440|19203875|P4|STARTED|Overall Study||18
7801164|NCT01207440|19203876|P3|STARTED|Overall Study||65
7801165|NCT01207440|19203877|P2|STARTED|Overall Study||64
7801166|NCT01207440|19203878|P1|STARTED|Overall Study||203
7801167|NCT01207427|19203945|P3|NOT COMPLETED|Run-out Placebo Period||0
7801168|NCT01207427|19203946|P2|NOT COMPLETED|Run-out Placebo Period||0
7801169|NCT01207427|19203947|P1|NOT COMPLETED|Run-out Placebo Period||0
7801170|NCT01207427|19203945|P3|COMPLETED|Run-out Placebo Period||41
7801171|NCT01207427|19203946|P2|COMPLETED|Run-out Placebo Period||43
7801172|NCT01207427|19203947|P1|COMPLETED|Run-out Placebo Period||40
7801173|NCT01207427|19203945|P3|STARTED|Run-out Placebo Period||41
7801174|NCT01207427|19203946|P2|STARTED|Run-out Placebo Period||43
7801175|NCT01207427|19203947|P1|STARTED|Run-out Placebo Period||40
7801176|NCT01207427|19203945|P3|NOT COMPLETED|Double-blind Treatment Period||2
7801177|NCT01207427|19203946|P2|NOT COMPLETED|Double-blind Treatment Period||2
7801178|NCT01207427|19203947|P1|NOT COMPLETED|Double-blind Treatment Period||3
7801179|NCT01207427|19203945|P3|COMPLETED|Double-blind Treatment Period||41
7801180|NCT01207427|19203946|P2|COMPLETED|Double-blind Treatment Period||43
7801181|NCT01207427|19203947|P1|COMPLETED|Double-blind Treatment Period||40
7801182|NCT01207427|19203945|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
7801183|NCT01207427|19203946|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45
7801184|NCT01207427|19203947|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
7801185|NCT01207427|19203945|P3|STARTED|Double-blind Treatment Period||43
7801186|NCT01207427|19203946|P2|STARTED|Double-blind Treatment Period||45
7801187|NCT01207427|19203947|P1|STARTED|Double-blind Treatment Period||43
7801188|NCT01207427|19203945|P3|NOT COMPLETED|Run-in Placebo Period||0
7801189|NCT01207427|19203946|P2|NOT COMPLETED|Run-in Placebo Period||0
7801190|NCT01207427|19203947|P1|NOT COMPLETED|Run-in Placebo Period||0
7801191|NCT01207427|19203945|P3|COMPLETED|Run-in Placebo Period||43
7801192|NCT01207427|19203946|P2|COMPLETED|Run-in Placebo Period||45
7801193|NCT01207427|19203947|P1|COMPLETED|Run-in Placebo Period||43
7801194|NCT01207427|19203945|P3|STARTED|Run-in Placebo Period||43
7801195|NCT01207427|19203946|P2|STARTED|Run-in Placebo Period||45
7801196|NCT01207427|19203947|P1|STARTED|Run-in Placebo Period||43
7801197|NCT01207414|19203957|P2|NOT COMPLETED|Overall Study||82
7801198|NCT01207414|19203958|P1|NOT COMPLETED|Overall Study||73
7801199|NCT01207414|19203957|P2|COMPLETED|Overall Study||178
7801200|NCT01207414|19203958|P1|COMPLETED|Overall Study||168
7801201|NCT01207414|19203957|P2|Safety Population: Received Study Drug|Overall Study||260
7801292|NCT01206517|19204193|P4|NOT COMPLETED|Overall Study||0
7801202|NCT01207414|19203958|P1|Safety Population: Received Study Drug|Overall Study||240
7801203|NCT01207414|19203957|P2|STARTED|Overall Study||260
7801204|NCT01207414|19203958|P1|STARTED|Overall Study|Includes 1 patient randomized in error.|241
7801205|NCT01207401|19203976|P2|NOT COMPLETED|Overall Study||0
7801206|NCT01207401|19203977|P1|NOT COMPLETED|Overall Study||0
7801207|NCT01207401|19203976|P2|COMPLETED|Overall Study||24
7801208|NCT01207401|19203977|P1|COMPLETED|Overall Study||26
7801209|NCT01207401|19203976|P2|STARTED|Overall Study||24
7801210|NCT01207401|19203977|P1|STARTED|Overall Study||26
7801211|NCT01207388|19203983|P1|NOT COMPLETED|Overall Study||68
7801212|NCT01207388|19203983|P1|COMPLETED|Overall Study||48
7801213|NCT01207388|19203983|P1|STARTED|Overall Study||116
7801214|NCT01207219|19204008|P3|NOT COMPLETED|Overall Study||7
7801215|NCT01207219|19204009|P2|NOT COMPLETED|Overall Study||11
7801216|NCT01207219|19204010|P1|NOT COMPLETED|Overall Study||11
7801217|NCT01207219|19204008|P3|COMPLETED|Overall Study||32
7801218|NCT01207219|19204009|P2|COMPLETED|Overall Study||29
7801219|NCT01207219|19204010|P1|COMPLETED|Overall Study||34
7801220|NCT01207219|19204008|P3|Included in ITT Analysis|Overall Study||38
7801221|NCT01207219|19204009|P2|Included in ITT Analysis|Overall Study||37
7801222|NCT01207219|19204010|P1|Included in ITT Analysis|Overall Study||40
7801223|NCT01207219|19204008|P3|STARTED|Overall Study||39
7801224|NCT01207219|19204009|P2|STARTED|Overall Study||40
7801225|NCT01207219|19204010|P1|STARTED|Overall Study||45
7801226|NCT01207102|19204030|P1|NOT COMPLETED|Overall Study||10
7801227|NCT01207102|19204030|P1|COMPLETED|Overall Study||0
7801228|NCT01207102|19204030|P1|STARTED|Overall Study||10
7801229|NCT01206816|19204042|P7|NOT COMPLETED|Overall Study||6
7801230|NCT01206816|19204043|P6|NOT COMPLETED|Overall Study||19
7801231|NCT01206816|19204044|P5|NOT COMPLETED|Overall Study||3
7801232|NCT01206816|19204045|P4|NOT COMPLETED|Overall Study||3
7801233|NCT01206816|19204046|P3|NOT COMPLETED|Overall Study||20
7801234|NCT01206816|19204047|P2|NOT COMPLETED|Overall Study||3
7801235|NCT01206816|19204048|P1|NOT COMPLETED|Overall Study||3
7801236|NCT01206816|19204042|P7|COMPLETED|Overall Study|1pt dist. due to 'other AE' & 1pt 'other' for vol & since,'PD' from aftb.|0
7801237|NCT01206816|19204043|P6|COMPLETED|Overall Study|1pt dist. due to 'PD' for vol & since, 'Other AE' from aftb|0
7801238|NCT01206816|19204044|P5|COMPLETED|Overall Study||0
7801239|NCT01206816|19204045|P4|COMPLETED|Overall Study|1pt discontinue (dist.)due to 'PD' for vol.& since, 'Other AE' from aftb|0
7801240|NCT01206816|19204046|P3|COMPLETED|Overall Study|1pt dist.due to 'Other AE' for vol& since 'other' from aftb.1pt 'PD' for vol& since,'DLT' from aftb|0
7801241|NCT01206816|19204047|P2|COMPLETED|Overall Study||0
7801242|NCT01206816|19204048|P1|COMPLETED|Overall Study||0
7801243|NCT01206816|19204042|P7|STARTED|Overall Study|Started=Treated|6
7801244|NCT01206816|19204043|P6|STARTED|Overall Study|Started=Treated|19
7801245|NCT01206816|19204044|P5|STARTED|Overall Study|Started=Treated|3
7801246|NCT01206816|19204045|P4|STARTED|Overall Study|Started=Treated|3
7801247|NCT01206816|19204046|P3|STARTED|Overall Study|Started=Treated|20
7801248|NCT01206816|19204047|P2|STARTED|Overall Study|Started=Treated|3
7801249|NCT01206816|19204048|P1|STARTED|Overall Study|Started=Treated|3
7801250|NCT01206777|19204094|P1|NOT COMPLETED|Overall Study||2
7801251|NCT01206777|19204094|P1|COMPLETED|Overall Study||50
7801252|NCT01206777|19204094|P1|Discontinued Trial and Deemed Ineligible|Overall Study||2
7801253|NCT01206777|19204094|P1|STARTED|Overall Study||52
7801254|NCT01206764|19204100|P1|NOT COMPLETED|Overall Study||138
7801255|NCT01206764|19204100|P1|COMPLETED|Overall Study||4
7801256|NCT01206764|19204100|P1|STARTED|Overall Study||142
7801257|NCT01206738|19204111|P3|NOT COMPLETED|Overall Study||19
7801258|NCT01206738|19204112|P2|NOT COMPLETED|Overall Study||25
7801259|NCT01206738|19204113|P1|NOT COMPLETED|Overall Study||23
7801260|NCT01206738|19204111|P3|COMPLETED|Overall Study||42
7801261|NCT01206738|19204112|P2|COMPLETED|Overall Study||49
7801262|NCT01206738|19204113|P1|COMPLETED|Overall Study||40
7801263|NCT01206738|19204111|P3|STARTED|Overall Study||61
7801264|NCT01206738|19204112|P2|STARTED|Overall Study||74
7801265|NCT01206738|19204113|P1|STARTED|Overall Study||63
7801266|NCT01206660|19204125|P2|NOT COMPLETED|Overall Study||0
7801267|NCT01206660|19204126|P1|NOT COMPLETED|Overall Study||0
7801268|NCT01206660|19204125|P2|COMPLETED|Overall Study||60
7801269|NCT01206660|19204126|P1|COMPLETED|Overall Study||60
7801270|NCT01206660|19204125|P2|STARTED|Overall Study||60
7801271|NCT01206660|19204126|P1|STARTED|Overall Study||60
7801272|NCT01206608|19204138|P2|NOT COMPLETED|Overall Study||0
7801273|NCT01206608|19204139|P1|NOT COMPLETED|Overall Study||0
7801274|NCT01206608|19204138|P2|COMPLETED|Overall Study||20
7801275|NCT01206608|19204139|P1|COMPLETED|Overall Study||20
7801276|NCT01206608|19204138|P2|STARTED|Overall Study||20
7801277|NCT01206608|19204139|P1|STARTED|Overall Study||20
7801278|NCT01206595|19204147|P2|NOT COMPLETED|Overall Study||0
7801279|NCT01206595|19204148|P1|NOT COMPLETED|Overall Study||0
7801280|NCT01206595|19204147|P2|COMPLETED|Overall Study||20
7801281|NCT01206595|19204148|P1|COMPLETED|Overall Study||38
7801282|NCT01206595|19204147|P2|STARTED|Overall Study||20
7801283|NCT01206595|19204148|P1|STARTED|Overall Study||38
7801284|NCT01206582|19204158|P2|NOT COMPLETED|Overall Study||2
7801285|NCT01206582|19204159|P1|NOT COMPLETED|Overall Study||2
7801286|NCT01206582|19204158|P2|COMPLETED|Overall Study||7
7801287|NCT01206582|19204159|P1|COMPLETED|Overall Study||9
7801288|NCT01206582|19204158|P2|STARTED|Overall Study||9
7801289|NCT01206582|19204159|P1|STARTED|Overall Study||11
7801290|NCT01206517|19204191|P6|NOT COMPLETED|Overall Study||0
7801291|NCT01206517|19204192|P5|NOT COMPLETED|Overall Study||1
7801293|NCT01206517|19204194|P3|NOT COMPLETED|Overall Study||2
7801294|NCT01206517|19204195|P2|NOT COMPLETED|Overall Study||0
7801295|NCT01206517|19204196|P1|NOT COMPLETED|Overall Study||0
7801296|NCT01206517|19204191|P6|COMPLETED|Overall Study||4
7801297|NCT01206517|19204192|P5|COMPLETED|Overall Study||3
7801298|NCT01206517|19204193|P4|COMPLETED|Overall Study||4
7801299|NCT01206517|19204194|P3|COMPLETED|Overall Study||4
7801300|NCT01206517|19204195|P2|COMPLETED|Overall Study||6
7801301|NCT01206517|19204196|P1|COMPLETED|Overall Study||6
7801302|NCT01206517|19204191|P6|STARTED|Overall Study||4
7801303|NCT01206517|19204192|P5|STARTED|Overall Study||4
7801304|NCT01206517|19204193|P4|STARTED|Overall Study||4
7801305|NCT01206517|19204194|P3|STARTED|Overall Study||6
7801306|NCT01206517|19204195|P2|STARTED|Overall Study||6
7801307|NCT01206517|19204196|P1|STARTED|Overall Study||6
7801308|NCT01206478|19204227|P2|NOT COMPLETED|Overall Study||5
7801309|NCT01206478|19204228|P1|NOT COMPLETED|Overall Study||2
7801310|NCT01206478|19204227|P2|COMPLETED|Overall Study||7
7801311|NCT01206478|19204228|P1|COMPLETED|Overall Study||7
7801312|NCT01206478|19204227|P2|STARTED|Overall Study||12
7801313|NCT01206478|19204228|P1|STARTED|Overall Study||9
7801314|NCT01206465|19204236|P5|NOT COMPLETED|Overall Study||0
7801315|NCT01206465|19204237|P4|NOT COMPLETED|Overall Study||0
7801316|NCT01206465|19204238|P3|NOT COMPLETED|Overall Study||0
7801317|NCT01206465|19204239|P2|NOT COMPLETED|Overall Study||0
7801318|NCT01206465|19204240|P1|NOT COMPLETED|Overall Study||0
7801319|NCT01206465|19204236|P5|COMPLETED|Overall Study||6
7801320|NCT01206465|19204237|P4|COMPLETED|Overall Study||6
7801321|NCT01206465|19204238|P3|COMPLETED|Overall Study||6
7801322|NCT01206465|19204239|P2|COMPLETED|Overall Study||6
7801323|NCT01206465|19204240|P1|COMPLETED|Overall Study||3
7801324|NCT01206465|19204236|P5|STARTED|Overall Study||6
7801325|NCT01206465|19204237|P4|STARTED|Overall Study||6
7801326|NCT01206465|19204238|P3|STARTED|Overall Study||6
7801327|NCT01206465|19204239|P2|STARTED|Overall Study||6
7801328|NCT01206465|19204240|P1|STARTED|Overall Study||3
7801329|NCT01206452|19204261|P2|NOT COMPLETED|Overall Study||0
7801330|NCT01206452|19204262|P1|NOT COMPLETED|Overall Study||0
7801331|NCT01206452|19204261|P2|COMPLETED|Overall Study||30
7801332|NCT01206452|19204262|P1|COMPLETED|Overall Study||30
7801333|NCT01206452|19204261|P2|STARTED|Overall Study||30
7801334|NCT01206452|19204262|P1|STARTED|Overall Study||30
7801335|NCT01206439|19204276|P1|NOT COMPLETED|Overall Study||1
7801336|NCT01206439|19204276|P1|COMPLETED|Overall Study||1
7801337|NCT01206439|19204276|P1|STARTED|Overall Study||2
7801338|NCT01206387|19204282|P2|NOT COMPLETED|Overall Study||0
7801339|NCT01206387|19204283|P1|NOT COMPLETED|Overall Study||1
7801340|NCT01206387|19204282|P2|COMPLETED|Overall Study||60
7801341|NCT01206387|19204283|P1|COMPLETED|Overall Study||59
7801342|NCT01206387|19204282|P2|STARTED|Overall Study||60
7801343|NCT01206387|19204283|P1|STARTED|Overall Study||60
7801344|NCT01206322|19204299|P4|NOT COMPLETED|Overall Study||1
7801345|NCT01206322|19204300|P3|NOT COMPLETED|Overall Study||0
7801346|NCT01206322|19204301|P2|NOT COMPLETED|Overall Study||0
7801347|NCT01206322|19204302|P1|NOT COMPLETED|Overall Study||0
7801348|NCT01206322|19204299|P4|COMPLETED|Overall Study||5
7801349|NCT01206322|19204300|P3|COMPLETED|Overall Study||9
7801350|NCT01206322|19204301|P2|COMPLETED|Overall Study||11
7801351|NCT01206322|19204302|P1|COMPLETED|Overall Study||4
7801352|NCT01206322|19204299|P4|STARTED|Overall Study||6
7801353|NCT01206322|19204300|P3|STARTED|Overall Study||9
7801354|NCT01206322|19204301|P2|STARTED|Overall Study||11
7801355|NCT01206322|19204302|P1|STARTED|Overall Study||4
7801356|NCT01206140|19204318|P2|NOT COMPLETED|Overall Study||0
7801357|NCT01206140|19204319|P1|NOT COMPLETED|Overall Study||1
7801358|NCT01206140|19204318|P2|COMPLETED|Overall Study||35
7801359|NCT01206140|19204319|P1|COMPLETED|Overall Study||34
7801360|NCT01206140|19204318|P2|STARTED|Overall Study||35
7801361|NCT01206140|19204319|P1|STARTED|Overall Study||35
7801362|NCT01206101|19204331|P2|NOT COMPLETED|Overall Study||1
7801363|NCT01206101|19204332|P1|NOT COMPLETED|Overall Study||2
7801364|NCT01206101|19204331|P2|COMPLETED|Overall Study||0
7801365|NCT01206101|19204332|P1|COMPLETED|Overall Study||0
7801366|NCT01206101|19204331|P2|STARTED|Overall Study||1
7801367|NCT01206101|19204332|P1|STARTED|Overall Study||2
7801368|NCT01206062|19204350|P2|NOT COMPLETED|Overall Study||0
7801369|NCT01206062|19204351|P1|NOT COMPLETED|Overall Study||0
7801370|NCT01206062|19204350|P2|COMPLETED|Overall Study||4683
7801371|NCT01206062|19204351|P1|COMPLETED|Overall Study||4678
7801372|NCT01206062|19204350|P2|STARTED|Overall Study||4683
7801373|NCT01206062|19204351|P1|STARTED|Overall Study||4678
7801374|NCT01205828|19204363|P1|NOT COMPLETED|Overall Study||0
7801375|NCT01205828|19204363|P1|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16
7801376|NCT01205828|19204363|P1|STARTED|Overall Study||16
7801377|NCT01205776|19204373|P2|NOT COMPLETED|Overall Study||95
7801378|NCT01205776|19204374|P1|NOT COMPLETED|Overall Study||64
7801379|NCT01205776|19204373|P2|COMPLETED|Overall Study||862
7801380|NCT01205776|19204374|P1|COMPLETED|Overall Study||884
7801381|NCT01205776|19204373|P2|STARTED|Overall Study||957
7801382|NCT01205776|19204374|P1|STARTED|Overall Study||948
7801383|NCT01205685|19204562|P1|NOT COMPLETED|Overall Study||11
7801384|NCT01205685|19204562|P1|COMPLETED|Overall Study||0
7801385|NCT01205685|19204562|P1|STARTED|Overall Study||11
7801386|NCT01205646|19204569|P1|NOT COMPLETED|Overall Study||0
7801387|NCT01205646|19204569|P1|COMPLETED|Overall Study||11
7801388|NCT01205646|19204569|P1|STARTED|Overall Study||11
7801389|NCT01205581|19204582|P6|NOT COMPLETED|Overall Study||0
7801390|NCT01205581|19204583|P5|NOT COMPLETED|Overall Study||0
7801391|NCT01205581|19204584|P4|NOT COMPLETED|Overall Study||0
7801392|NCT01205581|19204585|P3|NOT COMPLETED|Overall Study||0
7801393|NCT01205581|19204586|P2|NOT COMPLETED|Overall Study||0
7801394|NCT01205581|19204587|P1|NOT COMPLETED|Overall Study||1
7801395|NCT01205581|19204582|P6|COMPLETED|Overall Study||20
7801396|NCT01205581|19204583|P5|COMPLETED|Overall Study||20
7801397|NCT01205581|19204584|P4|COMPLETED|Overall Study||9
7801398|NCT01205581|19204585|P3|COMPLETED|Overall Study||8
7801399|NCT01205581|19204586|P2|COMPLETED|Overall Study||13
7801400|NCT01205581|19204587|P1|COMPLETED|Overall Study||13
7801401|NCT01205581|19204582|P6|STARTED|Overall Study||20
7801402|NCT01205581|19204583|P5|STARTED|Overall Study||20
7801403|NCT01205581|19204584|P4|STARTED|Overall Study||9
7801404|NCT01205581|19204585|P3|STARTED|Overall Study||8
7801405|NCT01205581|19204586|P2|STARTED|Overall Study||13
7801406|NCT01205581|19204587|P1|STARTED|Overall Study||14
7801407|NCT01205568|19204651|P2|NOT COMPLETED|Overall Study||0
7801408|NCT01205568|19204652|P1|NOT COMPLETED|Overall Study||0
7801409|NCT01205568|19204651|P2|COMPLETED|Overall Study||47
7801410|NCT01205568|19204652|P1|COMPLETED|Overall Study||65
7801411|NCT01205568|19204651|P2|STARTED|Overall Study|8 patients received only HPB therapy, 39 patients received both CB and HPB therapy.|47
7801412|NCT01205568|19204652|P1|STARTED|Overall Study|26 patients received only CB therapy, 39 patients received both CB and HPB therapy.|65
7801413|NCT01205529|19204657|P1|NOT COMPLETED|Overall Study||55
7801414|NCT01205529|19204657|P1|COMPLETED|Overall Study||106
7801415|NCT01205529|19204657|P1|STARTED|Overall Study||161
7801416|NCT01205503|19204663|P2|NOT COMPLETED|Second Intervention (2nd Cycle)||0
7801417|NCT01205503|19204664|P1|NOT COMPLETED|Second Intervention (2nd Cycle)||0
7801418|NCT01205503|19204663|P2|COMPLETED|Second Intervention (2nd Cycle)||16
7801419|NCT01205503|19204664|P1|COMPLETED|Second Intervention (2nd Cycle)||16
7801420|NCT01205503|19204663|P2|STARTED|Second Intervention (2nd Cycle)||16
7801421|NCT01205503|19204664|P1|STARTED|Second Intervention (2nd Cycle)||16
7801422|NCT01205503|19204663|P2|NOT COMPLETED|First Intervention (1st Cycle)||0
7801423|NCT01205503|19204664|P1|NOT COMPLETED|First Intervention (1st Cycle)||0
7801424|NCT01205503|19204663|P2|COMPLETED|First Intervention (1st Cycle)||16
7801425|NCT01205503|19204664|P1|COMPLETED|First Intervention (1st Cycle)||16
7801426|NCT01205503|19204663|P2|STARTED|First Intervention (1st Cycle)||16
7801427|NCT01205503|19204664|P1|STARTED|First Intervention (1st Cycle)||16
7801428|NCT01205451|19204680|P2|NOT COMPLETED|Overall Study||10
7801429|NCT01205451|19204681|P1|NOT COMPLETED|Overall Study||6
7801430|NCT01205451|19204680|P2|COMPLETED|Overall Study||46
7801431|NCT01205451|19204681|P1|COMPLETED|Overall Study||47
7801432|NCT01205451|19204680|P2|STARTED|Overall Study||56
7801433|NCT01205451|19204681|P1|STARTED|Overall Study||53
7801434|NCT01205438|19204726|P3|NOT COMPLETED|Overall Study||88
7801435|NCT01205438|19204727|P2|NOT COMPLETED|Overall Study||87
7801436|NCT01205438|19204728|P1|NOT COMPLETED|Overall Study||77
7801437|NCT01205438|19204726|P3|COMPLETED|Overall Study||288
7801438|NCT01205438|19204727|P2|COMPLETED|Overall Study||289
7801439|NCT01205438|19204728|P1|COMPLETED|Overall Study||295
7801440|NCT01205438|19204726|P3|Participated in Follow Up|Overall Study||66
7801441|NCT01205438|19204727|P2|Participated in Follow Up|Overall Study||78
7801442|NCT01205438|19204728|P1|Participated in Follow Up|Overall Study||72
7801443|NCT01205438|19204726|P3|Received At Least One Dose of Study Drug|Overall Study||376
7801444|NCT01205438|19204727|P2|Received At Least One Dose of Study Drug|Overall Study||374
7801445|NCT01205438|19204728|P1|Received At Least One Dose of Study Drug|Overall Study||371
7801446|NCT01205438|19204726|P3|STARTED|Overall Study||376
7801447|NCT01205438|19204727|P2|STARTED|Overall Study||376
7801448|NCT01205438|19204728|P1|STARTED|Overall Study||372
7801449|NCT01205399|19204778|P1|NOT COMPLETED|Overall Study||0
7801450|NCT01205399|19204778|P1|COMPLETED|Overall Study||78
7801451|NCT01205399|19204778|P1|STARTED|Overall Study||78
7801452|NCT01205269|19204784|P6|NOT COMPLETED|Period 5 - Third Intervention||0
7801453|NCT01205269|19204785|P5|NOT COMPLETED|Period 5 - Third Intervention||0
7801454|NCT01205269|19204786|P4|NOT COMPLETED|Period 5 - Third Intervention||0
7801455|NCT01205269|19204787|P3|NOT COMPLETED|Period 5 - Third Intervention||0
7801456|NCT01205269|19204788|P2|NOT COMPLETED|Period 5 - Third Intervention||0
7801457|NCT01205269|19204789|P1|NOT COMPLETED|Period 5 - Third Intervention||0
7801458|NCT01205269|19204784|P6|COMPLETED|Period 5 - Third Intervention||5
7801459|NCT01205269|19204785|P5|COMPLETED|Period 5 - Third Intervention||5
7801460|NCT01205269|19204786|P4|COMPLETED|Period 5 - Third Intervention||5
7801461|NCT01205269|19204787|P3|COMPLETED|Period 5 - Third Intervention||4
7801462|NCT01205269|19204788|P2|COMPLETED|Period 5 - Third Intervention||4
7801463|NCT01205269|19204789|P1|COMPLETED|Period 5 - Third Intervention||4
7801464|NCT01205269|19204784|P6|STARTED|Period 5 - Third Intervention||5
7801465|NCT01205269|19204785|P5|STARTED|Period 5 - Third Intervention||5
7801466|NCT01205269|19204786|P4|STARTED|Period 5 - Third Intervention||5
7801467|NCT01205269|19204787|P3|STARTED|Period 5 - Third Intervention||4
7801468|NCT01205269|19204788|P2|STARTED|Period 5 - Third Intervention||4
7801469|NCT01205269|19204789|P1|STARTED|Period 5 - Third Intervention||4
7801470|NCT01205269|19204784|P6|NOT COMPLETED|Period 4 - Washout||0
7801471|NCT01205269|19204785|P5|NOT COMPLETED|Period 4 - Washout||0
7801472|NCT01205269|19204786|P4|NOT COMPLETED|Period 4 - Washout||1
7801473|NCT01205269|19204787|P3|NOT COMPLETED|Period 4 - Washout||0
7801474|NCT01205269|19204788|P2|NOT COMPLETED|Period 4 - Washout||0
7801475|NCT01205269|19204789|P1|NOT COMPLETED|Period 4 - Washout||0
7801476|NCT01205269|19204784|P6|COMPLETED|Period 4 - Washout||5
7801477|NCT01205269|19204785|P5|COMPLETED|Period 4 - Washout||5
7801478|NCT01205269|19204786|P4|COMPLETED|Period 4 - Washout||5
7801479|NCT01205269|19204787|P3|COMPLETED|Period 4 - Washout||4
7801480|NCT01205269|19204788|P2|COMPLETED|Period 4 - Washout||4
7801481|NCT01205269|19204789|P1|COMPLETED|Period 4 - Washout||4
7801482|NCT01205269|19204784|P6|STARTED|Period 4 - Washout||5
7801483|NCT01205269|19204785|P5|STARTED|Period 4 - Washout||5
7801484|NCT01205269|19204786|P4|STARTED|Period 4 - Washout||6
7801485|NCT01205269|19204787|P3|STARTED|Period 4 - Washout||4
7801486|NCT01205269|19204788|P2|STARTED|Period 4 - Washout||4
7801487|NCT01205269|19204789|P1|STARTED|Period 4 - Washout||4
7801488|NCT01205269|19204784|P6|NOT COMPLETED|Period 3 - Second Intervention||0
7801489|NCT01205269|19204785|P5|NOT COMPLETED|Period 3 - Second Intervention||0
7801490|NCT01205269|19204786|P4|NOT COMPLETED|Period 3 - Second Intervention||0
7801491|NCT01205269|19204787|P3|NOT COMPLETED|Period 3 - Second Intervention||0
7801492|NCT01205269|19204788|P2|NOT COMPLETED|Period 3 - Second Intervention||0
7801493|NCT01205269|19204789|P1|NOT COMPLETED|Period 3 - Second Intervention||0
7801494|NCT01205269|19204784|P6|COMPLETED|Period 3 - Second Intervention||5
7801495|NCT01205269|19204785|P5|COMPLETED|Period 3 - Second Intervention||5
7801496|NCT01205269|19204786|P4|COMPLETED|Period 3 - Second Intervention||6
7801497|NCT01205269|19204787|P3|COMPLETED|Period 3 - Second Intervention||4
7801498|NCT01205269|19204788|P2|COMPLETED|Period 3 - Second Intervention||4
7801499|NCT01205269|19204789|P1|COMPLETED|Period 3 - Second Intervention||4
7801500|NCT01205269|19204784|P6|STARTED|Period 3 - Second Intervention||5
7801501|NCT01205269|19204785|P5|STARTED|Period 3 - Second Intervention||5
7801502|NCT01205269|19204786|P4|STARTED|Period 3 - Second Intervention||6
7801503|NCT01205269|19204787|P3|STARTED|Period 3 - Second Intervention||4
7801504|NCT01205269|19204788|P2|STARTED|Period 3 - Second Intervention||4
7801505|NCT01205269|19204789|P1|STARTED|Period 3 - Second Intervention||4
7801506|NCT01205269|19204784|P6|NOT COMPLETED|Period 2 - Washout||0
7801507|NCT01205269|19204785|P5|NOT COMPLETED|Period 2 - Washout||0
7801508|NCT01205269|19204786|P4|NOT COMPLETED|Period 2 - Washout||0
7801509|NCT01205269|19204787|P3|NOT COMPLETED|Period 2 - Washout||0
7801510|NCT01205269|19204788|P2|NOT COMPLETED|Period 2 - Washout||0
7801511|NCT01205269|19204789|P1|NOT COMPLETED|Period 2 - Washout||0
7801512|NCT01205269|19204784|P6|COMPLETED|Period 2 - Washout||5
7801513|NCT01205269|19204785|P5|COMPLETED|Period 2 - Washout||5
7801514|NCT01205269|19204786|P4|COMPLETED|Period 2 - Washout||6
7801515|NCT01205269|19204787|P3|COMPLETED|Period 2 - Washout||4
7801516|NCT01205269|19204788|P2|COMPLETED|Period 2 - Washout||4
7801517|NCT01205269|19204789|P1|COMPLETED|Period 2 - Washout||4
7801518|NCT01205269|19204784|P6|STARTED|Period 2 - Washout||5
7801519|NCT01205269|19204785|P5|STARTED|Period 2 - Washout||5
7801520|NCT01205269|19204786|P4|STARTED|Period 2 - Washout||6
7801521|NCT01205269|19204787|P3|STARTED|Period 2 - Washout||4
7801522|NCT01205269|19204788|P2|STARTED|Period 2 - Washout||4
7801523|NCT01205269|19204789|P1|STARTED|Period 2 - Washout||4
7801524|NCT01205269|19204784|P6|NOT COMPLETED|Period 1 - First Intervention||0
7801525|NCT01205269|19204785|P5|NOT COMPLETED|Period 1 - First Intervention||0
7801526|NCT01205269|19204786|P4|NOT COMPLETED|Period 1 - First Intervention||0
7801527|NCT01205269|19204787|P3|NOT COMPLETED|Period 1 - First Intervention||0
7801528|NCT01205269|19204788|P2|NOT COMPLETED|Period 1 - First Intervention||0
7801529|NCT01205269|19204789|P1|NOT COMPLETED|Period 1 - First Intervention||0
7801530|NCT01205269|19204784|P6|COMPLETED|Period 1 - First Intervention||5
7801531|NCT01205269|19204785|P5|COMPLETED|Period 1 - First Intervention||5
7801532|NCT01205269|19204786|P4|COMPLETED|Period 1 - First Intervention||6
7801533|NCT01205269|19204787|P3|COMPLETED|Period 1 - First Intervention||4
7801534|NCT01205269|19204788|P2|COMPLETED|Period 1 - First Intervention||4
7801535|NCT01205269|19204789|P1|COMPLETED|Period 1 - First Intervention||4
7801536|NCT01205269|19204784|P6|STARTED|Period 1 - First Intervention||5
7801537|NCT01205269|19204785|P5|STARTED|Period 1 - First Intervention||5
7801538|NCT01205269|19204786|P4|STARTED|Period 1 - First Intervention||6
7801539|NCT01205269|19204787|P3|STARTED|Period 1 - First Intervention||4
7801540|NCT01205269|19204788|P2|STARTED|Period 1 - First Intervention||4
7801541|NCT01205269|19204789|P1|STARTED|Period 1 - First Intervention||4
7801542|NCT01205230|19204829|P2|NOT COMPLETED|Overall Study||0
7801543|NCT01205230|19204830|P1|NOT COMPLETED|Overall Study||5
7801544|NCT01205230|19204829|P2|COMPLETED|Overall Study||13
7801545|NCT01205230|19204830|P1|COMPLETED|Overall Study||16
7801546|NCT01205230|19204829|P2|Combination Therapy|Overall Study||13
7801547|NCT01205230|19204830|P1|Combination Therapy|Overall Study||21
7801548|NCT01205230|19204829|P2|STARTED|Overall Study||13
7801549|NCT01205230|19204830|P1|STARTED|Overall Study||21
7801550|NCT01205165|19204873|P1|NOT COMPLETED|Overall Study||2
7801551|NCT01205165|19204873|P1|COMPLETED|Overall Study||102
7801552|NCT01205165|19204873|P1|STARTED|Overall Study||104
7801553|NCT01205152|19204886|P1|NOT COMPLETED|Overall Study||1
7801554|NCT01205152|19204886|P1|COMPLETED|Overall Study||9
7801555|NCT01205152|19204886|P1|STARTED|Overall Study||10
7801556|NCT01205126|19204899|P2|NOT COMPLETED|Maintenance Phase||40
7801557|NCT01205126|19204900|P1|NOT COMPLETED|Maintenance Phase||37
7801558|NCT01205126|19204899|P2|COMPLETED|Maintenance Phase||67
7801559|NCT01205126|19204900|P1|COMPLETED|Maintenance Phase||70
7801560|NCT01205126|19204899|P2|STARTED|Maintenance Phase||107
7801561|NCT01205126|19204900|P1|STARTED|Maintenance Phase||107
7801562|NCT01205126|19204899|P2|NOT COMPLETED|Between Titration & Maintenance Phase||4
7801563|NCT01205126|19204900|P1|NOT COMPLETED|Between Titration & Maintenance Phase||0
7801564|NCT01205126|19204899|P2|COMPLETED|Between Titration & Maintenance Phase||107
7801565|NCT01205126|19204900|P1|COMPLETED|Between Titration & Maintenance Phase||107
7801566|NCT01205126|19204899|P2|STARTED|Between Titration & Maintenance Phase||111
7801567|NCT01205126|19204900|P1|STARTED|Between Titration & Maintenance Phase||107
7801568|NCT01205126|19204899|P2|NOT COMPLETED|Titration Phase||19
7801569|NCT01205126|19204900|P1|NOT COMPLETED|Titration Phase||23
7801570|NCT01205126|19204899|P2|COMPLETED|Titration Phase||111
7801571|NCT01205126|19204900|P1|COMPLETED|Titration Phase||107
7801572|NCT01205126|19204899|P2|STARTED|Titration Phase||130
7801573|NCT01205126|19204900|P1|STARTED|Titration Phase||130
7801574|NCT01205035|19204918|P2|NOT COMPLETED|Overall Study||0
7801575|NCT01205035|19204919|P1|NOT COMPLETED|Overall Study||2
7801576|NCT01205035|19204918|P2|COMPLETED|Overall Study||3
7801577|NCT01205035|19204919|P1|COMPLETED|Overall Study||1
7801578|NCT01205035|19204918|P2|STARTED|Overall Study||3
7801579|NCT01205035|19204919|P1|STARTED|Overall Study||3
7801580|NCT01204918|19204936|P3|NOT COMPLETED|Overall Study||5
7801581|NCT01204918|19204937|P2|NOT COMPLETED|Overall Study||10
7801582|NCT01204918|19204938|P1|NOT COMPLETED|Overall Study||4
7801583|NCT01204918|19204936|P3|COMPLETED|Overall Study||35
7801584|NCT01204918|19204937|P2|COMPLETED|Overall Study||29
7801585|NCT01204918|19204938|P1|COMPLETED|Overall Study||21
7801586|NCT01204918|19204936|P3|Stage 2 End|Overall Study||35
7801587|NCT01204918|19204937|P2|Stage 2 End|Overall Study||29
7801588|NCT01204918|19204938|P1|Stage 2 End|Overall Study||21
7801589|NCT01204918|19204936|P3|Stage 2 Begin|Overall Study||36
7801590|NCT01204918|19204937|P2|Stage 2 Begin|Overall Study||35
7801591|NCT01204918|19204938|P1|Stage 2 Begin|Overall Study||22
7801592|NCT01204918|19204936|P3|Stage 1 End|Overall Study||36
7801593|NCT01204918|19204937|P2|Stage 1 End|Overall Study||35
7801594|NCT01204918|19204938|P1|Stage 1 End|Overall Study||22
7801595|NCT01204918|19204936|P3|Stage 1 Begin|Overall Study||40
7801596|NCT01204918|19204937|P2|Stage 1 Begin|Overall Study||39
7801597|NCT01204918|19204938|P1|Stage 1 Begin|Overall Study||25
7801598|NCT01204918|19204936|P3|STARTED|Overall Study||40
7801599|NCT01204918|19204937|P2|STARTED|Overall Study||39
7801600|NCT01204918|19204938|P1|STARTED|Overall Study||25
7801601|NCT01204905|19204955|P1|NOT COMPLETED|Overall Study||2
7801602|NCT01204905|19204955|P1|COMPLETED|Overall Study||5
7801603|NCT01204905|19204955|P1|STARTED|Overall Study||7
7801604|NCT01204853|19204960|P1|NOT COMPLETED|Overall Study||0
7801605|NCT01204853|19204960|P1|COMPLETED|Overall Study||2
7801606|NCT01204853|19204960|P1|STARTED|Overall Study||2
7801607|NCT01204788|19204972|P2|NOT COMPLETED|Overall Study||3
7801608|NCT01204788|19204973|P1|NOT COMPLETED|Overall Study||1
7801609|NCT01204788|19204972|P2|COMPLETED|Overall Study||0
7801610|NCT01204788|19204973|P1|COMPLETED|Overall Study||0
7801611|NCT01204788|19204972|P2|STARTED|Overall Study||3
7801612|NCT01204788|19204973|P1|STARTED|Overall Study||1
7801613|NCT01204775|19204981|P2|NOT COMPLETED|Overall Study||1
7801614|NCT01204775|19204982|P1|NOT COMPLETED|Overall Study||1
7801615|NCT01204775|19204981|P2|COMPLETED|Overall Study||3
7801616|NCT01204775|19204982|P1|COMPLETED|Overall Study||3
7801617|NCT01204775|19204981|P2|Double-blind Treatment Period|Overall Study||4
7801618|NCT01204775|19204982|P1|Double-blind Treatment Period|Overall Study||4
7801619|NCT01204775|19204981|P2|STARTED|Overall Study||4
7801620|NCT01204775|19204982|P1|STARTED|Overall Study||4
7801621|NCT01204736|19204992|P4|NOT COMPLETED|Overall Study||0
7801622|NCT01204736|19204993|P3|NOT COMPLETED|Overall Study||0
7801623|NCT01204736|19204994|P2|NOT COMPLETED|Overall Study||0
7801624|NCT01204736|19204995|P1|NOT COMPLETED|Overall Study||0
7801625|NCT01204736|19204992|P4|COMPLETED|Overall Study||2
7801626|NCT01204736|19204993|P3|COMPLETED|Overall Study||3
7801627|NCT01204736|19204994|P2|COMPLETED|Overall Study||5
7801628|NCT01204736|19204995|P1|COMPLETED|Overall Study||4
7801629|NCT01204736|19204992|P4|STARTED|Overall Study||2
7801630|NCT01204736|19204993|P3|STARTED|Overall Study||3
7801631|NCT01204736|19204994|P2|STARTED|Overall Study||5
7801632|NCT01204736|19204995|P1|STARTED|Overall Study||4
7801633|NCT01204710|19205007|P2|NOT COMPLETED|Optional Olaratumab Monotherapy||3
7801634|NCT01204710|19205008|P1|NOT COMPLETED|Optional Olaratumab Monotherapy||0
7801635|NCT01204710|19205007|P2|COMPLETED|Optional Olaratumab Monotherapy||16
7801636|NCT01204710|19205008|P1|COMPLETED|Optional Olaratumab Monotherapy||0
7801637|NCT01204710|19205007|P2|STARTED|Optional Olaratumab Monotherapy|Among 43 participants who experienced PD, 19 received olaratumab monotherapy.|19
7801638|NCT01204710|19205008|P1|STARTED|Optional Olaratumab Monotherapy|Olaratumab follow-on treatment was optional for participants in mitoxantrone group only who had PD.|0
7801639|NCT01204710|19205007|P2|NOT COMPLETED|Randomization Treatment||13
7801640|NCT01204710|19205008|P1|NOT COMPLETED|Randomization Treatment||14
7801641|NCT01204710|19205007|P2|COMPLETED|Randomization Treatment||47
7801642|NCT01204710|19205008|P1|COMPLETED|Randomization Treatment||49
7801643|NCT01204710|19205007|P2|Received ≥1 Dose of Study Drug|Randomization Treatment||59
7801644|NCT01204710|19205008|P1|Received ≥1 Dose of Study Drug|Randomization Treatment||62
7801645|NCT01204710|19205007|P2|STARTED|Randomization Treatment||60
7801646|NCT01204710|19205008|P1|STARTED|Randomization Treatment||63
7801647|NCT01204697|19205044|P2|NOT COMPLETED|Overall Study||36
7801648|NCT01204697|19205045|P1|NOT COMPLETED|Overall Study||31
7801649|NCT01204697|19205044|P2|COMPLETED|Overall Study||2
7801650|NCT01204697|19205045|P1|COMPLETED|Overall Study||5
7801651|NCT01204697|19205044|P2|Treated|Overall Study||37
7801652|NCT01204697|19205045|P1|Treated|Overall Study||36
7801653|NCT01204697|19205044|P2|STARTED|Overall Study||38
7801654|NCT01204697|19205045|P1|STARTED|Overall Study||36
7801655|NCT01204671|19205066|P5|NOT COMPLETED|Overall Study||4
7801656|NCT01204671|19205067|P4|NOT COMPLETED|Overall Study||13
7801657|NCT01204671|19205068|P3|NOT COMPLETED|Overall Study||13
7801658|NCT01204671|19205069|P2|NOT COMPLETED|Overall Study||15
7801659|NCT01204671|19205070|P1|NOT COMPLETED|Overall Study||14
7801660|NCT01204671|19205066|P5|COMPLETED|Overall Study||606
7801661|NCT01204671|19205067|P4|COMPLETED|Overall Study||997
7801662|NCT01204671|19205068|P3|COMPLETED|Overall Study||998
7801663|NCT01204671|19205069|P2|COMPLETED|Overall Study||998
7801664|NCT01204671|19205070|P1|COMPLETED|Overall Study||998
7801665|NCT01204671|19205066|P5|STARTED|Overall Study||610
7801666|NCT01204671|19205067|P4|STARTED|Overall Study||1010
7801667|NCT01204671|19205068|P3|STARTED|Overall Study||1011
7801668|NCT01204671|19205069|P2|STARTED|Overall Study||1013
7801669|NCT01204671|19205070|P1|STARTED|Overall Study||1012
7801670|NCT01204658|19205132|P4|NOT COMPLETED|Booster Phase||0
7801671|NCT01204658|19205133|P3|NOT COMPLETED|Booster Phase||0
7801672|NCT01204658|19205134|P2|NOT COMPLETED|Booster Phase||0
7801673|NCT01204658|19205135|P1|NOT COMPLETED|Booster Phase||0
7801674|NCT01204658|19205132|P4|COMPLETED|Booster Phase||140
7801675|NCT01204658|19205133|P3|COMPLETED|Booster Phase||140
7801676|NCT01204658|19205134|P2|COMPLETED|Booster Phase||140
7801677|NCT01204658|19205135|P1|COMPLETED|Booster Phase||144
7801678|NCT01204658|19205132|P4|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
7801679|NCT01204658|19205133|P3|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
7801680|NCT01204658|19205134|P2|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
7801681|NCT01204658|19205135|P1|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144
7801682|NCT01204658|19205132|P4|NOT COMPLETED|Primary Phase||0
7801683|NCT01204658|19205133|P3|NOT COMPLETED|Primary Phase||1
7801684|NCT01204658|19205134|P2|NOT COMPLETED|Primary Phase||0
7801685|NCT01204658|19205135|P1|NOT COMPLETED|Primary Phase||0
7801686|NCT01204658|19205132|P4|COMPLETED|Primary Phase||142
7801687|NCT01204658|19205133|P3|COMPLETED|Primary Phase||144
7801688|NCT01204658|19205134|P2|COMPLETED|Primary Phase||142
7801689|NCT01204658|19205135|P1|COMPLETED|Primary Phase||146
7801690|NCT01204658|19205132|P4|STARTED|Primary Phase||142
7801691|NCT01204658|19205133|P3|STARTED|Primary Phase||145
7801692|NCT01204658|19205134|P2|STARTED|Primary Phase||142
7801693|NCT01204658|19205135|P1|STARTED|Primary Phase||146
7801694|NCT01204398|19205253|P1|NOT COMPLETED|Overall Study||1
7801695|NCT01204398|19205253|P1|COMPLETED|Overall Study|Completed trial medication.|26
7801696|NCT01204398|19205253|P1|STARTED|Overall Study|Entered and treated.|27
7801697|NCT01204294|19205270|P7|NOT COMPLETED|Overall Study||2
7801698|NCT01204294|19205271|P6|NOT COMPLETED|Overall Study||5
7801699|NCT01204294|19205272|P5|NOT COMPLETED|Overall Study||2
7801700|NCT01204294|19205273|P4|NOT COMPLETED|Overall Study||11
7801701|NCT01204294|19205274|P3|NOT COMPLETED|Overall Study||5
7801702|NCT01204294|19205275|P2|NOT COMPLETED|Overall Study||8
7801703|NCT01204294|19205276|P1|NOT COMPLETED|Overall Study||3
7801704|NCT01204294|19205270|P7|COMPLETED|Overall Study||59
7801705|NCT01204294|19205271|P6|COMPLETED|Overall Study||58
7801706|NCT01204294|19205272|P5|COMPLETED|Overall Study||83
7801707|NCT01204294|19205273|P4|COMPLETED|Overall Study||132
7801708|NCT01204294|19205274|P3|COMPLETED|Overall Study||69
7801709|NCT01204294|19205275|P2|COMPLETED|Overall Study||58
7801710|NCT01204294|19205276|P1|COMPLETED|Overall Study||79
7801711|NCT01204294|19205270|P7|STARTED|Overall Study||61
7801712|NCT01204294|19205271|P6|STARTED|Overall Study||63
7801713|NCT01204294|19205272|P5|STARTED|Overall Study||85
7801714|NCT01204294|19205273|P4|STARTED|Overall Study||143
7801715|NCT01204294|19205274|P3|STARTED|Overall Study||74
7801716|NCT01204294|19205275|P2|STARTED|Overall Study||66
7801717|NCT01204294|19205276|P1|STARTED|Overall Study||82
7801718|NCT01204255|19205299|P1|NOT COMPLETED|Overall Study||1
7801719|NCT01204255|19205299|P1|COMPLETED|Overall Study||10
7801720|NCT01204255|19205299|P1|STARTED|Overall Study||11
7801721|NCT01204203|19205304|P1|NOT COMPLETED|Overall Study||0
7801722|NCT01204203|19205304|P1|COMPLETED|Overall Study||8
7801723|NCT01204203|19205304|P1|STARTED|Overall Study||8
7801724|NCT01203956|19205310|P2|NOT COMPLETED|Second Two-week Period||6
7801725|NCT01203956|19205311|P1|NOT COMPLETED|Second Two-week Period||5
7801726|NCT01203956|19205310|P2|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7
7801727|NCT01203956|19205311|P1|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10
7801728|NCT01203956|19205310|P2|Attended Sleep Studies for 14 Nights|Second Two-week Period||13
7801729|NCT01203956|19205311|P1|Attended Sleep Studies for 14 Nights|Second Two-week Period||15
7801730|NCT01203956|19205310|P2|STARTED|Second Two-week Period||13
7801731|NCT01203956|19205311|P1|STARTED|Second Two-week Period||15
7801732|NCT01203956|19205310|P2|NOT COMPLETED|First Two-week Period||0
7801733|NCT01203956|19205311|P1|NOT COMPLETED|First Two-week Period||0
7801734|NCT01203956|19205310|P2|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13
7801735|NCT01203956|19205311|P1|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15
7801736|NCT01203956|19205310|P2|STARTED|First Two-week Period||13
7801737|NCT01203956|19205311|P1|STARTED|First Two-week Period||15
7801738|NCT01203930|19205320|P2|NOT COMPLETED|Overall Study||41
7801739|NCT01203930|19205321|P1|NOT COMPLETED|Overall Study||21
7801740|NCT01203930|19205320|P2|COMPLETED|Overall Study||0
7801741|NCT01203930|19205321|P1|COMPLETED|Overall Study|43 participants completed 12 cycles and were then eligible to enroll in the extension study (101-99)|43
7801742|NCT01203930|19205320|P2|STARTED|Overall Study||41
7801743|NCT01203930|19205321|P1|STARTED|Overall Study||64
7801744|NCT01203917|19205343|P1|NOT COMPLETED|Overall Study||36
7801745|NCT01203917|19205343|P1|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71
7801746|NCT01203917|19205343|P1|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107
7801747|NCT01203878|19205356|P3|NOT COMPLETED|Overall Study||3
7801748|NCT01203878|19205357|P2|NOT COMPLETED|Overall Study||0
7801749|NCT01203878|19205358|P1|NOT COMPLETED|Overall Study||0
7801750|NCT01203878|19205356|P3|COMPLETED|Overall Study||0
7801751|NCT01203878|19205357|P2|COMPLETED|Overall Study||9
7801752|NCT01203878|19205358|P1|COMPLETED|Overall Study||9
7801753|NCT01203878|19205356|P3|STARTED|Overall Study||3
7801754|NCT01203878|19205357|P2|STARTED|Overall Study||9
7801755|NCT01203878|19205358|P1|STARTED|Overall Study||9
7801756|NCT01203852|19205369|P1|NOT COMPLETED|Chlorthalidone 8 Weeks||0
7801757|NCT01203852|19205369|P1|COMPLETED|Chlorthalidone 8 Weeks||328
7801758|NCT01203852|19205369|P1|Continued From Metoprolol|Chlorthalidone 8 Weeks||282
7801759|NCT01203852|19205369|P1|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328
7801760|NCT01203852|19205369|P1|NOT COMPLETED|Washout 2 Weeks||46
7801761|NCT01203852|19205369|P1|COMPLETED|Washout 2 Weeks||282
7801762|NCT01203852|19205369|P1|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328
7801763|NCT01203852|19205369|P1|NOT COMPLETED|Metoprolol 8 Weeks||470
7801764|NCT01203852|19205369|P1|COMPLETED|Metoprolol 8 Weeks||369
7801765|NCT01203852|19205369|P1|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839
7801766|NCT01203826|19205378|P2|NOT COMPLETED|Overall Study||0
7801767|NCT01203826|19205379|P1|NOT COMPLETED|Overall Study||0
7801768|NCT01203826|19205378|P2|COMPLETED|Overall Study||6
7801769|NCT01203826|19205379|P1|COMPLETED|Overall Study||6
7801770|NCT01203826|19205378|P2|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
7801771|NCT01203826|19205379|P1|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
7801772|NCT01203787|19205387|P2|NOT COMPLETED|Overall Study||27
7801773|NCT01203787|19205388|P1|NOT COMPLETED|Overall Study||31
7801774|NCT01203787|19205387|P2|COMPLETED|Overall Study||30
7801775|NCT01203787|19205388|P1|COMPLETED|Overall Study||32
7801776|NCT01203787|19205387|P2|STARTED|Overall Study||57
7801777|NCT01203787|19205388|P1|STARTED|Overall Study||63
7801778|NCT01203644|19205408|P2|NOT COMPLETED|Overall Study||0
7801779|NCT01203644|19205409|P1|NOT COMPLETED|Overall Study||0
7801780|NCT01203644|19205408|P2|COMPLETED|Overall Study||50
7801781|NCT01203644|19205409|P1|COMPLETED|Overall Study||26
7801782|NCT01203644|19205408|P2|STARTED|Overall Study||50
7801783|NCT01203644|19205409|P1|STARTED|Overall Study||26
7801784|NCT01203319|19205421|P3|NOT COMPLETED|Overall Study||5
7801785|NCT01203319|19205422|P2|NOT COMPLETED|Overall Study||9
7801786|NCT01203319|19205423|P1|NOT COMPLETED|Overall Study||6
7801787|NCT01203319|19205421|P3|COMPLETED|Overall Study||217
7801788|NCT01203319|19205422|P2|COMPLETED|Overall Study||426
7801789|NCT01203319|19205423|P1|COMPLETED|Overall Study||428
7801790|NCT01203319|19205421|P3|STARTED|Overall Study||222
7801791|NCT01203319|19205422|P2|STARTED|Overall Study||435
7801792|NCT01203319|19205423|P1|STARTED|Overall Study||434
7801793|NCT01203189|19205440|P3|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
7801794|NCT01203189|19205441|P2|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
7801795|NCT01203189|19205442|P1|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
7801796|NCT01203189|19205440|P3|COMPLETED|Cross Over Period 4 Weeks Treatment||3
7801797|NCT01203189|19205441|P2|COMPLETED|Cross Over Period 4 Weeks Treatment||0
7801798|NCT01203189|19205442|P1|COMPLETED|Cross Over Period 4 Weeks Treatment||0
7801799|NCT01203189|19205440|P3|STARTED|Cross Over Period 4 Weeks Treatment||3
7801800|NCT01203189|19205441|P2|STARTED|Cross Over Period 4 Weeks Treatment||0
7801801|NCT01203189|19205442|P1|STARTED|Cross Over Period 4 Weeks Treatment||0
7801802|NCT01203189|19205440|P3|NOT COMPLETED|First 4 Weeks Treatment||0
7801803|NCT01203189|19205441|P2|NOT COMPLETED|First 4 Weeks Treatment||2
7801804|NCT01203189|19205442|P1|NOT COMPLETED|First 4 Weeks Treatment||2
7801805|NCT01203189|19205440|P3|COMPLETED|First 4 Weeks Treatment||3
7801806|NCT01203189|19205441|P2|COMPLETED|First 4 Weeks Treatment||8
7801807|NCT01203189|19205442|P1|COMPLETED|First 4 Weeks Treatment||8
7801808|NCT01203189|19205440|P3|STARTED|First 4 Weeks Treatment||3
7801809|NCT01203189|19205441|P2|STARTED|First 4 Weeks Treatment||10
7801810|NCT01203189|19205442|P1|STARTED|First 4 Weeks Treatment||10
7801811|NCT01203098|19205459|P3|NOT COMPLETED|Overall Study||11
7801812|NCT01203098|19205460|P2|NOT COMPLETED|Overall Study||4
7801813|NCT01203098|19205461|P1|NOT COMPLETED|Overall Study||6
7801814|NCT01203098|19205459|P3|COMPLETED|Overall Study||78
7801815|NCT01203098|19205460|P2|COMPLETED|Overall Study||82
7801816|NCT01203098|19205461|P1|COMPLETED|Overall Study||83
7801817|NCT01203098|19205459|P3|Safety Analysis Dataset|Overall Study||87
7801818|NCT01203098|19205460|P2|Safety Analysis Dataset|Overall Study||85
7801819|NCT01203098|19205461|P1|Safety Analysis Dataset|Overall Study||89
7801820|NCT01203098|19205459|P3|STARTED|Overall Study||89
7801821|NCT01203098|19205460|P2|STARTED|Overall Study||86
7801822|NCT01203098|19205461|P1|STARTED|Overall Study||89
7801823|NCT01203072|19205477|P5|NOT COMPLETED|Overall Study||6
7801824|NCT01203072|19205478|P4|NOT COMPLETED|Overall Study||6
7801825|NCT01203072|19205479|P3|NOT COMPLETED|Overall Study||3
7801826|NCT01203072|19205480|P2|NOT COMPLETED|Overall Study||6
7801827|NCT01203072|19205481|P1|NOT COMPLETED|Overall Study||10
7801828|NCT01203072|19205477|P5|COMPLETED|Overall Study||96
7801829|NCT01203072|19205478|P4|COMPLETED|Overall Study||100
7801830|NCT01203072|19205479|P3|COMPLETED|Overall Study||101
7801831|NCT01203072|19205480|P2|COMPLETED|Overall Study||100
7801832|NCT01203072|19205481|P1|COMPLETED|Overall Study||95
7801833|NCT01203072|19205477|P5|STARTED|Overall Study||102
7801834|NCT01203072|19205478|P4|STARTED|Overall Study||106
7801835|NCT01203072|19205479|P3|STARTED|Overall Study||104
7801836|NCT01203072|19205480|P2|STARTED|Overall Study||106
7801837|NCT01203072|19205481|P1|STARTED|Overall Study||105
7801838|NCT01203046|19205500|P2|NOT COMPLETED|Overall Study||0
7801839|NCT01203046|19205501|P1|NOT COMPLETED|Overall Study||0
7801840|NCT01203046|19205500|P2|COMPLETED|Overall Study||28
7801841|NCT01203046|19205501|P1|COMPLETED|Overall Study||28
7801842|NCT01203046|19205500|P2|STARTED|Overall Study||28
7801843|NCT01203046|19205501|P1|STARTED|Overall Study||28
7801844|NCT01202994|19205509|P1|NOT COMPLETED|Overall Study||0
7801845|NCT01202994|19205509|P1|COMPLETED|Overall Study||27
7801846|NCT01202994|19205509|P1|STARTED|Overall Study||27
7801847|NCT01202955|19205516|P2|NOT COMPLETED|Period 3: 10 Days||0
7801848|NCT01202955|19205517|P1|NOT COMPLETED|Period 3: 10 Days||0
7801849|NCT01202955|19205516|P2|COMPLETED|Period 3: 10 Days||8
7801850|NCT01202955|19205517|P1|COMPLETED|Period 3: 10 Days||9
7801851|NCT01202955|19205516|P2|STARTED|Period 3: 10 Days||8
7801852|NCT01202955|19205517|P1|STARTED|Period 3: 10 Days||9
7801853|NCT01202955|19205516|P2|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
7801854|NCT01202955|19205517|P1|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
7801855|NCT01202955|19205516|P2|COMPLETED|Period 2: 7 Days (Wash-Out)||8
7801856|NCT01202955|19205517|P1|COMPLETED|Period 2: 7 Days (Wash-Out)||9
7801857|NCT01202955|19205516|P2|STARTED|Period 2: 7 Days (Wash-Out)||8
7801858|NCT01202955|19205517|P1|STARTED|Period 2: 7 Days (Wash-Out)||9
7801859|NCT01202955|19205516|P2|NOT COMPLETED|Period 1: 10 Days||2
7801860|NCT01202955|19205517|P1|NOT COMPLETED|Period 1: 10 Days||0
7801861|NCT01202955|19205516|P2|COMPLETED|Period 1: 10 Days||8
7801862|NCT01202955|19205517|P1|COMPLETED|Period 1: 10 Days||9
7801863|NCT01202955|19205516|P2|STARTED|Period 1: 10 Days||10
7801864|NCT01202955|19205517|P1|STARTED|Period 1: 10 Days||9
7801865|NCT01202903|19205529|P2|NOT COMPLETED|Overall Study||16
7801866|NCT01202903|19205530|P1|NOT COMPLETED|Overall Study||11
7801867|NCT01202903|19205529|P2|COMPLETED|Overall Study||292
7801868|NCT01202903|19205530|P1|COMPLETED|Overall Study||297
7801869|NCT01202903|19205529|P2|Safety Set*|Overall Study||299
7801870|NCT01202903|19205530|P1|Safety Set*|Overall Study||310
7801871|NCT01202903|19205529|P2|Full Analysis Set|Overall Study||302
7801872|NCT01202903|19205530|P1|Full Analysis Set|Overall Study||306
7801873|NCT01202903|19205529|P2|STARTED|Overall Study||308
7801874|NCT01202903|19205530|P1|STARTED|Overall Study||308
7801875|NCT01202877|19205557|P3|NOT COMPLETED|Overall Study||6
7801876|NCT01202877|19205558|P2|NOT COMPLETED|Overall Study||1
7801877|NCT01202877|19205559|P1|NOT COMPLETED|Overall Study||0
7801878|NCT01202877|19205557|P3|COMPLETED|Overall Study||34
7801879|NCT01202877|19205558|P2|COMPLETED|Overall Study||7
7801880|NCT01202877|19205559|P1|COMPLETED|Overall Study||6
7801881|NCT01202877|19205557|P3|STARTED|Overall Study||40
7801882|NCT01202877|19205558|P2|STARTED|Overall Study||8
7801883|NCT01202877|19205559|P1|STARTED|Overall Study||6
7801884|NCT01202773|19205573|P3|NOT COMPLETED|Overall Study||55
7801885|NCT01202773|19205574|P2|NOT COMPLETED|Overall Study||43
7801886|NCT01202773|19205575|P1|NOT COMPLETED|Overall Study||57
7801887|NCT01202773|19205573|P3|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|100
7801888|NCT01202773|19205574|P2|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|105
7801889|NCT01202773|19205575|P1|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|96
7801890|NCT01202773|19205573|P3|Post-Treatment Follow-Up Population|Overall Study||51
7801891|NCT01202773|19205574|P2|Post-Treatment Follow-Up Population|Overall Study||36
7801892|NCT01202773|19205575|P1|Post-Treatment Follow-Up Population|Overall Study||46
7801893|NCT01202773|19205573|P3|Week 16 NR|Overall Study||37
7801894|NCT01202773|19205574|P2|Week 16 NR|Overall Study||33
7801895|NCT01202773|19205575|P1|Week 16 NR|Overall Study||23
7801896|NCT01202773|19205573|P3|Received at Least 1 Dose of Study Drug|Overall Study||154
7801897|NCT01202773|19205574|P2|Received at Least 1 Dose of Study Drug|Overall Study||147
7801898|NCT01202773|19205575|P1|Received at Least 1 Dose of Study Drug|Overall Study||153
7801899|NCT01202773|19205573|P3|STARTED|Overall Study||155
7801900|NCT01202773|19205574|P2|STARTED|Overall Study||148
7801901|NCT01202773|19205575|P1|STARTED|Overall Study||153
7801902|NCT01202760|19205652|P3|NOT COMPLETED|Overall Study||35
7801903|NCT01202760|19205653|P2|NOT COMPLETED|Overall Study||52
7801904|NCT01202760|19205654|P1|NOT COMPLETED|Overall Study||47
7801905|NCT01202760|19205652|P3|COMPLETED|Overall Study||216
7801906|NCT01202760|19205653|P2|COMPLETED|Overall Study||322
7801907|NCT01202760|19205654|P1|COMPLETED|Overall Study||332
7801908|NCT01202760|19205652|P3|Received at Least One Dose of Study Drug|Overall Study||250
7801909|NCT01202760|19205653|P2|Received at Least One Dose of Study Drug|Overall Study||371
7801910|NCT01202760|19205654|P1|Received at Least One Dose of Study Drug|Overall Study||379
7801911|NCT01202760|19205652|P3|STARTED|Overall Study||251
7801912|NCT01202760|19205653|P2|STARTED|Overall Study||374
7801913|NCT01202760|19205654|P1|STARTED|Overall Study||379
7801914|NCT01202747|19205722|P1|NOT COMPLETED|Overall Study||1
7801915|NCT01202747|19205722|P1|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49
7801916|NCT01202747|19205722|P1|STARTED|Overall Study||50
7801917|NCT01202721|19205730|P4|NOT COMPLETED|Overall Study||0
7801918|NCT01202721|19205731|P3|NOT COMPLETED|Overall Study||0
7801919|NCT01202721|19205732|P2|NOT COMPLETED|Overall Study||0
7801920|NCT01202721|19205733|P1|NOT COMPLETED|Overall Study||0
7801921|NCT01202721|19205730|P4|COMPLETED|Overall Study||27
7801922|NCT01202721|19205731|P3|COMPLETED|Overall Study||14
7801923|NCT01202721|19205732|P2|COMPLETED|Overall Study||26
7801924|NCT01202721|19205733|P1|COMPLETED|Overall Study||18
7801925|NCT01202721|19205730|P4|STARTED|Overall Study||27
7801926|NCT01202721|19205731|P3|STARTED|Overall Study||14
7801927|NCT01202721|19205732|P2|STARTED|Overall Study||26
7801928|NCT01202721|19205733|P1|STARTED|Overall Study||18
7801929|NCT01202656|19205749|P2|NOT COMPLETED|CrossoverCycle||0
7801930|NCT01202656|19205750|P1|NOT COMPLETED|CrossoverCycle||0
7801931|NCT01202656|19205749|P2|COMPLETED|CrossoverCycle||14
7801932|NCT01202656|19205750|P1|COMPLETED|CrossoverCycle||18
7801933|NCT01202656|19205749|P2|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14
7801934|NCT01202656|19205750|P1|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18
7801935|NCT01202656|19205749|P2|NOT COMPLETED|Cycle 1||0
7801936|NCT01202656|19205750|P1|NOT COMPLETED|Cycle 1||0
7801937|NCT01202656|19205749|P2|COMPLETED|Cycle 1||62
7801938|NCT01202656|19205750|P1|COMPLETED|Cycle 1||67
7801939|NCT01202656|19205749|P2|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62
7801940|NCT01202656|19205750|P1|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67
7801941|NCT01202643|19205760|P2|NOT COMPLETED|Crossover Cycle||0
7801942|NCT01202643|19205761|P1|NOT COMPLETED|Crossover Cycle||0
7801943|NCT01202643|19205760|P2|COMPLETED|Crossover Cycle||2
7801944|NCT01202643|19205761|P1|COMPLETED|Crossover Cycle||1
7801945|NCT01202643|19205760|P2|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2
7801946|NCT01202643|19205761|P1|STARTED|Crossover Cycle|One patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1
7801947|NCT01202643|19205760|P2|NOT COMPLETED|Period 1||0
7801948|NCT01202643|19205761|P1|NOT COMPLETED|Period 1||0
7801949|NCT01202643|19205760|P2|COMPLETED|Period 1||6
7801950|NCT01202643|19205761|P1|COMPLETED|Period 1||6
7801951|NCT01202643|19205760|P2|STARTED|Period 1||6
7801952|NCT01202643|19205761|P1|STARTED|Period 1||6
7801953|NCT01202591|19205775|P6|NOT COMPLETED|Overall Study||4
7801954|NCT01202591|19205776|P5|NOT COMPLETED|Overall Study||5
7801955|NCT01202591|19205777|P4|NOT COMPLETED|Overall Study||7
7801956|NCT01202591|19205778|P3|NOT COMPLETED|Overall Study||11
7801957|NCT01202591|19205779|P2|NOT COMPLETED|Overall Study||5
7801958|NCT01202591|19205780|P1|NOT COMPLETED|Overall Study||5
7801959|NCT01202591|19205775|P6|COMPLETED|Overall Study||0
7801960|NCT01202591|19205776|P5|COMPLETED|Overall Study||0
7801961|NCT01202591|19205777|P4|COMPLETED|Overall Study||2
7801962|NCT01202591|19205778|P3|COMPLETED|Overall Study||1
7801963|NCT01202591|19205779|P2|COMPLETED|Overall Study||0
7801964|NCT01202591|19205780|P1|COMPLETED|Overall Study||0
7801965|NCT01202591|19205775|P6|STARTED|Overall Study||4
7801966|NCT01202591|19205776|P5|STARTED|Overall Study||5
7801967|NCT01202591|19205777|P4|STARTED|Overall Study||9
7801968|NCT01202591|19205778|P3|STARTED|Overall Study||12
7801969|NCT01202591|19205779|P2|STARTED|Overall Study||5
7801970|NCT01202591|19205780|P1|STARTED|Overall Study||5
7801971|NCT01202578|19205794|P1|NOT COMPLETED|Overall Study||0
7801972|NCT01202578|19205794|P1|COMPLETED|Overall Study||53
7801973|NCT01202578|19205794|P1|STARTED|Overall Study||53
7801974|NCT01202565|19205801|P1|NOT COMPLETED|Overall Study||67
7801975|NCT01202565|19205801|P1|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439
7801976|NCT01202565|19205801|P1|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501
7801977|NCT01202565|19205801|P1|STARTED|Overall Study||506
7801978|NCT01202409|19205824|P1|NOT COMPLETED|Overall Study||8
7801979|NCT01202409|19205824|P1|COMPLETED|Overall Study||11
7801980|NCT01202409|19205824|P1|STARTED|Overall Study||19
7801981|NCT01202279|19205831|P2|NOT COMPLETED|Overall Study||27
7801982|NCT01202279|19205832|P1|NOT COMPLETED|Overall Study||37
7801983|NCT01202279|19205831|P2|COMPLETED|Overall Study||561
7801984|NCT01202279|19205832|P1|COMPLETED|Overall Study||554
7801985|NCT01202279|19205831|P2|STARTED|Overall Study||588
7801986|NCT01202279|19205832|P1|STARTED|Overall Study||591
7801987|NCT01202253|19205840|P1|NOT COMPLETED|Overall Study||0
7801988|NCT01202253|19205840|P1|COMPLETED|Overall Study||50
7801989|NCT01202253|19205840|P1|STARTED|Overall Study||50
7801990|NCT01202227|19205884|P1|NOT COMPLETED|Overall Study||19
7801991|NCT01202227|19205884|P1|COMPLETED|Overall Study||84
7801992|NCT01202227|19205884|P1|STARTED|Overall Study|Treated|103
7801993|NCT01202188|19205908|P5|NOT COMPLETED|Overall Study||45
7801994|NCT01202188|19205909|P4|NOT COMPLETED|Overall Study||42
7801995|NCT01202188|19205910|P3|NOT COMPLETED|Overall Study||53
7801996|NCT01202188|19205911|P2|NOT COMPLETED|Overall Study||56
7801997|NCT01202188|19205912|P1|NOT COMPLETED|Overall Study||38
7801998|NCT01202188|19205908|P5|COMPLETED|Overall Study||189
7801999|NCT01202188|19205909|P4|COMPLETED|Overall Study||441
7802000|NCT01202188|19205910|P3|COMPLETED|Overall Study||422
7802001|NCT01202188|19205911|P2|COMPLETED|Overall Study||421
7802002|NCT01202188|19205912|P1|COMPLETED|Overall Study||437
7802003|NCT01202188|19205908|P5|Safety Set; Received Study Drug|Overall Study||232
7802004|NCT01202188|19205909|P4|Safety Set; Received Study Drug|Overall Study||480
7802005|NCT01202188|19205910|P3|Safety Set; Received Study Drug|Overall Study||473
7802006|NCT01202188|19205911|P2|Safety Set; Received Study Drug|Overall Study||476
7802007|NCT01202188|19205912|P1|Safety Set; Received Study Drug|Overall Study||474
7802008|NCT01202188|19205908|P5|STARTED|Overall Study||234
7802009|NCT01202188|19205909|P4|STARTED|Overall Study||483
7802010|NCT01202188|19205910|P3|STARTED|Overall Study||475
7802011|NCT01202188|19205911|P2|STARTED|Overall Study||477
7802012|NCT01202188|19205912|P1|STARTED|Overall Study||475
7802013|NCT01202175|19206020|P1|NOT COMPLETED|Overall Study||5
7802014|NCT01202175|19206020|P1|COMPLETED|Overall Study||45
7802015|NCT01202175|19206020|P1|Pacebo|Overall Study||25
7802016|NCT01202175|19206020|P1|Nebivolol|Overall Study||25
7802017|NCT01202175|19206020|P1|STARTED|Overall Study||50
7802018|NCT01202162|19206049|P2|NOT COMPLETED|Overall Study||2
7802019|NCT01202162|19206050|P1|NOT COMPLETED|Overall Study||3
7802020|NCT01202162|19206049|P2|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
7802021|NCT01202162|19206050|P1|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
7802022|NCT01202162|19206049|P2|STARTED|Overall Study||42
7802023|NCT01202162|19206050|P1|STARTED|Overall Study||43
7802024|NCT01202110|19206060|P2|NOT COMPLETED|Overall Study||0
7802025|NCT01202110|19206061|P1|NOT COMPLETED|Overall Study||0
7802026|NCT01202110|19206060|P2|COMPLETED|Overall Study||0
7802027|NCT01202110|19206061|P1|COMPLETED|Overall Study||10
7802028|NCT01202110|19206060|P2|STARTED|Overall Study||0
7802029|NCT01202110|19206061|P1|STARTED|Overall Study||10
7802030|NCT01202071|19206065|P4|NOT COMPLETED|Overall Study||0
7802031|NCT01202071|19206066|P3|NOT COMPLETED|Overall Study||0
7802032|NCT01202071|19206067|P2|NOT COMPLETED|Overall Study||0
7802033|NCT01202071|19206068|P1|NOT COMPLETED|Overall Study||0
7802034|NCT01202071|19206065|P4|COMPLETED|Overall Study||6
7802035|NCT01202071|19206066|P3|COMPLETED|Overall Study||6
7802036|NCT01202071|19206067|P2|COMPLETED|Overall Study||6
7802037|NCT01202071|19206068|P1|COMPLETED|Overall Study||6
7802038|NCT01202071|19206065|P4|STARTED|Overall Study||6
7802039|NCT01202071|19206066|P3|STARTED|Overall Study||6
7802040|NCT01202071|19206067|P2|STARTED|Overall Study||6
7802041|NCT01202071|19206068|P1|STARTED|Overall Study||6
7802042|NCT01201967|19206088|P2|NOT COMPLETED|Overall Study||5
7802043|NCT01201967|19206089|P1|NOT COMPLETED|Overall Study||6
7802044|NCT01201967|19206088|P2|COMPLETED|Overall Study||86
7802045|NCT01201967|19206089|P1|COMPLETED|Overall Study||86
7802046|NCT01201967|19206088|P2|STARTED|Overall Study||91
7802047|NCT01201967|19206089|P1|STARTED|Overall Study||92
7802048|NCT01201915|19206114|P3|NOT COMPLETED|Overall Study||6
7802049|NCT01201915|19206115|P2|NOT COMPLETED|Overall Study||11
7802050|NCT01201915|19206116|P1|NOT COMPLETED|Overall Study||8
7802051|NCT01201915|19206114|P3|COMPLETED|Overall Study||19
7802052|NCT01201915|19206115|P2|COMPLETED|Overall Study||14
7802053|NCT01201915|19206116|P1|COMPLETED|Overall Study||16
7802054|NCT01201915|19206114|P3|STARTED|Overall Study||25
7802055|NCT01201915|19206115|P2|STARTED|Overall Study||25
7802056|NCT01201915|19206116|P1|STARTED|Overall Study||24
7802057|NCT01201811|19206127|P1|NOT COMPLETED|Overall Study||19
7802058|NCT01201811|19206127|P1|COMPLETED|Overall Study||25
7802059|NCT01201811|19206127|P1|STARTED|Overall Study||44
7802060|NCT01201798|19206149|P2|NOT COMPLETED|Overall Study||15
7802061|NCT01201798|19206150|P1|NOT COMPLETED|Overall Study||9
7802062|NCT01201798|19206149|P2|COMPLETED|Overall Study||39
7802063|NCT01201798|19206150|P1|COMPLETED|Overall Study||47
7802064|NCT01201798|19206149|P2|STARTED|Overall Study||54
7802065|NCT01201798|19206150|P1|STARTED|Overall Study||56
7802066|NCT01201785|19206174|P1|NOT COMPLETED|Overall Study||16
7802067|NCT01201785|19206174|P1|COMPLETED|Overall Study||20
7802068|NCT01201785|19206174|P1|STARTED|Overall Study||36
7802069|NCT01201772|19206181|P3|NOT COMPLETED|Overall Study||0
7802070|NCT01201772|19206182|P2|NOT COMPLETED|Overall Study||0
7802071|NCT01201772|19206183|P1|NOT COMPLETED|Overall Study||1
7802072|NCT01201772|19206181|P3|COMPLETED|Overall Study||21
7802073|NCT01201772|19206182|P2|COMPLETED|Overall Study||21
7802074|NCT01201772|19206183|P1|COMPLETED|Overall Study||22
7802075|NCT01201772|19206181|P3|STARTED|Overall Study||21
7802076|NCT01201772|19206182|P2|STARTED|Overall Study||21
7802077|NCT01201772|19206183|P1|STARTED|Overall Study||23
7802078|NCT01201759|19206191|P2|NOT COMPLETED|Visit 5||0
7802079|NCT01201759|19206192|P1|NOT COMPLETED|Visit 5||0
7802080|NCT01201759|19206191|P2|COMPLETED|Visit 5||3
7802081|NCT01201759|19206192|P1|COMPLETED|Visit 5||7
7802082|NCT01201759|19206191|P2|STARTED|Visit 5||3
7802083|NCT01201759|19206192|P1|STARTED|Visit 5||7
7802084|NCT01201759|19206191|P2|NOT COMPLETED|Visit 4 Crossover||1
7802085|NCT01201759|19206192|P1|NOT COMPLETED|Visit 4 Crossover||0
7802086|NCT01201759|19206191|P2|COMPLETED|Visit 4 Crossover||3
7802087|NCT01201759|19206192|P1|COMPLETED|Visit 4 Crossover||7
7802088|NCT01201759|19206191|P2|STARTED|Visit 4 Crossover||4
7802089|NCT01201759|19206192|P1|STARTED|Visit 4 Crossover||7
7802090|NCT01201759|19206191|P2|NOT COMPLETED|Visit 3 - Washout||3
7802091|NCT01201759|19206192|P1|NOT COMPLETED|Visit 3 - Washout||1
7802092|NCT01201759|19206191|P2|COMPLETED|Visit 3 - Washout||4
7802093|NCT01201759|19206192|P1|COMPLETED|Visit 3 - Washout||7
7802094|NCT01201759|19206191|P2|STARTED|Visit 3 - Washout||7
7802095|NCT01201759|19206192|P1|STARTED|Visit 3 - Washout||8
7802096|NCT01201759|19206191|P2|NOT COMPLETED|Visit 2||0
7802097|NCT01201759|19206192|P1|NOT COMPLETED|Visit 2||0
7802098|NCT01201759|19206191|P2|COMPLETED|Visit 2||7
7802099|NCT01201759|19206192|P1|COMPLETED|Visit 2||8
7802100|NCT01201759|19206191|P2|STARTED|Visit 2||7
7802101|NCT01201759|19206192|P1|STARTED|Visit 2||8
7802102|NCT01201759|19206191|P2|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1
7802103|NCT01201759|19206192|P1|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2
7802104|NCT01201759|19206191|P2|COMPLETED|Visit 1 Wash-in ( Untreated)||7
7802105|NCT01201759|19206192|P1|COMPLETED|Visit 1 Wash-in ( Untreated)||8
7802106|NCT01201759|19206191|P2|STARTED|Visit 1 Wash-in ( Untreated)||8
7802107|NCT01201759|19206192|P1|STARTED|Visit 1 Wash-in ( Untreated)||10
7802108|NCT01201629|19206206|P2|NOT COMPLETED|Overall Study||0
7802109|NCT01201629|19206207|P1|NOT COMPLETED|Overall Study||0
7802110|NCT01201629|19206206|P2|COMPLETED|Overall Study||8
7802111|NCT01201629|19206207|P1|COMPLETED|Overall Study||8
7802112|NCT01201629|19206206|P2|STARTED|Overall Study||8
7802113|NCT01201629|19206207|P1|STARTED|Overall Study||8
7802114|NCT01201486|19206217|P1|NOT COMPLETED|Overall Study||0
7802115|NCT01201486|19206217|P1|COMPLETED|Overall Study||6781
7802116|NCT01201486|19206217|P1|STARTED|Overall Study||6781
7802117|NCT01201356|19206221|P1|NOT COMPLETED|Overall Study||644
7802118|NCT01201356|19206221|P1|COMPLETED|Overall Study||3481
7802119|NCT01201356|19206221|P1|Fingolimod Full Analysis Set|Overall Study||4046
7802120|NCT01201356|19206221|P1|Safety Set|Overall Study||4083
7802121|NCT01201356|19206221|P1|STARTED|Overall Study||4125
7802122|NCT01201343|19206235|P1|NOT COMPLETED|Overall Study||19
7802123|NCT01201343|19206235|P1|COMPLETED|Overall Study||60
7802124|NCT01201343|19206235|P1|Treated|Overall Study||76
7802125|NCT01201343|19206235|P1|STARTED|Overall Study||79
7802126|NCT01201317|19206249|P3|NOT COMPLETED|Overall Study||8
7802127|NCT01201317|19206250|P2|NOT COMPLETED|Overall Study||7
7802128|NCT01201317|19206251|P1|NOT COMPLETED|Overall Study||9
7802129|NCT01201317|19206249|P3|COMPLETED|Overall Study||33
7802130|NCT01201317|19206250|P2|COMPLETED|Overall Study||38
7802131|NCT01201317|19206251|P1|COMPLETED|Overall Study||39
7802132|NCT01201317|19206249|P3|STARTED|Overall Study||41
7802133|NCT01201317|19206250|P2|STARTED|Overall Study||45
7802134|NCT01201317|19206251|P1|STARTED|Overall Study||48
7802135|NCT01201265|19206271|P1|NOT COMPLETED|Overall Study||38
7802136|NCT01201265|19206271|P1|COMPLETED|Overall Study||2
7802137|NCT01201265|19206271|P1|STARTED|Overall Study||40
7802138|NCT01201057|19206287|P4|NOT COMPLETED|Overall Study||4
7802139|NCT01201057|19206288|P3|NOT COMPLETED|Overall Study||5
7802140|NCT01201057|19206289|P2|NOT COMPLETED|Overall Study||4
7802141|NCT01201057|19206290|P1|NOT COMPLETED|Overall Study||2
7802142|NCT01201057|19206287|P4|COMPLETED|Overall Study||29
7802143|NCT01201057|19206288|P3|COMPLETED|Overall Study||27
7802144|NCT01201057|19206289|P2|COMPLETED|Overall Study||29
7802145|NCT01201057|19206290|P1|COMPLETED|Overall Study||32
7802146|NCT01201057|19206287|P4|STARTED|Overall Study||33
7802147|NCT01201057|19206288|P3|STARTED|Overall Study||32
7802148|NCT01201057|19206289|P2|STARTED|Overall Study||33
7802149|NCT01201057|19206290|P1|STARTED|Overall Study||34
7802150|NCT01200992|19206318|P2|NOT COMPLETED|Overall Study||41
7802151|NCT01200992|19206319|P1|NOT COMPLETED|Overall Study||37
7802152|NCT01200992|19206318|P2|COMPLETED|Overall Study||4
7802153|NCT01200992|19206319|P1|COMPLETED|Overall Study||2
7802154|NCT01200992|19206318|P2|STARTED|Overall Study||45
7802155|NCT01200992|19206319|P1|STARTED|Overall Study||39
7802156|NCT01200875|19206327|P1|NOT COMPLETED|Overall Study||0
7802157|NCT01200875|19206327|P1|COMPLETED|Overall Study||25
7802158|NCT01200875|19206327|P1|STARTED|Overall Study||25
7802159|NCT01200862|19206334|P3|NOT COMPLETED|Part 2||0
7802160|NCT01200862|19206335|P2|NOT COMPLETED|Part 2||1
7802161|NCT01200862|19206336|P1|NOT COMPLETED|Part 2||0
7802162|NCT01200862|19206334|P3|COMPLETED|Part 2||8
7802163|NCT01200862|19206335|P2|COMPLETED|Part 2||6
7802164|NCT01200862|19206336|P1|COMPLETED|Part 2||0
7802165|NCT01200862|19206334|P3|STARTED|Part 2||8
7802166|NCT01200862|19206335|P2|STARTED|Part 2||7
7802167|NCT01200862|19206336|P1|STARTED|Part 2||0
7802168|NCT01200862|19206334|P3|NOT COMPLETED|Part 1||0
7802169|NCT01200862|19206335|P2|NOT COMPLETED|Part 1||0
7802170|NCT01200862|19206336|P1|NOT COMPLETED|Part 1||1
7802171|NCT01200862|19206334|P3|COMPLETED|Part 1||0
7802172|NCT01200862|19206335|P2|COMPLETED|Part 1||0
7802173|NCT01200862|19206336|P1|COMPLETED|Part 1||13
7802174|NCT01200862|19206334|P3|STARTED|Part 1||0
7802175|NCT01200862|19206335|P2|STARTED|Part 1||0
7802176|NCT01200862|19206336|P1|STARTED|Part 1||14
7802177|NCT01200810|19206350|P2|NOT COMPLETED|Overall Study||5
7802178|NCT01200810|19206351|P1|NOT COMPLETED|Overall Study||5
7802179|NCT01200810|19206350|P2|COMPLETED|Overall Study||0
7802180|NCT01200810|19206351|P1|COMPLETED|Overall Study||0
7802181|NCT01200810|19206350|P2|STARTED|Overall Study||5
7802182|NCT01200810|19206351|P1|STARTED|Overall Study||5
7802183|NCT01200797|19206371|P1|NOT COMPLETED|Overall Study||19
7802184|NCT01200797|19206371|P1|COMPLETED|Overall Study||0
7802185|NCT01200797|19206371|P1|STARTED|Overall Study||19
7802186|NCT01200758|19206381|P4|NOT COMPLETED|Stage 2||50
7802187|NCT01200758|19206382|P3|NOT COMPLETED|Stage 2||41
7802188|NCT01200758|19206383|P2|NOT COMPLETED|Stage 2||0
7802189|NCT01200758|19206384|P1|NOT COMPLETED|Stage 2||0
7802190|NCT01200758|19206381|P4|COMPLETED|Stage 2|Participants completed treatment period.|92
7802191|NCT01200758|19206382|P3|COMPLETED|Stage 2|Participants completed treatment period.|100
7802192|NCT01200758|19206383|P2|COMPLETED|Stage 2||0
7802193|NCT01200758|19206384|P1|COMPLETED|Stage 2||0
7802194|NCT01200758|19206381|P4|STARTED|Stage 2||142
7802195|NCT01200758|19206382|P3|STARTED|Stage 2||141
7802196|NCT01200758|19206383|P2|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
7802197|NCT01200758|19206384|P1|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
7802198|NCT01200758|19206381|P4|NOT COMPLETED|Stage I||0
7802199|NCT01200758|19206382|P3|NOT COMPLETED|Stage I||0
7802200|NCT01200758|19206383|P2|NOT COMPLETED|Stage I||17
7802201|NCT01200758|19206384|P1|NOT COMPLETED|Stage I||18
7802202|NCT01200758|19206381|P4|COMPLETED|Stage I||0
7802203|NCT01200758|19206382|P3|COMPLETED|Stage I||0
7802204|NCT01200758|19206383|P2|COMPLETED|Stage I|Participants completed treatment period.|46
7802205|NCT01200758|19206384|P1|COMPLETED|Stage I|Participants completed treatment period.|46
7802206|NCT01200758|19206381|P4|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
7802207|NCT01200758|19206382|P3|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
7802208|NCT01200758|19206383|P2|STARTED|Stage I||63
7802209|NCT01200758|19206384|P1|STARTED|Stage I||64
7802210|NCT01200602|19206440|P2|NOT COMPLETED|Overall Study||0
7802211|NCT01200602|19206441|P1|NOT COMPLETED|Overall Study||0
7802212|NCT01200602|19206440|P2|COMPLETED|Overall Study||0
7802213|NCT01200602|19206441|P1|COMPLETED|Overall Study||0
7802214|NCT01200602|19206440|P2|STARTED|Overall Study||0
7802215|NCT01200602|19206441|P1|STARTED|Overall Study||0
7802216|NCT01200589|19206457|P2|NOT COMPLETED|Overall Study||189
7802217|NCT01200589|19206458|P1|NOT COMPLETED|Overall Study||190
7802218|NCT01200589|19206457|P2|COMPLETED|Overall Study||30
7802219|NCT01200589|19206458|P1|COMPLETED|Overall Study||29
7802220|NCT01200589|19206457|P2|Safety Set|Overall Study||218
7802221|NCT01200589|19206458|P1|Safety Set|Overall Study||217
7802222|NCT01200589|19206457|P2|Intent-to-treat (ITT) Analysis Set|Overall Study||219
7802223|NCT01200589|19206458|P1|Intent-to-treat (ITT) Analysis Set|Overall Study||219
7802224|NCT01200589|19206457|P2|STARTED|Overall Study||219
7802225|NCT01200589|19206458|P1|STARTED|Overall Study||219
7802226|NCT01200524|19206485|P3|NOT COMPLETED|Overall Study||4
7802227|NCT01200524|19206486|P2|NOT COMPLETED|Overall Study||1
7802228|NCT01200524|19206487|P1|NOT COMPLETED|Overall Study||2
7802229|NCT01200524|19206485|P3|COMPLETED|Overall Study||40
7802230|NCT01200524|19206486|P2|COMPLETED|Overall Study||47
7802231|NCT01200524|19206487|P1|COMPLETED|Overall Study||39
7802232|NCT01200524|19206485|P3|STARTED|Overall Study||44
7802233|NCT01200524|19206486|P2|STARTED|Overall Study||48
7802234|NCT01200524|19206487|P1|STARTED|Overall Study||41
7802235|NCT01200511|19206507|P1|NOT COMPLETED|Overall Study||5
7802236|NCT01200511|19206507|P1|COMPLETED|Overall Study||44
7802237|NCT01200511|19206507|P1|STARTED|Overall Study||49
7802238|NCT01200498|19206515|P1|NOT COMPLETED|Overall Study||0
7802239|NCT01200498|19206515|P1|COMPLETED|Overall Study||22
7802240|NCT01200498|19206515|P1|STARTED|Overall Study||22
7802241|NCT01200485|19206519|P3|NOT COMPLETED|Cycle 2: Randomization||0
7802242|NCT01200485|19206520|P2|NOT COMPLETED|Cycle 2: Randomization||0
7802243|NCT01200485|19206521|P1|NOT COMPLETED|Cycle 2: Randomization||0
7802244|NCT01200485|19206519|P3|COMPLETED|Cycle 2: Randomization||25
7802245|NCT01200485|19206520|P2|COMPLETED|Cycle 2: Randomization||21
7802246|NCT01200485|19206521|P1|COMPLETED|Cycle 2: Randomization||0
7802247|NCT01200485|19206519|P3|STARTED|Cycle 2: Randomization||25
7802248|NCT01200485|19206520|P2|STARTED|Cycle 2: Randomization|Six not randomized: Methemoglobinemia-1, Kidney failure-2, Chemotherapy changed-2, Not evaluable-1|21
7802249|NCT01200485|19206521|P1|STARTED|Cycle 2: Randomization|Of 55 enrolled on study, 52 participants were treated in Cycle 1, only 46 randomized to Cycle 2|0
7802250|NCT01200485|19206519|P3|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
7802251|NCT01200485|19206520|P2|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
7802252|NCT01200485|19206521|P1|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||3
7802253|NCT01200485|19206519|P3|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
7802254|NCT01200485|19206520|P2|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
7802255|NCT01200485|19206521|P1|COMPLETED|Cycle 1: Rasburicase Alone Delivery||52
7802256|NCT01200485|19206519|P3|STARTED|Cycle 1: Rasburicase Alone Delivery||0
7802257|NCT01200485|19206520|P2|STARTED|Cycle 1: Rasburicase Alone Delivery||0
7802258|NCT01200485|19206521|P1|STARTED|Cycle 1: Rasburicase Alone Delivery|Of 55 participants screened, only 52 treated.|55
7802259|NCT01200433|19206532|P2|NOT COMPLETED|Overall Study||0
7802260|NCT01200433|19206533|P1|NOT COMPLETED|Overall Study||0
7802261|NCT01200433|19206532|P2|COMPLETED|Overall Study||23
7802262|NCT01200433|19206533|P1|COMPLETED|Overall Study||21
7802263|NCT01200433|19206532|P2|STARTED|Overall Study||23
7802264|NCT01200433|19206533|P1|STARTED|Overall Study||21
7802265|NCT01200394|19206555|P2|NOT COMPLETED|Overall Study||28
7802266|NCT01200394|19206556|P1|NOT COMPLETED|Overall Study||2
7802267|NCT01200394|19206555|P2|COMPLETED|Overall Study||164
7802268|NCT01200394|19206556|P1|COMPLETED|Overall Study||62
7802269|NCT01200394|19206555|P2|STARTED|Overall Study||192
7802270|NCT01200394|19206556|P1|STARTED|Overall Study||64
7802271|NCT01200368|19206594|P3|NOT COMPLETED|Toddler Dose||1
7802272|NCT01200368|19206595|P2|NOT COMPLETED|Toddler Dose||3
7802273|NCT01200368|19206596|P1|NOT COMPLETED|Toddler Dose||0
7802274|NCT01200368|19206594|P3|COMPLETED|Toddler Dose||168
7802275|NCT01200368|19206595|P2|COMPLETED|Toddler Dose||159
7802276|NCT01200368|19206596|P1|COMPLETED|Toddler Dose||162
7802277|NCT01200368|19206594|P3|STARTED|Toddler Dose||169
7802278|NCT01200368|19206595|P2|STARTED|Toddler Dose||162
7802279|NCT01200368|19206596|P1|STARTED|Toddler Dose||162
7802280|NCT01200368|19206594|P3|NOT COMPLETED|After Infant Series||9
7802281|NCT01200368|19206595|P2|NOT COMPLETED|After Infant Series||16
7802282|NCT01200368|19206596|P1|NOT COMPLETED|After Infant Series||18
7802283|NCT01200368|19206594|P3|COMPLETED|After Infant Series||169
7802284|NCT01200368|19206595|P2|COMPLETED|After Infant Series||162
7802285|NCT01200368|19206596|P1|COMPLETED|After Infant Series||162
7802286|NCT01200368|19206594|P3|STARTED|After Infant Series||178
7802287|NCT01200368|19206595|P2|STARTED|After Infant Series||178
7802288|NCT01200368|19206596|P1|STARTED|After Infant Series||180
7802289|NCT01200368|19206594|P3|NOT COMPLETED|Infant Series||6
7802290|NCT01200368|19206595|P2|NOT COMPLETED|Infant Series||6
7802291|NCT01200368|19206596|P1|NOT COMPLETED|Infant Series||3
7802292|NCT01200368|19206594|P3|COMPLETED|Infant Series||178
7802293|NCT01200368|19206595|P2|COMPLETED|Infant Series||178
7802294|NCT01200368|19206596|P1|COMPLETED|Infant Series||180
7802295|NCT01200368|19206594|P3|Vaccinated Dose 3|Infant Series||182
7802296|NCT01200368|19206595|P2|Vaccinated Dose 3|Infant Series||178
7802297|NCT01200368|19206596|P1|Vaccinated Dose 3|Infant Series||181
7802298|NCT01200368|19206594|P3|Vaccinated Dose 2|Infant Series||183
7802299|NCT01200368|19206595|P2|Vaccinated Dose 2|Infant Series||182
7802300|NCT01200368|19206596|P1|Vaccinated Dose 2|Infant Series||183
7802301|NCT01200368|19206594|P3|Vaccinated Dose 1|Infant Series||183
7802302|NCT01200368|19206595|P2|Vaccinated Dose 1|Infant Series||183
7802303|NCT01200368|19206596|P1|Vaccinated Dose 1|Infant Series||183
7802304|NCT01200368|19206594|P3|STARTED|Infant Series||184
7802305|NCT01200368|19206595|P2|STARTED|Infant Series||184
7802306|NCT01200368|19206596|P1|STARTED|Infant Series||183
7802307|NCT01200355|19206662|P2|NOT COMPLETED|Overall Study||2
7802308|NCT01200355|19206663|P1|NOT COMPLETED|Overall Study||7
7802309|NCT01200355|19206662|P2|COMPLETED|Overall Study||53
7802310|NCT01200355|19206663|P1|COMPLETED|Overall Study||51
7802311|NCT01200355|19206662|P2|STARTED|Overall Study||55
7802312|NCT01200355|19206663|P1|STARTED|Overall Study||58
7802313|NCT01200342|19206677|P1|NOT COMPLETED|Overall Study||1
7802314|NCT01200342|19206677|P1|COMPLETED|Overall Study||6
7802315|NCT01200342|19206677|P1|STARTED|Overall Study||7
7802316|NCT01200329|19206682|P1|NOT COMPLETED|Overall Study||3
7802317|NCT01200329|19206682|P1|COMPLETED|Overall Study||78
7802318|NCT01200329|19206682|P1|STARTED|Overall Study||81
7802319|NCT01200290|19206687|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||2
7802320|NCT01200290|19206687|P1|COMPLETED|Post-Treatment Follow-Up Period||16
7802321|NCT01200290|19206687|P1|STARTED|Post-Treatment Follow-Up Period|Participant who discontinued treatment was included in the post-treatment follow-up period.|18
7802322|NCT01200290|19206687|P1|NOT COMPLETED|Treatment Period||1
7802323|NCT01200290|19206687|P1|COMPLETED|Treatment Period||17
7802324|NCT01200290|19206687|P1|Received at Least 1 Dose of Study Drug|Treatment Period||18
7802325|NCT01200290|19206687|P1|STARTED|Treatment Period||18
7802326|NCT01200238|19206700|P2|NOT COMPLETED|Overall Study||10
7802327|NCT01200238|19206701|P1|NOT COMPLETED|Overall Study||7
7802328|NCT01200238|19206700|P2|COMPLETED|Overall Study||0
7802329|NCT01200238|19206701|P1|COMPLETED|Overall Study||0
7802330|NCT01200238|19206700|P2|STARTED|Overall Study||10
7802331|NCT01200238|19206701|P1|STARTED|Overall Study||7
7802332|NCT01200160|19206719|P1|NOT COMPLETED|Overall Study||62
7802333|NCT01200160|19206719|P1|COMPLETED|Overall Study||66
7802334|NCT01200160|19206719|P1|STARTED|Overall Study||128
7802335|NCT01200069|19206725|P2|NOT COMPLETED|Overall Study||1
7802336|NCT01200069|19206726|P1|NOT COMPLETED|Overall Study||0
7802337|NCT01200069|19206725|P2|COMPLETED|Overall Study||5
7802338|NCT01200069|19206726|P1|COMPLETED|Overall Study||8
7802339|NCT01200069|19206725|P2|STARTED|Overall Study||6
7802340|NCT01200069|19206726|P1|STARTED|Overall Study||8
7802341|NCT01200030|19206781|P3|NOT COMPLETED|Overall Study||0
7802342|NCT01200030|19206782|P2|NOT COMPLETED|Overall Study||0
7802343|NCT01200030|19206783|P1|NOT COMPLETED|Overall Study||0
7802344|NCT01200030|19206781|P3|COMPLETED|Overall Study||12
7802345|NCT01200030|19206782|P2|COMPLETED|Overall Study||13
7802346|NCT01200030|19206783|P1|COMPLETED|Overall Study||12
7802347|NCT01200030|19206781|P3|STARTED|Overall Study||12
7802348|NCT01200030|19206782|P2|STARTED|Overall Study||13
7802349|NCT01200030|19206783|P1|STARTED|Overall Study||12
7802350|NCT01199965|19206796|P2|NOT COMPLETED|Overall Study||0
7802351|NCT01199965|19206797|P1|NOT COMPLETED|Overall Study||1
7802352|NCT01199965|19206796|P2|COMPLETED|Overall Study||24
7802353|NCT01199965|19206797|P1|COMPLETED|Overall Study||22
7802354|NCT01199965|19206796|P2|STARTED|Overall Study||24
7802355|NCT01199965|19206797|P1|STARTED|Overall Study||23
7802356|NCT01199952|19206813|P2|NOT COMPLETED|Overall Study||45
7802357|NCT01199952|19206814|P1|NOT COMPLETED|Overall Study||52
7802358|NCT01199952|19206813|P2|COMPLETED|Overall Study||59
7802359|NCT01199952|19206814|P1|COMPLETED|Overall Study||51
7802360|NCT01199952|19206813|P2|STARTED|Overall Study||104
7802361|NCT01199952|19206814|P1|STARTED|Overall Study||103
7802362|NCT01199939|19206822|P1|NOT COMPLETED|Overall Study||13
7802363|NCT01199939|19206822|P1|COMPLETED|Overall Study||41
7802364|NCT01199939|19206822|P1|STARTED|Overall Study|Number of enrolled participants|54
7802365|NCT01199926|19206841|P2|NOT COMPLETED|Overall Study||4
7802366|NCT01199926|19206842|P1|NOT COMPLETED|Overall Study||7
7802367|NCT01199926|19206841|P2|COMPLETED|Overall Study||13
7802368|NCT01199926|19206842|P1|COMPLETED|Overall Study||10
7802369|NCT01199926|19206841|P2|STARTED|Overall Study||17
7802370|NCT01199926|19206842|P1|STARTED|Overall Study||17
7802371|NCT01199861|19206854|P2|NOT COMPLETED|Overall Study||0
7802372|NCT01199861|19206855|P1|NOT COMPLETED|Overall Study||2
7802373|NCT01199861|19206854|P2|COMPLETED|Overall Study||43
7802374|NCT01199861|19206855|P1|COMPLETED|Overall Study||93
7802375|NCT01199861|19206854|P2|STARTED|Overall Study||43
7802376|NCT01199861|19206855|P1|STARTED|Overall Study||95
7802377|NCT01199822|19206876|P3|NOT COMPLETED|Overall Study||0
7802378|NCT01199822|19206877|P2|NOT COMPLETED|Overall Study||1
7802379|NCT01199822|19206878|P1|NOT COMPLETED|Overall Study||0
7802380|NCT01199822|19206876|P3|COMPLETED|Overall Study||6
7802381|NCT01199822|19206877|P2|COMPLETED|Overall Study||6
7802382|NCT01199822|19206878|P1|COMPLETED|Overall Study||3
7802383|NCT01199822|19206876|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
7802384|NCT01199822|19206877|P2|Received at Least 1 Dose of Study Drug|Overall Study||7
7802385|NCT01199822|19206878|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
7802386|NCT01199822|19206876|P3|STARTED|Overall Study||6
7802387|NCT01199822|19206877|P2|STARTED|Overall Study||7
7802388|NCT01199822|19206878|P1|STARTED|Overall Study||3
7802389|NCT01199744|19206911|P1|NOT COMPLETED|Overall Study||0
7802390|NCT01199744|19206911|P1|COMPLETED|Overall Study||1575
7802391|NCT01199744|19206911|P1|STARTED|Overall Study||1575
7802392|NCT01199731|19206927|P3|NOT COMPLETED|Overall Study||10
7802393|NCT01199731|19206928|P2|NOT COMPLETED|Overall Study||11
7802394|NCT01199731|19206929|P1|NOT COMPLETED|Overall Study||9
7802395|NCT01199731|19206927|P3|COMPLETED|Overall Study||0
7802396|NCT01199731|19206928|P2|COMPLETED|Overall Study||0
7802397|NCT01199731|19206929|P1|COMPLETED|Overall Study||0
7802398|NCT01199731|19206927|P3|STARTED|Overall Study||10
7802399|NCT01199731|19206928|P2|STARTED|Overall Study||11
7802400|NCT01199731|19206929|P1|STARTED|Overall Study||9
7802401|NCT01199705|19206967|P1|NOT COMPLETED|SCIG Treatment (Efficacy)||0
7802402|NCT01199705|19206967|P1|COMPLETED|SCIG Treatment (Efficacy)||24
7802403|NCT01199705|19206967|P1|STARTED|SCIG Treatment (Efficacy)||24
7802404|NCT01199705|19206967|P1|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1
7802405|NCT01199705|19206967|P1|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24
7802406|NCT01199705|19206967|P1|STARTED|SCIG Treatment (Wash-in/Wash-out)||25
7802407|NCT01199705|19206967|P1|NOT COMPLETED|IVIG Treatment||0
7802408|NCT01199705|19206967|P1|COMPLETED|IVIG Treatment||25
7802409|NCT01199705|19206967|P1|STARTED|IVIG Treatment||25
7802410|NCT01199601|19206999|P2|NOT COMPLETED|Overall Study||78
7802411|NCT01199601|19207000|P1|NOT COMPLETED|Overall Study||69
7802412|NCT01199601|19206999|P2|COMPLETED|Overall Study||344
7802413|NCT01199601|19207000|P1|COMPLETED|Overall Study||353
7802414|NCT01199601|19206999|P2|STARTED|Overall Study|Intervention Group|422
7802415|NCT01199601|19207000|P1|STARTED|Overall Study|Control Group|422
7802416|NCT01199575|19207010|P1|NOT COMPLETED|Overall Study||5
7802417|NCT01199575|19207010|P1|COMPLETED|Overall Study||25
7802418|NCT01199575|19207010|P1|STARTED|Overall Study||30
7802419|NCT01199471|19207015|P1|NOT COMPLETED|Overall Study||6
7802420|NCT01199471|19207015|P1|COMPLETED|Overall Study||3994
7802421|NCT01199471|19207015|P1|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000
7802422|NCT01199380|19207026|P2|NOT COMPLETED|Overall Study||15
7802423|NCT01199380|19207027|P1|NOT COMPLETED|Overall Study||10
7802424|NCT01199380|19207026|P2|COMPLETED|Overall Study||81
7802425|NCT01199380|19207027|P1|COMPLETED|Overall Study||78
7802426|NCT01199380|19207026|P2|STARTED|Overall Study||96
7802427|NCT01199380|19207027|P1|STARTED|Overall Study||88
7802428|NCT01199263|19207035|P2|NOT COMPLETED|Overall Study||2
7802429|NCT01199263|19207036|P1|NOT COMPLETED|Overall Study||6
7802430|NCT01199263|19207035|P2|COMPLETED|Overall Study||52
7802431|NCT01199263|19207036|P1|COMPLETED|Overall Study||48
7802432|NCT01199263|19207035|P2|STARTED|Overall Study||54
7802433|NCT01199263|19207036|P1|STARTED|Overall Study||54
7802434|NCT01199237|19207052|P2|NOT COMPLETED|Overall Study||0
7802435|NCT01199237|19207053|P1|NOT COMPLETED|Overall Study||0
7802436|NCT01199237|19207052|P2|COMPLETED|Overall Study||40
7802437|NCT01199237|19207053|P1|COMPLETED|Overall Study||41
7802438|NCT01199237|19207052|P2|STARTED|Overall Study||40
7802439|NCT01199237|19207053|P1|STARTED|Overall Study||41
7802440|NCT01199198|19207069|P2|NOT COMPLETED|Overall Study||11
7802441|NCT01199198|19207070|P1|NOT COMPLETED|Overall Study||7
7802442|NCT01199198|19207069|P2|COMPLETED|Overall Study||13
7802443|NCT01199198|19207070|P1|COMPLETED|Overall Study||17
7802444|NCT01199198|19207069|P2|STARTED|Overall Study||24
7802445|NCT01199198|19207070|P1|STARTED|Overall Study||24
7802446|NCT01199146|19207078|P1|NOT COMPLETED|Overall Study||3
7802447|NCT01199146|19207078|P1|COMPLETED|Overall Study||39
7802448|NCT01199146|19207078|P1|STARTED|Overall Study||42
7802449|NCT01199068|19207087|P3|NOT COMPLETED|Overall Study||9
7802450|NCT01199068|19207088|P2|NOT COMPLETED|Overall Study||3
7802451|NCT01199068|19207089|P1|NOT COMPLETED|Overall Study||3
7802452|NCT01199068|19207087|P3|COMPLETED|Overall Study||0
7802453|NCT01199068|19207088|P2|COMPLETED|Overall Study||0
7802454|NCT01199068|19207089|P1|COMPLETED|Overall Study||0
7802455|NCT01199068|19207087|P3|Received Treatment|Overall Study||8
7802456|NCT01199068|19207088|P2|Received Treatment|Overall Study||3
7802457|NCT01199068|19207089|P1|Received Treatment|Overall Study||3
7802458|NCT01199068|19207087|P3|STARTED|Overall Study||9
7802459|NCT01199068|19207088|P2|STARTED|Overall Study||3
7802460|NCT01199068|19207089|P1|STARTED|Overall Study||3
7802461|NCT01199055|19207123|P3|NOT COMPLETED|Overall Study||4
7802462|NCT01199055|19207124|P2|NOT COMPLETED|Overall Study||3
7802463|NCT01199055|19207125|P1|NOT COMPLETED|Overall Study||2
7802464|NCT01199055|19207123|P3|COMPLETED|Overall Study||5
7802465|NCT01199055|19207124|P2|COMPLETED|Overall Study||1
7802466|NCT01199055|19207125|P1|COMPLETED|Overall Study||1
7802467|NCT01199055|19207123|P3|STARTED|Overall Study||9
7802468|NCT01199055|19207124|P2|STARTED|Overall Study||4
7802469|NCT01199055|19207125|P1|STARTED|Overall Study||3
7802470|NCT01199042|19207150|P1|NOT COMPLETED|At Home (3 Months)||1
7802471|NCT01199042|19207150|P1|COMPLETED|At Home (3 Months)||26
7802472|NCT01199042|19207150|P1|STARTED|At Home (3 Months)||27
7802473|NCT01199042|19207150|P1|NOT COMPLETED|Sleep Laboratory (3 Nights)||2
7802474|NCT01199042|19207150|P1|COMPLETED|Sleep Laboratory (3 Nights)||27
7802475|NCT01199042|19207150|P1|STARTED|Sleep Laboratory (3 Nights)||29
7802476|NCT01199016|19207159|P1|NOT COMPLETED|Overall Study||77
7802477|NCT01199016|19207159|P1|COMPLETED|Overall Study||162
7802478|NCT01199016|19207159|P1|Treated|Overall Study||236
7802479|NCT01199016|19207159|P1|STARTED|Overall Study||239
7802480|NCT01198977|19207168|P2|NOT COMPLETED|Overall Study||0
7802481|NCT01198977|19207169|P1|NOT COMPLETED|Overall Study||1
7802482|NCT01198977|19207168|P2|COMPLETED|Overall Study||33
7802483|NCT01198977|19207169|P1|COMPLETED|Overall Study||30
7802484|NCT01198977|19207168|P2|STARTED|Overall Study||33
7802485|NCT01198977|19207169|P1|STARTED|Overall Study||31
7802486|NCT01198873|19207181|P2|NOT COMPLETED|Overall Study||32
7802487|NCT01198873|19207182|P1|NOT COMPLETED|Overall Study||37
7802488|NCT01198873|19207181|P2|COMPLETED|Overall Study||3
7802489|NCT01198873|19207182|P1|COMPLETED|Overall Study||4
7802490|NCT01198873|19207181|P2|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26
7802491|NCT01198873|19207182|P1|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33
7802492|NCT01198873|19207181|P2|Treated|Overall Study||35
7802493|NCT01198873|19207182|P1|Treated|Overall Study||41
7802494|NCT01198873|19207181|P2|STARTED|Overall Study||35
7802495|NCT01198873|19207182|P1|STARTED|Overall Study||41
7802496|NCT01198795|19207196|P1|NOT COMPLETED|Overall Study||82
7802497|NCT01198795|19207196|P1|COMPLETED|Overall Study||80
7802498|NCT01198795|19207196|P1|STARTED|Overall Study||162
7802499|NCT01198769|19207200|P1|NOT COMPLETED|Overall Study||0
7802500|NCT01198769|19207200|P1|COMPLETED|Overall Study||15
7802501|NCT01198769|19207200|P1|STARTED|Overall Study||15
7802502|NCT01198756|19207213|P4|NOT COMPLETED|Overall Study||26
7802503|NCT01198756|19207214|P3|NOT COMPLETED|Overall Study||30
7802504|NCT01198756|19207215|P2|NOT COMPLETED|Overall Study||40
7802505|NCT01198756|19207216|P1|NOT COMPLETED|Overall Study||38
7802506|NCT01198756|19207213|P4|COMPLETED|Overall Study||275
7802507|NCT01198756|19207214|P3|COMPLETED|Overall Study||902
7802508|NCT01198756|19207215|P2|COMPLETED|Overall Study||889
7802509|NCT01198756|19207216|P1|COMPLETED|Overall Study||894
7802510|NCT01198756|19207213|P4|STARTED|Overall Study||301
7802511|NCT01198756|19207214|P3|STARTED|Overall Study||932
7802512|NCT01198756|19207215|P2|STARTED|Overall Study||929
7802513|NCT01198756|19207216|P1|STARTED|Overall Study||932
7802514|NCT01198691|19207314|P2|NOT COMPLETED|6 Week Post-partum Survey||24
7802515|NCT01198691|19207315|P1|NOT COMPLETED|6 Week Post-partum Survey||29
7802516|NCT01198691|19207314|P2|COMPLETED|6 Week Post-partum Survey||26
7802517|NCT01198691|19207315|P1|COMPLETED|6 Week Post-partum Survey||21
7802518|NCT01198691|19207314|P2|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
7802519|NCT01198691|19207315|P1|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
7802520|NCT01198691|19207314|P2|NOT COMPLETED|Survey Prior to Discharge||33
7802521|NCT01198691|19207315|P1|NOT COMPLETED|Survey Prior to Discharge||32
7802522|NCT01198691|19207314|P2|COMPLETED|Survey Prior to Discharge||17
7802523|NCT01198691|19207315|P1|COMPLETED|Survey Prior to Discharge||18
7802524|NCT01198691|19207314|P2|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
7802525|NCT01198691|19207315|P1|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
7802526|NCT01198691|19207314|P2|NOT COMPLETED|Completed VAS Score at Discharge||6
7802527|NCT01198691|19207315|P1|NOT COMPLETED|Completed VAS Score at Discharge||5
7802528|NCT01198691|19207314|P2|COMPLETED|Completed VAS Score at Discharge||44
7802529|NCT01198691|19207315|P1|COMPLETED|Completed VAS Score at Discharge||45
7802530|NCT01198691|19207314|P2|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
7802531|NCT01198691|19207315|P1|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
7802532|NCT01198691|19207314|P2|NOT COMPLETED|Completed VAS Score Postop Day 1||4
7802533|NCT01198691|19207315|P1|NOT COMPLETED|Completed VAS Score Postop Day 1||3
7802534|NCT01198691|19207314|P2|COMPLETED|Completed VAS Score Postop Day 1||46
7802535|NCT01198691|19207315|P1|COMPLETED|Completed VAS Score Postop Day 1||47
7802536|NCT01198691|19207314|P2|STARTED|Completed VAS Score Postop Day 1||50
7802537|NCT01198691|19207315|P1|STARTED|Completed VAS Score Postop Day 1||50
7802538|NCT01198691|19207314|P2|NOT COMPLETED|Completed Surgery -Received Intervention||0
7802539|NCT01198691|19207315|P1|NOT COMPLETED|Completed Surgery -Received Intervention||0
7802540|NCT01198691|19207314|P2|COMPLETED|Completed Surgery -Received Intervention||50
7802541|NCT01198691|19207315|P1|COMPLETED|Completed Surgery -Received Intervention||50
7802542|NCT01198691|19207314|P2|STARTED|Completed Surgery -Received Intervention||50
7802543|NCT01198691|19207315|P1|STARTED|Completed Surgery -Received Intervention||50
7802544|NCT01198600|19207327|P4|NOT COMPLETED|Phase 3: 43 Days of Wear||0
7802545|NCT01198600|19207328|P3|NOT COMPLETED|Phase 3: 43 Days of Wear||0
7802546|NCT01198600|19207329|P2|NOT COMPLETED|Phase 3: 43 Days of Wear||0
7802547|NCT01198600|19207330|P1|NOT COMPLETED|Phase 3: 43 Days of Wear||0
7802548|NCT01198600|19207327|P4|COMPLETED|Phase 3: 43 Days of Wear||38
7802549|NCT01198600|19207328|P3|COMPLETED|Phase 3: 43 Days of Wear||0
7802550|NCT01198600|19207329|P2|COMPLETED|Phase 3: 43 Days of Wear||0
7802551|NCT01198600|19207330|P1|COMPLETED|Phase 3: 43 Days of Wear||0
7802552|NCT01198600|19207327|P4|STARTED|Phase 3: 43 Days of Wear||38
7802553|NCT01198600|19207328|P3|STARTED|Phase 3: 43 Days of Wear||0
7802554|NCT01198600|19207329|P2|STARTED|Phase 3: 43 Days of Wear||0
7802555|NCT01198600|19207330|P1|STARTED|Phase 3: 43 Days of Wear||0
7802556|NCT01198600|19207327|P4|NOT COMPLETED|Phase 2: 56 Days of Wear||0
7802557|NCT01198600|19207328|P3|NOT COMPLETED|Phase 2: 56 Days of Wear||5
7802558|NCT01198600|19207329|P2|NOT COMPLETED|Phase 2: 56 Days of Wear||0
7802559|NCT01198600|19207330|P1|NOT COMPLETED|Phase 2: 56 Days of Wear||0
7802560|NCT01198600|19207327|P4|COMPLETED|Phase 2: 56 Days of Wear||0
7802561|NCT01198600|19207328|P3|COMPLETED|Phase 2: 56 Days of Wear||62
7802562|NCT01198600|19207329|P2|COMPLETED|Phase 2: 56 Days of Wear||0
7802563|NCT01198600|19207330|P1|COMPLETED|Phase 2: 56 Days of Wear||0
7802564|NCT01198600|19207327|P4|STARTED|Phase 2: 56 Days of Wear||0
7802565|NCT01198600|19207328|P3|STARTED|Phase 2: 56 Days of Wear||67
7802566|NCT01198600|19207329|P2|STARTED|Phase 2: 56 Days of Wear||0
7802567|NCT01198600|19207330|P1|STARTED|Phase 2: 56 Days of Wear||0
7802568|NCT01198600|19207327|P4|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
7802569|NCT01198600|19207328|P3|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
7802570|NCT01198600|19207329|P2|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1
7802571|NCT01198600|19207330|P1|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
7802572|NCT01198600|19207327|P4|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
7802573|NCT01198600|19207328|P3|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
7802574|NCT01198600|19207329|P2|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35
7802575|NCT01198600|19207330|P1|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32
7802576|NCT01198600|19207327|P4|STARTED|Phase 1: Period Two, 30 Days of Wear||0
7802577|NCT01198600|19207328|P3|STARTED|Phase 1: Period Two, 30 Days of Wear||0
7802578|NCT01198600|19207329|P2|STARTED|Phase 1: Period Two, 30 Days of Wear||36
7802579|NCT01198600|19207330|P1|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32
7802580|NCT01198600|19207327|P4|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
7802581|NCT01198600|19207328|P3|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
7802582|NCT01198600|19207329|P2|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1
7802583|NCT01198600|19207330|P1|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2
7802584|NCT01198600|19207327|P4|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
7802585|NCT01198600|19207328|P3|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
7802586|NCT01198600|19207329|P2|COMPLETED|Phase 1: Period One, 30 Days of Wear||36
7802587|NCT01198600|19207330|P1|COMPLETED|Phase 1: Period One, 30 Days of Wear||33
7802588|NCT01198600|19207327|P4|STARTED|Phase 1: Period One, 30 Days of Wear||0
7802589|NCT01198600|19207328|P3|STARTED|Phase 1: Period One, 30 Days of Wear||0
7802590|NCT01198600|19207329|P2|STARTED|Phase 1: Period One, 30 Days of Wear||37
7802591|NCT01198600|19207330|P1|STARTED|Phase 1: Period One, 30 Days of Wear||35
7802592|NCT01198587|19207356|P4|NOT COMPLETED|Overall Study||0
7802593|NCT01198587|19207357|P3|NOT COMPLETED|Overall Study||9
7802594|NCT01198587|19207358|P2|NOT COMPLETED|Overall Study||0
7802595|NCT01198587|19207359|P1|NOT COMPLETED|Overall Study||8
7802596|NCT01198587|19207356|P4|COMPLETED|Overall Study||5
7802597|NCT01198587|19207357|P3|COMPLETED|Overall Study||21
7802598|NCT01198587|19207358|P2|COMPLETED|Overall Study||5
7802599|NCT01198587|19207359|P1|COMPLETED|Overall Study||23
7802600|NCT01198587|19207356|P4|STARTED|Overall Study||5
7802601|NCT01198587|19207357|P3|STARTED|Overall Study||30
7802602|NCT01198587|19207358|P2|STARTED|Overall Study||5
7802603|NCT01198587|19207359|P1|STARTED|Overall Study||31
7802604|NCT01198574|19207381|P4|NOT COMPLETED|Overall Study||4
7802605|NCT01198574|19207382|P3|NOT COMPLETED|Overall Study||1
7802606|NCT01198574|19207383|P2|NOT COMPLETED|Overall Study||1
7802607|NCT01198574|19207384|P1|NOT COMPLETED|Overall Study||4
7802608|NCT01198574|19207381|P4|COMPLETED|Overall Study||98
7802609|NCT01198574|19207382|P3|COMPLETED|Overall Study||99
7802610|NCT01198574|19207383|P2|COMPLETED|Overall Study||101
7802611|NCT01198574|19207384|P1|COMPLETED|Overall Study||94
7802612|NCT01198574|19207381|P4|STARTED|Overall Study||102
7802613|NCT01198574|19207382|P3|STARTED|Overall Study||100
7802614|NCT01198574|19207383|P2|STARTED|Overall Study||102
7802615|NCT01198574|19207384|P1|STARTED|Overall Study||98
7802616|NCT01198548|19207402|P1|NOT COMPLETED|Overall Study||10
7802617|NCT01198548|19207402|P1|COMPLETED|Overall Study||0
7802618|NCT01198548|19207402|P1|STARTED|Overall Study||10
7802619|NCT01198509|19207417|P6|NOT COMPLETED|Overall Study||0
7802620|NCT01198509|19207418|P5|NOT COMPLETED|Overall Study||0
7802621|NCT01198509|19207419|P4|NOT COMPLETED|Overall Study||0
7802622|NCT01198509|19207420|P3|NOT COMPLETED|Overall Study||0
7802623|NCT01198509|19207421|P2|NOT COMPLETED|Overall Study||0
7802624|NCT01198509|19207422|P1|NOT COMPLETED|Overall Study||1
7802625|NCT01198509|19207417|P6|COMPLETED|Overall Study||58
7802626|NCT01198509|19207418|P5|COMPLETED|Overall Study||20
7802627|NCT01198509|19207419|P4|COMPLETED|Overall Study||66
7802628|NCT01198509|19207420|P3|COMPLETED|Overall Study||19
7802629|NCT01198509|19207421|P2|COMPLETED|Overall Study||10
7802630|NCT01198509|19207422|P1|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4
7802631|NCT01198509|19207417|P6|STARTED|Overall Study||58
7802632|NCT01198509|19207418|P5|STARTED|Overall Study||20
7802633|NCT01198509|19207419|P4|STARTED|Overall Study||66
7802634|NCT01198509|19207420|P3|STARTED|Overall Study||19
7802635|NCT01198509|19207421|P2|STARTED|Overall Study||10
7802636|NCT01198509|19207422|P1|STARTED|Overall Study||5
7802637|NCT01198470|19207439|P1|NOT COMPLETED|Overall Study||2
7802638|NCT01198470|19207439|P1|COMPLETED|Overall Study||18
7802639|NCT01198470|19207439|P1|STARTED|Overall Study||20
7802640|NCT01198366|19207452|P6|NOT COMPLETED|Overall Study||13
7802641|NCT01198366|19207453|P5|NOT COMPLETED|Overall Study||15
7802642|NCT01198366|19207454|P4|NOT COMPLETED|Overall Study||5
7802643|NCT01198366|19207455|P3|NOT COMPLETED|Overall Study||8
7802644|NCT01198366|19207456|P2|NOT COMPLETED|Overall Study||7
7802645|NCT01198366|19207457|P1|NOT COMPLETED|Overall Study||12
7802646|NCT01198366|19207452|P6|COMPLETED|Overall Study||128
7802647|NCT01198366|19207453|P5|COMPLETED|Overall Study||125
7802648|NCT01198366|19207454|P4|COMPLETED|Overall Study||47
7802649|NCT01198366|19207455|P3|COMPLETED|Overall Study||43
7802650|NCT01198366|19207456|P2|COMPLETED|Overall Study||44
7802651|NCT01198366|19207457|P1|COMPLETED|Overall Study||40
7802652|NCT01198366|19207452|P6|STARTED|Overall Study||141
7802653|NCT01198366|19207453|P5|STARTED|Overall Study||140
7802654|NCT01198366|19207454|P4|STARTED|Overall Study||52
7802655|NCT01198366|19207455|P3|STARTED|Overall Study||51
7802656|NCT01198366|19207456|P2|STARTED|Overall Study||51
7802657|NCT01198366|19207457|P1|STARTED|Overall Study||52
7802658|NCT01198327|19207495|P1|NOT COMPLETED|Overall Study||10
7802659|NCT01198327|19207495|P1|COMPLETED|Overall Study||56
7802660|NCT01198327|19207495|P1|STARTED|Overall Study||66
7802661|NCT01198275|19207505|P2|NOT COMPLETED|Overall Study||5
7802662|NCT01198275|19207506|P1|NOT COMPLETED|Overall Study||6
7802663|NCT01198275|19207505|P2|COMPLETED|Overall Study||94
7802664|NCT01198275|19207506|P1|COMPLETED|Overall Study||94
7802665|NCT01198275|19207505|P2|STARTED|Overall Study||99
7802666|NCT01198275|19207506|P1|STARTED|Overall Study||100
7802667|NCT01198158|19207514|P2|NOT COMPLETED|Overall Study||0
7802668|NCT01198158|19207515|P1|NOT COMPLETED|Overall Study||0
7802669|NCT01198158|19207514|P2|COMPLETED|Overall Study||36
7802670|NCT01198158|19207515|P1|COMPLETED|Overall Study||41
7802671|NCT01198158|19207514|P2|STARTED|Overall Study||36
7802672|NCT01198158|19207515|P1|STARTED|Overall Study||41
7802673|NCT01198145|19207529|P2|NOT COMPLETED|Overall Study||1
7802674|NCT01198145|19207530|P1|NOT COMPLETED|Overall Study||1
7802675|NCT01198145|19207529|P2|COMPLETED|Overall Study||42
7802676|NCT01198145|19207530|P1|COMPLETED|Overall Study||43
7802677|NCT01198145|19207529|P2|STARTED|Overall Study||43
7802678|NCT01198145|19207530|P1|STARTED|Overall Study||44
7802679|NCT01198132|19207552|P2|NOT COMPLETED|Overall Study||21
7802680|NCT01198132|19207553|P1|NOT COMPLETED|Overall Study||18
7802681|NCT01198132|19207552|P2|COMPLETED|Overall Study||45
7802682|NCT01198132|19207553|P1|COMPLETED|Overall Study||45
7802683|NCT01198132|19207552|P2|STARTED|Overall Study||66
7802684|NCT01198132|19207553|P1|STARTED|Overall Study||63
7802685|NCT01198028|19207577|P1|NOT COMPLETED|Overall Study||10
7802686|NCT01198028|19207577|P1|COMPLETED|Overall Study||29
7802687|NCT01198028|19207577|P1|STARTED|Overall Study||39
7802688|NCT01198002|19207589|P3|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||78
7802689|NCT01198002|19207590|P2|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||73
7802690|NCT01198002|19207591|P1|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||69
7802691|NCT01198002|19207589|P3|COMPLETED|Treatment Period 2 (Weeks 52-100)||2
7802692|NCT01198002|19207590|P2|COMPLETED|Treatment Period 2 (Weeks 52-100)||0
7802693|NCT01198002|19207591|P1|COMPLETED|Treatment Period 2 (Weeks 52-100)||1
7802694|NCT01198002|19207589|P3|STARTED|Treatment Period 2 (Weeks 52-100)||80
7802695|NCT01198002|19207590|P2|STARTED|Treatment Period 2 (Weeks 52-100)||73
7802696|NCT01198002|19207591|P1|STARTED|Treatment Period 2 (Weeks 52-100)||70
7802697|NCT01198002|19207589|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||269
7802698|NCT01198002|19207590|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||274
7802699|NCT01198002|19207591|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||275
7802700|NCT01198002|19207589|P3|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|80
7802701|NCT01198002|19207590|P2|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|73
7802702|NCT01198002|19207591|P1|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|70
7802703|NCT01198002|19207589|P3|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||307
7802704|NCT01198002|19207590|P2|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||303
7802705|NCT01198002|19207591|P1|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||293
7802706|NCT01198002|19207589|P3|Week 16 NR|Treatment Period 1 (Weeks 0-52)||90
7802707|NCT01198002|19207590|P2|Week 16 NR|Treatment Period 1 (Weeks 0-52)||62
7802708|NCT01198002|19207591|P1|Week 16 NR|Treatment Period 1 (Weeks 0-52)||58
7802709|NCT01198002|19207589|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||348
7802710|NCT01198002|19207590|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
7802711|NCT01198002|19207591|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
7802712|NCT01198002|19207589|P3|STARTED|Treatment Period 1 (Weeks 0-52)||349
7802713|NCT01198002|19207590|P2|STARTED|Treatment Period 1 (Weeks 0-52)||347
7802714|NCT01198002|19207591|P1|STARTED|Treatment Period 1 (Weeks 0-52)||345
7802715|NCT01197911|19207706|P3|NOT COMPLETED|Overall Study||1
7802716|NCT01197911|19207707|P2|NOT COMPLETED|Overall Study||0
7802717|NCT01197911|19207708|P1|NOT COMPLETED|Overall Study||0
7802718|NCT01197911|19207706|P3|COMPLETED|Overall Study||9
7802719|NCT01197911|19207707|P2|COMPLETED|Overall Study||10
7802720|NCT01197911|19207708|P1|COMPLETED|Overall Study||18
7802721|NCT01197911|19207706|P3|STARTED|Overall Study||10
7802722|NCT01197911|19207707|P2|STARTED|Overall Study||10
7802723|NCT01197911|19207708|P1|STARTED|Overall Study||18
7802724|NCT01197898|19207793|P2|NOT COMPLETED|Overall Study||0
7802725|NCT01197898|19207794|P1|NOT COMPLETED|Overall Study||0
7802726|NCT01197898|19207793|P2|COMPLETED|Overall Study||5
7802727|NCT01197898|19207794|P1|COMPLETED|Overall Study||5
7802728|NCT01197898|19207793|P2|STARTED|Overall Study||5
7802729|NCT01197898|19207794|P1|STARTED|Overall Study||5
7802730|NCT01197833|19207803|P3|NOT COMPLETED|Overall Study||0
7802731|NCT01197833|19207804|P2|NOT COMPLETED|Overall Study||0
7802732|NCT01197833|19207805|P1|NOT COMPLETED|Overall Study||0
7802733|NCT01197833|19207803|P3|COMPLETED|Overall Study||40
7802734|NCT01197833|19207804|P2|COMPLETED|Overall Study||39
7802735|NCT01197833|19207805|P1|COMPLETED|Overall Study||38
7802736|NCT01197833|19207803|P3|STARTED|Overall Study||40
7802737|NCT01197833|19207804|P2|STARTED|Overall Study||39
7802738|NCT01197833|19207805|P1|STARTED|Overall Study||38
7802739|NCT01197794|19207823|P7|NOT COMPLETED|Overall Study||21
7802740|NCT01197794|19207824|P6|NOT COMPLETED|Overall Study||19
7802741|NCT01197794|19207825|P5|NOT COMPLETED|Overall Study||14
7802742|NCT01197794|19207826|P4|NOT COMPLETED|Overall Study||12
7802743|NCT01197794|19207827|P3|NOT COMPLETED|Overall Study||13
7802744|NCT01197794|19207828|P2|NOT COMPLETED|Overall Study||15
7802745|NCT01197794|19207829|P1|NOT COMPLETED|Overall Study||16
7802746|NCT01197794|19207823|P7|COMPLETED|Overall Study||142
7802747|NCT01197794|19207824|P6|COMPLETED|Overall Study||144
7802748|NCT01197794|19207825|P5|COMPLETED|Overall Study||149
7802749|NCT01197794|19207826|P4|COMPLETED|Overall Study||152
7802750|NCT01197794|19207827|P3|COMPLETED|Overall Study||153
7802751|NCT01197794|19207828|P2|COMPLETED|Overall Study||146
7802752|NCT01197794|19207829|P1|COMPLETED|Overall Study||148
7802753|NCT01197794|19207823|P7|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
7802754|NCT01197794|19207824|P6|STARTED|Overall Study||163
7802755|NCT01197794|19207825|P5|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
7802756|NCT01197794|19207826|P4|STARTED|Overall Study||164
7802757|NCT01197794|19207827|P3|STARTED|Overall Study|Two participants did not receive study treatment|166
7802758|NCT01197794|19207828|P2|STARTED|Overall Study|Two participants did not receive study treatment|161
7802759|NCT01197794|19207829|P1|STARTED|Overall Study||164
7802760|NCT01197755|19207911|P3|NOT COMPLETED|Overall Study||54
7802761|NCT01197755|19207912|P2|NOT COMPLETED|Overall Study||43
7802762|NCT01197755|19207913|P1|NOT COMPLETED|Overall Study||38
7802763|NCT01197755|19207911|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55
7802764|NCT01197755|19207912|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65
7802765|NCT01197755|19207913|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67
7802766|NCT01197755|19207911|P3|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1
7802767|NCT01197755|19207912|P2|Randomised But Did Not Receive Treatment|Overall Study||0
7802768|NCT01197755|19207913|P1|Randomised But Did Not Receive Treatment|Overall Study||0
7802769|NCT01197755|19207911|P3|STARTED|Overall Study|Patients who received treatment|109
7802770|NCT01197755|19207912|P2|STARTED|Overall Study|Patients who received treatment|108
7802771|NCT01197755|19207913|P1|STARTED|Overall Study|Patients who received treatment|105
7802772|NCT01197612|19207953|P1|NOT COMPLETED|Overall Study||12
7802773|NCT01197612|19207953|P1|COMPLETED|Overall Study||6
7802774|NCT01197612|19207953|P1|Returned for Week 24|Overall Study||6
7802775|NCT01197612|19207953|P1|Week 3|Overall Study||16
7802776|NCT01197612|19207953|P1|STARTED|Overall Study||18
7802777|NCT01197573|19207968|P4|NOT COMPLETED|Overall Study||0
7802778|NCT01197573|19207969|P3|NOT COMPLETED|Overall Study||0
7802779|NCT01197573|19207970|P2|NOT COMPLETED|Overall Study||0
7802780|NCT01197573|19207971|P1|NOT COMPLETED|Overall Study||0
7802781|NCT01197573|19207968|P4|COMPLETED|Overall Study||12
7802782|NCT01197573|19207969|P3|COMPLETED|Overall Study||12
7802783|NCT01197573|19207970|P2|COMPLETED|Overall Study||46
7802784|NCT01197573|19207971|P1|COMPLETED|Overall Study||33
7802785|NCT01197573|19207968|P4|STARTED|Overall Study||12
7802786|NCT01197573|19207969|P3|STARTED|Overall Study||12
7802787|NCT01197573|19207970|P2|STARTED|Overall Study||46
7802788|NCT01197573|19207971|P1|STARTED|Overall Study||33
7802789|NCT01197560|19207985|P2|NOT COMPLETED|Overall Study||53
7802790|NCT01197560|19207986|P1|NOT COMPLETED|Overall Study||54
7802791|NCT01197560|19207985|P2|COMPLETED|Overall Study||4
7802792|NCT01197560|19207986|P1|COMPLETED|Overall Study||0
7802793|NCT01197560|19207985|P2|Discontinued Treatment After ≥ 6 Cycles|Overall Study||0
7802794|NCT01197560|19207986|P1|Discontinued Treatment After ≥ 6 Cycles|Overall Study||14
7802795|NCT01197560|19207985|P2|Lenalidomide Crossover|Overall Study||29
7802796|NCT01197560|19207986|P1|Lenalidomide Crossover|Overall Study||0
7802797|NCT01197560|19207985|P2|Received ≥ One Dose Study Drug|Overall Study||55
7802798|NCT01197560|19207986|P1|Received ≥ One Dose Study Drug|Overall Study||54
7802799|NCT01197560|19207985|P2|STARTED|Overall Study|This is the intent to treat population|57
7802800|NCT01197560|19207986|P1|STARTED|Overall Study|This is the intent to treat population|54
7802801|NCT01197547|19208024|P1|NOT COMPLETED|Overall Study||22
7802802|NCT01197547|19208024|P1|COMPLETED|Overall Study|992 Intent-To-Treat (ITT) 931 evaluable subjects|992
7802803|NCT01197547|19208024|P1|STARTED|Overall Study||1014
7802804|NCT01197534|19208033|P3|NOT COMPLETED|Overall Study||173
7802805|NCT01197534|19208034|P2|NOT COMPLETED|Overall Study||130
7802806|NCT01197534|19208035|P1|NOT COMPLETED|Overall Study||134
7802807|NCT01197534|19208033|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129
7802808|NCT01197534|19208034|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168
7802809|NCT01197534|19208035|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174
7802810|NCT01197534|19208033|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3
7802811|NCT01197534|19208034|P2|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2
7802812|NCT01197534|19208035|P1|Randomised But Did Not Receive Treatment|Overall Study||0
7802813|NCT01197534|19208033|P3|STARTED|Overall Study|Patients who received treatment|302
7802814|NCT01197534|19208034|P2|STARTED|Overall Study|Patients who received treatment|298
7802815|NCT01197534|19208035|P1|STARTED|Overall Study|Patients who received treatment|308
7802816|NCT01197521|19208079|P3|NOT COMPLETED|Overall Study||143
7802817|NCT01197521|19208080|P2|NOT COMPLETED|Overall Study||113
7802818|NCT01197521|19208081|P1|NOT COMPLETED|Overall Study||103
7802819|NCT01197521|19208079|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161
7802820|NCT01197521|19208080|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191
7802821|NCT01197521|19208081|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207
7802822|NCT01197521|19208079|P3|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2
7802823|NCT01197521|19208080|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2
7802824|NCT01197521|19208081|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
7802825|NCT01197521|19208079|P3|STARTED|Overall Study|Patients who received treatment|304
7802826|NCT01197521|19208080|P2|STARTED|Overall Study|Patients who received treatment|304
7802827|NCT01197521|19208081|P1|STARTED|Overall Study|Patients who received treatment|310
7802828|NCT01197508|19208126|P4|NOT COMPLETED|Overall Study||16
7802829|NCT01197508|19208127|P3|NOT COMPLETED|Overall Study||49
7802830|NCT01197508|19208128|P2|NOT COMPLETED|Overall Study||30
7802831|NCT01197508|19208129|P1|NOT COMPLETED|Overall Study||23
7802832|NCT01197508|19208126|P4|COMPLETED|Overall Study||158
7802833|NCT01197508|19208127|P3|COMPLETED|Overall Study||125
7802834|NCT01197508|19208128|P2|COMPLETED|Overall Study||144
7802835|NCT01197508|19208129|P1|COMPLETED|Overall Study||151
7802836|NCT01197508|19208126|P4|Received Treatment|Overall Study||174
7802837|NCT01197508|19208127|P3|Received Treatment|Overall Study||171
7802838|NCT01197508|19208128|P2|Received Treatment|Overall Study||174
7802839|NCT01197508|19208129|P1|Received Treatment|Overall Study||174
7802840|NCT01197508|19208126|P4|STARTED|Overall Study||174
7802841|NCT01197508|19208127|P3|STARTED|Overall Study||174
7802842|NCT01197508|19208128|P2|STARTED|Overall Study||174
7802843|NCT01197508|19208129|P1|STARTED|Overall Study||174
7802844|NCT01197495|19208225|P2|NOT COMPLETED|Overall Study||7
7802845|NCT01197495|19208226|P1|NOT COMPLETED|Overall Study||13
7802846|NCT01197495|19208225|P2|COMPLETED|Overall Study||49
7802847|NCT01197495|19208226|P1|COMPLETED|Overall Study||144
7802848|NCT01197495|19208225|P2|STARTED|Overall Study||56
7802849|NCT01197495|19208226|P1|STARTED|Overall Study||157
7802850|NCT01197456|19208239|P2|NOT COMPLETED|Overall Study||0
7802851|NCT01197456|19208240|P1|NOT COMPLETED|Overall Study||0
7802852|NCT01197456|19208239|P2|COMPLETED|Overall Study||61
7802853|NCT01197456|19208240|P1|COMPLETED|Overall Study||171
7802854|NCT01197456|19208239|P2|STARTED|Overall Study||61
7802855|NCT01197456|19208240|P1|STARTED|Overall Study||171
7802856|NCT01197417|19208250|P2|NOT COMPLETED|Overall Study||18
7802857|NCT01197417|19208251|P1|NOT COMPLETED|Overall Study||8
7802858|NCT01197417|19208250|P2|COMPLETED|Overall Study||86
7802859|NCT01197417|19208251|P1|COMPLETED|Overall Study||96
7802860|NCT01197417|19208250|P2|Received Study Drug|Overall Study||103
7802861|NCT01197417|19208251|P1|Received Study Drug|Overall Study||101
7802862|NCT01197417|19208250|P2|STARTED|Overall Study||104
7802863|NCT01197417|19208251|P1|STARTED|Overall Study||104
7802864|NCT01197378|19208269|P1|NOT COMPLETED|Overall Study||7
7802865|NCT01197378|19208269|P1|COMPLETED|Overall Study||53
7802866|NCT01197378|19208269|P1|Received Treatment|Overall Study||59
7802867|NCT01197378|19208269|P1|STARTED|Overall Study||60
7802868|NCT01197326|19208277|P2|NOT COMPLETED|Overall Study||0
7802869|NCT01197326|19208278|P1|NOT COMPLETED|Overall Study||0
7802870|NCT01197326|19208277|P2|COMPLETED|Overall Study||209
7802871|NCT01197326|19208278|P1|COMPLETED|Overall Study||205
7802872|NCT01197326|19208277|P2|STARTED|Overall Study||209
7802873|NCT01197326|19208278|P1|STARTED|Overall Study||205
7802874|NCT01197300|19208288|P2|NOT COMPLETED|Overall Study||2
7802875|NCT01197300|19208289|P1|NOT COMPLETED|Overall Study||0
7802876|NCT01197300|19208288|P2|COMPLETED|Overall Study||13
7802877|NCT01197300|19208289|P1|COMPLETED|Overall Study||10
7802878|NCT01197300|19208288|P2|STARTED|Overall Study||15
7802879|NCT01197300|19208289|P1|STARTED|Overall Study||10
7802880|NCT01196988|19208321|P4|NOT COMPLETED|Overall Study||1
7802881|NCT01196988|19208322|P3|NOT COMPLETED|Overall Study||25
7802882|NCT01196988|19208323|P2|NOT COMPLETED|Overall Study||32
7802883|NCT01196988|19208324|P1|NOT COMPLETED|Overall Study||24
7802884|NCT01196988|19208321|P4|COMPLETED|Overall Study||276
7802885|NCT01196988|19208322|P3|COMPLETED|Overall Study||886
7802886|NCT01196988|19208323|P2|COMPLETED|Overall Study||880
7802887|NCT01196988|19208324|P1|COMPLETED|Overall Study||891
7802888|NCT01196988|19208321|P4|STARTED|Overall Study||277
7802889|NCT01196988|19208322|P3|STARTED|Overall Study||911
7802890|NCT01196988|19208323|P2|STARTED|Overall Study||912
7802891|NCT01196988|19208324|P1|STARTED|Overall Study||915
7802892|NCT01196975|19208418|P5|NOT COMPLETED|Overall Study||13
7802893|NCT01196975|19208419|P4|NOT COMPLETED|Overall Study||6
7802894|NCT01196975|19208420|P3|NOT COMPLETED|Overall Study||5
7802895|NCT01196975|19208421|P2|NOT COMPLETED|Overall Study||9
7802896|NCT01196975|19208422|P1|NOT COMPLETED|Overall Study||15
7802897|NCT01196975|19208418|P5|COMPLETED|Overall Study||205
7802898|NCT01196975|19208419|P4|COMPLETED|Overall Study||207
7802899|NCT01196975|19208420|P3|COMPLETED|Overall Study||420
7802900|NCT01196975|19208421|P2|COMPLETED|Overall Study||415
7802901|NCT01196975|19208422|P1|COMPLETED|Overall Study||408
7802902|NCT01196975|19208418|P5|STARTED|Overall Study||218
7802903|NCT01196975|19208419|P4|STARTED|Overall Study||213
7802904|NCT01196975|19208420|P3|STARTED|Overall Study||425
7802905|NCT01196975|19208421|P2|STARTED|Overall Study||424
7802906|NCT01196975|19208422|P1|STARTED|Overall Study||423
7802907|NCT01196936|19208556|P2|NOT COMPLETED|Overall Study||17
7802908|NCT01196936|19208557|P1|NOT COMPLETED|Overall Study||11
7802909|NCT01196936|19208556|P2|COMPLETED|Overall Study||21
7802910|NCT01196936|19208557|P1|COMPLETED|Overall Study||23
7802911|NCT01196936|19208556|P2|Year One Post Treatment|Overall Study||28
7802912|NCT01196936|19208557|P1|Year One Post Treatment|Overall Study||27
7802913|NCT01196936|19208556|P2|STARTED|Overall Study||38
7802914|NCT01196936|19208557|P1|STARTED|Overall Study||34
7802915|NCT01196923|19208579|P1|NOT COMPLETED|Overall Study||0
7802916|NCT01196923|19208579|P1|COMPLETED|Overall Study||20
7802917|NCT01196923|19208579|P1|STARTED|Overall Study||20
7802918|NCT01196871|19208589|P6|NOT COMPLETED|Stage 2: Period 2||0
7802919|NCT01196871|19208590|P5|NOT COMPLETED|Stage 2: Period 2||0
7802920|NCT01196871|19208591|P4|NOT COMPLETED|Stage 2: Period 2||0
7802921|NCT01196871|19208592|P3|NOT COMPLETED|Stage 2: Period 2||0
7802922|NCT01196871|19208593|P2|NOT COMPLETED|Stage 2: Period 2||0
7802923|NCT01196871|19208594|P1|NOT COMPLETED|Stage 2: Period 2||0
7802924|NCT01196871|19208589|P6|COMPLETED|Stage 2: Period 2||4
7802925|NCT01196871|19208590|P5|COMPLETED|Stage 2: Period 2||6
7802926|NCT01196871|19208591|P4|COMPLETED|Stage 2: Period 2||1
7802927|NCT01196871|19208592|P3|COMPLETED|Stage 2: Period 2||0
7802928|NCT01196871|19208593|P2|COMPLETED|Stage 2: Period 2||0
7802929|NCT01196871|19208594|P1|COMPLETED|Stage 2: Period 2||0
7802930|NCT01196871|19208589|P6|PK Population|Stage 2: Period 2||4
7802931|NCT01196871|19208590|P5|PK Population|Stage 2: Period 2||6
7802932|NCT01196871|19208591|P4|PK Population|Stage 2: Period 2||1
7802933|NCT01196871|19208592|P3|PK Population|Stage 2: Period 2||0
7802934|NCT01196871|19208593|P2|PK Population|Stage 2: Period 2||0
7802935|NCT01196871|19208594|P1|PK Population|Stage 2: Period 2||0
7802936|NCT01196871|19208589|P6|STARTED|Stage 2: Period 2||4
7802937|NCT01196871|19208590|P5|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|6
7802938|NCT01196871|19208591|P4|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|1
7802939|NCT01196871|19208592|P3|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
7802940|NCT01196871|19208593|P2|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
7802941|NCT01196871|19208594|P1|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
7802942|NCT01196871|19208589|P6|NOT COMPLETED|Stage 2: Period 1||0
7802943|NCT01196871|19208590|P5|NOT COMPLETED|Stage 2: Period 1||0
7802944|NCT01196871|19208591|P4|NOT COMPLETED|Stage 2: Period 1||0
7802945|NCT01196871|19208592|P3|NOT COMPLETED|Stage 2: Period 1||0
7802946|NCT01196871|19208593|P2|NOT COMPLETED|Stage 2: Period 1||0
7802947|NCT01196871|19208594|P1|NOT COMPLETED|Stage 2: Period 1||0
7802948|NCT01196871|19208589|P6|COMPLETED|Stage 2: Period 1||4
7802949|NCT01196871|19208590|P5|COMPLETED|Stage 2: Period 1||5
7802950|NCT01196871|19208591|P4|COMPLETED|Stage 2: Period 1||2
7802951|NCT01196871|19208592|P3|COMPLETED|Stage 2: Period 1||0
7802952|NCT01196871|19208593|P2|COMPLETED|Stage 2: Period 1||0
7802953|NCT01196871|19208594|P1|COMPLETED|Stage 2: Period 1||0
7802954|NCT01196871|19208589|P6|PK Population|Stage 2: Period 1||4
7802955|NCT01196871|19208590|P5|PK Population|Stage 2: Period 1||5
7802956|NCT01196871|19208591|P4|PK Population|Stage 2: Period 1||1
7802957|NCT01196871|19208592|P3|PK Population|Stage 2: Period 1||0
7802958|NCT01196871|19208593|P2|PK Population|Stage 2: Period 1||0
7802959|NCT01196871|19208594|P1|PK Population|Stage 2: Period 1||0
7802960|NCT01196871|19208589|P6|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||4
7802961|NCT01196871|19208590|P5|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||5
7802962|NCT01196871|19208591|P4|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||2
7802963|NCT01196871|19208592|P3|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
7802964|NCT01196871|19208593|P2|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
7802965|NCT01196871|19208594|P1|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
7802966|NCT01196871|19208589|P6|STARTED|Stage 2: Period 1||4
7802967|NCT01196871|19208590|P5|STARTED|Stage 2: Period 1|One participant re-enrolled into Stage 2 after completing Stage 1|5
7802968|NCT01196871|19208591|P4|STARTED|Stage 2: Period 1|Both participants re-enrolled into Stage 2 after completing Stage 1|2
7802969|NCT01196871|19208592|P3|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
7802970|NCT01196871|19208593|P2|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
7802971|NCT01196871|19208594|P1|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
7802972|NCT01196871|19208589|P6|NOT COMPLETED|Stage 1: Period 3||0
7802973|NCT01196871|19208590|P5|NOT COMPLETED|Stage 1: Period 3||0
7802974|NCT01196871|19208591|P4|NOT COMPLETED|Stage 1: Period 3||0
7802975|NCT01196871|19208592|P3|NOT COMPLETED|Stage 1: Period 3||0
7802976|NCT01196871|19208593|P2|NOT COMPLETED|Stage 1: Period 3||0
7802977|NCT01196871|19208594|P1|NOT COMPLETED|Stage 1: Period 3||0
7802978|NCT01196871|19208589|P6|COMPLETED|Stage 1: Period 3||0
7802979|NCT01196871|19208590|P5|COMPLETED|Stage 1: Period 3||0
7802980|NCT01196871|19208591|P4|COMPLETED|Stage 1: Period 3||0
7802981|NCT01196871|19208592|P3|COMPLETED|Stage 1: Period 3||4
7802982|NCT01196871|19208593|P2|COMPLETED|Stage 1: Period 3||3
7802983|NCT01196871|19208594|P1|COMPLETED|Stage 1: Period 3||5
7802984|NCT01196871|19208589|P6|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
7802985|NCT01196871|19208590|P5|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
7802986|NCT01196871|19208591|P4|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
7802987|NCT01196871|19208592|P3|STARTED|Stage 1: Period 3||4
7802988|NCT01196871|19208593|P2|STARTED|Stage 1: Period 3||3
7802989|NCT01196871|19208594|P1|STARTED|Stage 1: Period 3||5
7802990|NCT01196871|19208589|P6|NOT COMPLETED|Stage 1: Period 2||0
7802991|NCT01196871|19208590|P5|NOT COMPLETED|Stage 1: Period 2||0
7802992|NCT01196871|19208591|P4|NOT COMPLETED|Stage 1: Period 2||0
7802993|NCT01196871|19208592|P3|NOT COMPLETED|Stage 1: Period 2||0
7802994|NCT01196871|19208593|P2|NOT COMPLETED|Stage 1: Period 2||0
7802995|NCT01196871|19208594|P1|NOT COMPLETED|Stage 1: Period 2||0
7802996|NCT01196871|19208589|P6|COMPLETED|Stage 1: Period 2||0
7802997|NCT01196871|19208590|P5|COMPLETED|Stage 1: Period 2||0
7802998|NCT01196871|19208591|P4|COMPLETED|Stage 1: Period 2||0
7802999|NCT01196871|19208592|P3|COMPLETED|Stage 1: Period 2||4
7803000|NCT01196871|19208593|P2|COMPLETED|Stage 1: Period 2||3
7803001|NCT01196871|19208594|P1|COMPLETED|Stage 1: Period 2||5
7803002|NCT01196871|19208589|P6|PK Population|Stage 1: Period 2||0
7803003|NCT01196871|19208590|P5|PK Population|Stage 1: Period 2||0
7803004|NCT01196871|19208591|P4|PK Population|Stage 1: Period 2||0
7803005|NCT01196871|19208592|P3|PK Population|Stage 1: Period 2||4
7803006|NCT01196871|19208593|P2|PK Population|Stage 1: Period 2||3
7803007|NCT01196871|19208594|P1|PK Population|Stage 1: Period 2||5
7803008|NCT01196871|19208589|P6|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
7803009|NCT01196871|19208590|P5|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
7803010|NCT01196871|19208591|P4|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
7803011|NCT01196871|19208592|P3|STARTED|Stage 1: Period 2||4
7803012|NCT01196871|19208593|P2|STARTED|Stage 1: Period 2||3
7803013|NCT01196871|19208594|P1|STARTED|Stage 1: Period 2||5
7803014|NCT01196871|19208589|P6|NOT COMPLETED|Stage 1: Period 1||0
7803015|NCT01196871|19208590|P5|NOT COMPLETED|Stage 1: Period 1||0
7803016|NCT01196871|19208591|P4|NOT COMPLETED|Stage 1: Period 1||0
7803017|NCT01196871|19208592|P3|NOT COMPLETED|Stage 1: Period 1||0
7803018|NCT01196871|19208593|P2|NOT COMPLETED|Stage 1: Period 1||0
7803019|NCT01196871|19208594|P1|NOT COMPLETED|Stage 1: Period 1||0
7803020|NCT01196871|19208589|P6|COMPLETED|Stage 1: Period 1||0
7803021|NCT01196871|19208590|P5|COMPLETED|Stage 1: Period 1||0
7803022|NCT01196871|19208591|P4|COMPLETED|Stage 1: Period 1||0
7803023|NCT01196871|19208592|P3|COMPLETED|Stage 1: Period 1||4
7803024|NCT01196871|19208593|P2|COMPLETED|Stage 1: Period 1||3
7803025|NCT01196871|19208594|P1|COMPLETED|Stage 1: Period 1||5
7803026|NCT01196871|19208589|P6|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
7803027|NCT01196871|19208590|P5|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
7803028|NCT01196871|19208591|P4|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
7803029|NCT01196871|19208592|P3|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||4
7803030|NCT01196871|19208593|P2|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||3
7803031|NCT01196871|19208594|P1|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||5
7803032|NCT01196871|19208589|P6|PK Population|Stage 1: Period 1||0
7803033|NCT01196871|19208590|P5|PK Population|Stage 1: Period 1||0
7803034|NCT01196871|19208591|P4|PK Population|Stage 1: Period 1||0
7803035|NCT01196871|19208592|P3|PK Population|Stage 1: Period 1||4
7803036|NCT01196871|19208593|P2|PK Population|Stage 1: Period 1||3
7803037|NCT01196871|19208594|P1|PK Population|Stage 1: Period 1||5
7803038|NCT01196871|19208589|P6|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
7803039|NCT01196871|19208590|P5|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
7803040|NCT01196871|19208591|P4|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
7803041|NCT01196871|19208592|P3|STARTED|Stage 1: Period 1||4
7803042|NCT01196871|19208593|P2|STARTED|Stage 1: Period 1||3
7803043|NCT01196871|19208594|P1|STARTED|Stage 1: Period 1||5
7803044|NCT01196819|19208679|P2|NOT COMPLETED|Overall Study||0
7803045|NCT01196819|19208680|P1|NOT COMPLETED|Overall Study||6
7803046|NCT01196819|19208679|P2|COMPLETED|Overall Study||227
7803047|NCT01196819|19208680|P1|COMPLETED|Overall Study||225
7803048|NCT01196819|19208679|P2|STARTED|Overall Study||227
7803049|NCT01196819|19208680|P1|STARTED|Overall Study||231
7803050|NCT01196793|19208700|P1|NOT COMPLETED|Overall Study||0
7803051|NCT01196793|19208700|P1|COMPLETED|Overall Study||108
7803052|NCT01196793|19208700|P1|STARTED|Overall Study||108
7803053|NCT01196741|19208706|P2|NOT COMPLETED|Overall Study||28
7803054|NCT01196741|19208707|P1|NOT COMPLETED|Overall Study||60
7803055|NCT01196741|19208706|P2|COMPLETED|Overall Study||8
7803056|NCT01196741|19208707|P1|COMPLETED|Overall Study||11
7803057|NCT01196741|19208706|P2|STARTED|Overall Study||36
7803058|NCT01196741|19208707|P1|STARTED|Overall Study||71
7803059|NCT01196533|19208721|P1|NOT COMPLETED|Overall Study||0
7803060|NCT01196533|19208721|P1|COMPLETED|Overall Study||94
7803061|NCT01196533|19208721|P1|STARTED|Overall Study||94
7803062|NCT01196442|19208725|P1|NOT COMPLETED|Overall Study||0
7803063|NCT01196442|19208725|P1|COMPLETED|Overall Study||39
7803064|NCT01196442|19208725|P1|STARTED|Overall Study||39
7803065|NCT01196429|19208737|P2|NOT COMPLETED|Overall Study||0
7803066|NCT01196429|19208738|P1|NOT COMPLETED|Overall Study||3
7803067|NCT01196429|19208737|P2|COMPLETED|Overall Study||45
7803068|NCT01196429|19208738|P1|COMPLETED|Overall Study||42
7803069|NCT01196429|19208737|P2|STARTED|Overall Study||45
7803070|NCT01196429|19208738|P1|STARTED|Overall Study||45
7803071|NCT01196416|19208754|P1|NOT COMPLETED|Overall Study||2
7803072|NCT01196416|19208754|P1|COMPLETED|Overall Study||12
7803073|NCT01196416|19208754|P1|STARTED|Overall Study||14
7803074|NCT01196377|19208772|P4|NOT COMPLETED|Overall Study||0
7803075|NCT01196377|19208773|P3|NOT COMPLETED|Overall Study||0
7803076|NCT01196377|19208774|P2|NOT COMPLETED|Overall Study||0
7803077|NCT01196377|19208775|P1|NOT COMPLETED|Overall Study||0
7803078|NCT01196377|19208772|P4|COMPLETED|Overall Study||4
7803079|NCT01196377|19208773|P3|COMPLETED|Overall Study||4
7803080|NCT01196377|19208774|P2|COMPLETED|Overall Study||4
7803081|NCT01196377|19208775|P1|COMPLETED|Overall Study||4
7803082|NCT01196377|19208772|P4|STARTED|Overall Study||4
7803083|NCT01196377|19208773|P3|STARTED|Overall Study||4
7803084|NCT01196377|19208774|P2|STARTED|Overall Study||4
7803085|NCT01196377|19208775|P1|STARTED|Overall Study||4
7803086|NCT01196117|19208785|P2|NOT COMPLETED|CPAP||0
7803087|NCT01196117|19208786|P1|NOT COMPLETED|CPAP||0
7803088|NCT01196117|19208785|P2|COMPLETED|CPAP||18
7803089|NCT01196117|19208786|P1|COMPLETED|CPAP||0
7803090|NCT01196117|19208785|P2|STARTED|CPAP||18
7803091|NCT01196117|19208786|P1|STARTED|CPAP||0
7803092|NCT01196117|19208785|P2|NOT COMPLETED|Placebo, Then CPAP||0
7803093|NCT01196117|19208786|P1|NOT COMPLETED|Placebo, Then CPAP||0
7803094|NCT01196117|19208785|P2|COMPLETED|Placebo, Then CPAP||0
7803095|NCT01196117|19208786|P1|COMPLETED|Placebo, Then CPAP||18
7803096|NCT01196117|19208785|P2|STARTED|Placebo, Then CPAP||0
7803097|NCT01196117|19208786|P1|STARTED|Placebo, Then CPAP||18
7803098|NCT01196104|19208812|P2|NOT COMPLETED|Overall Study||5
7803099|NCT01196104|19208813|P1|NOT COMPLETED|Overall Study||4
7803100|NCT01196104|19208812|P2|COMPLETED|Overall Study||15
7803101|NCT01196104|19208813|P1|COMPLETED|Overall Study||15
7803102|NCT01196104|19208812|P2|STARTED|Overall Study||20
7803103|NCT01196104|19208813|P1|STARTED|Overall Study||19
7803104|NCT01196091|19208856|P3|NOT COMPLETED|Overall Study||104
7803105|NCT01196091|19208857|P2|NOT COMPLETED|Overall Study||98
7803106|NCT01196091|19208858|P1|NOT COMPLETED|Overall Study||88
7803107|NCT01196091|19208856|P3|COMPLETED|Overall Study||284
7803108|NCT01196091|19208857|P2|COMPLETED|Overall Study||291
7803109|NCT01196091|19208858|P1|COMPLETED|Overall Study||299
7803110|NCT01196091|19208856|P3|Follow-Up|Overall Study||128
7803111|NCT01196091|19208857|P2|Follow-Up|Overall Study||105
7803112|NCT01196091|19208858|P1|Follow-Up|Overall Study||103
7803113|NCT01196091|19208856|P3|ITT-Received Drug and Excluded Sites|Overall Study||379
7803114|NCT01196091|19208857|P2|ITT-Received Drug and Excluded Sites|Overall Study||378
7803115|NCT01196091|19208858|P1|ITT-Received Drug and Excluded Sites|Overall Study||381
7803116|NCT01196091|19208856|P3|Received at Least 1 Dose of Study Drug|Overall Study||387
7803117|NCT01196091|19208857|P2|Received at Least 1 Dose of Study Drug|Overall Study||389
7803118|NCT01196091|19208858|P1|Received at Least 1 Dose of Study Drug|Overall Study||386
7803119|NCT01196091|19208856|P3|STARTED|Overall Study||388
7803120|NCT01196091|19208857|P2|STARTED|Overall Study||389
7803121|NCT01196091|19208858|P1|STARTED|Overall Study||387
7803122|NCT01196078|19208910|P2|NOT COMPLETED|Overall Study||37
7803123|NCT01196078|19208911|P1|NOT COMPLETED|Overall Study||33
7803124|NCT01196078|19208910|P2|COMPLETED|Overall Study||20
7803125|NCT01196078|19208911|P1|COMPLETED|Overall Study||24
7803126|NCT01196078|19208910|P2|STARTED|Overall Study||57
7803127|NCT01196078|19208911|P1|STARTED|Overall Study||57
7803128|NCT01196052|19208939|P1|NOT COMPLETED|Overall Study||23
7803129|NCT01196052|19208939|P1|COMPLETED|Overall Study||130
7803130|NCT01196052|19208939|P1|Received Trastuzumab Emtansine|Overall Study||148
7803131|NCT01196052|19208939|P1|STARTED|Overall Study||153
7803132|NCT01196026|19208956|P6|NOT COMPLETED|Overall Study||0
7803133|NCT01196026|19208957|P5|NOT COMPLETED|Overall Study||1
7803134|NCT01196026|19208958|P4|NOT COMPLETED|Overall Study||0
7803135|NCT01196026|19208959|P3|NOT COMPLETED|Overall Study||0
7803136|NCT01196026|19208960|P2|NOT COMPLETED|Overall Study||8
7803137|NCT01196026|19208961|P1|NOT COMPLETED|Overall Study||1
7803138|NCT01196026|19208956|P6|COMPLETED|Overall Study||24
7803139|NCT01196026|19208957|P5|COMPLETED|Overall Study||42
7803140|NCT01196026|19208958|P4|COMPLETED|Overall Study||10
7803141|NCT01196026|19208959|P3|COMPLETED|Overall Study||23
7803142|NCT01196026|19208960|P2|COMPLETED|Overall Study||36
7803143|NCT01196026|19208961|P1|COMPLETED|Overall Study||9
7803144|NCT01196026|19208956|P6|Completed at Day 28|Overall Study||24
7803145|NCT01196026|19208957|P5|Completed at Day 28|Overall Study||42
7803146|NCT01196026|19208958|P4|Completed at Day 28|Overall Study||10
7803147|NCT01196026|19208959|P3|Completed at Day 28|Overall Study||23
7803148|NCT01196026|19208960|P2|Completed at Day 28|Overall Study||41
7803149|NCT01196026|19208961|P1|Completed at Day 28|Overall Study||9
7803150|NCT01196026|19208956|P6|STARTED|Overall Study||24
7803151|NCT01196026|19208957|P5|STARTED|Overall Study||43
7803152|NCT01196026|19208958|P4|STARTED|Overall Study||10
7803153|NCT01196026|19208959|P3|STARTED|Overall Study||23
7803154|NCT01196026|19208960|P2|STARTED|Overall Study||44
7803155|NCT01196026|19208961|P1|STARTED|Overall Study||10
7803156|NCT01195948|19209195|P3|NOT COMPLETED|Overall Study||2
7803157|NCT01195948|19209196|P2|NOT COMPLETED|Overall Study||1
7803158|NCT01195948|19209197|P1|NOT COMPLETED|Overall Study||0
7803159|NCT01195948|19209195|P3|COMPLETED|Overall Study||9
7803160|NCT01195948|19209196|P2|COMPLETED|Overall Study||9
7803161|NCT01195948|19209197|P1|COMPLETED|Overall Study||10
7803162|NCT01195948|19209195|P3|Week 24|Overall Study||10
7803163|NCT01195948|19209196|P2|Week 24|Overall Study||10
7803164|NCT01195948|19209197|P1|Week 24|Overall Study||10
7803165|NCT01195948|19209195|P3|STARTED|Overall Study||11
7803166|NCT01195948|19209196|P2|STARTED|Overall Study||10
7803167|NCT01195948|19209197|P1|STARTED|Overall Study||10
7803168|NCT01195922|19209229|P1|NOT COMPLETED|Overall Study||0
7803169|NCT01195922|19209229|P1|COMPLETED|Overall Study||16
7803170|NCT01195922|19209229|P1|STARTED|Overall Study||16
7803171|NCT01195883|19209237|P2|NOT COMPLETED|Overall Study||26
7803172|NCT01195883|19209238|P1|NOT COMPLETED|Overall Study||19
7803173|NCT01195883|19209237|P2|COMPLETED|Overall Study||523
7803174|NCT01195883|19209238|P1|COMPLETED|Overall Study||534
7803175|NCT01195883|19209237|P2|STARTED|Overall Study||549
7803176|NCT01195883|19209238|P1|STARTED|Overall Study||553
7803177|NCT01195844|19209250|P1|NOT COMPLETED|Overall Study||40
7803178|NCT01195844|19209250|P1|COMPLETED|Overall Study||190
7803179|NCT01195844|19209250|P1|STARTED|Overall Study||230
7803180|NCT01195831|19209267|P2|NOT COMPLETED|Overall Study||10
7803181|NCT01195831|19209268|P1|NOT COMPLETED|Overall Study||8
7803182|NCT01195831|19209267|P2|COMPLETED|Overall Study||114
7803183|NCT01195831|19209268|P1|COMPLETED|Overall Study||112
7803184|NCT01195831|19209267|P2|STARTED|Overall Study||124
7803185|NCT01195831|19209268|P1|STARTED|Overall Study||120
7803186|NCT01195779|19209296|P14|NOT COMPLETED|Overall Study||0
7803187|NCT01195779|19209297|P13|NOT COMPLETED|Overall Study||0
7803188|NCT01195779|19209298|P12|NOT COMPLETED|Overall Study||0
7803189|NCT01195779|19209299|P11|NOT COMPLETED|Overall Study||0
7803190|NCT01195779|19209300|P10|NOT COMPLETED|Overall Study||0
7803191|NCT01195779|19209301|P9|NOT COMPLETED|Overall Study||0
7803192|NCT01195779|19209302|P8|NOT COMPLETED|Overall Study||0
7803193|NCT01195779|19209303|P7|NOT COMPLETED|Overall Study||0
7803194|NCT01195779|19209304|P6|NOT COMPLETED|Overall Study||0
7803195|NCT01195779|19209305|P5|NOT COMPLETED|Overall Study||0
7803196|NCT01195779|19209306|P4|NOT COMPLETED|Overall Study||0
7803197|NCT01195779|19209307|P3|NOT COMPLETED|Overall Study||0
7803198|NCT01195779|19209308|P2|NOT COMPLETED|Overall Study||0
7803199|NCT01195779|19209309|P1|NOT COMPLETED|Overall Study||0
7803200|NCT01195779|19209296|P14|COMPLETED|Overall Study||1
7803201|NCT01195779|19209297|P13|COMPLETED|Overall Study||0
7803202|NCT01195779|19209298|P12|COMPLETED|Overall Study||1
7803203|NCT01195779|19209299|P11|COMPLETED|Overall Study||0
7803204|NCT01195779|19209300|P10|COMPLETED|Overall Study||0
7803205|NCT01195779|19209301|P9|COMPLETED|Overall Study||0
7803206|NCT01195779|19209302|P8|COMPLETED|Overall Study||1
7803207|NCT01195779|19209303|P7|COMPLETED|Overall Study||0
7803208|NCT01195779|19209304|P6|COMPLETED|Overall Study||0
7803209|NCT01195779|19209305|P5|COMPLETED|Overall Study||1
7803210|NCT01195779|19209306|P4|COMPLETED|Overall Study||0
7803211|NCT01195779|19209307|P3|COMPLETED|Overall Study||0
7803212|NCT01195779|19209308|P2|COMPLETED|Overall Study||0
7803213|NCT01195779|19209309|P1|COMPLETED|Overall Study||0
7803214|NCT01195779|19209296|P14|STARTED|Overall Study||1
7803215|NCT01195779|19209297|P13|STARTED|Overall Study||0
7803216|NCT01195779|19209298|P12|STARTED|Overall Study||1
7803217|NCT01195779|19209299|P11|STARTED|Overall Study||0
7803218|NCT01195779|19209300|P10|STARTED|Overall Study||0
7803219|NCT01195779|19209301|P9|STARTED|Overall Study||0
7803220|NCT01195779|19209302|P8|STARTED|Overall Study||1
7803221|NCT01195779|19209303|P7|STARTED|Overall Study||0
7803222|NCT01195779|19209304|P6|STARTED|Overall Study||0
7803223|NCT01195779|19209305|P5|STARTED|Overall Study||1
7803224|NCT01195779|19209306|P4|STARTED|Overall Study||0
7803225|NCT01195779|19209307|P3|STARTED|Overall Study||0
7803226|NCT01195779|19209308|P2|STARTED|Overall Study||0
7803227|NCT01195779|19209309|P1|STARTED|Overall Study||0
7803228|NCT01195701|19209481|P2|NOT COMPLETED|Overall Study||5
7803229|NCT01195701|19209482|P1|NOT COMPLETED|Overall Study||0
7803230|NCT01195701|19209481|P2|COMPLETED|Overall Study||20
7803231|NCT01195701|19209482|P1|COMPLETED|Overall Study||10
7803232|NCT01195701|19209481|P2|STARTED|Overall Study||25
7803233|NCT01195701|19209482|P1|STARTED|Overall Study||10
7803234|NCT01195675|19209508|P1|NOT COMPLETED|Overall Study||3
7803235|NCT01195675|19209508|P1|COMPLETED|Overall Study||27
7803236|NCT01195675|19209508|P1|Received Placebo 2|Overall Study||28
7803237|NCT01195675|19209508|P1|Received Placebo 1|Overall Study||29
7803238|NCT01195675|19209508|P1|Received Moxifloxacin|Overall Study||29
7803239|NCT01195675|19209508|P1|Received Empa 200mg|Overall Study||30
7803240|NCT01195675|19209508|P1|Received Empa 25mg|Overall Study||28
7803241|NCT01195675|19209508|P1|STARTED|Overall Study||30
7803242|NCT01195662|19209541|P3|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1
7803243|NCT01195662|19209542|P2|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0
7803244|NCT01195662|19209543|P1|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3
7803245|NCT01195662|19209541|P3|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119
7803246|NCT01195662|19209542|P2|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209
7803247|NCT01195662|19209543|P1|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200
7803248|NCT01195662|19209541|P3|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120
7803249|NCT01195662|19209542|P2|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209
7803250|NCT01195662|19209543|P1|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203
7803251|NCT01195662|19209541|P3|NOT COMPLETED|Double Blind Treatment Period||14
7803252|NCT01195662|19209542|P2|NOT COMPLETED|Double Blind Treatment Period||14
7803253|NCT01195662|19209543|P1|NOT COMPLETED|Double Blind Treatment Period||22
7803254|NCT01195662|19209541|P3|COMPLETED|Double Blind Treatment Period||119
7803255|NCT01195662|19209542|P2|COMPLETED|Double Blind Treatment Period||211
7803256|NCT01195662|19209543|P1|COMPLETED|Double Blind Treatment Period||202
7803257|NCT01195662|19209541|P3|STARTED|Double Blind Treatment Period||133
7803258|NCT01195662|19209542|P2|STARTED|Double Blind Treatment Period||225
7803259|NCT01195662|19209543|P1|STARTED|Double Blind Treatment Period||224
7803260|NCT01195636|19209573|P2|NOT COMPLETED|Second Intervention (3 Weeks)||2
7803261|NCT01195636|19209574|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
7803262|NCT01195636|19209573|P2|COMPLETED|Second Intervention (3 Weeks)||27
7803263|NCT01195636|19209574|P1|COMPLETED|Second Intervention (3 Weeks)||27
7803264|NCT01195636|19209573|P2|STARTED|Second Intervention (3 Weeks)||29
7803265|NCT01195636|19209574|P1|STARTED|Second Intervention (3 Weeks)||28
7803266|NCT01195636|19209573|P2|NOT COMPLETED|Washout Period (2 Weeks)||3
7803267|NCT01195636|19209574|P1|NOT COMPLETED|Washout Period (2 Weeks)||2
7803268|NCT01195636|19209573|P2|COMPLETED|Washout Period (2 Weeks)||29
7803269|NCT01195636|19209574|P1|COMPLETED|Washout Period (2 Weeks)||28
7803270|NCT01195636|19209573|P2|STARTED|Washout Period (2 Weeks)||32
7803271|NCT01195636|19209574|P1|STARTED|Washout Period (2 Weeks)||30
7803272|NCT01195636|19209573|P2|NOT COMPLETED|First Intervention (3 Weeks)||3
7803273|NCT01195636|19209574|P1|NOT COMPLETED|First Intervention (3 Weeks)||5
7803274|NCT01195636|19209573|P2|COMPLETED|First Intervention (3 Weeks)||32
7803275|NCT01195636|19209574|P1|COMPLETED|First Intervention (3 Weeks)||30
7803276|NCT01195636|19209573|P2|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35
7803277|NCT01195636|19209574|P1|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33
7803278|NCT01195636|19209573|P2|STARTED|First Intervention (3 Weeks)||35
7803279|NCT01195636|19209574|P1|STARTED|First Intervention (3 Weeks)||35
7803280|NCT01195623|19209600|P2|NOT COMPLETED|Overall Study||37
7803281|NCT01195623|19209601|P1|NOT COMPLETED|Overall Study||35
7803282|NCT01195623|19209600|P2|COMPLETED|Overall Study|129 legs|108
7803283|NCT01195623|19209601|P1|COMPLETED|Overall Study|127 legs|113
7803284|NCT01195623|19209600|P2|STARTED|Overall Study|177 legs total operated|145
7803285|NCT01195623|19209601|P1|STARTED|Overall Study|166 legs total operated|148
7803286|NCT01195597|19209609|P1|NOT COMPLETED|Overall Study||13
7803287|NCT01195597|19209609|P1|COMPLETED|Overall Study||27
7803288|NCT01195597|19209609|P1|STARTED|Overall Study||40
7803289|NCT01195584|19209617|P3|NOT COMPLETED|Overall Study||0
7803290|NCT01195584|19209618|P2|NOT COMPLETED|Overall Study||0
7803291|NCT01195584|19209619|P1|NOT COMPLETED|Overall Study||0
7803292|NCT01195584|19209617|P3|COMPLETED|Overall Study||27
7803293|NCT01195584|19209618|P2|COMPLETED|Overall Study||25
7803294|NCT01195584|19209619|P1|COMPLETED|Overall Study||20
7803295|NCT01195584|19209617|P3|STARTED|Overall Study||27
7803296|NCT01195584|19209618|P2|STARTED|Overall Study||25
7803297|NCT01195584|19209619|P1|STARTED|Overall Study||20
7803298|NCT01195545|19209630|P1|NOT COMPLETED|Overall Study||4
7803299|NCT01195545|19209630|P1|COMPLETED|Overall Study||16
7803300|NCT01195545|19209630|P1|STARTED|Overall Study||20
7803301|NCT01195467|19209637|P1|NOT COMPLETED|Overall Study||10
7803302|NCT01195467|19209637|P1|COMPLETED|Overall Study||30
7803303|NCT01195467|19209637|P1|STARTED|Overall Study||40
7803304|NCT01195415|19209642|P1|NOT COMPLETED|Overall Study||2
7803305|NCT01195415|19209642|P1|COMPLETED|Overall Study||23
7803306|NCT01195415|19209642|P1|STARTED|Overall Study||25
7803307|NCT01195363|19209651|P2|NOT COMPLETED|Overall Study||9
7803308|NCT01195363|19209652|P1|NOT COMPLETED|Overall Study||11
7803309|NCT01195363|19209651|P2|COMPLETED|Overall Study||4
7803310|NCT01195363|19209652|P1|COMPLETED|Overall Study||4
7803311|NCT01195363|19209651|P2|STARTED|Overall Study||13
7803312|NCT01195363|19209652|P1|STARTED|Overall Study||15
7803313|NCT01195272|19209658|P1|NOT COMPLETED|Overall Study||4
7803314|NCT01195272|19209658|P1|COMPLETED|Overall Study||17
7803315|NCT01195272|19209658|P1|STARTED|Overall Study||21
7803316|NCT01195116|19209677|P2|NOT COMPLETED|Overall Study||0
7803317|NCT01195116|19209678|P1|NOT COMPLETED|Overall Study||0
7803318|NCT01195116|19209677|P2|COMPLETED|Overall Study||20
7803319|NCT01195116|19209678|P1|COMPLETED|Overall Study||21
7803320|NCT01195116|19209677|P2|STARTED|Overall Study||20
7803321|NCT01195116|19209678|P1|STARTED|Overall Study||21
7803322|NCT01195103|19209687|P3|NOT COMPLETED|Overall Study||0
7803323|NCT01195103|19209688|P2|NOT COMPLETED|Overall Study||0
7803324|NCT01195103|19209689|P1|NOT COMPLETED|Overall Study||1
7803325|NCT01195103|19209687|P3|COMPLETED|Overall Study||5
7803326|NCT01195103|19209688|P2|COMPLETED|Overall Study||2
7803327|NCT01195103|19209689|P1|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5
7803328|NCT01195103|19209687|P3|STARTED|Overall Study||5
7803329|NCT01195103|19209688|P2|STARTED|Overall Study||2
7803330|NCT01195103|19209689|P1|STARTED|Overall Study||6
7803331|NCT01195090|19209699|P2|NOT COMPLETED|Overall Study||8
7803332|NCT01195090|19209700|P1|NOT COMPLETED|Overall Study||6
7803333|NCT01195090|19209699|P2|COMPLETED|Overall Study||52
7803334|NCT01195090|19209700|P1|COMPLETED|Overall Study||54
7803335|NCT01195090|19209699|P2|STARTED|Overall Study||60
7803336|NCT01195090|19209700|P1|STARTED|Overall Study||60
7803337|NCT01195025|19209758|P5|NOT COMPLETED|Third Intervention C||0
7803338|NCT01195025|19209759|P4|NOT COMPLETED|Third Intervention C||0
7803339|NCT01195025|19209760|P3|NOT COMPLETED|Third Intervention C||0
7803340|NCT01195025|19209761|P2|NOT COMPLETED|Third Intervention C||0
7803341|NCT01195025|19209762|P1|NOT COMPLETED|Third Intervention C||0
7803342|NCT01195025|19209758|P5|COMPLETED|Third Intervention C||1
7803343|NCT01195025|19209759|P4|COMPLETED|Third Intervention C||2
7803344|NCT01195025|19209760|P3|COMPLETED|Third Intervention C||2
7803345|NCT01195025|19209761|P2|COMPLETED|Third Intervention C||3
7803346|NCT01195025|19209762|P1|COMPLETED|Third Intervention C||2
7803347|NCT01195025|19209758|P5|STARTED|Third Intervention C||1
7803348|NCT01195025|19209759|P4|STARTED|Third Intervention C||2
7803349|NCT01195025|19209760|P3|STARTED|Third Intervention C||2
7803350|NCT01195025|19209761|P2|STARTED|Third Intervention C||3
7803351|NCT01195025|19209762|P1|STARTED|Third Intervention C||2
7803352|NCT01195025|19209758|P5|NOT COMPLETED|Second Intervention B||0
7803353|NCT01195025|19209759|P4|NOT COMPLETED|Second Intervention B||0
7803354|NCT01195025|19209760|P3|NOT COMPLETED|Second Intervention B||0
7803355|NCT01195025|19209761|P2|NOT COMPLETED|Second Intervention B||0
7803356|NCT01195025|19209762|P1|NOT COMPLETED|Second Intervention B||0
7803357|NCT01195025|19209758|P5|COMPLETED|Second Intervention B||1
7803358|NCT01195025|19209759|P4|COMPLETED|Second Intervention B||2
7803359|NCT01195025|19209760|P3|COMPLETED|Second Intervention B||2
7803360|NCT01195025|19209761|P2|COMPLETED|Second Intervention B||3
7803361|NCT01195025|19209762|P1|COMPLETED|Second Intervention B||2
7803362|NCT01195025|19209758|P5|STARTED|Second Intervention B||1
7803363|NCT01195025|19209759|P4|STARTED|Second Intervention B||2
7803364|NCT01195025|19209760|P3|STARTED|Second Intervention B||2
7803365|NCT01195025|19209761|P2|STARTED|Second Intervention B||3
7803366|NCT01195025|19209762|P1|STARTED|Second Intervention B||2
7803367|NCT01195025|19209758|P5|NOT COMPLETED|First Intervention A||0
7803368|NCT01195025|19209759|P4|NOT COMPLETED|First Intervention A||0
7803369|NCT01195025|19209760|P3|NOT COMPLETED|First Intervention A||0
7803370|NCT01195025|19209761|P2|NOT COMPLETED|First Intervention A||0
7803371|NCT01195025|19209762|P1|NOT COMPLETED|First Intervention A||0
7803372|NCT01195025|19209758|P5|COMPLETED|First Intervention A||1
7803373|NCT01195025|19209759|P4|COMPLETED|First Intervention A||2
7803374|NCT01195025|19209760|P3|COMPLETED|First Intervention A||2
7803375|NCT01195025|19209761|P2|COMPLETED|First Intervention A||3
7803376|NCT01195025|19209762|P1|COMPLETED|First Intervention A||2
7803377|NCT01195025|19209758|P5|STARTED|First Intervention A||1
7803378|NCT01195025|19209759|P4|STARTED|First Intervention A||2
7803379|NCT01195025|19209760|P3|STARTED|First Intervention A||2
7803380|NCT01195025|19209761|P2|STARTED|First Intervention A||3
7803381|NCT01195025|19209762|P1|STARTED|First Intervention A||2
7803382|NCT01194999|19209769|P1|NOT COMPLETED|Overall Study||17
7803383|NCT01194999|19209769|P1|COMPLETED|Overall Study||115
7803384|NCT01194999|19209769|P1|STARTED|Overall Study||132
7803385|NCT01194973|19209773|P1|NOT COMPLETED|26 Week Treatment Period||3
7803386|NCT01194973|19209773|P1|COMPLETED|26 Week Treatment Period||38
7803387|NCT01194973|19209773|P1|STARTED|26 Week Treatment Period||41
7803388|NCT01194973|19209773|P1|NOT COMPLETED|Screening Period||3
7803389|NCT01194973|19209773|P1|COMPLETED|Screening Period||41
7803390|NCT01194973|19209773|P1|STARTED|Screening Period||44
7803391|NCT01194908|19209788|P1|NOT COMPLETED|Overall Study||0
7803392|NCT01194908|19209788|P1|COMPLETED|Overall Study||5
7803393|NCT01194908|19209788|P1|STARTED|Overall Study||5
7803394|NCT01194869|19209793|P1|NOT COMPLETED|Overall Study||4
7803395|NCT01194869|19209793|P1|COMPLETED|Overall Study||21
7803396|NCT01194869|19209793|P1|STARTED|Overall Study||25
7803397|NCT01194856|19209801|P2|NOT COMPLETED|Overall Study||0
7803398|NCT01194856|19209802|P1|NOT COMPLETED|Overall Study||1
7803399|NCT01194856|19209801|P2|COMPLETED|Overall Study||0
7803400|NCT01194856|19209802|P1|COMPLETED|Overall Study||0
7803401|NCT01194856|19209801|P2|STARTED|Overall Study||0
7803402|NCT01194856|19209802|P1|STARTED|Overall Study||1
7803403|NCT01194830|19209824|P2|NOT COMPLETED|Overall Study||27
7803404|NCT01194830|19209825|P1|NOT COMPLETED|Overall Study||36
7803405|NCT01194830|19209824|P2|COMPLETED|Overall Study||83
7803406|NCT01194830|19209825|P1|COMPLETED|Overall Study||88
7803407|NCT01194830|19209824|P2|STARTED|Overall Study||110
7803408|NCT01194830|19209825|P1|STARTED|Overall Study||124
7803409|NCT01194804|19209847|P1|NOT COMPLETED|Overall Study||1
7803410|NCT01194804|19209847|P1|COMPLETED|Overall Study||26
7803411|NCT01194804|19209847|P1|STARTED|Overall Study||27
7803412|NCT01194674|19209855|P1|NOT COMPLETED|Overall Study||0
7803413|NCT01194674|19209855|P1|COMPLETED|Overall Study||2
7803414|NCT01194674|19209855|P1|STARTED|Overall Study||2
7803415|NCT01194570|19209869|P2|NOT COMPLETED|Overall Study||488
7803416|NCT01194570|19209870|P1|NOT COMPLETED|Overall Study||244
7803417|NCT01194570|19209869|P2|COMPLETED|Overall Study||0
7803418|NCT01194570|19209870|P1|COMPLETED|Overall Study|"Reason for discontinuation were provided for Core Treatment Completion."|0
7803419|NCT01194570|19209869|P2|STARTED|Overall Study||488
7803420|NCT01194570|19209870|P1|STARTED|Overall Study||244
7803421|NCT01194531|19209890|P2|NOT COMPLETED|Overall Study||3
7803422|NCT01194531|19209891|P1|NOT COMPLETED|Overall Study||5
7803423|NCT01194531|19209890|P2|COMPLETED|Overall Study||27
7803424|NCT01194531|19209891|P1|COMPLETED|Overall Study||24
7803425|NCT01194531|19209890|P2|STARTED|Overall Study||30
7803426|NCT01194531|19209891|P1|STARTED|Overall Study||29
7803427|NCT01194479|19209899|P4|NOT COMPLETED|Overall Study||0
7803428|NCT01194479|19209900|P3|NOT COMPLETED|Overall Study||0
7803429|NCT01194479|19209901|P2|NOT COMPLETED|Overall Study||0
7803430|NCT01194479|19209902|P1|NOT COMPLETED|Overall Study||0
7803431|NCT01194479|19209899|P4|COMPLETED|Overall Study||5
7803432|NCT01194479|19209900|P3|COMPLETED|Overall Study||2
7803433|NCT01194479|19209901|P2|COMPLETED|Overall Study||4
7803434|NCT01194479|19209902|P1|COMPLETED|Overall Study||3
7803435|NCT01194479|19209899|P4|Cross-over at Second Visit|Overall Study||5
7803436|NCT01194479|19209900|P3|Cross-over at Second Visit|Overall Study||2
7803437|NCT01194479|19209901|P2|Cross-over at Second Visit|Overall Study||4
7803438|NCT01194479|19209902|P1|Cross-over at Second Visit|Overall Study||3
7803439|NCT01194479|19209899|P4|STARTED|Overall Study||5
7803440|NCT01194479|19209900|P3|STARTED|Overall Study||2
7803441|NCT01194479|19209901|P2|STARTED|Overall Study||4
7803442|NCT01194479|19209902|P1|STARTED|Overall Study||3
7803443|NCT01194466|19209924|P3|NOT COMPLETED|Overall Study||0
7803444|NCT01194466|19209925|P2|NOT COMPLETED|Overall Study||0
7803445|NCT01194466|19209926|P1|NOT COMPLETED|Overall Study||0
7803446|NCT01194466|19209924|P3|COMPLETED|Overall Study||13
7803447|NCT01194466|19209925|P2|COMPLETED|Overall Study||14
7803448|NCT01194466|19209926|P1|COMPLETED|Overall Study||14
7803449|NCT01194466|19209924|P3|STARTED|Overall Study||13
7803450|NCT01194466|19209925|P2|STARTED|Overall Study||14
7803451|NCT01194466|19209926|P1|STARTED|Overall Study||14
7803452|NCT01194453|19209936|P2|NOT COMPLETED|Overall Study||17
7803453|NCT01194453|19209937|P1|NOT COMPLETED|Overall Study||17
7803454|NCT01194453|19209936|P2|COMPLETED|Overall Study||127
7803455|NCT01194453|19209937|P1|COMPLETED|Overall Study||127
7803456|NCT01194453|19209936|P2|STARTED|Overall Study||144
7803457|NCT01194453|19209937|P1|STARTED|Overall Study||144
7803458|NCT01194440|19209945|P1|NOT COMPLETED|6-months (2nd Dose)||4
7803459|NCT01194440|19209945|P1|COMPLETED|6-months (2nd Dose)||48
7803460|NCT01194440|19209945|P1|STARTED|6-months (2nd Dose)||52
7803461|NCT01194440|19209945|P1|NOT COMPLETED|Baseline (First Dose)||7
7803462|NCT01194440|19209945|P1|COMPLETED|Baseline (First Dose)||52
7803463|NCT01194440|19209945|P1|STARTED|Baseline (First Dose)||59
7803464|NCT01194427|19209952|P1|NOT COMPLETED|Overall Study||0
7803465|NCT01194427|19209952|P1|COMPLETED|Overall Study||2
7803466|NCT01194427|19209952|P1|STARTED|Overall Study||2
7803467|NCT01194414|19209958|P4|NOT COMPLETED|72 Weeks Open Label Extension||26
7803468|NCT01194414|19209959|P3|NOT COMPLETED|72 Weeks Open Label Extension||8
7803469|NCT01194414|19209960|P2|NOT COMPLETED|72 Weeks Open Label Extension||66
7803470|NCT01194414|19209961|P1|NOT COMPLETED|72 Weeks Open Label Extension||79
7803471|NCT01194414|19209958|P4|COMPLETED|72 Weeks Open Label Extension||160
7803472|NCT01194414|19209959|P3|COMPLETED|72 Weeks Open Label Extension||40
7803473|NCT01194414|19209960|P2|COMPLETED|72 Weeks Open Label Extension||311
7803474|NCT01194414|19209961|P1|COMPLETED|72 Weeks Open Label Extension||445
7803475|NCT01194414|19209958|P4|STARTED|72 Weeks Open Label Extension||186
7803476|NCT01194414|19209959|P3|STARTED|72 Weeks Open Label Extension||48
7803477|NCT01194414|19209960|P2|STARTED|72 Weeks Open Label Extension||377
7803478|NCT01194414|19209961|P1|STARTED|72 Weeks Open Label Extension||524
7803479|NCT01194414|19209958|P4|NOT COMPLETED|24 Weeks Double Blind Period||0
7803480|NCT01194414|19209959|P3|NOT COMPLETED|24 Weeks Double Blind Period||0
7803481|NCT01194414|19209960|P2|NOT COMPLETED|24 Weeks Double Blind Period||67
7803482|NCT01194414|19209961|P1|NOT COMPLETED|24 Weeks Double Blind Period||59
7803483|NCT01194414|19209958|P4|COMPLETED|24 Weeks Double Blind Period||0
7803484|NCT01194414|19209959|P3|COMPLETED|24 Weeks Double Blind Period||0
7803485|NCT01194414|19209960|P2|COMPLETED|24 Weeks Double Blind Period||564
7803486|NCT01194414|19209961|P1|COMPLETED|24 Weeks Double Blind Period||572
7803487|NCT01194414|19209958|P4|Per Protocol Population|24 Weeks Double Blind Period||0
7803488|NCT01194414|19209959|P3|Per Protocol Population|24 Weeks Double Blind Period||0
7803489|NCT01194414|19209960|P2|Per Protocol Population|24 Weeks Double Blind Period||537
7803490|NCT01194414|19209961|P1|Per Protocol Population|24 Weeks Double Blind Period||558
7803491|NCT01194414|19209958|P4|STARTED|24 Weeks Double Blind Period||0
7803492|NCT01194414|19209959|P3|STARTED|24 Weeks Double Blind Period||0
7803493|NCT01194414|19209960|P2|STARTED|24 Weeks Double Blind Period||631
7803494|NCT01194414|19209961|P1|STARTED|24 Weeks Double Blind Period||631
7803495|NCT01194297|19210023|P2|NOT COMPLETED|Overall Study||0
7803496|NCT01194297|19210024|P1|NOT COMPLETED|Overall Study||0
7803497|NCT01194297|19210023|P2|COMPLETED|Overall Study||1
7803498|NCT01194297|19210024|P1|COMPLETED|Overall Study||2
7803499|NCT01194297|19210023|P2|STARTED|Overall Study||1
7803500|NCT01194297|19210024|P1|STARTED|Overall Study||2
7803501|NCT01194271|19210032|P1|NOT COMPLETED|Overall Study||3
7803502|NCT01194271|19210032|P1|COMPLETED|Overall Study||16
7803503|NCT01194271|19210032|P1|STARTED|Overall Study||19
7803504|NCT01194258|19210036|P5|NOT COMPLETED|Period 2 (12 Weeks)||2
7803505|NCT01194258|19210037|P4|NOT COMPLETED|Period 2 (12 Weeks)||0
7803506|NCT01194258|19210038|P3|NOT COMPLETED|Period 2 (12 Weeks)||1
7803507|NCT01194258|19210039|P2|NOT COMPLETED|Period 2 (12 Weeks)||2
7803508|NCT01194258|19210040|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
7803509|NCT01194258|19210036|P5|COMPLETED|Period 2 (12 Weeks)||30
7803510|NCT01194258|19210037|P4|COMPLETED|Period 2 (12 Weeks)||29
7803511|NCT01194258|19210038|P3|COMPLETED|Period 2 (12 Weeks)||29
7803512|NCT01194258|19210039|P2|COMPLETED|Period 2 (12 Weeks)||27
7803513|NCT01194258|19210040|P1|COMPLETED|Period 2 (12 Weeks)||0
7803514|NCT01194258|19210036|P5|STARTED|Period 2 (12 Weeks)||32
7803515|NCT01194258|19210037|P4|STARTED|Period 2 (12 Weeks)||29
7803516|NCT01194258|19210038|P3|STARTED|Period 2 (12 Weeks)||30
7803517|NCT01194258|19210039|P2|STARTED|Period 2 (12 Weeks)||29
7803518|NCT01194258|19210040|P1|STARTED|Period 2 (12 Weeks)||0
7803519|NCT01194258|19210036|P5|NOT COMPLETED|Period 1 (12 Weeks)||1
7803520|NCT01194258|19210037|P4|NOT COMPLETED|Period 1 (12 Weeks)||0
7803521|NCT01194258|19210038|P3|NOT COMPLETED|Period 1 (12 Weeks)||0
7803522|NCT01194258|19210039|P2|NOT COMPLETED|Period 1 (12 Weeks)||0
7803523|NCT01194258|19210040|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
7803524|NCT01194258|19210036|P5|COMPLETED|Period 1 (12 Weeks)||32
7803525|NCT01194258|19210037|P4|COMPLETED|Period 1 (12 Weeks)||29
7803526|NCT01194258|19210038|P3|COMPLETED|Period 1 (12 Weeks)||30
7803527|NCT01194258|19210039|P2|COMPLETED|Period 1 (12 Weeks)||29
7803528|NCT01194258|19210040|P1|COMPLETED|Period 1 (12 Weeks)||0
7803529|NCT01194258|19210036|P5|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33
7803530|NCT01194258|19210037|P4|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
7803531|NCT01194258|19210038|P3|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30
7803532|NCT01194258|19210039|P2|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
7803533|NCT01194258|19210040|P1|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0
7803534|NCT01194258|19210036|P5|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33
7803535|NCT01194258|19210037|P4|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29
7803536|NCT01194258|19210038|P3|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30
7803537|NCT01194258|19210039|P2|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29
7803538|NCT01194258|19210040|P1|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0
7803539|NCT01194258|19210036|P5|NOT COMPLETED|Titration Period||0
7803540|NCT01194258|19210037|P4|NOT COMPLETED|Titration Period||0
7803541|NCT01194258|19210038|P3|NOT COMPLETED|Titration Period||0
7803542|NCT01194258|19210039|P2|NOT COMPLETED|Titration Period||0
7803543|NCT01194258|19210040|P1|NOT COMPLETED|Titration Period||11
7803544|NCT01194258|19210036|P5|COMPLETED|Titration Period||0
7803545|NCT01194258|19210037|P4|COMPLETED|Titration Period||0
7803546|NCT01194258|19210038|P3|COMPLETED|Titration Period||0
7803547|NCT01194258|19210039|P2|COMPLETED|Titration Period||0
7803548|NCT01194258|19210040|P1|COMPLETED|Titration Period||121
7803549|NCT01194258|19210036|P5|STARTED|Titration Period||0
7803550|NCT01194258|19210037|P4|STARTED|Titration Period||0
7803551|NCT01194258|19210038|P3|STARTED|Titration Period||0
7803552|NCT01194258|19210039|P2|STARTED|Titration Period||0
7803553|NCT01194258|19210040|P1|STARTED|Titration Period||132
7803554|NCT01194245|19210064|P5|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
7803555|NCT01194245|19210065|P4|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
7803556|NCT01194245|19210066|P3|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
7803557|NCT01194245|19210067|P2|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
7803558|NCT01194245|19210068|P1|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
7803559|NCT01194245|19210064|P5|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28
7803560|NCT01194245|19210065|P4|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
7803561|NCT01194245|19210066|P3|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27
7803562|NCT01194245|19210067|P2|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
7803563|NCT01194245|19210068|P1|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
7803564|NCT01194245|19210064|P5|STARTED|Treatment Period 2 (Weeks 12 to 24)||28
7803565|NCT01194245|19210065|P4|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
7803566|NCT01194245|19210066|P3|STARTED|Treatment Period 2 (Weeks 12 to 24)||27
7803567|NCT01194245|19210067|P2|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
7803568|NCT01194245|19210068|P1|STARTED|Treatment Period 2 (Weeks 12 to 24)||0
7803569|NCT01194245|19210064|P5|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2
7803570|NCT01194245|19210065|P4|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
7803571|NCT01194245|19210066|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
7803572|NCT01194245|19210067|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
7803573|NCT01194245|19210068|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
7803574|NCT01194245|19210064|P5|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28
7803575|NCT01194245|19210065|P4|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
7803576|NCT01194245|19210066|P3|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27
7803577|NCT01194245|19210067|P2|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
7803578|NCT01194245|19210068|P1|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
7803579|NCT01194245|19210064|P5|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
7803580|NCT01194245|19210065|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
7803581|NCT01194245|19210066|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28
7803582|NCT01194245|19210067|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29
7803583|NCT01194245|19210068|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0
7803584|NCT01194245|19210064|P5|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
7803585|NCT01194245|19210065|P4|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
7803586|NCT01194245|19210066|P3|STARTED|Treatment Period 1 (Weeks 0 to 12)||28
7803587|NCT01194245|19210067|P2|STARTED|Treatment Period 1 (Weeks 0 to 12)||29
7803588|NCT01194245|19210068|P1|STARTED|Treatment Period 1 (Weeks 0 to 12)||0
7803589|NCT01194245|19210064|P5|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
7803590|NCT01194245|19210065|P4|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
7803591|NCT01194245|19210066|P3|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
7803592|NCT01194245|19210067|P2|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
7803593|NCT01194245|19210068|P1|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18
7803594|NCT01194245|19210064|P5|COMPLETED|Titration Period (4 to 6 Weeks)||0
7803595|NCT01194245|19210065|P4|COMPLETED|Titration Period (4 to 6 Weeks)||0
7803596|NCT01194245|19210066|P3|COMPLETED|Titration Period (4 to 6 Weeks)||0
7803597|NCT01194245|19210067|P2|COMPLETED|Titration Period (4 to 6 Weeks)||0
7803598|NCT01194245|19210068|P1|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117
7803599|NCT01194245|19210064|P5|STARTED|Titration Period (4 to 6 Weeks)||0
7803600|NCT01194245|19210065|P4|STARTED|Titration Period (4 to 6 Weeks)||0
7803601|NCT01194245|19210066|P3|STARTED|Titration Period (4 to 6 Weeks)||0
7803602|NCT01194245|19210067|P2|STARTED|Titration Period (4 to 6 Weeks)||0
7803603|NCT01194245|19210068|P1|STARTED|Titration Period (4 to 6 Weeks)||135
7803604|NCT01194219|19210089|P10|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||112
7803605|NCT01194219|19210090|P9|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||220
7803606|NCT01194219|19210091|P8|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
7803607|NCT01194219|19210092|P7|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
7803608|NCT01194219|19210093|P6|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
7803609|NCT01194219|19210094|P5|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
7803610|NCT01194219|19210095|P4|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
7803611|NCT01194219|19210096|P3|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
7803612|NCT01194219|19210097|P2|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
7803613|NCT01194219|19210098|P1|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
7803614|NCT01194219|19210089|P10|COMPLETED|Long-Term Extension Weeks 52 to 260||41
7803615|NCT01194219|19210090|P9|COMPLETED|Long-Term Extension Weeks 52 to 260||86
7803616|NCT01194219|19210091|P8|COMPLETED|Long-Term Extension Weeks 52 to 260||0
7803617|NCT01194219|19210092|P7|COMPLETED|Long-Term Extension Weeks 52 to 260||0
7803618|NCT01194219|19210093|P6|COMPLETED|Long-Term Extension Weeks 52 to 260||0
7803619|NCT01194219|19210094|P5|COMPLETED|Long-Term Extension Weeks 52 to 260||0
7803620|NCT01194219|19210095|P4|COMPLETED|Long-Term Extension Weeks 52 to 260||0
7803621|NCT01194219|19210096|P3|COMPLETED|Long-Term Extension Weeks 52 to 260||0
7803622|NCT01194219|19210097|P2|COMPLETED|Long-Term Extension Weeks 52 to 260||0
7803623|NCT01194219|19210098|P1|COMPLETED|Long-Term Extension Weeks 52 to 260||0
7803624|NCT01194219|19210089|P10|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||153
7803625|NCT01194219|19210090|P9|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||304
7803626|NCT01194219|19210091|P8|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
7803627|NCT01194219|19210092|P7|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
7803628|NCT01194219|19210093|P6|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
7803629|NCT01194219|19210094|P5|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
7803630|NCT01194219|19210095|P4|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
7803631|NCT01194219|19210096|P3|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
7803632|NCT01194219|19210097|P2|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
7803633|NCT01194219|19210098|P1|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
7803634|NCT01194219|19210089|P10|STARTED|Long-Term Extension Weeks 52 to 260||153
7803635|NCT01194219|19210090|P9|STARTED|Long-Term Extension Weeks 52 to 260||306
7803636|NCT01194219|19210091|P8|STARTED|Long-Term Extension Weeks 52 to 260||0
7803637|NCT01194219|19210092|P7|STARTED|Long-Term Extension Weeks 52 to 260||0
7803638|NCT01194219|19210093|P6|STARTED|Long-Term Extension Weeks 52 to 260||0
7803639|NCT01194219|19210094|P5|STARTED|Long-Term Extension Weeks 52 to 260||0
7803640|NCT01194219|19210095|P4|STARTED|Long-Term Extension Weeks 52 to 260||0
7803641|NCT01194219|19210096|P3|STARTED|Long-Term Extension Weeks 52 to 260||0
7803642|NCT01194219|19210097|P2|STARTED|Long-Term Extension Weeks 52 to 260||0
7803643|NCT01194219|19210098|P1|STARTED|Long-Term Extension Weeks 52 to 260||0
7803644|NCT01194219|19210089|P10|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
7803645|NCT01194219|19210090|P9|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
7803646|NCT01194219|19210091|P8|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||45
7803647|NCT01194219|19210092|P7|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||61
7803648|NCT01194219|19210093|P6|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
7803649|NCT01194219|19210094|P5|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
7803650|NCT01194219|19210095|P4|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
7803651|NCT01194219|19210096|P3|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
7803652|NCT01194219|19210097|P2|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
7803653|NCT01194219|19210098|P1|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
7803654|NCT01194219|19210089|P10|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
7803655|NCT01194219|19210090|P9|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
7803656|NCT01194219|19210091|P8|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163
7803657|NCT01194219|19210092|P7|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184
7803658|NCT01194219|19210093|P6|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73
7803659|NCT01194219|19210094|P5|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73
7803660|NCT01194219|19210095|P4|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
7803661|NCT01194219|19210096|P3|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
7803662|NCT01194219|19210097|P2|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
7803663|NCT01194219|19210098|P1|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
7803664|NCT01194219|19210089|P10|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
7803665|NCT01194219|19210090|P9|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
7803666|NCT01194219|19210091|P8|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||91
7803667|NCT01194219|19210092|P7|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||126
7803668|NCT01194219|19210093|P6|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
7803669|NCT01194219|19210094|P5|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
7803670|NCT01194219|19210095|P4|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
7803671|NCT01194219|19210096|P3|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
7803672|NCT01194219|19210097|P2|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
7803673|NCT01194219|19210098|P1|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
7803674|NCT01194219|19210089|P10|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
7803675|NCT01194219|19210090|P9|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
7803676|NCT01194219|19210091|P8|STARTED|Randomized Withdrawal Phase-Weeks 32-52||208
7803677|NCT01194219|19210092|P7|STARTED|Randomized Withdrawal Phase-Weeks 32-52||245
7803678|NCT01194219|19210093|P6|STARTED|Randomized Withdrawal Phase-Weeks 32-52|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
7803679|NCT01194219|19210094|P5|STARTED|Randomized Withdrawal Phase-Weeks 32-52|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
7803680|NCT01194219|19210095|P4|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
7803681|NCT01194219|19210096|P3|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
7803682|NCT01194219|19210097|P2|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
7803683|NCT01194219|19210098|P1|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
7803684|NCT01194219|19210089|P10|NOT COMPLETED|Maintenance Phase Weeks16-32||0
7803685|NCT01194219|19210090|P9|NOT COMPLETED|Maintenance Phase Weeks16-32||0
7803686|NCT01194219|19210091|P8|NOT COMPLETED|Maintenance Phase Weeks16-32||0
7803687|NCT01194219|19210092|P7|NOT COMPLETED|Maintenance Phase Weeks16-32||0
7803688|NCT01194219|19210093|P6|NOT COMPLETED|Maintenance Phase Weeks16-32||0
7803689|NCT01194219|19210094|P5|NOT COMPLETED|Maintenance Phase Weeks16-32||0
7803690|NCT01194219|19210095|P4|NOT COMPLETED|Maintenance Phase Weeks16-32||30
7803691|NCT01194219|19210096|P3|NOT COMPLETED|Maintenance Phase Weeks16-32||70
7803692|NCT01194219|19210097|P2|NOT COMPLETED|Maintenance Phase Weeks16-32||0
7803693|NCT01194219|19210098|P1|NOT COMPLETED|Maintenance Phase Weeks16-32||0
7803694|NCT01194219|19210089|P10|COMPLETED|Maintenance Phase Weeks16-32||0
7803695|NCT01194219|19210090|P9|COMPLETED|Maintenance Phase Weeks16-32||0
7803696|NCT01194219|19210091|P8|COMPLETED|Maintenance Phase Weeks16-32||0
7803697|NCT01194219|19210092|P7|COMPLETED|Maintenance Phase Weeks16-32||0
7803698|NCT01194219|19210093|P6|COMPLETED|Maintenance Phase Weeks16-32||0
7803699|NCT01194219|19210094|P5|COMPLETED|Maintenance Phase Weeks16-32||0
7803700|NCT01194219|19210095|P4|COMPLETED|Maintenance Phase Weeks16-32||215
7803701|NCT01194219|19210096|P3|COMPLETED|Maintenance Phase Weeks16-32||424
7803702|NCT01194219|19210097|P2|COMPLETED|Maintenance Phase Weeks16-32||0
7803703|NCT01194219|19210098|P1|COMPLETED|Maintenance Phase Weeks16-32||0
7803704|NCT01194219|19210089|P10|Received Apremilast|Maintenance Phase Weeks16-32||0
7803705|NCT01194219|19210090|P9|Received Apremilast|Maintenance Phase Weeks16-32||0
7803706|NCT01194219|19210091|P8|Received Apremilast|Maintenance Phase Weeks16-32||0
7803707|NCT01194219|19210092|P7|Received Apremilast|Maintenance Phase Weeks16-32||0
7803708|NCT01194219|19210093|P6|Received Apremilast|Maintenance Phase Weeks16-32||0
7803709|NCT01194219|19210094|P5|Received Apremilast|Maintenance Phase Weeks16-32||0
7803710|NCT01194219|19210095|P4|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|244
7803711|NCT01194219|19210096|P3|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|493
7803712|NCT01194219|19210097|P2|Received Apremilast|Maintenance Phase Weeks16-32||0
7803713|NCT01194219|19210098|P1|Received Apremilast|Maintenance Phase Weeks16-32||0
7803714|NCT01194219|19210089|P10|STARTED|Maintenance Phase Weeks16-32||0
7803715|NCT01194219|19210090|P9|STARTED|Maintenance Phase Weeks16-32||0
7803716|NCT01194219|19210091|P8|STARTED|Maintenance Phase Weeks16-32||0
7803717|NCT01194219|19210092|P7|STARTED|Maintenance Phase Weeks16-32||0
7803718|NCT01194219|19210093|P6|STARTED|Maintenance Phase Weeks16-32||0
7803719|NCT01194219|19210094|P5|STARTED|Maintenance Phase Weeks16-32||0
7803720|NCT01194219|19210095|P4|STARTED|Maintenance Phase Weeks16-32|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245
7803721|NCT01194219|19210096|P3|STARTED|Maintenance Phase Weeks16-32|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494
7803722|NCT01194219|19210097|P2|STARTED|Maintenance Phase Weeks16-32||0
7803723|NCT01194219|19210098|P1|STARTED|Maintenance Phase Weeks16-32||0
7803724|NCT01194219|19210089|P10|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
7803725|NCT01194219|19210090|P9|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
7803726|NCT01194219|19210091|P8|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
7803727|NCT01194219|19210092|P7|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
7803728|NCT01194219|19210093|P6|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
7803729|NCT01194219|19210094|P5|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
7803730|NCT01194219|19210095|P4|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
7803731|NCT01194219|19210096|P3|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
7803732|NCT01194219|19210097|P2|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||33
7803733|NCT01194219|19210098|P1|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||59
7803734|NCT01194219|19210089|P10|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
7803735|NCT01194219|19210090|P9|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
7803736|NCT01194219|19210091|P8|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
7803737|NCT01194219|19210092|P7|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
7803738|NCT01194219|19210093|P6|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
7803739|NCT01194219|19210094|P5|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
7803740|NCT01194219|19210095|P4|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
7803741|NCT01194219|19210096|P3|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
7803742|NCT01194219|19210097|P2|COMPLETED|Placebo-Controlled Phase Weeks 0-16||249
7803743|NCT01194219|19210098|P1|COMPLETED|Placebo-Controlled Phase Weeks 0-16||503
7803744|NCT01194219|19210089|P10|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
7803745|NCT01194219|19210090|P9|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
7803746|NCT01194219|19210091|P8|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
7803747|NCT01194219|19210092|P7|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
7803748|NCT01194219|19210093|P6|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
7803749|NCT01194219|19210094|P5|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
7803750|NCT01194219|19210095|P4|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
7803751|NCT01194219|19210096|P3|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
7803752|NCT01194219|19210097|P2|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||282
7803753|NCT01194219|19210098|P1|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||560
7803754|NCT01194219|19210089|P10|STARTED|Placebo-Controlled Phase Weeks 0-16||0
7803755|NCT01194219|19210090|P9|STARTED|Placebo-Controlled Phase Weeks 0-16||0
7803756|NCT01194219|19210091|P8|STARTED|Placebo-Controlled Phase Weeks 0-16||0
7803757|NCT01194219|19210092|P7|STARTED|Placebo-Controlled Phase Weeks 0-16||0
7803758|NCT01194219|19210093|P6|STARTED|Placebo-Controlled Phase Weeks 0-16||0
7803759|NCT01194219|19210094|P5|STARTED|Placebo-Controlled Phase Weeks 0-16||0
7803760|NCT01194219|19210095|P4|STARTED|Placebo-Controlled Phase Weeks 0-16||0
7803761|NCT01194219|19210096|P3|STARTED|Placebo-Controlled Phase Weeks 0-16||0
7803762|NCT01194219|19210097|P2|STARTED|Placebo-Controlled Phase Weeks 0-16||282
7803763|NCT01194219|19210098|P1|STARTED|Placebo-Controlled Phase Weeks 0-16||562
7803764|NCT01194154|19210132|P2|NOT COMPLETED|Overall Study||33
7803765|NCT01194154|19210133|P1|NOT COMPLETED|Overall Study||49
7803766|NCT01194154|19210132|P2|COMPLETED|Overall Study||91
7803767|NCT01194154|19210133|P1|COMPLETED|Overall Study||68
7803768|NCT01194154|19210132|P2|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117
7803769|NCT01194154|19210133|P1|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118
7803770|NCT01194154|19210132|P2|Full Analysis Set|Overall Study||120
7803771|NCT01194154|19210133|P1|Full Analysis Set|Overall Study||115
7803772|NCT01194154|19210132|P2|STARTED|Overall Study||124
7803773|NCT01194154|19210133|P1|STARTED|Overall Study||117
7803774|NCT01194089|19210153|P2|NOT COMPLETED|Overall Study||0
7803775|NCT01194089|19210154|P1|NOT COMPLETED|Overall Study||0
7803776|NCT01194089|19210153|P2|COMPLETED|Overall Study||47
7803777|NCT01194089|19210154|P1|COMPLETED|Overall Study||42
7803778|NCT01194089|19210153|P2|STARTED|Overall Study||47
7803779|NCT01194089|19210154|P1|STARTED|Overall Study||42
7803780|NCT01193920|19210174|P10|NOT COMPLETED|Overall Study||7
7803781|NCT01193920|19210175|P9|NOT COMPLETED|Overall Study||5
7803782|NCT01193920|19210176|P8|NOT COMPLETED|Overall Study||4
7803783|NCT01193920|19210177|P7|NOT COMPLETED|Overall Study||6
7803784|NCT01193920|19210178|P6|NOT COMPLETED|Overall Study||4
7803785|NCT01193920|19210179|P5|NOT COMPLETED|Overall Study||6
7803786|NCT01193920|19210180|P4|NOT COMPLETED|Overall Study||4
7803787|NCT01193920|19210181|P3|NOT COMPLETED|Overall Study||6
7803788|NCT01193920|19210182|P2|NOT COMPLETED|Overall Study||0
7803789|NCT01193920|19210183|P1|NOT COMPLETED|Overall Study||3
7803790|NCT01193920|19210174|P10|COMPLETED|Overall Study||74
7803791|NCT01193920|19210175|P9|COMPLETED|Overall Study||71
7803792|NCT01193920|19210176|P8|COMPLETED|Overall Study||76
7803793|NCT01193920|19210177|P7|COMPLETED|Overall Study||74
7803794|NCT01193920|19210178|P6|COMPLETED|Overall Study||76
7803795|NCT01193920|19210179|P5|COMPLETED|Overall Study||74
7803796|NCT01193920|19210180|P4|COMPLETED|Overall Study||76
7803797|NCT01193920|19210181|P3|COMPLETED|Overall Study||74
7803798|NCT01193920|19210182|P2|COMPLETED|Overall Study||20
7803799|NCT01193920|19210183|P1|COMPLETED|Overall Study||37
7803800|NCT01193920|19210174|P10|STARTED|Overall Study||81
7803801|NCT01193920|19210175|P9|STARTED|Overall Study||76
7803802|NCT01193920|19210176|P8|STARTED|Overall Study||80
7803803|NCT01193920|19210177|P7|STARTED|Overall Study||80
7803804|NCT01193920|19210178|P6|STARTED|Overall Study||80
7803805|NCT01193920|19210179|P5|STARTED|Overall Study||80
7803806|NCT01193920|19210180|P4|STARTED|Overall Study||80
7803807|NCT01193920|19210181|P3|STARTED|Overall Study||80
7803808|NCT01193920|19210182|P2|STARTED|Overall Study||20
7803809|NCT01193920|19210183|P1|STARTED|Overall Study||40
7803810|NCT01193907|19210237|P4|NOT COMPLETED|Overall Study||1
7803811|NCT01193907|19210238|P3|NOT COMPLETED|Overall Study||0
7803812|NCT01193907|19210239|P2|NOT COMPLETED|Overall Study||0
7803813|NCT01193907|19210240|P1|NOT COMPLETED|Overall Study||1
7803814|NCT01193907|19210237|P4|COMPLETED|Overall Study||21
7803815|NCT01193907|19210238|P3|COMPLETED|Overall Study||22
7803816|NCT01193907|19210239|P2|COMPLETED|Overall Study||22
7803817|NCT01193907|19210240|P1|COMPLETED|Overall Study||21
7803818|NCT01193907|19210237|P4|STARTED|Overall Study||22
7803819|NCT01193907|19210238|P3|STARTED|Overall Study||22
7803820|NCT01193907|19210239|P2|STARTED|Overall Study||22
7803821|NCT01193907|19210240|P1|STARTED|Overall Study||22
7803822|NCT01193868|19210262|P1|NOT COMPLETED|Overall Study||0
7803823|NCT01193868|19210262|P1|COMPLETED|Overall Study||6
7803824|NCT01193868|19210262|P1|STARTED|Overall Study||6
7803825|NCT01193842|19210279|P5|NOT COMPLETED|Phase II: Randomized Groups||10
7803826|NCT01193842|19210280|P4|NOT COMPLETED|Phase II: Randomized Groups||12
7803827|NCT01193842|19210281|P3|NOT COMPLETED|Phase II: Randomized Groups||0
7803828|NCT01193842|19210282|P2|NOT COMPLETED|Phase II: Randomized Groups||0
7803829|NCT01193842|19210283|P1|NOT COMPLETED|Phase II: Randomized Groups||0
7803830|NCT01193842|19210279|P5|COMPLETED|Phase II: Randomized Groups||36
7803831|NCT01193842|19210280|P4|COMPLETED|Phase II: Randomized Groups||33
7803832|NCT01193842|19210281|P3|COMPLETED|Phase II: Randomized Groups||0
7803833|NCT01193842|19210282|P2|COMPLETED|Phase II: Randomized Groups||0
7803834|NCT01193842|19210283|P1|COMPLETED|Phase II: Randomized Groups||0
7803835|NCT01193842|19210279|P5|STARTED|Phase II: Randomized Groups||46
7803836|NCT01193842|19210280|P4|STARTED|Phase II: Randomized Groups||45
7803837|NCT01193842|19210281|P3|STARTED|Phase II: Randomized Groups||0
7803838|NCT01193842|19210282|P2|STARTED|Phase II: Randomized Groups||0
7803839|NCT01193842|19210283|P1|STARTED|Phase II: Randomized Groups||0
7803840|NCT01193842|19210279|P5|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
7803841|NCT01193842|19210280|P4|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
7803842|NCT01193842|19210281|P3|NOT COMPLETED|Phase I: VR-CHOP, DL 1||1
7803843|NCT01193842|19210282|P2|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
7803844|NCT01193842|19210283|P1|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
7803845|NCT01193842|19210279|P5|COMPLETED|Phase I: VR-CHOP, DL 1||0
7803846|NCT01193842|19210280|P4|COMPLETED|Phase I: VR-CHOP, DL 1||0
7803847|NCT01193842|19210281|P3|COMPLETED|Phase I: VR-CHOP, DL 1||1
7803848|NCT01193842|19210282|P2|COMPLETED|Phase I: VR-CHOP, DL 1||0
7803849|NCT01193842|19210283|P1|COMPLETED|Phase I: VR-CHOP, DL 1||0
7803850|NCT01193842|19210279|P5|STARTED|Phase I: VR-CHOP, DL 1||0
7803851|NCT01193842|19210280|P4|STARTED|Phase I: VR-CHOP, DL 1||0
7803852|NCT01193842|19210281|P3|STARTED|Phase I: VR-CHOP, DL 1||2
7803853|NCT01193842|19210282|P2|STARTED|Phase I: VR-CHOP, DL 1||0
7803854|NCT01193842|19210283|P1|STARTED|Phase I: VR-CHOP, DL 1||0
7803855|NCT01193842|19210279|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
7803856|NCT01193842|19210280|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
7803857|NCT01193842|19210281|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
7803858|NCT01193842|19210282|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
7803859|NCT01193842|19210283|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||1
7803860|NCT01193842|19210279|P5|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
7803861|NCT01193842|19210280|P4|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
7803862|NCT01193842|19210281|P3|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
7803863|NCT01193842|19210282|P2|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
7803864|NCT01193842|19210283|P1|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||3
7803865|NCT01193842|19210279|P5|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
7803866|NCT01193842|19210280|P4|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
7803867|NCT01193842|19210281|P3|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
7803868|NCT01193842|19210282|P2|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
7803869|NCT01193842|19210283|P1|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||4
7803870|NCT01193842|19210279|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
7803871|NCT01193842|19210280|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
7803872|NCT01193842|19210281|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
7803873|NCT01193842|19210282|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||1
7803874|NCT01193842|19210283|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
7803875|NCT01193842|19210279|P5|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
7803876|NCT01193842|19210280|P4|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
7803877|NCT01193842|19210281|P3|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
7803878|NCT01193842|19210282|P2|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||6
7803879|NCT01193842|19210283|P1|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
7803880|NCT01193842|19210279|P5|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
7803881|NCT01193842|19210280|P4|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
7803882|NCT01193842|19210281|P3|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
7803883|NCT01193842|19210282|P2|STARTED|Phase I: VR-DA-EPOCH, DL 2||7
7803884|NCT01193842|19210283|P1|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
7803885|NCT01193842|19210279|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
7803886|NCT01193842|19210280|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
7803887|NCT01193842|19210281|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
7803888|NCT01193842|19210282|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
7803889|NCT01193842|19210283|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
7803890|NCT01193842|19210279|P5|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
7803891|NCT01193842|19210280|P4|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
7803892|NCT01193842|19210281|P3|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
7803893|NCT01193842|19210282|P2|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
7803894|NCT01193842|19210283|P1|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
7803895|NCT01193842|19210279|P5|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
7803896|NCT01193842|19210280|P4|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
7803897|NCT01193842|19210281|P3|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
7803898|NCT01193842|19210282|P2|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
7803899|NCT01193842|19210283|P1|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
7803900|NCT01193686|19210318|P2|NOT COMPLETED|Overall Study||1
7803901|NCT01193686|19210319|P1|NOT COMPLETED|Overall Study||7
7803902|NCT01193686|19210318|P2|COMPLETED|Overall Study||8
7803903|NCT01193686|19210319|P1|COMPLETED|Overall Study||8
7803904|NCT01193686|19210318|P2|Completed Visits and Final Assessment|Overall Study||8
7803905|NCT01193686|19210319|P1|Completed Visits and Final Assessment|Overall Study||8
7803906|NCT01193686|19210318|P2|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0
7803907|NCT01193686|19210319|P1|Completed Mentor Training|Overall Study||9
7803908|NCT01193686|19210318|P2|Completed Baseline Assessment|Overall Study||9
7803909|NCT01193686|19210319|P1|Completed Baseline Assessment|Overall Study||15
7803910|NCT01193686|19210318|P2|STARTED|Overall Study||9
7803911|NCT01193686|19210319|P1|STARTED|Overall Study||15
7803912|NCT01193660|19210336|P3|NOT COMPLETED|Overall Study||2
7803913|NCT01193660|19210337|P2|NOT COMPLETED|Overall Study||3
7803914|NCT01193660|19210338|P1|NOT COMPLETED|Overall Study||4
7803915|NCT01193660|19210336|P3|COMPLETED|Overall Study||32
7803916|NCT01193660|19210337|P2|COMPLETED|Overall Study||33
7803917|NCT01193660|19210338|P1|COMPLETED|Overall Study||31
7803918|NCT01193660|19210336|P3|STARTED|Overall Study||34
7803919|NCT01193660|19210337|P2|STARTED|Overall Study||36
7803920|NCT01193660|19210338|P1|STARTED|Overall Study||35
7803921|NCT01193608|19210382|P6|NOT COMPLETED|Overall Study||2
7803922|NCT01193608|19210383|P5|NOT COMPLETED|Overall Study||5
7803923|NCT01193608|19210384|P4|NOT COMPLETED|Overall Study||3
7803924|NCT01193608|19210385|P3|NOT COMPLETED|Overall Study||2
7803925|NCT01193608|19210386|P2|NOT COMPLETED|Overall Study||2
7803926|NCT01193608|19210387|P1|NOT COMPLETED|Overall Study||0
7803927|NCT01193608|19210382|P6|COMPLETED|Overall Study||17
7803928|NCT01193608|19210383|P5|COMPLETED|Overall Study||19
7803929|NCT01193608|19210384|P4|COMPLETED|Overall Study||14
7803930|NCT01193608|19210385|P3|COMPLETED|Overall Study||14
7803931|NCT01193608|19210386|P2|COMPLETED|Overall Study||4
7803932|NCT01193608|19210387|P1|COMPLETED|Overall Study||6
7803933|NCT01193608|19210382|P6|STARTED|Overall Study||19
7803934|NCT01193608|19210383|P5|STARTED|Overall Study||24
7803935|NCT01193608|19210384|P4|STARTED|Overall Study||17
7803936|NCT01193608|19210385|P3|STARTED|Overall Study||16
7803937|NCT01193608|19210386|P2|STARTED|Overall Study||6
7803938|NCT01193608|19210387|P1|STARTED|Overall Study||6
7803939|NCT01193582|19210624|P4|NOT COMPLETED|12 Month Follow-up||11
7803940|NCT01193582|19210625|P3|NOT COMPLETED|12 Month Follow-up||4
7803941|NCT01193582|19210626|P2|NOT COMPLETED|12 Month Follow-up||0
7803942|NCT01193582|19210627|P1|NOT COMPLETED|12 Month Follow-up||6
7803943|NCT01193582|19210624|P4|COMPLETED|12 Month Follow-up||166
7803944|NCT01193582|19210625|P3|COMPLETED|12 Month Follow-up||113
7803945|NCT01193582|19210626|P2|COMPLETED|12 Month Follow-up||88
7803946|NCT01193582|19210627|P1|COMPLETED|12 Month Follow-up||83
7803947|NCT01193582|19210624|P4|STARTED|12 Month Follow-up||177
7803948|NCT01193582|19210625|P3|STARTED|12 Month Follow-up||117
7803949|NCT01193582|19210626|P2|STARTED|12 Month Follow-up||88
7803950|NCT01193582|19210627|P1|STARTED|12 Month Follow-up||89
7803951|NCT01193582|19210624|P4|NOT COMPLETED|Vaccination Series||3
7803952|NCT01193582|19210625|P3|NOT COMPLETED|Vaccination Series||8
7803953|NCT01193582|19210626|P2|NOT COMPLETED|Vaccination Series||13
7803954|NCT01193582|19210627|P1|NOT COMPLETED|Vaccination Series||11
7803955|NCT01193582|19210624|P4|COMPLETED|Vaccination Series||177
7803956|NCT01193582|19210625|P3|COMPLETED|Vaccination Series||117
7803957|NCT01193582|19210626|P2|COMPLETED|Vaccination Series||88
7803958|NCT01193582|19210627|P1|COMPLETED|Vaccination Series||89
7803959|NCT01193582|19210624|P4|Vaccinated Dose 4|Vaccination Series||0
7803960|NCT01193582|19210625|P3|Vaccinated Dose 4|Vaccination Series||0
7803961|NCT01193582|19210626|P2|Vaccinated Dose 4|Vaccination Series||0
7803962|NCT01193582|19210627|P1|Vaccinated Dose 4|Vaccination Series||90
7803963|NCT01193582|19210624|P4|Vaccinated Dose 3|Vaccination Series||0
7803964|NCT01193582|19210625|P3|Vaccinated Dose 3|Vaccination Series||0
7803965|NCT01193582|19210626|P2|Vaccinated Dose 3|Vaccination Series||89
7803966|NCT01193582|19210627|P1|Vaccinated Dose 3|Vaccination Series||90
7803967|NCT01193582|19210624|P4|Vaccinated Dose 2|Vaccination Series||0
7803968|NCT01193582|19210625|P3|Vaccinated Dose 2|Vaccination Series||118
7803969|NCT01193582|19210626|P2|Vaccinated Dose 2|Vaccination Series||91
7803970|NCT01193582|19210627|P1|Vaccinated Dose 2|Vaccination Series||92
7803971|NCT01193582|19210624|P4|Vaccinated Dose 1|Vaccination Series||180
7803972|NCT01193582|19210625|P3|Vaccinated Dose 1|Vaccination Series||125
7803973|NCT01193582|19210626|P2|Vaccinated Dose 1|Vaccination Series||100
7803974|NCT01193582|19210627|P1|Vaccinated Dose 1|Vaccination Series||100
7803975|NCT01193582|19210624|P4|STARTED|Vaccination Series||180
7803976|NCT01193582|19210625|P3|STARTED|Vaccination Series||125
7803977|NCT01193582|19210626|P2|STARTED|Vaccination Series||101
7803978|NCT01193582|19210627|P1|STARTED|Vaccination Series||100
7803979|NCT01193556|19210657|P2|NOT COMPLETED|Overall Study||25
7803980|NCT01193556|19210658|P1|NOT COMPLETED|Overall Study||26
7803981|NCT01193556|19210657|P2|COMPLETED|Overall Study||0
7803982|NCT01193556|19210658|P1|COMPLETED|Overall Study||0
7803983|NCT01193556|19210657|P2|STARTED|Overall Study||25
7803984|NCT01193556|19210658|P1|STARTED|Overall Study||26
7803985|NCT01193530|19210668|P2|NOT COMPLETED|Overall Study||5
7803986|NCT01193530|19210669|P1|NOT COMPLETED|Overall Study||3
7803987|NCT01193530|19210668|P2|COMPLETED|Overall Study||3
7803988|NCT01193530|19210669|P1|COMPLETED|Overall Study||1
7803989|NCT01193530|19210668|P2|STARTED|Overall Study||8
7803990|NCT01193530|19210669|P1|STARTED|Overall Study||4
7803991|NCT01193517|19210678|P3|NOT COMPLETED|Overall Study||0
7803992|NCT01193517|19210679|P2|NOT COMPLETED|Overall Study||0
7803993|NCT01193517|19210680|P1|NOT COMPLETED|Overall Study||1
7803994|NCT01193517|19210678|P3|COMPLETED|Overall Study||11
7803995|NCT01193517|19210679|P2|COMPLETED|Overall Study||12
7803996|NCT01193517|19210680|P1|COMPLETED|Overall Study||2
7803997|NCT01193517|19210678|P3|STARTED|Overall Study||11
7803998|NCT01193517|19210679|P2|STARTED|Overall Study||12
7803999|NCT01193517|19210680|P1|STARTED|Overall Study||3
7804000|NCT01193348|19210689|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2
7804001|NCT01193348|19210689|P1|COMPLETED|Post Treatment Period (Patients Who Disc||8
7804002|NCT01193348|19210689|P1|STARTED|Post Treatment Period (Patients Who Disc||10
7804003|NCT01193348|19210689|P1|NOT COMPLETED|Extension Treatment Period||1
7804004|NCT01193348|19210689|P1|COMPLETED|Extension Treatment Period||16
7804005|NCT01193348|19210689|P1|STARTED|Extension Treatment Period||17
7804006|NCT01193348|19210689|P1|NOT COMPLETED|Treatment Period (26 Weeks)||3
7804007|NCT01193348|19210689|P1|COMPLETED|Treatment Period (26 Weeks)||19
7804008|NCT01193348|19210689|P1|STARTED|Treatment Period (26 Weeks)||22
7804009|NCT01193348|19210689|P1|NOT COMPLETED|Screening Period||5
7804010|NCT01193348|19210689|P1|COMPLETED|Screening Period||22
7804011|NCT01193348|19210689|P1|STARTED|Screening Period||27
7804012|NCT01193335|19210709|P2|NOT COMPLETED|2-Year Follow-up||8
7804013|NCT01193335|19210710|P1|NOT COMPLETED|2-Year Follow-up||7
7804014|NCT01193335|19210709|P2|COMPLETED|2-Year Follow-up||80
7804015|NCT01193335|19210710|P1|COMPLETED|2-Year Follow-up||81
7804016|NCT01193335|19210709|P2|STARTED|2-Year Follow-up||88
7804017|NCT01193335|19210710|P1|STARTED|2-Year Follow-up||88
7804018|NCT01193335|19210709|P2|NOT COMPLETED|1-Year Follow-up||9
7804019|NCT01193335|19210710|P1|NOT COMPLETED|1-Year Follow-up||11
7804020|NCT01193335|19210709|P2|COMPLETED|1-Year Follow-up||88
7804021|NCT01193335|19210710|P1|COMPLETED|1-Year Follow-up||88
7804022|NCT01193335|19210709|P2|STARTED|1-Year Follow-up||97
7804023|NCT01193335|19210710|P1|STARTED|1-Year Follow-up||99
7804024|NCT01193335|19210709|P2|NOT COMPLETED|Toddler Dose||0
7804025|NCT01193335|19210710|P1|NOT COMPLETED|Toddler Dose||0
7804026|NCT01193335|19210709|P2|COMPLETED|Toddler Dose||97
7804027|NCT01193335|19210710|P1|COMPLETED|Toddler Dose||99
7804028|NCT01193335|19210709|P2|STARTED|Toddler Dose||97
7804029|NCT01193335|19210710|P1|STARTED|Toddler Dose||99
7804030|NCT01193335|19210709|P2|NOT COMPLETED|After Infant Series||3
7804031|NCT01193335|19210710|P1|NOT COMPLETED|After Infant Series||1
7804032|NCT01193335|19210709|P2|COMPLETED|After Infant Series||97
7804033|NCT01193335|19210710|P1|COMPLETED|After Infant Series||99
7804034|NCT01193335|19210709|P2|STARTED|After Infant Series||100
7804035|NCT01193335|19210710|P1|STARTED|After Infant Series||100
7804036|NCT01193335|19210709|P2|NOT COMPLETED|Infant Series||0
7804037|NCT01193335|19210710|P1|NOT COMPLETED|Infant Series||0
7804038|NCT01193335|19210709|P2|COMPLETED|Infant Series||100
7804039|NCT01193335|19210710|P1|COMPLETED|Infant Series||100
7804040|NCT01193335|19210709|P2|STARTED|Infant Series||100
7804041|NCT01193335|19210710|P1|STARTED|Infant Series||100
7804042|NCT01193283|19210805|P1|NOT COMPLETED|Overall Study||1
7804043|NCT01193283|19210805|P1|COMPLETED|Overall Study||21
7804044|NCT01193283|19210805|P1|STARTED|Overall Study||22
7804045|NCT01193257|19210811|P2|NOT COMPLETED|Overall Study||734
7804046|NCT01193257|19210812|P1|NOT COMPLETED|Overall Study||365
7804047|NCT01193257|19210811|P2|COMPLETED|Overall Study||0
7804048|NCT01193257|19210812|P1|COMPLETED|Overall Study||0
7804049|NCT01193257|19210811|P2|Treated|Overall Study||732
7804050|NCT01193257|19210812|P1|Treated|Overall Study||363
7804051|NCT01193257|19210811|P2|STARTED|Overall Study||734
7804052|NCT01193257|19210812|P1|STARTED|Overall Study||365
7804053|NCT01193244|19210862|P2|NOT COMPLETED|Overall Study||390
7804054|NCT01193244|19210863|P1|NOT COMPLETED|Overall Study||388
7804055|NCT01193244|19210862|P2|COMPLETED|Overall Study||391
7804056|NCT01193244|19210863|P1|COMPLETED|Overall Study||391
7804057|NCT01193244|19210862|P2|Treated|Overall Study|Participants randomized to receive Placebo but crossed-over to receive Orteronel after unblinding.|784
7804058|NCT01193244|19210863|P1|Treated|Overall Study|Participants who continued to receive Placebo after unblinding.|770
7804059|NCT01193244|19210862|P2|STARTED|Overall Study||781
7804060|NCT01193244|19210863|P1|STARTED|Overall Study||779
7804061|NCT01193218|19210918|P8|NOT COMPLETED|12-52 Weeks||4
7804062|NCT01193218|19210919|P7|NOT COMPLETED|12-52 Weeks||3
7804063|NCT01193218|19210920|P6|NOT COMPLETED|12-52 Weeks||5
7804064|NCT01193218|19210921|P5|NOT COMPLETED|12-52 Weeks||4
7804065|NCT01193218|19210922|P4|NOT COMPLETED|12-52 Weeks||3
7804066|NCT01193218|19210923|P3|NOT COMPLETED|12-52 Weeks||4
7804067|NCT01193218|19210924|P2|NOT COMPLETED|12-52 Weeks||0
7804068|NCT01193218|19210925|P1|NOT COMPLETED|12-52 Weeks||5
7804069|NCT01193218|19210918|P8|COMPLETED|12-52 Weeks||49
7804070|NCT01193218|19210919|P7|COMPLETED|12-52 Weeks||51
7804071|NCT01193218|19210920|P6|COMPLETED|12-52 Weeks||101
7804072|NCT01193218|19210921|P5|COMPLETED|12-52 Weeks||104
7804073|NCT01193218|19210922|P4|COMPLETED|12-52 Weeks||50
7804074|NCT01193218|19210923|P3|COMPLETED|12-52 Weeks||50
7804075|NCT01193218|19210924|P2|COMPLETED|12-52 Weeks||50
7804076|NCT01193218|19210925|P1|COMPLETED|12-52 Weeks||45
7804077|NCT01193218|19210918|P8|STARTED|12-52 Weeks||53
7804078|NCT01193218|19210919|P7|STARTED|12-52 Weeks||54
7804079|NCT01193218|19210920|P6|STARTED|12-52 Weeks||106
7804080|NCT01193218|19210921|P5|STARTED|12-52 Weeks||108
7804081|NCT01193218|19210922|P4|STARTED|12-52 Weeks||53
7804082|NCT01193218|19210923|P3|STARTED|12-52 Weeks||54
7804083|NCT01193218|19210924|P2|STARTED|12-52 Weeks||50
7804084|NCT01193218|19210925|P1|STARTED|12-52 Weeks||50
7804085|NCT01193218|19210918|P8|NOT COMPLETED|0-12 Weeks||0
7804086|NCT01193218|19210919|P7|NOT COMPLETED|0-12 Weeks||3
7804087|NCT01193218|19210920|P6|NOT COMPLETED|0-12 Weeks||3
7804088|NCT01193218|19210921|P5|NOT COMPLETED|0-12 Weeks||1
7804089|NCT01193218|19210922|P4|NOT COMPLETED|0-12 Weeks||0
7804090|NCT01193218|19210923|P3|NOT COMPLETED|0-12 Weeks||3
7804091|NCT01193218|19210924|P2|NOT COMPLETED|0-12 Weeks||0
7804092|NCT01193218|19210925|P1|NOT COMPLETED|0-12 Weeks||9
7804093|NCT01193218|19210918|P8|COMPLETED|0-12 Weeks||0
7804094|NCT01193218|19210919|P7|COMPLETED|0-12 Weeks||107
7804095|NCT01193218|19210920|P6|COMPLETED|0-12 Weeks||106
7804096|NCT01193218|19210921|P5|COMPLETED|0-12 Weeks||108
7804097|NCT01193218|19210922|P4|COMPLETED|0-12 Weeks||0
7804098|NCT01193218|19210923|P3|COMPLETED|0-12 Weeks||107
7804099|NCT01193218|19210924|P2|COMPLETED|0-12 Weeks||0
7804100|NCT01193218|19210925|P1|COMPLETED|0-12 Weeks||100
7804101|NCT01193218|19210918|P8|STARTED|0-12 Weeks|It is actually N/A|0
7804102|NCT01193218|19210919|P7|STARTED|0-12 Weeks|It is actually empa 50mg group|110
7804103|NCT01193218|19210920|P6|STARTED|0-12 Weeks||109
7804104|NCT01193218|19210921|P5|STARTED|0-12 Weeks||109
7804105|NCT01193218|19210922|P4|STARTED|0-12 Weeks|It is actually N/A|0
7804106|NCT01193218|19210923|P3|STARTED|0-12 Weeks|It is actually empa 5mg group|110
7804107|NCT01193218|19210924|P2|STARTED|0-12 Weeks|It is actually N/A|0
7804108|NCT01193218|19210925|P1|STARTED|0-12 Weeks|It is actually placebo group|109
7804109|NCT01193153|19210956|P2|NOT COMPLETED|Double Blind Relapse Prevention Period||105
7804110|NCT01193153|19210957|P1|NOT COMPLETED|Double Blind Relapse Prevention Period||64
7804111|NCT01193153|19210956|P2|COMPLETED|Double Blind Relapse Prevention Period||65
7804112|NCT01193153|19210957|P1|COMPLETED|Double Blind Relapse Prevention Period||100
7804113|NCT01193153|19210956|P2|STARTED|Double Blind Relapse Prevention Period||170
7804114|NCT01193153|19210957|P1|STARTED|Double Blind Relapse Prevention Period||164
7804115|NCT01193153|19210956|P2|NOT COMPLETED|Open-label Stabilization Period||0
7804116|NCT01193153|19210957|P1|NOT COMPLETED|Open-label Stabilization Period||98
7804117|NCT01193153|19210956|P2|COMPLETED|Open-label Stabilization Period||0
7804118|NCT01193153|19210957|P1|COMPLETED|Open-label Stabilization Period||334
7804119|NCT01193153|19210956|P2|STARTED|Open-label Stabilization Period||0
7804120|NCT01193153|19210957|P1|STARTED|Open-label Stabilization Period||432
7804121|NCT01193153|19210956|P2|NOT COMPLETED|Open-label Lead in Period||0
7804122|NCT01193153|19210957|P1|NOT COMPLETED|Open-label Lead in Period||235
7804123|NCT01193153|19210956|P2|COMPLETED|Open-label Lead in Period||0
7804124|NCT01193153|19210957|P1|COMPLETED|Open-label Lead in Period||432
7804125|NCT01193153|19210956|P2|STARTED|Open-label Lead in Period||0
7804126|NCT01193153|19210957|P1|STARTED|Open-label Lead in Period||667
7804127|NCT01193127|19210992|P4|NOT COMPLETED|Treated||1
7804128|NCT01193127|19210993|P3|NOT COMPLETED|Treated||0
7804129|NCT01193127|19210994|P2|NOT COMPLETED|Treated||0
7804130|NCT01193127|19210995|P1|NOT COMPLETED|Treated||0
7804131|NCT01193127|19210992|P4|COMPLETED|Treated||55
7804132|NCT01193127|19210993|P3|COMPLETED|Treated||55
7804133|NCT01193127|19210994|P2|COMPLETED|Treated||54
7804134|NCT01193127|19210995|P1|COMPLETED|Treated||57
7804135|NCT01193127|19210992|P4|STARTED|Treated||56
7804136|NCT01193127|19210993|P3|STARTED|Treated||55
7804137|NCT01193127|19210994|P2|STARTED|Treated||54
7804138|NCT01193127|19210995|P1|STARTED|Treated||57
7804139|NCT01193127|19210992|P4|NOT COMPLETED|Randomized||1
7804140|NCT01193127|19210993|P3|NOT COMPLETED|Randomized||0
7804141|NCT01193127|19210994|P2|NOT COMPLETED|Randomized||0
7804142|NCT01193127|19210995|P1|NOT COMPLETED|Randomized||0
7804143|NCT01193127|19210992|P4|COMPLETED|Randomized||56
7804144|NCT01193127|19210993|P3|COMPLETED|Randomized||55
7804145|NCT01193127|19210994|P2|COMPLETED|Randomized||54
7804146|NCT01193127|19210995|P1|COMPLETED|Randomized||57
7804147|NCT01193127|19210992|P4|STARTED|Randomized||57
7804148|NCT01193127|19210993|P3|STARTED|Randomized||55
7804149|NCT01193127|19210994|P2|STARTED|Randomized||54
7804150|NCT01193127|19210995|P1|STARTED|Randomized||57
7804151|NCT01193114|19211299|P2|NOT COMPLETED|Overall Study||0
7804152|NCT01193114|19211300|P1|NOT COMPLETED|Overall Study||0
7804153|NCT01193114|19211299|P2|COMPLETED|Overall Study||30
7804154|NCT01193114|19211300|P1|COMPLETED|Overall Study||30
7804155|NCT01193114|19211299|P2|STARTED|Overall Study||30
7804156|NCT01193114|19211300|P1|STARTED|Overall Study||30
7804157|NCT01193101|19211320|P4|NOT COMPLETED|Overall Study||12
7804158|NCT01193101|19211321|P3|NOT COMPLETED|Overall Study||3
7804159|NCT01193101|19211322|P2|NOT COMPLETED|Overall Study||7
7804160|NCT01193101|19211323|P1|NOT COMPLETED|Overall Study||5
7804161|NCT01193101|19211320|P4|COMPLETED|Overall Study||80
7804162|NCT01193101|19211321|P3|COMPLETED|Overall Study||93
7804163|NCT01193101|19211322|P2|COMPLETED|Overall Study||94
7804164|NCT01193101|19211323|P1|COMPLETED|Overall Study||95
7804165|NCT01193101|19211320|P4|Placebo Withdrawal Set|Overall Study||80
7804166|NCT01193101|19211321|P3|Placebo Withdrawal Set|Overall Study||93
7804167|NCT01193101|19211322|P2|Placebo Withdrawal Set|Overall Study||94
7804168|NCT01193101|19211323|P1|Placebo Withdrawal Set|Overall Study||95
7804169|NCT01193101|19211320|P4|Full Analysis Set|Overall Study||92
7804170|NCT01193101|19211321|P3|Full Analysis Set|Overall Study||96
7804171|NCT01193101|19211322|P2|Full Analysis Set|Overall Study||101
7804172|NCT01193101|19211323|P1|Full Analysis Set|Overall Study||100
7804173|NCT01193101|19211320|P4|STARTED|Overall Study||92
7804174|NCT01193101|19211321|P3|STARTED|Overall Study||96
7804175|NCT01193101|19211322|P2|STARTED|Overall Study||101
7804176|NCT01193101|19211323|P1|STARTED|Overall Study||100
7804177|NCT01193049|19211379|P2|NOT COMPLETED|Period 3 : Double Blind Crossover||0
7804178|NCT01193049|19211380|P1|NOT COMPLETED|Period 3 : Double Blind Crossover||0
7804179|NCT01193049|19211379|P2|COMPLETED|Period 3 : Double Blind Crossover||6
7804180|NCT01193049|19211380|P1|COMPLETED|Period 3 : Double Blind Crossover||5
7804181|NCT01193049|19211379|P2|STARTED|Period 3 : Double Blind Crossover||6
7804182|NCT01193049|19211380|P1|STARTED|Period 3 : Double Blind Crossover||5
7804183|NCT01193049|19211379|P2|NOT COMPLETED|Washout 2 : 21 Day Washout||0
7804184|NCT01193049|19211380|P1|NOT COMPLETED|Washout 2 : 21 Day Washout||0
7804185|NCT01193049|19211379|P2|COMPLETED|Washout 2 : 21 Day Washout||6
7804186|NCT01193049|19211380|P1|COMPLETED|Washout 2 : 21 Day Washout||5
7804187|NCT01193049|19211379|P2|STARTED|Washout 2 : 21 Day Washout||6
7804188|NCT01193049|19211380|P1|STARTED|Washout 2 : 21 Day Washout||5
7804189|NCT01193049|19211379|P2|NOT COMPLETED|Period 2 : Double Blind Crossover||0
7804190|NCT01193049|19211380|P1|NOT COMPLETED|Period 2 : Double Blind Crossover||0
7804191|NCT01193049|19211379|P2|COMPLETED|Period 2 : Double Blind Crossover||6
7804192|NCT01193049|19211380|P1|COMPLETED|Period 2 : Double Blind Crossover||5
7804193|NCT01193049|19211379|P2|STARTED|Period 2 : Double Blind Crossover||6
7804194|NCT01193049|19211380|P1|STARTED|Period 2 : Double Blind Crossover||5
7804195|NCT01193049|19211379|P2|NOT COMPLETED|Washout 1 : 21 Day Washout||0
7804196|NCT01193049|19211380|P1|NOT COMPLETED|Washout 1 : 21 Day Washout||0
7804197|NCT01193049|19211379|P2|COMPLETED|Washout 1 : 21 Day Washout||6
7804198|NCT01193049|19211380|P1|COMPLETED|Washout 1 : 21 Day Washout||5
7804199|NCT01193049|19211379|P2|STARTED|Washout 1 : 21 Day Washout||6
7804200|NCT01193049|19211380|P1|STARTED|Washout 1 : 21 Day Washout||5
7804201|NCT01193049|19211379|P2|NOT COMPLETED|Period 1: Placebo Run-In||0
7804202|NCT01193049|19211380|P1|NOT COMPLETED|Period 1: Placebo Run-In||0
7804203|NCT01193049|19211379|P2|COMPLETED|Period 1: Placebo Run-In||6
7804204|NCT01193049|19211380|P1|COMPLETED|Period 1: Placebo Run-In||5
7804205|NCT01193049|19211379|P2|STARTED|Period 1: Placebo Run-In||6
7804206|NCT01193049|19211380|P1|STARTED|Period 1: Placebo Run-In||5
7804207|NCT01193010|19211412|P2|NOT COMPLETED|Overall Study||0
7804208|NCT01193010|19211413|P1|NOT COMPLETED|Overall Study||3
7804209|NCT01193010|19211412|P2|COMPLETED|Overall Study||20
7804210|NCT01193010|19211413|P1|COMPLETED|Overall Study||17
7804211|NCT01193010|19211412|P2|STARTED|Overall Study||20
7804212|NCT01193010|19211413|P1|STARTED|Overall Study||20
7804213|NCT01192828|19211425|P1|NOT COMPLETED|Overall Study||0
7804214|NCT01192828|19211425|P1|COMPLETED|Overall Study||14
7804215|NCT01192828|19211425|P1|STARTED|Overall Study||14
7804216|NCT01192815|19211440|P1|NOT COMPLETED|Overall Study||2
7804217|NCT01192815|19211440|P1|COMPLETED|Overall Study||0
7804218|NCT01192815|19211440|P1|STARTED|Overall Study||2
7804219|NCT01192776|19211455|P4|NOT COMPLETED|Overall Study||20
7804220|NCT01192776|19211456|P3|NOT COMPLETED|Overall Study||21
7804221|NCT01192776|19211457|P2|NOT COMPLETED|Overall Study||21
7804222|NCT01192776|19211458|P1|NOT COMPLETED|Overall Study||11
7804223|NCT01192776|19211455|P4|COMPLETED|Overall Study||63
7804224|NCT01192776|19211456|P3|COMPLETED|Overall Study||75
7804225|NCT01192776|19211457|P2|COMPLETED|Overall Study||69
7804226|NCT01192776|19211458|P1|COMPLETED|Overall Study||84
7804227|NCT01192776|19211455|P4|Died After Discharge|Overall Study||1
7804228|NCT01192776|19211456|P3|Died After Discharge|Overall Study||3
7804229|NCT01192776|19211457|P2|Died After Discharge|Overall Study||2
7804230|NCT01192776|19211458|P1|Died After Discharge|Overall Study||1
7804231|NCT01192776|19211455|P4|Died Prior to Discharge|Overall Study||14
7804232|NCT01192776|19211456|P3|Died Prior to Discharge|Overall Study||15
7804233|NCT01192776|19211457|P2|Died Prior to Discharge|Overall Study||13
7804234|NCT01192776|19211458|P1|Died Prior to Discharge|Overall Study||7
7804235|NCT01192776|19211455|P4|STARTED|Overall Study||83
7804236|NCT01192776|19211456|P3|STARTED|Overall Study||96
7804237|NCT01192776|19211457|P2|STARTED|Overall Study||90
7804238|NCT01192776|19211458|P1|STARTED|Overall Study||95
7804239|NCT01192698|19211514|P2|NOT COMPLETED|Overall Study||0
7804240|NCT01192698|19211515|P1|NOT COMPLETED|Overall Study||0
7804241|NCT01192698|19211514|P2|COMPLETED|Overall Study||5
7804242|NCT01192698|19211515|P1|COMPLETED|Overall Study||10
7804243|NCT01192698|19211514|P2|STARTED|Overall Study||5
7804244|NCT01192698|19211515|P1|STARTED|Overall Study||10
7804245|NCT01192542|19211521|P2|NOT COMPLETED|Period 2||0
7804246|NCT01192542|19211522|P1|NOT COMPLETED|Period 2||0
7804247|NCT01192542|19211521|P2|COMPLETED|Period 2||20
7804248|NCT01192542|19211522|P1|COMPLETED|Period 2||18
7804249|NCT01192542|19211521|P2|STARTED|Period 2||20
7804250|NCT01192542|19211522|P1|STARTED|Period 2||18
7804251|NCT01192542|19211521|P2|NOT COMPLETED|Period 1||0
7804252|NCT01192542|19211522|P1|NOT COMPLETED|Period 1||0
7804253|NCT01192542|19211521|P2|COMPLETED|Period 1||20
7804254|NCT01192542|19211522|P1|COMPLETED|Period 1||18
7804255|NCT01192542|19211521|P2|STARTED|Period 1||20
7804256|NCT01192542|19211522|P1|STARTED|Period 1||18
7804257|NCT01192516|19211536|P3|NOT COMPLETED|Overall Study||8
7804258|NCT01192516|19211537|P2|NOT COMPLETED|Overall Study||17
7804259|NCT01192516|19211538|P1|NOT COMPLETED|Overall Study||20
7804260|NCT01192516|19211536|P3|COMPLETED|Overall Study||55
7804261|NCT01192516|19211537|P2|COMPLETED|Overall Study||49
7804262|NCT01192516|19211538|P1|COMPLETED|Overall Study||46
7804263|NCT01192516|19211536|P3|STARTED|Overall Study|Indicates number of people initially randomized to group|63
7804264|NCT01192516|19211537|P2|STARTED|Overall Study|Indicates number of people initially randomized to group|66
7804265|NCT01192516|19211538|P1|STARTED|Overall Study|Indicates number of people initially randomized to group|66
7804266|NCT01192412|19211572|P2|NOT COMPLETED|Overall Study||2
7804267|NCT01192412|19211573|P1|NOT COMPLETED|Overall Study||4
7804268|NCT01192412|19211572|P2|COMPLETED|Overall Study||488
7804269|NCT01192412|19211573|P1|COMPLETED|Overall Study||493
7804270|NCT01192412|19211572|P2|STARTED|Overall Study||490
7804271|NCT01192412|19211573|P1|STARTED|Overall Study||497
7804272|NCT01192399|19211581|P1|NOT COMPLETED|Overall Study||2
7804273|NCT01192399|19211581|P1|COMPLETED|Overall Study||27
7804274|NCT01192399|19211581|P1|STARTED|Overall Study||29
7804275|NCT01192347|19211591|P1|NOT COMPLETED|Overall Study||12
7804276|NCT01192347|19211591|P1|COMPLETED|Overall Study||163
7804277|NCT01192347|19211591|P1|STARTED|Overall Study||175
7804278|NCT01192295|19211614|P2|NOT COMPLETED|Overall Study||23
7804279|NCT01192295|19211615|P1|NOT COMPLETED|Overall Study||10
7804280|NCT01192295|19211614|P2|COMPLETED|Overall Study||105
7804281|NCT01192295|19211615|P1|COMPLETED|Overall Study||17
7804282|NCT01192295|19211614|P2|STARTED|Overall Study||128
7804283|NCT01192295|19211615|P1|STARTED|Overall Study||27
7804284|NCT01192282|19211636|P1|NOT COMPLETED|Overall Study||0
7804285|NCT01192282|19211636|P1|COMPLETED|Overall Study||156
7804286|NCT01192282|19211636|P1|STARTED|Overall Study||156
7804287|NCT01192204|19211653|P2|NOT COMPLETED|Overall Study||0
7804288|NCT01192204|19211654|P1|NOT COMPLETED|Overall Study||1
7804289|NCT01192204|19211653|P2|COMPLETED|Overall Study||18
7804290|NCT01192204|19211654|P1|COMPLETED|Overall Study||22
7804291|NCT01192204|19211653|P2|STARTED|Overall Study||18
7804292|NCT01192204|19211654|P1|STARTED|Overall Study||23
7804293|NCT01192191|19211666|P2|NOT COMPLETED|Overall Study||21
7804294|NCT01192191|19211667|P1|NOT COMPLETED|Overall Study||11
7804295|NCT01192191|19211666|P2|COMPLETED|Overall Study||106
7804296|NCT01192191|19211667|P1|COMPLETED|Overall Study||49
7804297|NCT01192191|19211666|P2|STARTED|Overall Study||127
7804298|NCT01192191|19211667|P1|STARTED|Overall Study||60
7804299|NCT01192178|19211693|P2|NOT COMPLETED|Overall Study||23
7804300|NCT01192178|19211694|P1|NOT COMPLETED|Overall Study||24
7804301|NCT01192178|19211693|P2|COMPLETED|Overall Study||145
7804302|NCT01192178|19211694|P1|COMPLETED|Overall Study||147
7804303|NCT01192178|19211693|P2|STARTED|Overall Study||168
7804304|NCT01192178|19211694|P1|STARTED|Overall Study||171
7804305|NCT01192152|19211714|P2|NOT COMPLETED|Period 3||0
7804306|NCT01192152|19211715|P1|NOT COMPLETED|Period 3||1
7804307|NCT01192152|19211714|P2|COMPLETED|Period 3||0
7804308|NCT01192152|19211715|P1|COMPLETED|Period 3||14
7804309|NCT01192152|19211714|P2|STARTED|Period 3||0
7804310|NCT01192152|19211715|P1|STARTED|Period 3||15
7804311|NCT01192152|19211714|P2|NOT COMPLETED|Period 2||0
7804312|NCT01192152|19211715|P1|NOT COMPLETED|Period 2||0
7804313|NCT01192152|19211714|P2|COMPLETED|Period 2||14
7804314|NCT01192152|19211715|P1|COMPLETED|Period 2||15
7804315|NCT01192152|19211714|P2|STARTED|Period 2||14
7804316|NCT01192152|19211715|P1|STARTED|Period 2||15
7804317|NCT01192152|19211714|P2|NOT COMPLETED|Period 1||1
7804318|NCT01192152|19211715|P1|NOT COMPLETED|Period 1||0
7804319|NCT01192152|19211714|P2|COMPLETED|Period 1||14
7804320|NCT01192152|19211715|P1|COMPLETED|Period 1||15
7804321|NCT01192152|19211714|P2|STARTED|Period 1||15
7804322|NCT01192152|19211715|P1|STARTED|Period 1||15
7804323|NCT01192139|19211816|P6|NOT COMPLETED|Period 3||0
7804324|NCT01192139|19211817|P5|NOT COMPLETED|Period 3||0
7804325|NCT01192139|19211818|P4|NOT COMPLETED|Period 3||0
7804326|NCT01192139|19211819|P3|NOT COMPLETED|Period 3||0
7804327|NCT01192139|19211820|P2|NOT COMPLETED|Period 3||0
7804328|NCT01192139|19211821|P1|NOT COMPLETED|Period 3||0
7804329|NCT01192139|19211816|P6|COMPLETED|Period 3||5
7804330|NCT01192139|19211817|P5|COMPLETED|Period 3||5
7804331|NCT01192139|19211818|P4|COMPLETED|Period 3||5
7804332|NCT01192139|19211819|P3|COMPLETED|Period 3||5
7804333|NCT01192139|19211820|P2|COMPLETED|Period 3||5
7804334|NCT01192139|19211821|P1|COMPLETED|Period 3||5
7804335|NCT01192139|19211816|P6|STARTED|Period 3||5
7804336|NCT01192139|19211817|P5|STARTED|Period 3||5
7804337|NCT01192139|19211818|P4|STARTED|Period 3||5
7804338|NCT01192139|19211819|P3|STARTED|Period 3||5
7804339|NCT01192139|19211820|P2|STARTED|Period 3||5
7804340|NCT01192139|19211821|P1|STARTED|Period 3||5
7804341|NCT01192139|19211816|P6|NOT COMPLETED|Period 2||0
7804342|NCT01192139|19211817|P5|NOT COMPLETED|Period 2||0
7804343|NCT01192139|19211818|P4|NOT COMPLETED|Period 2||0
7804344|NCT01192139|19211819|P3|NOT COMPLETED|Period 2||0
7804345|NCT01192139|19211820|P2|NOT COMPLETED|Period 2||0
7804346|NCT01192139|19211821|P1|NOT COMPLETED|Period 2||0
7804347|NCT01192139|19211816|P6|COMPLETED|Period 2||5
7804348|NCT01192139|19211817|P5|COMPLETED|Period 2||5
7804349|NCT01192139|19211818|P4|COMPLETED|Period 2||5
7804350|NCT01192139|19211819|P3|COMPLETED|Period 2||5
7804351|NCT01192139|19211820|P2|COMPLETED|Period 2||5
7804352|NCT01192139|19211821|P1|COMPLETED|Period 2||5
7804353|NCT01192139|19211816|P6|STARTED|Period 2||5
7804354|NCT01192139|19211817|P5|STARTED|Period 2||5
7804355|NCT01192139|19211818|P4|STARTED|Period 2||5
7804356|NCT01192139|19211819|P3|STARTED|Period 2||5
7804357|NCT01192139|19211820|P2|STARTED|Period 2||5
7804358|NCT01192139|19211821|P1|STARTED|Period 2||5
7804359|NCT01192139|19211816|P6|NOT COMPLETED|Period 1||0
7804360|NCT01192139|19211817|P5|NOT COMPLETED|Period 1||0
7804361|NCT01192139|19211818|P4|NOT COMPLETED|Period 1||0
7804362|NCT01192139|19211819|P3|NOT COMPLETED|Period 1||0
7804363|NCT01192139|19211820|P2|NOT COMPLETED|Period 1||0
7804364|NCT01192139|19211821|P1|NOT COMPLETED|Period 1||0
7804365|NCT01192139|19211816|P6|COMPLETED|Period 1||5
7804366|NCT01192139|19211817|P5|COMPLETED|Period 1||5
7804367|NCT01192139|19211818|P4|COMPLETED|Period 1||5
7804368|NCT01192139|19211819|P3|COMPLETED|Period 1||5
7804369|NCT01192139|19211820|P2|COMPLETED|Period 1||5
7804370|NCT01192139|19211821|P1|COMPLETED|Period 1||5
7804371|NCT01192139|19211816|P6|STARTED|Period 1||5
7804372|NCT01192139|19211817|P5|STARTED|Period 1||5
7804373|NCT01192139|19211818|P4|STARTED|Period 1||5
7804374|NCT01192139|19211819|P3|STARTED|Period 1||5
7804375|NCT01192139|19211820|P2|STARTED|Period 1||5
7804376|NCT01192139|19211821|P1|STARTED|Period 1||5
7804377|NCT01192126|19211886|P2|NOT COMPLETED|Second Intervention (1 Week)||0
7804378|NCT01192126|19211887|P1|NOT COMPLETED|Second Intervention (1 Week)||0
7804379|NCT01192126|19211886|P2|COMPLETED|Second Intervention (1 Week)||50
7804380|NCT01192126|19211887|P1|COMPLETED|Second Intervention (1 Week)||49
7804381|NCT01192126|19211886|P2|STARTED|Second Intervention (1 Week)||50
7804382|NCT01192126|19211887|P1|STARTED|Second Intervention (1 Week)||49
7804383|NCT01192126|19211886|P2|NOT COMPLETED|First Intervention (1 Week)||1
7804384|NCT01192126|19211887|P1|NOT COMPLETED|First Intervention (1 Week)||2
7804385|NCT01192126|19211886|P2|COMPLETED|First Intervention (1 Week)||50
7804386|NCT01192126|19211887|P1|COMPLETED|First Intervention (1 Week)||49
7804387|NCT01192126|19211886|P2|STARTED|First Intervention (1 Week)||51
7804388|NCT01192126|19211887|P1|STARTED|First Intervention (1 Week)||51
7804389|NCT01192100|19211895|P6|NOT COMPLETED|Overall Study||0
7804390|NCT01192100|19211896|P5|NOT COMPLETED|Overall Study||1
7804391|NCT01192100|19211897|P4|NOT COMPLETED|Overall Study||1
7804392|NCT01192100|19211898|P3|NOT COMPLETED|Overall Study||0
7804393|NCT01192100|19211899|P2|NOT COMPLETED|Overall Study||0
7804394|NCT01192100|19211900|P1|NOT COMPLETED|Overall Study||0
7804395|NCT01192100|19211895|P6|COMPLETED|Overall Study||2
7804396|NCT01192100|19211896|P5|COMPLETED|Overall Study||2
7804397|NCT01192100|19211897|P4|COMPLETED|Overall Study||3
7804398|NCT01192100|19211898|P3|COMPLETED|Overall Study||3
7804399|NCT01192100|19211899|P2|COMPLETED|Overall Study||4
7804400|NCT01192100|19211900|P1|COMPLETED|Overall Study||6
7804401|NCT01192100|19211895|P6|Began 3rd Intervention Week|Overall Study||2
7804402|NCT01192100|19211896|P5|Began 3rd Intervention Week|Overall Study||2
7804403|NCT01192100|19211897|P4|Began 3rd Intervention Week|Overall Study||3
7804404|NCT01192100|19211898|P3|Began 3rd Intervention Week|Overall Study||3
7804405|NCT01192100|19211899|P2|Began 3rd Intervention Week|Overall Study||4
7804406|NCT01192100|19211900|P1|Began 3rd Intervention Week|Overall Study||6
7804407|NCT01192100|19211895|P6|Began 2nd Intervention Week|Overall Study||2
7804408|NCT01192100|19211896|P5|Began 2nd Intervention Week|Overall Study||2
7804409|NCT01192100|19211897|P4|Began 2nd Intervention Week|Overall Study||3
7804410|NCT01192100|19211898|P3|Began 2nd Intervention Week|Overall Study||3
7804411|NCT01192100|19211899|P2|Began 2nd Intervention Week|Overall Study||4
7804412|NCT01192100|19211900|P1|Began 2nd Intervention Week|Overall Study||6
7804413|NCT01192100|19211895|P6|Began 1st Intervention Week|Overall Study||2
7804414|NCT01192100|19211896|P5|Began 1st Intervention Week|Overall Study||3
7804415|NCT01192100|19211897|P4|Began 1st Intervention Week|Overall Study||4
7804416|NCT01192100|19211898|P3|Began 1st Intervention Week|Overall Study||3
7804417|NCT01192100|19211899|P2|Began 1st Intervention Week|Overall Study||4
7804418|NCT01192100|19211900|P1|Began 1st Intervention Week|Overall Study||6
7804419|NCT01192100|19211895|P6|STARTED|Overall Study||2
7804420|NCT01192100|19211896|P5|STARTED|Overall Study||3
7804421|NCT01192100|19211897|P4|STARTED|Overall Study||4
7804422|NCT01192100|19211898|P3|STARTED|Overall Study||3
7804423|NCT01192100|19211899|P2|STARTED|Overall Study||4
7804424|NCT01192100|19211900|P1|STARTED|Overall Study||6
7804425|NCT01192022|19211920|P5|NOT COMPLETED|Overall Study||1
7804426|NCT01192022|19211921|P4|NOT COMPLETED|Overall Study||2
7804427|NCT01192022|19211922|P3|NOT COMPLETED|Overall Study||1
7804428|NCT01192022|19211923|P2|NOT COMPLETED|Overall Study||11
7804429|NCT01192022|19211924|P1|NOT COMPLETED|Overall Study||13
7804430|NCT01192022|19211920|P5|COMPLETED|Overall Study||11
7804431|NCT01192022|19211921|P4|COMPLETED|Overall Study||7
7804432|NCT01192022|19211922|P3|COMPLETED|Overall Study||7
7804433|NCT01192022|19211923|P2|COMPLETED|Overall Study||99
7804434|NCT01192022|19211924|P1|COMPLETED|Overall Study||101
7804435|NCT01192022|19211920|P5|Safety Population-Received Treatment|Overall Study||12
7804436|NCT01192022|19211921|P4|Safety Population-Received Treatment|Overall Study||9
7804437|NCT01192022|19211922|P3|Safety Population-Received Treatment|Overall Study||8
7804438|NCT01192022|19211923|P2|Safety Population-Received Treatment|Overall Study||109
7804439|NCT01192022|19211924|P1|Safety Population-Received Treatment|Overall Study||114
7804440|NCT01192022|19211920|P5|STARTED|Overall Study||12
7804441|NCT01192022|19211921|P4|STARTED|Overall Study||9
7804442|NCT01192022|19211922|P3|STARTED|Overall Study||8
7804443|NCT01192022|19211923|P2|STARTED|Overall Study||110
7804444|NCT01192022|19211924|P1|STARTED|Overall Study||114
7804445|NCT01191944|19211947|P2|NOT COMPLETED|Overall Study||19
7804446|NCT01191944|19211948|P1|NOT COMPLETED|Overall Study||17
7804447|NCT01191944|19211947|P2|COMPLETED|Overall Study|Completed titration/maintenance|220
7804448|NCT01191944|19211948|P1|COMPLETED|Overall Study|Completed titration/maintenance|217
7804449|NCT01191944|19211947|P2|STARTED|Overall Study|Treated titration/maintenance|239
7804450|NCT01191944|19211948|P1|STARTED|Overall Study|Treated titration/maintenance|234
7804451|NCT01191840|19211994|P2|NOT COMPLETED|Overall Study||15
7804452|NCT01191840|19211995|P1|NOT COMPLETED|Overall Study||14
7804453|NCT01191840|19211994|P2|COMPLETED|Overall Study||240
7804454|NCT01191840|19211995|P1|COMPLETED|Overall Study||240
7804455|NCT01191840|19211994|P2|STARTED|Overall Study||255
7804456|NCT01191840|19211995|P1|STARTED|Overall Study||254
7804457|NCT01191827|19212011|P2|NOT COMPLETED|Overall Study||0
7804458|NCT01191827|19212012|P1|NOT COMPLETED|Overall Study||0
7804459|NCT01191827|19212011|P2|COMPLETED|Overall Study||20
7804460|NCT01191827|19212012|P1|COMPLETED|Overall Study||20
7804461|NCT01191827|19212011|P2|STARTED|Overall Study||20
7804462|NCT01191827|19212012|P1|STARTED|Overall Study||20
7804463|NCT01191801|19212020|P2|NOT COMPLETED|Overall Study||337
7804464|NCT01191801|19212021|P1|NOT COMPLETED|Overall Study||316
7804465|NCT01191801|19212020|P2|COMPLETED|Overall Study||18
7804466|NCT01191801|19212021|P1|COMPLETED|Overall Study||40
7804467|NCT01191801|19212020|P2|STARTED|Overall Study||355
7804468|NCT01191801|19212021|P1|STARTED|Overall Study||356
7804469|NCT01191788|19212041|P2|NOT COMPLETED|Overall Study||22
7804470|NCT01191788|19212042|P1|NOT COMPLETED|Overall Study||21
7804471|NCT01191788|19212041|P2|COMPLETED|Overall Study|Completed 3-month followup|137
7804472|NCT01191788|19212042|P1|COMPLETED|Overall Study|Completed 3-month followup|119
7804473|NCT01191788|19212041|P2|STARTED|Overall Study||159
7804474|NCT01191788|19212042|P1|STARTED|Overall Study||140
7804475|NCT01191762|19212052|P2|NOT COMPLETED|Overall Study||0
7804476|NCT01191762|19212053|P1|NOT COMPLETED|Overall Study||1
7804477|NCT01191762|19212052|P2|COMPLETED|Overall Study||15
7804478|NCT01191762|19212053|P1|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14
7804479|NCT01191762|19212052|P2|STARTED|Overall Study||15
7804480|NCT01191762|19212053|P1|STARTED|Overall Study||15
7804481|NCT01191749|19212059|P1|NOT COMPLETED|Overall Study||0
7804482|NCT01191749|19212059|P1|COMPLETED|Overall Study||7
7804483|NCT01191749|19212059|P1|STARTED|Overall Study||7
7804484|NCT01191736|19212070|P7|NOT COMPLETED|Overall Study||0
7804485|NCT01191736|19212071|P6|NOT COMPLETED|Overall Study||0
7804486|NCT01191736|19212072|P5|NOT COMPLETED|Overall Study||0
7804487|NCT01191736|19212073|P4|NOT COMPLETED|Overall Study||0
7804488|NCT01191736|19212074|P3|NOT COMPLETED|Overall Study||0
7804489|NCT01191736|19212075|P2|NOT COMPLETED|Overall Study||0
7804490|NCT01191736|19212076|P1|NOT COMPLETED|Overall Study||0
7804491|NCT01191736|19212070|P7|COMPLETED|Overall Study||45
7804492|NCT01191736|19212071|P6|COMPLETED|Overall Study||50
7804493|NCT01191736|19212072|P5|COMPLETED|Overall Study||48
7804494|NCT01191736|19212073|P4|COMPLETED|Overall Study||46
7804495|NCT01191736|19212074|P3|COMPLETED|Overall Study||49
7804496|NCT01191736|19212075|P2|COMPLETED|Overall Study||47
7804497|NCT01191736|19212076|P1|COMPLETED|Overall Study||51
7804498|NCT01191736|19212070|P7|STARTED|Overall Study||45
7804499|NCT01191736|19212071|P6|STARTED|Overall Study||50
7804500|NCT01191736|19212072|P5|STARTED|Overall Study||48
7804501|NCT01191736|19212073|P4|STARTED|Overall Study||46
7804502|NCT01191736|19212074|P3|STARTED|Overall Study||49
7804503|NCT01191736|19212075|P2|STARTED|Overall Study||47
7804504|NCT01191736|19212076|P1|STARTED|Overall Study||51
7804505|NCT01191723|19212099|P6|NOT COMPLETED|Overall Study||0
7804506|NCT01191723|19212100|P5|NOT COMPLETED|Overall Study||0
7804507|NCT01191723|19212101|P4|NOT COMPLETED|Overall Study||0
7804508|NCT01191723|19212102|P3|NOT COMPLETED|Overall Study||0
7804509|NCT01191723|19212103|P2|NOT COMPLETED|Overall Study||0
7804510|NCT01191723|19212104|P1|NOT COMPLETED|Overall Study||0
7804511|NCT01191723|19212099|P6|COMPLETED|Overall Study||9
7804512|NCT01191723|19212100|P5|COMPLETED|Overall Study||9
7804513|NCT01191723|19212101|P4|COMPLETED|Overall Study||9
7804514|NCT01191723|19212102|P3|COMPLETED|Overall Study||9
7804515|NCT01191723|19212103|P2|COMPLETED|Overall Study||9
7804516|NCT01191723|19212104|P1|COMPLETED|Overall Study||9
7804517|NCT01191723|19212099|P6|STARTED|Overall Study||9
7804518|NCT01191723|19212100|P5|STARTED|Overall Study||9
7804519|NCT01191723|19212101|P4|STARTED|Overall Study||9
7804520|NCT01191723|19212102|P3|STARTED|Overall Study||9
7804521|NCT01191723|19212103|P2|STARTED|Overall Study||9
7804522|NCT01191723|19212104|P1|STARTED|Overall Study||9
7804523|NCT01191476|19212125|P3|NOT COMPLETED|Overall Study||0
7804524|NCT01191476|19212126|P2|NOT COMPLETED|Overall Study||4
7804525|NCT01191476|19212127|P1|NOT COMPLETED|Overall Study||3
7804526|NCT01191476|19212125|P3|COMPLETED|Overall Study||111
7804527|NCT01191476|19212126|P2|COMPLETED|Overall Study||107
7804528|NCT01191476|19212127|P1|COMPLETED|Overall Study||109
7804529|NCT01191476|19212125|P3|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
7804530|NCT01191476|19212126|P2|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
7804531|NCT01191476|19212127|P1|STARTED|Overall Study||112
7804532|NCT01191411|19212150|P3|NOT COMPLETED|Overall Study||3427
7804533|NCT01191411|19212151|P2|NOT COMPLETED|Overall Study||361
7804534|NCT01191411|19212152|P1|NOT COMPLETED|Overall Study||945
7804535|NCT01191411|19212150|P3|COMPLETED|Overall Study||471
7804536|NCT01191411|19212151|P2|COMPLETED|Overall Study||118
7804537|NCT01191411|19212152|P1|COMPLETED|Overall Study||648
7804538|NCT01191411|19212150|P3|STARTED|Overall Study||3898
7804539|NCT01191411|19212151|P2|STARTED|Overall Study||479
7804540|NCT01191411|19212152|P1|STARTED|Overall Study||1593
7804541|NCT01191398|19212163|P3|NOT COMPLETED|Overall Study||0
7804542|NCT01191398|19212164|P2|NOT COMPLETED|Overall Study||0
7804543|NCT01191398|19212165|P1|NOT COMPLETED|Overall Study||0
7804544|NCT01191398|19212163|P3|COMPLETED|Overall Study||18
7804545|NCT01191398|19212164|P2|COMPLETED|Overall Study||17
7804546|NCT01191398|19212165|P1|COMPLETED|Overall Study||17
7804547|NCT01191398|19212163|P3|STARTED|Overall Study||18
7804548|NCT01191398|19212164|P2|STARTED|Overall Study||17
7804549|NCT01191398|19212165|P1|STARTED|Overall Study||17
7804550|NCT01191333|19212178|P2|NOT COMPLETED|Overall Study||18
7804551|NCT01191333|19212179|P1|NOT COMPLETED|Overall Study||21
7804552|NCT01191333|19212178|P2|COMPLETED|Overall Study||65
7804553|NCT01191333|19212179|P1|COMPLETED|Overall Study||60
7804554|NCT01191333|19212178|P2|STARTED|Overall Study||83
7804555|NCT01191333|19212179|P1|STARTED|Overall Study||81
7804556|NCT01191320|19212198|P3|NOT COMPLETED|Overall Study||7
7804557|NCT01191320|19212199|P2|NOT COMPLETED|Overall Study||6
7804558|NCT01191320|19212200|P1|NOT COMPLETED|Overall Study||7
7804559|NCT01191320|19212198|P3|COMPLETED|Overall Study||31
7804560|NCT01191320|19212199|P2|COMPLETED|Overall Study||32
7804561|NCT01191320|19212200|P1|COMPLETED|Overall Study||36
7804562|NCT01191320|19212198|P3|STARTED|Overall Study||38
7804563|NCT01191320|19212199|P2|STARTED|Overall Study||38
7804564|NCT01191320|19212200|P1|STARTED|Overall Study||43
7804565|NCT01191268|19212211|P3|NOT COMPLETED|Overall Study||52
7804566|NCT01191268|19212212|P2|NOT COMPLETED|Overall Study||55
7804567|NCT01191268|19212213|P1|NOT COMPLETED|Overall Study||58
7804568|NCT01191268|19212211|P3|COMPLETED|Overall Study||244
7804569|NCT01191268|19212212|P2|COMPLETED|Overall Study||238
7804570|NCT01191268|19212213|P1|COMPLETED|Overall Study||237
7804571|NCT01191268|19212211|P3|Received at Least One Dose of Study Drug|Overall Study||296
7804572|NCT01191268|19212212|P2|Received at Least One Dose of Study Drug|Overall Study||293
7804573|NCT01191268|19212213|P1|Received at Least One Dose of Study Drug|Overall Study||295
7804574|NCT01191268|19212211|P3|STARTED|Overall Study||296
7804575|NCT01191268|19212212|P2|STARTED|Overall Study||293
7804576|NCT01191268|19212213|P1|STARTED|Overall Study||295
7804577|NCT01191255|19212310|P4|NOT COMPLETED|Efficacy Assessment Period||6
7804578|NCT01191255|19212311|P3|NOT COMPLETED|Efficacy Assessment Period||26
7804579|NCT01191255|19212312|P2|NOT COMPLETED|Efficacy Assessment Period||0
7804580|NCT01191255|19212313|P1|NOT COMPLETED|Efficacy Assessment Period||0
7804581|NCT01191255|19212310|P4|COMPLETED|Efficacy Assessment Period||90
7804582|NCT01191255|19212311|P3|COMPLETED|Efficacy Assessment Period||70
7804583|NCT01191255|19212312|P2|COMPLETED|Efficacy Assessment Period||0
7804584|NCT01191255|19212313|P1|COMPLETED|Efficacy Assessment Period||0
7804585|NCT01191255|19212310|P4|STARTED|Efficacy Assessment Period||96
7804586|NCT01191255|19212311|P3|STARTED|Efficacy Assessment Period||96
7804587|NCT01191255|19212312|P2|STARTED|Efficacy Assessment Period||0
7804588|NCT01191255|19212313|P1|STARTED|Efficacy Assessment Period||0
7804589|NCT01191255|19212310|P4|NOT COMPLETED|Safety Assessment Period||0
7804590|NCT01191255|19212311|P3|NOT COMPLETED|Safety Assessment Period||0
7804591|NCT01191255|19212312|P2|NOT COMPLETED|Safety Assessment Period||99
7804592|NCT01191255|19212313|P1|NOT COMPLETED|Safety Assessment Period||38
7804593|NCT01191255|19212310|P4|COMPLETED|Safety Assessment Period||0
7804594|NCT01191255|19212311|P3|COMPLETED|Safety Assessment Period||0
7804595|NCT01191255|19212312|P2|COMPLETED|Safety Assessment Period||193
7804596|NCT01191255|19212313|P1|COMPLETED|Safety Assessment Period||111
7804597|NCT01191255|19212310|P4|Safety Population|Safety Assessment Period||0
7804598|NCT01191255|19212311|P3|Safety Population|Safety Assessment Period||0
7804599|NCT01191255|19212312|P2|Safety Population|Safety Assessment Period||289
7804600|NCT01191255|19212313|P1|Safety Population|Safety Assessment Period||149
7804601|NCT01191255|19212310|P4|STARTED|Safety Assessment Period||0
7804602|NCT01191255|19212311|P3|STARTED|Safety Assessment Period||0
7804603|NCT01191255|19212312|P2|STARTED|Safety Assessment Period||292
7804604|NCT01191255|19212313|P1|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149
7804605|NCT01191242|19212339|P1|NOT COMPLETED|Overall Study||0
7804606|NCT01191242|19212339|P1|COMPLETED|Overall Study||31
7804607|NCT01191242|19212339|P1|STARTED|Overall Study||31
7804608|NCT01191190|19212354|P1|NOT COMPLETED|Overall Study||1
7804609|NCT01191190|19212354|P1|COMPLETED|Overall Study||20
7804610|NCT01191190|19212354|P1|STARTED|Overall Study||21
7804611|NCT01191086|19212367|P1|NOT COMPLETED|Overall Study||62
7804612|NCT01191086|19212367|P1|COMPLETED|Overall Study||148
7804613|NCT01191086|19212367|P1|STARTED|Overall Study||210
7804614|NCT01191008|19212371|P1|NOT COMPLETED|Overall Study||15
7804615|NCT01191008|19212371|P1|COMPLETED|Overall Study||618
7804616|NCT01191008|19212371|P1|STARTED|Overall Study||633
7804617|NCT01190930|19212379|P10|NOT COMPLETED|Maintenance||37
7804618|NCT01190930|19212380|P9|NOT COMPLETED|Maintenance||46
7804619|NCT01190930|19212381|P8|NOT COMPLETED|Maintenance||46
7804620|NCT01190930|19212382|P7|NOT COMPLETED|Maintenance||26
7804621|NCT01190930|19212383|P6|NOT COMPLETED|Maintenance||12
7804622|NCT01190930|19212384|P5|NOT COMPLETED|Maintenance||9
7804623|NCT01190930|19212385|P4|NOT COMPLETED|Maintenance||40
7804624|NCT01190930|19212386|P3|NOT COMPLETED|Maintenance||0
7804625|NCT01190930|19212387|P2|NOT COMPLETED|Maintenance||10
7804626|NCT01190930|19212388|P1|NOT COMPLETED|Maintenance||0
7804627|NCT01190930|19212379|P10|COMPLETED|Maintenance||555
7804628|NCT01190930|19212380|P9|COMPLETED|Maintenance||540
7804629|NCT01190930|19212381|P8|COMPLETED|Maintenance||540
7804630|NCT01190930|19212382|P7|COMPLETED|Maintenance||574
7804631|NCT01190930|19212383|P6|COMPLETED|Maintenance||284
7804632|NCT01190930|19212384|P5|COMPLETED|Maintenance||287
7804633|NCT01190930|19212385|P4|COMPLETED|Maintenance||167
7804634|NCT01190930|19212386|P3|COMPLETED|Maintenance||0
7804635|NCT01190930|19212387|P2|COMPLETED|Maintenance||27
7804636|NCT01190930|19212388|P1|COMPLETED|Maintenance||0
7804637|NCT01190930|19212379|P10|STARTED|Maintenance||592
7804638|NCT01190930|19212380|P9|STARTED|Maintenance||586
7804639|NCT01190930|19212381|P8|STARTED|Maintenance||586
7804640|NCT01190930|19212382|P7|STARTED|Maintenance||600
7804641|NCT01190930|19212383|P6|STARTED|Maintenance||296
7804642|NCT01190930|19212384|P5|STARTED|Maintenance||296
7804643|NCT01190930|19212385|P4|STARTED|Maintenance||207
7804644|NCT01190930|19212386|P3|STARTED|Maintenance||0
7804645|NCT01190930|19212387|P2|STARTED|Maintenance||37
7804646|NCT01190930|19212388|P1|STARTED|Maintenance||0
7804647|NCT01190930|19212379|P10|NOT COMPLETED|Post Induction Pre-Maintenance||0
7804648|NCT01190930|19212380|P9|NOT COMPLETED|Post Induction Pre-Maintenance||0
7804649|NCT01190930|19212381|P8|NOT COMPLETED|Post Induction Pre-Maintenance||0
7804650|NCT01190930|19212382|P7|NOT COMPLETED|Post Induction Pre-Maintenance||0
7804651|NCT01190930|19212383|P6|NOT COMPLETED|Post Induction Pre-Maintenance||6
7804652|NCT01190930|19212384|P5|NOT COMPLETED|Post Induction Pre-Maintenance||5
7804653|NCT01190930|19212385|P4|NOT COMPLETED|Post Induction Pre-Maintenance||17
7804654|NCT01190930|19212386|P3|NOT COMPLETED|Post Induction Pre-Maintenance||758
7804655|NCT01190930|19212387|P2|NOT COMPLETED|Post Induction Pre-Maintenance||6
7804656|NCT01190930|19212388|P1|NOT COMPLETED|Post Induction Pre-Maintenance||0
7804657|NCT01190930|19212379|P10|COMPLETED|Post Induction Pre-Maintenance||0
7804658|NCT01190930|19212380|P9|COMPLETED|Post Induction Pre-Maintenance||0
7804659|NCT01190930|19212381|P8|COMPLETED|Post Induction Pre-Maintenance||0
7804660|NCT01190930|19212382|P7|COMPLETED|Post Induction Pre-Maintenance||0
7804661|NCT01190930|19212383|P6|COMPLETED|Post Induction Pre-Maintenance||296
7804662|NCT01190930|19212384|P5|COMPLETED|Post Induction Pre-Maintenance||296
7804663|NCT01190930|19212385|P4|COMPLETED|Post Induction Pre-Maintenance||207
7804664|NCT01190930|19212386|P3|COMPLETED|Post Induction Pre-Maintenance||2364
7804665|NCT01190930|19212387|P2|COMPLETED|Post Induction Pre-Maintenance||37
7804666|NCT01190930|19212388|P1|COMPLETED|Post Induction Pre-Maintenance||0
7804667|NCT01190930|19212379|P10|STARTED|Post Induction Pre-Maintenance||0
7804668|NCT01190930|19212380|P9|STARTED|Post Induction Pre-Maintenance||0
7804669|NCT01190930|19212381|P8|STARTED|Post Induction Pre-Maintenance||0
7804670|NCT01190930|19212382|P7|STARTED|Post Induction Pre-Maintenance||0
7804671|NCT01190930|19212383|P6|STARTED|Post Induction Pre-Maintenance||302
7804672|NCT01190930|19212384|P5|STARTED|Post Induction Pre-Maintenance||301
7804673|NCT01190930|19212385|P4|STARTED|Post Induction Pre-Maintenance||224
7804674|NCT01190930|19212386|P3|STARTED|Post Induction Pre-Maintenance||3122
7804675|NCT01190930|19212387|P2|STARTED|Post Induction Pre-Maintenance||43
7804676|NCT01190930|19212388|P1|STARTED|Post Induction Pre-Maintenance||0
7804677|NCT01190930|19212379|P10|NOT COMPLETED|Induction||0
7804678|NCT01190930|19212380|P9|NOT COMPLETED|Induction||0
7804679|NCT01190930|19212381|P8|NOT COMPLETED|Induction||0
7804680|NCT01190930|19212382|P7|NOT COMPLETED|Induction||0
7804681|NCT01190930|19212383|P6|NOT COMPLETED|Induction||0
7804682|NCT01190930|19212384|P5|NOT COMPLETED|Induction||0
7804683|NCT01190930|19212385|P4|NOT COMPLETED|Induction||0
7804684|NCT01190930|19212386|P3|NOT COMPLETED|Induction||0
7804685|NCT01190930|19212387|P2|NOT COMPLETED|Induction||9
7804686|NCT01190930|19212388|P1|NOT COMPLETED|Induction||5349
7804687|NCT01190930|19212379|P10|COMPLETED|Induction||0
7804688|NCT01190930|19212380|P9|COMPLETED|Induction||0
7804689|NCT01190930|19212381|P8|COMPLETED|Induction||0
7804690|NCT01190930|19212382|P7|COMPLETED|Induction||0
7804691|NCT01190930|19212383|P6|COMPLETED|Induction||0
7804692|NCT01190930|19212384|P5|COMPLETED|Induction||0
7804693|NCT01190930|19212385|P4|COMPLETED|Induction||0
7804694|NCT01190930|19212386|P3|COMPLETED|Induction||0
7804695|NCT01190930|19212387|P2|COMPLETED|Induction||43
7804696|NCT01190930|19212388|P1|COMPLETED|Induction||3949
7804697|NCT01190930|19212379|P10|STARTED|Induction||0
7804698|NCT01190930|19212380|P9|STARTED|Induction||0
7804699|NCT01190930|19212381|P8|STARTED|Induction||0
7804700|NCT01190930|19212382|P7|STARTED|Induction||0
7804701|NCT01190930|19212383|P6|STARTED|Induction||0
7804702|NCT01190930|19212384|P5|STARTED|Induction||0
7804703|NCT01190930|19212385|P4|STARTED|Induction||0
7804704|NCT01190930|19212386|P3|STARTED|Induction||0
7804705|NCT01190930|19212387|P2|STARTED|Induction||52
7804706|NCT01190930|19212388|P1|STARTED|Induction||9298
7804707|NCT01190891|19212412|P2|NOT COMPLETED|Overall Study||0
7804708|NCT01190891|19212413|P1|NOT COMPLETED|Overall Study||6
7804709|NCT01190891|19212412|P2|COMPLETED|Overall Study||52
7804710|NCT01190891|19212413|P1|COMPLETED|Overall Study||46
7804711|NCT01190891|19212412|P2|STARTED|Overall Study||52
7804712|NCT01190891|19212413|P1|STARTED|Overall Study||52
7804713|NCT01190878|19212425|P4|NOT COMPLETED|Overall Study||20
7804714|NCT01190878|19212426|P3|NOT COMPLETED|Overall Study||5
7804715|NCT01190878|19212427|P2|NOT COMPLETED|Overall Study||3
7804716|NCT01190878|19212428|P1|NOT COMPLETED|Overall Study||3
7804717|NCT01190878|19212425|P4|COMPLETED|Overall Study||22
7804718|NCT01190878|19212426|P3|COMPLETED|Overall Study||37
7804719|NCT01190878|19212427|P2|COMPLETED|Overall Study||42
7804720|NCT01190878|19212428|P1|COMPLETED|Overall Study||37
7804721|NCT01190878|19212425|P4|STARTED|Overall Study||42
7804722|NCT01190878|19212426|P3|STARTED|Overall Study||42
7804723|NCT01190878|19212427|P2|STARTED|Overall Study||45
7804724|NCT01190878|19212428|P1|STARTED|Overall Study||40
7804725|NCT01190865|19212438|P1|NOT COMPLETED|Overall Study||3
7804726|NCT01190865|19212438|P1|COMPLETED|Overall Study||25
7804727|NCT01190865|19212438|P1|STARTED|Overall Study||28
7804728|NCT01190839|19212445|P2|NOT COMPLETED|Overall Study||147
7804729|NCT01190839|19212446|P1|NOT COMPLETED|Overall Study||150
7804730|NCT01190839|19212445|P2|COMPLETED|Overall Study||0
7804731|NCT01190839|19212446|P1|COMPLETED|Overall Study||0
7804732|NCT01190839|19212445|P2|Treated|Overall Study||143
7804733|NCT01190839|19212446|P1|Treated|Overall Study||148
7804734|NCT01190839|19212445|P2|STARTED|Overall Study||147
7804735|NCT01190839|19212446|P1|STARTED|Overall Study||150
7804736|NCT01190813|19212460|P2|NOT COMPLETED|Overall Study||4
7804737|NCT01190813|19212461|P1|NOT COMPLETED|Overall Study||4
7804738|NCT01190813|19212460|P2|COMPLETED|Overall Study||45
7804739|NCT01190813|19212461|P1|COMPLETED|Overall Study||86
7804740|NCT01190813|19212460|P2|26-week Visit|Overall Study|0 missed, 0 dropped|45
7804741|NCT01190813|19212461|P1|26-week Visit|Overall Study|0 missed, 0 dropped|86
7804742|NCT01190813|19212460|P2|23-week Phone Call|Overall Study|4 missed, 0 dropped|41
7804743|NCT01190813|19212461|P1|23-week Phone Call|Overall Study|4 missed, 1 dropped|82
7804744|NCT01190813|19212460|P2|18-week Visit (Masked Primary)|Overall Study|1 dropped|45
7804745|NCT01190813|19212461|P1|18-week Visit (Masked Primary)|Overall Study|0 dropped|87
7804746|NCT01190813|19212460|P2|16-week Visit|Overall Study|2 dropped|46
7804747|NCT01190813|19212461|P1|16-week Visit|Overall Study|1 dropped|87
7804748|NCT01190813|19212460|P2|13-week Phone Call|Overall Study|0 dropped, 0 missed|48
7804749|NCT01190813|19212461|P1|13-week Phone Call|Overall Study|6 missed, 0 dropped|82
7804750|NCT01190813|19212460|P2|10-week Visit|Overall Study|0 dropped, 0 missed|48
7804751|NCT01190813|19212461|P1|10-week Visit|Overall Study|0 missed, 0 dropped|88
7804752|NCT01190813|19212460|P2|7-week Phone Call|Overall Study|2 missed, 0 dropped|46
7804753|NCT01190813|19212461|P1|7-week Phone Call|Overall Study|3 missed, 0 dropped|85
7804754|NCT01190813|19212460|P2|4-week Visit|Overall Study|1 missed, 1 dropped|47
7804755|NCT01190813|19212461|P1|4-week Visit|Overall Study|0 missed, 1 dropped|88
7804756|NCT01190813|19212460|P2|2-week Phone Call|Overall Study|1 missed, 0 dropped|48
7804757|NCT01190813|19212461|P1|2-week Phone Call|Overall Study|2 missed, 1 dropped|87
7804758|NCT01190813|19212460|P2|STARTED|Overall Study||49
7804759|NCT01190813|19212461|P1|STARTED|Overall Study||90
7804760|NCT01190566|19212553|P2|NOT COMPLETED|Overall Study||0
7804761|NCT01190566|19212554|P1|NOT COMPLETED|Overall Study||0
7804762|NCT01190566|19212553|P2|COMPLETED|Overall Study||42
7804763|NCT01190566|19212554|P1|COMPLETED|Overall Study||6
7804764|NCT01190566|19212553|P2|STARTED|Overall Study||42
7804765|NCT01190566|19212554|P1|STARTED|Overall Study||6
7804766|NCT01190527|19212575|P1|NOT COMPLETED|Overall Study||0
7804767|NCT01190527|19212575|P1|COMPLETED|Overall Study||42
7804768|NCT01190527|19212575|P1|STARTED|Overall Study||42
7804769|NCT01190514|19212582|P4|NOT COMPLETED|Fourth Intervention (Period 4)||0
7804770|NCT01190514|19212583|P3|NOT COMPLETED|Fourth Intervention (Period 4)||0
7804771|NCT01190514|19212584|P2|NOT COMPLETED|Fourth Intervention (Period 4)||0
7804772|NCT01190514|19212585|P1|NOT COMPLETED|Fourth Intervention (Period 4)||0
7804773|NCT01190514|19212582|P4|COMPLETED|Fourth Intervention (Period 4)||10
7804774|NCT01190514|19212583|P3|COMPLETED|Fourth Intervention (Period 4)||10
7804775|NCT01190514|19212584|P2|COMPLETED|Fourth Intervention (Period 4)||10
7804776|NCT01190514|19212585|P1|COMPLETED|Fourth Intervention (Period 4)||9
7804777|NCT01190514|19212582|P4|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10
7804778|NCT01190514|19212583|P3|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10
7804779|NCT01190514|19212584|P2|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10
7804780|NCT01190514|19212585|P1|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9
7804781|NCT01190514|19212582|P4|NOT COMPLETED|Third Intervention (Period 3)||0
7804782|NCT01190514|19212583|P3|NOT COMPLETED|Third Intervention (Period 3)||0
7804783|NCT01190514|19212584|P2|NOT COMPLETED|Third Intervention (Period 3)||0
7804784|NCT01190514|19212585|P1|NOT COMPLETED|Third Intervention (Period 3)||1
7804785|NCT01190514|19212582|P4|COMPLETED|Third Intervention (Period 3)||10
7804786|NCT01190514|19212583|P3|COMPLETED|Third Intervention (Period 3)||10
7804787|NCT01190514|19212584|P2|COMPLETED|Third Intervention (Period 3)||10
7804788|NCT01190514|19212585|P1|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9
7804789|NCT01190514|19212582|P4|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10
7804790|NCT01190514|19212583|P3|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10
7804791|NCT01190514|19212584|P2|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10
7804792|NCT01190514|19212585|P1|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10
7804793|NCT01190514|19212582|P4|NOT COMPLETED|Second Intervention (Period 2)||0
7804794|NCT01190514|19212583|P3|NOT COMPLETED|Second Intervention (Period 2)||0
7804795|NCT01190514|19212584|P2|NOT COMPLETED|Second Intervention (Period 2)||0
7804796|NCT01190514|19212585|P1|NOT COMPLETED|Second Intervention (Period 2)||0
7804797|NCT01190514|19212582|P4|COMPLETED|Second Intervention (Period 2)||10
7804798|NCT01190514|19212583|P3|COMPLETED|Second Intervention (Period 2)||10
7804799|NCT01190514|19212584|P2|COMPLETED|Second Intervention (Period 2)||10
7804800|NCT01190514|19212585|P1|COMPLETED|Second Intervention (Period 2)||10
7804801|NCT01190514|19212582|P4|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10
7804802|NCT01190514|19212583|P3|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10
7804803|NCT01190514|19212584|P2|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10
7804804|NCT01190514|19212585|P1|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10
7804805|NCT01190514|19212582|P4|NOT COMPLETED|First Intervention (Period 1)||0
7804806|NCT01190514|19212583|P3|NOT COMPLETED|First Intervention (Period 1)||0
7804807|NCT01190514|19212584|P2|NOT COMPLETED|First Intervention (Period 1)||0
7804808|NCT01190514|19212585|P1|NOT COMPLETED|First Intervention (Period 1)||1
7804809|NCT01190514|19212582|P4|COMPLETED|First Intervention (Period 1)||10
7804810|NCT01190514|19212583|P3|COMPLETED|First Intervention (Period 1)||10
7804811|NCT01190514|19212584|P2|COMPLETED|First Intervention (Period 1)||10
7804812|NCT01190514|19212585|P1|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10
7804813|NCT01190514|19212582|P4|STARTED|First Intervention (Period 1)||10
7804814|NCT01190514|19212583|P3|STARTED|First Intervention (Period 1)||10
7804815|NCT01190514|19212584|P2|STARTED|First Intervention (Period 1)||10
7804816|NCT01190514|19212585|P1|STARTED|First Intervention (Period 1)||11
7804817|NCT01190475|19212618|P3|NOT COMPLETED|Overall Study||1
7804818|NCT01190475|19212619|P2|NOT COMPLETED|Overall Study||0
7804819|NCT01190475|19212620|P1|NOT COMPLETED|Overall Study||0
7804820|NCT01190475|19212618|P3|COMPLETED|Overall Study||1
7804821|NCT01190475|19212619|P2|COMPLETED|Overall Study||2
7804822|NCT01190475|19212620|P1|COMPLETED|Overall Study||2
7804823|NCT01190475|19212618|P3|STARTED|Overall Study||2
7804824|NCT01190475|19212619|P2|STARTED|Overall Study||2
7804825|NCT01190475|19212620|P1|STARTED|Overall Study||2
7804826|NCT01190449|19212636|P2|NOT COMPLETED|Overall Study||4
7804827|NCT01190449|19212637|P1|NOT COMPLETED|Overall Study||0
7804828|NCT01190449|19212636|P2|COMPLETED|Overall Study||32
7804829|NCT01190449|19212637|P1|COMPLETED|Overall Study||15
7804830|NCT01190449|19212636|P2|STARTED|Overall Study||36
7804831|NCT01190449|19212637|P1|STARTED|Overall Study||15
7804832|NCT01190436|19212645|P1|NOT COMPLETED|Overall Study||39
7804833|NCT01190436|19212645|P1|COMPLETED|Overall Study||86
7804834|NCT01190436|19212645|P1|STARTED|Overall Study||125
7804835|NCT01190410|19212661|P2|NOT COMPLETED|Overall Study||9
7804836|NCT01190410|19212662|P1|NOT COMPLETED|Overall Study||1
7804837|NCT01190410|19212661|P2|COMPLETED|Overall Study||3
7804838|NCT01190410|19212662|P1|COMPLETED|Overall Study||3
7804839|NCT01190410|19212661|P2|Re-Induction|Overall Study||2
7804840|NCT01190410|19212662|P1|Re-Induction|Overall Study||0
7804841|NCT01190410|19212661|P2|STARTED|Overall Study||12
7804842|NCT01190410|19212662|P1|STARTED|Overall Study||4
7804843|NCT01190306|19212681|P2|NOT COMPLETED|Overall Study||0
7804844|NCT01190306|19212682|P1|NOT COMPLETED|Overall Study||0
7804845|NCT01190306|19212681|P2|COMPLETED|Overall Study||66
7804846|NCT01190306|19212682|P1|COMPLETED|Overall Study||61
7804847|NCT01190306|19212681|P2|STARTED|Overall Study||66
7804848|NCT01190306|19212682|P1|STARTED|Overall Study||61
7804849|NCT01190267|19212690|P2|NOT COMPLETED|Overall Study||4
7804850|NCT01190267|19212691|P1|NOT COMPLETED|Overall Study||41
7804851|NCT01190267|19212690|P2|COMPLETED|Overall Study||4
7804852|NCT01190267|19212691|P1|COMPLETED|Overall Study||155
7804853|NCT01190267|19212690|P2|STARTED|Overall Study||8
7804854|NCT01190267|19212691|P1|STARTED|Overall Study||196
7804855|NCT01190254|19212702|P3|NOT COMPLETED|Overall Study||22
7804856|NCT01190254|19212703|P2|NOT COMPLETED|Overall Study||17
7804857|NCT01190254|19212704|P1|NOT COMPLETED|Overall Study||21
7804858|NCT01190254|19212702|P3|COMPLETED|Overall Study||84
7804859|NCT01190254|19212703|P2|COMPLETED|Overall Study||81
7804860|NCT01190254|19212704|P1|COMPLETED|Overall Study||81
7804861|NCT01190254|19212702|P3|Treated|Overall Study||106
7804862|NCT01190254|19212703|P2|Treated|Overall Study||98
7804863|NCT01190254|19212704|P1|Treated|Overall Study||102
7804864|NCT01190254|19212702|P3|STARTED|Overall Study||106
7804865|NCT01190254|19212703|P2|STARTED|Overall Study||98
7804866|NCT01190254|19212704|P1|STARTED|Overall Study||102
7804867|NCT01190228|19212769|P3|NOT COMPLETED|Overall Study||0
7804868|NCT01190228|19212770|P2|NOT COMPLETED|Overall Study||0
7804869|NCT01190228|19212771|P1|NOT COMPLETED|Overall Study||5
7804870|NCT01190228|19212769|P3|COMPLETED|Overall Study||59
7804871|NCT01190228|19212770|P2|COMPLETED|Overall Study||46
7804872|NCT01190228|19212771|P1|COMPLETED|Overall Study||344
7804873|NCT01190228|19212769|P3|STARTED|Overall Study||59
7804874|NCT01190228|19212770|P2|STARTED|Overall Study||46
7804875|NCT01190228|19212771|P1|STARTED|Overall Study||349
7804876|NCT01190215|19212794|P2|NOT COMPLETED|Up to Month 6||0
7804877|NCT01190215|19212795|P1|NOT COMPLETED|Up to Month 6||2
7804878|NCT01190215|19212794|P2|COMPLETED|Up to Month 6||39
7804879|NCT01190215|19212795|P1|COMPLETED|Up to Month 6||36
7804880|NCT01190215|19212794|P2|STARTED|Up to Month 6||39
7804881|NCT01190215|19212795|P1|STARTED|Up to Month 6||38
7804882|NCT01190215|19212794|P2|NOT COMPLETED|Up to Day 28||0
7804883|NCT01190215|19212795|P1|NOT COMPLETED|Up to Day 28||0
7804884|NCT01190215|19212794|P2|COMPLETED|Up to Day 28||39
7804885|NCT01190215|19212795|P1|COMPLETED|Up to Day 28||38
7804886|NCT01190215|19212794|P2|STARTED|Up to Day 28||39
7804887|NCT01190215|19212795|P1|STARTED|Up to Day 28||38
7804888|NCT01190202|19212867|P4|NOT COMPLETED|Overall Study||0
7804889|NCT01190202|19212868|P3|NOT COMPLETED|Overall Study||0
7804890|NCT01190202|19212869|P2|NOT COMPLETED|Overall Study||0
7804891|NCT01190202|19212870|P1|NOT COMPLETED|Overall Study||0
7804892|NCT01190202|19212867|P4|COMPLETED|Overall Study||2400
7804893|NCT01190202|19212868|P3|COMPLETED|Overall Study||6400
7804894|NCT01190202|19212869|P2|COMPLETED|Overall Study||6414
7804895|NCT01190202|19212870|P1|COMPLETED|Overall Study||6404
7804896|NCT01190202|19212867|P4|STARTED|Overall Study||2400
7804897|NCT01190202|19212868|P3|STARTED|Overall Study||6400
7804898|NCT01190202|19212869|P2|STARTED|Overall Study||6414
7804899|NCT01190202|19212870|P1|STARTED|Overall Study||6404
7804900|NCT01190189|19213128|P1|NOT COMPLETED|Overall Study||6
7804901|NCT01190189|19213128|P1|COMPLETED|Overall Study||131
7804902|NCT01190189|19213128|P1|STARTED|Overall Study||137
7804903|NCT01190176|19213135|P1|NOT COMPLETED|Overall Study||2
7804904|NCT01190176|19213135|P1|COMPLETED|Overall Study||30
7804905|NCT01190176|19213135|P1|STARTED|Overall Study||32
7804906|NCT01190150|19213156|P2|NOT COMPLETED|Second Treatment||0
7804907|NCT01190150|19213157|P1|NOT COMPLETED|Second Treatment||0
7804908|NCT01190150|19213156|P2|COMPLETED|Second Treatment||7
7804909|NCT01190150|19213157|P1|COMPLETED|Second Treatment||10
7804910|NCT01190150|19213156|P2|STARTED|Second Treatment||7
7804911|NCT01190150|19213157|P1|STARTED|Second Treatment||10
7804912|NCT01190150|19213156|P2|NOT COMPLETED|Washout||2
7804913|NCT01190150|19213157|P1|NOT COMPLETED|Washout||0
7804914|NCT01190150|19213156|P2|COMPLETED|Washout||7
7804915|NCT01190150|19213157|P1|COMPLETED|Washout||10
7804916|NCT01190150|19213156|P2|STARTED|Washout||9
7804917|NCT01190150|19213157|P1|STARTED|Washout||10
7804918|NCT01190150|19213156|P2|NOT COMPLETED|First Treatment||0
7804919|NCT01190150|19213157|P1|NOT COMPLETED|First Treatment||1
7804920|NCT01190150|19213156|P2|COMPLETED|First Treatment||9
7804921|NCT01190150|19213157|P1|COMPLETED|First Treatment||10
7804922|NCT01190150|19213156|P2|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9
7804923|NCT01190150|19213157|P1|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11
7804924|NCT01190124|19213184|P3|NOT COMPLETED|Overall Study||1
7804925|NCT01190124|19213185|P2|NOT COMPLETED|Overall Study||0
7804926|NCT01190124|19213186|P1|NOT COMPLETED|Overall Study||17
7804927|NCT01190124|19213184|P3|COMPLETED|Overall Study||19
7804928|NCT01190124|19213185|P2|COMPLETED|Overall Study||24
7804929|NCT01190124|19213186|P1|COMPLETED|Overall Study||90
7804930|NCT01190124|19213184|P3|STARTED|Overall Study||20
7804931|NCT01190124|19213185|P2|STARTED|Overall Study||24
7804932|NCT01190124|19213186|P1|STARTED|Overall Study||107
7804933|NCT01190098|19213224|P2|NOT COMPLETED|Overall Study||2
7804934|NCT01190098|19213225|P1|NOT COMPLETED|Overall Study||3
7804935|NCT01190098|19213224|P2|COMPLETED|Overall Study||8
7804936|NCT01190098|19213225|P1|COMPLETED|Overall Study||39
7804937|NCT01190098|19213224|P2|STARTED|Overall Study||10
7804938|NCT01190098|19213225|P1|STARTED|Overall Study||42
7804939|NCT01190085|19213248|P3|NOT COMPLETED|Overall Study||0
7804940|NCT01190085|19213249|P2|NOT COMPLETED|Overall Study||0
7804941|NCT01190085|19213250|P1|NOT COMPLETED|Overall Study||0
7804942|NCT01190085|19213248|P3|COMPLETED|Overall Study||18
7804943|NCT01190085|19213249|P2|COMPLETED|Overall Study||14
7804944|NCT01190085|19213250|P1|COMPLETED|Overall Study||13
7804945|NCT01190085|19213248|P3|STARTED|Overall Study||18
7804946|NCT01190085|19213249|P2|STARTED|Overall Study||14
7804947|NCT01190085|19213250|P1|STARTED|Overall Study||13
7804948|NCT01190020|19213266|P2|NOT COMPLETED|Overall Study||0
7804949|NCT01190020|19213267|P1|NOT COMPLETED|Overall Study||7
7804950|NCT01190020|19213266|P2|COMPLETED|Overall Study||12
7804951|NCT01190020|19213267|P1|COMPLETED|Overall Study||22
7804952|NCT01190020|19213266|P2|STARTED|Overall Study||12
7804953|NCT01190020|19213267|P1|STARTED|Overall Study||29
7804954|NCT01190007|19213279|P1|NOT COMPLETED|Overall Study||14
7804955|NCT01190007|19213279|P1|COMPLETED|Overall Study||145
7804956|NCT01190007|19213279|P1|STARTED|Overall Study|Treated|159
7804957|NCT01189890|19213296|P2|NOT COMPLETED|Overall Study||39
7804958|NCT01189890|19213297|P1|NOT COMPLETED|Overall Study||37
7804959|NCT01189890|19213296|P2|COMPLETED|Overall Study||200
7804960|NCT01189890|19213297|P1|COMPLETED|Overall Study||204
7804961|NCT01189890|19213296|P2|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239
7804962|NCT01189890|19213297|P1|STARTED|Overall Study||241
7804963|NCT01189812|19213319|P2|NOT COMPLETED|Overall Study||8
7804964|NCT01189812|19213320|P1|NOT COMPLETED|Overall Study||8
7804965|NCT01189812|19213319|P2|COMPLETED|Overall Study||32
7804966|NCT01189812|19213320|P1|COMPLETED|Overall Study||32
7804967|NCT01189812|19213319|P2|STARTED|Overall Study||40
7804968|NCT01189812|19213320|P1|STARTED|Overall Study||40
7804969|NCT01189760|19213329|P3|NOT COMPLETED|Overall Study||51
7804970|NCT01189760|19213330|P2|NOT COMPLETED|Overall Study||23
7804971|NCT01189760|19213331|P1|NOT COMPLETED|Overall Study||14
7804972|NCT01189760|19213329|P3|COMPLETED|Overall Study||255
7804973|NCT01189760|19213330|P2|COMPLETED|Overall Study||283
7804974|NCT01189760|19213331|P1|COMPLETED|Overall Study||291
7804975|NCT01189760|19213329|P3|STARTED|Overall Study||306
7804976|NCT01189760|19213330|P2|STARTED|Overall Study||306
7804977|NCT01189760|19213331|P1|STARTED|Overall Study||305
7804978|NCT01189747|19213365|P2|NOT COMPLETED|Overall Study||18
7804979|NCT01189747|19213366|P1|NOT COMPLETED|Overall Study||12
7804980|NCT01189747|19213365|P2|COMPLETED|Overall Study||206
7804981|NCT01189747|19213366|P1|COMPLETED|Overall Study||210
7804982|NCT01189747|19213365|P2|STARTED|Overall Study||224
7804983|NCT01189747|19213366|P1|STARTED|Overall Study||222
7804984|NCT01189617|19213390|P2|NOT COMPLETED|Overall Study||0
7804985|NCT01189617|19213391|P1|NOT COMPLETED|Overall Study||0
7804986|NCT01189617|19213390|P2|COMPLETED|Overall Study||35
7804987|NCT01189617|19213391|P1|COMPLETED|Overall Study||35
7804988|NCT01189617|19213390|P2|STARTED|Overall Study||35
7804989|NCT01189617|19213391|P1|STARTED|Overall Study||35
7804990|NCT01189604|19213404|P7|NOT COMPLETED|Overall Study||1
7804991|NCT01189604|19213405|P6|NOT COMPLETED|Overall Study||1
7804992|NCT01189604|19213406|P5|NOT COMPLETED|Overall Study||2
7804993|NCT01189604|19213407|P4|NOT COMPLETED|Overall Study||0
7804994|NCT01189604|19213408|P3|NOT COMPLETED|Overall Study||0
7804995|NCT01189604|19213409|P2|NOT COMPLETED|Overall Study||1
7804996|NCT01189604|19213410|P1|NOT COMPLETED|Overall Study||1
7804997|NCT01189604|19213404|P7|COMPLETED|Overall Study||9
7804998|NCT01189604|19213405|P6|COMPLETED|Overall Study||10
7804999|NCT01189604|19213406|P5|COMPLETED|Overall Study||18
7805000|NCT01189604|19213407|P4|COMPLETED|Overall Study||20
7805001|NCT01189604|19213408|P3|COMPLETED|Overall Study||20
7805002|NCT01189604|19213409|P2|COMPLETED|Overall Study||20
7805003|NCT01189604|19213410|P1|COMPLETED|Overall Study||20
7805004|NCT01189604|19213404|P7|Administered Study Drug|Overall Study||10
7805005|NCT01189604|19213405|P6|Administered Study Drug|Overall Study||10
7805006|NCT01189604|19213406|P5|Administered Study Drug|Overall Study||20
7805007|NCT01189604|19213407|P4|Administered Study Drug|Overall Study||20
7805008|NCT01189604|19213408|P3|Administered Study Drug|Overall Study||20
7805009|NCT01189604|19213409|P2|Administered Study Drug|Overall Study||20
7805010|NCT01189604|19213410|P1|Administered Study Drug|Overall Study||20
7805011|NCT01189604|19213404|P7|STARTED|Overall Study||10
7805012|NCT01189604|19213405|P6|STARTED|Overall Study||11
7805013|NCT01189604|19213406|P5|STARTED|Overall Study||20
7805014|NCT01189604|19213407|P4|STARTED|Overall Study||20
7805015|NCT01189604|19213408|P3|STARTED|Overall Study||20
7805016|NCT01189604|19213409|P2|STARTED|Overall Study||21
7805017|NCT01189604|19213410|P1|STARTED|Overall Study||21
7805018|NCT01189500|19213454|P1|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1
7805019|NCT01189500|19213454|P1|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28
7805020|NCT01189500|19213454|P1|STARTED|Period 2: Coadministration TAMOX+DVS SR||29
7805021|NCT01189500|19213454|P1|NOT COMPLETED|Period 1: TAMOX Alone||1
7805022|NCT01189500|19213454|P1|COMPLETED|Period 1: TAMOX Alone||29
7805023|NCT01189500|19213454|P1|STARTED|Period 1: TAMOX Alone||30
7805024|NCT01189487|19213515|P1|NOT COMPLETED|Overall Study||3
7805025|NCT01189487|19213515|P1|COMPLETED|Overall Study||44
7805026|NCT01189487|19213515|P1|STARTED|Overall Study|Treated participants|47
7805027|NCT01189461|19213523|P1|NOT COMPLETED|Overall Study||34
7805028|NCT01189461|19213523|P1|COMPLETED|Overall Study||12
7805029|NCT01189461|19213523|P1|STARTED|Overall Study||46
7805030|NCT01189435|19213530|P1|NOT COMPLETED|Overall Study||2
7805031|NCT01189435|19213530|P1|COMPLETED|Overall Study||0
7805032|NCT01189435|19213530|P1|STARTED|Overall Study||2
7805033|NCT01189409|19213536|P2|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||8
7805034|NCT01189409|19213537|P1|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||6
7805035|NCT01189409|19213536|P2|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||15
7805036|NCT01189409|19213537|P1|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||13
7805037|NCT01189409|19213536|P2|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||23
7805038|NCT01189409|19213537|P1|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||19
7805039|NCT01189409|19213536|P2|NOT COMPLETED|First 3 Weeks||10
7805040|NCT01189409|19213537|P1|NOT COMPLETED|First 3 Weeks||18
7805041|NCT01189409|19213536|P2|COMPLETED|First 3 Weeks||23
7805042|NCT01189409|19213537|P1|COMPLETED|First 3 Weeks||19
7805043|NCT01189409|19213536|P2|STARTED|First 3 Weeks||33
7805044|NCT01189409|19213537|P1|STARTED|First 3 Weeks||37
7805045|NCT01189370|19213552|P3|NOT COMPLETED|Dose Level 3||6
7805046|NCT01189370|19213553|P2|NOT COMPLETED|Dose Level 3||0
7805047|NCT01189370|19213554|P1|NOT COMPLETED|Dose Level 3||0
7805048|NCT01189370|19213552|P3|COMPLETED|Dose Level 3||6
7805049|NCT01189370|19213553|P2|COMPLETED|Dose Level 3||0
7805050|NCT01189370|19213554|P1|COMPLETED|Dose Level 3||0
7805051|NCT01189370|19213552|P3|STARTED|Dose Level 3||12
7805052|NCT01189370|19213553|P2|STARTED|Dose Level 3||0
7805053|NCT01189370|19213554|P1|STARTED|Dose Level 3||0
7805054|NCT01189370|19213552|P3|NOT COMPLETED|Dose Level 2||0
7805055|NCT01189370|19213553|P2|NOT COMPLETED|Dose Level 2||4
7805056|NCT01189370|19213554|P1|NOT COMPLETED|Dose Level 2||0
7805057|NCT01189370|19213552|P3|COMPLETED|Dose Level 2||0
7805058|NCT01189370|19213553|P2|COMPLETED|Dose Level 2||12
7805059|NCT01189370|19213554|P1|COMPLETED|Dose Level 2||0
7805060|NCT01189370|19213552|P3|STARTED|Dose Level 2||0
7805061|NCT01189370|19213553|P2|STARTED|Dose Level 2||16
7805062|NCT01189370|19213554|P1|STARTED|Dose Level 2||0
7805063|NCT01189370|19213552|P3|NOT COMPLETED|Dose Level 1||0
7805064|NCT01189370|19213553|P2|NOT COMPLETED|Dose Level 1||0
7805065|NCT01189370|19213554|P1|NOT COMPLETED|Dose Level 1||9
7805066|NCT01189370|19213552|P3|COMPLETED|Dose Level 1||0
7805067|NCT01189370|19213553|P2|COMPLETED|Dose Level 1||0
7805068|NCT01189370|19213554|P1|COMPLETED|Dose Level 1||16
7805069|NCT01189370|19213552|P3|STARTED|Dose Level 1||0
7805070|NCT01189370|19213553|P2|STARTED|Dose Level 1||0
7805071|NCT01189370|19213554|P1|STARTED|Dose Level 1||25
7805072|NCT01189292|19213563|P2|NOT COMPLETED|Per Protocol Analysis||16
7805073|NCT01189292|19213564|P1|NOT COMPLETED|Per Protocol Analysis||11
7805074|NCT01189292|19213563|P2|COMPLETED|Per Protocol Analysis||60
7805075|NCT01189292|19213564|P1|COMPLETED|Per Protocol Analysis||65
7805076|NCT01189292|19213563|P2|STARTED|Per Protocol Analysis||76
7805077|NCT01189292|19213564|P1|STARTED|Per Protocol Analysis||76
7805078|NCT01189292|19213563|P2|NOT COMPLETED|Intention to Treat Analysis||0
7805079|NCT01189292|19213564|P1|NOT COMPLETED|Intention to Treat Analysis||0
7805080|NCT01189292|19213563|P2|COMPLETED|Intention to Treat Analysis||76
7805081|NCT01189292|19213564|P1|COMPLETED|Intention to Treat Analysis||76
7805082|NCT01189292|19213563|P2|STARTED|Intention to Treat Analysis||76
7805083|NCT01189292|19213564|P1|STARTED|Intention to Treat Analysis||76
7805084|NCT01189279|19213585|P3|NOT COMPLETED|Overall Study||1
7805085|NCT01189279|19213586|P2|NOT COMPLETED|Overall Study||0
7805086|NCT01189279|19213587|P1|NOT COMPLETED|Overall Study||1
7805087|NCT01189279|19213585|P3|COMPLETED|Overall Study||13
7805088|NCT01189279|19213586|P2|COMPLETED|Overall Study||14
7805089|NCT01189279|19213587|P1|COMPLETED|Overall Study||13
7805090|NCT01189279|19213585|P3|STARTED|Overall Study||14
7805091|NCT01189279|19213586|P2|STARTED|Overall Study||14
7805092|NCT01189279|19213587|P1|STARTED|Overall Study||14
7805093|NCT01189266|19213610|P3|NOT COMPLETED|Overall Study||65
7805094|NCT01189266|19213611|P2|NOT COMPLETED|Overall Study||6
7805095|NCT01189266|19213612|P1|NOT COMPLETED|Overall Study||6
7805096|NCT01189266|19213610|P3|COMPLETED|Overall Study||2
7805097|NCT01189266|19213611|P2|COMPLETED|Overall Study||0
7805098|NCT01189266|19213612|P1|COMPLETED|Overall Study||0
7805099|NCT01189266|19213610|P3|STARTED|Overall Study||67
7805100|NCT01189266|19213611|P2|STARTED|Overall Study||6
7805101|NCT01189266|19213612|P1|STARTED|Overall Study||6
7805102|NCT01189240|19213639|P3|NOT COMPLETED|Overall Study||0
7805103|NCT01189240|19213640|P2|NOT COMPLETED|Overall Study||0
7805104|NCT01189240|19213641|P1|NOT COMPLETED|Overall Study||0
7805105|NCT01189240|19213639|P3|COMPLETED|Overall Study||3
7805106|NCT01189240|19213640|P2|COMPLETED|Overall Study||6
7805107|NCT01189240|19213641|P1|COMPLETED|Overall Study||4
7805108|NCT01189240|19213639|P3|STARTED|Overall Study||3
7805109|NCT01189240|19213640|P2|STARTED|Overall Study||6
7805110|NCT01189240|19213641|P1|STARTED|Overall Study||4
7805111|NCT01189227|19213662|P2|NOT COMPLETED|Overall Study||3
7805112|NCT01189227|19213663|P1|NOT COMPLETED|Overall Study||6
7805113|NCT01189227|19213662|P2|COMPLETED|Overall Study||0
7805114|NCT01189227|19213663|P1|COMPLETED|Overall Study||0
7805115|NCT01189227|19213662|P2|STARTED|Overall Study||3
7805116|NCT01189227|19213663|P1|STARTED|Overall Study||6
7805117|NCT01189201|19213669|P1|NOT COMPLETED|Overall Study||1
7805118|NCT01189201|19213669|P1|COMPLETED|Overall Study||41
7805119|NCT01189201|19213669|P1|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24
7805120|NCT01189201|19213669|P1|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18
7805121|NCT01189201|19213669|P1|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41
7805122|NCT01189201|19213669|P1|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42
7805123|NCT01189201|19213669|P1|STARTED|Overall Study||42
7805124|NCT01189136|19213725|P2|NOT COMPLETED|Overall Study||0
7805125|NCT01189136|19213726|P1|NOT COMPLETED|Overall Study||0
7805126|NCT01189136|19213725|P2|COMPLETED|Overall Study||42
7805127|NCT01189136|19213726|P1|COMPLETED|Overall Study||42
7805128|NCT01189136|19213725|P2|STARTED|Overall Study||42
7805129|NCT01189136|19213726|P1|STARTED|Overall Study||42
7805130|NCT01189123|19213740|P2|NOT COMPLETED|Overall Study||6
7805131|NCT01189123|19213741|P1|NOT COMPLETED|Overall Study||2
7805132|NCT01189123|19213740|P2|COMPLETED|Overall Study||47
7805133|NCT01189123|19213741|P1|COMPLETED|Overall Study||50
7805134|NCT01189123|19213740|P2|STARTED|Overall Study||53
7805135|NCT01189123|19213741|P1|STARTED|Overall Study||52
7805136|NCT01189110|19213751|P2|NOT COMPLETED|Overall Study||0
7805137|NCT01189110|19213752|P1|NOT COMPLETED|Overall Study||0
7805138|NCT01189110|19213751|P2|COMPLETED|Overall Study||61
7805139|NCT01189110|19213752|P1|COMPLETED|Overall Study|February, 2011|64
7805140|NCT01189110|19213751|P2|STARTED|Overall Study||61
7805141|NCT01189110|19213752|P1|STARTED|Overall Study|September, 2010|64
7805142|NCT01189071|19213760|P2|NOT COMPLETED|Overall Study||0
7805143|NCT01189071|19213761|P1|NOT COMPLETED|Overall Study||0
7805144|NCT01189071|19213760|P2|COMPLETED|Overall Study||0
7805145|NCT01189071|19213761|P1|COMPLETED|Overall Study||0
7805146|NCT01189071|19213760|P2|STARTED|Overall Study||0
7805147|NCT01189071|19213761|P1|STARTED|Overall Study||0
7805148|NCT01189032|19213772|P3|NOT COMPLETED|Overall Study||6
7805149|NCT01189032|19213773|P2|NOT COMPLETED|Overall Study||7
7805150|NCT01189032|19213774|P1|NOT COMPLETED|Overall Study||5
7805151|NCT01189032|19213772|P3|COMPLETED|Overall Study||90
7805152|NCT01189032|19213773|P2|COMPLETED|Overall Study||89
7805153|NCT01189032|19213774|P1|COMPLETED|Overall Study||89
7805154|NCT01189032|19213772|P3|STARTED|Overall Study||96
7805155|NCT01189032|19213773|P2|STARTED|Overall Study||96
7805156|NCT01189032|19213774|P1|STARTED|Overall Study||94
7805157|NCT01188967|19213784|P2|NOT COMPLETED|Overall Study||4
7805158|NCT01188967|19213785|P1|NOT COMPLETED|Overall Study||5
7805159|NCT01188967|19213784|P2|COMPLETED|Overall Study||4
7805160|NCT01188967|19213785|P1|COMPLETED|Overall Study||5
7805161|NCT01188967|19213784|P2|STARTED|Overall Study||8
7805162|NCT01188967|19213785|P1|STARTED|Overall Study||10
7805163|NCT01188928|19213801|P4|NOT COMPLETED|Overall Study||18
7805164|NCT01188928|19213802|P3|NOT COMPLETED|Overall Study||14
7805165|NCT01188928|19213803|P2|NOT COMPLETED|Overall Study||62
7805166|NCT01188928|19213804|P1|NOT COMPLETED|Overall Study||38
7805167|NCT01188928|19213801|P4|COMPLETED|Overall Study||77
7805168|NCT01188928|19213802|P3|COMPLETED|Overall Study||82
7805169|NCT01188928|19213803|P2|COMPLETED|Overall Study||417
7805170|NCT01188928|19213804|P1|COMPLETED|Overall Study||444
7805171|NCT01188928|19213801|P4|STARTED|Overall Study||95
7805172|NCT01188928|19213802|P3|STARTED|Overall Study||96
7805173|NCT01188928|19213803|P2|STARTED|Overall Study||479
7805174|NCT01188928|19213804|P1|STARTED|Overall Study||482
7805175|NCT01188876|19213826|P1|NOT COMPLETED|Overall Study||0
7805176|NCT01188876|19213826|P1|COMPLETED|Overall Study||50
7805177|NCT01188876|19213826|P1|STARTED|Overall Study||50
7805178|NCT01188811|19213838|P2|NOT COMPLETED|Overall Study||2
7805179|NCT01188811|19213839|P1|NOT COMPLETED|Overall Study||6
7805180|NCT01188811|19213838|P2|COMPLETED|Overall Study||24
7805181|NCT01188811|19213839|P1|COMPLETED|Overall Study||22
7805182|NCT01188811|19213838|P2|STARTED|Overall Study||26
7805183|NCT01188811|19213839|P1|STARTED|Overall Study||28
7805184|NCT01188798|19213851|P2|NOT COMPLETED|Overall Study||3
7805185|NCT01188798|19213852|P1|NOT COMPLETED|Overall Study||2
7805186|NCT01188798|19213851|P2|COMPLETED|Overall Study||1
7805187|NCT01188798|19213852|P1|COMPLETED|Overall Study||0
7805188|NCT01188798|19213851|P2|STARTED|Overall Study||4
7805189|NCT01188798|19213852|P1|STARTED|Overall Study||2
7805190|NCT01188772|19213864|P4|NOT COMPLETED|Overall Study||1
7805191|NCT01188772|19213865|P3|NOT COMPLETED|Overall Study||11
7805192|NCT01188772|19213866|P2|NOT COMPLETED|Overall Study||3
7805193|NCT01188772|19213867|P1|NOT COMPLETED|Overall Study||5
7805194|NCT01188772|19213864|P4|COMPLETED|Overall Study||24
7805195|NCT01188772|19213865|P3|COMPLETED|Overall Study||15
7805196|NCT01188772|19213866|P2|COMPLETED|Overall Study||45
7805197|NCT01188772|19213867|P1|COMPLETED|Overall Study||43
7805198|NCT01188772|19213864|P4|Randomized and Treated|Overall Study||25
7805199|NCT01188772|19213865|P3|Randomized and Treated|Overall Study||26
7805200|NCT01188772|19213866|P2|Randomized and Treated|Overall Study||47
7805201|NCT01188772|19213867|P1|Randomized and Treated|Overall Study||48
7805202|NCT01188772|19213864|P4|STARTED|Overall Study||25
7805203|NCT01188772|19213865|P3|STARTED|Overall Study||26
7805204|NCT01188772|19213866|P2|STARTED|Overall Study||48
7805205|NCT01188772|19213867|P1|STARTED|Overall Study||48
7805206|NCT01188694|19213925|P3|NOT COMPLETED|Overall Study||1
7805207|NCT01188694|19213926|P2|NOT COMPLETED|Overall Study||1
7805208|NCT01188694|19213927|P1|NOT COMPLETED|Overall Study||5
7805209|NCT01188694|19213925|P3|COMPLETED|Overall Study||10
7805210|NCT01188694|19213926|P2|COMPLETED|Overall Study||15
7805211|NCT01188694|19213927|P1|COMPLETED|Overall Study||10
7805212|NCT01188694|19213925|P3|STARTED|Overall Study||11
7805213|NCT01188694|19213926|P2|STARTED|Overall Study||16
7805214|NCT01188694|19213927|P1|STARTED|Overall Study||15
7805215|NCT01188681|19213939|P4|NOT COMPLETED|Overall Study||1
7805216|NCT01188681|19213940|P3|NOT COMPLETED|Overall Study||1
7805217|NCT01188681|19213941|P2|NOT COMPLETED|Overall Study||0
7805218|NCT01188681|19213942|P1|NOT COMPLETED|Overall Study||0
7805219|NCT01188681|19213939|P4|COMPLETED|Overall Study||33
7805220|NCT01188681|19213940|P3|COMPLETED|Overall Study||32
7805221|NCT01188681|19213941|P2|COMPLETED|Overall Study||6
7805222|NCT01188681|19213942|P1|COMPLETED|Overall Study||6
7805223|NCT01188681|19213939|P4|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34
7805224|NCT01188681|19213940|P3|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33
7805225|NCT01188681|19213941|P2|STARTED|Overall Study||6
7805226|NCT01188681|19213942|P1|STARTED|Overall Study||6
7805227|NCT01188668|19213956|P1|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3
7805228|NCT01188668|19213956|P1|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33
7805229|NCT01188668|19213956|P1|STARTED|Period 2: Coadministration ARIP + DVS SR||36
7805230|NCT01188668|19213956|P1|NOT COMPLETED|Period 1: ARIP Alone||2
7805231|NCT01188668|19213956|P1|COMPLETED|Period 1: ARIP Alone||36
7805232|NCT01188668|19213956|P1|STARTED|Period 1: ARIP Alone||38
7805233|NCT01188655|19213989|P1|NOT COMPLETED|Overall Study||13
7805234|NCT01188655|19213989|P1|COMPLETED|Overall Study||76
7805235|NCT01188655|19213989|P1|STARTED|Overall Study||89
7805236|NCT01188603|19214004|P1|NOT COMPLETED|Overall Study||0
7805237|NCT01188603|19214004|P1|COMPLETED|Overall Study||24
7805238|NCT01188603|19214004|P1|STARTED|Overall Study||24
7805239|NCT01188577|19214014|P2|NOT COMPLETED|Visit 2||0
7805240|NCT01188577|19214015|P1|NOT COMPLETED|Visit 2||0
7805241|NCT01188577|19214014|P2|COMPLETED|Visit 2||12
7805242|NCT01188577|19214015|P1|COMPLETED|Visit 2||11
7805243|NCT01188577|19214014|P2|STARTED|Visit 2||12
7805244|NCT01188577|19214015|P1|STARTED|Visit 2||11
7805245|NCT01188577|19214014|P2|NOT COMPLETED|3-14 Day Washout||0
7805246|NCT01188577|19214015|P1|NOT COMPLETED|3-14 Day Washout||0
7805247|NCT01188577|19214014|P2|COMPLETED|3-14 Day Washout||12
7805248|NCT01188577|19214015|P1|COMPLETED|3-14 Day Washout||11
7805249|NCT01188577|19214014|P2|STARTED|3-14 Day Washout||12
7805250|NCT01188577|19214015|P1|STARTED|3-14 Day Washout||11
7805251|NCT01188577|19214014|P2|NOT COMPLETED|Visit 1||0
7805252|NCT01188577|19214015|P1|NOT COMPLETED|Visit 1||0
7805253|NCT01188577|19214014|P2|COMPLETED|Visit 1||12
7805254|NCT01188577|19214015|P1|COMPLETED|Visit 1||11
7805255|NCT01188577|19214014|P2|STARTED|Visit 1||12
7805256|NCT01188577|19214015|P1|STARTED|Visit 1||11
7805257|NCT01188564|19214033|P2|NOT COMPLETED|Open Label Phase||0
7805258|NCT01188564|19214034|P1|NOT COMPLETED|Open Label Phase||0
7805259|NCT01188564|19214033|P2|COMPLETED|Open Label Phase||20
7805260|NCT01188564|19214034|P1|COMPLETED|Open Label Phase||24
7805261|NCT01188564|19214033|P2|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20
7805262|NCT01188564|19214034|P1|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24
7805263|NCT01188564|19214033|P2|NOT COMPLETED|Double-blind Phase||0
7805264|NCT01188564|19214034|P1|NOT COMPLETED|Double-blind Phase||1
7805265|NCT01188564|19214033|P2|COMPLETED|Double-blind Phase||31
7805266|NCT01188564|19214034|P1|COMPLETED|Double-blind Phase||43
7805267|NCT01188564|19214033|P2|STARTED|Double-blind Phase||31
7805268|NCT01188564|19214034|P1|STARTED|Double-blind Phase||44
7805269|NCT01188551|19214046|P4|NOT COMPLETED|Overall Study||0
7805270|NCT01188551|19214047|P3|NOT COMPLETED|Overall Study||0
7805271|NCT01188551|19214048|P2|NOT COMPLETED|Overall Study||0
7805272|NCT01188551|19214049|P1|NOT COMPLETED|Overall Study||1
7805273|NCT01188551|19214046|P4|COMPLETED|Overall Study||25
7805274|NCT01188551|19214047|P3|COMPLETED|Overall Study||25
7805275|NCT01188551|19214048|P2|COMPLETED|Overall Study||25
7805276|NCT01188551|19214049|P1|COMPLETED|Overall Study||24
7805277|NCT01188551|19214046|P4|STARTED|Overall Study||25
7805278|NCT01188551|19214047|P3|STARTED|Overall Study||25
7805279|NCT01188551|19214048|P2|STARTED|Overall Study||25
7805280|NCT01188551|19214049|P1|STARTED|Overall Study||25
7805281|NCT01188538|19214065|P2|NOT COMPLETED|Overall Study||1
7805282|NCT01188538|19214066|P1|NOT COMPLETED|Overall Study||0
7805283|NCT01188538|19214065|P2|COMPLETED|Overall Study||19
7805284|NCT01188538|19214066|P1|COMPLETED|Overall Study||20
7805285|NCT01188538|19214065|P2|STARTED|Overall Study||20
7805286|NCT01188538|19214066|P1|STARTED|Overall Study||20
7805287|NCT01188499|19214079|P5|NOT COMPLETED|Overall Study||0
7805288|NCT01188499|19214080|P4|NOT COMPLETED|Overall Study||0
7805289|NCT01188499|19214081|P3|NOT COMPLETED|Overall Study||0
7805290|NCT01188499|19214082|P2|NOT COMPLETED|Overall Study||0
7805291|NCT01188499|19214083|P1|NOT COMPLETED|Overall Study||0
7805292|NCT01188499|19214079|P5|COMPLETED|Overall Study||18
7805293|NCT01188499|19214080|P4|COMPLETED|Overall Study||18
7805294|NCT01188499|19214081|P3|COMPLETED|Overall Study||33
7805295|NCT01188499|19214082|P2|COMPLETED|Overall Study||83
7805296|NCT01188499|19214083|P1|COMPLETED|Overall Study||24
7805297|NCT01188499|19214079|P5|STARTED|Overall Study||18
7805298|NCT01188499|19214080|P4|STARTED|Overall Study||18
7805299|NCT01188499|19214081|P3|STARTED|Overall Study||33
7805300|NCT01188499|19214082|P2|STARTED|Overall Study||83
7805301|NCT01188499|19214083|P1|STARTED|Overall Study||24
7805302|NCT01188460|19214102|P2|NOT COMPLETED|Overall Study||0
7805303|NCT01188460|19214103|P1|NOT COMPLETED|Overall Study||0
7805304|NCT01188460|19214102|P2|COMPLETED|Overall Study||23
7805305|NCT01188460|19214103|P1|COMPLETED|Overall Study||25
7805306|NCT01188460|19214102|P2|STARTED|Overall Study||23
7805307|NCT01188460|19214103|P1|STARTED|Overall Study||25
7805308|NCT01188447|19214129|P1|NOT COMPLETED|Overall Study||0
7805309|NCT01188447|19214129|P1|COMPLETED|Overall Study||4034
7805310|NCT01188447|19214129|P1|STARTED|Overall Study||4034
7805311|NCT01188421|19214140|P3|NOT COMPLETED|Overall Study||14
7805312|NCT01188421|19214141|P2|NOT COMPLETED|Overall Study||10
7805313|NCT01188421|19214142|P1|NOT COMPLETED|Overall Study||3
7805314|NCT01188421|19214140|P3|COMPLETED|Overall Study||22
7805315|NCT01188421|19214141|P2|COMPLETED|Overall Study||26
7805316|NCT01188421|19214142|P1|COMPLETED|Overall Study||28
7805317|NCT01188421|19214140|P3|STARTED|Overall Study||36
7805318|NCT01188421|19214141|P2|STARTED|Overall Study||36
7805319|NCT01188421|19214142|P1|STARTED|Overall Study||31
7805320|NCT01188369|19214152|P2|NOT COMPLETED|Overall Study||0
7805321|NCT01188369|19214153|P1|NOT COMPLETED|Overall Study||0
7805322|NCT01188369|19214152|P2|COMPLETED|Overall Study||10
7805323|NCT01188369|19214153|P1|COMPLETED|Overall Study||10
7805324|NCT01188369|19214152|P2|STARTED|Overall Study||10
7805325|NCT01188369|19214153|P1|STARTED|Overall Study||10
7805326|NCT01188343|19214162|P3|NOT COMPLETED|Overall Study||1
7805327|NCT01188343|19214163|P2|NOT COMPLETED|Overall Study||26
7805328|NCT01188343|19214164|P1|NOT COMPLETED|Overall Study||1
7805329|NCT01188343|19214162|P3|COMPLETED|Overall Study||220
7805330|NCT01188343|19214163|P2|COMPLETED|Overall Study||193
7805331|NCT01188343|19214164|P1|COMPLETED|Overall Study||101
7805332|NCT01188343|19214162|P3|STARTED|Overall Study||221
7805333|NCT01188343|19214163|P2|STARTED|Overall Study||219
7805334|NCT01188343|19214164|P1|STARTED|Overall Study||102
7805335|NCT01188226|19214190|P1|NOT COMPLETED|Overall Study||4
7805336|NCT01188226|19214190|P1|COMPLETED|Overall Study||6
7805337|NCT01188226|19214190|P1|STARTED|Overall Study||10
7805338|NCT01188109|19214229|P1|NOT COMPLETED|Overall Study||0
7805339|NCT01188109|19214229|P1|COMPLETED|Overall Study||22
7805340|NCT01188109|19214229|P1|STARTED|Overall Study||22
7805341|NCT01187953|19214236|P2|NOT COMPLETED|Overall Study||21
7805342|NCT01187953|19214237|P1|NOT COMPLETED|Overall Study||15
7805343|NCT01187953|19214236|P2|COMPLETED|Overall Study||254
7805344|NCT01187953|19214237|P1|COMPLETED|Overall Study||253
7805345|NCT01187953|19214236|P2|Dosed|Overall Study||271
7805346|NCT01187953|19214237|P1|Dosed|Overall Study||266
7805347|NCT01187953|19214236|P2|STARTED|Overall Study||275
7805348|NCT01187953|19214237|P1|STARTED|Overall Study||268
7805349|NCT01187914|19214245|P1|NOT COMPLETED|Overall Study||0
7805350|NCT01187914|19214245|P1|COMPLETED|Overall Study||40
7805351|NCT01187914|19214245|P1|STARTED|Overall Study||40
7805352|NCT01187901|19214251|P2|NOT COMPLETED|Overall Study||10
7805353|NCT01187901|19214252|P1|NOT COMPLETED|Overall Study||9
7805354|NCT01187901|19214251|P2|COMPLETED|Overall Study||36
7805355|NCT01187901|19214252|P1|COMPLETED|Overall Study||37
7805356|NCT01187901|19214251|P2|STARTED|Overall Study||46
7805357|NCT01187901|19214252|P1|STARTED|Overall Study||46
7805358|NCT01187771|19214270|P2|NOT COMPLETED|Overall Study||3
7805359|NCT01187771|19214271|P1|NOT COMPLETED|Overall Study||3
7805360|NCT01187771|19214270|P2|COMPLETED|Overall Study||18
7805361|NCT01187771|19214271|P1|COMPLETED|Overall Study||25
7805362|NCT01187771|19214270|P2|STARTED|Overall Study||21
7805363|NCT01187771|19214271|P1|STARTED|Overall Study||28
7805364|NCT01187550|19214293|P2|NOT COMPLETED|Overall Study||1
7805365|NCT01187550|19214294|P1|NOT COMPLETED|Overall Study||14
7805366|NCT01187550|19214293|P2|COMPLETED|Overall Study||29
7805367|NCT01187550|19214294|P1|COMPLETED|Overall Study||169
7805368|NCT01187550|19214293|P2|Treated|Overall Study||30
7805369|NCT01187550|19214294|P1|Treated|Overall Study||175
7805370|NCT01187550|19214293|P2|STARTED|Overall Study||30
7805371|NCT01187550|19214294|P1|STARTED|Overall Study||183
7805372|NCT01187511|19214312|P2|NOT COMPLETED|Overall Study||1
7805373|NCT01187511|19214313|P1|NOT COMPLETED|Overall Study||8
7805374|NCT01187511|19214312|P2|COMPLETED|Overall Study||21
7805375|NCT01187511|19214313|P1|COMPLETED|Overall Study||14
7805376|NCT01187511|19214312|P2|STARTED|Overall Study||22
7805377|NCT01187511|19214313|P1|STARTED|Overall Study||22
7805378|NCT01187498|19214421|P2|NOT COMPLETED|Overall Study||10
7805379|NCT01187498|19214422|P1|NOT COMPLETED|Overall Study||9
7805380|NCT01187498|19214421|P2|COMPLETED|Overall Study||60
7805381|NCT01187498|19214422|P1|COMPLETED|Overall Study||64
7805382|NCT01187498|19214421|P2|STARTED|Overall Study||70
7805383|NCT01187498|19214422|P1|STARTED|Overall Study||73
7805384|NCT01187446|19214450|P2|NOT COMPLETED|Overall Study||1
7805385|NCT01187446|19214451|P1|NOT COMPLETED|Overall Study||0
7805386|NCT01187446|19214450|P2|COMPLETED|Overall Study||13
7805387|NCT01187446|19214451|P1|COMPLETED|Overall Study||14
7805388|NCT01187446|19214450|P2|STARTED|Overall Study||14
7805389|NCT01187446|19214451|P1|STARTED|Overall Study||14
7805390|NCT01187433|19214467|P2|NOT COMPLETED|Overall Study||4
7805391|NCT01187433|19214468|P1|NOT COMPLETED|Overall Study||11
7805392|NCT01187433|19214467|P2|COMPLETED|Overall Study||46
7805393|NCT01187433|19214468|P1|COMPLETED|Overall Study||89
7805394|NCT01187433|19214467|P2|STARTED|Overall Study||50
7805395|NCT01187433|19214468|P1|STARTED|Overall Study||100
7805396|NCT01187407|19214498|P5|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||75
7805397|NCT01187407|19214499|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||29
7805398|NCT01187407|19214500|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
7805399|NCT01187407|19214501|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||36
7805400|NCT01187407|19214502|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
7805401|NCT01187407|19214498|P5|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||626
7805402|NCT01187407|19214499|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||202
7805403|NCT01187407|19214500|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||191
7805404|NCT01187407|19214501|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
7805405|NCT01187407|19214502|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
7805406|NCT01187407|19214498|P5|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|660
7805407|NCT01187407|19214499|P4|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|220
7805408|NCT01187407|19214500|P3|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|215
7805409|NCT01187407|19214501|P2|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|212
7805410|NCT01187407|19214502|P1|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
7805411|NCT01187407|19214498|P5|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||701
7805412|NCT01187407|19214499|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
7805413|NCT01187407|19214500|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||226
7805414|NCT01187407|19214501|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||232
7805415|NCT01187407|19214502|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
7805416|NCT01187407|19214498|P5|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7805417|NCT01187407|19214499|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7805418|NCT01187407|19214500|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7805419|NCT01187407|19214501|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7805420|NCT01187407|19214502|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||90
7805421|NCT01187407|19214498|P5|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7805422|NCT01187407|19214499|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7805423|NCT01187407|19214500|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7805424|NCT01187407|19214501|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7805425|NCT01187407|19214502|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|1390
7805426|NCT01187407|19214498|P5|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
7805427|NCT01187407|19214499|P4|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
7805428|NCT01187407|19214500|P3|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
7805429|NCT01187407|19214501|P2|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
7805521|NCT01186744|19214714|P6|STARTED|Overall Study||133
7805522|NCT01186744|19214715|P5|STARTED|Overall Study||45
7805430|NCT01187407|19214502|P1|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|25
7805431|NCT01187407|19214498|P5|STARTED|Confirmation (CF) Phase, 3 Weeks||0
7805432|NCT01187407|19214499|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
7805433|NCT01187407|19214500|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
7805434|NCT01187407|19214501|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
7805435|NCT01187407|19214502|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1480
7805436|NCT01187381|19214572|P1|NOT COMPLETED|Overall Study||0
7805437|NCT01187381|19214572|P1|COMPLETED|Overall Study|A participant completed study when the trastuzumab treatment was discontinued.|250
7805438|NCT01187381|19214572|P1|STARTED|Overall Study||250
7805439|NCT01187355|19214584|P2|NOT COMPLETED|Overall Study||20
7805440|NCT01187355|19214585|P1|NOT COMPLETED|Overall Study||18
7805441|NCT01187355|19214584|P2|COMPLETED|Overall Study||277
7805442|NCT01187355|19214585|P1|COMPLETED|Overall Study||276
7805443|NCT01187355|19214584|P2|STARTED|Overall Study||297
7805444|NCT01187355|19214585|P1|STARTED|Overall Study||294
7805445|NCT01187329|19214597|P2|NOT COMPLETED|Overall Study||2
7805446|NCT01187329|19214598|P1|NOT COMPLETED|Overall Study||1
7805447|NCT01187329|19214597|P2|COMPLETED|Overall Study||48
7805448|NCT01187329|19214598|P1|COMPLETED|Overall Study||49
7805449|NCT01187329|19214597|P2|STARTED|Overall Study||50
7805450|NCT01187329|19214598|P1|STARTED|Overall Study||50
7805451|NCT01187043|19214615|P5|NOT COMPLETED|Overall Study||2
7805452|NCT01187043|19214616|P4|NOT COMPLETED|Overall Study||0
7805453|NCT01187043|19214617|P3|NOT COMPLETED|Overall Study||4
7805454|NCT01187043|19214618|P2|NOT COMPLETED|Overall Study||0
7805455|NCT01187043|19214619|P1|NOT COMPLETED|Overall Study||1
7805456|NCT01187043|19214615|P5|COMPLETED|Overall Study||10
7805457|NCT01187043|19214616|P4|COMPLETED|Overall Study||12
7805458|NCT01187043|19214617|P3|COMPLETED|Overall Study||8
7805459|NCT01187043|19214618|P2|COMPLETED|Overall Study||10
7805460|NCT01187043|19214619|P1|COMPLETED|Overall Study||11
7805461|NCT01187043|19214615|P5|STARTED|Overall Study||12
7805462|NCT01187043|19214616|P4|STARTED|Overall Study||12
7805463|NCT01187043|19214617|P3|STARTED|Overall Study||12
7805464|NCT01187043|19214618|P2|STARTED|Overall Study||10
7805465|NCT01187043|19214619|P1|STARTED|Overall Study||12
7805466|NCT01187017|19214631|P1|NOT COMPLETED|Overall Study||0
7805467|NCT01187017|19214631|P1|COMPLETED|Overall Study||1
7805468|NCT01187017|19214631|P1|STARTED|Overall Study||1
7805469|NCT01187004|19214637|P2|NOT COMPLETED|Overall Study||0
7805470|NCT01187004|19214638|P1|NOT COMPLETED|Overall Study||0
7805471|NCT01187004|19214637|P2|COMPLETED|Overall Study||144
7805472|NCT01187004|19214638|P1|COMPLETED|Overall Study||20
7805473|NCT01187004|19214637|P2|STARTED|Overall Study||144
7805474|NCT01187004|19214638|P1|STARTED|Overall Study||20
7805475|NCT01186978|19214645|P1|NOT COMPLETED|Overall Study||1
7805476|NCT01186978|19214645|P1|COMPLETED|Overall Study||62
7805477|NCT01186978|19214645|P1|STARTED|Overall Study||63
7805478|NCT01186939|19214652|P1|NOT COMPLETED|Overall Study||40
7805479|NCT01186939|19214652|P1|COMPLETED|Overall Study||0
7805480|NCT01186939|19214652|P1|STARTED|Overall Study||40
7805481|NCT01186848|19214656|P1|NOT COMPLETED|Overall Study||8
7805482|NCT01186848|19214656|P1|COMPLETED|Overall Study||22
7805483|NCT01186848|19214656|P1|STARTED|Overall Study||30
7805484|NCT01186809|19214662|P1|NOT COMPLETED|Overall Study||30
7805485|NCT01186809|19214662|P1|COMPLETED|Overall Study||43
7805486|NCT01186809|19214662|P1|STARTED|Overall Study||73
7805487|NCT01186796|19214668|P2|NOT COMPLETED|Overall Study||2
7805488|NCT01186796|19214669|P1|NOT COMPLETED|Overall Study||4
7805489|NCT01186796|19214668|P2|COMPLETED|Overall Study||14
7805490|NCT01186796|19214669|P1|COMPLETED|Overall Study||10
7805491|NCT01186796|19214668|P2|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16
7805492|NCT01186796|19214669|P1|STARTED|Overall Study||14
7805493|NCT01186770|19214687|P4|NOT COMPLETED|Overall Study||58
7805494|NCT01186770|19214688|P3|NOT COMPLETED|Overall Study||52
7805495|NCT01186770|19214689|P2|NOT COMPLETED|Overall Study||46
7805496|NCT01186770|19214690|P1|NOT COMPLETED|Overall Study||41
7805497|NCT01186770|19214687|P4|COMPLETED|Overall Study||143
7805498|NCT01186770|19214688|P3|COMPLETED|Overall Study||148
7805499|NCT01186770|19214689|P2|COMPLETED|Overall Study||156
7805500|NCT01186770|19214690|P1|COMPLETED|Overall Study||160
7805501|NCT01186770|19214687|P4|Intent-to-treat (ITT Population)|Overall Study||201
7805502|NCT01186770|19214688|P3|Intent-to-treat (ITT Population)|Overall Study||200
7805503|NCT01186770|19214689|P2|Intent-to-treat (ITT Population)|Overall Study||201
7805504|NCT01186770|19214690|P1|Intent-to-treat (ITT Population)|Overall Study||201
7805505|NCT01186770|19214687|P4|STARTED|Overall Study||201
7805506|NCT01186770|19214688|P3|STARTED|Overall Study||200
7805507|NCT01186770|19214689|P2|STARTED|Overall Study||202
7805508|NCT01186770|19214690|P1|STARTED|Overall Study||201
7805509|NCT01186744|19214714|P6|NOT COMPLETED|Overall Study||26
7805510|NCT01186744|19214715|P5|NOT COMPLETED|Overall Study||6
7805511|NCT01186744|19214716|P4|NOT COMPLETED|Overall Study||12
7805512|NCT01186744|19214717|P3|NOT COMPLETED|Overall Study||6
7805513|NCT01186744|19214718|P2|NOT COMPLETED|Overall Study||152
7805514|NCT01186744|19214719|P1|NOT COMPLETED|Overall Study||208
7805515|NCT01186744|19214714|P6|COMPLETED|Overall Study||107
7805516|NCT01186744|19214715|P5|COMPLETED|Overall Study||39
7805517|NCT01186744|19214716|P4|COMPLETED|Overall Study||70
7805518|NCT01186744|19214717|P3|COMPLETED|Overall Study||25
7805519|NCT01186744|19214718|P2|COMPLETED|Overall Study||5
7805520|NCT01186744|19214719|P1|COMPLETED|Overall Study||10
7805523|NCT01186744|19214716|P4|STARTED|Overall Study||82
7805524|NCT01186744|19214717|P3|STARTED|Overall Study||31
7805525|NCT01186744|19214718|P2|STARTED|Overall Study||157
7805526|NCT01186744|19214719|P1|STARTED|Overall Study||218
7805527|NCT01186705|19215135|P1|NOT COMPLETED|Overall Study||0
7805528|NCT01186705|19215135|P1|COMPLETED|Overall Study||1
7805529|NCT01186705|19215135|P1|STARTED|Overall Study||1
7805530|NCT01186692|19215139|P1|NOT COMPLETED|Overall Study||32
7805531|NCT01186692|19215139|P1|COMPLETED|Overall Study||99
7805532|NCT01186692|19215139|P1|STARTED|Overall Study||131
7805533|NCT01186562|19215149|P2|NOT COMPLETED|Overall Study||2
7805534|NCT01186562|19215150|P1|NOT COMPLETED|Overall Study||4
7805535|NCT01186562|19215149|P2|COMPLETED|Overall Study||27
7805536|NCT01186562|19215150|P1|COMPLETED|Overall Study||50
7805537|NCT01186562|19215149|P2|STARTED|Overall Study||29
7805538|NCT01186562|19215150|P1|STARTED|Overall Study||54
7805539|NCT01186458|19215166|P1|NOT COMPLETED|Overall Study||1
7805540|NCT01186458|19215166|P1|COMPLETED|Overall Study||3
7805541|NCT01186458|19215166|P1|STARTED|Overall Study||4
7805542|NCT01186419|19215175|P2|NOT COMPLETED|Overall Study||9
7805543|NCT01186419|19215176|P1|NOT COMPLETED|Overall Study||7
7805544|NCT01186419|19215175|P2|COMPLETED|Overall Study||18
7805545|NCT01186419|19215176|P1|COMPLETED|Overall Study||17
7805546|NCT01186419|19215175|P2|STARTED|Overall Study||27
7805547|NCT01186419|19215176|P1|STARTED|Overall Study||24
7805548|NCT01186406|19215183|P1|NOT COMPLETED|Overall Study||0
7805549|NCT01186406|19215183|P1|COMPLETED|Overall Study||41
7805550|NCT01186406|19215183|P1|STARTED|Overall Study||41
7805551|NCT01186328|19215190|P3|NOT COMPLETED|Overall Study||0
7805552|NCT01186328|19215191|P2|NOT COMPLETED|Overall Study||0
7805553|NCT01186328|19215192|P1|NOT COMPLETED|Overall Study||1
7805554|NCT01186328|19215190|P3|COMPLETED|Overall Study||0
7805555|NCT01186328|19215191|P2|COMPLETED|Overall Study||0
7805556|NCT01186328|19215192|P1|COMPLETED|Overall Study||5
7805557|NCT01186328|19215190|P3|STARTED|Overall Study||0
7805558|NCT01186328|19215191|P2|STARTED|Overall Study||0
7805559|NCT01186328|19215192|P1|STARTED|Overall Study||6
7805560|NCT01186250|19215200|P2|NOT COMPLETED|Overall Study||0
7805561|NCT01186250|19215201|P1|NOT COMPLETED|Overall Study||1
7805562|NCT01186250|19215200|P2|COMPLETED|Overall Study||9
7805563|NCT01186250|19215201|P1|COMPLETED|Overall Study||8
7805564|NCT01186250|19215200|P2|STARTED|Overall Study||9
7805565|NCT01186250|19215201|P1|STARTED|Overall Study||9
7805566|NCT01185964|19215222|P4|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5
7805567|NCT01185964|19215223|P3|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
7805568|NCT01185964|19215224|P2|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
7805569|NCT01185964|19215225|P1|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
7805570|NCT01185964|19215222|P4|COMPLETED|Optional Olaratumab Monotherapy on Dox||25
7805571|NCT01185964|19215223|P3|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
7805572|NCT01185964|19215224|P2|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
7805573|NCT01185964|19215225|P1|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
7805574|NCT01185964|19215222|P4|STARTED|Optional Olaratumab Monotherapy on Dox|Participants with disease progression after treatment received olaratumab.|30
7805575|NCT01185964|19215223|P3|STARTED|Optional Olaratumab Monotherapy on Dox||0
7805576|NCT01185964|19215224|P2|STARTED|Optional Olaratumab Monotherapy on Dox||0
7805577|NCT01185964|19215225|P1|STARTED|Optional Olaratumab Monotherapy on Dox||0
7805578|NCT01185964|19215222|P4|NOT COMPLETED|Phase 1b and Phase 2||0
7805579|NCT01185964|19215223|P3|NOT COMPLETED|Phase 1b and Phase 2||9
7805580|NCT01185964|19215224|P2|NOT COMPLETED|Phase 1b and Phase 2||10
7805581|NCT01185964|19215225|P1|NOT COMPLETED|Phase 1b and Phase 2||2
7805582|NCT01185964|19215222|P4|COMPLETED|Phase 1b and Phase 2||0
7805583|NCT01185964|19215223|P3|COMPLETED|Phase 1b and Phase 2||58
7805584|NCT01185964|19215224|P2|COMPLETED|Phase 1b and Phase 2||56
7805585|NCT01185964|19215225|P1|COMPLETED|Phase 1b and Phase 2||13
7805586|NCT01185964|19215222|P4|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0
7805587|NCT01185964|19215223|P3|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65
7805588|NCT01185964|19215224|P2|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64
7805589|NCT01185964|19215225|P1|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15
7805590|NCT01185964|19215222|P4|STARTED|Phase 1b and Phase 2||0
7805591|NCT01185964|19215223|P3|STARTED|Phase 1b and Phase 2||67
7805592|NCT01185964|19215224|P2|STARTED|Phase 1b and Phase 2||66
7805593|NCT01185964|19215225|P1|STARTED|Phase 1b and Phase 2||15
7805594|NCT01185834|19215251|P1|NOT COMPLETED|Overall Study||14
7805595|NCT01185834|19215251|P1|COMPLETED|Overall Study||104
7805596|NCT01185834|19215251|P1|STARTED|Overall Study||118
7805597|NCT01185821|19215261|P5|NOT COMPLETED|Overall Study||24
7805598|NCT01185821|19215262|P4|NOT COMPLETED|Overall Study||6
7805599|NCT01185821|19215263|P3|NOT COMPLETED|Overall Study||10
7805600|NCT01185821|19215264|P2|NOT COMPLETED|Overall Study||9
7805601|NCT01185821|19215265|P1|NOT COMPLETED|Overall Study||7
7805602|NCT01185821|19215261|P5|COMPLETED|Overall Study||26
7805603|NCT01185821|19215262|P4|COMPLETED|Overall Study||23
7805604|NCT01185821|19215263|P3|COMPLETED|Overall Study||33
7805605|NCT01185821|19215264|P2|COMPLETED|Overall Study||20
7805606|NCT01185821|19215265|P1|COMPLETED|Overall Study||26
7805607|NCT01185821|19215261|P5|Patients on Placebo in Core|Overall Study||2
7805608|NCT01185821|19215262|P4|Patients on Placebo in Core|Overall Study||8
7805609|NCT01185821|19215263|P3|Patients on Placebo in Core|Overall Study||9
7805610|NCT01185821|19215264|P2|Patients on Placebo in Core|Overall Study||7
7805611|NCT01185821|19215265|P1|Patients on Placebo in Core|Overall Study||8
7805612|NCT01185821|19215261|P5|Patients Without Washout|Overall Study||17
7805613|NCT01185821|19215262|P4|Patients Without Washout|Overall Study||0
7805614|NCT01185821|19215263|P3|Patients Without Washout|Overall Study||4
7805615|NCT01185821|19215264|P2|Patients Without Washout|Overall Study||0
7805616|NCT01185821|19215265|P1|Patients Without Washout|Overall Study||0
7805617|NCT01185821|19215261|P5|Patients With Washout|Overall Study||33
7805618|NCT01185821|19215262|P4|Patients With Washout|Overall Study||29
7805619|NCT01185821|19215263|P3|Patients With Washout|Overall Study||39
7805620|NCT01185821|19215264|P2|Patients With Washout|Overall Study||29
7805621|NCT01185821|19215265|P1|Patients With Washout|Overall Study||33
7805622|NCT01185821|19215261|P5|STARTED|Overall Study||50
7805623|NCT01185821|19215262|P4|STARTED|Overall Study||29
7805624|NCT01185821|19215263|P3|STARTED|Overall Study||43
7805625|NCT01185821|19215264|P2|STARTED|Overall Study||29
7805626|NCT01185821|19215265|P1|STARTED|Overall Study||33
7805627|NCT01185782|19215316|P2|NOT COMPLETED|Overall Study||11
7805628|NCT01185782|19215317|P1|NOT COMPLETED|Overall Study||6
7805629|NCT01185782|19215316|P2|COMPLETED|Overall Study||125
7805630|NCT01185782|19215317|P1|COMPLETED|Overall Study||123
7805631|NCT01185782|19215316|P2|Treated|Overall Study||132
7805632|NCT01185782|19215317|P1|Treated|Overall Study||129
7805633|NCT01185782|19215316|P2|STARTED|Overall Study||136
7805634|NCT01185782|19215317|P1|STARTED|Overall Study||129
7805635|NCT01185704|19215345|P2|NOT COMPLETED|Overall Study||8
7805636|NCT01185704|19215346|P1|NOT COMPLETED|Overall Study||13
7805637|NCT01185704|19215345|P2|COMPLETED|Overall Study||60
7805638|NCT01185704|19215346|P1|COMPLETED|Overall Study||55
7805639|NCT01185704|19215345|P2|Treated|Overall Study||65
7805640|NCT01185704|19215346|P1|Treated|Overall Study||65
7805641|NCT01185704|19215345|P2|STARTED|Overall Study||68
7805642|NCT01185704|19215346|P1|STARTED|Overall Study||68
7805643|NCT01185639|19215380|P1|NOT COMPLETED|Overall Study||2
7805644|NCT01185639|19215380|P1|COMPLETED|Overall Study||27
7805645|NCT01185639|19215380|P1|STARTED|Overall Study||29
7805646|NCT01185600|19215390|P2|NOT COMPLETED|Overall Study||45
7805647|NCT01185600|19215391|P1|NOT COMPLETED|Overall Study||32
7805648|NCT01185600|19215390|P2|COMPLETED|Overall Study||59
7805649|NCT01185600|19215391|P1|COMPLETED|Overall Study||41
7805650|NCT01185600|19215390|P2|STARTED|Overall Study||104
7805651|NCT01185600|19215391|P1|STARTED|Overall Study||73
7805652|NCT01185561|19215413|P2|NOT COMPLETED|Overall Study||12
7805653|NCT01185561|19215414|P1|NOT COMPLETED|Overall Study||2
7805654|NCT01185561|19215413|P2|COMPLETED|Overall Study||26
7805655|NCT01185561|19215414|P1|COMPLETED|Overall Study||34
7805656|NCT01185561|19215413|P2|STARTED|Overall Study||38
7805657|NCT01185561|19215414|P1|STARTED|Overall Study||36
7805658|NCT01185548|19215426|P1|NOT COMPLETED|Period 3: Tasisulam and Tolbutamide||0
7805659|NCT01185548|19215426|P1|COMPLETED|Period 3: Tasisulam and Tolbutamide||2
7805660|NCT01185548|19215426|P1|STARTED|Period 3: Tasisulam and Tolbutamide||2
7805661|NCT01185548|19215426|P1|NOT COMPLETED|Period 2: Tasisulam and Tolbutamide||2
7805662|NCT01185548|19215426|P1|COMPLETED|Period 2: Tasisulam and Tolbutamide||2
7805663|NCT01185548|19215426|P1|STARTED|Period 2: Tasisulam and Tolbutamide||4
7805664|NCT01185548|19215426|P1|NOT COMPLETED|Period 1 : Tolbutamide||0
7805665|NCT01185548|19215426|P1|COMPLETED|Period 1 : Tolbutamide||4
7805666|NCT01185548|19215426|P1|STARTED|Period 1 : Tolbutamide||4
7805667|NCT01185522|19215439|P1|NOT COMPLETED|Overall Study||108
7805668|NCT01185522|19215439|P1|COMPLETED|Overall Study||585
7805669|NCT01185522|19215439|P1|STARTED|Overall Study||693
7805670|NCT01185509|19215465|P2|NOT COMPLETED|Overall Study||20
7805671|NCT01185509|19215466|P1|NOT COMPLETED|Overall Study||11
7805672|NCT01185509|19215465|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
7805673|NCT01185509|19215466|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
7805674|NCT01185509|19215465|P2|STARTED|Overall Study||20
7805675|NCT01185509|19215466|P1|STARTED|Overall Study||11
7805676|NCT01185353|19215482|P10|NOT COMPLETED|Part D (Weeks 76 Through 128)||1
7805677|NCT01185353|19215483|P9|NOT COMPLETED|Part D (Weeks 76 Through 128)||7
7805678|NCT01185353|19215484|P8|NOT COMPLETED|Part D (Weeks 76 Through 128)||3
7805679|NCT01185353|19215485|P7|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
7805680|NCT01185353|19215486|P6|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
7805681|NCT01185353|19215487|P5|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
7805682|NCT01185353|19215488|P4|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
7805683|NCT01185353|19215489|P3|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
7805684|NCT01185353|19215490|P2|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
7805685|NCT01185353|19215491|P1|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
7805686|NCT01185353|19215482|P10|COMPLETED|Part D (Weeks 76 Through 128)||17
7805687|NCT01185353|19215483|P9|COMPLETED|Part D (Weeks 76 Through 128)||40
7805688|NCT01185353|19215484|P8|COMPLETED|Part D (Weeks 76 Through 128)||76
7805689|NCT01185353|19215485|P7|COMPLETED|Part D (Weeks 76 Through 128)||0
7805690|NCT01185353|19215486|P6|COMPLETED|Part D (Weeks 76 Through 128)||0
7805691|NCT01185353|19215487|P5|COMPLETED|Part D (Weeks 76 Through 128)||0
7805692|NCT01185353|19215488|P4|COMPLETED|Part D (Weeks 76 Through 128)||0
7805693|NCT01185353|19215489|P3|COMPLETED|Part D (Weeks 76 Through 128)||0
7805694|NCT01185353|19215490|P2|COMPLETED|Part D (Weeks 76 Through 128)||0
7805695|NCT01185353|19215491|P1|COMPLETED|Part D (Weeks 76 Through 128)||0
7805696|NCT01185353|19215482|P10|STARTED|Part D (Weeks 76 Through 128)||18
7805697|NCT01185353|19215483|P9|STARTED|Part D (Weeks 76 Through 128)||47
7805698|NCT01185353|19215484|P8|STARTED|Part D (Weeks 76 Through 128)||79
7805699|NCT01185353|19215485|P7|STARTED|Part D (Weeks 76 Through 128)||0
7805700|NCT01185353|19215486|P6|STARTED|Part D (Weeks 76 Through 128)||0
7805701|NCT01185353|19215487|P5|STARTED|Part D (Weeks 76 Through 128)||0
7805702|NCT01185353|19215488|P4|STARTED|Part D (Weeks 76 Through 128)||0
7805703|NCT01185353|19215489|P3|STARTED|Part D (Weeks 76 Through 128)||0
7805704|NCT01185353|19215490|P2|STARTED|Part D (Weeks 76 Through 128)||0
7805705|NCT01185353|19215491|P1|STARTED|Part D (Weeks 76 Through 128)||0
7805706|NCT01185353|19215482|P10|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
7805707|NCT01185353|19215483|P9|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
7805708|NCT01185353|19215484|P8|NOT COMPLETED|Part C (Weeks 24 Through 76)||16
7805709|NCT01185353|19215485|P7|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
7805710|NCT01185353|19215486|P6|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
7805711|NCT01185353|19215487|P5|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
7805712|NCT01185353|19215488|P4|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
7805713|NCT01185353|19215489|P3|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
7805714|NCT01185353|19215490|P2|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
7805715|NCT01185353|19215491|P1|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
7805716|NCT01185353|19215482|P10|COMPLETED|Part C (Weeks 24 Through 76)||24
7805717|NCT01185353|19215483|P9|COMPLETED|Part C (Weeks 24 Through 76)||53
7805718|NCT01185353|19215484|P8|COMPLETED|Part C (Weeks 24 Through 76)||92
7805719|NCT01185353|19215485|P7|COMPLETED|Part C (Weeks 24 Through 76)||0
7805720|NCT01185353|19215486|P6|COMPLETED|Part C (Weeks 24 Through 76)||0
7805721|NCT01185353|19215487|P5|COMPLETED|Part C (Weeks 24 Through 76)||0
7805722|NCT01185353|19215488|P4|COMPLETED|Part C (Weeks 24 Through 76)||0
7805723|NCT01185353|19215489|P3|COMPLETED|Part C (Weeks 24 Through 76)||0
7805724|NCT01185353|19215490|P2|COMPLETED|Part C (Weeks 24 Through 76)||0
7805725|NCT01185353|19215491|P1|COMPLETED|Part C (Weeks 24 Through 76)||0
7805726|NCT01185353|19215482|P10|STARTED|Part C (Weeks 24 Through 76)||32
7805727|NCT01185353|19215483|P9|STARTED|Part C (Weeks 24 Through 76)||61
7805728|NCT01185353|19215484|P8|STARTED|Part C (Weeks 24 Through 76)||108
7805729|NCT01185353|19215485|P7|STARTED|Part C (Weeks 24 Through 76)||0
7805730|NCT01185353|19215486|P6|STARTED|Part C (Weeks 24 Through 76)||0
7805731|NCT01185353|19215487|P5|STARTED|Part C (Weeks 24 Through 76)||0
7805732|NCT01185353|19215488|P4|STARTED|Part C (Weeks 24 Through 76)||0
7805733|NCT01185353|19215489|P3|STARTED|Part C (Weeks 24 Through 76)||0
7805734|NCT01185353|19215490|P2|STARTED|Part C (Weeks 24 Through 76)||0
7805735|NCT01185353|19215491|P1|STARTED|Part C (Weeks 24 Through 76)||0
7805736|NCT01185353|19215482|P10|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
7805737|NCT01185353|19215483|P9|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
7805738|NCT01185353|19215484|P8|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
7805739|NCT01185353|19215485|P7|NOT COMPLETED|Part B (Weeks 12 Through 24)||6
7805740|NCT01185353|19215486|P6|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
7805741|NCT01185353|19215487|P5|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
7805742|NCT01185353|19215488|P4|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
7805743|NCT01185353|19215489|P3|NOT COMPLETED|Part B (Weeks 12 Through 24)||2
7805744|NCT01185353|19215490|P2|NOT COMPLETED|Part B (Weeks 12 Through 24)||1
7805745|NCT01185353|19215491|P1|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
7805746|NCT01185353|19215482|P10|COMPLETED|Part B (Weeks 12 Through 24)||0
7805747|NCT01185353|19215483|P9|COMPLETED|Part B (Weeks 12 Through 24)||0
7805748|NCT01185353|19215484|P8|COMPLETED|Part B (Weeks 12 Through 24)||0
7805749|NCT01185353|19215485|P7|COMPLETED|Part B (Weeks 12 Through 24)||57
7805750|NCT01185353|19215486|P6|COMPLETED|Part B (Weeks 12 Through 24)||59
7805751|NCT01185353|19215487|P5|COMPLETED|Part B (Weeks 12 Through 24)||0
7805752|NCT01185353|19215488|P4|COMPLETED|Part B (Weeks 12 Through 24)||45
7805753|NCT01185353|19215489|P3|COMPLETED|Part B (Weeks 12 Through 24)||48
7805754|NCT01185353|19215490|P2|COMPLETED|Part B (Weeks 12 Through 24)||50
7805755|NCT01185353|19215491|P1|COMPLETED|Part B (Weeks 12 Through 24)||0
7805756|NCT01185353|19215482|P10|STARTED|Part B (Weeks 12 Through 24)||0
7805757|NCT01185353|19215483|P9|STARTED|Part B (Weeks 12 Through 24)||0
7805758|NCT01185353|19215484|P8|STARTED|Part B (Weeks 12 Through 24)||0
7805759|NCT01185353|19215485|P7|STARTED|Part B (Weeks 12 Through 24)||63
7805760|NCT01185353|19215486|P6|STARTED|Part B (Weeks 12 Through 24)||63
7805761|NCT01185353|19215487|P5|STARTED|Part B (Weeks 12 Through 24)||0
7805762|NCT01185353|19215488|P4|STARTED|Part B (Weeks 12 Through 24)||49
7805763|NCT01185353|19215489|P3|STARTED|Part B (Weeks 12 Through 24)||50
7805764|NCT01185353|19215490|P2|STARTED|Part B (Weeks 12 Through 24)||51
7805765|NCT01185353|19215491|P1|STARTED|Part B (Weeks 12 Through 24)||0
7805766|NCT01185353|19215482|P10|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
7805767|NCT01185353|19215483|P9|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
7805768|NCT01185353|19215484|P8|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
7805769|NCT01185353|19215485|P7|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
7805770|NCT01185353|19215486|P6|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
7805771|NCT01185353|19215487|P5|NOT COMPLETED|Part A (Weeks 0 Through 12)||16
7805772|NCT01185353|19215488|P4|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
7805773|NCT01185353|19215489|P3|NOT COMPLETED|Part A (Weeks 0 Through 12)||2
7805774|NCT01185353|19215490|P2|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
7805775|NCT01185353|19215491|P1|NOT COMPLETED|Part A (Weeks 0 Through 12)||5
7805776|NCT01185353|19215482|P10|COMPLETED|Part A (Weeks 0 Through 12)||0
7805777|NCT01185353|19215483|P9|COMPLETED|Part A (Weeks 0 Through 12)||0
7805778|NCT01185353|19215484|P8|COMPLETED|Part A (Weeks 0 Through 12)||0
7805779|NCT01185353|19215485|P7|COMPLETED|Part A (Weeks 0 Through 12)||0
7805780|NCT01185353|19215486|P6|COMPLETED|Part A (Weeks 0 Through 12)||0
7805781|NCT01185353|19215487|P5|COMPLETED|Part A (Weeks 0 Through 12)||82
7805782|NCT01185353|19215488|P4|COMPLETED|Part A (Weeks 0 Through 12)||49
7805783|NCT01185353|19215489|P3|COMPLETED|Part A (Weeks 0 Through 12)||50
7805784|NCT01185353|19215490|P2|COMPLETED|Part A (Weeks 0 Through 12)||51
7805785|NCT01185353|19215491|P1|COMPLETED|Part A (Weeks 0 Through 12)||44
7805786|NCT01185353|19215482|P10|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
7805787|NCT01185353|19215483|P9|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
7805788|NCT01185353|19215484|P8|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
7805789|NCT01185353|19215485|P7|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
7805790|NCT01185353|19215486|P6|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
7805791|NCT01185353|19215487|P5|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98
7805792|NCT01185353|19215488|P4|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50
7805793|NCT01185353|19215489|P3|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
7805794|NCT01185353|19215490|P2|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
7805795|NCT01185353|19215491|P1|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49
7805796|NCT01185353|19215482|P10|STARTED|Part A (Weeks 0 Through 12)||0
7805797|NCT01185353|19215483|P9|STARTED|Part A (Weeks 0 Through 12)||0
7805798|NCT01185353|19215484|P8|STARTED|Part A (Weeks 0 Through 12)||0
7805799|NCT01185353|19215485|P7|STARTED|Part A (Weeks 0 Through 12)||0
7805800|NCT01185353|19215486|P6|STARTED|Part A (Weeks 0 Through 12)||0
7805801|NCT01185353|19215487|P5|STARTED|Part A (Weeks 0 Through 12)||98
7805802|NCT01185353|19215488|P4|STARTED|Part A (Weeks 0 Through 12)||50
7805803|NCT01185353|19215489|P3|STARTED|Part A (Weeks 0 Through 12)||52
7805804|NCT01185353|19215490|P2|STARTED|Part A (Weeks 0 Through 12)||52
7805805|NCT01185353|19215491|P1|STARTED|Part A (Weeks 0 Through 12)||49
7805806|NCT01185340|19215652|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||61
7805807|NCT01185340|19215653|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
7805808|NCT01185340|19215654|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
7805809|NCT01185340|19215655|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
7805810|NCT01185340|19215652|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||458
7805811|NCT01185340|19215653|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||186
7805812|NCT01185340|19215654|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||195
7805813|NCT01185340|19215655|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
7805814|NCT01185340|19215652|P4|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|483
7805815|NCT01185340|19215653|P3|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|204
7805816|NCT01185340|19215654|P2|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|206
7805817|NCT01185340|19215655|P1|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
7805818|NCT01185340|19215652|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||519
7805819|NCT01185340|19215653|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||219
7805820|NCT01185340|19215654|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
7805821|NCT01185340|19215655|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
7805822|NCT01185340|19215652|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7805823|NCT01185340|19215653|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7805824|NCT01185340|19215654|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7805825|NCT01185340|19215655|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
7805826|NCT01185340|19215652|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7805827|NCT01185340|19215653|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7805828|NCT01185340|19215654|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7805829|NCT01185340|19215655|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|968
7805830|NCT01185340|19215652|P4|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
7805831|NCT01185340|19215653|P3|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
7805832|NCT01185340|19215654|P2|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
7805833|NCT01185340|19215655|P1|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|18
7805834|NCT01185340|19215652|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
7805835|NCT01185340|19215653|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
7805836|NCT01185340|19215654|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
7805837|NCT01185340|19215655|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1056
7805838|NCT01185301|19215707|P4|NOT COMPLETED|Overall Study||9
7805839|NCT01185301|19215708|P3|NOT COMPLETED|Overall Study||6
7805840|NCT01185301|19215709|P2|NOT COMPLETED|Overall Study||7
7805841|NCT01185301|19215710|P1|NOT COMPLETED|Overall Study||15
7805842|NCT01185301|19215707|P4|COMPLETED|Overall Study||89
7805843|NCT01185301|19215708|P3|COMPLETED|Overall Study||93
7805844|NCT01185301|19215709|P2|COMPLETED|Overall Study||93
7805845|NCT01185301|19215710|P1|COMPLETED|Overall Study||83
7805846|NCT01185301|19215707|P4|STARTED|Overall Study||98
7805847|NCT01185301|19215708|P3|STARTED|Overall Study||99
7805848|NCT01185301|19215709|P2|STARTED|Overall Study||100
7805849|NCT01185301|19215710|P1|STARTED|Overall Study||98
7805850|NCT01185288|19215770|P2|NOT COMPLETED|Overall Study||16
7805851|NCT01185288|19215771|P1|NOT COMPLETED|Overall Study||19
7805852|NCT01185288|19215770|P2|COMPLETED|Overall Study||139
7805853|NCT01185288|19215771|P1|COMPLETED|Overall Study||135
7805854|NCT01185288|19215770|P2|STARTED|Overall Study||155
7805855|NCT01185288|19215771|P1|STARTED|Overall Study||154
7805856|NCT01185249|19215789|P1|NOT COMPLETED|Overall Study||42
7805857|NCT01185249|19215789|P1|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24
7805858|NCT01185249|19215789|P1|STARTED|Overall Study|Total number of patients consented to participate.|66
7805859|NCT01185171|19215794|P1|NOT COMPLETED|Maintenance||12
7805860|NCT01185171|19215794|P1|COMPLETED|Maintenance||48
7805861|NCT01185171|19215794|P1|STARTED|Maintenance||60
7805862|NCT01185171|19215794|P1|NOT COMPLETED|Concurrent Chemo and Radiation Treatment||3
7805863|NCT01185171|19215794|P1|COMPLETED|Concurrent Chemo and Radiation Treatment||66
7805864|NCT01185171|19215794|P1|STARTED|Concurrent Chemo and Radiation Treatment||69
7805865|NCT01185171|19215794|P1|NOT COMPLETED|Induction Chemotherapy||2
7805866|NCT01185171|19215794|P1|COMPLETED|Induction Chemotherapy||57
7805867|NCT01185171|19215794|P1|STARTED|Induction Chemotherapy||59
7805868|NCT01185080|19215804|P3|NOT COMPLETED|Overall Study||1
7805869|NCT01185080|19215805|P2|NOT COMPLETED|Overall Study||1
7805870|NCT01185080|19215806|P1|NOT COMPLETED|Overall Study||1
7805871|NCT01185080|19215804|P3|COMPLETED|Overall Study||16
7805872|NCT01185080|19215805|P2|COMPLETED|Overall Study||15
7805873|NCT01185080|19215806|P1|COMPLETED|Overall Study||49
7805874|NCT01185080|19215804|P3|STARTED|Overall Study||17
7805875|NCT01185080|19215805|P2|STARTED|Overall Study||16
7805876|NCT01185080|19215806|P1|STARTED|Overall Study||50
7805877|NCT01185028|19215853|P1|NOT COMPLETED|Overall Study||4
7805878|NCT01185028|19215853|P1|COMPLETED|Overall Study||4
7805879|NCT01185028|19215853|P1|STARTED|Overall Study||8
7805880|NCT01184989|19215858|P1|NOT COMPLETED|Overall Study||12
7805881|NCT01184989|19215858|P1|COMPLETED|Overall Study||100
7805882|NCT01184989|19215858|P1|STARTED|Overall Study|Treated Patients|112
7805883|NCT01184898|19215864|P1|NOT COMPLETED|Overall Study||0
7805884|NCT01184898|19215864|P1|COMPLETED|Overall Study||36
7805885|NCT01184898|19215864|P1|STARTED|Overall Study||36
7805886|NCT01184885|19215871|P1|NOT COMPLETED|Overall Study||0
7805887|NCT01184885|19215871|P1|COMPLETED|Overall Study||7
7805888|NCT01184885|19215871|P1|STARTED|Overall Study||7
7805889|NCT01184872|19215878|P2|NOT COMPLETED|Overall Study||8
7805890|NCT01184872|19215879|P1|NOT COMPLETED|Overall Study||10
7805891|NCT01184872|19215878|P2|COMPLETED|Overall Study||31
7805892|NCT01184872|19215879|P1|COMPLETED|Overall Study||71
7805893|NCT01184872|19215878|P2|Microbiologically Evaluable Set (MES)|Overall Study||27
7805894|NCT01184872|19215879|P1|Microbiologically Evaluable Set (MES)|Overall Study||65
7805895|NCT01184872|19215878|P2|Clinical Evaluable Set (CES)|Overall Study||30
7805896|NCT01184872|19215879|P1|Clinical Evaluable Set (CES)|Overall Study||73
7805897|NCT01184872|19215878|P2|Safety Set|Overall Study||40
7805898|NCT01184872|19215879|P1|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80
7805899|NCT01184872|19215878|P2|STARTED|Overall Study||39
7805900|NCT01184872|19215879|P1|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81
7805901|NCT01184859|19215898|P5|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
7805902|NCT01184859|19215899|P4|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
7805903|NCT01184859|19215900|P3|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
7805904|NCT01184859|19215901|P2|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
7805905|NCT01184859|19215902|P1|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
7805906|NCT01184859|19215898|P5|COMPLETED|Period 2: Daily Dose for 28 Days||22
7805907|NCT01184859|19215899|P4|COMPLETED|Period 2: Daily Dose for 28 Days||22
7805908|NCT01184859|19215900|P3|COMPLETED|Period 2: Daily Dose for 28 Days||22
7805909|NCT01184859|19215901|P2|COMPLETED|Period 2: Daily Dose for 28 Days||23
7805910|NCT01184859|19215902|P1|COMPLETED|Period 2: Daily Dose for 28 Days||22
7805911|NCT01184859|19215898|P5|STARTED|Period 2: Daily Dose for 28 Days||23
7805912|NCT01184859|19215899|P4|STARTED|Period 2: Daily Dose for 28 Days||22
7805913|NCT01184859|19215900|P3|STARTED|Period 2: Daily Dose for 28 Days||22
7805914|NCT01184859|19215901|P2|STARTED|Period 2: Daily Dose for 28 Days||23
7805915|NCT01184859|19215902|P1|STARTED|Period 2: Daily Dose for 28 Days||23
7805916|NCT01184859|19215898|P5|NOT COMPLETED|Washout Period||0
7805917|NCT01184859|19215899|P4|NOT COMPLETED|Washout Period||0
7805918|NCT01184859|19215900|P3|NOT COMPLETED|Washout Period||0
7805919|NCT01184859|19215901|P2|NOT COMPLETED|Washout Period||0
7805920|NCT01184859|19215902|P1|NOT COMPLETED|Washout Period||0
7805921|NCT01184859|19215898|P5|COMPLETED|Washout Period||23
7805922|NCT01184859|19215899|P4|COMPLETED|Washout Period||22
7805923|NCT01184859|19215900|P3|COMPLETED|Washout Period||22
7805924|NCT01184859|19215901|P2|COMPLETED|Washout Period||23
7805925|NCT01184859|19215902|P1|COMPLETED|Washout Period||23
7805926|NCT01184859|19215898|P5|STARTED|Washout Period||23
7805927|NCT01184859|19215899|P4|STARTED|Washout Period||22
7805928|NCT01184859|19215900|P3|STARTED|Washout Period||22
7805929|NCT01184859|19215901|P2|STARTED|Washout Period||23
7805930|NCT01184859|19215902|P1|STARTED|Washout Period||23
7805931|NCT01184859|19215898|P5|NOT COMPLETED|Period 1: Single Dose||1
7805932|NCT01184859|19215899|P4|NOT COMPLETED|Period 1: Single Dose||0
7805933|NCT01184859|19215900|P3|NOT COMPLETED|Period 1: Single Dose||0
7805934|NCT01184859|19215901|P2|NOT COMPLETED|Period 1: Single Dose||2
7805935|NCT01184859|19215902|P1|NOT COMPLETED|Period 1: Single Dose||0
7805936|NCT01184859|19215898|P5|COMPLETED|Period 1: Single Dose||23
7805937|NCT01184859|19215899|P4|COMPLETED|Period 1: Single Dose||22
7805938|NCT01184859|19215900|P3|COMPLETED|Period 1: Single Dose||22
7805939|NCT01184859|19215901|P2|COMPLETED|Period 1: Single Dose||23
7805940|NCT01184859|19215902|P1|COMPLETED|Period 1: Single Dose||23
7805941|NCT01184859|19215898|P5|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23
7805942|NCT01184859|19215899|P4|Per Protocol (PP)|Period 1: Single Dose||21
7805943|NCT01184859|19215900|P3|Per Protocol (PP)|Period 1: Single Dose||22
7805944|NCT01184859|19215901|P2|Per Protocol (PP)|Period 1: Single Dose||23
7805945|NCT01184859|19215902|P1|Per Protocol (PP)|Period 1: Single Dose||23
7805946|NCT01184859|19215898|P5|Full Analysis Set (FAS)|Period 1: Single Dose||24
7805947|NCT01184859|19215899|P4|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21
7805948|NCT01184859|19215900|P3|Full Analysis Set (FAS)|Period 1: Single Dose||22
7805949|NCT01184859|19215901|P2|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23
7805950|NCT01184859|19215902|P1|Full Analysis Set (FAS)|Period 1: Single Dose||23
7805951|NCT01184859|19215898|P5|STARTED|Period 1: Single Dose||24
7805952|NCT01184859|19215899|P4|STARTED|Period 1: Single Dose||22
7805953|NCT01184859|19215900|P3|STARTED|Period 1: Single Dose||22
7805954|NCT01184859|19215901|P2|STARTED|Period 1: Single Dose||25
7805955|NCT01184859|19215902|P1|STARTED|Period 1: Single Dose||23
7805956|NCT01184846|19215994|P1|NOT COMPLETED|Overall Study||3
7805957|NCT01184846|19215994|P1|COMPLETED|Overall Study||25
7805958|NCT01184846|19215994|P1|STARTED|Overall Study||28
7805959|NCT01184755|19216015|P3|NOT COMPLETED|Overall Study||6
7805960|NCT01184755|19216016|P2|NOT COMPLETED|Overall Study||11
7805961|NCT01184755|19216017|P1|NOT COMPLETED|Overall Study||25
7805962|NCT01184755|19216015|P3|COMPLETED|Overall Study||56
7805963|NCT01184755|19216016|P2|COMPLETED|Overall Study||54
7805964|NCT01184755|19216017|P1|COMPLETED|Overall Study||101
7805965|NCT01184755|19216015|P3|STARTED|Overall Study||62
7805966|NCT01184755|19216016|P2|STARTED|Overall Study||65
7805967|NCT01184755|19216017|P1|STARTED|Overall Study||126
7805968|NCT01184508|19216027|P2|NOT COMPLETED|Overall Study||15
7805969|NCT01184508|19216028|P1|NOT COMPLETED|Overall Study||16
7805970|NCT01184508|19216027|P2|COMPLETED|Overall Study||27
7805971|NCT01184508|19216028|P1|COMPLETED|Overall Study||29
7805972|NCT01184508|19216027|P2|Received at Least 1 Dose of Study Drug|Overall Study||41
7805973|NCT01184508|19216028|P1|Received at Least 1 Dose of Study Drug|Overall Study||45
7805974|NCT01184508|19216027|P2|STARTED|Overall Study||42
7805975|NCT01184508|19216028|P1|STARTED|Overall Study||45
7805976|NCT01184456|19216055|P2|NOT COMPLETED|Overall Study||0
7805977|NCT01184456|19216056|P1|NOT COMPLETED|Overall Study||0
7805978|NCT01184456|19216055|P2|COMPLETED|Overall Study||0
7805979|NCT01184456|19216056|P1|COMPLETED|Overall Study||0
7805980|NCT01184456|19216055|P2|STARTED|Overall Study||0
7805981|NCT01184456|19216056|P1|STARTED|Overall Study||0
7805982|NCT01184417|19216064|P2|NOT COMPLETED|Overall Study||0
7805983|NCT01184417|19216065|P1|NOT COMPLETED|Overall Study||0
7805984|NCT01184417|19216064|P2|COMPLETED|Overall Study||51
7805985|NCT01184417|19216065|P1|COMPLETED|Overall Study||51
7805986|NCT01184417|19216064|P2|STARTED|Overall Study||51
7805987|NCT01184417|19216065|P1|STARTED|Overall Study||51
7805988|NCT01184326|19216088|P3|NOT COMPLETED|Overall Study||14
7805989|NCT01184326|19216089|P2|NOT COMPLETED|Overall Study||6
7805990|NCT01184326|19216090|P1|NOT COMPLETED|Overall Study||3
7805991|NCT01184326|19216088|P3|COMPLETED|Overall Study||0
7805992|NCT01184326|19216089|P2|COMPLETED|Overall Study||0
7805993|NCT01184326|19216090|P1|COMPLETED|Overall Study||0
7805994|NCT01184326|19216088|P3|STARTED|Overall Study||14
7805995|NCT01184326|19216089|P2|STARTED|Overall Study||6
7805996|NCT01184326|19216090|P1|STARTED|Overall Study||3
7805997|NCT01184118|19216104|P1|NOT COMPLETED|Overall Study||18
7805998|NCT01184118|19216104|P1|COMPLETED|Overall Study||18
7805999|NCT01184118|19216104|P1|FP MDI as Indicated (2 Weeks)|Overall Study||18
7806000|NCT01184118|19216104|P1|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18
7806001|NCT01184118|19216104|P1|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18
7806002|NCT01184118|19216104|P1|STARTED|Overall Study||36
7806003|NCT01184079|19216112|P2|NOT COMPLETED|Overall Study||2
7806004|NCT01184079|19216113|P1|NOT COMPLETED|Overall Study||14
7806005|NCT01184079|19216112|P2|COMPLETED|Overall Study||107
7806006|NCT01184079|19216113|P1|COMPLETED|Overall Study||97
7806007|NCT01184079|19216112|P2|Final Blood Draw|Overall Study||107
7806008|NCT01184079|19216113|P1|Final Blood Draw|Overall Study||97
7806009|NCT01184079|19216112|P2|Dose 3|Overall Study||107
7806010|NCT01184079|19216113|P1|Dose 3|Overall Study||101
7806011|NCT01184079|19216112|P2|Dose 2|Overall Study||108
7806012|NCT01184079|19216113|P1|Dose 2|Overall Study||110
7806013|NCT01184079|19216112|P2|STARTED|Overall Study||109
7806014|NCT01184079|19216113|P1|STARTED|Overall Study||111
7806015|NCT01184053|19216123|P1|NOT COMPLETED|Overall Study||3
7806016|NCT01184053|19216123|P1|COMPLETED|Overall Study||0
7806017|NCT01184053|19216123|P1|STARTED|Overall Study||3
7806018|NCT01184014|19216132|P2|NOT COMPLETED|Overall Study||6
7806019|NCT01184014|19216133|P1|NOT COMPLETED|Overall Study||5
7806020|NCT01184014|19216132|P2|COMPLETED|Overall Study||31
7806021|NCT01184014|19216133|P1|COMPLETED|Overall Study||30
7806022|NCT01184014|19216132|P2|STARTED|Overall Study||37
7806023|NCT01184014|19216133|P1|STARTED|Overall Study||35
7806024|NCT01183975|19216139|P1|NOT COMPLETED|Overall Study||73
7806025|NCT01183975|19216139|P1|COMPLETED|Overall Study||444
7806026|NCT01183975|19216139|P1|STARTED|Overall Study||517
7806027|NCT01183923|19216144|P2|NOT COMPLETED|Intervention 2 (7 Days)||0
7806028|NCT01183923|19216145|P1|NOT COMPLETED|Intervention 2 (7 Days)||0
7806029|NCT01183923|19216144|P2|COMPLETED|Intervention 2 (7 Days)||0
7806030|NCT01183923|19216145|P1|COMPLETED|Intervention 2 (7 Days)||1
7806031|NCT01183923|19216144|P2|STARTED|Intervention 2 (7 Days)||0
7806032|NCT01183923|19216145|P1|STARTED|Intervention 2 (7 Days)||1
7806033|NCT01183923|19216144|P2|NOT COMPLETED|Washout (14 Days)||0
7806034|NCT01183923|19216145|P1|NOT COMPLETED|Washout (14 Days)||0
7806035|NCT01183923|19216144|P2|COMPLETED|Washout (14 Days)||0
7806036|NCT01183923|19216145|P1|COMPLETED|Washout (14 Days)||1
7806037|NCT01183923|19216144|P2|STARTED|Washout (14 Days)||0
7806038|NCT01183923|19216145|P1|STARTED|Washout (14 Days)||1
7806039|NCT01183923|19216144|P2|NOT COMPLETED|Intervention 1 (7 Days)||0
7806040|NCT01183923|19216145|P1|NOT COMPLETED|Intervention 1 (7 Days)||0
7806041|NCT01183923|19216144|P2|COMPLETED|Intervention 1 (7 Days)||0
7806042|NCT01183923|19216145|P1|COMPLETED|Intervention 1 (7 Days)||1
7806043|NCT01183923|19216144|P2|STARTED|Intervention 1 (7 Days)||0
7806044|NCT01183923|19216145|P1|STARTED|Intervention 1 (7 Days)||1
7806045|NCT01183897|19216150|P1|NOT COMPLETED|Overall Study||0
7806046|NCT01183897|19216150|P1|COMPLETED|Overall Study||31
7806047|NCT01183897|19216150|P1|STARTED|Overall Study||31
7806048|NCT01183884|19216156|P1|NOT COMPLETED|Overall Study||38
7806049|NCT01183884|19216156|P1|COMPLETED|Overall Study||8
7806050|NCT01183884|19216156|P1|STARTED|Overall Study||46
7806051|NCT01183858|19216164|P2|NOT COMPLETED|Overall Study||156
7806052|NCT01183858|19216165|P1|NOT COMPLETED|Overall Study||153
7806053|NCT01183858|19216164|P2|COMPLETED|Overall Study||3
7806054|NCT01183858|19216165|P1|COMPLETED|Overall Study||1
7806055|NCT01183858|19216164|P2|Safety Population|Overall Study||158
7806056|NCT01183858|19216165|P1|Safety Population|Overall Study||154
7806057|NCT01183858|19216164|P2|STARTED|Overall Study||159
7806058|NCT01183858|19216165|P1|STARTED|Overall Study||154
7806059|NCT01183780|19216187|P2|NOT COMPLETED|Overall Study||25
7806060|NCT01183780|19216188|P1|NOT COMPLETED|Overall Study||31
7806061|NCT01183780|19216187|P2|COMPLETED|Overall Study||511
7806062|NCT01183780|19216188|P1|COMPLETED|Overall Study||505
7806063|NCT01183780|19216187|P2|Received at Least 1 Dose of Study Drug|Overall Study||529
7806064|NCT01183780|19216188|P1|Received at Least 1 Dose of Study Drug|Overall Study||528
7806065|NCT01183780|19216187|P2|STARTED|Overall Study||536
7806066|NCT01183780|19216188|P1|STARTED|Overall Study||536
7806067|NCT01183728|19216205|P1|NOT COMPLETED|Overall Study||0
7806068|NCT01183728|19216205|P1|COMPLETED|Overall Study||12
7806069|NCT01183728|19216205|P1|STARTED|Overall Study||12
7806070|NCT01183689|19216213|P3|NOT COMPLETED|Overall Study||0
7806071|NCT01183689|19216214|P2|NOT COMPLETED|Overall Study||0
7806072|NCT01183689|19216215|P1|NOT COMPLETED|Overall Study||0
7806073|NCT01183689|19216213|P3|COMPLETED|Overall Study||197
7806074|NCT01183689|19216214|P2|COMPLETED|Overall Study||200
7806075|NCT01183689|19216215|P1|COMPLETED|Overall Study||202
7806076|NCT01183689|19216213|P3|Year 4 Visit|Overall Study||30
7806077|NCT01183689|19216214|P2|Year 4 Visit|Overall Study||33
7806078|NCT01183689|19216215|P1|Year 4 Visit|Overall Study||38
7806079|NCT01183689|19216213|P3|Year 3 Visit|Overall Study||126
7806080|NCT01183689|19216214|P2|Year 3 Visit|Overall Study||125
7806081|NCT01183689|19216215|P1|Year 3 Visit|Overall Study||139
7806082|NCT01183689|19216213|P3|Year 2 Visit|Overall Study||174
7806083|NCT01183689|19216214|P2|Year 2 Visit|Overall Study||172
7806084|NCT01183689|19216215|P1|Year 2 Visit|Overall Study||178
7806085|NCT01183689|19216213|P3|Year 1 Visit|Overall Study||183
7806086|NCT01183689|19216214|P2|Year 1 Visit|Overall Study||172
7806087|NCT01183689|19216215|P1|Year 1 Visit|Overall Study||187
7806088|NCT01183689|19216213|P3|Month 4 Visit|Overall Study||187
7806089|NCT01183689|19216214|P2|Month 4 Visit|Overall Study||192
7806090|NCT01183689|19216215|P1|Month 4 Visit|Overall Study||197
7806091|NCT01183689|19216213|P3|STARTED|Overall Study||197
7806092|NCT01183689|19216214|P2|STARTED|Overall Study||200
7806093|NCT01183689|19216215|P1|STARTED|Overall Study||202
7806094|NCT01183650|19216285|P2|NOT COMPLETED|Overall Study||0
7806095|NCT01183650|19216286|P1|NOT COMPLETED|Overall Study||0
7806096|NCT01183650|19216285|P2|COMPLETED|Overall Study||12
7806097|NCT01183650|19216286|P1|COMPLETED|Overall Study||12
7806098|NCT01183650|19216285|P2|STARTED|Overall Study||12
7806099|NCT01183650|19216286|P1|STARTED|Overall Study||12
7806100|NCT01183546|19216296|P1|NOT COMPLETED|Overall Study||0
7806101|NCT01183546|19216296|P1|COMPLETED|Overall Study||53
7806102|NCT01183546|19216296|P1|STARTED|Overall Study||53
7806103|NCT01183533|19216303|P1|NOT COMPLETED|Overall Study||0
7806104|NCT01183533|19216303|P1|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40
7806105|NCT01183533|19216303|P1|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40
7806106|NCT01183481|19216309|P1|NOT COMPLETED|Overall Study||0
7806107|NCT01183481|19216309|P1|COMPLETED|Overall Study||19
7806108|NCT01183481|19216309|P1|STARTED|Overall Study||19
7806109|NCT01183468|19216321|P4|NOT COMPLETED|Overall Study||0
7806110|NCT01183468|19216322|P3|NOT COMPLETED|Overall Study||0
7806111|NCT01183468|19216323|P2|NOT COMPLETED|Overall Study||2
7806112|NCT01183468|19216324|P1|NOT COMPLETED|Overall Study||3
7806113|NCT01183468|19216321|P4|COMPLETED|Overall Study||0
7806114|NCT01183468|19216322|P3|COMPLETED|Overall Study||0
7806115|NCT01183468|19216323|P2|COMPLETED|Overall Study||7
7806116|NCT01183468|19216324|P1|COMPLETED|Overall Study||5
7806117|NCT01183468|19216321|P4|STARTED|Overall Study||0
7806118|NCT01183468|19216322|P3|STARTED|Overall Study||0
7806119|NCT01183468|19216323|P2|STARTED|Overall Study||9
7806120|NCT01183468|19216324|P1|STARTED|Overall Study||8
7806121|NCT01183429|19216332|P1|NOT COMPLETED|Overall Study||0
7806122|NCT01183429|19216332|P1|COMPLETED|Overall Study||39
7806123|NCT01183429|19216332|P1|STARTED|Overall Study||39
7806124|NCT01183416|19216338|P1|NOT COMPLETED|Overall Study||0
7806125|NCT01183416|19216338|P1|COMPLETED|Overall Study||4
7806126|NCT01183416|19216338|P1|STARTED|Overall Study||4
7806127|NCT01183390|19216346|P2|NOT COMPLETED|Second Intervention||0
7806128|NCT01183390|19216347|P1|NOT COMPLETED|Second Intervention||0
7806129|NCT01183390|19216346|P2|COMPLETED|Second Intervention||10
7806130|NCT01183390|19216347|P1|COMPLETED|Second Intervention||11
7806131|NCT01183390|19216346|P2|STARTED|Second Intervention||10
7806132|NCT01183390|19216347|P1|STARTED|Second Intervention||11
7806133|NCT01183390|19216346|P2|NOT COMPLETED|Washout of 21 Days||0
7806134|NCT01183390|19216347|P1|NOT COMPLETED|Washout of 21 Days||0
7806135|NCT01183390|19216346|P2|COMPLETED|Washout of 21 Days||10
7806136|NCT01183390|19216347|P1|COMPLETED|Washout of 21 Days||11
7806137|NCT01183390|19216346|P2|STARTED|Washout of 21 Days||10
7806138|NCT01183390|19216347|P1|STARTED|Washout of 21 Days||11
7806139|NCT01183390|19216346|P2|NOT COMPLETED|First Intervention||1
7806140|NCT01183390|19216347|P1|NOT COMPLETED|First Intervention||0
7806141|NCT01183390|19216346|P2|COMPLETED|First Intervention||10
7806142|NCT01183390|19216347|P1|COMPLETED|First Intervention||11
7806143|NCT01183390|19216346|P2|STARTED|First Intervention||11
7806144|NCT01183390|19216347|P1|STARTED|First Intervention||11
7806145|NCT01183312|19216357|P2|NOT COMPLETED|Second Intervention Day||0
7806146|NCT01183312|19216358|P1|NOT COMPLETED|Second Intervention Day||0
7806147|NCT01183312|19216357|P2|COMPLETED|Second Intervention Day||5
7806148|NCT01183312|19216358|P1|COMPLETED|Second Intervention Day||5
7806149|NCT01183312|19216357|P2|STARTED|Second Intervention Day||5
7806150|NCT01183312|19216358|P1|STARTED|Second Intervention Day||5
7806151|NCT01183312|19216357|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
7806152|NCT01183312|19216358|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
7806153|NCT01183312|19216357|P2|COMPLETED|Washout Period of at Least 1 Week||5
7806154|NCT01183312|19216358|P1|COMPLETED|Washout Period of at Least 1 Week||5
7806155|NCT01183312|19216357|P2|STARTED|Washout Period of at Least 1 Week||5
7806156|NCT01183312|19216358|P1|STARTED|Washout Period of at Least 1 Week||5
7806157|NCT01183312|19216357|P2|NOT COMPLETED|First Intervention Day||0
7806158|NCT01183312|19216358|P1|NOT COMPLETED|First Intervention Day||0
7806159|NCT01183312|19216357|P2|COMPLETED|First Intervention Day||5
7806160|NCT01183312|19216358|P1|COMPLETED|First Intervention Day||5
7806161|NCT01183312|19216357|P2|STARTED|First Intervention Day||5
7806162|NCT01183312|19216358|P1|STARTED|First Intervention Day||5
7806163|NCT01183260|19216380|P2|NOT COMPLETED|Overall Study||2
7806164|NCT01183260|19216381|P1|NOT COMPLETED|Overall Study||4
7806165|NCT01183260|19216380|P2|COMPLETED|Overall Study||9
7806166|NCT01183260|19216381|P1|COMPLETED|Overall Study||10
7806167|NCT01183260|19216380|P2|STARTED|Overall Study||11
7806168|NCT01183260|19216381|P1|STARTED|Overall Study||14
7806169|NCT01183234|19216391|P2|NOT COMPLETED|Second Intervention||0
7806170|NCT01183234|19216392|P1|NOT COMPLETED|Second Intervention||0
7806171|NCT01183234|19216391|P2|COMPLETED|Second Intervention||14
7806172|NCT01183234|19216392|P1|COMPLETED|Second Intervention||13
7806173|NCT01183234|19216391|P2|STARTED|Second Intervention||14
7806174|NCT01183234|19216392|P1|STARTED|Second Intervention||13
7806175|NCT01183234|19216391|P2|NOT COMPLETED|Washout||0
7806176|NCT01183234|19216392|P1|NOT COMPLETED|Washout||0
7806177|NCT01183234|19216391|P2|COMPLETED|Washout||14
7806178|NCT01183234|19216392|P1|COMPLETED|Washout||13
7806179|NCT01183234|19216391|P2|STARTED|Washout||14
7806180|NCT01183234|19216392|P1|STARTED|Washout||13
7806181|NCT01183234|19216391|P2|NOT COMPLETED|First Intervention||0
7806182|NCT01183234|19216392|P1|NOT COMPLETED|First Intervention||1
7806183|NCT01183234|19216391|P2|COMPLETED|First Intervention||14
7806184|NCT01183234|19216392|P1|COMPLETED|First Intervention||13
7806185|NCT01183234|19216391|P2|STARTED|First Intervention||14
7806186|NCT01183234|19216392|P1|STARTED|First Intervention||14
7806187|NCT01183169|19216406|P7|NOT COMPLETED|Post-switch Phase||9
7806188|NCT01183169|19216407|P6|NOT COMPLETED|Post-switch Phase||14
7806189|NCT01183169|19216408|P5|NOT COMPLETED|Post-switch Phase||0
7806190|NCT01183169|19216409|P4|NOT COMPLETED|Post-switch Phase||0
7806191|NCT01183169|19216410|P3|NOT COMPLETED|Post-switch Phase||0
7806192|NCT01183169|19216411|P2|NOT COMPLETED|Post-switch Phase||0
7806193|NCT01183169|19216412|P1|NOT COMPLETED|Post-switch Phase||0
7806194|NCT01183169|19216406|P7|COMPLETED|Post-switch Phase||21
7806195|NCT01183169|19216407|P6|COMPLETED|Post-switch Phase||21
7806196|NCT01183169|19216408|P5|COMPLETED|Post-switch Phase||0
7806197|NCT01183169|19216409|P4|COMPLETED|Post-switch Phase||0
7806198|NCT01183169|19216410|P3|COMPLETED|Post-switch Phase||0
7806199|NCT01183169|19216411|P2|COMPLETED|Post-switch Phase||0
7806200|NCT01183169|19216412|P1|COMPLETED|Post-switch Phase||0
7806201|NCT01183169|19216406|P7|Completed Treatment|Post-switch Phase||13
7806202|NCT01183169|19216407|P6|Completed Treatment|Post-switch Phase||12
7806203|NCT01183169|19216408|P5|Completed Treatment|Post-switch Phase||0
7806204|NCT01183169|19216409|P4|Completed Treatment|Post-switch Phase||0
7806205|NCT01183169|19216410|P3|Completed Treatment|Post-switch Phase||0
7806206|NCT01183169|19216411|P2|Completed Treatment|Post-switch Phase||0
7806207|NCT01183169|19216412|P1|Completed Treatment|Post-switch Phase||0
7806208|NCT01183169|19216406|P7|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30
7806209|NCT01183169|19216407|P6|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35
7806210|NCT01183169|19216408|P5|STARTED|Post-switch Phase|Not a post-switch group|0
7806211|NCT01183169|19216409|P4|STARTED|Post-switch Phase|Not a post-switch group|0
7806212|NCT01183169|19216410|P3|STARTED|Post-switch Phase|Not a post-switch group|0
7806213|NCT01183169|19216411|P2|STARTED|Post-switch Phase|Not a post-switch group|0
7806214|NCT01183169|19216412|P1|STARTED|Post-switch Phase|Not a post-switch group|0
7806215|NCT01183169|19216406|P7|NOT COMPLETED|Main Phase||0
7806216|NCT01183169|19216407|P6|NOT COMPLETED|Main Phase||0
7806217|NCT01183169|19216408|P5|NOT COMPLETED|Main Phase||26
7806218|NCT01183169|19216409|P4|NOT COMPLETED|Main Phase||37
7806219|NCT01183169|19216410|P3|NOT COMPLETED|Main Phase||41
7806220|NCT01183169|19216411|P2|NOT COMPLETED|Main Phase||22
7806221|NCT01183169|19216412|P1|NOT COMPLETED|Main Phase||27
7806222|NCT01183169|19216406|P7|COMPLETED|Main Phase||0
7806223|NCT01183169|19216407|P6|COMPLETED|Main Phase||0
7806224|NCT01183169|19216408|P5|COMPLETED|Main Phase||83
7806225|NCT01183169|19216409|P4|COMPLETED|Main Phase||18
7806226|NCT01183169|19216410|P3|COMPLETED|Main Phase||18
7806227|NCT01183169|19216411|P2|COMPLETED|Main Phase||93
7806228|NCT01183169|19216412|P1|COMPLETED|Main Phase||94
7806229|NCT01183169|19216406|P7|Switched to ALV|Main Phase||0
7806230|NCT01183169|19216407|P6|Switched to ALV|Main Phase||0
7806231|NCT01183169|19216408|P5|Switched to ALV|Main Phase||0
7806232|NCT01183169|19216409|P4|Switched to ALV|Main Phase||30
7806233|NCT01183169|19216410|P3|Switched to ALV|Main Phase||35
7806234|NCT01183169|19216411|P2|Switched to ALV|Main Phase||0
7806235|NCT01183169|19216412|P1|Switched to ALV|Main Phase||0
7806236|NCT01183169|19216406|P7|Completed Treatment|Main Phase||0
7806237|NCT01183169|19216407|P6|Completed Treatment|Main Phase||0
7806238|NCT01183169|19216408|P5|Completed Treatment|Main Phase||77
7806239|NCT01183169|19216409|P4|Completed Treatment|Main Phase||17
7806240|NCT01183169|19216410|P3|Completed Treatment|Main Phase||17
7806241|NCT01183169|19216411|P2|Completed Treatment|Main Phase||78
7806242|NCT01183169|19216412|P1|Completed Treatment|Main Phase||72
7806243|NCT01183169|19216406|P7|STARTED|Main Phase||0
7806244|NCT01183169|19216407|P6|STARTED|Main Phase||0
7806245|NCT01183169|19216408|P5|STARTED|Main Phase||109
7806246|NCT01183169|19216409|P4|STARTED|Main Phase||55
7806247|NCT01183169|19216410|P3|STARTED|Main Phase||59
7806248|NCT01183169|19216411|P2|STARTED|Main Phase||115
7806249|NCT01183169|19216412|P1|STARTED|Main Phase||121
7806250|NCT01183143|19216484|P1|NOT COMPLETED|Overall Study||150
7806251|NCT01183143|19216484|P1|COMPLETED|Overall Study||65
7806252|NCT01183143|19216484|P1|Intention to Treat (ITT) Population|Overall Study|ITT=Subjects who received at least 1 dose of the investigational medicinal product (IMP).|204
7806253|NCT01183143|19216484|P1|STARTED|Overall Study||215
7806254|NCT01183104|19216500|P2|NOT COMPLETED|Overall Study||92
7806255|NCT01183104|19216501|P1|NOT COMPLETED|Overall Study||77
7806256|NCT01183104|19216500|P2|COMPLETED|Overall Study||60
7806257|NCT01183104|19216501|P1|COMPLETED|Overall Study||76
7806258|NCT01183104|19216500|P2|Enrolled in Extension Study|Overall Study||61
7806259|NCT01183104|19216501|P1|Enrolled in Extension Study|Overall Study||80
7806260|NCT01183104|19216500|P2|Completed 52-week Treatment|Overall Study||111
7806261|NCT01183104|19216501|P1|Completed 52-week Treatment|Overall Study||119
7806262|NCT01183104|19216500|P2|Continued Treatment for 12 Weeks|Overall Study||129
7806263|NCT01183104|19216501|P1|Continued Treatment for 12 Weeks|Overall Study||143
7806264|NCT01183104|19216500|P2|Received Study Drug|Overall Study||143
7806265|NCT01183104|19216501|P1|Received Study Drug|Overall Study||148
7806266|NCT01183104|19216500|P2|STARTED|Overall Study||152
7806267|NCT01183104|19216501|P1|STARTED|Overall Study||153
7806268|NCT01183065|19216517|P1|NOT COMPLETED|Overall Study||1
7806269|NCT01183065|19216517|P1|COMPLETED|Overall Study||12
7806270|NCT01183065|19216517|P1|STARTED|Overall Study||13
7806271|NCT01183013|19216528|P7|NOT COMPLETED|Overall Study||37
7806272|NCT01183013|19216529|P6|NOT COMPLETED|Overall Study||45
7806273|NCT01183013|19216530|P5|NOT COMPLETED|Overall Study||36
7806274|NCT01183013|19216531|P4|NOT COMPLETED|Overall Study||30
7806275|NCT01183013|19216532|P3|NOT COMPLETED|Overall Study||41
7806276|NCT01183013|19216533|P2|NOT COMPLETED|Overall Study||39
7806277|NCT01183013|19216534|P1|NOT COMPLETED|Overall Study||45
7806278|NCT01183013|19216528|P7|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96
7806279|NCT01183013|19216529|P6|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88
7806280|NCT01183013|19216530|P5|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90
7806281|NCT01183013|19216531|P4|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105
7806282|NCT01183013|19216532|P3|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97
7806283|NCT01183013|19216533|P2|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101
7806284|NCT01183013|19216534|P1|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86
7806285|NCT01183013|19216528|P7|STARTED|Overall Study||133
7806286|NCT01183013|19216529|P6|STARTED|Overall Study||133
7806287|NCT01183013|19216530|P5|STARTED|Overall Study||126
7806288|NCT01183013|19216531|P4|STARTED|Overall Study||135
7806289|NCT01183013|19216532|P3|STARTED|Overall Study||138
7806290|NCT01183013|19216533|P2|STARTED|Overall Study||140
7806291|NCT01183013|19216534|P1|STARTED|Overall Study||131
7806292|NCT01182844|19216615|P2|NOT COMPLETED|Overall Study||2
7806293|NCT01182844|19216616|P1|NOT COMPLETED|Overall Study||0
7806294|NCT01182844|19216615|P2|COMPLETED|Overall Study||13
7806295|NCT01182844|19216616|P1|COMPLETED|Overall Study||15
7806296|NCT01182844|19216615|P2|STARTED|Overall Study||15
7806297|NCT01182844|19216616|P1|STARTED|Overall Study||15
7806298|NCT01182805|19216634|P1|NOT COMPLETED|Overall Study||0
7806299|NCT01182805|19216634|P1|COMPLETED|Overall Study||50
7806300|NCT01182805|19216634|P1|STARTED|Overall Study||50
7806301|NCT01182727|19216643|P1|NOT COMPLETED|Overall Study||0
7806302|NCT01182727|19216643|P1|COMPLETED|Overall Study||10
7806303|NCT01182727|19216643|P1|STARTED|Overall Study||10
7806304|NCT01182675|19216649|P2|NOT COMPLETED|Overall Study||0
7806305|NCT01182675|19216650|P1|NOT COMPLETED|Overall Study||0
7806306|NCT01182675|19216649|P2|COMPLETED|Overall Study||0
7806307|NCT01182675|19216650|P1|COMPLETED|Overall Study||7
7806308|NCT01182675|19216649|P2|STARTED|Overall Study||0
7806309|NCT01182675|19216650|P1|STARTED|Overall Study||7
7806310|NCT01182610|19216666|P1|NOT COMPLETED|Overall Study||0
7806311|NCT01182610|19216666|P1|COMPLETED|Overall Study||1
7806312|NCT01182610|19216666|P1|STARTED|Overall Study||1
7806313|NCT01182493|19216676|P2|NOT COMPLETED|Overall Study||7
7806314|NCT01182493|19216677|P1|NOT COMPLETED|Overall Study||16
7806315|NCT01182493|19216676|P2|COMPLETED|Overall Study||156
7806316|NCT01182493|19216677|P1|COMPLETED|Overall Study||152
7806317|NCT01182493|19216676|P2|STARTED|Overall Study||163
7806318|NCT01182493|19216677|P1|STARTED|Overall Study||168
7806319|NCT01182480|19216695|P1|NOT COMPLETED|Overall Study||0
7806320|NCT01182480|19216695|P1|COMPLETED|Overall Study||47
7806321|NCT01182480|19216695|P1|STARTED|Overall Study||47
7806322|NCT01182441|19216701|P2|NOT COMPLETED|Overall Study||119
7806323|NCT01182441|19216702|P1|NOT COMPLETED|Overall Study||220
7806324|NCT01182441|19216701|P2|COMPLETED|Overall Study||19
7806325|NCT01182441|19216702|P1|COMPLETED|Overall Study||49
7806326|NCT01182441|19216701|P2|STARTED|Overall Study||138
7806327|NCT01182441|19216702|P1|STARTED|Overall Study||269
7806328|NCT01182428|19216713|P2|NOT COMPLETED|Overall Study||1
7806329|NCT01182428|19216714|P1|NOT COMPLETED|Overall Study||11
7806330|NCT01182428|19216713|P2|COMPLETED|Overall Study||150
7806331|NCT01182428|19216714|P1|COMPLETED|Overall Study||293
7806332|NCT01182428|19216713|P2|STARTED|Overall Study||151
7806333|NCT01182428|19216714|P1|STARTED|Overall Study||304
7806334|NCT01182415|19216778|P1|NOT COMPLETED|Overall Study||1
7806335|NCT01182415|19216778|P1|COMPLETED|Overall Study||29
7806336|NCT01182415|19216778|P1|STARTED|Overall Study||30
7806337|NCT01182376|19216787|P2|NOT COMPLETED|Overall Study||5
7806338|NCT01182376|19216788|P1|NOT COMPLETED|Overall Study||11
7806339|NCT01182376|19216787|P2|COMPLETED|Overall Study||13
7806340|NCT01182376|19216788|P1|COMPLETED|Overall Study||4
7806341|NCT01182376|19216787|P2|STARTED|Overall Study||18
7806342|NCT01182376|19216788|P1|STARTED|Overall Study||15
7806343|NCT01182350|19216794|P5|NOT COMPLETED|Overall Study||3
7806344|NCT01182350|19216795|P4|NOT COMPLETED|Overall Study||3
7806345|NCT01182350|19216796|P3|NOT COMPLETED|Overall Study||3
7806346|NCT01182350|19216797|P2|NOT COMPLETED|Overall Study||14
7806347|NCT01182350|19216798|P1|NOT COMPLETED|Overall Study||27
7806348|NCT01182350|19216794|P5|COMPLETED|Overall Study||0
7806349|NCT01182350|19216795|P4|COMPLETED|Overall Study||0
7806350|NCT01182350|19216796|P3|COMPLETED|Overall Study||0
7806351|NCT01182350|19216797|P2|COMPLETED|Overall Study||0
7806352|NCT01182350|19216798|P1|COMPLETED|Overall Study||3
7806353|NCT01182350|19216794|P5|Started Assigned Chemoradiation|Overall Study||0
7806354|NCT01182350|19216795|P4|Started Assigned Chemoradiation|Overall Study||2
7806355|NCT01182350|19216796|P3|Started Assigned Chemoradiation|Overall Study||2
7806356|NCT01182350|19216797|P2|Started Assigned Chemoradiation|Overall Study||14
7806357|NCT01182350|19216798|P1|Started Assigned Chemoradiation|Overall Study||27
7806358|NCT01182350|19216794|P5|Underwent Stereotactic Biopsy|Overall Study||0
7806359|NCT01182350|19216795|P4|Underwent Stereotactic Biopsy|Overall Study||3
7806360|NCT01182350|19216796|P3|Underwent Stereotactic Biopsy|Overall Study||3
7806361|NCT01182350|19216797|P2|Underwent Stereotactic Biopsy|Overall Study||14
7806362|NCT01182350|19216798|P1|Underwent Stereotactic Biopsy|Overall Study||30
7806363|NCT01182350|19216794|P5|STARTED|Overall Study||3
7806364|NCT01182350|19216795|P4|STARTED|Overall Study||3
7806365|NCT01182350|19216796|P3|STARTED|Overall Study||3
7806366|NCT01182350|19216797|P2|STARTED|Overall Study||14
7806367|NCT01182350|19216798|P1|STARTED|Overall Study||30
7806368|NCT01182337|19216820|P2|NOT COMPLETED|Overall Study||2
7806369|NCT01182337|19216821|P1|NOT COMPLETED|Overall Study||3
7806370|NCT01182337|19216820|P2|COMPLETED|Overall Study||7
7806371|NCT01182337|19216821|P1|COMPLETED|Overall Study||19
7806372|NCT01182337|19216820|P2|STARTED|Overall Study||9
7806373|NCT01182337|19216821|P1|STARTED|Overall Study||22
7806374|NCT01182298|19216839|P1|NOT COMPLETED|Overall Study||6
7806375|NCT01182298|19216839|P1|COMPLETED|Overall Study||4
7806376|NCT01182298|19216839|P1|STARTED|Overall Study||10
7806377|NCT01182285|19216843|P3|NOT COMPLETED|Third Intervention Week 11-52||8
7806378|NCT01182285|19216844|P2|NOT COMPLETED|Third Intervention Week 11-52||0
7806379|NCT01182285|19216845|P1|NOT COMPLETED|Third Intervention Week 11-52||0
7806380|NCT01182285|19216843|P3|COMPLETED|Third Intervention Week 11-52||0
7806381|NCT01182285|19216844|P2|COMPLETED|Third Intervention Week 11-52||0
7806382|NCT01182285|19216845|P1|COMPLETED|Third Intervention Week 11-52||0
7806383|NCT01182285|19216843|P3|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8
7806384|NCT01182285|19216844|P2|STARTED|Third Intervention Week 11-52||0
7806385|NCT01182285|19216845|P1|STARTED|Third Intervention Week 11-52||0
7806386|NCT01182285|19216843|P3|NOT COMPLETED|Second Intervention Week 11-17||0
7806387|NCT01182285|19216844|P2|NOT COMPLETED|Second Intervention Week 11-17||0
7806388|NCT01182285|19216845|P1|NOT COMPLETED|Second Intervention Week 11-17||0
7806389|NCT01182285|19216843|P3|COMPLETED|Second Intervention Week 11-17||0
7806390|NCT01182285|19216844|P2|COMPLETED|Second Intervention Week 11-17||0
7806391|NCT01182285|19216845|P1|COMPLETED|Second Intervention Week 11-17||0
7806392|NCT01182285|19216843|P3|STARTED|Second Intervention Week 11-17||0
7806393|NCT01182285|19216844|P2|STARTED|Second Intervention Week 11-17||0
7806394|NCT01182285|19216845|P1|STARTED|Second Intervention Week 11-17||0
7806395|NCT01182285|19216843|P3|NOT COMPLETED|First Intervention Week 1-10||0
7806396|NCT01182285|19216844|P2|NOT COMPLETED|First Intervention Week 1-10||0
7806397|NCT01182285|19216845|P1|NOT COMPLETED|First Intervention Week 1-10||3
7806398|NCT01182285|19216843|P3|COMPLETED|First Intervention Week 1-10||0
7806399|NCT01182285|19216844|P2|COMPLETED|First Intervention Week 1-10||0
7806400|NCT01182285|19216845|P1|COMPLETED|First Intervention Week 1-10||10
7806401|NCT01182285|19216843|P3|STARTED|First Intervention Week 1-10||0
7806402|NCT01182285|19216844|P2|STARTED|First Intervention Week 1-10||0
7806403|NCT01182285|19216845|P1|STARTED|First Intervention Week 1-10||13
7806404|NCT01182207|19216855|P2|NOT COMPLETED|Second Intervention||0
7806405|NCT01182207|19216856|P1|NOT COMPLETED|Second Intervention||1
7806406|NCT01182207|19216855|P2|COMPLETED|Second Intervention||14
7806407|NCT01182207|19216856|P1|COMPLETED|Second Intervention||17
7806408|NCT01182207|19216855|P2|STARTED|Second Intervention||14
7806409|NCT01182207|19216856|P1|STARTED|Second Intervention||18
7806410|NCT01182207|19216855|P2|NOT COMPLETED|Washout of 28 Days||0
7806411|NCT01182207|19216856|P1|NOT COMPLETED|Washout of 28 Days||0
7806412|NCT01182207|19216855|P2|COMPLETED|Washout of 28 Days||14
7806413|NCT01182207|19216856|P1|COMPLETED|Washout of 28 Days||18
7806414|NCT01182207|19216855|P2|STARTED|Washout of 28 Days||14
7806415|NCT01182207|19216856|P1|STARTED|Washout of 28 Days||18
7806416|NCT01182207|19216855|P2|NOT COMPLETED|First Intervention||1
7806417|NCT01182207|19216856|P1|NOT COMPLETED|First Intervention||0
7806418|NCT01182207|19216855|P2|COMPLETED|First Intervention||14
7806419|NCT01182207|19216856|P1|COMPLETED|First Intervention||18
7806420|NCT01182207|19216855|P2|STARTED|First Intervention||15
7806421|NCT01182207|19216856|P1|STARTED|First Intervention||18
7806422|NCT01182194|19216874|P2|NOT COMPLETED|Second Intervention||0
7806423|NCT01182194|19216875|P1|NOT COMPLETED|Second Intervention||0
7806424|NCT01182194|19216874|P2|COMPLETED|Second Intervention||16
7806425|NCT01182194|19216875|P1|COMPLETED|Second Intervention||15
7806426|NCT01182194|19216874|P2|STARTED|Second Intervention||16
7806427|NCT01182194|19216875|P1|STARTED|Second Intervention||15
7806428|NCT01182194|19216874|P2|NOT COMPLETED|Washout of 28 Days||0
7806429|NCT01182194|19216875|P1|NOT COMPLETED|Washout of 28 Days||1
7806430|NCT01182194|19216874|P2|COMPLETED|Washout of 28 Days||16
7806431|NCT01182194|19216875|P1|COMPLETED|Washout of 28 Days||15
7806432|NCT01182194|19216874|P2|STARTED|Washout of 28 Days||16
7806433|NCT01182194|19216875|P1|STARTED|Washout of 28 Days||16
7806434|NCT01182194|19216874|P2|NOT COMPLETED|First Intervention||0
7806435|NCT01182194|19216875|P1|NOT COMPLETED|First Intervention||0
7806436|NCT01182194|19216874|P2|COMPLETED|First Intervention||16
7806437|NCT01182194|19216875|P1|COMPLETED|First Intervention||16
7806438|NCT01182194|19216874|P2|STARTED|First Intervention||16
7806439|NCT01182194|19216875|P1|STARTED|First Intervention||16
7806440|NCT01182181|19216893|P2|NOT COMPLETED|Second Intervention||0
7806441|NCT01182181|19216894|P1|NOT COMPLETED|Second Intervention||0
7806442|NCT01182181|19216893|P2|COMPLETED|Second Intervention||10
7806443|NCT01182181|19216894|P1|COMPLETED|Second Intervention||10
7806444|NCT01182181|19216893|P2|STARTED|Second Intervention||10
7806445|NCT01182181|19216894|P1|STARTED|Second Intervention||10
7806446|NCT01182181|19216893|P2|NOT COMPLETED|Washout of 21 Days||1
7806447|NCT01182181|19216894|P1|NOT COMPLETED|Washout of 21 Days||0
7806448|NCT01182181|19216893|P2|COMPLETED|Washout of 21 Days||10
7806449|NCT01182181|19216894|P1|COMPLETED|Washout of 21 Days||10
7806450|NCT01182181|19216893|P2|STARTED|Washout of 21 Days||11
7806451|NCT01182181|19216894|P1|STARTED|Washout of 21 Days||10
7806452|NCT01182181|19216893|P2|NOT COMPLETED|First Intervention||0
7806453|NCT01182181|19216894|P1|NOT COMPLETED|First Intervention||1
7806454|NCT01182181|19216893|P2|COMPLETED|First Intervention||11
7806455|NCT01182181|19216894|P1|COMPLETED|First Intervention||10
7806456|NCT01182181|19216893|P2|STARTED|First Intervention||11
7806457|NCT01182181|19216894|P1|STARTED|First Intervention||11
7806458|NCT01182103|19216904|P2|NOT COMPLETED|Overall Study||0
7806459|NCT01182103|19216905|P1|NOT COMPLETED|Overall Study||0
7806460|NCT01182103|19216904|P2|COMPLETED|Overall Study||62
7806461|NCT01182103|19216905|P1|COMPLETED|Overall Study||48
7806462|NCT01182103|19216904|P2|STARTED|Overall Study||62
7806463|NCT01182103|19216905|P1|STARTED|Overall Study||48
7806464|NCT01181986|19216919|P3|NOT COMPLETED|Phase 2||0
7806465|NCT01181986|19216920|P2|NOT COMPLETED|Phase 2||4
7806466|NCT01181986|19216921|P1|NOT COMPLETED|Phase 2||0
7806467|NCT01181986|19216919|P3|COMPLETED|Phase 2||0
7806468|NCT01181986|19216920|P2|COMPLETED|Phase 2||18
7806469|NCT01181986|19216921|P1|COMPLETED|Phase 2||18
7806470|NCT01181986|19216919|P3|STARTED|Phase 2|N/A for Sub-study 2|0
7806471|NCT01181986|19216920|P2|STARTED|Phase 2||22
7806472|NCT01181986|19216921|P1|STARTED|Phase 2||18
7806473|NCT01181986|19216919|P3|NOT COMPLETED|Phase 1||2
7806474|NCT01181986|19216920|P2|NOT COMPLETED|Phase 1||1
7806475|NCT01181986|19216921|P1|NOT COMPLETED|Phase 1||1
7806476|NCT01181986|19216919|P3|COMPLETED|Phase 1||32
7806477|NCT01181986|19216920|P2|COMPLETED|Phase 1||22
7806478|NCT01181986|19216921|P1|COMPLETED|Phase 1||18
7806479|NCT01181986|19216919|P3|Exendin-9+Exenatide|Phase 1||33
7806480|NCT01181986|19216920|P2|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
7806481|NCT01181986|19216921|P1|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
7806482|NCT01181986|19216919|P3|Saline+Placebo|Phase 1||33
7806483|NCT01181986|19216920|P2|Saline+Placebo|Phase 1|N/A for this arm|0
7806484|NCT01181986|19216921|P1|Saline+Placebo|Phase 1|N/A for this arm|0
7806485|NCT01181986|19216919|P3|Saline+Exenatide|Phase 1||32
7806486|NCT01181986|19216920|P2|Saline+Exenatide|Phase 1|N/A for this arm|0
7806487|NCT01181986|19216921|P1|Saline+Exenatide|Phase 1|N/A for this arm|0
7806488|NCT01181986|19216919|P3|STARTED|Phase 1||34
7806489|NCT01181986|19216920|P2|STARTED|Phase 1||23
7806490|NCT01181986|19216921|P1|STARTED|Phase 1||19
7806491|NCT01181947|19216937|P1|NOT COMPLETED|Overall Study||0
7806492|NCT01181947|19216937|P1|COMPLETED|Overall Study||100
7806493|NCT01181947|19216937|P1|STARTED|Overall Study||100
7806494|NCT01181921|19216942|P1|NOT COMPLETED|Overall Study||1
7806495|NCT01181921|19216942|P1|COMPLETED|Overall Study||0
7806496|NCT01181921|19216942|P1|STARTED|Overall Study||1
7806497|NCT01181895|19216949|P3|NOT COMPLETED|Overall Study||18
7806498|NCT01181895|19216950|P2|NOT COMPLETED|Overall Study||14
7806499|NCT01181895|19216951|P1|NOT COMPLETED|Overall Study||17
7806500|NCT01181895|19216949|P3|COMPLETED|Overall Study||98
7806501|NCT01181895|19216950|P2|COMPLETED|Overall Study||101
7806502|NCT01181895|19216951|P1|COMPLETED|Overall Study||99
7806503|NCT01181895|19216949|P3|STARTED|Overall Study||116
7806504|NCT01181895|19216950|P2|STARTED|Overall Study||115
7806505|NCT01181895|19216951|P1|STARTED|Overall Study||116
7806506|NCT01181804|19216984|P4|NOT COMPLETED|Period 4, Fasted (Part 2)||0
7806507|NCT01181804|19216985|P3|NOT COMPLETED|Period 4, Fasted (Part 2)||1
7806508|NCT01181804|19216986|P2|NOT COMPLETED|Period 4, Fasted (Part 2)||0
7806509|NCT01181804|19216987|P1|NOT COMPLETED|Period 4, Fasted (Part 2)||0
7806510|NCT01181804|19216984|P4|COMPLETED|Period 4, Fasted (Part 2)||58
7806511|NCT01181804|19216985|P3|COMPLETED|Period 4, Fasted (Part 2)||58
7806512|NCT01181804|19216986|P2|COMPLETED|Period 4, Fasted (Part 2)||0
7806513|NCT01181804|19216987|P1|COMPLETED|Period 4, Fasted (Part 2)||0
7806514|NCT01181804|19216984|P4|STARTED|Period 4, Fasted (Part 2)||58
7806515|NCT01181804|19216985|P3|STARTED|Period 4, Fasted (Part 2)||59
7806516|NCT01181804|19216986|P2|STARTED|Period 4, Fasted (Part 2)||0
7806517|NCT01181804|19216987|P1|STARTED|Period 4, Fasted (Part 2)||0
7806518|NCT01181804|19216984|P4|NOT COMPLETED|Period 3, Fasted (Part 2)||0
7806519|NCT01181804|19216985|P3|NOT COMPLETED|Period 3, Fasted (Part 2)||0
7806520|NCT01181804|19216986|P2|NOT COMPLETED|Period 3, Fasted (Part 2)||0
7806521|NCT01181804|19216987|P1|NOT COMPLETED|Period 3, Fasted (Part 2)||0
7806522|NCT01181804|19216984|P4|COMPLETED|Period 3, Fasted (Part 2)||58
7806523|NCT01181804|19216985|P3|COMPLETED|Period 3, Fasted (Part 2)||59
7806524|NCT01181804|19216986|P2|COMPLETED|Period 3, Fasted (Part 2)||0
7806525|NCT01181804|19216987|P1|COMPLETED|Period 3, Fasted (Part 2)||0
7806526|NCT01181804|19216984|P4|STARTED|Period 3, Fasted (Part 2)||58
7806527|NCT01181804|19216985|P3|STARTED|Period 3, Fasted (Part 2)||59
7806528|NCT01181804|19216986|P2|STARTED|Period 3, Fasted (Part 2)||0
7806529|NCT01181804|19216987|P1|STARTED|Period 3, Fasted (Part 2)||0
7806530|NCT01181804|19216984|P4|NOT COMPLETED|Period 2, Fed (Part 1)||0
7806531|NCT01181804|19216985|P3|NOT COMPLETED|Period 2, Fed (Part 1)||0
7806532|NCT01181804|19216986|P2|NOT COMPLETED|Period 2, Fed (Part 1)||0
7806533|NCT01181804|19216987|P1|NOT COMPLETED|Period 2, Fed (Part 1)||0
7806534|NCT01181804|19216984|P4|COMPLETED|Period 2, Fed (Part 1)||0
7806535|NCT01181804|19216985|P3|COMPLETED|Period 2, Fed (Part 1)||0
7806536|NCT01181804|19216986|P2|COMPLETED|Period 2, Fed (Part 1)||30
7806537|NCT01181804|19216987|P1|COMPLETED|Period 2, Fed (Part 1)||30
7806538|NCT01181804|19216984|P4|STARTED|Period 2, Fed (Part 1)||0
7806539|NCT01181804|19216985|P3|STARTED|Period 2, Fed (Part 1)||0
7806540|NCT01181804|19216986|P2|STARTED|Period 2, Fed (Part 1)||30
7806541|NCT01181804|19216987|P1|STARTED|Period 2, Fed (Part 1)||30
7806542|NCT01181804|19216984|P4|NOT COMPLETED|Period 1, Fed (Part 1)||0
7806543|NCT01181804|19216985|P3|NOT COMPLETED|Period 1, Fed (Part 1)||0
7806544|NCT01181804|19216986|P2|NOT COMPLETED|Period 1, Fed (Part 1)||0
7806545|NCT01181804|19216987|P1|NOT COMPLETED|Period 1, Fed (Part 1)||0
7806546|NCT01181804|19216984|P4|COMPLETED|Period 1, Fed (Part 1)||0
7806547|NCT01181804|19216985|P3|COMPLETED|Period 1, Fed (Part 1)||0
7806548|NCT01181804|19216986|P2|COMPLETED|Period 1, Fed (Part 1)||30
7806549|NCT01181804|19216987|P1|COMPLETED|Period 1, Fed (Part 1)||30
7806550|NCT01181804|19216984|P4|STARTED|Period 1, Fed (Part 1)||0
7806551|NCT01181804|19216985|P3|STARTED|Period 1, Fed (Part 1)||0
7806552|NCT01181804|19216986|P2|STARTED|Period 1, Fed (Part 1)||30
7806553|NCT01181804|19216987|P1|STARTED|Period 1, Fed (Part 1)||30
7806554|NCT01181778|19217009|P1|NOT COMPLETED|Overall Study||48
7806555|NCT01181778|19217009|P1|COMPLETED|Overall Study||1871
7806556|NCT01181778|19217009|P1|STARTED|Overall Study||1919
7806557|NCT01181726|19217017|P2|NOT COMPLETED|Second Intervention||0
7806558|NCT01181726|19217018|P1|NOT COMPLETED|Second Intervention||0
7806559|NCT01181726|19217017|P2|COMPLETED|Second Intervention||20
7806560|NCT01181726|19217018|P1|COMPLETED|Second Intervention||19
7806561|NCT01181726|19217017|P2|STARTED|Second Intervention||20
7806562|NCT01181726|19217018|P1|STARTED|Second Intervention||19
7806563|NCT01181726|19217017|P2|NOT COMPLETED|Washout of 28 Days||0
7806564|NCT01181726|19217018|P1|NOT COMPLETED|Washout of 28 Days||0
7806565|NCT01181726|19217017|P2|COMPLETED|Washout of 28 Days||20
7806566|NCT01181726|19217018|P1|COMPLETED|Washout of 28 Days||19
7806567|NCT01181726|19217017|P2|STARTED|Washout of 28 Days||20
7806568|NCT01181726|19217018|P1|STARTED|Washout of 28 Days||19
7806569|NCT01181726|19217017|P2|NOT COMPLETED|First Intervention||0
7806570|NCT01181726|19217018|P1|NOT COMPLETED|First Intervention||1
7806571|NCT01181726|19217017|P2|COMPLETED|First Intervention||20
7806572|NCT01181726|19217018|P1|COMPLETED|First Intervention||19
7806573|NCT01181726|19217017|P2|STARTED|First Intervention||20
7806574|NCT01181726|19217018|P1|STARTED|First Intervention||20
7806575|NCT01181674|19217067|P3|NOT COMPLETED|Overall Study||2
7806576|NCT01181674|19217068|P2|NOT COMPLETED|Overall Study||0
7806577|NCT01181674|19217069|P1|NOT COMPLETED|Overall Study||0
7806578|NCT01181674|19217067|P3|COMPLETED|Overall Study|28 included in analyses|26
7806579|NCT01181674|19217068|P2|COMPLETED|Overall Study||27
7806580|NCT01181674|19217069|P1|COMPLETED|Overall Study||28
7806581|NCT01181674|19217067|P3|STARTED|Overall Study||28
7806582|NCT01181674|19217068|P2|STARTED|Overall Study||27
7806583|NCT01181674|19217069|P1|STARTED|Overall Study||28
7806584|NCT01181609|19217098|P1|NOT COMPLETED|Overall Study||53
7806585|NCT01181609|19217098|P1|COMPLETED|Overall Study||1
7806586|NCT01181609|19217098|P1|STARTED|Overall Study||54
7806587|NCT01181596|19217109|P1|NOT COMPLETED|Overall Study||0
7806588|NCT01181596|19217109|P1|COMPLETED|Overall Study||31
7806589|NCT01181596|19217109|P1|STARTED|Overall Study||31
7806590|NCT01181531|19217116|P2|NOT COMPLETED|Overall Study||53
7806591|NCT01181531|19217117|P1|NOT COMPLETED|Overall Study||61
7806592|NCT01181531|19217116|P2|COMPLETED|Overall Study||102
7806593|NCT01181531|19217117|P1|COMPLETED|Overall Study||96
7806594|NCT01181531|19217116|P2|Received Investigational Product|Overall Study||153
7806595|NCT01181531|19217117|P1|Received Investigational Product|Overall Study||155
7806596|NCT01181531|19217116|P2|STARTED|Overall Study|Subjects are randomized after washout.|155
7806597|NCT01181531|19217117|P1|STARTED|Overall Study|Subjects are randomized after washout.|157
7806598|NCT01181492|19217130|P3|NOT COMPLETED|Overall Study||0
7806599|NCT01181492|19217131|P2|NOT COMPLETED|Overall Study||0
7806600|NCT01181492|19217132|P1|NOT COMPLETED|Overall Study||0
7806601|NCT01181492|19217130|P3|COMPLETED|Overall Study||7
7806602|NCT01181492|19217131|P2|COMPLETED|Overall Study||66
7806603|NCT01181492|19217132|P1|COMPLETED|Overall Study||103
7806604|NCT01181492|19217130|P3|STARTED|Overall Study||7
7806605|NCT01181492|19217131|P2|STARTED|Overall Study||66
7806606|NCT01181492|19217132|P1|STARTED|Overall Study||103
7806607|NCT01181479|19217148|P3|NOT COMPLETED|Crossover Subjects Recieve AG200-15||99
7806608|NCT01181479|19217149|P2|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
7806609|NCT01181479|19217150|P1|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
7806610|NCT01181479|19217148|P3|COMPLETED|Crossover Subjects Recieve AG200-15||150
7806611|NCT01181479|19217149|P2|COMPLETED|Crossover Subjects Recieve AG200-15||0
7806612|NCT01181479|19217150|P1|COMPLETED|Crossover Subjects Recieve AG200-15||0
7806613|NCT01181479|19217148|P3|STARTED|Crossover Subjects Recieve AG200-15|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|249
7806614|NCT01181479|19217149|P2|STARTED|Crossover Subjects Recieve AG200-15||0
7806615|NCT01181479|19217150|P1|STARTED|Crossover Subjects Recieve AG200-15||0
7806616|NCT01181479|19217148|P3|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||0
7806617|NCT01181479|19217149|P2|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||126
7806618|NCT01181479|19217150|P1|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||644
7806619|NCT01181479|19217148|P3|COMPLETED|Subjects Receive AG200-15 or Lessina||0
7806620|NCT01181479|19217149|P2|COMPLETED|Subjects Receive AG200-15 or Lessina||249
7806621|NCT01181479|19217150|P1|COMPLETED|Subjects Receive AG200-15 or Lessina||485
7806622|NCT01181479|19217148|P3|STARTED|Subjects Receive AG200-15 or Lessina|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|0
7806623|NCT01181479|19217149|P2|STARTED|Subjects Receive AG200-15 or Lessina||375
7806624|NCT01181479|19217150|P1|STARTED|Subjects Receive AG200-15 or Lessina||1129
7806625|NCT01181349|19217165|P1|NOT COMPLETED|Overall Study||0
7806626|NCT01181349|19217165|P1|COMPLETED|Overall Study||350
7806627|NCT01181349|19217165|P1|STARTED|Overall Study||350
7806628|NCT01181323|19217181|P4|NOT COMPLETED|Overall Study||3
7806629|NCT01181323|19217182|P3|NOT COMPLETED|Overall Study||1
7806630|NCT01181323|19217183|P2|NOT COMPLETED|Overall Study||3
7806631|NCT01181323|19217184|P1|NOT COMPLETED|Overall Study||1
7806632|NCT01181323|19217181|P4|COMPLETED|Overall Study||122
7806633|NCT01181323|19217182|P3|COMPLETED|Overall Study||123
7806634|NCT01181323|19217183|P2|COMPLETED|Overall Study||121
7806635|NCT01181323|19217184|P1|COMPLETED|Overall Study||123
7806636|NCT01181323|19217181|P4|STARTED|Overall Study||125
7806637|NCT01181323|19217182|P3|STARTED|Overall Study||124
7806638|NCT01181323|19217183|P2|STARTED|Overall Study||124
7806639|NCT01181323|19217184|P1|STARTED|Overall Study||124
7806640|NCT01181271|19217259|P1|NOT COMPLETED|Allogeneic Transplant||0
7806641|NCT01181271|19217259|P1|COMPLETED|Allogeneic Transplant||29
7806642|NCT01181271|19217259|P1|STARTED|Allogeneic Transplant||29
7806643|NCT01181271|19217259|P1|NOT COMPLETED|Evaluation for Allogeneic Transplant||13
7806644|NCT01181271|19217259|P1|COMPLETED|Evaluation for Allogeneic Transplant||29
7806645|NCT01181271|19217259|P1|STARTED|Evaluation for Allogeneic Transplant||42
7806646|NCT01181271|19217259|P1|NOT COMPLETED|Autologous Transplant||0
7806647|NCT01181271|19217259|P1|COMPLETED|Autologous Transplant||42
7806648|NCT01181271|19217259|P1|STARTED|Autologous Transplant||42
7806649|NCT01181258|19217274|P1|NOT COMPLETED|Overall Study||0
7806650|NCT01181258|19217274|P1|COMPLETED|Overall Study||16
7806651|NCT01181258|19217274|P1|STARTED|Overall Study||16
7806652|NCT01181167|19217283|P2|NOT COMPLETED|Overall Study||32
7806653|NCT01181167|19217284|P1|NOT COMPLETED|Overall Study||23
7806654|NCT01181167|19217283|P2|COMPLETED|Overall Study||271
7806655|NCT01181167|19217284|P1|COMPLETED|Overall Study||284
7806656|NCT01181167|19217283|P2|Efficacy Analysis Population|Overall Study||248
7806657|NCT01181167|19217284|P1|Efficacy Analysis Population|Overall Study||255
7806658|NCT01181167|19217283|P2|STARTED|Overall Study||303
7806659|NCT01181167|19217284|P1|STARTED|Overall Study||307
7806660|NCT01181141|19217294|P2|NOT COMPLETED|Overall Study||4
7806661|NCT01181141|19217295|P1|NOT COMPLETED|Overall Study||12
7806662|NCT01181141|19217294|P2|COMPLETED|Overall Study||26
7806663|NCT01181141|19217295|P1|COMPLETED|Overall Study||50
7806664|NCT01181141|19217294|P2|Safety Analysis Population|Overall Study||29
7806665|NCT01181141|19217295|P1|Safety Analysis Population|Overall Study||59
7806666|NCT01181141|19217294|P2|STARTED|Overall Study||30
7806667|NCT01181141|19217295|P1|STARTED|Overall Study||62
7806668|NCT01181128|19217304|P3|NOT COMPLETED|Overall Study||1
7806669|NCT01181128|19217305|P2|NOT COMPLETED|Overall Study||5
7806670|NCT01181128|19217306|P1|NOT COMPLETED|Overall Study||6
7806671|NCT01181128|19217304|P3|COMPLETED|Overall Study||22
7806672|NCT01181128|19217305|P2|COMPLETED|Overall Study||19
7806673|NCT01181128|19217306|P1|COMPLETED|Overall Study||112
7806674|NCT01181128|19217304|P3|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0
7806675|NCT01181128|19217305|P2|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1
7806676|NCT01181128|19217306|P1|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8
7806677|NCT01181128|19217304|P3|Pharmacokinetic (PK) Subgroup|Overall Study||0
7806678|NCT01181128|19217305|P2|Pharmacokinetic (PK) Subgroup|Overall Study||0
7806679|NCT01181128|19217306|P1|Pharmacokinetic (PK) Subgroup|Overall Study||30
7806680|NCT01181128|19217304|P3|STARTED|Overall Study||23
7806681|NCT01181128|19217305|P2|STARTED|Overall Study||24
7806682|NCT01181128|19217306|P1|STARTED|Overall Study||118
7806683|NCT01181102|19217394|P2|NOT COMPLETED|Overall Study||46
7806684|NCT01181102|19217395|P1|NOT COMPLETED|Overall Study||51
7806685|NCT01181102|19217394|P2|COMPLETED|Overall Study||310
7806686|NCT01181102|19217395|P1|COMPLETED|Overall Study||309
7806687|NCT01181102|19217394|P2|Efficacy Analysis Population|Overall Study||295
7806688|NCT01181102|19217395|P1|Efficacy Analysis Population|Overall Study||299
7806689|NCT01181102|19217394|P2|Safety Analysis Set|Overall Study||349
7806690|NCT01181102|19217395|P1|Safety Analysis Set|Overall Study||354
7806691|NCT01181102|19217394|P2|STARTED|Overall Study||356
7806692|NCT01181102|19217395|P1|STARTED|Overall Study||360
7806693|NCT01181076|19217405|P2|NOT COMPLETED|Overall Study||12
7806694|NCT01181076|19217406|P1|NOT COMPLETED|Overall Study||19
7806695|NCT01181076|19217405|P2|COMPLETED|Overall Study|As determined|48
7806696|NCT01181076|19217406|P1|COMPLETED|Overall Study||40
7806697|NCT01181076|19217405|P2|STARTED|Overall Study||60
7806698|NCT01181076|19217406|P1|STARTED|Overall Study||59
7806699|NCT01181050|19217428|P2|NOT COMPLETED|Overall Study||0
7806700|NCT01181050|19217429|P1|NOT COMPLETED|Overall Study||0
7806701|NCT01181050|19217428|P2|COMPLETED|Overall Study||22
7806702|NCT01181050|19217429|P1|COMPLETED|Overall Study||41
7806703|NCT01181050|19217428|P2|STARTED|Overall Study||22
7806704|NCT01181050|19217429|P1|STARTED|Overall Study||41
7806705|NCT01181011|19217439|P1|NOT COMPLETED|Overall Study||3
7806706|NCT01181011|19217439|P1|COMPLETED|Overall Study||25
7806707|NCT01181011|19217439|P1|Received Amlodipine 5mg|Overall Study||26
7806708|NCT01181011|19217439|P1|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27
7806709|NCT01181011|19217439|P1|Received Telmisartan 80mg|Overall Study||27
7806710|NCT01181011|19217439|P1|STARTED|Overall Study||28
7806711|NCT01180998|19217489|P3|NOT COMPLETED|Overall Study||10
7806712|NCT01180998|19217490|P2|NOT COMPLETED|Overall Study||4
7806713|NCT01180998|19217491|P1|NOT COMPLETED|Overall Study||4
7806714|NCT01180998|19217489|P3|COMPLETED|Overall Study||51
7806715|NCT01180998|19217490|P2|COMPLETED|Overall Study||68
7806716|NCT01180998|19217491|P1|COMPLETED|Overall Study||63
7806717|NCT01180998|19217489|P3|STARTED|Overall Study||61
7806718|NCT01180998|19217490|P2|STARTED|Overall Study||72
7806719|NCT01180998|19217491|P1|STARTED|Overall Study||67
7806720|NCT01180985|19217505|P2|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0
7806721|NCT01180985|19217506|P1|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1
7806722|NCT01180985|19217505|P2|COMPLETED|Period 2 (7 +/- 1 Days)||26
7806723|NCT01180985|19217506|P1|COMPLETED|Period 2 (7 +/- 1 Days)||26
7806724|NCT01180985|19217505|P2|STARTED|Period 2 (7 +/- 1 Days)||26
7806725|NCT01180985|19217506|P1|STARTED|Period 2 (7 +/- 1 Days)||27
7806726|NCT01180985|19217505|P2|NOT COMPLETED|Period 1 (7 +/- Days)||0
7806727|NCT01180985|19217506|P1|NOT COMPLETED|Period 1 (7 +/- Days)||0
7806728|NCT01180985|19217505|P2|COMPLETED|Period 1 (7 +/- Days)||26
7806729|NCT01180985|19217506|P1|COMPLETED|Period 1 (7 +/- Days)||27
7806730|NCT01180985|19217505|P2|STARTED|Period 1 (7 +/- Days)||26
7806731|NCT01180985|19217506|P1|STARTED|Period 1 (7 +/- Days)||27
7806732|NCT01180894|19217525|P2|NOT COMPLETED|Overall Study||0
7806733|NCT01180894|19217526|P1|NOT COMPLETED|Overall Study||0
7806734|NCT01180894|19217525|P2|COMPLETED|Overall Study||75
7806735|NCT01180894|19217526|P1|COMPLETED|Overall Study||75
7806736|NCT01180894|19217525|P2|STARTED|Overall Study||75
7806737|NCT01180894|19217526|P1|STARTED|Overall Study||75
7806738|NCT01180790|19217545|P7|NOT COMPLETED|Overall Study||1
7806739|NCT01180790|19217546|P6|NOT COMPLETED|Overall Study||7
7806740|NCT01180790|19217547|P5|NOT COMPLETED|Overall Study||5
7806741|NCT01180790|19217548|P4|NOT COMPLETED|Overall Study||9
7806742|NCT01180790|19217549|P3|NOT COMPLETED|Overall Study||13
7806743|NCT01180790|19217550|P2|NOT COMPLETED|Overall Study||5
7806744|NCT01180790|19217551|P1|NOT COMPLETED|Overall Study||9
7806745|NCT01180790|19217545|P7|COMPLETED|Overall Study||18
7806746|NCT01180790|19217546|P6|COMPLETED|Overall Study||13
7806747|NCT01180790|19217547|P5|COMPLETED|Overall Study||14
7806748|NCT01180790|19217548|P4|COMPLETED|Overall Study||6
7806749|NCT01180790|19217549|P3|COMPLETED|Overall Study||4
7806750|NCT01180790|19217550|P2|COMPLETED|Overall Study||11
7806751|NCT01180790|19217551|P1|COMPLETED|Overall Study||7
7806752|NCT01180790|19217545|P7|STARTED|Overall Study||19
7806753|NCT01180790|19217546|P6|STARTED|Overall Study||20
7806754|NCT01180790|19217547|P5|STARTED|Overall Study||19
7806755|NCT01180790|19217548|P4|STARTED|Overall Study||15
7806756|NCT01180790|19217549|P3|STARTED|Overall Study||17
7806757|NCT01180790|19217550|P2|STARTED|Overall Study||16
7806758|NCT01180790|19217551|P1|STARTED|Overall Study||16
7806759|NCT01180777|19217616|P1|NOT COMPLETED|Overall Study||12
7806760|NCT01180777|19217616|P1|COMPLETED|Overall Study||80
7806761|NCT01180777|19217616|P1|STARTED|Overall Study||92
7806762|NCT01180660|19217630|P2|NOT COMPLETED|Overall Study||0
7806763|NCT01180660|19217631|P1|NOT COMPLETED|Overall Study||1
7806764|NCT01180660|19217630|P2|COMPLETED|Overall Study||26
7806765|NCT01180660|19217631|P1|COMPLETED|Overall Study||24
7806766|NCT01180660|19217630|P2|STARTED|Overall Study||26
7806767|NCT01180660|19217631|P1|STARTED|Overall Study||25
7806768|NCT01180647|19217641|P2|NOT COMPLETED|Overall Study||6
7806769|NCT01180647|19217642|P1|NOT COMPLETED|Overall Study||5
7806770|NCT01180647|19217641|P2|COMPLETED|Overall Study||11
7806771|NCT01180647|19217642|P1|COMPLETED|Overall Study||12
7806772|NCT01180647|19217641|P2|STARTED|Overall Study||17
7806773|NCT01180647|19217642|P1|STARTED|Overall Study||17
7806774|NCT01180478|19217660|P2|NOT COMPLETED|Overall Study||188
7806775|NCT01180478|19217661|P1|NOT COMPLETED|Overall Study||181
7806776|NCT01180478|19217660|P2|COMPLETED|Overall Study||293
7806777|NCT01180478|19217661|P1|COMPLETED|Overall Study||303
7806778|NCT01180478|19217660|P2|STARTED|Overall Study||481
7806779|NCT01180478|19217661|P1|STARTED|Overall Study||484
7806780|NCT01180400|19217677|P2|NOT COMPLETED|Overall Study||27
7806781|NCT01180400|19217678|P1|NOT COMPLETED|Overall Study||25
7806782|NCT01180400|19217677|P2|COMPLETED|Overall Study||121
7806783|NCT01180400|19217678|P1|COMPLETED|Overall Study||122
7806784|NCT01180400|19217677|P2|Received Treatment|Overall Study||146
7806785|NCT01180400|19217678|P1|Received Treatment|Overall Study||147
7806786|NCT01180400|19217677|P2|STARTED|Overall Study||148
7806787|NCT01180400|19217678|P1|STARTED|Overall Study||147
7806788|NCT01180296|19217726|P2|NOT COMPLETED|Overall Study||2
7806789|NCT01180296|19217727|P1|NOT COMPLETED|Overall Study||1
7806790|NCT01180296|19217726|P2|COMPLETED|Overall Study||14
7806791|NCT01180296|19217727|P1|COMPLETED|Overall Study||19
7806792|NCT01180296|19217726|P2|STARTED|Overall Study||16
7806793|NCT01180296|19217727|P1|STARTED|Overall Study||20
7806794|NCT01180244|19217737|P2|NOT COMPLETED|Overall Study||8
7806795|NCT01180244|19217738|P1|NOT COMPLETED|Overall Study||6
7806796|NCT01180244|19217737|P2|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38
7806797|NCT01180244|19217738|P1|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39
7806798|NCT01180244|19217737|P2|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45
7806799|NCT01180244|19217738|P1|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40
7806800|NCT01180244|19217737|P2|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46
7806801|NCT01180244|19217738|P1|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45
7806802|NCT01180127|19217756|P4|NOT COMPLETED|Overall Study||1
7806803|NCT01180127|19217757|P3|NOT COMPLETED|Overall Study||1
7806804|NCT01180127|19217758|P2|NOT COMPLETED|Overall Study||0
7806805|NCT01180127|19217759|P1|NOT COMPLETED|Overall Study||2
7806806|NCT01180127|19217756|P4|COMPLETED|Overall Study||9
7806807|NCT01180127|19217757|P3|COMPLETED|Overall Study||9
7806808|NCT01180127|19217758|P2|COMPLETED|Overall Study||11
7806809|NCT01180127|19217759|P1|COMPLETED|Overall Study||8
7806810|NCT01180127|19217756|P4|STARTED|Overall Study||10
7806811|NCT01180127|19217757|P3|STARTED|Overall Study||10
7806812|NCT01180127|19217758|P2|STARTED|Overall Study||11
7806813|NCT01180127|19217759|P1|STARTED|Overall Study||10
7806814|NCT01180049|19217783|P2|NOT COMPLETED|Overall Study||48
7806815|NCT01180049|19217784|P1|NOT COMPLETED|Overall Study||53
7806816|NCT01180049|19217783|P2|COMPLETED|Overall Study||0
7806817|NCT01180049|19217784|P1|COMPLETED|Overall Study||0
7806818|NCT01180049|19217783|P2|STARTED|Overall Study||48
7806819|NCT01180049|19217784|P1|STARTED|Overall Study||53
7806820|NCT01180036|19217806|P2|NOT COMPLETED|Overall Study||0
7806821|NCT01180036|19217807|P1|NOT COMPLETED|Overall Study||0
7806822|NCT01180036|19217806|P2|COMPLETED|Overall Study||65
7806823|NCT01180036|19217807|P1|COMPLETED|Overall Study||65
7806824|NCT01180036|19217806|P2|STARTED|Overall Study||65
7806825|NCT01180036|19217807|P1|STARTED|Overall Study||65
7806826|NCT01179984|19217815|P1|NOT COMPLETED|Overall Study||18
7806827|NCT01179984|19217815|P1|COMPLETED|Overall Study||58
7806828|NCT01179984|19217815|P1|STARTED|Overall Study||76
7806829|NCT01179919|19217821|P1|NOT COMPLETED|Overall Study||2
7806830|NCT01179919|19217821|P1|COMPLETED|Overall Study||19
7806831|NCT01179919|19217821|P1|STARTED|Overall Study||21
7806832|NCT01179737|19217830|P4|NOT COMPLETED|Extension||0
7806833|NCT01179737|19217831|P3|NOT COMPLETED|Extension||0
7806834|NCT01179737|19217832|P2|NOT COMPLETED|Extension||0
7806835|NCT01179737|19217833|P1|NOT COMPLETED|Extension||3
7806836|NCT01179737|19217830|P4|COMPLETED|Extension||0
7806837|NCT01179737|19217831|P3|COMPLETED|Extension||0
7806838|NCT01179737|19217832|P2|COMPLETED|Extension||0
7806839|NCT01179737|19217833|P1|COMPLETED|Extension||0
7806840|NCT01179737|19217830|P4|STARTED|Extension||0
7806841|NCT01179737|19217831|P3|STARTED|Extension||0
7806842|NCT01179737|19217832|P2|STARTED|Extension|One patient did not enrol in the extension|0
7806843|NCT01179737|19217833|P1|STARTED|Extension|Two patients did not enrol in the extension|3
7806844|NCT01179737|19217830|P4|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
7806845|NCT01179737|19217831|P3|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
7806846|NCT01179737|19217832|P2|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
7806847|NCT01179737|19217833|P1|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1
7806848|NCT01179737|19217830|P4|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
7806849|NCT01179737|19217831|P3|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
7806850|NCT01179737|19217832|P2|COMPLETED|Cohort 1 & Cohort 2 Expansion||1
7806851|NCT01179737|19217833|P1|COMPLETED|Cohort 1 & Cohort 2 Expansion||4
7806852|NCT01179737|19217830|P4|STARTED|Cohort 1 & Cohort 2 Expansion||0
7806853|NCT01179737|19217831|P3|STARTED|Cohort 1 & Cohort 2 Expansion||0
7806854|NCT01179737|19217832|P2|STARTED|Cohort 1 & Cohort 2 Expansion||1
7806855|NCT01179737|19217833|P1|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5
7806856|NCT01179737|19217830|P4|NOT COMPLETED|Cohort 1 & Cohort 2||4
7806857|NCT01179737|19217831|P3|NOT COMPLETED|Cohort 1 & Cohort 2||4
7806858|NCT01179737|19217832|P2|NOT COMPLETED|Cohort 1 & Cohort 2||2
7806859|NCT01179737|19217833|P1|NOT COMPLETED|Cohort 1 & Cohort 2||5
7806860|NCT01179737|19217830|P4|COMPLETED|Cohort 1 & Cohort 2||0
7806861|NCT01179737|19217831|P3|COMPLETED|Cohort 1 & Cohort 2||0
7806862|NCT01179737|19217832|P2|COMPLETED|Cohort 1 & Cohort 2||1
7806863|NCT01179737|19217833|P1|COMPLETED|Cohort 1 & Cohort 2||7
7806864|NCT01179737|19217830|P4|STARTED|Cohort 1 & Cohort 2||4
7806865|NCT01179737|19217831|P3|STARTED|Cohort 1 & Cohort 2||4
7806866|NCT01179737|19217832|P2|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3
7806867|NCT01179737|19217833|P1|STARTED|Cohort 1 & Cohort 2||12
7806868|NCT01179672|19217844|P2|NOT COMPLETED|Overall Study||26
7806869|NCT01179672|19217845|P1|NOT COMPLETED|Overall Study||30
7806870|NCT01179672|19217844|P2|COMPLETED|Overall Study||176
7806871|NCT01179672|19217845|P1|COMPLETED|Overall Study||173
7806872|NCT01179672|19217844|P2|Entered Taper|Overall Study||177
7806873|NCT01179672|19217845|P1|Entered Taper|Overall Study||181
7806874|NCT01179672|19217844|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
7806875|NCT01179672|19217845|P1|Received at Least 1 Dose of Study Drug|Overall Study||202
7806876|NCT01179672|19217844|P2|STARTED|Overall Study||202
7806877|NCT01179672|19217845|P1|STARTED|Overall Study||203
7806878|NCT01179568|19217875|P4|NOT COMPLETED|Overall Study||20
7806879|NCT01179568|19217876|P3|NOT COMPLETED|Overall Study||23
7806880|NCT01179568|19217877|P2|NOT COMPLETED|Overall Study||38
7806881|NCT01179568|19217878|P1|NOT COMPLETED|Overall Study||28
7806882|NCT01179568|19217875|P4|COMPLETED|Overall Study||76
7806883|NCT01179568|19217876|P3|COMPLETED|Overall Study||76
7806884|NCT01179568|19217877|P2|COMPLETED|Overall Study||61
7806885|NCT01179568|19217878|P1|COMPLETED|Overall Study||73
7806886|NCT01179568|19217875|P4|Completed Week 12 Assessment|Overall Study||75
7806887|NCT01179568|19217876|P3|Completed Week 12 Assessment|Overall Study||76
7806888|NCT01179568|19217877|P2|Completed Week 12 Assessment|Overall Study||69
7806889|NCT01179568|19217878|P1|Completed Week 12 Assessment|Overall Study||69
7806890|NCT01179568|19217875|P4|STARTED|Overall Study||96
7806891|NCT01179568|19217876|P3|STARTED|Overall Study||99
7806892|NCT01179568|19217877|P2|STARTED|Overall Study||99
7806893|NCT01179568|19217878|P1|STARTED|Overall Study||101
7806894|NCT01179516|19217901|P3|NOT COMPLETED|Overall Study||31
7806895|NCT01179516|19217902|P2|NOT COMPLETED|Overall Study||26
7806896|NCT01179516|19217903|P1|NOT COMPLETED|Overall Study||27
7806897|NCT01179516|19217901|P3|COMPLETED|Overall Study||121
7806898|NCT01179516|19217902|P2|COMPLETED|Overall Study||131
7806899|NCT01179516|19217903|P1|COMPLETED|Overall Study||133
7806900|NCT01179516|19217901|P3|Treated|Overall Study||151
7806901|NCT01179516|19217902|P2|Treated|Overall Study||154
7806902|NCT01179516|19217903|P1|Treated|Overall Study||160
7806903|NCT01179516|19217901|P3|STARTED|Overall Study||152
7806904|NCT01179516|19217902|P2|STARTED|Overall Study||157
7806905|NCT01179516|19217903|P1|STARTED|Overall Study||160
7806906|NCT01179490|19217926|P1|NOT COMPLETED|Overall Study||0
7806907|NCT01179490|19217926|P1|COMPLETED|Overall Study||5
7806908|NCT01179490|19217926|P1|STARTED|Overall Study||5
7806909|NCT01179477|19217947|P1|NOT COMPLETED|Overall Study||1087
7806910|NCT01179477|19217947|P1|COMPLETED|Overall Study||843
7806911|NCT01179477|19217947|P1|STARTED|Overall Study||1930
7806912|NCT01179399|19217952|P1|NOT COMPLETED|Overall Study||32
7806913|NCT01179399|19217952|P1|COMPLETED|Overall Study||0
7806914|NCT01179399|19217952|P1|STARTED|Overall Study||32
7806915|NCT01179347|19217958|P2|NOT COMPLETED|Open-label Period (12 Weeks)||16
7806916|NCT01179347|19217959|P1|NOT COMPLETED|Open-label Period (12 Weeks)||15
7806917|NCT01179347|19217958|P2|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278
7806918|NCT01179347|19217959|P1|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132
7806919|NCT01179347|19217958|P2|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294
7807004|NCT01178671|19218144|P2|NOT COMPLETED|Overall Study||15
7806920|NCT01179347|19217959|P1|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147
7806921|NCT01179347|19217958|P2|NOT COMPLETED|Double-blind Period (12 Weeks)||14
7806922|NCT01179347|19217959|P1|NOT COMPLETED|Double-blind Period (12 Weeks)||8
7806923|NCT01179347|19217958|P2|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294
7806924|NCT01179347|19217959|P1|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147
7806925|NCT01179347|19217958|P2|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308
7806926|NCT01179347|19217959|P1|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155
7806927|NCT01179334|19217981|P2|NOT COMPLETED|Long-term Extension (LTE) Period||6
7806928|NCT01179334|19217982|P1|NOT COMPLETED|Long-term Extension (LTE) Period||11
7806929|NCT01179334|19217981|P2|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
7806930|NCT01179334|19217982|P1|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
7806931|NCT01179334|19217981|P2|STARTED|Long-term Extension (LTE) Period||6
7806932|NCT01179334|19217982|P1|STARTED|Long-term Extension (LTE) Period||11
7806933|NCT01179334|19217981|P2|NOT COMPLETED|Treatment Period||0
7806934|NCT01179334|19217982|P1|NOT COMPLETED|Treatment Period||1
7806935|NCT01179334|19217981|P2|COMPLETED|Treatment Period||6
7806936|NCT01179334|19217982|P1|COMPLETED|Treatment Period||11
7806937|NCT01179334|19217981|P2|Participants Received Treatment|Treatment Period||6
7806938|NCT01179334|19217982|P1|Participants Received Treatment|Treatment Period||12
7806939|NCT01179334|19217981|P2|STARTED|Treatment Period||6
7806940|NCT01179334|19217982|P1|STARTED|Treatment Period||12
7806941|NCT01179217|19218012|P2|NOT COMPLETED|Overall Study||19
7806942|NCT01179217|19218013|P1|NOT COMPLETED|Overall Study||55
7806943|NCT01179217|19218012|P2|COMPLETED|Overall Study||59
7806944|NCT01179217|19218013|P1|COMPLETED|Overall Study||97
7806945|NCT01179217|19218012|P2|STARTED|Overall Study||78
7806946|NCT01179217|19218013|P1|STARTED|Overall Study||152
7806947|NCT01179191|19218037|P1|NOT COMPLETED|Maintenance Phase (8 Weeks)||117
7806948|NCT01179191|19218037|P1|COMPLETED|Maintenance Phase (8 Weeks)||234
7806949|NCT01179191|19218037|P1|STARTED|Maintenance Phase (8 Weeks)||351
7806950|NCT01179191|19218037|P1|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333
7806951|NCT01179191|19218037|P1|COMPLETED|Titration Phase (up to 6 Weeks)||351
7806952|NCT01179191|19218037|P1|STARTED|Titration Phase (up to 6 Weeks)||684
7806953|NCT01179113|19218056|P2|NOT COMPLETED|Overall Study||0
7806954|NCT01179113|19218057|P1|NOT COMPLETED|Overall Study||0
7806955|NCT01179113|19218056|P2|COMPLETED|Overall Study||16
7806956|NCT01179113|19218057|P1|COMPLETED|Overall Study||17
7806957|NCT01179113|19218056|P2|STARTED|Overall Study||16
7806958|NCT01179113|19218057|P1|STARTED|Overall Study||17
7806959|NCT01179048|19218069|P2|NOT COMPLETED|Overall Study||159
7806960|NCT01179048|19218070|P1|NOT COMPLETED|Overall Study||139
7806961|NCT01179048|19218069|P2|COMPLETED|Overall Study||4513
7806962|NCT01179048|19218070|P1|COMPLETED|Overall Study||4529
7806963|NCT01179048|19218069|P2|STARTED|Overall Study||4672
7806964|NCT01179048|19218070|P1|STARTED|Overall Study||4668
7806965|NCT01178944|19218086|P1|NOT COMPLETED|Overall Study||0
7806966|NCT01178944|19218086|P1|COMPLETED|Overall Study||35
7806967|NCT01178944|19218086|P1|STARTED|Overall Study||35
7806968|NCT01178853|19218097|P2|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3
7806969|NCT01178853|19218098|P1|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0
7806970|NCT01178853|19218097|P2|COMPLETED|Period 4 (Warfarin + Study Drug)||19
7806971|NCT01178853|19218098|P1|COMPLETED|Period 4 (Warfarin + Study Drug)||21
7806972|NCT01178853|19218097|P2|STARTED|Period 4 (Warfarin + Study Drug)||22
7806973|NCT01178853|19218098|P1|STARTED|Period 4 (Warfarin + Study Drug)||21
7806974|NCT01178853|19218097|P2|NOT COMPLETED|Period 3 (Warfarin Titration)||0
7806975|NCT01178853|19218098|P1|NOT COMPLETED|Period 3 (Warfarin Titration)||1
7806976|NCT01178853|19218097|P2|COMPLETED|Period 3 (Warfarin Titration)||22
7806977|NCT01178853|19218098|P1|COMPLETED|Period 3 (Warfarin Titration)||21
7806978|NCT01178853|19218097|P2|STARTED|Period 3 (Warfarin Titration)||22
7806979|NCT01178853|19218098|P1|STARTED|Period 3 (Warfarin Titration)||22
7806980|NCT01178853|19218097|P2|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0
7806981|NCT01178853|19218098|P1|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1
7806982|NCT01178853|19218097|P2|COMPLETED|Period 2 (Warfarin + Study Drug)||22
7806983|NCT01178853|19218098|P1|COMPLETED|Period 2 (Warfarin + Study Drug)||22
7806984|NCT01178853|19218097|P2|STARTED|Period 2 (Warfarin + Study Drug)||22
7806985|NCT01178853|19218098|P1|STARTED|Period 2 (Warfarin + Study Drug)||23
7806986|NCT01178853|19218097|P2|NOT COMPLETED|Period 1 (Warfarin Titration)||2
7806987|NCT01178853|19218098|P1|NOT COMPLETED|Period 1 (Warfarin Titration)||1
7806988|NCT01178853|19218097|P2|COMPLETED|Period 1 (Warfarin Titration)||22
7806989|NCT01178853|19218098|P1|COMPLETED|Period 1 (Warfarin Titration)||23
7806990|NCT01178853|19218097|P2|STARTED|Period 1 (Warfarin Titration)||24
7806991|NCT01178853|19218098|P1|STARTED|Period 1 (Warfarin Titration)||24
7806992|NCT01178827|19218107|P3|NOT COMPLETED|Overall Study||0
7806993|NCT01178827|19218108|P2|NOT COMPLETED|Overall Study||0
7806994|NCT01178827|19218109|P1|NOT COMPLETED|Overall Study||0
7806995|NCT01178827|19218107|P3|COMPLETED|Overall Study||4
7806996|NCT01178827|19218108|P2|COMPLETED|Overall Study||10
7806997|NCT01178827|19218109|P1|COMPLETED|Overall Study||6
7806998|NCT01178827|19218107|P3|STARTED|Overall Study||4
7806999|NCT01178827|19218108|P2|STARTED|Overall Study||10
7807000|NCT01178827|19218109|P1|STARTED|Overall Study||6
7807001|NCT01178762|19218138|P1|NOT COMPLETED|Overall Study||15
7807002|NCT01178762|19218138|P1|COMPLETED|Overall Study||27
7807003|NCT01178762|19218138|P1|STARTED|Overall Study||42
7807005|NCT01178671|19218145|P1|NOT COMPLETED|Overall Study||12
7807006|NCT01178671|19218144|P2|COMPLETED|Overall Study||3
7807007|NCT01178671|19218145|P1|COMPLETED|Overall Study||6
7807008|NCT01178671|19218144|P2|STARTED|Overall Study||18
7807009|NCT01178671|19218145|P1|STARTED|Overall Study||18
7807010|NCT01178528|19218172|P3|NOT COMPLETED|Overall Study||0
7807011|NCT01178528|19218173|P2|NOT COMPLETED|Overall Study||0
7807012|NCT01178528|19218174|P1|NOT COMPLETED|Overall Study||0
7807013|NCT01178528|19218172|P3|COMPLETED|Overall Study||42
7807014|NCT01178528|19218173|P2|COMPLETED|Overall Study||38
7807015|NCT01178528|19218174|P1|COMPLETED|Overall Study||41
7807016|NCT01178528|19218172|P3|STARTED|Overall Study||42
7807017|NCT01178528|19218173|P2|STARTED|Overall Study||38
7807018|NCT01178528|19218174|P1|STARTED|Overall Study||41
7807019|NCT01178385|19218193|P2|NOT COMPLETED|Overall Study||0
7807020|NCT01178385|19218194|P1|NOT COMPLETED|Overall Study||2
7807021|NCT01178385|19218193|P2|COMPLETED|Overall Study||21
7807022|NCT01178385|19218194|P1|COMPLETED|Overall Study||22
7807023|NCT01178385|19218193|P2|STARTED|Overall Study||21
7807024|NCT01178385|19218194|P1|STARTED|Overall Study||24
7807025|NCT01178333|19218207|P3|NOT COMPLETED|Overall Study||0
7807026|NCT01178333|19218208|P2|NOT COMPLETED|Overall Study||0
7807027|NCT01178333|19218209|P1|NOT COMPLETED|Overall Study||0
7807028|NCT01178333|19218207|P3|COMPLETED|Overall Study||87
7807029|NCT01178333|19218208|P2|COMPLETED|Overall Study||284
7807030|NCT01178333|19218209|P1|COMPLETED|Overall Study||71
7807031|NCT01178333|19218207|P3|STARTED|Overall Study||87
7807032|NCT01178333|19218208|P2|STARTED|Overall Study||284
7807033|NCT01178333|19218209|P1|STARTED|Overall Study||71
7807034|NCT01178294|19218263|P1|NOT COMPLETED|Overall Study||11
7807035|NCT01178294|19218263|P1|COMPLETED|Overall Study||18
7807036|NCT01178294|19218263|P1|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29
7807037|NCT01178281|19218287|P3|NOT COMPLETED|Overall Study||0
7807038|NCT01178281|19218288|P2|NOT COMPLETED|Overall Study||0
7807039|NCT01178281|19218289|P1|NOT COMPLETED|Overall Study||0
7807040|NCT01178281|19218287|P3|COMPLETED|Overall Study||15
7807041|NCT01178281|19218288|P2|COMPLETED|Overall Study||84
7807042|NCT01178281|19218289|P1|COMPLETED|Overall Study||168
7807043|NCT01178281|19218287|P3|Received Study Drug|Overall Study||15
7807044|NCT01178281|19218288|P2|Received Study Drug|Overall Study||83
7807045|NCT01178281|19218289|P1|Received Study Drug|Overall Study||167
7807046|NCT01178281|19218287|P3|STARTED|Overall Study||15
7807047|NCT01178281|19218288|P2|STARTED|Overall Study||84
7807048|NCT01178281|19218289|P1|STARTED|Overall Study||168
7807049|NCT01178268|19218316|P2|NOT COMPLETED|Overall Study||1
7807050|NCT01178268|19218317|P1|NOT COMPLETED|Overall Study||7
7807051|NCT01178268|19218316|P2|COMPLETED|Overall Study||120
7807052|NCT01178268|19218317|P1|COMPLETED|Overall Study||360
7807053|NCT01178268|19218316|P2|STARTED|Overall Study||121
7807054|NCT01178268|19218317|P1|STARTED|Overall Study||367
7807055|NCT01178216|19218534|P1|NOT COMPLETED|Overall Study||2
7807056|NCT01178216|19218534|P1|COMPLETED|Overall Study||39
7807057|NCT01178216|19218534|P1|STARTED|Overall Study||41
7807058|NCT01178138|19218543|P1|NOT COMPLETED|Overall Study||23
7807059|NCT01178138|19218543|P1|COMPLETED|Overall Study||1
7807060|NCT01178138|19218543|P1|Completed 3 Sessions|Overall Study||1
7807061|NCT01178138|19218543|P1|Completed 5 Sessions|Overall Study||1
7807062|NCT01178138|19218543|P1|Completed 6 Sessions|Overall Study||1
7807063|NCT01178138|19218543|P1|STARTED|Overall Study||24
7807064|NCT01178125|19218564|P1|NOT COMPLETED|Overall Study||1178
7807065|NCT01178125|19218564|P1|COMPLETED|Overall Study||1680
7807066|NCT01178125|19218564|P1|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401
7807067|NCT01178125|19218564|P1|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607
7807068|NCT01178125|19218564|P1|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765
7807069|NCT01178125|19218564|P1|STARTED|Overall Study|Number enrolled.|2858
7807070|NCT01178099|19218595|P2|NOT COMPLETED|Overall Study||1
7807071|NCT01178099|19218596|P1|NOT COMPLETED|Overall Study||0
7807072|NCT01178099|19218595|P2|COMPLETED|Overall Study||12
7807073|NCT01178099|19218596|P1|COMPLETED|Overall Study||13
7807074|NCT01178099|19218595|P2|STARTED|Overall Study||13
7807075|NCT01178099|19218596|P1|STARTED|Overall Study||13
7807076|NCT01178086|19218636|P1|NOT COMPLETED|Overall Study||332
7807077|NCT01178086|19218636|P1|COMPLETED|Overall Study||349
7807078|NCT01178086|19218636|P1|Effectiveness Analysis Set (EAS)|Overall Study|who received at least 1 dose of rituximab and had data from baseline and at least 1 follow-up visit.|661
7807079|NCT01178086|19218636|P1|STARTED|Overall Study|Safety analysis set: participants who received at least one dose of rituximab.|681
7807080|NCT01178073|19218663|P3|NOT COMPLETED|Overall Study||46
7807081|NCT01178073|19218664|P2|NOT COMPLETED|Overall Study||44
7807082|NCT01178073|19218665|P1|NOT COMPLETED|Overall Study||62
7807083|NCT01178073|19218663|P3|COMPLETED|Overall Study||105
7807084|NCT01178073|19218664|P2|COMPLETED|Overall Study||108
7807085|NCT01178073|19218665|P1|COMPLETED|Overall Study||240
7807086|NCT01178073|19218663|P3|STARTED|Overall Study||151
7807087|NCT01178073|19218664|P2|STARTED|Overall Study||152
7807088|NCT01178073|19218665|P1|STARTED|Overall Study||302
7807089|NCT01177969|19218696|P2|NOT COMPLETED|Overall Study||3
7807090|NCT01177969|19218697|P1|NOT COMPLETED|Overall Study||3
7807091|NCT01177969|19218696|P2|COMPLETED|Overall Study||11
7807092|NCT01177969|19218697|P1|COMPLETED|Overall Study||16
7807093|NCT01177969|19218696|P2|STARTED|Overall Study||14
7807094|NCT01177969|19218697|P1|STARTED|Overall Study||19
7807095|NCT01177956|19218705|P1|NOT COMPLETED|Overall Study||0
7807096|NCT01177956|19218705|P1|COMPLETED|Overall Study||68
7807097|NCT01177956|19218705|P1|STARTED|Overall Study||68
7807098|NCT01177943|19218720|P2|NOT COMPLETED|Second Intervention||0
7807099|NCT01177943|19218721|P1|NOT COMPLETED|Second Intervention||0
7807100|NCT01177943|19218720|P2|COMPLETED|Second Intervention||21
7807101|NCT01177943|19218721|P1|COMPLETED|Second Intervention||19
7807102|NCT01177943|19218720|P2|STARTED|Second Intervention||21
7807103|NCT01177943|19218721|P1|STARTED|Second Intervention||19
7807104|NCT01177943|19218720|P2|NOT COMPLETED|First Intervention||0
7807105|NCT01177943|19218721|P1|NOT COMPLETED|First Intervention||2
7807106|NCT01177943|19218720|P2|COMPLETED|First Intervention||21
7807107|NCT01177943|19218721|P1|COMPLETED|First Intervention||19
7807108|NCT01177943|19218720|P2|STARTED|First Intervention||21
7807109|NCT01177943|19218721|P1|STARTED|First Intervention||21
7807110|NCT01177813|19218734|P5|NOT COMPLETED|Overall Study||9
7807111|NCT01177813|19218735|P4|NOT COMPLETED|Overall Study||17
7807112|NCT01177813|19218736|P3|NOT COMPLETED|Overall Study||20
7807113|NCT01177813|19218737|P2|NOT COMPLETED|Overall Study||18
7807114|NCT01177813|19218738|P1|NOT COMPLETED|Overall Study||41
7807115|NCT01177813|19218734|P5|COMPLETED|Overall Study||78
7807116|NCT01177813|19218735|P4|COMPLETED|Overall Study||206
7807117|NCT01177813|19218736|P3|COMPLETED|Overall Study||204
7807118|NCT01177813|19218737|P2|COMPLETED|Overall Study||206
7807119|NCT01177813|19218738|P1|COMPLETED|Overall Study||187
7807120|NCT01177813|19218734|P5|STARTED|Overall Study||87
7807121|NCT01177813|19218735|P4|STARTED|Overall Study||223
7807122|NCT01177813|19218736|P3|STARTED|Overall Study||224
7807123|NCT01177813|19218737|P2|STARTED|Overall Study||224
7807124|NCT01177813|19218738|P1|STARTED|Overall Study||228
7807125|NCT01177800|19218767|P2|NOT COMPLETED|Overall Study||5
7807126|NCT01177800|19218768|P1|NOT COMPLETED|Overall Study||10
7807127|NCT01177800|19218767|P2|COMPLETED|Overall Study||40
7807128|NCT01177800|19218768|P1|COMPLETED|Overall Study||74
7807129|NCT01177800|19218767|P2|STARTED|Overall Study||45
7807130|NCT01177800|19218768|P1|STARTED|Overall Study||84
7807131|NCT01177735|19218782|P1|NOT COMPLETED|Overall Study||71
7807132|NCT01177735|19218782|P1|COMPLETED|Overall Study||0
7807133|NCT01177735|19218782|P1|STARTED|Overall Study||71
7807134|NCT01177722|19218790|P4|NOT COMPLETED|Overall Study||7
7807135|NCT01177722|19218791|P3|NOT COMPLETED|Overall Study||9
7807136|NCT01177722|19218792|P2|NOT COMPLETED|Overall Study||10
7807137|NCT01177722|19218793|P1|NOT COMPLETED|Overall Study||13
7807138|NCT01177722|19218790|P4|COMPLETED|Overall Study||338
7807139|NCT01177722|19218791|P3|COMPLETED|Overall Study||333
7807140|NCT01177722|19218792|P2|COMPLETED|Overall Study||334
7807141|NCT01177722|19218793|P1|COMPLETED|Overall Study||331
7807142|NCT01177722|19218790|P4|STARTED|Overall Study||345
7807143|NCT01177722|19218791|P3|STARTED|Overall Study||342
7807144|NCT01177722|19218792|P2|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344
7807145|NCT01177722|19218793|P1|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344
7807146|NCT01177709|19218819|P1|NOT COMPLETED|Overall Study||0
7807147|NCT01177709|19218819|P1|COMPLETED|Overall Study||12
7807148|NCT01177709|19218819|P1|STARTED|Overall Study||12
7807149|NCT01177670|19218825|P1|NOT COMPLETED|Overall Study||169
7807150|NCT01177670|19218825|P1|COMPLETED|Overall Study||0
7807151|NCT01177670|19218825|P1|STARTED|Overall Study||169
7807152|NCT01177553|19218832|P2|NOT COMPLETED|Overall Study||0
7807153|NCT01177553|19218833|P1|NOT COMPLETED|Overall Study||1
7807154|NCT01177553|19218832|P2|COMPLETED|Overall Study|data as of March 2009|2
7807155|NCT01177553|19218833|P1|COMPLETED|Overall Study|data as of March 2009|2
7807156|NCT01177553|19218832|P2|STARTED|Overall Study||2
7807157|NCT01177553|19218833|P1|STARTED|Overall Study||3
7807158|NCT01177410|19218842|P3|NOT COMPLETED|Overall Study||5
7807159|NCT01177410|19218843|P2|NOT COMPLETED|Overall Study||7
7807160|NCT01177410|19218844|P1|NOT COMPLETED|Overall Study||1
7807161|NCT01177410|19218842|P3|COMPLETED|Overall Study||45
7807162|NCT01177410|19218843|P2|COMPLETED|Overall Study||40
7807163|NCT01177410|19218844|P1|COMPLETED|Overall Study||50
7807164|NCT01177410|19218842|P3|STARTED|Overall Study||50
7807165|NCT01177410|19218843|P2|STARTED|Overall Study||47
7807166|NCT01177410|19218844|P1|STARTED|Overall Study||51
7807167|NCT01177384|19218857|P2|NOT COMPLETED|Overall Study||26
7807168|NCT01177384|19218858|P1|NOT COMPLETED|Overall Study||14
7807169|NCT01177384|19218857|P2|COMPLETED|Overall Study||164
7807170|NCT01177384|19218858|P1|COMPLETED|Overall Study||177
7807171|NCT01177384|19218857|P2|STARTED|Overall Study|Includes the second randomization of a participant|190
7807172|NCT01177384|19218858|P1|STARTED|Overall Study||191
7807173|NCT01177293|19218870|P2|NOT COMPLETED|Second Intervention Period||0
7807174|NCT01177293|19218871|P1|NOT COMPLETED|Second Intervention Period||0
7807175|NCT01177293|19218870|P2|COMPLETED|Second Intervention Period||6
7807176|NCT01177293|19218871|P1|COMPLETED|Second Intervention Period||7
7807177|NCT01177293|19218870|P2|STARTED|Second Intervention Period||6
7807178|NCT01177293|19218871|P1|STARTED|Second Intervention Period||7
7807179|NCT01177293|19218870|P2|NOT COMPLETED|Washout Period (of 14 Days)||1
7807180|NCT01177293|19218871|P1|NOT COMPLETED|Washout Period (of 14 Days)||0
7807181|NCT01177293|19218870|P2|COMPLETED|Washout Period (of 14 Days)||6
7807182|NCT01177293|19218871|P1|COMPLETED|Washout Period (of 14 Days)||7
7807183|NCT01177293|19218870|P2|STARTED|Washout Period (of 14 Days)||7
7807184|NCT01177293|19218871|P1|STARTED|Washout Period (of 14 Days)||7
7807185|NCT01177293|19218870|P2|NOT COMPLETED|First Intervention Period||0
7807186|NCT01177293|19218871|P1|NOT COMPLETED|First Intervention Period||0
7807187|NCT01177293|19218870|P2|COMPLETED|First Intervention Period||7
7807188|NCT01177293|19218871|P1|COMPLETED|First Intervention Period||7
7807189|NCT01177293|19218870|P2|STARTED|First Intervention Period||7
7807190|NCT01177293|19218871|P1|STARTED|First Intervention Period||7
7807191|NCT01177228|19218889|P4|NOT COMPLETED|Overall Study||0
7807192|NCT01177228|19218890|P3|NOT COMPLETED|Overall Study||0
7807193|NCT01177228|19218891|P2|NOT COMPLETED|Overall Study||2
7807194|NCT01177228|19218892|P1|NOT COMPLETED|Overall Study||1
7807195|NCT01177228|19218889|P4|COMPLETED|Overall Study||11
7807196|NCT01177228|19218890|P3|COMPLETED|Overall Study||14
7807197|NCT01177228|19218891|P2|COMPLETED|Overall Study||11
7807198|NCT01177228|19218892|P1|COMPLETED|Overall Study||8
7807199|NCT01177228|19218889|P4|Received Treatment|Overall Study||11
7807200|NCT01177228|19218890|P3|Received Treatment|Overall Study||14
7807201|NCT01177228|19218891|P2|Received Treatment|Overall Study||12
7807202|NCT01177228|19218892|P1|Received Treatment|Overall Study||9
7807203|NCT01177228|19218889|P4|STARTED|Overall Study||11
7807204|NCT01177228|19218890|P3|STARTED|Overall Study||14
7807205|NCT01177228|19218891|P2|STARTED|Overall Study||13
7807206|NCT01177228|19218892|P1|STARTED|Overall Study||9
7807207|NCT01177189|19218932|P2|NOT COMPLETED|Overall Study||0
7807208|NCT01177189|19218933|P1|NOT COMPLETED|Overall Study||0
7807209|NCT01177189|19218932|P2|COMPLETED|Overall Study||45
7807210|NCT01177189|19218933|P1|COMPLETED|Overall Study||42
7807211|NCT01177189|19218932|P2|STARTED|Overall Study||45
7807212|NCT01177189|19218933|P1|STARTED|Overall Study||42
7807213|NCT01177137|19218946|P3|NOT COMPLETED|Overall Study||2
7807214|NCT01177137|19218947|P2|NOT COMPLETED|Overall Study||10
7807215|NCT01177137|19218948|P1|NOT COMPLETED|Overall Study||10
7807216|NCT01177137|19218946|P3|COMPLETED|Overall Study||47
7807217|NCT01177137|19218947|P2|COMPLETED|Overall Study||41
7807218|NCT01177137|19218948|P1|COMPLETED|Overall Study||41
7807219|NCT01177137|19218946|P3|STARTED|Overall Study||49
7807220|NCT01177137|19218947|P2|STARTED|Overall Study||51
7807221|NCT01177137|19218948|P1|STARTED|Overall Study||51
7807222|NCT01177098|19219015|P2|NOT COMPLETED|Overall Study||12
7807223|NCT01177098|19219016|P1|NOT COMPLETED|Overall Study||9
7807224|NCT01177098|19219015|P2|COMPLETED|Overall Study||271
7807225|NCT01177098|19219016|P1|COMPLETED|Overall Study||269
7807226|NCT01177098|19219015|P2|STARTED|Overall Study||283
7807227|NCT01177098|19219016|P1|STARTED|Overall Study||278
7807228|NCT01177059|19219032|P1|NOT COMPLETED|Overall Study||50
7807229|NCT01177059|19219032|P1|COMPLETED|Overall Study||18
7807230|NCT01177059|19219032|P1|STARTED|Overall Study||68
7807231|NCT01177007|19219038|P1|NOT COMPLETED|Overall Study||38
7807232|NCT01177007|19219038|P1|COMPLETED|Overall Study||12
7807233|NCT01177007|19219038|P1|Completed First Clinical and Imaging|Overall Study||43
7807234|NCT01177007|19219038|P1|Completed First Y90 Treatment|Overall Study||50
7807235|NCT01177007|19219038|P1|STARTED|Overall Study||50
7807236|NCT01176968|19219052|P2|NOT COMPLETED|Overall Study||82
7807237|NCT01176968|19219053|P1|NOT COMPLETED|Overall Study||84
7807238|NCT01176968|19219052|P2|COMPLETED|Overall Study||424
7807239|NCT01176968|19219053|P1|COMPLETED|Overall Study||422
7807240|NCT01176968|19219052|P2|Treated|Overall Study||505
7807241|NCT01176968|19219053|P1|Treated|Overall Study||505
7807242|NCT01176968|19219052|P2|STARTED|Overall Study||506
7807243|NCT01176968|19219053|P1|STARTED|Overall Study||506
7807244|NCT01176955|19219087|P2|NOT COMPLETED|Overall Study||2
7807245|NCT01176955|19219088|P1|NOT COMPLETED|Overall Study||3
7807246|NCT01176955|19219087|P2|COMPLETED|Overall Study||8
7807247|NCT01176955|19219088|P1|COMPLETED|Overall Study||7
7807248|NCT01176955|19219087|P2|STARTED|Overall Study||10
7807249|NCT01176955|19219088|P1|STARTED|Overall Study||10
7807250|NCT01176916|19219099|P1|NOT COMPLETED|Overall Study||167
7807251|NCT01176916|19219099|P1|COMPLETED|Overall Study||397
7807252|NCT01176916|19219099|P1|Assigne But Not Treated|Overall Study||6
7807253|NCT01176916|19219099|P1|Treated|Overall Study||558
7807254|NCT01176916|19219099|P1|STARTED|Overall Study||564
7807255|NCT01176877|19219109|P1|NOT COMPLETED|Overall Study||9
7807256|NCT01176877|19219109|P1|COMPLETED|Overall Study||31
7807257|NCT01176877|19219109|P1|STARTED|Overall Study||40
7807258|NCT01176773|19219114|P1|NOT COMPLETED|Overall Study||3
7807259|NCT01176773|19219114|P1|COMPLETED|Overall Study||59
7807260|NCT01176773|19219114|P1|STARTED|Overall Study||62
7807261|NCT01176617|19219125|P3|NOT COMPLETED|6 - 12 Months (Randomized)||0
7807262|NCT01176617|19219126|P2|NOT COMPLETED|6 - 12 Months (Randomized)||0
7807263|NCT01176617|19219127|P1|NOT COMPLETED|6 - 12 Months (Randomized)||5
7807264|NCT01176617|19219125|P3|COMPLETED|6 - 12 Months (Randomized)||0
7807265|NCT01176617|19219126|P2|COMPLETED|6 - 12 Months (Randomized)||20
7807266|NCT01176617|19219127|P1|COMPLETED|6 - 12 Months (Randomized)||13
7807267|NCT01176617|19219125|P3|STARTED|6 - 12 Months (Randomized)||0
7807268|NCT01176617|19219126|P2|STARTED|6 - 12 Months (Randomized)||20
7807269|NCT01176617|19219127|P1|STARTED|6 - 12 Months (Randomized)||18
7807270|NCT01176617|19219125|P3|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
7807271|NCT01176617|19219126|P2|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
7807272|NCT01176617|19219127|P1|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
7807273|NCT01176617|19219125|P3|COMPLETED|1 - 6 Months (Ron-randomized)||38
7807274|NCT01176617|19219126|P2|COMPLETED|1 - 6 Months (Ron-randomized)||0
7807275|NCT01176617|19219127|P1|COMPLETED|1 - 6 Months (Ron-randomized)||0
7807276|NCT01176617|19219125|P3|STARTED|1 - 6 Months (Ron-randomized)||38
7807277|NCT01176617|19219126|P2|STARTED|1 - 6 Months (Ron-randomized)||0
7807278|NCT01176617|19219127|P1|STARTED|1 - 6 Months (Ron-randomized)||0
7807279|NCT01176591|19219138|P2|NOT COMPLETED|Session 2||0
7807280|NCT01176591|19219139|P1|NOT COMPLETED|Session 2||0
7807281|NCT01176591|19219138|P2|COMPLETED|Session 2||3
7807282|NCT01176591|19219139|P1|COMPLETED|Session 2||10
7807283|NCT01176591|19219138|P2|STARTED|Session 2||3
7807284|NCT01176591|19219139|P1|STARTED|Session 2||10
7807285|NCT01176591|19219138|P2|NOT COMPLETED|Session 1||0
7807286|NCT01176591|19219139|P1|NOT COMPLETED|Session 1||0
7807287|NCT01176591|19219138|P2|COMPLETED|Session 1||3
7807288|NCT01176591|19219139|P1|COMPLETED|Session 1||10
7807289|NCT01176591|19219138|P2|STARTED|Session 1||3
7807290|NCT01176591|19219139|P1|STARTED|Session 1||10
7807291|NCT01176565|19219157|P2|NOT COMPLETED|Overall Study||19
7807292|NCT01176565|19219158|P1|NOT COMPLETED|Overall Study||20
7807293|NCT01176565|19219157|P2|COMPLETED|Overall Study||481
7807294|NCT01176565|19219158|P1|COMPLETED|Overall Study||480
7807295|NCT01176565|19219157|P2|STARTED|Overall Study||500
7807296|NCT01176565|19219158|P1|STARTED|Overall Study||500
7807297|NCT01176513|19219176|P1|NOT COMPLETED|Overall Study||3
7807298|NCT01176513|19219176|P1|COMPLETED|Overall Study||22
7807299|NCT01176513|19219176|P1|STARTED|Overall Study||25
7807300|NCT01176448|19219181|P1|NOT COMPLETED|Overall Study||0
7807301|NCT01176448|19219181|P1|COMPLETED|Overall Study||6
7807302|NCT01176448|19219181|P1|STARTED|Overall Study||6
7807303|NCT01176435|19219192|P3|NOT COMPLETED|Overall Study||0
7807304|NCT01176435|19219193|P2|NOT COMPLETED|Overall Study||0
7807305|NCT01176435|19219194|P1|NOT COMPLETED|Overall Study||0
7807306|NCT01176435|19219192|P3|COMPLETED|Overall Study||15
7807307|NCT01176435|19219193|P2|COMPLETED|Overall Study||15
7807308|NCT01176435|19219194|P1|COMPLETED|Overall Study||15
7807309|NCT01176435|19219192|P3|STARTED|Overall Study||15
7807310|NCT01176435|19219193|P2|STARTED|Overall Study||15
7807311|NCT01176435|19219194|P1|STARTED|Overall Study||15
7807312|NCT01176292|19219204|P2|NOT COMPLETED|Overall Study||9
7807313|NCT01176292|19219205|P1|NOT COMPLETED|Overall Study||5
7807314|NCT01176292|19219204|P2|COMPLETED|Overall Study||62
7807315|NCT01176292|19219205|P1|COMPLETED|Overall Study||66
7807316|NCT01176292|19219204|P2|STARTED|Overall Study||71
7807317|NCT01176292|19219205|P1|STARTED|Overall Study||71
7807318|NCT01176266|19219223|P1|NOT COMPLETED|Overall Study||9
7807319|NCT01176266|19219223|P1|COMPLETED|Overall Study||60
7807320|NCT01176266|19219223|P1|STARTED|Overall Study||69
7807321|NCT01176240|19219247|P2|NOT COMPLETED|Study 306B||17
7807322|NCT01176240|19219248|P1|NOT COMPLETED|Study 306B||26
7807323|NCT01176240|19219247|P2|COMPLETED|Study 306B||68
7807324|NCT01176240|19219248|P1|COMPLETED|Study 306B||63
7807325|NCT01176240|19219247|P2|4 wk of Stable Dosing and Visit 6|Study 306B||73
7807326|NCT01176240|19219248|P1|4 wk of Stable Dosing and Visit 6|Study 306B||67
7807327|NCT01176240|19219247|P2|2 wk of Stable Dosing and Visit 5|Study 306B||75
7807328|NCT01176240|19219248|P1|2 wk of Stable Dosing and Visit 5|Study 306B||68
7807329|NCT01176240|19219247|P2|1 wk of Stable Dosing and Visit 4|Study 306B||78
7807330|NCT01176240|19219248|P1|1 wk of Stable Dosing and Visit 4|Study 306B||69
7807331|NCT01176240|19219247|P2|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84
7807332|NCT01176240|19219248|P1|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87
7807333|NCT01176240|19219247|P2|STARTED|Study 306B||85
7807334|NCT01176240|19219248|P1|STARTED|Study 306B||89
7807335|NCT01176240|19219247|P2|NOT COMPLETED|Study 306A||3
7807336|NCT01176240|19219248|P1|NOT COMPLETED|Study 306A||3
7807337|NCT01176240|19219247|P2|COMPLETED|Study 306A||24
7807338|NCT01176240|19219248|P1|COMPLETED|Study 306A||21
7807339|NCT01176240|19219247|P2|STARTED|Study 306A||27
7807340|NCT01176240|19219248|P1|STARTED|Study 306A||24
7807341|NCT01176058|19219274|P2|NOT COMPLETED|Overall Study||3
7807342|NCT01176058|19219275|P1|NOT COMPLETED|Overall Study||4
7807343|NCT01176058|19219274|P2|COMPLETED|Overall Study||5
7807344|NCT01176058|19219275|P1|COMPLETED|Overall Study||5
7807345|NCT01176058|19219274|P2|STARTED|Overall Study||8
7807346|NCT01176058|19219275|P1|STARTED|Overall Study||9
7807347|NCT01176032|19219299|P2|NOT COMPLETED|Overall Study||1
7807348|NCT01176032|19219300|P1|NOT COMPLETED|Overall Study||6
7807349|NCT01176032|19219299|P2|COMPLETED|Overall Study||36
7807350|NCT01176032|19219300|P1|COMPLETED|Overall Study||31
7807351|NCT01176032|19219299|P2|Intention-to-treat (ITT) Population|Overall Study||37
7807352|NCT01176032|19219300|P1|Intention-to-treat (ITT) Population|Overall Study||32
7807353|NCT01176032|19219299|P2|STARTED|Overall Study||37
7807354|NCT01176032|19219300|P1|STARTED|Overall Study|"Started indicates randomized and safety population"|37
7807355|NCT01175980|19219358|P1|NOT COMPLETED|Overall Study||0
7807356|NCT01175980|19219358|P1|COMPLETED|Overall Study||30
7807357|NCT01175980|19219358|P1|STARTED|Overall Study||30
7807358|NCT01175902|19219377|P2|NOT COMPLETED|Overall Study||0
7807359|NCT01175902|19219378|P1|NOT COMPLETED|Overall Study||0
7807360|NCT01175902|19219377|P2|COMPLETED|Overall Study||22
7807361|NCT01175902|19219378|P1|COMPLETED|Overall Study||22
7807362|NCT01175902|19219377|P2|STARTED|Overall Study||22
7807363|NCT01175902|19219378|P1|STARTED|Overall Study||22
7807364|NCT01175850|19219396|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
7807365|NCT01175850|19219397|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
7807366|NCT01175850|19219396|P2|COMPLETED|IN.PACT SFA II Phase||55
7807367|NCT01175850|19219397|P1|COMPLETED|IN.PACT SFA II Phase||109
7807368|NCT01175850|19219396|P2|STARTED|IN.PACT SFA II Phase||60
7807369|NCT01175850|19219397|P1|STARTED|IN.PACT SFA II Phase||121
7807370|NCT01175850|19219396|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
7807371|NCT01175850|19219397|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
7807372|NCT01175850|19219396|P2|COMPLETED|IN.PACT SFA I Phase||49
7807373|NCT01175850|19219397|P1|COMPLETED|IN.PACT SFA I Phase||88
7807374|NCT01175850|19219396|P2|STARTED|IN.PACT SFA I Phase||51
7807375|NCT01175850|19219397|P1|STARTED|IN.PACT SFA I Phase||99
7807376|NCT01175824|19219441|P2|NOT COMPLETED|Overall Study||22
7807377|NCT01175824|19219442|P1|NOT COMPLETED|Overall Study||16
7807378|NCT01175824|19219441|P2|COMPLETED|Overall Study||220
7807379|NCT01175824|19219442|P1|COMPLETED|Overall Study||220
7807380|NCT01175824|19219441|P2|Received at Least 1 Dose of Study Drug|Overall Study||240
7807381|NCT01175824|19219442|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
7807382|NCT01175824|19219441|P2|STARTED|Overall Study||242
7807383|NCT01175824|19219442|P1|STARTED|Overall Study||236
7807384|NCT01175811|19219476|P2|NOT COMPLETED|Overall Study||14
7807385|NCT01175811|19219477|P1|NOT COMPLETED|Overall Study||16
7807386|NCT01175811|19219476|P2|COMPLETED|Overall Study||189
7807387|NCT01175811|19219477|P1|COMPLETED|Overall Study||183
7807388|NCT01175811|19219476|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
7807389|NCT01175811|19219477|P1|Received at Least 1 Dose of Study Drug|Overall Study||197
7807390|NCT01175811|19219476|P2|STARTED|Overall Study||203
7807391|NCT01175811|19219477|P1|STARTED|Overall Study||199
7807392|NCT01175798|19219503|P2|NOT COMPLETED|Overall Study||21
7807393|NCT01175798|19219504|P1|NOT COMPLETED|Overall Study||7
7807394|NCT01175798|19219503|P2|COMPLETED|Overall Study||41
7807395|NCT01175798|19219504|P1|COMPLETED|Overall Study||27
7807396|NCT01175798|19219503|P2|STARTED|Overall Study||62
7807397|NCT01175798|19219504|P1|STARTED|Overall Study||34
7807398|NCT01175707|19219512|P2|NOT COMPLETED|Overall Study||6
7807399|NCT01175707|19219513|P1|NOT COMPLETED|Overall Study||4
7807400|NCT01175707|19219512|P2|COMPLETED|Overall Study||34
7807401|NCT01175707|19219513|P1|COMPLETED|Overall Study||36
7807402|NCT01175707|19219512|P2|STARTED|Overall Study||40
7807403|NCT01175707|19219513|P1|STARTED|Overall Study||40
7807404|NCT01175668|19219549|P2|NOT COMPLETED|Overall Study||0
7807405|NCT01175668|19219550|P1|NOT COMPLETED|Overall Study||2
7807406|NCT01175668|19219549|P2|COMPLETED|Overall Study||34
7807407|NCT01175668|19219550|P1|COMPLETED|Overall Study||32
7807408|NCT01175668|19219549|P2|STARTED|Overall Study||34
7807409|NCT01175668|19219550|P1|STARTED|Overall Study||34
7807410|NCT01175590|19219560|P2|NOT COMPLETED|Overall Study||10
7807411|NCT01175590|19219561|P1|NOT COMPLETED|Overall Study||12
7807412|NCT01175590|19219560|P2|COMPLETED|Overall Study||161
7807413|NCT01175590|19219561|P1|COMPLETED|Overall Study||335
7807414|NCT01175590|19219560|P2|Safety Population|Overall Study||170
7807415|NCT01175590|19219561|P1|Safety Population|Overall Study||344
7807416|NCT01175590|19219560|P2|Modified Intent to Treat Population|Overall Study||87
7807417|NCT01175590|19219561|P1|Modified Intent to Treat Population|Overall Study||212
7807418|NCT01175590|19219560|P2|STARTED|Overall Study||171
7807419|NCT01175590|19219561|P1|STARTED|Overall Study||347
7807420|NCT01175473|19219595|P2|NOT COMPLETED|Overall Study||2
7807421|NCT01175473|19219596|P1|NOT COMPLETED|Overall Study||2
7807422|NCT01175473|19219595|P2|COMPLETED|Overall Study||69
7807423|NCT01175473|19219596|P1|COMPLETED|Overall Study||75
7807424|NCT01175473|19219595|P2|Pharmacodynamic (PD) Population|Overall Study||68
7807425|NCT01175473|19219596|P1|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75
7807426|NCT01175473|19219595|P2|Safety Population|Overall Study||71
7807427|NCT01175473|19219596|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77
7807428|NCT01175473|19219595|P2|STARTED|Overall Study||71
7807429|NCT01175473|19219596|P1|STARTED|Overall Study|Randomized and treated.|77
7807430|NCT01175434|19219622|P2|NOT COMPLETED|Overall Study||0
7807431|NCT01175434|19219623|P1|NOT COMPLETED|Overall Study||0
7807432|NCT01175434|19219622|P2|COMPLETED|Overall Study||51
7807433|NCT01175434|19219623|P1|COMPLETED|Overall Study||48
7807434|NCT01175434|19219622|P2|STARTED|Overall Study||51
7807435|NCT01175434|19219623|P1|STARTED|Overall Study||48
7807436|NCT01175395|19219629|P1|NOT COMPLETED|Overall Study||0
7807437|NCT01175395|19219629|P1|COMPLETED|Overall Study||10
7807438|NCT01175395|19219629|P1|STARTED|Overall Study||10
7807439|NCT01175382|19219637|P3|NOT COMPLETED|Overall Study||6
7807440|NCT01175382|19219638|P2|NOT COMPLETED|Overall Study||7
7807441|NCT01175382|19219639|P1|NOT COMPLETED|Overall Study||8
7807442|NCT01175382|19219637|P3|COMPLETED|Overall Study||59
7807443|NCT01175382|19219638|P2|COMPLETED|Overall Study||61
7807444|NCT01175382|19219639|P1|COMPLETED|Overall Study||63
7807445|NCT01175382|19219637|P3|STARTED|Overall Study||65
7807446|NCT01175382|19219638|P2|STARTED|Overall Study||68
7807447|NCT01175382|19219639|P1|STARTED|Overall Study||71
7807448|NCT01175369|19219718|P2|NOT COMPLETED|Overall Study||5
7807449|NCT01175369|19219719|P1|NOT COMPLETED|Overall Study||2
7807450|NCT01175369|19219718|P2|COMPLETED|Overall Study||260
7807451|NCT01175369|19219719|P1|COMPLETED|Overall Study||263
7807452|NCT01175369|19219718|P2|STARTED|Overall Study||265
7807453|NCT01175369|19219719|P1|STARTED|Overall Study||265
7807454|NCT01175356|19219725|P1|NOT COMPLETED|Overall Study||81
7807455|NCT01175356|19219725|P1|COMPLETED|Overall Study||18
7807456|NCT01175356|19219725|P1|STARTED|Overall Study||99
7807457|NCT01175343|19219731|P1|NOT COMPLETED|Overall Study||0
7807458|NCT01175343|19219731|P1|COMPLETED|Overall Study||44
7807459|NCT01175343|19219731|P1|STARTED|Overall Study||44
7807460|NCT01175317|19219743|P2|NOT COMPLETED|Overall Study||0
7807461|NCT01175317|19219744|P1|NOT COMPLETED|Overall Study||0
7807462|NCT01175317|19219743|P2|COMPLETED|Overall Study||31
7807463|NCT01175317|19219744|P1|COMPLETED|Overall Study||27
7807464|NCT01175317|19219743|P2|STARTED|Overall Study||31
7807465|NCT01175317|19219744|P1|STARTED|Overall Study||27
7807466|NCT01175226|19219754|P2|NOT COMPLETED|Overall Study||5
7807467|NCT01175226|19219755|P1|NOT COMPLETED|Overall Study||11
7807468|NCT01175226|19219754|P2|COMPLETED|Overall Study||140
7807469|NCT01175226|19219755|P1|COMPLETED|Overall Study||144
7807470|NCT01175226|19219754|P2|STARTED|Overall Study||145
7807471|NCT01175226|19219755|P1|STARTED|Overall Study||155
7807472|NCT01175213|19219765|P2|NOT COMPLETED|Safety Follow-up||0
7807473|NCT01175213|19219766|P1|NOT COMPLETED|Safety Follow-up||1
7807474|NCT01175213|19219765|P2|COMPLETED|Safety Follow-up||3
7807475|NCT01175213|19219766|P1|COMPLETED|Safety Follow-up||47
7807476|NCT01175213|19219765|P2|STARTED|Safety Follow-up||3
7807477|NCT01175213|19219766|P1|STARTED|Safety Follow-up||48
7807478|NCT01175213|19219765|P2|NOT COMPLETED|IGSC, 10%/rHuPH20||0
7807479|NCT01175213|19219766|P1|NOT COMPLETED|IGSC, 10%/rHuPH20||15
7807480|NCT01175213|19219765|P2|COMPLETED|IGSC, 10%/rHuPH20||3
7807481|NCT01175213|19219766|P1|COMPLETED|IGSC, 10%/rHuPH20||48
7807482|NCT01175213|19219765|P2|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3
7807483|NCT01175213|19219766|P1|STARTED|IGSC, 10%/rHuPH20||63
7807484|NCT01175148|19219813|P2|NOT COMPLETED|Overall Study||0
7807485|NCT01175148|19219814|P1|NOT COMPLETED|Overall Study||0
7807486|NCT01175148|19219813|P2|COMPLETED|Overall Study||30
7807487|NCT01175148|19219814|P1|COMPLETED|Overall Study||30
7807488|NCT01175148|19219813|P2|STARTED|Overall Study||30
7807489|NCT01175148|19219814|P1|STARTED|Overall Study||30
7807490|NCT01175135|19219823|P4|NOT COMPLETED|Overall Study||14
7807491|NCT01175135|19219824|P3|NOT COMPLETED|Overall Study||12
7807492|NCT01175135|19219825|P2|NOT COMPLETED|Overall Study||22
7807493|NCT01175135|19219826|P1|NOT COMPLETED|Overall Study||16
7807494|NCT01175135|19219823|P4|COMPLETED|Overall Study||60
7807495|NCT01175135|19219824|P3|COMPLETED|Overall Study||25
7807496|NCT01175135|19219825|P2|COMPLETED|Overall Study||52
7807497|NCT01175135|19219826|P1|COMPLETED|Overall Study||58
7807498|NCT01175135|19219823|P4|Analyzed for Efficacy|Overall Study||73
7807499|NCT01175135|19219824|P3|Analyzed for Efficacy|Overall Study||34
7807500|NCT01175135|19219825|P2|Analyzed for Efficacy|Overall Study||73
7807501|NCT01175135|19219826|P1|Analyzed for Efficacy|Overall Study||74
7807502|NCT01175135|19219823|P4|Treated|Overall Study||74
7807503|NCT01175135|19219824|P3|Treated|Overall Study||36
7807504|NCT01175135|19219825|P2|Treated|Overall Study||74
7807505|NCT01175135|19219826|P1|Treated|Overall Study||74
7807506|NCT01175135|19219823|P4|STARTED|Overall Study||74
7807507|NCT01175135|19219824|P3|STARTED|Overall Study||37
7807508|NCT01175135|19219825|P2|STARTED|Overall Study||74
7807509|NCT01175135|19219826|P1|STARTED|Overall Study||74
7807510|NCT01175083|19219914|P6|NOT COMPLETED|Booster Epoch||0
7807511|NCT01175083|19219915|P5|NOT COMPLETED|Booster Epoch||0
7807512|NCT01175083|19219916|P4|NOT COMPLETED|Booster Epoch||1
7807513|NCT01175083|19219917|P3|NOT COMPLETED|Booster Epoch||1
7807514|NCT01175083|19219918|P2|NOT COMPLETED|Booster Epoch||0
7807515|NCT01175083|19219919|P1|NOT COMPLETED|Booster Epoch||0
7807516|NCT01175083|19219914|P6|COMPLETED|Booster Epoch||0
7807517|NCT01175083|19219915|P5|COMPLETED|Booster Epoch||0
7807518|NCT01175083|19219916|P4|COMPLETED|Booster Epoch||49
7807519|NCT01175083|19219917|P3|COMPLETED|Booster Epoch||49
7807520|NCT01175083|19219918|P2|COMPLETED|Booster Epoch||49
7807521|NCT01175083|19219919|P1|COMPLETED|Booster Epoch||49
7807522|NCT01175083|19219914|P6|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
7807523|NCT01175083|19219915|P5|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
7807524|NCT01175083|19219916|P4|STARTED|Booster Epoch||50
7807525|NCT01175083|19219917|P3|STARTED|Booster Epoch||50
7807526|NCT01175083|19219918|P2|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
7807527|NCT01175083|19219919|P1|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
7807528|NCT01175083|19219914|P6|NOT COMPLETED|Primary Epoch||3
7807529|NCT01175083|19219915|P5|NOT COMPLETED|Primary Epoch||0
7807530|NCT01175083|19219916|P4|NOT COMPLETED|Primary Epoch||0
7807531|NCT01175083|19219917|P3|NOT COMPLETED|Primary Epoch||0
7807532|NCT01175083|19219918|P2|NOT COMPLETED|Primary Epoch||0
7807533|NCT01175083|19219919|P1|NOT COMPLETED|Primary Epoch||0
7807534|NCT01175083|19219914|P6|COMPLETED|Primary Epoch||47
7807535|NCT01175083|19219915|P5|COMPLETED|Primary Epoch||50
7807536|NCT01175083|19219916|P4|COMPLETED|Primary Epoch||50
7807537|NCT01175083|19219917|P3|COMPLETED|Primary Epoch||50
7807538|NCT01175083|19219918|P2|COMPLETED|Primary Epoch||50
7807539|NCT01175083|19219919|P1|COMPLETED|Primary Epoch||50
7807540|NCT01175083|19219914|P6|STARTED|Primary Epoch||50
7807541|NCT01175083|19219915|P5|STARTED|Primary Epoch||50
7807542|NCT01175083|19219916|P4|STARTED|Primary Epoch||50
7807543|NCT01175083|19219917|P3|STARTED|Primary Epoch||50
7807544|NCT01175083|19219918|P2|STARTED|Primary Epoch||50
7807545|NCT01175083|19219919|P1|STARTED|Primary Epoch||50
7807546|NCT01175031|19220001|P1|NOT COMPLETED|Overall Study||0
7807547|NCT01175031|19220001|P1|COMPLETED|Overall Study||45
7807548|NCT01175031|19220001|P1|STARTED|Overall Study||45
7807549|NCT01175018|19220011|P2|NOT COMPLETED|Overall Study||1
7807550|NCT01175018|19220012|P1|NOT COMPLETED|Overall Study||3
7807551|NCT01175018|19220011|P2|COMPLETED|Overall Study||14
7807552|NCT01175018|19220012|P1|COMPLETED|Overall Study||12
7807553|NCT01175018|19220011|P2|STARTED|Overall Study||15
7807554|NCT01175018|19220012|P1|STARTED|Overall Study||15
7807555|NCT01175005|19220048|P1|NOT COMPLETED|Overall Study||0
7807556|NCT01175005|19220048|P1|COMPLETED|Overall Study||62
7807557|NCT01175005|19220048|P1|STARTED|Overall Study||62
7807558|NCT01174823|19220055|P2|NOT COMPLETED|Overall Study||4
7807559|NCT01174823|19220056|P1|NOT COMPLETED|Overall Study||7
7807560|NCT01174823|19220055|P2|COMPLETED|Overall Study||119
7807561|NCT01174823|19220056|P1|COMPLETED|Overall Study||115
7807562|NCT01174823|19220055|P2|STARTED|Overall Study||123
7807563|NCT01174823|19220056|P1|STARTED|Overall Study||122
7807564|NCT01174784|19220074|P1|NOT COMPLETED|Overall Study||4
7807565|NCT01174784|19220074|P1|COMPLETED|Overall Study|While 88 subjects did complete the procedure, 4 were considered screen failures post-procedure.|84
7807566|NCT01174784|19220074|P1|STARTED|Overall Study||88
7807567|NCT01174576|19220079|P1|NOT COMPLETED|Overall Study||0
7807568|NCT01174576|19220079|P1|COMPLETED|Overall Study||16
7807569|NCT01174576|19220079|P1|STARTED|Overall Study|All participants received all interventions without exception.|16
7807570|NCT01174563|19220120|P1|NOT COMPLETED|Overall Study||60
7807571|NCT01174563|19220120|P1|COMPLETED|Overall Study||0
7807572|NCT01174563|19220120|P1|Safety Set|Overall Study||59
7807573|NCT01174563|19220120|P1|Efficacy Set|Overall Study||59
7807574|NCT01174563|19220120|P1|STARTED|Overall Study||60
7807575|NCT01174550|19220128|P2|NOT COMPLETED|Overall Study||873
7807576|NCT01174550|19220129|P1|NOT COMPLETED|Overall Study||1270
7807577|NCT01174550|19220128|P2|COMPLETED|Overall Study||4123
7807578|NCT01174550|19220129|P1|COMPLETED|Overall Study||3737
7807579|NCT01174550|19220128|P2|STARTED|Overall Study||4996
7807580|NCT01174550|19220129|P1|STARTED|Overall Study||5007
7807581|NCT01174459|19220157|P1|NOT COMPLETED|Overall Study||5
7807582|NCT01174459|19220157|P1|COMPLETED|Overall Study|Case report form (CRF) collected|566
7807583|NCT01174459|19220157|P1|STARTED|Overall Study|Registered patients|571
7807584|NCT01174446|19220162|P4|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
7807585|NCT01174446|19220163|P3|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
7807586|NCT01174446|19220164|P2|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
7807587|NCT01174446|19220165|P1|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
7807588|NCT01174446|19220162|P4|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
7807589|NCT01174446|19220163|P3|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
7807590|NCT01174446|19220164|P2|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
7807591|NCT01174446|19220165|P1|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
7807592|NCT01174446|19220162|P4|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
7807593|NCT01174446|19220163|P3|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
7807594|NCT01174446|19220164|P2|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
7807595|NCT01174446|19220165|P1|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
7807596|NCT01174446|19220162|P4|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
7807597|NCT01174446|19220163|P3|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2
7807598|NCT01174446|19220164|P2|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
7807599|NCT01174446|19220165|P1|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
7807600|NCT01174446|19220162|P4|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
7807601|NCT01174446|19220163|P3|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29
7807602|NCT01174446|19220164|P2|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
7807603|NCT01174446|19220165|P1|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
7807604|NCT01174446|19220162|P4|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14
7807605|NCT01174446|19220163|P3|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31
7807606|NCT01174446|19220164|P2|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
7807607|NCT01174446|19220165|P1|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
7807608|NCT01174446|19220162|P4|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
7807609|NCT01174446|19220163|P3|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
7807610|NCT01174446|19220164|P2|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
7807611|NCT01174446|19220165|P1|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
7807612|NCT01174446|19220162|P4|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
7807613|NCT01174446|19220163|P3|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
7807614|NCT01174446|19220164|P2|COMPLETED|Part 1 -Pharmacokinetic Crossover||14
7807615|NCT01174446|19220165|P1|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14
7807616|NCT01174446|19220162|P4|STARTED|Part 1 -Pharmacokinetic Crossover||0
7807617|NCT01174446|19220163|P3|STARTED|Part 1 -Pharmacokinetic Crossover||0
7807618|NCT01174446|19220164|P2|STARTED|Part 1 -Pharmacokinetic Crossover||14
7807619|NCT01174446|19220165|P1|STARTED|Part 1 -Pharmacokinetic Crossover||14
7807620|NCT01174368|19220352|P1|NOT COMPLETED|Overall Study||1
7807621|NCT01174368|19220352|P1|COMPLETED|Overall Study||0
7807622|NCT01174368|19220352|P1|STARTED|Overall Study||1
7807623|NCT01174342|19220358|P1|NOT COMPLETED|Overall Study||4
7807624|NCT01174342|19220358|P1|COMPLETED|Overall Study||26
7807625|NCT01174342|19220358|P1|STARTED|Overall Study||30
7807626|NCT01174264|19220365|P3|NOT COMPLETED|Steady-state Pharmacokinetics||2
7807627|NCT01174264|19220366|P2|NOT COMPLETED|Steady-state Pharmacokinetics||0
7807628|NCT01174264|19220367|P1|NOT COMPLETED|Steady-state Pharmacokinetics||6
7807629|NCT01174264|19220365|P3|COMPLETED|Steady-state Pharmacokinetics||27
7807630|NCT01174264|19220366|P2|COMPLETED|Steady-state Pharmacokinetics||0
7807631|NCT01174264|19220367|P1|COMPLETED|Steady-state Pharmacokinetics||25
7807632|NCT01174264|19220365|P3|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29
7807633|NCT01174264|19220366|P2|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0
7807634|NCT01174264|19220367|P1|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31
7807635|NCT01174264|19220365|P3|NOT COMPLETED|Single Dose Pharmacokinetics||2
7807636|NCT01174264|19220366|P2|NOT COMPLETED|Single Dose Pharmacokinetics||0
7807637|NCT01174264|19220367|P1|NOT COMPLETED|Single Dose Pharmacokinetics||1
7807638|NCT01174264|19220365|P3|COMPLETED|Single Dose Pharmacokinetics||18
7807639|NCT01174264|19220366|P2|COMPLETED|Single Dose Pharmacokinetics||20
7807640|NCT01174264|19220367|P1|COMPLETED|Single Dose Pharmacokinetics||22
7807641|NCT01174264|19220365|P3|STARTED|Single Dose Pharmacokinetics||20
7807642|NCT01174264|19220366|P2|STARTED|Single Dose Pharmacokinetics||20
7807643|NCT01174264|19220367|P1|STARTED|Single Dose Pharmacokinetics||23
7807644|NCT01174238|19220399|P1|NOT COMPLETED|Overall Study||2
7807645|NCT01174238|19220399|P1|COMPLETED|Overall Study||36
7807646|NCT01174238|19220399|P1|Participants That Underwent FLT-PET Scan|Overall Study||6
7807647|NCT01174238|19220399|P1|STARTED|Overall Study||38
7807648|NCT01174186|19220410|P2|NOT COMPLETED|Overall Study||3
7807649|NCT01174186|19220411|P1|NOT COMPLETED|Overall Study||0
7807650|NCT01174186|19220410|P2|COMPLETED|Overall Study||12
7807651|NCT01174186|19220411|P1|COMPLETED|Overall Study||15
7807652|NCT01174186|19220410|P2|STARTED|Overall Study||15
7807653|NCT01174186|19220411|P1|STARTED|Overall Study|Patients were included over three years|15
7807654|NCT01174173|19220418|P1|NOT COMPLETED|Overall Study||1
7807655|NCT01174173|19220418|P1|COMPLETED|Overall Study||10
7807656|NCT01174173|19220418|P1|STARTED|Overall Study||11
7807657|NCT01174160|19220429|P2|NOT COMPLETED|Overall Study||6
7807658|NCT01174160|19220430|P1|NOT COMPLETED|Overall Study||8
7807659|NCT01174160|19220429|P2|COMPLETED|Overall Study||56
7807660|NCT01174160|19220430|P1|COMPLETED|Overall Study||53
7807661|NCT01174160|19220429|P2|Discontinued Post Dose|Overall Study||0
7807662|NCT01174160|19220430|P1|Discontinued Post Dose|Overall Study||2
7807663|NCT01174160|19220429|P2|Dosed|Overall Study||56
7807664|NCT01174160|19220430|P1|Dosed|Overall Study||55
7807665|NCT01174160|19220429|P2|Discontinued Pre Dose|Overall Study||6
7807666|NCT01174160|19220430|P1|Discontinued Pre Dose|Overall Study||6
7807667|NCT01174160|19220429|P2|STARTED|Overall Study||62
7807668|NCT01174160|19220430|P1|STARTED|Overall Study||61
7807669|NCT01174082|19220438|P2|NOT COMPLETED|Overall Study||0
7807670|NCT01174082|19220439|P1|NOT COMPLETED|Overall Study||0
7807671|NCT01174082|19220438|P2|COMPLETED|Overall Study||1
7807672|NCT01174082|19220439|P1|COMPLETED|Overall Study||1
7807673|NCT01174082|19220438|P2|STARTED|Overall Study||1
7807674|NCT01174082|19220439|P1|STARTED|Overall Study||1
7807675|NCT01174043|19220445|P1|NOT COMPLETED|Overall Study||11
7807676|NCT01174043|19220445|P1|COMPLETED|Overall Study||0
7807677|NCT01174043|19220445|P1|STARTED|Overall Study||11
7807678|NCT01174030|19220456|P5|NOT COMPLETED|Overall Study||1
7807679|NCT01174030|19220457|P4|NOT COMPLETED|Overall Study||2
7807680|NCT01174030|19220458|P3|NOT COMPLETED|Overall Study||2
7807681|NCT01174030|19220459|P2|NOT COMPLETED|Overall Study||2
7807682|NCT01174030|19220460|P1|NOT COMPLETED|Overall Study||2
7807683|NCT01174030|19220456|P5|COMPLETED|Overall Study||52
7807684|NCT01174030|19220457|P4|COMPLETED|Overall Study||53
7807685|NCT01174030|19220458|P3|COMPLETED|Overall Study||52
7807686|NCT01174030|19220459|P2|COMPLETED|Overall Study||52
7807687|NCT01174030|19220460|P1|COMPLETED|Overall Study||51
7807688|NCT01174030|19220456|P5|STARTED|Overall Study||53
7807689|NCT01174030|19220457|P4|STARTED|Overall Study||55
7807690|NCT01174030|19220458|P3|STARTED|Overall Study||54
7807691|NCT01174030|19220459|P2|STARTED|Overall Study||54
7807692|NCT01174030|19220460|P1|STARTED|Overall Study||53
7807693|NCT01174004|19220484|P2|NOT COMPLETED|Overall Study||16
7807694|NCT01174004|19220485|P1|NOT COMPLETED|Overall Study||7
7807695|NCT01174004|19220484|P2|COMPLETED|Overall Study||89
7807696|NCT01174004|19220485|P1|COMPLETED|Overall Study||87
7807697|NCT01174004|19220484|P2|STARTED|Overall Study||105
7807698|NCT01174004|19220485|P1|STARTED|Overall Study||94
7807699|NCT01173874|19220495|P2|NOT COMPLETED|Overall Study||23
7807700|NCT01173874|19220496|P1|NOT COMPLETED|Overall Study||23
7807701|NCT01173874|19220495|P2|COMPLETED|Overall Study||41
7807702|NCT01173874|19220496|P1|COMPLETED|Overall Study||33
7807703|NCT01173874|19220495|P2|STARTED|Overall Study||64
7807704|NCT01173874|19220496|P1|STARTED|Overall Study||56
7807705|NCT01173848|19220510|P2|NOT COMPLETED|Overall Study||8
7807706|NCT01173848|19220511|P1|NOT COMPLETED|Overall Study||4
7807707|NCT01173848|19220510|P2|COMPLETED|Overall Study||3
7807708|NCT01173848|19220511|P1|COMPLETED|Overall Study||4
7807709|NCT01173848|19220510|P2|STARTED|Overall Study||11
7807710|NCT01173848|19220511|P1|STARTED|Overall Study||8
7807711|NCT01173718|19220516|P1|NOT COMPLETED|Overall Study||44
7807712|NCT01173718|19220516|P1|COMPLETED|Overall Study||94
7807713|NCT01173718|19220516|P1|STARTED|Overall Study||138
7807714|NCT01173679|19220525|P1|NOT COMPLETED|Overall Study||1
7807715|NCT01173679|19220525|P1|COMPLETED|Overall Study||9
7807716|NCT01173679|19220525|P1|STARTED|Overall Study||10
7807717|NCT01173653|19220533|P2|NOT COMPLETED|Overall Study||41
7807718|NCT01173653|19220534|P1|NOT COMPLETED|Overall Study||53
7807719|NCT01173653|19220533|P2|COMPLETED|Overall Study||49
7807720|NCT01173653|19220534|P1|COMPLETED|Overall Study||56
7807721|NCT01173653|19220533|P2|STARTED|Overall Study||90
7807722|NCT01173653|19220534|P1|STARTED|Overall Study||109
7807723|NCT01173601|19220544|P5|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||68
7807724|NCT01173601|19220545|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||30
7807725|NCT01173601|19220546|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
7807726|NCT01173601|19220547|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
7807727|NCT01173601|19220548|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
7807728|NCT01173601|19220544|P5|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||559
7807729|NCT01173601|19220545|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||210
7807730|NCT01173601|19220546|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||197
7807731|NCT01173601|19220547|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
7807732|NCT01173601|19220548|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
7807733|NCT01173601|19220544|P5|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|586
7807734|NCT01173601|19220545|P4|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|221
7807735|NCT01173601|19220546|P3|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|108
7807736|NCT01173601|19220547|P2|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|100
7807737|NCT01173601|19220548|P1|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
7807738|NCT01173601|19220544|P5|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
7807739|NCT01173601|19220545|P4|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
7807740|NCT01173601|19220546|P3|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|107
7807741|NCT01173601|19220547|P2|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|100
7807742|NCT01173601|19220548|P1|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
7807743|NCT01173601|19220544|P5|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||627
7807744|NCT01173601|19220545|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||240
7807745|NCT01173601|19220546|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
7807746|NCT01173601|19220547|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
7807747|NCT01173601|19220548|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
7807748|NCT01173601|19220544|P5|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7807749|NCT01173601|19220545|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7807750|NCT01173601|19220546|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7807751|NCT01173601|19220547|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7807752|NCT01173601|19220548|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
7807753|NCT01173601|19220544|P5|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7807754|NCT01173601|19220545|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7807755|NCT01173601|19220546|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7807756|NCT01173601|19220547|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
7807757|NCT01173601|19220548|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the AT Phase.|1328
7807758|NCT01173601|19220544|P5|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
7807759|NCT01173601|19220545|P4|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
7807760|NCT01173601|19220546|P3|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
7807761|NCT01173601|19220547|P2|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
7807762|NCT01173601|19220548|P1|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase had the option to enter the DC phase.|21
7807763|NCT01173601|19220544|P5|STARTED|Confirmation (CF) Phase, 3 Weeks||0
7807764|NCT01173601|19220545|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
7807765|NCT01173601|19220546|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
7807766|NCT01173601|19220547|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
7807767|NCT01173601|19220548|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1416
7807768|NCT01173523|19220625|P2|NOT COMPLETED|Overall Study||12
7807769|NCT01173523|19220626|P1|NOT COMPLETED|Overall Study||13
7807770|NCT01173523|19220625|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
7807771|NCT01173523|19220626|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
7807772|NCT01173523|19220625|P2|STARTED|Overall Study||12
7807773|NCT01173523|19220626|P1|STARTED|Overall Study||13
7807774|NCT01173471|19220642|P4|NOT COMPLETED|Overall Study||1
7807775|NCT01173471|19220643|P3|NOT COMPLETED|Overall Study||3
7807776|NCT01173471|19220644|P2|NOT COMPLETED|Overall Study||0
7807777|NCT01173471|19220645|P1|NOT COMPLETED|Overall Study||2
7807778|NCT01173471|19220642|P4|COMPLETED|Overall Study|Completed study|18
7807779|NCT01173471|19220643|P3|COMPLETED|Overall Study|Completed study|15
7807780|NCT01173471|19220644|P2|COMPLETED|Overall Study|Completed study|7
7807781|NCT01173471|19220645|P1|COMPLETED|Overall Study|Completed study|4
7807782|NCT01173471|19220642|P4|Completed Treatment|Overall Study||18
7807783|NCT01173471|19220643|P3|Completed Treatment|Overall Study||15
7807784|NCT01173471|19220644|P2|Completed Treatment|Overall Study||7
7807785|NCT01173471|19220645|P1|Completed Treatment|Overall Study||4
7807786|NCT01173471|19220642|P4|Received Treatment|Overall Study||19
7807787|NCT01173471|19220643|P3|Received Treatment|Overall Study||18
7807788|NCT01173471|19220644|P2|Received Treatment|Overall Study||7
7807789|NCT01173471|19220645|P1|Received Treatment|Overall Study||6
7807790|NCT01173471|19220642|P4|STARTED|Overall Study|Randomized|19
7807791|NCT01173471|19220643|P3|STARTED|Overall Study|Randomized|18
7807792|NCT01173471|19220644|P2|STARTED|Overall Study|Randomized|7
7807793|NCT01173471|19220645|P1|STARTED|Overall Study|Randomized|6
7807794|NCT01173211|19220669|P6|NOT COMPLETED|Overall Study||0
7807795|NCT01173211|19220670|P5|NOT COMPLETED|Overall Study||0
7807796|NCT01173211|19220671|P4|NOT COMPLETED|Overall Study||0
7807797|NCT01173211|19220672|P3|NOT COMPLETED|Overall Study||2
7807798|NCT01173211|19220673|P2|NOT COMPLETED|Overall Study||1
7807799|NCT01173211|19220674|P1|NOT COMPLETED|Overall Study||2
7807800|NCT01173211|19220669|P6|COMPLETED|Overall Study||13
7807801|NCT01173211|19220670|P5|COMPLETED|Overall Study||16
7807802|NCT01173211|19220671|P4|COMPLETED|Overall Study||15
7807803|NCT01173211|19220672|P3|COMPLETED|Overall Study||44
7807804|NCT01173211|19220673|P2|COMPLETED|Overall Study||44
7807805|NCT01173211|19220674|P1|COMPLETED|Overall Study||46
7807806|NCT01173211|19220669|P6|STARTED|Overall Study||13
7807807|NCT01173211|19220670|P5|STARTED|Overall Study||16
7807808|NCT01173211|19220671|P4|STARTED|Overall Study||15
7807809|NCT01173211|19220672|P3|STARTED|Overall Study||46
7807810|NCT01173211|19220673|P2|STARTED|Overall Study||45
7807811|NCT01173211|19220674|P1|STARTED|Overall Study||48
7807812|NCT01173159|19220775|P1|NOT COMPLETED|Overall Study||0
7807813|NCT01173159|19220775|P1|COMPLETED|Overall Study||10
7807814|NCT01173159|19220775|P1|STARTED|Overall Study||10
7807815|NCT01173120|19220785|P1|NOT COMPLETED|Overall Study||62
7807816|NCT01173120|19220785|P1|COMPLETED|Overall Study||0
7807817|NCT01173120|19220785|P1|Discontinued ACP Substudy and Main Study|Overall Study||5
7807818|NCT01173120|19220785|P1|Switched Back to Main Study|Overall Study||57
7807819|NCT01173120|19220785|P1|STARTED|Overall Study||62
7807820|NCT01173055|19220803|P2|NOT COMPLETED|Period 2 - Day 64 to 112||1
7807821|NCT01173055|19220804|P1|NOT COMPLETED|Period 2 - Day 64 to 112||0
7807822|NCT01173055|19220803|P2|COMPLETED|Period 2 - Day 64 to 112||9
7807823|NCT01173055|19220804|P1|COMPLETED|Period 2 - Day 64 to 112||8
7807824|NCT01173055|19220803|P2|STARTED|Period 2 - Day 64 to 112||10
7807825|NCT01173055|19220804|P1|STARTED|Period 2 - Day 64 to 112||8
7807826|NCT01173055|19220803|P2|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
7807827|NCT01173055|19220804|P1|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
7807828|NCT01173055|19220803|P2|COMPLETED|Placebo Washout Period - Day 50 to 63||10
7807829|NCT01173055|19220804|P1|COMPLETED|Placebo Washout Period - Day 50 to 63||8
7807830|NCT01173055|19220803|P2|STARTED|Placebo Washout Period - Day 50 to 63||10
7807831|NCT01173055|19220804|P1|STARTED|Placebo Washout Period - Day 50 to 63||8
7807832|NCT01173055|19220803|P2|NOT COMPLETED|Period 1 - Day 1 to 49||2
7807833|NCT01173055|19220804|P1|NOT COMPLETED|Period 1 - Day 1 to 49||2
7807834|NCT01173055|19220803|P2|COMPLETED|Period 1 - Day 1 to 49||10
7807835|NCT01173055|19220804|P1|COMPLETED|Period 1 - Day 1 to 49||8
7807836|NCT01173055|19220803|P2|STARTED|Period 1 - Day 1 to 49||12
7807837|NCT01173055|19220804|P1|STARTED|Period 1 - Day 1 to 49||10
7807838|NCT01173029|19220822|P2|NOT COMPLETED|Overall Study||0
7807839|NCT01173029|19220823|P1|NOT COMPLETED|Overall Study||0
7807840|NCT01173029|19220822|P2|COMPLETED|Overall Study||31
7807841|NCT01173029|19220823|P1|COMPLETED|Overall Study||61
7807842|NCT01173029|19220822|P2|STARTED|Overall Study||31
7807843|NCT01173029|19220823|P1|STARTED|Overall Study||61
7807844|NCT01173016|19220840|P1|NOT COMPLETED|Overall Study||1
7807845|NCT01173016|19220840|P1|COMPLETED|Overall Study||10
7807846|NCT01173016|19220840|P1|STARTED|Overall Study||11
7807847|NCT01172938|19220855|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||2
7807848|NCT01172938|19220856|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
7807849|NCT01172938|19220857|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
7807850|NCT01172938|19220858|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
7807851|NCT01172938|19220859|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
7807852|NCT01172938|19220860|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
7807853|NCT01172938|19220861|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||8
7807854|NCT01172938|19220862|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
7807855|NCT01172938|19220863|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
7807856|NCT01172938|19220855|P9|COMPLETED|Active-Treatment Phase (Weeks 208-260)||32
7807857|NCT01172938|19220856|P8|COMPLETED|Active-Treatment Phase (Weeks 208-260)||29
7807858|NCT01172938|19220857|P7|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
7807859|NCT01172938|19220858|P6|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
7807860|NCT01172938|19220859|P5|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
7807861|NCT01172938|19220860|P4|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
7807862|NCT01172938|19220861|P3|COMPLETED|Active-Treatment Phase (Weeks 208-260)||80
7807863|NCT01172938|19220862|P2|COMPLETED|Active-Treatment Phase (Weeks 208-260)||72
7807864|NCT01172938|19220863|P1|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
7807865|NCT01172938|19220855|P9|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
7807866|NCT01172938|19220856|P8|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||25
7807867|NCT01172938|19220857|P7|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
7807868|NCT01172938|19220858|P6|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
7807869|NCT01172938|19220859|P5|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
7807870|NCT01172938|19220860|P4|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
7807871|NCT01172938|19220861|P3|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
7807872|NCT01172938|19220862|P2|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
7807873|NCT01172938|19220863|P1|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
7807874|NCT01172938|19220855|P9|STARTED|Active-Treatment Phase (Weeks 208-260)||34
7807875|NCT01172938|19220856|P8|STARTED|Active-Treatment Phase (Weeks 208-260)||32
7807876|NCT01172938|19220857|P7|STARTED|Active-Treatment Phase (Weeks 208-260)||0
7807877|NCT01172938|19220858|P6|STARTED|Active-Treatment Phase (Weeks 208-260)||0
7807878|NCT01172938|19220859|P5|STARTED|Active-Treatment Phase (Weeks 208-260)||0
7807879|NCT01172938|19220860|P4|STARTED|Active-Treatment Phase (Weeks 208-260)||0
7807880|NCT01172938|19220861|P3|STARTED|Active-Treatment Phase (Weeks 208-260)||88
7807881|NCT01172938|19220862|P2|STARTED|Active-Treatment Phase (Weeks 208-260)||75
7807882|NCT01172938|19220863|P1|STARTED|Active-Treatment Phase (Weeks 208-260)||0
7807883|NCT01172938|19220855|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||7
7807884|NCT01172938|19220856|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
7807885|NCT01172938|19220857|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
7807886|NCT01172938|19220858|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
7807887|NCT01172938|19220859|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
7807888|NCT01172938|19220860|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
7807889|NCT01172938|19220861|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||5
7807890|NCT01172938|19220862|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
7807891|NCT01172938|19220863|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
7807892|NCT01172938|19220855|P9|COMPLETED|Active-Treatment Phase (Weeks 156-208)||34
7807893|NCT01172938|19220856|P8|COMPLETED|Active-Treatment Phase (Weeks 156-208)||32
7807894|NCT01172938|19220857|P7|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
7807895|NCT01172938|19220858|P6|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
7807896|NCT01172938|19220859|P5|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
7807897|NCT01172938|19220860|P4|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
7807898|NCT01172938|19220861|P3|COMPLETED|Active-Treatment Phase (Weeks 156-208)||88
7807899|NCT01172938|19220862|P2|COMPLETED|Active-Treatment Phase (Weeks 156-208)||75
7807900|NCT01172938|19220863|P1|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
7807901|NCT01172938|19220855|P9|STARTED|Active-Treatment Phase (Weeks 156-208)||41
7807902|NCT01172938|19220856|P8|STARTED|Active-Treatment Phase (Weeks 156-208)||41
7807903|NCT01172938|19220857|P7|STARTED|Active-Treatment Phase (Weeks 156-208)||0
7807904|NCT01172938|19220858|P6|STARTED|Active-Treatment Phase (Weeks 156-208)||0
7807905|NCT01172938|19220859|P5|STARTED|Active-Treatment Phase (Weeks 156-208)||0
7807906|NCT01172938|19220860|P4|STARTED|Active-Treatment Phase (Weeks 156-208)||0
7807907|NCT01172938|19220861|P3|STARTED|Active-Treatment Phase (Weeks 156-208)||93
7807908|NCT01172938|19220862|P2|STARTED|Active-Treatment Phase (Weeks 156-208)||84
7807909|NCT01172938|19220863|P1|STARTED|Active-Treatment Phase (Weeks 156-208)||0
7807910|NCT01172938|19220855|P9|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||4
7807911|NCT01172938|19220856|P8|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||5
7807912|NCT01172938|19220857|P7|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
7807913|NCT01172938|19220858|P6|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
7807914|NCT01172938|19220859|P5|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
7807915|NCT01172938|19220860|P4|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
7807916|NCT01172938|19220861|P3|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||7
7807917|NCT01172938|19220862|P2|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||11
7807918|NCT01172938|19220863|P1|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
7807919|NCT01172938|19220855|P9|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
7807920|NCT01172938|19220856|P8|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
7807921|NCT01172938|19220857|P7|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
7807922|NCT01172938|19220858|P6|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
7807923|NCT01172938|19220859|P5|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
7807924|NCT01172938|19220860|P4|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
7807925|NCT01172938|19220861|P3|COMPLETED|Active-Treatment Phase Weeks (104-156)||93
7807926|NCT01172938|19220862|P2|COMPLETED|Active-Treatment Phase Weeks (104-156)||84
7807927|NCT01172938|19220863|P1|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
7807928|NCT01172938|19220855|P9|STARTED|Active-Treatment Phase Weeks (104-156)||45
7807929|NCT01172938|19220856|P8|STARTED|Active-Treatment Phase Weeks (104-156)||46
7807930|NCT01172938|19220857|P7|STARTED|Active-Treatment Phase Weeks (104-156)||0
7807931|NCT01172938|19220858|P6|STARTED|Active-Treatment Phase Weeks (104-156)||0
7807932|NCT01172938|19220859|P5|STARTED|Active-Treatment Phase Weeks (104-156)||0
7807933|NCT01172938|19220860|P4|STARTED|Active-Treatment Phase Weeks (104-156)||0
7807934|NCT01172938|19220861|P3|STARTED|Active-Treatment Phase Weeks (104-156)||100
7807935|NCT01172938|19220862|P2|STARTED|Active-Treatment Phase Weeks (104-156)||95
7807936|NCT01172938|19220863|P1|STARTED|Active-Treatment Phase Weeks (104-156)||0
7807937|NCT01172938|19220855|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||4
7807938|NCT01172938|19220856|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||15
7807939|NCT01172938|19220857|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
7807940|NCT01172938|19220858|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
7807941|NCT01172938|19220859|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
7807942|NCT01172938|19220860|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
7807943|NCT01172938|19220861|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||21
7807944|NCT01172938|19220862|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||23
7807945|NCT01172938|19220863|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
7807946|NCT01172938|19220855|P9|COMPLETED|Active-Treatment Phase (Weeks 52-104)||45
7807947|NCT01172938|19220856|P8|COMPLETED|Active-Treatment Phase (Weeks 52-104)||46
7807948|NCT01172938|19220857|P7|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
7807949|NCT01172938|19220858|P6|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
7807950|NCT01172938|19220859|P5|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
7807951|NCT01172938|19220860|P4|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
7807952|NCT01172938|19220861|P3|COMPLETED|Active-Treatment Phase (Weeks 52-104)||100
7807953|NCT01172938|19220862|P2|COMPLETED|Active-Treatment Phase (Weeks 52-104)||95
7807954|NCT01172938|19220863|P1|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
7807955|NCT01172938|19220855|P9|STARTED|Active-Treatment Phase (Weeks 52-104)||49
7807956|NCT01172938|19220856|P8|STARTED|Active-Treatment Phase (Weeks 52-104)||61
7807957|NCT01172938|19220857|P7|STARTED|Active-Treatment Phase (Weeks 52-104)||0
7807958|NCT01172938|19220858|P6|STARTED|Active-Treatment Phase (Weeks 52-104)||0
7807959|NCT01172938|19220859|P5|STARTED|Active-Treatment Phase (Weeks 52-104)||0
7807960|NCT01172938|19220860|P4|STARTED|Active-Treatment Phase (Weeks 52-104)||0
7807961|NCT01172938|19220861|P3|STARTED|Active-Treatment Phase (Weeks 52-104)|Nine participants who completed Week 52 did not enter the next year of active treatment phase|121
7807962|NCT01172938|19220862|P2|STARTED|Active-Treatment Phase (Weeks 52-104)|Six participants who completed Week 52 did not enter the next year of active treatment phase|118
7807963|NCT01172938|19220863|P1|STARTED|Active-Treatment Phase (Weeks 52-104)||0
7807964|NCT01172938|19220855|P9|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
7807965|NCT01172938|19220856|P8|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
7807966|NCT01172938|19220857|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||2
7807967|NCT01172938|19220858|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
7807968|NCT01172938|19220859|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||4
7807969|NCT01172938|19220860|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||7
7807970|NCT01172938|19220861|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
7807971|NCT01172938|19220862|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||12
7807972|NCT01172938|19220863|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
7807973|NCT01172938|19220855|P9|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
7807974|NCT01172938|19220856|P8|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
7807975|NCT01172938|19220857|P7|COMPLETED|Active Treatment Phase (Weeks 25-52)||22
7807976|NCT01172938|19220858|P6|COMPLETED|Active Treatment Phase (Weeks 25-52)||34
7807977|NCT01172938|19220859|P5|COMPLETED|Active Treatment Phase (Weeks 25-52)||19
7807978|NCT01172938|19220860|P4|COMPLETED|Active Treatment Phase (Weeks 25-52)||44
7807979|NCT01172938|19220861|P3|COMPLETED|Active Treatment Phase (Weeks 25-52)||130
7807980|NCT01172938|19220862|P2|COMPLETED|Active Treatment Phase (Weeks 25-52)||124
7807981|NCT01172938|19220863|P1|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
7807982|NCT01172938|19220855|P9|STARTED|Active Treatment Phase (Weeks 25-52)||0
7807983|NCT01172938|19220856|P8|STARTED|Active Treatment Phase (Weeks 25-52)||0
7807984|NCT01172938|19220857|P7|STARTED|Active Treatment Phase (Weeks 25-52)||24
7807985|NCT01172938|19220858|P6|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49
7807986|NCT01172938|19220859|P5|STARTED|Active Treatment Phase (Weeks 25-52)||23
7807987|NCT01172938|19220860|P4|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51
7807988|NCT01172938|19220861|P3|STARTED|Active Treatment Phase (Weeks 25-52)|Three participants who completed Week 24 did not enter the active treatment phase|145
7807989|NCT01172938|19220862|P2|STARTED|Active Treatment Phase (Weeks 25-52)|Ten participants who completed Week 24 did not enter the active treatment phase|136
7807990|NCT01172938|19220863|P1|STARTED|Active Treatment Phase (Weeks 25-52)||0
7807991|NCT01172938|19220855|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7807992|NCT01172938|19220856|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7807993|NCT01172938|19220857|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7807994|NCT01172938|19220858|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7807995|NCT01172938|19220859|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7807996|NCT01172938|19220860|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7807997|NCT01172938|19220861|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||20
7807998|NCT01172938|19220862|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||22
7807999|NCT01172938|19220863|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||18
7808000|NCT01172938|19220855|P9|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7808001|NCT01172938|19220856|P8|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7808002|NCT01172938|19220857|P7|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7808003|NCT01172938|19220858|P6|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7808004|NCT01172938|19220859|P5|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7808005|NCT01172938|19220860|P4|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
7808006|NCT01172938|19220861|P3|COMPLETED|Placebo-controlled Phase (Week 0-24)||148
7808007|NCT01172938|19220862|P2|COMPLETED|Placebo-controlled Phase (Week 0-24)||146
7808008|NCT01172938|19220863|P1|COMPLETED|Placebo-controlled Phase (Week 0-24)|One participant who completed Week 24 did not enter the active treatment phase|150
7808009|NCT01172938|19220855|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
7808010|NCT01172938|19220856|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
7808011|NCT01172938|19220857|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
7808012|NCT01172938|19220858|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
7808013|NCT01172938|19220859|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
7808014|NCT01172938|19220860|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
7808015|NCT01172938|19220861|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||58
7808016|NCT01172938|19220862|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Six participants who escaped early did not complete Week 24|78
7808017|NCT01172938|19220863|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Five participants who escaped early did not complete Week 24|107
7808018|NCT01172938|19220855|P9|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
7808019|NCT01172938|19220856|P8|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
7808020|NCT01172938|19220857|P7|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
7808021|NCT01172938|19220858|P6|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
7808022|NCT01172938|19220859|P5|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
7808023|NCT01172938|19220860|P4|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
7808024|NCT01172938|19220861|P3|Completed Week 16|Placebo-controlled Phase (Week 0-24)||154
7808025|NCT01172938|19220862|P2|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
7808026|NCT01172938|19220863|P1|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
7808027|NCT01172938|19220855|P9|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
7808028|NCT01172938|19220856|P8|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
7808029|NCT01172938|19220857|P7|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
7808030|NCT01172938|19220858|P6|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
7808031|NCT01172938|19220859|P5|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
7808032|NCT01172938|19220860|P4|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
7808033|NCT01172938|19220861|P3|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
7808034|NCT01172938|19220862|P2|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
7808035|NCT01172938|19220863|P1|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
7808036|NCT01172938|19220855|P9|STARTED|Placebo-controlled Phase (Week 0-24)||0
7808037|NCT01172938|19220856|P8|STARTED|Placebo-controlled Phase (Week 0-24)||0
7808038|NCT01172938|19220857|P7|STARTED|Placebo-controlled Phase (Week 0-24)||0
7808039|NCT01172938|19220858|P6|STARTED|Placebo-controlled Phase (Week 0-24)||0
7808040|NCT01172938|19220859|P5|STARTED|Placebo-controlled Phase (Week 0-24)||0
7808041|NCT01172938|19220860|P4|STARTED|Placebo-controlled Phase (Week 0-24)||0
7808042|NCT01172938|19220861|P3|STARTED|Placebo-controlled Phase (Week 0-24)||168
7808043|NCT01172938|19220862|P2|STARTED|Placebo-controlled Phase (Week 0-24)||168
7808044|NCT01172938|19220863|P1|STARTED|Placebo-controlled Phase (Week 0-24)||168
7808045|NCT01172873|19221049|P2|NOT COMPLETED|Overall Study||2
7808046|NCT01172873|19221050|P1|NOT COMPLETED|Overall Study||3
7808047|NCT01172873|19221049|P2|COMPLETED|Overall Study||3
7808048|NCT01172873|19221050|P1|COMPLETED|Overall Study||8
7808049|NCT01172873|19221049|P2|STARTED|Overall Study||5
7808050|NCT01172873|19221050|P1|STARTED|Overall Study||11
7808051|NCT01172847|19221060|P1|NOT COMPLETED|Overall Study||3
7808052|NCT01172847|19221060|P1|COMPLETED|Overall Study||21
7808053|NCT01172847|19221060|P1|Oseltamivir + Rimantadine|Overall Study||21
7808054|NCT01172847|19221060|P1|Rimantadine|Overall Study||22
7808055|NCT01172847|19221060|P1|Oseltamivir|Overall Study||24
7808056|NCT01172847|19221060|P1|STARTED|Overall Study||24
7808057|NCT01172821|19221089|P4|NOT COMPLETED|Overall Study||17
7808058|NCT01172821|19221090|P3|NOT COMPLETED|Overall Study||13
7808059|NCT01172821|19221091|P2|NOT COMPLETED|Overall Study||12
7808060|NCT01172821|19221092|P1|NOT COMPLETED|Overall Study||14
7808061|NCT01172821|19221089|P4|COMPLETED|Overall Study||249
7808062|NCT01172821|19221090|P3|COMPLETED|Overall Study||240
7808063|NCT01172821|19221091|P2|COMPLETED|Overall Study||245
7808064|NCT01172821|19221092|P1|COMPLETED|Overall Study||240
7808065|NCT01172821|19221089|P4|STARTED|Overall Study|Entered and Treated|266
7808066|NCT01172821|19221090|P3|STARTED|Overall Study|Entered and Treated|253
7808067|NCT01172821|19221091|P2|STARTED|Overall Study|Entered and Treated|257
7808068|NCT01172821|19221092|P1|STARTED|Overall Study|Entered and Treated|254
7808069|NCT01172808|19221182|P4|NOT COMPLETED|Overall Study||15
7808070|NCT01172808|19221183|P3|NOT COMPLETED|Overall Study||23
7808071|NCT01172808|19221184|P2|NOT COMPLETED|Overall Study||13
7808072|NCT01172808|19221185|P1|NOT COMPLETED|Overall Study||21
7808073|NCT01172808|19221182|P4|COMPLETED|Overall Study||260
7808074|NCT01172808|19221183|P3|COMPLETED|Overall Study||241
7808075|NCT01172808|19221184|P2|COMPLETED|Overall Study||249
7808076|NCT01172808|19221185|P1|COMPLETED|Overall Study||248
7808077|NCT01172808|19221182|P4|STARTED|Overall Study|Entered and Treated|275
7808078|NCT01172808|19221183|P3|STARTED|Overall Study|Entered and Treated|264
7808079|NCT01172808|19221184|P2|STARTED|Overall Study|Entered and Treated|262
7808080|NCT01172808|19221185|P1|STARTED|Overall Study|Entered and Treated|269
7808081|NCT01172639|19221276|P5|NOT COMPLETED|Overall Study||6
7808082|NCT01172639|19221277|P4|NOT COMPLETED|Overall Study||11
7808083|NCT01172639|19221278|P3|NOT COMPLETED|Overall Study||16
7808084|NCT01172639|19221279|P2|NOT COMPLETED|Overall Study||11
7808085|NCT01172639|19221280|P1|NOT COMPLETED|Overall Study||13
7808086|NCT01172639|19221276|P5|COMPLETED|Overall Study||41
7808087|NCT01172639|19221277|P4|COMPLETED|Overall Study||32
7808088|NCT01172639|19221278|P3|COMPLETED|Overall Study||77
7808089|NCT01172639|19221279|P2|COMPLETED|Overall Study||87
7808090|NCT01172639|19221280|P1|COMPLETED|Overall Study||85
7808091|NCT01172639|19221276|P5|Week 52|Overall Study||45
7808092|NCT01172639|19221277|P4|Week 52|Overall Study||38
7808093|NCT01172639|19221278|P3|Week 52|Overall Study||88
7808094|NCT01172639|19221279|P2|Week 52|Overall Study||89
7808095|NCT01172639|19221280|P1|Week 52|Overall Study||89
7808096|NCT01172639|19221276|P5|Week 16|Overall Study||47
7808097|NCT01172639|19221277|P4|Week 16|Overall Study||39
7808098|NCT01172639|19221278|P3|Week 16|Overall Study||91
7808099|NCT01172639|19221279|P2|Week 16|Overall Study||96
7808100|NCT01172639|19221280|P1|Week 16|Overall Study||94
7808101|NCT01172639|19221276|P5|STARTED|Overall Study||47
7808102|NCT01172639|19221277|P4|STARTED|Overall Study||43
7808103|NCT01172639|19221278|P3|STARTED|Overall Study||93
7808104|NCT01172639|19221279|P2|STARTED|Overall Study||98
7808105|NCT01172639|19221280|P1|STARTED|Overall Study||98
7808106|NCT01172600|19221324|P2|NOT COMPLETED|Overall Study||0
7808107|NCT01172600|19221325|P1|NOT COMPLETED|Overall Study||0
7808108|NCT01172600|19221324|P2|COMPLETED|Overall Study||39
7808109|NCT01172600|19221325|P1|COMPLETED|Overall Study||39
7808110|NCT01172600|19221324|P2|STARTED|Overall Study||39
7808111|NCT01172600|19221325|P1|STARTED|Overall Study||39
7808112|NCT01172535|19221355|P1|NOT COMPLETED|Overall Study||8
7808113|NCT01172535|19221355|P1|COMPLETED|Overall Study||89
7808114|NCT01172535|19221355|P1|STARTED|Overall Study||97
7808115|NCT01172522|19221372|P2|NOT COMPLETED|Overall Study||0
7808116|NCT01172522|19221373|P1|NOT COMPLETED|Overall Study||0
7808117|NCT01172522|19221372|P2|COMPLETED|Overall Study||15
7808118|NCT01172522|19221373|P1|COMPLETED|Overall Study||15
7808119|NCT01172522|19221372|P2|STARTED|Overall Study||15
7808120|NCT01172522|19221373|P1|STARTED|Overall Study||15
7808121|NCT01172418|19221380|P2|NOT COMPLETED|Overall Study||0
7808122|NCT01172418|19221381|P1|NOT COMPLETED|Overall Study||0
7808123|NCT01172418|19221380|P2|COMPLETED|Overall Study||100
7808124|NCT01172418|19221381|P1|COMPLETED|Overall Study||100
7808125|NCT01172418|19221380|P2|STARTED|Overall Study||100
7808126|NCT01172418|19221381|P1|STARTED|Overall Study||100
7808127|NCT01172353|19221397|P2|NOT COMPLETED|Overall Study||0
7808128|NCT01172353|19221398|P1|NOT COMPLETED|Overall Study||0
7808129|NCT01172353|19221397|P2|COMPLETED|Overall Study||151
7808130|NCT01172353|19221398|P1|COMPLETED|Overall Study||150
7808131|NCT01172353|19221397|P2|STARTED|Overall Study||151
7808132|NCT01172353|19221398|P1|STARTED|Overall Study||150
7808133|NCT01172288|19221408|P2|NOT COMPLETED|Overall Study||1
7808134|NCT01172288|19221409|P1|NOT COMPLETED|Overall Study||1
7808135|NCT01172288|19221408|P2|COMPLETED|Overall Study||13
7808136|NCT01172288|19221409|P1|COMPLETED|Overall Study||16
7808137|NCT01172288|19221408|P2|STARTED|Overall Study||14
7808138|NCT01172288|19221409|P1|STARTED|Overall Study||17
7808139|NCT01172275|19221425|P2|NOT COMPLETED|Overall Study||0
7808140|NCT01172275|19221426|P1|NOT COMPLETED|Overall Study||2
7808141|NCT01172275|19221425|P2|COMPLETED|Overall Study||6
7808142|NCT01172275|19221426|P1|COMPLETED|Overall Study||3
7808143|NCT01172275|19221425|P2|STARTED|Overall Study||6
7808144|NCT01172275|19221426|P1|STARTED|Overall Study||5
7808145|NCT01172197|19221436|P2|NOT COMPLETED|Overall Study||0
7808146|NCT01172197|19221437|P1|NOT COMPLETED|Overall Study||0
7808147|NCT01172197|19221436|P2|COMPLETED|Overall Study||7
7808148|NCT01172197|19221437|P1|COMPLETED|Overall Study||7
7808149|NCT01172197|19221436|P2|STARTED|Overall Study||7
7808150|NCT01172197|19221437|P1|STARTED|Overall Study||7
7808151|NCT01172184|19221443|P1|NOT COMPLETED|Overall Study||0
7808152|NCT01172184|19221443|P1|COMPLETED|Overall Study||111
7808153|NCT01172184|19221443|P1|STARTED|Overall Study||111
7808154|NCT01172145|19221451|P2|NOT COMPLETED|Overall Study||0
7808155|NCT01172145|19221452|P1|NOT COMPLETED|Overall Study||0
7808156|NCT01172145|19221451|P2|COMPLETED|Overall Study||11
7808157|NCT01172145|19221452|P1|COMPLETED|Overall Study||11
7808158|NCT01172145|19221451|P2|STARTED|Overall Study||11
7808159|NCT01172145|19221452|P1|STARTED|Overall Study||11
7808160|NCT01172067|19221474|P2|NOT COMPLETED|Overall Study||37
7808161|NCT01172067|19221475|P1|NOT COMPLETED|Overall Study||47
7808162|NCT01172067|19221474|P2|COMPLETED|Overall Study||163
7808163|NCT01172067|19221475|P1|COMPLETED|Overall Study||153
7808164|NCT01172067|19221474|P2|STARTED|Overall Study||200
7808165|NCT01172067|19221475|P1|STARTED|Overall Study||200
7808166|NCT01171989|19221484|P3|NOT COMPLETED|Overall Study||1
7808167|NCT01171989|19221485|P2|NOT COMPLETED|Overall Study||0
7808168|NCT01171989|19221486|P1|NOT COMPLETED|Overall Study||0
7808169|NCT01171989|19221484|P3|COMPLETED|Overall Study||120
7808170|NCT01171989|19221485|P2|COMPLETED|Overall Study||133
7808171|NCT01171989|19221486|P1|COMPLETED|Overall Study||137
7808172|NCT01171989|19221484|P3|STARTED|Overall Study||121
7808173|NCT01171989|19221485|P2|STARTED|Overall Study||133
7808174|NCT01171989|19221486|P1|STARTED|Overall Study||137
7808175|NCT01171976|19221560|P3|NOT COMPLETED|Overall Study||15
7808176|NCT01171976|19221561|P2|NOT COMPLETED|Overall Study||11
7808177|NCT01171976|19221562|P1|NOT COMPLETED|Overall Study||14
7808178|NCT01171976|19221560|P3|COMPLETED|Overall Study||108
7808179|NCT01171976|19221561|P2|COMPLETED|Overall Study||117
7808180|NCT01171976|19221562|P1|COMPLETED|Overall Study||107
7808181|NCT01171976|19221560|P3|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118
7808182|NCT01171976|19221561|P2|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126
7808183|NCT01171976|19221562|P1|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126
7808184|NCT01171976|19221560|P3|STARTED|Overall Study||123
7808185|NCT01171976|19221561|P2|STARTED|Overall Study||128
7808186|NCT01171976|19221562|P1|STARTED|Overall Study||121
7808187|NCT01171963|19221599|P2|NOT COMPLETED|Overall Study||168
7808188|NCT01171963|19221600|P1|NOT COMPLETED|Overall Study||148
7808189|NCT01171963|19221599|P2|COMPLETED|Overall Study||1499
7808190|NCT01171963|19221600|P1|COMPLETED|Overall Study||1518
7808191|NCT01171963|19221599|P2|STARTED|Overall Study||1667
7808192|NCT01171963|19221600|P1|STARTED|Overall Study||1666
7808193|NCT01171924|19221658|P2|NOT COMPLETED|Overall Study||23
7808194|NCT01171924|19221659|P1|NOT COMPLETED|Overall Study||23
7808195|NCT01171924|19221658|P2|COMPLETED|Overall Study||0
7808196|NCT01171924|19221659|P1|COMPLETED|Overall Study||0
7808197|NCT01171924|19221658|P2|STARTED|Overall Study||23
7808198|NCT01171924|19221659|P1|STARTED|Overall Study||23
7808199|NCT01171898|19221669|P4|NOT COMPLETED|Overall Study||6
7808200|NCT01171898|19221670|P3|NOT COMPLETED|Overall Study||12
7808201|NCT01171898|19221671|P2|NOT COMPLETED|Overall Study||19
7808202|NCT01171898|19221672|P1|NOT COMPLETED|Overall Study||4
7808203|NCT01171898|19221669|P4|COMPLETED|Overall Study||15
7808204|NCT01171898|19221670|P3|COMPLETED|Overall Study||13
7808205|NCT01171898|19221671|P2|COMPLETED|Overall Study||32
7808206|NCT01171898|19221672|P1|COMPLETED|Overall Study||26
7808207|NCT01171898|19221669|P4|STARTED|Overall Study||21
7808208|NCT01171898|19221670|P3|STARTED|Overall Study||25
7808209|NCT01171898|19221671|P2|STARTED|Overall Study||51
7808210|NCT01171898|19221672|P1|STARTED|Overall Study||30
7808211|NCT01171820|19221696|P2|NOT COMPLETED|Overall Study||6
7808212|NCT01171820|19221697|P1|NOT COMPLETED|Overall Study||6
7808213|NCT01171820|19221696|P2|COMPLETED|Overall Study||212
7808214|NCT01171820|19221697|P1|COMPLETED|Overall Study||100
7808215|NCT01171820|19221696|P2|STARTED|Overall Study||218
7808216|NCT01171820|19221697|P1|STARTED|Overall Study||106
7808217|NCT01171794|19221753|P2|NOT COMPLETED|Overall Study||0
7808218|NCT01171794|19221754|P1|NOT COMPLETED|Overall Study||3
7808219|NCT01171794|19221753|P2|COMPLETED|Overall Study||42
7808220|NCT01171794|19221754|P1|COMPLETED|Overall Study||44
7808221|NCT01171794|19221753|P2|STARTED|Overall Study||42
7808222|NCT01171794|19221754|P1|STARTED|Overall Study||47
7808223|NCT01171690|19221764|P2|NOT COMPLETED|Overall Study||0
7808224|NCT01171690|19221765|P1|NOT COMPLETED|Overall Study||0
7808225|NCT01171690|19221764|P2|COMPLETED|Overall Study||5
7808226|NCT01171690|19221765|P1|COMPLETED|Overall Study||5
7808227|NCT01171690|19221764|P2|STARTED|Overall Study||5
7808228|NCT01171690|19221765|P1|STARTED|Overall Study||5
7808229|NCT01171677|19221775|P2|NOT COMPLETED|Overall Study||3
7808230|NCT01171677|19221776|P1|NOT COMPLETED|Overall Study||6
7808231|NCT01171677|19221775|P2|COMPLETED|Overall Study||12
7808232|NCT01171677|19221776|P1|COMPLETED|Overall Study||11
7808233|NCT01171677|19221775|P2|STARTED|Overall Study||15
7808234|NCT01171677|19221776|P1|STARTED|Overall Study||17
7808235|NCT01171625|19221808|P1|NOT COMPLETED|Overall Study||180
7808236|NCT01171625|19221808|P1|COMPLETED|Overall Study||103
7808237|NCT01171625|19221808|P1|Subjects Implanted With Device|Overall Study||258
7808238|NCT01171625|19221808|P1|STARTED|Overall Study||283
7808239|NCT01171612|19221841|P1|NOT COMPLETED|Overall Study||51
7808240|NCT01171612|19221841|P1|COMPLETED|Overall Study||432
7808241|NCT01171612|19221841|P1|STARTED|Overall Study||483
7808242|NCT01171534|19221851|P2|NOT COMPLETED|Overall Study||3
7808243|NCT01171534|19221852|P1|NOT COMPLETED|Overall Study||0
7808244|NCT01171534|19221851|P2|COMPLETED|Overall Study||4
7808245|NCT01171534|19221852|P1|COMPLETED|Overall Study||0
7808246|NCT01171534|19221851|P2|STARTED|Overall Study||7
7808247|NCT01171534|19221852|P1|STARTED|Overall Study|retrospective arm never performed on study|0
7808248|NCT01171521|19221864|P1|NOT COMPLETED|Overall Study||6
7808249|NCT01171521|19221864|P1|COMPLETED|Overall Study||0
7808250|NCT01171521|19221864|P1|STARTED|Overall Study||6
7808251|NCT01171183|19221871|P2|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5
7808252|NCT01171183|19221872|P1|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10
7808253|NCT01171183|19221871|P2|COMPLETED|Outpatient Participation (Weeks 3-10)||4
7808254|NCT01171183|19221872|P1|COMPLETED|Outpatient Participation (Weeks 3-10)||2
7808255|NCT01171183|19221871|P2|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9
7808256|NCT01171183|19221872|P1|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12
7808257|NCT01171183|19221871|P2|NOT COMPLETED|Residential Facility (Weeks 1-2)||6
7808258|NCT01171183|19221872|P1|NOT COMPLETED|Residential Facility (Weeks 1-2)||2
7808259|NCT01171183|19221871|P2|COMPLETED|Residential Facility (Weeks 1-2)||10
7808260|NCT01171183|19221872|P1|COMPLETED|Residential Facility (Weeks 1-2)||13
7808261|NCT01171183|19221871|P2|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16
7808262|NCT01171183|19221872|P1|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15
7808263|NCT01171118|19221880|P1|NOT COMPLETED|Overall Study||0
7808264|NCT01171118|19221880|P1|COMPLETED|Overall Study||10
7808265|NCT01171118|19221880|P1|STARTED|Overall Study||10
7808266|NCT01170962|19221893|P3|NOT COMPLETED|Follow up Period||6
7808267|NCT01170962|19221894|P2|NOT COMPLETED|Follow up Period||27
7808268|NCT01170962|19221895|P1|NOT COMPLETED|Follow up Period||39
7808269|NCT01170962|19221893|P3|COMPLETED|Follow up Period||9
7808270|NCT01170962|19221894|P2|COMPLETED|Follow up Period||165
7808271|NCT01170962|19221895|P1|COMPLETED|Follow up Period||159
7808272|NCT01170962|19221893|P3|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15
7808273|NCT01170962|19221894|P2|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192
7808360|NCT01170390|19222066|P1|COMPLETED|Oral Contraceptives||31
7808274|NCT01170962|19221895|P1|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198
7808275|NCT01170962|19221893|P3|NOT COMPLETED|Treatment Period||12
7808276|NCT01170962|19221894|P2|NOT COMPLETED|Treatment Period||111
7808277|NCT01170962|19221895|P1|NOT COMPLETED|Treatment Period||127
7808278|NCT01170962|19221893|P3|COMPLETED|Treatment Period||5
7808279|NCT01170962|19221894|P2|COMPLETED|Treatment Period||88
7808280|NCT01170962|19221895|P1|COMPLETED|Treatment Period||76
7808281|NCT01170962|19221893|P3|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||0
7808282|NCT01170962|19221894|P2|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||36
7808283|NCT01170962|19221895|P1|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||28
7808284|NCT01170962|19221893|P3|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||0
7808285|NCT01170962|19221894|P2|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||36
7808286|NCT01170962|19221895|P1|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||30
7808287|NCT01170962|19221893|P3|No PDR|Treatment Period||17
7808288|NCT01170962|19221894|P2|No PDR|Treatment Period||127
7808289|NCT01170962|19221895|P1|No PDR|Treatment Period||145
7808290|NCT01170962|19221893|P3|STARTED|Treatment Period||17
7808291|NCT01170962|19221894|P2|STARTED|Treatment Period||199
7808292|NCT01170962|19221895|P1|STARTED|Treatment Period||203
7808293|NCT01170949|19221941|P2|NOT COMPLETED|Overall Study||4
7808294|NCT01170949|19221942|P1|NOT COMPLETED|Overall Study||7
7808295|NCT01170949|19221941|P2|COMPLETED|Overall Study||22
7808296|NCT01170949|19221942|P1|COMPLETED|Overall Study||43
7808297|NCT01170949|19221941|P2|STARTED|Overall Study||26
7808298|NCT01170949|19221942|P1|STARTED|Overall Study||50
7808299|NCT01170884|19221950|P2|NOT COMPLETED|Overall Study||2
7808300|NCT01170884|19221951|P1|NOT COMPLETED|Overall Study||5
7808301|NCT01170884|19221950|P2|COMPLETED|Overall Study||60
7808302|NCT01170884|19221951|P1|COMPLETED|Overall Study||54
7808303|NCT01170884|19221950|P2|STARTED|Overall Study||62
7808304|NCT01170884|19221951|P1|STARTED|Overall Study||59
7808305|NCT01170754|19221959|P2|NOT COMPLETED|Overall Study||0
7808306|NCT01170754|19221960|P1|NOT COMPLETED|Overall Study||0
7808307|NCT01170754|19221959|P2|COMPLETED|Overall Study||70
7808308|NCT01170754|19221960|P1|COMPLETED|Overall Study||66
7808309|NCT01170754|19221959|P2|STARTED|Overall Study||70
7808310|NCT01170754|19221960|P1|STARTED|Overall Study||66
7808311|NCT01170663|19221990|P2|NOT COMPLETED|Overall Study||20
7808312|NCT01170663|19221991|P1|NOT COMPLETED|Overall Study||14
7808313|NCT01170663|19221990|P2|COMPLETED|Overall Study||315
7808314|NCT01170663|19221991|P1|COMPLETED|Overall Study||316
7808315|NCT01170663|19221990|P2|Received Any Treatment (Safety Pop)|Overall Study||329
7808316|NCT01170663|19221991|P1|Received Any Treatment (Safety Pop)|Overall Study||327
7808317|NCT01170663|19221990|P2|STARTED|Overall Study|Participant was included in the placebo/paclitaxel treatment arm (intent-to-treat (ITT) population).|335
7808318|NCT01170663|19221991|P1|STARTED|Overall Study|Participant was included in ramucirumab (IMC-1121B)/paclitaxel treatment arm (safety population).|330
7808319|NCT01170598|19222019|P1|NOT COMPLETED|Overall Study||6
7808320|NCT01170598|19222019|P1|COMPLETED|Overall Study||29
7808321|NCT01170598|19222019|P1|STARTED|Overall Study||35
7808322|NCT01170546|19222038|P4|NOT COMPLETED|Overall Study||0
7808323|NCT01170546|19222039|P3|NOT COMPLETED|Overall Study||0
7808324|NCT01170546|19222040|P2|NOT COMPLETED|Overall Study||0
7808325|NCT01170546|19222041|P1|NOT COMPLETED|Overall Study||0
7808326|NCT01170546|19222038|P4|COMPLETED|Overall Study||8
7808327|NCT01170546|19222039|P3|COMPLETED|Overall Study||6
7808328|NCT01170546|19222040|P2|COMPLETED|Overall Study||7
7808329|NCT01170546|19222041|P1|COMPLETED|Overall Study||7
7808330|NCT01170546|19222038|P4|STARTED|Overall Study||8
7808331|NCT01170546|19222039|P3|STARTED|Overall Study||6
7808332|NCT01170546|19222040|P2|STARTED|Overall Study||7
7808333|NCT01170546|19222041|P1|STARTED|Overall Study||7
7808334|NCT01170533|19222051|P2|NOT COMPLETED|Pantoprazole Cross-over||0
7808335|NCT01170533|19222052|P1|NOT COMPLETED|Pantoprazole Cross-over||0
7808336|NCT01170533|19222051|P2|COMPLETED|Pantoprazole Cross-over||20
7808337|NCT01170533|19222052|P1|COMPLETED|Pantoprazole Cross-over||0
7808338|NCT01170533|19222051|P2|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20
7808339|NCT01170533|19222052|P1|STARTED|Pantoprazole Cross-over||0
7808340|NCT01170533|19222051|P2|NOT COMPLETED|Omeprazole Cross-over||0
7808341|NCT01170533|19222052|P1|NOT COMPLETED|Omeprazole Cross-over||0
7808342|NCT01170533|19222051|P2|COMPLETED|Omeprazole Cross-over||0
7808343|NCT01170533|19222052|P1|COMPLETED|Omeprazole Cross-over||20
7808344|NCT01170533|19222051|P2|STARTED|Omeprazole Cross-over||0
7808345|NCT01170533|19222052|P1|STARTED|Omeprazole Cross-over||20
7808346|NCT01170390|19222064|P3|NOT COMPLETED|Randomized Treatment||0
7808347|NCT01170390|19222065|P2|NOT COMPLETED|Randomized Treatment||1
7808348|NCT01170390|19222066|P1|NOT COMPLETED|Randomized Treatment||0
7808349|NCT01170390|19222064|P3|COMPLETED|Randomized Treatment||15
7808350|NCT01170390|19222065|P2|COMPLETED|Randomized Treatment||16
7808351|NCT01170390|19222066|P1|COMPLETED|Randomized Treatment||0
7808352|NCT01170390|19222064|P3|STARTED|Randomized Treatment||15
7808353|NCT01170390|19222065|P2|STARTED|Randomized Treatment||17
7808354|NCT01170390|19222066|P1|STARTED|Randomized Treatment||0
7808355|NCT01170390|19222064|P3|NOT COMPLETED|Oral Contraceptives||0
7808356|NCT01170390|19222065|P2|NOT COMPLETED|Oral Contraceptives||0
7808357|NCT01170390|19222066|P1|NOT COMPLETED|Oral Contraceptives||1
7808358|NCT01170390|19222064|P3|COMPLETED|Oral Contraceptives||0
7808359|NCT01170390|19222065|P2|COMPLETED|Oral Contraceptives||0
7808361|NCT01170390|19222064|P3|STARTED|Oral Contraceptives||0
7808362|NCT01170390|19222065|P2|STARTED|Oral Contraceptives||0
7808363|NCT01170390|19222066|P1|STARTED|Oral Contraceptives||32
7808364|NCT01170364|19222082|P2|NOT COMPLETED|Overall Study||1
7808365|NCT01170364|19222083|P1|NOT COMPLETED|Overall Study||4
7808366|NCT01170364|19222082|P2|COMPLETED|Overall Study|One participant was unable to begin the second testing period due to scheduling conflicts.|5
7808367|NCT01170364|19222083|P1|COMPLETED|Overall Study||4
7808368|NCT01170364|19222082|P2|STARTED|Overall Study||6
7808369|NCT01170364|19222083|P1|STARTED|Overall Study||8
7808370|NCT01170273|19222091|P2|NOT COMPLETED|Overall Study||9
7808371|NCT01170273|19222092|P1|NOT COMPLETED|Overall Study||8
7808372|NCT01170273|19222091|P2|COMPLETED|Overall Study||57
7808373|NCT01170273|19222092|P1|COMPLETED|Overall Study||56
7808374|NCT01170273|19222091|P2|STARTED|Overall Study||66
7808375|NCT01170273|19222092|P1|STARTED|Overall Study||64
7808376|NCT01170247|19222100|P2|NOT COMPLETED|Overall Study||0
7808377|NCT01170247|19222101|P1|NOT COMPLETED|Overall Study||0
7808378|NCT01170247|19222100|P2|COMPLETED|Overall Study||1
7808379|NCT01170247|19222101|P1|COMPLETED|Overall Study||2
7808380|NCT01170247|19222100|P2|STARTED|Overall Study||1
7808381|NCT01170247|19222101|P1|STARTED|Overall Study||2
7808382|NCT01170221|19222109|P2|NOT COMPLETED|Overall Study||28
7808383|NCT01170221|19222110|P1|NOT COMPLETED|Overall Study||33
7808384|NCT01170221|19222109|P2|COMPLETED|Overall Study||307
7808385|NCT01170221|19222110|P1|COMPLETED|Overall Study||299
7808386|NCT01170221|19222109|P2|STARTED|Overall Study||335
7808387|NCT01170221|19222110|P1|STARTED|Overall Study||332
7808388|NCT01170208|19222133|P3|NOT COMPLETED|Overall Study||2
7808389|NCT01170208|19222134|P2|NOT COMPLETED|Overall Study||0
7808390|NCT01170208|19222135|P1|NOT COMPLETED|Overall Study||6
7808391|NCT01170208|19222133|P3|COMPLETED|Overall Study||4
7808392|NCT01170208|19222134|P2|COMPLETED|Overall Study||20
7808393|NCT01170208|19222135|P1|COMPLETED|Overall Study||14
7808394|NCT01170208|19222133|P3|STARTED|Overall Study||6
7808395|NCT01170208|19222134|P2|STARTED|Overall Study||20
7808396|NCT01170208|19222135|P1|STARTED|Overall Study||20
7808397|NCT01170117|19222154|P2|NOT COMPLETED|Overall Study||20
7808398|NCT01170117|19222155|P1|NOT COMPLETED|Overall Study||30
7808399|NCT01170117|19222154|P2|COMPLETED|Overall Study||55
7808400|NCT01170117|19222155|P1|COMPLETED|Overall Study||47
7808401|NCT01170117|19222154|P2|STARTED|Overall Study||75
7808402|NCT01170117|19222155|P1|STARTED|Overall Study||77
7808403|NCT01170091|19222163|P1|NOT COMPLETED|Overall Study||24
7808404|NCT01170091|19222163|P1|COMPLETED|Overall Study||627
7808405|NCT01170091|19222163|P1|STARTED|Overall Study||651
7808406|NCT01170065|19222173|P3|NOT COMPLETED|Overall Study||26
7808407|NCT01170065|19222174|P2|NOT COMPLETED|Overall Study||92
7808408|NCT01170065|19222175|P1|NOT COMPLETED|Overall Study||28
7808409|NCT01170065|19222173|P3|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
7808410|NCT01170065|19222174|P2|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|34
7808411|NCT01170065|19222175|P1|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
7808412|NCT01170065|19222173|P3|STARTED|Overall Study||35
7808413|NCT01170065|19222174|P2|STARTED|Overall Study||126
7808414|NCT01170065|19222175|P1|STARTED|Overall Study||37
7808415|NCT01170039|19222206|P2|NOT COMPLETED|Overall Study||6
7808416|NCT01170039|19222207|P1|NOT COMPLETED|Overall Study||8
7808417|NCT01170039|19222206|P2|COMPLETED|Overall Study||33
7808418|NCT01170039|19222207|P1|COMPLETED|Overall Study||29
7808419|NCT01170039|19222206|P2|STARTED|Overall Study||39
7808420|NCT01170039|19222207|P1|STARTED|Overall Study||37
7808421|NCT01169987|19222219|P1|NOT COMPLETED|Overall Study||31
7808422|NCT01169987|19222219|P1|COMPLETED|Overall Study||160
7808423|NCT01169987|19222219|P1|STARTED|Overall Study||191
7808424|NCT01169779|19222285|P2|NOT COMPLETED|Overall Study||17
7808425|NCT01169779|19222286|P1|NOT COMPLETED|Overall Study||11
7808426|NCT01169779|19222285|P2|COMPLETED|Overall Study||179
7808427|NCT01169779|19222286|P1|COMPLETED|Overall Study||184
7808428|NCT01169779|19222285|P2|Subgroup for Standardized Meal Test|Overall Study||121
7808429|NCT01169779|19222286|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130
7808430|NCT01169779|19222285|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||195
7808431|NCT01169779|19222286|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193
7808432|NCT01169779|19222285|P2|Treated/Safety Population|Overall Study||196
7808433|NCT01169779|19222286|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194
7808434|NCT01169779|19222285|P2|STARTED|Overall Study||196
7808435|NCT01169779|19222286|P1|STARTED|Overall Study|Randomized.|195
7808436|NCT01169753|19222312|P2|NOT COMPLETED|Overall Study||1
7808437|NCT01169753|19222313|P1|NOT COMPLETED|Overall Study||0
7808438|NCT01169753|19222312|P2|COMPLETED|Overall Study||0
7808439|NCT01169753|19222313|P1|COMPLETED|Overall Study||0
7808440|NCT01169753|19222312|P2|STARTED|Overall Study||1
7808441|NCT01169753|19222313|P1|STARTED|Overall Study||0
7808442|NCT01169701|19222321|P2|NOT COMPLETED|Overall Study||10
7808443|NCT01169701|19222322|P1|NOT COMPLETED|Overall Study||5
7808444|NCT01169701|19222321|P2|COMPLETED|Overall Study||25
7808445|NCT01169701|19222322|P1|COMPLETED|Overall Study||31
7808446|NCT01169701|19222321|P2|Intent to Treat (ITT) Set|Overall Study||28
7808447|NCT01169701|19222322|P1|Intent to Treat (ITT) Set|Overall Study||32
7808448|NCT01169701|19222321|P2|Safety Set|Overall Study||35
7808449|NCT01169701|19222322|P1|Safety Set|Overall Study||36
7808450|NCT01169701|19222321|P2|STARTED|Overall Study||35
7808451|NCT01169701|19222322|P1|STARTED|Overall Study||36
7808452|NCT01169675|19222359|P5|NOT COMPLETED|Overall Study||6
7808453|NCT01169675|19222360|P4|NOT COMPLETED|Overall Study||17
7808454|NCT01169675|19222361|P3|NOT COMPLETED|Overall Study||7
7808455|NCT01169675|19222362|P2|NOT COMPLETED|Overall Study||3
7808456|NCT01169675|19222363|P1|NOT COMPLETED|Overall Study||20
7808457|NCT01169675|19222359|P5|COMPLETED|Overall Study||0
7808458|NCT01169675|19222360|P4|COMPLETED|Overall Study||0
7808459|NCT01169675|19222361|P3|COMPLETED|Overall Study||0
7808460|NCT01169675|19222362|P2|COMPLETED|Overall Study||0
7808461|NCT01169675|19222363|P1|COMPLETED|Overall Study||0
7808462|NCT01169675|19222359|P5|STARTED|Overall Study||6
7808463|NCT01169675|19222360|P4|STARTED|Overall Study||17
7808464|NCT01169675|19222361|P3|STARTED|Overall Study||7
7808465|NCT01169675|19222362|P2|STARTED|Overall Study||3
7808466|NCT01169675|19222363|P1|STARTED|Overall Study||20
7808467|NCT01169649|19222400|P1|NOT COMPLETED|Overall Study||3
7808468|NCT01169649|19222400|P1|COMPLETED|Overall Study||8
7808469|NCT01169649|19222400|P1|STARTED|Overall Study||11
7808470|NCT01169610|19222404|P1|NOT COMPLETED|Overall Study||0
7808471|NCT01169610|19222404|P1|COMPLETED|Overall Study||1
7808472|NCT01169610|19222404|P1|STARTED|Overall Study||1
7808473|NCT01169558|19222412|P1|NOT COMPLETED|Overall Study||156
7808474|NCT01169558|19222412|P1|COMPLETED|Overall Study||6
7808475|NCT01169558|19222412|P1|STARTED|Overall Study||162
7808476|NCT01169519|19222419|P1|NOT COMPLETED|Overall Study||0
7808477|NCT01169519|19222419|P1|COMPLETED|Overall Study||21
7808478|NCT01169519|19222419|P1|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21
7808479|NCT01169493|19222437|P6|NOT COMPLETED|Period 3 (6 Months)||0
7808480|NCT01169493|19222438|P5|NOT COMPLETED|Period 3 (6 Months)||0
7808481|NCT01169493|19222439|P4|NOT COMPLETED|Period 3 (6 Months)||0
7808482|NCT01169493|19222440|P3|NOT COMPLETED|Period 3 (6 Months)||1
7808483|NCT01169493|19222441|P2|NOT COMPLETED|Period 3 (6 Months)||2
7808484|NCT01169493|19222442|P1|NOT COMPLETED|Period 3 (6 Months)||0
7808485|NCT01169493|19222437|P6|COMPLETED|Period 3 (6 Months)||2
7808486|NCT01169493|19222438|P5|COMPLETED|Period 3 (6 Months)||0
7808487|NCT01169493|19222439|P4|COMPLETED|Period 3 (6 Months)||0
7808488|NCT01169493|19222440|P3|COMPLETED|Period 3 (6 Months)||2
7808489|NCT01169493|19222441|P2|COMPLETED|Period 3 (6 Months)||1
7808490|NCT01169493|19222442|P1|COMPLETED|Period 3 (6 Months)||2
7808491|NCT01169493|19222437|P6|STARTED|Period 3 (6 Months)||2
7808492|NCT01169493|19222438|P5|STARTED|Period 3 (6 Months)||0
7808493|NCT01169493|19222439|P4|STARTED|Period 3 (6 Months)||0
7808494|NCT01169493|19222440|P3|STARTED|Period 3 (6 Months)||3
7808495|NCT01169493|19222441|P2|STARTED|Period 3 (6 Months)||3
7808496|NCT01169493|19222442|P1|STARTED|Period 3 (6 Months)||2
7808497|NCT01169493|19222437|P6|NOT COMPLETED|Period 2 (6 Months)||0
7808498|NCT01169493|19222438|P5|NOT COMPLETED|Period 2 (6 Months)||0
7808499|NCT01169493|19222439|P4|NOT COMPLETED|Period 2 (6 Months)||0
7808500|NCT01169493|19222440|P3|NOT COMPLETED|Period 2 (6 Months)||0
7808501|NCT01169493|19222441|P2|NOT COMPLETED|Period 2 (6 Months)||0
7808502|NCT01169493|19222442|P1|NOT COMPLETED|Period 2 (6 Months)||0
7808503|NCT01169493|19222437|P6|COMPLETED|Period 2 (6 Months)||2
7808504|NCT01169493|19222438|P5|COMPLETED|Period 2 (6 Months)||0
7808505|NCT01169493|19222439|P4|COMPLETED|Period 2 (6 Months)||0
7808506|NCT01169493|19222440|P3|COMPLETED|Period 2 (6 Months)||3
7808507|NCT01169493|19222441|P2|COMPLETED|Period 2 (6 Months)||3
7808508|NCT01169493|19222442|P1|COMPLETED|Period 2 (6 Months)||2
7808509|NCT01169493|19222437|P6|STARTED|Period 2 (6 Months)||2
7808510|NCT01169493|19222438|P5|STARTED|Period 2 (6 Months)||0
7808511|NCT01169493|19222439|P4|STARTED|Period 2 (6 Months)||0
7808512|NCT01169493|19222440|P3|STARTED|Period 2 (6 Months)||3
7808513|NCT01169493|19222441|P2|STARTED|Period 2 (6 Months)||3
7808514|NCT01169493|19222442|P1|STARTED|Period 2 (6 Months)||2
7808515|NCT01169493|19222437|P6|NOT COMPLETED|Period 1 (6 Months)||3
7808516|NCT01169493|19222438|P5|NOT COMPLETED|Period 1 (6 Months)||0
7808517|NCT01169493|19222439|P4|NOT COMPLETED|Period 1 (6 Months)||0
7808518|NCT01169493|19222440|P3|NOT COMPLETED|Period 1 (6 Months)||2
7808519|NCT01169493|19222441|P2|NOT COMPLETED|Period 1 (6 Months)||1
7808520|NCT01169493|19222442|P1|NOT COMPLETED|Period 1 (6 Months)||0
7808521|NCT01169493|19222437|P6|COMPLETED|Period 1 (6 Months)||2
7808522|NCT01169493|19222438|P5|COMPLETED|Period 1 (6 Months)||0
7808523|NCT01169493|19222439|P4|COMPLETED|Period 1 (6 Months)||0
7808524|NCT01169493|19222440|P3|COMPLETED|Period 1 (6 Months)||3
7808525|NCT01169493|19222441|P2|COMPLETED|Period 1 (6 Months)||3
7808526|NCT01169493|19222442|P1|COMPLETED|Period 1 (6 Months)||2
7808527|NCT01169493|19222437|P6|STARTED|Period 1 (6 Months)||5
7808528|NCT01169493|19222438|P5|STARTED|Period 1 (6 Months)||0
7808529|NCT01169493|19222439|P4|STARTED|Period 1 (6 Months)||0
7808530|NCT01169493|19222440|P3|STARTED|Period 1 (6 Months)||5
7808531|NCT01169493|19222441|P2|STARTED|Period 1 (6 Months)||4
7808532|NCT01169493|19222442|P1|STARTED|Period 1 (6 Months)||2
7808533|NCT01169467|19222473|P2|NOT COMPLETED|Overall Study||4
7808534|NCT01169467|19222474|P1|NOT COMPLETED|Overall Study||7
7808535|NCT01169467|19222473|P2|COMPLETED|Overall Study||36
7808536|NCT01169467|19222474|P1|COMPLETED|Overall Study||37
7808537|NCT01169467|19222473|P2|STARTED|Overall Study||40
7808538|NCT01169467|19222474|P1|STARTED|Overall Study||44
7808539|NCT01169350|19222488|P1|NOT COMPLETED|Overall Study||5
7808540|NCT01169350|19222488|P1|COMPLETED|Overall Study||3
7808541|NCT01169350|19222488|P1|STARTED|Overall Study||8
7808542|NCT01169311|19222495|P1|NOT COMPLETED|Overall Study||0
7808543|NCT01169311|19222495|P1|COMPLETED|Overall Study||27
7808544|NCT01169311|19222495|P1|STARTED|Overall Study||27
7808545|NCT01169259|19222511|P4|NOT COMPLETED|Overall Study||0
7808546|NCT01169259|19222512|P3|NOT COMPLETED|Overall Study||0
7808547|NCT01169259|19222513|P2|NOT COMPLETED|Overall Study||0
7808548|NCT01169259|19222514|P1|NOT COMPLETED|Overall Study||0
7808549|NCT01169259|19222511|P4|COMPLETED|Overall Study||6474
7808550|NCT01169259|19222512|P3|COMPLETED|Overall Study||6470
7808551|NCT01169259|19222513|P2|COMPLETED|Overall Study||6464
7808552|NCT01169259|19222514|P1|COMPLETED|Overall Study||6463
7808553|NCT01169259|19222511|P4|STARTED|Overall Study||6474
7808554|NCT01169259|19222512|P3|STARTED|Overall Study||6470
7808555|NCT01169259|19222513|P2|STARTED|Overall Study||6464
7808556|NCT01169259|19222514|P1|STARTED|Overall Study||6463
7808557|NCT01169103|19222626|P2|NOT COMPLETED|Overall Study||4
7808558|NCT01169103|19222627|P1|NOT COMPLETED|Overall Study||6
7808559|NCT01169103|19222626|P2|COMPLETED|Overall Study||7
7808560|NCT01169103|19222627|P1|COMPLETED|Overall Study||5
7808561|NCT01169103|19222626|P2|STARTED|Overall Study||11
7808562|NCT01169103|19222627|P1|STARTED|Overall Study||11
7808563|NCT01169064|19222643|P2|NOT COMPLETED|Overall Study||0
7808564|NCT01169064|19222644|P1|NOT COMPLETED|Overall Study||0
7808565|NCT01169064|19222643|P2|COMPLETED|Overall Study||236
7808566|NCT01169064|19222644|P1|COMPLETED|Overall Study||239
7808567|NCT01169064|19222643|P2|STARTED|Overall Study||236
7808568|NCT01169064|19222644|P1|STARTED|Overall Study||239
7808569|NCT01169038|19222654|P1|NOT COMPLETED|Overall Study||7
7808570|NCT01169038|19222654|P1|COMPLETED|Overall Study||8
7808571|NCT01169038|19222654|P1|STARTED|Overall Study||15
7808572|NCT01168999|19222662|P4|NOT COMPLETED|Overall Study||0
7808573|NCT01168999|19222663|P3|NOT COMPLETED|Overall Study||0
7808574|NCT01168999|19222664|P2|NOT COMPLETED|Overall Study||1
7808575|NCT01168999|19222665|P1|NOT COMPLETED|Overall Study||2
7808576|NCT01168999|19222662|P4|COMPLETED|Overall Study||28
7808577|NCT01168999|19222663|P3|COMPLETED|Overall Study||27
7808578|NCT01168999|19222664|P2|COMPLETED|Overall Study||26
7808579|NCT01168999|19222665|P1|COMPLETED|Overall Study||26
7808580|NCT01168999|19222662|P4|STARTED|Overall Study||28
7808581|NCT01168999|19222663|P3|STARTED|Overall Study||27
7808582|NCT01168999|19222664|P2|STARTED|Overall Study||27
7808583|NCT01168999|19222665|P1|STARTED|Overall Study||28
7808584|NCT01168986|19222710|P3|NOT COMPLETED|Overall Study||0
7808585|NCT01168986|19222711|P2|NOT COMPLETED|Overall Study||1
7808586|NCT01168986|19222712|P1|NOT COMPLETED|Overall Study||2
7808587|NCT01168986|19222710|P3|COMPLETED|Overall Study||21
7808588|NCT01168986|19222711|P2|COMPLETED|Overall Study||20
7808589|NCT01168986|19222712|P1|COMPLETED|Overall Study||18
7808590|NCT01168986|19222710|P3|STARTED|Overall Study||21
7808591|NCT01168986|19222711|P2|STARTED|Overall Study||21
7808592|NCT01168986|19222712|P1|STARTED|Overall Study||20
7808593|NCT01168973|19222731|P2|NOT COMPLETED|Overall Study||611
7808594|NCT01168973|19222732|P1|NOT COMPLETED|Overall Study||613
7808595|NCT01168973|19222731|P2|COMPLETED|Overall Study||14
7808596|NCT01168973|19222732|P1|COMPLETED|Overall Study||15
7808597|NCT01168973|19222731|P2|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621
7808598|NCT01168973|19222732|P1|Received Any Quantity of Any Study Drug|Overall Study||624
7808599|NCT01168973|19222731|P2|STARTED|Overall Study||625
7808600|NCT01168973|19222732|P1|STARTED|Overall Study||628
7808601|NCT01168934|19222753|P2|NOT COMPLETED|Second Intervention Period||0
7808602|NCT01168934|19222754|P1|NOT COMPLETED|Second Intervention Period||0
7808603|NCT01168934|19222753|P2|COMPLETED|Second Intervention Period||7
7808604|NCT01168934|19222754|P1|COMPLETED|Second Intervention Period||7
7808605|NCT01168934|19222753|P2|STARTED|Second Intervention Period||7
7808606|NCT01168934|19222754|P1|STARTED|Second Intervention Period||7
7808607|NCT01168934|19222753|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7808608|NCT01168934|19222754|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7808609|NCT01168934|19222753|P2|COMPLETED|Washout Period (at Least 14 Days)||7
7808610|NCT01168934|19222754|P1|COMPLETED|Washout Period (at Least 14 Days)||7
7808611|NCT01168934|19222753|P2|STARTED|Washout Period (at Least 14 Days)||7
7808612|NCT01168934|19222754|P1|STARTED|Washout Period (at Least 14 Days)||7
7808613|NCT01168934|19222753|P2|NOT COMPLETED|First Intervention Period||0
7808614|NCT01168934|19222754|P1|NOT COMPLETED|First Intervention Period||0
7808615|NCT01168934|19222753|P2|COMPLETED|First Intervention Period||7
7808616|NCT01168934|19222754|P1|COMPLETED|First Intervention Period||7
7808617|NCT01168934|19222753|P2|STARTED|First Intervention Period||7
7808618|NCT01168934|19222754|P1|STARTED|First Intervention Period||7
7808619|NCT01168908|19222788|P2|NOT COMPLETED|Open Label||1
7808620|NCT01168908|19222789|P1|NOT COMPLETED|Open Label||1
7808621|NCT01168908|19222788|P2|COMPLETED|Open Label||7
7808622|NCT01168908|19222789|P1|COMPLETED|Open Label||6
7808623|NCT01168908|19222788|P2|STARTED|Open Label||8
7808624|NCT01168908|19222789|P1|STARTED|Open Label||7
7808625|NCT01168908|19222788|P2|NOT COMPLETED|Double Blind, Placebo Controlled||2
7808626|NCT01168908|19222789|P1|NOT COMPLETED|Double Blind, Placebo Controlled||3
7808627|NCT01168908|19222788|P2|COMPLETED|Double Blind, Placebo Controlled||8
7808628|NCT01168908|19222789|P1|COMPLETED|Double Blind, Placebo Controlled||7
7808629|NCT01168908|19222788|P2|STARTED|Double Blind, Placebo Controlled||10
7808630|NCT01168908|19222789|P1|STARTED|Double Blind, Placebo Controlled||10
7808631|NCT01168856|19222807|P2|NOT COMPLETED|Overall Study||343
7808632|NCT01168856|19222808|P1|NOT COMPLETED|Overall Study||18
7808633|NCT01168856|19222807|P2|COMPLETED|Overall Study||215
7808634|NCT01168856|19222808|P1|COMPLETED|Overall Study||158
7808635|NCT01168856|19222807|P2|STARTED|Overall Study||558
7808636|NCT01168856|19222808|P1|STARTED|Overall Study||176
7808637|NCT01168726|19222868|P3|NOT COMPLETED|Overall Study||5
7808638|NCT01168726|19222869|P2|NOT COMPLETED|Overall Study||9
7808639|NCT01168726|19222870|P1|NOT COMPLETED|Overall Study||8
7808640|NCT01168726|19222868|P3|COMPLETED|Overall Study||128
7808641|NCT01168726|19222869|P2|COMPLETED|Overall Study||112
7808642|NCT01168726|19222870|P1|COMPLETED|Overall Study||103
7808643|NCT01168726|19222868|P3|STARTED|Overall Study||133
7808644|NCT01168726|19222869|P2|STARTED|Overall Study||121
7808645|NCT01168726|19222870|P1|STARTED|Overall Study||111
7808646|NCT01168687|19222889|P2|NOT COMPLETED|Overall Study||0
7808647|NCT01168687|19222890|P1|NOT COMPLETED|Overall Study||0
7808648|NCT01168687|19222889|P2|COMPLETED|Overall Study||23
7808649|NCT01168687|19222890|P1|COMPLETED|Overall Study||23
7808650|NCT01168687|19222889|P2|STARTED|Overall Study||23
7808651|NCT01168687|19222890|P1|STARTED|Overall Study||23
7808652|NCT01168674|19222896|P2|NOT COMPLETED|Overall Study||0
7808653|NCT01168674|19222897|P1|NOT COMPLETED|Overall Study||0
7808654|NCT01168674|19222896|P2|COMPLETED|Overall Study||24
7808655|NCT01168674|19222897|P1|COMPLETED|Overall Study||25
7808656|NCT01168674|19222896|P2|STARTED|Overall Study||24
7808657|NCT01168674|19222897|P1|STARTED|Overall Study||25
7808658|NCT01168596|19222906|P2|NOT COMPLETED|Overall Study||1
7808659|NCT01168596|19222907|P1|NOT COMPLETED|Overall Study||3
7808660|NCT01168596|19222906|P2|COMPLETED|Overall Study||13
7808661|NCT01168596|19222907|P1|COMPLETED|Overall Study||13
7808662|NCT01168596|19222906|P2|STARTED|Overall Study||14
7808663|NCT01168596|19222907|P1|STARTED|Overall Study||16
7808664|NCT01168427|19222951|P1|NOT COMPLETED|Overall Study||1
7808665|NCT01168427|19222951|P1|COMPLETED|Overall Study||65
7808666|NCT01168427|19222951|P1|STARTED|Overall Study||66
7808667|NCT01168401|19222967|P11|NOT COMPLETED|Overall Study||0
7808668|NCT01168401|19222968|P10|NOT COMPLETED|Overall Study||0
7808669|NCT01168401|19222969|P9|NOT COMPLETED|Overall Study||0
7808670|NCT01168401|19222970|P8|NOT COMPLETED|Overall Study||0
7808671|NCT01168401|19222971|P7|NOT COMPLETED|Overall Study||0
7808672|NCT01168401|19222972|P6|NOT COMPLETED|Overall Study||0
7808673|NCT01168401|19222973|P5|NOT COMPLETED|Overall Study||0
7808674|NCT01168401|19222974|P4|NOT COMPLETED|Overall Study||2
7808675|NCT01168401|19222975|P3|NOT COMPLETED|Overall Study||2
7808676|NCT01168401|19222976|P2|NOT COMPLETED|Overall Study||1
7808677|NCT01168401|19222977|P1|NOT COMPLETED|Overall Study||1
7808678|NCT01168401|19222967|P11|COMPLETED|Overall Study||8
7808679|NCT01168401|19222968|P10|COMPLETED|Overall Study||8
7808680|NCT01168401|19222969|P9|COMPLETED|Overall Study||9
7808681|NCT01168401|19222970|P8|COMPLETED|Overall Study||10
7808682|NCT01168401|19222971|P7|COMPLETED|Overall Study||10
7808683|NCT01168401|19222972|P6|COMPLETED|Overall Study||9
7808684|NCT01168401|19222973|P5|COMPLETED|Overall Study||9
7808685|NCT01168401|19222974|P4|COMPLETED|Overall Study||7
7808686|NCT01168401|19222975|P3|COMPLETED|Overall Study||8
7808687|NCT01168401|19222976|P2|COMPLETED|Overall Study||9
7808688|NCT01168401|19222977|P1|COMPLETED|Overall Study||9
7808689|NCT01168401|19222967|P11|STARTED|Overall Study||8
7808690|NCT01168401|19222968|P10|STARTED|Overall Study||8
7808691|NCT01168401|19222969|P9|STARTED|Overall Study||9
7808692|NCT01168401|19222970|P8|STARTED|Overall Study||10
7808693|NCT01168401|19222971|P7|STARTED|Overall Study||10
7808694|NCT01168401|19222972|P6|STARTED|Overall Study||9
7808695|NCT01168401|19222973|P5|STARTED|Overall Study||9
7808696|NCT01168401|19222974|P4|STARTED|Overall Study||9
7808697|NCT01168401|19222975|P3|STARTED|Overall Study||10
7808698|NCT01168401|19222976|P2|STARTED|Overall Study||10
7808699|NCT01168401|19222977|P1|STARTED|Overall Study||10
7808700|NCT01168349|19223210|P1|NOT COMPLETED|Overall Study||301
7808701|NCT01168349|19223210|P1|COMPLETED|Overall Study||754
7808702|NCT01168349|19223210|P1|STARTED|Overall Study||1055
7808703|NCT01168232|19223316|P1|NOT COMPLETED|Overall Study||8
7808704|NCT01168232|19223316|P1|COMPLETED|Overall Study|Eligible and treated patients|34
7808705|NCT01168232|19223316|P1|STARTED|Overall Study||42
7808706|NCT01168219|19223323|P1|NOT COMPLETED|Overall Study||5
7808707|NCT01168219|19223323|P1|COMPLETED|Overall Study||63
7808708|NCT01168219|19223323|P1|STARTED|Overall Study||68
7808709|NCT01168024|19223331|P2|NOT COMPLETED|Overall Study||0
7808710|NCT01168024|19223332|P1|NOT COMPLETED|Overall Study||0
7808711|NCT01168024|19223331|P2|COMPLETED|Overall Study||3
7808712|NCT01168024|19223332|P1|COMPLETED|Overall Study||13
7808713|NCT01168024|19223331|P2|STARTED|Overall Study||3
7808714|NCT01168024|19223332|P1|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13
7808715|NCT01167907|19223346|P2|NOT COMPLETED|Overall Study||1
7808716|NCT01167907|19223347|P1|NOT COMPLETED|Overall Study||2
7808717|NCT01167907|19223346|P2|COMPLETED|Overall Study||14
7808718|NCT01167907|19223347|P1|COMPLETED|Overall Study||15
7808719|NCT01167907|19223346|P2|STARTED|Overall Study||15
7808720|NCT01167907|19223347|P1|STARTED|Overall Study||17
7808721|NCT01167881|19223365|P2|NOT COMPLETED|Overall Study||191
7808722|NCT01167881|19223366|P1|NOT COMPLETED|Overall Study||159
7808723|NCT01167881|19223365|P2|COMPLETED|Overall Study||589
7808724|NCT01167881|19223366|P1|COMPLETED|Overall Study||610
7808725|NCT01167881|19223365|P2|Completed After 4 Years Treatment|Overall Study||462
7808820|NCT01166971|19223615|P2|NOT COMPLETED|Overall Study||1
7808726|NCT01167881|19223366|P1|Completed After 4 Years Treatment|Overall Study||515
7808727|NCT01167881|19223365|P2|Completed After 2 Years Treatment|Overall Study||127
7808728|NCT01167881|19223366|P1|Completed After 2 Years Treatment|Overall Study||95
7808729|NCT01167881|19223365|P2|STARTED|Overall Study||780
7808730|NCT01167881|19223366|P1|STARTED|Overall Study||769
7808731|NCT01167829|19223390|P1|NOT COMPLETED|Overall Study||0
7808732|NCT01167829|19223390|P1|COMPLETED|Overall Study||12
7808733|NCT01167829|19223390|P1|STARTED|Overall Study||12
7808734|NCT01167712|19223405|P2|NOT COMPLETED|Overall Study||0
7808735|NCT01167712|19223406|P1|NOT COMPLETED|Overall Study||0
7808736|NCT01167712|19223405|P2|COMPLETED|Overall Study||346
7808737|NCT01167712|19223406|P1|COMPLETED|Overall Study||346
7808738|NCT01167712|19223405|P2|STARTED|Overall Study||346
7808739|NCT01167712|19223406|P1|STARTED|Overall Study||346
7808740|NCT01167634|19223420|P4|NOT COMPLETED|Overall Study||4
7808741|NCT01167634|19223421|P3|NOT COMPLETED|Overall Study||3
7808742|NCT01167634|19223422|P2|NOT COMPLETED|Overall Study||4
7808743|NCT01167634|19223423|P1|NOT COMPLETED|Overall Study||2
7808744|NCT01167634|19223420|P4|COMPLETED|Overall Study||29
7808745|NCT01167634|19223421|P3|COMPLETED|Overall Study||30
7808746|NCT01167634|19223422|P2|COMPLETED|Overall Study||29
7808747|NCT01167634|19223423|P1|COMPLETED|Overall Study||31
7808748|NCT01167634|19223420|P4|STARTED|Overall Study||33
7808749|NCT01167634|19223421|P3|STARTED|Overall Study||33
7808750|NCT01167634|19223422|P2|STARTED|Overall Study||33
7808751|NCT01167634|19223423|P1|STARTED|Overall Study||33
7808752|NCT01167608|19223433|P1|NOT COMPLETED|Overall Study||114
7808753|NCT01167608|19223433|P1|COMPLETED|Overall Study||769
7808754|NCT01167608|19223433|P1|STARTED|Overall Study||883
7808755|NCT01167582|19223444|P2|NOT COMPLETED|Overall Study||1
7808756|NCT01167582|19223445|P1|NOT COMPLETED|Overall Study||0
7808757|NCT01167582|19223444|P2|COMPLETED|Overall Study||54
7808758|NCT01167582|19223445|P1|COMPLETED|Overall Study||55
7808759|NCT01167582|19223444|P2|STARTED|Overall Study||55
7808760|NCT01167582|19223445|P1|STARTED|Overall Study||55
7808761|NCT01167569|19223477|P2|NOT COMPLETED|Overall Study||2
7808762|NCT01167569|19223478|P1|NOT COMPLETED|Overall Study||1
7808763|NCT01167569|19223477|P2|COMPLETED|Overall Study||27
7808764|NCT01167569|19223478|P1|COMPLETED|Overall Study||27
7808765|NCT01167569|19223477|P2|STARTED|Overall Study||29
7808766|NCT01167569|19223478|P1|STARTED|Overall Study||28
7808767|NCT01167504|19223486|P1|NOT COMPLETED|Overall Study||3
7808768|NCT01167504|19223486|P1|COMPLETED|Overall Study||12
7808769|NCT01167504|19223486|P1|STARTED|Overall Study||15
7808770|NCT01167452|19223491|P1|NOT COMPLETED|Overall Study||0
7808771|NCT01167452|19223491|P1|COMPLETED|Overall Study||36
7808772|NCT01167452|19223491|P1|STARTED|Overall Study||36
7808773|NCT01167426|19223496|P1|NOT COMPLETED|Overall Study||10
7808774|NCT01167426|19223496|P1|COMPLETED|Overall Study||138
7808775|NCT01167426|19223496|P1|STARTED|Overall Study||148
7808776|NCT01167257|19223504|P2|NOT COMPLETED|Overall Study||3
7808777|NCT01167257|19223505|P1|NOT COMPLETED|Overall Study||3
7808778|NCT01167257|19223504|P2|COMPLETED|Overall Study||28
7808779|NCT01167257|19223505|P1|COMPLETED|Overall Study||28
7808780|NCT01167257|19223504|P2|STARTED|Overall Study||31
7808781|NCT01167257|19223505|P1|STARTED|Overall Study||31
7808782|NCT01167192|19223527|P1|NOT COMPLETED|Overall Study||4
7808783|NCT01167192|19223527|P1|COMPLETED|Overall Study||6
7808784|NCT01167192|19223527|P1|STARTED|Overall Study||10
7808785|NCT01167179|19223544|P2|NOT COMPLETED|Overall Study||21
7808786|NCT01167179|19223545|P1|NOT COMPLETED|Overall Study||15
7808787|NCT01167179|19223544|P2|COMPLETED|Overall Study||59
7808788|NCT01167179|19223545|P1|COMPLETED|Overall Study||65
7808789|NCT01167179|19223544|P2|STARTED|Overall Study||80
7808790|NCT01167179|19223545|P1|STARTED|Overall Study||80
7808791|NCT01167153|19223555|P2|NOT COMPLETED|Overall Study||33
7808792|NCT01167153|19223556|P1|NOT COMPLETED|Overall Study||18
7808793|NCT01167153|19223555|P2|COMPLETED|Overall Study||249
7808794|NCT01167153|19223556|P1|COMPLETED|Overall Study||264
7808795|NCT01167153|19223555|P2|Intention to Treat (ITT)|Overall Study||268
7808796|NCT01167153|19223556|P1|Intention to Treat (ITT)|Overall Study||272
7808797|NCT01167153|19223555|P2|STARTED|Overall Study||282
7808798|NCT01167153|19223556|P1|STARTED|Overall Study||282
7808799|NCT01167140|19223574|P1|NOT COMPLETED|Overall Study||1
7808800|NCT01167140|19223574|P1|COMPLETED|Overall Study||41
7808801|NCT01167140|19223574|P1|STARTED|Overall Study||42
7808802|NCT01167023|19223582|P3|NOT COMPLETED|Overall Study||2
7808803|NCT01167023|19223583|P2|NOT COMPLETED|Overall Study||3
7808804|NCT01167023|19223584|P1|NOT COMPLETED|Overall Study||0
7808805|NCT01167023|19223582|P3|COMPLETED|Overall Study||39
7808806|NCT01167023|19223583|P2|COMPLETED|Overall Study||18
7808807|NCT01167023|19223584|P1|COMPLETED|Overall Study||0
7808808|NCT01167023|19223582|P3|Received at Least 1 Dose of Study Drug|Overall Study||41
7808809|NCT01167023|19223583|P2|Received at Least 1 Dose of Study Drug|Overall Study||19
7808810|NCT01167023|19223584|P1|Received at Least 1 Dose of Study Drug|Overall Study||0
7808811|NCT01167023|19223582|P3|STARTED|Overall Study||41
7808812|NCT01167023|19223583|P2|STARTED|Overall Study||21
7808813|NCT01167023|19223584|P1|STARTED|Overall Study||0
7808814|NCT01166997|19223604|P2|NOT COMPLETED|Overall Study||0
7808815|NCT01166997|19223605|P1|NOT COMPLETED|Overall Study||2
7808816|NCT01166997|19223604|P2|COMPLETED|Overall Study||30
7808817|NCT01166997|19223605|P1|COMPLETED|Overall Study||27
7808818|NCT01166997|19223604|P2|STARTED|Overall Study||30
7808819|NCT01166997|19223605|P1|STARTED|Overall Study||29
7808821|NCT01166971|19223616|P1|NOT COMPLETED|Overall Study||1
7808822|NCT01166971|19223615|P2|COMPLETED|Overall Study||30
7808823|NCT01166971|19223616|P1|COMPLETED|Overall Study||32
7808824|NCT01166971|19223615|P2|STARTED|Overall Study||31
7808825|NCT01166971|19223616|P1|STARTED|Overall Study||33
7808826|NCT01166958|19223624|P2|NOT COMPLETED|Overall Study||0
7808827|NCT01166958|19223625|P1|NOT COMPLETED|Overall Study||1
7808828|NCT01166958|19223624|P2|COMPLETED|Overall Study||13
7808829|NCT01166958|19223625|P1|COMPLETED|Overall Study||12
7808830|NCT01166958|19223624|P2|STARTED|Overall Study||13
7808831|NCT01166958|19223625|P1|STARTED|Overall Study||13
7808832|NCT01166945|19223641|P2|NOT COMPLETED|Day 30||3
7808833|NCT01166945|19223642|P1|NOT COMPLETED|Day 30||4
7808834|NCT01166945|19223641|P2|COMPLETED|Day 30||37
7808835|NCT01166945|19223642|P1|COMPLETED|Day 30||38
7808836|NCT01166945|19223641|P2|STARTED|Day 30||40
7808837|NCT01166945|19223642|P1|STARTED|Day 30||42
7808838|NCT01166945|19223641|P2|NOT COMPLETED|Day 20||0
7808839|NCT01166945|19223642|P1|NOT COMPLETED|Day 20||0
7808840|NCT01166945|19223641|P2|COMPLETED|Day 20||40
7808841|NCT01166945|19223642|P1|COMPLETED|Day 20||42
7808842|NCT01166945|19223641|P2|STARTED|Day 20||40
7808843|NCT01166945|19223642|P1|STARTED|Day 20||42
7808844|NCT01166945|19223641|P2|NOT COMPLETED|Day 15||1
7808845|NCT01166945|19223642|P1|NOT COMPLETED|Day 15||2
7808846|NCT01166945|19223641|P2|COMPLETED|Day 15||40
7808847|NCT01166945|19223642|P1|COMPLETED|Day 15||42
7808848|NCT01166945|19223641|P2|STARTED|Day 15||41
7808849|NCT01166945|19223642|P1|STARTED|Day 15||44
7808850|NCT01166945|19223641|P2|NOT COMPLETED|Day 10||2
7808851|NCT01166945|19223642|P1|NOT COMPLETED|Day 10||3
7808852|NCT01166945|19223641|P2|COMPLETED|Day 10||41
7808853|NCT01166945|19223642|P1|COMPLETED|Day 10||44
7808854|NCT01166945|19223641|P2|STARTED|Day 10||43
7808855|NCT01166945|19223642|P1|STARTED|Day 10||47
7808856|NCT01166945|19223641|P2|NOT COMPLETED|Day 5||0
7808857|NCT01166945|19223642|P1|NOT COMPLETED|Day 5||0
7808858|NCT01166945|19223641|P2|COMPLETED|Day 5||43
7808859|NCT01166945|19223642|P1|COMPLETED|Day 5||47
7808860|NCT01166945|19223641|P2|STARTED|Day 5||43
7808861|NCT01166945|19223642|P1|STARTED|Day 5||47
7808862|NCT01166945|19223641|P2|NOT COMPLETED|Randomized||4
7808863|NCT01166945|19223642|P1|NOT COMPLETED|Randomized||4
7808864|NCT01166945|19223641|P2|COMPLETED|Randomized||43
7808865|NCT01166945|19223642|P1|COMPLETED|Randomized||47
7808866|NCT01166945|19223641|P2|STARTED|Randomized||47
7808867|NCT01166945|19223642|P1|STARTED|Randomized||51
7808868|NCT01166763|19223650|P1|NOT COMPLETED|Overall Study||3
7808869|NCT01166763|19223650|P1|COMPLETED|Overall Study||27
7808870|NCT01166763|19223650|P1|STARTED|Overall Study||30
7808871|NCT01166750|19223658|P2|NOT COMPLETED|Overall Study||0
7808872|NCT01166750|19223659|P1|NOT COMPLETED|Overall Study||1
7808873|NCT01166750|19223658|P2|COMPLETED|Overall Study||13
7808874|NCT01166750|19223659|P1|COMPLETED|Overall Study||9
7808875|NCT01166750|19223658|P2|STARTED|Overall Study||13
7808876|NCT01166750|19223659|P1|STARTED|Overall Study||10
7808877|NCT01166724|19223667|P2|NOT COMPLETED|Overall Study||5
7808878|NCT01166724|19223668|P1|NOT COMPLETED|Overall Study||7
7808879|NCT01166724|19223667|P2|COMPLETED|Overall Study||0
7808880|NCT01166724|19223668|P1|COMPLETED|Overall Study||0
7808881|NCT01166724|19223667|P2|STARTED|Overall Study||5
7808882|NCT01166724|19223668|P1|STARTED|Overall Study||7
7808883|NCT01166659|19223676|P1|NOT COMPLETED|Overall Study||13
7808884|NCT01166659|19223676|P1|COMPLETED|Overall Study||35
7808885|NCT01166659|19223676|P1|STARTED|Overall Study||48
7808886|NCT01166646|19223685|P2|NOT COMPLETED|Overall Study||1
7808887|NCT01166646|19223686|P1|NOT COMPLETED|Overall Study||1
7808888|NCT01166646|19223685|P2|COMPLETED|Overall Study||21
7808889|NCT01166646|19223686|P1|COMPLETED|Overall Study||20
7808890|NCT01166646|19223685|P2|STARTED|Overall Study||22
7808891|NCT01166646|19223686|P1|STARTED|Overall Study||21
7808892|NCT01166568|19223705|P3|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
7808893|NCT01166568|19223706|P2|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
7808894|NCT01166568|19223707|P1|NOT COMPLETED|Implantation- Nonrandomized & Randomized||14
7808895|NCT01166568|19223705|P3|COMPLETED|Implantation- Nonrandomized & Randomized|(1) Primary eye implanted only subject withdrew consent after implantation of the device.|8
7808896|NCT01166568|19223706|P2|COMPLETED|Implantation- Nonrandomized & Randomized||32
7808897|NCT01166568|19223707|P1|COMPLETED|Implantation- Nonrandomized & Randomized||274
7808898|NCT01166568|19223705|P3|STARTED|Implantation- Nonrandomized & Randomized|15 subjects completed the observation phase and 9 subjects (17 eyes) proceeded with implantation.|9
7808899|NCT01166568|19223706|P2|STARTED|Implantation- Nonrandomized & Randomized||33
7808900|NCT01166568|19223707|P1|STARTED|Implantation- Nonrandomized & Randomized||288
7808901|NCT01166568|19223705|P3|NOT COMPLETED|Deferred Implantation- Randomized||1
7808902|NCT01166568|19223706|P2|NOT COMPLETED|Deferred Implantation- Randomized||0
7808903|NCT01166568|19223707|P1|NOT COMPLETED|Deferred Implantation- Randomized||0
7808904|NCT01166568|19223705|P3|COMPLETED|Deferred Implantation- Randomized|From the randomized sub-study control group (n=16), 1 subject withdrew during the observation phase|15
7808905|NCT01166568|19223706|P2|COMPLETED|Deferred Implantation- Randomized||0
7808906|NCT01166568|19223707|P1|COMPLETED|Deferred Implantation- Randomized||0
7808907|NCT01166568|19223705|P3|STARTED|Deferred Implantation- Randomized||16
7808908|NCT01166568|19223706|P2|STARTED|Deferred Implantation- Randomized||0
7808909|NCT01166568|19223707|P1|STARTED|Deferred Implantation- Randomized||0
7808910|NCT01166438|19223720|P2|NOT COMPLETED|Off Treatment Follow-up Phase||56
7808911|NCT01166438|19223721|P1|NOT COMPLETED|Off Treatment Follow-up Phase||34
7808912|NCT01166438|19223720|P2|COMPLETED|Off Treatment Follow-up Phase||33
7808913|NCT01166438|19223721|P1|COMPLETED|Off Treatment Follow-up Phase||51
7808914|NCT01166438|19223720|P2|STARTED|Off Treatment Follow-up Phase||89
7808915|NCT01166438|19223721|P1|STARTED|Off Treatment Follow-up Phase||85
7808916|NCT01166438|19223720|P2|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
7808917|NCT01166438|19223721|P1|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
7808918|NCT01166438|19223720|P2|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|118
7808919|NCT01166438|19223721|P1|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|113
7808920|NCT01166438|19223720|P2|Treated|Double-blind Phase: 1st 6 Months||126
7808921|NCT01166438|19223721|P1|Treated|Double-blind Phase: 1st 6 Months||121
7808922|NCT01166438|19223720|P2|STARTED|Double-blind Phase: 1st 6 Months||127
7808923|NCT01166438|19223721|P1|STARTED|Double-blind Phase: 1st 6 Months||122
7808924|NCT01166373|19223739|P4|NOT COMPLETED|Overall Study||5
7808925|NCT01166373|19223740|P3|NOT COMPLETED|Overall Study||4
7808926|NCT01166373|19223741|P2|NOT COMPLETED|Overall Study||4
7808927|NCT01166373|19223742|P1|NOT COMPLETED|Overall Study||5
7808928|NCT01166373|19223739|P4|COMPLETED|Overall Study||92
7808929|NCT01166373|19223740|P3|COMPLETED|Overall Study||87
7808930|NCT01166373|19223741|P2|COMPLETED|Overall Study||87
7808931|NCT01166373|19223742|P1|COMPLETED|Overall Study||90
7808932|NCT01166373|19223739|P4|Completed E-OPTIMAL Year 5 Visit|Overall Study||64
7808933|NCT01166373|19223740|P3|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
7808934|NCT01166373|19223741|P2|Completed E-OPTIMAL Year 5 Visit|Overall Study||56
7808935|NCT01166373|19223742|P1|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
7808936|NCT01166373|19223739|P4|Completed E-OPTIMAL Year 4 Visit|Overall Study||68
7808937|NCT01166373|19223740|P3|Completed E-OPTIMAL Year 4 Visit|Overall Study||63
7808938|NCT01166373|19223741|P2|Completed E-OPTIMAL Year 4 Visit|Overall Study||61
7808939|NCT01166373|19223742|P1|Completed E-OPTIMAL Year 4 Visit|Overall Study||67
7808940|NCT01166373|19223739|P4|Completed E-OPTIMAL Year 3 Visit|Overall Study||77
7808941|NCT01166373|19223740|P3|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
7808942|NCT01166373|19223741|P2|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
7808943|NCT01166373|19223742|P1|Completed E-OPTIMAL Year 3 Visit|Overall Study||70
7808944|NCT01166373|19223739|P4|Consented to Participate E-OPTIMAL|Overall Study||78
7808945|NCT01166373|19223740|P3|Consented to Participate E-OPTIMAL|Overall Study||69
7808946|NCT01166373|19223741|P2|Consented to Participate E-OPTIMAL|Overall Study||66
7808947|NCT01166373|19223742|P1|Consented to Participate E-OPTIMAL|Overall Study||72
7808948|NCT01166373|19223739|P4|Randomized to No Video|Overall Study||42
7808949|NCT01166373|19223740|P3|Randomized to No Video|Overall Study||34
7808950|NCT01166373|19223741|P2|Randomized to No Video|Overall Study||30
7808951|NCT01166373|19223742|P1|Randomized to No Video|Overall Study||45
7808952|NCT01166373|19223739|P4|Randomized to Video|Overall Study||40
7808953|NCT01166373|19223740|P3|Randomized to Video|Overall Study||38
7808954|NCT01166373|19223741|P2|Randomized to Video|Overall Study||43
7808955|NCT01166373|19223742|P1|Randomized to Video|Overall Study||32
7808956|NCT01166373|19223739|P4|Completed OPTIMAL Year 2 Visit|Overall Study||87
7808957|NCT01166373|19223740|P3|Completed OPTIMAL Year 2 Visit|Overall Study||79
7808958|NCT01166373|19223741|P2|Completed OPTIMAL Year 2 Visit|Overall Study||80
7808959|NCT01166373|19223742|P1|Completed OPTIMAL Year 2 Visit|Overall Study||81
7808960|NCT01166373|19223739|P4|STARTED|Overall Study||97
7808961|NCT01166373|19223740|P3|STARTED|Overall Study||91
7808962|NCT01166373|19223741|P2|STARTED|Overall Study||91
7808963|NCT01166373|19223742|P1|STARTED|Overall Study||95
7808964|NCT01166347|19223842|P2|NOT COMPLETED|Overall Study||1
7808965|NCT01166347|19223843|P1|NOT COMPLETED|Overall Study||2
7808966|NCT01166347|19223842|P2|COMPLETED|Overall Study||148
7808967|NCT01166347|19223843|P1|COMPLETED|Overall Study||295
7808968|NCT01166347|19223842|P2|STARTED|Overall Study||149
7808969|NCT01166347|19223843|P1|STARTED|Overall Study||297
7808970|NCT01166282|19223875|P3|NOT COMPLETED|Open-label Period||17
7808971|NCT01166282|19223876|P2|NOT COMPLETED|Open-label Period||0
7808972|NCT01166282|19223877|P1|NOT COMPLETED|Open-label Period||0
7808973|NCT01166282|19223875|P3|COMPLETED|Open-label Period||29
7808974|NCT01166282|19223876|P2|COMPLETED|Open-label Period||0
7808975|NCT01166282|19223877|P1|COMPLETED|Open-label Period||0
7808976|NCT01166282|19223875|P3|STARTED|Open-label Period||46
7808977|NCT01166282|19223876|P2|STARTED|Open-label Period||0
7808978|NCT01166282|19223877|P1|STARTED|Open-label Period||0
7808979|NCT01166282|19223875|P3|NOT COMPLETED|Double-blind Period||0
7808980|NCT01166282|19223876|P2|NOT COMPLETED|Double-blind Period||0
7808981|NCT01166282|19223877|P1|NOT COMPLETED|Double-blind Period||0
7808982|NCT01166282|19223875|P3|COMPLETED|Double-blind Period||0
7808983|NCT01166282|19223876|P2|COMPLETED|Double-blind Period||31
7808984|NCT01166282|19223877|P1|COMPLETED|Double-blind Period||15
7808985|NCT01166282|19223875|P3|STARTED|Double-blind Period||0
7808986|NCT01166282|19223876|P2|STARTED|Double-blind Period||31
7808987|NCT01166282|19223877|P1|STARTED|Double-blind Period||15
7808988|NCT01166230|19223901|P2|NOT COMPLETED|Overall Study||16
7808989|NCT01166230|19223902|P1|NOT COMPLETED|Overall Study||19
7808990|NCT01166230|19223901|P2|COMPLETED|Overall Study||255
7808991|NCT01166230|19223902|P1|COMPLETED|Overall Study||261
7808992|NCT01166230|19223901|P2|STARTED|Overall Study||271
7808993|NCT01166230|19223902|P1|STARTED|Overall Study||280
7808994|NCT01166178|19223916|P2|NOT COMPLETED|Overall Study||8
7808995|NCT01166178|19223917|P1|NOT COMPLETED|Overall Study||21
7808996|NCT01166178|19223916|P2|COMPLETED|Overall Study||0
7808997|NCT01166178|19223917|P1|COMPLETED|Overall Study||0
7808998|NCT01166178|19223916|P2|STARTED|Overall Study||8
7808999|NCT01166178|19223917|P1|STARTED|Overall Study||21
7809000|NCT01166139|19223943|P1|NOT COMPLETED|Overall Study||3
7809001|NCT01166139|19223943|P1|COMPLETED|Overall Study||7
7809002|NCT01166139|19223943|P1|STARTED|Overall Study||10
7809003|NCT01166126|19223949|P1|NOT COMPLETED|Overall Study||0
7809004|NCT01166126|19223949|P1|COMPLETED|Overall Study||4
7809005|NCT01166126|19223949|P1|STARTED|Overall Study||4
7809006|NCT01165996|19223956|P1|NOT COMPLETED|Overall Study||2
7809007|NCT01165996|19223956|P1|COMPLETED|Overall Study||23
7809008|NCT01165996|19223956|P1|Maintenance Phase|Overall Study||23
7809009|NCT01165996|19223956|P1|Induction Phase|Overall Study||25
7809010|NCT01165996|19223956|P1|STARTED|Overall Study||25
7809011|NCT01165983|19223968|P2|NOT COMPLETED|Overall Study||7
7809012|NCT01165983|19223969|P1|NOT COMPLETED|Overall Study||5
7809013|NCT01165983|19223968|P2|COMPLETED|Overall Study||42
7809014|NCT01165983|19223969|P1|COMPLETED|Overall Study||46
7809015|NCT01165983|19223968|P2|STARTED|Overall Study||49
7809016|NCT01165983|19223969|P1|STARTED|Overall Study||51
7809017|NCT01165840|19224013|P1|NOT COMPLETED|Overall Study||0
7809018|NCT01165840|19224013|P1|COMPLETED|Overall Study||36
7809019|NCT01165840|19224013|P1|STARTED|Overall Study||36
7809020|NCT01165775|19224017|P1|NOT COMPLETED|Overall Study||2
7809021|NCT01165775|19224017|P1|COMPLETED|Overall Study||15
7809022|NCT01165775|19224017|P1|STARTED|Overall Study||17
7809023|NCT01165684|19224027|P2|NOT COMPLETED|Overall Study||52
7809024|NCT01165684|19224028|P1|NOT COMPLETED|Overall Study||28
7809025|NCT01165684|19224027|P2|COMPLETED|Overall Study||148
7809026|NCT01165684|19224028|P1|COMPLETED|Overall Study||173
7809027|NCT01165684|19224027|P2|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199
7809028|NCT01165684|19224028|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198
7809029|NCT01165684|19224027|P2|STARTED|Overall Study||200
7809030|NCT01165684|19224028|P1|STARTED|Overall Study||201
7809031|NCT01165554|19224062|P1|NOT COMPLETED|Overall Study||23
7809032|NCT01165554|19224062|P1|COMPLETED|Overall Study||180
7809033|NCT01165554|19224062|P1|STARTED|Overall Study|This was the number of subjects that started the study.|203
7809034|NCT01165541|19224069|P1|NOT COMPLETED|Quetiapine XR and Mirtazepine||5
7809035|NCT01165541|19224069|P1|COMPLETED|Quetiapine XR and Mirtazepine||11
7809036|NCT01165541|19224069|P1|STARTED|Quetiapine XR and Mirtazepine||16
7809037|NCT01165541|19224069|P1|NOT COMPLETED|Quetiapine XR Monotherapy||4
7809038|NCT01165541|19224069|P1|COMPLETED|Quetiapine XR Monotherapy||16
7809039|NCT01165541|19224069|P1|STARTED|Quetiapine XR Monotherapy||20
7809040|NCT01165450|19224075|P1|NOT COMPLETED|Overall Study||0
7809041|NCT01165450|19224075|P1|COMPLETED|Overall Study||2
7809042|NCT01165450|19224075|P1|STARTED|Overall Study||2
7809043|NCT01165424|19224085|P1|NOT COMPLETED|Overall Study||4
7809044|NCT01165424|19224085|P1|COMPLETED|Overall Study||76
7809045|NCT01165424|19224085|P1|STARTED|Overall Study||80
7809046|NCT01165320|19224092|P3|NOT COMPLETED|Overall Study||0
7809047|NCT01165320|19224093|P2|NOT COMPLETED|Overall Study||4
7809048|NCT01165320|19224094|P1|NOT COMPLETED|Overall Study||3
7809049|NCT01165320|19224092|P3|COMPLETED|Overall Study||0
7809050|NCT01165320|19224093|P2|COMPLETED|Overall Study||4
7809051|NCT01165320|19224094|P1|COMPLETED|Overall Study||9
7809052|NCT01165320|19224092|P3|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0
7809053|NCT01165320|19224093|P2|STARTED|Overall Study||8
7809054|NCT01165320|19224094|P1|STARTED|Overall Study||12
7809055|NCT01165307|19224104|P2|NOT COMPLETED|Overall Study||3
7809056|NCT01165307|19224105|P1|NOT COMPLETED|Overall Study||14
7809057|NCT01165307|19224104|P2|COMPLETED|Overall Study||31
7809058|NCT01165307|19224105|P1|COMPLETED|Overall Study||19
7809059|NCT01165307|19224104|P2|STARTED|Overall Study||34
7809060|NCT01165307|19224105|P1|STARTED|Overall Study||33
7809061|NCT01165281|19224135|P2|NOT COMPLETED|Overall Study||51
7809062|NCT01165281|19224136|P1|NOT COMPLETED|Overall Study||58
7809063|NCT01165281|19224135|P2|COMPLETED|Overall Study||121
7809064|NCT01165281|19224136|P1|COMPLETED|Overall Study||110
7809065|NCT01165281|19224135|P2|STARTED|Overall Study||172
7809066|NCT01165281|19224136|P1|STARTED|Overall Study||168
7809067|NCT01165242|19224157|P3|NOT COMPLETED|Overall Study||14
7809068|NCT01165242|19224158|P2|NOT COMPLETED|Overall Study||10
7809069|NCT01165242|19224159|P1|NOT COMPLETED|Overall Study||10
7809070|NCT01165242|19224157|P3|COMPLETED|Overall Study||324
7809071|NCT01165242|19224158|P2|COMPLETED|Overall Study||326
7809072|NCT01165242|19224159|P1|COMPLETED|Overall Study||327
7809073|NCT01165242|19224157|P3|STARTED|Overall Study||338
7809074|NCT01165242|19224158|P2|STARTED|Overall Study||336
7809075|NCT01165242|19224159|P1|STARTED|Overall Study||337
7809076|NCT01165229|19224193|P2|NOT COMPLETED|Overall Study||1190
7809077|NCT01165229|19224194|P1|NOT COMPLETED|Overall Study||1180
7809078|NCT01165229|19224193|P2|COMPLETED|Overall Study||5760
7809079|NCT01165229|19224194|P1|COMPLETED|Overall Study||5770
7809080|NCT01165229|19224193|P2|STARTED|Overall Study||6950
7809081|NCT01165229|19224194|P1|STARTED|Overall Study||6950
7809082|NCT01165216|19224328|P2|NOT COMPLETED|Overall Study||7
7809083|NCT01165216|19224329|P1|NOT COMPLETED|Overall Study||8
7809084|NCT01165216|19224328|P2|COMPLETED|Overall Study|Completed=still on study drug|0
7809085|NCT01165216|19224329|P1|COMPLETED|Overall Study|Completed=still on study drug|0
7809086|NCT01165216|19224328|P2|Received at Least 1 Dose of Ipilimumab|Overall Study||6
7809179|NCT01164501|19224809|P1|COMPLETED|Overall Study||278
7809087|NCT01165216|19224329|P1|Received at Least 1 Dose of Ipilimumab|Overall Study||6
7809088|NCT01165216|19224328|P2|STARTED|Overall Study|Participants who received any study drug|7
7809089|NCT01165216|19224329|P1|STARTED|Overall Study|Participants who received any study drug|8
7809090|NCT01165203|19224351|P2|NOT COMPLETED|Extended Safety Follow-up Phase||4
7809091|NCT01165203|19224352|P1|NOT COMPLETED|Extended Safety Follow-up Phase||7
7809092|NCT01165203|19224351|P2|COMPLETED|Extended Safety Follow-up Phase||45
7809093|NCT01165203|19224352|P1|COMPLETED|Extended Safety Follow-up Phase||67
7809094|NCT01165203|19224351|P2|STARTED|Extended Safety Follow-up Phase||49
7809095|NCT01165203|19224352|P1|STARTED|Extended Safety Follow-up Phase||74
7809096|NCT01165203|19224351|P2|NOT COMPLETED|Active Phase||2
7809097|NCT01165203|19224352|P1|NOT COMPLETED|Active Phase||5
7809098|NCT01165203|19224351|P2|COMPLETED|Active Phase||47
7809099|NCT01165203|19224352|P1|COMPLETED|Active Phase||69
7809100|NCT01165203|19224351|P2|STARTED|Active Phase||49
7809101|NCT01165203|19224352|P1|STARTED|Active Phase||74
7809102|NCT01165177|19224442|P2|NOT COMPLETED|Overall Study||902
7809103|NCT01165177|19224443|P1|NOT COMPLETED|Overall Study||922
7809104|NCT01165177|19224442|P2|COMPLETED|Overall Study||6808
7809105|NCT01165177|19224443|P1|COMPLETED|Overall Study||6773
7809106|NCT01165177|19224442|P2|STARTED|Overall Study||7710
7809107|NCT01165177|19224443|P1|STARTED|Overall Study||7695
7809108|NCT01165138|19224572|P4|NOT COMPLETED|Overall Study||22
7809109|NCT01165138|19224573|P3|NOT COMPLETED|Overall Study||20
7809110|NCT01165138|19224574|P2|NOT COMPLETED|Overall Study||52
7809111|NCT01165138|19224575|P1|NOT COMPLETED|Overall Study||0
7809112|NCT01165138|19224572|P4|COMPLETED|Overall Study||179
7809113|NCT01165138|19224573|P3|COMPLETED|Overall Study||185
7809114|NCT01165138|19224574|P2|COMPLETED|Overall Study||151
7809115|NCT01165138|19224575|P1|COMPLETED|Overall Study||0
7809116|NCT01165138|19224572|P4|STARTED|Overall Study||201
7809117|NCT01165138|19224573|P3|STARTED|Overall Study||205
7809118|NCT01165138|19224574|P2|STARTED|Overall Study||203
7809119|NCT01165138|19224575|P1|STARTED|Overall Study||0
7809120|NCT01165112|19224634|P1|NOT COMPLETED|Overall Study||0
7809121|NCT01165112|19224634|P1|COMPLETED|Overall Study||48
7809122|NCT01165112|19224634|P1|STARTED|Overall Study||48
7809123|NCT01165047|19224641|P1|NOT COMPLETED|Overall Study||0
7809124|NCT01165047|19224641|P1|COMPLETED|Overall Study||10
7809125|NCT01165047|19224641|P1|STARTED|Overall Study||10
7809126|NCT01165021|19224645|P1|NOT COMPLETED|Overall Study||1
7809127|NCT01165021|19224645|P1|COMPLETED|Overall Study||18
7809128|NCT01165021|19224645|P1|3 Cycles of Chemo, Then Surgery|Overall Study||15
7809129|NCT01165021|19224645|P1|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17
7809130|NCT01165021|19224645|P1|≥1 Dose Chemo|Overall Study||19
7809131|NCT01165021|19224645|P1|STARTED|Overall Study||19
7809132|NCT01164956|19224653|P3|NOT COMPLETED|Overall Study||1
7809133|NCT01164956|19224654|P2|NOT COMPLETED|Overall Study||0
7809134|NCT01164956|19224655|P1|NOT COMPLETED|Overall Study||1
7809135|NCT01164956|19224653|P3|COMPLETED|Overall Study||0
7809136|NCT01164956|19224654|P2|COMPLETED|Overall Study||1
7809137|NCT01164956|19224655|P1|COMPLETED|Overall Study||0
7809138|NCT01164956|19224653|P3|Evaluable for pedsFACIT-F Score Change|Overall Study||0
7809139|NCT01164956|19224654|P2|Evaluable for pedsFACIT-F Score Change|Overall Study||1
7809140|NCT01164956|19224655|P1|Evaluable for pedsFACIT-F Score Change|Overall Study||0
7809141|NCT01164956|19224653|P3|STARTED|Overall Study||1
7809142|NCT01164956|19224654|P2|STARTED|Overall Study||1
7809143|NCT01164956|19224655|P1|STARTED|Overall Study||1
7809144|NCT01164891|19224663|P1|NOT COMPLETED|Overall Study||6
7809145|NCT01164891|19224663|P1|COMPLETED|Overall Study||1
7809146|NCT01164891|19224663|P1|STARTED|Overall Study||7
7809147|NCT01164865|19224683|P2|NOT COMPLETED|Overall Study||1
7809148|NCT01164865|19224684|P1|NOT COMPLETED|Overall Study||2
7809149|NCT01164865|19224683|P2|COMPLETED|Overall Study||38
7809150|NCT01164865|19224684|P1|COMPLETED|Overall Study||37
7809151|NCT01164865|19224683|P2|STARTED|Overall Study||39
7809152|NCT01164865|19224684|P1|STARTED|Overall Study||39
7809153|NCT01164722|19224694|P2|NOT COMPLETED|Overall Study||15
7809154|NCT01164722|19224695|P1|NOT COMPLETED|Overall Study||18
7809155|NCT01164722|19224694|P2|COMPLETED|Overall Study||45
7809156|NCT01164722|19224695|P1|COMPLETED|Overall Study||42
7809157|NCT01164722|19224694|P2|STARTED|Overall Study||60
7809158|NCT01164722|19224695|P1|STARTED|Overall Study||60
7809159|NCT01164644|19224711|P2|NOT COMPLETED|Overall Study||1
7809160|NCT01164644|19224712|P1|NOT COMPLETED|Overall Study||3
7809161|NCT01164644|19224711|P2|COMPLETED|Overall Study||13
7809162|NCT01164644|19224712|P1|COMPLETED|Overall Study||9
7809163|NCT01164644|19224711|P2|STARTED|Overall Study||14
7809164|NCT01164644|19224712|P1|STARTED|Overall Study||12
7809165|NCT01164579|19224725|P3|NOT COMPLETED|Overall Study||16
7809166|NCT01164579|19224726|P2|NOT COMPLETED|Overall Study||9
7809167|NCT01164579|19224727|P1|NOT COMPLETED|Overall Study||8
7809168|NCT01164579|19224725|P3|COMPLETED|Overall Study||21
7809169|NCT01164579|19224726|P2|COMPLETED|Overall Study||27
7809170|NCT01164579|19224727|P1|COMPLETED|Overall Study||28
7809171|NCT01164579|19224725|P3|STARTED|Overall Study||37
7809172|NCT01164579|19224726|P2|STARTED|Overall Study||36
7809173|NCT01164579|19224727|P1|STARTED|Overall Study||36
7809174|NCT01164501|19224807|P3|NOT COMPLETED|Overall Study||42
7809175|NCT01164501|19224808|P2|NOT COMPLETED|Overall Study||10
7809176|NCT01164501|19224809|P1|NOT COMPLETED|Overall Study||43
7809177|NCT01164501|19224807|P3|COMPLETED|Overall Study||280
7809178|NCT01164501|19224808|P2|COMPLETED|Overall Study||88
7809180|NCT01164501|19224807|P3|STARTED|Overall Study||322
7809181|NCT01164501|19224808|P2|STARTED|Overall Study||98
7809182|NCT01164501|19224809|P1|STARTED|Overall Study||321
7809183|NCT01164475|19224826|P2|NOT COMPLETED|Overall Study||2
7809184|NCT01164475|19224827|P1|NOT COMPLETED|Overall Study||2
7809185|NCT01164475|19224826|P2|COMPLETED|Overall Study||29
7809186|NCT01164475|19224827|P1|COMPLETED|Overall Study||28
7809187|NCT01164475|19224826|P2|STARTED|Overall Study||31
7809188|NCT01164475|19224827|P1|STARTED|Overall Study||30
7809189|NCT01164137|19224853|P2|NOT COMPLETED|Overall Study||0
7809190|NCT01164137|19224854|P1|NOT COMPLETED|Overall Study||3
7809191|NCT01164137|19224853|P2|COMPLETED|Overall Study||76
7809192|NCT01164137|19224854|P1|COMPLETED|Overall Study||77
7809193|NCT01164137|19224853|P2|STARTED|Overall Study||76
7809194|NCT01164137|19224854|P1|STARTED|Overall Study||80
7809195|NCT01164098|19224870|P2|NOT COMPLETED|Overall Study||0
7809196|NCT01164098|19224871|P1|NOT COMPLETED|Overall Study||0
7809197|NCT01164098|19224870|P2|COMPLETED|Overall Study||15
7809198|NCT01164098|19224871|P1|COMPLETED|Overall Study||15
7809199|NCT01164098|19224870|P2|STARTED|Overall Study||15
7809200|NCT01164098|19224871|P1|STARTED|Overall Study||15
7809201|NCT01164007|19224881|P1|NOT COMPLETED|Overall Study||40
7809202|NCT01164007|19224881|P1|COMPLETED|Overall Study||0
7809203|NCT01164007|19224881|P1|Treated|Overall Study||37
7809204|NCT01164007|19224881|P1|STARTED|Overall Study||40
7809205|NCT01163955|19224897|P2|NOT COMPLETED|Overall Study||4
7809206|NCT01163955|19224898|P1|NOT COMPLETED|Overall Study||0
7809207|NCT01163955|19224897|P2|COMPLETED|Overall Study||26
7809208|NCT01163955|19224898|P1|COMPLETED|Overall Study||26
7809209|NCT01163955|19224897|P2|STARTED|Overall Study||30
7809210|NCT01163955|19224898|P1|STARTED|Overall Study||26
7809211|NCT01163916|19224907|P3|NOT COMPLETED|Overall Study||20
7809212|NCT01163916|19224908|P2|NOT COMPLETED|Overall Study||4
7809213|NCT01163916|19224909|P1|NOT COMPLETED|Overall Study||30
7809214|NCT01163916|19224907|P3|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71
7809215|NCT01163916|19224908|P2|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31
7809216|NCT01163916|19224909|P1|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96
7809217|NCT01163916|19224907|P3|Safety Population|Overall Study||91
7809218|NCT01163916|19224908|P2|Safety Population|Overall Study||35
7809219|NCT01163916|19224909|P1|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125
7809220|NCT01163916|19224907|P3|STARTED|Overall Study||91
7809221|NCT01163916|19224908|P2|STARTED|Overall Study||35
7809222|NCT01163916|19224909|P1|STARTED|Overall Study||126
7809223|NCT01163851|19224947|P2|NOT COMPLETED|Overall Study||1
7809224|NCT01163851|19224948|P1|NOT COMPLETED|Overall Study||1
7809225|NCT01163851|19224947|P2|COMPLETED|Overall Study||11
7809226|NCT01163851|19224948|P1|COMPLETED|Overall Study||12
7809227|NCT01163851|19224947|P2|Treated|Overall Study||12
7809228|NCT01163851|19224948|P1|Treated|Overall Study||12
7809229|NCT01163851|19224947|P2|STARTED|Overall Study||12
7809230|NCT01163851|19224948|P1|STARTED|Overall Study||13
7809231|NCT01163786|19225026|P1|NOT COMPLETED|Completed Follow up (Visit 9 and 10)||1
7809232|NCT01163786|19225026|P1|COMPLETED|Completed Follow up (Visit 9 and 10)||13
7809233|NCT01163786|19225026|P1|Completed Week 18 Follow up (Visit 10)|Completed Follow up (Visit 9 and 10)||13
7809234|NCT01163786|19225026|P1|Completed Week 12 Follow up (Visit 9)|Completed Follow up (Visit 9 and 10)||14
7809235|NCT01163786|19225026|P1|STARTED|Completed Follow up (Visit 9 and 10)||14
7809236|NCT01163786|19225026|P1|NOT COMPLETED|Treatment With Bortezomib||3
7809237|NCT01163786|19225026|P1|COMPLETED|Treatment With Bortezomib||14
7809238|NCT01163786|19225026|P1|Completed 2nd Cycle|Treatment With Bortezomib|One patient completed cycle 2 but missed one dose of Bortezomib.|14
7809239|NCT01163786|19225026|P1|Completed 1st Cycle|Treatment With Bortezomib||17
7809240|NCT01163786|19225026|P1|STARTED|Treatment With Bortezomib||17
7809241|NCT01163760|19225032|P4|NOT COMPLETED|Period 4 (Follow-up)||0
7809242|NCT01163760|19225033|P3|NOT COMPLETED|Period 4 (Follow-up)||0
7809243|NCT01163760|19225034|P2|NOT COMPLETED|Period 4 (Follow-up)||0
7809244|NCT01163760|19225035|P1|NOT COMPLETED|Period 4 (Follow-up)||0
7809245|NCT01163760|19225032|P4|COMPLETED|Period 4 (Follow-up)||12
7809246|NCT01163760|19225033|P3|COMPLETED|Period 4 (Follow-up)||13
7809247|NCT01163760|19225034|P2|COMPLETED|Period 4 (Follow-up)||13
7809248|NCT01163760|19225035|P1|COMPLETED|Period 4 (Follow-up)||12
7809249|NCT01163760|19225032|P4|STARTED|Period 4 (Follow-up)||12
7809250|NCT01163760|19225033|P3|STARTED|Period 4 (Follow-up)||13
7809251|NCT01163760|19225034|P2|STARTED|Period 4 (Follow-up)||13
7809252|NCT01163760|19225035|P1|STARTED|Period 4 (Follow-up)||12
7809253|NCT01163760|19225032|P4|NOT COMPLETED|Period 3 (Fit)||0
7809254|NCT01163760|19225033|P3|NOT COMPLETED|Period 3 (Fit)||0
7809255|NCT01163760|19225034|P2|NOT COMPLETED|Period 3 (Fit)||0
7809256|NCT01163760|19225035|P1|NOT COMPLETED|Period 3 (Fit)||0
7809257|NCT01163760|19225032|P4|COMPLETED|Period 3 (Fit)||12
7809258|NCT01163760|19225033|P3|COMPLETED|Period 3 (Fit)||13
7809259|NCT01163760|19225034|P2|COMPLETED|Period 3 (Fit)||13
7809260|NCT01163760|19225035|P1|COMPLETED|Period 3 (Fit)||12
7809261|NCT01163760|19225032|P4|STARTED|Period 3 (Fit)||12
7809262|NCT01163760|19225033|P3|STARTED|Period 3 (Fit)||13
7809263|NCT01163760|19225034|P2|STARTED|Period 3 (Fit)||13
7809264|NCT01163760|19225035|P1|STARTED|Period 3 (Fit)||12
7809265|NCT01163760|19225032|P4|NOT COMPLETED|Period 2 (Follow-up)||0
7809266|NCT01163760|19225033|P3|NOT COMPLETED|Period 2 (Follow-up)||0
7809267|NCT01163760|19225034|P2|NOT COMPLETED|Period 2 (Follow-up)||0
7809268|NCT01163760|19225035|P1|NOT COMPLETED|Period 2 (Follow-up)||0
7809269|NCT01163760|19225032|P4|COMPLETED|Period 2 (Follow-up)||12
7809270|NCT01163760|19225033|P3|COMPLETED|Period 2 (Follow-up)||13
7809271|NCT01163760|19225034|P2|COMPLETED|Period 2 (Follow-up)||13
7809272|NCT01163760|19225035|P1|COMPLETED|Period 2 (Follow-up)||12
7809273|NCT01163760|19225032|P4|STARTED|Period 2 (Follow-up)||12
7809274|NCT01163760|19225033|P3|STARTED|Period 2 (Follow-up)||13
7809275|NCT01163760|19225034|P2|STARTED|Period 2 (Follow-up)||13
7809276|NCT01163760|19225035|P1|STARTED|Period 2 (Follow-up)||12
7809277|NCT01163760|19225032|P4|NOT COMPLETED|Period 1 (Fit)||0
7809278|NCT01163760|19225033|P3|NOT COMPLETED|Period 1 (Fit)||0
7809279|NCT01163760|19225034|P2|NOT COMPLETED|Period 1 (Fit)||0
7809280|NCT01163760|19225035|P1|NOT COMPLETED|Period 1 (Fit)||0
7809281|NCT01163760|19225032|P4|COMPLETED|Period 1 (Fit)||12
7809282|NCT01163760|19225033|P3|COMPLETED|Period 1 (Fit)||13
7809283|NCT01163760|19225034|P2|COMPLETED|Period 1 (Fit)||13
7809284|NCT01163760|19225035|P1|COMPLETED|Period 1 (Fit)||12
7809285|NCT01163760|19225032|P4|STARTED|Period 1 (Fit)||12
7809286|NCT01163760|19225033|P3|STARTED|Period 1 (Fit)||13
7809287|NCT01163760|19225034|P2|STARTED|Period 1 (Fit)||13
7809288|NCT01163760|19225035|P1|STARTED|Period 1 (Fit)||12
7809289|NCT01163747|19225049|P2|NOT COMPLETED|Overall Study||11
7809290|NCT01163747|19225050|P1|NOT COMPLETED|Overall Study||6
7809291|NCT01163747|19225049|P2|COMPLETED|Overall Study||49
7809292|NCT01163747|19225050|P1|COMPLETED|Overall Study||25
7809293|NCT01163747|19225049|P2|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54
7809294|NCT01163747|19225050|P1|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27
7809295|NCT01163747|19225049|P2|STARTED|Overall Study||60
7809296|NCT01163747|19225050|P1|STARTED|Overall Study||31
7809297|NCT01163721|19225070|P2|NOT COMPLETED|Overall Study||12
7809298|NCT01163721|19225071|P1|NOT COMPLETED|Overall Study||8
7809299|NCT01163721|19225070|P2|COMPLETED|Overall Study||29
7809300|NCT01163721|19225071|P1|COMPLETED|Overall Study||31
7809301|NCT01163721|19225070|P2|STARTED|Overall Study||41
7809302|NCT01163721|19225071|P1|STARTED|Overall Study||39
7809303|NCT01163656|19225083|P2|NOT COMPLETED|Overall Study||3
7809304|NCT01163656|19225084|P1|NOT COMPLETED|Overall Study||3
7809305|NCT01163656|19225083|P2|COMPLETED|Overall Study||30
7809306|NCT01163656|19225084|P1|COMPLETED|Overall Study||30
7809307|NCT01163656|19225083|P2|STARTED|Overall Study||33
7809308|NCT01163656|19225084|P1|STARTED|Overall Study||33
7809309|NCT01163643|19225096|P6|NOT COMPLETED|Overall Study||7
7809310|NCT01163643|19225097|P5|NOT COMPLETED|Overall Study||8
7809311|NCT01163643|19225098|P4|NOT COMPLETED|Overall Study||5
7809312|NCT01163643|19225099|P3|NOT COMPLETED|Overall Study||2
7809313|NCT01163643|19225100|P2|NOT COMPLETED|Overall Study||2
7809314|NCT01163643|19225101|P1|NOT COMPLETED|Overall Study||6
7809315|NCT01163643|19225096|P6|COMPLETED|Overall Study||66
7809316|NCT01163643|19225097|P5|COMPLETED|Overall Study||61
7809317|NCT01163643|19225098|P4|COMPLETED|Overall Study||69
7809318|NCT01163643|19225099|P3|COMPLETED|Overall Study||33
7809319|NCT01163643|19225100|P2|COMPLETED|Overall Study||35
7809320|NCT01163643|19225101|P1|COMPLETED|Overall Study||62
7809321|NCT01163643|19225096|P6|STARTED|Overall Study||73
7809322|NCT01163643|19225097|P5|STARTED|Overall Study||69
7809323|NCT01163643|19225098|P4|STARTED|Overall Study||74
7809324|NCT01163643|19225099|P3|STARTED|Overall Study||35
7809325|NCT01163643|19225100|P2|STARTED|Overall Study||37
7809326|NCT01163643|19225101|P1|STARTED|Overall Study||68
7809327|NCT01163617|19225121|P8|NOT COMPLETED|Phase B (Injection Time), Week 4||0
7809328|NCT01163617|19225122|P7|NOT COMPLETED|Phase B (Injection Time), Week 4||0
7809329|NCT01163617|19225123|P6|NOT COMPLETED|Phase B (Injection Time), Week 4||0
7809330|NCT01163617|19225124|P5|NOT COMPLETED|Phase B (Injection Time), Week 4||0
7809331|NCT01163617|19225125|P4|NOT COMPLETED|Phase B (Injection Time), Week 4||0
7809332|NCT01163617|19225126|P3|NOT COMPLETED|Phase B (Injection Time), Week 4||0
7809333|NCT01163617|19225127|P2|NOT COMPLETED|Phase B (Injection Time), Week 4||0
7809334|NCT01163617|19225128|P1|NOT COMPLETED|Phase B (Injection Time), Week 4||0
7809335|NCT01163617|19225121|P8|COMPLETED|Phase B (Injection Time), Week 4||20
7809336|NCT01163617|19225122|P7|COMPLETED|Phase B (Injection Time), Week 4||16
7809337|NCT01163617|19225123|P6|COMPLETED|Phase B (Injection Time), Week 4||27
7809338|NCT01163617|19225124|P5|COMPLETED|Phase B (Injection Time), Week 4||18
7809339|NCT01163617|19225125|P4|COMPLETED|Phase B (Injection Time), Week 4||0
7809340|NCT01163617|19225126|P3|COMPLETED|Phase B (Injection Time), Week 4||0
7809341|NCT01163617|19225127|P2|COMPLETED|Phase B (Injection Time), Week 4||0
7809342|NCT01163617|19225128|P1|COMPLETED|Phase B (Injection Time), Week 4||0
7809343|NCT01163617|19225121|P8|STARTED|Phase B (Injection Time), Week 4||20
7809344|NCT01163617|19225122|P7|STARTED|Phase B (Injection Time), Week 4||16
7809345|NCT01163617|19225123|P6|STARTED|Phase B (Injection Time), Week 4||27
7809346|NCT01163617|19225124|P5|STARTED|Phase B (Injection Time), Week 4||18
7809347|NCT01163617|19225125|P4|STARTED|Phase B (Injection Time), Week 4||0
7809348|NCT01163617|19225126|P3|STARTED|Phase B (Injection Time), Week 4||0
7809349|NCT01163617|19225127|P2|STARTED|Phase B (Injection Time), Week 4||0
7809350|NCT01163617|19225128|P1|STARTED|Phase B (Injection Time), Week 4||0
7809351|NCT01163617|19225121|P8|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
7809352|NCT01163617|19225122|P7|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
7809353|NCT01163617|19225123|P6|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
7809354|NCT01163617|19225124|P5|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
7809355|NCT01163617|19225125|P4|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
7809356|NCT01163617|19225126|P3|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1
7809357|NCT01163617|19225127|P2|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2
7809358|NCT01163617|19225128|P1|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
7809359|NCT01163617|19225121|P8|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
7809360|NCT01163617|19225122|P7|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
7809361|NCT01163617|19225123|P6|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
7809362|NCT01163617|19225124|P5|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
7809363|NCT01163617|19225125|P4|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
7809364|NCT01163617|19225126|P3|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20
7809365|NCT01163617|19225127|P2|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
7809366|NCT01163617|19225128|P1|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19
7809367|NCT01163617|19225121|P8|STARTED|Phase A (User Experience), Weeks 0 and 2||0
7809368|NCT01163617|19225122|P7|STARTED|Phase A (User Experience), Weeks 0 and 2||0
7809369|NCT01163617|19225123|P6|STARTED|Phase A (User Experience), Weeks 0 and 2||0
7809370|NCT01163617|19225124|P5|STARTED|Phase A (User Experience), Weeks 0 and 2||0
7809371|NCT01163617|19225125|P4|STARTED|Phase A (User Experience), Weeks 0 and 2||21
7809372|NCT01163617|19225126|P3|STARTED|Phase A (User Experience), Weeks 0 and 2||21
7809373|NCT01163617|19225127|P2|STARTED|Phase A (User Experience), Weeks 0 and 2||23
7809374|NCT01163617|19225128|P1|STARTED|Phase A (User Experience), Weeks 0 and 2||19
7809375|NCT01163604|19225150|P2|NOT COMPLETED|Overall Study||0
7809376|NCT01163604|19225151|P1|NOT COMPLETED|Overall Study||0
7809377|NCT01163604|19225150|P2|COMPLETED|Overall Study|August 2011|56
7809378|NCT01163604|19225151|P1|COMPLETED|Overall Study|August 2011|58
7809379|NCT01163604|19225150|P2|STARTED|Overall Study|August 2010|56
7809380|NCT01163604|19225151|P1|STARTED|Overall Study|August 2010|58
7809381|NCT01163474|19225157|P1|NOT COMPLETED|Overall Study||16
7809382|NCT01163474|19225157|P1|COMPLETED|Overall Study||24
7809383|NCT01163474|19225157|P1|STARTED|Overall Study||40
7809384|NCT01163461|19225164|P2|NOT COMPLETED|Overall Study||0
7809385|NCT01163461|19225165|P1|NOT COMPLETED|Overall Study||0
7809386|NCT01163461|19225164|P2|COMPLETED|Overall Study||14
7809387|NCT01163461|19225165|P1|COMPLETED|Overall Study||14
7809388|NCT01163461|19225164|P2|STARTED|Overall Study||14
7809389|NCT01163461|19225165|P1|STARTED|Overall Study||14
7809390|NCT01163318|19225169|P1|NOT COMPLETED|Overall Study||268
7809391|NCT01163318|19225169|P1|COMPLETED|Overall Study||284
7809392|NCT01163318|19225169|P1|STARTED|Overall Study||552
7809393|NCT01163292|19225178|P2|NOT COMPLETED|Overall Study||22
7809394|NCT01163292|19225179|P1|NOT COMPLETED|Overall Study||41
7809395|NCT01163292|19225178|P2|COMPLETED|Overall Study||92
7809396|NCT01163292|19225179|P1|COMPLETED|Overall Study||65
7809397|NCT01163292|19225178|P2|STARTED|Overall Study||114
7809398|NCT01163292|19225179|P1|STARTED|Overall Study||106
7809399|NCT01163279|19225195|P2|NOT COMPLETED|Overall Study||0
7809400|NCT01163279|19225196|P1|NOT COMPLETED|Overall Study||2
7809401|NCT01163279|19225195|P2|COMPLETED|Overall Study||9
7809402|NCT01163279|19225196|P1|COMPLETED|Overall Study||8
7809403|NCT01163279|19225195|P2|STARTED|Overall Study||9
7809404|NCT01163279|19225196|P1|STARTED|Overall Study||10
7809405|NCT01163266|19225225|P3|NOT COMPLETED|Overall Study||28
7809406|NCT01163266|19225226|P2|NOT COMPLETED|Overall Study||31
7809407|NCT01163266|19225227|P1|NOT COMPLETED|Overall Study||18
7809408|NCT01163266|19225225|P3|COMPLETED|Overall Study||122
7809409|NCT01163266|19225226|P2|COMPLETED|Overall Study||124
7809410|NCT01163266|19225227|P1|COMPLETED|Overall Study||139
7809411|NCT01163266|19225225|P3|Treated|Overall Study||150
7809412|NCT01163266|19225226|P2|Treated|Overall Study||155
7809413|NCT01163266|19225227|P1|Treated|Overall Study||157
7809414|NCT01163266|19225225|P3|STARTED|Overall Study||150
7809415|NCT01163266|19225226|P2|STARTED|Overall Study||155
7809416|NCT01163266|19225227|P1|STARTED|Overall Study||157
7809417|NCT01163253|19225252|P2|NOT COMPLETED|Overall Study||586
7809418|NCT01163253|19225253|P1|NOT COMPLETED|Overall Study||2281
7809419|NCT01163253|19225252|P2|COMPLETED|Overall Study||0
7809420|NCT01163253|19225253|P1|COMPLETED|Overall Study||0
7809421|NCT01163253|19225252|P2|STARTED|Overall Study||586
7809422|NCT01163253|19225253|P1|STARTED|Overall Study||2281
7809423|NCT01163214|19225415|P2|NOT COMPLETED|Overall Study||0
7809424|NCT01163214|19225416|P1|NOT COMPLETED|Overall Study||0
7809425|NCT01163214|19225415|P2|COMPLETED|Overall Study||81
7809426|NCT01163214|19225416|P1|COMPLETED|Overall Study||79
7809427|NCT01163214|19225415|P2|STARTED|Overall Study||81
7809428|NCT01163214|19225416|P1|STARTED|Overall Study||79
7809429|NCT01163162|19225432|P1|NOT COMPLETED|Overall Study||0
7809430|NCT01163162|19225432|P1|COMPLETED|Overall Study||16
7809431|NCT01163162|19225432|P1|STARTED|Overall Study||16
7809432|NCT01163149|19225441|P3|NOT COMPLETED|Extension Treatment Period||2
7809433|NCT01163149|19225442|P2|NOT COMPLETED|Extension Treatment Period||1
7809434|NCT01163149|19225443|P1|NOT COMPLETED|Extension Treatment Period||2
7809435|NCT01163149|19225441|P3|COMPLETED|Extension Treatment Period||4
7809436|NCT01163149|19225442|P2|COMPLETED|Extension Treatment Period||5
7809437|NCT01163149|19225443|P1|COMPLETED|Extension Treatment Period||5
7809438|NCT01163149|19225441|P3|STARTED|Extension Treatment Period||6
7809439|NCT01163149|19225442|P2|STARTED|Extension Treatment Period||6
7809440|NCT01163149|19225443|P1|STARTED|Extension Treatment Period||7
7809441|NCT01163149|19225441|P3|NOT COMPLETED|Primary Treatment Period||0
7809442|NCT01163149|19225442|P2|NOT COMPLETED|Primary Treatment Period||0
7809443|NCT01163149|19225443|P1|NOT COMPLETED|Primary Treatment Period||0
7809444|NCT01163149|19225441|P3|COMPLETED|Primary Treatment Period||6
7809445|NCT01163149|19225442|P2|COMPLETED|Primary Treatment Period||6
7809446|NCT01163149|19225443|P1|COMPLETED|Primary Treatment Period||7
7809447|NCT01163149|19225441|P3|STARTED|Primary Treatment Period||6
7809448|NCT01163149|19225442|P2|STARTED|Primary Treatment Period||6
7809449|NCT01163149|19225443|P1|STARTED|Primary Treatment Period||7
7809450|NCT01163097|19225488|P3|NOT COMPLETED|Overall Study||0
7809451|NCT01163097|19225489|P2|NOT COMPLETED|Overall Study||0
7809452|NCT01163097|19225490|P1|NOT COMPLETED|Overall Study||6
7809453|NCT01163097|19225488|P3|COMPLETED|Overall Study||8
7809454|NCT01163097|19225489|P2|COMPLETED|Overall Study||16
7809455|NCT01163097|19225490|P1|COMPLETED|Overall Study||14
7809456|NCT01163097|19225488|P3|STARTED|Overall Study||8
7809457|NCT01163097|19225489|P2|STARTED|Overall Study||16
7809458|NCT01163097|19225490|P1|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20
7809459|NCT01163084|19225542|P2|NOT COMPLETED|Overall Study||0
7809460|NCT01163084|19225543|P1|NOT COMPLETED|Overall Study||0
7809461|NCT01163084|19225542|P2|COMPLETED|Overall Study||5
7809462|NCT01163084|19225543|P1|COMPLETED|Overall Study||4
7809463|NCT01163084|19225542|P2|STARTED|Overall Study||5
7809464|NCT01163084|19225543|P1|STARTED|Overall Study||4
7809465|NCT01163032|19225552|P3|NOT COMPLETED|Open Label Extension Phase||16
7809466|NCT01163032|19225553|P2|NOT COMPLETED|Open Label Extension Phase||0
7809467|NCT01163032|19225554|P1|NOT COMPLETED|Open Label Extension Phase||0
7809468|NCT01163032|19225552|P3|COMPLETED|Open Label Extension Phase||39
7809469|NCT01163032|19225553|P2|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
7809470|NCT01163032|19225554|P1|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
7809471|NCT01163032|19225552|P3|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55
7809472|NCT01163032|19225553|P2|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
7809473|NCT01163032|19225554|P1|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
7809474|NCT01163032|19225552|P3|NOT COMPLETED|Randomization Phase||0
7809475|NCT01163032|19225553|P2|NOT COMPLETED|Randomization Phase||12
7809476|NCT01163032|19225554|P1|NOT COMPLETED|Randomization Phase||10
7809477|NCT01163032|19225552|P3|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0
7809478|NCT01163032|19225553|P2|COMPLETED|Randomization Phase||30
7809479|NCT01163032|19225554|P1|COMPLETED|Randomization Phase||32
7809480|NCT01163032|19225552|P3|STARTED|Randomization Phase|Not applicable for Randomized Phase|0
7809481|NCT01163032|19225553|P2|STARTED|Randomization Phase||42
7809482|NCT01163032|19225554|P1|STARTED|Randomization Phase||42
7809483|NCT01162863|19225587|P3|NOT COMPLETED|Overall Study||0
7809484|NCT01162863|19225588|P2|NOT COMPLETED|Overall Study||1
7809485|NCT01162863|19225589|P1|NOT COMPLETED|Overall Study||1
7809486|NCT01162863|19225587|P3|COMPLETED|Overall Study||17
7809487|NCT01162863|19225588|P2|COMPLETED|Overall Study||16
7809488|NCT01162863|19225589|P1|COMPLETED|Overall Study||17
7809489|NCT01162863|19225587|P3|STARTED|Overall Study||17
7809490|NCT01162863|19225588|P2|STARTED|Overall Study||17
7809491|NCT01162863|19225589|P1|STARTED|Overall Study||18
7809492|NCT01162733|19225605|P2|NOT COMPLETED|Overall Study||25
7809493|NCT01162733|19225606|P1|NOT COMPLETED|Overall Study||27
7809494|NCT01162733|19225605|P2|COMPLETED|Overall Study||25
7809495|NCT01162733|19225606|P1|COMPLETED|Overall Study||22
7809496|NCT01162733|19225605|P2|STARTED|Overall Study||50
7809497|NCT01162733|19225606|P1|STARTED|Overall Study||49
7809498|NCT01162551|19225614|P1|NOT COMPLETED|Overall Study||0
7809499|NCT01162551|19225614|P1|COMPLETED|Overall Study||3
7809500|NCT01162551|19225614|P1|STARTED|Overall Study|2 subjects were enrolled but withdrew before receiving any study treatment|3
7809501|NCT01162499|19225619|P2|NOT COMPLETED|Intervention 2 (4 Hours)||0
7809502|NCT01162499|19225620|P1|NOT COMPLETED|Intervention 2 (4 Hours)||0
7809503|NCT01162499|19225619|P2|COMPLETED|Intervention 2 (4 Hours)||3
7809504|NCT01162499|19225620|P1|COMPLETED|Intervention 2 (4 Hours)||3
7809505|NCT01162499|19225619|P2|STARTED|Intervention 2 (4 Hours)||3
7809506|NCT01162499|19225620|P1|STARTED|Intervention 2 (4 Hours)||3
7809507|NCT01162499|19225619|P2|NOT COMPLETED|Intervention 1 (4 Hours)||1
7809508|NCT01162499|19225620|P1|NOT COMPLETED|Intervention 1 (4 Hours)||0
7809509|NCT01162499|19225619|P2|COMPLETED|Intervention 1 (4 Hours)||3
7809510|NCT01162499|19225620|P1|COMPLETED|Intervention 1 (4 Hours)||3
7809511|NCT01162499|19225619|P2|Received Intervention|Intervention 1 (4 Hours)||3
7809512|NCT01162499|19225620|P1|Received Intervention|Intervention 1 (4 Hours)||3
7809513|NCT01162499|19225619|P2|STARTED|Intervention 1 (4 Hours)||4
7809514|NCT01162499|19225620|P1|STARTED|Intervention 1 (4 Hours)||3
7809515|NCT01162486|19225645|P5|NOT COMPLETED|Overall Study||0
7809516|NCT01162486|19225646|P4|NOT COMPLETED|Overall Study||1
7809517|NCT01162486|19225647|P3|NOT COMPLETED|Overall Study||1
7809518|NCT01162486|19225648|P2|NOT COMPLETED|Overall Study||0
7809519|NCT01162486|19225649|P1|NOT COMPLETED|Overall Study||2
7809520|NCT01162486|19225645|P5|COMPLETED|Overall Study||6
7809521|NCT01162486|19225646|P4|COMPLETED|Overall Study||6
7809522|NCT01162486|19225647|P3|COMPLETED|Overall Study||5
7809523|NCT01162486|19225648|P2|COMPLETED|Overall Study||6
7809524|NCT01162486|19225649|P1|COMPLETED|Overall Study||6
7809525|NCT01162486|19225645|P5|Took at Least One Dose Study Drug|Overall Study||6
7809526|NCT01162486|19225646|P4|Took at Least One Dose Study Drug|Overall Study||7
7809527|NCT01162486|19225647|P3|Took at Least One Dose Study Drug|Overall Study||6
7809528|NCT01162486|19225648|P2|Took at Least One Dose Study Drug|Overall Study||6
7809529|NCT01162486|19225649|P1|Took at Least One Dose Study Drug|Overall Study||8
7809530|NCT01162486|19225645|P5|STARTED|Overall Study||6
7809531|NCT01162486|19225646|P4|STARTED|Overall Study||7
7809532|NCT01162486|19225647|P3|STARTED|Overall Study||6
7809533|NCT01162486|19225648|P2|STARTED|Overall Study||6
7809534|NCT01162486|19225649|P1|STARTED|Overall Study||8
7809535|NCT01162473|19225682|P2|NOT COMPLETED|Overall Study||5
7809536|NCT01162473|19225683|P1|NOT COMPLETED|Overall Study||2
7809537|NCT01162473|19225682|P2|COMPLETED|Overall Study||12
7809538|NCT01162473|19225683|P1|COMPLETED|Overall Study||6
7809539|NCT01162473|19225682|P2|STARTED|Overall Study||17
7809540|NCT01162473|19225683|P1|STARTED|Overall Study||8
7809541|NCT01162421|19225691|P2|NOT COMPLETED|Overall Study||13
7809542|NCT01162421|19225692|P1|NOT COMPLETED|Overall Study||8
7809543|NCT01162421|19225691|P2|COMPLETED|Overall Study||27
7809544|NCT01162421|19225692|P1|COMPLETED|Overall Study||29
7809545|NCT01162421|19225691|P2|STARTED|Overall Study||40
7809546|NCT01162421|19225692|P1|STARTED|Overall Study||37
7809547|NCT01162382|19225770|P1|NOT COMPLETED|Overall Study||0
7809548|NCT01162382|19225770|P1|COMPLETED|Overall Study||0
7809549|NCT01162382|19225770|P1|STARTED|Overall Study||0
7809550|NCT01162343|19225775|P1|NOT COMPLETED|Overall Study||92
7809551|NCT01162343|19225775|P1|COMPLETED|Overall Study||406
7809552|NCT01162343|19225775|P1|STARTED|Overall Study||498
7809553|NCT01162317|19225781|P2|NOT COMPLETED|Overall Study||2
7809554|NCT01162317|19225782|P1|NOT COMPLETED|Overall Study||3
7809555|NCT01162317|19225781|P2|COMPLETED|Overall Study||28
7809556|NCT01162317|19225782|P1|COMPLETED|Overall Study||27
7809557|NCT01162317|19225781|P2|STARTED|Overall Study||30
7809558|NCT01162317|19225782|P1|STARTED|Overall Study||30
7809559|NCT01162304|19225790|P1|NOT COMPLETED|Overall Study||11
7809560|NCT01162304|19225790|P1|COMPLETED|Overall Study||7
7809561|NCT01162304|19225790|P1|STARTED|Overall Study||18
7809562|NCT01162239|19225808|P4|NOT COMPLETED|Extended Follow-up||6
7809563|NCT01162239|19225809|P3|NOT COMPLETED|Extended Follow-up||8
7809564|NCT01162239|19225810|P2|NOT COMPLETED|Extended Follow-up||13
7809565|NCT01162239|19225811|P1|NOT COMPLETED|Extended Follow-up||8
7809566|NCT01162239|19225808|P4|COMPLETED|Extended Follow-up||41
7809567|NCT01162239|19225809|P3|COMPLETED|Extended Follow-up||37
7809568|NCT01162239|19225810|P2|COMPLETED|Extended Follow-up||32
7809569|NCT01162239|19225811|P1|COMPLETED|Extended Follow-up||39
7809570|NCT01162239|19225808|P4|STARTED|Extended Follow-up||47
7809571|NCT01162239|19225809|P3|STARTED|Extended Follow-up||45
7809572|NCT01162239|19225810|P2|STARTED|Extended Follow-up||45
7809573|NCT01162239|19225811|P1|STARTED|Extended Follow-up||47
7809574|NCT01162239|19225808|P4|NOT COMPLETED|Treatment Phase||5
7809575|NCT01162239|19225809|P3|NOT COMPLETED|Treatment Phase||4
7809576|NCT01162239|19225810|P2|NOT COMPLETED|Treatment Phase||7
7809577|NCT01162239|19225811|P1|NOT COMPLETED|Treatment Phase||6
7809578|NCT01162239|19225808|P4|COMPLETED|Treatment Phase||50
7809579|NCT01162239|19225809|P3|COMPLETED|Treatment Phase||48
7809580|NCT01162239|19225810|P2|COMPLETED|Treatment Phase||47
7809581|NCT01162239|19225811|P1|COMPLETED|Treatment Phase||49
7809582|NCT01162239|19225808|P4|Week 52|Treatment Phase||50
7809583|NCT01162239|19225809|P3|Week 52|Treatment Phase||48
7809584|NCT01162239|19225810|P2|Week 52|Treatment Phase||47
7809585|NCT01162239|19225811|P1|Week 52|Treatment Phase||49
7809586|NCT01162239|19225808|P4|Week 24|Treatment Phase||50
7809587|NCT01162239|19225809|P3|Week 24|Treatment Phase||48
7809588|NCT01162239|19225810|P2|Week 24|Treatment Phase||48
7809589|NCT01162239|19225811|P1|Week 24|Treatment Phase||51
7809590|NCT01162239|19225808|P4|Week 12|Treatment Phase||53
7809591|NCT01162239|19225809|P3|Week 12|Treatment Phase||49
7809592|NCT01162239|19225810|P2|Week 12|Treatment Phase||51
7809593|NCT01162239|19225811|P1|Week 12|Treatment Phase||50
7809594|NCT01162239|19225808|P4|STARTED|Treatment Phase||55
7809595|NCT01162239|19225809|P3|STARTED|Treatment Phase||52
7809596|NCT01162239|19225810|P2|STARTED|Treatment Phase||54
7809597|NCT01162239|19225811|P1|STARTED|Treatment Phase||55
7809598|NCT01162135|19225841|P1|NOT COMPLETED|Overall Study||3
7809599|NCT01162135|19225841|P1|COMPLETED|Overall Study||13
7809600|NCT01162135|19225841|P1|STARTED|Overall Study||16
7809601|NCT01162122|19225847|P2|NOT COMPLETED|Overall Study||196
7809602|NCT01162122|19225848|P1|NOT COMPLETED|Overall Study||191
7809603|NCT01162122|19225847|P2|COMPLETED|Overall Study||3356
7809604|NCT01162122|19225848|P1|COMPLETED|Overall Study||3361
7809605|NCT01162122|19225847|P2|Vaccinated|Overall Study||3541
7809606|NCT01162122|19225848|P1|Vaccinated|Overall Study||3541
7809607|NCT01162122|19225847|P2|STARTED|Overall Study||3552
7809608|NCT01162122|19225848|P1|STARTED|Overall Study||3552
7809609|NCT01162096|19225905|P1|NOT COMPLETED|Overall Study||0
7809610|NCT01162096|19225905|P1|COMPLETED|Overall Study||34
7809611|NCT01162096|19225905|P1|STARTED|Overall Study||34
7809612|NCT01162005|19225913|P2|NOT COMPLETED|Overall Study||0
7809613|NCT01162005|19225914|P1|NOT COMPLETED|Overall Study||0
7809614|NCT01162005|19225913|P2|COMPLETED|Overall Study||33
7809615|NCT01162005|19225914|P1|COMPLETED|Overall Study||44
7809616|NCT01162005|19225913|P2|STARTED|Overall Study||33
7809617|NCT01162005|19225914|P1|STARTED|Overall Study||44
7809618|NCT01161862|19225924|P2|NOT COMPLETED|Overall Study||0
7809619|NCT01161862|19225925|P1|NOT COMPLETED|Overall Study||0
7809620|NCT01161862|19225924|P2|COMPLETED|Overall Study||12
7809621|NCT01161862|19225925|P1|COMPLETED|Overall Study||12
7809622|NCT01161862|19225924|P2|STARTED|Overall Study||12
7809623|NCT01161862|19225925|P1|STARTED|Overall Study||12
7809624|NCT01161771|19225945|P1|NOT COMPLETED|Overall Study||0
7809625|NCT01161771|19225945|P1|COMPLETED|Overall Study||32
7809626|NCT01161771|19225945|P1|STARTED|Overall Study||32
7809627|NCT01161628|19225954|P1|NOT COMPLETED|Overall Study||8
7809628|NCT01161628|19225954|P1|COMPLETED|Overall Study||17
7809629|NCT01161628|19225954|P1|STARTED|Overall Study||25
7809630|NCT01161563|19225968|P2|NOT COMPLETED|Overall Study||6
7809631|NCT01161563|19225969|P1|NOT COMPLETED|Overall Study||5
7809632|NCT01161563|19225968|P2|COMPLETED|Overall Study||49
7809633|NCT01161563|19225969|P1|COMPLETED|Overall Study||58
7809634|NCT01161563|19225968|P2|STARTED|Overall Study||55
7809635|NCT01161563|19225969|P1|STARTED|Overall Study||63
7809636|NCT01161537|19225977|P1|NOT COMPLETED|Part B||2
7809637|NCT01161537|19225977|P1|COMPLETED|Part B||7
7809638|NCT01161537|19225977|P1|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9
7809639|NCT01161537|19225977|P1|NOT COMPLETED|Part A||0
7809640|NCT01161537|19225977|P1|COMPLETED|Part A||8
7809641|NCT01161537|19225977|P1|STARTED|Part A||8
7809642|NCT01161524|19225995|P3|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||24
7809643|NCT01161524|19225996|P2|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
7809644|NCT01161524|19225997|P1|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
7809645|NCT01161524|19225995|P3|COMPLETED|Extension Phase (Approximately 83 Weeks)||90
7809646|NCT01161524|19225996|P2|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
7809647|NCT01161524|19225997|P1|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
7809648|NCT01161524|19225995|P3|STARTED|Extension Phase (Approximately 83 Weeks)||114
7809649|NCT01161524|19225996|P2|STARTED|Extension Phase (Approximately 83 Weeks)||0
7809650|NCT01161524|19225997|P1|STARTED|Extension Phase (Approximately 83 Weeks)||0
7809651|NCT01161524|19225995|P3|NOT COMPLETED|Core Study (23 Weeks)||0
7809652|NCT01161524|19225996|P2|NOT COMPLETED|Core Study (23 Weeks)||5
7809653|NCT01161524|19225997|P1|NOT COMPLETED|Core Study (23 Weeks)||9
7809654|NCT01161524|19225995|P3|COMPLETED|Core Study (23 Weeks)||0
7809655|NCT01161524|19225996|P2|COMPLETED|Core Study (23 Weeks)||43
7809656|NCT01161524|19225997|P1|COMPLETED|Core Study (23 Weeks)||76
7809657|NCT01161524|19225995|P3|STARTED|Core Study (23 Weeks)||0
7809658|NCT01161524|19225996|P2|STARTED|Core Study (23 Weeks)||48
7809659|NCT01161524|19225997|P1|STARTED|Core Study (23 Weeks)||85
7809660|NCT01161498|19226036|P2|NOT COMPLETED|Overall Study||1
7809661|NCT01161498|19226037|P1|NOT COMPLETED|Overall Study||0
7809662|NCT01161498|19226036|P2|COMPLETED|Overall Study||1
7809663|NCT01161498|19226037|P1|COMPLETED|Overall Study||3
7809664|NCT01161498|19226036|P2|STARTED|Overall Study||2
7809665|NCT01161498|19226037|P1|STARTED|Overall Study||3
7809666|NCT01161472|19226061|P4|NOT COMPLETED|Fourth Intervention Period||0
7809667|NCT01161472|19226062|P3|NOT COMPLETED|Fourth Intervention Period||0
7809668|NCT01161472|19226063|P2|NOT COMPLETED|Fourth Intervention Period||0
7809669|NCT01161472|19226064|P1|NOT COMPLETED|Fourth Intervention Period||0
7809670|NCT01161472|19226061|P4|COMPLETED|Fourth Intervention Period||5
7809671|NCT01161472|19226062|P3|COMPLETED|Fourth Intervention Period||5
7809672|NCT01161472|19226063|P2|COMPLETED|Fourth Intervention Period||5
7809673|NCT01161472|19226064|P1|COMPLETED|Fourth Intervention Period||4
7809674|NCT01161472|19226061|P4|STARTED|Fourth Intervention Period||5
7809675|NCT01161472|19226062|P3|STARTED|Fourth Intervention Period||5
7809676|NCT01161472|19226063|P2|STARTED|Fourth Intervention Period||5
7809677|NCT01161472|19226064|P1|STARTED|Fourth Intervention Period||4
7809678|NCT01161472|19226061|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
7809679|NCT01161472|19226062|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
7809680|NCT01161472|19226063|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
7809681|NCT01161472|19226064|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
7809682|NCT01161472|19226061|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
7809683|NCT01161472|19226062|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
7809684|NCT01161472|19226063|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
7809685|NCT01161472|19226064|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
7809686|NCT01161472|19226061|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
7809687|NCT01161472|19226062|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
7809688|NCT01161472|19226063|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
7809689|NCT01161472|19226064|P1|STARTED|Washout Period (At Least 3 to 6 Days)||4
7809690|NCT01161472|19226061|P4|NOT COMPLETED|Third Intervention Period||0
7809691|NCT01161472|19226062|P3|NOT COMPLETED|Third Intervention Period||0
7809692|NCT01161472|19226063|P2|NOT COMPLETED|Third Intervention Period||0
7809693|NCT01161472|19226064|P1|NOT COMPLETED|Third Intervention Period||0
7809694|NCT01161472|19226061|P4|COMPLETED|Third Intervention Period||5
7809695|NCT01161472|19226062|P3|COMPLETED|Third Intervention Period||5
7809696|NCT01161472|19226063|P2|COMPLETED|Third Intervention Period||5
7809697|NCT01161472|19226064|P1|COMPLETED|Third Intervention Period||4
7809698|NCT01161472|19226061|P4|STARTED|Third Intervention Period||5
7809699|NCT01161472|19226062|P3|STARTED|Third Intervention Period||5
7809700|NCT01161472|19226063|P2|STARTED|Third Intervention Period||5
7809701|NCT01161472|19226064|P1|STARTED|Third Intervention Period||4
7809702|NCT01161472|19226061|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
7809703|NCT01161472|19226062|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
7809704|NCT01161472|19226063|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
7809705|NCT01161472|19226064|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1
7809792|NCT01161173|19226203|P1|STARTED|Overall Study||347
7809706|NCT01161472|19226061|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
7809707|NCT01161472|19226062|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
7809708|NCT01161472|19226063|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
7809709|NCT01161472|19226064|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
7809710|NCT01161472|19226061|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
7809711|NCT01161472|19226062|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
7809712|NCT01161472|19226063|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
7809713|NCT01161472|19226064|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
7809714|NCT01161472|19226061|P4|NOT COMPLETED|Second Intervention Period||0
7809715|NCT01161472|19226062|P3|NOT COMPLETED|Second Intervention Period||0
7809716|NCT01161472|19226063|P2|NOT COMPLETED|Second Intervention Period||0
7809717|NCT01161472|19226064|P1|NOT COMPLETED|Second Intervention Period||0
7809718|NCT01161472|19226061|P4|COMPLETED|Second Intervention Period||5
7809719|NCT01161472|19226062|P3|COMPLETED|Second Intervention Period||5
7809720|NCT01161472|19226063|P2|COMPLETED|Second Intervention Period||5
7809721|NCT01161472|19226064|P1|COMPLETED|Second Intervention Period||5
7809722|NCT01161472|19226061|P4|STARTED|Second Intervention Period||5
7809723|NCT01161472|19226062|P3|STARTED|Second Intervention Period||5
7809724|NCT01161472|19226063|P2|STARTED|Second Intervention Period||5
7809725|NCT01161472|19226064|P1|STARTED|Second Intervention Period||5
7809726|NCT01161472|19226061|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
7809727|NCT01161472|19226062|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
7809728|NCT01161472|19226063|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
7809729|NCT01161472|19226064|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
7809730|NCT01161472|19226061|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
7809731|NCT01161472|19226062|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
7809732|NCT01161472|19226063|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
7809733|NCT01161472|19226064|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
7809734|NCT01161472|19226061|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
7809735|NCT01161472|19226062|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
7809736|NCT01161472|19226063|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
7809737|NCT01161472|19226064|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
7809738|NCT01161472|19226061|P4|NOT COMPLETED|First Intervention Period||0
7809739|NCT01161472|19226062|P3|NOT COMPLETED|First Intervention Period||0
7809740|NCT01161472|19226063|P2|NOT COMPLETED|First Intervention Period||0
7809741|NCT01161472|19226064|P1|NOT COMPLETED|First Intervention Period||0
7809742|NCT01161472|19226061|P4|COMPLETED|First Intervention Period||5
7809743|NCT01161472|19226062|P3|COMPLETED|First Intervention Period||5
7809744|NCT01161472|19226063|P2|COMPLETED|First Intervention Period||5
7809745|NCT01161472|19226064|P1|COMPLETED|First Intervention Period||5
7809746|NCT01161472|19226061|P4|Treated|First Intervention Period||5
7809747|NCT01161472|19226062|P3|Treated|First Intervention Period||5
7809748|NCT01161472|19226063|P2|Treated|First Intervention Period||5
7809749|NCT01161472|19226064|P1|Treated|First Intervention Period||5
7809750|NCT01161472|19226061|P4|STARTED|First Intervention Period||5
7809751|NCT01161472|19226062|P3|STARTED|First Intervention Period||5
7809752|NCT01161472|19226063|P2|STARTED|First Intervention Period||5
7809753|NCT01161472|19226064|P1|STARTED|First Intervention Period||5
7809754|NCT01161446|19226120|P2|NOT COMPLETED|Overall Study||15
7809755|NCT01161446|19226121|P1|NOT COMPLETED|Overall Study||18
7809756|NCT01161446|19226120|P2|COMPLETED|Overall Study||99
7809757|NCT01161446|19226121|P1|COMPLETED|Overall Study||98
7809758|NCT01161446|19226120|P2|STARTED|Overall Study||114
7809759|NCT01161446|19226121|P1|STARTED|Overall Study||116
7809760|NCT01161420|19226133|P1|NOT COMPLETED|Withdrawal Study - Withdrawal||0
7809761|NCT01161420|19226133|P1|COMPLETED|Withdrawal Study - Withdrawal||23
7809762|NCT01161420|19226133|P1|STARTED|Withdrawal Study - Withdrawal||23
7809763|NCT01161420|19226133|P1|NOT COMPLETED|Withdrawal Study - Maintenance||0
7809764|NCT01161420|19226133|P1|COMPLETED|Withdrawal Study - Maintenance||23
7809765|NCT01161420|19226133|P1|STARTED|Withdrawal Study - Maintenance||23
7809766|NCT01161420|19226133|P1|NOT COMPLETED|Inspire Therapy||2
7809767|NCT01161420|19226133|P1|COMPLETED|Inspire Therapy||124
7809768|NCT01161420|19226133|P1|STARTED|Inspire Therapy||126
7809769|NCT01161407|19226147|P2|NOT COMPLETED|Overall Study||1
7809770|NCT01161407|19226148|P1|NOT COMPLETED|Overall Study||3
7809771|NCT01161407|19226147|P2|COMPLETED|Overall Study||5
7809772|NCT01161407|19226148|P1|COMPLETED|Overall Study||3
7809773|NCT01161407|19226147|P2|STARTED|Overall Study||6
7809774|NCT01161407|19226148|P1|STARTED|Overall Study||6
7809775|NCT01161329|19226160|P2|NOT COMPLETED|Overall Study||10
7809776|NCT01161329|19226161|P1|NOT COMPLETED|Overall Study||4
7809777|NCT01161329|19226160|P2|COMPLETED|Overall Study||24
7809778|NCT01161329|19226161|P1|COMPLETED|Overall Study||29
7809779|NCT01161329|19226160|P2|STARTED|Overall Study||34
7809780|NCT01161329|19226161|P1|STARTED|Overall Study||33
7809781|NCT01161225|19226172|P3|NOT COMPLETED|Overall Study||2
7809782|NCT01161225|19226173|P2|NOT COMPLETED|Overall Study||9
7809783|NCT01161225|19226174|P1|NOT COMPLETED|Overall Study||14
7809784|NCT01161225|19226172|P3|COMPLETED|Overall Study||12
7809785|NCT01161225|19226173|P2|COMPLETED|Overall Study||44
7809786|NCT01161225|19226174|P1|COMPLETED|Overall Study||45
7809787|NCT01161225|19226172|P3|STARTED|Overall Study||14
7809788|NCT01161225|19226173|P2|STARTED|Overall Study||53
7809789|NCT01161225|19226174|P1|STARTED|Overall Study||59
7809790|NCT01161173|19226203|P1|NOT COMPLETED|Overall Study||347
7809791|NCT01161173|19226203|P1|COMPLETED|Overall Study||0
7809793|NCT01161160|19226215|P3|NOT COMPLETED|Overall Study||0
7809794|NCT01161160|19226216|P2|NOT COMPLETED|Overall Study||0
7809795|NCT01161160|19226217|P1|NOT COMPLETED|Overall Study||0
7809796|NCT01161160|19226215|P3|COMPLETED|Overall Study||58
7809797|NCT01161160|19226216|P2|COMPLETED|Overall Study||75
7809798|NCT01161160|19226217|P1|COMPLETED|Overall Study||76
7809799|NCT01161160|19226215|P3|STARTED|Overall Study||58
7809800|NCT01161160|19226216|P2|STARTED|Overall Study||75
7809801|NCT01161160|19226217|P1|STARTED|Overall Study||76
7809802|NCT01161121|19226288|P1|NOT COMPLETED|Overall Study||0
7809803|NCT01161121|19226288|P1|COMPLETED|Overall Study||46
7809804|NCT01161121|19226288|P1|STARTED|Overall Study||46
7809805|NCT01161043|19226298|P1|NOT COMPLETED|Overall Study||3
7809806|NCT01161043|19226298|P1|COMPLETED|Overall Study||80
7809807|NCT01161043|19226298|P1|STARTED|Overall Study||83
7809808|NCT01160848|19226305|P2|NOT COMPLETED|Overall Study||0
7809809|NCT01160848|19226306|P1|NOT COMPLETED|Overall Study||0
7809810|NCT01160848|19226305|P2|COMPLETED|Overall Study||8
7809811|NCT01160848|19226306|P1|COMPLETED|Overall Study||12
7809812|NCT01160848|19226305|P2|STARTED|Overall Study||8
7809813|NCT01160848|19226306|P1|STARTED|Overall Study||12
7809814|NCT01160822|19226335|P7|NOT COMPLETED|Overall Study||9
7809815|NCT01160822|19226336|P6|NOT COMPLETED|Overall Study||7
7809816|NCT01160822|19226337|P5|NOT COMPLETED|Overall Study||9
7809817|NCT01160822|19226338|P4|NOT COMPLETED|Overall Study||0
7809818|NCT01160822|19226339|P3|NOT COMPLETED|Overall Study||0
7809819|NCT01160822|19226340|P2|NOT COMPLETED|Overall Study||0
7809820|NCT01160822|19226341|P1|NOT COMPLETED|Overall Study||0
7809821|NCT01160822|19226335|P7|COMPLETED|Overall Study||44
7809822|NCT01160822|19226336|P6|COMPLETED|Overall Study||40
7809823|NCT01160822|19226337|P5|COMPLETED|Overall Study||36
7809824|NCT01160822|19226338|P4|COMPLETED|Overall Study||5
7809825|NCT01160822|19226339|P3|COMPLETED|Overall Study||6
7809826|NCT01160822|19226340|P2|COMPLETED|Overall Study||7
7809827|NCT01160822|19226341|P1|COMPLETED|Overall Study||6
7809828|NCT01160822|19226335|P7|STARTED|Overall Study||53
7809829|NCT01160822|19226336|P6|STARTED|Overall Study||47
7809830|NCT01160822|19226337|P5|STARTED|Overall Study||45
7809831|NCT01160822|19226338|P4|STARTED|Overall Study||5
7809832|NCT01160822|19226339|P3|STARTED|Overall Study||6
7809833|NCT01160822|19226340|P2|STARTED|Overall Study||7
7809834|NCT01160822|19226341|P1|STARTED|Overall Study||6
7809835|NCT01160770|19226430|P1|NOT COMPLETED|Overall Study||79
7809836|NCT01160770|19226430|P1|COMPLETED|Overall Study||188
7809837|NCT01160770|19226430|P1|STARTED|Overall Study||267
7809838|NCT01160744|19226443|P4|NOT COMPLETED|Overall Study||4
7809839|NCT01160744|19226444|P3|NOT COMPLETED|Overall Study||7
7809840|NCT01160744|19226445|P2|NOT COMPLETED|Overall Study||5
7809841|NCT01160744|19226446|P1|NOT COMPLETED|Overall Study||11
7809842|NCT01160744|19226443|P4|COMPLETED|Overall Study||67
7809843|NCT01160744|19226444|P3|COMPLETED|Overall Study||62
7809844|NCT01160744|19226445|P2|COMPLETED|Overall Study||64
7809845|NCT01160744|19226446|P1|COMPLETED|Overall Study||60
7809846|NCT01160744|19226443|P4|Received Study Drug|Overall Study||71
7809847|NCT01160744|19226444|P3|Received Study Drug|Overall Study||63
7809848|NCT01160744|19226445|P2|Received Study Drug|Overall Study||67
7809849|NCT01160744|19226446|P1|Received Study Drug|Overall Study||69
7809850|NCT01160744|19226443|P4|STARTED|Overall Study||71
7809851|NCT01160744|19226444|P3|STARTED|Overall Study||69
7809852|NCT01160744|19226445|P2|STARTED|Overall Study||69
7809853|NCT01160744|19226446|P1|STARTED|Overall Study||71
7809854|NCT01160640|19226482|P2|NOT COMPLETED|Overall Study||6
7809855|NCT01160640|19226483|P1|NOT COMPLETED|Overall Study||4
7809856|NCT01160640|19226482|P2|COMPLETED|Overall Study||110
7809857|NCT01160640|19226483|P1|COMPLETED|Overall Study||113
7809858|NCT01160640|19226482|P2|STARTED|Overall Study||116
7809859|NCT01160640|19226483|P1|STARTED|Overall Study||117
7809860|NCT01160614|19226499|P2|NOT COMPLETED|Overall Study||2
7809861|NCT01160614|19226500|P1|NOT COMPLETED|Overall Study||0
7809862|NCT01160614|19226499|P2|COMPLETED|Overall Study||23
7809863|NCT01160614|19226500|P1|COMPLETED|Overall Study||5
7809864|NCT01160614|19226499|P2|STARTED|Overall Study||25
7809865|NCT01160614|19226500|P1|STARTED|Overall Study||5
7809866|NCT01160484|19226548|P1|NOT COMPLETED|Overall Study||18
7809867|NCT01160484|19226548|P1|COMPLETED|Overall Study||22
7809868|NCT01160484|19226548|P1|STARTED|Overall Study||40
7809869|NCT01160458|19226558|P1|NOT COMPLETED|Overall Study||0
7809870|NCT01160458|19226558|P1|COMPLETED|Overall Study||20
7809871|NCT01160458|19226558|P1|STARTED|Overall Study||20
7809872|NCT01160445|19226568|P2|NOT COMPLETED|Overall Study||0
7809873|NCT01160445|19226569|P1|NOT COMPLETED|Overall Study||0
7809874|NCT01160445|19226568|P2|COMPLETED|Overall Study||2
7809875|NCT01160445|19226569|P1|COMPLETED|Overall Study||7
7809876|NCT01160445|19226568|P2|STARTED|Overall Study||2
7809877|NCT01160445|19226569|P1|STARTED|Overall Study||7
7809878|NCT01160380|19226579|P2|NOT COMPLETED|Overall Study||5
7809879|NCT01160380|19226580|P1|NOT COMPLETED|Overall Study||8
7809880|NCT01160380|19226579|P2|COMPLETED|Overall Study||20
7809881|NCT01160380|19226580|P1|COMPLETED|Overall Study||17
7809882|NCT01160380|19226579|P2|STARTED|Overall Study||25
7809883|NCT01160380|19226580|P1|STARTED|Overall Study||25
7809884|NCT01160354|19226601|P3|NOT COMPLETED|Overall Study||1
7809885|NCT01160354|19226602|P2|NOT COMPLETED|Overall Study||1
7809886|NCT01160354|19226603|P1|NOT COMPLETED|Overall Study||0
7809887|NCT01160354|19226601|P3|COMPLETED|Overall Study||14
7809888|NCT01160354|19226602|P2|COMPLETED|Overall Study||3
7809889|NCT01160354|19226603|P1|COMPLETED|Overall Study||3
7809890|NCT01160354|19226601|P3|STARTED|Overall Study||15
7809891|NCT01160354|19226602|P2|STARTED|Overall Study||4
7809892|NCT01160354|19226603|P1|STARTED|Overall Study||3
7809893|NCT01160289|19226622|P6|NOT COMPLETED|Post-Randomization Period||14
7809894|NCT01160289|19226623|P5|NOT COMPLETED|Post-Randomization Period||9
7809895|NCT01160289|19226624|P4|NOT COMPLETED|Post-Randomization Period||21
7809896|NCT01160289|19226625|P3|NOT COMPLETED|Post-Randomization Period||24
7809897|NCT01160289|19226626|P2|NOT COMPLETED|Post-Randomization Period||20
7809898|NCT01160289|19226627|P1|NOT COMPLETED|Post-Randomization Period||0
7809899|NCT01160289|19226622|P6|COMPLETED|Post-Randomization Period||73
7809900|NCT01160289|19226623|P5|COMPLETED|Post-Randomization Period||80
7809901|NCT01160289|19226624|P4|COMPLETED|Post-Randomization Period||31
7809902|NCT01160289|19226625|P3|COMPLETED|Post-Randomization Period||73
7809903|NCT01160289|19226626|P2|COMPLETED|Post-Randomization Period||65
7809904|NCT01160289|19226627|P1|COMPLETED|Post-Randomization Period||0
7809905|NCT01160289|19226622|P6|Received at Least 1 Dose of Study Drug|Post-Randomization Period||87
7809906|NCT01160289|19226623|P5|Received at Least 1 Dose of Study Drug|Post-Randomization Period||89
7809907|NCT01160289|19226624|P4|Received at Least 1 Dose of Study Drug|Post-Randomization Period||52
7809908|NCT01160289|19226625|P3|Received at Least 1 Dose of Study Drug|Post-Randomization Period||97
7809909|NCT01160289|19226626|P2|Received at Least 1 Dose of Study Drug|Post-Randomization Period||85
7809910|NCT01160289|19226627|P1|Received at Least 1 Dose of Study Drug|Post-Randomization Period||0
7809911|NCT01160289|19226622|P6|STARTED|Post-Randomization Period||87
7809912|NCT01160289|19226623|P5|STARTED|Post-Randomization Period||89
7809913|NCT01160289|19226624|P4|STARTED|Post-Randomization Period||52
7809914|NCT01160289|19226625|P3|STARTED|Post-Randomization Period||97
7809915|NCT01160289|19226626|P2|STARTED|Post-Randomization Period||85
7809916|NCT01160289|19226627|P1|STARTED|Post-Randomization Period||0
7809917|NCT01160289|19226622|P6|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
7809918|NCT01160289|19226623|P5|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
7809919|NCT01160289|19226624|P4|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
7809920|NCT01160289|19226625|P3|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
7809921|NCT01160289|19226626|P2|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
7809922|NCT01160289|19226627|P1|NOT COMPLETED|Screening, Washout, and Lead-In Period||484
7809923|NCT01160289|19226622|P6|COMPLETED|Screening, Washout, and Lead-In Period||0
7809924|NCT01160289|19226623|P5|COMPLETED|Screening, Washout, and Lead-In Period||0
7809925|NCT01160289|19226624|P4|COMPLETED|Screening, Washout, and Lead-In Period||0
7809926|NCT01160289|19226625|P3|COMPLETED|Screening, Washout, and Lead-In Period||0
7809927|NCT01160289|19226626|P2|COMPLETED|Screening, Washout, and Lead-In Period||0
7809928|NCT01160289|19226627|P1|COMPLETED|Screening, Washout, and Lead-In Period||410
7809929|NCT01160289|19226622|P6|STARTED|Screening, Washout, and Lead-In Period||0
7809930|NCT01160289|19226623|P5|STARTED|Screening, Washout, and Lead-In Period||0
7809931|NCT01160289|19226624|P4|STARTED|Screening, Washout, and Lead-In Period||0
7809932|NCT01160289|19226625|P3|STARTED|Screening, Washout, and Lead-In Period||0
7809933|NCT01160289|19226626|P2|STARTED|Screening, Washout, and Lead-In Period||0
7809934|NCT01160289|19226627|P1|STARTED|Screening, Washout, and Lead-In Period||894
7809935|NCT01160237|19226688|P3|NOT COMPLETED|Overall Study||0
7809936|NCT01160237|19226689|P2|NOT COMPLETED|Overall Study||0
7809937|NCT01160237|19226690|P1|NOT COMPLETED|Overall Study||0
7809938|NCT01160237|19226688|P3|COMPLETED|Overall Study||0
7809939|NCT01160237|19226689|P2|COMPLETED|Overall Study||3
7809940|NCT01160237|19226690|P1|COMPLETED|Overall Study||4
7809941|NCT01160237|19226688|P3|STARTED|Overall Study||0
7809942|NCT01160237|19226689|P2|STARTED|Overall Study||3
7809943|NCT01160237|19226690|P1|STARTED|Overall Study||4
7809944|NCT01160211|19226716|P3|NOT COMPLETED|Overall Study||87
7809945|NCT01160211|19226717|P2|NOT COMPLETED|Overall Study||87
7809946|NCT01160211|19226718|P1|NOT COMPLETED|Overall Study||99
7809947|NCT01160211|19226716|P3|COMPLETED|Overall Study||30
7809948|NCT01160211|19226717|P2|COMPLETED|Overall Study||31
7809949|NCT01160211|19226718|P1|COMPLETED|Overall Study||21
7809950|NCT01160211|19226716|P3|Ongoing|Overall Study||79
7809951|NCT01160211|19226717|P2|Ongoing|Overall Study||75
7809952|NCT01160211|19226718|P1|Ongoing|Overall Study||90
7809953|NCT01160211|19226716|P3|STARTED|Overall Study||117
7809954|NCT01160211|19226717|P2|STARTED|Overall Study||118
7809955|NCT01160211|19226718|P1|STARTED|Overall Study||120
7809956|NCT01160198|19226751|P3|NOT COMPLETED|Overall Study||1
7809957|NCT01160198|19226752|P2|NOT COMPLETED|Overall Study||3
7809958|NCT01160198|19226753|P1|NOT COMPLETED|Overall Study||2
7809959|NCT01160198|19226751|P3|COMPLETED|Overall Study||89
7809960|NCT01160198|19226752|P2|COMPLETED|Overall Study||88
7809961|NCT01160198|19226753|P1|COMPLETED|Overall Study||87
7809962|NCT01160198|19226751|P3|STARTED|Overall Study||90
7809963|NCT01160198|19226752|P2|STARTED|Overall Study||91
7809964|NCT01160198|19226753|P1|STARTED|Overall Study||89
7809965|NCT01159938|19226775|P5|NOT COMPLETED|Second Study Period||0
7809966|NCT01159938|19226776|P4|NOT COMPLETED|Second Study Period||0
7809967|NCT01159938|19226777|P3|NOT COMPLETED|Second Study Period||0
7809968|NCT01159938|19226778|P2|NOT COMPLETED|Second Study Period||0
7809969|NCT01159938|19226779|P1|NOT COMPLETED|Second Study Period||0
7809970|NCT01159938|19226775|P5|COMPLETED|Second Study Period||12
7809971|NCT01159938|19226776|P4|COMPLETED|Second Study Period||12
7809972|NCT01159938|19226777|P3|COMPLETED|Second Study Period||10
7809973|NCT01159938|19226778|P2|COMPLETED|Second Study Period||11
7809974|NCT01159938|19226779|P1|COMPLETED|Second Study Period||0
7809975|NCT01159938|19226775|P5|STARTED|Second Study Period||12
7809976|NCT01159938|19226776|P4|STARTED|Second Study Period||12
7809977|NCT01159938|19226777|P3|STARTED|Second Study Period||10
7809978|NCT01159938|19226778|P2|STARTED|Second Study Period||11
7809979|NCT01159938|19226779|P1|STARTED|Second Study Period||0
7809980|NCT01159938|19226775|P5|NOT COMPLETED|First Study Period||0
7809981|NCT01159938|19226776|P4|NOT COMPLETED|First Study Period||0
7809982|NCT01159938|19226777|P3|NOT COMPLETED|First Study Period||1
7809983|NCT01159938|19226778|P2|NOT COMPLETED|First Study Period||0
7809984|NCT01159938|19226779|P1|NOT COMPLETED|First Study Period||0
7809985|NCT01159938|19226775|P5|COMPLETED|First Study Period||12
7809986|NCT01159938|19226776|P4|COMPLETED|First Study Period||12
7809987|NCT01159938|19226777|P3|COMPLETED|First Study Period||10
7809988|NCT01159938|19226778|P2|COMPLETED|First Study Period||11
7809989|NCT01159938|19226779|P1|COMPLETED|First Study Period||26
7809990|NCT01159938|19226775|P5|Safety and Efficacy Analysis Population|First Study Period||12
7809991|NCT01159938|19226776|P4|Safety and Efficacy Analysis Population|First Study Period||12
7809992|NCT01159938|19226777|P3|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11
7809993|NCT01159938|19226778|P2|Safety and Efficacy Analysis Population|First Study Period||11
7809994|NCT01159938|19226779|P1|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25
7809995|NCT01159938|19226775|P5|Received at Least 1 Dose of Study Drug|First Study Period||12
7809996|NCT01159938|19226776|P4|Received at Least 1 Dose of Study Drug|First Study Period||12
7809997|NCT01159938|19226777|P3|Received at Least 1 Dose of Study Drug|First Study Period||11
7809998|NCT01159938|19226778|P2|Received at Least 1 Dose of Study Drug|First Study Period||11
7809999|NCT01159938|19226779|P1|Received at Least 1 Dose of Study Drug|First Study Period||0
7810000|NCT01159938|19226775|P5|STARTED|First Study Period||12
7810001|NCT01159938|19226776|P4|STARTED|First Study Period||12
7810002|NCT01159938|19226777|P3|STARTED|First Study Period||11
7810003|NCT01159938|19226778|P2|STARTED|First Study Period||11
7810004|NCT01159938|19226779|P1|STARTED|First Study Period||26
7810005|NCT01159912|19226842|P3|NOT COMPLETED|Overall Study||26
7810006|NCT01159912|19226843|P2|NOT COMPLETED|Overall Study||22
7810007|NCT01159912|19226844|P1|NOT COMPLETED|Overall Study||40
7810008|NCT01159912|19226842|P3|COMPLETED|Overall Study||88
7810009|NCT01159912|19226843|P2|COMPLETED|Overall Study||92
7810010|NCT01159912|19226844|P1|COMPLETED|Overall Study||75
7810011|NCT01159912|19226842|P3|STARTED|Overall Study||114
7810012|NCT01159912|19226843|P2|STARTED|Overall Study||114
7810013|NCT01159912|19226844|P1|STARTED|Overall Study||115
7810014|NCT01159769|19226867|P1|NOT COMPLETED|Overall Study||1
7810015|NCT01159769|19226867|P1|COMPLETED|Overall Study||214
7810016|NCT01159769|19226867|P1|STARTED|Overall Study||215
7810017|NCT01159743|19226874|P2|NOT COMPLETED|Overall Study||0
7810018|NCT01159743|19226875|P1|NOT COMPLETED|Overall Study||0
7810019|NCT01159743|19226874|P2|COMPLETED|Overall Study||109
7810020|NCT01159743|19226875|P1|COMPLETED|Overall Study||237
7810021|NCT01159743|19226874|P2|STARTED|Overall Study||109
7810022|NCT01159743|19226875|P1|STARTED|Overall Study||237
7810023|NCT01159691|19226887|P1|NOT COMPLETED|Overall Study||22
7810024|NCT01159691|19226887|P1|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54
7810025|NCT01159691|19226887|P1|STARTED|Overall Study||76
7810026|NCT01159665|19226900|P6|NOT COMPLETED|Overall Study||0
7810027|NCT01159665|19226901|P5|NOT COMPLETED|Overall Study||0
7810028|NCT01159665|19226902|P4|NOT COMPLETED|Overall Study||0
7810029|NCT01159665|19226903|P3|NOT COMPLETED|Overall Study||0
7810030|NCT01159665|19226904|P2|NOT COMPLETED|Overall Study||1
7810031|NCT01159665|19226905|P1|NOT COMPLETED|Overall Study||0
7810032|NCT01159665|19226900|P6|COMPLETED|Overall Study||4
7810033|NCT01159665|19226901|P5|COMPLETED|Overall Study||4
7810034|NCT01159665|19226902|P4|COMPLETED|Overall Study||4
7810035|NCT01159665|19226903|P3|COMPLETED|Overall Study||8
7810036|NCT01159665|19226904|P2|COMPLETED|Overall Study||8
7810037|NCT01159665|19226905|P1|COMPLETED|Overall Study||9
7810038|NCT01159665|19226900|P6|STARTED|Overall Study||4
7810039|NCT01159665|19226901|P5|STARTED|Overall Study||4
7810040|NCT01159665|19226902|P4|STARTED|Overall Study||4
7810041|NCT01159665|19226903|P3|STARTED|Overall Study||8
7810042|NCT01159665|19226904|P2|STARTED|Overall Study||9
7810043|NCT01159665|19226905|P1|STARTED|Overall Study||9
7810044|NCT01159600|19226933|P8|NOT COMPLETED|Overall Study||18
7810045|NCT01159600|19226934|P7|NOT COMPLETED|Overall Study||19
7810046|NCT01159600|19226935|P6|NOT COMPLETED|Overall Study||18
7810047|NCT01159600|19226936|P5|NOT COMPLETED|Overall Study||24
7810048|NCT01159600|19226937|P4|NOT COMPLETED|Overall Study||11
7810049|NCT01159600|19226938|P3|NOT COMPLETED|Overall Study||18
7810050|NCT01159600|19226939|P2|NOT COMPLETED|Overall Study||8
7810051|NCT01159600|19226940|P1|NOT COMPLETED|Overall Study||21
7810052|NCT01159600|19226933|P8|COMPLETED|Overall Study||85
7810053|NCT01159600|19226934|P7|COMPLETED|Overall Study||199
7810054|NCT01159600|19226935|P6|COMPLETED|Overall Study||208
7810055|NCT01159600|19226936|P5|COMPLETED|Overall Study||201
7810056|NCT01159600|19226937|P4|COMPLETED|Overall Study||58
7810057|NCT01159600|19226938|P3|COMPLETED|Overall Study||196
7810058|NCT01159600|19226939|P2|COMPLETED|Overall Study||209
7810059|NCT01159600|19226940|P1|COMPLETED|Overall Study||186
7810060|NCT01159600|19226933|P8|STARTED|Overall Study||103
7810061|NCT01159600|19226934|P7|STARTED|Overall Study||218
7810062|NCT01159600|19226935|P6|STARTED|Overall Study||226
7810063|NCT01159600|19226936|P5|STARTED|Overall Study||225
7810064|NCT01159600|19226937|P4|STARTED|Overall Study||69
7810065|NCT01159600|19226938|P3|STARTED|Overall Study||214
7810066|NCT01159600|19226939|P2|STARTED|Overall Study||217
7810067|NCT01159600|19226940|P1|STARTED|Overall Study||207
7810068|NCT01159574|19226982|P1|NOT COMPLETED|Follow Up Phase||20
7810069|NCT01159574|19226982|P1|COMPLETED|Follow Up Phase|Completion defined as those that are no longer in long term follow up due to death.|92
7810070|NCT01159574|19226982|P1|STARTED|Follow Up Phase||112
7810071|NCT01159574|19226982|P1|NOT COMPLETED|Treatment Phase||21
7810072|NCT01159574|19226982|P1|COMPLETED|Treatment Phase||100
7810073|NCT01159574|19226982|P1|STARTED|Treatment Phase||121
7810074|NCT01159535|19226991|P3|NOT COMPLETED|Overall Study||31
7810075|NCT01159535|19226992|P2|NOT COMPLETED|Overall Study||24
7810076|NCT01159535|19226993|P1|NOT COMPLETED|Overall Study||24
7810077|NCT01159535|19226991|P3|COMPLETED|Overall Study||64
7810078|NCT01159535|19226992|P2|COMPLETED|Overall Study||64
7810079|NCT01159535|19226993|P1|COMPLETED|Overall Study||79
7810080|NCT01159535|19226991|P3|STARTED|Overall Study||95
7810081|NCT01159535|19226992|P2|STARTED|Overall Study||88
7810082|NCT01159535|19226993|P1|STARTED|Overall Study||103
7810083|NCT01159431|19227003|P2|NOT COMPLETED|Overall Study||6
7810084|NCT01159431|19227004|P1|NOT COMPLETED|Overall Study||2
7810085|NCT01159431|19227003|P2|COMPLETED|Overall Study||19
7810086|NCT01159431|19227004|P1|COMPLETED|Overall Study||23
7810087|NCT01159431|19227003|P2|STARTED|Overall Study||25
7810088|NCT01159431|19227004|P1|STARTED|Overall Study||25
7810089|NCT01159262|19227023|P3|NOT COMPLETED|Overall Study||0
7810090|NCT01159262|19227024|P2|NOT COMPLETED|Overall Study||0
7810091|NCT01159262|19227025|P1|NOT COMPLETED|Overall Study||0
7810092|NCT01159262|19227023|P3|COMPLETED|Overall Study||8
7810093|NCT01159262|19227024|P2|COMPLETED|Overall Study||14
7810094|NCT01159262|19227025|P1|COMPLETED|Overall Study||14
7810095|NCT01159262|19227023|P3|STARTED|Overall Study||8
7810096|NCT01159262|19227024|P2|STARTED|Overall Study||14
7810097|NCT01159262|19227025|P1|STARTED|Overall Study||14
7810098|NCT01159171|19227057|P1|NOT COMPLETED|Overall Study||50
7810099|NCT01159171|19227057|P1|COMPLETED|Overall Study||0
7810100|NCT01159171|19227057|P1|STARTED|Overall Study||50
7810101|NCT01159067|19227072|P1|NOT COMPLETED|Overall Study||0
7810102|NCT01159067|19227072|P1|COMPLETED|Overall Study||1
7810103|NCT01159067|19227072|P1|STARTED|Overall Study||1
7810104|NCT01159054|19227079|P1|NOT COMPLETED|Overall Study||20
7810105|NCT01159054|19227079|P1|COMPLETED|Overall Study||2
7810106|NCT01159054|19227079|P1|STARTED|Overall Study||22
7810107|NCT01159015|19227093|P2|NOT COMPLETED|Overall Study||7
7810108|NCT01159015|19227094|P1|NOT COMPLETED|Overall Study||18
7810109|NCT01159015|19227093|P2|COMPLETED|Overall Study||170
7810110|NCT01159015|19227094|P1|COMPLETED|Overall Study||339
7810111|NCT01159015|19227093|P2|STARTED|Overall Study||177
7810112|NCT01159015|19227094|P1|STARTED|Overall Study||357
7810113|NCT01158976|19227102|P2|NOT COMPLETED|Overall Study||4
7810114|NCT01158976|19227103|P1|NOT COMPLETED|Overall Study||9
7810115|NCT01158976|19227102|P2|COMPLETED|Overall Study||17
7810116|NCT01158976|19227103|P1|COMPLETED|Overall Study||34
7810117|NCT01158976|19227102|P2|STARTED|Overall Study||21
7810118|NCT01158976|19227103|P1|STARTED|Overall Study||43
7810119|NCT01158950|19227145|P2|NOT COMPLETED|2nd Intervention (1 Day)||0
7810120|NCT01158950|19227146|P1|NOT COMPLETED|2nd Intervention (1 Day)||0
7810121|NCT01158950|19227145|P2|COMPLETED|2nd Intervention (1 Day)||11
7810122|NCT01158950|19227146|P1|COMPLETED|2nd Intervention (1 Day)||12
7810123|NCT01158950|19227145|P2|STARTED|2nd Intervention (1 Day)||11
7810124|NCT01158950|19227146|P1|STARTED|2nd Intervention (1 Day)||12
7810125|NCT01158950|19227145|P2|NOT COMPLETED|Washout (1 Week)||0
7810126|NCT01158950|19227146|P1|NOT COMPLETED|Washout (1 Week)||0
7810127|NCT01158950|19227145|P2|COMPLETED|Washout (1 Week)||11
7810128|NCT01158950|19227146|P1|COMPLETED|Washout (1 Week)||12
7810129|NCT01158950|19227145|P2|STARTED|Washout (1 Week)||11
7810130|NCT01158950|19227146|P1|STARTED|Washout (1 Week)||12
7810131|NCT01158950|19227145|P2|NOT COMPLETED|1st Intervention (1 Day)||2
7810132|NCT01158950|19227146|P1|NOT COMPLETED|1st Intervention (1 Day)||1
7810133|NCT01158950|19227145|P2|COMPLETED|1st Intervention (1 Day)||11
7810134|NCT01158950|19227146|P1|COMPLETED|1st Intervention (1 Day)||12
7810135|NCT01158950|19227145|P2|Data Collected|1st Intervention (1 Day)||11
7810136|NCT01158950|19227146|P1|Data Collected|1st Intervention (1 Day)||12
7810137|NCT01158950|19227145|P2|STARTED|1st Intervention (1 Day)||13
7810138|NCT01158950|19227146|P1|STARTED|1st Intervention (1 Day)||13
7810139|NCT01158924|19227154|P2|NOT COMPLETED|Overall Study||3
7810140|NCT01158924|19227155|P1|NOT COMPLETED|Overall Study||1
7810141|NCT01158924|19227154|P2|COMPLETED|Overall Study||23
7810142|NCT01158924|19227155|P1|COMPLETED|Overall Study||13
7810143|NCT01158924|19227154|P2|STARTED|Overall Study||26
7810144|NCT01158924|19227155|P1|STARTED|Overall Study||14
7810145|NCT01158885|19227169|P1|NOT COMPLETED|Treatment Course 2||0
7810146|NCT01158885|19227169|P1|COMPLETED|Treatment Course 2||0
7810147|NCT01158885|19227169|P1|STARTED|Treatment Course 2||0
7810148|NCT01158885|19227169|P1|NOT COMPLETED|Treatment Course 1||0
7810149|NCT01158885|19227169|P1|COMPLETED|Treatment Course 1||2
7810150|NCT01158885|19227169|P1|STARTED|Treatment Course 1||2
7810151|NCT01158820|19227177|P2|NOT COMPLETED|Overall Study||0
7810152|NCT01158820|19227178|P1|NOT COMPLETED|Overall Study||0
7810153|NCT01158820|19227177|P2|COMPLETED|Overall Study||25
7810154|NCT01158820|19227178|P1|COMPLETED|Overall Study||25
7810155|NCT01158820|19227177|P2|STARTED|Overall Study||25
7810156|NCT01158820|19227178|P1|STARTED|Overall Study||25
7810157|NCT01158716|19227200|P2|NOT COMPLETED|Overall Study||1
7810158|NCT01158716|19227201|P1|NOT COMPLETED|Overall Study||1
7810159|NCT01158716|19227200|P2|COMPLETED|Overall Study||47
7810160|NCT01158716|19227201|P1|COMPLETED|Overall Study||47
7810161|NCT01158716|19227200|P2|STARTED|Overall Study||48
7810162|NCT01158716|19227201|P1|STARTED|Overall Study||48
7810163|NCT01158703|19227209|P2|NOT COMPLETED|Overall Study||0
7810164|NCT01158703|19227210|P1|NOT COMPLETED|Overall Study||0
7810165|NCT01158703|19227209|P2|COMPLETED|Overall Study||8
7810166|NCT01158703|19227210|P1|COMPLETED|Overall Study||12
7810167|NCT01158703|19227209|P2|STARTED|Overall Study||8
7810168|NCT01158703|19227210|P1|STARTED|Overall Study||12
7810169|NCT01158651|19227226|P1|NOT COMPLETED|Overall Study||1
7810170|NCT01158651|19227226|P1|COMPLETED|Overall Study||22
7810171|NCT01158651|19227226|P1|STARTED|Overall Study||23
7810172|NCT01158573|19227235|P4|NOT COMPLETED|Overall Study||0
7810173|NCT01158573|19227236|P3|NOT COMPLETED|Overall Study||0
7810174|NCT01158573|19227237|P2|NOT COMPLETED|Overall Study||0
7810175|NCT01158573|19227238|P1|NOT COMPLETED|Overall Study||0
7810176|NCT01158573|19227235|P4|COMPLETED|Overall Study||28
7810177|NCT01158573|19227236|P3|COMPLETED|Overall Study||29
7810178|NCT01158573|19227237|P2|COMPLETED|Overall Study||30
7810179|NCT01158573|19227238|P1|COMPLETED|Overall Study|Study completed at 117 subjects.|30
7810180|NCT01158573|19227235|P4|STARTED|Overall Study||28
7810181|NCT01158573|19227236|P3|STARTED|Overall Study||29
7810182|NCT01158573|19227237|P2|STARTED|Overall Study||30
7810183|NCT01158573|19227238|P1|STARTED|Overall Study|Aimed to recruit 160 from July 2010 to May 2013. Each subject studied on one time point only|30
7810184|NCT01158534|19227260|P1|NOT COMPLETED|Overall Study||3
7810185|NCT01158534|19227260|P1|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14
7810186|NCT01158534|19227260|P1|STARTED|Overall Study||17
7810187|NCT01158521|19227268|P1|NOT COMPLETED|Overall Study||0
7810188|NCT01158521|19227268|P1|COMPLETED|Overall Study||25
7810189|NCT01158521|19227268|P1|STARTED|Overall Study||25
7810190|NCT01158404|19227285|P8|NOT COMPLETED|Overall Study||2
7810191|NCT01158404|19227286|P7|NOT COMPLETED|Overall Study||1
7810192|NCT01158404|19227287|P6|NOT COMPLETED|Overall Study||1
7810193|NCT01158404|19227288|P5|NOT COMPLETED|Overall Study||3
7810194|NCT01158404|19227289|P4|NOT COMPLETED|Overall Study||0
7810195|NCT01158404|19227290|P3|NOT COMPLETED|Overall Study||0
7810196|NCT01158404|19227291|P2|NOT COMPLETED|Overall Study||1
7810197|NCT01158404|19227292|P1|NOT COMPLETED|Overall Study||0
7810198|NCT01158404|19227285|P8|COMPLETED|Overall Study||6
7810199|NCT01158404|19227286|P7|COMPLETED|Overall Study||2
7810200|NCT01158404|19227287|P6|COMPLETED|Overall Study||4
7810201|NCT01158404|19227288|P5|COMPLETED|Overall Study||3
7810202|NCT01158404|19227289|P4|COMPLETED|Overall Study||3
7810203|NCT01158404|19227290|P3|COMPLETED|Overall Study||3
7810204|NCT01158404|19227291|P2|COMPLETED|Overall Study||3
7810205|NCT01158404|19227292|P1|COMPLETED|Overall Study||3
7810206|NCT01158404|19227285|P8|Received at Least 1 Dose of Study Drug|Overall Study||8
7810207|NCT01158404|19227286|P7|Received at Least 1 Dose of Study Drug|Overall Study||3
7810208|NCT01158404|19227287|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
7810209|NCT01158404|19227288|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
7810210|NCT01158404|19227289|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
7810211|NCT01158404|19227290|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
7810212|NCT01158404|19227291|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
7810213|NCT01158404|19227292|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
7810214|NCT01158404|19227285|P8|STARTED|Overall Study||8
7810215|NCT01158404|19227286|P7|STARTED|Overall Study||3
7810216|NCT01158404|19227287|P6|STARTED|Overall Study||5
7810217|NCT01158404|19227288|P5|STARTED|Overall Study||6
7810218|NCT01158404|19227289|P4|STARTED|Overall Study||3
7810219|NCT01158404|19227290|P3|STARTED|Overall Study||3
7810220|NCT01158404|19227291|P2|STARTED|Overall Study||4
7810221|NCT01158404|19227292|P1|STARTED|Overall Study||3
7810222|NCT01158378|19227334|P2|NOT COMPLETED|Overall Study||9
7810223|NCT01158378|19227335|P1|NOT COMPLETED|Overall Study||10
7810224|NCT01158378|19227334|P2|COMPLETED|Overall Study||117
7810225|NCT01158378|19227335|P1|COMPLETED|Overall Study||114
7810226|NCT01158378|19227334|P2|STARTED|Overall Study||126
7810227|NCT01158378|19227335|P1|STARTED|Overall Study||124
7810228|NCT01158261|19227347|P1|NOT COMPLETED|Overall Study||17
7810229|NCT01158261|19227347|P1|COMPLETED|Overall Study||283
7810230|NCT01158261|19227347|P1|STARTED|Overall Study||300
7810231|NCT01158222|19227351|P1|NOT COMPLETED|Overall Study||17
7810232|NCT01158222|19227351|P1|COMPLETED|Overall Study||20
7810233|NCT01158222|19227351|P1|STARTED|Overall Study||37
7810234|NCT01158157|19227357|P1|NOT COMPLETED|Overall Study||0
7810235|NCT01158157|19227357|P1|COMPLETED|Overall Study||25
7810236|NCT01158157|19227357|P1|STARTED|Overall Study|61 subjects screened; 25 subjects were vaccinated; 36 subjects were not eligible.|25
7810237|NCT01158118|19227363|P2|NOT COMPLETED|Overall Study||3
7810238|NCT01158118|19227364|P1|NOT COMPLETED|Overall Study||1
7810239|NCT01158118|19227363|P2|COMPLETED|Overall Study||21
7810240|NCT01158118|19227364|P1|COMPLETED|Overall Study||23
7810241|NCT01158118|19227363|P2|STARTED|Overall Study||24
7810242|NCT01158118|19227364|P1|STARTED|Overall Study||24
7810243|NCT01157897|19227384|P4|NOT COMPLETED|Overall Study||1
7810244|NCT01157897|19227385|P3|NOT COMPLETED|Overall Study||0
7810245|NCT01157897|19227386|P2|NOT COMPLETED|Overall Study||2
7810246|NCT01157897|19227387|P1|NOT COMPLETED|Overall Study||2
7810247|NCT01157897|19227384|P4|COMPLETED|Overall Study||5
7810248|NCT01157897|19227385|P3|COMPLETED|Overall Study||10
7810249|NCT01157897|19227386|P2|COMPLETED|Overall Study||8
7810250|NCT01157897|19227387|P1|COMPLETED|Overall Study||8
7810251|NCT01157897|19227384|P4|STARTED|Overall Study||6
7810252|NCT01157897|19227385|P3|STARTED|Overall Study||10
7810253|NCT01157897|19227386|P2|STARTED|Overall Study||10
7810254|NCT01157897|19227387|P1|STARTED|Overall Study||10
7810255|NCT01157845|19227412|P1|NOT COMPLETED|Overall Study||35
7810256|NCT01157845|19227412|P1|COMPLETED|Overall Study||130
7810257|NCT01157845|19227412|P1|STARTED|Overall Study||165
7810258|NCT01157676|19227419|P2|NOT COMPLETED|Surgery||9
7810259|NCT01157676|19227420|P1|NOT COMPLETED|Surgery||1
7810260|NCT01157676|19227419|P2|COMPLETED|Surgery|advanced disease=2, inadequate visualization=1, inability to tolerate position=1, colonic mass=1.|150
7810261|NCT01157676|19227420|P1|COMPLETED|Surgery||152
7810262|NCT01157676|19227419|P2|STARTED|Surgery||159
7810263|NCT01157676|19227420|P1|STARTED|Surgery||153
7810264|NCT01157676|19227419|P2|NOT COMPLETED|Randomization||17
7810265|NCT01157676|19227420|P1|NOT COMPLETED|Randomization||21
7810266|NCT01157676|19227419|P2|COMPLETED|Randomization||159
7810267|NCT01157676|19227420|P1|COMPLETED|Randomization||153
7810268|NCT01157676|19227419|P2|STARTED|Randomization||176
7810269|NCT01157676|19227420|P1|STARTED|Randomization||174
7810270|NCT01157676|19227419|P2|NOT COMPLETED|Enrollment||0
7810271|NCT01157676|19227420|P1|NOT COMPLETED|Enrollment||0
7810272|NCT01157676|19227419|P2|COMPLETED|Enrollment||176
7810273|NCT01157676|19227420|P1|COMPLETED|Enrollment||174
7810274|NCT01157676|19227419|P2|STARTED|Enrollment||176
7810275|NCT01157676|19227420|P1|STARTED|Enrollment||174
7810276|NCT01157533|19227466|P1|NOT COMPLETED|Overall Study||0
7810277|NCT01157533|19227466|P1|COMPLETED|Overall Study||1
7810278|NCT01157533|19227466|P1|STARTED|Overall Study||1
7810279|NCT01157429|19227472|P2|NOT COMPLETED|Overall Study||4
7810280|NCT01157429|19227473|P1|NOT COMPLETED|Overall Study||4
7810281|NCT01157429|19227472|P2|COMPLETED|Overall Study||8
7810282|NCT01157429|19227473|P1|COMPLETED|Overall Study||8
7810283|NCT01157429|19227472|P2|STARTED|Overall Study||12
7810284|NCT01157429|19227473|P1|STARTED|Overall Study||12
7810285|NCT01157416|19227481|P2|NOT COMPLETED|Overall Study||0
7810286|NCT01157416|19227482|P1|NOT COMPLETED|Overall Study||2
7810287|NCT01157416|19227481|P2|COMPLETED|Overall Study||16
7810288|NCT01157416|19227482|P1|COMPLETED|Overall Study||15
7810289|NCT01157416|19227481|P2|STARTED|Overall Study||16
7810290|NCT01157416|19227482|P1|STARTED|Overall Study||17
7810291|NCT01157377|19227495|P7|NOT COMPLETED|Overall Study||2
7810292|NCT01157377|19227496|P6|NOT COMPLETED|Overall Study||3
7810293|NCT01157377|19227497|P5|NOT COMPLETED|Overall Study||2
7810294|NCT01157377|19227498|P4|NOT COMPLETED|Overall Study||1
7810295|NCT01157377|19227499|P3|NOT COMPLETED|Overall Study||1
7810296|NCT01157377|19227500|P2|NOT COMPLETED|Overall Study||3
7810297|NCT01157377|19227501|P1|NOT COMPLETED|Overall Study||2
7810298|NCT01157377|19227495|P7|COMPLETED|Overall Study||27
7810299|NCT01157377|19227496|P6|COMPLETED|Overall Study||16
7810300|NCT01157377|19227497|P5|COMPLETED|Overall Study||18
7810301|NCT01157377|19227498|P4|COMPLETED|Overall Study||14
7810302|NCT01157377|19227499|P3|COMPLETED|Overall Study||26
7810303|NCT01157377|19227500|P2|COMPLETED|Overall Study||20
7810304|NCT01157377|19227501|P1|COMPLETED|Overall Study||21
7810305|NCT01157377|19227495|P7|STARTED|Overall Study||29
7810306|NCT01157377|19227496|P6|STARTED|Overall Study||19
7810307|NCT01157377|19227497|P5|STARTED|Overall Study||20
7810308|NCT01157377|19227498|P4|STARTED|Overall Study||15
7810309|NCT01157377|19227499|P3|STARTED|Overall Study||27
7810310|NCT01157377|19227500|P2|STARTED|Overall Study||23
7810311|NCT01157377|19227501|P1|STARTED|Overall Study||23
7810312|NCT01157364|19227523|P6|NOT COMPLETED|Overall Study||1
7810313|NCT01157364|19227524|P5|NOT COMPLETED|Overall Study||2
7810314|NCT01157364|19227525|P4|NOT COMPLETED|Overall Study||2
7810315|NCT01157364|19227526|P3|NOT COMPLETED|Overall Study||4
7810316|NCT01157364|19227527|P2|NOT COMPLETED|Overall Study||4
7810317|NCT01157364|19227528|P1|NOT COMPLETED|Overall Study||2
7810318|NCT01157364|19227523|P6|COMPLETED|Overall Study||22
7810319|NCT01157364|19227524|P5|COMPLETED|Overall Study||9
7810320|NCT01157364|19227525|P4|COMPLETED|Overall Study||16
7810321|NCT01157364|19227526|P3|COMPLETED|Overall Study||17
7810322|NCT01157364|19227527|P2|COMPLETED|Overall Study||17
7810323|NCT01157364|19227528|P1|COMPLETED|Overall Study||13
7810324|NCT01157364|19227523|P6|STARTED|Overall Study||23
7810325|NCT01157364|19227524|P5|STARTED|Overall Study||11
7810326|NCT01157364|19227525|P4|STARTED|Overall Study||18
7810327|NCT01157364|19227526|P3|STARTED|Overall Study||21
7810328|NCT01157364|19227527|P2|STARTED|Overall Study||21
7810329|NCT01157364|19227528|P1|STARTED|Overall Study||15
7810330|NCT01157351|19227562|P2|NOT COMPLETED|Overall Study||132
7810331|NCT01157351|19227563|P1|NOT COMPLETED|Overall Study||137
7810332|NCT01157351|19227562|P2|COMPLETED|Overall Study||88
7810333|NCT01157351|19227563|P1|COMPLETED|Overall Study||93
7810334|NCT01157351|19227562|P2|Treated|Overall Study||218
7810335|NCT01157351|19227563|P1|Treated|Overall Study||226
7810336|NCT01157351|19227562|P2|STARTED|Overall Study||220
7810337|NCT01157351|19227563|P1|STARTED|Overall Study||230
7810338|NCT01157234|19227581|P2|NOT COMPLETED|Overall Study||0
7810339|NCT01157234|19227582|P1|NOT COMPLETED|Overall Study||1
7810340|NCT01157234|19227581|P2|COMPLETED|Overall Study||15
7810341|NCT01157234|19227582|P1|COMPLETED|Overall Study||14
7810342|NCT01157234|19227581|P2|STARTED|Overall Study||15
7810343|NCT01157234|19227582|P1|STARTED|Overall Study||15
7810344|NCT01157182|19227614|P2|NOT COMPLETED|Second Intervention||0
7810345|NCT01157182|19227615|P1|NOT COMPLETED|Second Intervention||0
7810346|NCT01157182|19227614|P2|COMPLETED|Second Intervention||18
7810347|NCT01157182|19227615|P1|COMPLETED|Second Intervention||16
7810348|NCT01157182|19227614|P2|STARTED|Second Intervention||18
7810349|NCT01157182|19227615|P1|STARTED|Second Intervention||16
7810350|NCT01157182|19227614|P2|NOT COMPLETED|Washout of 28 Days||0
7810351|NCT01157182|19227615|P1|NOT COMPLETED|Washout of 28 Days||2
7810352|NCT01157182|19227614|P2|COMPLETED|Washout of 28 Days||18
7810353|NCT01157182|19227615|P1|COMPLETED|Washout of 28 Days||16
7810354|NCT01157182|19227614|P2|STARTED|Washout of 28 Days||18
7810355|NCT01157182|19227615|P1|STARTED|Washout of 28 Days||18
7810356|NCT01157182|19227614|P2|NOT COMPLETED|First Intervention||0
7810357|NCT01157182|19227615|P1|NOT COMPLETED|First Intervention||0
7810358|NCT01157182|19227614|P2|COMPLETED|First Intervention||18
7810359|NCT01157182|19227615|P1|COMPLETED|First Intervention||18
7810360|NCT01157182|19227614|P2|STARTED|First Intervention||18
7810361|NCT01157182|19227615|P1|STARTED|First Intervention||18
7810362|NCT01157169|19227663|P2|NOT COMPLETED|Second Intervention||1
7810363|NCT01157169|19227664|P1|NOT COMPLETED|Second Intervention||0
7810364|NCT01157169|19227663|P2|COMPLETED|Second Intervention||17
7810365|NCT01157169|19227664|P1|COMPLETED|Second Intervention||16
7810366|NCT01157169|19227663|P2|STARTED|Second Intervention||18
7810367|NCT01157169|19227664|P1|STARTED|Second Intervention||16
7810368|NCT01157169|19227663|P2|NOT COMPLETED|Washout of 10 Days||0
7810369|NCT01157169|19227664|P1|NOT COMPLETED|Washout of 10 Days||0
7810370|NCT01157169|19227663|P2|COMPLETED|Washout of 10 Days||18
7810371|NCT01157169|19227664|P1|COMPLETED|Washout of 10 Days||16
7810372|NCT01157169|19227663|P2|STARTED|Washout of 10 Days||18
7810373|NCT01157169|19227664|P1|STARTED|Washout of 10 Days||16
7810374|NCT01157169|19227663|P2|NOT COMPLETED|First Intervention||2
7810375|NCT01157169|19227664|P1|NOT COMPLETED|First Intervention||4
7810376|NCT01157169|19227663|P2|COMPLETED|First Intervention||18
7810377|NCT01157169|19227664|P1|COMPLETED|First Intervention||16
7810378|NCT01157169|19227663|P2|STARTED|First Intervention||20
7810379|NCT01157169|19227664|P1|STARTED|First Intervention||20
7810380|NCT01157117|19227683|P3|NOT COMPLETED|Overall Study||15
7810381|NCT01157117|19227684|P2|NOT COMPLETED|Overall Study||11
7810382|NCT01157117|19227685|P1|NOT COMPLETED|Overall Study||9
7810383|NCT01157117|19227683|P3|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5
7810384|NCT01157117|19227684|P2|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18
7810385|NCT01157117|19227685|P1|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19
7810386|NCT01157117|19227683|P3|Completed Final Month 38 Study Visit|Overall Study||3
7810387|NCT01157117|19227684|P2|Completed Final Month 38 Study Visit|Overall Study||18
7810388|NCT01157117|19227685|P1|Completed Final Month 38 Study Visit|Overall Study||19
7810389|NCT01157117|19227683|P3|Completed Month 32 Tolerance OFC|Overall Study||0
7810390|NCT01157117|19227684|P2|Completed Month 32 Tolerance OFC|Overall Study||20
7810391|NCT01157117|19227685|P1|Completed Month 32 Tolerance OFC|Overall Study||24
7810392|NCT01157117|19227683|P3|Discontinued Milk OIT at Month 30|Overall Study||0
7810393|NCT01157117|19227684|P2|Discontinued Milk OIT at Month 30|Overall Study||20
7810394|NCT01157117|19227685|P1|Discontinued Milk OIT at Month 30|Overall Study||24
7810395|NCT01157117|19227683|P3|Completed Month 28 Desensitization OFC|Overall Study||0
7810396|NCT01157117|19227684|P2|Completed Month 28 Desensitization OFC|Overall Study||24
7810397|NCT01157117|19227685|P1|Completed Month 28 Desensitization OFC|Overall Study||26
7810398|NCT01157117|19227683|P3|Unblinded at Month 16|Overall Study||0
7810399|NCT01157117|19227684|P2|Unblinded at Month 16|Overall Study||26
7810400|NCT01157117|19227685|P1|Unblinded at Month 16|Overall Study||26
7810401|NCT01157117|19227683|P3|Reached Milk OIT Maintenance Dosing|Overall Study||0
7810402|NCT01157117|19227684|P2|Reached Milk OIT Maintenance Dosing|Overall Study||26
7810403|NCT01157117|19227685|P1|Reached Milk OIT Maintenance Dosing|Overall Study||26
7810404|NCT01157117|19227683|P3|Began Milk OIT Dosing at Month 4|Overall Study||0
7810405|NCT01157117|19227684|P2|Began Milk OIT Dosing at Month 4|Overall Study||28
7810406|NCT01157117|19227685|P1|Began Milk OIT Dosing at Month 4|Overall Study||27
7810407|NCT01157117|19227683|P3|Began Omalizumab or Placebo Dosing|Overall Study||0
7810408|NCT01157117|19227684|P2|Began Omalizumab or Placebo Dosing|Overall Study||28
7810409|NCT01157117|19227685|P1|Began Omalizumab or Placebo Dosing|Overall Study||27
7810410|NCT01157117|19227683|P3|STARTED|Overall Study||20
7810411|NCT01157117|19227684|P2|STARTED|Overall Study||29
7810412|NCT01157117|19227685|P1|STARTED|Overall Study||28
7810413|NCT01157078|19227726|P2|NOT COMPLETED|Overall Study||36
7810414|NCT01157078|19227727|P1|NOT COMPLETED|Overall Study||35
7810415|NCT01157078|19227726|P2|COMPLETED|Overall Study||124
7810416|NCT01157078|19227727|P1|COMPLETED|Overall Study||124
7810417|NCT01157078|19227726|P2|Received Treatment|Overall Study||159
7810418|NCT01157078|19227727|P1|Received Treatment|Overall Study||157
7810419|NCT01157078|19227726|P2|STARTED|Overall Study||160
7810420|NCT01157078|19227727|P1|STARTED|Overall Study||159
7810421|NCT01157065|19227777|P2|NOT COMPLETED|Overall Study||1
7810422|NCT01157065|19227778|P1|NOT COMPLETED|Overall Study||0
7810423|NCT01157065|19227777|P2|COMPLETED|Overall Study||10
7810424|NCT01157065|19227778|P1|COMPLETED|Overall Study||38
7810425|NCT01157065|19227777|P2|STARTED|Overall Study||11
7810426|NCT01157065|19227778|P1|STARTED|Overall Study||38
7810427|NCT01156987|19227788|P2|NOT COMPLETED|Overall Study||11
7810428|NCT01156987|19227789|P1|NOT COMPLETED|Overall Study||0
7810429|NCT01156987|19227788|P2|COMPLETED|Overall Study||12
7810430|NCT01156987|19227789|P1|COMPLETED|Overall Study||8
7810431|NCT01156987|19227788|P2|STARTED|Overall Study||23
7810432|NCT01156987|19227789|P1|STARTED|Overall Study||8
7810433|NCT01156844|19227799|P4|NOT COMPLETED|Overall Study||6
7810434|NCT01156844|19227800|P3|NOT COMPLETED|Overall Study||6
7810435|NCT01156844|19227801|P2|NOT COMPLETED|Overall Study||2
7810436|NCT01156844|19227802|P1|NOT COMPLETED|Overall Study||2
7810437|NCT01156844|19227799|P4|COMPLETED|Overall Study||41
7810438|NCT01156844|19227800|P3|COMPLETED|Overall Study||42
7810439|NCT01156844|19227801|P2|COMPLETED|Overall Study||46
7810440|NCT01156844|19227802|P1|COMPLETED|Overall Study||46
7810441|NCT01156844|19227799|P4|PD & Safety Sets: Received Study Drug|Overall Study||46
7810442|NCT01156844|19227800|P3|PD & Safety Sets: Received Study Drug|Overall Study||48
7810443|NCT01156844|19227801|P2|PD & Safety Sets: Received Study Drug|Overall Study||47
7810444|NCT01156844|19227802|P1|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48
7810445|NCT01156844|19227799|P4|STARTED|Overall Study||47
7810446|NCT01156844|19227800|P3|STARTED|Overall Study||48
7810447|NCT01156844|19227801|P2|STARTED|Overall Study||48
7810448|NCT01156844|19227802|P1|STARTED|Overall Study|Randomized participants.|48
7810449|NCT01156805|19227823|P2|NOT COMPLETED|Overall Study||56
7810450|NCT01156805|19227824|P1|NOT COMPLETED|Overall Study||56
7810451|NCT01156805|19227823|P2|COMPLETED|Overall Study||216
7810452|NCT01156805|19227824|P1|COMPLETED|Overall Study||181
7810453|NCT01156805|19227823|P2|STARTED|Overall Study||272
7810454|NCT01156805|19227824|P1|STARTED|Overall Study||237
7810455|NCT01156792|19227836|P1|NOT COMPLETED|Overall Study||69
7810456|NCT01156792|19227836|P1|COMPLETED|Overall Study||93
7810457|NCT01156792|19227836|P1|STARTED|Overall Study||162
7810458|NCT01156714|19227904|P3|NOT COMPLETED|Overall Study||3
7810459|NCT01156714|19227905|P2|NOT COMPLETED|Overall Study||4
7810460|NCT01156714|19227906|P1|NOT COMPLETED|Overall Study||9
7810461|NCT01156714|19227904|P3|COMPLETED|Overall Study||17
7810462|NCT01156714|19227905|P2|COMPLETED|Overall Study||15
7810463|NCT01156714|19227906|P1|COMPLETED|Overall Study||11
7810464|NCT01156714|19227904|P3|STARTED|Overall Study||20
7810465|NCT01156714|19227905|P2|STARTED|Overall Study||19
7810466|NCT01156714|19227906|P1|STARTED|Overall Study||20
7810467|NCT01156701|19227929|P4|NOT COMPLETED|Overall Study||0
7810468|NCT01156701|19227930|P3|NOT COMPLETED|Overall Study||0
7810469|NCT01156701|19227931|P2|NOT COMPLETED|Overall Study||0
7810470|NCT01156701|19227932|P1|NOT COMPLETED|Overall Study||0
7810471|NCT01156701|19227929|P4|COMPLETED|Overall Study||6725
7810472|NCT01156701|19227930|P3|COMPLETED|Overall Study||163716
7810473|NCT01156701|19227931|P2|COMPLETED|Overall Study||1007
7810474|NCT01156701|19227932|P1|COMPLETED|Overall Study||257
7810475|NCT01156701|19227929|P4|STARTED|Overall Study||6725
7810476|NCT01156701|19227930|P3|STARTED|Overall Study||163716
7810477|NCT01156701|19227931|P2|STARTED|Overall Study||1007
7810478|NCT01156701|19227932|P1|STARTED|Overall Study||257
7810479|NCT01156675|19227969|P3|NOT COMPLETED|Overall Study||2
7810480|NCT01156675|19227970|P2|NOT COMPLETED|Overall Study||25
7810481|NCT01156675|19227971|P1|NOT COMPLETED|Overall Study||34
7810482|NCT01156675|19227969|P3|COMPLETED|Overall Study||0
7810483|NCT01156675|19227970|P2|COMPLETED|Overall Study||81
7810484|NCT01156675|19227971|P1|COMPLETED|Overall Study||73
7810485|NCT01156675|19227969|P3|STARTED|Overall Study||2
7810486|NCT01156675|19227970|P2|STARTED|Overall Study||106
7810487|NCT01156675|19227971|P1|STARTED|Overall Study||107
7810488|NCT01156597|19228005|P2|NOT COMPLETED|Overall Study||1
7810489|NCT01156597|19228006|P1|NOT COMPLETED|Overall Study||3
7810490|NCT01156597|19228005|P2|COMPLETED|Overall Study||13
7810491|NCT01156597|19228006|P1|COMPLETED|Overall Study||13
7810492|NCT01156597|19228005|P2|STARTED|Overall Study||14
7810493|NCT01156597|19228006|P1|STARTED|Overall Study||16
7810494|NCT01156571|19228018|P2|NOT COMPLETED|Overall Study||19
7810495|NCT01156571|19228019|P1|NOT COMPLETED|Overall Study||17
7810496|NCT01156571|19228018|P2|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545
7810497|NCT01156571|19228019|P1|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564
7810498|NCT01156571|19228018|P2|STARTED|Overall Study|ITT: defined as all patients randomized.|5564
7810499|NCT01156571|19228019|P1|STARTED|Overall Study|ITT: defined as all patients randomized.|5581
7810500|NCT01156532|19228029|P1|NOT COMPLETED|Overall Study||2
7810501|NCT01156532|19228029|P1|COMPLETED|Overall Study||28
7810502|NCT01156532|19228029|P1|STARTED|Overall Study||30
7810503|NCT01156480|19228041|P2|NOT COMPLETED|Overall Study||1
7810504|NCT01156480|19228042|P1|NOT COMPLETED|Overall Study||0
7810505|NCT01156480|19228041|P2|COMPLETED|Overall Study||1
7810506|NCT01156480|19228042|P1|COMPLETED|Overall Study||0
7810507|NCT01156480|19228041|P2|STARTED|Overall Study||2
7810508|NCT01156480|19228042|P1|STARTED|Overall Study||0
7810509|NCT01156376|19228071|P3|NOT COMPLETED|Overall Study||4
7810510|NCT01156376|19228072|P2|NOT COMPLETED|Overall Study||0
7810511|NCT01156376|19228073|P1|NOT COMPLETED|Overall Study||1
7810512|NCT01156376|19228071|P3|COMPLETED|Overall Study||23
7810513|NCT01156376|19228072|P2|COMPLETED|Overall Study||26
7810514|NCT01156376|19228073|P1|COMPLETED|Overall Study||26
7810515|NCT01156376|19228071|P3|STARTED|Overall Study||27
7810516|NCT01156376|19228072|P2|STARTED|Overall Study||26
7810517|NCT01156376|19228073|P1|STARTED|Overall Study||27
7810518|NCT01156363|19228294|P1|NOT COMPLETED|Overall Study||22
7810519|NCT01156363|19228294|P1|COMPLETED|Overall Study||64
7810520|NCT01156363|19228294|P1|STARTED|Overall Study||86
7810521|NCT01156311|19228316|P4|NOT COMPLETED|6-month Add-on Therapy Period||10
7810522|NCT01156311|19228317|P3|NOT COMPLETED|6-month Add-on Therapy Period||12
7810523|NCT01156311|19228318|P2|NOT COMPLETED|6-month Add-on Therapy Period||0
7810524|NCT01156311|19228319|P1|NOT COMPLETED|6-month Add-on Therapy Period||0
7810525|NCT01156311|19228316|P4|COMPLETED|6-month Add-on Therapy Period||37
7810526|NCT01156311|19228317|P3|COMPLETED|6-month Add-on Therapy Period||45
7810527|NCT01156311|19228318|P2|COMPLETED|6-month Add-on Therapy Period||0
7810528|NCT01156311|19228319|P1|COMPLETED|6-month Add-on Therapy Period||0
7810529|NCT01156311|19228316|P4|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38
7810530|NCT01156311|19228317|P3|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45
7810531|NCT01156311|19228318|P2|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
7810532|NCT01156311|19228319|P1|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
7810533|NCT01156311|19228316|P4|STARTED|6-month Add-on Therapy Period||47
7810534|NCT01156311|19228317|P3|STARTED|6-month Add-on Therapy Period||57
7810535|NCT01156311|19228318|P2|STARTED|6-month Add-on Therapy Period||0
7810536|NCT01156311|19228319|P1|STARTED|6-month Add-on Therapy Period||0
7810537|NCT01156311|19228316|P4|NOT COMPLETED|2-Month Monotherapy Period||0
7810538|NCT01156311|19228317|P3|NOT COMPLETED|2-Month Monotherapy Period||0
7810539|NCT01156311|19228318|P2|NOT COMPLETED|2-Month Monotherapy Period||2
7810540|NCT01156311|19228319|P1|NOT COMPLETED|2-Month Monotherapy Period||2
7810541|NCT01156311|19228316|P4|COMPLETED|2-Month Monotherapy Period||0
7810542|NCT01156311|19228317|P3|COMPLETED|2-Month Monotherapy Period||0
7810543|NCT01156311|19228318|P2|COMPLETED|2-Month Monotherapy Period||47
7810544|NCT01156311|19228319|P1|COMPLETED|2-Month Monotherapy Period||57
7810545|NCT01156311|19228316|P4|STARTED|2-Month Monotherapy Period||0
7810546|NCT01156311|19228317|P3|STARTED|2-Month Monotherapy Period||0
7810547|NCT01156311|19228318|P2|STARTED|2-Month Monotherapy Period||49
7810548|NCT01156311|19228319|P1|STARTED|2-Month Monotherapy Period||59
7810549|NCT01156142|19228343|P2|NOT COMPLETED|Overall Study||7
7810550|NCT01156142|19228344|P1|NOT COMPLETED|Overall Study||8
7810551|NCT01156142|19228343|P2|COMPLETED|Overall Study||71
7810552|NCT01156142|19228344|P1|COMPLETED|Overall Study||69
7810553|NCT01156142|19228343|P2|STARTED|Overall Study||78
7810554|NCT01156142|19228344|P1|STARTED|Overall Study||77
7810555|NCT01156116|19228362|P2|NOT COMPLETED|Overall Study||1
7810556|NCT01156116|19228363|P1|NOT COMPLETED|Overall Study||5
7810557|NCT01156116|19228362|P2|COMPLETED|Overall Study||12
7810558|NCT01156116|19228363|P1|COMPLETED|Overall Study||21
7810559|NCT01156116|19228362|P2|STARTED|Overall Study||13
7810560|NCT01156116|19228363|P1|STARTED|Overall Study||26
7810561|NCT01156051|19228377|P2|NOT COMPLETED|Overall Study||1
7810562|NCT01156051|19228378|P1|NOT COMPLETED|Overall Study||1
7810563|NCT01156051|19228377|P2|COMPLETED|Overall Study||16
7810564|NCT01156051|19228378|P1|COMPLETED|Overall Study||11
7810565|NCT01156051|19228377|P2|STARTED|Overall Study||17
7810566|NCT01156051|19228378|P1|STARTED|Overall Study||12
7810567|NCT01156012|19228392|P2|NOT COMPLETED|Overall Study||3
7810568|NCT01156012|19228393|P1|NOT COMPLETED|Overall Study||7
7810569|NCT01156012|19228392|P2|COMPLETED|Overall Study||186
7810570|NCT01156012|19228393|P1|COMPLETED|Overall Study||206
7810571|NCT01156012|19228392|P2|STARTED|Overall Study||189
7810572|NCT01156012|19228393|P1|STARTED|Overall Study||213
7810573|NCT01155999|19228401|P2|NOT COMPLETED|Overall Study||4
7810574|NCT01155999|19228402|P1|NOT COMPLETED|Overall Study||7
7810575|NCT01155999|19228401|P2|COMPLETED|Overall Study||136
7810576|NCT01155999|19228402|P1|COMPLETED|Overall Study||139
7810577|NCT01155999|19228401|P2|STARTED|Overall Study||140
7810578|NCT01155999|19228402|P1|STARTED|Overall Study||146
7810579|NCT01155869|19228410|P2|NOT COMPLETED|Overall Study||1
7810580|NCT01155869|19228411|P1|NOT COMPLETED|Overall Study||3
7810581|NCT01155869|19228410|P2|COMPLETED|Overall Study||3
7810582|NCT01155869|19228411|P1|COMPLETED|Overall Study||0
7810583|NCT01155869|19228410|P2|STARTED|Overall Study||4
7810584|NCT01155869|19228411|P1|STARTED|Overall Study||3
7810585|NCT01155830|19228422|P3|NOT COMPLETED|Overall Study||0
7810586|NCT01155830|19228423|P2|NOT COMPLETED|Overall Study||0
7810587|NCT01155830|19228424|P1|NOT COMPLETED|Overall Study||0
7810588|NCT01155830|19228422|P3|COMPLETED|Overall Study||21
7810589|NCT01155830|19228423|P2|COMPLETED|Overall Study||0
7810590|NCT01155830|19228424|P1|COMPLETED|Overall Study||0
7810591|NCT01155830|19228422|P3|STARTED|Overall Study||21
7810592|NCT01155830|19228423|P2|STARTED|Overall Study||0
7810593|NCT01155830|19228424|P1|STARTED|Overall Study||0
7810594|NCT01155778|19228438|P3|NOT COMPLETED|Overall Study||0
7810595|NCT01155778|19228439|P2|NOT COMPLETED|Overall Study||0
7810596|NCT01155778|19228440|P1|NOT COMPLETED|Overall Study||0
7810597|NCT01155778|19228438|P3|COMPLETED|Overall Study||4
7810598|NCT01155778|19228439|P2|COMPLETED|Overall Study||4
7810599|NCT01155778|19228440|P1|COMPLETED|Overall Study||4
7810600|NCT01155778|19228438|P3|STARTED|Overall Study||4
7810601|NCT01155778|19228439|P2|STARTED|Overall Study||4
7810602|NCT01155778|19228440|P1|STARTED|Overall Study||4
7810603|NCT01155726|19228520|P4|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
7810604|NCT01155726|19228521|P3|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
7810605|NCT01155726|19228522|P2|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
7810606|NCT01155726|19228523|P1|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
7810607|NCT01155726|19228520|P4|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25
7810608|NCT01155726|19228521|P3|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28
7810609|NCT01155726|19228522|P2|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20
7810610|NCT01155726|19228523|P1|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23
7810611|NCT01155726|19228520|P4|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25
7810612|NCT01155726|19228521|P3|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28
7810613|NCT01155726|19228522|P2|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20
7810614|NCT01155726|19228523|P1|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23
7810615|NCT01155726|19228520|P4|NOT COMPLETED|Period 1, 3 Days (Masked)||0
7810616|NCT01155726|19228521|P3|NOT COMPLETED|Period 1, 3 Days (Masked)||2
7810617|NCT01155726|19228522|P2|NOT COMPLETED|Period 1, 3 Days (Masked)||0
7810618|NCT01155726|19228523|P1|NOT COMPLETED|Period 1, 3 Days (Masked)||1
7810619|NCT01155726|19228520|P4|COMPLETED|Period 1, 3 Days (Masked)||25
7810620|NCT01155726|19228521|P3|COMPLETED|Period 1, 3 Days (Masked)||28
7810621|NCT01155726|19228522|P2|COMPLETED|Period 1, 3 Days (Masked)||20
7810622|NCT01155726|19228523|P1|COMPLETED|Period 1, 3 Days (Masked)||23
7810623|NCT01155726|19228520|P4|STARTED|Period 1, 3 Days (Masked)||25
7810624|NCT01155726|19228521|P3|STARTED|Period 1, 3 Days (Masked)||30
7810625|NCT01155726|19228522|P2|STARTED|Period 1, 3 Days (Masked)||20
7810626|NCT01155726|19228523|P1|STARTED|Period 1, 3 Days (Masked)||24
7810627|NCT01155661|19228545|P1|NOT COMPLETED|Overall Study||280
7810628|NCT01155661|19228545|P1|COMPLETED|Overall Study||328
7810629|NCT01155661|19228545|P1|STARTED|Overall Study||608
7810630|NCT01155583|19228580|P9|NOT COMPLETED|Phase II - Expansion Phase||0
7810631|NCT01155583|19228581|P8|NOT COMPLETED|Phase II - Expansion Phase||0
7810632|NCT01155583|19228582|P7|NOT COMPLETED|Phase II - Expansion Phase||0
7810633|NCT01155583|19228583|P6|NOT COMPLETED|Phase II - Expansion Phase||0
7810634|NCT01155583|19228584|P5|NOT COMPLETED|Phase II - Expansion Phase||0
7810635|NCT01155583|19228585|P4|NOT COMPLETED|Phase II - Expansion Phase||0
7810636|NCT01155583|19228586|P3|NOT COMPLETED|Phase II - Expansion Phase||0
7810637|NCT01155583|19228587|P2|NOT COMPLETED|Phase II - Expansion Phase||0
7810638|NCT01155583|19228588|P1|NOT COMPLETED|Phase II - Expansion Phase||0
7810639|NCT01155583|19228580|P9|COMPLETED|Phase II - Expansion Phase||11
7810640|NCT01155583|19228581|P8|COMPLETED|Phase II - Expansion Phase||0
7810641|NCT01155583|19228582|P7|COMPLETED|Phase II - Expansion Phase||0
7810642|NCT01155583|19228583|P6|COMPLETED|Phase II - Expansion Phase||0
7810643|NCT01155583|19228584|P5|COMPLETED|Phase II - Expansion Phase||0
7810644|NCT01155583|19228585|P4|COMPLETED|Phase II - Expansion Phase||0
7810645|NCT01155583|19228586|P3|COMPLETED|Phase II - Expansion Phase||0
7810646|NCT01155583|19228587|P2|COMPLETED|Phase II - Expansion Phase||0
7810647|NCT01155583|19228588|P1|COMPLETED|Phase II - Expansion Phase||0
7810648|NCT01155583|19228580|P9|STARTED|Phase II - Expansion Phase||11
7810649|NCT01155583|19228581|P8|STARTED|Phase II - Expansion Phase||0
7810650|NCT01155583|19228582|P7|STARTED|Phase II - Expansion Phase||0
7810651|NCT01155583|19228583|P6|STARTED|Phase II - Expansion Phase||0
7810652|NCT01155583|19228584|P5|STARTED|Phase II - Expansion Phase||0
7810653|NCT01155583|19228585|P4|STARTED|Phase II - Expansion Phase||0
7810654|NCT01155583|19228586|P3|STARTED|Phase II - Expansion Phase||0
7810655|NCT01155583|19228587|P2|STARTED|Phase II - Expansion Phase||0
7810656|NCT01155583|19228588|P1|STARTED|Phase II - Expansion Phase||0
7810657|NCT01155583|19228580|P9|NOT COMPLETED|Phase I||0
7810658|NCT01155583|19228581|P8|NOT COMPLETED|Phase I||3
7810659|NCT01155583|19228582|P7|NOT COMPLETED|Phase I||0
7810660|NCT01155583|19228583|P6|NOT COMPLETED|Phase I||0
7810661|NCT01155583|19228584|P5|NOT COMPLETED|Phase I||1
7810662|NCT01155583|19228585|P4|NOT COMPLETED|Phase I||0
7810663|NCT01155583|19228586|P3|NOT COMPLETED|Phase I||0
7810664|NCT01155583|19228587|P2|NOT COMPLETED|Phase I||0
7810665|NCT01155583|19228588|P1|NOT COMPLETED|Phase I||0
7810666|NCT01155583|19228580|P9|COMPLETED|Phase I||0
7810667|NCT01155583|19228581|P8|COMPLETED|Phase I||5
7810668|NCT01155583|19228582|P7|COMPLETED|Phase I||3
7810669|NCT01155583|19228583|P6|COMPLETED|Phase I||0
7810670|NCT01155583|19228584|P5|COMPLETED|Phase I||6
7810671|NCT01155583|19228585|P4|COMPLETED|Phase I||6
7810672|NCT01155583|19228586|P3|COMPLETED|Phase I||4
7810673|NCT01155583|19228587|P2|COMPLETED|Phase I||3
7810674|NCT01155583|19228588|P1|COMPLETED|Phase I||3
7810675|NCT01155583|19228580|P9|STARTED|Phase I||0
7810676|NCT01155583|19228581|P8|STARTED|Phase I||8
7810677|NCT01155583|19228582|P7|STARTED|Phase I||3
7810678|NCT01155583|19228583|P6|STARTED|Phase I||0
7810679|NCT01155583|19228584|P5|STARTED|Phase I||7
7810680|NCT01155583|19228585|P4|STARTED|Phase I||6
7810681|NCT01155583|19228586|P3|STARTED|Phase I||4
7810682|NCT01155583|19228587|P2|STARTED|Phase I||3
7810683|NCT01155583|19228588|P1|STARTED|Phase I||3
7810684|NCT01155570|19228607|P1|NOT COMPLETED|Overall Study||142
7810685|NCT01155570|19228607|P1|COMPLETED|Overall Study||592
7810686|NCT01155570|19228607|P1|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708
7810687|NCT01155570|19228607|P1|STARTED|Overall Study|Safety Analysis Population|734
7810688|NCT01155531|19228641|P4|NOT COMPLETED|Overall Study||1
7810689|NCT01155531|19228642|P3|NOT COMPLETED|Overall Study||2
7810690|NCT01155531|19228643|P2|NOT COMPLETED|Overall Study||0
7810691|NCT01155531|19228644|P1|NOT COMPLETED|Overall Study||1
7810692|NCT01155531|19228641|P4|COMPLETED|Overall Study||9
7810693|NCT01155531|19228642|P3|COMPLETED|Overall Study||8
7810694|NCT01155531|19228643|P2|COMPLETED|Overall Study||10
7810695|NCT01155531|19228644|P1|COMPLETED|Overall Study||9
7810696|NCT01155531|19228641|P4|STARTED|Overall Study||10
7810697|NCT01155531|19228642|P3|STARTED|Overall Study||10
7810698|NCT01155531|19228643|P2|STARTED|Overall Study||10
7810699|NCT01155531|19228644|P1|STARTED|Overall Study||10
7810700|NCT01155518|19228668|P6|NOT COMPLETED|Overall Study||0
7810701|NCT01155518|19228669|P5|NOT COMPLETED|Overall Study||0
7810702|NCT01155518|19228670|P4|NOT COMPLETED|Overall Study||0
7810703|NCT01155518|19228671|P3|NOT COMPLETED|Overall Study||0
7810704|NCT01155518|19228672|P2|NOT COMPLETED|Overall Study||1
7810705|NCT01155518|19228673|P1|NOT COMPLETED|Overall Study||0
7810706|NCT01155518|19228668|P6|COMPLETED|Overall Study||2
7810707|NCT01155518|19228669|P5|COMPLETED|Overall Study||1
7810708|NCT01155518|19228670|P4|COMPLETED|Overall Study||0
7810709|NCT01155518|19228671|P3|COMPLETED|Overall Study||0
7810710|NCT01155518|19228672|P2|COMPLETED|Overall Study|never started the study|0
7810711|NCT01155518|19228673|P1|COMPLETED|Overall Study||1
7810712|NCT01155518|19228668|P6|STARTED|Overall Study||2
7810713|NCT01155518|19228669|P5|STARTED|Overall Study||1
7810714|NCT01155518|19228670|P4|STARTED|Overall Study||0
7810715|NCT01155518|19228671|P3|STARTED|Overall Study||0
7810716|NCT01155518|19228672|P2|STARTED|Overall Study||1
7810717|NCT01155518|19228673|P1|STARTED|Overall Study||1
7810718|NCT01155479|19228692|P5|NOT COMPLETED|Part II||55
7810719|NCT01155479|19228693|P4|NOT COMPLETED|Part II||50
7810720|NCT01155479|19228694|P3|NOT COMPLETED|Part II||58
7810721|NCT01155479|19228695|P2|NOT COMPLETED|Part II||61
7810722|NCT01155479|19228696|P1|NOT COMPLETED|Part II||59
7810723|NCT01155479|19228692|P5|COMPLETED|Part II||126
7810724|NCT01155479|19228693|P4|COMPLETED|Part II||127
7810725|NCT01155479|19228694|P3|COMPLETED|Part II||109
7810726|NCT01155479|19228695|P2|COMPLETED|Part II||116
7810727|NCT01155479|19228696|P1|COMPLETED|Part II||107
7810728|NCT01155479|19228692|P5|STARTED|Part II||181
7810729|NCT01155479|19228693|P4|STARTED|Part II||177
7810730|NCT01155479|19228694|P3|STARTED|Part II||167
7810731|NCT01155479|19228695|P2|STARTED|Part II||177
7810732|NCT01155479|19228696|P1|STARTED|Part II||166
7810733|NCT01155479|19228692|P5|NOT COMPLETED|Part I||23
7810734|NCT01155479|19228693|P4|NOT COMPLETED|Part I||27
7810735|NCT01155479|19228694|P3|NOT COMPLETED|Part I||39
7810736|NCT01155479|19228695|P2|NOT COMPLETED|Part I||27
7810737|NCT01155479|19228696|P1|NOT COMPLETED|Part I||38
7810738|NCT01155479|19228692|P5|COMPLETED|Part I||181
7810739|NCT01155479|19228693|P4|COMPLETED|Part I||177
7810740|NCT01155479|19228694|P3|COMPLETED|Part I||167
7810741|NCT01155479|19228695|P2|COMPLETED|Part I||177
7810742|NCT01155479|19228696|P1|COMPLETED|Part I||166
7810743|NCT01155479|19228692|P5|Treated|Part I||203
7810744|NCT01155479|19228693|P4|Treated|Part I||198
7810745|NCT01155479|19228694|P3|Treated|Part I||204
7810746|NCT01155479|19228695|P2|Treated|Part I||202
7810747|NCT01155479|19228696|P1|Treated|Part I||200
7810748|NCT01155479|19228692|P5|STARTED|Part I||204
7810749|NCT01155479|19228693|P4|STARTED|Part I||204
7810750|NCT01155479|19228694|P3|STARTED|Part I||206
7810751|NCT01155479|19228695|P2|STARTED|Part I||204
7810752|NCT01155479|19228696|P1|STARTED|Part I||204
7810753|NCT01155466|19228748|P5|NOT COMPLETED|Overall Study||27
7810754|NCT01155466|19228749|P4|NOT COMPLETED|Overall Study||21
7810755|NCT01155466|19228750|P3|NOT COMPLETED|Overall Study||20
7810756|NCT01155466|19228751|P2|NOT COMPLETED|Overall Study||25
7810757|NCT01155466|19228752|P1|NOT COMPLETED|Overall Study||22
7810758|NCT01155466|19228748|P5|COMPLETED|Overall Study|Completed treatment phase|129
7810759|NCT01155466|19228749|P4|COMPLETED|Overall Study|Completed treatment phase|134
7810760|NCT01155466|19228750|P3|COMPLETED|Overall Study|Completed treatment phase|136
7810761|NCT01155466|19228751|P2|COMPLETED|Overall Study|Completed treatment phase|130
7810762|NCT01155466|19228752|P1|COMPLETED|Overall Study|Completed treatment phase|134
7810763|NCT01155466|19228748|P5|Treated|Overall Study||154
7810764|NCT01155466|19228749|P4|Treated|Overall Study||155
7810765|NCT01155466|19228750|P3|Treated|Overall Study||153
7810766|NCT01155466|19228751|P2|Treated|Overall Study||153
7810767|NCT01155466|19228752|P1|Treated|Overall Study||154
7810768|NCT01155466|19228748|P5|STARTED|Overall Study||156
7810769|NCT01155466|19228749|P4|STARTED|Overall Study||155
7810770|NCT01155466|19228750|P3|STARTED|Overall Study||156
7810771|NCT01155466|19228751|P2|STARTED|Overall Study||155
7810772|NCT01155466|19228752|P1|STARTED|Overall Study||156
7810773|NCT01155388|19228806|P2|NOT COMPLETED|Overall Study||0
7810774|NCT01155388|19228807|P1|NOT COMPLETED|Overall Study||1
7810775|NCT01155388|19228806|P2|COMPLETED|Overall Study||6
7810776|NCT01155388|19228807|P1|COMPLETED|Overall Study||7
7810777|NCT01155388|19228806|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
7810778|NCT01155388|19228807|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
7810779|NCT01155388|19228806|P2|STARTED|Overall Study||6
7810780|NCT01155388|19228807|P1|STARTED|Overall Study||8
7810781|NCT01155375|19228817|P2|NOT COMPLETED|Overall Study||0
7810782|NCT01155375|19228818|P1|NOT COMPLETED|Overall Study||1
7810783|NCT01155375|19228817|P2|COMPLETED|Overall Study||6
7810784|NCT01155375|19228818|P1|COMPLETED|Overall Study||7
7810785|NCT01155375|19228817|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
7810786|NCT01155375|19228818|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
7810787|NCT01155375|19228817|P2|STARTED|Overall Study||6
7810788|NCT01155375|19228818|P1|STARTED|Overall Study||8
7810789|NCT01155336|19228828|P2|NOT COMPLETED|Overall Study||0
7810790|NCT01155336|19228829|P1|NOT COMPLETED|Overall Study||0
7810791|NCT01155336|19228828|P2|COMPLETED|Overall Study|We did not complete the study.|4
7810792|NCT01155336|19228829|P1|COMPLETED|Overall Study|We did not complete the study.|0
7810793|NCT01155336|19228828|P2|STARTED|Overall Study|We did not complete the study.|4
7810794|NCT01155336|19228829|P1|STARTED|Overall Study|We did not complete the study.|0
7810795|NCT01155323|19228837|P2|NOT COMPLETED|Second Intervention||1
7810796|NCT01155323|19228838|P1|NOT COMPLETED|Second Intervention||1
7810797|NCT01155323|19228837|P2|COMPLETED|Second Intervention||56
7810798|NCT01155323|19228838|P1|COMPLETED|Second Intervention||58
7810799|NCT01155323|19228837|P2|STARTED|Second Intervention||57
7810800|NCT01155323|19228838|P1|STARTED|Second Intervention||59
7810801|NCT01155323|19228837|P2|NOT COMPLETED|First Intervention||1
7810802|NCT01155323|19228838|P1|NOT COMPLETED|First Intervention||1
7810803|NCT01155323|19228837|P2|COMPLETED|First Intervention||57
7810804|NCT01155323|19228838|P1|COMPLETED|First Intervention||59
7810805|NCT01155323|19228837|P2|STARTED|First Intervention||58
7810806|NCT01155323|19228838|P1|STARTED|First Intervention||60
7810807|NCT01155284|19228856|P2|NOT COMPLETED|Overall Study||5
7810808|NCT01155284|19228857|P1|NOT COMPLETED|Overall Study||7
7810809|NCT01155284|19228856|P2|COMPLETED|Overall Study||18
7810810|NCT01155284|19228857|P1|COMPLETED|Overall Study||40
7810811|NCT01155284|19228856|P2|STARTED|Overall Study||23
7810812|NCT01155284|19228857|P1|STARTED|Overall Study||47
7810813|NCT01155219|19228867|P2|NOT COMPLETED|Overall Study||3
7810814|NCT01155219|19228868|P1|NOT COMPLETED|Overall Study||4
7810815|NCT01155219|19228867|P2|COMPLETED|Overall Study||70
7810816|NCT01155219|19228868|P1|COMPLETED|Overall Study||73
7810817|NCT01155219|19228867|P2|STARTED|Overall Study||73
7810818|NCT01155219|19228868|P1|STARTED|Overall Study||77
7810819|NCT01155193|19228878|P4|NOT COMPLETED|Overall Study||91
7810820|NCT01155193|19228879|P3|NOT COMPLETED|Overall Study||12
7810821|NCT01155193|19228880|P2|NOT COMPLETED|Overall Study||13
7810822|NCT01155193|19228881|P1|NOT COMPLETED|Overall Study||238
7810823|NCT01155193|19228878|P4|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|13711
7810824|NCT01155193|19228879|P3|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|2248
7810825|NCT01155193|19228880|P2|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|3805
7810826|NCT01155193|19228881|P1|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|10686
7810827|NCT01155193|19228878|P4|STARTED|Overall Study||13802
7810828|NCT01155193|19228879|P3|STARTED|Overall Study||2260
7810829|NCT01155193|19228880|P2|STARTED|Overall Study||3818
7810830|NCT01155193|19228881|P1|STARTED|Overall Study||10924
7810831|NCT01155180|19228908|P2|NOT COMPLETED|Overall Study||0
7810832|NCT01155180|19228909|P1|NOT COMPLETED|Overall Study||0
7810833|NCT01155180|19228908|P2|COMPLETED|Overall Study||6
7810834|NCT01155180|19228909|P1|COMPLETED|Overall Study||18
7810835|NCT01155180|19228908|P2|STARTED|Overall Study||6
7810836|NCT01155180|19228909|P1|STARTED|Overall Study||18
7810837|NCT01155167|19228917|P2|NOT COMPLETED|Overall Study||0
7810838|NCT01155167|19228918|P1|NOT COMPLETED|Overall Study||3
7810839|NCT01155167|19228917|P2|COMPLETED|Overall Study||43
7810840|NCT01155167|19228918|P1|COMPLETED|Overall Study||40
7810841|NCT01155167|19228917|P2|STARTED|Overall Study||43
7810842|NCT01155167|19228918|P1|STARTED|Overall Study||43
7810843|NCT01155154|19228931|P3|NOT COMPLETED|Overall Study||0
7810844|NCT01155154|19228932|P2|NOT COMPLETED|Overall Study||0
7810845|NCT01155154|19228933|P1|NOT COMPLETED|Overall Study||0
7810846|NCT01155154|19228931|P3|COMPLETED|Overall Study||24
7810847|NCT01155154|19228932|P2|COMPLETED|Overall Study||24
7810848|NCT01155154|19228933|P1|COMPLETED|Overall Study||25
7810849|NCT01155154|19228931|P3|STARTED|Overall Study||24
7810850|NCT01155154|19228932|P2|STARTED|Overall Study||24
7810851|NCT01155154|19228933|P1|STARTED|Overall Study||25
7810852|NCT01155141|19228941|P1|NOT COMPLETED|Overall Study||2
7810853|NCT01155141|19228941|P1|COMPLETED|Overall Study||14
7810854|NCT01155141|19228941|P1|STARTED|Overall Study||16
7810855|NCT01155063|19228953|P1|NOT COMPLETED|Overall Study||89
7810856|NCT01155063|19228953|P1|COMPLETED|Overall Study||0
7810857|NCT01155063|19228953|P1|STARTED|Overall Study||89
7810858|NCT01155050|19228967|P4|NOT COMPLETED|Overall Study||22
7810859|NCT01155050|19228968|P3|NOT COMPLETED|Overall Study||19
7810860|NCT01155050|19228969|P2|NOT COMPLETED|Overall Study||20
7810861|NCT01155050|19228970|P1|NOT COMPLETED|Overall Study||15
7810862|NCT01155050|19228967|P4|COMPLETED|Overall Study||27
7810863|NCT01155050|19228968|P3|COMPLETED|Overall Study||33
7810864|NCT01155050|19228969|P2|COMPLETED|Overall Study||31
7810865|NCT01155050|19228970|P1|COMPLETED|Overall Study||35
7810866|NCT01155050|19228967|P4|STARTED|Overall Study||49
7810867|NCT01155050|19228968|P3|STARTED|Overall Study||52
7810868|NCT01155050|19228969|P2|STARTED|Overall Study||51
7810869|NCT01155050|19228970|P1|STARTED|Overall Study||50
7810870|NCT01155024|19229008|P2|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6
7810871|NCT01155024|19229009|P1|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0
7810872|NCT01155024|19229008|P2|COMPLETED|Direct Manufactured Socket 3 Month Trial||4
7810873|NCT01155024|19229009|P1|COMPLETED|Direct Manufactured Socket 3 Month Trial||0
7810874|NCT01155024|19229008|P2|STARTED|Direct Manufactured Socket 3 Month Trial||10
7810875|NCT01155024|19229009|P1|STARTED|Direct Manufactured Socket 3 Month Trial||0
7810876|NCT01155024|19229008|P2|NOT COMPLETED|Second Socket Intervention Fitting||0
7810877|NCT01155024|19229009|P1|NOT COMPLETED|Second Socket Intervention Fitting||0
7810878|NCT01155024|19229008|P2|COMPLETED|Second Socket Intervention Fitting||5
7810879|NCT01155024|19229009|P1|COMPLETED|Second Socket Intervention Fitting||5
7810880|NCT01155024|19229008|P2|STARTED|Second Socket Intervention Fitting||5
7810881|NCT01155024|19229009|P1|STARTED|Second Socket Intervention Fitting||5
7810882|NCT01155024|19229008|P2|NOT COMPLETED|First Socket Intervention Fitting||0
7810883|NCT01155024|19229009|P1|NOT COMPLETED|First Socket Intervention Fitting||0
7810884|NCT01155024|19229008|P2|COMPLETED|First Socket Intervention Fitting||5
7810885|NCT01155024|19229009|P1|COMPLETED|First Socket Intervention Fitting||5
7810886|NCT01155024|19229008|P2|STARTED|First Socket Intervention Fitting||5
7810887|NCT01155024|19229009|P1|STARTED|First Socket Intervention Fitting||5
7810888|NCT01155011|19229019|P2|NOT COMPLETED|6 to 12 Months||10
7810889|NCT01155011|19229020|P1|NOT COMPLETED|6 to 12 Months||9
7810890|NCT01155011|19229019|P2|COMPLETED|6 to 12 Months||121
7810891|NCT01155011|19229020|P1|COMPLETED|6 to 12 Months||120
7810892|NCT01155011|19229019|P2|STARTED|6 to 12 Months||131
7810893|NCT01155011|19229020|P1|STARTED|6 to 12 Months||129
7810894|NCT01155011|19229019|P2|NOT COMPLETED|Baseline to 6 Months||25
7810895|NCT01155011|19229020|P1|NOT COMPLETED|Baseline to 6 Months||22
7810896|NCT01155011|19229019|P2|COMPLETED|Baseline to 6 Months||131
7810897|NCT01155011|19229020|P1|COMPLETED|Baseline to 6 Months||129
7810898|NCT01155011|19229019|P2|STARTED|Baseline to 6 Months||156
7810899|NCT01155011|19229020|P1|STARTED|Baseline to 6 Months||151
7810900|NCT01154985|19229033|P3|NOT COMPLETED|Overall Study||18
7810901|NCT01154985|19229034|P2|NOT COMPLETED|Overall Study||27
7810902|NCT01154985|19229035|P1|NOT COMPLETED|Overall Study||17
7810903|NCT01154985|19229033|P3|COMPLETED|Overall Study||68
7810904|NCT01154985|19229034|P2|COMPLETED|Overall Study||55
7810905|NCT01154985|19229035|P1|COMPLETED|Overall Study||58
7810906|NCT01154985|19229033|P3|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64
7810907|NCT01154985|19229034|P2|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
7810908|NCT01154985|19229035|P1|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
7810909|NCT01154985|19229033|P3|Valid Biopsy -Baseline and Month 12.5|Overall Study||68
7810910|NCT01154985|19229034|P2|Valid Biopsy -Baseline and Month 12.5|Overall Study||62
7810911|NCT01154985|19229035|P1|Valid Biopsy -Baseline and Month 12.5|Overall Study||60
7810912|NCT01154985|19229033|P3|Full Analysis Set|Overall Study|Received at least one dose of study medication|86
7810913|NCT01154985|19229034|P2|Full Analysis Set|Overall Study|Received at least one dose of study medication|82
7810914|NCT01154985|19229035|P1|Full Analysis Set|Overall Study|Received at least one dose of study medication|75
7810915|NCT01154985|19229033|P3|STARTED|Overall Study|Randomized|86
7810916|NCT01154985|19229034|P2|STARTED|Overall Study|Randomized|82
7810917|NCT01154985|19229035|P1|STARTED|Overall Study|Randomized|75
7810918|NCT01154816|19229061|P12|NOT COMPLETED|Overall Study||4
7810919|NCT01154816|19229062|P11|NOT COMPLETED|Overall Study||11
7810920|NCT01154816|19229063|P10|NOT COMPLETED|Overall Study||10
7810921|NCT01154816|19229064|P9|NOT COMPLETED|Overall Study||9
7810922|NCT01154816|19229065|P8|NOT COMPLETED|Overall Study||7
7810923|NCT01154816|19229066|P7|NOT COMPLETED|Overall Study||6
7810924|NCT01154816|19229067|P6|NOT COMPLETED|Overall Study||8
7810925|NCT01154816|19229068|P5|NOT COMPLETED|Overall Study||10
7810926|NCT01154816|19229069|P4|NOT COMPLETED|Overall Study||10
7810927|NCT01154816|19229070|P3|NOT COMPLETED|Overall Study||10
7810928|NCT01154816|19229071|P2|NOT COMPLETED|Overall Study||10
7810929|NCT01154816|19229072|P1|NOT COMPLETED|Overall Study||20
7810930|NCT01154816|19229061|P12|COMPLETED|Overall Study||0
7810931|NCT01154816|19229062|P11|COMPLETED|Overall Study||0
7810932|NCT01154816|19229063|P10|COMPLETED|Overall Study||0
7810933|NCT01154816|19229064|P9|COMPLETED|Overall Study||1
7810934|NCT01154816|19229065|P8|COMPLETED|Overall Study||0
7810935|NCT01154816|19229066|P7|COMPLETED|Overall Study||0
7810936|NCT01154816|19229067|P6|COMPLETED|Overall Study||0
7810937|NCT01154816|19229068|P5|COMPLETED|Overall Study||0
7810938|NCT01154816|19229069|P4|COMPLETED|Overall Study||0
7810939|NCT01154816|19229070|P3|COMPLETED|Overall Study||0
7810940|NCT01154816|19229071|P2|COMPLETED|Overall Study||2
7810941|NCT01154816|19229072|P1|COMPLETED|Overall Study||0
7810942|NCT01154816|19229061|P12|STARTED|Overall Study||4
7810943|NCT01154816|19229062|P11|STARTED|Overall Study||11
7810944|NCT01154816|19229063|P10|STARTED|Overall Study||10
7810945|NCT01154816|19229064|P9|STARTED|Overall Study||10
7810946|NCT01154816|19229065|P8|STARTED|Overall Study||7
7810947|NCT01154816|19229066|P7|STARTED|Overall Study||6
7810948|NCT01154816|19229067|P6|STARTED|Overall Study||8
7810949|NCT01154816|19229068|P5|STARTED|Overall Study||10
7810950|NCT01154816|19229069|P4|STARTED|Overall Study||10
7810951|NCT01154816|19229070|P3|STARTED|Overall Study||10
7810952|NCT01154816|19229071|P2|STARTED|Overall Study||12
7810953|NCT01154816|19229072|P1|STARTED|Overall Study||20
7810954|NCT01154751|19229105|P1|NOT COMPLETED|3-year Follow-up||49
7810955|NCT01154751|19229105|P1|COMPLETED|3-year Follow-up||34
7810956|NCT01154751|19229105|P1|STARTED|3-year Follow-up||83
7810957|NCT01154751|19229105|P1|NOT COMPLETED|2-year Follow-up||10
7810958|NCT01154751|19229105|P1|COMPLETED|2-year Follow-up||83
7810959|NCT01154751|19229105|P1|STARTED|2-year Follow-up||93
7810960|NCT01154751|19229105|P1|NOT COMPLETED|1-year Follow-up||5
7810961|NCT01154751|19229105|P1|COMPLETED|1-year Follow-up||93
7810962|NCT01154751|19229105|P1|STARTED|1-year Follow-up||98
7810963|NCT01154751|19229105|P1|NOT COMPLETED|6-month Follow-up||11
7810964|NCT01154751|19229105|P1|COMPLETED|6-month Follow-up||98
7810965|NCT01154751|19229105|P1|STARTED|6-month Follow-up||109
7810966|NCT01154699|19229130|P2|NOT COMPLETED|Second Intervention||0
7810967|NCT01154699|19229131|P1|NOT COMPLETED|Second Intervention||0
7810968|NCT01154699|19229130|P2|COMPLETED|Second Intervention||8
7810969|NCT01154699|19229131|P1|COMPLETED|Second Intervention||13
7810970|NCT01154699|19229130|P2|Subjects With Asthma + OSA|Second Intervention||2
7810971|NCT01154699|19229131|P1|Subjects With Asthma + OSA|Second Intervention||6
7810972|NCT01154699|19229130|P2|Subjects With Asthma Only|Second Intervention||6
7810973|NCT01154699|19229131|P1|Subjects With Asthma Only|Second Intervention||7
7810974|NCT01154699|19229130|P2|STARTED|Second Intervention||8
7810975|NCT01154699|19229131|P1|STARTED|Second Intervention||13
7810976|NCT01154699|19229130|P2|NOT COMPLETED|Washout Period (4 Weeks)||0
7810977|NCT01154699|19229131|P1|NOT COMPLETED|Washout Period (4 Weeks)||0
7810978|NCT01154699|19229130|P2|COMPLETED|Washout Period (4 Weeks)||8
7810979|NCT01154699|19229131|P1|COMPLETED|Washout Period (4 Weeks)||13
7810980|NCT01154699|19229130|P2|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2
7810981|NCT01154699|19229131|P1|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6
7810982|NCT01154699|19229130|P2|Subjects With Asthma Only|Washout Period (4 Weeks)||6
7810983|NCT01154699|19229131|P1|Subjects With Asthma Only|Washout Period (4 Weeks)||7
7810984|NCT01154699|19229130|P2|STARTED|Washout Period (4 Weeks)||8
7810985|NCT01154699|19229131|P1|STARTED|Washout Period (4 Weeks)||13
7810986|NCT01154699|19229130|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
7810987|NCT01154699|19229131|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
7810988|NCT01154699|19229130|P2|COMPLETED|First Intervention (4 Weeks)||8
7810989|NCT01154699|19229131|P1|COMPLETED|First Intervention (4 Weeks)||13
7810990|NCT01154699|19229130|P2|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2
7810991|NCT01154699|19229131|P1|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6
7810992|NCT01154699|19229130|P2|Subjects With Asthma Only|First Intervention (4 Weeks)||6
7810993|NCT01154699|19229131|P1|Subjects With Asthma Only|First Intervention (4 Weeks)||7
7810994|NCT01154699|19229130|P2|STARTED|First Intervention (4 Weeks)||8
7810995|NCT01154699|19229131|P1|STARTED|First Intervention (4 Weeks)||13
7810996|NCT01154673|19229149|P2|NOT COMPLETED|Overall Study||0
7810997|NCT01154673|19229150|P1|NOT COMPLETED|Overall Study||2
7810998|NCT01154673|19229149|P2|COMPLETED|Overall Study||16
7810999|NCT01154673|19229150|P1|COMPLETED|Overall Study||14
7811000|NCT01154673|19229149|P2|STARTED|Overall Study||16
7811001|NCT01154673|19229150|P1|STARTED|Overall Study||16
7811002|NCT01154634|19229160|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
7811003|NCT01154634|19229161|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
7811004|NCT01154634|19229162|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
7811005|NCT01154634|19229163|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
7811006|NCT01154634|19229160|P4|COMPLETED|Period 7 - Fourth Intervention||5
7811007|NCT01154634|19229161|P3|COMPLETED|Period 7 - Fourth Intervention||4
7811008|NCT01154634|19229162|P2|COMPLETED|Period 7 - Fourth Intervention||7
7811009|NCT01154634|19229163|P1|COMPLETED|Period 7 - Fourth Intervention||4
7811010|NCT01154634|19229160|P4|STARTED|Period 7 - Fourth Intervention||5
7811011|NCT01154634|19229161|P3|STARTED|Period 7 - Fourth Intervention||4
7811012|NCT01154634|19229162|P2|STARTED|Period 7 - Fourth Intervention||7
7811013|NCT01154634|19229163|P1|STARTED|Period 7 - Fourth Intervention||4
7811014|NCT01154634|19229160|P4|NOT COMPLETED|Period 6 - Washout||0
7811015|NCT01154634|19229161|P3|NOT COMPLETED|Period 6 - Washout||0
7811016|NCT01154634|19229162|P2|NOT COMPLETED|Period 6 - Washout||0
7811017|NCT01154634|19229163|P1|NOT COMPLETED|Period 6 - Washout||0
7811018|NCT01154634|19229160|P4|COMPLETED|Period 6 - Washout||5
7811019|NCT01154634|19229161|P3|COMPLETED|Period 6 - Washout||4
7811020|NCT01154634|19229162|P2|COMPLETED|Period 6 - Washout||7
7811021|NCT01154634|19229163|P1|COMPLETED|Period 6 - Washout||4
7811022|NCT01154634|19229160|P4|STARTED|Period 6 - Washout||5
7811023|NCT01154634|19229161|P3|STARTED|Period 6 - Washout||4
7811024|NCT01154634|19229162|P2|STARTED|Period 6 - Washout||7
7811025|NCT01154634|19229163|P1|STARTED|Period 6 - Washout||4
7811026|NCT01154634|19229160|P4|NOT COMPLETED|Period 5 - Third Intervention||0
7811027|NCT01154634|19229161|P3|NOT COMPLETED|Period 5 - Third Intervention||0
7811028|NCT01154634|19229162|P2|NOT COMPLETED|Period 5 - Third Intervention||0
7811029|NCT01154634|19229163|P1|NOT COMPLETED|Period 5 - Third Intervention||0
7811030|NCT01154634|19229160|P4|COMPLETED|Period 5 - Third Intervention||5
7811031|NCT01154634|19229161|P3|COMPLETED|Period 5 - Third Intervention||4
7811032|NCT01154634|19229162|P2|COMPLETED|Period 5 - Third Intervention||7
7811033|NCT01154634|19229163|P1|COMPLETED|Period 5 - Third Intervention||4
7811034|NCT01154634|19229160|P4|STARTED|Period 5 - Third Intervention||5
7811035|NCT01154634|19229161|P3|STARTED|Period 5 - Third Intervention||4
7811036|NCT01154634|19229162|P2|STARTED|Period 5 - Third Intervention||7
7811037|NCT01154634|19229163|P1|STARTED|Period 5 - Third Intervention||4
7811038|NCT01154634|19229160|P4|NOT COMPLETED|Period 4 - Washout||0
7811039|NCT01154634|19229161|P3|NOT COMPLETED|Period 4 - Washout||0
7811040|NCT01154634|19229162|P2|NOT COMPLETED|Period 4 - Washout||0
7811041|NCT01154634|19229163|P1|NOT COMPLETED|Period 4 - Washout||0
7811042|NCT01154634|19229160|P4|COMPLETED|Period 4 - Washout||5
7811043|NCT01154634|19229161|P3|COMPLETED|Period 4 - Washout||4
7811044|NCT01154634|19229162|P2|COMPLETED|Period 4 - Washout||7
7811045|NCT01154634|19229163|P1|COMPLETED|Period 4 - Washout||4
7811046|NCT01154634|19229160|P4|STARTED|Period 4 - Washout||5
7811047|NCT01154634|19229161|P3|STARTED|Period 4 - Washout||4
7811048|NCT01154634|19229162|P2|STARTED|Period 4 - Washout||7
7811049|NCT01154634|19229163|P1|STARTED|Period 4 - Washout||4
7811050|NCT01154634|19229160|P4|NOT COMPLETED|Period 3- Second Intervention||0
7811051|NCT01154634|19229161|P3|NOT COMPLETED|Period 3- Second Intervention||0
7811052|NCT01154634|19229162|P2|NOT COMPLETED|Period 3- Second Intervention||0
7811053|NCT01154634|19229163|P1|NOT COMPLETED|Period 3- Second Intervention||0
7811054|NCT01154634|19229160|P4|COMPLETED|Period 3- Second Intervention||5
7811055|NCT01154634|19229161|P3|COMPLETED|Period 3- Second Intervention||4
7811056|NCT01154634|19229162|P2|COMPLETED|Period 3- Second Intervention||7
7811057|NCT01154634|19229163|P1|COMPLETED|Period 3- Second Intervention||4
7811058|NCT01154634|19229160|P4|STARTED|Period 3- Second Intervention||5
7811059|NCT01154634|19229161|P3|STARTED|Period 3- Second Intervention||4
7811060|NCT01154634|19229162|P2|STARTED|Period 3- Second Intervention||7
7811061|NCT01154634|19229163|P1|STARTED|Period 3- Second Intervention||4
7811062|NCT01154634|19229160|P4|NOT COMPLETED|Period 2 - Washout||0
7811063|NCT01154634|19229161|P3|NOT COMPLETED|Period 2 - Washout||0
7811064|NCT01154634|19229162|P2|NOT COMPLETED|Period 2 - Washout||0
7811065|NCT01154634|19229163|P1|NOT COMPLETED|Period 2 - Washout||0
7811066|NCT01154634|19229160|P4|COMPLETED|Period 2 - Washout||5
7811067|NCT01154634|19229161|P3|COMPLETED|Period 2 - Washout||4
7811068|NCT01154634|19229162|P2|COMPLETED|Period 2 - Washout||7
7811069|NCT01154634|19229163|P1|COMPLETED|Period 2 - Washout||4
7811070|NCT01154634|19229160|P4|STARTED|Period 2 - Washout||5
7811071|NCT01154634|19229161|P3|STARTED|Period 2 - Washout||4
7811072|NCT01154634|19229162|P2|STARTED|Period 2 - Washout||7
7811073|NCT01154634|19229163|P1|STARTED|Period 2 - Washout||4
7811074|NCT01154634|19229160|P4|NOT COMPLETED|Period 1 - First Intervention||0
7811075|NCT01154634|19229161|P3|NOT COMPLETED|Period 1 - First Intervention||0
7811076|NCT01154634|19229162|P2|NOT COMPLETED|Period 1 - First Intervention||0
7811077|NCT01154634|19229163|P1|NOT COMPLETED|Period 1 - First Intervention||0
7811078|NCT01154634|19229160|P4|COMPLETED|Period 1 - First Intervention||5
7811079|NCT01154634|19229161|P3|COMPLETED|Period 1 - First Intervention||4
7811080|NCT01154634|19229162|P2|COMPLETED|Period 1 - First Intervention||7
7811081|NCT01154634|19229163|P1|COMPLETED|Period 1 - First Intervention||4
7811082|NCT01154634|19229160|P4|STARTED|Period 1 - First Intervention||5
7811083|NCT01154634|19229161|P3|STARTED|Period 1 - First Intervention||4
7811084|NCT01154634|19229162|P2|STARTED|Period 1 - First Intervention||7
7811085|NCT01154634|19229163|P1|STARTED|Period 1 - First Intervention||4
7811086|NCT01154452|19229205|P4|NOT COMPLETED|Phase II||6
7811087|NCT01154452|19229206|P3|NOT COMPLETED|Phase II||5
7811088|NCT01154452|19229207|P2|NOT COMPLETED|Phase II||0
7811089|NCT01154452|19229208|P1|NOT COMPLETED|Phase II||0
7811090|NCT01154452|19229205|P4|COMPLETED|Phase II||27
7811091|NCT01154452|19229206|P3|COMPLETED|Phase II||30
7811092|NCT01154452|19229207|P2|COMPLETED|Phase II||0
7811093|NCT01154452|19229208|P1|COMPLETED|Phase II||0
7811094|NCT01154452|19229205|P4|STARTED|Phase II||33
7811095|NCT01154452|19229206|P3|STARTED|Phase II||35
7811096|NCT01154452|19229207|P2|STARTED|Phase II||0
7811097|NCT01154452|19229208|P1|STARTED|Phase II||0
7811098|NCT01154452|19229205|P4|NOT COMPLETED|Phase Ib||0
7811099|NCT01154452|19229206|P3|NOT COMPLETED|Phase Ib||0
7811100|NCT01154452|19229207|P2|NOT COMPLETED|Phase Ib||1
7811101|NCT01154452|19229208|P1|NOT COMPLETED|Phase Ib||3
7811102|NCT01154452|19229205|P4|COMPLETED|Phase Ib||0
7811103|NCT01154452|19229206|P3|COMPLETED|Phase Ib||0
7811104|NCT01154452|19229207|P2|COMPLETED|Phase Ib||3
7811105|NCT01154452|19229208|P1|COMPLETED|Phase Ib||3
7811106|NCT01154452|19229205|P4|STARTED|Phase Ib||0
7811107|NCT01154452|19229206|P3|STARTED|Phase Ib||0
7811108|NCT01154452|19229207|P2|STARTED|Phase Ib||4
7811109|NCT01154452|19229208|P1|STARTED|Phase Ib||6
7811110|NCT01154335|19229224|P3|NOT COMPLETED|Overall Study||5
7811111|NCT01154335|19229225|P2|NOT COMPLETED|Overall Study||6
7811112|NCT01154335|19229226|P1|NOT COMPLETED|Overall Study||7
7811113|NCT01154335|19229224|P3|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
7811114|NCT01154335|19229225|P2|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
7811115|NCT01154335|19229226|P1|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
7811116|NCT01154335|19229224|P3|STARTED|Overall Study||5
7811117|NCT01154335|19229225|P2|STARTED|Overall Study||6
7811118|NCT01154335|19229226|P1|STARTED|Overall Study||7
7811119|NCT01154322|19229233|P1|NOT COMPLETED|Overall Study||2
7811120|NCT01154322|19229233|P1|COMPLETED|Overall Study||14
7811121|NCT01154322|19229233|P1|STARTED|Overall Study||16
7811122|NCT01154296|19229240|P2|NOT COMPLETED|6-month Follow-up||328
7811123|NCT01154296|19229241|P1|NOT COMPLETED|6-month Follow-up||328
7811124|NCT01154296|19229240|P2|COMPLETED|6-month Follow-up||2179
7811125|NCT01154296|19229241|P1|COMPLETED|6-month Follow-up||2177
7811126|NCT01154296|19229240|P2|STARTED|6-month Follow-up||2507
7811127|NCT01154296|19229241|P1|STARTED|6-month Follow-up||2505
7811128|NCT01154296|19229240|P2|NOT COMPLETED|Randomization and Intervention||2
7811129|NCT01154296|19229241|P1|NOT COMPLETED|Randomization and Intervention||5
7811130|NCT01154296|19229240|P2|COMPLETED|Randomization and Intervention||2505
7811131|NCT01154296|19229241|P1|COMPLETED|Randomization and Intervention||2500
7811132|NCT01154296|19229240|P2|STARTED|Randomization and Intervention||2507
7811133|NCT01154296|19229241|P1|STARTED|Randomization and Intervention||2505
7811134|NCT01154283|19229259|P2|NOT COMPLETED|7-12 Weeks||1
7811135|NCT01154283|19229260|P1|NOT COMPLETED|7-12 Weeks||1
7811136|NCT01154283|19229259|P2|COMPLETED|7-12 Weeks||10
7811137|NCT01154283|19229260|P1|COMPLETED|7-12 Weeks||6
7811138|NCT01154283|19229259|P2|STARTED|7-12 Weeks||11
7811139|NCT01154283|19229260|P1|STARTED|7-12 Weeks||7
7811140|NCT01154283|19229259|P2|NOT COMPLETED|0-6 Weeks||3
7811141|NCT01154283|19229260|P1|NOT COMPLETED|0-6 Weeks||7
7811142|NCT01154283|19229259|P2|COMPLETED|0-6 Weeks||11
7811143|NCT01154283|19229260|P1|COMPLETED|0-6 Weeks||7
7811144|NCT01154283|19229259|P2|STARTED|0-6 Weeks||14
7811145|NCT01154283|19229260|P1|STARTED|0-6 Weeks||14
7811146|NCT01154231|19229272|P1|NOT COMPLETED|Overall Study||2
7811147|NCT01154231|19229272|P1|COMPLETED|Overall Study||312
7811148|NCT01154231|19229272|P1|STARTED|Overall Study||314
7811149|NCT01154218|19229278|P4|NOT COMPLETED|Fourth Intervention Period||0
7811150|NCT01154218|19229279|P3|NOT COMPLETED|Fourth Intervention Period||0
7811151|NCT01154218|19229280|P2|NOT COMPLETED|Fourth Intervention Period||0
7811152|NCT01154218|19229281|P1|NOT COMPLETED|Fourth Intervention Period||1
7811153|NCT01154218|19229278|P4|COMPLETED|Fourth Intervention Period||8
7811154|NCT01154218|19229279|P3|COMPLETED|Fourth Intervention Period||9
7811155|NCT01154218|19229280|P2|COMPLETED|Fourth Intervention Period||8
7811156|NCT01154218|19229281|P1|COMPLETED|Fourth Intervention Period||8
7811157|NCT01154218|19229278|P4|STARTED|Fourth Intervention Period||8
7811158|NCT01154218|19229279|P3|STARTED|Fourth Intervention Period||9
7811159|NCT01154218|19229280|P2|STARTED|Fourth Intervention Period||8
7811160|NCT01154218|19229281|P1|STARTED|Fourth Intervention Period||9
7811161|NCT01154218|19229278|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||1
7811162|NCT01154218|19229279|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7811163|NCT01154218|19229280|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7811164|NCT01154218|19229281|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7811165|NCT01154218|19229278|P4|COMPLETED|Washout Period (at Least 14 Days)||8
7811166|NCT01154218|19229279|P3|COMPLETED|Washout Period (at Least 14 Days)||9
7811167|NCT01154218|19229280|P2|COMPLETED|Washout Period (at Least 14 Days)||8
7811168|NCT01154218|19229281|P1|COMPLETED|Washout Period (at Least 14 Days)||9
7811169|NCT01154218|19229278|P4|STARTED|Washout Period (at Least 14 Days)||9
7811170|NCT01154218|19229279|P3|STARTED|Washout Period (at Least 14 Days)||9
7811171|NCT01154218|19229280|P2|STARTED|Washout Period (at Least 14 Days)||8
7811172|NCT01154218|19229281|P1|STARTED|Washout Period (at Least 14 Days)||9
7811173|NCT01154218|19229278|P4|NOT COMPLETED|Third Intervention Period||0
7811174|NCT01154218|19229279|P3|NOT COMPLETED|Third Intervention Period||0
7811175|NCT01154218|19229280|P2|NOT COMPLETED|Third Intervention Period||1
7811176|NCT01154218|19229281|P1|NOT COMPLETED|Third Intervention Period||0
7811177|NCT01154218|19229278|P4|COMPLETED|Third Intervention Period||9
7811178|NCT01154218|19229279|P3|COMPLETED|Third Intervention Period||9
7811179|NCT01154218|19229280|P2|COMPLETED|Third Intervention Period||8
7811180|NCT01154218|19229281|P1|COMPLETED|Third Intervention Period||9
7811181|NCT01154218|19229278|P4|STARTED|Third Intervention Period||9
7811182|NCT01154218|19229279|P3|STARTED|Third Intervention Period||9
7811183|NCT01154218|19229280|P2|STARTED|Third Intervention Period||9
7811184|NCT01154218|19229281|P1|STARTED|Third Intervention Period||9
7811185|NCT01154218|19229278|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7811186|NCT01154218|19229279|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7811187|NCT01154218|19229280|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7811188|NCT01154218|19229281|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7811189|NCT01154218|19229278|P4|COMPLETED|Washout Period (at Least 14 Days)||9
7811190|NCT01154218|19229279|P3|COMPLETED|Washout Period (at Least 14 Days)||9
7811191|NCT01154218|19229280|P2|COMPLETED|Washout Period (at Least 14 Days)||9
7811192|NCT01154218|19229281|P1|COMPLETED|Washout Period (at Least 14 Days)||9
7811193|NCT01154218|19229278|P4|STARTED|Washout Period (at Least 14 Days)||9
7811194|NCT01154218|19229279|P3|STARTED|Washout Period (at Least 14 Days)||9
7811195|NCT01154218|19229280|P2|STARTED|Washout Period (at Least 14 Days)||9
7811196|NCT01154218|19229281|P1|STARTED|Washout Period (at Least 14 Days)||9
7811197|NCT01154218|19229278|P4|NOT COMPLETED|Second Intervention Period||0
7811198|NCT01154218|19229279|P3|NOT COMPLETED|Second Intervention Period||0
7811199|NCT01154218|19229280|P2|NOT COMPLETED|Second Intervention Period||0
7811200|NCT01154218|19229281|P1|NOT COMPLETED|Second Intervention Period||0
7811201|NCT01154218|19229278|P4|COMPLETED|Second Intervention Period||9
7811202|NCT01154218|19229279|P3|COMPLETED|Second Intervention Period||9
7811203|NCT01154218|19229280|P2|COMPLETED|Second Intervention Period||9
7811204|NCT01154218|19229281|P1|COMPLETED|Second Intervention Period||9
7811205|NCT01154218|19229278|P4|STARTED|Second Intervention Period||9
7811206|NCT01154218|19229279|P3|STARTED|Second Intervention Period||9
7811207|NCT01154218|19229280|P2|STARTED|Second Intervention Period||9
7811208|NCT01154218|19229281|P1|STARTED|Second Intervention Period||9
7811209|NCT01154218|19229278|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7811210|NCT01154218|19229279|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7811211|NCT01154218|19229280|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7811212|NCT01154218|19229281|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7811213|NCT01154218|19229278|P4|COMPLETED|Washout Period (at Least 14 Days)||9
7811214|NCT01154218|19229279|P3|COMPLETED|Washout Period (at Least 14 Days)||9
7811215|NCT01154218|19229280|P2|COMPLETED|Washout Period (at Least 14 Days)||9
7811216|NCT01154218|19229281|P1|COMPLETED|Washout Period (at Least 14 Days)||9
7811217|NCT01154218|19229278|P4|STARTED|Washout Period (at Least 14 Days)||9
7811218|NCT01154218|19229279|P3|STARTED|Washout Period (at Least 14 Days)||9
7811219|NCT01154218|19229280|P2|STARTED|Washout Period (at Least 14 Days)||9
7811220|NCT01154218|19229281|P1|STARTED|Washout Period (at Least 14 Days)||9
7811221|NCT01154218|19229278|P4|NOT COMPLETED|First Intervention Period||0
7811222|NCT01154218|19229279|P3|NOT COMPLETED|First Intervention Period||0
7811223|NCT01154218|19229280|P2|NOT COMPLETED|First Intervention Period||0
7811224|NCT01154218|19229281|P1|NOT COMPLETED|First Intervention Period||0
7811225|NCT01154218|19229278|P4|COMPLETED|First Intervention Period||9
7811226|NCT01154218|19229279|P3|COMPLETED|First Intervention Period||9
7811227|NCT01154218|19229280|P2|COMPLETED|First Intervention Period||9
7811228|NCT01154218|19229281|P1|COMPLETED|First Intervention Period||9
7811229|NCT01154218|19229278|P4|STARTED|First Intervention Period||9
7811230|NCT01154218|19229279|P3|STARTED|First Intervention Period||9
7811231|NCT01154218|19229280|P2|STARTED|First Intervention Period||9
7811232|NCT01154218|19229281|P1|STARTED|First Intervention Period||9
7811233|NCT01154192|19229334|P3|NOT COMPLETED|Overall Study||0
7811234|NCT01154192|19229335|P2|NOT COMPLETED|Overall Study||0
7811235|NCT01154192|19229336|P1|NOT COMPLETED|Overall Study||0
7811236|NCT01154192|19229334|P3|COMPLETED|Overall Study||0
7811237|NCT01154192|19229335|P2|COMPLETED|Overall Study||10
7811238|NCT01154192|19229336|P1|COMPLETED|Overall Study||14
7811239|NCT01154192|19229334|P3|STARTED|Overall Study||0
7811240|NCT01154192|19229335|P2|STARTED|Overall Study||10
7811241|NCT01154192|19229336|P1|STARTED|Overall Study||14
7811242|NCT01154166|19229355|P2|NOT COMPLETED|Overall Study||12
7811243|NCT01154166|19229356|P1|NOT COMPLETED|Overall Study||34
7811244|NCT01154166|19229355|P2|COMPLETED|Overall Study||163
7811245|NCT01154166|19229356|P1|COMPLETED|Overall Study||135
7811246|NCT01154166|19229355|P2|STARTED|Overall Study||175
7811247|NCT01154166|19229356|P1|STARTED|Overall Study||169
7811248|NCT01154153|19229388|P2|NOT COMPLETED|Overall Study||3
7811249|NCT01154153|19229389|P1|NOT COMPLETED|Overall Study||5
7811250|NCT01154153|19229388|P2|COMPLETED|Overall Study||66
7811251|NCT01154153|19229389|P1|COMPLETED|Overall Study||66
7811252|NCT01154153|19229388|P2|STARTED|Overall Study||69
7811253|NCT01154153|19229389|P1|STARTED|Overall Study||71
7811254|NCT01154140|19229407|P2|NOT COMPLETED|Overall Study||102
7811255|NCT01154140|19229408|P1|NOT COMPLETED|Overall Study||91
7811256|NCT01154140|19229407|P2|COMPLETED|Overall Study||69
7811257|NCT01154140|19229408|P1|COMPLETED|Overall Study||81
7811258|NCT01154140|19229407|P2|Treated|Overall Study||169
7811259|NCT01154140|19229408|P1|Treated|Overall Study||171
7811260|NCT01154140|19229407|P2|STARTED|Overall Study||171
7811261|NCT01154140|19229408|P1|STARTED|Overall Study||172
7811262|NCT01154127|19229461|P2|NOT COMPLETED|Period 2 (21 Days)||1
7811263|NCT01154127|19229462|P1|NOT COMPLETED|Period 2 (21 Days)||0
7811264|NCT01154127|19229461|P2|COMPLETED|Period 2 (21 Days)||46
7811265|NCT01154127|19229462|P1|COMPLETED|Period 2 (21 Days)||49
7811266|NCT01154127|19229461|P2|STARTED|Period 2 (21 Days)||47
7811267|NCT01154127|19229462|P1|STARTED|Period 2 (21 Days)||49
7811268|NCT01154127|19229461|P2|NOT COMPLETED|Washout (14 - 28 Days)||0
7811269|NCT01154127|19229462|P1|NOT COMPLETED|Washout (14 - 28 Days)||3
7811270|NCT01154127|19229461|P2|COMPLETED|Washout (14 - 28 Days)||47
7811271|NCT01154127|19229462|P1|COMPLETED|Washout (14 - 28 Days)||49
7811272|NCT01154127|19229461|P2|STARTED|Washout (14 - 28 Days)||47
7811273|NCT01154127|19229462|P1|STARTED|Washout (14 - 28 Days)||52
7811274|NCT01154127|19229461|P2|NOT COMPLETED|Period 1 (21 Days)||6
7811275|NCT01154127|19229462|P1|NOT COMPLETED|Period 1 (21 Days)||3
7811276|NCT01154127|19229461|P2|COMPLETED|Period 1 (21 Days)||47
7811277|NCT01154127|19229462|P1|COMPLETED|Period 1 (21 Days)||52
7811278|NCT01154127|19229461|P2|STARTED|Period 1 (21 Days)||53
7811279|NCT01154127|19229462|P1|STARTED|Period 1 (21 Days)||55
7811280|NCT01154101|19229489|P5|NOT COMPLETED|Overall Study||1
7811281|NCT01154101|19229490|P4|NOT COMPLETED|Overall Study||2
7811282|NCT01154101|19229491|P3|NOT COMPLETED|Overall Study||3
7811283|NCT01154101|19229492|P2|NOT COMPLETED|Overall Study||4
7811284|NCT01154101|19229493|P1|NOT COMPLETED|Overall Study||0
7811285|NCT01154101|19229489|P5|COMPLETED|Overall Study||0
7811286|NCT01154101|19229490|P4|COMPLETED|Overall Study||9
7811287|NCT01154101|19229491|P3|COMPLETED|Overall Study||9
7811288|NCT01154101|19229492|P2|COMPLETED|Overall Study||5
7811289|NCT01154101|19229493|P1|COMPLETED|Overall Study||7
7811290|NCT01154101|19229489|P5|STARTED|Overall Study||1
7811291|NCT01154101|19229490|P4|STARTED|Overall Study||11
7811292|NCT01154101|19229491|P3|STARTED|Overall Study||12
7811293|NCT01154101|19229492|P2|STARTED|Overall Study||9
7811294|NCT01154101|19229493|P1|STARTED|Overall Study||7
7811295|NCT01154088|19229548|P3|NOT COMPLETED|Overall Study||7
7811296|NCT01154088|19229549|P2|NOT COMPLETED|Overall Study||6
7811297|NCT01154088|19229550|P1|NOT COMPLETED|Overall Study||4
7811298|NCT01154088|19229548|P3|COMPLETED|Overall Study||383
7811299|NCT01154088|19229549|P2|COMPLETED|Overall Study||384
7811300|NCT01154088|19229550|P1|COMPLETED|Overall Study||386
7811301|NCT01154088|19229548|P3|STARTED|Overall Study||390
7811302|NCT01154088|19229549|P2|STARTED|Overall Study||390
7811303|NCT01154088|19229550|P1|STARTED|Overall Study||390
7811304|NCT01154036|19229590|P8|NOT COMPLETED|Phase II||6
7811305|NCT01154036|19229591|P7|NOT COMPLETED|Phase II||9
7811306|NCT01154036|19229592|P6|NOT COMPLETED|Phase II||5
7811307|NCT01154036|19229593|P5|NOT COMPLETED|Phase II||8
7811308|NCT01154036|19229594|P4|NOT COMPLETED|Phase II||1
7811309|NCT01154036|19229595|P3|NOT COMPLETED|Phase II||0
7811310|NCT01154036|19229596|P2|NOT COMPLETED|Phase II||0
7811311|NCT01154036|19229597|P1|NOT COMPLETED|Phase II||0
7811312|NCT01154036|19229590|P8|COMPLETED|Phase II||200
7811313|NCT01154036|19229591|P7|COMPLETED|Phase II||225
7811314|NCT01154036|19229592|P6|COMPLETED|Phase II||121
7811315|NCT01154036|19229593|P5|COMPLETED|Phase II||116
7811316|NCT01154036|19229594|P4|COMPLETED|Phase II||27
7811317|NCT01154036|19229595|P3|COMPLETED|Phase II||0
7811318|NCT01154036|19229596|P2|COMPLETED|Phase II||0
7811319|NCT01154036|19229597|P1|COMPLETED|Phase II||0
7811320|NCT01154036|19229590|P8|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206
7811321|NCT01154036|19229591|P7|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234
7811322|NCT01154036|19229592|P6|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126
7811323|NCT01154036|19229593|P5|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124
7811324|NCT01154036|19229594|P4|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28
7811325|NCT01154036|19229595|P3|STARTED|Phase II||0
7811326|NCT01154036|19229596|P2|STARTED|Phase II||0
7811327|NCT01154036|19229597|P1|STARTED|Phase II||0
7811328|NCT01154036|19229590|P8|NOT COMPLETED|Phase I||0
7811329|NCT01154036|19229591|P7|NOT COMPLETED|Phase I||0
7811330|NCT01154036|19229592|P6|NOT COMPLETED|Phase I||0
7811331|NCT01154036|19229593|P5|NOT COMPLETED|Phase I||0
7811332|NCT01154036|19229594|P4|NOT COMPLETED|Phase I||0
7811333|NCT01154036|19229595|P3|NOT COMPLETED|Phase I||56
7811334|NCT01154036|19229596|P2|NOT COMPLETED|Phase I||28
7811335|NCT01154036|19229597|P1|NOT COMPLETED|Phase I||3
7811336|NCT01154036|19229590|P8|COMPLETED|Phase I||0
7811337|NCT01154036|19229591|P7|COMPLETED|Phase I||0
7811338|NCT01154036|19229592|P6|COMPLETED|Phase I||0
7811339|NCT01154036|19229593|P5|COMPLETED|Phase I||0
7811340|NCT01154036|19229594|P4|COMPLETED|Phase I||0
7811341|NCT01154036|19229595|P3|COMPLETED|Phase I|Not all completers were eligible for Phase II|888
7811342|NCT01154036|19229596|P2|COMPLETED|Phase I|Not all completers were eligible for Phase II|455
7811343|NCT01154036|19229597|P1|COMPLETED|Phase I|Not all completers were eligible for Phase II|117
7811344|NCT01154036|19229590|P8|STARTED|Phase I||0
7811345|NCT01154036|19229591|P7|STARTED|Phase I||0
7811346|NCT01154036|19229592|P6|STARTED|Phase I||0
7811347|NCT01154036|19229593|P5|STARTED|Phase I||0
7811348|NCT01154036|19229594|P4|STARTED|Phase I||0
7811349|NCT01154036|19229595|P3|STARTED|Phase I||944
7811350|NCT01154036|19229596|P2|STARTED|Phase I||483
7811351|NCT01154036|19229597|P1|STARTED|Phase I||120
7811352|NCT01154010|19229721|P2|NOT COMPLETED|Overall Study||1
7811353|NCT01154010|19229722|P1|NOT COMPLETED|Overall Study||0
7811354|NCT01154010|19229721|P2|COMPLETED|Overall Study||8
7811355|NCT01154010|19229722|P1|COMPLETED|Overall Study||9
7811356|NCT01154010|19229721|P2|STARTED|Overall Study||9
7811357|NCT01154010|19229722|P1|STARTED|Overall Study||9
7811358|NCT01153984|19229728|P1|NOT COMPLETED|Overall Study||2
7811359|NCT01153984|19229728|P1|COMPLETED|Overall Study||21
7811360|NCT01153984|19229728|P1|STARTED|Overall Study||23
7811361|NCT01153971|19229739|P1|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4
7811362|NCT01153971|19229739|P1|COMPLETED|Follow-up (Months 17-40 of Study)||37
7811363|NCT01153971|19229739|P1|STARTED|Follow-up (Months 17-40 of Study)||41
7811364|NCT01153971|19229739|P1|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3
7811365|NCT01153971|19229739|P1|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41
7811366|NCT01153971|19229739|P1|STARTED|Maintenance Phase (Months 8-16 of Study)||44
7811367|NCT01153971|19229739|P1|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3
7811368|NCT01153971|19229739|P1|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44
7811369|NCT01153971|19229739|P1|STARTED|Induction Phase (Months 1 to 7 of Study)||47
7811370|NCT01153958|19229762|P2|NOT COMPLETED|Overall Study||32
7811371|NCT01153958|19229763|P1|NOT COMPLETED|Overall Study||36
7811372|NCT01153958|19229762|P2|COMPLETED|Overall Study||35
7811373|NCT01153958|19229763|P1|COMPLETED|Overall Study||30
7811374|NCT01153958|19229762|P2|STARTED|Overall Study||67
7811375|NCT01153958|19229763|P1|STARTED|Overall Study||66
7811376|NCT01153893|19229781|P2|NOT COMPLETED|Overall Study||0
7811377|NCT01153893|19229782|P1|NOT COMPLETED|Overall Study||1
7811378|NCT01153893|19229781|P2|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36
7811379|NCT01153893|19229782|P1|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67
7811380|NCT01153893|19229781|P2|STARTED|Overall Study||36
7811381|NCT01153893|19229782|P1|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68
7811382|NCT01153841|19229808|P2|NOT COMPLETED|Overall Study||0
7811383|NCT01153841|19229809|P1|NOT COMPLETED|Overall Study||6
7811384|NCT01153841|19229808|P2|COMPLETED|Overall Study||99
7811385|NCT01153841|19229809|P1|COMPLETED|Overall Study||193
7811386|NCT01153841|19229808|P2|STARTED|Overall Study||99
7811387|NCT01153841|19229809|P1|STARTED|Overall Study||199
7811388|NCT01153815|19229825|P2|NOT COMPLETED|Overall Study||5
7811389|NCT01153815|19229826|P1|NOT COMPLETED|Overall Study||9
7811390|NCT01153815|19229825|P2|COMPLETED|Overall Study||82
7811391|NCT01153815|19229826|P1|COMPLETED|Overall Study||74
7811392|NCT01153815|19229825|P2|STARTED|Overall Study||87
7811393|NCT01153815|19229826|P1|STARTED|Overall Study||83
7811394|NCT01153763|19229848|P1|NOT COMPLETED|Overall Study||21
7811395|NCT01153763|19229848|P1|COMPLETED|Overall Study||71
7811396|NCT01153763|19229848|P1|STARTED|Overall Study||92
7811397|NCT01153724|19229864|P1|NOT COMPLETED|Treatment Period 2||2
7811398|NCT01153724|19229864|P1|COMPLETED|Treatment Period 2||32
7811399|NCT01153724|19229864|P1|STARTED|Treatment Period 2||34
7811400|NCT01153724|19229864|P1|NOT COMPLETED|Treatment Period 1||1
7811401|NCT01153724|19229864|P1|COMPLETED|Treatment Period 1||34
7811402|NCT01153724|19229864|P1|STARTED|Treatment Period 1||35
7811403|NCT01153711|19229884|P1|NOT COMPLETED|Overall Study||0
7811404|NCT01153711|19229884|P1|COMPLETED|Overall Study||32
7811405|NCT01153711|19229884|P1|STARTED|Overall Study||32
7811406|NCT01153698|19229904|P1|NOT COMPLETED|Overall Study||29
7811407|NCT01153698|19229904|P1|COMPLETED|Overall Study|Completed Pradaxa treatment.|139
7811408|NCT01153698|19229904|P1|STARTED|Overall Study|Entered and treated.|168
7811409|NCT01153685|19229920|P2|NOT COMPLETED|Overall Study||0
7811410|NCT01153685|19229921|P1|NOT COMPLETED|Overall Study||0
7811411|NCT01153685|19229920|P2|COMPLETED|Overall Study||70
7811412|NCT01153685|19229921|P1|COMPLETED|Overall Study||50
7811413|NCT01153685|19229920|P2|STARTED|Overall Study||70
7811414|NCT01153685|19229921|P1|STARTED|Overall Study||50
7811415|NCT01153672|19229945|P1|NOT COMPLETED|Overall Study||2
7811416|NCT01153672|19229945|P1|COMPLETED|Overall Study||6
7811417|NCT01153672|19229945|P1|STARTED|Overall Study||8
7811418|NCT01153633|19229955|P2|NOT COMPLETED|Overall Study||4
7811419|NCT01153633|19229956|P1|NOT COMPLETED|Overall Study||4
7811420|NCT01153633|19229955|P2|COMPLETED|Overall Study||13
7811421|NCT01153633|19229956|P1|COMPLETED|Overall Study||13
7811422|NCT01153633|19229955|P2|STARTED|Overall Study||17
7811423|NCT01153633|19229956|P1|STARTED|Overall Study||17
7811424|NCT01153620|19229974|P2|NOT COMPLETED|Overall Study||0
7811425|NCT01153620|19229975|P1|NOT COMPLETED|Overall Study||0
7811426|NCT01153620|19229974|P2|COMPLETED|Overall Study|30 patients (31 wounds)|30
7811427|NCT01153620|19229975|P1|COMPLETED|Overall Study||30
7811428|NCT01153620|19229974|P2|STARTED|Overall Study|30 patients (31 wounds)|30
7811429|NCT01153620|19229975|P1|STARTED|Overall Study||30
7811430|NCT01153581|19229981|P1|NOT COMPLETED|Overall Study||0
7811431|NCT01153581|19229981|P1|COMPLETED|Overall Study||109
7811432|NCT01153581|19229981|P1|STARTED|Overall Study||109
7811433|NCT01153516|19229993|P2|NOT COMPLETED|Overall Study||0
7811434|NCT01153516|19229994|P1|NOT COMPLETED|Overall Study||2
7811435|NCT01153516|19229993|P2|COMPLETED|Overall Study||10
7811436|NCT01153516|19229994|P1|COMPLETED|Overall Study||10
7811437|NCT01153516|19229993|P2|STARTED|Overall Study||10
7811438|NCT01153516|19229994|P1|STARTED|Overall Study||12
7811439|NCT01153503|19230007|P3|NOT COMPLETED|Overall Study||0
7811440|NCT01153503|19230008|P2|NOT COMPLETED|Overall Study||1
7811441|NCT01153503|19230009|P1|NOT COMPLETED|Overall Study||0
7811442|NCT01153503|19230007|P3|COMPLETED|Overall Study||25
7811443|NCT01153503|19230008|P2|COMPLETED|Overall Study||24
7811444|NCT01153503|19230009|P1|COMPLETED|Overall Study||25
7811445|NCT01153503|19230007|P3|STARTED|Overall Study||25
7811446|NCT01153503|19230008|P2|STARTED|Overall Study||25
7811447|NCT01153503|19230009|P1|STARTED|Overall Study||25
7811448|NCT01153425|19230019|P2|NOT COMPLETED|Overall Study||3
7811449|NCT01153425|19230020|P1|NOT COMPLETED|Overall Study||3
7811450|NCT01153425|19230019|P2|COMPLETED|Overall Study||14
7811451|NCT01153425|19230020|P1|COMPLETED|Overall Study||13
7811452|NCT01153425|19230019|P2|STARTED|Overall Study||17
7811453|NCT01153425|19230020|P1|STARTED|Overall Study||16
7811454|NCT01153347|19230032|P4|NOT COMPLETED|Overall Study||32
7811455|NCT01153347|19230033|P3|NOT COMPLETED|Overall Study||50
7811456|NCT01153347|19230034|P2|NOT COMPLETED|Overall Study||44
7811457|NCT01153347|19230035|P1|NOT COMPLETED|Overall Study||33
7811458|NCT01153347|19230032|P4|COMPLETED|Overall Study||129
7811459|NCT01153347|19230033|P3|COMPLETED|Overall Study||110
7811460|NCT01153347|19230034|P2|COMPLETED|Overall Study||116
7811461|NCT01153347|19230035|P1|COMPLETED|Overall Study||127
7811462|NCT01153347|19230032|P4|Received Treatment|Overall Study||160
7811463|NCT01153347|19230033|P3|Received Treatment|Overall Study||158
7811464|NCT01153347|19230034|P2|Received Treatment|Overall Study||158
7811465|NCT01153347|19230035|P1|Received Treatment|Overall Study||160
7811466|NCT01153347|19230032|P4|STARTED|Overall Study||161
7811467|NCT01153347|19230033|P3|STARTED|Overall Study||160
7811468|NCT01153347|19230034|P2|STARTED|Overall Study||160
7811469|NCT01153347|19230035|P1|STARTED|Overall Study||160
7811470|NCT01153321|19230135|P2|NOT COMPLETED|Overall Study||3
7811471|NCT01153321|19230136|P1|NOT COMPLETED|Overall Study||1
7811472|NCT01153321|19230135|P2|COMPLETED|Overall Study||19
7811473|NCT01153321|19230136|P1|COMPLETED|Overall Study||21
7811474|NCT01153321|19230135|P2|STARTED|Overall Study||22
7811475|NCT01153321|19230136|P1|STARTED|Overall Study||22
7811476|NCT01153269|19230248|P1|NOT COMPLETED|Overall Study||2
7811477|NCT01153269|19230248|P1|COMPLETED|Overall Study||31
7811478|NCT01153269|19230248|P1|Participants Analyzed|Overall Study||33
7811479|NCT01153269|19230248|P1|STARTED|Overall Study||33
7811480|NCT01153009|19230311|P4|NOT COMPLETED|Overall Study||37
7811481|NCT01153009|19230312|P3|NOT COMPLETED|Overall Study||41
7811482|NCT01153009|19230313|P2|NOT COMPLETED|Overall Study||34
7811483|NCT01153009|19230314|P1|NOT COMPLETED|Overall Study||32
7811484|NCT01153009|19230311|P4|COMPLETED|Overall Study||115
7811485|NCT01153009|19230312|P3|COMPLETED|Overall Study||113
7811486|NCT01153009|19230313|P2|COMPLETED|Overall Study||113
7811487|NCT01153009|19230314|P1|COMPLETED|Overall Study||129
7811488|NCT01153009|19230311|P4|Treated|Overall Study||150
7811489|NCT01153009|19230312|P3|Treated|Overall Study||154
7811490|NCT01153009|19230313|P2|Treated|Overall Study||147
7811491|NCT01153009|19230314|P1|Treated|Overall Study||159
7811492|NCT01153009|19230311|P4|STARTED|Overall Study||152
7811493|NCT01153009|19230312|P3|STARTED|Overall Study||154
7811494|NCT01153009|19230313|P2|STARTED|Overall Study||147
7811495|NCT01153009|19230314|P1|STARTED|Overall Study||161
7811496|NCT01152996|19230344|P1|NOT COMPLETED|Overall Study||537
7811497|NCT01152996|19230344|P1|COMPLETED|Overall Study||538
7811498|NCT01152996|19230344|P1|Treated|Overall Study||1073
7811499|NCT01152996|19230344|P1|STARTED|Overall Study||1075
7811500|NCT01152814|19230357|P1|NOT COMPLETED|Overall Study||2
7811501|NCT01152814|19230357|P1|COMPLETED|Overall Study||62
7811502|NCT01152814|19230357|P1|STARTED|Overall Study||64
7811503|NCT01152788|19230366|P2|NOT COMPLETED|Overall Study||4
7811504|NCT01152788|19230367|P1|NOT COMPLETED|Overall Study||0
7811505|NCT01152788|19230366|P2|COMPLETED|Overall Study||28
7811506|NCT01152788|19230367|P1|COMPLETED|Overall Study||32
7811507|NCT01152788|19230366|P2|STARTED|Overall Study||32
7811508|NCT01152788|19230367|P1|STARTED|Overall Study||32
7811509|NCT01152697|19230379|P1|NOT COMPLETED|Overall Study||19
7811510|NCT01152697|19230379|P1|COMPLETED|Overall Study||11
7811511|NCT01152697|19230379|P1|STARTED|Overall Study||30
7811512|NCT01152580|19230404|P2|NOT COMPLETED|Overall Study||1
7811513|NCT01152580|19230405|P1|NOT COMPLETED|Overall Study||0
7811514|NCT01152580|19230404|P2|COMPLETED|Overall Study||13
7811515|NCT01152580|19230405|P1|COMPLETED|Overall Study||5
7811516|NCT01152580|19230404|P2|STARTED|Overall Study||14
7811517|NCT01152580|19230405|P1|STARTED|Overall Study||5
7811518|NCT01152554|19230427|P2|NOT COMPLETED|Overall Study||111
7811519|NCT01152554|19230428|P1|NOT COMPLETED|Overall Study||334
7811520|NCT01152554|19230427|P2|COMPLETED|Overall Study||92
7811521|NCT01152554|19230428|P1|COMPLETED|Overall Study||276
7811522|NCT01152554|19230427|P2|Received Treatment|Overall Study||201
7811523|NCT01152554|19230428|P1|Received Treatment|Overall Study||607
7811524|NCT01152554|19230427|P2|STARTED|Overall Study||203
7811525|NCT01152554|19230428|P1|STARTED|Overall Study||610
7811526|NCT01152515|19230452|P2|NOT COMPLETED|Overall Study||0
7811527|NCT01152515|19230453|P1|NOT COMPLETED|Overall Study||0
7811528|NCT01152515|19230452|P2|COMPLETED|Overall Study||25
7811529|NCT01152515|19230453|P1|COMPLETED|Overall Study||25
7811530|NCT01152515|19230452|P2|STARTED|Overall Study||25
7811531|NCT01152515|19230453|P1|STARTED|Overall Study||25
7811532|NCT01152450|19230467|P6|NOT COMPLETED|Period 3 (4 Weeks)||0
7811533|NCT01152450|19230468|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
7811534|NCT01152450|19230469|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
7811535|NCT01152450|19230470|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
7811536|NCT01152450|19230471|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
7811537|NCT01152450|19230472|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
7811538|NCT01152450|19230467|P6|COMPLETED|Period 3 (4 Weeks)||12
7811539|NCT01152450|19230468|P5|COMPLETED|Period 3 (4 Weeks)||16
7811540|NCT01152450|19230469|P4|COMPLETED|Period 3 (4 Weeks)||15
7811541|NCT01152450|19230470|P3|COMPLETED|Period 3 (4 Weeks)||16
7811542|NCT01152450|19230471|P2|COMPLETED|Period 3 (4 Weeks)||15
7811543|NCT01152450|19230472|P1|COMPLETED|Period 3 (4 Weeks)||15
7811544|NCT01152450|19230467|P6|STARTED|Period 3 (4 Weeks)||12
7811545|NCT01152450|19230468|P5|STARTED|Period 3 (4 Weeks)||16
7811546|NCT01152450|19230469|P4|STARTED|Period 3 (4 Weeks)||15
7811547|NCT01152450|19230470|P3|STARTED|Period 3 (4 Weeks)||16
7811548|NCT01152450|19230471|P2|STARTED|Period 3 (4 Weeks)||15
7811549|NCT01152450|19230472|P1|STARTED|Period 3 (4 Weeks)||15
7811550|NCT01152450|19230467|P6|NOT COMPLETED|Period 2 (4 Weeks)||0
7811551|NCT01152450|19230468|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
7811552|NCT01152450|19230469|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
7811553|NCT01152450|19230470|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
7811554|NCT01152450|19230471|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
7811555|NCT01152450|19230472|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
7811556|NCT01152450|19230467|P6|COMPLETED|Period 2 (4 Weeks)||12
7811557|NCT01152450|19230468|P5|COMPLETED|Period 2 (4 Weeks)||16
7811558|NCT01152450|19230469|P4|COMPLETED|Period 2 (4 Weeks)||15
7811559|NCT01152450|19230470|P3|COMPLETED|Period 2 (4 Weeks)||16
7811560|NCT01152450|19230471|P2|COMPLETED|Period 2 (4 Weeks)||15
7811561|NCT01152450|19230472|P1|COMPLETED|Period 2 (4 Weeks)||15
7811562|NCT01152450|19230467|P6|STARTED|Period 2 (4 Weeks)||12
7811563|NCT01152450|19230468|P5|STARTED|Period 2 (4 Weeks)||16
7811564|NCT01152450|19230469|P4|STARTED|Period 2 (4 Weeks)||15
7811565|NCT01152450|19230470|P3|STARTED|Period 2 (4 Weeks)||16
7811566|NCT01152450|19230471|P2|STARTED|Period 2 (4 Weeks)||15
7811567|NCT01152450|19230472|P1|STARTED|Period 2 (4 Weeks)||15
7811568|NCT01152450|19230467|P6|NOT COMPLETED|Period 1 (4 Weeks)||1
7811569|NCT01152450|19230468|P5|NOT COMPLETED|Period 1 (4 Weeks)||2
7811570|NCT01152450|19230469|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
7811571|NCT01152450|19230470|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
7811572|NCT01152450|19230471|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
7811573|NCT01152450|19230472|P1|NOT COMPLETED|Period 1 (4 Weeks)||0
7811574|NCT01152450|19230467|P6|COMPLETED|Period 1 (4 Weeks)||12
7811575|NCT01152450|19230468|P5|COMPLETED|Period 1 (4 Weeks)||16
7811576|NCT01152450|19230469|P4|COMPLETED|Period 1 (4 Weeks)||15
7811577|NCT01152450|19230470|P3|COMPLETED|Period 1 (4 Weeks)||16
7811578|NCT01152450|19230471|P2|COMPLETED|Period 1 (4 Weeks)||15
7811579|NCT01152450|19230472|P1|COMPLETED|Period 1 (4 Weeks)||15
7811580|NCT01152450|19230467|P6|STARTED|Period 1 (4 Weeks)||13
7811581|NCT01152450|19230468|P5|STARTED|Period 1 (4 Weeks)||18
7811582|NCT01152450|19230469|P4|STARTED|Period 1 (4 Weeks)||15
7811583|NCT01152450|19230470|P3|STARTED|Period 1 (4 Weeks)||17
7811584|NCT01152450|19230471|P2|STARTED|Period 1 (4 Weeks)||16
7811585|NCT01152450|19230472|P1|STARTED|Period 1 (4 Weeks)||15
7811586|NCT01152437|19230543|P3|NOT COMPLETED|Overall Study||43
7811587|NCT01152437|19230544|P2|NOT COMPLETED|Overall Study||15
7811588|NCT01152437|19230545|P1|NOT COMPLETED|Overall Study||36
7811589|NCT01152437|19230543|P3|COMPLETED|Overall Study||0
7811590|NCT01152437|19230544|P2|COMPLETED|Overall Study||0
7811591|NCT01152437|19230545|P1|COMPLETED|Overall Study||0
7811592|NCT01152437|19230543|P3|STARTED|Overall Study|entered|43
7811593|NCT01152437|19230544|P2|STARTED|Overall Study|randomised|15
7811594|NCT01152437|19230545|P1|STARTED|Overall Study|randomised|36
7811595|NCT01152385|19230565|P4|NOT COMPLETED|Overall Study||5
7811596|NCT01152385|19230566|P3|NOT COMPLETED|Overall Study||5
7811597|NCT01152385|19230567|P2|NOT COMPLETED|Overall Study||6
7811598|NCT01152385|19230568|P1|NOT COMPLETED|Overall Study||9
7811599|NCT01152385|19230565|P4|COMPLETED|Overall Study||50
7811600|NCT01152385|19230566|P3|COMPLETED|Overall Study||51
7811601|NCT01152385|19230567|P2|COMPLETED|Overall Study||52
7811602|NCT01152385|19230568|P1|COMPLETED|Overall Study||46
7811603|NCT01152385|19230565|P4|STARTED|Overall Study||55
7811604|NCT01152385|19230566|P3|STARTED|Overall Study||56
7811605|NCT01152385|19230567|P2|STARTED|Overall Study||58
7811606|NCT01152385|19230568|P1|STARTED|Overall Study||55
7811607|NCT01152359|19230608|P2|NOT COMPLETED|Overall Study||22
7811608|NCT01152359|19230609|P1|NOT COMPLETED|Overall Study||24
7811609|NCT01152359|19230608|P2|COMPLETED|Overall Study||80
7811610|NCT01152359|19230609|P1|COMPLETED|Overall Study||81
7811611|NCT01152359|19230608|P2|STARTED|Overall Study||102
7811612|NCT01152359|19230609|P1|STARTED|Overall Study||105
7811613|NCT01152307|19230621|P2|NOT COMPLETED|Overall Study||0
7811614|NCT01152307|19230622|P1|NOT COMPLETED|Overall Study||0
7811615|NCT01152307|19230621|P2|COMPLETED|Overall Study||214
7811616|NCT01152307|19230622|P1|COMPLETED|Overall Study||191
7811617|NCT01152307|19230621|P2|STARTED|Overall Study||214
7811618|NCT01152307|19230622|P1|STARTED|Overall Study||191
7811619|NCT01152294|19230630|P2|NOT COMPLETED|Overall Study||0
7811620|NCT01152294|19230631|P1|NOT COMPLETED|Overall Study||0
7811621|NCT01152294|19230630|P2|COMPLETED|Overall Study||188
7811622|NCT01152294|19230631|P1|COMPLETED|Overall Study||213
7811623|NCT01152294|19230630|P2|STARTED|Overall Study||188
7811624|NCT01152294|19230631|P1|STARTED|Overall Study||213
7811625|NCT01152190|19230639|P2|NOT COMPLETED|Overall Study||8
7811626|NCT01152190|19230640|P1|NOT COMPLETED|Overall Study||5
7811627|NCT01152190|19230639|P2|COMPLETED|Overall Study||39
7811628|NCT01152190|19230640|P1|COMPLETED|Overall Study||45
7811629|NCT01152190|19230639|P2|Received at Least 1 Dose of Study Drug|Overall Study||47
7811630|NCT01152190|19230640|P1|Received at Least 1 Dose of Study Drug|Overall Study||50
7811631|NCT01152190|19230639|P2|STARTED|Overall Study||47
7811632|NCT01152190|19230640|P1|STARTED|Overall Study||50
7811633|NCT01152112|19230654|P2|NOT COMPLETED|Overall Study||0
7811634|NCT01152112|19230655|P1|NOT COMPLETED|Overall Study||0
7811635|NCT01152112|19230654|P2|COMPLETED|Overall Study||32
7811636|NCT01152112|19230655|P1|COMPLETED|Overall Study||42
7811637|NCT01152112|19230654|P2|STARTED|Overall Study||32
7811638|NCT01152112|19230655|P1|STARTED|Overall Study||42
7811639|NCT01152021|19230663|P2|NOT COMPLETED|Overall Study||6
7811640|NCT01152021|19230664|P1|NOT COMPLETED|Overall Study||6
7811641|NCT01152021|19230663|P2|COMPLETED|Overall Study||1
7811642|NCT01152021|19230664|P1|COMPLETED|Overall Study||2
7811643|NCT01152021|19230663|P2|STARTED|Overall Study||7
7811644|NCT01152021|19230664|P1|STARTED|Overall Study||8
7811645|NCT01151904|19230672|P1|NOT COMPLETED|Overall Study||0
7811646|NCT01151904|19230672|P1|COMPLETED|Overall Study||17
7811647|NCT01151904|19230672|P1|STARTED|Overall Study||17
7811648|NCT01151852|19230680|P2|NOT COMPLETED|Overall Study||0
7811649|NCT01151852|19230681|P1|NOT COMPLETED|Overall Study||0
7811650|NCT01151852|19230680|P2|COMPLETED|Overall Study||40
7811651|NCT01151852|19230681|P1|COMPLETED|Overall Study||41
7811652|NCT01151852|19230680|P2|STARTED|Overall Study||40
7811653|NCT01151852|19230681|P1|STARTED|Overall Study||41
7811654|NCT01151813|19230697|P2|NOT COMPLETED|Period 2||0
7811655|NCT01151813|19230698|P1|NOT COMPLETED|Period 2||0
7811656|NCT01151813|19230697|P2|COMPLETED|Period 2||7
7811657|NCT01151813|19230698|P1|COMPLETED|Period 2||8
7811658|NCT01151813|19230697|P2|STARTED|Period 2||7
7811659|NCT01151813|19230698|P1|STARTED|Period 2||8
7811660|NCT01151813|19230697|P2|NOT COMPLETED|Period 1||0
7811661|NCT01151813|19230698|P1|NOT COMPLETED|Period 1||0
7811662|NCT01151813|19230697|P2|COMPLETED|Period 1||7
7811663|NCT01151813|19230698|P1|COMPLETED|Period 1||8
7811664|NCT01151813|19230697|P2|STARTED|Period 1||7
7811665|NCT01151813|19230698|P1|STARTED|Period 1||8
7811666|NCT01151761|19230710|P1|NOT COMPLETED|Overall Study||0
7811667|NCT01151761|19230710|P1|COMPLETED|Overall Study||2
7811668|NCT01151761|19230710|P1|STARTED|Overall Study||2
7811669|NCT01151618|19230721|P1|NOT COMPLETED|Overall Study||9
7811670|NCT01151618|19230721|P1|COMPLETED|Overall Study||13
7811671|NCT01151618|19230721|P1|STARTED|Overall Study||22
7811672|NCT01151579|19230729|P2|NOT COMPLETED|Overall Study||7
7811673|NCT01151579|19230730|P1|NOT COMPLETED|Overall Study||12
7811674|NCT01151579|19230729|P2|COMPLETED|Overall Study||24
7811675|NCT01151579|19230730|P1|COMPLETED|Overall Study||46
7811676|NCT01151579|19230729|P2|STARTED|Overall Study||31
7811677|NCT01151579|19230730|P1|STARTED|Overall Study||58
7811678|NCT01151553|19230740|P1|NOT COMPLETED|Overall Study||0
7811679|NCT01151553|19230740|P1|COMPLETED|Overall Study||5
7811680|NCT01151553|19230740|P1|STARTED|Overall Study||5
7811681|NCT01151540|19230744|P1|NOT COMPLETED|Overall Study||13
7811682|NCT01151540|19230744|P1|COMPLETED|Overall Study||41
7811683|NCT01151540|19230744|P1|STARTED|Overall Study||54
7811684|NCT01151449|19230753|P1|NOT COMPLETED|Overall Study||0
7811685|NCT01151449|19230753|P1|COMPLETED|Overall Study||6
7811686|NCT01151449|19230753|P1|STARTED|Overall Study||6
7811687|NCT01151436|19230761|P1|NOT COMPLETED|Overall Study||1
7811688|NCT01151436|19230761|P1|COMPLETED|Overall Study||76
7811689|NCT01151436|19230761|P1|STARTED|Overall Study||77
7811690|NCT01151423|19230793|P2|NOT COMPLETED|Overall Study||18
7811691|NCT01151423|19230794|P1|NOT COMPLETED|Overall Study||16
7811692|NCT01151423|19230793|P2|COMPLETED|Overall Study||21
7811693|NCT01151423|19230794|P1|COMPLETED|Overall Study||20
7811694|NCT01151423|19230793|P2|Received Study Drug|Overall Study||37
7811695|NCT01151423|19230794|P1|Received Study Drug|Overall Study||35
7811696|NCT01151423|19230793|P2|STARTED|Overall Study||39
7811697|NCT01151423|19230794|P1|STARTED|Overall Study||36
7811698|NCT01151410|19230842|P2|NOT COMPLETED|Overall Study||15
7811699|NCT01151410|19230843|P1|NOT COMPLETED|Overall Study||11
7811700|NCT01151410|19230842|P2|COMPLETED|Overall Study||89
7811701|NCT01151410|19230843|P1|COMPLETED|Overall Study||93
7811702|NCT01151410|19230842|P2|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103
7811703|NCT01151410|19230843|P1|Safety Set (SAF)|Overall Study||105
7811704|NCT01151410|19230842|P2|STARTED|Overall Study||104
7811705|NCT01151410|19230843|P1|STARTED|Overall Study||104
7811706|NCT01151371|19230856|P3|NOT COMPLETED|Overall Study||7
7811707|NCT01151371|19230857|P2|NOT COMPLETED|Overall Study||1
7811708|NCT01151371|19230858|P1|NOT COMPLETED|Overall Study||5
7811709|NCT01151371|19230856|P3|COMPLETED|Overall Study||146
7811710|NCT01151371|19230857|P2|COMPLETED|Overall Study||149
7811711|NCT01151371|19230858|P1|COMPLETED|Overall Study||144
7811712|NCT01151371|19230856|P3|STARTED|Overall Study||153
7811713|NCT01151371|19230857|P2|STARTED|Overall Study||150
7811714|NCT01151371|19230858|P1|STARTED|Overall Study||149
7811715|NCT01151345|19230887|P2|NOT COMPLETED|Second Intervention Period||0
7811716|NCT01151345|19230888|P1|NOT COMPLETED|Second Intervention Period||0
7811717|NCT01151345|19230887|P2|COMPLETED|Second Intervention Period||12
7811718|NCT01151345|19230888|P1|COMPLETED|Second Intervention Period||13
7811719|NCT01151345|19230887|P2|STARTED|Second Intervention Period||12
7811720|NCT01151345|19230888|P1|STARTED|Second Intervention Period||13
7811721|NCT01151345|19230887|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
7811722|NCT01151345|19230888|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
7811723|NCT01151345|19230887|P2|COMPLETED|Wash-out Period (7 Days)||12
7811724|NCT01151345|19230888|P1|COMPLETED|Wash-out Period (7 Days)||13
7811725|NCT01151345|19230887|P2|STARTED|Wash-out Period (7 Days)||12
7811726|NCT01151345|19230888|P1|STARTED|Wash-out Period (7 Days)||13
7811727|NCT01151345|19230887|P2|NOT COMPLETED|First Intervention Period||1
7811728|NCT01151345|19230888|P1|NOT COMPLETED|First Intervention Period||0
7811729|NCT01151345|19230887|P2|COMPLETED|First Intervention Period||12
7811730|NCT01151345|19230888|P1|COMPLETED|First Intervention Period||13
7811731|NCT01151345|19230887|P2|Treated|First Intervention Period||12
7811732|NCT01151345|19230888|P1|Treated|First Intervention Period||13
7811733|NCT01151345|19230887|P2|STARTED|First Intervention Period||13
7811734|NCT01151345|19230888|P1|STARTED|First Intervention Period||13
7811735|NCT01151280|19230902|P1|NOT COMPLETED|Overall Study||4
7811736|NCT01151280|19230902|P1|COMPLETED|Overall Study||6
7811737|NCT01151280|19230902|P1|STARTED|Overall Study||10
7811738|NCT01151215|19230915|P3|NOT COMPLETED|Overall Study||19
7811739|NCT01151215|19230916|P2|NOT COMPLETED|Overall Study||23
7811740|NCT01151215|19230917|P1|NOT COMPLETED|Overall Study||20
7811741|NCT01151215|19230915|P3|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102
7811742|NCT01151215|19230916|P2|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95
7811743|NCT01151215|19230917|P1|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100
7811744|NCT01151215|19230915|P3|STARTED|Overall Study||121
7811745|NCT01151215|19230916|P2|STARTED|Overall Study||118
7811746|NCT01151215|19230917|P1|STARTED|Overall Study||120
7811747|NCT01151189|19230930|P2|NOT COMPLETED|Overall Study||10
7811748|NCT01151189|19230931|P1|NOT COMPLETED|Overall Study||15
7811749|NCT01151189|19230930|P2|COMPLETED|Overall Study||314
7811750|NCT01151189|19230931|P1|COMPLETED|Overall Study||311
7811751|NCT01151189|19230930|P2|Received Vaccine|Overall Study||324
7811752|NCT01151189|19230931|P1|Received Vaccine|Overall Study||325
7811753|NCT01151189|19230930|P2|STARTED|Overall Study||324
7811754|NCT01151189|19230931|P1|STARTED|Overall Study||326
7811755|NCT01151137|19230955|P2|NOT COMPLETED|Overall Study||28
7811756|NCT01151137|19230956|P1|NOT COMPLETED|Overall Study||16
7811757|NCT01151137|19230955|P2|COMPLETED|Overall Study||1591
7811758|NCT01151137|19230956|P1|COMPLETED|Overall Study||1601
7811759|NCT01151137|19230955|P2|Discontinued Treatment|Overall Study||342
7811760|NCT01151137|19230956|P1|Discontinued Treatment|Overall Study||171
7811761|NCT01151137|19230955|P2|Treated|Overall Study||1613
7811762|NCT01151137|19230956|P1|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610
7811763|NCT01151137|19230955|P2|STARTED|Overall Study||1619
7811764|NCT01151137|19230956|P1|STARTED|Overall Study||1617
7811765|NCT01151098|19230974|P1|NOT COMPLETED|Overall Study||117
7811766|NCT01151098|19230974|P1|COMPLETED|Overall Study||72
7811767|NCT01151098|19230974|P1|STARTED|Overall Study|Extension Safety Population|189
7811768|NCT01151085|19230978|P1|NOT COMPLETED|Overall Study||56
7811769|NCT01151085|19230978|P1|COMPLETED|Overall Study||946
7811770|NCT01151085|19230978|P1|STARTED|Overall Study||1002
7811771|NCT01151046|19230996|P2|NOT COMPLETED|Overall Study||0
7811772|NCT01151046|19230997|P1|NOT COMPLETED|Overall Study||3
7811773|NCT01151046|19230996|P2|COMPLETED|Overall Study||59
7811774|NCT01151046|19230997|P1|COMPLETED|Overall Study||56
7811775|NCT01151046|19230996|P2|STARTED|Overall Study||59
7811776|NCT01151046|19230997|P1|STARTED|Overall Study||59
7811777|NCT01151020|19231009|P1|NOT COMPLETED|Overall Study||110
7811778|NCT01151020|19231009|P1|COMPLETED|Overall Study||0
7811779|NCT01151020|19231009|P1|12-month|Overall Study||99
7811780|NCT01151020|19231009|P1|30-day|Overall Study||110
7811781|NCT01151020|19231009|P1|STARTED|Overall Study||110
7811782|NCT01150981|19231016|P2|NOT COMPLETED|Overall Study||2
7811783|NCT01150981|19231017|P1|NOT COMPLETED|Overall Study||4
7811784|NCT01150981|19231016|P2|COMPLETED|Overall Study||13
7811785|NCT01150981|19231017|P1|COMPLETED|Overall Study||16
7811786|NCT01150981|19231016|P2|STARTED|Overall Study||15
7811787|NCT01150981|19231017|P1|STARTED|Overall Study||20
7811788|NCT01150903|19231027|P2|NOT COMPLETED|Overall Study||0
7811789|NCT01150903|19231028|P1|NOT COMPLETED|Overall Study||0
7811790|NCT01150903|19231027|P2|COMPLETED|Overall Study||74124
7811791|NCT01150903|19231028|P1|COMPLETED|Overall Study||24708
7811792|NCT01150903|19231027|P2|STARTED|Overall Study||74124
7811793|NCT01150903|19231028|P1|STARTED|Overall Study||24708
7811794|NCT01150760|19231044|P2|NOT COMPLETED|Overall Study||0
7811795|NCT01150760|19231045|P1|NOT COMPLETED|Overall Study||0
7811796|NCT01150760|19231044|P2|COMPLETED|Overall Study||3525
7811797|NCT01150760|19231045|P1|COMPLETED|Overall Study||3525
7811798|NCT01150760|19231044|P2|STARTED|Overall Study||3525
7811799|NCT01150760|19231045|P1|STARTED|Overall Study||3525
7811800|NCT01150500|19231077|P1|NOT COMPLETED|Overall Study||65
7811801|NCT01150500|19231077|P1|COMPLETED|Overall Study||0
7811802|NCT01150500|19231077|P1|STARTED|Overall Study||65
7811803|NCT01150474|19231088|P2|NOT COMPLETED|Overall Study||3
7811804|NCT01150474|19231089|P1|NOT COMPLETED|Overall Study||10
7811805|NCT01150474|19231088|P2|COMPLETED|Overall Study||49
7811806|NCT01150474|19231089|P1|COMPLETED|Overall Study||41
7811807|NCT01150474|19231088|P2|STARTED|Overall Study||52
7811808|NCT01150474|19231089|P1|STARTED|Overall Study||51
7811809|NCT01150461|19231113|P2|NOT COMPLETED|Overall Study||0
7811810|NCT01150461|19231114|P1|NOT COMPLETED|Overall Study||0
7811811|NCT01150461|19231113|P2|COMPLETED|Overall Study||9
7811812|NCT01150461|19231114|P1|COMPLETED|Overall Study||11
7811813|NCT01150461|19231113|P2|STARTED|Overall Study||9
7811814|NCT01150461|19231114|P1|STARTED|Overall Study||11
7811815|NCT01150409|19231124|P2|NOT COMPLETED|Overall Study||0
7811816|NCT01150409|19231125|P1|NOT COMPLETED|Overall Study||0
7811817|NCT01150409|19231124|P2|COMPLETED|Overall Study||0
7811818|NCT01150409|19231125|P1|COMPLETED|Overall Study||11
7811819|NCT01150409|19231124|P2|STARTED|Overall Study||0
7811820|NCT01150409|19231125|P1|STARTED|Overall Study||11
7811821|NCT01150357|19231134|P3|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2
7811822|NCT01150357|19231135|P2|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0
7811823|NCT01150357|19231136|P1|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3
7811824|NCT01150357|19231134|P3|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100
7811825|NCT01150357|19231135|P2|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51
7811826|NCT01150357|19231136|P1|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104
7811827|NCT01150357|19231134|P3|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51
7811828|NCT01150357|19231135|P2|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21
7811829|NCT01150357|19231136|P1|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54
7811830|NCT01150357|19231134|P3|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52
7811831|NCT01150357|19231135|P2|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21
7811832|NCT01150357|19231136|P1|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57
7811833|NCT01150357|19231134|P3|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49
7811834|NCT01150357|19231135|P2|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
7811835|NCT01150357|19231136|P1|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
7811836|NCT01150357|19231134|P3|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
7811837|NCT01150357|19231135|P2|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
7811838|NCT01150357|19231136|P1|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
7811839|NCT01150357|19231134|P3|STARTED|Placebo-controlled Withdrawal (Phase 2)||102
7811840|NCT01150357|19231135|P2|STARTED|Placebo-controlled Withdrawal (Phase 2)||51
7811841|NCT01150357|19231136|P1|STARTED|Placebo-controlled Withdrawal (Phase 2)||107
7811842|NCT01150357|19231134|P3|NOT COMPLETED|Dose Response Phase (Phase 1)||3
7811843|NCT01150357|19231135|P2|NOT COMPLETED|Dose Response Phase (Phase 1)||3
7811844|NCT01150357|19231136|P1|NOT COMPLETED|Dose Response Phase (Phase 1)||1
7811845|NCT01150357|19231134|P3|COMPLETED|Dose Response Phase (Phase 1)||102
7811846|NCT01150357|19231135|P2|COMPLETED|Dose Response Phase (Phase 1)||51
7811847|NCT01150357|19231136|P1|COMPLETED|Dose Response Phase (Phase 1)||107
7811848|NCT01150357|19231134|P3|STARTED|Dose Response Phase (Phase 1)||105
7811849|NCT01150357|19231135|P2|STARTED|Dose Response Phase (Phase 1)||54
7811850|NCT01150357|19231136|P1|STARTED|Dose Response Phase (Phase 1)||108
7811851|NCT01150123|19231216|P18|NOT COMPLETED|Overall Study||1
7811852|NCT01150123|19231217|P17|NOT COMPLETED|Overall Study||0
7811853|NCT01150123|19231218|P16|NOT COMPLETED|Overall Study||1
7811854|NCT01150123|19231219|P15|NOT COMPLETED|Overall Study||0
7811855|NCT01150123|19231220|P14|NOT COMPLETED|Overall Study||0
7811856|NCT01150123|19231221|P13|NOT COMPLETED|Overall Study||3
7811857|NCT01150123|19231222|P12|NOT COMPLETED|Overall Study||1
7811858|NCT01150123|19231223|P11|NOT COMPLETED|Overall Study||2
7811859|NCT01150123|19231224|P10|NOT COMPLETED|Overall Study||1
7811860|NCT01150123|19231225|P9|NOT COMPLETED|Overall Study||5
7811861|NCT01150123|19231226|P8|NOT COMPLETED|Overall Study||3
7811862|NCT01150123|19231227|P7|NOT COMPLETED|Overall Study||0
7811863|NCT01150123|19231228|P6|NOT COMPLETED|Overall Study||6
7811864|NCT01150123|19231229|P5|NOT COMPLETED|Overall Study||3
7811865|NCT01150123|19231230|P4|NOT COMPLETED|Overall Study||3
7811866|NCT01150123|19231231|P3|NOT COMPLETED|Overall Study||4
7811867|NCT01150123|19231232|P2|NOT COMPLETED|Overall Study||2
7811868|NCT01150123|19231233|P1|NOT COMPLETED|Overall Study||3
7811869|NCT01150123|19231216|P18|COMPLETED|Overall Study||19
7811870|NCT01150123|19231217|P17|COMPLETED|Overall Study||40
7811871|NCT01150123|19231218|P16|COMPLETED|Overall Study||39
7811872|NCT01150123|19231219|P15|COMPLETED|Overall Study||40
7811873|NCT01150123|19231220|P14|COMPLETED|Overall Study||40
7811874|NCT01150123|19231221|P13|COMPLETED|Overall Study||37
7811875|NCT01150123|19231222|P12|COMPLETED|Overall Study||39
7811876|NCT01150123|19231223|P11|COMPLETED|Overall Study||38
7811877|NCT01150123|19231224|P10|COMPLETED|Overall Study||39
7811878|NCT01150123|19231225|P9|COMPLETED|Overall Study||15
7811879|NCT01150123|19231226|P8|COMPLETED|Overall Study||37
7811880|NCT01150123|19231227|P7|COMPLETED|Overall Study||39
7811881|NCT01150123|19231228|P6|COMPLETED|Overall Study||34
7811882|NCT01150123|19231229|P5|COMPLETED|Overall Study||37
7811883|NCT01150123|19231230|P4|COMPLETED|Overall Study||37
7811884|NCT01150123|19231231|P3|COMPLETED|Overall Study||35
7811885|NCT01150123|19231232|P2|COMPLETED|Overall Study||38
7811886|NCT01150123|19231233|P1|COMPLETED|Overall Study||37
7811887|NCT01150123|19231216|P18|STARTED|Overall Study||20
7811888|NCT01150123|19231217|P17|STARTED|Overall Study||40
7811889|NCT01150123|19231218|P16|STARTED|Overall Study||40
7811890|NCT01150123|19231219|P15|STARTED|Overall Study||40
7811891|NCT01150123|19231220|P14|STARTED|Overall Study||40
7811892|NCT01150123|19231221|P13|STARTED|Overall Study||40
7811893|NCT01150123|19231222|P12|STARTED|Overall Study||40
7811894|NCT01150123|19231223|P11|STARTED|Overall Study||40
7811895|NCT01150123|19231224|P10|STARTED|Overall Study||40
7811896|NCT01150123|19231225|P9|STARTED|Overall Study||20
7811897|NCT01150123|19231226|P8|STARTED|Overall Study||40
7811898|NCT01150123|19231227|P7|STARTED|Overall Study||39
7811899|NCT01150123|19231228|P6|STARTED|Overall Study||40
7811900|NCT01150123|19231229|P5|STARTED|Overall Study||40
7811901|NCT01150123|19231230|P4|STARTED|Overall Study||40
7811902|NCT01150123|19231231|P3|STARTED|Overall Study||39
7811903|NCT01150123|19231232|P2|STARTED|Overall Study||40
7811904|NCT01150123|19231233|P1|STARTED|Overall Study||40
7811905|NCT01150097|19231409|P3|NOT COMPLETED|Months 24 to 48 Post-transplantation||0
7811906|NCT01150097|19231410|P2|NOT COMPLETED|Months 24 to 48 Post-transplantation||4
7811907|NCT01150097|19231411|P1|NOT COMPLETED|Months 24 to 48 Post-transplantation||11
7811908|NCT01150097|19231409|P3|COMPLETED|Months 24 to 48 Post-transplantation||0
7811909|NCT01150097|19231410|P2|COMPLETED|Months 24 to 48 Post-transplantation||47
7811910|NCT01150097|19231411|P1|COMPLETED|Months 24 to 48 Post-transplantation||95
7811911|NCT01150097|19231409|P3|STARTED|Months 24 to 48 Post-transplantation||0
7811912|NCT01150097|19231410|P2|STARTED|Months 24 to 48 Post-transplantation||51
7811913|NCT01150097|19231411|P1|STARTED|Months 24 to 48 Post-transplantation||106
7811914|NCT01150097|19231409|P3|NOT COMPLETED|Months 24 to 36 Post-transplantation||8
7811915|NCT01150097|19231410|P2|NOT COMPLETED|Months 24 to 36 Post-transplantation||2
7811916|NCT01150097|19231411|P1|NOT COMPLETED|Months 24 to 36 Post-transplantation||10
7811917|NCT01150097|19231409|P3|COMPLETED|Months 24 to 36 Post-transplantation||117
7811918|NCT01150097|19231410|P2|COMPLETED|Months 24 to 36 Post-transplantation||49
7811919|NCT01150097|19231411|P1|COMPLETED|Months 24 to 36 Post-transplantation||96
7811920|NCT01150097|19231409|P3|STARTED|Months 24 to 36 Post-transplantation||125
7811921|NCT01150097|19231410|P2|STARTED|Months 24 to 36 Post-transplantation||51
7811922|NCT01150097|19231411|P1|STARTED|Months 24 to 36 Post-transplantation||106
7811923|NCT01149876|19231438|P4|NOT COMPLETED|Overall Study||0
7811924|NCT01149876|19231439|P3|NOT COMPLETED|Overall Study||1
7811925|NCT01149876|19231440|P2|NOT COMPLETED|Overall Study||0
7811926|NCT01149876|19231441|P1|NOT COMPLETED|Overall Study||1
7811927|NCT01149876|19231438|P4|COMPLETED|Overall Study||18
7811928|NCT01149876|19231439|P3|COMPLETED|Overall Study||20
7811929|NCT01149876|19231440|P2|COMPLETED|Overall Study||20
7811930|NCT01149876|19231441|P1|COMPLETED|Overall Study||20
7811931|NCT01149876|19231438|P4|STARTED|Overall Study||18
7811932|NCT01149876|19231439|P3|STARTED|Overall Study||21
7811933|NCT01149876|19231440|P2|STARTED|Overall Study||20
7811934|NCT01149876|19231441|P1|STARTED|Overall Study||21
7811935|NCT01149863|19231455|P1|NOT COMPLETED|Overall Study||3
7811936|NCT01149863|19231455|P1|COMPLETED|Overall Study||31
7811937|NCT01149863|19231455|P1|STARTED|Overall Study||34
7811938|NCT01149785|19231460|P2|NOT COMPLETED|Second Intervention||0
7811939|NCT01149785|19231461|P1|NOT COMPLETED|Second Intervention||0
7811940|NCT01149785|19231460|P2|COMPLETED|Second Intervention||15
7811941|NCT01149785|19231461|P1|COMPLETED|Second Intervention||0
7811942|NCT01149785|19231460|P2|STARTED|Second Intervention||15
7811943|NCT01149785|19231461|P1|STARTED|Second Intervention||0
7811944|NCT01149785|19231460|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
7811945|NCT01149785|19231461|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
7811946|NCT01149785|19231460|P2|COMPLETED|Washout Period of at Least 14 Days||0
7811947|NCT01149785|19231461|P1|COMPLETED|Washout Period of at Least 14 Days||15
7811948|NCT01149785|19231460|P2|STARTED|Washout Period of at Least 14 Days||0
7811949|NCT01149785|19231461|P1|STARTED|Washout Period of at Least 14 Days||15
7811950|NCT01149785|19231460|P2|NOT COMPLETED|First Intervention||0
7811951|NCT01149785|19231461|P1|NOT COMPLETED|First Intervention||0
7811952|NCT01149785|19231460|P2|COMPLETED|First Intervention||0
7811953|NCT01149785|19231461|P1|COMPLETED|First Intervention||15
7811954|NCT01149785|19231460|P2|STARTED|First Intervention||0
7811955|NCT01149785|19231461|P1|STARTED|First Intervention||15
7811956|NCT01149772|19231495|P2|NOT COMPLETED|Overall Study||21
7811957|NCT01149772|19231496|P1|NOT COMPLETED|Overall Study||48
7811958|NCT01149772|19231495|P2|COMPLETED|Overall Study||101
7811959|NCT01149772|19231496|P1|COMPLETED|Overall Study||132
7811960|NCT01149772|19231495|P2|STARTED|Overall Study||122
7811961|NCT01149772|19231496|P1|STARTED|Overall Study||180
7811962|NCT01149759|19231512|P1|NOT COMPLETED|Overall Study||0
7811963|NCT01149759|19231512|P1|COMPLETED|Overall Study||9
7811964|NCT01149759|19231512|P1|STARTED|Overall Study||9
7811965|NCT01149733|19231519|P2|NOT COMPLETED|Overall Study||0
7811966|NCT01149733|19231520|P1|NOT COMPLETED|Overall Study||0
7811967|NCT01149733|19231519|P2|COMPLETED|Overall Study||16
7811968|NCT01149733|19231520|P1|COMPLETED|Overall Study||16
7811969|NCT01149733|19231519|P2|STARTED|Overall Study||16
7811970|NCT01149733|19231520|P1|STARTED|Overall Study||16
7811971|NCT01149681|19231530|P1|NOT COMPLETED|Overall Study||12
7811972|NCT01149681|19231530|P1|COMPLETED|Overall Study||0
7811973|NCT01149681|19231530|P1|STARTED|Overall Study||12
7811974|NCT01149655|19231538|P4|NOT COMPLETED|Period 3-DB Maintenance Phase||42
7811975|NCT01149655|19231539|P3|NOT COMPLETED|Period 3-DB Maintenance Phase||83
7811976|NCT01149655|19231540|P2|NOT COMPLETED|Period 3-DB Maintenance Phase||0
7811977|NCT01149655|19231541|P1|NOT COMPLETED|Period 3-DB Maintenance Phase||0
7811978|NCT01149655|19231538|P4|COMPLETED|Period 3-DB Maintenance Phase||6
7811979|NCT01149655|19231539|P3|COMPLETED|Period 3-DB Maintenance Phase||15
7811980|NCT01149655|19231540|P2|COMPLETED|Period 3-DB Maintenance Phase||0
7811981|NCT01149655|19231541|P1|COMPLETED|Period 3-DB Maintenance Phase||0
7811982|NCT01149655|19231538|P4|STARTED|Period 3-DB Maintenance Phase||48
7811983|NCT01149655|19231539|P3|STARTED|Period 3-DB Maintenance Phase||98
7811984|NCT01149655|19231540|P2|STARTED|Period 3-DB Maintenance Phase||0
7811985|NCT01149655|19231541|P1|STARTED|Period 3-DB Maintenance Phase||0
7811986|NCT01149655|19231538|P4|NOT COMPLETED|Period 2-Stabilization Phase||0
7811987|NCT01149655|19231539|P3|NOT COMPLETED|Period 2-Stabilization Phase||0
7811988|NCT01149655|19231540|P2|NOT COMPLETED|Period 2-Stabilization Phase||37
7811989|NCT01149655|19231541|P1|NOT COMPLETED|Period 2-Stabilization Phase||0
7811990|NCT01149655|19231538|P4|COMPLETED|Period 2-Stabilization Phase||0
7811991|NCT01149655|19231539|P3|COMPLETED|Period 2-Stabilization Phase||0
7811992|NCT01149655|19231540|P2|COMPLETED|Period 2-Stabilization Phase||146
7811993|NCT01149655|19231541|P1|COMPLETED|Period 2-Stabilization Phase||0
7811994|NCT01149655|19231538|P4|STARTED|Period 2-Stabilization Phase||0
7811995|NCT01149655|19231539|P3|STARTED|Period 2-Stabilization Phase||0
7811996|NCT01149655|19231540|P2|STARTED|Period 2-Stabilization Phase||183
7811997|NCT01149655|19231541|P1|STARTED|Period 2-Stabilization Phase||0
7811998|NCT01149655|19231538|P4|NOT COMPLETED|Period 1 - Conversion Phase||0
7811999|NCT01149655|19231539|P3|NOT COMPLETED|Period 1 - Conversion Phase||0
7812000|NCT01149655|19231540|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
7812001|NCT01149655|19231541|P1|NOT COMPLETED|Period 1 - Conversion Phase||18
7812002|NCT01149655|19231538|P4|COMPLETED|Period 1 - Conversion Phase||0
7812003|NCT01149655|19231539|P3|COMPLETED|Period 1 - Conversion Phase||0
7812004|NCT01149655|19231540|P2|COMPLETED|Period 1 - Conversion Phase||0
7812005|NCT01149655|19231541|P1|COMPLETED|Period 1 - Conversion Phase||168
7812006|NCT01149655|19231538|P4|STARTED|Period 1 - Conversion Phase||0
7812007|NCT01149655|19231539|P3|STARTED|Period 1 - Conversion Phase||0
7812008|NCT01149655|19231540|P2|STARTED|Period 1 - Conversion Phase||0
7812009|NCT01149655|19231541|P1|STARTED|Period 1 - Conversion Phase||186
7812010|NCT01149616|19231571|P2|NOT COMPLETED|Overall Study||0
7812011|NCT01149616|19231572|P1|NOT COMPLETED|Overall Study||0
7812012|NCT01149616|19231571|P2|COMPLETED|Overall Study||41
7812013|NCT01149616|19231572|P1|COMPLETED|Overall Study||41
7812014|NCT01149616|19231571|P2|STARTED|Overall Study||41
7812015|NCT01149616|19231572|P1|STARTED|Overall Study||41
7812016|NCT01149538|19231584|P2|NOT COMPLETED|Overall Study||4
7812017|NCT01149538|19231585|P1|NOT COMPLETED|Overall Study||5
7812018|NCT01149538|19231584|P2|COMPLETED|Overall Study||25
7812019|NCT01149538|19231585|P1|COMPLETED|Overall Study||26
7812020|NCT01149538|19231584|P2|STARTED|Overall Study||29
7812021|NCT01149538|19231585|P1|STARTED|Overall Study||31
7812022|NCT01149512|19231599|P1|NOT COMPLETED|Overall Study||0
7812023|NCT01149512|19231599|P1|COMPLETED|Overall Study||178
7812024|NCT01149512|19231599|P1|STARTED|Overall Study||178
7812025|NCT01149486|19231606|P2|NOT COMPLETED|Second Intervention||0
7812026|NCT01149486|19231607|P1|NOT COMPLETED|Second Intervention||0
7812027|NCT01149486|19231606|P2|COMPLETED|Second Intervention||9
7812028|NCT01149486|19231607|P1|COMPLETED|Second Intervention||10
7812029|NCT01149486|19231606|P2|STARTED|Second Intervention||9
7812030|NCT01149486|19231607|P1|STARTED|Second Intervention||10
7812031|NCT01149486|19231606|P2|NOT COMPLETED|Washout of 7 Days||0
7812032|NCT01149486|19231607|P1|NOT COMPLETED|Washout of 7 Days||0
7812033|NCT01149486|19231606|P2|COMPLETED|Washout of 7 Days||9
7812034|NCT01149486|19231607|P1|COMPLETED|Washout of 7 Days||10
7812035|NCT01149486|19231606|P2|STARTED|Washout of 7 Days||9
7812036|NCT01149486|19231607|P1|STARTED|Washout of 7 Days||10
7812037|NCT01149486|19231606|P2|NOT COMPLETED|First Intervention||1
7812038|NCT01149486|19231607|P1|NOT COMPLETED|First Intervention||0
7812039|NCT01149486|19231606|P2|COMPLETED|First Intervention||9
7812040|NCT01149486|19231607|P1|COMPLETED|First Intervention||10
7812041|NCT01149486|19231606|P2|STARTED|First Intervention||10
7812042|NCT01149486|19231607|P1|STARTED|First Intervention||10
7812043|NCT01149473|19231631|P2|NOT COMPLETED|Second Intervention||0
7812044|NCT01149473|19231632|P1|NOT COMPLETED|Second Intervention||0
7812045|NCT01149473|19231631|P2|COMPLETED|Second Intervention||38
7812046|NCT01149473|19231632|P1|COMPLETED|Second Intervention||38
7812047|NCT01149473|19231631|P2|STARTED|Second Intervention||38
7812048|NCT01149473|19231632|P1|STARTED|Second Intervention||38
7812049|NCT01149473|19231631|P2|NOT COMPLETED|Washout of 7 Days||1
7812050|NCT01149473|19231632|P1|NOT COMPLETED|Washout of 7 Days||1
7812051|NCT01149473|19231631|P2|COMPLETED|Washout of 7 Days||38
7812052|NCT01149473|19231632|P1|COMPLETED|Washout of 7 Days||38
7812053|NCT01149473|19231631|P2|STARTED|Washout of 7 Days||39
7812054|NCT01149473|19231632|P1|STARTED|Washout of 7 Days||39
7812055|NCT01149473|19231631|P2|NOT COMPLETED|First Intervention||1
7812056|NCT01149473|19231632|P1|NOT COMPLETED|First Intervention||1
7812057|NCT01149473|19231631|P2|COMPLETED|First Intervention||39
7812058|NCT01149473|19231632|P1|COMPLETED|First Intervention||39
7812059|NCT01149473|19231631|P2|STARTED|First Intervention||40
7812060|NCT01149473|19231632|P1|STARTED|First Intervention||40
7812061|NCT01149460|19231650|P2|NOT COMPLETED|Overall Study||2
7812062|NCT01149460|19231651|P1|NOT COMPLETED|Overall Study||0
7812063|NCT01149460|19231650|P2|COMPLETED|Overall Study||16
7812064|NCT01149460|19231651|P1|COMPLETED|Overall Study||18
7812065|NCT01149460|19231650|P2|STARTED|Overall Study||18
7812066|NCT01149460|19231651|P1|STARTED|Overall Study||18
7812067|NCT01149434|19231669|P2|NOT COMPLETED|Overall Study||5
7812068|NCT01149434|19231670|P1|NOT COMPLETED|Overall Study||0
7812069|NCT01149434|19231669|P2|COMPLETED|Overall Study||10
7812070|NCT01149434|19231670|P1|COMPLETED|Overall Study||4
7812071|NCT01149434|19231669|P2|STARTED|Overall Study||15
7812072|NCT01149434|19231670|P1|STARTED|Overall Study||4
7812073|NCT01149421|19231684|P3|NOT COMPLETED|Overall Study||44
7812074|NCT01149421|19231685|P2|NOT COMPLETED|Overall Study||29
7812075|NCT01149421|19231686|P1|NOT COMPLETED|Overall Study||52
7812076|NCT01149421|19231684|P3|COMPLETED|Overall Study||206
7812077|NCT01149421|19231685|P2|COMPLETED|Overall Study||225
7812078|NCT01149421|19231686|P1|COMPLETED|Overall Study||199
7812079|NCT01149421|19231684|P3|Received at Least One Dose of Study Drug|Overall Study||250
7812080|NCT01149421|19231685|P2|Received at Least One Dose of Study Drug|Overall Study||254
7812081|NCT01149421|19231686|P1|Received at Least One Dose of Study Drug|Overall Study||251
7812082|NCT01149421|19231684|P3|STARTED|Overall Study||250
7812083|NCT01149421|19231685|P2|STARTED|Overall Study||254
7812084|NCT01149421|19231686|P1|STARTED|Overall Study||251
7812085|NCT01149369|19231767|P2|NOT COMPLETED|Overall Study||3
7812086|NCT01149369|19231768|P1|NOT COMPLETED|Overall Study||6
7812087|NCT01149369|19231767|P2|COMPLETED|Overall Study||60
7812088|NCT01149369|19231768|P1|COMPLETED|Overall Study||57
7812089|NCT01149369|19231767|P2|STARTED|Overall Study||63
7812090|NCT01149369|19231768|P1|STARTED|Overall Study||63
7812091|NCT01149343|19231936|P4|NOT COMPLETED|Overall Study||40
7812092|NCT01149343|19231937|P3|NOT COMPLETED|Overall Study||22
7812093|NCT01149343|19231938|P2|NOT COMPLETED|Overall Study||24
7812094|NCT01149343|19231939|P1|NOT COMPLETED|Overall Study||20
7812095|NCT01149343|19231936|P4|COMPLETED|Overall Study||0
7812096|NCT01149343|19231937|P3|COMPLETED|Overall Study||0
7812097|NCT01149343|19231938|P2|COMPLETED|Overall Study||0
7812098|NCT01149343|19231939|P1|COMPLETED|Overall Study||0
7812099|NCT01149343|19231936|P4|STARTED|Overall Study||40
7812100|NCT01149343|19231937|P3|STARTED|Overall Study||22
7812101|NCT01149343|19231938|P2|STARTED|Overall Study||24
7812102|NCT01149343|19231939|P1|STARTED|Overall Study||20
7812103|NCT01149148|19232024|P2|NOT COMPLETED|Overall Study||2
7812104|NCT01149148|19232025|P1|NOT COMPLETED|Overall Study||2
7812105|NCT01149148|19232024|P2|COMPLETED|Overall Study||11
7812106|NCT01149148|19232025|P1|COMPLETED|Overall Study||10
7812107|NCT01149148|19232024|P2|STARTED|Overall Study||13
7812108|NCT01149148|19232025|P1|STARTED|Overall Study||12
7812109|NCT01149096|19232035|P2|NOT COMPLETED|Overall Study||1
7812110|NCT01149096|19232036|P1|NOT COMPLETED|Overall Study||0
7812111|NCT01149096|19232035|P2|COMPLETED|Overall Study||6
7812112|NCT01149096|19232036|P1|COMPLETED|Overall Study||6
7812113|NCT01149096|19232035|P2|STARTED|Overall Study||7
7812114|NCT01149096|19232036|P1|STARTED|Overall Study||6
7812115|NCT01149057|19232060|P1|NOT COMPLETED|Overall Study||57
7812116|NCT01149057|19232060|P1|COMPLETED|Overall Study||88
7812117|NCT01149057|19232060|P1|STARTED|Overall Study||145
7812118|NCT01148979|19232087|P2|NOT COMPLETED|Overall Study||1
7812119|NCT01148979|19232088|P1|NOT COMPLETED|Overall Study||0
7812120|NCT01148979|19232087|P2|COMPLETED|Overall Study||15
7812121|NCT01148979|19232088|P1|COMPLETED|Overall Study||13
7812122|NCT01148979|19232087|P2|STARTED|Overall Study||16
7812123|NCT01148979|19232088|P1|STARTED|Overall Study||13
7812124|NCT01148940|19232096|P3|NOT COMPLETED|Overall Study||0
7812125|NCT01148940|19232097|P2|NOT COMPLETED|Overall Study||0
7812126|NCT01148940|19232098|P1|NOT COMPLETED|Overall Study||0
7812127|NCT01148940|19232096|P3|COMPLETED|Overall Study||0
7812128|NCT01148940|19232097|P2|COMPLETED|Overall Study||27
7812129|NCT01148940|19232098|P1|COMPLETED|Overall Study||7
7812130|NCT01148940|19232096|P3|STARTED|Overall Study||0
7812131|NCT01148940|19232097|P2|STARTED|Overall Study||27
7812132|NCT01148940|19232098|P1|STARTED|Overall Study||7
7812133|NCT01148862|19232106|P2|NOT COMPLETED|Second Intervention||2
7812134|NCT01148862|19232107|P1|NOT COMPLETED|Second Intervention||0
7812135|NCT01148862|19232106|P2|COMPLETED|Second Intervention||23
7812136|NCT01148862|19232107|P1|COMPLETED|Second Intervention||25
7812137|NCT01148862|19232106|P2|STARTED|Second Intervention||25
7812138|NCT01148862|19232107|P1|STARTED|Second Intervention||25
7812139|NCT01148862|19232106|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
7812140|NCT01148862|19232107|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
7812141|NCT01148862|19232106|P2|COMPLETED|Washout Period of 2 Weeks||25
7812142|NCT01148862|19232107|P1|COMPLETED|Washout Period of 2 Weeks||25
7812143|NCT01148862|19232106|P2|STARTED|Washout Period of 2 Weeks||25
7812144|NCT01148862|19232107|P1|STARTED|Washout Period of 2 Weeks||25
7812145|NCT01148862|19232106|P2|NOT COMPLETED|First Intervention||0
7812146|NCT01148862|19232107|P1|NOT COMPLETED|First Intervention||0
7812147|NCT01148862|19232106|P2|COMPLETED|First Intervention||25
7812148|NCT01148862|19232107|P1|COMPLETED|First Intervention||25
7812149|NCT01148862|19232106|P2|STARTED|First Intervention||25
7812150|NCT01148862|19232107|P1|STARTED|First Intervention||25
7812151|NCT01148836|19232117|P2|NOT COMPLETED|Overall Study||2
7812152|NCT01148836|19232118|P1|NOT COMPLETED|Overall Study||1
7812153|NCT01148836|19232117|P2|COMPLETED|Overall Study||8
7812154|NCT01148836|19232118|P1|COMPLETED|Overall Study|Enrollment completed|7
7812155|NCT01148836|19232117|P2|STARTED|Overall Study||10
7812156|NCT01148836|19232118|P1|STARTED|Overall Study|Enrollment completed|8
7812157|NCT01148810|19232139|P2|NOT COMPLETED|Overall Study||5
7812158|NCT01148810|19232140|P1|NOT COMPLETED|Overall Study||1
7812159|NCT01148810|19232139|P2|COMPLETED|Overall Study||5
7812160|NCT01148810|19232140|P1|COMPLETED|Overall Study||7
7812161|NCT01148810|19232139|P2|STARTED|Overall Study||10
7812162|NCT01148810|19232140|P1|STARTED|Overall Study||8
7812163|NCT01148771|19232167|P2|NOT COMPLETED|Second Intervention||0
7812164|NCT01148771|19232168|P1|NOT COMPLETED|Second Intervention||0
7812165|NCT01148771|19232167|P2|COMPLETED|Second Intervention||5
7812166|NCT01148771|19232168|P1|COMPLETED|Second Intervention||6
7812167|NCT01148771|19232167|P2|STARTED|Second Intervention||5
7812168|NCT01148771|19232168|P1|STARTED|Second Intervention||6
7812169|NCT01148771|19232167|P2|NOT COMPLETED|Washout Period||1
7812170|NCT01148771|19232168|P1|NOT COMPLETED|Washout Period||0
7812171|NCT01148771|19232167|P2|COMPLETED|Washout Period||5
7812172|NCT01148771|19232168|P1|COMPLETED|Washout Period||6
7812173|NCT01148771|19232167|P2|STARTED|Washout Period||6
7812174|NCT01148771|19232168|P1|STARTED|Washout Period||6
7812175|NCT01148771|19232167|P2|NOT COMPLETED|First Intervention||0
7812176|NCT01148771|19232168|P1|NOT COMPLETED|First Intervention||0
7812177|NCT01148771|19232167|P2|COMPLETED|First Intervention||6
7812178|NCT01148771|19232168|P1|COMPLETED|First Intervention||6
7812179|NCT01148771|19232167|P2|STARTED|First Intervention||6
7812180|NCT01148771|19232168|P1|STARTED|First Intervention||6
7812181|NCT01148745|19232180|P1|NOT COMPLETED|Overall Study||0
7812182|NCT01148745|19232180|P1|COMPLETED|Overall Study||15
7812183|NCT01148745|19232180|P1|STARTED|Overall Study||15
7812184|NCT01148693|19232188|P2|NOT COMPLETED|Overall Study||10
7812185|NCT01148693|19232189|P1|NOT COMPLETED|Overall Study||13
7812186|NCT01148693|19232188|P2|COMPLETED|Overall Study||57
7812187|NCT01148693|19232189|P1|COMPLETED|Overall Study||57
7812188|NCT01148693|19232188|P2|STARTED|Overall Study||67
7812189|NCT01148693|19232189|P1|STARTED|Overall Study||70
7812190|NCT01148563|19232197|P2|NOT COMPLETED|Overall Study||30
7812191|NCT01148563|19232198|P1|NOT COMPLETED|Overall Study||29
7812192|NCT01148563|19232197|P2|COMPLETED|Overall Study||37
7812193|NCT01148563|19232198|P1|COMPLETED|Overall Study||40
7812194|NCT01148563|19232197|P2|STARTED|Overall Study||67
7812195|NCT01148563|19232198|P1|STARTED|Overall Study||69
7812196|NCT01148537|19232209|P3|NOT COMPLETED|Overall Study||3
7812197|NCT01148537|19232210|P2|NOT COMPLETED|Overall Study||0
7812198|NCT01148537|19232211|P1|NOT COMPLETED|Overall Study||3
7812199|NCT01148537|19232209|P3|COMPLETED|Overall Study||41
7812200|NCT01148537|19232210|P2|COMPLETED|Overall Study||44
7812201|NCT01148537|19232211|P1|COMPLETED|Overall Study||41
7812202|NCT01148537|19232209|P3|STARTED|Overall Study||44
7812203|NCT01148537|19232210|P2|STARTED|Overall Study||44
7812204|NCT01148537|19232211|P1|STARTED|Overall Study||44
7812205|NCT01148524|19232241|P9|NOT COMPLETED|Overall Study||0
7812206|NCT01148524|19232242|P8|NOT COMPLETED|Overall Study||0
7812207|NCT01148524|19232243|P7|NOT COMPLETED|Overall Study||0
7812208|NCT01148524|19232244|P6|NOT COMPLETED|Overall Study||0
7812209|NCT01148524|19232245|P5|NOT COMPLETED|Overall Study||0
7812210|NCT01148524|19232246|P4|NOT COMPLETED|Overall Study||0
7812211|NCT01148524|19232247|P3|NOT COMPLETED|Overall Study||0
7812212|NCT01148524|19232248|P2|NOT COMPLETED|Overall Study||0
7812213|NCT01148524|19232249|P1|NOT COMPLETED|Overall Study||0
7812214|NCT01148524|19232241|P9|COMPLETED|Overall Study||151
7812215|NCT01148524|19232242|P8|COMPLETED|Overall Study||51
7812216|NCT01148524|19232243|P7|COMPLETED|Overall Study||153
7812217|NCT01148524|19232244|P6|COMPLETED|Overall Study||106
7812218|NCT01148524|19232245|P5|COMPLETED|Overall Study||57
7812219|NCT01148524|19232246|P4|COMPLETED|Overall Study||102
7812220|NCT01148524|19232247|P3|COMPLETED|Overall Study||53
7812221|NCT01148524|19232248|P2|COMPLETED|Overall Study||95
7812222|NCT01148524|19232249|P1|COMPLETED|Overall Study||49
7812223|NCT01148524|19232241|P9|STARTED|Overall Study||151
7812224|NCT01148524|19232242|P8|STARTED|Overall Study||51
7812225|NCT01148524|19232243|P7|STARTED|Overall Study||153
7812226|NCT01148524|19232244|P6|STARTED|Overall Study||106
7812227|NCT01148524|19232245|P5|STARTED|Overall Study||57
7812228|NCT01148524|19232246|P4|STARTED|Overall Study||102
7812229|NCT01148524|19232247|P3|STARTED|Overall Study||53
7812230|NCT01148524|19232248|P2|STARTED|Overall Study||95
7812231|NCT01148524|19232249|P1|STARTED|Overall Study||49
7812232|NCT01148511|19232297|P3|NOT COMPLETED|Randomized||6
7812233|NCT01148511|19232298|P2|NOT COMPLETED|Randomized||10
7812234|NCT01148511|19232299|P1|NOT COMPLETED|Randomized||0
7812235|NCT01148511|19232297|P3|COMPLETED|Randomized||39
7812236|NCT01148511|19232298|P2|COMPLETED|Randomized||38
7812237|NCT01148511|19232299|P1|COMPLETED|Randomized||0
7812238|NCT01148511|19232297|P3|STARTED|Randomized||45
7812239|NCT01148511|19232298|P2|STARTED|Randomized||48
7812240|NCT01148511|19232299|P1|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0
7812241|NCT01148511|19232297|P3|NOT COMPLETED|Exposed to Study Drug||0
7812242|NCT01148511|19232298|P2|NOT COMPLETED|Exposed to Study Drug||0
7812243|NCT01148511|19232299|P1|NOT COMPLETED|Exposed to Study Drug||6
7812244|NCT01148511|19232297|P3|COMPLETED|Exposed to Study Drug||0
7812245|NCT01148511|19232298|P2|COMPLETED|Exposed to Study Drug||0
7812246|NCT01148511|19232299|P1|COMPLETED|Exposed to Study Drug||93
7812247|NCT01148511|19232297|P3|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
7812248|NCT01148511|19232298|P2|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
7812249|NCT01148511|19232299|P1|STARTED|Exposed to Study Drug||99
7812250|NCT01148459|19232320|P2|NOT COMPLETED|Overall Study||11
7812251|NCT01148459|19232321|P1|NOT COMPLETED|Overall Study||12
7812252|NCT01148459|19232320|P2|COMPLETED|Overall Study||90
7812253|NCT01148459|19232321|P1|COMPLETED|Overall Study||87
7812254|NCT01148459|19232320|P2|STARTED|Overall Study||101
7812255|NCT01148459|19232321|P1|STARTED|Overall Study||99
7812256|NCT01148420|19232363|P1|NOT COMPLETED|Overall Study||0
7812257|NCT01148420|19232363|P1|COMPLETED|Overall Study||48
7812258|NCT01148420|19232363|P1|STARTED|Overall Study||48
7812259|NCT01148225|19232369|P1|NOT COMPLETED|Overall Study||185
7812260|NCT01148225|19232369|P1|COMPLETED|Overall Study||239
7812261|NCT01148225|19232369|P1|STARTED|Overall Study||424
7812262|NCT01148056|19232407|P1|NOT COMPLETED|Overall Study||0
7812263|NCT01148056|19232407|P1|COMPLETED|Overall Study||2
7812264|NCT01148056|19232407|P1|STARTED|Overall Study||2
7812265|NCT01148017|19232420|P4|NOT COMPLETED|Overall Study||0
7812266|NCT01148017|19232421|P3|NOT COMPLETED|Overall Study||0
7812267|NCT01148017|19232422|P2|NOT COMPLETED|Overall Study||34
7812268|NCT01148017|19232423|P1|NOT COMPLETED|Overall Study||80
7812269|NCT01148017|19232420|P4|COMPLETED|Overall Study||45
7812270|NCT01148017|19232421|P3|COMPLETED|Overall Study||53
7812271|NCT01148017|19232422|P2|COMPLETED|Overall Study||87
7812272|NCT01148017|19232423|P1|COMPLETED|Overall Study||134
7812273|NCT01148017|19232420|P4|STARTED|Overall Study||45
7812274|NCT01148017|19232421|P3|STARTED|Overall Study||53
7812275|NCT01148017|19232422|P2|STARTED|Overall Study||121
7812276|NCT01148017|19232423|P1|STARTED|Overall Study||214
7812277|NCT01147926|19232462|P2|NOT COMPLETED|Overall Study||29
7812278|NCT01147926|19232463|P1|NOT COMPLETED|Overall Study||27
7812279|NCT01147926|19232462|P2|COMPLETED|Overall Study||158
7812280|NCT01147926|19232463|P1|COMPLETED|Overall Study||160
7812281|NCT01147926|19232462|P2|STARTED|Overall Study||187
7812282|NCT01147926|19232463|P1|STARTED|Overall Study||187
7812283|NCT01147900|19232498|P3|NOT COMPLETED|At Year 10||0
7812284|NCT01147900|19232499|P2|NOT COMPLETED|At Year 10||1
7812285|NCT01147900|19232500|P1|NOT COMPLETED|At Year 10||0
7812286|NCT01147900|19232498|P3|COMPLETED|At Year 10||62
7812287|NCT01147900|19232499|P2|COMPLETED|At Year 10||59
7812288|NCT01147900|19232500|P1|COMPLETED|At Year 10||55
7812289|NCT01147900|19232498|P3|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62
7812290|NCT01147900|19232499|P2|STARTED|At Year 10||60
7812291|NCT01147900|19232500|P1|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55
7812292|NCT01147900|19232498|P3|NOT COMPLETED|At Year 8.5||0
7812293|NCT01147900|19232499|P2|NOT COMPLETED|At Year 8.5||0
7812294|NCT01147900|19232500|P1|NOT COMPLETED|At Year 8.5||0
7812295|NCT01147900|19232498|P3|COMPLETED|At Year 8.5||66
7812296|NCT01147900|19232499|P2|COMPLETED|At Year 8.5||60
7812297|NCT01147900|19232500|P1|COMPLETED|At Year 8.5||54
7812298|NCT01147900|19232498|P3|STARTED|At Year 8.5||66
7812299|NCT01147900|19232499|P2|STARTED|At Year 8.5||60
7812300|NCT01147900|19232500|P1|STARTED|At Year 8.5||54
7812301|NCT01147874|19232559|P1|NOT COMPLETED|Overall Study||67
7812302|NCT01147874|19232559|P1|COMPLETED|Overall Study||946
7812303|NCT01147874|19232559|P1|STARTED|Overall Study||1013
7812304|NCT01147848|19232567|P3|NOT COMPLETED|Randomized Phase||46
7812305|NCT01147848|19232568|P2|NOT COMPLETED|Randomized Phase||45
7812306|NCT01147848|19232569|P1|NOT COMPLETED|Randomized Phase||0
7812307|NCT01147848|19232567|P3|COMPLETED|Randomized Phase||357
7812308|NCT01147848|19232568|P2|COMPLETED|Randomized Phase||358
7812309|NCT01147848|19232569|P1|COMPLETED|Randomized Phase||0
7812310|NCT01147848|19232567|P3|STARTED|Randomized Phase||403
7812311|NCT01147848|19232568|P2|STARTED|Randomized Phase||403
7812312|NCT01147848|19232569|P1|STARTED|Randomized Phase||0
7812313|NCT01147848|19232567|P3|NOT COMPLETED|Run-in Period||0
7812314|NCT01147848|19232568|P2|NOT COMPLETED|Run-in Period||0
7812315|NCT01147848|19232569|P1|NOT COMPLETED|Run-in Period||758
7812316|NCT01147848|19232567|P3|COMPLETED|Run-in Period||0
7812317|NCT01147848|19232568|P2|COMPLETED|Run-in Period||0
7812318|NCT01147848|19232569|P1|COMPLETED|Run-in Period||806
7812319|NCT01147848|19232567|P3|STARTED|Run-in Period||0
7812320|NCT01147848|19232568|P2|STARTED|Run-in Period||0
7812321|NCT01147848|19232569|P1|STARTED|Run-in Period||1564
7812322|NCT01147822|19232601|P2|NOT COMPLETED|Overall Study||179
7812323|NCT01147822|19232602|P1|NOT COMPLETED|Overall Study||188
7812324|NCT01147822|19232601|P2|COMPLETED|Overall Study||0
7812325|NCT01147822|19232602|P1|COMPLETED|Overall Study||0
7812326|NCT01147822|19232601|P2|Not Completed/Ongoing|Overall Study||102
7812327|NCT01147822|19232602|P1|Not Completed/Ongoing|Overall Study||111
7812328|NCT01147822|19232601|P2|STARTED|Overall Study||179
7812329|NCT01147822|19232602|P1|STARTED|Overall Study||188
7812330|NCT01147809|19232622|P6|NOT COMPLETED|Phase II (168 Days)||33
7812331|NCT01147809|19232623|P5|NOT COMPLETED|Phase II (168 Days)||16
7812332|NCT01147809|19232624|P4|NOT COMPLETED|Phase II (168 Days)||0
7812333|NCT01147809|19232625|P3|NOT COMPLETED|Phase II (168 Days)||0
7812334|NCT01147809|19232626|P2|NOT COMPLETED|Phase II (168 Days)||0
7812335|NCT01147809|19232627|P1|NOT COMPLETED|Phase II (168 Days)||0
7812336|NCT01147809|19232622|P6|COMPLETED|Phase II (168 Days)||19
7812337|NCT01147809|19232623|P5|COMPLETED|Phase II (168 Days)||7
7812338|NCT01147809|19232624|P4|COMPLETED|Phase II (168 Days)||0
7812339|NCT01147809|19232625|P3|COMPLETED|Phase II (168 Days)||0
7812340|NCT01147809|19232626|P2|COMPLETED|Phase II (168 Days)||0
7812341|NCT01147809|19232627|P1|COMPLETED|Phase II (168 Days)||0
7812342|NCT01147809|19232622|P6|Ongoing|Phase II (168 Days)||0
7812343|NCT01147809|19232623|P5|Ongoing|Phase II (168 Days)||1
7812344|NCT01147809|19232624|P4|Ongoing|Phase II (168 Days)||0
7812345|NCT01147809|19232625|P3|Ongoing|Phase II (168 Days)||0
7812346|NCT01147809|19232626|P2|Ongoing|Phase II (168 Days)||0
7812347|NCT01147809|19232627|P1|Ongoing|Phase II (168 Days)||0
7812348|NCT01147809|19232622|P6|STARTED|Phase II (168 Days)||52
7812349|NCT01147809|19232623|P5|STARTED|Phase II (168 Days)||23
7812350|NCT01147809|19232624|P4|STARTED|Phase II (168 Days)||0
7812351|NCT01147809|19232625|P3|STARTED|Phase II (168 Days)||0
7812352|NCT01147809|19232626|P2|STARTED|Phase II (168 Days)||0
7812353|NCT01147809|19232627|P1|STARTED|Phase II (168 Days)||0
7812354|NCT01147809|19232622|P6|NOT COMPLETED|Phase I (168 Days)||0
7812355|NCT01147809|19232623|P5|NOT COMPLETED|Phase I (168 Days)||0
7812356|NCT01147809|19232624|P4|NOT COMPLETED|Phase I (168 Days)||5
7812357|NCT01147809|19232625|P3|NOT COMPLETED|Phase I (168 Days)||2
7812358|NCT01147809|19232626|P2|NOT COMPLETED|Phase I (168 Days)||1
7812359|NCT01147809|19232627|P1|NOT COMPLETED|Phase I (168 Days)||1
7812360|NCT01147809|19232622|P6|COMPLETED|Phase I (168 Days)||0
7812361|NCT01147809|19232623|P5|COMPLETED|Phase I (168 Days)||0
7812362|NCT01147809|19232624|P4|COMPLETED|Phase I (168 Days)||5
7812363|NCT01147809|19232625|P3|COMPLETED|Phase I (168 Days)||2
7812364|NCT01147809|19232626|P2|COMPLETED|Phase I (168 Days)||8
7812365|NCT01147809|19232627|P1|COMPLETED|Phase I (168 Days)||2
7812366|NCT01147809|19232622|P6|STARTED|Phase I (168 Days)||0
7812367|NCT01147809|19232623|P5|STARTED|Phase I (168 Days)||0
7812368|NCT01147809|19232624|P4|STARTED|Phase I (168 Days)||10
7812369|NCT01147809|19232625|P3|STARTED|Phase I (168 Days)||4
7812370|NCT01147809|19232626|P2|STARTED|Phase I (168 Days)||9
7812371|NCT01147809|19232627|P1|STARTED|Phase I (168 Days)||3
7812372|NCT01147744|19232748|P7|NOT COMPLETED|Overall Study||19
7812373|NCT01147744|19232749|P6|NOT COMPLETED|Overall Study||20
7812374|NCT01147744|19232750|P5|NOT COMPLETED|Overall Study||25
7812375|NCT01147744|19232751|P4|NOT COMPLETED|Overall Study||18
7812376|NCT01147744|19232752|P3|NOT COMPLETED|Overall Study||18
7812377|NCT01147744|19232753|P2|NOT COMPLETED|Overall Study||23
7812378|NCT01147744|19232754|P1|NOT COMPLETED|Overall Study||29
7812379|NCT01147744|19232748|P7|COMPLETED|Overall Study||78
7812380|NCT01147744|19232749|P6|COMPLETED|Overall Study||83
7812381|NCT01147744|19232750|P5|COMPLETED|Overall Study||76
7812382|NCT01147744|19232751|P4|COMPLETED|Overall Study||82
7812383|NCT01147744|19232752|P3|COMPLETED|Overall Study||82
7812384|NCT01147744|19232753|P2|COMPLETED|Overall Study||76
7812385|NCT01147744|19232754|P1|COMPLETED|Overall Study||71
7812386|NCT01147744|19232748|P7|STARTED|Overall Study||97
7812387|NCT01147744|19232749|P6|STARTED|Overall Study||103
7812388|NCT01147744|19232750|P5|STARTED|Overall Study||101
7812389|NCT01147744|19232751|P4|STARTED|Overall Study||100
7812390|NCT01147744|19232752|P3|STARTED|Overall Study||100
7812391|NCT01147744|19232753|P2|STARTED|Overall Study||99
7812392|NCT01147744|19232754|P1|STARTED|Overall Study||100
7812393|NCT01147653|19232849|P2|NOT COMPLETED|Year 2||3
7812394|NCT01147653|19232850|P1|NOT COMPLETED|Year 2||2
7812395|NCT01147653|19232849|P2|COMPLETED|Year 2||28
7812396|NCT01147653|19232850|P1|COMPLETED|Year 2||30
7812397|NCT01147653|19232849|P2|STARTED|Year 2||31
7812398|NCT01147653|19232850|P1|STARTED|Year 2||32
7812399|NCT01147653|19232849|P2|NOT COMPLETED|Year 1||0
7812400|NCT01147653|19232850|P1|NOT COMPLETED|Year 1||0
7812401|NCT01147653|19232849|P2|COMPLETED|Year 1||31
7812402|NCT01147653|19232850|P1|COMPLETED|Year 1||32
7812403|NCT01147653|19232849|P2|STARTED|Year 1||31
7812404|NCT01147653|19232850|P1|STARTED|Year 1||32
7812405|NCT01147640|19232911|P2|NOT COMPLETED|Overall Study||1
7812406|NCT01147640|19232912|P1|NOT COMPLETED|Overall Study||5
7812407|NCT01147640|19232911|P2|COMPLETED|Overall Study||38
7812408|NCT01147640|19232912|P1|COMPLETED|Overall Study||78
7812409|NCT01147640|19232911|P2|STARTED|Overall Study||39
7812410|NCT01147640|19232912|P1|STARTED|Overall Study||83
7812411|NCT01147627|19232923|P3|NOT COMPLETED|Overall Study||18
7812412|NCT01147627|19232924|P2|NOT COMPLETED|Overall Study||24
7812413|NCT01147627|19232925|P1|NOT COMPLETED|Overall Study||32
7812414|NCT01147627|19232923|P3|COMPLETED|Overall Study||118
7812415|NCT01147627|19232924|P2|COMPLETED|Overall Study||114
7812416|NCT01147627|19232925|P1|COMPLETED|Overall Study||110
7812417|NCT01147627|19232923|P3|STARTED|Overall Study||136
7812418|NCT01147627|19232924|P2|STARTED|Overall Study||138
7812419|NCT01147627|19232925|P1|STARTED|Overall Study||142
7812420|NCT01147601|19232935|P2|NOT COMPLETED|Overall Study||0
7812421|NCT01147601|19232936|P1|NOT COMPLETED|Overall Study||3
7812422|NCT01147601|19232935|P2|COMPLETED|Overall Study||1
7812423|NCT01147601|19232936|P1|COMPLETED|Overall Study||2
7812424|NCT01147601|19232935|P2|STARTED|Overall Study||1
7812425|NCT01147601|19232936|P1|STARTED|Overall Study||5
7812426|NCT01147497|19232944|P2|NOT COMPLETED|Overall Study||0
7812427|NCT01147497|19232945|P1|NOT COMPLETED|Overall Study||2
7812428|NCT01147497|19232944|P2|COMPLETED|Overall Study||36
7812429|NCT01147497|19232945|P1|COMPLETED|Overall Study||35
7812430|NCT01147497|19232944|P2|STARTED|Overall Study||36
7812431|NCT01147497|19232945|P1|STARTED|Overall Study||37
7812432|NCT01147471|19232965|P2|NOT COMPLETED|6 Month Follow Up||2
7812433|NCT01147471|19232966|P1|NOT COMPLETED|6 Month Follow Up||4
7812434|NCT01147471|19232965|P2|COMPLETED|6 Month Follow Up||4
7812435|NCT01147471|19232966|P1|COMPLETED|6 Month Follow Up||8
7812436|NCT01147471|19232965|P2|STARTED|6 Month Follow Up||6
7812437|NCT01147471|19232966|P1|STARTED|6 Month Follow Up||12
7812438|NCT01147471|19232965|P2|NOT COMPLETED|3 Month Follow Up||2
7812439|NCT01147471|19232966|P1|NOT COMPLETED|3 Month Follow Up||1
7812440|NCT01147471|19232965|P2|COMPLETED|3 Month Follow Up||6
7812441|NCT01147471|19232966|P1|COMPLETED|3 Month Follow Up||12
7812442|NCT01147471|19232965|P2|STARTED|3 Month Follow Up||8
7812443|NCT01147471|19232966|P1|STARTED|3 Month Follow Up||13
7812444|NCT01147471|19232965|P2|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3
7812445|NCT01147471|19232966|P1|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0
7812446|NCT01147471|19232965|P2|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8
7812447|NCT01147471|19232966|P1|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13
7812448|NCT01147471|19232965|P2|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11
7812449|NCT01147471|19232966|P1|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13
7812450|NCT01147471|19232965|P2|NOT COMPLETED|Through Initial Hospital Discharge||0
7812451|NCT01147471|19232966|P1|NOT COMPLETED|Through Initial Hospital Discharge||0
7812452|NCT01147471|19232965|P2|COMPLETED|Through Initial Hospital Discharge||11
7812453|NCT01147471|19232966|P1|COMPLETED|Through Initial Hospital Discharge||13
7812454|NCT01147471|19232965|P2|STARTED|Through Initial Hospital Discharge||11
7812455|NCT01147471|19232966|P1|STARTED|Through Initial Hospital Discharge||13
7812456|NCT01147458|19232980|P4|NOT COMPLETED|Second Intervention||4
7812457|NCT01147458|19232981|P3|NOT COMPLETED|Second Intervention||8
7812458|NCT01147458|19232982|P2|NOT COMPLETED|Second Intervention||7
7812459|NCT01147458|19232983|P1|NOT COMPLETED|Second Intervention||9
7812460|NCT01147458|19232980|P4|COMPLETED|Second Intervention||30
7812461|NCT01147458|19232981|P3|COMPLETED|Second Intervention||27
7812462|NCT01147458|19232982|P2|COMPLETED|Second Intervention||24
7812463|NCT01147458|19232983|P1|COMPLETED|Second Intervention||25
7812464|NCT01147458|19232980|P4|STARTED|Second Intervention||34
7812465|NCT01147458|19232981|P3|STARTED|Second Intervention||35
7812466|NCT01147458|19232982|P2|STARTED|Second Intervention||31
7812467|NCT01147458|19232983|P1|STARTED|Second Intervention||34
7812468|NCT01147458|19232980|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
7812469|NCT01147458|19232981|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
7812470|NCT01147458|19232982|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
7812471|NCT01147458|19232983|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
7812472|NCT01147458|19232980|P4|COMPLETED|Washout Period of 2 Weeks||34
7812473|NCT01147458|19232981|P3|COMPLETED|Washout Period of 2 Weeks||35
7812474|NCT01147458|19232982|P2|COMPLETED|Washout Period of 2 Weeks||31
7812475|NCT01147458|19232983|P1|COMPLETED|Washout Period of 2 Weeks||34
7812476|NCT01147458|19232980|P4|STARTED|Washout Period of 2 Weeks||34
7812477|NCT01147458|19232981|P3|STARTED|Washout Period of 2 Weeks||35
7812478|NCT01147458|19232982|P2|STARTED|Washout Period of 2 Weeks||31
7812479|NCT01147458|19232983|P1|STARTED|Washout Period of 2 Weeks||34
7812480|NCT01147458|19232980|P4|NOT COMPLETED|First Intervention||14
7812481|NCT01147458|19232981|P3|NOT COMPLETED|First Intervention||12
7812482|NCT01147458|19232982|P2|NOT COMPLETED|First Intervention||16
7812483|NCT01147458|19232983|P1|NOT COMPLETED|First Intervention||14
7812484|NCT01147458|19232980|P4|COMPLETED|First Intervention||34
7812485|NCT01147458|19232981|P3|COMPLETED|First Intervention||35
7812486|NCT01147458|19232982|P2|COMPLETED|First Intervention||31
7812487|NCT01147458|19232983|P1|COMPLETED|First Intervention||34
7812488|NCT01147458|19232980|P4|STARTED|First Intervention||48
7812489|NCT01147458|19232981|P3|STARTED|First Intervention||47
7812490|NCT01147458|19232982|P2|STARTED|First Intervention||47
7812491|NCT01147458|19232983|P1|STARTED|First Intervention||48
7812492|NCT01147406|19233037|P6|NOT COMPLETED|Overall Study||0
7812493|NCT01147406|19233038|P5|NOT COMPLETED|Overall Study||0
7812494|NCT01147406|19233039|P4|NOT COMPLETED|Overall Study||0
7812495|NCT01147406|19233040|P3|NOT COMPLETED|Overall Study||0
7812496|NCT01147406|19233041|P2|NOT COMPLETED|Overall Study||0
7812497|NCT01147406|19233042|P1|NOT COMPLETED|Overall Study||0
7812498|NCT01147406|19233037|P6|COMPLETED|Overall Study||10
7812499|NCT01147406|19233038|P5|COMPLETED|Overall Study||6
7812500|NCT01147406|19233039|P4|COMPLETED|Overall Study||6
7812501|NCT01147406|19233040|P3|COMPLETED|Overall Study||1
7812502|NCT01147406|19233041|P2|COMPLETED|Overall Study||12
7812503|NCT01147406|19233042|P1|COMPLETED|Overall Study||6
7812504|NCT01147406|19233037|P6|STARTED|Overall Study||10
7812505|NCT01147406|19233038|P5|STARTED|Overall Study||6
7812506|NCT01147406|19233039|P4|STARTED|Overall Study||6
7812507|NCT01147406|19233040|P3|STARTED|Overall Study||1
7812508|NCT01147406|19233041|P2|STARTED|Overall Study||12
7812509|NCT01147406|19233042|P1|STARTED|Overall Study||6
7812510|NCT01147393|19233062|P1|NOT COMPLETED|Dose Level -1||1
7812511|NCT01147393|19233062|P1|COMPLETED|Dose Level -1||0
7812512|NCT01147393|19233062|P1|STARTED|Dose Level -1||1
7812513|NCT01147393|19233062|P1|NOT COMPLETED|Dose Level 1||2
7812514|NCT01147393|19233062|P1|COMPLETED|Dose Level 1||1
7812515|NCT01147393|19233062|P1|STARTED|Dose Level 1||3
7812516|NCT01147380|19233072|P2|NOT COMPLETED|Overall Study||0
7812517|NCT01147380|19233073|P1|NOT COMPLETED|Overall Study||0
7812518|NCT01147380|19233072|P2|COMPLETED|Overall Study||12
7812519|NCT01147380|19233073|P1|COMPLETED|Overall Study||6
7812520|NCT01147380|19233072|P2|STARTED|Overall Study||12
7812521|NCT01147380|19233073|P1|STARTED|Overall Study||6
7812522|NCT01147341|19233083|P2|NOT COMPLETED|Open Label Period||0
7812523|NCT01147341|19233084|P1|NOT COMPLETED|Open Label Period||4
7812524|NCT01147341|19233083|P2|COMPLETED|Open Label Period||8
7812525|NCT01147341|19233084|P1|COMPLETED|Open Label Period||22
7812526|NCT01147341|19233083|P2|STARTED|Open Label Period||8
7812527|NCT01147341|19233084|P1|STARTED|Open Label Period||26
7812528|NCT01147341|19233083|P2|NOT COMPLETED|Double Blind Period||2
7812529|NCT01147341|19233084|P1|NOT COMPLETED|Double Blind Period||1
7812530|NCT01147341|19233083|P2|COMPLETED|Double Blind Period||8
7812531|NCT01147341|19233084|P1|COMPLETED|Double Blind Period||26
7812532|NCT01147341|19233083|P2|STARTED|Double Blind Period||10
7812533|NCT01147341|19233084|P1|STARTED|Double Blind Period||27
7812534|NCT01147302|19233114|P2|NOT COMPLETED|Overall Study||0
7812535|NCT01147302|19233115|P1|NOT COMPLETED|Overall Study||0
7812536|NCT01147302|19233114|P2|COMPLETED|Overall Study||9
7812537|NCT01147302|19233115|P1|COMPLETED|Overall Study||9
7812538|NCT01147302|19233114|P2|STARTED|Overall Study||9
7812539|NCT01147302|19233115|P1|STARTED|Overall Study||9
7812540|NCT01147250|19233147|P2|NOT COMPLETED|Overall Study||105
7812541|NCT01147250|19233148|P1|NOT COMPLETED|Overall Study||110
7812542|NCT01147250|19233147|P2|COMPLETED|Overall Study||2929
7812543|NCT01147250|19233148|P1|COMPLETED|Overall Study||2924
7812544|NCT01147250|19233147|P2|Treated|Overall Study||3031
7812545|NCT01147250|19233148|P1|Treated|Overall Study||3032
7812546|NCT01147250|19233147|P2|STARTED|Overall Study||3034
7812547|NCT01147250|19233148|P1|STARTED|Overall Study||3034
7812548|NCT01147172|19233160|P1|NOT COMPLETED|Overall Study||4
7812549|NCT01147172|19233160|P1|COMPLETED|Overall Study||96
7812550|NCT01147172|19233160|P1|STARTED|Overall Study||100
7812551|NCT01147068|19233178|P7|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
7812552|NCT01147068|19233179|P6|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
7812553|NCT01147068|19233180|P5|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
7812554|NCT01147068|19233181|P4|NOT COMPLETED|Subjects That Completed Safety Follow-up||2
7812555|NCT01147068|19233182|P3|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
7812556|NCT01147068|19233183|P2|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
7812557|NCT01147068|19233184|P1|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
7812558|NCT01147068|19233178|P7|COMPLETED|Subjects That Completed Safety Follow-up||54
7812559|NCT01147068|19233179|P6|COMPLETED|Subjects That Completed Safety Follow-up||52
7812560|NCT01147068|19233180|P5|COMPLETED|Subjects That Completed Safety Follow-up||56
7812561|NCT01147068|19233181|P4|COMPLETED|Subjects That Completed Safety Follow-up||54
7812562|NCT01147068|19233182|P3|COMPLETED|Subjects That Completed Safety Follow-up||55
7812563|NCT01147068|19233183|P2|COMPLETED|Subjects That Completed Safety Follow-up||56
7812564|NCT01147068|19233184|P1|COMPLETED|Subjects That Completed Safety Follow-up||59
7812565|NCT01147068|19233178|P7|STARTED|Subjects That Completed Safety Follow-up||55
7812566|NCT01147068|19233179|P6|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53
7812567|NCT01147068|19233180|P5|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56
7812568|NCT01147068|19233181|P4|STARTED|Subjects That Completed Safety Follow-up||56
7812569|NCT01147068|19233182|P3|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55
7812570|NCT01147068|19233183|P2|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57
7812571|NCT01147068|19233184|P1|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60
7812572|NCT01147068|19233178|P7|NOT COMPLETED|Subjects That Received 2nd Dose||0
7812573|NCT01147068|19233179|P6|NOT COMPLETED|Subjects That Received 2nd Dose||2
7812574|NCT01147068|19233180|P5|NOT COMPLETED|Subjects That Received 2nd Dose||1
7812575|NCT01147068|19233181|P4|NOT COMPLETED|Subjects That Received 2nd Dose||0
7812576|NCT01147068|19233182|P3|NOT COMPLETED|Subjects That Received 2nd Dose||3
7812577|NCT01147068|19233183|P2|NOT COMPLETED|Subjects That Received 2nd Dose||5
7812578|NCT01147068|19233184|P1|NOT COMPLETED|Subjects That Received 2nd Dose||1
7812579|NCT01147068|19233178|P7|COMPLETED|Subjects That Received 2nd Dose||55
7812580|NCT01147068|19233179|P6|COMPLETED|Subjects That Received 2nd Dose||51
7812581|NCT01147068|19233180|P5|COMPLETED|Subjects That Received 2nd Dose||55
7812582|NCT01147068|19233181|P4|COMPLETED|Subjects That Received 2nd Dose||56
7812583|NCT01147068|19233182|P3|COMPLETED|Subjects That Received 2nd Dose||52
7812584|NCT01147068|19233183|P2|COMPLETED|Subjects That Received 2nd Dose||52
7812585|NCT01147068|19233184|P1|COMPLETED|Subjects That Received 2nd Dose||59
7812586|NCT01147068|19233178|P7|STARTED|Subjects That Received 2nd Dose||55
7812587|NCT01147068|19233179|P6|STARTED|Subjects That Received 2nd Dose||53
7812588|NCT01147068|19233180|P5|STARTED|Subjects That Received 2nd Dose||56
7812589|NCT01147068|19233181|P4|STARTED|Subjects That Received 2nd Dose||56
7812590|NCT01147068|19233182|P3|STARTED|Subjects That Received 2nd Dose||55
7812591|NCT01147068|19233183|P2|STARTED|Subjects That Received 2nd Dose||57
7812592|NCT01147068|19233184|P1|STARTED|Subjects That Received 2nd Dose||60
7812593|NCT01147068|19233178|P7|NOT COMPLETED|Subjects That Received 1st Dose||0
7812594|NCT01147068|19233179|P6|NOT COMPLETED|Subjects That Received 1st Dose||0
7812595|NCT01147068|19233180|P5|NOT COMPLETED|Subjects That Received 1st Dose||0
7812596|NCT01147068|19233181|P4|NOT COMPLETED|Subjects That Received 1st Dose||0
7812597|NCT01147068|19233182|P3|NOT COMPLETED|Subjects That Received 1st Dose||0
7812598|NCT01147068|19233183|P2|NOT COMPLETED|Subjects That Received 1st Dose||0
7812599|NCT01147068|19233184|P1|NOT COMPLETED|Subjects That Received 1st Dose||0
7812600|NCT01147068|19233178|P7|COMPLETED|Subjects That Received 1st Dose||55
7812601|NCT01147068|19233179|P6|COMPLETED|Subjects That Received 1st Dose||53
7812602|NCT01147068|19233180|P5|COMPLETED|Subjects That Received 1st Dose||56
7812603|NCT01147068|19233181|P4|COMPLETED|Subjects That Received 1st Dose||56
7812604|NCT01147068|19233182|P3|COMPLETED|Subjects That Received 1st Dose||55
7812605|NCT01147068|19233183|P2|COMPLETED|Subjects That Received 1st Dose||57
7812606|NCT01147068|19233184|P1|COMPLETED|Subjects That Received 1st Dose||60
7812607|NCT01147068|19233178|P7|STARTED|Subjects That Received 1st Dose||55
7812608|NCT01147068|19233179|P6|STARTED|Subjects That Received 1st Dose||53
7812609|NCT01147068|19233180|P5|STARTED|Subjects That Received 1st Dose||56
7812610|NCT01147068|19233181|P4|STARTED|Subjects That Received 1st Dose||56
7812611|NCT01147068|19233182|P3|STARTED|Subjects That Received 1st Dose||55
7812612|NCT01147068|19233183|P2|STARTED|Subjects That Received 1st Dose||57
7812613|NCT01147068|19233184|P1|STARTED|Subjects That Received 1st Dose||60
7812614|NCT01147055|19233214|P2|NOT COMPLETED|Second Intervention Period||0
7812615|NCT01147055|19233215|P1|NOT COMPLETED|Second Intervention Period||0
7812616|NCT01147055|19233214|P2|COMPLETED|Second Intervention Period||14
7812617|NCT01147055|19233215|P1|COMPLETED|Second Intervention Period||0
7812618|NCT01147055|19233214|P2|STARTED|Second Intervention Period||14
7812619|NCT01147055|19233215|P1|STARTED|Second Intervention Period||0
7812620|NCT01147055|19233214|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7812621|NCT01147055|19233215|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7812622|NCT01147055|19233214|P2|COMPLETED|Washout Period (at Least 14 Days)||0
7812623|NCT01147055|19233215|P1|COMPLETED|Washout Period (at Least 14 Days)||14
7812624|NCT01147055|19233214|P2|STARTED|Washout Period (at Least 14 Days)||0
7812625|NCT01147055|19233215|P1|STARTED|Washout Period (at Least 14 Days)||14
7812626|NCT01147055|19233214|P2|NOT COMPLETED|First Intervention Period||0
7812627|NCT01147055|19233215|P1|NOT COMPLETED|First Intervention Period||1
7812628|NCT01147055|19233214|P2|COMPLETED|First Intervention Period||0
7812629|NCT01147055|19233215|P1|COMPLETED|First Intervention Period||14
7812630|NCT01147055|19233214|P2|STARTED|First Intervention Period||0
7812631|NCT01147055|19233215|P1|STARTED|First Intervention Period||15
7812632|NCT01147042|19233249|P2|NOT COMPLETED|Overall Study||0
7812633|NCT01147042|19233250|P1|NOT COMPLETED|Overall Study||0
7812634|NCT01147042|19233249|P2|COMPLETED|Overall Study||0
7812635|NCT01147042|19233250|P1|COMPLETED|Overall Study||2
7812636|NCT01147042|19233249|P2|STARTED|Overall Study||0
7812637|NCT01147042|19233250|P1|STARTED|Overall Study||2
7812638|NCT01146951|19233257|P2|NOT COMPLETED|Overall Study||1
7812639|NCT01146951|19233258|P1|NOT COMPLETED|Overall Study||4
7812640|NCT01146951|19233257|P2|COMPLETED|Overall Study||29
7812641|NCT01146951|19233258|P1|COMPLETED|Overall Study||25
7812642|NCT01146951|19233257|P2|STARTED|Overall Study||30
7812643|NCT01146951|19233258|P1|STARTED|Overall Study||29
7812644|NCT01146912|19233279|P8|NOT COMPLETED|Overall Study||0
7812645|NCT01146912|19233280|P7|NOT COMPLETED|Overall Study||56
7812646|NCT01146912|19233281|P6|NOT COMPLETED|Overall Study||61
7812647|NCT01146912|19233282|P5|NOT COMPLETED|Overall Study||41
7812648|NCT01146912|19233283|P4|NOT COMPLETED|Overall Study||17
7812649|NCT01146912|19233284|P3|NOT COMPLETED|Overall Study||17
7812650|NCT01146912|19233285|P2|NOT COMPLETED|Overall Study||822
7812651|NCT01146912|19233286|P1|NOT COMPLETED|Overall Study||817
7812652|NCT01146912|19233279|P8|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675
7812653|NCT01146912|19233280|P7|COMPLETED|Overall Study||1764
7812654|NCT01146912|19233281|P6|COMPLETED|Overall Study||1760
7812655|NCT01146912|19233282|P5|COMPLETED|Overall Study||1780
7812656|NCT01146912|19233283|P4|COMPLETED|Overall Study||577
7812657|NCT01146912|19233284|P3|COMPLETED|Overall Study||576
7812658|NCT01146912|19233285|P2|COMPLETED|Overall Study||3784
7812659|NCT01146912|19233286|P1|COMPLETED|Overall Study||3790
7812660|NCT01146912|19233279|P8|STARTED|Overall Study||14675
7812661|NCT01146912|19233280|P7|STARTED|Overall Study||1820
7812662|NCT01146912|19233281|P6|STARTED|Overall Study||1821
7812663|NCT01146912|19233282|P5|STARTED|Overall Study||1821
7812664|NCT01146912|19233283|P4|STARTED|Overall Study||594
7812665|NCT01146912|19233284|P3|STARTED|Overall Study||593
7812666|NCT01146912|19233285|P2|STARTED|Overall Study||4606
7812667|NCT01146912|19233286|P1|STARTED|Overall Study||4607
7812668|NCT01146873|19233308|P2|NOT COMPLETED|Overall Study||6
7812669|NCT01146873|19233309|P1|NOT COMPLETED|Overall Study||0
7812670|NCT01146873|19233308|P2|COMPLETED|Overall Study||144
7812671|NCT01146873|19233309|P1|COMPLETED|Overall Study||148
7812672|NCT01146873|19233308|P2|STARTED|Overall Study||150
7812673|NCT01146873|19233309|P1|STARTED|Overall Study||148
7812674|NCT01146860|19233325|P2|NOT COMPLETED|Overall Study||1
7812675|NCT01146860|19233326|P1|NOT COMPLETED|Overall Study||0
7812676|NCT01146860|19233325|P2|COMPLETED|Overall Study||191
7812677|NCT01146860|19233326|P1|COMPLETED|Overall Study||194
7812678|NCT01146860|19233325|P2|STARTED|Overall Study||192
7812679|NCT01146860|19233326|P1|STARTED|Overall Study||194
7812680|NCT01146834|19233345|P5|NOT COMPLETED|Overall Study||0
7812681|NCT01146834|19233346|P4|NOT COMPLETED|Overall Study||0
7812682|NCT01146834|19233347|P3|NOT COMPLETED|Overall Study||2
7812683|NCT01146834|19233348|P2|NOT COMPLETED|Overall Study||0
7812684|NCT01146834|19233349|P1|NOT COMPLETED|Overall Study||3
7812685|NCT01146834|19233345|P5|COMPLETED|Overall Study||0
7812686|NCT01146834|19233346|P4|COMPLETED|Overall Study||0
7812687|NCT01146834|19233347|P3|COMPLETED|Overall Study||21
7812688|NCT01146834|19233348|P2|COMPLETED|Overall Study||4
7812689|NCT01146834|19233349|P1|COMPLETED|Overall Study||17
7812690|NCT01146834|19233345|P5|STARTED|Overall Study||0
7812691|NCT01146834|19233346|P4|STARTED|Overall Study||0
7812692|NCT01146834|19233347|P3|STARTED|Overall Study||23
7812693|NCT01146834|19233348|P2|STARTED|Overall Study||4
7812694|NCT01146834|19233349|P1|STARTED|Overall Study||20
7812695|NCT01146808|19233371|P1|NOT COMPLETED|Overall Study||0
7812696|NCT01146808|19233371|P1|COMPLETED|Overall Study||16
7812697|NCT01146808|19233371|P1|STARTED|Overall Study||16
7812698|NCT01146782|19233377|P1|NOT COMPLETED|Primary Endpoint Cohort||6
7812699|NCT01146782|19233377|P1|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57
7812700|NCT01146782|19233377|P1|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63
7812701|NCT01146782|19233377|P1|NOT COMPLETED|Safety Cohort||83
7812702|NCT01146782|19233377|P1|COMPLETED|Safety Cohort||63
7812703|NCT01146782|19233377|P1|STARTED|Safety Cohort||146
7812704|NCT01146782|19233377|P1|NOT COMPLETED|Screening Cohort||221
7812705|NCT01146782|19233377|P1|COMPLETED|Screening Cohort||146
7812706|NCT01146782|19233377|P1|STARTED|Screening Cohort||367
7812707|NCT01146704|19233386|P2|NOT COMPLETED|Overall Study||0
7812708|NCT01146704|19233387|P1|NOT COMPLETED|Overall Study||0
7812709|NCT01146704|19233386|P2|COMPLETED|Overall Study||15
7812710|NCT01146704|19233387|P1|COMPLETED|Overall Study||16
7812711|NCT01146704|19233386|P2|STARTED|Overall Study||15
7812712|NCT01146704|19233387|P1|STARTED|Overall Study||16
7812713|NCT01146665|19233395|P2|NOT COMPLETED|Overall Study||16
7812714|NCT01146665|19233396|P1|NOT COMPLETED|Overall Study||10
7812715|NCT01146665|19233395|P2|COMPLETED|Overall Study||10
7812716|NCT01146665|19233396|P1|COMPLETED|Overall Study||8
7812717|NCT01146665|19233395|P2|3-month Post-ED Discharge (Follow-up)|Overall Study||10
7812718|NCT01146665|19233396|P1|3-month Post-ED Discharge (Follow-up)|Overall Study||8
7812719|NCT01146665|19233395|P2|1-month Post-ED Discharge (Follow-up)|Overall Study||12
7812720|NCT01146665|19233396|P1|1-month Post-ED Discharge (Follow-up)|Overall Study||9
7812721|NCT01146665|19233395|P2|STARTED|Overall Study||26
7812722|NCT01146665|19233396|P1|STARTED|Overall Study||18
7812723|NCT01146613|19233428|P2|NOT COMPLETED|Overall Study||12
7812724|NCT01146613|19233429|P1|NOT COMPLETED|Overall Study||7
7812725|NCT01146613|19233428|P2|COMPLETED|Overall Study||89
7812726|NCT01146613|19233429|P1|COMPLETED|Overall Study||92
7812727|NCT01146613|19233428|P2|STARTED|Overall Study||101
7812728|NCT01146613|19233429|P1|STARTED|Overall Study||99
7812729|NCT01146600|19233437|P2|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
7812730|NCT01146600|19233438|P1|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
7812731|NCT01146600|19233437|P2|COMPLETED|Period 2 (Weeks 4 & 5)||10
7812732|NCT01146600|19233438|P1|COMPLETED|Period 2 (Weeks 4 & 5)||10
7812733|NCT01146600|19233437|P2|STARTED|Period 2 (Weeks 4 & 5)||10
7812734|NCT01146600|19233438|P1|STARTED|Period 2 (Weeks 4 & 5)||10
7812735|NCT01146600|19233437|P2|NOT COMPLETED|Washout (Week 3)||0
7812736|NCT01146600|19233438|P1|NOT COMPLETED|Washout (Week 3)||0
7812737|NCT01146600|19233437|P2|COMPLETED|Washout (Week 3)||10
7812738|NCT01146600|19233438|P1|COMPLETED|Washout (Week 3)||10
7812739|NCT01146600|19233437|P2|STARTED|Washout (Week 3)||10
7812740|NCT01146600|19233438|P1|STARTED|Washout (Week 3)||10
7812741|NCT01146600|19233437|P2|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0
7812742|NCT01146600|19233438|P1|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3
7812743|NCT01146600|19233437|P2|COMPLETED|Period 1 (Weeks 1 & 2)||10
7812744|NCT01146600|19233438|P1|COMPLETED|Period 1 (Weeks 1 & 2)||10
7812745|NCT01146600|19233437|P2|STARTED|Period 1 (Weeks 1 & 2)||10
7812746|NCT01146600|19233438|P1|STARTED|Period 1 (Weeks 1 & 2)||13
7812747|NCT01146496|19233465|P2|NOT COMPLETED|Overall Study||0
7812748|NCT01146496|19233466|P1|NOT COMPLETED|Overall Study||0
7812749|NCT01146496|19233465|P2|COMPLETED|Overall Study||109693
7812750|NCT01146496|19233466|P1|COMPLETED|Overall Study||114168
7812751|NCT01146496|19233465|P2|STARTED|Overall Study||109693
7812752|NCT01146496|19233466|P1|STARTED|Overall Study||114168
7812753|NCT01146457|19233487|P5|NOT COMPLETED|Overall Study||0
7812754|NCT01146457|19233488|P4|NOT COMPLETED|Overall Study||0
7812755|NCT01146457|19233489|P3|NOT COMPLETED|Overall Study||1
7812756|NCT01146457|19233490|P2|NOT COMPLETED|Overall Study||0
7812757|NCT01146457|19233491|P1|NOT COMPLETED|Overall Study||0
7812758|NCT01146457|19233487|P5|COMPLETED|Overall Study||13
7812759|NCT01146457|19233488|P4|COMPLETED|Overall Study||13
7812760|NCT01146457|19233489|P3|COMPLETED|Overall Study||20
7812761|NCT01146457|19233490|P2|COMPLETED|Overall Study||17
7812762|NCT01146457|19233491|P1|COMPLETED|Overall Study||19
7812763|NCT01146457|19233487|P5|STARTED|Overall Study||13
7812764|NCT01146457|19233488|P4|STARTED|Overall Study||13
7812765|NCT01146457|19233489|P3|STARTED|Overall Study||21
7812766|NCT01146457|19233490|P2|STARTED|Overall Study||17
7812767|NCT01146457|19233491|P1|STARTED|Overall Study||19
7812768|NCT01146418|19233505|P4|NOT COMPLETED|Live-Born Infant Follow Up||5
7812769|NCT01146418|19233506|P3|NOT COMPLETED|Live-Born Infant Follow Up||6
7812770|NCT01146418|19233507|P2|NOT COMPLETED|Live-Born Infant Follow Up||0
7812771|NCT01146418|19233508|P1|NOT COMPLETED|Live-Born Infant Follow Up||0
7812772|NCT01146418|19233505|P4|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51
7812773|NCT01146418|19233506|P3|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55
7812774|NCT01146418|19233507|P2|COMPLETED|Live-Born Infant Follow Up||0
7812775|NCT01146418|19233508|P1|COMPLETED|Live-Born Infant Follow Up||0
7812776|NCT01146418|19233505|P4|STARTED|Live-Born Infant Follow Up||56
7812777|NCT01146418|19233506|P3|STARTED|Live-Born Infant Follow Up||61
7812778|NCT01146418|19233507|P2|STARTED|Live-Born Infant Follow Up||0
7812779|NCT01146418|19233508|P1|STARTED|Live-Born Infant Follow Up||0
7812780|NCT01146418|19233505|P4|NOT COMPLETED|Women/Expectant Mother Follow Up||0
7812781|NCT01146418|19233506|P3|NOT COMPLETED|Women/Expectant Mother Follow Up||0
7812782|NCT01146418|19233507|P2|NOT COMPLETED|Women/Expectant Mother Follow Up||40
7812783|NCT01146418|19233508|P1|NOT COMPLETED|Women/Expectant Mother Follow Up||44
7812784|NCT01146418|19233505|P4|COMPLETED|Women/Expectant Mother Follow Up||0
7812785|NCT01146418|19233506|P3|COMPLETED|Women/Expectant Mother Follow Up||0
7812786|NCT01146418|19233507|P2|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110
7812787|NCT01146418|19233508|P1|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113
7812788|NCT01146418|19233505|P4|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
7812789|NCT01146418|19233506|P3|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
7812790|NCT01146418|19233507|P2|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50
7812791|NCT01146418|19233508|P1|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52
7812792|NCT01146418|19233505|P4|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
7812793|NCT01146418|19233506|P3|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
7812794|NCT01146418|19233507|P2|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147
7812795|NCT01146418|19233508|P1|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151
7812796|NCT01146418|19233505|P4|STARTED|Women/Expectant Mother Follow Up||0
7812797|NCT01146418|19233506|P3|STARTED|Women/Expectant Mother Follow Up||0
7812798|NCT01146418|19233507|P2|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150
7812799|NCT01146418|19233508|P1|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157
7812800|NCT01146418|19233505|P4|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
7812801|NCT01146418|19233506|P3|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
7812802|NCT01146418|19233507|P2|NOT COMPLETED|Base Study P06029 (NCT01144416)||49
7812803|NCT01146418|19233508|P1|NOT COMPLETED|Base Study P06029 (NCT01144416)||62
7812804|NCT01146418|19233505|P4|COMPLETED|Base Study P06029 (NCT01144416)||0
7812805|NCT01146418|19233506|P3|COMPLETED|Base Study P06029 (NCT01144416)||0
7812806|NCT01146418|19233507|P2|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647
7812807|NCT01146418|19233508|P1|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632
7812808|NCT01146418|19233505|P4|STARTED|Base Study P06029 (NCT01144416)||0
7812809|NCT01146418|19233506|P3|STARTED|Base Study P06029 (NCT01144416)||0
7812810|NCT01146418|19233507|P2|STARTED|Base Study P06029 (NCT01144416)||696
7812811|NCT01146418|19233508|P1|STARTED|Base Study P06029 (NCT01144416)||694
7812812|NCT01146379|19233524|P4|NOT COMPLETED|Overall Study||1
7812813|NCT01146379|19233525|P3|NOT COMPLETED|Overall Study||0
7812814|NCT01146379|19233526|P2|NOT COMPLETED|Overall Study||1
7812815|NCT01146379|19233527|P1|NOT COMPLETED|Overall Study||1
7812816|NCT01146379|19233524|P4|COMPLETED|Overall Study||20
7812817|NCT01146379|19233525|P3|COMPLETED|Overall Study||21
7812818|NCT01146379|19233526|P2|COMPLETED|Overall Study||21
7812819|NCT01146379|19233527|P1|COMPLETED|Overall Study||20
7812820|NCT01146379|19233524|P4|STARTED|Overall Study||21
7812821|NCT01146379|19233525|P3|STARTED|Overall Study||21
7812822|NCT01146379|19233526|P2|STARTED|Overall Study||22
7812823|NCT01146379|19233527|P1|STARTED|Overall Study||21
7812824|NCT01146288|19233539|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7812825|NCT01146288|19233540|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7812826|NCT01146288|19233539|P2|COMPLETED|Second Intervention (1 Day)||5
7812827|NCT01146288|19233540|P1|COMPLETED|Second Intervention (1 Day)||7
7812828|NCT01146288|19233539|P2|STARTED|Second Intervention (1 Day)||5
7812829|NCT01146288|19233540|P1|STARTED|Second Intervention (1 Day)||7
7812830|NCT01146288|19233539|P2|NOT COMPLETED|First Intervention(1 Day)||1
7812831|NCT01146288|19233540|P1|NOT COMPLETED|First Intervention(1 Day)||0
7812832|NCT01146288|19233539|P2|COMPLETED|First Intervention(1 Day)||5
7812833|NCT01146288|19233540|P1|COMPLETED|First Intervention(1 Day)||7
7812834|NCT01146288|19233539|P2|STARTED|First Intervention(1 Day)||6
7812835|NCT01146288|19233540|P1|STARTED|First Intervention(1 Day)||7
7812836|NCT01146275|19233549|P1|NOT COMPLETED|Overall Study||0
7812837|NCT01146275|19233549|P1|COMPLETED|Overall Study||6
7812838|NCT01146275|19233549|P1|STARTED|Overall Study||6
7812839|NCT01146054|19233554|P1|NOT COMPLETED|Overall Study||10
7812840|NCT01146054|19233554|P1|COMPLETED|Overall Study||49
7812841|NCT01146054|19233554|P1|STARTED|Overall Study||59
7812842|NCT01145898|19233564|P2|NOT COMPLETED|3-year Treatment||16
7812843|NCT01145898|19233565|P1|NOT COMPLETED|3-year Treatment||3
7812844|NCT01145898|19233564|P2|COMPLETED|3-year Treatment||28
7812845|NCT01145898|19233565|P1|COMPLETED|3-year Treatment||9
7812846|NCT01145898|19233564|P2|STARTED|3-year Treatment||44
7812847|NCT01145898|19233565|P1|STARTED|3-year Treatment||12
7812848|NCT01145898|19233564|P2|NOT COMPLETED|6-month Treatment||0
7812849|NCT01145898|19233565|P1|NOT COMPLETED|6-month Treatment||0
7812850|NCT01145898|19233564|P2|COMPLETED|6-month Treatment||44
7812851|NCT01145898|19233565|P1|COMPLETED|6-month Treatment||12
7812852|NCT01145898|19233564|P2|STARTED|6-month Treatment||44
7812853|NCT01145898|19233565|P1|STARTED|6-month Treatment||12
7812854|NCT01145885|19233596|P1|NOT COMPLETED|Overall Study||7
7812855|NCT01145885|19233596|P1|COMPLETED|Overall Study||0
7812856|NCT01145885|19233596|P1|STARTED|Overall Study||7
7812857|NCT01145833|19233630|P2|NOT COMPLETED|Overall Study||0
7812858|NCT01145833|19233631|P1|NOT COMPLETED|Overall Study||3
7812859|NCT01145833|19233630|P2|COMPLETED|Overall Study||25
7812860|NCT01145833|19233631|P1|COMPLETED|Overall Study||22
7812861|NCT01145833|19233630|P2|STARTED|Overall Study||25
7812862|NCT01145833|19233631|P1|STARTED|Overall Study||25
7812863|NCT01145755|19233642|P3|NOT COMPLETED|Overall Study||25
7812864|NCT01145755|19233643|P2|NOT COMPLETED|Overall Study||28
7812865|NCT01145755|19233644|P1|NOT COMPLETED|Overall Study||20
7812866|NCT01145755|19233642|P3|COMPLETED|Overall Study||19
7812867|NCT01145755|19233643|P2|COMPLETED|Overall Study||19
7812868|NCT01145755|19233644|P1|COMPLETED|Overall Study||20
7812869|NCT01145755|19233642|P3|STARTED|Overall Study||44
7812870|NCT01145755|19233643|P2|STARTED|Overall Study||47
7812871|NCT01145755|19233644|P1|STARTED|Overall Study||40
7812872|NCT01145638|19233660|P2|NOT COMPLETED|Overall Study||57
7812873|NCT01145638|19233661|P1|NOT COMPLETED|Overall Study||90
7812874|NCT01145638|19233660|P2|COMPLETED|Overall Study||62
7812875|NCT01145638|19233661|P1|COMPLETED|Overall Study||141
7812876|NCT01145638|19233660|P2|STARTED|Overall Study||119
7812877|NCT01145638|19233661|P1|STARTED|Overall Study||231
7812878|NCT01145625|19233671|P2|NOT COMPLETED|Overall Study||31
7812879|NCT01145625|19233672|P1|NOT COMPLETED|Overall Study||24
7812880|NCT01145625|19233671|P2|COMPLETED|Overall Study||130
7812881|NCT01145625|19233672|P1|COMPLETED|Overall Study||137
7812882|NCT01145625|19233671|P2|STARTED|Overall Study||161
7812883|NCT01145625|19233672|P1|STARTED|Overall Study||161
7812884|NCT01145560|19233685|P3|NOT COMPLETED|Overall Study||2
7812885|NCT01145560|19233686|P2|NOT COMPLETED|Overall Study||4
7812886|NCT01145560|19233687|P1|NOT COMPLETED|Overall Study||4
7812887|NCT01145560|19233685|P3|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98
7812888|NCT01145560|19233686|P2|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
7812889|NCT01145560|19233687|P1|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
7812890|NCT01145560|19233685|P3|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78
7812891|NCT01145560|19233686|P2|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85
7812892|NCT01145560|19233687|P1|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69
7812893|NCT01145560|19233685|P3|Received Treatment|Overall Study||99
7812894|NCT01145560|19233686|P2|Received Treatment|Overall Study||98
7812895|NCT01145560|19233687|P1|Received Treatment|Overall Study||99
7812896|NCT01145560|19233685|P3|STARTED|Overall Study||100
7812897|NCT01145560|19233686|P2|STARTED|Overall Study||100
7812898|NCT01145560|19233687|P1|STARTED|Overall Study||100
7812899|NCT01145547|19233704|P2|NOT COMPLETED|Overall Study||0
7812900|NCT01145547|19233705|P1|NOT COMPLETED|Overall Study||0
7812901|NCT01145547|19233704|P2|COMPLETED|Overall Study||3
7812902|NCT01145547|19233705|P1|COMPLETED|Overall Study||4
7812903|NCT01145547|19233704|P2|STARTED|Overall Study||3
7812904|NCT01145547|19233705|P1|STARTED|Overall Study||4
7812905|NCT01145508|19233713|P2|NOT COMPLETED|Overall Study||2
7812906|NCT01145508|19233714|P1|NOT COMPLETED|Overall Study||5
7812907|NCT01145508|19233713|P2|COMPLETED|Overall Study||1
7812908|NCT01145508|19233714|P1|COMPLETED|Overall Study||2
7812909|NCT01145508|19233713|P2|Treated|Overall Study||2
7812910|NCT01145508|19233714|P1|Treated|Overall Study||6
7812911|NCT01145508|19233713|P2|STARTED|Overall Study||3
7812912|NCT01145508|19233714|P1|STARTED|Overall Study||7
7812913|NCT01145495|19233720|P1|NOT COMPLETED|Overall Study||12
7812914|NCT01145495|19233720|P1|COMPLETED|Overall Study||51
7812915|NCT01145495|19233720|P1|STARTED|Overall Study||63
7812916|NCT01145482|19233726|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7812917|NCT01145482|19233727|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7812918|NCT01145482|19233726|P2|COMPLETED|Second Intervention (1 Day)||6
7812919|NCT01145482|19233727|P1|COMPLETED|Second Intervention (1 Day)||5
7812920|NCT01145482|19233726|P2|STARTED|Second Intervention (1 Day)||6
7812921|NCT01145482|19233727|P1|STARTED|Second Intervention (1 Day)||5
7812922|NCT01145482|19233726|P2|NOT COMPLETED|First Intervention (1 Day)||1
7812923|NCT01145482|19233727|P1|NOT COMPLETED|First Intervention (1 Day)||0
7812924|NCT01145482|19233726|P2|COMPLETED|First Intervention (1 Day)||5
7812925|NCT01145482|19233727|P1|COMPLETED|First Intervention (1 Day)||6
7812926|NCT01145482|19233726|P2|STARTED|First Intervention (1 Day)||6
7812927|NCT01145482|19233727|P1|STARTED|First Intervention (1 Day)||6
7812928|NCT01145417|19233737|P2|NOT COMPLETED|Overall Study||47
7812929|NCT01145417|19233738|P1|NOT COMPLETED|Overall Study||41
7812930|NCT01145417|19233737|P2|COMPLETED|Overall Study||62
7812931|NCT01145417|19233738|P1|COMPLETED|Overall Study||67
7812932|NCT01145417|19233737|P2|STARTED|Overall Study||109
7812933|NCT01145417|19233738|P1|STARTED|Overall Study||108
7812934|NCT01145391|19233762|P2|NOT COMPLETED|Overall Study||0
7812935|NCT01145391|19233763|P1|NOT COMPLETED|Overall Study||0
7812936|NCT01145391|19233762|P2|COMPLETED|Overall Study||298
7812937|NCT01145391|19233763|P1|COMPLETED|Overall Study||293
7812938|NCT01145391|19233762|P2|9 Months Post-randomization|Overall Study||298
7812939|NCT01145391|19233763|P1|9 Months Post-randomization|Overall Study||293
7812940|NCT01145391|19233762|P2|STARTED|Overall Study||298
7812941|NCT01145391|19233763|P1|STARTED|Overall Study||293
7812942|NCT01145352|19233771|P1|NOT COMPLETED|Overall Study||11
7812943|NCT01145352|19233771|P1|COMPLETED|Overall Study||102
7812944|NCT01145352|19233771|P1|STARTED|Overall Study||113
7812945|NCT01145222|19233783|P4|NOT COMPLETED|Overall Study||1
7812946|NCT01145222|19233784|P3|NOT COMPLETED|Overall Study||1
7812947|NCT01145222|19233785|P2|NOT COMPLETED|Overall Study||0
7812948|NCT01145222|19233786|P1|NOT COMPLETED|Overall Study||0
7812949|NCT01145222|19233783|P4|COMPLETED|Overall Study||40
7812950|NCT01145222|19233784|P3|COMPLETED|Overall Study||40
7812951|NCT01145222|19233785|P2|COMPLETED|Overall Study||40
7812952|NCT01145222|19233786|P1|COMPLETED|Overall Study||40
7812953|NCT01145222|19233783|P4|Intention to Treat (ITT) Population|Overall Study||40
7812954|NCT01145222|19233784|P3|Intention to Treat (ITT) Population|Overall Study||40
7812955|NCT01145222|19233785|P2|Intention to Treat (ITT) Population|Overall Study||40
7812956|NCT01145222|19233786|P1|Intention to Treat (ITT) Population|Overall Study||40
7812957|NCT01145222|19233783|P4|Safety Population|Overall Study||41
7812958|NCT01145222|19233784|P3|Safety Population|Overall Study||40
7812959|NCT01145222|19233785|P2|Safety Population|Overall Study||40
7812960|NCT01145222|19233786|P1|Safety Population|Overall Study||40
7812961|NCT01145222|19233783|P4|STARTED|Overall Study||41
7812962|NCT01145222|19233784|P3|STARTED|Overall Study||41
7812963|NCT01145222|19233785|P2|STARTED|Overall Study||40
7812964|NCT01145222|19233786|P1|STARTED|Overall Study||40
7812965|NCT01145209|19233806|P2|NOT COMPLETED|Overall Study||1
7812966|NCT01145209|19233807|P1|NOT COMPLETED|Overall Study||3
7812967|NCT01145209|19233806|P2|COMPLETED|Overall Study||18
7812968|NCT01145209|19233807|P1|COMPLETED|Overall Study||10
7812969|NCT01145209|19233806|P2|STARTED|Overall Study||19
7812970|NCT01145209|19233807|P1|STARTED|Overall Study||13
7812971|NCT01145183|19233817|P4|NOT COMPLETED|Overall Study||0
7812972|NCT01145183|19233818|P3|NOT COMPLETED|Overall Study||0
7812973|NCT01145183|19233819|P2|NOT COMPLETED|Overall Study||0
7812974|NCT01145183|19233820|P1|NOT COMPLETED|Overall Study||0
7812975|NCT01145183|19233817|P4|COMPLETED|Overall Study||10
7812976|NCT01145183|19233818|P3|COMPLETED|Overall Study||19
7812977|NCT01145183|19233819|P2|COMPLETED|Overall Study||26
7812978|NCT01145183|19233820|P1|COMPLETED|Overall Study||21
7812979|NCT01145183|19233817|P4|STARTED|Overall Study||10
7812980|NCT01145183|19233818|P3|STARTED|Overall Study||19
7812981|NCT01145183|19233819|P2|STARTED|Overall Study||26
7812982|NCT01145183|19233820|P1|STARTED|Overall Study||21
7812983|NCT01145066|19233833|P3|NOT COMPLETED|Overall Study||4
7812984|NCT01145066|19233834|P2|NOT COMPLETED|Overall Study||4
7812985|NCT01145066|19233835|P1|NOT COMPLETED|Overall Study||4
7812986|NCT01145066|19233833|P3|COMPLETED|Overall Study||21
7812987|NCT01145066|19233834|P2|COMPLETED|Overall Study||16
7812988|NCT01145066|19233835|P1|COMPLETED|Overall Study||22
7812989|NCT01145066|19233833|P3|STARTED|Overall Study||25
7812990|NCT01145066|19233834|P2|STARTED|Overall Study||20
7812991|NCT01145066|19233835|P1|STARTED|Overall Study||26
7812992|NCT01145053|19233903|P1|NOT COMPLETED|Overall Study||93
7812993|NCT01145053|19233903|P1|COMPLETED|Overall Study||248
7812994|NCT01145053|19233903|P1|STARTED|Overall Study||341
7812995|NCT01145001|19233917|P4|NOT COMPLETED|Overall Study||6
7812996|NCT01145001|19233918|P3|NOT COMPLETED|Overall Study||5
7812997|NCT01145001|19233919|P2|NOT COMPLETED|Overall Study||6
7812998|NCT01145001|19233920|P1|NOT COMPLETED|Overall Study||8
7812999|NCT01145001|19233917|P4|COMPLETED|Overall Study||31
7813000|NCT01145001|19233918|P3|COMPLETED|Overall Study||39
7813001|NCT01145001|19233919|P2|COMPLETED|Overall Study||31
7813002|NCT01145001|19233920|P1|COMPLETED|Overall Study||28
7813003|NCT01145001|19233917|P4|STARTED|Overall Study||37
7813004|NCT01145001|19233918|P3|STARTED|Overall Study||44
7813005|NCT01145001|19233919|P2|STARTED|Overall Study||37
7813006|NCT01145001|19233920|P1|STARTED|Overall Study||36
7813007|NCT01144949|19233936|P2|NOT COMPLETED|Overall Study||14
7813008|NCT01144949|19233937|P1|NOT COMPLETED|Overall Study||11
7813009|NCT01144949|19233936|P2|COMPLETED|Overall Study||106
7813010|NCT01144949|19233937|P1|COMPLETED|Overall Study||108
7813011|NCT01144949|19233936|P2|STARTED|Overall Study||120
7813012|NCT01144949|19233937|P1|STARTED|Overall Study||119
7813013|NCT01144715|19233955|P2|NOT COMPLETED|Overall Study||3
7813014|NCT01144715|19233956|P1|NOT COMPLETED|Overall Study||4
7813015|NCT01144715|19233955|P2|COMPLETED|Overall Study||45
7813016|NCT01144715|19233956|P1|COMPLETED|Overall Study||47
7813017|NCT01144715|19233955|P2|STARTED|Overall Study||48
7813018|NCT01144715|19233956|P1|STARTED|Overall Study||51
7813019|NCT01144663|19233972|P4|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||1
7813020|NCT01144663|19233973|P3|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||7
7813021|NCT01144663|19233974|P2|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||9
7813022|NCT01144663|19233975|P1|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||5
7813023|NCT01144663|19233972|P4|COMPLETED|Extended Safety Follow-Up (ESFU)||505
7813024|NCT01144663|19233973|P3|COMPLETED|Extended Safety Follow-Up (ESFU)||496
7813025|NCT01144663|19233974|P2|COMPLETED|Extended Safety Follow-Up (ESFU)||502
7813026|NCT01144663|19233975|P1|COMPLETED|Extended Safety Follow-Up (ESFU)||492
7813027|NCT01144663|19233972|P4|STARTED|Extended Safety Follow-Up (ESFU)||506
7813028|NCT01144663|19233973|P3|STARTED|Extended Safety Follow-Up (ESFU)||503
7813029|NCT01144663|19233974|P2|STARTED|Extended Safety Follow-Up (ESFU)||511
7813030|NCT01144663|19233975|P1|STARTED|Extended Safety Follow-Up (ESFU)||497
7813031|NCT01144663|19233972|P4|NOT COMPLETED|Booster Vaccination Phase||1
7813032|NCT01144663|19233973|P3|NOT COMPLETED|Booster Vaccination Phase||5
7813033|NCT01144663|19233974|P2|NOT COMPLETED|Booster Vaccination Phase||2
7813034|NCT01144663|19233975|P1|NOT COMPLETED|Booster Vaccination Phase||3
7813035|NCT01144663|19233972|P4|COMPLETED|Booster Vaccination Phase||505
7813036|NCT01144663|19233973|P3|COMPLETED|Booster Vaccination Phase||498
7813037|NCT01144663|19233974|P2|COMPLETED|Booster Vaccination Phase||509
7813038|NCT01144663|19233975|P1|COMPLETED|Booster Vaccination Phase||494
7813039|NCT01144663|19233972|P4|STARTED|Booster Vaccination Phase||506
7813040|NCT01144663|19233973|P3|STARTED|Booster Vaccination Phase||503
7813041|NCT01144663|19233974|P2|STARTED|Booster Vaccination Phase||511
7813042|NCT01144663|19233975|P1|STARTED|Booster Vaccination Phase||497
7813043|NCT01144663|19233972|P4|NOT COMPLETED|Primary Vaccination Phase||18
7813044|NCT01144663|19233973|P3|NOT COMPLETED|Primary Vaccination Phase||8
7813045|NCT01144663|19233974|P2|NOT COMPLETED|Primary Vaccination Phase||7
7813046|NCT01144663|19233975|P1|NOT COMPLETED|Primary Vaccination Phase||20
7813047|NCT01144663|19233972|P4|COMPLETED|Primary Vaccination Phase||509
7813048|NCT01144663|19233973|P3|COMPLETED|Primary Vaccination Phase||508
7813049|NCT01144663|19233974|P2|COMPLETED|Primary Vaccination Phase||517
7813050|NCT01144663|19233975|P1|COMPLETED|Primary Vaccination Phase||508
7813051|NCT01144663|19233972|P4|STARTED|Primary Vaccination Phase||527
7813052|NCT01144663|19233973|P3|STARTED|Primary Vaccination Phase||516
7813053|NCT01144663|19233974|P2|STARTED|Primary Vaccination Phase||524
7813054|NCT01144663|19233975|P1|STARTED|Primary Vaccination Phase||528
7813055|NCT01144637|19234179|P4|NOT COMPLETED|Overall Study||56
7813056|NCT01144637|19234180|P3|NOT COMPLETED|Overall Study||60
7813057|NCT01144637|19234181|P2|NOT COMPLETED|Overall Study||76
7813058|NCT01144637|19234182|P1|NOT COMPLETED|Overall Study||74
7813059|NCT01144637|19234179|P4|COMPLETED|Overall Study||946
7813060|NCT01144637|19234180|P3|COMPLETED|Overall Study||939
7813061|NCT01144637|19234181|P2|COMPLETED|Overall Study||929
7813062|NCT01144637|19234182|P1|COMPLETED|Overall Study||925
7813063|NCT01144637|19234179|P4|STARTED|Overall Study||1002
7813064|NCT01144637|19234180|P3|STARTED|Overall Study||999
7813065|NCT01144637|19234181|P2|STARTED|Overall Study||1005
7813066|NCT01144637|19234182|P1|STARTED|Overall Study||999
7813067|NCT01144624|19234239|P3|NOT COMPLETED|Overall Study||0
7813068|NCT01144624|19234240|P2|NOT COMPLETED|Overall Study||0
7813069|NCT01144624|19234241|P1|NOT COMPLETED|Overall Study||0
7813070|NCT01144624|19234239|P3|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6
7813071|NCT01144624|19234240|P2|COMPLETED|Overall Study||7
7813072|NCT01144624|19234241|P1|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7
7813073|NCT01144624|19234239|P3|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6
7813074|NCT01144624|19234240|P2|Completed Treatment|Overall Study||7
7813075|NCT01144624|19234241|P1|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7
7813076|NCT01144624|19234239|P3|Received Treatment|Overall Study||6
7813077|NCT01144624|19234240|P2|Received Treatment|Overall Study||7
7813078|NCT01144624|19234241|P1|Received Treatment|Overall Study||7
7813079|NCT01144624|19234239|P3|STARTED|Overall Study||6
7813080|NCT01144624|19234240|P2|STARTED|Overall Study||7
7813081|NCT01144624|19234241|P1|STARTED|Overall Study||7
7813082|NCT01144598|19234255|P1|NOT COMPLETED|Overall Study||0
7813083|NCT01144598|19234255|P1|COMPLETED|Overall Study||356
7813084|NCT01144598|19234255|P1|Analysis Population|Overall Study||356
7813085|NCT01144598|19234255|P1|STARTED|Overall Study||356
7813086|NCT01144494|19234273|P2|NOT COMPLETED|Overall Study||4
7813087|NCT01144494|19234274|P1|NOT COMPLETED|Overall Study||0
7813088|NCT01144494|19234273|P2|COMPLETED|Overall Study||14
7813089|NCT01144494|19234274|P1|COMPLETED|Overall Study||15
7813090|NCT01144494|19234273|P2|STARTED|Overall Study||18
7813091|NCT01144494|19234274|P1|STARTED|Overall Study||15
7813092|NCT01144455|19234293|P3|NOT COMPLETED|Overall Study||36
7813093|NCT01144455|19234294|P2|NOT COMPLETED|Overall Study||42
7813094|NCT01144455|19234295|P1|NOT COMPLETED|Overall Study||50
7813095|NCT01144455|19234293|P3|COMPLETED|Overall Study||38
7813096|NCT01144455|19234294|P2|COMPLETED|Overall Study||29
7813097|NCT01144455|19234295|P1|COMPLETED|Overall Study||19
7813098|NCT01144455|19234293|P3|STARTED|Overall Study||74
7813099|NCT01144455|19234294|P2|STARTED|Overall Study||71
7813100|NCT01144455|19234295|P1|STARTED|Overall Study||69
7813101|NCT01144442|19234303|P1|NOT COMPLETED|Overall Study||0
7813102|NCT01144442|19234303|P1|COMPLETED|Overall Study||10
7813103|NCT01144442|19234303|P1|STARTED|Overall Study||10
7813104|NCT01144416|19234313|P2|NOT COMPLETED|Pregnancy Follow-up Period||10
7813105|NCT01144416|19234314|P1|NOT COMPLETED|Pregnancy Follow-up Period||8
7813106|NCT01144416|19234313|P2|COMPLETED|Pregnancy Follow-up Period||157
7813107|NCT01144416|19234314|P1|COMPLETED|Pregnancy Follow-up Period||146
7813182|NCT01144364|19234396|P2|COMPLETED|Induction Phase||0
7813108|NCT01144416|19234313|P2|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167
7813109|NCT01144416|19234314|P1|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154
7813110|NCT01144416|19234313|P2|NOT COMPLETED|Intervention Period||49
7813111|NCT01144416|19234314|P1|NOT COMPLETED|Intervention Period||62
7813112|NCT01144416|19234313|P2|COMPLETED|Intervention Period||647
7813113|NCT01144416|19234314|P1|COMPLETED|Intervention Period||632
7813114|NCT01144416|19234313|P2|STARTED|Intervention Period||696
7813115|NCT01144416|19234314|P1|STARTED|Intervention Period||694
7813116|NCT01144403|19234330|P1|NOT COMPLETED|Overall Study||5
7813117|NCT01144403|19234330|P1|COMPLETED|Overall Study||3
7813118|NCT01144403|19234330|P1|STARTED|Overall Study||8
7813119|NCT01144377|19234342|P5|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||2
7813120|NCT01144377|19234343|P4|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
7813121|NCT01144377|19234344|P3|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
7813122|NCT01144377|19234345|P2|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
7813123|NCT01144377|19234346|P1|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
7813124|NCT01144377|19234342|P5|COMPLETED|Optional 40 Week Safety Follow-up Period||21
7813125|NCT01144377|19234343|P4|COMPLETED|Optional 40 Week Safety Follow-up Period||3
7813126|NCT01144377|19234344|P3|COMPLETED|Optional 40 Week Safety Follow-up Period||23
7813127|NCT01144377|19234345|P2|COMPLETED|Optional 40 Week Safety Follow-up Period||24
7813128|NCT01144377|19234346|P1|COMPLETED|Optional 40 Week Safety Follow-up Period||21
7813129|NCT01144377|19234342|P5|STARTED|Optional 40 Week Safety Follow-up Period||23
7813130|NCT01144377|19234343|P4|STARTED|Optional 40 Week Safety Follow-up Period||3
7813131|NCT01144377|19234344|P3|STARTED|Optional 40 Week Safety Follow-up Period||23
7813132|NCT01144377|19234345|P2|STARTED|Optional 40 Week Safety Follow-up Period||25
7813133|NCT01144377|19234346|P1|STARTED|Optional 40 Week Safety Follow-up Period||22
7813134|NCT01144377|19234342|P5|NOT COMPLETED|12 Week Safety Follow-up Period||0
7813135|NCT01144377|19234343|P4|NOT COMPLETED|12 Week Safety Follow-up Period||0
7813136|NCT01144377|19234344|P3|NOT COMPLETED|12 Week Safety Follow-up Period||0
7813137|NCT01144377|19234345|P2|NOT COMPLETED|12 Week Safety Follow-up Period||0
7813138|NCT01144377|19234346|P1|NOT COMPLETED|12 Week Safety Follow-up Period||0
7813139|NCT01144377|19234342|P5|COMPLETED|12 Week Safety Follow-up Period|Of the 34 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|34
7813140|NCT01144377|19234343|P4|COMPLETED|12 Week Safety Follow-up Period|Of the 22 participants who completed this Period, 3 continued to the Optional 40 Week follow-up.|22
7813141|NCT01144377|19234344|P3|COMPLETED|12 Week Safety Follow-up Period|Of the 25 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|25
7813142|NCT01144377|19234345|P2|COMPLETED|12 Week Safety Follow-up Period|Of the 29 participants who completed this Period, 25 continued to the Optional 40 Week follow-up.|29
7813143|NCT01144377|19234346|P1|COMPLETED|12 Week Safety Follow-up Period|Of the 26 participants who completed this Period, 22 continued to the Optional 40 Week follow-up.|26
7813144|NCT01144377|19234342|P5|STARTED|12 Week Safety Follow-up Period||34
7813145|NCT01144377|19234343|P4|STARTED|12 Week Safety Follow-up Period||22
7813146|NCT01144377|19234344|P3|STARTED|12 Week Safety Follow-up Period||25
7813147|NCT01144377|19234345|P2|STARTED|12 Week Safety Follow-up Period||29
7813148|NCT01144377|19234346|P1|STARTED|12 Week Safety Follow-up Period||26
7813149|NCT01144377|19234342|P5|NOT COMPLETED|52 Week Treatment Period||3
7813150|NCT01144377|19234343|P4|NOT COMPLETED|52 Week Treatment Period||4
7813151|NCT01144377|19234344|P3|NOT COMPLETED|52 Week Treatment Period||5
7813152|NCT01144377|19234345|P2|NOT COMPLETED|52 Week Treatment Period||1
7813153|NCT01144377|19234346|P1|NOT COMPLETED|52 Week Treatment Period||5
7813154|NCT01144377|19234342|P5|COMPLETED|52 Week Treatment Period||34
7813155|NCT01144377|19234343|P4|COMPLETED|52 Week Treatment Period||22
7813156|NCT01144377|19234344|P3|COMPLETED|52 Week Treatment Period||25
7813157|NCT01144377|19234345|P2|COMPLETED|52 Week Treatment Period||29
7813158|NCT01144377|19234346|P1|COMPLETED|52 Week Treatment Period||26
7813159|NCT01144377|19234342|P5|Received at Least One Dose of Study Drug|52 Week Treatment Period||37
7813160|NCT01144377|19234343|P4|Received at Least One Dose of Study Drug|52 Week Treatment Period||25
7813161|NCT01144377|19234344|P3|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
7813162|NCT01144377|19234345|P2|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
7813163|NCT01144377|19234346|P1|Received at Least One Dose of Study Drug|52 Week Treatment Period||31
7813164|NCT01144377|19234342|P5|STARTED|52 Week Treatment Period||37
7813165|NCT01144377|19234343|P4|STARTED|52 Week Treatment Period||26
7813166|NCT01144377|19234344|P3|STARTED|52 Week Treatment Period||30
7813167|NCT01144377|19234345|P2|STARTED|52 Week Treatment Period||30
7813168|NCT01144377|19234346|P1|STARTED|52 Week Treatment Period||31
7813169|NCT01144364|19234395|P3|NOT COMPLETED|Follow-Up/Maintenance Phase||41
7813170|NCT01144364|19234396|P2|NOT COMPLETED|Follow-Up/Maintenance Phase||35
7813171|NCT01144364|19234397|P1|NOT COMPLETED|Follow-Up/Maintenance Phase||0
7813172|NCT01144364|19234395|P3|COMPLETED|Follow-Up/Maintenance Phase||60
7813173|NCT01144364|19234396|P2|COMPLETED|Follow-Up/Maintenance Phase||66
7813174|NCT01144364|19234397|P1|COMPLETED|Follow-Up/Maintenance Phase||0
7813175|NCT01144364|19234395|P3|STARTED|Follow-Up/Maintenance Phase||101
7813176|NCT01144364|19234396|P2|STARTED|Follow-Up/Maintenance Phase||101
7813177|NCT01144364|19234397|P1|STARTED|Follow-Up/Maintenance Phase||0
7813178|NCT01144364|19234395|P3|NOT COMPLETED|Induction Phase||0
7813179|NCT01144364|19234396|P2|NOT COMPLETED|Induction Phase||0
7813180|NCT01144364|19234397|P1|NOT COMPLETED|Induction Phase||32
7813181|NCT01144364|19234395|P3|COMPLETED|Induction Phase||0
7813183|NCT01144364|19234397|P1|COMPLETED|Induction Phase||202
7813184|NCT01144364|19234395|P3|STARTED|Induction Phase||0
7813185|NCT01144364|19234396|P2|STARTED|Induction Phase||0
7813186|NCT01144364|19234397|P1|STARTED|Induction Phase||234
7813187|NCT01144338|19234423|P2|NOT COMPLETED|Overall Study||262
7813188|NCT01144338|19234424|P1|NOT COMPLETED|Overall Study||303
7813189|NCT01144338|19234423|P2|COMPLETED|Overall Study||7094
7813190|NCT01144338|19234424|P1|COMPLETED|Overall Study||7093
7813191|NCT01144338|19234423|P2|STARTED|Overall Study||7356
7813192|NCT01144338|19234424|P1|STARTED|Overall Study||7396
7813193|NCT01144299|19234446|P2|NOT COMPLETED|Overall Study||0
7813194|NCT01144299|19234447|P1|NOT COMPLETED|Overall Study||2
7813195|NCT01144299|19234446|P2|COMPLETED|Overall Study||54
7813196|NCT01144299|19234447|P1|COMPLETED|Overall Study||58
7813197|NCT01144299|19234446|P2|STARTED|Overall Study||54
7813198|NCT01144299|19234447|P1|STARTED|Overall Study||60
7813199|NCT01144286|19234473|P4|NOT COMPLETED|Overall Study||0
7813200|NCT01144286|19234474|P3|NOT COMPLETED|Overall Study||0
7813201|NCT01144286|19234475|P2|NOT COMPLETED|Overall Study||0
7813202|NCT01144286|19234476|P1|NOT COMPLETED|Overall Study||0
7813203|NCT01144286|19234473|P4|COMPLETED|Overall Study||56
7813204|NCT01144286|19234474|P3|COMPLETED|Overall Study||58
7813205|NCT01144286|19234475|P2|COMPLETED|Overall Study||58
7813206|NCT01144286|19234476|P1|COMPLETED|Overall Study||57
7813207|NCT01144286|19234473|P4|STARTED|Overall Study||56
7813208|NCT01144286|19234474|P3|STARTED|Overall Study||58
7813209|NCT01144286|19234475|P2|STARTED|Overall Study||58
7813210|NCT01144286|19234476|P1|STARTED|Overall Study||57
7813211|NCT01144182|19234492|P2|NOT COMPLETED|Overall Study||21
7813212|NCT01144182|19234493|P1|NOT COMPLETED|Overall Study||17
7813213|NCT01144182|19234492|P2|COMPLETED|Overall Study||47
7813214|NCT01144182|19234493|P1|COMPLETED|Overall Study||51
7813215|NCT01144182|19234492|P2|STARTED|Overall Study||68
7813216|NCT01144182|19234493|P1|STARTED|Overall Study||68
7813217|NCT01144143|19234526|P3|NOT COMPLETED|Overall Study||0
7813218|NCT01144143|19234527|P2|NOT COMPLETED|Overall Study||0
7813219|NCT01144143|19234528|P1|NOT COMPLETED|Overall Study||0
7813220|NCT01144143|19234526|P3|COMPLETED|Overall Study||4
7813221|NCT01144143|19234527|P2|COMPLETED|Overall Study||4
7813222|NCT01144143|19234528|P1|COMPLETED|Overall Study||8
7813223|NCT01144143|19234526|P3|STARTED|Overall Study||4
7813224|NCT01144143|19234527|P2|STARTED|Overall Study||4
7813225|NCT01144143|19234528|P1|STARTED|Overall Study||8
7813226|NCT01144052|19234553|P2|NOT COMPLETED|Overall Study||1
7813227|NCT01144052|19234554|P1|NOT COMPLETED|Overall Study||1
7813228|NCT01144052|19234553|P2|COMPLETED|Overall Study||8
7813229|NCT01144052|19234554|P1|COMPLETED|Overall Study||9
7813230|NCT01144052|19234553|P2|STARTED|Overall Study||9
7813231|NCT01144052|19234554|P1|STARTED|Overall Study||10
7813232|NCT01144026|19234576|P2|NOT COMPLETED|Overall Study||0
7813233|NCT01144026|19234577|P1|NOT COMPLETED|Overall Study||0
7813234|NCT01144026|19234576|P2|COMPLETED|Overall Study||5
7813235|NCT01144026|19234577|P1|COMPLETED|Overall Study||10
7813236|NCT01144026|19234576|P2|STARTED|Overall Study||5
7813237|NCT01144026|19234577|P1|STARTED|Overall Study||10
7813238|NCT01143896|19234585|P2|NOT COMPLETED|Overall Study||25
7813239|NCT01143896|19234586|P1|NOT COMPLETED|Overall Study||42
7813240|NCT01143896|19234585|P2|COMPLETED|Overall Study||128
7813241|NCT01143896|19234586|P1|COMPLETED|Overall Study||114
7813242|NCT01143896|19234585|P2|STARTED|Overall Study||153
7813243|NCT01143896|19234586|P1|STARTED|Overall Study||156
7813244|NCT01143883|19234604|P2|NOT COMPLETED|Overall Study||0
7813245|NCT01143883|19234605|P1|NOT COMPLETED|Overall Study||0
7813246|NCT01143883|19234604|P2|COMPLETED|Overall Study||55
7813247|NCT01143883|19234605|P1|COMPLETED|Overall Study||55
7813248|NCT01143883|19234604|P2|STARTED|Overall Study||55
7813249|NCT01143883|19234605|P1|STARTED|Overall Study||55
7813250|NCT01143870|19234614|P3|NOT COMPLETED|Overall Study||0
7813251|NCT01143870|19234615|P2|NOT COMPLETED|Overall Study||0
7813252|NCT01143870|19234616|P1|NOT COMPLETED|Overall Study||0
7813253|NCT01143870|19234614|P3|COMPLETED|Overall Study||61
7813254|NCT01143870|19234615|P2|COMPLETED|Overall Study||58
7813255|NCT01143870|19234616|P1|COMPLETED|Overall Study||58
7813256|NCT01143870|19234614|P3|A1C Imputed|Overall Study||30
7813257|NCT01143870|19234615|P2|A1C Imputed|Overall Study||29
7813258|NCT01143870|19234616|P1|A1C Imputed|Overall Study||31
7813259|NCT01143870|19234614|P3|Had Available 6-month A1C|Overall Study||31
7813260|NCT01143870|19234615|P2|Had Available 6-month A1C|Overall Study||29
7813261|NCT01143870|19234616|P1|Had Available 6-month A1C|Overall Study||27
7813262|NCT01143870|19234614|P3|Post-intervention Survey|Overall Study||61
7813263|NCT01143870|19234615|P2|Post-intervention Survey|Overall Study||50
7813264|NCT01143870|19234616|P1|Post-intervention Survey|Overall Study||53
7813265|NCT01143870|19234614|P3|STARTED|Overall Study||61
7813266|NCT01143870|19234615|P2|STARTED|Overall Study||58
7813267|NCT01143870|19234616|P1|STARTED|Overall Study||58
7813268|NCT01143818|19234624|P1|NOT COMPLETED|Overall Study||250
7813269|NCT01143818|19234624|P1|COMPLETED|Overall Study||799
7813270|NCT01143818|19234624|P1|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049
7813271|NCT01143792|19234634|P3|NOT COMPLETED|Overall Study||0
7813272|NCT01143792|19234635|P2|NOT COMPLETED|Overall Study||0
7813273|NCT01143792|19234636|P1|NOT COMPLETED|Overall Study||0
7813274|NCT01143792|19234634|P3|COMPLETED|Overall Study||91
7813275|NCT01143792|19234635|P2|COMPLETED|Overall Study||86
7813276|NCT01143792|19234636|P1|COMPLETED|Overall Study||93
7813277|NCT01143792|19234634|P3|STARTED|Overall Study||91
7813278|NCT01143792|19234635|P2|STARTED|Overall Study||86
7813279|NCT01143792|19234636|P1|STARTED|Overall Study||93
7813280|NCT01143766|19234670|P2|NOT COMPLETED|Overall Study||0
7813281|NCT01143766|19234671|P1|NOT COMPLETED|Overall Study||0
7813282|NCT01143766|19234670|P2|COMPLETED|Overall Study||31
7813283|NCT01143766|19234671|P1|COMPLETED|Overall Study||25
7813284|NCT01143766|19234670|P2|STARTED|Overall Study||31
7813285|NCT01143766|19234671|P1|STARTED|Overall Study||25
7813286|NCT01143727|19234687|P2|NOT COMPLETED|Overall Study||0
7813287|NCT01143727|19234688|P1|NOT COMPLETED|Overall Study||0
7813288|NCT01143727|19234687|P2|COMPLETED|Overall Study||8
7813289|NCT01143727|19234688|P1|COMPLETED|Overall Study||9
7813290|NCT01143727|19234687|P2|STARTED|Overall Study||8
7813291|NCT01143727|19234688|P1|STARTED|Overall Study||9
7813292|NCT01143714|19234698|P2|NOT COMPLETED|Overall Study||3
7813293|NCT01143714|19234699|P1|NOT COMPLETED|Overall Study||7
7813294|NCT01143714|19234698|P2|COMPLETED|Overall Study||25
7813295|NCT01143714|19234699|P1|COMPLETED|Overall Study||22
7813296|NCT01143714|19234698|P2|STARTED|Overall Study||28
7813297|NCT01143714|19234699|P1|STARTED|Overall Study||29
7813298|NCT01143701|19234709|P2|NOT COMPLETED|Overall Study||32
7813299|NCT01143701|19234710|P1|NOT COMPLETED|Overall Study||23
7813300|NCT01143701|19234709|P2|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287
7813301|NCT01143701|19234710|P1|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235
7813302|NCT01143701|19234709|P2|STARTED|Overall Study||319
7813303|NCT01143701|19234710|P1|STARTED|Overall Study||258
7813304|NCT01143688|19234718|P1|NOT COMPLETED|Overall Study||0
7813305|NCT01143688|19234718|P1|COMPLETED|Overall Study||39
7813306|NCT01143688|19234718|P1|STARTED|Overall Study||39
7813307|NCT01143649|19234737|P6|NOT COMPLETED|Overall Study||2
7813308|NCT01143649|19234738|P5|NOT COMPLETED|Overall Study||1
7813309|NCT01143649|19234739|P4|NOT COMPLETED|Overall Study||0
7813310|NCT01143649|19234740|P3|NOT COMPLETED|Overall Study||0
7813311|NCT01143649|19234741|P2|NOT COMPLETED|Overall Study||0
7813312|NCT01143649|19234742|P1|NOT COMPLETED|Overall Study||0
7813313|NCT01143649|19234737|P6|COMPLETED|Overall Study||3
7813314|NCT01143649|19234738|P5|COMPLETED|Overall Study||4
7813315|NCT01143649|19234739|P4|COMPLETED|Overall Study||10
7813316|NCT01143649|19234740|P3|COMPLETED|Overall Study||10
7813317|NCT01143649|19234741|P2|COMPLETED|Overall Study||7
7813318|NCT01143649|19234742|P1|COMPLETED|Overall Study||7
7813319|NCT01143649|19234737|P6|STARTED|Overall Study||5
7813320|NCT01143649|19234738|P5|STARTED|Overall Study||5
7813321|NCT01143649|19234739|P4|STARTED|Overall Study||10
7813322|NCT01143649|19234740|P3|STARTED|Overall Study||10
7813323|NCT01143649|19234741|P2|STARTED|Overall Study||7
7813324|NCT01143649|19234742|P1|STARTED|Overall Study||7
7813325|NCT01143636|19234759|P4|NOT COMPLETED|Overall Study||0
7813326|NCT01143636|19234760|P3|NOT COMPLETED|Overall Study||0
7813327|NCT01143636|19234761|P2|NOT COMPLETED|Overall Study||1
7813328|NCT01143636|19234762|P1|NOT COMPLETED|Overall Study||1
7813329|NCT01143636|19234759|P4|COMPLETED|Overall Study||7
7813330|NCT01143636|19234760|P3|COMPLETED|Overall Study||8
7813331|NCT01143636|19234761|P2|COMPLETED|Overall Study||4
7813332|NCT01143636|19234762|P1|COMPLETED|Overall Study||5
7813333|NCT01143636|19234759|P4|STARTED|Overall Study||7
7813334|NCT01143636|19234760|P3|STARTED|Overall Study||8
7813335|NCT01143636|19234761|P2|STARTED|Overall Study||5
7813336|NCT01143636|19234762|P1|STARTED|Overall Study||6
7813337|NCT01143610|19234792|P2|NOT COMPLETED|Overall Study||0
7813338|NCT01143610|19234793|P1|NOT COMPLETED|Overall Study||0
7813339|NCT01143610|19234792|P2|COMPLETED|Overall Study||8
7813340|NCT01143610|19234793|P1|COMPLETED|Overall Study||7
7813341|NCT01143610|19234792|P2|STARTED|Overall Study||8
7813342|NCT01143610|19234793|P1|STARTED|Overall Study||7
7813343|NCT01143402|19234804|P3|NOT COMPLETED|Overall Study||1
7813344|NCT01143402|19234805|P2|NOT COMPLETED|Overall Study||1
7813345|NCT01143402|19234806|P1|NOT COMPLETED|Overall Study||1
7813346|NCT01143402|19234804|P3|COMPLETED|Overall Study||18
7813347|NCT01143402|19234805|P2|COMPLETED|Overall Study||49
7813348|NCT01143402|19234806|P1|COMPLETED|Overall Study||50
7813349|NCT01143402|19234804|P3|STARTED|Overall Study||19
7813350|NCT01143402|19234805|P2|STARTED|Overall Study||50
7813351|NCT01143402|19234806|P1|STARTED|Overall Study||51
7813352|NCT01143389|19234817|P2|NOT COMPLETED|Overall Study||25
7813353|NCT01143389|19234818|P1|NOT COMPLETED|Overall Study||26
7813354|NCT01143389|19234817|P2|COMPLETED|Overall Study||232
7813355|NCT01143389|19234818|P1|COMPLETED|Overall Study||227
7813356|NCT01143389|19234817|P2|STARTED|Overall Study||257
7813357|NCT01143389|19234818|P1|STARTED|Overall Study||253
7813358|NCT01143337|19234832|P3|NOT COMPLETED|Overall Study||12
7813359|NCT01143337|19234833|P2|NOT COMPLETED|Overall Study||11
7813360|NCT01143337|19234834|P1|NOT COMPLETED|Overall Study||10
7813361|NCT01143337|19234832|P3|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1
7813362|NCT01143337|19234833|P2|COMPLETED|Overall Study||39
7813363|NCT01143337|19234834|P1|COMPLETED|Overall Study||39
7813364|NCT01143337|19234832|P3|STARTED|Overall Study||13
7813365|NCT01143337|19234833|P2|STARTED|Overall Study||50
7813366|NCT01143337|19234834|P1|STARTED|Overall Study||49
7813367|NCT01143324|19234848|P1|NOT COMPLETED|Overall Study||19
7813368|NCT01143324|19234848|P1|COMPLETED|Overall Study||233
7813369|NCT01143324|19234848|P1|STARTED|Overall Study||252
7813370|NCT01143272|19234866|P2|NOT COMPLETED|Overall Study||0
7813371|NCT01143272|19234867|P1|NOT COMPLETED|Overall Study||0
7813372|NCT01143272|19234866|P2|COMPLETED|Overall Study||231
7813373|NCT01143272|19234867|P1|COMPLETED|Overall Study||246
7813374|NCT01143272|19234866|P2|STARTED|Overall Study||231
7813375|NCT01143272|19234867|P1|STARTED|Overall Study||246
7813376|NCT01143259|19234887|P2|NOT COMPLETED|Overall Study||20
7813377|NCT01143259|19234888|P1|NOT COMPLETED|Overall Study||23
7813378|NCT01143259|19234887|P2|COMPLETED|Overall Study||118
7813379|NCT01143259|19234888|P1|COMPLETED|Overall Study||113
7813380|NCT01143259|19234887|P2|STARTED|Overall Study||138
7813381|NCT01143259|19234888|P1|STARTED|Overall Study||136
7813382|NCT01143207|19234896|P1|NOT COMPLETED|Overall Study||2
7813383|NCT01143207|19234896|P1|COMPLETED|Overall Study||24
7813384|NCT01143207|19234896|P1|STARTED|Overall Study||26
7813385|NCT01143142|19234907|P2|NOT COMPLETED|Overall Study||0
7813386|NCT01143142|19234908|P1|NOT COMPLETED|Overall Study||0
7813387|NCT01143142|19234907|P2|COMPLETED|Overall Study||34
7813388|NCT01143142|19234908|P1|COMPLETED|Overall Study||36
7813389|NCT01143142|19234907|P2|STARTED|Overall Study||34
7813390|NCT01143142|19234908|P1|STARTED|Overall Study||36
7813391|NCT01143090|19234916|P1|NOT COMPLETED|Overall Study||51
7813392|NCT01143090|19234916|P1|COMPLETED|Overall Study||98
7813393|NCT01143090|19234916|P1|STARTED|Overall Study||149
7813394|NCT01143077|19234923|P3|NOT COMPLETED|Overall Study||15
7813395|NCT01143077|19234924|P2|NOT COMPLETED|Overall Study||15
7813396|NCT01143077|19234925|P1|NOT COMPLETED|Overall Study||16
7813397|NCT01143077|19234923|P3|COMPLETED|Overall Study||67
7813398|NCT01143077|19234924|P2|COMPLETED|Overall Study||73
7813399|NCT01143077|19234925|P1|COMPLETED|Overall Study||58
7813400|NCT01143077|19234923|P3|STARTED|Overall Study||82
7813401|NCT01143077|19234924|P2|STARTED|Overall Study||88
7813402|NCT01143077|19234925|P1|STARTED|Overall Study||74
7813403|NCT01143051|19234942|P6|NOT COMPLETED|Visit 3||0
7813404|NCT01143051|19234943|P5|NOT COMPLETED|Visit 3||0
7813405|NCT01143051|19234944|P4|NOT COMPLETED|Visit 3||0
7813406|NCT01143051|19234945|P3|NOT COMPLETED|Visit 3||0
7813407|NCT01143051|19234946|P2|NOT COMPLETED|Visit 3||0
7813408|NCT01143051|19234947|P1|NOT COMPLETED|Visit 3||0
7813409|NCT01143051|19234942|P6|COMPLETED|Visit 3||3
7813410|NCT01143051|19234943|P5|COMPLETED|Visit 3||4
7813411|NCT01143051|19234944|P4|COMPLETED|Visit 3||4
7813412|NCT01143051|19234945|P3|COMPLETED|Visit 3||3
7813413|NCT01143051|19234946|P2|COMPLETED|Visit 3||4
7813414|NCT01143051|19234947|P1|COMPLETED|Visit 3||4
7813415|NCT01143051|19234942|P6|STARTED|Visit 3||3
7813416|NCT01143051|19234943|P5|STARTED|Visit 3||4
7813417|NCT01143051|19234944|P4|STARTED|Visit 3||4
7813418|NCT01143051|19234945|P3|STARTED|Visit 3||3
7813419|NCT01143051|19234946|P2|STARTED|Visit 3||4
7813420|NCT01143051|19234947|P1|STARTED|Visit 3||4
7813421|NCT01143051|19234942|P6|NOT COMPLETED|3-14 Day Washout||1
7813422|NCT01143051|19234943|P5|NOT COMPLETED|3-14 Day Washout||0
7813423|NCT01143051|19234944|P4|NOT COMPLETED|3-14 Day Washout||0
7813424|NCT01143051|19234945|P3|NOT COMPLETED|3-14 Day Washout||0
7813425|NCT01143051|19234946|P2|NOT COMPLETED|3-14 Day Washout||0
7813426|NCT01143051|19234947|P1|NOT COMPLETED|3-14 Day Washout||0
7813427|NCT01143051|19234942|P6|COMPLETED|3-14 Day Washout||3
7813428|NCT01143051|19234943|P5|COMPLETED|3-14 Day Washout||4
7813429|NCT01143051|19234944|P4|COMPLETED|3-14 Day Washout||4
7813430|NCT01143051|19234945|P3|COMPLETED|3-14 Day Washout||3
7813431|NCT01143051|19234946|P2|COMPLETED|3-14 Day Washout||4
7813432|NCT01143051|19234947|P1|COMPLETED|3-14 Day Washout||4
7813433|NCT01143051|19234942|P6|STARTED|3-14 Day Washout||4
7813434|NCT01143051|19234943|P5|STARTED|3-14 Day Washout||4
7813435|NCT01143051|19234944|P4|STARTED|3-14 Day Washout||4
7813436|NCT01143051|19234945|P3|STARTED|3-14 Day Washout||3
7813437|NCT01143051|19234946|P2|STARTED|3-14 Day Washout||4
7813438|NCT01143051|19234947|P1|STARTED|3-14 Day Washout||4
7813439|NCT01143051|19234942|P6|NOT COMPLETED|Visit 2||0
7813440|NCT01143051|19234943|P5|NOT COMPLETED|Visit 2||0
7813441|NCT01143051|19234944|P4|NOT COMPLETED|Visit 2||0
7813442|NCT01143051|19234945|P3|NOT COMPLETED|Visit 2||0
7813443|NCT01143051|19234946|P2|NOT COMPLETED|Visit 2||0
7813444|NCT01143051|19234947|P1|NOT COMPLETED|Visit 2||0
7813445|NCT01143051|19234942|P6|COMPLETED|Visit 2||4
7813446|NCT01143051|19234943|P5|COMPLETED|Visit 2||4
7813447|NCT01143051|19234944|P4|COMPLETED|Visit 2||4
7813448|NCT01143051|19234945|P3|COMPLETED|Visit 2||3
7813449|NCT01143051|19234946|P2|COMPLETED|Visit 2||4
7813450|NCT01143051|19234947|P1|COMPLETED|Visit 2||4
7813451|NCT01143051|19234942|P6|STARTED|Visit 2||4
7813452|NCT01143051|19234943|P5|STARTED|Visit 2||4
7813453|NCT01143051|19234944|P4|STARTED|Visit 2||4
7813454|NCT01143051|19234945|P3|STARTED|Visit 2||3
7813455|NCT01143051|19234946|P2|STARTED|Visit 2||4
7813456|NCT01143051|19234947|P1|STARTED|Visit 2||4
7813457|NCT01143051|19234942|P6|NOT COMPLETED|3-14 Day Washout||0
7813458|NCT01143051|19234943|P5|NOT COMPLETED|3-14 Day Washout||0
7813459|NCT01143051|19234944|P4|NOT COMPLETED|3-14 Day Washout||0
7813460|NCT01143051|19234945|P3|NOT COMPLETED|3-14 Day Washout||1
7813461|NCT01143051|19234946|P2|NOT COMPLETED|3-14 Day Washout||0
7813462|NCT01143051|19234947|P1|NOT COMPLETED|3-14 Day Washout||0
7813463|NCT01143051|19234942|P6|COMPLETED|3-14 Day Washout||4
7813464|NCT01143051|19234943|P5|COMPLETED|3-14 Day Washout||4
7813465|NCT01143051|19234944|P4|COMPLETED|3-14 Day Washout||4
7813466|NCT01143051|19234945|P3|COMPLETED|3-14 Day Washout||3
7813467|NCT01143051|19234946|P2|COMPLETED|3-14 Day Washout||4
7813468|NCT01143051|19234947|P1|COMPLETED|3-14 Day Washout||4
7813469|NCT01143051|19234942|P6|STARTED|3-14 Day Washout||4
7813470|NCT01143051|19234943|P5|STARTED|3-14 Day Washout||4
7813471|NCT01143051|19234944|P4|STARTED|3-14 Day Washout||4
7813472|NCT01143051|19234945|P3|STARTED|3-14 Day Washout||4
7813473|NCT01143051|19234946|P2|STARTED|3-14 Day Washout||4
7813474|NCT01143051|19234947|P1|STARTED|3-14 Day Washout||4
7813475|NCT01143051|19234942|P6|NOT COMPLETED|Visit 1||0
7813476|NCT01143051|19234943|P5|NOT COMPLETED|Visit 1||0
7813477|NCT01143051|19234944|P4|NOT COMPLETED|Visit 1||0
7813478|NCT01143051|19234945|P3|NOT COMPLETED|Visit 1||0
7813479|NCT01143051|19234946|P2|NOT COMPLETED|Visit 1||0
7813480|NCT01143051|19234947|P1|NOT COMPLETED|Visit 1||0
7813481|NCT01143051|19234942|P6|COMPLETED|Visit 1||4
7813482|NCT01143051|19234943|P5|COMPLETED|Visit 1||4
7813483|NCT01143051|19234944|P4|COMPLETED|Visit 1||4
7813484|NCT01143051|19234945|P3|COMPLETED|Visit 1||4
7813485|NCT01143051|19234946|P2|COMPLETED|Visit 1||4
7813486|NCT01143051|19234947|P1|COMPLETED|Visit 1||4
7813487|NCT01143051|19234942|P6|STARTED|Visit 1||4
7813488|NCT01143051|19234943|P5|STARTED|Visit 1||4
7813489|NCT01143051|19234944|P4|STARTED|Visit 1||4
7813490|NCT01143051|19234945|P3|STARTED|Visit 1||4
7813491|NCT01143051|19234946|P2|STARTED|Visit 1||4
7813492|NCT01143051|19234947|P1|STARTED|Visit 1||4
7813493|NCT01143038|19234996|P1|NOT COMPLETED|Overall Study||16
7813494|NCT01143038|19234996|P1|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59
7813495|NCT01143038|19234996|P1|STARTED|Overall Study||75
7813496|NCT01142947|19235004|P1|NOT COMPLETED|Overall Study||118
7813497|NCT01142947|19235004|P1|COMPLETED|Overall Study||244
7813498|NCT01142947|19235004|P1|STARTED|Overall Study||362
7813499|NCT01142908|19235010|P2|NOT COMPLETED|Overall Study||22
7813500|NCT01142908|19235011|P1|NOT COMPLETED|Overall Study||32
7813501|NCT01142908|19235010|P2|COMPLETED|Overall Study||191
7813502|NCT01142908|19235011|P1|COMPLETED|Overall Study||183
7813503|NCT01142908|19235010|P2|6 Month f/u|Overall Study||196
7813504|NCT01142908|19235011|P1|6 Month f/u|Overall Study||188
7813505|NCT01142908|19235010|P2|STARTED|Overall Study||213
7813506|NCT01142908|19235011|P1|STARTED|Overall Study||215
7813507|NCT01142791|19235057|P2|NOT COMPLETED|Overall Study||6
7813508|NCT01142791|19235058|P1|NOT COMPLETED|Overall Study||7
7813509|NCT01142791|19235057|P2|COMPLETED|Overall Study||0
7813510|NCT01142791|19235058|P1|COMPLETED|Overall Study||108
7813511|NCT01142791|19235057|P2|Safety|Overall Study|Safety data only was reported for 6 participants receiving only 1 sonication.|6
7813512|NCT01142791|19235058|P1|Safety|Overall Study||115
7813513|NCT01142791|19235057|P2|STARTED|Overall Study|6 participants receiving only 1 sonication were included only in adverse events reporting.|6
7813514|NCT01142791|19235058|P1|STARTED|Overall Study||115
7813515|NCT01142726|19235065|P3|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3
7813516|NCT01142726|19235066|P2|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2
7813517|NCT01142726|19235067|P1|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1
7813518|NCT01142726|19235065|P3|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40
7813519|NCT01142726|19235066|P2|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46
7813520|NCT01142726|19235067|P1|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54
7813521|NCT01142726|19235065|P3|STARTED|Re-Exposure Phase: Months 24 up to 30||43
7813522|NCT01142726|19235066|P2|STARTED|Re-Exposure Phase: Months 24 up to 30||48
7813523|NCT01142726|19235067|P1|STARTED|Re-Exposure Phase: Months 24 up to 30||55
7813524|NCT01142726|19235065|P3|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58
7813525|NCT01142726|19235066|P2|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56
7813526|NCT01142726|19235067|P1|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70
7813527|NCT01142726|19235065|P3|COMPLETED|Withdrawal Phase: Months 12 up to 24||17
7813528|NCT01142726|19235066|P2|COMPLETED|Withdrawal Phase: Months 12 up to 24||10
7813529|NCT01142726|19235067|P1|COMPLETED|Withdrawal Phase: Months 12 up to 24||14
7813530|NCT01142726|19235065|P3|STARTED|Withdrawal Phase: Months 12 up to 24||75
7813531|NCT01142726|19235066|P2|STARTED|Withdrawal Phase: Months 12 up to 24||66
7813532|NCT01142726|19235067|P1|STARTED|Withdrawal Phase: Months 12 up to 24||84
7813533|NCT01142726|19235065|P3|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20
7813534|NCT01142726|19235066|P2|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25
7813535|NCT01142726|19235067|P1|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16
7813536|NCT01142726|19235065|P3|COMPLETED|Treatment Phase: Day 1 Through Month 12||96
7813537|NCT01142726|19235066|P2|COMPLETED|Treatment Phase: Day 1 Through Month 12||91
7813538|NCT01142726|19235067|P1|COMPLETED|Treatment Phase: Day 1 Through Month 12||103
7813539|NCT01142726|19235065|P3|STARTED|Treatment Phase: Day 1 Through Month 12||116
7813540|NCT01142726|19235066|P2|STARTED|Treatment Phase: Day 1 Through Month 12||116
7813541|NCT01142726|19235067|P1|STARTED|Treatment Phase: Day 1 Through Month 12||119
7813542|NCT01142661|19235130|P1|NOT COMPLETED|Overall Study||4
7813543|NCT01142661|19235130|P1|COMPLETED|Overall Study||5
7813544|NCT01142661|19235130|P1|STARTED|Overall Study||9
7813545|NCT01142596|19235137|P2|NOT COMPLETED|Overall Study||86
7813546|NCT01142596|19235138|P1|NOT COMPLETED|Overall Study||29
7813547|NCT01142596|19235137|P2|COMPLETED|Overall Study||71
7813548|NCT01142596|19235138|P1|COMPLETED|Overall Study||15
7813549|NCT01142596|19235137|P2|STARTED|Overall Study||157
7813550|NCT01142596|19235138|P1|STARTED|Overall Study||44
7813551|NCT01142466|19235190|P2|NOT COMPLETED|Overall Study||2
7813552|NCT01142466|19235191|P1|NOT COMPLETED|Overall Study||3
7813553|NCT01142466|19235190|P2|COMPLETED|Overall Study||13
7813554|NCT01142466|19235191|P1|COMPLETED|Overall Study||12
7813555|NCT01142466|19235190|P2|STARTED|Overall Study||15
7813556|NCT01142466|19235191|P1|STARTED|Overall Study||15
7813557|NCT01142388|19235211|P2|NOT COMPLETED|Overall Study||47
7813558|NCT01142388|19235212|P1|NOT COMPLETED|Overall Study||47
7813559|NCT01142388|19235211|P2|COMPLETED|Overall Study||0
7813560|NCT01142388|19235212|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0
7813561|NCT01142388|19235211|P2|Treated|Overall Study||44
7813562|NCT01142388|19235212|P1|Treated|Overall Study||40
7813563|NCT01142388|19235211|P2|Eligible|Overall Study||44
7813564|NCT01142388|19235212|P1|Eligible|Overall Study||43
7813565|NCT01142388|19235211|P2|STARTED|Overall Study||47
7813566|NCT01142388|19235212|P1|STARTED|Overall Study||47
7813567|NCT01142336|19235224|P2|NOT COMPLETED|Overall Study||2
7813568|NCT01142336|19235225|P1|NOT COMPLETED|Overall Study||1
7813569|NCT01142336|19235224|P2|COMPLETED|Overall Study||21
7813570|NCT01142336|19235225|P1|COMPLETED|Overall Study||25
7813571|NCT01142336|19235224|P2|STARTED|Overall Study||23
7813572|NCT01142336|19235225|P1|STARTED|Overall Study||26
7813573|NCT01142323|19235235|P1|NOT COMPLETED|Overall Study||0
7813574|NCT01142323|19235235|P1|COMPLETED|Overall Study||8
7813575|NCT01142323|19235235|P1|STARTED|Overall Study||8
7813576|NCT01142310|19235243|P2|NOT COMPLETED|Overall Study||12
7813577|NCT01142310|19235244|P1|NOT COMPLETED|Overall Study||9
7813578|NCT01142310|19235243|P2|COMPLETED|Overall Study||16
7813579|NCT01142310|19235244|P1|COMPLETED|Overall Study||17
7813580|NCT01142310|19235243|P2|STARTED|Overall Study||28
7813581|NCT01142310|19235244|P1|STARTED|Overall Study||26
7813582|NCT01142297|19235250|P1|NOT COMPLETED|Overall Study||6
7813583|NCT01142297|19235250|P1|COMPLETED|Overall Study||18
7813584|NCT01142297|19235250|P1|STARTED|Overall Study||24
7813585|NCT01142232|19235262|P5|NOT COMPLETED|Overall Study||34
7813586|NCT01142232|19235263|P4|NOT COMPLETED|Overall Study||5
7813587|NCT01142232|19235264|P3|NOT COMPLETED|Overall Study||3
7813588|NCT01142232|19235265|P2|NOT COMPLETED|Overall Study||4
7813589|NCT01142232|19235266|P1|NOT COMPLETED|Overall Study||3
7813590|NCT01142232|19235262|P5|COMPLETED|Overall Study||10
7813591|NCT01142232|19235263|P4|COMPLETED|Overall Study||1
7813592|NCT01142232|19235264|P3|COMPLETED|Overall Study||0
7813593|NCT01142232|19235265|P2|COMPLETED|Overall Study||0
7813594|NCT01142232|19235266|P1|COMPLETED|Overall Study||0
7813595|NCT01142232|19235262|P5|STARTED|Overall Study||44
7813596|NCT01142232|19235263|P4|STARTED|Overall Study||6
7813597|NCT01142232|19235264|P3|STARTED|Overall Study||3
7813598|NCT01142232|19235265|P2|STARTED|Overall Study||4
7813599|NCT01142232|19235266|P1|STARTED|Overall Study||3
7813600|NCT01142193|19235281|P2|NOT COMPLETED|Overall Study||11
7813601|NCT01142193|19235282|P1|NOT COMPLETED|Overall Study||21
7813602|NCT01142193|19235281|P2|COMPLETED|Overall Study||114
7813603|NCT01142193|19235282|P1|COMPLETED|Overall Study||103
7813604|NCT01142193|19235281|P2|STARTED|Overall Study||125
7813605|NCT01142193|19235282|P1|STARTED|Overall Study||124
7813606|NCT01142128|19235310|P1|NOT COMPLETED|Overall Study||4
7813607|NCT01142128|19235310|P1|COMPLETED|Overall Study||4
7813608|NCT01142128|19235310|P1|Viokase 16 Plus Placebo to Nexium|Overall Study||0
7813609|NCT01142128|19235310|P1|Viokase 16 Plus Nexium|Overall Study||2
7813610|NCT01142128|19235310|P1|Placebo to Nexium, Alone|Overall Study||3
7813611|NCT01142128|19235310|P1|Nexium Alone|Overall Study||3
7813612|NCT01142128|19235310|P1|STARTED|Overall Study||8
7813613|NCT01142115|19235320|P2|NOT COMPLETED|Second Intervention||0
7813614|NCT01142115|19235321|P1|NOT COMPLETED|Second Intervention||0
7813615|NCT01142115|19235320|P2|COMPLETED|Second Intervention||19
7813616|NCT01142115|19235321|P1|COMPLETED|Second Intervention||19
7813617|NCT01142115|19235320|P2|STARTED|Second Intervention||19
7813618|NCT01142115|19235321|P1|STARTED|Second Intervention||19
7813619|NCT01142115|19235320|P2|NOT COMPLETED|First Intervention||1
7813620|NCT01142115|19235321|P1|NOT COMPLETED|First Intervention||2
7813621|NCT01142115|19235320|P2|COMPLETED|First Intervention||19
7813622|NCT01142115|19235321|P1|COMPLETED|First Intervention||19
7813623|NCT01142115|19235320|P2|STARTED|First Intervention||20
7813624|NCT01142115|19235321|P1|STARTED|First Intervention||21
7813625|NCT01142089|19235338|P2|NOT COMPLETED|Overall Study||21
7813626|NCT01142089|19235339|P1|NOT COMPLETED|Overall Study||12
7813627|NCT01142089|19235338|P2|COMPLETED|Overall Study||178
7813628|NCT01142089|19235339|P1|COMPLETED|Overall Study||53
7813629|NCT01142089|19235338|P2|STARTED|Overall Study||199
7813630|NCT01142089|19235339|P1|STARTED|Overall Study||65
7813631|NCT01141907|19235349|P2|NOT COMPLETED|Overall Study||0
7813632|NCT01141907|19235350|P1|NOT COMPLETED|Overall Study||0
7813633|NCT01141907|19235349|P2|COMPLETED|Overall Study||5
7813634|NCT01141907|19235350|P1|COMPLETED|Overall Study||6
7813635|NCT01141907|19235349|P2|STARTED|Overall Study||5
7813636|NCT01141907|19235350|P1|STARTED|Overall Study||6
7813637|NCT01141725|19235356|P3|NOT COMPLETED|Overall Study||0
7813638|NCT01141725|19235357|P2|NOT COMPLETED|Overall Study||0
7813639|NCT01141725|19235358|P1|NOT COMPLETED|Overall Study||0
7813640|NCT01141725|19235356|P3|COMPLETED|Overall Study||3
7813641|NCT01141725|19235357|P2|COMPLETED|Overall Study||33
7813642|NCT01141725|19235358|P1|COMPLETED|Overall Study||3
7813643|NCT01141725|19235356|P3|STARTED|Overall Study||3
7813644|NCT01141725|19235357|P2|STARTED|Overall Study||33
7813645|NCT01141725|19235358|P1|STARTED|Overall Study||3
7813646|NCT01141712|19235370|P1|NOT COMPLETED|Overall Study||3
7813647|NCT01141712|19235370|P1|COMPLETED|Overall Study||40
7813648|NCT01141712|19235370|P1|STARTED|Overall Study||43
7813649|NCT01141660|19235391|P2|NOT COMPLETED|Overall Study||12
7813650|NCT01141660|19235392|P1|NOT COMPLETED|Overall Study||0
7813651|NCT01141660|19235391|P2|COMPLETED|Overall Study||48
7813652|NCT01141660|19235392|P1|COMPLETED|Overall Study||71
7813653|NCT01141660|19235391|P2|STARTED|Overall Study||60
7813654|NCT01141660|19235392|P1|STARTED|Overall Study||71
7813655|NCT01141647|19235400|P1|NOT COMPLETED|Overall Study||46
7813656|NCT01141647|19235400|P1|COMPLETED|Overall Study||167
7813657|NCT01141647|19235400|P1|STARTED|Overall Study||213
7813658|NCT01141608|19235415|P2|NOT COMPLETED|Overall Study||0
7813659|NCT01141608|19235416|P1|NOT COMPLETED|Overall Study||0
7813660|NCT01141608|19235415|P2|COMPLETED|Overall Study||150
7813661|NCT01141608|19235416|P1|COMPLETED|Overall Study||152
7813662|NCT01141608|19235415|P2|STARTED|Overall Study||150
7813663|NCT01141608|19235416|P1|STARTED|Overall Study||152
7813664|NCT01141595|19235422|P1|NOT COMPLETED|Overall Study||2
7813665|NCT01141595|19235422|P1|COMPLETED|Overall Study||8
7813666|NCT01141595|19235422|P1|STARTED|Overall Study||10
7813667|NCT01141569|19235426|P1|NOT COMPLETED|Overall Study||0
7813668|NCT01141569|19235426|P1|COMPLETED|Overall Study||12
7813669|NCT01141569|19235426|P1|STARTED|Overall Study||12
7813670|NCT01141491|19235437|P2|NOT COMPLETED|Overall Study||47
7813671|NCT01141491|19235438|P1|NOT COMPLETED|Overall Study||48
7813672|NCT01141491|19235437|P2|COMPLETED|Overall Study||21
7813673|NCT01141491|19235438|P1|COMPLETED|Overall Study||20
7813674|NCT01141491|19235437|P2|STARTED|Overall Study||68
7813675|NCT01141491|19235438|P1|STARTED|Overall Study||68
7813676|NCT01141374|19235447|P3|NOT COMPLETED|Overall Study||0
7813677|NCT01141374|19235448|P2|NOT COMPLETED|Overall Study||0
7813678|NCT01141374|19235449|P1|NOT COMPLETED|Overall Study||0
7813679|NCT01141374|19235447|P3|COMPLETED|Overall Study||22
7813680|NCT01141374|19235448|P2|COMPLETED|Overall Study||27
7813681|NCT01141374|19235449|P1|COMPLETED|Overall Study||26
7813682|NCT01141374|19235447|P3|STARTED|Overall Study||22
7813683|NCT01141374|19235448|P2|STARTED|Overall Study||27
7813684|NCT01141374|19235449|P1|STARTED|Overall Study||26
7813685|NCT01141283|19235460|P1|NOT COMPLETED|Overall Study||88
7813686|NCT01141283|19235460|P1|COMPLETED|Overall Study||202
7813687|NCT01141283|19235460|P1|STARTED|Overall Study||290
7813688|NCT01141205|19235466|P2|NOT COMPLETED|Overall Study||2
7813689|NCT01141205|19235467|P1|NOT COMPLETED|Overall Study||3
7813690|NCT01141205|19235466|P2|COMPLETED|Overall Study||3
7813691|NCT01141205|19235467|P1|COMPLETED|Overall Study||15
7813692|NCT01141205|19235466|P2|STARTED|Overall Study||5
7813693|NCT01141205|19235467|P1|STARTED|Overall Study||18
7813694|NCT01141075|19235479|P1|NOT COMPLETED|Cycle 2||0
7813695|NCT01141075|19235479|P1|COMPLETED|Cycle 2||11
7813696|NCT01141075|19235479|P1|Received at Least 1 Dose of Study Drug|Cycle 2||11
7813697|NCT01141075|19235479|P1|STARTED|Cycle 2||11
7813698|NCT01141075|19235479|P1|NOT COMPLETED|Cycle 1||0
7813699|NCT01141075|19235479|P1|COMPLETED|Cycle 1||11
7813700|NCT01141075|19235479|P1|Received at Least 1 Dose of Study Drug|Cycle 1||11
7813701|NCT01141075|19235479|P1|STARTED|Cycle 1||11
7813702|NCT01141049|19235493|P2|NOT COMPLETED|Overall Study||8
7813703|NCT01141049|19235494|P1|NOT COMPLETED|Overall Study||5
7813704|NCT01141049|19235493|P2|COMPLETED|Overall Study||13
7813705|NCT01141049|19235494|P1|COMPLETED|Overall Study||14
7813706|NCT01141049|19235493|P2|STARTED|Overall Study||21
7813707|NCT01141049|19235494|P1|STARTED|Overall Study||19
7813708|NCT01140906|19235506|P4|NOT COMPLETED|Overall Study||16
7813709|NCT01140906|19235507|P3|NOT COMPLETED|Overall Study||26
7813710|NCT01140906|19235508|P2|NOT COMPLETED|Overall Study||34
7813711|NCT01140906|19235509|P1|NOT COMPLETED|Overall Study||25
7813712|NCT01140906|19235506|P4|COMPLETED|Overall Study||131
7813713|NCT01140906|19235507|P3|COMPLETED|Overall Study||125
7813714|NCT01140906|19235508|P2|COMPLETED|Overall Study||117
7813715|NCT01140906|19235509|P1|COMPLETED|Overall Study||133
7813716|NCT01140906|19235506|P4|STARTED|Overall Study||147
7813717|NCT01140906|19235507|P3|STARTED|Overall Study||151
7813718|NCT01140906|19235508|P2|STARTED|Overall Study||151
7813719|NCT01140906|19235509|P1|STARTED|Overall Study||158
7813720|NCT01140880|19235549|P2|NOT COMPLETED|Overall Study||44
7813721|NCT01140880|19235550|P1|NOT COMPLETED|Overall Study||14
7813722|NCT01140880|19235549|P2|COMPLETED|Overall Study||56
7813723|NCT01140880|19235550|P1|COMPLETED|Overall Study||56
7813724|NCT01140880|19235549|P2|STARTED|Overall Study||100
7813725|NCT01140880|19235550|P1|STARTED|Overall Study||70
7813726|NCT01140867|19235562|P1|NOT COMPLETED|Overall Study||33
7813727|NCT01140867|19235562|P1|COMPLETED|Overall Study||88
7813728|NCT01140867|19235562|P1|STARTED|Overall Study||121
7813729|NCT01140815|19235571|P2|NOT COMPLETED|Overall Study||0
7813730|NCT01140815|19235572|P1|NOT COMPLETED|Overall Study||0
7813731|NCT01140815|19235571|P2|COMPLETED|Overall Study||25
7813732|NCT01140815|19235572|P1|COMPLETED|Overall Study||25
7813733|NCT01140815|19235571|P2|STARTED|Overall Study||25
7813734|NCT01140815|19235572|P1|STARTED|Overall Study||25
7813735|NCT01140646|19235602|P1|NOT COMPLETED|Overall Study||9
7813736|NCT01140646|19235602|P1|COMPLETED|Overall Study||34
7813737|NCT01140646|19235602|P1|STARTED|Overall Study||43
7813738|NCT01140568|19235610|P1|NOT COMPLETED|Overall Study||36
7813739|NCT01140568|19235610|P1|COMPLETED|Overall Study||2
7813740|NCT01140568|19235610|P1|Treated With Study Drug|Overall Study||34
7813741|NCT01140568|19235610|P1|Screen Fail|Overall Study||4
7813742|NCT01140568|19235610|P1|STARTED|Overall Study||38
7813743|NCT01140503|19235615|P1|NOT COMPLETED|Overall Study||1
7813744|NCT01140503|19235615|P1|COMPLETED|Overall Study||4
7813745|NCT01140503|19235615|P1|STARTED|Overall Study||5
7813746|NCT01140477|19235623|P2|NOT COMPLETED|Overall Study||6
7813747|NCT01140477|19235624|P1|NOT COMPLETED|Overall Study||8
7813748|NCT01140477|19235623|P2|COMPLETED|Overall Study||70
7813749|NCT01140477|19235624|P1|COMPLETED|Overall Study||145
7813750|NCT01140477|19235623|P2|STARTED|Overall Study||76
7813751|NCT01140477|19235624|P1|STARTED|Overall Study||153
7813752|NCT01140451|19235635|P2|NOT COMPLETED|Overall Study||42
7813753|NCT01140451|19235636|P1|NOT COMPLETED|Overall Study||38
7813754|NCT01140451|19235635|P2|COMPLETED|Overall Study||54
7813755|NCT01140451|19235636|P1|COMPLETED|Overall Study||57
7813756|NCT01140451|19235635|P2|144-Week Completer Population|Overall Study||54
7813757|NCT01140451|19235636|P1|144-Week Completer Population|Overall Study||57
7813758|NCT01140451|19235635|P2|96-Week Completer Population|Overall Study||70
7813759|NCT01140451|19235636|P1|96-Week Completer Population|Overall Study||78
7813760|NCT01140451|19235635|P2|As-Treated Population|Overall Study||96
7813761|NCT01140451|19235636|P1|As-Treated Population|Overall Study||95
7813762|NCT01140451|19235635|P2|Completed 96 Weeks|Overall Study||54
7813763|NCT01140451|19235636|P1|Completed 96 Weeks|Overall Study||57
7813764|NCT01140451|19235635|P2|Completed 72 Weeks|Overall Study||62
7813765|NCT01140451|19235636|P1|Completed 72 Weeks|Overall Study||63
7813766|NCT01140451|19235635|P2|Completed 48 Weeks|Overall Study||70
7813767|NCT01140451|19235636|P1|Completed 48 Weeks|Overall Study||78
7813768|NCT01140451|19235635|P2|Completed 24 Weeks|Overall Study||86
7813769|NCT01140451|19235636|P1|Completed 24 Weeks|Overall Study||89
7813770|NCT01140451|19235635|P2|STARTED|Overall Study||96
7813771|NCT01140451|19235636|P1|STARTED|Overall Study||95
7813772|NCT01140360|19235695|P1|NOT COMPLETED|Overall Study||6
7813773|NCT01140360|19235695|P1|COMPLETED|Overall Study||15
7813774|NCT01140360|19235695|P1|STARTED|Overall Study||21
7813775|NCT01140347|19235701|P2|NOT COMPLETED|Overall Study||14
7813776|NCT01140347|19235702|P1|NOT COMPLETED|Overall Study||18
7813777|NCT01140347|19235701|P2|COMPLETED|Overall Study||268
7813778|NCT01140347|19235702|P1|COMPLETED|Overall Study||265
7813779|NCT01140347|19235701|P2|Received at Least 1 Dose of Study Drug|Overall Study||276
7813780|NCT01140347|19235702|P1|Received at Least 1 Dose of Study Drug|Overall Study||277
7813781|NCT01140347|19235701|P2|STARTED|Overall Study||282
7813782|NCT01140347|19235702|P1|STARTED|Overall Study||283
7813783|NCT01140295|19235727|P2|NOT COMPLETED|Overall Study||2
7813784|NCT01140295|19235728|P1|NOT COMPLETED|Overall Study||1
7813785|NCT01140295|19235727|P2|COMPLETED|Overall Study||14
7813786|NCT01140295|19235728|P1|COMPLETED|Overall Study||16
7813787|NCT01140295|19235727|P2|STARTED|Overall Study||16
7813788|NCT01140295|19235728|P1|STARTED|Overall Study||17
7813789|NCT01140191|19235736|P1|NOT COMPLETED|Overall Study||0
7813790|NCT01140191|19235736|P1|COMPLETED|Overall Study||1
7813791|NCT01140191|19235736|P1|STARTED|Overall Study||1
7813792|NCT01140061|19235755|P10|NOT COMPLETED|Extension||1
7813793|NCT01140061|19235756|P9|NOT COMPLETED|Extension||0
7813794|NCT01140061|19235757|P8|NOT COMPLETED|Extension||0
7813795|NCT01140061|19235758|P7|NOT COMPLETED|Extension||0
7813796|NCT01140061|19235759|P6|NOT COMPLETED|Extension||0
7813797|NCT01140061|19235760|P5|NOT COMPLETED|Extension||0
7813798|NCT01140061|19235761|P4|NOT COMPLETED|Extension||0
7813799|NCT01140061|19235762|P3|NOT COMPLETED|Extension||0
7813800|NCT01140061|19235763|P2|NOT COMPLETED|Extension||0
7813801|NCT01140061|19235764|P1|NOT COMPLETED|Extension||0
7813802|NCT01140061|19235755|P10|COMPLETED|Extension||1
7813803|NCT01140061|19235756|P9|COMPLETED|Extension||7
7813804|NCT01140061|19235757|P8|COMPLETED|Extension||0
7813805|NCT01140061|19235758|P7|COMPLETED|Extension||0
7813806|NCT01140061|19235759|P6|COMPLETED|Extension||0
7813807|NCT01140061|19235760|P5|COMPLETED|Extension||0
7813808|NCT01140061|19235761|P4|COMPLETED|Extension||0
7813809|NCT01140061|19235762|P3|COMPLETED|Extension||0
7813810|NCT01140061|19235763|P2|COMPLETED|Extension||0
7813811|NCT01140061|19235764|P1|COMPLETED|Extension||0
7813812|NCT01140061|19235755|P10|STARTED|Extension||2
7813813|NCT01140061|19235756|P9|STARTED|Extension||7
7813814|NCT01140061|19235757|P8|STARTED|Extension||0
7813815|NCT01140061|19235758|P7|STARTED|Extension||0
7813816|NCT01140061|19235759|P6|STARTED|Extension||0
7813817|NCT01140061|19235760|P5|STARTED|Extension||0
7813818|NCT01140061|19235761|P4|STARTED|Extension||0
7813819|NCT01140061|19235762|P3|STARTED|Extension||0
7813820|NCT01140061|19235763|P2|STARTED|Extension||0
7813821|NCT01140061|19235764|P1|STARTED|Extension||0
7813822|NCT01140061|19235755|P10|NOT COMPLETED|Part III||0
7813823|NCT01140061|19235756|P9|NOT COMPLETED|Part III||0
7813824|NCT01140061|19235757|P8|NOT COMPLETED|Part III||0
7813825|NCT01140061|19235758|P7|NOT COMPLETED|Part III||0
7813826|NCT01140061|19235759|P6|NOT COMPLETED|Part III||0
7813827|NCT01140061|19235760|P5|NOT COMPLETED|Part III||0
7813828|NCT01140061|19235761|P4|NOT COMPLETED|Part III||0
7813829|NCT01140061|19235762|P3|NOT COMPLETED|Part III||0
7813830|NCT01140061|19235763|P2|NOT COMPLETED|Part III||0
7813831|NCT01140061|19235764|P1|NOT COMPLETED|Part III||0
7813832|NCT01140061|19235755|P10|COMPLETED|Part III||2
7813833|NCT01140061|19235756|P9|COMPLETED|Part III||7
7813834|NCT01140061|19235757|P8|COMPLETED|Part III||0
7813835|NCT01140061|19235758|P7|COMPLETED|Part III||0
7813836|NCT01140061|19235759|P6|COMPLETED|Part III||0
7813837|NCT01140061|19235760|P5|COMPLETED|Part III||0
7813838|NCT01140061|19235761|P4|COMPLETED|Part III||0
7813839|NCT01140061|19235762|P3|COMPLETED|Part III||0
7813840|NCT01140061|19235763|P2|COMPLETED|Part III||0
7813841|NCT01140061|19235764|P1|COMPLETED|Part III||0
7813842|NCT01140061|19235755|P10|STARTED|Part III|Includes 1 replacement participant|2
7813843|NCT01140061|19235756|P9|STARTED|Part III||7
7813844|NCT01140061|19235757|P8|STARTED|Part III||0
7813845|NCT01140061|19235758|P7|STARTED|Part III||0
7813846|NCT01140061|19235759|P6|STARTED|Part III||0
7813847|NCT01140061|19235760|P5|STARTED|Part III||0
7813848|NCT01140061|19235761|P4|STARTED|Part III||0
7813849|NCT01140061|19235762|P3|STARTED|Part III||0
7813850|NCT01140061|19235763|P2|STARTED|Part III||0
7813851|NCT01140061|19235764|P1|STARTED|Part III||0
7813852|NCT01140061|19235755|P10|NOT COMPLETED|Part II||0
7813853|NCT01140061|19235756|P9|NOT COMPLETED|Part II||0
7813854|NCT01140061|19235757|P8|NOT COMPLETED|Part II||0
7813855|NCT01140061|19235758|P7|NOT COMPLETED|Part II||0
7813856|NCT01140061|19235759|P6|NOT COMPLETED|Part II||0
7813857|NCT01140061|19235760|P5|NOT COMPLETED|Part II||0
7813858|NCT01140061|19235761|P4|NOT COMPLETED|Part II||0
7813859|NCT01140061|19235762|P3|NOT COMPLETED|Part II||0
7813860|NCT01140061|19235763|P2|NOT COMPLETED|Part II||0
7813861|NCT01140061|19235764|P1|NOT COMPLETED|Part II||0
7813862|NCT01140061|19235755|P10|COMPLETED|Part II||0
7813863|NCT01140061|19235756|P9|COMPLETED|Part II||0
7813864|NCT01140061|19235757|P8|COMPLETED|Part II||2
7813865|NCT01140061|19235758|P7|COMPLETED|Part II||6
7813866|NCT01140061|19235759|P6|COMPLETED|Part II||2
7813867|NCT01140061|19235760|P5|COMPLETED|Part II||6
7813868|NCT01140061|19235761|P4|COMPLETED|Part II||2
7813869|NCT01140061|19235762|P3|COMPLETED|Part II||6
7813870|NCT01140061|19235763|P2|COMPLETED|Part II||0
7813871|NCT01140061|19235764|P1|COMPLETED|Part II||0
7813872|NCT01140061|19235755|P10|STARTED|Part II||0
7813873|NCT01140061|19235756|P9|STARTED|Part II||0
7813874|NCT01140061|19235757|P8|STARTED|Part II||2
7813875|NCT01140061|19235758|P7|STARTED|Part II||6
7813876|NCT01140061|19235759|P6|STARTED|Part II||2
7813877|NCT01140061|19235760|P5|STARTED|Part II||6
7813878|NCT01140061|19235761|P4|STARTED|Part II||2
7813879|NCT01140061|19235762|P3|STARTED|Part II||6
7813880|NCT01140061|19235763|P2|STARTED|Part II||0
7813881|NCT01140061|19235764|P1|STARTED|Part II||0
7813882|NCT01140061|19235755|P10|NOT COMPLETED|Part I||0
7813883|NCT01140061|19235756|P9|NOT COMPLETED|Part I||0
7813884|NCT01140061|19235757|P8|NOT COMPLETED|Part I||0
7813885|NCT01140061|19235758|P7|NOT COMPLETED|Part I||0
7813886|NCT01140061|19235759|P6|NOT COMPLETED|Part I||0
7813887|NCT01140061|19235760|P5|NOT COMPLETED|Part I||0
7813888|NCT01140061|19235761|P4|NOT COMPLETED|Part I||0
7813889|NCT01140061|19235762|P3|NOT COMPLETED|Part I||0
7813890|NCT01140061|19235763|P2|NOT COMPLETED|Part I||0
7813891|NCT01140061|19235764|P1|NOT COMPLETED|Part I||1
7813892|NCT01140061|19235755|P10|COMPLETED|Part I||0
7813893|NCT01140061|19235756|P9|COMPLETED|Part I||0
7813894|NCT01140061|19235757|P8|COMPLETED|Part I||0
7813895|NCT01140061|19235758|P7|COMPLETED|Part I||0
7813896|NCT01140061|19235759|P6|COMPLETED|Part I||0
7813897|NCT01140061|19235760|P5|COMPLETED|Part I||0
7813898|NCT01140061|19235761|P4|COMPLETED|Part I||0
7813899|NCT01140061|19235762|P3|COMPLETED|Part I||0
7813900|NCT01140061|19235763|P2|COMPLETED|Part I||2
7813901|NCT01140061|19235764|P1|COMPLETED|Part I||6
7813902|NCT01140061|19235755|P10|STARTED|Part I||0
7813903|NCT01140061|19235756|P9|STARTED|Part I||0
7813904|NCT01140061|19235757|P8|STARTED|Part I||0
7813905|NCT01140061|19235758|P7|STARTED|Part I||0
7813906|NCT01140061|19235759|P6|STARTED|Part I||0
7813907|NCT01140061|19235760|P5|STARTED|Part I||0
7813908|NCT01140061|19235761|P4|STARTED|Part I||0
7813909|NCT01140061|19235762|P3|STARTED|Part I||0
7813910|NCT01140061|19235763|P2|STARTED|Part I||2
7813911|NCT01140061|19235764|P1|STARTED|Part I|Includes 1 replacement participant|7
7813912|NCT01140048|19235791|P1|NOT COMPLETED|Overall Study||45
7813913|NCT01140048|19235791|P1|COMPLETED|Overall Study||298
7813914|NCT01140048|19235791|P1|STARTED|Overall Study||343
7813915|NCT01139996|19235799|P2|NOT COMPLETED|Overall Study||0
7813916|NCT01139996|19235800|P1|NOT COMPLETED|Overall Study||0
7813917|NCT01139996|19235799|P2|COMPLETED|Overall Study||11
7813918|NCT01139996|19235800|P1|COMPLETED|Overall Study||11
7813919|NCT01139996|19235799|P2|STARTED|Overall Study||11
7813920|NCT01139996|19235800|P1|STARTED|Overall Study||11
7813921|NCT01139879|19235806|P1|NOT COMPLETED|Overall Study||0
7813922|NCT01139879|19235806|P1|COMPLETED|Overall Study||10
7813923|NCT01139879|19235806|P1|STARTED|Overall Study||10
7813924|NCT01139814|19235812|P1|NOT COMPLETED|Overall Study||0
7813925|NCT01139814|19235812|P1|COMPLETED|Overall Study||181
7813926|NCT01139814|19235812|P1|STARTED|Overall Study||181
7813927|NCT01139801|19235819|P2|NOT COMPLETED|Overall Study||0
7813928|NCT01139801|19235820|P1|NOT COMPLETED|Overall Study||0
7813929|NCT01139801|19235819|P2|COMPLETED|Overall Study||25
7813930|NCT01139801|19235820|P1|COMPLETED|Overall Study||25
7813931|NCT01139801|19235819|P2|STARTED|Overall Study||25
7813932|NCT01139801|19235820|P1|STARTED|Overall Study||25
7813933|NCT01139775|19235831|P3|NOT COMPLETED|Overall Study||6
7813934|NCT01139775|19235832|P2|NOT COMPLETED|Overall Study||13
7813935|NCT01139775|19235833|P1|NOT COMPLETED|Overall Study||1
7813936|NCT01139775|19235831|P3|COMPLETED|Overall Study||17
7813937|NCT01139775|19235832|P2|COMPLETED|Overall Study||26
7813938|NCT01139775|19235833|P1|COMPLETED|Overall Study||13
7813939|NCT01139775|19235831|P3|Received at Least 1 Dose of Study Drug|Overall Study||22
7813940|NCT01139775|19235832|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
7813941|NCT01139775|19235833|P1|Received at Least 1 Dose of Study Drug|Overall Study||14
7813942|NCT01139775|19235831|P3|STARTED|Overall Study||23
7813943|NCT01139775|19235832|P2|STARTED|Overall Study||39
7813944|NCT01139775|19235833|P1|STARTED|Overall Study||14
7813945|NCT01139762|19235865|P3|NOT COMPLETED|Double-Blind Randomized Active Treatment||64
7813946|NCT01139762|19235866|P2|NOT COMPLETED|Double-Blind Randomized Active Treatment||40
7813947|NCT01139762|19235867|P1|NOT COMPLETED|Double-Blind Randomized Active Treatment||0
7813948|NCT01139762|19235865|P3|COMPLETED|Double-Blind Randomized Active Treatment||286
7813949|NCT01139762|19235866|P2|COMPLETED|Double-Blind Randomized Active Treatment||306
7813950|NCT01139762|19235867|P1|COMPLETED|Double-Blind Randomized Active Treatment||0
7813951|NCT01139762|19235865|P3|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350
7813952|NCT01139762|19235866|P2|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345
7813953|NCT01139762|19235867|P1|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0
7813954|NCT01139762|19235865|P3|STARTED|Double-Blind Randomized Active Treatment||350
7813955|NCT01139762|19235866|P2|STARTED|Double-Blind Randomized Active Treatment||346
7813956|NCT01139762|19235867|P1|STARTED|Double-Blind Randomized Active Treatment||0
7813957|NCT01139762|19235865|P3|NOT COMPLETED|Washout and Placebo Lead-In Period||0
7813958|NCT01139762|19235866|P2|NOT COMPLETED|Washout and Placebo Lead-In Period||0
7813959|NCT01139762|19235867|P1|NOT COMPLETED|Washout and Placebo Lead-In Period||374
7813960|NCT01139762|19235865|P3|COMPLETED|Washout and Placebo Lead-In Period||0
7813961|NCT01139762|19235866|P2|COMPLETED|Washout and Placebo Lead-In Period||0
7813962|NCT01139762|19235867|P1|COMPLETED|Washout and Placebo Lead-In Period||696
7813963|NCT01139762|19235865|P3|STARTED|Washout and Placebo Lead-In Period||0
7813964|NCT01139762|19235866|P2|STARTED|Washout and Placebo Lead-In Period||0
7813965|NCT01139762|19235867|P1|STARTED|Washout and Placebo Lead-In Period||1070
7813966|NCT01139658|19235902|P2|NOT COMPLETED|Overall Study||113
7813967|NCT01139658|19235903|P1|NOT COMPLETED|Overall Study||56
7813968|NCT01139658|19235902|P2|COMPLETED|Overall Study||816
7813969|NCT01139658|19235903|P1|COMPLETED|Overall Study||691
7813970|NCT01139658|19235902|P2|STARTED|Overall Study||929
7813971|NCT01139658|19235903|P1|STARTED|Overall Study||747
7813972|NCT01139580|19235941|P2|NOT COMPLETED|Overall Study||18
7813973|NCT01139580|19235942|P1|NOT COMPLETED|Overall Study||23
7813974|NCT01139580|19235941|P2|COMPLETED|Overall Study||164
7813975|NCT01139580|19235942|P1|COMPLETED|Overall Study||158
7813976|NCT01139580|19235941|P2|STARTED|Overall Study||182
7813977|NCT01139580|19235942|P1|STARTED|Overall Study||181
7813978|NCT01139515|19235958|P4|NOT COMPLETED|Fourth Intervention Period||0
7813979|NCT01139515|19235959|P3|NOT COMPLETED|Fourth Intervention Period||0
7813980|NCT01139515|19235960|P2|NOT COMPLETED|Fourth Intervention Period||0
7813981|NCT01139515|19235961|P1|NOT COMPLETED|Fourth Intervention Period||0
7813982|NCT01139515|19235958|P4|COMPLETED|Fourth Intervention Period||4
7813983|NCT01139515|19235959|P3|COMPLETED|Fourth Intervention Period||4
7813984|NCT01139515|19235960|P2|COMPLETED|Fourth Intervention Period||4
7813985|NCT01139515|19235961|P1|COMPLETED|Fourth Intervention Period||4
7813986|NCT01139515|19235958|P4|STARTED|Fourth Intervention Period||4
7813987|NCT01139515|19235959|P3|STARTED|Fourth Intervention Period||4
7813988|NCT01139515|19235960|P2|STARTED|Fourth Intervention Period||4
7813989|NCT01139515|19235961|P1|STARTED|Fourth Intervention Period||4
7813990|NCT01139515|19235958|P4|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
7813991|NCT01139515|19235959|P3|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
7813992|NCT01139515|19235960|P2|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
7813993|NCT01139515|19235961|P1|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
7813994|NCT01139515|19235958|P4|COMPLETED|Washout Period 3 (46 Hrs)||4
7813995|NCT01139515|19235959|P3|COMPLETED|Washout Period 3 (46 Hrs)||4
7813996|NCT01139515|19235960|P2|COMPLETED|Washout Period 3 (46 Hrs)||4
7813997|NCT01139515|19235961|P1|COMPLETED|Washout Period 3 (46 Hrs)||4
7813998|NCT01139515|19235958|P4|STARTED|Washout Period 3 (46 Hrs)||4
7813999|NCT01139515|19235959|P3|STARTED|Washout Period 3 (46 Hrs)||4
7814000|NCT01139515|19235960|P2|STARTED|Washout Period 3 (46 Hrs)||4
7814001|NCT01139515|19235961|P1|STARTED|Washout Period 3 (46 Hrs)||4
7814002|NCT01139515|19235958|P4|NOT COMPLETED|Third Intervention Period||0
7814003|NCT01139515|19235959|P3|NOT COMPLETED|Third Intervention Period||0
7814004|NCT01139515|19235960|P2|NOT COMPLETED|Third Intervention Period||0
7814005|NCT01139515|19235961|P1|NOT COMPLETED|Third Intervention Period||0
7814006|NCT01139515|19235958|P4|COMPLETED|Third Intervention Period||4
7814007|NCT01139515|19235959|P3|COMPLETED|Third Intervention Period||4
7814008|NCT01139515|19235960|P2|COMPLETED|Third Intervention Period||4
7814009|NCT01139515|19235961|P1|COMPLETED|Third Intervention Period||4
7814010|NCT01139515|19235958|P4|STARTED|Third Intervention Period||4
7814011|NCT01139515|19235959|P3|STARTED|Third Intervention Period||4
7814012|NCT01139515|19235960|P2|STARTED|Third Intervention Period||4
7814013|NCT01139515|19235961|P1|STARTED|Third Intervention Period||4
7814014|NCT01139515|19235958|P4|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
7814015|NCT01139515|19235959|P3|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
7814016|NCT01139515|19235960|P2|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
7814017|NCT01139515|19235961|P1|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
7814018|NCT01139515|19235958|P4|COMPLETED|Washout Period 2 (46 Hrs)||4
7814019|NCT01139515|19235959|P3|COMPLETED|Washout Period 2 (46 Hrs)||4
7814020|NCT01139515|19235960|P2|COMPLETED|Washout Period 2 (46 Hrs)||4
7814021|NCT01139515|19235961|P1|COMPLETED|Washout Period 2 (46 Hrs)||4
7814022|NCT01139515|19235958|P4|STARTED|Washout Period 2 (46 Hrs)||4
7814023|NCT01139515|19235959|P3|STARTED|Washout Period 2 (46 Hrs)||4
7814024|NCT01139515|19235960|P2|STARTED|Washout Period 2 (46 Hrs)||4
7814025|NCT01139515|19235961|P1|STARTED|Washout Period 2 (46 Hrs)||4
7814026|NCT01139515|19235958|P4|NOT COMPLETED|Second Intervention Period||0
7814027|NCT01139515|19235959|P3|NOT COMPLETED|Second Intervention Period||0
7814028|NCT01139515|19235960|P2|NOT COMPLETED|Second Intervention Period||0
7814029|NCT01139515|19235961|P1|NOT COMPLETED|Second Intervention Period||0
7814030|NCT01139515|19235958|P4|COMPLETED|Second Intervention Period||4
7814031|NCT01139515|19235959|P3|COMPLETED|Second Intervention Period||4
7814032|NCT01139515|19235960|P2|COMPLETED|Second Intervention Period||4
7814033|NCT01139515|19235961|P1|COMPLETED|Second Intervention Period||4
7814034|NCT01139515|19235958|P4|STARTED|Second Intervention Period||4
7814035|NCT01139515|19235959|P3|STARTED|Second Intervention Period||4
7814036|NCT01139515|19235960|P2|STARTED|Second Intervention Period||4
7814037|NCT01139515|19235961|P1|STARTED|Second Intervention Period||4
7814038|NCT01139515|19235958|P4|NOT COMPLETED|Washout Period I (46hrs)||0
7814039|NCT01139515|19235959|P3|NOT COMPLETED|Washout Period I (46hrs)||0
7814040|NCT01139515|19235960|P2|NOT COMPLETED|Washout Period I (46hrs)||0
7814041|NCT01139515|19235961|P1|NOT COMPLETED|Washout Period I (46hrs)||0
7814042|NCT01139515|19235958|P4|COMPLETED|Washout Period I (46hrs)||4
7814043|NCT01139515|19235959|P3|COMPLETED|Washout Period I (46hrs)||4
7814044|NCT01139515|19235960|P2|COMPLETED|Washout Period I (46hrs)||4
7814045|NCT01139515|19235961|P1|COMPLETED|Washout Period I (46hrs)||4
7814046|NCT01139515|19235958|P4|STARTED|Washout Period I (46hrs)||4
7814047|NCT01139515|19235959|P3|STARTED|Washout Period I (46hrs)||4
7814048|NCT01139515|19235960|P2|STARTED|Washout Period I (46hrs)||4
7814049|NCT01139515|19235961|P1|STARTED|Washout Period I (46hrs)||4
7814050|NCT01139515|19235958|P4|NOT COMPLETED|First Intervention Period||0
7814051|NCT01139515|19235959|P3|NOT COMPLETED|First Intervention Period||0
7814052|NCT01139515|19235960|P2|NOT COMPLETED|First Intervention Period||0
7814053|NCT01139515|19235961|P1|NOT COMPLETED|First Intervention Period||0
7814054|NCT01139515|19235958|P4|COMPLETED|First Intervention Period||4
7814055|NCT01139515|19235959|P3|COMPLETED|First Intervention Period||4
7814056|NCT01139515|19235960|P2|COMPLETED|First Intervention Period||4
7814057|NCT01139515|19235961|P1|COMPLETED|First Intervention Period||4
7814058|NCT01139515|19235958|P4|STARTED|First Intervention Period||4
7814059|NCT01139515|19235959|P3|STARTED|First Intervention Period||4
7814060|NCT01139515|19235960|P2|STARTED|First Intervention Period||4
7814061|NCT01139515|19235961|P1|STARTED|First Intervention Period||4
7814062|NCT01139450|19235990|P3|NOT COMPLETED|Overall Study||38
7814063|NCT01139450|19235991|P2|NOT COMPLETED|Overall Study||25
7814064|NCT01139450|19235992|P1|NOT COMPLETED|Overall Study||27
7814065|NCT01139450|19235990|P3|COMPLETED|Overall Study||262
7814066|NCT01139450|19235991|P2|COMPLETED|Overall Study||272
7814067|NCT01139450|19235992|P1|COMPLETED|Overall Study||275
7814068|NCT01139450|19235990|P3|STARTED|Overall Study||300
7814069|NCT01139450|19235991|P2|STARTED|Overall Study||297
7814070|NCT01139450|19235992|P1|STARTED|Overall Study||302
7814071|NCT01139411|19236002|P2|NOT COMPLETED|Overall Study||4
7814072|NCT01139411|19236003|P1|NOT COMPLETED|Overall Study||2
7814073|NCT01139411|19236002|P2|COMPLETED|Overall Study||19
7814074|NCT01139411|19236003|P1|COMPLETED|Overall Study||24
7814075|NCT01139411|19236002|P2|STARTED|Overall Study||23
7814076|NCT01139411|19236003|P1|STARTED|Overall Study||26
7814077|NCT01139294|19236023|P2|NOT COMPLETED|Overall Study||0
7814078|NCT01139294|19236024|P1|NOT COMPLETED|Overall Study||0
7814079|NCT01139294|19236023|P2|COMPLETED|Overall Study||0
7814080|NCT01139294|19236024|P1|COMPLETED|Overall Study||0
7814081|NCT01139294|19236023|P2|STARTED|Overall Study||0
7814082|NCT01139294|19236024|P1|STARTED|Overall Study||0
7814083|NCT01139190|19236034|P2|NOT COMPLETED|Overall Study||1
7814084|NCT01139190|19236035|P1|NOT COMPLETED|Overall Study||0
7814085|NCT01139190|19236034|P2|COMPLETED|Overall Study||38
7814086|NCT01139190|19236035|P1|COMPLETED|Overall Study||38
7814087|NCT01139190|19236034|P2|STARTED|Overall Study||39
7814088|NCT01139190|19236035|P1|STARTED|Overall Study||38
7814089|NCT01139164|19236044|P3|NOT COMPLETED|Overall Study||0
7814090|NCT01139164|19236045|P2|NOT COMPLETED|Overall Study||2
7814091|NCT01139164|19236046|P1|NOT COMPLETED|Overall Study||0
7814092|NCT01139164|19236044|P3|COMPLETED|Overall Study||7
7814093|NCT01139164|19236045|P2|COMPLETED|Overall Study||65
7814094|NCT01139164|19236046|P1|COMPLETED|Overall Study||4
7814095|NCT01139164|19236044|P3|STARTED|Overall Study||7
7814096|NCT01139164|19236045|P2|STARTED|Overall Study||67
7814097|NCT01139164|19236046|P1|STARTED|Overall Study||4
7814098|NCT01139125|19236060|P1|NOT COMPLETED|Overall Study||1
7814099|NCT01139125|19236060|P1|COMPLETED|Overall Study||2
7814100|NCT01139125|19236060|P1|STARTED|Overall Study||3
7814101|NCT01139047|19236064|P1|NOT COMPLETED|Overall Study||1
7814102|NCT01139047|19236064|P1|COMPLETED|Overall Study||76
7814103|NCT01139047|19236064|P1|STARTED|Overall Study||77
7814104|NCT01139021|19236079|P6|NOT COMPLETED|Overall Study||0
7814105|NCT01139021|19236080|P5|NOT COMPLETED|Overall Study||9
7814106|NCT01139021|19236081|P4|NOT COMPLETED|Overall Study||1
7814107|NCT01139021|19236082|P3|NOT COMPLETED|Overall Study||0
7814108|NCT01139021|19236083|P2|NOT COMPLETED|Overall Study||0
7814109|NCT01139021|19236084|P1|NOT COMPLETED|Overall Study||1
7814110|NCT01139021|19236079|P6|COMPLETED|Overall Study||1
7814111|NCT01139021|19236080|P5|COMPLETED|Overall Study||107
7814112|NCT01139021|19236081|P4|COMPLETED|Overall Study||18
7814113|NCT01139021|19236082|P3|COMPLETED|Overall Study||67
7814114|NCT01139021|19236083|P2|COMPLETED|Overall Study||153
7814115|NCT01139021|19236084|P1|COMPLETED|Overall Study||151
7814116|NCT01139021|19236079|P6|STARTED|Overall Study||1
7814117|NCT01139021|19236080|P5|STARTED|Overall Study||116
7814118|NCT01139021|19236081|P4|STARTED|Overall Study||19
7814119|NCT01139021|19236082|P3|STARTED|Overall Study||67
7814120|NCT01139021|19236083|P2|STARTED|Overall Study||153
7814121|NCT01139021|19236084|P1|STARTED|Overall Study||152
7814122|NCT01139008|19236120|P1|NOT COMPLETED|Overall Study||6
7814123|NCT01139008|19236120|P1|COMPLETED|Overall Study||74
7814124|NCT01139008|19236120|P1|STARTED|Overall Study||80
7814125|NCT01138995|19236131|P2|NOT COMPLETED|Overall Study||25
7814126|NCT01138995|19236132|P1|NOT COMPLETED|Overall Study||10
7814127|NCT01138995|19236131|P2|COMPLETED|Overall Study||74
7814128|NCT01138995|19236132|P1|COMPLETED|Overall Study||88
7814129|NCT01138995|19236131|P2|STARTED|Overall Study||99
7814130|NCT01138995|19236132|P1|STARTED|Overall Study||98
7814131|NCT01138969|19236144|P2|NOT COMPLETED|Overall Study||0
7814132|NCT01138969|19236145|P1|NOT COMPLETED|Overall Study||0
7814133|NCT01138969|19236144|P2|COMPLETED|Overall Study||82
7814134|NCT01138969|19236145|P1|COMPLETED|Overall Study||83
7814135|NCT01138969|19236144|P2|STARTED|Overall Study||82
7814136|NCT01138969|19236145|P1|STARTED|Overall Study||83
7814137|NCT01138917|19236153|P1|NOT COMPLETED|Overall Study||24
7814138|NCT01138917|19236153|P1|COMPLETED|Overall Study||77
7814139|NCT01138917|19236153|P1|STARTED|Overall Study||101
7814140|NCT01138826|19236167|P6|NOT COMPLETED|Third Intervention Period||0
7814141|NCT01138826|19236168|P5|NOT COMPLETED|Third Intervention Period||0
7814142|NCT01138826|19236169|P4|NOT COMPLETED|Third Intervention Period||0
7814143|NCT01138826|19236170|P3|NOT COMPLETED|Third Intervention Period||0
7814144|NCT01138826|19236171|P2|NOT COMPLETED|Third Intervention Period||0
7814145|NCT01138826|19236172|P1|NOT COMPLETED|Third Intervention Period||0
7814146|NCT01138826|19236167|P6|COMPLETED|Third Intervention Period||3
7814147|NCT01138826|19236168|P5|COMPLETED|Third Intervention Period||2
7814148|NCT01138826|19236169|P4|COMPLETED|Third Intervention Period||3
7814149|NCT01138826|19236170|P3|COMPLETED|Third Intervention Period||3
7814150|NCT01138826|19236171|P2|COMPLETED|Third Intervention Period||2
7814151|NCT01138826|19236172|P1|COMPLETED|Third Intervention Period||2
7814152|NCT01138826|19236167|P6|STARTED|Third Intervention Period||3
7814153|NCT01138826|19236168|P5|STARTED|Third Intervention Period||2
7814154|NCT01138826|19236169|P4|STARTED|Third Intervention Period||3
7814155|NCT01138826|19236170|P3|STARTED|Third Intervention Period||3
7814156|NCT01138826|19236171|P2|STARTED|Third Intervention Period||2
7814157|NCT01138826|19236172|P1|STARTED|Third Intervention Period||2
7814158|NCT01138826|19236167|P6|NOT COMPLETED|Washout Period II (of 16 Days)||0
7814159|NCT01138826|19236168|P5|NOT COMPLETED|Washout Period II (of 16 Days)||0
7814160|NCT01138826|19236169|P4|NOT COMPLETED|Washout Period II (of 16 Days)||0
7814161|NCT01138826|19236170|P3|NOT COMPLETED|Washout Period II (of 16 Days)||0
7814162|NCT01138826|19236171|P2|NOT COMPLETED|Washout Period II (of 16 Days)||0
7814163|NCT01138826|19236172|P1|NOT COMPLETED|Washout Period II (of 16 Days)||0
7814164|NCT01138826|19236167|P6|COMPLETED|Washout Period II (of 16 Days)||3
7814165|NCT01138826|19236168|P5|COMPLETED|Washout Period II (of 16 Days)||2
7814166|NCT01138826|19236169|P4|COMPLETED|Washout Period II (of 16 Days)||3
7814167|NCT01138826|19236170|P3|COMPLETED|Washout Period II (of 16 Days)||3
7814168|NCT01138826|19236171|P2|COMPLETED|Washout Period II (of 16 Days)||2
7814169|NCT01138826|19236172|P1|COMPLETED|Washout Period II (of 16 Days)||2
7814170|NCT01138826|19236167|P6|STARTED|Washout Period II (of 16 Days)||3
7814171|NCT01138826|19236168|P5|STARTED|Washout Period II (of 16 Days)||2
7814172|NCT01138826|19236169|P4|STARTED|Washout Period II (of 16 Days)||3
7814173|NCT01138826|19236170|P3|STARTED|Washout Period II (of 16 Days)||3
7814174|NCT01138826|19236171|P2|STARTED|Washout Period II (of 16 Days)||2
7814175|NCT01138826|19236172|P1|STARTED|Washout Period II (of 16 Days)||2
7814176|NCT01138826|19236167|P6|NOT COMPLETED|Second Intervention Period||0
7814177|NCT01138826|19236168|P5|NOT COMPLETED|Second Intervention Period||0
7814178|NCT01138826|19236169|P4|NOT COMPLETED|Second Intervention Period||0
7814179|NCT01138826|19236170|P3|NOT COMPLETED|Second Intervention Period||0
7814180|NCT01138826|19236171|P2|NOT COMPLETED|Second Intervention Period||0
7814181|NCT01138826|19236172|P1|NOT COMPLETED|Second Intervention Period||0
7814182|NCT01138826|19236167|P6|COMPLETED|Second Intervention Period||3
7814183|NCT01138826|19236168|P5|COMPLETED|Second Intervention Period||2
7814184|NCT01138826|19236169|P4|COMPLETED|Second Intervention Period||3
7814185|NCT01138826|19236170|P3|COMPLETED|Second Intervention Period||3
7814186|NCT01138826|19236171|P2|COMPLETED|Second Intervention Period||2
7814187|NCT01138826|19236172|P1|COMPLETED|Second Intervention Period||2
7814188|NCT01138826|19236167|P6|STARTED|Second Intervention Period||3
7814189|NCT01138826|19236168|P5|STARTED|Second Intervention Period||2
7814190|NCT01138826|19236169|P4|STARTED|Second Intervention Period||3
7814191|NCT01138826|19236170|P3|STARTED|Second Intervention Period||3
7814192|NCT01138826|19236171|P2|STARTED|Second Intervention Period||2
7814193|NCT01138826|19236172|P1|STARTED|Second Intervention Period||2
7814194|NCT01138826|19236167|P6|NOT COMPLETED|Washout Period I (of 16 Days)||0
7814195|NCT01138826|19236168|P5|NOT COMPLETED|Washout Period I (of 16 Days)||1
7814196|NCT01138826|19236169|P4|NOT COMPLETED|Washout Period I (of 16 Days)||0
7814197|NCT01138826|19236170|P3|NOT COMPLETED|Washout Period I (of 16 Days)||0
7814198|NCT01138826|19236171|P2|NOT COMPLETED|Washout Period I (of 16 Days)||1
7814199|NCT01138826|19236172|P1|NOT COMPLETED|Washout Period I (of 16 Days)||1
7814200|NCT01138826|19236167|P6|COMPLETED|Washout Period I (of 16 Days)||3
7814201|NCT01138826|19236168|P5|COMPLETED|Washout Period I (of 16 Days)||2
7814202|NCT01138826|19236169|P4|COMPLETED|Washout Period I (of 16 Days)||3
7814203|NCT01138826|19236170|P3|COMPLETED|Washout Period I (of 16 Days)||3
7814204|NCT01138826|19236171|P2|COMPLETED|Washout Period I (of 16 Days)||2
7814205|NCT01138826|19236172|P1|COMPLETED|Washout Period I (of 16 Days)||2
7814206|NCT01138826|19236167|P6|STARTED|Washout Period I (of 16 Days)||3
7814207|NCT01138826|19236168|P5|STARTED|Washout Period I (of 16 Days)||3
7814208|NCT01138826|19236169|P4|STARTED|Washout Period I (of 16 Days)||3
7814209|NCT01138826|19236170|P3|STARTED|Washout Period I (of 16 Days)||3
7814210|NCT01138826|19236171|P2|STARTED|Washout Period I (of 16 Days)||3
7814211|NCT01138826|19236172|P1|STARTED|Washout Period I (of 16 Days)||3
7814212|NCT01138826|19236167|P6|NOT COMPLETED|First Intervention Period||0
7814213|NCT01138826|19236168|P5|NOT COMPLETED|First Intervention Period||0
7814214|NCT01138826|19236169|P4|NOT COMPLETED|First Intervention Period||0
7814215|NCT01138826|19236170|P3|NOT COMPLETED|First Intervention Period||0
7814216|NCT01138826|19236171|P2|NOT COMPLETED|First Intervention Period||0
7814217|NCT01138826|19236172|P1|NOT COMPLETED|First Intervention Period||0
7814218|NCT01138826|19236167|P6|COMPLETED|First Intervention Period||3
7814219|NCT01138826|19236168|P5|COMPLETED|First Intervention Period||3
7814220|NCT01138826|19236169|P4|COMPLETED|First Intervention Period||3
7814221|NCT01138826|19236170|P3|COMPLETED|First Intervention Period||3
7814222|NCT01138826|19236171|P2|COMPLETED|First Intervention Period||3
7814223|NCT01138826|19236172|P1|COMPLETED|First Intervention Period||3
7814224|NCT01138826|19236167|P6|STARTED|First Intervention Period||3
7814225|NCT01138826|19236168|P5|STARTED|First Intervention Period||3
7814226|NCT01138826|19236169|P4|STARTED|First Intervention Period||3
7814227|NCT01138826|19236170|P3|STARTED|First Intervention Period||3
7814228|NCT01138826|19236171|P2|STARTED|First Intervention Period||3
7814229|NCT01138826|19236172|P1|STARTED|First Intervention Period||3
7814230|NCT01138735|19236194|P2|NOT COMPLETED|Overall Study||17
7814231|NCT01138735|19236195|P1|NOT COMPLETED|Overall Study||8
7814232|NCT01138735|19236194|P2|COMPLETED|Overall Study||126
7814233|NCT01138735|19236195|P1|COMPLETED|Overall Study||134
7814234|NCT01138735|19236194|P2|STARTED|Overall Study||143
7814235|NCT01138735|19236195|P1|STARTED|Overall Study||142
7814236|NCT01138657|19236209|P2|NOT COMPLETED|Overall Study||18
7814237|NCT01138657|19236210|P1|NOT COMPLETED|Overall Study||8
7814238|NCT01138657|19236209|P2|COMPLETED|Overall Study||101
7814239|NCT01138657|19236210|P1|COMPLETED|Overall Study||112
7814240|NCT01138657|19236209|P2|Enrolled in Japan Sub-study|Overall Study||8
7814241|NCT01138657|19236210|P1|Enrolled in Japan Sub-study|Overall Study||8
7814242|NCT01138657|19236209|P2|Enrolled in Main Study|Overall Study||111
7814243|NCT01138657|19236210|P1|Enrolled in Main Study|Overall Study||112
7814244|NCT01138657|19236209|P2|STARTED|Overall Study||119
7814245|NCT01138657|19236210|P1|STARTED|Overall Study||120
7814246|NCT01138514|19236257|P3|NOT COMPLETED|Overall Study||93
7814247|NCT01138514|19236258|P2|NOT COMPLETED|Overall Study||53
7814248|NCT01138514|19236259|P1|NOT COMPLETED|Overall Study||48
7814249|NCT01138514|19236257|P3|COMPLETED|Overall Study||424
7814250|NCT01138514|19236258|P2|COMPLETED|Overall Study||463
7814251|NCT01138514|19236259|P1|COMPLETED|Overall Study||474
7814252|NCT01138514|19236257|P3|STARTED|Overall Study||517
7814253|NCT01138514|19236258|P2|STARTED|Overall Study||516
7814254|NCT01138514|19236259|P1|STARTED|Overall Study||522
7814255|NCT01138501|19236273|P1|NOT COMPLETED|Overall Study||5
7814256|NCT01138501|19236273|P1|COMPLETED|Overall Study||60
7814257|NCT01138501|19236273|P1|Exposed|Overall Study||63
7814258|NCT01138501|19236273|P1|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65
7814259|NCT01138475|19236281|P3|NOT COMPLETED|Overall Study||0
7814260|NCT01138475|19236282|P2|NOT COMPLETED|Overall Study||0
7814261|NCT01138475|19236283|P1|NOT COMPLETED|Overall Study||0
7814262|NCT01138475|19236281|P3|COMPLETED|Overall Study||17
7814263|NCT01138475|19236282|P2|COMPLETED|Overall Study||16
7814264|NCT01138475|19236283|P1|COMPLETED|Overall Study||16
7814265|NCT01138475|19236281|P3|STARTED|Overall Study||17
7814266|NCT01138475|19236282|P2|STARTED|Overall Study||16
7814267|NCT01138475|19236283|P1|STARTED|Overall Study||16
7814268|NCT01138150|19236317|P2|NOT COMPLETED|Overall Study||1
7814269|NCT01138150|19236318|P1|NOT COMPLETED|Overall Study||1
7814270|NCT01138150|19236317|P2|COMPLETED|Overall Study||17
7814271|NCT01138150|19236318|P1|COMPLETED|Overall Study||17
7814272|NCT01138150|19236317|P2|STARTED|Overall Study||18
7814273|NCT01138150|19236318|P1|STARTED|Overall Study||18
7814274|NCT01138124|19236374|P4|NOT COMPLETED|Overall Study||0
7814275|NCT01138124|19236375|P3|NOT COMPLETED|Overall Study||0
7814276|NCT01138124|19236376|P2|NOT COMPLETED|Overall Study||0
7814277|NCT01138124|19236377|P1|NOT COMPLETED|Overall Study||0
7814278|NCT01138124|19236374|P4|COMPLETED|Overall Study||19046
7814279|NCT01138124|19236375|P3|COMPLETED|Overall Study||1981
7814280|NCT01138124|19236376|P2|COMPLETED|Overall Study||30026
7814281|NCT01138124|19236377|P1|COMPLETED|Overall Study||3149
7814282|NCT01138124|19236374|P4|STARTED|Overall Study||19046
7814283|NCT01138124|19236375|P3|STARTED|Overall Study||1981
7814284|NCT01138124|19236376|P2|STARTED|Overall Study||30026
7814285|NCT01138124|19236377|P1|STARTED|Overall Study||3149
7814286|NCT01138111|19236399|P1|NOT COMPLETED|Overall Study||9
7814287|NCT01138111|19236399|P1|COMPLETED|Overall Study||36
7814288|NCT01138111|19236399|P1|STARTED|Overall Study||45
7814289|NCT01138098|19236430|P2|NOT COMPLETED|Overall Study||0
7814290|NCT01138098|19236431|P1|NOT COMPLETED|Overall Study||0
7814291|NCT01138098|19236430|P2|COMPLETED|Overall Study||90
7814292|NCT01138098|19236431|P1|COMPLETED|Overall Study||95
7814293|NCT01138098|19236430|P2|STARTED|Overall Study||90
7814294|NCT01138098|19236431|P1|STARTED|Overall Study||95
7814295|NCT01138046|19236453|P1|NOT COMPLETED|Overall Study||6
7814296|NCT01138046|19236453|P1|COMPLETED|Overall Study||6
7814297|NCT01138046|19236453|P1|STARTED|Overall Study||12
7814298|NCT01138007|19236473|P3|NOT COMPLETED|Overall Study||48
7814299|NCT01138007|19236474|P2|NOT COMPLETED|Overall Study||30
7814300|NCT01138007|19236475|P1|NOT COMPLETED|Overall Study||22
7814301|NCT01138007|19236473|P3|COMPLETED|Overall Study||144
7814302|NCT01138007|19236474|P2|COMPLETED|Overall Study||160
7814303|NCT01138007|19236475|P1|COMPLETED|Overall Study||165
7814304|NCT01138007|19236473|P3|STARTED|Overall Study||192
7814305|NCT01138007|19236474|P2|STARTED|Overall Study||190
7814306|NCT01138007|19236475|P1|STARTED|Overall Study||187
7814307|NCT01137890|19236509|P2|NOT COMPLETED|Overall Study||3
7814308|NCT01137890|19236510|P1|NOT COMPLETED|Overall Study||6
7814309|NCT01137890|19236509|P2|COMPLETED|Overall Study||2
7814310|NCT01137890|19236510|P1|COMPLETED|Overall Study||8
7814311|NCT01137890|19236509|P2|STARTED|Overall Study||5
7814312|NCT01137890|19236510|P1|STARTED|Overall Study||14
7814313|NCT01137812|19236582|P2|NOT COMPLETED|Overall Study||168
7814314|NCT01137812|19236583|P1|NOT COMPLETED|Overall Study||123
7814315|NCT01137812|19236582|P2|COMPLETED|Overall Study||210
7814316|NCT01137812|19236583|P1|COMPLETED|Overall Study||254
7814317|NCT01137812|19236582|P2|STARTED|Overall Study||378
7814318|NCT01137812|19236583|P1|STARTED|Overall Study||377
7814319|NCT01137786|19236603|P2|NOT COMPLETED|Overall Study||3
7814320|NCT01137786|19236604|P1|NOT COMPLETED|Overall Study||1
7814321|NCT01137786|19236603|P2|COMPLETED|Overall Study||21
7814322|NCT01137786|19236604|P1|COMPLETED|Overall Study||24
7814323|NCT01137786|19236603|P2|STARTED|Overall Study||24
7814324|NCT01137786|19236604|P1|STARTED|Overall Study||25
7814325|NCT01137773|19236614|P2|NOT COMPLETED|Overall Study||3
7814326|NCT01137773|19236615|P1|NOT COMPLETED|Overall Study||9
7814327|NCT01137773|19236614|P2|COMPLETED|Overall Study||20
7814328|NCT01137773|19236615|P1|COMPLETED|Overall Study||24
7814329|NCT01137773|19236614|P2|STARTED|Overall Study||23
7814330|NCT01137773|19236615|P1|STARTED|Overall Study||33
7814331|NCT01137682|19236626|P3|NOT COMPLETED|Overall Study||34
7814332|NCT01137682|19236627|P2|NOT COMPLETED|Overall Study||40
7814333|NCT01137682|19236628|P1|NOT COMPLETED|Overall Study||37
7814334|NCT01137682|19236626|P3|COMPLETED|Overall Study||34
7814335|NCT01137682|19236627|P2|COMPLETED|Overall Study||25
7814336|NCT01137682|19236628|P1|COMPLETED|Overall Study||28
7814337|NCT01137682|19236626|P3|Safety Set - Extension|Overall Study|1 patient did not receive study treatment|62
7814338|NCT01137682|19236627|P2|Safety Set - Extension|Overall Study||54
7814339|NCT01137682|19236628|P1|Safety Set - Extension|Overall Study||57
7814340|NCT01137682|19236626|P3|Safety Set - CORE|Overall Study|2 patients never received drug.|66
7814341|NCT01137682|19236627|P2|Safety Set - CORE|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62
7814342|NCT01137682|19236628|P1|Safety Set - CORE|Overall Study|2 patients never received drug.|63
7814343|NCT01137682|19236626|P3|Continuing Into Extension|Overall Study||63
7814344|NCT01137682|19236627|P2|Continuing Into Extension|Overall Study||54
7814345|NCT01137682|19236628|P1|Continuing Into Extension|Overall Study||57
7814346|NCT01137682|19236626|P3|Not Continuing Into Extension|Overall Study||2
7814347|NCT01137682|19236627|P2|Not Continuing Into Extension|Overall Study||3
7814348|NCT01137682|19236628|P1|Not Continuing Into Extension|Overall Study||2
7814349|NCT01137682|19236626|P3|Completed 24-Week Core Phase|Overall Study||65
7814350|NCT01137682|19236627|P2|Completed 24-Week Core Phase|Overall Study||57
7814351|NCT01137682|19236628|P1|Completed 24-Week Core Phase|Overall Study||59
7814352|NCT01137682|19236626|P3|Treated|Overall Study||67
7814353|NCT01137682|19236627|P2|Treated|Overall Study||63
7814354|NCT01137682|19236628|P1|Treated|Overall Study||63
7814355|NCT01137682|19236626|P3|Not Treated|Overall Study||1
7814356|NCT01137682|19236627|P2|Not Treated|Overall Study||2
7814357|NCT01137682|19236628|P1|Not Treated|Overall Study||2
7814358|NCT01137682|19236626|P3|STARTED|Overall Study||68
7814359|NCT01137682|19236627|P2|STARTED|Overall Study||65
7814360|NCT01137682|19236628|P1|STARTED|Overall Study||65
7814361|NCT01137604|19236678|P4|NOT COMPLETED|Overall Study||11
7814362|NCT01137604|19236679|P3|NOT COMPLETED|Overall Study||13
7814363|NCT01137604|19236680|P2|NOT COMPLETED|Overall Study||10
7814364|NCT01137604|19236681|P1|NOT COMPLETED|Overall Study||2
7814365|NCT01137604|19236678|P4|COMPLETED|Overall Study||21
7814366|NCT01137604|19236679|P3|COMPLETED|Overall Study||26
7814367|NCT01137604|19236680|P2|COMPLETED|Overall Study||32
7814368|NCT01137604|19236681|P1|COMPLETED|Overall Study|Participants with disease progression and treatment ongoing at data cutoff (19 Mar 2013)|36
7814369|NCT01137604|19236678|P4|Treatment Ongoing at Data Cutoff|Overall Study||0
7814370|NCT01137604|19236679|P3|Treatment Ongoing at Data Cutoff|Overall Study||1
7814371|NCT01137604|19236680|P2|Treatment Ongoing at Data Cutoff|Overall Study||3
7814372|NCT01137604|19236681|P1|Treatment Ongoing at Data Cutoff|Overall Study||2
7814373|NCT01137604|19236678|P4|Disease Progression|Overall Study||21
7814374|NCT01137604|19236679|P3|Disease Progression|Overall Study||25
7814375|NCT01137604|19236680|P2|Disease Progression|Overall Study||29
7814376|NCT01137604|19236681|P1|Disease Progression|Overall Study||34
7814377|NCT01137604|19236678|P4|STARTED|Overall Study||32
7814378|NCT01137604|19236679|P3|STARTED|Overall Study||39
7814379|NCT01137604|19236680|P2|STARTED|Overall Study||42
7814380|NCT01137604|19236681|P1|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38
7814381|NCT01137578|19236715|P3|NOT COMPLETED|Overall Study||6
7814382|NCT01137578|19236716|P2|NOT COMPLETED|Overall Study||2
7814383|NCT01137578|19236717|P1|NOT COMPLETED|Overall Study||16
7814384|NCT01137578|19236715|P3|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37
7814385|NCT01137578|19236716|P2|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12
7814386|NCT01137578|19236717|P1|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61
7814387|NCT01137578|19236715|P3|STARTED|Overall Study||43
7814388|NCT01137578|19236716|P2|STARTED|Overall Study||14
7814389|NCT01137578|19236717|P1|STARTED|Overall Study||77
7814390|NCT01137539|19236757|P1|NOT COMPLETED|Overall Study||0
7814391|NCT01137539|19236757|P1|COMPLETED|Overall Study||50
7814392|NCT01137539|19236757|P1|STARTED|Overall Study||50
7814393|NCT01137474|19236766|P4|NOT COMPLETED|Overall Study||21
7814394|NCT01137474|19236767|P3|NOT COMPLETED|Overall Study||7
7814395|NCT01137474|19236768|P2|NOT COMPLETED|Overall Study||12
7814396|NCT01137474|19236769|P1|NOT COMPLETED|Overall Study||24
7814397|NCT01137474|19236766|P4|COMPLETED|Overall Study||281
7814398|NCT01137474|19236767|P3|COMPLETED|Overall Study||158
7814399|NCT01137474|19236768|P2|COMPLETED|Overall Study||154
7814400|NCT01137474|19236769|P1|COMPLETED|Overall Study||287
7814401|NCT01137474|19236766|P4|Received Treatment|Overall Study||302
7814402|NCT01137474|19236767|P3|Received Treatment|Overall Study||165
7814403|NCT01137474|19236768|P2|Received Treatment|Overall Study||166
7814404|NCT01137474|19236769|P1|Received Treatment|Overall Study||311
7814405|NCT01137474|19236766|P4|STARTED|Overall Study||302
7814406|NCT01137474|19236767|P3|STARTED|Overall Study||165
7814407|NCT01137474|19236768|P2|STARTED|Overall Study||166
7814408|NCT01137474|19236769|P1|STARTED|Overall Study||311
7814409|NCT01137435|19236787|P1|NOT COMPLETED|Overall Study||28
7814410|NCT01137435|19236787|P1|COMPLETED|Overall Study||659
7814411|NCT01137435|19236787|P1|STARTED|Overall Study||687
7814412|NCT01137396|19236796|P2|NOT COMPLETED|Overall Study||2
7814413|NCT01137396|19236797|P1|NOT COMPLETED|Overall Study||8
7814414|NCT01137396|19236796|P2|COMPLETED|Overall Study||25
7814415|NCT01137396|19236797|P1|COMPLETED|Overall Study||22
7814416|NCT01137396|19236796|P2|STARTED|Overall Study||27
7814417|NCT01137396|19236797|P1|STARTED|Overall Study||30
7814418|NCT01137370|19236807|P2|NOT COMPLETED|Overall Study||0
7814419|NCT01137370|19236808|P1|NOT COMPLETED|Overall Study||0
7814420|NCT01137370|19236807|P2|COMPLETED|Overall Study||87
7814421|NCT01137370|19236808|P1|COMPLETED|Overall Study||116
7814422|NCT01137370|19236807|P2|STARTED|Overall Study||87
7814423|NCT01137370|19236808|P1|STARTED|Overall Study||116
7814424|NCT01137292|19236814|P1|NOT COMPLETED|Overall Study||54
7814425|NCT01137292|19236814|P1|COMPLETED|Overall Study||123
7814426|NCT01137292|19236814|P1|STARTED|Overall Study||177
7814427|NCT01137110|19236823|P2|NOT COMPLETED|Overall Study||0
7814428|NCT01137110|19236824|P1|NOT COMPLETED|Overall Study||1
7814429|NCT01137110|19236823|P2|COMPLETED|Overall Study||49
7814430|NCT01137110|19236824|P1|COMPLETED|Overall Study||34
7814431|NCT01137110|19236823|P2|STARTED|Overall Study||49
7814432|NCT01137110|19236824|P1|STARTED|Overall Study||35
7814433|NCT01137071|19236830|P1|NOT COMPLETED|Overall Study||14
7814434|NCT01137071|19236830|P1|COMPLETED|Overall Study|Of the eligible patients|15
7814435|NCT01137071|19236830|P1|STARTED|Overall Study|all patients considered eligible were included on the study|29
7814436|NCT01137032|19236891|P1|NOT COMPLETED|Overall Study||0
7814437|NCT01137032|19236891|P1|COMPLETED|Overall Study||19
7814438|NCT01137032|19236891|P1|STARTED|Overall Study||19
7814439|NCT01137006|19236904|P7|NOT COMPLETED|Overall Study||0
7814440|NCT01137006|19236905|P6|NOT COMPLETED|Overall Study||0
7814441|NCT01137006|19236906|P5|NOT COMPLETED|Overall Study||0
7814442|NCT01137006|19236907|P4|NOT COMPLETED|Overall Study||0
7814443|NCT01137006|19236908|P3|NOT COMPLETED|Overall Study||0
7814444|NCT01137006|19236909|P2|NOT COMPLETED|Overall Study||0
7814445|NCT01137006|19236910|P1|NOT COMPLETED|Overall Study||0
7814446|NCT01137006|19236904|P7|COMPLETED|Overall Study||3
7814447|NCT01137006|19236905|P6|COMPLETED|Overall Study||4
7814448|NCT01137006|19236906|P5|COMPLETED|Overall Study||3
7814449|NCT01137006|19236907|P4|COMPLETED|Overall Study||3
7814450|NCT01137006|19236908|P3|COMPLETED|Overall Study||8
7814451|NCT01137006|19236909|P2|COMPLETED|Overall Study||3
7814452|NCT01137006|19236910|P1|COMPLETED|Overall Study||3
7814453|NCT01137006|19236904|P7|Completed at Least 1 Treatment Cycle|Overall Study||3
7814454|NCT01137006|19236905|P6|Completed at Least 1 Treatment Cycle|Overall Study||4
7814455|NCT01137006|19236906|P5|Completed at Least 1 Treatment Cycle|Overall Study||3
7814456|NCT01137006|19236907|P4|Completed at Least 1 Treatment Cycle|Overall Study||3
7814457|NCT01137006|19236908|P3|Completed at Least 1 Treatment Cycle|Overall Study||8
7814458|NCT01137006|19236909|P2|Completed at Least 1 Treatment Cycle|Overall Study||3
7814459|NCT01137006|19236910|P1|Completed at Least 1 Treatment Cycle|Overall Study||3
7814460|NCT01137006|19236904|P7|STARTED|Overall Study||3
7814461|NCT01137006|19236905|P6|STARTED|Overall Study||4
7814462|NCT01137006|19236906|P5|STARTED|Overall Study||3
7814463|NCT01137006|19236907|P4|STARTED|Overall Study||3
7814464|NCT01137006|19236908|P3|STARTED|Overall Study||8
7814465|NCT01137006|19236909|P2|STARTED|Overall Study||3
7814466|NCT01137006|19236910|P1|STARTED|Overall Study||3
7814467|NCT01136967|19236986|P2|NOT COMPLETED|Overall Study||27
7814468|NCT01136967|19236987|P1|NOT COMPLETED|Overall Study||24
7814469|NCT01136967|19236986|P2|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62
7814470|NCT01136967|19236987|P1|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69
7814471|NCT01136967|19236986|P2|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6
7814472|NCT01136967|19236987|P1|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14
7814473|NCT01136967|19236986|P2|Disease Progression|Overall Study||56
7814474|NCT01136967|19236987|P1|Disease Progression|Overall Study||55
7814475|NCT01136967|19236986|P2|STARTED|Overall Study||89
7814476|NCT01136967|19236987|P1|STARTED|Overall Study||93
7814477|NCT01136954|19237009|P2|NOT COMPLETED|Overall Study||21
7814478|NCT01136954|19237010|P1|NOT COMPLETED|Overall Study||24
7814479|NCT01136954|19237009|P2|COMPLETED|Overall Study||51
7814480|NCT01136954|19237010|P1|COMPLETED|Overall Study||48
7814481|NCT01136954|19237009|P2|STARTED|Overall Study||72
7814482|NCT01136954|19237010|P1|STARTED|Overall Study||72
7814483|NCT01136915|19237024|P2|NOT COMPLETED|Overall Study||1
7814484|NCT01136915|19237025|P1|NOT COMPLETED|Overall Study||2
7814485|NCT01136915|19237024|P2|COMPLETED|Overall Study||6
7814486|NCT01136915|19237025|P1|COMPLETED|Overall Study||6
7814487|NCT01136915|19237024|P2|STARTED|Overall Study||7
7814488|NCT01136915|19237025|P1|STARTED|Overall Study||8
7814489|NCT01136876|19237035|P2|NOT COMPLETED|Overall Study||11
7814490|NCT01136876|19237036|P1|NOT COMPLETED|Overall Study||5
7814491|NCT01136876|19237035|P2|COMPLETED|Overall Study||18
7814492|NCT01136876|19237036|P1|COMPLETED|Overall Study||23
7814493|NCT01136876|19237035|P2|STARTED|Overall Study||29
7814494|NCT01136876|19237036|P1|STARTED|Overall Study||28
7814495|NCT01136798|19237046|P2|NOT COMPLETED|Overall Study||0
7814496|NCT01136798|19237047|P1|NOT COMPLETED|Overall Study||0
7814497|NCT01136798|19237046|P2|COMPLETED|Overall Study||8
7814498|NCT01136798|19237047|P1|COMPLETED|Overall Study||10
7814499|NCT01136798|19237046|P2|STARTED|Overall Study||8
7814500|NCT01136798|19237047|P1|STARTED|Overall Study||10
7814501|NCT01136785|19237065|P2|NOT COMPLETED|Overall Study||1
7814502|NCT01136785|19237066|P1|NOT COMPLETED|Overall Study||2
7814503|NCT01136785|19237065|P2|COMPLETED|Overall Study||6
7814504|NCT01136785|19237066|P1|COMPLETED|Overall Study||13
7814505|NCT01136785|19237065|P2|STARTED|Overall Study||7
7814506|NCT01136785|19237066|P1|STARTED|Overall Study||15
7814507|NCT01136772|19237081|P2|NOT COMPLETED|Overall Study||110
7814508|NCT01136772|19237082|P1|NOT COMPLETED|Overall Study||116
7814509|NCT01136772|19237081|P2|COMPLETED|Overall Study||44
7814510|NCT01136772|19237082|P1|COMPLETED|Overall Study||41
7814511|NCT01136772|19237081|P2|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
7814512|NCT01136772|19237082|P1|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
7814513|NCT01136772|19237081|P2|STARTED|Overall Study||154
7814514|NCT01136772|19237082|P1|STARTED|Overall Study||157
7814515|NCT01136746|19237092|P2|NOT COMPLETED|Overall Study||3
7814516|NCT01136746|19237093|P1|NOT COMPLETED|Overall Study||3
7814517|NCT01136746|19237092|P2|COMPLETED|Overall Study||4
7814518|NCT01136746|19237093|P1|COMPLETED|Overall Study||6
7814519|NCT01136746|19237092|P2|STARTED|Overall Study||7
7814520|NCT01136746|19237093|P1|STARTED|Overall Study||9
7814521|NCT01136733|19237160|P7|NOT COMPLETED|Phase 2||50
7814522|NCT01136733|19237161|P6|NOT COMPLETED|Phase 2||52
7814523|NCT01136733|19237162|P5|NOT COMPLETED|Phase 2||51
7814524|NCT01136733|19237163|P4|NOT COMPLETED|Phase 2||0
7814525|NCT01136733|19237164|P3|NOT COMPLETED|Phase 2||0
7814526|NCT01136733|19237165|P2|NOT COMPLETED|Phase 2||0
7814527|NCT01136733|19237166|P1|NOT COMPLETED|Phase 2||0
7814528|NCT01136733|19237160|P7|COMPLETED|Phase 2||0
7814529|NCT01136733|19237161|P6|COMPLETED|Phase 2||0
7814530|NCT01136733|19237162|P5|COMPLETED|Phase 2||0
7814531|NCT01136733|19237163|P4|COMPLETED|Phase 2||0
7814532|NCT01136733|19237164|P3|COMPLETED|Phase 2||0
7814533|NCT01136733|19237165|P2|COMPLETED|Phase 2||0
7814534|NCT01136733|19237166|P1|COMPLETED|Phase 2||0
7814535|NCT01136733|19237160|P7|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|50
7814536|NCT01136733|19237161|P6|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|52
7814537|NCT01136733|19237162|P5|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|51
7814538|NCT01136733|19237163|P4|STARTED|Phase 2||0
7814539|NCT01136733|19237164|P3|STARTED|Phase 2||0
7814540|NCT01136733|19237165|P2|STARTED|Phase 2||0
7814541|NCT01136733|19237166|P1|STARTED|Phase 2||0
7814542|NCT01136733|19237160|P7|NOT COMPLETED|Phase 1b||0
7814543|NCT01136733|19237161|P6|NOT COMPLETED|Phase 1b||0
7814544|NCT01136733|19237162|P5|NOT COMPLETED|Phase 1b||0
7814545|NCT01136733|19237163|P4|NOT COMPLETED|Phase 1b||0
7814546|NCT01136733|19237164|P3|NOT COMPLETED|Phase 1b||2
7814547|NCT01136733|19237165|P2|NOT COMPLETED|Phase 1b||5
7814548|NCT01136733|19237166|P1|NOT COMPLETED|Phase 1b||1
7814549|NCT01136733|19237160|P7|COMPLETED|Phase 1b||0
7814550|NCT01136733|19237161|P6|COMPLETED|Phase 1b||0
7814551|NCT01136733|19237162|P5|COMPLETED|Phase 1b||0
7814552|NCT01136733|19237163|P4|COMPLETED|Phase 1b||0
7814553|NCT01136733|19237164|P3|COMPLETED|Phase 1b||0
7814554|NCT01136733|19237165|P2|COMPLETED|Phase 1b||6
7814555|NCT01136733|19237166|P1|COMPLETED|Phase 1b||6
7814556|NCT01136733|19237160|P7|STARTED|Phase 1b||0
7814557|NCT01136733|19237161|P6|STARTED|Phase 1b||0
7814558|NCT01136733|19237162|P5|STARTED|Phase 1b||0
7814559|NCT01136733|19237163|P4|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|0
7814560|NCT01136733|19237164|P3|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|2
7814561|NCT01136733|19237165|P2|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|11
7814562|NCT01136733|19237166|P1|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|7
7814563|NCT01136655|19237249|P1|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0
7814564|NCT01136655|19237249|P1|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50
7814565|NCT01136655|19237249|P1|STARTED|Washout After BUD 160/ Foradil (7 Days)||50
7814566|NCT01136655|19237249|P1|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0
7814567|NCT01136655|19237249|P1|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50
7814568|NCT01136655|19237249|P1|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50
7814569|NCT01136655|19237249|P1|NOT COMPLETED|Washout After BUD 160 (7 Days)||0
7814570|NCT01136655|19237249|P1|COMPLETED|Washout After BUD 160 (7 Days)||51
7814571|NCT01136655|19237249|P1|STARTED|Washout After BUD 160 (7 Days)||51
7814572|NCT01136655|19237249|P1|NOT COMPLETED|BUD 160 (1 Dose)||0
7814573|NCT01136655|19237249|P1|COMPLETED|BUD 160 (1 Dose)||51
7814574|NCT01136655|19237249|P1|STARTED|BUD 160 (1 Dose)||51
7814575|NCT01136655|19237249|P1|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2
7814576|NCT01136655|19237249|P1|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51
7814577|NCT01136655|19237249|P1|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53
7814578|NCT01136655|19237249|P1|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0
7814579|NCT01136655|19237249|P1|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53
7814580|NCT01136655|19237249|P1|STARTED|BUD 160/FM 9.0 (1 Dose)||53
7814581|NCT01136655|19237249|P1|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1
7814582|NCT01136655|19237249|P1|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52
7814583|NCT01136655|19237249|P1|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53
7814584|NCT01136655|19237249|P1|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0
7814585|NCT01136655|19237249|P1|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53
7814586|NCT01136655|19237249|P1|STARTED|BUD 160/FM 4.5 (1 Dose)||53
7814587|NCT01136655|19237249|P1|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1
7814588|NCT01136655|19237249|P1|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53
7814589|NCT01136655|19237249|P1|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54
7814590|NCT01136655|19237249|P1|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0
7814591|NCT01136655|19237249|P1|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54
7814592|NCT01136655|19237249|P1|STARTED|BUD 160/FM 2.25 (1 Dose)||54
7814593|NCT01136486|19237275|P1|NOT COMPLETED|Overall Study||0
7814594|NCT01136486|19237275|P1|COMPLETED|Overall Study||56
7814595|NCT01136486|19237275|P1|STARTED|Overall Study||56
7814596|NCT01136408|19237282|P3|NOT COMPLETED|Overall Study||5
7814597|NCT01136408|19237283|P2|NOT COMPLETED|Overall Study||9
7814598|NCT01136408|19237284|P1|NOT COMPLETED|Overall Study||5
7814599|NCT01136408|19237282|P3|COMPLETED|Overall Study||57
7814600|NCT01136408|19237283|P2|COMPLETED|Overall Study||49
7814601|NCT01136408|19237284|P1|COMPLETED|Overall Study||41
7814602|NCT01136408|19237282|P3|STARTED|Overall Study||62
7814603|NCT01136408|19237283|P2|STARTED|Overall Study||58
7814604|NCT01136408|19237284|P1|STARTED|Overall Study||46
7814605|NCT01136382|19237341|P2|NOT COMPLETED|Overall Study||31
7814606|NCT01136382|19237342|P1|NOT COMPLETED|Overall Study||60
7814607|NCT01136382|19237341|P2|COMPLETED|Overall Study||121
7814608|NCT01136382|19237342|P1|COMPLETED|Overall Study||92
7814609|NCT01136382|19237341|P2|STARTED|Overall Study||152
7814610|NCT01136382|19237342|P1|STARTED|Overall Study||152
7814611|NCT01136356|19237368|P2|NOT COMPLETED|Second 18-day Withdrawal||1
7814612|NCT01136356|19237369|P1|NOT COMPLETED|Second 18-day Withdrawal||0
7814613|NCT01136356|19237368|P2|COMPLETED|Second 18-day Withdrawal||5
7814614|NCT01136356|19237369|P1|COMPLETED|Second 18-day Withdrawal||2
7814615|NCT01136356|19237368|P2|STARTED|Second 18-day Withdrawal||6
7814616|NCT01136356|19237369|P1|STARTED|Second 18-day Withdrawal||2
7814617|NCT01136356|19237368|P2|NOT COMPLETED|Second Intervention||0
7814618|NCT01136356|19237369|P1|NOT COMPLETED|Second Intervention||0
7814619|NCT01136356|19237368|P2|COMPLETED|Second Intervention||6
7814620|NCT01136356|19237369|P1|COMPLETED|Second Intervention||2
7814621|NCT01136356|19237368|P2|STARTED|Second Intervention||6
7814622|NCT01136356|19237369|P1|STARTED|Second Intervention||2
7814623|NCT01136356|19237368|P2|NOT COMPLETED|First 18-day Withdrawal||0
7814624|NCT01136356|19237369|P1|NOT COMPLETED|First 18-day Withdrawal||4
7814625|NCT01136356|19237368|P2|COMPLETED|First 18-day Withdrawal||6
7814626|NCT01136356|19237369|P1|COMPLETED|First 18-day Withdrawal||2
7814627|NCT01136356|19237368|P2|STARTED|First 18-day Withdrawal||6
7814628|NCT01136356|19237369|P1|STARTED|First 18-day Withdrawal||6
7814629|NCT01136356|19237368|P2|NOT COMPLETED|First Intervention||0
7814630|NCT01136356|19237369|P1|NOT COMPLETED|First Intervention||0
7814631|NCT01136356|19237368|P2|COMPLETED|First Intervention||6
7814632|NCT01136356|19237369|P1|COMPLETED|First Intervention||6
7814633|NCT01136356|19237368|P2|STARTED|First Intervention||6
7814634|NCT01136356|19237369|P1|STARTED|First Intervention||6
7814635|NCT01136291|19237380|P2|NOT COMPLETED|Overall Study||1
7814636|NCT01136291|19237381|P1|NOT COMPLETED|Overall Study||1
7814637|NCT01136291|19237380|P2|COMPLETED|Overall Study||41
7814638|NCT01136291|19237381|P1|COMPLETED|Overall Study||39
7814639|NCT01136291|19237380|P2|Follow|Overall Study||42
7814640|NCT01136291|19237381|P1|Follow|Overall Study||40
7814641|NCT01136291|19237380|P2|STARTED|Overall Study||42
7814642|NCT01136291|19237381|P1|STARTED|Overall Study||40
7814643|NCT01136226|19237391|P1|NOT COMPLETED|Overall Study||13
7814644|NCT01136226|19237391|P1|COMPLETED|Overall Study||29
7814645|NCT01136226|19237391|P1|STARTED|Overall Study||42
7814646|NCT01136174|19237400|P4|NOT COMPLETED|Overall Study||4
7814647|NCT01136174|19237401|P3|NOT COMPLETED|Overall Study||0
7814648|NCT01136174|19237402|P2|NOT COMPLETED|Overall Study||0
7814649|NCT01136174|19237403|P1|NOT COMPLETED|Overall Study||0
7814650|NCT01136174|19237400|P4|COMPLETED|Overall Study||20
7814651|NCT01136174|19237401|P3|COMPLETED|Overall Study||8
7814652|NCT01136174|19237402|P2|COMPLETED|Overall Study||6
7814653|NCT01136174|19237403|P1|COMPLETED|Overall Study||12
7814654|NCT01136174|19237400|P4|STARTED|Overall Study||24
7814655|NCT01136174|19237401|P3|STARTED|Overall Study||8
7814656|NCT01136174|19237402|P2|STARTED|Overall Study||6
7814657|NCT01136174|19237403|P1|STARTED|Overall Study||12
7814658|NCT01135992|19237483|P1|NOT COMPLETED|Overall Study||21
7814659|NCT01135992|19237483|P1|COMPLETED|Overall Study||122
7814660|NCT01135992|19237483|P1|Full Analysis Set|Overall Study||129
7814661|NCT01135992|19237483|P1|Exposed|Overall Study|One subject was withdrawn before being exposed.|142
7814662|NCT01135992|19237483|P1|STARTED|Overall Study||143
7814663|NCT01135914|19237495|P3|NOT COMPLETED|Overall Study||22
7814664|NCT01135914|19237496|P2|NOT COMPLETED|Overall Study||5
7814665|NCT01135914|19237497|P1|NOT COMPLETED|Overall Study||4
7814666|NCT01135914|19237495|P3|COMPLETED|Overall Study||59
7814667|NCT01135914|19237496|P2|COMPLETED|Overall Study||75
7814668|NCT01135914|19237497|P1|COMPLETED|Overall Study||74
7814669|NCT01135914|19237495|P3|Safety Population|Overall Study||74
7814670|NCT01135914|19237496|P2|Safety Population|Overall Study||75
7814671|NCT01135914|19237497|P1|Safety Population|Overall Study||73
7814672|NCT01135914|19237495|P3|Intent to Treat (ITT) Population|Overall Study||72
7814673|NCT01135914|19237496|P2|Intent to Treat (ITT) Population|Overall Study||75
7814674|NCT01135914|19237497|P1|Intent to Treat (ITT) Population|Overall Study||73
7814675|NCT01135914|19237495|P3|STARTED|Overall Study||81
7814676|NCT01135914|19237496|P2|STARTED|Overall Study||80
7814677|NCT01135914|19237497|P1|STARTED|Overall Study||78
7814678|NCT01135537|19237526|P1|NOT COMPLETED|Overall Study||13
7814679|NCT01135537|19237526|P1|COMPLETED|Overall Study||17
7814680|NCT01135537|19237526|P1|STARTED|Overall Study||30
7814681|NCT01135524|19237530|P1|NOT COMPLETED|Overall Study||196
7814682|NCT01135524|19237530|P1|COMPLETED|Overall Study||0
7814683|NCT01135524|19237530|P1|STARTED|Overall Study||196
7814684|NCT01135511|19237543|P9|NOT COMPLETED|Overall Study||1
7814685|NCT01135511|19237544|P8|NOT COMPLETED|Overall Study||1
7814686|NCT01135511|19237545|P7|NOT COMPLETED|Overall Study||1
7814687|NCT01135511|19237546|P6|NOT COMPLETED|Overall Study||1
7814688|NCT01135511|19237547|P5|NOT COMPLETED|Overall Study||1
7814689|NCT01135511|19237548|P4|NOT COMPLETED|Overall Study||3
7814690|NCT01135511|19237549|P3|NOT COMPLETED|Overall Study||8
7814691|NCT01135511|19237550|P2|NOT COMPLETED|Overall Study||3
7814692|NCT01135511|19237551|P1|NOT COMPLETED|Overall Study||0
7814693|NCT01135511|19237543|P9|COMPLETED|Overall Study||20
7814694|NCT01135511|19237544|P8|COMPLETED|Overall Study||20
7814695|NCT01135511|19237545|P7|COMPLETED|Overall Study||18
7814696|NCT01135511|19237546|P6|COMPLETED|Overall Study||20
7814697|NCT01135511|19237547|P5|COMPLETED|Overall Study||38
7814698|NCT01135511|19237548|P4|COMPLETED|Overall Study||37
7814699|NCT01135511|19237549|P3|COMPLETED|Overall Study||33
7814700|NCT01135511|19237550|P2|COMPLETED|Overall Study||39
7814701|NCT01135511|19237551|P1|COMPLETED|Overall Study||41
7814702|NCT01135511|19237543|P9|STARTED|Overall Study||21
7814703|NCT01135511|19237544|P8|STARTED|Overall Study||21
7814704|NCT01135511|19237545|P7|STARTED|Overall Study||19
7814705|NCT01135511|19237546|P6|STARTED|Overall Study||21
7814706|NCT01135511|19237547|P5|STARTED|Overall Study||39
7814707|NCT01135511|19237548|P4|STARTED|Overall Study||40
7814708|NCT01135511|19237549|P3|STARTED|Overall Study||41
7814709|NCT01135511|19237550|P2|STARTED|Overall Study||42
7814710|NCT01135511|19237551|P1|STARTED|Overall Study||41
7814711|NCT01135498|19237833|P1|NOT COMPLETED|Overall Study||90
7814712|NCT01135498|19237833|P1|COMPLETED|Overall Study||0
7814713|NCT01135498|19237833|P1|STARTED|Overall Study||90
7814714|NCT01135420|19237844|P2|NOT COMPLETED|Overall Study||32
7814715|NCT01135420|19237845|P1|NOT COMPLETED|Overall Study||44
7814716|NCT01135420|19237844|P2|COMPLETED|Overall Study||175
7814717|NCT01135420|19237845|P1|COMPLETED|Overall Study||155
7814718|NCT01135420|19237844|P2|STARTED|Overall Study||207
7814719|NCT01135420|19237845|P1|STARTED|Overall Study||199
7814720|NCT01135381|19237855|P4|NOT COMPLETED|Overall Study||1
7814721|NCT01135381|19237856|P3|NOT COMPLETED|Overall Study||4
7814722|NCT01135381|19237857|P2|NOT COMPLETED|Overall Study||7
7814723|NCT01135381|19237858|P1|NOT COMPLETED|Overall Study||21
7814724|NCT01135381|19237855|P4|COMPLETED|Overall Study||67
7814725|NCT01135381|19237856|P3|COMPLETED|Overall Study||65
7814726|NCT01135381|19237857|P2|COMPLETED|Overall Study||178
7814727|NCT01135381|19237858|P1|COMPLETED|Overall Study||168
7814728|NCT01135381|19237855|P4|STARTED|Overall Study||68
7814729|NCT01135381|19237856|P3|STARTED|Overall Study||69
7814730|NCT01135381|19237857|P2|STARTED|Overall Study||185
7814731|NCT01135381|19237858|P1|STARTED|Overall Study||189
7814732|NCT01135368|19237876|P1|NOT COMPLETED|Overall Study||251
7814733|NCT01135368|19237876|P1|COMPLETED|Overall Study||255
7814734|NCT01135368|19237876|P1|STARTED|Overall Study||506
7814735|NCT01135329|19237992|P1|NOT COMPLETED|Overall Study||0
7814736|NCT01135329|19237992|P1|COMPLETED|Overall Study||15
7814737|NCT01135329|19237992|P1|STARTED|Overall Study||15
7814738|NCT01135186|19238003|P1|NOT COMPLETED|Overall Study||0
7814739|NCT01135186|19238003|P1|COMPLETED|Overall Study||9
7814740|NCT01135186|19238003|P1|STARTED|Overall Study||9
7814741|NCT01135134|19238012|P2|NOT COMPLETED|Overall Study||1
7814742|NCT01135134|19238013|P1|NOT COMPLETED|Overall Study||2
7814743|NCT01135134|19238012|P2|COMPLETED|Overall Study||112
7814744|NCT01135134|19238013|P1|COMPLETED|Overall Study||218
7814745|NCT01135134|19238012|P2|STARTED|Overall Study||113
7814746|NCT01135134|19238013|P1|STARTED|Overall Study||220
7814747|NCT01135069|19238024|P3|NOT COMPLETED|Overall Study||10
7814748|NCT01135069|19238025|P2|NOT COMPLETED|Overall Study||32
7814749|NCT01135069|19238026|P1|NOT COMPLETED|Overall Study||36
7814750|NCT01135069|19238024|P3|COMPLETED|Overall Study||56
7814751|NCT01135069|19238025|P2|COMPLETED|Overall Study||177
7814752|NCT01135069|19238026|P1|COMPLETED|Overall Study||169
7814753|NCT01135069|19238024|P3|STARTED|Overall Study||66
7814754|NCT01135069|19238025|P2|STARTED|Overall Study||209
7814755|NCT01135069|19238026|P1|STARTED|Overall Study||205
7814756|NCT01135017|19238036|P2|NOT COMPLETED|Overall Study||12
7814757|NCT01135017|19238037|P1|NOT COMPLETED|Overall Study||6
7814758|NCT01135017|19238036|P2|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45
7814759|NCT01135017|19238037|P1|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49
7814760|NCT01135017|19238036|P2|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55
7814761|NCT01135017|19238037|P1|Evaluable for Efficacy|Overall Study||55
7814762|NCT01135017|19238036|P2|Treated|Overall Study||57
7814763|NCT01135017|19238037|P1|Treated|Overall Study||55
7814764|NCT01135017|19238036|P2|STARTED|Overall Study||57
7814765|NCT01135017|19238037|P1|STARTED|Overall Study||55
7814766|NCT01134952|19238053|P1|NOT COMPLETED|Overall Study||0
7814767|NCT01134952|19238053|P1|COMPLETED|Overall Study||11
7814768|NCT01134952|19238053|P1|STARTED|Overall Study||11
7814769|NCT01134939|19238075|P8|NOT COMPLETED|Overall Study||0
7814770|NCT01134939|19238076|P7|NOT COMPLETED|Overall Study||9
7814771|NCT01134939|19238077|P6|NOT COMPLETED|Overall Study||9
7814772|NCT01134939|19238078|P5|NOT COMPLETED|Overall Study||10
7814773|NCT01134939|19238079|P4|NOT COMPLETED|Overall Study||14
7814774|NCT01134939|19238080|P3|NOT COMPLETED|Overall Study||10
7814775|NCT01134939|19238081|P2|NOT COMPLETED|Overall Study||18
7814776|NCT01134939|19238082|P1|NOT COMPLETED|Overall Study||17
7814777|NCT01134939|19238075|P8|COMPLETED|Overall Study||1
7814778|NCT01134939|19238076|P7|COMPLETED|Overall Study||10
7814779|NCT01134939|19238077|P6|COMPLETED|Overall Study||5
7814780|NCT01134939|19238078|P5|COMPLETED|Overall Study||23
7814781|NCT01134939|19238079|P4|COMPLETED|Overall Study||32
7814782|NCT01134939|19238080|P3|COMPLETED|Overall Study||41
7814783|NCT01134939|19238081|P2|COMPLETED|Overall Study||24
7814784|NCT01134939|19238082|P1|COMPLETED|Overall Study||42
7814785|NCT01134939|19238075|P8|STARTED|Overall Study||1
7814786|NCT01134939|19238076|P7|STARTED|Overall Study||19
7814787|NCT01134939|19238077|P6|STARTED|Overall Study||14
7814788|NCT01134939|19238078|P5|STARTED|Overall Study||33
7814789|NCT01134939|19238079|P4|STARTED|Overall Study||46
7814790|NCT01134939|19238080|P3|STARTED|Overall Study||51
7814791|NCT01134939|19238081|P2|STARTED|Overall Study||42
7814792|NCT01134939|19238082|P1|STARTED|Overall Study||59
7814793|NCT01134900|19238194|P2|NOT COMPLETED|Overall Study||0
7814794|NCT01134900|19238195|P1|NOT COMPLETED|Overall Study||0
7814795|NCT01134900|19238194|P2|COMPLETED|Overall Study||196
7814796|NCT01134900|19238195|P1|COMPLETED|Overall Study||200
7814797|NCT01134900|19238194|P2|STARTED|Overall Study||196
7814798|NCT01134900|19238195|P1|STARTED|Overall Study||200
7814799|NCT01134887|19238207|P4|NOT COMPLETED|Overall Study||0
7814800|NCT01134887|19238208|P3|NOT COMPLETED|Overall Study||0
7814801|NCT01134887|19238209|P2|NOT COMPLETED|Overall Study||4
7814802|NCT01134887|19238210|P1|NOT COMPLETED|Overall Study||0
7814803|NCT01134887|19238207|P4|COMPLETED|Overall Study||5
7814804|NCT01134887|19238208|P3|COMPLETED|Overall Study||5
7814805|NCT01134887|19238209|P2|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7
7814806|NCT01134887|19238210|P1|COMPLETED|Overall Study||9
7814807|NCT01134887|19238207|P4|STARTED|Overall Study||5
7814808|NCT01134887|19238208|P3|STARTED|Overall Study||5
7814809|NCT01134887|19238209|P2|STARTED|Overall Study||11
7814810|NCT01134887|19238210|P1|STARTED|Overall Study||9
7814811|NCT01134783|19238220|P2|NOT COMPLETED|Overall Study||37
7814812|NCT01134783|19238221|P1|NOT COMPLETED|Overall Study||36
7814813|NCT01134783|19238220|P2|COMPLETED|Overall Study||180
7814814|NCT01134783|19238221|P1|COMPLETED|Overall Study||188
7814815|NCT01134783|19238220|P2|STARTED|Overall Study||217
7814816|NCT01134783|19238221|P1|STARTED|Overall Study||224
7814817|NCT01134731|19238240|P3|NOT COMPLETED|Overall Study||8
7814818|NCT01134731|19238241|P2|NOT COMPLETED|Overall Study||11
7814819|NCT01134731|19238242|P1|NOT COMPLETED|Overall Study||13
7814820|NCT01134731|19238240|P3|COMPLETED|Overall Study||2
7814821|NCT01134731|19238241|P2|COMPLETED|Overall Study||10
7814822|NCT01134731|19238242|P1|COMPLETED|Overall Study||10
7814823|NCT01134731|19238240|P3|STARTED|Overall Study||10
7814824|NCT01134731|19238241|P2|STARTED|Overall Study||21
7814825|NCT01134731|19238242|P1|STARTED|Overall Study||23
7814826|NCT01134705|19238255|P2|NOT COMPLETED|Overall Study||22
7814827|NCT01134705|19238256|P1|NOT COMPLETED|Overall Study||15
7814828|NCT01134705|19238255|P2|COMPLETED|Overall Study||216
7814829|NCT01134705|19238256|P1|COMPLETED|Overall Study||221
7814830|NCT01134705|19238255|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234
7814831|NCT01134705|19238256|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232
7814832|NCT01134705|19238255|P2|STARTED|Overall Study||238
7814833|NCT01134705|19238256|P1|STARTED|Overall Study||236
7814834|NCT01134627|19238268|P2|NOT COMPLETED|Overall Study||67
7814835|NCT01134627|19238269|P1|NOT COMPLETED|Overall Study||69
7814836|NCT01134627|19238268|P2|COMPLETED|Overall Study||88
7814837|NCT01134627|19238269|P1|COMPLETED|Overall Study||80
7814838|NCT01134627|19238268|P2|STARTED|Overall Study|Number of participants treated.|155
7814839|NCT01134627|19238269|P1|STARTED|Overall Study|Number of participants treated.|149
7814840|NCT01134614|19238299|P2|NOT COMPLETED|Overall Study||122
7814841|NCT01134614|19238300|P1|NOT COMPLETED|Overall Study||123
7814842|NCT01134614|19238299|P2|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0
7814843|NCT01134614|19238300|P1|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0
7814844|NCT01134614|19238299|P2|Treated and Toxicity Assessed|Overall Study||120
7814845|NCT01134614|19238300|P1|Treated and Toxicity Assessed|Overall Study||118
7814846|NCT01134614|19238299|P2|Treated|Overall Study||121
7814847|NCT01134614|19238300|P1|Treated|Overall Study||119
7814848|NCT01134614|19238299|P2|STARTED|Overall Study||122
7814849|NCT01134614|19238300|P1|STARTED|Overall Study||123
7814850|NCT01134575|19238313|P3|NOT COMPLETED|Overall Study||0
7814851|NCT01134575|19238314|P2|NOT COMPLETED|Overall Study||0
7814852|NCT01134575|19238315|P1|NOT COMPLETED|Overall Study||0
7814853|NCT01134575|19238313|P3|COMPLETED|Overall Study||42
7814854|NCT01134575|19238314|P2|COMPLETED|Overall Study||45
7814855|NCT01134575|19238315|P1|COMPLETED|Overall Study||3
7814856|NCT01134575|19238313|P3|STARTED|Overall Study||42
7814857|NCT01134575|19238314|P2|STARTED|Overall Study||45
7814858|NCT01134575|19238315|P1|STARTED|Overall Study||3
7814859|NCT01134562|19238328|P5|NOT COMPLETED|Overall Study||0
7814860|NCT01134562|19238329|P4|NOT COMPLETED|Overall Study||0
7814861|NCT01134562|19238330|P3|NOT COMPLETED|Overall Study||0
7814862|NCT01134562|19238331|P2|NOT COMPLETED|Overall Study||1
7814863|NCT01134562|19238332|P1|NOT COMPLETED|Overall Study||0
7814864|NCT01134562|19238328|P5|COMPLETED|Overall Study||8
7814865|NCT01134562|19238329|P4|COMPLETED|Overall Study||8
7814866|NCT01134562|19238330|P3|COMPLETED|Overall Study||4
7814867|NCT01134562|19238331|P2|COMPLETED|Overall Study||3
7814868|NCT01134562|19238332|P1|COMPLETED|Overall Study||4
7814869|NCT01134562|19238328|P5|STARTED|Overall Study||8
7814870|NCT01134562|19238329|P4|STARTED|Overall Study||8
7814871|NCT01134562|19238330|P3|STARTED|Overall Study||4
7814872|NCT01134562|19238331|P2|STARTED|Overall Study||4
7814873|NCT01134562|19238332|P1|STARTED|Overall Study||4
7814874|NCT01134549|19238401|P5|NOT COMPLETED|Overall Study||0
7814875|NCT01134549|19238402|P4|NOT COMPLETED|Overall Study||0
7814876|NCT01134549|19238403|P3|NOT COMPLETED|Overall Study||0
7814877|NCT01134549|19238404|P2|NOT COMPLETED|Overall Study||0
7814878|NCT01134549|19238405|P1|NOT COMPLETED|Overall Study||0
7814879|NCT01134549|19238401|P5|COMPLETED|Overall Study||6
7814880|NCT01134549|19238402|P4|COMPLETED|Overall Study||6
7814881|NCT01134549|19238403|P3|COMPLETED|Overall Study||6
7814882|NCT01134549|19238404|P2|COMPLETED|Overall Study||6
7814883|NCT01134549|19238405|P1|COMPLETED|Overall Study||8
7814884|NCT01134549|19238401|P5|STARTED|Overall Study||6
7814885|NCT01134549|19238402|P4|STARTED|Overall Study||6
7814886|NCT01134549|19238403|P3|STARTED|Overall Study||6
7814887|NCT01134549|19238404|P2|STARTED|Overall Study||6
7814888|NCT01134549|19238405|P1|STARTED|Overall Study||8
7814889|NCT01134510|19238491|P2|NOT COMPLETED|Overall Study||1
7814890|NCT01134510|19238492|P1|NOT COMPLETED|Overall Study||0
7814891|NCT01134510|19238491|P2|COMPLETED|Overall Study||9
7814892|NCT01134510|19238492|P1|COMPLETED|Overall Study||10
7814893|NCT01134510|19238491|P2|Month 3|Overall Study||9
7814894|NCT01134510|19238492|P1|Month 3|Overall Study||10
7814895|NCT01134510|19238491|P2|Month 1|Overall Study||10
7814896|NCT01134510|19238492|P1|Month 1|Overall Study||10
7814897|NCT01134510|19238491|P2|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
7814898|NCT01134510|19238492|P1|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
7814899|NCT01134510|19238491|P2|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
7814900|NCT01134510|19238492|P1|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
7814901|NCT01134510|19238491|P2|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
7814902|NCT01134510|19238492|P1|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
7814903|NCT01134510|19238491|P2|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
7814904|NCT01134510|19238492|P1|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
7814905|NCT01134510|19238491|P2|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
7814906|NCT01134510|19238492|P1|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
7814907|NCT01134510|19238491|P2|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
7814908|NCT01134510|19238492|P1|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
7814909|NCT01134510|19238491|P2|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
7814910|NCT01134510|19238492|P1|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
7814911|NCT01134510|19238491|P2|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
7814912|NCT01134510|19238492|P1|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
7814913|NCT01134393|19238504|P1|NOT COMPLETED|Overall Study||52
7814914|NCT01134393|19238504|P1|COMPLETED|Overall Study|Completed trial medication.|449
7814915|NCT01134393|19238504|P1|STARTED|Overall Study|Entered and treated.|501
7814916|NCT01134328|19238522|P4|NOT COMPLETED|Overall Study||4
7814917|NCT01134328|19238523|P3|NOT COMPLETED|Overall Study||3
7814918|NCT01134328|19238524|P2|NOT COMPLETED|Overall Study||3
7814919|NCT01134328|19238525|P1|NOT COMPLETED|Overall Study||2
7814920|NCT01134328|19238522|P4|COMPLETED|Overall Study||17
7814921|NCT01134328|19238523|P3|COMPLETED|Overall Study||17
7814922|NCT01134328|19238524|P2|COMPLETED|Overall Study||18
7814923|NCT01134328|19238525|P1|COMPLETED|Overall Study||19
7814924|NCT01134328|19238522|P4|STARTED|Overall Study||21
7814925|NCT01134328|19238523|P3|STARTED|Overall Study||20
7814926|NCT01134328|19238524|P2|STARTED|Overall Study||21
7814927|NCT01134328|19238525|P1|STARTED|Overall Study||21
7814928|NCT01134315|19238625|P2|NOT COMPLETED|Overall Study||19
7814929|NCT01134315|19238626|P1|NOT COMPLETED|Overall Study||9
7814930|NCT01134315|19238625|P2|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21
7814931|NCT01134315|19238626|P1|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12
7814932|NCT01134315|19238625|P2|STARTED|Overall Study||40
7814933|NCT01134315|19238626|P1|STARTED|Overall Study||21
7814934|NCT01134276|19238648|P2|NOT COMPLETED|Overall Study||0
7814935|NCT01134276|19238649|P1|NOT COMPLETED|Overall Study||0
7814936|NCT01134276|19238648|P2|COMPLETED|Overall Study||107
7814937|NCT01134276|19238649|P1|COMPLETED|Overall Study||104
7814938|NCT01134276|19238648|P2|STARTED|Overall Study||107
7814939|NCT01134276|19238649|P1|STARTED|Overall Study||104
7814940|NCT01134263|19238664|P5|NOT COMPLETED|Overall Study||9
7814941|NCT01134263|19238665|P4|NOT COMPLETED|Overall Study||19
7814942|NCT01134263|19238666|P3|NOT COMPLETED|Overall Study||29
7814943|NCT01134263|19238667|P2|NOT COMPLETED|Overall Study||20
7814944|NCT01134263|19238668|P1|NOT COMPLETED|Overall Study||24
7814945|NCT01134263|19238664|P5|COMPLETED|Overall Study||48
7814946|NCT01134263|19238665|P4|COMPLETED|Overall Study||149
7814947|NCT01134263|19238666|P3|COMPLETED|Overall Study||134
7814948|NCT01134263|19238667|P2|COMPLETED|Overall Study||143
7814949|NCT01134263|19238668|P1|COMPLETED|Overall Study||140
7814950|NCT01134263|19238664|P5|Safety Population|Overall Study||57
7814951|NCT01134263|19238665|P4|Safety Population|Overall Study||167
7814952|NCT01134263|19238666|P3|Safety Population|Overall Study|1 participant randomized to the Phase III Lot 2 group, received Phase III Lot 3 vaccination.|164
7814953|NCT01134263|19238667|P2|Safety Population|Overall Study||161
7814954|NCT01134263|19238668|P1|Safety Population|Overall Study||163
7814955|NCT01134263|19238664|P5|Received Vaccination 3|Overall Study||49
7814956|NCT01134263|19238665|P4|Received Vaccination 3|Overall Study||151
7814957|NCT01134263|19238666|P3|Received Vaccination 3|Overall Study||134
7814958|NCT01134263|19238667|P2|Received Vaccination 3|Overall Study||145
7814959|NCT01134263|19238668|P1|Received Vaccination 3|Overall Study||140
7814960|NCT01134263|19238664|P5|Received Vaccination 2|Overall Study||53
7814961|NCT01134263|19238665|P4|Received Vaccination 2|Overall Study||154
7814962|NCT01134263|19238666|P3|Received Vaccination 2|Overall Study||139
7814963|NCT01134263|19238667|P2|Received Vaccination 2|Overall Study||152
7814964|NCT01134263|19238668|P1|Received Vaccination 2|Overall Study||151
7814965|NCT01134263|19238664|P5|Received Vaccination 1|Overall Study||57
7814966|NCT01134263|19238665|P4|Received Vaccination 1|Overall Study||167
7814967|NCT01134263|19238666|P3|Received Vaccination 1|Overall Study||163
7814968|NCT01134263|19238667|P2|Received Vaccination 1|Overall Study||162
7814969|NCT01134263|19238668|P1|Received Vaccination 1|Overall Study||163
7814970|NCT01134263|19238664|P5|STARTED|Overall Study||57
7814971|NCT01134263|19238665|P4|STARTED|Overall Study||168
7814972|NCT01134263|19238666|P3|STARTED|Overall Study||163
7814973|NCT01134263|19238667|P2|STARTED|Overall Study||163
7814974|NCT01134263|19238668|P1|STARTED|Overall Study||164
7814975|NCT01134198|19238692|P2|NOT COMPLETED|Phase 2||4
7814976|NCT01134198|19238693|P1|NOT COMPLETED|Phase 2||0
7814977|NCT01134198|19238692|P2|COMPLETED|Phase 2||7
7814978|NCT01134198|19238693|P1|COMPLETED|Phase 2||9
7814979|NCT01134198|19238692|P2|STARTED|Phase 2||11
7814980|NCT01134198|19238693|P1|STARTED|Phase 2||9
7814981|NCT01134198|19238692|P2|NOT COMPLETED|Phase 1||2
7814982|NCT01134198|19238693|P1|NOT COMPLETED|Phase 1||7
7814983|NCT01134198|19238692|P2|COMPLETED|Phase 1||11
7814984|NCT01134198|19238693|P1|COMPLETED|Phase 1||9
7814985|NCT01134198|19238692|P2|STARTED|Phase 1||13
7814986|NCT01134198|19238693|P1|STARTED|Phase 1||16
7814987|NCT01134107|19238701|P2|NOT COMPLETED|Period 2-Second Treatment Intervention||0
7814988|NCT01134107|19238702|P1|NOT COMPLETED|Period 2-Second Treatment Intervention||4
7814989|NCT01134107|19238701|P2|COMPLETED|Period 2-Second Treatment Intervention||61
7814990|NCT01134107|19238702|P1|COMPLETED|Period 2-Second Treatment Intervention||57
7814991|NCT01134107|19238701|P2|STARTED|Period 2-Second Treatment Intervention||61
7814992|NCT01134107|19238702|P1|STARTED|Period 2-Second Treatment Intervention||61
7814993|NCT01134107|19238701|P2|NOT COMPLETED|Period 1-First Treatment Intervention||5
7814994|NCT01134107|19238702|P1|NOT COMPLETED|Period 1-First Treatment Intervention||6
7814995|NCT01134107|19238701|P2|COMPLETED|Period 1-First Treatment Intervention||61
7814996|NCT01134107|19238702|P1|COMPLETED|Period 1-First Treatment Intervention||61
7814997|NCT01134107|19238701|P2|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
7814998|NCT01134107|19238702|P1|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
7814999|NCT01134107|19238701|P2|STARTED|Period 1-First Treatment Intervention||66
7815000|NCT01134107|19238702|P1|STARTED|Period 1-First Treatment Intervention||67
7815001|NCT01134081|19238734|P1|NOT COMPLETED|Overall Study||0
7815002|NCT01134081|19238734|P1|COMPLETED|Overall Study||44
7815003|NCT01134081|19238734|P1|STARTED|Overall Study||44
7815004|NCT01134055|19238749|P7|NOT COMPLETED|Overall Study||11
7815005|NCT01134055|19238750|P6|NOT COMPLETED|Overall Study||7
7815006|NCT01134055|19238751|P5|NOT COMPLETED|Overall Study||6
7815007|NCT01134055|19238752|P4|NOT COMPLETED|Overall Study||6
7815008|NCT01134055|19238753|P3|NOT COMPLETED|Overall Study||3
7815009|NCT01134055|19238754|P2|NOT COMPLETED|Overall Study||6
7815010|NCT01134055|19238755|P1|NOT COMPLETED|Overall Study||8
7815011|NCT01134055|19238749|P7|COMPLETED|Overall Study||62
7815012|NCT01134055|19238750|P6|COMPLETED|Overall Study||65
7815013|NCT01134055|19238751|P5|COMPLETED|Overall Study||67
7815014|NCT01134055|19238752|P4|COMPLETED|Overall Study||67
7815015|NCT01134055|19238753|P3|COMPLETED|Overall Study||71
7815016|NCT01134055|19238754|P2|COMPLETED|Overall Study||66
7815017|NCT01134055|19238755|P1|COMPLETED|Overall Study||65
7815018|NCT01134055|19238749|P7|STARTED|Overall Study||73
7815019|NCT01134055|19238750|P6|STARTED|Overall Study||72
7815020|NCT01134055|19238751|P5|STARTED|Overall Study||73
7815021|NCT01134055|19238752|P4|STARTED|Overall Study||73
7815022|NCT01134055|19238753|P3|STARTED|Overall Study||74
7815023|NCT01134055|19238754|P2|STARTED|Overall Study||72
7815024|NCT01134055|19238755|P1|STARTED|Overall Study||73
7815025|NCT01134042|19238889|P3|NOT COMPLETED|Overall Study||34
7815026|NCT01134042|19238890|P2|NOT COMPLETED|Overall Study||28
7815027|NCT01134042|19238891|P1|NOT COMPLETED|Overall Study||48
7815028|NCT01134042|19238889|P3|COMPLETED|Overall Study||161
7815029|NCT01134042|19238890|P2|COMPLETED|Overall Study||169
7815030|NCT01134042|19238891|P1|COMPLETED|Overall Study||146
7815031|NCT01134042|19238889|P3|STARTED|Overall Study||195
7815032|NCT01134042|19238890|P2|STARTED|Overall Study||197
7815033|NCT01134042|19238891|P1|STARTED|Overall Study||194
7815034|NCT01134016|19238929|P1|NOT COMPLETED|Overall Study||3
7815035|NCT01134016|19238929|P1|COMPLETED|Overall Study||10
7815036|NCT01134016|19238929|P1|STARTED|Overall Study||13
7815037|NCT01133977|19238967|P5|NOT COMPLETED|Overall Study||38
7815038|NCT01133977|19238968|P4|NOT COMPLETED|Overall Study||39
7815039|NCT01133977|19238969|P3|NOT COMPLETED|Overall Study||6
7815040|NCT01133977|19238970|P2|NOT COMPLETED|Overall Study||7
7815041|NCT01133977|19238971|P1|NOT COMPLETED|Overall Study||3
7815042|NCT01133977|19238967|P5|COMPLETED|Overall Study||1
7815043|NCT01133977|19238968|P4|COMPLETED|Overall Study||3
7815044|NCT01133977|19238969|P3|COMPLETED|Overall Study||0
7815045|NCT01133977|19238970|P2|COMPLETED|Overall Study||0
7815046|NCT01133977|19238971|P1|COMPLETED|Overall Study||0
7815047|NCT01133977|19238967|P5|STARTED|Overall Study|Treated|39
7815048|NCT01133977|19238968|P4|STARTED|Overall Study|Treated|42
7815049|NCT01133977|19238969|P3|STARTED|Overall Study|Treated|6
7815050|NCT01133977|19238970|P2|STARTED|Overall Study|Treated|7
7815051|NCT01133977|19238971|P1|STARTED|Overall Study|Treated|3
7815052|NCT01133860|19238988|P1|NOT COMPLETED|Overall Study||0
7815053|NCT01133860|19238988|P1|COMPLETED|Overall Study||12
7815054|NCT01133860|19238988|P1|STARTED|Overall Study||12
7815055|NCT01133847|19238998|P3|NOT COMPLETED|Follow-Up Phase||7
7815056|NCT01133847|19238999|P2|NOT COMPLETED|Follow-Up Phase||3
7815057|NCT01133847|19239000|P1|NOT COMPLETED|Follow-Up Phase||1
7815058|NCT01133847|19238998|P3|COMPLETED|Follow-Up Phase||60
7815059|NCT01133847|19238999|P2|COMPLETED|Follow-Up Phase||70
7815060|NCT01133847|19239000|P1|COMPLETED|Follow-Up Phase||72
7815061|NCT01133847|19238998|P3|STARTED|Follow-Up Phase||67
7815062|NCT01133847|19238999|P2|STARTED|Follow-Up Phase||73
7815063|NCT01133847|19239000|P1|STARTED|Follow-Up Phase||73
7815064|NCT01133847|19238998|P3|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3
7815065|NCT01133847|19238999|P2|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1
7815066|NCT01133847|19239000|P1|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5
7815067|NCT01133847|19238998|P3|COMPLETED|Active Treatment Phase (Weeks 1-16)||67
7815068|NCT01133847|19238999|P2|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
7815069|NCT01133847|19239000|P1|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
7815070|NCT01133847|19238998|P3|STARTED|Active Treatment Phase (Weeks 1-16)||70
7815071|NCT01133847|19238999|P2|STARTED|Active Treatment Phase (Weeks 1-16)||74
7815072|NCT01133847|19239000|P1|STARTED|Active Treatment Phase (Weeks 1-16)||78
7815073|NCT01133821|19239040|P2|NOT COMPLETED|Overall Study||19
7815074|NCT01133821|19239041|P1|NOT COMPLETED|Overall Study||18
7815075|NCT01133821|19239040|P2|COMPLETED|Overall Study||28
7815076|NCT01133821|19239041|P1|COMPLETED|Overall Study||27
7815077|NCT01133821|19239040|P2|STARTED|Overall Study||47
7815078|NCT01133821|19239041|P1|STARTED|Overall Study||45
7815079|NCT01133756|19239052|P3|NOT COMPLETED|Overall Study||2
7815080|NCT01133756|19239053|P2|NOT COMPLETED|Overall Study||3
7815081|NCT01133756|19239054|P1|NOT COMPLETED|Overall Study||2
7815082|NCT01133756|19239052|P3|COMPLETED|Overall Study||0
7815083|NCT01133756|19239053|P2|COMPLETED|Overall Study||0
7815084|NCT01133756|19239054|P1|COMPLETED|Overall Study||0
7815085|NCT01133756|19239052|P3|Completed 6 Cycles|Overall Study||0
7815086|NCT01133756|19239053|P2|Completed 6 Cycles|Overall Study||0
7815087|NCT01133756|19239054|P1|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1
7815088|NCT01133756|19239052|P3|STARTED|Overall Study||2
7815089|NCT01133756|19239053|P2|STARTED|Overall Study||3
7815090|NCT01133756|19239054|P1|STARTED|Overall Study||2
7815091|NCT01133704|19239070|P2|NOT COMPLETED|Overall Study||26
7815092|NCT01133704|19239071|P1|NOT COMPLETED|Overall Study||49
7815093|NCT01133704|19239070|P2|COMPLETED|Overall Study|(including 3 year follow-up)|7
7815094|NCT01133704|19239071|P1|COMPLETED|Overall Study|(including 3 year follow-up)|16
7815095|NCT01133704|19239070|P2|STARTED|Overall Study||33
7815096|NCT01133704|19239071|P1|STARTED|Overall Study||65
7815097|NCT01133678|19239081|P2|NOT COMPLETED|Overall Study||1
7815098|NCT01133678|19239082|P1|NOT COMPLETED|Overall Study||1
7815099|NCT01133678|19239081|P2|COMPLETED|Overall Study||24
7815100|NCT01133678|19239082|P1|COMPLETED|Overall Study||24
7815101|NCT01133678|19239081|P2|STARTED|Overall Study||25
7815102|NCT01133678|19239082|P1|STARTED|Overall Study||25
7815103|NCT01133665|19239088|P1|NOT COMPLETED|Overall Study||2
7815104|NCT01133665|19239088|P1|COMPLETED|Overall Study||40
7815105|NCT01133665|19239088|P1|STARTED|Overall Study||42
7815106|NCT01133639|19239131|P2|NOT COMPLETED|Overall Study||0
7815107|NCT01133639|19239132|P1|NOT COMPLETED|Overall Study||0
7815108|NCT01133639|19239131|P2|COMPLETED|Overall Study|18 total subjects were enrolled,study was terminated prematurely and data was not analyzed|0
7815109|NCT01133639|19239132|P1|COMPLETED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
7815110|NCT01133639|19239131|P2|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
7815111|NCT01133639|19239132|P1|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
7815112|NCT01133626|19239148|P3|NOT COMPLETED|Overall Study||2
7815113|NCT01133626|19239149|P2|NOT COMPLETED|Overall Study||5
7815114|NCT01133626|19239150|P1|NOT COMPLETED|Overall Study||1
7815115|NCT01133626|19239148|P3|COMPLETED|Overall Study||9
7815116|NCT01133626|19239149|P2|COMPLETED|Overall Study||41
7815117|NCT01133626|19239150|P1|COMPLETED|Overall Study||49
7815118|NCT01133626|19239148|P3|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9
7815119|NCT01133626|19239149|P2|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41
7815120|NCT01133626|19239150|P1|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48
7815121|NCT01133626|19239148|P3|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11
7815122|NCT01133626|19239149|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46
7815123|NCT01133626|19239150|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50
7815124|NCT01133626|19239148|P3|STARTED|Overall Study||11
7815125|NCT01133626|19239149|P2|STARTED|Overall Study||46
7815126|NCT01133626|19239150|P1|STARTED|Overall Study||50
7815127|NCT01133522|19239168|P10|NOT COMPLETED|Overall Study||0
7815128|NCT01133522|19239169|P9|NOT COMPLETED|Overall Study||0
7815129|NCT01133522|19239170|P8|NOT COMPLETED|Overall Study||0
7815130|NCT01133522|19239171|P7|NOT COMPLETED|Overall Study||0
7815131|NCT01133522|19239172|P6|NOT COMPLETED|Overall Study||0
7815132|NCT01133522|19239173|P5|NOT COMPLETED|Overall Study||1
7815133|NCT01133522|19239174|P4|NOT COMPLETED|Overall Study||1
7815134|NCT01133522|19239175|P3|NOT COMPLETED|Overall Study||0
7815135|NCT01133522|19239176|P2|NOT COMPLETED|Overall Study||1
7815136|NCT01133522|19239177|P1|NOT COMPLETED|Overall Study||0
7815137|NCT01133522|19239168|P10|COMPLETED|Overall Study||4
7815138|NCT01133522|19239169|P9|COMPLETED|Overall Study||2
7815139|NCT01133522|19239170|P8|COMPLETED|Overall Study||9
7815140|NCT01133522|19239171|P7|COMPLETED|Overall Study||2
7815141|NCT01133522|19239172|P6|COMPLETED|Overall Study||6
7815142|NCT01133522|19239173|P5|COMPLETED|Overall Study||6
7815143|NCT01133522|19239174|P4|COMPLETED|Overall Study||6
7815144|NCT01133522|19239175|P3|COMPLETED|Overall Study||6
7815145|NCT01133522|19239176|P2|COMPLETED|Overall Study||6
7815146|NCT01133522|19239177|P1|COMPLETED|Overall Study||10
7815147|NCT01133522|19239168|P10|Received Treatment|Overall Study||4
7815148|NCT01133522|19239169|P9|Received Treatment|Overall Study||2
7815149|NCT01133522|19239170|P8|Received Treatment|Overall Study||9
7815150|NCT01133522|19239171|P7|Received Treatment|Overall Study||2
7815151|NCT01133522|19239172|P6|Received Treatment|Overall Study||6
7815152|NCT01133522|19239173|P5|Received Treatment|Overall Study||6
7815153|NCT01133522|19239174|P4|Received Treatment|Overall Study||6
7815154|NCT01133522|19239175|P3|Received Treatment|Overall Study||6
7815155|NCT01133522|19239176|P2|Received Treatment|Overall Study||6
7815156|NCT01133522|19239177|P1|Received Treatment|Overall Study||10
7815157|NCT01133522|19239168|P10|STARTED|Overall Study||4
7815158|NCT01133522|19239169|P9|STARTED|Overall Study||2
7815159|NCT01133522|19239170|P8|STARTED|Overall Study||9
7815160|NCT01133522|19239171|P7|STARTED|Overall Study||2
7815161|NCT01133522|19239172|P6|STARTED|Overall Study||6
7815162|NCT01133522|19239173|P5|STARTED|Overall Study||7
7815163|NCT01133522|19239174|P4|STARTED|Overall Study||7
7815164|NCT01133522|19239175|P3|STARTED|Overall Study||6
7815165|NCT01133522|19239176|P2|STARTED|Overall Study||7
7815166|NCT01133522|19239177|P1|STARTED|Overall Study||10
7815167|NCT01133418|19239245|P2|NOT COMPLETED|Overall Study||6
7815168|NCT01133418|19239246|P1|NOT COMPLETED|Overall Study||5
7815169|NCT01133418|19239245|P2|COMPLETED|Overall Study||32
7815170|NCT01133418|19239246|P1|COMPLETED|Overall Study||29
7815171|NCT01133418|19239245|P2|STARTED|Overall Study||38
7815172|NCT01133418|19239246|P1|STARTED|Overall Study||34
7815173|NCT01133405|19239268|P10|NOT COMPLETED|Period 3||0
7815174|NCT01133405|19239269|P9|NOT COMPLETED|Period 3||0
7815175|NCT01133405|19239270|P8|NOT COMPLETED|Period 3||0
7815176|NCT01133405|19239271|P7|NOT COMPLETED|Period 3||0
7815177|NCT01133405|19239272|P6|NOT COMPLETED|Period 3||0
7815178|NCT01133405|19239273|P5|NOT COMPLETED|Period 3||0
7815179|NCT01133405|19239274|P4|NOT COMPLETED|Period 3||0
7815180|NCT01133405|19239275|P3|NOT COMPLETED|Period 3||0
7815181|NCT01133405|19239276|P2|NOT COMPLETED|Period 3||0
7815182|NCT01133405|19239277|P1|NOT COMPLETED|Period 3||0
7815183|NCT01133405|19239268|P10|COMPLETED|Period 3||0
7815184|NCT01133405|19239269|P9|COMPLETED|Period 3||0
7815185|NCT01133405|19239270|P8|COMPLETED|Period 3||0
7815186|NCT01133405|19239271|P7|COMPLETED|Period 3||0
7815187|NCT01133405|19239272|P6|COMPLETED|Period 3||2
7815188|NCT01133405|19239273|P5|COMPLETED|Period 3||3
7815189|NCT01133405|19239274|P4|COMPLETED|Period 3||2
7815190|NCT01133405|19239275|P3|COMPLETED|Period 3||4
7815191|NCT01133405|19239276|P2|COMPLETED|Period 3||4
7815192|NCT01133405|19239277|P1|COMPLETED|Period 3||2
7815193|NCT01133405|19239268|P10|Received at Least 1 Dose of Study Drug|Period 3||0
7815194|NCT01133405|19239269|P9|Received at Least 1 Dose of Study Drug|Period 3||0
7815195|NCT01133405|19239270|P8|Received at Least 1 Dose of Study Drug|Period 3||0
7815196|NCT01133405|19239271|P7|Received at Least 1 Dose of Study Drug|Period 3||0
7815197|NCT01133405|19239272|P6|Received at Least 1 Dose of Study Drug|Period 3||2
7815198|NCT01133405|19239273|P5|Received at Least 1 Dose of Study Drug|Period 3||3
7815199|NCT01133405|19239274|P4|Received at Least 1 Dose of Study Drug|Period 3||2
7815200|NCT01133405|19239275|P3|Received at Least 1 Dose of Study Drug|Period 3||4
7815201|NCT01133405|19239276|P2|Received at Least 1 Dose of Study Drug|Period 3||4
7815202|NCT01133405|19239277|P1|Received at Least 1 Dose of Study Drug|Period 3||2
7815203|NCT01133405|19239268|P10|STARTED|Period 3||0
7815204|NCT01133405|19239269|P9|STARTED|Period 3||0
7815205|NCT01133405|19239270|P8|STARTED|Period 3||0
7815206|NCT01133405|19239271|P7|STARTED|Period 3||0
7815207|NCT01133405|19239272|P6|STARTED|Period 3||2
7815208|NCT01133405|19239273|P5|STARTED|Period 3||3
7815209|NCT01133405|19239274|P4|STARTED|Period 3||2
7815210|NCT01133405|19239275|P3|STARTED|Period 3|One participant started and received 35 mg LY2886721 only in period 3.|4
7815211|NCT01133405|19239276|P2|STARTED|Period 3|One participant started and received placebo only in period 3.|4
7815212|NCT01133405|19239277|P1|STARTED|Period 3||2
7815213|NCT01133405|19239268|P10|NOT COMPLETED|Period 2||0
7815214|NCT01133405|19239269|P9|NOT COMPLETED|Period 2||0
7815215|NCT01133405|19239270|P8|NOT COMPLETED|Period 2||0
7815216|NCT01133405|19239271|P7|NOT COMPLETED|Period 2||0
7815217|NCT01133405|19239272|P6|NOT COMPLETED|Period 2||2
7815218|NCT01133405|19239273|P5|NOT COMPLETED|Period 2||0
7815219|NCT01133405|19239274|P4|NOT COMPLETED|Period 2||1
7815220|NCT01133405|19239275|P3|NOT COMPLETED|Period 2||1
7815221|NCT01133405|19239276|P2|NOT COMPLETED|Period 2||1
7815222|NCT01133405|19239277|P1|NOT COMPLETED|Period 2||0
7815223|NCT01133405|19239268|P10|COMPLETED|Period 2||0
7815224|NCT01133405|19239269|P9|COMPLETED|Period 2||0
7815225|NCT01133405|19239270|P8|COMPLETED|Period 2||0
7815226|NCT01133405|19239271|P7|COMPLETED|Period 2||0
7815227|NCT01133405|19239272|P6|COMPLETED|Period 2||2
7815228|NCT01133405|19239273|P5|COMPLETED|Period 2||3
7815229|NCT01133405|19239274|P4|COMPLETED|Period 2||2
7815230|NCT01133405|19239275|P3|COMPLETED|Period 2||3
7815231|NCT01133405|19239276|P2|COMPLETED|Period 2||3
7815232|NCT01133405|19239277|P1|COMPLETED|Period 2||2
7815233|NCT01133405|19239268|P10|Received at Least 1 Dose of Study Drug|Period 2||0
7815234|NCT01133405|19239269|P9|Received at Least 1 Dose of Study Drug|Period 2||0
7815235|NCT01133405|19239270|P8|Received at Least 1 Dose of Study Drug|Period 2||0
7815236|NCT01133405|19239271|P7|Received at Least 1 Dose of Study Drug|Period 2||0
7815237|NCT01133405|19239272|P6|Received at Least 1 Dose of Study Drug|Period 2||4
7815238|NCT01133405|19239273|P5|Received at Least 1 Dose of Study Drug|Period 2||3
7815239|NCT01133405|19239274|P4|Received at Least 1 Dose of Study Drug|Period 2||3
7815240|NCT01133405|19239275|P3|Received at Least 1 Dose of Study Drug|Period 2||4
7815241|NCT01133405|19239276|P2|Received at Least 1 Dose of Study Drug|Period 2||4
7815242|NCT01133405|19239277|P1|Received at Least 1 Dose of Study Drug|Period 2||2
7815243|NCT01133405|19239268|P10|STARTED|Period 2|Cohort D was planned only for single period.|0
7815244|NCT01133405|19239269|P9|STARTED|Period 2|Cohort D was planned only for single period.|0
7815245|NCT01133405|19239270|P8|STARTED|Period 2|Cohort C was planned only for single period.|0
7815246|NCT01133405|19239271|P7|STARTED|Period 2|Cohort C was planned only for single period.|0
7815247|NCT01133405|19239272|P6|STARTED|Period 2|One participant started and received 25 mg LY2886721 only in period 2.|4
7815248|NCT01133405|19239273|P5|STARTED|Period 2||3
7815249|NCT01133405|19239274|P4|STARTED|Period 2|Two participants started and received 25 mg LY2886721 only in period 2.|3
7815250|NCT01133405|19239275|P3|STARTED|Period 2||4
7815251|NCT01133405|19239276|P2|STARTED|Period 2|One participant started and received 15 mg LY2886721 only in period 2.|4
7815252|NCT01133405|19239277|P1|STARTED|Period 2||2
7815253|NCT01133405|19239268|P10|NOT COMPLETED|Period 1||0
7815254|NCT01133405|19239269|P9|NOT COMPLETED|Period 1||0
7815255|NCT01133405|19239270|P8|NOT COMPLETED|Period 1||0
7815256|NCT01133405|19239271|P7|NOT COMPLETED|Period 1||1
7815257|NCT01133405|19239272|P6|NOT COMPLETED|Period 1||2
7815258|NCT01133405|19239273|P5|NOT COMPLETED|Period 1||0
7815259|NCT01133405|19239274|P4|NOT COMPLETED|Period 1||4
7815260|NCT01133405|19239275|P3|NOT COMPLETED|Period 1||1
7815261|NCT01133405|19239276|P2|NOT COMPLETED|Period 1||3
7815262|NCT01133405|19239277|P1|NOT COMPLETED|Period 1||1
7815263|NCT01133405|19239268|P10|COMPLETED|Period 1||2
7815264|NCT01133405|19239269|P9|COMPLETED|Period 1||4
7815265|NCT01133405|19239270|P8|COMPLETED|Period 1||2
7815266|NCT01133405|19239271|P7|COMPLETED|Period 1||4
7815267|NCT01133405|19239272|P6|COMPLETED|Period 1||3
7815268|NCT01133405|19239273|P5|COMPLETED|Period 1||3
7815269|NCT01133405|19239274|P4|COMPLETED|Period 1||1
7815270|NCT01133405|19239275|P3|COMPLETED|Period 1||4
7815271|NCT01133405|19239276|P2|COMPLETED|Period 1||3
7815272|NCT01133405|19239277|P1|COMPLETED|Period 1||2
7815273|NCT01133405|19239268|P10|Received at Least 1 Dose of Drug|Period 1||2
7815274|NCT01133405|19239269|P9|Received at Least 1 Dose of Drug|Period 1||4
7815275|NCT01133405|19239270|P8|Received at Least 1 Dose of Drug|Period 1||2
7815276|NCT01133405|19239271|P7|Received at Least 1 Dose of Drug|Period 1||4
7815277|NCT01133405|19239272|P6|Received at Least 1 Dose of Drug|Period 1||4
7815278|NCT01133405|19239273|P5|Received at Least 1 Dose of Drug|Period 1||3
7815279|NCT01133405|19239274|P4|Received at Least 1 Dose of Drug|Period 1||3
7815280|NCT01133405|19239275|P3|Received at Least 1 Dose of Drug|Period 1||4
7815281|NCT01133405|19239276|P2|Received at Least 1 Dose of Drug|Period 1||4
7815282|NCT01133405|19239277|P1|Received at Least 1 Dose of Drug|Period 1||2
7815283|NCT01133405|19239268|P10|Safety Analysis Population|Period 1||2
7815284|NCT01133405|19239269|P9|Safety Analysis Population|Period 1||4
7815285|NCT01133405|19239270|P8|Safety Analysis Population|Period 1||2
7815286|NCT01133405|19239271|P7|Safety Analysis Population|Period 1||5
7815287|NCT01133405|19239272|P6|Safety Analysis Population|Period 1||5
7815288|NCT01133405|19239273|P5|Safety Analysis Population|Period 1||3
7815289|NCT01133405|19239274|P4|Safety Analysis Population|Period 1||5
7815290|NCT01133405|19239275|P3|Safety Analysis Population|Period 1||5
7815291|NCT01133405|19239276|P2|Safety Analysis Population|Period 1||6
7815292|NCT01133405|19239277|P1|Safety Analysis Population|Period 1|One discontinued from study after randomization but before any study procedures.|2
7815293|NCT01133405|19239268|P10|STARTED|Period 1||2
7815294|NCT01133405|19239269|P9|STARTED|Period 1||4
7815295|NCT01133405|19239270|P8|STARTED|Period 1||2
7815296|NCT01133405|19239271|P7|STARTED|Period 1||5
7815297|NCT01133405|19239272|P6|STARTED|Period 1||5
7815298|NCT01133405|19239273|P5|STARTED|Period 1||3
7815299|NCT01133405|19239274|P4|STARTED|Period 1||5
7815300|NCT01133405|19239275|P3|STARTED|Period 1||5
7815301|NCT01133405|19239276|P2|STARTED|Period 1||6
7815302|NCT01133405|19239277|P1|STARTED|Period 1||3
7815303|NCT01133392|19239328|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
7815304|NCT01133392|19239329|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
7815305|NCT01133392|19239328|P2|COMPLETED|Fourth Intervention (1 Day)||16
7815306|NCT01133392|19239329|P1|COMPLETED|Fourth Intervention (1 Day)||20
7815307|NCT01133392|19239328|P2|STARTED|Fourth Intervention (1 Day)||16
7815308|NCT01133392|19239329|P1|STARTED|Fourth Intervention (1 Day)||20
7815309|NCT01133392|19239328|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
7815310|NCT01133392|19239329|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
7815311|NCT01133392|19239328|P2|COMPLETED|Interval Between Dosing (4-7 Days)||16
7815312|NCT01133392|19239329|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
7815313|NCT01133392|19239328|P2|STARTED|Interval Between Dosing (4-7 Days)||17
7815314|NCT01133392|19239329|P1|STARTED|Interval Between Dosing (4-7 Days)||20
7815315|NCT01133392|19239328|P2|NOT COMPLETED|Third Intervention (1 Day)||0
7815316|NCT01133392|19239329|P1|NOT COMPLETED|Third Intervention (1 Day)||0
7815317|NCT01133392|19239328|P2|COMPLETED|Third Intervention (1 Day)||17
7815318|NCT01133392|19239329|P1|COMPLETED|Third Intervention (1 Day)||20
7815319|NCT01133392|19239328|P2|STARTED|Third Intervention (1 Day)||17
7815320|NCT01133392|19239329|P1|STARTED|Third Intervention (1 Day)||20
7815321|NCT01133392|19239328|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
7815322|NCT01133392|19239329|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
7815323|NCT01133392|19239328|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
7815324|NCT01133392|19239329|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
7815325|NCT01133392|19239328|P2|STARTED|Interval Between Dosing (4-7 Days)||17
7815326|NCT01133392|19239329|P1|STARTED|Interval Between Dosing (4-7 Days)||20
7815327|NCT01133392|19239328|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7815328|NCT01133392|19239329|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7815329|NCT01133392|19239328|P2|COMPLETED|Second Intervention (1 Day)||17
7815330|NCT01133392|19239329|P1|COMPLETED|Second Intervention (1 Day)||20
7815331|NCT01133392|19239328|P2|STARTED|Second Intervention (1 Day)||17
7815332|NCT01133392|19239329|P1|STARTED|Second Intervention (1 Day)||20
7815333|NCT01133392|19239328|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
7815334|NCT01133392|19239329|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
7815335|NCT01133392|19239328|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
7815336|NCT01133392|19239329|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
7815337|NCT01133392|19239328|P2|STARTED|Interval Between Dosing (4-7 Days)||18
7815338|NCT01133392|19239329|P1|STARTED|Interval Between Dosing (4-7 Days)||20
7815339|NCT01133392|19239328|P2|NOT COMPLETED|First Intervention (1 Day )||0
7815340|NCT01133392|19239329|P1|NOT COMPLETED|First Intervention (1 Day )||0
7815341|NCT01133392|19239328|P2|COMPLETED|First Intervention (1 Day )||18
7815342|NCT01133392|19239329|P1|COMPLETED|First Intervention (1 Day )||20
7815343|NCT01133392|19239328|P2|STARTED|First Intervention (1 Day )||18
7815344|NCT01133392|19239329|P1|STARTED|First Intervention (1 Day )||20
7815345|NCT01133379|19239346|P3|NOT COMPLETED|Overall Study||2
7815346|NCT01133379|19239347|P2|NOT COMPLETED|Overall Study||2
7815347|NCT01133379|19239348|P1|NOT COMPLETED|Overall Study||1
7815348|NCT01133379|19239346|P3|COMPLETED|Overall Study||56
7815349|NCT01133379|19239347|P2|COMPLETED|Overall Study||56
7815350|NCT01133379|19239348|P1|COMPLETED|Overall Study||57
7815351|NCT01133379|19239346|P3|STARTED|Overall Study||58
7815352|NCT01133379|19239347|P2|STARTED|Overall Study||58
7815353|NCT01133379|19239348|P1|STARTED|Overall Study||58
7815354|NCT01133288|19239401|P1|NOT COMPLETED|Intervention Allocation||2
7815355|NCT01133288|19239401|P1|COMPLETED|Intervention Allocation||0
7815356|NCT01133288|19239401|P1|STARTED|Intervention Allocation||2
7815357|NCT01133288|19239401|P1|NOT COMPLETED|Eligibility Assessment||5
7815358|NCT01133288|19239401|P1|COMPLETED|Eligibility Assessment||2
7815359|NCT01133288|19239401|P1|STARTED|Eligibility Assessment||7
7815360|NCT01133275|19239406|P1|NOT COMPLETED|Overall Study||2
7815361|NCT01133275|19239406|P1|COMPLETED|Overall Study||26
7815362|NCT01133275|19239406|P1|STARTED|Overall Study||28
7815363|NCT01133171|19239414|P3|NOT COMPLETED|Overall Study||0
7815364|NCT01133171|19239415|P2|NOT COMPLETED|Overall Study||2
7815365|NCT01133171|19239416|P1|NOT COMPLETED|Overall Study||1
7815366|NCT01133171|19239414|P3|COMPLETED|Overall Study||25
7815367|NCT01133171|19239415|P2|COMPLETED|Overall Study||25
7815368|NCT01133171|19239416|P1|COMPLETED|Overall Study||24
7815369|NCT01133171|19239414|P3|STARTED|Overall Study||25
7815370|NCT01133171|19239415|P2|STARTED|Overall Study||27
7815371|NCT01133171|19239416|P1|STARTED|Overall Study||25
7815372|NCT01133158|19239426|P1|NOT COMPLETED|Overall Study||17
7815373|NCT01133158|19239426|P1|COMPLETED|Overall Study||43
7815374|NCT01133158|19239426|P1|STARTED|Overall Study||60
7815375|NCT01133067|19239432|P1|NOT COMPLETED|Overall Study||139
7815376|NCT01133067|19239432|P1|COMPLETED|Overall Study||61
7815377|NCT01133067|19239432|P1|STARTED|Overall Study||200
7815378|NCT01132846|19239440|P3|NOT COMPLETED|Overall Study||11
7815379|NCT01132846|19239441|P2|NOT COMPLETED|Overall Study||18
7815380|NCT01132846|19239442|P1|NOT COMPLETED|Overall Study||16
7815381|NCT01132846|19239440|P3|COMPLETED|Overall Study||108
7815382|NCT01132846|19239441|P2|COMPLETED|Overall Study||101
7815383|NCT01132846|19239442|P1|COMPLETED|Overall Study||106
7815384|NCT01132846|19239440|P3|STARTED|Overall Study||119
7815385|NCT01132846|19239441|P2|STARTED|Overall Study||119
7815386|NCT01132846|19239442|P1|STARTED|Overall Study||122
7815387|NCT01132820|19239492|P1|NOT COMPLETED|Overall Study||5
7815388|NCT01132820|19239492|P1|COMPLETED|Overall Study||48
7815389|NCT01132820|19239492|P1|STARTED|Overall Study||53
7815390|NCT01132755|19239501|P1|NOT COMPLETED|Overall Study||42
7815391|NCT01132755|19239501|P1|COMPLETED|Overall Study||70
7815392|NCT01132755|19239501|P1|STARTED|Overall Study||112
7815393|NCT01132690|19239508|P2|NOT COMPLETED|Overall Study||0
7815394|NCT01132690|19239509|P1|NOT COMPLETED|Overall Study||0
7815395|NCT01132690|19239508|P2|COMPLETED|Overall Study||5
7815396|NCT01132690|19239509|P1|COMPLETED|Overall Study||6
7815397|NCT01132690|19239508|P2|STARTED|Overall Study||5
7815398|NCT01132690|19239509|P1|STARTED|Overall Study||6
7815399|NCT01132664|19239530|P5|NOT COMPLETED|BM Cohort||6
7815400|NCT01132664|19239531|P4|NOT COMPLETED|BM Cohort||3
7815401|NCT01132664|19239532|P3|NOT COMPLETED|BM Cohort||0
7815402|NCT01132664|19239533|P2|NOT COMPLETED|BM Cohort||0
7815403|NCT01132664|19239534|P1|NOT COMPLETED|BM Cohort||0
7815404|NCT01132664|19239530|P5|COMPLETED|BM Cohort||0
7815405|NCT01132664|19239531|P4|COMPLETED|BM Cohort||0
7815406|NCT01132664|19239532|P3|COMPLETED|BM Cohort||0
7815407|NCT01132664|19239533|P2|COMPLETED|BM Cohort||0
7815408|NCT01132664|19239534|P1|COMPLETED|BM Cohort||0
7815409|NCT01132664|19239530|P5|STARTED|BM Cohort||6
7815410|NCT01132664|19239531|P4|STARTED|BM Cohort||3
7815411|NCT01132664|19239532|P3|STARTED|BM Cohort||0
7815412|NCT01132664|19239533|P2|STARTED|BM Cohort||0
7815413|NCT01132664|19239534|P1|STARTED|BM Cohort||0
7815414|NCT01132664|19239530|P5|NOT COMPLETED|Phase ll||0
7815415|NCT01132664|19239531|P4|NOT COMPLETED|Phase ll||0
7815416|NCT01132664|19239532|P3|NOT COMPLETED|Phase ll||50
7815417|NCT01132664|19239533|P2|NOT COMPLETED|Phase ll||0
7815418|NCT01132664|19239534|P1|NOT COMPLETED|Phase ll||0
7815419|NCT01132664|19239530|P5|COMPLETED|Phase ll||0
7815420|NCT01132664|19239531|P4|COMPLETED|Phase ll||0
7815421|NCT01132664|19239532|P3|COMPLETED|Phase ll||0
7815422|NCT01132664|19239533|P2|COMPLETED|Phase ll||0
7815423|NCT01132664|19239534|P1|COMPLETED|Phase ll||0
7815424|NCT01132664|19239530|P5|STARTED|Phase ll||0
7815425|NCT01132664|19239531|P4|STARTED|Phase ll||0
7815426|NCT01132664|19239532|P3|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50
7815427|NCT01132664|19239533|P2|STARTED|Phase ll||0
7815428|NCT01132664|19239534|P1|STARTED|Phase ll||0
7815429|NCT01132664|19239530|P5|NOT COMPLETED|Phase lb||0
7815430|NCT01132664|19239531|P4|NOT COMPLETED|Phase lb||0
7815431|NCT01132664|19239532|P3|NOT COMPLETED|Phase lb||0
7815432|NCT01132664|19239533|P2|NOT COMPLETED|Phase lb||12
7815433|NCT01132664|19239534|P1|NOT COMPLETED|Phase lb||5
7815434|NCT01132664|19239530|P5|COMPLETED|Phase lb||0
7815435|NCT01132664|19239531|P4|COMPLETED|Phase lb||0
7815436|NCT01132664|19239532|P3|COMPLETED|Phase lb||0
7815437|NCT01132664|19239533|P2|COMPLETED|Phase lb||0
7815438|NCT01132664|19239534|P1|COMPLETED|Phase lb||0
7815439|NCT01132664|19239530|P5|STARTED|Phase lb||0
7815440|NCT01132664|19239531|P4|STARTED|Phase lb||0
7815441|NCT01132664|19239532|P3|STARTED|Phase lb||0
7815442|NCT01132664|19239533|P2|STARTED|Phase lb||12
7815443|NCT01132664|19239534|P1|STARTED|Phase lb||5
7815444|NCT01132651|19239568|P2|NOT COMPLETED|Overall Study||1
7815445|NCT01132651|19239569|P1|NOT COMPLETED|Overall Study||1
7815446|NCT01132651|19239568|P2|COMPLETED|Overall Study||4
7815447|NCT01132651|19239569|P1|COMPLETED|Overall Study||3
7815448|NCT01132651|19239568|P2|STARTED|Overall Study||5
7815449|NCT01132651|19239569|P1|STARTED|Overall Study||4
7815450|NCT01132612|19239580|P3|NOT COMPLETED|Overall Study||170
7815451|NCT01132612|19239581|P2|NOT COMPLETED|Overall Study||35
7815452|NCT01132612|19239582|P1|NOT COMPLETED|Overall Study||40
7815453|NCT01132612|19239580|P3|COMPLETED|Overall Study||17
7815454|NCT01132612|19239581|P2|COMPLETED|Overall Study||7
7815455|NCT01132612|19239582|P1|COMPLETED|Overall Study||6
7815456|NCT01132612|19239580|P3|STARTED|Overall Study||187
7815457|NCT01132612|19239581|P2|STARTED|Overall Study||42
7815458|NCT01132612|19239582|P1|STARTED|Overall Study||46
7815459|NCT01132547|19239598|P2|NOT COMPLETED|Overall Study||1
7815460|NCT01132547|19239599|P1|NOT COMPLETED|Overall Study||4
7815461|NCT01132547|19239598|P2|COMPLETED|Overall Study||12
7815462|NCT01132547|19239599|P1|COMPLETED|Overall Study||5
7815463|NCT01132547|19239598|P2|STARTED|Overall Study||13
7815464|NCT01132547|19239599|P1|STARTED|Overall Study||9
7815465|NCT01132508|19239609|P1|NOT COMPLETED|Overall Study||9
7815466|NCT01132508|19239609|P1|COMPLETED|Overall Study||24
7815467|NCT01132508|19239609|P1|104 Weeks|Overall Study||27
7815468|NCT01132508|19239609|P1|78 Weeks|Overall Study||28
7815469|NCT01132508|19239609|P1|52 Weeks|Overall Study||30
7815470|NCT01132508|19239609|P1|26 Weeks|Overall Study||33
7815471|NCT01132508|19239609|P1|12 Weeks|Overall Study||33
7815472|NCT01132508|19239609|P1|6 Weeks|Overall Study||33
7815473|NCT01132508|19239609|P1|Treated at Baseline|Overall Study||33
7815474|NCT01132508|19239609|P1|STARTED|Overall Study||33
7815475|NCT01132495|19239669|P4|NOT COMPLETED|Overall Study||12
7815476|NCT01132495|19239670|P3|NOT COMPLETED|Overall Study||20
7815477|NCT01132495|19239671|P2|NOT COMPLETED|Overall Study||38
7815478|NCT01132495|19239672|P1|NOT COMPLETED|Overall Study||40
7815479|NCT01132495|19239669|P4|COMPLETED|Overall Study||104
7815480|NCT01132495|19239670|P3|COMPLETED|Overall Study||146
7815481|NCT01132495|19239671|P2|COMPLETED|Overall Study||403
7815482|NCT01132495|19239672|P1|COMPLETED|Overall Study||407
7815483|NCT01132495|19239669|P4|STARTED|Overall Study||116
7815484|NCT01132495|19239670|P3|STARTED|Overall Study||166
7815485|NCT01132495|19239671|P2|STARTED|Overall Study||441
7815486|NCT01132495|19239672|P1|STARTED|Overall Study||447
7815487|NCT01132482|19239685|P2|NOT COMPLETED|Overall Study||0
7815488|NCT01132482|19239686|P1|NOT COMPLETED|Overall Study||1
7815489|NCT01132482|19239685|P2|COMPLETED|Overall Study||6
7815490|NCT01132482|19239686|P1|COMPLETED|Overall Study||12
7815491|NCT01132482|19239685|P2|STARTED|Overall Study||6
7815492|NCT01132482|19239686|P1|STARTED|Overall Study||13
7815493|NCT01132378|19239704|P1|NOT COMPLETED|Overall Study||0
7815494|NCT01132378|19239704|P1|COMPLETED|Overall Study||40
7815495|NCT01132378|19239704|P1|STARTED|Overall Study||40
7815496|NCT01132326|19239709|P1|NOT COMPLETED|Overall Study||218
7815497|NCT01132326|19239709|P1|COMPLETED|Overall Study||132
7815498|NCT01132326|19239709|P1|STARTED|Overall Study||350
7815499|NCT01132313|19239725|P12|NOT COMPLETED|Overall Study||0
7815500|NCT01132313|19239726|P11|NOT COMPLETED|Overall Study||1
7815501|NCT01132313|19239727|P10|NOT COMPLETED|Overall Study||20
7815502|NCT01132313|19239728|P9|NOT COMPLETED|Overall Study||21
7815503|NCT01132313|19239729|P8|NOT COMPLETED|Overall Study||8
7815504|NCT01132313|19239730|P7|NOT COMPLETED|Overall Study||30
7815505|NCT01132313|19239731|P6|NOT COMPLETED|Overall Study||25
7815506|NCT01132313|19239732|P5|NOT COMPLETED|Overall Study||45
7815507|NCT01132313|19239733|P4|NOT COMPLETED|Overall Study||32
7815508|NCT01132313|19239734|P3|NOT COMPLETED|Overall Study||20
7815509|NCT01132313|19239735|P2|NOT COMPLETED|Overall Study||0
7815510|NCT01132313|19239736|P1|NOT COMPLETED|Overall Study||3
7815511|NCT01132313|19239725|P12|COMPLETED|Overall Study||2
7815512|NCT01132313|19239726|P11|COMPLETED|Overall Study||0
7815513|NCT01132313|19239727|P10|COMPLETED|Overall Study||5
7815514|NCT01132313|19239728|P9|COMPLETED|Overall Study||5
7815515|NCT01132313|19239729|P8|COMPLETED|Overall Study||24
7815516|NCT01132313|19239730|P7|COMPLETED|Overall Study||19
7815517|NCT01132313|19239731|P6|COMPLETED|Overall Study||54
7815518|NCT01132313|19239732|P5|COMPLETED|Overall Study||34
7815519|NCT01132313|19239733|P4|COMPLETED|Overall Study||48
7815520|NCT01132313|19239734|P3|COMPLETED|Overall Study||61
7815521|NCT01132313|19239735|P2|COMPLETED|Overall Study||17
7815522|NCT01132313|19239736|P1|COMPLETED|Overall Study||14
7815523|NCT01132313|19239725|P12|STARTED|Overall Study||2
7815524|NCT01132313|19239726|P11|STARTED|Overall Study||1
7815525|NCT01132313|19239727|P10|STARTED|Overall Study||25
7815526|NCT01132313|19239728|P9|STARTED|Overall Study||26
7815527|NCT01132313|19239729|P8|STARTED|Overall Study||32
7815528|NCT01132313|19239730|P7|STARTED|Overall Study||49
7815529|NCT01132313|19239731|P6|STARTED|Overall Study||79
7815530|NCT01132313|19239732|P5|STARTED|Overall Study||79
7815531|NCT01132313|19239733|P4|STARTED|Overall Study||80
7815532|NCT01132313|19239734|P3|STARTED|Overall Study||81
7815533|NCT01132313|19239735|P2|STARTED|Overall Study||17
7815534|NCT01132313|19239736|P1|STARTED|Overall Study||17
7815535|NCT01132144|19239793|P2|NOT COMPLETED|Overall Study||0
7815536|NCT01132144|19239794|P1|NOT COMPLETED|Overall Study||0
7815537|NCT01132144|19239793|P2|COMPLETED|Overall Study||79
7815538|NCT01132144|19239794|P1|COMPLETED|Overall Study||79
7815539|NCT01132144|19239793|P2|STARTED|Overall Study||79
7815540|NCT01132144|19239794|P1|STARTED|Overall Study||79
7815541|NCT01132118|19239816|P2|NOT COMPLETED|Second Intervention (8 Weeks)||1
7815542|NCT01132118|19239817|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
7815543|NCT01132118|19239816|P2|COMPLETED|Second Intervention (8 Weeks)||11
7815544|NCT01132118|19239817|P1|COMPLETED|Second Intervention (8 Weeks)||12
7815545|NCT01132118|19239816|P2|STARTED|Second Intervention (8 Weeks)||12
7815546|NCT01132118|19239817|P1|STARTED|Second Intervention (8 Weeks)||12
7815547|NCT01132118|19239816|P2|NOT COMPLETED|First Intervention (8 Weeks)||3
7815548|NCT01132118|19239817|P1|NOT COMPLETED|First Intervention (8 Weeks)||3
7815549|NCT01132118|19239816|P2|COMPLETED|First Intervention (8 Weeks)||12
7815550|NCT01132118|19239817|P1|COMPLETED|First Intervention (8 Weeks)||12
7815551|NCT01132118|19239816|P2|STARTED|First Intervention (8 Weeks)||15
7815552|NCT01132118|19239817|P1|STARTED|First Intervention (8 Weeks)||15
7815553|NCT01131884|19239837|P2|NOT COMPLETED|Overall Study||0
7815554|NCT01131884|19239838|P1|NOT COMPLETED|Overall Study||0
7815555|NCT01131884|19239837|P2|COMPLETED|Overall Study||0
7815556|NCT01131884|19239838|P1|COMPLETED|Overall Study||1
7815557|NCT01131884|19239837|P2|STARTED|Overall Study||0
7815558|NCT01131884|19239838|P1|STARTED|Overall Study||1
7815559|NCT01131676|19239847|P3|NOT COMPLETED|Discontinuation From Study (Treated Set)||63
7815560|NCT01131676|19239848|P2|NOT COMPLETED|Discontinuation From Study (Treated Set)||81
7815561|NCT01131676|19239849|P1|NOT COMPLETED|Discontinuation From Study (Treated Set)||67
7815562|NCT01131676|19239847|P3|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279
7815563|NCT01131676|19239848|P2|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264
7815564|NCT01131676|19239849|P1|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266
7815565|NCT01131676|19239847|P3|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327
7815566|NCT01131676|19239848|P2|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324
7815567|NCT01131676|19239849|P1|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316
7815568|NCT01131676|19239847|P3|STARTED|Discontinuation From Study (Treated Set)||2342
7815569|NCT01131676|19239848|P2|STARTED|Discontinuation From Study (Treated Set)||2345
7815570|NCT01131676|19239849|P1|STARTED|Discontinuation From Study (Treated Set)||2333
7815571|NCT01131676|19239847|P3|NOT COMPLETED|Discontinuation From Treatment||544
7815572|NCT01131676|19239848|P2|NOT COMPLETED|Discontinuation From Treatment||557
7815573|NCT01131676|19239849|P1|NOT COMPLETED|Discontinuation From Treatment||687
7815574|NCT01131676|19239847|P3|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800
7815575|NCT01131676|19239848|P2|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790
7815576|NCT01131676|19239849|P1|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650
7815577|NCT01131676|19239847|P3|STARTED|Discontinuation From Treatment|Randomised|2344
7815578|NCT01131676|19239848|P2|STARTED|Discontinuation From Treatment|Randomised|2347
7815579|NCT01131676|19239849|P1|STARTED|Discontinuation From Treatment|Randomised|2337
7815580|NCT01131585|19239884|P2|NOT COMPLETED|Overall Study||43
7815581|NCT01131585|19239885|P1|NOT COMPLETED|Overall Study||85
7815582|NCT01131585|19239884|P2|COMPLETED|Overall Study||0
7815583|NCT01131585|19239885|P1|COMPLETED|Overall Study||0
7815584|NCT01131585|19239884|P2|STARTED|Overall Study||43
7815585|NCT01131585|19239885|P1|STARTED|Overall Study||85
7815586|NCT01131520|19239893|P2|NOT COMPLETED|Overall Study||4
7815587|NCT01131520|19239894|P1|NOT COMPLETED|Overall Study||1
7815588|NCT01131520|19239893|P2|COMPLETED|Overall Study||176
7815589|NCT01131520|19239894|P1|COMPLETED|Overall Study||179
7815590|NCT01131520|19239893|P2|STARTED|Overall Study||180
7815591|NCT01131520|19239894|P1|STARTED|Overall Study||180
7815592|NCT01131507|19239916|P1|NOT COMPLETED|Overall Study||3
7815593|NCT01131507|19239916|P1|COMPLETED|Overall Study||12
7815594|NCT01131507|19239916|P1|STARTED|Overall Study||15
7815595|NCT01131494|19239921|P1|NOT COMPLETED|Overall Study||2
7815596|NCT01131494|19239921|P1|COMPLETED|Overall Study||15
7815597|NCT01131494|19239921|P1|STARTED|Overall Study||17
7815598|NCT01131455|19239931|P3|NOT COMPLETED|Overall Study||0
7815599|NCT01131455|19239932|P2|NOT COMPLETED|Overall Study||4
7815600|NCT01131455|19239933|P1|NOT COMPLETED|Overall Study||6
7815601|NCT01131455|19239931|P3|COMPLETED|Overall Study||0
7815602|NCT01131455|19239932|P2|COMPLETED|Overall Study||0
7815603|NCT01131455|19239933|P1|COMPLETED|Overall Study||0
7815604|NCT01131455|19239931|P3|STARTED|Overall Study||0
7815605|NCT01131455|19239932|P2|STARTED|Overall Study||4
7815606|NCT01131455|19239933|P1|STARTED|Overall Study||6
7815607|NCT01131312|19239944|P3|NOT COMPLETED|Overall Study||351
7815608|NCT01131312|19239945|P2|NOT COMPLETED|Overall Study||229
7815609|NCT01131312|19239946|P1|NOT COMPLETED|Overall Study||425
7815610|NCT01131312|19239944|P3|COMPLETED|Overall Study||1485
7815611|NCT01131312|19239945|P2|COMPLETED|Overall Study||1156
7815612|NCT01131312|19239946|P1|COMPLETED|Overall Study||1414
7815613|NCT01131312|19239944|P3|STARTED|Overall Study||1836
7815614|NCT01131312|19239945|P2|STARTED|Overall Study||1385
7815615|NCT01131312|19239946|P1|STARTED|Overall Study||1839
7815616|NCT01131299|19239957|P2|NOT COMPLETED|Overall Study||7
7815617|NCT01131299|19239958|P1|NOT COMPLETED|Overall Study||4
7815618|NCT01131299|19239957|P2|COMPLETED|Overall Study||37
7815619|NCT01131299|19239958|P1|COMPLETED|Overall Study||38
7815620|NCT01131299|19239957|P2|STARTED|Overall Study||44
7815621|NCT01131299|19239958|P1|STARTED|Overall Study||42
7815622|NCT01131260|19239971|P2|NOT COMPLETED|Overall Study||47
7815623|NCT01131260|19239972|P1|NOT COMPLETED|Overall Study||44
7815624|NCT01131260|19239971|P2|COMPLETED|Overall Study||5529
7815625|NCT01131260|19239972|P1|COMPLETED|Overall Study||5488
7815626|NCT01131260|19239971|P2|STARTED|Overall Study||5576
7815627|NCT01131260|19239972|P1|STARTED|Overall Study||5532
7815628|NCT01131182|19240020|P2|NOT COMPLETED|Overall Study||16
7815629|NCT01131182|19240021|P1|NOT COMPLETED|Overall Study||16
7815630|NCT01131182|19240020|P2|COMPLETED|Overall Study||521
7815631|NCT01131182|19240021|P1|COMPLETED|Overall Study||513
7815632|NCT01131182|19240020|P2|STARTED|Overall Study||537
7815633|NCT01131182|19240021|P1|STARTED|Overall Study||529
7815634|NCT01131130|19240029|P1|NOT COMPLETED|Period 3- Crossover||1
7815635|NCT01131130|19240029|P1|COMPLETED|Period 3- Crossover||116
7815636|NCT01131130|19240029|P1|STARTED|Period 3- Crossover||117
7815637|NCT01131130|19240029|P1|NOT COMPLETED|Period 2 - Crossover||0
7815638|NCT01131130|19240029|P1|COMPLETED|Period 2 - Crossover||117
7815639|NCT01131130|19240029|P1|STARTED|Period 2 - Crossover||117
7815640|NCT01131130|19240029|P1|NOT COMPLETED|Period 1 - Baseline||1
7815641|NCT01131130|19240029|P1|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117
7815642|NCT01131130|19240029|P1|STARTED|Period 1 - Baseline||118
7815643|NCT01131104|19240042|P1|NOT COMPLETED|Overall Study||13
7815644|NCT01131104|19240042|P1|COMPLETED|Overall Study||332
7815645|NCT01131104|19240042|P1|12-Month Analysis Set|Overall Study||26
7815646|NCT01131104|19240042|P1|42-Day Analysis Set|Overall Study||28
7815647|NCT01131104|19240042|P1|30-Day Analysis Set|Overall Study||24
7815648|NCT01131104|19240042|P1|Adjudication-Confirmed NAION Set|Overall Study||279
7815649|NCT01131104|19240042|P1|Study Set|Overall Study||344
7815650|NCT01131104|19240042|P1|STARTED|Overall Study||345
7815651|NCT01131078|19240049|P3|NOT COMPLETED|Overall Study||102
7815652|NCT01131078|19240050|P2|NOT COMPLETED|Overall Study||101
7815653|NCT01131078|19240051|P1|NOT COMPLETED|Overall Study||101
7815654|NCT01131078|19240049|P3|COMPLETED|Overall Study||1
7815655|NCT01131078|19240050|P2|COMPLETED|Overall Study||1
7815656|NCT01131078|19240051|P1|COMPLETED|Overall Study||0
7815657|NCT01131078|19240049|P3|STARTED|Overall Study||103
7815658|NCT01131078|19240050|P2|STARTED|Overall Study||102
7815659|NCT01131078|19240051|P1|STARTED|Overall Study||101
7815660|NCT01131065|19240107|P1|NOT COMPLETED|Overall Study||0
7815661|NCT01131065|19240107|P1|COMPLETED|Overall Study||15
7815662|NCT01131065|19240107|P1|STARTED|Overall Study||15
7815663|NCT01131052|19240115|P2|NOT COMPLETED|Overall Study||0
7815664|NCT01131052|19240116|P1|NOT COMPLETED|Overall Study||0
7815665|NCT01131052|19240115|P2|COMPLETED|Overall Study||75
7815666|NCT01131052|19240116|P1|COMPLETED|Overall Study||75
7815667|NCT01131052|19240115|P2|STARTED|Overall Study||75
7815668|NCT01131052|19240116|P1|STARTED|Overall Study||75
7815669|NCT01130974|19240138|P2|NOT COMPLETED|Overall Study||13
7815670|NCT01130974|19240139|P1|NOT COMPLETED|Overall Study||15
7815671|NCT01130974|19240138|P2|COMPLETED|Overall Study||87
7815672|NCT01130974|19240139|P1|COMPLETED|Overall Study||85
7815673|NCT01130974|19240138|P2|STARTED|Overall Study||100
7815674|NCT01130974|19240139|P1|STARTED|Overall Study||100
7815675|NCT01130896|19240159|P1|NOT COMPLETED|Overall Study||0
7815676|NCT01130896|19240159|P1|COMPLETED|Overall Study||1509
7815677|NCT01130896|19240159|P1|STARTED|Overall Study||1509
7815678|NCT01130883|19240165|P1|NOT COMPLETED|Overall Study||10
7815679|NCT01130883|19240165|P1|COMPLETED|Overall Study||3120
7815680|NCT01130883|19240165|P1|Participants Analyzed|Overall Study||3128
7815681|NCT01130883|19240165|P1|STARTED|Overall Study||3130
7815682|NCT01130844|19240182|P3|NOT COMPLETED|Overall Study||0
7815683|NCT01130844|19240183|P2|NOT COMPLETED|Overall Study||0
7815684|NCT01130844|19240184|P1|NOT COMPLETED|Overall Study||0
7815685|NCT01130844|19240182|P3|COMPLETED|Overall Study||9
7815686|NCT01130844|19240183|P2|COMPLETED|Overall Study||22
7815687|NCT01130844|19240184|P1|COMPLETED|Overall Study||21
7815688|NCT01130844|19240182|P3|STARTED|Overall Study||9
7815689|NCT01130844|19240183|P2|STARTED|Overall Study||22
7815690|NCT01130844|19240184|P1|STARTED|Overall Study||21
7815691|NCT01130831|19240222|P1|NOT COMPLETED|Overall Study||14
7815692|NCT01130831|19240222|P1|COMPLETED|Overall Study||52
7815693|NCT01130831|19240222|P1|STARTED|Overall Study||66
7815694|NCT01130740|19240250|P2|NOT COMPLETED|Overall Study||15
7815695|NCT01130740|19240251|P1|NOT COMPLETED|Overall Study||12
7815696|NCT01130740|19240250|P2|COMPLETED|Overall Study||136
7815697|NCT01130740|19240251|P1|COMPLETED|Overall Study||137
7815698|NCT01130740|19240250|P2|STARTED|Overall Study||151
7815699|NCT01130740|19240251|P1|STARTED|Overall Study||149
7815700|NCT01130597|19240261|P1|NOT COMPLETED|Overall Study||7
7815701|NCT01130597|19240261|P1|COMPLETED|Overall Study||56
7815702|NCT01130597|19240261|P1|STARTED|Overall Study||63
7815703|NCT01130532|19240286|P4|NOT COMPLETED|Period IV (Weeks 13-16)||10
7815704|NCT01130532|19240287|P3|NOT COMPLETED|Period IV (Weeks 13-16)||0
7815705|NCT01130532|19240288|P2|NOT COMPLETED|Period IV (Weeks 13-16)||0
7815706|NCT01130532|19240289|P1|NOT COMPLETED|Period IV (Weeks 13-16)||0
7815707|NCT01130532|19240286|P4|COMPLETED|Period IV (Weeks 13-16)||552
7815708|NCT01130532|19240287|P3|COMPLETED|Period IV (Weeks 13-16)||0
7815709|NCT01130532|19240288|P2|COMPLETED|Period IV (Weeks 13-16)||0
7815710|NCT01130532|19240289|P1|COMPLETED|Period IV (Weeks 13-16)||0
7815711|NCT01130532|19240286|P4|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546
7815712|NCT01130532|19240287|P3|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
7815713|NCT01130532|19240288|P2|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
7815714|NCT01130532|19240289|P1|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
7815715|NCT01130532|19240286|P4|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562
7815716|NCT01130532|19240287|P3|STARTED|Period IV (Weeks 13-16)||0
7815717|NCT01130532|19240288|P2|STARTED|Period IV (Weeks 13-16)||0
7815718|NCT01130532|19240289|P1|STARTED|Period IV (Weeks 13-16)||0
7815719|NCT01130532|19240286|P4|NOT COMPLETED|Period III (Weeks 0-12)||0
7815720|NCT01130532|19240287|P3|NOT COMPLETED|Period III (Weeks 0-12)||19
7815721|NCT01130532|19240288|P2|NOT COMPLETED|Period III (Weeks 0-12)||18
7815722|NCT01130532|19240289|P1|NOT COMPLETED|Period III (Weeks 0-12)||21
7815723|NCT01130532|19240286|P4|COMPLETED|Period III (Weeks 0-12)||0
7815724|NCT01130532|19240287|P3|COMPLETED|Period III (Weeks 0-12)||190
7815725|NCT01130532|19240288|P2|COMPLETED|Period III (Weeks 0-12)||189
7815726|NCT01130532|19240289|P1|COMPLETED|Period III (Weeks 0-12)||186
7815727|NCT01130532|19240286|P4|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0
7815728|NCT01130532|19240287|P3|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207
7815729|NCT01130532|19240288|P2|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
7815730|NCT01130532|19240289|P1|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
7815731|NCT01130532|19240286|P4|STARTED|Period III (Weeks 0-12)||0
7815732|NCT01130532|19240287|P3|STARTED|Period III (Weeks 0-12)||209
7815733|NCT01130532|19240288|P2|STARTED|Period III (Weeks 0-12)||207
7815734|NCT01130532|19240289|P1|STARTED|Period III (Weeks 0-12)||207
7815735|NCT01130493|19240334|P3|NOT COMPLETED|Part 2: OLE||5
7815736|NCT01130493|19240335|P2|NOT COMPLETED|Part 2: OLE||3
7815737|NCT01130493|19240336|P1|NOT COMPLETED|Part 2: OLE||0
7815738|NCT01130493|19240334|P3|COMPLETED|Part 2: OLE||30
7815739|NCT01130493|19240335|P2|COMPLETED|Part 2: OLE||36
7815740|NCT01130493|19240336|P1|COMPLETED|Part 2: OLE||0
7815741|NCT01130493|19240334|P3|STARTED|Part 2: OLE|No subjects received CLE during OLE|35
7815742|NCT01130493|19240335|P2|STARTED|Part 2: OLE|All subjects received IPX066 during OLE|39
7815743|NCT01130493|19240336|P1|STARTED|Part 2: OLE||0
7815744|NCT01130493|19240334|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||2
7815745|NCT01130493|19240335|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
7815746|NCT01130493|19240336|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
7815747|NCT01130493|19240334|P3|COMPLETED|Part 1: Double-blind Treatment Period 2||39
7815748|NCT01130493|19240335|P2|COMPLETED|Part 1: Double-blind Treatment Period 2||45
7815749|NCT01130493|19240336|P1|COMPLETED|Part 1: Double-blind Treatment Period 2||0
7815750|NCT01130493|19240334|P3|STARTED|Part 1: Double-blind Treatment Period 2||41
7815751|NCT01130493|19240335|P2|STARTED|Part 1: Double-blind Treatment Period 2||45
7815752|NCT01130493|19240336|P1|STARTED|Part 1: Double-blind Treatment Period 2||0
7815753|NCT01130493|19240334|P3|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||2
7815754|NCT01130493|19240335|P2|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||1
7815755|NCT01130493|19240336|P1|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||0
7815756|NCT01130493|19240334|P3|COMPLETED|Part 1: Open-Label IPX066 Washout||41
7815757|NCT01130493|19240335|P2|COMPLETED|Part 1: Open-Label IPX066 Washout||45
7815758|NCT01130493|19240336|P1|COMPLETED|Part 1: Open-Label IPX066 Washout||0
7815759|NCT01130493|19240334|P3|STARTED|Part 1: Open-Label IPX066 Washout||43
7815760|NCT01130493|19240335|P2|STARTED|Part 1: Open-Label IPX066 Washout||46
7815761|NCT01130493|19240336|P1|STARTED|Part 1: Open-Label IPX066 Washout||0
7815762|NCT01130493|19240334|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
7815763|NCT01130493|19240335|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||2
7815764|NCT01130493|19240336|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
7815765|NCT01130493|19240334|P3|COMPLETED|Part 1: Double-blind Treatment Period 1||43
7815766|NCT01130493|19240335|P2|COMPLETED|Part 1: Double-blind Treatment Period 1||46
7815767|NCT01130493|19240336|P1|COMPLETED|Part 1: Double-blind Treatment Period 1||0
7815768|NCT01130493|19240334|P3|STARTED|Part 1: Double-blind Treatment Period 1|43 were randomized to CLE-IPX066 double-blind treatment sequence|43
7815769|NCT01130493|19240335|P2|STARTED|Part 1: Double-blind Treatment Period 1|48 were randomized to IPX066-CLE double-blind treatment sequence|48
7815770|NCT01130493|19240336|P1|STARTED|Part 1: Double-blind Treatment Period 1|91 subjects completed IPX066 dose conversion and were then randomized to the two treatment sequences|0
7815771|NCT01130493|19240334|P3|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
7815772|NCT01130493|19240335|P2|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
7815773|NCT01130493|19240336|P1|NOT COMPLETED|Open-label Dose Conversion to IPX066||19
7815774|NCT01130493|19240334|P3|COMPLETED|Open-label Dose Conversion to IPX066||0
7815775|NCT01130493|19240335|P2|COMPLETED|Open-label Dose Conversion to IPX066||0
7815776|NCT01130493|19240336|P1|COMPLETED|Open-label Dose Conversion to IPX066||91
7815777|NCT01130493|19240334|P3|STARTED|Open-label Dose Conversion to IPX066||0
7815778|NCT01130493|19240335|P2|STARTED|Open-label Dose Conversion to IPX066||0
7815779|NCT01130493|19240336|P1|STARTED|Open-label Dose Conversion to IPX066|During the open-label dose conversion to IPX066, all subjects received IPX066|110
7815780|NCT01130337|19240353|P1|NOT COMPLETED|Overall Study||14
7815781|NCT01130337|19240353|P1|COMPLETED|Overall Study||22
7815782|NCT01130337|19240353|P1|STARTED|Overall Study||36
7815783|NCT01130272|19240365|P5|NOT COMPLETED|Overall Study||52
7815784|NCT01130272|19240366|P4|NOT COMPLETED|Overall Study||68
7815785|NCT01130272|19240367|P3|NOT COMPLETED|Overall Study||48
7815786|NCT01130272|19240368|P2|NOT COMPLETED|Overall Study||42
7815787|NCT01130272|19240369|P1|NOT COMPLETED|Overall Study||59
7815788|NCT01130272|19240365|P5|COMPLETED|Overall Study||117
7815789|NCT01130272|19240366|P4|COMPLETED|Overall Study||103
7815790|NCT01130272|19240367|P3|COMPLETED|Overall Study||121
7815791|NCT01130272|19240368|P2|COMPLETED|Overall Study||131
7815792|NCT01130272|19240369|P1|COMPLETED|Overall Study||48
7815793|NCT01130272|19240365|P5|Safety Analysis Set: Highest Dose Level|Overall Study|159 total represents 2 patients out to 25 mg arm; 1 patient out to 5 mg arm.|159
7815794|NCT01130272|19240366|P4|Safety Analysis Set: Highest Dose Level|Overall Study|172 total represents 1 patient in from 5 mg; 3 patients in from 25 mg;1 patient in from 100 mg arms.|172
7815795|NCT01130272|19240367|P3|Safety Analysis Set: Highest Dose Level|Overall Study|165 total represents 1 patient out to 200 mg arm.|165
7815796|NCT01130272|19240368|P2|Safety Analysis Set: Highest Dose Level|Overall Study|170 total represents 2 patients in from Placebo arm; 3 patients out to 200 mg arm.|170
7815797|NCT01130272|19240369|P1|Safety Analysis Set: Highest Dose Level|Overall Study|105 total represents 1 patient in from Placebo arm; 1 patient out to 200 mg arm.|105
7815798|NCT01130272|19240365|P5|Safety Analysis Set: as Randomized|Overall Study||162
7815799|NCT01130272|19240366|P4|Safety Analysis Set: as Randomized|Overall Study||167
7815800|NCT01130272|19240367|P3|Safety Analysis Set: as Randomized|Overall Study||166
7815801|NCT01130272|19240368|P2|Safety Analysis Set: as Randomized|Overall Study||171
7815802|NCT01130272|19240369|P1|Safety Analysis Set: as Randomized|Overall Study||105
7815803|NCT01130272|19240365|P5|STARTED|Overall Study||169
7815804|NCT01130272|19240366|P4|STARTED|Overall Study||171
7815805|NCT01130272|19240367|P3|STARTED|Overall Study||169
7815806|NCT01130272|19240368|P2|STARTED|Overall Study||173
7815807|NCT01130272|19240369|P1|STARTED|Overall Study||107
7815808|NCT01130168|19240406|P6|NOT COMPLETED|Period 3||0
7815809|NCT01130168|19240407|P5|NOT COMPLETED|Period 3||0
7815810|NCT01130168|19240408|P4|NOT COMPLETED|Period 3||0
7815811|NCT01130168|19240409|P3|NOT COMPLETED|Period 3||0
7815812|NCT01130168|19240410|P2|NOT COMPLETED|Period 3||0
7815813|NCT01130168|19240411|P1|NOT COMPLETED|Period 3||0
7815814|NCT01130168|19240406|P6|COMPLETED|Period 3||6
7815815|NCT01130168|19240407|P5|COMPLETED|Period 3||5
7815816|NCT01130168|19240408|P4|COMPLETED|Period 3||5
7815817|NCT01130168|19240409|P3|COMPLETED|Period 3||5
7815818|NCT01130168|19240410|P2|COMPLETED|Period 3||6
7815819|NCT01130168|19240411|P1|COMPLETED|Period 3||6
7815820|NCT01130168|19240406|P6|STARTED|Period 3||6
7815821|NCT01130168|19240407|P5|STARTED|Period 3||5
7815822|NCT01130168|19240408|P4|STARTED|Period 3||5
7815823|NCT01130168|19240409|P3|STARTED|Period 3||5
7815824|NCT01130168|19240410|P2|STARTED|Period 3||6
7815825|NCT01130168|19240411|P1|STARTED|Period 3||6
7815826|NCT01130168|19240406|P6|NOT COMPLETED|Period 2||0
7815827|NCT01130168|19240407|P5|NOT COMPLETED|Period 2||0
7815828|NCT01130168|19240408|P4|NOT COMPLETED|Period 2||0
7815829|NCT01130168|19240409|P3|NOT COMPLETED|Period 2||0
7815830|NCT01130168|19240410|P2|NOT COMPLETED|Period 2||0
7815831|NCT01130168|19240411|P1|NOT COMPLETED|Period 2||0
7815832|NCT01130168|19240406|P6|COMPLETED|Period 2||6
7815833|NCT01130168|19240407|P5|COMPLETED|Period 2||5
7815834|NCT01130168|19240408|P4|COMPLETED|Period 2||5
7815835|NCT01130168|19240409|P3|COMPLETED|Period 2||5
7815836|NCT01130168|19240410|P2|COMPLETED|Period 2||6
7815837|NCT01130168|19240411|P1|COMPLETED|Period 2||6
7815838|NCT01130168|19240406|P6|STARTED|Period 2||6
7815839|NCT01130168|19240407|P5|STARTED|Period 2||5
7815840|NCT01130168|19240408|P4|STARTED|Period 2||5
7815841|NCT01130168|19240409|P3|STARTED|Period 2||5
7815842|NCT01130168|19240410|P2|STARTED|Period 2||6
7815843|NCT01130168|19240411|P1|STARTED|Period 2||6
7815844|NCT01130168|19240406|P6|NOT COMPLETED|Period 1||0
7815845|NCT01130168|19240407|P5|NOT COMPLETED|Period 1||0
7815846|NCT01130168|19240408|P4|NOT COMPLETED|Period 1||3
7815847|NCT01130168|19240409|P3|NOT COMPLETED|Period 1||1
7815848|NCT01130168|19240410|P2|NOT COMPLETED|Period 1||1
7815849|NCT01130168|19240411|P1|NOT COMPLETED|Period 1||0
7815850|NCT01130168|19240406|P6|COMPLETED|Period 1||6
7815851|NCT01130168|19240407|P5|COMPLETED|Period 1||5
7815852|NCT01130168|19240408|P4|COMPLETED|Period 1||5
7815853|NCT01130168|19240409|P3|COMPLETED|Period 1||5
7815854|NCT01130168|19240410|P2|COMPLETED|Period 1||6
7815855|NCT01130168|19240411|P1|COMPLETED|Period 1||6
7815856|NCT01130168|19240406|P6|STARTED|Period 1||6
7815857|NCT01130168|19240407|P5|STARTED|Period 1||5
7815858|NCT01130168|19240408|P4|STARTED|Period 1||8
7815859|NCT01130168|19240409|P3|STARTED|Period 1||6
7815860|NCT01130168|19240410|P2|STARTED|Period 1||7
7815861|NCT01130168|19240411|P1|STARTED|Period 1||6
7815862|NCT01130103|19240448|P2|NOT COMPLETED|Maintenance Treatment||2
7815863|NCT01130103|19240449|P1|NOT COMPLETED|Maintenance Treatment||2
7815864|NCT01130103|19240448|P2|COMPLETED|Maintenance Treatment||11
7815865|NCT01130103|19240449|P1|COMPLETED|Maintenance Treatment||11
7815866|NCT01130103|19240448|P2|STARTED|Maintenance Treatment||13
7815867|NCT01130103|19240449|P1|STARTED|Maintenance Treatment||13
7815868|NCT01130103|19240448|P2|NOT COMPLETED|Randomized Treatment||5
7815869|NCT01130103|19240449|P1|NOT COMPLETED|Randomized Treatment||6
7815870|NCT01130103|19240448|P2|COMPLETED|Randomized Treatment||13
7815871|NCT01130103|19240449|P1|COMPLETED|Randomized Treatment||13
7815872|NCT01130103|19240448|P2|STARTED|Randomized Treatment||18
7815873|NCT01130103|19240449|P1|STARTED|Randomized Treatment||19
7815874|NCT01130051|19240463|P2|NOT COMPLETED|Period 2||0
7815875|NCT01130051|19240464|P1|NOT COMPLETED|Period 2||0
7815876|NCT01130051|19240463|P2|COMPLETED|Period 2||6
7815877|NCT01130051|19240464|P1|COMPLETED|Period 2||7
7815878|NCT01130051|19240463|P2|STARTED|Period 2||6
7815879|NCT01130051|19240464|P1|STARTED|Period 2||7
7815880|NCT01130051|19240463|P2|NOT COMPLETED|Washout Period of 14 Days||2
7815881|NCT01130051|19240464|P1|NOT COMPLETED|Washout Period of 14 Days||1
7815882|NCT01130051|19240463|P2|COMPLETED|Washout Period of 14 Days||6
7815883|NCT01130051|19240464|P1|COMPLETED|Washout Period of 14 Days||7
7815884|NCT01130051|19240463|P2|STARTED|Washout Period of 14 Days||8
7815885|NCT01130051|19240464|P1|STARTED|Washout Period of 14 Days||8
7815886|NCT01130051|19240463|P2|NOT COMPLETED|Period 1||0
7815887|NCT01130051|19240464|P1|NOT COMPLETED|Period 1||0
7815888|NCT01130051|19240463|P2|COMPLETED|Period 1||8
7815889|NCT01130051|19240464|P1|COMPLETED|Period 1||8
7815890|NCT01130051|19240463|P2|STARTED|Period 1||8
7815891|NCT01130051|19240464|P1|STARTED|Period 1||8
7815892|NCT01129960|19240478|P4|NOT COMPLETED|Overall Study||13
7815893|NCT01129960|19240479|P3|NOT COMPLETED|Overall Study||26
7815894|NCT01129960|19240480|P2|NOT COMPLETED|Overall Study||22
7815895|NCT01129960|19240481|P1|NOT COMPLETED|Overall Study||30
7815896|NCT01129960|19240478|P4|COMPLETED|Overall Study||70
7815897|NCT01129960|19240479|P3|COMPLETED|Overall Study||56
7815898|NCT01129960|19240480|P2|COMPLETED|Overall Study||61
7815899|NCT01129960|19240481|P1|COMPLETED|Overall Study||54
7815900|NCT01129960|19240478|P4|Full Analysis Set (FAS|Overall Study||71
7815901|NCT01129960|19240479|P3|Full Analysis Set (FAS|Overall Study||68
7815902|NCT01129960|19240480|P2|Full Analysis Set (FAS|Overall Study||67
7815903|NCT01129960|19240481|P1|Full Analysis Set (FAS|Overall Study||71
7815904|NCT01129960|19240478|P4|Per-Protocol|Overall Study||55
7815905|NCT01129960|19240479|P3|Per-Protocol|Overall Study||49
7815906|NCT01129960|19240480|P2|Per-Protocol|Overall Study||52
7815907|NCT01129960|19240481|P1|Per-Protocol|Overall Study||34
7815908|NCT01129960|19240478|P4|Intent-to-Treat|Overall Study||83
7815909|NCT01129960|19240479|P3|Intent-to-Treat|Overall Study||82
7815910|NCT01129960|19240480|P2|Intent-to-Treat|Overall Study||83
7815911|NCT01129960|19240481|P1|Intent-to-Treat|Overall Study||84
7815912|NCT01129960|19240478|P4|Safety|Overall Study||82
7815913|NCT01129960|19240479|P3|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83
7815914|NCT01129960|19240480|P2|Safety|Overall Study||83
7815915|NCT01129960|19240481|P1|Safety|Overall Study||84
7815916|NCT01129960|19240478|P4|STARTED|Overall Study||83
7815917|NCT01129960|19240479|P3|STARTED|Overall Study||82
7815918|NCT01129960|19240480|P2|STARTED|Overall Study||83
7815919|NCT01129960|19240481|P1|STARTED|Overall Study||84
7815920|NCT01129921|19240493|P2|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7
7815921|NCT01129921|19240494|P1|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2
7815922|NCT01129921|19240493|P2|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13
7815923|NCT01129921|19240494|P1|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18
7815924|NCT01129921|19240493|P2|STARTED|After Sham Cross-over to Mild, One Year||20
7815925|NCT01129921|19240494|P1|STARTED|After Sham Cross-over to Mild, One Year||20
7815926|NCT01129921|19240493|P2|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
7815927|NCT01129921|19240494|P1|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
7815928|NCT01129921|19240493|P2|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
7815929|NCT01129921|19240494|P1|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
7815930|NCT01129921|19240493|P2|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
7815931|NCT01129921|19240494|P1|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
7815932|NCT01129882|19240504|P1|NOT COMPLETED|Overall Study||278
7815933|NCT01129882|19240504|P1|COMPLETED|Overall Study||431
7815934|NCT01129882|19240504|P1|Received at Least 1 Dose of Study Drug|Overall Study||709
7815935|NCT01129882|19240504|P1|STARTED|Overall Study||709
7815936|NCT01129778|19240509|P1|NOT COMPLETED|Overall Study||7
7815937|NCT01129778|19240509|P1|COMPLETED|Overall Study||15
7815938|NCT01129778|19240509|P1|STARTED|Overall Study||22
7815939|NCT01129765|19240514|P1|NOT COMPLETED|Overall Study||0
7815940|NCT01129765|19240514|P1|COMPLETED|Overall Study||30
7815941|NCT01129765|19240514|P1|STARTED|Overall Study||30
7815942|NCT01129622|19240523|P1|NOT COMPLETED|Overall Study||2
7815943|NCT01129622|19240523|P1|COMPLETED|Overall Study||14
7815944|NCT01129622|19240523|P1|STARTED|Overall Study||16
7815945|NCT01129609|19240528|P1|NOT COMPLETED|Overall Study||2
7815946|NCT01129609|19240528|P1|COMPLETED|Overall Study||18
7815947|NCT01129609|19240528|P1|STARTED|Overall Study||20
7815948|NCT01129583|19240534|P2|NOT COMPLETED|Overall Study||2
7815949|NCT01129583|19240535|P1|NOT COMPLETED|Overall Study||3
7815950|NCT01129583|19240534|P2|COMPLETED|Overall Study||7
7815951|NCT01129583|19240535|P1|COMPLETED|Overall Study||6
7815952|NCT01129583|19240534|P2|STARTED|Overall Study||9
7815953|NCT01129583|19240535|P1|STARTED|Overall Study||9
7815954|NCT01129557|19240548|P3|NOT COMPLETED|Overall Study||4
7815955|NCT01129557|19240549|P2|NOT COMPLETED|Overall Study||5
7815956|NCT01129557|19240550|P1|NOT COMPLETED|Overall Study||4
7815957|NCT01129557|19240548|P3|COMPLETED|Overall Study||10
7815958|NCT01129557|19240549|P2|COMPLETED|Overall Study||12
7815959|NCT01129557|19240550|P1|COMPLETED|Overall Study||11
7815960|NCT01129557|19240548|P3|STARTED|Overall Study||14
7815961|NCT01129557|19240549|P2|STARTED|Overall Study||17
7815962|NCT01129557|19240550|P1|STARTED|Overall Study||15
7815963|NCT01129531|19240621|P3|NOT COMPLETED|Treatment Cycle 2||5
7815964|NCT01129531|19240622|P2|NOT COMPLETED|Treatment Cycle 2||3
7815965|NCT01129531|19240623|P1|NOT COMPLETED|Treatment Cycle 2||6
7815966|NCT01129531|19240621|P3|COMPLETED|Treatment Cycle 2||74
7815967|NCT01129531|19240622|P2|COMPLETED|Treatment Cycle 2||92
7815968|NCT01129531|19240623|P1|COMPLETED|Treatment Cycle 2||88
7815969|NCT01129531|19240621|P3|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79
7815970|NCT01129531|19240622|P2|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95
7815971|NCT01129531|19240623|P1|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94
7815972|NCT01129531|19240621|P3|NOT COMPLETED|Treatment Cycle 1||16
7815973|NCT01129531|19240622|P2|NOT COMPLETED|Treatment Cycle 1||6
7815974|NCT01129531|19240623|P1|NOT COMPLETED|Treatment Cycle 1||4
7815975|NCT01129531|19240621|P3|COMPLETED|Treatment Cycle 1||110
7815976|NCT01129531|19240622|P2|COMPLETED|Treatment Cycle 1||78
7815977|NCT01129531|19240623|P1|COMPLETED|Treatment Cycle 1||80
7815978|NCT01129531|19240621|P3|STARTED|Treatment Cycle 1||126
7815979|NCT01129531|19240622|P2|STARTED|Treatment Cycle 1||84
7815980|NCT01129531|19240623|P1|STARTED|Treatment Cycle 1||84
7815981|NCT01129440|19240645|P2|NOT COMPLETED|Overall Study||42
7815982|NCT01129440|19240646|P1|NOT COMPLETED|Overall Study||51
7815983|NCT01129440|19240645|P2|COMPLETED|Overall Study||258
7815984|NCT01129440|19240646|P1|COMPLETED|Overall Study||246
7815985|NCT01129440|19240645|P2|24 Month Follow-up|Overall Study||258
7815986|NCT01129440|19240646|P1|24 Month Follow-up|Overall Study||239
7815987|NCT01129440|19240645|P2|12 Month Follow-up|Overall Study||256
7815988|NCT01129440|19240646|P1|12 Month Follow-up|Overall Study||249
7815989|NCT01129440|19240645|P2|STARTED|Overall Study||300
7815990|NCT01129440|19240646|P1|STARTED|Overall Study||297
7815991|NCT01129336|19240663|P2|NOT COMPLETED|Overall Study||16
7815992|NCT01129336|19240664|P1|NOT COMPLETED|Overall Study||12
7815993|NCT01129336|19240663|P2|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13
7815994|NCT01129336|19240664|P1|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3
7815995|NCT01129336|19240663|P2|Completed Treatment|Overall Study||3
7815996|NCT01129336|19240664|P1|Completed Treatment|Overall Study||1
7815997|NCT01129336|19240663|P2|STARTED|Overall Study||29
7815998|NCT01129336|19240664|P1|STARTED|Overall Study||15
7815999|NCT01129284|19240679|P3|NOT COMPLETED|Overall Study||1
7816000|NCT01129284|19240680|P2|NOT COMPLETED|Overall Study||0
7816001|NCT01129284|19240681|P1|NOT COMPLETED|Overall Study||2
7816002|NCT01129284|19240679|P3|COMPLETED|Overall Study||4
7816003|NCT01129284|19240680|P2|COMPLETED|Overall Study||5
7816004|NCT01129284|19240681|P1|COMPLETED|Overall Study||3
7816005|NCT01129284|19240679|P3|STARTED|Overall Study||5
7816006|NCT01129284|19240680|P2|STARTED|Overall Study||5
7816007|NCT01129284|19240681|P1|STARTED|Overall Study||5
7816008|NCT01129245|19240694|P2|NOT COMPLETED|Treatment Cycle 2||0
7816009|NCT01129245|19240695|P1|NOT COMPLETED|Treatment Cycle 2||0
7816010|NCT01129245|19240694|P2|COMPLETED|Treatment Cycle 2||10
7816011|NCT01129245|19240695|P1|COMPLETED|Treatment Cycle 2||10
7816012|NCT01129245|19240694|P2|STARTED|Treatment Cycle 2||10
7816013|NCT01129245|19240695|P1|STARTED|Treatment Cycle 2||10
7816014|NCT01129245|19240694|P2|NOT COMPLETED|Washout Cycle||0
7816015|NCT01129245|19240695|P1|NOT COMPLETED|Washout Cycle||0
7816016|NCT01129245|19240694|P2|COMPLETED|Washout Cycle||10
7816017|NCT01129245|19240695|P1|COMPLETED|Washout Cycle||10
7816018|NCT01129245|19240694|P2|STARTED|Washout Cycle||10
7816019|NCT01129245|19240695|P1|STARTED|Washout Cycle||10
7816020|NCT01129245|19240694|P2|NOT COMPLETED|Treatment Cycle 1||0
7816021|NCT01129245|19240695|P1|NOT COMPLETED|Treatment Cycle 1||0
7816022|NCT01129245|19240694|P2|COMPLETED|Treatment Cycle 1||10
7816023|NCT01129245|19240695|P1|COMPLETED|Treatment Cycle 1||10
7816024|NCT01129245|19240694|P2|STARTED|Treatment Cycle 1||10
7816025|NCT01129245|19240695|P1|STARTED|Treatment Cycle 1||10
7816026|NCT01129245|19240694|P2|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
7816027|NCT01129245|19240695|P1|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
7816028|NCT01129245|19240694|P2|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
7816029|NCT01129245|19240695|P1|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
7816030|NCT01129245|19240694|P2|STARTED|Control Cycle (no Celecoxib or Placebo)||10
7816031|NCT01129245|19240695|P1|STARTED|Control Cycle (no Celecoxib or Placebo)||10
7816032|NCT01129206|19240709|P1|NOT COMPLETED|Overall Study||0
7816033|NCT01129206|19240709|P1|COMPLETED|Overall Study||6
7816034|NCT01129206|19240709|P1|STARTED|Overall Study||6
7816035|NCT01129141|19240719|P2|NOT COMPLETED|Overall Study||13
7816036|NCT01129141|19240720|P1|NOT COMPLETED|Overall Study||15
7816037|NCT01129141|19240719|P2|COMPLETED|Overall Study||91
7816038|NCT01129141|19240720|P1|COMPLETED|Overall Study||86
7816039|NCT01129141|19240719|P2|STARTED|Overall Study||104
7816040|NCT01129141|19240720|P1|STARTED|Overall Study||101
7816041|NCT01129128|19240729|P3|NOT COMPLETED|Overall Study||4
7816042|NCT01129128|19240730|P2|NOT COMPLETED|Overall Study||4
7816043|NCT01129128|19240731|P1|NOT COMPLETED|Overall Study||3
7816044|NCT01129128|19240729|P3|COMPLETED|Overall Study||19
7816045|NCT01129128|19240730|P2|COMPLETED|Overall Study||18
7816046|NCT01129128|19240731|P1|COMPLETED|Overall Study||19
7816047|NCT01129128|19240729|P3|STARTED|Overall Study||23
7816048|NCT01129128|19240730|P2|STARTED|Overall Study||22
7816049|NCT01129128|19240731|P1|STARTED|Overall Study||22
7816050|NCT01129115|19240755|P4|NOT COMPLETED|Overall Study||9
7816051|NCT01129115|19240756|P3|NOT COMPLETED|Overall Study||6
7816052|NCT01129115|19240757|P2|NOT COMPLETED|Overall Study||7
7816053|NCT01129115|19240758|P1|NOT COMPLETED|Overall Study||2
7816054|NCT01129115|19240755|P4|COMPLETED|Overall Study||15
7816055|NCT01129115|19240756|P3|COMPLETED|Overall Study||21
7816056|NCT01129115|19240757|P2|COMPLETED|Overall Study||18
7816057|NCT01129115|19240758|P1|COMPLETED|Overall Study||23
7816058|NCT01129115|19240755|P4|STARTED|Overall Study||24
7816059|NCT01129115|19240756|P3|STARTED|Overall Study||27
7816060|NCT01129115|19240757|P2|STARTED|Overall Study||25
7816061|NCT01129115|19240758|P1|STARTED|Overall Study||25
7816062|NCT01129102|19240795|P3|NOT COMPLETED|Overall Study||7
7816063|NCT01129102|19240796|P2|NOT COMPLETED|Overall Study||6
7816064|NCT01129102|19240797|P1|NOT COMPLETED|Overall Study||8
7816065|NCT01129102|19240795|P3|COMPLETED|Overall Study||48
7816066|NCT01129102|19240796|P2|COMPLETED|Overall Study||44
7816067|NCT01129102|19240797|P1|COMPLETED|Overall Study||102
7816068|NCT01129102|19240795|P3|STARTED|Overall Study||55
7816069|NCT01129102|19240796|P2|STARTED|Overall Study||50
7816070|NCT01129102|19240797|P1|STARTED|Overall Study||110
7816071|NCT01129011|19240808|P2|NOT COMPLETED|Overall Study||57
7816072|NCT01129011|19240809|P1|NOT COMPLETED|Overall Study||59
7816073|NCT01129011|19240808|P2|COMPLETED|Overall Study||153
7816074|NCT01129011|19240809|P1|COMPLETED|Overall Study||151
7816075|NCT01129011|19240808|P2|STARTED|Overall Study|Safety, Intent-to-Treat population|210
7816076|NCT01129011|19240809|P1|STARTED|Overall Study|Safety, Intent-to-Treat population|210
7816077|NCT01128972|19240831|P5|NOT COMPLETED|Period V||0
7816078|NCT01128972|19240832|P4|NOT COMPLETED|Period V||0
7816079|NCT01128972|19240833|P3|NOT COMPLETED|Period V||0
7816080|NCT01128972|19240834|P2|NOT COMPLETED|Period V||0
7816081|NCT01128972|19240835|P1|NOT COMPLETED|Period V||0
7816082|NCT01128972|19240831|P5|COMPLETED|Period V||7
7816083|NCT01128972|19240832|P4|COMPLETED|Period V||7
7816084|NCT01128972|19240833|P3|COMPLETED|Period V||7
7816085|NCT01128972|19240834|P2|COMPLETED|Period V||7
7816086|NCT01128972|19240835|P1|COMPLETED|Period V||8
7816087|NCT01128972|19240831|P5|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
7816088|NCT01128972|19240832|P4|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
7816089|NCT01128972|19240833|P3|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
7816090|NCT01128972|19240834|P2|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
7816091|NCT01128972|19240835|P1|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8
7816092|NCT01128972|19240831|P5|NOT COMPLETED|Period IV||0
7816093|NCT01128972|19240832|P4|NOT COMPLETED|Period IV||0
7816094|NCT01128972|19240833|P3|NOT COMPLETED|Period IV||0
7816095|NCT01128972|19240834|P2|NOT COMPLETED|Period IV||0
7816096|NCT01128972|19240835|P1|NOT COMPLETED|Period IV||0
7816097|NCT01128972|19240831|P5|COMPLETED|Period IV||7
7816098|NCT01128972|19240832|P4|COMPLETED|Period IV||7
7816099|NCT01128972|19240833|P3|COMPLETED|Period IV||7
7816100|NCT01128972|19240834|P2|COMPLETED|Period IV||8
7816101|NCT01128972|19240835|P1|COMPLETED|Period IV||7
7816102|NCT01128972|19240831|P5|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
7816103|NCT01128972|19240832|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
7816104|NCT01128972|19240833|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
7816105|NCT01128972|19240834|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8
7816106|NCT01128972|19240835|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
7816107|NCT01128972|19240831|P5|NOT COMPLETED|Period III||0
7816108|NCT01128972|19240832|P4|NOT COMPLETED|Period III||0
7816109|NCT01128972|19240833|P3|NOT COMPLETED|Period III||0
7816110|NCT01128972|19240834|P2|NOT COMPLETED|Period III||0
7816111|NCT01128972|19240835|P1|NOT COMPLETED|Period III||0
7816112|NCT01128972|19240831|P5|COMPLETED|Period III||7
7816113|NCT01128972|19240832|P4|COMPLETED|Period III||7
7816114|NCT01128972|19240833|P3|COMPLETED|Period III||8
7816115|NCT01128972|19240834|P2|COMPLETED|Period III||7
7816116|NCT01128972|19240835|P1|COMPLETED|Period III||7
7816117|NCT01128972|19240831|P5|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
7816118|NCT01128972|19240832|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
7816119|NCT01128972|19240833|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8
7816120|NCT01128972|19240834|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
7816121|NCT01128972|19240835|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
7816122|NCT01128972|19240831|P5|NOT COMPLETED|Period II||0
7816123|NCT01128972|19240832|P4|NOT COMPLETED|Period II||0
7816124|NCT01128972|19240833|P3|NOT COMPLETED|Period II||0
7816125|NCT01128972|19240834|P2|NOT COMPLETED|Period II||0
7816126|NCT01128972|19240835|P1|NOT COMPLETED|Period II||0
7816127|NCT01128972|19240831|P5|COMPLETED|Period II||7
7816128|NCT01128972|19240832|P4|COMPLETED|Period II||8
7816129|NCT01128972|19240833|P3|COMPLETED|Period II||7
7816130|NCT01128972|19240834|P2|COMPLETED|Period II||7
7816131|NCT01128972|19240835|P1|COMPLETED|Period II||7
7816132|NCT01128972|19240831|P5|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
7816133|NCT01128972|19240832|P4|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8
7816134|NCT01128972|19240833|P3|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
7816135|NCT01128972|19240834|P2|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
7816136|NCT01128972|19240835|P1|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
7816137|NCT01128972|19240831|P5|NOT COMPLETED|Period I||0
7816138|NCT01128972|19240832|P4|NOT COMPLETED|Period I||0
7816139|NCT01128972|19240833|P3|NOT COMPLETED|Period I||0
7816140|NCT01128972|19240834|P2|NOT COMPLETED|Period I||0
7816141|NCT01128972|19240835|P1|NOT COMPLETED|Period I||0
7816142|NCT01128972|19240831|P5|COMPLETED|Period I||8
7816143|NCT01128972|19240832|P4|COMPLETED|Period I||7
7816144|NCT01128972|19240833|P3|COMPLETED|Period I||7
7816145|NCT01128972|19240834|P2|COMPLETED|Period I||7
7816146|NCT01128972|19240835|P1|COMPLETED|Period I||7
7816147|NCT01128972|19240831|P5|STARTED|Period I||8
7816148|NCT01128972|19240832|P4|STARTED|Period I||7
7816149|NCT01128972|19240833|P3|STARTED|Period I||7
7816150|NCT01128972|19240834|P2|STARTED|Period I||7
7816151|NCT01128972|19240835|P1|STARTED|Period I||7
7816152|NCT01128959|19240864|P1|NOT COMPLETED|Treatment Period||4
7816153|NCT01128959|19240864|P1|COMPLETED|Treatment Period||101
7816154|NCT01128959|19240864|P1|STARTED|Treatment Period||105
7816155|NCT01128959|19240864|P1|NOT COMPLETED|Lead in Period||3
7816156|NCT01128959|19240864|P1|COMPLETED|Lead in Period||105
7816157|NCT01128959|19240864|P1|STARTED|Lead in Period||108
7816158|NCT01128946|19240870|P4|NOT COMPLETED|Period IV||0
7816159|NCT01128946|19240871|P3|NOT COMPLETED|Period IV||0
7816160|NCT01128946|19240872|P2|NOT COMPLETED|Period IV||0
7816161|NCT01128946|19240873|P1|NOT COMPLETED|Period IV||0
7816162|NCT01128946|19240870|P4|COMPLETED|Period IV||19
7816163|NCT01128946|19240871|P3|COMPLETED|Period IV||19
7816164|NCT01128946|19240872|P2|COMPLETED|Period IV||20
7816165|NCT01128946|19240873|P1|COMPLETED|Period IV||19
7816166|NCT01128946|19240870|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
7816167|NCT01128946|19240871|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
7816168|NCT01128946|19240872|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20
7816169|NCT01128946|19240873|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
7816170|NCT01128946|19240870|P4|NOT COMPLETED|Period III||0
7816171|NCT01128946|19240871|P3|NOT COMPLETED|Period III||0
7816172|NCT01128946|19240872|P2|NOT COMPLETED|Period III||0
7816173|NCT01128946|19240873|P1|NOT COMPLETED|Period III||1
7816174|NCT01128946|19240870|P4|COMPLETED|Period III||19
7816175|NCT01128946|19240871|P3|COMPLETED|Period III||20
7816176|NCT01128946|19240872|P2|COMPLETED|Period III||19
7816177|NCT01128946|19240873|P1|COMPLETED|Period III||19
7816178|NCT01128946|19240870|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
7816179|NCT01128946|19240871|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
7816180|NCT01128946|19240872|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
7816181|NCT01128946|19240873|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
7816182|NCT01128946|19240870|P4|NOT COMPLETED|Period II||1
7816183|NCT01128946|19240871|P3|NOT COMPLETED|Period II||0
7816184|NCT01128946|19240872|P2|NOT COMPLETED|Period II||1
7816185|NCT01128946|19240873|P1|NOT COMPLETED|Period II||0
7816186|NCT01128946|19240870|P4|COMPLETED|Period II||19
7816187|NCT01128946|19240871|P3|COMPLETED|Period II||20
7816188|NCT01128946|19240872|P2|COMPLETED|Period II||19
7816189|NCT01128946|19240873|P1|COMPLETED|Period II||20
7816190|NCT01128946|19240870|P4|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
7816191|NCT01128946|19240871|P3|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
7816192|NCT01128946|19240872|P2|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
7816193|NCT01128946|19240873|P1|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
7816194|NCT01128946|19240870|P4|NOT COMPLETED|Period I||1
7816195|NCT01128946|19240871|P3|NOT COMPLETED|Period I||1
7816196|NCT01128946|19240872|P2|NOT COMPLETED|Period I||1
7816197|NCT01128946|19240873|P1|NOT COMPLETED|Period I||0
7816198|NCT01128946|19240870|P4|COMPLETED|Period I||20
7816199|NCT01128946|19240871|P3|COMPLETED|Period I||20
7816200|NCT01128946|19240872|P2|COMPLETED|Period I||20
7816201|NCT01128946|19240873|P1|COMPLETED|Period I||20
7816202|NCT01128946|19240870|P4|STARTED|Period I||21
7816203|NCT01128946|19240871|P3|STARTED|Period I||21
7816204|NCT01128946|19240872|P2|STARTED|Period I||21
7816205|NCT01128946|19240873|P1|STARTED|Period I||20
7816206|NCT01128894|19240891|P2|NOT COMPLETED|Overall Study||68
7816207|NCT01128894|19240892|P1|NOT COMPLETED|Overall Study||58
7816208|NCT01128894|19240891|P2|COMPLETED|Overall Study||340
7816209|NCT01128894|19240892|P1|COMPLETED|Overall Study||346
7816210|NCT01128894|19240891|P2|STARTED|Overall Study||408
7816211|NCT01128894|19240892|P1|STARTED|Overall Study||404
7816212|NCT01128842|19240910|P1|NOT COMPLETED|Overall Study||7
7816213|NCT01128842|19240910|P1|COMPLETED|Overall Study||0
7816214|NCT01128842|19240910|P1|STARTED|Overall Study||7
7816215|NCT01128829|19240920|P2|NOT COMPLETED|Overall Study||0
7816216|NCT01128829|19240921|P1|NOT COMPLETED|Overall Study||0
7816217|NCT01128829|19240920|P2|COMPLETED|Overall Study||11
7816218|NCT01128829|19240921|P1|COMPLETED|Overall Study||6
7816219|NCT01128829|19240920|P2|STARTED|Overall Study||11
7816220|NCT01128829|19240921|P1|STARTED|Overall Study||6
7816221|NCT01128738|19240927|P2|NOT COMPLETED|Second TP||3
7816222|NCT01128738|19240928|P1|NOT COMPLETED|Second TP||0
7816223|NCT01128738|19240927|P2|COMPLETED|Second TP||63
7816224|NCT01128738|19240928|P1|COMPLETED|Second TP||34
7816225|NCT01128738|19240927|P2|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66
7816226|NCT01128738|19240928|P1|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34
7816227|NCT01128738|19240927|P2|NOT COMPLETED|First Treatment Phase (TP)||1
7816228|NCT01128738|19240928|P1|NOT COMPLETED|First Treatment Phase (TP)||4
7816229|NCT01128738|19240927|P2|COMPLETED|First Treatment Phase (TP)||73
7816230|NCT01128738|19240928|P1|COMPLETED|First Treatment Phase (TP)||74
7816231|NCT01128738|19240927|P2|STARTED|First Treatment Phase (TP)||74
7816232|NCT01128738|19240928|P1|STARTED|First Treatment Phase (TP)||78
7816233|NCT01128621|19241053|P2|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||2
7816234|NCT01128621|19241054|P1|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
7816235|NCT01128621|19241053|P2|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||65
7816236|NCT01128621|19241054|P1|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
7816237|NCT01128621|19241053|P2|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||67
7816238|NCT01128621|19241054|P1|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
7816239|NCT01128621|19241053|P2|NOT COMPLETED|Part A: GSK1292263 300 mg||0
7816240|NCT01128621|19241054|P1|NOT COMPLETED|Part A: GSK1292263 300 mg||0
7816241|NCT01128621|19241053|P2|COMPLETED|Part A: GSK1292263 300 mg||0
7816242|NCT01128621|19241054|P1|COMPLETED|Part A: GSK1292263 300 mg||6
7816243|NCT01128621|19241053|P2|STARTED|Part A: GSK1292263 300 mg||0
7816244|NCT01128621|19241054|P1|STARTED|Part A: GSK1292263 300 mg||6
7816245|NCT01128595|19241175|P4|NOT COMPLETED|Treatment Period 4||0
7816246|NCT01128595|19241176|P3|NOT COMPLETED|Treatment Period 4||0
7816247|NCT01128595|19241177|P2|NOT COMPLETED|Treatment Period 4||0
7816248|NCT01128595|19241178|P1|NOT COMPLETED|Treatment Period 4||0
7816249|NCT01128595|19241175|P4|COMPLETED|Treatment Period 4||7
7816250|NCT01128595|19241176|P3|COMPLETED|Treatment Period 4||7
7816251|NCT01128595|19241177|P2|COMPLETED|Treatment Period 4||5
7816252|NCT01128595|19241178|P1|COMPLETED|Treatment Period 4||7
7816253|NCT01128595|19241175|P4|STARTED|Treatment Period 4||7
7816254|NCT01128595|19241176|P3|STARTED|Treatment Period 4||7
7816255|NCT01128595|19241177|P2|STARTED|Treatment Period 4||5
7816256|NCT01128595|19241178|P1|STARTED|Treatment Period 4||7
7816257|NCT01128595|19241175|P4|NOT COMPLETED|Washout Period 3||0
7816258|NCT01128595|19241176|P3|NOT COMPLETED|Washout Period 3||0
7816259|NCT01128595|19241177|P2|NOT COMPLETED|Washout Period 3||0
7816260|NCT01128595|19241178|P1|NOT COMPLETED|Washout Period 3||0
7816261|NCT01128595|19241175|P4|COMPLETED|Washout Period 3||7
7816262|NCT01128595|19241176|P3|COMPLETED|Washout Period 3||7
7816263|NCT01128595|19241177|P2|COMPLETED|Washout Period 3||5
7816264|NCT01128595|19241178|P1|COMPLETED|Washout Period 3||7
7816265|NCT01128595|19241175|P4|STARTED|Washout Period 3||7
7816266|NCT01128595|19241176|P3|STARTED|Washout Period 3||7
7816267|NCT01128595|19241177|P2|STARTED|Washout Period 3||5
7816268|NCT01128595|19241178|P1|STARTED|Washout Period 3||7
7816269|NCT01128595|19241175|P4|NOT COMPLETED|Treatment Period 3||0
7816270|NCT01128595|19241176|P3|NOT COMPLETED|Treatment Period 3||0
7816271|NCT01128595|19241177|P2|NOT COMPLETED|Treatment Period 3||1
7816272|NCT01128595|19241178|P1|NOT COMPLETED|Treatment Period 3||0
7816273|NCT01128595|19241175|P4|COMPLETED|Treatment Period 3||7
7816274|NCT01128595|19241176|P3|COMPLETED|Treatment Period 3||7
7816275|NCT01128595|19241177|P2|COMPLETED|Treatment Period 3||5
7816276|NCT01128595|19241178|P1|COMPLETED|Treatment Period 3||7
7816277|NCT01128595|19241175|P4|STARTED|Treatment Period 3||7
7816278|NCT01128595|19241176|P3|STARTED|Treatment Period 3||7
7816279|NCT01128595|19241177|P2|STARTED|Treatment Period 3||6
7816280|NCT01128595|19241178|P1|STARTED|Treatment Period 3||7
7816281|NCT01128595|19241175|P4|NOT COMPLETED|Washout Period 2||0
7816282|NCT01128595|19241176|P3|NOT COMPLETED|Washout Period 2||0
7816283|NCT01128595|19241177|P2|NOT COMPLETED|Washout Period 2||0
7816284|NCT01128595|19241178|P1|NOT COMPLETED|Washout Period 2||0
7816285|NCT01128595|19241175|P4|COMPLETED|Washout Period 2||7
7816286|NCT01128595|19241176|P3|COMPLETED|Washout Period 2||7
7816287|NCT01128595|19241177|P2|COMPLETED|Washout Period 2||6
7816288|NCT01128595|19241178|P1|COMPLETED|Washout Period 2||7
7816289|NCT01128595|19241175|P4|STARTED|Washout Period 2||7
7816290|NCT01128595|19241176|P3|STARTED|Washout Period 2||7
7816291|NCT01128595|19241177|P2|STARTED|Washout Period 2||6
7816292|NCT01128595|19241178|P1|STARTED|Washout Period 2||7
7816293|NCT01128595|19241175|P4|NOT COMPLETED|Treatment Period 2||0
7816294|NCT01128595|19241176|P3|NOT COMPLETED|Treatment Period 2||0
7816295|NCT01128595|19241177|P2|NOT COMPLETED|Treatment Period 2||0
7816296|NCT01128595|19241178|P1|NOT COMPLETED|Treatment Period 2||0
7816297|NCT01128595|19241175|P4|COMPLETED|Treatment Period 2||7
7816298|NCT01128595|19241176|P3|COMPLETED|Treatment Period 2||7
7816299|NCT01128595|19241177|P2|COMPLETED|Treatment Period 2||6
7816300|NCT01128595|19241178|P1|COMPLETED|Treatment Period 2||7
7816301|NCT01128595|19241175|P4|STARTED|Treatment Period 2||7
7816302|NCT01128595|19241176|P3|STARTED|Treatment Period 2||7
7816303|NCT01128595|19241177|P2|STARTED|Treatment Period 2||6
7816304|NCT01128595|19241178|P1|STARTED|Treatment Period 2||7
7816305|NCT01128595|19241175|P4|NOT COMPLETED|Washout Period 1||0
7816306|NCT01128595|19241176|P3|NOT COMPLETED|Washout Period 1||0
7816307|NCT01128595|19241177|P2|NOT COMPLETED|Washout Period 1||0
7816308|NCT01128595|19241178|P1|NOT COMPLETED|Washout Period 1||0
7816309|NCT01128595|19241175|P4|COMPLETED|Washout Period 1||7
7816310|NCT01128595|19241176|P3|COMPLETED|Washout Period 1||7
7816311|NCT01128595|19241177|P2|COMPLETED|Washout Period 1||6
7816312|NCT01128595|19241178|P1|COMPLETED|Washout Period 1||7
7816313|NCT01128595|19241175|P4|STARTED|Washout Period 1||7
7816314|NCT01128595|19241176|P3|STARTED|Washout Period 1||7
7816315|NCT01128595|19241177|P2|STARTED|Washout Period 1||6
7816316|NCT01128595|19241178|P1|STARTED|Washout Period 1||7
7816317|NCT01128595|19241175|P4|NOT COMPLETED|Treatment Period 1||0
7816318|NCT01128595|19241176|P3|NOT COMPLETED|Treatment Period 1||0
7816319|NCT01128595|19241177|P2|NOT COMPLETED|Treatment Period 1||0
7816320|NCT01128595|19241178|P1|NOT COMPLETED|Treatment Period 1||0
7816321|NCT01128595|19241175|P4|COMPLETED|Treatment Period 1||7
7816322|NCT01128595|19241176|P3|COMPLETED|Treatment Period 1||7
7816323|NCT01128595|19241177|P2|COMPLETED|Treatment Period 1||6
7816324|NCT01128595|19241178|P1|COMPLETED|Treatment Period 1||7
7816325|NCT01128595|19241175|P4|STARTED|Treatment Period 1||7
7816326|NCT01128595|19241176|P3|STARTED|Treatment Period 1||7
7816327|NCT01128595|19241177|P2|STARTED|Treatment Period 1||6
7816328|NCT01128595|19241178|P1|STARTED|Treatment Period 1||7
7816329|NCT01128569|19241208|P6|NOT COMPLETED|Treatment Period 3||0
7816330|NCT01128569|19241209|P5|NOT COMPLETED|Treatment Period 3||0
7816331|NCT01128569|19241210|P4|NOT COMPLETED|Treatment Period 3||0
7816332|NCT01128569|19241211|P3|NOT COMPLETED|Treatment Period 3||0
7816333|NCT01128569|19241212|P2|NOT COMPLETED|Treatment Period 3||0
7816334|NCT01128569|19241213|P1|NOT COMPLETED|Treatment Period 3||0
7816335|NCT01128569|19241208|P6|COMPLETED|Treatment Period 3||9
7816336|NCT01128569|19241209|P5|COMPLETED|Treatment Period 3||9
7816337|NCT01128569|19241210|P4|COMPLETED|Treatment Period 3||8
7816338|NCT01128569|19241211|P3|COMPLETED|Treatment Period 3||8
7816339|NCT01128569|19241212|P2|COMPLETED|Treatment Period 3||7
7816340|NCT01128569|19241213|P1|COMPLETED|Treatment Period 3||9
7816341|NCT01128569|19241208|P6|STARTED|Treatment Period 3||9
7816342|NCT01128569|19241209|P5|STARTED|Treatment Period 3||9
7816343|NCT01128569|19241210|P4|STARTED|Treatment Period 3||8
7816344|NCT01128569|19241211|P3|STARTED|Treatment Period 3||8
7816345|NCT01128569|19241212|P2|STARTED|Treatment Period 3||7
7816346|NCT01128569|19241213|P1|STARTED|Treatment Period 3||9
7816347|NCT01128569|19241208|P6|NOT COMPLETED|Washout Period 2||0
7816348|NCT01128569|19241209|P5|NOT COMPLETED|Washout Period 2||0
7816349|NCT01128569|19241210|P4|NOT COMPLETED|Washout Period 2||0
7816350|NCT01128569|19241211|P3|NOT COMPLETED|Washout Period 2||0
7816351|NCT01128569|19241212|P2|NOT COMPLETED|Washout Period 2||0
7816352|NCT01128569|19241213|P1|NOT COMPLETED|Washout Period 2||0
7816353|NCT01128569|19241208|P6|COMPLETED|Washout Period 2||9
7816354|NCT01128569|19241209|P5|COMPLETED|Washout Period 2||9
7816355|NCT01128569|19241210|P4|COMPLETED|Washout Period 2||8
7816356|NCT01128569|19241211|P3|COMPLETED|Washout Period 2||8
7816357|NCT01128569|19241212|P2|COMPLETED|Washout Period 2||7
7816358|NCT01128569|19241213|P1|COMPLETED|Washout Period 2||9
7816359|NCT01128569|19241208|P6|STARTED|Washout Period 2||9
7816360|NCT01128569|19241209|P5|STARTED|Washout Period 2||9
7816361|NCT01128569|19241210|P4|STARTED|Washout Period 2||8
7816362|NCT01128569|19241211|P3|STARTED|Washout Period 2||8
7816363|NCT01128569|19241212|P2|STARTED|Washout Period 2||7
7816364|NCT01128569|19241213|P1|STARTED|Washout Period 2||9
7816365|NCT01128569|19241208|P6|NOT COMPLETED|Treatment Period 2||0
7816366|NCT01128569|19241209|P5|NOT COMPLETED|Treatment Period 2||0
7816367|NCT01128569|19241210|P4|NOT COMPLETED|Treatment Period 2||0
7816368|NCT01128569|19241211|P3|NOT COMPLETED|Treatment Period 2||0
7816369|NCT01128569|19241212|P2|NOT COMPLETED|Treatment Period 2||1
7816370|NCT01128569|19241213|P1|NOT COMPLETED|Treatment Period 2||0
7816371|NCT01128569|19241208|P6|COMPLETED|Treatment Period 2||9
7816372|NCT01128569|19241209|P5|COMPLETED|Treatment Period 2||9
7816373|NCT01128569|19241210|P4|COMPLETED|Treatment Period 2||8
7816374|NCT01128569|19241211|P3|COMPLETED|Treatment Period 2||8
7816375|NCT01128569|19241212|P2|COMPLETED|Treatment Period 2||7
7816376|NCT01128569|19241213|P1|COMPLETED|Treatment Period 2||9
7816377|NCT01128569|19241208|P6|STARTED|Treatment Period 2||9
7816378|NCT01128569|19241209|P5|STARTED|Treatment Period 2||9
7816379|NCT01128569|19241210|P4|STARTED|Treatment Period 2||8
7816380|NCT01128569|19241211|P3|STARTED|Treatment Period 2||8
7816381|NCT01128569|19241212|P2|STARTED|Treatment Period 2||8
7816382|NCT01128569|19241213|P1|STARTED|Treatment Period 2||9
7816383|NCT01128569|19241208|P6|NOT COMPLETED|Washout Period 1||0
7816384|NCT01128569|19241209|P5|NOT COMPLETED|Washout Period 1||0
7816385|NCT01128569|19241210|P4|NOT COMPLETED|Washout Period 1||0
7816386|NCT01128569|19241211|P3|NOT COMPLETED|Washout Period 1||1
7816387|NCT01128569|19241212|P2|NOT COMPLETED|Washout Period 1||0
7816388|NCT01128569|19241213|P1|NOT COMPLETED|Washout Period 1||0
7816389|NCT01128569|19241208|P6|COMPLETED|Washout Period 1||9
7816390|NCT01128569|19241209|P5|COMPLETED|Washout Period 1||9
7816391|NCT01128569|19241210|P4|COMPLETED|Washout Period 1||8
7816392|NCT01128569|19241211|P3|COMPLETED|Washout Period 1||8
7816393|NCT01128569|19241212|P2|COMPLETED|Washout Period 1||8
7816394|NCT01128569|19241213|P1|COMPLETED|Washout Period 1||9
7816395|NCT01128569|19241208|P6|STARTED|Washout Period 1||9
7816396|NCT01128569|19241209|P5|STARTED|Washout Period 1||9
7816397|NCT01128569|19241210|P4|STARTED|Washout Period 1||8
7816398|NCT01128569|19241211|P3|STARTED|Washout Period 1||9
7816399|NCT01128569|19241212|P2|STARTED|Washout Period 1||8
7816400|NCT01128569|19241213|P1|STARTED|Washout Period 1||9
7816401|NCT01128569|19241208|P6|NOT COMPLETED|Treatment Period 1||0
7816402|NCT01128569|19241209|P5|NOT COMPLETED|Treatment Period 1||0
7816403|NCT01128569|19241210|P4|NOT COMPLETED|Treatment Period 1||0
7816404|NCT01128569|19241211|P3|NOT COMPLETED|Treatment Period 1||0
7816405|NCT01128569|19241212|P2|NOT COMPLETED|Treatment Period 1||0
7816406|NCT01128569|19241213|P1|NOT COMPLETED|Treatment Period 1||0
7816407|NCT01128569|19241208|P6|COMPLETED|Treatment Period 1||9
7816408|NCT01128569|19241209|P5|COMPLETED|Treatment Period 1||9
7816409|NCT01128569|19241210|P4|COMPLETED|Treatment Period 1||8
7816410|NCT01128569|19241211|P3|COMPLETED|Treatment Period 1||9
7816411|NCT01128569|19241212|P2|COMPLETED|Treatment Period 1||8
7816412|NCT01128569|19241213|P1|COMPLETED|Treatment Period 1||9
7816413|NCT01128569|19241208|P6|STARTED|Treatment Period 1||9
7816414|NCT01128569|19241209|P5|STARTED|Treatment Period 1||9
7816415|NCT01128569|19241210|P4|STARTED|Treatment Period 1||8
7816416|NCT01128569|19241211|P3|STARTED|Treatment Period 1||9
7816417|NCT01128569|19241212|P2|STARTED|Treatment Period 1||8
7816418|NCT01128569|19241213|P1|STARTED|Treatment Period 1||9
7816419|NCT01128543|19241230|P1|NOT COMPLETED|Overall Study||4
7816420|NCT01128543|19241230|P1|COMPLETED|Overall Study||25
7816421|NCT01128543|19241230|P1|STARTED|Overall Study||29
7816422|NCT01128426|19241236|P1|NOT COMPLETED|Overall Study||0
7816423|NCT01128426|19241236|P1|COMPLETED|Overall Study||53902
7816424|NCT01128426|19241236|P1|STARTED|Overall Study||53902
7816425|NCT01128413|19241256|P2|NOT COMPLETED|Overall Study||1
7816426|NCT01128413|19241257|P1|NOT COMPLETED|Overall Study||4
7816427|NCT01128413|19241256|P2|COMPLETED|Overall Study||10
7816428|NCT01128413|19241257|P1|COMPLETED|Overall Study||7
7816429|NCT01128413|19241256|P2|STARTED|Overall Study||11
7816430|NCT01128413|19241257|P1|STARTED|Overall Study||11
7816431|NCT01128400|19241266|P3|NOT COMPLETED|Overall Study||16
7816432|NCT01128400|19241267|P2|NOT COMPLETED|Overall Study||1
7816433|NCT01128400|19241268|P1|NOT COMPLETED|Overall Study||2
7816434|NCT01128400|19241266|P3|COMPLETED|Overall Study||7
7816435|NCT01128400|19241267|P2|COMPLETED|Overall Study||8
7816436|NCT01128400|19241268|P1|COMPLETED|Overall Study||6
7816437|NCT01128400|19241266|P3|STARTED|Overall Study||23
7816438|NCT01128400|19241267|P2|STARTED|Overall Study||9
7816439|NCT01128400|19241268|P1|STARTED|Overall Study||8
7816440|NCT01128387|19241281|P2|NOT COMPLETED|Overall Study||1
7816441|NCT01128387|19241282|P1|NOT COMPLETED|Overall Study||0
7816442|NCT01128387|19241281|P2|COMPLETED|Overall Study||5
7816443|NCT01128387|19241282|P1|COMPLETED|Overall Study||5
7816444|NCT01128387|19241281|P2|STARTED|Overall Study||6
7816445|NCT01128387|19241282|P1|STARTED|Overall Study||5
7816446|NCT01128361|19241292|P2|NOT COMPLETED|Overall Study||3
7816447|NCT01128361|19241293|P1|NOT COMPLETED|Overall Study||5
7816448|NCT01128361|19241292|P2|COMPLETED|Overall Study||34
7816449|NCT01128361|19241293|P1|COMPLETED|Overall Study||34
7816450|NCT01128361|19241292|P2|STARTED|Overall Study||37
7816451|NCT01128361|19241293|P1|STARTED|Overall Study||39
7816452|NCT01128296|19241305|P6|NOT COMPLETED|Overall Study||5
7816453|NCT01128296|19241306|P5|NOT COMPLETED|Overall Study||0
7816454|NCT01128296|19241307|P4|NOT COMPLETED|Overall Study||0
7816455|NCT01128296|19241308|P3|NOT COMPLETED|Overall Study||0
7816456|NCT01128296|19241309|P2|NOT COMPLETED|Overall Study||0
7816457|NCT01128296|19241310|P1|NOT COMPLETED|Overall Study||0
7816458|NCT01128296|19241305|P6|COMPLETED|Overall Study||21
7816459|NCT01128296|19241306|P5|COMPLETED|Overall Study||1
7816460|NCT01128296|19241307|P4|COMPLETED|Overall Study||1
7816461|NCT01128296|19241308|P3|COMPLETED|Overall Study||1
7816462|NCT01128296|19241309|P2|COMPLETED|Overall Study||1
7816463|NCT01128296|19241310|P1|COMPLETED|Overall Study||1
7816464|NCT01128296|19241305|P6|STARTED|Overall Study||26
7816465|NCT01128296|19241306|P5|STARTED|Overall Study||1
7816466|NCT01128296|19241307|P4|STARTED|Overall Study||1
7816467|NCT01128296|19241308|P3|STARTED|Overall Study||1
7816468|NCT01128296|19241309|P2|STARTED|Overall Study||1
7816469|NCT01128296|19241310|P1|STARTED|Overall Study||1
7816470|NCT01128270|19241328|P1|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0
7816471|NCT01128270|19241328|P1|COMPLETED|Therapeutic Chloral Hydrate (2B)||8
7816472|NCT01128270|19241328|P1|STARTED|Therapeutic Chloral Hydrate (2B)||8
7816473|NCT01128270|19241328|P1|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0
7816474|NCT01128270|19241328|P1|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8
7816475|NCT01128270|19241328|P1|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8
7816476|NCT01128270|19241328|P1|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0
7816477|NCT01128270|19241328|P1|COMPLETED|Environmental Chloral Hydrate (1B)||8
7816478|NCT01128270|19241328|P1|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8
7816479|NCT01128270|19241328|P1|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0
7816480|NCT01128270|19241328|P1|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7
7816481|NCT01128270|19241328|P1|STARTED|Environment Chloral Hydrate and DCA (1A)||7
7816482|NCT01128244|19241341|P1|NOT COMPLETED|Overall Study||3
7816483|NCT01128244|19241341|P1|COMPLETED|Overall Study||10
7816484|NCT01128244|19241341|P1|STARTED|Overall Study||13
7816485|NCT01128192|19241351|P3|NOT COMPLETED|Overall Study||0
7816486|NCT01128192|19241352|P2|NOT COMPLETED|Overall Study||0
7816487|NCT01128192|19241353|P1|NOT COMPLETED|Overall Study||0
7816488|NCT01128192|19241351|P3|COMPLETED|Overall Study||7
7816489|NCT01128192|19241352|P2|COMPLETED|Overall Study||19
7816490|NCT01128192|19241353|P1|COMPLETED|Overall Study||19
7816491|NCT01128192|19241351|P3|STARTED|Overall Study||7
7816492|NCT01128192|19241352|P2|STARTED|Overall Study||19
7816493|NCT01128192|19241353|P1|STARTED|Overall Study||19
7816494|NCT01128179|19241382|P2|NOT COMPLETED|Overall Study||0
7816495|NCT01128179|19241383|P1|NOT COMPLETED|Overall Study||2
7816496|NCT01128179|19241382|P2|COMPLETED|Overall Study||12
7816497|NCT01128179|19241383|P1|COMPLETED|Overall Study||21
7816498|NCT01128179|19241382|P2|STARTED|Overall Study||12
7816499|NCT01128179|19241383|P1|STARTED|Overall Study||23
7816500|NCT01128153|19241403|P2|NOT COMPLETED|Overall Study||15
7816501|NCT01128153|19241404|P1|NOT COMPLETED|Overall Study||16
7816502|NCT01128153|19241403|P2|COMPLETED|Overall Study|Completed 24 weeks|113
7816503|NCT01128153|19241404|P1|COMPLETED|Overall Study|Completed 24 weeks|113
7816687|NCT01126593|19241885|P1|COMPLETED|Overall Study||29
7816504|NCT01128153|19241403|P2|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128
7816505|NCT01128153|19241404|P1|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127
7816506|NCT01128153|19241403|P2|STARTED|Overall Study|Randomised|128
7816507|NCT01128153|19241404|P1|STARTED|Overall Study|Randomised|129
7816508|NCT01128114|19241420|P1|NOT COMPLETED|Overall Study||8
7816509|NCT01128114|19241420|P1|COMPLETED|Overall Study||24
7816510|NCT01128114|19241420|P1|STARTED|Overall Study||32
7816511|NCT01128049|19241427|P3|NOT COMPLETED|Overall Study||0
7816512|NCT01128049|19241428|P2|NOT COMPLETED|Overall Study||0
7816513|NCT01128049|19241429|P1|NOT COMPLETED|Overall Study||0
7816514|NCT01128049|19241427|P3|COMPLETED|Overall Study||5
7816515|NCT01128049|19241428|P2|COMPLETED|Overall Study||5
7816516|NCT01128049|19241429|P1|COMPLETED|Overall Study||5
7816517|NCT01128049|19241427|P3|STARTED|Overall Study||5
7816518|NCT01128049|19241428|P2|STARTED|Overall Study||5
7816519|NCT01128049|19241429|P1|STARTED|Overall Study||5
7816520|NCT01127763|19241437|P1|NOT COMPLETED|Overall Study||5
7816521|NCT01127763|19241437|P1|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20
7816522|NCT01127763|19241437|P1|STARTED|Overall Study||25
7816523|NCT01127737|19241448|P2|NOT COMPLETED|Overall Study||0
7816524|NCT01127737|19241449|P1|NOT COMPLETED|Overall Study||0
7816525|NCT01127737|19241448|P2|COMPLETED|Overall Study||38
7816526|NCT01127737|19241449|P1|COMPLETED|Overall Study||37
7816527|NCT01127737|19241448|P2|STARTED|Overall Study||38
7816528|NCT01127737|19241449|P1|STARTED|Overall Study||37
7816529|NCT01127659|19241461|P6|NOT COMPLETED|Overall Study||0
7816530|NCT01127659|19241462|P5|NOT COMPLETED|Overall Study||0
7816531|NCT01127659|19241463|P4|NOT COMPLETED|Overall Study||4
7816532|NCT01127659|19241464|P3|NOT COMPLETED|Overall Study||2
7816533|NCT01127659|19241465|P2|NOT COMPLETED|Overall Study||8
7816534|NCT01127659|19241466|P1|NOT COMPLETED|Overall Study||2
7816535|NCT01127659|19241461|P6|COMPLETED|Overall Study||21
7816536|NCT01127659|19241462|P5|COMPLETED|Overall Study||50
7816537|NCT01127659|19241463|P4|COMPLETED|Overall Study||6
7816538|NCT01127659|19241464|P3|COMPLETED|Overall Study||10
7816539|NCT01127659|19241465|P2|COMPLETED|Overall Study||14
7816540|NCT01127659|19241466|P1|COMPLETED|Overall Study||20
7816541|NCT01127659|19241461|P6|STARTED|Overall Study||21
7816542|NCT01127659|19241462|P5|STARTED|Overall Study||50
7816543|NCT01127659|19241463|P4|STARTED|Overall Study||10
7816544|NCT01127659|19241464|P3|STARTED|Overall Study||12
7816545|NCT01127659|19241465|P2|STARTED|Overall Study||22
7816546|NCT01127659|19241466|P1|STARTED|Overall Study||22
7816547|NCT01127646|19241482|P2|NOT COMPLETED|Overall Study||1
7816548|NCT01127646|19241483|P1|NOT COMPLETED|Overall Study||1
7816549|NCT01127646|19241482|P2|COMPLETED|Overall Study||7
7816550|NCT01127646|19241483|P1|COMPLETED|Overall Study||14
7816551|NCT01127646|19241482|P2|STARTED|Overall Study||8
7816552|NCT01127646|19241483|P1|STARTED|Overall Study||15
7816553|NCT01127633|19241517|P2|NOT COMPLETED|Overall Study||673
7816554|NCT01127633|19241518|P1|NOT COMPLETED|Overall Study||653
7816555|NCT01127633|19241517|P2|COMPLETED|Overall Study||61
7816556|NCT01127633|19241518|P1|COMPLETED|Overall Study||70
7816557|NCT01127633|19241517|P2|Received at Least 1 Dose of Study Drug|Overall Study||734
7816558|NCT01127633|19241518|P1|Received at Least 1 Dose of Study Drug|Overall Study||723
7816559|NCT01127633|19241517|P2|STARTED|Overall Study||734
7816560|NCT01127633|19241518|P1|STARTED|Overall Study||723
7816561|NCT01127607|19241550|P2|NOT COMPLETED|Phase II (Between Subjects)||2
7816562|NCT01127607|19241551|P1|NOT COMPLETED|Phase II (Between Subjects)||1
7816563|NCT01127607|19241550|P2|COMPLETED|Phase II (Between Subjects)||11
7816564|NCT01127607|19241551|P1|COMPLETED|Phase II (Between Subjects)||13
7816565|NCT01127607|19241550|P2|STARTED|Phase II (Between Subjects)||13
7816566|NCT01127607|19241551|P1|STARTED|Phase II (Between Subjects)||14
7816567|NCT01127607|19241550|P2|NOT COMPLETED|Phase I (Within Subjects)||0
7816568|NCT01127607|19241551|P1|NOT COMPLETED|Phase I (Within Subjects)||0
7816569|NCT01127607|19241550|P2|COMPLETED|Phase I (Within Subjects)||13
7816570|NCT01127607|19241551|P1|COMPLETED|Phase I (Within Subjects)||14
7816571|NCT01127607|19241550|P2|STARTED|Phase I (Within Subjects)||13
7816572|NCT01127607|19241551|P1|STARTED|Phase I (Within Subjects)||14
7816573|NCT01127581|19241624|P2|NOT COMPLETED|Overall Study||0
7816574|NCT01127581|19241625|P1|NOT COMPLETED|Overall Study||0
7816575|NCT01127581|19241624|P2|COMPLETED|Overall Study||680
7816576|NCT01127581|19241625|P1|COMPLETED|Overall Study||678
7816577|NCT01127581|19241624|P2|STARTED|Overall Study||680
7816578|NCT01127581|19241625|P1|STARTED|Overall Study||678
7816579|NCT01127503|19241653|P2|NOT COMPLETED|Overall Study||0
7816580|NCT01127503|19241654|P1|NOT COMPLETED|Overall Study||0
7816581|NCT01127503|19241653|P2|COMPLETED|Overall Study||1
7816582|NCT01127503|19241654|P1|COMPLETED|Overall Study||1
7816583|NCT01127503|19241653|P2|STARTED|Overall Study||1
7816584|NCT01127503|19241654|P1|STARTED|Overall Study||1
7816585|NCT01127438|19241668|P6|NOT COMPLETED|Overall Study||0
7816586|NCT01127438|19241669|P5|NOT COMPLETED|Overall Study||0
7816587|NCT01127438|19241670|P4|NOT COMPLETED|Overall Study||0
7816588|NCT01127438|19241671|P3|NOT COMPLETED|Overall Study||0
7816589|NCT01127438|19241672|P2|NOT COMPLETED|Overall Study||0
7816590|NCT01127438|19241673|P1|NOT COMPLETED|Overall Study||0
7816591|NCT01127438|19241668|P6|COMPLETED|Overall Study||25
7816592|NCT01127438|19241669|P5|COMPLETED|Overall Study||28
7816593|NCT01127438|19241670|P4|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24
7816594|NCT01127438|19241671|P3|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26
7816595|NCT01127438|19241672|P2|COMPLETED|Overall Study||25
7816596|NCT01127438|19241673|P1|COMPLETED|Overall Study||25
7816597|NCT01127438|19241668|P6|STARTED|Overall Study||25
7816598|NCT01127438|19241669|P5|STARTED|Overall Study||28
7816599|NCT01127438|19241670|P4|STARTED|Overall Study||24
7816600|NCT01127438|19241671|P3|STARTED|Overall Study||26
7816601|NCT01127438|19241672|P2|STARTED|Overall Study||25
7816602|NCT01127438|19241673|P1|STARTED|Overall Study||25
7816603|NCT01127321|19241700|P5|NOT COMPLETED|Overall Study||0
7816604|NCT01127321|19241701|P4|NOT COMPLETED|Overall Study||0
7816605|NCT01127321|19241702|P3|NOT COMPLETED|Overall Study||0
7816606|NCT01127321|19241703|P2|NOT COMPLETED|Overall Study||0
7816607|NCT01127321|19241704|P1|NOT COMPLETED|Overall Study||0
7816608|NCT01127321|19241700|P5|COMPLETED|Overall Study||5
7816609|NCT01127321|19241701|P4|COMPLETED|Overall Study||7
7816610|NCT01127321|19241702|P3|COMPLETED|Overall Study||1
7816611|NCT01127321|19241703|P2|COMPLETED|Overall Study||1
7816612|NCT01127321|19241704|P1|COMPLETED|Overall Study||3
7816613|NCT01127321|19241700|P5|STARTED|Overall Study||5
7816614|NCT01127321|19241701|P4|STARTED|Overall Study||7
7816615|NCT01127321|19241702|P3|STARTED|Overall Study||1
7816616|NCT01127321|19241703|P2|STARTED|Overall Study||1
7816617|NCT01127321|19241704|P1|STARTED|Overall Study||3
7816618|NCT01127256|19241728|P2|NOT COMPLETED|Overall Study||39
7816619|NCT01127256|19241729|P1|NOT COMPLETED|Overall Study||39
7816620|NCT01127256|19241728|P2|COMPLETED|Overall Study||65
7816621|NCT01127256|19241729|P1|COMPLETED|Overall Study||57
7816622|NCT01127256|19241728|P2|STARTED|Overall Study||104
7816623|NCT01127256|19241729|P1|STARTED|Overall Study||96
7816624|NCT01127165|19241741|P2|NOT COMPLETED|Overall Study||19
7816625|NCT01127165|19241742|P1|NOT COMPLETED|Overall Study||16
7816626|NCT01127165|19241741|P2|COMPLETED|Overall Study||41
7816627|NCT01127165|19241742|P1|COMPLETED|Overall Study||49
7816628|NCT01127165|19241741|P2|STARTED|Overall Study||60
7816629|NCT01127165|19241742|P1|STARTED|Overall Study||65
7816630|NCT01127139|19241754|P1|NOT COMPLETED|Overall Study||57
7816631|NCT01127139|19241754|P1|COMPLETED|Overall Study||3771
7816632|NCT01127139|19241754|P1|Number of Participants Analyzed|Overall Study||3828
7816633|NCT01127139|19241754|P1|STARTED|Overall Study||3828
7816634|NCT01127087|19241771|P2|NOT COMPLETED|Overall Study||0
7816635|NCT01127087|19241772|P1|NOT COMPLETED|Overall Study||0
7816636|NCT01127087|19241771|P2|COMPLETED|Overall Study||2
7816637|NCT01127087|19241772|P1|COMPLETED|Overall Study||8
7816638|NCT01127087|19241771|P2|STARTED|Overall Study||2
7816639|NCT01127087|19241772|P1|STARTED|Overall Study||8
7816640|NCT01127061|19241782|P2|NOT COMPLETED|Overall Study||13
7816641|NCT01127061|19241783|P1|NOT COMPLETED|Overall Study||10
7816642|NCT01127061|19241782|P2|COMPLETED|Overall Study||56
7816643|NCT01127061|19241783|P1|COMPLETED|Overall Study||57
7816644|NCT01127061|19241782|P2|STARTED|Overall Study||69
7816645|NCT01127061|19241783|P1|STARTED|Overall Study||67
7816646|NCT01126957|19241813|P1|NOT COMPLETED|Overall Study||0
7816647|NCT01126957|19241813|P1|COMPLETED|Overall Study||103
7816648|NCT01126957|19241813|P1|STARTED|Overall Study||103
7816649|NCT01126879|19241820|P2|NOT COMPLETED|Overall Study||2
7816650|NCT01126879|19241821|P1|NOT COMPLETED|Overall Study||5
7816651|NCT01126879|19241820|P2|COMPLETED|Overall Study||2
7816652|NCT01126879|19241821|P1|COMPLETED|Overall Study||3
7816653|NCT01126879|19241820|P2|Completed 3 Months Genistein/Placebo|Overall Study||2
7816654|NCT01126879|19241821|P1|Completed 3 Months Genistein/Placebo|Overall Study||4
7816655|NCT01126879|19241820|P2|Prostatectomy or Radiation|Overall Study||4
7816656|NCT01126879|19241821|P1|Prostatectomy or Radiation|Overall Study||8
7816657|NCT01126879|19241820|P2|Started 3 Months of Genistein/Placebo|Overall Study||4
7816658|NCT01126879|19241821|P1|Started 3 Months of Genistein/Placebo|Overall Study||8
7816659|NCT01126879|19241820|P2|STARTED|Overall Study||4
7816660|NCT01126879|19241821|P1|STARTED|Overall Study||8
7816661|NCT01126801|19241835|P2|NOT COMPLETED|Overall Study||0
7816662|NCT01126801|19241836|P1|NOT COMPLETED|Overall Study||0
7816663|NCT01126801|19241835|P2|COMPLETED|Overall Study||1
7816664|NCT01126801|19241836|P1|COMPLETED|Overall Study||1
7816665|NCT01126801|19241835|P2|STARTED|Overall Study||1
7816666|NCT01126801|19241836|P1|STARTED|Overall Study||1
7816667|NCT01126723|19241846|P2|NOT COMPLETED|Overall Study||3
7816668|NCT01126723|19241847|P1|NOT COMPLETED|Overall Study||6
7816669|NCT01126723|19241846|P2|COMPLETED|Overall Study||28
7816670|NCT01126723|19241847|P1|COMPLETED|Overall Study||29
7816671|NCT01126723|19241846|P2|STARTED|Overall Study||31
7816672|NCT01126723|19241847|P1|STARTED|Overall Study||35
7816673|NCT01126671|19241855|P2|NOT COMPLETED|Overall Study||1
7816674|NCT01126671|19241856|P1|NOT COMPLETED|Overall Study||2
7816675|NCT01126671|19241855|P2|COMPLETED|Overall Study||29
7816676|NCT01126671|19241856|P1|COMPLETED|Overall Study||24
7816677|NCT01126671|19241855|P2|STARTED|Overall Study||30
7816678|NCT01126671|19241856|P1|STARTED|Overall Study||26
7816679|NCT01126619|19241868|P1|NOT COMPLETED|Overall Study||17
7816680|NCT01126619|19241868|P1|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86
7816681|NCT01126619|19241868|P1|STARTED|Overall Study||103
7816682|NCT01126593|19241883|P3|NOT COMPLETED|Overall Study||2
7816683|NCT01126593|19241884|P2|NOT COMPLETED|Overall Study||2
7816684|NCT01126593|19241885|P1|NOT COMPLETED|Overall Study||4
7816685|NCT01126593|19241883|P3|COMPLETED|Overall Study||32
7816686|NCT01126593|19241884|P2|COMPLETED|Overall Study||27
7816688|NCT01126593|19241883|P3|STARTED|Overall Study||34
7816689|NCT01126593|19241884|P2|STARTED|Overall Study||29
7816690|NCT01126593|19241885|P1|STARTED|Overall Study||33
7816691|NCT01126580|19241896|P3|NOT COMPLETED|Overall Study||55
7816692|NCT01126580|19241897|P2|NOT COMPLETED|Overall Study||52
7816693|NCT01126580|19241898|P1|NOT COMPLETED|Overall Study||49
7816694|NCT01126580|19241896|P3|COMPLETED|Overall Study||213
7816695|NCT01126580|19241897|P2|COMPLETED|Overall Study||218
7816696|NCT01126580|19241898|P1|COMPLETED|Overall Study||220
7816697|NCT01126580|19241896|P3|Completed 26 Weeks|Overall Study||226
7816698|NCT01126580|19241897|P2|Completed 26 Weeks|Overall Study||242
7816699|NCT01126580|19241898|P1|Completed 26 Weeks|Overall Study||233
7816700|NCT01126580|19241896|P3|Received at Least 1 Dose of Study Drug|Overall Study||268
7816701|NCT01126580|19241897|P2|Received at Least 1 Dose of Study Drug|Overall Study||270
7816702|NCT01126580|19241898|P1|Received at Least 1 Dose of Study Drug|Overall Study||269
7816703|NCT01126580|19241896|P3|STARTED|Overall Study||268
7816704|NCT01126580|19241897|P2|STARTED|Overall Study||270
7816705|NCT01126580|19241898|P1|STARTED|Overall Study||269
7816706|NCT01126541|19241993|P3|NOT COMPLETED|Overall Study||26
7816707|NCT01126541|19241994|P2|NOT COMPLETED|Overall Study||12
7816708|NCT01126541|19241995|P1|NOT COMPLETED|Overall Study||10
7816709|NCT01126541|19241993|P3|COMPLETED|Overall Study||55
7816710|NCT01126541|19241994|P2|COMPLETED|Overall Study||61
7816711|NCT01126541|19241995|P1|COMPLETED|Overall Study||60
7816712|NCT01126541|19241993|P3|STARTED|Overall Study||81
7816713|NCT01126541|19241994|P2|STARTED|Overall Study||73
7816714|NCT01126541|19241995|P1|STARTED|Overall Study||70
7816715|NCT01126437|19242079|P3|NOT COMPLETED|Overall Study||1313
7816716|NCT01126437|19242080|P2|NOT COMPLETED|Overall Study||1330
7816717|NCT01126437|19242081|P1|NOT COMPLETED|Overall Study||1341
7816718|NCT01126437|19242079|P3|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
7816719|NCT01126437|19242080|P2|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399
7816720|NCT01126437|19242081|P1|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
7816721|NCT01126437|19242079|P3|STARTED|Overall Study||5713
7816722|NCT01126437|19242080|P2|STARTED|Overall Study||5729
7816723|NCT01126437|19242081|P1|STARTED|Overall Study||5741
7816724|NCT01126424|19242119|P6|NOT COMPLETED|Overall Study||0
7816725|NCT01126424|19242120|P5|NOT COMPLETED|Overall Study||2
7816726|NCT01126424|19242121|P4|NOT COMPLETED|Overall Study||3
7816727|NCT01126424|19242122|P3|NOT COMPLETED|Overall Study||1
7816728|NCT01126424|19242123|P2|NOT COMPLETED|Overall Study||0
7816729|NCT01126424|19242124|P1|NOT COMPLETED|Overall Study||0
7816730|NCT01126424|19242119|P6|COMPLETED|Overall Study||4
7816731|NCT01126424|19242120|P5|COMPLETED|Overall Study||2
7816732|NCT01126424|19242121|P4|COMPLETED|Overall Study||3
7816733|NCT01126424|19242122|P3|COMPLETED|Overall Study||4
7816734|NCT01126424|19242123|P2|COMPLETED|Overall Study||4
7816735|NCT01126424|19242124|P1|COMPLETED|Overall Study||3
7816736|NCT01126424|19242119|P6|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
7816737|NCT01126424|19242120|P5|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
7816738|NCT01126424|19242121|P4|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
7816739|NCT01126424|19242122|P3|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
7816740|NCT01126424|19242123|P2|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
7816741|NCT01126424|19242124|P1|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3
7816742|NCT01126424|19242119|P6|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
7816743|NCT01126424|19242120|P5|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
7816744|NCT01126424|19242121|P4|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6
7816745|NCT01126424|19242122|P3|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5
7816746|NCT01126424|19242123|P2|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
7816747|NCT01126424|19242124|P1|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3
7816748|NCT01126359|19242147|P2|NOT COMPLETED|Second Intervention (20-minutes)||0
7816749|NCT01126359|19242148|P1|NOT COMPLETED|Second Intervention (20-minutes)||0
7816750|NCT01126359|19242147|P2|COMPLETED|Second Intervention (20-minutes)||5
7816751|NCT01126359|19242148|P1|COMPLETED|Second Intervention (20-minutes)||5
7816752|NCT01126359|19242147|P2|STARTED|Second Intervention (20-minutes)||5
7816753|NCT01126359|19242148|P1|STARTED|Second Intervention (20-minutes)||5
7816754|NCT01126359|19242147|P2|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
7816755|NCT01126359|19242148|P1|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
7816756|NCT01126359|19242147|P2|COMPLETED|Dressing Replacement/Healing (48-hours)||5
7816757|NCT01126359|19242148|P1|COMPLETED|Dressing Replacement/Healing (48-hours)||5
7816758|NCT01126359|19242147|P2|STARTED|Dressing Replacement/Healing (48-hours)||5
7816759|NCT01126359|19242148|P1|STARTED|Dressing Replacement/Healing (48-hours)||5
7816760|NCT01126359|19242147|P2|NOT COMPLETED|First Intervention (20-minutes)||1
7816761|NCT01126359|19242148|P1|NOT COMPLETED|First Intervention (20-minutes)||0
7816762|NCT01126359|19242147|P2|COMPLETED|First Intervention (20-minutes)||5
7816763|NCT01126359|19242148|P1|COMPLETED|First Intervention (20-minutes)||5
7816764|NCT01126359|19242147|P2|STARTED|First Intervention (20-minutes)||6
7816765|NCT01126359|19242148|P1|STARTED|First Intervention (20-minutes)||5
7816766|NCT01126268|19242160|P1|NOT COMPLETED|Overall Study||1
7816767|NCT01126268|19242160|P1|COMPLETED|Overall Study||37
7816768|NCT01126268|19242160|P1|STARTED|Overall Study||38
7816769|NCT01126099|19242184|P2|NOT COMPLETED|Open-label Extension||1
7816770|NCT01126099|19242185|P1|NOT COMPLETED|Open-label Extension||1
7816771|NCT01126099|19242184|P2|COMPLETED|Open-label Extension||6
7816772|NCT01126099|19242185|P1|COMPLETED|Open-label Extension||4
7816773|NCT01126099|19242184|P2|STARTED|Open-label Extension||7
7816774|NCT01126099|19242185|P1|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5
7816775|NCT01126099|19242184|P2|NOT COMPLETED|Double Blind Phase||2
7816776|NCT01126099|19242185|P1|NOT COMPLETED|Double Blind Phase||4
7816777|NCT01126099|19242184|P2|COMPLETED|Double Blind Phase||7
7816778|NCT01126099|19242185|P1|COMPLETED|Double Blind Phase||7
7816779|NCT01126099|19242184|P2|STARTED|Double Blind Phase||9
7816780|NCT01126099|19242185|P1|STARTED|Double Blind Phase||11
7816781|NCT01126060|19242199|P2|NOT COMPLETED|Overall Study||2
7816782|NCT01126060|19242200|P1|NOT COMPLETED|Overall Study||0
7816783|NCT01126060|19242199|P2|COMPLETED|Overall Study||38
7816784|NCT01126060|19242200|P1|COMPLETED|Overall Study||40
7816785|NCT01126060|19242199|P2|STARTED|Overall Study||40
7816786|NCT01126060|19242200|P1|STARTED|Overall Study||40
7816787|NCT01125930|19242208|P2|NOT COMPLETED|Overall Study||10
7816788|NCT01125930|19242209|P1|NOT COMPLETED|Overall Study||1
7816789|NCT01125930|19242208|P2|COMPLETED|Overall Study||36
7816790|NCT01125930|19242209|P1|COMPLETED|Overall Study||21
7816791|NCT01125930|19242208|P2|STARTED|Overall Study||46
7816792|NCT01125930|19242209|P1|STARTED|Overall Study||22
7816793|NCT01125917|19242363|P1|NOT COMPLETED|Overall Study||339
7816794|NCT01125917|19242363|P1|COMPLETED|Overall Study||15
7816795|NCT01125917|19242363|P1|STARTED|Overall Study||354
7816796|NCT01125813|19242367|P1|NOT COMPLETED|Overall Study||6
7816797|NCT01125813|19242367|P1|COMPLETED|Overall Study||30
7816798|NCT01125813|19242367|P1|STARTED|Overall Study||36
7816799|NCT01125800|19242377|P5|NOT COMPLETED|Phase II||11
7816800|NCT01125800|19242378|P4|NOT COMPLETED|Phase II||1
7816801|NCT01125800|19242379|P3|NOT COMPLETED|Phase II||0
7816802|NCT01125800|19242380|P2|NOT COMPLETED|Phase II||0
7816803|NCT01125800|19242381|P1|NOT COMPLETED|Phase II||0
7816804|NCT01125800|19242377|P5|COMPLETED|Phase II||5
7816805|NCT01125800|19242378|P4|COMPLETED|Phase II||0
7816806|NCT01125800|19242379|P3|COMPLETED|Phase II||0
7816807|NCT01125800|19242380|P2|COMPLETED|Phase II||0
7816808|NCT01125800|19242381|P1|COMPLETED|Phase II||0
7816809|NCT01125800|19242377|P5|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16
7816810|NCT01125800|19242378|P4|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1
7816811|NCT01125800|19242379|P3|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
7816812|NCT01125800|19242380|P2|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
7816813|NCT01125800|19242381|P1|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
7816814|NCT01125800|19242377|P5|NOT COMPLETED|Phase I||0
7816815|NCT01125800|19242378|P4|NOT COMPLETED|Phase I||11
7816816|NCT01125800|19242379|P3|NOT COMPLETED|Phase I||4
7816817|NCT01125800|19242380|P2|NOT COMPLETED|Phase I||9
7816818|NCT01125800|19242381|P1|NOT COMPLETED|Phase I||8
7816819|NCT01125800|19242377|P5|COMPLETED|Phase I||0
7816820|NCT01125800|19242378|P4|COMPLETED|Phase I||10
7816821|NCT01125800|19242379|P3|COMPLETED|Phase I||7
7816822|NCT01125800|19242380|P2|COMPLETED|Phase I||7
7816823|NCT01125800|19242381|P1|COMPLETED|Phase I||3
7816824|NCT01125800|19242377|P5|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0
7816825|NCT01125800|19242378|P4|STARTED|Phase I||21
7816826|NCT01125800|19242379|P3|STARTED|Phase I||11
7816827|NCT01125800|19242380|P2|STARTED|Phase I||16
7816828|NCT01125800|19242381|P1|STARTED|Phase I||11
7816829|NCT01125774|19242420|P4|NOT COMPLETED|Overall Study||3
7816830|NCT01125774|19242421|P3|NOT COMPLETED|Overall Study||9
7816831|NCT01125774|19242422|P2|NOT COMPLETED|Overall Study||554
7816832|NCT01125774|19242423|P1|NOT COMPLETED|Overall Study||1125
7816833|NCT01125774|19242420|P4|COMPLETED|Overall Study|Completed study at least once|3
7816834|NCT01125774|19242421|P3|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13
7816835|NCT01125774|19242422|P2|COMPLETED|Overall Study||948
7816836|NCT01125774|19242423|P1|COMPLETED|Overall Study||1893
7816837|NCT01125774|19242420|P4|Treated|Overall Study||5
7816838|NCT01125774|19242421|P3|Treated|Overall Study|Received telcagepant|21
7816839|NCT01125774|19242422|P2|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322
7816840|NCT01125774|19242423|P1|Treated|Overall Study||2638
7816841|NCT01125774|19242420|P4|STARTED|Overall Study|Unique participants randomized|6
7816842|NCT01125774|19242421|P3|STARTED|Overall Study|Unique participants randomized|22
7816843|NCT01125774|19242422|P2|STARTED|Overall Study|Randomized|1502
7816844|NCT01125774|19242423|P1|STARTED|Overall Study|Randomized|3018
7816845|NCT01125748|19242447|P2|NOT COMPLETED|Overall Study||14
7816846|NCT01125748|19242448|P1|NOT COMPLETED|Overall Study||10
7816847|NCT01125748|19242447|P2|COMPLETED|Overall Study||74
7816848|NCT01125748|19242448|P1|COMPLETED|Overall Study||78
7816849|NCT01125748|19242447|P2|STARTED|Overall Study||88
7816850|NCT01125748|19242448|P1|STARTED|Overall Study||88
7816851|NCT01125722|19242458|P2|NOT COMPLETED|Overall Study||1
7816852|NCT01125722|19242459|P1|NOT COMPLETED|Overall Study||3
7816853|NCT01125722|19242458|P2|COMPLETED|Overall Study||36
7816854|NCT01125722|19242459|P1|COMPLETED|Overall Study||34
7816855|NCT01125722|19242458|P2|STARTED|Overall Study||37
7816856|NCT01125722|19242459|P1|STARTED|Overall Study||37
7816857|NCT01125605|19242473|P1|NOT COMPLETED|Overall Study||0
7816858|NCT01125605|19242473|P1|COMPLETED|Overall Study||325
7816859|NCT01125605|19242473|P1|Safety|Overall Study|1 patient was only analysed for safety|326
7816860|NCT01125605|19242473|P1|STARTED|Overall Study|started = had baseline values|325
7816861|NCT01125566|19242506|P3|NOT COMPLETED|Patients Who Switched From AV to TV||73
7816862|NCT01125566|19242507|P2|NOT COMPLETED|Patients Who Switched From AV to TV||0
7816863|NCT01125566|19242508|P1|NOT COMPLETED|Patients Who Switched From AV to TV||0
7816864|NCT01125566|19242506|P3|COMPLETED|Patients Who Switched From AV to TV||2
7816865|NCT01125566|19242507|P2|COMPLETED|Patients Who Switched From AV to TV||0
7816866|NCT01125566|19242508|P1|COMPLETED|Patients Who Switched From AV to TV||0
7816867|NCT01125566|19242506|P3|STARTED|Patients Who Switched From AV to TV||75
7816868|NCT01125566|19242507|P2|STARTED|Patients Who Switched From AV to TV||0
7816869|NCT01125566|19242508|P1|STARTED|Patients Who Switched From AV to TV||0
7816870|NCT01125566|19242506|P3|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0
7816871|NCT01125566|19242507|P2|NOT COMPLETED|Patients Before the Switch (26Apr2013)||169
7816872|NCT01125566|19242508|P1|NOT COMPLETED|Patients Before the Switch (26Apr2013)||265
7816873|NCT01125566|19242506|P3|COMPLETED|Patients Before the Switch (26Apr2013)||0
7816874|NCT01125566|19242507|P2|COMPLETED|Patients Before the Switch (26Apr2013)||0
7816875|NCT01125566|19242508|P1|COMPLETED|Patients Before the Switch (26Apr2013)||74
7816876|NCT01125566|19242506|P3|Treated|Patients Before the Switch (26Apr2013)||0
7816877|NCT01125566|19242507|P2|Treated|Patients Before the Switch (26Apr2013)||169
7816878|NCT01125566|19242508|P1|Treated|Patients Before the Switch (26Apr2013)||337
7816879|NCT01125566|19242506|P3|STARTED|Patients Before the Switch (26Apr2013)||0
7816880|NCT01125566|19242507|P2|STARTED|Patients Before the Switch (26Apr2013)||169
7816881|NCT01125566|19242508|P1|STARTED|Patients Before the Switch (26Apr2013)||339
7816882|NCT01125514|19242521|P1|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4
7816883|NCT01125514|19242521|P1|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28
7816884|NCT01125514|19242521|P1|STARTED|Treatment Period2(Day9-Day27) and Day 28||32
7816885|NCT01125514|19242521|P1|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3
7816886|NCT01125514|19242521|P1|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32
7816887|NCT01125514|19242521|P1|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
7816888|NCT01125514|19242521|P1|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
7816889|NCT01125514|19242521|P1|STARTED|Treatment Period 2 (Day 8 - Day 17)||35
7816890|NCT01125514|19242521|P1|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2
7816891|NCT01125514|19242521|P1|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35
7816892|NCT01125514|19242521|P1|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37
7816893|NCT01125202|19242595|P2|NOT COMPLETED|Overall Study||7
7816894|NCT01125202|19242596|P1|NOT COMPLETED|Overall Study||12
7816895|NCT01125202|19242595|P2|COMPLETED|Overall Study||79
7816896|NCT01125202|19242596|P1|COMPLETED|Overall Study||81
7816897|NCT01125202|19242595|P2|STARTED|Overall Study||86
7816898|NCT01125202|19242596|P1|STARTED|Overall Study||93
7816899|NCT01125189|19242621|P3|NOT COMPLETED|Follow up Period||16
7816900|NCT01125189|19242622|P2|NOT COMPLETED|Follow up Period||15
7816901|NCT01125189|19242623|P1|NOT COMPLETED|Follow up Period||20
7816902|NCT01125189|19242621|P3|COMPLETED|Follow up Period||58
7816903|NCT01125189|19242622|P2|COMPLETED|Follow up Period||138
7816904|NCT01125189|19242623|P1|COMPLETED|Follow up Period||132
7816905|NCT01125189|19242621|P3|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74
7816906|NCT01125189|19242622|P2|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153
7816907|NCT01125189|19242623|P1|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152
7816908|NCT01125189|19242621|P3|NOT COMPLETED|Treatment Period||41
7816909|NCT01125189|19242622|P2|NOT COMPLETED|Treatment Period||35
7816910|NCT01125189|19242623|P1|NOT COMPLETED|Treatment Period||31
7816911|NCT01125189|19242621|P3|COMPLETED|Treatment Period||37
7816912|NCT01125189|19242622|P2|COMPLETED|Treatment Period||123
7816913|NCT01125189|19242623|P1|COMPLETED|Treatment Period||128
7816914|NCT01125189|19242621|P3|STARTED|Treatment Period||78
7816915|NCT01125189|19242622|P2|STARTED|Treatment Period||158
7816916|NCT01125189|19242623|P1|STARTED|Treatment Period||159
7816917|NCT01125176|19242649|P1|NOT COMPLETED|Post-treatment Follow-up Phase||11
7816918|NCT01125176|19242649|P1|COMPLETED|Post-treatment Follow-up Phase||2
7816919|NCT01125176|19242649|P1|STARTED|Post-treatment Follow-up Phase||13
7816920|NCT01125176|19242649|P1|NOT COMPLETED|Treatment Phase||1
7816921|NCT01125176|19242649|P1|COMPLETED|Treatment Phase||13
7816922|NCT01125176|19242649|P1|STARTED|Treatment Phase||14
7816923|NCT01125163|19242655|P2|NOT COMPLETED|Overall Study||0
7816924|NCT01125163|19242656|P1|NOT COMPLETED|Overall Study||0
7816925|NCT01125163|19242655|P2|COMPLETED|Overall Study||74
7816926|NCT01125163|19242656|P1|COMPLETED|Overall Study||76
7816927|NCT01125163|19242655|P2|STARTED|Overall Study||74
7816928|NCT01125163|19242656|P1|STARTED|Overall Study||76
7816929|NCT01125098|19242666|P2|NOT COMPLETED|Overall Study||0
7816930|NCT01125098|19242667|P1|NOT COMPLETED|Overall Study||3
7816931|NCT01125098|19242666|P2|COMPLETED|Overall Study||90
7816932|NCT01125098|19242667|P1|COMPLETED|Overall Study||88
7816933|NCT01125098|19242666|P2|STARTED|Overall Study||90
7816934|NCT01125098|19242667|P1|STARTED|Overall Study||91
7816935|NCT01124955|19242675|P2|NOT COMPLETED|Overall Study||0
7816936|NCT01124955|19242676|P1|NOT COMPLETED|Overall Study||0
7816937|NCT01124955|19242675|P2|COMPLETED|Overall Study||40
7816938|NCT01124955|19242676|P1|COMPLETED|Overall Study||40
7816939|NCT01124955|19242675|P2|STARTED|Overall Study||40
7816940|NCT01124955|19242676|P1|STARTED|Overall Study||40
7816941|NCT01124916|19242692|P2|NOT COMPLETED|Overall Study||2
7816942|NCT01124916|19242693|P1|NOT COMPLETED|Overall Study||3
7816943|NCT01124916|19242692|P2|COMPLETED|Overall Study||38
7816944|NCT01124916|19242693|P1|COMPLETED|Overall Study||35
7816945|NCT01124916|19242692|P2|STARTED|Overall Study||40
7816946|NCT01124916|19242693|P1|STARTED|Overall Study||38
7816947|NCT01124864|19242707|P6|NOT COMPLETED|Overall Study||3
7816948|NCT01124864|19242708|P5|NOT COMPLETED|Overall Study||30
7816949|NCT01124864|19242709|P4|NOT COMPLETED|Overall Study||21
7816950|NCT01124864|19242710|P3|NOT COMPLETED|Overall Study||34
7816951|NCT01124864|19242711|P2|NOT COMPLETED|Overall Study||35
7816952|NCT01124864|19242712|P1|NOT COMPLETED|Overall Study||28
7816953|NCT01124864|19242707|P6|COMPLETED|Overall Study||0
7816954|NCT01124864|19242708|P5|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
7816955|NCT01124864|19242709|P4|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
7816956|NCT01124864|19242710|P3|COMPLETED|Overall Study||0
7816957|NCT01124864|19242711|P2|COMPLETED|Overall Study||0
7816958|NCT01124864|19242712|P1|COMPLETED|Overall Study||0
7816959|NCT01124864|19242707|P6|STARTED|Overall Study||3
7816960|NCT01124864|19242708|P5|STARTED|Overall Study||31
7816961|NCT01124864|19242709|P4|STARTED|Overall Study||22
7816962|NCT01124864|19242710|P3|STARTED|Overall Study||34
7816963|NCT01124864|19242711|P2|STARTED|Overall Study||35
7816964|NCT01124864|19242712|P1|STARTED|Overall Study||28
7816965|NCT01124838|19242746|P2|NOT COMPLETED|Overall Study||15
7816966|NCT01124838|19242747|P1|NOT COMPLETED|Overall Study||18
7816967|NCT01124838|19242746|P2|COMPLETED|Overall Study||116
7816968|NCT01124838|19242747|P1|COMPLETED|Overall Study||112
7816969|NCT01124838|19242746|P2|Enrolled in Japan Sub-study|Overall Study||16
7816970|NCT01124838|19242747|P1|Enrolled in Japan Sub-study|Overall Study||16
7816971|NCT01124838|19242746|P2|Enrolled in Main Study|Overall Study||115
7816972|NCT01124838|19242747|P1|Enrolled in Main Study|Overall Study||114
7816973|NCT01124838|19242746|P2|STARTED|Overall Study||131
7816974|NCT01124838|19242747|P1|STARTED|Overall Study||130
7816975|NCT01124786|19242793|P2|NOT COMPLETED|Overall Study||5
7816976|NCT01124786|19242794|P1|NOT COMPLETED|Overall Study||4
7816977|NCT01124786|19242793|P2|COMPLETED|Overall Study||180
7816978|NCT01124786|19242794|P1|COMPLETED|Overall Study||178
7816979|NCT01124786|19242793|P2|Tumor Evaluable Population|Overall Study||180
7816980|NCT01124786|19242794|P1|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178
7816981|NCT01124786|19242793|P2|Safety Population|Overall Study||181
7816982|NCT01124786|19242794|P1|Safety Population|Overall Study|All pts who received at least one dose of study drug|179
7816983|NCT01124786|19242793|P2|Intent-to-Treat (ITT) Population|Overall Study||185
7816984|NCT01124786|19242794|P1|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182
7816985|NCT01124786|19242793|P2|STARTED|Overall Study||185
7816986|NCT01124786|19242794|P1|STARTED|Overall Study||182
7816987|NCT01124734|19242814|P1|NOT COMPLETED|Overall Study||17
7816988|NCT01124734|19242814|P1|COMPLETED|Overall Study|Closed to accrual|0
7816989|NCT01124734|19242814|P1|Initiation of Course 1 Cycle 2|Overall Study||17
7816990|NCT01124734|19242814|P1|Completion of Course 1 Cycle 1|Overall Study|All 17 participants successfully completed Course 1 Cycle 1|17
7816991|NCT01124734|19242814|P1|STARTED|Overall Study||17
7816992|NCT01124643|19242825|P1|NOT COMPLETED|Overall Study||1
7816993|NCT01124643|19242825|P1|COMPLETED|Overall Study||34
7816994|NCT01124643|19242825|P1|STARTED|Overall Study||35
7816995|NCT01124617|19242839|P2|NOT COMPLETED|Overall Study||6
7816996|NCT01124617|19242840|P1|NOT COMPLETED|Overall Study||19
7816997|NCT01124617|19242839|P2|COMPLETED|Overall Study||25
7816998|NCT01124617|19242840|P1|COMPLETED|Overall Study||41
7816999|NCT01124617|19242839|P2|STARTED|Overall Study||31
7817000|NCT01124617|19242840|P1|STARTED|Overall Study||60
7817001|NCT01124604|19242872|P2|NOT COMPLETED|Overall Study||2
7817002|NCT01124604|19242873|P1|NOT COMPLETED|Overall Study||15
7817003|NCT01124604|19242872|P2|COMPLETED|Overall Study||29
7817004|NCT01124604|19242873|P1|COMPLETED|Overall Study||45
7817005|NCT01124604|19242872|P2|STARTED|Overall Study||31
7817006|NCT01124604|19242873|P1|STARTED|Overall Study||60
7817007|NCT01124448|19242912|P2|NOT COMPLETED|Overall Study||3
7817008|NCT01124448|19242913|P1|NOT COMPLETED|Overall Study||2
7817009|NCT01124448|19242912|P2|COMPLETED|Overall Study||12
7817010|NCT01124448|19242913|P1|COMPLETED|Overall Study||23
7817011|NCT01124448|19242912|P2|STARTED|Overall Study||15
7817012|NCT01124448|19242913|P1|STARTED|Overall Study||25
7817013|NCT01124422|19242921|P3|NOT COMPLETED|4-Week Double-blind Treatment Phase||9
7817014|NCT01124422|19242922|P2|NOT COMPLETED|4-Week Double-blind Treatment Phase||11
7817015|NCT01124422|19242923|P1|NOT COMPLETED|4-Week Double-blind Treatment Phase||0
7817016|NCT01124422|19242921|P3|COMPLETED|4-Week Double-blind Treatment Phase||115
7817017|NCT01124422|19242922|P2|COMPLETED|4-Week Double-blind Treatment Phase||120
7817018|NCT01124422|19242923|P1|COMPLETED|4-Week Double-blind Treatment Phase||0
7817019|NCT01124422|19242921|P3|STARTED|4-Week Double-blind Treatment Phase||124
7817020|NCT01124422|19242922|P2|STARTED|4-Week Double-blind Treatment Phase||131
7817021|NCT01124422|19242923|P1|STARTED|4-Week Double-blind Treatment Phase||0
7817113|NCT01124097|19243123|P3|Safety Population|Overall Study||60
7817022|NCT01124422|19242921|P3|NOT COMPLETED|4-Week Open-label Run-in Phase||0
7817023|NCT01124422|19242922|P2|NOT COMPLETED|4-Week Open-label Run-in Phase||0
7817024|NCT01124422|19242923|P1|NOT COMPLETED|4-Week Open-label Run-in Phase||83
7817025|NCT01124422|19242921|P3|COMPLETED|4-Week Open-label Run-in Phase||0
7817026|NCT01124422|19242922|P2|COMPLETED|4-Week Open-label Run-in Phase||0
7817027|NCT01124422|19242923|P1|COMPLETED|4-Week Open-label Run-in Phase||255
7817028|NCT01124422|19242921|P3|STARTED|4-Week Open-label Run-in Phase||0
7817029|NCT01124422|19242922|P2|STARTED|4-Week Open-label Run-in Phase||0
7817030|NCT01124422|19242923|P1|STARTED|4-Week Open-label Run-in Phase||338
7817031|NCT01124370|19242965|P1|NOT COMPLETED|Overall Study||20
7817032|NCT01124370|19242965|P1|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37
7817033|NCT01124370|19242965|P1|3 Month Visit|Overall Study|Defines evaluable population|47
7817034|NCT01124370|19242965|P1|Therapy Initiated|Overall Study||48
7817035|NCT01124370|19242965|P1|Successfully Implanted|Overall Study||50
7817036|NCT01124370|19242965|P1|STARTED|Overall Study|Underwent implant attempt|57
7817037|NCT01124305|19242977|P2|NOT COMPLETED|Overall Study||10
7817038|NCT01124305|19242978|P1|NOT COMPLETED|Overall Study||8
7817039|NCT01124305|19242977|P2|COMPLETED|Overall Study||26
7817040|NCT01124305|19242978|P1|COMPLETED|Overall Study||26
7817041|NCT01124305|19242977|P2|STARTED|Overall Study||36
7817042|NCT01124305|19242978|P1|STARTED|Overall Study||34
7817043|NCT01124292|19242993|P3|NOT COMPLETED|Overall Study||10
7817044|NCT01124292|19242994|P2|NOT COMPLETED|Overall Study||15
7817045|NCT01124292|19242995|P1|NOT COMPLETED|Overall Study||2
7817046|NCT01124292|19242993|P3|COMPLETED|Overall Study||11
7817047|NCT01124292|19242994|P2|COMPLETED|Overall Study||9
7817048|NCT01124292|19242995|P1|COMPLETED|Overall Study||14
7817049|NCT01124292|19242993|P3|STARTED|Overall Study||21
7817050|NCT01124292|19242994|P2|STARTED|Overall Study||24
7817051|NCT01124292|19242995|P1|STARTED|Overall Study||16
7817052|NCT01124188|19243053|P2|NOT COMPLETED|Overall Study||6
7817053|NCT01124188|19243054|P1|NOT COMPLETED|Overall Study||8
7817054|NCT01124188|19243053|P2|COMPLETED|Overall Study||65
7817055|NCT01124188|19243054|P1|COMPLETED|Overall Study||60
7817056|NCT01124188|19243053|P2|STARTED|Overall Study||71
7817057|NCT01124188|19243054|P1|STARTED|Overall Study||68
7817058|NCT01124175|19243066|P2|NOT COMPLETED|Second Intervention||0
7817059|NCT01124175|19243067|P1|NOT COMPLETED|Second Intervention||0
7817060|NCT01124175|19243066|P2|COMPLETED|Second Intervention||38
7817061|NCT01124175|19243067|P1|COMPLETED|Second Intervention||40
7817062|NCT01124175|19243066|P2|STARTED|Second Intervention||38
7817063|NCT01124175|19243067|P1|STARTED|Second Intervention||40
7817064|NCT01124175|19243066|P2|NOT COMPLETED|Washout of 7 Days||2
7817065|NCT01124175|19243067|P1|NOT COMPLETED|Washout of 7 Days||0
7817066|NCT01124175|19243066|P2|COMPLETED|Washout of 7 Days||38
7817067|NCT01124175|19243067|P1|COMPLETED|Washout of 7 Days||40
7817068|NCT01124175|19243066|P2|STARTED|Washout of 7 Days||40
7817069|NCT01124175|19243067|P1|STARTED|Washout of 7 Days||40
7817070|NCT01124175|19243066|P2|NOT COMPLETED|First Intervention||0
7817071|NCT01124175|19243067|P1|NOT COMPLETED|First Intervention||0
7817072|NCT01124175|19243066|P2|COMPLETED|First Intervention||40
7817073|NCT01124175|19243067|P1|COMPLETED|First Intervention||40
7817074|NCT01124175|19243066|P2|STARTED|First Intervention||40
7817075|NCT01124175|19243067|P1|STARTED|First Intervention||40
7817076|NCT01124162|19243085|P2|NOT COMPLETED|Second Intervention||0
7817077|NCT01124162|19243086|P1|NOT COMPLETED|Second Intervention||0
7817078|NCT01124162|19243085|P2|COMPLETED|Second Intervention||40
7817079|NCT01124162|19243086|P1|COMPLETED|Second Intervention||37
7817080|NCT01124162|19243085|P2|STARTED|Second Intervention||40
7817081|NCT01124162|19243086|P1|STARTED|Second Intervention||37
7817082|NCT01124162|19243085|P2|NOT COMPLETED|Washout of 7 Days||0
7817083|NCT01124162|19243086|P1|NOT COMPLETED|Washout of 7 Days||1
7817084|NCT01124162|19243085|P2|COMPLETED|Washout of 7 Days||40
7817085|NCT01124162|19243086|P1|COMPLETED|Washout of 7 Days||37
7817086|NCT01124162|19243085|P2|STARTED|Washout of 7 Days||40
7817087|NCT01124162|19243086|P1|STARTED|Washout of 7 Days||38
7817088|NCT01124162|19243085|P2|NOT COMPLETED|First Intervention||0
7817089|NCT01124162|19243086|P1|NOT COMPLETED|First Intervention||2
7817090|NCT01124162|19243085|P2|COMPLETED|First Intervention||40
7817091|NCT01124162|19243086|P1|COMPLETED|First Intervention||38
7817092|NCT01124162|19243085|P2|STARTED|First Intervention||40
7817093|NCT01124162|19243086|P1|STARTED|First Intervention||40
7817094|NCT01124149|19243102|P1|NOT COMPLETED|Maintenance Phase||96
7817095|NCT01124149|19243102|P1|COMPLETED|Maintenance Phase||373
7817096|NCT01124149|19243102|P1|STARTED|Maintenance Phase||469
7817097|NCT01124149|19243102|P1|NOT COMPLETED|Acute Phase||83
7817098|NCT01124149|19243102|P1|COMPLETED|Acute Phase||639
7817099|NCT01124149|19243102|P1|STARTED|Acute Phase||722
7817100|NCT01124097|19243122|P4|NOT COMPLETED|Overall Study||14
7817101|NCT01124097|19243123|P3|NOT COMPLETED|Overall Study||20
7817102|NCT01124097|19243124|P2|NOT COMPLETED|Overall Study||22
7817103|NCT01124097|19243125|P1|NOT COMPLETED|Overall Study||34
7817104|NCT01124097|19243122|P4|COMPLETED|Overall Study||46
7817105|NCT01124097|19243123|P3|COMPLETED|Overall Study||40
7817106|NCT01124097|19243124|P2|COMPLETED|Overall Study||38
7817107|NCT01124097|19243125|P1|COMPLETED|Overall Study||26
7817108|NCT01124097|19243122|P4|Efficacy Population|Overall Study||51
7817109|NCT01124097|19243123|P3|Efficacy Population|Overall Study||53
7817110|NCT01124097|19243124|P2|Efficacy Population|Overall Study||53
7817111|NCT01124097|19243125|P1|Efficacy Population|Overall Study||52
7817112|NCT01124097|19243122|P4|Safety Population|Overall Study||60
7817114|NCT01124097|19243124|P2|Safety Population|Overall Study||60
7817115|NCT01124097|19243125|P1|Safety Population|Overall Study||60
7817116|NCT01124097|19243122|P4|STARTED|Overall Study||60
7817117|NCT01124097|19243123|P3|STARTED|Overall Study||60
7817118|NCT01124097|19243124|P2|STARTED|Overall Study||60
7817119|NCT01124097|19243125|P1|STARTED|Overall Study||60
7817120|NCT01124045|19243137|P2|NOT COMPLETED|Overall Study||3
7817121|NCT01124045|19243138|P1|NOT COMPLETED|Overall Study||0
7817122|NCT01124045|19243137|P2|COMPLETED|Overall Study||37
7817123|NCT01124045|19243138|P1|COMPLETED|Overall Study||39
7817124|NCT01124045|19243137|P2|STARTED|Overall Study||40
7817125|NCT01124045|19243138|P1|STARTED|Overall Study||39
7817126|NCT01124006|19243171|P3|NOT COMPLETED|Overall Study||2
7817127|NCT01124006|19243172|P2|NOT COMPLETED|Overall Study||2
7817128|NCT01124006|19243173|P1|NOT COMPLETED|Overall Study||3
7817129|NCT01124006|19243171|P3|COMPLETED|Overall Study||2
7817130|NCT01124006|19243172|P2|COMPLETED|Overall Study||8
7817131|NCT01124006|19243173|P1|COMPLETED|Overall Study||7
7817132|NCT01124006|19243171|P3|STARTED|Overall Study||4
7817133|NCT01124006|19243172|P2|STARTED|Overall Study||10
7817134|NCT01124006|19243173|P1|STARTED|Overall Study||10
7817135|NCT01123980|19243201|P2|NOT COMPLETED|Overall Study||24
7817136|NCT01123980|19243202|P1|NOT COMPLETED|Overall Study||19
7817137|NCT01123980|19243201|P2|COMPLETED|Overall Study||236
7817138|NCT01123980|19243202|P1|COMPLETED|Overall Study||242
7817139|NCT01123980|19243201|P2|STARTED|Overall Study||260
7817140|NCT01123980|19243202|P1|STARTED|Overall Study||261
7817141|NCT01123941|19243222|P2|NOT COMPLETED|Overall Study||1
7817142|NCT01123941|19243223|P1|NOT COMPLETED|Overall Study||2
7817143|NCT01123941|19243222|P2|COMPLETED|Overall Study||24
7817144|NCT01123941|19243223|P1|COMPLETED|Overall Study||23
7817145|NCT01123941|19243222|P2|STARTED|Overall Study||25
7817146|NCT01123941|19243223|P1|STARTED|Overall Study||25
7817147|NCT01123928|19243237|P2|NOT COMPLETED|Overall Study||0
7817148|NCT01123928|19243238|P1|NOT COMPLETED|Overall Study||0
7817149|NCT01123928|19243237|P2|COMPLETED|Overall Study||222
7817150|NCT01123928|19243238|P1|COMPLETED|Overall Study||212
7817151|NCT01123928|19243237|P2|STARTED|Overall Study||222
7817152|NCT01123928|19243238|P1|STARTED|Overall Study||212
7817153|NCT01123889|19243258|P2|NOT COMPLETED|Overall Study||1
7817154|NCT01123889|19243259|P1|NOT COMPLETED|Overall Study||3
7817155|NCT01123889|19243258|P2|COMPLETED|Overall Study||6
7817156|NCT01123889|19243259|P1|COMPLETED|Overall Study||2
7817157|NCT01123889|19243258|P2|STARTED|Overall Study||7
7817158|NCT01123889|19243259|P1|STARTED|Overall Study||5
7817159|NCT01123850|19243269|P1|NOT COMPLETED|Overall Study||45
7817160|NCT01123850|19243269|P1|COMPLETED|Overall Study||0
7817161|NCT01123850|19243269|P1|STARTED|Overall Study||45
7817162|NCT01123655|19243276|P3|NOT COMPLETED|Overall Study||1
7817163|NCT01123655|19243277|P2|NOT COMPLETED|Overall Study||1
7817164|NCT01123655|19243278|P1|NOT COMPLETED|Overall Study||1
7817165|NCT01123655|19243276|P3|COMPLETED|Overall Study||7
7817166|NCT01123655|19243277|P2|COMPLETED|Overall Study||3
7817167|NCT01123655|19243278|P1|COMPLETED|Overall Study||9
7817168|NCT01123655|19243276|P3|STARTED|Overall Study||8
7817169|NCT01123655|19243277|P2|STARTED|Overall Study||4
7817170|NCT01123655|19243278|P1|STARTED|Overall Study||10
7817171|NCT01123642|19243350|P1|NOT COMPLETED|Overall Study||68
7817172|NCT01123642|19243350|P1|COMPLETED|Overall Study||277
7817173|NCT01123642|19243350|P1|STARTED|Overall Study||345
7817174|NCT01123512|19243359|P2|NOT COMPLETED|Overall Study||21
7817175|NCT01123512|19243360|P1|NOT COMPLETED|Overall Study||26
7817176|NCT01123512|19243359|P2|COMPLETED|Overall Study||126
7817177|NCT01123512|19243360|P1|COMPLETED|Overall Study||127
7817178|NCT01123512|19243359|P2|STARTED|Overall Study||147
7817179|NCT01123512|19243360|P1|STARTED|Overall Study||153
7817180|NCT01123395|19243366|P2|NOT COMPLETED|Period 2||0
7817181|NCT01123395|19243367|P1|NOT COMPLETED|Period 2||0
7817182|NCT01123395|19243366|P2|COMPLETED|Period 2||7
7817183|NCT01123395|19243367|P1|COMPLETED|Period 2||8
7817184|NCT01123395|19243366|P2|STARTED|Period 2||7
7817185|NCT01123395|19243367|P1|STARTED|Period 2||8
7817186|NCT01123395|19243366|P2|NOT COMPLETED|Washout Period of 14 Days||1
7817187|NCT01123395|19243367|P1|NOT COMPLETED|Washout Period of 14 Days||0
7817188|NCT01123395|19243366|P2|COMPLETED|Washout Period of 14 Days||7
7817189|NCT01123395|19243367|P1|COMPLETED|Washout Period of 14 Days||8
7817190|NCT01123395|19243366|P2|STARTED|Washout Period of 14 Days||8
7817191|NCT01123395|19243367|P1|STARTED|Washout Period of 14 Days||8
7817192|NCT01123395|19243366|P2|NOT COMPLETED|Period 1||0
7817193|NCT01123395|19243367|P1|NOT COMPLETED|Period 1||0
7817194|NCT01123395|19243366|P2|COMPLETED|Period 1||8
7817195|NCT01123395|19243367|P1|COMPLETED|Period 1||8
7817196|NCT01123395|19243366|P2|STARTED|Period 1||8
7817197|NCT01123395|19243367|P1|STARTED|Period 1||8
7817198|NCT01123382|19243379|P2|NOT COMPLETED|Overall Study||6
7817199|NCT01123382|19243380|P1|NOT COMPLETED|Overall Study||2
7817200|NCT01123382|19243379|P2|COMPLETED|Overall Study||6
7817201|NCT01123382|19243380|P1|COMPLETED|Overall Study||11
7817202|NCT01123382|19243379|P2|Received Intervention|Overall Study||10
7817203|NCT01123382|19243380|P1|Received Intervention|Overall Study||12
7817204|NCT01123382|19243379|P2|STARTED|Overall Study||12
7817205|NCT01123382|19243380|P1|STARTED|Overall Study||13
7817206|NCT01123356|19243402|P1|NOT COMPLETED|Overall Study||7
7817207|NCT01123356|19243402|P1|COMPLETED|Overall Study||14
7817208|NCT01123356|19243402|P1|STARTED|Overall Study||21
7817209|NCT01123200|19243410|P1|NOT COMPLETED|Overall Study||1
7817210|NCT01123200|19243410|P1|COMPLETED|Overall Study||0
7817211|NCT01123200|19243410|P1|STARTED|Overall Study||1
7817212|NCT01123161|19243417|P2|NOT COMPLETED|Overall Study||0
7817213|NCT01123161|19243418|P1|NOT COMPLETED|Overall Study||2
7817214|NCT01123161|19243417|P2|COMPLETED|Overall Study||63
7817215|NCT01123161|19243418|P1|COMPLETED|Overall Study||55
7817216|NCT01123161|19243417|P2|STARTED|Overall Study||63
7817217|NCT01123161|19243418|P1|STARTED|Overall Study||57
7817218|NCT01123148|19243436|P1|NOT COMPLETED|Overall Study||2
7817219|NCT01123148|19243436|P1|COMPLETED|Overall Study||12
7817220|NCT01123148|19243436|P1|BCI Calibration >50% Accuracy|Overall Study||13
7817221|NCT01123148|19243436|P1|STARTED|Overall Study||14
7817222|NCT01123083|19243442|P2|NOT COMPLETED|Overall Study||15
7817223|NCT01123083|19243443|P1|NOT COMPLETED|Overall Study||11
7817224|NCT01123083|19243442|P2|COMPLETED|Overall Study||103
7817225|NCT01123083|19243443|P1|COMPLETED|Overall Study||50
7817226|NCT01123083|19243442|P2|STARTED|Overall Study||118
7817227|NCT01123083|19243443|P1|STARTED|Overall Study||61
7817228|NCT01122927|19243467|P2|NOT COMPLETED|Period 2- Open-label Treatment Phase||312
7817229|NCT01122927|19243468|P1|NOT COMPLETED|Period 2- Open-label Treatment Phase||0
7817230|NCT01122927|19243467|P2|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198
7817231|NCT01122927|19243468|P1|COMPLETED|Period 2- Open-label Treatment Phase||0
7817232|NCT01122927|19243467|P2|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510
7817233|NCT01122927|19243468|P1|STARTED|Period 2- Open-label Treatment Phase||0
7817234|NCT01122927|19243467|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
7817235|NCT01122927|19243468|P1|NOT COMPLETED|Period 1 - Conversion Phase||14
7817236|NCT01122927|19243467|P2|COMPLETED|Period 1 - Conversion Phase||0
7817237|NCT01122927|19243468|P1|COMPLETED|Period 1 - Conversion Phase||283
7817238|NCT01122927|19243467|P2|STARTED|Period 1 - Conversion Phase||0
7817239|NCT01122927|19243468|P1|STARTED|Period 1 - Conversion Phase||297
7817240|NCT01122901|19243501|P2|NOT COMPLETED|Overall Study||0
7817241|NCT01122901|19243502|P1|NOT COMPLETED|Overall Study||0
7817242|NCT01122901|19243501|P2|COMPLETED|Overall Study||7
7817243|NCT01122901|19243502|P1|COMPLETED|Overall Study||40
7817244|NCT01122901|19243501|P2|STARTED|Overall Study||7
7817245|NCT01122901|19243502|P1|STARTED|Overall Study||40
7817246|NCT01122862|19243520|P3|NOT COMPLETED|Period 3||0
7817247|NCT01122862|19243521|P2|NOT COMPLETED|Period 3||0
7817248|NCT01122862|19243522|P1|NOT COMPLETED|Period 3||0
7817249|NCT01122862|19243520|P3|COMPLETED|Period 3||8
7817250|NCT01122862|19243521|P2|COMPLETED|Period 3||7
7817251|NCT01122862|19243522|P1|COMPLETED|Period 3||6
7817252|NCT01122862|19243520|P3|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8
7817253|NCT01122862|19243521|P2|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7
7817254|NCT01122862|19243522|P1|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6
7817255|NCT01122862|19243520|P3|NOT COMPLETED|Period 2||1
7817256|NCT01122862|19243521|P2|NOT COMPLETED|Period 2||0
7817257|NCT01122862|19243522|P1|NOT COMPLETED|Period 2||0
7817258|NCT01122862|19243520|P3|COMPLETED|Period 2||6
7817259|NCT01122862|19243521|P2|COMPLETED|Period 2||7
7817260|NCT01122862|19243522|P1|COMPLETED|Period 2||8
7817261|NCT01122862|19243520|P3|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
7817262|NCT01122862|19243521|P2|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
7817263|NCT01122862|19243522|P1|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8
7817264|NCT01122862|19243520|P3|NOT COMPLETED|Period 1||0
7817265|NCT01122862|19243521|P2|NOT COMPLETED|Period 1||1
7817266|NCT01122862|19243522|P1|NOT COMPLETED|Period 1||0
7817267|NCT01122862|19243520|P3|COMPLETED|Period 1||7
7817268|NCT01122862|19243521|P2|COMPLETED|Period 1||7
7817269|NCT01122862|19243522|P1|COMPLETED|Period 1||8
7817270|NCT01122862|19243520|P3|STARTED|Period 1||7
7817271|NCT01122862|19243521|P2|STARTED|Period 1||8
7817272|NCT01122862|19243522|P1|STARTED|Period 1||8
7817273|NCT01122849|19243543|P3|NOT COMPLETED|Overall Study||0
7817274|NCT01122849|19243544|P2|NOT COMPLETED|Overall Study||0
7817275|NCT01122849|19243545|P1|NOT COMPLETED|Overall Study||0
7817276|NCT01122849|19243543|P3|COMPLETED|Overall Study||20
7817277|NCT01122849|19243544|P2|COMPLETED|Overall Study||21
7817278|NCT01122849|19243545|P1|COMPLETED|Overall Study||20
7817279|NCT01122849|19243543|P3|STARTED|Overall Study||20
7817280|NCT01122849|19243544|P2|STARTED|Overall Study||21
7817281|NCT01122849|19243545|P1|STARTED|Overall Study||20
7817282|NCT01122680|19243628|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
7817283|NCT01122680|19243629|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
7817284|NCT01122680|19243630|P2|NOT COMPLETED|Period 3 (4 Weeks)||1
7817285|NCT01122680|19243631|P1|NOT COMPLETED|Period 3 (4 Weeks)||1
7817286|NCT01122680|19243628|P4|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23
7817287|NCT01122680|19243629|P3|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26
7817288|NCT01122680|19243630|P2|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
7817289|NCT01122680|19243631|P1|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
7817290|NCT01122680|19243628|P4|STARTED|Period 3 (4 Weeks)|Entered this study period.|23
7817291|NCT01122680|19243629|P3|STARTED|Period 3 (4 Weeks)|Entered this study period.|26
7817376|NCT01122238|19243989|P15|NOT COMPLETED|Overall Study||0
7817292|NCT01122680|19243630|P2|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
7817293|NCT01122680|19243631|P1|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
7817294|NCT01122680|19243628|P4|NOT COMPLETED|Period 2 (4 Weeks)||1
7817295|NCT01122680|19243629|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
7817296|NCT01122680|19243630|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
7817297|NCT01122680|19243631|P1|NOT COMPLETED|Period 2 (4 Weeks)||1
7817298|NCT01122680|19243628|P4|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23
7817299|NCT01122680|19243629|P3|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26
7817300|NCT01122680|19243630|P2|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
7817301|NCT01122680|19243631|P1|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
7817302|NCT01122680|19243628|P4|STARTED|Period 2 (4 Weeks)|Entered this study period.|24
7817303|NCT01122680|19243629|P3|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
7817304|NCT01122680|19243630|P2|STARTED|Period 2 (4 Weeks)|Entered this study period.|25
7817305|NCT01122680|19243631|P1|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
7817306|NCT01122680|19243628|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
7817307|NCT01122680|19243629|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
7817308|NCT01122680|19243630|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
7817309|NCT01122680|19243631|P1|NOT COMPLETED|Period 1 (4 Weeks)||3
7817310|NCT01122680|19243628|P4|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24
7817311|NCT01122680|19243629|P3|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
7817312|NCT01122680|19243630|P2|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25
7817313|NCT01122680|19243631|P1|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
7817314|NCT01122680|19243628|P4|STARTED|Period 1 (4 Weeks)|Entered this study period.|24
7817315|NCT01122680|19243629|P3|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
7817316|NCT01122680|19243630|P2|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
7817317|NCT01122680|19243631|P1|STARTED|Period 1 (4 Weeks)|Entered this study period.|29
7817318|NCT01122576|19243696|P3|NOT COMPLETED|Post-Cataract Surgery||2
7817319|NCT01122576|19243697|P2|NOT COMPLETED|Post-Cataract Surgery||0
7817320|NCT01122576|19243698|P1|NOT COMPLETED|Post-Cataract Surgery||0
7817321|NCT01122576|19243696|P3|COMPLETED|Post-Cataract Surgery||22
7817322|NCT01122576|19243697|P2|COMPLETED|Post-Cataract Surgery||25
7817323|NCT01122576|19243698|P1|COMPLETED|Post-Cataract Surgery||26
7817324|NCT01122576|19243696|P3|STARTED|Post-Cataract Surgery||24
7817325|NCT01122576|19243697|P2|STARTED|Post-Cataract Surgery||25
7817326|NCT01122576|19243698|P1|STARTED|Post-Cataract Surgery||26
7817327|NCT01122576|19243696|P3|NOT COMPLETED|Pre-Cataract Surgery||2
7817328|NCT01122576|19243697|P2|NOT COMPLETED|Pre-Cataract Surgery||1
7817329|NCT01122576|19243698|P1|NOT COMPLETED|Pre-Cataract Surgery||0
7817330|NCT01122576|19243696|P3|COMPLETED|Pre-Cataract Surgery||24
7817331|NCT01122576|19243697|P2|COMPLETED|Pre-Cataract Surgery||25
7817332|NCT01122576|19243698|P1|COMPLETED|Pre-Cataract Surgery||26
7817333|NCT01122576|19243696|P3|STARTED|Pre-Cataract Surgery||26
7817334|NCT01122576|19243697|P2|STARTED|Pre-Cataract Surgery||26
7817335|NCT01122576|19243698|P1|STARTED|Pre-Cataract Surgery||26
7817336|NCT01122511|19243837|P2|NOT COMPLETED|Overall Study||2
7817337|NCT01122511|19243838|P1|NOT COMPLETED|Overall Study||2
7817338|NCT01122511|19243837|P2|COMPLETED|Overall Study||0
7817339|NCT01122511|19243838|P1|COMPLETED|Overall Study||0
7817340|NCT01122511|19243837|P2|STARTED|Overall Study||2
7817341|NCT01122511|19243838|P1|STARTED|Overall Study||2
7817342|NCT01122446|19243852|P2|NOT COMPLETED|Overall Study||0
7817343|NCT01122446|19243853|P1|NOT COMPLETED|Overall Study||0
7817344|NCT01122446|19243852|P2|COMPLETED|Overall Study||25
7817345|NCT01122446|19243853|P1|COMPLETED|Overall Study||25
7817346|NCT01122446|19243852|P2|STARTED|Overall Study||25
7817347|NCT01122446|19243853|P1|STARTED|Overall Study||25
7817348|NCT01122394|19243879|P2|NOT COMPLETED|Overall Study||4
7817349|NCT01122394|19243880|P1|NOT COMPLETED|Overall Study||3
7817350|NCT01122394|19243879|P2|COMPLETED|Overall Study||70
7817351|NCT01122394|19243880|P1|COMPLETED|Overall Study||63
7817352|NCT01122394|19243879|P2|STARTED|Overall Study||74
7817353|NCT01122394|19243880|P1|STARTED|Overall Study||66
7817354|NCT01122381|19243896|P2|NOT COMPLETED|Overall Study||1
7817355|NCT01122381|19243897|P1|NOT COMPLETED|Overall Study||0
7817356|NCT01122381|19243896|P2|COMPLETED|Overall Study||0
7817357|NCT01122381|19243897|P1|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1
7817358|NCT01122381|19243896|P2|STARTED|Overall Study||1
7817359|NCT01122381|19243897|P1|STARTED|Overall Study||1
7817360|NCT01122316|19243903|P1|NOT COMPLETED|Overall Study||2
7817361|NCT01122316|19243903|P1|COMPLETED|Overall Study||8
7817362|NCT01122316|19243903|P1|STARTED|Overall Study||10
7817363|NCT01122264|19243913|P3|NOT COMPLETED|Overall Study||47
7817364|NCT01122264|19243914|P2|NOT COMPLETED|Overall Study||29
7817365|NCT01122264|19243915|P1|NOT COMPLETED|Overall Study||32
7817366|NCT01122264|19243913|P3|COMPLETED|Overall Study||214
7817367|NCT01122264|19243914|P2|COMPLETED|Overall Study||228
7817368|NCT01122264|19243915|P1|COMPLETED|Overall Study||220
7817369|NCT01122264|19243913|P3|Received at Least 1 Dose of Study Drug|Overall Study||260
7817370|NCT01122264|19243914|P2|Received at Least 1 Dose of Study Drug|Overall Study||257
7817371|NCT01122264|19243915|P1|Received at Least 1 Dose of Study Drug|Overall Study||250
7817372|NCT01122264|19243913|P3|STARTED|Overall Study||261
7817373|NCT01122264|19243914|P2|STARTED|Overall Study||257
7817374|NCT01122264|19243915|P1|STARTED|Overall Study||252
7817375|NCT01122238|19243988|P16|NOT COMPLETED|Overall Study||0
7817377|NCT01122238|19243990|P14|NOT COMPLETED|Overall Study||1
7817378|NCT01122238|19243991|P13|NOT COMPLETED|Overall Study||2
7817379|NCT01122238|19243992|P12|NOT COMPLETED|Overall Study||2
7817380|NCT01122238|19243993|P11|NOT COMPLETED|Overall Study||0
7817381|NCT01122238|19243994|P10|NOT COMPLETED|Overall Study||1
7817382|NCT01122238|19243995|P9|NOT COMPLETED|Overall Study||1
7817383|NCT01122238|19243996|P8|NOT COMPLETED|Overall Study||0
7817384|NCT01122238|19243997|P7|NOT COMPLETED|Overall Study||1
7817385|NCT01122238|19243998|P6|NOT COMPLETED|Overall Study||1
7817386|NCT01122238|19243999|P5|NOT COMPLETED|Overall Study||0
7817387|NCT01122238|19244000|P4|NOT COMPLETED|Overall Study||0
7817388|NCT01122238|19244001|P3|NOT COMPLETED|Overall Study||5
7817389|NCT01122238|19244002|P2|NOT COMPLETED|Overall Study||1
7817390|NCT01122238|19244003|P1|NOT COMPLETED|Overall Study||2
7817391|NCT01122238|19243988|P16|COMPLETED|Overall Study||31
7817392|NCT01122238|19243989|P15|COMPLETED|Overall Study||28
7817393|NCT01122238|19243990|P14|COMPLETED|Overall Study||31
7817394|NCT01122238|19243991|P13|COMPLETED|Overall Study||28
7817395|NCT01122238|19243992|P12|COMPLETED|Overall Study||31
7817396|NCT01122238|19243993|P11|COMPLETED|Overall Study||32
7817397|NCT01122238|19243994|P10|COMPLETED|Overall Study||33
7817398|NCT01122238|19243995|P9|COMPLETED|Overall Study||31
7817399|NCT01122238|19243996|P8|COMPLETED|Overall Study||32
7817400|NCT01122238|19243997|P7|COMPLETED|Overall Study||34
7817401|NCT01122238|19243998|P6|COMPLETED|Overall Study||31
7817402|NCT01122238|19243999|P5|COMPLETED|Overall Study||33
7817403|NCT01122238|19244000|P4|COMPLETED|Overall Study||33
7817404|NCT01122238|19244001|P3|COMPLETED|Overall Study||28
7817405|NCT01122238|19244002|P2|COMPLETED|Overall Study||36
7817406|NCT01122238|19244003|P1|COMPLETED|Overall Study||28
7817407|NCT01122238|19243988|P16|STARTED|Overall Study||31
7817408|NCT01122238|19243989|P15|STARTED|Overall Study||28
7817409|NCT01122238|19243990|P14|STARTED|Overall Study||32
7817410|NCT01122238|19243991|P13|STARTED|Overall Study||30
7817411|NCT01122238|19243992|P12|STARTED|Overall Study||33
7817412|NCT01122238|19243993|P11|STARTED|Overall Study||32
7817413|NCT01122238|19243994|P10|STARTED|Overall Study||34
7817414|NCT01122238|19243995|P9|STARTED|Overall Study||32
7817415|NCT01122238|19243996|P8|STARTED|Overall Study||32
7817416|NCT01122238|19243997|P7|STARTED|Overall Study||35
7817417|NCT01122238|19243998|P6|STARTED|Overall Study||32
7817418|NCT01122238|19243999|P5|STARTED|Overall Study||33
7817419|NCT01122238|19244000|P4|STARTED|Overall Study||33
7817420|NCT01122238|19244001|P3|STARTED|Overall Study||33
7817421|NCT01122238|19244002|P2|STARTED|Overall Study||37
7817422|NCT01122238|19244003|P1|STARTED|Overall Study||30
7817423|NCT01122173|19244025|P1|NOT COMPLETED|Overall Study||9
7817424|NCT01122173|19244025|P1|COMPLETED|Overall Study||141
7817425|NCT01122173|19244025|P1|STARTED|Overall Study||150
7817426|NCT01122160|19244032|P2|NOT COMPLETED|Second Intervention (7 Days)||0
7817427|NCT01122160|19244033|P1|NOT COMPLETED|Second Intervention (7 Days)||0
7817428|NCT01122160|19244032|P2|COMPLETED|Second Intervention (7 Days)||5
7817429|NCT01122160|19244033|P1|COMPLETED|Second Intervention (7 Days)||6
7817430|NCT01122160|19244032|P2|STARTED|Second Intervention (7 Days)||5
7817431|NCT01122160|19244033|P1|STARTED|Second Intervention (7 Days)||6
7817432|NCT01122160|19244032|P2|NOT COMPLETED|Washout (7-14 Days)||0
7817433|NCT01122160|19244033|P1|NOT COMPLETED|Washout (7-14 Days)||0
7817434|NCT01122160|19244032|P2|COMPLETED|Washout (7-14 Days)||5
7817435|NCT01122160|19244033|P1|COMPLETED|Washout (7-14 Days)||6
7817436|NCT01122160|19244032|P2|STARTED|Washout (7-14 Days)||5
7817437|NCT01122160|19244033|P1|STARTED|Washout (7-14 Days)||6
7817438|NCT01122160|19244032|P2|NOT COMPLETED|First Intervention (7 Days)||0
7817439|NCT01122160|19244033|P1|NOT COMPLETED|First Intervention (7 Days)||0
7817440|NCT01122160|19244032|P2|COMPLETED|First Intervention (7 Days)||5
7817441|NCT01122160|19244033|P1|COMPLETED|First Intervention (7 Days)||6
7817442|NCT01122160|19244032|P2|STARTED|First Intervention (7 Days)||5
7817443|NCT01122160|19244033|P1|STARTED|First Intervention (7 Days)||6
7817444|NCT01122108|19244039|P2|NOT COMPLETED|Overall Study||0
7817445|NCT01122108|19244040|P1|NOT COMPLETED|Overall Study||0
7817446|NCT01122108|19244039|P2|COMPLETED|Overall Study||21
7817447|NCT01122108|19244040|P1|COMPLETED|Overall Study||21
7817448|NCT01122108|19244039|P2|STARTED|Overall Study||21
7817449|NCT01122108|19244040|P1|STARTED|Overall Study||21
7817450|NCT01122030|19244056|P7|NOT COMPLETED|Overall Study||0
7817451|NCT01122030|19244057|P6|NOT COMPLETED|Overall Study||0
7817452|NCT01122030|19244058|P5|NOT COMPLETED|Overall Study||0
7817453|NCT01122030|19244059|P4|NOT COMPLETED|Overall Study||0
7817454|NCT01122030|19244060|P3|NOT COMPLETED|Overall Study||0
7817455|NCT01122030|19244061|P2|NOT COMPLETED|Overall Study||0
7817456|NCT01122030|19244062|P1|NOT COMPLETED|Overall Study||0
7817457|NCT01122030|19244056|P7|COMPLETED|Overall Study||9
7817458|NCT01122030|19244057|P6|COMPLETED|Overall Study||9
7817459|NCT01122030|19244058|P5|COMPLETED|Overall Study||9
7817460|NCT01122030|19244059|P4|COMPLETED|Overall Study||9
7817461|NCT01122030|19244060|P3|COMPLETED|Overall Study||9
7817462|NCT01122030|19244061|P2|COMPLETED|Overall Study||9
7817463|NCT01122030|19244062|P1|COMPLETED|Overall Study||18
7817464|NCT01122030|19244056|P7|Received Treatment|Overall Study||9
7817465|NCT01122030|19244057|P6|Received Treatment|Overall Study||9
7817466|NCT01122030|19244058|P5|Received Treatment|Overall Study||9
7817467|NCT01122030|19244059|P4|Received Treatment|Overall Study||9
7817468|NCT01122030|19244060|P3|Received Treatment|Overall Study||9
7817469|NCT01122030|19244061|P2|Received Treatment|Overall Study||9
7817470|NCT01122030|19244062|P1|Received Treatment|Overall Study||18
7817471|NCT01122030|19244056|P7|STARTED|Overall Study||9
7817472|NCT01122030|19244057|P6|STARTED|Overall Study||9
7817473|NCT01122030|19244058|P5|STARTED|Overall Study||9
7817474|NCT01122030|19244059|P4|STARTED|Overall Study||9
7817475|NCT01122030|19244060|P3|STARTED|Overall Study||9
7817476|NCT01122030|19244061|P2|STARTED|Overall Study||9
7817477|NCT01122030|19244062|P1|STARTED|Overall Study||18
7817478|NCT01121991|19244248|P1|NOT COMPLETED|Overall Study||6
7817479|NCT01121991|19244248|P1|COMPLETED|Overall Study||46
7817480|NCT01121991|19244248|P1|STARTED|Overall Study|Number of participants treated|52
7817481|NCT01121939|19244259|P1|NOT COMPLETED|Overall Study||43
7817482|NCT01121939|19244259|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0
7817483|NCT01121939|19244259|P1|STARTED|Overall Study||43
7817484|NCT01121926|19244273|P2|NOT COMPLETED|Second Intervention Period||0
7817485|NCT01121926|19244274|P1|NOT COMPLETED|Second Intervention Period||0
7817486|NCT01121926|19244273|P2|COMPLETED|Second Intervention Period||13
7817487|NCT01121926|19244274|P1|COMPLETED|Second Intervention Period||14
7817488|NCT01121926|19244273|P2|STARTED|Second Intervention Period||13
7817489|NCT01121926|19244274|P1|STARTED|Second Intervention Period||14
7817490|NCT01121926|19244273|P2|NOT COMPLETED|Washout Period||2
7817491|NCT01121926|19244274|P1|NOT COMPLETED|Washout Period||0
7817492|NCT01121926|19244273|P2|COMPLETED|Washout Period||13
7817493|NCT01121926|19244274|P1|COMPLETED|Washout Period||14
7817494|NCT01121926|19244273|P2|STARTED|Washout Period||15
7817495|NCT01121926|19244274|P1|STARTED|Washout Period||14
7817496|NCT01121926|19244273|P2|NOT COMPLETED|First Intervention Period||0
7817497|NCT01121926|19244274|P1|NOT COMPLETED|First Intervention Period||1
7817498|NCT01121926|19244273|P2|COMPLETED|First Intervention Period||15
7817499|NCT01121926|19244274|P1|COMPLETED|First Intervention Period||14
7817500|NCT01121926|19244273|P2|STARTED|First Intervention Period||15
7817501|NCT01121926|19244274|P1|STARTED|First Intervention Period||15
7817502|NCT01121913|19244292|P4|NOT COMPLETED|Fourth Intervention Period||0
7817503|NCT01121913|19244293|P3|NOT COMPLETED|Fourth Intervention Period||0
7817504|NCT01121913|19244294|P2|NOT COMPLETED|Fourth Intervention Period||0
7817505|NCT01121913|19244295|P1|NOT COMPLETED|Fourth Intervention Period||0
7817506|NCT01121913|19244292|P4|COMPLETED|Fourth Intervention Period||6
7817507|NCT01121913|19244293|P3|COMPLETED|Fourth Intervention Period||3
7817508|NCT01121913|19244294|P2|COMPLETED|Fourth Intervention Period||6
7817509|NCT01121913|19244295|P1|COMPLETED|Fourth Intervention Period||4
7817510|NCT01121913|19244292|P4|STARTED|Fourth Intervention Period||6
7817511|NCT01121913|19244293|P3|STARTED|Fourth Intervention Period||3
7817512|NCT01121913|19244294|P2|STARTED|Fourth Intervention Period||6
7817513|NCT01121913|19244295|P1|STARTED|Fourth Intervention Period||4
7817514|NCT01121913|19244292|P4|NOT COMPLETED|Third Washout Period||0
7817515|NCT01121913|19244293|P3|NOT COMPLETED|Third Washout Period||0
7817516|NCT01121913|19244294|P2|NOT COMPLETED|Third Washout Period||0
7817517|NCT01121913|19244295|P1|NOT COMPLETED|Third Washout Period||1
7817518|NCT01121913|19244292|P4|COMPLETED|Third Washout Period||6
7817519|NCT01121913|19244293|P3|COMPLETED|Third Washout Period||3
7817520|NCT01121913|19244294|P2|COMPLETED|Third Washout Period||6
7817521|NCT01121913|19244295|P1|COMPLETED|Third Washout Period||4
7817522|NCT01121913|19244292|P4|STARTED|Third Washout Period||6
7817523|NCT01121913|19244293|P3|STARTED|Third Washout Period||3
7817524|NCT01121913|19244294|P2|STARTED|Third Washout Period||6
7817525|NCT01121913|19244295|P1|STARTED|Third Washout Period||5
7817526|NCT01121913|19244292|P4|NOT COMPLETED|Third Intervention Period||0
7817527|NCT01121913|19244293|P3|NOT COMPLETED|Third Intervention Period||0
7817528|NCT01121913|19244294|P2|NOT COMPLETED|Third Intervention Period||0
7817529|NCT01121913|19244295|P1|NOT COMPLETED|Third Intervention Period||0
7817530|NCT01121913|19244292|P4|COMPLETED|Third Intervention Period||6
7817531|NCT01121913|19244293|P3|COMPLETED|Third Intervention Period||3
7817532|NCT01121913|19244294|P2|COMPLETED|Third Intervention Period||6
7817533|NCT01121913|19244295|P1|COMPLETED|Third Intervention Period||5
7817534|NCT01121913|19244292|P4|STARTED|Third Intervention Period||6
7817535|NCT01121913|19244293|P3|STARTED|Third Intervention Period||3
7817536|NCT01121913|19244294|P2|STARTED|Third Intervention Period||6
7817537|NCT01121913|19244295|P1|STARTED|Third Intervention Period||5
7817538|NCT01121913|19244292|P4|NOT COMPLETED|Second Washout Period||0
7817539|NCT01121913|19244293|P3|NOT COMPLETED|Second Washout Period||1
7817540|NCT01121913|19244294|P2|NOT COMPLETED|Second Washout Period||0
7817541|NCT01121913|19244295|P1|NOT COMPLETED|Second Washout Period||0
7817542|NCT01121913|19244292|P4|COMPLETED|Second Washout Period||6
7817543|NCT01121913|19244293|P3|COMPLETED|Second Washout Period||3
7817544|NCT01121913|19244294|P2|COMPLETED|Second Washout Period||6
7817545|NCT01121913|19244295|P1|COMPLETED|Second Washout Period||5
7817546|NCT01121913|19244292|P4|STARTED|Second Washout Period||6
7817547|NCT01121913|19244293|P3|STARTED|Second Washout Period||4
7817548|NCT01121913|19244294|P2|STARTED|Second Washout Period||6
7817549|NCT01121913|19244295|P1|STARTED|Second Washout Period||5
7817550|NCT01121913|19244292|P4|NOT COMPLETED|Second Intervention Period||0
7817551|NCT01121913|19244293|P3|NOT COMPLETED|Second Intervention Period||1
7817552|NCT01121913|19244294|P2|NOT COMPLETED|Second Intervention Period||0
7817553|NCT01121913|19244295|P1|NOT COMPLETED|Second Intervention Period||0
7817554|NCT01121913|19244292|P4|COMPLETED|Second Intervention Period||6
7817555|NCT01121913|19244293|P3|COMPLETED|Second Intervention Period||4
7817556|NCT01121913|19244294|P2|COMPLETED|Second Intervention Period||6
7817557|NCT01121913|19244295|P1|COMPLETED|Second Intervention Period||5
7817558|NCT01121913|19244292|P4|STARTED|Second Intervention Period||6
7817559|NCT01121913|19244293|P3|STARTED|Second Intervention Period||5
7817560|NCT01121913|19244294|P2|STARTED|Second Intervention Period||6
7817561|NCT01121913|19244295|P1|STARTED|Second Intervention Period||5
7817562|NCT01121913|19244292|P4|NOT COMPLETED|First Washout Period||0
7817563|NCT01121913|19244293|P3|NOT COMPLETED|First Washout Period||0
7817564|NCT01121913|19244294|P2|NOT COMPLETED|First Washout Period||0
7817565|NCT01121913|19244295|P1|NOT COMPLETED|First Washout Period||1
7817566|NCT01121913|19244292|P4|COMPLETED|First Washout Period||6
7817567|NCT01121913|19244293|P3|COMPLETED|First Washout Period||5
7817568|NCT01121913|19244294|P2|COMPLETED|First Washout Period||6
7817569|NCT01121913|19244295|P1|COMPLETED|First Washout Period||5
7817570|NCT01121913|19244292|P4|STARTED|First Washout Period||6
7817571|NCT01121913|19244293|P3|STARTED|First Washout Period||5
7817572|NCT01121913|19244294|P2|STARTED|First Washout Period||6
7817573|NCT01121913|19244295|P1|STARTED|First Washout Period||6
7817574|NCT01121913|19244292|P4|NOT COMPLETED|First Intervention Period||0
7817575|NCT01121913|19244293|P3|NOT COMPLETED|First Intervention Period||1
7817576|NCT01121913|19244294|P2|NOT COMPLETED|First Intervention Period||0
7817577|NCT01121913|19244295|P1|NOT COMPLETED|First Intervention Period||0
7817578|NCT01121913|19244292|P4|COMPLETED|First Intervention Period||6
7817579|NCT01121913|19244293|P3|COMPLETED|First Intervention Period||5
7817580|NCT01121913|19244294|P2|COMPLETED|First Intervention Period||6
7817581|NCT01121913|19244295|P1|COMPLETED|First Intervention Period||6
7817582|NCT01121913|19244292|P4|STARTED|First Intervention Period||6
7817583|NCT01121913|19244293|P3|STARTED|First Intervention Period||6
7817584|NCT01121913|19244294|P2|STARTED|First Intervention Period||6
7817585|NCT01121913|19244295|P1|STARTED|First Intervention Period||6
7817586|NCT01121900|19244325|P2|NOT COMPLETED|Second Intervention Period||0
7817587|NCT01121900|19244326|P1|NOT COMPLETED|Second Intervention Period||0
7817588|NCT01121900|19244325|P2|COMPLETED|Second Intervention Period||11
7817589|NCT01121900|19244326|P1|COMPLETED|Second Intervention Period||12
7817590|NCT01121900|19244325|P2|STARTED|Second Intervention Period||11
7817591|NCT01121900|19244326|P1|STARTED|Second Intervention Period||12
7817592|NCT01121900|19244325|P2|NOT COMPLETED|Washout Period of 7 Days||1
7817593|NCT01121900|19244326|P1|NOT COMPLETED|Washout Period of 7 Days||0
7817594|NCT01121900|19244325|P2|COMPLETED|Washout Period of 7 Days||11
7817595|NCT01121900|19244326|P1|COMPLETED|Washout Period of 7 Days||12
7817596|NCT01121900|19244325|P2|STARTED|Washout Period of 7 Days||12
7817597|NCT01121900|19244326|P1|STARTED|Washout Period of 7 Days||12
7817598|NCT01121900|19244325|P2|NOT COMPLETED|First Intervention Period||1
7817599|NCT01121900|19244326|P1|NOT COMPLETED|First Intervention Period||1
7817600|NCT01121900|19244325|P2|COMPLETED|First Intervention Period||12
7817601|NCT01121900|19244326|P1|COMPLETED|First Intervention Period||12
7817602|NCT01121900|19244325|P2|STARTED|First Intervention Period||13
7817603|NCT01121900|19244326|P1|STARTED|First Intervention Period||13
7817604|NCT01121757|19244346|P2|NOT COMPLETED|Combination||1
7817605|NCT01121757|19244347|P1|NOT COMPLETED|Combination||2
7817606|NCT01121757|19244346|P2|COMPLETED|Combination||0
7817607|NCT01121757|19244347|P1|COMPLETED|Combination||0
7817608|NCT01121757|19244346|P2|STARTED|Combination||1
7817609|NCT01121757|19244347|P1|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2
7817610|NCT01121757|19244346|P2|NOT COMPLETED|Second Drug||0
7817611|NCT01121757|19244347|P1|NOT COMPLETED|Second Drug||0
7817612|NCT01121757|19244346|P2|COMPLETED|Second Drug||1
7817613|NCT01121757|19244347|P1|COMPLETED|Second Drug||4
7817614|NCT01121757|19244346|P2|STARTED|Second Drug||1
7817615|NCT01121757|19244347|P1|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4
7817616|NCT01121757|19244346|P2|NOT COMPLETED|First Drug||2
7817617|NCT01121757|19244347|P1|NOT COMPLETED|First Drug||1
7817618|NCT01121757|19244346|P2|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1
7817619|NCT01121757|19244347|P1|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5
7817620|NCT01121757|19244346|P2|STARTED|First Drug||3
7817621|NCT01121757|19244347|P1|STARTED|First Drug||6
7817622|NCT01121666|19244363|P2|NOT COMPLETED|Overall Study||10
7817623|NCT01121666|19244364|P1|NOT COMPLETED|Overall Study||29
7817624|NCT01121666|19244363|P2|COMPLETED|Overall Study||113
7817625|NCT01121666|19244364|P1|COMPLETED|Overall Study||220
7817626|NCT01121666|19244363|P2|STARTED|Overall Study||123
7817627|NCT01121666|19244364|P1|STARTED|Overall Study||249
7817628|NCT01121575|19244420|P6|NOT COMPLETED|Overall Study||12
7817629|NCT01121575|19244421|P5|NOT COMPLETED|Overall Study||25
7817630|NCT01121575|19244422|P4|NOT COMPLETED|Overall Study||6
7817631|NCT01121575|19244423|P3|NOT COMPLETED|Overall Study||7
7817632|NCT01121575|19244424|P2|NOT COMPLETED|Overall Study||6
7817633|NCT01121575|19244425|P1|NOT COMPLETED|Overall Study||14
7817634|NCT01121575|19244420|P6|COMPLETED|Overall Study||0
7817635|NCT01121575|19244421|P5|COMPLETED|Overall Study||0
7817636|NCT01121575|19244422|P4|COMPLETED|Overall Study||0
7817637|NCT01121575|19244423|P3|COMPLETED|Overall Study||0
7817638|NCT01121575|19244424|P2|COMPLETED|Overall Study||0
7817639|NCT01121575|19244425|P1|COMPLETED|Overall Study||0
7817640|NCT01121575|19244420|P6|Treated|Overall Study||12
7817641|NCT01121575|19244421|P5|Treated|Overall Study||25
7817642|NCT01121575|19244422|P4|Treated|Overall Study||6
7817643|NCT01121575|19244423|P3|Treated|Overall Study||7
7817644|NCT01121575|19244424|P2|Treated|Overall Study||6
7817645|NCT01121575|19244425|P1|Treated|Overall Study||14
7817646|NCT01121575|19244420|P6|STARTED|Overall Study||12
7817647|NCT01121575|19244421|P5|STARTED|Overall Study||25
7817648|NCT01121575|19244422|P4|STARTED|Overall Study||6
7817649|NCT01121575|19244423|P3|STARTED|Overall Study||7
7817650|NCT01121575|19244424|P2|STARTED|Overall Study||6
7817651|NCT01121575|19244425|P1|STARTED|Overall Study||14
7817652|NCT01121562|19244549|P1|NOT COMPLETED|Overall Study||12
7817653|NCT01121562|19244549|P1|COMPLETED|Overall Study||0
7817654|NCT01121562|19244549|P1|STARTED|Overall Study||12
7817655|NCT01121549|19244558|P1|NOT COMPLETED|Overall Study||347
7817656|NCT01121549|19244558|P1|COMPLETED|Overall Study||31
7817657|NCT01121549|19244558|P1|STARTED|Overall Study||378
7817658|NCT01121536|19244569|P1|NOT COMPLETED|Overall Study||361
7817659|NCT01121536|19244569|P1|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506
7817660|NCT01121536|19244569|P1|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859
7817661|NCT01121536|19244569|P1|Safety Population|Overall Study|Participants treated|863
7817662|NCT01121536|19244569|P1|STARTED|Overall Study||867
7817663|NCT01121484|19244590|P2|NOT COMPLETED|Overall Study||43
7817664|NCT01121484|19244591|P1|NOT COMPLETED|Overall Study||33
7817665|NCT01121484|19244590|P2|COMPLETED|Overall Study||178
7817666|NCT01121484|19244591|P1|COMPLETED|Overall Study||185
7817667|NCT01121484|19244590|P2|Treated|Overall Study||217
7817668|NCT01121484|19244591|P1|Treated|Overall Study||217
7817669|NCT01121484|19244590|P2|STARTED|Overall Study||221
7817670|NCT01121484|19244591|P1|STARTED|Overall Study||218
7817671|NCT01121406|19244609|P2|NOT COMPLETED|Overall Study||55
7817672|NCT01121406|19244610|P1|NOT COMPLETED|Overall Study||55
7817673|NCT01121406|19244609|P2|COMPLETED|Overall Study||0
7817674|NCT01121406|19244610|P1|COMPLETED|Overall Study||0
7817675|NCT01121406|19244609|P2|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55
7817676|NCT01121406|19244610|P1|STARTED|Overall Study||55
7817677|NCT01121393|19244660|P2|NOT COMPLETED|Overall Study||84
7817678|NCT01121393|19244661|P1|NOT COMPLETED|Overall Study||242
7817679|NCT01121393|19244660|P2|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38
7817680|NCT01121393|19244661|P1|COMPLETED|Overall Study|At the time of data cut-off for last-patient out (07 December 2017)|0
7817681|NCT01121393|19244660|P2|Treated|Overall Study|Treated|113
7817682|NCT01121393|19244661|P1|Treated|Overall Study|Treated|239
7817683|NCT01121393|19244660|P2|STARTED|Overall Study|Randomised|122
7817684|NCT01121393|19244661|P1|STARTED|Overall Study|Randomised|242
7817685|NCT01121263|19244706|P2|NOT COMPLETED|Overall Study||15
7817686|NCT01121263|19244707|P1|NOT COMPLETED|Overall Study||25
7817687|NCT01121263|19244706|P2|COMPLETED|Overall Study||83
7817688|NCT01121263|19244707|P1|COMPLETED|Overall Study||175
7817689|NCT01121263|19244706|P2|STARTED|Overall Study||98
7817690|NCT01121263|19244707|P1|STARTED|Overall Study||200
7817691|NCT01121250|19244718|P3|NOT COMPLETED|Overall Study||1
7817692|NCT01121250|19244719|P2|NOT COMPLETED|Overall Study||0
7817693|NCT01121250|19244720|P1|NOT COMPLETED|Overall Study||0
7817694|NCT01121250|19244718|P3|COMPLETED|Overall Study||75
7817695|NCT01121250|19244719|P2|COMPLETED|Overall Study||76
7817696|NCT01121250|19244720|P1|COMPLETED|Overall Study||76
7817697|NCT01121250|19244718|P3|STARTED|Overall Study||76
7817698|NCT01121250|19244719|P2|STARTED|Overall Study||76
7817699|NCT01121250|19244720|P1|STARTED|Overall Study||76
7817700|NCT01121224|19244736|P2|NOT COMPLETED|Overall Study||17
7817701|NCT01121224|19244737|P1|NOT COMPLETED|Overall Study||25
7817702|NCT01121224|19244736|P2|COMPLETED|Overall Study||275
7817703|NCT01121224|19244737|P1|COMPLETED|Overall Study||280
7817704|NCT01121224|19244736|P2|STARTED|Overall Study||292
7817705|NCT01121224|19244737|P1|STARTED|Overall Study||305
7817706|NCT01121211|19244787|P2|NOT COMPLETED|Overall Study||12
7817707|NCT01121211|19244788|P1|NOT COMPLETED|Overall Study||11
7817708|NCT01121211|19244787|P2|COMPLETED|Overall Study||35
7817709|NCT01121211|19244788|P1|COMPLETED|Overall Study||32
7817710|NCT01121211|19244787|P2|STARTED|Overall Study||47
7817711|NCT01121211|19244788|P1|STARTED|Overall Study||43
7817712|NCT01121185|19244798|P2|NOT COMPLETED|Overall Study||1
7817713|NCT01121185|19244799|P1|NOT COMPLETED|Overall Study||1
7817714|NCT01121185|19244798|P2|COMPLETED|Overall Study||5
7817715|NCT01121185|19244799|P1|COMPLETED|Overall Study||6
7817716|NCT01121185|19244798|P2|Transplanted|Overall Study||5
7817717|NCT01121185|19244799|P1|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6
7817718|NCT01121185|19244798|P2|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5
7817719|NCT01121185|19244799|P1|Infused|Overall Study||7
7817720|NCT01121185|19244798|P2|STARTED|Overall Study||6
7817721|NCT01121185|19244799|P1|STARTED|Overall Study||7
7817722|NCT01121172|19244823|P2|NOT COMPLETED|Overall Study||0
7817723|NCT01121172|19244824|P1|NOT COMPLETED|Overall Study||0
7817724|NCT01121172|19244823|P2|COMPLETED|Overall Study||90
7817725|NCT01121172|19244824|P1|COMPLETED|Overall Study||90
7817726|NCT01121172|19244823|P2|STARTED|Overall Study||90
7817727|NCT01121172|19244824|P1|STARTED|Overall Study||90
7817728|NCT01121146|19244833|P2|NOT COMPLETED|Overall Study||42
7817729|NCT01121146|19244834|P1|NOT COMPLETED|Overall Study||26
7817730|NCT01121146|19244833|P2|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72
7817824|NCT01120704|19244975|P6|COMPLETED|Overall Study||18
7817825|NCT01120704|19244976|P5|COMPLETED|Overall Study||14
7817731|NCT01121146|19244834|P1|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90
7817732|NCT01121146|19244833|P2|STARTED|Overall Study||114
7817733|NCT01121146|19244834|P1|STARTED|Overall Study||116
7817734|NCT01120990|19244848|P1|NOT COMPLETED|Overall Study||0
7817735|NCT01120990|19244848|P1|COMPLETED|Overall Study||51
7817736|NCT01120990|19244848|P1|STARTED|Overall Study||51
7817737|NCT01120899|19244855|P1|NOT COMPLETED|Overall Study||3
7817738|NCT01120899|19244855|P1|COMPLETED|Overall Study||3
7817739|NCT01120899|19244855|P1|Month 18|Overall Study||3
7817740|NCT01120899|19244855|P1|Month 12|Overall Study||3
7817741|NCT01120899|19244855|P1|Month 6|Overall Study||5
7817742|NCT01120899|19244855|P1|STARTED|Overall Study||6
7817743|NCT01120834|19244875|P1|NOT COMPLETED|Overall Study||0
7817744|NCT01120834|19244875|P1|COMPLETED|Overall Study||18
7817745|NCT01120834|19244875|P1|STARTED|Overall Study||18
7817746|NCT01120808|19244879|P1|NOT COMPLETED|Overall Study||46
7817747|NCT01120808|19244879|P1|COMPLETED|Overall Study||90
7817748|NCT01120808|19244879|P1|STARTED|Overall Study||136
7817749|NCT01120782|19244883|P1|NOT COMPLETED|Overall Study||11
7817750|NCT01120782|19244883|P1|COMPLETED|Overall Study||34
7817751|NCT01120782|19244883|P1|STARTED|Overall Study||45
7817752|NCT01120756|19244889|P2|NOT COMPLETED|Overall Study||1
7817753|NCT01120756|19244890|P1|NOT COMPLETED|Overall Study||1
7817754|NCT01120756|19244889|P2|COMPLETED|Overall Study||13
7817755|NCT01120756|19244890|P1|COMPLETED|Overall Study||20
7817756|NCT01120756|19244889|P2|STARTED|Overall Study||14
7817757|NCT01120756|19244890|P1|STARTED|Overall Study||21
7817758|NCT01120717|19244900|P2|NOT COMPLETED|Overall Study||24
7817759|NCT01120717|19244901|P1|NOT COMPLETED|Overall Study||32
7817760|NCT01120717|19244900|P2|COMPLETED|Overall Study||89
7817761|NCT01120717|19244901|P1|COMPLETED|Overall Study||194
7817762|NCT01120717|19244900|P2|Safety Population: Received Study Drug|Overall Study||113
7817763|NCT01120717|19244901|P1|Safety Population: Received Study Drug|Overall Study||225
7817764|NCT01120717|19244900|P2|STARTED|Overall Study||113
7817765|NCT01120717|19244901|P1|STARTED|Overall Study||226
7817766|NCT01120704|19244949|P32|NOT COMPLETED|Overall Study||1
7817767|NCT01120704|19244950|P31|NOT COMPLETED|Overall Study||2
7817768|NCT01120704|19244951|P30|NOT COMPLETED|Overall Study||3
7817769|NCT01120704|19244952|P29|NOT COMPLETED|Overall Study||5
7817770|NCT01120704|19244953|P28|NOT COMPLETED|Overall Study||2
7817771|NCT01120704|19244954|P27|NOT COMPLETED|Overall Study||3
7817772|NCT01120704|19244955|P26|NOT COMPLETED|Overall Study||0
7817773|NCT01120704|19244956|P25|NOT COMPLETED|Overall Study||2
7817774|NCT01120704|19244957|P24|NOT COMPLETED|Overall Study||3
7817775|NCT01120704|19244958|P23|NOT COMPLETED|Overall Study||4
7817776|NCT01120704|19244959|P22|NOT COMPLETED|Overall Study||0
7817777|NCT01120704|19244960|P21|NOT COMPLETED|Overall Study||3
7817778|NCT01120704|19244961|P20|NOT COMPLETED|Overall Study||3
7817779|NCT01120704|19244962|P19|NOT COMPLETED|Overall Study||2
7817780|NCT01120704|19244963|P18|NOT COMPLETED|Overall Study||0
7817781|NCT01120704|19244964|P17|NOT COMPLETED|Overall Study||1
7817782|NCT01120704|19244965|P16|NOT COMPLETED|Overall Study||2
7817783|NCT01120704|19244966|P15|NOT COMPLETED|Overall Study||1
7817784|NCT01120704|19244967|P14|NOT COMPLETED|Overall Study||4
7817785|NCT01120704|19244968|P13|NOT COMPLETED|Overall Study||3
7817786|NCT01120704|19244969|P12|NOT COMPLETED|Overall Study||2
7817787|NCT01120704|19244970|P11|NOT COMPLETED|Overall Study||1
7817788|NCT01120704|19244971|P10|NOT COMPLETED|Overall Study||1
7817789|NCT01120704|19244972|P9|NOT COMPLETED|Overall Study||3
7817790|NCT01120704|19244973|P8|NOT COMPLETED|Overall Study||2
7817791|NCT01120704|19244974|P7|NOT COMPLETED|Overall Study||3
7817792|NCT01120704|19244975|P6|NOT COMPLETED|Overall Study||1
7817793|NCT01120704|19244976|P5|NOT COMPLETED|Overall Study||2
7817794|NCT01120704|19244977|P4|NOT COMPLETED|Overall Study||4
7817795|NCT01120704|19244978|P3|NOT COMPLETED|Overall Study||1
7817796|NCT01120704|19244979|P2|NOT COMPLETED|Overall Study||4
7817797|NCT01120704|19244980|P1|NOT COMPLETED|Overall Study||3
7817798|NCT01120704|19244949|P32|COMPLETED|Overall Study||17
7817799|NCT01120704|19244950|P31|COMPLETED|Overall Study||12
7817800|NCT01120704|19244951|P30|COMPLETED|Overall Study||12
7817801|NCT01120704|19244952|P29|COMPLETED|Overall Study||14
7817802|NCT01120704|19244953|P28|COMPLETED|Overall Study||16
7817803|NCT01120704|19244954|P27|COMPLETED|Overall Study||15
7817804|NCT01120704|19244955|P26|COMPLETED|Overall Study||14
7817805|NCT01120704|19244956|P25|COMPLETED|Overall Study||16
7817806|NCT01120704|19244957|P24|COMPLETED|Overall Study||13
7817807|NCT01120704|19244958|P23|COMPLETED|Overall Study||17
7817808|NCT01120704|19244959|P22|COMPLETED|Overall Study||16
7817809|NCT01120704|19244960|P21|COMPLETED|Overall Study||14
7817810|NCT01120704|19244961|P20|COMPLETED|Overall Study||15
7817811|NCT01120704|19244962|P19|COMPLETED|Overall Study||15
7817812|NCT01120704|19244963|P18|COMPLETED|Overall Study||16
7817813|NCT01120704|19244964|P17|COMPLETED|Overall Study||13
7817814|NCT01120704|19244965|P16|COMPLETED|Overall Study||16
7817815|NCT01120704|19244966|P15|COMPLETED|Overall Study||17
7817816|NCT01120704|19244967|P14|COMPLETED|Overall Study||15
7817817|NCT01120704|19244968|P13|COMPLETED|Overall Study||14
7817818|NCT01120704|19244969|P12|COMPLETED|Overall Study||14
7817819|NCT01120704|19244970|P11|COMPLETED|Overall Study||16
7817820|NCT01120704|19244971|P10|COMPLETED|Overall Study||19
7817821|NCT01120704|19244972|P9|COMPLETED|Overall Study||19
7817822|NCT01120704|19244973|P8|COMPLETED|Overall Study||13
7817823|NCT01120704|19244974|P7|COMPLETED|Overall Study||12
7817826|NCT01120704|19244977|P4|COMPLETED|Overall Study||15
7817827|NCT01120704|19244978|P3|COMPLETED|Overall Study||13
7817828|NCT01120704|19244979|P2|COMPLETED|Overall Study||13
7817829|NCT01120704|19244980|P1|COMPLETED|Overall Study||10
7817830|NCT01120704|19244949|P32|STARTED|Overall Study||18
7817831|NCT01120704|19244950|P31|STARTED|Overall Study||14
7817832|NCT01120704|19244951|P30|STARTED|Overall Study||15
7817833|NCT01120704|19244952|P29|STARTED|Overall Study||19
7817834|NCT01120704|19244953|P28|STARTED|Overall Study||18
7817835|NCT01120704|19244954|P27|STARTED|Overall Study||18
7817836|NCT01120704|19244955|P26|STARTED|Overall Study||14
7817837|NCT01120704|19244956|P25|STARTED|Overall Study||18
7817838|NCT01120704|19244957|P24|STARTED|Overall Study||16
7817839|NCT01120704|19244958|P23|STARTED|Overall Study||21
7817840|NCT01120704|19244959|P22|STARTED|Overall Study||16
7817841|NCT01120704|19244960|P21|STARTED|Overall Study||17
7817842|NCT01120704|19244961|P20|STARTED|Overall Study||18
7817843|NCT01120704|19244962|P19|STARTED|Overall Study||17
7817844|NCT01120704|19244963|P18|STARTED|Overall Study||16
7817845|NCT01120704|19244964|P17|STARTED|Overall Study||14
7817846|NCT01120704|19244965|P16|STARTED|Overall Study||18
7817847|NCT01120704|19244966|P15|STARTED|Overall Study||18
7817848|NCT01120704|19244967|P14|STARTED|Overall Study||19
7817849|NCT01120704|19244968|P13|STARTED|Overall Study||17
7817850|NCT01120704|19244969|P12|STARTED|Overall Study||16
7817851|NCT01120704|19244970|P11|STARTED|Overall Study||17
7817852|NCT01120704|19244971|P10|STARTED|Overall Study||20
7817853|NCT01120704|19244972|P9|STARTED|Overall Study||22
7817854|NCT01120704|19244973|P8|STARTED|Overall Study||15
7817855|NCT01120704|19244974|P7|STARTED|Overall Study||15
7817856|NCT01120704|19244975|P6|STARTED|Overall Study||19
7817857|NCT01120704|19244976|P5|STARTED|Overall Study||16
7817858|NCT01120704|19244977|P4|STARTED|Overall Study||19
7817859|NCT01120704|19244978|P3|STARTED|Overall Study||14
7817860|NCT01120704|19244979|P2|STARTED|Overall Study||17
7817861|NCT01120704|19244980|P1|STARTED|Overall Study||13
7817862|NCT01120691|19245007|P3|NOT COMPLETED|Overall Study||183
7817863|NCT01120691|19245008|P2|NOT COMPLETED|Overall Study||203
7817864|NCT01120691|19245009|P1|NOT COMPLETED|Overall Study||171
7817865|NCT01120691|19245007|P3|COMPLETED|Overall Study||559
7817866|NCT01120691|19245008|P2|COMPLETED|Overall Study||538
7817867|NCT01120691|19245009|P1|COMPLETED|Overall Study||570
7817868|NCT01120691|19245007|P3|Modified Full Analysis Set (mFAS)|Overall Study||737
7817869|NCT01120691|19245008|P2|Modified Full Analysis Set (mFAS)|Overall Study||739
7817870|NCT01120691|19245009|P1|Modified Full Analysis Set (mFAS)|Overall Study||729
7817871|NCT01120691|19245007|P3|Modified Safety Set (mSAF)|Overall Study||737
7817872|NCT01120691|19245008|P2|Modified Safety Set (mSAF)|Overall Study||740
7817873|NCT01120691|19245009|P1|Modified Safety Set (mSAF)|Overall Study||729
7817874|NCT01120691|19245007|P3|Safety Set (SAF)|Overall Study||739
7817875|NCT01120691|19245008|P2|Safety Set (SAF)|Overall Study||740
7817876|NCT01120691|19245009|P1|Safety Set (SAF)|Overall Study||736
7817877|NCT01120691|19245007|P3|Full Analysis Set (FAS)|Overall Study||739
7817878|NCT01120691|19245008|P2|Full Analysis Set (FAS)|Overall Study||739
7817879|NCT01120691|19245009|P1|Full Analysis Set (FAS)|Overall Study||736
7817880|NCT01120691|19245007|P3|STARTED|Overall Study||742
7817881|NCT01120691|19245008|P2|STARTED|Overall Study||741
7817882|NCT01120691|19245009|P1|STARTED|Overall Study||741
7817883|NCT01120639|19245055|P4|NOT COMPLETED|Overall Study||0
7817884|NCT01120639|19245056|P3|NOT COMPLETED|Overall Study||0
7817885|NCT01120639|19245057|P2|NOT COMPLETED|Overall Study||0
7817886|NCT01120639|19245058|P1|NOT COMPLETED|Overall Study||0
7817887|NCT01120639|19245055|P4|COMPLETED|Overall Study||12
7817888|NCT01120639|19245056|P3|COMPLETED|Overall Study||6
7817889|NCT01120639|19245057|P2|COMPLETED|Overall Study||6
7817890|NCT01120639|19245058|P1|COMPLETED|Overall Study||6
7817891|NCT01120639|19245055|P4|STARTED|Overall Study||12
7817892|NCT01120639|19245056|P3|STARTED|Overall Study||6
7817893|NCT01120639|19245057|P2|STARTED|Overall Study||6
7817894|NCT01120639|19245058|P1|STARTED|Overall Study||6
7817895|NCT01120626|19245106|P2|NOT COMPLETED|Overall Study||0
7817896|NCT01120626|19245107|P1|NOT COMPLETED|Overall Study||1
7817897|NCT01120626|19245106|P2|COMPLETED|Overall Study||22
7817898|NCT01120626|19245107|P1|COMPLETED|Overall Study||19
7817899|NCT01120626|19245106|P2|STARTED|Overall Study||22
7817900|NCT01120626|19245107|P1|STARTED|Overall Study||20
7817901|NCT01120600|19245117|P2|NOT COMPLETED|Overall Study||32
7817902|NCT01120600|19245118|P1|NOT COMPLETED|Overall Study||19
7817903|NCT01120600|19245117|P2|COMPLETED|Overall Study||115
7817904|NCT01120600|19245118|P1|COMPLETED|Overall Study||128
7817905|NCT01120600|19245117|P2|Treated|Overall Study||146
7817906|NCT01120600|19245118|P1|Treated|Overall Study||146
7817907|NCT01120600|19245117|P2|STARTED|Overall Study||147
7817908|NCT01120600|19245118|P1|STARTED|Overall Study||147
7817909|NCT01120405|19245144|P2|NOT COMPLETED|Overall Study||33
7817910|NCT01120405|19245145|P1|NOT COMPLETED|Overall Study||27
7817911|NCT01120405|19245144|P2|COMPLETED|Overall Study||269
7817912|NCT01120405|19245145|P1|COMPLETED|Overall Study||271
7817913|NCT01120405|19245144|P2|STARTED|Overall Study||302
7817914|NCT01120405|19245145|P1|STARTED|Overall Study||298
7817915|NCT01120379|19245173|P1|NOT COMPLETED|Four Year Timepoint||368
7817916|NCT01120379|19245173|P1|COMPLETED|Four Year Timepoint||3923
7817917|NCT01120379|19245173|P1|STARTED|Four Year Timepoint||4291
7817918|NCT01120379|19245173|P1|NOT COMPLETED|Three Year Timepoint||214
7817919|NCT01120379|19245173|P1|COMPLETED|Three Year Timepoint||4291
7817920|NCT01120379|19245173|P1|STARTED|Three Year Timepoint||4505
7817921|NCT01120379|19245173|P1|NOT COMPLETED|Two Year Timepoint||237
7817922|NCT01120379|19245173|P1|COMPLETED|Two Year Timepoint||4505
7817923|NCT01120379|19245173|P1|STARTED|Two Year Timepoint||4742
7817924|NCT01120379|19245173|P1|NOT COMPLETED|One Year Timepoint||278
7817925|NCT01120379|19245173|P1|COMPLETED|One Year Timepoint||4742
7817926|NCT01120379|19245173|P1|STARTED|One Year Timepoint||5020
7817927|NCT01120275|19245209|P1|NOT COMPLETED|Overall Study||36
7817928|NCT01120275|19245209|P1|COMPLETED|Overall Study||0
7817929|NCT01120275|19245209|P1|Eligible and Treated|Overall Study||32
7817930|NCT01120275|19245209|P1|STARTED|Overall Study||36
7817931|NCT01120236|19245218|P2|NOT COMPLETED|Overall Study||1
7817932|NCT01120236|19245219|P1|NOT COMPLETED|Overall Study||0
7817933|NCT01120236|19245218|P2|COMPLETED|Overall Study||105
7817934|NCT01120236|19245219|P1|COMPLETED|Overall Study||105
7817935|NCT01120236|19245218|P2|Ineligble|Overall Study|Patient ineligible due to no demonstable radiographic metastasis and is excluded from all analyses.|1
7817936|NCT01120236|19245219|P1|Ineligble|Overall Study||0
7817937|NCT01120236|19245218|P2|STARTED|Overall Study||106
7817938|NCT01120236|19245219|P1|STARTED|Overall Study||105
7817939|NCT01120223|19245246|P1|NOT COMPLETED|Overall Study||4
7817940|NCT01120223|19245246|P1|COMPLETED|Overall Study||74
7817941|NCT01120223|19245246|P1|STARTED|Overall Study||78
7817942|NCT01120210|19245276|P2|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
7817943|NCT01120210|19245277|P1|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
7817944|NCT01120210|19245276|P2|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
7817945|NCT01120210|19245277|P1|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
7817946|NCT01120210|19245276|P2|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
7817947|NCT01120210|19245277|P1|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
7817948|NCT01120210|19245276|P2|NOT COMPLETED|MAIN INFUSION||1
7817949|NCT01120210|19245277|P1|NOT COMPLETED|MAIN INFUSION||1
7817950|NCT01120210|19245276|P2|COMPLETED|MAIN INFUSION||45
7817951|NCT01120210|19245277|P1|COMPLETED|MAIN INFUSION||15
7817952|NCT01120210|19245276|P2|STARTED|MAIN INFUSION||46
7817953|NCT01120210|19245277|P1|STARTED|MAIN INFUSION||16
7817954|NCT01120197|19245309|P2|NOT COMPLETED|Overall Study||10
7817955|NCT01120197|19245310|P1|NOT COMPLETED|Overall Study||9
7817956|NCT01120197|19245309|P2|COMPLETED|Overall Study||32
7817957|NCT01120197|19245310|P1|COMPLETED|Overall Study||38
7817958|NCT01120197|19245309|P2|STARTED|Overall Study||42
7817959|NCT01120197|19245310|P1|STARTED|Overall Study||47
7817960|NCT01120184|19245327|P3|NOT COMPLETED|Overall Study||363
7817961|NCT01120184|19245328|P2|NOT COMPLETED|Overall Study||367
7817962|NCT01120184|19245329|P1|NOT COMPLETED|Overall Study||365
7817963|NCT01120184|19245327|P3|COMPLETED|Overall Study||0
7817964|NCT01120184|19245328|P2|COMPLETED|Overall Study||0
7817965|NCT01120184|19245329|P1|COMPLETED|Overall Study||0
7817966|NCT01120184|19245327|P3|Treated|Overall Study||360
7817967|NCT01120184|19245328|P2|Treated|Overall Study||365
7817968|NCT01120184|19245329|P1|Treated|Overall Study||355
7817969|NCT01120184|19245327|P3|STARTED|Overall Study||363
7817970|NCT01120184|19245328|P2|STARTED|Overall Study||367
7817971|NCT01120184|19245329|P1|STARTED|Overall Study||365
7817972|NCT01120093|19245451|P5|NOT COMPLETED|Treatment Period 5||0
7817973|NCT01120093|19245452|P4|NOT COMPLETED|Treatment Period 5||1
7817974|NCT01120093|19245453|P3|NOT COMPLETED|Treatment Period 5||0
7817975|NCT01120093|19245454|P2|NOT COMPLETED|Treatment Period 5||1
7817976|NCT01120093|19245455|P1|NOT COMPLETED|Treatment Period 5||0
7817977|NCT01120093|19245451|P5|COMPLETED|Treatment Period 5||13
7817978|NCT01120093|19245452|P4|COMPLETED|Treatment Period 5||11
7817979|NCT01120093|19245453|P3|COMPLETED|Treatment Period 5||15
7817980|NCT01120093|19245454|P2|COMPLETED|Treatment Period 5||12
7817981|NCT01120093|19245455|P1|COMPLETED|Treatment Period 5||17
7817982|NCT01120093|19245451|P5|STARTED|Treatment Period 5||13
7817983|NCT01120093|19245452|P4|STARTED|Treatment Period 5||12
7817984|NCT01120093|19245453|P3|STARTED|Treatment Period 5||15
7817985|NCT01120093|19245454|P2|STARTED|Treatment Period 5||13
7817986|NCT01120093|19245455|P1|STARTED|Treatment Period 5||17
7817987|NCT01120093|19245451|P5|NOT COMPLETED|Treatment Period 4||0
7817988|NCT01120093|19245452|P4|NOT COMPLETED|Treatment Period 4||0
7817989|NCT01120093|19245453|P3|NOT COMPLETED|Treatment Period 4||0
7817990|NCT01120093|19245454|P2|NOT COMPLETED|Treatment Period 4||0
7817991|NCT01120093|19245455|P1|NOT COMPLETED|Treatment Period 4||1
7817992|NCT01120093|19245451|P5|COMPLETED|Treatment Period 4||13
7817993|NCT01120093|19245452|P4|COMPLETED|Treatment Period 4||12
7817994|NCT01120093|19245453|P3|COMPLETED|Treatment Period 4||15
7817995|NCT01120093|19245454|P2|COMPLETED|Treatment Period 4||13
7817996|NCT01120093|19245455|P1|COMPLETED|Treatment Period 4||17
7817997|NCT01120093|19245451|P5|STARTED|Treatment Period 4||13
7817998|NCT01120093|19245452|P4|STARTED|Treatment Period 4||12
7817999|NCT01120093|19245453|P3|STARTED|Treatment Period 4||15
7818000|NCT01120093|19245454|P2|STARTED|Treatment Period 4||13
7818001|NCT01120093|19245455|P1|STARTED|Treatment Period 4||18
7818002|NCT01120093|19245451|P5|NOT COMPLETED|Treatment Period 3||1
7818003|NCT01120093|19245452|P4|NOT COMPLETED|Treatment Period 3||1
7818004|NCT01120093|19245453|P3|NOT COMPLETED|Treatment Period 3||1
7818005|NCT01120093|19245454|P2|NOT COMPLETED|Treatment Period 3||0
7818006|NCT01120093|19245455|P1|NOT COMPLETED|Treatment Period 3||0
7818007|NCT01120093|19245451|P5|COMPLETED|Treatment Period 3||13
7818008|NCT01120093|19245452|P4|COMPLETED|Treatment Period 3||12
7818009|NCT01120093|19245453|P3|COMPLETED|Treatment Period 3||15
7818010|NCT01120093|19245454|P2|COMPLETED|Treatment Period 3||13
7818011|NCT01120093|19245455|P1|COMPLETED|Treatment Period 3||18
7818012|NCT01120093|19245451|P5|STARTED|Treatment Period 3||14
7818013|NCT01120093|19245452|P4|STARTED|Treatment Period 3||13
7818014|NCT01120093|19245453|P3|STARTED|Treatment Period 3||16
7818015|NCT01120093|19245454|P2|STARTED|Treatment Period 3||13
7818016|NCT01120093|19245455|P1|STARTED|Treatment Period 3||18
7818017|NCT01120093|19245451|P5|NOT COMPLETED|Treatment Period 2||1
7818018|NCT01120093|19245452|P4|NOT COMPLETED|Treatment Period 2||1
7818019|NCT01120093|19245453|P3|NOT COMPLETED|Treatment Period 2||0
7818020|NCT01120093|19245454|P2|NOT COMPLETED|Treatment Period 2||0
7818021|NCT01120093|19245455|P1|NOT COMPLETED|Treatment Period 2||0
7818022|NCT01120093|19245451|P5|COMPLETED|Treatment Period 2||14
7818023|NCT01120093|19245452|P4|COMPLETED|Treatment Period 2||13
7818024|NCT01120093|19245453|P3|COMPLETED|Treatment Period 2||16
7818025|NCT01120093|19245454|P2|COMPLETED|Treatment Period 2||13
7818026|NCT01120093|19245455|P1|COMPLETED|Treatment Period 2||18
7818027|NCT01120093|19245451|P5|STARTED|Treatment Period 2||15
7818028|NCT01120093|19245452|P4|STARTED|Treatment Period 2||14
7818029|NCT01120093|19245453|P3|STARTED|Treatment Period 2||16
7818030|NCT01120093|19245454|P2|STARTED|Treatment Period 2||13
7818031|NCT01120093|19245455|P1|STARTED|Treatment Period 2||18
7818032|NCT01120093|19245451|P5|NOT COMPLETED|Treatment Period 1||1
7818033|NCT01120093|19245452|P4|NOT COMPLETED|Treatment Period 1||0
7818034|NCT01120093|19245453|P3|NOT COMPLETED|Treatment Period 1||1
7818035|NCT01120093|19245454|P2|NOT COMPLETED|Treatment Period 1||1
7818036|NCT01120093|19245455|P1|NOT COMPLETED|Treatment Period 1||0
7818037|NCT01120093|19245451|P5|COMPLETED|Treatment Period 1||15
7818038|NCT01120093|19245452|P4|COMPLETED|Treatment Period 1||14
7818039|NCT01120093|19245453|P3|COMPLETED|Treatment Period 1||16
7818040|NCT01120093|19245454|P2|COMPLETED|Treatment Period 1||13
7818041|NCT01120093|19245455|P1|COMPLETED|Treatment Period 1||18
7818042|NCT01120093|19245451|P5|STARTED|Treatment Period 1||16
7818043|NCT01120093|19245452|P4|STARTED|Treatment Period 1||14
7818044|NCT01120093|19245453|P3|STARTED|Treatment Period 1||17
7818045|NCT01120093|19245454|P2|STARTED|Treatment Period 1||14
7818046|NCT01120093|19245455|P1|STARTED|Treatment Period 1||18
7818047|NCT01120067|19245484|P2|NOT COMPLETED|Overall Study||1
7818048|NCT01120067|19245485|P1|NOT COMPLETED|Overall Study||5
7818049|NCT01120067|19245484|P2|COMPLETED|Overall Study||10
7818050|NCT01120067|19245485|P1|COMPLETED|Overall Study||7
7818051|NCT01120067|19245484|P2|STARTED|Overall Study||11
7818052|NCT01120067|19245485|P1|STARTED|Overall Study||12
7818053|NCT01120028|19245495|P4|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
7818054|NCT01120028|19245496|P3|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
7818055|NCT01120028|19245497|P2|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
7818056|NCT01120028|19245498|P1|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
7818057|NCT01120028|19245495|P4|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
7818058|NCT01120028|19245496|P3|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
7818059|NCT01120028|19245497|P2|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
7818060|NCT01120028|19245498|P1|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
7818061|NCT01120028|19245495|P4|STARTED|Period 2: Tacrolimus or Sirolimus||197
7818062|NCT01120028|19245496|P3|STARTED|Period 2: Tacrolimus or Sirolimus||197
7818063|NCT01120028|19245497|P2|STARTED|Period 2: Tacrolimus or Sirolimus||0
7818064|NCT01120028|19245498|P1|STARTED|Period 2: Tacrolimus or Sirolimus||0
7818065|NCT01120028|19245495|P4|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
7818066|NCT01120028|19245496|P3|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
7818067|NCT01120028|19245497|P2|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||23
7818068|NCT01120028|19245498|P1|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||14
7818069|NCT01120028|19245495|P4|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
7818070|NCT01120028|19245496|P3|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
7818071|NCT01120028|19245497|P2|COMPLETED|Period 1: Alemtuzumab or Basiliximab||403
7818072|NCT01120028|19245498|P1|COMPLETED|Period 1: Alemtuzumab or Basiliximab||412
7818073|NCT01120028|19245495|P4|STARTED|Period 1: Alemtuzumab or Basiliximab||0
7818074|NCT01120028|19245496|P3|STARTED|Period 1: Alemtuzumab or Basiliximab||0
7818075|NCT01120028|19245497|P2|STARTED|Period 1: Alemtuzumab or Basiliximab||426
7818076|NCT01120028|19245498|P1|STARTED|Period 1: Alemtuzumab or Basiliximab||426
7818077|NCT01119963|19245522|P2|NOT COMPLETED|Overall Study||1
7818078|NCT01119963|19245523|P1|NOT COMPLETED|Overall Study||1
7818079|NCT01119963|19245522|P2|COMPLETED|Overall Study||77
7818080|NCT01119963|19245523|P1|COMPLETED|Overall Study||73
7818081|NCT01119963|19245522|P2|STARTED|Overall Study||78
7818082|NCT01119963|19245523|P1|STARTED|Overall Study||74
7818083|NCT01119950|19245533|P1|NOT COMPLETED|Overall Study||47
7818084|NCT01119950|19245533|P1|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341
7818085|NCT01119950|19245533|P1|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94
7818086|NCT01119950|19245533|P1|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94
7818087|NCT01119950|19245533|P1|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98
7818088|NCT01119950|19245533|P1|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100
7818089|NCT01119950|19245533|P1|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96
7818090|NCT01119950|19245533|P1|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99
7818269|NCT01119131|19246378|P2|NOT COMPLETED|Overall Study||1
7818091|NCT01119950|19245533|P1|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99
7818092|NCT01119950|19245533|P1|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96
7818093|NCT01119950|19245533|P1|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388
7818094|NCT01119937|19245780|P2|NOT COMPLETED|Overall Study||7
7818095|NCT01119937|19245781|P1|NOT COMPLETED|Overall Study||19
7818096|NCT01119937|19245780|P2|COMPLETED|Overall Study||33
7818097|NCT01119937|19245781|P1|COMPLETED|Overall Study||104
7818098|NCT01119937|19245780|P2|STARTED|Overall Study||40
7818099|NCT01119937|19245781|P1|STARTED|Overall Study||123
7818100|NCT01119898|19245809|P2|NOT COMPLETED|Overall Study||12
7818101|NCT01119898|19245810|P1|NOT COMPLETED|Overall Study||8
7818102|NCT01119898|19245809|P2|COMPLETED|Overall Study||117
7818103|NCT01119898|19245810|P1|COMPLETED|Overall Study||123
7818104|NCT01119898|19245809|P2|Received Study Drug (mITT)|Overall Study||129
7818105|NCT01119898|19245810|P1|Received Study Drug (mITT)|Overall Study||130
7818106|NCT01119898|19245809|P2|STARTED|Overall Study||129
7818107|NCT01119898|19245810|P1|STARTED|Overall Study||131
7818108|NCT01119859|19245836|P2|NOT COMPLETED|Overall Study||30
7818109|NCT01119859|19245837|P1|NOT COMPLETED|Overall Study||24
7818110|NCT01119859|19245836|P2|COMPLETED|Overall Study||133
7818111|NCT01119859|19245837|P1|COMPLETED|Overall Study||139
7818112|NCT01119859|19245836|P2|STARTED|Overall Study||163
7818113|NCT01119859|19245837|P1|STARTED|Overall Study||163
7818114|NCT01119846|19245856|P3|NOT COMPLETED|Overall Study||11
7818115|NCT01119846|19245857|P2|NOT COMPLETED|Overall Study||0
7818116|NCT01119846|19245858|P1|NOT COMPLETED|Overall Study||2
7818117|NCT01119846|19245856|P3|COMPLETED|Overall Study||72
7818118|NCT01119846|19245857|P2|COMPLETED|Overall Study||4
7818119|NCT01119846|19245858|P1|COMPLETED|Overall Study||11
7818120|NCT01119846|19245856|P3|STARTED|Overall Study||83
7818121|NCT01119846|19245857|P2|STARTED|Overall Study||4
7818122|NCT01119846|19245858|P1|STARTED|Overall Study||13
7818123|NCT01119794|19246066|P1|NOT COMPLETED|Overall Study||0
7818124|NCT01119794|19246066|P1|COMPLETED|Overall Study||10
7818125|NCT01119794|19246066|P1|STARTED|Overall Study||10
7818126|NCT01119768|19246072|P2|NOT COMPLETED|Follow-up||2
7818127|NCT01119768|19246073|P1|NOT COMPLETED|Follow-up||1
7818128|NCT01119768|19246072|P2|COMPLETED|Follow-up||122
7818129|NCT01119768|19246073|P1|COMPLETED|Follow-up||135
7818130|NCT01119768|19246072|P2|STARTED|Follow-up||124
7818131|NCT01119768|19246073|P1|STARTED|Follow-up||136
7818132|NCT01119768|19246072|P2|NOT COMPLETED|Treatment Period||25
7818133|NCT01119768|19246073|P1|NOT COMPLETED|Treatment Period||18
7818134|NCT01119768|19246072|P2|COMPLETED|Treatment Period||126
7818135|NCT01119768|19246073|P1|COMPLETED|Treatment Period||136
7818136|NCT01119768|19246072|P2|STARTED|Treatment Period||151
7818137|NCT01119768|19246073|P1|STARTED|Treatment Period||154
7818138|NCT01119755|19246095|P1|NOT COMPLETED|Overall Study||0
7818139|NCT01119755|19246095|P1|COMPLETED|Overall Study||80
7818140|NCT01119755|19246095|P1|STARTED|Overall Study||80
7818141|NCT01119716|19246106|P1|NOT COMPLETED|Overall Study||0
7818142|NCT01119716|19246106|P1|COMPLETED|Overall Study||4658
7818143|NCT01119716|19246106|P1|STARTED|Overall Study||4658
7818144|NCT01119703|19246129|P2|NOT COMPLETED|Overall Study||1
7818145|NCT01119703|19246130|P1|NOT COMPLETED|Overall Study||0
7818146|NCT01119703|19246129|P2|COMPLETED|Overall Study||143
7818147|NCT01119703|19246130|P1|COMPLETED|Overall Study||30
7818148|NCT01119703|19246129|P2|STARTED|Overall Study||144
7818149|NCT01119703|19246130|P1|STARTED|Overall Study||30
7818150|NCT01119625|19246144|P2|NOT COMPLETED|Overall Study||4
7818151|NCT01119625|19246145|P1|NOT COMPLETED|Overall Study||3
7818152|NCT01119625|19246144|P2|COMPLETED|Overall Study||116
7818153|NCT01119625|19246145|P1|COMPLETED|Overall Study||115
7818154|NCT01119625|19246144|P2|STARTED|Overall Study||120
7818155|NCT01119625|19246145|P1|STARTED|Overall Study||118
7818156|NCT01119508|19246185|P1|NOT COMPLETED|Overall Study||59
7818157|NCT01119508|19246185|P1|COMPLETED|Overall Study||5
7818158|NCT01119508|19246185|P1|Received Fifth Consolidation Dose week12|Overall Study||32
7818159|NCT01119508|19246185|P1|Received Four Induction Doses|Overall Study||45
7818160|NCT01119508|19246185|P1|STARTED|Overall Study||64
7818161|NCT01119456|19246197|P8|NOT COMPLETED|Overall Study||0
7818162|NCT01119456|19246198|P7|NOT COMPLETED|Overall Study||0
7818163|NCT01119456|19246199|P6|NOT COMPLETED|Overall Study||0
7818164|NCT01119456|19246200|P5|NOT COMPLETED|Overall Study||0
7818165|NCT01119456|19246201|P4|NOT COMPLETED|Overall Study||0
7818166|NCT01119456|19246202|P3|NOT COMPLETED|Overall Study||0
7818167|NCT01119456|19246203|P2|NOT COMPLETED|Overall Study||0
7818168|NCT01119456|19246204|P1|NOT COMPLETED|Overall Study||0
7818169|NCT01119456|19246197|P8|COMPLETED|Overall Study||3
7818170|NCT01119456|19246198|P7|COMPLETED|Overall Study||3
7818171|NCT01119456|19246199|P6|COMPLETED|Overall Study||3
7818172|NCT01119456|19246200|P5|COMPLETED|Overall Study||4
7818173|NCT01119456|19246201|P4|COMPLETED|Overall Study||13
7818174|NCT01119456|19246202|P3|COMPLETED|Overall Study||3
7818175|NCT01119456|19246203|P2|COMPLETED|Overall Study||3
7818176|NCT01119456|19246204|P1|COMPLETED|Overall Study||7
7818177|NCT01119456|19246197|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
7818178|NCT01119456|19246198|P7|Received at Least 1 Dose of Study Drug|Overall Study||3
7818179|NCT01119456|19246199|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
7818180|NCT01119456|19246200|P5|Received at Least 1 Dose of Study Drug|Overall Study||4
7818270|NCT01119131|19246379|P1|NOT COMPLETED|Overall Study||2
7818181|NCT01119456|19246201|P4|Received at Least 1 Dose of Study Drug|Overall Study||13
7818182|NCT01119456|19246202|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
7818183|NCT01119456|19246203|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
7818184|NCT01119456|19246204|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
7818185|NCT01119456|19246197|P8|STARTED|Overall Study||3
7818186|NCT01119456|19246198|P7|STARTED|Overall Study||3
7818187|NCT01119456|19246199|P6|STARTED|Overall Study||3
7818188|NCT01119456|19246200|P5|STARTED|Overall Study||4
7818189|NCT01119456|19246201|P4|STARTED|Overall Study||13
7818190|NCT01119456|19246202|P3|STARTED|Overall Study||3
7818191|NCT01119456|19246203|P2|STARTED|Overall Study||3
7818192|NCT01119456|19246204|P1|STARTED|Overall Study||7
7818193|NCT01119443|19246265|P2|NOT COMPLETED|End of Study (All Patients)||0
7818194|NCT01119443|19246266|P1|NOT COMPLETED|End of Study (All Patients)||0
7818195|NCT01119443|19246265|P2|COMPLETED|End of Study (All Patients)||14
7818196|NCT01119443|19246266|P1|COMPLETED|End of Study (All Patients)||14
7818197|NCT01119443|19246265|P2|STARTED|End of Study (All Patients)||14
7818198|NCT01119443|19246266|P1|STARTED|End of Study (All Patients)||14
7818199|NCT01119443|19246265|P2|NOT COMPLETED|Down-titration Period (1 Day)||0
7818200|NCT01119443|19246266|P1|NOT COMPLETED|Down-titration Period (1 Day)||0
7818201|NCT01119443|19246265|P2|COMPLETED|Down-titration Period (1 Day)||13
7818202|NCT01119443|19246266|P1|COMPLETED|Down-titration Period (1 Day)||14
7818203|NCT01119443|19246265|P2|STARTED|Down-titration Period (1 Day)||13
7818204|NCT01119443|19246266|P1|STARTED|Down-titration Period (1 Day)||14
7818205|NCT01119443|19246265|P2|NOT COMPLETED|Crossover Period 4 (5 Days)||0
7818206|NCT01119443|19246266|P1|NOT COMPLETED|Crossover Period 4 (5 Days)||0
7818207|NCT01119443|19246265|P2|COMPLETED|Crossover Period 4 (5 Days)||13
7818208|NCT01119443|19246266|P1|COMPLETED|Crossover Period 4 (5 Days)||14
7818209|NCT01119443|19246265|P2|STARTED|Crossover Period 4 (5 Days)||13
7818210|NCT01119443|19246266|P1|STARTED|Crossover Period 4 (5 Days)||14
7818211|NCT01119443|19246265|P2|NOT COMPLETED|Crossover Period 3 (5 Days)||0
7818212|NCT01119443|19246266|P1|NOT COMPLETED|Crossover Period 3 (5 Days)||0
7818213|NCT01119443|19246265|P2|COMPLETED|Crossover Period 3 (5 Days)||13
7818214|NCT01119443|19246266|P1|COMPLETED|Crossover Period 3 (5 Days)||14
7818215|NCT01119443|19246265|P2|STARTED|Crossover Period 3 (5 Days)||13
7818216|NCT01119443|19246266|P1|STARTED|Crossover Period 3 (5 Days)||14
7818217|NCT01119443|19246265|P2|NOT COMPLETED|Crossover Period 2 (5 Days)||0
7818218|NCT01119443|19246266|P1|NOT COMPLETED|Crossover Period 2 (5 Days)||0
7818219|NCT01119443|19246265|P2|COMPLETED|Crossover Period 2 (5 Days)||13
7818220|NCT01119443|19246266|P1|COMPLETED|Crossover Period 2 (5 Days)||14
7818221|NCT01119443|19246265|P2|STARTED|Crossover Period 2 (5 Days)||13
7818222|NCT01119443|19246266|P1|STARTED|Crossover Period 2 (5 Days)||14
7818223|NCT01119443|19246265|P2|NOT COMPLETED|Crossover Period 1 (5 Days)||1
7818224|NCT01119443|19246266|P1|NOT COMPLETED|Crossover Period 1 (5 Days)||0
7818225|NCT01119443|19246265|P2|COMPLETED|Crossover Period 1 (5 Days)||13
7818226|NCT01119443|19246266|P1|COMPLETED|Crossover Period 1 (5 Days)||14
7818227|NCT01119443|19246265|P2|STARTED|Crossover Period 1 (5 Days)||14
7818228|NCT01119443|19246266|P1|STARTED|Crossover Period 1 (5 Days)||14
7818229|NCT01119443|19246265|P2|NOT COMPLETED|Up-titration Period (10 Days)||0
7818230|NCT01119443|19246266|P1|NOT COMPLETED|Up-titration Period (10 Days)||0
7818231|NCT01119443|19246265|P2|COMPLETED|Up-titration Period (10 Days)||14
7818232|NCT01119443|19246266|P1|COMPLETED|Up-titration Period (10 Days)||14
7818233|NCT01119443|19246265|P2|STARTED|Up-titration Period (10 Days)||14
7818234|NCT01119443|19246266|P1|STARTED|Up-titration Period (10 Days)||14
7818235|NCT01119287|19246309|P6|NOT COMPLETED|Overall Study||0
7818236|NCT01119287|19246310|P5|NOT COMPLETED|Overall Study||1
7818237|NCT01119287|19246311|P4|NOT COMPLETED|Overall Study||2
7818238|NCT01119287|19246312|P3|NOT COMPLETED|Overall Study||2
7818239|NCT01119287|19246313|P2|NOT COMPLETED|Overall Study||0
7818240|NCT01119287|19246314|P1|NOT COMPLETED|Overall Study||0
7818241|NCT01119287|19246309|P6|COMPLETED|Overall Study||32
7818242|NCT01119287|19246310|P5|COMPLETED|Overall Study||30
7818243|NCT01119287|19246311|P4|COMPLETED|Overall Study||29
7818244|NCT01119287|19246312|P3|COMPLETED|Overall Study||24
7818245|NCT01119287|19246313|P2|COMPLETED|Overall Study||24
7818246|NCT01119287|19246314|P1|COMPLETED|Overall Study||26
7818247|NCT01119287|19246309|P6|STARTED|Overall Study||32
7818248|NCT01119287|19246310|P5|STARTED|Overall Study||31
7818249|NCT01119287|19246311|P4|STARTED|Overall Study||31
7818250|NCT01119287|19246312|P3|STARTED|Overall Study||26
7818251|NCT01119287|19246313|P2|STARTED|Overall Study||24
7818252|NCT01119287|19246314|P1|STARTED|Overall Study||26
7818253|NCT01119248|19246327|P1|NOT COMPLETED|Overall Study||5
7818254|NCT01119248|19246327|P1|COMPLETED|Overall Study||115
7818255|NCT01119248|19246327|P1|STARTED|Overall Study||120
7818256|NCT01119222|19246333|P4|NOT COMPLETED|Overall Study||0
7818257|NCT01119222|19246334|P3|NOT COMPLETED|Overall Study||0
7818258|NCT01119222|19246335|P2|NOT COMPLETED|Overall Study||0
7818259|NCT01119222|19246336|P1|NOT COMPLETED|Overall Study||0
7818260|NCT01119222|19246333|P4|COMPLETED|Overall Study||4
7818261|NCT01119222|19246334|P3|COMPLETED|Overall Study||5
7818262|NCT01119222|19246335|P2|COMPLETED|Overall Study||5
7818263|NCT01119222|19246336|P1|COMPLETED|Overall Study||5
7818264|NCT01119222|19246333|P4|STARTED|Overall Study||4
7818265|NCT01119222|19246334|P3|STARTED|Overall Study||5
7818266|NCT01119222|19246335|P2|STARTED|Overall Study||5
7818267|NCT01119222|19246336|P1|STARTED|Overall Study||5
7818268|NCT01119131|19246377|P3|NOT COMPLETED|Overall Study||6
7818271|NCT01119131|19246377|P3|COMPLETED|Overall Study||24
7818272|NCT01119131|19246378|P2|COMPLETED|Overall Study||27
7818273|NCT01119131|19246379|P1|COMPLETED|Overall Study||8
7818274|NCT01119131|19246377|P3|STARTED|Overall Study||30
7818275|NCT01119131|19246378|P2|STARTED|Overall Study||28
7818276|NCT01119131|19246379|P1|STARTED|Overall Study||10
7818277|NCT01119118|19246408|P1|NOT COMPLETED|Overall Study||1
7818278|NCT01119118|19246408|P1|COMPLETED|Overall Study||5
7818279|NCT01119118|19246408|P1|STARTED|Overall Study||6
7818280|NCT01119105|19246419|P3|NOT COMPLETED|Overall Study||8
7818281|NCT01119105|19246420|P2|NOT COMPLETED|Overall Study||6
7818282|NCT01119105|19246421|P1|NOT COMPLETED|Overall Study||4
7818283|NCT01119105|19246419|P3|COMPLETED|Overall Study||60
7818284|NCT01119105|19246420|P2|COMPLETED|Overall Study||66
7818285|NCT01119105|19246421|P1|COMPLETED|Overall Study||66
7818286|NCT01119105|19246419|P3|STARTED|Overall Study||68
7818287|NCT01119105|19246420|P2|STARTED|Overall Study||72
7818288|NCT01119105|19246421|P1|STARTED|Overall Study||70
7818289|NCT01119040|19246432|P1|NOT COMPLETED|Overall Study||1
7818290|NCT01119040|19246432|P1|COMPLETED|Overall Study||0
7818291|NCT01119040|19246432|P1|STARTED|Overall Study||1
7818292|NCT01119001|19246436|P1|NOT COMPLETED|Overall Study||2
7818293|NCT01119001|19246436|P1|COMPLETED|Overall Study||11
7818294|NCT01119001|19246436|P1|STARTED|Overall Study||13
7818295|NCT01118988|19246445|P3|NOT COMPLETED|Overall Study||4
7818296|NCT01118988|19246446|P2|NOT COMPLETED|Overall Study||1
7818297|NCT01118988|19246447|P1|NOT COMPLETED|Overall Study||5
7818298|NCT01118988|19246445|P3|COMPLETED|Overall Study||3
7818299|NCT01118988|19246446|P2|COMPLETED|Overall Study||3
7818300|NCT01118988|19246447|P1|COMPLETED|Overall Study||11
7818301|NCT01118988|19246445|P3|STARTED|Overall Study||7
7818302|NCT01118988|19246446|P2|STARTED|Overall Study||4
7818303|NCT01118988|19246447|P1|STARTED|Overall Study||16
7818304|NCT01118975|19246480|P2|NOT COMPLETED|Overall Study||1
7818305|NCT01118975|19246481|P1|NOT COMPLETED|Overall Study||0
7818306|NCT01118975|19246480|P2|COMPLETED|Overall Study||2
7818307|NCT01118975|19246481|P1|COMPLETED|Overall Study||9
7818308|NCT01118975|19246480|P2|STARTED|Overall Study||3
7818309|NCT01118975|19246481|P1|STARTED|Overall Study||9
7818310|NCT01118962|19246487|P1|NOT COMPLETED|Overall Study||10
7818311|NCT01118962|19246487|P1|COMPLETED|Overall Study||29
7818312|NCT01118962|19246487|P1|STARTED|Overall Study||39
7818313|NCT01118949|19246492|P1|NOT COMPLETED|Overall Study||9
7818314|NCT01118949|19246492|P1|COMPLETED|Overall Study||40
7818315|NCT01118949|19246492|P1|STARTED|Overall Study||49
7818316|NCT01118845|19246501|P1|NOT COMPLETED|Overall Study||42
7818317|NCT01118845|19246501|P1|COMPLETED|Overall Study||17
7818318|NCT01118845|19246501|P1|STARTED|Overall Study||59
7818319|NCT01118780|19246522|P2|NOT COMPLETED|Overall Study||35
7818320|NCT01118780|19246523|P1|NOT COMPLETED|Overall Study||36
7818321|NCT01118780|19246522|P2|COMPLETED|Overall Study||105
7818322|NCT01118780|19246523|P1|COMPLETED|Overall Study||115
7818323|NCT01118780|19246522|P2|STARTED|Overall Study||140
7818324|NCT01118780|19246523|P1|STARTED|Overall Study||151
7818325|NCT01118741|19246572|P2|NOT COMPLETED|Overall Study||0
7818326|NCT01118741|19246573|P1|NOT COMPLETED|Overall Study||0
7818327|NCT01118741|19246572|P2|COMPLETED|Overall Study||10
7818328|NCT01118741|19246573|P1|COMPLETED|Overall Study||9
7818329|NCT01118741|19246572|P2|STARTED|Overall Study||10
7818330|NCT01118741|19246573|P1|STARTED|Overall Study||9
7818331|NCT01118728|19246581|P1|NOT COMPLETED|Overall Study||223
7818332|NCT01118728|19246581|P1|COMPLETED|Overall Study||0
7818333|NCT01118728|19246581|P1|STARTED|Overall Study||223
7818334|NCT01118715|19246588|P2|NOT COMPLETED|Overall Study||0
7818335|NCT01118715|19246589|P1|NOT COMPLETED|Overall Study||0
7818336|NCT01118715|19246588|P2|COMPLETED|Overall Study||60
7818337|NCT01118715|19246589|P1|COMPLETED|Overall Study||68
7818338|NCT01118715|19246588|P2|STARTED|Overall Study||60
7818339|NCT01118715|19246589|P1|STARTED|Overall Study||68
7818340|NCT01118663|19246618|P2|NOT COMPLETED|Overall Study||2
7818341|NCT01118663|19246619|P1|NOT COMPLETED|Overall Study||2
7818342|NCT01118663|19246618|P2|COMPLETED|Overall Study||8
7818343|NCT01118663|19246619|P1|COMPLETED|Overall Study||5
7818344|NCT01118663|19246618|P2|STARTED|Overall Study||10
7818345|NCT01118663|19246619|P1|STARTED|Overall Study||7
7818346|NCT01118624|19246633|P1|NOT COMPLETED|Overall Study||22
7818347|NCT01118624|19246633|P1|COMPLETED|Overall Study||0
7818348|NCT01118624|19246633|P1|STARTED|Overall Study||22
7818349|NCT01118455|19246642|P2|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
7818350|NCT01118455|19246643|P1|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
7818351|NCT01118455|19246642|P2|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69
7818352|NCT01118455|19246643|P1|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65
7818353|NCT01118455|19246642|P2|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69
7818354|NCT01118455|19246643|P1|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65
7818355|NCT01118455|19246642|P2|NOT COMPLETED|Baseline [Visits 1 & 2]||0
7818356|NCT01118455|19246643|P1|NOT COMPLETED|Baseline [Visits 1 & 2]||1
7818357|NCT01118455|19246642|P2|COMPLETED|Baseline [Visits 1 & 2]||69
7818358|NCT01118455|19246643|P1|COMPLETED|Baseline [Visits 1 & 2]||65
7818359|NCT01118455|19246642|P2|Actual Patients Treated|Baseline [Visits 1 & 2]||69
7818360|NCT01118455|19246643|P1|Actual Patients Treated|Baseline [Visits 1 & 2]||65
7818361|NCT01118455|19246642|P2|STARTED|Baseline [Visits 1 & 2]||69
7818362|NCT01118455|19246643|P1|STARTED|Baseline [Visits 1 & 2]||66
7818363|NCT01118377|19246671|P1|NOT COMPLETED|Overall Study||42
7818364|NCT01118377|19246671|P1|COMPLETED|Overall Study||3
7818365|NCT01118377|19246671|P1|STARTED|Overall Study||45
7818366|NCT01118351|19246677|P1|NOT COMPLETED|Overall Study||4
7818367|NCT01118351|19246677|P1|COMPLETED|Overall Study||15
7818368|NCT01118351|19246677|P1|STARTED|Overall Study||19
7818369|NCT01118338|19246687|P2|NOT COMPLETED|Overall Study||9
7818370|NCT01118338|19246688|P1|NOT COMPLETED|Overall Study||3
7818371|NCT01118338|19246687|P2|COMPLETED|Overall Study||174
7818372|NCT01118338|19246688|P1|COMPLETED|Overall Study||182
7818373|NCT01118338|19246687|P2|STARTED|Overall Study||183
7818374|NCT01118338|19246688|P1|STARTED|Overall Study||185
7818375|NCT01118325|19246701|P3|NOT COMPLETED|Overall Study||1
7818376|NCT01118325|19246702|P2|NOT COMPLETED|Overall Study||0
7818377|NCT01118325|19246703|P1|NOT COMPLETED|Overall Study||1
7818378|NCT01118325|19246701|P3|COMPLETED|Overall Study||45
7818379|NCT01118325|19246702|P2|COMPLETED|Overall Study||43
7818380|NCT01118325|19246703|P1|COMPLETED|Overall Study||49
7818381|NCT01118325|19246701|P3|STARTED|Overall Study||46
7818382|NCT01118325|19246702|P2|STARTED|Overall Study||43
7818383|NCT01118325|19246703|P1|STARTED|Overall Study||50
7818384|NCT01118312|19246749|P2|NOT COMPLETED|Overall Study||35
7818385|NCT01118312|19246750|P1|NOT COMPLETED|Overall Study||34
7818386|NCT01118312|19246749|P2|COMPLETED|Overall Study||164
7818387|NCT01118312|19246750|P1|COMPLETED|Overall Study||155
7818388|NCT01118312|19246749|P2|STARTED|Overall Study||199
7818389|NCT01118312|19246750|P1|STARTED|Overall Study||189
7818390|NCT01118299|19246760|P2|NOT COMPLETED|Overall Study||29
7818391|NCT01118299|19246761|P1|NOT COMPLETED|Overall Study||23
7818392|NCT01118299|19246760|P2|COMPLETED|Overall Study||0
7818393|NCT01118299|19246761|P1|COMPLETED|Overall Study||45
7818394|NCT01118299|19246760|P2|STARTED|Overall Study||29
7818395|NCT01118299|19246761|P1|STARTED|Overall Study||68
7818396|NCT01118273|19246774|P6|NOT COMPLETED|Overall Study||0
7818397|NCT01118273|19246775|P5|NOT COMPLETED|Overall Study||0
7818398|NCT01118273|19246776|P4|NOT COMPLETED|Overall Study||0
7818399|NCT01118273|19246777|P3|NOT COMPLETED|Overall Study||0
7818400|NCT01118273|19246778|P2|NOT COMPLETED|Overall Study||0
7818401|NCT01118273|19246779|P1|NOT COMPLETED|Overall Study||0
7818402|NCT01118273|19246774|P6|COMPLETED|Overall Study||27
7818403|NCT01118273|19246775|P5|COMPLETED|Overall Study||27
7818404|NCT01118273|19246776|P4|COMPLETED|Overall Study||27
7818405|NCT01118273|19246777|P3|COMPLETED|Overall Study||27
7818406|NCT01118273|19246778|P2|COMPLETED|Overall Study||27
7818407|NCT01118273|19246779|P1|COMPLETED|Overall Study||27
7818408|NCT01118273|19246774|P6|STARTED|Overall Study||27
7818409|NCT01118273|19246775|P5|STARTED|Overall Study||27
7818410|NCT01118273|19246776|P4|STARTED|Overall Study||27
7818411|NCT01118273|19246777|P3|STARTED|Overall Study||27
7818412|NCT01118273|19246778|P2|STARTED|Overall Study||27
7818413|NCT01118273|19246779|P1|STARTED|Overall Study||27
7818414|NCT01118221|19246945|P2|NOT COMPLETED|Overall Study||1
7818415|NCT01118221|19246946|P1|NOT COMPLETED|Overall Study||3
7818416|NCT01118221|19246945|P2|COMPLETED|Overall Study||10
7818417|NCT01118221|19246946|P1|COMPLETED|Overall Study||11
7818418|NCT01118221|19246945|P2|STARTED|Overall Study||11
7818419|NCT01118221|19246946|P1|STARTED|Overall Study||14
7818420|NCT01118143|19246958|P2|NOT COMPLETED|Overall Study||5
7818421|NCT01118143|19246959|P1|NOT COMPLETED|Overall Study||2
7818422|NCT01118143|19246958|P2|COMPLETED|Overall Study||64
7818423|NCT01118143|19246959|P1|COMPLETED|Overall Study||62
7818424|NCT01118143|19246958|P2|STARTED|Overall Study||69
7818425|NCT01118143|19246959|P1|STARTED|Overall Study||64
7818426|NCT01118117|19246969|P2|NOT COMPLETED|Overall Study||0
7818427|NCT01118117|19246970|P1|NOT COMPLETED|Overall Study||21
7818428|NCT01118117|19246969|P2|COMPLETED|Overall Study||15
7818429|NCT01118117|19246970|P1|COMPLETED|Overall Study||240
7818430|NCT01118117|19246969|P2|STARTED|Overall Study||15
7818431|NCT01118117|19246970|P1|STARTED|Overall Study||261
7818432|NCT01118091|19246991|P2|NOT COMPLETED|Overall Study||0
7818433|NCT01118091|19246992|P1|NOT COMPLETED|Overall Study||0
7818434|NCT01118091|19246991|P2|COMPLETED|Overall Study||5
7818435|NCT01118091|19246992|P1|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7
7818436|NCT01118091|19246991|P2|STARTED|Overall Study||5
7818437|NCT01118091|19246992|P1|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7
7818438|NCT01118052|19247002|P1|NOT COMPLETED|Overall Study||2
7818439|NCT01118052|19247002|P1|COMPLETED|Overall Study||20
7818440|NCT01118052|19247002|P1|STARTED|Overall Study||22
7818441|NCT01118013|19247015|P1|NOT COMPLETED|Overall Study||0
7818442|NCT01118013|19247015|P1|COMPLETED|Overall Study||6
7818443|NCT01118013|19247015|P1|STARTED|Overall Study||6
7818444|NCT01117987|19247025|P2|NOT COMPLETED|Overall Study||74
7818445|NCT01117987|19247026|P1|NOT COMPLETED|Overall Study||61
7818446|NCT01117987|19247025|P2|COMPLETED|Overall Study||4
7818447|NCT01117987|19247026|P1|COMPLETED|Overall Study||5
7818448|NCT01117987|19247025|P2|STARTED|Overall Study||78
7818449|NCT01117987|19247026|P1|STARTED|Overall Study||66
7818450|NCT01117948|19247038|P2|NOT COMPLETED|Open Label||47
7818451|NCT01117948|19247039|P1|NOT COMPLETED|Open Label||52
7818452|NCT01117948|19247038|P2|COMPLETED|Open Label||51
7818453|NCT01117948|19247039|P1|COMPLETED|Open Label||41
7818454|NCT01117948|19247038|P2|STARTED|Open Label||98
7818455|NCT01117948|19247039|P1|STARTED|Open Label||93
7818456|NCT01117948|19247038|P2|NOT COMPLETED|Double Blind||10
7818457|NCT01117948|19247039|P1|NOT COMPLETED|Double Blind||18
7818458|NCT01117948|19247038|P2|COMPLETED|Double Blind||98
7818459|NCT01117948|19247039|P1|COMPLETED|Double Blind||93
7818460|NCT01117948|19247038|P2|STARTED|Double Blind||108
7818461|NCT01117948|19247039|P1|STARTED|Double Blind||111
7818462|NCT01117870|19247047|P2|NOT COMPLETED|Overall Study||0
7818463|NCT01117870|19247048|P1|NOT COMPLETED|Overall Study||1
7818464|NCT01117870|19247047|P2|COMPLETED|Overall Study||16
7818465|NCT01117870|19247048|P1|COMPLETED|Overall Study|One did not receive the allocated intervention; (degenerate spine/inability to place needle).|14
7818466|NCT01117870|19247047|P2|STARTED|Overall Study||16
7818467|NCT01117870|19247048|P1|STARTED|Overall Study||15
7818468|NCT01117857|19247062|P1|NOT COMPLETED|Overall Study||9
7818469|NCT01117857|19247062|P1|COMPLETED|Overall Study||13
7818470|NCT01117857|19247062|P1|STARTED|Overall Study||22
7818471|NCT01117766|19247070|P2|NOT COMPLETED|Second Intervention||5
7818472|NCT01117766|19247071|P1|NOT COMPLETED|Second Intervention||2
7818473|NCT01117766|19247070|P2|COMPLETED|Second Intervention||9
7818474|NCT01117766|19247071|P1|COMPLETED|Second Intervention||11
7818475|NCT01117766|19247070|P2|STARTED|Second Intervention||14
7818476|NCT01117766|19247071|P1|STARTED|Second Intervention||13
7818477|NCT01117766|19247070|P2|NOT COMPLETED|Washout Period||2
7818478|NCT01117766|19247071|P1|NOT COMPLETED|Washout Period||0
7818479|NCT01117766|19247070|P2|COMPLETED|Washout Period||14
7818480|NCT01117766|19247071|P1|COMPLETED|Washout Period||13
7818481|NCT01117766|19247070|P2|STARTED|Washout Period||16
7818482|NCT01117766|19247071|P1|STARTED|Washout Period||13
7818483|NCT01117766|19247070|P2|NOT COMPLETED|First Intervention||1
7818484|NCT01117766|19247071|P1|NOT COMPLETED|First Intervention||1
7818485|NCT01117766|19247070|P2|COMPLETED|First Intervention||16
7818486|NCT01117766|19247071|P1|COMPLETED|First Intervention||13
7818487|NCT01117766|19247070|P2|Received Treatment|First Intervention||17
7818488|NCT01117766|19247071|P1|Received Treatment|First Intervention||14
7818489|NCT01117766|19247070|P2|STARTED|First Intervention||17
7818490|NCT01117766|19247071|P1|STARTED|First Intervention||14
7818491|NCT01117727|19247095|P1|NOT COMPLETED|Overall Study||0
7818492|NCT01117727|19247095|P1|COMPLETED|Overall Study||1
7818493|NCT01117727|19247095|P1|STARTED|Overall Study||1
7818494|NCT01117623|19247108|P8|NOT COMPLETED|Overall Study||26
7818495|NCT01117623|19247109|P7|NOT COMPLETED|Overall Study||6
7818496|NCT01117623|19247110|P6|NOT COMPLETED|Overall Study||16
7818497|NCT01117623|19247111|P5|NOT COMPLETED|Overall Study||10
7818498|NCT01117623|19247112|P4|NOT COMPLETED|Overall Study||6
7818499|NCT01117623|19247113|P3|NOT COMPLETED|Overall Study||11
7818500|NCT01117623|19247114|P2|NOT COMPLETED|Overall Study||8
7818501|NCT01117623|19247115|P1|NOT COMPLETED|Overall Study||3
7818502|NCT01117623|19247108|P8|COMPLETED|Overall Study||0
7818503|NCT01117623|19247109|P7|COMPLETED|Overall Study||0
7818504|NCT01117623|19247110|P6|COMPLETED|Overall Study||0
7818505|NCT01117623|19247111|P5|COMPLETED|Overall Study||0
7818506|NCT01117623|19247112|P4|COMPLETED|Overall Study||0
7818507|NCT01117623|19247113|P3|COMPLETED|Overall Study||0
7818508|NCT01117623|19247114|P2|COMPLETED|Overall Study||0
7818509|NCT01117623|19247115|P1|COMPLETED|Overall Study||0
7818510|NCT01117623|19247108|P8|PK Population|Overall Study||24
7818511|NCT01117623|19247109|P7|PK Population|Overall Study||6
7818512|NCT01117623|19247110|P6|PK Population|Overall Study||14
7818513|NCT01117623|19247111|P5|PK Population|Overall Study||10
7818514|NCT01117623|19247112|P4|PK Population|Overall Study||6
7818515|NCT01117623|19247113|P3|PK Population|Overall Study||10
7818516|NCT01117623|19247114|P2|PK Population|Overall Study||8
7818517|NCT01117623|19247115|P1|PK Population|Overall Study||3
7818518|NCT01117623|19247108|P8|ITT Efficacy Analysis Population|Overall Study||22
7818519|NCT01117623|19247109|P7|ITT Efficacy Analysis Population|Overall Study||6
7818520|NCT01117623|19247110|P6|ITT Efficacy Analysis Population|Overall Study||16
7818521|NCT01117623|19247111|P5|ITT Efficacy Analysis Population|Overall Study||10
7818522|NCT01117623|19247112|P4|ITT Efficacy Analysis Population|Overall Study||5
7818523|NCT01117623|19247113|P3|ITT Efficacy Analysis Population|Overall Study||11
7818524|NCT01117623|19247114|P2|ITT Efficacy Analysis Population|Overall Study||8
7818525|NCT01117623|19247115|P1|ITT Efficacy Analysis Population|Overall Study||3
7818526|NCT01117623|19247108|P8|STARTED|Overall Study||26
7818527|NCT01117623|19247109|P7|STARTED|Overall Study||6
7818528|NCT01117623|19247110|P6|STARTED|Overall Study||16
7818529|NCT01117623|19247111|P5|STARTED|Overall Study||10
7818530|NCT01117623|19247112|P4|STARTED|Overall Study||6
7818531|NCT01117623|19247113|P3|STARTED|Overall Study||11
7818532|NCT01117623|19247114|P2|STARTED|Overall Study||8
7818533|NCT01117623|19247115|P1|STARTED|Overall Study||3
7818534|NCT01117480|19247267|P1|NOT COMPLETED|Overall Study||28
7818535|NCT01117480|19247267|P1|COMPLETED|Overall Study||985
7818536|NCT01117480|19247267|P1|STARTED|Overall Study||1013
7818537|NCT01117454|19247275|P2|NOT COMPLETED|Overall Study||1
7818538|NCT01117454|19247276|P1|NOT COMPLETED|Overall Study||0
7818539|NCT01117454|19247275|P2|COMPLETED|Overall Study||7
7818540|NCT01117454|19247276|P1|COMPLETED|Overall Study||6
7818541|NCT01117454|19247275|P2|STARTED|Overall Study||8
7818542|NCT01117454|19247276|P1|STARTED|Overall Study||6
7818543|NCT01117428|19247288|P6|NOT COMPLETED|Overall Study||20
7818544|NCT01117428|19247289|P5|NOT COMPLETED|Overall Study||17
7818545|NCT01117428|19247290|P4|NOT COMPLETED|Overall Study||12
7818546|NCT01117428|19247291|P3|NOT COMPLETED|Overall Study||13
7818547|NCT01117428|19247292|P2|NOT COMPLETED|Overall Study||29
7818548|NCT01117428|19247293|P1|NOT COMPLETED|Overall Study||20
7818549|NCT01117428|19247288|P6|COMPLETED|Overall Study||0
7818550|NCT01117428|19247289|P5|COMPLETED|Overall Study||0
7818551|NCT01117428|19247290|P4|COMPLETED|Overall Study||0
7818552|NCT01117428|19247291|P3|COMPLETED|Overall Study||0
7818553|NCT01117428|19247292|P2|COMPLETED|Overall Study||0
7818554|NCT01117428|19247293|P1|COMPLETED|Overall Study||0
7818555|NCT01117428|19247288|P6|STARTED|Overall Study||20
7818556|NCT01117428|19247289|P5|STARTED|Overall Study||17
7818557|NCT01117428|19247290|P4|STARTED|Overall Study||12
7818558|NCT01117428|19247291|P3|STARTED|Overall Study||13
7818559|NCT01117428|19247292|P2|STARTED|Overall Study||29
7818560|NCT01117428|19247293|P1|STARTED|Overall Study|"0.4 mg/kg=1
~0.75 mg/kg=1
~1.5 mg/kg=3
~3 mg/kg=3
~6 mg/kg=3
~9 mg/kg=6
~12 mg/kg=3"|20
7818561|NCT01117350|19247327|P2|NOT COMPLETED|Extension Period||63
7818562|NCT01117350|19247328|P1|NOT COMPLETED|Extension Period||0
7818563|NCT01117350|19247327|P2|COMPLETED|Extension Period||147
7818564|NCT01117350|19247328|P1|COMPLETED|Extension Period||0
7818565|NCT01117350|19247327|P2|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154
7818566|NCT01117350|19247328|P1|mITT Population (Extension)|Extension Period||0
7818567|NCT01117350|19247327|P2|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160
7818568|NCT01117350|19247328|P1|TREATED = Safety Population (Extension)|Extension Period||0
7818569|NCT01117350|19247327|P2|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210
7818570|NCT01117350|19247328|P1|STARTED|Extension Period||0
7818571|NCT01117350|19247327|P2|NOT COMPLETED|Comparative Period||75
7818572|NCT01117350|19247328|P1|NOT COMPLETED|Comparative Period||42
7818573|NCT01117350|19247327|P2|COMPLETED|Comparative Period||414
7818574|NCT01117350|19247328|P1|COMPLETED|Comparative Period||447
7818575|NCT01117350|19247327|P2|mITT Population|Comparative Period||470
7818576|NCT01117350|19247328|P1|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474
7818577|NCT01117350|19247327|P2|TREATED = Safety Population|Comparative Period||481
7818578|NCT01117350|19247328|P1|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484
7818579|NCT01117350|19247327|P2|STARTED|Comparative Period||489
7818580|NCT01117350|19247328|P1|STARTED|Comparative Period|STARTED: randomized|489
7818581|NCT01117337|19247360|P2|NOT COMPLETED|Overall Study||0
7818582|NCT01117337|19247361|P1|NOT COMPLETED|Overall Study||4
7818583|NCT01117337|19247360|P2|COMPLETED|Overall Study||52
7818584|NCT01117337|19247361|P1|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48
7818585|NCT01117337|19247360|P2|Underwent Surgery|Overall Study||52
7818586|NCT01117337|19247361|P1|Underwent Surgery|Overall Study|52 patients underwent surgery|52
7818587|NCT01117337|19247360|P2|STARTED|Overall Study||52
7818588|NCT01117337|19247361|P1|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52
7818589|NCT01117311|19247371|P2|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
7818590|NCT01117311|19247372|P1|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
7818591|NCT01117311|19247371|P2|COMPLETED|Second Intervention - Mixed Meal 3||4
7818592|NCT01117311|19247372|P1|COMPLETED|Second Intervention - Mixed Meal 3||3
7818593|NCT01117311|19247371|P2|STARTED|Second Intervention - Mixed Meal 3||4
7818594|NCT01117311|19247372|P1|STARTED|Second Intervention - Mixed Meal 3||3
7818595|NCT01117311|19247371|P2|NOT COMPLETED|First Intervention - Mixed Meal 2||0
7818596|NCT01117311|19247372|P1|NOT COMPLETED|First Intervention - Mixed Meal 2||0
7818597|NCT01117311|19247371|P2|COMPLETED|First Intervention - Mixed Meal 2||4
7818598|NCT01117311|19247372|P1|COMPLETED|First Intervention - Mixed Meal 2||3
7818599|NCT01117311|19247371|P2|STARTED|First Intervention - Mixed Meal 2||4
7818600|NCT01117311|19247372|P1|STARTED|First Intervention - Mixed Meal 2||3
7818601|NCT01117311|19247371|P2|NOT COMPLETED|Lead-in Mixed Meal 1||0
7818602|NCT01117311|19247372|P1|NOT COMPLETED|Lead-in Mixed Meal 1||0
7818603|NCT01117311|19247371|P2|COMPLETED|Lead-in Mixed Meal 1||4
7818604|NCT01117311|19247372|P1|COMPLETED|Lead-in Mixed Meal 1||3
7818605|NCT01117311|19247371|P2|STARTED|Lead-in Mixed Meal 1||4
7818606|NCT01117311|19247372|P1|STARTED|Lead-in Mixed Meal 1||3
7818607|NCT01117181|19247382|P2|NOT COMPLETED|Overall Study||2
7818608|NCT01117181|19247383|P1|NOT COMPLETED|Overall Study||1
7818609|NCT01117181|19247382|P2|COMPLETED|Overall Study||29
7818610|NCT01117181|19247383|P1|COMPLETED|Overall Study||28
7818611|NCT01117181|19247382|P2|STARTED|Overall Study||31
7818612|NCT01117181|19247383|P1|STARTED|Overall Study||29
7818613|NCT01117090|19247403|P1|NOT COMPLETED|Overall Study||0
7818614|NCT01117090|19247403|P1|COMPLETED|Overall Study||47
7818615|NCT01117090|19247403|P1|STARTED|Overall Study||47
7818616|NCT01117051|19247416|P2|NOT COMPLETED|Overall Study||11
7818617|NCT01117051|19247417|P1|NOT COMPLETED|Overall Study||13
7818618|NCT01117051|19247416|P2|COMPLETED|Overall Study||77
7818619|NCT01117051|19247417|P1|COMPLETED|Overall Study||73
7818620|NCT01117051|19247416|P2|STARTED|Overall Study||88
7818621|NCT01117051|19247417|P1|STARTED|Overall Study||86
7818622|NCT01117012|19247427|P2|NOT COMPLETED|Overall Study||5
7818623|NCT01117012|19247428|P1|NOT COMPLETED|Overall Study||8
7818624|NCT01117012|19247427|P2|COMPLETED|Overall Study||98
7818625|NCT01117012|19247428|P1|COMPLETED|Overall Study||81
7818626|NCT01117012|19247427|P2|STARTED|Overall Study||103
7818627|NCT01117012|19247428|P1|STARTED|Overall Study||89
7818628|NCT01116986|19247476|P32|NOT COMPLETED|Overall Study||3
7818629|NCT01116986|19247477|P31|NOT COMPLETED|Overall Study||1
7818630|NCT01116986|19247478|P30|NOT COMPLETED|Overall Study||0
7818631|NCT01116986|19247479|P29|NOT COMPLETED|Overall Study||0
7818632|NCT01116986|19247480|P28|NOT COMPLETED|Overall Study||1
7818633|NCT01116986|19247481|P27|NOT COMPLETED|Overall Study||4
7818634|NCT01116986|19247482|P26|NOT COMPLETED|Overall Study||0
7818635|NCT01116986|19247483|P25|NOT COMPLETED|Overall Study||3
7818636|NCT01116986|19247484|P24|NOT COMPLETED|Overall Study||2
7818637|NCT01116986|19247485|P23|NOT COMPLETED|Overall Study||4
7818638|NCT01116986|19247486|P22|NOT COMPLETED|Overall Study||2
7818639|NCT01116986|19247487|P21|NOT COMPLETED|Overall Study||2
7818640|NCT01116986|19247488|P20|NOT COMPLETED|Overall Study||2
7818641|NCT01116986|19247489|P19|NOT COMPLETED|Overall Study||3
7818642|NCT01116986|19247490|P18|NOT COMPLETED|Overall Study||5
7818643|NCT01116986|19247491|P17|NOT COMPLETED|Overall Study||3
7818644|NCT01116986|19247492|P16|NOT COMPLETED|Overall Study||6
7818645|NCT01116986|19247493|P15|NOT COMPLETED|Overall Study||0
7818646|NCT01116986|19247494|P14|NOT COMPLETED|Overall Study||3
7818647|NCT01116986|19247495|P13|NOT COMPLETED|Overall Study||1
7818648|NCT01116986|19247496|P12|NOT COMPLETED|Overall Study||0
7818649|NCT01116986|19247497|P11|NOT COMPLETED|Overall Study||1
7818650|NCT01116986|19247498|P10|NOT COMPLETED|Overall Study||4
7818651|NCT01116986|19247499|P9|NOT COMPLETED|Overall Study||1
7818652|NCT01116986|19247500|P8|NOT COMPLETED|Overall Study||2
7818653|NCT01116986|19247501|P7|NOT COMPLETED|Overall Study||2
7818654|NCT01116986|19247502|P6|NOT COMPLETED|Overall Study||2
7818655|NCT01116986|19247503|P5|NOT COMPLETED|Overall Study||4
7818656|NCT01116986|19247504|P4|NOT COMPLETED|Overall Study||2
7818657|NCT01116986|19247505|P3|NOT COMPLETED|Overall Study||2
7818658|NCT01116986|19247506|P2|NOT COMPLETED|Overall Study||3
7818659|NCT01116986|19247507|P1|NOT COMPLETED|Overall Study||2
7818660|NCT01116986|19247476|P32|COMPLETED|Overall Study||14
7818661|NCT01116986|19247477|P31|COMPLETED|Overall Study||16
7818662|NCT01116986|19247478|P30|COMPLETED|Overall Study||17
7818663|NCT01116986|19247479|P29|COMPLETED|Overall Study||17
7818664|NCT01116986|19247480|P28|COMPLETED|Overall Study||18
7818665|NCT01116986|19247481|P27|COMPLETED|Overall Study||14
7818666|NCT01116986|19247482|P26|COMPLETED|Overall Study||19
7818667|NCT01116986|19247483|P25|COMPLETED|Overall Study||15
7818668|NCT01116986|19247484|P24|COMPLETED|Overall Study||19
7818669|NCT01116986|19247485|P23|COMPLETED|Overall Study||19
7818670|NCT01116986|19247486|P22|COMPLETED|Overall Study||18
7818671|NCT01116986|19247487|P21|COMPLETED|Overall Study||22
7818672|NCT01116986|19247488|P20|COMPLETED|Overall Study||13
7818673|NCT01116986|19247489|P19|COMPLETED|Overall Study||20
7818674|NCT01116986|19247490|P18|COMPLETED|Overall Study||19
7818675|NCT01116986|19247491|P17|COMPLETED|Overall Study||13
7818676|NCT01116986|19247492|P16|COMPLETED|Overall Study||15
7818677|NCT01116986|19247493|P15|COMPLETED|Overall Study||17
7818678|NCT01116986|19247494|P14|COMPLETED|Overall Study||16
7818679|NCT01116986|19247495|P13|COMPLETED|Overall Study||16
7818680|NCT01116986|19247496|P12|COMPLETED|Overall Study||20
7818681|NCT01116986|19247497|P11|COMPLETED|Overall Study||18
7818682|NCT01116986|19247498|P10|COMPLETED|Overall Study||19
7818683|NCT01116986|19247499|P9|COMPLETED|Overall Study||19
7818684|NCT01116986|19247500|P8|COMPLETED|Overall Study||20
7818685|NCT01116986|19247501|P7|COMPLETED|Overall Study||20
7818686|NCT01116986|19247502|P6|COMPLETED|Overall Study||20
7818687|NCT01116986|19247503|P5|COMPLETED|Overall Study||20
7818688|NCT01116986|19247504|P4|COMPLETED|Overall Study||20
7818689|NCT01116986|19247505|P3|COMPLETED|Overall Study||16
7818690|NCT01116986|19247506|P2|COMPLETED|Overall Study||16
7818691|NCT01116986|19247507|P1|COMPLETED|Overall Study||22
7818692|NCT01116986|19247476|P32|STARTED|Overall Study||17
7818693|NCT01116986|19247477|P31|STARTED|Overall Study||17
7818694|NCT01116986|19247478|P30|STARTED|Overall Study||17
7818695|NCT01116986|19247479|P29|STARTED|Overall Study||17
7818696|NCT01116986|19247480|P28|STARTED|Overall Study||19
7818697|NCT01116986|19247481|P27|STARTED|Overall Study||18
7818698|NCT01116986|19247482|P26|STARTED|Overall Study||19
7818699|NCT01116986|19247483|P25|STARTED|Overall Study||18
7818700|NCT01116986|19247484|P24|STARTED|Overall Study||21
7818701|NCT01116986|19247485|P23|STARTED|Overall Study||23
7818702|NCT01116986|19247486|P22|STARTED|Overall Study||20
7818703|NCT01116986|19247487|P21|STARTED|Overall Study||24
7818704|NCT01116986|19247488|P20|STARTED|Overall Study||15
7818705|NCT01116986|19247489|P19|STARTED|Overall Study||23
7818706|NCT01116986|19247490|P18|STARTED|Overall Study||24
7818707|NCT01116986|19247491|P17|STARTED|Overall Study||16
7818708|NCT01116986|19247492|P16|STARTED|Overall Study||21
7818709|NCT01116986|19247493|P15|STARTED|Overall Study||17
7818710|NCT01116986|19247494|P14|STARTED|Overall Study||19
7818711|NCT01116986|19247495|P13|STARTED|Overall Study||17
7818712|NCT01116986|19247496|P12|STARTED|Overall Study||20
7818713|NCT01116986|19247497|P11|STARTED|Overall Study||19
7818714|NCT01116986|19247498|P10|STARTED|Overall Study||23
7818715|NCT01116986|19247499|P9|STARTED|Overall Study||20
7818716|NCT01116986|19247500|P8|STARTED|Overall Study||22
7818717|NCT01116986|19247501|P7|STARTED|Overall Study||22
7818718|NCT01116986|19247502|P6|STARTED|Overall Study||22
7818719|NCT01116986|19247503|P5|STARTED|Overall Study||24
7818720|NCT01116986|19247504|P4|STARTED|Overall Study||22
7818721|NCT01116986|19247505|P3|STARTED|Overall Study||18
7818722|NCT01116986|19247506|P2|STARTED|Overall Study||19
7818723|NCT01116986|19247507|P1|STARTED|Overall Study||24
7818724|NCT01116934|19247541|P2|NOT COMPLETED|Overall Study||0
7818725|NCT01116934|19247542|P1|NOT COMPLETED|Overall Study||0
7818726|NCT01116934|19247541|P2|COMPLETED|Overall Study||9
7818727|NCT01116934|19247542|P1|COMPLETED|Overall Study||8
7818728|NCT01116934|19247541|P2|STARTED|Overall Study||9
7818729|NCT01116934|19247542|P1|STARTED|Overall Study||8
7818730|NCT01116921|19247550|P2|NOT COMPLETED|Overall Study||0
7818731|NCT01116921|19247551|P1|NOT COMPLETED|Overall Study||0
7818732|NCT01116921|19247550|P2|COMPLETED|Overall Study||50
7818733|NCT01116921|19247551|P1|COMPLETED|Overall Study||53
7818734|NCT01116921|19247550|P2|STARTED|Overall Study||50
7818735|NCT01116921|19247551|P1|STARTED|Overall Study||53
7818736|NCT01116895|19247571|P4|NOT COMPLETED|Overall Study||3
7818737|NCT01116895|19247572|P3|NOT COMPLETED|Overall Study||4
7818738|NCT01116895|19247573|P2|NOT COMPLETED|Overall Study||7
7818739|NCT01116895|19247574|P1|NOT COMPLETED|Overall Study||4
7818740|NCT01116895|19247571|P4|COMPLETED|Overall Study||11
7818741|NCT01116895|19247572|P3|COMPLETED|Overall Study||14
7818742|NCT01116895|19247573|P2|COMPLETED|Overall Study||8
7818743|NCT01116895|19247574|P1|COMPLETED|Overall Study||12
7818744|NCT01116895|19247571|P4|STARTED|Overall Study||14
7818745|NCT01116895|19247572|P3|STARTED|Overall Study||18
7818746|NCT01116895|19247573|P2|STARTED|Overall Study||15
7818747|NCT01116895|19247574|P1|STARTED|Overall Study||16
7818748|NCT01116882|19247602|P2|NOT COMPLETED|12-month||99
7818749|NCT01116882|19247603|P1|NOT COMPLETED|12-month||267
7818750|NCT01116882|19247602|P2|COMPLETED|12-month||787
7818751|NCT01116882|19247603|P1|COMPLETED|12-month||2439
7818752|NCT01116882|19247602|P2|STARTED|12-month||886
7818753|NCT01116882|19247603|P1|STARTED|12-month||2706
7818754|NCT01116882|19247602|P2|NOT COMPLETED|30-day||31
7818755|NCT01116882|19247603|P1|NOT COMPLETED|30-day||68
7818756|NCT01116882|19247602|P2|COMPLETED|30-day||886
7818757|NCT01116882|19247603|P1|COMPLETED|30-day||2706
7818758|NCT01116882|19247602|P2|STARTED|30-day||917
7818759|NCT01116882|19247603|P1|STARTED|30-day||2774
7818760|NCT01116687|19247641|P1|NOT COMPLETED|Overall Study||4
7818761|NCT01116687|19247641|P1|COMPLETED|Overall Study||33
7818762|NCT01116687|19247641|P1|STARTED|Overall Study||37
7818763|NCT01116661|19247648|P1|NOT COMPLETED|Overall Study||2
7818764|NCT01116661|19247648|P1|COMPLETED|Overall Study||197
7818765|NCT01116661|19247648|P1|STARTED|Overall Study||199
7818766|NCT01116648|19247668|P15|NOT COMPLETED|Phase 1-T PKCed Expansion||0
7818767|NCT01116648|19247669|P14|NOT COMPLETED|Phase 1-T PKCed Expansion||0
7818768|NCT01116648|19247670|P13|NOT COMPLETED|Phase 1-T PKCed Expansion||0
7818769|NCT01116648|19247671|P12|NOT COMPLETED|Phase 1-T PKCed Expansion||0
7818770|NCT01116648|19247672|P11|NOT COMPLETED|Phase 1-T PKCed Expansion||0
7818771|NCT01116648|19247673|P10|NOT COMPLETED|Phase 1-T PKCed Expansion||0
7818772|NCT01116648|19247674|P9|NOT COMPLETED|Phase 1-T PKCed Expansion||0
7818773|NCT01116648|19247675|P8|NOT COMPLETED|Phase 1-T PKCed Expansion||0
7818774|NCT01116648|19247676|P7|NOT COMPLETED|Phase 1-T PKCed Expansion||0
7818775|NCT01116648|19247677|P6|NOT COMPLETED|Phase 1-T PKCed Expansion||0
7818776|NCT01116648|19247678|P5|NOT COMPLETED|Phase 1-T PKCed Expansion||0
7818777|NCT01116648|19247679|P4|NOT COMPLETED|Phase 1-T PKCed Expansion||0
7818778|NCT01116648|19247680|P3|NOT COMPLETED|Phase 1-T PKCed Expansion||0
7818779|NCT01116648|19247681|P2|NOT COMPLETED|Phase 1-T PKCed Expansion||0
7818780|NCT01116648|19247682|P1|NOT COMPLETED|Phase 1-T PKCed Expansion||0
7818781|NCT01116648|19247668|P15|COMPLETED|Phase 1-T PKCed Expansion||7
7818782|NCT01116648|19247669|P14|COMPLETED|Phase 1-T PKCed Expansion||0
7818783|NCT01116648|19247670|P13|COMPLETED|Phase 1-T PKCed Expansion||0
7818784|NCT01116648|19247671|P12|COMPLETED|Phase 1-T PKCed Expansion||0
7818785|NCT01116648|19247672|P11|COMPLETED|Phase 1-T PKCed Expansion||0
7818786|NCT01116648|19247673|P10|COMPLETED|Phase 1-T PKCed Expansion||0
7818787|NCT01116648|19247674|P9|COMPLETED|Phase 1-T PKCed Expansion||0
7818788|NCT01116648|19247675|P8|COMPLETED|Phase 1-T PKCed Expansion||0
7818789|NCT01116648|19247676|P7|COMPLETED|Phase 1-T PKCed Expansion||0
7818790|NCT01116648|19247677|P6|COMPLETED|Phase 1-T PKCed Expansion||0
7818791|NCT01116648|19247678|P5|COMPLETED|Phase 1-T PKCed Expansion||0
7818792|NCT01116648|19247679|P4|COMPLETED|Phase 1-T PKCed Expansion||0
7818793|NCT01116648|19247680|P3|COMPLETED|Phase 1-T PKCed Expansion||0
7818794|NCT01116648|19247681|P2|COMPLETED|Phase 1-T PKCed Expansion||0
7818795|NCT01116648|19247682|P1|COMPLETED|Phase 1-T PKCed Expansion||0
7818796|NCT01116648|19247668|P15|STARTED|Phase 1-T PKCed Expansion||7
7818797|NCT01116648|19247669|P14|STARTED|Phase 1-T PKCed Expansion||0
7818798|NCT01116648|19247670|P13|STARTED|Phase 1-T PKCed Expansion||0
7818799|NCT01116648|19247671|P12|STARTED|Phase 1-T PKCed Expansion||0
7818800|NCT01116648|19247672|P11|STARTED|Phase 1-T PKCed Expansion||0
7818801|NCT01116648|19247673|P10|STARTED|Phase 1-T PKCed Expansion||0
7818802|NCT01116648|19247674|P9|STARTED|Phase 1-T PKCed Expansion||0
7818803|NCT01116648|19247675|P8|STARTED|Phase 1-T PKCed Expansion||0
7818804|NCT01116648|19247676|P7|STARTED|Phase 1-T PKCed Expansion||0
7818805|NCT01116648|19247677|P6|STARTED|Phase 1-T PKCed Expansion||0
7818806|NCT01116648|19247678|P5|STARTED|Phase 1-T PKCed Expansion||0
7818807|NCT01116648|19247679|P4|STARTED|Phase 1-T PKCed Expansion||0
7818808|NCT01116648|19247680|P3|STARTED|Phase 1-T PKCed Expansion||0
7818809|NCT01116648|19247681|P2|STARTED|Phase 1-T PKCed Expansion||0
7818810|NCT01116648|19247682|P1|STARTED|Phase 1-T PKCed Expansion||0
7818811|NCT01116648|19247668|P15|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
7818812|NCT01116648|19247669|P14|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
7818813|NCT01116648|19247670|P13|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
7818814|NCT01116648|19247671|P12|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
7818815|NCT01116648|19247672|P11|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
7818816|NCT01116648|19247673|P10|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
7818817|NCT01116648|19247674|P9|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
7818818|NCT01116648|19247675|P8|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
7818819|NCT01116648|19247676|P7|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
7818820|NCT01116648|19247677|P6|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
7818821|NCT01116648|19247678|P5|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
7818822|NCT01116648|19247679|P4|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
7818823|NCT01116648|19247680|P3|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
7818824|NCT01116648|19247681|P2|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
7818825|NCT01116648|19247682|P1|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
7818826|NCT01116648|19247668|P15|COMPLETED|Phase 1-T PKOlap Expansion||0
7818827|NCT01116648|19247669|P14|COMPLETED|Phase 1-T PKOlap Expansion||6
7818828|NCT01116648|19247670|P13|COMPLETED|Phase 1-T PKOlap Expansion||0
7818829|NCT01116648|19247671|P12|COMPLETED|Phase 1-T PKOlap Expansion||0
7818830|NCT01116648|19247672|P11|COMPLETED|Phase 1-T PKOlap Expansion||0
7818831|NCT01116648|19247673|P10|COMPLETED|Phase 1-T PKOlap Expansion||0
7818832|NCT01116648|19247674|P9|COMPLETED|Phase 1-T PKOlap Expansion||0
7818833|NCT01116648|19247675|P8|COMPLETED|Phase 1-T PKOlap Expansion||0
7818834|NCT01116648|19247676|P7|COMPLETED|Phase 1-T PKOlap Expansion||0
7818835|NCT01116648|19247677|P6|COMPLETED|Phase 1-T PKOlap Expansion||0
7818836|NCT01116648|19247678|P5|COMPLETED|Phase 1-T PKOlap Expansion||0
7818837|NCT01116648|19247679|P4|COMPLETED|Phase 1-T PKOlap Expansion||0
7818838|NCT01116648|19247680|P3|COMPLETED|Phase 1-T PKOlap Expansion||0
7818839|NCT01116648|19247681|P2|COMPLETED|Phase 1-T PKOlap Expansion||0
7818840|NCT01116648|19247682|P1|COMPLETED|Phase 1-T PKOlap Expansion||0
7818841|NCT01116648|19247668|P15|STARTED|Phase 1-T PKOlap Expansion||0
7818842|NCT01116648|19247669|P14|STARTED|Phase 1-T PKOlap Expansion||6
7818843|NCT01116648|19247670|P13|STARTED|Phase 1-T PKOlap Expansion||0
7818844|NCT01116648|19247671|P12|STARTED|Phase 1-T PKOlap Expansion||0
7818845|NCT01116648|19247672|P11|STARTED|Phase 1-T PKOlap Expansion||0
7818846|NCT01116648|19247673|P10|STARTED|Phase 1-T PKOlap Expansion||0
7818847|NCT01116648|19247674|P9|STARTED|Phase 1-T PKOlap Expansion||0
7818848|NCT01116648|19247675|P8|STARTED|Phase 1-T PKOlap Expansion||0
7818849|NCT01116648|19247676|P7|STARTED|Phase 1-T PKOlap Expansion||0
7818850|NCT01116648|19247677|P6|STARTED|Phase 1-T PKOlap Expansion||0
7818851|NCT01116648|19247678|P5|STARTED|Phase 1-T PKOlap Expansion||0
7818852|NCT01116648|19247679|P4|STARTED|Phase 1-T PKOlap Expansion||0
7818853|NCT01116648|19247680|P3|STARTED|Phase 1-T PKOlap Expansion||0
7818854|NCT01116648|19247681|P2|STARTED|Phase 1-T PKOlap Expansion||0
7818855|NCT01116648|19247682|P1|STARTED|Phase 1-T PKOlap Expansion||0
7818856|NCT01116648|19247668|P15|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
7818857|NCT01116648|19247669|P14|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
7818858|NCT01116648|19247670|P13|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
7818859|NCT01116648|19247671|P12|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
7818860|NCT01116648|19247672|P11|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
7818861|NCT01116648|19247673|P10|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
7818862|NCT01116648|19247674|P9|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
7818863|NCT01116648|19247675|P8|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
7818864|NCT01116648|19247676|P7|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
7818865|NCT01116648|19247677|P6|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
7818866|NCT01116648|19247678|P5|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
7818867|NCT01116648|19247679|P4|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
7818868|NCT01116648|19247680|P3|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
7818869|NCT01116648|19247681|P2|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
7818870|NCT01116648|19247682|P1|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
7818871|NCT01116648|19247668|P15|COMPLETED|Phase 1-T Dose Level 2-TB||0
7818872|NCT01116648|19247669|P14|COMPLETED|Phase 1-T Dose Level 2-TB||0
7818873|NCT01116648|19247670|P13|COMPLETED|Phase 1-T Dose Level 2-TB||6
7818874|NCT01116648|19247671|P12|COMPLETED|Phase 1-T Dose Level 2-TB||0
7818875|NCT01116648|19247672|P11|COMPLETED|Phase 1-T Dose Level 2-TB||0
7818876|NCT01116648|19247673|P10|COMPLETED|Phase 1-T Dose Level 2-TB||0
7818877|NCT01116648|19247674|P9|COMPLETED|Phase 1-T Dose Level 2-TB||0
7818878|NCT01116648|19247675|P8|COMPLETED|Phase 1-T Dose Level 2-TB||0
7818879|NCT01116648|19247676|P7|COMPLETED|Phase 1-T Dose Level 2-TB||0
7818880|NCT01116648|19247677|P6|COMPLETED|Phase 1-T Dose Level 2-TB||0
7818881|NCT01116648|19247678|P5|COMPLETED|Phase 1-T Dose Level 2-TB||0
7818882|NCT01116648|19247679|P4|COMPLETED|Phase 1-T Dose Level 2-TB||0
7818883|NCT01116648|19247680|P3|COMPLETED|Phase 1-T Dose Level 2-TB||0
7818884|NCT01116648|19247681|P2|COMPLETED|Phase 1-T Dose Level 2-TB||0
7818885|NCT01116648|19247682|P1|COMPLETED|Phase 1-T Dose Level 2-TB||0
7818886|NCT01116648|19247668|P15|STARTED|Phase 1-T Dose Level 2-TB||0
7818887|NCT01116648|19247669|P14|STARTED|Phase 1-T Dose Level 2-TB||0
7818888|NCT01116648|19247670|P13|STARTED|Phase 1-T Dose Level 2-TB||6
7818889|NCT01116648|19247671|P12|STARTED|Phase 1-T Dose Level 2-TB||0
7818890|NCT01116648|19247672|P11|STARTED|Phase 1-T Dose Level 2-TB||0
7818891|NCT01116648|19247673|P10|STARTED|Phase 1-T Dose Level 2-TB||0
7818892|NCT01116648|19247674|P9|STARTED|Phase 1-T Dose Level 2-TB||0
7818893|NCT01116648|19247675|P8|STARTED|Phase 1-T Dose Level 2-TB||0
7818894|NCT01116648|19247676|P7|STARTED|Phase 1-T Dose Level 2-TB||0
7818895|NCT01116648|19247677|P6|STARTED|Phase 1-T Dose Level 2-TB||0
7818896|NCT01116648|19247678|P5|STARTED|Phase 1-T Dose Level 2-TB||0
7818897|NCT01116648|19247679|P4|STARTED|Phase 1-T Dose Level 2-TB||0
7818898|NCT01116648|19247680|P3|STARTED|Phase 1-T Dose Level 2-TB||0
7818899|NCT01116648|19247681|P2|STARTED|Phase 1-T Dose Level 2-TB||0
7818900|NCT01116648|19247682|P1|STARTED|Phase 1-T Dose Level 2-TB||0
7818901|NCT01116648|19247668|P15|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
7818902|NCT01116648|19247669|P14|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
7818903|NCT01116648|19247670|P13|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
7818904|NCT01116648|19247671|P12|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
7818905|NCT01116648|19247672|P11|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
7818906|NCT01116648|19247673|P10|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
7818907|NCT01116648|19247674|P9|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
7818908|NCT01116648|19247675|P8|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
7818909|NCT01116648|19247676|P7|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
7818910|NCT01116648|19247677|P6|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
7818911|NCT01116648|19247678|P5|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
7818912|NCT01116648|19247679|P4|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
7818913|NCT01116648|19247680|P3|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
7818914|NCT01116648|19247681|P2|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
7818915|NCT01116648|19247682|P1|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
7818916|NCT01116648|19247668|P15|COMPLETED|Phase 1-T Dose Level 1-TB||0
7818917|NCT01116648|19247669|P14|COMPLETED|Phase 1-T Dose Level 1-TB||0
7818918|NCT01116648|19247670|P13|COMPLETED|Phase 1-T Dose Level 1-TB||0
7818919|NCT01116648|19247671|P12|COMPLETED|Phase 1-T Dose Level 1-TB||3
7818920|NCT01116648|19247672|P11|COMPLETED|Phase 1-T Dose Level 1-TB||0
7818921|NCT01116648|19247673|P10|COMPLETED|Phase 1-T Dose Level 1-TB||0
7818922|NCT01116648|19247674|P9|COMPLETED|Phase 1-T Dose Level 1-TB||0
7818923|NCT01116648|19247675|P8|COMPLETED|Phase 1-T Dose Level 1-TB||0
7818924|NCT01116648|19247676|P7|COMPLETED|Phase 1-T Dose Level 1-TB||0
7818925|NCT01116648|19247677|P6|COMPLETED|Phase 1-T Dose Level 1-TB||0
7818926|NCT01116648|19247678|P5|COMPLETED|Phase 1-T Dose Level 1-TB||0
7818927|NCT01116648|19247679|P4|COMPLETED|Phase 1-T Dose Level 1-TB||0
7818928|NCT01116648|19247680|P3|COMPLETED|Phase 1-T Dose Level 1-TB||0
7818929|NCT01116648|19247681|P2|COMPLETED|Phase 1-T Dose Level 1-TB||0
7818930|NCT01116648|19247682|P1|COMPLETED|Phase 1-T Dose Level 1-TB||0
7818931|NCT01116648|19247668|P15|STARTED|Phase 1-T Dose Level 1-TB||0
7818932|NCT01116648|19247669|P14|STARTED|Phase 1-T Dose Level 1-TB||0
7818933|NCT01116648|19247670|P13|STARTED|Phase 1-T Dose Level 1-TB||0
7818934|NCT01116648|19247671|P12|STARTED|Phase 1-T Dose Level 1-TB||3
7818935|NCT01116648|19247672|P11|STARTED|Phase 1-T Dose Level 1-TB||0
7818936|NCT01116648|19247673|P10|STARTED|Phase 1-T Dose Level 1-TB||0
7818937|NCT01116648|19247674|P9|STARTED|Phase 1-T Dose Level 1-TB||0
7818938|NCT01116648|19247675|P8|STARTED|Phase 1-T Dose Level 1-TB||0
7818939|NCT01116648|19247676|P7|STARTED|Phase 1-T Dose Level 1-TB||0
7818940|NCT01116648|19247677|P6|STARTED|Phase 1-T Dose Level 1-TB||0
7818941|NCT01116648|19247678|P5|STARTED|Phase 1-T Dose Level 1-TB||0
7818942|NCT01116648|19247679|P4|STARTED|Phase 1-T Dose Level 1-TB||0
7818943|NCT01116648|19247680|P3|STARTED|Phase 1-T Dose Level 1-TB||0
7818944|NCT01116648|19247681|P2|STARTED|Phase 1-T Dose Level 1-TB||0
7818945|NCT01116648|19247682|P1|STARTED|Phase 1-T Dose Level 1-TB||0
7818946|NCT01116648|19247668|P15|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
7818947|NCT01116648|19247669|P14|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
7818948|NCT01116648|19247670|P13|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
7818949|NCT01116648|19247671|P12|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
7818950|NCT01116648|19247672|P11|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
7818951|NCT01116648|19247673|P10|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
7818952|NCT01116648|19247674|P9|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
7818953|NCT01116648|19247675|P8|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
7818954|NCT01116648|19247676|P7|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
7818955|NCT01116648|19247677|P6|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
7818956|NCT01116648|19247678|P5|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
7818957|NCT01116648|19247679|P4|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
7818958|NCT01116648|19247680|P3|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
7818959|NCT01116648|19247681|P2|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
7818960|NCT01116648|19247682|P1|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
7818961|NCT01116648|19247668|P15|COMPLETED|Phase 1-T Dose Level 0-TB||0
7818962|NCT01116648|19247669|P14|COMPLETED|Phase 1-T Dose Level 0-TB||0
7818963|NCT01116648|19247670|P13|COMPLETED|Phase 1-T Dose Level 0-TB||0
7818964|NCT01116648|19247671|P12|COMPLETED|Phase 1-T Dose Level 0-TB||0
7818965|NCT01116648|19247672|P11|COMPLETED|Phase 1-T Dose Level 0-TB||3
7818966|NCT01116648|19247673|P10|COMPLETED|Phase 1-T Dose Level 0-TB||0
7818967|NCT01116648|19247674|P9|COMPLETED|Phase 1-T Dose Level 0-TB||0
7818968|NCT01116648|19247675|P8|COMPLETED|Phase 1-T Dose Level 0-TB||0
7818969|NCT01116648|19247676|P7|COMPLETED|Phase 1-T Dose Level 0-TB||0
7818970|NCT01116648|19247677|P6|COMPLETED|Phase 1-T Dose Level 0-TB||0
7818971|NCT01116648|19247678|P5|COMPLETED|Phase 1-T Dose Level 0-TB||0
7818972|NCT01116648|19247679|P4|COMPLETED|Phase 1-T Dose Level 0-TB||0
7818973|NCT01116648|19247680|P3|COMPLETED|Phase 1-T Dose Level 0-TB||0
7818974|NCT01116648|19247681|P2|COMPLETED|Phase 1-T Dose Level 0-TB||0
7818975|NCT01116648|19247682|P1|COMPLETED|Phase 1-T Dose Level 0-TB||0
7818976|NCT01116648|19247668|P15|STARTED|Phase 1-T Dose Level 0-TB||0
7818977|NCT01116648|19247669|P14|STARTED|Phase 1-T Dose Level 0-TB||0
7818978|NCT01116648|19247670|P13|STARTED|Phase 1-T Dose Level 0-TB||0
7818979|NCT01116648|19247671|P12|STARTED|Phase 1-T Dose Level 0-TB||0
7818980|NCT01116648|19247672|P11|STARTED|Phase 1-T Dose Level 0-TB||3
7818981|NCT01116648|19247673|P10|STARTED|Phase 1-T Dose Level 0-TB||0
7818982|NCT01116648|19247674|P9|STARTED|Phase 1-T Dose Level 0-TB||0
7818983|NCT01116648|19247675|P8|STARTED|Phase 1-T Dose Level 0-TB||0
7818984|NCT01116648|19247676|P7|STARTED|Phase 1-T Dose Level 0-TB||0
7818985|NCT01116648|19247677|P6|STARTED|Phase 1-T Dose Level 0-TB||0
7818986|NCT01116648|19247678|P5|STARTED|Phase 1-T Dose Level 0-TB||0
7818987|NCT01116648|19247679|P4|STARTED|Phase 1-T Dose Level 0-TB||0
7818988|NCT01116648|19247680|P3|STARTED|Phase 1-T Dose Level 0-TB||0
7818989|NCT01116648|19247681|P2|STARTED|Phase 1-T Dose Level 0-TB||0
7818990|NCT01116648|19247682|P1|STARTED|Phase 1-T Dose Level 0-TB||0
7818991|NCT01116648|19247668|P15|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
7818992|NCT01116648|19247669|P14|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
7818993|NCT01116648|19247670|P13|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
7818994|NCT01116648|19247671|P12|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
7818995|NCT01116648|19247672|P11|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
7818996|NCT01116648|19247673|P10|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
7818997|NCT01116648|19247674|P9|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
7818998|NCT01116648|19247675|P8|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
7818999|NCT01116648|19247676|P7|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
7819000|NCT01116648|19247677|P6|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
7819001|NCT01116648|19247678|P5|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
7819002|NCT01116648|19247679|P4|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
7819003|NCT01116648|19247680|P3|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
7819004|NCT01116648|19247681|P2|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
7819005|NCT01116648|19247682|P1|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
7819006|NCT01116648|19247668|P15|COMPLETED|Phase 1-T Dose Level 2-TA||0
7819007|NCT01116648|19247669|P14|COMPLETED|Phase 1-T Dose Level 2-TA||0
7819008|NCT01116648|19247670|P13|COMPLETED|Phase 1-T Dose Level 2-TA||0
7819009|NCT01116648|19247671|P12|COMPLETED|Phase 1-T Dose Level 2-TA||0
7819010|NCT01116648|19247672|P11|COMPLETED|Phase 1-T Dose Level 2-TA||0
7819011|NCT01116648|19247673|P10|COMPLETED|Phase 1-T Dose Level 2-TA||3
7819012|NCT01116648|19247674|P9|COMPLETED|Phase 1-T Dose Level 2-TA||0
7819013|NCT01116648|19247675|P8|COMPLETED|Phase 1-T Dose Level 2-TA||0
7819014|NCT01116648|19247676|P7|COMPLETED|Phase 1-T Dose Level 2-TA||0
7819015|NCT01116648|19247677|P6|COMPLETED|Phase 1-T Dose Level 2-TA||0
7819016|NCT01116648|19247678|P5|COMPLETED|Phase 1-T Dose Level 2-TA||0
7819017|NCT01116648|19247679|P4|COMPLETED|Phase 1-T Dose Level 2-TA||0
7819018|NCT01116648|19247680|P3|COMPLETED|Phase 1-T Dose Level 2-TA||0
7819019|NCT01116648|19247681|P2|COMPLETED|Phase 1-T Dose Level 2-TA||0
7819020|NCT01116648|19247682|P1|COMPLETED|Phase 1-T Dose Level 2-TA||0
7819021|NCT01116648|19247668|P15|STARTED|Phase 1-T Dose Level 2-TA||0
7819022|NCT01116648|19247669|P14|STARTED|Phase 1-T Dose Level 2-TA||0
7819023|NCT01116648|19247670|P13|STARTED|Phase 1-T Dose Level 2-TA||0
7819024|NCT01116648|19247671|P12|STARTED|Phase 1-T Dose Level 2-TA||0
7819025|NCT01116648|19247672|P11|STARTED|Phase 1-T Dose Level 2-TA||0
7819026|NCT01116648|19247673|P10|STARTED|Phase 1-T Dose Level 2-TA||3
7819027|NCT01116648|19247674|P9|STARTED|Phase 1-T Dose Level 2-TA||0
7819028|NCT01116648|19247675|P8|STARTED|Phase 1-T Dose Level 2-TA||0
7819029|NCT01116648|19247676|P7|STARTED|Phase 1-T Dose Level 2-TA||0
7819030|NCT01116648|19247677|P6|STARTED|Phase 1-T Dose Level 2-TA||0
7819031|NCT01116648|19247678|P5|STARTED|Phase 1-T Dose Level 2-TA||0
7819032|NCT01116648|19247679|P4|STARTED|Phase 1-T Dose Level 2-TA||0
7819033|NCT01116648|19247680|P3|STARTED|Phase 1-T Dose Level 2-TA||0
7819034|NCT01116648|19247681|P2|STARTED|Phase 1-T Dose Level 2-TA||0
7819035|NCT01116648|19247682|P1|STARTED|Phase 1-T Dose Level 2-TA||0
7819036|NCT01116648|19247668|P15|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
7819037|NCT01116648|19247669|P14|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
7819038|NCT01116648|19247670|P13|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
7819039|NCT01116648|19247671|P12|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
7819040|NCT01116648|19247672|P11|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
7819041|NCT01116648|19247673|P10|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
7819042|NCT01116648|19247674|P9|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
7819043|NCT01116648|19247675|P8|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
7819044|NCT01116648|19247676|P7|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
7819045|NCT01116648|19247677|P6|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
7819046|NCT01116648|19247678|P5|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
7819047|NCT01116648|19247679|P4|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
7819048|NCT01116648|19247680|P3|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
7819049|NCT01116648|19247681|P2|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
7819050|NCT01116648|19247682|P1|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
7819051|NCT01116648|19247668|P15|COMPLETED|Phase 1-T Dose Level 1-TA||0
7819052|NCT01116648|19247669|P14|COMPLETED|Phase 1-T Dose Level 1-TA||0
7819053|NCT01116648|19247670|P13|COMPLETED|Phase 1-T Dose Level 1-TA||0
7819054|NCT01116648|19247671|P12|COMPLETED|Phase 1-T Dose Level 1-TA||0
7819055|NCT01116648|19247672|P11|COMPLETED|Phase 1-T Dose Level 1-TA||0
7819056|NCT01116648|19247673|P10|COMPLETED|Phase 1-T Dose Level 1-TA||0
7819057|NCT01116648|19247674|P9|COMPLETED|Phase 1-T Dose Level 1-TA||6
7819058|NCT01116648|19247675|P8|COMPLETED|Phase 1-T Dose Level 1-TA||0
7819059|NCT01116648|19247676|P7|COMPLETED|Phase 1-T Dose Level 1-TA||0
7819060|NCT01116648|19247677|P6|COMPLETED|Phase 1-T Dose Level 1-TA||0
7819061|NCT01116648|19247678|P5|COMPLETED|Phase 1-T Dose Level 1-TA||0
7819062|NCT01116648|19247679|P4|COMPLETED|Phase 1-T Dose Level 1-TA||0
7819063|NCT01116648|19247680|P3|COMPLETED|Phase 1-T Dose Level 1-TA||0
7819064|NCT01116648|19247681|P2|COMPLETED|Phase 1-T Dose Level 1-TA||0
7819065|NCT01116648|19247682|P1|COMPLETED|Phase 1-T Dose Level 1-TA||0
7819066|NCT01116648|19247668|P15|STARTED|Phase 1-T Dose Level 1-TA||0
7819067|NCT01116648|19247669|P14|STARTED|Phase 1-T Dose Level 1-TA||0
7819068|NCT01116648|19247670|P13|STARTED|Phase 1-T Dose Level 1-TA||0
7819069|NCT01116648|19247671|P12|STARTED|Phase 1-T Dose Level 1-TA||0
7819070|NCT01116648|19247672|P11|STARTED|Phase 1-T Dose Level 1-TA||0
7819071|NCT01116648|19247673|P10|STARTED|Phase 1-T Dose Level 1-TA||0
7819072|NCT01116648|19247674|P9|STARTED|Phase 1-T Dose Level 1-TA||6
7819073|NCT01116648|19247675|P8|STARTED|Phase 1-T Dose Level 1-TA||0
7819074|NCT01116648|19247676|P7|STARTED|Phase 1-T Dose Level 1-TA||0
7819075|NCT01116648|19247677|P6|STARTED|Phase 1-T Dose Level 1-TA||0
7819076|NCT01116648|19247678|P5|STARTED|Phase 1-T Dose Level 1-TA||0
7819077|NCT01116648|19247679|P4|STARTED|Phase 1-T Dose Level 1-TA||0
7819078|NCT01116648|19247680|P3|STARTED|Phase 1-T Dose Level 1-TA||0
7819079|NCT01116648|19247681|P2|STARTED|Phase 1-T Dose Level 1-TA||0
7819080|NCT01116648|19247682|P1|STARTED|Phase 1-T Dose Level 1-TA||0
7819081|NCT01116648|19247668|P15|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
7819082|NCT01116648|19247669|P14|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
7819083|NCT01116648|19247670|P13|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
7819084|NCT01116648|19247671|P12|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
7819085|NCT01116648|19247672|P11|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
7819086|NCT01116648|19247673|P10|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
7819087|NCT01116648|19247674|P9|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
7819088|NCT01116648|19247675|P8|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
7819089|NCT01116648|19247676|P7|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
7819090|NCT01116648|19247677|P6|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
7819091|NCT01116648|19247678|P5|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
7819092|NCT01116648|19247679|P4|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
7819093|NCT01116648|19247680|P3|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
7819094|NCT01116648|19247681|P2|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
7819095|NCT01116648|19247682|P1|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
7819096|NCT01116648|19247668|P15|COMPLETED|Phase 1-T Dose Level 0-TA||0
7819097|NCT01116648|19247669|P14|COMPLETED|Phase 1-T Dose Level 0-TA||0
7819098|NCT01116648|19247670|P13|COMPLETED|Phase 1-T Dose Level 0-TA||0
7819099|NCT01116648|19247671|P12|COMPLETED|Phase 1-T Dose Level 0-TA||0
7819100|NCT01116648|19247672|P11|COMPLETED|Phase 1-T Dose Level 0-TA||0
7819101|NCT01116648|19247673|P10|COMPLETED|Phase 1-T Dose Level 0-TA||0
7819102|NCT01116648|19247674|P9|COMPLETED|Phase 1-T Dose Level 0-TA||0
7819103|NCT01116648|19247675|P8|COMPLETED|Phase 1-T Dose Level 0-TA||3
7819104|NCT01116648|19247676|P7|COMPLETED|Phase 1-T Dose Level 0-TA||0
7819105|NCT01116648|19247677|P6|COMPLETED|Phase 1-T Dose Level 0-TA||0
7819106|NCT01116648|19247678|P5|COMPLETED|Phase 1-T Dose Level 0-TA||0
7819107|NCT01116648|19247679|P4|COMPLETED|Phase 1-T Dose Level 0-TA||0
7819108|NCT01116648|19247680|P3|COMPLETED|Phase 1-T Dose Level 0-TA||0
7819109|NCT01116648|19247681|P2|COMPLETED|Phase 1-T Dose Level 0-TA||0
7819110|NCT01116648|19247682|P1|COMPLETED|Phase 1-T Dose Level 0-TA||0
7819111|NCT01116648|19247668|P15|STARTED|Phase 1-T Dose Level 0-TA||0
7819112|NCT01116648|19247669|P14|STARTED|Phase 1-T Dose Level 0-TA||0
7819113|NCT01116648|19247670|P13|STARTED|Phase 1-T Dose Level 0-TA||0
7819114|NCT01116648|19247671|P12|STARTED|Phase 1-T Dose Level 0-TA||0
7819115|NCT01116648|19247672|P11|STARTED|Phase 1-T Dose Level 0-TA||0
7819116|NCT01116648|19247673|P10|STARTED|Phase 1-T Dose Level 0-TA||0
7819117|NCT01116648|19247674|P9|STARTED|Phase 1-T Dose Level 0-TA||0
7819118|NCT01116648|19247675|P8|STARTED|Phase 1-T Dose Level 0-TA||3
7819119|NCT01116648|19247676|P7|STARTED|Phase 1-T Dose Level 0-TA||0
7819120|NCT01116648|19247677|P6|STARTED|Phase 1-T Dose Level 0-TA||0
7819121|NCT01116648|19247678|P5|STARTED|Phase 1-T Dose Level 0-TA||0
7819122|NCT01116648|19247679|P4|STARTED|Phase 1-T Dose Level 0-TA||0
7819123|NCT01116648|19247680|P3|STARTED|Phase 1-T Dose Level 0-TA||0
7819124|NCT01116648|19247681|P2|STARTED|Phase 1-T Dose Level 0-TA||0
7819125|NCT01116648|19247682|P1|STARTED|Phase 1-T Dose Level 0-TA||0
7819126|NCT01116648|19247668|P15|NOT COMPLETED|Phase 2||0
7819127|NCT01116648|19247669|P14|NOT COMPLETED|Phase 2||0
7819128|NCT01116648|19247670|P13|NOT COMPLETED|Phase 2||0
7819129|NCT01116648|19247671|P12|NOT COMPLETED|Phase 2||0
7819130|NCT01116648|19247672|P11|NOT COMPLETED|Phase 2||0
7819131|NCT01116648|19247673|P10|NOT COMPLETED|Phase 2||0
7819132|NCT01116648|19247674|P9|NOT COMPLETED|Phase 2||0
7819133|NCT01116648|19247675|P8|NOT COMPLETED|Phase 2||0
7819134|NCT01116648|19247676|P7|NOT COMPLETED|Phase 2||0
7819135|NCT01116648|19247677|P6|NOT COMPLETED|Phase 2||0
7819136|NCT01116648|19247678|P5|NOT COMPLETED|Phase 2||0
7819137|NCT01116648|19247679|P4|NOT COMPLETED|Phase 2||0
7819138|NCT01116648|19247680|P3|NOT COMPLETED|Phase 2||0
7819139|NCT01116648|19247681|P2|NOT COMPLETED|Phase 2||0
7819140|NCT01116648|19247682|P1|NOT COMPLETED|Phase 2||0
7819141|NCT01116648|19247668|P15|COMPLETED|Phase 2||0
7819142|NCT01116648|19247669|P14|COMPLETED|Phase 2||0
7819143|NCT01116648|19247670|P13|COMPLETED|Phase 2||0
7819144|NCT01116648|19247671|P12|COMPLETED|Phase 2||0
7819145|NCT01116648|19247672|P11|COMPLETED|Phase 2||0
7819146|NCT01116648|19247673|P10|COMPLETED|Phase 2||0
7819147|NCT01116648|19247674|P9|COMPLETED|Phase 2||0
7819148|NCT01116648|19247675|P8|COMPLETED|Phase 2||0
7819149|NCT01116648|19247676|P7|COMPLETED|Phase 2||44
7819150|NCT01116648|19247677|P6|COMPLETED|Phase 2||46
7819151|NCT01116648|19247678|P5|COMPLETED|Phase 2||0
7819152|NCT01116648|19247679|P4|COMPLETED|Phase 2||0
7819153|NCT01116648|19247680|P3|COMPLETED|Phase 2||0
7819154|NCT01116648|19247681|P2|COMPLETED|Phase 2||0
7819155|NCT01116648|19247682|P1|COMPLETED|Phase 2||0
7819156|NCT01116648|19247668|P15|STARTED|Phase 2||0
7819157|NCT01116648|19247669|P14|STARTED|Phase 2||0
7819158|NCT01116648|19247670|P13|STARTED|Phase 2||0
7819159|NCT01116648|19247671|P12|STARTED|Phase 2||0
7819160|NCT01116648|19247672|P11|STARTED|Phase 2||0
7819161|NCT01116648|19247673|P10|STARTED|Phase 2||0
7819162|NCT01116648|19247674|P9|STARTED|Phase 2||0
7819163|NCT01116648|19247675|P8|STARTED|Phase 2||0
7819164|NCT01116648|19247676|P7|STARTED|Phase 2||44
7819165|NCT01116648|19247677|P6|STARTED|Phase 2||46
7819166|NCT01116648|19247678|P5|STARTED|Phase 2||0
7819167|NCT01116648|19247679|P4|STARTED|Phase 2||0
7819168|NCT01116648|19247680|P3|STARTED|Phase 2||0
7819169|NCT01116648|19247681|P2|STARTED|Phase 2||0
7819170|NCT01116648|19247682|P1|STARTED|Phase 2||0
7819171|NCT01116648|19247668|P15|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
7819172|NCT01116648|19247669|P14|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
7819173|NCT01116648|19247670|P13|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
7819174|NCT01116648|19247671|P12|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
7819175|NCT01116648|19247672|P11|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
7819176|NCT01116648|19247673|P10|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
7819177|NCT01116648|19247674|P9|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
7819178|NCT01116648|19247675|P8|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
7819179|NCT01116648|19247676|P7|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
7819180|NCT01116648|19247677|P6|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
7819181|NCT01116648|19247678|P5|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
7819182|NCT01116648|19247679|P4|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
7819183|NCT01116648|19247680|P3|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
7819184|NCT01116648|19247681|P2|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
7819185|NCT01116648|19247682|P1|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
7819186|NCT01116648|19247668|P15|COMPLETED|Expansion at Maximum Tolerated Dose||0
7819187|NCT01116648|19247669|P14|COMPLETED|Expansion at Maximum Tolerated Dose||0
7819188|NCT01116648|19247670|P13|COMPLETED|Expansion at Maximum Tolerated Dose||0
7819189|NCT01116648|19247671|P12|COMPLETED|Expansion at Maximum Tolerated Dose||0
7819190|NCT01116648|19247672|P11|COMPLETED|Expansion at Maximum Tolerated Dose||0
7819191|NCT01116648|19247673|P10|COMPLETED|Expansion at Maximum Tolerated Dose||0
7819192|NCT01116648|19247674|P9|COMPLETED|Expansion at Maximum Tolerated Dose||0
7819193|NCT01116648|19247675|P8|COMPLETED|Expansion at Maximum Tolerated Dose||0
7819194|NCT01116648|19247676|P7|COMPLETED|Expansion at Maximum Tolerated Dose||0
7819195|NCT01116648|19247677|P6|COMPLETED|Expansion at Maximum Tolerated Dose||0
7819196|NCT01116648|19247678|P5|COMPLETED|Expansion at Maximum Tolerated Dose||9
7819197|NCT01116648|19247679|P4|COMPLETED|Expansion at Maximum Tolerated Dose||0
7819198|NCT01116648|19247680|P3|COMPLETED|Expansion at Maximum Tolerated Dose||0
7819199|NCT01116648|19247681|P2|COMPLETED|Expansion at Maximum Tolerated Dose||0
7819200|NCT01116648|19247682|P1|COMPLETED|Expansion at Maximum Tolerated Dose||0
7819201|NCT01116648|19247668|P15|STARTED|Expansion at Maximum Tolerated Dose||0
7819202|NCT01116648|19247669|P14|STARTED|Expansion at Maximum Tolerated Dose||0
7819203|NCT01116648|19247670|P13|STARTED|Expansion at Maximum Tolerated Dose||0
7819204|NCT01116648|19247671|P12|STARTED|Expansion at Maximum Tolerated Dose||0
7819205|NCT01116648|19247672|P11|STARTED|Expansion at Maximum Tolerated Dose||0
7819206|NCT01116648|19247673|P10|STARTED|Expansion at Maximum Tolerated Dose||0
7819207|NCT01116648|19247674|P9|STARTED|Expansion at Maximum Tolerated Dose||0
7819208|NCT01116648|19247675|P8|STARTED|Expansion at Maximum Tolerated Dose||0
7819209|NCT01116648|19247676|P7|STARTED|Expansion at Maximum Tolerated Dose||0
7819210|NCT01116648|19247677|P6|STARTED|Expansion at Maximum Tolerated Dose||0
7819211|NCT01116648|19247678|P5|STARTED|Expansion at Maximum Tolerated Dose||9
7819212|NCT01116648|19247679|P4|STARTED|Expansion at Maximum Tolerated Dose||0
7819213|NCT01116648|19247680|P3|STARTED|Expansion at Maximum Tolerated Dose||0
7819214|NCT01116648|19247681|P2|STARTED|Expansion at Maximum Tolerated Dose||0
7819215|NCT01116648|19247682|P1|STARTED|Expansion at Maximum Tolerated Dose||0
7819216|NCT01116648|19247668|P15|NOT COMPLETED|Phase 1 Dose Level 3||0
7819217|NCT01116648|19247669|P14|NOT COMPLETED|Phase 1 Dose Level 3||0
7819218|NCT01116648|19247670|P13|NOT COMPLETED|Phase 1 Dose Level 3||0
7819219|NCT01116648|19247671|P12|NOT COMPLETED|Phase 1 Dose Level 3||0
7819220|NCT01116648|19247672|P11|NOT COMPLETED|Phase 1 Dose Level 3||0
7819221|NCT01116648|19247673|P10|NOT COMPLETED|Phase 1 Dose Level 3||0
7819222|NCT01116648|19247674|P9|NOT COMPLETED|Phase 1 Dose Level 3||0
7819223|NCT01116648|19247675|P8|NOT COMPLETED|Phase 1 Dose Level 3||0
7819224|NCT01116648|19247676|P7|NOT COMPLETED|Phase 1 Dose Level 3||0
7819225|NCT01116648|19247677|P6|NOT COMPLETED|Phase 1 Dose Level 3||0
7819226|NCT01116648|19247678|P5|NOT COMPLETED|Phase 1 Dose Level 3||0
7819227|NCT01116648|19247679|P4|NOT COMPLETED|Phase 1 Dose Level 3||2
7819228|NCT01116648|19247680|P3|NOT COMPLETED|Phase 1 Dose Level 3||0
7819229|NCT01116648|19247681|P2|NOT COMPLETED|Phase 1 Dose Level 3||0
7819230|NCT01116648|19247682|P1|NOT COMPLETED|Phase 1 Dose Level 3||0
7819231|NCT01116648|19247668|P15|COMPLETED|Phase 1 Dose Level 3||0
7819232|NCT01116648|19247669|P14|COMPLETED|Phase 1 Dose Level 3||0
7819233|NCT01116648|19247670|P13|COMPLETED|Phase 1 Dose Level 3||0
7819234|NCT01116648|19247671|P12|COMPLETED|Phase 1 Dose Level 3||0
7819235|NCT01116648|19247672|P11|COMPLETED|Phase 1 Dose Level 3||0
7819236|NCT01116648|19247673|P10|COMPLETED|Phase 1 Dose Level 3||0
7819237|NCT01116648|19247674|P9|COMPLETED|Phase 1 Dose Level 3||0
7819238|NCT01116648|19247675|P8|COMPLETED|Phase 1 Dose Level 3||0
7819239|NCT01116648|19247676|P7|COMPLETED|Phase 1 Dose Level 3||0
7819240|NCT01116648|19247677|P6|COMPLETED|Phase 1 Dose Level 3||0
7819241|NCT01116648|19247678|P5|COMPLETED|Phase 1 Dose Level 3||0
7819242|NCT01116648|19247679|P4|COMPLETED|Phase 1 Dose Level 3||4
7819243|NCT01116648|19247680|P3|COMPLETED|Phase 1 Dose Level 3||0
7819244|NCT01116648|19247681|P2|COMPLETED|Phase 1 Dose Level 3||0
7819245|NCT01116648|19247682|P1|COMPLETED|Phase 1 Dose Level 3||0
7819246|NCT01116648|19247668|P15|STARTED|Phase 1 Dose Level 3||0
7819247|NCT01116648|19247669|P14|STARTED|Phase 1 Dose Level 3||0
7819248|NCT01116648|19247670|P13|STARTED|Phase 1 Dose Level 3||0
7819249|NCT01116648|19247671|P12|STARTED|Phase 1 Dose Level 3||0
7819250|NCT01116648|19247672|P11|STARTED|Phase 1 Dose Level 3||0
7819251|NCT01116648|19247673|P10|STARTED|Phase 1 Dose Level 3||0
7819252|NCT01116648|19247674|P9|STARTED|Phase 1 Dose Level 3||0
7819253|NCT01116648|19247675|P8|STARTED|Phase 1 Dose Level 3||0
7819254|NCT01116648|19247676|P7|STARTED|Phase 1 Dose Level 3||0
7819255|NCT01116648|19247677|P6|STARTED|Phase 1 Dose Level 3||0
7819256|NCT01116648|19247678|P5|STARTED|Phase 1 Dose Level 3||0
7819257|NCT01116648|19247679|P4|STARTED|Phase 1 Dose Level 3||6
7819258|NCT01116648|19247680|P3|STARTED|Phase 1 Dose Level 3||0
7819259|NCT01116648|19247681|P2|STARTED|Phase 1 Dose Level 3||0
7819260|NCT01116648|19247682|P1|STARTED|Phase 1 Dose Level 3||0
7819261|NCT01116648|19247668|P15|NOT COMPLETED|Phase 1 Dose Level 2||0
7819262|NCT01116648|19247669|P14|NOT COMPLETED|Phase 1 Dose Level 2||0
7819263|NCT01116648|19247670|P13|NOT COMPLETED|Phase 1 Dose Level 2||0
7819264|NCT01116648|19247671|P12|NOT COMPLETED|Phase 1 Dose Level 2||0
7819265|NCT01116648|19247672|P11|NOT COMPLETED|Phase 1 Dose Level 2||0
7819266|NCT01116648|19247673|P10|NOT COMPLETED|Phase 1 Dose Level 2||0
7819267|NCT01116648|19247674|P9|NOT COMPLETED|Phase 1 Dose Level 2||0
7819268|NCT01116648|19247675|P8|NOT COMPLETED|Phase 1 Dose Level 2||0
7819269|NCT01116648|19247676|P7|NOT COMPLETED|Phase 1 Dose Level 2||0
7819270|NCT01116648|19247677|P6|NOT COMPLETED|Phase 1 Dose Level 2||0
7819271|NCT01116648|19247678|P5|NOT COMPLETED|Phase 1 Dose Level 2||0
7819272|NCT01116648|19247679|P4|NOT COMPLETED|Phase 1 Dose Level 2||0
7819273|NCT01116648|19247680|P3|NOT COMPLETED|Phase 1 Dose Level 2||0
7819274|NCT01116648|19247681|P2|NOT COMPLETED|Phase 1 Dose Level 2||0
7819275|NCT01116648|19247682|P1|NOT COMPLETED|Phase 1 Dose Level 2||0
7819276|NCT01116648|19247668|P15|COMPLETED|Phase 1 Dose Level 2||0
7819277|NCT01116648|19247669|P14|COMPLETED|Phase 1 Dose Level 2||0
7819278|NCT01116648|19247670|P13|COMPLETED|Phase 1 Dose Level 2||0
7819279|NCT01116648|19247671|P12|COMPLETED|Phase 1 Dose Level 2||0
7819280|NCT01116648|19247672|P11|COMPLETED|Phase 1 Dose Level 2||0
7819281|NCT01116648|19247673|P10|COMPLETED|Phase 1 Dose Level 2||0
7819282|NCT01116648|19247674|P9|COMPLETED|Phase 1 Dose Level 2||0
7819283|NCT01116648|19247675|P8|COMPLETED|Phase 1 Dose Level 2||0
7819284|NCT01116648|19247676|P7|COMPLETED|Phase 1 Dose Level 2||0
7819285|NCT01116648|19247677|P6|COMPLETED|Phase 1 Dose Level 2||0
7819286|NCT01116648|19247678|P5|COMPLETED|Phase 1 Dose Level 2||0
7819287|NCT01116648|19247679|P4|COMPLETED|Phase 1 Dose Level 2||0
7819288|NCT01116648|19247680|P3|COMPLETED|Phase 1 Dose Level 2||7
7819289|NCT01116648|19247681|P2|COMPLETED|Phase 1 Dose Level 2||0
7819290|NCT01116648|19247682|P1|COMPLETED|Phase 1 Dose Level 2||0
7819291|NCT01116648|19247668|P15|STARTED|Phase 1 Dose Level 2||0
7819292|NCT01116648|19247669|P14|STARTED|Phase 1 Dose Level 2||0
7819293|NCT01116648|19247670|P13|STARTED|Phase 1 Dose Level 2||0
7819294|NCT01116648|19247671|P12|STARTED|Phase 1 Dose Level 2||0
7819295|NCT01116648|19247672|P11|STARTED|Phase 1 Dose Level 2||0
7819296|NCT01116648|19247673|P10|STARTED|Phase 1 Dose Level 2||0
7819297|NCT01116648|19247674|P9|STARTED|Phase 1 Dose Level 2||0
7819298|NCT01116648|19247675|P8|STARTED|Phase 1 Dose Level 2||0
7819299|NCT01116648|19247676|P7|STARTED|Phase 1 Dose Level 2||0
7819300|NCT01116648|19247677|P6|STARTED|Phase 1 Dose Level 2||0
7819301|NCT01116648|19247678|P5|STARTED|Phase 1 Dose Level 2||0
7819302|NCT01116648|19247679|P4|STARTED|Phase 1 Dose Level 2||0
7819303|NCT01116648|19247680|P3|STARTED|Phase 1 Dose Level 2||7
7819304|NCT01116648|19247681|P2|STARTED|Phase 1 Dose Level 2||0
7819305|NCT01116648|19247682|P1|STARTED|Phase 1 Dose Level 2||0
7819306|NCT01116648|19247668|P15|NOT COMPLETED|Phase 1 Dose Level 1||0
7819307|NCT01116648|19247669|P14|NOT COMPLETED|Phase 1 Dose Level 1||0
7819308|NCT01116648|19247670|P13|NOT COMPLETED|Phase 1 Dose Level 1||0
7819309|NCT01116648|19247671|P12|NOT COMPLETED|Phase 1 Dose Level 1||0
7819310|NCT01116648|19247672|P11|NOT COMPLETED|Phase 1 Dose Level 1||0
7819311|NCT01116648|19247673|P10|NOT COMPLETED|Phase 1 Dose Level 1||0
7819312|NCT01116648|19247674|P9|NOT COMPLETED|Phase 1 Dose Level 1||0
7819313|NCT01116648|19247675|P8|NOT COMPLETED|Phase 1 Dose Level 1||0
7819314|NCT01116648|19247676|P7|NOT COMPLETED|Phase 1 Dose Level 1||0
7819315|NCT01116648|19247677|P6|NOT COMPLETED|Phase 1 Dose Level 1||0
7819316|NCT01116648|19247678|P5|NOT COMPLETED|Phase 1 Dose Level 1||0
7819317|NCT01116648|19247679|P4|NOT COMPLETED|Phase 1 Dose Level 1||0
7819318|NCT01116648|19247680|P3|NOT COMPLETED|Phase 1 Dose Level 1||0
7819319|NCT01116648|19247681|P2|NOT COMPLETED|Phase 1 Dose Level 1||0
7819320|NCT01116648|19247682|P1|NOT COMPLETED|Phase 1 Dose Level 1||0
7819321|NCT01116648|19247668|P15|COMPLETED|Phase 1 Dose Level 1||0
7819322|NCT01116648|19247669|P14|COMPLETED|Phase 1 Dose Level 1||0
7819323|NCT01116648|19247670|P13|COMPLETED|Phase 1 Dose Level 1||0
7819324|NCT01116648|19247671|P12|COMPLETED|Phase 1 Dose Level 1||0
7819325|NCT01116648|19247672|P11|COMPLETED|Phase 1 Dose Level 1||0
7819326|NCT01116648|19247673|P10|COMPLETED|Phase 1 Dose Level 1||0
7819327|NCT01116648|19247674|P9|COMPLETED|Phase 1 Dose Level 1||0
7819328|NCT01116648|19247675|P8|COMPLETED|Phase 1 Dose Level 1||0
7819329|NCT01116648|19247676|P7|COMPLETED|Phase 1 Dose Level 1||0
7819330|NCT01116648|19247677|P6|COMPLETED|Phase 1 Dose Level 1||0
7819331|NCT01116648|19247678|P5|COMPLETED|Phase 1 Dose Level 1||0
7819332|NCT01116648|19247679|P4|COMPLETED|Phase 1 Dose Level 1||0
7819333|NCT01116648|19247680|P3|COMPLETED|Phase 1 Dose Level 1||0
7819334|NCT01116648|19247681|P2|COMPLETED|Phase 1 Dose Level 1||3
7819335|NCT01116648|19247682|P1|COMPLETED|Phase 1 Dose Level 1||0
7819336|NCT01116648|19247668|P15|STARTED|Phase 1 Dose Level 1||0
7819337|NCT01116648|19247669|P14|STARTED|Phase 1 Dose Level 1||0
7819338|NCT01116648|19247670|P13|STARTED|Phase 1 Dose Level 1||0
7819339|NCT01116648|19247671|P12|STARTED|Phase 1 Dose Level 1||0
7819340|NCT01116648|19247672|P11|STARTED|Phase 1 Dose Level 1||0
7819341|NCT01116648|19247673|P10|STARTED|Phase 1 Dose Level 1||0
7819342|NCT01116648|19247674|P9|STARTED|Phase 1 Dose Level 1||0
7819343|NCT01116648|19247675|P8|STARTED|Phase 1 Dose Level 1||0
7819344|NCT01116648|19247676|P7|STARTED|Phase 1 Dose Level 1||0
7819345|NCT01116648|19247677|P6|STARTED|Phase 1 Dose Level 1||0
7819346|NCT01116648|19247678|P5|STARTED|Phase 1 Dose Level 1||0
7819347|NCT01116648|19247679|P4|STARTED|Phase 1 Dose Level 1||0
7819348|NCT01116648|19247680|P3|STARTED|Phase 1 Dose Level 1||0
7819349|NCT01116648|19247681|P2|STARTED|Phase 1 Dose Level 1||3
7819350|NCT01116648|19247682|P1|STARTED|Phase 1 Dose Level 1||0
7819351|NCT01116648|19247668|P15|NOT COMPLETED|Phase 1 Dose Level 0||0
7819352|NCT01116648|19247669|P14|NOT COMPLETED|Phase 1 Dose Level 0||0
7819353|NCT01116648|19247670|P13|NOT COMPLETED|Phase 1 Dose Level 0||0
7819354|NCT01116648|19247671|P12|NOT COMPLETED|Phase 1 Dose Level 0||0
7819355|NCT01116648|19247672|P11|NOT COMPLETED|Phase 1 Dose Level 0||0
7819356|NCT01116648|19247673|P10|NOT COMPLETED|Phase 1 Dose Level 0||0
7819357|NCT01116648|19247674|P9|NOT COMPLETED|Phase 1 Dose Level 0||0
7819358|NCT01116648|19247675|P8|NOT COMPLETED|Phase 1 Dose Level 0||0
7819359|NCT01116648|19247676|P7|NOT COMPLETED|Phase 1 Dose Level 0||0
7819360|NCT01116648|19247677|P6|NOT COMPLETED|Phase 1 Dose Level 0||0
7819361|NCT01116648|19247678|P5|NOT COMPLETED|Phase 1 Dose Level 0||0
7819362|NCT01116648|19247679|P4|NOT COMPLETED|Phase 1 Dose Level 0||0
7819363|NCT01116648|19247680|P3|NOT COMPLETED|Phase 1 Dose Level 0||0
7819364|NCT01116648|19247681|P2|NOT COMPLETED|Phase 1 Dose Level 0||0
7819365|NCT01116648|19247682|P1|NOT COMPLETED|Phase 1 Dose Level 0||0
7819366|NCT01116648|19247668|P15|COMPLETED|Phase 1 Dose Level 0||0
7819367|NCT01116648|19247669|P14|COMPLETED|Phase 1 Dose Level 0||0
7819368|NCT01116648|19247670|P13|COMPLETED|Phase 1 Dose Level 0||0
7819369|NCT01116648|19247671|P12|COMPLETED|Phase 1 Dose Level 0||0
7819370|NCT01116648|19247672|P11|COMPLETED|Phase 1 Dose Level 0||0
7819371|NCT01116648|19247673|P10|COMPLETED|Phase 1 Dose Level 0||0
7819372|NCT01116648|19247674|P9|COMPLETED|Phase 1 Dose Level 0||0
7819373|NCT01116648|19247675|P8|COMPLETED|Phase 1 Dose Level 0||0
7819374|NCT01116648|19247676|P7|COMPLETED|Phase 1 Dose Level 0||0
7819375|NCT01116648|19247677|P6|COMPLETED|Phase 1 Dose Level 0||0
7819376|NCT01116648|19247678|P5|COMPLETED|Phase 1 Dose Level 0||0
7819377|NCT01116648|19247679|P4|COMPLETED|Phase 1 Dose Level 0||0
7819378|NCT01116648|19247680|P3|COMPLETED|Phase 1 Dose Level 0||0
7819379|NCT01116648|19247681|P2|COMPLETED|Phase 1 Dose Level 0||0
7819380|NCT01116648|19247682|P1|COMPLETED|Phase 1 Dose Level 0||3
7819381|NCT01116648|19247668|P15|STARTED|Phase 1 Dose Level 0||0
7819382|NCT01116648|19247669|P14|STARTED|Phase 1 Dose Level 0||0
7819383|NCT01116648|19247670|P13|STARTED|Phase 1 Dose Level 0||0
7819384|NCT01116648|19247671|P12|STARTED|Phase 1 Dose Level 0||0
7819385|NCT01116648|19247672|P11|STARTED|Phase 1 Dose Level 0||0
7819386|NCT01116648|19247673|P10|STARTED|Phase 1 Dose Level 0||0
7819387|NCT01116648|19247674|P9|STARTED|Phase 1 Dose Level 0||0
7819388|NCT01116648|19247675|P8|STARTED|Phase 1 Dose Level 0||0
7819389|NCT01116648|19247676|P7|STARTED|Phase 1 Dose Level 0||0
7819390|NCT01116648|19247677|P6|STARTED|Phase 1 Dose Level 0||0
7819391|NCT01116648|19247678|P5|STARTED|Phase 1 Dose Level 0||0
7819392|NCT01116648|19247679|P4|STARTED|Phase 1 Dose Level 0||0
7819393|NCT01116648|19247680|P3|STARTED|Phase 1 Dose Level 0||0
7819394|NCT01116648|19247681|P2|STARTED|Phase 1 Dose Level 0||0
7819395|NCT01116648|19247682|P1|STARTED|Phase 1 Dose Level 0||3
7819396|NCT01116544|19247709|P2|NOT COMPLETED|Overall Study||1
7819397|NCT01116544|19247710|P1|NOT COMPLETED|Overall Study||2
7819398|NCT01116544|19247709|P2|COMPLETED|Overall Study||22
7819399|NCT01116544|19247710|P1|COMPLETED|Overall Study||21
7819400|NCT01116544|19247709|P2|STARTED|Overall Study||23
7819401|NCT01116544|19247710|P1|STARTED|Overall Study||23
7819402|NCT01116466|19247726|P1|NOT COMPLETED|Overall Study||0
7819403|NCT01116466|19247726|P1|COMPLETED|Overall Study||5
7819404|NCT01116466|19247726|P1|STARTED|Overall Study||5
7819405|NCT01116440|19247736|P2|NOT COMPLETED|Follow-up||2
7819406|NCT01116440|19247737|P1|NOT COMPLETED|Follow-up||0
7819407|NCT01116440|19247736|P2|COMPLETED|Follow-up||5
7819408|NCT01116440|19247737|P1|COMPLETED|Follow-up||8
7819409|NCT01116440|19247736|P2|STARTED|Follow-up||7
7819410|NCT01116440|19247737|P1|STARTED|Follow-up||8
7819411|NCT01116440|19247736|P2|NOT COMPLETED|Withdrawal||2
7819412|NCT01116440|19247737|P1|NOT COMPLETED|Withdrawal||0
7819413|NCT01116440|19247736|P2|COMPLETED|Withdrawal||7
7819414|NCT01116440|19247737|P1|COMPLETED|Withdrawal||8
7819415|NCT01116440|19247736|P2|STARTED|Withdrawal||9
7819416|NCT01116440|19247737|P1|STARTED|Withdrawal||8
7819417|NCT01116440|19247736|P2|NOT COMPLETED|Treatment||7
7819418|NCT01116440|19247737|P1|NOT COMPLETED|Treatment||3
7819419|NCT01116440|19247736|P2|COMPLETED|Treatment||9
7819420|NCT01116440|19247737|P1|COMPLETED|Treatment||8
7819421|NCT01116440|19247736|P2|STARTED|Treatment||16
7819422|NCT01116440|19247737|P1|STARTED|Treatment||11
7819423|NCT01116427|19247753|P2|NOT COMPLETED|Extension Phase||2
7819424|NCT01116427|19247754|P1|NOT COMPLETED|Extension Phase||9
7819425|NCT01116427|19247753|P2|COMPLETED|Extension Phase||18
7819426|NCT01116427|19247754|P1|COMPLETED|Extension Phase||29
7819427|NCT01116427|19247753|P2|STARTED|Extension Phase||20
7819428|NCT01116427|19247754|P1|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38
7819429|NCT01116427|19247753|P2|NOT COMPLETED|Core Phase||1
7819430|NCT01116427|19247754|P1|NOT COMPLETED|Core Phase||5
7819431|NCT01116427|19247753|P2|COMPLETED|Core Phase||20
7819432|NCT01116427|19247754|P1|COMPLETED|Core Phase||39
7819433|NCT01116427|19247753|P2|STARTED|Core Phase||21
7819434|NCT01116427|19247754|P1|STARTED|Core Phase||44
7819435|NCT01116401|19247790|P1|NOT COMPLETED|Overall Study||0
7819436|NCT01116401|19247790|P1|COMPLETED|Overall Study||29
7819437|NCT01116401|19247790|P1|STARTED|Overall Study||29
7819438|NCT01116232|19247795|P1|NOT COMPLETED|Overall Study||4
7819439|NCT01116232|19247795|P1|COMPLETED|Overall Study||0
7819440|NCT01116232|19247795|P1|STARTED|Overall Study||4
7819441|NCT01116102|19247814|P8|NOT COMPLETED|Overall Study||0
7819442|NCT01116102|19247815|P7|NOT COMPLETED|Overall Study||0
7819443|NCT01116102|19247816|P6|NOT COMPLETED|Overall Study||0
7819444|NCT01116102|19247817|P5|NOT COMPLETED|Overall Study||0
7819445|NCT01116102|19247818|P4|NOT COMPLETED|Overall Study||0
7819446|NCT01116102|19247819|P3|NOT COMPLETED|Overall Study||0
7819447|NCT01116102|19247820|P2|NOT COMPLETED|Overall Study||0
7819448|NCT01116102|19247821|P1|NOT COMPLETED|Overall Study||0
7819449|NCT01116102|19247814|P8|COMPLETED|Overall Study||3
7819450|NCT01116102|19247815|P7|COMPLETED|Overall Study||2
7819451|NCT01116102|19247816|P6|COMPLETED|Overall Study||2
7819452|NCT01116102|19247817|P5|COMPLETED|Overall Study||2
7819453|NCT01116102|19247818|P4|COMPLETED|Overall Study||3
7819454|NCT01116102|19247819|P3|COMPLETED|Overall Study||3
7819455|NCT01116102|19247820|P2|COMPLETED|Overall Study||3
7819456|NCT01116102|19247821|P1|COMPLETED|Overall Study||2
7819457|NCT01116102|19247814|P8|STARTED|Overall Study||3
7819458|NCT01116102|19247815|P7|STARTED|Overall Study||2
7819459|NCT01116102|19247816|P6|STARTED|Overall Study||2
7819460|NCT01116102|19247817|P5|STARTED|Overall Study||2
7819461|NCT01116102|19247818|P4|STARTED|Overall Study||3
7819462|NCT01116102|19247819|P3|STARTED|Overall Study||3
7819463|NCT01116102|19247820|P2|STARTED|Overall Study||3
7819464|NCT01116102|19247821|P1|STARTED|Overall Study||2
7819465|NCT01116037|19247863|P1|NOT COMPLETED|Overall Study||25
7819466|NCT01116037|19247863|P1|COMPLETED|Overall Study||1
7819467|NCT01116037|19247863|P1|STARTED|Overall Study||26
7819468|NCT01116024|19247868|P1|NOT COMPLETED|Overall Study||52
7819469|NCT01116024|19247868|P1|COMPLETED|Overall Study|Patient Enrollment stop date|96
7819470|NCT01116024|19247868|P1|STARTED|Overall Study|148 subjects left operating room with the device implanted and were included in the analysis.|148
7819471|NCT01115998|19247909|P2|NOT COMPLETED|Overall Study||6
7819472|NCT01115998|19247910|P1|NOT COMPLETED|Overall Study||6
7819473|NCT01115998|19247909|P2|COMPLETED|Overall Study||11
7819474|NCT01115998|19247910|P1|COMPLETED|Overall Study||11
7819475|NCT01115998|19247909|P2|STARTED|Overall Study||17
7819476|NCT01115998|19247910|P1|STARTED|Overall Study||17
7819477|NCT01115933|19247920|P1|NOT COMPLETED|Overall Study||1
7819478|NCT01115933|19247920|P1|COMPLETED|Overall Study||64
7819479|NCT01115933|19247920|P1|STARTED|Overall Study||65
7819480|NCT01115855|19248017|P2|NOT COMPLETED|Overall Study||36
7819481|NCT01115855|19248018|P1|NOT COMPLETED|Overall Study||36
7819482|NCT01115855|19248017|P2|COMPLETED|Overall Study||74
7819483|NCT01115855|19248018|P1|COMPLETED|Overall Study||75
7819484|NCT01115855|19248017|P2|STARTED|Overall Study||110
7819485|NCT01115855|19248018|P1|STARTED|Overall Study||111
7819486|NCT01115803|19248073|P7|NOT COMPLETED|Overall Study||2
7819487|NCT01115803|19248074|P6|NOT COMPLETED|Overall Study||0
7819488|NCT01115803|19248075|P5|NOT COMPLETED|Overall Study||0
7819489|NCT01115803|19248076|P4|NOT COMPLETED|Overall Study||0
7819490|NCT01115803|19248077|P3|NOT COMPLETED|Overall Study||1
7819491|NCT01115803|19248078|P2|NOT COMPLETED|Overall Study||0
7819492|NCT01115803|19248079|P1|NOT COMPLETED|Overall Study||0
7819493|NCT01115803|19248073|P7|COMPLETED|Overall Study||4
7819494|NCT01115803|19248074|P6|COMPLETED|Overall Study||3
7819495|NCT01115803|19248075|P5|COMPLETED|Overall Study||3
7819496|NCT01115803|19248076|P4|COMPLETED|Overall Study||5
7819497|NCT01115803|19248077|P3|COMPLETED|Overall Study||2
7819498|NCT01115803|19248078|P2|COMPLETED|Overall Study||5
7819499|NCT01115803|19248079|P1|COMPLETED|Overall Study||4
7819500|NCT01115803|19248073|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
7819501|NCT01115803|19248074|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
7819502|NCT01115803|19248075|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
7819503|NCT01115803|19248076|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
7819504|NCT01115803|19248077|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
7819505|NCT01115803|19248078|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
7819506|NCT01115803|19248079|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
7819507|NCT01115803|19248073|P7|STARTED|Overall Study||6
7819508|NCT01115803|19248074|P6|STARTED|Overall Study||3
7819509|NCT01115803|19248075|P5|STARTED|Overall Study||3
7819510|NCT01115803|19248076|P4|STARTED|Overall Study||5
7819511|NCT01115803|19248077|P3|STARTED|Overall Study||3
7819512|NCT01115803|19248078|P2|STARTED|Overall Study||5
7819513|NCT01115803|19248079|P1|STARTED|Overall Study||4
7819514|NCT01115738|19248142|P3|NOT COMPLETED|Overall Study||27
7819515|NCT01115738|19248143|P2|NOT COMPLETED|Overall Study||21
7819516|NCT01115738|19248144|P1|NOT COMPLETED|Overall Study||25
7819517|NCT01115738|19248142|P3|COMPLETED|Overall Study||62
7819518|NCT01115738|19248143|P2|COMPLETED|Overall Study||62
7819519|NCT01115738|19248144|P1|COMPLETED|Overall Study||85
7819520|NCT01115738|19248142|P3|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50
7819521|NCT01115738|19248143|P2|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47
7819522|NCT01115738|19248144|P1|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52
7819523|NCT01115738|19248142|P3|Received Any Treatment|Overall Study||88
7819524|NCT01115738|19248143|P2|Received Any Treatment|Overall Study||79
7819525|NCT01115738|19248144|P1|Received Any Treatment|Overall Study||109
7819526|NCT01115738|19248142|P3|STARTED|Overall Study||89
7819527|NCT01115738|19248143|P2|STARTED|Overall Study||83
7819528|NCT01115738|19248144|P1|STARTED|Overall Study||110
7819529|NCT01115699|19248178|P1|NOT COMPLETED|Overall Study||0
7819530|NCT01115699|19248178|P1|COMPLETED|Overall Study||2
7819531|NCT01115699|19248178|P1|STARTED|Overall Study||2
7819532|NCT01115673|19248186|P3|NOT COMPLETED|Overall Study||0
7819533|NCT01115673|19248187|P2|NOT COMPLETED|Overall Study||0
7819534|NCT01115673|19248188|P1|NOT COMPLETED|Overall Study||0
7819535|NCT01115673|19248186|P3|COMPLETED|Overall Study||60
7819536|NCT01115673|19248187|P2|COMPLETED|Overall Study||241
7819537|NCT01115673|19248188|P1|COMPLETED|Overall Study||239
7819538|NCT01115673|19248186|P3|STARTED|Overall Study||60
7819539|NCT01115673|19248187|P2|STARTED|Overall Study||241
7819540|NCT01115673|19248188|P1|STARTED|Overall Study||239
7819541|NCT01115660|19248324|P2|NOT COMPLETED|Overall Study||0
7819542|NCT01115660|19248325|P1|NOT COMPLETED|Overall Study||1
7819543|NCT01115660|19248324|P2|COMPLETED|Overall Study||10
7819544|NCT01115660|19248325|P1|COMPLETED|Overall Study||19
7819545|NCT01115660|19248324|P2|STARTED|Overall Study||10
7819546|NCT01115660|19248325|P1|STARTED|Overall Study||20
7819547|NCT01115582|19248333|P1|NOT COMPLETED|Overall Study||0
7819548|NCT01115582|19248333|P1|COMPLETED|Overall Study||16
7819549|NCT01115582|19248333|P1|STARTED|Overall Study||16
7819550|NCT01115569|19248342|P2|NOT COMPLETED|Maintenance Phase||139
7819551|NCT01115569|19248343|P1|NOT COMPLETED|Maintenance Phase||0
7819552|NCT01115569|19248342|P2|COMPLETED|Maintenance Phase||285
7819553|NCT01115569|19248343|P1|COMPLETED|Maintenance Phase||0
7819554|NCT01115569|19248342|P2|STARTED|Maintenance Phase||424
7819555|NCT01115569|19248343|P1|STARTED|Maintenance Phase||0
7819556|NCT01115569|19248342|P2|NOT COMPLETED|Conversion/Titration Phase||0
7819557|NCT01115569|19248343|P1|NOT COMPLETED|Conversion/Titration Phase||214
7819558|NCT01115569|19248342|P2|COMPLETED|Conversion/Titration Phase||0
7819559|NCT01115569|19248343|P1|COMPLETED|Conversion/Titration Phase||424
7819560|NCT01115569|19248342|P2|STARTED|Conversion/Titration Phase||0
7819561|NCT01115569|19248343|P1|STARTED|Conversion/Titration Phase||638
7819562|NCT01115556|19248350|P2|NOT COMPLETED|Overall Study||0
7819563|NCT01115556|19248351|P1|NOT COMPLETED|Overall Study||0
7819564|NCT01115556|19248350|P2|COMPLETED|Overall Study||2
7819565|NCT01115556|19248351|P1|COMPLETED|Overall Study||7
7819566|NCT01115556|19248350|P2|STARTED|Overall Study||2
7819567|NCT01115556|19248351|P1|STARTED|Overall Study||7
7819568|NCT01115517|19248361|P2|NOT COMPLETED|Overall Study||5
7819569|NCT01115517|19248362|P1|NOT COMPLETED|Overall Study||4
7819570|NCT01115517|19248361|P2|COMPLETED|Overall Study||16
7819571|NCT01115517|19248362|P1|COMPLETED|Overall Study||14
7819572|NCT01115517|19248361|P2|STARTED|Overall Study||21
7819573|NCT01115517|19248362|P1|STARTED|Overall Study||18
7819574|NCT01115491|19248372|P1|NOT COMPLETED|Overall Study||30
7819575|NCT01115491|19248372|P1|COMPLETED|Overall Study||2
7819576|NCT01115491|19248372|P1|STARTED|Overall Study||32
7819577|NCT01115452|19248381|P1|NOT COMPLETED|Overall Study||0
7819578|NCT01115452|19248381|P1|COMPLETED|Overall Study||32
7819579|NCT01115452|19248381|P1|STARTED|Overall Study||32
7819580|NCT01115309|19248431|P1|NOT COMPLETED|Long-term Follow-up||6
7819581|NCT01115309|19248431|P1|COMPLETED|Long-term Follow-up||44
7819582|NCT01115309|19248431|P1|12-Month Follow-up|Long-term Follow-up||44
7819583|NCT01115309|19248431|P1|6-Month Follow-up|Long-term Follow-up||46
7819584|NCT01115309|19248431|P1|STARTED|Long-term Follow-up||50
7819585|NCT01115309|19248431|P1|NOT COMPLETED|Procedure Safety (1-Month)||3
7819586|NCT01115309|19248431|P1|COMPLETED|Procedure Safety (1-Month)||172
7819587|NCT01115309|19248431|P1|STARTED|Procedure Safety (1-Month)||175
7819588|NCT01115244|19248441|P2|NOT COMPLETED|Overall Study||0
7819589|NCT01115244|19248442|P1|NOT COMPLETED|Overall Study||0
7819590|NCT01115244|19248441|P2|COMPLETED|Overall Study||0
7819591|NCT01115244|19248442|P1|COMPLETED|Overall Study||0
7819592|NCT01115244|19248441|P2|STARTED|Overall Study||0
7819593|NCT01115244|19248442|P1|STARTED|Overall Study||0
7819594|NCT01115231|19248454|P2|NOT COMPLETED|Overall Study||0
7819595|NCT01115231|19248455|P1|NOT COMPLETED|Overall Study||0
7819596|NCT01115231|19248454|P2|COMPLETED|Overall Study||90
7819597|NCT01115231|19248455|P1|COMPLETED|Overall Study||133
7819598|NCT01115231|19248454|P2|STARTED|Overall Study||90
7819599|NCT01115231|19248455|P1|STARTED|Overall Study||133
7819600|NCT01115166|19248467|P1|NOT COMPLETED|Overall Study||0
7819601|NCT01115166|19248467|P1|COMPLETED|Overall Study||10
7819602|NCT01115166|19248467|P1|STARTED|Overall Study||10
7819603|NCT01115101|19248475|P2|NOT COMPLETED|Overall Study||0
7819604|NCT01115101|19248476|P1|NOT COMPLETED|Overall Study||0
7819605|NCT01115101|19248475|P2|COMPLETED|Overall Study||126
7819606|NCT01115101|19248476|P1|COMPLETED|Overall Study||113
7819607|NCT01115101|19248475|P2|STARTED|Overall Study||126
7819608|NCT01115101|19248476|P1|STARTED|Overall Study||113
7819609|NCT01114997|19248485|P3|NOT COMPLETED|Overall Study||0
7819610|NCT01114997|19248486|P2|NOT COMPLETED|Overall Study||0
7819611|NCT01114997|19248487|P1|NOT COMPLETED|Overall Study||0
7819612|NCT01114997|19248485|P3|COMPLETED|Overall Study||11
7819613|NCT01114997|19248486|P2|COMPLETED|Overall Study||10
7819614|NCT01114997|19248487|P1|COMPLETED|Overall Study||11
7819615|NCT01114997|19248485|P3|STARTED|Overall Study||11
7819616|NCT01114997|19248486|P2|STARTED|Overall Study||10
7819617|NCT01114997|19248487|P1|STARTED|Overall Study||11
7819618|NCT01114971|19248516|P3|NOT COMPLETED|Overall Study||0
7819619|NCT01114971|19248517|P2|NOT COMPLETED|Overall Study||0
7819620|NCT01114971|19248518|P1|NOT COMPLETED|Overall Study||0
7819621|NCT01114971|19248516|P3|COMPLETED|Overall Study||25
7819622|NCT01114971|19248517|P2|COMPLETED|Overall Study||25
7819623|NCT01114971|19248518|P1|COMPLETED|Overall Study||25
7819624|NCT01114971|19248516|P3|STARTED|Overall Study||25
7819625|NCT01114971|19248517|P2|STARTED|Overall Study||25
7819626|NCT01114971|19248518|P1|STARTED|Overall Study||25
7819627|NCT01114945|19248545|P4|NOT COMPLETED|Overall Study||0
7819628|NCT01114945|19248546|P3|NOT COMPLETED|Overall Study||0
7819629|NCT01114945|19248547|P2|NOT COMPLETED|Overall Study||0
7819630|NCT01114945|19248548|P1|NOT COMPLETED|Overall Study||0
7819631|NCT01114945|19248545|P4|COMPLETED|Overall Study||31
7819632|NCT01114945|19248546|P3|COMPLETED|Overall Study||30
7819633|NCT01114945|19248547|P2|COMPLETED|Overall Study||30
7819634|NCT01114945|19248548|P1|COMPLETED|Overall Study||30
7819635|NCT01114945|19248545|P4|STARTED|Overall Study||31
7819636|NCT01114945|19248546|P3|STARTED|Overall Study||30
7819637|NCT01114945|19248547|P2|STARTED|Overall Study||30
7819638|NCT01114945|19248548|P1|STARTED|Overall Study||30
7819639|NCT01114893|19248575|P5|NOT COMPLETED|Overall Study||0
7819640|NCT01114893|19248576|P4|NOT COMPLETED|Overall Study||0
7819641|NCT01114893|19248577|P3|NOT COMPLETED|Overall Study||0
7819642|NCT01114893|19248578|P2|NOT COMPLETED|Overall Study||0
7819643|NCT01114893|19248579|P1|NOT COMPLETED|Overall Study||0
7819644|NCT01114893|19248575|P5|COMPLETED|Overall Study||12
7819645|NCT01114893|19248576|P4|COMPLETED|Overall Study||13
7819646|NCT01114893|19248577|P3|COMPLETED|Overall Study||14
7819647|NCT01114893|19248578|P2|COMPLETED|Overall Study||14
7819648|NCT01114893|19248579|P1|COMPLETED|Overall Study||14
7819649|NCT01114893|19248575|P5|STARTED|Overall Study||12
7819650|NCT01114893|19248576|P4|STARTED|Overall Study||13
7819651|NCT01114893|19248577|P3|STARTED|Overall Study||14
7819652|NCT01114893|19248578|P2|STARTED|Overall Study||14
7819653|NCT01114893|19248579|P1|STARTED|Overall Study||14
7819654|NCT01114880|19248598|P2|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2
7819655|NCT01114880|19248599|P1|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3
7819656|NCT01114880|19248598|P2|COMPLETED|Period 2 (Week 12 to Week 24)||111
7819657|NCT01114880|19248599|P1|COMPLETED|Period 2 (Week 12 to Week 24)||221
7819658|NCT01114880|19248598|P2|STARTED|Period 2 (Week 12 to Week 24)||113
7819659|NCT01114880|19248599|P1|STARTED|Period 2 (Week 12 to Week 24)||224
7819660|NCT01114880|19248598|P2|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2
7819661|NCT01114880|19248599|P1|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5
7819662|NCT01114880|19248598|P2|COMPLETED|Period 1 (Week 0 to Week 12)||113
7819663|NCT01114880|19248599|P1|COMPLETED|Period 1 (Week 0 to Week 12)||224
7819664|NCT01114880|19248598|P2|STARTED|Period 1 (Week 0 to Week 12)||115
7819665|NCT01114880|19248599|P1|STARTED|Period 1 (Week 0 to Week 12)||229
7819666|NCT01114828|19248651|P2|NOT COMPLETED|Overall Study||4
7819667|NCT01114828|19248652|P1|NOT COMPLETED|Overall Study||3
7819668|NCT01114828|19248651|P2|COMPLETED|Overall Study||17
7819669|NCT01114828|19248652|P1|COMPLETED|Overall Study||16
7819670|NCT01114828|19248651|P2|STARTED|Overall Study||21
7819671|NCT01114828|19248652|P1|STARTED|Overall Study||19
7819672|NCT01114737|19248662|P2|NOT COMPLETED|Open-Label Treatment Period||2
7819673|NCT01114737|19248663|P1|NOT COMPLETED|Open-Label Treatment Period||5
7819674|NCT01114737|19248662|P2|COMPLETED|Open-Label Treatment Period||95
7819675|NCT01114737|19248663|P1|COMPLETED|Open-Label Treatment Period||100
7819676|NCT01114737|19248662|P2|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97
7819677|NCT01114737|19248663|P1|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105
7819678|NCT01114737|19248662|P2|NOT COMPLETED|Randomized Treatment Period||1
7819679|NCT01114737|19248663|P1|NOT COMPLETED|Randomized Treatment Period||3
7819680|NCT01114737|19248662|P2|COMPLETED|Randomized Treatment Period||97
7819681|NCT01114737|19248663|P1|COMPLETED|Randomized Treatment Period||105
7819682|NCT01114737|19248662|P2|STARTED|Randomized Treatment Period||98
7819683|NCT01114737|19248663|P1|STARTED|Randomized Treatment Period||108
7819684|NCT01114724|19248711|P1|NOT COMPLETED|Overall Study||10
7819685|NCT01114724|19248711|P1|COMPLETED|Overall Study||40
7819686|NCT01114724|19248711|P1|STARTED|Overall Study||50
7819687|NCT01114672|19248731|P2|NOT COMPLETED|Overall Study||2
7819688|NCT01114672|19248732|P1|NOT COMPLETED|Overall Study||4
7819689|NCT01114672|19248731|P2|COMPLETED|Overall Study||23
7819690|NCT01114672|19248732|P1|COMPLETED|Overall Study||21
7819691|NCT01114672|19248731|P2|STARTED|Overall Study||25
7819692|NCT01114672|19248732|P1|STARTED|Overall Study||25
7819693|NCT01114646|19248740|P2|NOT COMPLETED|Overall Study||2
7819694|NCT01114646|19248741|P1|NOT COMPLETED|Overall Study||3
7819695|NCT01114646|19248740|P2|COMPLETED|Overall Study||62
7819696|NCT01114646|19248741|P1|COMPLETED|Overall Study||63
7819697|NCT01114646|19248740|P2|STARTED|Overall Study||64
7819698|NCT01114646|19248741|P1|STARTED|Overall Study||66
7819699|NCT01114620|19248747|P1|NOT COMPLETED|Overall Study||0
7819700|NCT01114620|19248747|P1|COMPLETED|Overall Study||50
7819701|NCT01114620|19248747|P1|STARTED|Overall Study||50
7819702|NCT01114581|19248780|P2|NOT COMPLETED|Overall Study||0
7819703|NCT01114581|19248781|P1|NOT COMPLETED|Overall Study||0
7819704|NCT01114581|19248780|P2|COMPLETED|Overall Study||19
7819705|NCT01114581|19248781|P1|COMPLETED|Overall Study||19
7819706|NCT01114581|19248780|P2|STARTED|Overall Study||19
7819707|NCT01114581|19248781|P1|STARTED|Overall Study||19
7819708|NCT01114555|19248791|P1|NOT COMPLETED|Overall Study||0
7819709|NCT01114555|19248791|P1|COMPLETED|Overall Study||34
7819710|NCT01114555|19248791|P1|STARTED|Overall Study||34
7819711|NCT01114529|19248801|P3|NOT COMPLETED|Completed Study Phase at Month 24||14
7819712|NCT01114529|19248802|P2|NOT COMPLETED|Completed Study Phase at Month 24||16
7819713|NCT01114529|19248803|P1|NOT COMPLETED|Completed Study Phase at Month 24||40
7819714|NCT01114529|19248801|P3|COMPLETED|Completed Study Phase at Month 24|at month 24|111
7819715|NCT01114529|19248802|P2|COMPLETED|Completed Study Phase at Month 24|at month 24|215
7819716|NCT01114529|19248803|P1|COMPLETED|Completed Study Phase at Month 24|at month 24|313
7819717|NCT01114529|19248801|P3|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|125
7819718|NCT01114529|19248802|P2|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|231
7819719|NCT01114529|19248803|P1|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|353
7819720|NCT01114529|19248801|P3|NOT COMPLETED|Completed Study Medication at Month 24||32
7819721|NCT01114529|19248802|P2|NOT COMPLETED|Completed Study Medication at Month 24||41
7819722|NCT01114529|19248803|P1|NOT COMPLETED|Completed Study Medication at Month 24||124
7819723|NCT01114529|19248801|P3|COMPLETED|Completed Study Medication at Month 24|completed at month 24|93
7819724|NCT01114529|19248802|P2|COMPLETED|Completed Study Medication at Month 24|completed at month 24|190
7819725|NCT01114529|19248803|P1|COMPLETED|Completed Study Medication at Month 24|completed at month 24|229
7819726|NCT01114529|19248801|P3|STARTED|Completed Study Medication at Month 24|Randomized set-125 Full analysis set -125 Safety analysis set -121***|125
7819727|NCT01114529|19248802|P2|STARTED|Completed Study Medication at Month 24|Randomized set -231 Full analysis set -231 Safety analysis set -238**|231
7819728|NCT01114529|19248803|P1|STARTED|Completed Study Medication at Month 24|Randomized set - 360 Full analysis set - 353 Safety analysis set -346*|353
7819729|NCT01114516|19248822|P2|NOT COMPLETED|Overall Study||1
7819730|NCT01114516|19248823|P1|NOT COMPLETED|Overall Study||2
7819731|NCT01114516|19248822|P2|COMPLETED|Overall Study||26
7819732|NCT01114516|19248823|P1|COMPLETED|Overall Study||24
7819733|NCT01114516|19248822|P2|STARTED|Overall Study||27
7819734|NCT01114516|19248823|P1|STARTED|Overall Study||26
7819735|NCT01114503|19248837|P1|NOT COMPLETED|Overall Study||0
7819736|NCT01114503|19248837|P1|COMPLETED|Overall Study||2
7819737|NCT01114503|19248837|P1|STARTED|Overall Study||2
7819738|NCT01114438|19248858|P1|NOT COMPLETED|Overall Study||14
7819739|NCT01114438|19248858|P1|COMPLETED|Overall Study||31
7819740|NCT01114438|19248858|P1|STARTED|Overall Study||45
7819741|NCT01114373|19248868|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||1
7819742|NCT01114373|19248869|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
7819743|NCT01114373|19248868|P2|COMPLETED|Intervention 2 (4 Weeks)||18
7819744|NCT01114373|19248869|P1|COMPLETED|Intervention 2 (4 Weeks)||18
7819745|NCT01114373|19248868|P2|STARTED|Intervention 2 (4 Weeks)||19
7819746|NCT01114373|19248869|P1|STARTED|Intervention 2 (4 Weeks)||18
7819747|NCT01114373|19248868|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||0
7819748|NCT01114373|19248869|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||3
7819749|NCT01114373|19248868|P2|COMPLETED|Intervention 1 (4 Weeks)||19
7819750|NCT01114373|19248869|P1|COMPLETED|Intervention 1 (4 Weeks)||18
7819751|NCT01114373|19248868|P2|STARTED|Intervention 1 (4 Weeks)||19
7819752|NCT01114373|19248869|P1|STARTED|Intervention 1 (4 Weeks)||21
7819753|NCT01114360|19248901|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||0
7819754|NCT01114360|19248902|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
7819755|NCT01114360|19248901|P2|COMPLETED|Intervention 2 (4 Weeks)||18
7819756|NCT01114360|19248902|P1|COMPLETED|Intervention 2 (4 Weeks)||18
7819757|NCT01114360|19248901|P2|STARTED|Intervention 2 (4 Weeks)||18
7819758|NCT01114360|19248902|P1|STARTED|Intervention 2 (4 Weeks)||18
7819759|NCT01114360|19248901|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||1
7819760|NCT01114360|19248902|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||0
7819761|NCT01114360|19248901|P2|COMPLETED|Intervention 1 (4 Weeks)||18
7819762|NCT01114360|19248902|P1|COMPLETED|Intervention 1 (4 Weeks)||18
7819763|NCT01114360|19248901|P2|STARTED|Intervention 1 (4 Weeks)||19
7819764|NCT01114360|19248902|P1|STARTED|Intervention 1 (4 Weeks)||18
7819765|NCT01114334|19248940|P2|NOT COMPLETED|Overall Study||22
7819766|NCT01114334|19248941|P1|NOT COMPLETED|Overall Study||21
7819767|NCT01114334|19248940|P2|COMPLETED|Overall Study||58
7819768|NCT01114334|19248941|P1|COMPLETED|Overall Study||67
7819769|NCT01114334|19248940|P2|STARTED|Overall Study||80
7819770|NCT01114334|19248941|P1|STARTED|Overall Study||88
7819771|NCT01114217|19248953|P2|NOT COMPLETED|Overall Study||98
7819772|NCT01114217|19248954|P1|NOT COMPLETED|Overall Study||75
7819773|NCT01114217|19248953|P2|COMPLETED|Overall Study||199
7819774|NCT01114217|19248954|P1|COMPLETED|Overall Study|Two participants lacked study completion data: one site stopped communicating during the study.|262
7819775|NCT01114217|19248953|P2|Received at Least 1 Dose of Ferumoxytol|Overall Study||0
7819776|NCT01114217|19248954|P1|Received at Least 1 Dose of Ferumoxytol|Overall Study||337
7819777|NCT01114217|19248953|P2|STARTED|Overall Study||297
7819778|NCT01114217|19248954|P1|STARTED|Overall Study||337
7819779|NCT01114204|19248966|P2|NOT COMPLETED|Overall Study||8
7819780|NCT01114204|19248967|P1|NOT COMPLETED|Overall Study||21
7819781|NCT01114204|19248966|P2|COMPLETED|Overall Study||191
7819782|NCT01114204|19248967|P1|COMPLETED|Overall Study||385
7819783|NCT01114204|19248966|P2|Received at Least 1 Dose of Study Drug|Overall Study||199
7819784|NCT01114204|19248967|P1|Received at Least 1 Dose of Study Drug|Overall Study||406
7819785|NCT01114204|19248966|P2|STARTED|Overall Study||199
7819786|NCT01114204|19248967|P1|STARTED|Overall Study||406
7819787|NCT01114139|19248985|P2|NOT COMPLETED|Overall Study||16
7819788|NCT01114139|19248986|P1|NOT COMPLETED|Overall Study||40
7819789|NCT01114139|19248985|P2|COMPLETED|Overall Study||187
7819790|NCT01114139|19248986|P1|COMPLETED|Overall Study||569
7819791|NCT01114139|19248985|P2|Received at Least 1 Dose of Study Drug|Overall Study||200
7819792|NCT01114139|19248986|P1|Received at Least 1 Dose of Study Drug|Overall Study||608
7819793|NCT01114139|19248985|P2|STARTED|Overall Study||203
7819794|NCT01114139|19248986|P1|STARTED|Overall Study||609
7819795|NCT01113983|19249004|P2|NOT COMPLETED|Overall Study||17
7819796|NCT01113983|19249005|P1|NOT COMPLETED|Overall Study||25
7819797|NCT01113983|19249004|P2|COMPLETED|Overall Study||10
7819798|NCT01113983|19249005|P1|COMPLETED|Overall Study||12
7819799|NCT01113983|19249004|P2|STARTED|Overall Study||27
7819800|NCT01113983|19249005|P1|STARTED|Overall Study||37
7819801|NCT01113931|19249015|P2|NOT COMPLETED|Overall Study||17
7819802|NCT01113931|19249016|P1|NOT COMPLETED|Overall Study||19
7819803|NCT01113931|19249015|P2|COMPLETED|Overall Study||231
7819804|NCT01113931|19249016|P1|COMPLETED|Overall Study||228
7819805|NCT01113931|19249015|P2|mITT Population|Overall Study||190
7819806|NCT01113931|19249016|P1|mITT Population|Overall Study||188
7819807|NCT01113931|19249015|P2|Safety Population|Overall Study||248
7819808|NCT01113931|19249016|P1|Safety Population|Overall Study|1 subject did not take any study medication|246
7819809|NCT01113931|19249015|P2|STARTED|Overall Study||248
7819810|NCT01113931|19249016|P1|STARTED|Overall Study||247
7819811|NCT01113892|19249030|P2|NOT COMPLETED|Overall Study||16
7819812|NCT01113892|19249031|P1|NOT COMPLETED|Overall Study||14
7819813|NCT01113892|19249030|P2|COMPLETED|Overall Study||90
7819814|NCT01113892|19249031|P1|COMPLETED|Overall Study||87
7819815|NCT01113892|19249030|P2|STARTED|Overall Study||106
7819816|NCT01113892|19249031|P1|STARTED|Overall Study||101
7819817|NCT01113879|19249059|P2|NOT COMPLETED|Period 2: Block 2||0
7819818|NCT01113879|19249060|P1|NOT COMPLETED|Period 2: Block 2||0
7819819|NCT01113879|19249059|P2|COMPLETED|Period 2: Block 2||2
7819820|NCT01113879|19249060|P1|COMPLETED|Period 2: Block 2||5
7819821|NCT01113879|19249059|P2|STARTED|Period 2: Block 2||2
7819822|NCT01113879|19249060|P1|STARTED|Period 2: Block 2||5
7819823|NCT01113879|19249059|P2|NOT COMPLETED|Period 1: Block 1||0
7819824|NCT01113879|19249060|P1|NOT COMPLETED|Period 1: Block 1||2
7819825|NCT01113879|19249059|P2|COMPLETED|Period 1: Block 1||2
7819826|NCT01113879|19249060|P1|COMPLETED|Period 1: Block 1||5
7819827|NCT01113879|19249059|P2|STARTED|Period 1: Block 1||2
7819828|NCT01113879|19249060|P1|STARTED|Period 1: Block 1||7
7819829|NCT01113801|19249072|P4|NOT COMPLETED|Overall Study||41
7819830|NCT01113801|19249073|P3|NOT COMPLETED|Overall Study||37
7819831|NCT01113801|19249074|P2|NOT COMPLETED|Overall Study||40
7819832|NCT01113801|19249075|P1|NOT COMPLETED|Overall Study||41
7819833|NCT01113801|19249072|P4|COMPLETED|Overall Study||65
7819834|NCT01113801|19249073|P3|COMPLETED|Overall Study||66
7819835|NCT01113801|19249074|P2|COMPLETED|Overall Study||65
7819836|NCT01113801|19249075|P1|COMPLETED|Overall Study||62
7819837|NCT01113801|19249072|P4|Received at Least One Dose of Drug|Overall Study||105
7819838|NCT01113801|19249073|P3|Received at Least One Dose of Drug|Overall Study||103
7819839|NCT01113801|19249074|P2|Received at Least One Dose of Drug|Overall Study||105
7819840|NCT01113801|19249075|P1|Received at Least One Dose of Drug|Overall Study||103
7819841|NCT01113801|19249072|P4|STARTED|Overall Study||106
7819842|NCT01113801|19249073|P3|STARTED|Overall Study||103
7819843|NCT01113801|19249074|P2|STARTED|Overall Study||105
7819844|NCT01113801|19249075|P1|STARTED|Overall Study||103
7819845|NCT01113749|19249103|P2|NOT COMPLETED|Overall Study||2
7819846|NCT01113749|19249104|P1|NOT COMPLETED|Overall Study||1
7819847|NCT01113749|19249103|P2|COMPLETED|Overall Study||127
7819848|NCT01113749|19249104|P1|COMPLETED|Overall Study||126
7819849|NCT01113749|19249103|P2|STARTED|Overall Study||129
7819850|NCT01113749|19249104|P1|STARTED|Overall Study||127
7819851|NCT01113723|19249116|P2|NOT COMPLETED|Overall Study||0
7819852|NCT01113723|19249117|P1|NOT COMPLETED|Overall Study||0
7819853|NCT01113723|19249116|P2|COMPLETED|Overall Study||70
7819854|NCT01113723|19249117|P1|COMPLETED|Overall Study||70
7819855|NCT01113723|19249116|P2|STARTED|Overall Study||70
7819856|NCT01113723|19249117|P1|STARTED|Overall Study||70
7819857|NCT01113710|19249127|P1|NOT COMPLETED|Overall Study||269
7819858|NCT01113710|19249127|P1|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418
7819859|NCT01113710|19249127|P1|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687
7819860|NCT01113632|19249138|P2|NOT COMPLETED|Overall Study||25
7819861|NCT01113632|19249139|P1|NOT COMPLETED|Overall Study||31
7819862|NCT01113632|19249138|P2|COMPLETED|Overall Study||19
7819863|NCT01113632|19249139|P1|COMPLETED|Overall Study||2
7819864|NCT01113632|19249138|P2|STARTED|Overall Study||44
7819865|NCT01113632|19249139|P1|STARTED|Overall Study||33
7819866|NCT01113580|19249155|P2|NOT COMPLETED|Overall Study||0
7819867|NCT01113580|19249156|P1|NOT COMPLETED|Overall Study||1
7819868|NCT01113580|19249155|P2|COMPLETED|Overall Study||60
7819869|NCT01113580|19249156|P1|COMPLETED|Overall Study||59
7819870|NCT01113580|19249155|P2|STARTED|Overall Study||60
7819871|NCT01113580|19249156|P1|STARTED|Overall Study||60
7819872|NCT01113541|19249170|P1|NOT COMPLETED|Overall Study||13
7819873|NCT01113541|19249170|P1|COMPLETED|Overall Study||0
7819874|NCT01113541|19249170|P1|STARTED|Overall Study||13
7819875|NCT01113463|19249203|P1|NOT COMPLETED|Overall Study||5
7819876|NCT01113463|19249203|P1|COMPLETED|Overall Study||12
7819877|NCT01113463|19249203|P1|STARTED|Overall Study||17
7819878|NCT01113398|19249208|P1|NOT COMPLETED|Overall Study||0
7819879|NCT01113398|19249208|P1|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36
7819880|NCT01113398|19249208|P1|STARTED|Overall Study||36
7819881|NCT01113385|19249215|P1|NOT COMPLETED|Overall Study||0
7819882|NCT01113385|19249215|P1|COMPLETED|Overall Study||7
7819883|NCT01113385|19249215|P1|STARTED|Overall Study||7
7819884|NCT01113008|19249222|P2|NOT COMPLETED|Overall Study||0
7819885|NCT01113008|19249223|P1|NOT COMPLETED|Overall Study||0
7819886|NCT01113008|19249222|P2|COMPLETED|Overall Study||133
7819887|NCT01113008|19249223|P1|COMPLETED|Overall Study||133
7819888|NCT01113008|19249222|P2|STARTED|Overall Study||133
7819889|NCT01113008|19249223|P1|STARTED|Overall Study||133
7819890|NCT01112982|19249233|P1|NOT COMPLETED|Overall Study||2
7819891|NCT01112982|19249233|P1|COMPLETED|Overall Study||72
7819892|NCT01112982|19249233|P1|STARTED|Overall Study||74
7819893|NCT01112917|19249245|P2|NOT COMPLETED|Overall Study||15
7819894|NCT01112917|19249246|P1|NOT COMPLETED|Overall Study||7
7819895|NCT01112917|19249245|P2|COMPLETED|Overall Study||38
7819896|NCT01112917|19249246|P1|COMPLETED|Overall Study||89
7819897|NCT01112917|19249245|P2|STARTED|Overall Study||53
7819898|NCT01112917|19249246|P1|STARTED|Overall Study||96
7819899|NCT01112865|19249251|P2|NOT COMPLETED|Second Intervention||0
7819900|NCT01112865|19249252|P1|NOT COMPLETED|Second Intervention||0
7819901|NCT01112865|19249251|P2|COMPLETED|Second Intervention||61
7819902|NCT01112865|19249252|P1|COMPLETED|Second Intervention||59
7819903|NCT01112865|19249251|P2|STARTED|Second Intervention||61
7819904|NCT01112865|19249252|P1|STARTED|Second Intervention||59
7819905|NCT01112865|19249251|P2|NOT COMPLETED|First Intervention||0
7819906|NCT01112865|19249252|P1|NOT COMPLETED|First Intervention||0
7819907|NCT01112865|19249251|P2|COMPLETED|First Intervention||61
7819908|NCT01112865|19249252|P1|COMPLETED|First Intervention||59
7819909|NCT01112865|19249251|P2|STARTED|First Intervention||61
7819910|NCT01112865|19249252|P1|STARTED|First Intervention||59
7819911|NCT01112735|19249264|P2|NOT COMPLETED|Overall Study||0
7819912|NCT01112735|19249265|P1|NOT COMPLETED|Overall Study||0
7819913|NCT01112735|19249264|P2|COMPLETED|Overall Study||20
7819914|NCT01112735|19249265|P1|COMPLETED|Overall Study||20
7819915|NCT01112735|19249264|P2|STARTED|Overall Study||20
7819916|NCT01112735|19249265|P1|STARTED|Overall Study||20
7819917|NCT01112696|19249289|P1|NOT COMPLETED|Overall Study||2
7819918|NCT01112696|19249289|P1|COMPLETED|Overall Study||98
7819919|NCT01112696|19249289|P1|STARTED|Overall Study||100
7819920|NCT01112683|19249296|P2|NOT COMPLETED|Overall Study||1
7819921|NCT01112683|19249297|P1|NOT COMPLETED|Overall Study||1
7819922|NCT01112683|19249296|P2|COMPLETED|Overall Study||19
7819923|NCT01112683|19249297|P1|COMPLETED|Overall Study||18
7819924|NCT01112683|19249296|P2|STARTED|Overall Study||20
7819925|NCT01112683|19249297|P1|STARTED|Overall Study||19
7819926|NCT01112670|19249307|P6|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
7819927|NCT01112670|19249308|P5|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
7819928|NCT01112670|19249309|P4|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
7819929|NCT01112670|19249310|P3|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
7819930|NCT01112670|19249311|P2|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
7819931|NCT01112670|19249312|P1|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
7819932|NCT01112670|19249307|P6|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5
7819933|NCT01112670|19249308|P5|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
7819934|NCT01112670|19249309|P4|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4
7819935|NCT01112670|19249310|P3|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
7819936|NCT01112670|19249311|P2|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3
7819937|NCT01112670|19249312|P1|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
7819938|NCT01112670|19249307|P6|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5
7819939|NCT01112670|19249308|P5|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
7819940|NCT01112670|19249309|P4|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4
7819941|NCT01112670|19249310|P3|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
7819942|NCT01112670|19249311|P2|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3
7819943|NCT01112670|19249312|P1|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
7819944|NCT01112670|19249307|P6|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
7819945|NCT01112670|19249308|P5|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
7819946|NCT01112670|19249309|P4|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
7819947|NCT01112670|19249310|P3|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
7819948|NCT01112670|19249311|P2|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
7819949|NCT01112670|19249312|P1|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
7819950|NCT01112670|19249307|P6|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
7819951|NCT01112670|19249308|P5|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5
7819952|NCT01112670|19249309|P4|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
7819953|NCT01112670|19249310|P3|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6
7819954|NCT01112670|19249311|P2|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
7819955|NCT01112670|19249312|P1|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7
7819956|NCT01112670|19249307|P6|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
7819957|NCT01112670|19249308|P5|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6
7819958|NCT01112670|19249309|P4|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
7819959|NCT01112670|19249310|P3|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7
7819960|NCT01112670|19249311|P2|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
7819961|NCT01112670|19249312|P1|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8
7819962|NCT01112579|19249350|P2|NOT COMPLETED|Overall Study||3
7819963|NCT01112579|19249351|P1|NOT COMPLETED|Overall Study||1
7819964|NCT01112579|19249350|P2|COMPLETED|Overall Study||21
7819965|NCT01112579|19249351|P1|COMPLETED|Overall Study||41
7819966|NCT01112579|19249350|P2|STARTED|Overall Study||24
7819967|NCT01112579|19249351|P1|STARTED|Overall Study||42
7819968|NCT01112514|19249361|P1|NOT COMPLETED|Overall Study||1
7819969|NCT01112514|19249361|P1|COMPLETED|Overall Study||3
7819970|NCT01112514|19249361|P1|STARTED|Overall Study||4
7819971|NCT01112358|19249367|P2|NOT COMPLETED|Overall Study||0
7819972|NCT01112358|19249368|P1|NOT COMPLETED|Overall Study||0
7819973|NCT01112358|19249367|P2|COMPLETED|Overall Study||33
7819974|NCT01112358|19249368|P1|COMPLETED|Overall Study||25
7819975|NCT01112358|19249367|P2|STARTED|Overall Study||33
7819976|NCT01112358|19249368|P1|STARTED|Overall Study||25
7819977|NCT01112293|19249404|P1|NOT COMPLETED|Overall Study||0
7819978|NCT01112293|19249404|P1|COMPLETED|Overall Study||14
7819979|NCT01112293|19249404|P1|STARTED|Overall Study||14
7819980|NCT01112267|19249417|P2|NOT COMPLETED|Overall Study||18
7819981|NCT01112267|19249418|P1|NOT COMPLETED|Overall Study||34
7819982|NCT01112267|19249417|P2|COMPLETED|Overall Study||104
7819983|NCT01112267|19249418|P1|COMPLETED|Overall Study||92
7819984|NCT01112267|19249417|P2|Treated|Overall Study||120
7819985|NCT01112267|19249418|P1|Treated|Overall Study||125
7819986|NCT01112267|19249417|P2|STARTED|Overall Study||122
7819987|NCT01112267|19249418|P1|STARTED|Overall Study||126
7819988|NCT01112241|19249436|P1|NOT COMPLETED|Overall Study||0
7819989|NCT01112241|19249436|P1|COMPLETED|Overall Study||17
7819990|NCT01112241|19249436|P1|STARTED|Overall Study||17
7819991|NCT01112228|19249449|P1|NOT COMPLETED|Overall Study||0
7819992|NCT01112228|19249449|P1|COMPLETED|Overall Study||600
7819993|NCT01112228|19249449|P1|STARTED|Overall Study||600
7819994|NCT01112059|19249457|P2|NOT COMPLETED|Overall Study||0
7819995|NCT01112059|19249458|P1|NOT COMPLETED|Overall Study||1
7819996|NCT01112059|19249457|P2|COMPLETED|Overall Study||20
7819997|NCT01112059|19249458|P1|COMPLETED|Overall Study||19
7819998|NCT01112059|19249457|P2|STARTED|Overall Study||20
7819999|NCT01112059|19249458|P1|STARTED|Overall Study||20
7820000|NCT01111851|19249472|P2|NOT COMPLETED|Overall Study||0
7820001|NCT01111851|19249473|P1|NOT COMPLETED|Overall Study||2
7820002|NCT01111851|19249472|P2|COMPLETED|Overall Study||8
7820003|NCT01111851|19249473|P1|COMPLETED|Overall Study||6
7820004|NCT01111851|19249472|P2|STARTED|Overall Study||8
7820005|NCT01111851|19249473|P1|STARTED|Overall Study||8
7820006|NCT01111838|19249485|P1|NOT COMPLETED|Overall Study||7
7820007|NCT01111838|19249485|P1|COMPLETED|Overall Study||15
7820008|NCT01111838|19249485|P1|STARTED|Overall Study||22
7820009|NCT01111825|19249493|P4|NOT COMPLETED|Overall Study||21
7820010|NCT01111825|19249494|P3|NOT COMPLETED|Overall Study||8
7820011|NCT01111825|19249495|P2|NOT COMPLETED|Overall Study||1
7820012|NCT01111825|19249496|P1|NOT COMPLETED|Overall Study||3
7820013|NCT01111825|19249493|P4|COMPLETED|Overall Study||27
7820014|NCT01111825|19249494|P3|COMPLETED|Overall Study||29
7820015|NCT01111825|19249495|P2|COMPLETED|Overall Study||5
7820016|NCT01111825|19249496|P1|COMPLETED|Overall Study||5
7820017|NCT01111825|19249493|P4|STARTED|Overall Study||48
7820018|NCT01111825|19249494|P3|STARTED|Overall Study||37
7820019|NCT01111825|19249495|P2|STARTED|Overall Study||6
7820020|NCT01111825|19249496|P1|STARTED|Overall Study||8
7820021|NCT01111604|19249518|P3|NOT COMPLETED|Overall Study||3
7820022|NCT01111604|19249519|P2|NOT COMPLETED|Overall Study||0
7820023|NCT01111604|19249520|P1|NOT COMPLETED|Overall Study||8
7820024|NCT01111604|19249518|P3|COMPLETED|Overall Study||49
7820025|NCT01111604|19249519|P2|COMPLETED|Overall Study||52
7820026|NCT01111604|19249520|P1|COMPLETED|Overall Study||46
7820027|NCT01111604|19249518|P3|Received at Least One Dose of Study Drug|Overall Study||52
7820028|NCT01111604|19249519|P2|Received at Least One Dose of Study Drug|Overall Study||52
7820029|NCT01111604|19249520|P1|Received at Least One Dose of Study Drug|Overall Study||49
7820030|NCT01111604|19249518|P3|STARTED|Overall Study||52
7820031|NCT01111604|19249519|P2|STARTED|Overall Study||52
7820032|NCT01111604|19249520|P1|STARTED|Overall Study||54
7820033|NCT01111526|19249558|P3|NOT COMPLETED|Overall Study||2
7820034|NCT01111526|19249559|P2|NOT COMPLETED|Overall Study||1
7820035|NCT01111526|19249560|P1|NOT COMPLETED|Overall Study||0
7820036|NCT01111526|19249558|P3|COMPLETED|Overall Study||8
7820037|NCT01111526|19249559|P2|COMPLETED|Overall Study||7
7820038|NCT01111526|19249560|P1|COMPLETED|Overall Study||4
7820039|NCT01111526|19249558|P3|STARTED|Overall Study||10
7820040|NCT01111526|19249559|P2|STARTED|Overall Study||8
7820041|NCT01111526|19249560|P1|STARTED|Overall Study||4
7820042|NCT01111474|19249572|P1|NOT COMPLETED|Overall Study||12
7820043|NCT01111474|19249572|P1|COMPLETED|Overall Study|434 teeth from 62 participants: 218 teeth teated with cyanoacrylate and 216 teeth with LILT|62
7820044|NCT01111474|19249572|P1|STARTED|Overall Study|593 teeth from 74 participants: 296 teeth treated with cyanoacrylate and 297 teeth with LILT|74
7820045|NCT01111461|19249580|P1|NOT COMPLETED|Overall Study||51
7820046|NCT01111461|19249580|P1|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82
7820047|NCT01111461|19249580|P1|STARTED|Overall Study||133
7820048|NCT01111370|19249593|P1|NOT COMPLETED|Overall Study||2
7820049|NCT01111370|19249593|P1|COMPLETED|Overall Study||58
7820050|NCT01111370|19249593|P1|STARTED|Overall Study||60
7820051|NCT01111331|19249597|P2|NOT COMPLETED|Overall Study||0
7820052|NCT01111331|19249598|P1|NOT COMPLETED|Overall Study||0
7820053|NCT01111331|19249597|P2|COMPLETED|Overall Study||9
7820054|NCT01111331|19249598|P1|COMPLETED|Overall Study||9
7820055|NCT01111331|19249597|P2|STARTED|Overall Study||9
7820056|NCT01111331|19249598|P1|STARTED|Overall Study||9
7820057|NCT01111318|19249680|P4|NOT COMPLETED|Overall Study||0
7820058|NCT01111318|19249681|P3|NOT COMPLETED|Overall Study||0
7820059|NCT01111318|19249682|P2|NOT COMPLETED|Overall Study||0
7820060|NCT01111318|19249683|P1|NOT COMPLETED|Overall Study||0
7820061|NCT01111318|19249680|P4|COMPLETED|Overall Study||8
7820062|NCT01111318|19249681|P3|COMPLETED|Overall Study||8
7820063|NCT01111318|19249682|P2|COMPLETED|Overall Study||8
7820064|NCT01111318|19249683|P1|COMPLETED|Overall Study||12
7820065|NCT01111318|19249680|P4|STARTED|Overall Study||8
7820066|NCT01111318|19249681|P3|STARTED|Overall Study||8
7820067|NCT01111318|19249682|P2|STARTED|Overall Study||8
7820068|NCT01111318|19249683|P1|STARTED|Overall Study||12
7820069|NCT01111305|19249747|P2|NOT COMPLETED|Overall Study||0
7820070|NCT01111305|19249748|P1|NOT COMPLETED|Overall Study||0
7820071|NCT01111305|19249747|P2|COMPLETED|Overall Study||4
7820072|NCT01111305|19249748|P1|COMPLETED|Overall Study||4
7820073|NCT01111305|19249747|P2|STARTED|Overall Study||4
7820074|NCT01111305|19249748|P1|STARTED|Overall Study||4
7820075|NCT01111292|19249760|P2|NOT COMPLETED|Follow-Up||0
7820076|NCT01111292|19249761|P1|NOT COMPLETED|Follow-Up||0
7820077|NCT01111292|19249760|P2|COMPLETED|Follow-Up||1
7820078|NCT01111292|19249761|P1|COMPLETED|Follow-Up||2
7820079|NCT01111292|19249760|P2|STARTED|Follow-Up||1
7820080|NCT01111292|19249761|P1|STARTED|Follow-Up||2
7820081|NCT01111292|19249760|P2|NOT COMPLETED|Post Treatment Biopsy||0
7820082|NCT01111292|19249761|P1|NOT COMPLETED|Post Treatment Biopsy||0
7820083|NCT01111292|19249760|P2|COMPLETED|Post Treatment Biopsy||1
7820084|NCT01111292|19249761|P1|COMPLETED|Post Treatment Biopsy||2
7820085|NCT01111292|19249760|P2|STARTED|Post Treatment Biopsy||1
7820086|NCT01111292|19249761|P1|STARTED|Post Treatment Biopsy||2
7820087|NCT01111292|19249760|P2|NOT COMPLETED|Treatment||1
7820088|NCT01111292|19249761|P1|NOT COMPLETED|Treatment||1
7820089|NCT01111292|19249760|P2|COMPLETED|Treatment||1
7820090|NCT01111292|19249761|P1|COMPLETED|Treatment||2
7820091|NCT01111292|19249760|P2|STARTED|Treatment||2
7820092|NCT01111292|19249761|P1|STARTED|Treatment||3
7820093|NCT01111292|19249760|P2|NOT COMPLETED|Randomization||0
7820094|NCT01111292|19249761|P1|NOT COMPLETED|Randomization||0
7820095|NCT01111292|19249760|P2|COMPLETED|Randomization||2
7820096|NCT01111292|19249761|P1|COMPLETED|Randomization||3
7820097|NCT01111292|19249760|P2|STARTED|Randomization||2
7820098|NCT01111292|19249761|P1|STARTED|Randomization||3
7820099|NCT01111240|19249767|P1|NOT COMPLETED|Overall Study||1066
7820100|NCT01111240|19249767|P1|COMPLETED|Overall Study||3569
7820101|NCT01111240|19249767|P1|STARTED|Overall Study||4635
7820102|NCT01111162|19249789|P1|NOT COMPLETED|Overall Study||0
7820103|NCT01111162|19249789|P1|COMPLETED|Overall Study||120
7820104|NCT01111162|19249789|P1|STARTED|Overall Study||120
7820105|NCT01111149|19249797|P3|NOT COMPLETED|Overall Study||4
7820106|NCT01111149|19249798|P2|NOT COMPLETED|Overall Study||1
7820107|NCT01111149|19249799|P1|NOT COMPLETED|Overall Study||2
7820108|NCT01111149|19249797|P3|COMPLETED|Overall Study||5
7820109|NCT01111149|19249798|P2|COMPLETED|Overall Study||5
7820110|NCT01111149|19249799|P1|COMPLETED|Overall Study||7
7820111|NCT01111149|19249797|P3|STARTED|Overall Study||9
7820112|NCT01111149|19249798|P2|STARTED|Overall Study||6
7820113|NCT01111149|19249799|P1|STARTED|Overall Study||9
7820114|NCT01111123|19249875|P2|NOT COMPLETED|Maintenance Phase||2
7820115|NCT01111123|19249876|P1|NOT COMPLETED|Maintenance Phase||0
7820116|NCT01111123|19249875|P2|COMPLETED|Maintenance Phase||18
7820117|NCT01111123|19249876|P1|COMPLETED|Maintenance Phase||21
7820118|NCT01111123|19249875|P2|STARTED|Maintenance Phase||20
7820119|NCT01111123|19249876|P1|STARTED|Maintenance Phase||21
7820120|NCT01111123|19249875|P2|NOT COMPLETED|Open- Label Phase||0
7820121|NCT01111123|19249876|P1|NOT COMPLETED|Open- Label Phase||14
7820122|NCT01111123|19249875|P2|COMPLETED|Open- Label Phase||0
7820123|NCT01111123|19249876|P1|COMPLETED|Open- Label Phase||41
7820124|NCT01111123|19249875|P2|STARTED|Open- Label Phase||0
7820125|NCT01111123|19249876|P1|STARTED|Open- Label Phase||55
7820126|NCT01111110|19249886|P2|NOT COMPLETED|Overall Study||0
7820127|NCT01111110|19249887|P1|NOT COMPLETED|Overall Study||0
7820128|NCT01111110|19249886|P2|COMPLETED|Overall Study||4
7820129|NCT01111110|19249887|P1|COMPLETED|Overall Study||3
7820130|NCT01111110|19249886|P2|STARTED|Overall Study||4
7820131|NCT01111110|19249887|P1|STARTED|Overall Study||3
7820132|NCT01111058|19249899|P2|NOT COMPLETED|Overall Study||0
7820133|NCT01111058|19249900|P1|NOT COMPLETED|Overall Study||0
7820134|NCT01111058|19249899|P2|COMPLETED|Overall Study||24
7820135|NCT01111058|19249900|P1|COMPLETED|Overall Study||28
7820136|NCT01111058|19249899|P2|STARTED|Overall Study||24
7820137|NCT01111058|19249900|P1|STARTED|Overall Study||28
7820138|NCT01111019|19249922|P1|NOT COMPLETED|Overall Study||3
7820139|NCT01111019|19249922|P1|COMPLETED|Overall Study||16
7820140|NCT01111019|19249922|P1|STARTED|Overall Study||19
7820141|NCT01110967|19249941|P1|NOT COMPLETED|Overall Study||9
7820142|NCT01110967|19249941|P1|COMPLETED|Overall Study||31
7820143|NCT01110967|19249941|P1|12 Months Follow up|Overall Study||31
7820144|NCT01110967|19249941|P1|6 Months Follow up|Overall Study||24
7820145|NCT01110967|19249941|P1|3 Months Follow up|Overall Study||28
7820146|NCT01110967|19249941|P1|1 Month Follow up|Overall Study||26
7820147|NCT01110967|19249941|P1|Surgery|Overall Study||40
7820148|NCT01110967|19249941|P1|STARTED|Overall Study||40
7820149|NCT01110915|19249954|P2|NOT COMPLETED|Overall Study||2
7820150|NCT01110915|19249955|P1|NOT COMPLETED|Overall Study||10
7820151|NCT01110915|19249954|P2|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84
7820152|NCT01110915|19249955|P1|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167
7820153|NCT01110915|19249954|P2|STARTED|Overall Study|Subjects being randomized to the Control group.|86
7820154|NCT01110915|19249955|P1|STARTED|Overall Study|Subjects being randomized to the MRI group.|177
7820155|NCT01110707|19249972|P2|NOT COMPLETED|Overall Study||3
7820156|NCT01110707|19249973|P1|NOT COMPLETED|Overall Study||0
7820157|NCT01110707|19249972|P2|COMPLETED|Overall Study||65
7820158|NCT01110707|19249973|P1|COMPLETED|Overall Study||63
7820159|NCT01110707|19249972|P2|STARTED|Overall Study||68
7820160|NCT01110707|19249973|P1|STARTED|Overall Study||63
7820161|NCT01110681|19249995|P1|NOT COMPLETED|Overall Study||32
7820162|NCT01110681|19249995|P1|COMPLETED|Overall Study||83
7820163|NCT01110681|19249995|P1|STARTED|Overall Study||115
7820164|NCT01110499|19250011|P8|NOT COMPLETED|Overall Study||0
7820165|NCT01110499|19250012|P7|NOT COMPLETED|Overall Study||0
7820166|NCT01110499|19250013|P6|NOT COMPLETED|Overall Study||0
7820167|NCT01110499|19250014|P5|NOT COMPLETED|Overall Study||0
7820168|NCT01110499|19250015|P4|NOT COMPLETED|Overall Study||0
7820169|NCT01110499|19250016|P3|NOT COMPLETED|Overall Study||0
7820170|NCT01110499|19250017|P2|NOT COMPLETED|Overall Study||0
7820171|NCT01110499|19250018|P1|NOT COMPLETED|Overall Study||0
7820172|NCT01110499|19250011|P8|COMPLETED|Overall Study||40
7820173|NCT01110499|19250012|P7|COMPLETED|Overall Study||39
7820174|NCT01110499|19250013|P6|COMPLETED|Overall Study||14
7820175|NCT01110499|19250014|P5|COMPLETED|Overall Study||14
7820176|NCT01110499|19250015|P4|COMPLETED|Overall Study||14
7820177|NCT01110499|19250016|P3|COMPLETED|Overall Study||14
7820178|NCT01110499|19250017|P2|COMPLETED|Overall Study||14
7820179|NCT01110499|19250018|P1|COMPLETED|Overall Study||14
7820180|NCT01110499|19250011|P8|STARTED|Overall Study||40
7820181|NCT01110499|19250012|P7|STARTED|Overall Study||39
7820182|NCT01110499|19250013|P6|STARTED|Overall Study||14
7820183|NCT01110499|19250014|P5|STARTED|Overall Study||14
7820184|NCT01110499|19250015|P4|STARTED|Overall Study||14
7820185|NCT01110499|19250016|P3|STARTED|Overall Study||14
7820186|NCT01110499|19250017|P2|STARTED|Overall Study||14
7820187|NCT01110499|19250018|P1|STARTED|Overall Study||14
7820188|NCT01110434|19250040|P2|NOT COMPLETED|Overall Study||6
7820189|NCT01110434|19250041|P1|NOT COMPLETED|Overall Study||11
7820190|NCT01110434|19250040|P2|COMPLETED|Overall Study||20
7820191|NCT01110434|19250041|P1|COMPLETED|Overall Study||29
7820192|NCT01110434|19250040|P2|STARTED|Overall Study||26
7820193|NCT01110434|19250041|P1|STARTED|Overall Study||40
7820194|NCT01110421|19250053|P2|NOT COMPLETED|Overall Study||0
7820195|NCT01110421|19250054|P1|NOT COMPLETED|Overall Study||0
7820196|NCT01110421|19250053|P2|COMPLETED|Overall Study||2
7820197|NCT01110421|19250054|P1|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5
7820198|NCT01110421|19250053|P2|STARTED|Overall Study||2
7820199|NCT01110421|19250054|P1|STARTED|Overall Study||5
7820200|NCT01110408|19250074|P2|NOT COMPLETED|Overall Study||0
7820201|NCT01110408|19250075|P1|NOT COMPLETED|Overall Study||1
7820202|NCT01110408|19250074|P2|COMPLETED|Overall Study||10
7820203|NCT01110408|19250075|P1|COMPLETED|Overall Study||30
7820204|NCT01110408|19250074|P2|STARTED|Overall Study||10
7820205|NCT01110408|19250075|P1|STARTED|Overall Study||31
7820206|NCT01110395|19250093|P1|NOT COMPLETED|Overall Study||0
7820207|NCT01110395|19250093|P1|COMPLETED|Overall Study||15
7820208|NCT01110395|19250093|P1|STARTED|Overall Study||15
7820209|NCT01110382|19250099|P2|NOT COMPLETED|Overall Study||2
7820210|NCT01110382|19250100|P1|NOT COMPLETED|Overall Study||0
7820211|NCT01110382|19250099|P2|COMPLETED|Overall Study||8
7820212|NCT01110382|19250100|P1|COMPLETED|Overall Study||31
7820213|NCT01110382|19250099|P2|STARTED|Overall Study||10
7820214|NCT01110382|19250100|P1|STARTED|Overall Study||31
7820215|NCT01110330|19250121|P3|NOT COMPLETED|Overall Study||26
7820216|NCT01110330|19250122|P2|NOT COMPLETED|Overall Study||23
7820217|NCT01110330|19250123|P1|NOT COMPLETED|Overall Study||15
7820218|NCT01110330|19250121|P3|COMPLETED|Overall Study||208
7820219|NCT01110330|19250122|P2|COMPLETED|Overall Study||207
7820220|NCT01110330|19250123|P1|COMPLETED|Overall Study||104
7820221|NCT01110330|19250121|P3|Positive Baseline Culture Set|Overall Study||114
7820222|NCT01110330|19250122|P2|Positive Baseline Culture Set|Overall Study||111
7820223|NCT01110330|19250123|P1|Positive Baseline Culture Set|Overall Study||56
7820224|NCT01110330|19250121|P3|STARTED|Overall Study||234
7820225|NCT01110330|19250122|P2|STARTED|Overall Study||230
7820226|NCT01110330|19250123|P1|STARTED|Overall Study||119
7820227|NCT01110252|19250134|P1|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0
7820228|NCT01110252|19250134|P1|COMPLETED|Post-procedure (Stem Cells Infusion)||4
7820229|NCT01110252|19250134|P1|STARTED|Post-procedure (Stem Cells Infusion)||4
7820230|NCT01110252|19250134|P1|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0
7820231|NCT01110252|19250134|P1|COMPLETED|Pre-procedure (Stem Cells Infusion)||4
7820232|NCT01110252|19250134|P1|STARTED|Pre-procedure (Stem Cells Infusion)||4
7820233|NCT01110239|19250151|P4|NOT COMPLETED|10 Min Ischemia||0
7820234|NCT01110239|19250152|P3|NOT COMPLETED|10 Min Ischemia||0
7820235|NCT01110239|19250153|P2|NOT COMPLETED|10 Min Ischemia||0
7820236|NCT01110239|19250154|P1|NOT COMPLETED|10 Min Ischemia||0
7820237|NCT01110239|19250151|P4|COMPLETED|10 Min Ischemia||6
7820238|NCT01110239|19250152|P3|COMPLETED|10 Min Ischemia||0
7820239|NCT01110239|19250153|P2|COMPLETED|10 Min Ischemia||0
7820240|NCT01110239|19250154|P1|COMPLETED|10 Min Ischemia||0
7820241|NCT01110239|19250151|P4|STARTED|10 Min Ischemia||6
7820242|NCT01110239|19250152|P3|STARTED|10 Min Ischemia||0
7820243|NCT01110239|19250153|P2|STARTED|10 Min Ischemia||0
7820244|NCT01110239|19250154|P1|STARTED|10 Min Ischemia||0
7820245|NCT01110239|19250151|P4|NOT COMPLETED|7.5 Min Ischemia||0
7820246|NCT01110239|19250152|P3|NOT COMPLETED|7.5 Min Ischemia||1
7820247|NCT01110239|19250153|P2|NOT COMPLETED|7.5 Min Ischemia||0
7820248|NCT01110239|19250154|P1|NOT COMPLETED|7.5 Min Ischemia||0
7820249|NCT01110239|19250151|P4|COMPLETED|7.5 Min Ischemia||0
7820250|NCT01110239|19250152|P3|COMPLETED|7.5 Min Ischemia||6
7820251|NCT01110239|19250153|P2|COMPLETED|7.5 Min Ischemia||0
7820252|NCT01110239|19250154|P1|COMPLETED|7.5 Min Ischemia||0
7820253|NCT01110239|19250151|P4|STARTED|7.5 Min Ischemia||0
7820254|NCT01110239|19250152|P3|STARTED|7.5 Min Ischemia||7
7820255|NCT01110239|19250153|P2|STARTED|7.5 Min Ischemia||0
7820256|NCT01110239|19250154|P1|STARTED|7.5 Min Ischemia||0
7820257|NCT01110239|19250151|P4|NOT COMPLETED|5 Min Ischemia||0
7820258|NCT01110239|19250152|P3|NOT COMPLETED|5 Min Ischemia||0
7820259|NCT01110239|19250153|P2|NOT COMPLETED|5 Min Ischemia||14
7820260|NCT01110239|19250154|P1|NOT COMPLETED|5 Min Ischemia||0
7820261|NCT01110239|19250151|P4|COMPLETED|5 Min Ischemia||0
7820262|NCT01110239|19250152|P3|COMPLETED|5 Min Ischemia||0
7820263|NCT01110239|19250153|P2|COMPLETED|5 Min Ischemia||0
7820264|NCT01110239|19250154|P1|COMPLETED|5 Min Ischemia||0
7820265|NCT01110239|19250151|P4|STARTED|5 Min Ischemia||0
7820266|NCT01110239|19250152|P3|STARTED|5 Min Ischemia||0
7820267|NCT01110239|19250153|P2|STARTED|5 Min Ischemia||14
7820268|NCT01110239|19250154|P1|STARTED|5 Min Ischemia||0
7820269|NCT01110239|19250151|P4|NOT COMPLETED|Sham Preconditioning||0
7820270|NCT01110239|19250152|P3|NOT COMPLETED|Sham Preconditioning||1
7820271|NCT01110239|19250153|P2|NOT COMPLETED|Sham Preconditioning||0
7820272|NCT01110239|19250154|P1|NOT COMPLETED|Sham Preconditioning||0
7820273|NCT01110239|19250151|P4|COMPLETED|Sham Preconditioning||6
7820274|NCT01110239|19250152|P3|COMPLETED|Sham Preconditioning||6
7820275|NCT01110239|19250153|P2|COMPLETED|Sham Preconditioning||14
7820276|NCT01110239|19250154|P1|COMPLETED|Sham Preconditioning||7
7820277|NCT01110239|19250151|P4|STARTED|Sham Preconditioning||6
7820278|NCT01110239|19250152|P3|STARTED|Sham Preconditioning||7
7820279|NCT01110239|19250153|P2|STARTED|Sham Preconditioning||14
7820280|NCT01110239|19250154|P1|STARTED|Sham Preconditioning||7
7820281|NCT01110200|19250170|P2|NOT COMPLETED|Overall Study||121
7820282|NCT01110200|19250171|P1|NOT COMPLETED|Overall Study||106
7820283|NCT01110200|19250170|P2|COMPLETED|Overall Study||204
7820284|NCT01110200|19250171|P1|COMPLETED|Overall Study||208
7820285|NCT01110200|19250170|P2|STARTED|Overall Study||325
7820286|NCT01110200|19250171|P1|STARTED|Overall Study||314
7820287|NCT01110187|19250187|P2|NOT COMPLETED|Overall Study||0
7820288|NCT01110187|19250188|P1|NOT COMPLETED|Overall Study||0
7820289|NCT01110187|19250187|P2|COMPLETED|Overall Study|completed 7 day treatment|4
7820290|NCT01110187|19250188|P1|COMPLETED|Overall Study|completed 7 day treatment|7
7820291|NCT01110187|19250187|P2|STARTED|Overall Study||4
7820292|NCT01110187|19250188|P1|STARTED|Overall Study||7
7820293|NCT01110174|19250196|P1|NOT COMPLETED|Overall Study||0
7820294|NCT01110174|19250196|P1|COMPLETED|Overall Study||8
7820295|NCT01110174|19250196|P1|STARTED|Overall Study||8
7820296|NCT01110135|19250201|P1|NOT COMPLETED|Overall Study||9
7820297|NCT01110135|19250201|P1|COMPLETED|Overall Study||34
7820298|NCT01110135|19250201|P1|STARTED|Overall Study||43
7820299|NCT01110005|19250207|P2|NOT COMPLETED|Overall Study||5
7820300|NCT01110005|19250208|P1|NOT COMPLETED|Overall Study||4
7820301|NCT01110005|19250207|P2|COMPLETED|Overall Study||156
7820302|NCT01110005|19250208|P1|COMPLETED|Overall Study||153
7820303|NCT01110005|19250207|P2|STARTED|Overall Study||161
7820304|NCT01110005|19250208|P1|STARTED|Overall Study||157
7820305|NCT01109992|19250220|P2|NOT COMPLETED|Overall Study||2
7820306|NCT01109992|19250221|P1|NOT COMPLETED|Overall Study||0
7820307|NCT01109992|19250220|P2|COMPLETED|Overall Study||30
7820308|NCT01109992|19250221|P1|COMPLETED|Overall Study||11
7820309|NCT01109992|19250220|P2|Subjects Enrolled|Overall Study||32
7820310|NCT01109992|19250221|P1|Subjects Enrolled|Overall Study||11
7820311|NCT01109992|19250220|P2|STARTED|Overall Study||32
7820312|NCT01109992|19250221|P1|STARTED|Overall Study||11
7820313|NCT01109979|19250235|P2|NOT COMPLETED|Overall Study||1
7820314|NCT01109979|19250236|P1|NOT COMPLETED|Overall Study||2
7820315|NCT01109979|19250235|P2|COMPLETED|Overall Study||11
7820316|NCT01109979|19250236|P1|COMPLETED|Overall Study||10
7820317|NCT01109979|19250235|P2|STARTED|Overall Study||12
7820318|NCT01109979|19250236|P1|STARTED|Overall Study||12
7820319|NCT01109849|19250244|P5|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
7820320|NCT01109849|19250245|P4|NOT COMPLETED|Adaptive Randomization: Weight Recovery||3
7820321|NCT01109849|19250246|P3|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
7820322|NCT01109849|19250247|P2|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
7820323|NCT01109849|19250248|P1|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
7820324|NCT01109849|19250244|P5|COMPLETED|Adaptive Randomization: Weight Recovery||24
7820325|NCT01109849|19250245|P4|COMPLETED|Adaptive Randomization: Weight Recovery||20
7820326|NCT01109849|19250246|P3|COMPLETED|Adaptive Randomization: Weight Recovery||23
7820327|NCT01109849|19250247|P2|COMPLETED|Adaptive Randomization: Weight Recovery||0
7820328|NCT01109849|19250248|P1|COMPLETED|Adaptive Randomization: Weight Recovery||0
7820329|NCT01109849|19250244|P5|STARTED|Adaptive Randomization: Weight Recovery||25
7820330|NCT01109849|19250245|P4|STARTED|Adaptive Randomization: Weight Recovery||23
7820331|NCT01109849|19250246|P3|STARTED|Adaptive Randomization: Weight Recovery||24
7820332|NCT01109849|19250247|P2|STARTED|Adaptive Randomization: Weight Recovery||0
7820333|NCT01109849|19250248|P1|STARTED|Adaptive Randomization: Weight Recovery||0
7820334|NCT01109849|19250244|P5|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
7820335|NCT01109849|19250245|P4|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
7820336|NCT01109849|19250246|P3|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
7820337|NCT01109849|19250247|P2|NOT COMPLETED|Initial Randomization: ADHD Treatment||49
7820338|NCT01109849|19250248|P1|NOT COMPLETED|Initial Randomization: ADHD Treatment||18
7820339|NCT01109849|19250244|P5|COMPLETED|Initial Randomization: ADHD Treatment||0
7820340|NCT01109849|19250245|P4|COMPLETED|Initial Randomization: ADHD Treatment||0
7820341|NCT01109849|19250246|P3|COMPLETED|Initial Randomization: ADHD Treatment||0
7820342|NCT01109849|19250247|P2|COMPLETED|Initial Randomization: ADHD Treatment||131
7820343|NCT01109849|19250248|P1|COMPLETED|Initial Randomization: ADHD Treatment||32
7820344|NCT01109849|19250244|P5|STARTED|Initial Randomization: ADHD Treatment||0
7820345|NCT01109849|19250245|P4|STARTED|Initial Randomization: ADHD Treatment||0
7820346|NCT01109849|19250246|P3|STARTED|Initial Randomization: ADHD Treatment||0
7820347|NCT01109849|19250247|P2|STARTED|Initial Randomization: ADHD Treatment||180
7820348|NCT01109849|19250248|P1|STARTED|Initial Randomization: ADHD Treatment||50
7820349|NCT01109602|19250300|P3|NOT COMPLETED|Overall Study||1
7820350|NCT01109602|19250301|P2|NOT COMPLETED|Overall Study||2
7820351|NCT01109602|19250302|P1|NOT COMPLETED|Overall Study||1
7820352|NCT01109602|19250300|P3|COMPLETED|Overall Study||9
7820353|NCT01109602|19250301|P2|COMPLETED|Overall Study||21
7820354|NCT01109602|19250302|P1|COMPLETED|Overall Study||13
7820355|NCT01109602|19250300|P3|STARTED|Overall Study||10
7820356|NCT01109602|19250301|P2|STARTED|Overall Study||23
7820357|NCT01109602|19250302|P1|STARTED|Overall Study||14
7820358|NCT01109576|19250313|P1|NOT COMPLETED|Overall Study||1
7820359|NCT01109576|19250313|P1|COMPLETED|Overall Study||12
7820360|NCT01109576|19250313|P1|STARTED|Overall Study||13
7820361|NCT01109524|19250317|P1|NOT COMPLETED|Overall Study||57
7820362|NCT01109524|19250317|P1|COMPLETED|Overall Study||3
7820363|NCT01109524|19250317|P1|STARTED|Overall Study||60
7820364|NCT01109381|19250327|P1|NOT COMPLETED|Overall Study||2
7820365|NCT01109381|19250327|P1|COMPLETED|Overall Study||31
7820366|NCT01109381|19250327|P1|STARTED|Overall Study||33
7820367|NCT01109316|19250339|P6|NOT COMPLETED|Study Period 3||0
7820368|NCT01109316|19250340|P5|NOT COMPLETED|Study Period 3||2
7820369|NCT01109316|19250341|P4|NOT COMPLETED|Study Period 3||0
7820370|NCT01109316|19250342|P3|NOT COMPLETED|Study Period 3||0
7820371|NCT01109316|19250343|P2|NOT COMPLETED|Study Period 3||0
7820372|NCT01109316|19250344|P1|NOT COMPLETED|Study Period 3||1
7820373|NCT01109316|19250339|P6|COMPLETED|Study Period 3||19
7820374|NCT01109316|19250340|P5|COMPLETED|Study Period 3||18
7820375|NCT01109316|19250341|P4|COMPLETED|Study Period 3||20
7820376|NCT01109316|19250342|P3|COMPLETED|Study Period 3||18
7820377|NCT01109316|19250343|P2|COMPLETED|Study Period 3||21
7820378|NCT01109316|19250344|P1|COMPLETED|Study Period 3||20
7820379|NCT01109316|19250339|P6|STARTED|Study Period 3||19
7820380|NCT01109316|19250340|P5|STARTED|Study Period 3||20
7820381|NCT01109316|19250341|P4|STARTED|Study Period 3||20
7820382|NCT01109316|19250342|P3|STARTED|Study Period 3||18
7820383|NCT01109316|19250343|P2|STARTED|Study Period 3||21
7820384|NCT01109316|19250344|P1|STARTED|Study Period 3||21
7820385|NCT01109316|19250339|P6|NOT COMPLETED|Study Period 2||1
7820386|NCT01109316|19250340|P5|NOT COMPLETED|Study Period 2||0
7820387|NCT01109316|19250341|P4|NOT COMPLETED|Study Period 2||1
7820388|NCT01109316|19250342|P3|NOT COMPLETED|Study Period 2||1
7820389|NCT01109316|19250343|P2|NOT COMPLETED|Study Period 2||1
7820390|NCT01109316|19250344|P1|NOT COMPLETED|Study Period 2||1
7820391|NCT01109316|19250339|P6|COMPLETED|Study Period 2||19
7820392|NCT01109316|19250340|P5|COMPLETED|Study Period 2||20
7820393|NCT01109316|19250341|P4|COMPLETED|Study Period 2||20
7820394|NCT01109316|19250342|P3|COMPLETED|Study Period 2||18
7820395|NCT01109316|19250343|P2|COMPLETED|Study Period 2||21
7820396|NCT01109316|19250344|P1|COMPLETED|Study Period 2||21
7820397|NCT01109316|19250339|P6|STARTED|Study Period 2||20
7820398|NCT01109316|19250340|P5|STARTED|Study Period 2||20
7820399|NCT01109316|19250341|P4|STARTED|Study Period 2||21
7820400|NCT01109316|19250342|P3|STARTED|Study Period 2||19
7820401|NCT01109316|19250343|P2|STARTED|Study Period 2||22
7820402|NCT01109316|19250344|P1|STARTED|Study Period 2||22
7820403|NCT01109316|19250339|P6|NOT COMPLETED|Study Period 1||2
7820404|NCT01109316|19250340|P5|NOT COMPLETED|Study Period 1||2
7820405|NCT01109316|19250341|P4|NOT COMPLETED|Study Period 1||1
7820406|NCT01109316|19250342|P3|NOT COMPLETED|Study Period 1||3
7820407|NCT01109316|19250343|P2|NOT COMPLETED|Study Period 1||0
7820408|NCT01109316|19250344|P1|NOT COMPLETED|Study Period 1||0
7820409|NCT01109316|19250339|P6|COMPLETED|Study Period 1||20
7820410|NCT01109316|19250340|P5|COMPLETED|Study Period 1||20
7820411|NCT01109316|19250341|P4|COMPLETED|Study Period 1||21
7820412|NCT01109316|19250342|P3|COMPLETED|Study Period 1||19
7820413|NCT01109316|19250343|P2|COMPLETED|Study Period 1||22
7820414|NCT01109316|19250344|P1|COMPLETED|Study Period 1||22
7820415|NCT01109316|19250339|P6|Received at Least One Dose of Study Drug|Study Period 1||20
7820416|NCT01109316|19250340|P5|Received at Least One Dose of Study Drug|Study Period 1||22
7820417|NCT01109316|19250341|P4|Received at Least One Dose of Study Drug|Study Period 1||22
7820418|NCT01109316|19250342|P3|Received at Least One Dose of Study Drug|Study Period 1||22
7820419|NCT01109316|19250343|P2|Received at Least One Dose of Study Drug|Study Period 1||22
7820420|NCT01109316|19250344|P1|Received at Least One Dose of Study Drug|Study Period 1||22
7820421|NCT01109316|19250339|P6|STARTED|Study Period 1||22
7820422|NCT01109316|19250340|P5|STARTED|Study Period 1||22
7820423|NCT01109316|19250341|P4|STARTED|Study Period 1||22
7820424|NCT01109316|19250342|P3|STARTED|Study Period 1||22
7820425|NCT01109316|19250343|P2|STARTED|Study Period 1||22
7820426|NCT01109316|19250344|P1|STARTED|Study Period 1||22
7820427|NCT01109173|19250392|P4|NOT COMPLETED|Overall Study||93
7820428|NCT01109173|19250393|P3|NOT COMPLETED|Overall Study||101
7820429|NCT01109173|19250394|P2|NOT COMPLETED|Overall Study||86
7820430|NCT01109173|19250395|P1|NOT COMPLETED|Overall Study||88
7820431|NCT01109173|19250392|P4|COMPLETED|Overall Study||120
7820432|NCT01109173|19250393|P3|COMPLETED|Overall Study||110
7820433|NCT01109173|19250394|P2|COMPLETED|Overall Study||759
7820434|NCT01109173|19250395|P1|COMPLETED|Overall Study||763
7820435|NCT01109173|19250392|P4|STARTED|Overall Study||213
7820436|NCT01109173|19250393|P3|STARTED|Overall Study||211
7820437|NCT01109173|19250394|P2|STARTED|Overall Study||845
7820438|NCT01109173|19250395|P1|STARTED|Overall Study||851
7820439|NCT01109147|19250412|P3|NOT COMPLETED|Overall Study||10
7820440|NCT01109147|19250413|P2|NOT COMPLETED|Overall Study||3
7820441|NCT01109147|19250414|P1|NOT COMPLETED|Overall Study||2
7820442|NCT01109147|19250412|P3|COMPLETED|Overall Study|10 have been excluded of the results|26
7820443|NCT01109147|19250413|P2|COMPLETED|Overall Study|3 have been excluded of the results|11
7820444|NCT01109147|19250414|P1|COMPLETED|Overall Study|2 have been excluded of the results|15
7820445|NCT01109147|19250412|P3|STARTED|Overall Study||36
7820446|NCT01109147|19250413|P2|STARTED|Overall Study||14
7820447|NCT01109147|19250414|P1|STARTED|Overall Study||17
7820448|NCT01109108|19250424|P2|NOT COMPLETED|Overall Study||0
7820449|NCT01109108|19250425|P1|NOT COMPLETED|Overall Study||0
7820450|NCT01109108|19250424|P2|COMPLETED|Overall Study||4755
7820451|NCT01109108|19250425|P1|COMPLETED|Overall Study||4035
7820452|NCT01109108|19250424|P2|STARTED|Overall Study||4755
7820453|NCT01109108|19250425|P1|STARTED|Overall Study||4035
7820454|NCT01109069|19250431|P1|NOT COMPLETED|Overall Study||93
7820455|NCT01109069|19250431|P1|COMPLETED|Overall Study||106
7820456|NCT01109069|19250431|P1|STARTED|Overall Study||199
7820457|NCT01109056|19250440|P2|NOT COMPLETED|Overall Study||5
7820458|NCT01109056|19250441|P1|NOT COMPLETED|Overall Study||7
7820459|NCT01109056|19250440|P2|COMPLETED|Overall Study||53
7820460|NCT01109056|19250441|P1|COMPLETED|Overall Study||50
7820461|NCT01109056|19250440|P2|STARTED|Overall Study||58
7820462|NCT01109056|19250441|P1|STARTED|Overall Study||57
7820463|NCT01109004|19250454|P3|NOT COMPLETED|Overall Study||0
7820464|NCT01109004|19250455|P2|NOT COMPLETED|Overall Study||0
7820465|NCT01109004|19250456|P1|NOT COMPLETED|Overall Study||0
7820466|NCT01109004|19250454|P3|COMPLETED|Overall Study||257
7820467|NCT01109004|19250455|P2|COMPLETED|Overall Study||254
7820468|NCT01109004|19250456|P1|COMPLETED|Overall Study||247
7820469|NCT01109004|19250454|P3|STARTED|Overall Study||257
7820470|NCT01109004|19250455|P2|STARTED|Overall Study||254
7820471|NCT01109004|19250456|P1|STARTED|Overall Study||247
7820472|NCT01108835|19250493|P2|NOT COMPLETED|Overall Study||21
7820473|NCT01108835|19250494|P1|NOT COMPLETED|Overall Study||17
7820474|NCT01108835|19250493|P2|COMPLETED|Overall Study||69
7820475|NCT01108835|19250494|P1|COMPLETED|Overall Study||73
7820476|NCT01108835|19250493|P2|STARTED|Overall Study||90
7820477|NCT01108835|19250494|P1|STARTED|Overall Study||90
7820478|NCT01108809|19250508|P1|NOT COMPLETED|Overall Study||4
7820479|NCT01108809|19250508|P1|COMPLETED|Overall Study||291
7820480|NCT01108809|19250508|P1|STARTED|Overall Study||295
7820481|NCT01108796|19250525|P2|NOT COMPLETED|Overall Study||7
7820482|NCT01108796|19250526|P1|NOT COMPLETED|Overall Study||7
7820483|NCT01108796|19250525|P2|COMPLETED|Overall Study||1060
7820484|NCT01108796|19250526|P1|COMPLETED|Overall Study||767
7820485|NCT01108796|19250525|P2|STARTED|Overall Study||1067
7820486|NCT01108796|19250526|P1|STARTED|Overall Study||774
7820487|NCT01108757|19250560|P2|NOT COMPLETED|Overall Study||0
7820488|NCT01108757|19250561|P1|NOT COMPLETED|Overall Study||0
7820489|NCT01108757|19250560|P2|COMPLETED|Overall Study||26
7820490|NCT01108757|19250561|P1|COMPLETED|Overall Study||26
7820491|NCT01108757|19250560|P2|STARTED|Overall Study||26
7820492|NCT01108757|19250561|P1|STARTED|Overall Study||26
7820493|NCT01108731|19250569|P2|NOT COMPLETED|Overall Study||4
7820494|NCT01108731|19250570|P1|NOT COMPLETED|Overall Study||4
7820495|NCT01108731|19250569|P2|COMPLETED|Overall Study||13
7820496|NCT01108731|19250570|P1|COMPLETED|Overall Study||13
7820497|NCT01108731|19250569|P2|STARTED|Overall Study||17
7820498|NCT01108731|19250570|P1|STARTED|Overall Study||17
7820499|NCT01108718|19250582|P2|NOT COMPLETED|Received Second Intervention (2 Months)||0
7820500|NCT01108718|19250583|P1|NOT COMPLETED|Received Second Intervention (2 Months)||1
7820501|NCT01108718|19250582|P2|COMPLETED|Received Second Intervention (2 Months)||7
7820502|NCT01108718|19250583|P1|COMPLETED|Received Second Intervention (2 Months)||4
7820503|NCT01108718|19250582|P2|STARTED|Received Second Intervention (2 Months)||7
7820592|NCT01108003|19250783|P1|COMPLETED|Overall Study||4
7820593|NCT01108003|19250782|P2|STARTED|Overall Study||3
7820504|NCT01108718|19250583|P1|STARTED|Received Second Intervention (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5
7820505|NCT01108718|19250582|P2|NOT COMPLETED|Received First Intervention (2 Months)||0
7820506|NCT01108718|19250583|P1|NOT COMPLETED|Received First Intervention (2 Months)||0
7820507|NCT01108718|19250582|P2|COMPLETED|Received First Intervention (2 Months)||7
7820508|NCT01108718|19250583|P1|COMPLETED|Received First Intervention (2 Months)||5
7820509|NCT01108718|19250582|P2|STARTED|Received First Intervention (2 Months)||7
7820510|NCT01108718|19250583|P1|STARTED|Received First Intervention (2 Months)||5
7820511|NCT01108666|19250588|P1|NOT COMPLETED|Overall Study||0
7820512|NCT01108666|19250588|P1|COMPLETED|Overall Study|Despite all possible efforts to contact the PI/study team, no data are available to be reported|0
7820513|NCT01108666|19250588|P1|STARTED|Overall Study|Despite all possible efforts to contact the PI/study, no data are available to be reported|0
7820514|NCT01108523|19250595|P1|NOT COMPLETED|Overall Study||4
7820515|NCT01108523|19250595|P1|COMPLETED|Overall Study||3
7820516|NCT01108523|19250595|P1|STARTED|Overall Study||7
7820517|NCT01108510|19250602|P2|NOT COMPLETED|Overall Study||268
7820518|NCT01108510|19250603|P1|NOT COMPLETED|Overall Study||279
7820519|NCT01108510|19250602|P2|COMPLETED|Overall Study||81
7820520|NCT01108510|19250603|P1|COMPLETED|Overall Study||70
7820521|NCT01108510|19250602|P2|STARTED|Overall Study||349
7820522|NCT01108510|19250603|P1|STARTED|Overall Study||349
7820523|NCT01108458|19250623|P1|NOT COMPLETED|Overall Study||1
7820524|NCT01108458|19250623|P1|COMPLETED|Overall Study||0
7820525|NCT01108458|19250623|P1|STARTED|Overall Study||1
7820526|NCT01108445|19250634|P2|NOT COMPLETED|Overall Study||49
7820527|NCT01108445|19250635|P1|NOT COMPLETED|Overall Study||56
7820528|NCT01108445|19250634|P2|COMPLETED|Overall Study||2
7820529|NCT01108445|19250635|P1|COMPLETED|Overall Study||1
7820530|NCT01108445|19250634|P2|STARTED|Overall Study||51
7820531|NCT01108445|19250635|P1|STARTED|Overall Study||57
7820532|NCT01108406|19250669|P1|NOT COMPLETED|Overall Study||0
7820533|NCT01108406|19250669|P1|COMPLETED|Overall Study||22
7820534|NCT01108406|19250669|P1|STARTED|Overall Study||22
7820535|NCT01108341|19250675|P1|NOT COMPLETED|Overall Study||5
7820536|NCT01108341|19250675|P1|COMPLETED|Overall Study||45
7820537|NCT01108341|19250675|P1|Safety Set (Enrolled and Treated)|Overall Study||49
7820538|NCT01108341|19250675|P1|STARTED|Overall Study||50
7820539|NCT01108263|19250682|P2|NOT COMPLETED|Overall Study||1
7820540|NCT01108263|19250683|P1|NOT COMPLETED|Overall Study||0
7820541|NCT01108263|19250682|P2|COMPLETED|Overall Study||2
7820542|NCT01108263|19250683|P1|COMPLETED|Overall Study||2
7820543|NCT01108263|19250682|P2|STARTED|Overall Study||3
7820544|NCT01108263|19250683|P1|STARTED|Overall Study||2
7820545|NCT01108237|19250693|P2|NOT COMPLETED|Overall Study||17
7820546|NCT01108237|19250694|P1|NOT COMPLETED|Overall Study||9
7820547|NCT01108237|19250693|P2|COMPLETED|Overall Study||84
7820548|NCT01108237|19250694|P1|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64
7820549|NCT01108237|19250693|P2|STARTED|Overall Study||101
7820550|NCT01108237|19250694|P1|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73
7820551|NCT01108185|19250700|P1|NOT COMPLETED|Overall Study||27
7820552|NCT01108185|19250700|P1|COMPLETED|Overall Study||3154
7820553|NCT01108185|19250700|P1|Per Protocol Population|Overall Study||3181
7820554|NCT01108185|19250700|P1|STARTED|Overall Study||3181
7820555|NCT01108094|19250717|P4|NOT COMPLETED|Overall Study||0
7820556|NCT01108094|19250718|P3|NOT COMPLETED|Overall Study||0
7820557|NCT01108094|19250719|P2|NOT COMPLETED|Overall Study||0
7820558|NCT01108094|19250720|P1|NOT COMPLETED|Overall Study||3
7820559|NCT01108094|19250717|P4|COMPLETED|Overall Study||10
7820560|NCT01108094|19250718|P3|COMPLETED|Overall Study||4
7820561|NCT01108094|19250719|P2|COMPLETED|Overall Study||3
7820562|NCT01108094|19250720|P1|COMPLETED|Overall Study||9
7820563|NCT01108094|19250717|P4|STARTED|Overall Study||10
7820564|NCT01108094|19250718|P3|STARTED|Overall Study||4
7820565|NCT01108094|19250719|P2|STARTED|Overall Study||3
7820566|NCT01108094|19250720|P1|STARTED|Overall Study||12
7820567|NCT01108081|19250745|P4|NOT COMPLETED|Overall Study||4
7820568|NCT01108081|19250746|P3|NOT COMPLETED|Overall Study||0
7820569|NCT01108081|19250747|P2|NOT COMPLETED|Overall Study||2
7820570|NCT01108081|19250748|P1|NOT COMPLETED|Overall Study||2
7820571|NCT01108081|19250745|P4|COMPLETED|Overall Study||39
7820572|NCT01108081|19250746|P3|COMPLETED|Overall Study||38
7820573|NCT01108081|19250747|P2|COMPLETED|Overall Study||40
7820574|NCT01108081|19250748|P1|COMPLETED|Overall Study||44
7820575|NCT01108081|19250745|P4|STARTED|Overall Study||43
7820576|NCT01108081|19250746|P3|STARTED|Overall Study||38
7820577|NCT01108081|19250747|P2|STARTED|Overall Study||42
7820578|NCT01108081|19250748|P1|STARTED|Overall Study||46
7820579|NCT01108068|19250764|P2|NOT COMPLETED|Overall Study||0
7820580|NCT01108068|19250765|P1|NOT COMPLETED|Overall Study||6
7820581|NCT01108068|19250764|P2|COMPLETED|Overall Study||16
7820582|NCT01108068|19250765|P1|COMPLETED|Overall Study|Only 5 individuals were recruited into the Lithium treatment arm|4
7820583|NCT01108068|19250764|P2|STARTED|Overall Study||16
7820584|NCT01108068|19250765|P1|STARTED|Overall Study||10
7820585|NCT01108055|19250772|P1|NOT COMPLETED|Overall Study||15
7820586|NCT01108055|19250772|P1|COMPLETED|Overall Study||28
7820587|NCT01108055|19250772|P1|Eligible and Started Treatment|Overall Study||32
7820588|NCT01108055|19250772|P1|STARTED|Overall Study||43
7820589|NCT01108003|19250782|P2|NOT COMPLETED|Overall Study||0
7820590|NCT01108003|19250783|P1|NOT COMPLETED|Overall Study||0
7820591|NCT01108003|19250782|P2|COMPLETED|Overall Study||3
7820594|NCT01108003|19250783|P1|STARTED|Overall Study||4
7820595|NCT01107964|19250793|P2|NOT COMPLETED|Overall Study||1
7820596|NCT01107964|19250794|P1|NOT COMPLETED|Overall Study||1
7820597|NCT01107964|19250793|P2|COMPLETED|Overall Study||13
7820598|NCT01107964|19250794|P1|COMPLETED|Overall Study||12
7820599|NCT01107964|19250793|P2|STARTED|Overall Study||14
7820600|NCT01107964|19250794|P1|STARTED|Overall Study||13
7820601|NCT01107925|19250810|P6|NOT COMPLETED|Period 3||0
7820602|NCT01107925|19250811|P5|NOT COMPLETED|Period 3||0
7820603|NCT01107925|19250812|P4|NOT COMPLETED|Period 3||0
7820604|NCT01107925|19250813|P3|NOT COMPLETED|Period 3||0
7820605|NCT01107925|19250814|P2|NOT COMPLETED|Period 3||0
7820606|NCT01107925|19250815|P1|NOT COMPLETED|Period 3||0
7820607|NCT01107925|19250810|P6|COMPLETED|Period 3||20
7820608|NCT01107925|19250811|P5|COMPLETED|Period 3||0
7820609|NCT01107925|19250812|P4|COMPLETED|Period 3||16
7820610|NCT01107925|19250813|P3|COMPLETED|Period 3||15
7820611|NCT01107925|19250814|P2|COMPLETED|Period 3||17
7820612|NCT01107925|19250815|P1|COMPLETED|Period 3||0
7820613|NCT01107925|19250810|P6|Took at Least 1 Dose of Study Drug|Period 3||20
7820614|NCT01107925|19250811|P5|Took at Least 1 Dose of Study Drug|Period 3||0
7820615|NCT01107925|19250812|P4|Took at Least 1 Dose of Study Drug|Period 3||16
7820616|NCT01107925|19250813|P3|Took at Least 1 Dose of Study Drug|Period 3||15
7820617|NCT01107925|19250814|P2|Took at Least 1 Dose of Study Drug|Period 3||17
7820618|NCT01107925|19250815|P1|Took at Least 1 Dose of Study Drug|Period 3||0
7820619|NCT01107925|19250810|P6|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20
7820620|NCT01107925|19250811|P5|STARTED|Period 3||0
7820621|NCT01107925|19250812|P4|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16
7820622|NCT01107925|19250813|P3|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15
7820623|NCT01107925|19250814|P2|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17
7820624|NCT01107925|19250815|P1|STARTED|Period 3||0
7820625|NCT01107925|19250810|P6|NOT COMPLETED|Period 2||1
7820626|NCT01107925|19250811|P5|NOT COMPLETED|Period 2||0
7820627|NCT01107925|19250812|P4|NOT COMPLETED|Period 2||0
7820628|NCT01107925|19250813|P3|NOT COMPLETED|Period 2||0
7820629|NCT01107925|19250814|P2|NOT COMPLETED|Period 2||1
7820630|NCT01107925|19250815|P1|NOT COMPLETED|Period 2||0
7820631|NCT01107925|19250810|P6|COMPLETED|Period 2||16
7820632|NCT01107925|19250811|P5|COMPLETED|Period 2||0
7820633|NCT01107925|19250812|P4|COMPLETED|Period 2||20
7820634|NCT01107925|19250813|P3|COMPLETED|Period 2||17
7820635|NCT01107925|19250814|P2|COMPLETED|Period 2||15
7820636|NCT01107925|19250815|P1|COMPLETED|Period 2||0
7820637|NCT01107925|19250810|P6|Took at Least 1 Dose of Study Drug|Period 2||17
7820638|NCT01107925|19250811|P5|Took at Least 1 Dose of Study Drug|Period 2||0
7820639|NCT01107925|19250812|P4|Took at Least 1 Dose of Study Drug|Period 2||20
7820640|NCT01107925|19250813|P3|Took at Least 1 Dose of Study Drug|Period 2||17
7820641|NCT01107925|19250814|P2|Took at Least 1 Dose of Study Drug|Period 2||16
7820642|NCT01107925|19250815|P1|Took at Least 1 Dose of Study Drug|Period 2||0
7820643|NCT01107925|19250810|P6|STARTED|Period 2||17
7820644|NCT01107925|19250811|P5|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0
7820645|NCT01107925|19250812|P4|STARTED|Period 2||20
7820646|NCT01107925|19250813|P3|STARTED|Period 2||17
7820647|NCT01107925|19250814|P2|STARTED|Period 2||16
7820648|NCT01107925|19250815|P1|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0
7820649|NCT01107925|19250810|P6|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
7820650|NCT01107925|19250811|P5|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
7820651|NCT01107925|19250812|P4|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
7820652|NCT01107925|19250813|P3|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
7820653|NCT01107925|19250814|P2|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
7820654|NCT01107925|19250815|P1|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
7820655|NCT01107925|19250810|P6|COMPLETED|Period 1-Randomization up Through Day 12||0
7820656|NCT01107925|19250811|P5|COMPLETED|Period 1-Randomization up Through Day 12||37
7820657|NCT01107925|19250812|P4|COMPLETED|Period 1-Randomization up Through Day 12||0
7820658|NCT01107925|19250813|P3|COMPLETED|Period 1-Randomization up Through Day 12||0
7820659|NCT01107925|19250814|P2|COMPLETED|Period 1-Randomization up Through Day 12||0
7820660|NCT01107925|19250815|P1|COMPLETED|Period 1-Randomization up Through Day 12||33
7820661|NCT01107925|19250810|P6|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
7820662|NCT01107925|19250811|P5|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38
7820663|NCT01107925|19250812|P4|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
7820664|NCT01107925|19250813|P3|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
7820665|NCT01107925|19250814|P2|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
7820666|NCT01107925|19250815|P1|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34
7820667|NCT01107925|19250810|P6|STARTED|Period 1-Randomization up Through Day 12||0
7820668|NCT01107925|19250811|P5|STARTED|Period 1-Randomization up Through Day 12||38
7820669|NCT01107925|19250812|P4|STARTED|Period 1-Randomization up Through Day 12||0
7820670|NCT01107925|19250813|P3|STARTED|Period 1-Randomization up Through Day 12||0
7820671|NCT01107925|19250814|P2|STARTED|Period 1-Randomization up Through Day 12||0
7820672|NCT01107925|19250815|P1|STARTED|Period 1-Randomization up Through Day 12||34
7820673|NCT01107912|19250853|P6|NOT COMPLETED|Period 3||0
7820674|NCT01107912|19250854|P5|NOT COMPLETED|Period 3||0
7820675|NCT01107912|19250855|P4|NOT COMPLETED|Period 3||1
7820676|NCT01107912|19250856|P3|NOT COMPLETED|Period 3||1
7820677|NCT01107912|19250857|P2|NOT COMPLETED|Period 3||1
7820678|NCT01107912|19250858|P1|NOT COMPLETED|Period 3||0
7820679|NCT01107912|19250853|P6|COMPLETED|Period 3||41
7820680|NCT01107912|19250854|P5|COMPLETED|Period 3||0
7820681|NCT01107912|19250855|P4|COMPLETED|Period 3||37
7820682|NCT01107912|19250856|P3|COMPLETED|Period 3||35
7820683|NCT01107912|19250857|P2|COMPLETED|Period 3||34
7820684|NCT01107912|19250858|P1|COMPLETED|Period 3||0
7820685|NCT01107912|19250853|P6|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41
7820686|NCT01107912|19250854|P5|STARTED|Period 3||0
7820687|NCT01107912|19250855|P4|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38
7820688|NCT01107912|19250856|P3|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36
7820689|NCT01107912|19250857|P2|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35
7820690|NCT01107912|19250858|P1|STARTED|Period 3||0
7820691|NCT01107912|19250853|P6|NOT COMPLETED|Period 2||0
7820692|NCT01107912|19250854|P5|NOT COMPLETED|Period 2||0
7820693|NCT01107912|19250855|P4|NOT COMPLETED|Period 2||0
7820694|NCT01107912|19250856|P3|NOT COMPLETED|Period 2||1
7820695|NCT01107912|19250857|P2|NOT COMPLETED|Period 2||0
7820696|NCT01107912|19250858|P1|NOT COMPLETED|Period 2||0
7820697|NCT01107912|19250853|P6|COMPLETED|Period 2||38
7820698|NCT01107912|19250854|P5|COMPLETED|Period 2||0
7820699|NCT01107912|19250855|P4|COMPLETED|Period 2||41
7820700|NCT01107912|19250856|P3|COMPLETED|Period 2||35
7820701|NCT01107912|19250857|P2|COMPLETED|Period 2||36
7820702|NCT01107912|19250858|P1|COMPLETED|Period 2||0
7820703|NCT01107912|19250853|P6|STARTED|Period 2||38
7820704|NCT01107912|19250854|P5|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0
7820705|NCT01107912|19250855|P4|STARTED|Period 2||41
7820706|NCT01107912|19250856|P3|STARTED|Period 2||36
7820707|NCT01107912|19250857|P2|STARTED|Period 2||36
7820708|NCT01107912|19250858|P1|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0
7820709|NCT01107912|19250853|P6|NOT COMPLETED|Period 1||0
7820710|NCT01107912|19250854|P5|NOT COMPLETED|Period 1||3
7820711|NCT01107912|19250855|P4|NOT COMPLETED|Period 1||0
7820712|NCT01107912|19250856|P3|NOT COMPLETED|Period 1||0
7820713|NCT01107912|19250857|P2|NOT COMPLETED|Period 1||0
7820714|NCT01107912|19250858|P1|NOT COMPLETED|Period 1||1
7820715|NCT01107912|19250853|P6|COMPLETED|Period 1||0
7820716|NCT01107912|19250854|P5|COMPLETED|Period 1||79
7820717|NCT01107912|19250855|P4|COMPLETED|Period 1||0
7820718|NCT01107912|19250856|P3|COMPLETED|Period 1||0
7820719|NCT01107912|19250857|P2|COMPLETED|Period 1||0
7820720|NCT01107912|19250858|P1|COMPLETED|Period 1||72
7820721|NCT01107912|19250853|P6|Received at Least 1 Dose of Study Drug|Period 1||0
7820722|NCT01107912|19250854|P5|Received at Least 1 Dose of Study Drug|Period 1||82
7820723|NCT01107912|19250855|P4|Received at Least 1 Dose of Study Drug|Period 1||0
7820724|NCT01107912|19250856|P3|Received at Least 1 Dose of Study Drug|Period 1||0
7820725|NCT01107912|19250857|P2|Received at Least 1 Dose of Study Drug|Period 1||0
7820726|NCT01107912|19250858|P1|Received at Least 1 Dose of Study Drug|Period 1||73
7820727|NCT01107912|19250853|P6|STARTED|Period 1||0
7820728|NCT01107912|19250854|P5|STARTED|Period 1||82
7820729|NCT01107912|19250855|P4|STARTED|Period 1||0
7820730|NCT01107912|19250856|P3|STARTED|Period 1||0
7820731|NCT01107912|19250857|P2|STARTED|Period 1||0
7820732|NCT01107912|19250858|P1|STARTED|Period 1||73
7820733|NCT01107899|19250895|P3|NOT COMPLETED|Overall Study||4
7820734|NCT01107899|19250896|P2|NOT COMPLETED|Overall Study||0
7820735|NCT01107899|19250897|P1|NOT COMPLETED|Overall Study||5
7820736|NCT01107899|19250895|P3|COMPLETED|Overall Study||5
7820737|NCT01107899|19250896|P2|COMPLETED|Overall Study||10
7820738|NCT01107899|19250897|P1|COMPLETED|Overall Study||5
7820739|NCT01107899|19250895|P3|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4
7820740|NCT01107899|19250896|P2|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10
7820741|NCT01107899|19250897|P1|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5
7820742|NCT01107899|19250895|P3|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6
7820743|NCT01107899|19250896|P2|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10
7820744|NCT01107899|19250897|P1|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5
7820745|NCT01107899|19250895|P3|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6
7820746|NCT01107899|19250896|P2|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10
7820747|NCT01107899|19250897|P1|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5
7820748|NCT01107899|19250895|P3|Received at Least One Dose of Study Drug|Overall Study||8
7820749|NCT01107899|19250896|P2|Received at Least One Dose of Study Drug|Overall Study||10
7820750|NCT01107899|19250897|P1|Received at Least One Dose of Study Drug|Overall Study||10
7820751|NCT01107899|19250895|P3|STARTED|Overall Study||9
7820752|NCT01107899|19250896|P2|STARTED|Overall Study||10
7820753|NCT01107899|19250897|P1|STARTED|Overall Study||10
7820754|NCT01107886|19250943|P2|NOT COMPLETED|Overall Study||214
7820755|NCT01107886|19250944|P1|NOT COMPLETED|Overall Study||202
7820756|NCT01107886|19250943|P2|COMPLETED|Overall Study|Completed subjects|7998
7820757|NCT01107886|19250944|P1|COMPLETED|Overall Study|Completed subjects|8078
7820758|NCT01107886|19250943|P2|STARTED|Overall Study|Randomized subjects|8212
7820759|NCT01107886|19250944|P1|STARTED|Overall Study|Randomized subjects|8280
7820760|NCT01107834|19250956|P2|NOT COMPLETED|Overall Study||0
7820761|NCT01107834|19250957|P1|NOT COMPLETED|Overall Study||0
7820762|NCT01107834|19250956|P2|COMPLETED|Overall Study||30
7820763|NCT01107834|19250957|P1|COMPLETED|Overall Study||30
7820764|NCT01107834|19250956|P2|STARTED|Overall Study||30
7820765|NCT01107834|19250957|P1|STARTED|Overall Study||30
7820766|NCT01107795|19250973|P1|NOT COMPLETED|Overall Study||0
7820767|NCT01107795|19250973|P1|COMPLETED|Overall Study||41
7820768|NCT01107795|19250973|P1|STARTED|Overall Study||41
7820769|NCT01107743|19250977|P1|NOT COMPLETED|Overall Study||46
7820770|NCT01107743|19250977|P1|COMPLETED|Overall Study||1245
7820771|NCT01107743|19250977|P1|STARTED|Overall Study||1291
7820772|NCT01107730|19251066|P3|NOT COMPLETED|Overall Study||0
7820773|NCT01107730|19251067|P2|NOT COMPLETED|Overall Study||0
7820774|NCT01107730|19251068|P1|NOT COMPLETED|Overall Study||0
7820775|NCT01107730|19251066|P3|COMPLETED|Overall Study||11
7820776|NCT01107730|19251067|P2|COMPLETED|Overall Study||11
7820777|NCT01107730|19251068|P1|COMPLETED|Overall Study||11
7820778|NCT01107730|19251066|P3|STARTED|Overall Study||11
7820779|NCT01107730|19251067|P2|STARTED|Overall Study||11
7820780|NCT01107730|19251068|P1|STARTED|Overall Study||11
7820781|NCT01107665|19251076|P1|NOT COMPLETED|Overall Study||49
7820782|NCT01107665|19251076|P1|COMPLETED|Overall Study||11
7820783|NCT01107665|19251076|P1|STARTED|Overall Study||60
7820784|NCT01107535|19251091|P1|NOT COMPLETED|Overall Study||5
7820785|NCT01107535|19251091|P1|COMPLETED|Overall Study||77
7820786|NCT01107535|19251091|P1|Number of Participants Analyzed|Overall Study||82
7820787|NCT01107535|19251091|P1|STARTED|Overall Study||82
7820788|NCT01107457|19251104|P6|NOT COMPLETED|Part B and C||120
7820789|NCT01107457|19251105|P5|NOT COMPLETED|Part B and C||0
7820790|NCT01107457|19251106|P4|NOT COMPLETED|Part B and C||0
7820791|NCT01107457|19251107|P3|NOT COMPLETED|Part B and C||0
7820792|NCT01107457|19251108|P2|NOT COMPLETED|Part B and C||0
7820793|NCT01107457|19251109|P1|NOT COMPLETED|Part B and C||0
7820794|NCT01107457|19251104|P6|COMPLETED|Part B and C|No participants completed the study as Part C was stopped.|0
7820795|NCT01107457|19251105|P5|COMPLETED|Part B and C||0
7820796|NCT01107457|19251106|P4|COMPLETED|Part B and C||0
7820797|NCT01107457|19251107|P3|COMPLETED|Part B and C||0
7820798|NCT01107457|19251108|P2|COMPLETED|Part B and C||0
7820799|NCT01107457|19251109|P1|COMPLETED|Part B and C||0
7820800|NCT01107457|19251104|P6|Post Treatment Safety Visits|Part B and C|Only participants with neutropenia entered the post treatment safety visits.|6
7820801|NCT01107457|19251105|P5|Post Treatment Safety Visits|Part B and C||0
7820802|NCT01107457|19251106|P4|Post Treatment Safety Visits|Part B and C||0
7820803|NCT01107457|19251107|P3|Post Treatment Safety Visits|Part B and C||0
7820804|NCT01107457|19251108|P2|Post Treatment Safety Visits|Part B and C||0
7820805|NCT01107457|19251109|P1|Post Treatment Safety Visits|Part B and C||0
7820806|NCT01107457|19251104|P6|Completed Part C|Part B and C|Part C was stopped once ixekizumab became available through marketing authorization.|0
7820807|NCT01107457|19251105|P5|Completed Part C|Part B and C||0
7820808|NCT01107457|19251106|P4|Completed Part C|Part B and C||0
7820809|NCT01107457|19251107|P3|Completed Part C|Part B and C||0
7820810|NCT01107457|19251108|P2|Completed Part C|Part B and C||0
7820811|NCT01107457|19251109|P1|Completed Part C|Part B and C||0
7820812|NCT01107457|19251104|P6|Completed Part B (Week 240)|Part B and C||74
7820813|NCT01107457|19251105|P5|Completed Part B (Week 240)|Part B and C||0
7820814|NCT01107457|19251106|P4|Completed Part B (Week 240)|Part B and C||0
7820815|NCT01107457|19251107|P3|Completed Part B (Week 240)|Part B and C||0
7820816|NCT01107457|19251108|P2|Completed Part B (Week 240)|Part B and C||0
7820817|NCT01107457|19251109|P1|Completed Part B (Week 240)|Part B and C||0
7820818|NCT01107457|19251104|P6|STARTED|Part B and C|80 and 120 mg ixekizumab were administered during Part B and C.|120
7820819|NCT01107457|19251105|P5|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
7820820|NCT01107457|19251106|P4|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
7820821|NCT01107457|19251107|P3|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
7820822|NCT01107457|19251108|P2|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
7820823|NCT01107457|19251109|P1|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
7820824|NCT01107457|19251104|P6|NOT COMPLETED|Part A||0
7820825|NCT01107457|19251105|P5|NOT COMPLETED|Part A||1
7820826|NCT01107457|19251106|P4|NOT COMPLETED|Part A||3
7820827|NCT01107457|19251107|P3|NOT COMPLETED|Part A||1
7820828|NCT01107457|19251108|P2|NOT COMPLETED|Part A||7
7820829|NCT01107457|19251109|P1|NOT COMPLETED|Part A||5
7820830|NCT01107457|19251104|P6|COMPLETED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
7820831|NCT01107457|19251105|P5|COMPLETED|Part A||27
7820832|NCT01107457|19251106|P4|COMPLETED|Part A||26
7820833|NCT01107457|19251107|P3|COMPLETED|Part A||29
7820834|NCT01107457|19251108|P2|COMPLETED|Part A||21
7820835|NCT01107457|19251109|P1|COMPLETED|Part A||22
7820836|NCT01107457|19251104|P6|Received at Least 1 Dose of Study Drug|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
7820837|NCT01107457|19251105|P5|Received at Least 1 Dose of Study Drug|Part A||28
7820838|NCT01107457|19251106|P4|Received at Least 1 Dose of Study Drug|Part A||29
7820839|NCT01107457|19251107|P3|Received at Least 1 Dose of Study Drug|Part A||30
7820840|NCT01107457|19251108|P2|Received at Least 1 Dose of Study Drug|Part A||28
7820841|NCT01107457|19251109|P1|Received at Least 1 Dose of Study Drug|Part A||27
7820842|NCT01107457|19251104|P6|STARTED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
7820843|NCT01107457|19251105|P5|STARTED|Part A||28
7820844|NCT01107457|19251106|P4|STARTED|Part A||29
7820845|NCT01107457|19251107|P3|STARTED|Part A||30
7820846|NCT01107457|19251108|P2|STARTED|Part A||28
7820847|NCT01107457|19251109|P1|STARTED|Part A||27
7820848|NCT01107444|19251237|P2|NOT COMPLETED|Overall Study||13
7820849|NCT01107444|19251238|P1|NOT COMPLETED|Overall Study||8
7820850|NCT01107444|19251237|P2|COMPLETED|Overall Study||47
7820851|NCT01107444|19251238|P1|COMPLETED|Overall Study||112
7820852|NCT01107444|19251237|P2|Received At Least 1 Dose of Study Drug|Overall Study||48
7820853|NCT01107444|19251238|P1|Received At Least 1 Dose of Study Drug|Overall Study||114
7820854|NCT01107444|19251237|P2|STARTED|Overall Study||60
7820855|NCT01107444|19251238|P1|STARTED|Overall Study||120
7820856|NCT01107418|19251272|P1|NOT COMPLETED|Overall Study||52
7820857|NCT01107418|19251272|P1|COMPLETED|Overall Study||0
7820858|NCT01107418|19251272|P1|STARTED|Overall Study||52
7820859|NCT01107405|19251345|P5|NOT COMPLETED|Overall Study||3
7820860|NCT01107405|19251346|P4|NOT COMPLETED|Overall Study||3
7820861|NCT01107405|19251347|P3|NOT COMPLETED|Overall Study||2
7820862|NCT01107405|19251348|P2|NOT COMPLETED|Overall Study||1
7820863|NCT01107405|19251349|P1|NOT COMPLETED|Overall Study||2
7820864|NCT01107405|19251345|P5|COMPLETED|Overall Study||17
7820865|NCT01107405|19251346|P4|COMPLETED|Overall Study||17
7820866|NCT01107405|19251347|P3|COMPLETED|Overall Study||18
7820867|NCT01107405|19251348|P2|COMPLETED|Overall Study||19
7820868|NCT01107405|19251349|P1|COMPLETED|Overall Study||19
7820869|NCT01107405|19251345|P5|STARTED|Overall Study||20
7820870|NCT01107405|19251346|P4|STARTED|Overall Study||20
7820871|NCT01107405|19251347|P3|STARTED|Overall Study||20
7820872|NCT01107405|19251348|P2|STARTED|Overall Study||20
7820873|NCT01107405|19251349|P1|STARTED|Overall Study||21
7820874|NCT01107392|19251388|P2|NOT COMPLETED|Overall Study||3
7820875|NCT01107392|19251389|P1|NOT COMPLETED|Overall Study||5
7820876|NCT01107392|19251388|P2|COMPLETED|Overall Study||154
7820877|NCT01107392|19251389|P1|COMPLETED|Overall Study||153
7820878|NCT01107392|19251388|P2|STARTED|Overall Study||157
7820879|NCT01107392|19251389|P1|STARTED|Overall Study||158
7820880|NCT01107379|19251401|P1|NOT COMPLETED|Overall Study||21
7820881|NCT01107379|19251401|P1|COMPLETED|Overall Study||182
7820882|NCT01107379|19251401|P1|STARTED|Overall Study||203
7820883|NCT01107353|19251412|P2|NOT COMPLETED|Overall Study||0
7820884|NCT01107353|19251413|P1|NOT COMPLETED|Overall Study||1
7820885|NCT01107353|19251412|P2|COMPLETED|Overall Study||20
7820886|NCT01107353|19251413|P1|COMPLETED|Overall Study||19
7820887|NCT01107353|19251412|P2|STARTED|Overall Study||20
7820888|NCT01107353|19251413|P1|STARTED|Overall Study||20
7820889|NCT01107197|19251421|P2|NOT COMPLETED|Overall Study||23
7820890|NCT01107197|19251422|P1|NOT COMPLETED|Overall Study||20
7820891|NCT01107197|19251421|P2|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78
7820892|NCT01107197|19251422|P1|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79
7820893|NCT01107197|19251421|P2|STARTED|Overall Study||101
7820894|NCT01107197|19251422|P1|STARTED|Overall Study||99
7820895|NCT01107015|19251444|P4|NOT COMPLETED|Overall Study||18
7820896|NCT01107015|19251445|P3|NOT COMPLETED|Overall Study||11
7820897|NCT01107015|19251446|P2|NOT COMPLETED|Overall Study||15
7820898|NCT01107015|19251447|P1|NOT COMPLETED|Overall Study||6
7820899|NCT01107015|19251444|P4|COMPLETED|Overall Study||62
7820900|NCT01107015|19251445|P3|COMPLETED|Overall Study||22
7820901|NCT01107015|19251446|P2|COMPLETED|Overall Study||23
7820902|NCT01107015|19251447|P1|COMPLETED|Overall Study||56
7820903|NCT01107015|19251444|P4|STARTED|Overall Study||80
7820904|NCT01107015|19251445|P3|STARTED|Overall Study||33
7820905|NCT01107015|19251446|P2|STARTED|Overall Study||38
7820906|NCT01107015|19251447|P1|STARTED|Overall Study||62
7820907|NCT01106976|19251457|P1|NOT COMPLETED|Overall Study||8
7820908|NCT01106976|19251457|P1|COMPLETED|Overall Study||59
7820909|NCT01106976|19251457|P1|STARTED|Overall Study||67
7820910|NCT01106950|19251461|P1|NOT COMPLETED|Overall Study||0
7820911|NCT01106950|19251461|P1|COMPLETED|Overall Study||15
7820912|NCT01106950|19251461|P1|STARTED|Overall Study||15
7820913|NCT01106911|19251471|P1|NOT COMPLETED|Overall Study||5
7820914|NCT01106911|19251471|P1|COMPLETED|Overall Study||1080
7820915|NCT01106911|19251471|P1|STARTED|Overall Study||1085
7820916|NCT01106898|19251475|P1|NOT COMPLETED|Overall Study||6
7820917|NCT01106898|19251475|P1|COMPLETED|Overall Study||94
7820918|NCT01106898|19251475|P1|STARTED|Overall Study||100
7820919|NCT01106859|19251479|P1|NOT COMPLETED|Overall Study||0
7820920|NCT01106859|19251479|P1|COMPLETED|Overall Study||40
7820921|NCT01106859|19251479|P1|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40
7820922|NCT01106846|19251520|P2|NOT COMPLETED|Overall Study||1
7820923|NCT01106846|19251521|P1|NOT COMPLETED|Overall Study||0
7820924|NCT01106846|19251520|P2|COMPLETED|Overall Study||9
7820925|NCT01106846|19251521|P1|COMPLETED|Overall Study||12
7820926|NCT01106846|19251520|P2|STARTED|Overall Study||10
7820927|NCT01106846|19251521|P1|STARTED|Overall Study||12
7820928|NCT01106833|19251529|P2|NOT COMPLETED|Overall Study||0
7820929|NCT01106833|19251530|P1|NOT COMPLETED|Overall Study||0
7820930|NCT01106833|19251529|P2|COMPLETED|Overall Study||77
7820931|NCT01106833|19251530|P1|COMPLETED|Overall Study||74
7820932|NCT01106833|19251529|P2|STARTED|Overall Study||77
7820933|NCT01106833|19251530|P1|STARTED|Overall Study||74
7820934|NCT01106690|19251571|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
7820935|NCT01106690|19251572|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
7820936|NCT01106690|19251573|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
7820937|NCT01106690|19251571|P3|COMPLETED|Extension Period: Week 26 to Week 52||89
7820938|NCT01106690|19251572|P2|COMPLETED|Extension Period: Week 26 to Week 52||96
7820939|NCT01106690|19251573|P1|COMPLETED|Extension Period: Week 26 to Week 52||78
7820940|NCT01106690|19251571|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96
7820941|NCT01106690|19251572|P2|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103
7820942|NCT01106690|19251573|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90
7820943|NCT01106690|19251571|P3|NOT COMPLETED|Core Period: Baseline to Week 26||13
7820944|NCT01106690|19251572|P2|NOT COMPLETED|Core Period: Baseline to Week 26||9
7820945|NCT01106690|19251573|P1|NOT COMPLETED|Core Period: Baseline to Week 26||24
7820946|NCT01106690|19251571|P3|COMPLETED|Core Period: Baseline to Week 26||101
7820947|NCT01106690|19251572|P2|COMPLETED|Core Period: Baseline to Week 26||104
7820948|NCT01106690|19251573|P1|COMPLETED|Core Period: Baseline to Week 26||91
7820949|NCT01106690|19251571|P3|STARTED|Core Period: Baseline to Week 26||114
7820950|NCT01106690|19251572|P2|STARTED|Core Period: Baseline to Week 26||113
7820951|NCT01106690|19251573|P1|STARTED|Core Period: Baseline to Week 26||115
7820952|NCT01106677|19251609|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||28
7820953|NCT01106677|19251610|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||22
7820954|NCT01106677|19251611|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
7820955|NCT01106677|19251612|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||15
7820956|NCT01106677|19251609|P4|COMPLETED|Extension Period: Week 26 to Week 52||285
7820957|NCT01106677|19251610|P3|COMPLETED|Extension Period: Week 26 to Week 52||299
7820958|NCT01106677|19251611|P2|COMPLETED|Extension Period: Week 26 to Week 52||298
7820959|NCT01106677|19251612|P1|COMPLETED|Extension Period: Week 26 to Week 52||138
7820960|NCT01106677|19251609|P4|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313
7820961|NCT01106677|19251610|P3|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321
7820962|NCT01106677|19251611|P2|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316
7820963|NCT01106677|19251612|P1|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153
7820964|NCT01106677|19251609|P4|NOT COMPLETED|Core Period: Baseline to Week 26||47
7820965|NCT01106677|19251610|P3|NOT COMPLETED|Core Period: Baseline to Week 26||44
7820966|NCT01106677|19251611|P2|NOT COMPLETED|Core Period: Baseline to Week 26||46
7820967|NCT01106677|19251612|P1|NOT COMPLETED|Core Period: Baseline to Week 26||28
7820968|NCT01106677|19251609|P4|COMPLETED|Core Period: Baseline to Week 26||319
7820969|NCT01106677|19251610|P3|COMPLETED|Core Period: Baseline to Week 26||323
7820970|NCT01106677|19251611|P2|COMPLETED|Core Period: Baseline to Week 26||322
7820971|NCT01106677|19251612|P1|COMPLETED|Core Period: Baseline to Week 26||155
7820972|NCT01106677|19251609|P4|STARTED|Core Period: Baseline to Week 26||366
7820973|NCT01106677|19251610|P3|STARTED|Core Period: Baseline to Week 26||367
7820974|NCT01106677|19251611|P2|STARTED|Core Period: Baseline to Week 26||368
7820975|NCT01106677|19251612|P1|STARTED|Core Period: Baseline to Week 26||183
7820976|NCT01106651|19251675|P3|NOT COMPLETED|Overall Study||58
7820977|NCT01106651|19251676|P2|NOT COMPLETED|Overall Study||57
7820978|NCT01106651|19251677|P1|NOT COMPLETED|Overall Study||79
7820979|NCT01106651|19251675|P3|COMPLETED|Overall Study||178
7820980|NCT01106651|19251676|P2|COMPLETED|Overall Study||184
7820981|NCT01106651|19251677|P1|COMPLETED|Overall Study||158
7820982|NCT01106651|19251675|P3|STARTED|Overall Study||236
7820983|NCT01106651|19251676|P2|STARTED|Overall Study||241
7820984|NCT01106651|19251677|P1|STARTED|Overall Study||237
7820985|NCT01106625|19251730|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||17
7820986|NCT01106625|19251731|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
7820987|NCT01106625|19251732|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||29
7820988|NCT01106625|19251730|P3|COMPLETED|Extension Period: Week 26 to Week 52||111
7820989|NCT01106625|19251731|P2|COMPLETED|Extension Period: Week 26 to Week 52||109
7820990|NCT01106625|19251732|P1|COMPLETED|Extension Period: Week 26 to Week 52||90
7820991|NCT01106625|19251730|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128
7820992|NCT01106625|19251731|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127
7820993|NCT01106625|19251732|P1|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119
7820994|NCT01106625|19251730|P3|NOT COMPLETED|Core Period: Baseline to Week 26||27
7820995|NCT01106625|19251731|P2|NOT COMPLETED|Core Period: Baseline to Week 26||28
7820996|NCT01106625|19251732|P1|NOT COMPLETED|Core Period: Baseline to Week 26||33
7820997|NCT01106625|19251730|P3|COMPLETED|Core Period: Baseline to Week 26||129
7820998|NCT01106625|19251731|P2|COMPLETED|Core Period: Baseline to Week 26||129
7820999|NCT01106625|19251732|P1|COMPLETED|Core Period: Baseline to Week 26||123
7821000|NCT01106625|19251730|P3|STARTED|Core Period: Baseline to Week 26||156
7821001|NCT01106625|19251731|P2|STARTED|Core Period: Baseline to Week 26||157
7821002|NCT01106625|19251732|P1|STARTED|Core Period: Baseline to Week 26||156
7821003|NCT01106586|19251763|P2|NOT COMPLETED|Overall Study||285
7821004|NCT01106586|19251764|P1|NOT COMPLETED|Overall Study||285
7821005|NCT01106586|19251763|P2|COMPLETED|Overall Study||70
7821006|NCT01106586|19251764|P1|COMPLETED|Overall Study||68
7821007|NCT01106586|19251763|P2|STARTED|Overall Study||355
7821008|NCT01106586|19251764|P1|STARTED|Overall Study||353
7821009|NCT01106534|19251782|P1|NOT COMPLETED|Overall Study||37
7821010|NCT01106534|19251782|P1|COMPLETED|Overall Study||2960
7821011|NCT01106534|19251782|P1|STARTED|Overall Study||2997
7821012|NCT01106456|19251805|P2|NOT COMPLETED|Overall Study||124
7821013|NCT01106456|19251806|P1|NOT COMPLETED|Overall Study||103
7821014|NCT01106456|19251805|P2|COMPLETED|Overall Study||96
7821015|NCT01106456|19251806|P1|COMPLETED|Overall Study||140
7821016|NCT01106456|19251805|P2|STARTED|Overall Study||220
7821017|NCT01106456|19251806|P1|STARTED|Overall Study||243
7821018|NCT01106430|19251814|P2|NOT COMPLETED|Overall Study||33
7821019|NCT01106430|19251815|P1|NOT COMPLETED|Overall Study||33
7821020|NCT01106430|19251814|P2|COMPLETED|Overall Study||101
7821021|NCT01106430|19251815|P1|COMPLETED|Overall Study||100
7821022|NCT01106430|19251814|P2|STARTED|Overall Study||134
7821023|NCT01106430|19251815|P1|STARTED|Overall Study||133
7821024|NCT01106404|19251837|P2|NOT COMPLETED|Period II (Second 6 Weeks)||0
7821025|NCT01106404|19251838|P1|NOT COMPLETED|Period II (Second 6 Weeks)||0
7821026|NCT01106404|19251837|P2|COMPLETED|Period II (Second 6 Weeks)||38
7821027|NCT01106404|19251838|P1|COMPLETED|Period II (Second 6 Weeks)||33
7821028|NCT01106404|19251837|P2|STARTED|Period II (Second 6 Weeks)||38
7821029|NCT01106404|19251838|P1|STARTED|Period II (Second 6 Weeks)||33
7821030|NCT01106404|19251837|P2|NOT COMPLETED|Period I (First 6 Weeks)||2
7821031|NCT01106404|19251838|P1|NOT COMPLETED|Period I (First 6 Weeks)||3
7821032|NCT01106404|19251837|P2|COMPLETED|Period I (First 6 Weeks)||38
7821033|NCT01106404|19251838|P1|COMPLETED|Period I (First 6 Weeks)||33
7821034|NCT01106404|19251837|P2|STARTED|Period I (First 6 Weeks)||40
7821035|NCT01106404|19251838|P1|STARTED|Period I (First 6 Weeks)||36
7821036|NCT01106391|19251851|P1|NOT COMPLETED|Overall Study||0
7821037|NCT01106391|19251851|P1|COMPLETED|Overall Study||60
7821038|NCT01106391|19251851|P1|STARTED|Overall Study||60
7821039|NCT01106352|19251861|P5|NOT COMPLETED|Overall Study||8
7821040|NCT01106352|19251862|P4|NOT COMPLETED|Overall Study||13
7821041|NCT01106352|19251863|P3|NOT COMPLETED|Overall Study||2
7821042|NCT01106352|19251864|P2|NOT COMPLETED|Overall Study||0
7821043|NCT01106352|19251865|P1|NOT COMPLETED|Overall Study||1
7821044|NCT01106352|19251861|P5|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9
7821045|NCT01106352|19251862|P4|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23
7821046|NCT01106352|19251863|P3|COMPLETED|Overall Study||5
7821047|NCT01106352|19251864|P2|COMPLETED|Overall Study||3
7821048|NCT01106352|19251865|P1|COMPLETED|Overall Study||6
7821049|NCT01106352|19251861|P5|Completed Safety Cohort|Overall Study||9
7821050|NCT01106352|19251862|P4|Completed Safety Cohort|Overall Study||23
7821051|NCT01106352|19251863|P3|Completed Safety Cohort|Overall Study||0
7821052|NCT01106352|19251864|P2|Completed Safety Cohort|Overall Study||0
7821053|NCT01106352|19251865|P1|Completed Safety Cohort|Overall Study||0
7821054|NCT01106352|19251861|P5|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13
7821055|NCT01106352|19251862|P4|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33
7821056|NCT01106352|19251863|P3|Treated Safety Cohort|Overall Study||0
7821057|NCT01106352|19251864|P2|Treated Safety Cohort|Overall Study||0
7821058|NCT01106352|19251865|P1|Treated Safety Cohort|Overall Study||0
7821059|NCT01106352|19251861|P5|Started Safety Cohort|Overall Study||17
7821060|NCT01106352|19251862|P4|Started Safety Cohort|Overall Study||36
7821061|NCT01106352|19251863|P3|Started Safety Cohort|Overall Study||0
7821062|NCT01106352|19251864|P2|Started Safety Cohort|Overall Study||0
7821063|NCT01106352|19251865|P1|Started Safety Cohort|Overall Study||0
7821064|NCT01106352|19251861|P5|Completed Dose Escalation|Overall Study||0
7821065|NCT01106352|19251862|P4|Completed Dose Escalation|Overall Study||0
7821066|NCT01106352|19251863|P3|Completed Dose Escalation|Overall Study||5
7821067|NCT01106352|19251864|P2|Completed Dose Escalation|Overall Study||3
7821068|NCT01106352|19251865|P1|Completed Dose Escalation|Overall Study||6
7821069|NCT01106352|19251861|P5|Started Dose Escalation|Overall Study||0
7821070|NCT01106352|19251862|P4|Started Dose Escalation|Overall Study||0
7821071|NCT01106352|19251863|P3|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
7821072|NCT01106352|19251864|P2|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3
7821073|NCT01106352|19251865|P1|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
7821074|NCT01106352|19251861|P5|STARTED|Overall Study||17
7821075|NCT01106352|19251862|P4|STARTED|Overall Study||36
7821076|NCT01106352|19251863|P3|STARTED|Overall Study||7
7821077|NCT01106352|19251864|P2|STARTED|Overall Study||3
7821078|NCT01106352|19251865|P1|STARTED|Overall Study||7
7821079|NCT01106326|19251951|P1|NOT COMPLETED|Overall Study||2
7821080|NCT01106326|19251951|P1|COMPLETED|Overall Study||28
7821081|NCT01106326|19251951|P1|STARTED|Overall Study||30
7821082|NCT01106287|19251961|P4|NOT COMPLETED|Overall Study||0
7821083|NCT01106287|19251962|P3|NOT COMPLETED|Overall Study||0
7821084|NCT01106287|19251963|P2|NOT COMPLETED|Overall Study||0
7821085|NCT01106287|19251964|P1|NOT COMPLETED|Overall Study||1
7821086|NCT01106287|19251961|P4|COMPLETED|Overall Study||3
7821087|NCT01106287|19251962|P3|COMPLETED|Overall Study||3
7821088|NCT01106287|19251963|P2|COMPLETED|Overall Study||3
7821089|NCT01106287|19251964|P1|COMPLETED|Overall Study||3
7821090|NCT01106287|19251961|P4|STARTED|Overall Study||3
7821091|NCT01106287|19251962|P3|STARTED|Overall Study||3
7821092|NCT01106287|19251963|P2|STARTED|Overall Study||3
7821093|NCT01106287|19251964|P1|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4
7821094|NCT01106248|19251984|P1|NOT COMPLETED|Overall Study||3
7821095|NCT01106248|19251984|P1|COMPLETED|Overall Study||23
7821096|NCT01106248|19251984|P1|STARTED|Overall Study||26
7821097|NCT01106157|19251992|P2|NOT COMPLETED|Overall Study||0
7821098|NCT01106157|19251993|P1|NOT COMPLETED|Overall Study||1
7821099|NCT01106157|19251992|P2|COMPLETED|Overall Study||8
7821100|NCT01106157|19251993|P1|COMPLETED|Overall Study||16
7821101|NCT01106157|19251992|P2|STARTED|Overall Study||8
7821102|NCT01106157|19251993|P1|STARTED|Overall Study||17
7821103|NCT01106092|19252021|P4|NOT COMPLETED|Overall Study||1
7821104|NCT01106092|19252022|P3|NOT COMPLETED|Overall Study||0
7821105|NCT01106092|19252023|P2|NOT COMPLETED|Overall Study||0
7821106|NCT01106092|19252024|P1|NOT COMPLETED|Overall Study||0
7821107|NCT01106092|19252021|P4|COMPLETED|Overall Study||77
7821108|NCT01106092|19252022|P3|COMPLETED|Overall Study||78
7821109|NCT01106092|19252023|P2|COMPLETED|Overall Study||78
7821110|NCT01106092|19252024|P1|COMPLETED|Overall Study||78
7821111|NCT01106092|19252021|P4|STARTED|Overall Study||78
7821112|NCT01106092|19252022|P3|STARTED|Overall Study||78
7821113|NCT01106092|19252023|P2|STARTED|Overall Study||78
7821114|NCT01106092|19252024|P1|STARTED|Overall Study||78
7821115|NCT01106040|19252102|P1|NOT COMPLETED|Overall Study||11
7821116|NCT01106040|19252102|P1|COMPLETED|Overall Study||152
7821117|NCT01106040|19252102|P1|STARTED|Overall Study||163
7821118|NCT01106027|19252107|P1|NOT COMPLETED|Overall Study||1
7821119|NCT01106027|19252107|P1|COMPLETED|Overall Study||1
7821120|NCT01106027|19252107|P1|STARTED|Overall Study||2
7821121|NCT01106014|19252113|P2|NOT COMPLETED|Overall Study||330
7821122|NCT01106014|19252114|P1|NOT COMPLETED|Overall Study||285
7821123|NCT01106014|19252113|P2|COMPLETED|Overall Study||252
7821124|NCT01106014|19252114|P1|COMPLETED|Overall Study||289
7821125|NCT01106014|19252113|P2|STARTED|Overall Study||582
7821126|NCT01106014|19252114|P1|STARTED|Overall Study||574
7821127|NCT01105975|19252134|P10|NOT COMPLETED|Overall Study||9
7821128|NCT01105975|19252135|P9|NOT COMPLETED|Overall Study||6
7821129|NCT01105975|19252136|P8|NOT COMPLETED|Overall Study||7
7821130|NCT01105975|19252137|P7|NOT COMPLETED|Overall Study||8
7821131|NCT01105975|19252138|P6|NOT COMPLETED|Overall Study||5
7821132|NCT01105975|19252139|P5|NOT COMPLETED|Overall Study||6
7821133|NCT01105975|19252140|P4|NOT COMPLETED|Overall Study||2
7821134|NCT01105975|19252141|P3|NOT COMPLETED|Overall Study||10
7821135|NCT01105975|19252142|P2|NOT COMPLETED|Overall Study||5
7821136|NCT01105975|19252143|P1|NOT COMPLETED|Overall Study||5
7821137|NCT01105975|19252134|P10|COMPLETED|Overall Study||32
7821138|NCT01105975|19252135|P9|COMPLETED|Overall Study||34
7821139|NCT01105975|19252136|P8|COMPLETED|Overall Study||33
7821140|NCT01105975|19252137|P7|COMPLETED|Overall Study||34
7821141|NCT01105975|19252138|P6|COMPLETED|Overall Study||30
7821142|NCT01105975|19252139|P5|COMPLETED|Overall Study||35
7821143|NCT01105975|19252140|P4|COMPLETED|Overall Study||36
7821144|NCT01105975|19252141|P3|COMPLETED|Overall Study||32
7821145|NCT01105975|19252142|P2|COMPLETED|Overall Study||34
7821146|NCT01105975|19252143|P1|COMPLETED|Overall Study||35
7821147|NCT01105975|19252134|P10|Took at Least One Dose of Study Drug|Overall Study||41
7821148|NCT01105975|19252135|P9|Took at Least One Dose of Study Drug|Overall Study||39
7821149|NCT01105975|19252136|P8|Took at Least One Dose of Study Drug|Overall Study||40
7821150|NCT01105975|19252137|P7|Took at Least One Dose of Study Drug|Overall Study||41
7821151|NCT01105975|19252138|P6|Took at Least One Dose of Study Drug|Overall Study||35
7821152|NCT01105975|19252139|P5|Took at Least One Dose of Study Drug|Overall Study||41
7821153|NCT01105975|19252140|P4|Took at Least One Dose of Study Drug|Overall Study||38
7821154|NCT01105975|19252141|P3|Took at Least One Dose of Study Drug|Overall Study||40
7821155|NCT01105975|19252142|P2|Took at Least One Dose of Study Drug|Overall Study||38
7821156|NCT01105975|19252143|P1|Took at Least One Dose of Study Drug|Overall Study||40
7821157|NCT01105975|19252134|P10|STARTED|Overall Study||41
7821158|NCT01105975|19252135|P9|STARTED|Overall Study||40
7821159|NCT01105975|19252136|P8|STARTED|Overall Study||40
7821160|NCT01105975|19252137|P7|STARTED|Overall Study||42
7821161|NCT01105975|19252138|P6|STARTED|Overall Study||35
7821162|NCT01105975|19252139|P5|STARTED|Overall Study||41
7821163|NCT01105975|19252140|P4|STARTED|Overall Study||38
7821164|NCT01105975|19252141|P3|STARTED|Overall Study||42
7821165|NCT01105975|19252142|P2|STARTED|Overall Study||39
7821166|NCT01105975|19252143|P1|STARTED|Overall Study||40
7821167|NCT01105936|19252291|P4|NOT COMPLETED|Period 3||0
7821168|NCT01105936|19252292|P3|NOT COMPLETED|Period 3||0
7821169|NCT01105936|19252293|P2|NOT COMPLETED|Period 3||2
7821170|NCT01105936|19252294|P1|NOT COMPLETED|Period 3||0
7821171|NCT01105936|19252291|P4|COMPLETED|Period 3||7
7821172|NCT01105936|19252292|P3|COMPLETED|Period 3||7
7821173|NCT01105936|19252293|P2|COMPLETED|Period 3||6
7821174|NCT01105936|19252294|P1|COMPLETED|Period 3||7
7821175|NCT01105936|19252291|P4|STARTED|Period 3||7
7821176|NCT01105936|19252292|P3|STARTED|Period 3||7
7821177|NCT01105936|19252293|P2|STARTED|Period 3||8
7821178|NCT01105936|19252294|P1|STARTED|Period 3||7
7821179|NCT01105936|19252291|P4|NOT COMPLETED|Wash-out Period 2||0
7821180|NCT01105936|19252292|P3|NOT COMPLETED|Wash-out Period 2||0
7821181|NCT01105936|19252293|P2|NOT COMPLETED|Wash-out Period 2||0
7821182|NCT01105936|19252294|P1|NOT COMPLETED|Wash-out Period 2||0
7821183|NCT01105936|19252291|P4|COMPLETED|Wash-out Period 2||7
7821184|NCT01105936|19252292|P3|COMPLETED|Wash-out Period 2||7
7821185|NCT01105936|19252293|P2|COMPLETED|Wash-out Period 2||8
7821186|NCT01105936|19252294|P1|COMPLETED|Wash-out Period 2||7
7821187|NCT01105936|19252291|P4|STARTED|Wash-out Period 2||7
7821188|NCT01105936|19252292|P3|STARTED|Wash-out Period 2||7
7821189|NCT01105936|19252293|P2|STARTED|Wash-out Period 2||8
7821190|NCT01105936|19252294|P1|STARTED|Wash-out Period 2||7
7821191|NCT01105936|19252291|P4|NOT COMPLETED|Period 2||0
7821192|NCT01105936|19252292|P3|NOT COMPLETED|Period 2||0
7821193|NCT01105936|19252293|P2|NOT COMPLETED|Period 2||0
7821194|NCT01105936|19252294|P1|NOT COMPLETED|Period 2||1
7821195|NCT01105936|19252291|P4|COMPLETED|Period 2||7
7821196|NCT01105936|19252292|P3|COMPLETED|Period 2||7
7821197|NCT01105936|19252293|P2|COMPLETED|Period 2||8
7821198|NCT01105936|19252294|P1|COMPLETED|Period 2||7
7821199|NCT01105936|19252291|P4|STARTED|Period 2||7
7821200|NCT01105936|19252292|P3|STARTED|Period 2||7
7821201|NCT01105936|19252293|P2|STARTED|Period 2||8
7821202|NCT01105936|19252294|P1|STARTED|Period 2||8
7821203|NCT01105936|19252291|P4|NOT COMPLETED|Wash-out Period 1||0
7821204|NCT01105936|19252292|P3|NOT COMPLETED|Wash-out Period 1||0
7821205|NCT01105936|19252293|P2|NOT COMPLETED|Wash-out Period 1||0
7821206|NCT01105936|19252294|P1|NOT COMPLETED|Wash-out Period 1||0
7821207|NCT01105936|19252291|P4|COMPLETED|Wash-out Period 1||7
7821208|NCT01105936|19252292|P3|COMPLETED|Wash-out Period 1||7
7821209|NCT01105936|19252293|P2|COMPLETED|Wash-out Period 1||8
7821210|NCT01105936|19252294|P1|COMPLETED|Wash-out Period 1||8
7821211|NCT01105936|19252291|P4|STARTED|Wash-out Period 1||7
7821212|NCT01105936|19252292|P3|STARTED|Wash-out Period 1||7
7821213|NCT01105936|19252293|P2|STARTED|Wash-out Period 1||8
7821214|NCT01105936|19252294|P1|STARTED|Wash-out Period 1||8
7821215|NCT01105936|19252291|P4|NOT COMPLETED|Period 1||1
7821216|NCT01105936|19252292|P3|NOT COMPLETED|Period 1||0
7821217|NCT01105936|19252293|P2|NOT COMPLETED|Period 1||0
7821218|NCT01105936|19252294|P1|NOT COMPLETED|Period 1||0
7821219|NCT01105936|19252291|P4|COMPLETED|Period 1||7
7821220|NCT01105936|19252292|P3|COMPLETED|Period 1||7
7821221|NCT01105936|19252293|P2|COMPLETED|Period 1||8
7821222|NCT01105936|19252294|P1|COMPLETED|Period 1||8
7821223|NCT01105936|19252291|P4|STARTED|Period 1||8
7821224|NCT01105936|19252292|P3|STARTED|Period 1||7
7821225|NCT01105936|19252293|P2|STARTED|Period 1||8
7821226|NCT01105936|19252294|P1|STARTED|Period 1||8
7821227|NCT01105767|19252323|P3|NOT COMPLETED|Overall Study||1184
7821228|NCT01105767|19252324|P2|NOT COMPLETED|Overall Study||1614
7821229|NCT01105767|19252325|P1|NOT COMPLETED|Overall Study||1160
7821230|NCT01105767|19252323|P3|COMPLETED|Overall Study||8846
7821231|NCT01105767|19252324|P2|COMPLETED|Overall Study||9250
7821232|NCT01105767|19252325|P1|COMPLETED|Overall Study||8155
7821233|NCT01105767|19252323|P3|STARTED|Overall Study||10030
7821234|NCT01105767|19252324|P2|STARTED|Overall Study||10864
7821235|NCT01105767|19252325|P1|STARTED|Overall Study||9315
7821236|NCT01105754|19252338|P2|NOT COMPLETED|Overall Study||12
7821237|NCT01105754|19252339|P1|NOT COMPLETED|Overall Study||15
7821238|NCT01105754|19252338|P2|COMPLETED|Overall Study||307
7821239|NCT01105754|19252339|P1|COMPLETED|Overall Study||304
7821240|NCT01105754|19252338|P2|STARTED|Overall Study||319
7821241|NCT01105754|19252339|P1|STARTED|Overall Study||319
7821242|NCT01105702|19252347|P1|NOT COMPLETED|Overall Study||18
7821243|NCT01105702|19252347|P1|COMPLETED|Overall Study||10
7821244|NCT01105702|19252347|P1|STARTED|Overall Study||28
7821245|NCT01105650|19252357|P4|NOT COMPLETED|Overall Study||0
7821246|NCT01105650|19252358|P3|NOT COMPLETED|Overall Study||0
7821247|NCT01105650|19252359|P2|NOT COMPLETED|Overall Study||0
7821248|NCT01105650|19252360|P1|NOT COMPLETED|Overall Study||0
7821249|NCT01105650|19252357|P4|COMPLETED|Overall Study||0
7821250|NCT01105650|19252358|P3|COMPLETED|Overall Study||7
7821251|NCT01105650|19252359|P2|COMPLETED|Overall Study||3
7821252|NCT01105650|19252360|P1|COMPLETED|Overall Study||3
7821253|NCT01105650|19252357|P4|STARTED|Overall Study|Arm 3 was determined to be successful, thus eliminating the need to test Arm 4.|0
7821254|NCT01105650|19252358|P3|STARTED|Overall Study||7
7821255|NCT01105650|19252359|P2|STARTED|Overall Study||3
7821256|NCT01105650|19252360|P1|STARTED|Overall Study||3
7821257|NCT01105533|19252377|P9|NOT COMPLETED|Overall Study||12
7821258|NCT01105533|19252378|P8|NOT COMPLETED|Overall Study||4
7821259|NCT01105533|19252379|P7|NOT COMPLETED|Overall Study||8
7821260|NCT01105533|19252380|P6|NOT COMPLETED|Overall Study||7
7821261|NCT01105533|19252381|P5|NOT COMPLETED|Overall Study||7
7821262|NCT01105533|19252382|P4|NOT COMPLETED|Overall Study||3
7821263|NCT01105533|19252383|P3|NOT COMPLETED|Overall Study||3
7821264|NCT01105533|19252384|P2|NOT COMPLETED|Overall Study||1
7821265|NCT01105533|19252385|P1|NOT COMPLETED|Overall Study||1
7821266|NCT01105533|19252377|P9|COMPLETED|Overall Study||0
7821267|NCT01105533|19252378|P8|COMPLETED|Overall Study||0
7821268|NCT01105533|19252379|P7|COMPLETED|Overall Study||0
7821269|NCT01105533|19252380|P6|COMPLETED|Overall Study||0
7821270|NCT01105533|19252381|P5|COMPLETED|Overall Study||0
7821271|NCT01105533|19252382|P4|COMPLETED|Overall Study||0
7821272|NCT01105533|19252383|P3|COMPLETED|Overall Study||0
7821273|NCT01105533|19252384|P2|COMPLETED|Overall Study||0
7821274|NCT01105533|19252385|P1|COMPLETED|Overall Study||0
7821275|NCT01105533|19252377|P9|STARTED|Overall Study||12
7821276|NCT01105533|19252378|P8|STARTED|Overall Study||4
7821277|NCT01105533|19252379|P7|STARTED|Overall Study||8
7821278|NCT01105533|19252380|P6|STARTED|Overall Study||7
7821279|NCT01105533|19252381|P5|STARTED|Overall Study||7
7821280|NCT01105533|19252382|P4|STARTED|Overall Study||3
7821281|NCT01105533|19252383|P3|STARTED|Overall Study||3
7821282|NCT01105533|19252384|P2|STARTED|Overall Study||1
7821283|NCT01105533|19252385|P1|STARTED|Overall Study||1
7821284|NCT01105377|19252475|P2|NOT COMPLETED|Overall Study||1
7821285|NCT01105377|19252476|P1|NOT COMPLETED|Overall Study||0
7821286|NCT01105377|19252475|P2|COMPLETED|Overall Study||22
7821287|NCT01105377|19252476|P1|COMPLETED|Overall Study||24
7821288|NCT01105377|19252475|P2|STARTED|Overall Study||23
7821289|NCT01105377|19252476|P1|STARTED|Overall Study||24
7821290|NCT01105312|19252487|P3|NOT COMPLETED|Overall Study||0
7821291|NCT01105312|19252488|P2|NOT COMPLETED|Overall Study||0
7821292|NCT01105312|19252489|P1|NOT COMPLETED|Overall Study||3
7821293|NCT01105312|19252487|P3|COMPLETED|Overall Study||6
7821294|NCT01105312|19252488|P2|COMPLETED|Overall Study||6
7821295|NCT01105312|19252489|P1|COMPLETED|Overall Study||13
7821296|NCT01105312|19252487|P3|STARTED|Overall Study||6
7821297|NCT01105312|19252488|P2|STARTED|Overall Study||6
7821298|NCT01105312|19252489|P1|STARTED|Overall Study||16
7821299|NCT01105247|19252507|P2|NOT COMPLETED|Overall Study||0
7821300|NCT01105247|19252508|P1|NOT COMPLETED|Overall Study||37
7821301|NCT01105247|19252507|P2|COMPLETED|Overall Study||16
7821302|NCT01105247|19252508|P1|COMPLETED|Overall Study||79
7821303|NCT01105247|19252507|P2|STARTED|Overall Study||16
7821304|NCT01105247|19252508|P1|STARTED|Overall Study||116
7821305|NCT01105130|19252524|P3|NOT COMPLETED|Overall Study||10
7821306|NCT01105130|19252525|P2|NOT COMPLETED|Overall Study||11
7821307|NCT01105130|19252526|P1|NOT COMPLETED|Overall Study||10
7821308|NCT01105130|19252524|P3|COMPLETED|Overall Study||37
7821309|NCT01105130|19252525|P2|COMPLETED|Overall Study||34
7821310|NCT01105130|19252526|P1|COMPLETED|Overall Study||38
7821311|NCT01105130|19252524|P3|STARTED|Overall Study||47
7821312|NCT01105130|19252525|P2|STARTED|Overall Study||45
7821313|NCT01105130|19252526|P1|STARTED|Overall Study||48
7821314|NCT01105117|19252545|P2|NOT COMPLETED|Overall Study||0
7821315|NCT01105117|19252546|P1|NOT COMPLETED|Overall Study||0
7821316|NCT01105117|19252545|P2|COMPLETED|Overall Study||1
7821317|NCT01105117|19252546|P1|COMPLETED|Overall Study||1
7821318|NCT01105117|19252545|P2|STARTED|Overall Study||1
7821319|NCT01105117|19252546|P1|STARTED|Overall Study||1
7821320|NCT01105091|19252556|P2|NOT COMPLETED|Overall Study||0
7821321|NCT01105091|19252557|P1|NOT COMPLETED|Overall Study||2
7821322|NCT01105091|19252556|P2|COMPLETED|Overall Study||10
7821323|NCT01105091|19252557|P1|COMPLETED|Overall Study||18
7821324|NCT01105091|19252556|P2|STARTED|Overall Study||10
7821325|NCT01105091|19252557|P1|STARTED|Overall Study||20
7821326|NCT01105065|19252581|P1|NOT COMPLETED|Overall Study||6
7821327|NCT01105065|19252581|P1|COMPLETED|Overall Study||17
7821328|NCT01105065|19252581|P1|STARTED|Overall Study||23
7821329|NCT01104870|19252590|P3|NOT COMPLETED|Overall Study||2
7821330|NCT01104870|19252591|P2|NOT COMPLETED|Overall Study||1
7821331|NCT01104870|19252592|P1|NOT COMPLETED|Overall Study||1
7821332|NCT01104870|19252590|P3|COMPLETED|Overall Study||18
7821333|NCT01104870|19252591|P2|COMPLETED|Overall Study||18
7821334|NCT01104870|19252592|P1|COMPLETED|Overall Study||10
7821335|NCT01104870|19252590|P3|STARTED|Overall Study||20
7821336|NCT01104870|19252591|P2|STARTED|Overall Study||19
7821337|NCT01104870|19252592|P1|STARTED|Overall Study||11
7821338|NCT01104792|19252621|P1|NOT COMPLETED|Overall Study||526
7821339|NCT01104792|19252621|P1|COMPLETED|Overall Study||226
7821340|NCT01104792|19252621|P1|STARTED|Overall Study||752
7821341|NCT01104779|19252629|P3|NOT COMPLETED|Overall Study||62
7821342|NCT01104779|19252630|P2|NOT COMPLETED|Overall Study||55
7821343|NCT01104779|19252631|P1|NOT COMPLETED|Overall Study||59
7821344|NCT01104779|19252629|P3|COMPLETED|Overall Study||86
7821345|NCT01104779|19252630|P2|COMPLETED|Overall Study||96
7821346|NCT01104779|19252631|P1|COMPLETED|Overall Study||88
7821347|NCT01104779|19252629|P3|STARTED|Overall Study||148
7821348|NCT01104779|19252630|P2|STARTED|Overall Study||151
7821349|NCT01104779|19252631|P1|STARTED|Overall Study||147
7821350|NCT01104766|19252646|P4|NOT COMPLETED|Overall Study||38
7821351|NCT01104766|19252647|P3|NOT COMPLETED|Overall Study||60
7821352|NCT01104766|19252648|P2|NOT COMPLETED|Overall Study||51
7821353|NCT01104766|19252649|P1|NOT COMPLETED|Overall Study||58
7821354|NCT01104766|19252646|P4|COMPLETED|Overall Study||114
7821355|NCT01104766|19252647|P3|COMPLETED|Overall Study||97
7821356|NCT01104766|19252648|P2|COMPLETED|Overall Study||104
7821357|NCT01104766|19252649|P1|COMPLETED|Overall Study||95
7821358|NCT01104766|19252646|P4|STARTED|Overall Study||152
7821359|NCT01104766|19252647|P3|STARTED|Overall Study||157
7821360|NCT01104766|19252648|P2|STARTED|Overall Study||155
7821361|NCT01104766|19252649|P1|STARTED|Overall Study||153
7821362|NCT01104701|19252667|P4|NOT COMPLETED|Overall Study||2
7821363|NCT01104701|19252668|P3|NOT COMPLETED|Overall Study||2
7821364|NCT01104701|19252669|P2|NOT COMPLETED|Overall Study||3
7821365|NCT01104701|19252670|P1|NOT COMPLETED|Overall Study||0
7821366|NCT01104701|19252667|P4|COMPLETED|Overall Study||28
7821367|NCT01104701|19252668|P3|COMPLETED|Overall Study||29
7821368|NCT01104701|19252669|P2|COMPLETED|Overall Study||27
7821369|NCT01104701|19252670|P1|COMPLETED|Overall Study||30
7821370|NCT01104701|19252667|P4|STARTED|Overall Study||30
7821371|NCT01104701|19252668|P3|STARTED|Overall Study||31
7821372|NCT01104701|19252669|P2|STARTED|Overall Study||30
7821373|NCT01104701|19252670|P1|STARTED|Overall Study||30
7821374|NCT01104662|19252732|P8|NOT COMPLETED|Overall Study||0
7821375|NCT01104662|19252733|P7|NOT COMPLETED|Overall Study||0
7821376|NCT01104662|19252734|P6|NOT COMPLETED|Overall Study||4
7821377|NCT01104662|19252735|P5|NOT COMPLETED|Overall Study||1
7821378|NCT01104662|19252736|P4|NOT COMPLETED|Overall Study||1
7821379|NCT01104662|19252737|P3|NOT COMPLETED|Overall Study||1
7821380|NCT01104662|19252738|P2|NOT COMPLETED|Overall Study||10
7821381|NCT01104662|19252739|P1|NOT COMPLETED|Overall Study||10
7821382|NCT01104662|19252732|P8|COMPLETED|Overall Study||6
7821383|NCT01104662|19252733|P7|COMPLETED|Overall Study||5
7821384|NCT01104662|19252734|P6|COMPLETED|Overall Study||12
7821385|NCT01104662|19252735|P5|COMPLETED|Overall Study||14
7821386|NCT01104662|19252736|P4|COMPLETED|Overall Study||3
7821387|NCT01104662|19252737|P3|COMPLETED|Overall Study||4
7821388|NCT01104662|19252738|P2|COMPLETED|Overall Study||11
7821389|NCT01104662|19252739|P1|COMPLETED|Overall Study||10
7821390|NCT01104662|19252732|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
7821391|NCT01104662|19252733|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
7821392|NCT01104662|19252734|P6|Received at Least 1 Dose of Study Drug|Overall Study||15
7821393|NCT01104662|19252735|P5|Received at Least 1 Dose of Study Drug|Overall Study||15
7821394|NCT01104662|19252736|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
7821395|NCT01104662|19252737|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
7821396|NCT01104662|19252738|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
7821397|NCT01104662|19252739|P1|Received at Least 1 Dose of Study Drug|Overall Study||17
7821398|NCT01104662|19252732|P8|STARTED|Overall Study||6
7821399|NCT01104662|19252733|P7|STARTED|Overall Study||5
7821400|NCT01104662|19252734|P6|STARTED|Overall Study||16
7821401|NCT01104662|19252735|P5|STARTED|Overall Study||15
7821402|NCT01104662|19252736|P4|STARTED|Overall Study||4
7821403|NCT01104662|19252737|P3|STARTED|Overall Study||5
7821404|NCT01104662|19252738|P2|STARTED|Overall Study||21
7821405|NCT01104662|19252739|P1|STARTED|Overall Study||20
7821406|NCT01104636|19252765|P1|NOT COMPLETED|Overall Study||178
7821407|NCT01104636|19252765|P1|COMPLETED|Overall Study||999
7821408|NCT01104636|19252765|P1|STARTED|Overall Study||1177
7821409|NCT01104584|19252770|P1|NOT COMPLETED|Overall Study||23
7821410|NCT01104584|19252770|P1|COMPLETED|Overall Study|study course completed|437
7821411|NCT01104584|19252770|P1|Fulfilled Requirements of FAS Population|Overall Study||397
7821412|NCT01104584|19252770|P1|Received Treatment|Overall Study|treatment started|439
7821413|NCT01104584|19252770|P1|STARTED|Overall Study|screened and enrolled|460
7821414|NCT01104558|19252840|P1|NOT COMPLETED|Overall Study||17
7821415|NCT01104558|19252840|P1|COMPLETED|Overall Study||83
7821416|NCT01104558|19252840|P1|STARTED|Overall Study||100
7821417|NCT01104545|19252884|P3|NOT COMPLETED|Overall Study||2
7821418|NCT01104545|19252885|P2|NOT COMPLETED|Overall Study||1
7821419|NCT01104545|19252886|P1|NOT COMPLETED|Overall Study||0
7821420|NCT01104545|19252884|P3|COMPLETED|Overall Study|Participants discontinued after receiving MK-3614 0.75 mg (Period 1)and placebo (Period 2)|6
7821421|NCT01104545|19252885|P2|COMPLETED|Overall Study|Participant discontinued after receiving 0.75 mg MK-3614 in Period 1|7
7821422|NCT01104545|19252886|P1|COMPLETED|Overall Study||8
7821423|NCT01104545|19252884|P3|STARTED|Overall Study|1 participant received 0.50 mg of MK-3614 or placebo in Periods 3 and 4 instead of planned 0.75 mg|8
7821424|NCT01104545|19252885|P2|STARTED|Overall Study||8
7821425|NCT01104545|19252886|P1|STARTED|Overall Study||8
7821426|NCT01104493|19253043|P2|NOT COMPLETED|Overall Study||2
7821427|NCT01104493|19253044|P1|NOT COMPLETED|Overall Study||0
7821428|NCT01104493|19253043|P2|COMPLETED|Overall Study||58
7821429|NCT01104493|19253044|P1|COMPLETED|Overall Study||240
7821430|NCT01104493|19253043|P2|STARTED|Overall Study||60
7821431|NCT01104493|19253044|P1|STARTED|Overall Study||240
7821432|NCT01104415|19253062|P2|NOT COMPLETED|Extension Period||11
7821433|NCT01104415|19253063|P1|NOT COMPLETED|Extension Period||0
7821434|NCT01104415|19253062|P2|COMPLETED|Extension Period||0
7821435|NCT01104415|19253063|P1|COMPLETED|Extension Period||0
7821436|NCT01104415|19253062|P2|STARTED|Extension Period|Out of 14 participants who completed Core Phase, 3 were not eligible to enter the Extension Period.|11
7821437|NCT01104415|19253063|P1|STARTED|Extension Period||0
7821438|NCT01104415|19253062|P2|NOT COMPLETED|Core Phase||0
7821439|NCT01104415|19253063|P1|NOT COMPLETED|Core Phase||1
7821440|NCT01104415|19253062|P2|COMPLETED|Core Phase||0
7821441|NCT01104415|19253063|P1|COMPLETED|Core Phase||14
7821442|NCT01104415|19253062|P2|STARTED|Core Phase||0
7821443|NCT01104415|19253063|P1|STARTED|Core Phase||15
7821444|NCT01104402|19253088|P2|NOT COMPLETED|Overall Study||33
7821445|NCT01104402|19253089|P1|NOT COMPLETED|Overall Study||21
7821446|NCT01104402|19253088|P2|COMPLETED|Overall Study||102
7821447|NCT01104402|19253089|P1|COMPLETED|Overall Study||111
7821448|NCT01104402|19253088|P2|STARTED|Overall Study||135
7821449|NCT01104402|19253089|P1|STARTED|Overall Study||132
7821450|NCT01104376|19253107|P1|NOT COMPLETED|Overall Study||28
7821451|NCT01104376|19253107|P1|COMPLETED|Overall Study||61
7821452|NCT01104376|19253107|P1|STARTED|Overall Study||89
7821453|NCT01104311|19253113|P2|NOT COMPLETED|Overall Study||12
7821454|NCT01104311|19253114|P1|NOT COMPLETED|Overall Study||10
7821455|NCT01104311|19253113|P2|COMPLETED|Overall Study||54
7821456|NCT01104311|19253114|P1|COMPLETED|Overall Study||56
7821457|NCT01104311|19253113|P2|STARTED|Overall Study||66
7821458|NCT01104311|19253114|P1|STARTED|Overall Study||66
7821459|NCT01104285|19253134|P2|NOT COMPLETED|Overall Study||0
7821460|NCT01104285|19253135|P1|NOT COMPLETED|Overall Study||0
7821461|NCT01104285|19253134|P2|COMPLETED|Overall Study||86
7821462|NCT01104285|19253135|P1|COMPLETED|Overall Study||112
7821463|NCT01104285|19253134|P2|STARTED|Overall Study||86
7821464|NCT01104285|19253135|P1|STARTED|Overall Study||112
7821465|NCT01104246|19253141|P1|NOT COMPLETED|Overall Study||5
7821466|NCT01104246|19253141|P1|COMPLETED|Overall Study||35
7821467|NCT01104246|19253141|P1|Baseline Characteristics Measured|Overall Study||35
7821468|NCT01104246|19253141|P1|STARTED|Overall Study||40
7821469|NCT01104207|19253147|P2|NOT COMPLETED|Overall Study||3
7821470|NCT01104207|19253148|P1|NOT COMPLETED|Overall Study||3
7821471|NCT01104207|19253147|P2|COMPLETED|Overall Study||32
7821472|NCT01104207|19253148|P1|COMPLETED|Overall Study||32
7821473|NCT01104207|19253147|P2|STARTED|Overall Study||35
7821474|NCT01104207|19253148|P1|STARTED|Overall Study||35
7821475|NCT01104155|19253156|P2|NOT COMPLETED|Overall Study||18
7821476|NCT01104155|19253157|P1|NOT COMPLETED|Overall Study||25
7821477|NCT01104155|19253156|P2|COMPLETED|Overall Study||42
7821478|NCT01104155|19253157|P1|COMPLETED|Overall Study||38
7821479|NCT01104155|19253156|P2|STARTED|Overall Study||60
7821480|NCT01104155|19253157|P1|STARTED|Overall Study||63
7821481|NCT01104116|19253171|P1|NOT COMPLETED|Overall Study||0
7821482|NCT01104116|19253171|P1|COMPLETED|Overall Study||1
7821483|NCT01104116|19253171|P1|STARTED|Overall Study||1
7821484|NCT01104103|19253178|P2|NOT COMPLETED|Overall Study||0
7821485|NCT01104103|19253179|P1|NOT COMPLETED|Overall Study||0
7821486|NCT01104103|19253178|P2|COMPLETED|Overall Study||224
7821487|NCT01104103|19253179|P1|COMPLETED|Overall Study||243
7821488|NCT01104103|19253178|P2|STARTED|Overall Study||224
7821489|NCT01104103|19253179|P1|STARTED|Overall Study||243
7821490|NCT01104025|19253187|P1|NOT COMPLETED|Follow up Until Day 100 Post BMT||2
7821491|NCT01104025|19253187|P1|COMPLETED|Follow up Until Day 100 Post BMT||9
7821492|NCT01104025|19253187|P1|STARTED|Follow up Until Day 100 Post BMT|only 11 participants proceeded to BMT; 14 did not|11
7821493|NCT01104025|19253187|P1|NOT COMPLETED|Follow up Until BMT OR 6 Months||3
7821494|NCT01104025|19253187|P1|COMPLETED|Follow up Until BMT OR 6 Months||22
7821495|NCT01104025|19253187|P1|STARTED|Follow up Until BMT OR 6 Months||25
7821496|NCT01104025|19253187|P1|NOT COMPLETED|Treatment Period||6
7821497|NCT01104025|19253187|P1|COMPLETED|Treatment Period||25
7821498|NCT01104025|19253187|P1|STARTED|Treatment Period||31
7821499|NCT01103973|19253198|P2|NOT COMPLETED|Overall Study||0
7821500|NCT01103973|19253199|P1|NOT COMPLETED|Overall Study||0
7821501|NCT01103973|19253198|P2|COMPLETED|Overall Study||46
7821502|NCT01103973|19253199|P1|COMPLETED|Overall Study||51
7821503|NCT01103973|19253198|P2|STARTED|Overall Study||46
7821504|NCT01103973|19253199|P1|STARTED|Overall Study||51
7821505|NCT01103960|19253209|P2|NOT COMPLETED|Overall Study||2
7821506|NCT01103960|19253210|P1|NOT COMPLETED|Overall Study||5
7821507|NCT01103960|19253209|P2|COMPLETED|Overall Study|Completed study medication.|158
7821508|NCT01103960|19253210|P1|COMPLETED|Overall Study|Completed study medication.|159
7821509|NCT01103960|19253209|P2|STARTED|Overall Study|Randomised and treated.|160
7821510|NCT01103960|19253210|P1|STARTED|Overall Study|Randomised and treated.|164
7821511|NCT01103934|19253236|P2|NOT COMPLETED|Overall Study||0
7821512|NCT01103934|19253237|P1|NOT COMPLETED|Overall Study||0
7821513|NCT01103934|19253236|P2|COMPLETED|Overall Study||18
7821514|NCT01103934|19253237|P1|COMPLETED|Overall Study||17
7821515|NCT01103934|19253236|P2|STARTED|Overall Study||18
7821516|NCT01103934|19253237|P1|STARTED|Overall Study||17
7821517|NCT01103778|19253245|P1|NOT COMPLETED|Overall Study||3
7821518|NCT01103778|19253245|P1|COMPLETED|Overall Study||8
7821519|NCT01103778|19253245|P1|STARTED|Overall Study||11
7821520|NCT01103713|19253252|P1|NOT COMPLETED|Overall Study||13
7821521|NCT01103713|19253252|P1|COMPLETED|Overall Study||155
7821522|NCT01103713|19253252|P1|STARTED|Overall Study||168
7821523|NCT01103505|19253280|P2|NOT COMPLETED|Overall Study||20
7821524|NCT01103505|19253281|P1|NOT COMPLETED|Overall Study||24
7821525|NCT01103505|19253280|P2|COMPLETED|Overall Study||737
7821526|NCT01103505|19253281|P1|COMPLETED|Overall Study||739
7821527|NCT01103505|19253280|P2|STARTED|Overall Study||757
7821528|NCT01103505|19253281|P1|STARTED|Overall Study||763
7821529|NCT01103492|19253295|P1|NOT COMPLETED|Overall Study||0
7821530|NCT01103492|19253295|P1|COMPLETED|Overall Study||1
7821531|NCT01103492|19253295|P1|STARTED|Overall Study||1
7821532|NCT01103479|19253302|P3|NOT COMPLETED|Overall Study||14
7821533|NCT01103479|19253303|P2|NOT COMPLETED|Overall Study||9
7821534|NCT01103479|19253304|P1|NOT COMPLETED|Overall Study||5
7821535|NCT01103479|19253302|P3|COMPLETED|Overall Study||174
7821536|NCT01103479|19253303|P2|COMPLETED|Overall Study||201
7821537|NCT01103479|19253304|P1|COMPLETED|Overall Study||163
7821538|NCT01103479|19253302|P3|STARTED|Overall Study||188
7821539|NCT01103479|19253303|P2|STARTED|Overall Study||210
7821540|NCT01103479|19253304|P1|STARTED|Overall Study||168
7821541|NCT01103466|19253317|P3|NOT COMPLETED|Third Period (14 +/- 3 Days)||1
7821542|NCT01103466|19253318|P2|NOT COMPLETED|Third Period (14 +/- 3 Days)||0
7821543|NCT01103466|19253319|P1|NOT COMPLETED|Third Period (14 +/- 3 Days)||2
7821544|NCT01103466|19253317|P3|COMPLETED|Third Period (14 +/- 3 Days)||13
7821545|NCT01103466|19253318|P2|COMPLETED|Third Period (14 +/- 3 Days)||8
7821546|NCT01103466|19253319|P1|COMPLETED|Third Period (14 +/- 3 Days)||6
7821547|NCT01103466|19253317|P3|STARTED|Third Period (14 +/- 3 Days)||14
7821548|NCT01103466|19253318|P2|STARTED|Third Period (14 +/- 3 Days)||8
7821549|NCT01103466|19253319|P1|STARTED|Third Period (14 +/- 3 Days)||8
7821550|NCT01103466|19253317|P3|NOT COMPLETED|Second Period (14 +/- 3 Days)||1
7821551|NCT01103466|19253318|P2|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
7821552|NCT01103466|19253319|P1|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
7821553|NCT01103466|19253317|P3|COMPLETED|Second Period (14 +/- 3 Days)||6
7821554|NCT01103466|19253318|P2|COMPLETED|Second Period (14 +/- 3 Days)||11
7821555|NCT01103466|19253319|P1|COMPLETED|Second Period (14 +/- 3 Days)||13
7821556|NCT01103466|19253317|P3|STARTED|Second Period (14 +/- 3 Days)||7
7821557|NCT01103466|19253318|P2|STARTED|Second Period (14 +/- 3 Days)||13
7821558|NCT01103466|19253319|P1|STARTED|Second Period (14 +/- 3 Days)||15
7821559|NCT01103466|19253317|P3|NOT COMPLETED|First Period (14 +/- 3 Days)||0
7821560|NCT01103466|19253318|P2|NOT COMPLETED|First Period (14 +/- 3 Days)||0
7821561|NCT01103466|19253319|P1|NOT COMPLETED|First Period (14 +/- 3 Days)||2
7821562|NCT01103466|19253317|P3|COMPLETED|First Period (14 +/- 3 Days)||13
7821563|NCT01103466|19253318|P2|COMPLETED|First Period (14 +/- 3 Days)||12
7821564|NCT01103466|19253319|P1|COMPLETED|First Period (14 +/- 3 Days)||10
7821565|NCT01103466|19253317|P3|STARTED|First Period (14 +/- 3 Days)||13
7821566|NCT01103466|19253318|P2|STARTED|First Period (14 +/- 3 Days)||12
7821567|NCT01103466|19253319|P1|STARTED|First Period (14 +/- 3 Days)||12
7821568|NCT01103440|19253329|P2|NOT COMPLETED|Overall Study||0
7821569|NCT01103440|19253330|P1|NOT COMPLETED|Overall Study||0
7821570|NCT01103440|19253329|P2|COMPLETED|Overall Study||18
7821571|NCT01103440|19253330|P1|COMPLETED|Overall Study||18
7821572|NCT01103440|19253329|P2|STARTED|Overall Study||18
7821573|NCT01103440|19253330|P1|STARTED|Overall Study||18
7821574|NCT01103414|19253343|P5|NOT COMPLETED|Overall Study||15
7821575|NCT01103414|19253344|P4|NOT COMPLETED|Overall Study||7
7821576|NCT01103414|19253345|P3|NOT COMPLETED|Overall Study||15
7821577|NCT01103414|19253346|P2|NOT COMPLETED|Overall Study||9
7821578|NCT01103414|19253347|P1|NOT COMPLETED|Overall Study||13
7821579|NCT01103414|19253343|P5|COMPLETED|Overall Study||56
7821580|NCT01103414|19253344|P4|COMPLETED|Overall Study||64
7821581|NCT01103414|19253345|P3|COMPLETED|Overall Study||56
7821582|NCT01103414|19253346|P2|COMPLETED|Overall Study||62
7821583|NCT01103414|19253347|P1|COMPLETED|Overall Study||59
7821584|NCT01103414|19253343|P5|STARTED|Overall Study||71
7821585|NCT01103414|19253344|P4|STARTED|Overall Study||71
7821586|NCT01103414|19253345|P3|STARTED|Overall Study||71
7821587|NCT01103414|19253346|P2|STARTED|Overall Study||71
7821588|NCT01103414|19253347|P1|STARTED|Overall Study||72
7821589|NCT01103362|19253409|P1|NOT COMPLETED|Overall Study||596
7821590|NCT01103362|19253409|P1|COMPLETED|Overall Study||0
7821591|NCT01103362|19253409|P1|STARTED|Overall Study||596
7821592|NCT01103323|19253415|P2|NOT COMPLETED|Switched From Placebo to Regorafenib||1
7821593|NCT01103323|19253416|P1|NOT COMPLETED|Switched From Placebo to Regorafenib||0
7821594|NCT01103323|19253415|P2|COMPLETED|Switched From Placebo to Regorafenib||3
7821595|NCT01103323|19253416|P1|COMPLETED|Switched From Placebo to Regorafenib||0
7821596|NCT01103323|19253415|P2|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4
7821597|NCT01103323|19253416|P1|STARTED|Switched From Placebo to Regorafenib||0
7821598|NCT01103323|19253415|P2|NOT COMPLETED|Without/Before Drug Switch||18
7821599|NCT01103323|19253416|P1|NOT COMPLETED|Without/Before Drug Switch||76
7821600|NCT01103323|19253415|P2|COMPLETED|Without/Before Drug Switch||237
7821601|NCT01103323|19253416|P1|COMPLETED|Without/Before Drug Switch||429
7821602|NCT01103323|19253415|P2|Participants Received Treatment|Without/Before Drug Switch||253
7821603|NCT01103323|19253416|P1|Participants Received Treatment|Without/Before Drug Switch||500
7821604|NCT01103323|19253415|P2|STARTED|Without/Before Drug Switch||255
7821605|NCT01103323|19253416|P1|STARTED|Without/Before Drug Switch||505
7821606|NCT01103284|19253433|P2|NOT COMPLETED|Overall Study||44
7821607|NCT01103284|19253434|P1|NOT COMPLETED|Overall Study||42
7821608|NCT01103284|19253433|P2|COMPLETED|Overall Study||195
7821609|NCT01103284|19253434|P1|COMPLETED|Overall Study||194
7821610|NCT01103284|19253433|P2|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235
7821611|NCT01103284|19253434|P1|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233
7821612|NCT01103284|19253433|P2|Treated|Overall Study||238
7821613|NCT01103284|19253434|P1|Treated|Overall Study||236
7821614|NCT01103284|19253433|P2|STARTED|Overall Study||239
7821615|NCT01103284|19253434|P1|STARTED|Overall Study||236
7821616|NCT01103271|19253450|P2|NOT COMPLETED|Overall Study||4
7821617|NCT01103271|19253451|P1|NOT COMPLETED|Overall Study||1
7821618|NCT01103271|19253450|P2|COMPLETED|Overall Study||5
7821619|NCT01103271|19253451|P1|COMPLETED|Overall Study||10
7821620|NCT01103271|19253450|P2|STARTED|Overall Study||9
7821621|NCT01103271|19253451|P1|STARTED|Overall Study||11
7821622|NCT01103245|19253462|P4|NOT COMPLETED|Overall Study||0
7821623|NCT01103245|19253463|P3|NOT COMPLETED|Overall Study||4
7821624|NCT01103245|19253464|P2|NOT COMPLETED|Overall Study||2
7821625|NCT01103245|19253465|P1|NOT COMPLETED|Overall Study||3
7821626|NCT01103245|19253462|P4|COMPLETED|Overall Study||6
7821627|NCT01103245|19253463|P3|COMPLETED|Overall Study||8
7821628|NCT01103245|19253464|P2|COMPLETED|Overall Study||5
7821629|NCT01103245|19253465|P1|COMPLETED|Overall Study||10
7821630|NCT01103245|19253462|P4|STARTED|Overall Study||6
7821631|NCT01103245|19253463|P3|STARTED|Overall Study||12
7821632|NCT01103245|19253464|P2|STARTED|Overall Study||7
7821633|NCT01103245|19253465|P1|STARTED|Overall Study||13
7821634|NCT01103232|19253481|P2|NOT COMPLETED|Overall Study||2
7821635|NCT01103232|19253482|P1|NOT COMPLETED|Overall Study||1
7821636|NCT01103232|19253481|P2|COMPLETED|Overall Study||11
7821637|NCT01103232|19253482|P1|COMPLETED|Overall Study||12
7821638|NCT01103232|19253481|P2|STARTED|Overall Study||13
7821639|NCT01103232|19253482|P1|STARTED|Overall Study||13
7821640|NCT01103180|19253490|P2|NOT COMPLETED|Overall Study||21
7821641|NCT01103180|19253491|P1|NOT COMPLETED|Overall Study||22
7821642|NCT01103180|19253490|P2|COMPLETED|Overall Study||14
7821643|NCT01103180|19253491|P1|COMPLETED|Overall Study||13
7821644|NCT01103180|19253490|P2|STARTED|Overall Study||35
7821645|NCT01103180|19253491|P1|STARTED|Overall Study||35
7821646|NCT01103141|19253501|P2|NOT COMPLETED|Overall Study||2
7821647|NCT01103141|19253502|P1|NOT COMPLETED|Overall Study||2
7821648|NCT01103141|19253501|P2|COMPLETED|Overall Study||74
7821649|NCT01103141|19253502|P1|COMPLETED|Overall Study||65
7821650|NCT01103141|19253501|P2|STARTED|Overall Study||76
7821651|NCT01103141|19253502|P1|STARTED|Overall Study||67
7821652|NCT01103063|19253510|P2|NOT COMPLETED|Overall Study||421
7821653|NCT01103063|19253511|P1|NOT COMPLETED|Overall Study||477
7821654|NCT01103063|19253510|P2|COMPLETED|Overall Study||1024
7821655|NCT01103063|19253511|P1|COMPLETED|Overall Study||969
7821656|NCT01103063|19253510|P2|STARTED|Overall Study||1445
7821657|NCT01103063|19253511|P1|STARTED|Overall Study||1446
7821658|NCT01102972|19253579|P2|NOT COMPLETED|Overall Study||14
7821659|NCT01102972|19253580|P1|NOT COMPLETED|Overall Study||29
7821660|NCT01102972|19253579|P2|COMPLETED|Overall Study|These participants completed Study Week 48.|83
7821661|NCT01102972|19253580|P1|COMPLETED|Overall Study|These participants completed Study Week 48.|170
7821662|NCT01102972|19253579|P2|Completed Week 24|Overall Study||88
7821663|NCT01102972|19253580|P1|Completed Week 24|Overall Study||180
7821664|NCT01102972|19253579|P2|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|97
7821665|NCT01102972|19253580|P1|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|199
7821666|NCT01102894|19253632|P1|NOT COMPLETED|Overall Study||0
7821667|NCT01102894|19253632|P1|COMPLETED|Overall Study||10
7821668|NCT01102894|19253632|P1|STARTED|Overall Study||10
7821669|NCT01102803|19253644|P2|NOT COMPLETED|Post to Follow-Up||3
7821670|NCT01102803|19253645|P1|NOT COMPLETED|Post to Follow-Up||1
7821671|NCT01102803|19253644|P2|COMPLETED|Post to Follow-Up||12
7821672|NCT01102803|19253645|P1|COMPLETED|Post to Follow-Up||10
7821673|NCT01102803|19253644|P2|STARTED|Post to Follow-Up||15
7821674|NCT01102803|19253645|P1|STARTED|Post to Follow-Up||11
7821675|NCT01102803|19253644|P2|NOT COMPLETED|Baseline to Post-Treatment||0
7821676|NCT01102803|19253645|P1|NOT COMPLETED|Baseline to Post-Treatment||3
7821677|NCT01102803|19253644|P2|COMPLETED|Baseline to Post-Treatment||15
7821678|NCT01102803|19253645|P1|COMPLETED|Baseline to Post-Treatment||11
7821679|NCT01102803|19253644|P2|STARTED|Baseline to Post-Treatment||15
7821680|NCT01102803|19253645|P1|STARTED|Baseline to Post-Treatment||14
7821681|NCT01102777|19253659|P2|NOT COMPLETED|Overall Study||16
7821682|NCT01102777|19253660|P1|NOT COMPLETED|Overall Study||9
7821683|NCT01102777|19253659|P2|COMPLETED|Overall Study||139
7821684|NCT01102777|19253660|P1|COMPLETED|Overall Study||75
7821685|NCT01102777|19253659|P2|STARTED|Overall Study||155
7821686|NCT01102777|19253660|P1|STARTED|Overall Study||84
7821687|NCT01102764|19253686|P2|NOT COMPLETED|Overall Study||13
7821688|NCT01102764|19253687|P1|NOT COMPLETED|Overall Study||21
7821689|NCT01102764|19253686|P2|COMPLETED|Overall Study||55
7821690|NCT01102764|19253687|P1|COMPLETED|Overall Study||43
7821691|NCT01102764|19253686|P2|STARTED|Overall Study||68
7821692|NCT01102764|19253687|P1|STARTED|Overall Study||64
7821693|NCT01102738|19253713|P1|NOT COMPLETED|Overall Study||0
7821694|NCT01102738|19253713|P1|COMPLETED|Overall Study||369
7821695|NCT01102738|19253713|P1|STARTED|Overall Study||369
7821696|NCT01102491|19253719|P2|NOT COMPLETED|Overall Study||12
7821697|NCT01102491|19253720|P1|NOT COMPLETED|Overall Study||11
7821698|NCT01102491|19253719|P2|COMPLETED|Overall Study|12 patients were excluded|59
7821699|NCT01102491|19253720|P1|COMPLETED|Overall Study|11 patient excluded|60
7821700|NCT01102491|19253719|P2|STARTED|Overall Study||71
7821701|NCT01102491|19253720|P1|STARTED|Overall Study||71
7821702|NCT01102426|19253728|P2|NOT COMPLETED|Overall Study||81
7821703|NCT01102426|19253729|P1|NOT COMPLETED|Overall Study||165
7821704|NCT01102426|19253728|P2|COMPLETED|Overall Study||3
7821705|NCT01102426|19253729|P1|COMPLETED|Overall Study||6
7821706|NCT01102426|19253728|P2|STARTED|Overall Study||84
7821707|NCT01102426|19253729|P1|STARTED|Overall Study||171
7821708|NCT01102413|19253769|P2|NOT COMPLETED|Overall Study||12
7821709|NCT01102413|19253770|P1|NOT COMPLETED|Overall Study||25
7821710|NCT01102413|19253769|P2|COMPLETED|Overall Study||106
7821711|NCT01102413|19253770|P1|COMPLETED|Overall Study||208
7821712|NCT01102413|19253769|P2|STARTED|Overall Study||118
7821713|NCT01102413|19253770|P1|STARTED|Overall Study||233
7821714|NCT01102374|19253780|P2|NOT COMPLETED|Overall Study||19
7821715|NCT01102374|19253781|P1|NOT COMPLETED|Overall Study||16
7821716|NCT01102374|19253780|P2|COMPLETED|Overall Study||33
7821717|NCT01102374|19253781|P1|COMPLETED|Overall Study||39
7821718|NCT01102374|19253780|P2|STARTED|Overall Study||52
7821719|NCT01102374|19253781|P1|STARTED|Overall Study||55
7821720|NCT01102270|19253815|P2|NOT COMPLETED|Overall Study||0
7821721|NCT01102270|19253816|P1|NOT COMPLETED|Overall Study||0
7821722|NCT01102270|19253815|P2|COMPLETED|Overall Study||9
7821723|NCT01102270|19253816|P1|COMPLETED|Overall Study||8
7821724|NCT01102270|19253815|P2|STARTED|Overall Study||9
7821725|NCT01102270|19253816|P1|STARTED|Overall Study||8
7821726|NCT01102257|19253830|P2|NOT COMPLETED|Overall Study||0
7821727|NCT01102257|19253831|P1|NOT COMPLETED|Overall Study||2
7821728|NCT01102257|19253830|P2|COMPLETED|Overall Study||9
7821729|NCT01102257|19253831|P1|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7
7821730|NCT01102257|19253830|P2|STARTED|Overall Study||9
7821731|NCT01102257|19253831|P1|STARTED|Overall Study||9
7821732|NCT01102218|19253839|P2|NOT COMPLETED|Overall Study||10
7821733|NCT01102218|19253840|P1|NOT COMPLETED|Overall Study||11
7821734|NCT01102218|19253839|P2|COMPLETED|Overall Study||14
7821735|NCT01102218|19253840|P1|COMPLETED|Overall Study||13
7821736|NCT01102218|19253839|P2|STARTED|Overall Study||24
7821737|NCT01102218|19253840|P1|STARTED|Overall Study||24
7821738|NCT01102140|19253848|P2|NOT COMPLETED|Overall Study||2
7821739|NCT01102140|19253849|P1|NOT COMPLETED|Overall Study||3
7821740|NCT01102140|19253848|P2|COMPLETED|Overall Study||5
7821741|NCT01102140|19253849|P1|COMPLETED|Overall Study||10
7821742|NCT01102140|19253848|P2|STARTED|Overall Study||7
7821743|NCT01102140|19253849|P1|STARTED|Overall Study||13
7821744|NCT01101997|19253861|P1|NOT COMPLETED|Overall Study||2
7821745|NCT01101997|19253861|P1|COMPLETED|Overall Study||58
7821746|NCT01101997|19253861|P1|STARTED|Overall Study||60
7821747|NCT01101971|19253867|P1|NOT COMPLETED|Overall Study||0
7821748|NCT01101971|19253867|P1|COMPLETED|Overall Study||45
7821749|NCT01101971|19253867|P1|STARTED|Overall Study||45
7821750|NCT01101958|19253873|P2|NOT COMPLETED|Overall Study||5
7821751|NCT01101958|19253874|P1|NOT COMPLETED|Overall Study||11
7821752|NCT01101958|19253873|P2|COMPLETED|Overall Study||29
7821753|NCT01101958|19253874|P1|COMPLETED|Overall Study||51
7821754|NCT01101958|19253873|P2|STARTED|Overall Study||34
7821755|NCT01101958|19253874|P1|STARTED|Overall Study||62
7821756|NCT01101880|19253880|P1|NOT COMPLETED|Overall Study||0
7821757|NCT01101880|19253880|P1|COMPLETED|Overall Study||50
7821758|NCT01101880|19253880|P1|STARTED|Overall Study||50
7821759|NCT01101867|19253891|P2|NOT COMPLETED|Overall Study||4
7821760|NCT01101867|19253892|P1|NOT COMPLETED|Overall Study||1
7821761|NCT01101867|19253891|P2|COMPLETED|Overall Study||59
7821762|NCT01101867|19253892|P1|COMPLETED|Overall Study||62
7821763|NCT01101867|19253891|P2|STARTED|Overall Study||63
7821764|NCT01101867|19253892|P1|STARTED|Overall Study||63
7821765|NCT01101841|19253910|P2|NOT COMPLETED|Overall Study||67
7821766|NCT01101841|19253911|P1|NOT COMPLETED|Overall Study||50
7821767|NCT01101841|19253910|P2|COMPLETED|Overall Study||218
7821768|NCT01101841|19253911|P1|COMPLETED|Overall Study||235
7821769|NCT01101841|19253910|P2|STARTED|Overall Study||285
7821770|NCT01101841|19253911|P1|STARTED|Overall Study||285
7821771|NCT01101750|19253949|P1|NOT COMPLETED|Overall Study||16
7821772|NCT01101750|19253949|P1|COMPLETED|Overall Study||9
7821773|NCT01101750|19253949|P1|STARTED|Overall Study||25
7821774|NCT01101542|19253953|P1|NOT COMPLETED|Year 6 Surveillance Period||991
7821775|NCT01101542|19253953|P1|COMPLETED|Year 6 Surveillance Period||2100
7821776|NCT01101542|19253953|P1|STARTED|Year 6 Surveillance Period||3091
7821777|NCT01101542|19253953|P1|NOT COMPLETED|Year 5 Surveillance Period||141
7821778|NCT01101542|19253953|P1|COMPLETED|Year 5 Surveillance Period||668
7821779|NCT01101542|19253953|P1|STARTED|Year 5 Surveillance Period||809
7821780|NCT01101542|19253953|P1|NOT COMPLETED|Year 4 Surveillance Period||287
7821781|NCT01101542|19253953|P1|COMPLETED|Year 4 Surveillance Period||282
7821782|NCT01101542|19253953|P1|STARTED|Year 4 Surveillance Period||569
7821783|NCT01101542|19253953|P1|NOT COMPLETED|Year 3 Surveillance Period||11
7821784|NCT01101542|19253953|P1|COMPLETED|Year 3 Surveillance Period||94
7821785|NCT01101542|19253953|P1|STARTED|Year 3 Surveillance Period||105
7821786|NCT01101477|19253969|P3|NOT COMPLETED|Overall Study||1
7821787|NCT01101477|19253970|P2|NOT COMPLETED|Overall Study||3
7821788|NCT01101477|19253971|P1|NOT COMPLETED|Overall Study||5
7821789|NCT01101477|19253969|P3|COMPLETED|Overall Study||45
7821790|NCT01101477|19253970|P2|COMPLETED|Overall Study||46
7821791|NCT01101477|19253971|P1|COMPLETED|Overall Study||44
7821792|NCT01101477|19253969|P3|STARTED|Overall Study||46
7821793|NCT01101477|19253970|P2|STARTED|Overall Study||49
7821794|NCT01101477|19253971|P1|STARTED|Overall Study||49
7821795|NCT01101464|19253981|P2|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
7821796|NCT01101464|19253982|P1|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
7821797|NCT01101464|19253981|P2|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
7821798|NCT01101464|19253982|P1|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
7821799|NCT01101464|19253981|P2|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
7821800|NCT01101464|19253982|P1|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
7821801|NCT01101464|19253981|P2|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
7821802|NCT01101464|19253982|P1|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
7821803|NCT01101464|19253981|P2|COMPLETED|Day 1 Through AM Dose of Day 5||4
7821804|NCT01101464|19253982|P1|COMPLETED|Day 1 Through AM Dose of Day 5||4
7821805|NCT01101464|19253981|P2|STARTED|Day 1 Through AM Dose of Day 5||4
7821806|NCT01101464|19253982|P1|STARTED|Day 1 Through AM Dose of Day 5||4
7821807|NCT01101334|19253994|P2|NOT COMPLETED|Overall Study||45
7821808|NCT01101334|19253995|P1|NOT COMPLETED|Overall Study||45
7821809|NCT01101334|19253994|P2|COMPLETED|Overall Study||0
7821810|NCT01101334|19253995|P1|COMPLETED|Overall Study||0
7821811|NCT01101334|19253994|P2|Received Study Treatment|Overall Study||45
7821812|NCT01101334|19253995|P1|Received Study Treatment|Overall Study||44
7821813|NCT01101334|19253994|P2|STARTED|Overall Study||45
7821814|NCT01101334|19253995|P1|STARTED|Overall Study||45
7821815|NCT01101321|19254007|P2|NOT COMPLETED|Period 2||0
7821816|NCT01101321|19254008|P1|NOT COMPLETED|Period 2||0
7821817|NCT01101321|19254007|P2|COMPLETED|Period 2||24
7821818|NCT01101321|19254008|P1|COMPLETED|Period 2||26
7821819|NCT01101321|19254007|P2|STARTED|Period 2||24
7821820|NCT01101321|19254008|P1|STARTED|Period 2||26
7821821|NCT01101321|19254007|P2|NOT COMPLETED|Period 1||4
7821822|NCT01101321|19254008|P1|NOT COMPLETED|Period 1||4
7821823|NCT01101321|19254007|P2|COMPLETED|Period 1||24
7821824|NCT01101321|19254008|P1|COMPLETED|Period 1||26
7821825|NCT01101321|19254007|P2|STARTED|Period 1||28
7821826|NCT01101321|19254008|P1|STARTED|Period 1||30
7821827|NCT01101308|19254018|P2|NOT COMPLETED|Period 2||0
7821828|NCT01101308|19254019|P1|NOT COMPLETED|Period 2||0
7821829|NCT01101308|19254018|P2|COMPLETED|Period 2||27
7821830|NCT01101308|19254019|P1|COMPLETED|Period 2||24
7821831|NCT01101308|19254018|P2|STARTED|Period 2||27
7821832|NCT01101308|19254019|P1|STARTED|Period 2||24
7821833|NCT01101308|19254018|P2|NOT COMPLETED|Period 1||1
7821834|NCT01101308|19254019|P1|NOT COMPLETED|Period 1||3
7821835|NCT01101308|19254018|P2|COMPLETED|Period 1||27
7821836|NCT01101308|19254019|P1|COMPLETED|Period 1||24
7821837|NCT01101308|19254018|P2|STARTED|Period 1||28
7821838|NCT01101308|19254019|P1|STARTED|Period 1||27
7821839|NCT01101191|19254030|P2|NOT COMPLETED|Period 2||0
7821840|NCT01101191|19254031|P1|NOT COMPLETED|Period 2||0
7821841|NCT01101191|19254030|P2|COMPLETED|Period 2||40
7821842|NCT01101191|19254031|P1|COMPLETED|Period 2||40
7821843|NCT01101191|19254030|P2|STARTED|Period 2||40
7821844|NCT01101191|19254031|P1|STARTED|Period 2||40
7821845|NCT01101191|19254030|P2|NOT COMPLETED|Period 1||2
7821846|NCT01101191|19254031|P1|NOT COMPLETED|Period 1||2
7821847|NCT01101191|19254030|P2|COMPLETED|Period 1||40
7821848|NCT01101191|19254031|P1|COMPLETED|Period 1||40
7821849|NCT01101191|19254030|P2|STARTED|Period 1||42
7821850|NCT01101191|19254031|P1|STARTED|Period 1||42
7821851|NCT01101178|19254042|P2|NOT COMPLETED|Period 2||1
7821852|NCT01101178|19254043|P1|NOT COMPLETED|Period 2||0
7821853|NCT01101178|19254042|P2|COMPLETED|Period 2||34
7821854|NCT01101178|19254043|P1|COMPLETED|Period 2||36
7821855|NCT01101178|19254042|P2|STARTED|Period 2||35
7821856|NCT01101178|19254043|P1|STARTED|Period 2||36
7821857|NCT01101178|19254042|P2|NOT COMPLETED|Period 1||4
7821858|NCT01101178|19254043|P1|NOT COMPLETED|Period 1||4
7821859|NCT01101178|19254042|P2|COMPLETED|Period 1||35
7821860|NCT01101178|19254043|P1|COMPLETED|Period 1||36
7821861|NCT01101178|19254042|P2|STARTED|Period 1||39
7821862|NCT01101178|19254043|P1|STARTED|Period 1||40
7821863|NCT01101165|19254054|P2|NOT COMPLETED|Period 2||1
7821864|NCT01101165|19254055|P1|NOT COMPLETED|Period 2||4
7821865|NCT01101165|19254054|P2|COMPLETED|Period 2||39
7821866|NCT01101165|19254055|P1|COMPLETED|Period 2||41
7821867|NCT01101165|19254054|P2|STARTED|Period 2||40
7821868|NCT01101165|19254055|P1|STARTED|Period 2||45
7821869|NCT01101165|19254054|P2|NOT COMPLETED|Period 1||5
7821870|NCT01101165|19254055|P1|NOT COMPLETED|Period 1||2
7821871|NCT01101165|19254054|P2|COMPLETED|Period 1||40
7821872|NCT01101165|19254055|P1|COMPLETED|Period 1||45
7821873|NCT01101165|19254054|P2|STARTED|Period 1||45
7821874|NCT01101165|19254055|P1|STARTED|Period 1||47
7821875|NCT01101100|19254065|P1|NOT COMPLETED|Overall Study||55
7821876|NCT01101100|19254065|P1|COMPLETED|Overall Study||126
7821877|NCT01101100|19254065|P1|STARTED|Overall Study||181
7821878|NCT01101061|19254076|P6|NOT COMPLETED|Overall Study||0
7821879|NCT01101061|19254077|P5|NOT COMPLETED|Overall Study||0
7821880|NCT01101061|19254078|P4|NOT COMPLETED|Overall Study||0
7821881|NCT01101061|19254079|P3|NOT COMPLETED|Overall Study||1
7821882|NCT01101061|19254080|P2|NOT COMPLETED|Overall Study||0
7821883|NCT01101061|19254081|P1|NOT COMPLETED|Overall Study||0
7821884|NCT01101061|19254076|P6|COMPLETED|Overall Study||4
7821885|NCT01101061|19254077|P5|COMPLETED|Overall Study||2
7821886|NCT01101061|19254078|P4|COMPLETED|Overall Study||6
7821887|NCT01101061|19254079|P3|COMPLETED|Overall Study||6
7821888|NCT01101061|19254080|P2|COMPLETED|Overall Study||6
7821889|NCT01101061|19254081|P1|COMPLETED|Overall Study||6
7821890|NCT01101061|19254076|P6|Received Study Drug|Overall Study||4
7821891|NCT01101061|19254077|P5|Received Study Drug|Overall Study||2
7821892|NCT01101061|19254078|P4|Received Study Drug|Overall Study||6
7821893|NCT01101061|19254079|P3|Received Study Drug|Overall Study||6
7821894|NCT01101061|19254080|P2|Received Study Drug|Overall Study||6
7821895|NCT01101061|19254081|P1|Received Study Drug|Overall Study||6
7821896|NCT01101061|19254076|P6|STARTED|Overall Study||4
7821897|NCT01101061|19254077|P5|STARTED|Overall Study||2
7821898|NCT01101061|19254078|P4|STARTED|Overall Study||6
7821899|NCT01101061|19254079|P3|STARTED|Overall Study||7
7821900|NCT01101061|19254080|P2|STARTED|Overall Study||6
7821901|NCT01101061|19254081|P1|STARTED|Overall Study||6
7821902|NCT01101035|19254161|P2|NOT COMPLETED|Overall Study||1391
7821903|NCT01101035|19254162|P1|NOT COMPLETED|Overall Study||1397
7821904|NCT01101035|19254161|P2|COMPLETED|Overall Study||1706
7821905|NCT01101035|19254162|P1|COMPLETED|Overall Study||1704
7821906|NCT01101035|19254161|P2|STARTED|Overall Study||3097
7821907|NCT01101035|19254162|P1|STARTED|Overall Study||3101
7821908|NCT01101022|19254182|P2|NOT COMPLETED|Overall Study||27
7821909|NCT01101022|19254183|P1|NOT COMPLETED|Overall Study||17
7821910|NCT01101022|19254182|P2|COMPLETED|Overall Study||53
7821911|NCT01101022|19254183|P1|COMPLETED|Overall Study||62
7821912|NCT01101022|19254182|P2|STARTED|Overall Study||80
7821913|NCT01101022|19254183|P1|STARTED|Overall Study||79
7821914|NCT01100944|19254217|P3|NOT COMPLETED|Expansion Phase - Phase 2||0
7821915|NCT01100944|19254218|P2|NOT COMPLETED|Expansion Phase - Phase 2||0
7821916|NCT01100944|19254219|P1|NOT COMPLETED|Expansion Phase - Phase 2||0
7821917|NCT01100944|19254217|P3|COMPLETED|Expansion Phase - Phase 2||18
7821918|NCT01100944|19254218|P2|COMPLETED|Expansion Phase - Phase 2||0
7821919|NCT01100944|19254219|P1|COMPLETED|Expansion Phase - Phase 2||0
7821920|NCT01100944|19254217|P3|STARTED|Expansion Phase - Phase 2||18
7821921|NCT01100944|19254218|P2|STARTED|Expansion Phase - Phase 2||0
7821922|NCT01100944|19254219|P1|STARTED|Expansion Phase - Phase 2||0
7821923|NCT01100944|19254217|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
7821924|NCT01100944|19254218|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2
7821925|NCT01100944|19254219|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
7821926|NCT01100944|19254217|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
7821927|NCT01100944|19254218|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
7821928|NCT01100944|19254219|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
7821929|NCT01100944|19254217|P3|STARTED|Dose Escalation Phase 1 Dose Level 2||0
7821930|NCT01100944|19254218|P2|STARTED|Dose Escalation Phase 1 Dose Level 2||2
7821931|NCT01100944|19254219|P1|STARTED|Dose Escalation Phase 1 Dose Level 2||0
7821932|NCT01100944|19254217|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
7821933|NCT01100944|19254218|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
7821934|NCT01100944|19254219|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4
7821935|NCT01100944|19254217|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
7821936|NCT01100944|19254218|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
7821937|NCT01100944|19254219|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2
7821938|NCT01100944|19254217|P3|STARTED|Dose Escalation Phase 1 Dose Level 1||0
7821939|NCT01100944|19254218|P2|STARTED|Dose Escalation Phase 1 Dose Level 1||0
7821940|NCT01100944|19254219|P1|STARTED|Dose Escalation Phase 1 Dose Level 1||6
7821941|NCT01100931|19254266|P2|NOT COMPLETED|Phase II||0
7821942|NCT01100931|19254267|P1|NOT COMPLETED|Phase II||0
7821943|NCT01100931|19254266|P2|COMPLETED|Phase II||19
7821944|NCT01100931|19254267|P1|COMPLETED|Phase II||0
7821945|NCT01100931|19254266|P2|STARTED|Phase II||19
7821946|NCT01100931|19254267|P1|STARTED|Phase II||0
7821947|NCT01100931|19254266|P2|NOT COMPLETED|Phase I||0
7821948|NCT01100931|19254267|P1|NOT COMPLETED|Phase I||0
7821949|NCT01100931|19254266|P2|COMPLETED|Phase I||0
7821950|NCT01100931|19254267|P1|COMPLETED|Phase I||22
7821951|NCT01100931|19254266|P2|STARTED|Phase I||0
7821952|NCT01100931|19254267|P1|STARTED|Phase I||22
7821953|NCT01100853|19254277|P2|NOT COMPLETED|Overall Study||23
7821954|NCT01100853|19254278|P1|NOT COMPLETED|Overall Study||27
7821955|NCT01100853|19254277|P2|COMPLETED|Overall Study||26
7821956|NCT01100853|19254278|P1|COMPLETED|Overall Study||24
7821957|NCT01100853|19254277|P2|STARTED|Overall Study||49
7821958|NCT01100853|19254278|P1|STARTED|Overall Study||51
7821959|NCT01100762|19254294|P1|NOT COMPLETED|Overall Study||0
7821960|NCT01100762|19254294|P1|COMPLETED|Overall Study||10
7821961|NCT01100762|19254294|P1|STARTED|Overall Study||10
7821962|NCT01100723|19254315|P1|NOT COMPLETED|Overall Study||14
7821963|NCT01100723|19254315|P1|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78
7821964|NCT01100723|19254315|P1|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85
7821965|NCT01100723|19254315|P1|STARTED|Overall Study||92
7821966|NCT01100658|19254324|P1|NOT COMPLETED|Overall Study||1
7821967|NCT01100658|19254324|P1|COMPLETED|Overall Study||0
7821968|NCT01100658|19254324|P1|STARTED|Overall Study||1
7821969|NCT01100606|19254329|P2|NOT COMPLETED|Second Treatment Period||0
7821970|NCT01100606|19254330|P1|NOT COMPLETED|Second Treatment Period||0
7821971|NCT01100606|19254329|P2|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7
7821972|NCT01100606|19254330|P1|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8
7821973|NCT01100606|19254329|P2|STARTED|Second Treatment Period||7
7821974|NCT01100606|19254330|P1|STARTED|Second Treatment Period||8
7821975|NCT01100606|19254329|P2|NOT COMPLETED|First Treatment Period||0
7821976|NCT01100606|19254330|P1|NOT COMPLETED|First Treatment Period||0
7821977|NCT01100606|19254329|P2|COMPLETED|First Treatment Period||7
7821978|NCT01100606|19254330|P1|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8
7821979|NCT01100606|19254329|P2|STARTED|First Treatment Period||7
7821980|NCT01100606|19254330|P1|STARTED|First Treatment Period||8
7821981|NCT01100567|19254356|P2|NOT COMPLETED|Overall Study||16
7821982|NCT01100567|19254357|P1|NOT COMPLETED|Overall Study||12
7821983|NCT01100567|19254356|P2|COMPLETED|Overall Study||35
7821984|NCT01100567|19254357|P1|COMPLETED|Overall Study||38
7821985|NCT01100567|19254356|P2|STARTED|Overall Study||51
7821986|NCT01100567|19254357|P1|STARTED|Overall Study||50
7821987|NCT01100528|19254365|P1|NOT COMPLETED|Overall Study||3
7821988|NCT01100528|19254365|P1|COMPLETED|Overall Study||35
7821989|NCT01100528|19254365|P1|STARTED|Overall Study||38
7821990|NCT01100502|19254373|P2|NOT COMPLETED|Long-Term Follow-up||139
7821991|NCT01100502|19254374|P1|NOT COMPLETED|Long-Term Follow-up||137
7821992|NCT01100502|19254373|P2|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|25
7821993|NCT01100502|19254374|P1|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|28
7821994|NCT01100502|19254373|P2|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|164
7821995|NCT01100502|19254374|P1|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|165
7821996|NCT01100502|19254373|P2|NOT COMPLETED|Treatment Period||83
7821997|NCT01100502|19254374|P1|NOT COMPLETED|Treatment Period||87
7821998|NCT01100502|19254373|P2|COMPLETED|Treatment Period||81
7821999|NCT01100502|19254374|P1|COMPLETED|Treatment Period||78
7822000|NCT01100502|19254373|P2|STARTED|Treatment Period||164
7822001|NCT01100502|19254374|P1|STARTED|Treatment Period||165
7822002|NCT01100437|19254384|P3|NOT COMPLETED|Treatment 2||0
7822003|NCT01100437|19254385|P2|NOT COMPLETED|Treatment 2||0
7822004|NCT01100437|19254386|P1|NOT COMPLETED|Treatment 2||0
7822005|NCT01100437|19254384|P3|COMPLETED|Treatment 2||0
7822006|NCT01100437|19254385|P2|COMPLETED|Treatment 2||2
7822007|NCT01100437|19254386|P1|COMPLETED|Treatment 2||4
7822008|NCT01100437|19254384|P3|STARTED|Treatment 2||0
7822009|NCT01100437|19254385|P2|STARTED|Treatment 2||2
7822010|NCT01100437|19254386|P1|STARTED|Treatment 2||4
7822011|NCT01100437|19254384|P3|NOT COMPLETED|Washout (4 Days)||0
7822012|NCT01100437|19254385|P2|NOT COMPLETED|Washout (4 Days)||0
7822013|NCT01100437|19254386|P1|NOT COMPLETED|Washout (4 Days)||0
7822014|NCT01100437|19254384|P3|COMPLETED|Washout (4 Days)||0
7822015|NCT01100437|19254385|P2|COMPLETED|Washout (4 Days)||2
7822016|NCT01100437|19254386|P1|COMPLETED|Washout (4 Days)||4
7822017|NCT01100437|19254384|P3|STARTED|Washout (4 Days)||0
7822018|NCT01100437|19254385|P2|STARTED|Washout (4 Days)||2
7822019|NCT01100437|19254386|P1|STARTED|Washout (4 Days)||4
7822020|NCT01100437|19254384|P3|NOT COMPLETED|Treatment 1||0
7822021|NCT01100437|19254385|P2|NOT COMPLETED|Treatment 1||0
7822022|NCT01100437|19254386|P1|NOT COMPLETED|Treatment 1||0
7822023|NCT01100437|19254384|P3|COMPLETED|Treatment 1||0
7822024|NCT01100437|19254385|P2|COMPLETED|Treatment 1||2
7822025|NCT01100437|19254386|P1|COMPLETED|Treatment 1||4
7822026|NCT01100437|19254384|P3|STARTED|Treatment 1||0
7822027|NCT01100437|19254385|P2|STARTED|Treatment 1||2
7822028|NCT01100437|19254386|P1|STARTED|Treatment 1||4
7822029|NCT01100437|19254384|P3|NOT COMPLETED|Maintenance||2
7822030|NCT01100437|19254385|P2|NOT COMPLETED|Maintenance||0
7822031|NCT01100437|19254386|P1|NOT COMPLETED|Maintenance||0
7822032|NCT01100437|19254384|P3|COMPLETED|Maintenance||0
7822033|NCT01100437|19254385|P2|COMPLETED|Maintenance||2
7822034|NCT01100437|19254386|P1|COMPLETED|Maintenance||4
7822035|NCT01100437|19254384|P3|STARTED|Maintenance||2
7822036|NCT01100437|19254385|P2|STARTED|Maintenance||2
7822037|NCT01100437|19254386|P1|STARTED|Maintenance||4
7822038|NCT01100437|19254384|P3|NOT COMPLETED|Titration/Stabilization||6
7822039|NCT01100437|19254385|P2|NOT COMPLETED|Titration/Stabilization||0
7822040|NCT01100437|19254386|P1|NOT COMPLETED|Titration/Stabilization||0
7822041|NCT01100437|19254384|P3|COMPLETED|Titration/Stabilization||2
7822042|NCT01100437|19254385|P2|COMPLETED|Titration/Stabilization||2
7822043|NCT01100437|19254386|P1|COMPLETED|Titration/Stabilization||4
7822044|NCT01100437|19254384|P3|STARTED|Titration/Stabilization||8
7822045|NCT01100437|19254385|P2|STARTED|Titration/Stabilization||2
7822046|NCT01100437|19254386|P1|STARTED|Titration/Stabilization||4
7822047|NCT01100437|19254384|P3|NOT COMPLETED|Screening||0
7822048|NCT01100437|19254385|P2|NOT COMPLETED|Screening||0
7822049|NCT01100437|19254386|P1|NOT COMPLETED|Screening||0
7822050|NCT01100437|19254384|P3|COMPLETED|Screening||8
7822051|NCT01100437|19254385|P2|COMPLETED|Screening||2
7822052|NCT01100437|19254386|P1|COMPLETED|Screening||4
7822053|NCT01100437|19254384|P3|STARTED|Screening||8
7822054|NCT01100437|19254385|P2|STARTED|Screening||2
7822055|NCT01100437|19254386|P1|STARTED|Screening||4
7822056|NCT01100320|19254423|P2|NOT COMPLETED|Period 2||1
7822057|NCT01100320|19254424|P1|NOT COMPLETED|Period 2||1
7822058|NCT01100320|19254423|P2|COMPLETED|Period 2||37
7822059|NCT01100320|19254424|P1|COMPLETED|Period 2||37
7822060|NCT01100320|19254423|P2|STARTED|Period 2||38
7822061|NCT01100320|19254424|P1|STARTED|Period 2||38
7822062|NCT01100320|19254423|P2|NOT COMPLETED|Period 1||7
7822063|NCT01100320|19254424|P1|NOT COMPLETED|Period 1||5
7822064|NCT01100320|19254423|P2|COMPLETED|Period 1||38
7822065|NCT01100320|19254424|P1|COMPLETED|Period 1||38
7822066|NCT01100320|19254423|P2|STARTED|Period 1||45
7822067|NCT01100320|19254424|P1|STARTED|Period 1||43
7822068|NCT01100307|19254436|P2|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13
7822069|NCT01100307|19254437|P1|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6
7822070|NCT01100307|19254436|P2|COMPLETED|Open Phase (Week 24 up to Week 54)||99
7822071|NCT01100307|19254437|P1|COMPLETED|Open Phase (Week 24 up to Week 54)||110
7822072|NCT01100307|19254436|P2|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112
7822073|NCT01100307|19254437|P1|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116
7822074|NCT01100307|19254436|P2|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4
7822075|NCT01100307|19254437|P1|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6
7822076|NCT01100307|19254436|P2|COMPLETED|Double Masked Phase (Up to Week 24)||116
7822077|NCT01100307|19254437|P1|COMPLETED|Double Masked Phase (Up to Week 24)||117
7822078|NCT01100307|19254436|P2|STARTED|Double Masked Phase (Up to Week 24)||120
7822079|NCT01100307|19254437|P1|STARTED|Double Masked Phase (Up to Week 24)||123
7822080|NCT01100268|19254479|P1|NOT COMPLETED|Overall Study||0
7822081|NCT01100268|19254479|P1|COMPLETED|Overall Study||4
7822082|NCT01100268|19254479|P1|STARTED|Overall Study||4
7822083|NCT01100255|19254486|P2|NOT COMPLETED|Overall Study||0
7822084|NCT01100255|19254487|P1|NOT COMPLETED|Overall Study||0
7822085|NCT01100255|19254486|P2|COMPLETED|Overall Study||7
7822086|NCT01100255|19254487|P1|COMPLETED|Overall Study||8
7822087|NCT01100255|19254486|P2|STARTED|Overall Study||7
7822088|NCT01100255|19254487|P1|STARTED|Overall Study||8
7822089|NCT01100242|19254493|P1|NOT COMPLETED|Overall Study||0
7822090|NCT01100242|19254493|P1|COMPLETED|Overall Study||17
7822091|NCT01100242|19254493|P1|STARTED|Overall Study||17
7822092|NCT01100112|19254499|P1|NOT COMPLETED|Overall Study||8
7822093|NCT01100112|19254499|P1|COMPLETED|Overall Study||52
7822094|NCT01100112|19254499|P1|STARTED|Overall Study||60
7822095|NCT01100086|19254506|P2|NOT COMPLETED|Period 2||0
7822096|NCT01100086|19254507|P1|NOT COMPLETED|Period 2||0
7822097|NCT01100086|19254506|P2|COMPLETED|Period 2||41
7822098|NCT01100086|19254507|P1|COMPLETED|Period 2||42
7822099|NCT01100086|19254506|P2|STARTED|Period 2||41
7822100|NCT01100086|19254507|P1|STARTED|Period 2||42
7822101|NCT01100086|19254506|P2|NOT COMPLETED|Period 1||0
7822102|NCT01100086|19254507|P1|NOT COMPLETED|Period 1||1
7822103|NCT01100086|19254506|P2|COMPLETED|Period 1||41
7822104|NCT01100086|19254507|P1|COMPLETED|Period 1||42
7822105|NCT01100086|19254506|P2|STARTED|Period 1||41
7822106|NCT01100086|19254507|P1|STARTED|Period 1||43
7822107|NCT01100073|19254517|P1|NOT COMPLETED|Overall Study||100
7822108|NCT01100073|19254517|P1|COMPLETED|Overall Study|End of study (Visit 3)|1599
7822109|NCT01100073|19254517|P1|STARTED|Overall Study|Baseline (Visit 1)|1699
7822110|NCT01100034|19254532|P1|NOT COMPLETED|Overall Study||43
7822111|NCT01100034|19254532|P1|COMPLETED|Overall Study||29
7822112|NCT01100034|19254532|P1|STARTED|Overall Study||72
7822113|NCT01099969|19254545|P4|NOT COMPLETED|Overall Study||0
7822114|NCT01099969|19254546|P3|NOT COMPLETED|Overall Study||0
7822115|NCT01099969|19254547|P2|NOT COMPLETED|Overall Study||0
7822116|NCT01099969|19254548|P1|NOT COMPLETED|Overall Study||0
7822117|NCT01099969|19254545|P4|COMPLETED|Overall Study||15
7822118|NCT01099969|19254546|P3|COMPLETED|Overall Study||15
7822119|NCT01099969|19254547|P2|COMPLETED|Overall Study||15
7822120|NCT01099969|19254548|P1|COMPLETED|Overall Study||15
7822121|NCT01099969|19254545|P4|STARTED|Overall Study||15
7822122|NCT01099969|19254546|P3|STARTED|Overall Study||15
7822123|NCT01099969|19254547|P2|STARTED|Overall Study||15
7822124|NCT01099969|19254548|P1|STARTED|Overall Study||15
7822125|NCT01099917|19254570|P1|NOT COMPLETED|Overall Study||27
7822126|NCT01099917|19254570|P1|COMPLETED|Overall Study||18
7822127|NCT01099917|19254570|P1|STARTED|Overall Study||45
7822128|NCT01099774|19254576|P2|NOT COMPLETED|Overall Study||6
7822129|NCT01099774|19254577|P1|NOT COMPLETED|Overall Study||6
7822130|NCT01099774|19254576|P2|COMPLETED|Overall Study||289
7822131|NCT01099774|19254577|P1|COMPLETED|Overall Study||296
7822132|NCT01099774|19254576|P2|STARTED|Overall Study||295
7822133|NCT01099774|19254577|P1|STARTED|Overall Study||302
7822134|NCT01099761|19254593|P4|NOT COMPLETED|Overall Study||0
7822135|NCT01099761|19254594|P3|NOT COMPLETED|Overall Study||0
7822136|NCT01099761|19254595|P2|NOT COMPLETED|Overall Study||0
7822137|NCT01099761|19254596|P1|NOT COMPLETED|Overall Study||0
7822138|NCT01099761|19254593|P4|COMPLETED|Overall Study||6
7822139|NCT01099761|19254594|P3|COMPLETED|Overall Study||0
7822140|NCT01099761|19254595|P2|COMPLETED|Overall Study||9
7822141|NCT01099761|19254596|P1|COMPLETED|Overall Study||9
7822142|NCT01099761|19254593|P4|STARTED|Overall Study||6
7822143|NCT01099761|19254594|P3|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0
7822144|NCT01099761|19254595|P2|STARTED|Overall Study||9
7822145|NCT01099761|19254596|P1|STARTED|Overall Study||9
7822146|NCT01099709|19254632|P2|NOT COMPLETED|Period 2||0
7822147|NCT01099709|19254633|P1|NOT COMPLETED|Period 2||0
7822148|NCT01099709|19254632|P2|COMPLETED|Period 2||41
7822149|NCT01099709|19254633|P1|COMPLETED|Period 2||41
7822150|NCT01099709|19254632|P2|STARTED|Period 2||41
7822151|NCT01099709|19254633|P1|STARTED|Period 2||41
7822152|NCT01099709|19254632|P2|NOT COMPLETED|Period 1||2
7822153|NCT01099709|19254633|P1|NOT COMPLETED|Period 1||1
7822154|NCT01099709|19254632|P2|COMPLETED|Period 1||41
7822155|NCT01099709|19254633|P1|COMPLETED|Period 1||41
7822156|NCT01099709|19254632|P2|STARTED|Period 1||43
7822157|NCT01099709|19254633|P1|STARTED|Period 1||42
7822158|NCT01099631|19254649|P6|NOT COMPLETED|Overall Study||0
7822159|NCT01099631|19254650|P5|NOT COMPLETED|Overall Study||0
7822160|NCT01099631|19254651|P4|NOT COMPLETED|Overall Study||0
7822161|NCT01099631|19254652|P3|NOT COMPLETED|Overall Study||0
7822162|NCT01099631|19254653|P2|NOT COMPLETED|Overall Study||0
7822163|NCT01099631|19254654|P1|NOT COMPLETED|Overall Study||0
7822164|NCT01099631|19254649|P6|COMPLETED|Overall Study||4
7822165|NCT01099631|19254650|P5|COMPLETED|Overall Study||3
7822166|NCT01099631|19254651|P4|COMPLETED|Overall Study||3
7822167|NCT01099631|19254652|P3|COMPLETED|Overall Study||3
7822168|NCT01099631|19254653|P2|COMPLETED|Overall Study||3
7822169|NCT01099631|19254654|P1|COMPLETED|Overall Study||6
7822170|NCT01099631|19254649|P6|STARTED|Overall Study||4
7822171|NCT01099631|19254650|P5|STARTED|Overall Study||3
7822172|NCT01099631|19254651|P4|STARTED|Overall Study||3
7822173|NCT01099631|19254652|P3|STARTED|Overall Study||3
7822174|NCT01099631|19254653|P2|STARTED|Overall Study||3
7822175|NCT01099631|19254654|P1|STARTED|Overall Study||6
7822176|NCT01099618|19254689|P3|NOT COMPLETED|Overall Study||0
7822177|NCT01099618|19254690|P2|NOT COMPLETED|Overall Study||0
7822178|NCT01099618|19254691|P1|NOT COMPLETED|Overall Study||0
7822179|NCT01099618|19254689|P3|COMPLETED|Overall Study||15
7822180|NCT01099618|19254690|P2|COMPLETED|Overall Study||16
7822181|NCT01099618|19254691|P1|COMPLETED|Overall Study||17
7822182|NCT01099618|19254689|P3|STARTED|Overall Study||15
7822183|NCT01099618|19254690|P2|STARTED|Overall Study||16
7822184|NCT01099618|19254691|P1|STARTED|Overall Study||17
7822185|NCT01099579|19254702|P3|NOT COMPLETED|Stage 2 (ATV Capsule)||6
7822186|NCT01099579|19254703|P2|NOT COMPLETED|Stage 2 (ATV Capsule)||5
7822187|NCT01099579|19254704|P1|NOT COMPLETED|Stage 2 (ATV Capsule)||6
7822188|NCT01099579|19254702|P3|COMPLETED|Stage 2 (ATV Capsule)||9
7822189|NCT01099579|19254703|P2|COMPLETED|Stage 2 (ATV Capsule)||9
7822190|NCT01099579|19254704|P1|COMPLETED|Stage 2 (ATV Capsule)||10
7822191|NCT01099579|19254702|P3|STARTED|Stage 2 (ATV Capsule)||15
7822192|NCT01099579|19254703|P2|STARTED|Stage 2 (ATV Capsule)||14
7822193|NCT01099579|19254704|P1|STARTED|Stage 2 (ATV Capsule)||16
7822194|NCT01099579|19254702|P3|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1
7822195|NCT01099579|19254703|P2|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5
7822196|NCT01099579|19254704|P1|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4
7822197|NCT01099579|19254702|P3|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15
7822198|NCT01099579|19254703|P2|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14
7822199|NCT01099579|19254704|P1|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17
7822200|NCT01099579|19254702|P3|STARTED|Stage 1 (ATV Powder Formulation)||16
7822201|NCT01099579|19254703|P2|STARTED|Stage 1 (ATV Powder Formulation)||19
7822202|NCT01099579|19254704|P1|STARTED|Stage 1 (ATV Powder Formulation)||21
7822203|NCT01099475|19254760|P2|NOT COMPLETED|Overall Study||0
7822204|NCT01099475|19254761|P1|NOT COMPLETED|Overall Study||0
7822205|NCT01099475|19254760|P2|COMPLETED|Overall Study||10
7822206|NCT01099475|19254761|P1|COMPLETED|Overall Study||10
7822207|NCT01099475|19254760|P2|STARTED|Overall Study||10
7822208|NCT01099475|19254761|P1|STARTED|Overall Study||10
7822209|NCT01099449|19254776|P3|NOT COMPLETED|Overall Study||0
7822210|NCT01099449|19254777|P2|NOT COMPLETED|Overall Study||0
7822211|NCT01099449|19254778|P1|NOT COMPLETED|Overall Study||0
7822212|NCT01099449|19254776|P3|COMPLETED|Overall Study||116
7822213|NCT01099449|19254777|P2|COMPLETED|Overall Study||119
7822214|NCT01099449|19254778|P1|COMPLETED|Overall Study||118
7822215|NCT01099449|19254776|P3|STARTED|Overall Study||116
7822216|NCT01099449|19254777|P2|STARTED|Overall Study||119
7822217|NCT01099449|19254778|P1|STARTED|Overall Study||118
7822218|NCT01099397|19254813|P1|NOT COMPLETED|Overall Study||13
7822219|NCT01099397|19254813|P1|COMPLETED|Overall Study||26
7822220|NCT01099397|19254813|P1|STARTED|Overall Study||39
7822221|NCT01099358|19254818|P4|NOT COMPLETED|Overall Study||4
7822222|NCT01099358|19254819|P3|NOT COMPLETED|Overall Study||8
7822223|NCT01099358|19254820|P2|NOT COMPLETED|Overall Study||1
7822224|NCT01099358|19254821|P1|NOT COMPLETED|Overall Study||3
7822225|NCT01099358|19254818|P4|COMPLETED|Overall Study||12
7822226|NCT01099358|19254819|P3|COMPLETED|Overall Study||13
7822227|NCT01099358|19254820|P2|COMPLETED|Overall Study||5
7822228|NCT01099358|19254821|P1|COMPLETED|Overall Study||1
7822229|NCT01099358|19254818|P4|Received at Least One Dose of Study Drug|Overall Study||15
7822230|NCT01099358|19254819|P3|Received at Least One Dose of Study Drug|Overall Study||20
7822231|NCT01099358|19254820|P2|Received at Least One Dose of Study Drug|Overall Study||6
7822232|NCT01099358|19254821|P1|Received at Least One Dose of Study Drug|Overall Study||3
7822233|NCT01099358|19254818|P4|STARTED|Overall Study||16
7822234|NCT01099358|19254819|P3|STARTED|Overall Study||21
7822235|NCT01099358|19254820|P2|STARTED|Overall Study||6
7822236|NCT01099358|19254821|P1|STARTED|Overall Study||4
7822237|NCT01099267|19254840|P1|NOT COMPLETED|MDS-009 Extension Follow-up||0
7822238|NCT01099267|19254840|P1|COMPLETED|MDS-009 Extension Follow-up||54
7822239|NCT01099267|19254840|P1|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21
7822240|NCT01099267|19254840|P1|Informed Consent Given|MDS-009 Extension Follow-up||33
7822241|NCT01099267|19254840|P1|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54
7822242|NCT01099267|19254840|P1|NOT COMPLETED|MDS-003 Study||124
7822243|NCT01099267|19254840|P1|COMPLETED|MDS-003 Study||24
7822244|NCT01099267|19254840|P1|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148
7822245|NCT01099215|19254850|P2|NOT COMPLETED|Overall Study||1
7822246|NCT01099215|19254851|P1|NOT COMPLETED|Overall Study||1
7822247|NCT01099215|19254850|P2|COMPLETED|Overall Study||9
7822248|NCT01099215|19254851|P1|COMPLETED|Overall Study||10
7822249|NCT01099215|19254850|P2|STARTED|Overall Study||10
7822250|NCT01099215|19254851|P1|STARTED|Overall Study||11
7822251|NCT01099202|19254889|P2|NOT COMPLETED|Overall Study||0
7822252|NCT01099202|19254890|P1|NOT COMPLETED|Overall Study||0
7822253|NCT01099202|19254889|P2|COMPLETED|Overall Study||54
7822254|NCT01099202|19254890|P1|COMPLETED|Overall Study||55
7822255|NCT01099202|19254889|P2|STARTED|Overall Study||54
7822256|NCT01099202|19254890|P1|STARTED|Overall Study||55
7822257|NCT01099111|19254903|P5|NOT COMPLETED|Overall Study||0
7822258|NCT01099111|19254904|P4|NOT COMPLETED|Overall Study||0
7822259|NCT01099111|19254905|P3|NOT COMPLETED|Overall Study||0
7822260|NCT01099111|19254906|P2|NOT COMPLETED|Overall Study||0
7822261|NCT01099111|19254907|P1|NOT COMPLETED|Overall Study||0
7822262|NCT01099111|19254903|P5|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
7822263|NCT01099111|19254904|P4|COMPLETED|Overall Study||29
7822264|NCT01099111|19254905|P3|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46
7822265|NCT01099111|19254906|P2|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
7822266|NCT01099111|19254907|P1|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
7822267|NCT01099111|19254903|P5|STARTED|Overall Study||50
7822268|NCT01099111|19254904|P4|STARTED|Overall Study||29
7822269|NCT01099111|19254905|P3|STARTED|Overall Study||46
7822270|NCT01099111|19254906|P2|STARTED|Overall Study||50
7822271|NCT01099111|19254907|P1|STARTED|Overall Study||50
7822272|NCT01098851|19254921|P2|NOT COMPLETED|Overall Study||0
7822273|NCT01098851|19254922|P1|NOT COMPLETED|Overall Study||1
7822274|NCT01098851|19254921|P2|COMPLETED|Overall Study||10
7822275|NCT01098851|19254922|P1|COMPLETED|Overall Study||10
7822276|NCT01098851|19254921|P2|STARTED|Overall Study||10
7822277|NCT01098851|19254922|P1|STARTED|Overall Study||11
7822278|NCT01098812|19254933|P3|NOT COMPLETED|Overall Study||1
7822279|NCT01098812|19254934|P2|NOT COMPLETED|Overall Study||1
7822280|NCT01098812|19254935|P1|NOT COMPLETED|Overall Study||2
7822281|NCT01098812|19254933|P3|COMPLETED|Overall Study||71
7822282|NCT01098812|19254934|P2|COMPLETED|Overall Study||101
7822283|NCT01098812|19254935|P1|COMPLETED|Overall Study||93
7822284|NCT01098812|19254933|P3|STARTED|Overall Study||72
7822285|NCT01098812|19254934|P2|STARTED|Overall Study||102
7822286|NCT01098812|19254935|P1|STARTED|Overall Study||95
7822287|NCT01098747|19254949|P4|NOT COMPLETED|Overall Study||0
7822288|NCT01098747|19254950|P3|NOT COMPLETED|Overall Study||0
7822289|NCT01098747|19254951|P2|NOT COMPLETED|Overall Study||0
7822290|NCT01098747|19254952|P1|NOT COMPLETED|Overall Study||0
7822291|NCT01098747|19254949|P4|COMPLETED|Overall Study||87
7822292|NCT01098747|19254950|P3|COMPLETED|Overall Study||86
7822293|NCT01098747|19254951|P2|COMPLETED|Overall Study||95
7822294|NCT01098747|19254952|P1|COMPLETED|Overall Study||48
7822295|NCT01098747|19254949|P4|STARTED|Overall Study||87
7822296|NCT01098747|19254950|P3|STARTED|Overall Study||86
7822297|NCT01098747|19254951|P2|STARTED|Overall Study||95
7822298|NCT01098747|19254952|P1|STARTED|Overall Study||48
7822299|NCT01098578|19255002|P1|NOT COMPLETED|Overall Study||0
7822300|NCT01098578|19255002|P1|COMPLETED|Overall Study||20
7822301|NCT01098578|19255002|P1|STARTED|Overall Study||20
7822302|NCT01098539|19255011|P2|NOT COMPLETED|Overall Study||68
7822303|NCT01098539|19255012|P1|NOT COMPLETED|Overall Study||51
7822304|NCT01098539|19255011|P2|COMPLETED|Overall Study||178
7822305|NCT01098539|19255012|P1|COMPLETED|Overall Study||198
7822306|NCT01098539|19255011|P2|STARTED|Overall Study||246
7822307|NCT01098539|19255012|P1|STARTED|Overall Study||249
7822308|NCT01098500|19255048|P1|NOT COMPLETED|Overall Study||0
7822309|NCT01098500|19255048|P1|COMPLETED|Overall Study||3800
7822310|NCT01098500|19255048|P1|STARTED|Overall Study||3800
7822311|NCT01098487|19255063|P1|NOT COMPLETED|Overall Study||44
7822312|NCT01098487|19255063|P1|COMPLETED|Overall Study||118
7822313|NCT01098487|19255063|P1|STARTED|Overall Study||162
7822314|NCT01098474|19255081|P6|NOT COMPLETED|Follow Up Phase||5
7822315|NCT01098474|19255082|P5|NOT COMPLETED|Follow Up Phase||2
7822316|NCT01098474|19255083|P4|NOT COMPLETED|Follow Up Phase||2
7822317|NCT01098474|19255084|P3|NOT COMPLETED|Follow Up Phase||0
7822318|NCT01098474|19255085|P2|NOT COMPLETED|Follow Up Phase||0
7822319|NCT01098474|19255086|P1|NOT COMPLETED|Follow Up Phase||0
7822320|NCT01098474|19255081|P6|COMPLETED|Follow Up Phase||44
7822321|NCT01098474|19255082|P5|COMPLETED|Follow Up Phase||50
7822322|NCT01098474|19255083|P4|COMPLETED|Follow Up Phase||47
7822323|NCT01098474|19255084|P3|COMPLETED|Follow Up Phase||45
7822324|NCT01098474|19255085|P2|COMPLETED|Follow Up Phase||49
7822325|NCT01098474|19255086|P1|COMPLETED|Follow Up Phase||48
7822326|NCT01098474|19255081|P6|STARTED|Follow Up Phase||49
7822327|NCT01098474|19255082|P5|STARTED|Follow Up Phase||52
7822328|NCT01098474|19255083|P4|STARTED|Follow Up Phase||49
7822329|NCT01098474|19255084|P3|STARTED|Follow Up Phase||45
7822330|NCT01098474|19255085|P2|STARTED|Follow Up Phase||49
7822331|NCT01098474|19255086|P1|STARTED|Follow Up Phase||48
7822332|NCT01098474|19255081|P6|NOT COMPLETED|Active Phase||0
7822333|NCT01098474|19255082|P5|NOT COMPLETED|Active Phase||0
7822334|NCT01098474|19255083|P4|NOT COMPLETED|Active Phase||0
7822335|NCT01098474|19255084|P3|NOT COMPLETED|Active Phase||5
7822336|NCT01098474|19255085|P2|NOT COMPLETED|Active Phase||1
7822337|NCT01098474|19255086|P1|NOT COMPLETED|Active Phase||2
7822338|NCT01098474|19255081|P6|COMPLETED|Active Phase||49
7822339|NCT01098474|19255082|P5|COMPLETED|Active Phase||52
7822340|NCT01098474|19255083|P4|COMPLETED|Active Phase||49
7822341|NCT01098474|19255084|P3|COMPLETED|Active Phase||45
7822342|NCT01098474|19255085|P2|COMPLETED|Active Phase||49
7822343|NCT01098474|19255086|P1|COMPLETED|Active Phase||48
7822344|NCT01098474|19255081|P6|STARTED|Active Phase||49
7822345|NCT01098474|19255082|P5|STARTED|Active Phase||52
7822346|NCT01098474|19255083|P4|STARTED|Active Phase||49
7822347|NCT01098474|19255084|P3|STARTED|Active Phase||50
7822348|NCT01098474|19255085|P2|STARTED|Active Phase||50
7822349|NCT01098474|19255086|P1|STARTED|Active Phase||50
7822350|NCT01098461|19255320|P4|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
7822351|NCT01098461|19255321|P3|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1
7822352|NCT01098461|19255322|P2|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3
7822353|NCT01098461|19255323|P1|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
7822354|NCT01098461|19255320|P4|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
7822355|NCT01098461|19255321|P3|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
7822356|NCT01098461|19255322|P2|COMPLETED|Follow-up (FU) Period (8 Weeks)||49
7822357|NCT01098461|19255323|P1|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
7822358|NCT01098461|19255320|P4|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
7822359|NCT01098461|19255321|P3|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53
7822360|NCT01098461|19255322|P2|STARTED|Follow-up (FU) Period (8 Weeks)||52
7822361|NCT01098461|19255323|P1|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
7822362|NCT01098461|19255320|P4|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3
7822363|NCT01098461|19255321|P3|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1
7822364|NCT01098461|19255322|P2|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7
7822365|NCT01098461|19255323|P1|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12
7822366|NCT01098461|19255320|P4|COMPLETED|Treatment Period (TP) (16 Weeks)||50
7822367|NCT01098461|19255321|P3|COMPLETED|Treatment Period (TP) (16 Weeks)||53
7822368|NCT01098461|19255322|P2|COMPLETED|Treatment Period (TP) (16 Weeks)||45
7822369|NCT01098461|19255323|P1|COMPLETED|Treatment Period (TP) (16 Weeks)||41
7822370|NCT01098461|19255320|P4|STARTED|Treatment Period (TP) (16 Weeks)||53
7822371|NCT01098461|19255321|P3|STARTED|Treatment Period (TP) (16 Weeks)||54
7822372|NCT01098461|19255322|P2|STARTED|Treatment Period (TP) (16 Weeks)||52
7822373|NCT01098461|19255323|P1|STARTED|Treatment Period (TP) (16 Weeks)||53
7822374|NCT01098318|19255356|P3|NOT COMPLETED|Overall Study||3
7822375|NCT01098318|19255357|P2|NOT COMPLETED|Overall Study||7
7822376|NCT01098318|19255358|P1|NOT COMPLETED|Overall Study||3
7822377|NCT01098318|19255356|P3|COMPLETED|Overall Study||15
7822378|NCT01098318|19255357|P2|COMPLETED|Overall Study||12
7822379|NCT01098318|19255358|P1|COMPLETED|Overall Study||17
7822380|NCT01098318|19255356|P3|STARTED|Overall Study||18
7822381|NCT01098318|19255357|P2|STARTED|Overall Study||19
7822382|NCT01098318|19255358|P1|STARTED|Overall Study||20
7822383|NCT01098305|19255383|P2|NOT COMPLETED|Overall Study||33
7822384|NCT01098305|19255384|P1|NOT COMPLETED|Overall Study||31
7822385|NCT01098305|19255383|P2|COMPLETED|Overall Study||85
7822386|NCT01098305|19255384|P1|COMPLETED|Overall Study||88
7822387|NCT01098305|19255383|P2|STARTED|Overall Study||118
7822388|NCT01098305|19255384|P1|STARTED|Overall Study||119
7822389|NCT01098266|19255394|P2|NOT COMPLETED|Overall Study||7
7822390|NCT01098266|19255395|P1|NOT COMPLETED|Overall Study||7
7822391|NCT01098266|19255394|P2|COMPLETED|Overall Study||193
7822392|NCT01098266|19255395|P1|COMPLETED|Overall Study||193
7822393|NCT01098266|19255394|P2|STARTED|Overall Study||200
7822394|NCT01098266|19255395|P1|STARTED|Overall Study||200
7822395|NCT01098253|19255415|P2|NOT COMPLETED|Overall Study||0
7822396|NCT01098253|19255416|P1|NOT COMPLETED|Overall Study||2
7822397|NCT01098253|19255415|P2|COMPLETED|Overall Study||88
7822398|NCT01098253|19255416|P1|COMPLETED|Overall Study||92
7822399|NCT01098253|19255415|P2|STARTED|Overall Study||88
7822400|NCT01098253|19255416|P1|STARTED|Overall Study||94
7822401|NCT01098240|19255424|P3|NOT COMPLETED|Double-Blind Phase||22
7822402|NCT01098240|19255425|P2|NOT COMPLETED|Double-Blind Phase||17
7822403|NCT01098240|19255426|P1|NOT COMPLETED|Double-Blind Phase||0
7822404|NCT01098240|19255424|P3|COMPLETED|Double-Blind Phase||63
7822405|NCT01098240|19255425|P2|COMPLETED|Double-Blind Phase||60
7822406|NCT01098240|19255426|P1|COMPLETED|Double-Blind Phase||0
7822407|NCT01098240|19255424|P3|STARTED|Double-Blind Phase||85
7822408|NCT01098240|19255425|P2|STARTED|Double-Blind Phase||77
7822409|NCT01098240|19255426|P1|STARTED|Double-Blind Phase||0
7822410|NCT01098240|19255424|P3|NOT COMPLETED|Open-Label Phase||0
7822411|NCT01098240|19255425|P2|NOT COMPLETED|Open-Label Phase||0
7822412|NCT01098240|19255426|P1|NOT COMPLETED|Open-Label Phase||135
7822413|NCT01098240|19255424|P3|COMPLETED|Open-Label Phase||0
7822414|NCT01098240|19255425|P2|COMPLETED|Open-Label Phase||0
7822415|NCT01098240|19255426|P1|COMPLETED|Open-Label Phase||162
7822416|NCT01098240|19255424|P3|STARTED|Open-Label Phase||0
7822417|NCT01098240|19255425|P2|STARTED|Open-Label Phase||0
7822418|NCT01098240|19255426|P1|STARTED|Open-Label Phase||297
7822419|NCT01098162|19255456|P1|NOT COMPLETED|Overall Study||112
7822420|NCT01098162|19255456|P1|COMPLETED|Overall Study||461
7822421|NCT01098162|19255456|P1|STARTED|Overall Study||573
7822422|NCT01098110|19255468|P3|NOT COMPLETED|Overall Study||94
7822423|NCT01098110|19255469|P2|NOT COMPLETED|Overall Study||73
7822424|NCT01098110|19255470|P1|NOT COMPLETED|Overall Study||62
7822425|NCT01098110|19255468|P3|COMPLETED|Overall Study||80
7822426|NCT01098110|19255469|P2|COMPLETED|Overall Study||109
7822427|NCT01098110|19255470|P1|COMPLETED|Overall Study||114
7822428|NCT01098110|19255468|P3|Treated|Overall Study|Received at least one dose of trial medication|174
7822429|NCT01098110|19255469|P2|Treated|Overall Study|Received at least one dose of trial medication|181
7822430|NCT01098110|19255470|P1|Treated|Overall Study|Received at least one dose of trial medication|175
7822431|NCT01098110|19255468|P3|STARTED|Overall Study|Randomized participants|174
7822432|NCT01098110|19255469|P2|STARTED|Overall Study|Randomized participants|182
7822433|NCT01098110|19255470|P1|STARTED|Overall Study|Randomized participants|176
7822434|NCT01098097|19255511|P1|NOT COMPLETED|Overall Study||82
7822435|NCT01098097|19255511|P1|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881
7822436|NCT01098097|19255511|P1|STARTED|Overall Study||963
7822437|NCT01098071|19255520|P1|NOT COMPLETED|Overall Study||15
7822438|NCT01098071|19255520|P1|COMPLETED|Overall Study||19
7822439|NCT01098071|19255520|P1|STARTED|Overall Study||34
7822440|NCT01098032|19255533|P2|NOT COMPLETED|Overall Study||1
7822441|NCT01098032|19255534|P1|NOT COMPLETED|Overall Study||1
7822442|NCT01098032|19255533|P2|COMPLETED|Overall Study||146
7822443|NCT01098032|19255534|P1|COMPLETED|Overall Study||146
7822444|NCT01098032|19255533|P2|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
7822445|NCT01098032|19255534|P1|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
7822446|NCT01098006|19255544|P4|NOT COMPLETED|Overall Study||0
7822447|NCT01098006|19255545|P3|NOT COMPLETED|Overall Study||0
7822448|NCT01098006|19255546|P2|NOT COMPLETED|Overall Study||0
7822449|NCT01098006|19255547|P1|NOT COMPLETED|Overall Study||0
7822450|NCT01098006|19255544|P4|COMPLETED|Overall Study||21
7822451|NCT01098006|19255545|P3|COMPLETED|Overall Study||60
7822452|NCT01098006|19255546|P2|COMPLETED|Overall Study||11
7822453|NCT01098006|19255547|P1|COMPLETED|Overall Study||7
7822454|NCT01098006|19255544|P4|STARTED|Overall Study||21
7822455|NCT01098006|19255545|P3|STARTED|Overall Study||60
7822456|NCT01098006|19255546|P2|STARTED|Overall Study||11
7822457|NCT01098006|19255547|P1|STARTED|Overall Study||7
7822458|NCT01097915|19255624|P3|NOT COMPLETED|Overall Study||30
7822459|NCT01097915|19255625|P2|NOT COMPLETED|Overall Study||42
7822460|NCT01097915|19255626|P1|NOT COMPLETED|Overall Study||23
7822461|NCT01097915|19255624|P3|COMPLETED|Overall Study||20
7822462|NCT01097915|19255625|P2|COMPLETED|Overall Study||28
7822463|NCT01097915|19255626|P1|COMPLETED|Overall Study||27
7822464|NCT01097915|19255624|P3|STARTED|Overall Study||50
7822465|NCT01097915|19255625|P2|STARTED|Overall Study||70
7822466|NCT01097915|19255626|P1|STARTED|Overall Study||50
7822467|NCT01097863|19255651|P3|NOT COMPLETED|Overall Study||2
7822468|NCT01097863|19255652|P2|NOT COMPLETED|Overall Study||0
7822469|NCT01097863|19255653|P1|NOT COMPLETED|Overall Study||1
7822470|NCT01097863|19255651|P3|COMPLETED|Overall Study||89
7822471|NCT01097863|19255652|P2|COMPLETED|Overall Study||98
7822472|NCT01097863|19255653|P1|COMPLETED|Overall Study||89
7822473|NCT01097863|19255651|P3|STARTED|Overall Study||91
7822474|NCT01097863|19255652|P2|STARTED|Overall Study||98
7822475|NCT01097863|19255653|P1|STARTED|Overall Study||90
7822476|NCT01097785|19255663|P2|NOT COMPLETED|Cycle 3 (30 Days)||0
7822477|NCT01097785|19255664|P1|NOT COMPLETED|Cycle 3 (30 Days)||0
7822478|NCT01097785|19255663|P2|COMPLETED|Cycle 3 (30 Days)||6
7822479|NCT01097785|19255664|P1|COMPLETED|Cycle 3 (30 Days)||6
7822480|NCT01097785|19255663|P2|STARTED|Cycle 3 (30 Days)||6
7822481|NCT01097785|19255664|P1|STARTED|Cycle 3 (30 Days)||6
7822482|NCT01097785|19255663|P2|NOT COMPLETED|Washout (2 Weeks)||0
7822483|NCT01097785|19255664|P1|NOT COMPLETED|Washout (2 Weeks)||0
7822484|NCT01097785|19255663|P2|COMPLETED|Washout (2 Weeks)||6
7822485|NCT01097785|19255664|P1|COMPLETED|Washout (2 Weeks)||6
7822486|NCT01097785|19255663|P2|STARTED|Washout (2 Weeks)||6
7822487|NCT01097785|19255664|P1|STARTED|Washout (2 Weeks)||6
7822488|NCT01097785|19255663|P2|NOT COMPLETED|Cycle 1 (30 Days)||0
7822489|NCT01097785|19255664|P1|NOT COMPLETED|Cycle 1 (30 Days)||0
7822490|NCT01097785|19255663|P2|COMPLETED|Cycle 1 (30 Days)||6
7822491|NCT01097785|19255664|P1|COMPLETED|Cycle 1 (30 Days)||6
7822492|NCT01097785|19255663|P2|STARTED|Cycle 1 (30 Days)||6
7822493|NCT01097785|19255664|P1|STARTED|Cycle 1 (30 Days)||6
7822494|NCT01097707|19255677|P5|NOT COMPLETED|Overall Study||50
7822495|NCT01097707|19255678|P4|NOT COMPLETED|Overall Study||44
7822496|NCT01097707|19255679|P3|NOT COMPLETED|Overall Study||45
7822497|NCT01097707|19255680|P2|NOT COMPLETED|Overall Study||43
7822498|NCT01097707|19255681|P1|NOT COMPLETED|Overall Study||44
7822499|NCT01097707|19255677|P5|COMPLETED|Overall Study||35
7822500|NCT01097707|19255678|P4|COMPLETED|Overall Study||40
7822501|NCT01097707|19255679|P3|COMPLETED|Overall Study||37
7822502|NCT01097707|19255680|P2|COMPLETED|Overall Study||37
7822503|NCT01097707|19255681|P1|COMPLETED|Overall Study||39
7822504|NCT01097707|19255677|P5|STARTED|Overall Study||85
7822505|NCT01097707|19255678|P4|STARTED|Overall Study||84
7822506|NCT01097707|19255679|P3|STARTED|Overall Study||82
7822507|NCT01097707|19255680|P2|STARTED|Overall Study||80
7822508|NCT01097707|19255681|P1|STARTED|Overall Study||83
7822509|NCT01097694|19255730|P2|NOT COMPLETED|Overall Study||4
7822510|NCT01097694|19255731|P1|NOT COMPLETED|Overall Study||8
7822511|NCT01097694|19255730|P2|COMPLETED|Overall Study||26
7822512|NCT01097694|19255731|P1|COMPLETED|Overall Study||24
7822513|NCT01097694|19255730|P2|STARTED|Overall Study||30
7822514|NCT01097694|19255731|P1|STARTED|Overall Study||32
7822515|NCT01097668|19255793|P2|NOT COMPLETED|Overall Study||2
7822516|NCT01097668|19255794|P1|NOT COMPLETED|Overall Study||2
7822517|NCT01097668|19255793|P2|COMPLETED|Overall Study||20
7822518|NCT01097668|19255794|P1|COMPLETED|Overall Study||19
7822519|NCT01097668|19255793|P2|Week 48|Overall Study||20
7822520|NCT01097668|19255794|P1|Week 48|Overall Study||19
7822521|NCT01097668|19255793|P2|Week 20|Overall Study|Patient evaluability time point = week 20|22
7822522|NCT01097668|19255794|P1|Week 20|Overall Study|Patient evaluability time point = week 20|21
7822523|NCT01097668|19255793|P2|STARTED|Overall Study||22
7822524|NCT01097668|19255794|P1|STARTED|Overall Study||21
7822525|NCT01097655|19255804|P1|NOT COMPLETED|Overall Study||10
7822526|NCT01097655|19255804|P1|COMPLETED|Overall Study|participants included for analysis|3039
7822527|NCT01097655|19255804|P1|STARTED|Overall Study||3049
7822528|NCT01097629|19255814|P8|NOT COMPLETED|DB RO Phase||1
7822529|NCT01097629|19255815|P7|NOT COMPLETED|DB RO Phase||3
7822530|NCT01097629|19255816|P6|NOT COMPLETED|DB RO Phase||1
7822531|NCT01097629|19255817|P5|NOT COMPLETED|DB RO Phase||0
7822532|NCT01097629|19255818|P4|NOT COMPLETED|DB RO Phase||1
7822533|NCT01097629|19255819|P3|NOT COMPLETED|DB RO Phase||0
7822534|NCT01097629|19255820|P2|NOT COMPLETED|DB RO Phase||0
7822535|NCT01097629|19255821|P1|NOT COMPLETED|DB RO Phase||0
7822536|NCT01097629|19255814|P8|COMPLETED|DB RO Phase||326
7822537|NCT01097629|19255815|P7|COMPLETED|DB RO Phase||168
7822538|NCT01097629|19255816|P6|COMPLETED|DB RO Phase||172
7822539|NCT01097629|19255817|P5|COMPLETED|DB RO Phase||108
7822540|NCT01097629|19255818|P4|COMPLETED|DB RO Phase||96
7822541|NCT01097629|19255819|P3|COMPLETED|DB RO Phase||0
7822542|NCT01097629|19255820|P2|COMPLETED|DB RO Phase||0
7822543|NCT01097629|19255821|P1|COMPLETED|DB RO Phase||0
7822544|NCT01097629|19255814|P8|STARTED|DB RO Phase||327
7822545|NCT01097629|19255815|P7|STARTED|DB RO Phase||171
7822546|NCT01097629|19255816|P6|STARTED|DB RO Phase||173
7822547|NCT01097629|19255817|P5|STARTED|DB RO Phase||108
7822548|NCT01097629|19255818|P4|STARTED|DB RO Phase||97
7822549|NCT01097629|19255819|P3|STARTED|DB RO Phase||0
7822550|NCT01097629|19255820|P2|STARTED|DB RO Phase||0
7822551|NCT01097629|19255821|P1|STARTED|DB RO Phase||0
7822552|NCT01097629|19255814|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
7822553|NCT01097629|19255815|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
7822554|NCT01097629|19255816|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
7822555|NCT01097629|19255817|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
7822556|NCT01097629|19255818|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
7822557|NCT01097629|19255819|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57
7822558|NCT01097629|19255820|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46
7822559|NCT01097629|19255821|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35
7822560|NCT01097629|19255814|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
7822561|NCT01097629|19255815|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
7822562|NCT01097629|19255816|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
7822563|NCT01097629|19255817|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
7822564|NCT01097629|19255818|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
7822565|NCT01097629|19255819|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330
7822566|NCT01097629|19255820|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346
7822567|NCT01097629|19255821|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205
7822568|NCT01097629|19255814|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
7822569|NCT01097629|19255815|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
7822570|NCT01097629|19255816|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
7822571|NCT01097629|19255817|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
7822572|NCT01097629|19255818|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
7822573|NCT01097629|19255819|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
7822574|NCT01097629|19255820|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||387
7822575|NCT01097629|19255821|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||239
7822576|NCT01097629|19255814|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
7822577|NCT01097629|19255815|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
7822578|NCT01097629|19255816|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
7822579|NCT01097629|19255817|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
7822580|NCT01097629|19255818|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
7822581|NCT01097629|19255819|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387
7822582|NCT01097629|19255820|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392
7822583|NCT01097629|19255821|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240
7822584|NCT01097616|19255872|P8|NOT COMPLETED|DB RO Phase||1
7822585|NCT01097616|19255873|P7|NOT COMPLETED|DB RO Phase||1
7822586|NCT01097616|19255874|P6|NOT COMPLETED|DB RO Phase||2
7822587|NCT01097616|19255875|P5|NOT COMPLETED|DB RO Phase||1
7822588|NCT01097616|19255876|P4|NOT COMPLETED|DB RO Phase||1
7822589|NCT01097616|19255877|P3|NOT COMPLETED|DB RO Phase||0
7822590|NCT01097616|19255878|P2|NOT COMPLETED|DB RO Phase||0
7822591|NCT01097616|19255879|P1|NOT COMPLETED|DB RO Phase||0
7822592|NCT01097616|19255872|P8|COMPLETED|DB RO Phase||326
7822593|NCT01097616|19255873|P7|COMPLETED|DB RO Phase||161
7822594|NCT01097616|19255874|P6|COMPLETED|DB RO Phase||159
7822595|NCT01097616|19255875|P5|COMPLETED|DB RO Phase||111
7822596|NCT01097616|19255876|P4|COMPLETED|DB RO Phase||100
7822597|NCT01097616|19255877|P3|COMPLETED|DB RO Phase||0
7822598|NCT01097616|19255878|P2|COMPLETED|DB RO Phase||0
7822599|NCT01097616|19255879|P1|COMPLETED|DB RO Phase||0
7822600|NCT01097616|19255872|P8|STARTED|DB RO Phase||327
7822601|NCT01097616|19255873|P7|STARTED|DB RO Phase||162
7822602|NCT01097616|19255874|P6|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161
7822603|NCT01097616|19255875|P5|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112
7822604|NCT01097616|19255876|P4|STARTED|DB RO Phase||101
7822605|NCT01097616|19255877|P3|STARTED|DB RO Phase||0
7822606|NCT01097616|19255878|P2|STARTED|DB RO Phase||0
7822607|NCT01097616|19255879|P1|STARTED|DB RO Phase||0
7822608|NCT01097616|19255872|P8|NOT COMPLETED|Optional DB EXT Phase||0
7822609|NCT01097616|19255873|P7|NOT COMPLETED|Optional DB EXT Phase||0
7822610|NCT01097616|19255874|P6|NOT COMPLETED|Optional DB EXT Phase||0
7822611|NCT01097616|19255875|P5|NOT COMPLETED|Optional DB EXT Phase||0
7822612|NCT01097616|19255876|P4|NOT COMPLETED|Optional DB EXT Phase||0
7822613|NCT01097616|19255877|P3|NOT COMPLETED|Optional DB EXT Phase||10
7822614|NCT01097616|19255878|P2|NOT COMPLETED|Optional DB EXT Phase||21
7822615|NCT01097616|19255879|P1|NOT COMPLETED|Optional DB EXT Phase||15
7822616|NCT01097616|19255872|P8|COMPLETED|Optional DB EXT Phase||0
7822617|NCT01097616|19255873|P7|COMPLETED|Optional DB EXT Phase||0
7822618|NCT01097616|19255874|P6|COMPLETED|Optional DB EXT Phase||0
7822619|NCT01097616|19255875|P5|COMPLETED|Optional DB EXT Phase||0
7822620|NCT01097616|19255876|P4|COMPLETED|Optional DB EXT Phase||0
7822621|NCT01097616|19255877|P3|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141
7822622|NCT01097616|19255878|P2|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151
7822623|NCT01097616|19255879|P1|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85
7822624|NCT01097616|19255872|P8|STARTED|Optional DB EXT Phase||0
7822625|NCT01097616|19255873|P7|STARTED|Optional DB EXT Phase||0
7822626|NCT01097616|19255874|P6|STARTED|Optional DB EXT Phase||0
7822627|NCT01097616|19255875|P5|STARTED|Optional DB EXT Phase||0
7822628|NCT01097616|19255876|P4|STARTED|Optional DB EXT Phase||0
7822629|NCT01097616|19255877|P3|STARTED|Optional DB EXT Phase||151
7822630|NCT01097616|19255878|P2|STARTED|Optional DB EXT Phase||172
7822631|NCT01097616|19255879|P1|STARTED|Optional DB EXT Phase||100
7822632|NCT01097616|19255872|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
7822633|NCT01097616|19255873|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
7822634|NCT01097616|19255874|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
7822635|NCT01097616|19255875|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
7822636|NCT01097616|19255876|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
7822637|NCT01097616|19255877|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44
7822638|NCT01097616|19255878|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38
7822639|NCT01097616|19255879|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24
7822640|NCT01097616|19255872|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
7822641|NCT01097616|19255873|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
7822642|NCT01097616|19255874|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
7822643|NCT01097616|19255875|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
7822644|NCT01097616|19255876|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
7822645|NCT01097616|19255877|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341
7822646|NCT01097616|19255878|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345
7822647|NCT01097616|19255879|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230
7822648|NCT01097616|19255872|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
7822649|NCT01097616|19255873|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
7822650|NCT01097616|19255874|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
7822651|NCT01097616|19255875|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
7822652|NCT01097616|19255876|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
7822653|NCT01097616|19255877|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||384
7822654|NCT01097616|19255878|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
7822655|NCT01097616|19255879|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||254
7822656|NCT01097616|19255872|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
7822657|NCT01097616|19255873|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
7822658|NCT01097616|19255874|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
7822659|NCT01097616|19255875|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
7822660|NCT01097616|19255876|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
7822661|NCT01097616|19255877|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385
7822662|NCT01097616|19255878|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383
7822663|NCT01097616|19255879|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254
7822664|NCT01097577|19255952|P2|NOT COMPLETED|Overall Study||1
7822665|NCT01097577|19255953|P1|NOT COMPLETED|Overall Study||0
7822666|NCT01097577|19255952|P2|COMPLETED|Overall Study||62
7822667|NCT01097577|19255953|P1|COMPLETED|Overall Study||67
7822668|NCT01097577|19255952|P2|STARTED|Overall Study||63
7822669|NCT01097577|19255953|P1|STARTED|Overall Study||67
7822670|NCT01097460|19255969|P1|NOT COMPLETED|Overall Study||0
7822671|NCT01097460|19255969|P1|COMPLETED|Overall Study||16
7822672|NCT01097460|19255969|P1|STARTED|Overall Study||16
7822673|NCT01097421|19255973|P1|NOT COMPLETED|Overall Study||14
7822674|NCT01097421|19255973|P1|COMPLETED|Overall Study||314
7822675|NCT01097421|19255973|P1|STARTED|Overall Study||328
7822676|NCT01097343|19255983|P2|NOT COMPLETED|Second Intervention- 30 Days||0
7822677|NCT01097343|19255984|P1|NOT COMPLETED|Second Intervention- 30 Days||0
7822678|NCT01097343|19255983|P2|COMPLETED|Second Intervention- 30 Days||25
7822679|NCT01097343|19255984|P1|COMPLETED|Second Intervention- 30 Days||25
7822680|NCT01097343|19255983|P2|STARTED|Second Intervention- 30 Days||25
7822681|NCT01097343|19255984|P1|STARTED|Second Intervention- 30 Days||25
7822682|NCT01097343|19255983|P2|NOT COMPLETED|First Intervention- 30 Days||0
7822683|NCT01097343|19255984|P1|NOT COMPLETED|First Intervention- 30 Days||0
7822684|NCT01097343|19255983|P2|COMPLETED|First Intervention- 30 Days||25
7822685|NCT01097343|19255984|P1|COMPLETED|First Intervention- 30 Days||25
7822686|NCT01097343|19255983|P2|STARTED|First Intervention- 30 Days||25
7822687|NCT01097343|19255984|P1|STARTED|First Intervention- 30 Days||25
7822688|NCT01097330|19255992|P2|NOT COMPLETED|Overall Study||5
7822689|NCT01097330|19255993|P1|NOT COMPLETED|Overall Study||7
7822690|NCT01097330|19255992|P2|COMPLETED|Overall Study||0
7822691|NCT01097330|19255993|P1|COMPLETED|Overall Study||0
7822692|NCT01097330|19255992|P2|STARTED|Overall Study||5
7822693|NCT01097330|19255993|P1|STARTED|Overall Study||7
7822694|NCT01097304|19256003|P1|NOT COMPLETED|Overall Study||7
7822695|NCT01097304|19256003|P1|COMPLETED|Overall Study||29
7822696|NCT01097304|19256003|P1|STARTED|Overall Study||36
7822697|NCT01097057|19256010|P1|NOT COMPLETED|Overall Study||3
7822698|NCT01097057|19256010|P1|COMPLETED|Overall Study||17
7822699|NCT01097057|19256010|P1|STARTED|Overall Study||20
7822700|NCT01097044|19256019|P2|NOT COMPLETED|Overall Study||5
7822701|NCT01097044|19256020|P1|NOT COMPLETED|Overall Study||5
7822702|NCT01097044|19256019|P2|COMPLETED|Overall Study||33
7822703|NCT01097044|19256020|P1|COMPLETED|Overall Study||34
7822704|NCT01097044|19256019|P2|STARTED|Overall Study||38
7822705|NCT01097044|19256020|P1|STARTED|Overall Study||39
7822706|NCT01097005|19256038|P1|NOT COMPLETED|Overall Study||365
7822707|NCT01097005|19256038|P1|COMPLETED|Overall Study||101
7822708|NCT01097005|19256038|P1|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249
7822709|NCT01097005|19256038|P1|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285
7822710|NCT01097005|19256038|P1|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340
7822711|NCT01097005|19256038|P1|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441
7822712|NCT01097005|19256038|P1|STARTED|Overall Study|number of participants who were enrolled for this study.|466
7822713|NCT01096992|19256049|P5|NOT COMPLETED|Overall Study||0
7822714|NCT01096992|19256050|P4|NOT COMPLETED|Overall Study||0
7822715|NCT01096992|19256051|P3|NOT COMPLETED|Overall Study||0
7822716|NCT01096992|19256052|P2|NOT COMPLETED|Overall Study||0
7822717|NCT01096992|19256053|P1|NOT COMPLETED|Overall Study||0
7822718|NCT01096992|19256049|P5|COMPLETED|Overall Study||30
7822719|NCT01096992|19256050|P4|COMPLETED|Overall Study||6
7822720|NCT01096992|19256051|P3|COMPLETED|Overall Study||6
7822721|NCT01096992|19256052|P2|COMPLETED|Overall Study||3
7822722|NCT01096992|19256053|P1|COMPLETED|Overall Study||6
7822723|NCT01096992|19256049|P5|STARTED|Overall Study||30
7822724|NCT01096992|19256050|P4|STARTED|Overall Study||6
7822725|NCT01096992|19256051|P3|STARTED|Overall Study||6
7822726|NCT01096992|19256052|P2|STARTED|Overall Study||3
7822727|NCT01096992|19256053|P1|STARTED|Overall Study||6
7822728|NCT01096875|19256068|P2|NOT COMPLETED|Overall Study||1
7822729|NCT01096875|19256069|P1|NOT COMPLETED|Overall Study||0
7822730|NCT01096875|19256068|P2|COMPLETED|Overall Study||29
7822731|NCT01096875|19256069|P1|COMPLETED|Overall Study||30
7822732|NCT01096875|19256068|P2|STARTED|Overall Study||30
7822733|NCT01096875|19256069|P1|STARTED|Overall Study||30
7822734|NCT01096849|19256084|P3|NOT COMPLETED|Overall Study||6
7822735|NCT01096849|19256085|P2|NOT COMPLETED|Overall Study||12
7822736|NCT01096849|19256086|P1|NOT COMPLETED|Overall Study||2
7822737|NCT01096849|19256084|P3|COMPLETED|Overall Study||41
7822738|NCT01096849|19256085|P2|COMPLETED|Overall Study||64
7822739|NCT01096849|19256086|P1|COMPLETED|Overall Study||20
7822740|NCT01096849|19256084|P3|STARTED|Overall Study||47
7822741|NCT01096849|19256085|P2|STARTED|Overall Study||76
7822742|NCT01096849|19256086|P1|STARTED|Overall Study||22
7822743|NCT01096823|19256141|P2|NOT COMPLETED|Overall Study||1
7822744|NCT01096823|19256142|P1|NOT COMPLETED|Overall Study||3
7822745|NCT01096823|19256141|P2|COMPLETED|Overall Study||15
7822746|NCT01096823|19256142|P1|COMPLETED|Overall Study||11
7822747|NCT01096823|19256141|P2|STARTED|Overall Study||16
7822748|NCT01096823|19256142|P1|STARTED|Overall Study||14
7822749|NCT01096810|19256154|P1|NOT COMPLETED|Overall Study||0
7822750|NCT01096810|19256154|P1|COMPLETED|Overall Study||20
7822751|NCT01096810|19256154|P1|STARTED|Overall Study||20
7822752|NCT01096784|19256162|P2|NOT COMPLETED|Overall Study||14
7822753|NCT01096784|19256163|P1|NOT COMPLETED|Overall Study||15
7822754|NCT01096784|19256162|P2|COMPLETED|Overall Study||46
7822755|NCT01096784|19256163|P1|COMPLETED|Overall Study||46
7822756|NCT01096784|19256162|P2|STARTED|Overall Study||60
7822757|NCT01096784|19256163|P1|STARTED|Overall Study||61
7822758|NCT01096771|19256197|P2|NOT COMPLETED|Overall Study||0
7822759|NCT01096771|19256198|P1|NOT COMPLETED|Overall Study||0
7822760|NCT01096771|19256197|P2|COMPLETED|Overall Study||7
7822761|NCT01096771|19256198|P1|COMPLETED|Overall Study||7
7822762|NCT01096771|19256197|P2|STARTED|Overall Study||7
7822763|NCT01096771|19256198|P1|STARTED|Overall Study||7
7822764|NCT01096680|19256227|P5|NOT COMPLETED|Overall Study||0
7822765|NCT01096680|19256228|P4|NOT COMPLETED|Overall Study||0
7822766|NCT01096680|19256229|P3|NOT COMPLETED|Overall Study||0
7822767|NCT01096680|19256230|P2|NOT COMPLETED|Overall Study||0
7822768|NCT01096680|19256231|P1|NOT COMPLETED|Overall Study||0
7822769|NCT01096680|19256227|P5|COMPLETED|Overall Study||27
7822770|NCT01096680|19256228|P4|COMPLETED|Overall Study||27
7822771|NCT01096680|19256229|P3|COMPLETED|Overall Study||27
7822772|NCT01096680|19256230|P2|COMPLETED|Overall Study||27
7822773|NCT01096680|19256231|P1|COMPLETED|Overall Study||27
7822774|NCT01096680|19256227|P5|STARTED|Overall Study||27
7822775|NCT01096680|19256228|P4|STARTED|Overall Study||27
7822776|NCT01096680|19256229|P3|STARTED|Overall Study||27
7822777|NCT01096680|19256230|P2|STARTED|Overall Study||27
7822778|NCT01096680|19256231|P1|STARTED|Overall Study||27
7822779|NCT01096667|19256268|P5|NOT COMPLETED|Overall Study||0
7822780|NCT01096667|19256269|P4|NOT COMPLETED|Overall Study||3
7822781|NCT01096667|19256270|P3|NOT COMPLETED|Overall Study||2
7822782|NCT01096667|19256271|P2|NOT COMPLETED|Overall Study||2
7822783|NCT01096667|19256272|P1|NOT COMPLETED|Overall Study||3
7822784|NCT01096667|19256268|P5|COMPLETED|Overall Study||39
7822785|NCT01096667|19256269|P4|COMPLETED|Overall Study||36
7822786|NCT01096667|19256270|P3|COMPLETED|Overall Study||36
7822787|NCT01096667|19256271|P2|COMPLETED|Overall Study||37
7822788|NCT01096667|19256272|P1|COMPLETED|Overall Study||36
7822789|NCT01096667|19256268|P5|Treated|Overall Study||39
7822790|NCT01096667|19256269|P4|Treated|Overall Study||39
7822791|NCT01096667|19256270|P3|Treated|Overall Study||38
7822792|NCT01096667|19256271|P2|Treated|Overall Study||39
7822793|NCT01096667|19256272|P1|Treated|Overall Study||38
7822794|NCT01096667|19256268|P5|STARTED|Overall Study||39
7822795|NCT01096667|19256269|P4|STARTED|Overall Study||39
7822796|NCT01096667|19256270|P3|STARTED|Overall Study||38
7822797|NCT01096667|19256271|P2|STARTED|Overall Study||39
7822798|NCT01096667|19256272|P1|STARTED|Overall Study||39
7822799|NCT01096589|19256414|P4|NOT COMPLETED|Overall Study||3
7822800|NCT01096589|19256415|P3|NOT COMPLETED|Overall Study||4
7822801|NCT01096589|19256416|P2|NOT COMPLETED|Overall Study||2
7822802|NCT01096589|19256417|P1|NOT COMPLETED|Overall Study||4
7822803|NCT01096589|19256414|P4|COMPLETED|Overall Study||15
7822804|NCT01096589|19256415|P3|COMPLETED|Overall Study||18
7822805|NCT01096589|19256416|P2|COMPLETED|Overall Study||18
7822806|NCT01096589|19256417|P1|COMPLETED|Overall Study||18
7822807|NCT01096589|19256414|P4|STARTED|Overall Study||18
7822808|NCT01096589|19256415|P3|STARTED|Overall Study||22
7822809|NCT01096589|19256416|P2|STARTED|Overall Study||20
7822810|NCT01096589|19256417|P1|STARTED|Overall Study||22
7822811|NCT01096550|19256433|P2|NOT COMPLETED|Overall Study||29
7822812|NCT01096550|19256434|P1|NOT COMPLETED|Overall Study||37
7822813|NCT01096550|19256433|P2|COMPLETED|Overall Study||146
7822814|NCT01096550|19256434|P1|COMPLETED|Overall Study||133
7822815|NCT01096550|19256433|P2|STARTED|Overall Study||175
7822816|NCT01096550|19256434|P1|STARTED|Overall Study||170
7822817|NCT01096446|19256442|P2|NOT COMPLETED|Overall Study||0
7822818|NCT01096446|19256443|P1|NOT COMPLETED|Overall Study||3
7822819|NCT01096446|19256442|P2|COMPLETED|Overall Study||10
7822820|NCT01096446|19256443|P1|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9
7822821|NCT01096446|19256442|P2|STARTED|Overall Study||10
7822822|NCT01096446|19256443|P1|STARTED|Overall Study||12
7822823|NCT01096342|19256448|P1|NOT COMPLETED|Overall Study||1
7822824|NCT01096342|19256448|P1|COMPLETED|Overall Study||15
7822825|NCT01096342|19256448|P1|STARTED|Overall Study||16
7822826|NCT01096316|19256456|P2|NOT COMPLETED|Overall Study||9
7822827|NCT01096316|19256457|P1|NOT COMPLETED|Overall Study||15
7822828|NCT01096316|19256456|P2|COMPLETED|Overall Study||94
7822829|NCT01096316|19256457|P1|COMPLETED|Overall Study||87
7822830|NCT01096316|19256456|P2|STARTED|Overall Study||103
7822831|NCT01096316|19256457|P1|STARTED|Overall Study||102
7822832|NCT01096290|19256469|P2|NOT COMPLETED|Overall Study||0
7822833|NCT01096290|19256470|P1|NOT COMPLETED|Overall Study||0
7822834|NCT01096290|19256469|P2|COMPLETED|Overall Study||14
7822835|NCT01096290|19256470|P1|COMPLETED|Overall Study||9
7822836|NCT01096290|19256469|P2|STARTED|Overall Study||14
7822837|NCT01096290|19256470|P1|STARTED|Overall Study||9
7822838|NCT01096186|19256478|P1|NOT COMPLETED|Overall Study||50
7822839|NCT01096186|19256478|P1|COMPLETED|Overall Study||567
7822840|NCT01096186|19256478|P1|STARTED|Overall Study||617
7822841|NCT01096160|19256494|P10|NOT COMPLETED|Overall Study||1
7822842|NCT01096160|19256495|P9|NOT COMPLETED|Overall Study||2
7822843|NCT01096160|19256496|P8|NOT COMPLETED|Overall Study||0
7822844|NCT01096160|19256497|P7|NOT COMPLETED|Overall Study||2
7822845|NCT01096160|19256498|P6|NOT COMPLETED|Overall Study||0
7822846|NCT01096160|19256499|P5|NOT COMPLETED|Overall Study||1
7822847|NCT01096160|19256500|P4|NOT COMPLETED|Overall Study||0
7822848|NCT01096160|19256501|P3|NOT COMPLETED|Overall Study||1
7822849|NCT01096160|19256502|P2|NOT COMPLETED|Overall Study||0
7822850|NCT01096160|19256503|P1|NOT COMPLETED|Overall Study||0
7822851|NCT01096160|19256494|P10|COMPLETED|Overall Study||1
7822852|NCT01096160|19256495|P9|COMPLETED|Overall Study||4
7822853|NCT01096160|19256496|P8|COMPLETED|Overall Study||2
7822854|NCT01096160|19256497|P7|COMPLETED|Overall Study||4
7822855|NCT01096160|19256498|P6|COMPLETED|Overall Study||2
7822856|NCT01096160|19256499|P5|COMPLETED|Overall Study||5
7822857|NCT01096160|19256500|P4|COMPLETED|Overall Study||2
7822858|NCT01096160|19256501|P3|COMPLETED|Overall Study||5
7822859|NCT01096160|19256502|P2|COMPLETED|Overall Study||2
7822860|NCT01096160|19256503|P1|COMPLETED|Overall Study||6
7822861|NCT01096160|19256494|P10|STARTED|Overall Study||2
7822862|NCT01096160|19256495|P9|STARTED|Overall Study||6
7822863|NCT01096160|19256496|P8|STARTED|Overall Study||2
7822864|NCT01096160|19256497|P7|STARTED|Overall Study||6
7822865|NCT01096160|19256498|P6|STARTED|Overall Study||2
7822866|NCT01096160|19256499|P5|STARTED|Overall Study||6
7822867|NCT01096160|19256500|P4|STARTED|Overall Study||2
7822868|NCT01096160|19256501|P3|STARTED|Overall Study||6
7822869|NCT01096160|19256502|P2|STARTED|Overall Study||2
7822870|NCT01096160|19256503|P1|STARTED|Overall Study||6
7822871|NCT01096056|19256561|P2|NOT COMPLETED|Overall Study||1
7822872|NCT01096056|19256562|P1|NOT COMPLETED|Overall Study||0
7822873|NCT01096056|19256561|P2|COMPLETED|Overall Study||19
7822874|NCT01096056|19256562|P1|COMPLETED|Overall Study||20
7822875|NCT01096056|19256561|P2|Completed at Day 42|Overall Study||20
7822876|NCT01096056|19256562|P1|Completed at Day 42|Overall Study||20
7822877|NCT01096056|19256561|P2|STARTED|Overall Study||20
7822878|NCT01096056|19256562|P1|STARTED|Overall Study||20
7822879|NCT01096017|19256594|P2|NOT COMPLETED|Treatment Period 2||1
7822880|NCT01096017|19256595|P1|NOT COMPLETED|Treatment Period 2||1
7822881|NCT01096017|19256594|P2|COMPLETED|Treatment Period 2||11
7822882|NCT01096017|19256595|P1|COMPLETED|Treatment Period 2||11
7822883|NCT01096017|19256594|P2|STARTED|Treatment Period 2||12
7822884|NCT01096017|19256595|P1|STARTED|Treatment Period 2||12
7822885|NCT01096017|19256594|P2|NOT COMPLETED|Washout 1 - 14 Days||0
7822886|NCT01096017|19256595|P1|NOT COMPLETED|Washout 1 - 14 Days||0
7822887|NCT01096017|19256594|P2|COMPLETED|Washout 1 - 14 Days||12
7822888|NCT01096017|19256595|P1|COMPLETED|Washout 1 - 14 Days||12
7822889|NCT01096017|19256594|P2|STARTED|Washout 1 - 14 Days||12
7822890|NCT01096017|19256595|P1|STARTED|Washout 1 - 14 Days||12
7822891|NCT01096017|19256594|P2|NOT COMPLETED|Treatment Period 1||0
7822892|NCT01096017|19256595|P1|NOT COMPLETED|Treatment Period 1||0
7822893|NCT01096017|19256594|P2|COMPLETED|Treatment Period 1||12
7822894|NCT01096017|19256595|P1|COMPLETED|Treatment Period 1||12
7822895|NCT01096017|19256594|P2|STARTED|Treatment Period 1||12
7822896|NCT01096017|19256595|P1|STARTED|Treatment Period 1||12
7822897|NCT01095978|19256623|P1|NOT COMPLETED|Overall Study||3
7822898|NCT01095978|19256623|P1|COMPLETED|Overall Study||2819
7822899|NCT01095978|19256623|P1|STARTED|Overall Study||2822
7822900|NCT01095887|19256650|P1|NOT COMPLETED|Overall Study||0
7822901|NCT01095887|19256650|P1|COMPLETED|Overall Study||6
7822902|NCT01095887|19256650|P1|STARTED|Overall Study||6
7822903|NCT01095835|19256657|P3|NOT COMPLETED|Overall Study||8
7822904|NCT01095835|19256658|P2|NOT COMPLETED|Overall Study||12
7822905|NCT01095835|19256659|P1|NOT COMPLETED|Overall Study||10
7822906|NCT01095835|19256657|P3|COMPLETED|Overall Study||17
7822907|NCT01095835|19256658|P2|COMPLETED|Overall Study||40
7822908|NCT01095835|19256659|P1|COMPLETED|Overall Study||41
7822909|NCT01095835|19256657|P3|STARTED|Overall Study||25
7822910|NCT01095835|19256658|P2|STARTED|Overall Study||52
7822911|NCT01095835|19256659|P1|STARTED|Overall Study||51
7822912|NCT01095796|19256697|P2|NOT COMPLETED|Overall Study||289
7822913|NCT01095796|19256698|P1|NOT COMPLETED|Overall Study||295
7822914|NCT01095796|19256697|P2|COMPLETED|Overall Study||65
7822915|NCT01095796|19256698|P1|COMPLETED|Overall Study||58
7822916|NCT01095796|19256697|P2|STARTED|Overall Study||354
7822917|NCT01095796|19256698|P1|STARTED|Overall Study||353
7822918|NCT01095757|19256716|P1|NOT COMPLETED|Overall Study||0
7822919|NCT01095757|19256716|P1|COMPLETED|Overall Study||45
7822920|NCT01095757|19256716|P1|STARTED|Overall Study||45
7822921|NCT01095666|19256728|P3|NOT COMPLETED|Overall Study||7
7822922|NCT01095666|19256729|P2|NOT COMPLETED|Overall Study||11
7822923|NCT01095666|19256730|P1|NOT COMPLETED|Overall Study||17
7822924|NCT01095666|19256728|P3|COMPLETED|Overall Study||145
7822925|NCT01095666|19256729|P2|COMPLETED|Overall Study||136
7822926|NCT01095666|19256730|P1|COMPLETED|Overall Study||128
7822927|NCT01095666|19256728|P3|STARTED|Overall Study||152
7822928|NCT01095666|19256729|P2|STARTED|Overall Study||147
7822929|NCT01095666|19256730|P1|STARTED|Overall Study||145
7822930|NCT01095653|19256753|P3|NOT COMPLETED|Overall Study||16
7822931|NCT01095653|19256754|P2|NOT COMPLETED|Overall Study||15
7822932|NCT01095653|19256755|P1|NOT COMPLETED|Overall Study||19
7822933|NCT01095653|19256753|P3|COMPLETED|Overall Study||117
7822934|NCT01095653|19256754|P2|COMPLETED|Overall Study||113
7822935|NCT01095653|19256755|P1|COMPLETED|Overall Study||113
7822936|NCT01095653|19256753|P3|STARTED|Overall Study||133
7822937|NCT01095653|19256754|P2|STARTED|Overall Study||128
7822938|NCT01095653|19256755|P1|STARTED|Overall Study||132
7822939|NCT01095510|19256778|P4|NOT COMPLETED|Overall Study||0
7822940|NCT01095510|19256779|P3|NOT COMPLETED|Overall Study||0
7822941|NCT01095510|19256780|P2|NOT COMPLETED|Overall Study||0
7822942|NCT01095510|19256781|P1|NOT COMPLETED|Overall Study||0
7822943|NCT01095510|19256778|P4|COMPLETED|Overall Study||3
7822944|NCT01095510|19256779|P3|COMPLETED|Overall Study||3
7822945|NCT01095510|19256780|P2|COMPLETED|Overall Study||0
7822946|NCT01095510|19256781|P1|COMPLETED|Overall Study||3
7822947|NCT01095510|19256778|P4|STARTED|Overall Study||3
7822948|NCT01095510|19256779|P3|STARTED|Overall Study||3
7822949|NCT01095510|19256780|P2|STARTED|Overall Study||0
7822950|NCT01095510|19256781|P1|STARTED|Overall Study||3
7822951|NCT01095497|19256800|P2|NOT COMPLETED|Subcutaneous CINRYZE||0
7822952|NCT01095497|19256801|P1|NOT COMPLETED|Subcutaneous CINRYZE||1
7822953|NCT01095497|19256800|P2|COMPLETED|Subcutaneous CINRYZE||12
7822954|NCT01095497|19256801|P1|COMPLETED|Subcutaneous CINRYZE||12
7822955|NCT01095497|19256800|P2|STARTED|Subcutaneous CINRYZE||12
7822956|NCT01095497|19256801|P1|STARTED|Subcutaneous CINRYZE||13
7822957|NCT01095497|19256800|P2|NOT COMPLETED|Intravenous CINRYZE||0
7822958|NCT01095497|19256801|P1|NOT COMPLETED|Intravenous CINRYZE||1
7822959|NCT01095497|19256800|P2|COMPLETED|Intravenous CINRYZE||12
7822960|NCT01095497|19256801|P1|COMPLETED|Intravenous CINRYZE||13
7822961|NCT01095497|19256800|P2|STARTED|Intravenous CINRYZE||12
7822962|NCT01095497|19256801|P1|STARTED|Intravenous CINRYZE||14
7822963|NCT01095250|19256813|P4|NOT COMPLETED|Overall Study||5
7822964|NCT01095250|19256814|P3|NOT COMPLETED|Overall Study||8
7822965|NCT01095250|19256815|P2|NOT COMPLETED|Overall Study||10
7822966|NCT01095250|19256816|P1|NOT COMPLETED|Overall Study||8
7822967|NCT01095250|19256813|P4|COMPLETED|Overall Study||0
7822968|NCT01095250|19256814|P3|COMPLETED|Overall Study||0
7822969|NCT01095250|19256815|P2|COMPLETED|Overall Study||0
7822970|NCT01095250|19256816|P1|COMPLETED|Overall Study||0
7822971|NCT01095250|19256813|P4|STARTED|Overall Study||5
7822972|NCT01095250|19256814|P3|STARTED|Overall Study||8
7822973|NCT01095250|19256815|P2|STARTED|Overall Study||10
7822974|NCT01095250|19256816|P1|STARTED|Overall Study||8
7822975|NCT01095094|19256846|P1|NOT COMPLETED|Overall Study||3
7822976|NCT01095094|19256846|P1|COMPLETED|Overall Study||16
7822977|NCT01095094|19256846|P1|STARTED|Overall Study||19
7822978|NCT01095003|19256853|P2|NOT COMPLETED|Overall Study||386
7822979|NCT01095003|19256854|P1|NOT COMPLETED|Overall Study||384
7822980|NCT01095003|19256853|P2|COMPLETED|Overall Study||0
7822981|NCT01095003|19256854|P1|COMPLETED|Overall Study||0
7822982|NCT01095003|19256853|P2|STARTED|Overall Study||386
7822983|NCT01095003|19256854|P1|STARTED|Overall Study||384
7822984|NCT01094886|19256868|P1|NOT COMPLETED|Overall Study||7
7822985|NCT01094886|19256868|P1|COMPLETED|Overall Study||46
7822986|NCT01094886|19256868|P1|STARTED|Overall Study||53
7822987|NCT01094808|19256878|P3|NOT COMPLETED|Overall Study||0
7822988|NCT01094808|19256879|P2|NOT COMPLETED|Overall Study||1
7822989|NCT01094808|19256880|P1|NOT COMPLETED|Overall Study||1
7822990|NCT01094808|19256878|P3|COMPLETED|Overall Study||21
7822991|NCT01094808|19256879|P2|COMPLETED|Overall Study||19
7822992|NCT01094808|19256880|P1|COMPLETED|Overall Study||20
7822993|NCT01094808|19256878|P3|STARTED|Overall Study||21
7822994|NCT01094808|19256879|P2|STARTED|Overall Study||20
7822995|NCT01094808|19256880|P1|STARTED|Overall Study||21
7822996|NCT01094782|19256921|P6|NOT COMPLETED|Overall Study||8
7822997|NCT01094782|19256922|P5|NOT COMPLETED|Overall Study||11
7822998|NCT01094782|19256923|P4|NOT COMPLETED|Overall Study||11
7822999|NCT01094782|19256924|P3|NOT COMPLETED|Overall Study||3
7823000|NCT01094782|19256925|P2|NOT COMPLETED|Overall Study||10
7823001|NCT01094782|19256926|P1|NOT COMPLETED|Overall Study||8
7823002|NCT01094782|19256921|P6|COMPLETED|Overall Study||30
7823003|NCT01094782|19256922|P5|COMPLETED|Overall Study||31
7823004|NCT01094782|19256923|P4|COMPLETED|Overall Study||45
7823005|NCT01094782|19256924|P3|COMPLETED|Overall Study||31
7823006|NCT01094782|19256925|P2|COMPLETED|Overall Study||29
7823007|NCT01094782|19256926|P1|COMPLETED|Overall Study||31
7823008|NCT01094782|19256921|P6|STARTED|Overall Study||38
7823009|NCT01094782|19256922|P5|STARTED|Overall Study||42
7823010|NCT01094782|19256923|P4|STARTED|Overall Study||56
7823011|NCT01094782|19256924|P3|STARTED|Overall Study||34
7823012|NCT01094782|19256925|P2|STARTED|Overall Study||39
7823013|NCT01094782|19256926|P1|STARTED|Overall Study||39
7823014|NCT01094743|19256970|P1|NOT COMPLETED|Period 2||0
7823015|NCT01094743|19256970|P1|COMPLETED|Period 2||50
7823016|NCT01094743|19256970|P1|STARTED|Period 2||50
7823017|NCT01094743|19256970|P1|NOT COMPLETED|Period 1||2
7823018|NCT01094743|19256970|P1|COMPLETED|Period 1||50
7823019|NCT01094743|19256970|P1|STARTED|Period 1||52
7823020|NCT01094730|19256987|P2|NOT COMPLETED|Period 2 (14 Days)||2
7823021|NCT01094730|19256988|P1|NOT COMPLETED|Period 2 (14 Days)||3
7823022|NCT01094730|19256987|P2|COMPLETED|Period 2 (14 Days)||84
7823023|NCT01094730|19256988|P1|COMPLETED|Period 2 (14 Days)||87
7823024|NCT01094730|19256987|P2|STARTED|Period 2 (14 Days)||86
7823025|NCT01094730|19256988|P1|STARTED|Period 2 (14 Days)||90
7823026|NCT01094730|19256987|P2|NOT COMPLETED|Period 1 (14 Days)||2
7823027|NCT01094730|19256988|P1|NOT COMPLETED|Period 1 (14 Days)||2
7823028|NCT01094730|19256987|P2|COMPLETED|Period 1 (14 Days)||86
7823029|NCT01094730|19256988|P1|COMPLETED|Period 1 (14 Days)||90
7823030|NCT01094730|19256987|P2|STARTED|Period 1 (14 Days)||88
7823031|NCT01094730|19256988|P1|STARTED|Period 1 (14 Days)||92
7823032|NCT01094717|19257001|P2|NOT COMPLETED|Overall Study||0
7823033|NCT01094717|19257002|P1|NOT COMPLETED|Overall Study||0
7823034|NCT01094717|19257001|P2|COMPLETED|Overall Study||10
7823035|NCT01094717|19257002|P1|COMPLETED|Overall Study||3
7823036|NCT01094717|19257001|P2|STARTED|Overall Study||10
7823037|NCT01094717|19257002|P1|STARTED|Overall Study||3
7823038|NCT01094704|19257020|P2|NOT COMPLETED|Overall Study||0
7823039|NCT01094704|19257021|P1|NOT COMPLETED|Overall Study||0
7823040|NCT01094704|19257020|P2|COMPLETED|Overall Study||8
7823041|NCT01094704|19257021|P1|COMPLETED|Overall Study||8
7823042|NCT01094704|19257020|P2|STARTED|Overall Study||8
7823043|NCT01094704|19257021|P1|STARTED|Overall Study||8
7823044|NCT01094574|19257033|P6|NOT COMPLETED|Overall Study||0
7823045|NCT01094574|19257034|P5|NOT COMPLETED|Overall Study||0
7823046|NCT01094574|19257035|P4|NOT COMPLETED|Overall Study||0
7823047|NCT01094574|19257036|P3|NOT COMPLETED|Overall Study||0
7823048|NCT01094574|19257037|P2|NOT COMPLETED|Overall Study||0
7823049|NCT01094574|19257038|P1|NOT COMPLETED|Overall Study||0
7823050|NCT01094574|19257033|P6|COMPLETED|Overall Study||2
7823051|NCT01094574|19257034|P5|COMPLETED|Overall Study||2
7823052|NCT01094574|19257035|P4|COMPLETED|Overall Study||2
7823053|NCT01094574|19257036|P3|COMPLETED|Overall Study||2
7823054|NCT01094574|19257037|P2|COMPLETED|Overall Study||1
7823055|NCT01094574|19257038|P1|COMPLETED|Overall Study||1
7823056|NCT01094574|19257033|P6|STARTED|Overall Study||2
7823057|NCT01094574|19257034|P5|STARTED|Overall Study||2
7823058|NCT01094574|19257035|P4|STARTED|Overall Study||2
7823059|NCT01094574|19257036|P3|STARTED|Overall Study||2
7823060|NCT01094574|19257037|P2|STARTED|Overall Study||1
7823061|NCT01094574|19257038|P1|STARTED|Overall Study||1
7823062|NCT01094561|19257085|P1|NOT COMPLETED|Overall Study||6
7823063|NCT01094561|19257085|P1|COMPLETED|Overall Study||17
7823064|NCT01094561|19257085|P1|STARTED|Overall Study||23
7823065|NCT01094548|19257092|P2|NOT COMPLETED|Overall Study||0
7823066|NCT01094548|19257093|P1|NOT COMPLETED|Overall Study||0
7823067|NCT01094548|19257092|P2|COMPLETED|Overall Study||17
7823068|NCT01094548|19257093|P1|COMPLETED|Overall Study||17
7823069|NCT01094548|19257092|P2|STARTED|Overall Study||17
7823070|NCT01094548|19257093|P1|STARTED|Overall Study||17
7823071|NCT01094522|19257113|P2|NOT COMPLETED|Overall Study||0
7823072|NCT01094522|19257114|P1|NOT COMPLETED|Overall Study||0
7823073|NCT01094522|19257113|P2|COMPLETED|Overall Study||20
7823074|NCT01094522|19257114|P1|COMPLETED|Overall Study||20
7823075|NCT01094522|19257113|P2|STARTED|Overall Study||20
7823076|NCT01094522|19257114|P1|STARTED|Overall Study||20
7823077|NCT01094301|19257124|P1|NOT COMPLETED|Implant Stage||8
7823078|NCT01094301|19257124|P1|COMPLETED|Implant Stage||5
7823079|NCT01094301|19257124|P1|Subjects Who Received SPR IPG|Implant Stage||5
7823080|NCT01094301|19257124|P1|Met Criteria for Implant Stage|Implant Stage||7
7823081|NCT01094301|19257124|P1|STARTED|Implant Stage||13
7823082|NCT01094301|19257124|P1|NOT COMPLETED|Trial Stage||1
7823083|NCT01094301|19257124|P1|COMPLETED|Trial Stage||27
7823084|NCT01094301|19257124|P1|Subjects Who Received Smartpatch Lead|Trial Stage||28
7823085|NCT01094301|19257124|P1|STARTED|Trial Stage||28
7823086|NCT01094288|19257154|P8|NOT COMPLETED|Overall Study||2
7823087|NCT01094288|19257155|P7|NOT COMPLETED|Overall Study||0
7823088|NCT01094288|19257156|P6|NOT COMPLETED|Overall Study||0
7823089|NCT01094288|19257157|P5|NOT COMPLETED|Overall Study||0
7823090|NCT01094288|19257158|P4|NOT COMPLETED|Overall Study||2
7823091|NCT01094288|19257159|P3|NOT COMPLETED|Overall Study||4
7823092|NCT01094288|19257160|P2|NOT COMPLETED|Overall Study||10
7823093|NCT01094288|19257161|P1|NOT COMPLETED|Overall Study||2
7823094|NCT01094288|19257154|P8|COMPLETED|Overall Study||2
7823095|NCT01094288|19257155|P7|COMPLETED|Overall Study||2
7823096|NCT01094288|19257156|P6|COMPLETED|Overall Study||4
7823097|NCT01094288|19257157|P5|COMPLETED|Overall Study||2
7823098|NCT01094288|19257158|P4|COMPLETED|Overall Study||1
7823099|NCT01094288|19257159|P3|COMPLETED|Overall Study||1
7823100|NCT01094288|19257160|P2|COMPLETED|Overall Study||5
7823101|NCT01094288|19257161|P1|COMPLETED|Overall Study|Completed=Completed Treatment|4
7823102|NCT01094288|19257154|P8|STARTED|Overall Study||4
7823103|NCT01094288|19257155|P7|STARTED|Overall Study||2
7823104|NCT01094288|19257156|P6|STARTED|Overall Study||4
7823105|NCT01094288|19257157|P5|STARTED|Overall Study||2
7823106|NCT01094288|19257158|P4|STARTED|Overall Study||3
7823107|NCT01094288|19257159|P3|STARTED|Overall Study||5
7823108|NCT01094288|19257160|P2|STARTED|Overall Study||15
7823109|NCT01094288|19257161|P1|STARTED|Overall Study||6
7823110|NCT01094184|19257273|P2|NOT COMPLETED|Overall Study||11
7823111|NCT01094184|19257274|P1|NOT COMPLETED|Overall Study||35
7823112|NCT01094184|19257273|P2|COMPLETED|Overall Study||2
7823113|NCT01094184|19257274|P1|COMPLETED|Overall Study||1
7823114|NCT01094184|19257273|P2|STARTED|Overall Study||13
7823115|NCT01094184|19257274|P1|STARTED|Overall Study||36
7823116|NCT01094171|19257508|P1|NOT COMPLETED|Overall Study||10
7823117|NCT01094171|19257508|P1|COMPLETED|Overall Study||390
7823118|NCT01094171|19257508|P1|STARTED|Overall Study||400
7823119|NCT01094119|19257517|P2|NOT COMPLETED|Overall Study||4
7823120|NCT01094119|19257518|P1|NOT COMPLETED|Overall Study||2
7823121|NCT01094119|19257517|P2|COMPLETED|Overall Study||32
7823122|NCT01094119|19257518|P1|COMPLETED|Overall Study||32
7823123|NCT01094119|19257517|P2|STARTED|Overall Study||36
7823124|NCT01094119|19257518|P1|STARTED|Overall Study||34
7823125|NCT01094106|19257528|P2|NOT COMPLETED|Overall Study||0
7823126|NCT01094106|19257529|P1|NOT COMPLETED|Overall Study||0
7823127|NCT01094106|19257528|P2|COMPLETED|Overall Study||34
7823128|NCT01094106|19257529|P1|COMPLETED|Overall Study||33
7823129|NCT01094106|19257528|P2|STARTED|Overall Study||34
7823130|NCT01094106|19257529|P1|STARTED|Overall Study||33
7823131|NCT01093976|19257539|P1|NOT COMPLETED|Overall Study||0
7823132|NCT01093976|19257539|P1|COMPLETED|Overall Study||14
7823133|NCT01093976|19257539|P1|STARTED|Overall Study||14
7823134|NCT01093885|19257543|P1|NOT COMPLETED|Overall Study||5
7823135|NCT01093885|19257543|P1|COMPLETED|Overall Study||10
7823136|NCT01093885|19257543|P1|STARTED|Overall Study||15
7823137|NCT01093846|19257551|P3|NOT COMPLETED|Overall Study||21
7823138|NCT01093846|19257552|P2|NOT COMPLETED|Overall Study||18
7823139|NCT01093846|19257553|P1|NOT COMPLETED|Overall Study||19
7823140|NCT01093846|19257551|P3|COMPLETED|Overall Study||1
7823141|NCT01093846|19257552|P2|COMPLETED|Overall Study||0
7823142|NCT01093846|19257553|P1|COMPLETED|Overall Study||0
7823143|NCT01093846|19257551|P3|STARTED|Overall Study||22
7823144|NCT01093846|19257552|P2|STARTED|Overall Study||18
7823145|NCT01093846|19257553|P1|STARTED|Overall Study||19
7823146|NCT01093794|19257559|P4|NOT COMPLETED|Treatment Period 4||0
7823147|NCT01093794|19257560|P3|NOT COMPLETED|Treatment Period 4||0
7823148|NCT01093794|19257561|P2|NOT COMPLETED|Treatment Period 4||0
7823149|NCT01093794|19257562|P1|NOT COMPLETED|Treatment Period 4||0
7823150|NCT01093794|19257559|P4|COMPLETED|Treatment Period 4||7
7823151|NCT01093794|19257560|P3|COMPLETED|Treatment Period 4||6
7823152|NCT01093794|19257561|P2|COMPLETED|Treatment Period 4||7
7823153|NCT01093794|19257562|P1|COMPLETED|Treatment Period 4||7
7823154|NCT01093794|19257559|P4|STARTED|Treatment Period 4||7
7823155|NCT01093794|19257560|P3|STARTED|Treatment Period 4||6
7823156|NCT01093794|19257561|P2|STARTED|Treatment Period 4||7
7823157|NCT01093794|19257562|P1|STARTED|Treatment Period 4||7
7823158|NCT01093794|19257559|P4|NOT COMPLETED|Treatment Period 3||0
7823159|NCT01093794|19257560|P3|NOT COMPLETED|Treatment Period 3||0
7823160|NCT01093794|19257561|P2|NOT COMPLETED|Treatment Period 3||0
7823161|NCT01093794|19257562|P1|NOT COMPLETED|Treatment Period 3||0
7823162|NCT01093794|19257559|P4|COMPLETED|Treatment Period 3||7
7823163|NCT01093794|19257560|P3|COMPLETED|Treatment Period 3||6
7823164|NCT01093794|19257561|P2|COMPLETED|Treatment Period 3||7
7823165|NCT01093794|19257562|P1|COMPLETED|Treatment Period 3||7
7823166|NCT01093794|19257559|P4|STARTED|Treatment Period 3||7
7823167|NCT01093794|19257560|P3|STARTED|Treatment Period 3||6
7823168|NCT01093794|19257561|P2|STARTED|Treatment Period 3||7
7823169|NCT01093794|19257562|P1|STARTED|Treatment Period 3||7
7823170|NCT01093794|19257559|P4|NOT COMPLETED|Treatment Period 2||0
7823171|NCT01093794|19257560|P3|NOT COMPLETED|Treatment Period 2||0
7823172|NCT01093794|19257561|P2|NOT COMPLETED|Treatment Period 2||0
7823173|NCT01093794|19257562|P1|NOT COMPLETED|Treatment Period 2||0
7823174|NCT01093794|19257559|P4|COMPLETED|Treatment Period 2||7
7823175|NCT01093794|19257560|P3|COMPLETED|Treatment Period 2||6
7823176|NCT01093794|19257561|P2|COMPLETED|Treatment Period 2||7
7823177|NCT01093794|19257562|P1|COMPLETED|Treatment Period 2||7
7823178|NCT01093794|19257559|P4|STARTED|Treatment Period 2||7
7823179|NCT01093794|19257560|P3|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6
7823180|NCT01093794|19257561|P2|STARTED|Treatment Period 2||7
7823181|NCT01093794|19257562|P1|STARTED|Treatment Period 2||7
7823182|NCT01093794|19257559|P4|NOT COMPLETED|Treatment Period 1||0
7823183|NCT01093794|19257560|P3|NOT COMPLETED|Treatment Period 1||0
7823184|NCT01093794|19257561|P2|NOT COMPLETED|Treatment Period 1||0
7823185|NCT01093794|19257562|P1|NOT COMPLETED|Treatment Period 1||0
7823186|NCT01093794|19257559|P4|COMPLETED|Treatment Period 1||7
7823187|NCT01093794|19257560|P3|COMPLETED|Treatment Period 1||7
7823188|NCT01093794|19257561|P2|COMPLETED|Treatment Period 1||7
7823189|NCT01093794|19257562|P1|COMPLETED|Treatment Period 1||7
7823190|NCT01093794|19257559|P4|STARTED|Treatment Period 1||7
7823191|NCT01093794|19257560|P3|STARTED|Treatment Period 1||7
7823192|NCT01093794|19257561|P2|STARTED|Treatment Period 1||7
7823193|NCT01093794|19257562|P1|STARTED|Treatment Period 1||7
7823194|NCT01093755|19257578|P2|NOT COMPLETED|Overall Study||4
7823195|NCT01093755|19257579|P1|NOT COMPLETED|Overall Study||3
7823196|NCT01093755|19257578|P2|COMPLETED|Overall Study||10
7823197|NCT01093755|19257579|P1|COMPLETED|Overall Study||13
7823198|NCT01093755|19257578|P2|STARTED|Overall Study||14
7823199|NCT01093755|19257579|P1|STARTED|Overall Study||16
7823200|NCT01093690|19257589|P2|NOT COMPLETED|Overall Study||0
7823201|NCT01093690|19257590|P1|NOT COMPLETED|Overall Study||0
7823202|NCT01093690|19257589|P2|COMPLETED|Overall Study||79
7823203|NCT01093690|19257590|P1|COMPLETED|Overall Study||83
7823204|NCT01093690|19257589|P2|STARTED|Overall Study||79
7823205|NCT01093690|19257590|P1|STARTED|Overall Study||83
7823206|NCT01093651|19257598|P2|NOT COMPLETED|Overall Study||0
7823207|NCT01093651|19257599|P1|NOT COMPLETED|Overall Study||0
7823208|NCT01093651|19257598|P2|COMPLETED|Overall Study||10
7823209|NCT01093651|19257599|P1|COMPLETED|Overall Study||10
7823210|NCT01093651|19257598|P2|STARTED|Overall Study||10
7823211|NCT01093651|19257599|P1|STARTED|Overall Study||10
7823212|NCT01093625|19257619|P2|NOT COMPLETED|1-Year Visit||3
7823213|NCT01093625|19257620|P1|NOT COMPLETED|1-Year Visit||5
7823214|NCT01093625|19257619|P2|COMPLETED|1-Year Visit||37
7823215|NCT01093625|19257620|P1|COMPLETED|1-Year Visit||29
7823216|NCT01093625|19257619|P2|STARTED|1-Year Visit||40
7823217|NCT01093625|19257620|P1|STARTED|1-Year Visit||34
7823218|NCT01093625|19257619|P2|NOT COMPLETED|6-Month Visit||9
7823219|NCT01093625|19257620|P1|NOT COMPLETED|6-Month Visit||8
7823220|NCT01093625|19257619|P2|COMPLETED|6-Month Visit||40
7823221|NCT01093625|19257620|P1|COMPLETED|6-Month Visit||34
7823222|NCT01093625|19257619|P2|STARTED|6-Month Visit||49
7823223|NCT01093625|19257620|P1|STARTED|6-Month Visit||42
7823224|NCT01093625|19257619|P2|NOT COMPLETED|3-Month Visit||0
7823225|NCT01093625|19257620|P1|NOT COMPLETED|3-Month Visit||2
7823226|NCT01093625|19257619|P2|COMPLETED|3-Month Visit||49
7823227|NCT01093625|19257620|P1|COMPLETED|3-Month Visit||42
7823228|NCT01093625|19257619|P2|STARTED|3-Month Visit||49
7823229|NCT01093625|19257620|P1|STARTED|3-Month Visit||44
7823230|NCT01093625|19257619|P2|NOT COMPLETED|1-Month Visit||0
7823231|NCT01093625|19257620|P1|NOT COMPLETED|1-Month Visit||2
7823232|NCT01093625|19257619|P2|COMPLETED|1-Month Visit||49
7823233|NCT01093625|19257620|P1|COMPLETED|1-Month Visit||44
7823234|NCT01093625|19257619|P2|STARTED|1-Month Visit||49
7823235|NCT01093625|19257620|P1|STARTED|1-Month Visit||46
7823236|NCT01093625|19257619|P2|NOT COMPLETED|2-Week Visit||0
7823237|NCT01093625|19257620|P1|NOT COMPLETED|2-Week Visit||1
7823238|NCT01093625|19257619|P2|COMPLETED|2-Week Visit||49
7823239|NCT01093625|19257620|P1|COMPLETED|2-Week Visit||46
7823240|NCT01093625|19257619|P2|STARTED|2-Week Visit||49
7823241|NCT01093625|19257620|P1|STARTED|2-Week Visit||47
7823242|NCT01093625|19257619|P2|NOT COMPLETED|Baseline and Dispensed||0
7823243|NCT01093625|19257620|P1|NOT COMPLETED|Baseline and Dispensed||2
7823244|NCT01093625|19257619|P2|COMPLETED|Baseline and Dispensed||49
7823245|NCT01093625|19257620|P1|COMPLETED|Baseline and Dispensed||47
7823246|NCT01093625|19257619|P2|STARTED|Baseline and Dispensed||49
7823247|NCT01093625|19257620|P1|STARTED|Baseline and Dispensed||49
7823248|NCT01093599|19257640|P2|NOT COMPLETED|Overall Study||46
7823249|NCT01093599|19257641|P1|NOT COMPLETED|Overall Study||32
7823250|NCT01093599|19257640|P2|COMPLETED|Overall Study||59
7823251|NCT01093599|19257641|P1|COMPLETED|Overall Study||59
7823252|NCT01093599|19257640|P2|STARTED|Overall Study||105
7823253|NCT01093599|19257641|P1|STARTED|Overall Study||91
7823254|NCT01093586|19257647|P1|NOT COMPLETED|Overall Study||3
7823255|NCT01093586|19257647|P1|COMPLETED|Overall Study||11
7823256|NCT01093586|19257647|P1|STARTED|Overall Study||14
7823257|NCT01093573|19257668|P3|NOT COMPLETED|Overall Study||2
7823258|NCT01093573|19257669|P2|NOT COMPLETED|Overall Study||0
7823259|NCT01093573|19257670|P1|NOT COMPLETED|Overall Study||0
7823260|NCT01093573|19257668|P3|COMPLETED|Overall Study||26
7823261|NCT01093573|19257669|P2|COMPLETED|Overall Study||3
7823262|NCT01093573|19257670|P1|COMPLETED|Overall Study||3
7823263|NCT01093573|19257668|P3|STARTED|Overall Study||28
7823264|NCT01093573|19257669|P2|STARTED|Overall Study||3
7823265|NCT01093573|19257670|P1|STARTED|Overall Study||3
7823266|NCT01093534|19257687|P3|NOT COMPLETED|Overall Study||9
7823267|NCT01093534|19257688|P2|NOT COMPLETED|Overall Study||16
7823268|NCT01093534|19257689|P1|NOT COMPLETED|Overall Study||10
7823269|NCT01093534|19257687|P3|COMPLETED|Overall Study||169
7823270|NCT01093534|19257688|P2|COMPLETED|Overall Study||167
7823271|NCT01093534|19257689|P1|COMPLETED|Overall Study||176
7823272|NCT01093534|19257687|P3|Received Study Treatment|Overall Study||175
7823273|NCT01093534|19257688|P2|Received Study Treatment|Overall Study||182
7823274|NCT01093534|19257689|P1|Received Study Treatment|Overall Study||186
7823275|NCT01093534|19257687|P3|STARTED|Overall Study||178
7823276|NCT01093534|19257688|P2|STARTED|Overall Study||183
7823277|NCT01093534|19257689|P1|STARTED|Overall Study||186
7823278|NCT01093521|19257794|P1|NOT COMPLETED|Overall Study||0
7823279|NCT01093521|19257794|P1|COMPLETED|Overall Study||20
7823280|NCT01093521|19257794|P1|STARTED|Overall Study||20
7823281|NCT01093482|19257809|P1|NOT COMPLETED|Overall Study||0
7823282|NCT01093482|19257809|P1|COMPLETED|Overall Study||8151
7823283|NCT01093482|19257809|P1|STARTED|Overall Study||8151
7823284|NCT01093469|19257816|P3|NOT COMPLETED|Overall Study||1
7823285|NCT01093469|19257817|P2|NOT COMPLETED|Overall Study||0
7823286|NCT01093469|19257818|P1|NOT COMPLETED|Overall Study||0
7823287|NCT01093469|19257816|P3|COMPLETED|Overall Study||12
7823288|NCT01093469|19257817|P2|COMPLETED|Overall Study||13
7823289|NCT01093469|19257818|P1|COMPLETED|Overall Study||13
7823290|NCT01093469|19257816|P3|STARTED|Overall Study||13
7823291|NCT01093469|19257817|P2|STARTED|Overall Study||13
7823292|NCT01093469|19257818|P1|STARTED|Overall Study||13
7823293|NCT01093417|19257828|P2|NOT COMPLETED|Overall Study||1
7823294|NCT01093417|19257829|P1|NOT COMPLETED|Overall Study||0
7823295|NCT01093417|19257828|P2|COMPLETED|Overall Study||29
7823296|NCT01093417|19257829|P1|COMPLETED|Overall Study||15
7823297|NCT01093417|19257828|P2|STARTED|Overall Study||30
7823298|NCT01093417|19257829|P1|STARTED|Overall Study||15
7823299|NCT01093222|19257837|P1|NOT COMPLETED|Overall Study||40
7823300|NCT01093222|19257837|P1|COMPLETED|Overall Study||0
7823301|NCT01093222|19257837|P1|Eligible and Began Protocol Therapy|Overall Study||34
7823302|NCT01093222|19257837|P1|STARTED|Overall Study||40
7823303|NCT01093183|19257844|P2|NOT COMPLETED|Overall Study||2
7823304|NCT01093183|19257845|P1|NOT COMPLETED|Overall Study||1
7823305|NCT01093183|19257844|P2|COMPLETED|Overall Study||4
7823306|NCT01093183|19257845|P1|COMPLETED|Overall Study||18
7823307|NCT01093183|19257844|P2|STARTED|Overall Study||6
7823308|NCT01093183|19257845|P1|STARTED|Overall Study||19
7823309|NCT01093027|19257855|P2|NOT COMPLETED|Visit 2||0
7823310|NCT01093027|19257856|P1|NOT COMPLETED|Visit 2||0
7823311|NCT01093027|19257855|P2|COMPLETED|Visit 2||10
7823312|NCT01093027|19257856|P1|COMPLETED|Visit 2||10
7823313|NCT01093027|19257855|P2|STARTED|Visit 2||10
7823314|NCT01093027|19257856|P1|STARTED|Visit 2||10
7823315|NCT01093027|19257855|P2|NOT COMPLETED|Visit 1||0
7823316|NCT01093027|19257856|P1|NOT COMPLETED|Visit 1||0
7823317|NCT01093027|19257855|P2|COMPLETED|Visit 1||10
7823318|NCT01093027|19257856|P1|COMPLETED|Visit 1||10
7823319|NCT01093027|19257855|P2|STARTED|Visit 1||10
7823320|NCT01093027|19257856|P1|STARTED|Visit 1||10
7823321|NCT01093014|19257867|P3|NOT COMPLETED|Overall Study||0
7823322|NCT01093014|19257868|P2|NOT COMPLETED|Overall Study||0
7823323|NCT01093014|19257869|P1|NOT COMPLETED|Overall Study||0
7823324|NCT01093014|19257867|P3|COMPLETED|Overall Study||12
7823325|NCT01093014|19257868|P2|COMPLETED|Overall Study||9
7823326|NCT01093014|19257869|P1|COMPLETED|Overall Study||12
7823327|NCT01093014|19257867|P3|STARTED|Overall Study||12
7823328|NCT01093014|19257868|P2|STARTED|Overall Study||9
7823329|NCT01093014|19257869|P1|STARTED|Overall Study||12
7823330|NCT01092923|19257888|P2|NOT COMPLETED|Overall Study||0
7823331|NCT01092923|19257889|P1|NOT COMPLETED|Overall Study||0
7823332|NCT01092923|19257888|P2|COMPLETED|Overall Study||10
7823333|NCT01092923|19257889|P1|COMPLETED|Overall Study||10
7823334|NCT01092923|19257888|P2|STARTED|Overall Study||10
7823335|NCT01092923|19257889|P1|STARTED|Overall Study||10
7823336|NCT01092910|19257898|P1|NOT COMPLETED|Overall Study||5
7823337|NCT01092910|19257898|P1|COMPLETED|Overall Study||52
7823338|NCT01092910|19257898|P1|10 Month Follow-up|Overall Study||52
7823339|NCT01092910|19257898|P1|4 Month Follow-up|Overall Study||54
7823340|NCT01092910|19257898|P1|STARTED|Overall Study||57
7823341|NCT01092832|19257913|P2|NOT COMPLETED|Overall Study||0
7823342|NCT01092832|19257914|P1|NOT COMPLETED|Overall Study||1
7823343|NCT01092832|19257913|P2|COMPLETED|Overall Study||8
7823344|NCT01092832|19257914|P1|COMPLETED|Overall Study||13
7823345|NCT01092832|19257913|P2|STARTED|Overall Study||8
7823346|NCT01092832|19257914|P1|STARTED|Overall Study||14
7823347|NCT01092780|19257926|P4|NOT COMPLETED|Treatment Period 4||0
7823348|NCT01092780|19257927|P3|NOT COMPLETED|Treatment Period 4||0
7823349|NCT01092780|19257928|P2|NOT COMPLETED|Treatment Period 4||0
7823350|NCT01092780|19257929|P1|NOT COMPLETED|Treatment Period 4||0
7823351|NCT01092780|19257926|P4|COMPLETED|Treatment Period 4||13
7823352|NCT01092780|19257927|P3|COMPLETED|Treatment Period 4||13
7823353|NCT01092780|19257928|P2|COMPLETED|Treatment Period 4||13
7823354|NCT01092780|19257929|P1|COMPLETED|Treatment Period 4||13
7823355|NCT01092780|19257926|P4|STARTED|Treatment Period 4||13
7823356|NCT01092780|19257927|P3|STARTED|Treatment Period 4||13
7823357|NCT01092780|19257928|P2|STARTED|Treatment Period 4||13
7823358|NCT01092780|19257929|P1|STARTED|Treatment Period 4||13
7823359|NCT01092780|19257926|P4|NOT COMPLETED|Washout Period 3||0
7823360|NCT01092780|19257927|P3|NOT COMPLETED|Washout Period 3||0
7823361|NCT01092780|19257928|P2|NOT COMPLETED|Washout Period 3||0
7823362|NCT01092780|19257929|P1|NOT COMPLETED|Washout Period 3||0
7823363|NCT01092780|19257926|P4|COMPLETED|Washout Period 3||13
7823364|NCT01092780|19257927|P3|COMPLETED|Washout Period 3||13
7823365|NCT01092780|19257928|P2|COMPLETED|Washout Period 3||13
7823366|NCT01092780|19257929|P1|COMPLETED|Washout Period 3||13
7823367|NCT01092780|19257926|P4|STARTED|Washout Period 3||13
7823368|NCT01092780|19257927|P3|STARTED|Washout Period 3||13
7823369|NCT01092780|19257928|P2|STARTED|Washout Period 3||13
7823370|NCT01092780|19257929|P1|STARTED|Washout Period 3||13
7823371|NCT01092780|19257926|P4|NOT COMPLETED|Treatment Period 3||0
7823372|NCT01092780|19257927|P3|NOT COMPLETED|Treatment Period 3||0
7823373|NCT01092780|19257928|P2|NOT COMPLETED|Treatment Period 3||0
7823374|NCT01092780|19257929|P1|NOT COMPLETED|Treatment Period 3||0
7823375|NCT01092780|19257926|P4|COMPLETED|Treatment Period 3||13
7823376|NCT01092780|19257927|P3|COMPLETED|Treatment Period 3||13
7823377|NCT01092780|19257928|P2|COMPLETED|Treatment Period 3||13
7823378|NCT01092780|19257929|P1|COMPLETED|Treatment Period 3||13
7823379|NCT01092780|19257926|P4|STARTED|Treatment Period 3||13
7823380|NCT01092780|19257927|P3|STARTED|Treatment Period 3||13
7823381|NCT01092780|19257928|P2|STARTED|Treatment Period 3||13
7823382|NCT01092780|19257929|P1|STARTED|Treatment Period 3||13
7823383|NCT01092780|19257926|P4|NOT COMPLETED|Washout Period 2||0
7823384|NCT01092780|19257927|P3|NOT COMPLETED|Washout Period 2||1
7823385|NCT01092780|19257928|P2|NOT COMPLETED|Washout Period 2||1
7823386|NCT01092780|19257929|P1|NOT COMPLETED|Washout Period 2||0
7823387|NCT01092780|19257926|P4|COMPLETED|Washout Period 2||13
7823388|NCT01092780|19257927|P3|COMPLETED|Washout Period 2||13
7823389|NCT01092780|19257928|P2|COMPLETED|Washout Period 2||13
7823390|NCT01092780|19257929|P1|COMPLETED|Washout Period 2||13
7823391|NCT01092780|19257926|P4|STARTED|Washout Period 2||13
7823392|NCT01092780|19257927|P3|STARTED|Washout Period 2||14
7823393|NCT01092780|19257928|P2|STARTED|Washout Period 2||14
7823394|NCT01092780|19257929|P1|STARTED|Washout Period 2||13
7823395|NCT01092780|19257926|P4|NOT COMPLETED|Treatment Period 2||0
7823396|NCT01092780|19257927|P3|NOT COMPLETED|Treatment Period 2||0
7823397|NCT01092780|19257928|P2|NOT COMPLETED|Treatment Period 2||0
7823398|NCT01092780|19257929|P1|NOT COMPLETED|Treatment Period 2||0
7823399|NCT01092780|19257926|P4|COMPLETED|Treatment Period 2||13
7823400|NCT01092780|19257927|P3|COMPLETED|Treatment Period 2||14
7823401|NCT01092780|19257928|P2|COMPLETED|Treatment Period 2||14
7823402|NCT01092780|19257929|P1|COMPLETED|Treatment Period 2||13
7823403|NCT01092780|19257926|P4|STARTED|Treatment Period 2||13
7823404|NCT01092780|19257927|P3|STARTED|Treatment Period 2||14
7823405|NCT01092780|19257928|P2|STARTED|Treatment Period 2||14
7823406|NCT01092780|19257929|P1|STARTED|Treatment Period 2||13
7823407|NCT01092780|19257926|P4|NOT COMPLETED|Washout Period 1||0
7823408|NCT01092780|19257927|P3|NOT COMPLETED|Washout Period 1||0
7823409|NCT01092780|19257928|P2|NOT COMPLETED|Washout Period 1||1
7823410|NCT01092780|19257929|P1|NOT COMPLETED|Washout Period 1||1
7823411|NCT01092780|19257926|P4|COMPLETED|Washout Period 1||13
7823412|NCT01092780|19257927|P3|COMPLETED|Washout Period 1||14
7823413|NCT01092780|19257928|P2|COMPLETED|Washout Period 1||14
7823414|NCT01092780|19257929|P1|COMPLETED|Washout Period 1||13
7823415|NCT01092780|19257926|P4|STARTED|Washout Period 1||13
7823416|NCT01092780|19257927|P3|STARTED|Washout Period 1||14
7823417|NCT01092780|19257928|P2|STARTED|Washout Period 1||15
7823418|NCT01092780|19257929|P1|STARTED|Washout Period 1||14
7823419|NCT01092780|19257926|P4|NOT COMPLETED|Treatment Period 1||0
7823420|NCT01092780|19257927|P3|NOT COMPLETED|Treatment Period 1||0
7823421|NCT01092780|19257928|P2|NOT COMPLETED|Treatment Period 1||0
7823422|NCT01092780|19257929|P1|NOT COMPLETED|Treatment Period 1||0
7823423|NCT01092780|19257926|P4|COMPLETED|Treatment Period 1||13
7823424|NCT01092780|19257927|P3|COMPLETED|Treatment Period 1||14
7823425|NCT01092780|19257928|P2|COMPLETED|Treatment Period 1||15
7823426|NCT01092780|19257929|P1|COMPLETED|Treatment Period 1||14
7823427|NCT01092780|19257926|P4|STARTED|Treatment Period 1||13
7823428|NCT01092780|19257927|P3|STARTED|Treatment Period 1||14
7823429|NCT01092780|19257928|P2|STARTED|Treatment Period 1||15
7823430|NCT01092780|19257929|P1|STARTED|Treatment Period 1||14
7823431|NCT01092767|19257959|P1|NOT COMPLETED|Overall Study||5
7823432|NCT01092767|19257959|P1|COMPLETED|Overall Study||45
7823433|NCT01092767|19257959|P1|STARTED|Overall Study||50
7823434|NCT01092728|19257965|P2|NOT COMPLETED|Overall Study||14
7823435|NCT01092728|19257966|P1|NOT COMPLETED|Overall Study||4
7823436|NCT01092728|19257965|P2|COMPLETED|Overall Study||0
7823437|NCT01092728|19257966|P1|COMPLETED|Overall Study||0
7823438|NCT01092728|19257965|P2|STARTED|Overall Study||14
7823439|NCT01092728|19257966|P1|STARTED|Overall Study||4
7823440|NCT01092702|19257974|P1|NOT COMPLETED|Overall Study||9
7823441|NCT01092702|19257974|P1|COMPLETED|Overall Study||23
7823442|NCT01092702|19257974|P1|STARTED|Overall Study||32
7823443|NCT01092676|19257980|P2|NOT COMPLETED|Overall Study||0
7823444|NCT01092676|19257981|P1|NOT COMPLETED|Overall Study||0
7823445|NCT01092676|19257980|P2|COMPLETED|Overall Study||49
7823446|NCT01092676|19257981|P1|COMPLETED|Overall Study||50
7823447|NCT01092676|19257980|P2|STARTED|Overall Study||49
7823448|NCT01092676|19257981|P1|STARTED|Overall Study||50
7823449|NCT01092663|19257991|P2|NOT COMPLETED|Overall Study||4
7823450|NCT01092663|19257992|P1|NOT COMPLETED|Overall Study||7
7823451|NCT01092663|19257991|P2|COMPLETED|Overall Study||26
7823452|NCT01092663|19257992|P1|COMPLETED|Overall Study||24
7823453|NCT01092663|19257991|P2|STARTED|Overall Study||30
7823454|NCT01092663|19257992|P1|STARTED|Overall Study||31
7823455|NCT01092637|19258040|P2|NOT COMPLETED|Overall Study||49
7823456|NCT01092637|19258041|P1|NOT COMPLETED|Overall Study||47
7823457|NCT01092637|19258040|P2|COMPLETED|Overall Study||86
7823458|NCT01092637|19258041|P1|COMPLETED|Overall Study||98
7823459|NCT01092637|19258040|P2|STARTED|Overall Study||135
7823460|NCT01092637|19258041|P1|STARTED|Overall Study||145
7823461|NCT01092559|19258051|P1|NOT COMPLETED|Overall Study||0
7823462|NCT01092559|19258051|P1|COMPLETED|Overall Study||10
7823463|NCT01092559|19258051|P1|STARTED|Overall Study||10
7823464|NCT01092546|19258056|P1|NOT COMPLETED|Overall Study||4
7823465|NCT01092546|19258056|P1|COMPLETED|Overall Study||12
7823466|NCT01092546|19258056|P1|STARTED|Overall Study||16
7823467|NCT01092507|19258063|P2|NOT COMPLETED|Overall Study||0
7823468|NCT01092507|19258064|P1|NOT COMPLETED|Overall Study||2
7823469|NCT01092507|19258063|P2|COMPLETED|Overall Study||150
7823470|NCT01092507|19258064|P1|COMPLETED|Overall Study||147
7823471|NCT01092507|19258063|P2|STARTED|Overall Study||150
7823472|NCT01092507|19258064|P1|STARTED|Overall Study||149
7823473|NCT01092442|19258084|P2|NOT COMPLETED|Overall Study||0
7823474|NCT01092442|19258085|P1|NOT COMPLETED|Overall Study||0
7823475|NCT01092442|19258084|P2|COMPLETED|Overall Study||60
7823476|NCT01092442|19258085|P1|COMPLETED|Overall Study||80
7823477|NCT01092442|19258084|P2|STARTED|Overall Study||60
7823478|NCT01092442|19258085|P1|STARTED|Overall Study||80
7823479|NCT01092416|19258099|P1|NOT COMPLETED|12-Month Follow-up||25
7823480|NCT01092416|19258099|P1|COMPLETED|12-Month Follow-up||413
7823481|NCT01092416|19258099|P1|STARTED|12-Month Follow-up||438
7823482|NCT01092416|19258099|P1|NOT COMPLETED|30-Day Follow-up||10
7823483|NCT01092416|19258099|P1|COMPLETED|30-Day Follow-up||430
7823484|NCT01092416|19258099|P1|STARTED|30-Day Follow-up||440
7823485|NCT01092416|19258099|P1|NOT COMPLETED|Enrollment||3
7823486|NCT01092416|19258099|P1|COMPLETED|Enrollment||440
7823487|NCT01092416|19258099|P1|STARTED|Enrollment||443
7823488|NCT01092364|19258111|P3|NOT COMPLETED|Overall Study||18
7823489|NCT01092364|19258112|P2|NOT COMPLETED|Overall Study||16
7823490|NCT01092364|19258113|P1|NOT COMPLETED|Overall Study||18
7823491|NCT01092364|19258111|P3|COMPLETED|Overall Study||105
7823492|NCT01092364|19258112|P2|COMPLETED|Overall Study||104
7823493|NCT01092364|19258113|P1|COMPLETED|Overall Study||104
7823494|NCT01092364|19258111|P3|STARTED|Overall Study||123
7823495|NCT01092364|19258112|P2|STARTED|Overall Study||120
7823496|NCT01092364|19258113|P1|STARTED|Overall Study||122
7823497|NCT01092338|19258123|P2|NOT COMPLETED|Overall Study||1
7823498|NCT01092338|19258124|P1|NOT COMPLETED|Overall Study||1
7823499|NCT01092338|19258123|P2|COMPLETED|Overall Study||21
7823500|NCT01092338|19258124|P1|COMPLETED|Overall Study||21
7823501|NCT01092338|19258123|P2|STARTED|Overall Study||22
7823502|NCT01092338|19258124|P1|STARTED|Overall Study||22
7823503|NCT01092195|19258135|P3|NOT COMPLETED|Overall Study||0
7823504|NCT01092195|19258136|P2|NOT COMPLETED|Overall Study||0
7823505|NCT01092195|19258137|P1|NOT COMPLETED|Overall Study||0
7823506|NCT01092195|19258135|P3|COMPLETED|Overall Study||20
7823507|NCT01092195|19258136|P2|COMPLETED|Overall Study||21
7823508|NCT01092195|19258137|P1|COMPLETED|Overall Study||23
7823509|NCT01092195|19258135|P3|STARTED|Overall Study||20
7823510|NCT01092195|19258136|P2|STARTED|Overall Study||21
7823511|NCT01092195|19258137|P1|STARTED|Overall Study||23
7823512|NCT01091974|19258149|P4|NOT COMPLETED|Overall Study||7
7823513|NCT01091974|19258150|P3|NOT COMPLETED|Overall Study||6
7823514|NCT01091974|19258151|P2|NOT COMPLETED|Overall Study||5
7823515|NCT01091974|19258152|P1|NOT COMPLETED|Overall Study||5
7823516|NCT01091974|19258149|P4|COMPLETED|Overall Study||17
7823517|NCT01091974|19258150|P3|COMPLETED|Overall Study||19
7823518|NCT01091974|19258151|P2|COMPLETED|Overall Study||18
7823519|NCT01091974|19258152|P1|COMPLETED|Overall Study||19
7823520|NCT01091974|19258149|P4|STARTED|Overall Study||24
7823521|NCT01091974|19258150|P3|STARTED|Overall Study||25
7823522|NCT01091974|19258151|P2|STARTED|Overall Study||23
7823523|NCT01091974|19258152|P1|STARTED|Overall Study||24
7823524|NCT01091948|19258168|P2|NOT COMPLETED|Overall Study||0
7823525|NCT01091948|19258169|P1|NOT COMPLETED|Overall Study||0
7823526|NCT01091948|19258168|P2|COMPLETED|Overall Study||38
7823527|NCT01091948|19258169|P1|COMPLETED|Overall Study||37
7823528|NCT01091948|19258168|P2|STARTED|Overall Study||38
7823529|NCT01091948|19258169|P1|STARTED|Overall Study||37
7823530|NCT01091675|19258187|P1|NOT COMPLETED|Overall Study||34
7823531|NCT01091675|19258187|P1|COMPLETED|Overall Study||23
7823532|NCT01091675|19258187|P1|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57
7823533|NCT01091662|19258193|P2|NOT COMPLETED|Overall Study||34
7823534|NCT01091662|19258194|P1|NOT COMPLETED|Overall Study||17
7823535|NCT01091662|19258193|P2|COMPLETED|Overall Study||80
7823536|NCT01091662|19258194|P1|COMPLETED|Overall Study||41
7823537|NCT01091662|19258193|P2|STARTED|Overall Study||114
7823538|NCT01091662|19258194|P1|STARTED|Overall Study||58
7823539|NCT01091519|19258232|P2|NOT COMPLETED|Overall Study||73
7823540|NCT01091519|19258233|P1|NOT COMPLETED|Overall Study||55
7823541|NCT01091519|19258232|P2|COMPLETED|Overall Study||362
7823542|NCT01091519|19258233|P1|COMPLETED|Overall Study||291
7823543|NCT01091519|19258232|P2|Treated|Overall Study||431
7823544|NCT01091519|19258233|P1|Treated|Overall Study||342
7823545|NCT01091519|19258232|P2|STARTED|Overall Study||435
7823546|NCT01091519|19258233|P1|STARTED|Overall Study||346
7823547|NCT01091454|19258245|P1|NOT COMPLETED|Overall Study||1
7823548|NCT01091454|19258245|P1|COMPLETED|Overall Study||47
7823549|NCT01091454|19258245|P1|STARTED|Overall Study||48
7823550|NCT01091428|19258258|P4|NOT COMPLETED|Phase 2||69
7823551|NCT01091428|19258259|P3|NOT COMPLETED|Phase 2||73
7823552|NCT01091428|19258260|P2|NOT COMPLETED|Phase 2||0
7823553|NCT01091428|19258261|P1|NOT COMPLETED|Phase 2||0
7823554|NCT01091428|19258258|P4|COMPLETED|Phase 2||0
7823555|NCT01091428|19258259|P3|COMPLETED|Phase 2||0
7823556|NCT01091428|19258260|P2|COMPLETED|Phase 2||0
7823557|NCT01091428|19258261|P1|COMPLETED|Phase 2||0
7823558|NCT01091428|19258258|P4|STARTED|Phase 2||69
7823559|NCT01091428|19258259|P3|STARTED|Phase 2||73
7823560|NCT01091428|19258260|P2|STARTED|Phase 2||0
7823561|NCT01091428|19258261|P1|STARTED|Phase 2||0
7823562|NCT01091428|19258258|P4|NOT COMPLETED|Phase 1||0
7823563|NCT01091428|19258259|P3|NOT COMPLETED|Phase 1||0
7823564|NCT01091428|19258260|P2|NOT COMPLETED|Phase 1||11
7823565|NCT01091428|19258261|P1|NOT COMPLETED|Phase 1||38
7823566|NCT01091428|19258258|P4|COMPLETED|Phase 1||0
7823567|NCT01091428|19258259|P3|COMPLETED|Phase 1||0
7823568|NCT01091428|19258260|P2|COMPLETED|Phase 1||0
7823569|NCT01091428|19258261|P1|COMPLETED|Phase 1|Completed = participants who completed the treatment.|0
7823570|NCT01091428|19258258|P4|STARTED|Phase 1||0
7823571|NCT01091428|19258259|P3|STARTED|Phase 1||0
7823572|NCT01091428|19258260|P2|STARTED|Phase 1||11
7823573|NCT01091428|19258261|P1|STARTED|Phase 1||38
7823574|NCT01091363|19258364|P2|NOT COMPLETED|Overall Study||17
7823575|NCT01091363|19258365|P1|NOT COMPLETED|Overall Study||13
7823576|NCT01091363|19258364|P2|COMPLETED|Overall Study||37
7823577|NCT01091363|19258365|P1|COMPLETED|Overall Study||42
7823578|NCT01091363|19258364|P2|STARTED|Overall Study||54
7823579|NCT01091363|19258365|P1|STARTED|Overall Study||55
7823580|NCT01091259|19258375|P1|NOT COMPLETED|Overall Study||5
7823581|NCT01091259|19258375|P1|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24
7823582|NCT01091259|19258375|P1|STARTED|Overall Study||29
7823583|NCT01091246|19258386|P3|NOT COMPLETED|Overall Study||13
7823584|NCT01091246|19258387|P2|NOT COMPLETED|Overall Study||16
7823585|NCT01091246|19258388|P1|NOT COMPLETED|Overall Study||35
7823586|NCT01091246|19258386|P3|COMPLETED|Overall Study||450
7823587|NCT01091246|19258387|P2|COMPLETED|Overall Study||448
7823588|NCT01091246|19258388|P1|COMPLETED|Overall Study||1350
7823589|NCT01091246|19258386|P3|STARTED|Overall Study||463
7823590|NCT01091246|19258387|P2|STARTED|Overall Study||464
7823591|NCT01091246|19258388|P1|STARTED|Overall Study||1385
7823592|NCT01091168|19258464|P2|NOT COMPLETED|Overall Study||296
7823593|NCT01091168|19258465|P1|NOT COMPLETED|Overall Study||298
7823594|NCT01091168|19258464|P2|COMPLETED|Overall Study||0
7823595|NCT01091168|19258465|P1|COMPLETED|Overall Study||0
7823596|NCT01091168|19258464|P2|STARTED|Overall Study||296
7823597|NCT01091168|19258465|P1|STARTED|Overall Study||298
7823598|NCT01091155|19258475|P1|NOT COMPLETED|Overall Study||9
7823599|NCT01091155|19258475|P1|COMPLETED|Overall Study||279
7823600|NCT01091155|19258475|P1|STARTED|Overall Study||288
7823601|NCT01091116|19258484|P5|NOT COMPLETED|Overall Study||11
7823602|NCT01091116|19258485|P4|NOT COMPLETED|Overall Study||4
7823603|NCT01091116|19258486|P3|NOT COMPLETED|Overall Study||11
7823604|NCT01091116|19258487|P2|NOT COMPLETED|Overall Study||8
7823605|NCT01091116|19258488|P1|NOT COMPLETED|Overall Study||6
7823606|NCT01091116|19258484|P5|COMPLETED|Overall Study||73
7823607|NCT01091116|19258485|P4|COMPLETED|Overall Study||80
7823608|NCT01091116|19258486|P3|COMPLETED|Overall Study||73
7823609|NCT01091116|19258487|P2|COMPLETED|Overall Study||80
7823610|NCT01091116|19258488|P1|COMPLETED|Overall Study||77
7823611|NCT01091116|19258484|P5|STARTED|Overall Study||84
7823612|NCT01091116|19258485|P4|STARTED|Overall Study||84
7823613|NCT01091116|19258486|P3|STARTED|Overall Study||84
7823614|NCT01091116|19258487|P2|STARTED|Overall Study||88
7823615|NCT01091116|19258488|P1|STARTED|Overall Study||83
7823616|NCT01091103|19258540|P1|NOT COMPLETED|Overall Study||4
7823617|NCT01091103|19258540|P1|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56
7823618|NCT01091103|19258540|P1|STARTED|Overall Study||60
7823619|NCT01090973|19258560|P1|NOT COMPLETED|Overall Study||1
7823620|NCT01090973|19258560|P1|COMPLETED|Overall Study||0
7823621|NCT01090973|19258560|P1|STARTED|Overall Study||1
7823622|NCT01090921|19258570|P1|NOT COMPLETED|Overall Study||27
7823623|NCT01090921|19258570|P1|COMPLETED|Overall Study||23
7823624|NCT01090921|19258570|P1|STARTED|Overall Study||50
7823625|NCT01090765|19258581|P6|NOT COMPLETED|Overall Study||1
7823626|NCT01090765|19258582|P5|NOT COMPLETED|Overall Study||2
7823627|NCT01090765|19258583|P4|NOT COMPLETED|Overall Study||1
7823628|NCT01090765|19258584|P3|NOT COMPLETED|Overall Study||0
7823629|NCT01090765|19258585|P2|NOT COMPLETED|Overall Study||0
7823630|NCT01090765|19258586|P1|NOT COMPLETED|Overall Study||0
7823631|NCT01090765|19258581|P6|COMPLETED|Overall Study||3
7823632|NCT01090765|19258582|P5|COMPLETED|Overall Study||4
7823633|NCT01090765|19258583|P4|COMPLETED|Overall Study||1
7823634|NCT01090765|19258584|P3|COMPLETED|Overall Study||3
7823635|NCT01090765|19258585|P2|COMPLETED|Overall Study||3
7823636|NCT01090765|19258586|P1|COMPLETED|Overall Study||3
7823637|NCT01090765|19258581|P6|STARTED|Overall Study||4
7823638|NCT01090765|19258582|P5|STARTED|Overall Study||6
7823639|NCT01090765|19258583|P4|STARTED|Overall Study||2
7823640|NCT01090765|19258584|P3|STARTED|Overall Study||3
7823641|NCT01090765|19258585|P2|STARTED|Overall Study||3
7823642|NCT01090765|19258586|P1|STARTED|Overall Study||3
7823643|NCT01090752|19258621|P2|NOT COMPLETED|Overall Study||0
7823644|NCT01090752|19258622|P1|NOT COMPLETED|Overall Study||0
7823645|NCT01090752|19258621|P2|COMPLETED|Overall Study||8
7823646|NCT01090752|19258622|P1|COMPLETED|Overall Study||8
7823647|NCT01090752|19258621|P2|STARTED|Overall Study||8
7823648|NCT01090752|19258622|P1|STARTED|Overall Study||8
7823649|NCT01090739|19258632|P1|NOT COMPLETED|36 Month Follow-up||23
7823650|NCT01090739|19258632|P1|COMPLETED|36 Month Follow-up||115
7823651|NCT01090739|19258632|P1|STARTED|36 Month Follow-up||138
7823652|NCT01090739|19258632|P1|NOT COMPLETED|24 Month Follow-up||9
7823653|NCT01090739|19258632|P1|COMPLETED|24 Month Follow-up||138
7823654|NCT01090739|19258632|P1|STARTED|24 Month Follow-up||147
7823655|NCT01090739|19258632|P1|NOT COMPLETED|12 Month Follow-up||5
7823656|NCT01090739|19258632|P1|COMPLETED|12 Month Follow-up||147
7823657|NCT01090739|19258632|P1|STARTED|12 Month Follow-up||152
7823658|NCT01090739|19258632|P1|NOT COMPLETED|Enrollment||55
7823659|NCT01090739|19258632|P1|COMPLETED|Enrollment||152
7823660|NCT01090739|19258632|P1|STARTED|Enrollment|Subject enrollment = signed informed consent form|207
7823661|NCT01090492|19258657|P8|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
7823662|NCT01090492|19258658|P7|NOT COMPLETED|Second Intervention Period (4 Weeks)||9
7823663|NCT01090492|19258659|P6|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
7823664|NCT01090492|19258660|P5|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
7823665|NCT01090492|19258661|P4|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
7823666|NCT01090492|19258662|P3|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
7823667|NCT01090492|19258663|P2|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
7823668|NCT01090492|19258664|P1|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
7823669|NCT01090492|19258657|P8|COMPLETED|Second Intervention Period (4 Weeks)||25
7823670|NCT01090492|19258658|P7|COMPLETED|Second Intervention Period (4 Weeks)||22
7823671|NCT01090492|19258659|P6|COMPLETED|Second Intervention Period (4 Weeks)||29
7823672|NCT01090492|19258660|P5|COMPLETED|Second Intervention Period (4 Weeks)||27
7823673|NCT01090492|19258661|P4|COMPLETED|Second Intervention Period (4 Weeks)||22
7823674|NCT01090492|19258662|P3|COMPLETED|Second Intervention Period (4 Weeks)||24
7823675|NCT01090492|19258663|P2|COMPLETED|Second Intervention Period (4 Weeks)||22
7823676|NCT01090492|19258664|P1|COMPLETED|Second Intervention Period (4 Weeks)||25
7823677|NCT01090492|19258657|P8|STARTED|Second Intervention Period (4 Weeks)||27
7823678|NCT01090492|19258658|P7|STARTED|Second Intervention Period (4 Weeks)||31
7823679|NCT01090492|19258659|P6|STARTED|Second Intervention Period (4 Weeks)||30
7823680|NCT01090492|19258660|P5|STARTED|Second Intervention Period (4 Weeks)||29
7823681|NCT01090492|19258661|P4|STARTED|Second Intervention Period (4 Weeks)||22
7823682|NCT01090492|19258662|P3|STARTED|Second Intervention Period (4 Weeks)||26
7823683|NCT01090492|19258663|P2|STARTED|Second Intervention Period (4 Weeks)||24
7823684|NCT01090492|19258664|P1|STARTED|Second Intervention Period (4 Weeks)||26
7823685|NCT01090492|19258657|P8|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
7823686|NCT01090492|19258658|P7|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
7823687|NCT01090492|19258659|P6|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
7823688|NCT01090492|19258660|P5|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
7823689|NCT01090492|19258661|P4|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
7823690|NCT01090492|19258662|P3|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
7823691|NCT01090492|19258663|P2|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
7823692|NCT01090492|19258664|P1|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
7823693|NCT01090492|19258657|P8|COMPLETED|Placebo Washout Period ( 2 Weeks)||27
7823694|NCT01090492|19258658|P7|COMPLETED|Placebo Washout Period ( 2 Weeks)||31
7823695|NCT01090492|19258659|P6|COMPLETED|Placebo Washout Period ( 2 Weeks)||30
7823696|NCT01090492|19258660|P5|COMPLETED|Placebo Washout Period ( 2 Weeks)||29
7823697|NCT01090492|19258661|P4|COMPLETED|Placebo Washout Period ( 2 Weeks)||22
7823698|NCT01090492|19258662|P3|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
7823699|NCT01090492|19258663|P2|COMPLETED|Placebo Washout Period ( 2 Weeks)||24
7823700|NCT01090492|19258664|P1|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
7823701|NCT01090492|19258657|P8|STARTED|Placebo Washout Period ( 2 Weeks)||27
7823702|NCT01090492|19258658|P7|STARTED|Placebo Washout Period ( 2 Weeks)||31
7823703|NCT01090492|19258659|P6|STARTED|Placebo Washout Period ( 2 Weeks)||30
7823704|NCT01090492|19258660|P5|STARTED|Placebo Washout Period ( 2 Weeks)||29
7823705|NCT01090492|19258661|P4|STARTED|Placebo Washout Period ( 2 Weeks)||22
7823706|NCT01090492|19258662|P3|STARTED|Placebo Washout Period ( 2 Weeks)||26
7823707|NCT01090492|19258663|P2|STARTED|Placebo Washout Period ( 2 Weeks)||24
7823708|NCT01090492|19258664|P1|STARTED|Placebo Washout Period ( 2 Weeks)||26
7823709|NCT01090492|19258657|P8|NOT COMPLETED|First Intervention Period (4 Weeks)||6
7823710|NCT01090492|19258658|P7|NOT COMPLETED|First Intervention Period (4 Weeks)||1
7823711|NCT01090492|19258659|P6|NOT COMPLETED|First Intervention Period (4 Weeks)||2
7823712|NCT01090492|19258660|P5|NOT COMPLETED|First Intervention Period (4 Weeks)||4
7823713|NCT01090492|19258661|P4|NOT COMPLETED|First Intervention Period (4 Weeks)||6
7823714|NCT01090492|19258662|P3|NOT COMPLETED|First Intervention Period (4 Weeks)||3
7823715|NCT01090492|19258663|P2|NOT COMPLETED|First Intervention Period (4 Weeks)||5
7823716|NCT01090492|19258664|P1|NOT COMPLETED|First Intervention Period (4 Weeks)||1
7823717|NCT01090492|19258657|P8|COMPLETED|First Intervention Period (4 Weeks)||27
7823718|NCT01090492|19258658|P7|COMPLETED|First Intervention Period (4 Weeks)||31
7823719|NCT01090492|19258659|P6|COMPLETED|First Intervention Period (4 Weeks)||30
7823720|NCT01090492|19258660|P5|COMPLETED|First Intervention Period (4 Weeks)||29
7823721|NCT01090492|19258661|P4|COMPLETED|First Intervention Period (4 Weeks)||22
7823722|NCT01090492|19258662|P3|COMPLETED|First Intervention Period (4 Weeks)||26
7823723|NCT01090492|19258663|P2|COMPLETED|First Intervention Period (4 Weeks)||24
7823724|NCT01090492|19258664|P1|COMPLETED|First Intervention Period (4 Weeks)||26
7823725|NCT01090492|19258657|P8|STARTED|First Intervention Period (4 Weeks)||33
7823726|NCT01090492|19258658|P7|STARTED|First Intervention Period (4 Weeks)||32
7823727|NCT01090492|19258659|P6|STARTED|First Intervention Period (4 Weeks)||32
7823728|NCT01090492|19258660|P5|STARTED|First Intervention Period (4 Weeks)||33
7823729|NCT01090492|19258661|P4|STARTED|First Intervention Period (4 Weeks)||28
7823730|NCT01090492|19258662|P3|STARTED|First Intervention Period (4 Weeks)||29
7823731|NCT01090492|19258663|P2|STARTED|First Intervention Period (4 Weeks)||29
7823732|NCT01090492|19258664|P1|STARTED|First Intervention Period (4 Weeks)||27
7823733|NCT01090479|19258723|P2|NOT COMPLETED|Overall Study||0
7823734|NCT01090479|19258724|P1|NOT COMPLETED|Overall Study||0
7823735|NCT01090479|19258723|P2|COMPLETED|Overall Study||50
7823736|NCT01090479|19258724|P1|COMPLETED|Overall Study||50
7823737|NCT01090479|19258723|P2|STARTED|Overall Study||50
7823738|NCT01090479|19258724|P1|STARTED|Overall Study||50
7823739|NCT01090453|19258732|P2|NOT COMPLETED|Overall Study||14
7823740|NCT01090453|19258733|P1|NOT COMPLETED|Overall Study||13
7823741|NCT01090453|19258732|P2|COMPLETED|Overall Study||228
7823742|NCT01090453|19258733|P1|COMPLETED|Overall Study||225
7823743|NCT01090453|19258732|P2|STARTED|Overall Study||242
7823744|NCT01090453|19258733|P1|STARTED|Overall Study||238
7823745|NCT01090427|19258784|P7|NOT COMPLETED|After Controlled Period||2
7823746|NCT01090427|19258785|P6|NOT COMPLETED|After Controlled Period||5
7823747|NCT01090427|19258786|P5|NOT COMPLETED|After Controlled Period||0
7823748|NCT01090427|19258787|P4|NOT COMPLETED|After Controlled Period||2
7823749|NCT01090427|19258788|P3|NOT COMPLETED|After Controlled Period||0
7823750|NCT01090427|19258789|P2|NOT COMPLETED|After Controlled Period||0
7823751|NCT01090427|19258790|P1|NOT COMPLETED|After Controlled Period||0
7823752|NCT01090427|19258784|P7|COMPLETED|After Controlled Period||34
7823753|NCT01090427|19258785|P6|COMPLETED|After Controlled Period||32
7823754|NCT01090427|19258786|P5|COMPLETED|After Controlled Period||18
7823755|NCT01090427|19258787|P4|COMPLETED|After Controlled Period||17
7823756|NCT01090427|19258788|P3|COMPLETED|After Controlled Period||0
7823757|NCT01090427|19258789|P2|COMPLETED|After Controlled Period||0
7823758|NCT01090427|19258790|P1|COMPLETED|After Controlled Period||0
7823759|NCT01090427|19258784|P7|STARTED|After Controlled Period||36
7823760|NCT01090427|19258785|P6|STARTED|After Controlled Period||37
7823761|NCT01090427|19258786|P5|STARTED|After Controlled Period||18
7823762|NCT01090427|19258787|P4|STARTED|After Controlled Period||19
7823763|NCT01090427|19258788|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
7823764|NCT01090427|19258789|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
7823765|NCT01090427|19258790|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
7823766|NCT01090427|19258784|P7|NOT COMPLETED|Controlled Period||0
7823767|NCT01090427|19258785|P6|NOT COMPLETED|Controlled Period||0
7823768|NCT01090427|19258786|P5|NOT COMPLETED|Controlled Period||0
7823769|NCT01090427|19258787|P4|NOT COMPLETED|Controlled Period||0
7823770|NCT01090427|19258788|P3|NOT COMPLETED|Controlled Period||0
7823771|NCT01090427|19258789|P2|NOT COMPLETED|Controlled Period||0
7823772|NCT01090427|19258790|P1|NOT COMPLETED|Controlled Period||0
7823773|NCT01090427|19258784|P7|COMPLETED|Controlled Period||0
7823774|NCT01090427|19258785|P6|COMPLETED|Controlled Period||0
7823775|NCT01090427|19258786|P5|COMPLETED|Controlled Period||0
7823776|NCT01090427|19258787|P4|COMPLETED|Controlled Period||0
7823777|NCT01090427|19258788|P3|COMPLETED|Controlled Period||36
7823778|NCT01090427|19258789|P2|COMPLETED|Controlled Period||37
7823779|NCT01090427|19258790|P1|COMPLETED|Controlled Period||37
7823780|NCT01090427|19258784|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
7823781|NCT01090427|19258785|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
7823782|NCT01090427|19258786|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
7823783|NCT01090427|19258787|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
7823784|NCT01090427|19258788|P3|STARTED|Controlled Period||36
7823785|NCT01090427|19258789|P2|STARTED|Controlled Period||37
7823786|NCT01090427|19258790|P1|STARTED|Controlled Period||37
7823787|NCT01090414|19258827|P4|NOT COMPLETED|Study 101-99||5
7823788|NCT01090414|19258828|P3|NOT COMPLETED|Study 101-99||41
7823789|NCT01090414|19258829|P2|NOT COMPLETED|Study 101-99||108
7823790|NCT01090414|19258830|P1|NOT COMPLETED|Study 101-99||48
7823791|NCT01090414|19258827|P4|COMPLETED|Study 101-99||0
7823792|NCT01090414|19258828|P3|COMPLETED|Study 101-99||0
7823793|NCT01090414|19258829|P2|COMPLETED|Study 101-99||0
7823794|NCT01090414|19258830|P1|COMPLETED|Study 101-99||0
7823795|NCT01090414|19258827|P4|STARTED|Study 101-99||5
7823796|NCT01090414|19258828|P3|STARTED|Study 101-99|43 participants completed the parent study, but only 41 participants enrolled into Study 101-99.|41
7823797|NCT01090414|19258829|P2|STARTED|Study 101-99|114 participants completed the parent study, but only 108 participants enrolled into Study 101-99.|108
7823798|NCT01090414|19258830|P1|STARTED|Study 101-99|50 participants completed the parent study, but only 48 participants enrolled into Study 101-99.|48
7823799|NCT01090414|19258827|P4|NOT COMPLETED|Parent Studies||13
7823800|NCT01090414|19258828|P3|NOT COMPLETED|Parent Studies||21
7823801|NCT01090414|19258829|P2|NOT COMPLETED|Parent Studies||127
7823802|NCT01090414|19258830|P1|NOT COMPLETED|Parent Studies||141
7823803|NCT01090414|19258827|P4|COMPLETED|Parent Studies||5
7823804|NCT01090414|19258828|P3|COMPLETED|Parent Studies||43
7823805|NCT01090414|19258829|P2|COMPLETED|Parent Studies||114
7823806|NCT01090414|19258830|P1|COMPLETED|Parent Studies||50
7823807|NCT01090414|19258827|P4|STARTED|Parent Studies||18
7823808|NCT01090414|19258828|P3|STARTED|Parent Studies||64
7823809|NCT01090414|19258829|P2|STARTED|Parent Studies||241
7823810|NCT01090414|19258830|P1|STARTED|Parent Studies||191
7823811|NCT01090323|19258897|P2|NOT COMPLETED|Overall Study||34
7823812|NCT01090323|19258898|P1|NOT COMPLETED|Overall Study||89
7823813|NCT01090323|19258897|P2|COMPLETED|Overall Study||19
7823814|NCT01090323|19258898|P1|COMPLETED|Overall Study||43
7823815|NCT01090323|19258897|P2|STARTED|Overall Study||53
7823816|NCT01090323|19258898|P1|STARTED|Overall Study||132
7823817|NCT01090310|19258910|P4|NOT COMPLETED|Extension Study||20
7823818|NCT01090310|19258911|P3|NOT COMPLETED|Extension Study||15
7823819|NCT01090310|19258912|P2|NOT COMPLETED|Extension Study||16
7823820|NCT01090310|19258913|P1|NOT COMPLETED|Extension Study||14
7823821|NCT01090310|19258910|P4|COMPLETED|Extension Study||1
7823822|NCT01090310|19258911|P3|COMPLETED|Extension Study||1
7823823|NCT01090310|19258912|P2|COMPLETED|Extension Study||0
7823824|NCT01090310|19258913|P1|COMPLETED|Extension Study||3
7823825|NCT01090310|19258910|P4|STARTED|Extension Study||21
7823826|NCT01090310|19258911|P3|STARTED|Extension Study||16
7823827|NCT01090310|19258912|P2|STARTED|Extension Study||16
7823828|NCT01090310|19258913|P1|STARTED|Extension Study||17
7823829|NCT01090310|19258910|P4|NOT COMPLETED|Core Study||7
7823830|NCT01090310|19258911|P3|NOT COMPLETED|Core Study||7
7823831|NCT01090310|19258912|P2|NOT COMPLETED|Core Study||11
7823832|NCT01090310|19258913|P1|NOT COMPLETED|Core Study||8
7823833|NCT01090310|19258910|P4|COMPLETED|Core Study||27
7823834|NCT01090310|19258911|P3|COMPLETED|Core Study||24
7823835|NCT01090310|19258912|P2|COMPLETED|Core Study||20
7823836|NCT01090310|19258913|P1|COMPLETED|Core Study||21
7823837|NCT01090310|19258910|P4|STARTED|Core Study||34
7823838|NCT01090310|19258911|P3|STARTED|Core Study||31
7823839|NCT01090310|19258912|P2|STARTED|Core Study||31
7823840|NCT01090310|19258913|P1|STARTED|Core Study||29
7823841|NCT01090180|19258941|P2|NOT COMPLETED|Overall Study||8
7823842|NCT01090180|19258942|P1|NOT COMPLETED|Overall Study||11
7823843|NCT01090180|19258941|P2|COMPLETED|Overall Study||21
7823844|NCT01090180|19258942|P1|COMPLETED|Overall Study||22
7823845|NCT01090180|19258941|P2|STARTED|Overall Study||29
7823846|NCT01090180|19258942|P1|STARTED|Overall Study||33
7823847|NCT01090141|19258952|P2|NOT COMPLETED|Overall Study||0
7823848|NCT01090141|19258953|P1|NOT COMPLETED|Overall Study||0
7823849|NCT01090141|19258952|P2|COMPLETED|Overall Study||0
7823850|NCT01090141|19258953|P1|COMPLETED|Overall Study||0
7823851|NCT01090141|19258952|P2|STARTED|Overall Study||0
7823852|NCT01090141|19258953|P1|STARTED|Overall Study||0
7823853|NCT01090102|19258961|P2|NOT COMPLETED|Second 12 Weeks||1
7823854|NCT01090102|19258962|P1|NOT COMPLETED|Second 12 Weeks||0
7823855|NCT01090102|19258961|P2|COMPLETED|Second 12 Weeks||15
7823856|NCT01090102|19258962|P1|COMPLETED|Second 12 Weeks||11
7823857|NCT01090102|19258961|P2|STARTED|Second 12 Weeks||16
7823858|NCT01090102|19258962|P1|STARTED|Second 12 Weeks||11
7823859|NCT01090102|19258961|P2|NOT COMPLETED|First 12 Weeks||2
7823860|NCT01090102|19258962|P1|NOT COMPLETED|First 12 Weeks||4
7823861|NCT01090102|19258961|P2|COMPLETED|First 12 Weeks||16
7823862|NCT01090102|19258962|P1|COMPLETED|First 12 Weeks||11
7823863|NCT01090102|19258961|P2|STARTED|First 12 Weeks||18
7823864|NCT01090102|19258962|P1|STARTED|First 12 Weeks||15
7823865|NCT01090076|19258972|P2|NOT COMPLETED|Overall Study||2
7823866|NCT01090076|19258973|P1|NOT COMPLETED|Overall Study||1
7823867|NCT01090076|19258972|P2|COMPLETED|Overall Study||12
7823868|NCT01090076|19258973|P1|COMPLETED|Overall Study||11
7823869|NCT01090076|19258972|P2|STARTED|Overall Study||14
7823870|NCT01090076|19258973|P1|STARTED|Overall Study||12
7823871|NCT01090063|19258983|P1|NOT COMPLETED|Treatment||4
7823872|NCT01090063|19258983|P1|COMPLETED|Treatment||20
7823873|NCT01090063|19258983|P1|STARTED|Treatment||24
7823874|NCT01090063|19258983|P1|NOT COMPLETED|Screen||4
7823875|NCT01090063|19258983|P1|COMPLETED|Screen||24
7823876|NCT01090063|19258983|P1|STARTED|Screen||28
7823877|NCT01090050|19258999|P2|NOT COMPLETED|Overall Study||7
7823878|NCT01090050|19259000|P1|NOT COMPLETED|Overall Study||1
7823879|NCT01090050|19258999|P2|COMPLETED|Overall Study||5
7823880|NCT01090050|19259000|P1|COMPLETED|Overall Study||15
7823881|NCT01090050|19258999|P2|STARTED|Overall Study||12
7823882|NCT01090050|19259000|P1|STARTED|Overall Study||16
7823883|NCT01090011|19259020|P1|NOT COMPLETED|Overall Study||171
7823884|NCT01090011|19259020|P1|COMPLETED|Overall Study||0
7823885|NCT01090011|19259020|P1|STARTED|Overall Study||171
7823886|NCT01089751|19259090|P2|NOT COMPLETED|Overall Study||27
7823887|NCT01089751|19259091|P1|NOT COMPLETED|Overall Study||34
7823888|NCT01089751|19259090|P2|COMPLETED|Overall Study||132
7823889|NCT01089751|19259091|P1|COMPLETED|Overall Study||129
7823890|NCT01089751|19259090|P2|STARTED|Overall Study||159
7823891|NCT01089751|19259091|P1|STARTED|Overall Study||163
7823892|NCT01089647|19259113|P2|NOT COMPLETED|Overall Study||4
7823893|NCT01089647|19259114|P1|NOT COMPLETED|Overall Study||4
7823894|NCT01089647|19259113|P2|COMPLETED|Overall Study||13
7823895|NCT01089647|19259114|P1|COMPLETED|Overall Study||13
7823896|NCT01089647|19259113|P2|STARTED|Overall Study||17
7823897|NCT01089647|19259114|P1|STARTED|Overall Study||17
7823898|NCT01089608|19259122|P2|NOT COMPLETED|Overall Study||6
7823899|NCT01089608|19259123|P1|NOT COMPLETED|Overall Study||0
7823900|NCT01089608|19259122|P2|COMPLETED|Overall Study||44
7823901|NCT01089608|19259123|P1|COMPLETED|Overall Study||43
7823902|NCT01089608|19259122|P2|STARTED|Overall Study||50
7823903|NCT01089608|19259123|P1|STARTED|Overall Study||43
7823904|NCT01089595|19259131|P2|NOT COMPLETED|Overall Study||0
7823905|NCT01089595|19259132|P1|NOT COMPLETED|Overall Study||0
7823906|NCT01089595|19259131|P2|COMPLETED|Overall Study||3
7823907|NCT01089595|19259132|P1|COMPLETED|Overall Study||2
7823908|NCT01089595|19259131|P2|STARTED|Overall Study||3
7823909|NCT01089595|19259132|P1|STARTED|Overall Study||2
7823910|NCT01089582|19259140|P1|NOT COMPLETED|Overall Study||30
7823911|NCT01089582|19259140|P1|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573
7823912|NCT01089582|19259140|P1|STARTED|Overall Study||603
7823913|NCT01089569|19259153|P3|NOT COMPLETED|Overall Study||4
7823914|NCT01089569|19259154|P2|NOT COMPLETED|Overall Study||3
7823915|NCT01089569|19259155|P1|NOT COMPLETED|Overall Study||4
7823916|NCT01089569|19259153|P3|COMPLETED|Overall Study||16
7823917|NCT01089569|19259154|P2|COMPLETED|Overall Study||17
7823918|NCT01089569|19259155|P1|COMPLETED|Overall Study||16
7823919|NCT01089569|19259153|P3|STARTED|Overall Study||20
7823920|NCT01089569|19259154|P2|STARTED|Overall Study||20
7823921|NCT01089569|19259155|P1|STARTED|Overall Study||20
7823922|NCT01089556|19259183|P6|NOT COMPLETED|Study Period III (Weeks 9-16)||7
7823923|NCT01089556|19259184|P5|NOT COMPLETED|Study Period III (Weeks 9-16)||12
7823924|NCT01089556|19259185|P4|NOT COMPLETED|Study Period III (Weeks 9-16)||9
7823925|NCT01089556|19259186|P3|NOT COMPLETED|Study Period III (Weeks 9-16)||14
7823926|NCT01089556|19259187|P2|NOT COMPLETED|Study Period III (Weeks 9-16)||0
7823927|NCT01089556|19259188|P1|NOT COMPLETED|Study Period III (Weeks 9-16)||0
7823928|NCT01089556|19259183|P6|COMPLETED|Study Period III (Weeks 9-16)||92
7823929|NCT01089556|19259184|P5|COMPLETED|Study Period III (Weeks 9-16)||83
7823930|NCT01089556|19259185|P4|COMPLETED|Study Period III (Weeks 9-16)||66
7823931|NCT01089556|19259186|P3|COMPLETED|Study Period III (Weeks 9-16)||60
7823932|NCT01089556|19259187|P2|COMPLETED|Study Period III (Weeks 9-16)||0
7823933|NCT01089556|19259188|P1|COMPLETED|Study Period III (Weeks 9-16)||0
7823934|NCT01089556|19259183|P6|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97
7823935|NCT01089556|19259184|P5|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94
7823936|NCT01089556|19259185|P4|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75
7823937|NCT01089556|19259186|P3|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73
7823938|NCT01089556|19259187|P2|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
7823939|NCT01089556|19259188|P1|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
7823940|NCT01089556|19259183|P6|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99
7823941|NCT01089556|19259184|P5|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95
7823942|NCT01089556|19259185|P4|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75
7823943|NCT01089556|19259186|P3|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74
7823944|NCT01089556|19259187|P2|STARTED|Study Period III (Weeks 9-16)||0
7823945|NCT01089556|19259188|P1|STARTED|Study Period III (Weeks 9-16)||0
7823946|NCT01089556|19259183|P6|NOT COMPLETED|Study Period II (Weeks 1-8)||0
7823947|NCT01089556|19259184|P5|NOT COMPLETED|Study Period II (Weeks 1-8)||0
7823948|NCT01089556|19259185|P4|NOT COMPLETED|Study Period II (Weeks 1-8)||0
7823949|NCT01089556|19259186|P3|NOT COMPLETED|Study Period II (Weeks 1-8)||0
7823950|NCT01089556|19259187|P2|NOT COMPLETED|Study Period II (Weeks 1-8)||74
7823951|NCT01089556|19259188|P1|NOT COMPLETED|Study Period II (Weeks 1-8)||71
7823952|NCT01089556|19259183|P6|COMPLETED|Study Period II (Weeks 1-8)||0
7823953|NCT01089556|19259184|P5|COMPLETED|Study Period II (Weeks 1-8)||0
7823954|NCT01089556|19259185|P4|COMPLETED|Study Period II (Weeks 1-8)||0
7823955|NCT01089556|19259186|P3|COMPLETED|Study Period II (Weeks 1-8)||0
7823956|NCT01089556|19259187|P2|COMPLETED|Study Period II (Weeks 1-8)||333
7823957|NCT01089556|19259188|P1|COMPLETED|Study Period II (Weeks 1-8)||333
7823958|NCT01089556|19259183|P6|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
7823959|NCT01089556|19259184|P5|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
7823960|NCT01089556|19259185|P4|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
7823961|NCT01089556|19259186|P3|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
7823962|NCT01089556|19259187|P2|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205
7823963|NCT01089556|19259188|P1|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158
7823964|NCT01089556|19259183|P6|Safety Population|Study Period II (Weeks 1-8)||0
7823965|NCT01089556|19259184|P5|Safety Population|Study Period II (Weeks 1-8)||0
7823966|NCT01089556|19259185|P4|Safety Population|Study Period II (Weeks 1-8)||0
7823967|NCT01089556|19259186|P3|Safety Population|Study Period II (Weeks 1-8)||0
7823968|NCT01089556|19259187|P2|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403
7823969|NCT01089556|19259188|P1|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401
7823970|NCT01089556|19259183|P6|STARTED|Study Period II (Weeks 1-8)||0
7823971|NCT01089556|19259184|P5|STARTED|Study Period II (Weeks 1-8)||0
7823972|NCT01089556|19259185|P4|STARTED|Study Period II (Weeks 1-8)||0
7823973|NCT01089556|19259186|P3|STARTED|Study Period II (Weeks 1-8)||0
7823974|NCT01089556|19259187|P2|STARTED|Study Period II (Weeks 1-8)||407
7823975|NCT01089556|19259188|P1|STARTED|Study Period II (Weeks 1-8)||404
7823976|NCT01089543|19259262|P4|NOT COMPLETED|Overall Study||2
7823977|NCT01089543|19259263|P3|NOT COMPLETED|Overall Study||3
7823978|NCT01089543|19259264|P2|NOT COMPLETED|Overall Study||4
7823979|NCT01089543|19259265|P1|NOT COMPLETED|Overall Study||3
7823980|NCT01089543|19259262|P4|COMPLETED|Overall Study||83
7823981|NCT01089543|19259263|P3|COMPLETED|Overall Study||81
7823982|NCT01089543|19259264|P2|COMPLETED|Overall Study||81
7823983|NCT01089543|19259265|P1|COMPLETED|Overall Study||81
7823984|NCT01089543|19259262|P4|STARTED|Overall Study||85
7823985|NCT01089543|19259263|P3|STARTED|Overall Study||84
7823986|NCT01089543|19259264|P2|STARTED|Overall Study||85
7823987|NCT01089543|19259265|P1|STARTED|Overall Study||84
7823988|NCT01089517|19259282|P3|NOT COMPLETED|Overall Study||5
7823989|NCT01089517|19259283|P2|NOT COMPLETED|Overall Study||5
7823990|NCT01089517|19259284|P1|NOT COMPLETED|Overall Study||4
7823991|NCT01089517|19259282|P3|COMPLETED|Overall Study||147
7823992|NCT01089517|19259283|P2|COMPLETED|Overall Study||144
7823993|NCT01089517|19259284|P1|COMPLETED|Overall Study||144
7823994|NCT01089517|19259282|P3|STARTED|Overall Study||152
7823995|NCT01089517|19259283|P2|STARTED|Overall Study||149
7823996|NCT01089517|19259284|P1|STARTED|Overall Study||148
7823997|NCT01089504|19259300|P2|NOT COMPLETED|Overall Study||1
7823998|NCT01089504|19259301|P1|NOT COMPLETED|Overall Study||3
7823999|NCT01089504|19259300|P2|COMPLETED|Overall Study||4
7824000|NCT01089504|19259301|P1|COMPLETED|Overall Study||5
7824001|NCT01089504|19259300|P2|STARTED|Overall Study||5
7824002|NCT01089504|19259301|P1|STARTED|Overall Study||8
7824003|NCT01089413|19259314|P1|NOT COMPLETED|Overall Study||201
7824004|NCT01089413|19259314|P1|COMPLETED|Overall Study||0
7824005|NCT01089413|19259314|P1|Received Bevacizumab in First Line|Overall Study||199
7824006|NCT01089413|19259314|P1|STARTED|Overall Study||201
7824007|NCT01089361|19259333|P2|NOT COMPLETED|Overall Study||0
7824008|NCT01089361|19259334|P1|NOT COMPLETED|Overall Study||1
7824009|NCT01089361|19259333|P2|COMPLETED|Overall Study||10
7824010|NCT01089361|19259334|P1|COMPLETED|Overall Study||8
7824011|NCT01089361|19259333|P2|STARTED|Overall Study||10
7824012|NCT01089361|19259334|P1|STARTED|Overall Study||9
7824013|NCT01089231|19259356|P4|NOT COMPLETED|Overall Study||1
7824014|NCT01089231|19259357|P3|NOT COMPLETED|Overall Study||2
7824015|NCT01089231|19259358|P2|NOT COMPLETED|Overall Study||2
7824016|NCT01089231|19259359|P1|NOT COMPLETED|Overall Study||4
7824017|NCT01089231|19259356|P4|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9
7824018|NCT01089231|19259357|P3|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8
7824019|NCT01089231|19259358|P2|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8
7824020|NCT01089231|19259359|P1|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6
7824021|NCT01089231|19259356|P4|STARTED|Overall Study||10
7824022|NCT01089231|19259357|P3|STARTED|Overall Study||10
7824023|NCT01089231|19259358|P2|STARTED|Overall Study||10
7824024|NCT01089231|19259359|P1|STARTED|Overall Study||10
7824025|NCT01089127|19259383|P6|NOT COMPLETED|Overall Study||3
7824026|NCT01089127|19259384|P5|NOT COMPLETED|Overall Study||2
7824027|NCT01089127|19259385|P4|NOT COMPLETED|Overall Study||1
7824028|NCT01089127|19259386|P3|NOT COMPLETED|Overall Study||2
7824029|NCT01089127|19259387|P2|NOT COMPLETED|Overall Study||5
7824030|NCT01089127|19259388|P1|NOT COMPLETED|Overall Study||8
7824031|NCT01089127|19259383|P6|COMPLETED|Overall Study||88
7824032|NCT01089127|19259384|P5|COMPLETED|Overall Study||90
7824033|NCT01089127|19259385|P4|COMPLETED|Overall Study||91
7824034|NCT01089127|19259386|P3|COMPLETED|Overall Study||92
7824035|NCT01089127|19259387|P2|COMPLETED|Overall Study||86
7824036|NCT01089127|19259388|P1|COMPLETED|Overall Study||84
7824037|NCT01089127|19259383|P6|Exposed to Study Drug|Overall Study||91
7824038|NCT01089127|19259384|P5|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91
7824039|NCT01089127|19259385|P4|Exposed to Study Drug|Overall Study||92
7824040|NCT01089127|19259386|P3|Exposed to Study Drug|Overall Study||94
7824041|NCT01089127|19259387|P2|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90
7824042|NCT01089127|19259388|P1|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89
7824043|NCT01089127|19259383|P6|STARTED|Overall Study||91
7824044|NCT01089127|19259384|P5|STARTED|Overall Study||92
7824045|NCT01089127|19259385|P4|STARTED|Overall Study||92
7824046|NCT01089127|19259386|P3|STARTED|Overall Study||94
7824047|NCT01089127|19259387|P2|STARTED|Overall Study||91
7824048|NCT01089127|19259388|P1|STARTED|Overall Study||92
7824049|NCT01089062|19259414|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
7824050|NCT01089062|19259415|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
7824051|NCT01089062|19259416|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
7824052|NCT01089062|19259417|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
7824053|NCT01089062|19259418|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
7824054|NCT01089062|19259419|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
7824055|NCT01089062|19259414|P6|COMPLETED|Follow-up Visit (Final Visit)||3
7824056|NCT01089062|19259415|P5|COMPLETED|Follow-up Visit (Final Visit)||3
7824057|NCT01089062|19259416|P4|COMPLETED|Follow-up Visit (Final Visit)||3
7824058|NCT01089062|19259417|P3|COMPLETED|Follow-up Visit (Final Visit)||3
7824059|NCT01089062|19259418|P2|COMPLETED|Follow-up Visit (Final Visit)||3
7824060|NCT01089062|19259419|P1|COMPLETED|Follow-up Visit (Final Visit)||3
7824061|NCT01089062|19259414|P6|STARTED|Follow-up Visit (Final Visit)||3
7824062|NCT01089062|19259415|P5|STARTED|Follow-up Visit (Final Visit)||3
7824063|NCT01089062|19259416|P4|STARTED|Follow-up Visit (Final Visit)||3
7824064|NCT01089062|19259417|P3|STARTED|Follow-up Visit (Final Visit)||3
7824065|NCT01089062|19259418|P2|STARTED|Follow-up Visit (Final Visit)||3
7824066|NCT01089062|19259419|P1|STARTED|Follow-up Visit (Final Visit)||3
7824067|NCT01089062|19259414|P6|NOT COMPLETED|Visit 4||0
7824068|NCT01089062|19259415|P5|NOT COMPLETED|Visit 4||0
7824069|NCT01089062|19259416|P4|NOT COMPLETED|Visit 4||0
7824070|NCT01089062|19259417|P3|NOT COMPLETED|Visit 4||0
7824071|NCT01089062|19259418|P2|NOT COMPLETED|Visit 4||0
7824072|NCT01089062|19259419|P1|NOT COMPLETED|Visit 4||0
7824073|NCT01089062|19259414|P6|COMPLETED|Visit 4||3
7824074|NCT01089062|19259415|P5|COMPLETED|Visit 4||3
7824075|NCT01089062|19259416|P4|COMPLETED|Visit 4||3
7824076|NCT01089062|19259417|P3|COMPLETED|Visit 4||3
7824077|NCT01089062|19259418|P2|COMPLETED|Visit 4||3
7824078|NCT01089062|19259419|P1|COMPLETED|Visit 4||3
7824079|NCT01089062|19259414|P6|STARTED|Visit 4||3
7824080|NCT01089062|19259415|P5|STARTED|Visit 4||3
7824081|NCT01089062|19259416|P4|STARTED|Visit 4||3
7824082|NCT01089062|19259417|P3|STARTED|Visit 4||3
7824083|NCT01089062|19259418|P2|STARTED|Visit 4||3
7824084|NCT01089062|19259419|P1|STARTED|Visit 4||3
7824085|NCT01089062|19259414|P6|NOT COMPLETED|Visit 3||0
7824086|NCT01089062|19259415|P5|NOT COMPLETED|Visit 3||0
7824087|NCT01089062|19259416|P4|NOT COMPLETED|Visit 3||1
7824088|NCT01089062|19259417|P3|NOT COMPLETED|Visit 3||0
7824089|NCT01089062|19259418|P2|NOT COMPLETED|Visit 3||0
7824090|NCT01089062|19259419|P1|NOT COMPLETED|Visit 3||0
7824091|NCT01089062|19259414|P6|COMPLETED|Visit 3||3
7824092|NCT01089062|19259415|P5|COMPLETED|Visit 3||3
7824093|NCT01089062|19259416|P4|COMPLETED|Visit 3||3
7824094|NCT01089062|19259417|P3|COMPLETED|Visit 3||3
7824095|NCT01089062|19259418|P2|COMPLETED|Visit 3||3
7824096|NCT01089062|19259419|P1|COMPLETED|Visit 3||3
7824097|NCT01089062|19259414|P6|STARTED|Visit 3||3
7824098|NCT01089062|19259415|P5|STARTED|Visit 3||3
7824099|NCT01089062|19259416|P4|STARTED|Visit 3||4
7824100|NCT01089062|19259417|P3|STARTED|Visit 3||3
7824101|NCT01089062|19259418|P2|STARTED|Visit 3||3
7824102|NCT01089062|19259419|P1|STARTED|Visit 3||3
7824103|NCT01089062|19259414|P6|NOT COMPLETED|Visit 2 (Randomization)||1
7824104|NCT01089062|19259415|P5|NOT COMPLETED|Visit 2 (Randomization)||1
7824105|NCT01089062|19259416|P4|NOT COMPLETED|Visit 2 (Randomization)||0
7824106|NCT01089062|19259417|P3|NOT COMPLETED|Visit 2 (Randomization)||1
7824107|NCT01089062|19259418|P2|NOT COMPLETED|Visit 2 (Randomization)||1
7824108|NCT01089062|19259419|P1|NOT COMPLETED|Visit 2 (Randomization)||1
7824109|NCT01089062|19259414|P6|COMPLETED|Visit 2 (Randomization)||3
7824110|NCT01089062|19259415|P5|COMPLETED|Visit 2 (Randomization)||3
7824111|NCT01089062|19259416|P4|COMPLETED|Visit 2 (Randomization)||4
7824112|NCT01089062|19259417|P3|COMPLETED|Visit 2 (Randomization)||3
7824113|NCT01089062|19259418|P2|COMPLETED|Visit 2 (Randomization)||3
7824114|NCT01089062|19259419|P1|COMPLETED|Visit 2 (Randomization)||3
7824115|NCT01089062|19259414|P6|STARTED|Visit 2 (Randomization)||4
7824116|NCT01089062|19259415|P5|STARTED|Visit 2 (Randomization)||4
7824117|NCT01089062|19259416|P4|STARTED|Visit 2 (Randomization)||4
7824118|NCT01089062|19259417|P3|STARTED|Visit 2 (Randomization)||4
7824119|NCT01089062|19259418|P2|STARTED|Visit 2 (Randomization)||4
7824120|NCT01089062|19259419|P1|STARTED|Visit 2 (Randomization)||4
7824121|NCT01089023|19259442|P1|NOT COMPLETED|Overall Study||7
7824122|NCT01089023|19259442|P1|COMPLETED|Overall Study||88
7824123|NCT01089023|19259442|P1|STARTED|Overall Study||95
7824124|NCT01088997|19259456|P2|NOT COMPLETED|Overall Study||3
7824125|NCT01088997|19259457|P1|NOT COMPLETED|Overall Study||3
7824126|NCT01088997|19259456|P2|COMPLETED|Overall Study||2
7824127|NCT01088997|19259457|P1|COMPLETED|Overall Study||4
7824128|NCT01088997|19259456|P2|STARTED|Overall Study||5
7824129|NCT01088997|19259457|P1|STARTED|Overall Study||7
7824130|NCT01088984|19259468|P2|NOT COMPLETED|Phase 2||32
7824131|NCT01088984|19259469|P1|NOT COMPLETED|Phase 2||0
7824132|NCT01088984|19259468|P2|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
7824133|NCT01088984|19259469|P1|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
7824134|NCT01088984|19259468|P2|STARTED|Phase 2||32
7824135|NCT01088984|19259469|P1|STARTED|Phase 2||0
7824136|NCT01088984|19259468|P2|NOT COMPLETED|Phase 1||6
7824137|NCT01088984|19259469|P1|NOT COMPLETED|Phase 1||5
7824138|NCT01088984|19259468|P2|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
7824139|NCT01088984|19259469|P1|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
7824140|NCT01088984|19259468|P2|STARTED|Phase 1||6
7824141|NCT01088984|19259469|P1|STARTED|Phase 1||5
7824142|NCT01088815|19259487|P1|NOT COMPLETED|Overall Study||0
7824143|NCT01088815|19259487|P1|COMPLETED|Overall Study||72
7824144|NCT01088815|19259487|P1|STARTED|Overall Study||72
7824145|NCT01088711|19259500|P4|NOT COMPLETED|Overall Study||0
7824146|NCT01088711|19259501|P3|NOT COMPLETED|Overall Study||0
7824147|NCT01088711|19259502|P2|NOT COMPLETED|Overall Study||0
7824148|NCT01088711|19259503|P1|NOT COMPLETED|Overall Study||0
7824149|NCT01088711|19259500|P4|COMPLETED|Overall Study||2
7824150|NCT01088711|19259501|P3|COMPLETED|Overall Study||6
7824151|NCT01088711|19259502|P2|COMPLETED|Overall Study||6
7824152|NCT01088711|19259503|P1|COMPLETED|Overall Study||18
7824153|NCT01088711|19259500|P4|STARTED|Overall Study||2
7824154|NCT01088711|19259501|P3|STARTED|Overall Study||6
7824155|NCT01088711|19259502|P2|STARTED|Overall Study||6
7824156|NCT01088711|19259503|P1|STARTED|Overall Study||18
7824157|NCT01088672|19259527|P1|NOT COMPLETED|Overall Study||0
7824158|NCT01088672|19259527|P1|COMPLETED|Overall Study||60
7824159|NCT01088672|19259527|P1|STARTED|Overall Study||60
7824160|NCT01088646|19259533|P1|NOT COMPLETED|Overall Study||0
7824161|NCT01088646|19259533|P1|COMPLETED|Overall Study||25
7824162|NCT01088646|19259533|P1|STARTED|Overall Study||25
7824163|NCT01088529|19259540|P2|NOT COMPLETED|Overall Study||1
7824164|NCT01088529|19259541|P1|NOT COMPLETED|Overall Study||0
7824165|NCT01088529|19259540|P2|COMPLETED|Overall Study||21
7824166|NCT01088529|19259541|P1|COMPLETED|Overall Study||44
7824167|NCT01088529|19259540|P2|Received Treatment|Overall Study||21
7824168|NCT01088529|19259541|P1|Received Treatment|Overall Study||44
7824169|NCT01088529|19259540|P2|STARTED|Overall Study||22
7824170|NCT01088529|19259541|P1|STARTED|Overall Study||44
7824171|NCT01088503|19259554|P3|NOT COMPLETED|Overall Study||17
7824172|NCT01088503|19259555|P2|NOT COMPLETED|Overall Study||685
7824173|NCT01088503|19259556|P1|NOT COMPLETED|Overall Study||182
7824174|NCT01088503|19259554|P3|COMPLETED|Overall Study||241
7824175|NCT01088503|19259555|P2|COMPLETED|Overall Study||8161
7824176|NCT01088503|19259556|P1|COMPLETED|Overall Study||2941
7824177|NCT01088503|19259554|P3|STARTED|Overall Study||258
7824178|NCT01088503|19259555|P2|STARTED|Overall Study||8846
7824179|NCT01088503|19259556|P1|STARTED|Overall Study||3123
7824180|NCT01088464|19259580|P3|NOT COMPLETED|Overall Study||0
7824181|NCT01088464|19259581|P2|NOT COMPLETED|Overall Study||0
7824182|NCT01088464|19259582|P1|NOT COMPLETED|Overall Study||0
7824183|NCT01088464|19259580|P3|COMPLETED|Overall Study||6
7824184|NCT01088464|19259581|P2|COMPLETED|Overall Study||6
7824185|NCT01088464|19259582|P1|COMPLETED|Overall Study||3
7824186|NCT01088464|19259580|P3|Received Any Quantity of Study Drug|Overall Study||6
7824187|NCT01088464|19259581|P2|Received Any Quantity of Study Drug|Overall Study||6
7824188|NCT01088464|19259582|P1|Received Any Quantity of Study Drug|Overall Study||3
7824189|NCT01088464|19259580|P3|STARTED|Overall Study||6
7824190|NCT01088464|19259581|P2|STARTED|Overall Study||6
7824191|NCT01088464|19259582|P1|STARTED|Overall Study||3
7824192|NCT01088438|19259634|P2|NOT COMPLETED|Overall Study||36
7824193|NCT01088438|19259635|P1|NOT COMPLETED|Overall Study||29
7824194|NCT01088438|19259634|P2|COMPLETED|Overall Study||59
7824195|NCT01088438|19259635|P1|COMPLETED|Overall Study||65
7824196|NCT01088438|19259634|P2|STARTED|Overall Study||95
7824197|NCT01088438|19259635|P1|STARTED|Overall Study||94
7824198|NCT01088412|19259648|P3|NOT COMPLETED|Overall Study||72
7824199|NCT01088412|19259649|P2|NOT COMPLETED|Overall Study||436
7824200|NCT01088412|19259650|P1|NOT COMPLETED|Overall Study||18017
7824201|NCT01088412|19259648|P3|COMPLETED|Overall Study||5
7824202|NCT01088412|19259649|P2|COMPLETED|Overall Study||21
7824203|NCT01088412|19259650|P1|COMPLETED|Overall Study||4294
7824204|NCT01088412|19259648|P3|SME+ >= 1 FU and Previous Cancer|Overall Study||0
7824205|NCT01088412|19259649|P2|SME+ >= 1 FU and Previous Cancer|Overall Study||114
7824206|NCT01088412|19259650|P1|SME+ >= 1 FU and Previous Cancer|Overall Study||622
7824207|NCT01088412|19259648|P3|SME+ >= 1 FU and No Previous Cancer|Overall Study||0
7824208|NCT01088412|19259649|P2|SME+ >= 1 FU and No Previous Cancer|Overall Study||192
7824209|NCT01088412|19259650|P1|SME+ >= 1 FU and No Previous Cancer|Overall Study||20556
7824210|NCT01088412|19259648|P3|SME+ >= 1 FU and Unknown Arm|Overall Study||40
7824211|NCT01088412|19259649|P2|SME+ >= 1 FU and Unknown Arm|Overall Study||306
7824212|NCT01088412|19259650|P1|SME+ >= 1 FU and Unknown Arm|Overall Study||21177
7824213|NCT01088412|19259648|P3|SME With at Least 1 Follow Up (FU)|Overall Study||0
7824214|NCT01088412|19259649|P2|SME With at Least 1 Follow Up (FU)|Overall Study||306
7824215|NCT01088412|19259650|P1|SME With at Least 1 Follow Up (FU)|Overall Study||21178
7824216|NCT01088412|19259648|P3|Safety Modified Evaluable (SME)|Overall Study||0
7824217|NCT01088412|19259649|P2|Safety Modified Evaluable (SME)|Overall Study||456
7824218|NCT01088412|19259650|P1|Safety Modified Evaluable (SME)|Overall Study||22294
7824219|NCT01088412|19259648|P3|STARTED|Overall Study||77
7824220|NCT01088412|19259649|P2|STARTED|Overall Study||457
7824221|NCT01088412|19259650|P1|STARTED|Overall Study||22311
7824222|NCT01088399|19259669|P3|NOT COMPLETED|Overall Study||281
7824223|NCT01088399|19259670|P2|NOT COMPLETED|Overall Study||1347
7824224|NCT01088399|19259671|P1|NOT COMPLETED|Overall Study||7121
7824225|NCT01088399|19259669|P3|COMPLETED|Overall Study||21
7824226|NCT01088399|19259670|P2|COMPLETED|Overall Study||308
7824227|NCT01088399|19259671|P1|COMPLETED|Overall Study||1595
7824228|NCT01088399|19259669|P3|STARTED|Overall Study||302
7824229|NCT01088399|19259670|P2|STARTED|Overall Study||1655
7824230|NCT01088399|19259671|P1|STARTED|Overall Study||8716
7824231|NCT01088295|19259694|P1|NOT COMPLETED|Overall Study||1
7824232|NCT01088295|19259694|P1|COMPLETED|Overall Study||35
7824233|NCT01088295|19259694|P1|STARTED|Overall Study||36
7824234|NCT01088243|19259700|P2|NOT COMPLETED|Overall Study||0
7824235|NCT01088243|19259701|P1|NOT COMPLETED|Overall Study||1
7824236|NCT01088243|19259700|P2|COMPLETED|Overall Study||5
7824237|NCT01088243|19259701|P1|COMPLETED|Overall Study||12
7824238|NCT01088243|19259700|P2|STARTED|Overall Study||5
7824239|NCT01088243|19259701|P1|STARTED|Overall Study||13
7824240|NCT01087996|19259719|P2|NOT COMPLETED|Overall Study||0
7824241|NCT01087996|19259720|P1|NOT COMPLETED|Overall Study||0
7824242|NCT01087996|19259719|P2|COMPLETED|Overall Study||15
7824243|NCT01087996|19259720|P1|COMPLETED|Overall Study||15
7824244|NCT01087996|19259719|P2|STARTED|Overall Study||15
7824245|NCT01087996|19259720|P1|STARTED|Overall Study||15
7824246|NCT01087970|19259742|P1|NOT COMPLETED|Overall Study||2
7824247|NCT01087970|19259742|P1|COMPLETED|Overall Study||67
7824248|NCT01087970|19259742|P1|Received Carboplatin|Overall Study||63
7824249|NCT01087970|19259742|P1|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58
7824250|NCT01087970|19259742|P1|Completed 6 Cycles|Overall Study||69
7824251|NCT01087970|19259742|P1|Received ≥1 Dose of Any Study Drug|Overall Study||69
7824252|NCT01087970|19259742|P1|STARTED|Overall Study||69
7824253|NCT01087957|19259754|P2|NOT COMPLETED|Overall Study||55
7824254|NCT01087957|19259755|P1|NOT COMPLETED|Overall Study||41
7824255|NCT01087957|19259754|P2|COMPLETED|Overall Study||187
7824256|NCT01087957|19259755|P1|COMPLETED|Overall Study||212
7824257|NCT01087957|19259754|P2|STARTED|Overall Study||242
7824258|NCT01087957|19259755|P1|STARTED|Overall Study||253
7824259|NCT01087944|19259781|P2|NOT COMPLETED|Period 2 (Week 4-6)||2
7824260|NCT01087944|19259782|P1|NOT COMPLETED|Period 2 (Week 4-6)||0
7824261|NCT01087944|19259781|P2|COMPLETED|Period 2 (Week 4-6)||28
7824262|NCT01087944|19259782|P1|COMPLETED|Period 2 (Week 4-6)||29
7824263|NCT01087944|19259781|P2|STARTED|Period 2 (Week 4-6)||30
7824264|NCT01087944|19259782|P1|STARTED|Period 2 (Week 4-6)||29
7824265|NCT01087944|19259781|P2|NOT COMPLETED|Period 1 (Week 1-3)||0
7824266|NCT01087944|19259782|P1|NOT COMPLETED|Period 1 (Week 1-3)||1
7824267|NCT01087944|19259781|P2|COMPLETED|Period 1 (Week 1-3)||30
7824268|NCT01087944|19259782|P1|COMPLETED|Period 1 (Week 1-3)||29
7824269|NCT01087944|19259781|P2|STARTED|Period 1 (Week 1-3)||30
7824270|NCT01087944|19259782|P1|STARTED|Period 1 (Week 1-3)||30
7824271|NCT01087931|19259812|P2|NOT COMPLETED|Overall Study||0
7824272|NCT01087931|19259813|P1|NOT COMPLETED|Overall Study||0
7824273|NCT01087931|19259812|P2|COMPLETED|Overall Study||20
7824274|NCT01087931|19259813|P1|COMPLETED|Overall Study||20
7824275|NCT01087931|19259812|P2|Final Follow up|Overall Study||17
7824276|NCT01087931|19259813|P1|Final Follow up|Overall Study||19
7824277|NCT01087931|19259812|P2|1st Follow up|Overall Study||19
7824278|NCT01087931|19259813|P1|1st Follow up|Overall Study||20
7824279|NCT01087931|19259812|P2|STARTED|Overall Study||20
7824280|NCT01087931|19259813|P1|STARTED|Overall Study||20
7824281|NCT01087918|19259827|P2|NOT COMPLETED|Overall Study||0
7824282|NCT01087918|19259828|P1|NOT COMPLETED|Overall Study||0
7824283|NCT01087918|19259827|P2|COMPLETED|Overall Study||4
7824284|NCT01087918|19259828|P1|COMPLETED|Overall Study||5
7824285|NCT01087918|19259827|P2|STARTED|Overall Study||4
7824286|NCT01087918|19259828|P1|STARTED|Overall Study||5
7824287|NCT01087905|19259862|P8|NOT COMPLETED|Overall Study||29
7824288|NCT01087905|19259863|P7|NOT COMPLETED|Overall Study||23
7824289|NCT01087905|19259864|P6|NOT COMPLETED|Overall Study||28
7824290|NCT01087905|19259865|P5|NOT COMPLETED|Overall Study||31
7824291|NCT01087905|19259866|P4|NOT COMPLETED|Overall Study||36
7824292|NCT01087905|19259867|P3|NOT COMPLETED|Overall Study||22
7824293|NCT01087905|19259868|P2|NOT COMPLETED|Overall Study||32
7824294|NCT01087905|19259869|P1|NOT COMPLETED|Overall Study||29
7824295|NCT01087905|19259862|P8|COMPLETED|Overall Study||98
7824296|NCT01087905|19259863|P7|COMPLETED|Overall Study||98
7824297|NCT01087905|19259864|P6|COMPLETED|Overall Study||99
7824298|NCT01087905|19259865|P5|COMPLETED|Overall Study||91
7824299|NCT01087905|19259866|P4|COMPLETED|Overall Study||86
7824300|NCT01087905|19259867|P3|COMPLETED|Overall Study||101
7824301|NCT01087905|19259868|P2|COMPLETED|Overall Study||94
7824302|NCT01087905|19259869|P1|COMPLETED|Overall Study||90
7824303|NCT01087905|19259862|P8|STARTED|Overall Study||127
7824304|NCT01087905|19259863|P7|STARTED|Overall Study||121
7824305|NCT01087905|19259864|P6|STARTED|Overall Study||127
7824306|NCT01087905|19259865|P5|STARTED|Overall Study||122
7824307|NCT01087905|19259866|P4|STARTED|Overall Study||122
7824308|NCT01087905|19259867|P3|STARTED|Overall Study||123
7824309|NCT01087905|19259868|P2|STARTED|Overall Study||126
7824310|NCT01087905|19259869|P1|STARTED|Overall Study||119
7824311|NCT01087814|19259891|P2|NOT COMPLETED|Second Intervention (5 Days)||0
7824312|NCT01087814|19259892|P1|NOT COMPLETED|Second Intervention (5 Days)||1
7824313|NCT01087814|19259891|P2|COMPLETED|Second Intervention (5 Days)||6
7824314|NCT01087814|19259892|P1|COMPLETED|Second Intervention (5 Days)||4
7824315|NCT01087814|19259891|P2|STARTED|Second Intervention (5 Days)||6
7824316|NCT01087814|19259892|P1|STARTED|Second Intervention (5 Days)||5
7824317|NCT01087814|19259891|P2|NOT COMPLETED|First Intervention (5 Days)||1
7824318|NCT01087814|19259892|P1|NOT COMPLETED|First Intervention (5 Days)||3
7824319|NCT01087814|19259891|P2|COMPLETED|First Intervention (5 Days)||6
7824320|NCT01087814|19259892|P1|COMPLETED|First Intervention (5 Days)||5
7824321|NCT01087814|19259891|P2|STARTED|First Intervention (5 Days)||7
7824322|NCT01087814|19259892|P1|STARTED|First Intervention (5 Days)||8
7824323|NCT01087801|19259900|P2|NOT COMPLETED|Overall Study||5
7824324|NCT01087801|19259901|P1|NOT COMPLETED|Overall Study||4
7824325|NCT01087801|19259900|P2|COMPLETED|Overall Study||29
7824326|NCT01087801|19259901|P1|COMPLETED|Overall Study||26
7824327|NCT01087801|19259900|P2|STARTED|Overall Study||34
7824328|NCT01087801|19259901|P1|STARTED|Overall Study||30
7824329|NCT01087788|19259910|P3|NOT COMPLETED|Open-Label Period (OL-P)||28
7824330|NCT01087788|19259911|P2|NOT COMPLETED|Open-Label Period (OL-P)||24
7824331|NCT01087788|19259912|P1|NOT COMPLETED|Open-Label Period (OL-P)||30
7824332|NCT01087788|19259910|P3|COMPLETED|Open-Label Period (OL-P)||86
7824333|NCT01087788|19259911|P2|COMPLETED|Open-Label Period (OL-P)||97
7824334|NCT01087788|19259912|P1|COMPLETED|Open-Label Period (OL-P)||81
7824335|NCT01087788|19259910|P3|STARTED|Open-Label Period (OL-P)||114
7824336|NCT01087788|19259911|P2|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121
7824337|NCT01087788|19259912|P1|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111
7824338|NCT01087788|19259910|P3|NOT COMPLETED|24-weeks Dose-blind Period||6
7824339|NCT01087788|19259911|P2|NOT COMPLETED|24-weeks Dose-blind Period||5
7824340|NCT01087788|19259912|P1|NOT COMPLETED|24-weeks Dose-blind Period||7
7824341|NCT01087788|19259910|P3|COMPLETED|24-weeks Dose-blind Period||114
7824342|NCT01087788|19259911|P2|COMPLETED|24-weeks Dose-blind Period||123
7824343|NCT01087788|19259912|P1|COMPLETED|24-weeks Dose-blind Period||113
7824344|NCT01087788|19259910|P3|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
7824345|NCT01087788|19259911|P2|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
7824415|NCT01087541|19260035|P2|NOT COMPLETED|Overall Study||0
7824416|NCT01087541|19260036|P1|NOT COMPLETED|Overall Study||0
7824346|NCT01087788|19259912|P1|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60
7824347|NCT01087788|19259910|P3|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
7824348|NCT01087788|19259911|P2|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
7824349|NCT01087788|19259912|P1|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60
7824350|NCT01087788|19259910|P3|STARTED|24-weeks Dose-blind Period||120
7824351|NCT01087788|19259911|P2|STARTED|24-weeks Dose-blind Period||128
7824352|NCT01087788|19259912|P1|STARTED|24-weeks Dose-blind Period||120
7824353|NCT01087788|19259910|P3|NOT COMPLETED|24-weeks Double-blind Period||15
7824354|NCT01087788|19259911|P2|NOT COMPLETED|24-weeks Double-blind Period||10
7824355|NCT01087788|19259912|P1|NOT COMPLETED|24-weeks Double-blind Period||16
7824356|NCT01087788|19259910|P3|COMPLETED|24-weeks Double-blind Period||120
7824357|NCT01087788|19259911|P2|COMPLETED|24-weeks Double-blind Period||128
7824358|NCT01087788|19259912|P1|COMPLETED|24-weeks Double-blind Period||120
7824359|NCT01087788|19259910|P3|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
7824360|NCT01087788|19259911|P2|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
7824361|NCT01087788|19259912|P1|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29
7824362|NCT01087788|19259910|P3|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
7824363|NCT01087788|19259911|P2|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
7824364|NCT01087788|19259912|P1|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30
7824365|NCT01087788|19259910|P3|STARTED|24-weeks Double-blind Period||135
7824366|NCT01087788|19259911|P2|STARTED|24-weeks Double-blind Period||138
7824367|NCT01087788|19259912|P1|STARTED|24-weeks Double-blind Period||136
7824368|NCT01087775|19259939|P1|NOT COMPLETED|Overall Study||2
7824369|NCT01087775|19259939|P1|COMPLETED|Overall Study|2 subjects were found to be ineligible for the study|23
7824370|NCT01087775|19259939|P1|STARTED|Overall Study||25
7824371|NCT01087762|19259947|P5|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57
7824372|NCT01087762|19259948|P4|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59
7824373|NCT01087762|19259949|P3|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
7824374|NCT01087762|19259950|P2|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
7824375|NCT01087762|19259951|P1|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
7824376|NCT01087762|19259947|P5|COMPLETED|Open-Label Period (Weeks 48-204)||100
7824377|NCT01087762|19259948|P4|COMPLETED|Open-Label Period (Weeks 48-204)||99
7824378|NCT01087762|19259949|P3|COMPLETED|Open-Label Period (Weeks 48-204)||0
7824379|NCT01087762|19259950|P2|COMPLETED|Open-Label Period (Weeks 48-204)||0
7824380|NCT01087762|19259951|P1|COMPLETED|Open-Label Period (Weeks 48-204)||0
7824381|NCT01087762|19259947|P5|STARTED|Open-Label Period (Weeks 48-204)||157
7824382|NCT01087762|19259948|P4|STARTED|Open-Label Period (Weeks 48-204)||158
7824383|NCT01087762|19259949|P3|STARTED|Open-Label Period (Weeks 48-204)||0
7824384|NCT01087762|19259950|P2|STARTED|Open-Label Period (Weeks 48-204)||0
7824385|NCT01087762|19259951|P1|STARTED|Open-Label Period (Weeks 48-204)||0
7824386|NCT01087762|19259947|P5|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
7824387|NCT01087762|19259948|P4|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
7824388|NCT01087762|19259949|P3|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9
7824389|NCT01087762|19259950|P2|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6
7824390|NCT01087762|19259951|P1|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12
7824391|NCT01087762|19259947|P5|COMPLETED|Double Blind Period (Weeks 0-24)||0
7824392|NCT01087762|19259948|P4|COMPLETED|Double Blind Period (Weeks 0-24)||0
7824393|NCT01087762|19259949|P3|COMPLETED|Double Blind Period (Weeks 0-24)||98
7824394|NCT01087762|19259950|P2|COMPLETED|Double Blind Period (Weeks 0-24)||105
7824395|NCT01087762|19259951|P1|COMPLETED|Double Blind Period (Weeks 0-24)||95
7824396|NCT01087762|19259947|P5|STARTED|Double Blind Period (Weeks 0-24)||0
7824397|NCT01087762|19259948|P4|STARTED|Double Blind Period (Weeks 0-24)||0
7824398|NCT01087762|19259949|P3|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
7824399|NCT01087762|19259950|P2|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111
7824400|NCT01087762|19259951|P1|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
7824401|NCT01087736|19259999|P2|NOT COMPLETED|Overall Study||2
7824402|NCT01087736|19260000|P1|NOT COMPLETED|Overall Study||1
7824403|NCT01087736|19259999|P2|COMPLETED|Overall Study||14
7824404|NCT01087736|19260000|P1|COMPLETED|Overall Study||13
7824405|NCT01087736|19259999|P2|STARTED|Overall Study||16
7824406|NCT01087736|19260000|P1|STARTED|Overall Study||14
7824407|NCT01087723|19260010|P2|NOT COMPLETED|Overall Study||20
7824408|NCT01087723|19260011|P1|NOT COMPLETED|Overall Study||14
7824409|NCT01087723|19260010|P2|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089
7824410|NCT01087723|19260011|P1|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075
7824411|NCT01087723|19260010|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094
7824412|NCT01087723|19260011|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099
7824413|NCT01087723|19260010|P2|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109
7824414|NCT01087723|19260011|P1|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089
7824417|NCT01087541|19260035|P2|COMPLETED|Overall Study||3523
7824418|NCT01087541|19260036|P1|COMPLETED|Overall Study||3307
7824419|NCT01087541|19260035|P2|STARTED|Overall Study||3523
7824420|NCT01087541|19260036|P1|STARTED|Overall Study||3307
7824421|NCT01087528|19260052|P1|NOT COMPLETED|Overall Study||7
7824422|NCT01087528|19260052|P1|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44
7824423|NCT01087528|19260052|P1|STARTED|Overall Study||51
7824424|NCT01087502|19260064|P2|NOT COMPLETED|Up to Final Analysis (Week 52)||23
7824425|NCT01087502|19260065|P1|NOT COMPLETED|Up to Final Analysis (Week 52)||33
7824426|NCT01087502|19260064|P2|COMPLETED|Up to Final Analysis (Week 52)||95
7824427|NCT01087502|19260065|P1|COMPLETED|Up to Final Analysis (Week 52)||90
7824428|NCT01087502|19260064|P2|STARTED|Up to Final Analysis (Week 52)||118
7824429|NCT01087502|19260065|P1|STARTED|Up to Final Analysis (Week 52)||123
7824430|NCT01087502|19260064|P2|NOT COMPLETED|Up to Interim Analysis (Week 12)||8
7824431|NCT01087502|19260065|P1|NOT COMPLETED|Up to Interim Analysis (Week 12)||9
7824432|NCT01087502|19260064|P2|COMPLETED|Up to Interim Analysis (Week 12)||110
7824433|NCT01087502|19260065|P1|COMPLETED|Up to Interim Analysis (Week 12)||114
7824434|NCT01087502|19260064|P2|STARTED|Up to Interim Analysis (Week 12)||118
7824435|NCT01087502|19260065|P1|STARTED|Up to Interim Analysis (Week 12)||123
7824436|NCT01087489|19260084|P2|NOT COMPLETED|Overall Study||3
7824437|NCT01087489|19260085|P1|NOT COMPLETED|Overall Study||0
7824438|NCT01087489|19260084|P2|COMPLETED|Overall Study||31
7824439|NCT01087489|19260085|P1|COMPLETED|Overall Study||19
7824440|NCT01087489|19260084|P2|STARTED|Overall Study||34
7824441|NCT01087489|19260085|P1|STARTED|Overall Study||19
7824442|NCT01086969|19260098|P3|NOT COMPLETED|Overall Study||0
7824443|NCT01086969|19260099|P2|NOT COMPLETED|Overall Study||2
7824444|NCT01086969|19260100|P1|NOT COMPLETED|Overall Study||1
7824445|NCT01086969|19260098|P3|COMPLETED|Overall Study||100
7824446|NCT01086969|19260099|P2|COMPLETED|Overall Study||98
7824447|NCT01086969|19260100|P1|COMPLETED|Overall Study||99
7824448|NCT01086969|19260098|P3|STARTED|Overall Study||100
7824449|NCT01086969|19260099|P2|STARTED|Overall Study||100
7824450|NCT01086969|19260100|P1|STARTED|Overall Study||100
7824451|NCT01086852|19260117|P1|NOT COMPLETED|Overall Study||0
7824452|NCT01086852|19260117|P1|COMPLETED|Overall Study||4
7824453|NCT01086852|19260117|P1|STARTED|Overall Study||4
7824454|NCT01086761|19260133|P6|NOT COMPLETED|Overall Study||0
7824455|NCT01086761|19260134|P5|NOT COMPLETED|Overall Study||0
7824456|NCT01086761|19260135|P4|NOT COMPLETED|Overall Study||0
7824457|NCT01086761|19260136|P3|NOT COMPLETED|Overall Study||0
7824458|NCT01086761|19260137|P2|NOT COMPLETED|Overall Study||0
7824459|NCT01086761|19260138|P1|NOT COMPLETED|Overall Study||0
7824460|NCT01086761|19260133|P6|COMPLETED|Overall Study||0
7824461|NCT01086761|19260134|P5|COMPLETED|Overall Study||4
7824462|NCT01086761|19260135|P4|COMPLETED|Overall Study||6
7824463|NCT01086761|19260136|P3|COMPLETED|Overall Study||6
7824464|NCT01086761|19260137|P2|COMPLETED|Overall Study||7
7824465|NCT01086761|19260138|P1|COMPLETED|Overall Study||9
7824466|NCT01086761|19260133|P6|STARTED|Overall Study||0
7824467|NCT01086761|19260134|P5|STARTED|Overall Study||4
7824468|NCT01086761|19260135|P4|STARTED|Overall Study||6
7824469|NCT01086761|19260136|P3|STARTED|Overall Study||6
7824470|NCT01086761|19260137|P2|STARTED|Overall Study||7
7824471|NCT01086761|19260138|P1|STARTED|Overall Study||9
7824472|NCT01086605|19260178|P2|NOT COMPLETED|Overall Study||0
7824473|NCT01086605|19260179|P1|NOT COMPLETED|Overall Study||0
7824474|NCT01086605|19260178|P2|COMPLETED|Overall Study||22
7824475|NCT01086605|19260179|P1|COMPLETED|Overall Study||24
7824476|NCT01086605|19260178|P2|STARTED|Overall Study||22
7824477|NCT01086605|19260179|P1|STARTED|Overall Study||24
7824478|NCT01086540|19260196|P2|NOT COMPLETED|Overall Study||2
7824479|NCT01086540|19260197|P1|NOT COMPLETED|Overall Study||6
7824480|NCT01086540|19260196|P2|COMPLETED|Overall Study||26
7824481|NCT01086540|19260197|P1|COMPLETED|Overall Study||23
7824482|NCT01086540|19260196|P2|STARTED|Overall Study||28
7824483|NCT01086540|19260197|P1|STARTED|Overall Study||29
7824484|NCT01086475|19260241|P2|NOT COMPLETED|Overall Study||0
7824485|NCT01086475|19260242|P1|NOT COMPLETED|Overall Study||0
7824486|NCT01086475|19260241|P2|COMPLETED|Overall Study||33
7824487|NCT01086475|19260242|P1|COMPLETED|Overall Study||34
7824488|NCT01086475|19260241|P2|STARTED|Overall Study||33
7824489|NCT01086475|19260242|P1|STARTED|Overall Study||34
7824490|NCT01086423|19260255|P3|NOT COMPLETED|Overall Study||9
7824491|NCT01086423|19260256|P2|NOT COMPLETED|Overall Study||3
7824492|NCT01086423|19260257|P1|NOT COMPLETED|Overall Study||10
7824493|NCT01086423|19260255|P3|COMPLETED|Overall Study||321
7824494|NCT01086423|19260256|P2|COMPLETED|Overall Study||321
7824495|NCT01086423|19260257|P1|COMPLETED|Overall Study||320
7824496|NCT01086423|19260255|P3|STARTED|Overall Study||330
7824497|NCT01086423|19260256|P2|STARTED|Overall Study||324
7824498|NCT01086423|19260257|P1|STARTED|Overall Study||330
7824499|NCT01086410|19260302|P4|NOT COMPLETED|Overall Study||2
7824500|NCT01086410|19260303|P3|NOT COMPLETED|Overall Study||1
7824501|NCT01086410|19260304|P2|NOT COMPLETED|Overall Study||2
7824502|NCT01086410|19260305|P1|NOT COMPLETED|Overall Study||3
7824503|NCT01086410|19260302|P4|COMPLETED|Overall Study||13
7824504|NCT01086410|19260303|P3|COMPLETED|Overall Study||55
7824505|NCT01086410|19260304|P2|COMPLETED|Overall Study||54
7824506|NCT01086410|19260305|P1|COMPLETED|Overall Study||55
7824507|NCT01086410|19260302|P4|STARTED|Overall Study||15
7824508|NCT01086410|19260303|P3|STARTED|Overall Study||56
7824509|NCT01086410|19260304|P2|STARTED|Overall Study||56
7824510|NCT01086410|19260305|P1|STARTED|Overall Study||58
7824511|NCT01086384|19260401|P3|NOT COMPLETED|Treatment Period||124
7824512|NCT01086384|19260402|P2|NOT COMPLETED|Treatment Period||148
7824513|NCT01086384|19260403|P1|NOT COMPLETED|Treatment Period||0
7824514|NCT01086384|19260401|P3|COMPLETED|Treatment Period||885
7824515|NCT01086384|19260402|P2|COMPLETED|Treatment Period||863
7824516|NCT01086384|19260403|P1|COMPLETED|Treatment Period||0
7824517|NCT01086384|19260401|P3|STARTED|Treatment Period||1009
7824518|NCT01086384|19260402|P2|STARTED|Treatment Period||1011
7824519|NCT01086384|19260403|P1|STARTED|Treatment Period||0
7824520|NCT01086384|19260401|P3|NOT COMPLETED|2-week Run-in Period||0
7824521|NCT01086384|19260402|P2|NOT COMPLETED|2-week Run-in Period||0
7824522|NCT01086384|19260403|P1|NOT COMPLETED|2-week Run-in Period||163
7824523|NCT01086384|19260401|P3|COMPLETED|2-week Run-in Period||0
7824524|NCT01086384|19260402|P2|COMPLETED|2-week Run-in Period||0
7824525|NCT01086384|19260403|P1|COMPLETED|2-week Run-in Period||2020
7824526|NCT01086384|19260401|P3|STARTED|2-week Run-in Period||0
7824527|NCT01086384|19260402|P2|STARTED|2-week Run-in Period||0
7824528|NCT01086384|19260403|P1|STARTED|2-week Run-in Period||2183
7824529|NCT01086358|19260413|P2|NOT COMPLETED|Second Intervention||4
7824530|NCT01086358|19260414|P1|NOT COMPLETED|Second Intervention||4
7824531|NCT01086358|19260413|P2|COMPLETED|Second Intervention||20
7824532|NCT01086358|19260414|P1|COMPLETED|Second Intervention||17
7824533|NCT01086358|19260413|P2|STARTED|Second Intervention||24
7824534|NCT01086358|19260414|P1|STARTED|Second Intervention||21
7824535|NCT01086358|19260413|P2|NOT COMPLETED|First Intervention||5
7824536|NCT01086358|19260414|P1|NOT COMPLETED|First Intervention||9
7824537|NCT01086358|19260413|P2|COMPLETED|First Intervention||24
7824538|NCT01086358|19260414|P1|COMPLETED|First Intervention||21
7824539|NCT01086358|19260413|P2|STARTED|First Intervention|30 subjects enrolled, 1 withdrew before randomization|29
7824540|NCT01086358|19260414|P1|STARTED|First Intervention|30 subjects enrolled.|30
7824541|NCT01086228|19260426|P1|NOT COMPLETED|5-year Follow-up||652
7824542|NCT01086228|19260426|P1|COMPLETED|5-year Follow-up||1012
7824543|NCT01086228|19260426|P1|STARTED|5-year Follow-up||1664
7824544|NCT01086228|19260426|P1|NOT COMPLETED|4-year Follow-up||103
7824545|NCT01086228|19260426|P1|COMPLETED|4-year Follow-up||1664
7824546|NCT01086228|19260426|P1|STARTED|4-year Follow-up||1767
7824547|NCT01086228|19260426|P1|NOT COMPLETED|3-year Follow-up||67
7824548|NCT01086228|19260426|P1|COMPLETED|3-year Follow-up||1767
7824549|NCT01086228|19260426|P1|STARTED|3-year Follow-up||1834
7824550|NCT01086228|19260426|P1|NOT COMPLETED|2-year Follow-up||60
7824551|NCT01086228|19260426|P1|COMPLETED|2-year Follow-up||1834
7824552|NCT01086228|19260426|P1|STARTED|2-year Follow-up||1894
7824553|NCT01086228|19260426|P1|NOT COMPLETED|1-year Follow-up||44
7824554|NCT01086228|19260426|P1|COMPLETED|1-year Follow-up||1894
7824555|NCT01086228|19260426|P1|STARTED|1-year Follow-up||1938
7824556|NCT01086228|19260426|P1|NOT COMPLETED|8 Month Follow-up||71
7824557|NCT01086228|19260426|P1|COMPLETED|8 Month Follow-up||1938
7824558|NCT01086228|19260426|P1|STARTED|8 Month Follow-up|Analysis population|2009
7824559|NCT01086215|19260484|P4|NOT COMPLETED|Overall Study||3
7824560|NCT01086215|19260485|P3|NOT COMPLETED|Overall Study||26
7824561|NCT01086215|19260486|P2|NOT COMPLETED|Overall Study||47
7824562|NCT01086215|19260487|P1|NOT COMPLETED|Overall Study||36
7824563|NCT01086215|19260484|P4|COMPLETED|Overall Study||11
7824564|NCT01086215|19260485|P3|COMPLETED|Overall Study||47
7824565|NCT01086215|19260486|P2|COMPLETED|Overall Study||154
7824566|NCT01086215|19260487|P1|COMPLETED|Overall Study||176
7824567|NCT01086215|19260484|P4|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11
7824568|NCT01086215|19260485|P3|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47
7824569|NCT01086215|19260486|P2|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154
7824570|NCT01086215|19260487|P1|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176
7824571|NCT01086215|19260484|P4|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12
7824572|NCT01086215|19260485|P3|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60
7824573|NCT01086215|19260486|P2|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172
7824574|NCT01086215|19260487|P1|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192
7824575|NCT01086215|19260484|P4|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13
7824576|NCT01086215|19260485|P3|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64
7824577|NCT01086215|19260486|P2|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187
7824578|NCT01086215|19260487|P1|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201
7824579|NCT01086215|19260484|P4|STARTED|Overall Study||14
7824580|NCT01086215|19260485|P3|STARTED|Overall Study||73
7824581|NCT01086215|19260486|P2|STARTED|Overall Study||201
7824582|NCT01086215|19260487|P1|STARTED|Overall Study||212
7824583|NCT01086150|19260508|P3|NOT COMPLETED|Overall Study||1
7824584|NCT01086150|19260509|P2|NOT COMPLETED|Overall Study||6
7824585|NCT01086150|19260510|P1|NOT COMPLETED|Overall Study||0
7824586|NCT01086150|19260508|P3|COMPLETED|Overall Study||12
7824587|NCT01086150|19260509|P2|COMPLETED|Overall Study||21
7824588|NCT01086150|19260510|P1|COMPLETED|Overall Study||11
7824589|NCT01086150|19260508|P3|STARTED|Overall Study||13
7824590|NCT01086150|19260509|P2|STARTED|Overall Study||27
7824591|NCT01086150|19260510|P1|STARTED|Overall Study||11
7824592|NCT01086033|19260521|P1|NOT COMPLETED|Overall Study||304
7824593|NCT01086033|19260521|P1|COMPLETED|Overall Study||262
7824594|NCT01086033|19260521|P1|STARTED|Overall Study||566
7824595|NCT01085968|19260535|P2|NOT COMPLETED|Overall Study||4
7824596|NCT01085968|19260536|P1|NOT COMPLETED|Overall Study||10
7824597|NCT01085968|19260535|P2|COMPLETED|Overall Study||21
7824598|NCT01085968|19260536|P1|COMPLETED|Overall Study||19
7824599|NCT01085968|19260535|P2|STARTED|Overall Study||25
7824600|NCT01085968|19260536|P1|STARTED|Overall Study||29
7824601|NCT01085903|19260552|P3|NOT COMPLETED|Overall Study||0
7824602|NCT01085903|19260553|P2|NOT COMPLETED|Overall Study||0
7824603|NCT01085903|19260554|P1|NOT COMPLETED|Overall Study||0
7824604|NCT01085903|19260552|P3|COMPLETED|Overall Study||3
7824605|NCT01085903|19260553|P2|COMPLETED|Overall Study||4
7824606|NCT01085903|19260554|P1|COMPLETED|Overall Study||21
7824607|NCT01085903|19260552|P3|STARTED|Overall Study||3
7824608|NCT01085903|19260553|P2|STARTED|Overall Study||4
7824609|NCT01085903|19260554|P1|STARTED|Overall Study||21
7824610|NCT01085825|19260580|P2|NOT COMPLETED|Overall Study||1
7824611|NCT01085825|19260581|P1|NOT COMPLETED|Overall Study||1
7824612|NCT01085825|19260580|P2|COMPLETED|Overall Study||247
7824613|NCT01085825|19260581|P1|COMPLETED|Overall Study||251
7824614|NCT01085825|19260580|P2|STARTED|Overall Study||248
7824615|NCT01085825|19260581|P1|STARTED|Overall Study|1st participant enrolled|252
7824616|NCT01085812|19260587|P2|NOT COMPLETED|Double-blind Intent-to-treat Population||56
7824617|NCT01085812|19260588|P1|NOT COMPLETED|Double-blind Intent-to-treat Population||20
7824618|NCT01085812|19260587|P2|COMPLETED|Double-blind Intent-to-treat Population||174
7824619|NCT01085812|19260588|P1|COMPLETED|Double-blind Intent-to-treat Population||92
7824620|NCT01085812|19260587|P2|STARTED|Double-blind Intent-to-treat Population||230
7824621|NCT01085812|19260588|P1|STARTED|Double-blind Intent-to-treat Population||112
7824622|NCT01085812|19260587|P2|NOT COMPLETED|Double-Blind Period||58
7824623|NCT01085812|19260588|P1|NOT COMPLETED|Double-Blind Period||21
7824624|NCT01085812|19260587|P2|COMPLETED|Double-Blind Period||177
7824625|NCT01085812|19260588|P1|COMPLETED|Double-Blind Period||92
7824626|NCT01085812|19260587|P2|STARTED|Double-Blind Period||235
7824627|NCT01085812|19260588|P1|STARTED|Double-Blind Period||113
7824628|NCT01085812|19260587|P2|NOT COMPLETED|Open-Label Period||240
7824629|NCT01085812|19260588|P1|NOT COMPLETED|Open-Label Period||0
7824630|NCT01085812|19260587|P2|COMPLETED|Open-Label Period||494
7824631|NCT01085812|19260588|P1|COMPLETED|Open-Label Period||0
7824632|NCT01085812|19260587|P2|STARTED|Open-Label Period||734
7824633|NCT01085812|19260588|P1|STARTED|Open-Label Period||0
7824634|NCT01085786|19260597|P2|NOT COMPLETED|Overall Study||0
7824635|NCT01085786|19260598|P1|NOT COMPLETED|Overall Study||0
7824636|NCT01085786|19260597|P2|COMPLETED|Overall Study||117
7824637|NCT01085786|19260598|P1|COMPLETED|Overall Study||123
7824638|NCT01085786|19260597|P2|STARTED|Overall Study||117
7824639|NCT01085786|19260598|P1|STARTED|Overall Study||123
7824640|NCT01085760|19260608|P4|NOT COMPLETED|Overall Study||3
7824641|NCT01085760|19260609|P3|NOT COMPLETED|Overall Study||2
7824642|NCT01085760|19260610|P2|NOT COMPLETED|Overall Study||1
7824643|NCT01085760|19260611|P1|NOT COMPLETED|Overall Study||1
7824644|NCT01085760|19260608|P4|COMPLETED|Overall Study||6
7824645|NCT01085760|19260609|P3|COMPLETED|Overall Study||7
7824646|NCT01085760|19260610|P2|COMPLETED|Overall Study||8
7824647|NCT01085760|19260611|P1|COMPLETED|Overall Study||7
7824648|NCT01085760|19260608|P4|STARTED|Overall Study||9
7824649|NCT01085760|19260609|P3|STARTED|Overall Study||9
7824650|NCT01085760|19260610|P2|STARTED|Overall Study||9
7824651|NCT01085760|19260611|P1|STARTED|Overall Study||8
7824652|NCT01085734|19260635|P2|NOT COMPLETED|Overall Study||4
7824653|NCT01085734|19260636|P1|NOT COMPLETED|Overall Study||1
7824654|NCT01085734|19260635|P2|COMPLETED|Overall Study||11
7824655|NCT01085734|19260636|P1|COMPLETED|Overall Study||14
7824656|NCT01085734|19260635|P2|STARTED|Overall Study||15
7824657|NCT01085734|19260636|P1|STARTED|Overall Study||15
7824658|NCT01085682|19260648|P2|NOT COMPLETED|Overall Study||25
7824659|NCT01085682|19260649|P1|NOT COMPLETED|Overall Study||25
7824660|NCT01085682|19260648|P2|COMPLETED|Overall Study||3
7824661|NCT01085682|19260649|P1|COMPLETED|Overall Study||6
7824662|NCT01085682|19260648|P2|STARTED|Overall Study||28
7824663|NCT01085682|19260649|P1|STARTED|Overall Study||31
7824664|NCT01085643|19260655|P1|NOT COMPLETED|Overall Study||0
7824665|NCT01085643|19260655|P1|COMPLETED|Overall Study||4
7824666|NCT01085643|19260655|P1|STARTED|Overall Study||4
7824667|NCT01085630|19260666|P2|NOT COMPLETED|Overall Study||0
7824668|NCT01085630|19260667|P1|NOT COMPLETED|Overall Study||4
7824669|NCT01085630|19260666|P2|COMPLETED|Overall Study||27
7824670|NCT01085630|19260667|P1|COMPLETED|Overall Study||22
7824671|NCT01085630|19260666|P2|STARTED|Overall Study||27
7824672|NCT01085630|19260667|P1|STARTED|Overall Study||26
7824673|NCT01085591|19260680|P3|NOT COMPLETED|Overall Study||7
7824674|NCT01085591|19260681|P2|NOT COMPLETED|Overall Study||6
7824675|NCT01085591|19260682|P1|NOT COMPLETED|Overall Study||3
7824676|NCT01085591|19260680|P3|COMPLETED|Overall Study||63
7824677|NCT01085591|19260681|P2|COMPLETED|Overall Study||65
7824678|NCT01085591|19260682|P1|COMPLETED|Overall Study||66
7824679|NCT01085591|19260680|P3|Received at Least 1 Dose of Study Drug|Overall Study||70
7824680|NCT01085591|19260681|P2|Received at Least 1 Dose of Study Drug|Overall Study||69
7824681|NCT01085591|19260682|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
7824682|NCT01085591|19260680|P3|STARTED|Overall Study||70
7824683|NCT01085591|19260681|P2|STARTED|Overall Study||71
7824684|NCT01085591|19260682|P1|STARTED|Overall Study||69
7824685|NCT01085539|19260705|P1|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0
7824686|NCT01085539|19260705|P1|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50
7824687|NCT01085539|19260705|P1|STARTED|100Sat Secs-100 Second Alarm Evaluation||50
7824688|NCT01085539|19260705|P1|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0
7824689|NCT01085539|19260705|P1|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50
7824690|NCT01085539|19260705|P1|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50
7824691|NCT01085539|19260705|P1|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0
7824692|NCT01085539|19260705|P1|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50
7824693|NCT01085539|19260705|P1|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50
7824694|NCT01085539|19260705|P1|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0
7824695|NCT01085539|19260705|P1|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50
7824696|NCT01085539|19260705|P1|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50
7824697|NCT01085539|19260705|P1|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0
7824698|NCT01085539|19260705|P1|COMPLETED|Sat Secs Off--No Alarm Evaluation||50
7824699|NCT01085539|19260705|P1|STARTED|Sat Secs Off--No Alarm Evaluation||50
7824700|NCT01085513|19260711|P2|NOT COMPLETED|Phase II - Validation Phase||0
7824701|NCT01085513|19260712|P1|NOT COMPLETED|Phase II - Validation Phase||0
7824702|NCT01085513|19260711|P2|COMPLETED|Phase II - Validation Phase||16
7824703|NCT01085513|19260712|P1|COMPLETED|Phase II - Validation Phase||21
7824704|NCT01085513|19260711|P2|STARTED|Phase II - Validation Phase||16
7824705|NCT01085513|19260712|P1|STARTED|Phase II - Validation Phase||21
7824706|NCT01085513|19260711|P2|NOT COMPLETED|Phase I - Development Phase||0
7824707|NCT01085513|19260712|P1|NOT COMPLETED|Phase I - Development Phase||0
7824708|NCT01085513|19260711|P2|COMPLETED|Phase I - Development Phase||52
7824709|NCT01085513|19260712|P1|COMPLETED|Phase I - Development Phase|recruitment was premature terminated|54
7824710|NCT01085513|19260711|P2|STARTED|Phase I - Development Phase||52
7824711|NCT01085513|19260712|P1|STARTED|Phase I - Development Phase||54
7824712|NCT01085500|19260722|P2|NOT COMPLETED|Overall Study||0
7824713|NCT01085500|19260723|P1|NOT COMPLETED|Overall Study||0
7824714|NCT01085500|19260722|P2|COMPLETED|Overall Study||24
7824715|NCT01085500|19260723|P1|COMPLETED|Overall Study||26
7824716|NCT01085500|19260722|P2|STARTED|Overall Study||24
7824717|NCT01085500|19260723|P1|STARTED|Overall Study||26
7824718|NCT01085357|19260735|P2|NOT COMPLETED|Overall Study||6
7824719|NCT01085357|19260736|P1|NOT COMPLETED|Overall Study||19
7824720|NCT01085357|19260735|P2|COMPLETED|Overall Study||125
7824721|NCT01085357|19260736|P1|COMPLETED|Overall Study||355
7824722|NCT01085357|19260735|P2|STARTED|Overall Study||131
7824723|NCT01085357|19260736|P1|STARTED|Overall Study||374
7824724|NCT01085344|19260746|P1|NOT COMPLETED|Overall Study||6
7824725|NCT01085344|19260746|P1|COMPLETED|Overall Study||50
7824726|NCT01085344|19260746|P1|STARTED|Overall Study||56
7824727|NCT01085331|19260758|P2|NOT COMPLETED|Overall Study||0
7824728|NCT01085331|19260759|P1|NOT COMPLETED|Overall Study||0
7824729|NCT01085331|19260758|P2|COMPLETED|Overall Study||6
7824730|NCT01085331|19260759|P1|COMPLETED|Overall Study||10
7824731|NCT01085331|19260758|P2|STARTED|Overall Study||6
7824732|NCT01085331|19260759|P1|STARTED|Overall Study||10
7824733|NCT01085318|19260798|P2|NOT COMPLETED|Overall Study||0
7824734|NCT01085318|19260799|P1|NOT COMPLETED|Overall Study||2
7824735|NCT01085318|19260798|P2|COMPLETED|Overall Study||15
7824736|NCT01085318|19260799|P1|COMPLETED|Overall Study||21
7824737|NCT01085318|19260798|P2|STARTED|Overall Study||15
7824738|NCT01085318|19260799|P1|STARTED|Overall Study||23
7824739|NCT01085214|19260809|P1|NOT COMPLETED|Overall Study||1
7824740|NCT01085214|19260809|P1|COMPLETED|Overall Study||36
7824741|NCT01085214|19260809|P1|STARTED|Overall Study||37
7824742|NCT01085201|19260821|P5|NOT COMPLETED|Overall Study||0
7824743|NCT01085201|19260822|P4|NOT COMPLETED|Overall Study||0
7824744|NCT01085201|19260823|P3|NOT COMPLETED|Overall Study||2
7824745|NCT01085201|19260824|P2|NOT COMPLETED|Overall Study||1
7824746|NCT01085201|19260825|P1|NOT COMPLETED|Overall Study||3
7824747|NCT01085201|19260821|P5|COMPLETED|Overall Study||3
7824748|NCT01085201|19260822|P4|COMPLETED|Overall Study||6
7824749|NCT01085201|19260823|P3|COMPLETED|Overall Study||3
7824750|NCT01085201|19260824|P2|COMPLETED|Overall Study||6
7824751|NCT01085201|19260825|P1|COMPLETED|Overall Study||15
7824752|NCT01085201|19260821|P5|STARTED|Overall Study||3
7824753|NCT01085201|19260822|P4|STARTED|Overall Study||6
7824754|NCT01085201|19260823|P3|STARTED|Overall Study||5
7824755|NCT01085201|19260824|P2|STARTED|Overall Study||7
7824756|NCT01085201|19260825|P1|STARTED|Overall Study||18
7824757|NCT01085136|19260847|P3|NOT COMPLETED|Part B||26
7824758|NCT01085136|19260848|P2|NOT COMPLETED|Part B||51
7824759|NCT01085136|19260849|P1|NOT COMPLETED|Part B||0
7824760|NCT01085136|19260847|P3|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42
7824761|NCT01085136|19260848|P2|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|87
7824762|NCT01085136|19260849|P1|COMPLETED|Part B|Afatinib monotherapy not administered in Part B|0
7824763|NCT01085136|19260847|P3|STARTED|Part B||68
7824764|NCT01085136|19260848|P2|STARTED|Part B||138
7824765|NCT01085136|19260849|P1|STARTED|Part B|Afatinib monotherapy not administered in Part B|0
7824766|NCT01085136|19260847|P3|NOT COMPLETED|Part A||0
7824767|NCT01085136|19260848|P2|NOT COMPLETED|Part A||0
7824768|NCT01085136|19260849|P1|NOT COMPLETED|Part A||323
7824769|NCT01085136|19260847|P3|COMPLETED|Part A||0
7824770|NCT01085136|19260848|P2|COMPLETED|Part A||0
7824771|NCT01085136|19260849|P1|COMPLETED|Part A|Randomized to Part B & completed trial as per protocol, had PD, clinical progression.|831
7824772|NCT01085136|19260847|P3|Randomized to Part B|Part A||0
7824773|NCT01085136|19260848|P2|Randomized to Part B|Part A||0
7824774|NCT01085136|19260849|P1|Randomized to Part B|Part A|Discontinued Part A -Randomized to Part B|206
7824775|NCT01085136|19260847|P3|STARTED|Part A||0
7824776|NCT01085136|19260848|P2|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0
7824777|NCT01085136|19260849|P1|STARTED|Part A||1154
7824778|NCT01085045|19260865|P1|NOT COMPLETED|Part B||15
7824779|NCT01085045|19260865|P1|COMPLETED|Part B||89
7824780|NCT01085045|19260865|P1|GP MDI 36 µg (PT001)|Part B||0
7824781|NCT01085045|19260865|P1|Foradil 12 µg|Part B||41
7824782|NCT01085045|19260865|P1|Placebo MDI|Part B||47
7824783|NCT01085045|19260865|P1|FF MDI 7.2 µg (PT005)|Part B||43
7824784|NCT01085045|19260865|P1|FF MDI 9.6 µg (PT005)|Part B||43
7824785|NCT01085045|19260865|P1|Spiriva 18 µg|Part B||0
7824786|NCT01085045|19260865|P1|GFF MDI 36/9.6 µg|Part B||0
7824787|NCT01085045|19260865|P1|GFF MDI 72/9.6mcg (PT003)|Part B||0
7824788|NCT01085045|19260865|P1|STARTED|Part B||104
7824789|NCT01085045|19260865|P1|NOT COMPLETED|Part A||18
7824790|NCT01085045|19260865|P1|COMPLETED|Part A||104
7824791|NCT01085045|19260865|P1|Foradil 12 µg|Part A||14
7824792|NCT01085045|19260865|P1|Placebo MDI|Part A||5
7824793|NCT01085045|19260865|P1|FF MDI 7.2 µg (PT005)|Part A||21
7824794|NCT01085045|19260865|P1|FF MDI 9.6 µg (PT005)|Part A||20
7824795|NCT01085045|19260865|P1|Spiriva 18 µg|Part A||58
7824796|NCT01085045|19260865|P1|GP MDI 36 µg (PT001)|Part A||40
7824797|NCT01085045|19260865|P1|GFF MDI 36/9.6 µg (PT003)|Part A||42
7824798|NCT01085045|19260865|P1|GFF MDI 72/9.6mcg|Part A||40
7824799|NCT01085045|19260865|P1|STARTED|Part A||122
7824800|NCT01085006|19260967|P2|NOT COMPLETED|Overall Study||0
7824801|NCT01085006|19260968|P1|NOT COMPLETED|Overall Study||0
7824802|NCT01085006|19260967|P2|COMPLETED|Overall Study||50
7824803|NCT01085006|19260968|P1|COMPLETED|Overall Study||50
7824804|NCT01085006|19260967|P2|STARTED|Overall Study||50
7824805|NCT01085006|19260968|P1|STARTED|Overall Study||50
7824806|NCT01084772|19260976|P2|NOT COMPLETED|2 Years||4
7824807|NCT01084772|19260977|P1|NOT COMPLETED|2 Years||9
7824808|NCT01084772|19260976|P2|COMPLETED|2 Years||46
7824809|NCT01084772|19260977|P1|COMPLETED|2 Years||46
7824810|NCT01084772|19260976|P2|STARTED|2 Years||50
7824811|NCT01084772|19260977|P1|STARTED|2 Years||55
7824812|NCT01084772|19260976|P2|NOT COMPLETED|1 Year||8
7824813|NCT01084772|19260977|P1|NOT COMPLETED|1 Year||3
7824814|NCT01084772|19260976|P2|COMPLETED|1 Year||50
7824815|NCT01084772|19260977|P1|COMPLETED|1 Year||55
7824816|NCT01084772|19260976|P2|STARTED|1 Year||58
7824817|NCT01084772|19260977|P1|STARTED|1 Year||58
7824818|NCT01084772|19260976|P2|NOT COMPLETED|3 Months||2
7824819|NCT01084772|19260977|P1|NOT COMPLETED|3 Months||3
7824820|NCT01084772|19260976|P2|COMPLETED|3 Months||58
7824821|NCT01084772|19260977|P1|COMPLETED|3 Months||58
7824822|NCT01084772|19260976|P2|STARTED|3 Months||60
7824823|NCT01084772|19260977|P1|STARTED|3 Months||61
7824824|NCT01084772|19260976|P2|NOT COMPLETED|Baseline||6
7824825|NCT01084772|19260977|P1|NOT COMPLETED|Baseline||7
7824826|NCT01084772|19260976|P2|COMPLETED|Baseline||60
7824827|NCT01084772|19260977|P1|COMPLETED|Baseline||61
7824828|NCT01084772|19260976|P2|STARTED|Baseline||66
7824829|NCT01084772|19260977|P1|STARTED|Baseline||68
7824830|NCT01084759|19261007|P1|NOT COMPLETED|Overall Study||2
7824831|NCT01084759|19261007|P1|COMPLETED|Overall Study||14
7824832|NCT01084759|19261007|P1|STARTED|Overall Study||16
7824833|NCT01084707|19261013|P1|NOT COMPLETED|Overall Study||6
7824834|NCT01084707|19261013|P1|COMPLETED|Overall Study||34
7824835|NCT01084707|19261013|P1|STARTED|Overall Study||40
7824836|NCT01084694|19261049|P2|NOT COMPLETED|Overall Study||20
7824837|NCT01084694|19261050|P1|NOT COMPLETED|Overall Study||6
7824838|NCT01084694|19261049|P2|COMPLETED|Overall Study||30
7824839|NCT01084694|19261050|P1|COMPLETED|Overall Study||44
7824840|NCT01084694|19261049|P2|STARTED|Overall Study||50
7824841|NCT01084694|19261050|P1|STARTED|Overall Study||50
7824842|NCT01084668|19261066|P1|NOT COMPLETED|Overall Study||9
7824843|NCT01084668|19261066|P1|COMPLETED|Overall Study||33
7824844|NCT01084668|19261066|P1|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42
7824845|NCT01084655|19261078|P3|NOT COMPLETED|Overall Study||19
7824846|NCT01084655|19261079|P2|NOT COMPLETED|Overall Study||6
7824847|NCT01084655|19261080|P1|NOT COMPLETED|Overall Study||6
7824848|NCT01084655|19261078|P3|COMPLETED|Overall Study||5
7824849|NCT01084655|19261079|P2|COMPLETED|Overall Study||2
7824850|NCT01084655|19261080|P1|COMPLETED|Overall Study||0
7824851|NCT01084655|19261078|P3|Treated|Overall Study||23
7824852|NCT01084655|19261079|P2|Treated|Overall Study||8
7824853|NCT01084655|19261080|P1|Treated|Overall Study||6
7824854|NCT01084655|19261078|P3|STARTED|Overall Study||24
7824855|NCT01084655|19261079|P2|STARTED|Overall Study||8
7824856|NCT01084655|19261080|P1|STARTED|Overall Study||6
7824857|NCT01084603|19261115|P1|NOT COMPLETED|Oral Nicotine 4||0
7824858|NCT01084603|19261115|P1|COMPLETED|Oral Nicotine 4||39
7824859|NCT01084603|19261115|P1|STARTED|Oral Nicotine 4||39
7824860|NCT01084603|19261115|P1|NOT COMPLETED|Washout Period 4||1
7824861|NCT01084603|19261115|P1|COMPLETED|Washout Period 4||39
7824862|NCT01084603|19261115|P1|STARTED|Washout Period 4||40
7824863|NCT01084603|19261115|P1|NOT COMPLETED|Oral Nicotine 2||0
7824864|NCT01084603|19261115|P1|COMPLETED|Oral Nicotine 2||40
7824865|NCT01084603|19261115|P1|STARTED|Oral Nicotine 2||40
7824866|NCT01084603|19261115|P1|NOT COMPLETED|Washout Period 3||0
7824867|NCT01084603|19261115|P1|COMPLETED|Washout Period 3||40
7824868|NCT01084603|19261115|P1|STARTED|Washout Period 3||40
7824869|NCT01084603|19261115|P1|NOT COMPLETED|Oral Nicotine 1||1
7824870|NCT01084603|19261115|P1|COMPLETED|Oral Nicotine 1||40
7824871|NCT01084603|19261115|P1|STARTED|Oral Nicotine 1||41
7824872|NCT01084603|19261115|P1|NOT COMPLETED|Washout Period 2||0
7824873|NCT01084603|19261115|P1|COMPLETED|Washout Period 2||41
7824874|NCT01084603|19261115|P1|STARTED|Washout Period 2||41
7824875|NCT01084603|19261115|P1|NOT COMPLETED|Nicorette® Gum||1
7824876|NCT01084603|19261115|P1|COMPLETED|Nicorette® Gum||41
7824877|NCT01084603|19261115|P1|STARTED|Nicorette® Gum||42
7824878|NCT01084603|19261115|P1|NOT COMPLETED|Washout Period 1||0
7824879|NCT01084603|19261115|P1|COMPLETED|Washout Period 1||42
7824880|NCT01084603|19261115|P1|STARTED|Washout Period 1||42
7824881|NCT01084603|19261115|P1|NOT COMPLETED|NiQuitinTM Lozenge||1
7824882|NCT01084603|19261115|P1|COMPLETED|NiQuitinTM Lozenge||42
7824883|NCT01084603|19261115|P1|STARTED|NiQuitinTM Lozenge||43
7824884|NCT01084603|19261115|P1|NOT COMPLETED|Baseline||2
7824885|NCT01084603|19261115|P1|COMPLETED|Baseline||43
7824886|NCT01084603|19261115|P1|STARTED|Baseline||45
7824887|NCT01084551|19261151|P3|NOT COMPLETED|Overall Study||8
7824888|NCT01084551|19261152|P2|NOT COMPLETED|Overall Study||14
7824889|NCT01084551|19261153|P1|NOT COMPLETED|Overall Study||9
7824890|NCT01084551|19261151|P3|COMPLETED|Overall Study||86
7824891|NCT01084551|19261152|P2|COMPLETED|Overall Study||81
7824892|NCT01084551|19261153|P1|COMPLETED|Overall Study||86
7824893|NCT01084551|19261151|P3|STARTED|Overall Study||94
7824894|NCT01084551|19261152|P2|STARTED|Overall Study||95
7824895|NCT01084551|19261153|P1|STARTED|Overall Study||95
7824896|NCT01084538|19261191|P1|NOT COMPLETED|Overall Study||68
7824897|NCT01084538|19261191|P1|COMPLETED|Overall Study||113
7824898|NCT01084538|19261191|P1|STARTED|Overall Study||181
7824899|NCT01084499|19261200|P2|NOT COMPLETED|Overall Study||0
7824900|NCT01084499|19261201|P1|NOT COMPLETED|Overall Study||0
7824901|NCT01084499|19261200|P2|COMPLETED|Overall Study|Second Intervention (Sequence 2) : Femara (1 Day)|13
7824902|NCT01084499|19261201|P1|COMPLETED|Overall Study|Second Intervention (Sequence 1) : Peratra (1 Day)|13
7824903|NCT01084499|19261200|P2|Washout (5 Weeks)|Overall Study||13
7824904|NCT01084499|19261201|P1|Washout (5 Weeks)|Overall Study||13
7824905|NCT01084499|19261200|P2|STARTED|Overall Study|First Intervention (Sequence 2) : Peratra (1 Day)|13
7824906|NCT01084499|19261201|P1|STARTED|Overall Study|First Intervention (Sequence 1) : Femara (1 Day)|13
7824907|NCT01084278|19261214|P5|NOT COMPLETED|Overall Study||0
7824908|NCT01084278|19261215|P4|NOT COMPLETED|Overall Study||0
7824909|NCT01084278|19261216|P3|NOT COMPLETED|Overall Study||0
7824910|NCT01084278|19261217|P2|NOT COMPLETED|Overall Study||0
7824911|NCT01084278|19261218|P1|NOT COMPLETED|Overall Study||0
7824912|NCT01084278|19261214|P5|COMPLETED|Overall Study||8
7824913|NCT01084278|19261215|P4|COMPLETED|Overall Study||8
7824914|NCT01084278|19261216|P3|COMPLETED|Overall Study||8
7824915|NCT01084278|19261217|P2|COMPLETED|Overall Study||8
7824916|NCT01084278|19261218|P1|COMPLETED|Overall Study||8
7824917|NCT01084278|19261214|P5|STARTED|Overall Study||8
7824918|NCT01084278|19261215|P4|STARTED|Overall Study||8
7824919|NCT01084278|19261216|P3|STARTED|Overall Study||8
7824920|NCT01084278|19261217|P2|STARTED|Overall Study||8
7824921|NCT01084278|19261218|P1|STARTED|Overall Study||8
7824922|NCT01084265|19261299|P1|NOT COMPLETED|Overall Study||0
7824923|NCT01084265|19261299|P1|COMPLETED|Overall Study||31
7824924|NCT01084265|19261299|P1|STARTED|Overall Study||31
7824925|NCT01084252|19261325|P14|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||55
7824926|NCT01084252|19261326|P13|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||110
7824927|NCT01084252|19261327|P12|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824928|NCT01084252|19261328|P11|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824929|NCT01084252|19261329|P10|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824930|NCT01084252|19261330|P9|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824931|NCT01084252|19261331|P8|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824932|NCT01084252|19261332|P7|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824933|NCT01084252|19261333|P6|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824934|NCT01084252|19261334|P5|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824935|NCT01084252|19261335|P4|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824936|NCT01084252|19261336|P3|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824937|NCT01084252|19261337|P2|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824938|NCT01084252|19261338|P1|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824939|NCT01084252|19261325|P14|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824940|NCT01084252|19261326|P13|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824941|NCT01084252|19261327|P12|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824942|NCT01084252|19261328|P11|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824943|NCT01084252|19261329|P10|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824944|NCT01084252|19261330|P9|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824945|NCT01084252|19261331|P8|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824946|NCT01084252|19261332|P7|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824947|NCT01084252|19261333|P6|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824948|NCT01084252|19261334|P5|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824949|NCT01084252|19261335|P4|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824950|NCT01084252|19261336|P3|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824951|NCT01084252|19261337|P2|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824952|NCT01084252|19261338|P1|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
7824953|NCT01084252|19261325|P14|AT Population|Phase 2 Stage 2 (97 Weeks)||55
7824954|NCT01084252|19261326|P13|AT Population|Phase 2 Stage 2 (97 Weeks)||109
7824955|NCT01084252|19261327|P12|AT Population|Phase 2 Stage 2 (97 Weeks)||0
7824956|NCT01084252|19261328|P11|AT Population|Phase 2 Stage 2 (97 Weeks)||0
7824957|NCT01084252|19261329|P10|AT Population|Phase 2 Stage 2 (97 Weeks)||0
7824958|NCT01084252|19261330|P9|AT Population|Phase 2 Stage 2 (97 Weeks)||0
7824959|NCT01084252|19261331|P8|AT Population|Phase 2 Stage 2 (97 Weeks)||0
7824960|NCT01084252|19261332|P7|AT Population|Phase 2 Stage 2 (97 Weeks)||0
7824961|NCT01084252|19261333|P6|AT Population|Phase 2 Stage 2 (97 Weeks)||0
7824962|NCT01084252|19261334|P5|AT Population|Phase 2 Stage 2 (97 Weeks)||0
7824963|NCT01084252|19261335|P4|AT Population|Phase 2 Stage 2 (97 Weeks)||0
7824964|NCT01084252|19261336|P3|AT Population|Phase 2 Stage 2 (97 Weeks)||0
7824965|NCT01084252|19261337|P2|AT Population|Phase 2 Stage 2 (97 Weeks)||0
7824966|NCT01084252|19261338|P1|AT Population|Phase 2 Stage 2 (97 Weeks)||0
7824967|NCT01084252|19261325|P14|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|55
7824968|NCT01084252|19261326|P13|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|110
7824969|NCT01084252|19261327|P12|STARTED|Phase 2 Stage 2 (97 Weeks)||0
7824970|NCT01084252|19261328|P11|STARTED|Phase 2 Stage 2 (97 Weeks)||0
7824971|NCT01084252|19261329|P10|STARTED|Phase 2 Stage 2 (97 Weeks)||0
7824972|NCT01084252|19261330|P9|STARTED|Phase 2 Stage 2 (97 Weeks)||0
7824973|NCT01084252|19261331|P8|STARTED|Phase 2 Stage 2 (97 Weeks)||0
7824974|NCT01084252|19261332|P7|STARTED|Phase 2 Stage 2 (97 Weeks)||0
7824975|NCT01084252|19261333|P6|STARTED|Phase 2 Stage 2 (97 Weeks)||0
7824976|NCT01084252|19261334|P5|STARTED|Phase 2 Stage 2 (97 Weeks)||0
7824977|NCT01084252|19261335|P4|STARTED|Phase 2 Stage 2 (97 Weeks)||0
7824978|NCT01084252|19261336|P3|STARTED|Phase 2 Stage 2 (97 Weeks)||0
7824979|NCT01084252|19261337|P2|STARTED|Phase 2 Stage 2 (97 Weeks)||0
7824980|NCT01084252|19261338|P1|STARTED|Phase 2 Stage 2 (97 Weeks)||0
7824981|NCT01084252|19261325|P14|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7824982|NCT01084252|19261326|P13|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7824983|NCT01084252|19261327|P12|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
7824984|NCT01084252|19261328|P11|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
7824985|NCT01084252|19261329|P10|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
7824986|NCT01084252|19261330|P9|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
7824987|NCT01084252|19261331|P8|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7824988|NCT01084252|19261332|P7|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7824989|NCT01084252|19261333|P6|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7824990|NCT01084252|19261334|P5|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7824991|NCT01084252|19261335|P4|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7824992|NCT01084252|19261336|P3|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7824993|NCT01084252|19261337|P2|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7824994|NCT01084252|19261338|P1|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7824995|NCT01084252|19261325|P14|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7824996|NCT01084252|19261326|P13|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7824997|NCT01084252|19261327|P12|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7824998|NCT01084252|19261328|P11|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7824999|NCT01084252|19261329|P10|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825000|NCT01084252|19261330|P9|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825001|NCT01084252|19261331|P8|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825002|NCT01084252|19261332|P7|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825003|NCT01084252|19261333|P6|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825004|NCT01084252|19261334|P5|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825005|NCT01084252|19261335|P4|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825006|NCT01084252|19261336|P3|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825007|NCT01084252|19261337|P2|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825008|NCT01084252|19261338|P1|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825009|NCT01084252|19261325|P14|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825010|NCT01084252|19261326|P13|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825011|NCT01084252|19261327|P12|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
7825012|NCT01084252|19261328|P11|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
7825013|NCT01084252|19261329|P10|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
7825014|NCT01084252|19261330|P9|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
7825015|NCT01084252|19261331|P8|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825016|NCT01084252|19261332|P7|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825017|NCT01084252|19261333|P6|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825018|NCT01084252|19261334|P5|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825019|NCT01084252|19261335|P4|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825020|NCT01084252|19261336|P3|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825021|NCT01084252|19261337|P2|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825022|NCT01084252|19261338|P1|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825023|NCT01084252|19261325|P14|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825024|NCT01084252|19261326|P13|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825025|NCT01084252|19261327|P12|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
7825026|NCT01084252|19261328|P11|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
7825027|NCT01084252|19261329|P10|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|24
7825028|NCT01084252|19261330|P9|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|23
7825029|NCT01084252|19261331|P8|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825030|NCT01084252|19261332|P7|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825031|NCT01084252|19261333|P6|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825032|NCT01084252|19261334|P5|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825033|NCT01084252|19261335|P4|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825118|NCT01084148|19261563|P1|STARTED|Overall Study||118
7825034|NCT01084252|19261336|P3|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825035|NCT01084252|19261337|P2|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825036|NCT01084252|19261338|P1|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
7825037|NCT01084252|19261325|P14|NOT COMPLETED|Phase 1 (120 Weeks)||0
7825038|NCT01084252|19261326|P13|NOT COMPLETED|Phase 1 (120 Weeks)||0
7825039|NCT01084252|19261327|P12|NOT COMPLETED|Phase 1 (120 Weeks)||0
7825040|NCT01084252|19261328|P11|NOT COMPLETED|Phase 1 (120 Weeks)||0
7825041|NCT01084252|19261329|P10|NOT COMPLETED|Phase 1 (120 Weeks)||0
7825042|NCT01084252|19261330|P9|NOT COMPLETED|Phase 1 (120 Weeks)||0
7825043|NCT01084252|19261331|P8|NOT COMPLETED|Phase 1 (120 Weeks)||7
7825044|NCT01084252|19261332|P7|NOT COMPLETED|Phase 1 (120 Weeks)||7
7825045|NCT01084252|19261333|P6|NOT COMPLETED|Phase 1 (120 Weeks)||6
7825046|NCT01084252|19261334|P5|NOT COMPLETED|Phase 1 (120 Weeks)||18
7825047|NCT01084252|19261335|P4|NOT COMPLETED|Phase 1 (120 Weeks)||26
7825048|NCT01084252|19261336|P3|NOT COMPLETED|Phase 1 (120 Weeks)||3
7825049|NCT01084252|19261337|P2|NOT COMPLETED|Phase 1 (120 Weeks)||6
7825050|NCT01084252|19261338|P1|NOT COMPLETED|Phase 1 (120 Weeks)||16
7825051|NCT01084252|19261325|P14|COMPLETED|Phase 1 (120 Weeks)||0
7825052|NCT01084252|19261326|P13|COMPLETED|Phase 1 (120 Weeks)||0
7825053|NCT01084252|19261327|P12|COMPLETED|Phase 1 (120 Weeks)||0
7825054|NCT01084252|19261328|P11|COMPLETED|Phase 1 (120 Weeks)||0
7825055|NCT01084252|19261329|P10|COMPLETED|Phase 1 (120 Weeks)||0
7825056|NCT01084252|19261330|P9|COMPLETED|Phase 1 (120 Weeks)||0
7825057|NCT01084252|19261331|P8|COMPLETED|Phase 1 (120 Weeks)||0
7825058|NCT01084252|19261332|P7|COMPLETED|Phase 1 (120 Weeks)||0
7825059|NCT01084252|19261333|P6|COMPLETED|Phase 1 (120 Weeks)||0
7825060|NCT01084252|19261334|P5|COMPLETED|Phase 1 (120 Weeks)||0
7825061|NCT01084252|19261335|P4|COMPLETED|Phase 1 (120 Weeks)||0
7825062|NCT01084252|19261336|P3|COMPLETED|Phase 1 (120 Weeks)||0
7825063|NCT01084252|19261337|P2|COMPLETED|Phase 1 (120 Weeks)||0
7825064|NCT01084252|19261338|P1|COMPLETED|Phase 1 (120 Weeks)||0
7825065|NCT01084252|19261325|P14|All Treated (AT) Population|Phase 1 (120 Weeks)||0
7825066|NCT01084252|19261326|P13|All Treated (AT) Population|Phase 1 (120 Weeks)||0
7825067|NCT01084252|19261327|P12|All Treated (AT) Population|Phase 1 (120 Weeks)||0
7825068|NCT01084252|19261328|P11|All Treated (AT) Population|Phase 1 (120 Weeks)||0
7825069|NCT01084252|19261329|P10|All Treated (AT) Population|Phase 1 (120 Weeks)||0
7825070|NCT01084252|19261330|P9|All Treated (AT) Population|Phase 1 (120 Weeks)||0
7825071|NCT01084252|19261331|P8|All Treated (AT) Population|Phase 1 (120 Weeks)||7
7825072|NCT01084252|19261332|P7|All Treated (AT) Population|Phase 1 (120 Weeks)||7
7825073|NCT01084252|19261333|P6|All Treated (AT) Population|Phase 1 (120 Weeks)||6
7825074|NCT01084252|19261334|P5|All Treated (AT) Population|Phase 1 (120 Weeks)||18
7825075|NCT01084252|19261335|P4|All Treated (AT) Population|Phase 1 (120 Weeks)||26
7825076|NCT01084252|19261336|P3|All Treated (AT) Population|Phase 1 (120 Weeks)||3
7825077|NCT01084252|19261337|P2|All Treated (AT) Population|Phase 1 (120 Weeks)||6
7825078|NCT01084252|19261338|P1|All Treated (AT) Population|Phase 1 (120 Weeks)||16
7825079|NCT01084252|19261325|P14|STARTED|Phase 1 (120 Weeks)||0
7825080|NCT01084252|19261326|P13|STARTED|Phase 1 (120 Weeks)||0
7825081|NCT01084252|19261327|P12|STARTED|Phase 1 (120 Weeks)||0
7825082|NCT01084252|19261328|P11|STARTED|Phase 1 (120 Weeks)||0
7825083|NCT01084252|19261329|P10|STARTED|Phase 1 (120 Weeks)||0
7825084|NCT01084252|19261330|P9|STARTED|Phase 1 (120 Weeks)||0
7825085|NCT01084252|19261331|P8|STARTED|Phase 1 (120 Weeks)||7
7825086|NCT01084252|19261332|P7|STARTED|Phase 1 (120 Weeks)||7
7825087|NCT01084252|19261333|P6|STARTED|Phase 1 (120 Weeks)||6
7825088|NCT01084252|19261334|P5|STARTED|Phase 1 (120 Weeks)||18
7825089|NCT01084252|19261335|P4|STARTED|Phase 1 (120 Weeks)||26
7825090|NCT01084252|19261336|P3|STARTED|Phase 1 (120 Weeks)||3
7825091|NCT01084252|19261337|P2|STARTED|Phase 1 (120 Weeks)||6
7825092|NCT01084252|19261338|P1|STARTED|Phase 1 (120 Weeks)||16
7825093|NCT01084239|19261522|P2|NOT COMPLETED|28-Day Follow-up||9
7825094|NCT01084239|19261523|P1|NOT COMPLETED|28-Day Follow-up||4
7825095|NCT01084239|19261522|P2|COMPLETED|28-Day Follow-up||490
7825096|NCT01084239|19261523|P1|COMPLETED|28-Day Follow-up||497
7825097|NCT01084239|19261522|P2|STARTED|28-Day Follow-up||499
7825098|NCT01084239|19261523|P1|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501
7825099|NCT01084239|19261522|P2|NOT COMPLETED|Randomization - Index Hospitalization||0
7825100|NCT01084239|19261523|P1|NOT COMPLETED|Randomization - Index Hospitalization||0
7825101|NCT01084239|19261522|P2|COMPLETED|Randomization - Index Hospitalization||499
7825102|NCT01084239|19261523|P1|COMPLETED|Randomization - Index Hospitalization||501
7825103|NCT01084239|19261522|P2|STARTED|Randomization - Index Hospitalization||499
7825104|NCT01084239|19261523|P1|STARTED|Randomization - Index Hospitalization||501
7825105|NCT01084174|19261541|P2|NOT COMPLETED|Overall Study||4
7825106|NCT01084174|19261542|P1|NOT COMPLETED|Overall Study||1
7825107|NCT01084174|19261541|P2|COMPLETED|Overall Study||7
7825108|NCT01084174|19261542|P1|COMPLETED|Overall Study||9
7825109|NCT01084174|19261541|P2|STARTED|Overall Study||11
7825110|NCT01084174|19261542|P1|STARTED|Overall Study||10
7825111|NCT01084148|19261562|P2|NOT COMPLETED|Overall Study||16
7825112|NCT01084148|19261563|P1|NOT COMPLETED|Overall Study||30
7825113|NCT01084148|19261562|P2|COMPLETED|Overall Study||102
7825114|NCT01084148|19261563|P1|COMPLETED|Overall Study||88
7825115|NCT01084148|19261562|P2|Treated Patients|Overall Study|Patients who received test product at least once|117
7825116|NCT01084148|19261563|P1|Treated Patients|Overall Study||118
7825117|NCT01084148|19261562|P2|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118
7825119|NCT01084135|19261575|P2|NOT COMPLETED|20 Week||1
7825120|NCT01084135|19261576|P1|NOT COMPLETED|20 Week||0
7825121|NCT01084135|19261575|P2|COMPLETED|20 Week||10
7825122|NCT01084135|19261576|P1|COMPLETED|20 Week||12
7825123|NCT01084135|19261575|P2|STARTED|20 Week||11
7825124|NCT01084135|19261576|P1|STARTED|20 Week||12
7825125|NCT01084135|19261575|P2|NOT COMPLETED|12 Week||0
7825126|NCT01084135|19261576|P1|NOT COMPLETED|12 Week||0
7825127|NCT01084135|19261575|P2|COMPLETED|12 Week||4
7825128|NCT01084135|19261576|P1|COMPLETED|12 Week||4
7825129|NCT01084135|19261575|P2|STARTED|12 Week||4
7825130|NCT01084135|19261576|P1|STARTED|12 Week||4
7825131|NCT01084083|19261586|P1|NOT COMPLETED|Overall Study||12
7825132|NCT01084083|19261586|P1|COMPLETED|Overall Study||78
7825133|NCT01084083|19261586|P1|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44
7825134|NCT01084083|19261586|P1|CR to Induction Therapy|Overall Study||56
7825135|NCT01084083|19261586|P1|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80
7825136|NCT01084083|19261586|P1|Eligible|Overall Study||81
7825137|NCT01084083|19261586|P1|Treated|Overall Study|This is the all treated patients for toxicity analysis|89
7825138|NCT01084083|19261586|P1|STARTED|Overall Study||90
7825139|NCT01084005|19261594|P2|NOT COMPLETED|Overall Study||16
7825140|NCT01084005|19261595|P1|NOT COMPLETED|Overall Study||5
7825141|NCT01084005|19261594|P2|COMPLETED|Overall Study||146
7825142|NCT01084005|19261595|P1|COMPLETED|Overall Study||74
7825143|NCT01084005|19261594|P2|STARTED|Overall Study||162
7825144|NCT01084005|19261595|P1|STARTED|Overall Study||79
7825145|NCT01083979|19261623|P1|NOT COMPLETED|Overall Study||0
7825146|NCT01083979|19261623|P1|COMPLETED|Overall Study||1
7825147|NCT01083979|19261623|P1|STARTED|Overall Study||1
7825148|NCT01083901|19261631|P3|NOT COMPLETED|Overall Study||2
7825149|NCT01083901|19261632|P2|NOT COMPLETED|Overall Study||2
7825150|NCT01083901|19261633|P1|NOT COMPLETED|Overall Study||1
7825151|NCT01083901|19261631|P3|COMPLETED|Overall Study||11
7825152|NCT01083901|19261632|P2|COMPLETED|Overall Study||6
7825153|NCT01083901|19261633|P1|COMPLETED|Overall Study||12
7825154|NCT01083901|19261631|P3|STARTED|Overall Study||13
7825155|NCT01083901|19261632|P2|STARTED|Overall Study||8
7825156|NCT01083901|19261633|P1|STARTED|Overall Study||13
7825157|NCT01083849|19261652|P2|NOT COMPLETED|Overall Study||111
7825158|NCT01083849|19261653|P1|NOT COMPLETED|Overall Study||60
7825159|NCT01083849|19261652|P2|COMPLETED|Overall Study||527
7825160|NCT01083849|19261653|P1|COMPLETED|Overall Study||61
7825161|NCT01083849|19261652|P2|STARTED|Overall Study||638
7825162|NCT01083849|19261653|P1|STARTED|Overall Study||121
7825163|NCT01083810|19261676|P3|NOT COMPLETED|Overall Study||20
7825164|NCT01083810|19261677|P2|NOT COMPLETED|Overall Study||45
7825165|NCT01083810|19261678|P1|NOT COMPLETED|Overall Study||65
7825166|NCT01083810|19261676|P3|COMPLETED|Overall Study||35
7825167|NCT01083810|19261677|P2|COMPLETED|Overall Study||47
7825168|NCT01083810|19261678|P1|COMPLETED|Overall Study||72
7825169|NCT01083810|19261676|P3|STARTED|Overall Study||55
7825170|NCT01083810|19261677|P2|STARTED|Overall Study||92
7825171|NCT01083810|19261678|P1|STARTED|Overall Study||137
7825172|NCT01083771|19261699|P1|NOT COMPLETED|Overall Study||5
7825173|NCT01083771|19261699|P1|COMPLETED|Overall Study||16
7825174|NCT01083771|19261699|P1|STARTED|Overall Study||21
7825175|NCT01083758|19261704|P1|NOT COMPLETED|Overall Study||2
7825176|NCT01083758|19261704|P1|COMPLETED|Overall Study||29
7825177|NCT01083758|19261704|P1|STARTED|Overall Study||31
7825178|NCT01083732|19261738|P3|NOT COMPLETED|Overall Study||0
7825179|NCT01083732|19261739|P2|NOT COMPLETED|Overall Study||0
7825180|NCT01083732|19261740|P1|NOT COMPLETED|Overall Study||0
7825181|NCT01083732|19261738|P3|COMPLETED|Overall Study||3
7825182|NCT01083732|19261739|P2|COMPLETED|Overall Study||9
7825183|NCT01083732|19261740|P1|COMPLETED|Overall Study||6
7825184|NCT01083732|19261738|P3|STARTED|Overall Study||3
7825185|NCT01083732|19261739|P2|STARTED|Overall Study||9
7825186|NCT01083732|19261740|P1|STARTED|Overall Study||6
7825187|NCT01083706|19261791|P1|NOT COMPLETED|Overall Study||0
7825188|NCT01083706|19261791|P1|COMPLETED|Overall Study||39
7825189|NCT01083706|19261791|P1|STARTED|Overall Study||39
7825190|NCT01083693|19261800|P3|NOT COMPLETED|Overall Study||7
7825191|NCT01083693|19261801|P2|NOT COMPLETED|Overall Study||6
7825192|NCT01083693|19261802|P1|NOT COMPLETED|Overall Study||20
7825193|NCT01083693|19261800|P3|COMPLETED|Overall Study||33
7825194|NCT01083693|19261801|P2|COMPLETED|Overall Study||22
7825195|NCT01083693|19261802|P1|COMPLETED|Overall Study||73
7825196|NCT01083693|19261800|P3|STARTED|Overall Study||40
7825197|NCT01083693|19261801|P2|STARTED|Overall Study||28
7825198|NCT01083693|19261802|P1|STARTED|Overall Study||93
7825199|NCT01083680|19261837|P1|NOT COMPLETED|Overall Study||3844
7825200|NCT01083680|19261837|P1|COMPLETED|Overall Study||263
7825201|NCT01083680|19261837|P1|Full Analysis Set (FAS), Efficacy|Overall Study||1621
7825202|NCT01083680|19261837|P1|STARTED|Overall Study||4107
7825203|NCT01083667|19261846|P1|NOT COMPLETED|Overall Study||10
7825204|NCT01083667|19261846|P1|COMPLETED|Overall Study|22 completed to visit 9, the last visit on study.|22
7825205|NCT01083667|19261846|P1|STARTED|Overall Study|enrolled|32
7825206|NCT01083654|19261853|P2|NOT COMPLETED|Overall Study||0
7825207|NCT01083654|19261854|P1|NOT COMPLETED|Overall Study||0
7825208|NCT01083654|19261853|P2|COMPLETED|Overall Study||50
7825209|NCT01083654|19261854|P1|COMPLETED|Overall Study||53
7825210|NCT01083654|19261853|P2|STARTED|Overall Study||50
7825211|NCT01083654|19261854|P1|STARTED|Overall Study||53
7825212|NCT01083641|19261860|P1|NOT COMPLETED|Overall Study||2
7825213|NCT01083641|19261860|P1|COMPLETED|Overall Study||15
7825214|NCT01083641|19261860|P1|STARTED|Overall Study||17
7825215|NCT01083628|19261869|P2|NOT COMPLETED|Overall Study||0
7825216|NCT01083628|19261870|P1|NOT COMPLETED|Overall Study||0
7825217|NCT01083628|19261869|P2|COMPLETED|Overall Study||40
7825218|NCT01083628|19261870|P1|COMPLETED|Overall Study||45
7825219|NCT01083628|19261869|P2|STARTED|Overall Study||40
7825220|NCT01083628|19261870|P1|STARTED|Overall Study||45
7825221|NCT01083602|19261880|P1|NOT COMPLETED|Overall Study||55
7825222|NCT01083602|19261880|P1|COMPLETED|Overall Study||0
7825223|NCT01083602|19261880|P1|STARTED|Overall Study||55
7825224|NCT01083576|19261891|P2|NOT COMPLETED|Overall Study||1
7825225|NCT01083576|19261892|P1|NOT COMPLETED|Overall Study||6
7825226|NCT01083576|19261891|P2|COMPLETED|Overall Study||14
7825227|NCT01083576|19261892|P1|COMPLETED|Overall Study||9
7825228|NCT01083576|19261891|P2|STARTED|Overall Study||15
7825229|NCT01083576|19261892|P1|STARTED|Overall Study||15
7825230|NCT01083485|19261922|P2|NOT COMPLETED|Overall Study||3
7825231|NCT01083485|19261923|P1|NOT COMPLETED|Overall Study||7
7825232|NCT01083485|19261922|P2|COMPLETED|Overall Study||64
7825233|NCT01083485|19261923|P1|COMPLETED|Overall Study||63
7825234|NCT01083485|19261922|P2|STARTED|Overall Study||67
7825235|NCT01083485|19261923|P1|STARTED|Overall Study||70
7825236|NCT01083472|19261933|P2|NOT COMPLETED|Overall Study||0
7825237|NCT01083472|19261934|P1|NOT COMPLETED|Overall Study||0
7825238|NCT01083472|19261933|P2|COMPLETED|Overall Study||19
7825239|NCT01083472|19261934|P1|COMPLETED|Overall Study||18
7825240|NCT01083472|19261933|P2|STARTED|Overall Study||19
7825241|NCT01083472|19261934|P1|STARTED|Overall Study||18
7825242|NCT01083368|19261942|P4|NOT COMPLETED|Phase II - Efficacy/Safety||0
7825243|NCT01083368|19261943|P3|NOT COMPLETED|Phase II - Efficacy/Safety||0
7825244|NCT01083368|19261944|P2|NOT COMPLETED|Phase II - Efficacy/Safety||0
7825245|NCT01083368|19261945|P1|NOT COMPLETED|Phase II - Efficacy/Safety||0
7825246|NCT01083368|19261942|P4|COMPLETED|Phase II - Efficacy/Safety|14 plus 6 participants from previous period|20
7825247|NCT01083368|19261943|P3|COMPLETED|Phase II - Efficacy/Safety||0
7825248|NCT01083368|19261944|P2|COMPLETED|Phase II - Efficacy/Safety||0
7825249|NCT01083368|19261945|P1|COMPLETED|Phase II - Efficacy/Safety||0
7825250|NCT01083368|19261942|P4|STARTED|Phase II - Efficacy/Safety||20
7825251|NCT01083368|19261943|P3|STARTED|Phase II - Efficacy/Safety||0
7825252|NCT01083368|19261944|P2|STARTED|Phase II - Efficacy/Safety||0
7825253|NCT01083368|19261945|P1|STARTED|Phase II - Efficacy/Safety||0
7825254|NCT01083368|19261942|P4|NOT COMPLETED|Dose Escalation Weeks 5-9||0
7825255|NCT01083368|19261943|P3|NOT COMPLETED|Dose Escalation Weeks 5-9||0
7825256|NCT01083368|19261944|P2|NOT COMPLETED|Dose Escalation Weeks 5-9||0
7825257|NCT01083368|19261945|P1|NOT COMPLETED|Dose Escalation Weeks 5-9||0
7825258|NCT01083368|19261942|P4|COMPLETED|Dose Escalation Weeks 5-9|3 participants on dose level 1 moved to dose level 2, 3 more new participants joined.|6
7825259|NCT01083368|19261943|P3|COMPLETED|Dose Escalation Weeks 5-9||1
7825260|NCT01083368|19261944|P2|COMPLETED|Dose Escalation Weeks 5-9||0
7825261|NCT01083368|19261945|P1|COMPLETED|Dose Escalation Weeks 5-9||0
7825262|NCT01083368|19261942|P4|STARTED|Dose Escalation Weeks 5-9||6
7825263|NCT01083368|19261943|P3|STARTED|Dose Escalation Weeks 5-9|Participant on DL1 did not move to dose level 2 because of disease progression.|1
7825264|NCT01083368|19261944|P2|STARTED|Dose Escalation Weeks 5-9||0
7825265|NCT01083368|19261945|P1|STARTED|Dose Escalation Weeks 5-9||0
7825266|NCT01083368|19261942|P4|NOT COMPLETED|Dose Escalation Weeks 1-4||0
7825267|NCT01083368|19261943|P3|NOT COMPLETED|Dose Escalation Weeks 1-4||0
7825268|NCT01083368|19261944|P2|NOT COMPLETED|Dose Escalation Weeks 1-4||0
7825269|NCT01083368|19261945|P1|NOT COMPLETED|Dose Escalation Weeks 1-4||0
7825270|NCT01083368|19261942|P4|COMPLETED|Dose Escalation Weeks 1-4||0
7825271|NCT01083368|19261943|P3|COMPLETED|Dose Escalation Weeks 1-4||4
7825272|NCT01083368|19261944|P2|COMPLETED|Dose Escalation Weeks 1-4||0
7825273|NCT01083368|19261945|P1|COMPLETED|Dose Escalation Weeks 1-4||0
7825274|NCT01083368|19261942|P4|Disease Progression|Dose Escalation Weeks 1-4||0
7825275|NCT01083368|19261943|P3|Disease Progression|Dose Escalation Weeks 1-4||1
7825276|NCT01083368|19261944|P2|Disease Progression|Dose Escalation Weeks 1-4||0
7825277|NCT01083368|19261945|P1|Disease Progression|Dose Escalation Weeks 1-4||0
7825278|NCT01083368|19261942|P4|STARTED|Dose Escalation Weeks 1-4||0
7825279|NCT01083368|19261943|P3|STARTED|Dose Escalation Weeks 1-4||4
7825280|NCT01083368|19261944|P2|STARTED|Dose Escalation Weeks 1-4||0
7825281|NCT01083368|19261945|P1|STARTED|Dose Escalation Weeks 1-4||0
7825282|NCT01083316|19261955|P1|NOT COMPLETED|Overall Study||3
7825283|NCT01083316|19261955|P1|COMPLETED|Overall Study||32
7825284|NCT01083316|19261955|P1|STARTED|Overall Study||35
7825285|NCT01083199|19261962|P1|NOT COMPLETED|Overall Study||0
7825286|NCT01083199|19261962|P1|COMPLETED|Overall Study||10
7825287|NCT01083199|19261962|P1|STARTED|Overall Study||10
7825288|NCT01083186|19261967|P1|NOT COMPLETED|Overall Study||94
7825289|NCT01083186|19261967|P1|COMPLETED|Overall Study||406
7825290|NCT01083186|19261967|P1|STARTED|Overall Study||500
7825291|NCT01083173|19262008|P2|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377
7825292|NCT01083173|19262009|P1|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0
7825293|NCT01083173|19262008|P2|COMPLETED|Long-term Surveillance: Effectiveness Gr||102
7825294|NCT01083173|19262009|P1|COMPLETED|Long-term Surveillance: Effectiveness Gr||0
7825295|NCT01083173|19262008|P2|STARTED|Long-term Surveillance: Effectiveness Gr||479
7825296|NCT01083173|19262009|P1|STARTED|Long-term Surveillance: Effectiveness Gr||0
7825297|NCT01083173|19262008|P2|NOT COMPLETED|Long-term Surveillance: Safety Group||116
7825298|NCT01083173|19262009|P1|NOT COMPLETED|Long-term Surveillance: Safety Group||0
7825299|NCT01083173|19262008|P2|COMPLETED|Long-term Surveillance: Safety Group||479
7825300|NCT01083173|19262009|P1|COMPLETED|Long-term Surveillance: Safety Group||0
7825301|NCT01083173|19262008|P2|STARTED|Long-term Surveillance: Safety Group||595
7825302|NCT01083173|19262009|P1|STARTED|Long-term Surveillance: Safety Group||0
7825303|NCT01083173|19262008|P2|NOT COMPLETED|Main Surveillance: Effectiveness Group||0
7825304|NCT01083173|19262009|P1|NOT COMPLETED|Main Surveillance: Effectiveness Group||382
7825305|NCT01083173|19262008|P2|COMPLETED|Main Surveillance: Effectiveness Group||0
7825306|NCT01083173|19262009|P1|COMPLETED|Main Surveillance: Effectiveness Group||198
7825307|NCT01083173|19262008|P2|STARTED|Main Surveillance: Effectiveness Group||0
7825308|NCT01083173|19262009|P1|STARTED|Main Surveillance: Effectiveness Group||580
7825309|NCT01083173|19262008|P2|NOT COMPLETED|Main Surveillance: Safety Group||0
7825310|NCT01083173|19262009|P1|NOT COMPLETED|Main Surveillance: Safety Group||15
7825311|NCT01083173|19262008|P2|COMPLETED|Main Surveillance: Safety Group||0
7825312|NCT01083173|19262009|P1|COMPLETED|Main Surveillance: Safety Group||580
7825313|NCT01083173|19262008|P2|STARTED|Main Surveillance: Safety Group||0
7825314|NCT01083173|19262009|P1|STARTED|Main Surveillance: Safety Group||595
7825315|NCT01083160|19262027|P1|NOT COMPLETED|Overall Study||1
7825316|NCT01083160|19262027|P1|COMPLETED|Overall Study||81
7825317|NCT01083160|19262027|P1|Evaluable Population|Overall Study||71
7825318|NCT01083160|19262027|P1|STARTED|Overall Study||82
7825319|NCT01083121|19262034|P1|NOT COMPLETED|Overall Study||81
7825320|NCT01083121|19262034|P1|COMPLETED|Overall Study|Participants included in the analysis|1698
7825321|NCT01083121|19262034|P1|STARTED|Overall Study|Participants who were enrolled in the study|1779
7825322|NCT01082965|19262044|P2|NOT COMPLETED|Overall Study||2
7825323|NCT01082965|19262045|P1|NOT COMPLETED|Overall Study||1
7825324|NCT01082965|19262044|P2|COMPLETED|Overall Study||6
7825325|NCT01082965|19262045|P1|COMPLETED|Overall Study||9
7825326|NCT01082965|19262044|P2|STARTED|Overall Study||8
7825327|NCT01082965|19262045|P1|STARTED|Overall Study||10
7825328|NCT01082952|19262065|P2|NOT COMPLETED|Overall Study||0
7825329|NCT01082952|19262066|P1|NOT COMPLETED|Overall Study||0
7825330|NCT01082952|19262065|P2|COMPLETED|Overall Study||6
7825331|NCT01082952|19262066|P1|COMPLETED|Overall Study||6
7825332|NCT01082952|19262065|P2|STARTED|Overall Study||6
7825333|NCT01082952|19262066|P1|STARTED|Overall Study||6
7825334|NCT01082939|19262074|P1|NOT COMPLETED|Overall Study||0
7825335|NCT01082939|19262074|P1|COMPLETED|Overall Study||80
7825336|NCT01082939|19262074|P1|STARTED|Overall Study||80
7825337|NCT01082874|19262082|P4|NOT COMPLETED|Overall Study||13
7825338|NCT01082874|19262083|P3|NOT COMPLETED|Overall Study||11
7825339|NCT01082874|19262084|P2|NOT COMPLETED|Overall Study||12
7825340|NCT01082874|19262085|P1|NOT COMPLETED|Overall Study||11
7825341|NCT01082874|19262082|P4|COMPLETED|Overall Study||2489
7825342|NCT01082874|19262083|P3|COMPLETED|Overall Study||2488
7825343|NCT01082874|19262084|P2|COMPLETED|Overall Study||2498
7825344|NCT01082874|19262085|P1|COMPLETED|Overall Study||2488
7825345|NCT01082874|19262082|P4|STARTED|Overall Study||2502
7825346|NCT01082874|19262083|P3|STARTED|Overall Study||2499
7825347|NCT01082874|19262084|P2|STARTED|Overall Study||2510
7825348|NCT01082874|19262085|P1|STARTED|Overall Study||2499
7825349|NCT01082640|19262098|P3|NOT COMPLETED|Overall Study||8
7825350|NCT01082640|19262099|P2|NOT COMPLETED|Overall Study||15
7825351|NCT01082640|19262100|P1|NOT COMPLETED|Overall Study||17
7825352|NCT01082640|19262098|P3|COMPLETED|Overall Study||24
7825353|NCT01082640|19262099|P2|COMPLETED|Overall Study||17
7825354|NCT01082640|19262100|P1|COMPLETED|Overall Study||15
7825355|NCT01082640|19262098|P3|STARTED|Overall Study||32
7825356|NCT01082640|19262099|P2|STARTED|Overall Study||32
7825357|NCT01082640|19262100|P1|STARTED|Overall Study||32
7825358|NCT01082614|19262122|P2|NOT COMPLETED|Overall Study||5
7825359|NCT01082614|19262123|P1|NOT COMPLETED|Overall Study||3
7825360|NCT01082614|19262122|P2|COMPLETED|Overall Study||18
7825361|NCT01082614|19262123|P1|COMPLETED|Overall Study||20
7825362|NCT01082614|19262122|P2|STARTED|Overall Study||23
7825363|NCT01082614|19262123|P1|STARTED|Overall Study||23
7825364|NCT01082588|19262135|P2|NOT COMPLETED|Overall Study||5
7825365|NCT01082588|19262136|P1|NOT COMPLETED|Overall Study||6
7825366|NCT01082588|19262135|P2|COMPLETED|Overall Study||25
7825367|NCT01082588|19262136|P1|COMPLETED|Overall Study||24
7825368|NCT01082588|19262135|P2|STARTED|Overall Study||30
7825369|NCT01082588|19262136|P1|STARTED|Overall Study||30
7825370|NCT01082575|19262154|P1|NOT COMPLETED|Overall Study||0
7825371|NCT01082575|19262154|P1|COMPLETED|Overall Study||100
7825372|NCT01082575|19262154|P1|STARTED|Overall Study||100
7825373|NCT01082380|19262159|P1|NOT COMPLETED|Overall Study||0
7825374|NCT01082380|19262159|P1|COMPLETED|Overall Study||6
7825375|NCT01082380|19262159|P1|STARTED|Overall Study||6
7825376|NCT01082367|19262194|P2|NOT COMPLETED|Follow-up (F-U) Period||1
7825377|NCT01082367|19262195|P1|NOT COMPLETED|Follow-up (F-U) Period||2
7825378|NCT01082367|19262194|P2|COMPLETED|Follow-up (F-U) Period||9
7825379|NCT01082367|19262195|P1|COMPLETED|Follow-up (F-U) Period||17
7825380|NCT01082367|19262194|P2|Treated in F-U|Follow-up (F-U) Period||5
7825381|NCT01082367|19262195|P1|Treated in F-U|Follow-up (F-U) Period||5
7825382|NCT01082367|19262194|P2|STARTED|Follow-up (F-U) Period||10
7825383|NCT01082367|19262195|P1|STARTED|Follow-up (F-U) Period||19
7825384|NCT01082367|19262194|P2|NOT COMPLETED|Double-blind Period||13
7825385|NCT01082367|19262195|P1|NOT COMPLETED|Double-blind Period||5
7825386|NCT01082367|19262194|P2|COMPLETED|Double-blind Period||12
7825387|NCT01082367|19262195|P1|COMPLETED|Double-blind Period||21
7825552|NCT01081301|19262617|P1|STARTED|Overall Study||36
7825388|NCT01082367|19262194|P2|Stage 4:no tx for Patients Not in co|Double-blind Period||0
7825389|NCT01082367|19262195|P1|Stage 4:no tx for Patients Not in co|Double-blind Period||0
7825390|NCT01082367|19262194|P2|Stage 3: Cross-over (co) tx|Double-blind Period||6
7825391|NCT01082367|19262195|P1|Stage 3: Cross-over (co) tx|Double-blind Period||13
7825392|NCT01082367|19262194|P2|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0
7825393|NCT01082367|19262195|P1|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9
7825394|NCT01082367|19262194|P2|Entered OL TOBI|Double-blind Period||18
7825395|NCT01082367|19262195|P1|Entered OL TOBI|Double-blind Period||4
7825396|NCT01082367|19262194|P2|Stage 2:no tx|Double-blind Period||0
7825397|NCT01082367|19262195|P1|Stage 2:no tx|Double-blind Period||0
7825398|NCT01082367|19262194|P2|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25
7825399|NCT01082367|19262195|P1|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26
7825400|NCT01082367|19262194|P2|STARTED|Double-blind Period||25
7825401|NCT01082367|19262195|P1|STARTED|Double-blind Period||26
7825402|NCT01082328|19262209|P1|NOT COMPLETED|Overall Study||1
7825403|NCT01082328|19262209|P1|COMPLETED|Overall Study||58
7825404|NCT01082328|19262209|P1|STARTED|Overall Study||59
7825405|NCT01082211|19262218|P1|NOT COMPLETED|Overall Study||7
7825406|NCT01082211|19262218|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
7825407|NCT01082211|19262218|P1|All Eligible Patients|Overall Study||58
7825408|NCT01082211|19262218|P1|Has Baseline/36-Month MD QOL Data|Overall Study||27
7825409|NCT01082211|19262218|P1|Has Baseline/36-month PT QOL Data|Overall Study||32
7825410|NCT01082211|19262218|P1|Has Baseline/12-Month MD QOL Data|Overall Study||35
7825411|NCT01082211|19262218|P1|Has Baseline/12-month PT QOL Data|Overall Study||36
7825412|NCT01082211|19262218|P1|Has Baseline MD QOL Data|Overall Study||44
7825413|NCT01082211|19262218|P1|Has Baseline PT QOL Data|Overall Study||46
7825414|NCT01082211|19262218|P1|STARTED|Overall Study||65
7825415|NCT01082159|19262236|P1|NOT COMPLETED|Overall Study||9
7825416|NCT01082159|19262236|P1|COMPLETED|Overall Study||46
7825417|NCT01082159|19262236|P1|STARTED|Overall Study||55
7825418|NCT01082081|19262245|P3|NOT COMPLETED|Overall Study||2
7825419|NCT01082081|19262246|P2|NOT COMPLETED|Overall Study||1
7825420|NCT01082081|19262247|P1|NOT COMPLETED|Overall Study||0
7825421|NCT01082081|19262245|P3|COMPLETED|Overall Study||58
7825422|NCT01082081|19262246|P2|COMPLETED|Overall Study||118
7825423|NCT01082081|19262247|P1|COMPLETED|Overall Study||121
7825424|NCT01082081|19262245|P3|STARTED|Overall Study||60
7825425|NCT01082081|19262246|P2|STARTED|Overall Study||119
7825426|NCT01082081|19262247|P1|STARTED|Overall Study||121
7825427|NCT01081951|19262299|P2|NOT COMPLETED|Overall Study||55
7825428|NCT01081951|19262300|P1|NOT COMPLETED|Overall Study||56
7825429|NCT01081951|19262299|P2|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26
7825430|NCT01081951|19262300|P1|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25
7825431|NCT01081951|19262299|P2|Ongoing Study Treatment at Data Cut-off|Overall Study||0
7825432|NCT01081951|19262300|P1|Ongoing Study Treatment at Data Cut-off|Overall Study||11
7825433|NCT01081951|19262299|P2|Entered Maintenance Phase|Overall Study||55
7825434|NCT01081951|19262300|P1|Entered Maintenance Phase|Overall Study||66
7825435|NCT01081951|19262299|P2|Received Study Treatment|Overall Study||75
7825436|NCT01081951|19262300|P1|Received Study Treatment|Overall Study||81
7825437|NCT01081951|19262299|P2|STARTED|Overall Study||81
7825438|NCT01081951|19262300|P1|STARTED|Overall Study||81
7825439|NCT01081912|19262310|P3|NOT COMPLETED|Maintenance Treatment||92
7825440|NCT01081912|19262311|P2|NOT COMPLETED|Maintenance Treatment||27
7825441|NCT01081912|19262312|P1|NOT COMPLETED|Maintenance Treatment||0
7825442|NCT01081912|19262310|P3|COMPLETED|Maintenance Treatment||59
7825443|NCT01081912|19262311|P2|COMPLETED|Maintenance Treatment||124
7825444|NCT01081912|19262312|P1|COMPLETED|Maintenance Treatment||0
7825445|NCT01081912|19262310|P3|STARTED|Maintenance Treatment||151
7825446|NCT01081912|19262311|P2|STARTED|Maintenance Treatment||151
7825447|NCT01081912|19262312|P1|STARTED|Maintenance Treatment||0
7825448|NCT01081912|19262310|P3|NOT COMPLETED|Conversion/Titration||0
7825449|NCT01081912|19262311|P2|NOT COMPLETED|Conversion/Titration||0
7825450|NCT01081912|19262312|P1|NOT COMPLETED|Conversion/Titration||208
7825451|NCT01081912|19262310|P3|COMPLETED|Conversion/Titration||0
7825452|NCT01081912|19262311|P2|COMPLETED|Conversion/Titration||0
7825453|NCT01081912|19262312|P1|COMPLETED|Conversion/Titration||302
7825454|NCT01081912|19262310|P3|STARTED|Conversion/Titration||0
7825455|NCT01081912|19262311|P2|STARTED|Conversion/Titration||0
7825456|NCT01081912|19262312|P1|STARTED|Conversion/Titration||510
7825457|NCT01081886|19262321|P2|NOT COMPLETED|Overall Study||13
7825458|NCT01081886|19262322|P1|NOT COMPLETED|Overall Study||11
7825459|NCT01081886|19262321|P2|COMPLETED|Overall Study||0
7825460|NCT01081886|19262322|P1|COMPLETED|Overall Study||0
7825461|NCT01081886|19262321|P2|STARTED|Overall Study||13
7825462|NCT01081886|19262322|P1|STARTED|Overall Study||11
7825463|NCT01081873|19262330|P1|NOT COMPLETED|Overall Study||298
7825464|NCT01081873|19262330|P1|COMPLETED|Overall Study||2416
7825465|NCT01081873|19262330|P1|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714
7825466|NCT01081834|19262402|P5|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
7825467|NCT01081834|19262403|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
7825468|NCT01081834|19262404|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
7825469|NCT01081834|19262405|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
7825470|NCT01081834|19262406|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||20
7825471|NCT01081834|19262402|P5|COMPLETED|Extension Period: Week 26 to Week 52||0
7825472|NCT01081834|19262403|P4|COMPLETED|Extension Period: Week 26 to Week 52||0
7825473|NCT01081834|19262404|P3|COMPLETED|Extension Period: Week 26 to Week 52||165
7825474|NCT01081834|19262405|P2|COMPLETED|Extension Period: Week 26 to Week 52||152
7825475|NCT01081834|19262406|P1|COMPLETED|Extension Period: Week 26 to Week 52||135
7825476|NCT01081834|19262402|P5|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
7825477|NCT01081834|19262403|P4|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
7825478|NCT01081834|19262404|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170
7825479|NCT01081834|19262405|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170
7825480|NCT01081834|19262406|P1|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155
7825481|NCT01081834|19262402|P5|NOT COMPLETED|Core Period: Baseline to Week 26||4
7825482|NCT01081834|19262403|P4|NOT COMPLETED|Core Period: Baseline to Week 26||7
7825483|NCT01081834|19262404|P3|NOT COMPLETED|Core Period: Baseline to Week 26||22
7825484|NCT01081834|19262405|P2|NOT COMPLETED|Core Period: Baseline to Week 26||23
7825485|NCT01081834|19262406|P1|NOT COMPLETED|Core Period: Baseline to Week 26||32
7825486|NCT01081834|19262402|P5|COMPLETED|Core Period: Baseline to Week 26||40
7825487|NCT01081834|19262403|P4|COMPLETED|Core Period: Baseline to Week 26||40
7825488|NCT01081834|19262404|P3|COMPLETED|Core Period: Baseline to Week 26||175
7825489|NCT01081834|19262405|P2|COMPLETED|Core Period: Baseline to Week 26||172
7825490|NCT01081834|19262406|P1|COMPLETED|Core Period: Baseline to Week 26||160
7825491|NCT01081834|19262402|P5|STARTED|Core Period: Baseline to Week 26||44
7825492|NCT01081834|19262403|P4|STARTED|Core Period: Baseline to Week 26||47
7825493|NCT01081834|19262404|P3|STARTED|Core Period: Baseline to Week 26||197
7825494|NCT01081834|19262405|P2|STARTED|Core Period: Baseline to Week 26||195
7825495|NCT01081834|19262406|P1|STARTED|Core Period: Baseline to Week 26||192
7825496|NCT01081795|19262467|P3|NOT COMPLETED|Overall Study||30
7825497|NCT01081795|19262468|P2|NOT COMPLETED|Overall Study||35
7825498|NCT01081795|19262469|P1|NOT COMPLETED|Overall Study||33
7825499|NCT01081795|19262467|P3|COMPLETED|Overall Study||97
7825500|NCT01081795|19262468|P2|COMPLETED|Overall Study||95
7825501|NCT01081795|19262469|P1|COMPLETED|Overall Study||97
7825502|NCT01081795|19262467|P3|STARTED|Overall Study||127
7825503|NCT01081795|19262468|P2|STARTED|Overall Study||130
7825504|NCT01081795|19262469|P1|STARTED|Overall Study||130
7825505|NCT01081769|19262506|P2|NOT COMPLETED|CORE Intent-To-Treat||97
7825506|NCT01081769|19262507|P1|NOT COMPLETED|CORE Intent-To-Treat||80
7825507|NCT01081769|19262506|P2|COMPLETED|CORE Intent-To-Treat||266
7825508|NCT01081769|19262507|P1|COMPLETED|CORE Intent-To-Treat||272
7825509|NCT01081769|19262506|P2|STARTED|CORE Intent-To-Treat||363
7825510|NCT01081769|19262507|P1|STARTED|CORE Intent-To-Treat||352
7825511|NCT01081769|19262506|P2|NOT COMPLETED|Whole Intent-to-Treat||25
7825512|NCT01081769|19262507|P1|NOT COMPLETED|Whole Intent-to-Treat||24
7825513|NCT01081769|19262506|P2|COMPLETED|Whole Intent-to-Treat||363
7825514|NCT01081769|19262507|P1|COMPLETED|Whole Intent-to-Treat||352
7825515|NCT01081769|19262506|P2|STARTED|Whole Intent-to-Treat||388
7825516|NCT01081769|19262507|P1|STARTED|Whole Intent-to-Treat||376
7825517|NCT01081678|19262545|P4|NOT COMPLETED|Overall Study||29
7825518|NCT01081678|19262546|P3|NOT COMPLETED|Overall Study||31
7825519|NCT01081678|19262547|P2|NOT COMPLETED|Overall Study||16
7825520|NCT01081678|19262548|P1|NOT COMPLETED|Overall Study||27
7825521|NCT01081678|19262545|P4|COMPLETED|Overall Study||61
7825522|NCT01081678|19262546|P3|COMPLETED|Overall Study||62
7825523|NCT01081678|19262547|P2|COMPLETED|Overall Study||44
7825524|NCT01081678|19262548|P1|COMPLETED|Overall Study||62
7825525|NCT01081678|19262545|P4|Completed 24 Weeks of Study|Overall Study||68
7825526|NCT01081678|19262546|P3|Completed 24 Weeks of Study|Overall Study||72
7825527|NCT01081678|19262547|P2|Completed 24 Weeks of Study|Overall Study||50
7825528|NCT01081678|19262548|P1|Completed 24 Weeks of Study|Overall Study||73
7825529|NCT01081678|19262545|P4|Received Study Drug|Overall Study||89
7825530|NCT01081678|19262546|P3|Received Study Drug|Overall Study||89
7825531|NCT01081678|19262547|P2|Received Study Drug|Overall Study||60
7825532|NCT01081678|19262548|P1|Received Study Drug|Overall Study||87
7825533|NCT01081678|19262545|P4|STARTED|Overall Study||90
7825534|NCT01081678|19262546|P3|STARTED|Overall Study||93
7825535|NCT01081678|19262547|P2|STARTED|Overall Study||60
7825536|NCT01081678|19262548|P1|STARTED|Overall Study||89
7825537|NCT01081665|19262578|P1|NOT COMPLETED|Overall Study||95
7825538|NCT01081665|19262578|P1|COMPLETED|Overall Study||142
7825539|NCT01081665|19262578|P1|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212
7825540|NCT01081665|19262578|P1|Full Analysis Set|Overall Study||237
7825541|NCT01081665|19262578|P1|STARTED|Overall Study||237
7825542|NCT01081626|19262590|P2|NOT COMPLETED|Overall Study||61
7825543|NCT01081626|19262591|P1|NOT COMPLETED|Overall Study||60
7825544|NCT01081626|19262590|P2|COMPLETED|Overall Study||94
7825545|NCT01081626|19262591|P1|COMPLETED|Overall Study||95
7825546|NCT01081626|19262590|P2|Assessed for Efficacy|Overall Study||125
7825547|NCT01081626|19262591|P1|Assessed for Efficacy|Overall Study||122
7825548|NCT01081626|19262590|P2|STARTED|Overall Study||155
7825549|NCT01081626|19262591|P1|STARTED|Overall Study||155
7825550|NCT01081301|19262617|P1|NOT COMPLETED|Overall Study||14
7825551|NCT01081301|19262617|P1|COMPLETED|Overall Study||22
7825553|NCT01081262|19262659|P4|NOT COMPLETED|Overall Study||0
7825554|NCT01081262|19262660|P3|NOT COMPLETED|Overall Study||0
7825555|NCT01081262|19262661|P2|NOT COMPLETED|Overall Study||0
7825556|NCT01081262|19262662|P1|NOT COMPLETED|Overall Study||0
7825557|NCT01081262|19262659|P4|COMPLETED|Overall Study||11
7825558|NCT01081262|19262660|P3|COMPLETED|Overall Study||13
7825559|NCT01081262|19262661|P2|COMPLETED|Overall Study||13
7825560|NCT01081262|19262662|P1|COMPLETED|Overall Study||13
7825561|NCT01081262|19262659|P4|STARTED|Overall Study||11
7825562|NCT01081262|19262660|P3|STARTED|Overall Study||13
7825563|NCT01081262|19262661|P2|STARTED|Overall Study||13
7825564|NCT01081262|19262662|P1|STARTED|Overall Study||13
7825565|NCT01081249|19262692|P2|NOT COMPLETED|Overall Study||1
7825566|NCT01081249|19262693|P1|NOT COMPLETED|Overall Study||0
7825567|NCT01081249|19262692|P2|COMPLETED|Overall Study||6
7825568|NCT01081249|19262693|P1|COMPLETED|Overall Study||11
7825569|NCT01081249|19262692|P2|Second Psychotherapy Appointment (1 Day)|Overall Study||6
7825570|NCT01081249|19262693|P1|Second Psychotherapy Appointment (1 Day)|Overall Study||11
7825571|NCT01081249|19262692|P2|Washout (5-10 Days)|Overall Study||6
7825572|NCT01081249|19262693|P1|Washout (5-10 Days)|Overall Study||11
7825573|NCT01081249|19262692|P2|First Psychotherapy Appointment (1 Day)|Overall Study||6
7825574|NCT01081249|19262693|P1|First Psychotherapy Appointment (1 Day)|Overall Study||11
7825575|NCT01081249|19262692|P2|STARTED|Overall Study||7
7825576|NCT01081249|19262693|P1|STARTED|Overall Study||11
7825577|NCT01081145|19262699|P2|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106
7825578|NCT01081145|19262700|P1|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81
7825579|NCT01081145|19262699|P2|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53
7825580|NCT01081145|19262700|P1|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76
7825581|NCT01081145|19262699|P2|STARTED|Double-Blind Randomized-Withdrawal Phase||159
7825582|NCT01081145|19262700|P1|STARTED|Double-Blind Randomized-Withdrawal Phase||157
7825583|NCT01081145|19262699|P2|NOT COMPLETED|Open-Label Phase||0
7825584|NCT01081145|19262700|P1|NOT COMPLETED|Open-Label Phase||212
7825585|NCT01081145|19262699|P2|COMPLETED|Open-Label Phase||0
7825586|NCT01081145|19262700|P1|COMPLETED|Open-Label Phase||316
7825587|NCT01081145|19262699|P2|STARTED|Open-Label Phase||0
7825588|NCT01081145|19262700|P1|STARTED|Open-Label Phase||528
7825589|NCT01081132|19262728|P2|NOT COMPLETED|Overall Study||52
7825590|NCT01081132|19262729|P1|NOT COMPLETED|Overall Study||55
7825591|NCT01081132|19262728|P2|COMPLETED|Overall Study||105
7825592|NCT01081132|19262729|P1|COMPLETED|Overall Study||102
7825593|NCT01081132|19262728|P2|STARTED|Overall Study||157
7825594|NCT01081132|19262729|P1|STARTED|Overall Study||157
7825595|NCT01081041|19262770|P3|NOT COMPLETED|Overall Study||2
7825596|NCT01081041|19262771|P2|NOT COMPLETED|Overall Study||4
7825597|NCT01081041|19262772|P1|NOT COMPLETED|Overall Study||0
7825598|NCT01081041|19262770|P3|COMPLETED|Overall Study||71
7825599|NCT01081041|19262771|P2|COMPLETED|Overall Study||77
7825600|NCT01081041|19262772|P1|COMPLETED|Overall Study||33
7825601|NCT01081041|19262770|P3|Received at Least 1 Dose of Study Drug|Overall Study||71
7825602|NCT01081041|19262771|P2|Received at Least 1 Dose of Study Drug|Overall Study||77
7825603|NCT01081041|19262772|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
7825604|NCT01081041|19262770|P3|STARTED|Overall Study||73
7825605|NCT01081041|19262771|P2|STARTED|Overall Study||81
7825606|NCT01081041|19262772|P1|STARTED|Overall Study||33
7825607|NCT01080976|19262802|P2|NOT COMPLETED|Overall Study||0
7825608|NCT01080976|19262803|P1|NOT COMPLETED|Overall Study||0
7825609|NCT01080976|19262802|P2|COMPLETED|Overall Study||5
7825610|NCT01080976|19262803|P1|COMPLETED|Overall Study||5
7825611|NCT01080976|19262802|P2|STARTED|Overall Study||5
7825612|NCT01080976|19262803|P1|STARTED|Overall Study||5
7825613|NCT01080807|19262813|P2|NOT COMPLETED|Overall Study||23
7825614|NCT01080807|19262814|P1|NOT COMPLETED|Overall Study||35
7825615|NCT01080807|19262813|P2|COMPLETED|Overall Study||167
7825616|NCT01080807|19262814|P1|COMPLETED|Overall Study||158
7825617|NCT01080807|19262813|P2|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190
7825618|NCT01080807|19262814|P1|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193
7825619|NCT01080794|19262872|P4|NOT COMPLETED|Overall Study||2
7825620|NCT01080794|19262873|P3|NOT COMPLETED|Overall Study||2
7825621|NCT01080794|19262874|P2|NOT COMPLETED|Overall Study||2
7825622|NCT01080794|19262875|P1|NOT COMPLETED|Overall Study||5
7825623|NCT01080794|19262872|P4|COMPLETED|Overall Study||13
7825624|NCT01080794|19262873|P3|COMPLETED|Overall Study||10
7825625|NCT01080794|19262874|P2|COMPLETED|Overall Study||12
7825626|NCT01080794|19262875|P1|COMPLETED|Overall Study||15
7825627|NCT01080794|19262872|P4|STARTED|Overall Study||15
7825628|NCT01080794|19262873|P3|STARTED|Overall Study||12
7825629|NCT01080794|19262874|P2|STARTED|Overall Study||14
7825630|NCT01080794|19262875|P1|STARTED|Overall Study||20
7825631|NCT01080768|19262923|P2|NOT COMPLETED|Overall Study||1
7825632|NCT01080768|19262924|P1|NOT COMPLETED|Overall Study||2
7825633|NCT01080768|19262923|P2|COMPLETED|Overall Study||16
7825634|NCT01080768|19262924|P1|COMPLETED|Overall Study||12
7825635|NCT01080768|19262923|P2|STARTED|Overall Study||17
7825636|NCT01080768|19262924|P1|STARTED|Overall Study||14
7825637|NCT01080716|19262934|P4|NOT COMPLETED|Part 2||0
7825638|NCT01080716|19262935|P3|NOT COMPLETED|Part 2||0
7825639|NCT01080716|19262936|P2|NOT COMPLETED|Part 2||0
7825640|NCT01080716|19262937|P1|NOT COMPLETED|Part 2||0
7825641|NCT01080716|19262934|P4|COMPLETED|Part 2||10
7825642|NCT01080716|19262935|P3|COMPLETED|Part 2||10
7825643|NCT01080716|19262936|P2|COMPLETED|Part 2||0
7825644|NCT01080716|19262937|P1|COMPLETED|Part 2||0
7825645|NCT01080716|19262934|P4|STARTED|Part 2||10
7825646|NCT01080716|19262935|P3|STARTED|Part 2||10
7825647|NCT01080716|19262936|P2|STARTED|Part 2||0
7825648|NCT01080716|19262937|P1|STARTED|Part 2||0
7825649|NCT01080716|19262934|P4|NOT COMPLETED|Part 1||0
7825650|NCT01080716|19262935|P3|NOT COMPLETED|Part 1||0
7825651|NCT01080716|19262936|P2|NOT COMPLETED|Part 1||0
7825652|NCT01080716|19262937|P1|NOT COMPLETED|Part 1||1
7825653|NCT01080716|19262934|P4|COMPLETED|Part 1||0
7825654|NCT01080716|19262935|P3|COMPLETED|Part 1||0
7825655|NCT01080716|19262936|P2|COMPLETED|Part 1||6
7825656|NCT01080716|19262937|P1|COMPLETED|Part 1||13
7825657|NCT01080716|19262934|P4|STARTED|Part 1||0
7825658|NCT01080716|19262935|P3|STARTED|Part 1||0
7825659|NCT01080716|19262936|P2|STARTED|Part 1||6
7825660|NCT01080716|19262937|P1|STARTED|Part 1||14
7825661|NCT01080677|19262954|P3|NOT COMPLETED|Overall Study||0
7825662|NCT01080677|19262955|P2|NOT COMPLETED|Overall Study||0
7825663|NCT01080677|19262956|P1|NOT COMPLETED|Overall Study||0
7825664|NCT01080677|19262954|P3|COMPLETED|Overall Study||20
7825665|NCT01080677|19262955|P2|COMPLETED|Overall Study||20
7825666|NCT01080677|19262956|P1|COMPLETED|Overall Study||20
7825667|NCT01080677|19262954|P3|STARTED|Overall Study||20
7825668|NCT01080677|19262955|P2|STARTED|Overall Study||20
7825669|NCT01080677|19262956|P1|STARTED|Overall Study||20
7825670|NCT01080625|19262976|P3|NOT COMPLETED|Overall Study||1
7825671|NCT01080625|19262977|P2|NOT COMPLETED|Overall Study||2
7825672|NCT01080625|19262978|P1|NOT COMPLETED|Overall Study||0
7825673|NCT01080625|19262976|P3|COMPLETED|Overall Study||31
7825674|NCT01080625|19262977|P2|COMPLETED|Overall Study||31
7825675|NCT01080625|19262978|P1|COMPLETED|Overall Study||31
7825676|NCT01080625|19262976|P3|STARTED|Overall Study||32
7825677|NCT01080625|19262977|P2|STARTED|Overall Study||33
7825678|NCT01080625|19262978|P1|STARTED|Overall Study||31
7825679|NCT01080391|19262988|P2|NOT COMPLETED|Overall Study||4
7825680|NCT01080391|19262989|P1|NOT COMPLETED|Overall Study||7
7825681|NCT01080391|19262988|P2|COMPLETED|Overall Study||392
7825682|NCT01080391|19262989|P1|COMPLETED|Overall Study||389
7825683|NCT01080391|19262988|P2|Treated|Overall Study||392
7825684|NCT01080391|19262989|P1|Treated|Overall Study||389
7825685|NCT01080391|19262988|P2|STARTED|Overall Study||396
7825686|NCT01080391|19262989|P1|STARTED|Overall Study||396
7825687|NCT01080326|19263007|P1|NOT COMPLETED|Overall Study||4
7825688|NCT01080326|19263007|P1|COMPLETED|Overall Study||3
7825689|NCT01080326|19263007|P1|STARTED|Overall Study||7
7825690|NCT01080300|19263013|P2|NOT COMPLETED|Overall Study||104
7825691|NCT01080300|19263014|P1|NOT COMPLETED|Overall Study||94
7825692|NCT01080300|19263013|P2|COMPLETED|Overall Study||191
7825693|NCT01080300|19263014|P1|COMPLETED|Overall Study||206
7825694|NCT01080300|19263013|P2|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295
7825695|NCT01080300|19263014|P1|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300
7825696|NCT01080261|19263042|P1|NOT COMPLETED|Overall Study||0
7825697|NCT01080261|19263042|P1|COMPLETED|Overall Study||60
7825698|NCT01080261|19263042|P1|STARTED|Overall Study||60
7825699|NCT01080248|19263057|P1|NOT COMPLETED|Overall Study||0
7825700|NCT01080248|19263057|P1|COMPLETED|Overall Study||2
7825701|NCT01080248|19263057|P1|STARTED|Overall Study||2
7825702|NCT01080209|19263071|P7|NOT COMPLETED|Overall Study||7
7825703|NCT01080209|19263072|P6|NOT COMPLETED|Overall Study||0
7825704|NCT01080209|19263073|P5|NOT COMPLETED|Overall Study||0
7825705|NCT01080209|19263074|P4|NOT COMPLETED|Overall Study||5
7825706|NCT01080209|19263075|P3|NOT COMPLETED|Overall Study||5
7825707|NCT01080209|19263076|P2|NOT COMPLETED|Overall Study||11
7825708|NCT01080209|19263077|P1|NOT COMPLETED|Overall Study||6
7825709|NCT01080209|19263071|P7|COMPLETED|Overall Study||44
7825710|NCT01080209|19263072|P6|COMPLETED|Overall Study||2
7825711|NCT01080209|19263073|P5|COMPLETED|Overall Study||6
7825712|NCT01080209|19263074|P4|COMPLETED|Overall Study||37
7825713|NCT01080209|19263075|P3|COMPLETED|Overall Study||28
7825714|NCT01080209|19263076|P2|COMPLETED|Overall Study||42
7825715|NCT01080209|19263077|P1|COMPLETED|Overall Study||22
7825716|NCT01080209|19263071|P7|STARTED|Overall Study||51
7825717|NCT01080209|19263072|P6|STARTED|Overall Study||2
7825718|NCT01080209|19263073|P5|STARTED|Overall Study||6
7825719|NCT01080209|19263074|P4|STARTED|Overall Study||42
7825720|NCT01080209|19263075|P3|STARTED|Overall Study||33
7825721|NCT01080209|19263076|P2|STARTED|Overall Study||53
7825722|NCT01080209|19263077|P1|STARTED|Overall Study||28
7825723|NCT01080196|19263102|P2|NOT COMPLETED|Overall Study||0
7825724|NCT01080196|19263103|P1|NOT COMPLETED|Overall Study||0
7825725|NCT01080196|19263102|P2|COMPLETED|Overall Study||66
7825726|NCT01080196|19263103|P1|COMPLETED|Overall Study||68
7825727|NCT01080196|19263102|P2|STARTED|Overall Study||66
7825728|NCT01080196|19263103|P1|STARTED|Overall Study||68
7825729|NCT01080131|19263119|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11
7825730|NCT01080131|19263120|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8
7825731|NCT01080131|19263119|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||54
7825732|NCT01080131|19263120|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||64
7825733|NCT01080131|19263119|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41
7825734|NCT01080131|19263120|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62
7825735|NCT01080131|19263119|P2|STARTED|Extension Study 2 (25-72 Weeks)||65
7825736|NCT01080131|19263120|P1|STARTED|Extension Study 2 (25-72 Weeks)||72
7825737|NCT01080131|19263119|P2|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4
7825738|NCT01080131|19263120|P1|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6
7825739|NCT01080131|19263119|P2|COMPLETED|Extension Study 1 (12 -24 Weeks)||72
7825740|NCT01080131|19263120|P1|COMPLETED|Extension Study 1 (12 -24 Weeks)||78
7825741|NCT01080131|19263119|P2|STARTED|Extension Study 1 (12 -24 Weeks)||76
7825742|NCT01080131|19263120|P1|STARTED|Extension Study 1 (12 -24 Weeks)||84
7825743|NCT01080131|19263119|P2|NOT COMPLETED|Core Study (0- 12 Weeks)||11
7825744|NCT01080131|19263120|P1|NOT COMPLETED|Core Study (0- 12 Weeks)||13
7825745|NCT01080131|19263119|P2|COMPLETED|Core Study (0- 12 Weeks)||103
7825746|NCT01080131|19263120|P1|COMPLETED|Core Study (0- 12 Weeks)||99
7825747|NCT01080131|19263119|P2|STARTED|Core Study (0- 12 Weeks)||114
7825748|NCT01080131|19263120|P1|STARTED|Core Study (0- 12 Weeks)||112
7825749|NCT01080118|19263199|P4|NOT COMPLETED|Overall Study||0
7825750|NCT01080118|19263200|P3|NOT COMPLETED|Overall Study||0
7825751|NCT01080118|19263201|P2|NOT COMPLETED|Overall Study||0
7825752|NCT01080118|19263202|P1|NOT COMPLETED|Overall Study||0
7825753|NCT01080118|19263199|P4|COMPLETED|Overall Study||30
7825754|NCT01080118|19263200|P3|COMPLETED|Overall Study||30
7825755|NCT01080118|19263201|P2|COMPLETED|Overall Study||15
7825756|NCT01080118|19263202|P1|COMPLETED|Overall Study||15
7825757|NCT01080118|19263199|P4|STARTED|Overall Study||30
7825758|NCT01080118|19263200|P3|STARTED|Overall Study||30
7825759|NCT01080118|19263201|P2|STARTED|Overall Study||15
7825760|NCT01080118|19263202|P1|STARTED|Overall Study||15
7825761|NCT01079988|19263215|P5|NOT COMPLETED|Overall Study||1
7825762|NCT01079988|19263216|P4|NOT COMPLETED|Overall Study||3
7825763|NCT01079988|19263217|P3|NOT COMPLETED|Overall Study||0
7825764|NCT01079988|19263218|P2|NOT COMPLETED|Overall Study||0
7825765|NCT01079988|19263219|P1|NOT COMPLETED|Overall Study||1
7825766|NCT01079988|19263215|P5|COMPLETED|Overall Study||1
7825767|NCT01079988|19263216|P4|COMPLETED|Overall Study||17
7825768|NCT01079988|19263217|P3|COMPLETED|Overall Study||8
7825769|NCT01079988|19263218|P2|COMPLETED|Overall Study||1
7825770|NCT01079988|19263219|P1|COMPLETED|Overall Study||9
7825771|NCT01079988|19263215|P5|STARTED|Overall Study||2
7825772|NCT01079988|19263216|P4|STARTED|Overall Study||20
7825773|NCT01079988|19263217|P3|STARTED|Overall Study||8
7825774|NCT01079988|19263218|P2|STARTED|Overall Study||1
7825775|NCT01079988|19263219|P1|STARTED|Overall Study||10
7825776|NCT01079962|19263238|P2|NOT COMPLETED|Overall Study||15
7825777|NCT01079962|19263239|P1|NOT COMPLETED|Overall Study||15
7825778|NCT01079962|19263238|P2|COMPLETED|Overall Study||89
7825779|NCT01079962|19263239|P1|COMPLETED|Overall Study||90
7825780|NCT01079962|19263238|P2|STARTED|Overall Study||104
7825781|NCT01079962|19263239|P1|STARTED|Overall Study||105
7825782|NCT01079949|19263267|P2|NOT COMPLETED|Overall Study||13
7825783|NCT01079949|19263268|P1|NOT COMPLETED|Overall Study||15
7825784|NCT01079949|19263267|P2|COMPLETED|Overall Study||34
7825785|NCT01079949|19263268|P1|COMPLETED|Overall Study||31
7825786|NCT01079949|19263267|P2|STARTED|Overall Study||47
7825787|NCT01079949|19263268|P1|STARTED|Overall Study||46
7825788|NCT01079936|19263314|P5|NOT COMPLETED|Phase II||1
7825789|NCT01079936|19263315|P4|NOT COMPLETED|Phase II||0
7825790|NCT01079936|19263316|P3|NOT COMPLETED|Phase II||1
7825791|NCT01079936|19263317|P2|NOT COMPLETED|Phase II||0
7825792|NCT01079936|19263318|P1|NOT COMPLETED|Phase II||0
7825793|NCT01079936|19263314|P5|COMPLETED|Phase II||25
7825794|NCT01079936|19263315|P4|COMPLETED|Phase II||24
7825795|NCT01079936|19263316|P3|COMPLETED|Phase II||5
7825796|NCT01079936|19263317|P2|COMPLETED|Phase II||3
7825797|NCT01079936|19263318|P1|COMPLETED|Phase II||0
7825798|NCT01079936|19263314|P5|STARTED|Phase II||26
7825799|NCT01079936|19263315|P4|STARTED|Phase II||24
7825800|NCT01079936|19263316|P3|STARTED|Phase II||6
7825801|NCT01079936|19263317|P2|STARTED|Phase II||3
7825802|NCT01079936|19263318|P1|STARTED|Phase II||0
7825803|NCT01079936|19263314|P5|NOT COMPLETED|Phase I: MTD||0
7825804|NCT01079936|19263315|P4|NOT COMPLETED|Phase I: MTD||0
7825805|NCT01079936|19263316|P3|NOT COMPLETED|Phase I: MTD||0
7825806|NCT01079936|19263317|P2|NOT COMPLETED|Phase I: MTD||0
7825807|NCT01079936|19263318|P1|NOT COMPLETED|Phase I: MTD||4
7825808|NCT01079936|19263314|P5|COMPLETED|Phase I: MTD||0
7825809|NCT01079936|19263315|P4|COMPLETED|Phase I: MTD||0
7825810|NCT01079936|19263316|P3|COMPLETED|Phase I: MTD||0
7825811|NCT01079936|19263317|P2|COMPLETED|Phase I: MTD||0
7825812|NCT01079936|19263318|P1|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12
7825813|NCT01079936|19263314|P5|STARTED|Phase I: MTD||0
7825814|NCT01079936|19263315|P4|STARTED|Phase I: MTD||0
7825815|NCT01079936|19263316|P3|STARTED|Phase I: MTD||0
7825816|NCT01079936|19263317|P2|STARTED|Phase I: MTD||0
7825817|NCT01079936|19263318|P1|STARTED|Phase I: MTD||16
7825818|NCT01079832|19263337|P1|NOT COMPLETED|Overall Study||1
7825819|NCT01079832|19263337|P1|COMPLETED|Overall Study||49
7825820|NCT01079832|19263337|P1|STARTED|Overall Study||50
7825821|NCT01079806|19263347|P2|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||15
7825822|NCT01079806|19263348|P1|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||19
7825823|NCT01079806|19263347|P2|COMPLETED|Long-term Follow-up: Day 1-End of Study||43
7825824|NCT01079806|19263348|P1|COMPLETED|Long-term Follow-up: Day 1-End of Study||92
7825825|NCT01079806|19263347|P2|STARTED|Long-term Follow-up: Day 1-End of Study||58
7825826|NCT01079806|19263348|P1|STARTED|Long-term Follow-up: Day 1-End of Study||111
7825827|NCT01079806|19263347|P2|NOT COMPLETED|Day 1 to Week 96||7
7825828|NCT01079806|19263348|P1|NOT COMPLETED|Day 1 to Week 96||7
7825829|NCT01079806|19263347|P2|COMPLETED|Day 1 to Week 96||53
7825830|NCT01079806|19263348|P1|COMPLETED|Day 1 to Week 96||113
7825831|NCT01079806|19263347|P2|Primary Endpoint Cohort|Day 1 to Week 96||41
7825832|NCT01079806|19263348|P1|Primary Endpoint Cohort|Day 1 to Week 96||82
7825833|NCT01079806|19263347|P2|Received Treatment|Day 1 to Week 96||60
7825834|NCT01079806|19263348|P1|Received Treatment|Day 1 to Week 96||120
7825835|NCT01079806|19263347|P2|STARTED|Day 1 to Week 96||60
7825836|NCT01079806|19263348|P1|STARTED|Day 1 to Week 96||120
7825837|NCT01079741|19263383|P5|NOT COMPLETED|Phase 2 (Weeks 37-48)||3
7825838|NCT01079741|19263384|P4|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
7825839|NCT01079741|19263385|P3|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
7825840|NCT01079741|19263386|P2|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
7825841|NCT01079741|19263387|P1|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
7825842|NCT01079741|19263383|P5|COMPLETED|Phase 2 (Weeks 37-48)||9
7825843|NCT01079741|19263384|P4|COMPLETED|Phase 2 (Weeks 37-48)||12
7825844|NCT01079741|19263385|P3|COMPLETED|Phase 2 (Weeks 37-48)||0
7825845|NCT01079741|19263386|P2|COMPLETED|Phase 2 (Weeks 37-48)||0
7825846|NCT01079741|19263387|P1|COMPLETED|Phase 2 (Weeks 37-48)||0
7825847|NCT01079741|19263383|P5|STARTED|Phase 2 (Weeks 37-48)||12
7825848|NCT01079741|19263384|P4|STARTED|Phase 2 (Weeks 37-48)||12
7825849|NCT01079741|19263385|P3|STARTED|Phase 2 (Weeks 37-48)||0
7825850|NCT01079741|19263386|P2|STARTED|Phase 2 (Weeks 37-48)||0
7825851|NCT01079741|19263387|P1|STARTED|Phase 2 (Weeks 37-48)||0
7825852|NCT01079741|19263383|P5|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
7825853|NCT01079741|19263384|P4|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
7825854|NCT01079741|19263385|P3|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
7825855|NCT01079741|19263386|P2|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
7825856|NCT01079741|19263387|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
7825857|NCT01079741|19263383|P5|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
7825858|NCT01079741|19263384|P4|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
7825859|NCT01079741|19263385|P3|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
7825860|NCT01079741|19263386|P2|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
7825861|NCT01079741|19263387|P1|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
7825862|NCT01079741|19263383|P5|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
7825863|NCT01079741|19263384|P4|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
7825864|NCT01079741|19263385|P3|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
7825865|NCT01079741|19263386|P2|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
7825866|NCT01079741|19263387|P1|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
7825867|NCT01079741|19263383|P5|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
7825868|NCT01079741|19263384|P4|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
7825869|NCT01079741|19263385|P3|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
7825870|NCT01079741|19263386|P2|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||1
7825871|NCT01079741|19263387|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
7825872|NCT01079741|19263383|P5|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
7825873|NCT01079741|19263384|P4|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
7825874|NCT01079741|19263385|P3|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
7825875|NCT01079741|19263386|P2|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||3
7825876|NCT01079741|19263387|P1|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
7825877|NCT01079741|19263383|P5|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
7825878|NCT01079741|19263384|P4|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
7825879|NCT01079741|19263385|P3|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
7825880|NCT01079741|19263386|P2|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||4
7825881|NCT01079741|19263387|P1|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
7825882|NCT01079741|19263383|P5|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
7825883|NCT01079741|19263384|P4|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
7825884|NCT01079741|19263385|P3|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
7825885|NCT01079741|19263386|P2|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
7825886|NCT01079741|19263387|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
7825887|NCT01079741|19263383|P5|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
7825888|NCT01079741|19263384|P4|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
7825889|NCT01079741|19263385|P3|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
7825890|NCT01079741|19263386|P2|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
7825891|NCT01079741|19263387|P1|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
7825892|NCT01079741|19263383|P5|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
7825893|NCT01079741|19263384|P4|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
7825894|NCT01079741|19263385|P3|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
7825895|NCT01079741|19263386|P2|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
7825896|NCT01079741|19263387|P1|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
7825897|NCT01079598|19263401|P1|NOT COMPLETED|Overall Study||0
7825898|NCT01079598|19263401|P1|COMPLETED|Overall Study||8
7825899|NCT01079598|19263401|P1|STARTED|Overall Study||8
7825900|NCT01079390|19263411|P3|NOT COMPLETED|Overall Study||4
7825901|NCT01079390|19263412|P2|NOT COMPLETED|Overall Study||5
7825902|NCT01079390|19263413|P1|NOT COMPLETED|Overall Study||5
7825903|NCT01079390|19263411|P3|COMPLETED|Overall Study||10
7825904|NCT01079390|19263412|P2|COMPLETED|Overall Study||10
7825905|NCT01079390|19263413|P1|COMPLETED|Overall Study||10
7825906|NCT01079390|19263411|P3|STARTED|Overall Study||14
7825907|NCT01079390|19263412|P2|STARTED|Overall Study||15
7825908|NCT01079390|19263413|P1|STARTED|Overall Study||15
7825909|NCT01079299|19263425|P2|NOT COMPLETED|Overall Study||0
7825910|NCT01079299|19263426|P1|NOT COMPLETED|Overall Study||0
7825911|NCT01079299|19263425|P2|COMPLETED|Overall Study||25
7825912|NCT01079299|19263426|P1|COMPLETED|Overall Study||27
7825913|NCT01079299|19263425|P2|STARTED|Overall Study||25
7825914|NCT01079299|19263426|P1|STARTED|Overall Study||27
7825915|NCT01079234|19263435|P4|NOT COMPLETED|Extension: Week 27 to 52||16
7825916|NCT01079234|19263436|P3|NOT COMPLETED|Extension: Week 27 to 52||11
7825917|NCT01079234|19263437|P2|NOT COMPLETED|Extension: Week 27 to 52||0
7825918|NCT01079234|19263438|P1|NOT COMPLETED|Extension: Week 27 to 52||0
7825919|NCT01079234|19263435|P4|COMPLETED|Extension: Week 27 to 52||223
7825920|NCT01079234|19263436|P3|COMPLETED|Extension: Week 27 to 52||122
7825921|NCT01079234|19263437|P2|COMPLETED|Extension: Week 27 to 52||0
7825922|NCT01079234|19263438|P1|COMPLETED|Extension: Week 27 to 52||0
7825923|NCT01079234|19263435|P4|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239
7825924|NCT01079234|19263436|P3|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133
7825925|NCT01079234|19263437|P2|STARTED|Extension: Week 27 to 52||0
7825926|NCT01079234|19263438|P1|STARTED|Extension: Week 27 to 52||0
7825927|NCT01079234|19263435|P4|NOT COMPLETED|Main: Week 0 to 26||0
7825928|NCT01079234|19263436|P3|NOT COMPLETED|Main: Week 0 to 26||12
7825929|NCT01079234|19263437|P2|NOT COMPLETED|Main: Week 0 to 26||26
7825930|NCT01079234|19263438|P1|NOT COMPLETED|Main: Week 0 to 26||26
7825931|NCT01079234|19263435|P4|COMPLETED|Main: Week 0 to 26||0
7825932|NCT01079234|19263436|P3|COMPLETED|Main: Week 0 to 26||152
7825933|NCT01079234|19263437|P2|COMPLETED|Main: Week 0 to 26||139
7825934|NCT01079234|19263438|P1|COMPLETED|Main: Week 0 to 26||138
7825935|NCT01079234|19263435|P4|Exposed|Main: Week 0 to 26||0
7825936|NCT01079234|19263436|P3|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161
7825937|NCT01079234|19263437|P2|Exposed|Main: Week 0 to 26||165
7825938|NCT01079234|19263438|P1|Exposed|Main: Week 0 to 26||164
7825939|NCT01079234|19263435|P4|STARTED|Main: Week 0 to 26||0
7825940|NCT01079234|19263436|P3|STARTED|Main: Week 0 to 26||164
7825941|NCT01079234|19263437|P2|STARTED|Main: Week 0 to 26||165
7825942|NCT01079234|19263438|P1|STARTED|Main: Week 0 to 26||164
7825943|NCT01079195|19263456|P1|NOT COMPLETED|Overall Study||1431
7825944|NCT01079195|19263456|P1|COMPLETED|Overall Study||14442
7825945|NCT01079195|19263456|P1|STARTED|Overall Study||15873
7825946|NCT01079182|19263462|P1|NOT COMPLETED|Overall Study||2719
7825947|NCT01079182|19263462|P1|COMPLETED|Overall Study||1962
7825948|NCT01079182|19263462|P1|STARTED|Overall Study||4681
7825949|NCT01079143|19263493|P4|NOT COMPLETED|Overall Study||5
7825950|NCT01079143|19263494|P3|NOT COMPLETED|Overall Study||5
7825951|NCT01079143|19263495|P2|NOT COMPLETED|Overall Study||17
7825952|NCT01079143|19263496|P1|NOT COMPLETED|Overall Study||9
7825953|NCT01079143|19263493|P4|COMPLETED|Overall Study||54
7825954|NCT01079143|19263494|P3|COMPLETED|Overall Study||34
7825955|NCT01079143|19263495|P2|COMPLETED|Overall Study||43
7825956|NCT01079143|19263496|P1|COMPLETED|Overall Study||27
7825957|NCT01079143|19263493|P4|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
7825958|NCT01079143|19263494|P3|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
7825959|NCT01079143|19263495|P2|M3 and M12 Biopsies|Overall Study||43
7825960|NCT01079143|19263496|P1|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
7825961|NCT01079143|19263493|P4|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
7825962|NCT01079143|19263494|P3|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
7825963|NCT01079143|19263495|P2|Month 12 (M12) Biopsies|Overall Study||43
7825964|NCT01079143|19263496|P1|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
7825965|NCT01079143|19263493|P4|Month 3 (M3) Biopsies|Overall Study||59
7825966|NCT01079143|19263494|P3|Month 3 (M3) Biopsies|Overall Study||39
7825967|NCT01079143|19263495|P2|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59
7825968|NCT01079143|19263496|P1|Month 3 (M3) Biopsies|Overall Study||36
7825969|NCT01079143|19263493|P4|Exposed|Overall Study||59
7825970|NCT01079143|19263494|P3|Exposed|Overall Study||39
7825971|NCT01079143|19263495|P2|Exposed|Overall Study||60
7825972|NCT01079143|19263496|P1|Exposed|Overall Study||36
7825973|NCT01079143|19263493|P4|STARTED|Overall Study||59
7825974|NCT01079143|19263494|P3|STARTED|Overall Study||39
7825975|NCT01079143|19263495|P2|STARTED|Overall Study||60
7825976|NCT01079143|19263496|P1|STARTED|Overall Study||36
7825977|NCT01079130|19263570|P6|NOT COMPLETED|Overall Study||5
7825978|NCT01079130|19263571|P5|NOT COMPLETED|Overall Study||8
7825979|NCT01079130|19263572|P4|NOT COMPLETED|Overall Study||5
7825980|NCT01079130|19263573|P3|NOT COMPLETED|Overall Study||1
7825981|NCT01079130|19263574|P2|NOT COMPLETED|Overall Study||7
7825982|NCT01079130|19263575|P1|NOT COMPLETED|Overall Study||2
7825983|NCT01079130|19263570|P6|COMPLETED|Overall Study||80
7825984|NCT01079130|19263571|P5|COMPLETED|Overall Study||78
7825985|NCT01079130|19263572|P4|COMPLETED|Overall Study||81
7825986|NCT01079130|19263573|P3|COMPLETED|Overall Study||83
7825987|NCT01079130|19263574|P2|COMPLETED|Overall Study||78
7825988|NCT01079130|19263575|P1|COMPLETED|Overall Study||83
7825989|NCT01079130|19263570|P6|Full Analysis Set (FAS)|Overall Study||84
7825990|NCT01079130|19263571|P5|Full Analysis Set (FAS)|Overall Study||84
7825991|NCT01079130|19263572|P4|Full Analysis Set (FAS)|Overall Study||85
7825992|NCT01079130|19263573|P3|Full Analysis Set (FAS)|Overall Study||83
7825993|NCT01079130|19263574|P2|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80
7825994|NCT01079130|19263575|P1|Full Analysis Set (FAS)|Overall Study||84
7825995|NCT01079130|19263570|P6|Safety Set: Received Study Drug|Overall Study||84
7825996|NCT01079130|19263571|P5|Safety Set: Received Study Drug|Overall Study||84
7825997|NCT01079130|19263572|P4|Safety Set: Received Study Drug|Overall Study||85
7825998|NCT01079130|19263573|P3|Safety Set: Received Study Drug|Overall Study||84
7825999|NCT01079130|19263574|P2|Safety Set: Received Study Drug|Overall Study||81
7826000|NCT01079130|19263575|P1|Safety Set: Received Study Drug|Overall Study||84
7826001|NCT01079130|19263570|P6|STARTED|Overall Study||85
7826002|NCT01079130|19263571|P5|STARTED|Overall Study||86
7826003|NCT01079130|19263572|P4|STARTED|Overall Study||86
7826004|NCT01079130|19263573|P3|STARTED|Overall Study||84
7826005|NCT01079130|19263574|P2|STARTED|Overall Study||85
7826006|NCT01079130|19263575|P1|STARTED|Overall Study||85
7826007|NCT01078974|19263595|P1|NOT COMPLETED|Overall Study||3
7826008|NCT01078974|19263595|P1|COMPLETED|Overall Study||4
7826009|NCT01078974|19263595|P1|STARTED|Overall Study||7
7826010|NCT01078922|19263600|P1|NOT COMPLETED|Overall Study||1
7826011|NCT01078922|19263600|P1|COMPLETED|Overall Study||10
7826012|NCT01078922|19263600|P1|STARTED|Overall Study||11
7826013|NCT01078909|19263610|P5|NOT COMPLETED|Overall Study||2
7826014|NCT01078909|19263611|P4|NOT COMPLETED|Overall Study||1
7826015|NCT01078909|19263612|P3|NOT COMPLETED|Overall Study||1
7826016|NCT01078909|19263613|P2|NOT COMPLETED|Overall Study||4
7826017|NCT01078909|19263614|P1|NOT COMPLETED|Overall Study||2
7826018|NCT01078909|19263610|P5|COMPLETED|Overall Study||23
7826019|NCT01078909|19263611|P4|COMPLETED|Overall Study||24
7826020|NCT01078909|19263612|P3|COMPLETED|Overall Study||24
7826021|NCT01078909|19263613|P2|COMPLETED|Overall Study||21
7826022|NCT01078909|19263614|P1|COMPLETED|Overall Study||23
7826023|NCT01078909|19263610|P5|STARTED|Overall Study||25
7826024|NCT01078909|19263611|P4|STARTED|Overall Study||25
7826025|NCT01078909|19263612|P3|STARTED|Overall Study||25
7826026|NCT01078909|19263613|P2|STARTED|Overall Study||25
7826027|NCT01078909|19263614|P1|STARTED|Overall Study||25
7826028|NCT01078844|19263636|P1|NOT COMPLETED|Overall Study||4
7826029|NCT01078844|19263636|P1|COMPLETED|Overall Study||0
7826030|NCT01078844|19263636|P1|STARTED|Overall Study||4
7826031|NCT01078805|19263641|P1|NOT COMPLETED|Overall Study||2050
7826032|NCT01078805|19263641|P1|COMPLETED|Overall Study||2117
7826033|NCT01078805|19263641|P1|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720
7826034|NCT01078805|19263641|P1|Took at Least 1 Dose of Study Drug|Overall Study||4085
7826035|NCT01078805|19263641|P1|STARTED|Overall Study||4167
7826036|NCT01078753|19263655|P2|NOT COMPLETED|Treatment Period II||0
7826037|NCT01078753|19263656|P1|NOT COMPLETED|Treatment Period II||0
7826038|NCT01078753|19263655|P2|COMPLETED|Treatment Period II||44
7826039|NCT01078753|19263656|P1|COMPLETED|Treatment Period II||45
7826040|NCT01078753|19263655|P2|Full Analysis Set|Treatment Period II||44
7826041|NCT01078753|19263656|P1|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
7826042|NCT01078753|19263655|P2|STARTED|Treatment Period II||44
7826043|NCT01078753|19263656|P1|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45
7826044|NCT01078753|19263655|P2|NOT COMPLETED|Treatment Period I||0
7826045|NCT01078753|19263656|P1|NOT COMPLETED|Treatment Period I||0
7826046|NCT01078753|19263655|P2|COMPLETED|Treatment Period I||44
7826047|NCT01078753|19263656|P1|COMPLETED|Treatment Period I||45
7826048|NCT01078753|19263655|P2|Full Analysis Set|Treatment Period I||44
7826049|NCT01078753|19263656|P1|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
7826050|NCT01078753|19263655|P2|STARTED|Treatment Period I||44
7826051|NCT01078753|19263656|P1|STARTED|Treatment Period I||45
7826052|NCT01078675|19263668|P2|NOT COMPLETED|Overall Study||6
7826053|NCT01078675|19263669|P1|NOT COMPLETED|Overall Study||68
7826054|NCT01078675|19263668|P2|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59
7826055|NCT01078675|19263669|P1|COMPLETED|Overall Study||182
7826056|NCT01078675|19263668|P2|Patients Treated|Overall Study||0
7826057|NCT01078675|19263669|P1|Patients Treated|Overall Study||198
7826058|NCT01078675|19263668|P2|STARTED|Overall Study||65
7826059|NCT01078675|19263669|P1|STARTED|Overall Study||250
7826060|NCT01078662|19263691|P5|NOT COMPLETED|Overall Study||11
7826061|NCT01078662|19263692|P4|NOT COMPLETED|Overall Study||7
7826062|NCT01078662|19263693|P3|NOT COMPLETED|Overall Study||21
7826063|NCT01078662|19263694|P2|NOT COMPLETED|Overall Study||168
7826064|NCT01078662|19263695|P1|NOT COMPLETED|Overall Study||58
7826065|NCT01078662|19263691|P5|COMPLETED|Overall Study||1
7826066|NCT01078662|19263692|P4|COMPLETED|Overall Study||1
7826067|NCT01078662|19263693|P3|COMPLETED|Overall Study||2
7826068|NCT01078662|19263694|P2|COMPLETED|Overall Study||25
7826069|NCT01078662|19263695|P1|COMPLETED|Overall Study||4
7826070|NCT01078662|19263691|P5|STARTED|Overall Study||12
7826071|NCT01078662|19263692|P4|STARTED|Overall Study||8
7826072|NCT01078662|19263693|P3|STARTED|Overall Study||23
7826073|NCT01078662|19263694|P2|STARTED|Overall Study||193
7826074|NCT01078662|19263695|P1|STARTED|Overall Study||62
7826075|NCT01078623|19263734|P20|NOT COMPLETED|Treatment Period 4||0
7826076|NCT01078623|19263735|P19|NOT COMPLETED|Treatment Period 4||0
7826077|NCT01078623|19263736|P18|NOT COMPLETED|Treatment Period 4||0
7826078|NCT01078623|19263737|P17|NOT COMPLETED|Treatment Period 4||0
7826079|NCT01078623|19263738|P16|NOT COMPLETED|Treatment Period 4||1
7826080|NCT01078623|19263739|P15|NOT COMPLETED|Treatment Period 4||0
7826081|NCT01078623|19263740|P14|NOT COMPLETED|Treatment Period 4||0
7826082|NCT01078623|19263741|P13|NOT COMPLETED|Treatment Period 4||0
7826083|NCT01078623|19263742|P12|NOT COMPLETED|Treatment Period 4||0
7826084|NCT01078623|19263743|P11|NOT COMPLETED|Treatment Period 4||0
7826085|NCT01078623|19263744|P10|NOT COMPLETED|Treatment Period 4||0
7826086|NCT01078623|19263745|P9|NOT COMPLETED|Treatment Period 4||0
7826087|NCT01078623|19263746|P8|NOT COMPLETED|Treatment Period 4||0
7826088|NCT01078623|19263747|P7|NOT COMPLETED|Treatment Period 4||0
7826089|NCT01078623|19263748|P6|NOT COMPLETED|Treatment Period 4||0
7826090|NCT01078623|19263749|P5|NOT COMPLETED|Treatment Period 4||0
7826091|NCT01078623|19263750|P4|NOT COMPLETED|Treatment Period 4||0
7826092|NCT01078623|19263751|P3|NOT COMPLETED|Treatment Period 4||1
7826093|NCT01078623|19263752|P2|NOT COMPLETED|Treatment Period 4||0
7826094|NCT01078623|19263753|P1|NOT COMPLETED|Treatment Period 4||0
7826095|NCT01078623|19263734|P20|COMPLETED|Treatment Period 4||7
7826096|NCT01078623|19263735|P19|COMPLETED|Treatment Period 4||6
7826097|NCT01078623|19263736|P18|COMPLETED|Treatment Period 4||7
7826098|NCT01078623|19263737|P17|COMPLETED|Treatment Period 4||7
7826099|NCT01078623|19263738|P16|COMPLETED|Treatment Period 4||6
7826100|NCT01078623|19263739|P15|COMPLETED|Treatment Period 4||7
7826101|NCT01078623|19263740|P14|COMPLETED|Treatment Period 4||6
7826102|NCT01078623|19263741|P13|COMPLETED|Treatment Period 4||7
7826103|NCT01078623|19263742|P12|COMPLETED|Treatment Period 4||7
7826104|NCT01078623|19263743|P11|COMPLETED|Treatment Period 4||6
7826105|NCT01078623|19263744|P10|COMPLETED|Treatment Period 4||6
7826106|NCT01078623|19263745|P9|COMPLETED|Treatment Period 4||5
7826107|NCT01078623|19263746|P8|COMPLETED|Treatment Period 4||6
7826108|NCT01078623|19263747|P7|COMPLETED|Treatment Period 4||5
7826109|NCT01078623|19263748|P6|COMPLETED|Treatment Period 4||4
7826110|NCT01078623|19263749|P5|COMPLETED|Treatment Period 4||6
7826111|NCT01078623|19263750|P4|COMPLETED|Treatment Period 4||6
7826112|NCT01078623|19263751|P3|COMPLETED|Treatment Period 4||5
7826113|NCT01078623|19263752|P2|COMPLETED|Treatment Period 4||5
7826114|NCT01078623|19263753|P1|COMPLETED|Treatment Period 4||5
7826115|NCT01078623|19263734|P20|STARTED|Treatment Period 4||7
7826116|NCT01078623|19263735|P19|STARTED|Treatment Period 4||6
7826117|NCT01078623|19263736|P18|STARTED|Treatment Period 4||7
7826118|NCT01078623|19263737|P17|STARTED|Treatment Period 4||7
7826119|NCT01078623|19263738|P16|STARTED|Treatment Period 4||7
7826120|NCT01078623|19263739|P15|STARTED|Treatment Period 4||7
7826121|NCT01078623|19263740|P14|STARTED|Treatment Period 4||6
7826122|NCT01078623|19263741|P13|STARTED|Treatment Period 4||7
7826123|NCT01078623|19263742|P12|STARTED|Treatment Period 4||7
7826124|NCT01078623|19263743|P11|STARTED|Treatment Period 4||6
7826125|NCT01078623|19263744|P10|STARTED|Treatment Period 4||6
7826126|NCT01078623|19263745|P9|STARTED|Treatment Period 4||5
7826127|NCT01078623|19263746|P8|STARTED|Treatment Period 4||6
7826128|NCT01078623|19263747|P7|STARTED|Treatment Period 4||5
7826129|NCT01078623|19263748|P6|STARTED|Treatment Period 4||4
7826130|NCT01078623|19263749|P5|STARTED|Treatment Period 4||6
7826131|NCT01078623|19263750|P4|STARTED|Treatment Period 4||6
7826132|NCT01078623|19263751|P3|STARTED|Treatment Period 4||6
7826133|NCT01078623|19263752|P2|STARTED|Treatment Period 4||5
7826134|NCT01078623|19263753|P1|STARTED|Treatment Period 4||5
7826135|NCT01078623|19263734|P20|NOT COMPLETED|Treatment Period 3||0
7826136|NCT01078623|19263735|P19|NOT COMPLETED|Treatment Period 3||0
7826137|NCT01078623|19263736|P18|NOT COMPLETED|Treatment Period 3||0
7826138|NCT01078623|19263737|P17|NOT COMPLETED|Treatment Period 3||0
7826139|NCT01078623|19263738|P16|NOT COMPLETED|Treatment Period 3||0
7826140|NCT01078623|19263739|P15|NOT COMPLETED|Treatment Period 3||0
7826141|NCT01078623|19263740|P14|NOT COMPLETED|Treatment Period 3||1
7826142|NCT01078623|19263741|P13|NOT COMPLETED|Treatment Period 3||0
7826143|NCT01078623|19263742|P12|NOT COMPLETED|Treatment Period 3||0
7826144|NCT01078623|19263743|P11|NOT COMPLETED|Treatment Period 3||0
7826145|NCT01078623|19263744|P10|NOT COMPLETED|Treatment Period 3||0
7826146|NCT01078623|19263745|P9|NOT COMPLETED|Treatment Period 3||0
7826147|NCT01078623|19263746|P8|NOT COMPLETED|Treatment Period 3||0
7826148|NCT01078623|19263747|P7|NOT COMPLETED|Treatment Period 3||0
7826149|NCT01078623|19263748|P6|NOT COMPLETED|Treatment Period 3||0
7826150|NCT01078623|19263749|P5|NOT COMPLETED|Treatment Period 3||1
7826151|NCT01078623|19263750|P4|NOT COMPLETED|Treatment Period 3||0
7826152|NCT01078623|19263751|P3|NOT COMPLETED|Treatment Period 3||0
7826153|NCT01078623|19263752|P2|NOT COMPLETED|Treatment Period 3||0
7826154|NCT01078623|19263753|P1|NOT COMPLETED|Treatment Period 3||0
7826155|NCT01078623|19263734|P20|COMPLETED|Treatment Period 3||7
7826156|NCT01078623|19263735|P19|COMPLETED|Treatment Period 3||6
7826157|NCT01078623|19263736|P18|COMPLETED|Treatment Period 3||7
7826158|NCT01078623|19263737|P17|COMPLETED|Treatment Period 3||7
7826159|NCT01078623|19263738|P16|COMPLETED|Treatment Period 3||7
7826160|NCT01078623|19263739|P15|COMPLETED|Treatment Period 3||7
7826161|NCT01078623|19263740|P14|COMPLETED|Treatment Period 3||6
7826162|NCT01078623|19263741|P13|COMPLETED|Treatment Period 3||7
7826163|NCT01078623|19263742|P12|COMPLETED|Treatment Period 3||7
7826164|NCT01078623|19263743|P11|COMPLETED|Treatment Period 3||6
7826165|NCT01078623|19263744|P10|COMPLETED|Treatment Period 3||6
7826166|NCT01078623|19263745|P9|COMPLETED|Treatment Period 3||5
7826167|NCT01078623|19263746|P8|COMPLETED|Treatment Period 3||6
7826168|NCT01078623|19263747|P7|COMPLETED|Treatment Period 3||5
7826169|NCT01078623|19263748|P6|COMPLETED|Treatment Period 3||4
7826170|NCT01078623|19263749|P5|COMPLETED|Treatment Period 3||6
7826171|NCT01078623|19263750|P4|COMPLETED|Treatment Period 3||6
7826172|NCT01078623|19263751|P3|COMPLETED|Treatment Period 3||6
7826173|NCT01078623|19263752|P2|COMPLETED|Treatment Period 3||5
7826174|NCT01078623|19263753|P1|COMPLETED|Treatment Period 3||5
7826175|NCT01078623|19263734|P20|STARTED|Treatment Period 3||7
7826176|NCT01078623|19263735|P19|STARTED|Treatment Period 3||6
7826177|NCT01078623|19263736|P18|STARTED|Treatment Period 3||7
7826178|NCT01078623|19263737|P17|STARTED|Treatment Period 3||7
7826179|NCT01078623|19263738|P16|STARTED|Treatment Period 3||7
7826180|NCT01078623|19263739|P15|STARTED|Treatment Period 3||7
7826181|NCT01078623|19263740|P14|STARTED|Treatment Period 3||7
7826182|NCT01078623|19263741|P13|STARTED|Treatment Period 3||7
7826183|NCT01078623|19263742|P12|STARTED|Treatment Period 3||7
7826184|NCT01078623|19263743|P11|STARTED|Treatment Period 3||6
7826185|NCT01078623|19263744|P10|STARTED|Treatment Period 3||6
7826186|NCT01078623|19263745|P9|STARTED|Treatment Period 3||5
7826187|NCT01078623|19263746|P8|STARTED|Treatment Period 3||6
7826188|NCT01078623|19263747|P7|STARTED|Treatment Period 3||5
7826189|NCT01078623|19263748|P6|STARTED|Treatment Period 3||4
7826190|NCT01078623|19263749|P5|STARTED|Treatment Period 3||7
7826191|NCT01078623|19263750|P4|STARTED|Treatment Period 3||6
7826192|NCT01078623|19263751|P3|STARTED|Treatment Period 3||6
7826193|NCT01078623|19263752|P2|STARTED|Treatment Period 3||5
7826194|NCT01078623|19263753|P1|STARTED|Treatment Period 3||5
7826195|NCT01078623|19263734|P20|NOT COMPLETED|Treatment Period 2||0
7826196|NCT01078623|19263735|P19|NOT COMPLETED|Treatment Period 2||1
7826197|NCT01078623|19263736|P18|NOT COMPLETED|Treatment Period 2||0
7826198|NCT01078623|19263737|P17|NOT COMPLETED|Treatment Period 2||0
7826199|NCT01078623|19263738|P16|NOT COMPLETED|Treatment Period 2||0
7826200|NCT01078623|19263739|P15|NOT COMPLETED|Treatment Period 2||0
7826201|NCT01078623|19263740|P14|NOT COMPLETED|Treatment Period 2||0
7826202|NCT01078623|19263741|P13|NOT COMPLETED|Treatment Period 2||0
7826203|NCT01078623|19263742|P12|NOT COMPLETED|Treatment Period 2||0
7826204|NCT01078623|19263743|P11|NOT COMPLETED|Treatment Period 2||0
7826205|NCT01078623|19263744|P10|NOT COMPLETED|Treatment Period 2||0
7826206|NCT01078623|19263745|P9|NOT COMPLETED|Treatment Period 2||0
7826207|NCT01078623|19263746|P8|NOT COMPLETED|Treatment Period 2||0
7826208|NCT01078623|19263747|P7|NOT COMPLETED|Treatment Period 2||1
7826209|NCT01078623|19263748|P6|NOT COMPLETED|Treatment Period 2||1
7826210|NCT01078623|19263749|P5|NOT COMPLETED|Treatment Period 2||0
7826211|NCT01078623|19263750|P4|NOT COMPLETED|Treatment Period 2||0
7826212|NCT01078623|19263751|P3|NOT COMPLETED|Treatment Period 2||0
7826213|NCT01078623|19263752|P2|NOT COMPLETED|Treatment Period 2||0
7826214|NCT01078623|19263753|P1|NOT COMPLETED|Treatment Period 2||0
7826215|NCT01078623|19263734|P20|COMPLETED|Treatment Period 2||7
7826216|NCT01078623|19263735|P19|COMPLETED|Treatment Period 2||6
7826217|NCT01078623|19263736|P18|COMPLETED|Treatment Period 2||7
7826218|NCT01078623|19263737|P17|COMPLETED|Treatment Period 2||7
7826219|NCT01078623|19263738|P16|COMPLETED|Treatment Period 2||7
7826220|NCT01078623|19263739|P15|COMPLETED|Treatment Period 2||7
7826221|NCT01078623|19263740|P14|COMPLETED|Treatment Period 2||7
7826222|NCT01078623|19263741|P13|COMPLETED|Treatment Period 2||7
7826223|NCT01078623|19263742|P12|COMPLETED|Treatment Period 2||7
7826224|NCT01078623|19263743|P11|COMPLETED|Treatment Period 2||6
7826225|NCT01078623|19263744|P10|COMPLETED|Treatment Period 2||6
7826226|NCT01078623|19263745|P9|COMPLETED|Treatment Period 2||5
7826227|NCT01078623|19263746|P8|COMPLETED|Treatment Period 2||6
7826228|NCT01078623|19263747|P7|COMPLETED|Treatment Period 2||5
7826229|NCT01078623|19263748|P6|COMPLETED|Treatment Period 2||4
7826230|NCT01078623|19263749|P5|COMPLETED|Treatment Period 2||7
7826231|NCT01078623|19263750|P4|COMPLETED|Treatment Period 2||6
7826232|NCT01078623|19263751|P3|COMPLETED|Treatment Period 2||6
7826233|NCT01078623|19263752|P2|COMPLETED|Treatment Period 2||5
7826234|NCT01078623|19263753|P1|COMPLETED|Treatment Period 2||5
7826235|NCT01078623|19263734|P20|STARTED|Treatment Period 2||7
7826236|NCT01078623|19263735|P19|STARTED|Treatment Period 2||7
7826237|NCT01078623|19263736|P18|STARTED|Treatment Period 2||7
7826238|NCT01078623|19263737|P17|STARTED|Treatment Period 2||7
7826239|NCT01078623|19263738|P16|STARTED|Treatment Period 2||7
7826240|NCT01078623|19263739|P15|STARTED|Treatment Period 2||7
7826241|NCT01078623|19263740|P14|STARTED|Treatment Period 2||7
7826242|NCT01078623|19263741|P13|STARTED|Treatment Period 2||7
7826243|NCT01078623|19263742|P12|STARTED|Treatment Period 2||7
7826244|NCT01078623|19263743|P11|STARTED|Treatment Period 2||6
7826245|NCT01078623|19263744|P10|STARTED|Treatment Period 2||6
7826246|NCT01078623|19263745|P9|STARTED|Treatment Period 2||5
7826247|NCT01078623|19263746|P8|STARTED|Treatment Period 2||6
7826248|NCT01078623|19263747|P7|STARTED|Treatment Period 2||6
7826249|NCT01078623|19263748|P6|STARTED|Treatment Period 2||5
7826250|NCT01078623|19263749|P5|STARTED|Treatment Period 2||7
7826251|NCT01078623|19263750|P4|STARTED|Treatment Period 2||6
7826252|NCT01078623|19263751|P3|STARTED|Treatment Period 2||6
7826253|NCT01078623|19263752|P2|STARTED|Treatment Period 2||5
7826254|NCT01078623|19263753|P1|STARTED|Treatment Period 2||5
7826255|NCT01078623|19263734|P20|NOT COMPLETED|Treatment Period 1||0
7826256|NCT01078623|19263735|P19|NOT COMPLETED|Treatment Period 1||0
7826257|NCT01078623|19263736|P18|NOT COMPLETED|Treatment Period 1||0
7826258|NCT01078623|19263737|P17|NOT COMPLETED|Treatment Period 1||0
7826259|NCT01078623|19263738|P16|NOT COMPLETED|Treatment Period 1||0
7826260|NCT01078623|19263739|P15|NOT COMPLETED|Treatment Period 1||0
7826261|NCT01078623|19263740|P14|NOT COMPLETED|Treatment Period 1||0
7826262|NCT01078623|19263741|P13|NOT COMPLETED|Treatment Period 1||0
7826263|NCT01078623|19263742|P12|NOT COMPLETED|Treatment Period 1||0
7826264|NCT01078623|19263743|P11|NOT COMPLETED|Treatment Period 1||1
7826265|NCT01078623|19263744|P10|NOT COMPLETED|Treatment Period 1||1
7826266|NCT01078623|19263745|P9|NOT COMPLETED|Treatment Period 1||1
7826267|NCT01078623|19263746|P8|NOT COMPLETED|Treatment Period 1||1
7826268|NCT01078623|19263747|P7|NOT COMPLETED|Treatment Period 1||1
7826269|NCT01078623|19263748|P6|NOT COMPLETED|Treatment Period 1||1
7826270|NCT01078623|19263749|P5|NOT COMPLETED|Treatment Period 1||0
7826271|NCT01078623|19263750|P4|NOT COMPLETED|Treatment Period 1||0
7826272|NCT01078623|19263751|P3|NOT COMPLETED|Treatment Period 1||1
7826273|NCT01078623|19263752|P2|NOT COMPLETED|Treatment Period 1||1
7826274|NCT01078623|19263753|P1|NOT COMPLETED|Treatment Period 1||1
7826275|NCT01078623|19263734|P20|COMPLETED|Treatment Period 1||7
7826276|NCT01078623|19263735|P19|COMPLETED|Treatment Period 1||7
7826277|NCT01078623|19263736|P18|COMPLETED|Treatment Period 1||7
7826278|NCT01078623|19263737|P17|COMPLETED|Treatment Period 1||7
7826279|NCT01078623|19263738|P16|COMPLETED|Treatment Period 1||7
7826280|NCT01078623|19263739|P15|COMPLETED|Treatment Period 1||7
7826281|NCT01078623|19263740|P14|COMPLETED|Treatment Period 1||7
7826282|NCT01078623|19263741|P13|COMPLETED|Treatment Period 1||7
7826283|NCT01078623|19263742|P12|COMPLETED|Treatment Period 1||7
7826284|NCT01078623|19263743|P11|COMPLETED|Treatment Period 1||6
7826285|NCT01078623|19263744|P10|COMPLETED|Treatment Period 1||6
7826286|NCT01078623|19263745|P9|COMPLETED|Treatment Period 1||5
7826287|NCT01078623|19263746|P8|COMPLETED|Treatment Period 1||6
7826288|NCT01078623|19263747|P7|COMPLETED|Treatment Period 1||6
7826289|NCT01078623|19263748|P6|COMPLETED|Treatment Period 1||5
7826290|NCT01078623|19263749|P5|COMPLETED|Treatment Period 1||7
7826291|NCT01078623|19263750|P4|COMPLETED|Treatment Period 1||6
7826292|NCT01078623|19263751|P3|COMPLETED|Treatment Period 1||6
7826293|NCT01078623|19263752|P2|COMPLETED|Treatment Period 1||5
7826294|NCT01078623|19263753|P1|COMPLETED|Treatment Period 1||5
7826295|NCT01078623|19263734|P20|STARTED|Treatment Period 1||7
7826296|NCT01078623|19263735|P19|STARTED|Treatment Period 1||7
7826297|NCT01078623|19263736|P18|STARTED|Treatment Period 1||7
7826298|NCT01078623|19263737|P17|STARTED|Treatment Period 1||7
7826299|NCT01078623|19263738|P16|STARTED|Treatment Period 1||7
7826300|NCT01078623|19263739|P15|STARTED|Treatment Period 1||7
7826301|NCT01078623|19263740|P14|STARTED|Treatment Period 1||7
7826302|NCT01078623|19263741|P13|STARTED|Treatment Period 1||7
7826303|NCT01078623|19263742|P12|STARTED|Treatment Period 1||7
7826304|NCT01078623|19263743|P11|STARTED|Treatment Period 1||7
7826305|NCT01078623|19263744|P10|STARTED|Treatment Period 1||7
7826306|NCT01078623|19263745|P9|STARTED|Treatment Period 1||6
7826307|NCT01078623|19263746|P8|STARTED|Treatment Period 1||7
7826308|NCT01078623|19263747|P7|STARTED|Treatment Period 1||7
7826309|NCT01078623|19263748|P6|STARTED|Treatment Period 1||6
7826310|NCT01078623|19263749|P5|STARTED|Treatment Period 1||7
7826311|NCT01078623|19263750|P4|STARTED|Treatment Period 1||6
7826312|NCT01078623|19263751|P3|STARTED|Treatment Period 1||7
7826313|NCT01078623|19263752|P2|STARTED|Treatment Period 1||6
7826314|NCT01078623|19263753|P1|STARTED|Treatment Period 1||6
7826315|NCT01078584|19263775|P1|NOT COMPLETED|Overall Study||3010
7826316|NCT01078584|19263775|P1|COMPLETED|Overall Study||4983
7826317|NCT01078584|19263775|P1|Participants Conducted Visit 4(12-month)|Overall Study||4983
7826318|NCT01078584|19263775|P1|Participants Conducted Visit 3 (6-month)|Overall Study||5833
7826319|NCT01078584|19263775|P1|Participants Conducted Visit 2 (3-month)|Overall Study||7125
7826320|NCT01078584|19263775|P1|STARTED|Overall Study||7993
7826321|NCT01078571|19263856|P1|NOT COMPLETED|Overall Study||115
7826322|NCT01078571|19263856|P1|COMPLETED|Overall Study||590
7826323|NCT01078571|19263856|P1|Intent-to-treat (ITT) Population|Overall Study||591
7826324|NCT01078571|19263856|P1|Safety Population|Overall Study||675
7826325|NCT01078571|19263856|P1|STARTED|Overall Study||705
7826326|NCT01078558|19263875|P3|NOT COMPLETED|Overall Study||1361
7826327|NCT01078558|19263876|P2|NOT COMPLETED|Overall Study||755
7826328|NCT01078558|19263877|P1|NOT COMPLETED|Overall Study||2018
7826329|NCT01078558|19263875|P3|COMPLETED|Overall Study||596
7826330|NCT01078558|19263876|P2|COMPLETED|Overall Study||372
7826331|NCT01078558|19263877|P1|COMPLETED|Overall Study||818
7826332|NCT01078558|19263875|P3|Oligoarticular PsA|Overall Study||0
7826333|NCT01078558|19263876|P2|Oligoarticular PsA|Overall Study||197
7826334|NCT01078558|19263877|P1|Oligoarticular PsA|Overall Study||0
7826335|NCT01078558|19263875|P3|STARTED|Overall Study||1957
7826336|NCT01078558|19263876|P2|STARTED|Overall Study||1127
7826337|NCT01078558|19263877|P1|STARTED|Overall Study||2836
7826338|NCT01078545|19263907|P1|NOT COMPLETED|Overall Study||26
7826339|NCT01078545|19263907|P1|COMPLETED|Overall Study||703
7826340|NCT01078545|19263907|P1|Per Protocol Population|Overall Study||661
7826341|NCT01078545|19263907|P1|Intent-to-treat Population|Overall Study||729
7826342|NCT01078545|19263907|P1|STARTED|Overall Study||729
7826343|NCT01078454|19263917|P2|NOT COMPLETED|Overall Study||2
7826344|NCT01078454|19263918|P1|NOT COMPLETED|Overall Study||1
7826345|NCT01078454|19263917|P2|COMPLETED|Overall Study||3
7826346|NCT01078454|19263918|P1|COMPLETED|Overall Study||5
7826347|NCT01078454|19263917|P2|STARTED|Overall Study||5
7826348|NCT01078454|19263918|P1|STARTED|Overall Study||6
7826349|NCT01078441|19263924|P1|NOT COMPLETED|Overall Study||1
7826350|NCT01078441|19263924|P1|COMPLETED|Overall Study||1
7826351|NCT01078441|19263924|P1|STARTED|Overall Study||2
7826352|NCT01078402|19263931|P3|NOT COMPLETED|Overall Study||68
7826353|NCT01078402|19263932|P2|NOT COMPLETED|Overall Study||29
7826354|NCT01078402|19263933|P1|NOT COMPLETED|Overall Study||107
7826355|NCT01078402|19263931|P3|COMPLETED|Overall Study||166
7826356|NCT01078402|19263932|P2|COMPLETED|Overall Study||95
7826357|NCT01078402|19263933|P1|COMPLETED|Overall Study||324
7826358|NCT01078402|19263931|P3|STARTED|Overall Study||234
7826359|NCT01078402|19263932|P2|STARTED|Overall Study||124
7826360|NCT01078402|19263933|P1|STARTED|Overall Study||431
7826361|NCT01078389|19263964|P2|NOT COMPLETED|Overall Study||67
7826362|NCT01078389|19263965|P1|NOT COMPLETED|Overall Study||64
7826363|NCT01078389|19263964|P2|COMPLETED|Overall Study||90
7826364|NCT01078389|19263965|P1|COMPLETED|Overall Study||93
7826365|NCT01078389|19263964|P2|STARTED|Overall Study||157
7826366|NCT01078389|19263965|P1|STARTED|Overall Study||157
7826367|NCT01078376|19263983|P4|NOT COMPLETED|Overall Study||0
7826368|NCT01078376|19263984|P3|NOT COMPLETED|Overall Study||0
7826369|NCT01078376|19263985|P2|NOT COMPLETED|Overall Study||0
7826370|NCT01078376|19263986|P1|NOT COMPLETED|Overall Study||0
7826371|NCT01078376|19263983|P4|COMPLETED|Overall Study||3
7826372|NCT01078376|19263984|P3|COMPLETED|Overall Study||8
7826373|NCT01078376|19263985|P2|COMPLETED|Overall Study||9
7826374|NCT01078376|19263986|P1|COMPLETED|Overall Study||9
7826375|NCT01078376|19263983|P4|STARTED|Overall Study||3
7826376|NCT01078376|19263984|P3|STARTED|Overall Study||8
7826377|NCT01078376|19263985|P2|STARTED|Overall Study||9
7826378|NCT01078376|19263986|P1|STARTED|Overall Study||9
7826379|NCT01078363|19264107|P2|NOT COMPLETED|Overall Study||0
7826380|NCT01078363|19264108|P1|NOT COMPLETED|Overall Study||0
7826381|NCT01078363|19264107|P2|COMPLETED|Overall Study||49
7826382|NCT01078363|19264108|P1|COMPLETED|Overall Study||47
7826383|NCT01078363|19264107|P2|STARTED|Overall Study||49
7826384|NCT01078363|19264108|P1|STARTED|Overall Study||47
7826385|NCT01078298|19264126|P2|NOT COMPLETED|Overall Study||90
7826386|NCT01078298|19264127|P1|NOT COMPLETED|Overall Study||81
7826387|NCT01078298|19264126|P2|COMPLETED|Overall Study||179
7826388|NCT01078298|19264127|P1|COMPLETED|Overall Study||175
7826389|NCT01078298|19264126|P2|STARTED|Overall Study||269
7826390|NCT01078298|19264127|P1|STARTED|Overall Study||256
7826391|NCT01078246|19264160|P7|NOT COMPLETED|Overall Study||0
7826392|NCT01078246|19264161|P6|NOT COMPLETED|Overall Study||0
7826393|NCT01078246|19264162|P5|NOT COMPLETED|Overall Study||0
7826394|NCT01078246|19264163|P4|NOT COMPLETED|Overall Study||0
7826395|NCT01078246|19264164|P3|NOT COMPLETED|Overall Study||0
7826396|NCT01078246|19264165|P2|NOT COMPLETED|Overall Study||0
7826397|NCT01078246|19264166|P1|NOT COMPLETED|Overall Study||0
7826398|NCT01078246|19264160|P7|COMPLETED|Overall Study||22
7826399|NCT01078246|19264161|P6|COMPLETED|Overall Study||231
7826400|NCT01078246|19264162|P5|COMPLETED|Overall Study||3310
7826401|NCT01078246|19264163|P4|COMPLETED|Overall Study||152
7826402|NCT01078246|19264164|P3|COMPLETED|Overall Study||1963
7826403|NCT01078246|19264165|P2|COMPLETED|Overall Study||405
7826404|NCT01078246|19264166|P1|COMPLETED|Overall Study||1041
7826405|NCT01078246|19264160|P7|STARTED|Overall Study||22
7826406|NCT01078246|19264161|P6|STARTED|Overall Study||231
7826407|NCT01078246|19264162|P5|STARTED|Overall Study||3310
7826408|NCT01078246|19264163|P4|STARTED|Overall Study||152
7826409|NCT01078246|19264164|P3|STARTED|Overall Study||1963
7826410|NCT01078246|19264165|P2|STARTED|Overall Study||405
7826411|NCT01078246|19264166|P1|STARTED|Overall Study||1041
7826412|NCT01078233|19264198|P6|NOT COMPLETED|Overall Study||0
7826413|NCT01078233|19264199|P5|NOT COMPLETED|Overall Study||0
7826414|NCT01078233|19264200|P4|NOT COMPLETED|Overall Study||0
7826415|NCT01078233|19264201|P3|NOT COMPLETED|Overall Study||0
7826416|NCT01078233|19264202|P2|NOT COMPLETED|Overall Study||0
7826417|NCT01078233|19264203|P1|NOT COMPLETED|Overall Study||0
7826418|NCT01078233|19264198|P6|COMPLETED|Overall Study||154
7826419|NCT01078233|19264199|P5|COMPLETED|Overall Study||3199
7826420|NCT01078233|19264200|P4|COMPLETED|Overall Study||631
7826421|NCT01078233|19264201|P3|COMPLETED|Overall Study||1681
7826422|NCT01078233|19264202|P2|COMPLETED|Overall Study||296
7826423|NCT01078233|19264203|P1|COMPLETED|Overall Study||656
7826424|NCT01078233|19264198|P6|STARTED|Overall Study||154
7826425|NCT01078233|19264199|P5|STARTED|Overall Study||3199
7826426|NCT01078233|19264200|P4|STARTED|Overall Study||631
7826427|NCT01078233|19264201|P3|STARTED|Overall Study||1681
7826428|NCT01078233|19264202|P2|STARTED|Overall Study||296
7826429|NCT01078233|19264203|P1|STARTED|Overall Study||656
7826430|NCT01078220|19264220|P1|NOT COMPLETED|Overall Study||0
7826431|NCT01078220|19264220|P1|COMPLETED|Overall Study||189629
7826432|NCT01078220|19264220|P1|STARTED|Overall Study||189629
7826433|NCT01078207|19264230|P1|NOT COMPLETED|Overall Study||0
7826434|NCT01078207|19264230|P1|COMPLETED|Overall Study||100
7826435|NCT01078207|19264230|P1|STARTED|Overall Study||100
7826436|NCT01078168|19264237|P2|NOT COMPLETED|Overall Study||1
7826437|NCT01078168|19264238|P1|NOT COMPLETED|Overall Study||0
7826438|NCT01078168|19264237|P2|COMPLETED|Overall Study||10
7826439|NCT01078168|19264238|P1|COMPLETED|Overall Study||11
7826440|NCT01078168|19264237|P2|STARTED|Overall Study||11
7826441|NCT01078168|19264238|P1|STARTED|Overall Study||11
7826442|NCT01078155|19264244|P1|NOT COMPLETED|Overall Study||44
7826443|NCT01078155|19264244|P1|COMPLETED|Overall Study||87
7826444|NCT01078155|19264244|P1|STARTED|Overall Study||131
7826445|NCT01078116|19264260|P1|NOT COMPLETED|Overall Study||48
7826446|NCT01078116|19264260|P1|COMPLETED|Overall Study||76
7826447|NCT01078116|19264260|P1|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124
7826448|NCT01078090|19264268|P1|NOT COMPLETED|Overall Study||4593
7826449|NCT01078090|19264268|P1|COMPLETED|Overall Study||1152
7826450|NCT01078090|19264268|P1|STARTED|Overall Study||5745
7826451|NCT01077973|19264312|P3|NOT COMPLETED|Overall Study||0
7826452|NCT01077973|19264313|P2|NOT COMPLETED|Overall Study||0
7826453|NCT01077973|19264314|P1|NOT COMPLETED|Overall Study||0
7826454|NCT01077973|19264312|P3|COMPLETED|Overall Study||80
7826455|NCT01077973|19264313|P2|COMPLETED|Overall Study||79
7826456|NCT01077973|19264314|P1|COMPLETED|Overall Study||41
7826457|NCT01077973|19264312|P3|STARTED|Overall Study||80
7826458|NCT01077973|19264313|P2|STARTED|Overall Study||79
7826459|NCT01077973|19264314|P1|STARTED|Overall Study||41
7826460|NCT01077960|19264362|P1|NOT COMPLETED|Overall Study||16
7826461|NCT01077960|19264362|P1|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110
7826462|NCT01077960|19264362|P1|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126
7826463|NCT01077921|19264373|P2|NOT COMPLETED|Second Intervention||1
7826464|NCT01077921|19264374|P1|NOT COMPLETED|Second Intervention||0
7826465|NCT01077921|19264373|P2|COMPLETED|Second Intervention||9
7826466|NCT01077921|19264374|P1|COMPLETED|Second Intervention||13
7826467|NCT01077921|19264373|P2|STARTED|Second Intervention||10
7826468|NCT01077921|19264374|P1|STARTED|Second Intervention||13
7826469|NCT01077921|19264373|P2|NOT COMPLETED|Washout||2
7826470|NCT01077921|19264374|P1|NOT COMPLETED|Washout||0
7826471|NCT01077921|19264373|P2|COMPLETED|Washout||10
7826472|NCT01077921|19264374|P1|COMPLETED|Washout||13
7826473|NCT01077921|19264373|P2|STARTED|Washout||12
7826474|NCT01077921|19264374|P1|STARTED|Washout||13
7826475|NCT01077921|19264373|P2|NOT COMPLETED|First Intervention||1
7826476|NCT01077921|19264374|P1|NOT COMPLETED|First Intervention||1
7826477|NCT01077921|19264373|P2|COMPLETED|First Intervention||12
7826478|NCT01077921|19264374|P1|COMPLETED|First Intervention||13
7826479|NCT01077921|19264373|P2|STARTED|First Intervention||13
7826480|NCT01077921|19264374|P1|STARTED|First Intervention||14
7826481|NCT01077856|19264407|P3|NOT COMPLETED|Overall Study||0
7826482|NCT01077856|19264408|P2|NOT COMPLETED|Overall Study||0
7826483|NCT01077856|19264409|P1|NOT COMPLETED|Overall Study||0
7826484|NCT01077856|19264407|P3|COMPLETED|Overall Study||15713
7826485|NCT01077856|19264408|P2|COMPLETED|Overall Study||16604
7826486|NCT01077856|19264409|P1|COMPLETED|Overall Study||22199
7826487|NCT01077856|19264407|P3|STARTED|Overall Study||15713
7826488|NCT01077856|19264408|P2|STARTED|Overall Study||16604
7826489|NCT01077856|19264409|P1|STARTED|Overall Study||22199
7826490|NCT01077830|19264590|P2|NOT COMPLETED|Overall Study||0
7826491|NCT01077830|19264591|P1|NOT COMPLETED|Overall Study||0
7826492|NCT01077830|19264590|P2|COMPLETED|Overall Study||682
7826493|NCT01077830|19264591|P1|COMPLETED|Overall Study||677
7826494|NCT01077830|19264590|P2|STARTED|Overall Study||682
7826495|NCT01077830|19264591|P1|STARTED|Overall Study||677
7826496|NCT01077817|19264601|P1|NOT COMPLETED|Overall Study||0
7826497|NCT01077817|19264601|P1|COMPLETED|Overall Study||684815
7826498|NCT01077817|19264601|P1|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815
7826499|NCT01077804|19264612|P1|NOT COMPLETED|Overall Study||199
7826500|NCT01077804|19264612|P1|COMPLETED|Overall Study||7386
7826501|NCT01077804|19264612|P1|STARTED|Overall Study||7585
7826502|NCT01077739|19264621|P2|NOT COMPLETED|Overall Study||10
7826503|NCT01077739|19264622|P1|NOT COMPLETED|Overall Study||5
7826504|NCT01077739|19264621|P2|COMPLETED|Overall Study||40
7826505|NCT01077739|19264622|P1|COMPLETED|Overall Study||20
7826506|NCT01077739|19264621|P2|STARTED|Overall Study||50
7826507|NCT01077739|19264622|P1|STARTED|Overall Study||25
7826508|NCT01077713|19264636|P2|NOT COMPLETED|Overall Study||36
7826509|NCT01077713|19264637|P1|NOT COMPLETED|Overall Study||36
7826510|NCT01077713|19264636|P2|COMPLETED|Overall Study||6
7826511|NCT01077713|19264637|P1|COMPLETED|Overall Study||8
7826512|NCT01077713|19264636|P2|STARTED|Overall Study||42
7826513|NCT01077713|19264637|P1|STARTED|Overall Study||44
7826514|NCT01077622|19264661|P1|NOT COMPLETED|Overall Study||3
7826515|NCT01077622|19264661|P1|COMPLETED|Overall Study||7
7826516|NCT01077622|19264661|P1|STARTED|Overall Study||10
7826517|NCT01077596|19264719|P12|NOT COMPLETED|Overall Study||0
7826518|NCT01077596|19264720|P11|NOT COMPLETED|Overall Study||0
7826519|NCT01077596|19264721|P10|NOT COMPLETED|Overall Study||0
7826520|NCT01077596|19264722|P9|NOT COMPLETED|Overall Study||0
7826521|NCT01077596|19264723|P8|NOT COMPLETED|Overall Study||0
7826522|NCT01077596|19264724|P7|NOT COMPLETED|Overall Study||0
7826523|NCT01077596|19264725|P6|NOT COMPLETED|Overall Study||0
7826524|NCT01077596|19264726|P5|NOT COMPLETED|Overall Study||0
7826525|NCT01077596|19264727|P4|NOT COMPLETED|Overall Study||0
7826526|NCT01077596|19264728|P3|NOT COMPLETED|Overall Study||0
7826527|NCT01077596|19264729|P2|NOT COMPLETED|Overall Study||0
7826528|NCT01077596|19264730|P1|NOT COMPLETED|Overall Study||0
7826529|NCT01077596|19264719|P12|COMPLETED|Overall Study||22150
7826530|NCT01077596|19264720|P11|COMPLETED|Overall Study||2215
7826531|NCT01077596|19264721|P10|COMPLETED|Overall Study||28420
7826532|NCT01077596|19264722|P9|COMPLETED|Overall Study||2842
7826533|NCT01077596|19264723|P8|COMPLETED|Overall Study||837
7826534|NCT01077596|19264724|P7|COMPLETED|Overall Study||308
7826535|NCT01077596|19264725|P6|COMPLETED|Overall Study||882
7826536|NCT01077596|19264726|P5|COMPLETED|Overall Study||294
7826537|NCT01077596|19264727|P4|COMPLETED|Overall Study||1370
7826538|NCT01077596|19264728|P3|COMPLETED|Overall Study||457
7826539|NCT01077596|19264729|P2|COMPLETED|Overall Study||1050
7826540|NCT01077596|19264730|P1|COMPLETED|Overall Study||350
7826541|NCT01077596|19264719|P12|STARTED|Overall Study||22150
7826542|NCT01077596|19264720|P11|STARTED|Overall Study||2215
7826543|NCT01077596|19264721|P10|STARTED|Overall Study||28420
7826544|NCT01077596|19264722|P9|STARTED|Overall Study||2842
7826545|NCT01077596|19264723|P8|STARTED|Overall Study||837
7826546|NCT01077596|19264724|P7|STARTED|Overall Study||308
7826547|NCT01077596|19264725|P6|STARTED|Overall Study||882
7826548|NCT01077596|19264726|P5|STARTED|Overall Study||294
7826549|NCT01077596|19264727|P4|STARTED|Overall Study||1370
7826550|NCT01077596|19264728|P3|STARTED|Overall Study||457
7826551|NCT01077596|19264729|P2|STARTED|Overall Study||1050
7826552|NCT01077596|19264730|P1|STARTED|Overall Study||350
7826553|NCT01077544|19264781|P2|NOT COMPLETED|Overall Study||5
7826554|NCT01077544|19264782|P1|NOT COMPLETED|Overall Study||3
7826555|NCT01077544|19264781|P2|COMPLETED|Overall Study||2
7826556|NCT01077544|19264782|P1|COMPLETED|Overall Study||5
7826557|NCT01077544|19264781|P2|STARTED|Overall Study||7
7826558|NCT01077544|19264782|P1|STARTED|Overall Study||8
7826559|NCT01077518|19264810|P3|NOT COMPLETED|Optional Ofa Phase||16
7826560|NCT01077518|19264811|P2|NOT COMPLETED|Optional Ofa Phase||0
7826561|NCT01077518|19264812|P1|NOT COMPLETED|Optional Ofa Phase||0
7826562|NCT01077518|19264810|P3|COMPLETED|Optional Ofa Phase||16
7826563|NCT01077518|19264811|P2|COMPLETED|Optional Ofa Phase||0
7826564|NCT01077518|19264812|P1|COMPLETED|Optional Ofa Phase||0
7826565|NCT01077518|19264810|P3|Completed 5-year Follow-up|Optional Ofa Phase||12
7826566|NCT01077518|19264811|P2|Completed 5-year Follow-up|Optional Ofa Phase||0
7826567|NCT01077518|19264812|P1|Completed 5-year Follow-up|Optional Ofa Phase||0
7826568|NCT01077518|19264810|P3|STARTED|Optional Ofa Phase||32
7826569|NCT01077518|19264811|P2|STARTED|Optional Ofa Phase||0
7826570|NCT01077518|19264812|P1|STARTED|Optional Ofa Phase||0
7826571|NCT01077518|19264810|P3|NOT COMPLETED|Treatment Phase - no Optional Ofa||0
7826572|NCT01077518|19264811|P2|NOT COMPLETED|Treatment Phase - no Optional Ofa||65
7826573|NCT01077518|19264812|P1|NOT COMPLETED|Treatment Phase - no Optional Ofa||78
7826574|NCT01077518|19264810|P3|COMPLETED|Treatment Phase - no Optional Ofa||0
7826575|NCT01077518|19264811|P2|COMPLETED|Treatment Phase - no Optional Ofa||108
7826576|NCT01077518|19264812|P1|COMPLETED|Treatment Phase - no Optional Ofa||95
7826577|NCT01077518|19264810|P3|Safety Population|Treatment Phase - no Optional Ofa||0
7826578|NCT01077518|19264811|P2|Safety Population|Treatment Phase - no Optional Ofa||170
7826579|NCT01077518|19264812|P1|Safety Population|Treatment Phase - no Optional Ofa||172
7826580|NCT01077518|19264810|P3|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||0
7826581|NCT01077518|19264811|P2|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
7826582|NCT01077518|19264812|P1|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
7826583|NCT01077518|19264810|P3|STARTED|Treatment Phase - no Optional Ofa||0
7826584|NCT01077518|19264811|P2|STARTED|Treatment Phase - no Optional Ofa||173
7826585|NCT01077518|19264812|P1|STARTED|Treatment Phase - no Optional Ofa||173
7826586|NCT01077401|19264872|P2|NOT COMPLETED|Overall Study||21
7826587|NCT01077401|19264873|P1|NOT COMPLETED|Overall Study||18
7826588|NCT01077401|19264872|P2|COMPLETED|Overall Study||54
7826589|NCT01077401|19264873|P1|COMPLETED|Overall Study||59
7826590|NCT01077401|19264872|P2|STARTED|Overall Study||75
7826591|NCT01077401|19264873|P1|STARTED|Overall Study||77
7826592|NCT01077375|19264885|P2|NOT COMPLETED|Overall Study||35
7826593|NCT01077375|19264886|P1|NOT COMPLETED|Overall Study||10
7826594|NCT01077375|19264885|P2|COMPLETED|Overall Study||51
7826595|NCT01077375|19264886|P1|COMPLETED|Overall Study||11
7826596|NCT01077375|19264885|P2|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86
7826597|NCT01077375|19264886|P1|STARTED|Overall Study||21
7826598|NCT01077362|19264897|P3|NOT COMPLETED|Overall Study||24
7826599|NCT01077362|19264898|P2|NOT COMPLETED|Overall Study||19
7826600|NCT01077362|19264899|P1|NOT COMPLETED|Overall Study||31
7826601|NCT01077362|19264897|P3|COMPLETED|Overall Study||81
7826602|NCT01077362|19264898|P2|COMPLETED|Overall Study||84
7826603|NCT01077362|19264899|P1|COMPLETED|Overall Study||73
7826604|NCT01077362|19264897|P3|STARTED|Overall Study||105
7826605|NCT01077362|19264898|P2|STARTED|Overall Study||103
7826606|NCT01077362|19264899|P1|STARTED|Overall Study||104
7826607|NCT01077323|19264935|P3|NOT COMPLETED|Overall Study||11912089
7826608|NCT01077323|19264936|P2|NOT COMPLETED|Overall Study||386263
7826609|NCT01077323|19264937|P1|NOT COMPLETED|Overall Study||11378
7826610|NCT01077323|19264935|P3|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511
7826611|NCT01077323|19264936|P2|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536
7826612|NCT01077323|19264937|P1|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719
7826613|NCT01077323|19264935|P3|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600
7826614|NCT01077323|19264936|P2|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799
7826615|NCT01077323|19264937|P1|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097
7826616|NCT01077310|19264956|P2|NOT COMPLETED|Overall Study||0
7826617|NCT01077310|19264957|P1|NOT COMPLETED|Overall Study||0
7826618|NCT01077310|19264956|P2|COMPLETED|Overall Study||33
7826619|NCT01077310|19264957|P1|COMPLETED|Overall Study||67
7826620|NCT01077310|19264956|P2|STARTED|Overall Study||33
7826621|NCT01077310|19264957|P1|STARTED|Overall Study||67
7826622|NCT01077284|19264980|P3|NOT COMPLETED|Overall Study||3
7826623|NCT01077284|19264981|P2|NOT COMPLETED|Overall Study||5
7826624|NCT01077284|19264982|P1|NOT COMPLETED|Overall Study||5
7826625|NCT01077284|19264980|P3|COMPLETED|Overall Study||30
7826626|NCT01077284|19264981|P2|COMPLETED|Overall Study||28
7826627|NCT01077284|19264982|P1|COMPLETED|Overall Study||28
7826628|NCT01077284|19264980|P3|STARTED|Overall Study||33
7826629|NCT01077284|19264981|P2|STARTED|Overall Study||33
7826630|NCT01077284|19264982|P1|STARTED|Overall Study||33
7826631|NCT01077271|19265003|P1|NOT COMPLETED|Overall Study||22
7826632|NCT01077271|19265003|P1|COMPLETED|Overall Study||102
7826633|NCT01077271|19265003|P1|Number of Participants Analyzed|Overall Study||120
7826634|NCT01077271|19265003|P1|Participants Treated With Palivizumab|Overall Study||120
7826635|NCT01077271|19265003|P1|STARTED|Overall Study||124
7826636|NCT01077258|19265041|P1|NOT COMPLETED|Overall Study||2568
7826637|NCT01077258|19265041|P1|COMPLETED|Overall Study||1640
7826638|NCT01077258|19265041|P1|STARTED|Overall Study||4208
7826639|NCT01077193|19265077|P1|NOT COMPLETED|Overall Study||44
7826640|NCT01077193|19265077|P1|COMPLETED|Overall Study||0
7826641|NCT01077193|19265077|P1|STARTED|Overall Study||44
7826642|NCT01077154|19265083|P2|NOT COMPLETED|Overall Study||2228
7826643|NCT01077154|19265084|P1|NOT COMPLETED|Overall Study||2226
7826644|NCT01077154|19265083|P2|COMPLETED|Overall Study||28
7826645|NCT01077154|19265084|P1|COMPLETED|Overall Study||27
7826646|NCT01077154|19265083|P2|Received Study Drug|Overall Study||2230
7826647|NCT01077154|19265084|P1|Received Study Drug|Overall Study||2229
7826648|NCT01077154|19265083|P2|STARTED|Overall Study||2256
7826649|NCT01077154|19265084|P1|STARTED|Overall Study||2253
7826650|NCT01077128|19265098|P1|NOT COMPLETED|Overall Study||67
7826651|NCT01077128|19265098|P1|COMPLETED|Overall Study||433
7826652|NCT01077128|19265098|P1|STARTED|Overall Study||500
7826653|NCT01077076|19265156|P6|NOT COMPLETED|Third Intervention||1
7826654|NCT01077076|19265157|P5|NOT COMPLETED|Third Intervention||0
7826655|NCT01077076|19265158|P4|NOT COMPLETED|Third Intervention||0
7826656|NCT01077076|19265159|P3|NOT COMPLETED|Third Intervention||0
7826657|NCT01077076|19265160|P2|NOT COMPLETED|Third Intervention||0
7826658|NCT01077076|19265161|P1|NOT COMPLETED|Third Intervention||0
7826659|NCT01077076|19265156|P6|COMPLETED|Third Intervention||4
7826660|NCT01077076|19265157|P5|COMPLETED|Third Intervention||5
7826661|NCT01077076|19265158|P4|COMPLETED|Third Intervention||5
7826662|NCT01077076|19265159|P3|COMPLETED|Third Intervention||5
7826663|NCT01077076|19265160|P2|COMPLETED|Third Intervention||5
7826664|NCT01077076|19265161|P1|COMPLETED|Third Intervention||4
7826665|NCT01077076|19265156|P6|STARTED|Third Intervention||5
7826666|NCT01077076|19265157|P5|STARTED|Third Intervention||5
7826667|NCT01077076|19265158|P4|STARTED|Third Intervention||5
7826668|NCT01077076|19265159|P3|STARTED|Third Intervention||5
7826669|NCT01077076|19265160|P2|STARTED|Third Intervention||5
7826670|NCT01077076|19265161|P1|STARTED|Third Intervention||4
7826671|NCT01077076|19265156|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
7826672|NCT01077076|19265157|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
7826673|NCT01077076|19265158|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
7826674|NCT01077076|19265159|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
7826675|NCT01077076|19265160|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
7826676|NCT01077076|19265161|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
7826677|NCT01077076|19265156|P6|COMPLETED|Washout Period of 2 Weeks||5
7826678|NCT01077076|19265157|P5|COMPLETED|Washout Period of 2 Weeks||5
7826679|NCT01077076|19265158|P4|COMPLETED|Washout Period of 2 Weeks||5
7826680|NCT01077076|19265159|P3|COMPLETED|Washout Period of 2 Weeks||5
7826681|NCT01077076|19265160|P2|COMPLETED|Washout Period of 2 Weeks||5
7826682|NCT01077076|19265161|P1|COMPLETED|Washout Period of 2 Weeks||4
7826683|NCT01077076|19265156|P6|STARTED|Washout Period of 2 Weeks||5
7826684|NCT01077076|19265157|P5|STARTED|Washout Period of 2 Weeks||5
7826685|NCT01077076|19265158|P4|STARTED|Washout Period of 2 Weeks||5
7826686|NCT01077076|19265159|P3|STARTED|Washout Period of 2 Weeks||5
7826687|NCT01077076|19265160|P2|STARTED|Washout Period of 2 Weeks||5
7826688|NCT01077076|19265161|P1|STARTED|Washout Period of 2 Weeks||4
7826689|NCT01077076|19265156|P6|NOT COMPLETED|Second Intervention||0
7826690|NCT01077076|19265157|P5|NOT COMPLETED|Second Intervention||0
7826691|NCT01077076|19265158|P4|NOT COMPLETED|Second Intervention||0
7826692|NCT01077076|19265159|P3|NOT COMPLETED|Second Intervention||0
7826693|NCT01077076|19265160|P2|NOT COMPLETED|Second Intervention||0
7826694|NCT01077076|19265161|P1|NOT COMPLETED|Second Intervention||0
7826695|NCT01077076|19265156|P6|COMPLETED|Second Intervention||5
7826696|NCT01077076|19265157|P5|COMPLETED|Second Intervention||5
7826697|NCT01077076|19265158|P4|COMPLETED|Second Intervention||5
7826698|NCT01077076|19265159|P3|COMPLETED|Second Intervention||5
7826699|NCT01077076|19265160|P2|COMPLETED|Second Intervention||5
7826700|NCT01077076|19265161|P1|COMPLETED|Second Intervention||4
7826701|NCT01077076|19265156|P6|STARTED|Second Intervention||5
7826702|NCT01077076|19265157|P5|STARTED|Second Intervention||5
7826703|NCT01077076|19265158|P4|STARTED|Second Intervention||5
7826704|NCT01077076|19265159|P3|STARTED|Second Intervention||5
7826705|NCT01077076|19265160|P2|STARTED|Second Intervention||5
7826706|NCT01077076|19265161|P1|STARTED|Second Intervention||4
7826707|NCT01077076|19265156|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
7826708|NCT01077076|19265157|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
7826709|NCT01077076|19265158|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
7826710|NCT01077076|19265159|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
7826711|NCT01077076|19265160|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
7826712|NCT01077076|19265161|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
7826713|NCT01077076|19265156|P6|COMPLETED|Washout Period of 2 Weeks||5
7826714|NCT01077076|19265157|P5|COMPLETED|Washout Period of 2 Weeks||5
7826715|NCT01077076|19265158|P4|COMPLETED|Washout Period of 2 Weeks||5
7826716|NCT01077076|19265159|P3|COMPLETED|Washout Period of 2 Weeks||5
7826717|NCT01077076|19265160|P2|COMPLETED|Washout Period of 2 Weeks||5
7826718|NCT01077076|19265161|P1|COMPLETED|Washout Period of 2 Weeks||4
7826719|NCT01077076|19265156|P6|STARTED|Washout Period of 2 Weeks||5
7826720|NCT01077076|19265157|P5|STARTED|Washout Period of 2 Weeks||5
7826721|NCT01077076|19265158|P4|STARTED|Washout Period of 2 Weeks||5
7826722|NCT01077076|19265159|P3|STARTED|Washout Period of 2 Weeks||5
7826723|NCT01077076|19265160|P2|STARTED|Washout Period of 2 Weeks||5
7826724|NCT01077076|19265161|P1|STARTED|Washout Period of 2 Weeks||4
7826725|NCT01077076|19265156|P6|NOT COMPLETED|First Intervention||0
7826726|NCT01077076|19265157|P5|NOT COMPLETED|First Intervention||0
7826727|NCT01077076|19265158|P4|NOT COMPLETED|First Intervention||0
7826728|NCT01077076|19265159|P3|NOT COMPLETED|First Intervention||0
7826729|NCT01077076|19265160|P2|NOT COMPLETED|First Intervention||0
7826730|NCT01077076|19265161|P1|NOT COMPLETED|First Intervention||1
7826731|NCT01077076|19265156|P6|COMPLETED|First Intervention||5
7826732|NCT01077076|19265157|P5|COMPLETED|First Intervention||5
7826733|NCT01077076|19265158|P4|COMPLETED|First Intervention||5
7826734|NCT01077076|19265159|P3|COMPLETED|First Intervention||5
7826735|NCT01077076|19265160|P2|COMPLETED|First Intervention||5
7826736|NCT01077076|19265161|P1|COMPLETED|First Intervention||4
7826737|NCT01077076|19265156|P6|STARTED|First Intervention||5
7826738|NCT01077076|19265157|P5|STARTED|First Intervention||5
7826739|NCT01077076|19265158|P4|STARTED|First Intervention||5
7826740|NCT01077076|19265159|P3|STARTED|First Intervention||5
7826741|NCT01077076|19265160|P2|STARTED|First Intervention||5
7826742|NCT01077076|19265161|P1|STARTED|First Intervention||5
7826743|NCT01077063|19265171|P2|NOT COMPLETED|Overall Study||3
7826744|NCT01077063|19265172|P1|NOT COMPLETED|Overall Study||4
7826745|NCT01077063|19265171|P2|COMPLETED|Overall Study||0
7826746|NCT01077063|19265172|P1|COMPLETED|Overall Study||0
7826747|NCT01077063|19265171|P2|STARTED|Overall Study||3
7826748|NCT01077063|19265172|P1|STARTED|Overall Study||4
7826749|NCT01077050|19265178|P1|NOT COMPLETED|Overall Study||9
7826750|NCT01077050|19265178|P1|COMPLETED|Overall Study||1942
7826751|NCT01077050|19265178|P1|STARTED|Overall Study||1951
7826752|NCT01077024|19265184|P2|NOT COMPLETED|Overall Study||28
7826753|NCT01077024|19265185|P1|NOT COMPLETED|Overall Study||31
7826754|NCT01077024|19265184|P2|COMPLETED|Overall Study||243
7826755|NCT01077024|19265185|P1|COMPLETED|Overall Study||236
7826756|NCT01077024|19265184|P2|STARTED|Overall Study||271
7826757|NCT01077024|19265185|P1|STARTED|Overall Study||267
7826758|NCT01076985|19265203|P1|NOT COMPLETED|Overall Study||0
7826759|NCT01076985|19265203|P1|COMPLETED|Overall Study||24
7826760|NCT01076985|19265203|P1|STARTED|Overall Study||24
7826761|NCT01076972|19265209|P1|NOT COMPLETED|Overall Study||0
7826762|NCT01076972|19265209|P1|COMPLETED|Overall Study||1184
7826763|NCT01076972|19265209|P1|STARTED|Overall Study||1184
7826764|NCT01076959|19265224|P1|NOT COMPLETED|Overall Study||2250
7826765|NCT01076959|19265224|P1|COMPLETED|Overall Study||5490
7826766|NCT01076959|19265224|P1|STARTED|Overall Study||7740
7826767|NCT01076686|19265245|P4|NOT COMPLETED|Overall Study||0
7826768|NCT01076686|19265246|P3|NOT COMPLETED|Overall Study||0
7826769|NCT01076686|19265247|P2|NOT COMPLETED|Overall Study||0
7826770|NCT01076686|19265248|P1|NOT COMPLETED|Overall Study||0
7826771|NCT01076686|19265245|P4|COMPLETED|Overall Study||31
7826772|NCT01076686|19265246|P3|COMPLETED|Overall Study||32
7826773|NCT01076686|19265247|P2|COMPLETED|Overall Study||14
7826774|NCT01076686|19265248|P1|COMPLETED|Overall Study||17
7826775|NCT01076686|19265245|P4|STARTED|Overall Study||31
7826776|NCT01076686|19265246|P3|STARTED|Overall Study||32
7826777|NCT01076686|19265247|P2|STARTED|Overall Study||14
7826778|NCT01076686|19265248|P1|STARTED|Overall Study||17
7826779|NCT01076647|19265260|P2|NOT COMPLETED|Overall Study||25
7826780|NCT01076647|19265261|P1|NOT COMPLETED|Overall Study||25
7826781|NCT01076647|19265260|P2|COMPLETED|Overall Study||209
7826782|NCT01076647|19265261|P1|COMPLETED|Overall Study||208
7826783|NCT01076647|19265260|P2|STARTED|Overall Study||234
7826784|NCT01076647|19265261|P1|STARTED|Overall Study||233
7826785|NCT01076543|19265275|P6|NOT COMPLETED|Overall Study||0
7826786|NCT01076543|19265276|P5|NOT COMPLETED|Overall Study||0
7826787|NCT01076543|19265277|P4|NOT COMPLETED|Overall Study||0
7826788|NCT01076543|19265278|P3|NOT COMPLETED|Overall Study||0
7826789|NCT01076543|19265279|P2|NOT COMPLETED|Overall Study||0
7826790|NCT01076543|19265280|P1|NOT COMPLETED|Overall Study||2
7826791|NCT01076543|19265275|P6|COMPLETED|Overall Study||39
7826792|NCT01076543|19265276|P5|COMPLETED|Overall Study||15
7826793|NCT01076543|19265277|P4|COMPLETED|Overall Study||39
7826794|NCT01076543|19265278|P3|COMPLETED|Overall Study||6
7826795|NCT01076543|19265279|P2|COMPLETED|Overall Study||3
7826796|NCT01076543|19265280|P1|COMPLETED|Overall Study||6
7826797|NCT01076543|19265275|P6|STARTED|Overall Study||39
7826798|NCT01076543|19265276|P5|STARTED|Overall Study||15
7826799|NCT01076543|19265277|P4|STARTED|Overall Study||39
7826800|NCT01076543|19265278|P3|STARTED|Overall Study||6
7826801|NCT01076543|19265279|P2|STARTED|Overall Study||3
7826802|NCT01076543|19265280|P1|STARTED|Overall Study||8
7826803|NCT01076504|19265318|P1|NOT COMPLETED|Overall Study||80
7826804|NCT01076504|19265318|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0
7826805|NCT01076504|19265318|P1|STARTED|Overall Study||80
7826806|NCT01076452|19265328|P2|NOT COMPLETED|Overall Study||14
7826807|NCT01076452|19265329|P1|NOT COMPLETED|Overall Study||24
7826808|NCT01076452|19265328|P2|COMPLETED|Overall Study||138
7826809|NCT01076452|19265329|P1|COMPLETED|Overall Study||123
7826810|NCT01076452|19265328|P2|STARTED|Overall Study||152
7826811|NCT01076452|19265329|P1|STARTED|Overall Study||147
7826812|NCT01076400|19265341|P3|NOT COMPLETED|Overall Study||0
7826813|NCT01076400|19265342|P2|NOT COMPLETED|Overall Study||0
7826814|NCT01076400|19265343|P1|NOT COMPLETED|Overall Study||7
7826815|NCT01076400|19265341|P3|COMPLETED|Overall Study||0
7826816|NCT01076400|19265342|P2|COMPLETED|Overall Study||0
7826817|NCT01076400|19265343|P1|COMPLETED|Overall Study||0
7826818|NCT01076400|19265341|P3|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
7826819|NCT01076400|19265342|P2|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
7826820|NCT01076400|19265343|P1|STARTED|Overall Study||7
7826821|NCT01076361|19265349|P1|NOT COMPLETED|Overall Study||21
7826822|NCT01076361|19265349|P1|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349
7826823|NCT01076361|19265349|P1|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370
7826824|NCT01076348|19265353|P1|NOT COMPLETED|Overall Study||22
7826825|NCT01076348|19265353|P1|COMPLETED|Overall Study||51
7826826|NCT01076348|19265353|P1|STARTED|Overall Study||73
7826827|NCT01076335|19265357|P1|NOT COMPLETED|Overall Study||4
7826828|NCT01076335|19265357|P1|COMPLETED|Overall Study||36
7826829|NCT01076335|19265357|P1|STARTED|Overall Study||40
7826830|NCT01076296|19265361|P8|NOT COMPLETED|Overall Study||0
7826831|NCT01076296|19265362|P7|NOT COMPLETED|Overall Study||0
7826832|NCT01076296|19265363|P6|NOT COMPLETED|Overall Study||0
7826833|NCT01076296|19265364|P5|NOT COMPLETED|Overall Study||0
7826834|NCT01076296|19265365|P4|NOT COMPLETED|Overall Study||0
7826835|NCT01076296|19265366|P3|NOT COMPLETED|Overall Study||0
7826836|NCT01076296|19265367|P2|NOT COMPLETED|Overall Study||0
7826837|NCT01076296|19265368|P1|NOT COMPLETED|Overall Study||0
7826838|NCT01076296|19265361|P8|COMPLETED|Overall Study||199
7826839|NCT01076296|19265362|P7|COMPLETED|Overall Study||51
7826840|NCT01076296|19265363|P6|COMPLETED|Overall Study||191
7826841|NCT01076296|19265364|P5|COMPLETED|Overall Study||59
7826842|NCT01076296|19265365|P4|COMPLETED|Overall Study||199
7826843|NCT01076296|19265366|P3|COMPLETED|Overall Study||51
7826844|NCT01076296|19265367|P2|COMPLETED|Overall Study||196
7826845|NCT01076296|19265368|P1|COMPLETED|Overall Study||54
7826846|NCT01076296|19265361|P8|STARTED|Overall Study||199
7826847|NCT01076296|19265362|P7|STARTED|Overall Study||51
7826848|NCT01076296|19265363|P6|STARTED|Overall Study||191
7826849|NCT01076296|19265364|P5|STARTED|Overall Study||59
7826850|NCT01076296|19265365|P4|STARTED|Overall Study||199
7826851|NCT01076296|19265366|P3|STARTED|Overall Study||51
7826852|NCT01076296|19265367|P2|STARTED|Overall Study||196
7826853|NCT01076296|19265368|P1|STARTED|Overall Study||54
7826854|NCT01076283|19265388|P2|NOT COMPLETED|Overall Study||0
7826855|NCT01076283|19265389|P1|NOT COMPLETED|Overall Study||1
7826856|NCT01076283|19265388|P2|COMPLETED|Overall Study||7
7826857|NCT01076283|19265389|P1|COMPLETED|Overall Study||6
7826858|NCT01076283|19265388|P2|STARTED|Overall Study||7
7826859|NCT01076283|19265389|P1|STARTED|Overall Study||7
7826860|NCT01076270|19265397|P1|NOT COMPLETED|Overall Study||0
7826861|NCT01076270|19265397|P1|COMPLETED|Overall Study||1
7826862|NCT01076270|19265397|P1|STARTED|Overall Study||1
7826863|NCT01076244|19265402|P1|NOT COMPLETED|Overall Study||4
7826864|NCT01076244|19265402|P1|COMPLETED|Overall Study||42
7826865|NCT01076244|19265402|P1|STARTED|Overall Study||46
7826866|NCT01076205|19265409|P1|NOT COMPLETED|Overall Study||6019
7826867|NCT01076205|19265409|P1|COMPLETED|Overall Study||1210
7826868|NCT01076205|19265409|P1|STARTED|Overall Study||7229
7826869|NCT01076192|19265462|P1|NOT COMPLETED|Overall Study||197
7826870|NCT01076192|19265462|P1|COMPLETED|Overall Study||350
7826871|NCT01076192|19265462|P1|STARTED|Overall Study||547
7826872|NCT01076179|19265477|P1|NOT COMPLETED|Overall Study||1
7826873|NCT01076179|19265477|P1|COMPLETED|Overall Study||501
7826874|NCT01076179|19265477|P1|STARTED|Overall Study||502
7826875|NCT01076166|19265500|P1|NOT COMPLETED|Overall Study||9
7826876|NCT01076166|19265500|P1|COMPLETED|Overall Study||328
7826877|NCT01076166|19265500|P1|STARTED|Overall Study||337
7826878|NCT01076153|19265507|P1|NOT COMPLETED|Overall Study||11
7826879|NCT01076153|19265507|P1|COMPLETED|Overall Study||749
7826880|NCT01076153|19265507|P1|STARTED|Overall Study||760
7826881|NCT01076088|19265521|P6|NOT COMPLETED|Overall Study||23
7826882|NCT01076088|19265522|P5|NOT COMPLETED|Overall Study||16
7826883|NCT01076088|19265523|P4|NOT COMPLETED|Overall Study||15
7826884|NCT01076088|19265524|P3|NOT COMPLETED|Overall Study||17
7826885|NCT01076088|19265525|P2|NOT COMPLETED|Overall Study||18
7826886|NCT01076088|19265526|P1|NOT COMPLETED|Overall Study||11
7826887|NCT01076088|19265521|P6|COMPLETED|Overall Study||104
7826888|NCT01076088|19265522|P5|COMPLETED|Overall Study||104
7826889|NCT01076088|19265523|P4|COMPLETED|Overall Study||109
7826890|NCT01076088|19265524|P3|COMPLETED|Overall Study||109
7826891|NCT01076088|19265525|P2|COMPLETED|Overall Study||107
7826892|NCT01076088|19265526|P1|COMPLETED|Overall Study||111
7826893|NCT01076088|19265521|P6|STARTED|Overall Study||127
7826894|NCT01076088|19265522|P5|STARTED|Overall Study||120
7826895|NCT01076088|19265523|P4|STARTED|Overall Study||124
7826896|NCT01076088|19265524|P3|STARTED|Overall Study||126
7826897|NCT01076088|19265525|P2|STARTED|Overall Study||125
7826898|NCT01076088|19265526|P1|STARTED|Overall Study||122
7826899|NCT01076075|19265554|P2|NOT COMPLETED|Overall Study||47
7826900|NCT01076075|19265555|P1|NOT COMPLETED|Overall Study||41
7826901|NCT01076075|19265554|P2|COMPLETED|Overall Study||167
7826902|NCT01076075|19265555|P1|COMPLETED|Overall Study||172
7826903|NCT01076075|19265554|P2|Completed Phase A|Overall Study||189
7826904|NCT01076075|19265555|P1|Completed Phase A|Overall Study||199
7826905|NCT01076075|19265554|P2|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214
7826906|NCT01076075|19265555|P1|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213
7826907|NCT01076036|19265569|P1|NOT COMPLETED|Overall Study||2
7826908|NCT01076036|19265569|P1|COMPLETED|Overall Study||8
7826909|NCT01076036|19265569|P1|Complete CorPath Procedures|Overall Study||8
7826910|NCT01076036|19265569|P1|# of Procedures|Overall Study||8
7826911|NCT01076036|19265569|P1|STARTED|Overall Study||10
7826912|NCT01076010|19265577|P3|NOT COMPLETED|Overall Study||2
7826913|NCT01076010|19265578|P2|NOT COMPLETED|Overall Study||39
7826914|NCT01076010|19265579|P1|NOT COMPLETED|Overall Study||125
7826915|NCT01076010|19265577|P3|COMPLETED|Overall Study||26
7826916|NCT01076010|19265578|P2|COMPLETED|Overall Study||49
7826917|NCT01076010|19265579|P1|COMPLETED|Overall Study||36
7826918|NCT01076010|19265577|P3|STARTED|Overall Study||28
7826919|NCT01076010|19265578|P2|STARTED|Overall Study||88
7826920|NCT01076010|19265579|P1|STARTED|Overall Study||161
7826921|NCT01075984|19265619|P5|NOT COMPLETED|Follow-up Phase||47
7826922|NCT01075984|19265620|P4|NOT COMPLETED|Follow-up Phase||2
7826923|NCT01075984|19265621|P3|NOT COMPLETED|Follow-up Phase||1
7826924|NCT01075984|19265622|P2|NOT COMPLETED|Follow-up Phase||0
7826925|NCT01075984|19265623|P1|NOT COMPLETED|Follow-up Phase||0
7826926|NCT01075984|19265619|P5|COMPLETED|Follow-up Phase||165
7826927|NCT01075984|19265620|P4|COMPLETED|Follow-up Phase||19
7826928|NCT01075984|19265621|P3|COMPLETED|Follow-up Phase||19
7826929|NCT01075984|19265622|P2|COMPLETED|Follow-up Phase||10
7826930|NCT01075984|19265623|P1|COMPLETED|Follow-up Phase||10
7826931|NCT01075984|19265619|P5|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212
7826932|NCT01075984|19265620|P4|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21
7826933|NCT01075984|19265621|P3|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20
7826934|NCT01075984|19265622|P2|STARTED|Follow-up Phase||10
7826935|NCT01075984|19265623|P1|STARTED|Follow-up Phase||10
7826936|NCT01075984|19265619|P5|NOT COMPLETED|Treatment Phase||60
7826937|NCT01075984|19265620|P4|NOT COMPLETED|Treatment Phase||7
7826938|NCT01075984|19265621|P3|NOT COMPLETED|Treatment Phase||7
7826939|NCT01075984|19265622|P2|NOT COMPLETED|Treatment Phase||1
7826940|NCT01075984|19265623|P1|NOT COMPLETED|Treatment Phase||0
7826941|NCT01075984|19265619|P5|COMPLETED|Treatment Phase||153
7826942|NCT01075984|19265620|P4|COMPLETED|Treatment Phase||17
7826943|NCT01075984|19265621|P3|COMPLETED|Treatment Phase||14
7826944|NCT01075984|19265622|P2|COMPLETED|Treatment Phase||10
7826945|NCT01075984|19265623|P1|COMPLETED|Treatment Phase||10
7826946|NCT01075984|19265619|P5|STARTED|Treatment Phase||213
7826947|NCT01075984|19265620|P4|STARTED|Treatment Phase||24
7826948|NCT01075984|19265621|P3|STARTED|Treatment Phase||21
7826949|NCT01075984|19265622|P2|STARTED|Treatment Phase||11
7826950|NCT01075984|19265623|P1|STARTED|Treatment Phase||10
7826951|NCT01075971|19265677|P1|NOT COMPLETED|Overall Study||0
7826952|NCT01075971|19265677|P1|COMPLETED|Overall Study||52
7826953|NCT01075971|19265677|P1|STARTED|Overall Study||52
7826954|NCT01075958|19265681|P1|NOT COMPLETED|Overall Study||44
7826955|NCT01075958|19265681|P1|COMPLETED|Overall Study||239
7826956|NCT01075958|19265681|P1|STARTED|Overall Study||283
7826957|NCT01075815|19265697|P2|NOT COMPLETED|Overall Study||4
7826958|NCT01075815|19265698|P1|NOT COMPLETED|Overall Study||10
7826959|NCT01075815|19265697|P2|COMPLETED|Overall Study||31
7826960|NCT01075815|19265698|P1|COMPLETED|Overall Study||30
7826961|NCT01075815|19265697|P2|STARTED|Overall Study|Number of participants treated.|35
7826962|NCT01075815|19265698|P1|STARTED|Overall Study|Number of participants treated.|40
7826963|NCT01075763|19265736|P2|NOT COMPLETED|Overall Study||4
7826964|NCT01075763|19265737|P1|NOT COMPLETED|Overall Study||4
7826965|NCT01075763|19265736|P2|COMPLETED|Overall Study||15
7826966|NCT01075763|19265737|P1|COMPLETED|Overall Study||19
7826967|NCT01075763|19265736|P2|STARTED|Overall Study||19
7826968|NCT01075763|19265737|P1|STARTED|Overall Study||23
7826969|NCT01075685|19265761|P2|NOT COMPLETED|Overall Study||226
7826970|NCT01075685|19265762|P1|NOT COMPLETED|Overall Study||592
7826971|NCT01075685|19265761|P2|COMPLETED|Overall Study||188
7826972|NCT01075685|19265762|P1|COMPLETED|Overall Study||151
7826973|NCT01075685|19265761|P2|Completed Baseline Measures|Overall Study||263
7826974|NCT01075685|19265762|P1|Completed Baseline Measures|Overall Study||225
7826975|NCT01075685|19265761|P2|Met Inclusion Criteria|Overall Study||413
7826976|NCT01075685|19265762|P1|Met Inclusion Criteria|Overall Study||734
7826977|NCT01075685|19265761|P2|STARTED|Overall Study||414
7826978|NCT01075685|19265762|P1|STARTED|Overall Study||743
7826979|NCT01075646|19265778|P4|NOT COMPLETED|Overall Study||2
7826980|NCT01075646|19265779|P3|NOT COMPLETED|Overall Study||1
7826981|NCT01075646|19265780|P2|NOT COMPLETED|Overall Study||3
7826982|NCT01075646|19265781|P1|NOT COMPLETED|Overall Study||4
7826983|NCT01075646|19265778|P4|COMPLETED|Overall Study||44
7826984|NCT01075646|19265779|P3|COMPLETED|Overall Study||52
7826985|NCT01075646|19265780|P2|COMPLETED|Overall Study||31
7826986|NCT01075646|19265781|P1|COMPLETED|Overall Study||29
7826987|NCT01075646|19265778|P4|STARTED|Overall Study||46
7826988|NCT01075646|19265779|P3|STARTED|Overall Study||53
7826989|NCT01075646|19265780|P2|STARTED|Overall Study||34
7826990|NCT01075646|19265781|P1|STARTED|Overall Study||33
7826991|NCT01075412|19265813|P2|NOT COMPLETED|Overall Study||1
7826992|NCT01075412|19265814|P1|NOT COMPLETED|Overall Study||0
7826993|NCT01075412|19265813|P2|COMPLETED|Overall Study||1
7826994|NCT01075412|19265814|P1|COMPLETED|Overall Study||4
7826995|NCT01075412|19265813|P2|STARTED|Overall Study||2
7826996|NCT01075412|19265814|P1|STARTED|Overall Study||4
7826997|NCT01075399|19265824|P1|NOT COMPLETED|Overall Study||8
7826998|NCT01075399|19265824|P1|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42
7826999|NCT01075399|19265824|P1|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50
7827000|NCT01075347|19265830|P2|NOT COMPLETED|Overall Study||0
7827001|NCT01075347|19265831|P1|NOT COMPLETED|Overall Study||0
7827002|NCT01075347|19265830|P2|COMPLETED|Overall Study||83
7827003|NCT01075347|19265831|P1|COMPLETED|Overall Study||82
7827004|NCT01075347|19265830|P2|STARTED|Overall Study||83
7827005|NCT01075347|19265831|P1|STARTED|Overall Study||82
7827006|NCT01075321|19265839|P4|NOT COMPLETED|Overall Study||2
7827007|NCT01075321|19265840|P3|NOT COMPLETED|Overall Study||2
7827008|NCT01075321|19265841|P2|NOT COMPLETED|Overall Study||0
7827009|NCT01075321|19265842|P1|NOT COMPLETED|Overall Study||1
7827010|NCT01075321|19265839|P4|COMPLETED|Overall Study||31
7827011|NCT01075321|19265840|P3|COMPLETED|Overall Study||7
7827012|NCT01075321|19265841|P2|COMPLETED|Overall Study||9
7827013|NCT01075321|19265842|P1|COMPLETED|Overall Study||6
7827014|NCT01075321|19265839|P4|STARTED|Overall Study||33
7827015|NCT01075321|19265840|P3|STARTED|Overall Study||9
7827016|NCT01075321|19265841|P2|STARTED|Overall Study||9
7827017|NCT01075321|19265842|P1|STARTED|Overall Study||7
7827018|NCT01075282|19265860|P3|NOT COMPLETED|Overall Study||27
7827019|NCT01075282|19265861|P2|NOT COMPLETED|Overall Study||29
7827020|NCT01075282|19265862|P1|NOT COMPLETED|Overall Study||31
7827021|NCT01075282|19265860|P3|COMPLETED|Overall Study||238
7827022|NCT01075282|19265861|P2|COMPLETED|Overall Study||243
7827023|NCT01075282|19265862|P1|COMPLETED|Overall Study||242
7827024|NCT01075282|19265860|P3|Received at Least One Dose of Study Drug|Overall Study||262
7827025|NCT01075282|19265861|P2|Received at Least One Dose of Study Drug|Overall Study||272
7827026|NCT01075282|19265862|P1|Received at Least One Dose of Study Drug|Overall Study||273
7827027|NCT01075282|19265860|P3|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265
7827028|NCT01075282|19265861|P2|STARTED|Overall Study||272
7827029|NCT01075282|19265862|P1|STARTED|Overall Study||273
7827030|NCT01075256|19265945|P3|NOT COMPLETED|Overall Study||0
7827031|NCT01075256|19265946|P2|NOT COMPLETED|Overall Study||0
7827032|NCT01075256|19265947|P1|NOT COMPLETED|Overall Study||1
7827033|NCT01075256|19265945|P3|COMPLETED|Overall Study||65
7827034|NCT01075256|19265946|P2|COMPLETED|Overall Study||66
7827035|NCT01075256|19265947|P1|COMPLETED|Overall Study||63
7827036|NCT01075256|19265945|P3|STARTED|Overall Study||65
7827037|NCT01075256|19265946|P2|STARTED|Overall Study||66
7827038|NCT01075256|19265947|P1|STARTED|Overall Study||64
7827039|NCT01075243|19265979|P3|NOT COMPLETED|Overall Study||0
7827040|NCT01075243|19265980|P2|NOT COMPLETED|Overall Study||3
7827041|NCT01075243|19265981|P1|NOT COMPLETED|Overall Study||6
7827042|NCT01075243|19265979|P3|COMPLETED|Overall Study||80
7827043|NCT01075243|19265980|P2|COMPLETED|Overall Study||155
7827044|NCT01075243|19265981|P1|COMPLETED|Overall Study||157
7827045|NCT01075243|19265979|P3|STARTED|Overall Study||80
7827046|NCT01075243|19265980|P2|STARTED|Overall Study||158
7827047|NCT01075243|19265981|P1|STARTED|Overall Study||163
7827048|NCT01075217|19266033|P2|NOT COMPLETED|Overall Study||1
7827049|NCT01075217|19266034|P1|NOT COMPLETED|Overall Study||2
7827050|NCT01075217|19266033|P2|COMPLETED|Overall Study||84
7827051|NCT01075217|19266034|P1|COMPLETED|Overall Study||82
7827052|NCT01075217|19266033|P2|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85
7827053|NCT01075217|19266034|P1|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84
7827054|NCT01075204|19266050|P1|NOT COMPLETED|Overall Study||0
7827055|NCT01075204|19266050|P1|COMPLETED|Overall Study||335
7827056|NCT01075204|19266050|P1|STARTED|Overall Study||335
7827057|NCT01075191|19266067|P1|NOT COMPLETED|Overall Study||18
7827058|NCT01075191|19266067|P1|COMPLETED|Overall Study||42
7827059|NCT01075191|19266067|P1|Discontinued Year 3|Overall Study||5
7827060|NCT01075191|19266067|P1|Discontinued Year 2|Overall Study||6
7827061|NCT01075191|19266067|P1|Discontinued Year 1|Overall Study||7
7827062|NCT01075191|19266067|P1|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60
7827063|NCT01075178|19266078|P2|NOT COMPLETED|Subject Chart Review||9
7827064|NCT01075178|19266079|P1|NOT COMPLETED|Subject Chart Review||9
7827065|NCT01075178|19266078|P2|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
7827066|NCT01075178|19266079|P1|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
7827067|NCT01075178|19266078|P2|STARTED|Subject Chart Review|subjects matched|1018
7827068|NCT01075178|19266079|P1|STARTED|Subject Chart Review|subjects matched|1018
7827069|NCT01075178|19266078|P2|NOT COMPLETED|Subject Matching||403
7827070|NCT01075178|19266079|P1|NOT COMPLETED|Subject Matching||130
7827071|NCT01075178|19266078|P2|COMPLETED|Subject Matching|subjects matched|1018
7827072|NCT01075178|19266079|P1|COMPLETED|Subject Matching|subjects matched|1018
7827073|NCT01075178|19266078|P2|STARTED|Subject Matching|eligible for matching|1421
7827074|NCT01075178|19266079|P1|STARTED|Subject Matching|eligible for matching|1148
7827075|NCT01075152|19266093|P2|NOT COMPLETED|Overall Study||0
7827076|NCT01075152|19266094|P1|NOT COMPLETED|Overall Study||1
7827077|NCT01075152|19266093|P2|COMPLETED|Overall Study||89
7827078|NCT01075152|19266094|P1|COMPLETED|Overall Study||87
7827079|NCT01075152|19266093|P2|STARTED|Overall Study|randomized|89
7827080|NCT01075152|19266094|P1|STARTED|Overall Study|randomized|88
7827081|NCT01075100|19266120|P2|NOT COMPLETED|Overall Study||53
7827082|NCT01075100|19266121|P1|NOT COMPLETED|Overall Study||49
7827083|NCT01075100|19266120|P2|COMPLETED|Overall Study||1
7827084|NCT01075100|19266121|P1|COMPLETED|Overall Study||0
7827085|NCT01075100|19266120|P2|STARTED|Overall Study||54
7827086|NCT01075100|19266121|P1|STARTED|Overall Study||49
7827087|NCT01075087|19266139|P2|NOT COMPLETED|Overall Study||0
7827088|NCT01075087|19266140|P1|NOT COMPLETED|Overall Study||0
7827089|NCT01075087|19266139|P2|COMPLETED|Overall Study||10
7827090|NCT01075087|19266140|P1|COMPLETED|Overall Study||9
7827091|NCT01075087|19266139|P2|STARTED|Overall Study||10
7827092|NCT01075087|19266140|P1|STARTED|Overall Study||9
7827093|NCT01075074|19266151|P3|NOT COMPLETED|Overall Study||2
7827094|NCT01075074|19266152|P2|NOT COMPLETED|Overall Study||2
7827095|NCT01075074|19266153|P1|NOT COMPLETED|Overall Study||1
7827096|NCT01075074|19266151|P3|COMPLETED|Overall Study||23
7827097|NCT01075074|19266152|P2|COMPLETED|Overall Study||23
7827098|NCT01075074|19266153|P1|COMPLETED|Overall Study||24
7827099|NCT01075074|19266151|P3|STARTED|Overall Study||25
7827100|NCT01075074|19266152|P2|STARTED|Overall Study||25
7827101|NCT01075074|19266153|P1|STARTED|Overall Study||25
7827102|NCT01075048|19266173|P3|NOT COMPLETED|Overall Study||62
7827103|NCT01075048|19266174|P2|NOT COMPLETED|Overall Study||60
7827104|NCT01075048|19266175|P1|NOT COMPLETED|Overall Study||9
7827105|NCT01075048|19266173|P3|COMPLETED|Overall Study||0
7827106|NCT01075048|19266174|P2|COMPLETED|Overall Study||0
7827107|NCT01075048|19266175|P1|COMPLETED|Overall Study||0
7827108|NCT01075048|19266173|P3|Did Not Receive Treatment|Overall Study||0
7827109|NCT01075048|19266174|P2|Did Not Receive Treatment|Overall Study||1
7827110|NCT01075048|19266175|P1|Did Not Receive Treatment|Overall Study||0
7827111|NCT01075048|19266173|P3|STARTED|Overall Study||62
7827112|NCT01075048|19266174|P2|STARTED|Overall Study||60
7827113|NCT01075048|19266175|P1|STARTED|Overall Study||9
7827114|NCT01074944|19266198|P5|NOT COMPLETED|Extended Treatment (up to 42 Months)||5
7827115|NCT01074944|19266199|P4|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
7827116|NCT01074944|19266200|P3|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
7827117|NCT01074944|19266201|P2|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
7827118|NCT01074944|19266202|P1|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
7827119|NCT01074944|19266198|P5|COMPLETED|Extended Treatment (up to 42 Months)||20
7827120|NCT01074944|19266199|P4|COMPLETED|Extended Treatment (up to 42 Months)||0
7827121|NCT01074944|19266200|P3|COMPLETED|Extended Treatment (up to 42 Months)||0
7827122|NCT01074944|19266201|P2|COMPLETED|Extended Treatment (up to 42 Months)||0
7827123|NCT01074944|19266202|P1|COMPLETED|Extended Treatment (up to 42 Months)||0
7827124|NCT01074944|19266198|P5|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25
7827125|NCT01074944|19266199|P4|STARTED|Extended Treatment (up to 42 Months)||0
7827126|NCT01074944|19266200|P3|STARTED|Extended Treatment (up to 42 Months)||0
7827127|NCT01074944|19266201|P2|STARTED|Extended Treatment (up to 42 Months)||0
7827128|NCT01074944|19266202|P1|STARTED|Extended Treatment (up to 42 Months)||0
7827129|NCT01074944|19266198|P5|NOT COMPLETED|Long Term Treatment||0
7827130|NCT01074944|19266199|P4|NOT COMPLETED|Long Term Treatment||26
7827131|NCT01074944|19266200|P3|NOT COMPLETED|Long Term Treatment||0
7827132|NCT01074944|19266201|P2|NOT COMPLETED|Long Term Treatment||0
7827133|NCT01074944|19266202|P1|NOT COMPLETED|Long Term Treatment||0
7827134|NCT01074944|19266198|P5|COMPLETED|Long Term Treatment||0
7827135|NCT01074944|19266199|P4|COMPLETED|Long Term Treatment||95
7827136|NCT01074944|19266200|P3|COMPLETED|Long Term Treatment||0
7827137|NCT01074944|19266201|P2|COMPLETED|Long Term Treatment||0
7827138|NCT01074944|19266202|P1|COMPLETED|Long Term Treatment||0
7827139|NCT01074944|19266198|P5|STARTED|Long Term Treatment||0
7827140|NCT01074944|19266199|P4|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121
7827141|NCT01074944|19266200|P3|STARTED|Long Term Treatment||0
7827142|NCT01074944|19266201|P2|STARTED|Long Term Treatment||0
7827143|NCT01074944|19266202|P1|STARTED|Long Term Treatment||0
7827144|NCT01074944|19266198|P5|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
7827145|NCT01074944|19266199|P4|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
7827146|NCT01074944|19266200|P3|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6
7827147|NCT01074944|19266201|P2|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11
7827148|NCT01074944|19266202|P1|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
7827149|NCT01074944|19266198|P5|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
7827150|NCT01074944|19266199|P4|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
7827151|NCT01074944|19266200|P3|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60
7827152|NCT01074944|19266201|P2|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54
7827153|NCT01074944|19266202|P1|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
7827154|NCT01074944|19266198|P5|STARTED|Primary Analysis Period (up to 52 Weeks)||0
7827155|NCT01074944|19266199|P4|STARTED|Primary Analysis Period (up to 52 Weeks)||0
7827156|NCT01074944|19266200|P3|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66
7827157|NCT01074944|19266201|P2|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65
7827158|NCT01074944|19266202|P1|STARTED|Primary Analysis Period (up to 52 Weeks)||0
7827159|NCT01074944|19266198|P5|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
7827160|NCT01074944|19266199|P4|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
7827161|NCT01074944|19266200|P3|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
7827162|NCT01074944|19266201|P2|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
7827163|NCT01074944|19266202|P1|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13
7827164|NCT01074944|19266198|P5|COMPLETED|Lead-in Period (up to 78 Weeks)||0
7827165|NCT01074944|19266199|P4|COMPLETED|Lead-in Period (up to 78 Weeks)||0
7827166|NCT01074944|19266200|P3|COMPLETED|Lead-in Period (up to 78 Weeks)||0
7827167|NCT01074944|19266201|P2|COMPLETED|Lead-in Period (up to 78 Weeks)||0
7827168|NCT01074944|19266202|P1|COMPLETED|Lead-in Period (up to 78 Weeks)||157
7827169|NCT01074944|19266198|P5|STARTED|Lead-in Period (up to 78 Weeks)||0
7827170|NCT01074944|19266199|P4|STARTED|Lead-in Period (up to 78 Weeks)||0
7827171|NCT01074944|19266200|P3|STARTED|Lead-in Period (up to 78 Weeks)||0
7827172|NCT01074944|19266201|P2|STARTED|Lead-in Period (up to 78 Weeks)||0
7827173|NCT01074944|19266202|P1|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170
7827174|NCT01074931|19266256|P1|NOT COMPLETED|Overall Study||6
7827175|NCT01074931|19266256|P1|COMPLETED|Overall Study||92
7827176|NCT01074931|19266256|P1|STARTED|Overall Study||98
7827177|NCT01074658|19266268|P1|NOT COMPLETED|Overall Study||19
7827178|NCT01074658|19266268|P1|COMPLETED|Overall Study||996
7827179|NCT01074658|19266268|P1|Attempted Implant|Overall Study||996
7827180|NCT01074658|19266268|P1|STARTED|Overall Study||1015
7827181|NCT01074554|19266276|P2|NOT COMPLETED|Overall Study||4
7827182|NCT01074554|19266277|P1|NOT COMPLETED|Overall Study||3
7827183|NCT01074554|19266276|P2|COMPLETED|Overall Study||11
7827184|NCT01074554|19266277|P1|COMPLETED|Overall Study||11
7827185|NCT01074554|19266276|P2|STARTED|Overall Study||15
7827186|NCT01074554|19266277|P1|STARTED|Overall Study||14
7827187|NCT01074502|19266287|P1|NOT COMPLETED|Overall Study||1
7827188|NCT01074502|19266287|P1|COMPLETED|Overall Study||2
7827189|NCT01074502|19266287|P1|STARTED|Overall Study||3
7827190|NCT01074463|19266298|P2|NOT COMPLETED|Second Intervention||0
7827191|NCT01074463|19266299|P1|NOT COMPLETED|Second Intervention||0
7827192|NCT01074463|19266298|P2|COMPLETED|Second Intervention||12
7827193|NCT01074463|19266299|P1|COMPLETED|Second Intervention||12
7827194|NCT01074463|19266298|P2|STARTED|Second Intervention||12
7827195|NCT01074463|19266299|P1|STARTED|Second Intervention||12
7827196|NCT01074463|19266298|P2|NOT COMPLETED|Washout of 7 Days||0
7827197|NCT01074463|19266299|P1|NOT COMPLETED|Washout of 7 Days||0
7827198|NCT01074463|19266298|P2|COMPLETED|Washout of 7 Days||12
7827199|NCT01074463|19266299|P1|COMPLETED|Washout of 7 Days||12
7827200|NCT01074463|19266298|P2|STARTED|Washout of 7 Days||12
7827201|NCT01074463|19266299|P1|STARTED|Washout of 7 Days||12
7827202|NCT01074463|19266298|P2|NOT COMPLETED|First Intervention||0
7827203|NCT01074463|19266299|P1|NOT COMPLETED|First Intervention||0
7827204|NCT01074463|19266298|P2|COMPLETED|First Intervention||12
7827205|NCT01074463|19266299|P1|COMPLETED|First Intervention||12
7827206|NCT01074463|19266298|P2|STARTED|First Intervention||12
7827207|NCT01074463|19266299|P1|STARTED|First Intervention||12
7827208|NCT01074450|19266311|P2|NOT COMPLETED|Second Intervention||1
7827209|NCT01074450|19266312|P1|NOT COMPLETED|Second Intervention||1
7827210|NCT01074450|19266311|P2|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9
7827211|NCT01074450|19266312|P1|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11
7827212|NCT01074450|19266311|P2|STARTED|Second Intervention||10
7827213|NCT01074450|19266312|P1|STARTED|Second Intervention||12
7827214|NCT01074450|19266311|P2|NOT COMPLETED|Washout of 7 Days||0
7827215|NCT01074450|19266312|P1|NOT COMPLETED|Washout of 7 Days||0
7827216|NCT01074450|19266311|P2|COMPLETED|Washout of 7 Days||10
7827217|NCT01074450|19266312|P1|COMPLETED|Washout of 7 Days||12
7827218|NCT01074450|19266311|P2|STARTED|Washout of 7 Days||10
7827219|NCT01074450|19266312|P1|STARTED|Washout of 7 Days||12
7827220|NCT01074450|19266311|P2|NOT COMPLETED|First Intervention||2
7827221|NCT01074450|19266312|P1|NOT COMPLETED|First Intervention||0
7827222|NCT01074450|19266311|P2|COMPLETED|First Intervention||10
7827223|NCT01074450|19266312|P1|COMPLETED|First Intervention||12
7827224|NCT01074450|19266311|P2|STARTED|First Intervention||12
7827225|NCT01074450|19266312|P1|STARTED|First Intervention||12
7827226|NCT01074437|19266324|P2|NOT COMPLETED|Overall Study||0
7827227|NCT01074437|19266325|P1|NOT COMPLETED|Overall Study||0
7827228|NCT01074437|19266324|P2|COMPLETED|Overall Study||5
7827229|NCT01074437|19266325|P1|COMPLETED|Overall Study||4
7827230|NCT01074437|19266324|P2|STARTED|Overall Study||5
7827231|NCT01074437|19266325|P1|STARTED|Overall Study||4
7827232|NCT01074307|19266341|P2|NOT COMPLETED|Overall Study||12
7827233|NCT01074307|19266342|P1|NOT COMPLETED|Overall Study||22
7827234|NCT01074307|19266341|P2|COMPLETED|Overall Study||102
7827235|NCT01074307|19266342|P1|COMPLETED|Overall Study||44
7827236|NCT01074307|19266341|P2|STARTED|Overall Study||114
7827237|NCT01074307|19266342|P1|STARTED|Overall Study||66
7827238|NCT01074268|19266364|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7
7827239|NCT01074268|19266365|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6
7827240|NCT01074268|19266364|P2|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115
7827241|NCT01074268|19266365|P1|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242
7827242|NCT01074268|19266364|P2|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122
7827243|NCT01074268|19266365|P1|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248
7827244|NCT01074268|19266364|P2|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15
7827245|NCT01074268|19266365|P1|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20
7827246|NCT01074268|19266364|P2|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138
7827247|NCT01074268|19266365|P1|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283
7827248|NCT01074268|19266364|P2|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152
7827249|NCT01074268|19266365|P1|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301
7827250|NCT01074268|19266364|P2|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153
7827251|NCT01074268|19266365|P1|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302
7827252|NCT01074268|19266364|P2|STARTED|Main: Week 0 to 26 (NN1250-3585)||153
7827253|NCT01074268|19266365|P1|STARTED|Main: Week 0 to 26 (NN1250-3585)||303
7827254|NCT01074255|19266391|P1|NOT COMPLETED|Overall Study||2
7827255|NCT01074255|19266391|P1|COMPLETED|Overall Study||3139
7827256|NCT01074255|19266391|P1|Treated|Overall Study||3139
7827257|NCT01074255|19266391|P1|STARTED|Overall Study||3141
7827258|NCT01074242|19266395|P1|NOT COMPLETED|Overall Study||403
7827259|NCT01074242|19266395|P1|COMPLETED|Overall Study||3395
7827260|NCT01074242|19266395|P1|Received at Least 1 Dose of Vaccine|Overall Study||3395
7827261|NCT01074242|19266395|P1|STARTED|Overall Study||3798
7827262|NCT01074229|19266403|P3|NOT COMPLETED|Overall Study||4
7827263|NCT01074229|19266404|P2|NOT COMPLETED|Overall Study||3
7827264|NCT01074229|19266405|P1|NOT COMPLETED|Overall Study||2
7827265|NCT01074229|19266403|P3|COMPLETED|Overall Study||21
7827266|NCT01074229|19266404|P2|COMPLETED|Overall Study||22
7827267|NCT01074229|19266405|P1|COMPLETED|Overall Study||23
7827268|NCT01074229|19266403|P3|STARTED|Overall Study||25
7827269|NCT01074229|19266404|P2|STARTED|Overall Study||25
7827270|NCT01074229|19266405|P1|STARTED|Overall Study||25
7827271|NCT01074216|19266416|P1|NOT COMPLETED|Overall Study||13
7827272|NCT01074216|19266416|P1|COMPLETED|Overall Study||41
7827273|NCT01074216|19266416|P1|STARTED|Overall Study||54
7827274|NCT01074177|19266420|P1|NOT COMPLETED|Overall Study||0
7827275|NCT01074177|19266420|P1|COMPLETED|Overall Study||24
7827276|NCT01074177|19266420|P1|STARTED|Overall Study||24
7827277|NCT01074164|19266429|P2|NOT COMPLETED|Overall Study||1
7827278|NCT01074164|19266430|P1|NOT COMPLETED|Overall Study||3
7827279|NCT01074164|19266429|P2|COMPLETED|Overall Study||7
7827280|NCT01074164|19266430|P1|COMPLETED|Overall Study||4
7827281|NCT01074164|19266429|P2|STARTED|Overall Study||8
7827282|NCT01074164|19266430|P1|STARTED|Overall Study||7
7827283|NCT01074125|19266451|P3|NOT COMPLETED|Overall Study||12
7827284|NCT01074125|19266452|P2|NOT COMPLETED|Overall Study||5
7827285|NCT01074125|19266453|P1|NOT COMPLETED|Overall Study||12
7827286|NCT01074125|19266451|P3|COMPLETED|Overall Study||36
7827287|NCT01074125|19266452|P2|COMPLETED|Overall Study||47
7827288|NCT01074125|19266453|P1|COMPLETED|Overall Study||39
7827289|NCT01074125|19266451|P3|STARTED|Overall Study||48
7827290|NCT01074125|19266452|P2|STARTED|Overall Study||52
7827291|NCT01074125|19266453|P1|STARTED|Overall Study||51
7827292|NCT01074099|19266469|P2|NOT COMPLETED|Overall Study||0
7827293|NCT01074099|19266470|P1|NOT COMPLETED|Overall Study||0
7827294|NCT01074099|19266469|P2|COMPLETED|Overall Study||3
7827295|NCT01074099|19266470|P1|COMPLETED|Overall Study||2
7827296|NCT01074099|19266469|P2|STARTED|Overall Study||3
7827297|NCT01074099|19266470|P1|STARTED|Overall Study||2
7827298|NCT01074047|19266480|P2|NOT COMPLETED|Extension Phase||0
7827299|NCT01074047|19266481|P1|NOT COMPLETED|Extension Phase||22
7827300|NCT01074047|19266480|P2|COMPLETED|Extension Phase||0
7827301|NCT01074047|19266481|P1|COMPLETED|Extension Phase||0
7827302|NCT01074047|19266480|P2|Safety Population|Extension Phase||0
7827303|NCT01074047|19266481|P1|Safety Population|Extension Phase|Participants who enrolled in the extension phase|22
7827304|NCT01074047|19266480|P2|STARTED|Extension Phase||0
7827305|NCT01074047|19266481|P1|STARTED|Extension Phase|2 participants did not enroll in the extension period.|22
7827306|NCT01074047|19266480|P2|NOT COMPLETED|Survival Follow-Up Phase||136
7827307|NCT01074047|19266481|P1|NOT COMPLETED|Survival Follow-Up Phase||124
7827308|NCT01074047|19266480|P2|COMPLETED|Survival Follow-Up Phase||27
7827309|NCT01074047|19266481|P1|COMPLETED|Survival Follow-Up Phase||16
7827310|NCT01074047|19266480|P2|STARTED|Survival Follow-Up Phase||163
7827311|NCT01074047|19266481|P1|STARTED|Survival Follow-Up Phase||140
7827312|NCT01074047|19266480|P2|NOT COMPLETED|Treatment Phase||234
7827313|NCT01074047|19266481|P1|NOT COMPLETED|Treatment Phase||217
7827314|NCT01074047|19266480|P2|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|13
7827315|NCT01074047|19266481|P1|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|24
7827316|NCT01074047|19266480|P2|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|191
7827317|NCT01074047|19266481|P1|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|179
7827318|NCT01074047|19266480|P2|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|235
7827319|NCT01074047|19266481|P1|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|236
7827320|NCT01074047|19266480|P2|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240
7827321|NCT01074047|19266481|P1|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236
7827322|NCT01074047|19266480|P2|STARTED|Treatment Phase||247
7827323|NCT01074047|19266481|P1|STARTED|Treatment Phase||241
7827324|NCT01074034|19266555|P1|NOT COMPLETED|Overall Study||6
7827325|NCT01074034|19266555|P1|COMPLETED|Overall Study||205
7827326|NCT01074034|19266555|P1|STARTED|Overall Study||211
7827327|NCT01074008|19266569|P9|NOT COMPLETED|Overall Study||4
7827328|NCT01074008|19266570|P8|NOT COMPLETED|Overall Study||0
7827329|NCT01074008|19266571|P7|NOT COMPLETED|Overall Study||1
7827330|NCT01074008|19266572|P6|NOT COMPLETED|Overall Study||0
7827331|NCT01074008|19266573|P5|NOT COMPLETED|Overall Study||2
7827332|NCT01074008|19266574|P4|NOT COMPLETED|Overall Study||1
7827333|NCT01074008|19266575|P3|NOT COMPLETED|Overall Study||2
7827334|NCT01074008|19266576|P2|NOT COMPLETED|Overall Study||3
7827335|NCT01074008|19266577|P1|NOT COMPLETED|Overall Study||1
7827336|NCT01074008|19266569|P9|COMPLETED|Overall Study||7
7827337|NCT01074008|19266570|P8|COMPLETED|Overall Study||8
7827338|NCT01074008|19266571|P7|COMPLETED|Overall Study||7
7827339|NCT01074008|19266572|P6|COMPLETED|Overall Study||7
7827340|NCT01074008|19266573|P5|COMPLETED|Overall Study||6
7827341|NCT01074008|19266574|P4|COMPLETED|Overall Study||7
7827342|NCT01074008|19266575|P3|COMPLETED|Overall Study||6
7827343|NCT01074008|19266576|P2|COMPLETED|Overall Study||5
7827344|NCT01074008|19266577|P1|COMPLETED|Overall Study||7
7827345|NCT01074008|19266569|P9|Completed Direct-acting Antiviral Agent|Overall Study||5
7827346|NCT01074008|19266570|P8|Completed Direct-acting Antiviral Agent|Overall Study||7
7827347|NCT01074008|19266571|P7|Completed Direct-acting Antiviral Agent|Overall Study||8
7827348|NCT01074008|19266572|P6|Completed Direct-acting Antiviral Agent|Overall Study||5
7827349|NCT01074008|19266573|P5|Completed Direct-acting Antiviral Agent|Overall Study||8
7827350|NCT01074008|19266574|P4|Completed Direct-acting Antiviral Agent|Overall Study||8
7827351|NCT01074008|19266575|P3|Completed Direct-acting Antiviral Agent|Overall Study||7
7827352|NCT01074008|19266576|P2|Completed Direct-acting Antiviral Agent|Overall Study||7
7827353|NCT01074008|19266577|P1|Completed Direct-acting Antiviral Agent|Overall Study||8
7827354|NCT01074008|19266569|P9|STARTED|Overall Study||11
7827355|NCT01074008|19266570|P8|STARTED|Overall Study||8
7827356|NCT01074008|19266571|P7|STARTED|Overall Study||8
7827357|NCT01074008|19266572|P6|STARTED|Overall Study||7
7827358|NCT01074008|19266573|P5|STARTED|Overall Study||8
7827359|NCT01074008|19266574|P4|STARTED|Overall Study||8
7827360|NCT01074008|19266575|P3|STARTED|Overall Study||8
7827361|NCT01074008|19266576|P2|STARTED|Overall Study||8
7827362|NCT01074008|19266577|P1|STARTED|Overall Study||8
7827363|NCT01073943|19266687|P2|NOT COMPLETED|Overall Study||8
7827364|NCT01073943|19266688|P1|NOT COMPLETED|Overall Study||13
7827365|NCT01073943|19266687|P2|COMPLETED|Overall Study||295
7827366|NCT01073943|19266688|P1|COMPLETED|Overall Study||287
7827367|NCT01073943|19266687|P2|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300
7827368|NCT01073943|19266688|P1|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294
7827369|NCT01073943|19266687|P2|Safety Population (Treated)|Overall Study||302
7827370|NCT01073943|19266688|P1|Safety Population (Treated)|Overall Study||296
7827371|NCT01073943|19266687|P2|STARTED|Overall Study||303
7827372|NCT01073943|19266688|P1|STARTED|Overall Study||300
7827373|NCT01073930|19266714|P2|NOT COMPLETED|Overall Study||6
7827374|NCT01073930|19266715|P1|NOT COMPLETED|Overall Study||3
7827375|NCT01073930|19266714|P2|COMPLETED|Overall Study||295
7827376|NCT01073930|19266715|P1|COMPLETED|Overall Study||304
7827377|NCT01073930|19266714|P2|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297
7827378|NCT01073930|19266715|P1|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304
7827379|NCT01073930|19266714|P2|Safety Population (Treated)|Overall Study||298
7827380|NCT01073930|19266715|P1|Safety Population (Treated)|Overall Study||305
7827381|NCT01073930|19266714|P2|STARTED|Overall Study||301
7827382|NCT01073930|19266715|P1|STARTED|Overall Study||307
7827383|NCT01073865|19266739|P2|NOT COMPLETED|Overall Study||39
7827384|NCT01073865|19266740|P1|NOT COMPLETED|Overall Study||28
7827385|NCT01073865|19266739|P2|COMPLETED|Overall Study|Number of patients completed the study|74
7827386|NCT01073865|19266740|P1|COMPLETED|Overall Study|Number of patients completed the study|81
7827387|NCT01073865|19266739|P2|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113
7827388|NCT01073865|19266740|P1|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108
7827389|NCT01073865|19266739|P2|STARTED|Overall Study|Number of patients randomised|113
7827390|NCT01073865|19266740|P1|STARTED|Overall Study|Number of patients randomised|109
7827391|NCT01073657|19266752|P2|NOT COMPLETED|Overall Study||0
7827392|NCT01073657|19266753|P1|NOT COMPLETED|Overall Study||0
7827393|NCT01073657|19266752|P2|COMPLETED|Overall Study||16
7827394|NCT01073657|19266753|P1|COMPLETED|Overall Study||17
7827395|NCT01073657|19266752|P2|STARTED|Overall Study||16
7827396|NCT01073657|19266753|P1|STARTED|Overall Study||17
7827397|NCT01073631|19266759|P1|NOT COMPLETED|Overall Study||169
7827398|NCT01073631|19266759|P1|COMPLETED|Overall Study||374
7827399|NCT01073631|19266759|P1|STARTED|Overall Study||543
7827400|NCT01073618|19266764|P1|NOT COMPLETED|Overall Study||307
7827401|NCT01073618|19266764|P1|COMPLETED|Overall Study||385
7827402|NCT01073618|19266764|P1|STARTED|Overall Study||692
7827403|NCT01073605|19266772|P3|NOT COMPLETED|Overall Study||61
7827404|NCT01073605|19266773|P2|NOT COMPLETED|Overall Study||67
7827405|NCT01073605|19266774|P1|NOT COMPLETED|Overall Study||62
7827406|NCT01073605|19266772|P3|COMPLETED|Overall Study|Corresponds to follow-up until final height|8
7827407|NCT01073605|19266773|P2|COMPLETED|Overall Study|Corresponds to follow-up until final height|4
7827408|NCT01073605|19266774|P1|COMPLETED|Overall Study|Corresponds to follow-up until final height|6
7827409|NCT01073605|19266772|P3|Received Treatment|Overall Study||68
7827410|NCT01073605|19266773|P2|Received Treatment|Overall Study||70
7827411|NCT01073605|19266774|P1|Received Treatment|Overall Study||68
7827412|NCT01073605|19266772|P3|STARTED|Overall Study||69
7827413|NCT01073605|19266773|P2|STARTED|Overall Study||71
7827414|NCT01073605|19266774|P1|STARTED|Overall Study||68
7827415|NCT01073566|19266820|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
7827416|NCT01073566|19266821|P1|NOT COMPLETED|Period 2 (6 Weeks)||1
7827417|NCT01073566|19266820|P2|COMPLETED|Period 2 (6 Weeks)||19
7827418|NCT01073566|19266821|P1|COMPLETED|Period 2 (6 Weeks)||18
7827419|NCT01073566|19266820|P2|STARTED|Period 2 (6 Weeks)||19
7827420|NCT01073566|19266821|P1|STARTED|Period 2 (6 Weeks)||19
7827421|NCT01073566|19266820|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
7827422|NCT01073566|19266821|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
7827423|NCT01073566|19266820|P2|COMPLETED|Period 1 (6 Weeks)||19
7827424|NCT01073566|19266821|P1|COMPLETED|Period 1 (6 Weeks)||19
7827425|NCT01073566|19266820|P2|STARTED|Period 1 (6 Weeks)||19
7827426|NCT01073566|19266821|P1|STARTED|Period 1 (6 Weeks)||19
7827427|NCT01073462|19266833|P1|NOT COMPLETED|Overall Study||41
7827428|NCT01073462|19266833|P1|COMPLETED|Overall Study||26
7827429|NCT01073462|19266833|P1|STARTED|Overall Study||67
7827430|NCT01073449|19266844|P1|NOT COMPLETED|Overall Study||0
7827431|NCT01073449|19266844|P1|COMPLETED|Overall Study||3362
7827432|NCT01073449|19266844|P1|STARTED|Overall Study||3362
7827433|NCT01073293|19266852|P2|NOT COMPLETED|Overall Study||11
7827434|NCT01073293|19266853|P1|NOT COMPLETED|Overall Study||5
7827435|NCT01073293|19266852|P2|COMPLETED|Overall Study||517
7827436|NCT01073293|19266853|P1|COMPLETED|Overall Study||521
7827437|NCT01073293|19266852|P2|STARTED|Overall Study||528
7827438|NCT01073293|19266853|P1|STARTED|Overall Study||526
7827439|NCT01073267|19266875|P1|NOT COMPLETED|Overall Study||3
7827440|NCT01073267|19266875|P1|COMPLETED|Overall Study||1
7827441|NCT01073267|19266875|P1|STARTED|Overall Study||4
7827442|NCT01073163|19266879|P1|NOT COMPLETED|Overall Study||3
7827443|NCT01073163|19266879|P1|COMPLETED|Overall Study|Patients completed study|51
7827444|NCT01073163|19266879|P1|Treated With >=6 Cycles|Overall Study||49
7827445|NCT01073163|19266879|P1|Treated With <6 Cycles|Overall Study||4
7827446|NCT01073163|19266879|P1|Enrolled But Not Treated|Overall Study||1
7827447|NCT01073163|19266879|P1|STARTED|Overall Study||54
7827448|NCT01072929|19266902|P3|NOT COMPLETED|Overall Study||9
7827449|NCT01072929|19266903|P2|NOT COMPLETED|Overall Study||51
7827450|NCT01072929|19266904|P1|NOT COMPLETED|Overall Study||44
7827451|NCT01072929|19266902|P3|COMPLETED|Overall Study||24
7827452|NCT01072929|19266903|P2|COMPLETED|Overall Study||150
7827453|NCT01072929|19266904|P1|COMPLETED|Overall Study||155
7827454|NCT01072929|19266902|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31
7827455|NCT01072929|19266903|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
7827456|NCT01072929|19266904|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
7827457|NCT01072929|19266902|P3|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32
7827458|NCT01072929|19266903|P2|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198
7827459|NCT01072929|19266904|P1|Safety Population|Overall Study|Treated participants|199
7827460|NCT01072929|19266902|P3|STARTED|Overall Study||33
7827461|NCT01072929|19266903|P2|STARTED|Overall Study||201
7827462|NCT01072929|19266904|P1|STARTED|Overall Study||199
7827463|NCT01072877|19266983|P5|NOT COMPLETED|Overall Study||0
7827464|NCT01072877|19266984|P4|NOT COMPLETED|Overall Study||2
7827465|NCT01072877|19266985|P3|NOT COMPLETED|Overall Study||0
7827466|NCT01072877|19266986|P2|NOT COMPLETED|Overall Study||1
7827467|NCT01072877|19266987|P1|NOT COMPLETED|Overall Study||1
7827468|NCT01072877|19266983|P5|COMPLETED|Overall Study||63
7827469|NCT01072877|19266984|P4|COMPLETED|Overall Study||50
7827470|NCT01072877|19266985|P3|COMPLETED|Overall Study||51
7827471|NCT01072877|19266986|P2|COMPLETED|Overall Study||56
7827472|NCT01072877|19266987|P1|COMPLETED|Overall Study||55
7827473|NCT01072877|19266983|P5|STARTED|Overall Study||63
7827474|NCT01072877|19266984|P4|STARTED|Overall Study||52
7827475|NCT01072877|19266985|P3|STARTED|Overall Study||51
7827476|NCT01072877|19266986|P2|STARTED|Overall Study||57
7827477|NCT01072877|19266987|P1|STARTED|Overall Study||56
7827478|NCT01072773|19267009|P1|NOT COMPLETED|Overall Study||0
7827479|NCT01072773|19267009|P1|COMPLETED|Overall Study||2
7827480|NCT01072773|19267009|P1|STARTED|Overall Study||2
7827481|NCT01072669|19267020|P2|NOT COMPLETED|Overall Study||0
7827482|NCT01072669|19267021|P1|NOT COMPLETED|Overall Study||0
7827483|NCT01072669|19267020|P2|COMPLETED|Overall Study||5
7827484|NCT01072669|19267021|P1|COMPLETED|Overall Study||15
7827485|NCT01072669|19267020|P2|STARTED|Overall Study||5
7827486|NCT01072669|19267021|P1|STARTED|Overall Study||15
7827487|NCT01072656|19267029|P2|NOT COMPLETED|Second Intervention||0
7827488|NCT01072656|19267030|P1|NOT COMPLETED|Second Intervention||0
7827489|NCT01072656|19267029|P2|COMPLETED|Second Intervention||4
7827490|NCT01072656|19267030|P1|COMPLETED|Second Intervention||5
7827491|NCT01072656|19267029|P2|STARTED|Second Intervention||4
7827492|NCT01072656|19267030|P1|STARTED|Second Intervention||5
7827493|NCT01072656|19267029|P2|NOT COMPLETED|First Intervention||0
7827494|NCT01072656|19267030|P1|NOT COMPLETED|First Intervention||0
7827495|NCT01072656|19267029|P2|COMPLETED|First Intervention||4
7827496|NCT01072656|19267030|P1|COMPLETED|First Intervention||5
7827497|NCT01072656|19267029|P2|STARTED|First Intervention||4
7827498|NCT01072656|19267030|P1|STARTED|First Intervention||5
7827499|NCT01072643|19267040|P1|NOT COMPLETED|Overall Study||0
7827500|NCT01072643|19267040|P1|COMPLETED|Overall Study||4
7827501|NCT01072643|19267040|P1|STARTED|Overall Study||4
7827502|NCT01072630|19267066|P3|NOT COMPLETED|Overall Study||13
7827503|NCT01072630|19267067|P2|NOT COMPLETED|Overall Study||60
7827504|NCT01072630|19267068|P1|NOT COMPLETED|Overall Study||55
7827505|NCT01072630|19267066|P3|COMPLETED|Overall Study||17
7827506|NCT01072630|19267067|P2|COMPLETED|Overall Study||172
7827507|NCT01072630|19267068|P1|COMPLETED|Overall Study||175
7827508|NCT01072630|19267066|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28
7827509|NCT01072630|19267067|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230
7827510|NCT01072630|19267068|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224
7827511|NCT01072630|19267066|P3|Safety Population|Overall Study|Treated participants.|30
7827512|NCT01072630|19267067|P2|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231
7827513|NCT01072630|19267068|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229
7827514|NCT01072630|19267066|P3|STARTED|Overall Study||30
7827515|NCT01072630|19267067|P2|STARTED|Overall Study||232
7827516|NCT01072630|19267068|P1|STARTED|Overall Study||230
7827517|NCT01072617|19267142|P1|NOT COMPLETED|Overall Study||0
7827518|NCT01072617|19267142|P1|COMPLETED|Overall Study||8
7827519|NCT01072617|19267142|P1|STARTED|Overall Study||8
7827520|NCT01072539|19267149|P1|NOT COMPLETED|Overall Study||3
7827521|NCT01072539|19267149|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169
7827522|NCT01072539|19267149|P1|STARTED|Overall Study||3172
7827523|NCT01072526|19267157|P2|NOT COMPLETED|Overall Study||0
7827524|NCT01072526|19267158|P1|NOT COMPLETED|Overall Study||0
7827525|NCT01072526|19267157|P2|COMPLETED|Overall Study||0
7827526|NCT01072526|19267158|P1|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6
7827527|NCT01072526|19267157|P2|STARTED|Overall Study||0
7827528|NCT01072526|19267158|P1|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6
7827529|NCT01072500|19267173|P2|NOT COMPLETED|Overall Study||14
7827530|NCT01072500|19267174|P1|NOT COMPLETED|Overall Study||24
7827531|NCT01072500|19267173|P2|COMPLETED|Overall Study||803
7827532|NCT01072500|19267174|P1|COMPLETED|Overall Study||794
7827533|NCT01072500|19267173|P2|STARTED|Overall Study||817
7827534|NCT01072500|19267174|P1|STARTED|Overall Study||818
7827535|NCT01072448|19267184|P2|NOT COMPLETED|Overall Study||30
7827536|NCT01072448|19267185|P1|NOT COMPLETED|Overall Study||19
7827537|NCT01072448|19267184|P2|COMPLETED|Overall Study||130
7827538|NCT01072448|19267185|P1|COMPLETED|Overall Study||144
7827539|NCT01072448|19267184|P2|STARTED|Overall Study||160
7827540|NCT01072448|19267185|P1|STARTED|Overall Study||163
7827541|NCT01072409|19267193|P1|NOT COMPLETED|Overall Study||7
7827542|NCT01072409|19267193|P1|COMPLETED|Overall Study||38
7827543|NCT01072409|19267193|P1|STARTED|Overall Study||45
7827544|NCT01072396|19267199|P2|NOT COMPLETED|Period Two||3
7827545|NCT01072396|19267200|P1|NOT COMPLETED|Period Two||1
7827546|NCT01072396|19267199|P2|COMPLETED|Period Two||57
7827547|NCT01072396|19267200|P1|COMPLETED|Period Two||57
7827548|NCT01072396|19267199|P2|STARTED|Period Two||60
7827549|NCT01072396|19267200|P1|STARTED|Period Two||58
7827550|NCT01072396|19267199|P2|NOT COMPLETED|Washout Period||1
7827551|NCT01072396|19267200|P1|NOT COMPLETED|Washout Period||0
7827552|NCT01072396|19267199|P2|COMPLETED|Washout Period||60
7827553|NCT01072396|19267200|P1|COMPLETED|Washout Period||58
7827554|NCT01072396|19267199|P2|STARTED|Washout Period||61
7827555|NCT01072396|19267200|P1|STARTED|Washout Period||58
7827556|NCT01072396|19267199|P2|NOT COMPLETED|Period One||2
7827557|NCT01072396|19267200|P1|NOT COMPLETED|Period One||5
7827558|NCT01072396|19267199|P2|COMPLETED|Period One||61
7827559|NCT01072396|19267200|P1|COMPLETED|Period One||58
7827560|NCT01072396|19267199|P2|STARTED|Period One||63
7827561|NCT01072396|19267200|P1|STARTED|Period One||63
7827562|NCT01072357|19267212|P2|NOT COMPLETED|Overall Study||1
7827563|NCT01072357|19267213|P1|NOT COMPLETED|Overall Study||0
7827564|NCT01072357|19267212|P2|COMPLETED|Overall Study||14
7827565|NCT01072357|19267213|P1|COMPLETED|Overall Study||15
7827566|NCT01072357|19267212|P2|STARTED|Overall Study||15
7827567|NCT01072357|19267213|P1|STARTED|Overall Study||15
7827568|NCT01072344|19267223|P2|NOT COMPLETED|Overall Study||18
7827569|NCT01072344|19267224|P1|NOT COMPLETED|Overall Study||11
7827570|NCT01072344|19267223|P2|COMPLETED|Overall Study||29
7827571|NCT01072344|19267224|P1|COMPLETED|Overall Study||35
7827572|NCT01072344|19267223|P2|STARTED|Overall Study||47
7827573|NCT01072344|19267224|P1|STARTED|Overall Study||46
7827574|NCT01072331|19267241|P3|NOT COMPLETED|Overall Study||0
7827575|NCT01072331|19267242|P2|NOT COMPLETED|Overall Study||0
7827576|NCT01072331|19267243|P1|NOT COMPLETED|Overall Study||0
7827577|NCT01072331|19267241|P3|COMPLETED|Overall Study||32
7827578|NCT01072331|19267242|P2|COMPLETED|Overall Study||33
7827579|NCT01072331|19267243|P1|COMPLETED|Overall Study||34
7827580|NCT01072331|19267241|P3|STARTED|Overall Study||32
7827581|NCT01072331|19267242|P2|STARTED|Overall Study||33
7827582|NCT01072331|19267243|P1|STARTED|Overall Study||34
7827583|NCT01072201|19267262|P2|NOT COMPLETED|Overall Study||1
7827584|NCT01072201|19267263|P1|NOT COMPLETED|Overall Study||0
7827585|NCT01072201|19267262|P2|COMPLETED|Overall Study||29
7827586|NCT01072201|19267263|P1|COMPLETED|Overall Study||30
7827587|NCT01072201|19267262|P2|STARTED|Overall Study||30
7827588|NCT01072201|19267263|P1|STARTED|Overall Study||30
7827589|NCT01072188|19267275|P2|NOT COMPLETED|Overall Study||0
7827590|NCT01072188|19267276|P1|NOT COMPLETED|Overall Study||0
7827591|NCT01072188|19267275|P2|COMPLETED|Overall Study||23
7827592|NCT01072188|19267276|P1|COMPLETED|Overall Study||22
7827593|NCT01072188|19267275|P2|STARTED|Overall Study||23
7827594|NCT01072188|19267276|P1|STARTED|Overall Study||22
7827595|NCT01072175|19267296|P13|NOT COMPLETED|Part D (HPMC Capsules)||39
7827596|NCT01072175|19267297|P12|NOT COMPLETED|Part D (HPMC Capsules)||43
7827597|NCT01072175|19267298|P11|NOT COMPLETED|Part D (HPMC Capsules)||16
7827598|NCT01072175|19267299|P10|NOT COMPLETED|Part D (HPMC Capsules)||12
7827599|NCT01072175|19267300|P9|NOT COMPLETED|Part D (HPMC Capsules)||0
7827600|NCT01072175|19267301|P8|NOT COMPLETED|Part D (HPMC Capsules)||0
7827601|NCT01072175|19267302|P7|NOT COMPLETED|Part D (HPMC Capsules)||0
7827602|NCT01072175|19267303|P6|NOT COMPLETED|Part D (HPMC Capsules)||0
7827603|NCT01072175|19267304|P5|NOT COMPLETED|Part D (HPMC Capsules)||0
7827604|NCT01072175|19267305|P4|NOT COMPLETED|Part D (HPMC Capsules)||0
7827605|NCT01072175|19267306|P3|NOT COMPLETED|Part D (HPMC Capsules)||0
7827606|NCT01072175|19267307|P2|NOT COMPLETED|Part D (HPMC Capsules)||0
7827607|NCT01072175|19267308|P1|NOT COMPLETED|Part D (HPMC Capsules)||0
7827608|NCT01072175|19267296|P13|COMPLETED|Part D (HPMC Capsules)||0
7827609|NCT01072175|19267297|P12|COMPLETED|Part D (HPMC Capsules)||0
7827610|NCT01072175|19267298|P11|COMPLETED|Part D (HPMC Capsules)||0
7827611|NCT01072175|19267299|P10|COMPLETED|Part D (HPMC Capsules)||0
7827612|NCT01072175|19267300|P9|COMPLETED|Part D (HPMC Capsules)||0
7827613|NCT01072175|19267301|P8|COMPLETED|Part D (HPMC Capsules)||0
7827614|NCT01072175|19267302|P7|COMPLETED|Part D (HPMC Capsules)||0
7827615|NCT01072175|19267303|P6|COMPLETED|Part D (HPMC Capsules)||0
7827616|NCT01072175|19267304|P5|COMPLETED|Part D (HPMC Capsules)||0
7827617|NCT01072175|19267305|P4|COMPLETED|Part D (HPMC Capsules)||0
7827618|NCT01072175|19267306|P3|COMPLETED|Part D (HPMC Capsules)||0
7827619|NCT01072175|19267307|P2|COMPLETED|Part D (HPMC Capsules)||0
7827620|NCT01072175|19267308|P1|COMPLETED|Part D (HPMC Capsules)||0
7827621|NCT01072175|19267296|P13|STARTED|Part D (HPMC Capsules)||39
7827622|NCT01072175|19267297|P12|STARTED|Part D (HPMC Capsules)||43
7827623|NCT01072175|19267298|P11|STARTED|Part D (HPMC Capsules)||16
7827624|NCT01072175|19267299|P10|STARTED|Part D (HPMC Capsules)||12
7827625|NCT01072175|19267300|P9|STARTED|Part D (HPMC Capsules)||0
7827626|NCT01072175|19267301|P8|STARTED|Part D (HPMC Capsules)||0
7827627|NCT01072175|19267302|P7|STARTED|Part D (HPMC Capsules)||0
7827628|NCT01072175|19267303|P6|STARTED|Part D (HPMC Capsules)||0
7827629|NCT01072175|19267304|P5|STARTED|Part D (HPMC Capsules)||0
7827630|NCT01072175|19267305|P4|STARTED|Part D (HPMC Capsules)||0
7827631|NCT01072175|19267306|P3|STARTED|Part D (HPMC Capsules)||0
7827632|NCT01072175|19267307|P2|STARTED|Part D (HPMC Capsules)||0
7827633|NCT01072175|19267308|P1|STARTED|Part D (HPMC Capsules)||0
7827634|NCT01072175|19267296|P13|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827635|NCT01072175|19267297|P12|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827636|NCT01072175|19267298|P11|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827637|NCT01072175|19267299|P10|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827638|NCT01072175|19267300|P9|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||45
7827639|NCT01072175|19267301|P8|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827640|NCT01072175|19267302|P7|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827641|NCT01072175|19267303|P6|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827642|NCT01072175|19267304|P5|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827643|NCT01072175|19267305|P4|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827644|NCT01072175|19267306|P3|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827645|NCT01072175|19267307|P2|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827646|NCT01072175|19267308|P1|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827647|NCT01072175|19267296|P13|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827648|NCT01072175|19267297|P12|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827649|NCT01072175|19267298|P11|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827650|NCT01072175|19267299|P10|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827651|NCT01072175|19267300|P9|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827652|NCT01072175|19267301|P8|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827653|NCT01072175|19267302|P7|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827654|NCT01072175|19267303|P6|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827655|NCT01072175|19267304|P5|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827656|NCT01072175|19267305|P4|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827657|NCT01072175|19267306|P3|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827658|NCT01072175|19267307|P2|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827659|NCT01072175|19267308|P1|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
7827660|NCT01072175|19267296|P13|STARTED|Part C (Phase II: Crossover Phase [CP])||0
7827661|NCT01072175|19267297|P12|STARTED|Part C (Phase II: Crossover Phase [CP])||0
7827662|NCT01072175|19267298|P11|STARTED|Part C (Phase II: Crossover Phase [CP])||0
7827663|NCT01072175|19267299|P10|STARTED|Part C (Phase II: Crossover Phase [CP])||0
7827664|NCT01072175|19267300|P9|STARTED|Part C (Phase II: Crossover Phase [CP])||45
7827665|NCT01072175|19267301|P8|STARTED|Part C (Phase II: Crossover Phase [CP])||0
7827666|NCT01072175|19267302|P7|STARTED|Part C (Phase II: Crossover Phase [CP])||0
7827667|NCT01072175|19267303|P6|STARTED|Part C (Phase II: Crossover Phase [CP])||0
7827668|NCT01072175|19267304|P5|STARTED|Part C (Phase II: Crossover Phase [CP])||0
7827669|NCT01072175|19267305|P4|STARTED|Part C (Phase II: Crossover Phase [CP])||0
7827670|NCT01072175|19267306|P3|STARTED|Part C (Phase II: Crossover Phase [CP])||0
7827671|NCT01072175|19267307|P2|STARTED|Part C (Phase II: Crossover Phase [CP])||0
7827672|NCT01072175|19267308|P1|STARTED|Part C (Phase II: Crossover Phase [CP])||0
7827673|NCT01072175|19267296|P13|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
7827674|NCT01072175|19267297|P12|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
7827675|NCT01072175|19267298|P11|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
7827676|NCT01072175|19267299|P10|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
7827677|NCT01072175|19267300|P9|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
7827678|NCT01072175|19267301|P8|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
7827679|NCT01072175|19267302|P7|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
7827680|NCT01072175|19267303|P6|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
7827681|NCT01072175|19267304|P5|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
7827682|NCT01072175|19267305|P4|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
7827683|NCT01072175|19267306|P3|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
7827684|NCT01072175|19267307|P2|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
7827685|NCT01072175|19267308|P1|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
7827686|NCT01072175|19267296|P13|COMPLETED|Part C (Phase II: Randomized Phase)||0
7827687|NCT01072175|19267297|P12|COMPLETED|Part C (Phase II: Randomized Phase)||0
7827688|NCT01072175|19267298|P11|COMPLETED|Part C (Phase II: Randomized Phase)||0
7827689|NCT01072175|19267299|P10|COMPLETED|Part C (Phase II: Randomized Phase)||0
7827690|NCT01072175|19267300|P9|COMPLETED|Part C (Phase II: Randomized Phase)||0
7827691|NCT01072175|19267301|P8|COMPLETED|Part C (Phase II: Randomized Phase)||0
7827692|NCT01072175|19267302|P7|COMPLETED|Part C (Phase II: Randomized Phase)||0
7827693|NCT01072175|19267303|P6|COMPLETED|Part C (Phase II: Randomized Phase)||0
7827694|NCT01072175|19267304|P5|COMPLETED|Part C (Phase II: Randomized Phase)||0
7827695|NCT01072175|19267305|P4|COMPLETED|Part C (Phase II: Randomized Phase)||0
7827696|NCT01072175|19267306|P3|COMPLETED|Part C (Phase II: Randomized Phase)||0
7827697|NCT01072175|19267307|P2|COMPLETED|Part C (Phase II: Randomized Phase)||0
7827698|NCT01072175|19267308|P1|COMPLETED|Part C (Phase II: Randomized Phase)||0
7827699|NCT01072175|19267296|P13|STARTED|Part C (Phase II: Randomized Phase)||0
7827700|NCT01072175|19267297|P12|STARTED|Part C (Phase II: Randomized Phase)||0
7827701|NCT01072175|19267298|P11|STARTED|Part C (Phase II: Randomized Phase)||0
7827702|NCT01072175|19267299|P10|STARTED|Part C (Phase II: Randomized Phase)||0
7827703|NCT01072175|19267300|P9|STARTED|Part C (Phase II: Randomized Phase)||0
7827704|NCT01072175|19267301|P8|STARTED|Part C (Phase II: Randomized Phase)||54
7827705|NCT01072175|19267302|P7|STARTED|Part C (Phase II: Randomized Phase)||54
7827706|NCT01072175|19267303|P6|STARTED|Part C (Phase II: Randomized Phase)||54
7827707|NCT01072175|19267304|P5|STARTED|Part C (Phase II: Randomized Phase)||0
7827708|NCT01072175|19267305|P4|STARTED|Part C (Phase II: Randomized Phase)||0
7827709|NCT01072175|19267306|P3|STARTED|Part C (Phase II: Randomized Phase)||0
7827710|NCT01072175|19267307|P2|STARTED|Part C (Phase II: Randomized Phase)||0
7827711|NCT01072175|19267308|P1|STARTED|Part C (Phase II: Randomized Phase)||0
7827712|NCT01072175|19267296|P13|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
7827713|NCT01072175|19267297|P12|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
7827714|NCT01072175|19267298|P11|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
7827715|NCT01072175|19267299|P10|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
7827716|NCT01072175|19267300|P9|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
7827717|NCT01072175|19267301|P8|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
7827718|NCT01072175|19267302|P7|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
7827719|NCT01072175|19267303|P6|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
7827720|NCT01072175|19267304|P5|NOT COMPLETED|Part B (Dose Escalation and Expansion)||94
7827721|NCT01072175|19267305|P4|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27
7827722|NCT01072175|19267306|P3|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23
7827723|NCT01072175|19267307|P2|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6
7827724|NCT01072175|19267308|P1|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
7827725|NCT01072175|19267296|P13|COMPLETED|Part B (Dose Escalation and Expansion)||0
7827726|NCT01072175|19267297|P12|COMPLETED|Part B (Dose Escalation and Expansion)||0
7827727|NCT01072175|19267298|P11|COMPLETED|Part B (Dose Escalation and Expansion)||0
7827728|NCT01072175|19267299|P10|COMPLETED|Part B (Dose Escalation and Expansion)||0
7827729|NCT01072175|19267300|P9|COMPLETED|Part B (Dose Escalation and Expansion)||0
7827730|NCT01072175|19267301|P8|COMPLETED|Part B (Dose Escalation and Expansion)||0
7827731|NCT01072175|19267302|P7|COMPLETED|Part B (Dose Escalation and Expansion)||0
7827732|NCT01072175|19267303|P6|COMPLETED|Part B (Dose Escalation and Expansion)||0
7827733|NCT01072175|19267304|P5|COMPLETED|Part B (Dose Escalation and Expansion)||0
7827734|NCT01072175|19267305|P4|COMPLETED|Part B (Dose Escalation and Expansion)||0
7827735|NCT01072175|19267306|P3|COMPLETED|Part B (Dose Escalation and Expansion)||0
7827736|NCT01072175|19267307|P2|COMPLETED|Part B (Dose Escalation and Expansion)||0
7827737|NCT01072175|19267308|P1|COMPLETED|Part B (Dose Escalation and Expansion)||0
7827738|NCT01072175|19267296|P13|STARTED|Part B (Dose Escalation and Expansion)||0
7827739|NCT01072175|19267297|P12|STARTED|Part B (Dose Escalation and Expansion)||0
7827740|NCT01072175|19267298|P11|STARTED|Part B (Dose Escalation and Expansion)||0
7827741|NCT01072175|19267299|P10|STARTED|Part B (Dose Escalation and Expansion)||0
7827742|NCT01072175|19267300|P9|STARTED|Part B (Dose Escalation and Expansion)||0
7827743|NCT01072175|19267301|P8|STARTED|Part B (Dose Escalation and Expansion)||0
7827744|NCT01072175|19267302|P7|STARTED|Part B (Dose Escalation and Expansion)||0
7827745|NCT01072175|19267303|P6|STARTED|Part B (Dose Escalation and Expansion)||0
7827746|NCT01072175|19267304|P5|STARTED|Part B (Dose Escalation and Expansion)||94
7827747|NCT01072175|19267305|P4|STARTED|Part B (Dose Escalation and Expansion)||27
7827748|NCT01072175|19267306|P3|STARTED|Part B (Dose Escalation and Expansion)||23
7827749|NCT01072175|19267307|P2|STARTED|Part B (Dose Escalation and Expansion)||6
7827750|NCT01072175|19267308|P1|STARTED|Part B (Dose Escalation and Expansion)||0
7827751|NCT01072175|19267296|P13|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
7827752|NCT01072175|19267297|P12|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
7827753|NCT01072175|19267298|P11|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
7827754|NCT01072175|19267299|P10|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
7827755|NCT01072175|19267300|P9|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
7827756|NCT01072175|19267301|P8|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
7827757|NCT01072175|19267302|P7|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
7827758|NCT01072175|19267303|P6|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
7827759|NCT01072175|19267304|P5|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
7827760|NCT01072175|19267305|P4|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
7827761|NCT01072175|19267306|P3|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
7827762|NCT01072175|19267307|P2|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
7827763|NCT01072175|19267308|P1|NOT COMPLETED|Part A (Drug-Drug Interaction)||8
7827764|NCT01072175|19267296|P13|COMPLETED|Part A (Drug-Drug Interaction)||0
7827765|NCT01072175|19267297|P12|COMPLETED|Part A (Drug-Drug Interaction)||0
7827766|NCT01072175|19267298|P11|COMPLETED|Part A (Drug-Drug Interaction)||0
7827767|NCT01072175|19267299|P10|COMPLETED|Part A (Drug-Drug Interaction)||0
7827768|NCT01072175|19267300|P9|COMPLETED|Part A (Drug-Drug Interaction)||0
7827769|NCT01072175|19267301|P8|COMPLETED|Part A (Drug-Drug Interaction)||0
7827770|NCT01072175|19267302|P7|COMPLETED|Part A (Drug-Drug Interaction)||0
7827771|NCT01072175|19267303|P6|COMPLETED|Part A (Drug-Drug Interaction)||0
7827772|NCT01072175|19267304|P5|COMPLETED|Part A (Drug-Drug Interaction)||0
7827773|NCT01072175|19267305|P4|COMPLETED|Part A (Drug-Drug Interaction)||0
7827774|NCT01072175|19267306|P3|COMPLETED|Part A (Drug-Drug Interaction)||0
7827775|NCT01072175|19267307|P2|COMPLETED|Part A (Drug-Drug Interaction)||0
7827776|NCT01072175|19267308|P1|COMPLETED|Part A (Drug-Drug Interaction)||0
7827777|NCT01072175|19267296|P13|STARTED|Part A (Drug-Drug Interaction)||0
7827778|NCT01072175|19267297|P12|STARTED|Part A (Drug-Drug Interaction)||0
7827779|NCT01072175|19267298|P11|STARTED|Part A (Drug-Drug Interaction)||0
7827780|NCT01072175|19267299|P10|STARTED|Part A (Drug-Drug Interaction)||0
7827781|NCT01072175|19267300|P9|STARTED|Part A (Drug-Drug Interaction)||0
7827782|NCT01072175|19267301|P8|STARTED|Part A (Drug-Drug Interaction)||0
7827783|NCT01072175|19267302|P7|STARTED|Part A (Drug-Drug Interaction)||0
7827784|NCT01072175|19267303|P6|STARTED|Part A (Drug-Drug Interaction)||0
7827785|NCT01072175|19267304|P5|STARTED|Part A (Drug-Drug Interaction)||0
7827786|NCT01072175|19267305|P4|STARTED|Part A (Drug-Drug Interaction)||0
7827787|NCT01072175|19267306|P3|STARTED|Part A (Drug-Drug Interaction)||0
7827788|NCT01072175|19267307|P2|STARTED|Part A (Drug-Drug Interaction)||0
7827789|NCT01072175|19267308|P1|STARTED|Part A (Drug-Drug Interaction)||8
7827790|NCT01072149|19267517|P18|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7827791|NCT01072149|19267518|P17|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7827792|NCT01072149|19267519|P16|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7827793|NCT01072149|19267520|P15|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7827794|NCT01072149|19267521|P14|NOT COMPLETED|Treatment Period 3 (28 Days)||1
7827795|NCT01072149|19267522|P13|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7827796|NCT01072149|19267523|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7827797|NCT01072149|19267524|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7827798|NCT01072149|19267525|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7827799|NCT01072149|19267526|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7827800|NCT01072149|19267527|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7827801|NCT01072149|19267528|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7827802|NCT01072149|19267529|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7827803|NCT01072149|19267530|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7827804|NCT01072149|19267531|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7827805|NCT01072149|19267532|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||1
7827806|NCT01072149|19267533|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7827807|NCT01072149|19267534|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7827808|NCT01072149|19267517|P18|COMPLETED|Treatment Period 3 (28 Days)||2
7827809|NCT01072149|19267518|P17|COMPLETED|Treatment Period 3 (28 Days)||3
7827810|NCT01072149|19267519|P16|COMPLETED|Treatment Period 3 (28 Days)||1
7827811|NCT01072149|19267520|P15|COMPLETED|Treatment Period 3 (28 Days)||3
7827812|NCT01072149|19267521|P14|COMPLETED|Treatment Period 3 (28 Days)||2
7827813|NCT01072149|19267522|P13|COMPLETED|Treatment Period 3 (28 Days)||2
7827814|NCT01072149|19267523|P12|COMPLETED|Treatment Period 3 (28 Days)||3
7827815|NCT01072149|19267524|P11|COMPLETED|Treatment Period 3 (28 Days)||2
7827816|NCT01072149|19267525|P10|COMPLETED|Treatment Period 3 (28 Days)||3
7827817|NCT01072149|19267526|P9|COMPLETED|Treatment Period 3 (28 Days)||3
7827818|NCT01072149|19267527|P8|COMPLETED|Treatment Period 3 (28 Days)||2
7827819|NCT01072149|19267528|P7|COMPLETED|Treatment Period 3 (28 Days)||3
7827820|NCT01072149|19267529|P6|COMPLETED|Treatment Period 3 (28 Days)||3
7827821|NCT01072149|19267530|P5|COMPLETED|Treatment Period 3 (28 Days)||3
7827822|NCT01072149|19267531|P4|COMPLETED|Treatment Period 3 (28 Days)||3
7827823|NCT01072149|19267532|P3|COMPLETED|Treatment Period 3 (28 Days)||0
7827824|NCT01072149|19267533|P2|COMPLETED|Treatment Period 3 (28 Days)||2
7827825|NCT01072149|19267534|P1|COMPLETED|Treatment Period 3 (28 Days)||2
7827826|NCT01072149|19267517|P18|STARTED|Treatment Period 3 (28 Days)||2
7827827|NCT01072149|19267518|P17|STARTED|Treatment Period 3 (28 Days)||3
7827828|NCT01072149|19267519|P16|STARTED|Treatment Period 3 (28 Days)||1
7827829|NCT01072149|19267520|P15|STARTED|Treatment Period 3 (28 Days)||3
7827830|NCT01072149|19267521|P14|STARTED|Treatment Period 3 (28 Days)||3
7827831|NCT01072149|19267522|P13|STARTED|Treatment Period 3 (28 Days)||2
7827832|NCT01072149|19267523|P12|STARTED|Treatment Period 3 (28 Days)||3
7827833|NCT01072149|19267524|P11|STARTED|Treatment Period 3 (28 Days)||2
7827834|NCT01072149|19267525|P10|STARTED|Treatment Period 3 (28 Days)||3
7827835|NCT01072149|19267526|P9|STARTED|Treatment Period 3 (28 Days)||3
7827836|NCT01072149|19267527|P8|STARTED|Treatment Period 3 (28 Days)||2
7827837|NCT01072149|19267528|P7|STARTED|Treatment Period 3 (28 Days)||3
7827838|NCT01072149|19267529|P6|STARTED|Treatment Period 3 (28 Days)||3
7827839|NCT01072149|19267530|P5|STARTED|Treatment Period 3 (28 Days)||3
7827840|NCT01072149|19267531|P4|STARTED|Treatment Period 3 (28 Days)||3
7827841|NCT01072149|19267532|P3|STARTED|Treatment Period 3 (28 Days)||1
7827842|NCT01072149|19267533|P2|STARTED|Treatment Period 3 (28 Days)||2
7827843|NCT01072149|19267534|P1|STARTED|Treatment Period 3 (28 Days)||2
7827844|NCT01072149|19267517|P18|NOT COMPLETED|Washout Period 2 (14 Days)||0
7827845|NCT01072149|19267518|P17|NOT COMPLETED|Washout Period 2 (14 Days)||0
7827846|NCT01072149|19267519|P16|NOT COMPLETED|Washout Period 2 (14 Days)||2
7827847|NCT01072149|19267520|P15|NOT COMPLETED|Washout Period 2 (14 Days)||0
7827848|NCT01072149|19267521|P14|NOT COMPLETED|Washout Period 2 (14 Days)||0
7827849|NCT01072149|19267522|P13|NOT COMPLETED|Washout Period 2 (14 Days)||1
7827850|NCT01072149|19267523|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
7827851|NCT01072149|19267524|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
7827852|NCT01072149|19267525|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
7827853|NCT01072149|19267526|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
7827854|NCT01072149|19267527|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
7827855|NCT01072149|19267528|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
7827856|NCT01072149|19267529|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
7827857|NCT01072149|19267530|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
7827858|NCT01072149|19267531|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
7827859|NCT01072149|19267532|P3|NOT COMPLETED|Washout Period 2 (14 Days)||0
7827860|NCT01072149|19267533|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
7827861|NCT01072149|19267534|P1|NOT COMPLETED|Washout Period 2 (14 Days)||1
7827862|NCT01072149|19267517|P18|COMPLETED|Washout Period 2 (14 Days)||2
7827863|NCT01072149|19267518|P17|COMPLETED|Washout Period 2 (14 Days)||3
7827864|NCT01072149|19267519|P16|COMPLETED|Washout Period 2 (14 Days)||1
7827865|NCT01072149|19267520|P15|COMPLETED|Washout Period 2 (14 Days)||3
7827866|NCT01072149|19267521|P14|COMPLETED|Washout Period 2 (14 Days)||3
7827867|NCT01072149|19267522|P13|COMPLETED|Washout Period 2 (14 Days)||2
7827868|NCT01072149|19267523|P12|COMPLETED|Washout Period 2 (14 Days)||3
7827869|NCT01072149|19267524|P11|COMPLETED|Washout Period 2 (14 Days)||2
7827870|NCT01072149|19267525|P10|COMPLETED|Washout Period 2 (14 Days)||3
7827871|NCT01072149|19267526|P9|COMPLETED|Washout Period 2 (14 Days)||3
7827872|NCT01072149|19267527|P8|COMPLETED|Washout Period 2 (14 Days)||2
7827873|NCT01072149|19267528|P7|COMPLETED|Washout Period 2 (14 Days)||3
7827874|NCT01072149|19267529|P6|COMPLETED|Washout Period 2 (14 Days)||3
7827875|NCT01072149|19267530|P5|COMPLETED|Washout Period 2 (14 Days)||3
7827876|NCT01072149|19267531|P4|COMPLETED|Washout Period 2 (14 Days)||3
7827877|NCT01072149|19267532|P3|COMPLETED|Washout Period 2 (14 Days)||1
7827878|NCT01072149|19267533|P2|COMPLETED|Washout Period 2 (14 Days)||2
7827879|NCT01072149|19267534|P1|COMPLETED|Washout Period 2 (14 Days)||2
7827880|NCT01072149|19267517|P18|STARTED|Washout Period 2 (14 Days)||2
7827881|NCT01072149|19267518|P17|STARTED|Washout Period 2 (14 Days)||3
7827882|NCT01072149|19267519|P16|STARTED|Washout Period 2 (14 Days)||3
7827883|NCT01072149|19267520|P15|STARTED|Washout Period 2 (14 Days)||3
7827884|NCT01072149|19267521|P14|STARTED|Washout Period 2 (14 Days)||3
7827885|NCT01072149|19267522|P13|STARTED|Washout Period 2 (14 Days)||3
7827886|NCT01072149|19267523|P12|STARTED|Washout Period 2 (14 Days)||3
7827887|NCT01072149|19267524|P11|STARTED|Washout Period 2 (14 Days)||2
7827888|NCT01072149|19267525|P10|STARTED|Washout Period 2 (14 Days)||3
7827889|NCT01072149|19267526|P9|STARTED|Washout Period 2 (14 Days)||3
7827890|NCT01072149|19267527|P8|STARTED|Washout Period 2 (14 Days)||2
7827891|NCT01072149|19267528|P7|STARTED|Washout Period 2 (14 Days)||3
7827892|NCT01072149|19267529|P6|STARTED|Washout Period 2 (14 Days)||3
7827893|NCT01072149|19267530|P5|STARTED|Washout Period 2 (14 Days)||3
7827894|NCT01072149|19267531|P4|STARTED|Washout Period 2 (14 Days)||3
7827895|NCT01072149|19267532|P3|STARTED|Washout Period 2 (14 Days)||1
7827896|NCT01072149|19267533|P2|STARTED|Washout Period 2 (14 Days)||2
7827897|NCT01072149|19267534|P1|STARTED|Washout Period 2 (14 Days)||3
7827898|NCT01072149|19267517|P18|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7827899|NCT01072149|19267518|P17|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7827900|NCT01072149|19267519|P16|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7827901|NCT01072149|19267520|P15|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7827902|NCT01072149|19267521|P14|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7827903|NCT01072149|19267522|P13|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7827904|NCT01072149|19267523|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7827905|NCT01072149|19267524|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7827906|NCT01072149|19267525|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7827907|NCT01072149|19267526|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7827908|NCT01072149|19267527|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||1
7827909|NCT01072149|19267528|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7827910|NCT01072149|19267529|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7827911|NCT01072149|19267530|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7827912|NCT01072149|19267531|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7827913|NCT01072149|19267532|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
7827914|NCT01072149|19267533|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||1
7827915|NCT01072149|19267534|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7827916|NCT01072149|19267517|P18|COMPLETED|Treatment Period 2 (28 Days)||2
7827917|NCT01072149|19267518|P17|COMPLETED|Treatment Period 2 (28 Days)||3
7827918|NCT01072149|19267519|P16|COMPLETED|Treatment Period 2 (28 Days)||3
7827919|NCT01072149|19267520|P15|COMPLETED|Treatment Period 2 (28 Days)||3
7827920|NCT01072149|19267521|P14|COMPLETED|Treatment Period 2 (28 Days)||3
7827921|NCT01072149|19267522|P13|COMPLETED|Treatment Period 2 (28 Days)||3
7827922|NCT01072149|19267523|P12|COMPLETED|Treatment Period 2 (28 Days)||3
7827923|NCT01072149|19267524|P11|COMPLETED|Treatment Period 2 (28 Days)||2
7827924|NCT01072149|19267525|P10|COMPLETED|Treatment Period 2 (28 Days)||3
7827925|NCT01072149|19267526|P9|COMPLETED|Treatment Period 2 (28 Days)||3
7827926|NCT01072149|19267527|P8|COMPLETED|Treatment Period 2 (28 Days)||2
7827927|NCT01072149|19267528|P7|COMPLETED|Treatment Period 2 (28 Days)||3
7827928|NCT01072149|19267529|P6|COMPLETED|Treatment Period 2 (28 Days)||3
7827929|NCT01072149|19267530|P5|COMPLETED|Treatment Period 2 (28 Days)||3
7827930|NCT01072149|19267531|P4|COMPLETED|Treatment Period 2 (28 Days)||3
7827931|NCT01072149|19267532|P3|COMPLETED|Treatment Period 2 (28 Days)||1
7827932|NCT01072149|19267533|P2|COMPLETED|Treatment Period 2 (28 Days)||2
7827933|NCT01072149|19267534|P1|COMPLETED|Treatment Period 2 (28 Days)||3
7827934|NCT01072149|19267517|P18|STARTED|Treatment Period 2 (28 Days)||2
7827935|NCT01072149|19267518|P17|STARTED|Treatment Period 2 (28 Days)||3
7827936|NCT01072149|19267519|P16|STARTED|Treatment Period 2 (28 Days)||3
7827937|NCT01072149|19267520|P15|STARTED|Treatment Period 2 (28 Days)||3
7827938|NCT01072149|19267521|P14|STARTED|Treatment Period 2 (28 Days)||3
7827939|NCT01072149|19267522|P13|STARTED|Treatment Period 2 (28 Days)||3
7827940|NCT01072149|19267523|P12|STARTED|Treatment Period 2 (28 Days)||3
7827941|NCT01072149|19267524|P11|STARTED|Treatment Period 2 (28 Days)||2
7827942|NCT01072149|19267525|P10|STARTED|Treatment Period 2 (28 Days)||3
7827943|NCT01072149|19267526|P9|STARTED|Treatment Period 2 (28 Days)||3
7827944|NCT01072149|19267527|P8|STARTED|Treatment Period 2 (28 Days)||3
7827945|NCT01072149|19267528|P7|STARTED|Treatment Period 2 (28 Days)||3
7827946|NCT01072149|19267529|P6|STARTED|Treatment Period 2 (28 Days)||3
7827947|NCT01072149|19267530|P5|STARTED|Treatment Period 2 (28 Days)||3
7827948|NCT01072149|19267531|P4|STARTED|Treatment Period 2 (28 Days)||3
7827949|NCT01072149|19267532|P3|STARTED|Treatment Period 2 (28 Days)||2
7827950|NCT01072149|19267533|P2|STARTED|Treatment Period 2 (28 Days)||3
7827951|NCT01072149|19267534|P1|STARTED|Treatment Period 2 (28 Days)||3
7827952|NCT01072149|19267517|P18|NOT COMPLETED|Washout Period 1 (14 Days)||0
7827953|NCT01072149|19267518|P17|NOT COMPLETED|Washout Period 1 (14 Days)||0
7827954|NCT01072149|19267519|P16|NOT COMPLETED|Washout Period 1 (14 Days)||0
7827955|NCT01072149|19267520|P15|NOT COMPLETED|Washout Period 1 (14 Days)||0
7827956|NCT01072149|19267521|P14|NOT COMPLETED|Washout Period 1 (14 Days)||0
7827957|NCT01072149|19267522|P13|NOT COMPLETED|Washout Period 1 (14 Days)||0
7827958|NCT01072149|19267523|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
7827959|NCT01072149|19267524|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
7827960|NCT01072149|19267525|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
7827961|NCT01072149|19267526|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
7827962|NCT01072149|19267527|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
7827963|NCT01072149|19267528|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
7827964|NCT01072149|19267529|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
7827965|NCT01072149|19267530|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
7827966|NCT01072149|19267531|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
7827967|NCT01072149|19267532|P3|NOT COMPLETED|Washout Period 1 (14 Days)||0
7827968|NCT01072149|19267533|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
7827969|NCT01072149|19267534|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
7827970|NCT01072149|19267517|P18|COMPLETED|Washout Period 1 (14 Days)||2
7827971|NCT01072149|19267518|P17|COMPLETED|Washout Period 1 (14 Days)||3
7827972|NCT01072149|19267519|P16|COMPLETED|Washout Period 1 (14 Days)||3
7827973|NCT01072149|19267520|P15|COMPLETED|Washout Period 1 (14 Days)||3
7827974|NCT01072149|19267521|P14|COMPLETED|Washout Period 1 (14 Days)||3
7827975|NCT01072149|19267522|P13|COMPLETED|Washout Period 1 (14 Days)||3
7827976|NCT01072149|19267523|P12|COMPLETED|Washout Period 1 (14 Days)||3
7827977|NCT01072149|19267524|P11|COMPLETED|Washout Period 1 (14 Days)||2
7827978|NCT01072149|19267525|P10|COMPLETED|Washout Period 1 (14 Days)||3
7827979|NCT01072149|19267526|P9|COMPLETED|Washout Period 1 (14 Days)||3
7827980|NCT01072149|19267527|P8|COMPLETED|Washout Period 1 (14 Days)||3
7827981|NCT01072149|19267528|P7|COMPLETED|Washout Period 1 (14 Days)||3
7827982|NCT01072149|19267529|P6|COMPLETED|Washout Period 1 (14 Days)||3
7827983|NCT01072149|19267530|P5|COMPLETED|Washout Period 1 (14 Days)||3
7827984|NCT01072149|19267531|P4|COMPLETED|Washout Period 1 (14 Days)||3
7827985|NCT01072149|19267532|P3|COMPLETED|Washout Period 1 (14 Days)||2
7827986|NCT01072149|19267533|P2|COMPLETED|Washout Period 1 (14 Days)||3
7827987|NCT01072149|19267534|P1|COMPLETED|Washout Period 1 (14 Days)||3
7827988|NCT01072149|19267517|P18|STARTED|Washout Period 1 (14 Days)||2
7827989|NCT01072149|19267518|P17|STARTED|Washout Period 1 (14 Days)||3
7827990|NCT01072149|19267519|P16|STARTED|Washout Period 1 (14 Days)||3
7827991|NCT01072149|19267520|P15|STARTED|Washout Period 1 (14 Days)||3
7827992|NCT01072149|19267521|P14|STARTED|Washout Period 1 (14 Days)||3
7827993|NCT01072149|19267522|P13|STARTED|Washout Period 1 (14 Days)||3
7827994|NCT01072149|19267523|P12|STARTED|Washout Period 1 (14 Days)||3
7827995|NCT01072149|19267524|P11|STARTED|Washout Period 1 (14 Days)||2
7827996|NCT01072149|19267525|P10|STARTED|Washout Period 1 (14 Days)||3
7827997|NCT01072149|19267526|P9|STARTED|Washout Period 1 (14 Days)||3
7827998|NCT01072149|19267527|P8|STARTED|Washout Period 1 (14 Days)||3
7827999|NCT01072149|19267528|P7|STARTED|Washout Period 1 (14 Days)||3
7828000|NCT01072149|19267529|P6|STARTED|Washout Period 1 (14 Days)||3
7828001|NCT01072149|19267530|P5|STARTED|Washout Period 1 (14 Days)||3
7828002|NCT01072149|19267531|P4|STARTED|Washout Period 1 (14 Days)||3
7828003|NCT01072149|19267532|P3|STARTED|Washout Period 1 (14 Days)||2
7828004|NCT01072149|19267533|P2|STARTED|Washout Period 1 (14 Days)||3
7828005|NCT01072149|19267534|P1|STARTED|Washout Period 1 (14 Days)||3
7828006|NCT01072149|19267517|P18|NOT COMPLETED|Treatment Period 1 (28 Days)||1
7828007|NCT01072149|19267518|P17|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7828008|NCT01072149|19267519|P16|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7828009|NCT01072149|19267520|P15|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7828010|NCT01072149|19267521|P14|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7828011|NCT01072149|19267522|P13|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7828012|NCT01072149|19267523|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7828013|NCT01072149|19267524|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||1
7828014|NCT01072149|19267525|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7828015|NCT01072149|19267526|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7828016|NCT01072149|19267527|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7828017|NCT01072149|19267528|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7828018|NCT01072149|19267529|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7828019|NCT01072149|19267530|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7828020|NCT01072149|19267531|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7828021|NCT01072149|19267532|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||1
7828022|NCT01072149|19267533|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7828023|NCT01072149|19267534|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7828024|NCT01072149|19267517|P18|COMPLETED|Treatment Period 1 (28 Days)||2
7828025|NCT01072149|19267518|P17|COMPLETED|Treatment Period 1 (28 Days)||3
7828026|NCT01072149|19267519|P16|COMPLETED|Treatment Period 1 (28 Days)||3
7828027|NCT01072149|19267520|P15|COMPLETED|Treatment Period 1 (28 Days)||3
7828028|NCT01072149|19267521|P14|COMPLETED|Treatment Period 1 (28 Days)||3
7828029|NCT01072149|19267522|P13|COMPLETED|Treatment Period 1 (28 Days)||3
7828030|NCT01072149|19267523|P12|COMPLETED|Treatment Period 1 (28 Days)||3
7828031|NCT01072149|19267524|P11|COMPLETED|Treatment Period 1 (28 Days)||2
7828032|NCT01072149|19267525|P10|COMPLETED|Treatment Period 1 (28 Days)||3
7828033|NCT01072149|19267526|P9|COMPLETED|Treatment Period 1 (28 Days)||3
7828034|NCT01072149|19267527|P8|COMPLETED|Treatment Period 1 (28 Days)||3
7828035|NCT01072149|19267528|P7|COMPLETED|Treatment Period 1 (28 Days)||3
7828036|NCT01072149|19267529|P6|COMPLETED|Treatment Period 1 (28 Days)||3
7828037|NCT01072149|19267530|P5|COMPLETED|Treatment Period 1 (28 Days)||3
7828038|NCT01072149|19267531|P4|COMPLETED|Treatment Period 1 (28 Days)||3
7828039|NCT01072149|19267532|P3|COMPLETED|Treatment Period 1 (28 Days)||2
7828040|NCT01072149|19267533|P2|COMPLETED|Treatment Period 1 (28 Days)||3
7828041|NCT01072149|19267534|P1|COMPLETED|Treatment Period 1 (28 Days)||3
7828042|NCT01072149|19267517|P18|STARTED|Treatment Period 1 (28 Days)||3
7828043|NCT01072149|19267518|P17|STARTED|Treatment Period 1 (28 Days)||3
7828044|NCT01072149|19267519|P16|STARTED|Treatment Period 1 (28 Days)||3
7828045|NCT01072149|19267520|P15|STARTED|Treatment Period 1 (28 Days)||3
7828046|NCT01072149|19267521|P14|STARTED|Treatment Period 1 (28 Days)||3
7828047|NCT01072149|19267522|P13|STARTED|Treatment Period 1 (28 Days)||3
7828048|NCT01072149|19267523|P12|STARTED|Treatment Period 1 (28 Days)||3
7828049|NCT01072149|19267524|P11|STARTED|Treatment Period 1 (28 Days)||3
7828050|NCT01072149|19267525|P10|STARTED|Treatment Period 1 (28 Days)||3
7828051|NCT01072149|19267526|P9|STARTED|Treatment Period 1 (28 Days)||3
7828052|NCT01072149|19267527|P8|STARTED|Treatment Period 1 (28 Days)||3
7828053|NCT01072149|19267528|P7|STARTED|Treatment Period 1 (28 Days)||3
7828054|NCT01072149|19267529|P6|STARTED|Treatment Period 1 (28 Days)||3
7828055|NCT01072149|19267530|P5|STARTED|Treatment Period 1 (28 Days)||3
7828056|NCT01072149|19267531|P4|STARTED|Treatment Period 1 (28 Days)||3
7828057|NCT01072149|19267532|P3|STARTED|Treatment Period 1 (28 Days)||3
7828058|NCT01072149|19267533|P2|STARTED|Treatment Period 1 (28 Days)||3
7828059|NCT01072149|19267534|P1|STARTED|Treatment Period 1 (28 Days)||3
7828060|NCT01072136|19267554|P2|NOT COMPLETED|Overall Study||31
7828061|NCT01072136|19267555|P1|NOT COMPLETED|Overall Study||23
7828062|NCT01072136|19267554|P2|COMPLETED|Overall Study||12
7828063|NCT01072136|19267555|P1|COMPLETED|Overall Study||21
7828064|NCT01072136|19267554|P2|Met All Enrollment Criteria|Overall Study||25
7828065|NCT01072136|19267555|P1|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30
7828066|NCT01072136|19267554|P2|STARTED|Overall Study||43
7828067|NCT01072136|19267555|P1|STARTED|Overall Study||44
7828068|NCT01072032|19267579|P2|NOT COMPLETED|Overall Study||9
7828069|NCT01072032|19267580|P1|NOT COMPLETED|Overall Study||8
7828070|NCT01072032|19267579|P2|COMPLETED|Overall Study||5
7828071|NCT01072032|19267580|P1|COMPLETED|Overall Study||5
7828072|NCT01072032|19267579|P2|STARTED|Overall Study||14
7828073|NCT01072032|19267580|P1|STARTED|Overall Study||13
7828074|NCT01072006|19267594|P4|NOT COMPLETED|Overall Study||0
7828075|NCT01072006|19267595|P3|NOT COMPLETED|Overall Study||0
7828076|NCT01072006|19267596|P2|NOT COMPLETED|Overall Study||0
7828077|NCT01072006|19267597|P1|NOT COMPLETED|Overall Study||0
7828078|NCT01072006|19267594|P4|COMPLETED|Overall Study||11
7828079|NCT01072006|19267595|P3|COMPLETED|Overall Study||0
7828080|NCT01072006|19267596|P2|COMPLETED|Overall Study||5
7828081|NCT01072006|19267597|P1|COMPLETED|Overall Study||14
7828082|NCT01072006|19267594|P4|STARTED|Overall Study||11
7828083|NCT01072006|19267595|P3|STARTED|Overall Study||0
7828084|NCT01072006|19267596|P2|STARTED|Overall Study||5
7828085|NCT01072006|19267597|P1|STARTED|Overall Study||14
7828086|NCT01071993|19267616|P2|NOT COMPLETED|Overall Study||0
7828087|NCT01071993|19267617|P1|NOT COMPLETED|Overall Study||0
7828088|NCT01071993|19267616|P2|COMPLETED|Overall Study||0
7828089|NCT01071993|19267617|P1|COMPLETED|Overall Study||0
7828090|NCT01071993|19267616|P2|STARTED|Overall Study||0
7828091|NCT01071993|19267617|P1|STARTED|Overall Study||0
7828092|NCT01071954|19267623|P1|NOT COMPLETED|Overall Study||27
7828093|NCT01071954|19267623|P1|COMPLETED|Overall Study||39
7828094|NCT01071954|19267623|P1|Received Treatment|Overall Study||65
7828095|NCT01071954|19267623|P1|STARTED|Overall Study||66
7828096|NCT01071915|19267632|P1|NOT COMPLETED|Overall Study||9
7828097|NCT01071915|19267632|P1|COMPLETED|Overall Study||148
7828098|NCT01071915|19267632|P1|Safety Analysis Set|Overall Study||156
7828099|NCT01071915|19267632|P1|Full Analysis Set (FAS)|Overall Study||155
7828100|NCT01071915|19267632|P1|STARTED|Overall Study|Intention to Treat Analysis Set|157
7828101|NCT01071798|19267642|P1|NOT COMPLETED|Subpopulation Who Received Two Cycles||15
7828102|NCT01071798|19267642|P1|COMPLETED|Subpopulation Who Received Two Cycles||805
7828103|NCT01071798|19267642|P1|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820
7828104|NCT01071798|19267642|P1|STARTED|Subpopulation Who Received Two Cycles||820
7828105|NCT01071798|19267642|P1|NOT COMPLETED|Participants Who Received One Cycle||65
7828106|NCT01071798|19267642|P1|COMPLETED|Participants Who Received One Cycle||1588
7828107|NCT01071798|19267642|P1|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653
7828108|NCT01071798|19267642|P1|STARTED|Participants Who Received One Cycle||1653
7828109|NCT01071538|19267662|P1|NOT COMPLETED|Overall Study||2
7828110|NCT01071538|19267662|P1|COMPLETED|Overall Study||13
7828111|NCT01071538|19267662|P1|STARTED|Overall Study||15
7828112|NCT01071512|19267672|P1|NOT COMPLETED|Overall Study||5
7828113|NCT01071512|19267672|P1|COMPLETED|Overall Study||15
7828114|NCT01071512|19267672|P1|STARTED|Overall Study||20
7828115|NCT01071395|19267682|P2|NOT COMPLETED|Overall Study||2
7828116|NCT01071395|19267683|P1|NOT COMPLETED|Overall Study||5
7828117|NCT01071395|19267682|P2|COMPLETED|Overall Study||30
7828118|NCT01071395|19267683|P1|COMPLETED|Overall Study||31
7828119|NCT01071395|19267682|P2|STARTED|Overall Study||32
7828120|NCT01071395|19267683|P1|STARTED|Overall Study||36
7828121|NCT01071356|19267691|P2|NOT COMPLETED|Overall Study||9
7828122|NCT01071356|19267692|P1|NOT COMPLETED|Overall Study||7
7828123|NCT01071356|19267691|P2|COMPLETED|Overall Study||97
7828124|NCT01071356|19267692|P1|COMPLETED|Overall Study||104
7828125|NCT01071356|19267691|P2|STARTED|Overall Study||106
7828126|NCT01071356|19267692|P1|STARTED|Overall Study||111
7828127|NCT01071317|19267702|P2|NOT COMPLETED|Overall Study||2
7828128|NCT01071317|19267703|P1|NOT COMPLETED|Overall Study||2
7828129|NCT01071317|19267702|P2|COMPLETED|Overall Study||23
7828130|NCT01071317|19267703|P1|COMPLETED|Overall Study||23
7828131|NCT01071317|19267702|P2|STARTED|Overall Study||25
7828132|NCT01071317|19267703|P1|STARTED|Overall Study||25
7828133|NCT01071278|19267715|P1|NOT COMPLETED|Overall Study||713
7828134|NCT01071278|19267715|P1|COMPLETED|Overall Study||1677
7828135|NCT01071278|19267715|P1|STARTED|Overall Study||2390
7828136|NCT01071252|19267726|P5|NOT COMPLETED|Overall Study||11
7828137|NCT01071252|19267727|P4|NOT COMPLETED|Overall Study||7
7828138|NCT01071252|19267728|P3|NOT COMPLETED|Overall Study||4
7828139|NCT01071252|19267729|P2|NOT COMPLETED|Overall Study||10
7828140|NCT01071252|19267730|P1|NOT COMPLETED|Overall Study||15
7828141|NCT01071252|19267726|P5|COMPLETED|Overall Study||11
7828142|NCT01071252|19267727|P4|COMPLETED|Overall Study||20
7828143|NCT01071252|19267728|P3|COMPLETED|Overall Study||17
7828144|NCT01071252|19267729|P2|COMPLETED|Overall Study||16
7828145|NCT01071252|19267730|P1|COMPLETED|Overall Study||14
7828146|NCT01071252|19267726|P5|STARTED|Overall Study||22
7828147|NCT01071252|19267727|P4|STARTED|Overall Study||27
7828148|NCT01071252|19267728|P3|STARTED|Overall Study||21
7828149|NCT01071252|19267729|P2|STARTED|Overall Study||26
7828150|NCT01071252|19267730|P1|STARTED|Overall Study||29
7828151|NCT01071200|19267758|P2|NOT COMPLETED|Overall Study||3
7828152|NCT01071200|19267759|P1|NOT COMPLETED|Overall Study||7
7828153|NCT01071200|19267758|P2|COMPLETED|Overall Study||63
7828154|NCT01071200|19267759|P1|COMPLETED|Overall Study||60
7828155|NCT01071200|19267758|P2|STARTED|Overall Study||66
7828156|NCT01071200|19267759|P1|STARTED|Overall Study||67
7828157|NCT01071096|19267791|P2|NOT COMPLETED|Second Intervention (90 Days)||0
7828158|NCT01071096|19267792|P1|NOT COMPLETED|Second Intervention (90 Days)||0
7828159|NCT01071096|19267791|P2|COMPLETED|Second Intervention (90 Days)||10
7828160|NCT01071096|19267792|P1|COMPLETED|Second Intervention (90 Days)||9
7828161|NCT01071096|19267791|P2|STARTED|Second Intervention (90 Days)||10
7828162|NCT01071096|19267792|P1|STARTED|Second Intervention (90 Days)||9
7828163|NCT01071096|19267791|P2|NOT COMPLETED|Washout Period (30 Days)||0
7828164|NCT01071096|19267792|P1|NOT COMPLETED|Washout Period (30 Days)||0
7828165|NCT01071096|19267791|P2|COMPLETED|Washout Period (30 Days)||10
7828166|NCT01071096|19267792|P1|COMPLETED|Washout Period (30 Days)||9
7828167|NCT01071096|19267791|P2|STARTED|Washout Period (30 Days)||10
7828168|NCT01071096|19267792|P1|STARTED|Washout Period (30 Days)||9
7828169|NCT01071096|19267791|P2|NOT COMPLETED|First Intervention (90 Days)||0
7828170|NCT01071096|19267792|P1|NOT COMPLETED|First Intervention (90 Days)||1
7828171|NCT01071096|19267791|P2|COMPLETED|First Intervention (90 Days)||10
7828172|NCT01071096|19267792|P1|COMPLETED|First Intervention (90 Days)||9
7828173|NCT01071096|19267791|P2|STARTED|First Intervention (90 Days)||10
7828174|NCT01071096|19267792|P1|STARTED|First Intervention (90 Days)||10
7828175|NCT01071083|19267816|P5|NOT COMPLETED|Overall Study||8
7828176|NCT01071083|19267817|P4|NOT COMPLETED|Overall Study||2
7828177|NCT01071083|19267818|P3|NOT COMPLETED|Overall Study||5
7828178|NCT01071083|19267819|P2|NOT COMPLETED|Overall Study||2
7828179|NCT01071083|19267820|P1|NOT COMPLETED|Overall Study||7
7828180|NCT01071083|19267816|P5|COMPLETED|Overall Study||46
7828181|NCT01071083|19267817|P4|COMPLETED|Overall Study||15
7828182|NCT01071083|19267818|P3|COMPLETED|Overall Study||12
7828183|NCT01071083|19267819|P2|COMPLETED|Overall Study||43
7828184|NCT01071083|19267820|P1|COMPLETED|Overall Study||35
7828185|NCT01071083|19267816|P5|STARTED|Overall Study||54
7828186|NCT01071083|19267817|P4|STARTED|Overall Study||17
7828187|NCT01071083|19267818|P3|STARTED|Overall Study||17
7828188|NCT01071083|19267819|P2|STARTED|Overall Study||45
7828189|NCT01071083|19267820|P1|STARTED|Overall Study||42
7828190|NCT01071070|19267839|P2|NOT COMPLETED|Overall Study||3
7828191|NCT01071070|19267840|P1|NOT COMPLETED|Overall Study||4
7828192|NCT01071070|19267839|P2|COMPLETED|Overall Study||105
7828193|NCT01071070|19267840|P1|COMPLETED|Overall Study||104
7828194|NCT01071070|19267839|P2|STARTED|Overall Study||108
7828195|NCT01071070|19267840|P1|STARTED|Overall Study||108
7828196|NCT01071044|19267864|P2|NOT COMPLETED|Overall Study||0
7828197|NCT01071044|19267865|P1|NOT COMPLETED|Overall Study||2
7828198|NCT01071044|19267864|P2|COMPLETED|Overall Study||11
7828199|NCT01071044|19267865|P1|COMPLETED|Overall Study||13
7828200|NCT01071044|19267864|P2|STARTED|Overall Study||11
7828201|NCT01071044|19267865|P1|STARTED|Overall Study||15
7828202|NCT01070979|19267886|P3|NOT COMPLETED|Overall Study||13
7828203|NCT01070979|19267887|P2|NOT COMPLETED|Overall Study||12
7828204|NCT01070979|19267888|P1|NOT COMPLETED|Overall Study||11
7828205|NCT01070979|19267886|P3|COMPLETED|Overall Study||72
7828206|NCT01070979|19267887|P2|COMPLETED|Overall Study||73
7828207|NCT01070979|19267888|P1|COMPLETED|Overall Study||68
7828208|NCT01070979|19267886|P3|STARTED|Overall Study||85
7828209|NCT01070979|19267887|P2|STARTED|Overall Study||85
7828210|NCT01070979|19267888|P1|STARTED|Overall Study||79
7828211|NCT01070966|19267914|P1|NOT COMPLETED|Participants for Efficacy Evaluation||82
7828212|NCT01070966|19267914|P1|COMPLETED|Participants for Efficacy Evaluation||1929
7828213|NCT01070966|19267914|P1|STARTED|Participants for Efficacy Evaluation||2011
7828214|NCT01070966|19267914|P1|NOT COMPLETED|Participants for Safety Evaluation||78
7828215|NCT01070966|19267914|P1|COMPLETED|Participants for Safety Evaluation||2011
7828216|NCT01070966|19267914|P1|STARTED|Participants for Safety Evaluation||2089
7828217|NCT01070953|19267925|P1|NOT COMPLETED|Participants for Efficacy Evaluation||227
7828218|NCT01070953|19267925|P1|COMPLETED|Participants for Efficacy Evaluation||3309
7828219|NCT01070953|19267925|P1|STARTED|Participants for Efficacy Evaluation||3536
7828220|NCT01070953|19267925|P1|NOT COMPLETED|Participants for Safety Evaluation||931
7828221|NCT01070953|19267925|P1|COMPLETED|Participants for Safety Evaluation||3536
7828222|NCT01070953|19267925|P1|STARTED|Participants for Safety Evaluation||4467
7828223|NCT01070888|19267938|P2|NOT COMPLETED|Second Intervention (14 Days)||0
7828224|NCT01070888|19267939|P1|NOT COMPLETED|Second Intervention (14 Days)||0
7828225|NCT01070888|19267938|P2|COMPLETED|Second Intervention (14 Days)||2
7828226|NCT01070888|19267939|P1|COMPLETED|Second Intervention (14 Days)||1
7828227|NCT01070888|19267938|P2|STARTED|Second Intervention (14 Days)||2
7828228|NCT01070888|19267939|P1|STARTED|Second Intervention (14 Days)||1
7828229|NCT01070888|19267938|P2|NOT COMPLETED|Washout (14 Days)||0
7828230|NCT01070888|19267939|P1|NOT COMPLETED|Washout (14 Days)||1
7828231|NCT01070888|19267938|P2|COMPLETED|Washout (14 Days)||2
7828232|NCT01070888|19267939|P1|COMPLETED|Washout (14 Days)||1
7828233|NCT01070888|19267938|P2|STARTED|Washout (14 Days)||2
7828234|NCT01070888|19267939|P1|STARTED|Washout (14 Days)||2
7828235|NCT01070888|19267938|P2|NOT COMPLETED|First Intervention (14 Days)||2
7828236|NCT01070888|19267939|P1|NOT COMPLETED|First Intervention (14 Days)||0
7828237|NCT01070888|19267938|P2|COMPLETED|First Intervention (14 Days)||2
7828238|NCT01070888|19267939|P1|COMPLETED|First Intervention (14 Days)||2
7828239|NCT01070888|19267938|P2|STARTED|First Intervention (14 Days)||4
7828240|NCT01070888|19267939|P1|STARTED|First Intervention (14 Days)||2
7828241|NCT01070810|19267947|P2|NOT COMPLETED|Overall Study||0
7828242|NCT01070810|19267948|P1|NOT COMPLETED|Overall Study||0
7828243|NCT01070810|19267947|P2|COMPLETED|Overall Study||43
7828244|NCT01070810|19267948|P1|COMPLETED|Overall Study||45
7828245|NCT01070810|19267947|P2|STARTED|Overall Study||43
7828246|NCT01070810|19267948|P1|STARTED|Overall Study||45
7828247|NCT01070784|19267964|P2|NOT COMPLETED|Overall Study||18
7828248|NCT01070784|19267965|P1|NOT COMPLETED|Overall Study||20
7828249|NCT01070784|19267964|P2|COMPLETED|Overall Study||112
7828250|NCT01070784|19267965|P1|COMPLETED|Overall Study||110
7828251|NCT01070784|19267964|P2|STARTED|Overall Study||130
7828252|NCT01070784|19267965|P1|STARTED|Overall Study||130
7828253|NCT01070771|19268053|P1|NOT COMPLETED|Overall Study||3
7828254|NCT01070771|19268053|P1|COMPLETED|Overall Study|August 2012|200
7828255|NCT01070771|19268053|P1|STARTED|Overall Study|September 2008|203
7828256|NCT01070693|19268060|P2|NOT COMPLETED|Overall Study||39
7828257|NCT01070693|19268061|P1|NOT COMPLETED|Overall Study||28
7828258|NCT01070693|19268060|P2|COMPLETED|Overall Study||110
7828259|NCT01070693|19268061|P1|COMPLETED|Overall Study||122
7828260|NCT01070693|19268060|P2|STARTED|Overall Study||149
7828261|NCT01070693|19268061|P1|STARTED|Overall Study||150
7828262|NCT01070550|19268073|P6|NOT COMPLETED|Overall Study||7
7828263|NCT01070550|19268074|P5|NOT COMPLETED|Overall Study||1
7828264|NCT01070550|19268075|P4|NOT COMPLETED|Overall Study||77
7828265|NCT01070550|19268076|P3|NOT COMPLETED|Overall Study||216
7828266|NCT01070550|19268077|P2|NOT COMPLETED|Overall Study||62
7828267|NCT01070550|19268078|P1|NOT COMPLETED|Overall Study||1285
7828268|NCT01070550|19268073|P6|COMPLETED|Overall Study||35
7828269|NCT01070550|19268074|P5|COMPLETED|Overall Study||20
7828270|NCT01070550|19268075|P4|COMPLETED|Overall Study||124
7828271|NCT01070550|19268076|P3|COMPLETED|Overall Study||528
7828272|NCT01070550|19268077|P2|COMPLETED|Overall Study||254
7828273|NCT01070550|19268078|P1|COMPLETED|Overall Study||2071
7828274|NCT01070550|19268073|P6|STARTED|Overall Study||42
7828275|NCT01070550|19268074|P5|STARTED|Overall Study||21
7828276|NCT01070550|19268075|P4|STARTED|Overall Study||201
7828277|NCT01070550|19268076|P3|STARTED|Overall Study||744
7828278|NCT01070550|19268077|P2|STARTED|Overall Study||316
7828279|NCT01070550|19268078|P1|STARTED|Overall Study||3356
7828280|NCT01070394|19268218|P1|NOT COMPLETED|Overall Study||7
7828281|NCT01070394|19268218|P1|COMPLETED|Overall Study||33
7828282|NCT01070394|19268218|P1|STARTED|Overall Study||40
7828283|NCT01070381|19268229|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
7828284|NCT01070381|19268230|P1|NOT COMPLETED|Period 2, 1 Week of Wear||1
7828285|NCT01070381|19268229|P2|COMPLETED|Period 2, 1 Week of Wear||106
7828286|NCT01070381|19268230|P1|COMPLETED|Period 2, 1 Week of Wear||108
7828287|NCT01070381|19268229|P2|STARTED|Period 2, 1 Week of Wear||107
7828288|NCT01070381|19268230|P1|STARTED|Period 2, 1 Week of Wear||109
7828289|NCT01070381|19268229|P2|NOT COMPLETED|Period 1, 1 Week of Wear||0
7828290|NCT01070381|19268230|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
7828291|NCT01070381|19268229|P2|COMPLETED|Period 1, 1 Week of Wear||107
7828292|NCT01070381|19268230|P1|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109
7828293|NCT01070381|19268229|P2|STARTED|Period 1, 1 Week of Wear||107
7828294|NCT01070381|19268230|P1|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109
7828295|NCT01070329|19268238|P2|NOT COMPLETED|Overall Study||49
7828296|NCT01070329|19268239|P1|NOT COMPLETED|Overall Study||52
7828297|NCT01070329|19268238|P2|COMPLETED|Overall Study||217
7828298|NCT01070329|19268239|P1|COMPLETED|Overall Study||209
7828299|NCT01070329|19268238|P2|STARTED|Overall Study||266
7828300|NCT01070329|19268239|P1|STARTED|Overall Study||261
7828301|NCT01070316|19268271|P1|NOT COMPLETED|Extension Phase||4
7828302|NCT01070316|19268271|P1|COMPLETED|Extension Phase||14
7828303|NCT01070316|19268271|P1|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18
7828304|NCT01070316|19268271|P1|NOT COMPLETED|Main Phase||0
7828305|NCT01070316|19268271|P1|COMPLETED|Main Phase||20
7828306|NCT01070316|19268271|P1|STARTED|Main Phase||20
7828307|NCT01070303|19268278|P1|NOT COMPLETED|Overall Study||89
7828308|NCT01070303|19268278|P1|COMPLETED|Overall Study||88
7828309|NCT01070303|19268278|P1|STARTED|Overall Study||177
7828310|NCT01070173|19268337|P3|NOT COMPLETED|Overall Study||0
7828311|NCT01070173|19268338|P2|NOT COMPLETED|Overall Study||0
7828312|NCT01070173|19268339|P1|NOT COMPLETED|Overall Study||0
7828313|NCT01070173|19268337|P3|COMPLETED|Overall Study||11
7828314|NCT01070173|19268338|P2|COMPLETED|Overall Study||8
7828315|NCT01070173|19268339|P1|COMPLETED|Overall Study||33
7828316|NCT01070173|19268337|P3|STARTED|Overall Study||11
7828317|NCT01070173|19268338|P2|STARTED|Overall Study||8
7828318|NCT01070173|19268339|P1|STARTED|Overall Study||33
7828319|NCT01070095|19268350|P2|NOT COMPLETED|Intervention Period||0
7828320|NCT01070095|19268351|P1|NOT COMPLETED|Intervention Period||0
7828321|NCT01070095|19268350|P2|COMPLETED|Intervention Period||890
7828322|NCT01070095|19268351|P1|COMPLETED|Intervention Period||18
7828323|NCT01070095|19268350|P2|STARTED|Intervention Period||890
7828324|NCT01070095|19268351|P1|STARTED|Intervention Period||18
7828325|NCT01070095|19268350|P2|NOT COMPLETED|Baseline Period||0
7828326|NCT01070095|19268351|P1|NOT COMPLETED|Baseline Period||1
7828327|NCT01070095|19268350|P2|COMPLETED|Baseline Period||830
7828328|NCT01070095|19268351|P1|COMPLETED|Baseline Period||18
7828329|NCT01070095|19268350|P2|STARTED|Baseline Period||830
7828330|NCT01070095|19268351|P1|STARTED|Baseline Period||19
7828331|NCT01070043|19268373|P3|NOT COMPLETED|Double-Blind Treatment||2
7828332|NCT01070043|19268374|P2|NOT COMPLETED|Double-Blind Treatment||0
7828333|NCT01070043|19268375|P1|NOT COMPLETED|Double-Blind Treatment||0
7828334|NCT01070043|19268373|P3|COMPLETED|Double-Blind Treatment||19
7828335|NCT01070043|19268374|P2|COMPLETED|Double-Blind Treatment||21
7828336|NCT01070043|19268375|P1|COMPLETED|Double-Blind Treatment||0
7828337|NCT01070043|19268373|P3|STARTED|Double-Blind Treatment||21
7828338|NCT01070043|19268374|P2|STARTED|Double-Blind Treatment||21
7828339|NCT01070043|19268375|P1|STARTED|Double-Blind Treatment||0
7828340|NCT01070043|19268373|P3|NOT COMPLETED|Run-In Phase||0
7828341|NCT01070043|19268374|P2|NOT COMPLETED|Run-In Phase||0
7828342|NCT01070043|19268375|P1|NOT COMPLETED|Run-In Phase||18
7828343|NCT01070043|19268373|P3|COMPLETED|Run-In Phase||0
7828344|NCT01070043|19268374|P2|COMPLETED|Run-In Phase||0
7828345|NCT01070043|19268375|P1|COMPLETED|Run-In Phase||42
7828346|NCT01070043|19268373|P3|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0
7828347|NCT01070043|19268374|P2|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0
7828348|NCT01070043|19268375|P1|STARTED|Run-In Phase||60
7828349|NCT01069939|19268391|P2|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32
7828350|NCT01069939|19268392|P1|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31
7828351|NCT01069939|19268391|P2|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
7828352|NCT01069939|19268392|P1|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
7828353|NCT01069939|19268391|P2|STARTED|At Data Cut Off Date (26 Feb 2011)||214
7828354|NCT01069939|19268392|P1|STARTED|At Data Cut Off Date (26 Feb 2011)||213
7828355|NCT01069939|19268391|P2|NOT COMPLETED|Randomised and Included in the Analyses||77
7828356|NCT01069939|19268392|P1|NOT COMPLETED|Randomised and Included in the Analyses||49
7828357|NCT01069939|19268391|P2|COMPLETED|Randomised and Included in the Analyses||137
7828358|NCT01069939|19268392|P1|COMPLETED|Randomised and Included in the Analyses||164
7828359|NCT01069939|19268391|P2|STARTED|Randomised and Included in the Analyses||214
7828360|NCT01069939|19268392|P1|STARTED|Randomised and Included in the Analyses||213
7828361|NCT01069900|19268418|P2|NOT COMPLETED|Overall Study||4
7828362|NCT01069900|19268419|P1|NOT COMPLETED|Overall Study||18
7828363|NCT01069900|19268418|P2|COMPLETED|Overall Study||149
7828364|NCT01069900|19268419|P1|COMPLETED|Overall Study||287
7828365|NCT01069900|19268418|P2|Treated|Overall Study||150
7828366|NCT01069900|19268419|P1|Treated|Overall Study||301
7828367|NCT01069900|19268418|P2|STARTED|Overall Study||153
7828368|NCT01069900|19268419|P1|STARTED|Overall Study||305
7828369|NCT01069861|19268463|P1|NOT COMPLETED|Overall Study||3
7828370|NCT01069861|19268463|P1|COMPLETED|Overall Study||1
7828371|NCT01069861|19268463|P1|STARTED|Overall Study||4
7828372|NCT01069627|19268476|P1|NOT COMPLETED|Overall Study||20
7828373|NCT01069627|19268476|P1|COMPLETED|Overall Study||0
7828374|NCT01069627|19268476|P1|STARTED|Overall Study||20
7828375|NCT01069562|19268499|P2|NOT COMPLETED|Overall Study||0
7828376|NCT01069562|19268500|P1|NOT COMPLETED|Overall Study||0
7828377|NCT01069562|19268499|P2|COMPLETED|Overall Study||20
7828378|NCT01069562|19268500|P1|COMPLETED|Overall Study||20
7828379|NCT01069562|19268499|P2|STARTED|Overall Study||20
7828380|NCT01069562|19268500|P1|STARTED|Overall Study||20
7828381|NCT01069523|19268526|P2|NOT COMPLETED|Overall Study||7
7828382|NCT01069523|19268527|P1|NOT COMPLETED|Overall Study||4
7828383|NCT01069523|19268526|P2|COMPLETED|Overall Study||9
7828384|NCT01069523|19268527|P1|COMPLETED|Overall Study||9
7828385|NCT01069523|19268526|P2|STARTED|Overall Study||16
7828386|NCT01069523|19268527|P1|STARTED|Overall Study||13
7828387|NCT01069510|19268537|P2|NOT COMPLETED|Overall Study||0
7828388|NCT01069510|19268538|P1|NOT COMPLETED|Overall Study||0
7828389|NCT01069510|19268537|P2|COMPLETED|Overall Study||7
7828390|NCT01069510|19268538|P1|COMPLETED|Overall Study||8
7828391|NCT01069510|19268537|P2|STARTED|Overall Study||7
7828392|NCT01069510|19268538|P1|STARTED|Overall Study||8
7828393|NCT01069484|19268550|P2|NOT COMPLETED|Overall Study||3
7828394|NCT01069484|19268551|P1|NOT COMPLETED|Overall Study||12
7828395|NCT01069484|19268550|P2|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85
7828396|NCT01069484|19268551|P1|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75
7828397|NCT01069484|19268550|P2|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88
7828398|NCT01069484|19268551|P1|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87
7828399|NCT01069419|19268559|P1|NOT COMPLETED|Overall Study||715
7828400|NCT01069419|19268559|P1|COMPLETED|Overall Study||402
7828401|NCT01069419|19268559|P1|Full Analysis Set|Overall Study||851
7828402|NCT01069419|19268559|P1|Safety Set|Overall Study||1111
7828403|NCT01069419|19268559|P1|STARTED|Overall Study||1117
7828404|NCT01069354|19268566|P1|NOT COMPLETED|Overall Study||1
7828405|NCT01069354|19268566|P1|COMPLETED|Overall Study|One subject's treatment fold not injected due to adverse event during control fold injection|101
7828406|NCT01069354|19268566|P1|STARTED|Overall Study||102
7828407|NCT01069341|19268588|P1|NOT COMPLETED|Overall Study||1
7828408|NCT01069341|19268588|P1|COMPLETED|Overall Study||3
7828409|NCT01069341|19268588|P1|STARTED|Overall Study||4
7828410|NCT01069315|19268603|P4|NOT COMPLETED|Overall Study||7
7828411|NCT01069315|19268604|P3|NOT COMPLETED|Overall Study||5
7828412|NCT01069315|19268605|P2|NOT COMPLETED|Overall Study||6
7828413|NCT01069315|19268606|P1|NOT COMPLETED|Overall Study||4
7828414|NCT01069315|19268603|P4|COMPLETED|Overall Study||19
7828415|NCT01069315|19268604|P3|COMPLETED|Overall Study||23
7828416|NCT01069315|19268605|P2|COMPLETED|Overall Study||24
7828417|NCT01069315|19268606|P1|COMPLETED|Overall Study||23
7828418|NCT01069315|19268603|P4|STARTED|Overall Study||26
7828419|NCT01069315|19268604|P3|STARTED|Overall Study||28
7828420|NCT01069315|19268605|P2|STARTED|Overall Study||30
7828421|NCT01069315|19268606|P1|STARTED|Overall Study||27
7828422|NCT01069289|19268630|P2|NOT COMPLETED|Overall Study||56
7828423|NCT01069289|19268631|P1|NOT COMPLETED|Overall Study||42
7828424|NCT01069289|19268630|P2|COMPLETED|Overall Study||601
7828425|NCT01069289|19268631|P1|COMPLETED|Overall Study||594
7828426|NCT01069289|19268630|P2|STARTED|Overall Study||657
7828427|NCT01069289|19268631|P1|STARTED|Overall Study||636
7828428|NCT01069185|19268671|P2|NOT COMPLETED|Overall Study||0
7828429|NCT01069185|19268672|P1|NOT COMPLETED|Overall Study||0
7828430|NCT01069185|19268671|P2|COMPLETED|Overall Study||45
7828431|NCT01069185|19268672|P1|COMPLETED|Overall Study||47
7828432|NCT01069185|19268671|P2|STARTED|Overall Study||45
7828433|NCT01069185|19268672|P1|STARTED|Overall Study||47
7828434|NCT01069172|19268680|P2|NOT COMPLETED|Overall Study||0
7828435|NCT01069172|19268681|P1|NOT COMPLETED|Overall Study||1
7828436|NCT01069172|19268680|P2|COMPLETED|Overall Study|30 eyes|30
7828437|NCT01069172|19268681|P1|COMPLETED|Overall Study|29 eyes|29
7828438|NCT01069172|19268680|P2|STARTED|Overall Study|30 eyes|30
7828439|NCT01069172|19268681|P1|STARTED|Overall Study|30 eyes|30
7828440|NCT01069120|19268691|P1|NOT COMPLETED|Overall Study||27
7828441|NCT01069120|19268691|P1|COMPLETED|Overall Study||0
7828442|NCT01069120|19268691|P1|STARTED|Overall Study||27
7828443|NCT01069003|19268700|P3|NOT COMPLETED|Overall Study||475
7828444|NCT01069003|19268701|P2|NOT COMPLETED|Overall Study||54
7828445|NCT01069003|19268702|P1|NOT COMPLETED|Overall Study||46
7828446|NCT01069003|19268700|P3|COMPLETED|Overall Study||976
7828447|NCT01069003|19268701|P2|COMPLETED|Overall Study||358
7828448|NCT01069003|19268702|P1|COMPLETED|Overall Study||353
7828449|NCT01069003|19268700|P3|STARTED|Overall Study||1451
7828450|NCT01069003|19268701|P2|STARTED|Overall Study||412
7828451|NCT01069003|19268702|P1|STARTED|Overall Study||399
7828452|NCT01068964|19268718|P2|NOT COMPLETED|Overall Study||10
7828453|NCT01068964|19268719|P1|NOT COMPLETED|Overall Study||8
7828454|NCT01068964|19268718|P2|COMPLETED|Overall Study||104
7828455|NCT01068964|19268719|P1|COMPLETED|Overall Study||113
7828456|NCT01068964|19268718|P2|STARTED|Overall Study||114
7828457|NCT01068964|19268719|P1|STARTED|Overall Study||121
7828458|NCT01068912|19268728|P3|NOT COMPLETED|Overall Study||15
7828459|NCT01068912|19268729|P2|NOT COMPLETED|Overall Study||22
7828460|NCT01068912|19268730|P1|NOT COMPLETED|Overall Study||11
7828461|NCT01068912|19268728|P3|COMPLETED|Overall Study||186
7828462|NCT01068912|19268729|P2|COMPLETED|Overall Study||173
7828463|NCT01068912|19268730|P1|COMPLETED|Overall Study||123
7828464|NCT01068912|19268728|P3|STARTED|Overall Study||201
7828465|NCT01068912|19268729|P2|STARTED|Overall Study||195
7828466|NCT01068912|19268730|P1|STARTED|Overall Study||134
7828467|NCT01068873|19268738|P1|NOT COMPLETED|Overall Study||0
7828468|NCT01068873|19268738|P1|COMPLETED|Overall Study||1
7828469|NCT01068873|19268738|P1|STARTED|Overall Study||1
7828470|NCT01068860|19268758|P10|NOT COMPLETED|Overall Study||4
7828471|NCT01068860|19268759|P9|NOT COMPLETED|Overall Study||0
7828472|NCT01068860|19268760|P8|NOT COMPLETED|Overall Study||0
7828473|NCT01068860|19268761|P7|NOT COMPLETED|Overall Study||0
7828474|NCT01068860|19268762|P6|NOT COMPLETED|Overall Study||2
7828475|NCT01068860|19268763|P5|NOT COMPLETED|Overall Study||0
7828476|NCT01068860|19268764|P4|NOT COMPLETED|Overall Study||1
7828477|NCT01068860|19268765|P3|NOT COMPLETED|Overall Study||0
7828478|NCT01068860|19268766|P2|NOT COMPLETED|Overall Study||1
7828479|NCT01068860|19268767|P1|NOT COMPLETED|Overall Study||0
7828480|NCT01068860|19268758|P10|COMPLETED|Overall Study||23
7828481|NCT01068860|19268759|P9|COMPLETED|Overall Study||28
7828482|NCT01068860|19268760|P8|COMPLETED|Overall Study||15
7828483|NCT01068860|19268761|P7|COMPLETED|Overall Study||28
7828484|NCT01068860|19268762|P6|COMPLETED|Overall Study||14
7828485|NCT01068860|19268763|P5|COMPLETED|Overall Study||32
7828486|NCT01068860|19268764|P4|COMPLETED|Overall Study||16
7828487|NCT01068860|19268765|P3|COMPLETED|Overall Study||33
7828488|NCT01068860|19268766|P2|COMPLETED|Overall Study||16
7828489|NCT01068860|19268767|P1|COMPLETED|Overall Study||33
7828490|NCT01068860|19268758|P10|STARTED|Overall Study||27
7828491|NCT01068860|19268759|P9|STARTED|Overall Study||28
7828492|NCT01068860|19268760|P8|STARTED|Overall Study||15
7828493|NCT01068860|19268761|P7|STARTED|Overall Study||28
7828494|NCT01068860|19268762|P6|STARTED|Overall Study||16
7828495|NCT01068860|19268763|P5|STARTED|Overall Study||32
7828496|NCT01068860|19268764|P4|STARTED|Overall Study||17
7828497|NCT01068860|19268765|P3|STARTED|Overall Study||33
7828498|NCT01068860|19268766|P2|STARTED|Overall Study||17
7828499|NCT01068860|19268767|P1|STARTED|Overall Study||33
7828500|NCT01068821|19268941|P2|NOT COMPLETED|Overall Study||0
7828501|NCT01068821|19268942|P1|NOT COMPLETED|Overall Study||1
7828502|NCT01068821|19268941|P2|COMPLETED|Overall Study||29
7828503|NCT01068821|19268942|P1|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30
7828504|NCT01068821|19268941|P2|STARTED|Overall Study||29
7828505|NCT01068821|19268942|P1|STARTED|Overall Study||31
7828506|NCT01068769|19268950|P1|NOT COMPLETED|Overall Study||1
7828507|NCT01068769|19268950|P1|COMPLETED|Overall Study||33
7828508|NCT01068769|19268950|P1|STARTED|Overall Study||34
7828509|NCT01068743|19268955|P4|NOT COMPLETED|Period 4||0
7828510|NCT01068743|19268956|P3|NOT COMPLETED|Period 4||0
7828511|NCT01068743|19268957|P2|NOT COMPLETED|Period 4||0
7828512|NCT01068743|19268958|P1|NOT COMPLETED|Period 4||0
7828513|NCT01068743|19268955|P4|COMPLETED|Period 4||6
7828514|NCT01068743|19268956|P3|COMPLETED|Period 4||6
7828515|NCT01068743|19268957|P2|COMPLETED|Period 4||5
7828516|NCT01068743|19268958|P1|COMPLETED|Period 4||6
7828517|NCT01068743|19268955|P4|STARTED|Period 4||6
7828518|NCT01068743|19268956|P3|STARTED|Period 4||6
7828519|NCT01068743|19268957|P2|STARTED|Period 4||5
7828520|NCT01068743|19268958|P1|STARTED|Period 4||6
7828521|NCT01068743|19268955|P4|NOT COMPLETED|Period 3||0
7828522|NCT01068743|19268956|P3|NOT COMPLETED|Period 3||0
7828523|NCT01068743|19268957|P2|NOT COMPLETED|Period 3||1
7828524|NCT01068743|19268958|P1|NOT COMPLETED|Period 3||0
7828525|NCT01068743|19268955|P4|COMPLETED|Period 3||6
7828526|NCT01068743|19268956|P3|COMPLETED|Period 3||6
7828527|NCT01068743|19268957|P2|COMPLETED|Period 3||5
7828528|NCT01068743|19268958|P1|COMPLETED|Period 3||6
7828529|NCT01068743|19268955|P4|STARTED|Period 3||6
7828530|NCT01068743|19268956|P3|STARTED|Period 3||6
7828531|NCT01068743|19268957|P2|STARTED|Period 3||6
7828532|NCT01068743|19268958|P1|STARTED|Period 3||6
7828533|NCT01068743|19268955|P4|NOT COMPLETED|Period 2||0
7828534|NCT01068743|19268956|P3|NOT COMPLETED|Period 2||0
7828535|NCT01068743|19268957|P2|NOT COMPLETED|Period 2||0
7828536|NCT01068743|19268958|P1|NOT COMPLETED|Period 2||0
7828537|NCT01068743|19268955|P4|COMPLETED|Period 2||6
7828538|NCT01068743|19268956|P3|COMPLETED|Period 2||6
7828539|NCT01068743|19268957|P2|COMPLETED|Period 2||6
7828540|NCT01068743|19268958|P1|COMPLETED|Period 2||6
7828541|NCT01068743|19268955|P4|STARTED|Period 2||6
7828542|NCT01068743|19268956|P3|STARTED|Period 2||6
7828543|NCT01068743|19268957|P2|STARTED|Period 2||6
7828544|NCT01068743|19268958|P1|STARTED|Period 2||6
7828545|NCT01068743|19268955|P4|NOT COMPLETED|Period 1||0
7828546|NCT01068743|19268956|P3|NOT COMPLETED|Period 1||0
7828547|NCT01068743|19268957|P2|NOT COMPLETED|Period 1||0
7828548|NCT01068743|19268958|P1|NOT COMPLETED|Period 1||0
7828549|NCT01068743|19268955|P4|COMPLETED|Period 1||6
7828550|NCT01068743|19268956|P3|COMPLETED|Period 1||6
7828551|NCT01068743|19268957|P2|COMPLETED|Period 1||6
7828552|NCT01068743|19268958|P1|COMPLETED|Period 1||6
7828553|NCT01068743|19268955|P4|STARTED|Period 1||6
7828554|NCT01068743|19268956|P3|STARTED|Period 1||6
7828555|NCT01068743|19268957|P2|STARTED|Period 1||6
7828556|NCT01068743|19268958|P1|STARTED|Period 1||6
7828557|NCT01068730|19269032|P4|NOT COMPLETED|Period 4||0
7828558|NCT01068730|19269033|P3|NOT COMPLETED|Period 4||0
7828559|NCT01068730|19269034|P2|NOT COMPLETED|Period 4||1
7828560|NCT01068730|19269035|P1|NOT COMPLETED|Period 4||0
7828561|NCT01068730|19269032|P4|COMPLETED|Period 4||7
7828562|NCT01068730|19269033|P3|COMPLETED|Period 4||7
7828563|NCT01068730|19269034|P2|COMPLETED|Period 4||6
7828564|NCT01068730|19269035|P1|COMPLETED|Period 4||6
7828565|NCT01068730|19269032|P4|STARTED|Period 4||7
7828566|NCT01068730|19269033|P3|STARTED|Period 4||7
7828567|NCT01068730|19269034|P2|STARTED|Period 4||7
7828568|NCT01068730|19269035|P1|STARTED|Period 4||6
7828569|NCT01068730|19269032|P4|NOT COMPLETED|Period 3||0
7828570|NCT01068730|19269033|P3|NOT COMPLETED|Period 3||0
7828571|NCT01068730|19269034|P2|NOT COMPLETED|Period 3||0
7828572|NCT01068730|19269035|P1|NOT COMPLETED|Period 3||1
7828573|NCT01068730|19269032|P4|COMPLETED|Period 3||7
7828574|NCT01068730|19269033|P3|COMPLETED|Period 3||7
7828575|NCT01068730|19269034|P2|COMPLETED|Period 3||7
7828576|NCT01068730|19269035|P1|COMPLETED|Period 3||6
7828577|NCT01068730|19269032|P4|STARTED|Period 3||7
7828578|NCT01068730|19269033|P3|STARTED|Period 3||7
7828579|NCT01068730|19269034|P2|STARTED|Period 3||7
7828580|NCT01068730|19269035|P1|STARTED|Period 3||7
7828581|NCT01068730|19269032|P4|NOT COMPLETED|Period 2||0
7828582|NCT01068730|19269033|P3|NOT COMPLETED|Period 2||0
7828583|NCT01068730|19269034|P2|NOT COMPLETED|Period 2||0
7828584|NCT01068730|19269035|P1|NOT COMPLETED|Period 2||0
7828585|NCT01068730|19269032|P4|COMPLETED|Period 2||7
7828586|NCT01068730|19269033|P3|COMPLETED|Period 2||7
7828587|NCT01068730|19269034|P2|COMPLETED|Period 2||7
7828588|NCT01068730|19269035|P1|COMPLETED|Period 2||7
7828589|NCT01068730|19269032|P4|STARTED|Period 2||7
7828590|NCT01068730|19269033|P3|STARTED|Period 2||7
7828591|NCT01068730|19269034|P2|STARTED|Period 2||7
7828592|NCT01068730|19269035|P1|STARTED|Period 2||7
7828593|NCT01068730|19269032|P4|NOT COMPLETED|Period 1||0
7828594|NCT01068730|19269033|P3|NOT COMPLETED|Period 1||0
7828595|NCT01068730|19269034|P2|NOT COMPLETED|Period 1||0
7828596|NCT01068730|19269035|P1|NOT COMPLETED|Period 1||0
7828597|NCT01068730|19269032|P4|COMPLETED|Period 1||7
7828598|NCT01068730|19269033|P3|COMPLETED|Period 1||7
7828599|NCT01068730|19269034|P2|COMPLETED|Period 1||7
7828600|NCT01068730|19269035|P1|COMPLETED|Period 1||7
7828601|NCT01068730|19269032|P4|STARTED|Period 1||7
7828602|NCT01068730|19269033|P3|STARTED|Period 1||7
7828603|NCT01068730|19269034|P2|STARTED|Period 1||7
7828604|NCT01068730|19269035|P1|STARTED|Period 1||7
7828605|NCT01068717|19269089|P4|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
7828606|NCT01068717|19269090|P3|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
7828607|NCT01068717|19269091|P2|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
7828608|NCT01068717|19269092|P1|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
7828609|NCT01068717|19269089|P4|COMPLETED|Period 4: Treatment Schedule Phase 4||7
7828610|NCT01068717|19269090|P3|COMPLETED|Period 4: Treatment Schedule Phase 4||7
7828611|NCT01068717|19269091|P2|COMPLETED|Period 4: Treatment Schedule Phase 4||6
7828612|NCT01068717|19269092|P1|COMPLETED|Period 4: Treatment Schedule Phase 4||7
7828613|NCT01068717|19269089|P4|STARTED|Period 4: Treatment Schedule Phase 4||7
7828614|NCT01068717|19269090|P3|STARTED|Period 4: Treatment Schedule Phase 4||7
7828615|NCT01068717|19269091|P2|STARTED|Period 4: Treatment Schedule Phase 4||6
7828616|NCT01068717|19269092|P1|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
7828617|NCT01068717|19269089|P4|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
7828618|NCT01068717|19269090|P3|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
7828619|NCT01068717|19269091|P2|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
7828620|NCT01068717|19269092|P1|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
7828621|NCT01068717|19269089|P4|COMPLETED|Period 3: Treatment Schedule Phase 3||7
7828622|NCT01068717|19269090|P3|COMPLETED|Period 3: Treatment Schedule Phase 3||7
7828623|NCT01068717|19269091|P2|COMPLETED|Period 3: Treatment Schedule Phase 3||6
7828624|NCT01068717|19269092|P1|COMPLETED|Period 3: Treatment Schedule Phase 3||7
7828625|NCT01068717|19269089|P4|STARTED|Period 3: Treatment Schedule Phase 3||7
7828626|NCT01068717|19269090|P3|STARTED|Period 3: Treatment Schedule Phase 3||7
7828627|NCT01068717|19269091|P2|STARTED|Period 3: Treatment Schedule Phase 3||6
7828628|NCT01068717|19269092|P1|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
7828629|NCT01068717|19269089|P4|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
7828630|NCT01068717|19269090|P3|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
7828631|NCT01068717|19269091|P2|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
7828632|NCT01068717|19269092|P1|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
7828633|NCT01068717|19269089|P4|COMPLETED|Period 2: Treatment Schedule Phase 2||7
7828634|NCT01068717|19269090|P3|COMPLETED|Period 2: Treatment Schedule Phase 2||7
7828635|NCT01068717|19269091|P2|COMPLETED|Period 2: Treatment Schedule Phase 2||6
7828636|NCT01068717|19269092|P1|COMPLETED|Period 2: Treatment Schedule Phase 2||6
7828637|NCT01068717|19269089|P4|STARTED|Period 2: Treatment Schedule Phase 2||7
7828638|NCT01068717|19269090|P3|STARTED|Period 2: Treatment Schedule Phase 2||7
7828639|NCT01068717|19269091|P2|STARTED|Period 2: Treatment Schedule Phase 2||6
7828640|NCT01068717|19269092|P1|STARTED|Period 2: Treatment Schedule Phase 2||6
7828641|NCT01068717|19269089|P4|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
7828642|NCT01068717|19269090|P3|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
7828643|NCT01068717|19269091|P2|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
7828644|NCT01068717|19269092|P1|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1
7828645|NCT01068717|19269089|P4|COMPLETED|Period 1: Treatment Schedule Phase 1||7
7828646|NCT01068717|19269090|P3|COMPLETED|Period 1: Treatment Schedule Phase 1||7
7828647|NCT01068717|19269091|P2|COMPLETED|Period 1: Treatment Schedule Phase 1||6
7828648|NCT01068717|19269092|P1|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6
7828649|NCT01068717|19269089|P4|STARTED|Period 1: Treatment Schedule Phase 1||7
7828650|NCT01068717|19269090|P3|STARTED|Period 1: Treatment Schedule Phase 1||7
7828651|NCT01068717|19269091|P2|STARTED|Period 1: Treatment Schedule Phase 1||6
7828652|NCT01068717|19269092|P1|STARTED|Period 1: Treatment Schedule Phase 1||7
7828653|NCT01068678|19269148|P2|NOT COMPLETED|Overall Study||24
7828654|NCT01068678|19269149|P1|NOT COMPLETED|Overall Study||38
7828655|NCT01068678|19269148|P2|COMPLETED|Overall Study||206
7828656|NCT01068678|19269149|P1|COMPLETED|Overall Study||192
7828657|NCT01068678|19269148|P2|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229
7828658|NCT01068678|19269149|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227
7828659|NCT01068678|19269148|P2|STARTED|Overall Study||230
7828660|NCT01068678|19269149|P1|STARTED|Overall Study||230
7828661|NCT01068665|19269159|P2|NOT COMPLETED|Overall Study||29
7828662|NCT01068665|19269160|P1|NOT COMPLETED|Overall Study||30
7828663|NCT01068665|19269159|P2|COMPLETED|Overall Study||201
7828664|NCT01068665|19269160|P1|COMPLETED|Overall Study||200
7828665|NCT01068665|19269159|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228
7828666|NCT01068665|19269160|P1|Exposed|Overall Study||228
7828667|NCT01068665|19269159|P2|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229
7828668|NCT01068665|19269160|P1|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228
7828669|NCT01068665|19269159|P2|STARTED|Overall Study||230
7828670|NCT01068665|19269160|P1|STARTED|Overall Study||230
7828671|NCT01068652|19269170|P2|NOT COMPLETED|Overall Study||15
7828672|NCT01068652|19269171|P1|NOT COMPLETED|Overall Study||18
7828673|NCT01068652|19269170|P2|COMPLETED|Overall Study||188
7828674|NCT01068652|19269171|P1|COMPLETED|Overall Study||182
7828675|NCT01068652|19269170|P2|STARTED|Overall Study||203
7828676|NCT01068652|19269171|P1|STARTED|Overall Study||200
7828677|NCT01068626|19269211|P2|NOT COMPLETED|Overall Study||2
7828678|NCT01068626|19269212|P1|NOT COMPLETED|Overall Study||3
7828679|NCT01068626|19269211|P2|COMPLETED|Overall Study||27
7828680|NCT01068626|19269212|P1|COMPLETED|Overall Study||27
7828681|NCT01068626|19269211|P2|STARTED|Overall Study||29
7828682|NCT01068626|19269212|P1|STARTED|Overall Study||30
7828683|NCT01068600|19269230|P2|NOT COMPLETED|Overall Study||17
7828684|NCT01068600|19269231|P1|NOT COMPLETED|Overall Study||11
7828685|NCT01068600|19269230|P2|COMPLETED|Overall Study||142
7828686|NCT01068600|19269231|P1|COMPLETED|Overall Study||148
7828687|NCT01068600|19269230|P2|STARTED|Overall Study||159
7828688|NCT01068600|19269231|P1|STARTED|Overall Study||159
7828689|NCT01068548|19269241|P2|NOT COMPLETED|Overall Study||0
7828690|NCT01068548|19269242|P1|NOT COMPLETED|Overall Study||0
7828691|NCT01068548|19269241|P2|COMPLETED|Overall Study||63
7828692|NCT01068548|19269242|P1|COMPLETED|Overall Study||66
7828693|NCT01068548|19269241|P2|STARTED|Overall Study||63
7828694|NCT01068548|19269242|P1|STARTED|Overall Study||66
7828695|NCT01068509|19269253|P3|NOT COMPLETED|Overall Study||21
7828696|NCT01068509|19269254|P2|NOT COMPLETED|Overall Study||22
7828697|NCT01068509|19269255|P1|NOT COMPLETED|Overall Study||6
7828698|NCT01068509|19269253|P3|COMPLETED|Overall Study||6
7828699|NCT01068509|19269254|P2|COMPLETED|Overall Study||7
7828700|NCT01068509|19269255|P1|COMPLETED|Overall Study||1
7828701|NCT01068509|19269253|P3|STARTED|Overall Study||27
7828702|NCT01068509|19269254|P2|STARTED|Overall Study||29
7828703|NCT01068509|19269255|P1|STARTED|Overall Study||7
7828704|NCT01068418|19269268|P1|NOT COMPLETED|Overall Study||12
7828705|NCT01068418|19269268|P1|COMPLETED|Overall Study|14 participants completed all study procedures.|14
7828706|NCT01068418|19269268|P1|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17
7828707|NCT01068418|19269268|P1|STARTED|Overall Study|26 participants found to be eligible|26
7828708|NCT01068262|19269277|P4|NOT COMPLETED|Overall Study||0
7828709|NCT01068262|19269278|P3|NOT COMPLETED|Overall Study||1
7828710|NCT01068262|19269279|P2|NOT COMPLETED|Overall Study||1
7828711|NCT01068262|19269280|P1|NOT COMPLETED|Overall Study||3
7828712|NCT01068262|19269277|P4|COMPLETED|Overall Study||2
7828713|NCT01068262|19269278|P3|COMPLETED|Overall Study||9
7828714|NCT01068262|19269279|P2|COMPLETED|Overall Study||8
7828715|NCT01068262|19269280|P1|COMPLETED|Overall Study||20
7828716|NCT01068262|19269277|P4|STARTED|Overall Study||2
7828717|NCT01068262|19269278|P3|STARTED|Overall Study||10
7828718|NCT01068262|19269279|P2|STARTED|Overall Study||9
7828719|NCT01068262|19269280|P1|STARTED|Overall Study||23
7828720|NCT01068158|19269310|P2|NOT COMPLETED|Overall Study||4
7828721|NCT01068158|19269311|P1|NOT COMPLETED|Overall Study||8
7828722|NCT01068158|19269310|P2|COMPLETED|Overall Study||198
7828723|NCT01068158|19269311|P1|COMPLETED|Overall Study||161
7828724|NCT01068158|19269310|P2|STARTED|Overall Study||202
7828725|NCT01068158|19269311|P1|STARTED|Overall Study||169
7828726|NCT01067976|19269323|P1|NOT COMPLETED|Overall Study||22
7828727|NCT01067976|19269323|P1|COMPLETED|Overall Study|study course completed|424
7828728|NCT01067976|19269323|P1|Fulfilled Requirements of FAS Population|Overall Study||390
7828729|NCT01067976|19269323|P1|Received Treatment|Overall Study|treatment started|426
7828730|NCT01067976|19269323|P1|STARTED|Overall Study|screened and enrolled|446
7828731|NCT01067846|19269384|P2|NOT COMPLETED|Overall Study||19
7828732|NCT01067846|19269385|P1|NOT COMPLETED|Overall Study||19
7828733|NCT01067846|19269384|P2|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11
7828734|NCT01067846|19269385|P1|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10
7828735|NCT01067846|19269384|P2|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
7828736|NCT01067846|19269385|P1|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
7828737|NCT01067846|19269384|P2|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30
7828738|NCT01067846|19269385|P1|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29
7828739|NCT01067781|19269397|P4|NOT COMPLETED|180 to Day 720||89
7828740|NCT01067781|19269398|P3|NOT COMPLETED|180 to Day 720||89
7828741|NCT01067781|19269399|P2|NOT COMPLETED|180 to Day 720||164
7828742|NCT01067781|19269400|P1|NOT COMPLETED|180 to Day 720||170
7828743|NCT01067781|19269397|P4|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
7828744|NCT01067781|19269398|P3|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
7828745|NCT01067781|19269399|P2|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4
7828746|NCT01067781|19269400|P1|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3
7828747|NCT01067781|19269397|P4|STARTED|180 to Day 720||89
7828748|NCT01067781|19269398|P3|STARTED|180 to Day 720||89
7828749|NCT01067781|19269399|P2|STARTED|180 to Day 720||168
7828750|NCT01067781|19269400|P1|STARTED|180 to Day 720||173
7828751|NCT01067781|19269397|P4|NOT COMPLETED|Up to Day 180||12
7828752|NCT01067781|19269398|P3|NOT COMPLETED|Up to Day 180||8
7828753|NCT01067781|19269399|P2|NOT COMPLETED|Up to Day 180||31
7828754|NCT01067781|19269400|P1|NOT COMPLETED|Up to Day 180||30
7828755|NCT01067781|19269397|P4|COMPLETED|Up to Day 180||89
7828756|NCT01067781|19269398|P3|COMPLETED|Up to Day 180||89
7828757|NCT01067781|19269399|P2|COMPLETED|Up to Day 180||168
7828758|NCT01067781|19269400|P1|COMPLETED|Up to Day 180||173
7828759|NCT01067781|19269397|P4|STARTED|Up to Day 180||101
7828760|NCT01067781|19269398|P3|STARTED|Up to Day 180||97
7828761|NCT01067781|19269399|P2|STARTED|Up to Day 180||199
7828762|NCT01067781|19269400|P1|STARTED|Up to Day 180||203
7828763|NCT01067768|19269422|P2|NOT COMPLETED|Overall Study||0
7828764|NCT01067768|19269423|P1|NOT COMPLETED|Overall Study||0
7828765|NCT01067768|19269422|P2|COMPLETED|Overall Study||605
7828766|NCT01067768|19269423|P1|COMPLETED|Overall Study||604
7828767|NCT01067768|19269422|P2|STARTED|Overall Study||605
7828768|NCT01067768|19269423|P1|STARTED|Overall Study||604
7828769|NCT01067716|19269434|P3|NOT COMPLETED|Overall Study||0
7828770|NCT01067716|19269435|P2|NOT COMPLETED|Overall Study||0
7828771|NCT01067716|19269436|P1|NOT COMPLETED|Overall Study||0
7828772|NCT01067716|19269434|P3|COMPLETED|Overall Study|15 eyes|9
7828773|NCT01067716|19269435|P2|COMPLETED|Overall Study|25 eyes|13
7828774|NCT01067716|19269436|P1|COMPLETED|Overall Study|110 eyes|57
7828775|NCT01067716|19269434|P3|STARTED|Overall Study|15 eyes|9
7828776|NCT01067716|19269435|P2|STARTED|Overall Study|25 eyes|13
7828777|NCT01067716|19269436|P1|STARTED|Overall Study|110 eyes|57
7828778|NCT01067521|19269455|P2|NOT COMPLETED|Open-Label Period||158
7828779|NCT01067521|19269456|P1|NOT COMPLETED|Open-Label Period||254
7828780|NCT01067521|19269455|P2|COMPLETED|Open-Label Period||261
7828781|NCT01067521|19269456|P1|COMPLETED|Open-Label Period||580
7828782|NCT01067521|19269455|P2|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|419
7828783|NCT01067521|19269456|P1|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|834
7828784|NCT01067521|19269455|P2|NOT COMPLETED|Double-Blind Placebo-Controlled Period||31
7828785|NCT01067521|19269456|P1|NOT COMPLETED|Double-Blind Placebo-Controlled Period||84
7828786|NCT01067521|19269455|P2|COMPLETED|Double-Blind Placebo-Controlled Period||430
7828787|NCT01067521|19269456|P1|COMPLETED|Double-Blind Placebo-Controlled Period||859
7828788|NCT01067521|19269455|P2|STARTED|Double-Blind Placebo-Controlled Period||461
7828789|NCT01067521|19269456|P1|STARTED|Double-Blind Placebo-Controlled Period||943
7828790|NCT01067508|19269482|P2|NOT COMPLETED|Overall Study||2
7828791|NCT01067508|19269483|P1|NOT COMPLETED|Overall Study||0
7828792|NCT01067508|19269482|P2|COMPLETED|Overall Study||7
7828793|NCT01067508|19269483|P1|COMPLETED|Overall Study||10
7828794|NCT01067508|19269482|P2|STARTED|Overall Study||9
7828795|NCT01067508|19269483|P1|STARTED|Overall Study||10
7828796|NCT01067469|19269491|P2|NOT COMPLETED|Overall Study||2
7828797|NCT01067469|19269492|P1|NOT COMPLETED|Overall Study||0
7828798|NCT01067469|19269491|P2|COMPLETED|Overall Study||33
7828799|NCT01067469|19269492|P1|COMPLETED|Overall Study||36
7828800|NCT01067469|19269491|P2|75 mg/m^2|Overall Study||21
7828801|NCT01067469|19269492|P1|75 mg/m^2|Overall Study||0
7828802|NCT01067469|19269491|P2|90 mg/m^2|Overall Study||12
7828803|NCT01067469|19269492|P1|90 mg/m^2|Overall Study||0
7828804|NCT01067469|19269491|P2|STARTED|Overall Study||35
7828805|NCT01067469|19269492|P1|STARTED|Overall Study||36
7828806|NCT01067456|19269510|P2|NOT COMPLETED|Overall Study||0
7828807|NCT01067456|19269511|P1|NOT COMPLETED|Overall Study||0
7828808|NCT01067456|19269510|P2|COMPLETED|Overall Study||29
7828809|NCT01067456|19269511|P1|COMPLETED|Overall Study||30
7828810|NCT01067456|19269510|P2|STARTED|Overall Study||29
7828811|NCT01067456|19269511|P1|STARTED|Overall Study||30
7828812|NCT01067352|19269524|P3|NOT COMPLETED|Overall Study||1
7828813|NCT01067352|19269525|P2|NOT COMPLETED|Overall Study||3
7828814|NCT01067352|19269526|P1|NOT COMPLETED|Overall Study||1
7828815|NCT01067352|19269524|P3|COMPLETED|Overall Study||9
7828816|NCT01067352|19269525|P2|COMPLETED|Overall Study||3
7828817|NCT01067352|19269526|P1|COMPLETED|Overall Study||8
7828818|NCT01067352|19269524|P3|STARTED|Overall Study||10
7828819|NCT01067352|19269525|P2|STARTED|Overall Study||6
7828820|NCT01067352|19269526|P1|STARTED|Overall Study||9
7828821|NCT01067339|19269542|P2|NOT COMPLETED|Overall Study||5
7828822|NCT01067339|19269543|P1|NOT COMPLETED|Overall Study||6
7828823|NCT01067339|19269542|P2|COMPLETED|Overall Study||29
7828824|NCT01067339|19269543|P1|COMPLETED|Overall Study||25
7828825|NCT01067339|19269542|P2|STARTED|Overall Study||34
7828826|NCT01067339|19269543|P1|STARTED|Overall Study||31
7828827|NCT01067326|19269553|P2|NOT COMPLETED|Overall Study||3
7828828|NCT01067326|19269554|P1|NOT COMPLETED|Overall Study||2
7828829|NCT01067326|19269553|P2|COMPLETED|Overall Study||5
7828830|NCT01067326|19269554|P1|COMPLETED|Overall Study||12
7828831|NCT01067326|19269553|P2|STARTED|Overall Study||8
7828832|NCT01067326|19269554|P1|STARTED|Overall Study||14
7828833|NCT01067144|19269568|P2|NOT COMPLETED|Follow-up||56
7828834|NCT01067144|19269569|P1|NOT COMPLETED|Follow-up||59
7828835|NCT01067144|19269568|P2|COMPLETED|Follow-up||152
7828836|NCT01067144|19269569|P1|COMPLETED|Follow-up||144
7828837|NCT01067144|19269568|P2|Intention-to-Treat Analysis Set|Follow-up||208
7828838|NCT01067144|19269569|P1|Intention-to-Treat Analysis Set|Follow-up||202
7828839|NCT01067144|19269568|P2|STARTED|Follow-up||208
7828840|NCT01067144|19269569|P1|STARTED|Follow-up||203
7828841|NCT01067144|19269568|P2|NOT COMPLETED|Treatment||7
7828842|NCT01067144|19269569|P1|NOT COMPLETED|Treatment||4
7828843|NCT01067144|19269568|P2|COMPLETED|Treatment||208
7828844|NCT01067144|19269569|P1|COMPLETED|Treatment||203
7828845|NCT01067144|19269568|P2|STARTED|Treatment||215
7828846|NCT01067144|19269569|P1|STARTED|Treatment||207
7828847|NCT01067105|19269585|P1|NOT COMPLETED|Overall Study||141
7828848|NCT01067105|19269585|P1|COMPLETED|Overall Study||683
7828849|NCT01067105|19269585|P1|STARTED|Overall Study||824
7828850|NCT01066936|19269602|P1|NOT COMPLETED|Overall Study||10
7828851|NCT01066936|19269602|P1|COMPLETED|Overall Study||10
7828852|NCT01066936|19269602|P1|STARTED|Overall Study||20
7828853|NCT01066923|19269638|P4|NOT COMPLETED|Overall Study||8
7828854|NCT01066923|19269639|P3|NOT COMPLETED|Overall Study||8
7828855|NCT01066923|19269640|P2|NOT COMPLETED|Overall Study||3
7828856|NCT01066923|19269641|P1|NOT COMPLETED|Overall Study||3
7828857|NCT01066923|19269638|P4|COMPLETED|Overall Study||23
7828858|NCT01066923|19269639|P3|COMPLETED|Overall Study||25
7828859|NCT01066923|19269640|P2|COMPLETED|Overall Study||29
7828860|NCT01066923|19269641|P1|COMPLETED|Overall Study||25
7828861|NCT01066923|19269638|P4|Retinal Imaging|Overall Study||0
7828862|NCT01066923|19269639|P3|Retinal Imaging|Overall Study||0
7828863|NCT01066923|19269640|P2|Retinal Imaging|Overall Study||0
7828864|NCT01066923|19269641|P1|Retinal Imaging|Overall Study||0
7828865|NCT01066923|19269638|P4|Activation of Coagulation|Overall Study||0
7828866|NCT01066923|19269639|P3|Activation of Coagulation|Overall Study||0
7828867|NCT01066923|19269640|P2|Activation of Coagulation|Overall Study||0
7828868|NCT01066923|19269641|P1|Activation of Coagulation|Overall Study||0
7828869|NCT01066923|19269638|P4|Vascular Function|Overall Study||13
7828870|NCT01066923|19269639|P3|Vascular Function|Overall Study||12
7828871|NCT01066923|19269640|P2|Vascular Function|Overall Study||14
7828872|NCT01066923|19269641|P1|Vascular Function|Overall Study||13
7828873|NCT01066923|19269638|P4|Platelet Closure Time|Overall Study||23
7828874|NCT01066923|19269639|P3|Platelet Closure Time|Overall Study||25
7828875|NCT01066923|19269640|P2|Platelet Closure Time|Overall Study||29
7828876|NCT01066923|19269641|P1|Platelet Closure Time|Overall Study||25
7828877|NCT01066923|19269638|P4|STARTED|Overall Study||31
7828878|NCT01066923|19269639|P3|STARTED|Overall Study||33
7828879|NCT01066923|19269640|P2|STARTED|Overall Study||32
7828880|NCT01066923|19269641|P1|STARTED|Overall Study||28
7828881|NCT01066897|19269665|P2|NOT COMPLETED|Overall Study||0
7828882|NCT01066897|19269666|P1|NOT COMPLETED|Overall Study||2
7828883|NCT01066897|19269665|P2|COMPLETED|Overall Study||9
7828884|NCT01066897|19269666|P1|COMPLETED|Overall Study||5
7828885|NCT01066897|19269665|P2|STARTED|Overall Study||9
7828886|NCT01066897|19269666|P1|STARTED|Overall Study||7
7828887|NCT01066871|19269680|P4|NOT COMPLETED|Overall Study||5
7828888|NCT01066871|19269681|P3|NOT COMPLETED|Overall Study||6
7828889|NCT01066871|19269682|P2|NOT COMPLETED|Overall Study||5
7828890|NCT01066871|19269683|P1|NOT COMPLETED|Overall Study||4
7828891|NCT01066871|19269680|P4|COMPLETED|Overall Study||13
7828892|NCT01066871|19269681|P3|COMPLETED|Overall Study||12
7828893|NCT01066871|19269682|P2|COMPLETED|Overall Study||13
7828894|NCT01066871|19269683|P1|COMPLETED|Overall Study||16
7828895|NCT01066871|19269680|P4|STARTED|Overall Study||18
7828896|NCT01066871|19269681|P3|STARTED|Overall Study||18
7828897|NCT01066871|19269682|P2|STARTED|Overall Study||18
7828898|NCT01066871|19269683|P1|STARTED|Overall Study||20
7828899|NCT01066819|19269747|P6|NOT COMPLETED|Overall Study||6
7828900|NCT01066819|19269748|P5|NOT COMPLETED|Overall Study||4
7828901|NCT01066819|19269749|P4|NOT COMPLETED|Overall Study||17
7828902|NCT01066819|19269750|P3|NOT COMPLETED|Overall Study||146
7828903|NCT01066819|19269751|P2|NOT COMPLETED|Overall Study||171
7828904|NCT01066819|19269752|P1|NOT COMPLETED|Overall Study||689
7828905|NCT01066819|19269747|P6|COMPLETED|Overall Study||7
7828906|NCT01066819|19269748|P5|COMPLETED|Overall Study||3
7828907|NCT01066819|19269749|P4|COMPLETED|Overall Study||8
7828908|NCT01066819|19269750|P3|COMPLETED|Overall Study||111
7828909|NCT01066819|19269751|P2|COMPLETED|Overall Study||177
7828910|NCT01066819|19269752|P1|COMPLETED|Overall Study||317
7828911|NCT01066819|19269747|P6|STARTED|Overall Study||13
7828912|NCT01066819|19269748|P5|STARTED|Overall Study||7
7828913|NCT01066819|19269749|P4|STARTED|Overall Study||25
7828914|NCT01066819|19269750|P3|STARTED|Overall Study||257
7828915|NCT01066819|19269751|P2|STARTED|Overall Study||348
7828916|NCT01066819|19269752|P1|STARTED|Overall Study||1006
7828917|NCT01066793|19269893|P6|NOT COMPLETED|Overall Study||1
7828918|NCT01066793|19269894|P5|NOT COMPLETED|Overall Study||0
7828919|NCT01066793|19269895|P4|NOT COMPLETED|Overall Study||49
7828920|NCT01066793|19269896|P3|NOT COMPLETED|Overall Study||115
7828921|NCT01066793|19269897|P2|NOT COMPLETED|Overall Study||77
7828922|NCT01066793|19269898|P1|NOT COMPLETED|Overall Study||374
7828923|NCT01066793|19269893|P6|COMPLETED|Overall Study||4
7828924|NCT01066793|19269894|P5|COMPLETED|Overall Study||11
7828925|NCT01066793|19269895|P4|COMPLETED|Overall Study||94
7828926|NCT01066793|19269896|P3|COMPLETED|Overall Study||369
7828927|NCT01066793|19269897|P2|COMPLETED|Overall Study||495
7828928|NCT01066793|19269898|P1|COMPLETED|Overall Study||754
7828929|NCT01066793|19269893|P6|STARTED|Overall Study||5
7828930|NCT01066793|19269894|P5|STARTED|Overall Study||11
7828931|NCT01066793|19269895|P4|STARTED|Overall Study||143
7828932|NCT01066793|19269896|P3|STARTED|Overall Study||484
7828933|NCT01066793|19269897|P2|STARTED|Overall Study||572
7828934|NCT01066793|19269898|P1|STARTED|Overall Study||1128
7828935|NCT01066780|19270038|P2|NOT COMPLETED|Overall Study||1
7828936|NCT01066780|19270039|P1|NOT COMPLETED|Overall Study||1
7828937|NCT01066780|19270038|P2|COMPLETED|Overall Study||23
7828938|NCT01066780|19270039|P1|COMPLETED|Overall Study||23
7828939|NCT01066780|19270038|P2|STARTED|Overall Study||24
7828940|NCT01066780|19270039|P1|STARTED|Overall Study||24
7828941|NCT01066637|19270045|P2|NOT COMPLETED|Overall Study||0
7828942|NCT01066637|19270046|P1|NOT COMPLETED|Overall Study||0
7828943|NCT01066637|19270045|P2|COMPLETED|Overall Study||10
7828944|NCT01066637|19270046|P1|COMPLETED|Overall Study||16
7828945|NCT01066637|19270045|P2|STARTED|Overall Study||10
7828946|NCT01066637|19270046|P1|STARTED|Overall Study||16
7828947|NCT01066624|19270057|P3|NOT COMPLETED|Overall Study||0
7828948|NCT01066624|19270058|P2|NOT COMPLETED|Overall Study||0
7828949|NCT01066624|19270059|P1|NOT COMPLETED|Overall Study||0
7828950|NCT01066624|19270057|P3|COMPLETED|Overall Study||39
7828951|NCT01066624|19270058|P2|COMPLETED|Overall Study||40
7828952|NCT01066624|19270059|P1|COMPLETED|Overall Study||38
7828953|NCT01066624|19270057|P3|STARTED|Overall Study||39
7828954|NCT01066624|19270058|P2|STARTED|Overall Study||40
7828955|NCT01066624|19270059|P1|STARTED|Overall Study||38
7828956|NCT01066585|19270069|P2|NOT COMPLETED|Overall Study||3
7828957|NCT01066585|19270070|P1|NOT COMPLETED|Overall Study||1
7828958|NCT01066585|19270069|P2|COMPLETED|Overall Study||196
7828959|NCT01066585|19270070|P1|COMPLETED|Overall Study||210
7828960|NCT01066585|19270069|P2|STARTED|Overall Study||199
7828961|NCT01066585|19270070|P1|STARTED|Overall Study||211
7828962|NCT01066546|19270082|P1|NOT COMPLETED|Overall Study||5
7828963|NCT01066546|19270082|P1|COMPLETED|Overall Study||0
7828964|NCT01066546|19270082|P1|STARTED|Overall Study||5
7828965|NCT01066520|19270096|P3|NOT COMPLETED|Overall Study||0
7828966|NCT01066520|19270097|P2|NOT COMPLETED|Overall Study||0
7828967|NCT01066520|19270098|P1|NOT COMPLETED|Overall Study||0
7828968|NCT01066520|19270096|P3|COMPLETED|Overall Study||137
7828969|NCT01066520|19270097|P2|COMPLETED|Overall Study||140
7828970|NCT01066520|19270098|P1|COMPLETED|Overall Study||143
7828971|NCT01066520|19270096|P3|STARTED|Overall Study||137
7828972|NCT01066520|19270097|P2|STARTED|Overall Study||140
7828973|NCT01066520|19270098|P1|STARTED|Overall Study||143
7828974|NCT01066364|19270114|P2|NOT COMPLETED|Overall Study||2
7828975|NCT01066364|19270115|P1|NOT COMPLETED|Overall Study||3
7828976|NCT01066364|19270114|P2|COMPLETED|Overall Study||23
7828977|NCT01066364|19270115|P1|COMPLETED|Overall Study||22
7828978|NCT01066364|19270114|P2|STARTED|Overall Study||25
7828979|NCT01066364|19270115|P1|STARTED|Overall Study||25
7828980|NCT01066156|19270127|P1|NOT COMPLETED|Overall Study||10
7828981|NCT01066156|19270127|P1|COMPLETED|Overall Study||24
7828982|NCT01066156|19270127|P1|STARTED|Overall Study||34
7828983|NCT01066143|19270131|P1|NOT COMPLETED|Overall Study||8
7828984|NCT01066143|19270131|P1|COMPLETED|Overall Study||0
7828985|NCT01066143|19270131|P1|STARTED|Overall Study||8
7828986|NCT01066104|19270137|P2|NOT COMPLETED|Overall Study||1
7828987|NCT01066104|19270138|P1|NOT COMPLETED|Overall Study||2
7828988|NCT01066104|19270137|P2|COMPLETED|Overall Study||12
7828989|NCT01066104|19270138|P1|COMPLETED|Overall Study||12
7828990|NCT01066104|19270137|P2|STARTED|Overall Study||13
7828991|NCT01066104|19270138|P1|STARTED|Overall Study||14
7828992|NCT01066052|19270148|P2|NOT COMPLETED|Overall Study||0
7828993|NCT01066052|19270149|P1|NOT COMPLETED|Overall Study||3
7828994|NCT01066052|19270148|P2|COMPLETED|Overall Study||51
7828995|NCT01066052|19270149|P1|COMPLETED|Overall Study||61
7828996|NCT01066052|19270148|P2|Treated|Overall Study||0
7828997|NCT01066052|19270149|P1|Treated|Overall Study||61
7828998|NCT01066052|19270148|P2|STARTED|Overall Study||51
7828999|NCT01066052|19270149|P1|STARTED|Overall Study||64
7829000|NCT01066039|19270160|P1|NOT COMPLETED|Overall Study||44
7829001|NCT01066039|19270160|P1|COMPLETED|Overall Study||158
7829002|NCT01066039|19270160|P1|Treated|Overall Study||200
7829003|NCT01066039|19270160|P1|STARTED|Overall Study||202
7829004|NCT01066026|19270173|P1|NOT COMPLETED|Overall Study||2
7829005|NCT01066026|19270173|P1|COMPLETED|Overall Study||23
7829006|NCT01066026|19270173|P1|STARTED|Overall Study|Each patient was injected with hyaluronic acid in each nasolabial fold (total: 2 injections)|25
7829007|NCT01066000|19270185|P1|NOT COMPLETED|Overall Study||9
7829008|NCT01066000|19270185|P1|COMPLETED|Overall Study||24
7829009|NCT01066000|19270185|P1|STARTED|Overall Study||33
7829010|NCT01065844|19270196|P1|NOT COMPLETED|Overall Study||5
7829011|NCT01065844|19270196|P1|COMPLETED|Overall Study||10
7829012|NCT01065844|19270196|P1|STARTED|Overall Study||15
7829013|NCT01065818|19270200|P1|NOT COMPLETED|Overall Study||2
7829014|NCT01065818|19270200|P1|COMPLETED|Overall Study||4
7829015|NCT01065818|19270200|P1|STARTED|Overall Study||6
7829016|NCT01065779|19270204|P1|NOT COMPLETED|Overall Study||82
7829017|NCT01065779|19270204|P1|COMPLETED|Overall Study||798
7829018|NCT01065779|19270204|P1|STARTED|Overall Study||880
7829019|NCT01065766|19270215|P1|NOT COMPLETED|Overall Study||32
7829020|NCT01065766|19270215|P1|COMPLETED|Overall Study||4033
7829021|NCT01065766|19270215|P1|STARTED|Overall Study||4065
7829022|NCT01065714|19270227|P1|NOT COMPLETED|Overall Study||0
7829023|NCT01065714|19270227|P1|COMPLETED|Overall Study||20
7829024|NCT01065714|19270227|P1|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20
7829025|NCT01065597|19270234|P1|NOT COMPLETED|Overall Study||1
7829026|NCT01065597|19270234|P1|COMPLETED|Overall Study||12
7829027|NCT01065597|19270234|P1|STARTED|Overall Study||13
7829028|NCT01065571|19270243|P2|NOT COMPLETED|Overall Study||0
7829029|NCT01065571|19270244|P1|NOT COMPLETED|Overall Study||3
7829030|NCT01065571|19270243|P2|COMPLETED|Overall Study||5
7829031|NCT01065571|19270244|P1|COMPLETED|Overall Study||7
7829032|NCT01065571|19270243|P2|STARTED|Overall Study||5
7829033|NCT01065571|19270244|P1|STARTED|Overall Study||10
7829034|NCT01065558|19270254|P1|NOT COMPLETED|Overall Study||0
7829035|NCT01065558|19270254|P1|COMPLETED|Overall Study||5
7829036|NCT01065558|19270254|P1|STARTED|Overall Study||5
7829037|NCT01065506|19270261|P2|NOT COMPLETED|Overall Study||38
7829038|NCT01065506|19270262|P1|NOT COMPLETED|Overall Study||32
7829039|NCT01065506|19270261|P2|COMPLETED|Overall Study||34
7829040|NCT01065506|19270262|P1|COMPLETED|Overall Study||32
7829041|NCT01065506|19270261|P2|4-Month Follow-Up|Overall Study||34
7829042|NCT01065506|19270262|P1|4-Month Follow-Up|Overall Study||35
7829043|NCT01065506|19270261|P2|End of Treatment|Overall Study||37
7829044|NCT01065506|19270262|P1|End of Treatment|Overall Study||44
7829045|NCT01065506|19270261|P2|STARTED|Overall Study||72
7829046|NCT01065506|19270262|P1|STARTED|Overall Study||64
7829047|NCT01065480|19270270|P2|NOT COMPLETED|Overall Study||0
7829048|NCT01065480|19270271|P1|NOT COMPLETED|Overall Study||0
7829049|NCT01065480|19270270|P2|COMPLETED|Overall Study||43
7829050|NCT01065480|19270271|P1|COMPLETED|Overall Study||48
7829051|NCT01065480|19270270|P2|STARTED|Overall Study||43
7829052|NCT01065480|19270271|P1|STARTED|Overall Study||48
7829053|NCT01065454|19270281|P4|NOT COMPLETED|Follow up||44
7829054|NCT01065454|19270282|P3|NOT COMPLETED|Follow up||17
7829055|NCT01065454|19270283|P2|NOT COMPLETED|Follow up||24
7829056|NCT01065454|19270284|P1|NOT COMPLETED|Follow up||39
7829057|NCT01065454|19270281|P4|COMPLETED|Follow up||13
7829058|NCT01065454|19270282|P3|COMPLETED|Follow up||6
7829059|NCT01065454|19270283|P2|COMPLETED|Follow up||4
7829060|NCT01065454|19270284|P1|COMPLETED|Follow up||15
7829061|NCT01065454|19270281|P4|Entering Follow-up|Follow up||51
7829062|NCT01065454|19270282|P3|Entering Follow-up|Follow up||23
7829063|NCT01065454|19270283|P2|Entering Follow-up|Follow up||27
7829064|NCT01065454|19270284|P1|Entering Follow-up|Follow up||49
7829065|NCT01065454|19270281|P4|STARTED|Follow up||57
7829066|NCT01065454|19270282|P3|STARTED|Follow up||23
7829067|NCT01065454|19270283|P2|STARTED|Follow up||28
7829068|NCT01065454|19270284|P1|STARTED|Follow up||54
7829069|NCT01065454|19270281|P4|NOT COMPLETED|Treatment||12
7829070|NCT01065454|19270282|P3|NOT COMPLETED|Treatment||9
7829071|NCT01065454|19270283|P2|NOT COMPLETED|Treatment||5
7829072|NCT01065454|19270284|P1|NOT COMPLETED|Treatment||13
7829073|NCT01065454|19270281|P4|COMPLETED|Treatment||57
7829074|NCT01065454|19270282|P3|COMPLETED|Treatment||23
7829075|NCT01065454|19270283|P2|COMPLETED|Treatment||28
7829076|NCT01065454|19270284|P1|COMPLETED|Treatment||54
7829077|NCT01065454|19270281|P4|STARTED|Treatment||69
7829078|NCT01065454|19270282|P3|STARTED|Treatment||32
7829079|NCT01065454|19270283|P2|STARTED|Treatment||33
7829080|NCT01065454|19270284|P1|STARTED|Treatment||67
7829081|NCT01065428|19270396|P2|NOT COMPLETED|Overall Study||0
7829082|NCT01065428|19270397|P1|NOT COMPLETED|Overall Study||0
7829083|NCT01065428|19270396|P2|COMPLETED|Overall Study||35
7829084|NCT01065428|19270397|P1|COMPLETED|Overall Study||17
7829085|NCT01065428|19270396|P2|STARTED|Overall Study||35
7829086|NCT01065428|19270397|P1|STARTED|Overall Study||17
7829087|NCT01065350|19270407|P2|NOT COMPLETED|Overall Study||1
7829088|NCT01065350|19270408|P1|NOT COMPLETED|Overall Study||0
7829089|NCT01065350|19270407|P2|COMPLETED|Overall Study||41
7829090|NCT01065350|19270408|P1|COMPLETED|Overall Study||43
7829091|NCT01065350|19270407|P2|STARTED|Overall Study||42
7829092|NCT01065350|19270408|P1|STARTED|Overall Study||43
7829093|NCT01065051|19270442|P2|NOT COMPLETED|Overall Study||0
7829094|NCT01065051|19270443|P1|NOT COMPLETED|Overall Study||0
7829095|NCT01065051|19270442|P2|COMPLETED|Overall Study||0
7829096|NCT01065051|19270443|P1|COMPLETED|Overall Study||1
7829097|NCT01065051|19270442|P2|STARTED|Overall Study||0
7829098|NCT01065051|19270443|P1|STARTED|Overall Study||1
7829099|NCT01064947|19270469|P1|NOT COMPLETED|Overall Study||41
7829100|NCT01064947|19270469|P1|COMPLETED|Overall Study||29
7829101|NCT01064947|19270469|P1|STARTED|Overall Study||70
7829102|NCT01064882|19270480|P3|NOT COMPLETED|Overall Study||2
7829103|NCT01064882|19270481|P2|NOT COMPLETED|Overall Study||2
7829104|NCT01064882|19270482|P1|NOT COMPLETED|Overall Study||2
7829105|NCT01064882|19270480|P3|COMPLETED|Overall Study||32
7829106|NCT01064882|19270481|P2|COMPLETED|Overall Study||32
7829107|NCT01064882|19270482|P1|COMPLETED|Overall Study||34
7829108|NCT01064882|19270480|P3|STARTED|Overall Study||34
7829109|NCT01064882|19270481|P2|STARTED|Overall Study||34
7829110|NCT01064882|19270482|P1|STARTED|Overall Study||36
7829111|NCT01064856|19270510|P4|NOT COMPLETED|Open-label (OL) Period||20
7829112|NCT01064856|19270511|P3|NOT COMPLETED|Open-label (OL) Period||26
7829113|NCT01064856|19270512|P2|NOT COMPLETED|Open-label (OL) Period||0
7829114|NCT01064856|19270513|P1|NOT COMPLETED|Open-label (OL) Period||0
7829115|NCT01064856|19270510|P4|COMPLETED|Open-label (OL) Period||61
7829116|NCT01064856|19270511|P3|COMPLETED|Open-label (OL) Period||56
7829117|NCT01064856|19270512|P2|COMPLETED|Open-label (OL) Period||0
7829118|NCT01064856|19270513|P1|COMPLETED|Open-label (OL) Period||0
7829119|NCT01064856|19270510|P4|STARTED|Open-label (OL) Period||81
7829120|NCT01064856|19270511|P3|STARTED|Open-label (OL) Period||82
7829121|NCT01064856|19270512|P2|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
7829122|NCT01064856|19270513|P1|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
7829123|NCT01064856|19270510|P4|NOT COMPLETED|Double-blind (DB) Period||0
7829124|NCT01064856|19270511|P3|NOT COMPLETED|Double-blind (DB) Period||0
7829125|NCT01064856|19270512|P2|NOT COMPLETED|Double-blind (DB) Period||0
7829126|NCT01064856|19270513|P1|NOT COMPLETED|Double-blind (DB) Period||2
7829127|NCT01064856|19270510|P4|COMPLETED|Double-blind (DB) Period||0
7829128|NCT01064856|19270511|P3|COMPLETED|Double-blind (DB) Period||0
7829129|NCT01064856|19270512|P2|COMPLETED|Double-blind (DB) Period||81
7829130|NCT01064856|19270513|P1|COMPLETED|Double-blind (DB) Period||82
7829131|NCT01064856|19270510|P4|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
7829132|NCT01064856|19270511|P3|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
7829133|NCT01064856|19270512|P2|STARTED|Double-blind (DB) Period||81
7829134|NCT01064856|19270513|P1|STARTED|Double-blind (DB) Period||84
7829135|NCT01064830|19270546|P2|NOT COMPLETED|Overall Study||4
7829136|NCT01064830|19270547|P1|NOT COMPLETED|Overall Study||2
7829137|NCT01064830|19270546|P2|COMPLETED|Overall Study||7
7829138|NCT01064830|19270547|P1|COMPLETED|Overall Study||8
7829139|NCT01064830|19270546|P2|STARTED|Overall Study||11
7829140|NCT01064830|19270547|P1|STARTED|Overall Study||10
7829141|NCT01064817|19270557|P2|NOT COMPLETED|Study Completion||0
7829142|NCT01064817|19270558|P1|NOT COMPLETED|Study Completion||2
7829143|NCT01064817|19270557|P2|COMPLETED|Study Completion||62
7829144|NCT01064817|19270558|P1|COMPLETED|Study Completion||60
7829145|NCT01064817|19270557|P2|STARTED|Study Completion||62
7829146|NCT01064817|19270558|P1|STARTED|Study Completion||62
7829147|NCT01064817|19270557|P2|NOT COMPLETED|All Study Treatment Days 1-9||0
7829148|NCT01064817|19270558|P1|NOT COMPLETED|All Study Treatment Days 1-9||0
7829149|NCT01064817|19270557|P2|COMPLETED|All Study Treatment Days 1-9||62
7829150|NCT01064817|19270558|P1|COMPLETED|All Study Treatment Days 1-9||62
7829151|NCT01064817|19270557|P2|STARTED|All Study Treatment Days 1-9||62
7829152|NCT01064817|19270558|P1|STARTED|All Study Treatment Days 1-9||62
7829153|NCT01064739|19270570|P1|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1
7829154|NCT01064739|19270570|P1|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13
7829155|NCT01064739|19270570|P1|STARTED|Fixed Sodium Diet + Fava Beans||14
7829156|NCT01064739|19270570|P1|NOT COMPLETED|Fixed Sodium Study Diet||0
7829157|NCT01064739|19270570|P1|COMPLETED|Fixed Sodium Study Diet||14
7829158|NCT01064739|19270570|P1|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14
7829159|NCT01064713|19270628|P2|NOT COMPLETED|Overall Study||0
7829160|NCT01064713|19270629|P1|NOT COMPLETED|Overall Study||0
7829161|NCT01064713|19270628|P2|COMPLETED|Overall Study||4
7829162|NCT01064713|19270629|P1|COMPLETED|Overall Study||13
7829163|NCT01064713|19270628|P2|STARTED|Overall Study||4
7829164|NCT01064713|19270629|P1|STARTED|Overall Study||13
7829165|NCT01064687|19270641|P4|NOT COMPLETED|Overall Study||17
7829166|NCT01064687|19270642|P3|NOT COMPLETED|Overall Study||41
7829167|NCT01064687|19270643|P2|NOT COMPLETED|Overall Study||26
7829168|NCT01064687|19270644|P1|NOT COMPLETED|Overall Study||34
7829169|NCT01064687|19270641|P4|COMPLETED|Overall Study||124
7829170|NCT01064687|19270642|P3|COMPLETED|Overall Study||237
7829171|NCT01064687|19270643|P2|COMPLETED|Overall Study||254
7829172|NCT01064687|19270644|P1|COMPLETED|Overall Study||245
7829173|NCT01064687|19270641|P4|Completed 26 Weeks|Overall Study||124
7829174|NCT01064687|19270642|P3|Completed 26 Weeks|Overall Study||252
7829175|NCT01064687|19270643|P2|Completed 26 Weeks|Overall Study||263
7829176|NCT01064687|19270644|P1|Completed 26 Weeks|Overall Study||260
7829177|NCT01064687|19270641|P4|Received at Least 1 Dose of Study Drug|Overall Study||141
7829178|NCT01064687|19270642|P3|Received at Least 1 Dose of Study Drug|Overall Study||276
7829179|NCT01064687|19270643|P2|Received at Least 1 Dose of Study Drug|Overall Study||280
7829180|NCT01064687|19270644|P1|Received at Least 1 Dose of Study Drug|Overall Study||279
7829181|NCT01064687|19270641|P4|STARTED|Overall Study||141
7829182|NCT01064687|19270642|P3|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278
7829183|NCT01064687|19270643|P2|STARTED|Overall Study||280
7829184|NCT01064687|19270644|P1|STARTED|Overall Study||279
7829185|NCT01064648|19270824|P4|NOT COMPLETED|Phase II||48
7829186|NCT01064648|19270825|P3|NOT COMPLETED|Phase II||49
7829187|NCT01064648|19270826|P2|NOT COMPLETED|Phase II||0
7829188|NCT01064648|19270827|P1|NOT COMPLETED|Phase II||0
7829189|NCT01064648|19270824|P4|COMPLETED|Phase II||0
7829190|NCT01064648|19270825|P3|COMPLETED|Phase II||0
7829191|NCT01064648|19270826|P2|COMPLETED|Phase II||0
7829192|NCT01064648|19270827|P1|COMPLETED|Phase II||0
7829193|NCT01064648|19270824|P4|STARTED|Phase II||48
7829194|NCT01064648|19270825|P3|STARTED|Phase II||49
7829195|NCT01064648|19270826|P2|STARTED|Phase II||0
7829196|NCT01064648|19270827|P1|STARTED|Phase II||0
7829197|NCT01064648|19270824|P4|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
7829198|NCT01064648|19270825|P3|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
7829199|NCT01064648|19270826|P2|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||13
7829200|NCT01064648|19270827|P1|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
7829201|NCT01064648|19270824|P4|COMPLETED|Phase I Cohort 2: Dose Level 2||0
7829202|NCT01064648|19270825|P3|COMPLETED|Phase I Cohort 2: Dose Level 2||0
7829203|NCT01064648|19270826|P2|COMPLETED|Phase I Cohort 2: Dose Level 2||0
7829204|NCT01064648|19270827|P1|COMPLETED|Phase I Cohort 2: Dose Level 2||0
7829205|NCT01064648|19270824|P4|STARTED|Phase I Cohort 2: Dose Level 2||0
7829206|NCT01064648|19270825|P3|STARTED|Phase I Cohort 2: Dose Level 2||0
7829207|NCT01064648|19270826|P2|STARTED|Phase I Cohort 2: Dose Level 2||13
7829208|NCT01064648|19270827|P1|STARTED|Phase I Cohort 2: Dose Level 2||0
7829209|NCT01064648|19270824|P4|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
7829210|NCT01064648|19270825|P3|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
7829211|NCT01064648|19270826|P2|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
7829212|NCT01064648|19270827|P1|NOT COMPLETED|Phase I Cohort1: Dose Level 1||7
7829213|NCT01064648|19270824|P4|COMPLETED|Phase I Cohort1: Dose Level 1||0
7829214|NCT01064648|19270825|P3|COMPLETED|Phase I Cohort1: Dose Level 1||0
7829215|NCT01064648|19270826|P2|COMPLETED|Phase I Cohort1: Dose Level 1||0
7829216|NCT01064648|19270827|P1|COMPLETED|Phase I Cohort1: Dose Level 1||0
7829217|NCT01064648|19270824|P4|STARTED|Phase I Cohort1: Dose Level 1||0
7829218|NCT01064648|19270825|P3|STARTED|Phase I Cohort1: Dose Level 1||0
7829219|NCT01064648|19270826|P2|STARTED|Phase I Cohort1: Dose Level 1||0
7829220|NCT01064648|19270827|P1|STARTED|Phase I Cohort1: Dose Level 1||7
7829221|NCT01064622|19270853|P2|NOT COMPLETED|Crossover of Arm I||0
7829222|NCT01064622|19270854|P1|NOT COMPLETED|Crossover of Arm I||0
7829223|NCT01064622|19270853|P2|COMPLETED|Crossover of Arm I||0
7829224|NCT01064622|19270854|P1|COMPLETED|Crossover of Arm I||22
7829225|NCT01064622|19270853|P2|STARTED|Crossover of Arm I||0
7829226|NCT01064622|19270854|P1|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22
7829227|NCT01064622|19270853|P2|NOT COMPLETED|Randomized Phase II||3
7829228|NCT01064622|19270854|P1|NOT COMPLETED|Randomized Phase II||2
7829229|NCT01064622|19270853|P2|COMPLETED|Randomized Phase II||53
7829230|NCT01064622|19270854|P1|COMPLETED|Randomized Phase II||53
7829231|NCT01064622|19270853|P2|STARTED|Randomized Phase II||56
7829232|NCT01064622|19270854|P1|STARTED|Randomized Phase II||55
7829233|NCT01064622|19270853|P2|NOT COMPLETED|Lead-in Phase I||0
7829234|NCT01064622|19270854|P1|NOT COMPLETED|Lead-in Phase I||0
7829235|NCT01064622|19270853|P2|COMPLETED|Lead-in Phase I||7
7829236|NCT01064622|19270854|P1|COMPLETED|Lead-in Phase I||0
7829237|NCT01064622|19270853|P2|STARTED|Lead-in Phase I||7
7829238|NCT01064622|19270854|P1|STARTED|Lead-in Phase I||0
7829239|NCT01064531|19270877|P2|NOT COMPLETED|Overall Study||7
7829240|NCT01064531|19270878|P1|NOT COMPLETED|Overall Study||3
7829241|NCT01064531|19270877|P2|COMPLETED|Overall Study||13
7829242|NCT01064531|19270878|P1|COMPLETED|Overall Study||18
7829243|NCT01064531|19270877|P2|STARTED|Overall Study||20
7829244|NCT01064531|19270878|P1|STARTED|Overall Study||21
7829245|NCT01064414|19270925|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
7829246|NCT01064414|19270926|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
7829247|NCT01064414|19270927|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
7829248|NCT01064414|19270925|P3|COMPLETED|Extension Period: Week 26 to Week 52||76
7829249|NCT01064414|19270926|P2|COMPLETED|Extension Period: Week 26 to Week 52||67
7829250|NCT01064414|19270927|P1|COMPLETED|Extension Period: Week 26 to Week 52||64
7829251|NCT01064414|19270925|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81
7829252|NCT01064414|19270926|P2|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72
7829253|NCT01064414|19270927|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76
7829254|NCT01064414|19270925|P3|NOT COMPLETED|Core Period: Baseline to Week 26||7
7829255|NCT01064414|19270926|P2|NOT COMPLETED|Core Period: Baseline to Week 26||15
7829256|NCT01064414|19270927|P1|NOT COMPLETED|Core Period: Baseline to Week 26||13
7829257|NCT01064414|19270925|P3|COMPLETED|Core Period: Baseline to Week 26||82
7829258|NCT01064414|19270926|P2|COMPLETED|Core Period: Baseline to Week 26||75
7829259|NCT01064414|19270927|P1|COMPLETED|Core Period: Baseline to Week 26||77
7829260|NCT01064414|19270925|P3|STARTED|Core Period: Baseline to Week 26||89
7829261|NCT01064414|19270926|P2|STARTED|Core Period: Baseline to Week 26||90
7829262|NCT01064414|19270927|P1|STARTED|Core Period: Baseline to Week 26||90
7829263|NCT01064401|19270946|P2|NOT COMPLETED|Overall Study||195
7829264|NCT01064401|19270947|P1|NOT COMPLETED|Overall Study||228
7829265|NCT01064401|19270946|P2|COMPLETED|Overall Study||724
7829266|NCT01064401|19270947|P1|COMPLETED|Overall Study||694
7829267|NCT01064401|19270946|P2|STARTED|Overall Study||919
7829268|NCT01064401|19270947|P1|STARTED|Overall Study||922
7829269|NCT01064362|19270963|P2|NOT COMPLETED|Overall Study||0
7829270|NCT01064362|19270964|P1|NOT COMPLETED|Overall Study||0
7829271|NCT01064362|19270963|P2|COMPLETED|Overall Study||11883
7829272|NCT01064362|19270964|P1|COMPLETED|Overall Study||1559
7829273|NCT01064362|19270963|P2|STARTED|Overall Study||11883
7829274|NCT01064362|19270964|P1|STARTED|Overall Study||1559
7829275|NCT01064323|19270972|P1|NOT COMPLETED|Overall Study||0
7829276|NCT01064323|19270972|P1|COMPLETED|Overall Study||10
7829277|NCT01064323|19270972|P1|STARTED|Overall Study||10
7829278|NCT01064310|19270996|P3|NOT COMPLETED|Open Label Pazopinib||84
7829279|NCT01064310|19270997|P2|NOT COMPLETED|Open Label Pazopinib||0
7829280|NCT01064310|19270998|P1|NOT COMPLETED|Open Label Pazopinib||0
7829281|NCT01064310|19270996|P3|COMPLETED|Open Label Pazopinib||0
7829282|NCT01064310|19270997|P2|COMPLETED|Open Label Pazopinib||0
7829283|NCT01064310|19270998|P1|COMPLETED|Open Label Pazopinib||0
7829284|NCT01064310|19270996|P3|STARTED|Open Label Pazopinib||84
7829285|NCT01064310|19270997|P2|STARTED|Open Label Pazopinib||0
7829286|NCT01064310|19270998|P1|STARTED|Open Label Pazopinib||0
7829287|NCT01064310|19270996|P3|NOT COMPLETED|Period 2||0
7829288|NCT01064310|19270997|P2|NOT COMPLETED|Period 2||6
7829289|NCT01064310|19270998|P1|NOT COMPLETED|Period 2||4
7829290|NCT01064310|19270996|P3|COMPLETED|Period 2||0
7829291|NCT01064310|19270997|P2|COMPLETED|Period 2||62
7829292|NCT01064310|19270998|P1|COMPLETED|Period 2||64
7829293|NCT01064310|19270996|P3|STARTED|Period 2||0
7829294|NCT01064310|19270997|P2|STARTED|Period 2||68
7829295|NCT01064310|19270998|P1|STARTED|Period 2||68
7829296|NCT01064310|19270996|P3|NOT COMPLETED|Period 1||0
7829297|NCT01064310|19270997|P2|NOT COMPLETED|Period 1||18
7829298|NCT01064310|19270998|P1|NOT COMPLETED|Period 1||14
7829299|NCT01064310|19270996|P3|COMPLETED|Period 1||0
7829300|NCT01064310|19270997|P2|COMPLETED|Period 1||68
7829301|NCT01064310|19270998|P1|COMPLETED|Period 1||68
7829302|NCT01064310|19270996|P3|STARTED|Period 1||0
7829303|NCT01064310|19270997|P2|STARTED|Period 1||86
7829304|NCT01064310|19270998|P1|STARTED|Period 1||82
7829305|NCT01064297|19271028|P3|NOT COMPLETED|Overall Study||133
7829306|NCT01064297|19271029|P2|NOT COMPLETED|Overall Study||48
7829307|NCT01064297|19271030|P1|NOT COMPLETED|Overall Study||791
7829308|NCT01064297|19271028|P3|COMPLETED|Overall Study||497
7829309|NCT01064297|19271029|P2|COMPLETED|Overall Study||171
7829310|NCT01064297|19271030|P1|COMPLETED|Overall Study||1776
7829311|NCT01064297|19271028|P3|STARTED|Overall Study||630
7829312|NCT01064297|19271029|P2|STARTED|Overall Study||219
7829313|NCT01064297|19271030|P1|STARTED|Overall Study||2567
7829314|NCT01064284|19271076|P2|NOT COMPLETED|Overall Study||17
7829315|NCT01064284|19271077|P1|NOT COMPLETED|Overall Study||18
7829316|NCT01064284|19271076|P2|COMPLETED|Overall Study||109
7829317|NCT01064284|19271077|P1|COMPLETED|Overall Study||107
7829318|NCT01064284|19271076|P2|STARTED|Overall Study|Taking into account the analyzed patients only|126
7829319|NCT01064284|19271077|P1|STARTED|Overall Study|Taking into account the analyzed patients only|125
7829320|NCT01064167|19271099|P2|NOT COMPLETED|Overall Study||15
7829321|NCT01064167|19271100|P1|NOT COMPLETED|Overall Study||14
7829322|NCT01064167|19271099|P2|COMPLETED|Overall Study||115
7829323|NCT01064167|19271100|P1|COMPLETED|Overall Study||116
7829324|NCT01064167|19271099|P2|STARTED|Overall Study||130
7829325|NCT01064167|19271100|P1|STARTED|Overall Study||130
7829326|NCT01064076|19271108|P1|NOT COMPLETED|Overall Study||18
7829327|NCT01064076|19271108|P1|COMPLETED|Overall Study|303 subjects completed a minimum of 180 days of follow up|303
7829328|NCT01064076|19271108|P1|STARTED|Overall Study|321 subjects underwent an implant procedure for the S-ICD System|321
7829329|NCT01063972|19271115|P2|NOT COMPLETED|Overall Study||12
7829330|NCT01063972|19271116|P1|NOT COMPLETED|Overall Study||14
7829331|NCT01063972|19271115|P2|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|284
7829332|NCT01063972|19271116|P1|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|296
7829333|NCT01063972|19271115|P2|STARTED|Overall Study||296
7829334|NCT01063972|19271116|P1|STARTED|Overall Study||310
7829335|NCT01063907|19271132|P2|NOT COMPLETED|Overall Study||0
7829336|NCT01063907|19271133|P1|NOT COMPLETED|Overall Study||0
7829337|NCT01063907|19271132|P2|COMPLETED|Overall Study||80
7829338|NCT01063907|19271133|P1|COMPLETED|Overall Study||15
7829339|NCT01063907|19271132|P2|STARTED|Overall Study||80
7829340|NCT01063907|19271133|P1|STARTED|Overall Study||15
7829341|NCT01063881|19271166|P3|NOT COMPLETED|Overall Study||1
7829342|NCT01063881|19271167|P2|NOT COMPLETED|Overall Study||11
7829343|NCT01063881|19271168|P1|NOT COMPLETED|Overall Study||55
7829344|NCT01063881|19271166|P3|COMPLETED|Overall Study||12
7829345|NCT01063881|19271167|P2|COMPLETED|Overall Study||114
7829346|NCT01063881|19271168|P1|COMPLETED|Overall Study||92
7829347|NCT01063881|19271166|P3|STARTED|Overall Study||13
7829348|NCT01063881|19271167|P2|STARTED|Overall Study||125
7829349|NCT01063881|19271168|P1|STARTED|Overall Study||147
7829350|NCT01063868|19271192|P2|NOT COMPLETED|Overall Study||12
7829351|NCT01063868|19271193|P1|NOT COMPLETED|Overall Study||35
7829352|NCT01063868|19271192|P2|COMPLETED|Overall Study||0
7829353|NCT01063868|19271193|P1|COMPLETED|Overall Study||0
7829354|NCT01063868|19271192|P2|STARTED|Overall Study||12
7829355|NCT01063868|19271193|P1|STARTED|Overall Study||35
7829356|NCT01063855|19271201|P2|NOT COMPLETED|Overall Study||29
7829357|NCT01063855|19271202|P1|NOT COMPLETED|Overall Study||37
7829358|NCT01063855|19271201|P2|COMPLETED|Overall Study||221
7829359|NCT01063855|19271202|P1|COMPLETED|Overall Study||208
7829360|NCT01063855|19271201|P2|STARTED|Overall Study||250
7829361|NCT01063855|19271202|P1|STARTED|Overall Study||245
7829362|NCT01063829|19271228|P4|NOT COMPLETED|Overall Study||21
7829363|NCT01063829|19271229|P3|NOT COMPLETED|Overall Study||10
7829364|NCT01063829|19271230|P2|NOT COMPLETED|Overall Study||10
7829365|NCT01063829|19271231|P1|NOT COMPLETED|Overall Study||16
7829366|NCT01063829|19271228|P4|COMPLETED|Overall Study|Non-completers considered as failure; FAS|12
7829367|NCT01063829|19271229|P3|COMPLETED|Overall Study|Non-completers considered as failure; FAS|24
7829368|NCT01063829|19271230|P2|COMPLETED|Overall Study|Non-completers considered as failure; FAS|21
7829369|NCT01063829|19271231|P1|COMPLETED|Overall Study|Non-completers considered as failure; FAS|17
7829370|NCT01063829|19271228|P4|STARTED|Overall Study||33
7829371|NCT01063829|19271229|P3|STARTED|Overall Study||34
7829372|NCT01063829|19271230|P2|STARTED|Overall Study||31
7829373|NCT01063829|19271231|P1|STARTED|Overall Study||33
7829374|NCT01063764|19271249|P1|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20
7829375|NCT01063764|19271249|P1|COMPLETED|2nd Period (Week 22 to the End of Study)||35
7829376|NCT01063764|19271249|P1|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55
7829377|NCT01063764|19271249|P1|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11
7829378|NCT01063764|19271249|P1|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62
7829379|NCT01063764|19271249|P1|STARTED|1st Period (From Week 8 to Week 22)||73
7829380|NCT01063712|19271263|P1|NOT COMPLETED|Overall Study||0
7829381|NCT01063712|19271263|P1|COMPLETED|Overall Study||29
7829382|NCT01063712|19271263|P1|STARTED|Overall Study||29
7829383|NCT01063595|19271268|P2|NOT COMPLETED|Second Intervention||0
7829384|NCT01063595|19271269|P1|NOT COMPLETED|Second Intervention||0
7829385|NCT01063595|19271268|P2|COMPLETED|Second Intervention||24
7829386|NCT01063595|19271269|P1|COMPLETED|Second Intervention||29
7829387|NCT01063595|19271268|P2|STARTED|Second Intervention||24
7829388|NCT01063595|19271269|P1|STARTED|Second Intervention||29
7829389|NCT01063595|19271268|P2|NOT COMPLETED|First Intervention||5
7829390|NCT01063595|19271269|P1|NOT COMPLETED|First Intervention||2
7829391|NCT01063595|19271268|P2|COMPLETED|First Intervention||24
7829392|NCT01063595|19271269|P1|COMPLETED|First Intervention||29
7829393|NCT01063595|19271268|P2|STARTED|First Intervention||29
7829394|NCT01063595|19271269|P1|STARTED|First Intervention||31
7829395|NCT01063595|19271268|P2|NOT COMPLETED|Enrolled in Study and Randomized||2
7829396|NCT01063595|19271269|P1|NOT COMPLETED|Enrolled in Study and Randomized||1
7829397|NCT01063595|19271268|P2|COMPLETED|Enrolled in Study and Randomized||29
7829398|NCT01063595|19271269|P1|COMPLETED|Enrolled in Study and Randomized||31
7829399|NCT01063595|19271268|P2|Received Treatment|Enrolled in Study and Randomized||29
7829400|NCT01063595|19271269|P1|Received Treatment|Enrolled in Study and Randomized||31
7829401|NCT01063595|19271268|P2|STARTED|Enrolled in Study and Randomized||31
7829402|NCT01063595|19271269|P1|STARTED|Enrolled in Study and Randomized||32
7829403|NCT01063517|19271281|P2|NOT COMPLETED|Overall Study||60
7829404|NCT01063517|19271282|P1|NOT COMPLETED|Overall Study||58
7829405|NCT01063517|19271281|P2|COMPLETED|Overall Study||2
7829406|NCT01063517|19271282|P1|COMPLETED|Overall Study||4
7829407|NCT01063517|19271281|P2|Received Randomised Treatment|Overall Study||62
7829408|NCT01063517|19271282|P1|Received Randomised Treatment|Overall Study||61
7829409|NCT01063517|19271281|P2|STARTED|Overall Study||62
7829410|NCT01063517|19271282|P1|STARTED|Overall Study||62
7829411|NCT01063348|19271322|P2|NOT COMPLETED|Overall Study||10
7829412|NCT01063348|19271323|P1|NOT COMPLETED|Overall Study||3
7829413|NCT01063348|19271322|P2|COMPLETED|Overall Study||21
7829414|NCT01063348|19271323|P1|COMPLETED|Overall Study||32
7829415|NCT01063348|19271322|P2|STARTED|Overall Study||31
7829416|NCT01063348|19271323|P1|STARTED|Overall Study||35
7829417|NCT01063283|19271333|P3|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
7829418|NCT01063283|19271334|P2|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
7829419|NCT01063283|19271335|P1|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
7829420|NCT01063283|19271333|P3|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||11
7829421|NCT01063283|19271334|P2|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||6
7829422|NCT01063283|19271335|P1|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
7829423|NCT01063283|19271333|P3|STARTED|Randomized Phase (Cycle 2 and Beyond)||11
7829424|NCT01063283|19271334|P2|STARTED|Randomized Phase (Cycle 2 and Beyond)||6
7829425|NCT01063283|19271335|P1|STARTED|Randomized Phase (Cycle 2 and Beyond)||0
7829426|NCT01063283|19271333|P3|NOT COMPLETED|Cycle 1||0
7829427|NCT01063283|19271334|P2|NOT COMPLETED|Cycle 1||0
7829428|NCT01063283|19271335|P1|NOT COMPLETED|Cycle 1||3
7829429|NCT01063283|19271333|P3|COMPLETED|Cycle 1||0
7829430|NCT01063283|19271334|P2|COMPLETED|Cycle 1||0
7829431|NCT01063283|19271335|P1|COMPLETED|Cycle 1||17
7829432|NCT01063283|19271333|P3|STARTED|Cycle 1||0
7829433|NCT01063283|19271334|P2|STARTED|Cycle 1||0
7829434|NCT01063283|19271335|P1|STARTED|Cycle 1||20
7829435|NCT01063153|19271349|P2|NOT COMPLETED|Overall Study||12
7829436|NCT01063153|19271350|P1|NOT COMPLETED|Overall Study||2
7829437|NCT01063153|19271349|P2|COMPLETED|Overall Study||26
7829438|NCT01063153|19271350|P1|COMPLETED|Overall Study||31
7829439|NCT01063153|19271349|P2|STARTED|Overall Study||38
7829440|NCT01063153|19271350|P1|STARTED|Overall Study||33
7829441|NCT01063075|19271360|P4|NOT COMPLETED|Overall Study||1
7829442|NCT01063075|19271361|P3|NOT COMPLETED|Overall Study||5
7829443|NCT01063075|19271362|P2|NOT COMPLETED|Overall Study||2
7829444|NCT01063075|19271363|P1|NOT COMPLETED|Overall Study||1
7829445|NCT01063075|19271360|P4|COMPLETED|Overall Study||14
7829446|NCT01063075|19271361|P3|COMPLETED|Overall Study||9
7829447|NCT01063075|19271362|P2|COMPLETED|Overall Study||1
7829448|NCT01063075|19271363|P1|COMPLETED|Overall Study||1
7829449|NCT01063075|19271360|P4|STARTED|Overall Study||15
7829450|NCT01063075|19271361|P3|STARTED|Overall Study||14
7829451|NCT01063075|19271362|P2|STARTED|Overall Study||3
7829452|NCT01063075|19271363|P1|STARTED|Overall Study||2
7829453|NCT01063062|19271381|P2|NOT COMPLETED|Overall Study||12
7829454|NCT01063062|19271382|P1|NOT COMPLETED|Overall Study||8
7829455|NCT01063062|19271381|P2|COMPLETED|Overall Study||65
7829456|NCT01063062|19271382|P1|COMPLETED|Overall Study||22
7829457|NCT01063062|19271381|P2|Received Study Drug|Overall Study||76
7829458|NCT01063062|19271382|P1|Received Study Drug|Overall Study||29
7829459|NCT01063062|19271381|P2|STARTED|Overall Study||77
7829460|NCT01063062|19271382|P1|STARTED|Overall Study||30
7829461|NCT01063049|19271423|P3|NOT COMPLETED|Overall Study||0
7829462|NCT01063049|19271424|P2|NOT COMPLETED|Overall Study||0
7829463|NCT01063049|19271425|P1|NOT COMPLETED|Overall Study||0
7829464|NCT01063049|19271423|P3|COMPLETED|Overall Study||200
7829465|NCT01063049|19271424|P2|COMPLETED|Overall Study||200
7829466|NCT01063049|19271425|P1|COMPLETED|Overall Study||200
7829467|NCT01063049|19271423|P3|STARTED|Overall Study||200
7829468|NCT01063049|19271424|P2|STARTED|Overall Study||200
7829469|NCT01063049|19271425|P1|STARTED|Overall Study||200
7829470|NCT01063036|19271436|P1|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39
7829471|NCT01063036|19271436|P1|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46
7829472|NCT01063036|19271436|P1|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85
7829473|NCT01063036|19271436|P1|NOT COMPLETED|Participants Treated With Study Drug||6
7829474|NCT01063036|19271436|P1|COMPLETED|Participants Treated With Study Drug||86
7829475|NCT01063036|19271436|P1|STARTED|Participants Treated With Study Drug||92
7829476|NCT01062971|19271452|P2|NOT COMPLETED|Overall Study||7
7829477|NCT01062971|19271453|P1|NOT COMPLETED|Overall Study||4
7829478|NCT01062971|19271452|P2|COMPLETED|Overall Study||56
7829479|NCT01062971|19271453|P1|COMPLETED|Overall Study||56
7829480|NCT01062971|19271452|P2|STARTED|Overall Study||63
7829481|NCT01062971|19271453|P1|STARTED|Overall Study||60
7829482|NCT01062893|19271463|P2|NOT COMPLETED|Overall Study||13
7829483|NCT01062893|19271464|P1|NOT COMPLETED|Overall Study||14
7829484|NCT01062893|19271463|P2|COMPLETED|Overall Study||28
7829485|NCT01062893|19271464|P1|COMPLETED|Overall Study||27
7829486|NCT01062893|19271463|P2|STARTED|Overall Study||41
7829487|NCT01062893|19271464|P1|STARTED|Overall Study||41
7829488|NCT01062841|19271492|P2|NOT COMPLETED|Overall Study||53
7829489|NCT01062841|19271493|P1|NOT COMPLETED|Overall Study||49
7829490|NCT01062841|19271492|P2|COMPLETED|Overall Study||162
7829491|NCT01062841|19271493|P1|COMPLETED|Overall Study||154
7829492|NCT01062841|19271492|P2|STARTED|Overall Study||215
7829493|NCT01062841|19271493|P1|STARTED|Overall Study||203
7829494|NCT01062763|19271523|P2|NOT COMPLETED|Overall Study||4
7829495|NCT01062763|19271524|P1|NOT COMPLETED|Overall Study||3
7829496|NCT01062763|19271523|P2|COMPLETED|Overall Study||57
7829497|NCT01062763|19271524|P1|COMPLETED|Overall Study||55
7829498|NCT01062763|19271523|P2|STARTED|Overall Study||61
7829499|NCT01062763|19271524|P1|STARTED|Overall Study|119 randomized.|58
7829500|NCT01062568|19271536|P2|NOT COMPLETED|Overall Study||0
7829501|NCT01062568|19271537|P1|NOT COMPLETED|Overall Study||0
7829502|NCT01062568|19271536|P2|COMPLETED|Overall Study||40
7829503|NCT01062568|19271537|P1|COMPLETED|Overall Study||10
7829504|NCT01062568|19271536|P2|STARTED|Overall Study||40
7829505|NCT01062568|19271537|P1|STARTED|Overall Study||10
7829506|NCT01062555|19271550|P4|NOT COMPLETED|Phase 2||34
7829507|NCT01062555|19271551|P3|NOT COMPLETED|Phase 2||15
7829508|NCT01062555|19271552|P2|NOT COMPLETED|Phase 2||0
7829509|NCT01062555|19271553|P1|NOT COMPLETED|Phase 2||0
7829510|NCT01062555|19271550|P4|COMPLETED|Phase 2||53
7829511|NCT01062555|19271551|P3|COMPLETED|Phase 2||71
7829512|NCT01062555|19271552|P2|COMPLETED|Phase 2||0
7829513|NCT01062555|19271553|P1|COMPLETED|Phase 2||0
7829514|NCT01062555|19271550|P4|STARTED|Phase 2||87
7829515|NCT01062555|19271551|P3|STARTED|Phase 2||86
7829516|NCT01062555|19271552|P2|STARTED|Phase 2||0
7829517|NCT01062555|19271553|P1|STARTED|Phase 2||0
7829518|NCT01062555|19271550|P4|NOT COMPLETED|Phase 1||0
7829519|NCT01062555|19271551|P3|NOT COMPLETED|Phase 1||0
7829520|NCT01062555|19271552|P2|NOT COMPLETED|Phase 1||26
7829521|NCT01062555|19271553|P1|NOT COMPLETED|Phase 1||23
7829522|NCT01062555|19271550|P4|COMPLETED|Phase 1||0
7829523|NCT01062555|19271551|P3|COMPLETED|Phase 1||0
7829524|NCT01062555|19271552|P2|COMPLETED|Phase 1||235
7829525|NCT01062555|19271553|P1|COMPLETED|Phase 1||243
7829526|NCT01062555|19271550|P4|STARTED|Phase 1||0
7829527|NCT01062555|19271551|P3|STARTED|Phase 1||0
7829528|NCT01062555|19271552|P2|STARTED|Phase 1||261
7829529|NCT01062555|19271553|P1|STARTED|Phase 1||266
7829530|NCT01062425|19271573|P2|NOT COMPLETED|Overall Study||6
7829531|NCT01062425|19271574|P1|NOT COMPLETED|Overall Study||3
7829532|NCT01062425|19271573|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97
7829533|NCT01062425|19271574|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52
7829534|NCT01062425|19271573|P2|STARTED|Overall Study||103
7829535|NCT01062425|19271574|P1|STARTED|Overall Study||55
7829536|NCT01062399|19271591|P5|NOT COMPLETED|Overall Study||4
7829537|NCT01062399|19271592|P4|NOT COMPLETED|Overall Study||6
7829538|NCT01062399|19271593|P3|NOT COMPLETED|Overall Study||0
7829539|NCT01062399|19271594|P2|NOT COMPLETED|Overall Study||1
7829540|NCT01062399|19271595|P1|NOT COMPLETED|Overall Study||0
7829541|NCT01062399|19271591|P5|COMPLETED|Overall Study||88
7829542|NCT01062399|19271592|P4|COMPLETED|Overall Study||83
7829543|NCT01062399|19271593|P3|COMPLETED|Overall Study||8
7829544|NCT01062399|19271594|P2|COMPLETED|Overall Study||9
7829545|NCT01062399|19271595|P1|COMPLETED|Overall Study|Subjects with data available for the primary analyses are considered to have completed the study.|8
7829546|NCT01062399|19271591|P5|STARTED|Overall Study||92
7829547|NCT01062399|19271592|P4|STARTED|Overall Study||89
7829548|NCT01062399|19271593|P3|STARTED|Overall Study||8
7829549|NCT01062399|19271594|P2|STARTED|Overall Study||10
7829550|NCT01062399|19271595|P1|STARTED|Overall Study||8
7829551|NCT01062308|19271616|P2|NOT COMPLETED|Overall Study||10
7829552|NCT01062308|19271617|P1|NOT COMPLETED|Overall Study||16
7829553|NCT01062308|19271616|P2|COMPLETED|Overall Study||72
7829554|NCT01062308|19271617|P1|COMPLETED|Overall Study||64
7829555|NCT01062308|19271616|P2|STARTED|Overall Study||82
7829556|NCT01062308|19271617|P1|STARTED|Overall Study||80
7829557|NCT01062269|19271625|P1|NOT COMPLETED|Overall Study||0
7829558|NCT01062269|19271625|P1|COMPLETED|Overall Study||42
7829559|NCT01062269|19271625|P1|STARTED|Overall Study||42
7829560|NCT01062256|19271639|P3|NOT COMPLETED|Overall Study||4
7829561|NCT01062256|19271640|P2|NOT COMPLETED|Overall Study||7
7829562|NCT01062256|19271641|P1|NOT COMPLETED|Overall Study||3
7829563|NCT01062256|19271639|P3|COMPLETED|Overall Study||103
7829564|NCT01062256|19271640|P2|COMPLETED|Overall Study||96
7829565|NCT01062256|19271641|P1|COMPLETED|Overall Study||52
7829566|NCT01062256|19271639|P3|STARTED|Overall Study||107
7829567|NCT01062256|19271640|P2|STARTED|Overall Study||103
7829568|NCT01062256|19271641|P1|STARTED|Overall Study||55
7829569|NCT01062230|19271664|P1|NOT COMPLETED|Overall Study||0
7829570|NCT01062230|19271664|P1|COMPLETED|Overall Study||6
7829571|NCT01062230|19271664|P1|STARTED|Overall Study||6
7829572|NCT01062165|19271668|P1|NOT COMPLETED|Overall Study||0
7829573|NCT01062165|19271668|P1|COMPLETED|Overall Study||18
7829574|NCT01062165|19271668|P1|STARTED|Overall Study||18
7829575|NCT01062126|19271672|P1|NOT COMPLETED|Overall Study||533
7829576|NCT01062126|19271672|P1|COMPLETED|Overall Study||2856
7829577|NCT01062126|19271672|P1|STARTED|Overall Study||3389
7829578|NCT01062113|19271679|P3|NOT COMPLETED|Overall Study||31
7829579|NCT01062113|19271680|P2|NOT COMPLETED|Overall Study||22
7829580|NCT01062113|19271681|P1|NOT COMPLETED|Overall Study||40
7829581|NCT01062113|19271679|P3|COMPLETED|Overall Study||27
7829582|NCT01062113|19271680|P2|COMPLETED|Overall Study||42
7829583|NCT01062113|19271681|P1|COMPLETED|Overall Study||93
7829584|NCT01062113|19271679|P3|STARTED|Overall Study||58
7829585|NCT01062113|19271680|P2|STARTED|Overall Study||64
7829586|NCT01062113|19271681|P1|STARTED|Overall Study||133
7829587|NCT01062074|19271694|P1|NOT COMPLETED|Overall Study||0
7829588|NCT01062074|19271694|P1|COMPLETED|Overall Study||3605
7829589|NCT01062074|19271694|P1|STARTED|Overall Study||3605
7829590|NCT01062061|19271699|P1|NOT COMPLETED|Overall Study||27
7829591|NCT01062061|19271699|P1|COMPLETED|Overall Study||727
7829592|NCT01062061|19271699|P1|STARTED|Overall Study||754
7829593|NCT01062009|19271717|P4|NOT COMPLETED|Overall Study||0
7829594|NCT01062009|19271718|P3|NOT COMPLETED|Overall Study||0
7829595|NCT01062009|19271719|P2|NOT COMPLETED|Overall Study||0
7829596|NCT01062009|19271720|P1|NOT COMPLETED|Overall Study||1
7829597|NCT01062009|19271717|P4|COMPLETED|Overall Study||6
7829598|NCT01062009|19271718|P3|COMPLETED|Overall Study||6
7829599|NCT01062009|19271719|P2|COMPLETED|Overall Study||6
7829600|NCT01062009|19271720|P1|COMPLETED|Overall Study||6
7829601|NCT01062009|19271717|P4|STARTED|Overall Study||6
7829602|NCT01062009|19271718|P3|STARTED|Overall Study||6
7829603|NCT01062009|19271719|P2|STARTED|Overall Study||6
7829604|NCT01062009|19271720|P1|STARTED|Overall Study||7
7829605|NCT01061866|19271738|P1|NOT COMPLETED|Overall Study||2
7829606|NCT01061866|19271738|P1|COMPLETED|Overall Study||5
7829607|NCT01061866|19271738|P1|STARTED|Overall Study||7
7829608|NCT01061775|19271742|P1|NOT COMPLETED|Overall Study||3
7829609|NCT01061775|19271742|P1|COMPLETED|Overall Study||16
7829610|NCT01061775|19271742|P1|STARTED|Overall Study||19
7829611|NCT01061736|19271759|P10|NOT COMPLETED|Overall Study||74
7829612|NCT01061736|19271760|P9|NOT COMPLETED|Overall Study||97
7829613|NCT01061736|19271761|P8|NOT COMPLETED|Overall Study||94
7829614|NCT01061736|19271762|P7|NOT COMPLETED|Overall Study||84
7829615|NCT01061736|19271763|P6|NOT COMPLETED|Overall Study||3
7829616|NCT01061736|19271764|P5|NOT COMPLETED|Overall Study||7
7829617|NCT01061736|19271765|P4|NOT COMPLETED|Overall Study||3
7829618|NCT01061736|19271766|P3|NOT COMPLETED|Overall Study||6
7829619|NCT01061736|19271767|P2|NOT COMPLETED|Overall Study||4
7829620|NCT01061736|19271768|P1|NOT COMPLETED|Overall Study||13
7829621|NCT01061736|19271759|P10|COMPLETED|Overall Study||354
7829622|NCT01061736|19271760|P9|COMPLETED|Overall Study||330
7829623|NCT01061736|19271761|P8|COMPLETED|Overall Study||336
7829624|NCT01061736|19271762|P7|COMPLETED|Overall Study||0
7829625|NCT01061736|19271763|P6|COMPLETED|Overall Study||49
7829626|NCT01061736|19271764|P5|COMPLETED|Overall Study||45
7829627|NCT01061736|19271765|P4|COMPLETED|Overall Study||48
7829628|NCT01061736|19271766|P3|COMPLETED|Overall Study||45
7829629|NCT01061736|19271767|P2|COMPLETED|Overall Study||46
7829630|NCT01061736|19271768|P1|COMPLETED|Overall Study||37
7829631|NCT01061736|19271759|P10|Rescued|Overall Study|Included both participants who completed and did not complete the study.|168
7829632|NCT01061736|19271760|P9|Rescued|Overall Study|Included both participants who completed and did not complete the study.|55
7829633|NCT01061736|19271761|P8|Rescued|Overall Study|Included both participants who completed and did not complete the study.|61
7829634|NCT01061736|19271762|P7|Rescued|Overall Study||0
7829635|NCT01061736|19271763|P6|Rescued|Overall Study||0
7829636|NCT01061736|19271764|P5|Rescued|Overall Study||0
7829637|NCT01061736|19271765|P4|Rescued|Overall Study||0
7829638|NCT01061736|19271766|P3|Rescued|Overall Study||0
7829639|NCT01061736|19271767|P2|Rescued|Overall Study||0
7829640|NCT01061736|19271768|P1|Rescued|Overall Study||0
7829641|NCT01061736|19271759|P10|Treated|Overall Study||428
7829642|NCT01061736|19271760|P9|Treated|Overall Study||426
7829643|NCT01061736|19271761|P8|Treated|Overall Study||428
7829644|NCT01061736|19271762|P7|Treated|Overall Study||84
7829645|NCT01061736|19271763|P6|Treated|Overall Study||52
7829646|NCT01061736|19271764|P5|Treated|Overall Study||51
7829647|NCT01061736|19271765|P4|Treated|Overall Study||51
7829648|NCT01061736|19271766|P3|Treated|Overall Study||51
7829649|NCT01061736|19271767|P2|Treated|Overall Study||50
7829650|NCT01061736|19271768|P1|Treated|Overall Study||50
7829651|NCT01061736|19271759|P10|STARTED|Overall Study||428
7829652|NCT01061736|19271760|P9|STARTED|Overall Study||427
7829653|NCT01061736|19271761|P8|STARTED|Overall Study||430
7829654|NCT01061736|19271762|P7|STARTED|Overall Study||84
7829655|NCT01061736|19271763|P6|STARTED|Overall Study||52
7829656|NCT01061736|19271764|P5|STARTED|Overall Study||52
7829657|NCT01061736|19271765|P4|STARTED|Overall Study||51
7829658|NCT01061736|19271766|P3|STARTED|Overall Study||51
7829659|NCT01061736|19271767|P2|STARTED|Overall Study||50
7829660|NCT01061736|19271768|P1|STARTED|Overall Study||50
7829661|NCT01061723|19271807|P6|NOT COMPLETED|Overall Study||9
7829662|NCT01061723|19271808|P5|NOT COMPLETED|Overall Study||3
7829663|NCT01061723|19271809|P4|NOT COMPLETED|Overall Study||8
7829664|NCT01061723|19271810|P3|NOT COMPLETED|Overall Study||10
7829665|NCT01061723|19271811|P2|NOT COMPLETED|Overall Study||6
7829666|NCT01061723|19271812|P1|NOT COMPLETED|Overall Study||4
7829667|NCT01061723|19271807|P6|COMPLETED|Overall Study||41
7829668|NCT01061723|19271808|P5|COMPLETED|Overall Study||47
7829669|NCT01061723|19271809|P4|COMPLETED|Overall Study||44
7829670|NCT01061723|19271810|P3|COMPLETED|Overall Study||40
7829671|NCT01061723|19271811|P2|COMPLETED|Overall Study||43
7829672|NCT01061723|19271812|P1|COMPLETED|Overall Study||46
7829673|NCT01061723|19271807|P6|Treated|Overall Study||49
7829674|NCT01061723|19271808|P5|Treated|Overall Study||50
7829675|NCT01061723|19271809|P4|Treated|Overall Study||52
7829676|NCT01061723|19271810|P3|Treated|Overall Study||50
7829677|NCT01061723|19271811|P2|Treated|Overall Study||49
7829678|NCT01061723|19271812|P1|Treated|Overall Study||50
7829679|NCT01061723|19271807|P6|STARTED|Overall Study||50
7829680|NCT01061723|19271808|P5|STARTED|Overall Study||50
7829681|NCT01061723|19271809|P4|STARTED|Overall Study||52
7829682|NCT01061723|19271810|P3|STARTED|Overall Study||50
7829683|NCT01061723|19271811|P2|STARTED|Overall Study||49
7829684|NCT01061723|19271812|P1|STARTED|Overall Study||50
7829685|NCT01061710|19271892|P1|NOT COMPLETED|Overall Study||14
7829686|NCT01061710|19271892|P1|COMPLETED|Overall Study||6
7829687|NCT01061710|19271892|P1|STARTED|Overall Study||20
7829688|NCT01061671|19271902|P2|NOT COMPLETED|Overall Study||55
7829689|NCT01061671|19271903|P1|NOT COMPLETED|Overall Study||47
7829690|NCT01061671|19271902|P2|COMPLETED|Overall Study||397
7829691|NCT01061671|19271903|P1|COMPLETED|Overall Study||386
7829692|NCT01061671|19271902|P2|STARTED|Overall Study||452
7829693|NCT01061671|19271903|P1|STARTED|Overall Study||433
7829694|NCT01061606|19271915|P1|NOT COMPLETED|Overall Study||8
7829695|NCT01061606|19271915|P1|COMPLETED|Overall Study||0
7829696|NCT01061606|19271915|P1|STARTED|Overall Study||8
7829697|NCT01061567|19271924|P1|NOT COMPLETED|Overall Study||76
7829698|NCT01061567|19271924|P1|COMPLETED|Overall Study||1738
7829699|NCT01061567|19271924|P1|STARTED|Overall Study||1814
7829700|NCT01061528|19271935|P2|NOT COMPLETED|Overall Study||2
7829701|NCT01061528|19271936|P1|NOT COMPLETED|Overall Study||3
7829702|NCT01061528|19271935|P2|COMPLETED|Overall Study||52
7829703|NCT01061528|19271936|P1|COMPLETED|Overall Study||59
7829704|NCT01061528|19271935|P2|STARTED|Overall Study||54
7829705|NCT01061528|19271936|P1|STARTED|Overall Study||62
7829706|NCT01061476|19271942|P1|NOT COMPLETED|Overall Study||0
7829707|NCT01061476|19271942|P1|COMPLETED|Overall Study||12
7829708|NCT01061476|19271942|P1|STARTED|Overall Study||12
7829709|NCT01061385|19271948|P2|NOT COMPLETED|Overall Study||1
7829710|NCT01061385|19271949|P1|NOT COMPLETED|Overall Study||1
7829711|NCT01061385|19271948|P2|COMPLETED|Overall Study||8
7829712|NCT01061385|19271949|P1|COMPLETED|Overall Study||20
7829713|NCT01061385|19271948|P2|STARTED|Overall Study||9
7829714|NCT01061385|19271949|P1|STARTED|Overall Study||21
7829715|NCT01061359|19271957|P1|NOT COMPLETED|Overall Study||1302
7829716|NCT01061359|19271957|P1|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670
7829717|NCT01061359|19271957|P1|STARTED|Overall Study||1972
7829718|NCT01061333|19271963|P2|NOT COMPLETED|Period 7: Mometasone||0
7829719|NCT01061333|19271964|P1|NOT COMPLETED|Period 7: Mometasone||0
7829720|NCT01061333|19271963|P2|COMPLETED|Period 7: Mometasone||7
7829721|NCT01061333|19271964|P1|COMPLETED|Period 7: Mometasone||8
7829722|NCT01061333|19271963|P2|STARTED|Period 7: Mometasone||7
7829723|NCT01061333|19271964|P1|STARTED|Period 7: Mometasone||8
7829724|NCT01061333|19271963|P2|NOT COMPLETED|Period 6: 20-day Washout||0
7829725|NCT01061333|19271964|P1|NOT COMPLETED|Period 6: 20-day Washout||0
7829726|NCT01061333|19271963|P2|COMPLETED|Period 6: 20-day Washout||7
7829727|NCT01061333|19271964|P1|COMPLETED|Period 6: 20-day Washout||8
7829728|NCT01061333|19271963|P2|STARTED|Period 6: 20-day Washout||7
7829729|NCT01061333|19271964|P1|STARTED|Period 6: 20-day Washout||8
7829730|NCT01061333|19271963|P2|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
7829731|NCT01061333|19271964|P1|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
7829732|NCT01061333|19271963|P2|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7
7829733|NCT01061333|19271964|P1|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8
7829734|NCT01061333|19271963|P2|STARTED|Period 5: Nedocromil-Montelukast X-over||7
7829735|NCT01061333|19271964|P1|STARTED|Period 5: Nedocromil-Montelukast X-over||8
7829736|NCT01061333|19271963|P2|NOT COMPLETED|Period 4: 20-day Washout||1
7829737|NCT01061333|19271964|P1|NOT COMPLETED|Period 4: 20-day Washout||0
7829738|NCT01061333|19271963|P2|COMPLETED|Period 4: 20-day Washout||7
7829739|NCT01061333|19271964|P1|COMPLETED|Period 4: 20-day Washout||8
7829740|NCT01061333|19271963|P2|STARTED|Period 4: 20-day Washout||8
7829741|NCT01061333|19271964|P1|STARTED|Period 4: 20-day Washout||8
7829742|NCT01061333|19271963|P2|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
7829743|NCT01061333|19271964|P1|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
7829744|NCT01061333|19271963|P2|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
7829745|NCT01061333|19271964|P1|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
7829746|NCT01061333|19271963|P2|STARTED|Period 3: Nedocromil-Montelukast X-over||8
7829747|NCT01061333|19271964|P1|STARTED|Period 3: Nedocromil-Montelukast X-over||8
7829748|NCT01061333|19271963|P2|NOT COMPLETED|Period 2: 20-day Washout||0
7829749|NCT01061333|19271964|P1|NOT COMPLETED|Period 2: 20-day Washout||0
7829750|NCT01061333|19271963|P2|COMPLETED|Period 2: 20-day Washout||8
7829751|NCT01061333|19271964|P1|COMPLETED|Period 2: 20-day Washout||8
7829752|NCT01061333|19271963|P2|STARTED|Period 2: 20-day Washout||8
7829753|NCT01061333|19271964|P1|STARTED|Period 2: 20-day Washout||8
7829754|NCT01061333|19271963|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
7829755|NCT01061333|19271964|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
7829756|NCT01061333|19271963|P2|COMPLETED|Period 1: Placebo Run-in||8
7829757|NCT01061333|19271964|P1|COMPLETED|Period 1: Placebo Run-in||8
7829758|NCT01061333|19271963|P2|STARTED|Period 1: Placebo Run-in||8
7829759|NCT01061333|19271964|P1|STARTED|Period 1: Placebo Run-in||8
7829760|NCT01061177|19272002|P1|NOT COMPLETED|Overall Study||208
7829761|NCT01061177|19272002|P1|COMPLETED|Overall Study||881
7829762|NCT01061177|19272002|P1|ITT_CyR (Ph+ Patients Only)|Overall Study||983
7829763|NCT01061177|19272002|P1|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056
7829764|NCT01061177|19272002|P1|STARTED|Overall Study||1089
7829765|NCT01061151|19272025|P4|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||20
7829766|NCT01061151|19272026|P3|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||77
7829767|NCT01061151|19272027|P2|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||138
7829768|NCT01061151|19272028|P1|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||152
7829769|NCT01061151|19272025|P4|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||55
7829770|NCT01061151|19272026|P3|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||345
7829771|NCT01061151|19272027|P2|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||548
7829772|NCT01061151|19272028|P1|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||542
7829773|NCT01061151|19272025|P4|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||75
7829774|NCT01061151|19272026|P3|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||421
7829775|NCT01061151|19272027|P2|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||684
7829776|NCT01061151|19272028|P1|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||694
7829777|NCT01061151|19272025|P4|STARTED|Protocol Version 3.0: 10/2012-10/2014||75
7829778|NCT01061151|19272026|P3|STARTED|Protocol Version 3.0: 10/2012-10/2014||422
7829779|NCT01061151|19272027|P2|STARTED|Protocol Version 3.0: 10/2012-10/2014||686
7829780|NCT01061151|19272028|P1|STARTED|Protocol Version 3.0: 10/2012-10/2014||694
7829781|NCT01061151|19272025|P4|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||28
7829782|NCT01061151|19272026|P3|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||9
7829783|NCT01061151|19272027|P2|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||241
7829784|NCT01061151|19272028|P1|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||232
7829785|NCT01061151|19272025|P4|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||101
7829786|NCT01061151|19272026|P3|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||16
7829787|NCT01061151|19272027|P2|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||620
7829788|NCT01061151|19272028|P1|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||623
7829789|NCT01061151|19272025|P4|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||129
7829790|NCT01061151|19272026|P3|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||24
7829791|NCT01061151|19272027|P2|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||861
7829792|NCT01061151|19272028|P1|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||853
7829793|NCT01061151|19272025|P4|STARTED|Protocol Version 2.0: 04/2011-09/2012||129
7829794|NCT01061151|19272026|P3|STARTED|Protocol Version 2.0: 04/2011-09/2012||25
7829795|NCT01061151|19272027|P2|STARTED|Protocol Version 2.0: 04/2011-09/2012||861
7829796|NCT01061151|19272028|P1|STARTED|Protocol Version 2.0: 04/2011-09/2012||855
7829797|NCT01061034|19272080|P1|NOT COMPLETED|Aspirin Plus Omeprazole||0
7829798|NCT01061034|19272080|P1|COMPLETED|Aspirin Plus Omeprazole||9
7829799|NCT01061034|19272080|P1|STARTED|Aspirin Plus Omeprazole||9
7829800|NCT01061034|19272080|P1|NOT COMPLETED|Aspirin||0
7829801|NCT01061034|19272080|P1|COMPLETED|Aspirin||9
7829802|NCT01061034|19272080|P1|STARTED|Aspirin||9
7829803|NCT01061008|19272087|P2|NOT COMPLETED|Overall Study||6
7829804|NCT01061008|19272088|P1|NOT COMPLETED|Overall Study||6
7829805|NCT01061008|19272087|P2|COMPLETED|Overall Study||9
7829806|NCT01061008|19272088|P1|COMPLETED|Overall Study||10
7829807|NCT01061008|19272087|P2|STARTED|Overall Study||15
7829808|NCT01061008|19272088|P1|STARTED|Overall Study||16
7829809|NCT01060670|19272096|P2|NOT COMPLETED|Follow up Phase||35
7829810|NCT01060670|19272097|P1|NOT COMPLETED|Follow up Phase||22
7829811|NCT01060670|19272096|P2|COMPLETED|Follow up Phase||82
7829812|NCT01060670|19272097|P1|COMPLETED|Follow up Phase||106
7829813|NCT01060670|19272096|P2|Withdrew From Follow up Phase|Follow up Phase||35
7829814|NCT01060670|19272097|P1|Withdrew From Follow up Phase|Follow up Phase||22
7829815|NCT01060670|19272096|P2|Recurrence|Follow up Phase||9
7829816|NCT01060670|19272097|P1|Recurrence|Follow up Phase||14
7829817|NCT01060670|19272096|P2|STARTED|Follow up Phase||117
7829818|NCT01060670|19272097|P1|STARTED|Follow up Phase||128
7829819|NCT01060670|19272096|P2|NOT COMPLETED|Treatment Phase||36
7829820|NCT01060670|19272097|P1|NOT COMPLETED|Treatment Phase||26
7829821|NCT01060670|19272096|P2|COMPLETED|Treatment Phase||117
7829822|NCT01060670|19272097|P1|COMPLETED|Treatment Phase||128
7829823|NCT01060670|19272096|P2|Withdrew From Treatment|Treatment Phase||36
7829824|NCT01060670|19272097|P1|Withdrew From Treatment|Treatment Phase||26
7829825|NCT01060670|19272096|P2|Did Not Heal by Treatment Visit 17|Treatment Phase||68
7829826|NCT01060670|19272097|P1|Did Not Heal by Treatment Visit 17|Treatment Phase||49
7829827|NCT01060670|19272096|P2|Healed at End of Treatment Phase|Treatment Phase||49
7829828|NCT01060670|19272097|P1|Healed at End of Treatment Phase|Treatment Phase||79
7829829|NCT01060670|19272096|P2|STARTED|Treatment Phase||153
7829830|NCT01060670|19272097|P1|STARTED|Treatment Phase||154
7829831|NCT01060670|19272096|P2|NOT COMPLETED|Run In||238
7829832|NCT01060670|19272097|P1|NOT COMPLETED|Run In||0
7829833|NCT01060670|19272096|P2|COMPLETED|Run In||307
7829834|NCT01060670|19272097|P1|COMPLETED|Run In||0
7829835|NCT01060670|19272096|P2|STARTED|Run In||545
7829836|NCT01060670|19272097|P1|STARTED|Run In||0
7829837|NCT01060592|19272117|P2|NOT COMPLETED|12m||18
7829838|NCT01060592|19272118|P1|NOT COMPLETED|12m||0
7829839|NCT01060592|19272117|P2|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31
7829840|NCT01060592|19272118|P1|COMPLETED|12m||35
7829841|NCT01060592|19272117|P2|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49
7829842|NCT01060592|19272118|P1|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35
7829843|NCT01060592|19272117|P2|NOT COMPLETED|4-6w||10
7829844|NCT01060592|19272118|P1|NOT COMPLETED|4-6w||12
7829845|NCT01060592|19272117|P2|COMPLETED|4-6w||39
7829846|NCT01060592|19272118|P1|COMPLETED|4-6w||23
7829847|NCT01060592|19272117|P2|STARTED|4-6w||49
7829848|NCT01060592|19272118|P1|STARTED|4-6w||35
7829849|NCT01060553|19272132|P2|NOT COMPLETED|Overall Study||10
7829850|NCT01060553|19272133|P1|NOT COMPLETED|Overall Study||9
7829851|NCT01060553|19272132|P2|COMPLETED|Overall Study||5
7829852|NCT01060553|19272133|P1|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6
7829853|NCT01060553|19272132|P2|STARTED|Overall Study||15
7829854|NCT01060553|19272133|P1|STARTED|Overall Study||15
7829855|NCT01060540|19272140|P2|NOT COMPLETED|Overall Study||65
7829856|NCT01060540|19272141|P1|NOT COMPLETED|Overall Study||64
7829857|NCT01060540|19272140|P2|COMPLETED|Overall Study||233
7829858|NCT01060540|19272141|P1|COMPLETED|Overall Study||239
7829859|NCT01060540|19272140|P2|STARTED|Overall Study||298
7829860|NCT01060540|19272141|P1|STARTED|Overall Study||303
7829861|NCT01060384|19272155|P5|NOT COMPLETED|Overall Study||2
7829862|NCT01060384|19272156|P4|NOT COMPLETED|Overall Study||0
7829863|NCT01060384|19272157|P3|NOT COMPLETED|Overall Study||0
7829864|NCT01060384|19272158|P2|NOT COMPLETED|Overall Study||1
7829865|NCT01060384|19272159|P1|NOT COMPLETED|Overall Study||0
7829866|NCT01060384|19272155|P5|COMPLETED|Overall Study||34
7829867|NCT01060384|19272156|P4|COMPLETED|Overall Study||0
7829868|NCT01060384|19272157|P3|COMPLETED|Overall Study||0
7829869|NCT01060384|19272158|P2|COMPLETED|Overall Study||3
7829870|NCT01060384|19272159|P1|COMPLETED|Overall Study||6
7829871|NCT01060384|19272155|P5|STARTED|Overall Study||36
7829872|NCT01060384|19272156|P4|STARTED|Overall Study||0
7829873|NCT01060384|19272157|P3|STARTED|Overall Study||0
7829874|NCT01060384|19272158|P2|STARTED|Overall Study||4
7829875|NCT01060384|19272159|P1|STARTED|Overall Study||6
7829876|NCT01060345|19272168|P1|NOT COMPLETED|Overall Study||0
7829877|NCT01060345|19272168|P1|COMPLETED|Overall Study||20
7829878|NCT01060345|19272168|P1|STARTED|Overall Study||20
7829879|NCT01060150|19272178|P1|NOT COMPLETED|Overall Study||23
7829880|NCT01060150|19272178|P1|COMPLETED|Overall Study||92
7829881|NCT01060150|19272178|P1|Treated|Overall Study||113
7829882|NCT01060150|19272178|P1|STARTED|Overall Study||115
7829883|NCT01060124|19272193|P1|NOT COMPLETED|Overall Study||37
7829884|NCT01060124|19272193|P1|COMPLETED|Overall Study||66
7829885|NCT01060124|19272193|P1|STARTED|Overall Study||103
7829886|NCT01060111|19272204|P3|NOT COMPLETED|Overall Study||35
7829887|NCT01060111|19272205|P2|NOT COMPLETED|Overall Study||23
7829888|NCT01060111|19272206|P1|NOT COMPLETED|Overall Study||27
7829889|NCT01060111|19272204|P3|COMPLETED|Overall Study||45
7829890|NCT01060111|19272205|P2|COMPLETED|Overall Study||61
7829891|NCT01060111|19272206|P1|COMPLETED|Overall Study||54
7829892|NCT01060111|19272204|P3|Treated|Overall Study||79
7829893|NCT01060111|19272205|P2|Treated|Overall Study||83
7829894|NCT01060111|19272206|P1|Treated|Overall Study||81
7829895|NCT01060111|19272204|P3|STARTED|Overall Study||80
7829896|NCT01060111|19272205|P2|STARTED|Overall Study||84
7829897|NCT01060111|19272206|P1|STARTED|Overall Study||81
7829898|NCT01060098|19272226|P3|NOT COMPLETED|Overall Study||0
7829899|NCT01060098|19272227|P2|NOT COMPLETED|Overall Study||0
7829900|NCT01060098|19272228|P1|NOT COMPLETED|Overall Study||0
7829901|NCT01060098|19272226|P3|COMPLETED|Overall Study||8
7829902|NCT01060098|19272227|P2|COMPLETED|Overall Study||15
7829903|NCT01060098|19272228|P1|COMPLETED|Overall Study||25
7829904|NCT01060098|19272226|P3|STARTED|Overall Study||8
7829905|NCT01060098|19272227|P2|STARTED|Overall Study||15
7829906|NCT01060098|19272228|P1|STARTED|Overall Study||25
7829907|NCT01060072|19272238|P2|NOT COMPLETED|Overall Study||5
7829908|NCT01060072|19272239|P1|NOT COMPLETED|Overall Study||2
7829909|NCT01060072|19272238|P2|COMPLETED|Overall Study||196
7829910|NCT01060072|19272239|P1|COMPLETED|Overall Study||204
7829911|NCT01060072|19272238|P2|STARTED|Overall Study||201
7829912|NCT01060072|19272239|P1|STARTED|Overall Study||206
7829913|NCT01060059|19272255|P2|NOT COMPLETED|Overall Study||67
7829914|NCT01060059|19272256|P1|NOT COMPLETED|Overall Study||67
7829915|NCT01060059|19272255|P2|COMPLETED|Overall Study||371
7829916|NCT01060059|19272256|P1|COMPLETED|Overall Study||377
7829917|NCT01060059|19272255|P2|STARTED|Overall Study||438
7829918|NCT01060059|19272256|P1|STARTED|Overall Study||444
7829919|NCT01060020|19272306|P1|NOT COMPLETED|Overall Study||0
7829920|NCT01060020|19272306|P1|COMPLETED|Overall Study||20
7829921|NCT01060020|19272306|P1|STARTED|Overall Study||20
7829922|NCT01060007|19272314|P1|NOT COMPLETED|Overall Study||4
7829923|NCT01060007|19272314|P1|COMPLETED|Overall Study||76
7829924|NCT01060007|19272314|P1|STARTED|Overall Study||80
7829925|NCT01059994|19272332|P4|NOT COMPLETED|Overall Study||1
7829926|NCT01059994|19272333|P3|NOT COMPLETED|Overall Study||0
7829927|NCT01059994|19272334|P2|NOT COMPLETED|Overall Study||0
7829928|NCT01059994|19272335|P1|NOT COMPLETED|Overall Study||0
7829929|NCT01059994|19272332|P4|COMPLETED|Overall Study||3
7829930|NCT01059994|19272333|P3|COMPLETED|Overall Study||3
7829931|NCT01059994|19272334|P2|COMPLETED|Overall Study||2
7829932|NCT01059994|19272335|P1|COMPLETED|Overall Study||3
7829933|NCT01059994|19272332|P4|STARTED|Overall Study||4
7829934|NCT01059994|19272333|P3|STARTED|Overall Study||3
7829935|NCT01059994|19272334|P2|STARTED|Overall Study||2
7829936|NCT01059994|19272335|P1|STARTED|Overall Study||3
7829937|NCT01059929|19272351|P2|NOT COMPLETED|Overall Study||0
7829938|NCT01059929|19272352|P1|NOT COMPLETED|Overall Study||0
7829939|NCT01059929|19272351|P2|COMPLETED|Overall Study||21
7829940|NCT01059929|19272352|P1|COMPLETED|Overall Study||20
7829941|NCT01059929|19272351|P2|STARTED|Overall Study||21
7829942|NCT01059929|19272352|P1|STARTED|Overall Study||20
7829943|NCT01059903|19272382|P2|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
7829944|NCT01059903|19272383|P1|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
7829945|NCT01059903|19272382|P2|COMPLETED|Period 3: Second Intervention- 24 Hours||24
7829946|NCT01059903|19272383|P1|COMPLETED|Period 3: Second Intervention- 24 Hours||24
7829947|NCT01059903|19272382|P2|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22
7829948|NCT01059903|19272383|P1|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18
7829949|NCT01059903|19272382|P2|STARTED|Period 3: Second Intervention- 24 Hours||24
7829950|NCT01059903|19272383|P1|STARTED|Period 3: Second Intervention- 24 Hours||24
7829951|NCT01059903|19272382|P2|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
7829952|NCT01059903|19272383|P1|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
7829953|NCT01059903|19272382|P2|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
7830035|NCT01059825|19272508|P1|NOT COMPLETED|Enrolled, Run-in Period||0
7829954|NCT01059903|19272383|P1|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
7829955|NCT01059903|19272382|P2|STARTED|Period 2: Washout Period (>= 5 Days)||24
7829956|NCT01059903|19272383|P1|STARTED|Period 2: Washout Period (>= 5 Days)||24
7829957|NCT01059903|19272382|P2|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
7829958|NCT01059903|19272383|P1|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
7829959|NCT01059903|19272382|P2|COMPLETED|Period 1: First Intervention- 24 Hours||24
7829960|NCT01059903|19272383|P1|COMPLETED|Period 1: First Intervention- 24 Hours||24
7829961|NCT01059903|19272382|P2|STARTED|Period 1: First Intervention- 24 Hours||25
7829962|NCT01059903|19272383|P1|STARTED|Period 1: First Intervention- 24 Hours||25
7829963|NCT01059877|19272419|P2|NOT COMPLETED|Overall Study||2
7829964|NCT01059877|19272420|P1|NOT COMPLETED|Overall Study||0
7829965|NCT01059877|19272419|P2|COMPLETED|Overall Study||3
7829966|NCT01059877|19272420|P1|COMPLETED|Overall Study||6
7829967|NCT01059877|19272419|P2|STARTED|Overall Study||5
7829968|NCT01059877|19272420|P1|STARTED|Overall Study||6
7829969|NCT01059864|19272426|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
7829970|NCT01059864|19272427|P2|NOT COMPLETED|Double-Blind Treatment Phase||3
7829971|NCT01059864|19272428|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
7829972|NCT01059864|19272426|P3|COMPLETED|Double-Blind Treatment Phase||45
7829973|NCT01059864|19272427|P2|COMPLETED|Double-Blind Treatment Phase||47
7829974|NCT01059864|19272428|P1|COMPLETED|Double-Blind Treatment Phase||0
7829975|NCT01059864|19272426|P3|Treated|Double-Blind Treatment Phase||47
7829976|NCT01059864|19272427|P2|Treated|Double-Blind Treatment Phase||50
7829977|NCT01059864|19272428|P1|Treated|Double-Blind Treatment Phase||0
7829978|NCT01059864|19272426|P3|STARTED|Double-Blind Treatment Phase||48
7829979|NCT01059864|19272427|P2|STARTED|Double-Blind Treatment Phase||50
7829980|NCT01059864|19272428|P1|STARTED|Double-Blind Treatment Phase||0
7829981|NCT01059864|19272426|P3|NOT COMPLETED|Open-Label Run-In Phase||0
7829982|NCT01059864|19272427|P2|NOT COMPLETED|Open-Label Run-In Phase||0
7829983|NCT01059864|19272428|P1|NOT COMPLETED|Open-Label Run-In Phase||13
7829984|NCT01059864|19272426|P3|COMPLETED|Open-Label Run-In Phase||0
7829985|NCT01059864|19272427|P2|COMPLETED|Open-Label Run-In Phase||0
7829986|NCT01059864|19272428|P1|COMPLETED|Open-Label Run-In Phase||98
7829987|NCT01059864|19272426|P3|STARTED|Open-Label Run-In Phase||0
7829988|NCT01059864|19272427|P2|STARTED|Open-Label Run-In Phase||0
7829989|NCT01059864|19272428|P1|STARTED|Open-Label Run-In Phase||111
7829990|NCT01059851|19272477|P6|NOT COMPLETED|Overall Study||0
7829991|NCT01059851|19272478|P5|NOT COMPLETED|Overall Study||0
7829992|NCT01059851|19272479|P4|NOT COMPLETED|Overall Study||0
7829993|NCT01059851|19272480|P3|NOT COMPLETED|Overall Study||0
7829994|NCT01059851|19272481|P2|NOT COMPLETED|Overall Study||0
7829995|NCT01059851|19272482|P1|NOT COMPLETED|Overall Study||0
7829996|NCT01059851|19272477|P6|COMPLETED|Overall Study||0
7829997|NCT01059851|19272478|P5|COMPLETED|Overall Study||0
7829998|NCT01059851|19272479|P4|COMPLETED|Overall Study||0
7829999|NCT01059851|19272480|P3|COMPLETED|Overall Study||0
7830000|NCT01059851|19272481|P2|COMPLETED|Overall Study||8
7830001|NCT01059851|19272482|P1|COMPLETED|Overall Study||8
7830002|NCT01059851|19272477|P6|STARTED|Overall Study||0
7830003|NCT01059851|19272478|P5|STARTED|Overall Study||0
7830004|NCT01059851|19272479|P4|STARTED|Overall Study||0
7830005|NCT01059851|19272480|P3|STARTED|Overall Study||0
7830006|NCT01059851|19272481|P2|STARTED|Overall Study||8
7830007|NCT01059851|19272482|P1|STARTED|Overall Study||8
7830008|NCT01059825|19272502|P7|NOT COMPLETED|Treatment Period||0
7830009|NCT01059825|19272503|P6|NOT COMPLETED|Treatment Period||3
7830010|NCT01059825|19272504|P5|NOT COMPLETED|Treatment Period||8
7830011|NCT01059825|19272505|P4|NOT COMPLETED|Treatment Period||11
7830012|NCT01059825|19272506|P3|NOT COMPLETED|Treatment Period||6
7830013|NCT01059825|19272507|P2|NOT COMPLETED|Treatment Period||4
7830014|NCT01059825|19272508|P1|NOT COMPLETED|Treatment Period||10
7830015|NCT01059825|19272502|P7|COMPLETED|Treatment Period||0
7830016|NCT01059825|19272503|P6|COMPLETED|Treatment Period||52
7830017|NCT01059825|19272504|P5|COMPLETED|Treatment Period||47
7830018|NCT01059825|19272505|P4|COMPLETED|Treatment Period||44
7830019|NCT01059825|19272506|P3|COMPLETED|Treatment Period||49
7830020|NCT01059825|19272507|P2|COMPLETED|Treatment Period||50
7830021|NCT01059825|19272508|P1|COMPLETED|Treatment Period||44
7830022|NCT01059825|19272502|P7|STARTED|Treatment Period|Participants who completed run-in were randomized to 1 of 6 treatment groups.|0
7830023|NCT01059825|19272503|P6|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
7830024|NCT01059825|19272504|P5|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
7830025|NCT01059825|19272505|P4|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
7830026|NCT01059825|19272506|P3|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
7830027|NCT01059825|19272507|P2|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
7830028|NCT01059825|19272508|P1|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
7830029|NCT01059825|19272502|P7|NOT COMPLETED|Enrolled, Run-in Period||47
7830030|NCT01059825|19272503|P6|NOT COMPLETED|Enrolled, Run-in Period||0
7830031|NCT01059825|19272504|P5|NOT COMPLETED|Enrolled, Run-in Period||0
7830032|NCT01059825|19272505|P4|NOT COMPLETED|Enrolled, Run-in Period||0
7830033|NCT01059825|19272506|P3|NOT COMPLETED|Enrolled, Run-in Period||0
7830034|NCT01059825|19272507|P2|NOT COMPLETED|Enrolled, Run-in Period||0
7830036|NCT01059825|19272502|P7|COMPLETED|Enrolled, Run-in Period||328
7830037|NCT01059825|19272503|P6|COMPLETED|Enrolled, Run-in Period||0
7830038|NCT01059825|19272504|P5|COMPLETED|Enrolled, Run-in Period||0
7830039|NCT01059825|19272505|P4|COMPLETED|Enrolled, Run-in Period||0
7830040|NCT01059825|19272506|P3|COMPLETED|Enrolled, Run-in Period||0
7830041|NCT01059825|19272507|P2|COMPLETED|Enrolled, Run-in Period||0
7830042|NCT01059825|19272508|P1|COMPLETED|Enrolled, Run-in Period||0
7830043|NCT01059825|19272502|P7|STARTED|Enrolled, Run-in Period||375
7830044|NCT01059825|19272503|P6|STARTED|Enrolled, Run-in Period||0
7830045|NCT01059825|19272504|P5|STARTED|Enrolled, Run-in Period||0
7830046|NCT01059825|19272505|P4|STARTED|Enrolled, Run-in Period||0
7830047|NCT01059825|19272506|P3|STARTED|Enrolled, Run-in Period||0
7830048|NCT01059825|19272507|P2|STARTED|Enrolled, Run-in Period||0
7830049|NCT01059825|19272508|P1|STARTED|Enrolled, Run-in Period||0
7830050|NCT01059812|19272695|P2|NOT COMPLETED|Overall Study||16
7830051|NCT01059812|19272696|P1|NOT COMPLETED|Overall Study||37
7830052|NCT01059812|19272695|P2|COMPLETED|Overall Study||126
7830053|NCT01059812|19272696|P1|COMPLETED|Overall Study||245
7830054|NCT01059812|19272695|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141
7830055|NCT01059812|19272696|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279
7830056|NCT01059812|19272695|P2|STARTED|Overall Study||142
7830057|NCT01059812|19272696|P1|STARTED|Overall Study||282
7830058|NCT01059799|19272712|P2|NOT COMPLETED|Overall Study||10
7830059|NCT01059799|19272713|P1|NOT COMPLETED|Overall Study||31
7830060|NCT01059799|19272712|P2|COMPLETED|Overall Study||136
7830061|NCT01059799|19272713|P1|COMPLETED|Overall Study||258
7830062|NCT01059799|19272712|P2|Exposed|Overall Study||146
7830063|NCT01059799|19272713|P1|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284
7830064|NCT01059799|19272712|P2|STARTED|Overall Study||146
7830065|NCT01059799|19272713|P1|STARTED|Overall Study||289
7830066|NCT01059773|19272727|P2|NOT COMPLETED|Overall Study||24
7830067|NCT01059773|19272728|P1|NOT COMPLETED|Overall Study||20
7830068|NCT01059773|19272727|P2|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221
7830069|NCT01059773|19272728|P1|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224
7830070|NCT01059773|19272727|P2|STARTED|Overall Study||245
7830071|NCT01059773|19272728|P1|STARTED|Overall Study||244
7830072|NCT01059760|19272760|P2|NOT COMPLETED|Overall Study||0
7830073|NCT01059760|19272761|P1|NOT COMPLETED|Overall Study||0
7830074|NCT01059760|19272760|P2|COMPLETED|Overall Study||14
7830075|NCT01059760|19272761|P1|COMPLETED|Overall Study||16
7830076|NCT01059760|19272760|P2|STARTED|Overall Study||14
7830077|NCT01059760|19272761|P1|STARTED|Overall Study||16
7830078|NCT01059682|19272869|P2|NOT COMPLETED|Overall Study||18
7830079|NCT01059682|19272870|P1|NOT COMPLETED|Overall Study||10
7830080|NCT01059682|19272869|P2|COMPLETED|Overall Study||444
7830081|NCT01059682|19272870|P1|COMPLETED|Overall Study||464
7830082|NCT01059682|19272869|P2|STARTED|Overall Study||462
7830083|NCT01059682|19272870|P1|STARTED|Overall Study||474
7830084|NCT01059643|19272884|P1|NOT COMPLETED|Overall Study||6
7830085|NCT01059643|19272884|P1|COMPLETED|Overall Study||97
7830086|NCT01059643|19272884|P1|Received at Least 1 Dose of Study Drug|Overall Study||103
7830087|NCT01059643|19272884|P1|STARTED|Overall Study||103
7830088|NCT01059630|19272899|P2|NOT COMPLETED|Overall Study||103
7830089|NCT01059630|19272900|P1|NOT COMPLETED|Overall Study||127
7830090|NCT01059630|19272899|P2|COMPLETED|Overall Study||101
7830091|NCT01059630|19272900|P1|COMPLETED|Overall Study||82
7830092|NCT01059630|19272899|P2|STARTED|Overall Study||204
7830093|NCT01059630|19272900|P1|STARTED|Overall Study||209
7830094|NCT01059617|19272974|P4|NOT COMPLETED|Overall Study||6
7830095|NCT01059617|19272975|P3|NOT COMPLETED|Overall Study||8
7830096|NCT01059617|19272976|P2|NOT COMPLETED|Overall Study||1
7830097|NCT01059617|19272977|P1|NOT COMPLETED|Overall Study||7
7830098|NCT01059617|19272974|P4|COMPLETED|Overall Study||27
7830099|NCT01059617|19272975|P3|COMPLETED|Overall Study||25
7830100|NCT01059617|19272976|P2|COMPLETED|Overall Study||33
7830101|NCT01059617|19272977|P1|COMPLETED|Overall Study||26
7830102|NCT01059617|19272974|P4|STARTED|Overall Study||33
7830103|NCT01059617|19272975|P3|STARTED|Overall Study||33
7830104|NCT01059617|19272976|P2|STARTED|Overall Study||34
7830105|NCT01059617|19272977|P1|STARTED|Overall Study||33
7830106|NCT01059565|19273147|P2|NOT COMPLETED|24-Week Open-Label Phase||3
7830107|NCT01059565|19273148|P1|NOT COMPLETED|24-Week Open-Label Phase||5
7830108|NCT01059565|19273147|P2|COMPLETED|24-Week Open-Label Phase||42
7830109|NCT01059565|19273148|P1|COMPLETED|24-Week Open-Label Phase||34
7830110|NCT01059565|19273147|P2|STARTED|24-Week Open-Label Phase||45
7830111|NCT01059565|19273148|P1|STARTED|24-Week Open-Label Phase||39
7830112|NCT01059565|19273147|P2|NOT COMPLETED|24-Week Randomized Phase||7
7830113|NCT01059565|19273148|P1|NOT COMPLETED|24-Week Randomized Phase||10
7830114|NCT01059565|19273147|P2|COMPLETED|24-Week Randomized Phase||45
7830115|NCT01059565|19273148|P1|COMPLETED|24-Week Randomized Phase||39
7830116|NCT01059565|19273147|P2|Randomized and Treated|24-Week Randomized Phase||52
7830117|NCT01059565|19273148|P1|Randomized and Treated|24-Week Randomized Phase||48
7830118|NCT01059565|19273147|P2|STARTED|24-Week Randomized Phase||52
7830119|NCT01059565|19273148|P1|STARTED|24-Week Randomized Phase||49
7830120|NCT01059539|19273182|P1|NOT COMPLETED|Overall Study||271
7830121|NCT01059539|19273182|P1|COMPLETED|Overall Study||132
7830122|NCT01059539|19273182|P1|STARTED|Overall Study||403
7830123|NCT01059526|19273189|P2|NOT COMPLETED|Overall Study||22
7830124|NCT01059526|19273190|P1|NOT COMPLETED|Overall Study||30
7830125|NCT01059526|19273189|P2|COMPLETED|Overall Study||18
7830126|NCT01059526|19273190|P1|COMPLETED|Overall Study||11
7830127|NCT01059526|19273189|P2|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23
7830128|NCT01059526|19273190|P1|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21
7830129|NCT01059526|19273189|P2|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40
7830130|NCT01059526|19273190|P1|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41
7830131|NCT01059435|19273208|P10|NOT COMPLETED|Overall Study||0
7830132|NCT01059435|19273209|P9|NOT COMPLETED|Overall Study||0
7830133|NCT01059435|19273210|P8|NOT COMPLETED|Overall Study||0
7830134|NCT01059435|19273211|P7|NOT COMPLETED|Overall Study||0
7830135|NCT01059435|19273212|P6|NOT COMPLETED|Overall Study||0
7830136|NCT01059435|19273213|P5|NOT COMPLETED|Overall Study||0
7830137|NCT01059435|19273214|P4|NOT COMPLETED|Overall Study||0
7830138|NCT01059435|19273215|P3|NOT COMPLETED|Overall Study||2
7830139|NCT01059435|19273216|P2|NOT COMPLETED|Overall Study||0
7830140|NCT01059435|19273217|P1|NOT COMPLETED|Overall Study||0
7830141|NCT01059435|19273208|P10|COMPLETED|Overall Study||6
7830142|NCT01059435|19273209|P9|COMPLETED|Overall Study||6
7830143|NCT01059435|19273210|P8|COMPLETED|Overall Study||4
7830144|NCT01059435|19273211|P7|COMPLETED|Overall Study||6
7830145|NCT01059435|19273212|P6|COMPLETED|Overall Study||9
7830146|NCT01059435|19273213|P5|COMPLETED|Overall Study||6
7830147|NCT01059435|19273214|P4|COMPLETED|Overall Study||9
7830148|NCT01059435|19273215|P3|COMPLETED|Overall Study||6
7830149|NCT01059435|19273216|P2|COMPLETED|Overall Study||6
7830150|NCT01059435|19273217|P1|COMPLETED|Overall Study||14
7830151|NCT01059435|19273208|P10|Received Study Drug|Overall Study||6
7830152|NCT01059435|19273209|P9|Received Study Drug|Overall Study||6
7830153|NCT01059435|19273210|P8|Received Study Drug|Overall Study||4
7830154|NCT01059435|19273211|P7|Received Study Drug|Overall Study||6
7830155|NCT01059435|19273212|P6|Received Study Drug|Overall Study||9
7830156|NCT01059435|19273213|P5|Received Study Drug|Overall Study||6
7830157|NCT01059435|19273214|P4|Received Study Drug|Overall Study||9
7830158|NCT01059435|19273215|P3|Received Study Drug|Overall Study||6
7830159|NCT01059435|19273216|P2|Received Study Drug|Overall Study||6
7830160|NCT01059435|19273217|P1|Received Study Drug|Overall Study||14
7830161|NCT01059435|19273208|P10|STARTED|Overall Study||6
7830162|NCT01059435|19273209|P9|STARTED|Overall Study||6
7830163|NCT01059435|19273210|P8|STARTED|Overall Study||4
7830164|NCT01059435|19273211|P7|STARTED|Overall Study||6
7830165|NCT01059435|19273212|P6|STARTED|Overall Study||9
7830166|NCT01059435|19273213|P5|STARTED|Overall Study||6
7830167|NCT01059435|19273214|P4|STARTED|Overall Study||9
7830168|NCT01059435|19273215|P3|STARTED|Overall Study||8
7830169|NCT01059435|19273216|P2|STARTED|Overall Study||6
7830170|NCT01059435|19273217|P1|STARTED|Overall Study||14
7830171|NCT01059357|19273525|P1|NOT COMPLETED|Overall Study||4
7830172|NCT01059357|19273525|P1|COMPLETED|Overall Study||54
7830173|NCT01059357|19273525|P1|STARTED|Overall Study||58
7830174|NCT01059344|19273536|P2|NOT COMPLETED|Overall Study||46
7830175|NCT01059344|19273537|P1|NOT COMPLETED|Overall Study||22
7830176|NCT01059344|19273536|P2|COMPLETED|Overall Study||95
7830177|NCT01059344|19273537|P1|COMPLETED|Overall Study||118
7830178|NCT01059344|19273536|P2|STARTED|Overall Study||141
7830179|NCT01059344|19273537|P1|STARTED|Overall Study||140
7830180|NCT01059318|19273555|P1|NOT COMPLETED|Extension (36 Week)||3
7830181|NCT01059318|19273555|P1|COMPLETED|Extension (36 Week)||17
7830182|NCT01059318|19273555|P1|STARTED|Extension (36 Week)||20
7830183|NCT01059318|19273555|P1|NOT COMPLETED|Core Study (26 Week)||4
7830184|NCT01059318|19273555|P1|COMPLETED|Core Study (26 Week)||20
7830185|NCT01059318|19273555|P1|Pharmacokinetics (PK) Analysis Set|Core Study (26 Week)|For 8 patients plasma rather than whole blood sample was collected, hence excluded from PK set.|16
7830186|NCT01059318|19273555|P1|Everolimus 10 mg for 18 Weeks|Core Study (26 Week)||24
7830187|NCT01059318|19273555|P1|Everolimus 5 mg for 4 Weeks|Core Study (26 Week)||24
7830188|NCT01059318|19273555|P1|Everolimus 2.5 mg for 4 Weeks|Core Study (26 Week)||24
7830189|NCT01059318|19273555|P1|STARTED|Core Study (26 Week)|This is safety set and Pharmacodynamic set|24
7830190|NCT01059305|19273570|P1|NOT COMPLETED|Overall Study||0
7830191|NCT01059305|19273570|P1|COMPLETED|Overall Study||10
7830192|NCT01059305|19273570|P1|STARTED|Overall Study||10
7830193|NCT01059175|19273576|P2|NOT COMPLETED|Overall Study||20
7830194|NCT01059175|19273577|P1|NOT COMPLETED|Overall Study||21
7830195|NCT01059175|19273576|P2|COMPLETED|Overall Study|17 patients deceased 3 patients were prematurely exited|21
7830196|NCT01059175|19273577|P1|COMPLETED|Overall Study|17 patients deceased 4 additional patients were prematurely exited|22
7830197|NCT01059175|19273576|P2|STARTED|Overall Study||41
7830198|NCT01059175|19273577|P1|STARTED|Overall Study||43
7830199|NCT01059071|19273599|P4|NOT COMPLETED|Overall Study||6
7830200|NCT01059071|19273600|P3|NOT COMPLETED|Overall Study||2
7830201|NCT01059071|19273601|P2|NOT COMPLETED|Overall Study||4
7830202|NCT01059071|19273602|P1|NOT COMPLETED|Overall Study||2
7830203|NCT01059071|19273599|P4|COMPLETED|Overall Study||3
7830204|NCT01059071|19273600|P3|COMPLETED|Overall Study||1
7830205|NCT01059071|19273601|P2|COMPLETED|Overall Study||1
7830206|NCT01059071|19273602|P1|COMPLETED|Overall Study||2
7830207|NCT01059071|19273599|P4|STARTED|Overall Study||9
7830208|NCT01059071|19273600|P3|STARTED|Overall Study||3
7830209|NCT01059071|19273601|P2|STARTED|Overall Study||5
7830210|NCT01059071|19273602|P1|STARTED|Overall Study||4
7830211|NCT01058993|19273614|P1|NOT COMPLETED|Overall Study||0
7830212|NCT01058993|19273614|P1|COMPLETED|Overall Study||6
7830213|NCT01058993|19273614|P1|STARTED|Overall Study||6
7830214|NCT01058941|19273620|P2|NOT COMPLETED|Overall Study||11
7830215|NCT01058941|19273621|P1|NOT COMPLETED|Overall Study||9
7830216|NCT01058941|19273620|P2|COMPLETED|Overall Study||22
7830217|NCT01058941|19273621|P1|COMPLETED|Overall Study||25
7830218|NCT01058941|19273620|P2|STARTED|Overall Study||33
7830219|NCT01058941|19273621|P1|STARTED|Overall Study||34
7830220|NCT01058863|19273629|P1|NOT COMPLETED|Overall Study||4
7830221|NCT01058863|19273629|P1|COMPLETED|Overall Study||68
7830222|NCT01058863|19273629|P1|Treated With Placebo Inhaler|Overall Study||69
7830223|NCT01058863|19273629|P1|Treated With ProAir® HFA 180 mcg|Overall Study||68
7830224|NCT01058863|19273629|P1|Treated With ProAir® HFA 90 mcg|Overall Study||70
7830225|NCT01058863|19273629|P1|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68
7830226|NCT01058863|19273629|P1|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68
7830227|NCT01058863|19273629|P1|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71
7830228|NCT01058863|19273629|P1|STARTED|Overall Study||72
7830229|NCT01058707|19273654|P7|NOT COMPLETED|Overall Study||26
7830230|NCT01058707|19273655|P6|NOT COMPLETED|Overall Study||17
7830231|NCT01058707|19273656|P5|NOT COMPLETED|Overall Study||39
7830232|NCT01058707|19273657|P4|NOT COMPLETED|Overall Study||22
7830233|NCT01058707|19273658|P3|NOT COMPLETED|Overall Study||33
7830234|NCT01058707|19273659|P2|NOT COMPLETED|Overall Study||30
7830235|NCT01058707|19273660|P1|NOT COMPLETED|Overall Study||31
7830236|NCT01058707|19273654|P7|COMPLETED|Overall Study||0
7830237|NCT01058707|19273655|P6|COMPLETED|Overall Study||0
7830238|NCT01058707|19273656|P5|COMPLETED|Overall Study||0
7830239|NCT01058707|19273657|P4|COMPLETED|Overall Study||0
7830240|NCT01058707|19273658|P3|COMPLETED|Overall Study||0
7830241|NCT01058707|19273659|P2|COMPLETED|Overall Study||0
7830242|NCT01058707|19273660|P1|COMPLETED|Overall Study||0
7830243|NCT01058707|19273654|P7|STARTED|Overall Study||26
7830244|NCT01058707|19273655|P6|STARTED|Overall Study||17
7830245|NCT01058707|19273656|P5|STARTED|Overall Study||39
7830246|NCT01058707|19273657|P4|STARTED|Overall Study||22
7830247|NCT01058707|19273658|P3|STARTED|Overall Study||33
7830248|NCT01058707|19273659|P2|STARTED|Overall Study||30
7830249|NCT01058707|19273660|P1|STARTED|Overall Study||31
7830250|NCT01058668|19273826|P3|NOT COMPLETED|Safety Follow-up||7
7830251|NCT01058668|19273827|P2|NOT COMPLETED|Safety Follow-up||0
7830252|NCT01058668|19273828|P1|NOT COMPLETED|Safety Follow-up||5
7830253|NCT01058668|19273826|P3|COMPLETED|Safety Follow-up||141
7830254|NCT01058668|19273827|P2|COMPLETED|Safety Follow-up||146
7830255|NCT01058668|19273828|P1|COMPLETED|Safety Follow-up||139
7830256|NCT01058668|19273826|P3|STARTED|Safety Follow-up||148
7830257|NCT01058668|19273827|P2|STARTED|Safety Follow-up||146
7830258|NCT01058668|19273828|P1|STARTED|Safety Follow-up|Not all participants entered the Safety-Follow-up|144
7830259|NCT01058668|19273826|P3|NOT COMPLETED|Double-blind Treatment Phase||50
7830260|NCT01058668|19273827|P2|NOT COMPLETED|Double-blind Treatment Phase||38
7830261|NCT01058668|19273828|P1|NOT COMPLETED|Double-blind Treatment Phase||39
7830262|NCT01058668|19273826|P3|COMPLETED|Double-blind Treatment Phase||119
7830263|NCT01058668|19273827|P2|COMPLETED|Double-blind Treatment Phase||129
7830264|NCT01058668|19273828|P1|COMPLETED|Double-blind Treatment Phase||122
7830265|NCT01058668|19273826|P3|STARTED|Double-blind Treatment Phase||169
7830266|NCT01058668|19273827|P2|STARTED|Double-blind Treatment Phase||167
7830267|NCT01058668|19273828|P1|STARTED|Double-blind Treatment Phase||161
7830268|NCT01058655|19273843|P4|NOT COMPLETED|Overall Study||42
7830269|NCT01058655|19273844|P3|NOT COMPLETED|Overall Study||8
7830270|NCT01058655|19273845|P2|NOT COMPLETED|Overall Study||3
7830271|NCT01058655|19273846|P1|NOT COMPLETED|Overall Study||3
7830272|NCT01058655|19273843|P4|COMPLETED|Overall Study||0
7830273|NCT01058655|19273844|P3|COMPLETED|Overall Study||0
7830274|NCT01058655|19273845|P2|COMPLETED|Overall Study||0
7830275|NCT01058655|19273846|P1|COMPLETED|Overall Study||0
7830276|NCT01058655|19273843|P4|Evaluable|Overall Study||40
7830277|NCT01058655|19273844|P3|Evaluable|Overall Study||6
7830278|NCT01058655|19273845|P2|Evaluable|Overall Study||3
7830279|NCT01058655|19273846|P1|Evaluable|Overall Study||3
7830280|NCT01058655|19273843|P4|STARTED|Overall Study||42
7830281|NCT01058655|19273844|P3|STARTED|Overall Study||8
7830282|NCT01058655|19273845|P2|STARTED|Overall Study||3
7830283|NCT01058655|19273846|P1|STARTED|Overall Study||3
7830284|NCT01058642|19273864|P4|NOT COMPLETED|Treatment Period 2||0
7830285|NCT01058642|19273865|P3|NOT COMPLETED|Treatment Period 2||0
7830286|NCT01058642|19273866|P2|NOT COMPLETED|Treatment Period 2||0
7830287|NCT01058642|19273867|P1|NOT COMPLETED|Treatment Period 2||0
7830288|NCT01058642|19273864|P4|COMPLETED|Treatment Period 2||7
7830289|NCT01058642|19273865|P3|COMPLETED|Treatment Period 2||9
7830290|NCT01058642|19273866|P2|COMPLETED|Treatment Period 2||11
7830291|NCT01058642|19273867|P1|COMPLETED|Treatment Period 2||7
7830292|NCT01058642|19273864|P4|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
7830293|NCT01058642|19273865|P3|Received at Least 1 Dose of Study Drug|Treatment Period 2||9
7830294|NCT01058642|19273866|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||11
7830295|NCT01058642|19273867|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
7830296|NCT01058642|19273864|P4|STARTED|Treatment Period 2||7
7830297|NCT01058642|19273865|P3|STARTED|Treatment Period 2||9
7830298|NCT01058642|19273866|P2|STARTED|Treatment Period 2||11
7830299|NCT01058642|19273867|P1|STARTED|Treatment Period 2||7
7830300|NCT01058642|19273864|P4|NOT COMPLETED|Washout Period||0
7830301|NCT01058642|19273865|P3|NOT COMPLETED|Washout Period||0
7830302|NCT01058642|19273866|P2|NOT COMPLETED|Washout Period||0
7830303|NCT01058642|19273867|P1|NOT COMPLETED|Washout Period||0
7830304|NCT01058642|19273864|P4|COMPLETED|Washout Period||7
7830305|NCT01058642|19273865|P3|COMPLETED|Washout Period||9
7830306|NCT01058642|19273866|P2|COMPLETED|Washout Period||11
7830307|NCT01058642|19273867|P1|COMPLETED|Washout Period||7
7830308|NCT01058642|19273864|P4|STARTED|Washout Period||7
7830309|NCT01058642|19273865|P3|STARTED|Washout Period||9
7830310|NCT01058642|19273866|P2|STARTED|Washout Period||11
7830311|NCT01058642|19273867|P1|STARTED|Washout Period||7
7830312|NCT01058642|19273864|P4|NOT COMPLETED|Treatment Period 1||2
7830313|NCT01058642|19273865|P3|NOT COMPLETED|Treatment Period 1||2
7830314|NCT01058642|19273866|P2|NOT COMPLETED|Treatment Period 1||1
7830315|NCT01058642|19273867|P1|NOT COMPLETED|Treatment Period 1||2
7830316|NCT01058642|19273864|P4|COMPLETED|Treatment Period 1||7
7830317|NCT01058642|19273865|P3|COMPLETED|Treatment Period 1||9
7830318|NCT01058642|19273866|P2|COMPLETED|Treatment Period 1||11
7830319|NCT01058642|19273867|P1|COMPLETED|Treatment Period 1||7
7830320|NCT01058642|19273864|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
7830321|NCT01058642|19273865|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1||11
7830322|NCT01058642|19273866|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||12
7830323|NCT01058642|19273867|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
7830324|NCT01058642|19273864|P4|STARTED|Treatment Period 1||9
7830325|NCT01058642|19273865|P3|STARTED|Treatment Period 1||11
7830326|NCT01058642|19273866|P2|STARTED|Treatment Period 1||12
7830327|NCT01058642|19273867|P1|STARTED|Treatment Period 1||9
7830328|NCT01058421|19273877|P2|NOT COMPLETED|6 Month Outcomes||26
7830329|NCT01058421|19273878|P1|NOT COMPLETED|6 Month Outcomes||19
7830330|NCT01058421|19273877|P2|COMPLETED|6 Month Outcomes||24
7830331|NCT01058421|19273878|P1|COMPLETED|6 Month Outcomes||27
7830332|NCT01058421|19273877|P2|STARTED|6 Month Outcomes|61 (subjects started Period 1) minus 11 (deceased subjects in Periods 1 & 2) = 50 started Period 3.|50
7830333|NCT01058421|19273878|P1|STARTED|6 Month Outcomes|55 (subjects started Period 1) minus 13 (deceased subjects in Periods 1 & 2) = 46 started Period 3.|46
7830334|NCT01058421|19273877|P2|NOT COMPLETED|3 Month Outcomes||26
7830335|NCT01058421|19273878|P1|NOT COMPLETED|3 Month Outcomes||20
7830336|NCT01058421|19273877|P2|COMPLETED|3 Month Outcomes||29
7830337|NCT01058421|19273878|P1|COMPLETED|3 Month Outcomes||29
7830338|NCT01058421|19273877|P2|STARTED|3 Month Outcomes|61 (Subjects started Period 1) minus 6 (deceased subjects during Period 1) = 55 started Period 2.|55
7830339|NCT01058421|19273878|P1|STARTED|3 Month Outcomes|59 (Subjects started Period 1) minus 10 (deceased subjects during Period 1) = 49 started Period 2.|49
7830340|NCT01058421|19273877|P2|NOT COMPLETED|1 Month Outcomes||42
7830341|NCT01058421|19273878|P1|NOT COMPLETED|1 Month Outcomes||39
7830342|NCT01058421|19273877|P2|COMPLETED|1 Month Outcomes||19
7830343|NCT01058421|19273878|P1|COMPLETED|1 Month Outcomes||20
7830344|NCT01058421|19273877|P2|STARTED|1 Month Outcomes||61
7830345|NCT01058421|19273878|P1|STARTED|1 Month Outcomes||59
7830346|NCT01058395|19273902|P2|NOT COMPLETED|Overall Study||1
7830347|NCT01058395|19273903|P1|NOT COMPLETED|Overall Study||3
7830348|NCT01058395|19273902|P2|COMPLETED|Overall Study|One died after enrollment. The patient died in the first 48 hours.|7
7830349|NCT01058395|19273903|P1|COMPLETED|Overall Study|Two died, and one was lost to followup.|4
7830350|NCT01058395|19273902|P2|STARTED|Overall Study||8
7830351|NCT01058395|19273903|P1|STARTED|Overall Study||7
7830352|NCT01058369|19273912|P1|NOT COMPLETED|Overall Study||2
7830353|NCT01058369|19273912|P1|COMPLETED|Overall Study||0
7830354|NCT01058369|19273912|P1|STARTED|Overall Study||2
7830355|NCT01058356|19273916|P1|NOT COMPLETED|Overall Study||42
7830356|NCT01058356|19273916|P1|COMPLETED|Overall Study||172
7830357|NCT01058356|19273916|P1|STARTED|Overall Study||214
7830358|NCT01058304|19273923|P2|NOT COMPLETED|Overall Study||33
7830359|NCT01058304|19273924|P1|NOT COMPLETED|Overall Study||27
7830360|NCT01058304|19273923|P2|COMPLETED|Overall Study||128
7830361|NCT01058304|19273924|P1|COMPLETED|Overall Study||132
7830362|NCT01058304|19273923|P2|STARTED|Overall Study||161
7830363|NCT01058304|19273924|P1|STARTED|Overall Study||159
7830364|NCT01058265|19273934|P2|NOT COMPLETED|Overall Study||12
7830365|NCT01058265|19273935|P1|NOT COMPLETED|Overall Study||11
7830366|NCT01058265|19273934|P2|COMPLETED|Overall Study||13
7830367|NCT01058265|19273935|P1|COMPLETED|Overall Study||11
7830368|NCT01058265|19273934|P2|STARTED|Overall Study||25
7830369|NCT01058265|19273935|P1|STARTED|Overall Study||22
7830370|NCT01058239|19273943|P1|NOT COMPLETED|Overall Study||0
7830371|NCT01058239|19273943|P1|COMPLETED|Overall Study||7
7830372|NCT01058239|19273943|P1|STARTED|Overall Study||7
7830373|NCT01058096|19273954|P2|NOT COMPLETED|Safety Follow-up||4
7830374|NCT01058096|19273955|P1|NOT COMPLETED|Safety Follow-up||4
7830375|NCT01058096|19273954|P2|COMPLETED|Safety Follow-up||130
7830376|NCT01058096|19273955|P1|COMPLETED|Safety Follow-up||129
7830377|NCT01058096|19273954|P2|STARTED|Safety Follow-up||134
7830378|NCT01058096|19273955|P1|STARTED|Safety Follow-up|Not all participants continued to Safety Follow-up.|133
7830379|NCT01058096|19273954|P2|NOT COMPLETED|Double-blind Treatment Phase||50
7830380|NCT01058096|19273955|P1|NOT COMPLETED|Double-blind Treatment Phase||48
7830381|NCT01058096|19273954|P2|COMPLETED|Double-blind Treatment Phase||108
7830382|NCT01058096|19273955|P1|COMPLETED|Double-blind Treatment Phase||106
7830383|NCT01058096|19273954|P2|STARTED|Double-blind Treatment Phase||158
7830384|NCT01058096|19273955|P1|STARTED|Double-blind Treatment Phase||154
7830385|NCT01058070|19273963|P1|NOT COMPLETED|Overall Study||11
7830386|NCT01058070|19273963|P1|COMPLETED|Overall Study||33
7830387|NCT01058070|19273963|P1|STARTED|Overall Study||44
7830388|NCT01058005|19273971|P3|NOT COMPLETED|Overall Study||20
7830389|NCT01058005|19273972|P2|NOT COMPLETED|Overall Study||25
7830390|NCT01058005|19273973|P1|NOT COMPLETED|Overall Study||38
7830391|NCT01058005|19273971|P3|COMPLETED|Overall Study||1
7830392|NCT01058005|19273972|P2|COMPLETED|Overall Study||0
7830393|NCT01058005|19273973|P1|COMPLETED|Overall Study||0
7830394|NCT01058005|19273971|P3|Dosed With Study Treatment|Overall Study||17
7830395|NCT01058005|19273972|P2|Dosed With Study Treatment|Overall Study||22
7830396|NCT01058005|19273973|P1|Dosed With Study Treatment|Overall Study||36
7830397|NCT01058005|19273971|P3|STARTED|Overall Study||21
7830398|NCT01058005|19273972|P2|STARTED|Overall Study||25
7830399|NCT01058005|19273973|P1|STARTED|Overall Study||38
7830400|NCT01057901|19273983|P2|NOT COMPLETED|Overall Study||246
7830401|NCT01057901|19273984|P1|NOT COMPLETED|Overall Study||260
7830402|NCT01057901|19273983|P2|COMPLETED|Overall Study||126
7830403|NCT01057901|19273984|P1|COMPLETED|Overall Study||116
7830404|NCT01057901|19273983|P2|STARTED|Overall Study||372
7830405|NCT01057901|19273984|P1|STARTED|Overall Study||376
7830406|NCT01057888|19273995|P3|NOT COMPLETED|Overall Study||0
7830407|NCT01057888|19273996|P2|NOT COMPLETED|Overall Study||0
7830408|NCT01057888|19273997|P1|NOT COMPLETED|Overall Study||0
7830409|NCT01057888|19273995|P3|COMPLETED|Overall Study||2494
7830410|NCT01057888|19273996|P2|COMPLETED|Overall Study||2406
7830411|NCT01057888|19273997|P1|COMPLETED|Overall Study||2504
7830412|NCT01057888|19273995|P3|STARTED|Overall Study||2494
7830413|NCT01057888|19273996|P2|STARTED|Overall Study||2406
7830414|NCT01057888|19273997|P1|STARTED|Overall Study||2504
7830415|NCT01057862|19274008|P2|NOT COMPLETED|Overall Study||2
7830416|NCT01057862|19274009|P1|NOT COMPLETED|Overall Study||1
7830417|NCT01057862|19274008|P2|COMPLETED|Overall Study||2
7830418|NCT01057862|19274009|P1|COMPLETED|Overall Study||4
7830419|NCT01057862|19274008|P2|STARTED|Overall Study||4
7830420|NCT01057862|19274009|P1|STARTED|Overall Study||5
7830421|NCT01057810|19274019|P2|NOT COMPLETED|Overall Study||398
7830422|NCT01057810|19274020|P1|NOT COMPLETED|Overall Study||198
7830423|NCT01057810|19274019|P2|COMPLETED|Overall Study||1
7830424|NCT01057810|19274020|P1|COMPLETED|Overall Study||1
7830425|NCT01057810|19274019|P2|STARTED|Overall Study||399
7830426|NCT01057810|19274020|P1|STARTED|Overall Study||199
7830427|NCT01057693|19274036|P3|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36
7830428|NCT01057693|19274037|P2|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22
7830429|NCT01057693|19274038|P1|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
7830430|NCT01057693|19274036|P3|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113
7830431|NCT01057693|19274037|P2|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125
7830432|NCT01057693|19274038|P1|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
7830433|NCT01057693|19274036|P3|Treated|Double-Blind Phase (Week 7 to Week 19)||147
7830434|NCT01057693|19274037|P2|Treated|Double-Blind Phase (Week 7 to Week 19)||147
7830435|NCT01057693|19274038|P1|Treated|Double-Blind Phase (Week 7 to Week 19)||0
7830436|NCT01057693|19274036|P3|STARTED|Double-Blind Phase (Week 7 to Week 19)||149
7830437|NCT01057693|19274037|P2|STARTED|Double-Blind Phase (Week 7 to Week 19)||147
7830438|NCT01057693|19274038|P1|STARTED|Double-Blind Phase (Week 7 to Week 19)||0
7830439|NCT01057693|19274036|P3|NOT COMPLETED|Between Single-Blind and Double-Blind||0
7830440|NCT01057693|19274037|P2|NOT COMPLETED|Between Single-Blind and Double-Blind||0
7830441|NCT01057693|19274038|P1|NOT COMPLETED|Between Single-Blind and Double-Blind||270
7830442|NCT01057693|19274036|P3|COMPLETED|Between Single-Blind and Double-Blind||0
7830443|NCT01057693|19274037|P2|COMPLETED|Between Single-Blind and Double-Blind||0
7830444|NCT01057693|19274038|P1|COMPLETED|Between Single-Blind and Double-Blind||296
7830445|NCT01057693|19274036|P3|STARTED|Between Single-Blind and Double-Blind||0
7830446|NCT01057693|19274037|P2|STARTED|Between Single-Blind and Double-Blind||0
7830447|NCT01057693|19274038|P1|STARTED|Between Single-Blind and Double-Blind||566
7830448|NCT01057693|19274036|P3|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
7830449|NCT01057693|19274037|P2|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
7830450|NCT01057693|19274038|P1|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99
7830451|NCT01057693|19274036|P3|COMPLETED|Single-Blind Phase (Up to Week 6)||0
7830452|NCT01057693|19274037|P2|COMPLETED|Single-Blind Phase (Up to Week 6)||0
7830453|NCT01057693|19274038|P1|COMPLETED|Single-Blind Phase (Up to Week 6)||566
7830454|NCT01057693|19274036|P3|STARTED|Single-Blind Phase (Up to Week 6)||0
7830455|NCT01057693|19274037|P2|STARTED|Single-Blind Phase (Up to Week 6)||0
7830456|NCT01057693|19274038|P1|STARTED|Single-Blind Phase (Up to Week 6)||665
7830457|NCT01057589|19274084|P1|NOT COMPLETED|Overall Study||66
7830458|NCT01057589|19274084|P1|COMPLETED|Overall Study||0
7830459|NCT01057589|19274084|P1|STARTED|Overall Study||66
7830460|NCT01057433|19274093|P1|NOT COMPLETED|Overall Study||1
7830461|NCT01057433|19274093|P1|COMPLETED|Overall Study||23
7830462|NCT01057433|19274093|P1|STARTED|Overall Study||24
7830463|NCT01057394|19274097|P2|NOT COMPLETED|Overall Study||2
7830464|NCT01057394|19274098|P1|NOT COMPLETED|Overall Study||0
7830465|NCT01057394|19274097|P2|COMPLETED|Overall Study|19 treated participants|19
7830466|NCT01057394|19274098|P1|COMPLETED|Overall Study||0
7830467|NCT01057394|19274097|P2|STARTED|Overall Study|21 enrolled participants|21
7830468|NCT01057394|19274098|P1|STARTED|Overall Study||0
7830469|NCT01057277|19274102|P1|NOT COMPLETED|Overall Study||0
7830470|NCT01057277|19274102|P1|COMPLETED|Overall Study||3
7830471|NCT01057277|19274102|P1|STARTED|Overall Study||3
7830472|NCT01057251|19274108|P2|NOT COMPLETED|Overall Study||29
7830473|NCT01057251|19274109|P1|NOT COMPLETED|Overall Study||28
7830474|NCT01057251|19274108|P2|COMPLETED|Overall Study||114
7830475|NCT01057251|19274109|P1|COMPLETED|Overall Study||262
7830476|NCT01057251|19274108|P2|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143
7830477|NCT01057251|19274109|P1|STARTED|Overall Study||290
7830478|NCT01057225|19274117|P6|NOT COMPLETED|Overall Study||0
7830479|NCT01057225|19274118|P5|NOT COMPLETED|Overall Study||0
7830480|NCT01057225|19274119|P4|NOT COMPLETED|Overall Study||0
7830481|NCT01057225|19274120|P3|NOT COMPLETED|Overall Study||0
7830482|NCT01057225|19274121|P2|NOT COMPLETED|Overall Study||0
7830483|NCT01057225|19274122|P1|NOT COMPLETED|Overall Study||0
7830484|NCT01057225|19274117|P6|COMPLETED|Overall Study||23
7830485|NCT01057225|19274118|P5|COMPLETED|Overall Study||22
7830486|NCT01057225|19274119|P4|COMPLETED|Overall Study||7
7830487|NCT01057225|19274120|P3|COMPLETED|Overall Study||6
7830488|NCT01057225|19274121|P2|COMPLETED|Overall Study||3
7830489|NCT01057225|19274122|P1|COMPLETED|Overall Study||3
7830490|NCT01057225|19274117|P6|STARTED|Overall Study||23
7830491|NCT01057225|19274118|P5|STARTED|Overall Study||22
7830492|NCT01057225|19274119|P4|STARTED|Overall Study||7
7830493|NCT01057225|19274120|P3|STARTED|Overall Study||6
7830494|NCT01057225|19274121|P2|STARTED|Overall Study||3
7830495|NCT01057225|19274122|P1|STARTED|Overall Study||3
7830496|NCT01057121|19274144|P5|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
7830497|NCT01057121|19274145|P4|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
7830498|NCT01057121|19274146|P3|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
7830499|NCT01057121|19274147|P2|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
7830500|NCT01057121|19274148|P1|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
7830501|NCT01057121|19274144|P5|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23
7830502|NCT01057121|19274145|P4|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
7830503|NCT01057121|19274146|P3|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
7830504|NCT01057121|19274147|P2|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
7830505|NCT01057121|19274148|P1|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
7830506|NCT01057121|19274144|P5|STARTED|Phase II: 25 mg/Day Lenalidomide||23
7830507|NCT01057121|19274145|P4|STARTED|Phase II: 25 mg/Day Lenalidomide||0
7830508|NCT01057121|19274146|P3|STARTED|Phase II: 25 mg/Day Lenalidomide||0
7830509|NCT01057121|19274147|P2|STARTED|Phase II: 25 mg/Day Lenalidomide||0
7830510|NCT01057121|19274148|P1|STARTED|Phase II: 25 mg/Day Lenalidomide||0
7830511|NCT01057121|19274144|P5|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
7830512|NCT01057121|19274145|P4|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
7830513|NCT01057121|19274146|P3|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
7830514|NCT01057121|19274147|P2|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
7830515|NCT01057121|19274148|P1|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
7830516|NCT01057121|19274144|P5|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
7830517|NCT01057121|19274145|P4|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6
7830518|NCT01057121|19274146|P3|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
7830519|NCT01057121|19274147|P2|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
7830520|NCT01057121|19274148|P1|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
7830521|NCT01057121|19274144|P5|STARTED|Phase I: 25 mg/Day Lenalidomide||0
7830522|NCT01057121|19274145|P4|STARTED|Phase I: 25 mg/Day Lenalidomide||6
7830523|NCT01057121|19274146|P3|STARTED|Phase I: 25 mg/Day Lenalidomide||0
7830524|NCT01057121|19274147|P2|STARTED|Phase I: 25 mg/Day Lenalidomide||0
7830525|NCT01057121|19274148|P1|STARTED|Phase I: 25 mg/Day Lenalidomide||0
7830526|NCT01057121|19274144|P5|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
7830527|NCT01057121|19274145|P4|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
7830528|NCT01057121|19274146|P3|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
7830529|NCT01057121|19274147|P2|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
7830530|NCT01057121|19274148|P1|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
7830531|NCT01057121|19274144|P5|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
7830532|NCT01057121|19274145|P4|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
7830533|NCT01057121|19274146|P3|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3
7830534|NCT01057121|19274147|P2|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
7830535|NCT01057121|19274148|P1|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
7830536|NCT01057121|19274144|P5|STARTED|Phase I: 20 mg/Day Lenalidomide||0
7830537|NCT01057121|19274145|P4|STARTED|Phase I: 20 mg/Day Lenalidomide||0
7830538|NCT01057121|19274146|P3|STARTED|Phase I: 20 mg/Day Lenalidomide||3
7830539|NCT01057121|19274147|P2|STARTED|Phase I: 20 mg/Day Lenalidomide||0
7830540|NCT01057121|19274148|P1|STARTED|Phase I: 20 mg/Day Lenalidomide||0
7830541|NCT01057121|19274144|P5|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
7830542|NCT01057121|19274145|P4|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
7830543|NCT01057121|19274146|P3|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
7830544|NCT01057121|19274147|P2|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
7830545|NCT01057121|19274148|P1|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
7830546|NCT01057121|19274144|P5|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
7830547|NCT01057121|19274145|P4|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
7830548|NCT01057121|19274146|P3|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
7830549|NCT01057121|19274147|P2|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3
7830550|NCT01057121|19274148|P1|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
7830551|NCT01057121|19274144|P5|STARTED|Phase I: 15 mg/Day Lenolidomide||0
7830552|NCT01057121|19274145|P4|STARTED|Phase I: 15 mg/Day Lenolidomide||0
7830553|NCT01057121|19274146|P3|STARTED|Phase I: 15 mg/Day Lenolidomide||0
7830554|NCT01057121|19274147|P2|STARTED|Phase I: 15 mg/Day Lenolidomide||3
7830555|NCT01057121|19274148|P1|STARTED|Phase I: 15 mg/Day Lenolidomide||0
7830556|NCT01057121|19274144|P5|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
7830557|NCT01057121|19274145|P4|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
7830558|NCT01057121|19274146|P3|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
7830559|NCT01057121|19274147|P2|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
7830560|NCT01057121|19274148|P1|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
7830561|NCT01057121|19274144|P5|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
7830562|NCT01057121|19274145|P4|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
7830563|NCT01057121|19274146|P3|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
7830564|NCT01057121|19274147|P2|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
7830565|NCT01057121|19274148|P1|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3
7830566|NCT01057121|19274144|P5|STARTED|Phase I: 10 mg/Day Lenalidomide||0
7830567|NCT01057121|19274145|P4|STARTED|Phase I: 10 mg/Day Lenalidomide||0
7830568|NCT01057121|19274146|P3|STARTED|Phase I: 10 mg/Day Lenalidomide||0
7830569|NCT01057121|19274147|P2|STARTED|Phase I: 10 mg/Day Lenalidomide||0
7830570|NCT01057121|19274148|P1|STARTED|Phase I: 10 mg/Day Lenalidomide||3
7830571|NCT01057017|19274177|P1|NOT COMPLETED|Overall Study||0
7830572|NCT01057017|19274177|P1|COMPLETED|Overall Study||5
7830573|NCT01057017|19274177|P1|STARTED|Overall Study||5
7830574|NCT01056913|19274181|P1|NOT COMPLETED|Overall Study||0
7830575|NCT01056913|19274181|P1|COMPLETED|Overall Study||62
7830576|NCT01056913|19274181|P1|STARTED|Overall Study||62
7830577|NCT01056822|19274187|P2|NOT COMPLETED|Overall Study||7
7830578|NCT01056822|19274188|P1|NOT COMPLETED|Overall Study||8
7830579|NCT01056822|19274187|P2|COMPLETED|Overall Study||35
7830580|NCT01056822|19274188|P1|COMPLETED|Overall Study||39
7830581|NCT01056822|19274187|P2|Safety (SAF) Population: NO|Overall Study||2
7830582|NCT01056822|19274188|P1|Safety (SAF) Population: NO|Overall Study||1
7830583|NCT01056822|19274187|P2|Safety (SAF) Population: YES|Overall Study||40
7830584|NCT01056822|19274188|P1|Safety (SAF) Population: YES|Overall Study||46
7830585|NCT01056822|19274187|P2|Per-protocol (PP) Population: NO|Overall Study||17
7830586|NCT01056822|19274188|P1|Per-protocol (PP) Population: NO|Overall Study||18
7830587|NCT01056822|19274187|P2|Per-protocol (PP) Population: YES|Overall Study||25
7830588|NCT01056822|19274188|P1|Per-protocol (PP) Population: YES|Overall Study||29
7830589|NCT01056822|19274187|P2|Intention-to-treat (ITT) Population: NO|Overall Study||4
7830590|NCT01056822|19274188|P1|Intention-to-treat (ITT) Population: NO|Overall Study||4
7830591|NCT01056822|19274187|P2|Intention-to-treat (ITT) Population: YES|Overall Study||38
7830592|NCT01056822|19274188|P1|Intention-to-treat (ITT) Population: YES|Overall Study||43
7830593|NCT01056822|19274187|P2|STARTED|Overall Study||42
7830594|NCT01056822|19274188|P1|STARTED|Overall Study||47
7830595|NCT01056718|19274237|P1|NOT COMPLETED|Overall Study||3
7830596|NCT01056718|19274237|P1|COMPLETED|Overall Study||50
7830597|NCT01056718|19274237|P1|STARTED|Overall Study||53
7830598|NCT01056653|19274270|P3|NOT COMPLETED|Overall Study||2
7830599|NCT01056653|19274271|P2|NOT COMPLETED|Overall Study||0
7830600|NCT01056653|19274272|P1|NOT COMPLETED|Overall Study||0
7830601|NCT01056653|19274270|P3|COMPLETED|Overall Study|2 were lost to follow-up because one mother left the country and one father was too busy.|42
7830602|NCT01056653|19274271|P2|COMPLETED|Overall Study||23
7830603|NCT01056653|19274272|P1|COMPLETED|Overall Study||46
7830604|NCT01056653|19274270|P3|STARTED|Overall Study||44
7830605|NCT01056653|19274271|P2|STARTED|Overall Study||23
7830606|NCT01056653|19274272|P1|STARTED|Overall Study||46
7830607|NCT01056640|19274288|P2|NOT COMPLETED|Overall Study||12
7830608|NCT01056640|19274289|P1|NOT COMPLETED|Overall Study||26
7830609|NCT01056640|19274288|P2|COMPLETED|Overall Study||91
7830610|NCT01056640|19274289|P1|COMPLETED|Overall Study||76
7830611|NCT01056640|19274288|P2|STARTED|Overall Study||103
7830612|NCT01056640|19274289|P1|STARTED|Overall Study||102
7830613|NCT01056601|19274295|P1|NOT COMPLETED|Overall Study||0
7830614|NCT01056601|19274295|P1|COMPLETED|Overall Study||7
7830615|NCT01056601|19274295|P1|STARTED|Overall Study||7
7830616|NCT01056536|19274304|P3|NOT COMPLETED|Overall Study||248
7830617|NCT01056536|19274305|P2|NOT COMPLETED|Overall Study||116
7830618|NCT01056536|19274306|P1|NOT COMPLETED|Overall Study||202
7830619|NCT01056536|19274304|P3|COMPLETED|Overall Study||481
7830620|NCT01056536|19274305|P2|COMPLETED|Overall Study||240
7830621|NCT01056536|19274306|P1|COMPLETED|Overall Study||394
7830622|NCT01056536|19274304|P3|STARTED|Overall Study||729
7830623|NCT01056536|19274305|P2|STARTED|Overall Study||356
7830624|NCT01056536|19274306|P1|STARTED|Overall Study||596
7830625|NCT01056523|19274317|P7|NOT COMPLETED|Overall Study||1
7830626|NCT01056523|19274318|P6|NOT COMPLETED|Overall Study||0
7830627|NCT01056523|19274319|P5|NOT COMPLETED|Overall Study||0
7830628|NCT01056523|19274320|P4|NOT COMPLETED|Overall Study||3
7830629|NCT01056523|19274321|P3|NOT COMPLETED|Overall Study||2
7830630|NCT01056523|19274322|P2|NOT COMPLETED|Overall Study||0
7830631|NCT01056523|19274323|P1|NOT COMPLETED|Overall Study||1
7830632|NCT01056523|19274317|P7|COMPLETED|Overall Study||4
7830633|NCT01056523|19274318|P6|COMPLETED|Overall Study||3
7830634|NCT01056523|19274319|P5|COMPLETED|Overall Study||3
7830635|NCT01056523|19274320|P4|COMPLETED|Overall Study||3
7830636|NCT01056523|19274321|P3|COMPLETED|Overall Study||3
7830637|NCT01056523|19274322|P2|COMPLETED|Overall Study||3
7830638|NCT01056523|19274323|P1|COMPLETED|Overall Study||3
7830639|NCT01056523|19274317|P7|STARTED|Overall Study||5
7830640|NCT01056523|19274318|P6|STARTED|Overall Study||3
7830641|NCT01056523|19274319|P5|STARTED|Overall Study||3
7830642|NCT01056523|19274320|P4|STARTED|Overall Study||6
7830643|NCT01056523|19274321|P3|STARTED|Overall Study||5
7830644|NCT01056523|19274322|P2|STARTED|Overall Study||3
7830645|NCT01056523|19274323|P1|STARTED|Overall Study||4
7830646|NCT01056510|19274333|P2|NOT COMPLETED|Overall Study||64
7830647|NCT01056510|19274334|P1|NOT COMPLETED|Overall Study||54
7830648|NCT01056510|19274333|P2|COMPLETED|Overall Study||115
7830649|NCT01056510|19274334|P1|COMPLETED|Overall Study||124
7830650|NCT01056510|19274333|P2|STARTED|Overall Study||179
7830651|NCT01056510|19274334|P1|STARTED|Overall Study||178
7830652|NCT01056484|19274380|P2|NOT COMPLETED|Follow up - Non-randomized||2
7830653|NCT01056484|19274381|P1|NOT COMPLETED|Follow up - Non-randomized||0
7830654|NCT01056484|19274380|P2|COMPLETED|Follow up - Non-randomized||56
7830655|NCT01056484|19274381|P1|COMPLETED|Follow up - Non-randomized||57
7830656|NCT01056484|19274380|P2|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58
7830657|NCT01056484|19274381|P1|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57
7830658|NCT01056484|19274380|P2|NOT COMPLETED|Randomized Controlled Trial||1
7830659|NCT01056484|19274381|P1|NOT COMPLETED|Randomized Controlled Trial||7
7830660|NCT01056484|19274380|P2|COMPLETED|Randomized Controlled Trial||58
7830661|NCT01056484|19274381|P1|COMPLETED|Randomized Controlled Trial||57
7830662|NCT01056484|19274380|P2|STARTED|Randomized Controlled Trial||59
7830663|NCT01056484|19274381|P1|STARTED|Randomized Controlled Trial||64
7830664|NCT01056380|19274397|P2|NOT COMPLETED|Overall Study||3
7830665|NCT01056380|19274398|P1|NOT COMPLETED|Overall Study||2
7830666|NCT01056380|19274397|P2|COMPLETED|Overall Study||39
7830667|NCT01056380|19274398|P1|COMPLETED|Overall Study||35
7830668|NCT01056380|19274397|P2|STARTED|Overall Study||42
7830669|NCT01056380|19274398|P1|STARTED|Overall Study||37
7830670|NCT01056341|19274425|P5|NOT COMPLETED|Overall Study||14
7830671|NCT01056341|19274426|P4|NOT COMPLETED|Overall Study||36
7830672|NCT01056341|19274427|P3|NOT COMPLETED|Overall Study||15
7830673|NCT01056341|19274428|P2|NOT COMPLETED|Overall Study||36
7830674|NCT01056341|19274429|P1|NOT COMPLETED|Overall Study||36
7830675|NCT01056341|19274425|P5|COMPLETED|Overall Study||88
7830676|NCT01056341|19274426|P4|COMPLETED|Overall Study||65
7830677|NCT01056341|19274427|P3|COMPLETED|Overall Study||88
7830678|NCT01056341|19274428|P2|COMPLETED|Overall Study||63
7830679|NCT01056341|19274429|P1|COMPLETED|Overall Study||19
7830680|NCT01056341|19274425|P5|Interim Analysis|Overall Study||43
7830681|NCT01056341|19274426|P4|Interim Analysis|Overall Study||40
7830682|NCT01056341|19274427|P3|Interim Analysis|Overall Study||41
7830683|NCT01056341|19274428|P2|Interim Analysis|Overall Study||41
7830684|NCT01056341|19274429|P1|Interim Analysis|Overall Study||25
7830685|NCT01056341|19274425|P5|STARTED|Overall Study||102
7830686|NCT01056341|19274426|P4|STARTED|Overall Study||101
7830687|NCT01056341|19274427|P3|STARTED|Overall Study||103
7830688|NCT01056341|19274428|P2|STARTED|Overall Study||99
7830689|NCT01056341|19274429|P1|STARTED|Overall Study||55
7830690|NCT01056328|19274450|P2|NOT COMPLETED|Overall Study||16
7830691|NCT01056328|19274451|P1|NOT COMPLETED|Overall Study||17
7830692|NCT01056328|19274450|P2|COMPLETED|Overall Study||144
7830693|NCT01056328|19274451|P1|COMPLETED|Overall Study||147
7830694|NCT01056328|19274450|P2|STARTED|Overall Study||160
7830695|NCT01056328|19274451|P1|STARTED|Overall Study||164
7830696|NCT01056315|19274467|P2|NOT COMPLETED|Overall Study||11
7830697|NCT01056315|19274468|P1|NOT COMPLETED|Overall Study||14
7830698|NCT01056315|19274467|P2|COMPLETED|Overall Study||12
7830699|NCT01056315|19274468|P1|COMPLETED|Overall Study||13
7830700|NCT01056315|19274467|P2|STARTED|Overall Study||23
7830701|NCT01056315|19274468|P1|STARTED|Overall Study||27
7830702|NCT01056302|19274502|P1|NOT COMPLETED|Overall Study||0
7830703|NCT01056302|19274502|P1|COMPLETED|Overall Study|The study was completed with 3 datasets from patients who had maxillofacial trauma and were treated|3
7830704|NCT01056302|19274502|P1|STARTED|Overall Study||3
7830705|NCT01056289|19274508|P4|NOT COMPLETED|Double-blind Phase||10
7830706|NCT01056289|19274509|P3|NOT COMPLETED|Double-blind Phase||13
7830707|NCT01056289|19274510|P2|NOT COMPLETED|Double-blind Phase||4
7830708|NCT01056289|19274511|P1|NOT COMPLETED|Double-blind Phase||0
7830709|NCT01056289|19274508|P4|COMPLETED|Double-blind Phase||138
7830710|NCT01056289|19274509|P3|COMPLETED|Double-blind Phase||127
7830711|NCT01056289|19274510|P2|COMPLETED|Double-blind Phase||69
7830712|NCT01056289|19274511|P1|COMPLETED|Double-blind Phase||0
7830713|NCT01056289|19274508|P4|STARTED|Double-blind Phase||148
7830714|NCT01056289|19274509|P3|STARTED|Double-blind Phase||140
7830715|NCT01056289|19274510|P2|STARTED|Double-blind Phase||73
7830716|NCT01056289|19274511|P1|STARTED|Double-blind Phase||0
7830717|NCT01056289|19274508|P4|NOT COMPLETED|Open-label Phase||0
7830718|NCT01056289|19274509|P3|NOT COMPLETED|Open-label Phase||0
7830719|NCT01056289|19274510|P2|NOT COMPLETED|Open-label Phase||0
7830720|NCT01056289|19274511|P1|NOT COMPLETED|Open-label Phase||119
7830721|NCT01056289|19274508|P4|COMPLETED|Open-label Phase||0
7830722|NCT01056289|19274509|P3|COMPLETED|Open-label Phase||0
7830723|NCT01056289|19274510|P2|COMPLETED|Open-label Phase||0
7830724|NCT01056289|19274511|P1|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361
7830725|NCT01056289|19274508|P4|STARTED|Open-label Phase||0
7830726|NCT01056289|19274509|P3|STARTED|Open-label Phase||0
7830727|NCT01056289|19274510|P2|STARTED|Open-label Phase||0
7830728|NCT01056289|19274511|P1|STARTED|Open-label Phase||480
7830729|NCT01056276|19274528|P2|NOT COMPLETED|Maintenance Therapy||28
7830730|NCT01056276|19274529|P1|NOT COMPLETED|Maintenance Therapy||0
7830731|NCT01056276|19274528|P2|COMPLETED|Maintenance Therapy|14 patients are continuing maintenance therapy.|0
7830732|NCT01056276|19274529|P1|COMPLETED|Maintenance Therapy||0
7830733|NCT01056276|19274528|P2|STARTED|Maintenance Therapy|5 patients completed 8 cycles but did not have maintenance therapy.|28
7830734|NCT01056276|19274529|P1|STARTED|Maintenance Therapy|Original regimen did not include maintenance therapy.|0
7830735|NCT01056276|19274528|P2|NOT COMPLETED|Treatment Period-Cycles 1-8||8
7830736|NCT01056276|19274529|P1|NOT COMPLETED|Treatment Period-Cycles 1-8||13
7830737|NCT01056276|19274528|P2|COMPLETED|Treatment Period-Cycles 1-8||33
7830738|NCT01056276|19274529|P1|COMPLETED|Treatment Period-Cycles 1-8||5
7830739|NCT01056276|19274528|P2|STARTED|Treatment Period-Cycles 1-8||41
7830740|NCT01056276|19274529|P1|STARTED|Treatment Period-Cycles 1-8||18
7830741|NCT01056263|19274543|P1|NOT COMPLETED|Overall Study||52
7830742|NCT01056263|19274543|P1|COMPLETED|Overall Study||0
7830743|NCT01056263|19274543|P1|STARTED|Overall Study||52
7830744|NCT01056198|19274549|P2|NOT COMPLETED|Overall Study||0
7830745|NCT01056198|19274550|P1|NOT COMPLETED|Overall Study||0
7830746|NCT01056198|19274549|P2|COMPLETED|Overall Study||24
7830747|NCT01056198|19274550|P1|COMPLETED|Overall Study||24
7830748|NCT01056198|19274549|P2|STARTED|Overall Study||24
7830749|NCT01056198|19274550|P1|STARTED|Overall Study||24
7830750|NCT01056107|19274566|P4|NOT COMPLETED|Overall Study||0
7830751|NCT01056107|19274567|P3|NOT COMPLETED|Overall Study||3
7830752|NCT01056107|19274568|P2|NOT COMPLETED|Overall Study||1
7830753|NCT01056107|19274569|P1|NOT COMPLETED|Overall Study||0
7830754|NCT01056107|19274566|P4|COMPLETED|Overall Study||12
7830755|NCT01056107|19274567|P3|COMPLETED|Overall Study||9
7830756|NCT01056107|19274568|P2|COMPLETED|Overall Study||10
7830757|NCT01056107|19274569|P1|COMPLETED|Overall Study||11
7830758|NCT01056107|19274566|P4|STARTED|Overall Study||12
7830759|NCT01056107|19274567|P3|STARTED|Overall Study||12
7830760|NCT01056107|19274568|P2|STARTED|Overall Study||11
7830761|NCT01056107|19274569|P1|STARTED|Overall Study||11
7830762|NCT01056016|19274617|P2|NOT COMPLETED|Overall Study||1
7830763|NCT01056016|19274618|P1|NOT COMPLETED|Overall Study||2
7830764|NCT01056016|19274617|P2|COMPLETED|Overall Study||26
7830765|NCT01056016|19274618|P1|COMPLETED|Overall Study||20
7830766|NCT01056016|19274617|P2|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27
7830767|NCT01056016|19274618|P1|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22
7830768|NCT01055886|19274626|P2|NOT COMPLETED|Overall Study||11
7830769|NCT01055886|19274627|P1|NOT COMPLETED|Overall Study||5
7830770|NCT01055886|19274626|P2|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21
7830771|NCT01055886|19274627|P1|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28
7830772|NCT01055886|19274626|P2|Reached Pre-quit Period|Overall Study|1 lost to contact|31
7830773|NCT01055886|19274627|P1|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30
7830774|NCT01055886|19274626|P2|STARTED|Overall Study||32
7830775|NCT01055886|19274627|P1|STARTED|Overall Study||33
7830776|NCT01055834|19274639|P2|NOT COMPLETED|Treatment Period III||0
7830777|NCT01055834|19274640|P1|NOT COMPLETED|Treatment Period III||0
7830778|NCT01055834|19274639|P2|COMPLETED|Treatment Period III||14
7830779|NCT01055834|19274640|P1|COMPLETED|Treatment Period III||0
7830780|NCT01055834|19274639|P2|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14
7830781|NCT01055834|19274640|P1|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0
7830782|NCT01055834|19274639|P2|NOT COMPLETED|Treatment Period II||0
7830783|NCT01055834|19274640|P1|NOT COMPLETED|Treatment Period II||0
7830784|NCT01055834|19274639|P2|COMPLETED|Treatment Period II||21
7830785|NCT01055834|19274640|P1|COMPLETED|Treatment Period II||20
7830786|NCT01055834|19274639|P2|STARTED|Treatment Period II||21
7830787|NCT01055834|19274640|P1|STARTED|Treatment Period II||20
7830788|NCT01055834|19274639|P2|NOT COMPLETED|Treatment Period I||0
7830789|NCT01055834|19274640|P1|NOT COMPLETED|Treatment Period I||1
7830790|NCT01055834|19274639|P2|COMPLETED|Treatment Period I||21
7830791|NCT01055834|19274640|P1|COMPLETED|Treatment Period I||20
7830792|NCT01055834|19274639|P2|STARTED|Treatment Period I||21
7830793|NCT01055834|19274640|P1|STARTED|Treatment Period I||21
7830794|NCT01055782|19274654|P2|NOT COMPLETED|Overall Study||0
7830795|NCT01055782|19274655|P1|NOT COMPLETED|Overall Study||0
7830796|NCT01055782|19274654|P2|COMPLETED|Overall Study||449
7830797|NCT01055782|19274655|P1|COMPLETED|Overall Study||555
7830798|NCT01055782|19274654|P2|STARTED|Overall Study||449
7830799|NCT01055782|19274655|P1|STARTED|Overall Study||555
7830800|NCT01055769|19274663|P2|NOT COMPLETED|Second Intervention||0
7830801|NCT01055769|19274664|P1|NOT COMPLETED|Second Intervention||0
7830802|NCT01055769|19274663|P2|COMPLETED|Second Intervention||10
7830803|NCT01055769|19274664|P1|COMPLETED|Second Intervention||10
7830804|NCT01055769|19274663|P2|STARTED|Second Intervention||10
7830805|NCT01055769|19274664|P1|STARTED|Second Intervention||10
7830806|NCT01055769|19274663|P2|NOT COMPLETED|Washout Period of Atleast 4 Days||0
7830807|NCT01055769|19274664|P1|NOT COMPLETED|Washout Period of Atleast 4 Days||0
7830808|NCT01055769|19274663|P2|COMPLETED|Washout Period of Atleast 4 Days||10
7830809|NCT01055769|19274664|P1|COMPLETED|Washout Period of Atleast 4 Days||10
7830810|NCT01055769|19274663|P2|STARTED|Washout Period of Atleast 4 Days||10
7830811|NCT01055769|19274664|P1|STARTED|Washout Period of Atleast 4 Days||10
7830812|NCT01055769|19274663|P2|NOT COMPLETED|First Intervention||0
7830813|NCT01055769|19274664|P1|NOT COMPLETED|First Intervention||0
7830814|NCT01055769|19274663|P2|COMPLETED|First Intervention||10
7830815|NCT01055769|19274664|P1|COMPLETED|First Intervention||10
7830816|NCT01055769|19274663|P2|STARTED|First Intervention||10
7830817|NCT01055769|19274664|P1|STARTED|First Intervention||10
7830818|NCT01055704|19274682|P4|NOT COMPLETED|Overall Study||0
7830819|NCT01055704|19274683|P3|NOT COMPLETED|Overall Study||0
7830820|NCT01055704|19274684|P2|NOT COMPLETED|Overall Study||0
7830821|NCT01055704|19274685|P1|NOT COMPLETED|Overall Study||0
7830822|NCT01055704|19274682|P4|COMPLETED|Overall Study||8
7830823|NCT01055704|19274683|P3|COMPLETED|Overall Study||16
7830824|NCT01055704|19274684|P2|COMPLETED|Overall Study||8
7830825|NCT01055704|19274685|P1|COMPLETED|Overall Study||16
7830826|NCT01055704|19274682|P4|STARTED|Overall Study||8
7830827|NCT01055704|19274683|P3|STARTED|Overall Study||16
7830828|NCT01055704|19274684|P2|STARTED|Overall Study||8
7830829|NCT01055704|19274685|P1|STARTED|Overall Study||16
7830830|NCT01055639|19274725|P2|NOT COMPLETED|Overall Study||29
7830831|NCT01055639|19274726|P1|NOT COMPLETED|Overall Study||21
7830832|NCT01055639|19274725|P2|COMPLETED|Overall Study||31
7830833|NCT01055639|19274726|P1|COMPLETED|Overall Study||45
7830834|NCT01055639|19274725|P2|STARTED|Overall Study||60
7830835|NCT01055639|19274726|P1|STARTED|Overall Study||66
7830836|NCT01055613|19274750|P2|NOT COMPLETED|Overall Study||4
7830837|NCT01055613|19274751|P1|NOT COMPLETED|Overall Study||9
7830838|NCT01055613|19274750|P2|COMPLETED|Overall Study||96
7830839|NCT01055613|19274751|P1|COMPLETED|Overall Study||191
7830840|NCT01055613|19274750|P2|STARTED|Overall Study||100
7830841|NCT01055613|19274751|P1|STARTED|Overall Study||200
7830842|NCT01055496|19274761|P2|NOT COMPLETED|Overall Study||30
7830843|NCT01055496|19274762|P1|NOT COMPLETED|Overall Study||15
7830844|NCT01055496|19274761|P2|COMPLETED|Overall Study||25
7830845|NCT01055496|19274762|P1|COMPLETED|Overall Study||33
7830846|NCT01055496|19274761|P2|STARTED|Overall Study||55
7830847|NCT01055496|19274762|P1|STARTED|Overall Study||48
7830848|NCT01055457|19274819|P10|NOT COMPLETED|Overall Study||1
7830849|NCT01055457|19274820|P9|NOT COMPLETED|Overall Study||0
7830850|NCT01055457|19274821|P8|NOT COMPLETED|Overall Study||1
7830851|NCT01055457|19274822|P7|NOT COMPLETED|Overall Study||1
7830852|NCT01055457|19274823|P6|NOT COMPLETED|Overall Study||3
7830853|NCT01055457|19274824|P5|NOT COMPLETED|Overall Study||3
7830854|NCT01055457|19274825|P4|NOT COMPLETED|Overall Study||3
7830855|NCT01055457|19274826|P3|NOT COMPLETED|Overall Study||2
7830856|NCT01055457|19274827|P2|NOT COMPLETED|Overall Study||1
7830857|NCT01055457|19274828|P1|NOT COMPLETED|Overall Study||1
7830858|NCT01055457|19274819|P10|COMPLETED|Overall Study||19
7830859|NCT01055457|19274820|P9|COMPLETED|Overall Study||20
7830860|NCT01055457|19274821|P8|COMPLETED|Overall Study||18
7830861|NCT01055457|19274822|P7|COMPLETED|Overall Study||18
7830862|NCT01055457|19274823|P6|COMPLETED|Overall Study||15
7830863|NCT01055457|19274824|P5|COMPLETED|Overall Study||38
7830864|NCT01055457|19274825|P4|COMPLETED|Overall Study||37
7830865|NCT01055457|19274826|P3|COMPLETED|Overall Study||36
7830866|NCT01055457|19274827|P2|COMPLETED|Overall Study||39
7830867|NCT01055457|19274828|P1|COMPLETED|Overall Study||39
7830868|NCT01055457|19274819|P10|STARTED|Overall Study||20
7830869|NCT01055457|19274820|P9|STARTED|Overall Study||20
7830870|NCT01055457|19274821|P8|STARTED|Overall Study||19
7830871|NCT01055457|19274822|P7|STARTED|Overall Study||19
7830872|NCT01055457|19274823|P6|STARTED|Overall Study||18
7830873|NCT01055457|19274824|P5|STARTED|Overall Study||41
7830874|NCT01055457|19274825|P4|STARTED|Overall Study||40
7830875|NCT01055457|19274826|P3|STARTED|Overall Study||38
7830876|NCT01055457|19274827|P2|STARTED|Overall Study||40
7830877|NCT01055457|19274828|P1|STARTED|Overall Study||40
7830878|NCT01055314|19274862|P2|NOT COMPLETED|Overall Study||38
7830879|NCT01055314|19274863|P1|NOT COMPLETED|Overall Study||45
7830880|NCT01055314|19274862|P2|COMPLETED|Overall Study||37
7830881|NCT01055314|19274863|P1|COMPLETED|Overall Study||55
7830882|NCT01055314|19274862|P2|STARTED|Overall Study||75
7830883|NCT01055314|19274863|P1|STARTED|Overall Study||100
7830884|NCT01055262|19274875|P1|NOT COMPLETED|Overall Study||9
7830885|NCT01055262|19274875|P1|COMPLETED|Overall Study||160
7830886|NCT01055262|19274875|P1|STARTED|Overall Study||169
7830887|NCT01055223|19274886|P1|NOT COMPLETED|Overall Study||0
7830888|NCT01055223|19274886|P1|COMPLETED|Overall Study||98483
7830889|NCT01055223|19274886|P1|STARTED|Overall Study||98483
7830890|NCT01055197|19274916|P2|NOT COMPLETED|Overall Study||2
7830891|NCT01055197|19274917|P1|NOT COMPLETED|Overall Study||9
7830892|NCT01055197|19274916|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
7830893|NCT01055197|19274917|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42
7830894|NCT01055197|19274916|P2|STARTED|Overall Study||46
7830895|NCT01055197|19274917|P1|STARTED|Overall Study||51
7830896|NCT01055184|19274931|P1|NOT COMPLETED|Overall Study||0
7830897|NCT01055184|19274931|P1|COMPLETED|Overall Study||34
7830898|NCT01055184|19274931|P1|STARTED|Overall Study||34
7830899|NCT01055171|19274937|P2|NOT COMPLETED|Overall Study||7
7830900|NCT01055171|19274938|P1|NOT COMPLETED|Overall Study||11
7830901|NCT01055171|19274937|P2|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21
7830902|NCT01055171|19274938|P1|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18
7830903|NCT01055171|19274937|P2|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23
7830904|NCT01055171|19274938|P1|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21
7830905|NCT01055171|19274937|P2|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24
7831081|NCT01054339|19275401|P3|NOT COMPLETED|Overall Study||0
7830906|NCT01055171|19274938|P1|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25
7830907|NCT01055171|19274937|P2|STARTED|Overall Study|Randomized to receive placebo.|28
7830908|NCT01055171|19274938|P1|STARTED|Overall Study|Randomized to receive medication.|29
7830909|NCT01055132|19274952|P2|NOT COMPLETED|Period 2 (5-9 Days)||1
7830910|NCT01055132|19274953|P1|NOT COMPLETED|Period 2 (5-9 Days)||0
7830911|NCT01055132|19274952|P2|COMPLETED|Period 2 (5-9 Days)||32
7830912|NCT01055132|19274953|P1|COMPLETED|Period 2 (5-9 Days)||35
7830913|NCT01055132|19274952|P2|STARTED|Period 2 (5-9 Days)||33
7830914|NCT01055132|19274953|P1|STARTED|Period 2 (5-9 Days)||35
7830915|NCT01055132|19274952|P2|NOT COMPLETED|Period 1 (5-9 Days)||0
7830916|NCT01055132|19274953|P1|NOT COMPLETED|Period 1 (5-9 Days)||1
7830917|NCT01055132|19274952|P2|COMPLETED|Period 1 (5-9 Days)||33
7830918|NCT01055132|19274953|P1|COMPLETED|Period 1 (5-9 Days)||35
7830919|NCT01055132|19274952|P2|STARTED|Period 1 (5-9 Days)||33
7830920|NCT01055132|19274953|P1|STARTED|Period 1 (5-9 Days)||36
7830921|NCT01055067|19274964|P1|NOT COMPLETED|Overall Study||0
7830922|NCT01055067|19274964|P1|COMPLETED|Overall Study||27
7830923|NCT01055067|19274964|P1|STARTED|Overall Study||27
7830924|NCT01055028|19274978|P2|NOT COMPLETED|Treatment Cycles 4 to 6||0
7830925|NCT01055028|19274979|P1|NOT COMPLETED|Treatment Cycles 4 to 6||0
7830926|NCT01055028|19274978|P2|COMPLETED|Treatment Cycles 4 to 6||2
7830927|NCT01055028|19274979|P1|COMPLETED|Treatment Cycles 4 to 6||6
7830928|NCT01055028|19274978|P2|STARTED|Treatment Cycles 4 to 6||2
7830929|NCT01055028|19274979|P1|STARTED|Treatment Cycles 4 to 6||6
7830930|NCT01055028|19274978|P2|NOT COMPLETED|Inter-treatment Period||3
7830931|NCT01055028|19274979|P1|NOT COMPLETED|Inter-treatment Period||0
7830932|NCT01055028|19274978|P2|COMPLETED|Inter-treatment Period||2
7830933|NCT01055028|19274979|P1|COMPLETED|Inter-treatment Period||6
7830934|NCT01055028|19274978|P2|STARTED|Inter-treatment Period||5
7830935|NCT01055028|19274979|P1|STARTED|Inter-treatment Period||6
7830936|NCT01055028|19274978|P2|NOT COMPLETED|Treatment Cycles 1 to 3||3
7830937|NCT01055028|19274979|P1|NOT COMPLETED|Treatment Cycles 1 to 3||2
7830938|NCT01055028|19274978|P2|COMPLETED|Treatment Cycles 1 to 3||5
7830939|NCT01055028|19274979|P1|COMPLETED|Treatment Cycles 1 to 3||6
7830940|NCT01055028|19274978|P2|STARTED|Treatment Cycles 1 to 3||8
7830941|NCT01055028|19274979|P1|STARTED|Treatment Cycles 1 to 3||8
7830942|NCT01055028|19274978|P2|NOT COMPLETED|Screening||1
7830943|NCT01055028|19274979|P1|NOT COMPLETED|Screening||1
7830944|NCT01055028|19274978|P2|COMPLETED|Screening||8
7830945|NCT01055028|19274979|P1|COMPLETED|Screening||8
7830946|NCT01055028|19274978|P2|STARTED|Screening||9
7830947|NCT01055028|19274979|P1|STARTED|Screening||9
7830948|NCT01054976|19274993|P1|NOT COMPLETED|Overall Study||35
7830949|NCT01054976|19274993|P1|COMPLETED|Overall Study||57
7830950|NCT01054976|19274993|P1|STARTED|Overall Study||92
7830951|NCT01054911|19275001|P1|NOT COMPLETED|Overall Study||0
7830952|NCT01054911|19275001|P1|COMPLETED|Overall Study||5
7830953|NCT01054911|19275001|P1|STARTED|Overall Study||5
7830954|NCT01054885|19275014|P7|NOT COMPLETED|24-week, Double-blind Treatment Period||47
7830955|NCT01054885|19275015|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||60
7830956|NCT01054885|19275016|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||42
7830957|NCT01054885|19275017|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||43
7830958|NCT01054885|19275018|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||49
7830959|NCT01054885|19275019|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||59
7830960|NCT01054885|19275020|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
7830961|NCT01054885|19275014|P7|COMPLETED|24-week, Double-blind Treatment Period||158
7830962|NCT01054885|19275015|P6|COMPLETED|24-week, Double-blind Treatment Period||144
7830963|NCT01054885|19275016|P5|COMPLETED|24-week, Double-blind Treatment Period||161
7830964|NCT01054885|19275017|P4|COMPLETED|24-week, Double-blind Treatment Period||160
7830965|NCT01054885|19275018|P3|COMPLETED|24-week, Double-blind Treatment Period||155
7830966|NCT01054885|19275019|P2|COMPLETED|24-week, Double-blind Treatment Period||146
7830967|NCT01054885|19275020|P1|COMPLETED|24-week, Double-blind Treatment Period||0
7830968|NCT01054885|19275014|P7|STARTED|24-week, Double-blind Treatment Period||205
7830969|NCT01054885|19275015|P6|STARTED|24-week, Double-blind Treatment Period||204
7830970|NCT01054885|19275016|P5|STARTED|24-week, Double-blind Treatment Period||203
7830971|NCT01054885|19275017|P4|STARTED|24-week, Double-blind Treatment Period||203
7830972|NCT01054885|19275018|P3|STARTED|24-week, Double-blind Treatment Period||204
7830973|NCT01054885|19275019|P2|STARTED|24-week, Double-blind Treatment Period||205
7830974|NCT01054885|19275020|P1|STARTED|24-week, Double-blind Treatment Period||0
7830975|NCT01054885|19275014|P7|NOT COMPLETED|2-week, Single-blind Run-In Period||0
7830976|NCT01054885|19275015|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
7830977|NCT01054885|19275016|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
7830978|NCT01054885|19275017|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
7830979|NCT01054885|19275018|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
7830980|NCT01054885|19275019|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
7830981|NCT01054885|19275020|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||351
7830982|NCT01054885|19275014|P7|COMPLETED|2-week, Single-blind Run-In Period||0
7830983|NCT01054885|19275015|P6|COMPLETED|2-week, Single-blind Run-In Period||0
7830984|NCT01054885|19275016|P5|COMPLETED|2-week, Single-blind Run-In Period||0
7830985|NCT01054885|19275017|P4|COMPLETED|2-week, Single-blind Run-In Period||0
7830986|NCT01054885|19275018|P3|COMPLETED|2-week, Single-blind Run-In Period||0
7830987|NCT01054885|19275019|P2|COMPLETED|2-week, Single-blind Run-In Period||0
7830988|NCT01054885|19275020|P1|COMPLETED|2-week, Single-blind Run-In Period||1226
7830989|NCT01054885|19275014|P7|STARTED|2-week, Single-blind Run-In Period||0
7830990|NCT01054885|19275015|P6|STARTED|2-week, Single-blind Run-In Period||0
7830991|NCT01054885|19275016|P5|STARTED|2-week, Single-blind Run-In Period||0
7830992|NCT01054885|19275017|P4|STARTED|2-week, Single-blind Run-In Period||0
7830993|NCT01054885|19275018|P3|STARTED|2-week, Single-blind Run-In Period||0
7830994|NCT01054885|19275019|P2|STARTED|2-week, Single-blind Run-In Period||0
7830995|NCT01054885|19275020|P1|STARTED|2-week, Single-blind Run-In Period||1577
7830996|NCT01054846|19275060|P2|NOT COMPLETED|Overall Study||17
7830997|NCT01054846|19275061|P1|NOT COMPLETED|Overall Study||76
7830998|NCT01054846|19275060|P2|COMPLETED|Overall Study||51
7830999|NCT01054846|19275061|P1|COMPLETED|Overall Study||246
7831000|NCT01054846|19275060|P2|STARTED|Overall Study||68
7831001|NCT01054846|19275061|P1|STARTED|Overall Study||322
7831002|NCT01054820|19275068|P1|NOT COMPLETED|Overall Study||2
7831003|NCT01054820|19275068|P1|COMPLETED|Overall Study||121
7831004|NCT01054820|19275068|P1|STARTED|Overall Study||123
7831005|NCT01054742|19275082|P1|NOT COMPLETED|Overall Study||0
7831006|NCT01054742|19275082|P1|COMPLETED|Overall Study||2
7831007|NCT01054742|19275082|P1|STARTED|Overall Study||2
7831008|NCT01054729|19275090|P4|NOT COMPLETED|Overall Study||3
7831009|NCT01054729|19275091|P3|NOT COMPLETED|Overall Study||6
7831010|NCT01054729|19275092|P2|NOT COMPLETED|Overall Study||5
7831011|NCT01054729|19275093|P1|NOT COMPLETED|Overall Study||4
7831012|NCT01054729|19275090|P4|COMPLETED|Overall Study||11
7831013|NCT01054729|19275091|P3|COMPLETED|Overall Study||9
7831014|NCT01054729|19275092|P2|COMPLETED|Overall Study||14
7831015|NCT01054729|19275093|P1|COMPLETED|Overall Study||12
7831016|NCT01054729|19275090|P4|Randomized and Treated|Overall Study||14
7831017|NCT01054729|19275091|P3|Randomized and Treated|Overall Study||15
7831018|NCT01054729|19275092|P2|Randomized and Treated|Overall Study||18
7831019|NCT01054729|19275093|P1|Randomized and Treated|Overall Study||16
7831020|NCT01054729|19275090|P4|STARTED|Overall Study||14
7831021|NCT01054729|19275091|P3|STARTED|Overall Study||15
7831022|NCT01054729|19275092|P2|STARTED|Overall Study||19
7831023|NCT01054729|19275093|P1|STARTED|Overall Study||16
7831024|NCT01054703|19275154|P1|NOT COMPLETED|Overall Study||0
7831025|NCT01054703|19275154|P1|COMPLETED|Overall Study||14
7831026|NCT01054703|19275154|P1|STARTED|Overall Study||14
7831027|NCT01054625|19275161|P3|NOT COMPLETED|Overall Study||1
7831028|NCT01054625|19275162|P2|NOT COMPLETED|Overall Study||3
7831029|NCT01054625|19275163|P1|NOT COMPLETED|Overall Study||2
7831030|NCT01054625|19275161|P3|COMPLETED|Overall Study||9
7831031|NCT01054625|19275162|P2|COMPLETED|Overall Study||9
7831032|NCT01054625|19275163|P1|COMPLETED|Overall Study||6
7831033|NCT01054625|19275161|P3|STARTED|Overall Study||10
7831034|NCT01054625|19275162|P2|STARTED|Overall Study||12
7831035|NCT01054625|19275163|P1|STARTED|Overall Study|A total of 31 patients were enrolled, 1 patient died before receiving any zalutumumab|8
7831036|NCT01054599|19275191|P2|NOT COMPLETED|Overall Study||7
7831037|NCT01054599|19275192|P1|NOT COMPLETED|Overall Study||4
7831038|NCT01054599|19275191|P2|COMPLETED|Overall Study||9
7831039|NCT01054599|19275192|P1|COMPLETED|Overall Study||9
7831040|NCT01054599|19275191|P2|STARTED|Overall Study||16
7831041|NCT01054599|19275192|P1|STARTED|Overall Study||13
7831042|NCT01054586|19275204|P4|NOT COMPLETED|Overall Study||0
7831043|NCT01054586|19275205|P3|NOT COMPLETED|Overall Study||0
7831044|NCT01054586|19275206|P2|NOT COMPLETED|Overall Study||0
7831045|NCT01054586|19275207|P1|NOT COMPLETED|Overall Study||0
7831046|NCT01054586|19275204|P4|COMPLETED|Overall Study||101
7831047|NCT01054586|19275205|P3|COMPLETED|Overall Study||8
7831048|NCT01054586|19275206|P2|COMPLETED|Overall Study||15
7831049|NCT01054586|19275207|P1|COMPLETED|Overall Study||43
7831050|NCT01054586|19275204|P4|STARTED|Overall Study||101
7831051|NCT01054586|19275205|P3|STARTED|Overall Study||8
7831052|NCT01054586|19275206|P2|STARTED|Overall Study||15
7831053|NCT01054586|19275207|P1|STARTED|Overall Study||43
7831054|NCT01054573|19275299|P4|NOT COMPLETED|Overall Study||2
7831055|NCT01054573|19275300|P3|NOT COMPLETED|Overall Study||3
7831056|NCT01054573|19275301|P2|NOT COMPLETED|Overall Study||4
7831057|NCT01054573|19275302|P1|NOT COMPLETED|Overall Study||1
7831058|NCT01054573|19275299|P4|COMPLETED|Overall Study||25
7831059|NCT01054573|19275300|P3|COMPLETED|Overall Study||19
7831060|NCT01054573|19275301|P2|COMPLETED|Overall Study||28
7831061|NCT01054573|19275302|P1|COMPLETED|Overall Study||8
7831062|NCT01054573|19275299|P4|STARTED|Overall Study||27
7831063|NCT01054573|19275300|P3|STARTED|Overall Study||22
7831064|NCT01054573|19275301|P2|STARTED|Overall Study||32
7831065|NCT01054573|19275302|P1|STARTED|Overall Study||9
7831066|NCT01054560|19275348|P2|NOT COMPLETED|Overall Study||28
7831067|NCT01054560|19275349|P1|NOT COMPLETED|Overall Study||13
7831068|NCT01054560|19275348|P2|COMPLETED|Overall Study||27
7831069|NCT01054560|19275349|P1|COMPLETED|Overall Study||45
7831070|NCT01054560|19275348|P2|STARTED|Overall Study||55
7831071|NCT01054560|19275349|P1|STARTED|Overall Study||58
7831072|NCT01054456|19275371|P1|NOT COMPLETED|Overall Study||1
7831073|NCT01054456|19275371|P1|COMPLETED|Overall Study||35
7831074|NCT01054456|19275371|P1|STARTED|Overall Study||36
7831075|NCT01054404|19275391|P2|NOT COMPLETED|Overall Study||0
7831076|NCT01054404|19275392|P1|NOT COMPLETED|Overall Study||0
7831077|NCT01054404|19275391|P2|COMPLETED|Overall Study||13
7831078|NCT01054404|19275392|P1|COMPLETED|Overall Study||10
7831079|NCT01054404|19275391|P2|STARTED|Overall Study||13
7831080|NCT01054404|19275392|P1|STARTED|Overall Study||10
7831082|NCT01054339|19275402|P2|NOT COMPLETED|Overall Study||0
7831083|NCT01054339|19275403|P1|NOT COMPLETED|Overall Study||0
7831084|NCT01054339|19275401|P3|COMPLETED|Overall Study||3
7831085|NCT01054339|19275402|P2|COMPLETED|Overall Study||3
7831086|NCT01054339|19275403|P1|COMPLETED|Overall Study||3
7831087|NCT01054339|19275401|P3|STARTED|Overall Study||3
7831088|NCT01054339|19275402|P2|STARTED|Overall Study||3
7831089|NCT01054339|19275403|P1|STARTED|Overall Study||3
7831090|NCT01054300|19275419|P4|NOT COMPLETED|Period 2||0
7831091|NCT01054300|19275420|P3|NOT COMPLETED|Period 2||1
7831092|NCT01054300|19275421|P2|NOT COMPLETED|Period 2||0
7831093|NCT01054300|19275422|P1|NOT COMPLETED|Period 2||0
7831094|NCT01054300|19275419|P4|COMPLETED|Period 2||13
7831095|NCT01054300|19275420|P3|COMPLETED|Period 2||12
7831096|NCT01054300|19275421|P2|COMPLETED|Period 2||13
7831097|NCT01054300|19275422|P1|COMPLETED|Period 2||12
7831098|NCT01054300|19275419|P4|STARTED|Period 2||13
7831099|NCT01054300|19275420|P3|STARTED|Period 2||13
7831100|NCT01054300|19275421|P2|STARTED|Period 2||13
7831101|NCT01054300|19275422|P1|STARTED|Period 2||12
7831102|NCT01054300|19275419|P4|NOT COMPLETED|Period 1||0
7831103|NCT01054300|19275420|P3|NOT COMPLETED|Period 1||0
7831104|NCT01054300|19275421|P2|NOT COMPLETED|Period 1||0
7831105|NCT01054300|19275422|P1|NOT COMPLETED|Period 1||1
7831106|NCT01054300|19275419|P4|COMPLETED|Period 1||13
7831107|NCT01054300|19275420|P3|COMPLETED|Period 1||13
7831108|NCT01054300|19275421|P2|COMPLETED|Period 1||13
7831109|NCT01054300|19275422|P1|COMPLETED|Period 1|Discontinuation occurred prior to Period 2 dose.|12
7831110|NCT01054300|19275419|P4|STARTED|Period 1||13
7831111|NCT01054300|19275420|P3|STARTED|Period 1||13
7831112|NCT01054300|19275421|P2|STARTED|Period 1||13
7831113|NCT01054300|19275422|P1|STARTED|Period 1||13
7831114|NCT01054222|19275472|P1|NOT COMPLETED|Overall Study||11
7831115|NCT01054222|19275472|P1|COMPLETED|Overall Study||20
7831116|NCT01054222|19275472|P1|STARTED|Overall Study||31
7831117|NCT01054209|19275493|P2|NOT COMPLETED|Overall Study||0
7831118|NCT01054209|19275494|P1|NOT COMPLETED|Overall Study||0
7831119|NCT01054209|19275493|P2|COMPLETED|Overall Study||58
7831120|NCT01054209|19275494|P1|COMPLETED|Overall Study||58
7831121|NCT01054209|19275493|P2|STARTED|Overall Study||58
7831122|NCT01054209|19275494|P1|STARTED|Overall Study||58
7831123|NCT01054183|19275502|P2|NOT COMPLETED|Overall Study||0
7831124|NCT01054183|19275503|P1|NOT COMPLETED|Overall Study||0
7831125|NCT01054183|19275502|P2|COMPLETED|Overall Study||12
7831126|NCT01054183|19275503|P1|COMPLETED|Overall Study||10
7831127|NCT01054183|19275502|P2|STARTED|Overall Study||12
7831128|NCT01054183|19275503|P1|STARTED|Overall Study||10
7831129|NCT01054170|19275513|P2|NOT COMPLETED|Overall Study||6
7831130|NCT01054170|19275514|P1|NOT COMPLETED|Overall Study||4
7831131|NCT01054170|19275513|P2|COMPLETED|Overall Study||21
7831132|NCT01054170|19275514|P1|COMPLETED|Overall Study||21
7831133|NCT01054170|19275513|P2|STARTED|Overall Study||27
7831134|NCT01054170|19275514|P1|STARTED|Overall Study||25
7831135|NCT01054079|19275566|P1|NOT COMPLETED|Overall Study||0
7831136|NCT01054079|19275566|P1|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20
7831137|NCT01054079|19275566|P1|# Recieved Proper PSA Testing|Overall Study||10
7831138|NCT01054079|19275566|P1|STARTED|Overall Study||20
7831139|NCT01053988|19275579|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||55
7831140|NCT01053988|19275580|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||59
7831141|NCT01053988|19275581|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||63
7831142|NCT01053988|19275582|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||61
7831143|NCT01053988|19275583|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||69
7831144|NCT01053988|19275584|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
7831145|NCT01053988|19275579|P6|COMPLETED|24-week, Double-blind Treatment Period||151
7831146|NCT01053988|19275580|P5|COMPLETED|24-week, Double-blind Treatment Period||147
7831147|NCT01053988|19275581|P4|COMPLETED|24-week, Double-blind Treatment Period||142
7831148|NCT01053988|19275582|P3|COMPLETED|24-week, Double-blind Treatment Period||145
7831149|NCT01053988|19275583|P2|COMPLETED|24-week, Double-blind Treatment Period||138
7831150|NCT01053988|19275584|P1|COMPLETED|24-week, Double-blind Treatment Period||0
7831151|NCT01053988|19275579|P6|STARTED|24-week, Double-blind Treatment Period||206
7831152|NCT01053988|19275580|P5|STARTED|24-week, Double-blind Treatment Period||206
7831153|NCT01053988|19275581|P4|STARTED|24-week, Double-blind Treatment Period||205
7831154|NCT01053988|19275582|P3|STARTED|24-week, Double-blind Treatment Period||206
7831155|NCT01053988|19275583|P2|STARTED|24-week, Double-blind Treatment Period||207
7831156|NCT01053988|19275584|P1|STARTED|24-week, Double-blind Treatment Period||0
7831157|NCT01053988|19275579|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
7831158|NCT01053988|19275580|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
7831159|NCT01053988|19275581|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
7831160|NCT01053988|19275582|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
7831161|NCT01053988|19275583|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
7831162|NCT01053988|19275584|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||360
7831163|NCT01053988|19275579|P6|COMPLETED|2-week, Single-blind Run-In Period||0
7831164|NCT01053988|19275580|P5|COMPLETED|2-week, Single-blind Run-In Period||0
7831165|NCT01053988|19275581|P4|COMPLETED|2-week, Single-blind Run-In Period||0
7831166|NCT01053988|19275582|P3|COMPLETED|2-week, Single-blind Run-In Period||0
7831167|NCT01053988|19275583|P2|COMPLETED|2-week, Single-blind Run-In Period||0
7831168|NCT01053988|19275584|P1|COMPLETED|2-week, Single-blind Run-In Period||1030
7831169|NCT01053988|19275579|P6|STARTED|2-week, Single-blind Run-In Period||0
7831170|NCT01053988|19275580|P5|STARTED|2-week, Single-blind Run-In Period||0
7831171|NCT01053988|19275581|P4|STARTED|2-week, Single-blind Run-In Period||0
7831172|NCT01053988|19275582|P3|STARTED|2-week, Single-blind Run-In Period||0
7831173|NCT01053988|19275583|P2|STARTED|2-week, Single-blind Run-In Period||0
7831174|NCT01053988|19275584|P1|STARTED|2-week, Single-blind Run-In Period||1390
7831175|NCT01053962|19275621|P5|NOT COMPLETED|Follow-up Period||0
7831176|NCT01053962|19275622|P4|NOT COMPLETED|Follow-up Period||0
7831177|NCT01053962|19275623|P3|NOT COMPLETED|Follow-up Period||0
7831178|NCT01053962|19275624|P2|NOT COMPLETED|Follow-up Period||0
7831179|NCT01053962|19275625|P1|NOT COMPLETED|Follow-up Period||0
7831180|NCT01053962|19275621|P5|COMPLETED|Follow-up Period||17
7831181|NCT01053962|19275622|P4|COMPLETED|Follow-up Period||15
7831182|NCT01053962|19275623|P3|COMPLETED|Follow-up Period||15
7831183|NCT01053962|19275624|P2|COMPLETED|Follow-up Period||14
7831184|NCT01053962|19275625|P1|COMPLETED|Follow-up Period||13
7831185|NCT01053962|19275621|P5|STARTED|Follow-up Period||17
7831186|NCT01053962|19275622|P4|STARTED|Follow-up Period||15
7831187|NCT01053962|19275623|P3|STARTED|Follow-up Period||15
7831188|NCT01053962|19275624|P2|STARTED|Follow-up Period||14
7831189|NCT01053962|19275625|P1|STARTED|Follow-up Period||13
7831190|NCT01053962|19275621|P5|NOT COMPLETED|Treatment Period||3
7831191|NCT01053962|19275622|P4|NOT COMPLETED|Treatment Period||0
7831192|NCT01053962|19275623|P3|NOT COMPLETED|Treatment Period||0
7831193|NCT01053962|19275624|P2|NOT COMPLETED|Treatment Period||0
7831194|NCT01053962|19275625|P1|NOT COMPLETED|Treatment Period||1
7831195|NCT01053962|19275621|P5|COMPLETED|Treatment Period||17
7831196|NCT01053962|19275622|P4|COMPLETED|Treatment Period||15
7831197|NCT01053962|19275623|P3|COMPLETED|Treatment Period||15
7831198|NCT01053962|19275624|P2|COMPLETED|Treatment Period||14
7831199|NCT01053962|19275625|P1|COMPLETED|Treatment Period||13
7831200|NCT01053962|19275621|P5|STARTED|Treatment Period||20
7831201|NCT01053962|19275622|P4|STARTED|Treatment Period||15
7831202|NCT01053962|19275623|P3|STARTED|Treatment Period||15
7831203|NCT01053962|19275624|P2|STARTED|Treatment Period||14
7831204|NCT01053962|19275625|P1|STARTED|Treatment Period||14
7831205|NCT01053962|19275621|P5|NOT COMPLETED|Pretreatment Period||2
7831206|NCT01053962|19275622|P4|NOT COMPLETED|Pretreatment Period||2
7831207|NCT01053962|19275623|P3|NOT COMPLETED|Pretreatment Period||1
7831208|NCT01053962|19275624|P2|NOT COMPLETED|Pretreatment Period||1
7831209|NCT01053962|19275625|P1|NOT COMPLETED|Pretreatment Period||0
7831210|NCT01053962|19275621|P5|COMPLETED|Pretreatment Period||20
7831211|NCT01053962|19275622|P4|COMPLETED|Pretreatment Period||15
7831212|NCT01053962|19275623|P3|COMPLETED|Pretreatment Period||15
7831213|NCT01053962|19275624|P2|COMPLETED|Pretreatment Period||14
7831214|NCT01053962|19275625|P1|COMPLETED|Pretreatment Period||14
7831215|NCT01053962|19275621|P5|STARTED|Pretreatment Period||22
7831216|NCT01053962|19275622|P4|STARTED|Pretreatment Period||17
7831217|NCT01053962|19275623|P3|STARTED|Pretreatment Period||16
7831218|NCT01053962|19275624|P2|STARTED|Pretreatment Period||15
7831219|NCT01053962|19275625|P1|STARTED|Pretreatment Period||14
7831220|NCT01053897|19275657|P1|NOT COMPLETED|Overall Study||0
7831221|NCT01053897|19275657|P1|COMPLETED|Overall Study||5
7831222|NCT01053897|19275657|P1|STARTED|Overall Study||5
7831223|NCT01053819|19275669|P1|NOT COMPLETED|Overall Study||0
7831224|NCT01053819|19275669|P1|COMPLETED|Overall Study||6
7831225|NCT01053819|19275669|P1|STARTED|Overall Study||6
7831226|NCT01053741|19275676|P2|NOT COMPLETED|2nd Study Intervention||1
7831227|NCT01053741|19275677|P1|NOT COMPLETED|2nd Study Intervention||0
7831228|NCT01053741|19275676|P2|COMPLETED|2nd Study Intervention||5
7831229|NCT01053741|19275677|P1|COMPLETED|2nd Study Intervention||5
7831230|NCT01053741|19275676|P2|STARTED|2nd Study Intervention||6
7831231|NCT01053741|19275677|P1|STARTED|2nd Study Intervention||5
7831232|NCT01053741|19275676|P2|NOT COMPLETED|14 Day Washout||0
7831233|NCT01053741|19275677|P1|NOT COMPLETED|14 Day Washout||0
7831234|NCT01053741|19275676|P2|COMPLETED|14 Day Washout||6
7831235|NCT01053741|19275677|P1|COMPLETED|14 Day Washout||5
7831236|NCT01053741|19275676|P2|STARTED|14 Day Washout||6
7831237|NCT01053741|19275677|P1|STARTED|14 Day Washout||5
7831238|NCT01053741|19275676|P2|NOT COMPLETED|1st Intervention||0
7831239|NCT01053741|19275677|P1|NOT COMPLETED|1st Intervention||0
7831240|NCT01053741|19275676|P2|COMPLETED|1st Intervention||6
7831241|NCT01053741|19275677|P1|COMPLETED|1st Intervention||5
7831242|NCT01053741|19275676|P2|STARTED|1st Intervention||6
7831243|NCT01053741|19275677|P1|STARTED|1st Intervention||5
7831244|NCT01053663|19275686|P1|NOT COMPLETED|Overall Study||6
7831245|NCT01053663|19275686|P1|COMPLETED|Overall Study||3
7831246|NCT01053663|19275686|P1|STARTED|Overall Study||9
7831247|NCT01053507|19275729|P2|NOT COMPLETED|Overall Study||1
7831248|NCT01053507|19275730|P1|NOT COMPLETED|Overall Study||3
7831249|NCT01053507|19275729|P2|COMPLETED|Overall Study||11
7831250|NCT01053507|19275730|P1|COMPLETED|Overall Study||8
7831251|NCT01053507|19275729|P2|STARTED|Overall Study||12
7831252|NCT01053507|19275730|P1|STARTED|Overall Study||11
7831253|NCT01053429|19275744|P1|NOT COMPLETED|Overall Study||373
7831254|NCT01053429|19275744|P1|COMPLETED|Overall Study||3018
7831255|NCT01053429|19275744|P1|STARTED|Overall Study||3391
7831256|NCT01053312|19275753|P1|NOT COMPLETED|Overall Study||0
7831257|NCT01053312|19275753|P1|COMPLETED|Overall Study||7
7831258|NCT01053312|19275753|P1|STARTED|Overall Study||7
7831259|NCT01053247|19275774|P3|NOT COMPLETED|Overall Study||28
7831260|NCT01053247|19275775|P2|NOT COMPLETED|Overall Study||19
7831261|NCT01053247|19275776|P1|NOT COMPLETED|Overall Study||20
7831262|NCT01053247|19275774|P3|COMPLETED|Overall Study||236
7831263|NCT01053247|19275775|P2|COMPLETED|Overall Study||241
7831264|NCT01053247|19275776|P1|COMPLETED|Overall Study||249
7831265|NCT01053247|19275774|P3|STARTED|Overall Study||264
7831266|NCT01053247|19275775|P2|STARTED|Overall Study||260
7831267|NCT01053247|19275776|P1|STARTED|Overall Study||269
7831268|NCT01053221|19275786|P2|NOT COMPLETED|Overall Study||9
7831269|NCT01053221|19275787|P1|NOT COMPLETED|Overall Study||5
7831270|NCT01053221|19275786|P2|COMPLETED|Overall Study||0
7831271|NCT01053221|19275787|P1|COMPLETED|Overall Study||0
7831272|NCT01053221|19275786|P2|STARTED|Overall Study||9
7831273|NCT01053221|19275787|P1|STARTED|Overall Study||5
7831274|NCT01053156|19275803|P2|NOT COMPLETED|Second Intervention (Week 13-24)||5
7831275|NCT01053156|19275804|P1|NOT COMPLETED|Second Intervention (Week 13-24)||2
7831276|NCT01053156|19275803|P2|COMPLETED|Second Intervention (Week 13-24)||22
7831277|NCT01053156|19275804|P1|COMPLETED|Second Intervention (Week 13-24)||26
7831278|NCT01053156|19275803|P2|STARTED|Second Intervention (Week 13-24)||27
7831279|NCT01053156|19275804|P1|STARTED|Second Intervention (Week 13-24)||28
7831280|NCT01053156|19275803|P2|NOT COMPLETED|First Intervention (Week 1-12)||6
7831281|NCT01053156|19275804|P1|NOT COMPLETED|First Intervention (Week 1-12)||5
7831282|NCT01053156|19275803|P2|COMPLETED|First Intervention (Week 1-12)||27
7831283|NCT01053156|19275804|P1|COMPLETED|First Intervention (Week 1-12)||28
7831284|NCT01053156|19275803|P2|STARTED|First Intervention (Week 1-12)||33
7831285|NCT01053156|19275804|P1|STARTED|First Intervention (Week 1-12)||33
7831286|NCT01053078|19275842|P2|NOT COMPLETED|Overall Study||3
7831287|NCT01053078|19275843|P1|NOT COMPLETED|Overall Study||4
7831288|NCT01053078|19275842|P2|COMPLETED|Overall Study||12
7831289|NCT01053078|19275843|P1|COMPLETED|Overall Study||10
7831290|NCT01053078|19275842|P2|STARTED|Overall Study||15
7831291|NCT01053078|19275843|P1|STARTED|Overall Study||14
7831292|NCT01053000|19275851|P2|NOT COMPLETED|Overall Study||0
7831293|NCT01053000|19275852|P1|NOT COMPLETED|Overall Study||0
7831294|NCT01053000|19275851|P2|COMPLETED|Overall Study||5
7831295|NCT01053000|19275852|P1|COMPLETED|Overall Study||5
7831296|NCT01053000|19275851|P2|STARTED|Overall Study||5
7831297|NCT01053000|19275852|P1|STARTED|Overall Study||5
7831298|NCT01052948|19275862|P4|NOT COMPLETED|Overall Study||0
7831299|NCT01052948|19275863|P3|NOT COMPLETED|Overall Study||0
7831300|NCT01052948|19275864|P2|NOT COMPLETED|Overall Study||0
7831301|NCT01052948|19275865|P1|NOT COMPLETED|Overall Study||0
7831302|NCT01052948|19275862|P4|COMPLETED|Overall Study||29311
7831303|NCT01052948|19275863|P3|COMPLETED|Overall Study||15147
7831304|NCT01052948|19275864|P2|COMPLETED|Overall Study||14669
7831305|NCT01052948|19275865|P1|COMPLETED|Overall Study||27812
7831306|NCT01052948|19275862|P4|STARTED|Overall Study||29311
7831307|NCT01052948|19275863|P3|STARTED|Overall Study||15147
7831308|NCT01052948|19275864|P2|STARTED|Overall Study||14669
7831309|NCT01052948|19275865|P1|STARTED|Overall Study||27812
7831310|NCT01052844|19275889|P2|NOT COMPLETED|Overall Study||1
7831311|NCT01052844|19275890|P1|NOT COMPLETED|Overall Study||0
7831312|NCT01052844|19275889|P2|COMPLETED|Overall Study||39
7831313|NCT01052844|19275890|P1|COMPLETED|Overall Study||40
7831314|NCT01052844|19275889|P2|STARTED|Overall Study||40
7831315|NCT01052844|19275890|P1|STARTED|Overall Study||40
7831316|NCT01052831|19275900|P2|NOT COMPLETED|Overall Study||1
7831317|NCT01052831|19275901|P1|NOT COMPLETED|Overall Study||4
7831318|NCT01052831|19275900|P2|COMPLETED|Overall Study||23
7831319|NCT01052831|19275901|P1|COMPLETED|Overall Study||22
7831320|NCT01052831|19275900|P2|STARTED|Overall Study||24
7831321|NCT01052831|19275901|P1|STARTED|Overall Study||26
7831322|NCT01052779|19275911|P2|NOT COMPLETED|Overall Study||9
7831323|NCT01052779|19275912|P1|NOT COMPLETED|Overall Study||5
7831324|NCT01052779|19275911|P2|COMPLETED|Overall Study||73
7831325|NCT01052779|19275912|P1|COMPLETED|Overall Study||75
7831326|NCT01052779|19275911|P2|Received at Least 1 Dose of Study Drug|Overall Study||81
7831327|NCT01052779|19275912|P1|Received at Least 1 Dose of Study Drug|Overall Study||80
7831328|NCT01052779|19275911|P2|STARTED|Overall Study||82
7831329|NCT01052779|19275912|P1|STARTED|Overall Study||80
7831330|NCT01052714|19275922|P3|NOT COMPLETED|Overall Study||2
7831331|NCT01052714|19275923|P2|NOT COMPLETED|Overall Study||29
7831332|NCT01052714|19275924|P1|NOT COMPLETED|Overall Study||25
7831333|NCT01052714|19275922|P3|COMPLETED|Overall Study||15
7831334|NCT01052714|19275923|P2|COMPLETED|Overall Study||33
7831335|NCT01052714|19275924|P1|COMPLETED|Overall Study||17
7831336|NCT01052714|19275922|P3|STARTED|Overall Study||17
7831337|NCT01052714|19275923|P2|STARTED|Overall Study||62
7831338|NCT01052714|19275924|P1|STARTED|Overall Study||42
7831339|NCT01052701|19275966|P2|NOT COMPLETED|Overall Study||0
7831340|NCT01052701|19275967|P1|NOT COMPLETED|Overall Study||0
7831341|NCT01052701|19275966|P2|COMPLETED|Overall Study||12
7831342|NCT01052701|19275967|P1|COMPLETED|Overall Study||14
7831343|NCT01052701|19275966|P2|STARTED|Overall Study||12
7831344|NCT01052701|19275967|P1|STARTED|Overall Study||14
7831345|NCT01052662|19275978|P3|NOT COMPLETED|Overall Study||22
7831346|NCT01052662|19275979|P2|NOT COMPLETED|Overall Study||22
7831347|NCT01052662|19275980|P1|NOT COMPLETED|Overall Study||22
7831348|NCT01052662|19275978|P3|COMPLETED|Overall Study||10
7831349|NCT01052662|19275979|P2|COMPLETED|Overall Study||5
7831350|NCT01052662|19275980|P1|COMPLETED|Overall Study||6
7831351|NCT01052662|19275978|P3|Discontinuation Phase|Overall Study||10
7831352|NCT01052662|19275979|P2|Discontinuation Phase|Overall Study||5
7831353|NCT01052662|19275980|P1|Discontinuation Phase|Overall Study||6
7831354|NCT01052662|19275978|P3|Stabilization Phase|Overall Study||26
7831355|NCT01052662|19275979|P2|Stabilization Phase|Overall Study||21
7831356|NCT01052662|19275980|P1|Stabilization Phase|Overall Study||21
7831357|NCT01052662|19275978|P3|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32
7831358|NCT01052662|19275979|P2|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27
7831359|NCT01052662|19275980|P1|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28
7831360|NCT01052545|19275996|P2|NOT COMPLETED|Overall Study||0
7831361|NCT01052545|19275997|P1|NOT COMPLETED|Overall Study||0
7831362|NCT01052545|19275996|P2|COMPLETED|Overall Study||731
7831363|NCT01052545|19275997|P1|COMPLETED|Overall Study||867
7831364|NCT01052545|19275996|P2|STARTED|Overall Study||731
7831365|NCT01052545|19275997|P1|STARTED|Overall Study||867
7831366|NCT01052480|19276021|P2|NOT COMPLETED|Overall Study||17
7831367|NCT01052480|19276022|P1|NOT COMPLETED|Overall Study||8
7831368|NCT01052480|19276021|P2|COMPLETED|Overall Study||32
7831369|NCT01052480|19276022|P1|COMPLETED|Overall Study||41
7831370|NCT01052480|19276021|P2|STARTED|Overall Study||49
7831371|NCT01052480|19276022|P1|STARTED|Overall Study||49
7831372|NCT01052428|19276072|P2|NOT COMPLETED|Overall Study||1
7831373|NCT01052428|19276073|P1|NOT COMPLETED|Overall Study||1
7831374|NCT01052428|19276072|P2|COMPLETED|Overall Study||18
7831375|NCT01052428|19276073|P1|COMPLETED|Overall Study||18
7831376|NCT01052428|19276072|P2|STARTED|Overall Study||19
7831377|NCT01052428|19276073|P1|STARTED|Overall Study||19
7831378|NCT01052272|19276095|P4|NOT COMPLETED|Overall Study||7
7831379|NCT01052272|19276096|P3|NOT COMPLETED|Overall Study||8
7831380|NCT01052272|19276097|P2|NOT COMPLETED|Overall Study||7
7831381|NCT01052272|19276098|P1|NOT COMPLETED|Overall Study||5
7831382|NCT01052272|19276095|P4|COMPLETED|Overall Study||11
7831383|NCT01052272|19276096|P3|COMPLETED|Overall Study||10
7831384|NCT01052272|19276097|P2|COMPLETED|Overall Study||11
7831385|NCT01052272|19276098|P1|COMPLETED|Overall Study||13
7831386|NCT01052272|19276095|P4|STARTED|Overall Study||18
7831387|NCT01052272|19276096|P3|STARTED|Overall Study||18
7831388|NCT01052272|19276097|P2|STARTED|Overall Study||18
7831389|NCT01052272|19276098|P1|STARTED|Overall Study||18
7831390|NCT01052207|19276134|P2|NOT COMPLETED|Overall Study||0
7831391|NCT01052207|19276135|P1|NOT COMPLETED|Overall Study||0
7831392|NCT01052207|19276134|P2|COMPLETED|Overall Study||42
7831393|NCT01052207|19276135|P1|COMPLETED|Overall Study||60
7831394|NCT01052207|19276134|P2|STARTED|Overall Study||42
7831395|NCT01052207|19276135|P1|STARTED|Overall Study||60
7831396|NCT01052116|19276143|P2|NOT COMPLETED|Overall Study||27
7831397|NCT01052116|19276144|P1|NOT COMPLETED|Overall Study||14
7831398|NCT01052116|19276143|P2|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166
7831399|NCT01052116|19276144|P1|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179
7831400|NCT01052116|19276143|P2|STARTED|Overall Study||193
7831401|NCT01052116|19276144|P1|STARTED|Overall Study||193
7831402|NCT01052077|19276152|P4|NOT COMPLETED|Phase A+||21
7831403|NCT01052077|19276153|P3|NOT COMPLETED|Phase A+||0
7831404|NCT01052077|19276154|P2|NOT COMPLETED|Phase A+||0
7831405|NCT01052077|19276155|P1|NOT COMPLETED|Phase A+||0
7831406|NCT01052077|19276152|P4|COMPLETED|Phase A+||230
7831407|NCT01052077|19276153|P3|COMPLETED|Phase A+||0
7831408|NCT01052077|19276154|P2|COMPLETED|Phase A+||0
7831409|NCT01052077|19276155|P1|COMPLETED|Phase A+||0
7831410|NCT01052077|19276152|P4|STARTED|Phase A+||251
7831411|NCT01052077|19276153|P3|STARTED|Phase A+||0
7831412|NCT01052077|19276154|P2|STARTED|Phase A+||0
7831413|NCT01052077|19276155|P1|STARTED|Phase A+||0
7831414|NCT01052077|19276152|P4|NOT COMPLETED|Phase B||0
7831415|NCT01052077|19276153|P3|NOT COMPLETED|Phase B||16
7831416|NCT01052077|19276154|P2|NOT COMPLETED|Phase B||18
7831417|NCT01052077|19276155|P1|NOT COMPLETED|Phase B||0
7831418|NCT01052077|19276152|P4|COMPLETED|Phase B||0
7831419|NCT01052077|19276153|P3|COMPLETED|Phase B||171
7831420|NCT01052077|19276154|P2|COMPLETED|Phase B||167
7831421|NCT01052077|19276155|P1|COMPLETED|Phase B||0
7831422|NCT01052077|19276152|P4|STARTED|Phase B||0
7831423|NCT01052077|19276153|P3|STARTED|Phase B||187
7831424|NCT01052077|19276154|P2|STARTED|Phase B||185
7831425|NCT01052077|19276155|P1|STARTED|Phase B||0
7831426|NCT01052077|19276152|P4|NOT COMPLETED|Phase A||0
7831427|NCT01052077|19276153|P3|NOT COMPLETED|Phase A||0
7831428|NCT01052077|19276154|P2|NOT COMPLETED|Phase A||0
7831429|NCT01052077|19276155|P1|NOT COMPLETED|Phase A||146
7831430|NCT01052077|19276152|P4|COMPLETED|Phase A||0
7831431|NCT01052077|19276153|P3|COMPLETED|Phase A||0
7831432|NCT01052077|19276154|P2|COMPLETED|Phase A||0
7831433|NCT01052077|19276155|P1|COMPLETED|Phase A||623
7831434|NCT01052077|19276152|P4|STARTED|Phase A||0
7831435|NCT01052077|19276153|P3|STARTED|Phase A||0
7831436|NCT01052077|19276154|P2|STARTED|Phase A||0
7831437|NCT01052077|19276155|P1|STARTED|Phase A||769
7831438|NCT01052038|19276182|P3|NOT COMPLETED|Overall Study||4
7831439|NCT01052038|19276183|P2|NOT COMPLETED|Overall Study||6
7831440|NCT01052038|19276184|P1|NOT COMPLETED|Overall Study||4
7831441|NCT01052038|19276182|P3|COMPLETED|Overall Study||36
7831442|NCT01052038|19276183|P2|COMPLETED|Overall Study||34
7831443|NCT01052038|19276184|P1|COMPLETED|Overall Study||36
7831444|NCT01052038|19276182|P3|STARTED|Overall Study||40
7831445|NCT01052038|19276183|P2|STARTED|Overall Study||40
7831446|NCT01052038|19276184|P1|STARTED|Overall Study||40
7831447|NCT01051986|19276206|P2|NOT COMPLETED|Overall Study||4
7831448|NCT01051986|19276207|P1|NOT COMPLETED|Overall Study||5
7831449|NCT01051986|19276206|P2|COMPLETED|Overall Study||108
7831450|NCT01051986|19276207|P1|COMPLETED|Overall Study||107
7831451|NCT01051986|19276206|P2|STARTED|Overall Study||112
7831452|NCT01051986|19276207|P1|STARTED|Overall Study||112
7831453|NCT01051960|19276221|P1|NOT COMPLETED|Overall Study||1
7831454|NCT01051960|19276221|P1|COMPLETED|Overall Study||11
7831455|NCT01051960|19276221|P1|STARTED|Overall Study||12
7831456|NCT01051921|19276229|P1|NOT COMPLETED|Overall Study||30
7831457|NCT01051921|19276229|P1|COMPLETED|Overall Study||37
7831458|NCT01051921|19276229|P1|STARTED|Overall Study||67
7831459|NCT01051856|19276236|P2|NOT COMPLETED|Overall Study||0
7831460|NCT01051856|19276237|P1|NOT COMPLETED|Overall Study||1
7831461|NCT01051856|19276236|P2|COMPLETED|Overall Study||35
7831462|NCT01051856|19276237|P1|COMPLETED|Overall Study||32
7831463|NCT01051856|19276236|P2|STARTED|Overall Study||35
7831464|NCT01051856|19276237|P1|STARTED|Overall Study||33
7831465|NCT01051817|19276247|P2|NOT COMPLETED|Overall Study||9
7831466|NCT01051817|19276248|P1|NOT COMPLETED|Overall Study||3
7831467|NCT01051817|19276247|P2|COMPLETED|Overall Study||26
7831468|NCT01051817|19276248|P1|COMPLETED|Overall Study||35
7831469|NCT01051817|19276247|P2|STARTED|Overall Study||35
7831470|NCT01051817|19276248|P1|STARTED|Overall Study||38
7831471|NCT01051791|19276258|P1|NOT COMPLETED|Overall Study||4
7831472|NCT01051791|19276258|P1|COMPLETED|Overall Study||9
7831473|NCT01051791|19276258|P1|STARTED|Overall Study||13
7831474|NCT01051778|19276267|P2|NOT COMPLETED|Overall Study||0
7831475|NCT01051778|19276268|P1|NOT COMPLETED|Overall Study||0
7831476|NCT01051778|19276267|P2|COMPLETED|Overall Study|November 2009|30
7831477|NCT01051778|19276268|P1|COMPLETED|Overall Study|November 2009|30
7831478|NCT01051778|19276267|P2|STARTED|Overall Study|June 2006|30
7831479|NCT01051778|19276268|P1|STARTED|Overall Study|June 2006|30
7831480|NCT01051739|19276276|P2|NOT COMPLETED|Overall Study||13
7831481|NCT01051739|19276277|P1|NOT COMPLETED|Overall Study||28
7831482|NCT01051739|19276276|P2|COMPLETED|Overall Study||47
7831483|NCT01051739|19276277|P1|COMPLETED|Overall Study||92
7831484|NCT01051739|19276276|P2|STARTED|Overall Study||60
7831485|NCT01051739|19276277|P1|STARTED|Overall Study||120
7831486|NCT01051661|19276289|P6|NOT COMPLETED|Overall Study||67
7831487|NCT01051661|19276290|P5|NOT COMPLETED|Overall Study||35
7831488|NCT01051661|19276291|P4|NOT COMPLETED|Overall Study||56
7831489|NCT01051661|19276292|P3|NOT COMPLETED|Overall Study||39
7831490|NCT01051661|19276293|P2|NOT COMPLETED|Overall Study||63
7831491|NCT01051661|19276294|P1|NOT COMPLETED|Overall Study||34
7831492|NCT01051661|19276289|P6|COMPLETED|Overall Study||1369
7831493|NCT01051661|19276290|P5|COMPLETED|Overall Study||578
7831494|NCT01051661|19276291|P4|COMPLETED|Overall Study||1380
7831495|NCT01051661|19276292|P3|COMPLETED|Overall Study||573
7831496|NCT01051661|19276293|P2|COMPLETED|Overall Study||1375
7831497|NCT01051661|19276294|P1|COMPLETED|Overall Study||576
7831498|NCT01051661|19276289|P6|STARTED|Overall Study||1436
7831499|NCT01051661|19276290|P5|STARTED|Overall Study||613
7831500|NCT01051661|19276291|P4|STARTED|Overall Study||1436
7831501|NCT01051661|19276292|P3|STARTED|Overall Study||612
7831502|NCT01051661|19276293|P2|STARTED|Overall Study||1438
7831503|NCT01051661|19276294|P1|STARTED|Overall Study||610
7831504|NCT01051596|19276473|P1|NOT COMPLETED|Overall Study||0
7831505|NCT01051596|19276473|P1|COMPLETED|Overall Study||75
7831506|NCT01051596|19276473|P1|STARTED|Overall Study||75
7831507|NCT01051570|19276480|P1|NOT COMPLETED|Overall Study||0
7831508|NCT01051570|19276480|P1|COMPLETED|Overall Study||26
7831509|NCT01051570|19276480|P1|STARTED|Overall Study||26
7831510|NCT01051557|19276496|P7|NOT COMPLETED|Overall Study||6
7831511|NCT01051557|19276497|P6|NOT COMPLETED|Overall Study||6
7831512|NCT01051557|19276498|P5|NOT COMPLETED|Overall Study||7
7831513|NCT01051557|19276499|P4|NOT COMPLETED|Overall Study||3
7831514|NCT01051557|19276500|P3|NOT COMPLETED|Overall Study||6
7831515|NCT01051557|19276501|P2|NOT COMPLETED|Overall Study||3
7831516|NCT01051557|19276502|P1|NOT COMPLETED|Overall Study||4
7831517|NCT01051557|19276496|P7|COMPLETED|Overall Study||0
7831518|NCT01051557|19276497|P6|COMPLETED|Overall Study||0
7831519|NCT01051557|19276498|P5|COMPLETED|Overall Study||1
7831520|NCT01051557|19276499|P4|COMPLETED|Overall Study||0
7831521|NCT01051557|19276500|P3|COMPLETED|Overall Study||0
7831522|NCT01051557|19276501|P2|COMPLETED|Overall Study||0
7831523|NCT01051557|19276502|P1|COMPLETED|Overall Study||0
7831524|NCT01051557|19276496|P7|STARTED|Overall Study||6
7831525|NCT01051557|19276497|P6|STARTED|Overall Study||6
7831526|NCT01051557|19276498|P5|STARTED|Overall Study||8
7831527|NCT01051557|19276499|P4|STARTED|Overall Study||3
7831528|NCT01051557|19276500|P3|STARTED|Overall Study||6
7831529|NCT01051557|19276501|P2|STARTED|Overall Study||3
7831530|NCT01051557|19276502|P1|STARTED|Overall Study||4
7831531|NCT01051518|19276521|P1|NOT COMPLETED|Overall Study||73
7831532|NCT01051518|19276521|P1|COMPLETED|Overall Study||53
7831533|NCT01051518|19276521|P1|STARTED|Overall Study||126
7831534|NCT01051466|19276533|P2|NOT COMPLETED|Overall Study||5
7831535|NCT01051466|19276534|P1|NOT COMPLETED|Overall Study||8
7831536|NCT01051466|19276533|P2|COMPLETED|Overall Study||23
7831537|NCT01051466|19276534|P1|COMPLETED|Overall Study||24
7831538|NCT01051466|19276533|P2|STARTED|Overall Study||28
7831539|NCT01051466|19276534|P1|STARTED|Overall Study||32
7831540|NCT01051440|19276568|P2|NOT COMPLETED|Overall Study||0
7831541|NCT01051440|19276569|P1|NOT COMPLETED|Overall Study||0
7831542|NCT01051440|19276568|P2|COMPLETED|Overall Study||1
7831543|NCT01051440|19276569|P1|COMPLETED|Overall Study||1
7831544|NCT01051440|19276568|P2|STARTED|Overall Study||1
7831545|NCT01051440|19276569|P1|STARTED|Overall Study||1
7831546|NCT01051349|19276579|P1|NOT COMPLETED|Overall Study||173
7831547|NCT01051349|19276579|P1|COMPLETED|Overall Study||237
7831548|NCT01051349|19276579|P1|STARTED|Overall Study||410
7831549|NCT01051323|19276608|P1|NOT COMPLETED|Overall Study||539
7831550|NCT01051323|19276608|P1|COMPLETED|Overall Study||1041
7831551|NCT01051323|19276608|P1|Received at Least One Dose|Overall Study||1547
7831552|NCT01051323|19276608|P1|STARTED|Overall Study||1580
7831553|NCT01051310|19276630|P1|NOT COMPLETED|Overall Study||5
7831554|NCT01051310|19276630|P1|COMPLETED|Overall Study||13
7831555|NCT01051310|19276630|P1|STARTED|Overall Study||18
7831556|NCT01051063|19276637|P2|NOT COMPLETED|Overall Study||4
7831557|NCT01051063|19276638|P1|NOT COMPLETED|Overall Study||10
7831558|NCT01051063|19276637|P2|COMPLETED|Overall Study||1
7831559|NCT01051063|19276638|P1|COMPLETED|Overall Study||2
7831560|NCT01051063|19276637|P2|STARTED|Overall Study||5
7831561|NCT01051063|19276638|P1|STARTED|Overall Study||12
7831562|NCT01050998|19276658|P5|NOT COMPLETED|Overall Study||14
7831563|NCT01050998|19276659|P4|NOT COMPLETED|Overall Study||3
7831564|NCT01050998|19276660|P3|NOT COMPLETED|Overall Study||3
7831565|NCT01050998|19276661|P2|NOT COMPLETED|Overall Study||2
7831566|NCT01050998|19276662|P1|NOT COMPLETED|Overall Study||4
7831567|NCT01050998|19276658|P5|COMPLETED|Overall Study||82
7831568|NCT01050998|19276659|P4|COMPLETED|Overall Study||45
7831569|NCT01050998|19276660|P3|COMPLETED|Overall Study||46
7831570|NCT01050998|19276661|P2|COMPLETED|Overall Study||47
7831571|NCT01050998|19276662|P1|COMPLETED|Overall Study||44
7831572|NCT01050998|19276658|P5|STARTED|Overall Study||96
7831573|NCT01050998|19276659|P4|STARTED|Overall Study||48
7831574|NCT01050998|19276660|P3|STARTED|Overall Study||49
7831575|NCT01050998|19276661|P2|STARTED|Overall Study||49
7831576|NCT01050998|19276662|P1|STARTED|Overall Study||48
7831577|NCT01050946|19276986|P1|NOT COMPLETED|Overall Study||0
7831578|NCT01050946|19276986|P1|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1
7831579|NCT01050946|19276986|P1|STARTED|Overall Study||1
7831580|NCT01050907|19276996|P1|NOT COMPLETED|Overall Study||0
7831581|NCT01050907|19276996|P1|COMPLETED|Overall Study||4
7831582|NCT01050907|19276996|P1|STARTED|Overall Study||4
7831583|NCT01050816|19277001|P1|NOT COMPLETED|Overall Study||4
7831584|NCT01050816|19277001|P1|COMPLETED|Overall Study||26
7831585|NCT01050816|19277001|P1|STARTED|Overall Study||30
7831586|NCT01050790|19277007|P1|NOT COMPLETED|Overall Study||1
7831587|NCT01050790|19277007|P1|COMPLETED|Overall Study||16
7831588|NCT01050790|19277007|P1|STARTED|Overall Study||17
7831589|NCT01050764|19277017|P1|NOT COMPLETED|Overall Study||3
7831590|NCT01050764|19277017|P1|COMPLETED|Overall Study||7
7831591|NCT01050764|19277017|P1|Received Infusion of T-con Cells|Overall Study||7
7831592|NCT01050764|19277017|P1|Received Infusion of T-reg Cells|Overall Study||7
7831593|NCT01050764|19277017|P1|Received HSCT Graft|Overall Study||8
7831594|NCT01050764|19277017|P1|STARTED|Overall Study||10
7831595|NCT01050673|19277028|P2|NOT COMPLETED|Overall Study||5
7831596|NCT01050673|19277029|P1|NOT COMPLETED|Overall Study||4
7831597|NCT01050673|19277028|P2|COMPLETED|Overall Study||14
7831598|NCT01050673|19277029|P1|COMPLETED|Overall Study||17
7831599|NCT01050673|19277028|P2|STARTED|Overall Study||19
7831600|NCT01050673|19277029|P1|STARTED|Overall Study||21
7831601|NCT01050660|19277053|P2|NOT COMPLETED|Overall Study||0
7831602|NCT01050660|19277054|P1|NOT COMPLETED|Overall Study||0
7831603|NCT01050660|19277053|P2|COMPLETED|Overall Study||69
7831604|NCT01050660|19277054|P1|COMPLETED|Overall Study||67
7831605|NCT01050660|19277053|P2|STARTED|Overall Study||69
7831606|NCT01050660|19277054|P1|STARTED|Overall Study||67
7831607|NCT01050647|19277080|P2|NOT COMPLETED|Overall Study||0
7831608|NCT01050647|19277081|P1|NOT COMPLETED|Overall Study||0
7831609|NCT01050647|19277080|P2|COMPLETED|Overall Study||11
7831610|NCT01050647|19277081|P1|COMPLETED|Overall Study||10
7831611|NCT01050647|19277080|P2|STARTED|Overall Study||11
7831612|NCT01050647|19277081|P1|STARTED|Overall Study||10
7831613|NCT01050634|19277097|P1|NOT COMPLETED|Overall Study||128
7831614|NCT01050634|19277097|P1|COMPLETED|Overall Study||852
7831615|NCT01050634|19277097|P1|Received Treatment|Overall Study||924
7831616|NCT01050634|19277097|P1|STARTED|Overall Study||980
7831617|NCT01050582|19277107|P2|NOT COMPLETED|Overall Study||0
7831618|NCT01050582|19277108|P1|NOT COMPLETED|Overall Study||0
7831619|NCT01050582|19277107|P2|COMPLETED|Overall Study||51
7831620|NCT01050582|19277108|P1|COMPLETED|Overall Study||133
7831621|NCT01050582|19277107|P2|STARTED|Overall Study||51
7831622|NCT01050582|19277108|P1|STARTED|Overall Study||133
7831623|NCT01050569|19277121|P3|NOT COMPLETED|Overall Study||33
7831624|NCT01050569|19277122|P2|NOT COMPLETED|Overall Study||24
7831625|NCT01050569|19277123|P1|NOT COMPLETED|Overall Study||38
7831626|NCT01050569|19277121|P3|COMPLETED|Overall Study||47
7831627|NCT01050569|19277122|P2|COMPLETED|Overall Study||52
7831628|NCT01050569|19277123|P1|COMPLETED|Overall Study||41
7831629|NCT01050569|19277121|P3|STARTED|Overall Study||80
7831630|NCT01050569|19277122|P2|STARTED|Overall Study||76
7831631|NCT01050569|19277123|P1|STARTED|Overall Study||79
7831632|NCT01050543|19277142|P2|NOT COMPLETED|Overall Study||4
7831633|NCT01050543|19277143|P1|NOT COMPLETED|Overall Study||4
7831634|NCT01050543|19277142|P2|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
7831635|NCT01050543|19277143|P1|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
7831722|NCT01049776|19277346|P1|STARTED|Overall Study||32
7831636|NCT01050543|19277142|P2|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
7831637|NCT01050543|19277143|P1|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
7831638|NCT01050530|19277151|P2|NOT COMPLETED|Overall Study||10
7831639|NCT01050530|19277152|P1|NOT COMPLETED|Overall Study||8
7831640|NCT01050530|19277151|P2|COMPLETED|Overall Study||70
7831641|NCT01050530|19277152|P1|COMPLETED|Overall Study||74
7831642|NCT01050530|19277151|P2|STARTED|Overall Study||80
7831643|NCT01050530|19277152|P1|STARTED|Overall Study||82
7831644|NCT01050257|19277163|P3|NOT COMPLETED|Overall Study||7
7831645|NCT01050257|19277164|P2|NOT COMPLETED|Overall Study||13
7831646|NCT01050257|19277165|P1|NOT COMPLETED|Overall Study||11
7831647|NCT01050257|19277163|P3|COMPLETED|Overall Study||8
7831648|NCT01050257|19277164|P2|COMPLETED|Overall Study||40
7831649|NCT01050257|19277165|P1|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39
7831650|NCT01050257|19277163|P3|Switched to Oral Treatment|Overall Study||3
7831651|NCT01050257|19277164|P2|Switched to Oral Treatment|Overall Study||31
7831652|NCT01050257|19277165|P1|Switched to Oral Treatment|Overall Study||28
7831653|NCT01050257|19277163|P3|Intent-to-treat Infected Confirmed|Overall Study||10
7831654|NCT01050257|19277164|P2|Intent-to-treat Infected Confirmed|Overall Study||32
7831655|NCT01050257|19277165|P1|Intent-to-treat Infected Confirmed|Overall Study||30
7831656|NCT01050257|19277163|P3|Safety Population: Actual Dose Received|Overall Study||14
7831657|NCT01050257|19277164|P2|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51
7831658|NCT01050257|19277165|P1|Safety Population: Actual Dose Received|Overall Study||48
7831659|NCT01050257|19277163|P3|Received Treatment|Overall Study||14
7831660|NCT01050257|19277164|P2|Received Treatment|Overall Study||50
7831661|NCT01050257|19277165|P1|Received Treatment|Overall Study||49
7831662|NCT01050257|19277163|P3|STARTED|Overall Study||15
7831663|NCT01050257|19277164|P2|STARTED|Overall Study||53
7831664|NCT01050257|19277165|P1|STARTED|Overall Study||50
7831665|NCT01050218|19277200|P1|NOT COMPLETED|Overall Study||95
7831666|NCT01050218|19277200|P1|COMPLETED|Overall Study||142
7831667|NCT01050218|19277200|P1|STARTED|Overall Study||237
7831668|NCT01050205|19277206|P2|NOT COMPLETED|Overall Study||4
7831669|NCT01050205|19277207|P1|NOT COMPLETED|Overall Study||11
7831670|NCT01050205|19277206|P2|COMPLETED|Overall Study||71
7831671|NCT01050205|19277207|P1|COMPLETED|Overall Study||137
7831672|NCT01050205|19277206|P2|STARTED|Overall Study||75
7831673|NCT01050205|19277207|P1|STARTED|Overall Study||148
7831674|NCT01050153|19277237|P2|NOT COMPLETED|Overall Study||0
7831675|NCT01050153|19277238|P1|NOT COMPLETED|Overall Study||0
7831676|NCT01050153|19277237|P2|COMPLETED|Overall Study||25
7831677|NCT01050153|19277238|P1|COMPLETED|Overall Study||25
7831678|NCT01050153|19277237|P2|STARTED|Overall Study||25
7831679|NCT01050153|19277238|P1|STARTED|Overall Study||25
7831680|NCT01050062|19277264|P2|NOT COMPLETED|Overall Study||112
7831681|NCT01050062|19277265|P1|NOT COMPLETED|Overall Study||271
7831682|NCT01050062|19277264|P2|COMPLETED|Overall Study||243
7831683|NCT01050062|19277265|P1|COMPLETED|Overall Study||799
7831684|NCT01050062|19277264|P2|STARTED|Overall Study||355
7831685|NCT01050062|19277265|P1|STARTED|Overall Study||1070
7831686|NCT01049984|19277287|P2|NOT COMPLETED|Overall Study||19
7831687|NCT01049984|19277288|P1|NOT COMPLETED|Overall Study||19
7831688|NCT01049984|19277287|P2|COMPLETED|Overall Study||146
7831689|NCT01049984|19277288|P1|COMPLETED|Overall Study||144
7831690|NCT01049984|19277287|P2|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162
7831691|NCT01049984|19277288|P1|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159
7831692|NCT01049984|19277287|P2|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164
7831693|NCT01049984|19277288|P1|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162
7831694|NCT01049984|19277287|P2|STARTED|Overall Study||165
7831695|NCT01049984|19277288|P1|STARTED|Overall Study||163
7831696|NCT01049945|19277306|P6|NOT COMPLETED|Overall Study||0
7831697|NCT01049945|19277307|P5|NOT COMPLETED|Overall Study||0
7831698|NCT01049945|19277308|P4|NOT COMPLETED|Overall Study||0
7831699|NCT01049945|19277309|P3|NOT COMPLETED|Overall Study||0
7831700|NCT01049945|19277310|P2|NOT COMPLETED|Overall Study||0
7831701|NCT01049945|19277311|P1|NOT COMPLETED|Overall Study||0
7831702|NCT01049945|19277306|P6|COMPLETED|Overall Study||49
7831703|NCT01049945|19277307|P5|COMPLETED|Overall Study||3
7831704|NCT01049945|19277308|P4|COMPLETED|Overall Study||6
7831705|NCT01049945|19277309|P3|COMPLETED|Overall Study||3
7831706|NCT01049945|19277310|P2|COMPLETED|Overall Study||6
7831707|NCT01049945|19277311|P1|COMPLETED|Overall Study||3
7831708|NCT01049945|19277306|P6|STARTED|Overall Study||49
7831709|NCT01049945|19277307|P5|STARTED|Overall Study||3
7831710|NCT01049945|19277308|P4|STARTED|Overall Study||6
7831711|NCT01049945|19277309|P3|STARTED|Overall Study||3
7831712|NCT01049945|19277310|P2|STARTED|Overall Study||6
7831713|NCT01049945|19277311|P1|STARTED|Overall Study||3
7831714|NCT01049802|19277331|P2|NOT COMPLETED|Overall Study||0
7831715|NCT01049802|19277332|P1|NOT COMPLETED|Overall Study||0
7831716|NCT01049802|19277331|P2|COMPLETED|Overall Study||10
7831717|NCT01049802|19277332|P1|COMPLETED|Overall Study||20
7831718|NCT01049802|19277331|P2|STARTED|Overall Study||10
7831719|NCT01049802|19277332|P1|STARTED|Overall Study||20
7831720|NCT01049776|19277346|P1|NOT COMPLETED|Overall Study||20
7831721|NCT01049776|19277346|P1|COMPLETED|Overall Study||12
7831723|NCT01049581|19277352|P2|NOT COMPLETED|Overall Study||1
7831724|NCT01049581|19277353|P1|NOT COMPLETED|Overall Study||2
7831725|NCT01049581|19277352|P2|COMPLETED|Overall Study||13
7831726|NCT01049581|19277353|P1|COMPLETED|Overall Study||11
7831727|NCT01049581|19277352|P2|STARTED|Overall Study||14
7831728|NCT01049581|19277353|P1|STARTED|Overall Study||13
7831729|NCT01049503|19277368|P6|NOT COMPLETED|Overall Study||8
7831730|NCT01049503|19277369|P5|NOT COMPLETED|Overall Study||27
7831731|NCT01049503|19277370|P4|NOT COMPLETED|Overall Study||26
7831732|NCT01049503|19277371|P3|NOT COMPLETED|Overall Study||24
7831733|NCT01049503|19277372|P2|NOT COMPLETED|Overall Study||12
7831734|NCT01049503|19277373|P1|NOT COMPLETED|Overall Study||11
7831735|NCT01049503|19277368|P6|COMPLETED|Overall Study||40
7831736|NCT01049503|19277369|P5|COMPLETED|Overall Study||29
7831737|NCT01049503|19277370|P4|COMPLETED|Overall Study||29
7831738|NCT01049503|19277371|P3|COMPLETED|Overall Study||32
7831739|NCT01049503|19277372|P2|COMPLETED|Overall Study||36
7831740|NCT01049503|19277373|P1|COMPLETED|Overall Study||41
7831741|NCT01049503|19277368|P6|STARTED|Overall Study||48
7831742|NCT01049503|19277369|P5|STARTED|Overall Study||56
7831743|NCT01049503|19277370|P4|STARTED|Overall Study||55
7831744|NCT01049503|19277371|P3|STARTED|Overall Study||56
7831745|NCT01049503|19277372|P2|STARTED|Overall Study||48
7831746|NCT01049503|19277373|P1|STARTED|Overall Study||52
7831747|NCT01049412|19277404|P2|NOT COMPLETED|Period II||3
7831748|NCT01049412|19277405|P1|NOT COMPLETED|Period II||4
7831749|NCT01049412|19277404|P2|COMPLETED|Period II||52
7831750|NCT01049412|19277405|P1|COMPLETED|Period II||58
7831751|NCT01049412|19277404|P2|STARTED|Period II||55
7831752|NCT01049412|19277405|P1|STARTED|Period II||62
7831753|NCT01049412|19277404|P2|NOT COMPLETED|Period I||13
7831754|NCT01049412|19277405|P1|NOT COMPLETED|Period I||8
7831755|NCT01049412|19277404|P2|COMPLETED|Period I||55
7831756|NCT01049412|19277405|P1|COMPLETED|Period I||62
7831757|NCT01049412|19277404|P2|Took at Least One Dose of Study Drug|Period I||68
7831758|NCT01049412|19277405|P1|Took at Least One Dose of Study Drug|Period I||69
7831759|NCT01049412|19277404|P2|STARTED|Period I||68
7831760|NCT01049412|19277405|P1|STARTED|Period I||70
7831761|NCT01049373|19277434|P2|NOT COMPLETED|Overall Study||44
7831762|NCT01049373|19277435|P1|NOT COMPLETED|Overall Study||39
7831763|NCT01049373|19277434|P2|COMPLETED|Overall Study||65
7831764|NCT01049373|19277435|P1|COMPLETED|Overall Study||73
7831765|NCT01049373|19277434|P2|STARTED|Overall Study||109
7831766|NCT01049373|19277435|P1|STARTED|Overall Study||112
7831767|NCT01049360|19277449|P20|NOT COMPLETED|Period 4||0
7831768|NCT01049360|19277450|P19|NOT COMPLETED|Period 4||0
7831769|NCT01049360|19277451|P18|NOT COMPLETED|Period 4||1
7831770|NCT01049360|19277452|P17|NOT COMPLETED|Period 4||0
7831771|NCT01049360|19277453|P16|NOT COMPLETED|Period 4||0
7831772|NCT01049360|19277454|P15|NOT COMPLETED|Period 4||0
7831773|NCT01049360|19277455|P14|NOT COMPLETED|Period 4||0
7831774|NCT01049360|19277456|P13|NOT COMPLETED|Period 4||0
7831775|NCT01049360|19277457|P12|NOT COMPLETED|Period 4||0
7831776|NCT01049360|19277458|P11|NOT COMPLETED|Period 4||0
7831777|NCT01049360|19277459|P10|NOT COMPLETED|Period 4||0
7831778|NCT01049360|19277460|P9|NOT COMPLETED|Period 4||0
7831779|NCT01049360|19277461|P8|NOT COMPLETED|Period 4||0
7831780|NCT01049360|19277462|P7|NOT COMPLETED|Period 4||0
7831781|NCT01049360|19277463|P6|NOT COMPLETED|Period 4||0
7831782|NCT01049360|19277464|P5|NOT COMPLETED|Period 4||0
7831783|NCT01049360|19277465|P4|NOT COMPLETED|Period 4||1
7831784|NCT01049360|19277466|P3|NOT COMPLETED|Period 4||0
7831785|NCT01049360|19277467|P2|NOT COMPLETED|Period 4||0
7831786|NCT01049360|19277468|P1|NOT COMPLETED|Period 4||0
7831787|NCT01049360|19277449|P20|COMPLETED|Period 4||5
7831788|NCT01049360|19277450|P19|COMPLETED|Period 4||5
7831789|NCT01049360|19277451|P18|COMPLETED|Period 4||5
7831790|NCT01049360|19277452|P17|COMPLETED|Period 4||5
7831791|NCT01049360|19277453|P16|COMPLETED|Period 4||6
7831792|NCT01049360|19277454|P15|COMPLETED|Period 4||5
7831793|NCT01049360|19277455|P14|COMPLETED|Period 4||6
7831794|NCT01049360|19277456|P13|COMPLETED|Period 4||4
7831795|NCT01049360|19277457|P12|COMPLETED|Period 4||6
7831796|NCT01049360|19277458|P11|COMPLETED|Period 4||5
7831797|NCT01049360|19277459|P10|COMPLETED|Period 4||6
7831798|NCT01049360|19277460|P9|COMPLETED|Period 4||4
7831799|NCT01049360|19277461|P8|COMPLETED|Period 4||4
7831800|NCT01049360|19277462|P7|COMPLETED|Period 4||6
7831801|NCT01049360|19277463|P6|COMPLETED|Period 4||5
7831802|NCT01049360|19277464|P5|COMPLETED|Period 4||7
7831803|NCT01049360|19277465|P4|COMPLETED|Period 4||3
7831804|NCT01049360|19277466|P3|COMPLETED|Period 4||7
7831805|NCT01049360|19277467|P2|COMPLETED|Period 4||4
7831806|NCT01049360|19277468|P1|COMPLETED|Period 4||6
7831807|NCT01049360|19277449|P20|STARTED|Period 4||5
7831808|NCT01049360|19277450|P19|STARTED|Period 4||5
7831809|NCT01049360|19277451|P18|STARTED|Period 4||6
7831810|NCT01049360|19277452|P17|STARTED|Period 4||5
7831811|NCT01049360|19277453|P16|STARTED|Period 4||6
7831812|NCT01049360|19277454|P15|STARTED|Period 4||5
7831813|NCT01049360|19277455|P14|STARTED|Period 4||6
7831814|NCT01049360|19277456|P13|STARTED|Period 4||4
7831815|NCT01049360|19277457|P12|STARTED|Period 4||6
7831816|NCT01049360|19277458|P11|STARTED|Period 4||5
7831817|NCT01049360|19277459|P10|STARTED|Period 4||6
7831818|NCT01049360|19277460|P9|STARTED|Period 4||4
7831819|NCT01049360|19277461|P8|STARTED|Period 4||4
7831820|NCT01049360|19277462|P7|STARTED|Period 4||6
7831821|NCT01049360|19277463|P6|STARTED|Period 4||5
7831822|NCT01049360|19277464|P5|STARTED|Period 4||7
7831823|NCT01049360|19277465|P4|STARTED|Period 4||4
7831824|NCT01049360|19277466|P3|STARTED|Period 4||7
7831825|NCT01049360|19277467|P2|STARTED|Period 4||4
7831826|NCT01049360|19277468|P1|STARTED|Period 4||6
7831827|NCT01049360|19277449|P20|NOT COMPLETED|Period 3||0
7831828|NCT01049360|19277450|P19|NOT COMPLETED|Period 3||0
7831829|NCT01049360|19277451|P18|NOT COMPLETED|Period 3||0
7831830|NCT01049360|19277452|P17|NOT COMPLETED|Period 3||0
7831831|NCT01049360|19277453|P16|NOT COMPLETED|Period 3||0
7831832|NCT01049360|19277454|P15|NOT COMPLETED|Period 3||0
7831833|NCT01049360|19277455|P14|NOT COMPLETED|Period 3||0
7831834|NCT01049360|19277456|P13|NOT COMPLETED|Period 3||0
7831835|NCT01049360|19277457|P12|NOT COMPLETED|Period 3||0
7831836|NCT01049360|19277458|P11|NOT COMPLETED|Period 3||0
7831837|NCT01049360|19277459|P10|NOT COMPLETED|Period 3||0
7831838|NCT01049360|19277460|P9|NOT COMPLETED|Period 3||0
7831839|NCT01049360|19277461|P8|NOT COMPLETED|Period 3||0
7831840|NCT01049360|19277462|P7|NOT COMPLETED|Period 3||0
7831841|NCT01049360|19277463|P6|NOT COMPLETED|Period 3||0
7831842|NCT01049360|19277464|P5|NOT COMPLETED|Period 3||0
7831843|NCT01049360|19277465|P4|NOT COMPLETED|Period 3||0
7831844|NCT01049360|19277466|P3|NOT COMPLETED|Period 3||0
7831845|NCT01049360|19277467|P2|NOT COMPLETED|Period 3||0
7831846|NCT01049360|19277468|P1|NOT COMPLETED|Period 3||0
7831847|NCT01049360|19277449|P20|COMPLETED|Period 3||5
7831848|NCT01049360|19277450|P19|COMPLETED|Period 3||5
7831849|NCT01049360|19277451|P18|COMPLETED|Period 3||6
7831850|NCT01049360|19277452|P17|COMPLETED|Period 3||5
7831851|NCT01049360|19277453|P16|COMPLETED|Period 3||6
7831852|NCT01049360|19277454|P15|COMPLETED|Period 3||5
7831853|NCT01049360|19277455|P14|COMPLETED|Period 3||6
7831854|NCT01049360|19277456|P13|COMPLETED|Period 3||4
7831855|NCT01049360|19277457|P12|COMPLETED|Period 3||6
7831856|NCT01049360|19277458|P11|COMPLETED|Period 3||5
7831857|NCT01049360|19277459|P10|COMPLETED|Period 3||6
7831858|NCT01049360|19277460|P9|COMPLETED|Period 3||4
7831859|NCT01049360|19277461|P8|COMPLETED|Period 3||4
7831860|NCT01049360|19277462|P7|COMPLETED|Period 3||6
7831861|NCT01049360|19277463|P6|COMPLETED|Period 3||5
7831862|NCT01049360|19277464|P5|COMPLETED|Period 3||7
7831863|NCT01049360|19277465|P4|COMPLETED|Period 3||4
7831864|NCT01049360|19277466|P3|COMPLETED|Period 3||7
7831865|NCT01049360|19277467|P2|COMPLETED|Period 3||4
7831866|NCT01049360|19277468|P1|COMPLETED|Period 3||6
7831867|NCT01049360|19277449|P20|STARTED|Period 3||5
7831868|NCT01049360|19277450|P19|STARTED|Period 3||5
7831869|NCT01049360|19277451|P18|STARTED|Period 3||6
7831870|NCT01049360|19277452|P17|STARTED|Period 3||5
7831871|NCT01049360|19277453|P16|STARTED|Period 3||6
7831872|NCT01049360|19277454|P15|STARTED|Period 3||5
7831873|NCT01049360|19277455|P14|STARTED|Period 3||6
7831874|NCT01049360|19277456|P13|STARTED|Period 3||4
7831875|NCT01049360|19277457|P12|STARTED|Period 3||6
7831876|NCT01049360|19277458|P11|STARTED|Period 3||5
7831877|NCT01049360|19277459|P10|STARTED|Period 3||6
7831878|NCT01049360|19277460|P9|STARTED|Period 3||4
7831879|NCT01049360|19277461|P8|STARTED|Period 3||4
7831880|NCT01049360|19277462|P7|STARTED|Period 3||6
7831881|NCT01049360|19277463|P6|STARTED|Period 3||5
7831882|NCT01049360|19277464|P5|STARTED|Period 3||7
7831883|NCT01049360|19277465|P4|STARTED|Period 3||4
7831884|NCT01049360|19277466|P3|STARTED|Period 3||7
7831885|NCT01049360|19277467|P2|STARTED|Period 3||4
7831886|NCT01049360|19277468|P1|STARTED|Period 3||6
7831887|NCT01049360|19277449|P20|NOT COMPLETED|Period 2||2
7831888|NCT01049360|19277450|P19|NOT COMPLETED|Period 2||0
7831889|NCT01049360|19277451|P18|NOT COMPLETED|Period 2||0
7831890|NCT01049360|19277452|P17|NOT COMPLETED|Period 2||0
7831891|NCT01049360|19277453|P16|NOT COMPLETED|Period 2||1
7831892|NCT01049360|19277454|P15|NOT COMPLETED|Period 2||2
7831893|NCT01049360|19277455|P14|NOT COMPLETED|Period 2||0
7831894|NCT01049360|19277456|P13|NOT COMPLETED|Period 2||0
7831895|NCT01049360|19277457|P12|NOT COMPLETED|Period 2||0
7831896|NCT01049360|19277458|P11|NOT COMPLETED|Period 2||0
7831897|NCT01049360|19277459|P10|NOT COMPLETED|Period 2||0
7831898|NCT01049360|19277460|P9|NOT COMPLETED|Period 2||1
7831899|NCT01049360|19277461|P8|NOT COMPLETED|Period 2||0
7831900|NCT01049360|19277462|P7|NOT COMPLETED|Period 2||0
7831901|NCT01049360|19277463|P6|NOT COMPLETED|Period 2||1
7831902|NCT01049360|19277464|P5|NOT COMPLETED|Period 2||0
7831903|NCT01049360|19277465|P4|NOT COMPLETED|Period 2||2
7831904|NCT01049360|19277466|P3|NOT COMPLETED|Period 2||0
7831905|NCT01049360|19277467|P2|NOT COMPLETED|Period 2||1
7831906|NCT01049360|19277468|P1|NOT COMPLETED|Period 2||0
7831907|NCT01049360|19277449|P20|COMPLETED|Period 2||5
7831908|NCT01049360|19277450|P19|COMPLETED|Period 2||5
7831909|NCT01049360|19277451|P18|COMPLETED|Period 2||6
7831910|NCT01049360|19277452|P17|COMPLETED|Period 2||5
7831911|NCT01049360|19277453|P16|COMPLETED|Period 2||6
7831912|NCT01049360|19277454|P15|COMPLETED|Period 2||5
7831913|NCT01049360|19277455|P14|COMPLETED|Period 2||6
7831914|NCT01049360|19277456|P13|COMPLETED|Period 2||4
7831915|NCT01049360|19277457|P12|COMPLETED|Period 2||6
7831916|NCT01049360|19277458|P11|COMPLETED|Period 2||5
7831917|NCT01049360|19277459|P10|COMPLETED|Period 2||6
7831918|NCT01049360|19277460|P9|COMPLETED|Period 2||4
7831919|NCT01049360|19277461|P8|COMPLETED|Period 2||4
7831920|NCT01049360|19277462|P7|COMPLETED|Period 2||6
7831921|NCT01049360|19277463|P6|COMPLETED|Period 2||5
7831922|NCT01049360|19277464|P5|COMPLETED|Period 2||7
7831923|NCT01049360|19277465|P4|COMPLETED|Period 2||4
7831924|NCT01049360|19277466|P3|COMPLETED|Period 2||7
7831925|NCT01049360|19277467|P2|COMPLETED|Period 2||4
7831926|NCT01049360|19277468|P1|COMPLETED|Period 2||6
7831927|NCT01049360|19277449|P20|STARTED|Period 2||7
7831928|NCT01049360|19277450|P19|STARTED|Period 2||5
7831929|NCT01049360|19277451|P18|STARTED|Period 2||6
7831930|NCT01049360|19277452|P17|STARTED|Period 2||5
7831931|NCT01049360|19277453|P16|STARTED|Period 2||7
7831932|NCT01049360|19277454|P15|STARTED|Period 2||7
7831933|NCT01049360|19277455|P14|STARTED|Period 2||6
7831934|NCT01049360|19277456|P13|STARTED|Period 2||4
7831935|NCT01049360|19277457|P12|STARTED|Period 2||6
7831936|NCT01049360|19277458|P11|STARTED|Period 2||5
7831937|NCT01049360|19277459|P10|STARTED|Period 2||6
7831938|NCT01049360|19277460|P9|STARTED|Period 2||5
7831939|NCT01049360|19277461|P8|STARTED|Period 2||4
7831940|NCT01049360|19277462|P7|STARTED|Period 2||6
7831941|NCT01049360|19277463|P6|STARTED|Period 2||6
7831942|NCT01049360|19277464|P5|STARTED|Period 2||7
7831943|NCT01049360|19277465|P4|STARTED|Period 2||6
7831944|NCT01049360|19277466|P3|STARTED|Period 2||7
7831945|NCT01049360|19277467|P2|STARTED|Period 2||5
7831946|NCT01049360|19277468|P1|STARTED|Period 2||6
7831947|NCT01049360|19277449|P20|NOT COMPLETED|Period 1||0
7831948|NCT01049360|19277450|P19|NOT COMPLETED|Period 1||1
7831949|NCT01049360|19277451|P18|NOT COMPLETED|Period 1||0
7831950|NCT01049360|19277452|P17|NOT COMPLETED|Period 1||1
7831951|NCT01049360|19277453|P16|NOT COMPLETED|Period 1||0
7831952|NCT01049360|19277454|P15|NOT COMPLETED|Period 1||0
7831953|NCT01049360|19277455|P14|NOT COMPLETED|Period 1||1
7831954|NCT01049360|19277456|P13|NOT COMPLETED|Period 1||2
7831955|NCT01049360|19277457|P12|NOT COMPLETED|Period 1||0
7831956|NCT01049360|19277458|P11|NOT COMPLETED|Period 1||1
7831957|NCT01049360|19277459|P10|NOT COMPLETED|Period 1||0
7831958|NCT01049360|19277460|P9|NOT COMPLETED|Period 1||2
7831959|NCT01049360|19277461|P8|NOT COMPLETED|Period 1||2
7831960|NCT01049360|19277462|P7|NOT COMPLETED|Period 1||0
7831961|NCT01049360|19277463|P6|NOT COMPLETED|Period 1||0
7831962|NCT01049360|19277464|P5|NOT COMPLETED|Period 1||0
7831963|NCT01049360|19277465|P4|NOT COMPLETED|Period 1||1
7831964|NCT01049360|19277466|P3|NOT COMPLETED|Period 1||0
7831965|NCT01049360|19277467|P2|NOT COMPLETED|Period 1||1
7831966|NCT01049360|19277468|P1|NOT COMPLETED|Period 1||0
7831967|NCT01049360|19277449|P20|COMPLETED|Period 1||7
7831968|NCT01049360|19277450|P19|COMPLETED|Period 1||5
7831969|NCT01049360|19277451|P18|COMPLETED|Period 1||6
7831970|NCT01049360|19277452|P17|COMPLETED|Period 1||5
7831971|NCT01049360|19277453|P16|COMPLETED|Period 1||7
7831972|NCT01049360|19277454|P15|COMPLETED|Period 1||7
7831973|NCT01049360|19277455|P14|COMPLETED|Period 1||6
7831974|NCT01049360|19277456|P13|COMPLETED|Period 1||4
7831975|NCT01049360|19277457|P12|COMPLETED|Period 1||6
7831976|NCT01049360|19277458|P11|COMPLETED|Period 1||5
7831977|NCT01049360|19277459|P10|COMPLETED|Period 1||6
7831978|NCT01049360|19277460|P9|COMPLETED|Period 1||5
7831979|NCT01049360|19277461|P8|COMPLETED|Period 1||4
7831980|NCT01049360|19277462|P7|COMPLETED|Period 1||6
7831981|NCT01049360|19277463|P6|COMPLETED|Period 1||6
7831982|NCT01049360|19277464|P5|COMPLETED|Period 1||7
7831983|NCT01049360|19277465|P4|COMPLETED|Period 1||6
7831984|NCT01049360|19277466|P3|COMPLETED|Period 1||7
7831985|NCT01049360|19277467|P2|COMPLETED|Period 1||5
7831986|NCT01049360|19277468|P1|COMPLETED|Period 1||6
7831987|NCT01049360|19277449|P20|STARTED|Period 1||7
7831988|NCT01049360|19277450|P19|STARTED|Period 1||6
7831989|NCT01049360|19277451|P18|STARTED|Period 1||6
7831990|NCT01049360|19277452|P17|STARTED|Period 1||6
7831991|NCT01049360|19277453|P16|STARTED|Period 1||7
7831992|NCT01049360|19277454|P15|STARTED|Period 1||7
7831993|NCT01049360|19277455|P14|STARTED|Period 1||7
7831994|NCT01049360|19277456|P13|STARTED|Period 1||6
7831995|NCT01049360|19277457|P12|STARTED|Period 1||6
7831996|NCT01049360|19277458|P11|STARTED|Period 1||6
7831997|NCT01049360|19277459|P10|STARTED|Period 1||6
7831998|NCT01049360|19277460|P9|STARTED|Period 1||7
7831999|NCT01049360|19277461|P8|STARTED|Period 1||6
7832000|NCT01049360|19277462|P7|STARTED|Period 1||6
7832001|NCT01049360|19277463|P6|STARTED|Period 1||6
7832002|NCT01049360|19277464|P5|STARTED|Period 1||7
7832003|NCT01049360|19277465|P4|STARTED|Period 1||7
7832004|NCT01049360|19277466|P3|STARTED|Period 1||7
7832005|NCT01049360|19277467|P2|STARTED|Period 1||6
7832006|NCT01049360|19277468|P1|STARTED|Period 1||6
7832007|NCT01049334|19277492|P2|NOT COMPLETED|Overall Study||7
7832008|NCT01049334|19277493|P1|NOT COMPLETED|Overall Study||9
7832009|NCT01049334|19277492|P2|COMPLETED|Overall Study||95
7832010|NCT01049334|19277493|P1|COMPLETED|Overall Study||93
7832011|NCT01049334|19277492|P2|STARTED|Overall Study||102
7832012|NCT01049334|19277493|P1|STARTED|Overall Study||102
7832013|NCT01049308|19277529|P1|NOT COMPLETED|Pill Counts||83
7832014|NCT01049308|19277529|P1|COMPLETED|Pill Counts||168
7832015|NCT01049308|19277529|P1|STARTED|Pill Counts||251
7832016|NCT01049308|19277529|P1|NOT COMPLETED|Evaluation of Cognitive Impairment||0
7832017|NCT01049308|19277529|P1|COMPLETED|Evaluation of Cognitive Impairment||251
7832018|NCT01049308|19277529|P1|STARTED|Evaluation of Cognitive Impairment||251
7832019|NCT01049243|19277536|P1|NOT COMPLETED|Overall Study||2
7832020|NCT01049243|19277536|P1|COMPLETED|Overall Study||18
7832021|NCT01049243|19277536|P1|STARTED|Overall Study||20
7832022|NCT01049217|19277543|P2|NOT COMPLETED|Overall Study||63
7832023|NCT01049217|19277544|P1|NOT COMPLETED|Overall Study||56
7832024|NCT01049217|19277543|P2|COMPLETED|Overall Study||131
7832025|NCT01049217|19277544|P1|COMPLETED|Overall Study||127
7832026|NCT01049217|19277543|P2|Treated|Overall Study||192
7832027|NCT01049217|19277544|P1|Treated|Overall Study||183
7832028|NCT01049217|19277543|P2|STARTED|Overall Study||194
7832029|NCT01049217|19277544|P1|STARTED|Overall Study||183
7832030|NCT01049035|19277621|P7|NOT COMPLETED|Overall Study||15
7832031|NCT01049035|19277622|P6|NOT COMPLETED|Overall Study||12
7832032|NCT01049035|19277623|P5|NOT COMPLETED|Overall Study||4
7832033|NCT01049035|19277624|P4|NOT COMPLETED|Overall Study||11
7832034|NCT01049035|19277625|P3|NOT COMPLETED|Overall Study||27
7832035|NCT01049035|19277626|P2|NOT COMPLETED|Overall Study||21
7832036|NCT01049035|19277627|P1|NOT COMPLETED|Overall Study||33
7832037|NCT01049035|19277621|P7|COMPLETED|Overall Study||39
7832038|NCT01049035|19277622|P6|COMPLETED|Overall Study||42
7832039|NCT01049035|19277623|P5|COMPLETED|Overall Study||71
7832040|NCT01049035|19277624|P4|COMPLETED|Overall Study||64
7832041|NCT01049035|19277625|P3|COMPLETED|Overall Study||80
7832042|NCT01049035|19277626|P2|COMPLETED|Overall Study||87
7832043|NCT01049035|19277627|P1|COMPLETED|Overall Study||74
7832044|NCT01049035|19277621|P7|Safety Population|Overall Study||49
7832045|NCT01049035|19277622|P6|Safety Population|Overall Study||52
7832046|NCT01049035|19277623|P5|Safety Population|Overall Study||70
7832047|NCT01049035|19277624|P4|Safety Population|Overall Study||74
7832048|NCT01049035|19277625|P3|Safety Population|Overall Study||100
7832049|NCT01049035|19277626|P2|Safety Population|Overall Study||102
7832050|NCT01049035|19277627|P1|Safety Population|Overall Study||104
7832051|NCT01049035|19277621|P7|STARTED|Overall Study||54
7832052|NCT01049035|19277622|P6|STARTED|Overall Study||54
7832053|NCT01049035|19277623|P5|STARTED|Overall Study||75
7832054|NCT01049035|19277624|P4|STARTED|Overall Study||75
7832055|NCT01049035|19277625|P3|STARTED|Overall Study||107
7832056|NCT01049035|19277626|P2|STARTED|Overall Study||108
7832057|NCT01049035|19277627|P1|STARTED|Overall Study||107
7832058|NCT01049009|19277786|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
7832059|NCT01049009|19277787|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
7832060|NCT01049009|19277786|P2|COMPLETED|Treatment Period 2 (12 Weeks)||8
7832061|NCT01049009|19277787|P1|COMPLETED|Treatment Period 2 (12 Weeks)||11
7832062|NCT01049009|19277786|P2|STARTED|Treatment Period 2 (12 Weeks)||18
7832063|NCT01049009|19277787|P1|STARTED|Treatment Period 2 (12 Weeks)||21
7832064|NCT01049009|19277786|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
7832065|NCT01049009|19277787|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
7832066|NCT01049009|19277786|P2|COMPLETED|Treatment Period 1 (12 Weeks)||18
7832067|NCT01049009|19277787|P1|COMPLETED|Treatment Period 1 (12 Weeks)||21
7832068|NCT01049009|19277786|P2|STARTED|Treatment Period 1 (12 Weeks)||21
7832069|NCT01049009|19277787|P1|STARTED|Treatment Period 1 (12 Weeks)||23
7832070|NCT01048944|19277799|P4|NOT COMPLETED|Overall Study||2
7832071|NCT01048944|19277800|P3|NOT COMPLETED|Overall Study||10
7832072|NCT01048944|19277801|P2|NOT COMPLETED|Overall Study||10
7832073|NCT01048944|19277802|P1|NOT COMPLETED|Overall Study||8
7832074|NCT01048944|19277799|P4|COMPLETED|Overall Study||19
7832075|NCT01048944|19277800|P3|COMPLETED|Overall Study||25
7832076|NCT01048944|19277801|P2|COMPLETED|Overall Study||28
7832077|NCT01048944|19277802|P1|COMPLETED|Overall Study||24
7832078|NCT01048944|19277799|P4|STARTED|Overall Study||21
7832079|NCT01048944|19277800|P3|STARTED|Overall Study||35
7832080|NCT01048944|19277801|P2|STARTED|Overall Study||38
7832081|NCT01048944|19277802|P1|STARTED|Overall Study||32
7832082|NCT01048879|19277819|P3|NOT COMPLETED|Overall Study||0
7832083|NCT01048879|19277820|P2|NOT COMPLETED|Overall Study||0
7832084|NCT01048879|19277821|P1|NOT COMPLETED|Overall Study||0
7832085|NCT01048879|19277819|P3|COMPLETED|Overall Study||5
7832086|NCT01048879|19277820|P2|COMPLETED|Overall Study||9
7832087|NCT01048879|19277821|P1|COMPLETED|Overall Study||1
7832088|NCT01048879|19277819|P3|STARTED|Overall Study||5
7832089|NCT01048879|19277820|P2|STARTED|Overall Study||9
7832090|NCT01048879|19277821|P1|STARTED|Overall Study||1
7832091|NCT01048866|19277834|P2|NOT COMPLETED|Overall Study||5
7832092|NCT01048866|19277835|P1|NOT COMPLETED|Overall Study||4
7832093|NCT01048866|19277834|P2|COMPLETED|Overall Study||92
7832094|NCT01048866|19277835|P1|COMPLETED|Overall Study||97
7832095|NCT01048866|19277834|P2|STARTED|Overall Study||97
7832096|NCT01048866|19277835|P1|STARTED|Overall Study||101
7832097|NCT01048788|19277880|P3|NOT COMPLETED|Overall Study||2
7832098|NCT01048788|19277881|P2|NOT COMPLETED|Overall Study||2
7832099|NCT01048788|19277882|P1|NOT COMPLETED|Overall Study||5
7832100|NCT01048788|19277880|P3|COMPLETED|Overall Study||11
7832101|NCT01048788|19277881|P2|COMPLETED|Overall Study||28
7832102|NCT01048788|19277882|P1|COMPLETED|Overall Study||3
7832103|NCT01048788|19277880|P3|STARTED|Overall Study||13
7832104|NCT01048788|19277881|P2|STARTED|Overall Study||30
7832105|NCT01048788|19277882|P1|STARTED|Overall Study||8
7832106|NCT01048723|19277890|P1|NOT COMPLETED|Overall Study||0
7832107|NCT01048723|19277890|P1|COMPLETED|Overall Study||2
7832108|NCT01048723|19277890|P1|STARTED|Overall Study||2
7832109|NCT01048697|19277897|P1|NOT COMPLETED|Overall Study||0
7832110|NCT01048697|19277897|P1|COMPLETED|Overall Study||18
7832111|NCT01048697|19277897|P1|STARTED|Overall Study||18
7832112|NCT01048671|19277904|P3|NOT COMPLETED|Overall Study||1
7832113|NCT01048671|19277905|P2|NOT COMPLETED|Overall Study||1
7832114|NCT01048671|19277906|P1|NOT COMPLETED|Overall Study||0
7832115|NCT01048671|19277904|P3|COMPLETED|Overall Study||151
7832116|NCT01048671|19277905|P2|COMPLETED|Overall Study||263
7832117|NCT01048671|19277906|P1|COMPLETED|Overall Study||66
7832118|NCT01048671|19277904|P3|STARTED|Overall Study||152
7832119|NCT01048671|19277905|P2|STARTED|Overall Study||264
7832120|NCT01048671|19277906|P1|STARTED|Overall Study||66
7832121|NCT01048658|19277929|P2|NOT COMPLETED|Overall Study||0
7832122|NCT01048658|19277930|P1|NOT COMPLETED|Overall Study||0
7832123|NCT01048658|19277929|P2|COMPLETED|Overall Study||80
7832124|NCT01048658|19277930|P1|COMPLETED|Overall Study||80
7832125|NCT01048658|19277929|P2|STARTED|Overall Study||80
7832126|NCT01048658|19277930|P1|STARTED|Overall Study||80
7832127|NCT01048606|19277948|P4|NOT COMPLETED|Overall Study||5
7832128|NCT01048606|19277949|P3|NOT COMPLETED|Overall Study||10
7832129|NCT01048606|19277950|P2|NOT COMPLETED|Overall Study||7
7832130|NCT01048606|19277951|P1|NOT COMPLETED|Overall Study||12
7832131|NCT01048606|19277948|P4|COMPLETED|Overall Study||5
7832132|NCT01048606|19277949|P3|COMPLETED|Overall Study||16
7832133|NCT01048606|19277950|P2|COMPLETED|Overall Study||8
7832134|NCT01048606|19277951|P1|COMPLETED|Overall Study||16
7832135|NCT01048606|19277948|P4|STARTED|Overall Study||10
7832136|NCT01048606|19277949|P3|STARTED|Overall Study||26
7832137|NCT01048606|19277950|P2|STARTED|Overall Study||15
7832138|NCT01048606|19277951|P1|STARTED|Overall Study||28
7832139|NCT01048593|19277964|P3|NOT COMPLETED|Overall Study||0
7832140|NCT01048593|19277965|P2|NOT COMPLETED|Overall Study||0
7832141|NCT01048593|19277966|P1|NOT COMPLETED|Overall Study||0
7832142|NCT01048593|19277964|P3|COMPLETED|Overall Study||1
7832143|NCT01048593|19277965|P2|COMPLETED|Overall Study||2
7832144|NCT01048593|19277966|P1|COMPLETED|Overall Study||3
7832145|NCT01048593|19277964|P3|STARTED|Overall Study||1
7832146|NCT01048593|19277965|P2|STARTED|Overall Study||2
7832147|NCT01048593|19277966|P1|STARTED|Overall Study||3
7832148|NCT01048541|19277986|P2|NOT COMPLETED|Overall Study||0
7832149|NCT01048541|19277987|P1|NOT COMPLETED|Overall Study||1
7832150|NCT01048541|19277986|P2|COMPLETED|Overall Study||19
7832151|NCT01048541|19277987|P1|COMPLETED|Overall Study||17
7832152|NCT01048541|19277986|P2|STARTED|Overall Study||19
7832153|NCT01048541|19277987|P1|STARTED|Overall Study||18
7832154|NCT01048502|19277997|P4|NOT COMPLETED|Overall Study||4
7832155|NCT01048502|19277998|P3|NOT COMPLETED|Overall Study||5
7832156|NCT01048502|19277999|P2|NOT COMPLETED|Overall Study||7
7832157|NCT01048502|19278000|P1|NOT COMPLETED|Overall Study||4
7832158|NCT01048502|19277997|P4|COMPLETED|Overall Study||21
7832159|NCT01048502|19277998|P3|COMPLETED|Overall Study||23
7832160|NCT01048502|19277999|P2|COMPLETED|Overall Study||16
7832161|NCT01048502|19278000|P1|COMPLETED|Overall Study||20
7832162|NCT01048502|19277997|P4|STARTED|Overall Study||25
7832163|NCT01048502|19277998|P3|STARTED|Overall Study||28
7832164|NCT01048502|19277999|P2|STARTED|Overall Study||23
7832165|NCT01048502|19278000|P1|STARTED|Overall Study||24
7832166|NCT01048424|19278013|P2|NOT COMPLETED|Overall Study||0
7832167|NCT01048424|19278014|P1|NOT COMPLETED|Overall Study||2
7832168|NCT01048424|19278013|P2|COMPLETED|Overall Study||10
7832169|NCT01048424|19278014|P1|COMPLETED|Overall Study||8
7832170|NCT01048424|19278013|P2|STARTED|Overall Study||10
7832171|NCT01048424|19278014|P1|STARTED|Overall Study||10
7832172|NCT01048333|19278036|P6|NOT COMPLETED|Treatment Period 3||0
7832173|NCT01048333|19278037|P5|NOT COMPLETED|Treatment Period 3||0
7832174|NCT01048333|19278038|P4|NOT COMPLETED|Treatment Period 3||0
7832175|NCT01048333|19278039|P3|NOT COMPLETED|Treatment Period 3||0
7832176|NCT01048333|19278040|P2|NOT COMPLETED|Treatment Period 3||0
7832177|NCT01048333|19278041|P1|NOT COMPLETED|Treatment Period 3||0
7832178|NCT01048333|19278036|P6|COMPLETED|Treatment Period 3||18
7832179|NCT01048333|19278037|P5|COMPLETED|Treatment Period 3||17
7832180|NCT01048333|19278038|P4|COMPLETED|Treatment Period 3||18
7832181|NCT01048333|19278039|P3|COMPLETED|Treatment Period 3||16
7832182|NCT01048333|19278040|P2|COMPLETED|Treatment Period 3||18
7832183|NCT01048333|19278041|P1|COMPLETED|Treatment Period 3||21
7832184|NCT01048333|19278036|P6|STARTED|Treatment Period 3||18
7832185|NCT01048333|19278037|P5|STARTED|Treatment Period 3||17
7832186|NCT01048333|19278038|P4|STARTED|Treatment Period 3||18
7832187|NCT01048333|19278039|P3|STARTED|Treatment Period 3||16
7832188|NCT01048333|19278040|P2|STARTED|Treatment Period 3||18
7832189|NCT01048333|19278041|P1|STARTED|Treatment Period 3||21
7832190|NCT01048333|19278036|P6|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
7832191|NCT01048333|19278037|P5|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
7832192|NCT01048333|19278038|P4|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
7832193|NCT01048333|19278039|P3|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
7832194|NCT01048333|19278040|P2|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1
7832195|NCT01048333|19278041|P1|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
7832196|NCT01048333|19278036|P6|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
7832197|NCT01048333|19278037|P5|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17
7832198|NCT01048333|19278038|P4|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
7832199|NCT01048333|19278039|P3|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16
7832200|NCT01048333|19278040|P2|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
7832201|NCT01048333|19278041|P1|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21
7832202|NCT01048333|19278036|P6|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
7832203|NCT01048333|19278037|P5|STARTED|Wash-Out Period 2 of 2 - 7 Days||17
7832204|NCT01048333|19278038|P4|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
7832205|NCT01048333|19278039|P3|STARTED|Wash-Out Period 2 of 2 - 7 Days||16
7832206|NCT01048333|19278040|P2|STARTED|Wash-Out Period 2 of 2 - 7 Days||19
7832207|NCT01048333|19278041|P1|STARTED|Wash-Out Period 2 of 2 - 7 Days||21
7832208|NCT01048333|19278036|P6|NOT COMPLETED|Treatment Period 2||0
7832209|NCT01048333|19278037|P5|NOT COMPLETED|Treatment Period 2||0
7832210|NCT01048333|19278038|P4|NOT COMPLETED|Treatment Period 2||0
7832211|NCT01048333|19278039|P3|NOT COMPLETED|Treatment Period 2||0
7832212|NCT01048333|19278040|P2|NOT COMPLETED|Treatment Period 2||0
7832213|NCT01048333|19278041|P1|NOT COMPLETED|Treatment Period 2||0
7832214|NCT01048333|19278036|P6|COMPLETED|Treatment Period 2||18
7832215|NCT01048333|19278037|P5|COMPLETED|Treatment Period 2||17
7832216|NCT01048333|19278038|P4|COMPLETED|Treatment Period 2||18
7832217|NCT01048333|19278039|P3|COMPLETED|Treatment Period 2||16
7832218|NCT01048333|19278040|P2|COMPLETED|Treatment Period 2||19
7832219|NCT01048333|19278041|P1|COMPLETED|Treatment Period 2||21
7832220|NCT01048333|19278036|P6|STARTED|Treatment Period 2||18
7832221|NCT01048333|19278037|P5|STARTED|Treatment Period 2||17
7832222|NCT01048333|19278038|P4|STARTED|Treatment Period 2||18
7832223|NCT01048333|19278039|P3|STARTED|Treatment Period 2||16
7832224|NCT01048333|19278040|P2|STARTED|Treatment Period 2||19
7832225|NCT01048333|19278041|P1|STARTED|Treatment Period 2||21
7832226|NCT01048333|19278036|P6|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
7832227|NCT01048333|19278037|P5|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
7832228|NCT01048333|19278038|P4|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
7832229|NCT01048333|19278039|P3|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
7832230|NCT01048333|19278040|P2|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
7832231|NCT01048333|19278041|P1|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
7832232|NCT01048333|19278036|P6|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
7832233|NCT01048333|19278037|P5|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17
7832234|NCT01048333|19278038|P4|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
7832235|NCT01048333|19278039|P3|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16
7832236|NCT01048333|19278040|P2|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19
7832237|NCT01048333|19278041|P1|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21
7832238|NCT01048333|19278036|P6|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
7832239|NCT01048333|19278037|P5|STARTED|Wash-Out Period 1 of 2 - 7 Days||17
7832240|NCT01048333|19278038|P4|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
7832241|NCT01048333|19278039|P3|STARTED|Wash-Out Period 1 of 2 - 7 Days||16
7832242|NCT01048333|19278040|P2|STARTED|Wash-Out Period 1 of 2 - 7 Days||19
7832243|NCT01048333|19278041|P1|STARTED|Wash-Out Period 1 of 2 - 7 Days||21
7832244|NCT01048333|19278036|P6|NOT COMPLETED|Treatment Period 1||0
7832245|NCT01048333|19278037|P5|NOT COMPLETED|Treatment Period 1||0
7832246|NCT01048333|19278038|P4|NOT COMPLETED|Treatment Period 1||0
7832247|NCT01048333|19278039|P3|NOT COMPLETED|Treatment Period 1||0
7832248|NCT01048333|19278040|P2|NOT COMPLETED|Treatment Period 1||0
7832249|NCT01048333|19278041|P1|NOT COMPLETED|Treatment Period 1||0
7832250|NCT01048333|19278036|P6|COMPLETED|Treatment Period 1||18
7832251|NCT01048333|19278037|P5|COMPLETED|Treatment Period 1||17
7832252|NCT01048333|19278038|P4|COMPLETED|Treatment Period 1||18
7832253|NCT01048333|19278039|P3|COMPLETED|Treatment Period 1||16
7832254|NCT01048333|19278040|P2|COMPLETED|Treatment Period 1||19
7832255|NCT01048333|19278041|P1|COMPLETED|Treatment Period 1||21
7832256|NCT01048333|19278036|P6|STARTED|Treatment Period 1||18
7832257|NCT01048333|19278037|P5|STARTED|Treatment Period 1||17
7832258|NCT01048333|19278038|P4|STARTED|Treatment Period 1||18
7832259|NCT01048333|19278039|P3|STARTED|Treatment Period 1||16
7832260|NCT01048333|19278040|P2|STARTED|Treatment Period 1||19
7832261|NCT01048333|19278041|P1|STARTED|Treatment Period 1||21
7832262|NCT01048242|19278063|P2|NOT COMPLETED|Overall Study||2
7832263|NCT01048242|19278064|P1|NOT COMPLETED|Overall Study||4
7832264|NCT01048242|19278063|P2|COMPLETED|Overall Study||13
7832265|NCT01048242|19278064|P1|COMPLETED|Overall Study||8
7832266|NCT01048242|19278063|P2|STARTED|Overall Study||15
7832267|NCT01048242|19278064|P1|STARTED|Overall Study||12
7832268|NCT01048125|19278072|P2|NOT COMPLETED|Overall Study||0
7832269|NCT01048125|19278073|P1|NOT COMPLETED|Overall Study||0
7832270|NCT01048125|19278072|P2|COMPLETED|Overall Study||0
7832271|NCT01048125|19278073|P1|COMPLETED|Overall Study||0
7832272|NCT01048125|19278072|P2|STARTED|Overall Study||0
7832273|NCT01048125|19278073|P1|STARTED|Overall Study||0
7832274|NCT01048099|19278079|P1|NOT COMPLETED|Treatment Per Protocol||14
7832275|NCT01048099|19278079|P1|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0
7832276|NCT01048099|19278079|P1|STARTED|Treatment Per Protocol||14
7832277|NCT01048099|19278079|P1|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10
7832278|NCT01048099|19278079|P1|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14
7832279|NCT01048099|19278079|P1|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24
7832280|NCT01048099|19278079|P1|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202
7832281|NCT01048099|19278079|P1|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24
7832282|NCT01048099|19278079|P1|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226
7832283|NCT01048099|19278079|P1|NOT COMPLETED|Patients Enrolled and Blood Collected||57
7832284|NCT01048099|19278079|P1|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226
7832285|NCT01048099|19278079|P1|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283
7832286|NCT01047839|19278090|P3|NOT COMPLETED|Overall Study||6
7832287|NCT01047839|19278091|P2|NOT COMPLETED|Overall Study||0
7832288|NCT01047839|19278092|P1|NOT COMPLETED|Overall Study||2
7832289|NCT01047839|19278090|P3|COMPLETED|Overall Study||53
7832290|NCT01047839|19278091|P2|COMPLETED|Overall Study||29
7832291|NCT01047839|19278092|P1|COMPLETED|Overall Study||10
7832292|NCT01047839|19278090|P3|STARTED|Overall Study||59
7832293|NCT01047839|19278091|P2|STARTED|Overall Study||29
7832294|NCT01047839|19278092|P1|STARTED|Overall Study||12
7832295|NCT01047709|19278118|P2|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
7832296|NCT01047709|19278119|P1|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
7832297|NCT01047709|19278118|P2|COMPLETED|Control/Positioning ad Lib (1 Night)||9
7832298|NCT01047709|19278119|P1|COMPLETED|Control/Positioning ad Lib (1 Night)||9
7832299|NCT01047709|19278118|P2|STARTED|Control/Positioning ad Lib (1 Night)||9
7832300|NCT01047709|19278119|P1|STARTED|Control/Positioning ad Lib (1 Night)||9
7832301|NCT01047709|19278118|P2|NOT COMPLETED|Positional Therapy (1 Night)||0
7832302|NCT01047709|19278119|P1|NOT COMPLETED|Positional Therapy (1 Night)||0
7832303|NCT01047709|19278118|P2|COMPLETED|Positional Therapy (1 Night)||9
7832304|NCT01047709|19278119|P1|COMPLETED|Positional Therapy (1 Night)||9
7832305|NCT01047709|19278118|P2|STARTED|Positional Therapy (1 Night)||9
7832306|NCT01047709|19278119|P1|STARTED|Positional Therapy (1 Night)||9
7832307|NCT01047553|19278127|P2|NOT COMPLETED|Overall Study||9
7832308|NCT01047553|19278128|P1|NOT COMPLETED|Overall Study||17
7832309|NCT01047553|19278127|P2|COMPLETED|Overall Study||117
7832310|NCT01047553|19278128|P1|COMPLETED|Overall Study||108
7832311|NCT01047553|19278127|P2|STARTED|Overall Study||126
7832312|NCT01047553|19278128|P1|STARTED|Overall Study||125
7832313|NCT01047527|19278213|P3|NOT COMPLETED|Overall Study||65
7832314|NCT01047527|19278214|P2|NOT COMPLETED|Overall Study||61
7832315|NCT01047527|19278215|P1|NOT COMPLETED|Overall Study||85
7832316|NCT01047527|19278213|P3|COMPLETED|Overall Study||107
7832317|NCT01047527|19278214|P2|COMPLETED|Overall Study||112
7832318|NCT01047527|19278215|P1|COMPLETED|Overall Study||95
7832319|NCT01047527|19278213|P3|24 Weeks|Overall Study||119
7832320|NCT01047527|19278214|P2|24 Weeks|Overall Study||123
7832321|NCT01047527|19278215|P1|24 Weeks|Overall Study||111
7832322|NCT01047527|19278213|P3|8 Weeks|Overall Study||138
7832323|NCT01047527|19278214|P2|8 Weeks|Overall Study||142
7832324|NCT01047527|19278215|P1|8 Weeks|Overall Study||148
7832325|NCT01047527|19278213|P3|STARTED|Overall Study||172
7832326|NCT01047527|19278214|P2|STARTED|Overall Study||173
7832327|NCT01047527|19278215|P1|STARTED|Overall Study||180
7832328|NCT01047475|19278226|P2|NOT COMPLETED|Overall Study||7
7832329|NCT01047475|19278227|P1|NOT COMPLETED|Overall Study||5
7832330|NCT01047475|19278226|P2|COMPLETED|Overall Study||31
7832331|NCT01047475|19278227|P1|COMPLETED|Overall Study||29
7832332|NCT01047475|19278226|P2|STARTED|Overall Study||38
7832333|NCT01047475|19278227|P1|STARTED|Overall Study||34
7832334|NCT01047436|19278235|P2|NOT COMPLETED|Overall Study||0
7832335|NCT01047436|19278236|P1|NOT COMPLETED|Overall Study||1
7832336|NCT01047436|19278235|P2|COMPLETED|Overall Study||15
7832337|NCT01047436|19278236|P1|COMPLETED|Overall Study||15
7832338|NCT01047436|19278235|P2|STARTED|Overall Study||15
7832339|NCT01047436|19278236|P1|STARTED|Overall Study||16
7832340|NCT01047358|19278252|P1|NOT COMPLETED|Overall Study||0
7832341|NCT01047358|19278252|P1|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206
7832342|NCT01047358|19278252|P1|STARTED|Overall Study||206
7832343|NCT01047345|19278261|P3|NOT COMPLETED|Extension||6
7832344|NCT01047345|19278262|P2|NOT COMPLETED|Extension||0
7832345|NCT01047345|19278263|P1|NOT COMPLETED|Extension||0
7832346|NCT01047345|19278261|P3|COMPLETED|Extension||96
7832347|NCT01047345|19278262|P2|COMPLETED|Extension||0
7832348|NCT01047345|19278263|P1|COMPLETED|Extension||0
7832349|NCT01047345|19278261|P3|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95
7832350|NCT01047345|19278262|P2|Vaccination 6|Extension||0
7832351|NCT01047345|19278263|P1|Vaccination 6|Extension||0
7832352|NCT01047345|19278261|P3|Vaccination 5|Extension||99
7832353|NCT01047345|19278262|P2|Vaccination 5|Extension||0
7832354|NCT01047345|19278263|P1|Vaccination 5|Extension||0
7832355|NCT01047345|19278261|P3|Vaccination 4|Extension||102
7832356|NCT01047345|19278262|P2|Vaccination 4|Extension||0
7832357|NCT01047345|19278263|P1|Vaccination 4|Extension||0
7832358|NCT01047345|19278261|P3|STARTED|Extension|Not all eligible participants elected to participate in extension|102
7832359|NCT01047345|19278262|P2|STARTED|Extension||0
7832360|NCT01047345|19278263|P1|STARTED|Extension||0
7832361|NCT01047345|19278261|P3|NOT COMPLETED|Base Study||0
7832362|NCT01047345|19278262|P2|NOT COMPLETED|Base Study||6
7832363|NCT01047345|19278263|P1|NOT COMPLETED|Base Study||22
7832364|NCT01047345|19278261|P3|COMPLETED|Base Study||0
7832365|NCT01047345|19278262|P2|COMPLETED|Base Study||300
7832366|NCT01047345|19278263|P1|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596
7832367|NCT01047345|19278261|P3|Vaccination 3|Base Study||0
7832368|NCT01047345|19278262|P2|Vaccination 3|Base Study||300
7832369|NCT01047345|19278263|P1|Vaccination 3|Base Study||597
7832370|NCT01047345|19278261|P3|Vaccination 2|Base Study||0
7832371|NCT01047345|19278262|P2|Vaccination 2|Base Study||304
7832372|NCT01047345|19278263|P1|Vaccination 2|Base Study||604
7832373|NCT01047345|19278261|P3|Vaccination 1|Base Study||0
7832374|NCT01047345|19278262|P2|Vaccination 1|Base Study||306
7832375|NCT01047345|19278263|P1|Vaccination 1|Base Study||615
7832376|NCT01047345|19278261|P3|STARTED|Base Study||0
7832377|NCT01047345|19278262|P2|STARTED|Base Study||306
7832378|NCT01047345|19278263|P1|STARTED|Base Study||618
7832379|NCT01047332|19278285|P2|NOT COMPLETED|Overall Study||64
7832380|NCT01047332|19278286|P1|NOT COMPLETED|Overall Study||57
7832381|NCT01047332|19278285|P2|COMPLETED|Overall Study|Alive at final follow-up|4
7832382|NCT01047332|19278286|P1|COMPLETED|Overall Study|Alive at final follow-up|4
7832383|NCT01047332|19278285|P2|STARTED|Overall Study||68
7832384|NCT01047332|19278286|P1|STARTED|Overall Study||61
7832385|NCT01047319|19278301|P3|NOT COMPLETED|Overall Study||352
7832386|NCT01047319|19278302|P2|NOT COMPLETED|Overall Study||350
7832387|NCT01047319|19278303|P1|NOT COMPLETED|Overall Study||345
7832388|NCT01047319|19278301|P3|COMPLETED|Overall Study||0
7832389|NCT01047319|19278302|P2|COMPLETED|Overall Study||0
7832390|NCT01047319|19278303|P1|COMPLETED|Overall Study||0
7832391|NCT01047319|19278301|P3|STARTED|Overall Study||352
7832392|NCT01047319|19278302|P2|STARTED|Overall Study||350
7832393|NCT01047319|19278303|P1|STARTED|Overall Study||345
7832394|NCT01047306|19278325|P2|NOT COMPLETED|Overall Study||0
7832395|NCT01047306|19278326|P1|NOT COMPLETED|Overall Study||3
7832396|NCT01047306|19278325|P2|COMPLETED|Overall Study||6
7832397|NCT01047306|19278326|P1|COMPLETED|Overall Study||16
7832398|NCT01047306|19278325|P2|Discontinued From the Study|Overall Study||0
7832399|NCT01047306|19278326|P1|Discontinued From the Study|Overall Study||3
7832400|NCT01047306|19278325|P2|STARTED|Overall Study||6
7832401|NCT01047306|19278326|P1|STARTED|Overall Study||19
7832402|NCT01047293|19278400|P4|NOT COMPLETED|Overall Study||0
7832403|NCT01047293|19278401|P3|NOT COMPLETED|Overall Study||0
7832404|NCT01047293|19278402|P2|NOT COMPLETED|Overall Study||1
7832405|NCT01047293|19278403|P1|NOT COMPLETED|Overall Study||1
7832406|NCT01047293|19278400|P4|COMPLETED|Overall Study||26
7832407|NCT01047293|19278401|P3|COMPLETED|Overall Study||9
7832408|NCT01047293|19278402|P2|COMPLETED|Overall Study||7
7832409|NCT01047293|19278403|P1|COMPLETED|Overall Study||3
7832410|NCT01047293|19278400|P4|STARTED|Overall Study||26
7832411|NCT01047293|19278401|P3|STARTED|Overall Study||9
7832412|NCT01047293|19278402|P2|STARTED|Overall Study||8
7832413|NCT01047293|19278403|P1|STARTED|Overall Study||4
7832414|NCT01047241|19278410|P1|NOT COMPLETED|Overall Study||0
7832415|NCT01047241|19278410|P1|COMPLETED|Overall Study||50
7832416|NCT01047241|19278410|P1|STARTED|Overall Study||50
7832417|NCT01047189|19278421|P2|NOT COMPLETED|Overall Study||0
7832418|NCT01047189|19278422|P1|NOT COMPLETED|Overall Study||4
7832419|NCT01047189|19278421|P2|COMPLETED|Overall Study||13
7832420|NCT01047189|19278422|P1|COMPLETED|Overall Study||9
7832421|NCT01047189|19278421|P2|STARTED|Overall Study||13
7832422|NCT01047189|19278422|P1|STARTED|Overall Study||13
7832423|NCT01047007|19278434|P4|NOT COMPLETED|Overall Study||0
7832424|NCT01047007|19278435|P3|NOT COMPLETED|Overall Study||2
7832425|NCT01047007|19278436|P2|NOT COMPLETED|Overall Study||6
7832426|NCT01047007|19278437|P1|NOT COMPLETED|Overall Study||2
7832427|NCT01047007|19278434|P4|COMPLETED|Overall Study||0
7832428|NCT01047007|19278435|P3|COMPLETED|Overall Study||0
7832429|NCT01047007|19278436|P2|COMPLETED|Overall Study||0
7832430|NCT01047007|19278437|P1|COMPLETED|Overall Study||1
7832431|NCT01047007|19278434|P4|Treated|Overall Study||0
7832432|NCT01047007|19278435|P3|Treated|Overall Study||2
7832433|NCT01047007|19278436|P2|Treated|Overall Study||6
7832434|NCT01047007|19278437|P1|Treated|Overall Study||3
7832435|NCT01047007|19278434|P4|STARTED|Overall Study||0
7832436|NCT01047007|19278435|P3|STARTED|Overall Study||2
7832437|NCT01047007|19278436|P2|STARTED|Overall Study||6
7832438|NCT01047007|19278437|P1|STARTED|Overall Study||3
7832439|NCT01046903|19278448|P1|NOT COMPLETED|Overall Study||28
7832440|NCT01046903|19278448|P1|COMPLETED|Overall Study||475
7832441|NCT01046903|19278448|P1|STARTED|Overall Study||503
7832442|NCT01046877|19278461|P1|NOT COMPLETED|Overall Study||18
7832443|NCT01046877|19278461|P1|COMPLETED|Overall Study||7
7832444|NCT01046877|19278461|P1|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1
7832445|NCT01046877|19278461|P1|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6
7832446|NCT01046877|19278461|P1|STARTED|Overall Study||25
7832447|NCT01046695|19278477|P2|NOT COMPLETED|Overall Study||2
7832448|NCT01046695|19278478|P1|NOT COMPLETED|Overall Study||0
7832449|NCT01046695|19278477|P2|COMPLETED|Overall Study||20
7832450|NCT01046695|19278478|P1|COMPLETED|Overall Study||20
7832451|NCT01046695|19278477|P2|STARTED|Overall Study||22
7832452|NCT01046695|19278478|P1|STARTED|Overall Study||20
7832453|NCT01046682|19278490|P2|NOT COMPLETED|Overall Study||0
7832454|NCT01046682|19278491|P1|NOT COMPLETED|Overall Study||2
7832455|NCT01046682|19278490|P2|COMPLETED|Overall Study||20
7832456|NCT01046682|19278491|P1|COMPLETED|Overall Study||18
7832457|NCT01046682|19278490|P2|STARTED|Overall Study||20
7832458|NCT01046682|19278491|P1|STARTED|Overall Study||20
7832459|NCT01046669|19278499|P2|NOT COMPLETED|Overall Study||1
7832460|NCT01046669|19278500|P1|NOT COMPLETED|Overall Study||0
7832461|NCT01046669|19278499|P2|COMPLETED|Overall Study||223
7832462|NCT01046669|19278500|P1|COMPLETED|Overall Study||226
7832463|NCT01046669|19278499|P2|STARTED|Overall Study||224
7832464|NCT01046669|19278500|P1|STARTED|Overall Study||226
7832465|NCT01046643|19278508|P4|NOT COMPLETED|Second Period Treatment or Placebo||0
7832466|NCT01046643|19278509|P3|NOT COMPLETED|Second Period Treatment or Placebo||0
7832467|NCT01046643|19278510|P2|NOT COMPLETED|Second Period Treatment or Placebo||0
7832468|NCT01046643|19278511|P1|NOT COMPLETED|Second Period Treatment or Placebo||0
7832469|NCT01046643|19278508|P4|COMPLETED|Second Period Treatment or Placebo||7
7832470|NCT01046643|19278509|P3|COMPLETED|Second Period Treatment or Placebo||7
7832471|NCT01046643|19278510|P2|COMPLETED|Second Period Treatment or Placebo||6
7832472|NCT01046643|19278511|P1|COMPLETED|Second Period Treatment or Placebo||9
7832473|NCT01046643|19278508|P4|STARTED|Second Period Treatment or Placebo||7
7832474|NCT01046643|19278509|P3|STARTED|Second Period Treatment or Placebo||7
7832475|NCT01046643|19278510|P2|STARTED|Second Period Treatment or Placebo||6
7832476|NCT01046643|19278511|P1|STARTED|Second Period Treatment or Placebo||9
7832477|NCT01046643|19278508|P4|NOT COMPLETED|Washout Period||0
7832478|NCT01046643|19278509|P3|NOT COMPLETED|Washout Period||0
7832479|NCT01046643|19278510|P2|NOT COMPLETED|Washout Period||0
7832480|NCT01046643|19278511|P1|NOT COMPLETED|Washout Period||0
7832481|NCT01046643|19278508|P4|COMPLETED|Washout Period||7
7832482|NCT01046643|19278509|P3|COMPLETED|Washout Period||7
7832483|NCT01046643|19278510|P2|COMPLETED|Washout Period||6
7832484|NCT01046643|19278511|P1|COMPLETED|Washout Period||9
7832485|NCT01046643|19278508|P4|STARTED|Washout Period||7
7832486|NCT01046643|19278509|P3|STARTED|Washout Period||7
7832487|NCT01046643|19278510|P2|STARTED|Washout Period||6
7832488|NCT01046643|19278511|P1|STARTED|Washout Period||9
7832489|NCT01046643|19278508|P4|NOT COMPLETED|First Period Treatment or Placebo||0
7832490|NCT01046643|19278509|P3|NOT COMPLETED|First Period Treatment or Placebo||0
7832491|NCT01046643|19278510|P2|NOT COMPLETED|First Period Treatment or Placebo||1
7832492|NCT01046643|19278511|P1|NOT COMPLETED|First Period Treatment or Placebo||0
7832493|NCT01046643|19278508|P4|COMPLETED|First Period Treatment or Placebo||7
7832494|NCT01046643|19278509|P3|COMPLETED|First Period Treatment or Placebo||7
7832495|NCT01046643|19278510|P2|COMPLETED|First Period Treatment or Placebo||6
7832496|NCT01046643|19278511|P1|COMPLETED|First Period Treatment or Placebo||9
7832497|NCT01046643|19278508|P4|STARTED|First Period Treatment or Placebo||7
7832498|NCT01046643|19278509|P3|STARTED|First Period Treatment or Placebo||7
7832499|NCT01046643|19278510|P2|STARTED|First Period Treatment or Placebo||7
7832500|NCT01046643|19278511|P1|STARTED|First Period Treatment or Placebo||9
7832501|NCT01046565|19278533|P1|NOT COMPLETED|Overall Study||9
7832502|NCT01046565|19278533|P1|COMPLETED|Overall Study||66
7832503|NCT01046565|19278533|P1|STARTED|Overall Study||75
7832504|NCT01046396|19278542|P1|NOT COMPLETED|Overall Study||5
7832505|NCT01046396|19278542|P1|COMPLETED|Overall Study||64
7832506|NCT01046396|19278542|P1|STARTED|Overall Study||69
7832507|NCT01046253|19278553|P2|NOT COMPLETED|Fourth Intervention||0
7832508|NCT01046253|19278554|P1|NOT COMPLETED|Fourth Intervention||0
7832509|NCT01046253|19278553|P2|COMPLETED|Fourth Intervention||23
7832510|NCT01046253|19278554|P1|COMPLETED|Fourth Intervention||25
7832511|NCT01046253|19278553|P2|STARTED|Fourth Intervention||23
7832512|NCT01046253|19278554|P1|STARTED|Fourth Intervention||25
7832513|NCT01046253|19278553|P2|NOT COMPLETED|Third Washout of 7 Days||0
7832514|NCT01046253|19278554|P1|NOT COMPLETED|Third Washout of 7 Days||0
7832515|NCT01046253|19278553|P2|COMPLETED|Third Washout of 7 Days||23
7832516|NCT01046253|19278554|P1|COMPLETED|Third Washout of 7 Days||25
7832517|NCT01046253|19278553|P2|STARTED|Third Washout of 7 Days||23
7832518|NCT01046253|19278554|P1|STARTED|Third Washout of 7 Days||25
7832519|NCT01046253|19278553|P2|NOT COMPLETED|Third Intervention||0
7832520|NCT01046253|19278554|P1|NOT COMPLETED|Third Intervention||0
7832521|NCT01046253|19278553|P2|COMPLETED|Third Intervention||23
7832522|NCT01046253|19278554|P1|COMPLETED|Third Intervention||25
7832523|NCT01046253|19278553|P2|STARTED|Third Intervention||23
7832524|NCT01046253|19278554|P1|STARTED|Third Intervention||25
7832525|NCT01046253|19278553|P2|NOT COMPLETED|Second Washout of 7 Days||0
7832526|NCT01046253|19278554|P1|NOT COMPLETED|Second Washout of 7 Days||0
7832527|NCT01046253|19278553|P2|COMPLETED|Second Washout of 7 Days||23
7832528|NCT01046253|19278554|P1|COMPLETED|Second Washout of 7 Days||25
7832529|NCT01046253|19278553|P2|STARTED|Second Washout of 7 Days||23
7832530|NCT01046253|19278554|P1|STARTED|Second Washout of 7 Days||25
7832531|NCT01046253|19278553|P2|NOT COMPLETED|Second Intervention||2
7832532|NCT01046253|19278554|P1|NOT COMPLETED|Second Intervention||0
7832533|NCT01046253|19278553|P2|COMPLETED|Second Intervention||23
7832534|NCT01046253|19278554|P1|COMPLETED|Second Intervention||25
7832535|NCT01046253|19278553|P2|STARTED|Second Intervention||25
7832536|NCT01046253|19278554|P1|STARTED|Second Intervention||25
7832537|NCT01046253|19278553|P2|NOT COMPLETED|First Washout of 7 Days||0
7832538|NCT01046253|19278554|P1|NOT COMPLETED|First Washout of 7 Days||0
7832539|NCT01046253|19278553|P2|COMPLETED|First Washout of 7 Days||25
7832540|NCT01046253|19278554|P1|COMPLETED|First Washout of 7 Days||25
7832541|NCT01046253|19278553|P2|STARTED|First Washout of 7 Days||25
7832542|NCT01046253|19278554|P1|STARTED|First Washout of 7 Days||25
7832543|NCT01046253|19278553|P2|NOT COMPLETED|First Intervention||0
7832544|NCT01046253|19278554|P1|NOT COMPLETED|First Intervention||0
7832545|NCT01046253|19278553|P2|COMPLETED|First Intervention||25
7832546|NCT01046253|19278554|P1|COMPLETED|First Intervention||25
7832547|NCT01046253|19278553|P2|STARTED|First Intervention||25
7832548|NCT01046253|19278554|P1|STARTED|First Intervention||25
7832549|NCT01046136|19278566|P2|NOT COMPLETED|Overall Study||8
7832550|NCT01046136|19278567|P1|NOT COMPLETED|Overall Study||4
7832551|NCT01046136|19278566|P2|COMPLETED|Overall Study||182
7832552|NCT01046136|19278567|P1|COMPLETED|Overall Study||184
7832553|NCT01046136|19278566|P2|STARTED|Overall Study||190
7832554|NCT01046136|19278567|P1|STARTED|Overall Study||188
7832555|NCT01046110|19278579|P2|NOT COMPLETED|Overall Study||55
7832556|NCT01046110|19278580|P1|NOT COMPLETED|Overall Study||55
7832557|NCT01046110|19278579|P2|COMPLETED|Overall Study||174
7832558|NCT01046110|19278580|P1|COMPLETED|Overall Study||174
7832559|NCT01046110|19278579|P2|Exposed|Overall Study|1 subject was randomised in error|228
7832560|NCT01046110|19278580|P1|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226
7832561|NCT01046110|19278579|P2|STARTED|Overall Study||229
7832562|NCT01046110|19278580|P1|STARTED|Overall Study||229
7832563|NCT01046084|19278590|P2|NOT COMPLETED|Fourth Intervention||0
7832564|NCT01046084|19278591|P1|NOT COMPLETED|Fourth Intervention||0
7832565|NCT01046084|19278590|P2|COMPLETED|Fourth Intervention||25
7832566|NCT01046084|19278591|P1|COMPLETED|Fourth Intervention||23
7832567|NCT01046084|19278590|P2|STARTED|Fourth Intervention||25
7832568|NCT01046084|19278591|P1|STARTED|Fourth Intervention||23
7832569|NCT01046084|19278590|P2|NOT COMPLETED|Third Washout of 7 Days||0
7832570|NCT01046084|19278591|P1|NOT COMPLETED|Third Washout of 7 Days||2
7832571|NCT01046084|19278590|P2|COMPLETED|Third Washout of 7 Days||25
7832572|NCT01046084|19278591|P1|COMPLETED|Third Washout of 7 Days||23
7832573|NCT01046084|19278590|P2|STARTED|Third Washout of 7 Days||25
7832574|NCT01046084|19278591|P1|STARTED|Third Washout of 7 Days||25
7832575|NCT01046084|19278590|P2|NOT COMPLETED|Third Intervention||0
7832576|NCT01046084|19278591|P1|NOT COMPLETED|Third Intervention||0
7832577|NCT01046084|19278590|P2|COMPLETED|Third Intervention||25
7832578|NCT01046084|19278591|P1|COMPLETED|Third Intervention||25
7832579|NCT01046084|19278590|P2|STARTED|Third Intervention||25
7832580|NCT01046084|19278591|P1|STARTED|Third Intervention||25
7832581|NCT01046084|19278590|P2|NOT COMPLETED|Second Washout of 7 Days||0
7832582|NCT01046084|19278591|P1|NOT COMPLETED|Second Washout of 7 Days||0
7832583|NCT01046084|19278590|P2|COMPLETED|Second Washout of 7 Days||25
7832584|NCT01046084|19278591|P1|COMPLETED|Second Washout of 7 Days||25
7832585|NCT01046084|19278590|P2|STARTED|Second Washout of 7 Days||25
7832586|NCT01046084|19278591|P1|STARTED|Second Washout of 7 Days||25
7832587|NCT01046084|19278590|P2|NOT COMPLETED|Second Intervention||0
7832588|NCT01046084|19278591|P1|NOT COMPLETED|Second Intervention||0
7832589|NCT01046084|19278590|P2|COMPLETED|Second Intervention||25
7832590|NCT01046084|19278591|P1|COMPLETED|Second Intervention||25
7832591|NCT01046084|19278590|P2|STARTED|Second Intervention||25
7832592|NCT01046084|19278591|P1|STARTED|Second Intervention||25
7832593|NCT01046084|19278590|P2|NOT COMPLETED|First Washout of 7 Days||0
7832594|NCT01046084|19278591|P1|NOT COMPLETED|First Washout of 7 Days||0
7832595|NCT01046084|19278590|P2|COMPLETED|First Washout of 7 Days||25
7832596|NCT01046084|19278591|P1|COMPLETED|First Washout of 7 Days||25
7832597|NCT01046084|19278590|P2|STARTED|First Washout of 7 Days||25
7832598|NCT01046084|19278591|P1|STARTED|First Washout of 7 Days||25
7832599|NCT01046084|19278590|P2|NOT COMPLETED|First Intervention||0
7832600|NCT01046084|19278591|P1|NOT COMPLETED|First Intervention||0
7832601|NCT01046084|19278590|P2|COMPLETED|First Intervention||25
7832602|NCT01046084|19278591|P1|COMPLETED|First Intervention||25
7832603|NCT01046084|19278590|P2|STARTED|First Intervention||25
7832604|NCT01046084|19278591|P1|STARTED|First Intervention||25
7832605|NCT01045993|19278605|P4|NOT COMPLETED|Overall Study||0
7832606|NCT01045993|19278606|P3|NOT COMPLETED|Overall Study||0
7832607|NCT01045993|19278607|P2|NOT COMPLETED|Overall Study||1
7832608|NCT01045993|19278608|P1|NOT COMPLETED|Overall Study||0
7832609|NCT01045993|19278605|P4|COMPLETED|Overall Study||25
7832610|NCT01045993|19278606|P3|COMPLETED|Overall Study||5
7832611|NCT01045993|19278607|P2|COMPLETED|Overall Study||4
7832612|NCT01045993|19278608|P1|COMPLETED|Overall Study||26
7832613|NCT01045993|19278605|P4|STARTED|Overall Study||25
7832614|NCT01045993|19278606|P3|STARTED|Overall Study||5
7832615|NCT01045993|19278607|P2|STARTED|Overall Study||5
7832616|NCT01045993|19278608|P1|STARTED|Overall Study||26
7832617|NCT01045967|19278684|P2|NOT COMPLETED|Second Intervention||1
7832618|NCT01045967|19278685|P1|NOT COMPLETED|Second Intervention||0
7832619|NCT01045967|19278684|P2|COMPLETED|Second Intervention||27
7832620|NCT01045967|19278685|P1|COMPLETED|Second Intervention||28
7832621|NCT01045967|19278684|P2|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28
7832622|NCT01045967|19278685|P1|STARTED|Second Intervention||28
7832623|NCT01045967|19278684|P2|NOT COMPLETED|Washout of 7 Days||0
7832624|NCT01045967|19278685|P1|NOT COMPLETED|Washout of 7 Days||0
7832625|NCT01045967|19278684|P2|COMPLETED|Washout of 7 Days||28
7832626|NCT01045967|19278685|P1|COMPLETED|Washout of 7 Days||28
7832627|NCT01045967|19278684|P2|STARTED|Washout of 7 Days||28
7832628|NCT01045967|19278685|P1|STARTED|Washout of 7 Days||28
7832629|NCT01045967|19278684|P2|NOT COMPLETED|First Intervention||0
7832630|NCT01045967|19278685|P1|NOT COMPLETED|First Intervention||0
7832631|NCT01045967|19278684|P2|COMPLETED|First Intervention||28
7832632|NCT01045967|19278685|P1|COMPLETED|First Intervention||28
7832633|NCT01045967|19278684|P2|STARTED|First Intervention||28
7832634|NCT01045967|19278685|P1|STARTED|First Intervention||28
7832635|NCT01045798|19278697|P2|NOT COMPLETED|Overall Study||4
7832636|NCT01045798|19278698|P1|NOT COMPLETED|Overall Study||2
7832637|NCT01045798|19278697|P2|COMPLETED|Overall Study||5
7832638|NCT01045798|19278698|P1|COMPLETED|Overall Study||4
7832639|NCT01045798|19278697|P2|STARTED|Overall Study||9
7832640|NCT01045798|19278698|P1|STARTED|Overall Study||6
7832641|NCT01045707|19278706|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12
7832642|NCT01045707|19278707|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13
7832643|NCT01045707|19278706|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209
7832644|NCT01045707|19278707|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179
7832645|NCT01045707|19278706|P2|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221
7832646|NCT01045707|19278707|P1|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192
7832647|NCT01045707|19278706|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32
7832648|NCT01045707|19278707|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47
7832649|NCT01045707|19278706|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232
7832650|NCT01045707|19278707|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219
7832651|NCT01045707|19278706|P2|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261
7832652|NCT01045707|19278707|P1|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265
7832653|NCT01045707|19278706|P2|STARTED|Main: Week 0 to 26 (NN5401-3590)||264
7832654|NCT01045707|19278707|P1|STARTED|Main: Week 0 to 26 (NN5401-3590)||266
7832655|NCT01045694|19278723|P1|NOT COMPLETED|Overall Study||2
7832656|NCT01045694|19278723|P1|COMPLETED|Overall Study||6
7832657|NCT01045694|19278723|P1|STARTED|Overall Study||8
7832658|NCT01045551|19278729|P1|NOT COMPLETED|Overall Study||0
7832659|NCT01045551|19278729|P1|COMPLETED|Overall Study||10
7832660|NCT01045551|19278729|P1|STARTED|Overall Study||10
7832661|NCT01045499|19278737|P1|NOT COMPLETED|Overall Study||10
7832662|NCT01045499|19278737|P1|COMPLETED|Overall Study||127
7832663|NCT01045499|19278737|P1|STARTED|Overall Study||137
7832664|NCT01045460|19278744|P2|NOT COMPLETED|Overall Study||3
7832665|NCT01045460|19278745|P1|NOT COMPLETED|Overall Study||6
7832666|NCT01045460|19278744|P2|COMPLETED|Overall Study||15
7832667|NCT01045460|19278745|P1|COMPLETED|Overall Study||11
7832668|NCT01045460|19278744|P2|STARTED|Overall Study||18
7832669|NCT01045460|19278745|P1|STARTED|Overall Study||17
7832670|NCT01045447|19278757|P2|NOT COMPLETED|Overall Study||28
7832671|NCT01045447|19278758|P1|NOT COMPLETED|Overall Study||36
7832672|NCT01045447|19278757|P2|COMPLETED|Overall Study||205
7832673|NCT01045447|19278758|P1|COMPLETED|Overall Study||196
7832674|NCT01045447|19278757|P2|Exposed|Overall Study||233
7832675|NCT01045447|19278758|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230
7832676|NCT01045447|19278757|P2|STARTED|Overall Study||233
7832677|NCT01045447|19278758|P1|STARTED|Overall Study||232
7832678|NCT01045421|19278772|P11|NOT COMPLETED|Phase 2||2
7832679|NCT01045421|19278773|P10|NOT COMPLETED|Phase 2||3
7832680|NCT01045421|19278774|P9|NOT COMPLETED|Phase 2||2
7832681|NCT01045421|19278775|P8|NOT COMPLETED|Phase 2||5
7832682|NCT01045421|19278776|P7|NOT COMPLETED|Phase 2||0
7832683|NCT01045421|19278777|P6|NOT COMPLETED|Phase 2||0
7832684|NCT01045421|19278778|P5|NOT COMPLETED|Phase 2||0
7832685|NCT01045421|19278779|P4|NOT COMPLETED|Phase 2||0
7832686|NCT01045421|19278780|P3|NOT COMPLETED|Phase 2||0
7832687|NCT01045421|19278781|P2|NOT COMPLETED|Phase 2||0
7832688|NCT01045421|19278782|P1|NOT COMPLETED|Phase 2||0
7832689|NCT01045421|19278772|P11|COMPLETED|Phase 2||58
7832690|NCT01045421|19278773|P10|COMPLETED|Phase 2||23
7832691|NCT01045421|19278774|P9|COMPLETED|Phase 2||53
7832692|NCT01045421|19278775|P8|COMPLETED|Phase 2||50
7832693|NCT01045421|19278776|P7|COMPLETED|Phase 2||53
7832694|NCT01045421|19278777|P6|COMPLETED|Phase 2||0
7832695|NCT01045421|19278778|P5|COMPLETED|Phase 2||0
7832696|NCT01045421|19278779|P4|COMPLETED|Phase 2||0
7832697|NCT01045421|19278780|P3|COMPLETED|Phase 2||0
7832698|NCT01045421|19278781|P2|COMPLETED|Phase 2||0
7832699|NCT01045421|19278782|P1|COMPLETED|Phase 2||0
7832700|NCT01045421|19278772|P11|STARTED|Phase 2||60
7832701|NCT01045421|19278773|P10|STARTED|Phase 2||26
7832702|NCT01045421|19278774|P9|STARTED|Phase 2||55
7832703|NCT01045421|19278775|P8|STARTED|Phase 2||55
7832704|NCT01045421|19278776|P7|STARTED|Phase 2||53
7832705|NCT01045421|19278777|P6|STARTED|Phase 2||0
7832706|NCT01045421|19278778|P5|STARTED|Phase 2||0
7832707|NCT01045421|19278779|P4|STARTED|Phase 2||0
7832708|NCT01045421|19278780|P3|STARTED|Phase 2||0
7832709|NCT01045421|19278781|P2|STARTED|Phase 2||0
7832710|NCT01045421|19278782|P1|STARTED|Phase 2||0
7832711|NCT01045421|19278772|P11|NOT COMPLETED|Phase 1||0
7832712|NCT01045421|19278773|P10|NOT COMPLETED|Phase 1||0
7832713|NCT01045421|19278774|P9|NOT COMPLETED|Phase 1||0
7832714|NCT01045421|19278775|P8|NOT COMPLETED|Phase 1||0
7832715|NCT01045421|19278776|P7|NOT COMPLETED|Phase 1||0
7832716|NCT01045421|19278777|P6|NOT COMPLETED|Phase 1||0
7832717|NCT01045421|19278778|P5|NOT COMPLETED|Phase 1||1
7832718|NCT01045421|19278779|P4|NOT COMPLETED|Phase 1||1
7832719|NCT01045421|19278780|P3|NOT COMPLETED|Phase 1||0
7832720|NCT01045421|19278781|P2|NOT COMPLETED|Phase 1||0
7832721|NCT01045421|19278782|P1|NOT COMPLETED|Phase 1||0
7832722|NCT01045421|19278772|P11|COMPLETED|Phase 1||0
7832723|NCT01045421|19278773|P10|COMPLETED|Phase 1||0
7832724|NCT01045421|19278774|P9|COMPLETED|Phase 1||0
7832725|NCT01045421|19278775|P8|COMPLETED|Phase 1||0
7832726|NCT01045421|19278776|P7|COMPLETED|Phase 1||0
7832727|NCT01045421|19278777|P6|COMPLETED|Phase 1||1
7832728|NCT01045421|19278778|P5|COMPLETED|Phase 1||2
7832729|NCT01045421|19278779|P4|COMPLETED|Phase 1||11
7832730|NCT01045421|19278780|P3|COMPLETED|Phase 1||4
7832731|NCT01045421|19278781|P2|COMPLETED|Phase 1||3
7832732|NCT01045421|19278782|P1|COMPLETED|Phase 1||1
7832733|NCT01045421|19278772|P11|STARTED|Phase 1||0
7832734|NCT01045421|19278773|P10|STARTED|Phase 1||0
7832735|NCT01045421|19278774|P9|STARTED|Phase 1||0
7832736|NCT01045421|19278775|P8|STARTED|Phase 1||0
7832737|NCT01045421|19278776|P7|STARTED|Phase 1||0
7832738|NCT01045421|19278777|P6|STARTED|Phase 1||1
7832739|NCT01045421|19278778|P5|STARTED|Phase 1||3
7832740|NCT01045421|19278779|P4|STARTED|Phase 1||12
7832741|NCT01045421|19278780|P3|STARTED|Phase 1||4
7832742|NCT01045421|19278781|P2|STARTED|Phase 1||3
7832743|NCT01045421|19278782|P1|STARTED|Phase 1||1
7832744|NCT01045265|19278862|P1|NOT COMPLETED|Overall Study||0
7832745|NCT01045265|19278862|P1|COMPLETED|Overall Study||16
7832746|NCT01045265|19278862|P1|STARTED|Overall Study||16
7832747|NCT01045187|19278869|P1|NOT COMPLETED|Overall Study||0
7832748|NCT01045187|19278869|P1|COMPLETED|Overall Study||15
7832749|NCT01045187|19278869|P1|STARTED|Overall Study||15
7832750|NCT01045174|19278875|P2|NOT COMPLETED|Overall Study||0
7832751|NCT01045174|19278876|P1|NOT COMPLETED|Overall Study||0
7832752|NCT01045174|19278875|P2|COMPLETED|Overall Study||90
7832753|NCT01045174|19278876|P1|COMPLETED|Overall Study||90
7832754|NCT01045174|19278875|P2|STARTED|Overall Study||90
7832755|NCT01045174|19278876|P1|STARTED|Overall Study||90
7832756|NCT01045161|19278891|P3|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32
7832757|NCT01045161|19278892|P2|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
7832758|NCT01045161|19278893|P1|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
7832759|NCT01045161|19278891|P3|COMPLETED|Part B - 40 Additional Weeks Open Label||115
7832760|NCT01045161|19278892|P2|COMPLETED|Part B - 40 Additional Weeks Open Label||118
7832761|NCT01045161|19278893|P1|COMPLETED|Part B - 40 Additional Weeks Open Label||111
7832762|NCT01045161|19278891|P3|STARTED|Part B - 40 Additional Weeks Open Label||147
7832763|NCT01045161|19278892|P2|STARTED|Part B - 40 Additional Weeks Open Label||154
7832764|NCT01045161|19278893|P1|STARTED|Part B - 40 Additional Weeks Open Label||147
7832765|NCT01045161|19278891|P3|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30
7832766|NCT01045161|19278892|P2|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29
7832767|NCT01045161|19278893|P1|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31
7832768|NCT01045161|19278891|P3|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148
7832769|NCT01045161|19278892|P2|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155
7832770|NCT01045161|19278893|P1|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151
7832771|NCT01045161|19278891|P3|STARTED|Part A - 12 Weeks Double Blind Treatment||178
7832772|NCT01045161|19278892|P2|STARTED|Part A - 12 Weeks Double Blind Treatment||184
7832773|NCT01045161|19278893|P1|STARTED|Part A - 12 Weeks Double Blind Treatment||182
7832774|NCT01045135|19278913|P1|NOT COMPLETED|Overall Study||26
7832775|NCT01045135|19278913|P1|COMPLETED|Overall Study||274
7832776|NCT01045135|19278913|P1|STARTED|Overall Study||300
7832777|NCT01045122|19278920|P2|NOT COMPLETED|Propofol Then Dexmedetomidine||0
7832778|NCT01045122|19278921|P1|NOT COMPLETED|Propofol Then Dexmedetomidine||0
7832779|NCT01045122|19278920|P2|COMPLETED|Propofol Then Dexmedetomidine||6
7832780|NCT01045122|19278921|P1|COMPLETED|Propofol Then Dexmedetomidine||5
7832781|NCT01045122|19278920|P2|STARTED|Propofol Then Dexmedetomidine||6
7832782|NCT01045122|19278921|P1|STARTED|Propofol Then Dexmedetomidine||5
7832783|NCT01045122|19278920|P2|NOT COMPLETED|Dexmedetomidine Then Propofol||0
7832784|NCT01045122|19278921|P1|NOT COMPLETED|Dexmedetomidine Then Propofol||0
7832785|NCT01045122|19278920|P2|COMPLETED|Dexmedetomidine Then Propofol||6
7832786|NCT01045122|19278921|P1|COMPLETED|Dexmedetomidine Then Propofol||5
7832787|NCT01045122|19278920|P2|STARTED|Dexmedetomidine Then Propofol||6
7832788|NCT01045122|19278921|P1|STARTED|Dexmedetomidine Then Propofol||5
7832789|NCT01045096|19278930|P3|NOT COMPLETED|Overall Study||0
7832790|NCT01045096|19278931|P2|NOT COMPLETED|Overall Study||0
7832791|NCT01045096|19278932|P1|NOT COMPLETED|Overall Study||3
7832792|NCT01045096|19278930|P3|COMPLETED|Overall Study||12
7832793|NCT01045096|19278931|P2|COMPLETED|Overall Study||12
7832794|NCT01045096|19278932|P1|COMPLETED|Overall Study||9
7832795|NCT01045096|19278930|P3|Pharmacokinetic Set|Overall Study||11
7832796|NCT01045096|19278931|P2|Pharmacokinetic Set|Overall Study||11
7832797|NCT01045096|19278932|P1|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9
7832798|NCT01045096|19278930|P3|STARTED|Overall Study||12
7832799|NCT01045096|19278931|P2|STARTED|Overall Study||12
7832800|NCT01045096|19278932|P1|STARTED|Overall Study||12
7832801|NCT01045057|19278958|P1|NOT COMPLETED|Overall Study||0
7832802|NCT01045057|19278958|P1|COMPLETED|Overall Study||27
7832803|NCT01045057|19278958|P1|STARTED|Overall Study||27
7832804|NCT01045031|19278967|P2|NOT COMPLETED|Overall Study||6
7832805|NCT01045031|19278968|P1|NOT COMPLETED|Overall Study||9
7832806|NCT01045031|19278967|P2|COMPLETED|Overall Study||50
7832807|NCT01045031|19278968|P1|COMPLETED|Overall Study||49
7832808|NCT01045031|19278967|P2|STARTED|Overall Study||56
7832809|NCT01045031|19278968|P1|STARTED|Overall Study||58
7832810|NCT01044966|19278978|P1|NOT COMPLETED|Consolidation Phase||10
7832811|NCT01044966|19278978|P1|COMPLETED|Consolidation Phase||2
7832812|NCT01044966|19278978|P1|STARTED|Consolidation Phase||12
7832813|NCT01044966|19278978|P1|NOT COMPLETED|Induction Phase||0
7832814|NCT01044966|19278978|P1|COMPLETED|Induction Phase||12
7832815|NCT01044966|19278978|P1|STARTED|Induction Phase||12
7832816|NCT01044862|19278989|P3|NOT COMPLETED|Overall Study||52
7832817|NCT01044862|19278990|P2|NOT COMPLETED|Overall Study||49
7832818|NCT01044862|19278991|P1|NOT COMPLETED|Overall Study||53
7832819|NCT01044862|19278989|P3|COMPLETED|Overall Study||249
7832820|NCT01044862|19278990|P2|COMPLETED|Overall Study||251
7832821|NCT01044862|19278991|P1|COMPLETED|Overall Study||246
7832822|NCT01044862|19278989|P3|STARTED|Overall Study||301
7832823|NCT01044862|19278990|P2|STARTED|Overall Study||300
7832824|NCT01044862|19278991|P1|STARTED|Overall Study||299
7832825|NCT01044771|19279008|P1|NOT COMPLETED|Overall Study||0
7832826|NCT01044771|19279008|P1|COMPLETED|Overall Study||20
7832827|NCT01044771|19279008|P1|STARTED|Overall Study||20
7832828|NCT01044758|19279020|P7|NOT COMPLETED|Overall Study||10
7832829|NCT01044758|19279021|P6|NOT COMPLETED|Overall Study||3
7832830|NCT01044758|19279022|P5|NOT COMPLETED|Overall Study||2
7832831|NCT01044758|19279023|P4|NOT COMPLETED|Overall Study||2
7832832|NCT01044758|19279024|P3|NOT COMPLETED|Overall Study||4
7832833|NCT01044758|19279025|P2|NOT COMPLETED|Overall Study||0
7832834|NCT01044758|19279026|P1|NOT COMPLETED|Overall Study||4
7832835|NCT01044758|19279020|P7|COMPLETED|Overall Study||17
7832836|NCT01044758|19279021|P6|COMPLETED|Overall Study||8
7832837|NCT01044758|19279022|P5|COMPLETED|Overall Study||9
7832838|NCT01044758|19279023|P4|COMPLETED|Overall Study||10
7832839|NCT01044758|19279024|P3|COMPLETED|Overall Study||7
7832840|NCT01044758|19279025|P2|COMPLETED|Overall Study||12
7832841|NCT01044758|19279026|P1|COMPLETED|Overall Study||8
7832842|NCT01044758|19279020|P7|STARTED|Overall Study||27
7832843|NCT01044758|19279021|P6|STARTED|Overall Study||11
7832844|NCT01044758|19279022|P5|STARTED|Overall Study||11
7832845|NCT01044758|19279023|P4|STARTED|Overall Study||12
7832846|NCT01044758|19279024|P3|STARTED|Overall Study||11
7832847|NCT01044758|19279025|P2|STARTED|Overall Study||12
7832848|NCT01044758|19279026|P1|STARTED|Overall Study||12
7832849|NCT01044745|19279049|P1|NOT COMPLETED|Overall Study||2
7832850|NCT01044745|19279049|P1|COMPLETED|Overall Study||18
7832851|NCT01044745|19279049|P1|STARTED|Overall Study||20
7832852|NCT01044732|19279058|P2|NOT COMPLETED|Overall Study||50
7832853|NCT01044732|19279059|P1|NOT COMPLETED|Overall Study||49
7832854|NCT01044732|19279058|P2|COMPLETED|Overall Study||176
7832855|NCT01044732|19279059|P1|COMPLETED|Overall Study||173
7832856|NCT01044732|19279058|P2|STARTED|Overall Study||226
7832857|NCT01044732|19279059|P1|STARTED|Overall Study||222
7832858|NCT01044706|19279069|P2|NOT COMPLETED|Overall Study||0
7832859|NCT01044706|19279070|P1|NOT COMPLETED|Overall Study||0
7832860|NCT01044706|19279069|P2|COMPLETED|Overall Study||30
7832861|NCT01044706|19279070|P1|COMPLETED|Overall Study||30
7832862|NCT01044706|19279069|P2|STARTED|Overall Study||30
7832863|NCT01044706|19279070|P1|STARTED|Overall Study||30
7832864|NCT01044693|19279078|P16|NOT COMPLETED|Overall Study||0
7832865|NCT01044693|19279079|P15|NOT COMPLETED|Overall Study||0
7832866|NCT01044693|19279080|P14|NOT COMPLETED|Overall Study||0
7832867|NCT01044693|19279081|P13|NOT COMPLETED|Overall Study||0
7832868|NCT01044693|19279082|P12|NOT COMPLETED|Overall Study||0
7832869|NCT01044693|19279083|P11|NOT COMPLETED|Overall Study||0
7832870|NCT01044693|19279084|P10|NOT COMPLETED|Overall Study||0
7832871|NCT01044693|19279085|P9|NOT COMPLETED|Overall Study||0
7832872|NCT01044693|19279086|P8|NOT COMPLETED|Overall Study||0
7832873|NCT01044693|19279087|P7|NOT COMPLETED|Overall Study||0
7832874|NCT01044693|19279088|P6|NOT COMPLETED|Overall Study||0
7832875|NCT01044693|19279089|P5|NOT COMPLETED|Overall Study||0
7832876|NCT01044693|19279090|P4|NOT COMPLETED|Overall Study||0
7832877|NCT01044693|19279091|P3|NOT COMPLETED|Overall Study||0
7832878|NCT01044693|19279092|P2|NOT COMPLETED|Overall Study||0
7832879|NCT01044693|19279093|P1|NOT COMPLETED|Overall Study||0
7832880|NCT01044693|19279078|P16|COMPLETED|Overall Study||1
7832881|NCT01044693|19279079|P15|COMPLETED|Overall Study||1
7832882|NCT01044693|19279080|P14|COMPLETED|Overall Study||1
7832883|NCT01044693|19279081|P13|COMPLETED|Overall Study||2
7832884|NCT01044693|19279082|P12|COMPLETED|Overall Study||1
7832885|NCT01044693|19279083|P11|COMPLETED|Overall Study||1
7832886|NCT01044693|19279084|P10|COMPLETED|Overall Study||1
7832887|NCT01044693|19279085|P9|COMPLETED|Overall Study||1
7832888|NCT01044693|19279086|P8|COMPLETED|Overall Study||1
7832889|NCT01044693|19279087|P7|COMPLETED|Overall Study||1
7832890|NCT01044693|19279088|P6|COMPLETED|Overall Study||2
7832891|NCT01044693|19279089|P5|COMPLETED|Overall Study||1
7832892|NCT01044693|19279090|P4|COMPLETED|Overall Study||1
7832893|NCT01044693|19279091|P3|COMPLETED|Overall Study||1
7832894|NCT01044693|19279092|P2|COMPLETED|Overall Study||1
7832895|NCT01044693|19279093|P1|COMPLETED|Overall Study||3
7832896|NCT01044693|19279078|P16|STARTED|Overall Study||1
7832897|NCT01044693|19279079|P15|STARTED|Overall Study||1
7832898|NCT01044693|19279080|P14|STARTED|Overall Study||1
7832899|NCT01044693|19279081|P13|STARTED|Overall Study||2
7832900|NCT01044693|19279082|P12|STARTED|Overall Study||1
7832901|NCT01044693|19279083|P11|STARTED|Overall Study||1
7832902|NCT01044693|19279084|P10|STARTED|Overall Study||1
7832903|NCT01044693|19279085|P9|STARTED|Overall Study||1
7832904|NCT01044693|19279086|P8|STARTED|Overall Study||1
7832905|NCT01044693|19279087|P7|STARTED|Overall Study||1
7832906|NCT01044693|19279088|P6|STARTED|Overall Study||2
7832907|NCT01044693|19279089|P5|STARTED|Overall Study||1
7832908|NCT01044693|19279090|P4|STARTED|Overall Study||1
7832909|NCT01044693|19279091|P3|STARTED|Overall Study||1
7832910|NCT01044693|19279092|P2|STARTED|Overall Study||1
7832911|NCT01044693|19279093|P1|STARTED|Overall Study||3
7832912|NCT01044589|19279117|P2|NOT COMPLETED|Overall Study||5
7832913|NCT01044589|19279118|P1|NOT COMPLETED|Overall Study||3
7832914|NCT01044589|19279117|P2|COMPLETED|Overall Study||2
7832915|NCT01044589|19279118|P1|COMPLETED|Overall Study||3
7832916|NCT01044589|19279117|P2|STARTED|Overall Study||7
7832917|NCT01044589|19279118|P1|STARTED|Overall Study||6
7832918|NCT01044537|19279133|P7|NOT COMPLETED|Overall Study||0
7832919|NCT01044537|19279134|P6|NOT COMPLETED|Overall Study||0
7832920|NCT01044537|19279135|P5|NOT COMPLETED|Overall Study||0
7832921|NCT01044537|19279136|P4|NOT COMPLETED|Overall Study||0
7832922|NCT01044537|19279137|P3|NOT COMPLETED|Overall Study||0
7832923|NCT01044537|19279138|P2|NOT COMPLETED|Overall Study||0
7832924|NCT01044537|19279139|P1|NOT COMPLETED|Overall Study||0
7832925|NCT01044537|19279133|P7|COMPLETED|Overall Study||16
7832926|NCT01044537|19279134|P6|COMPLETED|Overall Study||5
7832927|NCT01044537|19279135|P5|COMPLETED|Overall Study||5
7832928|NCT01044537|19279136|P4|COMPLETED|Overall Study||6
7832929|NCT01044537|19279137|P3|COMPLETED|Overall Study||6
7832930|NCT01044537|19279138|P2|COMPLETED|Overall Study||6
7832931|NCT01044537|19279139|P1|COMPLETED|Overall Study||6
7832932|NCT01044537|19279133|P7|STARTED|Overall Study||16
7832933|NCT01044537|19279134|P6|STARTED|Overall Study||5
7832934|NCT01044537|19279135|P5|STARTED|Overall Study||5
7832935|NCT01044537|19279136|P4|STARTED|Overall Study||6
7832936|NCT01044537|19279137|P3|STARTED|Overall Study||6
7832937|NCT01044537|19279138|P2|STARTED|Overall Study||6
7832938|NCT01044537|19279139|P1|STARTED|Overall Study||6
7832939|NCT01044498|19279248|P2|NOT COMPLETED|Overall Study||2
7832940|NCT01044498|19279249|P1|NOT COMPLETED|Overall Study||3
7832941|NCT01044498|19279248|P2|COMPLETED|Overall Study||21
7832942|NCT01044498|19279249|P1|COMPLETED|Overall Study||20
7832943|NCT01044498|19279248|P2|STARTED|Overall Study||23
7832944|NCT01044498|19279249|P1|STARTED|Overall Study||23
7832945|NCT01044459|19279275|P2|NOT COMPLETED|Overall Study||131
7832946|NCT01044459|19279276|P1|NOT COMPLETED|Overall Study||133
7832947|NCT01044459|19279275|P2|COMPLETED|Overall Study||162
7832948|NCT01044459|19279276|P1|COMPLETED|Overall Study||179
7832949|NCT01044459|19279275|P2|STARTED|Overall Study||293
7832950|NCT01044459|19279276|P1|STARTED|Overall Study||312
7832951|NCT01044433|19279284|P1|NOT COMPLETED|Overall Study||6
7832952|NCT01044433|19279284|P1|COMPLETED|Overall Study||38
7832953|NCT01044433|19279284|P1|STARTED|Overall Study||44
7832954|NCT01044303|19279292|P1|NOT COMPLETED|Overall Study||2
7832955|NCT01044303|19279292|P1|COMPLETED|Overall Study||30
7832956|NCT01044303|19279292|P1|STARTED|Overall Study||32
7832957|NCT01044290|19279302|P3|NOT COMPLETED|Follow-Up 2||2
7832958|NCT01044290|19279303|P2|NOT COMPLETED|Follow-Up 2||2
7832959|NCT01044290|19279304|P1|NOT COMPLETED|Follow-Up 2||0
7832960|NCT01044290|19279302|P3|COMPLETED|Follow-Up 2||69
7832961|NCT01044290|19279303|P2|COMPLETED|Follow-Up 2||67
7832962|NCT01044290|19279304|P1|COMPLETED|Follow-Up 2||70
7832963|NCT01044290|19279302|P3|Completed F2 Interview|Follow-Up 2||64
7832964|NCT01044290|19279303|P2|Completed F2 Interview|Follow-Up 2||57
7832965|NCT01044290|19279304|P1|Completed F2 Interview|Follow-Up 2||64
7832966|NCT01044290|19279302|P3|STARTED|Follow-Up 2||71
7832967|NCT01044290|19279303|P2|STARTED|Follow-Up 2||69
7832968|NCT01044290|19279304|P1|STARTED|Follow-Up 2||70
7832969|NCT01044290|19279302|P3|NOT COMPLETED|Follow-up 1||1
7832970|NCT01044290|19279303|P2|NOT COMPLETED|Follow-up 1||5
7832971|NCT01044290|19279304|P1|NOT COMPLETED|Follow-up 1||5
7832972|NCT01044290|19279302|P3|COMPLETED|Follow-up 1||71
7832973|NCT01044290|19279303|P2|COMPLETED|Follow-up 1||69
7832974|NCT01044290|19279304|P1|COMPLETED|Follow-up 1||70
7832975|NCT01044290|19279302|P3|Completed F1 Interview|Follow-up 1||61
7832976|NCT01044290|19279303|P2|Completed F1 Interview|Follow-up 1||60
7832977|NCT01044290|19279304|P1|Completed F1 Interview|Follow-up 1||61
7832978|NCT01044290|19279302|P3|STARTED|Follow-up 1||72
7832979|NCT01044290|19279303|P2|STARTED|Follow-up 1||74
7832980|NCT01044290|19279304|P1|STARTED|Follow-up 1||75
7832981|NCT01044290|19279302|P3|NOT COMPLETED|Randomization||0
7832982|NCT01044290|19279303|P2|NOT COMPLETED|Randomization||0
7832983|NCT01044290|19279304|P1|NOT COMPLETED|Randomization||0
7832984|NCT01044290|19279302|P3|COMPLETED|Randomization||72
7832985|NCT01044290|19279303|P2|COMPLETED|Randomization||74
7832986|NCT01044290|19279304|P1|COMPLETED|Randomization||75
7832987|NCT01044290|19279302|P3|Randomized|Randomization||72
7832988|NCT01044290|19279303|P2|Randomized|Randomization||74
7832989|NCT01044290|19279304|P1|Randomized|Randomization||75
7832990|NCT01044290|19279302|P3|STARTED|Randomization||72
7832991|NCT01044290|19279303|P2|STARTED|Randomization||74
7832992|NCT01044290|19279304|P1|STARTED|Randomization||75
7832993|NCT01044264|19279330|P3|NOT COMPLETED|Overall Study||92
7832994|NCT01044264|19279331|P2|NOT COMPLETED|Overall Study||94
7832995|NCT01044264|19279332|P1|NOT COMPLETED|Overall Study||90
7832996|NCT01044264|19279330|P3|COMPLETED|Overall Study||108
7832997|NCT01044264|19279331|P2|COMPLETED|Overall Study||108
7832998|NCT01044264|19279332|P1|COMPLETED|Overall Study||110
7832999|NCT01044264|19279330|P3|STARTED|Overall Study||200
7833000|NCT01044264|19279331|P2|STARTED|Overall Study||202
7833001|NCT01044264|19279332|P1|STARTED|Overall Study||200
7833002|NCT01044212|19279342|P2|NOT COMPLETED|Overall Study||7
7833003|NCT01044212|19279343|P1|NOT COMPLETED|Overall Study||5
7833004|NCT01044212|19279342|P2|COMPLETED|Overall Study||30
7833005|NCT01044212|19279343|P1|COMPLETED|Overall Study||30
7833006|NCT01044212|19279342|P2|STARTED|Overall Study||37
7833007|NCT01044212|19279343|P1|STARTED|Overall Study||35
7833008|NCT01044056|19279356|P3|NOT COMPLETED|Overall Study||0
7833009|NCT01044056|19279357|P2|NOT COMPLETED|Overall Study||0
7833010|NCT01044056|19279358|P1|NOT COMPLETED|Overall Study||0
7833011|NCT01044056|19279356|P3|COMPLETED|Overall Study||8
7833012|NCT01044056|19279357|P2|COMPLETED|Overall Study||8
7833013|NCT01044056|19279358|P1|COMPLETED|Overall Study||8
7833014|NCT01044056|19279356|P3|STARTED|Overall Study||8
7833015|NCT01044056|19279357|P2|STARTED|Overall Study||8
7833016|NCT01044056|19279358|P1|STARTED|Overall Study||8
7833017|NCT01044030|19279377|P2|NOT COMPLETED|Overall Study||20
7833018|NCT01044030|19279378|P1|NOT COMPLETED|Overall Study||19
7833019|NCT01044030|19279377|P2|COMPLETED|Overall Study||146
7833020|NCT01044030|19279378|P1|COMPLETED|Overall Study||141
7833021|NCT01044030|19279377|P2|STARTED|Overall Study||166
7833022|NCT01044030|19279378|P1|STARTED|Overall Study||160
7833023|NCT01043939|19279392|P2|NOT COMPLETED|Second Intervention||0
7833024|NCT01043939|19279393|P1|NOT COMPLETED|Second Intervention||0
7833025|NCT01043939|19279392|P2|COMPLETED|Second Intervention||12
7833026|NCT01043939|19279393|P1|COMPLETED|Second Intervention||12
7833027|NCT01043939|19279392|P2|STARTED|Second Intervention||12
7833028|NCT01043939|19279393|P1|STARTED|Second Intervention||12
7833029|NCT01043939|19279392|P2|NOT COMPLETED|Washout Period||0
7833030|NCT01043939|19279393|P1|NOT COMPLETED|Washout Period||0
7833031|NCT01043939|19279392|P2|COMPLETED|Washout Period||12
7833032|NCT01043939|19279393|P1|COMPLETED|Washout Period||12
7833033|NCT01043939|19279392|P2|STARTED|Washout Period||12
7833034|NCT01043939|19279393|P1|STARTED|Washout Period||12
7833035|NCT01043939|19279392|P2|NOT COMPLETED|First Intervention||0
7833036|NCT01043939|19279393|P1|NOT COMPLETED|First Intervention||0
7833037|NCT01043939|19279392|P2|COMPLETED|First Intervention||12
7833038|NCT01043939|19279393|P1|COMPLETED|First Intervention||12
7833039|NCT01043939|19279392|P2|STARTED|First Intervention||12
7833040|NCT01043939|19279393|P1|STARTED|First Intervention||12
7833041|NCT01043926|19279407|P4|NOT COMPLETED|Overall Study||0
7833042|NCT01043926|19279408|P3|NOT COMPLETED|Overall Study||0
7833043|NCT01043926|19279409|P2|NOT COMPLETED|Overall Study||0
7833044|NCT01043926|19279410|P1|NOT COMPLETED|Overall Study||0
7833045|NCT01043926|19279407|P4|COMPLETED|Overall Study||0
7833046|NCT01043926|19279408|P3|COMPLETED|Overall Study||0
7833047|NCT01043926|19279409|P2|COMPLETED|Overall Study||8
7833048|NCT01043926|19279410|P1|COMPLETED|Overall Study||8
7833049|NCT01043926|19279407|P4|STARTED|Overall Study||0
7833050|NCT01043926|19279408|P3|STARTED|Overall Study||0
7833051|NCT01043926|19279409|P2|STARTED|Overall Study||8
7833052|NCT01043926|19279410|P1|STARTED|Overall Study||8
7833053|NCT01043874|19279424|P1|NOT COMPLETED|Overall Study||6
7833054|NCT01043874|19279424|P1|COMPLETED|Overall Study||39
7833055|NCT01043874|19279424|P1|STARTED|Overall Study||45
7833056|NCT01043705|19279434|P3|NOT COMPLETED|Overall Study||80
7833057|NCT01043705|19279435|P2|NOT COMPLETED|Overall Study||131
7833058|NCT01043705|19279436|P1|NOT COMPLETED|Overall Study||107
7833059|NCT01043705|19279434|P3|COMPLETED|Overall Study||498
7833060|NCT01043705|19279435|P2|COMPLETED|Overall Study||447
7833061|NCT01043705|19279436|P1|COMPLETED|Overall Study||352
7833062|NCT01043705|19279434|P3|STARTED|Overall Study||578
7833063|NCT01043705|19279435|P2|STARTED|Overall Study||578
7833064|NCT01043705|19279436|P1|STARTED|Overall Study||459
7833065|NCT01043653|19279446|P1|NOT COMPLETED|Overall Study||64
7833066|NCT01043653|19279446|P1|COMPLETED|Overall Study||186
7833067|NCT01043653|19279446|P1|STARTED|Overall Study||250
7833068|NCT01043640|19279451|P1|NOT COMPLETED|Overall Study||0
7833069|NCT01043640|19279451|P1|COMPLETED|Overall Study||46
7833070|NCT01043640|19279451|P1|STARTED|Overall Study||46
7833071|NCT01043562|19279466|P1|NOT COMPLETED|Overall Study||0
7833072|NCT01043562|19279466|P1|COMPLETED|Overall Study||20
7833073|NCT01043562|19279466|P1|STARTED|Overall Study||20
7833074|NCT01043523|19279473|P1|NOT COMPLETED|Overall Study||0
7833075|NCT01043523|19279473|P1|COMPLETED|Overall Study||52
7833076|NCT01043523|19279473|P1|Participants With Unenhanced Images|Overall Study||51
7833077|NCT01043523|19279473|P1|STARTED|Overall Study||52
7833078|NCT01043432|19279502|P4|NOT COMPLETED|Overall Study||0
7833079|NCT01043432|19279503|P3|NOT COMPLETED|Overall Study||0
7833080|NCT01043432|19279504|P2|NOT COMPLETED|Overall Study||0
7833081|NCT01043432|19279505|P1|NOT COMPLETED|Overall Study||0
7833082|NCT01043432|19279502|P4|COMPLETED|Overall Study||48
7833083|NCT01043432|19279503|P3|COMPLETED|Overall Study||12
7833084|NCT01043432|19279504|P2|COMPLETED|Overall Study||51
7833085|NCT01043432|19279505|P1|COMPLETED|Overall Study||22
7833086|NCT01043432|19279502|P4|STARTED|Overall Study||48
7833087|NCT01043432|19279503|P3|STARTED|Overall Study||12
7833088|NCT01043432|19279504|P2|STARTED|Overall Study||51
7833089|NCT01043432|19279505|P1|STARTED|Overall Study||22
7833090|NCT01043393|19279514|P2|NOT COMPLETED|Overall Study||0
7833091|NCT01043393|19279515|P1|NOT COMPLETED|Overall Study||0
7833092|NCT01043393|19279514|P2|COMPLETED|Overall Study||12
7833093|NCT01043393|19279515|P1|COMPLETED|Overall Study||12
7833094|NCT01043393|19279514|P2|STARTED|Overall Study||12
7833095|NCT01043393|19279515|P1|STARTED|Overall Study||12
7833096|NCT01043185|19279525|P10|NOT COMPLETED|Period 7 - Fourth Intervention||0
7833097|NCT01043185|19279526|P9|NOT COMPLETED|Period 7 - Fourth Intervention||0
7833098|NCT01043185|19279527|P8|NOT COMPLETED|Period 7 - Fourth Intervention||0
7833099|NCT01043185|19279528|P7|NOT COMPLETED|Period 7 - Fourth Intervention||0
7833100|NCT01043185|19279529|P6|NOT COMPLETED|Period 7 - Fourth Intervention||0
7833101|NCT01043185|19279530|P5|NOT COMPLETED|Period 7 - Fourth Intervention||0
7833102|NCT01043185|19279531|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
7833103|NCT01043185|19279532|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
7833104|NCT01043185|19279533|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
7833105|NCT01043185|19279534|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
7833106|NCT01043185|19279525|P10|COMPLETED|Period 7 - Fourth Intervention||3
7833107|NCT01043185|19279526|P9|COMPLETED|Period 7 - Fourth Intervention||2
7833108|NCT01043185|19279527|P8|COMPLETED|Period 7 - Fourth Intervention||3
7833109|NCT01043185|19279528|P7|COMPLETED|Period 7 - Fourth Intervention||3
7833110|NCT01043185|19279529|P6|COMPLETED|Period 7 - Fourth Intervention||3
7833111|NCT01043185|19279530|P5|COMPLETED|Period 7 - Fourth Intervention||2
7833112|NCT01043185|19279531|P4|COMPLETED|Period 7 - Fourth Intervention||2
7833113|NCT01043185|19279532|P3|COMPLETED|Period 7 - Fourth Intervention||3
7833114|NCT01043185|19279533|P2|COMPLETED|Period 7 - Fourth Intervention||2
7833115|NCT01043185|19279534|P1|COMPLETED|Period 7 - Fourth Intervention||3
7833116|NCT01043185|19279525|P10|STARTED|Period 7 - Fourth Intervention||3
7833117|NCT01043185|19279526|P9|STARTED|Period 7 - Fourth Intervention||2
7833118|NCT01043185|19279527|P8|STARTED|Period 7 - Fourth Intervention||3
7833119|NCT01043185|19279528|P7|STARTED|Period 7 - Fourth Intervention||3
7833120|NCT01043185|19279529|P6|STARTED|Period 7 - Fourth Intervention||3
7833121|NCT01043185|19279530|P5|STARTED|Period 7 - Fourth Intervention||2
7833122|NCT01043185|19279531|P4|STARTED|Period 7 - Fourth Intervention||2
7833123|NCT01043185|19279532|P3|STARTED|Period 7 - Fourth Intervention||3
7833124|NCT01043185|19279533|P2|STARTED|Period 7 - Fourth Intervention||2
7833125|NCT01043185|19279534|P1|STARTED|Period 7 - Fourth Intervention||3
7833126|NCT01043185|19279525|P10|NOT COMPLETED|Period 6 - Third Washout Period||0
7833127|NCT01043185|19279526|P9|NOT COMPLETED|Period 6 - Third Washout Period||1
7833128|NCT01043185|19279527|P8|NOT COMPLETED|Period 6 - Third Washout Period||0
7833129|NCT01043185|19279528|P7|NOT COMPLETED|Period 6 - Third Washout Period||0
7833130|NCT01043185|19279529|P6|NOT COMPLETED|Period 6 - Third Washout Period||0
7833131|NCT01043185|19279530|P5|NOT COMPLETED|Period 6 - Third Washout Period||0
7833132|NCT01043185|19279531|P4|NOT COMPLETED|Period 6 - Third Washout Period||0
7833133|NCT01043185|19279532|P3|NOT COMPLETED|Period 6 - Third Washout Period||0
7833134|NCT01043185|19279533|P2|NOT COMPLETED|Period 6 - Third Washout Period||0
7833135|NCT01043185|19279534|P1|NOT COMPLETED|Period 6 - Third Washout Period||0
7833136|NCT01043185|19279525|P10|COMPLETED|Period 6 - Third Washout Period||3
7833137|NCT01043185|19279526|P9|COMPLETED|Period 6 - Third Washout Period||2
7833138|NCT01043185|19279527|P8|COMPLETED|Period 6 - Third Washout Period||3
7833139|NCT01043185|19279528|P7|COMPLETED|Period 6 - Third Washout Period||3
7833140|NCT01043185|19279529|P6|COMPLETED|Period 6 - Third Washout Period||3
7833141|NCT01043185|19279530|P5|COMPLETED|Period 6 - Third Washout Period||2
7833142|NCT01043185|19279531|P4|COMPLETED|Period 6 - Third Washout Period||2
7833143|NCT01043185|19279532|P3|COMPLETED|Period 6 - Third Washout Period||3
7833144|NCT01043185|19279533|P2|COMPLETED|Period 6 - Third Washout Period||2
7833145|NCT01043185|19279534|P1|COMPLETED|Period 6 - Third Washout Period||3
7833146|NCT01043185|19279525|P10|STARTED|Period 6 - Third Washout Period||3
7833147|NCT01043185|19279526|P9|STARTED|Period 6 - Third Washout Period||3
7833148|NCT01043185|19279527|P8|STARTED|Period 6 - Third Washout Period||3
7833149|NCT01043185|19279528|P7|STARTED|Period 6 - Third Washout Period||3
7833150|NCT01043185|19279529|P6|STARTED|Period 6 - Third Washout Period||3
7833151|NCT01043185|19279530|P5|STARTED|Period 6 - Third Washout Period||2
7833152|NCT01043185|19279531|P4|STARTED|Period 6 - Third Washout Period||2
7833153|NCT01043185|19279532|P3|STARTED|Period 6 - Third Washout Period||3
7833154|NCT01043185|19279533|P2|STARTED|Period 6 - Third Washout Period||2
7833155|NCT01043185|19279534|P1|STARTED|Period 6 - Third Washout Period||3
7833156|NCT01043185|19279525|P10|NOT COMPLETED|Period 5 - Third Intervention||0
7833157|NCT01043185|19279526|P9|NOT COMPLETED|Period 5 - Third Intervention||0
7833158|NCT01043185|19279527|P8|NOT COMPLETED|Period 5 - Third Intervention||0
7833159|NCT01043185|19279528|P7|NOT COMPLETED|Period 5 - Third Intervention||0
7833160|NCT01043185|19279529|P6|NOT COMPLETED|Period 5 - Third Intervention||0
7833161|NCT01043185|19279530|P5|NOT COMPLETED|Period 5 - Third Intervention||0
7833162|NCT01043185|19279531|P4|NOT COMPLETED|Period 5 - Third Intervention||0
7833163|NCT01043185|19279532|P3|NOT COMPLETED|Period 5 - Third Intervention||0
7833164|NCT01043185|19279533|P2|NOT COMPLETED|Period 5 - Third Intervention||0
7833165|NCT01043185|19279534|P1|NOT COMPLETED|Period 5 - Third Intervention||0
7833166|NCT01043185|19279525|P10|COMPLETED|Period 5 - Third Intervention||3
7833167|NCT01043185|19279526|P9|COMPLETED|Period 5 - Third Intervention||3
7833168|NCT01043185|19279527|P8|COMPLETED|Period 5 - Third Intervention||3
7833169|NCT01043185|19279528|P7|COMPLETED|Period 5 - Third Intervention||3
7833170|NCT01043185|19279529|P6|COMPLETED|Period 5 - Third Intervention||3
7833171|NCT01043185|19279530|P5|COMPLETED|Period 5 - Third Intervention||2
7833172|NCT01043185|19279531|P4|COMPLETED|Period 5 - Third Intervention||2
7833173|NCT01043185|19279532|P3|COMPLETED|Period 5 - Third Intervention||3
7833174|NCT01043185|19279533|P2|COMPLETED|Period 5 - Third Intervention||2
7833175|NCT01043185|19279534|P1|COMPLETED|Period 5 - Third Intervention||3
7833176|NCT01043185|19279525|P10|STARTED|Period 5 - Third Intervention||3
7833177|NCT01043185|19279526|P9|STARTED|Period 5 - Third Intervention||3
7833178|NCT01043185|19279527|P8|STARTED|Period 5 - Third Intervention||3
7833179|NCT01043185|19279528|P7|STARTED|Period 5 - Third Intervention||3
7833180|NCT01043185|19279529|P6|STARTED|Period 5 - Third Intervention||3
7833181|NCT01043185|19279530|P5|STARTED|Period 5 - Third Intervention||2
7833182|NCT01043185|19279531|P4|STARTED|Period 5 - Third Intervention||2
7833183|NCT01043185|19279532|P3|STARTED|Period 5 - Third Intervention||3
7833184|NCT01043185|19279533|P2|STARTED|Period 5 - Third Intervention||2
7833185|NCT01043185|19279534|P1|STARTED|Period 5 - Third Intervention||3
7833186|NCT01043185|19279525|P10|NOT COMPLETED|Period 4 - Second Washout Period||0
7833187|NCT01043185|19279526|P9|NOT COMPLETED|Period 4 - Second Washout Period||0
7833188|NCT01043185|19279527|P8|NOT COMPLETED|Period 4 - Second Washout Period||0
7833189|NCT01043185|19279528|P7|NOT COMPLETED|Period 4 - Second Washout Period||0
7833190|NCT01043185|19279529|P6|NOT COMPLETED|Period 4 - Second Washout Period||0
7833191|NCT01043185|19279530|P5|NOT COMPLETED|Period 4 - Second Washout Period||0
7833192|NCT01043185|19279531|P4|NOT COMPLETED|Period 4 - Second Washout Period||0
7833193|NCT01043185|19279532|P3|NOT COMPLETED|Period 4 - Second Washout Period||0
7833194|NCT01043185|19279533|P2|NOT COMPLETED|Period 4 - Second Washout Period||0
7833195|NCT01043185|19279534|P1|NOT COMPLETED|Period 4 - Second Washout Period||0
7833196|NCT01043185|19279525|P10|COMPLETED|Period 4 - Second Washout Period||3
7833197|NCT01043185|19279526|P9|COMPLETED|Period 4 - Second Washout Period||3
7833198|NCT01043185|19279527|P8|COMPLETED|Period 4 - Second Washout Period||3
7833199|NCT01043185|19279528|P7|COMPLETED|Period 4 - Second Washout Period||3
7833200|NCT01043185|19279529|P6|COMPLETED|Period 4 - Second Washout Period||3
7833201|NCT01043185|19279530|P5|COMPLETED|Period 4 - Second Washout Period||2
7833202|NCT01043185|19279531|P4|COMPLETED|Period 4 - Second Washout Period||2
7833203|NCT01043185|19279532|P3|COMPLETED|Period 4 - Second Washout Period||3
7833204|NCT01043185|19279533|P2|COMPLETED|Period 4 - Second Washout Period||2
7833205|NCT01043185|19279534|P1|COMPLETED|Period 4 - Second Washout Period||3
7833206|NCT01043185|19279525|P10|STARTED|Period 4 - Second Washout Period||3
7833207|NCT01043185|19279526|P9|STARTED|Period 4 - Second Washout Period||3
7833208|NCT01043185|19279527|P8|STARTED|Period 4 - Second Washout Period||3
7833209|NCT01043185|19279528|P7|STARTED|Period 4 - Second Washout Period||3
7833210|NCT01043185|19279529|P6|STARTED|Period 4 - Second Washout Period||3
7833211|NCT01043185|19279530|P5|STARTED|Period 4 - Second Washout Period||2
7833212|NCT01043185|19279531|P4|STARTED|Period 4 - Second Washout Period||2
7833213|NCT01043185|19279532|P3|STARTED|Period 4 - Second Washout Period||3
7833214|NCT01043185|19279533|P2|STARTED|Period 4 - Second Washout Period||2
7833215|NCT01043185|19279534|P1|STARTED|Period 4 - Second Washout Period||3
7833216|NCT01043185|19279525|P10|NOT COMPLETED|Period 3 - Second Intervention||0
7833217|NCT01043185|19279526|P9|NOT COMPLETED|Period 3 - Second Intervention||0
7833218|NCT01043185|19279527|P8|NOT COMPLETED|Period 3 - Second Intervention||0
7833219|NCT01043185|19279528|P7|NOT COMPLETED|Period 3 - Second Intervention||0
7833220|NCT01043185|19279529|P6|NOT COMPLETED|Period 3 - Second Intervention||0
7833221|NCT01043185|19279530|P5|NOT COMPLETED|Period 3 - Second Intervention||0
7833222|NCT01043185|19279531|P4|NOT COMPLETED|Period 3 - Second Intervention||0
7833223|NCT01043185|19279532|P3|NOT COMPLETED|Period 3 - Second Intervention||0
7833224|NCT01043185|19279533|P2|NOT COMPLETED|Period 3 - Second Intervention||0
7833225|NCT01043185|19279534|P1|NOT COMPLETED|Period 3 - Second Intervention||0
7833226|NCT01043185|19279525|P10|COMPLETED|Period 3 - Second Intervention||3
7833227|NCT01043185|19279526|P9|COMPLETED|Period 3 - Second Intervention||3
7833228|NCT01043185|19279527|P8|COMPLETED|Period 3 - Second Intervention||3
7833229|NCT01043185|19279528|P7|COMPLETED|Period 3 - Second Intervention||3
7833230|NCT01043185|19279529|P6|COMPLETED|Period 3 - Second Intervention||3
7833231|NCT01043185|19279530|P5|COMPLETED|Period 3 - Second Intervention||2
7833232|NCT01043185|19279531|P4|COMPLETED|Period 3 - Second Intervention||2
7833233|NCT01043185|19279532|P3|COMPLETED|Period 3 - Second Intervention||3
7833234|NCT01043185|19279533|P2|COMPLETED|Period 3 - Second Intervention||2
7833235|NCT01043185|19279534|P1|COMPLETED|Period 3 - Second Intervention||3
7833236|NCT01043185|19279525|P10|STARTED|Period 3 - Second Intervention||3
7833237|NCT01043185|19279526|P9|STARTED|Period 3 - Second Intervention||3
7833238|NCT01043185|19279527|P8|STARTED|Period 3 - Second Intervention||3
7833239|NCT01043185|19279528|P7|STARTED|Period 3 - Second Intervention||3
7833240|NCT01043185|19279529|P6|STARTED|Period 3 - Second Intervention||3
7833241|NCT01043185|19279530|P5|STARTED|Period 3 - Second Intervention||2
7833242|NCT01043185|19279531|P4|STARTED|Period 3 - Second Intervention||2
7833243|NCT01043185|19279532|P3|STARTED|Period 3 - Second Intervention||3
7833244|NCT01043185|19279533|P2|STARTED|Period 3 - Second Intervention||2
7833245|NCT01043185|19279534|P1|STARTED|Period 3 - Second Intervention||3
7833246|NCT01043185|19279525|P10|NOT COMPLETED|Period 2 - First Washout Period||0
7833247|NCT01043185|19279526|P9|NOT COMPLETED|Period 2 - First Washout Period||0
7833248|NCT01043185|19279527|P8|NOT COMPLETED|Period 2 - First Washout Period||0
7833249|NCT01043185|19279528|P7|NOT COMPLETED|Period 2 - First Washout Period||0
7833250|NCT01043185|19279529|P6|NOT COMPLETED|Period 2 - First Washout Period||0
7833251|NCT01043185|19279530|P5|NOT COMPLETED|Period 2 - First Washout Period||0
7833252|NCT01043185|19279531|P4|NOT COMPLETED|Period 2 - First Washout Period||0
7833253|NCT01043185|19279532|P3|NOT COMPLETED|Period 2 - First Washout Period||0
7833254|NCT01043185|19279533|P2|NOT COMPLETED|Period 2 - First Washout Period||0
7833255|NCT01043185|19279534|P1|NOT COMPLETED|Period 2 - First Washout Period||0
7833256|NCT01043185|19279525|P10|COMPLETED|Period 2 - First Washout Period||3
7833257|NCT01043185|19279526|P9|COMPLETED|Period 2 - First Washout Period||3
7833258|NCT01043185|19279527|P8|COMPLETED|Period 2 - First Washout Period||3
7833259|NCT01043185|19279528|P7|COMPLETED|Period 2 - First Washout Period||3
7833260|NCT01043185|19279529|P6|COMPLETED|Period 2 - First Washout Period||3
7833261|NCT01043185|19279530|P5|COMPLETED|Period 2 - First Washout Period||2
7833262|NCT01043185|19279531|P4|COMPLETED|Period 2 - First Washout Period||2
7833263|NCT01043185|19279532|P3|COMPLETED|Period 2 - First Washout Period||3
7833264|NCT01043185|19279533|P2|COMPLETED|Period 2 - First Washout Period||2
7833265|NCT01043185|19279534|P1|COMPLETED|Period 2 - First Washout Period||3
7833266|NCT01043185|19279525|P10|STARTED|Period 2 - First Washout Period||3
7833267|NCT01043185|19279526|P9|STARTED|Period 2 - First Washout Period||3
7833268|NCT01043185|19279527|P8|STARTED|Period 2 - First Washout Period||3
7833269|NCT01043185|19279528|P7|STARTED|Period 2 - First Washout Period||3
7833270|NCT01043185|19279529|P6|STARTED|Period 2 - First Washout Period||3
7833271|NCT01043185|19279530|P5|STARTED|Period 2 - First Washout Period||2
7833272|NCT01043185|19279531|P4|STARTED|Period 2 - First Washout Period||2
7833273|NCT01043185|19279532|P3|STARTED|Period 2 - First Washout Period||3
7833274|NCT01043185|19279533|P2|STARTED|Period 2 - First Washout Period||2
7833275|NCT01043185|19279534|P1|STARTED|Period 2 - First Washout Period||3
7833276|NCT01043185|19279525|P10|NOT COMPLETED|Period 1 - First Intervention||0
7833277|NCT01043185|19279526|P9|NOT COMPLETED|Period 1 - First Intervention||0
7833278|NCT01043185|19279527|P8|NOT COMPLETED|Period 1 - First Intervention||0
7833279|NCT01043185|19279528|P7|NOT COMPLETED|Period 1 - First Intervention||0
7833280|NCT01043185|19279529|P6|NOT COMPLETED|Period 1 - First Intervention||0
7833281|NCT01043185|19279530|P5|NOT COMPLETED|Period 1 - First Intervention||0
7833282|NCT01043185|19279531|P4|NOT COMPLETED|Period 1 - First Intervention||0
7833283|NCT01043185|19279532|P3|NOT COMPLETED|Period 1 - First Intervention||0
7833284|NCT01043185|19279533|P2|NOT COMPLETED|Period 1 - First Intervention||0
7833285|NCT01043185|19279534|P1|NOT COMPLETED|Period 1 - First Intervention||0
7833286|NCT01043185|19279525|P10|COMPLETED|Period 1 - First Intervention||3
7833287|NCT01043185|19279526|P9|COMPLETED|Period 1 - First Intervention||3
7833288|NCT01043185|19279527|P8|COMPLETED|Period 1 - First Intervention||3
7833289|NCT01043185|19279528|P7|COMPLETED|Period 1 - First Intervention||3
7833290|NCT01043185|19279529|P6|COMPLETED|Period 1 - First Intervention||3
7833291|NCT01043185|19279530|P5|COMPLETED|Period 1 - First Intervention||2
7833292|NCT01043185|19279531|P4|COMPLETED|Period 1 - First Intervention||2
7833293|NCT01043185|19279532|P3|COMPLETED|Period 1 - First Intervention||3
7833294|NCT01043185|19279533|P2|COMPLETED|Period 1 - First Intervention||2
7833295|NCT01043185|19279534|P1|COMPLETED|Period 1 - First Intervention||3
7833296|NCT01043185|19279525|P10|STARTED|Period 1 - First Intervention||3
7833297|NCT01043185|19279526|P9|STARTED|Period 1 - First Intervention||3
7833298|NCT01043185|19279527|P8|STARTED|Period 1 - First Intervention||3
7833299|NCT01043185|19279528|P7|STARTED|Period 1 - First Intervention||3
7833300|NCT01043185|19279529|P6|STARTED|Period 1 - First Intervention||3
7833301|NCT01043185|19279530|P5|STARTED|Period 1 - First Intervention||2
7833302|NCT01043185|19279531|P4|STARTED|Period 1 - First Intervention||2
7833303|NCT01043185|19279532|P3|STARTED|Period 1 - First Intervention||3
7833304|NCT01043185|19279533|P2|STARTED|Period 1 - First Intervention||2
7833305|NCT01043185|19279534|P1|STARTED|Period 1 - First Intervention||3
7833306|NCT01043146|19279567|P6|NOT COMPLETED|Overall Study||0
7833307|NCT01043146|19279568|P5|NOT COMPLETED|Overall Study||0
7833308|NCT01043146|19279569|P4|NOT COMPLETED|Overall Study||0
7833309|NCT01043146|19279570|P3|NOT COMPLETED|Overall Study||0
7833310|NCT01043146|19279571|P2|NOT COMPLETED|Overall Study||0
7833311|NCT01043146|19279572|P1|NOT COMPLETED|Overall Study||0
7833312|NCT01043146|19279567|P6|COMPLETED|Overall Study||8
7833313|NCT01043146|19279568|P5|COMPLETED|Overall Study||8
7833314|NCT01043146|19279569|P4|COMPLETED|Overall Study||8
7833315|NCT01043146|19279570|P3|COMPLETED|Overall Study||8
7833316|NCT01043146|19279571|P2|COMPLETED|Overall Study||8
7833317|NCT01043146|19279572|P1|COMPLETED|Overall Study||10
7833318|NCT01043146|19279567|P6|STARTED|Overall Study||8
7833319|NCT01043146|19279568|P5|STARTED|Overall Study||8
7833320|NCT01043146|19279569|P4|STARTED|Overall Study||8
7833321|NCT01043146|19279570|P3|STARTED|Overall Study||8
7833322|NCT01043146|19279571|P2|STARTED|Overall Study||8
7833323|NCT01043146|19279572|P1|STARTED|Overall Study||10
7833324|NCT01043133|19279588|P2|NOT COMPLETED|Overall Study||2
7833325|NCT01043133|19279589|P1|NOT COMPLETED|Overall Study||1
7833326|NCT01043133|19279588|P2|COMPLETED|Overall Study||78
7833327|NCT01043133|19279589|P1|COMPLETED|Overall Study||74
7833328|NCT01043133|19279588|P2|STARTED|Overall Study||80
7833329|NCT01043133|19279589|P1|STARTED|Overall Study||75
7833330|NCT01043094|19279599|P2|NOT COMPLETED|Overall Study||0
7833331|NCT01043094|19279600|P1|NOT COMPLETED|Overall Study||0
7833332|NCT01043094|19279599|P2|COMPLETED|Overall Study||8
7833333|NCT01043094|19279600|P1|COMPLETED|Overall Study||8
7833334|NCT01043094|19279599|P2|STARTED|Overall Study||8
7833335|NCT01043094|19279600|P1|STARTED|Overall Study||8
7833336|NCT01042977|19279610|P2|NOT COMPLETED|Overall Study||55
7833337|NCT01042977|19279611|P1|NOT COMPLETED|Overall Study||41
7833338|NCT01042977|19279610|P2|COMPLETED|Overall Study||428
7833339|NCT01042977|19279611|P1|COMPLETED|Overall Study||441
7833340|NCT01042977|19279610|P2|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483
7833341|NCT01042977|19279611|P1|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482
7833342|NCT01042938|19279631|P2|NOT COMPLETED|Overall Study||2
7833343|NCT01042938|19279632|P1|NOT COMPLETED|Overall Study||3
7833344|NCT01042938|19279631|P2|COMPLETED|Overall Study||16
7833345|NCT01042938|19279632|P1|COMPLETED|Overall Study||14
7833346|NCT01042938|19279631|P2|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18
7833347|NCT01042938|19279632|P1|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17
7833348|NCT01042795|19279644|P1|NOT COMPLETED|Follow up - 22 Months After Drug Start||2
7833349|NCT01042795|19279644|P1|COMPLETED|Follow up - 22 Months After Drug Start||0
7833350|NCT01042795|19279644|P1|STARTED|Follow up - 22 Months After Drug Start||2
7833351|NCT01042795|19279644|P1|NOT COMPLETED|Dosing Period - 16 Weeks of Daily Doses||5
7833352|NCT01042795|19279644|P1|COMPLETED|Dosing Period - 16 Weeks of Daily Doses||2
7833353|NCT01042795|19279644|P1|STARTED|Dosing Period - 16 Weeks of Daily Doses||7
7833354|NCT01042678|19279651|P6|NOT COMPLETED|Overall Study||0
7833355|NCT01042678|19279652|P5|NOT COMPLETED|Overall Study||0
7833356|NCT01042678|19279653|P4|NOT COMPLETED|Overall Study||0
7833357|NCT01042678|19279654|P3|NOT COMPLETED|Overall Study||0
7833358|NCT01042678|19279655|P2|NOT COMPLETED|Overall Study||0
7833359|NCT01042678|19279656|P1|NOT COMPLETED|Overall Study||1
7833360|NCT01042678|19279651|P6|COMPLETED|Overall Study||0
7833361|NCT01042678|19279652|P5|COMPLETED|Overall Study||0
7833362|NCT01042678|19279653|P4|COMPLETED|Overall Study||0
7833363|NCT01042678|19279654|P3|COMPLETED|Overall Study||6
7833364|NCT01042678|19279655|P2|COMPLETED|Overall Study||6
7833365|NCT01042678|19279656|P1|COMPLETED|Overall Study||5
7833366|NCT01042678|19279651|P6|STARTED|Overall Study||0
7833367|NCT01042678|19279652|P5|STARTED|Overall Study||0
7833368|NCT01042678|19279653|P4|STARTED|Overall Study||0
7833369|NCT01042678|19279654|P3|STARTED|Overall Study||6
7833370|NCT01042678|19279655|P2|STARTED|Overall Study||6
7833371|NCT01042678|19279656|P1|STARTED|Overall Study||6
7833372|NCT01042613|19279681|P2|NOT COMPLETED|Overall Study||0
7833373|NCT01042613|19279682|P1|NOT COMPLETED|Overall Study||0
7833374|NCT01042613|19279681|P2|COMPLETED|Overall Study||74
7833375|NCT01042613|19279682|P1|COMPLETED|Overall Study||72
7833376|NCT01042613|19279681|P2|STARTED|Overall Study||74
7833377|NCT01042613|19279682|P1|STARTED|Overall Study||72
7833378|NCT01042600|19279694|P2|NOT COMPLETED|Overall Study||0
7833379|NCT01042600|19279695|P1|NOT COMPLETED|Overall Study||1
7833380|NCT01042600|19279694|P2|COMPLETED|Overall Study||30
7833381|NCT01042600|19279695|P1|COMPLETED|Overall Study||30
7833382|NCT01042600|19279694|P2|STARTED|Overall Study||30
7833383|NCT01042600|19279695|P1|STARTED|Overall Study||31
7833384|NCT01042535|19279715|P1|NOT COMPLETED|Overall Study||8
7833385|NCT01042535|19279715|P1|COMPLETED|Overall Study||36
7833386|NCT01042535|19279715|P1|STARTED|Overall Study||44
7833387|NCT01042509|19279723|P1|NOT COMPLETED|Overall Study||0
7833388|NCT01042509|19279723|P1|COMPLETED|Overall Study||15
7833389|NCT01042509|19279723|P1|STARTED|Overall Study||15
7833390|NCT01042496|19279730|P2|NOT COMPLETED|Overall Study||0
7833391|NCT01042496|19279731|P1|NOT COMPLETED|Overall Study||0
7833392|NCT01042496|19279730|P2|COMPLETED|Overall Study||33
7833393|NCT01042496|19279731|P1|COMPLETED|Overall Study||29
7833394|NCT01042496|19279730|P2|STARTED|Overall Study||33
7833395|NCT01042496|19279731|P1|STARTED|Overall Study||29
7833396|NCT01042392|19279749|P4|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
7833397|NCT01042392|19279750|P3|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4
7833398|NCT01042392|19279751|P2|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
7833399|NCT01042392|19279752|P1|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2
7833400|NCT01042392|19279749|P4|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121
7833401|NCT01042392|19279750|P3|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115
7833402|NCT01042392|19279751|P2|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117
7833403|NCT01042392|19279752|P1|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127
7833404|NCT01042392|19279749|P4|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82
7833405|NCT01042392|19279750|P3|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93
7833406|NCT01042392|19279751|P2|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73
7833407|NCT01042392|19279752|P1|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98
7833408|NCT01042392|19279749|P4|STARTED|Period III (Unblinded,Controlled, 1 Day)||122
7833409|NCT01042392|19279750|P3|STARTED|Period III (Unblinded,Controlled, 1 Day)||119
7833410|NCT01042392|19279751|P2|STARTED|Period III (Unblinded,Controlled, 1 Day)||118
7833411|NCT01042392|19279752|P1|STARTED|Period III (Unblinded,Controlled, 1 Day)||129
7833412|NCT01042392|19279749|P4|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
7833413|NCT01042392|19279750|P3|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8
7833414|NCT01042392|19279751|P2|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
7833415|NCT01042392|19279752|P1|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10
7833416|NCT01042392|19279749|P4|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
7833417|NCT01042392|19279750|P3|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241
7833418|NCT01042392|19279751|P2|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
7833419|NCT01042392|19279752|P1|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247
7833420|NCT01042392|19279749|P4|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
7833421|NCT01042392|19279750|P3|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222
7833422|NCT01042392|19279751|P2|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
7833423|NCT01042392|19279752|P1|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222
7833424|NCT01042392|19279749|P4|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
7833425|NCT01042392|19279750|P3|STARTED|Period II(Randomized,Double Blinded,8wk)||249
7833426|NCT01042392|19279751|P2|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
7833427|NCT01042392|19279752|P1|STARTED|Period II(Randomized,Double Blinded,8wk)||257
7833428|NCT01042366|19279781|P3|NOT COMPLETED|Overall Study||0
7833429|NCT01042366|19279782|P2|NOT COMPLETED|Overall Study||0
7833430|NCT01042366|19279783|P1|NOT COMPLETED|Overall Study||0
7833431|NCT01042366|19279781|P3|COMPLETED|Overall Study||4
7833432|NCT01042366|19279782|P2|COMPLETED|Overall Study||6
7833433|NCT01042366|19279783|P1|COMPLETED|Overall Study||5
7833434|NCT01042366|19279781|P3|STARTED|Overall Study||4
7833435|NCT01042366|19279782|P2|STARTED|Overall Study||6
7833436|NCT01042366|19279783|P1|STARTED|Overall Study||5
7833437|NCT01042288|19279792|P1|NOT COMPLETED|Overall Study||69
7833438|NCT01042288|19279792|P1|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0
7833439|NCT01042288|19279792|P1|Maintenance|Overall Study||27
7833440|NCT01042288|19279792|P1|STARTED|Overall Study||69
7833441|NCT01042236|19279800|P6|NOT COMPLETED|Treatment Period 3||0
7833442|NCT01042236|19279801|P5|NOT COMPLETED|Treatment Period 3||0
7833443|NCT01042236|19279802|P4|NOT COMPLETED|Treatment Period 3||2
7833444|NCT01042236|19279803|P3|NOT COMPLETED|Treatment Period 3||0
7833445|NCT01042236|19279804|P2|NOT COMPLETED|Treatment Period 3||0
7833446|NCT01042236|19279805|P1|NOT COMPLETED|Treatment Period 3||0
7833447|NCT01042236|19279800|P6|COMPLETED|Treatment Period 3||3
7833448|NCT01042236|19279801|P5|COMPLETED|Treatment Period 3||3
7833449|NCT01042236|19279802|P4|COMPLETED|Treatment Period 3||3
7833450|NCT01042236|19279803|P3|COMPLETED|Treatment Period 3||3
7833451|NCT01042236|19279804|P2|COMPLETED|Treatment Period 3||3
7833452|NCT01042236|19279805|P1|COMPLETED|Treatment Period 3||3
7833453|NCT01042236|19279800|P6|STARTED|Treatment Period 3||3
7833454|NCT01042236|19279801|P5|STARTED|Treatment Period 3||3
7833455|NCT01042236|19279802|P4|STARTED|Treatment Period 3||5
7833456|NCT01042236|19279803|P3|STARTED|Treatment Period 3||3
7833457|NCT01042236|19279804|P2|STARTED|Treatment Period 3||3
7833458|NCT01042236|19279805|P1|STARTED|Treatment Period 3||3
7833459|NCT01042236|19279800|P6|NOT COMPLETED|Treatment Period 2||0
7833460|NCT01042236|19279801|P5|NOT COMPLETED|Treatment Period 2||0
7833461|NCT01042236|19279802|P4|NOT COMPLETED|Treatment Period 2||0
7833462|NCT01042236|19279803|P3|NOT COMPLETED|Treatment Period 2||0
7833463|NCT01042236|19279804|P2|NOT COMPLETED|Treatment Period 2||0
7833464|NCT01042236|19279805|P1|NOT COMPLETED|Treatment Period 2||0
7833465|NCT01042236|19279800|P6|COMPLETED|Treatment Period 2||3
7833466|NCT01042236|19279801|P5|COMPLETED|Treatment Period 2||3
7833467|NCT01042236|19279802|P4|COMPLETED|Treatment Period 2||5
7833468|NCT01042236|19279803|P3|COMPLETED|Treatment Period 2||3
7833469|NCT01042236|19279804|P2|COMPLETED|Treatment Period 2||3
7833470|NCT01042236|19279805|P1|COMPLETED|Treatment Period 2||3
7833471|NCT01042236|19279800|P6|STARTED|Treatment Period 2||3
7833472|NCT01042236|19279801|P5|STARTED|Treatment Period 2||3
7833473|NCT01042236|19279802|P4|STARTED|Treatment Period 2||5
7833474|NCT01042236|19279803|P3|STARTED|Treatment Period 2||3
7833475|NCT01042236|19279804|P2|STARTED|Treatment Period 2||3
7833476|NCT01042236|19279805|P1|STARTED|Treatment Period 2||3
7833477|NCT01042236|19279800|P6|NOT COMPLETED|Treatment Period 1||0
7833478|NCT01042236|19279801|P5|NOT COMPLETED|Treatment Period 1||1
7833479|NCT01042236|19279802|P4|NOT COMPLETED|Treatment Period 1||0
7833480|NCT01042236|19279803|P3|NOT COMPLETED|Treatment Period 1||0
7833481|NCT01042236|19279804|P2|NOT COMPLETED|Treatment Period 1||1
7833482|NCT01042236|19279805|P1|NOT COMPLETED|Treatment Period 1||0
7833483|NCT01042236|19279800|P6|COMPLETED|Treatment Period 1||3
7833484|NCT01042236|19279801|P5|COMPLETED|Treatment Period 1||3
7833485|NCT01042236|19279802|P4|COMPLETED|Treatment Period 1||5
7833486|NCT01042236|19279803|P3|COMPLETED|Treatment Period 1||3
7833487|NCT01042236|19279804|P2|COMPLETED|Treatment Period 1||3
7833488|NCT01042236|19279805|P1|COMPLETED|Treatment Period 1||3
7833489|NCT01042236|19279800|P6|STARTED|Treatment Period 1||3
7833490|NCT01042236|19279801|P5|STARTED|Treatment Period 1||4
7833491|NCT01042236|19279802|P4|STARTED|Treatment Period 1||5
7833492|NCT01042236|19279803|P3|STARTED|Treatment Period 1||3
7833493|NCT01042236|19279804|P2|STARTED|Treatment Period 1||4
7833494|NCT01042236|19279805|P1|STARTED|Treatment Period 1||3
7833495|NCT01042158|19279842|P1|NOT COMPLETED|Overall Study||1
7833496|NCT01042158|19279842|P1|COMPLETED|Overall Study||24
7833497|NCT01042158|19279842|P1|STARTED|Overall Study||25
7833498|NCT01042145|19279851|P2|NOT COMPLETED|Overall Study||1
7833499|NCT01042145|19279852|P1|NOT COMPLETED|Overall Study||1
7833500|NCT01042145|19279851|P2|COMPLETED|Overall Study||45
7833501|NCT01042145|19279852|P1|COMPLETED|Overall Study||40
7833502|NCT01042145|19279851|P2|STARTED|Overall Study||46
7833503|NCT01042145|19279852|P1|STARTED|Overall Study||41
7833504|NCT01042093|19279872|P4|NOT COMPLETED|Overall Study||4
7833505|NCT01042093|19279873|P3|NOT COMPLETED|Overall Study||2
7833506|NCT01042093|19279874|P2|NOT COMPLETED|Overall Study||2
7833507|NCT01042093|19279875|P1|NOT COMPLETED|Overall Study||2
7833508|NCT01042093|19279872|P4|COMPLETED|Overall Study||36
7833509|NCT01042093|19279873|P3|COMPLETED|Overall Study||38
7833510|NCT01042093|19279874|P2|COMPLETED|Overall Study||38
7833511|NCT01042093|19279875|P1|COMPLETED|Overall Study||38
7833512|NCT01042093|19279872|P4|STARTED|Overall Study||40
7833513|NCT01042093|19279873|P3|STARTED|Overall Study||40
7833514|NCT01042093|19279874|P2|STARTED|Overall Study||40
7833515|NCT01042093|19279875|P1|STARTED|Overall Study||40
7833516|NCT01041976|19279895|P2|NOT COMPLETED|Overall Study||4
7833517|NCT01041976|19279896|P1|NOT COMPLETED|Overall Study||5
7833518|NCT01041976|19279895|P2|COMPLETED|Overall Study||38
7833519|NCT01041976|19279896|P1|COMPLETED|Overall Study||37
7833520|NCT01041976|19279895|P2|18 Month Follow-up|Overall Study||38
7833521|NCT01041976|19279896|P1|18 Month Follow-up|Overall Study||37
7833522|NCT01041976|19279895|P2|12 Month Follow-up|Overall Study||38
7833523|NCT01041976|19279896|P1|12 Month Follow-up|Overall Study||37
7833524|NCT01041976|19279895|P2|6 Month Follow-up|Overall Study||41
7833525|NCT01041976|19279896|P1|6 Month Follow-up|Overall Study||39
7833526|NCT01041976|19279895|P2|STARTED|Overall Study||42
7833527|NCT01041976|19279896|P1|STARTED|Overall Study||42
7833528|NCT01041859|19279906|P3|NOT COMPLETED|Double-Blind Maintenance||45
7833529|NCT01041859|19279907|P2|NOT COMPLETED|Double-Blind Maintenance||46
7833530|NCT01041859|19279908|P1|NOT COMPLETED|Double-Blind Maintenance||0
7833531|NCT01041859|19279906|P3|COMPLETED|Double-Blind Maintenance||107
7833532|NCT01041859|19279907|P2|COMPLETED|Double-Blind Maintenance||120
7833533|NCT01041859|19279908|P1|COMPLETED|Double-Blind Maintenance||0
7833534|NCT01041859|19279906|P3|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152
7833535|NCT01041859|19279907|P2|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166
7833536|NCT01041859|19279908|P1|STARTED|Double-Blind Maintenance||0
7833537|NCT01041859|19279906|P3|NOT COMPLETED|Open-Label Titration||0
7833538|NCT01041859|19279907|P2|NOT COMPLETED|Open-Label Titration||0
7833539|NCT01041859|19279908|P1|NOT COMPLETED|Open-Label Titration||101
7833540|NCT01041859|19279906|P3|COMPLETED|Open-Label Titration||0
7833541|NCT01041859|19279907|P2|COMPLETED|Open-Label Titration||0
7833542|NCT01041859|19279908|P1|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358
7833543|NCT01041859|19279906|P3|STARTED|Open-Label Titration||0
7833544|NCT01041859|19279907|P2|STARTED|Open-Label Titration||0
7833545|NCT01041859|19279908|P1|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459
7833546|NCT01041781|19279925|P2|NOT COMPLETED|Overall Study||0
7833547|NCT01041781|19279926|P1|NOT COMPLETED|Overall Study||0
7833548|NCT01041781|19279925|P2|COMPLETED|Overall Study||158
7833549|NCT01041781|19279926|P1|COMPLETED|Overall Study||154
7833550|NCT01041781|19279925|P2|STARTED|Overall Study||158
7833551|NCT01041781|19279926|P1|STARTED|Overall Study||154
7833552|NCT01041638|19279944|P1|NOT COMPLETED|Overall Study||27
7833553|NCT01041638|19279944|P1|COMPLETED|Overall Study||78
7833554|NCT01041638|19279944|P1|STARTED|Overall Study||105
7833555|NCT01041573|19279954|P4|NOT COMPLETED|Overall Study||2
7833556|NCT01041573|19279955|P3|NOT COMPLETED|Overall Study||7
7833557|NCT01041573|19279956|P2|NOT COMPLETED|Overall Study||13
7833558|NCT01041573|19279957|P1|NOT COMPLETED|Overall Study||5
7833559|NCT01041573|19279954|P4|COMPLETED|Overall Study||62
7833560|NCT01041573|19279955|P3|COMPLETED|Overall Study||387
7833561|NCT01041573|19279956|P2|COMPLETED|Overall Study||858
7833562|NCT01041573|19279957|P1|COMPLETED|Overall Study||535
7833563|NCT01041573|19279954|P4|STARTED|Overall Study||64
7833564|NCT01041573|19279955|P3|STARTED|Overall Study||394
7833565|NCT01041573|19279956|P2|STARTED|Overall Study||871
7833566|NCT01041573|19279957|P1|STARTED|Overall Study||540
7833567|NCT01041521|19279969|P2|NOT COMPLETED|Overall Study||16
7833568|NCT01041521|19279970|P1|NOT COMPLETED|Overall Study||17
7833569|NCT01041521|19279969|P2|COMPLETED|Overall Study||40
7833570|NCT01041521|19279970|P1|COMPLETED|Overall Study||44
7833571|NCT01041521|19279969|P2|STARTED|Overall Study||56
7833572|NCT01041521|19279970|P1|STARTED|Overall Study||61
7833573|NCT01041417|19279980|P2|NOT COMPLETED|Overall Study||3
7833574|NCT01041417|19279981|P1|NOT COMPLETED|Overall Study||7
7833575|NCT01041417|19279980|P2|COMPLETED|Overall Study||76
7833576|NCT01041417|19279981|P1|COMPLETED|Overall Study||73
7833577|NCT01041417|19279980|P2|STARTED|Overall Study||79
7833578|NCT01041417|19279981|P1|STARTED|Overall Study||80
7833579|NCT01041404|19280019|P2|NOT COMPLETED|Overall Study||294
7833580|NCT01041404|19280020|P1|NOT COMPLETED|Overall Study||290
7833581|NCT01041404|19280019|P2|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
7833582|NCT01041404|19280020|P1|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
7833583|NCT01041404|19280019|P2|Alive in Follow-up|Overall Study||41
7833584|NCT01041404|19280020|P1|Alive in Follow-up|Overall Study||40
7833585|NCT01041404|19280019|P2|Lost to Follow-up|Overall Study||10
7833586|NCT01041404|19280020|P1|Lost to Follow-up|Overall Study||12
7833587|NCT01041404|19280019|P2|Died in Follow-up|Overall Study||200
7833588|NCT01041404|19280020|P1|Died in Follow-up|Overall Study||199
7833589|NCT01041404|19280019|P2|Entered Follow-Up|Overall Study||251
7833590|NCT01041404|19280020|P1|Entered Follow-Up|Overall Study||251
7833591|NCT01041404|19280019|P2|STARTED|Overall Study||294
7833592|NCT01041404|19280020|P1|STARTED|Overall Study||290
7833593|NCT01041287|19280061|P2|NOT COMPLETED|Treatment Period 2 (3 Months)||5
7833594|NCT01041287|19280062|P1|NOT COMPLETED|Treatment Period 2 (3 Months)||3
7833595|NCT01041287|19280061|P2|COMPLETED|Treatment Period 2 (3 Months)||14
7833596|NCT01041287|19280062|P1|COMPLETED|Treatment Period 2 (3 Months)||16
7833597|NCT01041287|19280061|P2|STARTED|Treatment Period 2 (3 Months)||19
7833598|NCT01041287|19280062|P1|STARTED|Treatment Period 2 (3 Months)||19
7833599|NCT01041287|19280061|P2|NOT COMPLETED|Treatment Period 1 (3 Months)||0
7833600|NCT01041287|19280062|P1|NOT COMPLETED|Treatment Period 1 (3 Months)||0
7833601|NCT01041287|19280061|P2|COMPLETED|Treatment Period 1 (3 Months)||19
7833602|NCT01041287|19280062|P1|COMPLETED|Treatment Period 1 (3 Months)||19
7833603|NCT01041287|19280061|P2|STARTED|Treatment Period 1 (3 Months)||19
7833604|NCT01041287|19280062|P1|STARTED|Treatment Period 1 (3 Months)||19
7833605|NCT01041274|19280074|P2|NOT COMPLETED|Overall Study||21
7833606|NCT01041274|19280075|P1|NOT COMPLETED|Overall Study||23
7833607|NCT01041274|19280074|P2|COMPLETED|Overall Study||25
7833608|NCT01041274|19280075|P1|COMPLETED|Overall Study||26
7833609|NCT01041274|19280074|P2|STARTED|Overall Study||46
7833610|NCT01041274|19280075|P1|STARTED|Overall Study||49
7833611|NCT01041209|19280091|P2|NOT COMPLETED|Overall Study||0
7833612|NCT01041209|19280092|P1|NOT COMPLETED|Overall Study||0
7833613|NCT01041209|19280091|P2|COMPLETED|Overall Study||60
7833614|NCT01041209|19280092|P1|COMPLETED|Overall Study||60
7833615|NCT01041209|19280091|P2|STARTED|Overall Study||60
7833616|NCT01041209|19280092|P1|STARTED|Overall Study||60
7833617|NCT01040871|19280102|P2|NOT COMPLETED|Overall Study||7
7833618|NCT01040871|19280103|P1|NOT COMPLETED|Overall Study||13
7833619|NCT01040871|19280102|P2|COMPLETED|Overall Study||73
7833620|NCT01040871|19280103|P1|COMPLETED|Overall Study||71
7833621|NCT01040871|19280102|P2|STARTED|Overall Study|Intent to Treat, Randomized|80
7833622|NCT01040871|19280103|P1|STARTED|Overall Study|Intent to Treat, Randomized|84
7833623|NCT01040858|19280123|P2|NOT COMPLETED|Overall Study||0
7833624|NCT01040858|19280124|P1|NOT COMPLETED|Overall Study||9
7833625|NCT01040858|19280123|P2|COMPLETED|Overall Study||69
7833626|NCT01040858|19280124|P1|COMPLETED|Overall Study||50
7833627|NCT01040858|19280123|P2|STARTED|Overall Study||69
7833628|NCT01040858|19280124|P1|STARTED|Overall Study||59
7833629|NCT01040845|19280154|P2|NOT COMPLETED|Overall Study||1
7833630|NCT01040845|19280155|P1|NOT COMPLETED|Overall Study||2
7833631|NCT01040845|19280154|P2|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14
7833632|NCT01040845|19280155|P1|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13
7833633|NCT01040845|19280154|P2|STARTED|Overall Study||15
7833634|NCT01040845|19280155|P1|STARTED|Overall Study||15
7833635|NCT01040832|19280170|P2|NOT COMPLETED|Overall Study||37
7833636|NCT01040832|19280171|P1|NOT COMPLETED|Overall Study||46
7833637|NCT01040832|19280170|P2|COMPLETED|Overall Study||16
7833638|NCT01040832|19280171|P1|COMPLETED|Overall Study||8
7833639|NCT01040832|19280170|P2|STARTED|Overall Study||53
7833640|NCT01040832|19280171|P1|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54
7833641|NCT01040819|19280187|P2|NOT COMPLETED|Overall Study||0
7833642|NCT01040819|19280188|P1|NOT COMPLETED|Overall Study||0
7833643|NCT01040819|19280187|P2|COMPLETED|Overall Study||12
7833644|NCT01040819|19280188|P1|COMPLETED|Overall Study||13
7833645|NCT01040819|19280187|P2|STARTED|Overall Study||12
7833646|NCT01040819|19280188|P1|STARTED|Overall Study||13
7833647|NCT01040793|19280194|P6|NOT COMPLETED|Overall Study||1
7833648|NCT01040793|19280195|P5|NOT COMPLETED|Overall Study||4
7833649|NCT01040793|19280196|P4|NOT COMPLETED|Overall Study||4
7833650|NCT01040793|19280197|P3|NOT COMPLETED|Overall Study||3
7833651|NCT01040793|19280198|P2|NOT COMPLETED|Overall Study||5
7833652|NCT01040793|19280199|P1|NOT COMPLETED|Overall Study||6
7833653|NCT01040793|19280194|P6|COMPLETED|Overall Study||26
7833654|NCT01040793|19280195|P5|COMPLETED|Overall Study||22
7833655|NCT01040793|19280196|P4|COMPLETED|Overall Study||22
7833656|NCT01040793|19280197|P3|COMPLETED|Overall Study||23
7833657|NCT01040793|19280198|P2|COMPLETED|Overall Study||21
7833658|NCT01040793|19280199|P1|COMPLETED|Overall Study||20
7833659|NCT01040793|19280194|P6|STARTED|Overall Study||27
7833660|NCT01040793|19280195|P5|STARTED|Overall Study||26
7833661|NCT01040793|19280196|P4|STARTED|Overall Study||26
7833662|NCT01040793|19280197|P3|STARTED|Overall Study||26
7833663|NCT01040793|19280198|P2|STARTED|Overall Study||26
7833664|NCT01040793|19280199|P1|STARTED|Overall Study|Entered and treated|26
7833665|NCT01040780|19280278|P2|NOT COMPLETED|Overall Study||3
7833666|NCT01040780|19280279|P1|NOT COMPLETED|Overall Study||1
7833667|NCT01040780|19280278|P2|COMPLETED|Overall Study||196
7833668|NCT01040780|19280279|P1|COMPLETED|Overall Study||199
7833669|NCT01040780|19280278|P2|STARTED|Overall Study||199
7833670|NCT01040780|19280279|P1|STARTED|Overall Study||200
7833671|NCT01040728|19280293|P4|NOT COMPLETED|Overall Study||6
7833672|NCT01040728|19280294|P3|NOT COMPLETED|Overall Study||1
7833673|NCT01040728|19280295|P2|NOT COMPLETED|Overall Study||11
7833674|NCT01040728|19280296|P1|NOT COMPLETED|Overall Study||4
7833675|NCT01040728|19280293|P4|COMPLETED|Overall Study||24
7833676|NCT01040728|19280294|P3|COMPLETED|Overall Study||30
7833677|NCT01040728|19280295|P2|COMPLETED|Overall Study||19
7833678|NCT01040728|19280296|P1|COMPLETED|Overall Study||27
7833679|NCT01040728|19280293|P4|STARTED|Overall Study||30
7833680|NCT01040728|19280294|P3|STARTED|Overall Study||31
7833681|NCT01040728|19280295|P2|STARTED|Overall Study||30
7833682|NCT01040728|19280296|P1|STARTED|Overall Study||31
7833683|NCT01040689|19280366|P4|NOT COMPLETED|Overall Study||4
7833684|NCT01040689|19280367|P3|NOT COMPLETED|Overall Study||4
7833685|NCT01040689|19280368|P2|NOT COMPLETED|Overall Study||2
7833686|NCT01040689|19280369|P1|NOT COMPLETED|Overall Study||3
7833687|NCT01040689|19280366|P4|COMPLETED|Overall Study||23
7833688|NCT01040689|19280367|P3|COMPLETED|Overall Study||23
7833689|NCT01040689|19280368|P2|COMPLETED|Overall Study||25
7833690|NCT01040689|19280369|P1|COMPLETED|Overall Study||24
7833691|NCT01040689|19280366|P4|STARTED|Overall Study||27
7833692|NCT01040689|19280367|P3|STARTED|Overall Study||27
7833693|NCT01040689|19280368|P2|STARTED|Overall Study||27
7833694|NCT01040689|19280369|P1|STARTED|Overall Study||27
7833695|NCT01040624|19280441|P2|NOT COMPLETED|Overall Study||0
7833696|NCT01040624|19280442|P1|NOT COMPLETED|Overall Study||0
7833697|NCT01040624|19280441|P2|COMPLETED|Overall Study||19
7833698|NCT01040624|19280442|P1|COMPLETED|Overall Study||58
7833699|NCT01040624|19280441|P2|STARTED|Overall Study||19
7833700|NCT01040624|19280442|P1|STARTED|Overall Study||58
7833701|NCT01040403|19280448|P1|NOT COMPLETED|Overall Study||20
7833702|NCT01040403|19280448|P1|COMPLETED|Overall Study|All treatment periods|213
7833703|NCT01040403|19280448|P1|Completed T+O 5/10|Overall Study||107
7833704|NCT01040403|19280448|P1|Completed T+O 2.5/10|Overall Study||110
7833705|NCT01040403|19280448|P1|Completed T+O 1.25/10|Overall Study||106
7833706|NCT01040403|19280448|P1|Completed Olo 10|Overall Study||109
7833707|NCT01040403|19280448|P1|Completed T+O 5/5|Overall Study||106
7833708|NCT01040403|19280448|P1|Completed T+O 2.5/5|Overall Study||111
7833709|NCT01040403|19280448|P1|Completed T+O 1.25/5|Overall Study||105
7833710|NCT01040403|19280448|P1|Completed Olo 5|Overall Study||106
7833711|NCT01040403|19280448|P1|STARTED|Overall Study||233
7833712|NCT01040351|19280636|P2|NOT COMPLETED|Overall Study||2
7833713|NCT01040351|19280637|P1|NOT COMPLETED|Overall Study||1
7833714|NCT01040351|19280636|P2|COMPLETED|Overall Study|May 2010|53
7833715|NCT01040351|19280637|P1|COMPLETED|Overall Study|May 2010|54
7833716|NCT01040351|19280636|P2|STARTED|Overall Study|October 2006|55
7833717|NCT01040351|19280637|P1|STARTED|Overall Study|October 2006|55
7833718|NCT01040260|19280647|P2|NOT COMPLETED|Overall Study||11
7833719|NCT01040260|19280648|P1|NOT COMPLETED|Overall Study||15
7833720|NCT01040260|19280647|P2|COMPLETED|Overall Study||39
7833721|NCT01040260|19280648|P1|COMPLETED|Overall Study||38
7833722|NCT01040260|19280647|P2|STARTED|Overall Study||50
7833723|NCT01040260|19280648|P1|STARTED|Overall Study||53
7833724|NCT01040208|19280657|P3|NOT COMPLETED|Overall Study||3
7833725|NCT01040208|19280658|P2|NOT COMPLETED|Overall Study||13
7833726|NCT01040208|19280659|P1|NOT COMPLETED|Overall Study||6
7833727|NCT01040208|19280657|P3|COMPLETED|Overall Study||35
7833728|NCT01040208|19280658|P2|COMPLETED|Overall Study||15
7833729|NCT01040208|19280659|P1|COMPLETED|Overall Study||39
7833730|NCT01040208|19280657|P3|STARTED|Overall Study||38
7833731|NCT01040208|19280658|P2|STARTED|Overall Study||28
7833732|NCT01040208|19280659|P1|STARTED|Overall Study||45
7833733|NCT01040169|19280675|P2|NOT COMPLETED|Overall Study||8
7833734|NCT01040169|19280676|P1|NOT COMPLETED|Overall Study||3
7833735|NCT01040169|19280675|P2|COMPLETED|Overall Study||36
7833736|NCT01040169|19280676|P1|COMPLETED|Overall Study||32
7833737|NCT01040169|19280675|P2|STARTED|Overall Study||44
7833738|NCT01040169|19280676|P1|STARTED|Overall Study||35
7833739|NCT01040130|19280684|P6|NOT COMPLETED|Overall Study||4
7833740|NCT01040130|19280685|P5|NOT COMPLETED|Overall Study||0
7833741|NCT01040130|19280686|P4|NOT COMPLETED|Overall Study||5
7833742|NCT01040130|19280687|P3|NOT COMPLETED|Overall Study||2
7833743|NCT01040130|19280688|P2|NOT COMPLETED|Overall Study||3
7833744|NCT01040130|19280689|P1|NOT COMPLETED|Overall Study||3
7833745|NCT01040130|19280684|P6|COMPLETED|Overall Study||22
7833746|NCT01040130|19280685|P5|COMPLETED|Overall Study||25
7833747|NCT01040130|19280686|P4|COMPLETED|Overall Study||20
7833748|NCT01040130|19280687|P3|COMPLETED|Overall Study||23
7833749|NCT01040130|19280688|P2|COMPLETED|Overall Study||22
7833750|NCT01040130|19280689|P1|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22
7833751|NCT01040130|19280684|P6|STARTED|Overall Study||26
7833752|NCT01040130|19280685|P5|STARTED|Overall Study||25
7833753|NCT01040130|19280686|P4|STARTED|Overall Study||25
7833754|NCT01040130|19280687|P3|STARTED|Overall Study||25
7833755|NCT01040130|19280688|P2|STARTED|Overall Study||25
7833756|NCT01040130|19280689|P1|STARTED|Overall Study|Number of patients entered and treated|25
7833757|NCT01040052|19280766|P1|NOT COMPLETED|Overall Study||0
7833758|NCT01040052|19280766|P1|COMPLETED|Overall Study||30
7833759|NCT01040052|19280766|P1|STARTED|Overall Study||30
7833760|NCT01039792|19280772|P2|NOT COMPLETED|Overall Study||1
7833761|NCT01039792|19280773|P1|NOT COMPLETED|Overall Study||6
7833762|NCT01039792|19280772|P2|COMPLETED|Overall Study||27
7833763|NCT01039792|19280773|P1|COMPLETED|Overall Study||23
7833764|NCT01039792|19280772|P2|STARTED|Overall Study||28
7833765|NCT01039792|19280773|P1|STARTED|Overall Study||29
7833766|NCT01039688|19280782|P3|NOT COMPLETED|Overall Study||80
7833767|NCT01039688|19280783|P2|NOT COMPLETED|Overall Study||111
7833768|NCT01039688|19280784|P1|NOT COMPLETED|Overall Study||107
7833769|NCT01039688|19280782|P3|COMPLETED|Overall Study||106
7833770|NCT01039688|19280783|P2|COMPLETED|Overall Study||286
7833771|NCT01039688|19280784|P1|COMPLETED|Overall Study||266
7833772|NCT01039688|19280782|P3|STARTED|Overall Study||186
7833773|NCT01039688|19280783|P2|STARTED|Overall Study||397
7833774|NCT01039688|19280784|P1|STARTED|Overall Study||373
7833775|NCT01039675|19281055|P2|NOT COMPLETED|Overall Study||7
7833776|NCT01039675|19281056|P1|NOT COMPLETED|Overall Study||0
7833777|NCT01039675|19281055|P2|COMPLETED|Overall Study||35
7833778|NCT01039675|19281056|P1|COMPLETED|Overall Study||9
7833779|NCT01039675|19281055|P2|STARTED|Overall Study||42
7833780|NCT01039675|19281056|P1|STARTED|Overall Study||9
7833781|NCT01039584|19281069|P3|NOT COMPLETED|Overall Study||57
7833782|NCT01039584|19281070|P2|NOT COMPLETED|Overall Study||97
7833783|NCT01039584|19281071|P1|NOT COMPLETED|Overall Study||103
7833784|NCT01039584|19281069|P3|COMPLETED|Overall Study||65
7833785|NCT01039584|19281070|P2|COMPLETED|Overall Study||146
7833786|NCT01039584|19281071|P1|COMPLETED|Overall Study||143
7833787|NCT01039584|19281069|P3|STARTED|Overall Study||122
7833788|NCT01039584|19281070|P2|STARTED|Overall Study||243
7833789|NCT01039584|19281071|P1|STARTED|Overall Study||246
7833790|NCT01039519|19281085|P1|NOT COMPLETED|Survival Follow-up||27
7833791|NCT01039519|19281085|P1|COMPLETED|Survival Follow-up||0
7833792|NCT01039519|19281085|P1|STARTED|Survival Follow-up||27
7833793|NCT01039519|19281085|P1|NOT COMPLETED|Treatment||27
7833794|NCT01039519|19281085|P1|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0
7833795|NCT01039519|19281085|P1|STARTED|Treatment||27
7833796|NCT01039467|19281096|P2|NOT COMPLETED|Overall Study||49
7833797|NCT01039467|19281097|P1|NOT COMPLETED|Overall Study||40
7833798|NCT01039467|19281096|P2|COMPLETED|Overall Study||140
7833799|NCT01039467|19281097|P1|COMPLETED|Overall Study||156
7833800|NCT01039467|19281096|P2|STARTED|Overall Study||189
7833801|NCT01039467|19281097|P1|STARTED|Overall Study||196
7833802|NCT01039428|19281121|P2|NOT COMPLETED|Overall Study||0
7833803|NCT01039428|19281122|P1|NOT COMPLETED|Overall Study||2
7833804|NCT01039428|19281121|P2|COMPLETED|Overall Study||28
7833805|NCT01039428|19281122|P1|COMPLETED|Overall Study||33
7833806|NCT01039428|19281121|P2|STARTED|Overall Study||28
7833807|NCT01039428|19281122|P1|STARTED|Overall Study||35
7833808|NCT01039376|19281146|P2|NOT COMPLETED|Overall Study||126
7833809|NCT01039376|19281147|P1|NOT COMPLETED|Overall Study||130
7833810|NCT01039376|19281146|P2|COMPLETED|Overall Study||114
7833811|NCT01039376|19281147|P1|COMPLETED|Overall Study||110
7833812|NCT01039376|19281146|P2|STARTED|Overall Study||240
7833813|NCT01039376|19281147|P1|STARTED|Overall Study||240
7833814|NCT01039207|19281206|P1|NOT COMPLETED|Overall Study||0
7833815|NCT01039207|19281206|P1|COMPLETED|Overall Study||31
7833816|NCT01039207|19281206|P1|STARTED|Overall Study||31
7833817|NCT01038921|19281216|P2|NOT COMPLETED|Overall Study||0
7833818|NCT01038921|19281217|P1|NOT COMPLETED|Overall Study||2
7833819|NCT01038921|19281216|P2|COMPLETED|Overall Study||20
7833820|NCT01038921|19281217|P1|COMPLETED|Overall Study|2 subjects withdrew|17
7833821|NCT01038921|19281216|P2|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20
7833822|NCT01038921|19281217|P1|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19
7833823|NCT01038869|19281223|P1|NOT COMPLETED|Overall Study||7
7833824|NCT01038869|19281223|P1|COMPLETED|Overall Study||13
7833825|NCT01038869|19281223|P1|STARTED|Overall Study||20
7833826|NCT01038856|19281231|P1|NOT COMPLETED|Overall Study||2
7833827|NCT01038856|19281231|P1|COMPLETED|Overall Study||3
7833828|NCT01038856|19281231|P1|STARTED|Overall Study||5
7833829|NCT01038752|19281240|P2|NOT COMPLETED|Overall Study||5
7833830|NCT01038752|19281241|P1|NOT COMPLETED|Overall Study||5
7833831|NCT01038752|19281240|P2|COMPLETED|Overall Study||1
7833832|NCT01038752|19281241|P1|COMPLETED|Overall Study||3
7833833|NCT01038752|19281240|P2|STARTED|Overall Study||6
7833834|NCT01038752|19281241|P1|STARTED|Overall Study||8
7833835|NCT01038713|19281264|P3|NOT COMPLETED|Overall Study||1
7833836|NCT01038713|19281265|P2|NOT COMPLETED|Overall Study||3
7833837|NCT01038713|19281266|P1|NOT COMPLETED|Overall Study||5
7833838|NCT01038713|19281264|P3|COMPLETED|Overall Study||16
7833839|NCT01038713|19281265|P2|COMPLETED|Overall Study||17
7833840|NCT01038713|19281266|P1|COMPLETED|Overall Study||21
7833841|NCT01038713|19281264|P3|STARTED|Overall Study||17
7833842|NCT01038713|19281265|P2|STARTED|Overall Study||20
7833843|NCT01038713|19281266|P1|STARTED|Overall Study||26
7833844|NCT01038687|19281289|P3|NOT COMPLETED|Overall Study||1
7833845|NCT01038687|19281290|P2|NOT COMPLETED|Overall Study||2
7833846|NCT01038687|19281291|P1|NOT COMPLETED|Overall Study||0
7833847|NCT01038687|19281289|P3|COMPLETED|Overall Study||12
7833848|NCT01038687|19281290|P2|COMPLETED|Overall Study||9
7833849|NCT01038687|19281291|P1|COMPLETED|Overall Study||12
7833850|NCT01038687|19281289|P3|STARTED|Overall Study||13
7833851|NCT01038687|19281290|P2|STARTED|Overall Study||11
7833852|NCT01038687|19281291|P1|STARTED|Overall Study||12
7833853|NCT01038635|19281332|P9|NOT COMPLETED|Overall Study||2
7833854|NCT01038635|19281333|P8|NOT COMPLETED|Overall Study||5
7833855|NCT01038635|19281334|P7|NOT COMPLETED|Overall Study||2
7833856|NCT01038635|19281335|P6|NOT COMPLETED|Overall Study||0
7833857|NCT01038635|19281336|P5|NOT COMPLETED|Overall Study||1
7833858|NCT01038635|19281337|P4|NOT COMPLETED|Overall Study||0
7833859|NCT01038635|19281338|P3|NOT COMPLETED|Overall Study||0
7833860|NCT01038635|19281339|P2|NOT COMPLETED|Overall Study||0
7833861|NCT01038635|19281340|P1|NOT COMPLETED|Overall Study||2
7833862|NCT01038635|19281332|P9|COMPLETED|Overall Study||38
7833863|NCT01038635|19281333|P8|COMPLETED|Overall Study||15
7833864|NCT01038635|19281334|P7|COMPLETED|Overall Study||5
7833865|NCT01038635|19281335|P6|COMPLETED|Overall Study||3
7833866|NCT01038635|19281336|P5|COMPLETED|Overall Study||3
7833867|NCT01038635|19281337|P4|COMPLETED|Overall Study||3
7833868|NCT01038635|19281338|P3|COMPLETED|Overall Study||3
7833869|NCT01038635|19281339|P2|COMPLETED|Overall Study||3
7833870|NCT01038635|19281340|P1|COMPLETED|Overall Study||3
7833871|NCT01038635|19281332|P9|STARTED|Overall Study||40
7833872|NCT01038635|19281333|P8|STARTED|Overall Study||20
7833873|NCT01038635|19281334|P7|STARTED|Overall Study||7
7833874|NCT01038635|19281335|P6|STARTED|Overall Study||3
7833875|NCT01038635|19281336|P5|STARTED|Overall Study||4
7833876|NCT01038635|19281337|P4|STARTED|Overall Study||3
7833877|NCT01038635|19281338|P3|STARTED|Overall Study||3
7833878|NCT01038635|19281339|P2|STARTED|Overall Study||3
7833879|NCT01038635|19281340|P1|STARTED|Overall Study||5
7833880|NCT01038609|19281366|P5|NOT COMPLETED|Overall Study||1
7833881|NCT01038609|19281367|P4|NOT COMPLETED|Overall Study||1
7833882|NCT01038609|19281368|P3|NOT COMPLETED|Overall Study||1
7833883|NCT01038609|19281369|P2|NOT COMPLETED|Overall Study||1
7833884|NCT01038609|19281370|P1|NOT COMPLETED|Overall Study||1
7833885|NCT01038609|19281366|P5|COMPLETED|Overall Study||50
7833886|NCT01038609|19281367|P4|COMPLETED|Overall Study||47
7833887|NCT01038609|19281368|P3|COMPLETED|Overall Study||48
7833888|NCT01038609|19281369|P2|COMPLETED|Overall Study||51
7833889|NCT01038609|19281370|P1|COMPLETED|Overall Study||49
7833890|NCT01038609|19281366|P5|STARTED|Overall Study||51
7833891|NCT01038609|19281367|P4|STARTED|Overall Study||48
7833892|NCT01038609|19281368|P3|STARTED|Overall Study||49
7833893|NCT01038609|19281369|P2|STARTED|Overall Study||52
7833894|NCT01038609|19281370|P1|STARTED|Overall Study||50
7833895|NCT01038557|19281415|P3|NOT COMPLETED|Overall Study||0
7833896|NCT01038557|19281416|P2|NOT COMPLETED|Overall Study||0
7833897|NCT01038557|19281417|P1|NOT COMPLETED|Overall Study||0
7833898|NCT01038557|19281415|P3|COMPLETED|Overall Study||86
7833899|NCT01038557|19281416|P2|COMPLETED|Overall Study||86
7833900|NCT01038557|19281417|P1|COMPLETED|Overall Study||82
7833901|NCT01038557|19281415|P3|STARTED|Overall Study||86
7833902|NCT01038557|19281416|P2|STARTED|Overall Study||86
7833903|NCT01038557|19281417|P1|STARTED|Overall Study||82
7833904|NCT01038336|19281455|P3|NOT COMPLETED|Overall Study||0
7833905|NCT01038336|19281456|P2|NOT COMPLETED|Overall Study||0
7833906|NCT01038336|19281457|P1|NOT COMPLETED|Overall Study||0
7833907|NCT01038336|19281455|P3|COMPLETED|Overall Study||44
7833908|NCT01038336|19281456|P2|COMPLETED|Overall Study||42
7833909|NCT01038336|19281457|P1|COMPLETED|Overall Study||43
7833910|NCT01038336|19281455|P3|STARTED|Overall Study||44
7833911|NCT01038336|19281456|P2|STARTED|Overall Study||42
7833912|NCT01038336|19281457|P1|STARTED|Overall Study||43
7833913|NCT01038323|19281489|P3|NOT COMPLETED|Overall Study||4
7833914|NCT01038323|19281490|P2|NOT COMPLETED|Overall Study||2
7833915|NCT01038323|19281491|P1|NOT COMPLETED|Overall Study||3
7833916|NCT01038323|19281489|P3|COMPLETED|Overall Study||15
7833917|NCT01038323|19281490|P2|COMPLETED|Overall Study||17
7833918|NCT01038323|19281491|P1|COMPLETED|Overall Study||17
7833919|NCT01038323|19281489|P3|STARTED|Overall Study||19
7833920|NCT01038323|19281490|P2|STARTED|Overall Study||19
7833921|NCT01038323|19281491|P1|STARTED|Overall Study||20
7833922|NCT01038128|19281505|P1|NOT COMPLETED|Overall Study||4
7833923|NCT01038128|19281505|P1|COMPLETED|Overall Study||1
7833924|NCT01038128|19281505|P1|Baseline Visit|Overall Study||3
7833925|NCT01038128|19281505|P1|STARTED|Overall Study||5
7833926|NCT01037881|19281520|P7|NOT COMPLETED|Overall Study||2
7833927|NCT01037881|19281521|P6|NOT COMPLETED|Overall Study||3
7833928|NCT01037881|19281522|P5|NOT COMPLETED|Overall Study||3
7833929|NCT01037881|19281523|P4|NOT COMPLETED|Overall Study||1
7833930|NCT01037881|19281524|P3|NOT COMPLETED|Overall Study||3
7833931|NCT01037881|19281525|P2|NOT COMPLETED|Overall Study||2
7833932|NCT01037881|19281526|P1|NOT COMPLETED|Overall Study||6
7833933|NCT01037881|19281520|P7|COMPLETED|Overall Study||23
7833934|NCT01037881|19281521|P6|COMPLETED|Overall Study||27
7833935|NCT01037881|19281522|P5|COMPLETED|Overall Study||26
7833936|NCT01037881|19281523|P4|COMPLETED|Overall Study||24
7833937|NCT01037881|19281524|P3|COMPLETED|Overall Study||22
7833938|NCT01037881|19281525|P2|COMPLETED|Overall Study||22
7833939|NCT01037881|19281526|P1|COMPLETED|Overall Study||19
7833940|NCT01037881|19281520|P7|STARTED|Overall Study||25
7833941|NCT01037881|19281521|P6|STARTED|Overall Study||30
7833942|NCT01037881|19281522|P5|STARTED|Overall Study||29
7833943|NCT01037881|19281523|P4|STARTED|Overall Study||25
7833944|NCT01037881|19281524|P3|STARTED|Overall Study||25
7833945|NCT01037881|19281525|P2|STARTED|Overall Study||24
7833946|NCT01037881|19281526|P1|STARTED|Overall Study||25
7833947|NCT01037452|19281588|P4|NOT COMPLETED|Overall Study||0
7833948|NCT01037452|19281589|P3|NOT COMPLETED|Overall Study||0
7833949|NCT01037452|19281590|P2|NOT COMPLETED|Overall Study||0
7833950|NCT01037452|19281591|P1|NOT COMPLETED|Overall Study||0
7833951|NCT01037452|19281588|P4|COMPLETED|Overall Study||30
7833952|NCT01037452|19281589|P3|COMPLETED|Overall Study||30
7833953|NCT01037452|19281590|P2|COMPLETED|Overall Study||30
7833954|NCT01037452|19281591|P1|COMPLETED|Overall Study||30
7833955|NCT01037452|19281588|P4|STARTED|Overall Study||30
7833956|NCT01037452|19281589|P3|STARTED|Overall Study||30
7833957|NCT01037452|19281590|P2|STARTED|Overall Study||30
7833958|NCT01037452|19281591|P1|STARTED|Overall Study||30
7833959|NCT01037309|19281619|P9|NOT COMPLETED|Intravenous Period 7 - 9||0
7833960|NCT01037309|19281620|P8|NOT COMPLETED|Intravenous Period 7 - 9||0
7833961|NCT01037309|19281621|P7|NOT COMPLETED|Intravenous Period 7 - 9||0
7833962|NCT01037309|19281622|P6|NOT COMPLETED|Intravenous Period 7 - 9||0
7833963|NCT01037309|19281623|P5|NOT COMPLETED|Intravenous Period 7 - 9||0
7833964|NCT01037309|19281624|P4|NOT COMPLETED|Intravenous Period 7 - 9||0
7833965|NCT01037309|19281625|P3|NOT COMPLETED|Intravenous Period 7 - 9||0
7833966|NCT01037309|19281626|P2|NOT COMPLETED|Intravenous Period 7 - 9||0
7833967|NCT01037309|19281627|P1|NOT COMPLETED|Intravenous Period 7 - 9||0
7833968|NCT01037309|19281619|P9|COMPLETED|Intravenous Period 7 - 9||3
7833969|NCT01037309|19281620|P8|COMPLETED|Intravenous Period 7 - 9||3
7833970|NCT01037309|19281621|P7|COMPLETED|Intravenous Period 7 - 9||3
7833971|NCT01037309|19281622|P6|COMPLETED|Intravenous Period 7 - 9||0
7833972|NCT01037309|19281623|P5|COMPLETED|Intravenous Period 7 - 9||0
7833973|NCT01037309|19281624|P4|COMPLETED|Intravenous Period 7 - 9||0
7833974|NCT01037309|19281625|P3|COMPLETED|Intravenous Period 7 - 9||0
7833975|NCT01037309|19281626|P2|COMPLETED|Intravenous Period 7 - 9||0
7833976|NCT01037309|19281627|P1|COMPLETED|Intravenous Period 7 - 9||0
7833977|NCT01037309|19281619|P9|STARTED|Intravenous Period 7 - 9||3
7833978|NCT01037309|19281620|P8|STARTED|Intravenous Period 7 - 9||3
7833979|NCT01037309|19281621|P7|STARTED|Intravenous Period 7 - 9||3
7833980|NCT01037309|19281622|P6|STARTED|Intravenous Period 7 - 9||0
7833981|NCT01037309|19281623|P5|STARTED|Intravenous Period 7 - 9||0
7833982|NCT01037309|19281624|P4|STARTED|Intravenous Period 7 - 9||0
7833983|NCT01037309|19281625|P3|STARTED|Intravenous Period 7 - 9||0
7833984|NCT01037309|19281626|P2|STARTED|Intravenous Period 7 - 9||0
7833985|NCT01037309|19281627|P1|STARTED|Intravenous Period 7 - 9||0
7833986|NCT01037309|19281619|P9|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
7833987|NCT01037309|19281620|P8|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
7833988|NCT01037309|19281621|P7|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
7833989|NCT01037309|19281622|P6|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
7833990|NCT01037309|19281623|P5|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
7833991|NCT01037309|19281624|P4|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
7833992|NCT01037309|19281625|P3|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
7833993|NCT01037309|19281626|P2|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
7833994|NCT01037309|19281627|P1|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
7833995|NCT01037309|19281619|P9|COMPLETED|Subcutaneous Cohort 1 - 6||0
7833996|NCT01037309|19281620|P8|COMPLETED|Subcutaneous Cohort 1 - 6||0
7833997|NCT01037309|19281621|P7|COMPLETED|Subcutaneous Cohort 1 - 6||0
7833998|NCT01037309|19281622|P6|COMPLETED|Subcutaneous Cohort 1 - 6||3
7833999|NCT01037309|19281623|P5|COMPLETED|Subcutaneous Cohort 1 - 6||3
7834000|NCT01037309|19281624|P4|COMPLETED|Subcutaneous Cohort 1 - 6||3
7834001|NCT01037309|19281625|P3|COMPLETED|Subcutaneous Cohort 1 - 6||3
7834002|NCT01037309|19281626|P2|COMPLETED|Subcutaneous Cohort 1 - 6||3
7834003|NCT01037309|19281627|P1|COMPLETED|Subcutaneous Cohort 1 - 6||3
7834004|NCT01037309|19281619|P9|STARTED|Subcutaneous Cohort 1 - 6||0
7834005|NCT01037309|19281620|P8|STARTED|Subcutaneous Cohort 1 - 6||0
7834006|NCT01037309|19281621|P7|STARTED|Subcutaneous Cohort 1 - 6||0
7834007|NCT01037309|19281622|P6|STARTED|Subcutaneous Cohort 1 - 6||3
7834008|NCT01037309|19281623|P5|STARTED|Subcutaneous Cohort 1 - 6||3
7834009|NCT01037309|19281624|P4|STARTED|Subcutaneous Cohort 1 - 6||3
7834010|NCT01037309|19281625|P3|STARTED|Subcutaneous Cohort 1 - 6||3
7834011|NCT01037309|19281626|P2|STARTED|Subcutaneous Cohort 1 - 6||3
7834012|NCT01037309|19281627|P1|STARTED|Subcutaneous Cohort 1 - 6||3
7834013|NCT01037244|19281669|P4|NOT COMPLETED|Overall Study||14
7834014|NCT01037244|19281670|P3|NOT COMPLETED|Overall Study||14
7834015|NCT01037244|19281671|P2|NOT COMPLETED|Overall Study||14
7834016|NCT01037244|19281672|P1|NOT COMPLETED|Overall Study||13
7834017|NCT01037244|19281669|P4|COMPLETED|Overall Study||140
7834018|NCT01037244|19281670|P3|COMPLETED|Overall Study||144
7834019|NCT01037244|19281671|P2|COMPLETED|Overall Study||138
7834020|NCT01037244|19281672|P1|COMPLETED|Overall Study||141
7834021|NCT01037244|19281669|P4|Safety Population|Overall Study||152
7834022|NCT01037244|19281670|P3|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159
7834023|NCT01037244|19281671|P2|Safety Population|Overall Study||150
7834024|NCT01037244|19281672|P1|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155
7834025|NCT01037244|19281669|P4|mITT (Modified Intent-to-Treat)|Overall Study||153
7834026|NCT01037244|19281670|P3|mITT (Modified Intent-to-Treat)|Overall Study||154
7834027|NCT01037244|19281671|P2|mITT (Modified Intent-to-Treat)|Overall Study||148
7834028|NCT01037244|19281672|P1|mITT (Modified Intent-to-Treat)|Overall Study||150
7834029|NCT01037244|19281669|P4|STARTED|Overall Study||154
7834030|NCT01037244|19281670|P3|STARTED|Overall Study||158
7834031|NCT01037244|19281671|P2|STARTED|Overall Study||152
7834032|NCT01037244|19281672|P1|STARTED|Overall Study||154
7834033|NCT01037218|19281734|P4|NOT COMPLETED|Overall Study||16
7834034|NCT01037218|19281735|P3|NOT COMPLETED|Overall Study||21
7834035|NCT01037218|19281736|P2|NOT COMPLETED|Overall Study||21
7834036|NCT01037218|19281737|P1|NOT COMPLETED|Overall Study||16
7834037|NCT01037218|19281734|P4|COMPLETED|Overall Study||134
7834038|NCT01037218|19281735|P3|COMPLETED|Overall Study||134
7834039|NCT01037218|19281736|P2|COMPLETED|Overall Study||128
7834040|NCT01037218|19281737|P1|COMPLETED|Overall Study||131
7834041|NCT01037218|19281734|P4|mITT Population|Overall Study||141
7834042|NCT01037218|19281735|P3|mITT Population|Overall Study||147
7834043|NCT01037218|19281736|P2|mITT Population|Overall Study||140
7834044|NCT01037218|19281737|P1|mITT Population|Overall Study||141
7834045|NCT01037218|19281734|P4|Safety Population|Overall Study||150
7834046|NCT01037218|19281735|P3|Safety Population|Overall Study||154
7834047|NCT01037218|19281736|P2|Safety Population|Overall Study||148
7834048|NCT01037218|19281737|P1|Safety Population|Overall Study||147
7834049|NCT01037218|19281734|P4|STARTED|Overall Study||150
7834050|NCT01037218|19281735|P3|STARTED|Overall Study||155
7834051|NCT01037218|19281736|P2|STARTED|Overall Study||149
7834052|NCT01037218|19281737|P1|STARTED|Overall Study||147
7834053|NCT01037192|19281797|P2|NOT COMPLETED|Overall Study||0
7834054|NCT01037192|19281798|P1|NOT COMPLETED|Overall Study||0
7834055|NCT01037192|19281797|P2|COMPLETED|Overall Study||1
7834056|NCT01037192|19281798|P1|COMPLETED|Overall Study||3
7834057|NCT01037192|19281797|P2|STARTED|Overall Study||1
7834058|NCT01037192|19281798|P1|STARTED|Overall Study||3
7834059|NCT01037127|19281808|P2|NOT COMPLETED|Overall Study||21
7834060|NCT01037127|19281809|P1|NOT COMPLETED|Overall Study||5
7834061|NCT01037127|19281808|P2|COMPLETED|Overall Study||36
7834062|NCT01037127|19281809|P1|COMPLETED|Overall Study||35
7834063|NCT01037127|19281808|P2|STARTED|Overall Study||57
7834064|NCT01037127|19281809|P1|STARTED|Overall Study||40
7834065|NCT01037114|19281841|P1|NOT COMPLETED|Year 20||1
7834066|NCT01037114|19281841|P1|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44
7834067|NCT01037114|19281841|P1|STARTED|Year 20||45
7834068|NCT01037114|19281841|P1|NOT COMPLETED|Year 19||0
7834069|NCT01037114|19281841|P1|COMPLETED|Year 19||45
7834070|NCT01037114|19281841|P1|STARTED|Year 19||45
7834071|NCT01037114|19281841|P1|NOT COMPLETED|Year 18||0
7834072|NCT01037114|19281841|P1|COMPLETED|Year 18||44
7834073|NCT01037114|19281841|P1|STARTED|Year 18||44
7834074|NCT01037114|19281841|P1|NOT COMPLETED|Year 17||0
7834075|NCT01037114|19281841|P1|COMPLETED|Year 17||48
7834076|NCT01037114|19281841|P1|STARTED|Year 17||48
7834077|NCT01037114|19281841|P1|NOT COMPLETED|Year 16||0
7834078|NCT01037114|19281841|P1|COMPLETED|Year 16||49
7834079|NCT01037114|19281841|P1|STARTED|Year 16||49
7834080|NCT01037088|19281854|P1|NOT COMPLETED|Overall Study||3
7834081|NCT01037088|19281854|P1|COMPLETED|Overall Study||36
7834082|NCT01037088|19281854|P1|Received Placebo|Overall Study||38
7834083|NCT01037088|19281854|P1|Received 1.29% THC|Overall Study||37
7834084|NCT01037088|19281854|P1|Received 3.53% THC|Overall Study||36
7834085|NCT01037088|19281854|P1|STARTED|Overall Study||39
7834086|NCT01036802|19281867|P2|NOT COMPLETED|Overall Study||0
7834087|NCT01036802|19281868|P1|NOT COMPLETED|Overall Study||0
7834088|NCT01036802|19281867|P2|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1
7834089|NCT01036802|19281868|P1|COMPLETED|Overall Study||2
7834090|NCT01036802|19281867|P2|STARTED|Overall Study||1
7834091|NCT01036802|19281868|P1|STARTED|Overall Study||2
7834092|NCT01036763|19281886|P1|NOT COMPLETED|Overall Study||93
7834093|NCT01036763|19281886|P1|COMPLETED|Overall Study||1171
7834094|NCT01036763|19281886|P1|STARTED|Overall Study||1264
7834095|NCT01036724|19281898|P2|NOT COMPLETED|Overall Study||8
7834096|NCT01036724|19281899|P1|NOT COMPLETED|Overall Study||6
7834097|NCT01036724|19281898|P2|COMPLETED|Overall Study||47
7834098|NCT01036724|19281899|P1|COMPLETED|Overall Study||46
7834099|NCT01036724|19281898|P2|STARTED|Overall Study||55
7834100|NCT01036724|19281899|P1|STARTED|Overall Study||52
7834101|NCT01036594|19281907|P2|NOT COMPLETED|Treatment Regiments Post Week 12||4
7834102|NCT01036594|19281908|P1|NOT COMPLETED|Treatment Regiments Post Week 12||2
7834103|NCT01036594|19281907|P2|COMPLETED|Treatment Regiments Post Week 12||5
7834104|NCT01036594|19281908|P1|COMPLETED|Treatment Regiments Post Week 12||13
7834105|NCT01036594|19281907|P2|STARTED|Treatment Regiments Post Week 12||9
7834106|NCT01036594|19281908|P1|STARTED|Treatment Regiments Post Week 12||15
7834107|NCT01036594|19281907|P2|NOT COMPLETED|Week 12 Evaluation||0
7834108|NCT01036594|19281908|P1|NOT COMPLETED|Week 12 Evaluation||6
7834109|NCT01036594|19281907|P2|COMPLETED|Week 12 Evaluation||0
7834110|NCT01036594|19281908|P1|COMPLETED|Week 12 Evaluation||24
7834111|NCT01036594|19281907|P2|STARTED|Week 12 Evaluation|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
7834112|NCT01036594|19281908|P1|STARTED|Week 12 Evaluation||30
7834113|NCT01036594|19281907|P2|NOT COMPLETED|First Treatment Regimen||0
7834114|NCT01036594|19281908|P1|NOT COMPLETED|First Treatment Regimen||1
7834115|NCT01036594|19281907|P2|COMPLETED|First Treatment Regimen||0
7834116|NCT01036594|19281908|P1|COMPLETED|First Treatment Regimen||30
7834117|NCT01036594|19281907|P2|STARTED|First Treatment Regimen|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
7834118|NCT01036594|19281908|P1|STARTED|First Treatment Regimen||31
7834119|NCT01036594|19281907|P2|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
7834120|NCT01036594|19281908|P1|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||1
7834121|NCT01036594|19281907|P2|COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
7834122|NCT01036594|19281908|P1|COMPLETED|Run-In: Ketoconazole Only (200 mg)||31
7834123|NCT01036594|19281907|P2|STARTED|Run-In: Ketoconazole Only (200 mg)|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
7834124|NCT01036594|19281908|P1|STARTED|Run-In: Ketoconazole Only (200 mg)||32
7834125|NCT01036529|19281932|P2|NOT COMPLETED|Overall Study||15
7834126|NCT01036529|19281933|P1|NOT COMPLETED|Overall Study||13
7834127|NCT01036529|19281932|P2|COMPLETED|Overall Study||0
7834128|NCT01036529|19281933|P1|COMPLETED|Overall Study||0
7834129|NCT01036529|19281932|P2|Crossover to Other Group|Overall Study||1
7834130|NCT01036529|19281933|P1|Crossover to Other Group|Overall Study||1
7834131|NCT01036529|19281932|P2|Requested Crossover|Overall Study||2
7834132|NCT01036529|19281933|P1|Requested Crossover|Overall Study||1
7834133|NCT01036529|19281932|P2|12 Month Follow-up|Overall Study||3
7834134|NCT01036529|19281933|P1|12 Month Follow-up|Overall Study||4
7834135|NCT01036529|19281932|P2|6 Month Follow-up|Overall Study||7
7834136|NCT01036529|19281933|P1|6 Month Follow-up|Overall Study||6
7834137|NCT01036529|19281932|P2|3 Month Follow-up|Overall Study||9
7834138|NCT01036529|19281933|P1|3 Month Follow-up|Overall Study||7
7834139|NCT01036529|19281932|P2|Index Procedure|Overall Study|Index Procedure: Surgery|11
7834140|NCT01036529|19281933|P1|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10
7834141|NCT01036529|19281932|P2|Baseline Visit|Overall Study||13
7834142|NCT01036529|19281933|P1|Baseline Visit|Overall Study||10
7834143|NCT01036529|19281932|P2|STARTED|Overall Study||15
7834144|NCT01036529|19281933|P1|STARTED|Overall Study||13
7834145|NCT01036490|19281941|P2|NOT COMPLETED|Overall Study||0
7834146|NCT01036490|19281942|P1|NOT COMPLETED|Overall Study||4
7834147|NCT01036490|19281941|P2|COMPLETED|Overall Study||18
7834148|NCT01036490|19281942|P1|COMPLETED|Overall Study||14
7834149|NCT01036490|19281941|P2|STARTED|Overall Study||18
7834150|NCT01036490|19281942|P1|STARTED|Overall Study||18
7834151|NCT01036438|19281960|P2|NOT COMPLETED|Overall Study||10
7834152|NCT01036438|19281961|P1|NOT COMPLETED|Overall Study||10
7834153|NCT01036438|19281960|P2|COMPLETED|Overall Study||90
7834154|NCT01036438|19281961|P1|COMPLETED|Overall Study||91
7834155|NCT01036438|19281960|P2|STARTED|Overall Study||100
7834156|NCT01036438|19281961|P1|STARTED|Overall Study||101
7834157|NCT01036321|19281969|P2|NOT COMPLETED|Overall Study||4
7834158|NCT01036321|19281970|P1|NOT COMPLETED|Overall Study||5
7834159|NCT01036321|19281969|P2|COMPLETED|Overall Study||31
7834160|NCT01036321|19281970|P1|COMPLETED|Overall Study||31
7834161|NCT01036321|19281969|P2|STARTED|Overall Study||35
7834162|NCT01036321|19281970|P1|STARTED|Overall Study||36
7834163|NCT01036165|19281994|P1|NOT COMPLETED|Overall Study||15
7834164|NCT01036165|19281994|P1|COMPLETED|Overall Study||88
7834165|NCT01036165|19281994|P1|STARTED|Overall Study||103
7834166|NCT01036022|19282005|P6|NOT COMPLETED|Overall Study||3
7834167|NCT01036022|19282006|P5|NOT COMPLETED|Overall Study||3
7834168|NCT01036022|19282007|P4|NOT COMPLETED|Overall Study||2
7834169|NCT01036022|19282008|P3|NOT COMPLETED|Overall Study||4
7834170|NCT01036022|19282009|P2|NOT COMPLETED|Overall Study||4
7834171|NCT01036022|19282010|P1|NOT COMPLETED|Overall Study||2
7834172|NCT01036022|19282005|P6|COMPLETED|Overall Study||13
7834173|NCT01036022|19282006|P5|COMPLETED|Overall Study||9
7834174|NCT01036022|19282007|P4|COMPLETED|Overall Study||10
7834175|NCT01036022|19282008|P3|COMPLETED|Overall Study||8
7834176|NCT01036022|19282009|P2|COMPLETED|Overall Study||7
7834177|NCT01036022|19282010|P1|COMPLETED|Overall Study||13
7834178|NCT01036022|19282005|P6|STARTED|Overall Study||16
7834179|NCT01036022|19282006|P5|STARTED|Overall Study||12
7834180|NCT01036022|19282007|P4|STARTED|Overall Study||12
7834181|NCT01036022|19282008|P3|STARTED|Overall Study||12
7834182|NCT01036022|19282009|P2|STARTED|Overall Study||11
7834183|NCT01036022|19282010|P1|STARTED|Overall Study||15
7834184|NCT01036009|19282112|P2|NOT COMPLETED|Overall Study||0
7834185|NCT01036009|19282113|P1|NOT COMPLETED|Overall Study||0
7834186|NCT01036009|19282112|P2|COMPLETED|Overall Study||26
7834187|NCT01036009|19282113|P1|COMPLETED|Overall Study||17
7834188|NCT01036009|19282112|P2|STARTED|Overall Study||26
7834189|NCT01036009|19282113|P1|STARTED|Overall Study||17
7834190|NCT01035944|19282131|P4|NOT COMPLETED|Overall Study||0
7834191|NCT01035944|19282132|P3|NOT COMPLETED|Overall Study||1
7834192|NCT01035944|19282133|P2|NOT COMPLETED|Overall Study||1
7834193|NCT01035944|19282134|P1|NOT COMPLETED|Overall Study||3
7834194|NCT01035944|19282131|P4|COMPLETED|Overall Study||4
7834195|NCT01035944|19282132|P3|COMPLETED|Overall Study||4
7834196|NCT01035944|19282133|P2|COMPLETED|Overall Study||13
7834197|NCT01035944|19282134|P1|COMPLETED|Overall Study||11
7834198|NCT01035944|19282131|P4|STARTED|Overall Study||4
7834199|NCT01035944|19282132|P3|STARTED|Overall Study||5
7834200|NCT01035944|19282133|P2|STARTED|Overall Study||14
7834201|NCT01035944|19282134|P1|STARTED|Overall Study||14
7834202|NCT01035905|19282146|P2|NOT COMPLETED|Overall Study||1
7834203|NCT01035905|19282147|P1|NOT COMPLETED|Overall Study||1
7834204|NCT01035905|19282146|P2|COMPLETED|Overall Study||30
7834205|NCT01035905|19282147|P1|COMPLETED|Overall Study||31
7834206|NCT01035905|19282146|P2|STARTED|Overall Study||31
7834207|NCT01035905|19282147|P1|STARTED|Overall Study||32
7834208|NCT01035788|19282155|P2|NOT COMPLETED|Overall Study||14
7834209|NCT01035788|19282156|P1|NOT COMPLETED|Overall Study||6
7834210|NCT01035788|19282155|P2|COMPLETED|Overall Study||9
7834211|NCT01035788|19282156|P1|COMPLETED|Overall Study||17
7834212|NCT01035788|19282155|P2|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
7834213|NCT01035788|19282156|P1|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
7834214|NCT01035749|19282166|P4|NOT COMPLETED|Overall Study||0
7834215|NCT01035749|19282167|P3|NOT COMPLETED|Overall Study||0
7834216|NCT01035749|19282168|P2|NOT COMPLETED|Overall Study||0
7834217|NCT01035749|19282169|P1|NOT COMPLETED|Overall Study||0
7834218|NCT01035749|19282166|P4|COMPLETED|Overall Study||110
7834219|NCT01035749|19282167|P3|COMPLETED|Overall Study||68
7834220|NCT01035749|19282168|P2|COMPLETED|Overall Study||66
7834221|NCT01035749|19282169|P1|COMPLETED|Overall Study||66
7834222|NCT01035749|19282166|P4|STARTED|Overall Study||110
7834223|NCT01035749|19282167|P3|STARTED|Overall Study||68
7834224|NCT01035749|19282168|P2|STARTED|Overall Study||66
7834225|NCT01035749|19282169|P1|STARTED|Overall Study||66
7834226|NCT01035658|19282291|P4|NOT COMPLETED|Overall Study||0
7834227|NCT01035658|19282292|P3|NOT COMPLETED|Overall Study||0
7834228|NCT01035658|19282293|P2|NOT COMPLETED|Overall Study||0
7834229|NCT01035658|19282294|P1|NOT COMPLETED|Overall Study||0
7834230|NCT01035658|19282291|P4|COMPLETED|Overall Study||6
7834231|NCT01035658|19282292|P3|COMPLETED|Overall Study||3
7834232|NCT01035658|19282293|P2|COMPLETED|Overall Study||8
7834233|NCT01035658|19282294|P1|COMPLETED|Overall Study||5
7834234|NCT01035658|19282291|P4|STARTED|Overall Study||6
7834235|NCT01035658|19282292|P3|STARTED|Overall Study||3
7834236|NCT01035658|19282293|P2|STARTED|Overall Study||8
7834237|NCT01035658|19282294|P1|STARTED|Overall Study||5
7834238|NCT01035606|19282320|P3|NOT COMPLETED|Overall Study||4
7834239|NCT01035606|19282321|P2|NOT COMPLETED|Overall Study||3
7834240|NCT01035606|19282322|P1|NOT COMPLETED|Overall Study||3
7834241|NCT01035606|19282320|P3|COMPLETED|Overall Study||7
7834242|NCT01035606|19282321|P2|COMPLETED|Overall Study||16
7834243|NCT01035606|19282322|P1|COMPLETED|Overall Study||16
7834244|NCT01035606|19282320|P3|STARTED|Overall Study||11
7834245|NCT01035606|19282321|P2|STARTED|Overall Study||19
7834246|NCT01035606|19282322|P1|STARTED|Overall Study||19
7834247|NCT01035463|19282338|P6|NOT COMPLETED|Overall Study||18
7834248|NCT01035463|19282339|P5|NOT COMPLETED|Overall Study||6
7834249|NCT01035463|19282340|P4|NOT COMPLETED|Overall Study||2
7834250|NCT01035463|19282341|P3|NOT COMPLETED|Overall Study||5
7834251|NCT01035463|19282342|P2|NOT COMPLETED|Overall Study||2
7834252|NCT01035463|19282343|P1|NOT COMPLETED|Overall Study||0
7834253|NCT01035463|19282338|P6|COMPLETED|Overall Study||15
7834254|NCT01035463|19282339|P5|COMPLETED|Overall Study||1
7834255|NCT01035463|19282340|P4|COMPLETED|Overall Study||2
7834256|NCT01035463|19282341|P3|COMPLETED|Overall Study||1
7834257|NCT01035463|19282342|P2|COMPLETED|Overall Study||1
7834258|NCT01035463|19282343|P1|COMPLETED|Overall Study||6
7834259|NCT01035463|19282338|P6|STARTED|Overall Study||33
7834260|NCT01035463|19282339|P5|STARTED|Overall Study||7
7834261|NCT01035463|19282340|P4|STARTED|Overall Study||4
7834262|NCT01035463|19282341|P3|STARTED|Overall Study||6
7834263|NCT01035463|19282342|P2|STARTED|Overall Study||3
7834264|NCT01035463|19282343|P1|STARTED|Overall Study||6
7834265|NCT01035346|19282354|P2|NOT COMPLETED|Overall Study||0
7834266|NCT01035346|19282355|P1|NOT COMPLETED|Overall Study||0
7834267|NCT01035346|19282354|P2|COMPLETED|Overall Study||9
7834268|NCT01035346|19282355|P1|COMPLETED|Overall Study||7
7834269|NCT01035346|19282354|P2|STARTED|Overall Study||9
7834270|NCT01035346|19282355|P1|STARTED|Overall Study||7
7834271|NCT01035333|19282373|P1|NOT COMPLETED|Overall Study||10
7834272|NCT01035333|19282373|P1|COMPLETED|Overall Study||9
7834273|NCT01035333|19282373|P1|STARTED|Overall Study||19
7834274|NCT01035255|19282380|P2|NOT COMPLETED|Overall Study||862
7834275|NCT01035255|19282381|P1|NOT COMPLETED|Overall Study||741
7834276|NCT01035255|19282380|P2|COMPLETED|Overall Study||3371
7834277|NCT01035255|19282381|P1|COMPLETED|Overall Study||3468
7834278|NCT01035255|19282380|P2|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212
7834279|NCT01035255|19282381|P1|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187
7834280|NCT01035255|19282380|P2|Mis-randomized|Overall Study||2
7834281|NCT01035255|19282381|P1|Mis-randomized|Overall Study||4
7834282|NCT01035255|19282380|P2|GCP Violations|Overall Study||19
7834283|NCT01035255|19282381|P1|GCP Violations|Overall Study||18
7834284|NCT01035255|19282380|P2|STARTED|Overall Study||4233
7834285|NCT01035255|19282381|P1|STARTED|Overall Study||4209
7834286|NCT01035229|19282399|P2|NOT COMPLETED|Overall Study||184
7834287|NCT01035229|19282400|P1|NOT COMPLETED|Overall Study||362
7834288|NCT01035229|19282399|P2|COMPLETED|Overall Study||0
7834289|NCT01035229|19282400|P1|COMPLETED|Overall Study||0
7834290|NCT01035229|19282399|P2|STARTED|Overall Study||184
7834291|NCT01035229|19282400|P1|STARTED|Overall Study||362
7834292|NCT01035151|19282420|P2|NOT COMPLETED|Overall Study||15
7834293|NCT01035151|19282421|P1|NOT COMPLETED|Overall Study||21
7834294|NCT01035151|19282420|P2|COMPLETED|Overall Study||185
7834295|NCT01035151|19282421|P1|COMPLETED|Overall Study||188
7834296|NCT01035151|19282420|P2|STARTED|Overall Study||200
7834297|NCT01035151|19282421|P1|STARTED|Overall Study||209
7834298|NCT01035138|19282430|P3|NOT COMPLETED|Overall Study||47
7834299|NCT01035138|19282431|P2|NOT COMPLETED|Overall Study||60
7834300|NCT01035138|19282432|P1|NOT COMPLETED|Overall Study||73
7834301|NCT01035138|19282430|P3|COMPLETED|Overall Study||0
7834302|NCT01035138|19282431|P2|COMPLETED|Overall Study||0
7834303|NCT01035138|19282432|P1|COMPLETED|Overall Study||0
7834304|NCT01035138|19282430|P3|STARTED|Overall Study||47
7834305|NCT01035138|19282431|P2|STARTED|Overall Study||60
7834306|NCT01035138|19282432|P1|STARTED|Overall Study||73
7834307|NCT01035099|19282488|P2|NOT COMPLETED|Overall Study||0
7834308|NCT01035099|19282489|P1|NOT COMPLETED|Overall Study||0
7834309|NCT01035099|19282488|P2|COMPLETED|Overall Study||22
7834310|NCT01035099|19282489|P1|COMPLETED|Overall Study||18
7834311|NCT01035099|19282488|P2|STARTED|Overall Study||22
7834312|NCT01035099|19282489|P1|STARTED|Overall Study||18
7834313|NCT01035073|19282525|P1|NOT COMPLETED|Overall Study||0
7834314|NCT01035073|19282525|P1|COMPLETED|Overall Study||0
7834315|NCT01035073|19282525|P1|STARTED|Overall Study||0
7834316|NCT01035060|19282532|P2|NOT COMPLETED|Overall Study||14
7834317|NCT01035060|19282533|P1|NOT COMPLETED|Overall Study||24
7834318|NCT01035060|19282532|P2|COMPLETED|Overall Study||15
7834319|NCT01035060|19282533|P1|COMPLETED|Overall Study||15
7834320|NCT01035060|19282532|P2|STARTED|Overall Study||29
7834321|NCT01035060|19282533|P1|STARTED|Overall Study||39
7834322|NCT01035047|19282541|P2|NOT COMPLETED|Overall Study||0
7834323|NCT01035047|19282542|P1|NOT COMPLETED|Overall Study||0
7834324|NCT01035047|19282541|P2|COMPLETED|Overall Study||53
7834325|NCT01035047|19282542|P1|COMPLETED|Overall Study||52
7834326|NCT01035047|19282541|P2|STARTED|Overall Study||53
7834327|NCT01035047|19282542|P1|STARTED|Overall Study||52
7834328|NCT01034709|19282558|P2|NOT COMPLETED|Overall Study||16
7834329|NCT01034709|19282559|P1|NOT COMPLETED|Overall Study||9
7834330|NCT01034709|19282558|P2|COMPLETED|Overall Study||42
7834331|NCT01034709|19282559|P1|COMPLETED|Overall Study||44
7834332|NCT01034709|19282558|P2|STARTED|Overall Study||58
7834333|NCT01034709|19282559|P1|STARTED|Overall Study||53
7834334|NCT01034657|19282565|P3|NOT COMPLETED|Randomized Phase||1
7834335|NCT01034657|19282566|P2|NOT COMPLETED|Randomized Phase||6
7834336|NCT01034657|19282567|P1|NOT COMPLETED|Randomized Phase||5
7834337|NCT01034657|19282565|P3|COMPLETED|Randomized Phase||0
7834338|NCT01034657|19282566|P2|COMPLETED|Randomized Phase||0
7834339|NCT01034657|19282567|P1|COMPLETED|Randomized Phase||1
7834340|NCT01034657|19282565|P3|STARTED|Randomized Phase||1
7834341|NCT01034657|19282566|P2|STARTED|Randomized Phase||6
7834342|NCT01034657|19282567|P1|STARTED|Randomized Phase||6
7834343|NCT01034657|19282565|P3|NOT COMPLETED|Core Phase||0
7834344|NCT01034657|19282566|P2|NOT COMPLETED|Core Phase||0
7834345|NCT01034657|19282567|P1|NOT COMPLETED|Core Phase||14
7834346|NCT01034657|19282565|P3|COMPLETED|Core Phase||0
7834347|NCT01034657|19282566|P2|COMPLETED|Core Phase||0
7834348|NCT01034657|19282567|P1|COMPLETED|Core Phase||20
7834349|NCT01034657|19282565|P3|STARTED|Core Phase||0
7834350|NCT01034657|19282566|P2|STARTED|Core Phase||0
7834351|NCT01034657|19282567|P1|STARTED|Core Phase||34
7834352|NCT01034631|19282608|P3|NOT COMPLETED|Phase II||2
7834353|NCT01034631|19282609|P2|NOT COMPLETED|Phase II||1
7834354|NCT01034631|19282610|P1|NOT COMPLETED|Phase II||0
7834355|NCT01034631|19282608|P3|COMPLETED|Phase II||67
7834356|NCT01034631|19282609|P2|COMPLETED|Phase II||69
7834357|NCT01034631|19282610|P1|COMPLETED|Phase II||0
7834358|NCT01034631|19282608|P3|STARTED|Phase II||69
7834359|NCT01034631|19282609|P2|STARTED|Phase II||70
7834360|NCT01034631|19282610|P1|STARTED|Phase II|No Phase I Participants were enrolled during this time period.|0
7834361|NCT01034631|19282608|P3|NOT COMPLETED|Phase I||0
7834362|NCT01034631|19282609|P2|NOT COMPLETED|Phase I||0
7834363|NCT01034631|19282610|P1|NOT COMPLETED|Phase I||3
7834364|NCT01034631|19282608|P3|COMPLETED|Phase I||0
7834365|NCT01034631|19282609|P2|COMPLETED|Phase I||0
7834366|NCT01034631|19282610|P1|COMPLETED|Phase I||12
7834367|NCT01034631|19282608|P3|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
7834368|NCT01034631|19282609|P2|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
7834369|NCT01034631|19282610|P1|STARTED|Phase I||15
7834370|NCT01034592|19282629|P1|NOT COMPLETED|Overall Study||0
7834371|NCT01034592|19282629|P1|COMPLETED|Overall Study||2
7834372|NCT01034592|19282629|P1|STARTED|Overall Study||2
7834373|NCT01034579|19282641|P2|NOT COMPLETED|Overall Study||0
7834374|NCT01034579|19282642|P1|NOT COMPLETED|Overall Study||0
7834375|NCT01034579|19282641|P2|COMPLETED|Overall Study||166
7834376|NCT01034579|19282642|P1|COMPLETED|Overall Study||158
7834377|NCT01034579|19282641|P2|STARTED|Overall Study||166
7834378|NCT01034579|19282642|P1|STARTED|Overall Study||158
7834379|NCT01034553|19282656|P6|NOT COMPLETED|Overall Study||0
7834380|NCT01034553|19282657|P5|NOT COMPLETED|Overall Study||0
7834381|NCT01034553|19282658|P4|NOT COMPLETED|Overall Study||0
7834382|NCT01034553|19282659|P3|NOT COMPLETED|Overall Study||0
7834383|NCT01034553|19282660|P2|NOT COMPLETED|Overall Study||0
7834384|NCT01034553|19282661|P1|NOT COMPLETED|Overall Study||0
7834385|NCT01034553|19282656|P6|COMPLETED|Overall Study||7
7834386|NCT01034553|19282657|P5|COMPLETED|Overall Study||6
7834387|NCT01034553|19282658|P4|COMPLETED|Overall Study||3
7834388|NCT01034553|19282659|P3|COMPLETED|Overall Study||3
7834389|NCT01034553|19282660|P2|COMPLETED|Overall Study||4
7834390|NCT01034553|19282661|P1|COMPLETED|Overall Study||3
7834391|NCT01034553|19282656|P6|STARTED|Overall Study||7
7834392|NCT01034553|19282657|P5|STARTED|Overall Study||6
7834393|NCT01034553|19282658|P4|STARTED|Overall Study||3
7834394|NCT01034553|19282659|P3|STARTED|Overall Study||3
7834395|NCT01034553|19282660|P2|STARTED|Overall Study||4
7834396|NCT01034553|19282661|P1|STARTED|Overall Study||3
7834397|NCT01034540|19282677|P2|NOT COMPLETED|Overall Study||1
7834398|NCT01034540|19282678|P1|NOT COMPLETED|Overall Study||0
7834399|NCT01034540|19282677|P2|COMPLETED|Overall Study||11
7834400|NCT01034540|19282678|P1|COMPLETED|Overall Study||11
7834401|NCT01034540|19282677|P2|Completed 1st Treatment Intervention|Overall Study||11
7834402|NCT01034540|19282678|P1|Completed 1st Treatment Intervention|Overall Study||11
7834403|NCT01034540|19282677|P2|STARTED|Overall Study||12
7834404|NCT01034540|19282678|P1|STARTED|Overall Study||11
7834405|NCT01034527|19282688|P2|NOT COMPLETED|Overall Study||0
7834406|NCT01034527|19282689|P1|NOT COMPLETED|Overall Study||0
7834407|NCT01034527|19282688|P2|COMPLETED|Overall Study||216
7834408|NCT01034527|19282689|P1|COMPLETED|Overall Study||307
7834409|NCT01034527|19282688|P2|STARTED|Overall Study||216
7834410|NCT01034527|19282689|P1|STARTED|Overall Study||307
7834411|NCT01034462|19282697|P2|NOT COMPLETED|Overall Study||54
7834412|NCT01034462|19282698|P1|NOT COMPLETED|Overall Study||45
7834413|NCT01034462|19282697|P2|COMPLETED|Overall Study||163
7834414|NCT01034462|19282698|P1|COMPLETED|Overall Study||172
7834415|NCT01034462|19282697|P2|STARTED|Overall Study||217
7834416|NCT01034462|19282698|P1|STARTED|Overall Study||217
7834417|NCT01034397|19282708|P2|NOT COMPLETED|Overall Study||2
7834418|NCT01034397|19282709|P1|NOT COMPLETED|Overall Study||7
7834419|NCT01034397|19282708|P2|COMPLETED|Overall Study||17
7834420|NCT01034397|19282709|P1|COMPLETED|Overall Study||28
7834421|NCT01034397|19282708|P2|STARTED|Overall Study||19
7834422|NCT01034397|19282709|P1|STARTED|Overall Study||35
7834423|NCT01034358|19282858|P1|NOT COMPLETED|Overall Study||2
7834424|NCT01034358|19282858|P1|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13
7834425|NCT01034358|19282858|P1|STARTED|Overall Study||15
7834426|NCT01034306|19282864|P2|NOT COMPLETED|Overall Study||3
7834427|NCT01034306|19282865|P1|NOT COMPLETED|Overall Study||5
7834428|NCT01034306|19282864|P2|COMPLETED|Overall Study||34
7834429|NCT01034306|19282865|P1|COMPLETED|Overall Study||37
7834430|NCT01034306|19282864|P2|STARTED|Overall Study||37
7834431|NCT01034306|19282865|P1|STARTED|Overall Study||42
7834432|NCT01034176|19282873|P2|NOT COMPLETED|Overall Study||2
7834433|NCT01034176|19282874|P1|NOT COMPLETED|Overall Study||2
7834434|NCT01034176|19282873|P2|COMPLETED|Overall Study||19
7834435|NCT01034176|19282874|P1|COMPLETED|Overall Study||20
7834436|NCT01034176|19282873|P2|STARTED|Overall Study||21
7834437|NCT01034176|19282874|P1|STARTED|Overall Study||22
7834438|NCT01034163|19282884|P2|NOT COMPLETED|Overall Study||14
7834439|NCT01034163|19282885|P1|NOT COMPLETED|Overall Study||27
7834440|NCT01034163|19282884|P2|COMPLETED|Overall Study||0
7834441|NCT01034163|19282885|P1|COMPLETED|Overall Study||0
7834442|NCT01034163|19282884|P2|In Open Label Phase After Unblinding|Overall Study||0
7834443|NCT01034163|19282885|P1|In Open Label Phase After Unblinding|Overall Study||5
7834444|NCT01034163|19282884|P2|Safety Set|Overall Study||12
7834445|NCT01034163|19282885|P1|Safety Set|Overall Study||26
7834446|NCT01034163|19282884|P2|Untreated (Not in Safety Set)|Overall Study||2
7834447|NCT01034163|19282885|P1|Untreated (Not in Safety Set)|Overall Study||1
7834448|NCT01034163|19282884|P2|STARTED|Overall Study||14
7834449|NCT01034163|19282885|P1|STARTED|Overall Study||27
7834450|NCT01034137|19282894|P3|NOT COMPLETED|Overall Study||30
7834451|NCT01034137|19282895|P2|NOT COMPLETED|Overall Study||22
7834452|NCT01034137|19282896|P1|NOT COMPLETED|Overall Study||28
7834453|NCT01034137|19282894|P3|COMPLETED|Overall Study||78
7834454|NCT01034137|19282895|P2|COMPLETED|Overall Study||81
7834455|NCT01034137|19282896|P1|COMPLETED|Overall Study||78
7834456|NCT01034137|19282894|P3|STARTED|Overall Study||108
7834457|NCT01034137|19282895|P2|STARTED|Overall Study||103
7834458|NCT01034137|19282896|P1|STARTED|Overall Study||106
7834459|NCT01034111|19283027|P1|NOT COMPLETED|Overall Study||0
7834460|NCT01034111|19283027|P1|COMPLETED|Overall Study||30
7834461|NCT01034111|19283027|P1|STARTED|Overall Study||30
7834462|NCT01033942|19283035|P3|NOT COMPLETED|Overall Study||1
7834463|NCT01033942|19283036|P2|NOT COMPLETED|Overall Study||4
7834464|NCT01033942|19283037|P1|NOT COMPLETED|Overall Study||2
7834465|NCT01033942|19283035|P3|COMPLETED|Overall Study||18
7834466|NCT01033942|19283036|P2|COMPLETED|Overall Study||15
7834467|NCT01033942|19283037|P1|COMPLETED|Overall Study||18
7834468|NCT01033942|19283035|P3|STARTED|Overall Study||19
7834469|NCT01033942|19283036|P2|STARTED|Overall Study||19
7834470|NCT01033942|19283037|P1|STARTED|Overall Study||20
7834471|NCT01033864|19283309|P2|NOT COMPLETED|Overall Study||0
7834472|NCT01033864|19283310|P1|NOT COMPLETED|Overall Study||0
7834473|NCT01033864|19283309|P2|COMPLETED|Overall Study||11
7834474|NCT01033864|19283310|P1|COMPLETED|Overall Study||12
7834475|NCT01033864|19283309|P2|STARTED|Overall Study||11
7834476|NCT01033864|19283310|P1|STARTED|Overall Study||12
7834477|NCT01033851|19283335|P2|NOT COMPLETED|Overall Study||7
7834478|NCT01033851|19283336|P1|NOT COMPLETED|Overall Study||3
7834479|NCT01033851|19283335|P2|COMPLETED|Overall Study||34
7834480|NCT01033851|19283336|P1|COMPLETED|Overall Study||45
7834481|NCT01033851|19283335|P2|STARTED|Overall Study||41
7834482|NCT01033851|19283336|P1|STARTED|Overall Study||48
7834483|NCT01033825|19283351|P7|NOT COMPLETED|Overall Study||0
7834484|NCT01033825|19283352|P6|NOT COMPLETED|Overall Study||0
7834485|NCT01033825|19283353|P5|NOT COMPLETED|Overall Study||2
7834486|NCT01033825|19283354|P4|NOT COMPLETED|Overall Study||2
7834487|NCT01033825|19283355|P3|NOT COMPLETED|Overall Study||2
7834488|NCT01033825|19283356|P2|NOT COMPLETED|Overall Study||3
7834489|NCT01033825|19283357|P1|NOT COMPLETED|Overall Study||3
7834490|NCT01033825|19283351|P7|COMPLETED|Overall Study||18
7834491|NCT01033825|19283352|P6|COMPLETED|Overall Study||18
7834492|NCT01033825|19283353|P5|COMPLETED|Overall Study||56
7834493|NCT01033825|19283354|P4|COMPLETED|Overall Study||46
7834494|NCT01033825|19283355|P3|COMPLETED|Overall Study||55
7834495|NCT01033825|19283356|P2|COMPLETED|Overall Study||57
7834496|NCT01033825|19283357|P1|COMPLETED|Overall Study||48
7834497|NCT01033825|19283351|P7|STARTED|Overall Study||18
7834498|NCT01033825|19283352|P6|STARTED|Overall Study||18
7834499|NCT01033825|19283353|P5|STARTED|Overall Study||58
7834500|NCT01033825|19283354|P4|STARTED|Overall Study||48
7834501|NCT01033825|19283355|P3|STARTED|Overall Study||57
7834502|NCT01033825|19283356|P2|STARTED|Overall Study||60
7834503|NCT01033825|19283357|P1|STARTED|Overall Study||51
7834504|NCT01033773|19283576|P1|NOT COMPLETED|Overall Study||35
7834505|NCT01033773|19283576|P1|COMPLETED|Overall Study||51
7834506|NCT01033773|19283576|P1|STARTED|Overall Study||86
7834507|NCT01033747|19283584|P2|NOT COMPLETED|Overall Study||15
7834508|NCT01033747|19283585|P1|NOT COMPLETED|Overall Study||37
7834509|NCT01033747|19283584|P2|COMPLETED|Overall Study||4
7834510|NCT01033747|19283585|P1|COMPLETED|Overall Study||14
7834511|NCT01033747|19283584|P2|STARTED|Overall Study||19
7834512|NCT01033747|19283585|P1|STARTED|Overall Study||51
7834513|NCT01033734|19283593|P1|NOT COMPLETED|Overall Study||1
7834514|NCT01033734|19283593|P1|COMPLETED|Overall Study||7
7834515|NCT01033734|19283593|P1|STARTED|Overall Study||8
7834516|NCT01033565|19283645|P1|NOT COMPLETED|Overall Study||0
7834517|NCT01033565|19283645|P1|COMPLETED|Overall Study||1
7834518|NCT01033565|19283645|P1|STARTED|Overall Study||1
7834519|NCT01033487|19283649|P10|NOT COMPLETED|Fifth Intervention Period||0
7834520|NCT01033487|19283650|P9|NOT COMPLETED|Fifth Intervention Period||0
7834521|NCT01033487|19283651|P8|NOT COMPLETED|Fifth Intervention Period||0
7834522|NCT01033487|19283652|P7|NOT COMPLETED|Fifth Intervention Period||0
7834523|NCT01033487|19283653|P6|NOT COMPLETED|Fifth Intervention Period||0
7834524|NCT01033487|19283654|P5|NOT COMPLETED|Fifth Intervention Period||0
7834525|NCT01033487|19283655|P4|NOT COMPLETED|Fifth Intervention Period||0
7834526|NCT01033487|19283656|P3|NOT COMPLETED|Fifth Intervention Period||0
7834527|NCT01033487|19283657|P2|NOT COMPLETED|Fifth Intervention Period||0
7834528|NCT01033487|19283658|P1|NOT COMPLETED|Fifth Intervention Period||0
7834529|NCT01033487|19283649|P10|COMPLETED|Fifth Intervention Period||2
7834530|NCT01033487|19283650|P9|COMPLETED|Fifth Intervention Period||1
7834531|NCT01033487|19283651|P8|COMPLETED|Fifth Intervention Period||3
7834532|NCT01033487|19283652|P7|COMPLETED|Fifth Intervention Period||2
7834533|NCT01033487|19283653|P6|COMPLETED|Fifth Intervention Period||2
7834534|NCT01033487|19283654|P5|COMPLETED|Fifth Intervention Period||2
7834535|NCT01033487|19283655|P4|COMPLETED|Fifth Intervention Period||2
7834536|NCT01033487|19283656|P3|COMPLETED|Fifth Intervention Period||2
7834537|NCT01033487|19283657|P2|COMPLETED|Fifth Intervention Period||3
7834538|NCT01033487|19283658|P1|COMPLETED|Fifth Intervention Period||2
7834539|NCT01033487|19283649|P10|STARTED|Fifth Intervention Period||2
7834540|NCT01033487|19283650|P9|STARTED|Fifth Intervention Period||1
7834541|NCT01033487|19283651|P8|STARTED|Fifth Intervention Period||3
7834542|NCT01033487|19283652|P7|STARTED|Fifth Intervention Period||2
7834543|NCT01033487|19283653|P6|STARTED|Fifth Intervention Period||2
7834544|NCT01033487|19283654|P5|STARTED|Fifth Intervention Period||2
7834545|NCT01033487|19283655|P4|STARTED|Fifth Intervention Period||2
7834546|NCT01033487|19283656|P3|STARTED|Fifth Intervention Period||2
7834547|NCT01033487|19283657|P2|STARTED|Fifth Intervention Period||3
7834548|NCT01033487|19283658|P1|STARTED|Fifth Intervention Period||2
7834549|NCT01033487|19283649|P10|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
7834550|NCT01033487|19283650|P9|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
7834551|NCT01033487|19283651|P8|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
7834552|NCT01033487|19283652|P7|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
7834553|NCT01033487|19283653|P6|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
7834554|NCT01033487|19283654|P5|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
7834555|NCT01033487|19283655|P4|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
7834556|NCT01033487|19283656|P3|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
7834557|NCT01033487|19283657|P2|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
7834558|NCT01033487|19283658|P1|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
7834559|NCT01033487|19283649|P10|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
7834560|NCT01033487|19283650|P9|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1
7834561|NCT01033487|19283651|P8|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
7834562|NCT01033487|19283652|P7|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
7834563|NCT01033487|19283653|P6|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
7834564|NCT01033487|19283654|P5|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
7834565|NCT01033487|19283655|P4|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
7834566|NCT01033487|19283656|P3|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
7834567|NCT01033487|19283657|P2|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
7834568|NCT01033487|19283658|P1|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
7834569|NCT01033487|19283649|P10|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
7834570|NCT01033487|19283650|P9|STARTED|Between Period 4 and 5 (At Least 7 Days)||1
7834571|NCT01033487|19283651|P8|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
7834572|NCT01033487|19283652|P7|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
7834573|NCT01033487|19283653|P6|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
7834574|NCT01033487|19283654|P5|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
7834575|NCT01033487|19283655|P4|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
7834576|NCT01033487|19283656|P3|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
7834577|NCT01033487|19283657|P2|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
7834578|NCT01033487|19283658|P1|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
7834579|NCT01033487|19283649|P10|NOT COMPLETED|Fourth Intervention Period||0
7834580|NCT01033487|19283650|P9|NOT COMPLETED|Fourth Intervention Period||1
7834581|NCT01033487|19283651|P8|NOT COMPLETED|Fourth Intervention Period||0
7834582|NCT01033487|19283652|P7|NOT COMPLETED|Fourth Intervention Period||0
7834583|NCT01033487|19283653|P6|NOT COMPLETED|Fourth Intervention Period||0
7834584|NCT01033487|19283654|P5|NOT COMPLETED|Fourth Intervention Period||0
7834585|NCT01033487|19283655|P4|NOT COMPLETED|Fourth Intervention Period||0
7834586|NCT01033487|19283656|P3|NOT COMPLETED|Fourth Intervention Period||0
7834587|NCT01033487|19283657|P2|NOT COMPLETED|Fourth Intervention Period||0
7834588|NCT01033487|19283658|P1|NOT COMPLETED|Fourth Intervention Period||0
7834589|NCT01033487|19283649|P10|COMPLETED|Fourth Intervention Period||2
7834590|NCT01033487|19283650|P9|COMPLETED|Fourth Intervention Period||1
7834591|NCT01033487|19283651|P8|COMPLETED|Fourth Intervention Period||3
7834592|NCT01033487|19283652|P7|COMPLETED|Fourth Intervention Period||2
7834593|NCT01033487|19283653|P6|COMPLETED|Fourth Intervention Period||2
7834594|NCT01033487|19283654|P5|COMPLETED|Fourth Intervention Period||2
7834595|NCT01033487|19283655|P4|COMPLETED|Fourth Intervention Period||2
7834596|NCT01033487|19283656|P3|COMPLETED|Fourth Intervention Period||2
7834597|NCT01033487|19283657|P2|COMPLETED|Fourth Intervention Period||3
7834598|NCT01033487|19283658|P1|COMPLETED|Fourth Intervention Period||2
7834599|NCT01033487|19283649|P10|STARTED|Fourth Intervention Period||2
7834600|NCT01033487|19283650|P9|STARTED|Fourth Intervention Period||2
7834601|NCT01033487|19283651|P8|STARTED|Fourth Intervention Period||3
7834602|NCT01033487|19283652|P7|STARTED|Fourth Intervention Period||2
7834603|NCT01033487|19283653|P6|STARTED|Fourth Intervention Period||2
7834604|NCT01033487|19283654|P5|STARTED|Fourth Intervention Period||2
7834605|NCT01033487|19283655|P4|STARTED|Fourth Intervention Period||2
7834606|NCT01033487|19283656|P3|STARTED|Fourth Intervention Period||2
7834607|NCT01033487|19283657|P2|STARTED|Fourth Intervention Period||3
7834608|NCT01033487|19283658|P1|STARTED|Fourth Intervention Period||2
7834609|NCT01033487|19283649|P10|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
7834610|NCT01033487|19283650|P9|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
7834611|NCT01033487|19283651|P8|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
7834612|NCT01033487|19283652|P7|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
7834613|NCT01033487|19283653|P6|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
7834614|NCT01033487|19283654|P5|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
7834615|NCT01033487|19283655|P4|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
7834616|NCT01033487|19283656|P3|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
7834617|NCT01033487|19283657|P2|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
7834618|NCT01033487|19283658|P1|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
7834619|NCT01033487|19283649|P10|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
7834620|NCT01033487|19283650|P9|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
7834621|NCT01033487|19283651|P8|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
7834622|NCT01033487|19283652|P7|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
7834623|NCT01033487|19283653|P6|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
7834624|NCT01033487|19283654|P5|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
7834625|NCT01033487|19283655|P4|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
7834626|NCT01033487|19283656|P3|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
7834627|NCT01033487|19283657|P2|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
7834628|NCT01033487|19283658|P1|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
7834629|NCT01033487|19283649|P10|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
7834630|NCT01033487|19283650|P9|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
7834631|NCT01033487|19283651|P8|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
7834632|NCT01033487|19283652|P7|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
7834633|NCT01033487|19283653|P6|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
7834634|NCT01033487|19283654|P5|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
7834635|NCT01033487|19283655|P4|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
7834636|NCT01033487|19283656|P3|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
7834637|NCT01033487|19283657|P2|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
7834638|NCT01033487|19283658|P1|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
7834639|NCT01033487|19283649|P10|NOT COMPLETED|Third Intervention Period||0
7834640|NCT01033487|19283650|P9|NOT COMPLETED|Third Intervention Period||0
7834641|NCT01033487|19283651|P8|NOT COMPLETED|Third Intervention Period||0
7834642|NCT01033487|19283652|P7|NOT COMPLETED|Third Intervention Period||0
7834643|NCT01033487|19283653|P6|NOT COMPLETED|Third Intervention Period||0
7834644|NCT01033487|19283654|P5|NOT COMPLETED|Third Intervention Period||0
7834645|NCT01033487|19283655|P4|NOT COMPLETED|Third Intervention Period||0
7834646|NCT01033487|19283656|P3|NOT COMPLETED|Third Intervention Period||0
7834647|NCT01033487|19283657|P2|NOT COMPLETED|Third Intervention Period||0
7834648|NCT01033487|19283658|P1|NOT COMPLETED|Third Intervention Period||0
7834649|NCT01033487|19283649|P10|COMPLETED|Third Intervention Period||2
7834650|NCT01033487|19283650|P9|COMPLETED|Third Intervention Period||2
7834651|NCT01033487|19283651|P8|COMPLETED|Third Intervention Period||3
7834652|NCT01033487|19283652|P7|COMPLETED|Third Intervention Period||2
7834653|NCT01033487|19283653|P6|COMPLETED|Third Intervention Period||2
7834654|NCT01033487|19283654|P5|COMPLETED|Third Intervention Period||2
7834655|NCT01033487|19283655|P4|COMPLETED|Third Intervention Period||2
7834656|NCT01033487|19283656|P3|COMPLETED|Third Intervention Period||2
7834657|NCT01033487|19283657|P2|COMPLETED|Third Intervention Period||3
7834658|NCT01033487|19283658|P1|COMPLETED|Third Intervention Period||2
7834659|NCT01033487|19283649|P10|STARTED|Third Intervention Period||2
7834660|NCT01033487|19283650|P9|STARTED|Third Intervention Period||2
7834661|NCT01033487|19283651|P8|STARTED|Third Intervention Period||3
7834662|NCT01033487|19283652|P7|STARTED|Third Intervention Period||2
7834663|NCT01033487|19283653|P6|STARTED|Third Intervention Period||2
7834664|NCT01033487|19283654|P5|STARTED|Third Intervention Period||2
7834665|NCT01033487|19283655|P4|STARTED|Third Intervention Period||2
7834666|NCT01033487|19283656|P3|STARTED|Third Intervention Period||2
7834667|NCT01033487|19283657|P2|STARTED|Third Intervention Period||3
7834668|NCT01033487|19283658|P1|STARTED|Third Intervention Period||2
7834669|NCT01033487|19283649|P10|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
7834670|NCT01033487|19283650|P9|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
7834671|NCT01033487|19283651|P8|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
7834672|NCT01033487|19283652|P7|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
7834673|NCT01033487|19283653|P6|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
7834674|NCT01033487|19283654|P5|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
7834675|NCT01033487|19283655|P4|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
7834676|NCT01033487|19283656|P3|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
7834677|NCT01033487|19283657|P2|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
7834678|NCT01033487|19283658|P1|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
7834679|NCT01033487|19283649|P10|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
7834680|NCT01033487|19283650|P9|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
7834681|NCT01033487|19283651|P8|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
7834682|NCT01033487|19283652|P7|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
7834683|NCT01033487|19283653|P6|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
7834684|NCT01033487|19283654|P5|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
7834685|NCT01033487|19283655|P4|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
7834686|NCT01033487|19283656|P3|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
7834687|NCT01033487|19283657|P2|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
7834688|NCT01033487|19283658|P1|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
7834689|NCT01033487|19283649|P10|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
7834690|NCT01033487|19283650|P9|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
7834691|NCT01033487|19283651|P8|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
7834692|NCT01033487|19283652|P7|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
7834693|NCT01033487|19283653|P6|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
7834694|NCT01033487|19283654|P5|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
7834695|NCT01033487|19283655|P4|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
7834696|NCT01033487|19283656|P3|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
7834697|NCT01033487|19283657|P2|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
7834698|NCT01033487|19283658|P1|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
7834699|NCT01033487|19283649|P10|NOT COMPLETED|Second Intervention Period||0
7834700|NCT01033487|19283650|P9|NOT COMPLETED|Second Intervention Period||0
7834701|NCT01033487|19283651|P8|NOT COMPLETED|Second Intervention Period||0
7834702|NCT01033487|19283652|P7|NOT COMPLETED|Second Intervention Period||0
7834703|NCT01033487|19283653|P6|NOT COMPLETED|Second Intervention Period||0
7834704|NCT01033487|19283654|P5|NOT COMPLETED|Second Intervention Period||0
7834705|NCT01033487|19283655|P4|NOT COMPLETED|Second Intervention Period||0
7834706|NCT01033487|19283656|P3|NOT COMPLETED|Second Intervention Period||0
7834707|NCT01033487|19283657|P2|NOT COMPLETED|Second Intervention Period||0
7834708|NCT01033487|19283658|P1|NOT COMPLETED|Second Intervention Period||0
7834709|NCT01033487|19283649|P10|COMPLETED|Second Intervention Period||2
7834710|NCT01033487|19283650|P9|COMPLETED|Second Intervention Period||2
7834711|NCT01033487|19283651|P8|COMPLETED|Second Intervention Period||3
7834712|NCT01033487|19283652|P7|COMPLETED|Second Intervention Period||2
7834713|NCT01033487|19283653|P6|COMPLETED|Second Intervention Period||2
7834714|NCT01033487|19283654|P5|COMPLETED|Second Intervention Period||2
7834715|NCT01033487|19283655|P4|COMPLETED|Second Intervention Period||2
7834716|NCT01033487|19283656|P3|COMPLETED|Second Intervention Period||2
7834717|NCT01033487|19283657|P2|COMPLETED|Second Intervention Period||3
7834718|NCT01033487|19283658|P1|COMPLETED|Second Intervention Period||2
7834719|NCT01033487|19283649|P10|STARTED|Second Intervention Period||2
7834720|NCT01033487|19283650|P9|STARTED|Second Intervention Period||2
7834721|NCT01033487|19283651|P8|STARTED|Second Intervention Period||3
7834722|NCT01033487|19283652|P7|STARTED|Second Intervention Period||2
7834723|NCT01033487|19283653|P6|STARTED|Second Intervention Period||2
7834724|NCT01033487|19283654|P5|STARTED|Second Intervention Period||2
7834725|NCT01033487|19283655|P4|STARTED|Second Intervention Period||2
7834726|NCT01033487|19283656|P3|STARTED|Second Intervention Period||2
7834727|NCT01033487|19283657|P2|STARTED|Second Intervention Period||3
7834728|NCT01033487|19283658|P1|STARTED|Second Intervention Period||2
7834729|NCT01033487|19283649|P10|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
7834730|NCT01033487|19283650|P9|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
7834731|NCT01033487|19283651|P8|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
7834732|NCT01033487|19283652|P7|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
7834733|NCT01033487|19283653|P6|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
7834734|NCT01033487|19283654|P5|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
7834735|NCT01033487|19283655|P4|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
7834736|NCT01033487|19283656|P3|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
7834737|NCT01033487|19283657|P2|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
7834738|NCT01033487|19283658|P1|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
7834739|NCT01033487|19283649|P10|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
7834740|NCT01033487|19283650|P9|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
7834741|NCT01033487|19283651|P8|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
7834742|NCT01033487|19283652|P7|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
7834743|NCT01033487|19283653|P6|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
7834744|NCT01033487|19283654|P5|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
7834745|NCT01033487|19283655|P4|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
7834746|NCT01033487|19283656|P3|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
7834747|NCT01033487|19283657|P2|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
7834748|NCT01033487|19283658|P1|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
7834749|NCT01033487|19283649|P10|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
7834750|NCT01033487|19283650|P9|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
7834751|NCT01033487|19283651|P8|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
7834752|NCT01033487|19283652|P7|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
7834753|NCT01033487|19283653|P6|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
7834754|NCT01033487|19283654|P5|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
7834755|NCT01033487|19283655|P4|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
7834756|NCT01033487|19283656|P3|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
7834757|NCT01033487|19283657|P2|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
7834758|NCT01033487|19283658|P1|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
7834759|NCT01033487|19283649|P10|NOT COMPLETED|First Intervention Period||0
7834760|NCT01033487|19283650|P9|NOT COMPLETED|First Intervention Period||0
7834761|NCT01033487|19283651|P8|NOT COMPLETED|First Intervention Period||0
7834762|NCT01033487|19283652|P7|NOT COMPLETED|First Intervention Period||0
7834763|NCT01033487|19283653|P6|NOT COMPLETED|First Intervention Period||0
7834764|NCT01033487|19283654|P5|NOT COMPLETED|First Intervention Period||0
7834765|NCT01033487|19283655|P4|NOT COMPLETED|First Intervention Period||0
7834766|NCT01033487|19283656|P3|NOT COMPLETED|First Intervention Period||0
7834767|NCT01033487|19283657|P2|NOT COMPLETED|First Intervention Period||0
7834768|NCT01033487|19283658|P1|NOT COMPLETED|First Intervention Period||0
7834769|NCT01033487|19283649|P10|COMPLETED|First Intervention Period||2
7834770|NCT01033487|19283650|P9|COMPLETED|First Intervention Period||2
7834771|NCT01033487|19283651|P8|COMPLETED|First Intervention Period||3
7834772|NCT01033487|19283652|P7|COMPLETED|First Intervention Period||2
7834773|NCT01033487|19283653|P6|COMPLETED|First Intervention Period||2
7834774|NCT01033487|19283654|P5|COMPLETED|First Intervention Period||2
7834775|NCT01033487|19283655|P4|COMPLETED|First Intervention Period||2
7834776|NCT01033487|19283656|P3|COMPLETED|First Intervention Period||2
7834777|NCT01033487|19283657|P2|COMPLETED|First Intervention Period||3
7834778|NCT01033487|19283658|P1|COMPLETED|First Intervention Period||2
7834779|NCT01033487|19283649|P10|STARTED|First Intervention Period||2
7834780|NCT01033487|19283650|P9|STARTED|First Intervention Period||2
7834781|NCT01033487|19283651|P8|STARTED|First Intervention Period||3
7834782|NCT01033487|19283652|P7|STARTED|First Intervention Period||2
7834783|NCT01033487|19283653|P6|STARTED|First Intervention Period||2
7834784|NCT01033487|19283654|P5|STARTED|First Intervention Period||2
7834785|NCT01033487|19283655|P4|STARTED|First Intervention Period||2
7834786|NCT01033487|19283656|P3|STARTED|First Intervention Period||2
7834787|NCT01033487|19283657|P2|STARTED|First Intervention Period||3
7834788|NCT01033487|19283658|P1|STARTED|First Intervention Period||2
7834789|NCT01033448|19283712|P1|NOT COMPLETED|Overall Study||12
7834790|NCT01033448|19283712|P1|COMPLETED|Overall Study||47
7834791|NCT01033448|19283712|P1|STARTED|Overall Study||59
7834792|NCT01033422|19283723|P3|NOT COMPLETED|Overall Study||1
7834793|NCT01033422|19283724|P2|NOT COMPLETED|Overall Study||4
7834794|NCT01033422|19283725|P1|NOT COMPLETED|Overall Study||1
7834795|NCT01033422|19283723|P3|COMPLETED|Overall Study||22
7834796|NCT01033422|19283724|P2|COMPLETED|Overall Study||28
7834797|NCT01033422|19283725|P1|COMPLETED|Overall Study||33
7834798|NCT01033422|19283723|P3|STARTED|Overall Study||23
7834799|NCT01033422|19283724|P2|STARTED|Overall Study||32
7834800|NCT01033422|19283725|P1|STARTED|Overall Study||34
7834801|NCT01033383|19283737|P4|NOT COMPLETED|Overall Study||0
7834802|NCT01033383|19283738|P3|NOT COMPLETED|Overall Study||0
7834803|NCT01033383|19283739|P2|NOT COMPLETED|Overall Study||0
7834804|NCT01033383|19283740|P1|NOT COMPLETED|Overall Study||0
7834805|NCT01033383|19283737|P4|COMPLETED|Overall Study||20
7834806|NCT01033383|19283738|P3|COMPLETED|Overall Study||20
7834807|NCT01033383|19283739|P2|COMPLETED|Overall Study||20
7834808|NCT01033383|19283740|P1|COMPLETED|Overall Study||20
7834809|NCT01033383|19283737|P4|STARTED|Overall Study||20
7834810|NCT01033383|19283738|P3|STARTED|Overall Study||20
7834811|NCT01033383|19283739|P2|STARTED|Overall Study||20
7834812|NCT01033383|19283740|P1|STARTED|Overall Study||20
7834813|NCT01033227|19283760|P2|NOT COMPLETED|Overall Study||0
7834814|NCT01033227|19283761|P1|NOT COMPLETED|Overall Study||0
7834815|NCT01033227|19283760|P2|COMPLETED|Overall Study||2
7834816|NCT01033227|19283761|P1|COMPLETED|Overall Study||3
7834817|NCT01033227|19283760|P2|STARTED|Overall Study||2
7834818|NCT01033227|19283761|P1|STARTED|Overall Study||3
7834819|NCT01033136|19283771|P2|NOT COMPLETED|Follow-Up (3 Month)||2
7834820|NCT01033136|19283772|P1|NOT COMPLETED|Follow-Up (3 Month)||2
7834821|NCT01033136|19283771|P2|COMPLETED|Follow-Up (3 Month)||13
7834822|NCT01033136|19283772|P1|COMPLETED|Follow-Up (3 Month)||14
7834823|NCT01033136|19283771|P2|STARTED|Follow-Up (3 Month)||15
7834824|NCT01033136|19283772|P1|STARTED|Follow-Up (3 Month)||16
7834825|NCT01033136|19283771|P2|NOT COMPLETED|Post-Treatment (1 Week)||11
7834826|NCT01033136|19283772|P1|NOT COMPLETED|Post-Treatment (1 Week)||14
7834827|NCT01033136|19283771|P2|COMPLETED|Post-Treatment (1 Week)||15
7834828|NCT01033136|19283772|P1|COMPLETED|Post-Treatment (1 Week)||16
7834829|NCT01033136|19283771|P2|STARTED|Post-Treatment (1 Week)||26
7834830|NCT01033136|19283772|P1|STARTED|Post-Treatment (1 Week)||30
7834831|NCT01033136|19283771|P2|NOT COMPLETED|Baseline Assessment||6
7834832|NCT01033136|19283772|P1|NOT COMPLETED|Baseline Assessment||6
7834833|NCT01033136|19283771|P2|COMPLETED|Baseline Assessment||26
7834834|NCT01033136|19283772|P1|COMPLETED|Baseline Assessment||30
7834835|NCT01033136|19283771|P2|STARTED|Baseline Assessment||32
7834836|NCT01033136|19283772|P1|STARTED|Baseline Assessment||36
7834837|NCT01033071|19283783|P3|NOT COMPLETED|Overall Study||47
7834838|NCT01033071|19283784|P2|NOT COMPLETED|Overall Study||77
7834839|NCT01033071|19283785|P1|NOT COMPLETED|Overall Study||55
7834840|NCT01033071|19283783|P3|COMPLETED|Overall Study||317
7834841|NCT01033071|19283784|P2|COMPLETED|Overall Study||275
7834842|NCT01033071|19283785|P1|COMPLETED|Overall Study||300
7834843|NCT01033071|19283783|P3|STARTED|Overall Study||364
7834844|NCT01033071|19283784|P2|STARTED|Overall Study||352
7834845|NCT01033071|19283785|P1|STARTED|Overall Study||355
7834846|NCT01033032|19283844|P4|NOT COMPLETED|Phase II||0
7834847|NCT01033032|19283845|P3|NOT COMPLETED|Phase II||66
7834848|NCT01033032|19283846|P2|NOT COMPLETED|Phase II||0
7834849|NCT01033032|19283847|P1|NOT COMPLETED|Phase II||0
7834850|NCT01033032|19283844|P4|COMPLETED|Phase II||0
7834851|NCT01033032|19283845|P3|COMPLETED|Phase II|Patients continued recieving treatment until disease progression or unacceptable toxicity|0
7834852|NCT01033032|19283846|P2|COMPLETED|Phase II||0
7834853|NCT01033032|19283847|P1|COMPLETED|Phase II||0
7834854|NCT01033032|19283844|P4|STARTED|Phase II||0
7834855|NCT01033032|19283845|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I (3 patients); 63 additional patients enrolled|66
7834856|NCT01033032|19283846|P2|STARTED|Phase II||0
7834857|NCT01033032|19283847|P1|STARTED|Phase II||0
7834858|NCT01033032|19283844|P4|NOT COMPLETED|Phase I||6
7834859|NCT01033032|19283845|P3|NOT COMPLETED|Phase I||0
7834860|NCT01033032|19283846|P2|NOT COMPLETED|Phase I||3
7834861|NCT01033032|19283847|P1|NOT COMPLETED|Phase I||3
7834862|NCT01033032|19283844|P4|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
7834863|NCT01033032|19283845|P3|COMPLETED|Phase I||3
7834864|NCT01033032|19283846|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
7834865|NCT01033032|19283847|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
7834866|NCT01033032|19283844|P4|STARTED|Phase I||6
7834867|NCT01033032|19283845|P3|STARTED|Phase I||3
7834868|NCT01033032|19283846|P2|STARTED|Phase I||3
7834869|NCT01033032|19283847|P1|STARTED|Phase I||3
7834870|NCT01033019|19283856|P2|NOT COMPLETED|Overall Study||0
7834871|NCT01033019|19283857|P1|NOT COMPLETED|Overall Study||1
7834872|NCT01033019|19283856|P2|COMPLETED|Overall Study||8
7834873|NCT01033019|19283857|P1|COMPLETED|Overall Study||15
7834874|NCT01033019|19283856|P2|STARTED|Overall Study||8
7834875|NCT01033019|19283857|P1|STARTED|Overall Study||16
7834876|NCT01032993|19283866|P2|NOT COMPLETED|Overall Study||0
7834877|NCT01032993|19283867|P1|NOT COMPLETED|Overall Study||0
7834878|NCT01032993|19283866|P2|COMPLETED|Overall Study||20
7834879|NCT01032993|19283867|P1|COMPLETED|Overall Study||19
7834880|NCT01032993|19283866|P2|STARTED|Overall Study||20
7834881|NCT01032993|19283867|P1|STARTED|Overall Study||19
7834882|NCT01032954|19283882|P3|NOT COMPLETED|Overall Study||0
7834883|NCT01032954|19283883|P2|NOT COMPLETED|Overall Study||1
7834884|NCT01032954|19283884|P1|NOT COMPLETED|Overall Study||4
7834885|NCT01032954|19283882|P3|COMPLETED|Overall Study||30
7834886|NCT01032954|19283883|P2|COMPLETED|Overall Study||29
7834887|NCT01032954|19283884|P1|COMPLETED|Overall Study||26
7834888|NCT01032954|19283882|P3|STARTED|Overall Study||30
7834889|NCT01032954|19283883|P2|STARTED|Overall Study||30
7834890|NCT01032954|19283884|P1|STARTED|Overall Study||30
7834891|NCT01032928|19283898|P1|NOT COMPLETED|Overall Study||0
7834892|NCT01032928|19283898|P1|COMPLETED|Overall Study||30
7834893|NCT01032928|19283898|P1|STARTED|Overall Study||30
7834894|NCT01032915|19283914|P4|NOT COMPLETED|Overall Study||7
7834895|NCT01032915|19283915|P3|NOT COMPLETED|Overall Study||7
7834896|NCT01032915|19283916|P2|NOT COMPLETED|Overall Study||11
7834897|NCT01032915|19283917|P1|NOT COMPLETED|Overall Study||8
7834898|NCT01032915|19283914|P4|COMPLETED|Overall Study||27
7834899|NCT01032915|19283915|P3|COMPLETED|Overall Study||24
7834900|NCT01032915|19283916|P2|COMPLETED|Overall Study||20
7834901|NCT01032915|19283917|P1|COMPLETED|Overall Study||21
7834902|NCT01032915|19283914|P4|STARTED|Overall Study||34
7834903|NCT01032915|19283915|P3|STARTED|Overall Study||31
7834904|NCT01032915|19283916|P2|STARTED|Overall Study||31
7834905|NCT01032915|19283917|P1|STARTED|Overall Study||29
7834906|NCT01032889|19283942|P3|NOT COMPLETED|Overall Study||3
7834907|NCT01032889|19283943|P2|NOT COMPLETED|Overall Study||15
7834908|NCT01032889|19283944|P1|NOT COMPLETED|Overall Study||8
7834909|NCT01032889|19283942|P3|COMPLETED|Overall Study||42
7834910|NCT01032889|19283943|P2|COMPLETED|Overall Study||28
7834911|NCT01032889|19283944|P1|COMPLETED|Overall Study||33
7834912|NCT01032889|19283942|P3|Received Treatment|Overall Study||45
7834913|NCT01032889|19283943|P2|Received Treatment|Overall Study||43
7834914|NCT01032889|19283944|P1|Received Treatment|Overall Study||41
7834915|NCT01032889|19283942|P3|STARTED|Overall Study||45
7834916|NCT01032889|19283943|P2|STARTED|Overall Study||43
7834917|NCT01032889|19283944|P1|STARTED|Overall Study||41
7834918|NCT01032850|19283964|P1|NOT COMPLETED|Overall Study||2
7834919|NCT01032850|19283964|P1|COMPLETED|Overall Study||13
7834920|NCT01032850|19283964|P1|STARTED|Overall Study||15
7834921|NCT01032837|19283975|P4|NOT COMPLETED|Overall Study||3
7834922|NCT01032837|19283976|P3|NOT COMPLETED|Overall Study||1
7834923|NCT01032837|19283977|P2|NOT COMPLETED|Overall Study||3
7834924|NCT01032837|19283978|P1|NOT COMPLETED|Overall Study||0
7834925|NCT01032837|19283975|P4|COMPLETED|Overall Study|Represents patients who completed treatment.|22
7834926|NCT01032837|19283976|P3|COMPLETED|Overall Study|Represents patients who completed treatment.|24
7834927|NCT01032837|19283977|P2|COMPLETED|Overall Study|Represents patients who completed treatment.|23
7834928|NCT01032837|19283978|P1|COMPLETED|Overall Study|Represents patients who completed treatment.|26
7834929|NCT01032837|19283975|P4|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24
7834930|NCT01032837|19283976|P3|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25
7834931|NCT01032837|19283977|P2|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
7834932|NCT01032837|19283978|P1|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
7834933|NCT01032837|19283975|P4|STARTED|Overall Study||25
7834934|NCT01032837|19283976|P3|STARTED|Overall Study||25
7834935|NCT01032837|19283977|P2|STARTED|Overall Study||26
7834936|NCT01032837|19283978|P1|STARTED|Overall Study||26
7834937|NCT01032759|19284026|P2|NOT COMPLETED|Overall Study||3
7834938|NCT01032759|19284027|P1|NOT COMPLETED|Overall Study||1
7834939|NCT01032759|19284026|P2|COMPLETED|Overall Study||28
7834940|NCT01032759|19284027|P1|COMPLETED|Overall Study||31
7834941|NCT01032759|19284026|P2|Completed 48 Hour Assessment|Overall Study||28
7834942|NCT01032759|19284027|P1|Completed 48 Hour Assessment|Overall Study||31
7834943|NCT01032759|19284026|P2|Completed 24 Hour Assessment|Overall Study||30
7834944|NCT01032759|19284027|P1|Completed 24 Hour Assessment|Overall Study||32
7834945|NCT01032759|19284026|P2|STARTED|Overall Study||31
7834946|NCT01032759|19284027|P1|STARTED|Overall Study||32
7834947|NCT01032733|19284047|P2|NOT COMPLETED|Overall Study||1
7834948|NCT01032733|19284048|P1|NOT COMPLETED|Overall Study||1
7834949|NCT01032733|19284047|P2|COMPLETED|Overall Study||16
7834950|NCT01032733|19284048|P1|COMPLETED|Overall Study||16
7834951|NCT01032733|19284047|P2|STARTED|Overall Study||17
7834952|NCT01032733|19284048|P1|STARTED|Overall Study||17
7834953|NCT01032694|19284064|P2|NOT COMPLETED|Overall Study||0
7834954|NCT01032694|19284065|P1|NOT COMPLETED|Overall Study||0
7834955|NCT01032694|19284064|P2|COMPLETED|Overall Study||10
7834956|NCT01032694|19284065|P1|COMPLETED|Overall Study||20
7834957|NCT01032694|19284064|P2|STARTED|Overall Study||10
7834958|NCT01032694|19284065|P1|STARTED|Overall Study||20
7834959|NCT01032629|19284078|P3|NOT COMPLETED|Overall Study||88
7834960|NCT01032629|19284079|P2|NOT COMPLETED|Overall Study||101
7834961|NCT01032629|19284080|P1|NOT COMPLETED|Overall Study||145
7834962|NCT01032629|19284078|P3|COMPLETED|Overall Study|Participants who died on trial were considered completed|1355
7834963|NCT01032629|19284079|P2|COMPLETED|Overall Study|Participants who died on trial were considered completed|1344
7834964|NCT01032629|19284080|P1|COMPLETED|Overall Study|Participants who died on trial were considered completed|1297
7834965|NCT01032629|19284078|P3|Treated|Overall Study||1441
7834966|NCT01032629|19284079|P2|Treated|Overall Study||1445
7834967|NCT01032629|19284080|P1|Treated|Overall Study||1441
7834968|NCT01032629|19284078|P3|STARTED|Overall Study||1443
7834969|NCT01032629|19284079|P2|STARTED|Overall Study||1445
7834970|NCT01032629|19284080|P1|STARTED|Overall Study||1442
7834971|NCT01032603|19284127|P2|NOT COMPLETED|Overall Study||19
7834972|NCT01032603|19284128|P1|NOT COMPLETED|Overall Study||15
7834973|NCT01032603|19284127|P2|COMPLETED|Overall Study||77
7834974|NCT01032603|19284128|P1|COMPLETED|Overall Study||86
7834975|NCT01032603|19284127|P2|STARTED|Overall Study||96
7834976|NCT01032603|19284128|P1|STARTED|Overall Study||101
7834977|NCT01032538|19284184|P1|NOT COMPLETED|Overall Study||0
7834978|NCT01032538|19284184|P1|COMPLETED|Overall Study|Knees|99
7834979|NCT01032538|19284184|P1|STARTED|Overall Study|Knees|99
7834980|NCT01032382|19284192|P2|NOT COMPLETED|Overall Study||5
7834981|NCT01032382|19284193|P1|NOT COMPLETED|Overall Study||5
7834982|NCT01032382|19284192|P2|COMPLETED|Overall Study||9
7834983|NCT01032382|19284193|P1|COMPLETED|Overall Study||11
7834984|NCT01032382|19284192|P2|STARTED|Overall Study||14
7834985|NCT01032382|19284193|P1|STARTED|Overall Study||16
7834986|NCT01032330|19284223|P4|NOT COMPLETED|Overall Study||14
7834987|NCT01032330|19284224|P3|NOT COMPLETED|Overall Study||10
7834988|NCT01032330|19284225|P2|NOT COMPLETED|Overall Study||24
7834989|NCT01032330|19284226|P1|NOT COMPLETED|Overall Study||18
7834990|NCT01032330|19284223|P4|COMPLETED|Overall Study||90
7834991|NCT01032330|19284224|P3|COMPLETED|Overall Study||87
7834992|NCT01032330|19284225|P2|COMPLETED|Overall Study||151
7834993|NCT01032330|19284226|P1|COMPLETED|Overall Study||165
7834994|NCT01032330|19284223|P4|STARTED|Overall Study||104
7834995|NCT01032330|19284224|P3|STARTED|Overall Study||97
7834996|NCT01032330|19284225|P2|STARTED|Overall Study||175
7834997|NCT01032330|19284226|P1|STARTED|Overall Study||183
7834998|NCT01032291|19284281|P3|NOT COMPLETED|Proof of Concept||3
7834999|NCT01032291|19284282|P2|NOT COMPLETED|Proof of Concept||8
7835000|NCT01032291|19284283|P1|NOT COMPLETED|Proof of Concept||0
7835001|NCT01032291|19284281|P3|COMPLETED|Proof of Concept|Participants with disease progression|18
7835002|NCT01032291|19284282|P2|COMPLETED|Proof of Concept|Participants with disease progression|14
7835003|NCT01032291|19284283|P1|COMPLETED|Proof of Concept||0
7835004|NCT01032291|19284281|P3|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
7835005|NCT01032291|19284282|P2|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
7835006|NCT01032291|19284283|P1|Intent to Treat and Safety Populations|Proof of Concept||0
7835007|NCT01032291|19284281|P3|STARTED|Proof of Concept||21
7835008|NCT01032291|19284282|P2|STARTED|Proof of Concept||22
7835009|NCT01032291|19284283|P1|STARTED|Proof of Concept||0
7835010|NCT01032291|19284281|P3|NOT COMPLETED|Safety Lead-in||0
7835011|NCT01032291|19284282|P2|NOT COMPLETED|Safety Lead-in||0
7835012|NCT01032291|19284283|P1|NOT COMPLETED|Safety Lead-in||2
7835013|NCT01032291|19284281|P3|COMPLETED|Safety Lead-in||0
7835014|NCT01032291|19284282|P2|COMPLETED|Safety Lead-in||0
7835015|NCT01032291|19284283|P1|COMPLETED|Safety Lead-in|Participants with disease progression|6
7835016|NCT01032291|19284281|P3|STARTED|Safety Lead-in||0
7835017|NCT01032291|19284282|P2|STARTED|Safety Lead-in||0
7835018|NCT01032291|19284283|P1|STARTED|Safety Lead-in||8
7835019|NCT01032265|19284309|P2|NOT COMPLETED|Overall Study||17
7835020|NCT01032265|19284310|P1|NOT COMPLETED|Overall Study||13
7835021|NCT01032265|19284309|P2|COMPLETED|Overall Study||107
7835022|NCT01032265|19284310|P1|COMPLETED|Overall Study||113
7835023|NCT01032265|19284309|P2|STARTED|Overall Study||124
7835024|NCT01032265|19284310|P1|STARTED|Overall Study||126
7835025|NCT01032239|19284330|P2|NOT COMPLETED|Overall Study||5
7835026|NCT01032239|19284331|P1|NOT COMPLETED|Overall Study||7
7835027|NCT01032239|19284330|P2|COMPLETED|Overall Study||24
7835028|NCT01032239|19284331|P1|COMPLETED|Overall Study||24
7835029|NCT01032239|19284330|P2|Implant|Overall Study||0
7835030|NCT01032239|19284331|P1|Implant|Overall Study|implanted|25
7835031|NCT01032239|19284330|P2|STARTED|Overall Study|randomized to BMT arm|29
7835032|NCT01032239|19284331|P1|STARTED|Overall Study|randomized to ITB arm|31
7835033|NCT01032200|19284361|P2|NOT COMPLETED|Overall Study||7
7835034|NCT01032200|19284362|P1|NOT COMPLETED|Overall Study||4
7835035|NCT01032200|19284361|P2|COMPLETED|Overall Study||21
7835036|NCT01032200|19284362|P1|COMPLETED|Overall Study||22
7835037|NCT01032200|19284361|P2|STARTED|Overall Study||28
7835038|NCT01032200|19284362|P1|STARTED|Overall Study||26
7835039|NCT01032174|19284378|P2|NOT COMPLETED|Overall Study||1
7835040|NCT01032174|19284379|P1|NOT COMPLETED|Overall Study||0
7835041|NCT01032174|19284378|P2|COMPLETED|Overall Study||59
7835042|NCT01032174|19284379|P1|COMPLETED|Overall Study||63
7835043|NCT01032174|19284378|P2|STARTED|Overall Study||60
7835044|NCT01032174|19284379|P1|STARTED|Overall Study||63
7835045|NCT01032135|19284394|P7|NOT COMPLETED|8 Week Randomization||18
7835046|NCT01032135|19284395|P6|NOT COMPLETED|8 Week Randomization||17
7835047|NCT01032135|19284396|P5|NOT COMPLETED|8 Week Randomization||9
7835048|NCT01032135|19284397|P4|NOT COMPLETED|8 Week Randomization||11
7835049|NCT01032135|19284398|P3|NOT COMPLETED|8 Week Randomization||0
7835050|NCT01032135|19284399|P2|NOT COMPLETED|8 Week Randomization||0
7835051|NCT01032135|19284400|P1|NOT COMPLETED|8 Week Randomization||26
7835052|NCT01032135|19284394|P7|COMPLETED|8 Week Randomization||36
7835053|NCT01032135|19284395|P6|COMPLETED|8 Week Randomization||31
7835054|NCT01032135|19284396|P5|COMPLETED|8 Week Randomization||34
7835055|NCT01032135|19284397|P4|COMPLETED|8 Week Randomization||30
7835056|NCT01032135|19284398|P3|COMPLETED|8 Week Randomization||0
7835057|NCT01032135|19284399|P2|COMPLETED|8 Week Randomization||0
7835058|NCT01032135|19284400|P1|COMPLETED|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|201
7835059|NCT01032135|19284394|P7|12 Week Follow up|8 Week Randomization||41
7835060|NCT01032135|19284395|P6|12 Week Follow up|8 Week Randomization||36
7835061|NCT01032135|19284396|P5|12 Week Follow up|8 Week Randomization||38
7835062|NCT01032135|19284397|P4|12 Week Follow up|8 Week Randomization||34
7835063|NCT01032135|19284398|P3|12 Week Follow up|8 Week Randomization||0
7835064|NCT01032135|19284399|P2|12 Week Follow up|8 Week Randomization||0
7835065|NCT01032135|19284400|P1|12 Week Follow up|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|217
7835066|NCT01032135|19284394|P7|STARTED|8 Week Randomization||54
7835067|NCT01032135|19284395|P6|STARTED|8 Week Randomization||48
7835068|NCT01032135|19284396|P5|STARTED|8 Week Randomization||43
7835069|NCT01032135|19284397|P4|STARTED|8 Week Randomization||41
7835070|NCT01032135|19284398|P3|STARTED|8 Week Randomization||0
7835071|NCT01032135|19284399|P2|STARTED|8 Week Randomization||0
7835072|NCT01032135|19284400|P1|STARTED|8 Week Randomization||227
7835073|NCT01032135|19284394|P7|NOT COMPLETED|2 Week Randomization||0
7835074|NCT01032135|19284395|P6|NOT COMPLETED|2 Week Randomization||0
7835075|NCT01032135|19284396|P5|NOT COMPLETED|2 Week Randomization||0
7835076|NCT01032135|19284397|P4|NOT COMPLETED|2 Week Randomization||0
7835077|NCT01032135|19284398|P3|NOT COMPLETED|2 Week Randomization||0
7835078|NCT01032135|19284399|P2|NOT COMPLETED|2 Week Randomization||0
7835079|NCT01032135|19284400|P1|NOT COMPLETED|2 Week Randomization||0
7835080|NCT01032135|19284394|P7|COMPLETED|2 Week Randomization||0
7835081|NCT01032135|19284395|P6|COMPLETED|2 Week Randomization||0
7835082|NCT01032135|19284396|P5|COMPLETED|2 Week Randomization||0
7835083|NCT01032135|19284397|P4|COMPLETED|2 Week Randomization||0
7835084|NCT01032135|19284398|P3|COMPLETED|2 Week Randomization||96
7835085|NCT01032135|19284399|P2|COMPLETED|2 Week Randomization||93
7835086|NCT01032135|19284400|P1|COMPLETED|2 Week Randomization||311
7835087|NCT01032135|19284394|P7|STARTED|2 Week Randomization||0
7835088|NCT01032135|19284395|P6|STARTED|2 Week Randomization||0
7835089|NCT01032135|19284396|P5|STARTED|2 Week Randomization||0
7835090|NCT01032135|19284397|P4|STARTED|2 Week Randomization||0
7835091|NCT01032135|19284398|P3|STARTED|2 Week Randomization||96
7835092|NCT01032135|19284399|P2|STARTED|2 Week Randomization||93
7835093|NCT01032135|19284400|P1|STARTED|2 Week Randomization||311
7835094|NCT01032070|19284619|P2|NOT COMPLETED|Overall Study||12
7835095|NCT01032070|19284620|P1|NOT COMPLETED|Overall Study||13
7835096|NCT01032070|19284619|P2|COMPLETED|Overall Study||0
7835097|NCT01032070|19284620|P1|COMPLETED|Overall Study||0
7835098|NCT01032070|19284619|P2|STARTED|Overall Study||12
7835099|NCT01032070|19284620|P1|STARTED|Overall Study||13
7835100|NCT01032044|19284649|P2|NOT COMPLETED|Overall Study||20
7835101|NCT01032044|19284650|P1|NOT COMPLETED|Overall Study||25
7835102|NCT01032044|19284649|P2|COMPLETED|Overall Study||62
7835103|NCT01032044|19284650|P1|COMPLETED|Overall Study||57
7835104|NCT01032044|19284649|P2|Procedure|Overall Study||75
7835105|NCT01032044|19284650|P1|Procedure|Overall Study||74
7835106|NCT01032044|19284649|P2|STARTED|Overall Study||82
7835107|NCT01032044|19284650|P1|STARTED|Overall Study||82
7835108|NCT01032018|19284658|P2|NOT COMPLETED|Overall Study||6
7835109|NCT01032018|19284659|P1|NOT COMPLETED|Overall Study||6
7835110|NCT01032018|19284658|P2|COMPLETED|Overall Study||67
7835111|NCT01032018|19284659|P1|COMPLETED|Overall Study||71
7835112|NCT01032018|19284658|P2|STARTED|Overall Study||73
7835113|NCT01032018|19284659|P1|STARTED|Overall Study||77
7835114|NCT01031979|19284669|P2|NOT COMPLETED|Overall Study||4
7835115|NCT01031979|19284670|P1|NOT COMPLETED|Overall Study||5
7835116|NCT01031979|19284669|P2|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|8
7835117|NCT01031979|19284670|P1|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|9
7835118|NCT01031979|19284669|P2|Completed Primary Outcome Measure|Overall Study||12
7835119|NCT01031979|19284670|P1|Completed Primary Outcome Measure|Overall Study||12
7835120|NCT01031979|19284669|P2|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|12
7835121|NCT01031979|19284670|P1|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|14
7835122|NCT01031953|19284682|P1|NOT COMPLETED|Overall Study||0
7835123|NCT01031953|19284682|P1|COMPLETED|Overall Study||11
7835124|NCT01031953|19284682|P1|STARTED|Overall Study||11
7835125|NCT01031914|19284693|P1|NOT COMPLETED|Overall Study||0
7835126|NCT01031914|19284693|P1|COMPLETED|Overall Study||36
7835127|NCT01031914|19284693|P1|STARTED|Overall Study||36
7835128|NCT01031836|19284703|P6|NOT COMPLETED|Stage II||1
7835129|NCT01031836|19284704|P5|NOT COMPLETED|Stage II||2
7835130|NCT01031836|19284705|P4|NOT COMPLETED|Stage II||3
7835131|NCT01031836|19284706|P3|NOT COMPLETED|Stage II||2
7835132|NCT01031836|19284707|P2|NOT COMPLETED|Stage II||0
7835133|NCT01031836|19284708|P1|NOT COMPLETED|Stage II||2
7835134|NCT01031836|19284703|P6|COMPLETED|Stage II||3
7835135|NCT01031836|19284704|P5|COMPLETED|Stage II||3
7835136|NCT01031836|19284705|P4|COMPLETED|Stage II||1
7835137|NCT01031836|19284706|P3|COMPLETED|Stage II||2
7835138|NCT01031836|19284707|P2|COMPLETED|Stage II||1
7835139|NCT01031836|19284708|P1|COMPLETED|Stage II||1
7835140|NCT01031836|19284703|P6|STARTED|Stage II||4
7835141|NCT01031836|19284704|P5|STARTED|Stage II||5
7835142|NCT01031836|19284705|P4|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
7835143|NCT01031836|19284706|P3|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
7835144|NCT01031836|19284707|P2|STARTED|Stage II|2 patient who completed the study treatment in Stage I did not register in Stage II.|1
7835145|NCT01031836|19284708|P1|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|3
7835146|NCT01031836|19284703|P6|NOT COMPLETED|Stage I||1
7835147|NCT01031836|19284704|P5|NOT COMPLETED|Stage I||0
7835148|NCT01031836|19284705|P4|NOT COMPLETED|Stage I||0
7835149|NCT01031836|19284706|P3|NOT COMPLETED|Stage I||0
7835150|NCT01031836|19284707|P2|NOT COMPLETED|Stage I||2
7835151|NCT01031836|19284708|P1|NOT COMPLETED|Stage I||1
7835152|NCT01031836|19284703|P6|COMPLETED|Stage I||4
7835153|NCT01031836|19284704|P5|COMPLETED|Stage I||5
7835154|NCT01031836|19284705|P4|COMPLETED|Stage I||5
7835155|NCT01031836|19284706|P3|COMPLETED|Stage I||5
7835156|NCT01031836|19284707|P2|COMPLETED|Stage I||3
7835157|NCT01031836|19284708|P1|COMPLETED|Stage I||4
7835158|NCT01031836|19284703|P6|STARTED|Stage I||5
7835159|NCT01031836|19284704|P5|STARTED|Stage I||5
7835160|NCT01031836|19284705|P4|STARTED|Stage I||5
7835161|NCT01031836|19284706|P3|STARTED|Stage I||5
7835162|NCT01031836|19284707|P2|STARTED|Stage I||5
7835163|NCT01031836|19284708|P1|STARTED|Stage I||5
7835164|NCT01031810|19284758|P1|NOT COMPLETED|Overall Study||4
7835165|NCT01031810|19284758|P1|COMPLETED|Overall Study||9
7835166|NCT01031810|19284758|P1|STARTED|Overall Study||13
7835167|NCT01031706|19284769|P2|NOT COMPLETED|Overall Study||1
7835168|NCT01031706|19284770|P1|NOT COMPLETED|Overall Study||2
7835169|NCT01031706|19284769|P2|COMPLETED|Overall Study||8
7835170|NCT01031706|19284770|P1|COMPLETED|Overall Study||12
7835171|NCT01031706|19284769|P2|STARTED|Overall Study||9
7835172|NCT01031706|19284770|P1|STARTED|Overall Study||14
7835173|NCT01031680|19284780|P2|NOT COMPLETED|Overall Study||58
7835174|NCT01031680|19284781|P1|NOT COMPLETED|Overall Study||57
7835175|NCT01031680|19284780|P2|COMPLETED|Overall Study||404
7835176|NCT01031680|19284781|P1|COMPLETED|Overall Study||403
7835177|NCT01031680|19284780|P2|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462
7835178|NCT01031680|19284781|P1|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460
7835179|NCT01031628|19284801|P4|NOT COMPLETED|Overall Study||0
7835180|NCT01031628|19284802|P3|NOT COMPLETED|Overall Study||3
7835181|NCT01031628|19284803|P2|NOT COMPLETED|Overall Study||1
7835182|NCT01031628|19284804|P1|NOT COMPLETED|Overall Study||0
7835183|NCT01031628|19284801|P4|COMPLETED|Overall Study||0
7835184|NCT01031628|19284802|P3|COMPLETED|Overall Study||0
7835185|NCT01031628|19284803|P2|COMPLETED|Overall Study||0
7835186|NCT01031628|19284804|P1|COMPLETED|Overall Study||0
7835187|NCT01031628|19284801|P4|STARTED|Overall Study||0
7835188|NCT01031628|19284802|P3|STARTED|Overall Study||3
7835189|NCT01031628|19284803|P2|STARTED|Overall Study||1
7835190|NCT01031628|19284804|P1|STARTED|Overall Study||0
7835191|NCT01031550|19284816|P2|NOT COMPLETED|Overall Study||0
7835192|NCT01031550|19284817|P1|NOT COMPLETED|Overall Study||0
7835193|NCT01031550|19284816|P2|COMPLETED|Overall Study||3
7835194|NCT01031550|19284817|P1|COMPLETED|Overall Study||5
7835195|NCT01031550|19284816|P2|STARTED|Overall Study||3
7835196|NCT01031550|19284817|P1|STARTED|Overall Study||5
7835197|NCT01031537|19284829|P1|NOT COMPLETED|Overall Study||32
7835198|NCT01031537|19284829|P1|COMPLETED|Overall Study||34
7835199|NCT01031537|19284829|P1|STARTED|Overall Study||66
7835200|NCT01031498|19284837|P3|NOT COMPLETED|Overall Study||2
7835201|NCT01031498|19284838|P2|NOT COMPLETED|Overall Study||3
7835202|NCT01031498|19284839|P1|NOT COMPLETED|Overall Study||2
7835203|NCT01031498|19284837|P3|COMPLETED|Overall Study||48
7835204|NCT01031498|19284838|P2|COMPLETED|Overall Study||48
7835205|NCT01031498|19284839|P1|COMPLETED|Overall Study||47
7835206|NCT01031498|19284837|P3|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50
7835207|NCT01031498|19284838|P2|STARTED|Overall Study|3 patients were not evaluable in arm 2|51
7835208|NCT01031498|19284839|P1|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49
7835209|NCT01031446|19284847|P1|NOT COMPLETED|Overall Study||55
7835210|NCT01031446|19284847|P1|COMPLETED|Overall Study||0
7835211|NCT01031446|19284847|P1|STARTED|Overall Study||55
7835212|NCT01031420|19284856|P1|NOT COMPLETED|Overall Study||10
7835213|NCT01031420|19284856|P1|COMPLETED|Overall Study||44
7835214|NCT01031420|19284856|P1|STARTED|Overall Study||54
7835215|NCT01031381|19284861|P1|NOT COMPLETED|Overall Study||9
7835216|NCT01031381|19284861|P1|COMPLETED|Overall Study||50
7835217|NCT01031381|19284861|P1|STARTED|Overall Study||59
7835218|NCT01031134|19284868|P2|NOT COMPLETED|Overall Study||10
7835219|NCT01031134|19284869|P1|NOT COMPLETED|Overall Study||11
7835220|NCT01031134|19284868|P2|COMPLETED|Overall Study||78
7835221|NCT01031134|19284869|P1|COMPLETED|Overall Study||103
7835222|NCT01031134|19284868|P2|STARTED|Overall Study||88
7835223|NCT01031134|19284869|P1|STARTED|Overall Study||114
7835224|NCT01031095|19284879|P2|NOT COMPLETED|Overall Study||0
7835225|NCT01031095|19284880|P1|NOT COMPLETED|Overall Study||0
7835226|NCT01031095|19284879|P2|COMPLETED|Overall Study||100
7835227|NCT01031095|19284880|P1|COMPLETED|Overall Study||100
7835228|NCT01031095|19284879|P2|STARTED|Overall Study||100
7835229|NCT01031095|19284880|P1|STARTED|Overall Study||100
7835230|NCT01031069|19284890|P4|NOT COMPLETED|Overall Study||34
7835231|NCT01031069|19284891|P3|NOT COMPLETED|Overall Study||41
7835232|NCT01031069|19284892|P2|NOT COMPLETED|Overall Study||11
7835233|NCT01031069|19284893|P1|NOT COMPLETED|Overall Study||12
7835234|NCT01031069|19284890|P4|COMPLETED|Overall Study||111
7835235|NCT01031069|19284891|P3|COMPLETED|Overall Study||103
7835236|NCT01031069|19284892|P2|COMPLETED|Overall Study||117
7835237|NCT01031069|19284893|P1|COMPLETED|Overall Study||117
7835238|NCT01031069|19284890|P4|STARTED|Overall Study||145
7835239|NCT01031069|19284891|P3|STARTED|Overall Study||144
7835240|NCT01031069|19284892|P2|STARTED|Overall Study||128
7835241|NCT01031069|19284893|P1|STARTED|Overall Study||129
7835242|NCT01031043|19284989|P1|NOT COMPLETED|Overall Study||1
7835243|NCT01031043|19284989|P1|COMPLETED|Overall Study||4
7835244|NCT01031043|19284989|P1|STARTED|Overall Study||5
7835245|NCT01031004|19284995|P2|NOT COMPLETED|Overall Study||1
7835246|NCT01031004|19284996|P1|NOT COMPLETED|Overall Study||1
7835247|NCT01031004|19284995|P2|COMPLETED|Overall Study||24
7835248|NCT01031004|19284996|P1|COMPLETED|Overall Study||24
7835249|NCT01031004|19284995|P2|STARTED|Overall Study||25
7835250|NCT01031004|19284996|P1|STARTED|Overall Study||25
7835251|NCT01030965|19285040|P4|NOT COMPLETED|Overall Study||7
7835252|NCT01030965|19285041|P3|NOT COMPLETED|Overall Study||4
7835253|NCT01030965|19285042|P2|NOT COMPLETED|Overall Study||6
7835254|NCT01030965|19285043|P1|NOT COMPLETED|Overall Study||4
7835255|NCT01030965|19285040|P4|COMPLETED|Overall Study||64
7835256|NCT01030965|19285041|P3|COMPLETED|Overall Study||68
7835257|NCT01030965|19285042|P2|COMPLETED|Overall Study||65
7835258|NCT01030965|19285043|P1|COMPLETED|Overall Study||67
7835259|NCT01030965|19285040|P4|STARTED|Overall Study||71
7835260|NCT01030965|19285041|P3|STARTED|Overall Study||72
7835261|NCT01030965|19285042|P2|STARTED|Overall Study||71
7835262|NCT01030965|19285043|P1|STARTED|Overall Study||71
7835263|NCT01030952|19285063|P2|NOT COMPLETED|Overall Study||3
7835264|NCT01030952|19285064|P1|NOT COMPLETED|Overall Study||2
7835265|NCT01030952|19285063|P2|COMPLETED|Overall Study||49
7835266|NCT01030952|19285064|P1|COMPLETED|Overall Study||49
7835267|NCT01030952|19285063|P2|STARTED|Overall Study||52
7835268|NCT01030952|19285064|P1|STARTED|Overall Study||51
7835269|NCT01030861|19285100|P2|NOT COMPLETED|Overall Study||0
7835270|NCT01030861|19285101|P1|NOT COMPLETED|Overall Study||0
7835271|NCT01030861|19285100|P2|COMPLETED|Overall Study||32
7835272|NCT01030861|19285101|P1|COMPLETED|Overall Study||44
7835273|NCT01030861|19285100|P2|STARTED|Overall Study||32
7835274|NCT01030861|19285101|P1|STARTED|Overall Study||44
7835275|NCT01030822|19285112|P3|NOT COMPLETED|Overall Study||26
7835276|NCT01030822|19285113|P2|NOT COMPLETED|Overall Study||24
7835277|NCT01030822|19285114|P1|NOT COMPLETED|Overall Study||31
7835278|NCT01030822|19285112|P3|COMPLETED|Overall Study||61
7835279|NCT01030822|19285113|P2|COMPLETED|Overall Study||71
7835280|NCT01030822|19285114|P1|COMPLETED|Overall Study||69
7835281|NCT01030822|19285112|P3|STARTED|Overall Study||87
7835282|NCT01030822|19285113|P2|STARTED|Overall Study||95
7835283|NCT01030822|19285114|P1|STARTED|Overall Study||100
7835284|NCT01030783|19285163|P2|NOT COMPLETED|Overall Study||26
7835285|NCT01030783|19285164|P1|NOT COMPLETED|Overall Study||49
7835286|NCT01030783|19285163|P2|COMPLETED|Overall Study||231
7835287|NCT01030783|19285164|P1|COMPLETED|Overall Study||211
7835288|NCT01030783|19285163|P2|STARTED|Overall Study||257
7835289|NCT01030783|19285164|P1|STARTED|Overall Study||260
7835290|NCT01030757|19285181|P1|NOT COMPLETED|Overall Study||0
7835291|NCT01030757|19285181|P1|COMPLETED|Overall Study||2
7835292|NCT01030757|19285181|P1|STARTED|Overall Study||2
7835293|NCT01030718|19285189|P3|NOT COMPLETED|Study CA180-036 Only||5
7835294|NCT01030718|19285190|P2|NOT COMPLETED|Study CA180-036 Only||7
7835295|NCT01030718|19285191|P1|NOT COMPLETED|Study CA180-036 Only||3
7835296|NCT01030718|19285189|P3|COMPLETED|Study CA180-036 Only||1
7835297|NCT01030718|19285190|P2|COMPLETED|Study CA180-036 Only||2
7835298|NCT01030718|19285191|P1|COMPLETED|Study CA180-036 Only||26
7835299|NCT01030718|19285189|P3|STARTED|Study CA180-036 Only||6
7835300|NCT01030718|19285190|P2|STARTED|Study CA180-036 Only||9
7835301|NCT01030718|19285191|P1|STARTED|Study CA180-036 Only||29
7835302|NCT01030718|19285189|P3|NOT COMPLETED|Studies CA180-031 and -036 Combined||12
7835303|NCT01030718|19285190|P2|NOT COMPLETED|Studies CA180-031 and -036 Combined||9
7835304|NCT01030718|19285191|P1|NOT COMPLETED|Studies CA180-031 and -036 Combined||4
7835305|NCT01030718|19285189|P3|COMPLETED|Studies CA180-031 and -036 Combined||1
7835306|NCT01030718|19285190|P2|COMPLETED|Studies CA180-031 and -036 Combined||2
7835307|NCT01030718|19285191|P1|COMPLETED|Studies CA180-031 and -036 Combined||26
7835308|NCT01030718|19285189|P3|STARTED|Studies CA180-031 and -036 Combined||13
7835309|NCT01030718|19285190|P2|STARTED|Studies CA180-031 and -036 Combined||11
7835310|NCT01030718|19285191|P1|STARTED|Studies CA180-031 and -036 Combined||30
7835311|NCT01030666|19285252|P2|NOT COMPLETED|Overall Study||2
7835312|NCT01030666|19285253|P1|NOT COMPLETED|Overall Study||3
7835313|NCT01030666|19285252|P2|COMPLETED|Overall Study||31
7835314|NCT01030666|19285253|P1|COMPLETED|Overall Study||25
7835315|NCT01030666|19285252|P2|STARTED|Overall Study||33
7835316|NCT01030666|19285253|P1|STARTED|Overall Study||28
7835317|NCT01030653|19285263|P2|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
7835318|NCT01030653|19285264|P1|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
7835319|NCT01030653|19285263|P2|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
7835320|NCT01030653|19285264|P1|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
7835321|NCT01030653|19285263|P2|STARTED|Loading Dose & 2nd Maintenance Regimen||4
7835322|NCT01030653|19285264|P1|STARTED|Loading Dose & 2nd Maintenance Regimen||4
7835323|NCT01030653|19285263|P2|NOT COMPLETED|7-Day Washout Period||0
7835324|NCT01030653|19285264|P1|NOT COMPLETED|7-Day Washout Period||0
7835325|NCT01030653|19285263|P2|COMPLETED|7-Day Washout Period||4
7835326|NCT01030653|19285264|P1|COMPLETED|7-Day Washout Period||4
7835327|NCT01030653|19285263|P2|STARTED|7-Day Washout Period||4
7835328|NCT01030653|19285264|P1|STARTED|7-Day Washout Period||4
7835329|NCT01030653|19285263|P2|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
7835330|NCT01030653|19285264|P1|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
7835331|NCT01030653|19285263|P2|COMPLETED|Loading Dose & First Maintenance Regimen||4
7835332|NCT01030653|19285264|P1|COMPLETED|Loading Dose & First Maintenance Regimen||4
7835333|NCT01030653|19285263|P2|STARTED|Loading Dose & First Maintenance Regimen||4
7835334|NCT01030653|19285264|P1|STARTED|Loading Dose & First Maintenance Regimen||4
7835335|NCT01030536|19285278|P5|NOT COMPLETED|Overall Study||1
7835336|NCT01030536|19285279|P4|NOT COMPLETED|Overall Study||3
7835337|NCT01030536|19285280|P3|NOT COMPLETED|Overall Study||6
7835338|NCT01030536|19285281|P2|NOT COMPLETED|Overall Study||6
7835339|NCT01030536|19285282|P1|NOT COMPLETED|Overall Study||7
7835340|NCT01030536|19285278|P5|COMPLETED|Overall Study||0
7835341|NCT01030536|19285279|P4|COMPLETED|Overall Study||0
7835342|NCT01030536|19285280|P3|COMPLETED|Overall Study||0
7835343|NCT01030536|19285281|P2|COMPLETED|Overall Study||0
7835344|NCT01030536|19285282|P1|COMPLETED|Overall Study||0
7835345|NCT01030536|19285278|P5|STARTED|Overall Study||1
7835346|NCT01030536|19285279|P4|STARTED|Overall Study||3
7835347|NCT01030536|19285280|P3|STARTED|Overall Study||6
7835348|NCT01030536|19285281|P2|STARTED|Overall Study||6
7835349|NCT01030536|19285282|P1|STARTED|Overall Study||7
7835350|NCT01030523|19285387|P2|NOT COMPLETED|Overall Study||5
7835351|NCT01030523|19285388|P1|NOT COMPLETED|Overall Study||6
7835352|NCT01030523|19285387|P2|COMPLETED|Overall Study||46
7835353|NCT01030523|19285388|P1|COMPLETED|Overall Study||44
7835354|NCT01030523|19285387|P2|STARTED|Overall Study||51
7835355|NCT01030523|19285388|P1|STARTED|Overall Study||50
7835356|NCT01030458|19285402|P2|NOT COMPLETED|Overall Study||32
7835357|NCT01030458|19285403|P1|NOT COMPLETED|Overall Study||27
7835358|NCT01030458|19285402|P2|COMPLETED|Overall Study||57
7835359|NCT01030458|19285403|P1|COMPLETED|Overall Study||67
7835360|NCT01030458|19285402|P2|STARTED|Overall Study||89
7835361|NCT01030458|19285403|P1|STARTED|Overall Study||94
7835362|NCT01030406|19285420|P5|NOT COMPLETED|Overall Study||0
7835363|NCT01030406|19285421|P4|NOT COMPLETED|Overall Study||1
7835364|NCT01030406|19285422|P3|NOT COMPLETED|Overall Study||1
7835365|NCT01030406|19285423|P2|NOT COMPLETED|Overall Study||0
7835366|NCT01030406|19285424|P1|NOT COMPLETED|Overall Study||0
7835367|NCT01030406|19285420|P5|COMPLETED|Overall Study||9
7835368|NCT01030406|19285421|P4|COMPLETED|Overall Study||9
7835369|NCT01030406|19285422|P3|COMPLETED|Overall Study||9
7835370|NCT01030406|19285423|P2|COMPLETED|Overall Study||10
7835371|NCT01030406|19285424|P1|COMPLETED|Overall Study||10
7835372|NCT01030406|19285420|P5|STARTED|Overall Study||9
7835373|NCT01030406|19285421|P4|STARTED|Overall Study||10
7835374|NCT01030406|19285422|P3|STARTED|Overall Study||10
7835375|NCT01030406|19285423|P2|STARTED|Overall Study||10
7835376|NCT01030406|19285424|P1|STARTED|Overall Study||10
7835377|NCT01030341|19285436|P1|NOT COMPLETED|Overall Study||3
7835378|NCT01030341|19285436|P1|COMPLETED|Overall Study|42 participants completed the study|42
7835379|NCT01030341|19285436|P1|STARTED|Overall Study|45 participants met all enrollment criteria by completing the screening and run-in phases|45
7835380|NCT01030289|19285441|P2|NOT COMPLETED|Overall Study||0
7835381|NCT01030289|19285442|P1|NOT COMPLETED|Overall Study||0
7835382|NCT01030289|19285441|P2|COMPLETED|Overall Study||10
7835383|NCT01030289|19285442|P1|COMPLETED|Overall Study||9
7835384|NCT01030289|19285441|P2|STARTED|Overall Study||10
7835385|NCT01030289|19285442|P1|STARTED|Overall Study||9
7835386|NCT01030198|19285459|P2|NOT COMPLETED|Overall Study||7
7835387|NCT01030198|19285460|P1|NOT COMPLETED|Overall Study||0
7835388|NCT01030198|19285459|P2|COMPLETED|Overall Study|Study terminated due to poor results and lack of enrollment|0
7835389|NCT01030198|19285460|P1|COMPLETED|Overall Study|None recruited|0
7835390|NCT01030198|19285459|P2|STARTED|Overall Study||7
7835391|NCT01030198|19285460|P1|STARTED|Overall Study|None recruited|0
7835392|NCT01030133|19285468|P2|NOT COMPLETED|Overall Study||2
7835393|NCT01030133|19285469|P1|NOT COMPLETED|Overall Study||2
7835394|NCT01030133|19285468|P2|COMPLETED|Overall Study||12
7835395|NCT01030133|19285469|P1|COMPLETED|Overall Study||12
7835396|NCT01030133|19285468|P2|STARTED|Overall Study||14
7835397|NCT01030133|19285469|P1|STARTED|Overall Study||14
7835398|NCT01029925|19285481|P1|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1
7835399|NCT01029925|19285481|P1|COMPLETED|Completion of Cycle 2 (56 Days)||2
7835400|NCT01029925|19285481|P1|STARTED|Completion of Cycle 2 (56 Days)||3
7835401|NCT01029925|19285481|P1|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4
7835402|NCT01029925|19285481|P1|COMPLETED|Completion of Cycle 1 (28 Days)||3
7835403|NCT01029925|19285481|P1|STARTED|Completion of Cycle 1 (28 Days)||7
7835404|NCT01029912|19285487|P2|NOT COMPLETED|Overall Study||0
7835405|NCT01029912|19285488|P1|NOT COMPLETED|Overall Study||2
7835406|NCT01029912|19285487|P2|COMPLETED|Overall Study||12
7835407|NCT01029912|19285488|P1|COMPLETED|Overall Study||12
7835408|NCT01029912|19285487|P2|STARTED|Overall Study||12
7835409|NCT01029912|19285488|P1|STARTED|Overall Study||14
7835410|NCT01029886|19285500|P2|NOT COMPLETED|Overall Study||60
7835411|NCT01029886|19285501|P1|NOT COMPLETED|Overall Study||61
7835412|NCT01029886|19285500|P2|COMPLETED|Overall Study||391
7835413|NCT01029886|19285501|P1|COMPLETED|Overall Study||400
7835414|NCT01029886|19285500|P2|Intent to Treat (ITT)|Overall Study||450
7835415|NCT01029886|19285501|P1|Intent to Treat (ITT)|Overall Study||461
7835416|NCT01029886|19285500|P2|STARTED|Overall Study||451
7835417|NCT01029886|19285501|P1|STARTED|Overall Study||461
7835418|NCT01029795|19285529|P2|NOT COMPLETED|Overall Study||22
7835419|NCT01029795|19285530|P1|NOT COMPLETED|Overall Study||16
7835420|NCT01029795|19285529|P2|COMPLETED|Overall Study||0
7835421|NCT01029795|19285530|P1|COMPLETED|Overall Study||0
7835422|NCT01029795|19285529|P2|STARTED|Overall Study||22
7835423|NCT01029795|19285530|P1|STARTED|Overall Study||16
7835424|NCT01029782|19285584|P2|NOT COMPLETED|Overall Study||8
7835425|NCT01029782|19285585|P1|NOT COMPLETED|Overall Study||3
7835426|NCT01029782|19285584|P2|COMPLETED|Overall Study||96
7835427|NCT01029782|19285585|P1|COMPLETED|Overall Study||99
7835428|NCT01029782|19285584|P2|STARTED|Overall Study||104
7835429|NCT01029782|19285585|P1|STARTED|Overall Study||102
7835430|NCT01029730|19285591|P1|NOT COMPLETED|Maintenance Therapy||23
7835431|NCT01029730|19285591|P1|COMPLETED|Maintenance Therapy||14
7835432|NCT01029730|19285591|P1|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37
7835433|NCT01029730|19285591|P1|NOT COMPLETED|Combination Therapy||16
7835434|NCT01029730|19285591|P1|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39
7835435|NCT01029730|19285591|P1|STARTED|Combination Therapy||55
7835436|NCT01029704|19285603|P5|NOT COMPLETED|Overall Study||0
7835437|NCT01029704|19285604|P4|NOT COMPLETED|Overall Study||0
7835438|NCT01029704|19285605|P3|NOT COMPLETED|Overall Study||0
7835439|NCT01029704|19285606|P2|NOT COMPLETED|Overall Study||0
7835440|NCT01029704|19285607|P1|NOT COMPLETED|Overall Study||0
7835441|NCT01029704|19285603|P5|COMPLETED|Overall Study||26
7835442|NCT01029704|19285604|P4|COMPLETED|Overall Study||28
7835443|NCT01029704|19285605|P3|COMPLETED|Overall Study||23
7835444|NCT01029704|19285606|P2|COMPLETED|Overall Study||24
7835445|NCT01029704|19285607|P1|COMPLETED|Overall Study||28
7835446|NCT01029704|19285603|P5|STARTED|Overall Study||26
7835447|NCT01029704|19285604|P4|STARTED|Overall Study||28
7835448|NCT01029704|19285605|P3|STARTED|Overall Study||23
7835449|NCT01029704|19285606|P2|STARTED|Overall Study||24
7835450|NCT01029704|19285607|P1|STARTED|Overall Study||28
7835451|NCT01029691|19285637|P3|NOT COMPLETED|Continued APAP to Delivery||1
7835452|NCT01029691|19285638|P2|NOT COMPLETED|Continued APAP to Delivery||0
7835453|NCT01029691|19285639|P1|NOT COMPLETED|Continued APAP to Delivery||0
7835454|NCT01029691|19285637|P3|COMPLETED|Continued APAP to Delivery||76
7835455|NCT01029691|19285638|P2|COMPLETED|Continued APAP to Delivery||16
7835456|NCT01029691|19285639|P1|COMPLETED|Continued APAP to Delivery||20
7835457|NCT01029691|19285637|P3|STARTED|Continued APAP to Delivery||77
7835458|NCT01029691|19285638|P2|STARTED|Continued APAP to Delivery||16
7835459|NCT01029691|19285639|P1|STARTED|Continued APAP to Delivery||20
7835460|NCT01029691|19285637|P3|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
7835461|NCT01029691|19285638|P2|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||11
7835462|NCT01029691|19285639|P1|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
7835463|NCT01029691|19285637|P3|COMPLETED|APAP Initiation to Week 1 or Delivery||77
7835464|NCT01029691|19285638|P2|COMPLETED|APAP Initiation to Week 1 or Delivery||16
7835465|NCT01029691|19285639|P1|COMPLETED|APAP Initiation to Week 1 or Delivery||20
7835466|NCT01029691|19285637|P3|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||77
7835467|NCT01029691|19285638|P2|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||16
7835468|NCT01029691|19285639|P1|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||20
7835469|NCT01029691|19285637|P3|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||77
7835470|NCT01029691|19285638|P2|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||23
7835471|NCT01029691|19285639|P1|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||20
7835472|NCT01029691|19285637|P3|STARTED|APAP Initiation to Week 1 or Delivery||77
7835473|NCT01029691|19285638|P2|STARTED|APAP Initiation to Week 1 or Delivery|4 delivered before APAP initiation 7 elected not to have APAP following baseline study|27
7835474|NCT01029691|19285639|P1|STARTED|APAP Initiation to Week 1 or Delivery||20
7835475|NCT01029652|19285664|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3
7835476|NCT01029652|19285665|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1
7835477|NCT01029652|19285664|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||63
7835478|NCT01029652|19285665|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||68
7835479|NCT01029652|19285664|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39
7835480|NCT01029652|19285665|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69
7835481|NCT01029652|19285664|P2|STARTED|Extension Study 2 (25-72 Weeks)||66
7835482|NCT01029652|19285665|P1|STARTED|Extension Study 2 (25-72 Weeks)||69
7835483|NCT01029652|19285664|P2|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5
7835484|NCT01029652|19285665|P1|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3
7835485|NCT01029652|19285664|P2|COMPLETED|Extension Study 1 (12-24 Weeks)||80
7835486|NCT01029652|19285665|P1|COMPLETED|Extension Study 1 (12-24 Weeks)||87
7835487|NCT01029652|19285664|P2|STARTED|Extension Study 1 (12-24 Weeks)||85
7835488|NCT01029652|19285665|P1|STARTED|Extension Study 1 (12-24 Weeks)||90
7835489|NCT01029652|19285664|P2|NOT COMPLETED|Core Study (0-12 Weeks)||10
7835490|NCT01029652|19285665|P1|NOT COMPLETED|Core Study (0-12 Weeks)||6
7835491|NCT01029652|19285664|P2|COMPLETED|Core Study (0-12 Weeks)||105
7835492|NCT01029652|19285665|P1|COMPLETED|Core Study (0-12 Weeks)||109
7835493|NCT01029652|19285664|P2|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115
7835494|NCT01029652|19285665|P1|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113
7835495|NCT01029652|19285664|P2|STARTED|Core Study (0-12 Weeks)||115
7835496|NCT01029652|19285665|P1|STARTED|Core Study (0-12 Weeks)||115
7835497|NCT01029587|19285743|P1|NOT COMPLETED|Overall Study||0
7835498|NCT01029587|19285743|P1|COMPLETED|Overall Study||1
7835499|NCT01029587|19285743|P1|STARTED|Overall Study||1
7835500|NCT01029535|19285749|P1|NOT COMPLETED|Overall Study||31
7835501|NCT01029535|19285749|P1|COMPLETED|Overall Study||72
7835502|NCT01029535|19285749|P1|STARTED|Overall Study||103
7835503|NCT01029405|19285778|P4|NOT COMPLETED|Overall Study||5
7835504|NCT01029405|19285779|P3|NOT COMPLETED|Overall Study||4
7835505|NCT01029405|19285780|P2|NOT COMPLETED|Overall Study||3
7835506|NCT01029405|19285781|P1|NOT COMPLETED|Overall Study||2
7835507|NCT01029405|19285778|P4|COMPLETED|Overall Study||32
7835508|NCT01029405|19285779|P3|COMPLETED|Overall Study||31
7835509|NCT01029405|19285780|P2|COMPLETED|Overall Study||34
7835510|NCT01029405|19285781|P1|COMPLETED|Overall Study||34
7835511|NCT01029405|19285778|P4|STARTED|Overall Study||37
7835512|NCT01029405|19285779|P3|STARTED|Overall Study||35
7835513|NCT01029405|19285780|P2|STARTED|Overall Study||37
7835514|NCT01029405|19285781|P1|STARTED|Overall Study||36
7835515|NCT01029392|19285793|P2|NOT COMPLETED|Overall Study||11
7835516|NCT01029392|19285794|P1|NOT COMPLETED|Overall Study||20
7835517|NCT01029392|19285793|P2|COMPLETED|Overall Study||27
7835518|NCT01029392|19285794|P1|COMPLETED|Overall Study||17
7835519|NCT01029392|19285793|P2|STARTED|Overall Study||38
7835520|NCT01029392|19285794|P1|STARTED|Overall Study||37
7835521|NCT01029366|19285804|P2|NOT COMPLETED|Overall Study||2
7835522|NCT01029366|19285805|P1|NOT COMPLETED|Overall Study||4
7835523|NCT01029366|19285804|P2|COMPLETED|Overall Study||6
7835524|NCT01029366|19285805|P1|COMPLETED|Overall Study||14
7835525|NCT01029366|19285804|P2|STARTED|Overall Study||8
7835526|NCT01029366|19285805|P1|STARTED|Overall Study||18
7835527|NCT01029340|19285817|P6|NOT COMPLETED|Part C Follow up Period||0
7835528|NCT01029340|19285818|P5|NOT COMPLETED|Part C Follow up Period||0
7835529|NCT01029340|19285819|P4|NOT COMPLETED|Part C Follow up Period||0
7835530|NCT01029340|19285820|P3|NOT COMPLETED|Part C Follow up Period||0
7835531|NCT01029340|19285821|P2|NOT COMPLETED|Part C Follow up Period||0
7835532|NCT01029340|19285822|P1|NOT COMPLETED|Part C Follow up Period||0
7835533|NCT01029340|19285817|P6|COMPLETED|Part C Follow up Period||0
7835534|NCT01029340|19285818|P5|COMPLETED|Part C Follow up Period||5
7835535|NCT01029340|19285819|P4|COMPLETED|Part C Follow up Period||0
7835536|NCT01029340|19285820|P3|COMPLETED|Part C Follow up Period||0
7835537|NCT01029340|19285821|P2|COMPLETED|Part C Follow up Period||0
7835538|NCT01029340|19285822|P1|COMPLETED|Part C Follow up Period||0
7835539|NCT01029340|19285817|P6|STARTED|Part C Follow up Period||0
7835540|NCT01029340|19285818|P5|STARTED|Part C Follow up Period||5
7835541|NCT01029340|19285819|P4|STARTED|Part C Follow up Period||0
7835542|NCT01029340|19285820|P3|STARTED|Part C Follow up Period||0
7835543|NCT01029340|19285821|P2|STARTED|Part C Follow up Period||0
7835544|NCT01029340|19285822|P1|STARTED|Part C Follow up Period||0
7835545|NCT01029340|19285817|P6|NOT COMPLETED|Part C Treatment Period||0
7835546|NCT01029340|19285818|P5|NOT COMPLETED|Part C Treatment Period||0
7835547|NCT01029340|19285819|P4|NOT COMPLETED|Part C Treatment Period||0
7835548|NCT01029340|19285820|P3|NOT COMPLETED|Part C Treatment Period||0
7835549|NCT01029340|19285821|P2|NOT COMPLETED|Part C Treatment Period||0
7835550|NCT01029340|19285822|P1|NOT COMPLETED|Part C Treatment Period||0
7835551|NCT01029340|19285817|P6|COMPLETED|Part C Treatment Period||0
7835552|NCT01029340|19285818|P5|COMPLETED|Part C Treatment Period||5
7835553|NCT01029340|19285819|P4|COMPLETED|Part C Treatment Period||0
7835554|NCT01029340|19285820|P3|COMPLETED|Part C Treatment Period||0
7835555|NCT01029340|19285821|P2|COMPLETED|Part C Treatment Period||0
7835556|NCT01029340|19285822|P1|COMPLETED|Part C Treatment Period||0
7835557|NCT01029340|19285817|P6|Participants Received Treatment|Part C Treatment Period||0
7835558|NCT01029340|19285818|P5|Participants Received Treatment|Part C Treatment Period||5
7835559|NCT01029340|19285819|P4|Participants Received Treatment|Part C Treatment Period||0
7835560|NCT01029340|19285820|P3|Participants Received Treatment|Part C Treatment Period||0
7835561|NCT01029340|19285821|P2|Participants Received Treatment|Part C Treatment Period||0
7835562|NCT01029340|19285822|P1|Participants Received Treatment|Part C Treatment Period||0
7835563|NCT01029340|19285817|P6|STARTED|Part C Treatment Period||0
7835564|NCT01029340|19285818|P5|STARTED|Part C Treatment Period||5
7835565|NCT01029340|19285819|P4|STARTED|Part C Treatment Period||0
7835566|NCT01029340|19285820|P3|STARTED|Part C Treatment Period||0
7835567|NCT01029340|19285821|P2|STARTED|Part C Treatment Period||0
7835568|NCT01029340|19285822|P1|STARTED|Part C Treatment Period||0
7835569|NCT01029340|19285817|P6|NOT COMPLETED|Extension Period||12
7835570|NCT01029340|19285818|P5|NOT COMPLETED|Extension Period||0
7835571|NCT01029340|19285819|P4|NOT COMPLETED|Extension Period||0
7835572|NCT01029340|19285820|P3|NOT COMPLETED|Extension Period||0
7835573|NCT01029340|19285821|P2|NOT COMPLETED|Extension Period||0
7835574|NCT01029340|19285822|P1|NOT COMPLETED|Extension Period||0
7835575|NCT01029340|19285817|P6|COMPLETED|Extension Period||43
7835576|NCT01029340|19285818|P5|COMPLETED|Extension Period||0
7835577|NCT01029340|19285819|P4|COMPLETED|Extension Period||0
7835578|NCT01029340|19285820|P3|COMPLETED|Extension Period||0
7835579|NCT01029340|19285821|P2|COMPLETED|Extension Period||0
7835580|NCT01029340|19285822|P1|COMPLETED|Extension Period||0
7835581|NCT01029340|19285817|P6|STARTED|Extension Period||55
7835582|NCT01029340|19285818|P5|STARTED|Extension Period||0
7835583|NCT01029340|19285819|P4|STARTED|Extension Period||0
7835584|NCT01029340|19285820|P3|STARTED|Extension Period||0
7835585|NCT01029340|19285821|P2|STARTED|Extension Period||0
7835586|NCT01029340|19285822|P1|STARTED|Extension Period||0
7835587|NCT01029340|19285817|P6|NOT COMPLETED|Part B Follow up Period||0
7835588|NCT01029340|19285818|P5|NOT COMPLETED|Part B Follow up Period||0
7835589|NCT01029340|19285819|P4|NOT COMPLETED|Part B Follow up Period||0
7835590|NCT01029340|19285820|P3|NOT COMPLETED|Part B Follow up Period||0
7835591|NCT01029340|19285821|P2|NOT COMPLETED|Part B Follow up Period||0
7835592|NCT01029340|19285822|P1|NOT COMPLETED|Part B Follow up Period||0
7835593|NCT01029340|19285817|P6|COMPLETED|Part B Follow up Period||0
7835594|NCT01029340|19285818|P5|COMPLETED|Part B Follow up Period||0
7835595|NCT01029340|19285819|P4|COMPLETED|Part B Follow up Period||32
7835596|NCT01029340|19285820|P3|COMPLETED|Part B Follow up Period||29
7835597|NCT01029340|19285821|P2|COMPLETED|Part B Follow up Period||0
7835598|NCT01029340|19285822|P1|COMPLETED|Part B Follow up Period||0
7835599|NCT01029340|19285817|P6|STARTED|Part B Follow up Period||0
7835600|NCT01029340|19285818|P5|STARTED|Part B Follow up Period||0
7835601|NCT01029340|19285819|P4|STARTED|Part B Follow up Period||32
7835602|NCT01029340|19285820|P3|STARTED|Part B Follow up Period||29
7835603|NCT01029340|19285821|P2|STARTED|Part B Follow up Period||0
7835604|NCT01029340|19285822|P1|STARTED|Part B Follow up Period||0
7835605|NCT01029340|19285817|P6|NOT COMPLETED|Part B Treatment Period||0
7835606|NCT01029340|19285818|P5|NOT COMPLETED|Part B Treatment Period||0
7835607|NCT01029340|19285819|P4|NOT COMPLETED|Part B Treatment Period||0
7835608|NCT01029340|19285820|P3|NOT COMPLETED|Part B Treatment Period||2
7835609|NCT01029340|19285821|P2|NOT COMPLETED|Part B Treatment Period||0
7835610|NCT01029340|19285822|P1|NOT COMPLETED|Part B Treatment Period||0
7835611|NCT01029340|19285817|P6|COMPLETED|Part B Treatment Period||0
7835612|NCT01029340|19285818|P5|COMPLETED|Part B Treatment Period||0
7835613|NCT01029340|19285819|P4|COMPLETED|Part B Treatment Period||32
7835614|NCT01029340|19285820|P3|COMPLETED|Part B Treatment Period||29
7835615|NCT01029340|19285821|P2|COMPLETED|Part B Treatment Period||0
7835616|NCT01029340|19285822|P1|COMPLETED|Part B Treatment Period||0
7835617|NCT01029340|19285817|P6|Participants Received Treatment|Part B Treatment Period||0
7835618|NCT01029340|19285818|P5|Participants Received Treatment|Part B Treatment Period||0
7835619|NCT01029340|19285819|P4|Participants Received Treatment|Part B Treatment Period||32
7835620|NCT01029340|19285820|P3|Participants Received Treatment|Part B Treatment Period||30
7835621|NCT01029340|19285821|P2|Participants Received Treatment|Part B Treatment Period||0
7835622|NCT01029340|19285822|P1|Participants Received Treatment|Part B Treatment Period||0
7835623|NCT01029340|19285817|P6|STARTED|Part B Treatment Period||0
7835624|NCT01029340|19285818|P5|STARTED|Part B Treatment Period||0
7835625|NCT01029340|19285819|P4|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32
7835626|NCT01029340|19285820|P3|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31
7835627|NCT01029340|19285821|P2|STARTED|Part B Treatment Period||0
7835628|NCT01029340|19285822|P1|STARTED|Part B Treatment Period||0
7835629|NCT01029340|19285817|P6|NOT COMPLETED|Part A Follow up Period||0
7835630|NCT01029340|19285818|P5|NOT COMPLETED|Part A Follow up Period||0
7835631|NCT01029340|19285819|P4|NOT COMPLETED|Part A Follow up Period||0
7835632|NCT01029340|19285820|P3|NOT COMPLETED|Part A Follow up Period||0
7835633|NCT01029340|19285821|P2|NOT COMPLETED|Part A Follow up Period||0
7835634|NCT01029340|19285822|P1|NOT COMPLETED|Part A Follow up Period||0
7835635|NCT01029340|19285817|P6|COMPLETED|Part A Follow up Period||0
7835636|NCT01029340|19285818|P5|COMPLETED|Part A Follow up Period||0
7835637|NCT01029340|19285819|P4|COMPLETED|Part A Follow up Period||0
7835638|NCT01029340|19285820|P3|COMPLETED|Part A Follow up Period||0
7835639|NCT01029340|19285821|P2|COMPLETED|Part A Follow up Period||14
7835640|NCT01029340|19285822|P1|COMPLETED|Part A Follow up Period||14
7835641|NCT01029340|19285817|P6|STARTED|Part A Follow up Period||0
7835642|NCT01029340|19285818|P5|STARTED|Part A Follow up Period||0
7835643|NCT01029340|19285819|P4|STARTED|Part A Follow up Period||0
7835644|NCT01029340|19285820|P3|STARTED|Part A Follow up Period||0
7835645|NCT01029340|19285821|P2|STARTED|Part A Follow up Period||14
7835646|NCT01029340|19285822|P1|STARTED|Part A Follow up Period||14
7835647|NCT01029340|19285817|P6|NOT COMPLETED|Part A Treatment Period||0
7835648|NCT01029340|19285818|P5|NOT COMPLETED|Part A Treatment Period||0
7835649|NCT01029340|19285819|P4|NOT COMPLETED|Part A Treatment Period||0
7835650|NCT01029340|19285820|P3|NOT COMPLETED|Part A Treatment Period||0
7835651|NCT01029340|19285821|P2|NOT COMPLETED|Part A Treatment Period||0
7835652|NCT01029340|19285822|P1|NOT COMPLETED|Part A Treatment Period||0
7835653|NCT01029340|19285817|P6|COMPLETED|Part A Treatment Period||0
7835654|NCT01029340|19285818|P5|COMPLETED|Part A Treatment Period||0
7835655|NCT01029340|19285819|P4|COMPLETED|Part A Treatment Period||0
7835656|NCT01029340|19285820|P3|COMPLETED|Part A Treatment Period||0
7835657|NCT01029340|19285821|P2|COMPLETED|Part A Treatment Period||14
7835658|NCT01029340|19285822|P1|COMPLETED|Part A Treatment Period||14
7835659|NCT01029340|19285817|P6|Safety Population|Part A Treatment Period||0
7835660|NCT01029340|19285818|P5|Safety Population|Part A Treatment Period||0
7835661|NCT01029340|19285819|P4|Safety Population|Part A Treatment Period||0
7835662|NCT01029340|19285820|P3|Safety Population|Part A Treatment Period||0
7835663|NCT01029340|19285821|P2|Safety Population|Part A Treatment Period||14
7835664|NCT01029340|19285822|P1|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13
7835665|NCT01029340|19285817|P6|Participants Received Treatment|Part A Treatment Period||0
7835666|NCT01029340|19285818|P5|Participants Received Treatment|Part A Treatment Period||0
7835667|NCT01029340|19285819|P4|Participants Received Treatment|Part A Treatment Period||0
7835668|NCT01029340|19285820|P3|Participants Received Treatment|Part A Treatment Period||0
7835669|NCT01029340|19285821|P2|Participants Received Treatment|Part A Treatment Period||14
7835670|NCT01029340|19285822|P1|Participants Received Treatment|Part A Treatment Period||14
7835671|NCT01029340|19285817|P6|STARTED|Part A Treatment Period||0
7835672|NCT01029340|19285818|P5|STARTED|Part A Treatment Period||0
7835673|NCT01029340|19285819|P4|STARTED|Part A Treatment Period||0
7835674|NCT01029340|19285820|P3|STARTED|Part A Treatment Period||0
7835675|NCT01029340|19285821|P2|STARTED|Part A Treatment Period||14
7835676|NCT01029340|19285822|P1|STARTED|Part A Treatment Period||14
7835677|NCT01029262|19285853|P2|NOT COMPLETED|Overall Study||160
7835678|NCT01029262|19285854|P1|NOT COMPLETED|Overall Study||79
7835679|NCT01029262|19285853|P2|COMPLETED|Overall Study||0
7835680|NCT01029262|19285854|P1|COMPLETED|Overall Study||0
7835681|NCT01029262|19285853|P2|STARTED|Overall Study||160
7835682|NCT01029262|19285854|P1|STARTED|Overall Study||79
7835683|NCT01029054|19285916|P3|NOT COMPLETED|Phase II||0
7835684|NCT01029054|19285917|P2|NOT COMPLETED|Phase II||0
7835685|NCT01029054|19285918|P1|NOT COMPLETED|Phase II||0
7835686|NCT01029054|19285916|P3|COMPLETED|Phase II||18
7835687|NCT01029054|19285917|P2|COMPLETED|Phase II||0
7835688|NCT01029054|19285918|P1|COMPLETED|Phase II||0
7835689|NCT01029054|19285916|P3|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18
7835690|NCT01029054|19285917|P2|STARTED|Phase II||0
7835691|NCT01029054|19285918|P1|STARTED|Phase II||0
7835692|NCT01029054|19285916|P3|NOT COMPLETED|Phase I||0
7835693|NCT01029054|19285917|P2|NOT COMPLETED|Phase I||0
7835694|NCT01029054|19285918|P1|NOT COMPLETED|Phase I||0
7835695|NCT01029054|19285916|P3|COMPLETED|Phase I||18
7835696|NCT01029054|19285917|P2|COMPLETED|Phase I||13
7835697|NCT01029054|19285918|P1|COMPLETED|Phase I||4
7835698|NCT01029054|19285916|P3|STARTED|Phase I||18
7835699|NCT01029054|19285917|P2|STARTED|Phase I||13
7835700|NCT01029054|19285918|P1|STARTED|Phase I||4
7835701|NCT01028937|19285924|P1|NOT COMPLETED|Overall Study||0
7835702|NCT01028937|19285924|P1|COMPLETED|Overall Study||6
7835703|NCT01028937|19285924|P1|STARTED|Overall Study||6
7835704|NCT01028911|19285931|P2|NOT COMPLETED|Overall Study||0
7835705|NCT01028911|19285932|P1|NOT COMPLETED|Overall Study||0
7835706|NCT01028911|19285931|P2|COMPLETED|Overall Study||2
7835707|NCT01028911|19285932|P1|COMPLETED|Overall Study||7
7835708|NCT01028911|19285931|P2|STARTED|Overall Study||2
7835709|NCT01028911|19285932|P1|STARTED|Overall Study||7
7835710|NCT01028820|19285997|P1|NOT COMPLETED|Overall Study||1
7835711|NCT01028820|19285997|P1|COMPLETED|Overall Study||12
7835712|NCT01028820|19285997|P1|STARTED|Overall Study||13
7835713|NCT01028677|19286006|P2|NOT COMPLETED|Overall Study||1
7835714|NCT01028677|19286007|P1|NOT COMPLETED|Overall Study||2
7835715|NCT01028677|19286006|P2|COMPLETED|Overall Study||6
7835716|NCT01028677|19286007|P1|COMPLETED|Overall Study||8
7835717|NCT01028677|19286006|P2|STARTED|Overall Study||7
7835718|NCT01028677|19286007|P1|STARTED|Overall Study||10
7835719|NCT01028651|19286023|P1|NOT COMPLETED|Overall Study||3
7835720|NCT01028651|19286023|P1|COMPLETED|Overall Study||10
7835721|NCT01028651|19286023|P1|STARTED|Overall Study||13
7835722|NCT01028560|19286046|P2|NOT COMPLETED|Overall Study||18
7835723|NCT01028560|19286047|P1|NOT COMPLETED|Overall Study||10
7835724|NCT01028560|19286046|P2|COMPLETED|Overall Study||13
7835725|NCT01028560|19286047|P1|COMPLETED|Overall Study||17
7835726|NCT01028560|19286046|P2|Started Study Protocol|Overall Study||27
7835727|NCT01028560|19286047|P1|Started Study Protocol|Overall Study||23
7835728|NCT01028560|19286046|P2|STARTED|Overall Study|4 of 31 withdrew consent immediately after randomization and are excluded from outcome analysis|31
7835729|NCT01028560|19286047|P1|STARTED|Overall Study|4 of 27 withdrew consent immediately after randomization and are excluded from outcome analysis|27
7835730|NCT01028391|19286061|P2|NOT COMPLETED|Overall Study||11
7835731|NCT01028391|19286062|P1|NOT COMPLETED|Overall Study||14
7835732|NCT01028391|19286061|P2|COMPLETED|Overall Study||142
7835733|NCT01028391|19286062|P1|COMPLETED|Overall Study||150
7835734|NCT01028391|19286061|P2|STARTED|Overall Study||153
7835735|NCT01028391|19286062|P1|STARTED|Overall Study||164
7835736|NCT01028378|19286070|P1|NOT COMPLETED|Overall Study||17
7835737|NCT01028378|19286070|P1|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195
7835738|NCT01028378|19286070|P1|STARTED|Overall Study|212 participants (249 eyes) with myopia|212
7835739|NCT01028352|19286082|P1|NOT COMPLETED|Overall Study||6
7835740|NCT01028352|19286082|P1|COMPLETED|Overall Study||29
7835741|NCT01028352|19286082|P1|STARTED|Overall Study||35
7835742|NCT01028300|19286087|P1|NOT COMPLETED|Overall Study||4
7835743|NCT01028300|19286087|P1|COMPLETED|Overall Study||0
7835744|NCT01028300|19286087|P1|STARTED|Overall Study||4
7835745|NCT01028222|19286096|P2|NOT COMPLETED|Overall Study||13
7835746|NCT01028222|19286097|P1|NOT COMPLETED|Overall Study||38
7835747|NCT01028222|19286096|P2|COMPLETED|Overall Study||0
7835748|NCT01028222|19286097|P1|COMPLETED|Overall Study||4
7835749|NCT01028222|19286096|P2|Cross Over From DTIC to Nilotinib|Overall Study||10
7835750|NCT01028222|19286097|P1|Cross Over From DTIC to Nilotinib|Overall Study||0
7835751|NCT01028222|19286096|P2|STARTED|Overall Study||13
7835752|NCT01028222|19286097|P1|STARTED|Overall Study||42
7835753|NCT01028131|19286122|P4|NOT COMPLETED|Overall Study||4
7835754|NCT01028131|19286123|P3|NOT COMPLETED|Overall Study||6
7835755|NCT01028131|19286124|P2|NOT COMPLETED|Overall Study||3
7835756|NCT01028131|19286125|P1|NOT COMPLETED|Overall Study||3
7835757|NCT01028131|19286122|P4|COMPLETED|Overall Study||26
7835758|NCT01028131|19286123|P3|COMPLETED|Overall Study||22
7835759|NCT01028131|19286124|P2|COMPLETED|Overall Study||23
7835760|NCT01028131|19286125|P1|COMPLETED|Overall Study||23
7835761|NCT01028131|19286122|P4|Completed Intervention/Control Session|Overall Study||30
7835762|NCT01028131|19286123|P3|Completed Intervention/Control Session|Overall Study||28
7835763|NCT01028131|19286124|P2|Completed Intervention/Control Session|Overall Study||26
7835764|NCT01028131|19286125|P1|Completed Intervention/Control Session|Overall Study||26
7835765|NCT01028131|19286122|P4|STARTED|Overall Study||30
7835766|NCT01028131|19286123|P3|STARTED|Overall Study||28
7835767|NCT01028131|19286124|P2|STARTED|Overall Study||26
7835768|NCT01028131|19286125|P1|STARTED|Overall Study||26
7835769|NCT01028053|19286139|P1|NOT COMPLETED|Overall Study||133
7835770|NCT01028053|19286139|P1|COMPLETED|Overall Study||232
7835771|NCT01028053|19286139|P1|STARTED|Overall Study||365
7835772|NCT01028027|19286147|P2|NOT COMPLETED|Overall Study||13
7835773|NCT01028027|19286148|P1|NOT COMPLETED|Overall Study||16
7835774|NCT01028027|19286147|P2|COMPLETED|Overall Study||164
7835775|NCT01028027|19286148|P1|COMPLETED|Overall Study||164
7835776|NCT01028027|19286147|P2|STARTED|Overall Study||177
7835777|NCT01028027|19286148|P1|STARTED|Overall Study||180
7835778|NCT01028014|19286170|P6|NOT COMPLETED|Overall Study||2
7835779|NCT01028014|19286171|P5|NOT COMPLETED|Overall Study||1
7835780|NCT01028014|19286172|P4|NOT COMPLETED|Overall Study||1
7835781|NCT01028014|19286173|P3|NOT COMPLETED|Overall Study||0
7835782|NCT01028014|19286174|P2|NOT COMPLETED|Overall Study||2
7835783|NCT01028014|19286175|P1|NOT COMPLETED|Overall Study||1
7835784|NCT01028014|19286170|P6|COMPLETED|Overall Study||4
7835785|NCT01028014|19286171|P5|COMPLETED|Overall Study||9
7835786|NCT01028014|19286172|P4|COMPLETED|Overall Study||9
7835787|NCT01028014|19286173|P3|COMPLETED|Overall Study||10
7835788|NCT01028014|19286174|P2|COMPLETED|Overall Study||8
7835789|NCT01028014|19286175|P1|COMPLETED|Overall Study||9
7835790|NCT01028014|19286170|P6|STARTED|Overall Study||6
7835791|NCT01028014|19286171|P5|STARTED|Overall Study||10
7835792|NCT01028014|19286172|P4|STARTED|Overall Study||10
7835793|NCT01028014|19286173|P3|STARTED|Overall Study||10
7835794|NCT01028014|19286174|P2|STARTED|Overall Study||10
7835795|NCT01028014|19286175|P1|STARTED|Overall Study||10
7835796|NCT01027910|19286203|P2|NOT COMPLETED|Overall Study||0
7835797|NCT01027910|19286204|P1|NOT COMPLETED|Overall Study||0
7835798|NCT01027910|19286203|P2|COMPLETED|Overall Study||14
7835799|NCT01027910|19286204|P1|COMPLETED|Overall Study||6
7835800|NCT01027910|19286203|P2|STARTED|Overall Study||14
7835801|NCT01027910|19286204|P1|STARTED|Overall Study||6
7835802|NCT01027897|19286216|P1|NOT COMPLETED|Overall Study||2
7835803|NCT01027897|19286216|P1|COMPLETED|Overall Study||28
7835804|NCT01027897|19286216|P1|STARTED|Overall Study||30
7835805|NCT01027884|19286224|P2|NOT COMPLETED|Overall Study||7
7835806|NCT01027884|19286225|P1|NOT COMPLETED|Overall Study||4
7835807|NCT01027884|19286224|P2|COMPLETED|Overall Study||25
7835808|NCT01027884|19286225|P1|COMPLETED|Overall Study||30
7835809|NCT01027884|19286224|P2|STARTED|Overall Study||32
7835810|NCT01027884|19286225|P1|STARTED|Overall Study||34
7835811|NCT01027871|19286242|P3|NOT COMPLETED|Overall Study||7
7835812|NCT01027871|19286243|P2|NOT COMPLETED|Overall Study||13
7835813|NCT01027871|19286244|P1|NOT COMPLETED|Overall Study||2
7835814|NCT01027871|19286242|P3|COMPLETED|Overall Study||91
7835815|NCT01027871|19286243|P2|COMPLETED|Overall Study||85
7835816|NCT01027871|19286244|P1|COMPLETED|Overall Study||91
7835817|NCT01027871|19286242|P3|Received at Least One Dose of Study Drug|Overall Study||97
7835818|NCT01027871|19286243|P2|Received at Least One Dose of Study Drug|Overall Study||98
7835819|NCT01027871|19286244|P1|Received at Least One Dose of Study Drug|Overall Study||93
7835820|NCT01027871|19286242|P3|STARTED|Overall Study||98
7835821|NCT01027871|19286243|P2|STARTED|Overall Study||98
7835822|NCT01027871|19286244|P1|STARTED|Overall Study||93
7835823|NCT01027845|19286303|P4|NOT COMPLETED|Booster Vaccination Phase||0
7835824|NCT01027845|19286304|P3|NOT COMPLETED|Booster Vaccination Phase||0
7835825|NCT01027845|19286305|P2|NOT COMPLETED|Booster Vaccination Phase||0
7835826|NCT01027845|19286306|P1|NOT COMPLETED|Booster Vaccination Phase||2
7835827|NCT01027845|19286303|P4|COMPLETED|Booster Vaccination Phase||1
7835828|NCT01027845|19286304|P3|COMPLETED|Booster Vaccination Phase||119
7835829|NCT01027845|19286305|P2|COMPLETED|Booster Vaccination Phase||0
7835830|NCT01027845|19286306|P1|COMPLETED|Booster Vaccination Phase||226
7835831|NCT01027845|19286303|P4|STARTED|Booster Vaccination Phase||1
7835832|NCT01027845|19286304|P3|STARTED|Booster Vaccination Phase||119
7835833|NCT01027845|19286305|P2|STARTED|Booster Vaccination Phase|Subjects from this group were assigned to DTPa+Prevenar&DTPa-No Prevenar Groups in the booster phase|0
7835834|NCT01027845|19286306|P1|STARTED|Booster Vaccination Phase||228
7835835|NCT01027845|19286303|P4|NOT COMPLETED|Primary Vaccination Phase||0
7835836|NCT01027845|19286304|P3|NOT COMPLETED|Primary Vaccination Phase||0
7835837|NCT01027845|19286305|P2|NOT COMPLETED|Primary Vaccination Phase||1
7835838|NCT01027845|19286306|P1|NOT COMPLETED|Primary Vaccination Phase||4
7835839|NCT01027845|19286303|P4|COMPLETED|Primary Vaccination Phase||0
7835840|NCT01027845|19286304|P3|COMPLETED|Primary Vaccination Phase||0
7835841|NCT01027845|19286305|P2|COMPLETED|Primary Vaccination Phase||122
7835842|NCT01027845|19286306|P1|COMPLETED|Primary Vaccination Phase||233
7835843|NCT01027845|19286303|P4|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
7835844|NCT01027845|19286304|P3|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
7835845|NCT01027845|19286305|P2|STARTED|Primary Vaccination Phase||123
7835846|NCT01027845|19286306|P1|STARTED|Primary Vaccination Phase||237
7835847|NCT01027819|19286358|P2|NOT COMPLETED|Overall Study||0
7835848|NCT01027819|19286359|P1|NOT COMPLETED|Overall Study||0
7835849|NCT01027819|19286358|P2|COMPLETED|Overall Study||40
7835850|NCT01027819|19286359|P1|COMPLETED|Overall Study||40
7835851|NCT01027819|19286358|P2|STARTED|Overall Study||40
7835852|NCT01027819|19286359|P1|STARTED|Overall Study||40
7835853|NCT01027806|19286367|P2|NOT COMPLETED|Overall Study||3
7835854|NCT01027806|19286368|P1|NOT COMPLETED|Overall Study||4
7835855|NCT01027806|19286367|P2|COMPLETED|Overall Study||29
7835856|NCT01027806|19286368|P1|COMPLETED|Overall Study||28
7835857|NCT01027806|19286367|P2|STARTED|Overall Study||32
7835858|NCT01027806|19286368|P1|STARTED|Overall Study||32
7835859|NCT01027780|19286376|P2|NOT COMPLETED|Overall Study||1
7835860|NCT01027780|19286377|P1|NOT COMPLETED|Overall Study||0
7835861|NCT01027780|19286376|P2|COMPLETED|Overall Study||102
7835862|NCT01027780|19286377|P1|COMPLETED|Overall Study||105
7835863|NCT01027780|19286376|P2|STARTED|Overall Study||103
7835864|NCT01027780|19286377|P1|STARTED|Overall Study||105
7835865|NCT01027754|19286389|P2|NOT COMPLETED|Overall Study||8
7835866|NCT01027754|19286390|P1|NOT COMPLETED|Overall Study||2
7835867|NCT01027754|19286389|P2|COMPLETED|Overall Study||47
7835868|NCT01027754|19286390|P1|COMPLETED|Overall Study||55
7835869|NCT01027754|19286389|P2|STARTED|Overall Study||55
7835870|NCT01027754|19286390|P1|STARTED|Overall Study||57
7835871|NCT01027702|19286424|P7|NOT COMPLETED|Overall Study||1
7835872|NCT01027702|19286425|P6|NOT COMPLETED|Overall Study||0
7835873|NCT01027702|19286426|P5|NOT COMPLETED|Overall Study||1
7835874|NCT01027702|19286427|P4|NOT COMPLETED|Overall Study||4
7835875|NCT01027702|19286428|P3|NOT COMPLETED|Overall Study||1
7835876|NCT01027702|19286429|P2|NOT COMPLETED|Overall Study||2
7835877|NCT01027702|19286430|P1|NOT COMPLETED|Overall Study||1
7835878|NCT01027702|19286424|P7|COMPLETED|Overall Study||1
7835879|NCT01027702|19286425|P6|COMPLETED|Overall Study||1
7835880|NCT01027702|19286426|P5|COMPLETED|Overall Study||9
7835881|NCT01027702|19286427|P4|COMPLETED|Overall Study||10
7835882|NCT01027702|19286428|P3|COMPLETED|Overall Study||2
7835883|NCT01027702|19286429|P2|COMPLETED|Overall Study||2
7835884|NCT01027702|19286430|P1|COMPLETED|Overall Study||3
7835885|NCT01027702|19286424|P7|STARTED|Overall Study||2
7835886|NCT01027702|19286425|P6|STARTED|Overall Study||1
7835887|NCT01027702|19286426|P5|STARTED|Overall Study||10
7835888|NCT01027702|19286427|P4|STARTED|Overall Study||14
7835889|NCT01027702|19286428|P3|STARTED|Overall Study||3
7835890|NCT01027702|19286429|P2|STARTED|Overall Study||4
7835891|NCT01027702|19286430|P1|STARTED|Overall Study||4
7835892|NCT01027650|19286456|P8|NOT COMPLETED|Overall Study||0
7835893|NCT01027650|19286457|P7|NOT COMPLETED|Overall Study||1
7835894|NCT01027650|19286458|P6|NOT COMPLETED|Overall Study||2
7835895|NCT01027650|19286459|P5|NOT COMPLETED|Overall Study||2
7835896|NCT01027650|19286460|P4|NOT COMPLETED|Overall Study||0
7835897|NCT01027650|19286461|P3|NOT COMPLETED|Overall Study||0
7835898|NCT01027650|19286462|P2|NOT COMPLETED|Overall Study||0
7835899|NCT01027650|19286463|P1|NOT COMPLETED|Overall Study||0
7835900|NCT01027650|19286456|P8|COMPLETED|Overall Study||24
7835901|NCT01027650|19286457|P7|COMPLETED|Overall Study||24
7835902|NCT01027650|19286458|P6|COMPLETED|Overall Study||24
7835903|NCT01027650|19286459|P5|COMPLETED|Overall Study||23
7835904|NCT01027650|19286460|P4|COMPLETED|Overall Study||3
7835905|NCT01027650|19286461|P3|COMPLETED|Overall Study||6
7835906|NCT01027650|19286462|P2|COMPLETED|Overall Study||6
7835907|NCT01027650|19286463|P1|COMPLETED|Overall Study||6
7835908|NCT01027650|19286456|P8|STARTED|Overall Study||24
7835909|NCT01027650|19286457|P7|STARTED|Overall Study||25
7835910|NCT01027650|19286458|P6|STARTED|Overall Study||26
7835911|NCT01027650|19286459|P5|STARTED|Overall Study||25
7835912|NCT01027650|19286460|P4|STARTED|Overall Study||3
7835913|NCT01027650|19286461|P3|STARTED|Overall Study||6
7835914|NCT01027650|19286462|P2|STARTED|Overall Study||6
7835915|NCT01027650|19286463|P1|STARTED|Overall Study||6
7835916|NCT01027598|19286507|P2|NOT COMPLETED|Overall Study||67
7835917|NCT01027598|19286508|P1|NOT COMPLETED|Overall Study||134
7835918|NCT01027598|19286507|P2|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
7835919|NCT01027598|19286508|P1|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
7835920|NCT01027598|19286507|P2|STARTED|Overall Study||67
7835921|NCT01027598|19286508|P1|STARTED|Overall Study|One patient was enrolled but not treated|134
7835922|NCT01027559|19286521|P3|NOT COMPLETED|Overall Study||9
7835923|NCT01027559|19286522|P2|NOT COMPLETED|Overall Study||8
7835924|NCT01027559|19286523|P1|NOT COMPLETED|Overall Study||6
7835925|NCT01027559|19286521|P3|COMPLETED|Overall Study||22
7835926|NCT01027559|19286522|P2|COMPLETED|Overall Study||26
7835927|NCT01027559|19286523|P1|COMPLETED|Overall Study||20
7835928|NCT01027559|19286521|P3|STARTED|Overall Study||31
7835929|NCT01027559|19286522|P2|STARTED|Overall Study||34
7835930|NCT01027559|19286523|P1|STARTED|Overall Study||26
7835931|NCT01027468|19286533|P1|NOT COMPLETED|Overall Study||0
7835932|NCT01027468|19286533|P1|COMPLETED|Overall Study||160
7835933|NCT01027468|19286533|P1|STARTED|Overall Study||160
7835934|NCT01027416|19286541|P2|NOT COMPLETED|Overall Study||5
7835935|NCT01027416|19286542|P1|NOT COMPLETED|Overall Study||1
7835936|NCT01027416|19286541|P2|COMPLETED|Overall Study||23
7835937|NCT01027416|19286542|P1|COMPLETED|Overall Study||30
7835938|NCT01027416|19286541|P2|STARTED|Overall Study||28
7835939|NCT01027416|19286542|P1|STARTED|Overall Study||31
7835940|NCT01027364|19286554|P4|NOT COMPLETED|Overall Study||1
7835941|NCT01027364|19286555|P3|NOT COMPLETED|Overall Study||1
7835942|NCT01027364|19286556|P2|NOT COMPLETED|Overall Study||2
7835943|NCT01027364|19286557|P1|NOT COMPLETED|Overall Study||4
7835944|NCT01027364|19286554|P4|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3
7835945|NCT01027364|19286555|P3|COMPLETED|Overall Study||26
7835946|NCT01027364|19286556|P2|COMPLETED|Overall Study||27
7835947|NCT01027364|19286557|P1|COMPLETED|Overall Study||59
7835948|NCT01027364|19286554|P4|Started Arm 4 Then Joined Another Arm|Overall Study||0
7835949|NCT01027364|19286555|P3|Started Arm 4 Then Joined Another Arm|Overall Study||0
7835950|NCT01027364|19286556|P2|Started Arm 4 Then Joined Another Arm|Overall Study||0
7835951|NCT01027364|19286557|P1|Started Arm 4 Then Joined Another Arm|Overall Study||2
7835952|NCT01027364|19286554|P4|Joined Arm 4 for Surgery Then Returned|Overall Study||0
7835953|NCT01027364|19286555|P3|Joined Arm 4 for Surgery Then Returned|Overall Study||1
7835954|NCT01027364|19286556|P2|Joined Arm 4 for Surgery Then Returned|Overall Study||0
7835955|NCT01027364|19286557|P1|Joined Arm 4 for Surgery Then Returned|Overall Study||5
7835956|NCT01027364|19286554|P4|Enrolled in Sequential PK Subgroup|Overall Study||0
7835957|NCT01027364|19286555|P3|Enrolled in Sequential PK Subgroup|Overall Study||0
7835958|NCT01027364|19286556|P2|Enrolled in Sequential PK Subgroup|Overall Study||0
7835959|NCT01027364|19286557|P1|Enrolled in Sequential PK Subgroup|Overall Study||22
7835960|NCT01027364|19286554|P4|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4
7835961|NCT01027364|19286555|P3|STARTED|Overall Study||27
7835962|NCT01027364|19286556|P2|STARTED|Overall Study||29
7835963|NCT01027364|19286557|P1|STARTED|Overall Study||63
7835964|NCT01027351|19286652|P6|NOT COMPLETED|Overall Study||5
7835965|NCT01027351|19286653|P5|NOT COMPLETED|Overall Study||11
7835966|NCT01027351|19286654|P4|NOT COMPLETED|Overall Study||2
7835967|NCT01027351|19286655|P3|NOT COMPLETED|Overall Study||1
7835968|NCT01027351|19286656|P2|NOT COMPLETED|Overall Study||1
7835969|NCT01027351|19286657|P1|NOT COMPLETED|Overall Study||3
7835970|NCT01027351|19286652|P6|COMPLETED|Overall Study||45
7835971|NCT01027351|19286653|P5|COMPLETED|Overall Study||32
7835972|NCT01027351|19286654|P4|COMPLETED|Overall Study||6
7835973|NCT01027351|19286655|P3|COMPLETED|Overall Study||13
7835974|NCT01027351|19286656|P2|COMPLETED|Overall Study||18
7835975|NCT01027351|19286657|P1|COMPLETED|Overall Study||26
7835976|NCT01027351|19286652|P6|STARTED|Overall Study||50
7835977|NCT01027351|19286653|P5|STARTED|Overall Study||43
7835978|NCT01027351|19286654|P4|STARTED|Overall Study||8
7835979|NCT01027351|19286655|P3|STARTED|Overall Study||14
7835980|NCT01027351|19286656|P2|STARTED|Overall Study||19
7835981|NCT01027351|19286657|P1|STARTED|Overall Study||29
7835982|NCT01027286|19286741|P2|NOT COMPLETED|Overall Study||1
7835983|NCT01027286|19286742|P1|NOT COMPLETED|Overall Study||1
7835984|NCT01027286|19286741|P2|COMPLETED|Overall Study||49
7835985|NCT01027286|19286742|P1|COMPLETED|Overall Study||49
7835986|NCT01027286|19286741|P2|12 Week Postoperative|Overall Study||49
7835987|NCT01027286|19286742|P1|12 Week Postoperative|Overall Study||49
7835988|NCT01027286|19286741|P2|4 Week Postoperative|Overall Study||50
7835989|NCT01027286|19286742|P1|4 Week Postoperative|Overall Study||49
7835990|NCT01027286|19286741|P2|Day of Surgery|Overall Study||50
7835991|NCT01027286|19286742|P1|Day of Surgery|Overall Study||50
7835992|NCT01027286|19286741|P2|Preoperative|Overall Study||50
7835993|NCT01027286|19286742|P1|Preoperative|Overall Study||50
7835994|NCT01027286|19286741|P2|STARTED|Overall Study||50
7835995|NCT01027286|19286742|P1|STARTED|Overall Study||50
7835996|NCT01027273|19286762|P2|NOT COMPLETED|Overall Study||33
7835997|NCT01027273|19286763|P1|NOT COMPLETED|Overall Study||59
7835998|NCT01027273|19286762|P2|COMPLETED|Overall Study||266
7835999|NCT01027273|19286763|P1|COMPLETED|Overall Study||242
7836000|NCT01027273|19286762|P2|STARTED|Overall Study||299
7836001|NCT01027273|19286763|P1|STARTED|Overall Study||301
7836002|NCT01027195|19286781|P2|NOT COMPLETED|Overall Study||0
7836003|NCT01027195|19286782|P1|NOT COMPLETED|Overall Study||0
7836004|NCT01027195|19286781|P2|COMPLETED|Overall Study||69
7836005|NCT01027195|19286782|P1|COMPLETED|Overall Study||71
7836006|NCT01027195|19286781|P2|STARTED|Overall Study||69
7836007|NCT01027195|19286782|P1|STARTED|Overall Study||71
7836008|NCT01027000|19286802|P1|NOT COMPLETED|Overall Study||0
7836009|NCT01027000|19286802|P1|COMPLETED|Overall Study||68
7836010|NCT01027000|19286802|P1|STARTED|Overall Study||68
7836011|NCT01026974|19286810|P4|NOT COMPLETED|Overall Study||3
7836012|NCT01026974|19286811|P3|NOT COMPLETED|Overall Study||12
7836013|NCT01026974|19286812|P2|NOT COMPLETED|Overall Study||2
7836014|NCT01026974|19286813|P1|NOT COMPLETED|Overall Study||1
7836015|NCT01026974|19286810|P4|COMPLETED|Overall Study||46
7836016|NCT01026974|19286811|P3|COMPLETED|Overall Study||29
7836017|NCT01026974|19286812|P2|COMPLETED|Overall Study||12
7836018|NCT01026974|19286813|P1|COMPLETED|Overall Study||15
7836019|NCT01026974|19286810|P4|STARTED|Overall Study||49
7836020|NCT01026974|19286811|P3|STARTED|Overall Study||41
7836021|NCT01026974|19286812|P2|STARTED|Overall Study||14
7836022|NCT01026974|19286813|P1|STARTED|Overall Study||16
7836023|NCT01026948|19286870|P1|NOT COMPLETED|Overall Study||8
7836024|NCT01026948|19286870|P1|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62
7836025|NCT01026948|19286870|P1|STARTED|Overall Study||70
7836026|NCT01026909|19286877|P2|NOT COMPLETED|Overall Study||0
7836027|NCT01026909|19286878|P1|NOT COMPLETED|Overall Study||0
7836028|NCT01026909|19286877|P2|COMPLETED|Overall Study||2
7836029|NCT01026909|19286878|P1|COMPLETED|Overall Study||1
7836030|NCT01026909|19286877|P2|STARTED|Overall Study||2
7836031|NCT01026909|19286878|P1|STARTED|Overall Study||1
7836032|NCT01026844|19286888|P2|NOT COMPLETED|Overall Study||0
7836033|NCT01026844|19286889|P1|NOT COMPLETED|Overall Study||0
7836034|NCT01026844|19286888|P2|COMPLETED|Overall Study||8
7836035|NCT01026844|19286889|P1|COMPLETED|Overall Study||19
7836036|NCT01026844|19286888|P2|STARTED|Overall Study||8
7836037|NCT01026844|19286889|P1|STARTED|Overall Study||19
7836038|NCT01026831|19286903|P2|NOT COMPLETED|Overall Study||11
7836039|NCT01026831|19286904|P1|NOT COMPLETED|Overall Study||14
7836040|NCT01026831|19286903|P2|COMPLETED|Overall Study||312
7836041|NCT01026831|19286904|P1|COMPLETED|Overall Study||306
7836042|NCT01026831|19286903|P2|STARTED|Overall Study|randomized|323
7836043|NCT01026831|19286904|P1|STARTED|Overall Study|randomized|320
7836044|NCT01026818|19286915|P4|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3
7836045|NCT01026818|19286916|P3|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5
7836046|NCT01026818|19286917|P2|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7
7836047|NCT01026818|19286918|P1|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0
7836048|NCT01026818|19286915|P4|COMPLETED|OL Period (Month 10.5 - 13.5)||105
7836049|NCT01026818|19286916|P3|COMPLETED|OL Period (Month 10.5 - 13.5)||112
7836050|NCT01026818|19286917|P2|COMPLETED|OL Period (Month 10.5 - 13.5)||98
7836051|NCT01026818|19286918|P1|COMPLETED|OL Period (Month 10.5 - 13.5)||0
7836052|NCT01026818|19286915|P4|STARTED|OL Period (Month 10.5 - 13.5)||108
7836053|NCT01026818|19286916|P3|STARTED|OL Period (Month 10.5 - 13.5)||117
7836054|NCT01026818|19286917|P2|STARTED|OL Period (Month 10.5 - 13.5)||105
7836055|NCT01026818|19286918|P1|STARTED|OL Period (Month 10.5 - 13.5)||0
7836056|NCT01026818|19286915|P4|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7
7836057|NCT01026818|19286916|P3|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5
7836058|NCT01026818|19286917|P2|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9
7836059|NCT01026818|19286918|P1|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
7836060|NCT01026818|19286915|P4|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108
7836061|NCT01026818|19286916|P3|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117
7836062|NCT01026818|19286917|P2|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105
7836063|NCT01026818|19286918|P1|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
7836064|NCT01026818|19286915|P4|STARTED|Drug-Free Washout Period (Month 9-10.5)||115
7836065|NCT01026818|19286916|P3|STARTED|Drug-Free Washout Period (Month 9-10.5)||122
7836066|NCT01026818|19286917|P2|STARTED|Drug-Free Washout Period (Month 9-10.5)||114
7836067|NCT01026818|19286918|P1|STARTED|Drug-Free Washout Period (Month 9-10.5)||0
7836068|NCT01026818|19286915|P4|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26
7836069|NCT01026818|19286916|P3|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21
7836070|NCT01026818|19286917|P2|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25
7836071|NCT01026818|19286918|P1|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0
7836072|NCT01026818|19286915|P4|COMPLETED|DB Treatment Period (Month 0 - 9)||115
7836073|NCT01026818|19286916|P3|COMPLETED|DB Treatment Period (Month 0 - 9)||122
7836074|NCT01026818|19286917|P2|COMPLETED|DB Treatment Period (Month 0 - 9)||114
7836075|NCT01026818|19286918|P1|COMPLETED|DB Treatment Period (Month 0 - 9)||0
7836076|NCT01026818|19286915|P4|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141
7836077|NCT01026818|19286916|P3|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143
7836078|NCT01026818|19286917|P2|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139
7836079|NCT01026818|19286918|P1|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0
7836080|NCT01026818|19286915|P4|STARTED|DB Treatment Period (Month 0 - 9)||141
7836081|NCT01026818|19286916|P3|STARTED|DB Treatment Period (Month 0 - 9)||143
7836082|NCT01026818|19286917|P2|STARTED|DB Treatment Period (Month 0 - 9)||139
7836083|NCT01026818|19286918|P1|STARTED|DB Treatment Period (Month 0 - 9)||0
7836084|NCT01026818|19286915|P4|NOT COMPLETED|Screening Period||0
7836085|NCT01026818|19286916|P3|NOT COMPLETED|Screening Period||0
7836086|NCT01026818|19286917|P2|NOT COMPLETED|Screening Period||0
7836087|NCT01026818|19286918|P1|NOT COMPLETED|Screening Period||160
7836088|NCT01026818|19286915|P4|COMPLETED|Screening Period||0
7836089|NCT01026818|19286916|P3|COMPLETED|Screening Period||0
7836090|NCT01026818|19286917|P2|COMPLETED|Screening Period||0
7836091|NCT01026818|19286918|P1|COMPLETED|Screening Period||423
7836092|NCT01026818|19286915|P4|STARTED|Screening Period||0
7836093|NCT01026818|19286916|P3|STARTED|Screening Period||0
7836094|NCT01026818|19286917|P2|STARTED|Screening Period||0
7836095|NCT01026818|19286918|P1|STARTED|Screening Period||583
7836096|NCT01026805|19286996|P1|NOT COMPLETED|Overall Study||0
7836097|NCT01026805|19286996|P1|COMPLETED|Overall Study||11
7836098|NCT01026805|19286996|P1|STARTED|Overall Study||11
7836099|NCT01026792|19287006|P1|NOT COMPLETED|Overall Study||1
7836100|NCT01026792|19287006|P1|COMPLETED|Overall Study||37
7836101|NCT01026792|19287006|P1|STARTED|Overall Study||38
7836102|NCT01026623|19287013|P3|NOT COMPLETED|Overall Study||0
7836103|NCT01026623|19287014|P2|NOT COMPLETED|Overall Study||0
7836104|NCT01026623|19287015|P1|NOT COMPLETED|Overall Study||0
7836105|NCT01026623|19287013|P3|COMPLETED|Overall Study||5
7836106|NCT01026623|19287014|P2|COMPLETED|Overall Study||5
7836107|NCT01026623|19287015|P1|COMPLETED|Overall Study||6
7836108|NCT01026623|19287013|P3|STARTED|Overall Study||5
7836109|NCT01026623|19287014|P2|STARTED|Overall Study||5
7836110|NCT01026623|19287015|P1|STARTED|Overall Study||6
7836111|NCT01026493|19287049|P8|NOT COMPLETED|Overall Study||1
7836112|NCT01026493|19287050|P7|NOT COMPLETED|Overall Study||4
7836113|NCT01026493|19287051|P6|NOT COMPLETED|Overall Study||3
7836114|NCT01026493|19287052|P5|NOT COMPLETED|Overall Study||2
7836115|NCT01026493|19287053|P4|NOT COMPLETED|Overall Study||0
7836116|NCT01026493|19287054|P3|NOT COMPLETED|Overall Study||0
7836117|NCT01026493|19287055|P2|NOT COMPLETED|Overall Study||1
7836118|NCT01026493|19287056|P1|NOT COMPLETED|Overall Study||0
7836119|NCT01026493|19287049|P8|COMPLETED|Overall Study||37
7836120|NCT01026493|19287050|P7|COMPLETED|Overall Study||32
7836121|NCT01026493|19287051|P6|COMPLETED|Overall Study||73
7836122|NCT01026493|19287052|P5|COMPLETED|Overall Study||73
7836123|NCT01026493|19287053|P4|COMPLETED|Overall Study||8
7836124|NCT01026493|19287054|P3|COMPLETED|Overall Study||9
7836125|NCT01026493|19287055|P2|COMPLETED|Overall Study||6
7836126|NCT01026493|19287056|P1|COMPLETED|Overall Study||8
7836127|NCT01026493|19287049|P8|STARTED|Overall Study||38
7836128|NCT01026493|19287050|P7|STARTED|Overall Study||36
7836129|NCT01026493|19287051|P6|STARTED|Overall Study||76
7836130|NCT01026493|19287052|P5|STARTED|Overall Study||75
7836131|NCT01026493|19287053|P4|STARTED|Overall Study||8
7836132|NCT01026493|19287054|P3|STARTED|Overall Study||9
7836133|NCT01026493|19287055|P2|STARTED|Overall Study||7
7836134|NCT01026493|19287056|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|8
7836135|NCT01026454|19287084|P2|NOT COMPLETED|Second Intervention||1
7836136|NCT01026454|19287085|P1|NOT COMPLETED|Second Intervention||1
7836137|NCT01026454|19287084|P2|COMPLETED|Second Intervention||13
7836138|NCT01026454|19287085|P1|COMPLETED|Second Intervention||16
7836139|NCT01026454|19287084|P2|STARTED|Second Intervention||14
7836140|NCT01026454|19287085|P1|STARTED|Second Intervention||17
7836141|NCT01026454|19287084|P2|NOT COMPLETED|Washout||0
7836142|NCT01026454|19287085|P1|NOT COMPLETED|Washout||0
7836143|NCT01026454|19287084|P2|COMPLETED|Washout||14
7836144|NCT01026454|19287085|P1|COMPLETED|Washout||18
7836145|NCT01026454|19287084|P2|STARTED|Washout||14
7836146|NCT01026454|19287085|P1|STARTED|Washout||18
7836147|NCT01026454|19287084|P2|NOT COMPLETED|First Intervention||0
7836148|NCT01026454|19287085|P1|NOT COMPLETED|First Intervention||0
7836149|NCT01026454|19287084|P2|COMPLETED|First Intervention||14
7836150|NCT01026454|19287085|P1|COMPLETED|First Intervention||18
7836151|NCT01026454|19287084|P2|STARTED|First Intervention||14
7836152|NCT01026454|19287085|P1|STARTED|First Intervention||18
7836153|NCT01026402|19287108|P17|NOT COMPLETED|Overall Study||0
7836154|NCT01026402|19287109|P16|NOT COMPLETED|Overall Study||0
7836155|NCT01026402|19287110|P15|NOT COMPLETED|Overall Study||0
7836156|NCT01026402|19287111|P14|NOT COMPLETED|Overall Study||0
7836157|NCT01026402|19287112|P13|NOT COMPLETED|Overall Study||0
7836158|NCT01026402|19287113|P12|NOT COMPLETED|Overall Study||0
7836159|NCT01026402|19287114|P11|NOT COMPLETED|Overall Study||0
7836160|NCT01026402|19287115|P10|NOT COMPLETED|Overall Study||0
7836161|NCT01026402|19287116|P9|NOT COMPLETED|Overall Study||0
7836162|NCT01026402|19287117|P8|NOT COMPLETED|Overall Study||0
7836163|NCT01026402|19287118|P7|NOT COMPLETED|Overall Study||0
7836164|NCT01026402|19287119|P6|NOT COMPLETED|Overall Study||0
7836165|NCT01026402|19287120|P5|NOT COMPLETED|Overall Study||0
7836166|NCT01026402|19287121|P4|NOT COMPLETED|Overall Study||0
7836167|NCT01026402|19287122|P3|NOT COMPLETED|Overall Study||0
7836168|NCT01026402|19287123|P2|NOT COMPLETED|Overall Study||0
7836169|NCT01026402|19287124|P1|NOT COMPLETED|Overall Study||0
7836170|NCT01026402|19287108|P17|COMPLETED|Overall Study||4
7836171|NCT01026402|19287109|P16|COMPLETED|Overall Study||5
7836172|NCT01026402|19287110|P15|COMPLETED|Overall Study||3
7836173|NCT01026402|19287111|P14|COMPLETED|Overall Study||6
7836174|NCT01026402|19287112|P13|COMPLETED|Overall Study||8
7836175|NCT01026402|19287113|P12|COMPLETED|Overall Study||8
7836176|NCT01026402|19287114|P11|COMPLETED|Overall Study||7
7836177|NCT01026402|19287115|P10|COMPLETED|Overall Study||3
7836178|NCT01026402|19287116|P9|COMPLETED|Overall Study||7
7836179|NCT01026402|19287117|P8|COMPLETED|Overall Study||3
7836180|NCT01026402|19287118|P7|COMPLETED|Overall Study||8
7836181|NCT01026402|19287119|P6|COMPLETED|Overall Study||5
7836182|NCT01026402|19287120|P5|COMPLETED|Overall Study||3
7836183|NCT01026402|19287121|P4|COMPLETED|Overall Study||18
7836184|NCT01026402|19287122|P3|COMPLETED|Overall Study||33
7836185|NCT01026402|19287123|P2|COMPLETED|Overall Study||8
7836186|NCT01026402|19287124|P1|COMPLETED|Overall Study||6
7836187|NCT01026402|19287108|P17|STARTED|Overall Study||4
7836188|NCT01026402|19287109|P16|STARTED|Overall Study||5
7836189|NCT01026402|19287110|P15|STARTED|Overall Study||3
7836190|NCT01026402|19287111|P14|STARTED|Overall Study||6
7836191|NCT01026402|19287112|P13|STARTED|Overall Study||8
7836192|NCT01026402|19287113|P12|STARTED|Overall Study||8
7836193|NCT01026402|19287114|P11|STARTED|Overall Study||7
7836194|NCT01026402|19287115|P10|STARTED|Overall Study||3
7836195|NCT01026402|19287116|P9|STARTED|Overall Study||7
7836196|NCT01026402|19287117|P8|STARTED|Overall Study||3
7836197|NCT01026402|19287118|P7|STARTED|Overall Study||8
7836198|NCT01026402|19287119|P6|STARTED|Overall Study||5
7836199|NCT01026402|19287120|P5|STARTED|Overall Study||3
7836200|NCT01026402|19287121|P4|STARTED|Overall Study||18
7836201|NCT01026402|19287122|P3|STARTED|Overall Study||33
7836202|NCT01026402|19287123|P2|STARTED|Overall Study||8
7836203|NCT01026402|19287124|P1|STARTED|Overall Study||6
7836204|NCT01026389|19287434|P2|NOT COMPLETED|Overall Study||5
7836205|NCT01026389|19287435|P1|NOT COMPLETED|Overall Study||5
7836206|NCT01026389|19287434|P2|COMPLETED|Overall Study||88
7836207|NCT01026389|19287435|P1|COMPLETED|Overall Study||88
7836208|NCT01026389|19287434|P2|STARTED|Overall Study||93
7836209|NCT01026389|19287435|P1|STARTED|Overall Study||93
7836210|NCT01026324|19287450|P3|NOT COMPLETED|Follow up/Survival||0
7836211|NCT01026324|19287451|P2|NOT COMPLETED|Follow up/Survival||0
7836212|NCT01026324|19287452|P1|NOT COMPLETED|Follow up/Survival||1
7836213|NCT01026324|19287450|P3|COMPLETED|Follow up/Survival||4
7836214|NCT01026324|19287451|P2|COMPLETED|Follow up/Survival||3
7836215|NCT01026324|19287452|P1|COMPLETED|Follow up/Survival||4
7836216|NCT01026324|19287450|P3|Follow up Discontinuation (Death)|Follow up/Survival||4
7836217|NCT01026324|19287451|P2|Follow up Discontinuation (Death)|Follow up/Survival||3
7836218|NCT01026324|19287452|P1|Follow up Discontinuation (Death)|Follow up/Survival||4
7836219|NCT01026324|19287450|P3|STARTED|Follow up/Survival||4
7836220|NCT01026324|19287451|P2|STARTED|Follow up/Survival||3
7836221|NCT01026324|19287452|P1|STARTED|Follow up/Survival||5
7836222|NCT01026324|19287450|P3|NOT COMPLETED|Treatment Allocation||0
7836223|NCT01026324|19287451|P2|NOT COMPLETED|Treatment Allocation||0
7836224|NCT01026324|19287452|P1|NOT COMPLETED|Treatment Allocation||0
7836225|NCT01026324|19287450|P3|COMPLETED|Treatment Allocation||4
7836226|NCT01026324|19287451|P2|COMPLETED|Treatment Allocation||3
7836227|NCT01026324|19287452|P1|COMPLETED|Treatment Allocation||5
7836228|NCT01026324|19287450|P3|Discontinued Intervention (Withdrew)|Treatment Allocation||0
7836229|NCT01026324|19287451|P2|Discontinued Intervention (Withdrew)|Treatment Allocation||0
7836230|NCT01026324|19287452|P1|Discontinued Intervention (Withdrew)|Treatment Allocation||1
7836231|NCT01026324|19287450|P3|Discontinuted Intervention (Progression)|Treatment Allocation||4
7836232|NCT01026324|19287451|P2|Discontinuted Intervention (Progression)|Treatment Allocation||3
7836233|NCT01026324|19287452|P1|Discontinuted Intervention (Progression)|Treatment Allocation||3
7836234|NCT01026324|19287450|P3|Discontinued Intervention (Toxicity)|Treatment Allocation||0
7836235|NCT01026324|19287451|P2|Discontinued Intervention (Toxicity)|Treatment Allocation||0
7836236|NCT01026324|19287452|P1|Discontinued Intervention (Toxicity)|Treatment Allocation||1
7836237|NCT01026324|19287450|P3|STARTED|Treatment Allocation||4
7836238|NCT01026324|19287451|P2|STARTED|Treatment Allocation||3
7836239|NCT01026324|19287452|P1|STARTED|Treatment Allocation||5
7836240|NCT01026220|19287462|P3|NOT COMPLETED|Consolidation Maintenance||14
7836241|NCT01026220|19287463|P2|NOT COMPLETED|Consolidation Maintenance||6
7836242|NCT01026220|19287464|P1|NOT COMPLETED|Consolidation Maintenance||0
7836243|NCT01026220|19287462|P3|COMPLETED|Consolidation Maintenance||66
7836244|NCT01026220|19287463|P2|COMPLETED|Consolidation Maintenance||75
7836245|NCT01026220|19287464|P1|COMPLETED|Consolidation Maintenance||0
7836246|NCT01026220|19287462|P3|STARTED|Consolidation Maintenance||80
7836247|NCT01026220|19287463|P2|STARTED|Consolidation Maintenance||81
7836248|NCT01026220|19287464|P1|STARTED|Consolidation Maintenance||0
7836249|NCT01026220|19287462|P3|NOT COMPLETED|Induction||0
7836250|NCT01026220|19287463|P2|NOT COMPLETED|Induction||0
7836251|NCT01026220|19287464|P1|NOT COMPLETED|Induction||25
7836252|NCT01026220|19287462|P3|COMPLETED|Induction||0
7836253|NCT01026220|19287463|P2|COMPLETED|Induction||0
7836254|NCT01026220|19287464|P1|COMPLETED|Induction||141
7836255|NCT01026220|19287462|P3|STARTED|Induction||0
7836256|NCT01026220|19287463|P2|STARTED|Induction||0
7836257|NCT01026220|19287464|P1|STARTED|Induction||166
7836258|NCT01026194|19287488|P2|NOT COMPLETED|Period 2：Open-label Period||10
7836259|NCT01026194|19287489|P1|NOT COMPLETED|Period 2：Open-label Period||7
7836260|NCT01026194|19287488|P2|COMPLETED|Period 2：Open-label Period||88
7836261|NCT01026194|19287489|P1|COMPLETED|Period 2：Open-label Period||91
7836262|NCT01026194|19287488|P2|STARTED|Period 2：Open-label Period||98
7836263|NCT01026194|19287489|P1|STARTED|Period 2：Open-label Period||98
7836264|NCT01026194|19287488|P2|NOT COMPLETED|Period 1：Double Blind Period||5
7836265|NCT01026194|19287489|P1|NOT COMPLETED|Period 1：Double Blind Period||3
7836266|NCT01026194|19287488|P2|COMPLETED|Period 1：Double Blind Period||98
7836267|NCT01026194|19287489|P1|COMPLETED|Period 1：Double Blind Period||98
7836268|NCT01026194|19287488|P2|STARTED|Period 1：Double Blind Period||103
7836269|NCT01026194|19287489|P1|STARTED|Period 1：Double Blind Period||101
7836270|NCT01026181|19287506|P3|NOT COMPLETED|Overall Study||0
7836271|NCT01026181|19287507|P2|NOT COMPLETED|Overall Study||0
7836272|NCT01026181|19287508|P1|NOT COMPLETED|Overall Study||0
7836273|NCT01026181|19287506|P3|COMPLETED|Overall Study||48
7836274|NCT01026181|19287507|P2|COMPLETED|Overall Study||51
7836275|NCT01026181|19287508|P1|COMPLETED|Overall Study||51
7836276|NCT01026181|19287506|P3|STARTED|Overall Study||48
7836277|NCT01026181|19287507|P2|STARTED|Overall Study||51
7836278|NCT01026181|19287508|P1|STARTED|Overall Study||51
7836279|NCT01026142|19287521|P2|NOT COMPLETED|Overall Study||163
7836280|NCT01026142|19287522|P1|NOT COMPLETED|Overall Study||172
7836281|NCT01026142|19287521|P2|COMPLETED|Overall Study||65
7836282|NCT01026142|19287522|P1|COMPLETED|Overall Study||52
7836283|NCT01026142|19287521|P2|STARTED|Overall Study||228
7836284|NCT01026142|19287522|P1|STARTED|Overall Study||224
7836285|NCT01026103|19287544|P1|NOT COMPLETED|Overall Study||2
7836286|NCT01026103|19287544|P1|COMPLETED|Overall Study||28
7836287|NCT01026103|19287544|P1|Consented|Overall Study||30
7836288|NCT01026103|19287544|P1|STARTED|Overall Study||30
7836289|NCT01026038|19287554|P3|NOT COMPLETED|Overall Study||0
7836290|NCT01026038|19287555|P2|NOT COMPLETED|Overall Study||1
7836291|NCT01026038|19287556|P1|NOT COMPLETED|Overall Study||1
7836292|NCT01026038|19287554|P3|COMPLETED|Overall Study||67
7836293|NCT01026038|19287555|P2|COMPLETED|Overall Study||64
7836294|NCT01026038|19287556|P1|COMPLETED|Overall Study||129
7836295|NCT01026038|19287554|P3|STARTED|Overall Study||67
7836296|NCT01026038|19287555|P2|STARTED|Overall Study||65
7836297|NCT01026038|19287556|P1|STARTED|Overall Study||130
7836298|NCT01026012|19287591|P1|NOT COMPLETED|Overall Study||0
7836299|NCT01026012|19287591|P1|COMPLETED|Overall Study||40
7836300|NCT01026012|19287591|P1|STARTED|Overall Study||40
7836301|NCT01025843|19287605|P10|NOT COMPLETED|Period 5||0
7836302|NCT01025843|19287606|P9|NOT COMPLETED|Period 5||0
7836303|NCT01025843|19287607|P8|NOT COMPLETED|Period 5||0
7836304|NCT01025843|19287608|P7|NOT COMPLETED|Period 5||0
7836305|NCT01025843|19287609|P6|NOT COMPLETED|Period 5||0
7836306|NCT01025843|19287610|P5|NOT COMPLETED|Period 5||0
7836307|NCT01025843|19287611|P4|NOT COMPLETED|Period 5||0
7836308|NCT01025843|19287612|P3|NOT COMPLETED|Period 5||0
7836309|NCT01025843|19287613|P2|NOT COMPLETED|Period 5||0
7836310|NCT01025843|19287614|P1|NOT COMPLETED|Period 5||0
7836311|NCT01025843|19287605|P10|COMPLETED|Period 5||2
7836312|NCT01025843|19287606|P9|COMPLETED|Period 5||2
7836313|NCT01025843|19287607|P8|COMPLETED|Period 5||2
7836314|NCT01025843|19287608|P7|COMPLETED|Period 5||2
7836315|NCT01025843|19287609|P6|COMPLETED|Period 5||2
7836316|NCT01025843|19287610|P5|COMPLETED|Period 5||2
7836317|NCT01025843|19287611|P4|COMPLETED|Period 5||1
7836318|NCT01025843|19287612|P3|COMPLETED|Period 5||1
7836319|NCT01025843|19287613|P2|COMPLETED|Period 5||2
7836320|NCT01025843|19287614|P1|COMPLETED|Period 5||2
7836321|NCT01025843|19287605|P10|STARTED|Period 5||2
7836322|NCT01025843|19287606|P9|STARTED|Period 5||2
7836323|NCT01025843|19287607|P8|STARTED|Period 5||2
7836324|NCT01025843|19287608|P7|STARTED|Period 5||2
7836325|NCT01025843|19287609|P6|STARTED|Period 5||2
7836326|NCT01025843|19287610|P5|STARTED|Period 5||2
7836327|NCT01025843|19287611|P4|STARTED|Period 5||1
7836328|NCT01025843|19287612|P3|STARTED|Period 5||1
7836329|NCT01025843|19287613|P2|STARTED|Period 5||2
7836330|NCT01025843|19287614|P1|STARTED|Period 5||2
7836331|NCT01025843|19287605|P10|NOT COMPLETED|Washout 4||0
7836332|NCT01025843|19287606|P9|NOT COMPLETED|Washout 4||0
7836333|NCT01025843|19287607|P8|NOT COMPLETED|Washout 4||0
7836334|NCT01025843|19287608|P7|NOT COMPLETED|Washout 4||0
7836335|NCT01025843|19287609|P6|NOT COMPLETED|Washout 4||0
7836336|NCT01025843|19287610|P5|NOT COMPLETED|Washout 4||0
7836337|NCT01025843|19287611|P4|NOT COMPLETED|Washout 4||1
7836338|NCT01025843|19287612|P3|NOT COMPLETED|Washout 4||1
7836339|NCT01025843|19287613|P2|NOT COMPLETED|Washout 4||0
7836340|NCT01025843|19287614|P1|NOT COMPLETED|Washout 4||0
7836341|NCT01025843|19287605|P10|COMPLETED|Washout 4||2
7836342|NCT01025843|19287606|P9|COMPLETED|Washout 4||2
7836343|NCT01025843|19287607|P8|COMPLETED|Washout 4||2
7836344|NCT01025843|19287608|P7|COMPLETED|Washout 4||2
7836345|NCT01025843|19287609|P6|COMPLETED|Washout 4||2
7836346|NCT01025843|19287610|P5|COMPLETED|Washout 4||2
7836347|NCT01025843|19287611|P4|COMPLETED|Washout 4||1
7836348|NCT01025843|19287612|P3|COMPLETED|Washout 4||1
7836349|NCT01025843|19287613|P2|COMPLETED|Washout 4||2
7836350|NCT01025843|19287614|P1|COMPLETED|Washout 4||2
7836351|NCT01025843|19287605|P10|STARTED|Washout 4||2
7836352|NCT01025843|19287606|P9|STARTED|Washout 4||2
7836353|NCT01025843|19287607|P8|STARTED|Washout 4||2
7836354|NCT01025843|19287608|P7|STARTED|Washout 4||2
7836355|NCT01025843|19287609|P6|STARTED|Washout 4||2
7836356|NCT01025843|19287610|P5|STARTED|Washout 4||2
7836357|NCT01025843|19287611|P4|STARTED|Washout 4||2
7836358|NCT01025843|19287612|P3|STARTED|Washout 4||2
7836359|NCT01025843|19287613|P2|STARTED|Washout 4||2
7836360|NCT01025843|19287614|P1|STARTED|Washout 4||2
7836361|NCT01025843|19287605|P10|NOT COMPLETED|Period 4||0
7836362|NCT01025843|19287606|P9|NOT COMPLETED|Period 4||0
7836363|NCT01025843|19287607|P8|NOT COMPLETED|Period 4||0
7836364|NCT01025843|19287608|P7|NOT COMPLETED|Period 4||0
7836365|NCT01025843|19287609|P6|NOT COMPLETED|Period 4||0
7836366|NCT01025843|19287610|P5|NOT COMPLETED|Period 4||0
7836367|NCT01025843|19287611|P4|NOT COMPLETED|Period 4||0
7836368|NCT01025843|19287612|P3|NOT COMPLETED|Period 4||0
7836369|NCT01025843|19287613|P2|NOT COMPLETED|Period 4||0
7836370|NCT01025843|19287614|P1|NOT COMPLETED|Period 4||0
7836371|NCT01025843|19287605|P10|COMPLETED|Period 4||2
7836372|NCT01025843|19287606|P9|COMPLETED|Period 4||2
7836373|NCT01025843|19287607|P8|COMPLETED|Period 4||2
7836374|NCT01025843|19287608|P7|COMPLETED|Period 4||2
7836375|NCT01025843|19287609|P6|COMPLETED|Period 4||2
7836376|NCT01025843|19287610|P5|COMPLETED|Period 4||2
7836377|NCT01025843|19287611|P4|COMPLETED|Period 4||2
7836378|NCT01025843|19287612|P3|COMPLETED|Period 4||2
7836379|NCT01025843|19287613|P2|COMPLETED|Period 4||2
7836380|NCT01025843|19287614|P1|COMPLETED|Period 4||2
7836381|NCT01025843|19287605|P10|STARTED|Period 4||2
7836382|NCT01025843|19287606|P9|STARTED|Period 4||2
7836383|NCT01025843|19287607|P8|STARTED|Period 4||2
7836384|NCT01025843|19287608|P7|STARTED|Period 4||2
7836385|NCT01025843|19287609|P6|STARTED|Period 4||2
7836386|NCT01025843|19287610|P5|STARTED|Period 4||2
7836387|NCT01025843|19287611|P4|STARTED|Period 4||2
7836388|NCT01025843|19287612|P3|STARTED|Period 4||2
7836389|NCT01025843|19287613|P2|STARTED|Period 4||2
7836390|NCT01025843|19287614|P1|STARTED|Period 4||2
7836391|NCT01025843|19287605|P10|NOT COMPLETED|Washout 3||0
7836392|NCT01025843|19287606|P9|NOT COMPLETED|Washout 3||0
7836393|NCT01025843|19287607|P8|NOT COMPLETED|Washout 3||0
7836394|NCT01025843|19287608|P7|NOT COMPLETED|Washout 3||0
7836395|NCT01025843|19287609|P6|NOT COMPLETED|Washout 3||0
7836396|NCT01025843|19287610|P5|NOT COMPLETED|Washout 3||0
7836397|NCT01025843|19287611|P4|NOT COMPLETED|Washout 3||0
7836398|NCT01025843|19287612|P3|NOT COMPLETED|Washout 3||0
7836399|NCT01025843|19287613|P2|NOT COMPLETED|Washout 3||0
7836400|NCT01025843|19287614|P1|NOT COMPLETED|Washout 3||0
7836401|NCT01025843|19287605|P10|COMPLETED|Washout 3||2
7836402|NCT01025843|19287606|P9|COMPLETED|Washout 3||2
7836403|NCT01025843|19287607|P8|COMPLETED|Washout 3||2
7836404|NCT01025843|19287608|P7|COMPLETED|Washout 3||2
7836405|NCT01025843|19287609|P6|COMPLETED|Washout 3||2
7836406|NCT01025843|19287610|P5|COMPLETED|Washout 3||2
7836407|NCT01025843|19287611|P4|COMPLETED|Washout 3||2
7836408|NCT01025843|19287612|P3|COMPLETED|Washout 3||2
7836409|NCT01025843|19287613|P2|COMPLETED|Washout 3||2
7836410|NCT01025843|19287614|P1|COMPLETED|Washout 3||2
7836411|NCT01025843|19287605|P10|STARTED|Washout 3||2
7836412|NCT01025843|19287606|P9|STARTED|Washout 3||2
7836413|NCT01025843|19287607|P8|STARTED|Washout 3||2
7836414|NCT01025843|19287608|P7|STARTED|Washout 3||2
7836415|NCT01025843|19287609|P6|STARTED|Washout 3||2
7836416|NCT01025843|19287610|P5|STARTED|Washout 3||2
7836417|NCT01025843|19287611|P4|STARTED|Washout 3||2
7836418|NCT01025843|19287612|P3|STARTED|Washout 3||2
7836419|NCT01025843|19287613|P2|STARTED|Washout 3||2
7836420|NCT01025843|19287614|P1|STARTED|Washout 3||2
7836421|NCT01025843|19287605|P10|NOT COMPLETED|Period 3||0
7836422|NCT01025843|19287606|P9|NOT COMPLETED|Period 3||0
7836423|NCT01025843|19287607|P8|NOT COMPLETED|Period 3||0
7836424|NCT01025843|19287608|P7|NOT COMPLETED|Period 3||0
7836425|NCT01025843|19287609|P6|NOT COMPLETED|Period 3||0
7836426|NCT01025843|19287610|P5|NOT COMPLETED|Period 3||0
7836427|NCT01025843|19287611|P4|NOT COMPLETED|Period 3||0
7836428|NCT01025843|19287612|P3|NOT COMPLETED|Period 3||0
7836429|NCT01025843|19287613|P2|NOT COMPLETED|Period 3||0
7836430|NCT01025843|19287614|P1|NOT COMPLETED|Period 3||0
7836431|NCT01025843|19287605|P10|COMPLETED|Period 3||2
7836432|NCT01025843|19287606|P9|COMPLETED|Period 3||2
7836433|NCT01025843|19287607|P8|COMPLETED|Period 3||2
7836434|NCT01025843|19287608|P7|COMPLETED|Period 3||2
7836435|NCT01025843|19287609|P6|COMPLETED|Period 3||2
7836436|NCT01025843|19287610|P5|COMPLETED|Period 3||2
7836437|NCT01025843|19287611|P4|COMPLETED|Period 3||2
7836438|NCT01025843|19287612|P3|COMPLETED|Period 3||2
7836439|NCT01025843|19287613|P2|COMPLETED|Period 3||2
7836440|NCT01025843|19287614|P1|COMPLETED|Period 3||2
7836441|NCT01025843|19287605|P10|STARTED|Period 3||2
7836442|NCT01025843|19287606|P9|STARTED|Period 3||2
7836443|NCT01025843|19287607|P8|STARTED|Period 3||2
7836444|NCT01025843|19287608|P7|STARTED|Period 3||2
7836445|NCT01025843|19287609|P6|STARTED|Period 3||2
7836446|NCT01025843|19287610|P5|STARTED|Period 3||2
7836447|NCT01025843|19287611|P4|STARTED|Period 3||2
7836448|NCT01025843|19287612|P3|STARTED|Period 3||2
7836449|NCT01025843|19287613|P2|STARTED|Period 3||2
7836450|NCT01025843|19287614|P1|STARTED|Period 3||2
7836451|NCT01025843|19287605|P10|NOT COMPLETED|Washout 2||0
7836452|NCT01025843|19287606|P9|NOT COMPLETED|Washout 2||0
7836453|NCT01025843|19287607|P8|NOT COMPLETED|Washout 2||0
7836454|NCT01025843|19287608|P7|NOT COMPLETED|Washout 2||0
7836455|NCT01025843|19287609|P6|NOT COMPLETED|Washout 2||0
7836456|NCT01025843|19287610|P5|NOT COMPLETED|Washout 2||0
7836457|NCT01025843|19287611|P4|NOT COMPLETED|Washout 2||0
7836458|NCT01025843|19287612|P3|NOT COMPLETED|Washout 2||0
7836459|NCT01025843|19287613|P2|NOT COMPLETED|Washout 2||0
7836460|NCT01025843|19287614|P1|NOT COMPLETED|Washout 2||0
7836461|NCT01025843|19287605|P10|COMPLETED|Washout 2||2
7836462|NCT01025843|19287606|P9|COMPLETED|Washout 2||2
7836463|NCT01025843|19287607|P8|COMPLETED|Washout 2||2
7836464|NCT01025843|19287608|P7|COMPLETED|Washout 2||2
7836465|NCT01025843|19287609|P6|COMPLETED|Washout 2||2
7836466|NCT01025843|19287610|P5|COMPLETED|Washout 2||2
7836467|NCT01025843|19287611|P4|COMPLETED|Washout 2||2
7836468|NCT01025843|19287612|P3|COMPLETED|Washout 2||2
7836469|NCT01025843|19287613|P2|COMPLETED|Washout 2||2
7836470|NCT01025843|19287614|P1|COMPLETED|Washout 2||2
7836471|NCT01025843|19287605|P10|STARTED|Washout 2||2
7836472|NCT01025843|19287606|P9|STARTED|Washout 2||2
7836473|NCT01025843|19287607|P8|STARTED|Washout 2||2
7836474|NCT01025843|19287608|P7|STARTED|Washout 2||2
7836475|NCT01025843|19287609|P6|STARTED|Washout 2||2
7836476|NCT01025843|19287610|P5|STARTED|Washout 2||2
7836477|NCT01025843|19287611|P4|STARTED|Washout 2||2
7836478|NCT01025843|19287612|P3|STARTED|Washout 2||2
7836479|NCT01025843|19287613|P2|STARTED|Washout 2||2
7836480|NCT01025843|19287614|P1|STARTED|Washout 2||2
7836481|NCT01025843|19287605|P10|NOT COMPLETED|Period 2||0
7836482|NCT01025843|19287606|P9|NOT COMPLETED|Period 2||0
7836483|NCT01025843|19287607|P8|NOT COMPLETED|Period 2||0
7836484|NCT01025843|19287608|P7|NOT COMPLETED|Period 2||0
7836485|NCT01025843|19287609|P6|NOT COMPLETED|Period 2||0
7836486|NCT01025843|19287610|P5|NOT COMPLETED|Period 2||0
7836487|NCT01025843|19287611|P4|NOT COMPLETED|Period 2||0
7836488|NCT01025843|19287612|P3|NOT COMPLETED|Period 2||0
7836489|NCT01025843|19287613|P2|NOT COMPLETED|Period 2||0
7836490|NCT01025843|19287614|P1|NOT COMPLETED|Period 2||0
7836491|NCT01025843|19287605|P10|COMPLETED|Period 2||2
7836492|NCT01025843|19287606|P9|COMPLETED|Period 2||2
7836493|NCT01025843|19287607|P8|COMPLETED|Period 2||2
7836494|NCT01025843|19287608|P7|COMPLETED|Period 2||2
7836495|NCT01025843|19287609|P6|COMPLETED|Period 2||2
7836496|NCT01025843|19287610|P5|COMPLETED|Period 2||2
7836497|NCT01025843|19287611|P4|COMPLETED|Period 2||2
7836498|NCT01025843|19287612|P3|COMPLETED|Period 2||2
7836499|NCT01025843|19287613|P2|COMPLETED|Period 2||2
7836500|NCT01025843|19287614|P1|COMPLETED|Period 2||2
7836501|NCT01025843|19287605|P10|STARTED|Period 2||2
7836502|NCT01025843|19287606|P9|STARTED|Period 2||2
7836503|NCT01025843|19287607|P8|STARTED|Period 2||2
7836504|NCT01025843|19287608|P7|STARTED|Period 2||2
7836505|NCT01025843|19287609|P6|STARTED|Period 2||2
7836506|NCT01025843|19287610|P5|STARTED|Period 2||2
7836507|NCT01025843|19287611|P4|STARTED|Period 2||2
7836508|NCT01025843|19287612|P3|STARTED|Period 2||2
7836509|NCT01025843|19287613|P2|STARTED|Period 2||2
7836510|NCT01025843|19287614|P1|STARTED|Period 2||2
7836511|NCT01025843|19287605|P10|NOT COMPLETED|Washout 1||0
7836512|NCT01025843|19287606|P9|NOT COMPLETED|Washout 1||0
7836513|NCT01025843|19287607|P8|NOT COMPLETED|Washout 1||0
7836514|NCT01025843|19287608|P7|NOT COMPLETED|Washout 1||0
7836515|NCT01025843|19287609|P6|NOT COMPLETED|Washout 1||0
7836516|NCT01025843|19287610|P5|NOT COMPLETED|Washout 1||0
7836517|NCT01025843|19287611|P4|NOT COMPLETED|Washout 1||0
7836518|NCT01025843|19287612|P3|NOT COMPLETED|Washout 1||0
7836519|NCT01025843|19287613|P2|NOT COMPLETED|Washout 1||0
7836520|NCT01025843|19287614|P1|NOT COMPLETED|Washout 1||0
7836521|NCT01025843|19287605|P10|COMPLETED|Washout 1||2
7836522|NCT01025843|19287606|P9|COMPLETED|Washout 1||2
7836523|NCT01025843|19287607|P8|COMPLETED|Washout 1||2
7836524|NCT01025843|19287608|P7|COMPLETED|Washout 1||2
7836525|NCT01025843|19287609|P6|COMPLETED|Washout 1||2
7836526|NCT01025843|19287610|P5|COMPLETED|Washout 1||2
7836527|NCT01025843|19287611|P4|COMPLETED|Washout 1||2
7836528|NCT01025843|19287612|P3|COMPLETED|Washout 1||2
7836529|NCT01025843|19287613|P2|COMPLETED|Washout 1||2
7836530|NCT01025843|19287614|P1|COMPLETED|Washout 1||2
7836531|NCT01025843|19287605|P10|STARTED|Washout 1||2
7836532|NCT01025843|19287606|P9|STARTED|Washout 1||2
7836533|NCT01025843|19287607|P8|STARTED|Washout 1||2
7836534|NCT01025843|19287608|P7|STARTED|Washout 1||2
7836535|NCT01025843|19287609|P6|STARTED|Washout 1||2
7836536|NCT01025843|19287610|P5|STARTED|Washout 1||2
7836537|NCT01025843|19287611|P4|STARTED|Washout 1||2
7836538|NCT01025843|19287612|P3|STARTED|Washout 1||2
7836539|NCT01025843|19287613|P2|STARTED|Washout 1||2
7836540|NCT01025843|19287614|P1|STARTED|Washout 1||2
7836541|NCT01025843|19287605|P10|NOT COMPLETED|Period 1||0
7836542|NCT01025843|19287606|P9|NOT COMPLETED|Period 1||0
7836543|NCT01025843|19287607|P8|NOT COMPLETED|Period 1||0
7836544|NCT01025843|19287608|P7|NOT COMPLETED|Period 1||0
7836545|NCT01025843|19287609|P6|NOT COMPLETED|Period 1||0
7836546|NCT01025843|19287610|P5|NOT COMPLETED|Period 1||0
7836547|NCT01025843|19287611|P4|NOT COMPLETED|Period 1||0
7836548|NCT01025843|19287612|P3|NOT COMPLETED|Period 1||0
7836549|NCT01025843|19287613|P2|NOT COMPLETED|Period 1||0
7836550|NCT01025843|19287614|P1|NOT COMPLETED|Period 1||0
7836551|NCT01025843|19287605|P10|COMPLETED|Period 1||2
7836552|NCT01025843|19287606|P9|COMPLETED|Period 1||2
7836553|NCT01025843|19287607|P8|COMPLETED|Period 1||2
7836554|NCT01025843|19287608|P7|COMPLETED|Period 1||2
7836555|NCT01025843|19287609|P6|COMPLETED|Period 1||2
7836556|NCT01025843|19287610|P5|COMPLETED|Period 1||2
7836557|NCT01025843|19287611|P4|COMPLETED|Period 1||2
7836558|NCT01025843|19287612|P3|COMPLETED|Period 1||2
7836559|NCT01025843|19287613|P2|COMPLETED|Period 1||2
7836560|NCT01025843|19287614|P1|COMPLETED|Period 1||2
7836561|NCT01025843|19287605|P10|STARTED|Period 1||2
7836562|NCT01025843|19287606|P9|STARTED|Period 1||2
7836563|NCT01025843|19287607|P8|STARTED|Period 1||2
7836564|NCT01025843|19287608|P7|STARTED|Period 1||2
7836565|NCT01025843|19287609|P6|STARTED|Period 1||2
7836566|NCT01025843|19287610|P5|STARTED|Period 1||2
7836567|NCT01025843|19287611|P4|STARTED|Period 1||2
7836568|NCT01025843|19287612|P3|STARTED|Period 1||2
7836569|NCT01025843|19287613|P2|STARTED|Period 1||2
7836570|NCT01025843|19287614|P1|STARTED|Period 1||2
7836571|NCT01025830|19287688|P2|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
7836572|NCT01025830|19287689|P1|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
7836573|NCT01025830|19287688|P2|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
7836574|NCT01025830|19287689|P1|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
7836575|NCT01025830|19287688|P2|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
7836576|NCT01025830|19287689|P1|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
7836577|NCT01025830|19287688|P2|NOT COMPLETED|Washout Period of 30 Days||0
7836578|NCT01025830|19287689|P1|NOT COMPLETED|Washout Period of 30 Days||0
7836579|NCT01025830|19287688|P2|COMPLETED|Washout Period of 30 Days||12
7836580|NCT01025830|19287689|P1|COMPLETED|Washout Period of 30 Days||8
7836581|NCT01025830|19287688|P2|STARTED|Washout Period of 30 Days||12
7836582|NCT01025830|19287689|P1|STARTED|Washout Period of 30 Days||8
7836583|NCT01025830|19287688|P2|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
7836584|NCT01025830|19287689|P1|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
7836585|NCT01025830|19287688|P2|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
7836586|NCT01025830|19287689|P1|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
7836587|NCT01025830|19287688|P2|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
7836588|NCT01025830|19287689|P1|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
7836589|NCT01025817|19287708|P2|NOT COMPLETED|Completed Study||22
7836590|NCT01025817|19287709|P1|NOT COMPLETED|Completed Study||16
7836591|NCT01025817|19287708|P2|COMPLETED|Completed Study|Completed study phase|282
7836592|NCT01025817|19287709|P1|COMPLETED|Completed Study|Completed study phase|293
7836593|NCT01025817|19287708|P2|STARTED|Completed Study||304
7836594|NCT01025817|19287709|P1|STARTED|Completed Study||309
7836595|NCT01025817|19287708|P2|NOT COMPLETED|Completed Study Medication||72
7836596|NCT01025817|19287709|P1|NOT COMPLETED|Completed Study Medication||105
7836597|NCT01025817|19287708|P2|COMPLETED|Completed Study Medication||232
7836598|NCT01025817|19287709|P1|COMPLETED|Completed Study Medication||204
7836599|NCT01025817|19287708|P2|STARTED|Completed Study Medication||304
7836600|NCT01025817|19287709|P1|STARTED|Completed Study Medication||309
7836601|NCT01025791|19287730|P14|NOT COMPLETED|Period 5||0
7836602|NCT01025791|19287731|P13|NOT COMPLETED|Period 5||0
7836603|NCT01025791|19287732|P12|NOT COMPLETED|Period 5||0
7836604|NCT01025791|19287733|P11|NOT COMPLETED|Period 5||0
7836605|NCT01025791|19287734|P10|NOT COMPLETED|Period 5||0
7836606|NCT01025791|19287735|P9|NOT COMPLETED|Period 5||0
7836607|NCT01025791|19287736|P8|NOT COMPLETED|Period 5||0
7836608|NCT01025791|19287737|P7|NOT COMPLETED|Period 5||0
7836609|NCT01025791|19287738|P6|NOT COMPLETED|Period 5||0
7836610|NCT01025791|19287739|P5|NOT COMPLETED|Period 5||0
7836611|NCT01025791|19287740|P4|NOT COMPLETED|Period 5||0
7836612|NCT01025791|19287741|P3|NOT COMPLETED|Period 5||0
7836613|NCT01025791|19287742|P2|NOT COMPLETED|Period 5||0
7836614|NCT01025791|19287743|P1|NOT COMPLETED|Period 5||0
7836615|NCT01025791|19287730|P14|COMPLETED|Period 5||0
7836616|NCT01025791|19287731|P13|COMPLETED|Period 5||0
7836617|NCT01025791|19287732|P12|COMPLETED|Period 5||0
7836618|NCT01025791|19287733|P11|COMPLETED|Period 5||0
7836619|NCT01025791|19287734|P10|COMPLETED|Period 5||0
7836620|NCT01025791|19287735|P9|COMPLETED|Period 5||0
7836621|NCT01025791|19287736|P8|COMPLETED|Period 5||0
7836622|NCT01025791|19287737|P7|COMPLETED|Period 5||0
7836623|NCT01025791|19287738|P6|COMPLETED|Period 5||0
7836624|NCT01025791|19287739|P5|COMPLETED|Period 5||0
7836625|NCT01025791|19287740|P4|COMPLETED|Period 5||2
7836626|NCT01025791|19287741|P3|COMPLETED|Period 5||2
7836627|NCT01025791|19287742|P2|COMPLETED|Period 5||2
7836628|NCT01025791|19287743|P1|COMPLETED|Period 5||2
7836629|NCT01025791|19287730|P14|STARTED|Period 5||0
7836630|NCT01025791|19287731|P13|STARTED|Period 5||0
7836631|NCT01025791|19287732|P12|STARTED|Period 5||0
7836632|NCT01025791|19287733|P11|STARTED|Period 5||0
7836633|NCT01025791|19287734|P10|STARTED|Period 5||0
7836634|NCT01025791|19287735|P9|STARTED|Period 5||0
7836635|NCT01025791|19287736|P8|STARTED|Period 5||0
7836636|NCT01025791|19287737|P7|STARTED|Period 5||0
7836637|NCT01025791|19287738|P6|STARTED|Period 5||0
7836638|NCT01025791|19287739|P5|STARTED|Period 5||0
7836639|NCT01025791|19287740|P4|STARTED|Period 5||2
7836640|NCT01025791|19287741|P3|STARTED|Period 5||2
7836641|NCT01025791|19287742|P2|STARTED|Period 5||2
7836642|NCT01025791|19287743|P1|STARTED|Period 5||2
7836643|NCT01025791|19287730|P14|NOT COMPLETED|Period 4||0
7836644|NCT01025791|19287731|P13|NOT COMPLETED|Period 4||0
7836645|NCT01025791|19287732|P12|NOT COMPLETED|Period 4||0
7836646|NCT01025791|19287733|P11|NOT COMPLETED|Period 4||0
7836647|NCT01025791|19287734|P10|NOT COMPLETED|Period 4||0
7836648|NCT01025791|19287735|P9|NOT COMPLETED|Period 4||0
7836649|NCT01025791|19287736|P8|NOT COMPLETED|Period 4||0
7836650|NCT01025791|19287737|P7|NOT COMPLETED|Period 4||0
7836651|NCT01025791|19287738|P6|NOT COMPLETED|Period 4||0
7836652|NCT01025791|19287739|P5|NOT COMPLETED|Period 4||0
7836653|NCT01025791|19287740|P4|NOT COMPLETED|Period 4||0
7836654|NCT01025791|19287741|P3|NOT COMPLETED|Period 4||0
7836655|NCT01025791|19287742|P2|NOT COMPLETED|Period 4||0
7836656|NCT01025791|19287743|P1|NOT COMPLETED|Period 4||0
7836657|NCT01025791|19287730|P14|COMPLETED|Period 4||1
7836658|NCT01025791|19287731|P13|COMPLETED|Period 4||2
7836659|NCT01025791|19287732|P12|COMPLETED|Period 4||1
7836660|NCT01025791|19287733|P11|COMPLETED|Period 4||2
7836661|NCT01025791|19287734|P10|COMPLETED|Period 4||1
7836662|NCT01025791|19287735|P9|COMPLETED|Period 4||2
7836663|NCT01025791|19287736|P8|COMPLETED|Period 4||2
7836664|NCT01025791|19287737|P7|COMPLETED|Period 4||2
7836665|NCT01025791|19287738|P6|COMPLETED|Period 4||2
7836666|NCT01025791|19287739|P5|COMPLETED|Period 4||2
7836667|NCT01025791|19287740|P4|COMPLETED|Period 4||2
7836668|NCT01025791|19287741|P3|COMPLETED|Period 4||2
7836669|NCT01025791|19287742|P2|COMPLETED|Period 4||2
7836670|NCT01025791|19287743|P1|COMPLETED|Period 4||2
7836671|NCT01025791|19287730|P14|STARTED|Period 4||1
7836672|NCT01025791|19287731|P13|STARTED|Period 4||2
7836673|NCT01025791|19287732|P12|STARTED|Period 4||1
7836674|NCT01025791|19287733|P11|STARTED|Period 4||2
7836675|NCT01025791|19287734|P10|STARTED|Period 4||1
7836676|NCT01025791|19287735|P9|STARTED|Period 4||2
7836677|NCT01025791|19287736|P8|STARTED|Period 4||2
7836678|NCT01025791|19287737|P7|STARTED|Period 4||2
7836679|NCT01025791|19287738|P6|STARTED|Period 4||2
7836680|NCT01025791|19287739|P5|STARTED|Period 4||2
7836681|NCT01025791|19287740|P4|STARTED|Period 4||2
7836682|NCT01025791|19287741|P3|STARTED|Period 4||2
7836683|NCT01025791|19287742|P2|STARTED|Period 4||2
7836684|NCT01025791|19287743|P1|STARTED|Period 4||2
7836685|NCT01025791|19287730|P14|NOT COMPLETED|Period 3||0
7836686|NCT01025791|19287731|P13|NOT COMPLETED|Period 3||0
7836687|NCT01025791|19287732|P12|NOT COMPLETED|Period 3||0
7836688|NCT01025791|19287733|P11|NOT COMPLETED|Period 3||0
7836689|NCT01025791|19287734|P10|NOT COMPLETED|Period 3||0
7836690|NCT01025791|19287735|P9|NOT COMPLETED|Period 3||0
7836691|NCT01025791|19287736|P8|NOT COMPLETED|Period 3||0
7836692|NCT01025791|19287737|P7|NOT COMPLETED|Period 3||0
7836693|NCT01025791|19287738|P6|NOT COMPLETED|Period 3||0
7836694|NCT01025791|19287739|P5|NOT COMPLETED|Period 3||0
7836695|NCT01025791|19287740|P4|NOT COMPLETED|Period 3||0
7836696|NCT01025791|19287741|P3|NOT COMPLETED|Period 3||0
7836697|NCT01025791|19287742|P2|NOT COMPLETED|Period 3||0
7836698|NCT01025791|19287743|P1|NOT COMPLETED|Period 3||0
7836699|NCT01025791|19287730|P14|COMPLETED|Period 3||1
7836700|NCT01025791|19287731|P13|COMPLETED|Period 3||2
7836701|NCT01025791|19287732|P12|COMPLETED|Period 3||1
7836702|NCT01025791|19287733|P11|COMPLETED|Period 3||2
7836703|NCT01025791|19287734|P10|COMPLETED|Period 3||1
7836704|NCT01025791|19287735|P9|COMPLETED|Period 3||2
7836705|NCT01025791|19287736|P8|COMPLETED|Period 3||2
7836706|NCT01025791|19287737|P7|COMPLETED|Period 3||2
7836707|NCT01025791|19287738|P6|COMPLETED|Period 3||2
7836708|NCT01025791|19287739|P5|COMPLETED|Period 3||2
7836709|NCT01025791|19287740|P4|COMPLETED|Period 3||2
7836710|NCT01025791|19287741|P3|COMPLETED|Period 3||2
7836711|NCT01025791|19287742|P2|COMPLETED|Period 3||2
7836712|NCT01025791|19287743|P1|COMPLETED|Period 3||2
7836713|NCT01025791|19287730|P14|STARTED|Period 3||1
7836714|NCT01025791|19287731|P13|STARTED|Period 3||2
7836715|NCT01025791|19287732|P12|STARTED|Period 3||1
7836716|NCT01025791|19287733|P11|STARTED|Period 3||2
7836717|NCT01025791|19287734|P10|STARTED|Period 3||1
7836718|NCT01025791|19287735|P9|STARTED|Period 3||2
7836719|NCT01025791|19287736|P8|STARTED|Period 3||2
7836720|NCT01025791|19287737|P7|STARTED|Period 3||2
7836721|NCT01025791|19287738|P6|STARTED|Period 3||2
7836722|NCT01025791|19287739|P5|STARTED|Period 3||2
7836723|NCT01025791|19287740|P4|STARTED|Period 3||2
7836724|NCT01025791|19287741|P3|STARTED|Period 3||2
7836725|NCT01025791|19287742|P2|STARTED|Period 3||2
7836726|NCT01025791|19287743|P1|STARTED|Period 3||2
7836727|NCT01025791|19287730|P14|NOT COMPLETED|Period 2||0
7836728|NCT01025791|19287731|P13|NOT COMPLETED|Period 2||0
7836729|NCT01025791|19287732|P12|NOT COMPLETED|Period 2||0
7836730|NCT01025791|19287733|P11|NOT COMPLETED|Period 2||0
7836731|NCT01025791|19287734|P10|NOT COMPLETED|Period 2||0
7836732|NCT01025791|19287735|P9|NOT COMPLETED|Period 2||0
7836733|NCT01025791|19287736|P8|NOT COMPLETED|Period 2||0
7836734|NCT01025791|19287737|P7|NOT COMPLETED|Period 2||0
7836735|NCT01025791|19287738|P6|NOT COMPLETED|Period 2||0
7836736|NCT01025791|19287739|P5|NOT COMPLETED|Period 2||0
7836737|NCT01025791|19287740|P4|NOT COMPLETED|Period 2||0
7836738|NCT01025791|19287741|P3|NOT COMPLETED|Period 2||0
7836739|NCT01025791|19287742|P2|NOT COMPLETED|Period 2||0
7836740|NCT01025791|19287743|P1|NOT COMPLETED|Period 2||0
7836741|NCT01025791|19287730|P14|COMPLETED|Period 2||1
7836742|NCT01025791|19287731|P13|COMPLETED|Period 2||2
7836743|NCT01025791|19287732|P12|COMPLETED|Period 2||1
7836744|NCT01025791|19287733|P11|COMPLETED|Period 2||2
7836745|NCT01025791|19287734|P10|COMPLETED|Period 2||1
7836746|NCT01025791|19287735|P9|COMPLETED|Period 2||2
7836747|NCT01025791|19287736|P8|COMPLETED|Period 2||2
7836748|NCT01025791|19287737|P7|COMPLETED|Period 2||2
7836749|NCT01025791|19287738|P6|COMPLETED|Period 2||2
7836750|NCT01025791|19287739|P5|COMPLETED|Period 2||2
7836751|NCT01025791|19287740|P4|COMPLETED|Period 2||2
7836752|NCT01025791|19287741|P3|COMPLETED|Period 2||2
7836753|NCT01025791|19287742|P2|COMPLETED|Period 2||2
7836754|NCT01025791|19287743|P1|COMPLETED|Period 2||2
7836755|NCT01025791|19287730|P14|STARTED|Period 2||1
7836756|NCT01025791|19287731|P13|STARTED|Period 2||2
7836757|NCT01025791|19287732|P12|STARTED|Period 2||1
7836758|NCT01025791|19287733|P11|STARTED|Period 2||2
7836759|NCT01025791|19287734|P10|STARTED|Period 2||1
7836760|NCT01025791|19287735|P9|STARTED|Period 2||2
7836761|NCT01025791|19287736|P8|STARTED|Period 2||2
7836762|NCT01025791|19287737|P7|STARTED|Period 2||2
7836763|NCT01025791|19287738|P6|STARTED|Period 2||2
7836764|NCT01025791|19287739|P5|STARTED|Period 2||2
7836765|NCT01025791|19287740|P4|STARTED|Period 2||2
7836766|NCT01025791|19287741|P3|STARTED|Period 2||2
7836767|NCT01025791|19287742|P2|STARTED|Period 2||2
7836768|NCT01025791|19287743|P1|STARTED|Period 2||2
7836769|NCT01025791|19287730|P14|NOT COMPLETED|Period 1||0
7836770|NCT01025791|19287731|P13|NOT COMPLETED|Period 1||0
7836771|NCT01025791|19287732|P12|NOT COMPLETED|Period 1||0
7836772|NCT01025791|19287733|P11|NOT COMPLETED|Period 1||0
7836773|NCT01025791|19287734|P10|NOT COMPLETED|Period 1||0
7836774|NCT01025791|19287735|P9|NOT COMPLETED|Period 1||0
7836775|NCT01025791|19287736|P8|NOT COMPLETED|Period 1||0
7836776|NCT01025791|19287737|P7|NOT COMPLETED|Period 1||0
7836777|NCT01025791|19287738|P6|NOT COMPLETED|Period 1||0
7836778|NCT01025791|19287739|P5|NOT COMPLETED|Period 1||0
7836779|NCT01025791|19287740|P4|NOT COMPLETED|Period 1||0
7836780|NCT01025791|19287741|P3|NOT COMPLETED|Period 1||0
7836781|NCT01025791|19287742|P2|NOT COMPLETED|Period 1||0
7836782|NCT01025791|19287743|P1|NOT COMPLETED|Period 1||0
7836783|NCT01025791|19287730|P14|COMPLETED|Period 1||1
7836784|NCT01025791|19287731|P13|COMPLETED|Period 1||2
7836785|NCT01025791|19287732|P12|COMPLETED|Period 1||1
7836786|NCT01025791|19287733|P11|COMPLETED|Period 1||2
7836787|NCT01025791|19287734|P10|COMPLETED|Period 1||1
7836788|NCT01025791|19287735|P9|COMPLETED|Period 1||2
7836789|NCT01025791|19287736|P8|COMPLETED|Period 1||2
7836790|NCT01025791|19287737|P7|COMPLETED|Period 1||2
7836791|NCT01025791|19287738|P6|COMPLETED|Period 1||2
7836792|NCT01025791|19287739|P5|COMPLETED|Period 1||2
7836793|NCT01025791|19287740|P4|COMPLETED|Period 1||2
7836794|NCT01025791|19287741|P3|COMPLETED|Period 1||2
7836795|NCT01025791|19287742|P2|COMPLETED|Period 1||2
7836796|NCT01025791|19287743|P1|COMPLETED|Period 1||2
7836797|NCT01025791|19287730|P14|STARTED|Period 1||1
7836798|NCT01025791|19287731|P13|STARTED|Period 1||2
7836799|NCT01025791|19287732|P12|STARTED|Period 1||1
7836800|NCT01025791|19287733|P11|STARTED|Period 1||2
7836801|NCT01025791|19287734|P10|STARTED|Period 1||1
7836802|NCT01025791|19287735|P9|STARTED|Period 1||2
7836803|NCT01025791|19287736|P8|STARTED|Period 1||2
7836804|NCT01025791|19287737|P7|STARTED|Period 1||2
7836805|NCT01025791|19287738|P6|STARTED|Period 1||2
7836806|NCT01025791|19287739|P5|STARTED|Period 1||2
7836807|NCT01025791|19287740|P4|STARTED|Period 1||2
7836808|NCT01025791|19287741|P3|STARTED|Period 1||2
7836809|NCT01025791|19287742|P2|STARTED|Period 1||2
7836810|NCT01025791|19287743|P1|STARTED|Period 1||2
7836811|NCT01025752|19287875|P2|NOT COMPLETED|Overall Study||13
7836812|NCT01025752|19287876|P1|NOT COMPLETED|Overall Study||8
7836813|NCT01025752|19287875|P2|COMPLETED|Overall Study||50
7836814|NCT01025752|19287876|P1|COMPLETED|Overall Study||54
7836815|NCT01025752|19287875|P2|STARTED|Overall Study||63
7836816|NCT01025752|19287876|P1|STARTED|Overall Study||62
7836817|NCT01025635|19287896|P2|NOT COMPLETED|Overall Study||25
7836818|NCT01025635|19287897|P1|NOT COMPLETED|Overall Study||23
7836819|NCT01025635|19287896|P2|COMPLETED|Overall Study||178
7836820|NCT01025635|19287897|P1|COMPLETED|Overall Study||175
7836821|NCT01025635|19287896|P2|STARTED|Overall Study||203
7836822|NCT01025635|19287897|P1|STARTED|Overall Study||198
7836823|NCT01025492|19287909|P1|NOT COMPLETED|Overall Study||0
7836824|NCT01025492|19287909|P1|COMPLETED|Overall Study||24
7836825|NCT01025492|19287909|P1|STARTED|Overall Study||24
7836826|NCT01025453|19287913|P1|NOT COMPLETED|Overall Study||0
7836827|NCT01025453|19287913|P1|COMPLETED|Overall Study||37
7836828|NCT01025453|19287913|P1|STARTED|Overall Study||37
7836829|NCT01025427|19287920|P1|NOT COMPLETED|Overall Study||0
7836830|NCT01025427|19287920|P1|COMPLETED|Overall Study||16
7836831|NCT01025427|19287920|P1|STARTED|Overall Study||16
7836832|NCT01025336|19287929|P5|NOT COMPLETED|Overall Study||0
7836833|NCT01025336|19287930|P4|NOT COMPLETED|Overall Study||2
7836834|NCT01025336|19287931|P3|NOT COMPLETED|Overall Study||0
7836835|NCT01025336|19287932|P2|NOT COMPLETED|Overall Study||0
7836836|NCT01025336|19287933|P1|NOT COMPLETED|Overall Study||0
7836837|NCT01025336|19287929|P5|COMPLETED|Overall Study||222
7836838|NCT01025336|19287930|P4|COMPLETED|Overall Study||219
7836839|NCT01025336|19287931|P3|COMPLETED|Overall Study||179
7836840|NCT01025336|19287932|P2|COMPLETED|Overall Study||210
7836841|NCT01025336|19287933|P1|COMPLETED|Overall Study||130
7836842|NCT01025336|19287929|P5|STARTED|Overall Study||222
7836843|NCT01025336|19287930|P4|STARTED|Overall Study||221
7836844|NCT01025336|19287931|P3|STARTED|Overall Study||179
7836845|NCT01025336|19287932|P2|STARTED|Overall Study||210
7836846|NCT01025336|19287933|P1|STARTED|Overall Study||130
7836847|NCT01025284|19287988|P3|NOT COMPLETED|Overall Study||0
7836848|NCT01025284|19287989|P2|NOT COMPLETED|Overall Study||2
7836849|NCT01025284|19287990|P1|NOT COMPLETED|Overall Study||0
7836850|NCT01025284|19287988|P3|COMPLETED|Overall Study||8
7836851|NCT01025284|19287989|P2|COMPLETED|Overall Study||16
7836852|NCT01025284|19287990|P1|COMPLETED|Overall Study||38
7836853|NCT01025284|19287988|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
7836854|NCT01025284|19287989|P2|Received at Least 1 Dose of Study Drug|Overall Study||18
7836855|NCT01025284|19287990|P1|Received at Least 1 Dose of Study Drug|Overall Study||38
7836856|NCT01025284|19287988|P3|STARTED|Overall Study||8
7836857|NCT01025284|19287989|P2|STARTED|Overall Study||18
7836858|NCT01025284|19287990|P1|STARTED|Overall Study||38
7836859|NCT01025271|19288008|P1|NOT COMPLETED|Overall Study||0
7836860|NCT01025271|19288008|P1|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
7836861|NCT01025271|19288008|P1|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
7836862|NCT01025232|19288015|P2|NOT COMPLETED|Overall Study||6
7836863|NCT01025232|19288016|P1|NOT COMPLETED|Overall Study||3
7836864|NCT01025232|19288015|P2|COMPLETED|Overall Study||36
7836865|NCT01025232|19288016|P1|COMPLETED|Overall Study||43
7836866|NCT01025232|19288015|P2|STARTED|Overall Study||42
7836867|NCT01025232|19288016|P1|STARTED|Overall Study||46
7836868|NCT01025193|19288034|P1|NOT COMPLETED|Overall Study||4
7836869|NCT01025193|19288034|P1|COMPLETED|Overall Study|one patient was transplanted 2 weeks after 8 month belimumab dose and did not receive further doses.|4
7836870|NCT01025193|19288034|P1|STARTED|Overall Study||8
7836871|NCT01025154|19288044|P1|NOT COMPLETED|Overall Study||2
7836872|NCT01025154|19288044|P1|COMPLETED|Overall Study||57
7836873|NCT01025154|19288044|P1|STARTED|Overall Study||59
7836874|NCT01025076|19288049|P1|NOT COMPLETED|Overall Study||0
7836875|NCT01025076|19288049|P1|COMPLETED|Overall Study||14
7836876|NCT01025076|19288049|P1|STARTED|Overall Study||14
7836877|NCT01025037|19288053|P1|NOT COMPLETED|Overall Study||11
7836878|NCT01025037|19288053|P1|COMPLETED|Overall Study||50
7836879|NCT01025037|19288053|P1|STARTED|Overall Study||61
7836880|NCT01024972|19288064|P2|NOT COMPLETED|Overall Study||0
7836881|NCT01024972|19288065|P1|NOT COMPLETED|Overall Study||0
7836882|NCT01024972|19288064|P2|COMPLETED|Overall Study||15
7836883|NCT01024972|19288065|P1|COMPLETED|Overall Study||16
7836884|NCT01024972|19288064|P2|STARTED|Overall Study||15
7836885|NCT01024972|19288065|P1|STARTED|Overall Study||16
7836886|NCT01024959|19288075|P1|NOT COMPLETED|Overall Study||41
7836887|NCT01024959|19288075|P1|COMPLETED|Overall Study||466
7836888|NCT01024959|19288075|P1|STARTED|Overall Study||507
7836889|NCT01024946|19288084|P1|NOT COMPLETED|Overall Study||5
7836890|NCT01024946|19288084|P1|COMPLETED|Overall Study||6
7836891|NCT01024946|19288084|P1|STARTED|Overall Study||11
7836892|NCT01024920|19288090|P2|NOT COMPLETED|Overall Study||22
7836893|NCT01024920|19288091|P1|NOT COMPLETED|Overall Study||45
7836894|NCT01024920|19288090|P2|COMPLETED|Overall Study||10
7836895|NCT01024920|19288091|P1|COMPLETED|Overall Study||22
7836896|NCT01024920|19288090|P2|Treated|Overall Study||32
7836897|NCT01024920|19288091|P1|Treated|Overall Study||64
7836898|NCT01024920|19288090|P2|STARTED|Overall Study||32
7836899|NCT01024920|19288091|P1|STARTED|Overall Study||67
7836900|NCT01024855|19288109|P1|NOT COMPLETED|Overall Study||1
7836901|NCT01024855|19288109|P1|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29
7836902|NCT01024855|19288109|P1|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30
7836903|NCT01024751|19288116|P2|NOT COMPLETED|Eligible Participants||3
7836904|NCT01024751|19288117|P1|NOT COMPLETED|Eligible Participants||0
7836905|NCT01024751|19288116|P2|COMPLETED|Eligible Participants||149
7836906|NCT01024751|19288117|P1|COMPLETED|Eligible Participants||153
7836907|NCT01024751|19288116|P2|STARTED|Eligible Participants||152
7836908|NCT01024751|19288117|P1|STARTED|Eligible Participants||153
7836909|NCT01024751|19288116|P2|NOT COMPLETED|Enrolled Participants||4
7836910|NCT01024751|19288117|P1|NOT COMPLETED|Enrolled Participants||3
7836911|NCT01024751|19288116|P2|COMPLETED|Enrolled Participants||152
7836912|NCT01024751|19288117|P1|COMPLETED|Enrolled Participants||153
7836913|NCT01024751|19288116|P2|STARTED|Enrolled Participants||156
7836914|NCT01024751|19288117|P1|STARTED|Enrolled Participants||156
7836915|NCT01024738|19288128|P3|NOT COMPLETED|Third Intervention:||0
7836916|NCT01024738|19288129|P2|NOT COMPLETED|Third Intervention:||0
7836917|NCT01024738|19288130|P1|NOT COMPLETED|Third Intervention:||0
7836918|NCT01024738|19288128|P3|COMPLETED|Third Intervention:||8
7836919|NCT01024738|19288129|P2|COMPLETED|Third Intervention:||7
7836920|NCT01024738|19288130|P1|COMPLETED|Third Intervention:||7
7836921|NCT01024738|19288128|P3|STARTED|Third Intervention:||8
7836922|NCT01024738|19288129|P2|STARTED|Third Intervention:||7
7836923|NCT01024738|19288130|P1|STARTED|Third Intervention:||7
7836924|NCT01024738|19288128|P3|NOT COMPLETED|Washout After 2nd Intervention||0
7836925|NCT01024738|19288129|P2|NOT COMPLETED|Washout After 2nd Intervention||0
7836926|NCT01024738|19288130|P1|NOT COMPLETED|Washout After 2nd Intervention||0
7836927|NCT01024738|19288128|P3|COMPLETED|Washout After 2nd Intervention||8
7836928|NCT01024738|19288129|P2|COMPLETED|Washout After 2nd Intervention||7
7836929|NCT01024738|19288130|P1|COMPLETED|Washout After 2nd Intervention||7
7836930|NCT01024738|19288128|P3|STARTED|Washout After 2nd Intervention||8
7836931|NCT01024738|19288129|P2|STARTED|Washout After 2nd Intervention||7
7836932|NCT01024738|19288130|P1|STARTED|Washout After 2nd Intervention||7
7836933|NCT01024738|19288128|P3|NOT COMPLETED|Second Intervention:||0
7836934|NCT01024738|19288129|P2|NOT COMPLETED|Second Intervention:||0
7836935|NCT01024738|19288130|P1|NOT COMPLETED|Second Intervention:||0
7836936|NCT01024738|19288128|P3|COMPLETED|Second Intervention:||8
7836937|NCT01024738|19288129|P2|COMPLETED|Second Intervention:||7
7836938|NCT01024738|19288130|P1|COMPLETED|Second Intervention:||7
7836939|NCT01024738|19288128|P3|STARTED|Second Intervention:||8
7836940|NCT01024738|19288129|P2|STARTED|Second Intervention:||7
7836941|NCT01024738|19288130|P1|STARTED|Second Intervention:||7
7836942|NCT01024738|19288128|P3|NOT COMPLETED|Washout After 1st Intervention||0
7836943|NCT01024738|19288129|P2|NOT COMPLETED|Washout After 1st Intervention||0
7836944|NCT01024738|19288130|P1|NOT COMPLETED|Washout After 1st Intervention||0
7836945|NCT01024738|19288128|P3|COMPLETED|Washout After 1st Intervention||8
7836946|NCT01024738|19288129|P2|COMPLETED|Washout After 1st Intervention||7
7836947|NCT01024738|19288130|P1|COMPLETED|Washout After 1st Intervention||7
7836948|NCT01024738|19288128|P3|STARTED|Washout After 1st Intervention||8
7836949|NCT01024738|19288129|P2|STARTED|Washout After 1st Intervention||7
7836950|NCT01024738|19288130|P1|STARTED|Washout After 1st Intervention||7
7836951|NCT01024738|19288128|P3|NOT COMPLETED|First Intervention:||0
7836952|NCT01024738|19288129|P2|NOT COMPLETED|First Intervention:||0
7836953|NCT01024738|19288130|P1|NOT COMPLETED|First Intervention:||0
7836954|NCT01024738|19288128|P3|COMPLETED|First Intervention:||8
7836955|NCT01024738|19288129|P2|COMPLETED|First Intervention:||7
7836956|NCT01024738|19288130|P1|COMPLETED|First Intervention:||7
7836957|NCT01024738|19288128|P3|STARTED|First Intervention:||8
7836958|NCT01024738|19288129|P2|STARTED|First Intervention:||7
7836959|NCT01024738|19288130|P1|STARTED|First Intervention:||7
7836960|NCT01024686|19288141|P3|NOT COMPLETED|Overall Study||0
7836961|NCT01024686|19288142|P2|NOT COMPLETED|Overall Study||0
7836962|NCT01024686|19288143|P1|NOT COMPLETED|Overall Study||0
7836963|NCT01024686|19288141|P3|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
7836964|NCT01024686|19288142|P2|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
7836965|NCT01024686|19288143|P1|COMPLETED|Overall Study||6
7836966|NCT01024686|19288141|P3|STARTED|Overall Study||0
7836967|NCT01024686|19288142|P2|STARTED|Overall Study||0
7836968|NCT01024686|19288143|P1|STARTED|Overall Study|July 11, 2010: unexpected adverse event, (1) participant|6
7836969|NCT01024608|19288174|P2|NOT COMPLETED|Overall Study||4
7836970|NCT01024608|19288175|P1|NOT COMPLETED|Overall Study||4
7836971|NCT01024608|19288174|P2|COMPLETED|Overall Study||167
7836972|NCT01024608|19288175|P1|COMPLETED|Overall Study||165
7836973|NCT01024608|19288174|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171
7836974|NCT01024608|19288175|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167
7836975|NCT01024608|19288174|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171
7836976|NCT01024608|19288175|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167
7836977|NCT01024608|19288174|P2|STARTED|Overall Study||171
7836978|NCT01024608|19288175|P1|STARTED|Overall Study||169
7836979|NCT01024569|19288189|P2|NOT COMPLETED|Overall Study||11
7836980|NCT01024569|19288190|P1|NOT COMPLETED|Overall Study||25
7836981|NCT01024569|19288189|P2|COMPLETED|Overall Study||268
7836982|NCT01024569|19288190|P1|COMPLETED|Overall Study||251
7836983|NCT01024569|19288189|P2|STARTED|Overall Study||279
7836984|NCT01024569|19288190|P1|STARTED|Overall Study||276
7836985|NCT01024465|19288204|P1|NOT COMPLETED|Overall Study||3
7836986|NCT01024465|19288204|P1|COMPLETED|Overall Study||23
7836987|NCT01024465|19288204|P1|STARTED|Overall Study||26
7836988|NCT01024387|19288208|P1|NOT COMPLETED|Overall Study||60
7836989|NCT01024387|19288208|P1|COMPLETED|Overall Study||0
7836990|NCT01024387|19288208|P1|Evaluable for Response|Overall Study||53
7836991|NCT01024387|19288208|P1|Evaluable for PFS|Overall Study||54
7836992|NCT01024387|19288208|P1|STARTED|Overall Study||60
7836993|NCT01024335|19288218|P2|NOT COMPLETED|Overall Study||26
7836994|NCT01024335|19288219|P1|NOT COMPLETED|Overall Study||13
7836995|NCT01024335|19288218|P2|COMPLETED|Overall Study||14
7836996|NCT01024335|19288219|P1|COMPLETED|Overall Study||7
7836997|NCT01024335|19288218|P2|STARTED|Overall Study||40
7836998|NCT01024335|19288219|P1|STARTED|Overall Study||20
7836999|NCT01024309|19288229|P2|NOT COMPLETED|Overall Study||4
7837000|NCT01024309|19288230|P1|NOT COMPLETED|Overall Study||8
7837001|NCT01024309|19288229|P2|COMPLETED|Overall Study||27
7837002|NCT01024309|19288230|P1|COMPLETED|Overall Study||27
7837003|NCT01024309|19288229|P2|STARTED|Overall Study||31
7837004|NCT01024309|19288230|P1|STARTED|Overall Study||35
7837005|NCT01024296|19288252|P1|NOT COMPLETED|Overall Study||0
7837006|NCT01024296|19288252|P1|COMPLETED|Overall Study||4
7837007|NCT01024296|19288252|P1|STARTED|Overall Study||4
7837008|NCT01024244|19288262|P5|NOT COMPLETED|Overall Study||14
7837009|NCT01024244|19288263|P4|NOT COMPLETED|Overall Study||13
7837010|NCT01024244|19288264|P3|NOT COMPLETED|Overall Study||14
7837011|NCT01024244|19288265|P2|NOT COMPLETED|Overall Study||11
7837012|NCT01024244|19288266|P1|NOT COMPLETED|Overall Study||17
7837013|NCT01024244|19288262|P5|COMPLETED|Overall Study||1
7837014|NCT01024244|19288263|P4|COMPLETED|Overall Study||1
7837015|NCT01024244|19288264|P3|COMPLETED|Overall Study||1
7837016|NCT01024244|19288265|P2|COMPLETED|Overall Study||1
7837017|NCT01024244|19288266|P1|COMPLETED|Overall Study||5
7837018|NCT01024244|19288262|P5|STARTED|Overall Study||15
7837019|NCT01024244|19288263|P4|STARTED|Overall Study||14
7837020|NCT01024244|19288264|P3|STARTED|Overall Study||15
7837021|NCT01024244|19288265|P2|STARTED|Overall Study||12
7837022|NCT01024244|19288266|P1|STARTED|Overall Study||22
7837023|NCT01024036|19288380|P2|NOT COMPLETED|Follow-Up Period||3
7837024|NCT01024036|19288381|P1|NOT COMPLETED|Follow-Up Period||5
7837025|NCT01024036|19288380|P2|COMPLETED|Follow-Up Period||3
7837026|NCT01024036|19288381|P1|COMPLETED|Follow-Up Period||9
7837027|NCT01024036|19288380|P2|STARTED|Follow-Up Period||6
7837028|NCT01024036|19288381|P1|STARTED|Follow-Up Period||14
7837029|NCT01024036|19288380|P2|NOT COMPLETED|Unblinded Treatment||3
7837030|NCT01024036|19288381|P1|NOT COMPLETED|Unblinded Treatment||0
7837031|NCT01024036|19288380|P2|COMPLETED|Unblinded Treatment||10
7837032|NCT01024036|19288381|P1|COMPLETED|Unblinded Treatment||0
7837033|NCT01024036|19288380|P2|STARTED|Unblinded Treatment|Placebo participants had an option to receive siltuximab in unblinded treatment period|13
7837034|NCT01024036|19288381|P1|STARTED|Unblinded Treatment|No participants in this group received treatment during unblinded treatment period|0
7837035|NCT01024036|19288380|P2|NOT COMPLETED|Blinded Treatment||20
7837036|NCT01024036|19288381|P1|NOT COMPLETED|Blinded Treatment||22
7837037|NCT01024036|19288380|P2|COMPLETED|Blinded Treatment||6
7837038|NCT01024036|19288381|P1|COMPLETED|Blinded Treatment||31
7837039|NCT01024036|19288380|P2|STARTED|Blinded Treatment||26
7837040|NCT01024036|19288381|P1|STARTED|Blinded Treatment||53
7837041|NCT01024010|19288414|P2|NOT COMPLETED|Overall Study||0
7837042|NCT01024010|19288415|P1|NOT COMPLETED|Overall Study||0
7837043|NCT01024010|19288414|P2|COMPLETED|Overall Study||34
7837044|NCT01024010|19288415|P1|COMPLETED|Overall Study||48
7837045|NCT01024010|19288414|P2|STARTED|Overall Study||34
7837046|NCT01024010|19288415|P1|STARTED|Overall Study||48
7837047|NCT01023958|19288428|P1|NOT COMPLETED|Overall Study||50
7837048|NCT01023958|19288428|P1|COMPLETED|Overall Study||0
7837049|NCT01023958|19288428|P1|STARTED|Overall Study||50
7837050|NCT01023841|19288457|P2|NOT COMPLETED|Overall Study||0
7837051|NCT01023841|19288458|P1|NOT COMPLETED|Overall Study||1
7837052|NCT01023841|19288457|P2|COMPLETED|Overall Study||23
7837053|NCT01023841|19288458|P1|COMPLETED|Overall Study||47
7837054|NCT01023841|19288457|P2|STARTED|Overall Study||23
7837055|NCT01023841|19288458|P1|STARTED|Overall Study||48
7837056|NCT01023815|19288476|P4|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
7837057|NCT01023815|19288477|P3|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8
7837058|NCT01023815|19288478|P2|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
7837059|NCT01023815|19288479|P1|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0
7837060|NCT01023815|19288476|P4|COMPLETED|Randomized Period (Day 90 to Month 12)||68
7837061|NCT01023815|19288477|P3|COMPLETED|Randomized Period (Day 90 to Month 12)||60
7837062|NCT01023815|19288478|P2|COMPLETED|Randomized Period (Day 90 to Month 12)||42
7837063|NCT01023815|19288479|P1|COMPLETED|Randomized Period (Day 90 to Month 12)||0
7837064|NCT01023815|19288476|P4|STARTED|Randomized Period (Day 90 to Month 12)||71
7837065|NCT01023815|19288477|P3|STARTED|Randomized Period (Day 90 to Month 12)||68
7837066|NCT01023815|19288478|P2|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45
7837067|NCT01023815|19288479|P1|STARTED|Randomized Period (Day 90 to Month 12)||0
7837068|NCT01023815|19288476|P4|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
7837069|NCT01023815|19288477|P3|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
7837070|NCT01023815|19288478|P2|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
7837071|NCT01023815|19288479|P1|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144
7837072|NCT01023815|19288476|P4|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
7837073|NCT01023815|19288477|P3|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
7837074|NCT01023815|19288478|P2|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
7837075|NCT01023815|19288479|P1|COMPLETED|Pre-randomization Period (Day 1 to 90)||184
7837076|NCT01023815|19288476|P4|STARTED|Pre-randomization Period (Day 1 to 90)||0
7837077|NCT01023815|19288477|P3|STARTED|Pre-randomization Period (Day 1 to 90)||0
7837078|NCT01023815|19288478|P2|STARTED|Pre-randomization Period (Day 1 to 90)||0
7837079|NCT01023815|19288479|P1|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328
7837080|NCT01023789|19288498|P1|NOT COMPLETED|3 - Year Visit||43
7837081|NCT01023789|19288498|P1|COMPLETED|3 - Year Visit||769
7837082|NCT01023789|19288498|P1|STARTED|3 - Year Visit||812
7837083|NCT01023789|19288498|P1|NOT COMPLETED|2 - Year Visit||0
7837084|NCT01023789|19288498|P1|COMPLETED|2 - Year Visit||812
7837085|NCT01023789|19288498|P1|STARTED|2 - Year Visit||812
7837086|NCT01023789|19288498|P1|NOT COMPLETED|1 - Year Visit||0
7837087|NCT01023789|19288498|P1|COMPLETED|1 - Year Visit||812
7837088|NCT01023789|19288498|P1|STARTED|1 - Year Visit||812
7837089|NCT01023789|19288498|P1|NOT COMPLETED|180-day Clinical Follow-up||0
7837090|NCT01023789|19288498|P1|COMPLETED|180-day Clinical Follow-up||812
7837091|NCT01023789|19288498|P1|STARTED|180-day Clinical Follow-up||812
7837092|NCT01023789|19288498|P1|NOT COMPLETED|30-day Follow-up Visit||0
7837093|NCT01023789|19288498|P1|COMPLETED|30-day Follow-up Visit||812
7837094|NCT01023789|19288498|P1|STARTED|30-day Follow-up Visit|Intent-to-treat population (ITT).|812
7837095|NCT01023776|19288565|P1|NOT COMPLETED|Overall Study||0
7837096|NCT01023776|19288565|P1|COMPLETED|Overall Study||20
7837097|NCT01023776|19288565|P1|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20
7837098|NCT01023724|19288572|P2|NOT COMPLETED|Overall Study||3
7837099|NCT01023724|19288573|P1|NOT COMPLETED|Overall Study||4
7837100|NCT01023724|19288572|P2|COMPLETED|Overall Study||22
7837101|NCT01023724|19288573|P1|COMPLETED|Overall Study||21
7837102|NCT01023724|19288572|P2|STARTED|Overall Study||25
7837103|NCT01023724|19288573|P1|STARTED|Overall Study||25
7837104|NCT01023711|19288579|P1|NOT COMPLETED|Overall Study||0
7837105|NCT01023711|19288579|P1|COMPLETED|Overall Study||107
7837106|NCT01023711|19288579|P1|STARTED|Overall Study||107
7837107|NCT01023672|19288584|P1|NOT COMPLETED|Overall Study||3
7837108|NCT01023672|19288584|P1|COMPLETED|Overall Study||17
7837109|NCT01023672|19288584|P1|STARTED|Overall Study||20
7837110|NCT01023659|19288591|P3|NOT COMPLETED|Overall Study||99
7837111|NCT01023659|19288592|P2|NOT COMPLETED|Overall Study||228
7837112|NCT01023659|19288593|P1|NOT COMPLETED|Overall Study||73
7837113|NCT01023659|19288591|P3|COMPLETED|Overall Study||165
7837114|NCT01023659|19288592|P2|COMPLETED|Overall Study||137
7837115|NCT01023659|19288593|P1|COMPLETED|Overall Study||185
7837116|NCT01023659|19288591|P3|STARTED|Overall Study||264
7837117|NCT01023659|19288592|P2|STARTED|Overall Study||365
7837118|NCT01023659|19288593|P1|STARTED|Overall Study||258
7837119|NCT01023620|19288604|P2|NOT COMPLETED|Overall Study||0
7837120|NCT01023620|19288605|P1|NOT COMPLETED|Overall Study||0
7837121|NCT01023620|19288604|P2|COMPLETED|Overall Study||0
7837122|NCT01023620|19288605|P1|COMPLETED|Overall Study||0
7837123|NCT01023620|19288604|P2|STARTED|Overall Study||0
7837124|NCT01023620|19288605|P1|STARTED|Overall Study||0
7837125|NCT01023581|19288620|P7|NOT COMPLETED|Overall Study||20
7837126|NCT01023581|19288621|P6|NOT COMPLETED|Overall Study||19
7837127|NCT01023581|19288622|P5|NOT COMPLETED|Overall Study||16
7837128|NCT01023581|19288623|P4|NOT COMPLETED|Overall Study||20
7837129|NCT01023581|19288624|P3|NOT COMPLETED|Overall Study||42
7837130|NCT01023581|19288625|P2|NOT COMPLETED|Overall Study||23
7837131|NCT01023581|19288626|P1|NOT COMPLETED|Overall Study||35
7837132|NCT01023581|19288620|P7|COMPLETED|Overall Study||94
7837133|NCT01023581|19288621|P6|COMPLETED|Overall Study||92
7837134|NCT01023581|19288622|P5|COMPLETED|Overall Study||95
7837135|NCT01023581|19288623|P4|COMPLETED|Overall Study||94
7837136|NCT01023581|19288624|P3|COMPLETED|Overall Study||71
7837137|NCT01023581|19288625|P2|COMPLETED|Overall Study||89
7837138|NCT01023581|19288626|P1|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74
7837139|NCT01023581|19288620|P7|Received Study Treatment|Overall Study||114
7837140|NCT01023581|19288621|P6|Received Study Treatment|Overall Study||106
7837141|NCT01023581|19288622|P5|Received Study Treatment|Overall Study||111
7837142|NCT01023581|19288623|P4|Received Study Treatment|Overall Study||109
7837143|NCT01023581|19288624|P3|Received Study Treatment|Overall Study||110
7837144|NCT01023581|19288625|P2|Received Study Treatment|Overall Study||112
7837145|NCT01023581|19288626|P1|Received Study Treatment|Overall Study||106
7837146|NCT01023581|19288620|P7|STARTED|Overall Study||114
7837147|NCT01023581|19288621|P6|STARTED|Overall Study||111
7837148|NCT01023581|19288622|P5|STARTED|Overall Study||111
7837149|NCT01023581|19288623|P4|STARTED|Overall Study||114
7837150|NCT01023581|19288624|P3|STARTED|Overall Study||113
7837151|NCT01023581|19288625|P2|STARTED|Overall Study||112
7837152|NCT01023581|19288626|P1|STARTED|Overall Study||109
7837153|NCT01023568|19288659|P3|NOT COMPLETED|Overall Study||0
7837154|NCT01023568|19288660|P2|NOT COMPLETED|Overall Study||0
7837155|NCT01023568|19288661|P1|NOT COMPLETED|Overall Study||0
7837156|NCT01023568|19288659|P3|COMPLETED|Overall Study||45
7837157|NCT01023568|19288660|P2|COMPLETED|Overall Study||44
7837158|NCT01023568|19288661|P1|COMPLETED|Overall Study||45
7837159|NCT01023568|19288659|P3|STARTED|Overall Study||45
7837160|NCT01023568|19288660|P2|STARTED|Overall Study||44
7837161|NCT01023568|19288661|P1|STARTED|Overall Study||45
7837162|NCT01023516|19288683|P2|NOT COMPLETED|Overall Study||18
7837163|NCT01023516|19288684|P1|NOT COMPLETED|Overall Study||24
7837164|NCT01023516|19288683|P2|COMPLETED|Overall Study||284
7837165|NCT01023516|19288684|P1|COMPLETED|Overall Study||289
7837166|NCT01023516|19288683|P2|STARTED|Overall Study||302
7837167|NCT01023516|19288684|P1|STARTED|Overall Study||313
7837168|NCT01023308|19288766|P2|NOT COMPLETED|Overall Study||279
7837169|NCT01023308|19288767|P1|NOT COMPLETED|Overall Study||285
7837170|NCT01023308|19288766|P2|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
7837171|NCT01023308|19288767|P1|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
7837172|NCT01023308|19288766|P2|STARTED|Overall Study||381
7837173|NCT01023308|19288767|P1|STARTED|Overall Study||387
7837174|NCT01023269|19288793|P2|NOT COMPLETED|Overall Study||0
7837175|NCT01023269|19288794|P1|NOT COMPLETED|Overall Study||2
7837176|NCT01023269|19288793|P2|COMPLETED|Overall Study||2
7837177|NCT01023269|19288794|P1|COMPLETED|Overall Study||1
7837178|NCT01023269|19288793|P2|STARTED|Overall Study||2
7837179|NCT01023269|19288794|P1|STARTED|Overall Study||3
7837180|NCT01023256|19288802|P4|NOT COMPLETED|Overall Study||5
7837181|NCT01023256|19288803|P3|NOT COMPLETED|Overall Study||1
7837182|NCT01023256|19288804|P2|NOT COMPLETED|Overall Study||3
7837183|NCT01023256|19288805|P1|NOT COMPLETED|Overall Study||4
7837184|NCT01023256|19288802|P4|COMPLETED|Overall Study||22
7837185|NCT01023256|19288803|P3|COMPLETED|Overall Study||23
7837186|NCT01023256|19288804|P2|COMPLETED|Overall Study||19
7837187|NCT01023256|19288805|P1|COMPLETED|Overall Study||21
7837188|NCT01023256|19288802|P4|STARTED|Overall Study||27
7837189|NCT01023256|19288803|P3|STARTED|Overall Study||24
7837190|NCT01023256|19288804|P2|STARTED|Overall Study||22
7837191|NCT01023256|19288805|P1|STARTED|Overall Study||25
7837192|NCT01023217|19288847|P2|NOT COMPLETED|Overall Study||0
7837193|NCT01023217|19288848|P1|NOT COMPLETED|Overall Study||1
7837194|NCT01023217|19288847|P2|COMPLETED|Overall Study||45
7837195|NCT01023217|19288848|P1|COMPLETED|Overall Study||44
7837196|NCT01023217|19288847|P2|STARTED|Overall Study||45
7837197|NCT01023217|19288848|P1|STARTED|Overall Study||45
7837198|NCT01023178|19288857|P3|NOT COMPLETED|Overall Study||3
7837199|NCT01023178|19288858|P2|NOT COMPLETED|Overall Study||2
7837200|NCT01023178|19288859|P1|NOT COMPLETED|Overall Study||2
7837201|NCT01023178|19288857|P3|COMPLETED|Overall Study||4
7837202|NCT01023178|19288858|P2|COMPLETED|Overall Study||6
7837203|NCT01023178|19288859|P1|COMPLETED|Overall Study||3
7837204|NCT01023178|19288857|P3|STARTED|Overall Study||7
7837205|NCT01023178|19288858|P2|STARTED|Overall Study||8
7837206|NCT01023178|19288859|P1|STARTED|Overall Study||5
7837207|NCT01023074|19288870|P3|NOT COMPLETED|Overall Study||0
7837208|NCT01023074|19288871|P2|NOT COMPLETED|Overall Study||0
7837209|NCT01023074|19288872|P1|NOT COMPLETED|Overall Study||0
7837210|NCT01023074|19288870|P3|COMPLETED|Overall Study||13
7837211|NCT01023074|19288871|P2|COMPLETED|Overall Study||13
7837212|NCT01023074|19288872|P1|COMPLETED|Overall Study||26
7837213|NCT01023074|19288870|P3|STARTED|Overall Study||13
7837214|NCT01023074|19288871|P2|STARTED|Overall Study||13
7837215|NCT01023074|19288872|P1|STARTED|Overall Study||26
7837216|NCT01023061|19288886|P1|NOT COMPLETED|Overall Study||2
7837217|NCT01023061|19288886|P1|COMPLETED|Overall Study||22
7837218|NCT01023061|19288886|P1|STARTED|Overall Study||24
7837219|NCT01023035|19288895|P3|NOT COMPLETED|Follow-up Period (up to Week 72)||39
7837220|NCT01023035|19288896|P2|NOT COMPLETED|Follow-up Period (up to Week 72)||28
7837221|NCT01023035|19288897|P1|NOT COMPLETED|Follow-up Period (up to Week 72)||28
7837222|NCT01023035|19288895|P3|COMPLETED|Follow-up Period (up to Week 72)||108
7837223|NCT01023035|19288896|P2|COMPLETED|Follow-up Period (up to Week 72)||207
7837224|NCT01023035|19288897|P1|COMPLETED|Follow-up Period (up to Week 72)||210
7837225|NCT01023035|19288895|P3|STARTED|Follow-up Period (up to Week 72)||147
7837226|NCT01023035|19288896|P2|STARTED|Follow-up Period (up to Week 72)||235
7837227|NCT01023035|19288897|P1|STARTED|Follow-up Period (up to Week 72)||238
7837228|NCT01023035|19288895|P3|NOT COMPLETED|Treatment Period||118
7837229|NCT01023035|19288896|P2|NOT COMPLETED|Treatment Period||85
7837230|NCT01023035|19288897|P1|NOT COMPLETED|Treatment Period||72
7837231|NCT01023035|19288895|P3|COMPLETED|Treatment Period||69
7837232|NCT01023035|19288896|P2|COMPLETED|Treatment Period||166
7837233|NCT01023035|19288897|P1|COMPLETED|Treatment Period||177
7837234|NCT01023035|19288895|P3|STARTED|Treatment Period||187
7837235|NCT01023035|19288896|P2|STARTED|Treatment Period||251
7837236|NCT01023035|19288897|P1|STARTED|Treatment Period||249
7837237|NCT01023022|19288907|P1|NOT COMPLETED|Overall Study||14
7837238|NCT01023022|19288907|P1|COMPLETED|Overall Study||162
7837239|NCT01023022|19288907|P1|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176
7837240|NCT01022996|19288913|P1|NOT COMPLETED|Overall Study||57
7837241|NCT01022996|19288913|P1|COMPLETED|Overall Study||0
7837242|NCT01022996|19288913|P1|STARTED|Overall Study||57
7837243|NCT01022853|19288927|P5|NOT COMPLETED|Overall Study||2
7837244|NCT01022853|19288928|P4|NOT COMPLETED|Overall Study||8
7837245|NCT01022853|19288929|P3|NOT COMPLETED|Overall Study||13
7837246|NCT01022853|19288930|P2|NOT COMPLETED|Overall Study||4
7837247|NCT01022853|19288931|P1|NOT COMPLETED|Overall Study||3
7837248|NCT01022853|19288927|P5|COMPLETED|Overall Study||0
7837249|NCT01022853|19288928|P4|COMPLETED|Overall Study||0
7837250|NCT01022853|19288929|P3|COMPLETED|Overall Study||0
7837251|NCT01022853|19288930|P2|COMPLETED|Overall Study||0
7837252|NCT01022853|19288931|P1|COMPLETED|Overall Study||0
7837253|NCT01022853|19288927|P5|STARTED|Overall Study|entered and treated|2
7837254|NCT01022853|19288928|P4|STARTED|Overall Study|entered and treated|8
7837255|NCT01022853|19288929|P3|STARTED|Overall Study|entered and treated|13
7837256|NCT01022853|19288930|P2|STARTED|Overall Study|entered and treated|4
7837257|NCT01022853|19288931|P1|STARTED|Overall Study|entered and treated|3
7837258|NCT01022762|19289010|P2|NOT COMPLETED|Overall Study||28
7837259|NCT01022762|19289011|P1|NOT COMPLETED|Overall Study||22
7837260|NCT01022762|19289010|P2|COMPLETED|Overall Study||194
7837261|NCT01022762|19289011|P1|COMPLETED|Overall Study||196
7837262|NCT01022762|19289010|P2|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218
7837263|NCT01022762|19289011|P1|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217
7837264|NCT01022762|19289010|P2|STARTED|Overall Study||222
7837265|NCT01022762|19289011|P1|STARTED|Overall Study||218
7837266|NCT01022567|19289039|P2|NOT COMPLETED|Overall Study||15
7837267|NCT01022567|19289040|P1|NOT COMPLETED|Overall Study||1
7837268|NCT01022567|19289039|P2|COMPLETED|Overall Study||242
7837269|NCT01022567|19289040|P1|COMPLETED|Overall Study||272
7837270|NCT01022567|19289039|P2|STARTED|Overall Study||257
7837271|NCT01022567|19289040|P1|STARTED|Overall Study||273
7837272|NCT01022502|19289046|P1|NOT COMPLETED|Overall Study||3
7837273|NCT01022502|19289046|P1|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35
7837274|NCT01022502|19289046|P1|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38
7837275|NCT01022424|19289060|P1|NOT COMPLETED|Overall Study||4
7837276|NCT01022424|19289060|P1|COMPLETED|Overall Study||9
7837277|NCT01022424|19289060|P1|STARTED|Overall Study||13
7837278|NCT01022398|19289075|P2|NOT COMPLETED|Overall Study||2
7837279|NCT01022398|19289076|P1|NOT COMPLETED|Overall Study||2
7837280|NCT01022398|19289075|P2|COMPLETED|Overall Study||0
7837281|NCT01022398|19289076|P1|COMPLETED|Overall Study||0
7837282|NCT01022398|19289075|P2|STARTED|Overall Study||2
7837283|NCT01022398|19289076|P1|STARTED|Overall Study||2
7837284|NCT01022307|19289083|P2|NOT COMPLETED|Overall Study||4
7837285|NCT01022307|19289084|P1|NOT COMPLETED|Overall Study||0
7837286|NCT01022307|19289083|P2|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24
7837287|NCT01022307|19289084|P1|COMPLETED|Overall Study||184
7837288|NCT01022307|19289083|P2|STARTED|Overall Study||28
7837289|NCT01022307|19289084|P1|STARTED|Overall Study||184
7837290|NCT01022242|19289092|P2|NOT COMPLETED|Overall Study||19
7837291|NCT01022242|19289093|P1|NOT COMPLETED|Overall Study||21
7837292|NCT01022242|19289092|P2|COMPLETED|Overall Study||46
7837293|NCT01022242|19289093|P1|COMPLETED|Overall Study||49
7837294|NCT01022242|19289092|P2|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65
7837295|NCT01022242|19289093|P1|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70
7837296|NCT01022203|19289101|P2|NOT COMPLETED|Follow-Up Assessment||2
7837297|NCT01022203|19289102|P1|NOT COMPLETED|Follow-Up Assessment||2
7837298|NCT01022203|19289101|P2|COMPLETED|Follow-Up Assessment||40
7837299|NCT01022203|19289102|P1|COMPLETED|Follow-Up Assessment||42
7837300|NCT01022203|19289101|P2|STARTED|Follow-Up Assessment||42
7837301|NCT01022203|19289102|P1|STARTED|Follow-Up Assessment||44
7837302|NCT01022203|19289101|P2|NOT COMPLETED|Post Treatment Assessment||14
7837303|NCT01022203|19289102|P1|NOT COMPLETED|Post Treatment Assessment||14
7837304|NCT01022203|19289101|P2|COMPLETED|Post Treatment Assessment||42
7837305|NCT01022203|19289102|P1|COMPLETED|Post Treatment Assessment||44
7837306|NCT01022203|19289101|P2|STARTED|Post Treatment Assessment||56
7837307|NCT01022203|19289102|P1|STARTED|Post Treatment Assessment||58
7837308|NCT01022203|19289101|P2|NOT COMPLETED|PreTreatment Assessment||0
7837309|NCT01022203|19289102|P1|NOT COMPLETED|PreTreatment Assessment||0
7837310|NCT01022203|19289101|P2|COMPLETED|PreTreatment Assessment||56
7837311|NCT01022203|19289102|P1|COMPLETED|PreTreatment Assessment||58
7837312|NCT01022203|19289101|P2|STARTED|PreTreatment Assessment||56
7837313|NCT01022203|19289102|P1|STARTED|PreTreatment Assessment||58
7837314|NCT01022190|19289112|P1|NOT COMPLETED|Overall Study||0
7837315|NCT01022190|19289112|P1|COMPLETED|Overall Study||42
7837316|NCT01022190|19289112|P1|STARTED|Overall Study||42
7837317|NCT01022112|19289121|P5|NOT COMPLETED|Overall Study||10
7837318|NCT01022112|19289122|P4|NOT COMPLETED|Overall Study||3
7837319|NCT01022112|19289123|P3|NOT COMPLETED|Overall Study||3
7837320|NCT01022112|19289124|P2|NOT COMPLETED|Overall Study||3
7837321|NCT01022112|19289125|P1|NOT COMPLETED|Overall Study||3
7837322|NCT01022112|19289121|P5|COMPLETED|Overall Study||65
7837323|NCT01022112|19289122|P4|COMPLETED|Overall Study||72
7837324|NCT01022112|19289123|P3|COMPLETED|Overall Study||74
7837325|NCT01022112|19289124|P2|COMPLETED|Overall Study||71
7837326|NCT01022112|19289125|P1|COMPLETED|Overall Study||79
7837327|NCT01022112|19289121|P5|STARTED|Overall Study||75
7837328|NCT01022112|19289122|P4|STARTED|Overall Study||75
7837329|NCT01022112|19289123|P3|STARTED|Overall Study||77
7837330|NCT01022112|19289124|P2|STARTED|Overall Study||74
7837331|NCT01022112|19289125|P1|STARTED|Overall Study||82
7837332|NCT01022073|19289139|P2|NOT COMPLETED|Overall Study||18
7837333|NCT01022073|19289140|P1|NOT COMPLETED|Overall Study||19
7837334|NCT01022073|19289139|P2|COMPLETED|Overall Study||52
7837335|NCT01022073|19289140|P1|COMPLETED|Overall Study||67
7837336|NCT01022073|19289139|P2|STARTED|Overall Study||70
7837337|NCT01022073|19289140|P1|STARTED|Overall Study||86
7837338|NCT01021956|19289150|P4|NOT COMPLETED|Overall Study||0
7837339|NCT01021956|19289151|P3|NOT COMPLETED|Overall Study||0
7837340|NCT01021956|19289152|P2|NOT COMPLETED|Overall Study||0
7837341|NCT01021956|19289153|P1|NOT COMPLETED|Overall Study||0
7837342|NCT01021956|19289150|P4|COMPLETED|Overall Study||1
7837343|NCT01021956|19289151|P3|COMPLETED|Overall Study||3
7837344|NCT01021956|19289152|P2|COMPLETED|Overall Study||3
7837345|NCT01021956|19289153|P1|COMPLETED|Overall Study||3
7837346|NCT01021956|19289150|P4|STARTED|Overall Study||1
7837347|NCT01021956|19289151|P3|STARTED|Overall Study||3
7837348|NCT01021956|19289152|P2|STARTED|Overall Study||3
7837349|NCT01021956|19289153|P1|STARTED|Overall Study||3
7837350|NCT01021878|19289174|P2|NOT COMPLETED|Overall Study||10
7837351|NCT01021878|19289175|P1|NOT COMPLETED|Overall Study||16
7837352|NCT01021878|19289174|P2|COMPLETED|Overall Study||17
7837353|NCT01021878|19289175|P1|COMPLETED|Overall Study||17
7837354|NCT01021878|19289174|P2|Completed Follow-up|Overall Study||17
7837355|NCT01021878|19289175|P1|Completed Follow-up|Overall Study||17
7837356|NCT01021878|19289174|P2|STARTED|Overall Study||27
7837357|NCT01021878|19289175|P1|STARTED|Overall Study||33
7837358|NCT01021852|19289197|P8|NOT COMPLETED|Treatment Period 2||2
7837359|NCT01021852|19289198|P7|NOT COMPLETED|Treatment Period 2||3
7837360|NCT01021852|19289199|P6|NOT COMPLETED|Treatment Period 2||1
7837361|NCT01021852|19289200|P5|NOT COMPLETED|Treatment Period 2||2
7837362|NCT01021852|19289201|P4|NOT COMPLETED|Treatment Period 2||0
7837363|NCT01021852|19289202|P3|NOT COMPLETED|Treatment Period 2||1
7837364|NCT01021852|19289203|P2|NOT COMPLETED|Treatment Period 2||1
7837365|NCT01021852|19289204|P1|NOT COMPLETED|Treatment Period 2||0
7837366|NCT01021852|19289197|P8|COMPLETED|Treatment Period 2||38
7837367|NCT01021852|19289198|P7|COMPLETED|Treatment Period 2||37
7837368|NCT01021852|19289199|P6|COMPLETED|Treatment Period 2||37
7837369|NCT01021852|19289200|P5|COMPLETED|Treatment Period 2||37
7837370|NCT01021852|19289201|P4|COMPLETED|Treatment Period 2||37
7837371|NCT01021852|19289202|P3|COMPLETED|Treatment Period 2||38
7837372|NCT01021852|19289203|P2|COMPLETED|Treatment Period 2||38
7837373|NCT01021852|19289204|P1|COMPLETED|Treatment Period 2||37
7837374|NCT01021852|19289197|P8|STARTED|Treatment Period 2||40
7837375|NCT01021852|19289198|P7|STARTED|Treatment Period 2||40
7837376|NCT01021852|19289199|P6|STARTED|Treatment Period 2||38
7837377|NCT01021852|19289200|P5|STARTED|Treatment Period 2||39
7837378|NCT01021852|19289201|P4|STARTED|Treatment Period 2||37
7837379|NCT01021852|19289202|P3|STARTED|Treatment Period 2||39
7837380|NCT01021852|19289203|P2|STARTED|Treatment Period 2||39
7837381|NCT01021852|19289204|P1|STARTED|Treatment Period 2||37
7837382|NCT01021852|19289197|P8|NOT COMPLETED|Washout Period-No Drug||0
7837383|NCT01021852|19289198|P7|NOT COMPLETED|Washout Period-No Drug||0
7837384|NCT01021852|19289199|P6|NOT COMPLETED|Washout Period-No Drug||1
7837385|NCT01021852|19289200|P5|NOT COMPLETED|Washout Period-No Drug||0
7837386|NCT01021852|19289201|P4|NOT COMPLETED|Washout Period-No Drug||0
7837387|NCT01021852|19289202|P3|NOT COMPLETED|Washout Period-No Drug||0
7837388|NCT01021852|19289203|P2|NOT COMPLETED|Washout Period-No Drug||0
7837389|NCT01021852|19289204|P1|NOT COMPLETED|Washout Period-No Drug||1
7837390|NCT01021852|19289197|P8|COMPLETED|Washout Period-No Drug||40
7837391|NCT01021852|19289198|P7|COMPLETED|Washout Period-No Drug||40
7837392|NCT01021852|19289199|P6|COMPLETED|Washout Period-No Drug||38
7837393|NCT01021852|19289200|P5|COMPLETED|Washout Period-No Drug||39
7837394|NCT01021852|19289201|P4|COMPLETED|Washout Period-No Drug||37
7837395|NCT01021852|19289202|P3|COMPLETED|Washout Period-No Drug||39
7837396|NCT01021852|19289203|P2|COMPLETED|Washout Period-No Drug||39
7837397|NCT01021852|19289204|P1|COMPLETED|Washout Period-No Drug||37
7837398|NCT01021852|19289197|P8|STARTED|Washout Period-No Drug||40
7837399|NCT01021852|19289198|P7|STARTED|Washout Period-No Drug||40
7837400|NCT01021852|19289199|P6|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39
7837401|NCT01021852|19289200|P5|STARTED|Washout Period-No Drug||39
7837402|NCT01021852|19289201|P4|STARTED|Washout Period-No Drug||37
7837403|NCT01021852|19289202|P3|STARTED|Washout Period-No Drug||39
7837404|NCT01021852|19289203|P2|STARTED|Washout Period-No Drug||39
7837405|NCT01021852|19289204|P1|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38
7837406|NCT01021852|19289197|P8|NOT COMPLETED|Washout Period-Placebo||0
7837407|NCT01021852|19289198|P7|NOT COMPLETED|Washout Period-Placebo||1
7837408|NCT01021852|19289199|P6|NOT COMPLETED|Washout Period-Placebo||1
7837409|NCT01021852|19289200|P5|NOT COMPLETED|Washout Period-Placebo||1
7837410|NCT01021852|19289201|P4|NOT COMPLETED|Washout Period-Placebo||1
7837411|NCT01021852|19289202|P3|NOT COMPLETED|Washout Period-Placebo||0
7837412|NCT01021852|19289203|P2|NOT COMPLETED|Washout Period-Placebo||0
7837413|NCT01021852|19289204|P1|NOT COMPLETED|Washout Period-Placebo||0
7837414|NCT01021852|19289197|P8|COMPLETED|Washout Period-Placebo||40
7837415|NCT01021852|19289198|P7|COMPLETED|Washout Period-Placebo||40
7837416|NCT01021852|19289199|P6|COMPLETED|Washout Period-Placebo||38
7837417|NCT01021852|19289200|P5|COMPLETED|Washout Period-Placebo||39
7837418|NCT01021852|19289201|P4|COMPLETED|Washout Period-Placebo||37
7837419|NCT01021852|19289202|P3|COMPLETED|Washout Period-Placebo||39
7837420|NCT01021852|19289203|P2|COMPLETED|Washout Period-Placebo||39
7837421|NCT01021852|19289204|P1|COMPLETED|Washout Period-Placebo||37
7837422|NCT01021852|19289197|P8|STARTED|Washout Period-Placebo||40
7837423|NCT01021852|19289198|P7|STARTED|Washout Period-Placebo||41
7837424|NCT01021852|19289199|P6|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39
7837425|NCT01021852|19289200|P5|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40
7837426|NCT01021852|19289201|P4|STARTED|Washout Period-Placebo||38
7837427|NCT01021852|19289202|P3|STARTED|Washout Period-Placebo||39
7837428|NCT01021852|19289203|P2|STARTED|Washout Period-Placebo||39
7837429|NCT01021852|19289204|P1|STARTED|Washout Period-Placebo||37
7837430|NCT01021852|19289197|P8|NOT COMPLETED|Treatment Period 1||1
7837431|NCT01021852|19289198|P7|NOT COMPLETED|Treatment Period 1||0
7837432|NCT01021852|19289199|P6|NOT COMPLETED|Treatment Period 1||2
7837433|NCT01021852|19289200|P5|NOT COMPLETED|Treatment Period 1||3
7837434|NCT01021852|19289201|P4|NOT COMPLETED|Treatment Period 1||2
7837435|NCT01021852|19289202|P3|NOT COMPLETED|Treatment Period 1||2
7837436|NCT01021852|19289203|P2|NOT COMPLETED|Treatment Period 1||1
7837437|NCT01021852|19289204|P1|NOT COMPLETED|Treatment Period 1||3
7837438|NCT01021852|19289197|P8|COMPLETED|Treatment Period 1||40
7837439|NCT01021852|19289198|P7|COMPLETED|Treatment Period 1||41
7837440|NCT01021852|19289199|P6|COMPLETED|Treatment Period 1||39
7837441|NCT01021852|19289200|P5|COMPLETED|Treatment Period 1||39
7837442|NCT01021852|19289201|P4|COMPLETED|Treatment Period 1||38
7837443|NCT01021852|19289202|P3|COMPLETED|Treatment Period 1||39
7837444|NCT01021852|19289203|P2|COMPLETED|Treatment Period 1||39
7837445|NCT01021852|19289204|P1|COMPLETED|Treatment Period 1||37
7837446|NCT01021852|19289197|P8|Treated|Treatment Period 1||41
7837447|NCT01021852|19289198|P7|Treated|Treatment Period 1||41
7837448|NCT01021852|19289199|P6|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41
7837449|NCT01021852|19289200|P5|Treated|Treatment Period 1||42
7837450|NCT01021852|19289201|P4|Treated|Treatment Period 1||38
7837451|NCT01021852|19289202|P3|Treated|Treatment Period 1||41
7837452|NCT01021852|19289203|P2|Treated|Treatment Period 1||40
7837453|NCT01021852|19289204|P1|Treated|Treatment Period 1||40
7837454|NCT01021852|19289197|P8|STARTED|Treatment Period 1||41
7837455|NCT01021852|19289198|P7|STARTED|Treatment Period 1||41
7837456|NCT01021852|19289199|P6|STARTED|Treatment Period 1||41
7837457|NCT01021852|19289200|P5|STARTED|Treatment Period 1||42
7837458|NCT01021852|19289201|P4|STARTED|Treatment Period 1||40
7837459|NCT01021852|19289202|P3|STARTED|Treatment Period 1||41
7837460|NCT01021852|19289203|P2|STARTED|Treatment Period 1||40
7837461|NCT01021852|19289204|P1|STARTED|Treatment Period 1||40
7837462|NCT01021813|19289240|P5|NOT COMPLETED|DB Randomized Discontinuation Phase||5
7837463|NCT01021813|19289241|P4|NOT COMPLETED|DB Randomized Discontinuation Phase||5
7837464|NCT01021813|19289242|P3|NOT COMPLETED|DB Randomized Discontinuation Phase||4
7837465|NCT01021813|19289243|P2|NOT COMPLETED|DB Randomized Discontinuation Phase||0
7837466|NCT01021813|19289244|P1|NOT COMPLETED|DB Randomized Discontinuation Phase||0
7837467|NCT01021813|19289240|P5|COMPLETED|DB Randomized Discontinuation Phase||157
7837468|NCT01021813|19289241|P4|COMPLETED|DB Randomized Discontinuation Phase||161
7837469|NCT01021813|19289242|P3|COMPLETED|DB Randomized Discontinuation Phase||152
7837470|NCT01021813|19289243|P2|COMPLETED|DB Randomized Discontinuation Phase||0
7837471|NCT01021813|19289244|P1|COMPLETED|DB Randomized Discontinuation Phase||0
7837472|NCT01021813|19289240|P5|STARTED|DB Randomized Discontinuation Phase||162
7837473|NCT01021813|19289241|P4|STARTED|DB Randomized Discontinuation Phase||166
7837474|NCT01021813|19289242|P3|STARTED|DB Randomized Discontinuation Phase||156
7837475|NCT01021813|19289243|P2|STARTED|DB Randomized Discontinuation Phase||0
7837476|NCT01021813|19289244|P1|STARTED|DB Randomized Discontinuation Phase||0
7837477|NCT01021813|19289240|P5|NOT COMPLETED|DB Treatment Phase||0
7837478|NCT01021813|19289241|P4|NOT COMPLETED|DB Treatment Phase||0
7837479|NCT01021813|19289242|P3|NOT COMPLETED|DB Treatment Phase||0
7837480|NCT01021813|19289243|P2|NOT COMPLETED|DB Treatment Phase||97
7837481|NCT01021813|19289244|P1|NOT COMPLETED|DB Treatment Phase||200
7837482|NCT01021813|19289240|P5|COMPLETED|DB Treatment Phase||0
7837483|NCT01021813|19289241|P4|COMPLETED|DB Treatment Phase||0
7837484|NCT01021813|19289242|P3|COMPLETED|DB Treatment Phase||0
7837485|NCT01021813|19289243|P2|COMPLETED|DB Treatment Phase||162
7837486|NCT01021813|19289244|P1|COMPLETED|DB Treatment Phase||322
7837487|NCT01021813|19289240|P5|Treated|DB Treatment Phase||0
7837488|NCT01021813|19289241|P4|Treated|DB Treatment Phase||0
7837489|NCT01021813|19289242|P3|Treated|DB Treatment Phase||0
7837490|NCT01021813|19289243|P2|Treated|DB Treatment Phase||258
7837491|NCT01021813|19289244|P1|Treated|DB Treatment Phase||521
7837492|NCT01021813|19289240|P5|STARTED|DB Treatment Phase||0
7837493|NCT01021813|19289241|P4|STARTED|DB Treatment Phase||0
7837494|NCT01021813|19289242|P3|STARTED|DB Treatment Phase||0
7837495|NCT01021813|19289243|P2|STARTED|DB Treatment Phase||259
7837496|NCT01021813|19289244|P1|STARTED|DB Treatment Phase||522
7837497|NCT01021761|19289286|P3|NOT COMPLETED|Overall Study||0
7837498|NCT01021761|19289287|P2|NOT COMPLETED|Overall Study||4
7837499|NCT01021761|19289288|P1|NOT COMPLETED|Overall Study||1
7837500|NCT01021761|19289286|P3|COMPLETED|Overall Study||42
7837501|NCT01021761|19289287|P2|COMPLETED|Overall Study||38
7837502|NCT01021761|19289288|P1|COMPLETED|Overall Study||41
7837503|NCT01021761|19289286|P3|STARTED|Overall Study||42
7837504|NCT01021761|19289287|P2|STARTED|Overall Study||42
7837505|NCT01021761|19289288|P1|STARTED|Overall Study||42
7837506|NCT01021748|19289305|P9|NOT COMPLETED|Overall Study||16
7837507|NCT01021748|19289306|P8|NOT COMPLETED|Overall Study||6
7837508|NCT01021748|19289307|P7|NOT COMPLETED|Overall Study||3
7837509|NCT01021748|19289308|P6|NOT COMPLETED|Overall Study||3
7837510|NCT01021748|19289309|P5|NOT COMPLETED|Overall Study||9
7837511|NCT01021748|19289310|P4|NOT COMPLETED|Overall Study||7
7837512|NCT01021748|19289311|P3|NOT COMPLETED|Overall Study||7
7837513|NCT01021748|19289312|P2|NOT COMPLETED|Overall Study||5
7837514|NCT01021748|19289313|P1|NOT COMPLETED|Overall Study||6
7837515|NCT01021748|19289305|P9|COMPLETED|Overall Study||1
7837516|NCT01021748|19289306|P8|COMPLETED|Overall Study||0
7837517|NCT01021748|19289307|P7|COMPLETED|Overall Study||0
7837518|NCT01021748|19289308|P6|COMPLETED|Overall Study||0
7837519|NCT01021748|19289309|P5|COMPLETED|Overall Study||0
7837520|NCT01021748|19289310|P4|COMPLETED|Overall Study||0
7837521|NCT01021748|19289311|P3|COMPLETED|Overall Study||0
7837522|NCT01021748|19289312|P2|COMPLETED|Overall Study||0
7837523|NCT01021748|19289313|P1|COMPLETED|Overall Study||0
7837524|NCT01021748|19289305|P9|Treated|Overall Study||17
7837525|NCT01021748|19289306|P8|Treated|Overall Study||6
7837526|NCT01021748|19289307|P7|Treated|Overall Study||3
7837527|NCT01021748|19289308|P6|Treated|Overall Study||3
7837528|NCT01021748|19289309|P5|Treated|Overall Study||9
7837529|NCT01021748|19289310|P4|Treated|Overall Study||7
7837530|NCT01021748|19289311|P3|Treated|Overall Study||7
7837531|NCT01021748|19289312|P2|Treated|Overall Study|One participant was allocated, but not treated.|4
7837532|NCT01021748|19289313|P1|Treated|Overall Study||6
7837533|NCT01021748|19289305|P9|STARTED|Overall Study||17
7837534|NCT01021748|19289306|P8|STARTED|Overall Study||6
7837535|NCT01021748|19289307|P7|STARTED|Overall Study||3
7837536|NCT01021748|19289308|P6|STARTED|Overall Study||3
7837537|NCT01021748|19289309|P5|STARTED|Overall Study||9
7837538|NCT01021748|19289310|P4|STARTED|Overall Study||7
7837539|NCT01021748|19289311|P3|STARTED|Overall Study||7
7837540|NCT01021748|19289312|P2|STARTED|Overall Study||5
7837541|NCT01021748|19289313|P1|STARTED|Overall Study||6
7837542|NCT01021683|19289360|P1|NOT COMPLETED|Overall Study||71
7837543|NCT01021683|19289360|P1|COMPLETED|Overall Study||132
7837544|NCT01021683|19289360|P1|STARTED|Overall Study||203
7837545|NCT01021618|19289374|P2|NOT COMPLETED|Overall Study||0
7837546|NCT01021618|19289375|P1|NOT COMPLETED|Overall Study||0
7837547|NCT01021618|19289374|P2|COMPLETED|Overall Study||96
7837548|NCT01021618|19289375|P1|COMPLETED|Overall Study||44
7837549|NCT01021618|19289374|P2|STARTED|Overall Study||96
7837550|NCT01021618|19289375|P1|STARTED|Overall Study||44
7837551|NCT01021553|19289386|P3|NOT COMPLETED|Overall Study||3
7837552|NCT01021553|19289387|P2|NOT COMPLETED|Overall Study||5
7837553|NCT01021553|19289388|P1|NOT COMPLETED|Overall Study||4
7837554|NCT01021553|19289386|P3|COMPLETED|Overall Study||25
7837555|NCT01021553|19289387|P2|COMPLETED|Overall Study||17
7837556|NCT01021553|19289388|P1|COMPLETED|Overall Study||23
7837557|NCT01021553|19289386|P3|STARTED|Overall Study||28
7837558|NCT01021553|19289387|P2|STARTED|Overall Study||22
7837559|NCT01021553|19289388|P1|STARTED|Overall Study||27
7837560|NCT01021423|19289442|P2|NOT COMPLETED|Overall Study||5
7837561|NCT01021423|19289443|P1|NOT COMPLETED|Overall Study||4
7837562|NCT01021423|19289442|P2|COMPLETED|Overall Study||0
7837563|NCT01021423|19289443|P1|COMPLETED|Overall Study||0
7837564|NCT01021423|19289442|P2|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5
7837565|NCT01021423|19289443|P1|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4
7837566|NCT01021332|19289459|P1|NOT COMPLETED|Overall Study||106
7837567|NCT01021332|19289459|P1|COMPLETED|Overall Study||960
7837568|NCT01021332|19289459|P1|Full Analysis Set (FAS)|Overall Study||1009
7837569|NCT01021332|19289459|P1|Safety Analysis Set (SAF)|Overall Study||1066
7837570|NCT01021332|19289459|P1|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066
7837571|NCT01021306|19289497|P4|NOT COMPLETED|6 Month (Follow-up)||3
7837572|NCT01021306|19289498|P3|NOT COMPLETED|6 Month (Follow-up)||0
7837573|NCT01021306|19289499|P2|NOT COMPLETED|6 Month (Follow-up)||1
7837574|NCT01021306|19289500|P1|NOT COMPLETED|6 Month (Follow-up)||3
7837575|NCT01021306|19289497|P4|COMPLETED|6 Month (Follow-up)||14
7837576|NCT01021306|19289498|P3|COMPLETED|6 Month (Follow-up)||14
7837577|NCT01021306|19289499|P2|COMPLETED|6 Month (Follow-up)||13
7837578|NCT01021306|19289500|P1|COMPLETED|6 Month (Follow-up)||11
7837579|NCT01021306|19289497|P4|STARTED|6 Month (Follow-up)||17
7837580|NCT01021306|19289498|P3|STARTED|6 Month (Follow-up)||14
7837581|NCT01021306|19289499|P2|STARTED|6 Month (Follow-up)||14
7837582|NCT01021306|19289500|P1|STARTED|6 Month (Follow-up)||14
7837583|NCT01021306|19289497|P4|NOT COMPLETED|2 Month (Primary Outcome)||4
7837584|NCT01021306|19289498|P3|NOT COMPLETED|2 Month (Primary Outcome)||5
7837585|NCT01021306|19289499|P2|NOT COMPLETED|2 Month (Primary Outcome)||6
7837586|NCT01021306|19289500|P1|NOT COMPLETED|2 Month (Primary Outcome)||6
7837587|NCT01021306|19289497|P4|COMPLETED|2 Month (Primary Outcome)||17
7837588|NCT01021306|19289498|P3|COMPLETED|2 Month (Primary Outcome)||14
7837589|NCT01021306|19289499|P2|COMPLETED|2 Month (Primary Outcome)||14
7837590|NCT01021306|19289500|P1|COMPLETED|2 Month (Primary Outcome)||14
7837591|NCT01021306|19289497|P4|STARTED|2 Month (Primary Outcome)||21
7837592|NCT01021306|19289498|P3|STARTED|2 Month (Primary Outcome)||19
7837593|NCT01021306|19289499|P2|STARTED|2 Month (Primary Outcome)||20
7837594|NCT01021306|19289500|P1|STARTED|2 Month (Primary Outcome)||20
7837595|NCT01021293|19289520|P2|NOT COMPLETED|Overall Study||24
7837596|NCT01021293|19289521|P1|NOT COMPLETED|Overall Study||12
7837597|NCT01021293|19289520|P2|COMPLETED|Overall Study||526
7837598|NCT01021293|19289521|P1|COMPLETED|Overall Study||538
7837599|NCT01021293|19289520|P2|STARTED|Overall Study||550
7837600|NCT01021293|19289521|P1|STARTED|Overall Study||550
7837601|NCT01021215|19289540|P2|NOT COMPLETED|Overall Study||0
7837602|NCT01021215|19289541|P1|NOT COMPLETED|Overall Study||3
7837603|NCT01021215|19289540|P2|COMPLETED|Overall Study||20
7837604|NCT01021215|19289541|P1|COMPLETED|Overall Study||57
7837605|NCT01021215|19289540|P2|Received Allocated Intervention|Overall Study||20
7837606|NCT01021215|19289541|P1|Received Allocated Intervention|Overall Study||60
7837607|NCT01021215|19289540|P2|STARTED|Overall Study||20
7837608|NCT01021215|19289541|P1|STARTED|Overall Study||60
7837609|NCT01021137|19289555|P4|NOT COMPLETED|Overall Study||9
7837610|NCT01021137|19289556|P3|NOT COMPLETED|Overall Study||2
7837611|NCT01021137|19289557|P2|NOT COMPLETED|Overall Study||4
7837612|NCT01021137|19289558|P1|NOT COMPLETED|Overall Study||10
7837613|NCT01021137|19289555|P4|COMPLETED|Overall Study||32
7837614|NCT01021137|19289556|P3|COMPLETED|Overall Study||9
7837615|NCT01021137|19289557|P2|COMPLETED|Overall Study||16
7837616|NCT01021137|19289558|P1|COMPLETED|Overall Study||52
7837617|NCT01021137|19289555|P4|STARTED|Overall Study||41
7837618|NCT01021137|19289556|P3|STARTED|Overall Study||11
7837619|NCT01021137|19289557|P2|STARTED|Overall Study||20
7837620|NCT01021137|19289558|P1|STARTED|Overall Study||62
7837621|NCT01021111|19289596|P1|NOT COMPLETED|Overall Study||0
7837622|NCT01021111|19289596|P1|COMPLETED|Overall Study||17
7837623|NCT01021111|19289596|P1|STARTED|Overall Study||17
7837624|NCT01021020|19289601|P1|NOT COMPLETED|Period III||0
7837625|NCT01021020|19289601|P1|COMPLETED|Period III||25
7837626|NCT01021020|19289601|P1|STARTED|Period III||25
7837627|NCT01021020|19289601|P1|NOT COMPLETED|14 Day Washout Period B||0
7837628|NCT01021020|19289601|P1|COMPLETED|14 Day Washout Period B||25
7837629|NCT01021020|19289601|P1|STARTED|14 Day Washout Period B||25
7837630|NCT01021020|19289601|P1|NOT COMPLETED|Period II||0
7837631|NCT01021020|19289601|P1|COMPLETED|Period II||25
7837632|NCT01021020|19289601|P1|STARTED|Period II||25
7837633|NCT01021020|19289601|P1|NOT COMPLETED|14 Day Washout Period A||1
7837634|NCT01021020|19289601|P1|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25
7837635|NCT01021020|19289601|P1|STARTED|14 Day Washout Period A||26
7837636|NCT01021020|19289601|P1|NOT COMPLETED|Period I||2
7837637|NCT01021020|19289601|P1|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26
7837638|NCT01021020|19289601|P1|STARTED|Period I||28
7837639|NCT01021007|19289617|P2|NOT COMPLETED|Overall Study||4
7837640|NCT01021007|19289618|P1|NOT COMPLETED|Overall Study||2
7837641|NCT01021007|19289617|P2|COMPLETED|Overall Study||33
7837642|NCT01021007|19289618|P1|COMPLETED|Overall Study||34
7837643|NCT01021007|19289617|P2|STARTED|Overall Study||37
7837644|NCT01021007|19289618|P1|STARTED|Overall Study||36
7837645|NCT01020981|19289630|P2|NOT COMPLETED|Overall Study||90
7837646|NCT01020981|19289631|P1|NOT COMPLETED|Overall Study||84
7837647|NCT01020981|19289630|P2|COMPLETED|Overall Study||60
7837648|NCT01020981|19289631|P1|COMPLETED|Overall Study||66
7837649|NCT01020981|19289630|P2|STARTED|Overall Study||150
7837650|NCT01020981|19289631|P1|STARTED|Overall Study||150
7837651|NCT01020903|19289643|P2|NOT COMPLETED|Overall Study||0
7837652|NCT01020903|19289644|P1|NOT COMPLETED|Overall Study||0
7837653|NCT01020903|19289643|P2|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100
7837654|NCT01020903|19289644|P1|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
7837655|NCT01020903|19289643|P2|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
7837656|NCT01020903|19289644|P1|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
7837657|NCT01020877|19289652|P2|NOT COMPLETED|Second Intervention||0
7837658|NCT01020877|19289653|P1|NOT COMPLETED|Second Intervention||1
7837659|NCT01020877|19289652|P2|COMPLETED|Second Intervention||19
7837660|NCT01020877|19289653|P1|COMPLETED|Second Intervention||18
7837661|NCT01020877|19289652|P2|STARTED|Second Intervention||19
7837662|NCT01020877|19289653|P1|STARTED|Second Intervention||19
7837663|NCT01020877|19289652|P2|NOT COMPLETED|Washout of 7 Days||0
7837664|NCT01020877|19289653|P1|NOT COMPLETED|Washout of 7 Days||0
7837665|NCT01020877|19289652|P2|COMPLETED|Washout of 7 Days||19
7837666|NCT01020877|19289653|P1|COMPLETED|Washout of 7 Days||19
7837667|NCT01020877|19289652|P2|STARTED|Washout of 7 Days||19
7837668|NCT01020877|19289653|P1|STARTED|Washout of 7 Days||19
7837669|NCT01020877|19289652|P2|NOT COMPLETED|First Intervention||0
7837670|NCT01020877|19289653|P1|NOT COMPLETED|First Intervention||0
7837671|NCT01020877|19289652|P2|COMPLETED|First Intervention||19
7837672|NCT01020877|19289653|P1|COMPLETED|First Intervention||19
7837673|NCT01020877|19289652|P2|STARTED|First Intervention||19
7837674|NCT01020877|19289653|P1|STARTED|First Intervention||19
7837675|NCT01020838|19289663|P1|NOT COMPLETED|Overall Study||183
7837676|NCT01020838|19289663|P1|COMPLETED|Overall Study||35
7837677|NCT01020838|19289663|P1|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34
7837678|NCT01020838|19289663|P1|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91
7837679|NCT01020838|19289663|P1|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97
7837680|NCT01020838|19289663|P1|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41
7837681|NCT01020838|19289663|P1|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216
7837682|NCT01020838|19289663|P1|STARTED|Overall Study||218
7837683|NCT01020812|19289678|P1|NOT COMPLETED|Overall Study||3
7837684|NCT01020812|19289678|P1|COMPLETED|Overall Study||8
7837685|NCT01020812|19289678|P1|STARTED|Overall Study||11
7837686|NCT01020799|19289688|P3|NOT COMPLETED|Overall Study||7
7837687|NCT01020799|19289689|P2|NOT COMPLETED|Overall Study||14
7837688|NCT01020799|19289690|P1|NOT COMPLETED|Overall Study||19
7837689|NCT01020799|19289688|P3|COMPLETED|Overall Study||43
7837690|NCT01020799|19289689|P2|COMPLETED|Overall Study||85
7837691|NCT01020799|19289690|P1|COMPLETED|Overall Study||79
7837692|NCT01020799|19289688|P3|Full Analysis Set|Overall Study||49
7837693|NCT01020799|19289689|P2|Full Analysis Set|Overall Study||94
7837694|NCT01020799|19289690|P1|Full Analysis Set|Overall Study||91
7837695|NCT01020799|19289688|P3|Patients Received Treatment|Overall Study||50
7837696|NCT01020799|19289689|P2|Patients Received Treatment|Overall Study||99
7837697|NCT01020799|19289690|P1|Patients Received Treatment|Overall Study||96
7837698|NCT01020799|19289688|P3|STARTED|Overall Study||50
7837699|NCT01020799|19289689|P2|STARTED|Overall Study||99
7837700|NCT01020799|19289690|P1|STARTED|Overall Study||98
7837701|NCT01020786|19289713|P1|NOT COMPLETED|Maintenance Period||60
7837702|NCT01020786|19289713|P1|COMPLETED|Maintenance Period||0
7837703|NCT01020786|19289713|P1|STARTED|Maintenance Period||60
7837704|NCT01020786|19289713|P1|NOT COMPLETED|Induction Period||49
7837705|NCT01020786|19289713|P1|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60
7837706|NCT01020786|19289713|P1|STARTED|Induction Period||109
7837707|NCT01020773|19289727|P2|NOT COMPLETED|Overall Study||3
7837708|NCT01020773|19289728|P1|NOT COMPLETED|Overall Study||4
7837709|NCT01020773|19289727|P2|COMPLETED|Overall Study||29
7837710|NCT01020773|19289728|P1|COMPLETED|Overall Study||31
7837711|NCT01020773|19289727|P2|STARTED|Overall Study||32
7837712|NCT01020773|19289728|P1|STARTED|Overall Study||35
7837713|NCT01020747|19289734|P1|NOT COMPLETED|Overall Study||1
7837714|NCT01020747|19289734|P1|COMPLETED|Overall Study||19
7837715|NCT01020747|19289734|P1|STARTED|Overall Study||20
7837716|NCT01020591|19289741|P2|NOT COMPLETED|Overall Study||0
7837717|NCT01020591|19289742|P1|NOT COMPLETED|Overall Study||0
7837718|NCT01020591|19289741|P2|COMPLETED|Overall Study||15
7837719|NCT01020591|19289742|P1|COMPLETED|Overall Study||15
7837720|NCT01020591|19289741|P2|STARTED|Overall Study||15
7837721|NCT01020591|19289742|P1|STARTED|Overall Study||15
7837722|NCT01020526|19289750|P1|NOT COMPLETED|Overall Study||14
7837723|NCT01020526|19289750|P1|COMPLETED|Overall Study||49
7837724|NCT01020526|19289750|P1|STARTED|Overall Study||63
7837725|NCT01020474|19289756|P2|NOT COMPLETED|Overall Study||17
7837726|NCT01020474|19289757|P1|NOT COMPLETED|Overall Study||10
7837727|NCT01020474|19289756|P2|COMPLETED|Overall Study||36
7837728|NCT01020474|19289757|P1|COMPLETED|Overall Study||44
7837729|NCT01020474|19289756|P2|STARTED|Overall Study||53
7837730|NCT01020474|19289757|P1|STARTED|Overall Study||54
7837731|NCT01020448|19289777|P1|NOT COMPLETED|Treatment||26
7837732|NCT01020448|19289777|P1|COMPLETED|Treatment||299
7837733|NCT01020448|19289777|P1|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325
7837734|NCT01020448|19289777|P1|NOT COMPLETED|Pre-assignment||13
7837735|NCT01020448|19289777|P1|COMPLETED|Pre-assignment||326
7837736|NCT01020448|19289777|P1|STARTED|Pre-assignment||339
7837737|NCT01020435|19289788|P2|NOT COMPLETED|Overall Study||1
7837738|NCT01020435|19289789|P1|NOT COMPLETED|Overall Study||0
7837739|NCT01020435|19289788|P2|COMPLETED|Overall Study||26
7837740|NCT01020435|19289789|P1|COMPLETED|Overall Study||24
7837741|NCT01020435|19289788|P2|STARTED|Overall Study||27
7837742|NCT01020435|19289789|P1|STARTED|Overall Study||24
7837743|NCT01020305|19289797|P1|NOT COMPLETED|Overall Study||2
7837744|NCT01020305|19289797|P1|COMPLETED|Overall Study||3
7837745|NCT01020305|19289797|P1|STARTED|Overall Study||5
7837746|NCT01020123|19289808|P7|NOT COMPLETED|Extention Period||1
7837747|NCT01020123|19289809|P6|NOT COMPLETED|Extention Period||2
7837748|NCT01020123|19289810|P5|NOT COMPLETED|Extention Period||0
7837749|NCT01020123|19289811|P4|NOT COMPLETED|Extention Period||1
7837750|NCT01020123|19289812|P3|NOT COMPLETED|Extention Period||2
7837751|NCT01020123|19289813|P2|NOT COMPLETED|Extention Period||2
7837752|NCT01020123|19289814|P1|NOT COMPLETED|Extention Period||3
7837753|NCT01020123|19289808|P7|COMPLETED|Extention Period||18
7837754|NCT01020123|19289809|P6|COMPLETED|Extention Period||36
7837755|NCT01020123|19289810|P5|COMPLETED|Extention Period||31
7837756|NCT01020123|19289811|P4|COMPLETED|Extention Period||12
7837757|NCT01020123|19289812|P3|COMPLETED|Extention Period||17
7837758|NCT01020123|19289813|P2|COMPLETED|Extention Period||33
7837759|NCT01020123|19289814|P1|COMPLETED|Extention Period||37
7837760|NCT01020123|19289808|P7|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
7837761|NCT01020123|19289809|P6|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38
7837762|NCT01020123|19289810|P5|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31
7837763|NCT01020123|19289811|P4|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13
7837764|NCT01020123|19289812|P3|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
7837765|NCT01020123|19289813|P2|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35
7837766|NCT01020123|19289814|P1|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40
7837767|NCT01020123|19289808|P7|NOT COMPLETED|Main Period||11
7837768|NCT01020123|19289809|P6|NOT COMPLETED|Main Period||11
7837769|NCT01020123|19289810|P5|NOT COMPLETED|Main Period||11
7837770|NCT01020123|19289811|P4|NOT COMPLETED|Main Period||7
7837771|NCT01020123|19289812|P3|NOT COMPLETED|Main Period||8
7837772|NCT01020123|19289813|P2|NOT COMPLETED|Main Period||14
7837773|NCT01020123|19289814|P1|NOT COMPLETED|Main Period||17
7837774|NCT01020123|19289808|P7|COMPLETED|Main Period||61
7837775|NCT01020123|19289809|P6|COMPLETED|Main Period||83
7837776|NCT01020123|19289810|P5|COMPLETED|Main Period||77
7837777|NCT01020123|19289811|P4|COMPLETED|Main Period||33
7837778|NCT01020123|19289812|P3|COMPLETED|Main Period||44
7837779|NCT01020123|19289813|P2|COMPLETED|Main Period||77
7837780|NCT01020123|19289814|P1|COMPLETED|Main Period||76
7837781|NCT01020123|19289808|P7|STARTED|Main Period||72
7837782|NCT01020123|19289809|P6|STARTED|Main Period||94
7837783|NCT01020123|19289810|P5|STARTED|Main Period||88
7837784|NCT01020123|19289811|P4|STARTED|Main Period||40
7837785|NCT01020123|19289812|P3|STARTED|Main Period||52
7837786|NCT01020123|19289813|P2|STARTED|Main Period||91
7837787|NCT01020123|19289814|P1|STARTED|Main Period||93
7837788|NCT01020019|19290009|P2|NOT COMPLETED|Overall Study||29
7837789|NCT01020019|19290010|P1|NOT COMPLETED|Overall Study||26
7837790|NCT01020019|19290009|P2|COMPLETED|Overall Study||32
7837791|NCT01020019|19290010|P1|COMPLETED|Overall Study||35
7837792|NCT01020019|19290009|P2|STARTED|Overall Study||61
7837793|NCT01020019|19290010|P1|STARTED|Overall Study||61
7837794|NCT01020006|19290019|P3|NOT COMPLETED|Overall Study||16
7837795|NCT01020006|19290020|P2|NOT COMPLETED|Overall Study||18
7837796|NCT01020006|19290021|P1|NOT COMPLETED|Overall Study||8
7837797|NCT01020006|19290019|P3|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
7837798|NCT01020006|19290020|P2|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
7837799|NCT01020006|19290021|P1|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
7837800|NCT01020006|19290019|P3|STARTED|Overall Study||16
7837801|NCT01020006|19290020|P2|STARTED|Overall Study||18
7837802|NCT01020006|19290021|P1|STARTED|Overall Study||8
7837803|NCT01019980|19290031|P2|NOT COMPLETED|Overall Study||0
7837804|NCT01019980|19290032|P1|NOT COMPLETED|Overall Study||2
7837805|NCT01019980|19290031|P2|COMPLETED|Overall Study||0
7837806|NCT01019980|19290032|P1|COMPLETED|Overall Study||0
7837807|NCT01019980|19290031|P2|Discontinued|Overall Study||0
7837808|NCT01019980|19290032|P1|Discontinued|Overall Study||2
7837809|NCT01019980|19290031|P2|STARTED|Overall Study||0
7837810|NCT01019980|19290032|P1|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2
7837811|NCT01019928|19290040|P2|NOT COMPLETED|Period 3||0
7837812|NCT01019928|19290041|P1|NOT COMPLETED|Period 3||0
7837813|NCT01019928|19290040|P2|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
7837814|NCT01019928|19290041|P1|COMPLETED|Period 3||7
7837815|NCT01019928|19290040|P2|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
7837816|NCT01019928|19290041|P1|STARTED|Period 3||7
7837817|NCT01019928|19290040|P2|NOT COMPLETED|Period 2||1
7837818|NCT01019928|19290041|P1|NOT COMPLETED|Period 2||0
7837819|NCT01019928|19290040|P2|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
7837820|NCT01019928|19290041|P1|COMPLETED|Period 2||7
7837821|NCT01019928|19290040|P2|STARTED|Period 2||7
7837822|NCT01019928|19290041|P1|STARTED|Period 2||7
7837823|NCT01019928|19290040|P2|NOT COMPLETED|Period 1||0
7837824|NCT01019928|19290041|P1|NOT COMPLETED|Period 1||0
7837825|NCT01019928|19290040|P2|COMPLETED|Period 1||7
7837826|NCT01019928|19290041|P1|COMPLETED|Period 1||7
7837827|NCT01019928|19290040|P2|STARTED|Period 1||7
7837828|NCT01019928|19290041|P1|STARTED|Period 1||7
7837829|NCT01019707|19290081|P2|NOT COMPLETED|Second Phase||0
7837830|NCT01019707|19290082|P1|NOT COMPLETED|Second Phase||0
7837831|NCT01019707|19290081|P2|COMPLETED|Second Phase||1
7837832|NCT01019707|19290082|P1|COMPLETED|Second Phase||3
7837833|NCT01019707|19290081|P2|STARTED|Second Phase||1
7837834|NCT01019707|19290082|P1|STARTED|Second Phase||3
7837835|NCT01019707|19290081|P2|NOT COMPLETED|Washout||2
7837836|NCT01019707|19290082|P1|NOT COMPLETED|Washout||0
7837837|NCT01019707|19290081|P2|COMPLETED|Washout||1
7837838|NCT01019707|19290082|P1|COMPLETED|Washout||3
7837839|NCT01019707|19290081|P2|STARTED|Washout||3
7837840|NCT01019707|19290082|P1|STARTED|Washout||3
7837841|NCT01019707|19290081|P2|NOT COMPLETED|First Phase||0
7837842|NCT01019707|19290082|P1|NOT COMPLETED|First Phase||0
7837843|NCT01019707|19290081|P2|COMPLETED|First Phase||3
7837844|NCT01019707|19290082|P1|COMPLETED|First Phase||3
7837845|NCT01019707|19290081|P2|STARTED|First Phase||3
7837846|NCT01019707|19290082|P1|STARTED|First Phase||3
7837847|NCT01019694|19290095|P3|NOT COMPLETED|Overall Study||47
7837848|NCT01019694|19290096|P2|NOT COMPLETED|Overall Study||38
7837849|NCT01019694|19290097|P1|NOT COMPLETED|Overall Study||24
7837850|NCT01019694|19290095|P3|COMPLETED|Overall Study||110
7837851|NCT01019694|19290096|P2|COMPLETED|Overall Study||118
7837852|NCT01019694|19290097|P1|COMPLETED|Overall Study||133
7837853|NCT01019694|19290095|P3|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
7837854|NCT01019694|19290096|P2|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156
7837855|NCT01019694|19290097|P1|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
7837856|NCT01019486|19290222|P3|NOT COMPLETED|Overall Study||1
7837857|NCT01019486|19290223|P2|NOT COMPLETED|Overall Study||1
7837858|NCT01019486|19290224|P1|NOT COMPLETED|Overall Study||1
7837859|NCT01019486|19290222|P3|COMPLETED|Overall Study||15
7837860|NCT01019486|19290223|P2|COMPLETED|Overall Study||4
7837861|NCT01019486|19290224|P1|COMPLETED|Overall Study||4
7837862|NCT01019486|19290222|P3|STARTED|Overall Study||16
7837863|NCT01019486|19290223|P2|STARTED|Overall Study||5
7837864|NCT01019486|19290224|P1|STARTED|Overall Study||5
7837865|NCT01019369|19290238|P2|NOT COMPLETED|Overall Study||7
7837866|NCT01019369|19290239|P1|NOT COMPLETED|Overall Study||10
7837867|NCT01019369|19290238|P2|COMPLETED|Overall Study||39
7837868|NCT01019369|19290239|P1|COMPLETED|Overall Study||76
7837869|NCT01019369|19290238|P2|STARTED|Overall Study||46
7837870|NCT01019369|19290239|P1|STARTED|Overall Study||86
7837871|NCT01019317|19290255|P1|NOT COMPLETED|Overall Study||4
7837872|NCT01019317|19290255|P1|COMPLETED|Overall Study||147
7837873|NCT01019317|19290255|P1|STARTED|Overall Study||151
7837874|NCT01019252|19290261|P2|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||7
7837875|NCT01019252|19290262|P1|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||0
7837876|NCT01019252|19290261|P2|COMPLETED|Wait List Cross-over to CBT for ADHD||15
7837877|NCT01019252|19290262|P1|COMPLETED|Wait List Cross-over to CBT for ADHD||21
7837878|NCT01019252|19290261|P2|STARTED|Wait List Cross-over to CBT for ADHD||22
7837879|NCT01019252|19290262|P1|STARTED|Wait List Cross-over to CBT for ADHD|Lost to follow up, did not start treatment following wait list completion (n=3)|21
7837880|NCT01019252|19290261|P2|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||0
7837881|NCT01019252|19290262|P1|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||3
7837882|NCT01019252|19290261|P2|COMPLETED|Initial CBT for ADHD vs. Wait List||22
7837883|NCT01019252|19290262|P1|COMPLETED|Initial CBT for ADHD vs. Wait List||21
7837884|NCT01019252|19290261|P2|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|22
7837885|NCT01019252|19290262|P1|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|24
7837886|NCT01019135|19290275|P3|NOT COMPLETED|Overall Study||31
7837887|NCT01019135|19290276|P2|NOT COMPLETED|Overall Study||19
7837888|NCT01019135|19290277|P1|NOT COMPLETED|Overall Study||20
7837889|NCT01019135|19290275|P3|COMPLETED|Overall Study||24
7837890|NCT01019135|19290276|P2|COMPLETED|Overall Study||40
7837891|NCT01019135|19290277|P1|COMPLETED|Overall Study||35
7837892|NCT01019135|19290275|P3|STARTED|Overall Study||55
7837893|NCT01019135|19290276|P2|STARTED|Overall Study||59
7837894|NCT01019135|19290277|P1|STARTED|Overall Study||55
7837895|NCT01018992|19290305|P2|NOT COMPLETED|Overall Study||16
7837896|NCT01018992|19290306|P1|NOT COMPLETED|Overall Study||16
7837897|NCT01018992|19290305|P2|COMPLETED|Overall Study||49
7837898|NCT01018992|19290306|P1|COMPLETED|Overall Study||47
7837899|NCT01018992|19290305|P2|STARTED|Overall Study||65
7837900|NCT01018992|19290306|P1|STARTED|Overall Study||63
7837901|NCT01018979|19290320|P2|NOT COMPLETED|Overall Study||10
7837902|NCT01018979|19290321|P1|NOT COMPLETED|Overall Study||3
7837903|NCT01018979|19290320|P2|COMPLETED|Overall Study||3
7837904|NCT01018979|19290321|P1|COMPLETED|Overall Study||4
7837905|NCT01018979|19290320|P2|Received at Least One Dose|Overall Study||12
7837906|NCT01018979|19290321|P1|Received at Least One Dose|Overall Study||7
7837907|NCT01018979|19290320|P2|STARTED|Overall Study|A total of 20 subjects were randomized.|13
7837908|NCT01018979|19290321|P1|STARTED|Overall Study||7
7837909|NCT01018953|19290351|P1|NOT COMPLETED|Overall Study||8
7837910|NCT01018953|19290351|P1|COMPLETED|Overall Study||0
7837911|NCT01018953|19290351|P1|BIM 23A760 4 mg|Overall Study||3
7837912|NCT01018953|19290351|P1|BIM 23A760 2 mg|Overall Study||2
7837913|NCT01018953|19290351|P1|BIM 23A760 1 mg|Overall Study||3
7837914|NCT01018953|19290351|P1|STARTED|Overall Study||8
7837915|NCT01018862|19290364|P3|NOT COMPLETED|Overall Study||16
7837916|NCT01018862|19290365|P2|NOT COMPLETED|Overall Study||10
7837917|NCT01018862|19290366|P1|NOT COMPLETED|Overall Study||13
7837918|NCT01018862|19290364|P3|COMPLETED|Overall Study||146
7837919|NCT01018862|19290365|P2|COMPLETED|Overall Study||156
7837920|NCT01018862|19290366|P1|COMPLETED|Overall Study||148
7837921|NCT01018862|19290364|P3|STARTED|Overall Study||162
7837922|NCT01018862|19290365|P2|STARTED|Overall Study||166
7837923|NCT01018862|19290366|P1|STARTED|Overall Study||161
7837924|NCT01018810|19290388|P5|NOT COMPLETED|Overall Study||1
7837925|NCT01018810|19290389|P4|NOT COMPLETED|Overall Study||1
7837926|NCT01018810|19290390|P3|NOT COMPLETED|Overall Study||1
7837927|NCT01018810|19290391|P2|NOT COMPLETED|Overall Study||1
7837928|NCT01018810|19290392|P1|NOT COMPLETED|Overall Study||2
7837929|NCT01018810|19290388|P5|COMPLETED|Overall Study||0
7837930|NCT01018810|19290389|P4|COMPLETED|Overall Study||0
7837931|NCT01018810|19290390|P3|COMPLETED|Overall Study||0
7837932|NCT01018810|19290391|P2|COMPLETED|Overall Study||0
7837933|NCT01018810|19290392|P1|COMPLETED|Overall Study||2
7837934|NCT01018810|19290388|P5|STARTED|Overall Study||1
7837935|NCT01018810|19290389|P4|STARTED|Overall Study||1
7837936|NCT01018810|19290390|P3|STARTED|Overall Study||1
7837937|NCT01018810|19290391|P2|STARTED|Overall Study||1
7837938|NCT01018810|19290392|P1|STARTED|Overall Study||4
7837939|NCT01018732|19290452|P3|NOT COMPLETED|Overall Study||4
7837940|NCT01018732|19290453|P2|NOT COMPLETED|Overall Study||2
7837941|NCT01018732|19290454|P1|NOT COMPLETED|Overall Study||1
7837942|NCT01018732|19290452|P3|COMPLETED|Overall Study||50
7837943|NCT01018732|19290453|P2|COMPLETED|Overall Study||49
7837944|NCT01018732|19290454|P1|COMPLETED|Overall Study||49
7837945|NCT01018732|19290452|P3|STARTED|Overall Study||54
7837946|NCT01018732|19290453|P2|STARTED|Overall Study||51
7837947|NCT01018732|19290454|P1|STARTED|Overall Study||50
7837948|NCT01018680|19290488|P2|NOT COMPLETED|Overall Study||75
7837949|NCT01018680|19290489|P1|NOT COMPLETED|Overall Study||61
7837950|NCT01018680|19290488|P2|COMPLETED|Overall Study||189
7837951|NCT01018680|19290489|P1|COMPLETED|Overall Study||199
7837952|NCT01018680|19290488|P2|STARTED|Overall Study||264
7837953|NCT01018680|19290489|P1|STARTED|Overall Study||260
7837954|NCT01020487|19290532|P3|NOT COMPLETED|Part 2 Open-label Period||1
7837955|NCT01020487|19290533|P2|NOT COMPLETED|Part 2 Open-label Period||4
7837956|NCT01020487|19290534|P1|NOT COMPLETED|Part 2 Open-label Period||0
7837957|NCT01020487|19290532|P3|COMPLETED|Part 2 Open-label Period||12
7837958|NCT01020487|19290533|P2|COMPLETED|Part 2 Open-label Period||12
7837959|NCT01020487|19290534|P1|COMPLETED|Part 2 Open-label Period||0
7837960|NCT01020487|19290532|P3|STARTED|Part 2 Open-label Period||13
7837961|NCT01020487|19290533|P2|STARTED|Part 2 Open-label Period||16
7837962|NCT01020487|19290534|P1|STARTED|Part 2 Open-label Period||0
7837963|NCT01020487|19290532|P3|NOT COMPLETED|Part 2 Double-blind Treatment Period||6
7837964|NCT01020487|19290533|P2|NOT COMPLETED|Part 2 Double-blind Treatment Period||2
7837965|NCT01020487|19290534|P1|NOT COMPLETED|Part 2 Double-blind Treatment Period||0
7837966|NCT01020487|19290532|P3|COMPLETED|Part 2 Double-blind Treatment Period||13
7837967|NCT01020487|19290533|P2|COMPLETED|Part 2 Double-blind Treatment Period||16
7837968|NCT01020487|19290534|P1|COMPLETED|Part 2 Double-blind Treatment Period||0
7837969|NCT01020487|19290532|P3|Received Treatment|Part 2 Double-blind Treatment Period||18
7837970|NCT01020487|19290533|P2|Received Treatment|Part 2 Double-blind Treatment Period||18
7837971|NCT01020487|19290534|P1|Received Treatment|Part 2 Double-blind Treatment Period||0
7837972|NCT01020487|19290532|P3|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|19
7837973|NCT01020487|19290533|P2|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|18
7837974|NCT01020487|19290534|P1|STARTED|Part 2 Double-blind Treatment Period||0
7837975|NCT01020487|19290532|P3|NOT COMPLETED|Part 1||0
7837976|NCT01020487|19290533|P2|NOT COMPLETED|Part 1||0
7837977|NCT01020487|19290534|P1|NOT COMPLETED|Part 1||0
7837978|NCT01020487|19290532|P3|COMPLETED|Part 1||0
7837979|NCT01020487|19290533|P2|COMPLETED|Part 1||0
7837980|NCT01020487|19290534|P1|COMPLETED|Part 1||12
7837981|NCT01020487|19290532|P3|STARTED|Part 1||0
7837982|NCT01020487|19290533|P2|STARTED|Part 1||0
7837983|NCT01020487|19290534|P1|STARTED|Part 1||12
7837984|NCT01018511|19290559|P4|NOT COMPLETED|Overall Study||33
7837985|NCT01018511|19290560|P3|NOT COMPLETED|Overall Study||40
7837986|NCT01018511|19290561|P2|NOT COMPLETED|Overall Study||32
7837987|NCT01018511|19290562|P1|NOT COMPLETED|Overall Study||26
7837988|NCT01018511|19290559|P4|COMPLETED|Overall Study||294
7837989|NCT01018511|19290560|P3|COMPLETED|Overall Study||299
7837990|NCT01018511|19290561|P2|COMPLETED|Overall Study||295
7837991|NCT01018511|19290562|P1|COMPLETED|Overall Study||315
7837992|NCT01018511|19290559|P4|Randomized and Treated|Overall Study||324
7837993|NCT01018511|19290560|P3|Randomized and Treated|Overall Study||338
7837994|NCT01018511|19290561|P2|Randomized and Treated|Overall Study||326
7837995|NCT01018511|19290562|P1|Randomized and Treated|Overall Study||341
7837996|NCT01018511|19290559|P4|STARTED|Overall Study||327
7837997|NCT01018511|19290560|P3|STARTED|Overall Study||339
7837998|NCT01018511|19290561|P2|STARTED|Overall Study||327
7837999|NCT01018511|19290562|P1|STARTED|Overall Study||341
7838000|NCT01018420|19290731|P2|NOT COMPLETED|Overall Study||0
7838001|NCT01018420|19290732|P1|NOT COMPLETED|Overall Study||0
7838002|NCT01018420|19290731|P2|COMPLETED|Overall Study||3
7838003|NCT01018420|19290732|P1|COMPLETED|Overall Study||15
7838004|NCT01018420|19290731|P2|STARTED|Overall Study||3
7838005|NCT01018420|19290732|P1|STARTED|Overall Study||15
7838006|NCT01018394|19290759|P2|NOT COMPLETED|Overall Study||8
7838007|NCT01018394|19290760|P1|NOT COMPLETED|Overall Study||9
7838008|NCT01018394|19290759|P2|COMPLETED|Overall Study||33
7838009|NCT01018394|19290760|P1|COMPLETED|Overall Study||31
7838010|NCT01018394|19290759|P2|STARTED|Overall Study||41
7838011|NCT01018394|19290760|P1|STARTED|Overall Study||40
7838012|NCT01018264|19290770|P2|NOT COMPLETED|Overall Study||1
7838013|NCT01018264|19290771|P1|NOT COMPLETED|Overall Study||1
7838014|NCT01018264|19290770|P2|COMPLETED|Overall Study||12
7838015|NCT01018264|19290771|P1|COMPLETED|Overall Study||9
7838016|NCT01018264|19290770|P2|STARTED|Overall Study||13
7838017|NCT01018264|19290771|P1|STARTED|Overall Study||10
7838018|NCT01018186|19290788|P4|NOT COMPLETED|52-week Double-blind Treatment Period||29
7838019|NCT01018186|19290789|P3|NOT COMPLETED|52-week Double-blind Treatment Period||41
7838020|NCT01018186|19290790|P2|NOT COMPLETED|52-week Double-blind Treatment Period||40
7838021|NCT01018186|19290791|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
7838022|NCT01018186|19290788|P4|COMPLETED|52-week Double-blind Treatment Period||71
7838023|NCT01018186|19290789|P3|COMPLETED|52-week Double-blind Treatment Period||161
7838024|NCT01018186|19290790|P2|COMPLETED|52-week Double-blind Treatment Period||161
7838025|NCT01018186|19290791|P1|COMPLETED|52-week Double-blind Treatment Period||0
7838026|NCT01018186|19290788|P4|STARTED|52-week Double-blind Treatment Period||100
7838027|NCT01018186|19290789|P3|STARTED|52-week Double-blind Treatment Period||202
7838028|NCT01018186|19290790|P2|STARTED|52-week Double-blind Treatment Period||201
7838029|NCT01018186|19290791|P1|STARTED|52-week Double-blind Treatment Period||0
7838030|NCT01018186|19290788|P4|NOT COMPLETED|2-week Run-in Period||0
7838031|NCT01018186|19290789|P3|NOT COMPLETED|2-week Run-in Period||0
7838032|NCT01018186|19290790|P2|NOT COMPLETED|2-week Run-in Period||0
7838033|NCT01018186|19290791|P1|NOT COMPLETED|2-week Run-in Period||114
7838034|NCT01018186|19290788|P4|COMPLETED|2-week Run-in Period||0
7838035|NCT01018186|19290789|P3|COMPLETED|2-week Run-in Period||0
7838036|NCT01018186|19290790|P2|COMPLETED|2-week Run-in Period||0
7838037|NCT01018186|19290791|P1|COMPLETED|2-week Run-in Period||503
7838038|NCT01018186|19290788|P4|STARTED|2-week Run-in Period||0
7838039|NCT01018186|19290789|P3|STARTED|2-week Run-in Period||0
7838040|NCT01018186|19290790|P2|STARTED|2-week Run-in Period||0
7838041|NCT01018186|19290791|P1|STARTED|2-week Run-in Period||617
7838042|NCT01018134|19290883|P6|NOT COMPLETED|Overall Study||0
7838043|NCT01018134|19290884|P5|NOT COMPLETED|Overall Study||0
7838044|NCT01018134|19290885|P4|NOT COMPLETED|Overall Study||0
7838045|NCT01018134|19290886|P3|NOT COMPLETED|Overall Study||1
7838046|NCT01018134|19290887|P2|NOT COMPLETED|Overall Study||1
7838047|NCT01018134|19290888|P1|NOT COMPLETED|Overall Study||0
7838048|NCT01018134|19290883|P6|COMPLETED|Overall Study||15
7838049|NCT01018134|19290884|P5|COMPLETED|Overall Study||15
7838050|NCT01018134|19290885|P4|COMPLETED|Overall Study||29
7838051|NCT01018134|19290886|P3|COMPLETED|Overall Study||29
7838052|NCT01018134|19290887|P2|COMPLETED|Overall Study||30
7838053|NCT01018134|19290888|P1|COMPLETED|Overall Study||30
7838054|NCT01018134|19290883|P6|STARTED|Overall Study||15
7838055|NCT01018134|19290884|P5|STARTED|Overall Study||15
7838056|NCT01018134|19290885|P4|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29
7838057|NCT01018134|19290886|P3|STARTED|Overall Study||30
7838058|NCT01018134|19290887|P2|STARTED|Overall Study||31
7838059|NCT01018134|19290888|P1|STARTED|Overall Study||30
7838060|NCT01018095|19290928|P2|NOT COMPLETED|Overall Study||62
7838061|NCT01018095|19290929|P1|NOT COMPLETED|Overall Study||56
7838062|NCT01018095|19290928|P2|COMPLETED|Overall Study||73
7838063|NCT01018095|19290929|P1|COMPLETED|Overall Study||79
7838064|NCT01018095|19290928|P2|STARTED|Overall Study||135
7838065|NCT01018095|19290929|P1|STARTED|Overall Study||135
7838066|NCT01018056|19290940|P3|NOT COMPLETED|Overall Study||1
7838067|NCT01018056|19290941|P2|NOT COMPLETED|Overall Study||2
7838068|NCT01018056|19290942|P1|NOT COMPLETED|Overall Study||3
7838069|NCT01018056|19290940|P3|COMPLETED|Overall Study||5
7838070|NCT01018056|19290941|P2|COMPLETED|Overall Study||10
7838071|NCT01018056|19290942|P1|COMPLETED|Overall Study||9
7838072|NCT01018056|19290940|P3|STARTED|Overall Study||6
7838073|NCT01018056|19290941|P2|STARTED|Overall Study||12
7838074|NCT01018056|19290942|P1|STARTED|Overall Study||12
7838075|NCT01018030|19290992|P3|NOT COMPLETED|Overall Study||13
7838076|NCT01018030|19290993|P2|NOT COMPLETED|Overall Study||11
7838077|NCT01018030|19290994|P1|NOT COMPLETED|Overall Study||19
7838078|NCT01018030|19290992|P3|COMPLETED|Overall Study||239
7838079|NCT01018030|19290993|P2|COMPLETED|Overall Study||232
7838080|NCT01018030|19290994|P1|COMPLETED|Overall Study||227
7838081|NCT01018030|19290992|P3|STARTED|Overall Study||252
7838082|NCT01018030|19290993|P2|STARTED|Overall Study||243
7838083|NCT01018030|19290994|P1|STARTED|Overall Study||246
7838084|NCT01017952|19291045|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||103
7838085|NCT01017952|19291046|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||112
7838086|NCT01017952|19291047|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||109
7838087|NCT01017952|19291048|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||125
7838088|NCT01017952|19291049|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
7838089|NCT01017952|19291045|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306
7838090|NCT01017952|19291046|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291
7838091|NCT01017952|19291047|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303
7838092|NCT01017952|19291048|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284
7838093|NCT01017952|19291049|P1|COMPLETED|52-week, Double-blind Treatment Period||0
7838094|NCT01017952|19291045|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307
7838095|NCT01017952|19291046|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293
7838096|NCT01017952|19291047|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305
7838097|NCT01017952|19291048|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285
7838098|NCT01017952|19291049|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
7838099|NCT01017952|19291045|P5|STARTED|52-week, Double-blind Treatment Period||409
7838100|NCT01017952|19291046|P4|STARTED|52-week, Double-blind Treatment Period||403
7838101|NCT01017952|19291047|P3|STARTED|52-week, Double-blind Treatment Period||412
7838102|NCT01017952|19291048|P2|STARTED|52-week, Double-blind Treatment Period||409
7838103|NCT01017952|19291049|P1|STARTED|52-week, Double-blind Treatment Period||0
7838104|NCT01017952|19291045|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
7838105|NCT01017952|19291046|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
7838106|NCT01017952|19291047|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
7838107|NCT01017952|19291048|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
7838108|NCT01017952|19291049|P1|NOT COMPLETED|4-week, Open-label Run-In Period||459
7838109|NCT01017952|19291045|P5|COMPLETED|4-week, Open-label Run-In Period||0
7838110|NCT01017952|19291046|P4|COMPLETED|4-week, Open-label Run-In Period||0
7838111|NCT01017952|19291047|P3|COMPLETED|4-week, Open-label Run-In Period||0
7838112|NCT01017952|19291048|P2|COMPLETED|4-week, Open-label Run-In Period||0
7838113|NCT01017952|19291049|P1|COMPLETED|4-week, Open-label Run-In Period||1633
7838114|NCT01017952|19291045|P5|STARTED|4-week, Open-label Run-In Period||0
7838115|NCT01017952|19291046|P4|STARTED|4-week, Open-label Run-In Period||0
7838116|NCT01017952|19291047|P3|STARTED|4-week, Open-label Run-In Period||0
7838117|NCT01017952|19291048|P2|STARTED|4-week, Open-label Run-In Period||0
7838118|NCT01017952|19291049|P1|STARTED|4-week, Open-label Run-In Period||2092
7838119|NCT01017874|19291073|P2|NOT COMPLETED|Overall Study||26
7838120|NCT01017874|19291074|P1|NOT COMPLETED|Overall Study||30
7838121|NCT01017874|19291073|P2|COMPLETED|Overall Study||92
7838122|NCT01017874|19291074|P1|COMPLETED|Overall Study||88
7838123|NCT01017874|19291073|P2|Received at Least 1 Dose of Study Drug|Overall Study||118
7838124|NCT01017874|19291074|P1|Received at Least 1 Dose of Study Drug|Overall Study||114
7838125|NCT01017874|19291073|P2|STARTED|Overall Study||118
7838126|NCT01017874|19291074|P1|STARTED|Overall Study||118
7838127|NCT01017731|19291092|P1|NOT COMPLETED|Overall Study||8
7838128|NCT01017731|19291092|P1|COMPLETED|Overall Study||60
7838129|NCT01017731|19291092|P1|Received at Least 1 Dose of Study Drug|Overall Study||66
7838130|NCT01017731|19291092|P1|STARTED|Overall Study||68
7838131|NCT01017653|19291109|P1|NOT COMPLETED|Overall Study||0
7838132|NCT01017653|19291109|P1|COMPLETED|Overall Study||16
7838133|NCT01017653|19291109|P1|STARTED|Overall Study||16
7838134|NCT01017601|19291121|P2|NOT COMPLETED|Overall Study||13
7838135|NCT01017601|19291122|P1|NOT COMPLETED|Overall Study||12
7838136|NCT01017601|19291121|P2|COMPLETED|Overall Study||11
7838137|NCT01017601|19291122|P1|COMPLETED|Overall Study||14
7838138|NCT01017601|19291121|P2|STARTED|Overall Study||24
7838139|NCT01017601|19291122|P1|STARTED|Overall Study||26
7838140|NCT01017575|19291149|P5|NOT COMPLETED|Overall Study||3
7838141|NCT01017575|19291150|P4|NOT COMPLETED|Overall Study||1
7838142|NCT01017575|19291151|P3|NOT COMPLETED|Overall Study||0
7838143|NCT01017575|19291152|P2|NOT COMPLETED|Overall Study||2
7838144|NCT01017575|19291153|P1|NOT COMPLETED|Overall Study||1
7838145|NCT01017575|19291149|P5|COMPLETED|Overall Study||6
7838146|NCT01017575|19291150|P4|COMPLETED|Overall Study||7
7838147|NCT01017575|19291151|P3|COMPLETED|Overall Study||8
7838148|NCT01017575|19291152|P2|COMPLETED|Overall Study||7
7838149|NCT01017575|19291153|P1|COMPLETED|Overall Study||7
7838150|NCT01017575|19291149|P5|STARTED|Overall Study||9
7838151|NCT01017575|19291150|P4|STARTED|Overall Study||8
7838152|NCT01017575|19291151|P3|STARTED|Overall Study||8
7838153|NCT01017575|19291152|P2|STARTED|Overall Study||9
7838154|NCT01017575|19291153|P1|STARTED|Overall Study||8
7838155|NCT01017549|19291190|P1|NOT COMPLETED|5 Year Follow-up||12
7838156|NCT01017549|19291190|P1|COMPLETED|5 Year Follow-up||24
7838157|NCT01017549|19291190|P1|STARTED|5 Year Follow-up||36
7838158|NCT01017549|19291190|P1|NOT COMPLETED|One-year Follow-up||7
7838159|NCT01017549|19291190|P1|COMPLETED|One-year Follow-up||36
7838160|NCT01017549|19291190|P1|STARTED|One-year Follow-up||43
7838161|NCT01017549|19291190|P1|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1
7838162|NCT01017549|19291190|P1|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43
7838163|NCT01017549|19291190|P1|STARTED|Eligibility Through 6 Month Follow-up||44
7838164|NCT01017536|19291197|P2|NOT COMPLETED|Overall Study||0
7838165|NCT01017536|19291198|P1|NOT COMPLETED|Overall Study||0
7838166|NCT01017536|19291197|P2|COMPLETED|Overall Study||13
7838167|NCT01017536|19291198|P1|COMPLETED|Overall Study||13
7838168|NCT01017536|19291197|P2|STARTED|Overall Study||13
7838169|NCT01017536|19291198|P1|STARTED|Overall Study||13
7838170|NCT01017497|19291208|P1|NOT COMPLETED|Overall Study||0
7838171|NCT01017497|19291208|P1|COMPLETED|Overall Study||49
7838172|NCT01017497|19291208|P1|STARTED|Overall Study||49
7838173|NCT01017263|19291221|P1|NOT COMPLETED|Overall Study||12
7838174|NCT01017263|19291221|P1|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2
7838175|NCT01017263|19291221|P1|STARTED|Overall Study||14
7838176|NCT01017250|19291225|P1|NOT COMPLETED|Overall Study||0
7838177|NCT01017250|19291225|P1|COMPLETED|Overall Study||15
7838178|NCT01017250|19291225|P1|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14
7838179|NCT01017250|19291225|P1|STARTED|Overall Study||15
7838180|NCT01017237|19291247|P2|NOT COMPLETED|Overall Study||2
7838181|NCT01017237|19291248|P1|NOT COMPLETED|Overall Study||5
7838182|NCT01017237|19291247|P2|COMPLETED|Overall Study||6
7838183|NCT01017237|19291248|P1|COMPLETED|Overall Study||5
7838184|NCT01017237|19291247|P2|STARTED|Overall Study||8
7838185|NCT01017237|19291248|P1|STARTED|Overall Study||10
7838186|NCT01017146|19291302|P2|NOT COMPLETED|Overall Study||39
7838187|NCT01017146|19291303|P1|NOT COMPLETED|Overall Study||66
7838188|NCT01017146|19291302|P2|COMPLETED|Overall Study||333
7838189|NCT01017146|19291303|P1|COMPLETED|Overall Study||306
7838190|NCT01017146|19291302|P2|STARTED|Overall Study||372
7838191|NCT01017146|19291303|P1|STARTED|Overall Study||372
7838192|NCT01017120|19291341|P2|NOT COMPLETED|Overall Study||35
7838193|NCT01017120|19291342|P1|NOT COMPLETED|Overall Study||66
7838194|NCT01017120|19291341|P2|COMPLETED|Overall Study||334
7838195|NCT01017120|19291342|P1|COMPLETED|Overall Study||307
7838196|NCT01017120|19291341|P2|STARTED|Overall Study||369
7838197|NCT01017120|19291342|P1|STARTED|Overall Study||373
7838198|NCT01017042|19291390|P1|NOT COMPLETED|Overall Study||0
7838199|NCT01017042|19291390|P1|COMPLETED|Overall Study||13
7838200|NCT01017042|19291390|P1|STARTED|Overall Study||13
7838201|NCT01017029|19291403|P2|NOT COMPLETED|Overall Study||2
7838202|NCT01017029|19291404|P1|NOT COMPLETED|Overall Study||4
7838203|NCT01017029|19291403|P2|COMPLETED|Overall Study||90
7838204|NCT01017029|19291404|P1|COMPLETED|Overall Study||85
7838205|NCT01017029|19291403|P2|STARTED|Overall Study||92
7838206|NCT01017029|19291404|P1|STARTED|Overall Study||89
7838207|NCT01017003|19291420|P1|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0
7838208|NCT01017003|19291420|P1|COMPLETED|Colchicine 0.6 mg Final Dose||13
7838209|NCT01017003|19291420|P1|STARTED|Colchicine 0.6 mg Final Dose||13
7838210|NCT01017003|19291420|P1|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0
7838211|NCT01017003|19291420|P1|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13
7838212|NCT01017003|19291420|P1|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13
7838213|NCT01017003|19291420|P1|NOT COMPLETED|14 Day Washout Period||0
7838214|NCT01017003|19291420|P1|COMPLETED|14 Day Washout Period||13
7838215|NCT01017003|19291420|P1|STARTED|14 Day Washout Period||13
7838216|NCT01017003|19291420|P1|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0
7838217|NCT01017003|19291420|P1|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13
7838218|NCT01017003|19291420|P1|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13
7838219|NCT01016977|19291432|P2|NOT COMPLETED|Overall Study||2
7838220|NCT01016977|19291433|P1|NOT COMPLETED|Overall Study||3
7838221|NCT01016977|19291432|P2|COMPLETED|Overall Study||18
7838222|NCT01016977|19291433|P1|COMPLETED|Overall Study||17
7838223|NCT01016977|19291432|P2|STARTED|Overall Study||20
7838224|NCT01016977|19291433|P1|STARTED|Overall Study||20
7838225|NCT01016964|19291469|P2|NOT COMPLETED|Overall Study||3
7838226|NCT01016964|19291470|P1|NOT COMPLETED|Overall Study||3
7838227|NCT01016964|19291469|P2|COMPLETED|Overall Study||39
7838228|NCT01016964|19291470|P1|COMPLETED|Overall Study||18
7838229|NCT01016964|19291469|P2|STARTED|Overall Study||42
7838230|NCT01016964|19291470|P1|STARTED|Overall Study||21
7838231|NCT01016938|19291476|P1|NOT COMPLETED|Overall Study||9
7838232|NCT01016938|19291476|P1|COMPLETED|Overall Study||7
7838233|NCT01016938|19291476|P1|STARTED|Overall Study||16
7838234|NCT01016912|19291486|P5|NOT COMPLETED|Follow-up Period||0
7838235|NCT01016912|19291487|P4|NOT COMPLETED|Follow-up Period||1
7838236|NCT01016912|19291488|P3|NOT COMPLETED|Follow-up Period||1
7838237|NCT01016912|19291489|P2|NOT COMPLETED|Follow-up Period||0
7838238|NCT01016912|19291490|P1|NOT COMPLETED|Follow-up Period||0
7838239|NCT01016912|19291486|P5|COMPLETED|Follow-up Period||9
7838240|NCT01016912|19291487|P4|COMPLETED|Follow-up Period||8
7838241|NCT01016912|19291488|P3|COMPLETED|Follow-up Period||9
7838242|NCT01016912|19291489|P2|COMPLETED|Follow-up Period||9
7838243|NCT01016912|19291490|P1|COMPLETED|Follow-up Period||8
7838244|NCT01016912|19291486|P5|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
7838245|NCT01016912|19291487|P4|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
7838246|NCT01016912|19291488|P3|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10
7838247|NCT01016912|19291489|P2|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
7838248|NCT01016912|19291490|P1|STARTED|Follow-up Period||8
7838249|NCT01016912|19291486|P5|NOT COMPLETED|End of Treatment Period||4
7838250|NCT01016912|19291487|P4|NOT COMPLETED|End of Treatment Period||4
7838251|NCT01016912|19291488|P3|NOT COMPLETED|End of Treatment Period||1
7838252|NCT01016912|19291489|P2|NOT COMPLETED|End of Treatment Period||3
7838253|NCT01016912|19291490|P1|NOT COMPLETED|End of Treatment Period||0
7838254|NCT01016912|19291486|P5|COMPLETED|End of Treatment Period||5
7838255|NCT01016912|19291487|P4|COMPLETED|End of Treatment Period||5
7838256|NCT01016912|19291488|P3|COMPLETED|End of Treatment Period||9
7838257|NCT01016912|19291489|P2|COMPLETED|End of Treatment Period||6
7838258|NCT01016912|19291490|P1|COMPLETED|End of Treatment Period||8
7838259|NCT01016912|19291486|P5|Received Treatment|End of Treatment Period||9
7838260|NCT01016912|19291487|P4|Received Treatment|End of Treatment Period||9
7838261|NCT01016912|19291488|P3|Received Treatment|End of Treatment Period||10
7838262|NCT01016912|19291489|P2|Received Treatment|End of Treatment Period||9
7838263|NCT01016912|19291490|P1|Received Treatment|End of Treatment Period||8
7838264|NCT01016912|19291486|P5|STARTED|End of Treatment Period||9
7838265|NCT01016912|19291487|P4|STARTED|End of Treatment Period||9
7838266|NCT01016912|19291488|P3|STARTED|End of Treatment Period||10
7838267|NCT01016912|19291489|P2|STARTED|End of Treatment Period||9
7838268|NCT01016912|19291490|P1|STARTED|End of Treatment Period||8
7838269|NCT01016873|19291535|P3|NOT COMPLETED|36 Months||6
7838270|NCT01016873|19291536|P2|NOT COMPLETED|36 Months||4
7838271|NCT01016873|19291537|P1|NOT COMPLETED|36 Months||11
7838272|NCT01016873|19291535|P3|COMPLETED|36 Months||67
7838273|NCT01016873|19291536|P2|COMPLETED|36 Months||64
7838274|NCT01016873|19291537|P1|COMPLETED|36 Months||58
7838275|NCT01016873|19291535|P3|STARTED|36 Months||73
7838276|NCT01016873|19291536|P2|STARTED|36 Months||68
7838277|NCT01016873|19291537|P1|STARTED|36 Months||69
7838278|NCT01016873|19291535|P3|NOT COMPLETED|24 Months||6
7838279|NCT01016873|19291536|P2|NOT COMPLETED|24 Months||4
7838280|NCT01016873|19291537|P1|NOT COMPLETED|24 Months||5
7838281|NCT01016873|19291535|P3|COMPLETED|24 Months||73
7838282|NCT01016873|19291536|P2|COMPLETED|24 Months||68
7838283|NCT01016873|19291537|P1|COMPLETED|24 Months||69
7838284|NCT01016873|19291535|P3|STARTED|24 Months||79
7838285|NCT01016873|19291536|P2|STARTED|24 Months||72
7838286|NCT01016873|19291537|P1|STARTED|24 Months||74
7838287|NCT01016873|19291535|P3|NOT COMPLETED|12 Months||1
7838288|NCT01016873|19291536|P2|NOT COMPLETED|12 Months||3
7838289|NCT01016873|19291537|P1|NOT COMPLETED|12 Months||1
7838290|NCT01016873|19291535|P3|COMPLETED|12 Months||79
7838291|NCT01016873|19291536|P2|COMPLETED|12 Months||72
7838292|NCT01016873|19291537|P1|COMPLETED|12 Months||74
7838293|NCT01016873|19291535|P3|STARTED|12 Months||80
7838294|NCT01016873|19291536|P2|STARTED|12 Months||75
7838295|NCT01016873|19291537|P1|STARTED|12 Months||75
7838296|NCT01016847|19291568|P2|NOT COMPLETED|Overall Study||0
7838297|NCT01016847|19291569|P1|NOT COMPLETED|Overall Study||0
7838298|NCT01016847|19291568|P2|COMPLETED|Overall Study||2
7838299|NCT01016847|19291569|P1|COMPLETED|Overall Study||1
7838300|NCT01016847|19291568|P2|STARTED|Overall Study||2
7838301|NCT01016847|19291569|P1|STARTED|Overall Study||1
7838302|NCT01016834|19291585|P1|NOT COMPLETED|Overall Study||22
7838303|NCT01016834|19291585|P1|COMPLETED|Overall Study||220
7838304|NCT01016834|19291585|P1|STARTED|Overall Study||242
7838305|NCT01016769|19291595|P4|NOT COMPLETED|Overall Study||0
7838306|NCT01016769|19291596|P3|NOT COMPLETED|Overall Study||1
7838307|NCT01016769|19291597|P2|NOT COMPLETED|Overall Study||1
7838308|NCT01016769|19291598|P1|NOT COMPLETED|Overall Study||1
7838309|NCT01016769|19291595|P4|COMPLETED|Overall Study||30
7838310|NCT01016769|19291596|P3|COMPLETED|Overall Study||6
7838311|NCT01016769|19291597|P2|COMPLETED|Overall Study||6
7838312|NCT01016769|19291598|P1|COMPLETED|Overall Study||3
7838313|NCT01016769|19291595|P4|STARTED|Overall Study||30
7838314|NCT01016769|19291596|P3|STARTED|Overall Study||7
7838315|NCT01016769|19291597|P2|STARTED|Overall Study||7
7838316|NCT01016769|19291598|P1|STARTED|Overall Study||4
7838317|NCT01016691|19291612|P3|NOT COMPLETED|Overall Study||0
7838318|NCT01016691|19291613|P2|NOT COMPLETED|Overall Study||0
7838319|NCT01016691|19291614|P1|NOT COMPLETED|Overall Study||0
7838320|NCT01016691|19291612|P3|COMPLETED|Overall Study||18
7838321|NCT01016691|19291613|P2|COMPLETED|Overall Study||12
7838322|NCT01016691|19291614|P1|COMPLETED|Overall Study||17
7838323|NCT01016691|19291612|P3|STARTED|Overall Study||18
7838324|NCT01016691|19291613|P2|STARTED|Overall Study||12
7838325|NCT01016691|19291614|P1|STARTED|Overall Study||17
7838326|NCT01016678|19291622|P5|NOT COMPLETED|Overall Study||6
7838327|NCT01016678|19291623|P4|NOT COMPLETED|Overall Study||0
7838328|NCT01016678|19291624|P3|NOT COMPLETED|Overall Study||4
7838329|NCT01016678|19291625|P2|NOT COMPLETED|Overall Study||3
7838330|NCT01016678|19291626|P1|NOT COMPLETED|Overall Study||2
7838331|NCT01016678|19291622|P5|COMPLETED|Overall Study||13
7838332|NCT01016678|19291623|P4|COMPLETED|Overall Study||19
7838333|NCT01016678|19291624|P3|COMPLETED|Overall Study||15
7838334|NCT01016678|19291625|P2|COMPLETED|Overall Study||14
7838335|NCT01016678|19291626|P1|COMPLETED|Overall Study||18
7838336|NCT01016678|19291622|P5|STARTED|Overall Study||19
7838337|NCT01016678|19291623|P4|STARTED|Overall Study||19
7838338|NCT01016678|19291624|P3|STARTED|Overall Study||19
7838339|NCT01016678|19291625|P2|STARTED|Overall Study||17
7838340|NCT01016678|19291626|P1|STARTED|Overall Study||20
7838341|NCT01016652|19291648|P2|NOT COMPLETED|Period 2||0
7838342|NCT01016652|19291649|P1|NOT COMPLETED|Period 2||0
7838343|NCT01016652|19291648|P2|COMPLETED|Period 2||24
7838344|NCT01016652|19291649|P1|COMPLETED|Period 2||25
7838345|NCT01016652|19291648|P2|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24
7838346|NCT01016652|19291649|P1|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25
7838347|NCT01016652|19291648|P2|NOT COMPLETED|Period 1||0
7838348|NCT01016652|19291649|P1|NOT COMPLETED|Period 1||0
7838349|NCT01016652|19291648|P2|COMPLETED|Period 1||24
7838350|NCT01016652|19291649|P1|COMPLETED|Period 1||25
7838351|NCT01016652|19291648|P2|STARTED|Period 1||24
7838352|NCT01016652|19291649|P1|STARTED|Period 1||25
7838353|NCT01016600|19291669|P4|NOT COMPLETED|Overall Study||0
7838354|NCT01016600|19291670|P3|NOT COMPLETED|Overall Study||0
7838355|NCT01016600|19291671|P2|NOT COMPLETED|Overall Study||0
7838356|NCT01016600|19291672|P1|NOT COMPLETED|Overall Study||1
7838357|NCT01016600|19291669|P4|COMPLETED|Overall Study||12
7838358|NCT01016600|19291670|P3|COMPLETED|Overall Study||6
7838359|NCT01016600|19291671|P2|COMPLETED|Overall Study||4
7838360|NCT01016600|19291672|P1|COMPLETED|Overall Study||8
7838361|NCT01016600|19291669|P4|STARTED|Overall Study||12
7838362|NCT01016600|19291670|P3|STARTED|Overall Study||6
7838363|NCT01016600|19291671|P2|STARTED|Overall Study||4
7838364|NCT01016600|19291672|P1|STARTED|Overall Study||9
7838365|NCT01016483|19291739|P4|NOT COMPLETED|Phase II||0
7838366|NCT01016483|19291740|P3|NOT COMPLETED|Phase II||0
7838367|NCT01016483|19291741|P2|NOT COMPLETED|Phase II||0
7838368|NCT01016483|19291742|P1|NOT COMPLETED|Phase II||0
7838369|NCT01016483|19291739|P4|COMPLETED|Phase II||44
7838370|NCT01016483|19291740|P3|COMPLETED|Phase II||44
7838371|NCT01016483|19291741|P2|COMPLETED|Phase II||0
7838372|NCT01016483|19291742|P1|COMPLETED|Phase II||0
7838373|NCT01016483|19291739|P4|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|45
7838374|NCT01016483|19291740|P3|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|42
7838375|NCT01016483|19291741|P2|Treated (Safety Analysis Set [SAF])|Phase II||0
7838376|NCT01016483|19291742|P1|Treated (Safety Analysis Set [SAF])|Phase II||0
7838377|NCT01016483|19291739|P4|STARTED|Phase II|Subjects presented as randomized (ITT Analysis Set).|44
7838378|NCT01016483|19291740|P3|STARTED|Phase II|Subjects presented as randomized (Intention-to-Treat [ITT] Analysis Set).|44
7838379|NCT01016483|19291741|P2|STARTED|Phase II||0
7838380|NCT01016483|19291742|P1|STARTED|Phase II||0
7838381|NCT01016483|19291739|P4|NOT COMPLETED|Safety Run-in Part||0
7838382|NCT01016483|19291740|P3|NOT COMPLETED|Safety Run-in Part||0
7838383|NCT01016483|19291741|P2|NOT COMPLETED|Safety Run-in Part||0
7838384|NCT01016483|19291742|P1|NOT COMPLETED|Safety Run-in Part||0
7838385|NCT01016483|19291739|P4|COMPLETED|Safety Run-in Part||0
7838386|NCT01016483|19291740|P3|COMPLETED|Safety Run-in Part||0
7838387|NCT01016483|19291741|P2|COMPLETED|Safety Run-in Part||26
7838388|NCT01016483|19291742|P1|COMPLETED|Safety Run-in Part||27
7838389|NCT01016483|19291739|P4|STARTED|Safety Run-in Part||0
7838390|NCT01016483|19291740|P3|STARTED|Safety Run-in Part||0
7838391|NCT01016483|19291741|P2|STARTED|Safety Run-in Part||26
7838392|NCT01016483|19291742|P1|STARTED|Safety Run-in Part||27
7838393|NCT01016353|19291850|P2|NOT COMPLETED|Overall Study||1
7838394|NCT01016353|19291851|P1|NOT COMPLETED|Overall Study||2
7838395|NCT01016353|19291850|P2|COMPLETED|Overall Study||102
7838396|NCT01016353|19291851|P1|COMPLETED|Overall Study||178
7838397|NCT01016353|19291850|P2|STARTED|Overall Study||103
7838398|NCT01016353|19291851|P1|STARTED|Overall Study||180
7838399|NCT01016262|19291860|P6|NOT COMPLETED|Open-Label Phase||0
7838400|NCT01016262|19291861|P5|NOT COMPLETED|Open-Label Phase||2
7838401|NCT01016262|19291862|P4|NOT COMPLETED|Open-Label Phase||2
7838402|NCT01016262|19291863|P3|NOT COMPLETED|Open-Label Phase||0
7838403|NCT01016262|19291864|P2|NOT COMPLETED|Open-Label Phase||0
7838404|NCT01016262|19291865|P1|NOT COMPLETED|Open-Label Phase||0
7838405|NCT01016262|19291860|P6|COMPLETED|Open-Label Phase||20
7838406|NCT01016262|19291861|P5|COMPLETED|Open-Label Phase||50
7838407|NCT01016262|19291862|P4|COMPLETED|Open-Label Phase||42
7838408|NCT01016262|19291863|P3|COMPLETED|Open-Label Phase||0
7838409|NCT01016262|19291864|P2|COMPLETED|Open-Label Phase||0
7838410|NCT01016262|19291865|P1|COMPLETED|Open-Label Phase||0
7838411|NCT01016262|19291860|P6|STARTED|Open-Label Phase||20
7838412|NCT01016262|19291861|P5|STARTED|Open-Label Phase||52
7838413|NCT01016262|19291862|P4|STARTED|Open-Label Phase||44
7838414|NCT01016262|19291863|P3|STARTED|Open-Label Phase||0
7838415|NCT01016262|19291864|P2|STARTED|Open-Label Phase||0
7838416|NCT01016262|19291865|P1|STARTED|Open-Label Phase||0
7838417|NCT01016262|19291860|P6|NOT COMPLETED|Double-blind Phase||0
7838418|NCT01016262|19291861|P5|NOT COMPLETED|Double-blind Phase||0
7838419|NCT01016262|19291862|P4|NOT COMPLETED|Double-blind Phase||0
7838420|NCT01016262|19291863|P3|NOT COMPLETED|Double-blind Phase||9
7838421|NCT01016262|19291864|P2|NOT COMPLETED|Double-blind Phase||1
7838422|NCT01016262|19291865|P1|NOT COMPLETED|Double-blind Phase||1
7838423|NCT01016262|19291860|P6|COMPLETED|Double-blind Phase||0
7838424|NCT01016262|19291861|P5|COMPLETED|Double-blind Phase||0
7838425|NCT01016262|19291862|P4|COMPLETED|Double-blind Phase||0
7838426|NCT01016262|19291863|P3|COMPLETED|Double-blind Phase||30
7838427|NCT01016262|19291864|P2|COMPLETED|Double-blind Phase||38
7838428|NCT01016262|19291865|P1|COMPLETED|Double-blind Phase||40
7838429|NCT01016262|19291860|P6|STARTED|Double-blind Phase||0
7838430|NCT01016262|19291861|P5|STARTED|Double-blind Phase||0
7838431|NCT01016262|19291862|P4|STARTED|Double-blind Phase||0
7838432|NCT01016262|19291863|P3|STARTED|Double-blind Phase||39
7838433|NCT01016262|19291864|P2|STARTED|Double-blind Phase||39
7838434|NCT01016262|19291865|P1|STARTED|Double-blind Phase||41
7838435|NCT01016132|19291888|P1|NOT COMPLETED|Overall Study||1
7838436|NCT01016132|19291888|P1|COMPLETED|Overall Study||151
7838437|NCT01016132|19291888|P1|STARTED|Overall Study||152
7838438|NCT01016106|19291894|P2|NOT COMPLETED|Overall Study||0
7838439|NCT01016106|19291895|P1|NOT COMPLETED|Overall Study||0
7838440|NCT01016106|19291894|P2|COMPLETED|Overall Study||18
7838441|NCT01016106|19291895|P1|COMPLETED|Overall Study||17
7838442|NCT01016106|19291894|P2|STARTED|Overall Study||18
7838443|NCT01016106|19291895|P1|STARTED|Overall Study||17
7838444|NCT01016067|19291903|P2|NOT COMPLETED|Overall Study||4
7838445|NCT01016067|19291904|P1|NOT COMPLETED|Overall Study||2
7838446|NCT01016067|19291903|P2|COMPLETED|Overall Study||8
7838447|NCT01016067|19291904|P1|COMPLETED|Overall Study||9
7838448|NCT01016067|19291903|P2|STARTED|Overall Study||12
7838449|NCT01016067|19291904|P1|STARTED|Overall Study||11
7838450|NCT01016015|19291922|P1|NOT COMPLETED|Overall Study||19
7838451|NCT01016015|19291922|P1|COMPLETED|Overall Study||159
7838452|NCT01016015|19291922|P1|STARTED|Overall Study||178
7838453|NCT01015976|19291926|P2|NOT COMPLETED|Overall Study||0
7838454|NCT01015976|19291927|P1|NOT COMPLETED|Overall Study||0
7838455|NCT01015976|19291926|P2|COMPLETED|Overall Study||5
7838456|NCT01015976|19291927|P1|COMPLETED|Overall Study||5
7838457|NCT01015976|19291926|P2|STARTED|Overall Study||5
7838458|NCT01015976|19291927|P1|STARTED|Overall Study||5
7838459|NCT01015833|19291933|P2|NOT COMPLETED|Overall Study||5
7838460|NCT01015833|19291934|P1|NOT COMPLETED|Overall Study||13
7838461|NCT01015833|19291933|P2|COMPLETED|Overall Study||171
7838462|NCT01015833|19291934|P1|COMPLETED|Overall Study||167
7838463|NCT01015833|19291933|P2|STARTED|Overall Study||176
7838464|NCT01015833|19291934|P1|STARTED|Overall Study||180
7838465|NCT01015820|19291950|P2|NOT COMPLETED|Overall Study||0
7838466|NCT01015820|19291951|P1|NOT COMPLETED|Overall Study||1
7838467|NCT01015820|19291950|P2|COMPLETED|Overall Study||15
7838468|NCT01015820|19291951|P1|COMPLETED|Overall Study||14
7838469|NCT01015820|19291950|P2|STARTED|Overall Study||15
7838470|NCT01015820|19291951|P1|STARTED|Overall Study||15
7838471|NCT01015807|19291962|P3|NOT COMPLETED|Overall Study||0
7838472|NCT01015807|19291963|P2|NOT COMPLETED|Overall Study||0
7838473|NCT01015807|19291964|P1|NOT COMPLETED|Overall Study||0
7838474|NCT01015807|19291962|P3|COMPLETED|Overall Study||30
7838475|NCT01015807|19291963|P2|COMPLETED|Overall Study||30
7838476|NCT01015807|19291964|P1|COMPLETED|Overall Study||30
7838477|NCT01015807|19291962|P3|STARTED|Overall Study||30
7838478|NCT01015807|19291963|P2|STARTED|Overall Study||30
7838479|NCT01015807|19291964|P1|STARTED|Overall Study||30
7838480|NCT01015781|19291974|P2|NOT COMPLETED|Overall Study||29
7838481|NCT01015781|19291975|P1|NOT COMPLETED|Overall Study||37
7838482|NCT01015781|19291974|P2|COMPLETED|Overall Study||121
7838483|NCT01015781|19291975|P1|COMPLETED|Overall Study||113
7838484|NCT01015781|19291974|P2|STARTED|Overall Study||150
7838485|NCT01015781|19291975|P1|STARTED|Overall Study||150
7838486|NCT01015768|19291981|P2|NOT COMPLETED|Overall Study||4
7838487|NCT01015768|19291982|P1|NOT COMPLETED|Overall Study||4
7838488|NCT01015768|19291981|P2|COMPLETED|Overall Study||26
7838489|NCT01015768|19291982|P1|COMPLETED|Overall Study||26
7838490|NCT01015768|19291981|P2|STARTED|Overall Study||30
7838491|NCT01015768|19291982|P1|STARTED|Overall Study||30
7838492|NCT01015703|19291997|P5|NOT COMPLETED|Overall Study||0
7838493|NCT01015703|19291998|P4|NOT COMPLETED|Overall Study||0
7838494|NCT01015703|19291999|P3|NOT COMPLETED|Overall Study||0
7838495|NCT01015703|19292000|P2|NOT COMPLETED|Overall Study||1
7838496|NCT01015703|19292001|P1|NOT COMPLETED|Overall Study||2
7838497|NCT01015703|19291997|P5|COMPLETED|Overall Study||10
7838498|NCT01015703|19291998|P4|COMPLETED|Overall Study||10
7838499|NCT01015703|19291999|P3|COMPLETED|Overall Study||10
7838500|NCT01015703|19292000|P2|COMPLETED|Overall Study||9
7838501|NCT01015703|19292001|P1|COMPLETED|Overall Study||8
7838502|NCT01015703|19291997|P5|STARTED|Overall Study||10
7838503|NCT01015703|19291998|P4|STARTED|Overall Study||10
7838504|NCT01015703|19291999|P3|STARTED|Overall Study||10
7838505|NCT01015703|19292000|P2|STARTED|Overall Study||10
7838506|NCT01015703|19292001|P1|STARTED|Overall Study||10
7838507|NCT01015677|19292016|P3|NOT COMPLETED|Overall Study||0
7838508|NCT01015677|19292017|P2|NOT COMPLETED|Overall Study||4
7838509|NCT01015677|19292018|P1|NOT COMPLETED|Overall Study||1
7838510|NCT01015677|19292016|P3|COMPLETED|Overall Study||33
7838511|NCT01015677|19292017|P2|COMPLETED|Overall Study||28
7838512|NCT01015677|19292018|P1|COMPLETED|Overall Study||33
7838513|NCT01015677|19292016|P3|STARTED|Overall Study||33
7838514|NCT01015677|19292017|P2|STARTED|Overall Study||32
7838515|NCT01015677|19292018|P1|STARTED|Overall Study||34
7838516|NCT01015638|19292040|P2|NOT COMPLETED|Overall Study||0
7838517|NCT01015638|19292041|P1|NOT COMPLETED|Overall Study||1
7838518|NCT01015638|19292040|P2|COMPLETED|Overall Study||19
7838519|NCT01015638|19292041|P1|COMPLETED|Overall Study||16
7838520|NCT01015638|19292040|P2|STARTED|Overall Study||19
7838521|NCT01015638|19292041|P1|STARTED|Overall Study||17
7838522|NCT01015612|19292069|P1|NOT COMPLETED|Overall Study||153
7838523|NCT01015612|19292069|P1|COMPLETED|Overall Study||481
7838524|NCT01015612|19292069|P1|STARTED|Overall Study||634
7838525|NCT01015586|19292081|P2|NOT COMPLETED|Overall Study||11
7838526|NCT01015586|19292082|P1|NOT COMPLETED|Overall Study||7
7838527|NCT01015586|19292081|P2|COMPLETED|Overall Study||11
7838528|NCT01015586|19292082|P1|COMPLETED|Overall Study||14
7838529|NCT01015586|19292081|P2|STARTED|Overall Study||22
7838530|NCT01015586|19292082|P1|STARTED|Overall Study||21
7838531|NCT01015560|19292100|P1|NOT COMPLETED|Overall Study||3
7838532|NCT01015560|19292100|P1|COMPLETED|Overall Study||41
7838533|NCT01015560|19292100|P1|Eligible and Analyzable|Overall Study||43
7838534|NCT01015560|19292100|P1|STARTED|Overall Study||44
7838535|NCT01015534|19292106|P2|NOT COMPLETED|Overall Study||0
7838536|NCT01015534|19292107|P1|NOT COMPLETED|Overall Study||1
7838537|NCT01015534|19292106|P2|COMPLETED|Overall Study||27
7838538|NCT01015534|19292107|P1|COMPLETED|Overall Study||27
7838539|NCT01015534|19292106|P2|STARTED|Overall Study||27
7838540|NCT01015534|19292107|P1|STARTED|Overall Study||28
7838541|NCT01015443|19292121|P2|NOT COMPLETED|Overall Study||0
7838542|NCT01015443|19292122|P1|NOT COMPLETED|Overall Study||0
7838543|NCT01015443|19292121|P2|COMPLETED|Overall Study||94
7838544|NCT01015443|19292122|P1|COMPLETED|Overall Study||191
7838545|NCT01015443|19292121|P2|Treated|Overall Study||93
7838546|NCT01015443|19292122|P1|Treated|Overall Study||191
7838547|NCT01015443|19292121|P2|STARTED|Overall Study||94
7838548|NCT01015443|19292122|P1|STARTED|Overall Study||191
7838549|NCT01015326|19292140|P2|NOT COMPLETED|Overall Study||2
7838550|NCT01015326|19292141|P1|NOT COMPLETED|Overall Study||1
7838551|NCT01015326|19292140|P2|COMPLETED|Overall Study||18
7838552|NCT01015326|19292141|P1|COMPLETED|Overall Study||11
7838553|NCT01015326|19292140|P2|STARTED|Overall Study||20
7838554|NCT01015326|19292141|P1|STARTED|Overall Study||12
7838555|NCT01015287|19292149|P2|NOT COMPLETED|Overall Study||79
7838556|NCT01015287|19292150|P1|NOT COMPLETED|Overall Study||72
7838557|NCT01015287|19292149|P2|COMPLETED|Overall Study||1958
7838558|NCT01015287|19292150|P1|COMPLETED|Overall Study||1924
7838559|NCT01015287|19292149|P2|Received at Least 1 Dose of Study Drug|Overall Study||2037
7838560|NCT01015287|19292150|P1|Received at Least 1 Dose of Study Drug|Overall Study||1996
7838561|NCT01015287|19292149|P2|STARTED|Overall Study||2037
7838562|NCT01015287|19292150|P1|STARTED|Overall Study||1996
7838563|NCT01015170|19292176|P1|NOT COMPLETED|Overall Study||239
7838564|NCT01015170|19292176|P1|COMPLETED|Overall Study||215
7838565|NCT01015170|19292176|P1|STARTED|Overall Study||454
7838566|NCT01015131|19292182|P1|NOT COMPLETED|Overall Study||8
7838567|NCT01015131|19292182|P1|COMPLETED|Overall Study||36
7838568|NCT01015131|19292182|P1|STARTED|Overall Study||44
7838569|NCT01015118|19292198|P2|NOT COMPLETED|Overall Study||327
7838570|NCT01015118|19292199|P1|NOT COMPLETED|Overall Study||669
7838571|NCT01015118|19292198|P2|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|128
7838572|NCT01015118|19292199|P1|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|242
7838573|NCT01015118|19292198|P2|STARTED|Overall Study||455
7838574|NCT01015118|19292199|P1|STARTED|Overall Study||911
7838575|NCT01014988|19292227|P6|NOT COMPLETED|Overall Study||3
7838576|NCT01014988|19292228|P5|NOT COMPLETED|Overall Study||1
7838577|NCT01014988|19292229|P4|NOT COMPLETED|Overall Study||0
7838578|NCT01014988|19292230|P3|NOT COMPLETED|Overall Study||2
7838579|NCT01014988|19292231|P2|NOT COMPLETED|Overall Study||0
7838580|NCT01014988|19292232|P1|NOT COMPLETED|Overall Study||23
7838581|NCT01014988|19292227|P6|COMPLETED|Overall Study||11
7838582|NCT01014988|19292228|P5|COMPLETED|Overall Study||26
7838583|NCT01014988|19292229|P4|COMPLETED|Overall Study||12
7838584|NCT01014988|19292230|P3|COMPLETED|Overall Study||9
7838585|NCT01014988|19292231|P2|COMPLETED|Overall Study||7
7838586|NCT01014988|19292232|P1|COMPLETED|Overall Study||107
7838587|NCT01014988|19292227|P6|STARTED|Overall Study||14
7838588|NCT01014988|19292228|P5|STARTED|Overall Study||27
7838589|NCT01014988|19292229|P4|STARTED|Overall Study||12
7838590|NCT01014988|19292230|P3|STARTED|Overall Study||11
7838591|NCT01014988|19292231|P2|STARTED|Overall Study||7
7838592|NCT01014988|19292232|P1|STARTED|Overall Study||130
7838593|NCT01014975|19292404|P3|NOT COMPLETED|Overall Study||6
7838594|NCT01014975|19292405|P2|NOT COMPLETED|Overall Study||3
7838595|NCT01014975|19292406|P1|NOT COMPLETED|Overall Study||4
7838596|NCT01014975|19292404|P3|COMPLETED|Overall Study||10
7838597|NCT01014975|19292405|P2|COMPLETED|Overall Study||13
7838598|NCT01014975|19292406|P1|COMPLETED|Overall Study||4
7838599|NCT01014975|19292404|P3|STARTED|Overall Study||16
7838600|NCT01014975|19292405|P2|STARTED|Overall Study||16
7838601|NCT01014975|19292406|P1|STARTED|Overall Study||8
7838602|NCT01014936|19292417|P3|NOT COMPLETED|Overall Study||0
7838603|NCT01014936|19292418|P2|NOT COMPLETED|Overall Study||0
7838604|NCT01014936|19292419|P1|NOT COMPLETED|Overall Study||0
7838605|NCT01014936|19292417|P3|COMPLETED|Overall Study||62
7838606|NCT01014936|19292418|P2|COMPLETED|Overall Study||45
7838607|NCT01014936|19292419|P1|COMPLETED|Overall Study||42
7838608|NCT01014936|19292417|P3|STARTED|Overall Study||62
7838609|NCT01014936|19292418|P2|STARTED|Overall Study||45
7838610|NCT01014936|19292419|P1|STARTED|Overall Study||42
7838611|NCT01014910|19292911|P2|NOT COMPLETED|Overall Study||2
7838612|NCT01014910|19292912|P1|NOT COMPLETED|Overall Study||0
7838613|NCT01014910|19292911|P2|COMPLETED|Overall Study||79
7838614|NCT01014910|19292912|P1|COMPLETED|Overall Study||80
7838615|NCT01014910|19292911|P2|STARTED|Overall Study||81
7838616|NCT01014910|19292912|P1|STARTED|Overall Study||80
7838617|NCT01014871|19292920|P1|NOT COMPLETED|Overall Study||0
7838618|NCT01014871|19292920|P1|COMPLETED|Overall Study||30
7838619|NCT01014871|19292920|P1|STARTED|Overall Study||30
7838620|NCT01014767|19292930|P4|NOT COMPLETED|Overall Study||1
7838621|NCT01014767|19292931|P3|NOT COMPLETED|Overall Study||4
7838622|NCT01014767|19292932|P2|NOT COMPLETED|Overall Study||1
7838623|NCT01014767|19292933|P1|NOT COMPLETED|Overall Study||12
7838624|NCT01014767|19292930|P4|COMPLETED|Overall Study||0
7838625|NCT01014767|19292931|P3|COMPLETED|Overall Study||0
7838626|NCT01014767|19292932|P2|COMPLETED|Overall Study||0
7838627|NCT01014767|19292933|P1|COMPLETED|Overall Study||0
7838628|NCT01014767|19292930|P4|STARTED|Overall Study||1
7838629|NCT01014767|19292931|P3|STARTED|Overall Study||4
7838630|NCT01014767|19292932|P2|STARTED|Overall Study||1
7838631|NCT01014767|19292933|P1|STARTED|Overall Study||12
7838632|NCT01014741|19292949|P2|NOT COMPLETED|Overall Study||5
7838633|NCT01014741|19292950|P1|NOT COMPLETED|Overall Study||11
7838634|NCT01014741|19292949|P2|COMPLETED|Overall Study||90
7838635|NCT01014741|19292950|P1|COMPLETED|Overall Study||94
7838636|NCT01014741|19292949|P2|STARTED|Overall Study||95
7838637|NCT01014741|19292950|P1|STARTED|Overall Study||105
7838638|NCT01014728|19292964|P2|NOT COMPLETED|Overall Study||0
7838639|NCT01014728|19292965|P1|NOT COMPLETED|Overall Study||0
7838640|NCT01014728|19292964|P2|COMPLETED|Overall Study||15
7838641|NCT01014728|19292965|P1|COMPLETED|Overall Study||18
7838642|NCT01014728|19292964|P2|STARTED|Overall Study||15
7838643|NCT01014728|19292965|P1|STARTED|Overall Study||18
7838644|NCT01014689|19292977|P2|NOT COMPLETED|Overall Study||13
7838645|NCT01014689|19292978|P1|NOT COMPLETED|Overall Study||13
7838646|NCT01014689|19292977|P2|COMPLETED|Overall Study||174
7838647|NCT01014689|19292978|P1|COMPLETED|Overall Study||178
7838648|NCT01014689|19292977|P2|STARTED|Overall Study||187
7838649|NCT01014689|19292978|P1|STARTED|Overall Study||191
7838650|NCT01014624|19292988|P2|NOT COMPLETED|Overall Study||1
7838651|NCT01014624|19292989|P1|NOT COMPLETED|Overall Study||2
7838652|NCT01014624|19292988|P2|COMPLETED|Overall Study||26
7838653|NCT01014624|19292989|P1|COMPLETED|Overall Study||27
7838654|NCT01014624|19292988|P2|STARTED|Overall Study||27
7838655|NCT01014624|19292989|P1|STARTED|Overall Study||29
7838656|NCT01014585|19293013|P4|NOT COMPLETED|Overall Study||30
7838657|NCT01014585|19293014|P3|NOT COMPLETED|Overall Study||23
7838658|NCT01014585|19293015|P2|NOT COMPLETED|Overall Study||25
7838659|NCT01014585|19293016|P1|NOT COMPLETED|Overall Study||20
7838660|NCT01014585|19293013|P4|COMPLETED|Overall Study||99
7838661|NCT01014585|19293014|P3|COMPLETED|Overall Study||37
7838662|NCT01014585|19293015|P2|COMPLETED|Overall Study||75
7838663|NCT01014585|19293016|P1|COMPLETED|Overall Study||31
7838664|NCT01014585|19293013|P4|STARTED|Overall Study||129
7838665|NCT01014585|19293014|P3|STARTED|Overall Study||60
7838666|NCT01014585|19293015|P2|STARTED|Overall Study||100
7838667|NCT01014585|19293016|P1|STARTED|Overall Study||51
7838668|NCT01014533|19293036|P2|NOT COMPLETED|Overall Study||5
7838669|NCT01014533|19293037|P1|NOT COMPLETED|Overall Study||5
7838670|NCT01014533|19293036|P2|COMPLETED|Overall Study||25
7838671|NCT01014533|19293037|P1|COMPLETED|Overall Study||24
7838672|NCT01014533|19293036|P2|STARTED|Overall Study||30
7838673|NCT01014533|19293037|P1|STARTED|Overall Study||29
7838674|NCT01014455|19293049|P2|NOT COMPLETED|Overall Study||0
7838675|NCT01014455|19293050|P1|NOT COMPLETED|Overall Study||0
7838676|NCT01014455|19293049|P2|COMPLETED|Overall Study||87
7838677|NCT01014455|19293050|P1|COMPLETED|Overall Study||82
7838678|NCT01014455|19293049|P2|STARTED|Overall Study||87
7838679|NCT01014455|19293050|P1|STARTED|Overall Study||82
7838680|NCT01014442|19293058|P2|NOT COMPLETED|Overall Study||19
7838681|NCT01014442|19293059|P1|NOT COMPLETED|Overall Study||7
7838682|NCT01014442|19293058|P2|COMPLETED|Overall Study||16
7838683|NCT01014442|19293059|P1|COMPLETED|Overall Study||26
7838684|NCT01014442|19293058|P2|STARTED|Overall Study||35
7838685|NCT01014442|19293059|P1|STARTED|Overall Study||33
7838686|NCT01014390|19293171|P1|NOT COMPLETED|Overall Study||10
7838687|NCT01014390|19293171|P1|COMPLETED|Overall Study||177
7838688|NCT01014390|19293171|P1|STARTED|Overall Study||187
7838689|NCT01014351|19293175|P1|NOT COMPLETED|Overall Study||37
7838690|NCT01014351|19293175|P1|COMPLETED|Overall Study||33
7838691|NCT01014351|19293175|P1|STARTED|Overall Study||70
7838692|NCT01014208|19293183|P2|NOT COMPLETED|Overall Study||100
7838693|NCT01014208|19293184|P1|NOT COMPLETED|Overall Study||94
7838694|NCT01014208|19293183|P2|COMPLETED|Overall Study||122
7838695|NCT01014208|19293184|P1|COMPLETED|Overall Study||131
7838696|NCT01014208|19293183|P2|Intent-to-Treat Population|Overall Study||222
7838697|NCT01014208|19293184|P1|Intent-to-Treat Population|Overall Study||223
7838698|NCT01014208|19293183|P2|STARTED|Overall Study||222
7838699|NCT01014208|19293184|P1|STARTED|Overall Study||225
7838700|NCT01014169|19293212|P2|NOT COMPLETED|Overall Study||13
7838701|NCT01014169|19293213|P1|NOT COMPLETED|Overall Study||7
7838702|NCT01014169|19293212|P2|COMPLETED|Overall Study||48
7838703|NCT01014169|19293213|P1|COMPLETED|Overall Study||58
7838704|NCT01014169|19293212|P2|STARTED|Overall Study||61
7838705|NCT01014169|19293213|P1|STARTED|Overall Study||65
7838706|NCT01014143|19293226|P3|NOT COMPLETED|Third Intervention||0
7838707|NCT01014143|19293227|P2|NOT COMPLETED|Third Intervention||0
7838708|NCT01014143|19293228|P1|NOT COMPLETED|Third Intervention||0
7838709|NCT01014143|19293226|P3|COMPLETED|Third Intervention||9
7838710|NCT01014143|19293227|P2|COMPLETED|Third Intervention||9
7838711|NCT01014143|19293228|P1|COMPLETED|Third Intervention||8
7838712|NCT01014143|19293226|P3|STARTED|Third Intervention||9
7838713|NCT01014143|19293227|P2|STARTED|Third Intervention||9
7838714|NCT01014143|19293228|P1|STARTED|Third Intervention||8
7838715|NCT01014143|19293226|P3|NOT COMPLETED|Washout After 2nd Intervention||0
7838716|NCT01014143|19293227|P2|NOT COMPLETED|Washout After 2nd Intervention||0
7838717|NCT01014143|19293228|P1|NOT COMPLETED|Washout After 2nd Intervention||0
7838718|NCT01014143|19293226|P3|COMPLETED|Washout After 2nd Intervention||9
7838719|NCT01014143|19293227|P2|COMPLETED|Washout After 2nd Intervention||9
7838720|NCT01014143|19293228|P1|COMPLETED|Washout After 2nd Intervention||8
7838721|NCT01014143|19293226|P3|STARTED|Washout After 2nd Intervention||9
7838722|NCT01014143|19293227|P2|STARTED|Washout After 2nd Intervention||9
7838723|NCT01014143|19293228|P1|STARTED|Washout After 2nd Intervention||8
7838724|NCT01014143|19293226|P3|NOT COMPLETED|Second Intervention||0
7838725|NCT01014143|19293227|P2|NOT COMPLETED|Second Intervention||0
7838726|NCT01014143|19293228|P1|NOT COMPLETED|Second Intervention||2
7838727|NCT01014143|19293226|P3|COMPLETED|Second Intervention||9
7838728|NCT01014143|19293227|P2|COMPLETED|Second Intervention||9
7838729|NCT01014143|19293228|P1|COMPLETED|Second Intervention||8
7838730|NCT01014143|19293226|P3|STARTED|Second Intervention||9
7838731|NCT01014143|19293227|P2|STARTED|Second Intervention||9
7838732|NCT01014143|19293228|P1|STARTED|Second Intervention||10
7838733|NCT01014143|19293226|P3|NOT COMPLETED|Washout Period After 1st Intervention||0
7838734|NCT01014143|19293227|P2|NOT COMPLETED|Washout Period After 1st Intervention||0
7838735|NCT01014143|19293228|P1|NOT COMPLETED|Washout Period After 1st Intervention||0
7838736|NCT01014143|19293226|P3|COMPLETED|Washout Period After 1st Intervention||9
7838737|NCT01014143|19293227|P2|COMPLETED|Washout Period After 1st Intervention||9
7838738|NCT01014143|19293228|P1|COMPLETED|Washout Period After 1st Intervention||10
7838739|NCT01014143|19293226|P3|STARTED|Washout Period After 1st Intervention||9
7838740|NCT01014143|19293227|P2|STARTED|Washout Period After 1st Intervention||9
7838741|NCT01014143|19293228|P1|STARTED|Washout Period After 1st Intervention||10
7838742|NCT01014143|19293226|P3|NOT COMPLETED|First Intervention||0
7838743|NCT01014143|19293227|P2|NOT COMPLETED|First Intervention||0
7838744|NCT01014143|19293228|P1|NOT COMPLETED|First Intervention||0
7838745|NCT01014143|19293226|P3|COMPLETED|First Intervention||9
7838746|NCT01014143|19293227|P2|COMPLETED|First Intervention||9
7838747|NCT01014143|19293228|P1|COMPLETED|First Intervention||10
7838748|NCT01014143|19293226|P3|STARTED|First Intervention||9
7838749|NCT01014143|19293227|P2|STARTED|First Intervention||9
7838750|NCT01014143|19293228|P1|STARTED|First Intervention||10
7838751|NCT01014091|19293242|P6|NOT COMPLETED|Overall Study||0
7838752|NCT01014091|19293243|P5|NOT COMPLETED|Overall Study||0
7838753|NCT01014091|19293244|P4|NOT COMPLETED|Overall Study||0
7838754|NCT01014091|19293245|P3|NOT COMPLETED|Overall Study||0
7838755|NCT01014091|19293246|P2|NOT COMPLETED|Overall Study||0
7838756|NCT01014091|19293247|P1|NOT COMPLETED|Overall Study||0
7838757|NCT01014091|19293242|P6|COMPLETED|Overall Study||12
7838758|NCT01014091|19293243|P5|COMPLETED|Overall Study||6
7838759|NCT01014091|19293244|P4|COMPLETED|Overall Study||15
7838760|NCT01014091|19293245|P3|COMPLETED|Overall Study||5
7838761|NCT01014091|19293246|P2|COMPLETED|Overall Study||13
7838762|NCT01014091|19293247|P1|COMPLETED|Overall Study||7
7838763|NCT01014091|19293242|P6|STARTED|Overall Study||12
7838764|NCT01014091|19293243|P5|STARTED|Overall Study||6
7838765|NCT01014091|19293244|P4|STARTED|Overall Study||15
7838766|NCT01014091|19293245|P3|STARTED|Overall Study||5
7838767|NCT01014091|19293246|P2|STARTED|Overall Study||13
7838768|NCT01014091|19293247|P1|STARTED|Overall Study||7
7838769|NCT01014013|19293323|P2|NOT COMPLETED|Overall Study||56
7838770|NCT01014013|19293324|P1|NOT COMPLETED|Overall Study||51
7838771|NCT01014013|19293323|P2|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80
7838772|NCT01014013|19293324|P1|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84
7838773|NCT01014013|19293323|P2|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88
7838774|NCT01014013|19293324|P1|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous
~infusion at least 3 days"|87
7838775|NCT01014013|19293323|P2|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135
7838776|NCT01014013|19293324|P1|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132
7838777|NCT01014013|19293323|P2|STARTED|Overall Study||136
7838778|NCT01014013|19293324|P1|STARTED|Overall Study||135
7838779|NCT01013961|19293336|P2|NOT COMPLETED|Overall Study||3
7838780|NCT01013961|19293337|P1|NOT COMPLETED|Overall Study||3
7838781|NCT01013961|19293336|P2|COMPLETED|Overall Study||12
7838782|NCT01013961|19293337|P1|COMPLETED|Overall Study||13
7838783|NCT01013961|19293336|P2|STARTED|Overall Study||15
7838784|NCT01013961|19293337|P1|STARTED|Overall Study||16
7838785|NCT01013883|19293355|P2|NOT COMPLETED|Overall Study||2
7838786|NCT01013883|19293356|P1|NOT COMPLETED|Overall Study||2
7838787|NCT01013883|19293355|P2|COMPLETED|Overall Study||241
7838788|NCT01013883|19293356|P1|COMPLETED|Overall Study||268
7838789|NCT01013883|19293355|P2|STARTED|Overall Study||243
7838790|NCT01013883|19293356|P1|STARTED|Overall Study||270
7838791|NCT01013870|19293368|P2|NOT COMPLETED|Overall Study||3
7838792|NCT01013870|19293369|P1|NOT COMPLETED|Overall Study||1
7838793|NCT01013870|19293368|P2|COMPLETED|Overall Study||21
7838794|NCT01013870|19293369|P1|COMPLETED|Overall Study||27
7838795|NCT01013870|19293368|P2|STARTED|Overall Study||24
7838796|NCT01013870|19293369|P1|STARTED|Overall Study||28
7838797|NCT01013844|19293393|P2|NOT COMPLETED|Overall Study||0
7838798|NCT01013844|19293394|P1|NOT COMPLETED|Overall Study||0
7838799|NCT01013844|19293393|P2|COMPLETED|Overall Study||65
7838800|NCT01013844|19293394|P1|COMPLETED|Overall Study||65
7838801|NCT01013844|19293393|P2|STARTED|Overall Study||65
7838802|NCT01013844|19293394|P1|STARTED|Overall Study||65
7838803|NCT01013792|19293418|P2|NOT COMPLETED|Overall Study||5
7838804|NCT01013792|19293419|P1|NOT COMPLETED|Overall Study||2
7838805|NCT01013792|19293418|P2|COMPLETED|Overall Study||11
7838806|NCT01013792|19293419|P1|COMPLETED|Overall Study||12
7838807|NCT01013792|19293418|P2|STARTED|Overall Study||16
7838808|NCT01013792|19293419|P1|STARTED|Overall Study||14
7838809|NCT01013753|19293425|P1|NOT COMPLETED|Overall Study||16
7838810|NCT01013753|19293425|P1|COMPLETED|Overall Study||182
7838811|NCT01013753|19293425|P1|Received Form 12 mcg Bid|Overall Study||125
7838812|NCT01013753|19293425|P1|Received Olo 20 mcg qd|Overall Study||124
7838813|NCT01013753|19293425|P1|Received Olo 10 mcg qd|Overall Study||127
7838814|NCT01013753|19293425|P1|Received Olo 5 mcg qd|Overall Study||130
7838815|NCT01013753|19293425|P1|Received Olo 2 mcg qd|Overall Study||121
7838816|NCT01013753|19293425|P1|Received Placebo|Overall Study||125
7838817|NCT01013753|19293425|P1|STARTED|Overall Study|Entered and treated|198
7838818|NCT01013740|19293621|P2|NOT COMPLETED|Overall Study||19
7838819|NCT01013740|19293622|P1|NOT COMPLETED|Overall Study||11
7838820|NCT01013740|19293621|P2|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|56
7838821|NCT01013740|19293622|P1|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|26
7838822|NCT01013740|19293621|P2|Ongoing|Overall Study||0
7838823|NCT01013740|19293622|P1|Ongoing|Overall Study||0
7838824|NCT01013740|19293621|P2|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75
7838825|NCT01013740|19293622|P1|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37
7838826|NCT01013701|19293646|P1|NOT COMPLETED|Overall Study||7
7838827|NCT01013701|19293646|P1|COMPLETED|Overall Study||0
7838828|NCT01013701|19293646|P1|STARTED|Overall Study||7
7838829|NCT01013597|19293653|P1|NOT COMPLETED|Overall Study||1
7838830|NCT01013597|19293653|P1|COMPLETED|Overall Study||12
7838831|NCT01013597|19293653|P1|STARTED|Overall Study||13
7838832|NCT01013350|19293665|P2|NOT COMPLETED|Overall Study||192
7838833|NCT01013350|19293666|P1|NOT COMPLETED|Overall Study||38
7838834|NCT01013350|19293665|P2|COMPLETED|Overall Study||771
7838835|NCT01013350|19293666|P1|COMPLETED|Overall Study||160
7838836|NCT01013350|19293665|P2|Safety Analysis Set|Overall Study||950
7838837|NCT01013350|19293666|P1|Safety Analysis Set|Overall Study||198
7838838|NCT01013350|19293665|P2|STARTED|Overall Study||963
7838839|NCT01013350|19293666|P1|STARTED|Overall Study||198
7838840|NCT01013285|19293679|P2|NOT COMPLETED|Overall Study||89
7838841|NCT01013285|19293680|P1|NOT COMPLETED|Overall Study||48
7838842|NCT01013285|19293679|P2|COMPLETED|Overall Study||21
7838843|NCT01013285|19293680|P1|COMPLETED|Overall Study||22
7838844|NCT01013285|19293679|P2|STARTED|Overall Study||110
7838845|NCT01013285|19293680|P1|STARTED|Overall Study||70
7838846|NCT01013207|19293693|P1|NOT COMPLETED|CPAP Post Nexus (S9)||6
7838847|NCT01013207|19293693|P1|COMPLETED|CPAP Post Nexus (S9)||44
7838848|NCT01013207|19293693|P1|STARTED|CPAP Post Nexus (S9)||50
7838849|NCT01013207|19293693|P1|NOT COMPLETED|Nexus (S9)||0
7838850|NCT01013207|19293693|P1|COMPLETED|Nexus (S9)||50
7838851|NCT01013207|19293693|P1|STARTED|Nexus (S9)||50
7838852|NCT01013207|19293693|P1|NOT COMPLETED|CPAP Pre Nexus (S9)||0
7838853|NCT01013207|19293693|P1|COMPLETED|CPAP Pre Nexus (S9)||50
7838854|NCT01013207|19293693|P1|STARTED|CPAP Pre Nexus (S9)||50
7838855|NCT01013194|19293700|P2|NOT COMPLETED|Overall Study||0
7838856|NCT01013194|19293701|P1|NOT COMPLETED|Overall Study||0
7838857|NCT01013194|19293700|P2|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16
7838858|NCT01013194|19293701|P1|COMPLETED|Overall Study|Consecutive patients|9
7838859|NCT01013194|19293700|P2|STARTED|Overall Study||16
7838860|NCT01013194|19293701|P1|STARTED|Overall Study||9
7838861|NCT01012999|19293711|P1|NOT COMPLETED|Overall Study||1
7838862|NCT01012999|19293711|P1|COMPLETED|Overall Study||15
7838863|NCT01012999|19293711|P1|STARTED|Overall Study||16
7838864|NCT01012973|19293717|P2|NOT COMPLETED|Overall Study||19
7838865|NCT01012973|19293718|P1|NOT COMPLETED|Overall Study||16
7838866|NCT01012973|19293717|P2|COMPLETED|Overall Study||52
7838867|NCT01012973|19293718|P1|COMPLETED|Overall Study||90
7838868|NCT01012973|19293717|P2|Completed Week 52, From FAS|Overall Study||52
7838869|NCT01012973|19293718|P1|Completed Week 52, From FAS|Overall Study||91
7838870|NCT01012973|19293717|P2|Completed Week 24, From FAS|Overall Study||57
7838871|NCT01012973|19293718|P1|Completed Week 24, From FAS|Overall Study||97
7838872|NCT01012973|19293717|P2|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68
7838873|NCT01012973|19293718|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103
7838874|NCT01012973|19293717|P2|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68
7838875|NCT01012973|19293718|P1|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104
7838876|NCT01012973|19293717|P2|STARTED|Overall Study||71
7838877|NCT01012973|19293718|P1|STARTED|Overall Study||106
7838878|NCT01012947|19293743|P5|NOT COMPLETED|Overall Study||142
7838879|NCT01012947|19293744|P4|NOT COMPLETED|Overall Study||118
7838880|NCT01012947|19293745|P3|NOT COMPLETED|Overall Study||130
7838881|NCT01012947|19293746|P2|NOT COMPLETED|Overall Study||135
7838882|NCT01012947|19293747|P1|NOT COMPLETED|Overall Study||131
7838883|NCT01012947|19293743|P5|COMPLETED|Overall Study||94
7838884|NCT01012947|19293744|P4|COMPLETED|Overall Study||93
7838885|NCT01012947|19293745|P3|COMPLETED|Overall Study||111
7838886|NCT01012947|19293746|P2|COMPLETED|Overall Study||80
7838887|NCT01012947|19293747|P1|COMPLETED|Overall Study||81
7838888|NCT01012947|19293743|P5|STARTED|Overall Study||236
7838889|NCT01012947|19293744|P4|STARTED|Overall Study||211
7838890|NCT01012947|19293745|P3|STARTED|Overall Study||241
7838891|NCT01012947|19293746|P2|STARTED|Overall Study||215
7838892|NCT01012947|19293747|P1|STARTED|Overall Study||212
7838893|NCT01012921|19293761|P2|NOT COMPLETED|Overall Study||13
7838894|NCT01012921|19293762|P1|NOT COMPLETED|Overall Study||10
7838895|NCT01012921|19293761|P2|COMPLETED|Overall Study||47
7838896|NCT01012921|19293762|P1|COMPLETED|Overall Study||47
7838897|NCT01012921|19293761|P2|STARTED|Overall Study||60
7838898|NCT01012921|19293762|P1|STARTED|Overall Study||57
7838899|NCT01012765|19293768|P6|NOT COMPLETED|Treatment Period 3||0
7838900|NCT01012765|19293769|P5|NOT COMPLETED|Treatment Period 3||0
7838901|NCT01012765|19293770|P4|NOT COMPLETED|Treatment Period 3||0
7838902|NCT01012765|19293771|P3|NOT COMPLETED|Treatment Period 3||0
7838903|NCT01012765|19293772|P2|NOT COMPLETED|Treatment Period 3||0
7838904|NCT01012765|19293773|P1|NOT COMPLETED|Treatment Period 3||0
7838905|NCT01012765|19293768|P6|COMPLETED|Treatment Period 3||24
7838906|NCT01012765|19293769|P5|COMPLETED|Treatment Period 3||18
7838907|NCT01012765|19293770|P4|COMPLETED|Treatment Period 3||15
7838908|NCT01012765|19293771|P3|COMPLETED|Treatment Period 3||18
7838909|NCT01012765|19293772|P2|COMPLETED|Treatment Period 3||19
7838910|NCT01012765|19293773|P1|COMPLETED|Treatment Period 3||16
7838911|NCT01012765|19293768|P6|STARTED|Treatment Period 3||24
7838912|NCT01012765|19293769|P5|STARTED|Treatment Period 3||18
7838913|NCT01012765|19293770|P4|STARTED|Treatment Period 3||15
7838914|NCT01012765|19293771|P3|STARTED|Treatment Period 3||18
7838915|NCT01012765|19293772|P2|STARTED|Treatment Period 3||19
7838916|NCT01012765|19293773|P1|STARTED|Treatment Period 3||16
7838917|NCT01012765|19293768|P6|NOT COMPLETED|Treatment Period 2||1
7838918|NCT01012765|19293769|P5|NOT COMPLETED|Treatment Period 2||1
7838919|NCT01012765|19293770|P4|NOT COMPLETED|Treatment Period 2||0
7838920|NCT01012765|19293771|P3|NOT COMPLETED|Treatment Period 2||3
7838921|NCT01012765|19293772|P2|NOT COMPLETED|Treatment Period 2||2
7838922|NCT01012765|19293773|P1|NOT COMPLETED|Treatment Period 2||1
7838923|NCT01012765|19293768|P6|COMPLETED|Treatment Period 2||24
7838924|NCT01012765|19293769|P5|COMPLETED|Treatment Period 2||18
7838925|NCT01012765|19293770|P4|COMPLETED|Treatment Period 2||15
7838926|NCT01012765|19293771|P3|COMPLETED|Treatment Period 2||18
7838927|NCT01012765|19293772|P2|COMPLETED|Treatment Period 2||19
7838928|NCT01012765|19293773|P1|COMPLETED|Treatment Period 2||16
7838929|NCT01012765|19293768|P6|STARTED|Treatment Period 2||25
7838930|NCT01012765|19293769|P5|STARTED|Treatment Period 2||19
7838931|NCT01012765|19293770|P4|STARTED|Treatment Period 2||15
7838932|NCT01012765|19293771|P3|STARTED|Treatment Period 2||21
7838933|NCT01012765|19293772|P2|STARTED|Treatment Period 2||21
7838934|NCT01012765|19293773|P1|STARTED|Treatment Period 2||17
7838935|NCT01012765|19293768|P6|NOT COMPLETED|Treatment Period 1||0
7838936|NCT01012765|19293769|P5|NOT COMPLETED|Treatment Period 1||3
7838937|NCT01012765|19293770|P4|NOT COMPLETED|Treatment Period 1||3
7838938|NCT01012765|19293771|P3|NOT COMPLETED|Treatment Period 1||2
7838939|NCT01012765|19293772|P2|NOT COMPLETED|Treatment Period 1||0
7838940|NCT01012765|19293773|P1|NOT COMPLETED|Treatment Period 1||3
7838941|NCT01012765|19293768|P6|COMPLETED|Treatment Period 1||25
7838942|NCT01012765|19293769|P5|COMPLETED|Treatment Period 1||19
7838943|NCT01012765|19293770|P4|COMPLETED|Treatment Period 1||15
7838944|NCT01012765|19293771|P3|COMPLETED|Treatment Period 1||21
7838945|NCT01012765|19293772|P2|COMPLETED|Treatment Period 1||21
7838946|NCT01012765|19293773|P1|COMPLETED|Treatment Period 1||17
7838947|NCT01012765|19293768|P6|STARTED|Treatment Period 1||25
7838948|NCT01012765|19293769|P5|STARTED|Treatment Period 1||22
7838949|NCT01012765|19293770|P4|STARTED|Treatment Period 1||18
7838950|NCT01012765|19293771|P3|STARTED|Treatment Period 1||23
7838951|NCT01012765|19293772|P2|STARTED|Treatment Period 1||21
7838952|NCT01012765|19293773|P1|STARTED|Treatment Period 1||20
7838953|NCT01012739|19293802|P4|NOT COMPLETED|Treatment Period 4||0
7838954|NCT01012739|19293803|P3|NOT COMPLETED|Treatment Period 4||0
7838955|NCT01012739|19293804|P2|NOT COMPLETED|Treatment Period 4||0
7838956|NCT01012739|19293805|P1|NOT COMPLETED|Treatment Period 4||0
7838957|NCT01012739|19293802|P4|COMPLETED|Treatment Period 4||7
7838958|NCT01012739|19293803|P3|COMPLETED|Treatment Period 4||9
7838959|NCT01012739|19293804|P2|COMPLETED|Treatment Period 4||8
7838960|NCT01012739|19293805|P1|COMPLETED|Treatment Period 4||9
7838961|NCT01012739|19293802|P4|STARTED|Treatment Period 4||7
7838962|NCT01012739|19293803|P3|STARTED|Treatment Period 4||9
7838963|NCT01012739|19293804|P2|STARTED|Treatment Period 4||8
7838964|NCT01012739|19293805|P1|STARTED|Treatment Period 4||9
7838965|NCT01012739|19293802|P4|NOT COMPLETED|Treatment Period 3||0
7838966|NCT01012739|19293803|P3|NOT COMPLETED|Treatment Period 3||0
7838967|NCT01012739|19293804|P2|NOT COMPLETED|Treatment Period 3||0
7838968|NCT01012739|19293805|P1|NOT COMPLETED|Treatment Period 3||0
7838969|NCT01012739|19293802|P4|COMPLETED|Treatment Period 3||7
7838970|NCT01012739|19293803|P3|COMPLETED|Treatment Period 3||9
7838971|NCT01012739|19293804|P2|COMPLETED|Treatment Period 3||8
7838972|NCT01012739|19293805|P1|COMPLETED|Treatment Period 3||9
7838973|NCT01012739|19293802|P4|STARTED|Treatment Period 3||7
7838974|NCT01012739|19293803|P3|STARTED|Treatment Period 3||9
7838975|NCT01012739|19293804|P2|STARTED|Treatment Period 3||8
7838976|NCT01012739|19293805|P1|STARTED|Treatment Period 3||9
7838977|NCT01012739|19293802|P4|NOT COMPLETED|Treatment Period 2||1
7838978|NCT01012739|19293803|P3|NOT COMPLETED|Treatment Period 2||0
7838979|NCT01012739|19293804|P2|NOT COMPLETED|Treatment Period 2||0
7838980|NCT01012739|19293805|P1|NOT COMPLETED|Treatment Period 2||0
7838981|NCT01012739|19293802|P4|COMPLETED|Treatment Period 2||7
7838982|NCT01012739|19293803|P3|COMPLETED|Treatment Period 2||9
7838983|NCT01012739|19293804|P2|COMPLETED|Treatment Period 2||8
7838984|NCT01012739|19293805|P1|COMPLETED|Treatment Period 2||9
7838985|NCT01012739|19293802|P4|STARTED|Treatment Period 2||8
7838986|NCT01012739|19293803|P3|STARTED|Treatment Period 2||9
7838987|NCT01012739|19293804|P2|STARTED|Treatment Period 2||8
7838988|NCT01012739|19293805|P1|STARTED|Treatment Period 2||9
7838989|NCT01012739|19293802|P4|NOT COMPLETED|Treatment Period 1||1
7838990|NCT01012739|19293803|P3|NOT COMPLETED|Treatment Period 1||0
7838991|NCT01012739|19293804|P2|NOT COMPLETED|Treatment Period 1||0
7838992|NCT01012739|19293805|P1|NOT COMPLETED|Treatment Period 1||0
7838993|NCT01012739|19293802|P4|COMPLETED|Treatment Period 1||8
7838994|NCT01012739|19293803|P3|COMPLETED|Treatment Period 1||9
7838995|NCT01012739|19293804|P2|COMPLETED|Treatment Period 1||8
7838996|NCT01012739|19293805|P1|COMPLETED|Treatment Period 1||9
7838997|NCT01012739|19293802|P4|STARTED|Treatment Period 1||9
7838998|NCT01012739|19293803|P3|STARTED|Treatment Period 1||9
7838999|NCT01012739|19293804|P2|STARTED|Treatment Period 1||8
7839000|NCT01012739|19293805|P1|STARTED|Treatment Period 1||9
7839001|NCT01012713|19293833|P1|NOT COMPLETED|Overall Study||3
7839002|NCT01012713|19293833|P1|COMPLETED|Overall Study||27
7839003|NCT01012713|19293833|P1|STARTED|Overall Study||30
7839004|NCT01012674|19293839|P1|NOT COMPLETED|Overall Study||24
7839005|NCT01012674|19293839|P1|COMPLETED|Overall Study||187
7839006|NCT01012674|19293839|P1|STARTED|Overall Study||211
7839007|NCT01012661|19293851|P1|NOT COMPLETED|Overall Study||0
7839008|NCT01012661|19293851|P1|COMPLETED|Overall Study||50
7839009|NCT01012661|19293851|P1|STARTED|Overall Study||50
7839010|NCT01012622|19293859|P1|NOT COMPLETED|Overall Study||31
7839011|NCT01012622|19293859|P1|COMPLETED|Overall Study||111
7839012|NCT01012622|19293859|P1|STARTED|Overall Study||142
7839013|NCT01012492|19293878|P1|NOT COMPLETED|Overall Study||0
7839014|NCT01012492|19293878|P1|COMPLETED|Overall Study||10
7839015|NCT01012492|19293878|P1|STARTED|Overall Study||10
7839016|NCT01012440|19293885|P1|NOT COMPLETED|Overall Study||2
7839017|NCT01012440|19293885|P1|COMPLETED|Overall Study||3
7839018|NCT01012440|19293885|P1|STARTED|Overall Study||5
7839019|NCT01012414|19293889|P1|NOT COMPLETED|Overall Study||10
7839020|NCT01012414|19293889|P1|COMPLETED|Overall Study|No subjects completed the study.|0
7839021|NCT01012414|19293889|P1|STARTED|Overall Study||10
7839022|NCT01012388|19293896|P1|NOT COMPLETED|Overall Study||0
7839023|NCT01012388|19293896|P1|COMPLETED|Overall Study||100
7839024|NCT01012388|19293896|P1|STARTED|Overall Study||100
7839025|NCT01012362|19293906|P5|NOT COMPLETED|Overall Study||0
7839026|NCT01012362|19293907|P4|NOT COMPLETED|Overall Study||0
7839027|NCT01012362|19293908|P3|NOT COMPLETED|Overall Study||0
7839028|NCT01012362|19293909|P2|NOT COMPLETED|Overall Study||0
7839029|NCT01012362|19293910|P1|NOT COMPLETED|Overall Study||0
7839030|NCT01012362|19293906|P5|COMPLETED|Overall Study||9
7839031|NCT01012362|19293907|P4|COMPLETED|Overall Study||4
7839032|NCT01012362|19293908|P3|COMPLETED|Overall Study||3
7839033|NCT01012362|19293909|P2|COMPLETED|Overall Study||6
7839034|NCT01012362|19293910|P1|COMPLETED|Overall Study||9
7839035|NCT01012362|19293906|P5|STARTED|Overall Study||9
7839036|NCT01012362|19293907|P4|STARTED|Overall Study||4
7839037|NCT01012362|19293908|P3|STARTED|Overall Study||3
7839038|NCT01012362|19293909|P2|STARTED|Overall Study||6
7839039|NCT01012362|19293910|P1|STARTED|Overall Study||9
7839040|NCT01012336|19293926|P1|NOT COMPLETED|Overall Study||0
7839041|NCT01012336|19293926|P1|COMPLETED|Overall Study||85
7839042|NCT01012336|19293926|P1|STARTED|Overall Study||85
7839043|NCT01012323|19293930|P1|NOT COMPLETED|Overall Study||1
7839044|NCT01012323|19293930|P1|COMPLETED|Overall Study||50
7839045|NCT01012323|19293930|P1|STARTED|Overall Study||51
7839046|NCT01012297|19293954|P2|NOT COMPLETED|Overall Study||0
7839047|NCT01012297|19293955|P1|NOT COMPLETED|Overall Study||0
7839048|NCT01012297|19293954|P2|COMPLETED|Overall Study||53
7839049|NCT01012297|19293955|P1|COMPLETED|Overall Study||54
7839050|NCT01012297|19293954|P2|STARTED|Overall Study||53
7839051|NCT01012297|19293955|P1|STARTED|Overall Study||54
7839052|NCT01012258|19293967|P1|NOT COMPLETED|Overall Study||66
7839053|NCT01012258|19293967|P1|COMPLETED|Overall Study||0
7839054|NCT01012258|19293967|P1|STARTED|Overall Study||66
7839055|NCT01012245|19293977|P1|NOT COMPLETED|Overall Study||2427
7839056|NCT01012245|19293977|P1|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385
7839057|NCT01012245|19293977|P1|STARTED|Overall Study||28812
7839058|NCT01012219|19294014|P1|NOT COMPLETED|Period 3||0
7839059|NCT01012219|19294014|P1|COMPLETED|Period 3||20
7839060|NCT01012219|19294014|P1|STARTED|Period 3|of the 36 who started Period 1|20
7839061|NCT01012219|19294014|P1|NOT COMPLETED|Period 2||1
7839062|NCT01012219|19294014|P1|COMPLETED|Period 2||34
7839063|NCT01012219|19294014|P1|STARTED|Period 2|Number who completed Period 1|35
7839064|NCT01012219|19294014|P1|NOT COMPLETED|Period 1||1
7839065|NCT01012219|19294014|P1|COMPLETED|Period 1||35
7839066|NCT01012219|19294014|P1|STARTED|Period 1|Number randomized|36
7839067|NCT01012167|19294024|P3|NOT COMPLETED|Overall Study||4
7839068|NCT01012167|19294025|P2|NOT COMPLETED|Overall Study||2
7839069|NCT01012167|19294026|P1|NOT COMPLETED|Overall Study||2
7839070|NCT01012167|19294024|P3|COMPLETED|Overall Study||17
7839071|NCT01012167|19294025|P2|COMPLETED|Overall Study||18
7839072|NCT01012167|19294026|P1|COMPLETED|Overall Study||15
7839073|NCT01012167|19294024|P3|Exposed to Study Drug|Overall Study||20
7839074|NCT01012167|19294025|P2|Exposed to Study Drug|Overall Study||20
7839075|NCT01012167|19294026|P1|Exposed to Study Drug|Overall Study||16
7839076|NCT01012167|19294024|P3|Withdrawn Prior to Study Drug Exposure|Overall Study||1
7839077|NCT01012167|19294025|P2|Withdrawn Prior to Study Drug Exposure|Overall Study||0
7839078|NCT01012167|19294026|P1|Withdrawn Prior to Study Drug Exposure|Overall Study||1
7839079|NCT01012167|19294024|P3|STARTED|Overall Study||21
7839080|NCT01012167|19294025|P2|STARTED|Overall Study||20
7839081|NCT01012167|19294026|P1|STARTED|Overall Study||17
7839082|NCT01012089|19294282|P1|NOT COMPLETED|Overall Study||0
7839083|NCT01012089|19294282|P1|COMPLETED|Overall Study||6
7839084|NCT01012089|19294282|P1|STARTED|Overall Study||6
7839085|NCT01012037|19294305|P3|NOT COMPLETED|Overall Study||10
7839086|NCT01012037|19294306|P2|NOT COMPLETED|Overall Study||16
7839087|NCT01012037|19294307|P1|NOT COMPLETED|Overall Study||1
7839088|NCT01012037|19294305|P3|COMPLETED|Overall Study||214
7839089|NCT01012037|19294306|P2|COMPLETED|Overall Study||207
7839090|NCT01012037|19294307|P1|COMPLETED|Overall Study||43
7839091|NCT01012037|19294305|P3|STARTED|Overall Study||224
7839092|NCT01012037|19294306|P2|STARTED|Overall Study||223
7839093|NCT01012037|19294307|P1|STARTED|Overall Study||44
7839094|NCT01011946|19294342|P1|NOT COMPLETED|Overall Study||3
7839095|NCT01011946|19294342|P1|COMPLETED|Overall Study||33
7839096|NCT01011946|19294342|P1|STARTED|Overall Study||36
7839097|NCT01011933|19294346|P1|NOT COMPLETED|Overall Study||4
7839098|NCT01011933|19294346|P1|COMPLETED|Overall Study|total eligible and evaluable|50
7839099|NCT01011933|19294346|P1|STARTED|Overall Study|total enrolled|54
7839100|NCT01011907|19294363|P2|NOT COMPLETED|Overall Study||15
7839101|NCT01011907|19294364|P1|NOT COMPLETED|Overall Study||14
7839102|NCT01011907|19294363|P2|COMPLETED|Overall Study||18
7839103|NCT01011907|19294364|P1|COMPLETED|Overall Study||17
7839104|NCT01011907|19294363|P2|STARTED|Overall Study||33
7839105|NCT01011907|19294364|P1|STARTED|Overall Study||31
7839106|NCT01011894|19294374|P1|NOT COMPLETED|Overall Study||0
7839107|NCT01011894|19294374|P1|COMPLETED|Overall Study||26
7839108|NCT01011894|19294374|P1|STARTED|Overall Study||26
7839109|NCT01011868|19294381|P3|NOT COMPLETED|After Week 78 Follow-up||44
7839110|NCT01011868|19294382|P2|NOT COMPLETED|After Week 78 Follow-up||38
7839111|NCT01011868|19294383|P1|NOT COMPLETED|After Week 78 Follow-up||52
7839112|NCT01011868|19294381|P3|COMPLETED|After Week 78 Follow-up||111
7839113|NCT01011868|19294382|P2|COMPLETED|After Week 78 Follow-up||131
7839114|NCT01011868|19294383|P1|COMPLETED|After Week 78 Follow-up||118
7839115|NCT01011868|19294381|P3|STARTED|After Week 78 Follow-up||155
7839116|NCT01011868|19294382|P2|STARTED|After Week 78 Follow-up||169
7839117|NCT01011868|19294383|P1|STARTED|After Week 78 Follow-up||170
7839118|NCT01011868|19294381|P3|NOT COMPLETED|After Week 18 Follow-up||26
7839119|NCT01011868|19294382|P2|NOT COMPLETED|After Week 18 Follow-up||16
7839120|NCT01011868|19294383|P1|NOT COMPLETED|After Week 18 Follow-up||23
7839121|NCT01011868|19294381|P3|COMPLETED|After Week 18 Follow-up||129
7839122|NCT01011868|19294382|P2|COMPLETED|After Week 18 Follow-up||153
7839123|NCT01011868|19294383|P1|COMPLETED|After Week 18 Follow-up||147
7839124|NCT01011868|19294381|P3|STARTED|After Week 18 Follow-up||155
7839125|NCT01011868|19294382|P2|STARTED|After Week 18 Follow-up||169
7839126|NCT01011868|19294383|P1|STARTED|After Week 18 Follow-up||170
7839127|NCT01011829|19294420|P2|NOT COMPLETED|Overall Study||9
7839128|NCT01011829|19294421|P1|NOT COMPLETED|Overall Study||4
7839129|NCT01011829|19294420|P2|COMPLETED|Overall Study||1
7839130|NCT01011829|19294421|P1|COMPLETED|Overall Study||6
7839131|NCT01011829|19294420|P2|STARTED|Overall Study||10
7839132|NCT01011829|19294421|P1|STARTED|Overall Study||10
7839133|NCT01011816|19294431|P2|NOT COMPLETED|78-Week Extended Follow-up||28
7839134|NCT01011816|19294432|P1|NOT COMPLETED|78-Week Extended Follow-up||72
7839135|NCT01011816|19294431|P2|COMPLETED|78-Week Extended Follow-up||26
7839136|NCT01011816|19294432|P1|COMPLETED|78-Week Extended Follow-up||85
7839137|NCT01011816|19294431|P2|STARTED|78-Week Extended Follow-up||54
7839138|NCT01011816|19294432|P1|STARTED|78-Week Extended Follow-up||157
7839139|NCT01011816|19294431|P2|NOT COMPLETED|26-Week Primary Endpoint||2
7839140|NCT01011816|19294432|P1|NOT COMPLETED|26-Week Primary Endpoint||7
7839141|NCT01011816|19294431|P2|COMPLETED|26-Week Primary Endpoint||54
7839142|NCT01011816|19294432|P1|COMPLETED|26-Week Primary Endpoint||157
7839143|NCT01011816|19294431|P2|STARTED|26-Week Primary Endpoint||56
7839144|NCT01011816|19294432|P1|STARTED|26-Week Primary Endpoint||164
7839145|NCT01011738|19294445|P3|NOT COMPLETED|Overall Study||17
7839146|NCT01011738|19294446|P2|NOT COMPLETED|Overall Study||294
7839147|NCT01011738|19294447|P1|NOT COMPLETED|Overall Study||324
7839148|NCT01011738|19294445|P3|COMPLETED|Overall Study||36
7839149|NCT01011738|19294446|P2|COMPLETED|Overall Study||618
7839150|NCT01011738|19294447|P1|COMPLETED|Overall Study||553
7839151|NCT01011738|19294445|P3|STARTED|Overall Study||53
7839152|NCT01011738|19294446|P2|STARTED|Overall Study||912
7839153|NCT01011738|19294447|P1|STARTED|Overall Study||877
7839154|NCT01011673|19294487|P2|NOT COMPLETED|24 Hour Follow-up||3
7839155|NCT01011673|19294488|P1|NOT COMPLETED|24 Hour Follow-up||3
7839156|NCT01011673|19294487|P2|COMPLETED|24 Hour Follow-up||57
7839157|NCT01011673|19294488|P1|COMPLETED|24 Hour Follow-up||57
7839158|NCT01011673|19294487|P2|STARTED|24 Hour Follow-up||60
7839159|NCT01011673|19294488|P1|STARTED|24 Hour Follow-up||60
7839160|NCT01011673|19294487|P2|NOT COMPLETED|Emergency Department Portion||0
7839161|NCT01011673|19294488|P1|NOT COMPLETED|Emergency Department Portion||0
7839162|NCT01011673|19294487|P2|COMPLETED|Emergency Department Portion||60
7839163|NCT01011673|19294488|P1|COMPLETED|Emergency Department Portion||60
7839164|NCT01011673|19294487|P2|STARTED|Emergency Department Portion||60
7839165|NCT01011673|19294488|P1|STARTED|Emergency Department Portion||60
7839166|NCT01011673|19294487|P2|NOT COMPLETED|Randomized||1
7839167|NCT01011673|19294488|P1|NOT COMPLETED|Randomized||2
7839168|NCT01011673|19294487|P2|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60
7839169|NCT01011673|19294488|P1|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60
7839170|NCT01011673|19294487|P2|STARTED|Randomized||61
7839171|NCT01011673|19294488|P1|STARTED|Randomized||62
7839172|NCT01011634|19294498|P2|NOT COMPLETED|Overall Study||1
7839173|NCT01011634|19294499|P1|NOT COMPLETED|Overall Study||0
7839174|NCT01011634|19294498|P2|COMPLETED|Overall Study||8
7839175|NCT01011634|19294499|P1|COMPLETED|Overall Study||9
7839176|NCT01011634|19294498|P2|STARTED|Overall Study||9
7839177|NCT01011634|19294499|P1|STARTED|Overall Study||9
7839178|NCT01011556|19294511|P4|NOT COMPLETED|Overall Study||13
7839179|NCT01011556|19294512|P3|NOT COMPLETED|Overall Study||10
7839180|NCT01011556|19294513|P2|NOT COMPLETED|Overall Study||8
7839181|NCT01011556|19294514|P1|NOT COMPLETED|Overall Study||6
7839182|NCT01011556|19294511|P4|COMPLETED|Overall Study||51
7839183|NCT01011556|19294512|P3|COMPLETED|Overall Study||45
7839184|NCT01011556|19294513|P2|COMPLETED|Overall Study||48
7839185|NCT01011556|19294514|P1|COMPLETED|Overall Study||52
7839186|NCT01011556|19294511|P4|Received at Least 1 Dose of Study Drug|Overall Study||64
7839187|NCT01011556|19294512|P3|Received at Least 1 Dose of Study Drug|Overall Study||54
7839188|NCT01011556|19294513|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
7839189|NCT01011556|19294514|P1|Received at Least 1 Dose of Study Drug|Overall Study||57
7839190|NCT01011556|19294511|P4|STARTED|Overall Study||64
7839191|NCT01011556|19294512|P3|STARTED|Overall Study||55
7839192|NCT01011556|19294513|P2|STARTED|Overall Study||56
7839193|NCT01011556|19294514|P1|STARTED|Overall Study||58
7839194|NCT01011465|19294592|P8|NOT COMPLETED|Overall Study||0
7839195|NCT01011465|19294593|P7|NOT COMPLETED|Overall Study||1
7839196|NCT01011465|19294594|P6|NOT COMPLETED|Overall Study||0
7839197|NCT01011465|19294595|P5|NOT COMPLETED|Overall Study||1
7839198|NCT01011465|19294596|P4|NOT COMPLETED|Overall Study||0
7839199|NCT01011465|19294597|P3|NOT COMPLETED|Overall Study||0
7839200|NCT01011465|19294598|P2|NOT COMPLETED|Overall Study||1
7839201|NCT01011465|19294599|P1|NOT COMPLETED|Overall Study||2
7839202|NCT01011465|19294592|P8|COMPLETED|Overall Study||32
7839203|NCT01011465|19294593|P7|COMPLETED|Overall Study||51
7839204|NCT01011465|19294594|P6|COMPLETED|Overall Study||29
7839205|NCT01011465|19294595|P5|COMPLETED|Overall Study||46
7839206|NCT01011465|19294596|P4|COMPLETED|Overall Study||18
7839207|NCT01011465|19294597|P3|COMPLETED|Overall Study||36
7839208|NCT01011465|19294598|P2|COMPLETED|Overall Study||19
7839209|NCT01011465|19294599|P1|COMPLETED|Overall Study||34
7839210|NCT01011465|19294592|P8|STARTED|Overall Study||32
7839211|NCT01011465|19294593|P7|STARTED|Overall Study||52
7839212|NCT01011465|19294594|P6|STARTED|Overall Study||29
7839213|NCT01011465|19294595|P5|STARTED|Overall Study||47
7839214|NCT01011465|19294596|P4|STARTED|Overall Study||18
7839215|NCT01011465|19294597|P3|STARTED|Overall Study||36
7839216|NCT01011465|19294598|P2|STARTED|Overall Study||20
7839217|NCT01011465|19294599|P1|STARTED|Overall Study||36
7839218|NCT01011439|19294627|P1|NOT COMPLETED|Overall Study||57
7839219|NCT01011439|19294627|P1|COMPLETED|Overall Study||15
7839220|NCT01011439|19294627|P1|STARTED|Overall Study||72
7839221|NCT01011413|19294639|P2|NOT COMPLETED|Overall Study||25
7839222|NCT01011413|19294640|P1|NOT COMPLETED|Overall Study||26
7839223|NCT01011413|19294639|P2|COMPLETED|Overall Study||299
7839224|NCT01011413|19294640|P1|COMPLETED|Overall Study||286
7839225|NCT01011413|19294639|P2|Lost to Follow-up Between Week 48 and 96|Overall Study||4
7839226|NCT01011413|19294640|P1|Lost to Follow-up Between Week 48 and 96|Overall Study||10
7839227|NCT01011413|19294639|P2|Withdrew Consent Between Week 48 and 96|Overall Study||6
7839228|NCT01011413|19294640|P1|Withdrew Consent Between Week 48 and 96|Overall Study||2
7839229|NCT01011413|19294639|P2|Died Between Week 48 and 96|Overall Study||3
7839230|NCT01011413|19294640|P1|Died Between Week 48 and 96|Overall Study||2
7839231|NCT01011413|19294639|P2|Attended w48 Visit|Overall Study||311
7839232|NCT01011413|19294640|P1|Attended w48 Visit|Overall Study||295
7839233|NCT01011413|19294639|P2|Withdrew Consent Before w48|Overall Study||3
7839234|NCT01011413|19294640|P1|Withdrew Consent Before w48|Overall Study||3
7839235|NCT01011413|19294639|P2|Lost to Follow up Before w48|Overall Study||4
7839236|NCT01011413|19294640|P1|Lost to Follow up Before w48|Overall Study||3
7839237|NCT01011413|19294639|P2|Died Before Week 48|Overall Study||2
7839238|NCT01011413|19294640|P1|Died Before Week 48|Overall Study||3
7839239|NCT01011413|19294639|P2|In Modified ITT|Overall Study||321
7839240|NCT01011413|19294640|P1|In Modified ITT|Overall Study||309
7839241|NCT01011413|19294639|P2|Did Not Start Study Drug|Overall Study||3
7839242|NCT01011413|19294640|P1|Did Not Start Study Drug|Overall Study||3
7839243|NCT01011413|19294639|P2|STARTED|Overall Study|324 randomised|324
7839244|NCT01011413|19294640|P1|STARTED|Overall Study|312 randomised|312
7839245|NCT01011387|19294664|P1|NOT COMPLETED|Overall Study||6
7839246|NCT01011387|19294664|P1|COMPLETED|Overall Study||10
7839247|NCT01011387|19294664|P1|STARTED|Overall Study||16
7839248|NCT01011335|19294672|P13|NOT COMPLETED|Overall Study||3
7839249|NCT01011335|19294673|P12|NOT COMPLETED|Overall Study||1
7839250|NCT01011335|19294674|P11|NOT COMPLETED|Overall Study||6
7839251|NCT01011335|19294675|P10|NOT COMPLETED|Overall Study||0
7839252|NCT01011335|19294676|P9|NOT COMPLETED|Overall Study||2
7839253|NCT01011335|19294677|P8|NOT COMPLETED|Overall Study||2
7839254|NCT01011335|19294678|P7|NOT COMPLETED|Overall Study||3
7839255|NCT01011335|19294679|P6|NOT COMPLETED|Overall Study||1
7839256|NCT01011335|19294680|P5|NOT COMPLETED|Overall Study||1
7839257|NCT01011335|19294681|P4|NOT COMPLETED|Overall Study||2
7839258|NCT01011335|19294682|P3|NOT COMPLETED|Overall Study||1
7839259|NCT01011335|19294683|P2|NOT COMPLETED|Overall Study||1
7839260|NCT01011335|19294684|P1|NOT COMPLETED|Overall Study||1
7839261|NCT01011335|19294672|P13|COMPLETED|Overall Study||19
7839262|NCT01011335|19294673|P12|COMPLETED|Overall Study||21
7839263|NCT01011335|19294674|P11|COMPLETED|Overall Study||6
7839264|NCT01011335|19294675|P10|COMPLETED|Overall Study||12
7839265|NCT01011335|19294676|P9|COMPLETED|Overall Study||10
7839266|NCT01011335|19294677|P8|COMPLETED|Overall Study||10
7839267|NCT01011335|19294678|P7|COMPLETED|Overall Study||9
7839268|NCT01011335|19294679|P6|COMPLETED|Overall Study||11
7839269|NCT01011335|19294680|P5|COMPLETED|Overall Study||12
7839270|NCT01011335|19294681|P4|COMPLETED|Overall Study||10
7839271|NCT01011335|19294682|P3|COMPLETED|Overall Study||11
7839272|NCT01011335|19294683|P2|COMPLETED|Overall Study||11
7839273|NCT01011335|19294684|P1|COMPLETED|Overall Study||10
7839274|NCT01011335|19294672|P13|STARTED|Overall Study||22
7839275|NCT01011335|19294673|P12|STARTED|Overall Study||22
7839276|NCT01011335|19294674|P11|STARTED|Overall Study||12
7839277|NCT01011335|19294675|P10|STARTED|Overall Study||12
7839278|NCT01011335|19294676|P9|STARTED|Overall Study||12
7839279|NCT01011335|19294677|P8|STARTED|Overall Study||12
7839280|NCT01011335|19294678|P7|STARTED|Overall Study||12
7839281|NCT01011335|19294679|P6|STARTED|Overall Study||12
7839282|NCT01011335|19294680|P5|STARTED|Overall Study||13
7839283|NCT01011335|19294681|P4|STARTED|Overall Study||12
7839284|NCT01011335|19294682|P3|STARTED|Overall Study||12
7839285|NCT01011335|19294683|P2|STARTED|Overall Study||12
7839286|NCT01011335|19294684|P1|STARTED|Overall Study||11
7839287|NCT01011309|19294724|P3|NOT COMPLETED|Overall Study||5
7839288|NCT01011309|19294725|P2|NOT COMPLETED|Overall Study||3
7839289|NCT01011309|19294726|P1|NOT COMPLETED|Overall Study||2
7839290|NCT01011309|19294724|P3|COMPLETED|Overall Study||16
7839291|NCT01011309|19294725|P2|COMPLETED|Overall Study||7
7839292|NCT01011309|19294726|P1|COMPLETED|Overall Study||12
7839293|NCT01011309|19294724|P3|STARTED|Overall Study||21
7839294|NCT01011309|19294725|P2|STARTED|Overall Study||10
7839295|NCT01011309|19294726|P1|STARTED|Overall Study||14
7839296|NCT01011283|19294742|P2|NOT COMPLETED|Overall Study||11
7839297|NCT01011283|19294743|P1|NOT COMPLETED|Overall Study||11
7839298|NCT01011283|19294742|P2|COMPLETED|Overall Study||2
7839299|NCT01011283|19294743|P1|COMPLETED|Overall Study||2
7839300|NCT01011283|19294742|P2|STARTED|Overall Study||13
7839301|NCT01011283|19294743|P1|STARTED|Overall Study||13
7839302|NCT01011218|19294755|P4|NOT COMPLETED|Overall Study||0
7839303|NCT01011218|19294756|P3|NOT COMPLETED|Overall Study||0
7839304|NCT01011218|19294757|P2|NOT COMPLETED|Overall Study||0
7839305|NCT01011218|19294758|P1|NOT COMPLETED|Overall Study||0
7839306|NCT01011218|19294755|P4|COMPLETED|Overall Study||26
7839307|NCT01011218|19294756|P3|COMPLETED|Overall Study||26
7839308|NCT01011218|19294757|P2|COMPLETED|Overall Study||9
7839309|NCT01011218|19294758|P1|COMPLETED|Overall Study||9
7839310|NCT01011218|19294755|P4|STARTED|Overall Study||26
7839311|NCT01011218|19294756|P3|STARTED|Overall Study||26
7839312|NCT01011218|19294757|P2|STARTED|Overall Study||9
7839313|NCT01011218|19294758|P1|STARTED|Overall Study||9
7839314|NCT01011179|19294782|P2|NOT COMPLETED|Overall Study||2
7839315|NCT01011179|19294783|P1|NOT COMPLETED|Overall Study||4
7839316|NCT01011179|19294782|P2|COMPLETED|Overall Study||20
7839317|NCT01011179|19294783|P1|COMPLETED|Overall Study||20
7839318|NCT01011179|19294782|P2|STARTED|Overall Study||22
7839319|NCT01011179|19294783|P1|STARTED|Overall Study||24
7839320|NCT01011153|19294792|P3|NOT COMPLETED|Overall Study||9
7839321|NCT01011153|19294793|P2|NOT COMPLETED|Overall Study||11
7839322|NCT01011153|19294794|P1|NOT COMPLETED|Overall Study||8
7839323|NCT01011153|19294792|P3|COMPLETED|Overall Study||45
7839324|NCT01011153|19294793|P2|COMPLETED|Overall Study||64
7839325|NCT01011153|19294794|P1|COMPLETED|Overall Study||46
7839326|NCT01011153|19294792|P3|STARTED|Overall Study||54
7839327|NCT01011153|19294793|P2|STARTED|Overall Study||75
7839328|NCT01011153|19294794|P1|STARTED|Overall Study||54
7839329|NCT01011075|19294812|P1|NOT COMPLETED|Overall Study||0
7839330|NCT01011075|19294812|P1|COMPLETED|Overall Study||34
7839331|NCT01011075|19294812|P1|STARTED|Overall Study||34
7839332|NCT01011049|19294823|P4|NOT COMPLETED|Overall Study||0
7839333|NCT01011049|19294824|P3|NOT COMPLETED|Overall Study||4
7839334|NCT01011049|19294825|P2|NOT COMPLETED|Overall Study||2
7839335|NCT01011049|19294826|P1|NOT COMPLETED|Overall Study||1
7839336|NCT01011049|19294823|P4|COMPLETED|Overall Study||246
7839337|NCT01011049|19294824|P3|COMPLETED|Overall Study||239
7839338|NCT01011049|19294825|P2|COMPLETED|Overall Study||250
7839339|NCT01011049|19294826|P1|COMPLETED|Overall Study||506
7839340|NCT01011049|19294823|P4|STARTED|Overall Study||246
7839341|NCT01011049|19294824|P3|STARTED|Overall Study||243
7839342|NCT01011049|19294825|P2|STARTED|Overall Study||252
7839343|NCT01011049|19294826|P1|STARTED|Overall Study||507
7839344|NCT01010984|19294848|P1|NOT COMPLETED|Overall Study||0
7839345|NCT01010984|19294848|P1|COMPLETED|Overall Study||20
7839346|NCT01010984|19294848|P1|STARTED|Overall Study||20
7839347|NCT01010971|19294856|P3|NOT COMPLETED|Overall Study||13
7839348|NCT01010971|19294857|P2|NOT COMPLETED|Overall Study||8
7839349|NCT01010971|19294858|P1|NOT COMPLETED|Overall Study||3
7839350|NCT01010971|19294856|P3|COMPLETED|Overall Study||207
7839351|NCT01010971|19294857|P2|COMPLETED|Overall Study||218
7839352|NCT01010971|19294858|P1|COMPLETED|Overall Study||222
7839353|NCT01010971|19294856|P3|STARTED|Overall Study||220
7839354|NCT01010971|19294857|P2|STARTED|Overall Study||226
7839355|NCT01010971|19294858|P1|STARTED|Overall Study||225
7839356|NCT01010932|19294943|P1|NOT COMPLETED|Overall Study||22
7839357|NCT01010932|19294943|P1|COMPLETED|Overall Study||200
7839358|NCT01010932|19294943|P1|STARTED|Overall Study||222
7839359|NCT01010906|19294961|P6|NOT COMPLETED|Overall Study||0
7839360|NCT01010906|19294962|P5|NOT COMPLETED|Overall Study||0
7839361|NCT01010906|19294963|P4|NOT COMPLETED|Overall Study||0
7839362|NCT01010906|19294964|P3|NOT COMPLETED|Overall Study||0
7839363|NCT01010906|19294965|P2|NOT COMPLETED|Overall Study||0
7839364|NCT01010906|19294966|P1|NOT COMPLETED|Overall Study||0
7839365|NCT01010906|19294961|P6|COMPLETED|Overall Study||10
7839366|NCT01010906|19294962|P5|COMPLETED|Overall Study||10
7839367|NCT01010906|19294963|P4|COMPLETED|Overall Study||10
7839368|NCT01010906|19294964|P3|COMPLETED|Overall Study||10
7839369|NCT01010906|19294965|P2|COMPLETED|Overall Study||10
7839370|NCT01010906|19294966|P1|COMPLETED|Overall Study||10
7839371|NCT01010906|19294961|P6|STARTED|Overall Study||10
7839372|NCT01010906|19294962|P5|STARTED|Overall Study||10
7839373|NCT01010906|19294963|P4|STARTED|Overall Study||10
7839374|NCT01010906|19294964|P3|STARTED|Overall Study||10
7839375|NCT01010906|19294965|P2|STARTED|Overall Study||10
7839376|NCT01010906|19294966|P1|STARTED|Overall Study||10
7839377|NCT01010867|19294986|P1|NOT COMPLETED|Overall Study||1
7839378|NCT01010867|19294986|P1|COMPLETED|Overall Study||30
7839379|NCT01010867|19294986|P1|STARTED|Overall Study||31
7839380|NCT01010854|19294993|P1|NOT COMPLETED|Overall Study||0
7839381|NCT01010854|19294993|P1|COMPLETED|Overall Study||6
7839382|NCT01010854|19294993|P1|STARTED|Overall Study||6
7839383|NCT01010776|19294998|P1|NOT COMPLETED|Extension Phase||3
7839384|NCT01010776|19294998|P1|COMPLETED|Extension Phase||156
7839385|NCT01010776|19294998|P1|STARTED|Extension Phase||159
7839386|NCT01010776|19294998|P1|NOT COMPLETED|In-Between Main Phase & Extension Phase||15
7839387|NCT01010776|19294998|P1|COMPLETED|In-Between Main Phase & Extension Phase||159
7839388|NCT01010776|19294998|P1|STARTED|In-Between Main Phase & Extension Phase||174
7839389|NCT01010776|19294998|P1|NOT COMPLETED|Main Phase||49
7839390|NCT01010776|19294998|P1|COMPLETED|Main Phase||174
7839391|NCT01010776|19294998|P1|Treated|Main Phase||218
7839392|NCT01010776|19294998|P1|STARTED|Main Phase||223
7839393|NCT01010763|19295022|P2|NOT COMPLETED|Overall Study||30
7839394|NCT01010763|19295023|P1|NOT COMPLETED|Overall Study||35
7839395|NCT01010763|19295022|P2|COMPLETED|Overall Study||54
7839396|NCT01010763|19295023|P1|COMPLETED|Overall Study||61
7839397|NCT01010763|19295022|P2|STARTED|Overall Study||84
7839398|NCT01010763|19295023|P1|STARTED|Overall Study||96
7839399|NCT01010750|19295055|P6|NOT COMPLETED|Third Intervention||0
7839400|NCT01010750|19295056|P5|NOT COMPLETED|Third Intervention||0
7839401|NCT01010750|19295057|P4|NOT COMPLETED|Third Intervention||0
7839402|NCT01010750|19295058|P3|NOT COMPLETED|Third Intervention||0
7839403|NCT01010750|19295059|P2|NOT COMPLETED|Third Intervention||0
7839404|NCT01010750|19295060|P1|NOT COMPLETED|Third Intervention||0
7839405|NCT01010750|19295055|P6|COMPLETED|Third Intervention||3
7839406|NCT01010750|19295056|P5|COMPLETED|Third Intervention||2
7839407|NCT01010750|19295057|P4|COMPLETED|Third Intervention||3
7839408|NCT01010750|19295058|P3|COMPLETED|Third Intervention||3
7839409|NCT01010750|19295059|P2|COMPLETED|Third Intervention||3
7839410|NCT01010750|19295060|P1|COMPLETED|Third Intervention||3
7839411|NCT01010750|19295055|P6|STARTED|Third Intervention||3
7839412|NCT01010750|19295056|P5|STARTED|Third Intervention||2
7839413|NCT01010750|19295057|P4|STARTED|Third Intervention||3
7839414|NCT01010750|19295058|P3|STARTED|Third Intervention||3
7839415|NCT01010750|19295059|P2|STARTED|Third Intervention||3
7839416|NCT01010750|19295060|P1|STARTED|Third Intervention||3
7839417|NCT01010750|19295055|P6|NOT COMPLETED|Second Intervention||0
7839418|NCT01010750|19295056|P5|NOT COMPLETED|Second Intervention||0
7839419|NCT01010750|19295057|P4|NOT COMPLETED|Second Intervention||0
7839420|NCT01010750|19295058|P3|NOT COMPLETED|Second Intervention||0
7839421|NCT01010750|19295059|P2|NOT COMPLETED|Second Intervention||1
7839422|NCT01010750|19295060|P1|NOT COMPLETED|Second Intervention||0
7839423|NCT01010750|19295055|P6|COMPLETED|Second Intervention||3
7839424|NCT01010750|19295056|P5|COMPLETED|Second Intervention||2
7839425|NCT01010750|19295057|P4|COMPLETED|Second Intervention||3
7839426|NCT01010750|19295058|P3|COMPLETED|Second Intervention||3
7839427|NCT01010750|19295059|P2|COMPLETED|Second Intervention||3
7839428|NCT01010750|19295060|P1|COMPLETED|Second Intervention||3
7839429|NCT01010750|19295055|P6|STARTED|Second Intervention||3
7839430|NCT01010750|19295056|P5|STARTED|Second Intervention||2
7839431|NCT01010750|19295057|P4|STARTED|Second Intervention||3
7839432|NCT01010750|19295058|P3|STARTED|Second Intervention||3
7839433|NCT01010750|19295059|P2|STARTED|Second Intervention||4
7839434|NCT01010750|19295060|P1|STARTED|Second Intervention||3
7839435|NCT01010750|19295055|P6|NOT COMPLETED|First Intervention||0
7839436|NCT01010750|19295056|P5|NOT COMPLETED|First Intervention||0
7839437|NCT01010750|19295057|P4|NOT COMPLETED|First Intervention||0
7839438|NCT01010750|19295058|P3|NOT COMPLETED|First Intervention||0
7839439|NCT01010750|19295059|P2|NOT COMPLETED|First Intervention||0
7839440|NCT01010750|19295060|P1|NOT COMPLETED|First Intervention||0
7839441|NCT01010750|19295055|P6|COMPLETED|First Intervention||3
7839442|NCT01010750|19295056|P5|COMPLETED|First Intervention||2
7839443|NCT01010750|19295057|P4|COMPLETED|First Intervention||3
7839444|NCT01010750|19295058|P3|COMPLETED|First Intervention||3
7839445|NCT01010750|19295059|P2|COMPLETED|First Intervention||4
7839446|NCT01010750|19295060|P1|COMPLETED|First Intervention||3
7839447|NCT01010750|19295055|P6|STARTED|First Intervention||3
7839448|NCT01010750|19295056|P5|STARTED|First Intervention||2
7839449|NCT01010750|19295057|P4|STARTED|First Intervention||3
7839450|NCT01010750|19295058|P3|STARTED|First Intervention||3
7839451|NCT01010750|19295059|P2|STARTED|First Intervention||4
7839452|NCT01010750|19295060|P1|STARTED|First Intervention||3
7839453|NCT01010633|19295085|P2|NOT COMPLETED|Overall Study||5
7839454|NCT01010633|19295086|P1|NOT COMPLETED|Overall Study||4
7839455|NCT01010633|19295085|P2|COMPLETED|Overall Study||198
7839456|NCT01010633|19295086|P1|COMPLETED|Overall Study||199
7839457|NCT01010633|19295085|P2|STARTED|Overall Study||203
7839458|NCT01010633|19295086|P1|STARTED|Overall Study||203
7839459|NCT01010568|19295096|P1|NOT COMPLETED|Overall Study||5
7839460|NCT01010568|19295096|P1|COMPLETED|Overall Study||5
7839461|NCT01010568|19295096|P1|STARTED|Overall Study||10
7839462|NCT01010555|19295102|P2|NOT COMPLETED|Second Four Weeks of Wear||0
7839463|NCT01010555|19295103|P1|NOT COMPLETED|Second Four Weeks of Wear||0
7839464|NCT01010555|19295102|P2|COMPLETED|Second Four Weeks of Wear||9
7839465|NCT01010555|19295103|P1|COMPLETED|Second Four Weeks of Wear||10
7839466|NCT01010555|19295102|P2|STARTED|Second Four Weeks of Wear||9
7839467|NCT01010555|19295103|P1|STARTED|Second Four Weeks of Wear||10
7839468|NCT01010555|19295102|P2|NOT COMPLETED|First Four Weeks of Wear||0
7839469|NCT01010555|19295103|P1|NOT COMPLETED|First Four Weeks of Wear||0
7839470|NCT01010555|19295102|P2|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10
7839471|NCT01010555|19295103|P1|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11
7839472|NCT01010555|19295102|P2|STARTED|First Four Weeks of Wear||10
7839473|NCT01010555|19295103|P1|STARTED|First Four Weeks of Wear||11
7839474|NCT01010503|19295113|P1|NOT COMPLETED|Overall Study||2
7839475|NCT01010503|19295113|P1|COMPLETED|Overall Study||30
7839476|NCT01010503|19295113|P1|STARTED|Overall Study||32
7839477|NCT01010477|19295133|P2|NOT COMPLETED|Overall Study||3
7839478|NCT01010477|19295134|P1|NOT COMPLETED|Overall Study||6
7839479|NCT01010477|19295133|P2|COMPLETED|Overall Study||22
7839480|NCT01010477|19295134|P1|COMPLETED|Overall Study||21
7839481|NCT01010477|19295133|P2|STARTED|Overall Study||25
7839482|NCT01010477|19295134|P1|STARTED|Overall Study||27
7839483|NCT01010399|19295140|P1|NOT COMPLETED|Overall Study||5
7839484|NCT01010399|19295140|P1|COMPLETED|Overall Study||31
7839485|NCT01010399|19295140|P1|STARTED|Overall Study||36
7839486|NCT01010282|19295148|P3|NOT COMPLETED|Overall Study||19
7839487|NCT01010282|19295149|P2|NOT COMPLETED|Overall Study||7
7839488|NCT01010282|19295150|P1|NOT COMPLETED|Overall Study||6
7839489|NCT01010282|19295148|P3|COMPLETED|Overall Study||77
7839490|NCT01010282|19295149|P2|COMPLETED|Overall Study||88
7839491|NCT01010282|19295150|P1|COMPLETED|Overall Study||91
7839492|NCT01010282|19295148|P3|STARTED|Overall Study||96
7839493|NCT01010282|19295149|P2|STARTED|Overall Study||95
7839494|NCT01010282|19295150|P1|STARTED|Overall Study||97
7839495|NCT01010230|19295172|P2|NOT COMPLETED|Overall Study||7
7839496|NCT01010230|19295173|P1|NOT COMPLETED|Overall Study||10
7839497|NCT01010230|19295172|P2|COMPLETED|Overall Study||26
7839498|NCT01010230|19295173|P1|COMPLETED|Overall Study||22
7839499|NCT01010230|19295172|P2|STARTED|Overall Study||33
7839500|NCT01010230|19295173|P1|STARTED|Overall Study||32
7839501|NCT01010217|19295208|P5|NOT COMPLETED|Overall Study||3
7839502|NCT01010217|19295209|P4|NOT COMPLETED|Overall Study||6
7839503|NCT01010217|19295210|P3|NOT COMPLETED|Overall Study||1
7839504|NCT01010217|19295211|P2|NOT COMPLETED|Overall Study||5
7839505|NCT01010217|19295212|P1|NOT COMPLETED|Overall Study||5
7839506|NCT01010217|19295208|P5|COMPLETED|Overall Study||0
7839507|NCT01010217|19295209|P4|COMPLETED|Overall Study||0
7839508|NCT01010217|19295210|P3|COMPLETED|Overall Study||21
7839509|NCT01010217|19295211|P2|COMPLETED|Overall Study||51
7839510|NCT01010217|19295212|P1|COMPLETED|Overall Study||84
7839511|NCT01010217|19295208|P5|STARTED|Overall Study||3
7839512|NCT01010217|19295209|P4|STARTED|Overall Study||6
7839513|NCT01010217|19295210|P3|STARTED|Overall Study||22
7839514|NCT01010217|19295211|P2|STARTED|Overall Study||56
7839515|NCT01010217|19295212|P1|STARTED|Overall Study||89
7839516|NCT01010204|19295251|P2|NOT COMPLETED|Overall Study||9
7839517|NCT01010204|19295252|P1|NOT COMPLETED|Overall Study||7
7839518|NCT01010204|19295251|P2|COMPLETED|Overall Study||20
7839519|NCT01010204|19295252|P1|COMPLETED|Overall Study||24
7839520|NCT01010204|19295251|P2|STARTED|Overall Study||29
7839521|NCT01010204|19295252|P1|STARTED|Overall Study||31
7839522|NCT01010126|19295268|P6|NOT COMPLETED|Overall Study||0
7839523|NCT01010126|19295269|P5|NOT COMPLETED|Overall Study||3
7839524|NCT01010126|19295270|P4|NOT COMPLETED|Overall Study||0
7839525|NCT01010126|19295271|P3|NOT COMPLETED|Overall Study||1
7839526|NCT01010126|19295272|P2|NOT COMPLETED|Overall Study||0
7839527|NCT01010126|19295273|P1|NOT COMPLETED|Overall Study||1
7839528|NCT01010126|19295268|P6|COMPLETED|Overall Study||24
7839529|NCT01010126|19295269|P5|COMPLETED|Overall Study||55
7839530|NCT01010126|19295270|P4|COMPLETED|Overall Study||57
7839531|NCT01010126|19295271|P3|COMPLETED|Overall Study||27
7839532|NCT01010126|19295272|P2|COMPLETED|Overall Study||58
7839533|NCT01010126|19295273|P1|COMPLETED|Overall Study||26
7839534|NCT01010126|19295268|P6|STARTED|Overall Study||24
7839535|NCT01010126|19295269|P5|STARTED|Overall Study||58
7839536|NCT01010126|19295270|P4|STARTED|Overall Study||57
7839537|NCT01010126|19295271|P3|STARTED|Overall Study||28
7839538|NCT01010126|19295272|P2|STARTED|Overall Study||58
7839539|NCT01010126|19295273|P1|STARTED|Overall Study||27
7839540|NCT01010061|19295325|P2|NOT COMPLETED|Overall Study||40
7839541|NCT01010061|19295326|P1|NOT COMPLETED|Overall Study||48
7839542|NCT01010061|19295325|P2|COMPLETED|Overall Study||78
7839543|NCT01010061|19295326|P1|COMPLETED|Overall Study|Completed=Completed treatment.|190
7839544|NCT01010061|19295325|P2|Received Study Drug|Overall Study||116
7839545|NCT01010061|19295326|P1|Received Study Drug|Overall Study||236
7839546|NCT01010061|19295325|P2|STARTED|Overall Study||118
7839547|NCT01010061|19295326|P1|STARTED|Overall Study||238
7839548|NCT01010009|19295361|P3|NOT COMPLETED|Overall Study||0
7839549|NCT01010009|19295362|P2|NOT COMPLETED|Overall Study||0
7839550|NCT01010009|19295363|P1|NOT COMPLETED|Overall Study||0
7839551|NCT01010009|19295361|P3|COMPLETED|Overall Study||8
7839552|NCT01010009|19295362|P2|COMPLETED|Overall Study||8
7839553|NCT01010009|19295363|P1|COMPLETED|Overall Study||8
7839554|NCT01010009|19295361|P3|STARTED|Overall Study||8
7839555|NCT01010009|19295362|P2|STARTED|Overall Study||8
7839556|NCT01010009|19295363|P1|STARTED|Overall Study||8
7839557|NCT01009983|19295377|P1|NOT COMPLETED|Overall Study||1
7839558|NCT01009983|19295377|P1|COMPLETED|Overall Study||13
7839559|NCT01009983|19295377|P1|STARTED|Overall Study||14
7839560|NCT01009931|19295384|P1|NOT COMPLETED|Overall Study||1
7839561|NCT01009931|19295384|P1|COMPLETED|Overall Study||0
7839562|NCT01009931|19295384|P1|STARTED|Overall Study||1
7839563|NCT01009840|19295390|P1|NOT COMPLETED|Overall Study||14
7839564|NCT01009840|19295390|P1|COMPLETED|Overall Study||16
7839565|NCT01009840|19295390|P1|STARTED|Overall Study||30
7839566|NCT01009814|19295408|P5|NOT COMPLETED|Overall Study||0
7839567|NCT01009814|19295409|P4|NOT COMPLETED|Overall Study||0
7839568|NCT01009814|19295410|P3|NOT COMPLETED|Overall Study||0
7839569|NCT01009814|19295411|P2|NOT COMPLETED|Overall Study||1
7839570|NCT01009814|19295412|P1|NOT COMPLETED|Overall Study||1
7839571|NCT01009814|19295408|P5|COMPLETED|Overall Study||10
7839572|NCT01009814|19295409|P4|COMPLETED|Overall Study||10
7839573|NCT01009814|19295410|P3|COMPLETED|Overall Study||10
7839574|NCT01009814|19295411|P2|COMPLETED|Overall Study||9
7839575|NCT01009814|19295412|P1|COMPLETED|Overall Study||9
7839576|NCT01009814|19295408|P5|STARTED|Overall Study||10
7839577|NCT01009814|19295409|P4|STARTED|Overall Study||10
7839578|NCT01009814|19295410|P3|STARTED|Overall Study||10
7839579|NCT01009814|19295411|P2|STARTED|Overall Study||10
7839580|NCT01009814|19295412|P1|STARTED|Overall Study||10
7839581|NCT01009762|19295521|P2|NOT COMPLETED|Overall Study||0
7839582|NCT01009762|19295522|P1|NOT COMPLETED|Overall Study||0
7839583|NCT01009762|19295521|P2|COMPLETED|Overall Study|10 participants received vaccine|10
7839584|NCT01009762|19295522|P1|COMPLETED|Overall Study|according to randomization this one participant received placebo|1
7839585|NCT01009762|19295521|P2|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0
7839586|NCT01009762|19295522|P1|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0
7839587|NCT01009762|19295521|P2|STARTED|Overall Study||10
7839588|NCT01009762|19295522|P1|STARTED|Overall Study||1
7839589|NCT01009645|19295536|P4|NOT COMPLETED|Overall Study||5
7839590|NCT01009645|19295537|P3|NOT COMPLETED|Overall Study||4
7839591|NCT01009645|19295538|P2|NOT COMPLETED|Overall Study||8
7839592|NCT01009645|19295539|P1|NOT COMPLETED|Overall Study||2
7839593|NCT01009645|19295536|P4|COMPLETED|Overall Study||26
7839594|NCT01009645|19295537|P3|COMPLETED|Overall Study||28
7839595|NCT01009645|19295538|P2|COMPLETED|Overall Study||23
7839596|NCT01009645|19295539|P1|COMPLETED|Overall Study||29
7839597|NCT01009645|19295536|P4|STARTED|Overall Study||31
7839598|NCT01009645|19295537|P3|STARTED|Overall Study||32
7839599|NCT01009645|19295538|P2|STARTED|Overall Study||31
7839600|NCT01009645|19295539|P1|STARTED|Overall Study||31
7839601|NCT01009619|19295555|P2|NOT COMPLETED|Overall Study||0
7839602|NCT01009619|19295556|P1|NOT COMPLETED|Overall Study||0
7839603|NCT01009619|19295555|P2|COMPLETED|Overall Study||43
7839604|NCT01009619|19295556|P1|COMPLETED|Overall Study||40
7839605|NCT01009619|19295555|P2|STARTED|Overall Study||43
7839606|NCT01009619|19295556|P1|STARTED|Overall Study||40
7839607|NCT01009580|19295576|P2|NOT COMPLETED|Overall Study||35
7839608|NCT01009580|19295577|P1|NOT COMPLETED|Overall Study||27
7839609|NCT01009580|19295576|P2|COMPLETED|Overall Study||188
7839610|NCT01009580|19295577|P1|COMPLETED|Overall Study||197
7839611|NCT01009580|19295576|P2|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222
7839612|NCT01009580|19295577|P1|Exposed|Overall Study||224
7839613|NCT01009580|19295576|P2|STARTED|Overall Study||223
7839614|NCT01009580|19295577|P1|STARTED|Overall Study||224
7839615|NCT01009554|19295591|P2|NOT COMPLETED|Overall Study||7
7839616|NCT01009554|19295592|P1|NOT COMPLETED|Overall Study||2
7839617|NCT01009554|19295591|P2|COMPLETED|Overall Study||41
7839618|NCT01009554|19295592|P1|COMPLETED|Overall Study||46
7839619|NCT01009554|19295591|P2|STARTED|Overall Study||48
7839620|NCT01009554|19295592|P1|STARTED|Overall Study||48
7839621|NCT01009515|19295724|P1|NOT COMPLETED|Overall Study||3
7839622|NCT01009515|19295724|P1|COMPLETED|Overall Study||16
7839623|NCT01009515|19295724|P1|STARTED|Overall Study||19
7839624|NCT01009463|19295735|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||101
7839625|NCT01009463|19295736|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||91
7839626|NCT01009463|19295737|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||93
7839627|NCT01009463|19295738|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||115
7839628|NCT01009463|19295739|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
7839629|NCT01009463|19295735|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301
7839630|NCT01009463|19295736|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312
7839631|NCT01009463|19295737|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315
7839632|NCT01009463|19295738|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294
7839633|NCT01009463|19295739|P1|COMPLETED|52-week, Double-blind Treatment Period||0
7839634|NCT01009463|19295735|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303
7839635|NCT01009463|19295736|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314
7839636|NCT01009463|19295737|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318
7839637|NCT01009463|19295738|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295
7839638|NCT01009463|19295739|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
7839639|NCT01009463|19295735|P5|STARTED|52-week, Double-blind Treatment Period||402
7839640|NCT01009463|19295736|P4|STARTED|52-week, Double-blind Treatment Period||403
7839641|NCT01009463|19295737|P3|STARTED|52-week, Double-blind Treatment Period||408
7839642|NCT01009463|19295738|P2|STARTED|52-week, Double-blind Treatment Period||409
7839643|NCT01009463|19295739|P1|STARTED|52-week, Double-blind Treatment Period||0
7839644|NCT01009463|19295735|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
7839645|NCT01009463|19295736|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
7839646|NCT01009463|19295737|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
7839647|NCT01009463|19295738|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
7839648|NCT01009463|19295739|P1|NOT COMPLETED|4-week, Open-label Run-In Period||449
7839649|NCT01009463|19295735|P5|COMPLETED|4-week, Open-label Run-In Period||0
7839650|NCT01009463|19295736|P4|COMPLETED|4-week, Open-label Run-In Period||0
7839651|NCT01009463|19295737|P3|COMPLETED|4-week, Open-label Run-In Period||0
7839652|NCT01009463|19295738|P2|COMPLETED|4-week, Open-label Run-In Period||0
7839653|NCT01009463|19295739|P1|COMPLETED|4-week, Open-label Run-In Period||1622
7839654|NCT01009463|19295735|P5|STARTED|4-week, Open-label Run-In Period||0
7839655|NCT01009463|19295736|P4|STARTED|4-week, Open-label Run-In Period||0
7839656|NCT01009463|19295737|P3|STARTED|4-week, Open-label Run-In Period||0
7839657|NCT01009463|19295738|P2|STARTED|4-week, Open-label Run-In Period||0
7839658|NCT01009463|19295739|P1|STARTED|4-week, Open-label Run-In Period||2071
7839659|NCT01009346|19295761|P1|NOT COMPLETED|Overall Study||4
7839660|NCT01009346|19295761|P1|COMPLETED|Overall Study||5
7839661|NCT01009346|19295761|P1|STARTED|Overall Study||9
7839662|NCT01009333|19295766|P6|NOT COMPLETED|Week 3||0
7839663|NCT01009333|19295767|P5|NOT COMPLETED|Week 3||0
7839664|NCT01009333|19295768|P4|NOT COMPLETED|Week 3||0
7839665|NCT01009333|19295769|P3|NOT COMPLETED|Week 3||0
7839666|NCT01009333|19295770|P2|NOT COMPLETED|Week 3||0
7839667|NCT01009333|19295771|P1|NOT COMPLETED|Week 3||0
7839668|NCT01009333|19295766|P6|COMPLETED|Week 3||2
7839669|NCT01009333|19295767|P5|COMPLETED|Week 3||2
7839670|NCT01009333|19295768|P4|COMPLETED|Week 3||2
7839671|NCT01009333|19295769|P3|COMPLETED|Week 3||2
7839672|NCT01009333|19295770|P2|COMPLETED|Week 3||2
7839673|NCT01009333|19295771|P1|COMPLETED|Week 3||2
7839674|NCT01009333|19295766|P6|STARTED|Week 3||2
7839675|NCT01009333|19295767|P5|STARTED|Week 3||2
7839676|NCT01009333|19295768|P4|STARTED|Week 3||2
7839677|NCT01009333|19295769|P3|STARTED|Week 3||2
7839678|NCT01009333|19295770|P2|STARTED|Week 3||2
7839679|NCT01009333|19295771|P1|STARTED|Week 3||2
7839680|NCT01009333|19295766|P6|NOT COMPLETED|Week 2||0
7839681|NCT01009333|19295767|P5|NOT COMPLETED|Week 2||0
7839682|NCT01009333|19295768|P4|NOT COMPLETED|Week 2||0
7839683|NCT01009333|19295769|P3|NOT COMPLETED|Week 2||0
7839684|NCT01009333|19295770|P2|NOT COMPLETED|Week 2||0
7839685|NCT01009333|19295771|P1|NOT COMPLETED|Week 2||0
7839686|NCT01009333|19295766|P6|COMPLETED|Week 2||2
7839687|NCT01009333|19295767|P5|COMPLETED|Week 2||2
7839688|NCT01009333|19295768|P4|COMPLETED|Week 2||2
7839689|NCT01009333|19295769|P3|COMPLETED|Week 2||2
7839690|NCT01009333|19295770|P2|COMPLETED|Week 2||2
7839691|NCT01009333|19295771|P1|COMPLETED|Week 2||2
7839692|NCT01009333|19295766|P6|STARTED|Week 2||2
7839693|NCT01009333|19295767|P5|STARTED|Week 2||2
7839694|NCT01009333|19295768|P4|STARTED|Week 2||2
7839695|NCT01009333|19295769|P3|STARTED|Week 2||2
7839696|NCT01009333|19295770|P2|STARTED|Week 2||2
7839697|NCT01009333|19295771|P1|STARTED|Week 2||2
7839698|NCT01009333|19295766|P6|NOT COMPLETED|Week 1||0
7839699|NCT01009333|19295767|P5|NOT COMPLETED|Week 1||0
7839700|NCT01009333|19295768|P4|NOT COMPLETED|Week 1||0
7839701|NCT01009333|19295769|P3|NOT COMPLETED|Week 1||0
7839702|NCT01009333|19295770|P2|NOT COMPLETED|Week 1||0
7839703|NCT01009333|19295771|P1|NOT COMPLETED|Week 1||0
7839704|NCT01009333|19295766|P6|COMPLETED|Week 1||2
7839705|NCT01009333|19295767|P5|COMPLETED|Week 1||2
7839706|NCT01009333|19295768|P4|COMPLETED|Week 1||2
7839707|NCT01009333|19295769|P3|COMPLETED|Week 1||2
7839708|NCT01009333|19295770|P2|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3
7839709|NCT01009333|19295771|P1|COMPLETED|Week 1||2
7839710|NCT01009333|19295766|P6|STARTED|Week 1||2
7839711|NCT01009333|19295767|P5|STARTED|Week 1||2
7839712|NCT01009333|19295768|P4|STARTED|Week 1||2
7839713|NCT01009333|19295769|P3|STARTED|Week 1||2
7839714|NCT01009333|19295770|P2|STARTED|Week 1||3
7839715|NCT01009333|19295771|P1|STARTED|Week 1||2
7839716|NCT01009294|19295785|P1|NOT COMPLETED|Overall Study||6
7839717|NCT01009294|19295785|P1|COMPLETED|Overall Study||0
7839718|NCT01009294|19295785|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
7839719|NCT01009294|19295785|P1|STARTED|Overall Study||6
7839720|NCT01009203|19295806|P1|NOT COMPLETED|Overall Study||7
7839721|NCT01009203|19295806|P1|COMPLETED|Overall Study||6
7839722|NCT01009203|19295806|P1|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12
7839723|NCT01009203|19295806|P1|STARTED|Overall Study||13
7839724|NCT01009138|19295815|P2|NOT COMPLETED|Overall Study||20
7839725|NCT01009138|19295816|P1|NOT COMPLETED|Overall Study||13
7839726|NCT01009138|19295815|P2|COMPLETED|Overall Study||88
7839727|NCT01009138|19295816|P1|COMPLETED|Overall Study||93
7839728|NCT01009138|19295815|P2|STARTED|Overall Study||108
7839729|NCT01009138|19295816|P1|STARTED|Overall Study||106
7839730|NCT01009099|19295846|P2|NOT COMPLETED|Overall Study||4
7839731|NCT01009099|19295847|P1|NOT COMPLETED|Overall Study||5
7839732|NCT01009099|19295846|P2|COMPLETED|Overall Study||57
7839733|NCT01009099|19295847|P1|COMPLETED|Overall Study||53
7839734|NCT01009099|19295846|P2|STARTED|Overall Study||61
7839735|NCT01009099|19295847|P1|STARTED|Overall Study||58
7839736|NCT01009086|19295856|P3|NOT COMPLETED|Overall Study||34
7839737|NCT01009086|19295857|P2|NOT COMPLETED|Overall Study||47
7839738|NCT01009086|19295858|P1|NOT COMPLETED|Overall Study||44
7839739|NCT01009086|19295856|P3|COMPLETED|Overall Study||170
7839740|NCT01009086|19295857|P2|COMPLETED|Overall Study||158
7839741|NCT01009086|19295858|P1|COMPLETED|Overall Study||162
7839742|NCT01009086|19295856|P3|STARTED|Overall Study||204
7839743|NCT01009086|19295857|P2|STARTED|Overall Study||205
7839744|NCT01009086|19295858|P1|STARTED|Overall Study||206
7839745|NCT01009060|19295893|P2|NOT COMPLETED|Overall Study||5
7839746|NCT01009060|19295894|P1|NOT COMPLETED|Overall Study||4
7839747|NCT01009060|19295893|P2|COMPLETED|Overall Study||20
7839748|NCT01009060|19295894|P1|COMPLETED|Overall Study||21
7839749|NCT01009060|19295893|P2|STARTED|Overall Study||25
7839750|NCT01009060|19295894|P1|STARTED|Overall Study||25
7839751|NCT01009047|19295932|P2|NOT COMPLETED|Overall Study||26
7839752|NCT01009047|19295933|P1|NOT COMPLETED|Overall Study||28
7839753|NCT01009047|19295932|P2|COMPLETED|Overall Study||89
7839754|NCT01009047|19295933|P1|COMPLETED|Overall Study||85
7839755|NCT01009047|19295932|P2|STARTED|Overall Study||115
7839756|NCT01009047|19295933|P1|STARTED|Overall Study||113
7839757|NCT01009034|19295955|P1|NOT COMPLETED|Overall Study||4
7839758|NCT01009034|19295955|P1|COMPLETED|Overall Study||10
7839759|NCT01009034|19295955|P1|STARTED|Overall Study||14
7839760|NCT01008995|19295963|P4|NOT COMPLETED|After Controlled Period||1
7839761|NCT01008995|19295964|P3|NOT COMPLETED|After Controlled Period||2
7839762|NCT01008995|19295965|P2|NOT COMPLETED|After Controlled Period||0
7839763|NCT01008995|19295966|P1|NOT COMPLETED|After Controlled Period||0
7839764|NCT01008995|19295963|P4|COMPLETED|After Controlled Period||156
7839765|NCT01008995|19295964|P3|COMPLETED|After Controlled Period||156
7839766|NCT01008995|19295965|P2|COMPLETED|After Controlled Period||0
7839767|NCT01008995|19295966|P1|COMPLETED|After Controlled Period||0
7839768|NCT01008995|19295963|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157
7839769|NCT01008995|19295964|P3|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158
7839770|NCT01008995|19295965|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
7839771|NCT01008995|19295966|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
7839772|NCT01008995|19295963|P4|NOT COMPLETED|Controlled Period||0
7839773|NCT01008995|19295964|P3|NOT COMPLETED|Controlled Period||0
7839774|NCT01008995|19295965|P2|NOT COMPLETED|Controlled Period||3
7839775|NCT01008995|19295966|P1|NOT COMPLETED|Controlled Period||3
7839776|NCT01008995|19295963|P4|COMPLETED|Controlled Period||0
7839777|NCT01008995|19295964|P3|COMPLETED|Controlled Period||0
7839778|NCT01008995|19295965|P2|COMPLETED|Controlled Period||157
7839779|NCT01008995|19295966|P1|COMPLETED|Controlled Period||159
7839780|NCT01008995|19295963|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
7839781|NCT01008995|19295964|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
7839782|NCT01008995|19295965|P2|STARTED|Controlled Period||160
7839783|NCT01008995|19295966|P1|STARTED|Controlled Period||162
7839784|NCT01008969|19295978|P1|NOT COMPLETED|Overall Study||0
7839785|NCT01008969|19295978|P1|COMPLETED|Overall Study||10
7839786|NCT01008969|19295978|P1|STARTED|Overall Study||10
7839787|NCT01008943|19295983|P1|NOT COMPLETED|Overall Study||1
7839788|NCT01008943|19295983|P1|COMPLETED|Overall Study||15
7839789|NCT01008943|19295983|P1|STARTED|Overall Study||16
7839790|NCT01008904|19295990|P1|NOT COMPLETED|Overall Study||4
7839791|NCT01008904|19295990|P1|COMPLETED|Overall Study||25
7839792|NCT01008904|19295990|P1|STARTED|Overall Study||29
7839793|NCT01008748|19295995|P1|NOT COMPLETED|Overall Study||81
7839794|NCT01008748|19295995|P1|COMPLETED|Overall Study||119
7839795|NCT01008748|19295995|P1|Week 26|Overall Study||119
7839796|NCT01008748|19295995|P1|Week 3|Overall Study||168
7839797|NCT01008748|19295995|P1|Week 0|Overall Study||182
7839798|NCT01008748|19295995|P1|Baseline|Overall Study||188
7839799|NCT01008748|19295995|P1|STARTED|Overall Study||200
7839800|NCT01008722|19296009|P2|NOT COMPLETED|Overall Study||0
7839801|NCT01008722|19296010|P1|NOT COMPLETED|Overall Study||0
7839802|NCT01008722|19296009|P2|COMPLETED|Overall Study||71
7839803|NCT01008722|19296010|P1|COMPLETED|Overall Study||36
7839804|NCT01008722|19296009|P2|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71
7839805|NCT01008722|19296010|P1|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36
7839806|NCT01008696|19296020|P2|NOT COMPLETED|Overall Study||17
7839807|NCT01008696|19296021|P1|NOT COMPLETED|Overall Study||17
7839808|NCT01008696|19296020|P2|COMPLETED|Overall Study||92
7839809|NCT01008696|19296021|P1|COMPLETED|Overall Study||91
7839810|NCT01008696|19296020|P2|STARTED|Overall Study||109
7839811|NCT01008696|19296021|P1|STARTED|Overall Study||108
7839812|NCT01008618|19296031|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||38
7839813|NCT01008618|19296032|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||36
7839814|NCT01008618|19296033|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
7839815|NCT01008618|19296031|P3|COMPLETED|Period 2 (Double-Blind Period)||39
7839816|NCT01008618|19296032|P2|COMPLETED|Period 2 (Double-Blind Period)||37
7839817|NCT01008618|19296033|P1|COMPLETED|Period 2 (Double-Blind Period)||0
7839818|NCT01008618|19296031|P3|STARTED|Period 2 (Double-Blind Period)||77
7839819|NCT01008618|19296032|P2|STARTED|Period 2 (Double-Blind Period)||73
7839820|NCT01008618|19296033|P1|STARTED|Period 2 (Double-Blind Period)||0
7839821|NCT01008618|19296031|P3|NOT COMPLETED|Period 1 (Titration Period)||0
7839822|NCT01008618|19296032|P2|NOT COMPLETED|Period 1 (Titration Period)||0
7839823|NCT01008618|19296033|P1|NOT COMPLETED|Period 1 (Titration Period)||68
7839824|NCT01008618|19296031|P3|COMPLETED|Period 1 (Titration Period)||0
7839825|NCT01008618|19296032|P2|COMPLETED|Period 1 (Titration Period)||0
7839826|NCT01008618|19296033|P1|COMPLETED|Period 1 (Titration Period)||150
7839827|NCT01008618|19296031|P3|STARTED|Period 1 (Titration Period)||0
7839828|NCT01008618|19296032|P2|STARTED|Period 1 (Titration Period)||0
7839829|NCT01008618|19296033|P1|STARTED|Period 1 (Titration Period)||218
7839830|NCT01008605|19296058|P1|NOT COMPLETED|Overall Study||0
7839831|NCT01008605|19296058|P1|COMPLETED|Overall Study||48
7839832|NCT01008605|19296058|P1|STARTED|Overall Study||48
7839833|NCT01008553|19296082|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||51
7839834|NCT01008553|19296083|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||37
7839835|NCT01008553|19296084|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
7839836|NCT01008553|19296082|P3|COMPLETED|Period 2 (Double-Blind Period)||28
7839837|NCT01008553|19296083|P2|COMPLETED|Period 2 (Double-Blind Period)||47
7839838|NCT01008553|19296084|P1|COMPLETED|Period 2 (Double-Blind Period)||0
7839839|NCT01008553|19296082|P3|STARTED|Period 2 (Double-Blind Period)||79
7839840|NCT01008553|19296083|P2|STARTED|Period 2 (Double-Blind Period)||84
7839841|NCT01008553|19296084|P1|STARTED|Period 2 (Double-Blind Period)||0
7839842|NCT01008553|19296082|P3|NOT COMPLETED|Period 1 (Titration Period)||0
7839843|NCT01008553|19296083|P2|NOT COMPLETED|Period 1 (Titration Period)||0
7839844|NCT01008553|19296084|P1|NOT COMPLETED|Period 1 (Titration Period)||95
7839845|NCT01008553|19296082|P3|COMPLETED|Period 1 (Titration Period)||0
7839846|NCT01008553|19296083|P2|COMPLETED|Period 1 (Titration Period)||0
7839847|NCT01008553|19296084|P1|COMPLETED|Period 1 (Titration Period)||163
7839848|NCT01008553|19296082|P3|STARTED|Period 1 (Titration Period)||0
7839849|NCT01008553|19296083|P2|STARTED|Period 1 (Titration Period)||0
7839850|NCT01008553|19296084|P1|STARTED|Period 1 (Titration Period)||258
7839851|NCT01008475|19296116|P7|NOT COMPLETED|Overall Study||4
7839852|NCT01008475|19296117|P6|NOT COMPLETED|Overall Study||6
7839853|NCT01008475|19296118|P5|NOT COMPLETED|Overall Study||5
7839854|NCT01008475|19296119|P4|NOT COMPLETED|Overall Study||0
7839855|NCT01008475|19296120|P3|NOT COMPLETED|Overall Study||0
7839856|NCT01008475|19296121|P2|NOT COMPLETED|Overall Study||0
7839857|NCT01008475|19296122|P1|NOT COMPLETED|Overall Study||0
7839858|NCT01008475|19296116|P7|COMPLETED|Overall Study||67
7839859|NCT01008475|19296117|P6|COMPLETED|Overall Study||67
7839860|NCT01008475|19296118|P5|COMPLETED|Overall Study||67
7839861|NCT01008475|19296119|P4|COMPLETED|Overall Study||3
7839862|NCT01008475|19296120|P3|COMPLETED|Overall Study||7
7839863|NCT01008475|19296121|P2|COMPLETED|Overall Study||3
7839864|NCT01008475|19296122|P1|COMPLETED|Overall Study||3
7839865|NCT01008475|19296116|P7|Safety Analysis Set|Overall Study||69
7839866|NCT01008475|19296117|P6|Safety Analysis Set|Overall Study||72
7839867|NCT01008475|19296118|P5|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73
7839868|NCT01008475|19296119|P4|Safety Analysis Set|Overall Study||3
7839869|NCT01008475|19296120|P3|Safety Analysis Set|Overall Study||7
7839870|NCT01008475|19296121|P2|Safety Analysis Set|Overall Study||3
7839871|NCT01008475|19296122|P1|Safety Analysis Set|Overall Study||3
7839872|NCT01008475|19296116|P7|STARTED|Overall Study||71
7839873|NCT01008475|19296117|P6|STARTED|Overall Study||73
7839874|NCT01008475|19296118|P5|STARTED|Overall Study||72
7839875|NCT01008475|19296119|P4|STARTED|Overall Study||3
7839876|NCT01008475|19296120|P3|STARTED|Overall Study||7
7839877|NCT01008475|19296121|P2|STARTED|Overall Study||3
7839878|NCT01008475|19296122|P1|STARTED|Overall Study||3
7839879|NCT01008462|19296150|P1|NOT COMPLETED|Overall Study||0
7839880|NCT01008462|19296150|P1|COMPLETED|Overall Study||16
7839881|NCT01008462|19296150|P1|STARTED|Overall Study||16
7839882|NCT01008449|19296162|P2|NOT COMPLETED|Overall Study||19
7839883|NCT01008449|19296163|P1|NOT COMPLETED|Overall Study||29
7839884|NCT01008449|19296162|P2|COMPLETED|Overall Study||179
7839885|NCT01008449|19296163|P1|COMPLETED|Overall Study||171
7839886|NCT01008449|19296162|P2|STARTED|Overall Study||198
7839887|NCT01008449|19296163|P1|STARTED|Overall Study||200
7839888|NCT01008423|19296185|P2|NOT COMPLETED|Overall Study||22
7839889|NCT01008423|19296186|P1|NOT COMPLETED|Overall Study||19
7839890|NCT01008423|19296185|P2|COMPLETED|Overall Study||125
7839891|NCT01008423|19296186|P1|COMPLETED|Overall Study||115
7839892|NCT01008423|19296185|P2|Received at Least 1 Dose of Study Drug|Overall Study||147
7839893|NCT01008423|19296186|P1|Received at Least 1 Dose of Study Drug|Overall Study||134
7839894|NCT01008423|19296185|P2|STARTED|Overall Study||147
7839895|NCT01008423|19296186|P1|STARTED|Overall Study||134
7839896|NCT01008410|19296212|P2|NOT COMPLETED|Overall Study||16
7839897|NCT01008410|19296213|P1|NOT COMPLETED|Overall Study||25
7839898|NCT01008410|19296212|P2|COMPLETED|Overall Study||116
7839899|NCT01008410|19296213|P1|COMPLETED|Overall Study||108
7839900|NCT01008410|19296212|P2|Received at Least 1 Dose of Study Drug|Overall Study||132
7839901|NCT01008410|19296213|P1|Received at Least 1 Dose of Study Drug|Overall Study||133
7839902|NCT01008410|19296212|P2|STARTED|Overall Study||132
7839903|NCT01008410|19296213|P1|STARTED|Overall Study||133
7839904|NCT01008319|19296239|P2|NOT COMPLETED|Overall Study||0
7839905|NCT01008319|19296240|P1|NOT COMPLETED|Overall Study||0
7839906|NCT01008319|19296239|P2|COMPLETED|Overall Study||60
7839907|NCT01008319|19296240|P1|COMPLETED|Overall Study||60
7839908|NCT01008319|19296239|P2|STARTED|Overall Study||60
7839909|NCT01008319|19296240|P1|STARTED|Overall Study||60
7839910|NCT01008280|19296252|P2|NOT COMPLETED|Overall Study||19
7839911|NCT01008280|19296253|P1|NOT COMPLETED|Overall Study||21
7839912|NCT01008280|19296252|P2|COMPLETED|Overall Study||73
7839913|NCT01008280|19296253|P1|COMPLETED|Overall Study||67
7839914|NCT01008280|19296252|P2|STARTED|Overall Study||92
7839915|NCT01008280|19296253|P1|STARTED|Overall Study||88
7839916|NCT01008150|19296267|P4|NOT COMPLETED|Overall Study||0
7839917|NCT01008150|19296268|P3|NOT COMPLETED|Overall Study||1
7839918|NCT01008150|19296269|P2|NOT COMPLETED|Overall Study||1
7839919|NCT01008150|19296270|P1|NOT COMPLETED|Overall Study||1
7839920|NCT01008150|19296267|P4|COMPLETED|Overall Study||12
7839921|NCT01008150|19296268|P3|COMPLETED|Overall Study||42
7839922|NCT01008150|19296269|P2|COMPLETED|Overall Study||42
7839923|NCT01008150|19296270|P1|COMPLETED|Overall Study||42
7839924|NCT01008150|19296267|P4|STARTED|Overall Study||12
7839925|NCT01008150|19296268|P3|STARTED|Overall Study||43
7839926|NCT01008150|19296269|P2|STARTED|Overall Study||43
7839927|NCT01008150|19296270|P1|STARTED|Overall Study||43
7839928|NCT01008059|19296300|P8|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
7839929|NCT01008059|19296301|P7|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
7839930|NCT01008059|19296302|P6|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
7839931|NCT01008059|19296303|P5|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
7839932|NCT01008059|19296304|P4|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
7839933|NCT01008059|19296305|P3|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
7839934|NCT01008059|19296306|P2|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
7839935|NCT01008059|19296307|P1|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
7839936|NCT01008059|19296300|P8|COMPLETED|Ketoconazole Simultaneous Alfentanil||6
7839937|NCT01008059|19296301|P7|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
7839938|NCT01008059|19296302|P6|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
7839939|NCT01008059|19296303|P5|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
7839940|NCT01008059|19296304|P4|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
7839941|NCT01008059|19296305|P3|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
7839942|NCT01008059|19296306|P2|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
7839943|NCT01008059|19296307|P1|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
7839944|NCT01008059|19296300|P8|STARTED|Ketoconazole Simultaneous Alfentanil||6
7839945|NCT01008059|19296301|P7|STARTED|Ketoconazole Simultaneous Alfentanil||0
7839946|NCT01008059|19296302|P6|STARTED|Ketoconazole Simultaneous Alfentanil||0
7839947|NCT01008059|19296303|P5|STARTED|Ketoconazole Simultaneous Alfentanil||0
7839948|NCT01008059|19296304|P4|STARTED|Ketoconazole Simultaneous Alfentanil||0
7839949|NCT01008059|19296305|P3|STARTED|Ketoconazole Simultaneous Alfentanil||0
7839950|NCT01008059|19296306|P2|STARTED|Ketoconazole Simultaneous Alfentanil||0
7839951|NCT01008059|19296307|P1|STARTED|Ketoconazole Simultaneous Alfentanil||0
7839952|NCT01008059|19296300|P8|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
7839953|NCT01008059|19296301|P7|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
7839954|NCT01008059|19296302|P6|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
7839955|NCT01008059|19296303|P5|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
7839956|NCT01008059|19296304|P4|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
7839957|NCT01008059|19296305|P3|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
7839958|NCT01008059|19296306|P2|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
7839959|NCT01008059|19296307|P1|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
7839960|NCT01008059|19296300|P8|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
7839961|NCT01008059|19296301|P7|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||6
7839962|NCT01008059|19296302|P6|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
7839963|NCT01008059|19296303|P5|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
7839964|NCT01008059|19296304|P4|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
7839965|NCT01008059|19296305|P3|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
7839966|NCT01008059|19296306|P2|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
7839967|NCT01008059|19296307|P1|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
7839968|NCT01008059|19296300|P8|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
7839969|NCT01008059|19296301|P7|STARTED|Grapefruit Juice Simultaneous Alfentanil||6
7839970|NCT01008059|19296302|P6|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
7839971|NCT01008059|19296303|P5|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
7839972|NCT01008059|19296304|P4|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
7839973|NCT01008059|19296305|P3|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
7839974|NCT01008059|19296306|P2|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
7839975|NCT01008059|19296307|P1|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
7839976|NCT01008059|19296300|P8|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
7839977|NCT01008059|19296301|P7|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
7839978|NCT01008059|19296302|P6|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
7839979|NCT01008059|19296303|P5|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
7839980|NCT01008059|19296304|P4|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
7839981|NCT01008059|19296305|P3|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
7839982|NCT01008059|19296306|P2|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
7839983|NCT01008059|19296307|P1|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
7839984|NCT01008059|19296300|P8|COMPLETED|Rifampin Simultaneous Alfentanil||0
7839985|NCT01008059|19296301|P7|COMPLETED|Rifampin Simultaneous Alfentanil||0
7839986|NCT01008059|19296302|P6|COMPLETED|Rifampin Simultaneous Alfentanil||6
7839987|NCT01008059|19296303|P5|COMPLETED|Rifampin Simultaneous Alfentanil||0
7839988|NCT01008059|19296304|P4|COMPLETED|Rifampin Simultaneous Alfentanil||0
7839989|NCT01008059|19296305|P3|COMPLETED|Rifampin Simultaneous Alfentanil||0
7839990|NCT01008059|19296306|P2|COMPLETED|Rifampin Simultaneous Alfentanil||0
7839991|NCT01008059|19296307|P1|COMPLETED|Rifampin Simultaneous Alfentanil||0
7839992|NCT01008059|19296300|P8|STARTED|Rifampin Simultaneous Alfentanil||0
7839993|NCT01008059|19296301|P7|STARTED|Rifampin Simultaneous Alfentanil||0
7839994|NCT01008059|19296302|P6|STARTED|Rifampin Simultaneous Alfentanil||6
7839995|NCT01008059|19296303|P5|STARTED|Rifampin Simultaneous Alfentanil||0
7839996|NCT01008059|19296304|P4|STARTED|Rifampin Simultaneous Alfentanil||0
7839997|NCT01008059|19296305|P3|STARTED|Rifampin Simultaneous Alfentanil||0
7839998|NCT01008059|19296306|P2|STARTED|Rifampin Simultaneous Alfentanil||0
7839999|NCT01008059|19296307|P1|STARTED|Rifampin Simultaneous Alfentanil||0
7840000|NCT01008059|19296300|P8|NOT COMPLETED|Control Simultaneous Alfentanil||0
7840001|NCT01008059|19296301|P7|NOT COMPLETED|Control Simultaneous Alfentanil||0
7840002|NCT01008059|19296302|P6|NOT COMPLETED|Control Simultaneous Alfentanil||0
7840003|NCT01008059|19296303|P5|NOT COMPLETED|Control Simultaneous Alfentanil||0
7840004|NCT01008059|19296304|P4|NOT COMPLETED|Control Simultaneous Alfentanil||0
7840005|NCT01008059|19296305|P3|NOT COMPLETED|Control Simultaneous Alfentanil||0
7840006|NCT01008059|19296306|P2|NOT COMPLETED|Control Simultaneous Alfentanil||0
7840007|NCT01008059|19296307|P1|NOT COMPLETED|Control Simultaneous Alfentanil||0
7840008|NCT01008059|19296300|P8|COMPLETED|Control Simultaneous Alfentanil||0
7840009|NCT01008059|19296301|P7|COMPLETED|Control Simultaneous Alfentanil||0
7840010|NCT01008059|19296302|P6|COMPLETED|Control Simultaneous Alfentanil||0
7840011|NCT01008059|19296303|P5|COMPLETED|Control Simultaneous Alfentanil||6
7840012|NCT01008059|19296304|P4|COMPLETED|Control Simultaneous Alfentanil||0
7840013|NCT01008059|19296305|P3|COMPLETED|Control Simultaneous Alfentanil||0
7840014|NCT01008059|19296306|P2|COMPLETED|Control Simultaneous Alfentanil||0
7840015|NCT01008059|19296307|P1|COMPLETED|Control Simultaneous Alfentanil||0
7840016|NCT01008059|19296300|P8|STARTED|Control Simultaneous Alfentanil||0
7840017|NCT01008059|19296301|P7|STARTED|Control Simultaneous Alfentanil||0
7840018|NCT01008059|19296302|P6|STARTED|Control Simultaneous Alfentanil||0
7840019|NCT01008059|19296303|P5|STARTED|Control Simultaneous Alfentanil||6
7840020|NCT01008059|19296304|P4|STARTED|Control Simultaneous Alfentanil||0
7840021|NCT01008059|19296305|P3|STARTED|Control Simultaneous Alfentanil||0
7840022|NCT01008059|19296306|P2|STARTED|Control Simultaneous Alfentanil||0
7840023|NCT01008059|19296307|P1|STARTED|Control Simultaneous Alfentanil||0
7840024|NCT01008059|19296300|P8|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
7840025|NCT01008059|19296301|P7|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
7840026|NCT01008059|19296302|P6|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
7840027|NCT01008059|19296303|P5|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
7840028|NCT01008059|19296304|P4|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
7840029|NCT01008059|19296305|P3|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
7840030|NCT01008059|19296306|P2|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
7840031|NCT01008059|19296307|P1|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
7840032|NCT01008059|19296300|P8|COMPLETED|Ketoconazole Sequential Alfentanil||0
7840033|NCT01008059|19296301|P7|COMPLETED|Ketoconazole Sequential Alfentanil||0
7840034|NCT01008059|19296302|P6|COMPLETED|Ketoconazole Sequential Alfentanil||0
7840035|NCT01008059|19296303|P5|COMPLETED|Ketoconazole Sequential Alfentanil||0
7840036|NCT01008059|19296304|P4|COMPLETED|Ketoconazole Sequential Alfentanil||6
7840037|NCT01008059|19296305|P3|COMPLETED|Ketoconazole Sequential Alfentanil||0
7840038|NCT01008059|19296306|P2|COMPLETED|Ketoconazole Sequential Alfentanil||0
7840039|NCT01008059|19296307|P1|COMPLETED|Ketoconazole Sequential Alfentanil||0
7840040|NCT01008059|19296300|P8|STARTED|Ketoconazole Sequential Alfentanil||0
7840041|NCT01008059|19296301|P7|STARTED|Ketoconazole Sequential Alfentanil||0
7840042|NCT01008059|19296302|P6|STARTED|Ketoconazole Sequential Alfentanil||0
7840043|NCT01008059|19296303|P5|STARTED|Ketoconazole Sequential Alfentanil||0
7840044|NCT01008059|19296304|P4|STARTED|Ketoconazole Sequential Alfentanil||6
7840045|NCT01008059|19296305|P3|STARTED|Ketoconazole Sequential Alfentanil||0
7840046|NCT01008059|19296306|P2|STARTED|Ketoconazole Sequential Alfentanil||0
7840047|NCT01008059|19296307|P1|STARTED|Ketoconazole Sequential Alfentanil||0
7840048|NCT01008059|19296300|P8|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
7840049|NCT01008059|19296301|P7|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
7840050|NCT01008059|19296302|P6|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
7840051|NCT01008059|19296303|P5|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
7840052|NCT01008059|19296304|P4|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
7840053|NCT01008059|19296305|P3|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
7840054|NCT01008059|19296306|P2|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
7840055|NCT01008059|19296307|P1|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
7840056|NCT01008059|19296300|P8|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
7840057|NCT01008059|19296301|P7|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
7840058|NCT01008059|19296302|P6|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
7840059|NCT01008059|19296303|P5|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
7840060|NCT01008059|19296304|P4|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
7840061|NCT01008059|19296305|P3|COMPLETED|Grapefruit Juice Sequential Alfentanil||6
7840062|NCT01008059|19296306|P2|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
7840063|NCT01008059|19296307|P1|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
7840064|NCT01008059|19296300|P8|STARTED|Grapefruit Juice Sequential Alfentanil||0
7840065|NCT01008059|19296301|P7|STARTED|Grapefruit Juice Sequential Alfentanil||0
7840066|NCT01008059|19296302|P6|STARTED|Grapefruit Juice Sequential Alfentanil||0
7840067|NCT01008059|19296303|P5|STARTED|Grapefruit Juice Sequential Alfentanil||0
7840068|NCT01008059|19296304|P4|STARTED|Grapefruit Juice Sequential Alfentanil||0
7840069|NCT01008059|19296305|P3|STARTED|Grapefruit Juice Sequential Alfentanil||6
7840070|NCT01008059|19296306|P2|STARTED|Grapefruit Juice Sequential Alfentanil||0
7840071|NCT01008059|19296307|P1|STARTED|Grapefruit Juice Sequential Alfentanil||0
7840072|NCT01008059|19296300|P8|NOT COMPLETED|Rifampin Sequential Alfentanil||0
7840073|NCT01008059|19296301|P7|NOT COMPLETED|Rifampin Sequential Alfentanil||0
7840074|NCT01008059|19296302|P6|NOT COMPLETED|Rifampin Sequential Alfentanil||0
7840075|NCT01008059|19296303|P5|NOT COMPLETED|Rifampin Sequential Alfentanil||0
7840076|NCT01008059|19296304|P4|NOT COMPLETED|Rifampin Sequential Alfentanil||0
7840077|NCT01008059|19296305|P3|NOT COMPLETED|Rifampin Sequential Alfentanil||0
7840078|NCT01008059|19296306|P2|NOT COMPLETED|Rifampin Sequential Alfentanil||0
7840079|NCT01008059|19296307|P1|NOT COMPLETED|Rifampin Sequential Alfentanil||0
7840080|NCT01008059|19296300|P8|COMPLETED|Rifampin Sequential Alfentanil||0
7840081|NCT01008059|19296301|P7|COMPLETED|Rifampin Sequential Alfentanil||0
7840082|NCT01008059|19296302|P6|COMPLETED|Rifampin Sequential Alfentanil||0
7840083|NCT01008059|19296303|P5|COMPLETED|Rifampin Sequential Alfentanil||0
7840084|NCT01008059|19296304|P4|COMPLETED|Rifampin Sequential Alfentanil||0
7840085|NCT01008059|19296305|P3|COMPLETED|Rifampin Sequential Alfentanil||0
7840086|NCT01008059|19296306|P2|COMPLETED|Rifampin Sequential Alfentanil||6
7840087|NCT01008059|19296307|P1|COMPLETED|Rifampin Sequential Alfentanil||0
7840088|NCT01008059|19296300|P8|STARTED|Rifampin Sequential Alfentanil||0
7840089|NCT01008059|19296301|P7|STARTED|Rifampin Sequential Alfentanil||0
7840090|NCT01008059|19296302|P6|STARTED|Rifampin Sequential Alfentanil||0
7840091|NCT01008059|19296303|P5|STARTED|Rifampin Sequential Alfentanil||0
7840092|NCT01008059|19296304|P4|STARTED|Rifampin Sequential Alfentanil||0
7840093|NCT01008059|19296305|P3|STARTED|Rifampin Sequential Alfentanil||0
7840094|NCT01008059|19296306|P2|STARTED|Rifampin Sequential Alfentanil||6
7840095|NCT01008059|19296307|P1|STARTED|Rifampin Sequential Alfentanil||0
7840096|NCT01008059|19296300|P8|NOT COMPLETED|Control Sequential Alfentanil||0
7840097|NCT01008059|19296301|P7|NOT COMPLETED|Control Sequential Alfentanil||0
7840098|NCT01008059|19296302|P6|NOT COMPLETED|Control Sequential Alfentanil||0
7840099|NCT01008059|19296303|P5|NOT COMPLETED|Control Sequential Alfentanil||0
7840100|NCT01008059|19296304|P4|NOT COMPLETED|Control Sequential Alfentanil||0
7840101|NCT01008059|19296305|P3|NOT COMPLETED|Control Sequential Alfentanil||0
7840102|NCT01008059|19296306|P2|NOT COMPLETED|Control Sequential Alfentanil||0
7840103|NCT01008059|19296307|P1|NOT COMPLETED|Control Sequential Alfentanil||0
7840104|NCT01008059|19296300|P8|COMPLETED|Control Sequential Alfentanil||0
7840105|NCT01008059|19296301|P7|COMPLETED|Control Sequential Alfentanil||0
7840106|NCT01008059|19296302|P6|COMPLETED|Control Sequential Alfentanil||0
7840107|NCT01008059|19296303|P5|COMPLETED|Control Sequential Alfentanil||0
7840108|NCT01008059|19296304|P4|COMPLETED|Control Sequential Alfentanil||0
7840109|NCT01008059|19296305|P3|COMPLETED|Control Sequential Alfentanil||0
7840110|NCT01008059|19296306|P2|COMPLETED|Control Sequential Alfentanil||0
7840111|NCT01008059|19296307|P1|COMPLETED|Control Sequential Alfentanil||6
7840112|NCT01008059|19296300|P8|STARTED|Control Sequential Alfentanil||0
7840113|NCT01008059|19296301|P7|STARTED|Control Sequential Alfentanil||0
7840114|NCT01008059|19296302|P6|STARTED|Control Sequential Alfentanil||0
7840115|NCT01008059|19296303|P5|STARTED|Control Sequential Alfentanil||0
7840116|NCT01008059|19296304|P4|STARTED|Control Sequential Alfentanil||0
7840117|NCT01008059|19296305|P3|STARTED|Control Sequential Alfentanil||0
7840118|NCT01008059|19296306|P2|STARTED|Control Sequential Alfentanil||0
7840119|NCT01008059|19296307|P1|STARTED|Control Sequential Alfentanil||6
7840120|NCT01007916|19296318|P2|NOT COMPLETED|Period 2, 4 Weeks of Wear||0
7840121|NCT01007916|19296319|P1|NOT COMPLETED|Period 2, 4 Weeks of Wear||1
7840122|NCT01007916|19296318|P2|COMPLETED|Period 2, 4 Weeks of Wear||25
7840123|NCT01007916|19296319|P1|COMPLETED|Period 2, 4 Weeks of Wear||21
7840124|NCT01007916|19296318|P2|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25
7840125|NCT01007916|19296319|P1|STARTED|Period 2, 4 Weeks of Wear||22
7840126|NCT01007916|19296318|P2|NOT COMPLETED|Period 1, 4 Weeks of Wear||0
7840127|NCT01007916|19296319|P1|NOT COMPLETED|Period 1, 4 Weeks of Wear||1
7840128|NCT01007916|19296318|P2|COMPLETED|Period 1, 4 Weeks of Wear||26
7840129|NCT01007916|19296319|P1|COMPLETED|Period 1, 4 Weeks of Wear||22
7840130|NCT01007916|19296318|P2|STARTED|Period 1, 4 Weeks of Wear||26
7840131|NCT01007916|19296319|P1|STARTED|Period 1, 4 Weeks of Wear||23
7840132|NCT01007942|19296327|P2|NOT COMPLETED|Overall Study||278
7840133|NCT01007942|19296328|P1|NOT COMPLETED|Overall Study||281
7840134|NCT01007942|19296327|P2|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|7
7840135|NCT01007942|19296328|P1|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|3
7840136|NCT01007942|19296327|P2|STARTED|Overall Study||285
7840137|NCT01007942|19296328|P1|STARTED|Overall Study||284
7840138|NCT01007838|19296354|P4|NOT COMPLETED|Overall Study||0
7840139|NCT01007838|19296355|P3|NOT COMPLETED|Overall Study||0
7840140|NCT01007838|19296356|P2|NOT COMPLETED|Overall Study||0
7840141|NCT01007838|19296357|P1|NOT COMPLETED|Overall Study||3
7840142|NCT01007838|19296354|P4|COMPLETED|Overall Study||4
7840143|NCT01007838|19296355|P3|COMPLETED|Overall Study||5
7840144|NCT01007838|19296356|P2|COMPLETED|Overall Study||11
7840145|NCT01007838|19296357|P1|COMPLETED|Overall Study||9
7840146|NCT01007838|19296354|P4|STARTED|Overall Study||4
7840147|NCT01007838|19296355|P3|STARTED|Overall Study||5
7840148|NCT01007838|19296356|P2|STARTED|Overall Study||11
7840149|NCT01007838|19296357|P1|STARTED|Overall Study||12
7840150|NCT01007812|19296367|P2|NOT COMPLETED|Period 2, One Week||0
7840151|NCT01007812|19296368|P1|NOT COMPLETED|Period 2, One Week||0
7840152|NCT01007812|19296367|P2|COMPLETED|Period 2, One Week||24
7840153|NCT01007812|19296368|P1|COMPLETED|Period 2, One Week||24
7840154|NCT01007812|19296367|P2|STARTED|Period 2, One Week||24
7840155|NCT01007812|19296368|P1|STARTED|Period 2, One Week||24
7840156|NCT01007812|19296367|P2|NOT COMPLETED|Period 1, One Week||1
7840157|NCT01007812|19296368|P1|NOT COMPLETED|Period 1, One Week||1
7840158|NCT01007812|19296367|P2|COMPLETED|Period 1, One Week||24
7840159|NCT01007812|19296368|P1|COMPLETED|Period 1, One Week||24
7840160|NCT01007812|19296367|P2|STARTED|Period 1, One Week||25
7840161|NCT01007812|19296368|P1|STARTED|Period 1, One Week||25
7840162|NCT01007656|19296374|P1|NOT COMPLETED|Overall Study||0
7840163|NCT01007656|19296374|P1|COMPLETED|Overall Study||31
7840164|NCT01007656|19296374|P1|STARTED|Overall Study||31
7840165|NCT01007643|19296394|P2|NOT COMPLETED|Overall Study||0
7840166|NCT01007643|19296395|P1|NOT COMPLETED|Overall Study||0
7840167|NCT01007643|19296394|P2|COMPLETED|Overall Study||14
7840168|NCT01007643|19296395|P1|COMPLETED|Overall Study||8
7840169|NCT01007643|19296394|P2|STARTED|Overall Study||14
7840170|NCT01007643|19296395|P1|STARTED|Overall Study||8
7840171|NCT01007591|19296403|P2|NOT COMPLETED|Overall Study||1
7840172|NCT01007591|19296404|P1|NOT COMPLETED|Overall Study||1
7840173|NCT01007591|19296403|P2|COMPLETED|Overall Study||12
7840174|NCT01007591|19296404|P1|COMPLETED|Overall Study||26
7840175|NCT01007591|19296403|P2|STARTED|Overall Study||13
7840176|NCT01007591|19296404|P1|STARTED|Overall Study||27
7840177|NCT01007552|19296418|P1|NOT COMPLETED|Overall Study||1
7840178|NCT01007552|19296418|P1|COMPLETED|Overall Study||49
7840179|NCT01007552|19296418|P1|STARTED|Overall Study||50
7840180|NCT01007526|19296428|P1|NOT COMPLETED|Overall Study||0
7840181|NCT01007526|19296428|P1|COMPLETED|Overall Study||31
7840182|NCT01007526|19296428|P1|STARTED|Overall Study||31
7840183|NCT01007448|19296434|P2|NOT COMPLETED|Overall Study||9
7840184|NCT01007448|19296435|P1|NOT COMPLETED|Overall Study||10
7840185|NCT01007448|19296434|P2|COMPLETED|Overall Study||20
7840186|NCT01007448|19296435|P1|COMPLETED|Overall Study||20
7840187|NCT01007448|19296434|P2|Safety Population|Overall Study||29
7840188|NCT01007448|19296435|P1|Safety Population|Overall Study||30
7840189|NCT01007448|19296434|P2|Full Analysis Population|Overall Study||29
7840190|NCT01007448|19296435|P1|Full Analysis Population|Overall Study||30
7840191|NCT01007448|19296434|P2|STARTED|Overall Study||29
7840192|NCT01007448|19296435|P1|STARTED|Overall Study||30
7840193|NCT01007435|19296467|P4|NOT COMPLETED|Overall Study||56
7840194|NCT01007435|19296468|P3|NOT COMPLETED|Overall Study||64
7840195|NCT01007435|19296469|P2|NOT COMPLETED|Overall Study||59
7840196|NCT01007435|19296470|P1|NOT COMPLETED|Overall Study||63
7840197|NCT01007435|19296467|P4|COMPLETED|Overall Study||236
7840198|NCT01007435|19296468|P3|COMPLETED|Overall Study||227
7840199|NCT01007435|19296469|P2|COMPLETED|Overall Study||231
7840200|NCT01007435|19296470|P1|COMPLETED|Overall Study||226
7840201|NCT01007435|19296467|P4|STARTED|Overall Study||292
7840202|NCT01007435|19296468|P3|STARTED|Overall Study||291
7840203|NCT01007435|19296469|P2|STARTED|Overall Study||290
7840204|NCT01007435|19296470|P1|STARTED|Overall Study||289
7840205|NCT01007396|19296512|P1|NOT COMPLETED|Overall Study||47
7840206|NCT01007396|19296512|P1|COMPLETED|Overall Study||275
7840207|NCT01007396|19296512|P1|STARTED|Overall Study||322
7840208|NCT01007253|19296517|P4|NOT COMPLETED|Fourth Intervention||0
7840209|NCT01007253|19296518|P3|NOT COMPLETED|Fourth Intervention||0
7840210|NCT01007253|19296519|P2|NOT COMPLETED|Fourth Intervention||0
7840211|NCT01007253|19296520|P1|NOT COMPLETED|Fourth Intervention||0
7840212|NCT01007253|19296517|P4|COMPLETED|Fourth Intervention||5
7840213|NCT01007253|19296518|P3|COMPLETED|Fourth Intervention||5
7840214|NCT01007253|19296519|P2|COMPLETED|Fourth Intervention||5
7840215|NCT01007253|19296520|P1|COMPLETED|Fourth Intervention||5
7840216|NCT01007253|19296517|P4|STARTED|Fourth Intervention||5
7840217|NCT01007253|19296518|P3|STARTED|Fourth Intervention||5
7840218|NCT01007253|19296519|P2|STARTED|Fourth Intervention||5
7840219|NCT01007253|19296520|P1|STARTED|Fourth Intervention||5
7840220|NCT01007253|19296517|P4|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
7840221|NCT01007253|19296518|P3|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
7840222|NCT01007253|19296519|P2|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
7840223|NCT01007253|19296520|P1|NOT COMPLETED|Washout Period (2 Weeks) # 3||1
7840224|NCT01007253|19296517|P4|COMPLETED|Washout Period (2 Weeks) # 3||5
7840225|NCT01007253|19296518|P3|COMPLETED|Washout Period (2 Weeks) # 3||5
7840226|NCT01007253|19296519|P2|COMPLETED|Washout Period (2 Weeks) # 3||5
7840227|NCT01007253|19296520|P1|COMPLETED|Washout Period (2 Weeks) # 3||5
7840228|NCT01007253|19296517|P4|STARTED|Washout Period (2 Weeks) # 3||5
7840229|NCT01007253|19296518|P3|STARTED|Washout Period (2 Weeks) # 3||5
7840230|NCT01007253|19296519|P2|STARTED|Washout Period (2 Weeks) # 3||5
7840231|NCT01007253|19296520|P1|STARTED|Washout Period (2 Weeks) # 3||6
7840232|NCT01007253|19296517|P4|NOT COMPLETED|Third Intervention||0
7840233|NCT01007253|19296518|P3|NOT COMPLETED|Third Intervention||0
7840234|NCT01007253|19296519|P2|NOT COMPLETED|Third Intervention||0
7840235|NCT01007253|19296520|P1|NOT COMPLETED|Third Intervention||0
7840236|NCT01007253|19296517|P4|COMPLETED|Third Intervention||5
7840237|NCT01007253|19296518|P3|COMPLETED|Third Intervention||5
7840238|NCT01007253|19296519|P2|COMPLETED|Third Intervention||5
7840239|NCT01007253|19296520|P1|COMPLETED|Third Intervention||6
7840240|NCT01007253|19296517|P4|STARTED|Third Intervention||5
7840241|NCT01007253|19296518|P3|STARTED|Third Intervention||5
7840242|NCT01007253|19296519|P2|STARTED|Third Intervention||5
7840243|NCT01007253|19296520|P1|STARTED|Third Intervention||6
7840244|NCT01007253|19296517|P4|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
7840245|NCT01007253|19296518|P3|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
7840246|NCT01007253|19296519|P2|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
7840247|NCT01007253|19296520|P1|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
7840248|NCT01007253|19296517|P4|COMPLETED|Washout Period (2 Weeks) # 2||5
7840249|NCT01007253|19296518|P3|COMPLETED|Washout Period (2 Weeks) # 2||5
7840250|NCT01007253|19296519|P2|COMPLETED|Washout Period (2 Weeks) # 2||5
7840251|NCT01007253|19296520|P1|COMPLETED|Washout Period (2 Weeks) # 2||6
7840252|NCT01007253|19296517|P4|STARTED|Washout Period (2 Weeks) # 2||5
7840253|NCT01007253|19296518|P3|STARTED|Washout Period (2 Weeks) # 2||5
7840254|NCT01007253|19296519|P2|STARTED|Washout Period (2 Weeks) # 2||5
7840255|NCT01007253|19296520|P1|STARTED|Washout Period (2 Weeks) # 2||6
7840256|NCT01007253|19296517|P4|NOT COMPLETED|Second Intervention||0
7840257|NCT01007253|19296518|P3|NOT COMPLETED|Second Intervention||0
7840258|NCT01007253|19296519|P2|NOT COMPLETED|Second Intervention||0
7840259|NCT01007253|19296520|P1|NOT COMPLETED|Second Intervention||0
7840260|NCT01007253|19296517|P4|COMPLETED|Second Intervention||5
7840261|NCT01007253|19296518|P3|COMPLETED|Second Intervention||5
7840262|NCT01007253|19296519|P2|COMPLETED|Second Intervention||5
7840263|NCT01007253|19296520|P1|COMPLETED|Second Intervention||6
7840264|NCT01007253|19296517|P4|STARTED|Second Intervention||5
7840265|NCT01007253|19296518|P3|STARTED|Second Intervention||5
7840266|NCT01007253|19296519|P2|STARTED|Second Intervention||5
7840267|NCT01007253|19296520|P1|STARTED|Second Intervention||6
7840268|NCT01007253|19296517|P4|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
7840269|NCT01007253|19296518|P3|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
7840270|NCT01007253|19296519|P2|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
7840271|NCT01007253|19296520|P1|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
7840272|NCT01007253|19296517|P4|COMPLETED|Washout Period (2 Weeks) # 1||5
7840273|NCT01007253|19296518|P3|COMPLETED|Washout Period (2 Weeks) # 1||5
7840274|NCT01007253|19296519|P2|COMPLETED|Washout Period (2 Weeks) # 1||5
7840275|NCT01007253|19296520|P1|COMPLETED|Washout Period (2 Weeks) # 1||6
7840276|NCT01007253|19296517|P4|STARTED|Washout Period (2 Weeks) # 1||5
7840277|NCT01007253|19296518|P3|STARTED|Washout Period (2 Weeks) # 1||5
7840278|NCT01007253|19296519|P2|STARTED|Washout Period (2 Weeks) # 1||5
7840279|NCT01007253|19296520|P1|STARTED|Washout Period (2 Weeks) # 1||6
7840280|NCT01007253|19296517|P4|NOT COMPLETED|First Intervention||0
7840281|NCT01007253|19296518|P3|NOT COMPLETED|First Intervention||0
7840282|NCT01007253|19296519|P2|NOT COMPLETED|First Intervention||0
7840283|NCT01007253|19296520|P1|NOT COMPLETED|First Intervention||0
7840284|NCT01007253|19296517|P4|COMPLETED|First Intervention||5
7840285|NCT01007253|19296518|P3|COMPLETED|First Intervention||5
7840286|NCT01007253|19296519|P2|COMPLETED|First Intervention||5
7840287|NCT01007253|19296520|P1|COMPLETED|First Intervention||6
7840288|NCT01007253|19296517|P4|STARTED|First Intervention||5
7840289|NCT01007253|19296518|P3|STARTED|First Intervention||5
7840290|NCT01007253|19296519|P2|STARTED|First Intervention||5
7840291|NCT01007253|19296520|P1|STARTED|First Intervention||6
7840292|NCT01007149|19296552|P2|NOT COMPLETED|Overall Study||1
7840293|NCT01007149|19296553|P1|NOT COMPLETED|Overall Study||0
7840294|NCT01007149|19296552|P2|COMPLETED|Overall Study||20
7840295|NCT01007149|19296553|P1|COMPLETED|Overall Study||20
7840296|NCT01007149|19296552|P2|STARTED|Overall Study||21
7840297|NCT01007149|19296553|P1|STARTED|Overall Study||20
7840298|NCT01007136|19296580|P5|NOT COMPLETED|Overall Study||0
7840299|NCT01007136|19296581|P4|NOT COMPLETED|Overall Study||0
7840300|NCT01007136|19296582|P3|NOT COMPLETED|Overall Study||0
7840301|NCT01007136|19296583|P2|NOT COMPLETED|Overall Study||4
7840302|NCT01007136|19296584|P1|NOT COMPLETED|Overall Study||4
7840303|NCT01007136|19296580|P5|COMPLETED|Overall Study||4
7840304|NCT01007136|19296581|P4|COMPLETED|Overall Study||6
7840305|NCT01007136|19296582|P3|COMPLETED|Overall Study||15
7840306|NCT01007136|19296583|P2|COMPLETED|Overall Study||13
7840307|NCT01007136|19296584|P1|COMPLETED|Overall Study||15
7840308|NCT01007136|19296580|P5|STARTED|Overall Study||4
7840309|NCT01007136|19296581|P4|STARTED|Overall Study||6
7840310|NCT01007136|19296582|P3|STARTED|Overall Study||15
7840311|NCT01007136|19296583|P2|STARTED|Overall Study|One additional subject was excluded prior to randomization due to illicit drug use.|17
7840312|NCT01007136|19296584|P1|STARTED|Overall Study||19
7840313|NCT01007123|19296627|P4|NOT COMPLETED|Overall Study||6
7840314|NCT01007123|19296628|P3|NOT COMPLETED|Overall Study||11
7840315|NCT01007123|19296629|P2|NOT COMPLETED|Overall Study||6
7840316|NCT01007123|19296630|P1|NOT COMPLETED|Overall Study||6
7840317|NCT01007123|19296627|P4|COMPLETED|Overall Study||41
7840318|NCT01007123|19296628|P3|COMPLETED|Overall Study||37
7840319|NCT01007123|19296629|P2|COMPLETED|Overall Study||41
7840320|NCT01007123|19296630|P1|COMPLETED|Overall Study||42
7840321|NCT01007123|19296627|P4|STARTED|Overall Study||47
7840322|NCT01007123|19296628|P3|STARTED|Overall Study||48
7840323|NCT01007123|19296629|P2|STARTED|Overall Study||47
7840324|NCT01007123|19296630|P1|STARTED|Overall Study||48
7840325|NCT01007110|19296661|P2|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5
7840326|NCT01007110|19296662|P1|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
7840327|NCT01007110|19296661|P2|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15
7840328|NCT01007110|19296662|P1|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
7840329|NCT01007110|19296661|P2|STARTED|Neonatal Behavioral Assessment Scale (NB||20
7840330|NCT01007110|19296662|P1|STARTED|Neonatal Behavioral Assessment Scale (NB||24
7840331|NCT01007110|19296661|P2|NOT COMPLETED|Follow-Up at 36 Weeks||2
7840332|NCT01007110|19296662|P1|NOT COMPLETED|Follow-Up at 36 Weeks||0
7840333|NCT01007110|19296661|P2|COMPLETED|Follow-Up at 36 Weeks||20
7840334|NCT01007110|19296662|P1|COMPLETED|Follow-Up at 36 Weeks||24
7840335|NCT01007110|19296661|P2|STARTED|Follow-Up at 36 Weeks||22
7840336|NCT01007110|19296662|P1|STARTED|Follow-Up at 36 Weeks||24
7840337|NCT01007110|19296661|P2|NOT COMPLETED|Follow-Up at 32 Weeks||1
7840338|NCT01007110|19296662|P1|NOT COMPLETED|Follow-Up at 32 Weeks||1
7840339|NCT01007110|19296661|P2|COMPLETED|Follow-Up at 32 Weeks||22
7840340|NCT01007110|19296662|P1|COMPLETED|Follow-Up at 32 Weeks||24
7840341|NCT01007110|19296661|P2|STARTED|Follow-Up at 32 Weeks||23
7840342|NCT01007110|19296662|P1|STARTED|Follow-Up at 32 Weeks||25
7840343|NCT01007110|19296661|P2|NOT COMPLETED|Follow-Up at 24 Weeks||4
7840344|NCT01007110|19296662|P1|NOT COMPLETED|Follow-Up at 24 Weeks||0
7840345|NCT01007110|19296661|P2|COMPLETED|Follow-Up at 24 Weeks||23
7840346|NCT01007110|19296662|P1|COMPLETED|Follow-Up at 24 Weeks||25
7840347|NCT01007110|19296661|P2|STARTED|Follow-Up at 24 Weeks||27
7840348|NCT01007110|19296662|P1|STARTED|Follow-Up at 24 Weeks||25
7840349|NCT01007110|19296661|P2|NOT COMPLETED|Allocation||8
7840350|NCT01007110|19296662|P1|NOT COMPLETED|Allocation||7
7840351|NCT01007110|19296661|P2|COMPLETED|Allocation||27
7840352|NCT01007110|19296662|P1|COMPLETED|Allocation||25
7840353|NCT01007110|19296661|P2|STARTED|Allocation||35
7840354|NCT01007110|19296662|P1|STARTED|Allocation||32
7840355|NCT01007071|19296678|P2|NOT COMPLETED|Overall Study||0
7840356|NCT01007071|19296679|P1|NOT COMPLETED|Overall Study||0
7840357|NCT01007071|19296678|P2|COMPLETED|Overall Study||5
7840358|NCT01007071|19296679|P1|COMPLETED|Overall Study||6
7840359|NCT01007071|19296678|P2|STARTED|Overall Study||5
7840360|NCT01007071|19296679|P1|STARTED|Overall Study||6
7840361|NCT01007032|19296691|P4|NOT COMPLETED|Overall Study||1
7840362|NCT01007032|19296692|P3|NOT COMPLETED|Overall Study||1
7840363|NCT01007032|19296693|P2|NOT COMPLETED|Overall Study||1
7840364|NCT01007032|19296694|P1|NOT COMPLETED|Overall Study||0
7840365|NCT01007032|19296691|P4|COMPLETED|Overall Study||6
7840366|NCT01007032|19296692|P3|COMPLETED|Overall Study||2
7840367|NCT01007032|19296693|P2|COMPLETED|Overall Study||6
7840368|NCT01007032|19296694|P1|COMPLETED|Overall Study||4
7840369|NCT01007032|19296691|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
7840370|NCT01007032|19296692|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
7840371|NCT01007032|19296693|P2|Received at Least 1 Dose of Study Drug|Overall Study||7
7840372|NCT01007032|19296694|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
7840373|NCT01007032|19296691|P4|STARTED|Overall Study||7
7840374|NCT01007032|19296692|P3|STARTED|Overall Study||3
7840375|NCT01007032|19296693|P2|STARTED|Overall Study||7
7840376|NCT01007032|19296694|P1|STARTED|Overall Study||4
7840377|NCT01006980|19296738|P2|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84
7840378|NCT01006980|19296739|P1|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
7840379|NCT01006980|19296738|P2|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
7840380|NCT01006980|19296739|P1|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
7840381|NCT01006980|19296738|P2|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84
7840382|NCT01006980|19296739|P1|STARTED|Crossover: Dacarbazine to Vemurafenib||0
7840383|NCT01006980|19296738|P2|NOT COMPLETED|Vemurafenib and Dacarbazine||338
7840384|NCT01006980|19296739|P1|NOT COMPLETED|Vemurafenib and Dacarbazine||337
7840385|NCT01006980|19296738|P2|COMPLETED|Vemurafenib and Dacarbazine||0
7840386|NCT01006980|19296739|P1|COMPLETED|Vemurafenib and Dacarbazine||0
7840387|NCT01006980|19296738|P2|Treated|Vemurafenib and Dacarbazine||293
7840388|NCT01006980|19296739|P1|Treated|Vemurafenib and Dacarbazine||336
7840389|NCT01006980|19296738|P2|STARTED|Vemurafenib and Dacarbazine||338
7840390|NCT01006980|19296739|P1|STARTED|Vemurafenib and Dacarbazine||337
7840391|NCT01006967|19296761|P2|NOT COMPLETED|Overall Study||63
7840392|NCT01006967|19296762|P1|NOT COMPLETED|Overall Study||66
7840393|NCT01006967|19296761|P2|COMPLETED|Overall Study||190
7840394|NCT01006967|19296762|P1|COMPLETED|Overall Study||187
7840395|NCT01006967|19296761|P2|3 Month Follow-up|Overall Study||210
7840396|NCT01006967|19296762|P1|3 Month Follow-up|Overall Study||212
7840397|NCT01006967|19296761|P2|Received Treatment|Overall Study||245
7840398|NCT01006967|19296762|P1|Received Treatment|Overall Study||245
7840399|NCT01006967|19296761|P2|STARTED|Overall Study||253
7840400|NCT01006967|19296762|P1|STARTED|Overall Study||253
7840401|NCT01006889|19296778|P1|NOT COMPLETED|Overall Study||3
7840402|NCT01006889|19296778|P1|COMPLETED|Overall Study||17
7840403|NCT01006889|19296778|P1|STARTED|Overall Study||20
7840404|NCT01006707|19296789|P3|NOT COMPLETED|Study Session 3||0
7840405|NCT01006707|19296790|P2|NOT COMPLETED|Study Session 3||0
7840406|NCT01006707|19296791|P1|NOT COMPLETED|Study Session 3||0
7840407|NCT01006707|19296789|P3|COMPLETED|Study Session 3||6
7840408|NCT01006707|19296790|P2|COMPLETED|Study Session 3||4
7840409|NCT01006707|19296791|P1|COMPLETED|Study Session 3||0
7840410|NCT01006707|19296789|P3|STARTED|Study Session 3||6
7840411|NCT01006707|19296790|P2|STARTED|Study Session 3||4
7840412|NCT01006707|19296791|P1|STARTED|Study Session 3||0
7840413|NCT01006707|19296789|P3|NOT COMPLETED|Study Session 2||0
7840414|NCT01006707|19296790|P2|NOT COMPLETED|Study Session 2||0
7840415|NCT01006707|19296791|P1|NOT COMPLETED|Study Session 2||0
7840416|NCT01006707|19296789|P3|COMPLETED|Study Session 2||6
7840417|NCT01006707|19296790|P2|COMPLETED|Study Session 2||4
7840418|NCT01006707|19296791|P1|COMPLETED|Study Session 2||0
7840419|NCT01006707|19296789|P3|STARTED|Study Session 2||6
7840420|NCT01006707|19296790|P2|STARTED|Study Session 2||4
7840421|NCT01006707|19296791|P1|STARTED|Study Session 2||0
7840422|NCT01006707|19296789|P3|NOT COMPLETED|Study Session 1||0
7840423|NCT01006707|19296790|P2|NOT COMPLETED|Study Session 1||0
7840424|NCT01006707|19296791|P1|NOT COMPLETED|Study Session 1||5
7840425|NCT01006707|19296789|P3|COMPLETED|Study Session 1||0
7840426|NCT01006707|19296790|P2|COMPLETED|Study Session 1||0
7840427|NCT01006707|19296791|P1|COMPLETED|Study Session 1||10
7840428|NCT01006707|19296789|P3|STARTED|Study Session 1||0
7840429|NCT01006707|19296790|P2|STARTED|Study Session 1||0
7840430|NCT01006707|19296791|P1|STARTED|Study Session 1||15
7840431|NCT01006655|19296804|P2|NOT COMPLETED|Second Intervention||0
7840432|NCT01006655|19296805|P1|NOT COMPLETED|Second Intervention||0
7840433|NCT01006655|19296804|P2|COMPLETED|Second Intervention||10
7840434|NCT01006655|19296805|P1|COMPLETED|Second Intervention||11
7840435|NCT01006655|19296804|P2|STARTED|Second Intervention||10
7840436|NCT01006655|19296805|P1|STARTED|Second Intervention||11
7840437|NCT01006655|19296804|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
7840438|NCT01006655|19296805|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
7840439|NCT01006655|19296804|P2|COMPLETED|Washout Period of 2 Weeks||10
7840440|NCT01006655|19296805|P1|COMPLETED|Washout Period of 2 Weeks||11
7840441|NCT01006655|19296804|P2|STARTED|Washout Period of 2 Weeks||10
7840442|NCT01006655|19296805|P1|STARTED|Washout Period of 2 Weeks||11
7840443|NCT01006655|19296804|P2|NOT COMPLETED|First Intervention||0
7840444|NCT01006655|19296805|P1|NOT COMPLETED|First Intervention||0
7840445|NCT01006655|19296804|P2|COMPLETED|First Intervention||10
7840446|NCT01006655|19296805|P1|COMPLETED|First Intervention||11
7840447|NCT01006655|19296804|P2|STARTED|First Intervention||10
7840448|NCT01006655|19296805|P1|STARTED|First Intervention||11
7840449|NCT01006629|19296811|P1|NOT COMPLETED|Overall Study||6
7840450|NCT01006629|19296811|P1|COMPLETED|Overall Study||94
7840451|NCT01006629|19296811|P1|STARTED|Overall Study||100
7840452|NCT01006616|19296826|P4|NOT COMPLETED|Period 2 (18 Months)||82
7840453|NCT01006616|19296827|P3|NOT COMPLETED|Period 2 (18 Months)||55
7840454|NCT01006616|19296828|P2|NOT COMPLETED|Period 2 (18 Months)||63
7840455|NCT01006616|19296829|P1|NOT COMPLETED|Period 2 (18 Months)||75
7840456|NCT01006616|19296826|P4|COMPLETED|Period 2 (18 Months)||0
7840457|NCT01006616|19296827|P3|COMPLETED|Period 2 (18 Months)||0
7840458|NCT01006616|19296828|P2|COMPLETED|Period 2 (18 Months)||0
7840459|NCT01006616|19296829|P1|COMPLETED|Period 2 (18 Months)||0
7840460|NCT01006616|19296826|P4|Treated|Period 2 (18 Months)||82
7840461|NCT01006616|19296827|P3|Treated|Period 2 (18 Months)||55
7840462|NCT01006616|19296828|P2|Treated|Period 2 (18 Months)||63
7840463|NCT01006616|19296829|P1|Treated|Period 2 (18 Months)||75
7840464|NCT01006616|19296826|P4|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82
7840465|NCT01006616|19296827|P3|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55
7840466|NCT01006616|19296828|P2|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63
7840467|NCT01006616|19296829|P1|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75
7840468|NCT01006616|19296826|P4|NOT COMPLETED|Period 1 (6 Months)||27
7840469|NCT01006616|19296827|P3|NOT COMPLETED|Period 1 (6 Months)||51
7840470|NCT01006616|19296828|P2|NOT COMPLETED|Period 1 (6 Months)||54
7840471|NCT01006616|19296829|P1|NOT COMPLETED|Period 1 (6 Months)||26
7840472|NCT01006616|19296826|P4|COMPLETED|Period 1 (6 Months)||128
7840473|NCT01006616|19296827|P3|COMPLETED|Period 1 (6 Months)||102
7840474|NCT01006616|19296828|P2|COMPLETED|Period 1 (6 Months)||102
7840475|NCT01006616|19296829|P1|COMPLETED|Period 1 (6 Months)||126
7840476|NCT01006616|19296826|P4|Treated|Period 1 (6 Months)||154
7840477|NCT01006616|19296827|P3|Treated|Period 1 (6 Months)||152
7840478|NCT01006616|19296828|P2|Treated|Period 1 (6 Months)||156
7840479|NCT01006616|19296829|P1|Treated|Period 1 (6 Months)||152
7840480|NCT01006616|19296826|P4|STARTED|Period 1 (6 Months)||155
7840481|NCT01006616|19296827|P3|STARTED|Period 1 (6 Months)||153
7840482|NCT01006616|19296828|P2|STARTED|Period 1 (6 Months)||156
7840483|NCT01006616|19296829|P1|STARTED|Period 1 (6 Months)||152
7840484|NCT01006603|19296965|P2|NOT COMPLETED|Overall Study||75
7840485|NCT01006603|19296966|P1|NOT COMPLETED|Overall Study||71
7840486|NCT01006603|19296965|P2|COMPLETED|Overall Study||285
7840487|NCT01006603|19296966|P1|COMPLETED|Overall Study||289
7840488|NCT01006603|19296965|P2|STARTED|Overall Study|Completed lead-in period and were randomised|360
7840489|NCT01006603|19296966|P1|STARTED|Overall Study|Completed lead-in period and were randomised|360
7840490|NCT01006590|19296986|P2|NOT COMPLETED|Overall Study||32
7840491|NCT01006590|19296987|P1|NOT COMPLETED|Overall Study||28
7840492|NCT01006590|19296986|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|107
7840493|NCT01006590|19296987|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|119
7840494|NCT01006590|19296986|P2|STARTED|Overall Study|Randomised and treated|139
7840495|NCT01006590|19296987|P1|STARTED|Overall Study|Randomised and treated|147
7840496|NCT01006538|19297005|P2|NOT COMPLETED|Overall Study||4
7840497|NCT01006538|19297006|P1|NOT COMPLETED|Overall Study||11
7840498|NCT01006538|19297005|P2|COMPLETED|Overall Study||115
7840499|NCT01006538|19297006|P1|COMPLETED|Overall Study||233
7840500|NCT01006538|19297005|P2|STARTED|Overall Study||119
7840501|NCT01006538|19297006|P1|STARTED|Overall Study||244
7840502|NCT01006356|19297026|P1|NOT COMPLETED|Overall Study||42
7840503|NCT01006356|19297026|P1|COMPLETED|Overall Study||99
7840504|NCT01006356|19297026|P1|STARTED|Overall Study||141
7840505|NCT01006291|19297041|P3|NOT COMPLETED|Overall Study||27
7840506|NCT01006291|19297042|P2|NOT COMPLETED|Overall Study||24
7840507|NCT01006291|19297043|P1|NOT COMPLETED|Overall Study||26
7840508|NCT01006291|19297041|P3|COMPLETED|Overall Study||203
7840509|NCT01006291|19297042|P2|COMPLETED|Overall Study||204
7840510|NCT01006291|19297043|P1|COMPLETED|Overall Study||203
7840511|NCT01006291|19297041|P3|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229
7840512|NCT01006291|19297042|P2|Exposed|Overall Study|2 subjects received IDeg OD FF|226
7840513|NCT01006291|19297043|P1|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230
7840514|NCT01006291|19297041|P3|STARTED|Overall Study||230
7840515|NCT01006291|19297042|P2|STARTED|Overall Study||228
7840516|NCT01006291|19297043|P1|STARTED|Overall Study||229
7840517|NCT01006252|19297062|P2|NOT COMPLETED|Overall Study||0
7840518|NCT01006252|19297063|P1|NOT COMPLETED|Overall Study||0
7840519|NCT01006252|19297062|P2|COMPLETED|Overall Study||168
7840520|NCT01006252|19297063|P1|COMPLETED|Overall Study||168
7840521|NCT01006252|19297062|P2|Received Treatment|Overall Study||161
7840522|NCT01006252|19297063|P1|Received Treatment|Overall Study||164
7840523|NCT01006252|19297062|P2|STARTED|Overall Study||168
7840524|NCT01006252|19297063|P1|STARTED|Overall Study||168
7840525|NCT01006135|19297093|P1|NOT COMPLETED|Overall Study||140
7840526|NCT01006135|19297093|P1|COMPLETED|Overall Study||4712
7840527|NCT01006135|19297093|P1|STARTED|Overall Study||4852
7840528|NCT01006122|19297100|P2|NOT COMPLETED|Second Double-blind Intervention Period||7
7840529|NCT01006122|19297101|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
7840530|NCT01006122|19297100|P2|COMPLETED|Second Double-blind Intervention Period||24
7840531|NCT01006122|19297101|P1|COMPLETED|Second Double-blind Intervention Period||29
7840532|NCT01006122|19297100|P2|STARTED|Second Double-blind Intervention Period||31
7840533|NCT01006122|19297101|P1|STARTED|Second Double-blind Intervention Period||31
7840534|NCT01006122|19297100|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
7840535|NCT01006122|19297101|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
7840536|NCT01006122|19297100|P2|COMPLETED|Wash-out Period (at Least 7 Days)||31
7840537|NCT01006122|19297101|P1|COMPLETED|Wash-out Period (at Least 7 Days)||31
7840538|NCT01006122|19297100|P2|STARTED|Wash-out Period (at Least 7 Days)||31
7840539|NCT01006122|19297101|P1|STARTED|Wash-out Period (at Least 7 Days)||31
7840540|NCT01006122|19297100|P2|NOT COMPLETED|First Double-blind Intervention Period||17
7840541|NCT01006122|19297101|P1|NOT COMPLETED|First Double-blind Intervention Period||16
7840542|NCT01006122|19297100|P2|COMPLETED|First Double-blind Intervention Period||31
7840543|NCT01006122|19297101|P1|COMPLETED|First Double-blind Intervention Period||31
7840544|NCT01006122|19297100|P2|STARTED|First Double-blind Intervention Period||48
7840545|NCT01006122|19297101|P1|STARTED|First Double-blind Intervention Period||47
7840546|NCT01006018|19297142|P3|NOT COMPLETED|Overall Study||0
7840547|NCT01006018|19297143|P2|NOT COMPLETED|Overall Study||0
7840548|NCT01006018|19297144|P1|NOT COMPLETED|Overall Study||0
7840549|NCT01006018|19297142|P3|COMPLETED|Overall Study||0
7840550|NCT01006018|19297143|P2|COMPLETED|Overall Study||0
7840551|NCT01006018|19297144|P1|COMPLETED|Overall Study||0
7840552|NCT01006018|19297142|P3|STARTED|Overall Study||0
7840553|NCT01006018|19297143|P2|STARTED|Overall Study||0
7840554|NCT01006018|19297144|P1|STARTED|Overall Study||0
7840555|NCT01005966|19297152|P5|NOT COMPLETED|Treatment Period 5 (14 Days)||0
7840556|NCT01005966|19297153|P4|NOT COMPLETED|Treatment Period 5 (14 Days)||0
7840557|NCT01005966|19297154|P3|NOT COMPLETED|Treatment Period 5 (14 Days)||0
7840558|NCT01005966|19297155|P2|NOT COMPLETED|Treatment Period 5 (14 Days)||0
7840559|NCT01005966|19297156|P1|NOT COMPLETED|Treatment Period 5 (14 Days)||0
7840560|NCT01005966|19297152|P5|COMPLETED|Treatment Period 5 (14 Days)||10
7840561|NCT01005966|19297153|P4|COMPLETED|Treatment Period 5 (14 Days)||11
7840562|NCT01005966|19297154|P3|COMPLETED|Treatment Period 5 (14 Days)||11
7840563|NCT01005966|19297155|P2|COMPLETED|Treatment Period 5 (14 Days)||12
7840564|NCT01005966|19297156|P1|COMPLETED|Treatment Period 5 (14 Days)||9
7840565|NCT01005966|19297152|P5|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10
7840566|NCT01005966|19297153|P4|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
7840567|NCT01005966|19297154|P3|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
7840568|NCT01005966|19297155|P2|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12
7840569|NCT01005966|19297156|P1|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9
7840570|NCT01005966|19297152|P5|NOT COMPLETED|Washout Period 4 (4 Days)||0
7840571|NCT01005966|19297153|P4|NOT COMPLETED|Washout Period 4 (4 Days)||0
7840572|NCT01005966|19297154|P3|NOT COMPLETED|Washout Period 4 (4 Days)||0
7840573|NCT01005966|19297155|P2|NOT COMPLETED|Washout Period 4 (4 Days)||0
7840574|NCT01005966|19297156|P1|NOT COMPLETED|Washout Period 4 (4 Days)||0
7840575|NCT01005966|19297152|P5|COMPLETED|Washout Period 4 (4 Days)||12
7840576|NCT01005966|19297153|P4|COMPLETED|Washout Period 4 (4 Days)||10
7840577|NCT01005966|19297154|P3|COMPLETED|Washout Period 4 (4 Days)||11
7840578|NCT01005966|19297155|P2|COMPLETED|Washout Period 4 (4 Days)||10
7840579|NCT01005966|19297156|P1|COMPLETED|Washout Period 4 (4 Days)||10
7840580|NCT01005966|19297152|P5|STARTED|Washout Period 4 (4 Days)||12
7840581|NCT01005966|19297153|P4|STARTED|Washout Period 4 (4 Days)||10
7840582|NCT01005966|19297154|P3|STARTED|Washout Period 4 (4 Days)||11
7840583|NCT01005966|19297155|P2|STARTED|Washout Period 4 (4 Days)||10
7840584|NCT01005966|19297156|P1|STARTED|Washout Period 4 (4 Days)||10
7840585|NCT01005966|19297152|P5|NOT COMPLETED|Treatment Period 4 (14 Days)||1
7840586|NCT01005966|19297153|P4|NOT COMPLETED|Treatment Period 4 (14 Days)||0
7840587|NCT01005966|19297154|P3|NOT COMPLETED|Treatment Period 4 (14 Days)||0
7840588|NCT01005966|19297155|P2|NOT COMPLETED|Treatment Period 4 (14 Days)||1
7840589|NCT01005966|19297156|P1|NOT COMPLETED|Treatment Period 4 (14 Days)||0
7840590|NCT01005966|19297152|P5|COMPLETED|Treatment Period 4 (14 Days)||12
7840591|NCT01005966|19297153|P4|COMPLETED|Treatment Period 4 (14 Days)||10
7840592|NCT01005966|19297154|P3|COMPLETED|Treatment Period 4 (14 Days)||11
7840593|NCT01005966|19297155|P2|COMPLETED|Treatment Period 4 (14 Days)||10
7840594|NCT01005966|19297156|P1|COMPLETED|Treatment Period 4 (14 Days)||10
7840595|NCT01005966|19297152|P5|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13
7840596|NCT01005966|19297153|P4|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
7840597|NCT01005966|19297154|P3|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
7840598|NCT01005966|19297155|P2|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
7840599|NCT01005966|19297156|P1|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
7840600|NCT01005966|19297152|P5|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
7840601|NCT01005966|19297153|P4|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
7840602|NCT01005966|19297154|P3|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
7840603|NCT01005966|19297155|P2|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
7840604|NCT01005966|19297156|P1|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
7840605|NCT01005966|19297152|P5|COMPLETED|Washout Period 3 ( 4 Days)||11
7840606|NCT01005966|19297153|P4|COMPLETED|Washout Period 3 ( 4 Days)||13
7840607|NCT01005966|19297154|P3|COMPLETED|Washout Period 3 ( 4 Days)||12
7840608|NCT01005966|19297155|P2|COMPLETED|Washout Period 3 ( 4 Days)||7
7840609|NCT01005966|19297156|P1|COMPLETED|Washout Period 3 ( 4 Days)||12
7840610|NCT01005966|19297152|P5|STARTED|Washout Period 3 ( 4 Days)||11
7840611|NCT01005966|19297153|P4|STARTED|Washout Period 3 ( 4 Days)||13
7840612|NCT01005966|19297154|P3|STARTED|Washout Period 3 ( 4 Days)||12
7840613|NCT01005966|19297155|P2|STARTED|Washout Period 3 ( 4 Days)||7
7840614|NCT01005966|19297156|P1|STARTED|Washout Period 3 ( 4 Days)||12
7840615|NCT01005966|19297152|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||1
7840616|NCT01005966|19297153|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
7840617|NCT01005966|19297154|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||0
7840618|NCT01005966|19297155|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
7840619|NCT01005966|19297156|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
7840620|NCT01005966|19297152|P5|COMPLETED|Treatment Period 3 (14 Days)||11
7840621|NCT01005966|19297153|P4|COMPLETED|Treatment Period 3 (14 Days)||13
7840622|NCT01005966|19297154|P3|COMPLETED|Treatment Period 3 (14 Days)||12
7840623|NCT01005966|19297155|P2|COMPLETED|Treatment Period 3 (14 Days)||7
7840624|NCT01005966|19297156|P1|COMPLETED|Treatment Period 3 (14 Days)||12
7840625|NCT01005966|19297152|P5|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
7840626|NCT01005966|19297153|P4|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13
7840627|NCT01005966|19297154|P3|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
7840628|NCT01005966|19297155|P2|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8
7840629|NCT01005966|19297156|P1|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
7840630|NCT01005966|19297152|P5|NOT COMPLETED|Washout Period 2 (4 Days)||0
7840631|NCT01005966|19297153|P4|NOT COMPLETED|Washout Period 2 (4 Days)||0
7840632|NCT01005966|19297154|P3|NOT COMPLETED|Washout Period 2 (4 Days)||0
7840633|NCT01005966|19297155|P2|NOT COMPLETED|Washout Period 2 (4 Days)||0
7840634|NCT01005966|19297156|P1|NOT COMPLETED|Washout Period 2 (4 Days)||0
7840635|NCT01005966|19297152|P5|COMPLETED|Washout Period 2 (4 Days)||11
7840636|NCT01005966|19297153|P4|COMPLETED|Washout Period 2 (4 Days)||11
7840637|NCT01005966|19297154|P3|COMPLETED|Washout Period 2 (4 Days)||10
7840638|NCT01005966|19297155|P2|COMPLETED|Washout Period 2 (4 Days)||12
7840639|NCT01005966|19297156|P1|COMPLETED|Washout Period 2 (4 Days)||13
7840640|NCT01005966|19297152|P5|STARTED|Washout Period 2 (4 Days)||11
7840641|NCT01005966|19297153|P4|STARTED|Washout Period 2 (4 Days)||11
7840642|NCT01005966|19297154|P3|STARTED|Washout Period 2 (4 Days)||10
7840643|NCT01005966|19297155|P2|STARTED|Washout Period 2 (4 Days)||12
7840644|NCT01005966|19297156|P1|STARTED|Washout Period 2 (4 Days)||13
7840645|NCT01005966|19297152|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
7840646|NCT01005966|19297153|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
7840647|NCT01005966|19297154|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
7840648|NCT01005966|19297155|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
7840649|NCT01005966|19297156|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
7840650|NCT01005966|19297152|P5|COMPLETED|Treatment Period 2 (14 Days)||11
7840651|NCT01005966|19297153|P4|COMPLETED|Treatment Period 2 (14 Days)||11
7840652|NCT01005966|19297154|P3|COMPLETED|Treatment Period 2 (14 Days)||10
7840653|NCT01005966|19297155|P2|COMPLETED|Treatment Period 2 (14 Days)||12
7840654|NCT01005966|19297156|P1|COMPLETED|Treatment Period 2 (14 Days)||13
7840655|NCT01005966|19297152|P5|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
7840656|NCT01005966|19297153|P4|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
7840657|NCT01005966|19297154|P3|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
7840658|NCT01005966|19297155|P2|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
7840659|NCT01005966|19297156|P1|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
7840660|NCT01005966|19297152|P5|NOT COMPLETED|Washout Period 1 (4 Days)||0
7840661|NCT01005966|19297153|P4|NOT COMPLETED|Washout Period 1 (4 Days)||1
7840662|NCT01005966|19297154|P3|NOT COMPLETED|Washout Period 1 (4 Days)||0
7840663|NCT01005966|19297155|P2|NOT COMPLETED|Washout Period 1 (4 Days)||0
7840664|NCT01005966|19297156|P1|NOT COMPLETED|Washout Period 1 (4 Days)||0
7840665|NCT01005966|19297152|P5|COMPLETED|Washout Period 1 (4 Days)||13
7840666|NCT01005966|19297153|P4|COMPLETED|Washout Period 1 (4 Days)||12
7840667|NCT01005966|19297154|P3|COMPLETED|Washout Period 1 (4 Days)||12
7840668|NCT01005966|19297155|P2|COMPLETED|Washout Period 1 (4 Days)||13
7840669|NCT01005966|19297156|P1|COMPLETED|Washout Period 1 (4 Days)||11
7840670|NCT01005966|19297152|P5|STARTED|Washout Period 1 (4 Days)||13
7840671|NCT01005966|19297153|P4|STARTED|Washout Period 1 (4 Days)||13
7840672|NCT01005966|19297154|P3|STARTED|Washout Period 1 (4 Days)||12
7840673|NCT01005966|19297155|P2|STARTED|Washout Period 1 (4 Days)||13
7840674|NCT01005966|19297156|P1|STARTED|Washout Period 1 (4 Days)||11
7840675|NCT01005966|19297152|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
7840676|NCT01005966|19297153|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||0
7840677|NCT01005966|19297154|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
7840678|NCT01005966|19297155|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||0
7840679|NCT01005966|19297156|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
7840680|NCT01005966|19297152|P5|COMPLETED|Treatment Period 1 (14 Days)||13
7840681|NCT01005966|19297153|P4|COMPLETED|Treatment Period 1 (14 Days)||13
7840682|NCT01005966|19297154|P3|COMPLETED|Treatment Period 1 (14 Days)||12
7840683|NCT01005966|19297155|P2|COMPLETED|Treatment Period 1 (14 Days)||13
7840684|NCT01005966|19297156|P1|COMPLETED|Treatment Period 1 (14 Days)||11
7840685|NCT01005966|19297152|P5|STARTED|Treatment Period 1 (14 Days)||13
7840686|NCT01005966|19297153|P4|STARTED|Treatment Period 1 (14 Days)||13
7840687|NCT01005966|19297154|P3|STARTED|Treatment Period 1 (14 Days)||13
7840688|NCT01005966|19297155|P2|STARTED|Treatment Period 1 (14 Days)||13
7840689|NCT01005966|19297156|P1|STARTED|Treatment Period 1 (14 Days)||13
7840690|NCT01005914|19297176|P1|NOT COMPLETED|Overall Study||10
7840691|NCT01005914|19297176|P1|COMPLETED|Overall Study||1
7840692|NCT01005914|19297176|P1|STARTED|Overall Study||11
7840693|NCT01005901|19297182|P2|NOT COMPLETED|Overall Study||58
7840694|NCT01005901|19297183|P1|NOT COMPLETED|Overall Study||102
7840695|NCT01005901|19297182|P2|COMPLETED|Overall Study||212
7840696|NCT01005901|19297183|P1|COMPLETED|Overall Study||450
7840697|NCT01005901|19297182|P2|Full Analysis Set|Overall Study||260
7840698|NCT01005901|19297183|P1|Full Analysis Set|Overall Study||534
7840699|NCT01005901|19297182|P2|Safety Population|Overall Study||267
7840700|NCT01005901|19297183|P1|Safety Population|Overall Study||550
7840701|NCT01005901|19297182|P2|STARTED|Overall Study||270
7840702|NCT01005901|19297183|P1|STARTED|Overall Study||552
7840703|NCT01005888|19297225|P2|NOT COMPLETED|Second Intervention||1
7840704|NCT01005888|19297226|P1|NOT COMPLETED|Second Intervention||1
7840705|NCT01005888|19297225|P2|COMPLETED|Second Intervention||10
7840706|NCT01005888|19297226|P1|COMPLETED|Second Intervention||10
7840707|NCT01005888|19297225|P2|STARTED|Second Intervention||11
7840708|NCT01005888|19297226|P1|STARTED|Second Intervention||11
7840709|NCT01005888|19297225|P2|NOT COMPLETED|First Intervention||1
7840710|NCT01005888|19297226|P1|NOT COMPLETED|First Intervention||1
7840711|NCT01005888|19297225|P2|COMPLETED|First Intervention||11
7840712|NCT01005888|19297226|P1|COMPLETED|First Intervention||11
7840713|NCT01005888|19297225|P2|STARTED|First Intervention||12
7840714|NCT01005888|19297226|P1|STARTED|First Intervention||12
7840715|NCT01005875|19297246|P1|NOT COMPLETED|Overall Study||3
7840716|NCT01005875|19297246|P1|COMPLETED|Overall Study||2
7840717|NCT01005875|19297246|P1|STARTED|Overall Study||5
7840718|NCT01005810|19297256|P2|NOT COMPLETED|Overall Study||25
7840719|NCT01005810|19297257|P1|NOT COMPLETED|Overall Study||21
7840720|NCT01005810|19297256|P2|COMPLETED|Overall Study||33
7840721|NCT01005810|19297257|P1|COMPLETED|Overall Study||37
7840722|NCT01005810|19297256|P2|STARTED|Overall Study||58
7840723|NCT01005810|19297257|P1|STARTED|Overall Study||58
7840724|NCT01005745|19297263|P1|NOT COMPLETED|Overall Study||6
7840725|NCT01005745|19297263|P1|COMPLETED|Overall Study||13
7840726|NCT01005745|19297263|P1|STARTED|Overall Study||19
7840727|NCT01005732|19297268|P1|NOT COMPLETED|Overall Study||11
7840728|NCT01005732|19297268|P1|COMPLETED|Overall Study||43
7840729|NCT01005732|19297268|P1|STARTED|Overall Study||54
7840730|NCT01005719|19297284|P6|NOT COMPLETED|Period 3||0
7840731|NCT01005719|19297285|P5|NOT COMPLETED|Period 3||0
7840732|NCT01005719|19297286|P4|NOT COMPLETED|Period 3||0
7840733|NCT01005719|19297287|P3|NOT COMPLETED|Period 3||0
7840734|NCT01005719|19297288|P2|NOT COMPLETED|Period 3||0
7840735|NCT01005719|19297289|P1|NOT COMPLETED|Period 3||0
7840736|NCT01005719|19297284|P6|COMPLETED|Period 3||9
7840737|NCT01005719|19297285|P5|COMPLETED|Period 3||10
7840738|NCT01005719|19297286|P4|COMPLETED|Period 3||10
7840739|NCT01005719|19297287|P3|COMPLETED|Period 3||10
7840740|NCT01005719|19297288|P2|COMPLETED|Period 3||10
7840741|NCT01005719|19297289|P1|COMPLETED|Period 3||10
7840742|NCT01005719|19297284|P6|STARTED|Period 3||9
7840743|NCT01005719|19297285|P5|STARTED|Period 3||10
7840744|NCT01005719|19297286|P4|STARTED|Period 3||10
7840745|NCT01005719|19297287|P3|STARTED|Period 3||10
7840746|NCT01005719|19297288|P2|STARTED|Period 3||10
7840747|NCT01005719|19297289|P1|STARTED|Period 3||10
7840748|NCT01005719|19297284|P6|NOT COMPLETED|Period 2||1
7840749|NCT01005719|19297285|P5|NOT COMPLETED|Period 2||1
7840750|NCT01005719|19297286|P4|NOT COMPLETED|Period 2||0
7840751|NCT01005719|19297287|P3|NOT COMPLETED|Period 2||0
7840752|NCT01005719|19297288|P2|NOT COMPLETED|Period 2||0
7840753|NCT01005719|19297289|P1|NOT COMPLETED|Period 2||0
7840754|NCT01005719|19297284|P6|COMPLETED|Period 2||9
7840755|NCT01005719|19297285|P5|COMPLETED|Period 2||10
7840756|NCT01005719|19297286|P4|COMPLETED|Period 2||10
7840757|NCT01005719|19297287|P3|COMPLETED|Period 2||10
7840758|NCT01005719|19297288|P2|COMPLETED|Period 2||10
7840759|NCT01005719|19297289|P1|COMPLETED|Period 2||10
7840760|NCT01005719|19297284|P6|STARTED|Period 2||10
7840761|NCT01005719|19297285|P5|STARTED|Period 2||11
7840762|NCT01005719|19297286|P4|STARTED|Period 2||10
7840763|NCT01005719|19297287|P3|STARTED|Period 2||10
7840764|NCT01005719|19297288|P2|STARTED|Period 2||10
7840765|NCT01005719|19297289|P1|STARTED|Period 2||10
7840766|NCT01005719|19297284|P6|NOT COMPLETED|Period 1||1
7840767|NCT01005719|19297285|P5|NOT COMPLETED|Period 1||0
7840768|NCT01005719|19297286|P4|NOT COMPLETED|Period 1||1
7840769|NCT01005719|19297287|P3|NOT COMPLETED|Period 1||0
7840770|NCT01005719|19297288|P2|NOT COMPLETED|Period 1||0
7840771|NCT01005719|19297289|P1|NOT COMPLETED|Period 1||0
7840772|NCT01005719|19297284|P6|COMPLETED|Period 1||10
7840773|NCT01005719|19297285|P5|COMPLETED|Period 1||11
7840774|NCT01005719|19297286|P4|COMPLETED|Period 1||10
7840775|NCT01005719|19297287|P3|COMPLETED|Period 1||10
7840776|NCT01005719|19297288|P2|COMPLETED|Period 1||10
7840777|NCT01005719|19297289|P1|COMPLETED|Period 1||10
7840778|NCT01005719|19297284|P6|STARTED|Period 1||11
7840779|NCT01005719|19297285|P5|STARTED|Period 1||11
7840780|NCT01005719|19297286|P4|STARTED|Period 1||11
7840781|NCT01005719|19297287|P3|STARTED|Period 1||10
7840782|NCT01005719|19297288|P2|STARTED|Period 1||10
7840783|NCT01005719|19297289|P1|STARTED|Period 1||10
7840784|NCT01005706|19297347|P2|NOT COMPLETED|Overall Study||0
7840785|NCT01005706|19297348|P1|NOT COMPLETED|Overall Study||0
7840786|NCT01005706|19297347|P2|COMPLETED|Overall Study||17
7840787|NCT01005706|19297348|P1|COMPLETED|Overall Study||23
7840788|NCT01005706|19297347|P2|STARTED|Overall Study||17
7840789|NCT01005706|19297348|P1|STARTED|Overall Study||23
7840790|NCT01005680|19297356|P2|NOT COMPLETED|Overall Study||11
7840791|NCT01005680|19297357|P1|NOT COMPLETED|Overall Study||6
7840792|NCT01005680|19297356|P2|COMPLETED|Overall Study||119
7840793|NCT01005680|19297357|P1|COMPLETED|Overall Study||120
7840794|NCT01005680|19297356|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
7840795|NCT01005680|19297357|P1|Received at Least 1 Dose of Study Drug|Overall Study||125
7840796|NCT01005680|19297356|P2|STARTED|Overall Study||130
7840797|NCT01005680|19297357|P1|STARTED|Overall Study||126
7840798|NCT01005602|19297381|P2|NOT COMPLETED|Overall Study||0
7840799|NCT01005602|19297382|P1|NOT COMPLETED|Overall Study||1
7840800|NCT01005602|19297381|P2|COMPLETED|Overall Study||66
7840801|NCT01005602|19297382|P1|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65
7840802|NCT01005602|19297381|P2|STARTED|Overall Study||66
7840803|NCT01005602|19297382|P1|STARTED|Overall Study||66
7840804|NCT01005576|19297402|P1|NOT COMPLETED|Overall Study||0
7840805|NCT01005576|19297402|P1|COMPLETED|Overall Study|All participants completed the conditioning regimen and received their stem cell transplant|21
7840806|NCT01005576|19297402|P1|STARTED|Overall Study||21
7840807|NCT01005459|19297412|P2|NOT COMPLETED|Overall Study||0
7840808|NCT01005459|19297413|P1|NOT COMPLETED|Overall Study||0
7840809|NCT01005459|19297412|P2|COMPLETED|Overall Study||23
7840810|NCT01005459|19297413|P1|COMPLETED|Overall Study||23
7840811|NCT01005459|19297412|P2|STARTED|Overall Study||23
7840812|NCT01005459|19297413|P1|STARTED|Overall Study||23
7840813|NCT01005407|19297421|P2|NOT COMPLETED|Overall Study||32
7840814|NCT01005407|19297422|P1|NOT COMPLETED|Overall Study||151
7840815|NCT01005407|19297421|P2|COMPLETED|Overall Study||451
7840816|NCT01005407|19297422|P1|COMPLETED|Overall Study||1818
7840817|NCT01005407|19297421|P2|STARTED|Overall Study||483
7840818|NCT01005407|19297422|P1|STARTED|Overall Study||1969
7840819|NCT01005355|19297433|P3|NOT COMPLETED|Overall Study||0
7840820|NCT01005355|19297434|P2|NOT COMPLETED|Overall Study||0
7840821|NCT01005355|19297435|P1|NOT COMPLETED|Overall Study||0
7840822|NCT01005355|19297433|P3|COMPLETED|Overall Study||6
7840823|NCT01005355|19297434|P2|COMPLETED|Overall Study||6
7840824|NCT01005355|19297435|P1|COMPLETED|Overall Study||3
7840825|NCT01005355|19297433|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
7840826|NCT01005355|19297434|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
7840827|NCT01005355|19297435|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
7840828|NCT01005355|19297433|P3|STARTED|Overall Study||6
7840829|NCT01005355|19297434|P2|STARTED|Overall Study||6
7840830|NCT01005355|19297435|P1|STARTED|Overall Study||3
7840831|NCT01005329|19297470|P1|NOT COMPLETED|Overall Study||4
7840832|NCT01005329|19297470|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30
7840833|NCT01005329|19297470|P1|STARTED|Overall Study||34
7840834|NCT01005316|19297483|P4|NOT COMPLETED|Overall Study||108
7840835|NCT01005316|19297484|P3|NOT COMPLETED|Overall Study||11
7840836|NCT01005316|19297485|P2|NOT COMPLETED|Overall Study||76
7840837|NCT01005316|19297486|P1|NOT COMPLETED|Overall Study||50
7840838|NCT01005316|19297483|P4|COMPLETED|Overall Study||19
7840839|NCT01005316|19297484|P3|COMPLETED|Overall Study||5
7840840|NCT01005316|19297485|P2|COMPLETED|Overall Study||21
7840841|NCT01005316|19297486|P1|COMPLETED|Overall Study||0
7840842|NCT01005316|19297483|P4|STARTED|Overall Study||127
7840843|NCT01005316|19297484|P3|STARTED|Overall Study||16
7840844|NCT01005316|19297485|P2|STARTED|Overall Study||97
7840845|NCT01005316|19297486|P1|STARTED|Overall Study||50
7840846|NCT01005290|19297538|P3|NOT COMPLETED|Period 2 (5 Weeks)||2
7840847|NCT01005290|19297539|P2|NOT COMPLETED|Period 2 (5 Weeks)||0
7840848|NCT01005290|19297540|P1|NOT COMPLETED|Period 2 (5 Weeks)||0
7840849|NCT01005290|19297538|P3|COMPLETED|Period 2 (5 Weeks)||7
7840850|NCT01005290|19297539|P2|COMPLETED|Period 2 (5 Weeks)||13
7840851|NCT01005290|19297540|P1|COMPLETED|Period 2 (5 Weeks)||0
7840852|NCT01005290|19297538|P3|STARTED|Period 2 (5 Weeks)||9
7840853|NCT01005290|19297539|P2|STARTED|Period 2 (5 Weeks)||13
7840854|NCT01005290|19297540|P1|STARTED|Period 2 (5 Weeks)||0
7840855|NCT01005290|19297538|P3|NOT COMPLETED|Washout Period (2 Weeks)||0
7840856|NCT01005290|19297539|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
7840857|NCT01005290|19297540|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
7840858|NCT01005290|19297538|P3|COMPLETED|Washout Period (2 Weeks)||9
7840859|NCT01005290|19297539|P2|COMPLETED|Washout Period (2 Weeks)||13
7840860|NCT01005290|19297540|P1|COMPLETED|Washout Period (2 Weeks)||0
7840861|NCT01005290|19297538|P3|STARTED|Washout Period (2 Weeks)||9
7840862|NCT01005290|19297539|P2|STARTED|Washout Period (2 Weeks)||13
7840863|NCT01005290|19297540|P1|STARTED|Washout Period (2 Weeks)||0
7840864|NCT01005290|19297538|P3|NOT COMPLETED|Period 1 (5 Weeks)||9
7840865|NCT01005290|19297539|P2|NOT COMPLETED|Period 1 (5 Weeks)||7
7840866|NCT01005290|19297540|P1|NOT COMPLETED|Period 1 (5 Weeks)||0
7840867|NCT01005290|19297538|P3|COMPLETED|Period 1 (5 Weeks)||9
7840868|NCT01005290|19297539|P2|COMPLETED|Period 1 (5 Weeks)||13
7840869|NCT01005290|19297540|P1|COMPLETED|Period 1 (5 Weeks)||0
7840870|NCT01005290|19297538|P3|STARTED|Period 1 (5 Weeks)||18
7840871|NCT01005290|19297539|P2|STARTED|Period 1 (5 Weeks)||20
7840872|NCT01005290|19297540|P1|STARTED|Period 1 (5 Weeks)||0
7840873|NCT01005290|19297538|P3|NOT COMPLETED|Run-In||0
7840874|NCT01005290|19297539|P2|NOT COMPLETED|Run-In||0
7840875|NCT01005290|19297540|P1|NOT COMPLETED|Run-In||14
7840876|NCT01005290|19297538|P3|COMPLETED|Run-In||0
7840877|NCT01005290|19297539|P2|COMPLETED|Run-In||0
7840878|NCT01005290|19297540|P1|COMPLETED|Run-In||38
7840879|NCT01005290|19297538|P3|STARTED|Run-In||0
7840880|NCT01005290|19297539|P2|STARTED|Run-In||0
7840881|NCT01005290|19297540|P1|STARTED|Run-In||52
7840882|NCT01005251|19297553|P5|NOT COMPLETED|Overall Study||18
7840883|NCT01005251|19297554|P4|NOT COMPLETED|Overall Study||12
7840884|NCT01005251|19297555|P3|NOT COMPLETED|Overall Study||22
7840885|NCT01005251|19297556|P2|NOT COMPLETED|Overall Study||16
7840886|NCT01005251|19297557|P1|NOT COMPLETED|Overall Study||13
7840887|NCT01005251|19297553|P5|COMPLETED|Overall Study||122
7840888|NCT01005251|19297554|P4|COMPLETED|Overall Study||114
7840889|NCT01005251|19297555|P3|COMPLETED|Overall Study||114
7840890|NCT01005251|19297556|P2|COMPLETED|Overall Study||109
7840891|NCT01005251|19297557|P1|COMPLETED|Overall Study||121
7840892|NCT01005251|19297553|P5|STARTED|Overall Study||140
7840893|NCT01005251|19297554|P4|STARTED|Overall Study||126
7840894|NCT01005251|19297555|P3|STARTED|Overall Study||136
7840895|NCT01005251|19297556|P2|STARTED|Overall Study||125
7840896|NCT01005251|19297557|P1|STARTED|Overall Study||134
7840897|NCT01004991|19297574|P1|NOT COMPLETED|Overall Study||0
7840898|NCT01004991|19297574|P1|COMPLETED|Overall Study||12
7840899|NCT01004991|19297574|P1|STARTED|Overall Study||12
7840900|NCT01004939|19297578|P1|NOT COMPLETED|Overall Study||0
7840901|NCT01004939|19297578|P1|COMPLETED|Overall Study||120
7840902|NCT01004939|19297578|P1|STARTED|Overall Study||120
7840903|NCT01004874|19297619|P1|NOT COMPLETED|Overall Study||0
7840904|NCT01004874|19297619|P1|COMPLETED|Overall Study||80
7840905|NCT01004874|19297619|P1|STARTED|Overall Study||80
7840906|NCT01004861|19297641|P13|NOT COMPLETED|Overall Study||20
7840907|NCT01004861|19297642|P12|NOT COMPLETED|Overall Study||8
7840908|NCT01004861|19297643|P11|NOT COMPLETED|Overall Study||9
7840909|NCT01004861|19297644|P10|NOT COMPLETED|Overall Study||11
7840910|NCT01004861|19297645|P9|NOT COMPLETED|Overall Study||39
7840911|NCT01004861|19297646|P8|NOT COMPLETED|Overall Study||4
7840912|NCT01004861|19297647|P7|NOT COMPLETED|Overall Study||7
7840913|NCT01004861|19297648|P6|NOT COMPLETED|Overall Study||6
7840914|NCT01004861|19297649|P5|NOT COMPLETED|Overall Study||7
7840915|NCT01004861|19297650|P4|NOT COMPLETED|Overall Study||6
7840916|NCT01004861|19297651|P3|NOT COMPLETED|Overall Study||6
7840917|NCT01004861|19297652|P2|NOT COMPLETED|Overall Study||6
7840918|NCT01004861|19297653|P1|NOT COMPLETED|Overall Study||3
7840919|NCT01004861|19297641|P13|COMPLETED|Overall Study||0
7840920|NCT01004861|19297642|P12|COMPLETED|Overall Study||0
7840921|NCT01004861|19297643|P11|COMPLETED|Overall Study||0
7840922|NCT01004861|19297644|P10|COMPLETED|Overall Study||0
7840923|NCT01004861|19297645|P9|COMPLETED|Overall Study||0
7840924|NCT01004861|19297646|P8|COMPLETED|Overall Study||0
7840925|NCT01004861|19297647|P7|COMPLETED|Overall Study||0
7840926|NCT01004861|19297648|P6|COMPLETED|Overall Study||0
7840927|NCT01004861|19297649|P5|COMPLETED|Overall Study||0
7840928|NCT01004861|19297650|P4|COMPLETED|Overall Study||0
7840929|NCT01004861|19297651|P3|COMPLETED|Overall Study||0
7840930|NCT01004861|19297652|P2|COMPLETED|Overall Study||0
7840931|NCT01004861|19297653|P1|COMPLETED|Overall Study||0
7840932|NCT01004861|19297641|P13|STARTED|Overall Study||20
7840933|NCT01004861|19297642|P12|STARTED|Overall Study||8
7840934|NCT01004861|19297643|P11|STARTED|Overall Study||9
7840935|NCT01004861|19297644|P10|STARTED|Overall Study||11
7840936|NCT01004861|19297645|P9|STARTED|Overall Study||39
7840937|NCT01004861|19297646|P8|STARTED|Overall Study||4
7840938|NCT01004861|19297647|P7|STARTED|Overall Study||7
7840939|NCT01004861|19297648|P6|STARTED|Overall Study||6
7840940|NCT01004861|19297649|P5|STARTED|Overall Study||7
7840941|NCT01004861|19297650|P4|STARTED|Overall Study||6
7840942|NCT01004861|19297651|P3|STARTED|Overall Study||6
7840943|NCT01004861|19297652|P2|STARTED|Overall Study||6
7840944|NCT01004861|19297653|P1|STARTED|Overall Study||3
7840945|NCT01004848|19297719|P2|NOT COMPLETED|Overall Study||45
7840946|NCT01004848|19297720|P1|NOT COMPLETED|Overall Study||55
7840947|NCT01004848|19297719|P2|COMPLETED|Overall Study||147
7840948|NCT01004848|19297720|P1|COMPLETED|Overall Study||155
7840949|NCT01004848|19297719|P2|STARTED|Overall Study||192
7840950|NCT01004848|19297720|P1|STARTED|Overall Study||210
7840951|NCT01004822|19297758|P8|NOT COMPLETED|Overall Study||5
7840952|NCT01004822|19297759|P7|NOT COMPLETED|Overall Study||4
7840953|NCT01004822|19297760|P6|NOT COMPLETED|Overall Study||4
7840954|NCT01004822|19297761|P5|NOT COMPLETED|Overall Study||4
7840955|NCT01004822|19297762|P4|NOT COMPLETED|Overall Study||4
7840956|NCT01004822|19297763|P3|NOT COMPLETED|Overall Study||4
7840957|NCT01004822|19297764|P2|NOT COMPLETED|Overall Study||3
7840958|NCT01004822|19297765|P1|NOT COMPLETED|Overall Study||3
7840959|NCT01004822|19297758|P8|COMPLETED|Overall Study||0
7840960|NCT01004822|19297759|P7|COMPLETED|Overall Study||0
7840961|NCT01004822|19297760|P6|COMPLETED|Overall Study||0
7840962|NCT01004822|19297761|P5|COMPLETED|Overall Study||0
7840963|NCT01004822|19297762|P4|COMPLETED|Overall Study||0
7840964|NCT01004822|19297763|P3|COMPLETED|Overall Study||0
7840965|NCT01004822|19297764|P2|COMPLETED|Overall Study||0
7840966|NCT01004822|19297765|P1|COMPLETED|Overall Study||0
7840967|NCT01004822|19297758|P8|Treated|Overall Study||5
7840968|NCT01004822|19297759|P7|Treated|Overall Study||4
7840969|NCT01004822|19297760|P6|Treated|Overall Study||4
7840970|NCT01004822|19297761|P5|Treated|Overall Study||4
7840971|NCT01004822|19297762|P4|Treated|Overall Study||4
7840972|NCT01004822|19297763|P3|Treated|Overall Study||3
7840973|NCT01004822|19297764|P2|Treated|Overall Study||3
7840974|NCT01004822|19297765|P1|Treated|Overall Study||3
7840975|NCT01004822|19297758|P8|STARTED|Overall Study||5
7840976|NCT01004822|19297759|P7|STARTED|Overall Study||4
7840977|NCT01004822|19297760|P6|STARTED|Overall Study||4
7840978|NCT01004822|19297761|P5|STARTED|Overall Study||4
7840979|NCT01004822|19297762|P4|STARTED|Overall Study||4
7840980|NCT01004822|19297763|P3|STARTED|Overall Study||4
7840981|NCT01004822|19297764|P2|STARTED|Overall Study||3
7840982|NCT01004822|19297765|P1|STARTED|Overall Study||3
7840983|NCT01004770|19297879|P5|NOT COMPLETED|Overall Study||0
7840984|NCT01004770|19297880|P4|NOT COMPLETED|Overall Study||0
7840985|NCT01004770|19297881|P3|NOT COMPLETED|Overall Study||0
7840986|NCT01004770|19297882|P2|NOT COMPLETED|Overall Study||0
7840987|NCT01004770|19297883|P1|NOT COMPLETED|Overall Study||0
7840988|NCT01004770|19297879|P5|COMPLETED|Overall Study||10
7840989|NCT01004770|19297880|P4|COMPLETED|Overall Study||10
7840990|NCT01004770|19297881|P3|COMPLETED|Overall Study||10
7840991|NCT01004770|19297882|P2|COMPLETED|Overall Study||10
7840992|NCT01004770|19297883|P1|COMPLETED|Overall Study||10
7840993|NCT01004770|19297879|P5|STARTED|Overall Study||10
7840994|NCT01004770|19297880|P4|STARTED|Overall Study||10
7840995|NCT01004770|19297881|P3|STARTED|Overall Study||10
7840996|NCT01004770|19297882|P2|STARTED|Overall Study||10
7840997|NCT01004770|19297883|P1|STARTED|Overall Study||10
7840998|NCT01004705|19297915|P3|NOT COMPLETED|Period 2 (12 Weeks)||4
7840999|NCT01004705|19297916|P2|NOT COMPLETED|Period 2 (12 Weeks)||0
7841000|NCT01004705|19297917|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
7841001|NCT01004705|19297915|P3|COMPLETED|Period 2 (12 Weeks)||9
7841002|NCT01004705|19297916|P2|COMPLETED|Period 2 (12 Weeks)||13
7841003|NCT01004705|19297917|P1|COMPLETED|Period 2 (12 Weeks)||0
7841004|NCT01004705|19297915|P3|STARTED|Period 2 (12 Weeks)||13
7841005|NCT01004705|19297916|P2|STARTED|Period 2 (12 Weeks)||13
7841006|NCT01004705|19297917|P1|STARTED|Period 2 (12 Weeks)||0
7841007|NCT01004705|19297915|P3|NOT COMPLETED|Washout Period (6 Weeks)||0
7841008|NCT01004705|19297916|P2|NOT COMPLETED|Washout Period (6 Weeks)||0
7841009|NCT01004705|19297917|P1|NOT COMPLETED|Washout Period (6 Weeks)||0
7841010|NCT01004705|19297915|P3|COMPLETED|Washout Period (6 Weeks)||13
7841011|NCT01004705|19297916|P2|COMPLETED|Washout Period (6 Weeks)||13
7841012|NCT01004705|19297917|P1|COMPLETED|Washout Period (6 Weeks)||0
7841013|NCT01004705|19297915|P3|STARTED|Washout Period (6 Weeks)||13
7841014|NCT01004705|19297916|P2|STARTED|Washout Period (6 Weeks)||13
7841015|NCT01004705|19297917|P1|STARTED|Washout Period (6 Weeks)||0
7841016|NCT01004705|19297915|P3|NOT COMPLETED|Period 1 (12 Weeks)||5
7841017|NCT01004705|19297916|P2|NOT COMPLETED|Period 1 (12 Weeks)||5
7841018|NCT01004705|19297917|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
7841019|NCT01004705|19297915|P3|COMPLETED|Period 1 (12 Weeks)||13
7841020|NCT01004705|19297916|P2|COMPLETED|Period 1 (12 Weeks)||13
7841021|NCT01004705|19297917|P1|COMPLETED|Period 1 (12 Weeks)||0
7841022|NCT01004705|19297915|P3|STARTED|Period 1 (12 Weeks)||18
7841023|NCT01004705|19297916|P2|STARTED|Period 1 (12 Weeks)||18
7841024|NCT01004705|19297917|P1|STARTED|Period 1 (12 Weeks)||0
7841025|NCT01004705|19297915|P3|NOT COMPLETED|Run-In||0
7841026|NCT01004705|19297916|P2|NOT COMPLETED|Run-In||0
7841027|NCT01004705|19297917|P1|NOT COMPLETED|Run-In||8
7841028|NCT01004705|19297915|P3|COMPLETED|Run-In||0
7841029|NCT01004705|19297916|P2|COMPLETED|Run-In||0
7841030|NCT01004705|19297917|P1|COMPLETED|Run-In||36
7841031|NCT01004705|19297915|P3|STARTED|Run-In||0
7841032|NCT01004705|19297916|P2|STARTED|Run-In||0
7841033|NCT01004705|19297917|P1|STARTED|Run-In||44
7841034|NCT01004614|19297930|P4|NOT COMPLETED|Second Intervention||0
7841035|NCT01004614|19297931|P3|NOT COMPLETED|Second Intervention||0
7841036|NCT01004614|19297932|P2|NOT COMPLETED|Second Intervention||0
7841037|NCT01004614|19297933|P1|NOT COMPLETED|Second Intervention||0
7841038|NCT01004614|19297930|P4|COMPLETED|Second Intervention||12
7841039|NCT01004614|19297931|P3|COMPLETED|Second Intervention||12
7841040|NCT01004614|19297932|P2|COMPLETED|Second Intervention||11
7841041|NCT01004614|19297933|P1|COMPLETED|Second Intervention||12
7841042|NCT01004614|19297930|P4|STARTED|Second Intervention||12
7841043|NCT01004614|19297931|P3|STARTED|Second Intervention||12
7841044|NCT01004614|19297932|P2|STARTED|Second Intervention||11
7841045|NCT01004614|19297933|P1|STARTED|Second Intervention||12
7841046|NCT01004614|19297930|P4|NOT COMPLETED|Washout||0
7841047|NCT01004614|19297931|P3|NOT COMPLETED|Washout||0
7841048|NCT01004614|19297932|P2|NOT COMPLETED|Washout||1
7841049|NCT01004614|19297933|P1|NOT COMPLETED|Washout||0
7841050|NCT01004614|19297930|P4|COMPLETED|Washout||12
7841051|NCT01004614|19297931|P3|COMPLETED|Washout||12
7841052|NCT01004614|19297932|P2|COMPLETED|Washout||11
7841053|NCT01004614|19297933|P1|COMPLETED|Washout||12
7841054|NCT01004614|19297930|P4|STARTED|Washout||12
7841055|NCT01004614|19297931|P3|STARTED|Washout||12
7841056|NCT01004614|19297932|P2|STARTED|Washout||12
7841057|NCT01004614|19297933|P1|STARTED|Washout||12
7841058|NCT01004614|19297930|P4|NOT COMPLETED|First Intervention||0
7841059|NCT01004614|19297931|P3|NOT COMPLETED|First Intervention||0
7841060|NCT01004614|19297932|P2|NOT COMPLETED|First Intervention||0
7841061|NCT01004614|19297933|P1|NOT COMPLETED|First Intervention||0
7841062|NCT01004614|19297930|P4|COMPLETED|First Intervention||12
7841063|NCT01004614|19297931|P3|COMPLETED|First Intervention||12
7841064|NCT01004614|19297932|P2|COMPLETED|First Intervention||12
7841065|NCT01004614|19297933|P1|COMPLETED|First Intervention||12
7841066|NCT01004614|19297930|P4|STARTED|First Intervention||12
7841067|NCT01004614|19297931|P3|STARTED|First Intervention||12
7841068|NCT01004614|19297932|P2|STARTED|First Intervention||12
7841069|NCT01004614|19297933|P1|STARTED|First Intervention||12
7841070|NCT01004510|19297967|P1|NOT COMPLETED|Overall Study||1
7841071|NCT01004510|19297967|P1|COMPLETED|Overall Study||2
7841072|NCT01004510|19297967|P1|STARTED|Overall Study||3
7841073|NCT01004432|19297971|P5|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18
7841074|NCT01004432|19297972|P4|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
7841075|NCT01004432|19297973|P3|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
7841076|NCT01004432|19297974|P2|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
7841077|NCT01004432|19297975|P1|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
7841078|NCT01004432|19297971|P5|COMPLETED|OL Study Extension (Week 52 - 76)||194
7841079|NCT01004432|19297972|P4|COMPLETED|OL Study Extension (Week 52 - 76)||0
7841080|NCT01004432|19297973|P3|COMPLETED|OL Study Extension (Week 52 - 76)||0
7841081|NCT01004432|19297974|P2|COMPLETED|OL Study Extension (Week 52 - 76)||0
7841082|NCT01004432|19297975|P1|COMPLETED|OL Study Extension (Week 52 - 76)||0
7841083|NCT01004432|19297971|P5|STARTED|OL Study Extension (Week 52 - 76)||212
7841084|NCT01004432|19297972|P4|STARTED|OL Study Extension (Week 52 - 76)||0
7841085|NCT01004432|19297973|P3|STARTED|OL Study Extension (Week 52 - 76)||0
7841086|NCT01004432|19297974|P2|STARTED|OL Study Extension (Week 52 - 76)||0
7841087|NCT01004432|19297975|P1|STARTED|OL Study Extension (Week 52 - 76)||0
7841088|NCT01004432|19297971|P5|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
7841089|NCT01004432|19297972|P4|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58
7841090|NCT01004432|19297973|P3|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37
7841091|NCT01004432|19297974|P2|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10
7841092|NCT01004432|19297975|P1|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
7841093|NCT01004432|19297971|P5|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
7841094|NCT01004432|19297972|P4|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126
7841095|NCT01004432|19297973|P3|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54
7841096|NCT01004432|19297974|P2|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65
7841097|NCT01004432|19297975|P1|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
7841098|NCT01004432|19297971|P5|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
7841099|NCT01004432|19297972|P4|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184
7841100|NCT01004432|19297973|P3|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91
7841101|NCT01004432|19297974|P2|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75
7841102|NCT01004432|19297975|P1|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
7841103|NCT01004432|19297971|P5|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
7841104|NCT01004432|19297972|P4|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
7841105|NCT01004432|19297973|P3|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
7841106|NCT01004432|19297974|P2|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
7841107|NCT01004432|19297975|P1|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||83
7841108|NCT01004432|19297971|P5|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
7841109|NCT01004432|19297972|P4|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
7841110|NCT01004432|19297973|P3|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
7841111|NCT01004432|19297974|P2|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
7841112|NCT01004432|19297975|P1|COMPLETED|Open-label (OL) Period (Week 0 - 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350
7841113|NCT01004432|19297971|P5|STARTED|Open-label (OL) Period (Week 0 - 16)||0
7841114|NCT01004432|19297972|P4|STARTED|Open-label (OL) Period (Week 0 - 16)||0
7841115|NCT01004432|19297973|P3|STARTED|Open-label (OL) Period (Week 0 - 16)||0
7841116|NCT01004432|19297974|P2|STARTED|Open-label (OL) Period (Week 0 - 16)||0
7841117|NCT01004432|19297975|P1|STARTED|Open-label (OL) Period (Week 0 - 16)||433
7841118|NCT01004406|19297997|P2|NOT COMPLETED|Overall Study||0
7841119|NCT01004406|19297998|P1|NOT COMPLETED|Overall Study||3
7841120|NCT01004406|19297997|P2|COMPLETED|Overall Study||10
7841121|NCT01004406|19297998|P1|COMPLETED|Overall Study||18
7841122|NCT01004406|19297997|P2|STARTED|Overall Study||10
7841123|NCT01004406|19297998|P1|STARTED|Overall Study||21
7841124|NCT01004393|19298010|P1|NOT COMPLETED|Overall Study||0
7841125|NCT01004393|19298010|P1|COMPLETED|Overall Study||12
7841126|NCT01004393|19298010|P1|STARTED|Overall Study||12
7841127|NCT01004354|19298021|P1|NOT COMPLETED|Overall Study||0
7841128|NCT01004354|19298021|P1|COMPLETED|Overall Study||12
7841129|NCT01004354|19298021|P1|STARTED|Overall Study||12
7841130|NCT01004263|19298033|P1|NOT COMPLETED|Overall Study||179
7841131|NCT01004263|19298033|P1|COMPLETED|Overall Study||427
7841132|NCT01004263|19298033|P1|STARTED|Overall Study|Participants who took study drug|606
7841133|NCT01004250|19298041|P1|NOT COMPLETED|Follow-Up (FU) Period||1
7841134|NCT01004250|19298041|P1|COMPLETED|Follow-Up (FU) Period||100
7841135|NCT01004250|19298041|P1|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101
7841136|NCT01004250|19298041|P1|NOT COMPLETED|Maintenance Therapy Period||26
7841137|NCT01004250|19298041|P1|COMPLETED|Maintenance Therapy Period||46
7841138|NCT01004250|19298041|P1|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46
7841139|NCT01004250|19298041|P1|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72
7841140|NCT01004250|19298041|P1|NOT COMPLETED|Induction Therapy Period||15
7841141|NCT01004250|19298041|P1|COMPLETED|Induction Therapy Period||94
7841142|NCT01004250|19298041|P1|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21
7841143|NCT01004250|19298041|P1|Received at Least One Dose of Study Drug|Induction Therapy Period||109
7841144|NCT01004250|19298041|P1|STARTED|Induction Therapy Period||109
7841145|NCT01004185|19298053|P2|NOT COMPLETED|Overall Study||9
7841146|NCT01004185|19298054|P1|NOT COMPLETED|Overall Study||9
7841147|NCT01004185|19298053|P2|COMPLETED|Overall Study||11
7841148|NCT01004185|19298054|P1|COMPLETED|Overall Study||10
7841149|NCT01004185|19298053|P2|STARTED|Overall Study||20
7841150|NCT01004185|19298054|P1|STARTED|Overall Study||19
7841151|NCT01004172|19298062|P1|NOT COMPLETED|Overall Study||38
7841152|NCT01004172|19298062|P1|COMPLETED|Overall Study||0
7841153|NCT01004172|19298062|P1|STARTED|Overall Study||38
7841154|NCT01004159|19298070|P1|NOT COMPLETED|Overall Study||20
7841155|NCT01004159|19298070|P1|COMPLETED|Overall Study||0
7841156|NCT01004159|19298070|P1|STARTED|Overall Study||20
7841157|NCT01004146|19298077|P2|NOT COMPLETED|Overall Study||5
7841158|NCT01004146|19298078|P1|NOT COMPLETED|Overall Study||4
7841159|NCT01004146|19298077|P2|COMPLETED|Overall Study||20
7841160|NCT01004146|19298078|P1|COMPLETED|Overall Study||21
7841161|NCT01004146|19298077|P2|Have Incentive Spirometry Data|Overall Study||20
7841162|NCT01004146|19298078|P1|Have Incentive Spirometry Data|Overall Study||21
7841163|NCT01004146|19298077|P2|STARTED|Overall Study||25
7841164|NCT01004146|19298078|P1|STARTED|Overall Study||25
7841165|NCT01004107|19298086|P2|NOT COMPLETED|Overall Study||2
7841166|NCT01004107|19298087|P1|NOT COMPLETED|Overall Study||1
7841167|NCT01004107|19298086|P2|COMPLETED|Overall Study||23
7841168|NCT01004107|19298087|P1|COMPLETED|Overall Study||75
7841169|NCT01004107|19298086|P2|STARTED|Overall Study||25
7841170|NCT01004107|19298087|P1|STARTED|Overall Study||76
7841171|NCT01004003|19298172|P9|NOT COMPLETED|Overall Study||30
7841172|NCT01004003|19298173|P8|NOT COMPLETED|Overall Study||60
7841173|NCT01004003|19298174|P7|NOT COMPLETED|Overall Study||8
7841174|NCT01004003|19298175|P6|NOT COMPLETED|Overall Study||4
7841175|NCT01004003|19298176|P5|NOT COMPLETED|Overall Study||4
7841176|NCT01004003|19298177|P4|NOT COMPLETED|Overall Study||3
7841177|NCT01004003|19298178|P3|NOT COMPLETED|Overall Study||4
7841178|NCT01004003|19298179|P2|NOT COMPLETED|Overall Study||3
7841179|NCT01004003|19298180|P1|NOT COMPLETED|Overall Study||6
7841180|NCT01004003|19298172|P9|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1
7841181|NCT01004003|19298173|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2
7841182|NCT01004003|19298174|P7|COMPLETED|Overall Study||0
7841183|NCT01004003|19298175|P6|COMPLETED|Overall Study||0
7841184|NCT01004003|19298176|P5|COMPLETED|Overall Study||0
7841185|NCT01004003|19298177|P4|COMPLETED|Overall Study||0
7841186|NCT01004003|19298178|P3|COMPLETED|Overall Study||0
7841187|NCT01004003|19298179|P2|COMPLETED|Overall Study||0
7841188|NCT01004003|19298180|P1|COMPLETED|Overall Study||0
7841189|NCT01004003|19298172|P9|STARTED|Overall Study||31
7841190|NCT01004003|19298173|P8|STARTED|Overall Study||62
7841191|NCT01004003|19298174|P7|STARTED|Overall Study||8
7841192|NCT01004003|19298175|P6|STARTED|Overall Study||4
7841193|NCT01004003|19298176|P5|STARTED|Overall Study||4
7841194|NCT01004003|19298177|P4|STARTED|Overall Study||3
7841195|NCT01004003|19298178|P3|STARTED|Overall Study||4
7841196|NCT01004003|19298179|P2|STARTED|Overall Study||3
7841197|NCT01004003|19298180|P1|STARTED|Overall Study||6
7841198|NCT01003990|19298211|P3|NOT COMPLETED|Overall Study||43
7841199|NCT01003990|19298212|P2|NOT COMPLETED|Overall Study||51
7841200|NCT01003990|19298213|P1|NOT COMPLETED|Overall Study||92
7841201|NCT01003990|19298211|P3|COMPLETED|Overall Study||53
7841202|NCT01003990|19298212|P2|COMPLETED|Overall Study||103
7841203|NCT01003990|19298213|P1|COMPLETED|Overall Study||367
7841204|NCT01003990|19298211|P3|STARTED|Overall Study||96
7841205|NCT01003990|19298212|P2|STARTED|Overall Study||154
7841206|NCT01003990|19298213|P1|STARTED|Overall Study||459
7841207|NCT01003938|19298221|P1|NOT COMPLETED|Overall Study||0
7841208|NCT01003938|19298221|P1|COMPLETED|Overall Study||6
7841209|NCT01003938|19298221|P1|STARTED|Overall Study||6
7841210|NCT01003899|19298230|P1|NOT COMPLETED|Overall Study||47
7841211|NCT01003899|19298230|P1|COMPLETED|Overall Study||0
7841212|NCT01003899|19298230|P1|STARTED|Overall Study|enrolled|47
7841213|NCT01003886|19298239|P1|NOT COMPLETED|Overall Study||230
7841214|NCT01003886|19298239|P1|COMPLETED|Overall Study||759
7841215|NCT01003886|19298239|P1|STARTED|Overall Study||989
7841216|NCT01003769|19298248|P1|NOT COMPLETED|Overall Study||0
7841217|NCT01003769|19298248|P1|COMPLETED|Overall Study||5
7841218|NCT01003769|19298248|P1|STARTED|Overall Study||5
7841219|NCT01003639|19298260|P2|NOT COMPLETED|Overall Study||22
7841220|NCT01003639|19298261|P1|NOT COMPLETED|Overall Study||17
7841221|NCT01003639|19298260|P2|COMPLETED|Overall Study||57
7841222|NCT01003639|19298261|P1|COMPLETED|Overall Study||69
7841223|NCT01003639|19298260|P2|STARTED|Overall Study||79
7841224|NCT01003639|19298261|P1|STARTED|Overall Study||86
7841225|NCT01003418|19298275|P2|NOT COMPLETED|Overall Study||0
7841226|NCT01003418|19298276|P1|NOT COMPLETED|Overall Study||0
7841227|NCT01003418|19298275|P2|COMPLETED|Overall Study||3
7841228|NCT01003418|19298276|P1|COMPLETED|Overall Study||5
7841229|NCT01003418|19298275|P2|STARTED|Overall Study||3
7841230|NCT01003418|19298276|P1|STARTED|Overall Study||5
7841231|NCT01003301|19298294|P2|NOT COMPLETED|Overall Study||0
7841232|NCT01003301|19298295|P1|NOT COMPLETED|Overall Study||0
7841233|NCT01003301|19298294|P2|COMPLETED|Overall Study||9
7841234|NCT01003301|19298295|P1|COMPLETED|Overall Study||10
7841235|NCT01003301|19298294|P2|STARTED|Overall Study||9
7841236|NCT01003301|19298295|P1|STARTED|Overall Study||10
7841237|NCT01003288|19298303|P1|NOT COMPLETED|Overall Study||0
7841238|NCT01003288|19298303|P1|COMPLETED|Overall Study||255
7841239|NCT01003288|19298303|P1|STARTED|Overall Study||255
7841240|NCT01003275|19298310|P2|NOT COMPLETED|Overall Study||0
7841241|NCT01003275|19298311|P1|NOT COMPLETED|Overall Study||1
7841242|NCT01003275|19298310|P2|COMPLETED|Overall Study||11
7841243|NCT01003275|19298311|P1|COMPLETED|Overall Study||10
7841244|NCT01003275|19298310|P2|STARTED|Overall Study||11
7841245|NCT01003275|19298311|P1|STARTED|Overall Study||11
7841246|NCT01003249|19298317|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
7841247|NCT01003249|19298318|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
7841248|NCT01003249|19298317|P2|COMPLETED|Second Intervention (4 Weeks)||2
7841249|NCT01003249|19298318|P1|COMPLETED|Second Intervention (4 Weeks)||3
7841250|NCT01003249|19298317|P2|STARTED|Second Intervention (4 Weeks)||3
7841251|NCT01003249|19298318|P1|STARTED|Second Intervention (4 Weeks)||4
7841252|NCT01003249|19298317|P2|NOT COMPLETED|Washout (3 Weeks)||0
7841253|NCT01003249|19298318|P1|NOT COMPLETED|Washout (3 Weeks)||0
7841254|NCT01003249|19298317|P2|COMPLETED|Washout (3 Weeks)||3
7841255|NCT01003249|19298318|P1|COMPLETED|Washout (3 Weeks)||4
7841256|NCT01003249|19298317|P2|STARTED|Washout (3 Weeks)||3
7841257|NCT01003249|19298318|P1|STARTED|Washout (3 Weeks)||4
7841258|NCT01003249|19298317|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
7841259|NCT01003249|19298318|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
7841260|NCT01003249|19298317|P2|COMPLETED|First Intervention (4 Weeks)||3
7841261|NCT01003249|19298318|P1|COMPLETED|First Intervention (4 Weeks)||5
7841262|NCT01003249|19298317|P2|Received Intervention|First Intervention (4 Weeks)||5
7841263|NCT01003249|19298318|P1|Received Intervention|First Intervention (4 Weeks)||7
7841264|NCT01003249|19298317|P2|STARTED|First Intervention (4 Weeks)||5
7841265|NCT01003249|19298318|P1|STARTED|First Intervention (4 Weeks)||7
7841266|NCT01003210|19298336|P2|NOT COMPLETED|Overall Study||3
7841267|NCT01003210|19298337|P1|NOT COMPLETED|Overall Study||1
7841268|NCT01003210|19298336|P2|COMPLETED|Overall Study||102
7841269|NCT01003210|19298337|P1|COMPLETED|Overall Study||104
7841270|NCT01003210|19298336|P2|STARTED|Overall Study||105
7841271|NCT01003210|19298337|P1|STARTED|Overall Study||105
7841272|NCT01003184|19298349|P2|NOT COMPLETED|Overall Study||12
7841273|NCT01003184|19298350|P1|NOT COMPLETED|Overall Study||19
7841274|NCT01003184|19298349|P2|COMPLETED|Overall Study||99
7841275|NCT01003184|19298350|P1|COMPLETED|Overall Study||92
7841276|NCT01003184|19298349|P2|Full Analysis Set (FAS)|Overall Study||105
7841277|NCT01003184|19298350|P1|Full Analysis Set (FAS)|Overall Study||111
7841278|NCT01003184|19298349|P2|STARTED|Overall Study||111
7841279|NCT01003184|19298350|P1|STARTED|Overall Study||111
7841280|NCT01003106|19298386|P8|NOT COMPLETED|Month 6-Month 36||0
7841281|NCT01003106|19298387|P7|NOT COMPLETED|Month 6-Month 36||1
7841282|NCT01003106|19298388|P6|NOT COMPLETED|Month 6-Month 36||0
7841283|NCT01003106|19298389|P5|NOT COMPLETED|Month 6-Month 36||0
7841284|NCT01003106|19298390|P4|NOT COMPLETED|Month 6-Month 36||0
7841285|NCT01003106|19298391|P3|NOT COMPLETED|Month 6-Month 36||1
7841286|NCT01003106|19298392|P2|NOT COMPLETED|Month 6-Month 36||0
7841287|NCT01003106|19298393|P1|NOT COMPLETED|Month 6-Month 36||0
7841288|NCT01003106|19298386|P8|COMPLETED|Month 6-Month 36||18
7841289|NCT01003106|19298387|P7|COMPLETED|Month 6-Month 36||19
7841290|NCT01003106|19298388|P6|COMPLETED|Month 6-Month 36||0
7841291|NCT01003106|19298389|P5|COMPLETED|Month 6-Month 36||0
7841292|NCT01003106|19298390|P4|COMPLETED|Month 6-Month 36||20
7841293|NCT01003106|19298391|P3|COMPLETED|Month 6-Month 36||18
7841294|NCT01003106|19298392|P2|COMPLETED|Month 6-Month 36||0
7841295|NCT01003106|19298393|P1|COMPLETED|Month 6-Month 36||0
7841296|NCT01003106|19298386|P8|STARTED|Month 6-Month 36||18
7841297|NCT01003106|19298387|P7|STARTED|Month 6-Month 36||20
7841298|NCT01003106|19298388|P6|STARTED|Month 6-Month 36||0
7841299|NCT01003106|19298389|P5|STARTED|Month 6-Month 36||0
7841300|NCT01003106|19298390|P4|STARTED|Month 6-Month 36||20
7841301|NCT01003106|19298391|P3|STARTED|Month 6-Month 36||19
7841302|NCT01003106|19298392|P2|STARTED|Month 6-Month 36||0
7841303|NCT01003106|19298393|P1|STARTED|Month 6-Month 36||0
7841304|NCT01003106|19298386|P8|NOT COMPLETED|Baseline to Month 6||0
7841305|NCT01003106|19298387|P7|NOT COMPLETED|Baseline to Month 6||0
7841306|NCT01003106|19298388|P6|NOT COMPLETED|Baseline to Month 6||0
7841307|NCT01003106|19298389|P5|NOT COMPLETED|Baseline to Month 6||0
7841308|NCT01003106|19298390|P4|NOT COMPLETED|Baseline to Month 6||0
7841309|NCT01003106|19298391|P3|NOT COMPLETED|Baseline to Month 6||0
7841310|NCT01003106|19298392|P2|NOT COMPLETED|Baseline to Month 6||0
7841311|NCT01003106|19298393|P1|NOT COMPLETED|Baseline to Month 6||0
7841312|NCT01003106|19298386|P8|COMPLETED|Baseline to Month 6||0
7841313|NCT01003106|19298387|P7|COMPLETED|Baseline to Month 6||0
7841314|NCT01003106|19298388|P6|COMPLETED|Baseline to Month 6||20
7841315|NCT01003106|19298389|P5|COMPLETED|Baseline to Month 6||19
7841316|NCT01003106|19298390|P4|COMPLETED|Baseline to Month 6||0
7841317|NCT01003106|19298391|P3|COMPLETED|Baseline to Month 6||0
7841318|NCT01003106|19298392|P2|COMPLETED|Baseline to Month 6||20
7841319|NCT01003106|19298393|P1|COMPLETED|Baseline to Month 6||22
7841320|NCT01003106|19298386|P8|STARTED|Baseline to Month 6||0
7841321|NCT01003106|19298387|P7|STARTED|Baseline to Month 6||0
7841322|NCT01003106|19298388|P6|STARTED|Baseline to Month 6||20
7841323|NCT01003106|19298389|P5|STARTED|Baseline to Month 6||19
7841324|NCT01003106|19298390|P4|STARTED|Baseline to Month 6||0
7841325|NCT01003106|19298391|P3|STARTED|Baseline to Month 6||0
7841326|NCT01003106|19298392|P2|STARTED|Baseline to Month 6||20
7841327|NCT01003106|19298393|P1|STARTED|Baseline to Month 6||22
7841328|NCT01003080|19298417|P2|NOT COMPLETED|Overall Study||0
7841329|NCT01003080|19298418|P1|NOT COMPLETED|Overall Study||0
7841330|NCT01003080|19298417|P2|COMPLETED|Overall Study||61
7841331|NCT01003080|19298418|P1|COMPLETED|Overall Study||50
7841332|NCT01003080|19298417|P2|STARTED|Overall Study||61
7841333|NCT01003080|19298418|P1|STARTED|Overall Study||50
7841334|NCT01003067|19298426|P2|NOT COMPLETED|Overall Study||24
7841335|NCT01003067|19298427|P1|NOT COMPLETED|Overall Study||33
7841336|NCT01003067|19298426|P2|COMPLETED|Overall Study||107
7841337|NCT01003067|19298427|P1|COMPLETED|Overall Study||103
7841338|NCT01003067|19298426|P2|STARTED|Overall Study||131
7841339|NCT01003067|19298427|P1|STARTED|Overall Study||136
7841340|NCT01002989|19298433|P1|NOT COMPLETED|Overall Study||5
7841341|NCT01002989|19298433|P1|COMPLETED|Overall Study||93
7841342|NCT01002989|19298433|P1|STARTED|Overall Study||98
7841343|NCT01002755|19298440|P1|NOT COMPLETED|Overall Study||0
7841344|NCT01002755|19298440|P1|COMPLETED|Overall Study||36
7841345|NCT01002755|19298440|P1|STARTED|Overall Study||36
7841346|NCT01002742|19298448|P2|NOT COMPLETED|Overall Study||1
7841347|NCT01002742|19298449|P1|NOT COMPLETED|Overall Study||0
7841348|NCT01002742|19298448|P2|COMPLETED|Overall Study||116
7841349|NCT01002742|19298449|P1|COMPLETED|Overall Study||119
7841350|NCT01002742|19298448|P2|STARTED|Overall Study||117
7841351|NCT01002742|19298449|P1|STARTED|Overall Study||119
7841352|NCT01002573|19298485|P2|NOT COMPLETED|Overall Study||7
7841353|NCT01002573|19298486|P1|NOT COMPLETED|Overall Study||11
7841354|NCT01002573|19298485|P2|COMPLETED|Overall Study||53
7841355|NCT01002573|19298486|P1|COMPLETED|Overall Study||47
7841356|NCT01002573|19298485|P2|STARTED|Overall Study||60
7841357|NCT01002573|19298486|P1|STARTED|Overall Study||58
7841358|NCT01002547|19298507|P3|NOT COMPLETED|Overall Study||8
7841359|NCT01002547|19298508|P2|NOT COMPLETED|Overall Study||3
7841360|NCT01002547|19298509|P1|NOT COMPLETED|Overall Study||8
7841361|NCT01002547|19298507|P3|COMPLETED|Overall Study||29
7841362|NCT01002547|19298508|P2|COMPLETED|Overall Study||33
7841363|NCT01002547|19298509|P1|COMPLETED|Overall Study||24
7841364|NCT01002547|19298507|P3|STARTED|Overall Study||37
7841365|NCT01002547|19298508|P2|STARTED|Overall Study||36
7841366|NCT01002547|19298509|P1|STARTED|Overall Study||32
7841367|NCT01002482|19298567|P2|NOT COMPLETED|Overall Study||21
7841368|NCT01002482|19298568|P1|NOT COMPLETED|Overall Study||15
7841369|NCT01002482|19298567|P2|COMPLETED|Overall Study||1312
7841370|NCT01002482|19298568|P1|COMPLETED|Overall Study||1336
7841371|NCT01002482|19298567|P2|STARTED|Overall Study||1333
7841372|NCT01002482|19298568|P1|STARTED|Overall Study||1351
7841373|NCT01002456|19298590|P2|NOT COMPLETED|Overall Study||0
7841374|NCT01002456|19298591|P1|NOT COMPLETED|Overall Study||0
7841375|NCT01002456|19298590|P2|COMPLETED|Overall Study||122
7841376|NCT01002456|19298591|P1|COMPLETED|Overall Study||98
7841377|NCT01002456|19298590|P2|STARTED|Overall Study||122
7841378|NCT01002456|19298591|P1|STARTED|Overall Study||98
7841379|NCT01002339|19298602|P3|NOT COMPLETED|Overall Study||5
7841380|NCT01002339|19298603|P2|NOT COMPLETED|Overall Study||1
7841381|NCT01002339|19298604|P1|NOT COMPLETED|Overall Study||0
7841382|NCT01002339|19298602|P3|COMPLETED|Overall Study||42
7841383|NCT01002339|19298603|P2|COMPLETED|Overall Study||42
7841384|NCT01002339|19298604|P1|COMPLETED|Overall Study||44
7841385|NCT01002339|19298602|P3|STARTED|Overall Study||47
7841386|NCT01002339|19298603|P2|STARTED|Overall Study||43
7841387|NCT01002339|19298604|P1|STARTED|Overall Study||44
7841388|NCT01002287|19298659|P2|NOT COMPLETED|Overall Study||0
7841389|NCT01002287|19298660|P1|NOT COMPLETED|Overall Study||0
7841390|NCT01002287|19298659|P2|COMPLETED|Overall Study||3
7841391|NCT01002287|19298660|P1|COMPLETED|Overall Study||8
7841392|NCT01002287|19298659|P2|STARTED|Overall Study||3
7841393|NCT01002287|19298660|P1|STARTED|Overall Study||8
7841394|NCT01002118|19298672|P1|NOT COMPLETED|Overall Study||0
7841395|NCT01002118|19298672|P1|COMPLETED|Overall Study||1
7841396|NCT01002118|19298672|P1|Randomized Only Patient|Overall Study||1
7841397|NCT01002118|19298672|P1|STARTED|Overall Study||1
7841398|NCT01002105|19298680|P2|NOT COMPLETED|Overall Study||21
7841399|NCT01002105|19298681|P1|NOT COMPLETED|Overall Study||19
7841400|NCT01002105|19298680|P2|COMPLETED|Overall Study||11
7841401|NCT01002105|19298681|P1|COMPLETED|Overall Study||13
7841402|NCT01002105|19298680|P2|STARTED|Overall Study||32
7841403|NCT01002105|19298681|P1|STARTED|Overall Study||32
7841404|NCT01001988|19298697|P1|NOT COMPLETED|Overall Study||117
7841405|NCT01001988|19298697|P1|COMPLETED|Overall Study||479
7841406|NCT01001988|19298697|P1|STARTED|Overall Study||596
7841407|NCT01001975|19298704|P2|NOT COMPLETED|Overall Study||0
7841408|NCT01001975|19298705|P1|NOT COMPLETED|Overall Study||0
7841409|NCT01001975|19298704|P2|COMPLETED|Overall Study||5
7841410|NCT01001975|19298705|P1|COMPLETED|Overall Study||5
7841411|NCT01001975|19298704|P2|STARTED|Overall Study||5
7841412|NCT01001975|19298705|P1|STARTED|Overall Study||5
7841413|NCT01001832|19298715|P2|NOT COMPLETED|Follow-up Period||21
7841414|NCT01001832|19298716|P1|NOT COMPLETED|Follow-up Period||18
7841415|NCT01001832|19298715|P2|COMPLETED|Follow-up Period||30
7841416|NCT01001832|19298716|P1|COMPLETED|Follow-up Period||34
7841417|NCT01001832|19298715|P2|STARTED|Follow-up Period||51
7841418|NCT01001832|19298716|P1|STARTED|Follow-up Period||52
7841419|NCT01001832|19298715|P2|NOT COMPLETED|Long-term Period||5
7841420|NCT01001832|19298716|P1|NOT COMPLETED|Long-term Period||4
7841421|NCT01001832|19298715|P2|COMPLETED|Long-term Period||51
7841422|NCT01001832|19298716|P1|COMPLETED|Long-term Period||52
7841423|NCT01001832|19298715|P2|STARTED|Long-term Period||56
7841424|NCT01001832|19298716|P1|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56
7841425|NCT01001832|19298715|P2|NOT COMPLETED|Short-term Period||3
7841426|NCT01001832|19298716|P1|NOT COMPLETED|Short-term Period||2
7841427|NCT01001832|19298715|P2|COMPLETED|Short-term Period||56
7841428|NCT01001832|19298716|P1|COMPLETED|Short-term Period||57
7841429|NCT01001832|19298715|P2|STARTED|Short-term Period||59
7841430|NCT01001832|19298716|P1|STARTED|Short-term Period||59
7841431|NCT01001806|19298762|P3|NOT COMPLETED|Overall Study||4
7841432|NCT01001806|19298763|P2|NOT COMPLETED|Overall Study||1
7841433|NCT01001806|19298764|P1|NOT COMPLETED|Overall Study||0
7841434|NCT01001806|19298762|P3|COMPLETED|Overall Study||38
7841435|NCT01001806|19298763|P2|COMPLETED|Overall Study||41
7841436|NCT01001806|19298764|P1|COMPLETED|Overall Study||42
7841437|NCT01001806|19298762|P3|STARTED|Overall Study||42
7841438|NCT01001806|19298763|P2|STARTED|Overall Study||42
7841439|NCT01001806|19298764|P1|STARTED|Overall Study||42
7841440|NCT01001767|19298774|P2|NOT COMPLETED|Overall Study||0
7841441|NCT01001767|19298775|P1|NOT COMPLETED|Overall Study||4
7841442|NCT01001767|19298774|P2|COMPLETED|Overall Study||17
7841443|NCT01001767|19298775|P1|COMPLETED|Overall Study||14
7841444|NCT01001767|19298774|P2|STARTED|Overall Study||17
7841445|NCT01001767|19298775|P1|STARTED|Overall Study||18
7841446|NCT01001702|19298781|P1|NOT COMPLETED|Overall Study||72
7841447|NCT01001702|19298781|P1|COMPLETED|Overall Study||13
7841448|NCT01001702|19298781|P1|STARTED|Overall Study||85
7841449|NCT01001598|19298792|P1|NOT COMPLETED|Overall Study||2
7841450|NCT01001598|19298792|P1|COMPLETED|Overall Study|3 completed study (2 FA and 1 DC) in 2011|3
7841451|NCT01001598|19298792|P1|STARTED|Overall Study||5
7841452|NCT01001572|19298800|P3|NOT COMPLETED|Double-Blind Treatment Phase||19
7841453|NCT01001572|19298801|P2|NOT COMPLETED|Double-Blind Treatment Phase||10
7841454|NCT01001572|19298802|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
7841455|NCT01001572|19298800|P3|COMPLETED|Double-Blind Treatment Phase||306
7841456|NCT01001572|19298801|P2|COMPLETED|Double-Blind Treatment Phase||319
7841457|NCT01001572|19298802|P1|COMPLETED|Double-Blind Treatment Phase||0
7841458|NCT01001572|19298800|P3|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323
7841459|NCT01001572|19298801|P2|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328
7841460|NCT01001572|19298802|P1|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0
7841461|NCT01001572|19298800|P3|STARTED|Double-Blind Treatment Phase||325
7841462|NCT01001572|19298801|P2|STARTED|Double-Blind Treatment Phase||329
7841463|NCT01001572|19298802|P1|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0
7841464|NCT01001572|19298800|P3|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
7841465|NCT01001572|19298801|P2|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
7841466|NCT01001572|19298802|P1|NOT COMPLETED|Single-Blind Valsartan 160 mg||278
7841467|NCT01001572|19298800|P3|COMPLETED|Single-Blind Valsartan 160 mg||0
7841468|NCT01001572|19298801|P2|COMPLETED|Single-Blind Valsartan 160 mg||0
7841469|NCT01001572|19298802|P1|COMPLETED|Single-Blind Valsartan 160 mg||654
7841470|NCT01001572|19298800|P3|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
7841471|NCT01001572|19298801|P2|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
7841472|NCT01001572|19298802|P1|STARTED|Single-Blind Valsartan 160 mg||932
7841473|NCT01001559|19298818|P2|NOT COMPLETED|Overall Study||0
7841474|NCT01001559|19298819|P1|NOT COMPLETED|Overall Study||0
7841475|NCT01001559|19298818|P2|COMPLETED|Overall Study||147
7841476|NCT01001559|19298819|P1|COMPLETED|Overall Study||95
7841477|NCT01001559|19298818|P2|STARTED|Overall Study||147
7841478|NCT01001559|19298819|P1|STARTED|Overall Study||95
7841479|NCT01001546|19298833|P2|NOT COMPLETED|Overall Study||0
7841480|NCT01001546|19298834|P1|NOT COMPLETED|Overall Study||0
7841481|NCT01001546|19298833|P2|COMPLETED|Overall Study||207
7841482|NCT01001546|19298834|P1|COMPLETED|Overall Study||206
7841483|NCT01001546|19298833|P2|STARTED|Overall Study||207
7841484|NCT01001546|19298834|P1|STARTED|Overall Study||206
7841485|NCT01001520|19298840|P2|NOT COMPLETED|Medication Period 2||3
7841486|NCT01001520|19298841|P1|NOT COMPLETED|Medication Period 2||0
7841487|NCT01001520|19298840|P2|COMPLETED|Medication Period 2||13
7841488|NCT01001520|19298841|P1|COMPLETED|Medication Period 2||16
7841489|NCT01001520|19298840|P2|STARTED|Medication Period 2||16
7841490|NCT01001520|19298841|P1|STARTED|Medication Period 2||16
7841491|NCT01001520|19298840|P2|NOT COMPLETED|Washout Period||1
7841492|NCT01001520|19298841|P1|NOT COMPLETED|Washout Period||2
7841493|NCT01001520|19298840|P2|COMPLETED|Washout Period||16
7841494|NCT01001520|19298841|P1|COMPLETED|Washout Period||16
7841495|NCT01001520|19298840|P2|STARTED|Washout Period||17
7841496|NCT01001520|19298841|P1|STARTED|Washout Period||18
7841497|NCT01001520|19298840|P2|NOT COMPLETED|Medication Period 1||7
7841498|NCT01001520|19298841|P1|NOT COMPLETED|Medication Period 1||4
7841499|NCT01001520|19298840|P2|COMPLETED|Medication Period 1||17
7841500|NCT01001520|19298841|P1|COMPLETED|Medication Period 1||18
7841501|NCT01001520|19298840|P2|STARTED|Medication Period 1||24
7841502|NCT01001520|19298841|P1|STARTED|Medication Period 1||22
7841503|NCT01001494|19298868|P3|NOT COMPLETED|Overall Study||41
7841504|NCT01001494|19298869|P2|NOT COMPLETED|Overall Study||17
7841505|NCT01001494|19298870|P1|NOT COMPLETED|Overall Study||24
7841506|NCT01001494|19298868|P3|COMPLETED|Overall Study||232
7841507|NCT01001494|19298869|P2|COMPLETED|Overall Study||252
7841508|NCT01001494|19298870|P1|COMPLETED|Overall Study||253
7841509|NCT01001494|19298868|P3|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273
7841510|NCT01001494|19298869|P2|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269
7841511|NCT01001494|19298870|P1|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277
7841512|NCT01001442|19298898|P8|NOT COMPLETED|Overall Study||2
7841513|NCT01001442|19298899|P7|NOT COMPLETED|Overall Study||4
7841514|NCT01001442|19298900|P6|NOT COMPLETED|Overall Study||0
7841515|NCT01001442|19298901|P5|NOT COMPLETED|Overall Study||2
7841516|NCT01001442|19298902|P4|NOT COMPLETED|Overall Study||0
7841517|NCT01001442|19298903|P3|NOT COMPLETED|Overall Study||0
7841518|NCT01001442|19298904|P2|NOT COMPLETED|Overall Study||0
7841519|NCT01001442|19298905|P1|NOT COMPLETED|Overall Study||0
7841520|NCT01001442|19298898|P8|COMPLETED|Overall Study||2
7841521|NCT01001442|19298899|P7|COMPLETED|Overall Study||6
7841522|NCT01001442|19298900|P6|COMPLETED|Overall Study||3
7841523|NCT01001442|19298901|P5|COMPLETED|Overall Study||2
7841524|NCT01001442|19298902|P4|COMPLETED|Overall Study||3
7841525|NCT01001442|19298903|P3|COMPLETED|Overall Study||4
7841526|NCT01001442|19298904|P2|COMPLETED|Overall Study||3
7841527|NCT01001442|19298905|P1|COMPLETED|Overall Study||4
7841528|NCT01001442|19298898|P8|STARTED|Overall Study||4
7841529|NCT01001442|19298899|P7|STARTED|Overall Study||10
7841530|NCT01001442|19298900|P6|STARTED|Overall Study||3
7841531|NCT01001442|19298901|P5|STARTED|Overall Study||4
7841532|NCT01001442|19298902|P4|STARTED|Overall Study||3
7841533|NCT01001442|19298903|P3|STARTED|Overall Study||4
7841534|NCT01001442|19298904|P2|STARTED|Overall Study||3
7841535|NCT01001442|19298905|P1|STARTED|Overall Study||4
7841536|NCT01001429|19298955|P2|NOT COMPLETED|Overall Study||1
7841537|NCT01001429|19298956|P1|NOT COMPLETED|Overall Study||0
7841538|NCT01001429|19298955|P2|COMPLETED|Overall Study||37
7841539|NCT01001429|19298956|P1|COMPLETED|Overall Study||39
7841540|NCT01001429|19298955|P2|STARTED|Overall Study||38
7841541|NCT01001429|19298956|P1|STARTED|Overall Study||39
7841542|NCT01001403|19298988|P2|NOT COMPLETED|Overall Study||0
7841543|NCT01001403|19298989|P1|NOT COMPLETED|Overall Study||0
7841544|NCT01001403|19298988|P2|COMPLETED|Overall Study||31
7841545|NCT01001403|19298989|P1|COMPLETED|Overall Study||31
7841546|NCT01001403|19298988|P2|STARTED|Overall Study||31
7841547|NCT01001403|19298989|P1|STARTED|Overall Study||31
7841548|NCT01001390|19298995|P2|NOT COMPLETED|Overall Study||0
7841549|NCT01001390|19298996|P1|NOT COMPLETED|Overall Study||2
7841550|NCT01001390|19298995|P2|COMPLETED|Overall Study||0
7841551|NCT01001390|19298996|P1|COMPLETED|Overall Study||0
7841552|NCT01001390|19298995|P2|STARTED|Overall Study||0
7841553|NCT01001390|19298996|P1|STARTED|Overall Study||2
7841554|NCT01001377|19299004|P2|NOT COMPLETED|Overall Study||421
7841555|NCT01001377|19299005|P1|NOT COMPLETED|Overall Study||426
7841556|NCT01001377|19299004|P2|COMPLETED|Overall Study|Indicates participants continuing in study|85
7841557|NCT01001377|19299005|P1|COMPLETED|Overall Study|Indicates participants continuing in study|78
7841558|NCT01001377|19299004|P2|Received Treatment|Overall Study||499
7841559|NCT01001377|19299005|P1|Received Treatment|Overall Study||500
7841560|NCT01001377|19299004|P2|STARTED|Overall Study||506
7841561|NCT01001377|19299005|P1|STARTED|Overall Study||504
7841562|NCT01001325|19299035|P2|NOT COMPLETED|Overall Study||10
7841563|NCT01001325|19299036|P1|NOT COMPLETED|Overall Study||18
7841564|NCT01001325|19299035|P2|COMPLETED|Overall Study||224
7841565|NCT01001325|19299036|P1|COMPLETED|Overall Study||216
7841566|NCT01001325|19299035|P2|STARTED|Overall Study||234
7841567|NCT01001325|19299036|P1|STARTED|Overall Study||234
7841568|NCT01001299|19299042|P1|NOT COMPLETED|Overall Study||25
7841569|NCT01001299|19299042|P1|COMPLETED|Overall Study||0
7841570|NCT01001299|19299042|P1|STARTED|Overall Study||25
7841571|NCT01001234|19299071|P5|NOT COMPLETED|Overall Study||0
7841572|NCT01001234|19299072|P4|NOT COMPLETED|Overall Study||25
7841573|NCT01001234|19299073|P3|NOT COMPLETED|Overall Study||32
7841574|NCT01001234|19299074|P2|NOT COMPLETED|Overall Study||26
7841575|NCT01001234|19299075|P1|NOT COMPLETED|Overall Study||405
7841576|NCT01001234|19299071|P5|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40
7841577|NCT01001234|19299072|P4|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385
7841578|NCT01001234|19299073|P3|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377
7841579|NCT01001234|19299074|P2|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5
7841580|NCT01001234|19299075|P1|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87
7841581|NCT01001234|19299071|P5|Participants Not Treated|Overall Study|Participants who did not take study drug|0
7841582|NCT01001234|19299072|P4|Participants Not Treated|Overall Study|Participants who did not take study drug|5
7841583|NCT01001234|19299073|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|9
7841584|NCT01001234|19299074|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|23
7841585|NCT01001234|19299075|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|368
7841586|NCT01001234|19299071|P5|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40
7841587|NCT01001234|19299072|P4|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405
7841588|NCT01001234|19299073|P3|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400
7841589|NCT01001234|19299074|P2|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8
7841590|NCT01001234|19299075|P1|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124
7841591|NCT01001234|19299071|P5|STARTED|Overall Study|Participants who were randomized to study drug|40
7841592|NCT01001234|19299072|P4|STARTED|Overall Study|Participants who were randomized to study drug|410
7841593|NCT01001234|19299073|P3|STARTED|Overall Study|Participants who were randomized to study drug|409
7841594|NCT01001234|19299074|P2|STARTED|Overall Study|Participants who were randomized to study drug|31
7841595|NCT01001234|19299075|P1|STARTED|Overall Study|Participants who were randomized to study drug|492
7841596|NCT01001221|19299091|P5|NOT COMPLETED|Overall Study||0
7841597|NCT01001221|19299092|P4|NOT COMPLETED|Overall Study||6
7841598|NCT01001221|19299093|P3|NOT COMPLETED|Overall Study||3
7841599|NCT01001221|19299094|P2|NOT COMPLETED|Overall Study||5
7841600|NCT01001221|19299095|P1|NOT COMPLETED|Overall Study||5
7841601|NCT01001221|19299091|P5|COMPLETED|Overall Study||0
7841602|NCT01001221|19299092|P4|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
7841603|NCT01001221|19299093|P3|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
7841604|NCT01001221|19299094|P2|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
7841605|NCT01001221|19299095|P1|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
7841606|NCT01001221|19299091|P5|Completed 1st Treatment Cycle|Overall Study||0
7841607|NCT01001221|19299092|P4|Completed 1st Treatment Cycle|Overall Study||6
7841608|NCT01001221|19299093|P3|Completed 1st Treatment Cycle|Overall Study||2
7841609|NCT01001221|19299094|P2|Completed 1st Treatment Cycle|Overall Study||5
7841610|NCT01001221|19299095|P1|Completed 1st Treatment Cycle|Overall Study||5
7841611|NCT01001221|19299091|P5|Treated|Overall Study||0
7841612|NCT01001221|19299092|P4|Treated|Overall Study||6
7841613|NCT01001221|19299093|P3|Treated|Overall Study||2
7841614|NCT01001221|19299094|P2|Treated|Overall Study||5
7841615|NCT01001221|19299095|P1|Treated|Overall Study||5
7841616|NCT01001221|19299091|P5|STARTED|Overall Study|Inability to determine the MTD during study part 1|0
7841617|NCT01001221|19299092|P4|STARTED|Overall Study||6
7841618|NCT01001221|19299093|P3|STARTED|Overall Study||3
7841619|NCT01001221|19299094|P2|STARTED|Overall Study||5
7841620|NCT01001221|19299095|P1|STARTED|Overall Study||5
7841621|NCT01001208|19299270|P2|NOT COMPLETED|Overall Study||33
7841622|NCT01001208|19299271|P1|NOT COMPLETED|Overall Study||28
7841623|NCT01001208|19299270|P2|COMPLETED|Overall Study||206
7841624|NCT01001208|19299271|P1|COMPLETED|Overall Study||211
7841625|NCT01001208|19299270|P2|STARTED|Overall Study||239
7841626|NCT01001208|19299271|P1|STARTED|Overall Study||239
7841627|NCT01001195|19299299|P4|NOT COMPLETED|Overall Study||0
7841628|NCT01001195|19299300|P3|NOT COMPLETED|Overall Study||0
7841629|NCT01001195|19299301|P2|NOT COMPLETED|Overall Study||2
7841630|NCT01001195|19299302|P1|NOT COMPLETED|Overall Study||2
7841631|NCT01001195|19299299|P4|COMPLETED|Overall Study||41
7841632|NCT01001195|19299300|P3|COMPLETED|Overall Study||44
7841633|NCT01001195|19299301|P2|COMPLETED|Overall Study||39
7841634|NCT01001195|19299302|P1|COMPLETED|Overall Study||37
7841635|NCT01001195|19299299|P4|STARTED|Overall Study||41
7841636|NCT01001195|19299300|P3|STARTED|Overall Study||44
7841637|NCT01001195|19299301|P2|STARTED|Overall Study||41
7841638|NCT01001195|19299302|P1|STARTED|Overall Study||39
7841639|NCT01001169|19299314|P2|NOT COMPLETED|Overall Study||1
7841640|NCT01001169|19299315|P1|NOT COMPLETED|Overall Study||2
7841641|NCT01001169|19299314|P2|COMPLETED|Overall Study||29
7841642|NCT01001169|19299315|P1|COMPLETED|Overall Study||28
7841643|NCT01001169|19299314|P2|STARTED|Overall Study||30
7841644|NCT01001169|19299315|P1|STARTED|Overall Study||30
7841645|NCT01001104|19299423|P4|NOT COMPLETED|Overall Study||3
7841646|NCT01001104|19299424|P3|NOT COMPLETED|Overall Study||1
7841647|NCT01001104|19299425|P2|NOT COMPLETED|Overall Study||1
7841648|NCT01001104|19299426|P1|NOT COMPLETED|Overall Study||2
7841649|NCT01001104|19299423|P4|COMPLETED|Overall Study||34
7841650|NCT01001104|19299424|P3|COMPLETED|Overall Study||35
7841651|NCT01001104|19299425|P2|COMPLETED|Overall Study||36
7841652|NCT01001104|19299426|P1|COMPLETED|Overall Study||33
7841653|NCT01001104|19299423|P4|STARTED|Overall Study||37
7841654|NCT01001104|19299424|P3|STARTED|Overall Study||36
7841655|NCT01001104|19299425|P2|STARTED|Overall Study||37
7841656|NCT01001104|19299426|P1|STARTED|Overall Study||35
7841657|NCT01001078|19299473|P2|NOT COMPLETED|Overall Study||0
7841658|NCT01001078|19299474|P1|NOT COMPLETED|Overall Study||0
7841659|NCT01001078|19299473|P2|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50
7841660|NCT01001078|19299474|P1|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50
7841661|NCT01001078|19299473|P2|Lost to Followup Interview|Overall Study|Could not be interviewed.|2
7841662|NCT01001078|19299474|P1|Lost to Followup Interview|Overall Study|Could not be interviewed.|5
7841663|NCT01001078|19299473|P2|Intubated|Overall Study||1
7841664|NCT01001078|19299474|P1|Intubated|Overall Study||2
7841665|NCT01001078|19299473|P2|Received Crossover|Overall Study||3
7841666|NCT01001078|19299474|P1|Received Crossover|Overall Study||2
7841667|NCT01001078|19299473|P2|Received Allocated Intervention|Overall Study||46
7841668|NCT01001078|19299474|P1|Received Allocated Intervention|Overall Study||46
7841669|NCT01001078|19299473|P2|STARTED|Overall Study||50
7841670|NCT01001078|19299474|P1|STARTED|Overall Study||50
7841671|NCT01001052|19299490|P2|NOT COMPLETED|Overall Study||0
7841672|NCT01001052|19299491|P1|NOT COMPLETED|Overall Study||0
7841673|NCT01001052|19299490|P2|COMPLETED|Overall Study||18
7841674|NCT01001052|19299491|P1|COMPLETED|Overall Study||20
7841675|NCT01001052|19299490|P2|STARTED|Overall Study||18
7841676|NCT01001052|19299491|P1|STARTED|Overall Study||20
7841677|NCT01000987|19299504|P3|NOT COMPLETED|Overall Study||0
7841678|NCT01000987|19299505|P2|NOT COMPLETED|Overall Study||0
7841679|NCT01000987|19299506|P1|NOT COMPLETED|Overall Study||0
7841680|NCT01000987|19299504|P3|COMPLETED|Overall Study||17
7841681|NCT01000987|19299505|P2|COMPLETED|Overall Study||15
7841682|NCT01000987|19299506|P1|COMPLETED|Overall Study||12
7841683|NCT01000987|19299504|P3|STARTED|Overall Study||17
7841684|NCT01000987|19299505|P2|STARTED|Overall Study||15
7841685|NCT01000987|19299506|P1|STARTED|Overall Study||12
7841686|NCT01000974|19299517|P3|NOT COMPLETED|Booster Vaccination Phase||14
7841687|NCT01000974|19299518|P2|NOT COMPLETED|Booster Vaccination Phase||12
7841688|NCT01000974|19299519|P1|NOT COMPLETED|Booster Vaccination Phase||67
7841689|NCT01000974|19299517|P3|COMPLETED|Booster Vaccination Phase||386
7841690|NCT01000974|19299518|P2|COMPLETED|Booster Vaccination Phase||423
7841691|NCT01000974|19299519|P1|COMPLETED|Booster Vaccination Phase||2270
7841692|NCT01000974|19299517|P3|STARTED|Booster Vaccination Phase||400
7841693|NCT01000974|19299518|P2|STARTED|Booster Vaccination Phase||435
7841694|NCT01000974|19299519|P1|STARTED|Booster Vaccination Phase||2337
7841695|NCT01000974|19299517|P3|NOT COMPLETED|Primary Vaccination Phase||63
7841696|NCT01000974|19299518|P2|NOT COMPLETED|Primary Vaccination Phase||50
7841697|NCT01000974|19299519|P1|NOT COMPLETED|Primary Vaccination Phase||338
7841698|NCT01000974|19299517|P3|COMPLETED|Primary Vaccination Phase||457
7841699|NCT01000974|19299518|P2|COMPLETED|Primary Vaccination Phase||470
7841700|NCT01000974|19299519|P1|COMPLETED|Primary Vaccination Phase||2625
7841701|NCT01000974|19299517|P3|STARTED|Primary Vaccination Phase||520
7841702|NCT01000974|19299518|P2|STARTED|Primary Vaccination Phase||520
7841703|NCT01000974|19299519|P1|STARTED|Primary Vaccination Phase||2963
7841704|NCT01000961|19299626|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
7841705|NCT01000961|19299627|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
7841706|NCT01000961|19299626|P2|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20
7841707|NCT01000961|19299627|P1|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21
7841708|NCT01000961|19299626|P2|STARTED|Second Intervention (3 Weeks)||20
7841709|NCT01000961|19299627|P1|STARTED|Second Intervention (3 Weeks)||21
7841710|NCT01000961|19299626|P2|NOT COMPLETED|First Intervention (3 Weeks)||2
7841711|NCT01000961|19299627|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
7841712|NCT01000961|19299626|P2|COMPLETED|First Intervention (3 Weeks)||20
7841713|NCT01000961|19299627|P1|COMPLETED|First Intervention (3 Weeks)||21
7841714|NCT01000961|19299626|P2|STARTED|First Intervention (3 Weeks)||22
7841715|NCT01000961|19299627|P1|STARTED|First Intervention (3 Weeks)||21
7841716|NCT01000961|19299626|P2|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
7841717|NCT01000961|19299627|P1|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
7841718|NCT01000961|19299626|P2|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22
7841719|NCT01000961|19299627|P1|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21
7841720|NCT01000961|19299626|P2|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22
7841721|NCT01000961|19299627|P1|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21
7841722|NCT01000818|19299639|P1|NOT COMPLETED|Omeprazole + Raltegravir||0
7841723|NCT01000818|19299639|P1|COMPLETED|Omeprazole + Raltegravir||18
7841724|NCT01000818|19299639|P1|STARTED|Omeprazole + Raltegravir||18
7841725|NCT01000818|19299639|P1|NOT COMPLETED|Famotidine + Raltegravir||0
7841726|NCT01000818|19299639|P1|COMPLETED|Famotidine + Raltegravir||18
7841727|NCT01000818|19299639|P1|STARTED|Famotidine + Raltegravir||18
7841728|NCT01000818|19299639|P1|NOT COMPLETED|Raltegravir||0
7841729|NCT01000818|19299639|P1|COMPLETED|Raltegravir||18
7841730|NCT01000818|19299639|P1|STARTED|Raltegravir||18
7841731|NCT01000805|19299650|P2|NOT COMPLETED|Overall Study||62
7841732|NCT01000805|19299651|P1|NOT COMPLETED|Overall Study||70
7841733|NCT01000805|19299650|P2|COMPLETED|Overall Study||204
7841734|NCT01000805|19299651|P1|COMPLETED|Overall Study||192
7841735|NCT01000805|19299650|P2|STARTED|Overall Study||266
7841736|NCT01000805|19299651|P1|STARTED|Overall Study||262
7841737|NCT01000727|19299685|P2|NOT COMPLETED|Overall Study||176
7841738|NCT01000727|19299686|P1|NOT COMPLETED|Overall Study||175
7841739|NCT01000727|19299685|P2|COMPLETED|Overall Study||6328
7841740|NCT01000727|19299686|P1|COMPLETED|Overall Study||6347
7841741|NCT01000727|19299685|P2|STARTED|Overall Study||6504
7841742|NCT01000727|19299686|P1|STARTED|Overall Study||6522
7841743|NCT01000662|19299716|P2|NOT COMPLETED|Overall Study||8
7841744|NCT01000662|19299717|P1|NOT COMPLETED|Overall Study||4
7841745|NCT01000662|19299716|P2|COMPLETED|Overall Study||198
7841746|NCT01000662|19299717|P1|COMPLETED|Overall Study||202
7841747|NCT01000662|19299716|P2|STARTED|Overall Study||206
7841748|NCT01000662|19299717|P1|STARTED|Overall Study||206
7841749|NCT01000649|19299751|P4|NOT COMPLETED|Overall Study||6
7841750|NCT01000649|19299752|P3|NOT COMPLETED|Overall Study||2
7841751|NCT01000649|19299753|P2|NOT COMPLETED|Overall Study||3
7841752|NCT01000649|19299754|P1|NOT COMPLETED|Overall Study||5
7841753|NCT01000649|19299751|P4|COMPLETED|Overall Study||15
7841754|NCT01000649|19299752|P3|COMPLETED|Overall Study||0
7841755|NCT01000649|19299753|P2|COMPLETED|Overall Study||16
7841756|NCT01000649|19299754|P1|COMPLETED|Overall Study||5
7841757|NCT01000649|19299751|P4|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|21
7841758|NCT01000649|19299752|P3|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|2
7841759|NCT01000649|19299753|P2|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|20
7841760|NCT01000649|19299754|P1|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|10
7841761|NCT01000649|19299751|P4|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|21
7841762|NCT01000649|19299752|P3|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|2
7841763|NCT01000649|19299753|P2|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|19
7841764|NCT01000649|19299754|P1|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|10
7841765|NCT01000610|19299835|P1|NOT COMPLETED|Overall Study||6
7841766|NCT01000610|19299835|P1|COMPLETED|Overall Study||12
7841767|NCT01000610|19299835|P1|STARTED|Overall Study||18
7841768|NCT01000506|19299846|P4|NOT COMPLETED|Overall Study||23
7841769|NCT01000506|19299847|P3|NOT COMPLETED|Overall Study||21
7841770|NCT01000506|19299848|P2|NOT COMPLETED|Overall Study||24
7841771|NCT01000506|19299849|P1|NOT COMPLETED|Overall Study||28
7841772|NCT01000506|19299846|P4|COMPLETED|Overall Study||133
7841773|NCT01000506|19299847|P3|COMPLETED|Overall Study||131
7841774|NCT01000506|19299848|P2|COMPLETED|Overall Study||129
7841775|NCT01000506|19299849|P1|COMPLETED|Overall Study||127
7841776|NCT01000506|19299846|P4|STARTED|Overall Study||156
7841777|NCT01000506|19299847|P3|STARTED|Overall Study||152
7841778|NCT01000506|19299848|P2|STARTED|Overall Study||153
7841779|NCT01000506|19299849|P1|STARTED|Overall Study||155
7841780|NCT01000493|19299893|P2|NOT COMPLETED|Overall Study||55
7841781|NCT01000493|19299894|P1|NOT COMPLETED|Overall Study||39
7841782|NCT01000493|19299893|P2|COMPLETED|Overall Study||14
7841783|NCT01000493|19299894|P1|COMPLETED|Overall Study||21
7841784|NCT01000493|19299893|P2|STARTED|Overall Study||69
7841785|NCT01000493|19299894|P1|STARTED|Overall Study||60
7841786|NCT01000480|19299944|P1|NOT COMPLETED|Follow-Up Period||0
7841787|NCT01000480|19299944|P1|COMPLETED|Follow-Up Period||88
7841788|NCT01000480|19299944|P1|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88
7841789|NCT01000480|19299944|P1|NOT COMPLETED|Concurrent Therapy Phase||10
7841790|NCT01000480|19299944|P1|COMPLETED|Concurrent Therapy Phase||65
7841791|NCT01000480|19299944|P1|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1
7841792|NCT01000480|19299944|P1|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75
7841793|NCT01000480|19299944|P1|NOT COMPLETED|Induction Phase||7
7841794|NCT01000480|19299944|P1|COMPLETED|Induction Phase||83
7841795|NCT01000480|19299944|P1|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8
7841796|NCT01000480|19299944|P1|Received at Least 1 Dose of Either Drug|Induction Phase||90
7841797|NCT01000480|19299944|P1|STARTED|Induction Phase||90
7841798|NCT01000376|19299952|P2|NOT COMPLETED|Cycle 1 Day 15||0
7841799|NCT01000376|19299953|P1|NOT COMPLETED|Cycle 1 Day 15||0
7841800|NCT01000376|19299952|P2|COMPLETED|Cycle 1 Day 15||6
7841801|NCT01000376|19299953|P1|COMPLETED|Cycle 1 Day 15||4
7841802|NCT01000376|19299952|P2|STARTED|Cycle 1 Day 15||6
7841803|NCT01000376|19299953|P1|STARTED|Cycle 1 Day 15||4
7841804|NCT01000376|19299952|P2|NOT COMPLETED|Cycle 1 Day 1||0
7841805|NCT01000376|19299953|P1|NOT COMPLETED|Cycle 1 Day 1||2
7841806|NCT01000376|19299952|P2|COMPLETED|Cycle 1 Day 1||6
7841807|NCT01000376|19299953|P1|COMPLETED|Cycle 1 Day 1||4
7841808|NCT01000376|19299952|P2|STARTED|Cycle 1 Day 1||6
7841809|NCT01000376|19299953|P1|STARTED|Cycle 1 Day 1||6
7841810|NCT01000337|19299963|P2|NOT COMPLETED|Overall Study||3
7841811|NCT01000337|19299964|P1|NOT COMPLETED|Overall Study||4
7841812|NCT01000337|19299963|P2|COMPLETED|Overall Study||30
7841813|NCT01000337|19299964|P1|COMPLETED|Overall Study||30
7841814|NCT01000337|19299963|P2|STARTED|Overall Study||33
7841815|NCT01000337|19299964|P1|STARTED|Overall Study||34
7841816|NCT01000324|19299970|P1|NOT COMPLETED|Year 20||0
7841817|NCT01000324|19299970|P1|COMPLETED|Year 20||28
7841818|NCT01000324|19299970|P1|STARTED|Year 20||28
7841819|NCT01000324|19299970|P1|NOT COMPLETED|Year 19||0
7841820|NCT01000324|19299970|P1|COMPLETED|Year 19||28
7841821|NCT01000324|19299970|P1|STARTED|Year 19||28
7841822|NCT01000324|19299970|P1|NOT COMPLETED|Year 18||0
7841823|NCT01000324|19299970|P1|COMPLETED|Year 18||29
7841824|NCT01000324|19299970|P1|STARTED|Year 18||29
7841825|NCT01000324|19299970|P1|NOT COMPLETED|Year 17||0
7841826|NCT01000324|19299970|P1|COMPLETED|Year 17||32
7841827|NCT01000324|19299970|P1|STARTED|Year 17||32
7841828|NCT01000324|19299970|P1|NOT COMPLETED|Year 16||0
7841829|NCT01000324|19299970|P1|COMPLETED|Year 16||40
7841830|NCT01000324|19299970|P1|STARTED|Year 16||40
7841831|NCT01000311|19299982|P2|NOT COMPLETED|Overall Study||70
7841832|NCT01000311|19299983|P1|NOT COMPLETED|Overall Study||45
7841833|NCT01000311|19299982|P2|COMPLETED|Overall Study||201
7841834|NCT01000311|19299983|P1|COMPLETED|Overall Study||213
7841835|NCT01000311|19299982|P2|STARTED|Overall Study||271
7841836|NCT01000311|19299983|P1|STARTED|Overall Study||258
7841837|NCT01000285|19300013|P1|NOT COMPLETED|Overall Study||0
7841838|NCT01000285|19300013|P1|COMPLETED|Overall Study||18
7841839|NCT01000285|19300013|P1|STARTED|Overall Study||18
7841840|NCT01000155|19300033|P1|NOT COMPLETED|Overall Study||2
7841841|NCT01000155|19300033|P1|COMPLETED|Overall Study||3
7841842|NCT01000155|19300033|P1|STARTED|Overall Study||5
7841843|NCT01000064|19300039|P2|NOT COMPLETED|Overall Study||1
7841844|NCT01000064|19300040|P1|NOT COMPLETED|Overall Study||1
7841845|NCT01000064|19300039|P2|COMPLETED|Overall Study||5
7841846|NCT01000064|19300040|P1|COMPLETED|Overall Study||6
7841847|NCT01000064|19300039|P2|STARTED|Overall Study||6
7841848|NCT01000064|19300040|P1|STARTED|Overall Study||7
7841849|NCT01000051|19300063|P2|NOT COMPLETED|Overall Study||1
7841850|NCT01000051|19300064|P1|NOT COMPLETED|Overall Study||3
7841851|NCT01000051|19300063|P2|COMPLETED|Overall Study||17
7841852|NCT01000051|19300064|P1|COMPLETED|Overall Study||39
7841853|NCT01000051|19300063|P2|STARTED|Overall Study||18
7841854|NCT01000051|19300064|P1|STARTED|Overall Study||42
7841855|NCT01000025|19300072|P2|NOT COMPLETED|Overall Study||238
7841856|NCT01000025|19300073|P1|NOT COMPLETED|Overall Study||468
7841857|NCT01000025|19300072|P2|COMPLETED|Overall Study||2
7841858|NCT01000025|19300073|P1|COMPLETED|Overall Study||12
7841859|NCT01000025|19300072|P2|STARTED|Overall Study||240
7841860|NCT01000025|19300073|P1|STARTED|Overall Study||480
7841861|NCT00999921|19300091|P2|NOT COMPLETED|Overall Study||19
7841862|NCT00999921|19300092|P1|NOT COMPLETED|Overall Study||10
7841863|NCT00999921|19300091|P2|COMPLETED|Overall Study||110
7841864|NCT00999921|19300092|P1|COMPLETED|Overall Study||117
7841865|NCT00999921|19300091|P2|STARTED|Overall Study||129
7841866|NCT00999921|19300092|P1|STARTED|Overall Study||127
7841867|NCT00999908|19300102|P3|NOT COMPLETED|Treatment Period 3||0
7841868|NCT00999908|19300103|P2|NOT COMPLETED|Treatment Period 3||0
7841869|NCT00999908|19300104|P1|NOT COMPLETED|Treatment Period 3||0
7841870|NCT00999908|19300102|P3|COMPLETED|Treatment Period 3||19
7841871|NCT00999908|19300103|P2|COMPLETED|Treatment Period 3||16
7841872|NCT00999908|19300104|P1|COMPLETED|Treatment Period 3||16
7841873|NCT00999908|19300102|P3|STARTED|Treatment Period 3||19
7841874|NCT00999908|19300103|P2|STARTED|Treatment Period 3||16
7841875|NCT00999908|19300104|P1|STARTED|Treatment Period 3||16
7841876|NCT00999908|19300102|P3|NOT COMPLETED|Treatment Period 2||0
7841877|NCT00999908|19300103|P2|NOT COMPLETED|Treatment Period 2||0
7841878|NCT00999908|19300104|P1|NOT COMPLETED|Treatment Period 2||1
7841879|NCT00999908|19300102|P3|COMPLETED|Treatment Period 2||19
7841880|NCT00999908|19300103|P2|COMPLETED|Treatment Period 2||16
7841881|NCT00999908|19300104|P1|COMPLETED|Treatment Period 2||16
7841882|NCT00999908|19300102|P3|STARTED|Treatment Period 2||19
7841883|NCT00999908|19300103|P2|STARTED|Treatment Period 2||16
7841884|NCT00999908|19300104|P1|STARTED|Treatment Period 2||17
7841885|NCT00999908|19300102|P3|NOT COMPLETED|Treatment Period 1||0
7841886|NCT00999908|19300103|P2|NOT COMPLETED|Treatment Period 1||0
7841887|NCT00999908|19300104|P1|NOT COMPLETED|Treatment Period 1||2
7841888|NCT00999908|19300102|P3|COMPLETED|Treatment Period 1||19
7841889|NCT00999908|19300103|P2|COMPLETED|Treatment Period 1||16
7841890|NCT00999908|19300104|P1|COMPLETED|Treatment Period 1||17
7841891|NCT00999908|19300102|P3|STARTED|Treatment Period 1||19
7841892|NCT00999908|19300103|P2|STARTED|Treatment Period 1||16
7841893|NCT00999908|19300104|P1|STARTED|Treatment Period 1||19
7841894|NCT00999830|19300120|P2|NOT COMPLETED|Overall Study||0
7841895|NCT00999830|19300121|P1|NOT COMPLETED|Overall Study||0
7841896|NCT00999830|19300120|P2|COMPLETED|Overall Study||13
7841897|NCT00999830|19300121|P1|COMPLETED|Overall Study||14
7841898|NCT00999830|19300120|P2|STARTED|Overall Study||13
7841899|NCT00999830|19300121|P1|STARTED|Overall Study||14
7841900|NCT00999804|19300133|P2|NOT COMPLETED|Overall Study||5
7841901|NCT00999804|19300134|P1|NOT COMPLETED|Overall Study||21
7841902|NCT00999804|19300133|P2|COMPLETED|Overall Study||38
7841903|NCT00999804|19300134|P1|COMPLETED|Overall Study||64
7841904|NCT00999804|19300133|P2|STARTED|Overall Study||43
7841905|NCT00999804|19300134|P1|STARTED|Overall Study||85
7841906|NCT00999713|19300148|P2|NOT COMPLETED|Overall Study||0
7841907|NCT00999713|19300149|P1|NOT COMPLETED|Overall Study||2
7841908|NCT00999713|19300148|P2|COMPLETED|Overall Study||17
7841909|NCT00999713|19300149|P1|COMPLETED|Overall Study||24
7841910|NCT00999713|19300148|P2|STARTED|Overall Study||17
7841911|NCT00999713|19300149|P1|STARTED|Overall Study||26
7841912|NCT00999687|19300163|P1|NOT COMPLETED|Second Intervention||3
7841913|NCT00999687|19300163|P1|COMPLETED|Second Intervention||27
7841914|NCT00999687|19300163|P1|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30
7841915|NCT00999687|19300163|P1|NOT COMPLETED|First Intervention||1
7841916|NCT00999687|19300163|P1|COMPLETED|First Intervention||30
7841917|NCT00999687|19300163|P1|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31
7841918|NCT00999661|19300170|P1|NOT COMPLETED|Overall Study||70
7841919|NCT00999661|19300170|P1|COMPLETED|Overall Study||161
7841920|NCT00999661|19300170|P1|STARTED|Overall Study||231
7841921|NCT00999609|19300178|P2|NOT COMPLETED|Overall Study||1
7841922|NCT00999609|19300179|P1|NOT COMPLETED|Overall Study||1
7841923|NCT00999609|19300178|P2|COMPLETED|Overall Study|1 year post intervention|9
7841924|NCT00999609|19300179|P1|COMPLETED|Overall Study|1 year post intervention|20
7841925|NCT00999609|19300178|P2|STARTED|Overall Study||10
7841926|NCT00999609|19300179|P1|STARTED|Overall Study|Before intervention|21
7841927|NCT00999596|19300191|P1|NOT COMPLETED|Overall Study||101
7841928|NCT00999596|19300191|P1|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6
7841929|NCT00999596|19300191|P1|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6
7841930|NCT00999596|19300191|P1|STARTED|Overall Study||107
7841931|NCT00999544|19300196|P1|NOT COMPLETED|Overall Study||1
7841932|NCT00999544|19300196|P1|COMPLETED|Overall Study||8
7841933|NCT00999544|19300196|P1|STARTED|Overall Study||9
7841934|NCT00999466|19300232|P3|NOT COMPLETED|Main Part||4
7841935|NCT00999466|19300233|P2|NOT COMPLETED|Main Part||4
7841936|NCT00999466|19300234|P1|NOT COMPLETED|Main Part||0
7841937|NCT00999466|19300232|P3|COMPLETED|Main Part||21
7841938|NCT00999466|19300233|P2|COMPLETED|Main Part||22
7841939|NCT00999466|19300234|P1|COMPLETED|Main Part||0
7841940|NCT00999466|19300232|P3|STARTED|Main Part||25
7841941|NCT00999466|19300233|P2|STARTED|Main Part||26
7841942|NCT00999466|19300234|P1|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0
7841943|NCT00999466|19300232|P3|NOT COMPLETED|Pilot Part||0
7841944|NCT00999466|19300233|P2|NOT COMPLETED|Pilot Part||0
7841945|NCT00999466|19300234|P1|NOT COMPLETED|Pilot Part||0
7841946|NCT00999466|19300232|P3|COMPLETED|Pilot Part||3
7841947|NCT00999466|19300233|P2|COMPLETED|Pilot Part||0
7841948|NCT00999466|19300234|P1|COMPLETED|Pilot Part||6
7841949|NCT00999466|19300232|P3|STARTED|Pilot Part||3
7841950|NCT00999466|19300233|P2|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0
7841951|NCT00999466|19300234|P1|STARTED|Pilot Part||6
7841952|NCT00999167|19300511|P3|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21
7841953|NCT00999167|19300512|P2|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35
7841954|NCT00999167|19300513|P1|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0
7841955|NCT00999167|19300511|P3|COMPLETED|Part B: Randomized, Placebo Controlled||67
7841956|NCT00999167|19300512|P2|COMPLETED|Part B: Randomized, Placebo Controlled||55
7841957|NCT00999167|19300513|P1|COMPLETED|Part B: Randomized, Placebo Controlled||0
7841958|NCT00999167|19300511|P3|STARTED|Part B: Randomized, Placebo Controlled||88
7841959|NCT00999167|19300512|P2|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90
7841960|NCT00999167|19300513|P1|STARTED|Part B: Randomized, Placebo Controlled||0
7841961|NCT00999167|19300511|P3|NOT COMPLETED|Part A: Open Label Safety run-in||0
7841962|NCT00999167|19300512|P2|NOT COMPLETED|Part A: Open Label Safety run-in||0
7841963|NCT00999167|19300513|P1|NOT COMPLETED|Part A: Open Label Safety run-in||7
7841964|NCT00999167|19300511|P3|COMPLETED|Part A: Open Label Safety run-in||0
7841965|NCT00999167|19300512|P2|COMPLETED|Part A: Open Label Safety run-in||0
7841966|NCT00999167|19300513|P1|COMPLETED|Part A: Open Label Safety run-in||8
7841967|NCT00999167|19300511|P3|Received 9 mL BID|Part A: Open Label Safety run-in||0
7841968|NCT00999167|19300512|P2|Received 9 mL BID|Part A: Open Label Safety run-in||0
7841969|NCT00999167|19300513|P1|Received 9 mL BID|Part A: Open Label Safety run-in||15
7841970|NCT00999167|19300511|P3|STARTED|Part A: Open Label Safety run-in||0
7841971|NCT00999167|19300512|P2|STARTED|Part A: Open Label Safety run-in||0
7841972|NCT00999167|19300513|P1|STARTED|Part A: Open Label Safety run-in||15
7841973|NCT00999141|19300527|P1|NOT COMPLETED|Overall Study||0
7841974|NCT00999141|19300527|P1|COMPLETED|Overall Study||75
7841975|NCT00999141|19300527|P1|STARTED|Overall Study|Randomized and treated|75
7841976|NCT00999102|19300609|P2|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
7841977|NCT00999102|19300610|P1|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
7841978|NCT00999102|19300609|P2|COMPLETED|4 Weeks at Higher Dose of Second Drug||16
7841979|NCT00999102|19300610|P1|COMPLETED|4 Weeks at Higher Dose of Second Drug||15
7841980|NCT00999102|19300609|P2|STARTED|4 Weeks at Higher Dose of Second Drug||16
7841981|NCT00999102|19300610|P1|STARTED|4 Weeks at Higher Dose of Second Drug||15
7841982|NCT00999102|19300609|P2|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
7841983|NCT00999102|19300610|P1|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
7841984|NCT00999102|19300609|P2|COMPLETED|4 Weeks at Lower Dose of Second Drug||16
7841985|NCT00999102|19300610|P1|COMPLETED|4 Weeks at Lower Dose of Second Drug||15
7841986|NCT00999102|19300609|P2|STARTED|4 Weeks at Lower Dose of Second Drug||16
7841987|NCT00999102|19300610|P1|STARTED|4 Weeks at Lower Dose of Second Drug||15
7841988|NCT00999102|19300609|P2|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
7841989|NCT00999102|19300610|P1|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
7841990|NCT00999102|19300609|P2|COMPLETED|4 Weeks at Higher Dose of First Drug||16
7841991|NCT00999102|19300610|P1|COMPLETED|4 Weeks at Higher Dose of First Drug||15
7841992|NCT00999102|19300609|P2|STARTED|4 Weeks at Higher Dose of First Drug||16
7841993|NCT00999102|19300610|P1|STARTED|4 Weeks at Higher Dose of First Drug||15
7841994|NCT00999102|19300609|P2|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
7841995|NCT00999102|19300610|P1|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
7841996|NCT00999102|19300609|P2|COMPLETED|4 Weeks at Lower Dose of First Drug||16
7841997|NCT00999102|19300610|P1|COMPLETED|4 Weeks at Lower Dose of First Drug||15
7841998|NCT00999102|19300609|P2|STARTED|4 Weeks at Lower Dose of First Drug||17
7841999|NCT00999102|19300610|P1|STARTED|4 Weeks at Lower Dose of First Drug||16
7842000|NCT00999037|19300626|P2|NOT COMPLETED|Overall Study||0
7842001|NCT00999037|19300627|P1|NOT COMPLETED|Overall Study||0
7842002|NCT00999037|19300626|P2|COMPLETED|Overall Study||9
7842003|NCT00999037|19300627|P1|COMPLETED|Overall Study||9
7842004|NCT00999037|19300626|P2|STARTED|Overall Study|20|9
7842005|NCT00999037|19300627|P1|STARTED|Overall Study||9
7842006|NCT00998985|19300651|P14|NOT COMPLETED|Overall Study||0
7842007|NCT00998985|19300652|P13|NOT COMPLETED|Overall Study||0
7842008|NCT00998985|19300653|P12|NOT COMPLETED|Overall Study||0
7842009|NCT00998985|19300654|P11|NOT COMPLETED|Overall Study||0
7842010|NCT00998985|19300655|P10|NOT COMPLETED|Overall Study||0
7842011|NCT00998985|19300656|P9|NOT COMPLETED|Overall Study||1
7842012|NCT00998985|19300657|P8|NOT COMPLETED|Overall Study||0
7842013|NCT00998985|19300658|P7|NOT COMPLETED|Overall Study||0
7842014|NCT00998985|19300659|P6|NOT COMPLETED|Overall Study||1
7842015|NCT00998985|19300660|P5|NOT COMPLETED|Overall Study||0
7842016|NCT00998985|19300661|P4|NOT COMPLETED|Overall Study||0
7842017|NCT00998985|19300662|P3|NOT COMPLETED|Overall Study||0
7842018|NCT00998985|19300663|P2|NOT COMPLETED|Overall Study||0
7842019|NCT00998985|19300664|P1|NOT COMPLETED|Overall Study||0
7842020|NCT00998985|19300651|P14|COMPLETED|Overall Study||15
7842021|NCT00998985|19300652|P13|COMPLETED|Overall Study||5
7842022|NCT00998985|19300653|P12|COMPLETED|Overall Study||5
7842023|NCT00998985|19300654|P11|COMPLETED|Overall Study||5
7842024|NCT00998985|19300655|P10|COMPLETED|Overall Study||5
7842025|NCT00998985|19300656|P9|COMPLETED|Overall Study||5
7842026|NCT00998985|19300657|P8|COMPLETED|Overall Study||5
7842027|NCT00998985|19300658|P7|COMPLETED|Overall Study||5
7842028|NCT00998985|19300659|P6|COMPLETED|Overall Study||4
7842029|NCT00998985|19300660|P5|COMPLETED|Overall Study||5
7842030|NCT00998985|19300661|P4|COMPLETED|Overall Study||5
7842031|NCT00998985|19300662|P3|COMPLETED|Overall Study||15
7842032|NCT00998985|19300663|P2|COMPLETED|Overall Study||5
7842033|NCT00998985|19300664|P1|COMPLETED|Overall Study||5
7842034|NCT00998985|19300651|P14|STARTED|Overall Study||15
7842035|NCT00998985|19300652|P13|STARTED|Overall Study||5
7842036|NCT00998985|19300653|P12|STARTED|Overall Study||5
7842037|NCT00998985|19300654|P11|STARTED|Overall Study||5
7842038|NCT00998985|19300655|P10|STARTED|Overall Study||5
7842039|NCT00998985|19300656|P9|STARTED|Overall Study||6
7842040|NCT00998985|19300657|P8|STARTED|Overall Study||5
7842041|NCT00998985|19300658|P7|STARTED|Overall Study||5
7842042|NCT00998985|19300659|P6|STARTED|Overall Study||5
7842043|NCT00998985|19300660|P5|STARTED|Overall Study||5
7842044|NCT00998985|19300661|P4|STARTED|Overall Study||5
7842045|NCT00998985|19300662|P3|STARTED|Overall Study||15
7842046|NCT00998985|19300663|P2|STARTED|Overall Study||5
7842047|NCT00998985|19300664|P1|STARTED|Overall Study||5
7842048|NCT00998881|19300732|P2|NOT COMPLETED|Overall Study||2
7842049|NCT00998881|19300733|P1|NOT COMPLETED|Overall Study||8
7842050|NCT00998881|19300732|P2|COMPLETED|Overall Study||97
7842051|NCT00998881|19300733|P1|COMPLETED|Overall Study||96
7842052|NCT00998881|19300732|P2|STARTED|Overall Study||99
7842053|NCT00998881|19300733|P1|STARTED|Overall Study||104
7842054|NCT00998868|19300745|P1|NOT COMPLETED|Overall Study||0
7842055|NCT00998868|19300745|P1|COMPLETED|Overall Study||51
7842056|NCT00998868|19300745|P1|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51
7842057|NCT00998790|19300752|P1|NOT COMPLETED|Overall Study||21
7842058|NCT00998790|19300752|P1|COMPLETED|Overall Study||93
7842059|NCT00998790|19300752|P1|Participants Who Were Treated|Overall Study||113
7842060|NCT00998790|19300752|P1|STARTED|Overall Study||114
7842061|NCT00998764|19300762|P2|NOT COMPLETED|Overall Study||274
7842062|NCT00998764|19300763|P1|NOT COMPLETED|Overall Study||216
7842063|NCT00998764|19300762|P2|COMPLETED|Overall Study||2
7842064|NCT00998764|19300763|P1|COMPLETED|Overall Study||0
7842065|NCT00998764|19300762|P2|Treated|Overall Study||275
7842066|NCT00998764|19300763|P1|Treated|Overall Study||215
7842067|NCT00998764|19300762|P2|STARTED|Overall Study||276
7842068|NCT00998764|19300763|P1|STARTED|Overall Study||216
7842069|NCT00998738|19300785|P1|NOT COMPLETED|Overall Study||1
7842070|NCT00998738|19300785|P1|COMPLETED|Overall Study||0
7842071|NCT00998738|19300785|P1|STARTED|Overall Study||1
7842072|NCT00998660|19300800|P1|NOT COMPLETED|Overall Study||13
7842073|NCT00998660|19300800|P1|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87
7842074|NCT00998660|19300800|P1|Month 3 Visit|Overall Study||87
7842075|NCT00998660|19300800|P1|Implanted|Overall Study||93
7842076|NCT00998660|19300800|P1|STARTED|Overall Study||100
7842077|NCT00998582|19300806|P2|NOT COMPLETED|Overall Study||0
7842078|NCT00998582|19300807|P1|NOT COMPLETED|Overall Study||0
7842079|NCT00998582|19300806|P2|COMPLETED|Overall Study||14
7842080|NCT00998582|19300807|P1|COMPLETED|Overall Study||13
7842081|NCT00998582|19300806|P2|STARTED|Overall Study||14
7842082|NCT00998582|19300807|P1|STARTED|Overall Study||13
7842083|NCT00998517|19300818|P3|NOT COMPLETED|Overall Study||0
7842084|NCT00998517|19300819|P2|NOT COMPLETED|Overall Study||0
7842085|NCT00998517|19300820|P1|NOT COMPLETED|Overall Study||0
7842086|NCT00998517|19300818|P3|COMPLETED|Overall Study||918
7842087|NCT00998517|19300819|P2|COMPLETED|Overall Study||906
7842088|NCT00998517|19300820|P1|COMPLETED|Overall Study||888
7842089|NCT00998517|19300818|P3|STARTED|Overall Study||918
7842090|NCT00998517|19300819|P2|STARTED|Overall Study||906
7842091|NCT00998517|19300820|P1|STARTED|Overall Study||888
7842092|NCT00998426|19300846|P1|NOT COMPLETED|Overall Study||0
7842093|NCT00998426|19300846|P1|COMPLETED|Overall Study||5
7842094|NCT00998426|19300846|P1|Blood Glucose Monitoring|Overall Study||5
7842095|NCT00998426|19300846|P1|STARTED|Overall Study||5
7842096|NCT00998400|19300853|P2|NOT COMPLETED|Overall Study||2
7842097|NCT00998400|19300854|P1|NOT COMPLETED|Overall Study||2
7842098|NCT00998400|19300853|P2|COMPLETED|Overall Study||48
7842099|NCT00998400|19300854|P1|COMPLETED|Overall Study||48
7842100|NCT00998400|19300853|P2|STARTED|Overall Study||50
7842101|NCT00998400|19300854|P1|STARTED|Overall Study||50
7842102|NCT00998374|19300884|P2|NOT COMPLETED|Overall Study||11
7842103|NCT00998374|19300885|P1|NOT COMPLETED|Overall Study||12
7842104|NCT00998374|19300884|P2|COMPLETED|Overall Study||12
7842105|NCT00998374|19300885|P1|COMPLETED|Overall Study||27
7842106|NCT00998374|19300884|P2|STARTED|Overall Study||23
7842107|NCT00998374|19300885|P1|STARTED|Overall Study||39
7842108|NCT00998335|19300899|P2|NOT COMPLETED|Randomized Period (Months 3 to 6)||2
7842109|NCT00998335|19300900|P1|NOT COMPLETED|Randomized Period (Months 3 to 6)||0
7842110|NCT00998335|19300899|P2|COMPLETED|Randomized Period (Months 3 to 6)||20
7842111|NCT00998335|19300900|P1|COMPLETED|Randomized Period (Months 3 to 6)||8
7842112|NCT00998335|19300899|P2|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22
7842113|NCT00998335|19300900|P1|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8
7842114|NCT00998335|19300899|P2|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
7842115|NCT00998335|19300900|P1|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
7842116|NCT00998335|19300899|P2|COMPLETED|Initial Treatment (Months 0 - 3)||0
7842117|NCT00998335|19300900|P1|COMPLETED|Initial Treatment (Months 0 - 3)||30
7842118|NCT00998335|19300899|P2|STARTED|Initial Treatment (Months 0 - 3)||0
7842119|NCT00998335|19300900|P1|STARTED|Initial Treatment (Months 0 - 3)||30
7842120|NCT00998309|19300928|P1|NOT COMPLETED|Overall Study||4
7842121|NCT00998309|19300928|P1|COMPLETED|Overall Study||498
7842122|NCT00998309|19300928|P1|STARTED|Overall Study||502
7842123|NCT00998296|19300995|P11|NOT COMPLETED|Overall Study||7
7842124|NCT00998296|19300996|P10|NOT COMPLETED|Overall Study||18
7842125|NCT00998296|19300997|P9|NOT COMPLETED|Overall Study||2
7842126|NCT00998296|19300998|P8|NOT COMPLETED|Overall Study||2
7842127|NCT00998296|19300999|P7|NOT COMPLETED|Overall Study||1
7842128|NCT00998296|19301000|P6|NOT COMPLETED|Overall Study||0
7842129|NCT00998296|19301001|P5|NOT COMPLETED|Overall Study||2
7842130|NCT00998296|19301002|P4|NOT COMPLETED|Overall Study||0
7842131|NCT00998296|19301003|P3|NOT COMPLETED|Overall Study||0
7842132|NCT00998296|19301004|P2|NOT COMPLETED|Overall Study||1
7842133|NCT00998296|19301005|P1|NOT COMPLETED|Overall Study||0
7842134|NCT00998296|19300995|P11|COMPLETED|Overall Study||0
7842135|NCT00998296|19300996|P10|COMPLETED|Overall Study||0
7842136|NCT00998296|19300997|P9|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
7842137|NCT00998296|19300998|P8|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
7842138|NCT00998296|19300999|P7|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
7842139|NCT00998296|19301000|P6|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
7842140|NCT00998296|19301001|P5|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
7842141|NCT00998296|19301002|P4|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
7842142|NCT00998296|19301003|P3|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
7842143|NCT00998296|19301004|P2|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2
7842144|NCT00998296|19301005|P1|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
7842145|NCT00998296|19300995|P11|STARTED|Overall Study||7
7842146|NCT00998296|19300996|P10|STARTED|Overall Study||18
7842147|NCT00998296|19300997|P9|STARTED|Overall Study||6
7842148|NCT00998296|19300998|P8|STARTED|Overall Study||6
7842149|NCT00998296|19300999|P7|STARTED|Overall Study||7
7842150|NCT00998296|19301000|P6|STARTED|Overall Study||3
7842151|NCT00998296|19301001|P5|STARTED|Overall Study||8
7842152|NCT00998296|19301002|P4|STARTED|Overall Study||3
7842153|NCT00998296|19301003|P3|STARTED|Overall Study||3
7842154|NCT00998296|19301004|P2|STARTED|Overall Study||3
7842155|NCT00998296|19301005|P1|STARTED|Overall Study||6
7842156|NCT00998205|19301072|P1|NOT COMPLETED|Overall Study||0
7842157|NCT00998205|19301072|P1|COMPLETED|Overall Study||16
7842158|NCT00998205|19301072|P1|STARTED|Overall Study||16
7842159|NCT00998049|19301077|P1|NOT COMPLETED|Overall Study||0
7842160|NCT00998049|19301077|P1|COMPLETED|Overall Study||39
7842161|NCT00998049|19301077|P1|STARTED|Overall Study||39
7842162|NCT00998023|19301088|P2|NOT COMPLETED|Overall Study||0
7842163|NCT00998023|19301089|P1|NOT COMPLETED|Overall Study||0
7842164|NCT00998023|19301088|P2|COMPLETED|Overall Study||32
7842165|NCT00998023|19301089|P1|COMPLETED|Overall Study||32
7842166|NCT00998023|19301088|P2|STARTED|Overall Study||32
7842167|NCT00998023|19301089|P1|STARTED|Overall Study||32
7842168|NCT00998010|19301097|P1|NOT COMPLETED|Overall Study||0
7842169|NCT00998010|19301097|P1|COMPLETED|Overall Study||24
7842170|NCT00998010|19301097|P1|STARTED|Overall Study||24
7842171|NCT00997984|19301108|P3|NOT COMPLETED|Overall Study||26
7842172|NCT00997984|19301109|P2|NOT COMPLETED|Overall Study||34
7842173|NCT00997984|19301110|P1|NOT COMPLETED|Overall Study||37
7842174|NCT00997984|19301108|P3|COMPLETED|Overall Study||88
7842175|NCT00997984|19301109|P2|COMPLETED|Overall Study||79
7842176|NCT00997984|19301110|P1|COMPLETED|Overall Study||76
7842177|NCT00997984|19301108|P3|STARTED|Overall Study||114
7842178|NCT00997984|19301109|P2|STARTED|Overall Study||113
7842179|NCT00997984|19301110|P1|STARTED|Overall Study||113
7842180|NCT00997932|19301176|P1|NOT COMPLETED|Overall Study||2
7842181|NCT00997932|19301176|P1|COMPLETED|Overall Study||27
7842182|NCT00997932|19301176|P1|STARTED|Overall Study||29
7842183|NCT00997893|19301184|P3|NOT COMPLETED|Overall Study||0
7842184|NCT00997893|19301185|P2|NOT COMPLETED|Overall Study||1
7842185|NCT00997893|19301186|P1|NOT COMPLETED|Overall Study||2
7842186|NCT00997893|19301184|P3|COMPLETED|Overall Study||13
7842187|NCT00997893|19301185|P2|COMPLETED|Overall Study||12
7842188|NCT00997893|19301186|P1|COMPLETED|Overall Study||12
7842189|NCT00997893|19301184|P3|STARTED|Overall Study||13
7842190|NCT00997893|19301185|P2|STARTED|Overall Study||13
7842191|NCT00997893|19301186|P1|STARTED|Overall Study||14
7842192|NCT00997672|19301208|P2|NOT COMPLETED|Overall Study||4
7842193|NCT00997672|19301209|P1|NOT COMPLETED|Overall Study||4
7842194|NCT00997672|19301208|P2|COMPLETED|Overall Study||1
7842195|NCT00997672|19301209|P1|COMPLETED|Overall Study||0
7842196|NCT00997672|19301208|P2|STARTED|Overall Study||5
7842197|NCT00997672|19301209|P1|STARTED|Overall Study||4
7842198|NCT00997620|19301217|P2|NOT COMPLETED|Overall Study||0
7842199|NCT00997620|19301218|P1|NOT COMPLETED|Overall Study||0
7842200|NCT00997620|19301217|P2|COMPLETED|Overall Study||21
7842201|NCT00997620|19301218|P1|COMPLETED|Overall Study||19
7842202|NCT00997620|19301217|P2|STARTED|Overall Study||21
7842203|NCT00997620|19301218|P1|STARTED|Overall Study||19
7842204|NCT00997594|19301236|P2|NOT COMPLETED|Overall Study||0
7842205|NCT00997594|19301237|P1|NOT COMPLETED|Overall Study||0
7842206|NCT00997594|19301236|P2|COMPLETED|Overall Study||9
7842207|NCT00997594|19301237|P1|COMPLETED|Overall Study||9
7842208|NCT00997594|19301236|P2|Completion of Ablation Procedure|Overall Study||9
7842209|NCT00997594|19301237|P1|Completion of Ablation Procedure|Overall Study||9
7842210|NCT00997594|19301236|P2|STARTED|Overall Study||9
7842211|NCT00997594|19301237|P1|STARTED|Overall Study||9
7842212|NCT00997555|19301245|P2|NOT COMPLETED|Overall Study||0
7842213|NCT00997555|19301246|P1|NOT COMPLETED|Overall Study||0
7842214|NCT00997555|19301245|P2|COMPLETED|Overall Study||15
7842215|NCT00997555|19301246|P1|COMPLETED|Overall Study||13
7842216|NCT00997555|19301245|P2|STARTED|Overall Study||15
7842217|NCT00997555|19301246|P1|STARTED|Overall Study||13
7842218|NCT00997516|19301264|P2|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2
7842219|NCT00997516|19301265|P1|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6
7842220|NCT00997516|19301264|P2|COMPLETED|Long-term Follow-up (After 6 Months)||36
7842221|NCT00997516|19301265|P1|COMPLETED|Long-term Follow-up (After 6 Months)||31
7842222|NCT00997516|19301264|P2|STARTED|Long-term Follow-up (After 6 Months)||38
7842223|NCT00997516|19301265|P1|STARTED|Long-term Follow-up (After 6 Months)||37
7842224|NCT00997516|19301264|P2|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
7842225|NCT00997516|19301265|P1|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
7842226|NCT00997516|19301264|P2|COMPLETED|Short-term Follow-up (Post Operative)||38
7842227|NCT00997516|19301265|P1|COMPLETED|Short-term Follow-up (Post Operative)||37
7842228|NCT00997516|19301264|P2|STARTED|Short-term Follow-up (Post Operative)||38
7842229|NCT00997516|19301265|P1|STARTED|Short-term Follow-up (Post Operative)||37
7842230|NCT00997503|19301293|P1|NOT COMPLETED|Overall Study||273
7842231|NCT00997503|19301293|P1|COMPLETED|Overall Study||3926
7842232|NCT00997503|19301293|P1|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059
7842233|NCT00997503|19301293|P1|STARTED|Overall Study||4199
7842234|NCT00997438|19301336|P3|NOT COMPLETED|Overall Study||4
7842235|NCT00997438|19301337|P2|NOT COMPLETED|Overall Study||3
7842236|NCT00997438|19301338|P1|NOT COMPLETED|Overall Study||5
7842237|NCT00997438|19301336|P3|COMPLETED|Overall Study||20
7842238|NCT00997438|19301337|P2|COMPLETED|Overall Study||21
7842239|NCT00997438|19301338|P1|COMPLETED|Overall Study||16
7842240|NCT00997438|19301336|P3|STARTED|Overall Study||24
7842241|NCT00997438|19301337|P2|STARTED|Overall Study||24
7842242|NCT00997438|19301338|P1|STARTED|Overall Study||21
7842243|NCT00997425|19301373|P1|NOT COMPLETED|Overall Study||0
7842244|NCT00997425|19301373|P1|COMPLETED|Overall Study||19
7842245|NCT00997425|19301373|P1|STARTED|Overall Study||19
7842246|NCT00997386|19301378|P1|NOT COMPLETED|Overall Study||7
7842247|NCT00997386|19301378|P1|COMPLETED|Overall Study||9
7842248|NCT00997386|19301378|P1|STARTED|Overall Study||16
7842249|NCT00997373|19301387|P2|NOT COMPLETED|Overall Study||0
7842250|NCT00997373|19301388|P1|NOT COMPLETED|Overall Study||15
7842251|NCT00997373|19301387|P2|COMPLETED|Overall Study||15
7842252|NCT00997373|19301388|P1|COMPLETED|Overall Study||13
7842253|NCT00997373|19301387|P2|Completed Hysterectomy|Overall Study||15
7842254|NCT00997373|19301388|P1|Completed Hysterectomy|Overall Study||17
7842255|NCT00997373|19301387|P2|Received Letrozole|Overall Study||0
7842256|NCT00997373|19301388|P1|Received Letrozole|Overall Study||23
7842257|NCT00997373|19301387|P2|STARTED|Overall Study||15
7842258|NCT00997373|19301388|P1|STARTED|Overall Study||28
7842259|NCT00997334|19301394|P1|NOT COMPLETED|Overall Study||25
7842260|NCT00997334|19301394|P1|COMPLETED|Overall Study||35
7842261|NCT00997334|19301394|P1|Evaluable|Overall Study|Patients with tissue available for re-biopsy at time of progression|35
7842262|NCT00997334|19301394|P1|Eligible for Repeat Biopsy|Overall Study|Patients who experience disease progression on treatment were eligible for repeat biopsy|44
7842263|NCT00997334|19301394|P1|STARTED|Overall Study||60
7842264|NCT00997321|19301403|P2|NOT COMPLETED|Overall Study||3
7842265|NCT00997321|19301404|P1|NOT COMPLETED|Overall Study||0
7842266|NCT00997321|19301403|P2|COMPLETED|Overall Study||47
7842267|NCT00997321|19301404|P1|COMPLETED|Overall Study||50
7842268|NCT00997321|19301403|P2|STARTED|Overall Study||50
7842269|NCT00997321|19301404|P1|STARTED|Overall Study||50
7842270|NCT00997243|19301416|P1|NOT COMPLETED|Overall Study||7
7842271|NCT00997243|19301416|P1|COMPLETED|Overall Study||0
7842272|NCT00997243|19301416|P1|STARTED|Overall Study||7
7842273|NCT00997204|19301428|P2|NOT COMPLETED|Self-administration Phase||1
7842274|NCT00997204|19301429|P1|NOT COMPLETED|Self-administration Phase||0
7842275|NCT00997204|19301428|P2|COMPLETED|Self-administration Phase||77
7842276|NCT00997204|19301429|P1|COMPLETED|Self-administration Phase||19
7842277|NCT00997204|19301428|P2|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78
7842278|NCT00997204|19301429|P1|STARTED|Self-administration Phase||19
7842279|NCT00997204|19301428|P2|NOT COMPLETED|Naive Treatment Phase||79
7842280|NCT00997204|19301429|P1|NOT COMPLETED|Naive Treatment Phase||6
7842281|NCT00997204|19301428|P2|COMPLETED|Naive Treatment Phase||0
7842282|NCT00997204|19301429|P1|COMPLETED|Naive Treatment Phase||19
7842283|NCT00997204|19301428|P2|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79
7842284|NCT00997204|19301429|P1|STARTED|Naive Treatment Phase||25
7842285|NCT00997139|19301440|P1|NOT COMPLETED|Overall Study||186
7842286|NCT00997139|19301440|P1|COMPLETED|Overall Study||30
7842287|NCT00997139|19301440|P1|Treated for Positive Baseline Culture|Overall Study||30
7842288|NCT00997139|19301440|P1|STARTED|Overall Study||216
7842289|NCT00997126|19301448|P2|NOT COMPLETED|Overall Study||11
7842290|NCT00997126|19301449|P1|NOT COMPLETED|Overall Study||7
7842291|NCT00997126|19301448|P2|COMPLETED|Overall Study||52
7842292|NCT00997126|19301449|P1|COMPLETED|Overall Study||56
7842293|NCT00997126|19301448|P2|STARTED|Overall Study||63
7842294|NCT00997126|19301449|P1|STARTED|Overall Study||63
7842295|NCT00997113|19301465|P2|NOT COMPLETED|Overall Study||0
7842296|NCT00997113|19301466|P1|NOT COMPLETED|Overall Study||0
7842297|NCT00997113|19301465|P2|COMPLETED|Overall Study||10
7842298|NCT00997113|19301466|P1|COMPLETED|Overall Study||10
7842299|NCT00997113|19301465|P2|STARTED|Overall Study||10
7842300|NCT00997113|19301466|P1|STARTED|Overall Study||10
7842301|NCT00997035|19301478|P2|NOT COMPLETED|3-month Follow-up Visit||6
7842302|NCT00997035|19301479|P1|NOT COMPLETED|3-month Follow-up Visit||12
7842303|NCT00997035|19301478|P2|COMPLETED|3-month Follow-up Visit||107
7842304|NCT00997035|19301479|P1|COMPLETED|3-month Follow-up Visit||100
7842305|NCT00997035|19301478|P2|STARTED|3-month Follow-up Visit||113
7842306|NCT00997035|19301479|P1|STARTED|3-month Follow-up Visit||112
7842307|NCT00997035|19301478|P2|NOT COMPLETED|3-week Followup Visit||6
7842308|NCT00997035|19301479|P1|NOT COMPLETED|3-week Followup Visit||9
7842309|NCT00997035|19301478|P2|COMPLETED|3-week Followup Visit||113
7842310|NCT00997035|19301479|P1|COMPLETED|3-week Followup Visit||112
7842311|NCT00997035|19301478|P2|STARTED|3-week Followup Visit||119
7842312|NCT00997035|19301479|P1|STARTED|3-week Followup Visit||121
7842313|NCT00996996|19301503|P1|NOT COMPLETED|Overall Study||33
7842314|NCT00996996|19301503|P1|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44
7842315|NCT00996996|19301503|P1|STARTED|Overall Study||77
7842316|NCT00996944|19301537|P2|NOT COMPLETED|Long-term Treatment Period||5
7842317|NCT00996944|19301538|P1|NOT COMPLETED|Long-term Treatment Period||12
7842318|NCT00996944|19301537|P2|COMPLETED|Long-term Treatment Period||0
7842319|NCT00996944|19301538|P1|COMPLETED|Long-term Treatment Period||0
7842320|NCT00996944|19301537|P2|STARTED|Long-term Treatment Period||5
7842321|NCT00996944|19301538|P1|STARTED|Long-term Treatment Period||12
7842322|NCT00996944|19301537|P2|NOT COMPLETED|Double-blind Treatment Period||7
7842323|NCT00996944|19301538|P1|NOT COMPLETED|Double-blind Treatment Period||10
7842324|NCT00996944|19301537|P2|COMPLETED|Double-blind Treatment Period||5
7842325|NCT00996944|19301538|P1|COMPLETED|Double-blind Treatment Period||12
7842326|NCT00996944|19301537|P2|STARTED|Double-blind Treatment Period||12
7842327|NCT00996944|19301538|P1|STARTED|Double-blind Treatment Period||22
7842328|NCT00996931|19301580|P1|NOT COMPLETED|Overall Study||0
7842329|NCT00996931|19301580|P1|COMPLETED|Overall Study||6
7842330|NCT00996931|19301580|P1|STARTED|Overall Study||6
7842331|NCT00996918|19301590|P5|NOT COMPLETED|Overall Study||4
7842332|NCT00996918|19301591|P4|NOT COMPLETED|Overall Study||56
7842333|NCT00996918|19301592|P3|NOT COMPLETED|Overall Study||37
7842334|NCT00996918|19301593|P2|NOT COMPLETED|Overall Study||66
7842335|NCT00996918|19301594|P1|NOT COMPLETED|Overall Study||39
7842336|NCT00996918|19301590|P5|COMPLETED|Overall Study||0
7842337|NCT00996918|19301591|P4|COMPLETED|Overall Study||0
7842338|NCT00996918|19301592|P3|COMPLETED|Overall Study||0
7842339|NCT00996918|19301593|P2|COMPLETED|Overall Study||0
7842340|NCT00996918|19301594|P1|COMPLETED|Overall Study||0
7842341|NCT00996918|19301590|P5|Treated|Overall Study||4
7842342|NCT00996918|19301591|P4|Treated|Overall Study||56
7842343|NCT00996918|19301592|P3|Treated|Overall Study||37
7842344|NCT00996918|19301593|P2|Treated|Overall Study||66
7842345|NCT00996918|19301594|P1|Treated|Overall Study||39
7842346|NCT00996918|19301590|P5|STARTED|Overall Study||4
7842347|NCT00996918|19301591|P4|STARTED|Overall Study||56
7842348|NCT00996918|19301592|P3|STARTED|Overall Study||37
7842349|NCT00996918|19301593|P2|STARTED|Overall Study||66
7842350|NCT00996918|19301594|P1|STARTED|Overall Study||39
7842351|NCT00996892|19301638|P20|NOT COMPLETED|Expansion Stage 2A||45
7842352|NCT00996892|19301639|P19|NOT COMPLETED|Expansion Stage 2A||0
7842353|NCT00996892|19301640|P18|NOT COMPLETED|Expansion Stage 2A||0
7842354|NCT00996892|19301641|P17|NOT COMPLETED|Expansion Stage 2A||0
7842355|NCT00996892|19301642|P16|NOT COMPLETED|Expansion Stage 2A||0
7842356|NCT00996892|19301643|P15|NOT COMPLETED|Expansion Stage 2A||0
7842357|NCT00996892|19301644|P14|NOT COMPLETED|Expansion Stage 2A||0
7842358|NCT00996892|19301645|P13|NOT COMPLETED|Expansion Stage 2A||0
7842359|NCT00996892|19301646|P12|NOT COMPLETED|Expansion Stage 2A||0
7842360|NCT00996892|19301647|P11|NOT COMPLETED|Expansion Stage 2A||0
7842361|NCT00996892|19301648|P10|NOT COMPLETED|Expansion Stage 2A||0
7842362|NCT00996892|19301649|P9|NOT COMPLETED|Expansion Stage 2A||0
7842363|NCT00996892|19301650|P8|NOT COMPLETED|Expansion Stage 2A||0
7842364|NCT00996892|19301651|P7|NOT COMPLETED|Expansion Stage 2A||0
7842365|NCT00996892|19301652|P6|NOT COMPLETED|Expansion Stage 2A||0
7842366|NCT00996892|19301653|P5|NOT COMPLETED|Expansion Stage 2A||0
7842367|NCT00996892|19301654|P4|NOT COMPLETED|Expansion Stage 2A||0
7842368|NCT00996892|19301655|P3|NOT COMPLETED|Expansion Stage 2A||0
7842369|NCT00996892|19301656|P2|NOT COMPLETED|Expansion Stage 2A||0
7842370|NCT00996892|19301657|P1|NOT COMPLETED|Expansion Stage 2A||0
7842371|NCT00996892|19301638|P20|COMPLETED|Expansion Stage 2A||0
7842372|NCT00996892|19301639|P19|COMPLETED|Expansion Stage 2A||0
7842373|NCT00996892|19301640|P18|COMPLETED|Expansion Stage 2A||0
7842374|NCT00996892|19301641|P17|COMPLETED|Expansion Stage 2A||0
7842375|NCT00996892|19301642|P16|COMPLETED|Expansion Stage 2A||0
7842376|NCT00996892|19301643|P15|COMPLETED|Expansion Stage 2A||0
7842377|NCT00996892|19301644|P14|COMPLETED|Expansion Stage 2A||0
7842378|NCT00996892|19301645|P13|COMPLETED|Expansion Stage 2A||0
7842379|NCT00996892|19301646|P12|COMPLETED|Expansion Stage 2A||0
7842380|NCT00996892|19301647|P11|COMPLETED|Expansion Stage 2A||0
7842381|NCT00996892|19301648|P10|COMPLETED|Expansion Stage 2A||0
7842382|NCT00996892|19301649|P9|COMPLETED|Expansion Stage 2A||0
7842383|NCT00996892|19301650|P8|COMPLETED|Expansion Stage 2A||0
7842384|NCT00996892|19301651|P7|COMPLETED|Expansion Stage 2A||0
7842385|NCT00996892|19301652|P6|COMPLETED|Expansion Stage 2A||0
7842386|NCT00996892|19301653|P5|COMPLETED|Expansion Stage 2A||0
7842387|NCT00996892|19301654|P4|COMPLETED|Expansion Stage 2A||0
7842388|NCT00996892|19301655|P3|COMPLETED|Expansion Stage 2A||0
7842389|NCT00996892|19301656|P2|COMPLETED|Expansion Stage 2A||0
7842390|NCT00996892|19301657|P1|COMPLETED|Expansion Stage 2A||0
7842391|NCT00996892|19301638|P20|STARTED|Expansion Stage 2A||45
7842392|NCT00996892|19301639|P19|STARTED|Expansion Stage 2A||0
7842393|NCT00996892|19301640|P18|STARTED|Expansion Stage 2A||0
7842394|NCT00996892|19301641|P17|STARTED|Expansion Stage 2A||0
7842395|NCT00996892|19301642|P16|STARTED|Expansion Stage 2A||0
7842396|NCT00996892|19301643|P15|STARTED|Expansion Stage 2A||0
7842397|NCT00996892|19301644|P14|STARTED|Expansion Stage 2A||0
7842398|NCT00996892|19301645|P13|STARTED|Expansion Stage 2A||0
7842399|NCT00996892|19301646|P12|STARTED|Expansion Stage 2A||0
7842400|NCT00996892|19301647|P11|STARTED|Expansion Stage 2A||0
7842401|NCT00996892|19301648|P10|STARTED|Expansion Stage 2A||0
7842402|NCT00996892|19301649|P9|STARTED|Expansion Stage 2A||0
7842403|NCT00996892|19301650|P8|STARTED|Expansion Stage 2A||0
7842404|NCT00996892|19301651|P7|STARTED|Expansion Stage 2A||0
7842405|NCT00996892|19301652|P6|STARTED|Expansion Stage 2A||0
7842406|NCT00996892|19301653|P5|STARTED|Expansion Stage 2A||0
7842407|NCT00996892|19301654|P4|STARTED|Expansion Stage 2A||0
7842408|NCT00996892|19301655|P3|STARTED|Expansion Stage 2A||0
7842409|NCT00996892|19301656|P2|STARTED|Expansion Stage 2A||0
7842410|NCT00996892|19301657|P1|STARTED|Expansion Stage 2A||0
7842411|NCT00996892|19301638|P20|NOT COMPLETED|Expansion Stage 2||0
7842412|NCT00996892|19301639|P19|NOT COMPLETED|Expansion Stage 2||35
7842413|NCT00996892|19301640|P18|NOT COMPLETED|Expansion Stage 2||0
7842414|NCT00996892|19301641|P17|NOT COMPLETED|Expansion Stage 2||0
7842415|NCT00996892|19301642|P16|NOT COMPLETED|Expansion Stage 2||0
7842416|NCT00996892|19301643|P15|NOT COMPLETED|Expansion Stage 2||0
7842417|NCT00996892|19301644|P14|NOT COMPLETED|Expansion Stage 2||0
7842418|NCT00996892|19301645|P13|NOT COMPLETED|Expansion Stage 2||0
7842419|NCT00996892|19301646|P12|NOT COMPLETED|Expansion Stage 2||0
7842420|NCT00996892|19301647|P11|NOT COMPLETED|Expansion Stage 2||0
7842421|NCT00996892|19301648|P10|NOT COMPLETED|Expansion Stage 2||0
7842422|NCT00996892|19301649|P9|NOT COMPLETED|Expansion Stage 2||0
7842423|NCT00996892|19301650|P8|NOT COMPLETED|Expansion Stage 2||0
7842424|NCT00996892|19301651|P7|NOT COMPLETED|Expansion Stage 2||0
7842425|NCT00996892|19301652|P6|NOT COMPLETED|Expansion Stage 2||0
7842426|NCT00996892|19301653|P5|NOT COMPLETED|Expansion Stage 2||0
7842427|NCT00996892|19301654|P4|NOT COMPLETED|Expansion Stage 2||0
7842428|NCT00996892|19301655|P3|NOT COMPLETED|Expansion Stage 2||0
7842429|NCT00996892|19301656|P2|NOT COMPLETED|Expansion Stage 2||0
7842430|NCT00996892|19301657|P1|NOT COMPLETED|Expansion Stage 2||0
7842431|NCT00996892|19301638|P20|COMPLETED|Expansion Stage 2||0
7842432|NCT00996892|19301639|P19|COMPLETED|Expansion Stage 2||0
7842433|NCT00996892|19301640|P18|COMPLETED|Expansion Stage 2||0
7842434|NCT00996892|19301641|P17|COMPLETED|Expansion Stage 2||0
7842435|NCT00996892|19301642|P16|COMPLETED|Expansion Stage 2||0
7842436|NCT00996892|19301643|P15|COMPLETED|Expansion Stage 2||0
7842437|NCT00996892|19301644|P14|COMPLETED|Expansion Stage 2||0
7842438|NCT00996892|19301645|P13|COMPLETED|Expansion Stage 2||0
7842439|NCT00996892|19301646|P12|COMPLETED|Expansion Stage 2||0
7842440|NCT00996892|19301647|P11|COMPLETED|Expansion Stage 2||0
7842441|NCT00996892|19301648|P10|COMPLETED|Expansion Stage 2||0
7842442|NCT00996892|19301649|P9|COMPLETED|Expansion Stage 2||0
7842443|NCT00996892|19301650|P8|COMPLETED|Expansion Stage 2||0
7842444|NCT00996892|19301651|P7|COMPLETED|Expansion Stage 2||0
7842445|NCT00996892|19301652|P6|COMPLETED|Expansion Stage 2||0
7842446|NCT00996892|19301653|P5|COMPLETED|Expansion Stage 2||0
7842447|NCT00996892|19301654|P4|COMPLETED|Expansion Stage 2||0
7842448|NCT00996892|19301655|P3|COMPLETED|Expansion Stage 2||0
7842449|NCT00996892|19301656|P2|COMPLETED|Expansion Stage 2||0
7842450|NCT00996892|19301657|P1|COMPLETED|Expansion Stage 2||0
7842451|NCT00996892|19301638|P20|STARTED|Expansion Stage 2||0
7842452|NCT00996892|19301639|P19|STARTED|Expansion Stage 2||35
7842453|NCT00996892|19301640|P18|STARTED|Expansion Stage 2||0
7842454|NCT00996892|19301641|P17|STARTED|Expansion Stage 2||0
7842455|NCT00996892|19301642|P16|STARTED|Expansion Stage 2||0
7842456|NCT00996892|19301643|P15|STARTED|Expansion Stage 2||0
7842457|NCT00996892|19301644|P14|STARTED|Expansion Stage 2||0
7842458|NCT00996892|19301645|P13|STARTED|Expansion Stage 2||0
7842459|NCT00996892|19301646|P12|STARTED|Expansion Stage 2||0
7842460|NCT00996892|19301647|P11|STARTED|Expansion Stage 2||0
7842461|NCT00996892|19301648|P10|STARTED|Expansion Stage 2||0
7842462|NCT00996892|19301649|P9|STARTED|Expansion Stage 2||0
7842463|NCT00996892|19301650|P8|STARTED|Expansion Stage 2||0
7842464|NCT00996892|19301651|P7|STARTED|Expansion Stage 2||0
7842465|NCT00996892|19301652|P6|STARTED|Expansion Stage 2||0
7842466|NCT00996892|19301653|P5|STARTED|Expansion Stage 2||0
7842467|NCT00996892|19301654|P4|STARTED|Expansion Stage 2||0
7842468|NCT00996892|19301655|P3|STARTED|Expansion Stage 2||0
7842469|NCT00996892|19301656|P2|STARTED|Expansion Stage 2||0
7842470|NCT00996892|19301657|P1|STARTED|Expansion Stage 2||0
7842471|NCT00996892|19301638|P20|NOT COMPLETED|Dose-Escalation Stage 1B||0
7842472|NCT00996892|19301639|P19|NOT COMPLETED|Dose-Escalation Stage 1B||0
7842473|NCT00996892|19301640|P18|NOT COMPLETED|Dose-Escalation Stage 1B||5
7842474|NCT00996892|19301641|P17|NOT COMPLETED|Dose-Escalation Stage 1B||3
7842475|NCT00996892|19301642|P16|NOT COMPLETED|Dose-Escalation Stage 1B||3
7842476|NCT00996892|19301643|P15|NOT COMPLETED|Dose-Escalation Stage 1B||4
7842477|NCT00996892|19301644|P14|NOT COMPLETED|Dose-Escalation Stage 1B||0
7842478|NCT00996892|19301645|P13|NOT COMPLETED|Dose-Escalation Stage 1B||0
7842479|NCT00996892|19301646|P12|NOT COMPLETED|Dose-Escalation Stage 1B||0
7842480|NCT00996892|19301647|P11|NOT COMPLETED|Dose-Escalation Stage 1B||0
7842481|NCT00996892|19301648|P10|NOT COMPLETED|Dose-Escalation Stage 1B||0
7842482|NCT00996892|19301649|P9|NOT COMPLETED|Dose-Escalation Stage 1B||0
7842483|NCT00996892|19301650|P8|NOT COMPLETED|Dose-Escalation Stage 1B||0
7842484|NCT00996892|19301651|P7|NOT COMPLETED|Dose-Escalation Stage 1B||0
7842485|NCT00996892|19301652|P6|NOT COMPLETED|Dose-Escalation Stage 1B||0
7842486|NCT00996892|19301653|P5|NOT COMPLETED|Dose-Escalation Stage 1B||0
7842487|NCT00996892|19301654|P4|NOT COMPLETED|Dose-Escalation Stage 1B||0
7842488|NCT00996892|19301655|P3|NOT COMPLETED|Dose-Escalation Stage 1B||0
7842489|NCT00996892|19301656|P2|NOT COMPLETED|Dose-Escalation Stage 1B||0
7842490|NCT00996892|19301657|P1|NOT COMPLETED|Dose-Escalation Stage 1B||0
7842491|NCT00996892|19301638|P20|COMPLETED|Dose-Escalation Stage 1B||0
7842492|NCT00996892|19301639|P19|COMPLETED|Dose-Escalation Stage 1B||0
7842493|NCT00996892|19301640|P18|COMPLETED|Dose-Escalation Stage 1B||0
7842494|NCT00996892|19301641|P17|COMPLETED|Dose-Escalation Stage 1B||0
7842495|NCT00996892|19301642|P16|COMPLETED|Dose-Escalation Stage 1B||0
7842496|NCT00996892|19301643|P15|COMPLETED|Dose-Escalation Stage 1B||0
7842497|NCT00996892|19301644|P14|COMPLETED|Dose-Escalation Stage 1B||0
7842498|NCT00996892|19301645|P13|COMPLETED|Dose-Escalation Stage 1B||0
7842499|NCT00996892|19301646|P12|COMPLETED|Dose-Escalation Stage 1B||0
7842500|NCT00996892|19301647|P11|COMPLETED|Dose-Escalation Stage 1B||0
7842501|NCT00996892|19301648|P10|COMPLETED|Dose-Escalation Stage 1B||0
7842502|NCT00996892|19301649|P9|COMPLETED|Dose-Escalation Stage 1B||0
7842503|NCT00996892|19301650|P8|COMPLETED|Dose-Escalation Stage 1B||0
7842504|NCT00996892|19301651|P7|COMPLETED|Dose-Escalation Stage 1B||0
7842505|NCT00996892|19301652|P6|COMPLETED|Dose-Escalation Stage 1B||0
7842506|NCT00996892|19301653|P5|COMPLETED|Dose-Escalation Stage 1B||0
7842507|NCT00996892|19301654|P4|COMPLETED|Dose-Escalation Stage 1B||0
7842508|NCT00996892|19301655|P3|COMPLETED|Dose-Escalation Stage 1B||0
7842509|NCT00996892|19301656|P2|COMPLETED|Dose-Escalation Stage 1B||0
7842510|NCT00996892|19301657|P1|COMPLETED|Dose-Escalation Stage 1B||0
7842511|NCT00996892|19301638|P20|STARTED|Dose-Escalation Stage 1B||0
7842512|NCT00996892|19301639|P19|STARTED|Dose-Escalation Stage 1B||0
7842513|NCT00996892|19301640|P18|STARTED|Dose-Escalation Stage 1B||5
7842514|NCT00996892|19301641|P17|STARTED|Dose-Escalation Stage 1B||3
7842515|NCT00996892|19301642|P16|STARTED|Dose-Escalation Stage 1B||3
7842516|NCT00996892|19301643|P15|STARTED|Dose-Escalation Stage 1B||4
7842517|NCT00996892|19301644|P14|STARTED|Dose-Escalation Stage 1B||0
7842518|NCT00996892|19301645|P13|STARTED|Dose-Escalation Stage 1B||0
7842519|NCT00996892|19301646|P12|STARTED|Dose-Escalation Stage 1B||0
7842520|NCT00996892|19301647|P11|STARTED|Dose-Escalation Stage 1B||0
7842521|NCT00996892|19301648|P10|STARTED|Dose-Escalation Stage 1B||0
7842522|NCT00996892|19301649|P9|STARTED|Dose-Escalation Stage 1B||0
7842523|NCT00996892|19301650|P8|STARTED|Dose-Escalation Stage 1B||0
7842524|NCT00996892|19301651|P7|STARTED|Dose-Escalation Stage 1B||0
7842525|NCT00996892|19301652|P6|STARTED|Dose-Escalation Stage 1B||0
7842526|NCT00996892|19301653|P5|STARTED|Dose-Escalation Stage 1B||0
7842527|NCT00996892|19301654|P4|STARTED|Dose-Escalation Stage 1B||0
7842528|NCT00996892|19301655|P3|STARTED|Dose-Escalation Stage 1B||0
7842529|NCT00996892|19301656|P2|STARTED|Dose-Escalation Stage 1B||0
7842530|NCT00996892|19301657|P1|STARTED|Dose-Escalation Stage 1B||0
7842531|NCT00996892|19301638|P20|NOT COMPLETED|Dose-Escalation Stage 1A||0
7842532|NCT00996892|19301639|P19|NOT COMPLETED|Dose-Escalation Stage 1A||0
7842533|NCT00996892|19301640|P18|NOT COMPLETED|Dose-Escalation Stage 1A||0
7842534|NCT00996892|19301641|P17|NOT COMPLETED|Dose-Escalation Stage 1A||0
7842535|NCT00996892|19301642|P16|NOT COMPLETED|Dose-Escalation Stage 1A||0
7842536|NCT00996892|19301643|P15|NOT COMPLETED|Dose-Escalation Stage 1A||0
7842537|NCT00996892|19301644|P14|NOT COMPLETED|Dose-Escalation Stage 1A||5
7842538|NCT00996892|19301645|P13|NOT COMPLETED|Dose-Escalation Stage 1A||8
7842539|NCT00996892|19301646|P12|NOT COMPLETED|Dose-Escalation Stage 1A||9
7842540|NCT00996892|19301647|P11|NOT COMPLETED|Dose-Escalation Stage 1A||7
7842541|NCT00996892|19301648|P10|NOT COMPLETED|Dose-Escalation Stage 1A||4
7842542|NCT00996892|19301649|P9|NOT COMPLETED|Dose-Escalation Stage 1A||3
7842543|NCT00996892|19301650|P8|NOT COMPLETED|Dose-Escalation Stage 1A||3
7842544|NCT00996892|19301651|P7|NOT COMPLETED|Dose-Escalation Stage 1A||0
7842545|NCT00996892|19301652|P6|NOT COMPLETED|Dose-Escalation Stage 1A||0
7842546|NCT00996892|19301653|P5|NOT COMPLETED|Dose-Escalation Stage 1A||0
7842547|NCT00996892|19301654|P4|NOT COMPLETED|Dose-Escalation Stage 1A||0
7842548|NCT00996892|19301655|P3|NOT COMPLETED|Dose-Escalation Stage 1A||0
7842549|NCT00996892|19301656|P2|NOT COMPLETED|Dose-Escalation Stage 1A||0
7842550|NCT00996892|19301657|P1|NOT COMPLETED|Dose-Escalation Stage 1A||0
7842551|NCT00996892|19301638|P20|COMPLETED|Dose-Escalation Stage 1A||0
7842552|NCT00996892|19301639|P19|COMPLETED|Dose-Escalation Stage 1A||0
7842553|NCT00996892|19301640|P18|COMPLETED|Dose-Escalation Stage 1A||0
7842554|NCT00996892|19301641|P17|COMPLETED|Dose-Escalation Stage 1A||0
7842555|NCT00996892|19301642|P16|COMPLETED|Dose-Escalation Stage 1A||0
7842556|NCT00996892|19301643|P15|COMPLETED|Dose-Escalation Stage 1A||0
7842557|NCT00996892|19301644|P14|COMPLETED|Dose-Escalation Stage 1A||0
7842558|NCT00996892|19301645|P13|COMPLETED|Dose-Escalation Stage 1A||0
7842559|NCT00996892|19301646|P12|COMPLETED|Dose-Escalation Stage 1A||0
7842560|NCT00996892|19301647|P11|COMPLETED|Dose-Escalation Stage 1A||0
7842561|NCT00996892|19301648|P10|COMPLETED|Dose-Escalation Stage 1A||0
7842562|NCT00996892|19301649|P9|COMPLETED|Dose-Escalation Stage 1A||0
7842563|NCT00996892|19301650|P8|COMPLETED|Dose-Escalation Stage 1A||0
7842564|NCT00996892|19301651|P7|COMPLETED|Dose-Escalation Stage 1A||0
7842565|NCT00996892|19301652|P6|COMPLETED|Dose-Escalation Stage 1A||0
7842566|NCT00996892|19301653|P5|COMPLETED|Dose-Escalation Stage 1A||0
7842567|NCT00996892|19301654|P4|COMPLETED|Dose-Escalation Stage 1A||0
7842568|NCT00996892|19301655|P3|COMPLETED|Dose-Escalation Stage 1A||0
7842569|NCT00996892|19301656|P2|COMPLETED|Dose-Escalation Stage 1A||0
7842570|NCT00996892|19301657|P1|COMPLETED|Dose-Escalation Stage 1A||0
7842571|NCT00996892|19301638|P20|STARTED|Dose-Escalation Stage 1A||0
7842572|NCT00996892|19301639|P19|STARTED|Dose-Escalation Stage 1A||0
7842573|NCT00996892|19301640|P18|STARTED|Dose-Escalation Stage 1A||0
7842574|NCT00996892|19301641|P17|STARTED|Dose-Escalation Stage 1A||0
7842575|NCT00996892|19301642|P16|STARTED|Dose-Escalation Stage 1A||0
7842576|NCT00996892|19301643|P15|STARTED|Dose-Escalation Stage 1A||0
7842577|NCT00996892|19301644|P14|STARTED|Dose-Escalation Stage 1A||5
7842578|NCT00996892|19301645|P13|STARTED|Dose-Escalation Stage 1A||8
7842579|NCT00996892|19301646|P12|STARTED|Dose-Escalation Stage 1A||9
7842580|NCT00996892|19301647|P11|STARTED|Dose-Escalation Stage 1A||7
7842581|NCT00996892|19301648|P10|STARTED|Dose-Escalation Stage 1A||4
7842582|NCT00996892|19301649|P9|STARTED|Dose-Escalation Stage 1A||3
7842583|NCT00996892|19301650|P8|STARTED|Dose-Escalation Stage 1A||3
7842584|NCT00996892|19301651|P7|STARTED|Dose-Escalation Stage 1A||0
7842585|NCT00996892|19301652|P6|STARTED|Dose-Escalation Stage 1A||0
7842586|NCT00996892|19301653|P5|STARTED|Dose-Escalation Stage 1A||0
7842587|NCT00996892|19301654|P4|STARTED|Dose-Escalation Stage 1A||0
7842588|NCT00996892|19301655|P3|STARTED|Dose-Escalation Stage 1A||0
7842589|NCT00996892|19301656|P2|STARTED|Dose-Escalation Stage 1A||0
7842590|NCT00996892|19301657|P1|STARTED|Dose-Escalation Stage 1A||0
7842591|NCT00996892|19301638|P20|NOT COMPLETED|Dose-Escalation Stage 1||0
7842592|NCT00996892|19301639|P19|NOT COMPLETED|Dose-Escalation Stage 1||0
7842593|NCT00996892|19301640|P18|NOT COMPLETED|Dose-Escalation Stage 1||0
7842594|NCT00996892|19301641|P17|NOT COMPLETED|Dose-Escalation Stage 1||0
7842595|NCT00996892|19301642|P16|NOT COMPLETED|Dose-Escalation Stage 1||0
7842596|NCT00996892|19301643|P15|NOT COMPLETED|Dose-Escalation Stage 1||0
7842597|NCT00996892|19301644|P14|NOT COMPLETED|Dose-Escalation Stage 1||0
7842598|NCT00996892|19301645|P13|NOT COMPLETED|Dose-Escalation Stage 1||0
7842599|NCT00996892|19301646|P12|NOT COMPLETED|Dose-Escalation Stage 1||0
7842600|NCT00996892|19301647|P11|NOT COMPLETED|Dose-Escalation Stage 1||0
7842601|NCT00996892|19301648|P10|NOT COMPLETED|Dose-Escalation Stage 1||0
7842602|NCT00996892|19301649|P9|NOT COMPLETED|Dose-Escalation Stage 1||0
7842603|NCT00996892|19301650|P8|NOT COMPLETED|Dose-Escalation Stage 1||0
7842604|NCT00996892|19301651|P7|NOT COMPLETED|Dose-Escalation Stage 1||4
7842605|NCT00996892|19301652|P6|NOT COMPLETED|Dose-Escalation Stage 1||10
7842606|NCT00996892|19301653|P5|NOT COMPLETED|Dose-Escalation Stage 1||11
7842607|NCT00996892|19301654|P4|NOT COMPLETED|Dose-Escalation Stage 1||9
7842608|NCT00996892|19301655|P3|NOT COMPLETED|Dose-Escalation Stage 1||3
7842609|NCT00996892|19301656|P2|NOT COMPLETED|Dose-Escalation Stage 1||3
7842610|NCT00996892|19301657|P1|NOT COMPLETED|Dose-Escalation Stage 1||4
7842611|NCT00996892|19301638|P20|COMPLETED|Dose-Escalation Stage 1||0
7842612|NCT00996892|19301639|P19|COMPLETED|Dose-Escalation Stage 1||0
7842613|NCT00996892|19301640|P18|COMPLETED|Dose-Escalation Stage 1||0
7842614|NCT00996892|19301641|P17|COMPLETED|Dose-Escalation Stage 1||0
7842615|NCT00996892|19301642|P16|COMPLETED|Dose-Escalation Stage 1||0
7842616|NCT00996892|19301643|P15|COMPLETED|Dose-Escalation Stage 1||0
7842617|NCT00996892|19301644|P14|COMPLETED|Dose-Escalation Stage 1||0
7842618|NCT00996892|19301645|P13|COMPLETED|Dose-Escalation Stage 1||0
7842619|NCT00996892|19301646|P12|COMPLETED|Dose-Escalation Stage 1||0
7842620|NCT00996892|19301647|P11|COMPLETED|Dose-Escalation Stage 1||0
7842621|NCT00996892|19301648|P10|COMPLETED|Dose-Escalation Stage 1||0
7842622|NCT00996892|19301649|P9|COMPLETED|Dose-Escalation Stage 1||0
7842623|NCT00996892|19301650|P8|COMPLETED|Dose-Escalation Stage 1||0
7842624|NCT00996892|19301651|P7|COMPLETED|Dose-Escalation Stage 1||0
7842625|NCT00996892|19301652|P6|COMPLETED|Dose-Escalation Stage 1||0
7842626|NCT00996892|19301653|P5|COMPLETED|Dose-Escalation Stage 1||0
7842627|NCT00996892|19301654|P4|COMPLETED|Dose-Escalation Stage 1||0
7842628|NCT00996892|19301655|P3|COMPLETED|Dose-Escalation Stage 1||0
7842629|NCT00996892|19301656|P2|COMPLETED|Dose-Escalation Stage 1||0
7842630|NCT00996892|19301657|P1|COMPLETED|Dose-Escalation Stage 1||0
7842631|NCT00996892|19301638|P20|STARTED|Dose-Escalation Stage 1||0
7842632|NCT00996892|19301639|P19|STARTED|Dose-Escalation Stage 1||0
7842633|NCT00996892|19301640|P18|STARTED|Dose-Escalation Stage 1||0
7842634|NCT00996892|19301641|P17|STARTED|Dose-Escalation Stage 1||0
7842635|NCT00996892|19301642|P16|STARTED|Dose-Escalation Stage 1||0
7842636|NCT00996892|19301643|P15|STARTED|Dose-Escalation Stage 1||0
7842637|NCT00996892|19301644|P14|STARTED|Dose-Escalation Stage 1||0
7842638|NCT00996892|19301645|P13|STARTED|Dose-Escalation Stage 1||0
7842639|NCT00996892|19301646|P12|STARTED|Dose-Escalation Stage 1||0
7842640|NCT00996892|19301647|P11|STARTED|Dose-Escalation Stage 1||0
7842641|NCT00996892|19301648|P10|STARTED|Dose-Escalation Stage 1||0
7842642|NCT00996892|19301649|P9|STARTED|Dose-Escalation Stage 1||0
7842643|NCT00996892|19301650|P8|STARTED|Dose-Escalation Stage 1||0
7842644|NCT00996892|19301651|P7|STARTED|Dose-Escalation Stage 1||4
7842645|NCT00996892|19301652|P6|STARTED|Dose-Escalation Stage 1||10
7842646|NCT00996892|19301653|P5|STARTED|Dose-Escalation Stage 1||11
7842647|NCT00996892|19301654|P4|STARTED|Dose-Escalation Stage 1||9
7842648|NCT00996892|19301655|P3|STARTED|Dose-Escalation Stage 1||3
7842649|NCT00996892|19301656|P2|STARTED|Dose-Escalation Stage 1||3
7842650|NCT00996892|19301657|P1|STARTED|Dose-Escalation Stage 1||4
7842651|NCT00996840|19302251|P5|NOT COMPLETED|Overall Study||2
7842652|NCT00996840|19302252|P4|NOT COMPLETED|Overall Study||1
7842653|NCT00996840|19302253|P3|NOT COMPLETED|Overall Study||1
7842654|NCT00996840|19302254|P2|NOT COMPLETED|Overall Study||2
7842655|NCT00996840|19302255|P1|NOT COMPLETED|Overall Study||1
7842656|NCT00996840|19302251|P5|COMPLETED|Overall Study||16
7842657|NCT00996840|19302252|P4|COMPLETED|Overall Study||17
7842658|NCT00996840|19302253|P3|COMPLETED|Overall Study||11
7842659|NCT00996840|19302254|P2|COMPLETED|Overall Study||7
7842660|NCT00996840|19302255|P1|COMPLETED|Overall Study||19
7842661|NCT00996840|19302251|P5|STARTED|Overall Study||18
7842662|NCT00996840|19302252|P4|STARTED|Overall Study||18
7842663|NCT00996840|19302253|P3|STARTED|Overall Study||12
7842664|NCT00996840|19302254|P2|STARTED|Overall Study||9
7842665|NCT00996840|19302255|P1|STARTED|Overall Study||20
7842666|NCT00996801|19302405|P6|NOT COMPLETED|Overall Study||19
7842667|NCT00996801|19302406|P5|NOT COMPLETED|Overall Study||88
7842668|NCT00996801|19302407|P4|NOT COMPLETED|Overall Study||31
7842669|NCT00996801|19302408|P3|NOT COMPLETED|Overall Study||23
7842670|NCT00996801|19302409|P2|NOT COMPLETED|Overall Study||16
7842671|NCT00996801|19302410|P1|NOT COMPLETED|Overall Study||20
7842672|NCT00996801|19302405|P6|COMPLETED|Overall Study||68
7842673|NCT00996801|19302406|P5|COMPLETED|Overall Study||0
7842674|NCT00996801|19302407|P4|COMPLETED|Overall Study||56
7842675|NCT00996801|19302408|P3|COMPLETED|Overall Study||65
7842676|NCT00996801|19302409|P2|COMPLETED|Overall Study||72
7842677|NCT00996801|19302410|P1|COMPLETED|Overall Study||68
7842678|NCT00996801|19302405|P6|STARTED|Overall Study||87
7842679|NCT00996801|19302406|P5|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88
7842680|NCT00996801|19302407|P4|STARTED|Overall Study||87
7842681|NCT00996801|19302408|P3|STARTED|Overall Study||88
7842682|NCT00996801|19302409|P2|STARTED|Overall Study||88
7842683|NCT00996801|19302410|P1|STARTED|Overall Study||88
7842684|NCT00996775|19302513|P2|NOT COMPLETED|Overall Study||14
7842685|NCT00996775|19302514|P1|NOT COMPLETED|Overall Study||11
7842686|NCT00996775|19302513|P2|COMPLETED|Overall Study||75
7842687|NCT00996775|19302514|P1|COMPLETED|Overall Study||67
7842688|NCT00996775|19302513|P2|STARTED|Overall Study||89
7842689|NCT00996775|19302514|P1|STARTED|Overall Study||78
7842690|NCT00996736|19302522|P2|NOT COMPLETED|Overall Study||18
7842691|NCT00996736|19302523|P1|NOT COMPLETED|Overall Study||21
7842692|NCT00996736|19302522|P2|COMPLETED|Overall Study||143
7842693|NCT00996736|19302523|P1|COMPLETED|Overall Study||141
7842694|NCT00996736|19302522|P2|3-month Visit|Overall Study||146
7842695|NCT00996736|19302523|P1|3-month Visit|Overall Study||146
7842696|NCT00996736|19302522|P2|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151
7842697|NCT00996736|19302523|P1|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155
7842698|NCT00996736|19302522|P2|STARTED|Overall Study||161
7842699|NCT00996736|19302523|P1|STARTED|Overall Study||162
7842700|NCT00996658|19302543|P2|NOT COMPLETED|Overall Study||21
7842701|NCT00996658|19302544|P1|NOT COMPLETED|Overall Study||16
7842702|NCT00996658|19302543|P2|COMPLETED|Overall Study||165
7842703|NCT00996658|19302544|P1|COMPLETED|Overall Study||76
7842704|NCT00996658|19302543|P2|STARTED|Overall Study||186
7842705|NCT00996658|19302544|P1|STARTED|Overall Study||92
7842706|NCT00996632|19302572|P2|NOT COMPLETED|Overall Study||0
7842707|NCT00996632|19302573|P1|NOT COMPLETED|Overall Study||0
7842708|NCT00996632|19302572|P2|COMPLETED|Overall Study||56
7842709|NCT00996632|19302573|P1|COMPLETED|Overall Study||38
7842710|NCT00996632|19302572|P2|STARTED|Overall Study||56
7842711|NCT00996632|19302573|P1|STARTED|Overall Study||38
7842712|NCT00996606|19302581|P1|NOT COMPLETED|Overall Study||8
7842713|NCT00996606|19302581|P1|COMPLETED|Overall Study||50
7842714|NCT00996606|19302581|P1|STARTED|Overall Study||58
7842715|NCT00996593|19302675|P1|NOT COMPLETED|Long-Term Follow-Up||3
7842716|NCT00996593|19302675|P1|COMPLETED|Long-Term Follow-Up||6
7842717|NCT00996593|19302675|P1|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9
7842718|NCT00996593|19302675|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43
7842719|NCT00996593|19302675|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
7842720|NCT00996593|19302675|P1|STARTED|Dosimetric and Therapeutic Treatment||43
7842721|NCT00996580|19302703|P1|NOT COMPLETED|Overall Study||1453
7842722|NCT00996580|19302703|P1|COMPLETED|Overall Study||2144
7842723|NCT00996580|19302703|P1|Pregnancy Intent-to-Treat Population|Overall Study||3019
7842724|NCT00996580|19302703|P1|STARTED|Overall Study||3597
7842725|NCT00996502|19302731|P1|NOT COMPLETED|Overall Study||0
7842726|NCT00996502|19302731|P1|COMPLETED|Overall Study||4
7842727|NCT00996502|19302731|P1|STARTED|Overall Study||4
7842728|NCT00996489|19302738|P1|NOT COMPLETED|Overall Study||161
7842729|NCT00996489|19302738|P1|COMPLETED|Overall Study||298
7842730|NCT00996489|19302738|P1|STARTED|Overall Study||459
7842731|NCT00996476|19302758|P5|NOT COMPLETED|Overall Study||2
7842732|NCT00996476|19302759|P4|NOT COMPLETED|Overall Study||0
7842733|NCT00996476|19302760|P3|NOT COMPLETED|Overall Study||1
7842734|NCT00996476|19302761|P2|NOT COMPLETED|Overall Study||3
7842735|NCT00996476|19302762|P1|NOT COMPLETED|Overall Study||1
7842736|NCT00996476|19302758|P5|COMPLETED|Overall Study||11
7842737|NCT00996476|19302759|P4|COMPLETED|Overall Study||13
7842738|NCT00996476|19302760|P3|COMPLETED|Overall Study||12
7842739|NCT00996476|19302761|P2|COMPLETED|Overall Study||23
7842740|NCT00996476|19302762|P1|COMPLETED|Overall Study||26
7842741|NCT00996476|19302758|P5|STARTED|Overall Study||13
7842742|NCT00996476|19302759|P4|STARTED|Overall Study||13
7842743|NCT00996476|19302760|P3|STARTED|Overall Study||13
7842744|NCT00996476|19302761|P2|STARTED|Overall Study||26
7842745|NCT00996476|19302762|P1|STARTED|Overall Study||27
7842746|NCT00996437|19302830|P2|NOT COMPLETED|Overall Study||7
7842747|NCT00996437|19302831|P1|NOT COMPLETED|Overall Study||5
7842748|NCT00996437|19302830|P2|COMPLETED|Overall Study||129
7842749|NCT00996437|19302831|P1|COMPLETED|Overall Study||120
7842750|NCT00996437|19302830|P2|STARTED|Overall Study||136
7842751|NCT00996437|19302831|P1|STARTED|Overall Study||125
7842752|NCT00996372|19302853|P2|NOT COMPLETED|Overall Study||84
7842753|NCT00996372|19302854|P1|NOT COMPLETED|Overall Study||103
7842754|NCT00996372|19302853|P2|COMPLETED|Overall Study||397
7842755|NCT00996372|19302854|P1|COMPLETED|Overall Study||365
7842756|NCT00996372|19302853|P2|STARTED|Overall Study||481
7842757|NCT00996372|19302854|P1|STARTED|Overall Study||468
7842758|NCT00996346|19302867|P3|NOT COMPLETED|Overall Study||0
7842759|NCT00996346|19302868|P2|NOT COMPLETED|Overall Study||0
7842760|NCT00996346|19302869|P1|NOT COMPLETED|Overall Study||0
7842761|NCT00996346|19302867|P3|COMPLETED|Overall Study||3
7842762|NCT00996346|19302868|P2|COMPLETED|Overall Study||8
7842763|NCT00996346|19302869|P1|COMPLETED|Overall Study||6
7842764|NCT00996346|19302867|P3|STARTED|Overall Study||3
7842765|NCT00996346|19302868|P2|STARTED|Overall Study||8
7842766|NCT00996346|19302869|P1|STARTED|Overall Study||6
7842767|NCT00996333|19302876|P1|NOT COMPLETED|Overall Study||13
7842768|NCT00996333|19302876|P1|COMPLETED|Overall Study||33
7842769|NCT00996333|19302876|P1|STARTED|Overall Study||46
7842770|NCT00996307|19302886|P4|NOT COMPLETED|Overall Study||21
7842771|NCT00996307|19302887|P3|NOT COMPLETED|Overall Study||14
7842772|NCT00996307|19302888|P2|NOT COMPLETED|Overall Study||17
7842773|NCT00996307|19302889|P1|NOT COMPLETED|Overall Study||20
7842774|NCT00996307|19302886|P4|COMPLETED|Overall Study||144
7842775|NCT00996307|19302887|P3|COMPLETED|Overall Study||146
7842776|NCT00996307|19302888|P2|COMPLETED|Overall Study||148
7842777|NCT00996307|19302889|P1|COMPLETED|Overall Study||144
7842778|NCT00996307|19302886|P4|STARTED|Overall Study||165
7842779|NCT00996307|19302887|P3|STARTED|Overall Study||160
7842780|NCT00996307|19302888|P2|STARTED|Overall Study||165
7842781|NCT00996307|19302889|P1|STARTED|Overall Study||164
7842782|NCT00996281|19302949|P2|NOT COMPLETED|Overall Study||89
7842783|NCT00996281|19302950|P1|NOT COMPLETED|Overall Study||131
7842784|NCT00996281|19302949|P2|COMPLETED|Overall Study||330
7842785|NCT00996281|19302950|P1|COMPLETED|Overall Study||287
7842786|NCT00996281|19302949|P2|STARTED|Overall Study||419
7842787|NCT00996281|19302950|P1|STARTED|Overall Study||418
7842788|NCT00996216|19302958|P1|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4
7842789|NCT00996216|19302958|P1|COMPLETED|Part 2 (Antiviral Treatment Phase)||21
7842790|NCT00996216|19302958|P1|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn't qualify to begin antiviral treatment in Part 2.|25
7842791|NCT00996216|19302958|P1|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1
7842792|NCT00996216|19302958|P1|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26
7842793|NCT00996216|19302958|P1|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27
7842794|NCT00996203|19302974|P1|NOT COMPLETED|Overall Study||7
7842795|NCT00996203|19302974|P1|COMPLETED|Overall Study||194
7842796|NCT00996203|19302974|P1|STARTED|Overall Study||201
7842797|NCT00996164|19302995|P2|NOT COMPLETED|Overall Study||101
7842798|NCT00996164|19302996|P1|NOT COMPLETED|Overall Study||135
7842799|NCT00996164|19302995|P2|COMPLETED|Overall Study||446
7842800|NCT00996164|19302996|P1|COMPLETED|Overall Study||408
7842801|NCT00996164|19302995|P2|STARTED|Overall Study||547
7842802|NCT00996164|19302996|P1|STARTED|Overall Study||543
7842803|NCT00996125|19303006|P2|NOT COMPLETED|Overall Study||11
7842804|NCT00996125|19303007|P1|NOT COMPLETED|Overall Study||5
7842805|NCT00996125|19303006|P2|COMPLETED|Overall Study||365
7842806|NCT00996125|19303007|P1|COMPLETED|Overall Study||369
7842807|NCT00996125|19303006|P2|STARTED|Overall Study||376
7842808|NCT00996125|19303007|P1|STARTED|Overall Study||374
7842809|NCT00996034|19303027|P1|NOT COMPLETED|Overall Study||3
7842810|NCT00996034|19303027|P1|COMPLETED|Overall Study||11
7842811|NCT00996034|19303027|P1|STARTED|Overall Study||14
7842812|NCT00995930|19303033|P2|NOT COMPLETED|Overall Study||28
7842813|NCT00995930|19303034|P1|NOT COMPLETED|Overall Study||21
7842814|NCT00995930|19303033|P2|COMPLETED|Overall Study||67
7842815|NCT00995930|19303034|P1|COMPLETED|Overall Study||73
7842816|NCT00995930|19303033|P2|Imaging Analysis Set|Overall Study||92
7842817|NCT00995930|19303034|P1|Imaging Analysis Set|Overall Study||92
7842818|NCT00995930|19303033|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||92
7842819|NCT00995930|19303034|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||92
7842820|NCT00995930|19303033|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||95
7842821|NCT00995930|19303034|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||0
7842822|NCT00995930|19303033|P2|Safety Analysis Set|Overall Study||95
7842823|NCT00995930|19303034|P1|Safety Analysis Set|Overall Study||94
7842824|NCT00995930|19303033|P2|STARTED|Overall Study||95
7842825|NCT00995930|19303034|P1|STARTED|Overall Study||94
7842826|NCT00995904|19303063|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
7842827|NCT00995904|19303064|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
7842828|NCT00995904|19303065|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
7842829|NCT00995904|19303066|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
7842830|NCT00995904|19303067|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
7842831|NCT00995904|19303068|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
7842832|NCT00995904|19303063|P6|COMPLETED|Follow-up Visit (Final Visit)||3
7842833|NCT00995904|19303064|P5|COMPLETED|Follow-up Visit (Final Visit)||5
7842834|NCT00995904|19303065|P4|COMPLETED|Follow-up Visit (Final Visit)||5
7842835|NCT00995904|19303066|P3|COMPLETED|Follow-up Visit (Final Visit)||4
7842836|NCT00995904|19303067|P2|COMPLETED|Follow-up Visit (Final Visit)||3
7842837|NCT00995904|19303068|P1|COMPLETED|Follow-up Visit (Final Visit)||4
7842838|NCT00995904|19303063|P6|STARTED|Follow-up Visit (Final Visit)||3
7842839|NCT00995904|19303064|P5|STARTED|Follow-up Visit (Final Visit)||5
7842840|NCT00995904|19303065|P4|STARTED|Follow-up Visit (Final Visit)||5
7842841|NCT00995904|19303066|P3|STARTED|Follow-up Visit (Final Visit)||4
7842842|NCT00995904|19303067|P2|STARTED|Follow-up Visit (Final Visit)||3
7842843|NCT00995904|19303068|P1|STARTED|Follow-up Visit (Final Visit)||4
7842844|NCT00995904|19303063|P6|NOT COMPLETED|Visit 4||0
7842845|NCT00995904|19303064|P5|NOT COMPLETED|Visit 4||0
7842846|NCT00995904|19303065|P4|NOT COMPLETED|Visit 4||0
7842847|NCT00995904|19303066|P3|NOT COMPLETED|Visit 4||0
7842848|NCT00995904|19303067|P2|NOT COMPLETED|Visit 4||0
7842849|NCT00995904|19303068|P1|NOT COMPLETED|Visit 4||0
7842850|NCT00995904|19303063|P6|COMPLETED|Visit 4||3
7842851|NCT00995904|19303064|P5|COMPLETED|Visit 4||5
7842852|NCT00995904|19303065|P4|COMPLETED|Visit 4||5
7842853|NCT00995904|19303066|P3|COMPLETED|Visit 4||4
7842854|NCT00995904|19303067|P2|COMPLETED|Visit 4||3
7842855|NCT00995904|19303068|P1|COMPLETED|Visit 4||4
7842856|NCT00995904|19303063|P6|STARTED|Visit 4||3
7842857|NCT00995904|19303064|P5|STARTED|Visit 4||5
7842858|NCT00995904|19303065|P4|STARTED|Visit 4||5
7842859|NCT00995904|19303066|P3|STARTED|Visit 4||4
7842860|NCT00995904|19303067|P2|STARTED|Visit 4||3
7842861|NCT00995904|19303068|P1|STARTED|Visit 4||4
7842862|NCT00995904|19303063|P6|NOT COMPLETED|Visit 3||0
7842863|NCT00995904|19303064|P5|NOT COMPLETED|Visit 3||0
7842864|NCT00995904|19303065|P4|NOT COMPLETED|Visit 3||0
7842865|NCT00995904|19303066|P3|NOT COMPLETED|Visit 3||0
7842866|NCT00995904|19303067|P2|NOT COMPLETED|Visit 3||0
7842867|NCT00995904|19303068|P1|NOT COMPLETED|Visit 3||0
7842868|NCT00995904|19303063|P6|COMPLETED|Visit 3||3
7842869|NCT00995904|19303064|P5|COMPLETED|Visit 3||5
7842870|NCT00995904|19303065|P4|COMPLETED|Visit 3||5
7842871|NCT00995904|19303066|P3|COMPLETED|Visit 3||4
7842872|NCT00995904|19303067|P2|COMPLETED|Visit 3||3
7842873|NCT00995904|19303068|P1|COMPLETED|Visit 3||4
7842874|NCT00995904|19303063|P6|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3
7842875|NCT00995904|19303064|P5|STARTED|Visit 3||5
7842876|NCT00995904|19303065|P4|STARTED|Visit 3||5
7842877|NCT00995904|19303066|P3|STARTED|Visit 3||4
7842878|NCT00995904|19303067|P2|STARTED|Visit 3||3
7842879|NCT00995904|19303068|P1|STARTED|Visit 3||4
7842880|NCT00995904|19303063|P6|NOT COMPLETED|Visit 2 (Randomization)||0
7842881|NCT00995904|19303064|P5|NOT COMPLETED|Visit 2 (Randomization)||0
7842882|NCT00995904|19303065|P4|NOT COMPLETED|Visit 2 (Randomization)||0
7842883|NCT00995904|19303066|P3|NOT COMPLETED|Visit 2 (Randomization)||0
7842884|NCT00995904|19303067|P2|NOT COMPLETED|Visit 2 (Randomization)||0
7842885|NCT00995904|19303068|P1|NOT COMPLETED|Visit 2 (Randomization)||0
7842886|NCT00995904|19303063|P6|COMPLETED|Visit 2 (Randomization)||4
7842887|NCT00995904|19303064|P5|COMPLETED|Visit 2 (Randomization)||5
7842888|NCT00995904|19303065|P4|COMPLETED|Visit 2 (Randomization)||5
7842889|NCT00995904|19303066|P3|COMPLETED|Visit 2 (Randomization)||4
7842890|NCT00995904|19303067|P2|COMPLETED|Visit 2 (Randomization)||3
7842891|NCT00995904|19303068|P1|COMPLETED|Visit 2 (Randomization)||4
7842892|NCT00995904|19303063|P6|STARTED|Visit 2 (Randomization)||4
7842893|NCT00995904|19303064|P5|STARTED|Visit 2 (Randomization)||5
7842894|NCT00995904|19303065|P4|STARTED|Visit 2 (Randomization)||5
7842895|NCT00995904|19303066|P3|STARTED|Visit 2 (Randomization)||4
7842896|NCT00995904|19303067|P2|STARTED|Visit 2 (Randomization)||3
7842897|NCT00995904|19303068|P1|STARTED|Visit 2 (Randomization)||4
7842898|NCT00995865|19303085|P3|NOT COMPLETED|Overall Study||1
7842899|NCT00995865|19303086|P2|NOT COMPLETED|Overall Study||0
7842900|NCT00995865|19303087|P1|NOT COMPLETED|Overall Study||2
7842901|NCT00995865|19303085|P3|COMPLETED|Overall Study||11
7842902|NCT00995865|19303086|P2|COMPLETED|Overall Study||24
7842903|NCT00995865|19303087|P1|COMPLETED|Overall Study||22
7842904|NCT00995865|19303085|P3|STARTED|Overall Study||12
7842905|NCT00995865|19303086|P2|STARTED|Overall Study||24
7842906|NCT00995865|19303087|P1|STARTED|Overall Study||24
7842907|NCT00995774|19303109|P2|NOT COMPLETED|Training Period 2||0
7842908|NCT00995774|19303110|P1|NOT COMPLETED|Training Period 2||2
7842909|NCT00995774|19303109|P2|COMPLETED|Training Period 2||5
7842910|NCT00995774|19303110|P1|COMPLETED|Training Period 2||5
7842911|NCT00995774|19303109|P2|STARTED|Training Period 2||5
7842912|NCT00995774|19303110|P1|STARTED|Training Period 2||7
7842913|NCT00995774|19303109|P2|NOT COMPLETED|Washout Period||0
7842914|NCT00995774|19303110|P1|NOT COMPLETED|Washout Period||0
7842915|NCT00995774|19303109|P2|COMPLETED|Washout Period||5
7842916|NCT00995774|19303110|P1|COMPLETED|Washout Period||7
7842917|NCT00995774|19303109|P2|STARTED|Washout Period||5
7842918|NCT00995774|19303110|P1|STARTED|Washout Period||7
7842919|NCT00995774|19303109|P2|NOT COMPLETED|Training Period 1||0
7842920|NCT00995774|19303110|P1|NOT COMPLETED|Training Period 1||0
7842921|NCT00995774|19303109|P2|COMPLETED|Training Period 1||5
7842922|NCT00995774|19303110|P1|COMPLETED|Training Period 1||7
7842923|NCT00995774|19303109|P2|STARTED|Training Period 1||5
7842924|NCT00995774|19303110|P1|STARTED|Training Period 1||7
7842925|NCT00995761|19303120|P1|NOT COMPLETED|Overall Study||0
7842926|NCT00995761|19303120|P1|COMPLETED|Overall Study||48
7842927|NCT00995761|19303120|P1|STARTED|Overall Study||48
7842928|NCT00995722|19303126|P2|NOT COMPLETED|Overall Study: 36 Weeks||2
7842929|NCT00995722|19303127|P1|NOT COMPLETED|Overall Study: 36 Weeks||2
7842930|NCT00995722|19303126|P2|COMPLETED|Overall Study: 36 Weeks||2
7842931|NCT00995722|19303127|P1|COMPLETED|Overall Study: 36 Weeks||3
7842932|NCT00995722|19303126|P2|STARTED|Overall Study: 36 Weeks||4
7842933|NCT00995722|19303127|P1|STARTED|Overall Study: 36 Weeks||5
7842934|NCT00995722|19303126|P2|NOT COMPLETED|Double Blinded: 16 Weeks||1
7842935|NCT00995722|19303127|P1|NOT COMPLETED|Double Blinded: 16 Weeks||1
7842936|NCT00995722|19303126|P2|COMPLETED|Double Blinded: 16 Weeks||4
7842937|NCT00995722|19303127|P1|COMPLETED|Double Blinded: 16 Weeks||5
7842938|NCT00995722|19303126|P2|STARTED|Double Blinded: 16 Weeks||5
7842939|NCT00995722|19303127|P1|STARTED|Double Blinded: 16 Weeks||6
7842940|NCT00995709|19303144|P3|NOT COMPLETED|Overall Study||5
7842941|NCT00995709|19303145|P2|NOT COMPLETED|Overall Study||9
7842942|NCT00995709|19303146|P1|NOT COMPLETED|Overall Study||7
7842943|NCT00995709|19303144|P3|COMPLETED|Overall Study||34
7842944|NCT00995709|19303145|P2|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31
7842945|NCT00995709|19303146|P1|COMPLETED|Overall Study||32
7842946|NCT00995709|19303144|P3|STARTED|Overall Study||39
7842947|NCT00995709|19303145|P2|STARTED|Overall Study||40
7842948|NCT00995709|19303146|P1|STARTED|Overall Study||39
7842949|NCT00995670|19303172|P3|NOT COMPLETED|Overall Study||3
7842950|NCT00995670|19303173|P2|NOT COMPLETED|Overall Study||0
7842951|NCT00995670|19303174|P1|NOT COMPLETED|Overall Study||1
7842952|NCT00995670|19303172|P3|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14
7842953|NCT00995670|19303173|P2|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16
7842954|NCT00995670|19303174|P1|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25
7842955|NCT00995670|19303172|P3|STARTED|Overall Study||17
7842956|NCT00995670|19303173|P2|STARTED|Overall Study||16
7842957|NCT00995670|19303174|P1|STARTED|Overall Study||26
7842958|NCT00995566|19303182|P1|NOT COMPLETED|Overall Study||54
7842959|NCT00995566|19303182|P1|COMPLETED|Overall Study||0
7842960|NCT00995566|19303182|P1|STARTED|Overall Study||54
7842961|NCT00995553|19303196|P2|NOT COMPLETED|Overall Study||6
7842962|NCT00995553|19303197|P1|NOT COMPLETED|Overall Study||2
7842963|NCT00995553|19303196|P2|COMPLETED|Overall Study||35
7842964|NCT00995553|19303197|P1|COMPLETED|Overall Study||38
7842965|NCT00995553|19303196|P2|STARTED|Overall Study||41
7842966|NCT00995553|19303197|P1|STARTED|Overall Study||40
7842967|NCT00995501|19303213|P8|NOT COMPLETED|Overall Study||0
7842968|NCT00995501|19303214|P7|NOT COMPLETED|Overall Study||0
7842969|NCT00995501|19303215|P6|NOT COMPLETED|Overall Study||0
7842970|NCT00995501|19303216|P5|NOT COMPLETED|Overall Study||0
7842971|NCT00995501|19303217|P4|NOT COMPLETED|Overall Study||0
7842972|NCT00995501|19303218|P3|NOT COMPLETED|Overall Study||0
7842973|NCT00995501|19303219|P2|NOT COMPLETED|Overall Study||0
7842974|NCT00995501|19303220|P1|NOT COMPLETED|Overall Study||0
7842975|NCT00995501|19303213|P8|COMPLETED|Overall Study||46
7842976|NCT00995501|19303214|P7|COMPLETED|Overall Study||49
7842977|NCT00995501|19303215|P6|COMPLETED|Overall Study||44
7842978|NCT00995501|19303216|P5|COMPLETED|Overall Study||46
7842979|NCT00995501|19303217|P4|COMPLETED|Overall Study||46
7842980|NCT00995501|19303218|P3|COMPLETED|Overall Study||47
7842981|NCT00995501|19303219|P2|COMPLETED|Overall Study||51
7842982|NCT00995501|19303220|P1|COMPLETED|Overall Study||52
7842983|NCT00995501|19303213|P8|STARTED|Overall Study||46
7842984|NCT00995501|19303214|P7|STARTED|Overall Study||49
7842985|NCT00995501|19303215|P6|STARTED|Overall Study||44
7842986|NCT00995501|19303216|P5|STARTED|Overall Study||46
7842987|NCT00995501|19303217|P4|STARTED|Overall Study||46
7842988|NCT00995501|19303218|P3|STARTED|Overall Study||47
7842989|NCT00995501|19303219|P2|STARTED|Overall Study||51
7842990|NCT00995501|19303220|P1|STARTED|Overall Study||52
7842991|NCT00995488|19303246|P1|NOT COMPLETED|Overall Study||1
7842992|NCT00995488|19303246|P1|COMPLETED|Overall Study||15
7842993|NCT00995488|19303246|P1|STARTED|Overall Study||16
7842994|NCT00995475|19303251|P2|NOT COMPLETED|Second Intervention||0
7842995|NCT00995475|19303252|P1|NOT COMPLETED|Second Intervention||0
7842996|NCT00995475|19303251|P2|COMPLETED|Second Intervention||9
7842997|NCT00995475|19303252|P1|COMPLETED|Second Intervention||9
7842998|NCT00995475|19303251|P2|STARTED|Second Intervention||9
7842999|NCT00995475|19303252|P1|STARTED|Second Intervention||9
7843000|NCT00995475|19303251|P2|NOT COMPLETED|Wash-out Two Week||0
7843001|NCT00995475|19303252|P1|NOT COMPLETED|Wash-out Two Week||0
7843002|NCT00995475|19303251|P2|COMPLETED|Wash-out Two Week||9
7843003|NCT00995475|19303252|P1|COMPLETED|Wash-out Two Week||9
7843004|NCT00995475|19303251|P2|STARTED|Wash-out Two Week||9
7843005|NCT00995475|19303252|P1|STARTED|Wash-out Two Week||9
7843006|NCT00995475|19303251|P2|NOT COMPLETED|First Intervention||0
7843007|NCT00995475|19303252|P1|NOT COMPLETED|First Intervention||0
7843008|NCT00995475|19303251|P2|COMPLETED|First Intervention||9
7843009|NCT00995475|19303252|P1|COMPLETED|First Intervention||9
7843010|NCT00995475|19303251|P2|STARTED|First Intervention||9
7843011|NCT00995475|19303252|P1|STARTED|First Intervention||9
7843012|NCT00995449|19303266|P4|NOT COMPLETED|Overall Study||0
7843013|NCT00995449|19303267|P3|NOT COMPLETED|Overall Study||2
7843014|NCT00995449|19303268|P2|NOT COMPLETED|Overall Study||0
7843015|NCT00995449|19303269|P1|NOT COMPLETED|Overall Study||0
7843016|NCT00995449|19303266|P4|COMPLETED|Overall Study||2
7843017|NCT00995449|19303267|P3|COMPLETED|Overall Study||5
7843018|NCT00995449|19303268|P2|COMPLETED|Overall Study||0
7843019|NCT00995449|19303269|P1|COMPLETED|Overall Study||0
7843020|NCT00995449|19303266|P4|STARTED|Overall Study||2
7843021|NCT00995449|19303267|P3|STARTED|Overall Study||7
7843022|NCT00995449|19303268|P2|STARTED|Overall Study||0
7843023|NCT00995449|19303269|P1|STARTED|Overall Study||0
7843024|NCT00995436|19303280|P3|NOT COMPLETED|Overall Study||0
7843025|NCT00995436|19303281|P2|NOT COMPLETED|Overall Study||5
7843026|NCT00995436|19303282|P1|NOT COMPLETED|Overall Study||2
7843027|NCT00995436|19303280|P3|COMPLETED|Overall Study||26
7843028|NCT00995436|19303281|P2|COMPLETED|Overall Study||22
7843029|NCT00995436|19303282|P1|COMPLETED|Overall Study||23
7843030|NCT00995436|19303280|P3|STARTED|Overall Study||26
7843031|NCT00995436|19303281|P2|STARTED|Overall Study||27
7843032|NCT00995436|19303282|P1|STARTED|Overall Study|25|25
7843033|NCT00995410|19303290|P1|NOT COMPLETED|Overall Study||88
7843034|NCT00995410|19303290|P1|COMPLETED|Overall Study||292
7843035|NCT00995410|19303290|P1|Treated|Overall Study||379
7843036|NCT00995410|19303290|P1|STARTED|Overall Study||380
7843037|NCT00995371|19303297|P2|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
7843038|NCT00995371|19303298|P1|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
7843039|NCT00995371|19303297|P2|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12
7843040|NCT00995371|19303298|P1|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16
7843041|NCT00995371|19303297|P2|STARTED|After ESI Cross-over to Mild, 26 Weeks||17
7843042|NCT00995371|19303298|P1|STARTED|After ESI Cross-over to Mild, 26 Weeks||21
7843043|NCT00995371|19303297|P2|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
7843044|NCT00995371|19303298|P1|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
7843045|NCT00995371|19303297|P2|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17
7843046|NCT00995371|19303298|P1|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21
7843047|NCT00995371|19303297|P2|STARTED|Prior to ESI Cross-over, 6 Weeks||17
7843048|NCT00995371|19303298|P1|STARTED|Prior to ESI Cross-over, 6 Weeks||21
7843049|NCT00995345|19303316|P5|NOT COMPLETED|Overall Study||5
7843050|NCT00995345|19303317|P4|NOT COMPLETED|Overall Study||5
7843051|NCT00995345|19303318|P3|NOT COMPLETED|Overall Study||7
7843052|NCT00995345|19303319|P2|NOT COMPLETED|Overall Study||7
7843053|NCT00995345|19303320|P1|NOT COMPLETED|Overall Study||11
7843054|NCT00995345|19303316|P5|COMPLETED|Overall Study||75
7843055|NCT00995345|19303317|P4|COMPLETED|Overall Study||76
7843056|NCT00995345|19303318|P3|COMPLETED|Overall Study||73
7843057|NCT00995345|19303319|P2|COMPLETED|Overall Study||74
7843058|NCT00995345|19303320|P1|COMPLETED|Overall Study||70
7843059|NCT00995345|19303316|P5|STARTED|Overall Study||80
7843060|NCT00995345|19303317|P4|STARTED|Overall Study||81
7843061|NCT00995345|19303318|P3|STARTED|Overall Study||80
7843062|NCT00995345|19303319|P2|STARTED|Overall Study||81
7843063|NCT00995345|19303320|P1|STARTED|Overall Study||81
7843064|NCT00995215|19303347|P1|NOT COMPLETED|Overall Study||0
7843065|NCT00995215|19303347|P1|COMPLETED|Overall Study||6
7843066|NCT00995215|19303347|P1|STARTED|Overall Study||6
7843067|NCT00995085|19303352|P1|NOT COMPLETED|Overall Study||5
7843068|NCT00995085|19303352|P1|COMPLETED|Overall Study||38
7843069|NCT00995085|19303352|P1|STARTED|Overall Study||43
7843070|NCT00995072|19303358|P2|NOT COMPLETED|Overall Study||3
7843071|NCT00995072|19303359|P1|NOT COMPLETED|Overall Study||1
7843072|NCT00995072|19303358|P2|COMPLETED|Overall Study||12
7843073|NCT00995072|19303359|P1|COMPLETED|Overall Study||9
7843074|NCT00995072|19303358|P2|STARTED|Overall Study||15
7843075|NCT00995072|19303359|P1|STARTED|Overall Study||10
7843076|NCT00995020|19303369|P2|NOT COMPLETED|Overall Study||7
7843077|NCT00995020|19303370|P1|NOT COMPLETED|Overall Study||3
7843078|NCT00995020|19303369|P2|COMPLETED|Overall Study|"Reasons for not completed:
~margin analysis not performed specimen fragmentation thermal damage"|45
7843079|NCT00995020|19303370|P1|COMPLETED|Overall Study|"Reasons for not completed:
~margin analysis not performed specimen fragmentation thermal damage"|48
7843080|NCT00995020|19303369|P2|STARTED|Overall Study||52
7843081|NCT00995020|19303370|P1|STARTED|Overall Study||51
7843082|NCT00995007|19303380|P2|NOT COMPLETED|Overall Study||2
7843083|NCT00995007|19303381|P1|NOT COMPLETED|Overall Study||17
7843084|NCT00995007|19303380|P2|COMPLETED|Overall Study||54
7843085|NCT00995007|19303381|P1|COMPLETED|Overall Study||39
7843086|NCT00995007|19303380|P2|Crossover to Vandetanib|Overall Study||0
7843087|NCT00995007|19303381|P1|Crossover to Vandetanib|Overall Study||42
7843088|NCT00995007|19303380|P2|STARTED|Overall Study||56
7843089|NCT00995007|19303381|P1|STARTED|Overall Study||56
7843090|NCT00994929|19303397|P1|NOT COMPLETED|Overall Study||0
7843091|NCT00994929|19303397|P1|COMPLETED|Overall Study||9
7843092|NCT00994929|19303397|P1|STARTED|Overall Study||9
7843093|NCT00994760|19303403|P1|NOT COMPLETED|Overall Study||24
7843094|NCT00994760|19303403|P1|COMPLETED|Overall Study||107
7843095|NCT00994760|19303403|P1|STARTED|Overall Study||131
7843096|NCT00994682|19303444|P2|NOT COMPLETED|Pioglitazone Open Label||7
7843097|NCT00994682|19303445|P1|NOT COMPLETED|Pioglitazone Open Label||13
7843098|NCT00994682|19303444|P2|COMPLETED|Pioglitazone Open Label||34
7843099|NCT00994682|19303445|P1|COMPLETED|Pioglitazone Open Label||29
7843100|NCT00994682|19303444|P2|STARTED|Pioglitazone Open Label||41
7843101|NCT00994682|19303445|P1|STARTED|Pioglitazone Open Label||42
7843102|NCT00994682|19303444|P2|NOT COMPLETED|Double Bilnd||9
7843103|NCT00994682|19303445|P1|NOT COMPLETED|Double Bilnd||9
7843104|NCT00994682|19303444|P2|COMPLETED|Double Bilnd||41
7843105|NCT00994682|19303445|P1|COMPLETED|Double Bilnd||42
7843106|NCT00994682|19303444|P2|STARTED|Double Bilnd||50
7843107|NCT00994682|19303445|P1|STARTED|Double Bilnd||51
7843108|NCT00994643|19303489|P1|NOT COMPLETED|Overall Study||1
7843109|NCT00994643|19303489|P1|COMPLETED|Overall Study||10
7843110|NCT00994643|19303489|P1|STARTED|Overall Study||11
7843111|NCT00994604|19303493|P1|NOT COMPLETED|Overall Study||6
7843112|NCT00994604|19303493|P1|COMPLETED|Overall Study||45
7843113|NCT00994604|19303493|P1|STARTED|Overall Study||51
7843114|NCT00994461|19303503|P3|NOT COMPLETED|Overall Study||0
7843115|NCT00994461|19303504|P2|NOT COMPLETED|Overall Study||1
7843116|NCT00994461|19303505|P1|NOT COMPLETED|Overall Study||2
7843117|NCT00994461|19303503|P3|COMPLETED|Overall Study||37
7843118|NCT00994461|19303504|P2|COMPLETED|Overall Study||75
7843119|NCT00994461|19303505|P1|COMPLETED|Overall Study||74
7843120|NCT00994461|19303503|P3|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37
7843121|NCT00994461|19303504|P2|STARTED|Overall Study||76
7843122|NCT00994461|19303505|P1|STARTED|Overall Study||76
7843123|NCT00994448|19303533|P2|NOT COMPLETED|Overall Study||2
7843124|NCT00994448|19303534|P1|NOT COMPLETED|Overall Study||8
7843125|NCT00994448|19303533|P2|COMPLETED|Overall Study||5
7843126|NCT00994448|19303534|P1|COMPLETED|Overall Study||4
7843127|NCT00994448|19303533|P2|STARTED|Overall Study||7
7843128|NCT00994448|19303534|P1|STARTED|Overall Study||12
7843129|NCT00994422|19303542|P2|NOT COMPLETED|Overall Study||1
7843130|NCT00994422|19303543|P1|NOT COMPLETED|Overall Study||7
7843131|NCT00994422|19303542|P2|COMPLETED|Overall Study||54
7843132|NCT00994422|19303543|P1|COMPLETED|Overall Study||185
7843133|NCT00994422|19303542|P2|STARTED|Overall Study||55
7843134|NCT00994422|19303543|P1|STARTED|Overall Study||192
7843135|NCT00994318|19303556|P3|NOT COMPLETED|Overall Study||67
7843136|NCT00994318|19303557|P2|NOT COMPLETED|Overall Study||18
7843137|NCT00994318|19303558|P1|NOT COMPLETED|Overall Study||22
7843138|NCT00994318|19303556|P3|COMPLETED|Overall Study||250
7843139|NCT00994318|19303557|P2|COMPLETED|Overall Study||136
7843140|NCT00994318|19303558|P1|COMPLETED|Overall Study||133
7843141|NCT00994318|19303556|P3|STARTED|Overall Study||317
7843142|NCT00994318|19303557|P2|STARTED|Overall Study||154
7843143|NCT00994318|19303558|P1|STARTED|Overall Study||155
7843144|NCT00994279|19303568|P2|NOT COMPLETED|Overall Study||5
7843145|NCT00994279|19303569|P1|NOT COMPLETED|Overall Study||4
7843146|NCT00994279|19303568|P2|COMPLETED|Overall Study||13
7843147|NCT00994279|19303569|P1|COMPLETED|Overall Study||18
7843148|NCT00994279|19303568|P2|STARTED|Overall Study||18
7843149|NCT00994279|19303569|P1|STARTED|Overall Study||22
7843150|NCT00994240|19303579|P2|NOT COMPLETED|Overall Study||5
7843151|NCT00994240|19303580|P1|NOT COMPLETED|Overall Study||6
7843152|NCT00994240|19303579|P2|COMPLETED|Overall Study||39
7843153|NCT00994240|19303580|P1|COMPLETED|Overall Study||35
7843154|NCT00994240|19303579|P2|STARTED|Overall Study||44
7843155|NCT00994240|19303580|P1|STARTED|Overall Study||41
7843156|NCT00994214|19303590|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
7843157|NCT00994214|19303591|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2
7843158|NCT00994214|19303592|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
7843159|NCT00994214|19303593|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4
7843160|NCT00994214|19303590|P4|COMPLETED|ITT (Intention-to-Treat) - Part B||0
7843161|NCT00994214|19303591|P3|COMPLETED|ITT (Intention-to-Treat) - Part B||0
7843162|NCT00994214|19303592|P2|COMPLETED|ITT (Intention-to-Treat) - Part B||0
7843163|NCT00994214|19303593|P1|COMPLETED|ITT (Intention-to-Treat) - Part B||0
7843164|NCT00994214|19303590|P4|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3
7843165|NCT00994214|19303591|P3|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2
7843166|NCT00994214|19303592|P2|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
7843167|NCT00994214|19303593|P1|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
7843168|NCT00994214|19303590|P4|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
7843169|NCT00994214|19303591|P3|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
7843170|NCT00994214|19303592|P2|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3
7843171|NCT00994214|19303593|P1|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1
7843172|NCT00994214|19303590|P4|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
7843173|NCT00994214|19303591|P3|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
7843174|NCT00994214|19303592|P2|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
7843175|NCT00994214|19303593|P1|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3
7843176|NCT00994214|19303590|P4|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
7843177|NCT00994214|19303591|P3|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
7843178|NCT00994214|19303592|P2|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
7843179|NCT00994214|19303593|P1|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
7843180|NCT00994214|19303590|P4|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3
7843181|NCT00994214|19303591|P3|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2
7843182|NCT00994214|19303592|P2|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3
7843183|NCT00994214|19303593|P1|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4
7843184|NCT00994214|19303590|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15
7843185|NCT00994214|19303591|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
7843186|NCT00994214|19303592|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
7843187|NCT00994214|19303593|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14
7843188|NCT00994214|19303590|P4|COMPLETED|ITT (Intention-to-Treat) - Part A||5
7843189|NCT00994214|19303591|P3|COMPLETED|ITT (Intention-to-Treat) - Part A||5
7843190|NCT00994214|19303592|P2|COMPLETED|ITT (Intention-to-Treat) - Part A||6
7843191|NCT00994214|19303593|P1|COMPLETED|ITT (Intention-to-Treat) - Part A||5
7843192|NCT00994214|19303590|P4|STARTED|ITT (Intention-to-Treat) - Part A||20
7843193|NCT00994214|19303591|P3|STARTED|ITT (Intention-to-Treat) - Part A||18
7843194|NCT00994214|19303592|P2|STARTED|ITT (Intention-to-Treat) - Part A||19
7843195|NCT00994214|19303593|P1|STARTED|ITT (Intention-to-Treat) - Part A||19
7843196|NCT00994175|19303637|P2|NOT COMPLETED|Second Intervention||0
7843197|NCT00994175|19303638|P1|NOT COMPLETED|Second Intervention||0
7843198|NCT00994175|19303637|P2|COMPLETED|Second Intervention||8
7843199|NCT00994175|19303638|P1|COMPLETED|Second Intervention||4
7843200|NCT00994175|19303637|P2|STARTED|Second Intervention||8
7843201|NCT00994175|19303638|P1|STARTED|Second Intervention||4
7843202|NCT00994175|19303637|P2|NOT COMPLETED|First Intervention||1
7843203|NCT00994175|19303638|P1|NOT COMPLETED|First Intervention||2
7843204|NCT00994175|19303637|P2|COMPLETED|First Intervention||8
7843205|NCT00994175|19303638|P1|COMPLETED|First Intervention||4
7843206|NCT00994175|19303637|P2|STARTED|First Intervention||9
7843207|NCT00994175|19303638|P1|STARTED|First Intervention||6
7843208|NCT00994123|19303649|P3|NOT COMPLETED|Overall Study||0
7843209|NCT00994123|19303650|P2|NOT COMPLETED|Overall Study||0
7843210|NCT00994123|19303651|P1|NOT COMPLETED|Overall Study||0
7843211|NCT00994123|19303649|P3|COMPLETED|Overall Study||44
7843212|NCT00994123|19303650|P2|COMPLETED|Overall Study||85
7843213|NCT00994123|19303651|P1|COMPLETED|Overall Study||33
7843214|NCT00994123|19303649|P3|STARTED|Overall Study||44
7843215|NCT00994123|19303650|P2|STARTED|Overall Study||85
7843216|NCT00994123|19303651|P1|STARTED|Overall Study||33
7843217|NCT00994110|19303672|P2|NOT COMPLETED|Overall Study||74
7843218|NCT00994110|19303673|P1|NOT COMPLETED|Overall Study||65
7843219|NCT00994110|19303672|P2|COMPLETED|Overall Study||148
7843220|NCT00994110|19303673|P1|COMPLETED|Overall Study||152
7843221|NCT00994110|19303672|P2|STARTED|Overall Study||222
7843222|NCT00994110|19303673|P1|STARTED|Overall Study||217
7843223|NCT00993967|19303679|P1|NOT COMPLETED|Overall Study||61
7843224|NCT00993967|19303679|P1|COMPLETED|Overall Study||139
7843225|NCT00993967|19303679|P1|STARTED|Overall Study||200
7843226|NCT00993954|19303686|P2|NOT COMPLETED|Overall Study||2
7843227|NCT00993954|19303687|P1|NOT COMPLETED|Overall Study||21
7843228|NCT00993954|19303686|P2|COMPLETED|Overall Study||121
7843229|NCT00993954|19303687|P1|COMPLETED|Overall Study||124
7843230|NCT00993954|19303686|P2|STARTED|Overall Study||123
7843231|NCT00993954|19303687|P1|STARTED|Overall Study||145
7843232|NCT00993928|19303700|P2|NOT COMPLETED|Overall Study||7
7843233|NCT00993928|19303701|P1|NOT COMPLETED|Overall Study||5
7843234|NCT00993928|19303700|P2|COMPLETED|Overall Study||38
7843235|NCT00993928|19303701|P1|COMPLETED|Overall Study||43
7843236|NCT00993928|19303700|P2|STARTED|Overall Study||45
7843237|NCT00993928|19303701|P1|STARTED|Overall Study||48
7843238|NCT00993915|19303715|P1|NOT COMPLETED|Overall Study||9
7843239|NCT00993915|19303715|P1|COMPLETED|Overall Study||678
7843240|NCT00993915|19303715|P1|STARTED|Overall Study||687
7843241|NCT00993824|19303726|P2|NOT COMPLETED|Overall Study||0
7843242|NCT00993824|19303727|P1|NOT COMPLETED|Overall Study||0
7843243|NCT00993824|19303726|P2|COMPLETED|Overall Study||10
7843244|NCT00993824|19303727|P1|COMPLETED|Overall Study||11
7843245|NCT00993824|19303726|P2|STARTED|Overall Study||10
7843246|NCT00993824|19303727|P1|STARTED|Overall Study||11
7843247|NCT00993668|19303741|P2|NOT COMPLETED|Open-Label Period||15
7843248|NCT00993668|19303742|P1|NOT COMPLETED|Open-Label Period||23
7843249|NCT00993668|19303741|P2|COMPLETED|Open-Label Period||91
7843250|NCT00993668|19303742|P1|COMPLETED|Open-Label Period||86
7843251|NCT00993668|19303741|P2|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106
7843252|NCT00993668|19303742|P1|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109
7843253|NCT00993668|19303741|P2|NOT COMPLETED|Single-Blind Period||3
7843254|NCT00993668|19303742|P1|NOT COMPLETED|Single-Blind Period||4
7843255|NCT00993668|19303741|P2|COMPLETED|Single-Blind Period||107
7843256|NCT00993668|19303742|P1|COMPLETED|Single-Blind Period||110
7843257|NCT00993668|19303741|P2|STARTED|Single-Blind Period||110
7843258|NCT00993668|19303742|P1|STARTED|Single-Blind Period||114
7843259|NCT00993655|19303770|P3|NOT COMPLETED|Overall Study||0
7843260|NCT00993655|19303771|P2|NOT COMPLETED|Overall Study||0
7843261|NCT00993655|19303772|P1|NOT COMPLETED|Overall Study||0
7843262|NCT00993655|19303770|P3|COMPLETED|Overall Study||102
7843263|NCT00993655|19303771|P2|COMPLETED|Overall Study||72
7843264|NCT00993655|19303772|P1|COMPLETED|Overall Study||101
7843265|NCT00993655|19303770|P3|STARTED|Overall Study||102
7843266|NCT00993655|19303771|P2|STARTED|Overall Study||72
7843267|NCT00993655|19303772|P1|STARTED|Overall Study||101
7843268|NCT00993616|19303786|P1|NOT COMPLETED|Overall Study||2
7843269|NCT00993616|19303786|P1|COMPLETED|Overall Study|Number of eligible and evaluable participants|27
7843270|NCT00993616|19303786|P1|STARTED|Overall Study||29
7843271|NCT00993499|19303804|P6|NOT COMPLETED|Discontinued After Starting Course 3||3
7843272|NCT00993499|19303805|P5|NOT COMPLETED|Discontinued After Starting Course 3||3
7843273|NCT00993499|19303806|P4|NOT COMPLETED|Discontinued After Starting Course 3||2
7843274|NCT00993499|19303807|P3|NOT COMPLETED|Discontinued After Starting Course 3||6
7843275|NCT00993499|19303808|P2|NOT COMPLETED|Discontinued After Starting Course 3||5
7843276|NCT00993499|19303809|P1|NOT COMPLETED|Discontinued After Starting Course 3||8
7843277|NCT00993499|19303804|P6|COMPLETED|Discontinued After Starting Course 3||0
7843278|NCT00993499|19303805|P5|COMPLETED|Discontinued After Starting Course 3||0
7843279|NCT00993499|19303806|P4|COMPLETED|Discontinued After Starting Course 3||1
7843280|NCT00993499|19303807|P3|COMPLETED|Discontinued After Starting Course 3||3
7843281|NCT00993499|19303808|P2|COMPLETED|Discontinued After Starting Course 3||4
7843282|NCT00993499|19303809|P1|COMPLETED|Discontinued After Starting Course 3||4
7843283|NCT00993499|19303804|P6|STARTED|Discontinued After Starting Course 3||3
7843284|NCT00993499|19303805|P5|STARTED|Discontinued After Starting Course 3||3
7843285|NCT00993499|19303806|P4|STARTED|Discontinued After Starting Course 3||3
7843286|NCT00993499|19303807|P3|STARTED|Discontinued After Starting Course 3||9
7843287|NCT00993499|19303808|P2|STARTED|Discontinued After Starting Course 3||9
7843288|NCT00993499|19303809|P1|STARTED|Discontinued After Starting Course 3||12
7843289|NCT00993499|19303804|P6|NOT COMPLETED|Discontinued Before Starting Course 3||0
7843290|NCT00993499|19303805|P5|NOT COMPLETED|Discontinued Before Starting Course 3||0
7843291|NCT00993499|19303806|P4|NOT COMPLETED|Discontinued Before Starting Course 3||1
7843292|NCT00993499|19303807|P3|NOT COMPLETED|Discontinued Before Starting Course 3||3
7843293|NCT00993499|19303808|P2|NOT COMPLETED|Discontinued Before Starting Course 3||4
7843294|NCT00993499|19303809|P1|NOT COMPLETED|Discontinued Before Starting Course 3||4
7843295|NCT00993499|19303804|P6|COMPLETED|Discontinued Before Starting Course 3||3
7843296|NCT00993499|19303805|P5|COMPLETED|Discontinued Before Starting Course 3||3
7843297|NCT00993499|19303806|P4|COMPLETED|Discontinued Before Starting Course 3||2
7843298|NCT00993499|19303807|P3|COMPLETED|Discontinued Before Starting Course 3||6
7843299|NCT00993499|19303808|P2|COMPLETED|Discontinued Before Starting Course 3||5
7843300|NCT00993499|19303809|P1|COMPLETED|Discontinued Before Starting Course 3||8
7843301|NCT00993499|19303804|P6|STARTED|Discontinued Before Starting Course 3||3
7843302|NCT00993499|19303805|P5|STARTED|Discontinued Before Starting Course 3||3
7843303|NCT00993499|19303806|P4|STARTED|Discontinued Before Starting Course 3||3
7843304|NCT00993499|19303807|P3|STARTED|Discontinued Before Starting Course 3||9
7843305|NCT00993499|19303808|P2|STARTED|Discontinued Before Starting Course 3||9
7843306|NCT00993499|19303809|P1|STARTED|Discontinued Before Starting Course 3||12
7843307|NCT00993499|19303804|P6|NOT COMPLETED|Run-in Period (8 Days)||0
7843308|NCT00993499|19303805|P5|NOT COMPLETED|Run-in Period (8 Days)||0
7843309|NCT00993499|19303806|P4|NOT COMPLETED|Run-in Period (8 Days)||0
7843310|NCT00993499|19303807|P3|NOT COMPLETED|Run-in Period (8 Days)||1
7843311|NCT00993499|19303808|P2|NOT COMPLETED|Run-in Period (8 Days)||3
7843312|NCT00993499|19303809|P1|NOT COMPLETED|Run-in Period (8 Days)||1
7843313|NCT00993499|19303804|P6|COMPLETED|Run-in Period (8 Days)||3
7843314|NCT00993499|19303805|P5|COMPLETED|Run-in Period (8 Days)||3
7843315|NCT00993499|19303806|P4|COMPLETED|Run-in Period (8 Days)||3
7843316|NCT00993499|19303807|P3|COMPLETED|Run-in Period (8 Days)||9
7843317|NCT00993499|19303808|P2|COMPLETED|Run-in Period (8 Days)||9
7843318|NCT00993499|19303809|P1|COMPLETED|Run-in Period (8 Days)||12
7843319|NCT00993499|19303804|P6|STARTED|Run-in Period (8 Days)||3
7843320|NCT00993499|19303805|P5|STARTED|Run-in Period (8 Days)||3
7843321|NCT00993499|19303806|P4|STARTED|Run-in Period (8 Days)||3
7843322|NCT00993499|19303807|P3|STARTED|Run-in Period (8 Days)||10
7843323|NCT00993499|19303808|P2|STARTED|Run-in Period (8 Days)||12
7843324|NCT00993499|19303809|P1|STARTED|Run-in Period (8 Days)||13
7843325|NCT00993473|19303891|P2|NOT COMPLETED|Overall Study||10
7843326|NCT00993473|19303892|P1|NOT COMPLETED|Overall Study||4
7843327|NCT00993473|19303891|P2|COMPLETED|Overall Study||54
7843328|NCT00993473|19303892|P1|COMPLETED|Overall Study||57
7843329|NCT00993473|19303891|P2|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64
7843330|NCT00993473|19303892|P1|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61
7843331|NCT00993447|19303930|P2|NOT COMPLETED|Overall Study||19
7843332|NCT00993447|19303931|P1|NOT COMPLETED|Overall Study||37
7843333|NCT00993447|19303930|P2|COMPLETED|Overall Study||180
7843334|NCT00993447|19303931|P1|COMPLETED|Overall Study||364
7843335|NCT00993447|19303930|P2|STARTED|Overall Study||199
7843336|NCT00993447|19303931|P1|STARTED|Overall Study||401
7843337|NCT00993421|19303968|P7|NOT COMPLETED|Overall Study||42
7843338|NCT00993421|19303969|P6|NOT COMPLETED|Overall Study||46
7843339|NCT00993421|19303970|P5|NOT COMPLETED|Overall Study||46
7843340|NCT00993421|19303971|P4|NOT COMPLETED|Overall Study||45
7843341|NCT00993421|19303972|P3|NOT COMPLETED|Overall Study||43
7843342|NCT00993421|19303973|P2|NOT COMPLETED|Overall Study||45
7843343|NCT00993421|19303974|P1|NOT COMPLETED|Overall Study||44
7843344|NCT00993421|19303968|P7|COMPLETED|Overall Study||4
7843345|NCT00993421|19303969|P6|COMPLETED|Overall Study||4
7843346|NCT00993421|19303970|P5|COMPLETED|Overall Study||6
7843347|NCT00993421|19303971|P4|COMPLETED|Overall Study||4
7843348|NCT00993421|19303972|P3|COMPLETED|Overall Study||5
7843349|NCT00993421|19303973|P2|COMPLETED|Overall Study||4
7843350|NCT00993421|19303974|P1|COMPLETED|Overall Study||5
7843351|NCT00993421|19303968|P7|STARTED|Overall Study||46
7843352|NCT00993421|19303969|P6|STARTED|Overall Study||50
7843353|NCT00993421|19303970|P5|STARTED|Overall Study||52
7843354|NCT00993421|19303971|P4|STARTED|Overall Study||49
7843355|NCT00993421|19303972|P3|STARTED|Overall Study||48
7843356|NCT00993421|19303973|P2|STARTED|Overall Study||49
7843357|NCT00993421|19303974|P1|STARTED|Overall Study||49
7843358|NCT00993317|19304125|P2|NOT COMPLETED|Overall Study||25
7843359|NCT00993317|19304126|P1|NOT COMPLETED|Overall Study||21
7843360|NCT00993317|19304125|P2|COMPLETED|Overall Study||60
7843361|NCT00993317|19304126|P1|COMPLETED|Overall Study||21
7843362|NCT00993317|19304125|P2|STARTED|Overall Study||85
7843363|NCT00993317|19304126|P1|STARTED|Overall Study||42
7843364|NCT00993291|19304144|P1|NOT COMPLETED|Overall Study||1
7843365|NCT00993291|19304144|P1|COMPLETED|Overall Study||19
7843366|NCT00993291|19304144|P1|STARTED|Overall Study||20
7843367|NCT00993265|19304150|P2|NOT COMPLETED|Overall Study||0
7843368|NCT00993265|19304151|P1|NOT COMPLETED|Overall Study||4
7843369|NCT00993265|19304150|P2|COMPLETED|Overall Study||19
7843370|NCT00993265|19304151|P1|COMPLETED|Overall Study||16
7843371|NCT00993265|19304150|P2|STARTED|Overall Study||19
7843372|NCT00993265|19304151|P1|STARTED|Overall Study||20
7843373|NCT00993200|19304171|P2|NOT COMPLETED|Overall Study||0
7843374|NCT00993200|19304172|P1|NOT COMPLETED|Overall Study||0
7843375|NCT00993200|19304171|P2|COMPLETED|Overall Study||13
7843376|NCT00993200|19304172|P1|COMPLETED|Overall Study||13
7843377|NCT00993200|19304171|P2|STARTED|Overall Study||13
7843378|NCT00993200|19304172|P1|STARTED|Overall Study||13
7843379|NCT00993187|19304184|P2|NOT COMPLETED|Overall Study||37
7843380|NCT00993187|19304185|P1|NOT COMPLETED|Overall Study||26
7843381|NCT00993187|19304184|P2|COMPLETED|Overall Study||108
7843382|NCT00993187|19304185|P1|COMPLETED|Overall Study||121
7843383|NCT00993187|19304184|P2|Received at Least 1 Dose of Study Drug|Overall Study||144
7843384|NCT00993187|19304185|P1|Received at Least 1 Dose of Study Drug|Overall Study||146
7843385|NCT00993187|19304184|P2|STARTED|Overall Study||145
7843386|NCT00993187|19304185|P1|STARTED|Overall Study||147
7843387|NCT00993148|19304203|P1|NOT COMPLETED|Overall Study||3
7843388|NCT00993148|19304203|P1|COMPLETED|Overall Study||22
7843389|NCT00993148|19304203|P1|STARTED|Overall Study||25
7843390|NCT00993044|19304215|P1|NOT COMPLETED|Irinotecan 50 mg||1
7843391|NCT00993044|19304215|P1|COMPLETED|Irinotecan 50 mg||6
7843392|NCT00993044|19304215|P1|STARTED|Irinotecan 50 mg||7
7843393|NCT00993044|19304215|P1|NOT COMPLETED|Irinotecan 30 mg||0
7843394|NCT00993044|19304215|P1|COMPLETED|Irinotecan 30 mg||6
7843395|NCT00993044|19304215|P1|STARTED|Irinotecan 30 mg||6
7843396|NCT00993031|19304222|P2|NOT COMPLETED|Overall Study||19
7843397|NCT00993031|19304223|P1|NOT COMPLETED|Overall Study||22
7843398|NCT00993031|19304222|P2|COMPLETED|Overall Study||175
7843399|NCT00993031|19304223|P1|COMPLETED|Overall Study||173
7843400|NCT00993031|19304222|P2|Delivered|Overall Study||190
7843401|NCT00993031|19304223|P1|Delivered|Overall Study||187
7843402|NCT00993031|19304222|P2|STARTED|Overall Study||194
7843403|NCT00993031|19304223|P1|STARTED|Overall Study||195
7843404|NCT00992992|19304255|P1|NOT COMPLETED|Overall Study||25
7843405|NCT00992992|19304255|P1|COMPLETED|Overall Study||0
7843406|NCT00992992|19304255|P1|STARTED|Overall Study||25
7843407|NCT00992927|19304277|P2|NOT COMPLETED|Overall Study||0
7843408|NCT00992927|19304278|P1|NOT COMPLETED|Overall Study||0
7843409|NCT00992927|19304277|P2|COMPLETED|Overall Study||22
7843410|NCT00992927|19304278|P1|COMPLETED|Overall Study||32
7843411|NCT00992927|19304277|P2|STARTED|Overall Study||22
7843412|NCT00992927|19304278|P1|STARTED|Overall Study||32
7843413|NCT00992836|19304286|P1|NOT COMPLETED|Overall Study||5
7843414|NCT00992836|19304286|P1|COMPLETED|Overall Study||150
7843415|NCT00992836|19304286|P1|Received Both Study Vaccinations|Overall Study||150
7843416|NCT00992836|19304286|P1|STARTED|Overall Study||155
7843417|NCT00992784|19304301|P3|NOT COMPLETED|Overall Study||1
7843418|NCT00992784|19304302|P2|NOT COMPLETED|Overall Study||2
7843419|NCT00992784|19304303|P1|NOT COMPLETED|Overall Study||3
7843420|NCT00992784|19304301|P3|COMPLETED|Overall Study||85
7843421|NCT00992784|19304302|P2|COMPLETED|Overall Study||102
7843422|NCT00992784|19304303|P1|COMPLETED|Overall Study||177
7843423|NCT00992784|19304301|P3|STARTED|Overall Study||86
7843424|NCT00992784|19304302|P2|STARTED|Overall Study||104
7843425|NCT00992784|19304303|P1|STARTED|Overall Study||180
7843426|NCT00992719|19304374|P3|NOT COMPLETED|Overall Study||0
7843427|NCT00992719|19304375|P2|NOT COMPLETED|Overall Study||1
7843428|NCT00992719|19304376|P1|NOT COMPLETED|Overall Study||1
7843429|NCT00992719|19304374|P3|COMPLETED|Overall Study||28
7843430|NCT00992719|19304375|P2|COMPLETED|Overall Study||27
7843431|NCT00992719|19304376|P1|COMPLETED|Overall Study||27
7843432|NCT00992719|19304374|P3|STARTED|Overall Study||28
7843433|NCT00992719|19304375|P2|STARTED|Overall Study||28
7843434|NCT00992719|19304376|P1|STARTED|Overall Study||28
7843435|NCT00992602|19304410|P1|NOT COMPLETED|Overall Study||3
7843436|NCT00992602|19304410|P1|COMPLETED|Overall Study||0
7843437|NCT00992602|19304410|P1|STARTED|Overall Study||3
7843438|NCT00992589|19304415|P4|NOT COMPLETED|Double-Blind Phase||10
7843439|NCT00992589|19304416|P3|NOT COMPLETED|Double-Blind Phase||13
7843440|NCT00992589|19304417|P2|NOT COMPLETED|Double-Blind Phase||13
7843441|NCT00992589|19304418|P1|NOT COMPLETED|Double-Blind Phase||0
7843442|NCT00992589|19304415|P4|COMPLETED|Double-Blind Phase||78
7843443|NCT00992589|19304416|P3|COMPLETED|Double-Blind Phase||77
7843444|NCT00992589|19304417|P2|COMPLETED|Double-Blind Phase||76
7843445|NCT00992589|19304418|P1|COMPLETED|Double-Blind Phase||0
7843446|NCT00992589|19304415|P4|STARTED|Double-Blind Phase||88
7843447|NCT00992589|19304416|P3|STARTED|Double-Blind Phase||90
7843448|NCT00992589|19304417|P2|STARTED|Double-Blind Phase||89
7843449|NCT00992589|19304418|P1|STARTED|Double-Blind Phase||0
7843450|NCT00992589|19304415|P4|NOT COMPLETED|Open-Label Phase||0
7843451|NCT00992589|19304416|P3|NOT COMPLETED|Open-Label Phase||0
7843452|NCT00992589|19304417|P2|NOT COMPLETED|Open-Label Phase||0
7843453|NCT00992589|19304418|P1|NOT COMPLETED|Open-Label Phase||77
7843454|NCT00992589|19304415|P4|COMPLETED|Open-Label Phase||0
7843455|NCT00992589|19304416|P3|COMPLETED|Open-Label Phase||0
7843456|NCT00992589|19304417|P2|COMPLETED|Open-Label Phase||0
7843457|NCT00992589|19304418|P1|COMPLETED|Open-Label Phase||267
7843458|NCT00992589|19304415|P4|STARTED|Open-Label Phase||0
7843459|NCT00992589|19304416|P3|STARTED|Open-Label Phase||0
7843460|NCT00992589|19304417|P2|STARTED|Open-Label Phase||0
7843461|NCT00992589|19304418|P1|STARTED|Open-Label Phase||344
7843462|NCT00992511|19304464|P4|NOT COMPLETED|Overall Study||5
7843463|NCT00992511|19304465|P3|NOT COMPLETED|Overall Study||2
7843464|NCT00992511|19304466|P2|NOT COMPLETED|Overall Study||0
7843465|NCT00992511|19304467|P1|NOT COMPLETED|Overall Study||2
7843466|NCT00992511|19304464|P4|COMPLETED|Overall Study||70
7843467|NCT00992511|19304465|P3|COMPLETED|Overall Study||74
7843468|NCT00992511|19304466|P2|COMPLETED|Overall Study||73
7843469|NCT00992511|19304467|P1|COMPLETED|Overall Study||74
7843470|NCT00992511|19304464|P4|STARTED|Overall Study||75
7843471|NCT00992511|19304465|P3|STARTED|Overall Study||76
7843472|NCT00992511|19304466|P2|STARTED|Overall Study||73
7843473|NCT00992511|19304467|P1|STARTED|Overall Study||76
7843474|NCT00992459|19304551|P2|NOT COMPLETED|Overall Study||1
7843475|NCT00992459|19304552|P1|NOT COMPLETED|Overall Study||1
7843476|NCT00992459|19304551|P2|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23
7843477|NCT00992459|19304552|P1|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21
7843478|NCT00992459|19304551|P2|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24
7843479|NCT00992459|19304552|P1|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22
7843480|NCT00992446|19304576|P1|NOT COMPLETED|Overall Study||8
7843481|NCT00992446|19304576|P1|COMPLETED|Overall Study||19
7843482|NCT00992446|19304576|P1|STARTED|Overall Study||27
7843483|NCT00992433|19304586|P2|NOT COMPLETED|Overall Study||7
7843484|NCT00992433|19304587|P1|NOT COMPLETED|Overall Study||4
7843485|NCT00992433|19304586|P2|COMPLETED|Overall Study||90
7843486|NCT00992433|19304587|P1|COMPLETED|Overall Study||91
7843487|NCT00992433|19304586|P2|STARTED|Overall Study||97
7843488|NCT00992433|19304587|P1|STARTED|Overall Study||95
7843489|NCT00992407|19304651|P2|NOT COMPLETED|Overall Study||24
7843490|NCT00992407|19304652|P1|NOT COMPLETED|Overall Study||31
7843491|NCT00992407|19304651|P2|COMPLETED|Overall Study||14
7843492|NCT00992407|19304652|P1|COMPLETED|Overall Study||6
7843493|NCT00992407|19304651|P2|Treated|Overall Study||25
7843494|NCT00992407|19304652|P1|Treated|Overall Study||20
7843495|NCT00992407|19304651|P2|STARTED|Overall Study||38
7843496|NCT00992407|19304652|P1|STARTED|Overall Study||37
7843497|NCT00992394|19304702|P2|NOT COMPLETED|Overall Study||14
7843498|NCT00992394|19304703|P1|NOT COMPLETED|Overall Study||24
7843499|NCT00992394|19304702|P2|COMPLETED|Overall Study||72
7843500|NCT00992394|19304703|P1|COMPLETED|Overall Study||64
7843501|NCT00992394|19304702|P2|mITT Population|Overall Study||84
7843502|NCT00992394|19304703|P1|mITT Population|Overall Study||86
7843503|NCT00992394|19304702|P2|Safety Population|Overall Study||84
7843504|NCT00992394|19304703|P1|Safety Population|Overall Study||87
7843505|NCT00992394|19304702|P2|STARTED|Overall Study||86
7843506|NCT00992394|19304703|P1|STARTED|Overall Study||88
7843507|NCT00992264|19304761|P16|NOT COMPLETED|Overall Study||0
7843508|NCT00992264|19304762|P15|NOT COMPLETED|Overall Study||0
7843509|NCT00992264|19304763|P14|NOT COMPLETED|Overall Study||0
7843510|NCT00992264|19304764|P13|NOT COMPLETED|Overall Study||0
7843511|NCT00992264|19304765|P12|NOT COMPLETED|Overall Study||0
7843512|NCT00992264|19304766|P11|NOT COMPLETED|Overall Study||0
7843513|NCT00992264|19304767|P10|NOT COMPLETED|Overall Study||0
7843514|NCT00992264|19304768|P9|NOT COMPLETED|Overall Study||0
7843515|NCT00992264|19304769|P8|NOT COMPLETED|Overall Study||0
7843516|NCT00992264|19304770|P7|NOT COMPLETED|Overall Study||0
7843517|NCT00992264|19304771|P6|NOT COMPLETED|Overall Study||0
7843518|NCT00992264|19304772|P5|NOT COMPLETED|Overall Study||0
7843519|NCT00992264|19304773|P4|NOT COMPLETED|Overall Study||0
7843520|NCT00992264|19304774|P3|NOT COMPLETED|Overall Study||0
7843521|NCT00992264|19304775|P2|NOT COMPLETED|Overall Study||0
7843522|NCT00992264|19304776|P1|NOT COMPLETED|Overall Study||0
7843523|NCT00992264|19304761|P16|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
7843524|NCT00992264|19304762|P15|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
7843525|NCT00992264|19304763|P14|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
7843526|NCT00992264|19304764|P13|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
7843527|NCT00992264|19304765|P12|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
7843528|NCT00992264|19304766|P11|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
7843529|NCT00992264|19304767|P10|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
7843530|NCT00992264|19304768|P9|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
7843531|NCT00992264|19304769|P8|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
7843532|NCT00992264|19304770|P7|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
7843533|NCT00992264|19304771|P6|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
7843534|NCT00992264|19304772|P5|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
7843535|NCT00992264|19304773|P4|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
7843536|NCT00992264|19304774|P3|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
7843537|NCT00992264|19304775|P2|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
7843538|NCT00992264|19304776|P1|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
7843539|NCT00992264|19304761|P16|STARTED|Overall Study||116
7843540|NCT00992264|19304762|P15|STARTED|Overall Study||117
7843541|NCT00992264|19304763|P14|STARTED|Overall Study||117
7843542|NCT00992264|19304764|P13|STARTED|Overall Study||116
7843543|NCT00992264|19304765|P12|STARTED|Overall Study||117
7843544|NCT00992264|19304766|P11|STARTED|Overall Study||117
7843545|NCT00992264|19304767|P10|STARTED|Overall Study||116
7843546|NCT00992264|19304768|P9|STARTED|Overall Study||116
7843547|NCT00992264|19304769|P8|STARTED|Overall Study||117
7843548|NCT00992264|19304770|P7|STARTED|Overall Study||116
7843549|NCT00992264|19304771|P6|STARTED|Overall Study||117
7843550|NCT00992264|19304772|P5|STARTED|Overall Study||117
7843551|NCT00992264|19304773|P4|STARTED|Overall Study||117
7843552|NCT00992264|19304774|P3|STARTED|Overall Study||117
7843553|NCT00992264|19304775|P2|STARTED|Overall Study||116
7843554|NCT00992264|19304776|P1|STARTED|Overall Study||116
7843555|NCT00992225|19304790|P1|NOT COMPLETED|Overall Study||10
7843556|NCT00992225|19304790|P1|COMPLETED|Overall Study||33
7843557|NCT00992225|19304790|P1|Received at Least One Dose of Study Drug|Overall Study||33
7843558|NCT00992225|19304790|P1|STARTED|Overall Study||43
7843559|NCT00992186|19304800|P1|NOT COMPLETED|Overall Study||46
7843560|NCT00992186|19304800|P1|COMPLETED|Overall Study||0
7843561|NCT00992186|19304800|P1|STARTED|Overall Study||46
7843562|NCT00992108|19304819|P2|NOT COMPLETED|Overall Study||1
7843563|NCT00992108|19304820|P1|NOT COMPLETED|Overall Study||0
7843564|NCT00992108|19304819|P2|COMPLETED|Overall Study||9
7843565|NCT00992108|19304820|P1|COMPLETED|Overall Study||7
7843566|NCT00992108|19304819|P2|STARTED|Overall Study||10
7843567|NCT00992108|19304820|P1|STARTED|Overall Study||7
7843568|NCT00992056|19304834|P2|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
7843569|NCT00992056|19304835|P1|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
7843570|NCT00992056|19304834|P2|COMPLETED|Treatment Period 2 (6 Weeks)||10
7843571|NCT00992056|19304835|P1|COMPLETED|Treatment Period 2 (6 Weeks)||10
7843572|NCT00992056|19304834|P2|STARTED|Treatment Period 2 (6 Weeks)||10
7843573|NCT00992056|19304835|P1|STARTED|Treatment Period 2 (6 Weeks)||10
7843574|NCT00992056|19304834|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
7843575|NCT00992056|19304835|P1|NOT COMPLETED|Washout Period (2 Weeks)||1
7843576|NCT00992056|19304834|P2|COMPLETED|Washout Period (2 Weeks)||10
7843577|NCT00992056|19304835|P1|COMPLETED|Washout Period (2 Weeks)||10
7843578|NCT00992056|19304834|P2|STARTED|Washout Period (2 Weeks)||10
7843579|NCT00992056|19304835|P1|STARTED|Washout Period (2 Weeks)||11
7843580|NCT00992056|19304834|P2|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2
7843581|NCT00992056|19304835|P1|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1
7843582|NCT00992056|19304834|P2|COMPLETED|Treatment Period 1 (6 Weeks)||10
7843583|NCT00992056|19304835|P1|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11
7843584|NCT00992056|19304834|P2|STARTED|Treatment Period 1 (6 Weeks)||12
7843585|NCT00992056|19304835|P1|STARTED|Treatment Period 1 (6 Weeks)||12
7843586|NCT00992017|19304841|P1|NOT COMPLETED|Overall Study||10
7843587|NCT00992017|19304841|P1|COMPLETED|Overall Study||118
7843588|NCT00992017|19304841|P1|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4
7843589|NCT00992017|19304841|P1|Received Both Study Vaccinations|Overall Study||124
7843590|NCT00992017|19304841|P1|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128
7843591|NCT00991952|19304856|P2|NOT COMPLETED|Overall Study||1
7843592|NCT00991952|19304857|P1|NOT COMPLETED|Overall Study||0
7843593|NCT00991952|19304856|P2|COMPLETED|Overall Study||5
7843594|NCT00991952|19304857|P1|COMPLETED|Overall Study||13
7843595|NCT00991952|19304856|P2|STARTED|Overall Study||6
7843596|NCT00991952|19304857|P1|STARTED|Overall Study||13
7843597|NCT00991939|19304865|P2|NOT COMPLETED|Overall Study||2
7843598|NCT00991939|19304866|P1|NOT COMPLETED|Overall Study||5
7843599|NCT00991939|19304865|P2|COMPLETED|Overall Study||1
7843600|NCT00991939|19304866|P1|COMPLETED|Overall Study||0
7843601|NCT00991939|19304865|P2|STARTED|Overall Study||3
7843602|NCT00991939|19304866|P1|STARTED|Overall Study||5
7843603|NCT00991887|19304900|P2|NOT COMPLETED|Overall Study||1
7843604|NCT00991887|19304901|P1|NOT COMPLETED|Overall Study||2
7843605|NCT00991887|19304900|P2|COMPLETED|Overall Study||21
7843606|NCT00991887|19304901|P1|COMPLETED|Overall Study||24
7843607|NCT00991887|19304900|P2|STARTED|Overall Study||22
7843608|NCT00991887|19304901|P1|STARTED|Overall Study||26
7843609|NCT00991809|19304909|P2|NOT COMPLETED|Overall Study||6
7843610|NCT00991809|19304910|P1|NOT COMPLETED|Overall Study||4
7843611|NCT00991809|19304909|P2|COMPLETED|Overall Study||4
7843612|NCT00991809|19304910|P1|COMPLETED|Overall Study||8
7843613|NCT00991809|19304909|P2|STARTED|Overall Study||10
7843614|NCT00991809|19304910|P1|STARTED|Overall Study||12
7843615|NCT00991510|19304920|P2|NOT COMPLETED|Period III (Days 29-112)||1
7843616|NCT00991510|19304921|P1|NOT COMPLETED|Period III (Days 29-112)||1
7843617|NCT00991510|19304920|P2|COMPLETED|Period III (Days 29-112)||20
7843618|NCT00991510|19304921|P1|COMPLETED|Period III (Days 29-112)||20
7843619|NCT00991510|19304920|P2|STARTED|Period III (Days 29-112)||21
7843620|NCT00991510|19304921|P1|STARTED|Period III (Days 29-112)||21
7843621|NCT00991510|19304920|P2|NOT COMPLETED|Period II (Days 15-28)||0
7843622|NCT00991510|19304921|P1|NOT COMPLETED|Period II (Days 15-28)||0
7843623|NCT00991510|19304920|P2|COMPLETED|Period II (Days 15-28)||21
7843624|NCT00991510|19304921|P1|COMPLETED|Period II (Days 15-28)||21
7843625|NCT00991510|19304920|P2|STARTED|Period II (Days 15-28)||21
7843626|NCT00991510|19304921|P1|STARTED|Period II (Days 15-28)||21
7843627|NCT00991510|19304920|P2|NOT COMPLETED|Period I (Days 1-14)||0
7843628|NCT00991510|19304921|P1|NOT COMPLETED|Period I (Days 1-14)||1
7843629|NCT00991510|19304920|P2|COMPLETED|Period I (Days 1-14)||21
7843630|NCT00991510|19304921|P1|COMPLETED|Period I (Days 1-14)||21
7843631|NCT00991510|19304920|P2|STARTED|Period I (Days 1-14)||21
7843632|NCT00991510|19304921|P1|STARTED|Period I (Days 1-14)||22
7843633|NCT00991458|19304946|P3|NOT COMPLETED|Overall Study||25
7843634|NCT00991458|19304947|P2|NOT COMPLETED|Overall Study||28
7843635|NCT00991458|19304948|P1|NOT COMPLETED|Overall Study||20
7843636|NCT00991458|19304946|P3|COMPLETED|Overall Study||180
7843637|NCT00991458|19304947|P2|COMPLETED|Overall Study||181
7843638|NCT00991458|19304948|P1|COMPLETED|Overall Study||187
7843639|NCT00991458|19304946|P3|STARTED|Overall Study||205
7843640|NCT00991458|19304947|P2|STARTED|Overall Study||209
7843641|NCT00991458|19304948|P1|STARTED|Overall Study||207
7843642|NCT00991406|19304965|P1|NOT COMPLETED|Overall Study||1
7843643|NCT00991406|19304965|P1|COMPLETED|Overall Study|One participant did not respond to FES due to tone.|8
7843644|NCT00991406|19304965|P1|STARTED|Overall Study||9
7843645|NCT00991341|19304974|P2|NOT COMPLETED|Overall Study||179
7843646|NCT00991341|19304975|P1|NOT COMPLETED|Overall Study||204
7843647|NCT00991341|19304974|P2|COMPLETED|Overall Study||560
7843648|NCT00991341|19304975|P1|COMPLETED|Overall Study||538
7843649|NCT00991341|19304974|P2|STARTED|Overall Study||739
7843650|NCT00991341|19304975|P1|STARTED|Overall Study||742
7843651|NCT00991302|19305013|P2|NOT COMPLETED|Overall Study||13
7843652|NCT00991302|19305014|P1|NOT COMPLETED|Overall Study||14
7843653|NCT00991302|19305013|P2|COMPLETED|Overall Study||73
7843654|NCT00991302|19305014|P1|COMPLETED|Overall Study||72
7843655|NCT00991302|19305013|P2|STARTED|Overall Study||86
7843656|NCT00991302|19305014|P1|STARTED|Overall Study||86
7843657|NCT00991289|19305030|P1|NOT COMPLETED|Overall Study||12
7843658|NCT00991289|19305030|P1|COMPLETED|Overall Study|Completed study.|55
7843659|NCT00991289|19305030|P1|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61
7843660|NCT00991289|19305030|P1|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67
7843661|NCT00991276|19305050|P6|NOT COMPLETED|Third Intervention Period||1
7843662|NCT00991276|19305051|P5|NOT COMPLETED|Third Intervention Period||0
7843663|NCT00991276|19305052|P4|NOT COMPLETED|Third Intervention Period||1
7843664|NCT00991276|19305053|P3|NOT COMPLETED|Third Intervention Period||1
7843665|NCT00991276|19305054|P2|NOT COMPLETED|Third Intervention Period||0
7843666|NCT00991276|19305055|P1|NOT COMPLETED|Third Intervention Period||1
7843667|NCT00991276|19305050|P6|COMPLETED|Third Intervention Period||10
7843668|NCT00991276|19305051|P5|COMPLETED|Third Intervention Period||10
7843669|NCT00991276|19305052|P4|COMPLETED|Third Intervention Period||8
7843670|NCT00991276|19305053|P3|COMPLETED|Third Intervention Period||13
7843671|NCT00991276|19305054|P2|COMPLETED|Third Intervention Period||8
7843672|NCT00991276|19305055|P1|COMPLETED|Third Intervention Period||13
7843673|NCT00991276|19305050|P6|STARTED|Third Intervention Period||11
7843674|NCT00991276|19305051|P5|STARTED|Third Intervention Period||10
7843675|NCT00991276|19305052|P4|STARTED|Third Intervention Period||9
7843676|NCT00991276|19305053|P3|STARTED|Third Intervention Period||14
7843677|NCT00991276|19305054|P2|STARTED|Third Intervention Period||8
7843678|NCT00991276|19305055|P1|STARTED|Third Intervention Period||14
7843679|NCT00991276|19305050|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
7843680|NCT00991276|19305051|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
7843681|NCT00991276|19305052|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
7843682|NCT00991276|19305053|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
7843683|NCT00991276|19305054|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
7843684|NCT00991276|19305055|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
7843685|NCT00991276|19305050|P6|COMPLETED|Placebo Wash-out Period (7 Days)||11
7843686|NCT00991276|19305051|P5|COMPLETED|Placebo Wash-out Period (7 Days)||10
7843687|NCT00991276|19305052|P4|COMPLETED|Placebo Wash-out Period (7 Days)||9
7843688|NCT00991276|19305053|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
7843689|NCT00991276|19305054|P2|COMPLETED|Placebo Wash-out Period (7 Days)||8
7843690|NCT00991276|19305055|P1|COMPLETED|Placebo Wash-out Period (7 Days)||14
7843691|NCT00991276|19305050|P6|STARTED|Placebo Wash-out Period (7 Days)||11
7843692|NCT00991276|19305051|P5|STARTED|Placebo Wash-out Period (7 Days)||10
7843693|NCT00991276|19305052|P4|STARTED|Placebo Wash-out Period (7 Days)||9
7843694|NCT00991276|19305053|P3|STARTED|Placebo Wash-out Period (7 Days)||14
7843695|NCT00991276|19305054|P2|STARTED|Placebo Wash-out Period (7 Days)||8
7843696|NCT00991276|19305055|P1|STARTED|Placebo Wash-out Period (7 Days)||14
7843697|NCT00991276|19305050|P6|NOT COMPLETED|Second Intervention Period||1
7843698|NCT00991276|19305051|P5|NOT COMPLETED|Second Intervention Period||1
7843699|NCT00991276|19305052|P4|NOT COMPLETED|Second Intervention Period||2
7843700|NCT00991276|19305053|P3|NOT COMPLETED|Second Intervention Period||0
7843701|NCT00991276|19305054|P2|NOT COMPLETED|Second Intervention Period||2
7843702|NCT00991276|19305055|P1|NOT COMPLETED|Second Intervention Period||1
7843703|NCT00991276|19305050|P6|COMPLETED|Second Intervention Period||11
7843704|NCT00991276|19305051|P5|COMPLETED|Second Intervention Period||10
7843705|NCT00991276|19305052|P4|COMPLETED|Second Intervention Period||9
7843706|NCT00991276|19305053|P3|COMPLETED|Second Intervention Period||14
7843707|NCT00991276|19305054|P2|COMPLETED|Second Intervention Period||8
7843708|NCT00991276|19305055|P1|COMPLETED|Second Intervention Period||14
7843709|NCT00991276|19305050|P6|STARTED|Second Intervention Period||12
7843710|NCT00991276|19305051|P5|STARTED|Second Intervention Period||11
7843711|NCT00991276|19305052|P4|STARTED|Second Intervention Period||11
7843712|NCT00991276|19305053|P3|STARTED|Second Intervention Period||14
7843713|NCT00991276|19305054|P2|STARTED|Second Intervention Period||10
7843714|NCT00991276|19305055|P1|STARTED|Second Intervention Period||15
7843715|NCT00991276|19305050|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
7843716|NCT00991276|19305051|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
7843717|NCT00991276|19305052|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
7843718|NCT00991276|19305053|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
7843719|NCT00991276|19305054|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
7843720|NCT00991276|19305055|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
7843721|NCT00991276|19305050|P6|COMPLETED|Placebo Wash-out Period (7 Days)||12
7843722|NCT00991276|19305051|P5|COMPLETED|Placebo Wash-out Period (7 Days)||11
7843723|NCT00991276|19305052|P4|COMPLETED|Placebo Wash-out Period (7 Days)||11
7843724|NCT00991276|19305053|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
7843725|NCT00991276|19305054|P2|COMPLETED|Placebo Wash-out Period (7 Days)||10
7843726|NCT00991276|19305055|P1|COMPLETED|Placebo Wash-out Period (7 Days)||15
7843727|NCT00991276|19305050|P6|STARTED|Placebo Wash-out Period (7 Days)||12
7843728|NCT00991276|19305051|P5|STARTED|Placebo Wash-out Period (7 Days)||11
7843729|NCT00991276|19305052|P4|STARTED|Placebo Wash-out Period (7 Days)||11
7843730|NCT00991276|19305053|P3|STARTED|Placebo Wash-out Period (7 Days)||14
7843731|NCT00991276|19305054|P2|STARTED|Placebo Wash-out Period (7 Days)||10
7843732|NCT00991276|19305055|P1|STARTED|Placebo Wash-out Period (7 Days)||15
7843733|NCT00991276|19305050|P6|NOT COMPLETED|First Intervention Period||1
7843734|NCT00991276|19305051|P5|NOT COMPLETED|First Intervention Period||4
7843735|NCT00991276|19305052|P4|NOT COMPLETED|First Intervention Period||4
7843736|NCT00991276|19305053|P3|NOT COMPLETED|First Intervention Period||0
7843737|NCT00991276|19305054|P2|NOT COMPLETED|First Intervention Period||3
7843738|NCT00991276|19305055|P1|NOT COMPLETED|First Intervention Period||0
7843739|NCT00991276|19305050|P6|COMPLETED|First Intervention Period||12
7843740|NCT00991276|19305051|P5|COMPLETED|First Intervention Period||11
7843741|NCT00991276|19305052|P4|COMPLETED|First Intervention Period||11
7843742|NCT00991276|19305053|P3|COMPLETED|First Intervention Period||14
7843743|NCT00991276|19305054|P2|COMPLETED|First Intervention Period||10
7843744|NCT00991276|19305055|P1|COMPLETED|First Intervention Period||15
7843745|NCT00991276|19305050|P6|STARTED|First Intervention Period||13
7843746|NCT00991276|19305051|P5|STARTED|First Intervention Period||15
7843747|NCT00991276|19305052|P4|STARTED|First Intervention Period||15
7843748|NCT00991276|19305053|P3|STARTED|First Intervention Period||14
7843749|NCT00991276|19305054|P2|STARTED|First Intervention Period||13
7843750|NCT00991276|19305055|P1|STARTED|First Intervention Period||15
7843751|NCT00991185|19305153|P1|NOT COMPLETED|Overall Study||0
7843752|NCT00991185|19305153|P1|COMPLETED|Overall Study||8
7843753|NCT00991185|19305153|P1|STARTED|Overall Study||8
7843754|NCT00991081|19305159|P3|NOT COMPLETED|Phase II, Randomized Control Trial||4
7843755|NCT00991081|19305160|P2|NOT COMPLETED|Phase II, Randomized Control Trial||2
7843756|NCT00991081|19305161|P1|NOT COMPLETED|Phase II, Randomized Control Trial||0
7843757|NCT00991081|19305159|P3|COMPLETED|Phase II, Randomized Control Trial||15
7843758|NCT00991081|19305160|P2|COMPLETED|Phase II, Randomized Control Trial||15
7843759|NCT00991081|19305161|P1|COMPLETED|Phase II, Randomized Control Trial||0
7843760|NCT00991081|19305159|P3|Received First Clinical Call|Phase II, Randomized Control Trial||17
7843761|NCT00991081|19305160|P2|Received First Clinical Call|Phase II, Randomized Control Trial||16
7843762|NCT00991081|19305161|P1|Received First Clinical Call|Phase II, Randomized Control Trial||0
7843763|NCT00991081|19305159|P3|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19
7843764|NCT00991081|19305160|P2|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17
7843765|NCT00991081|19305161|P1|STARTED|Phase II, Randomized Control Trial||0
7843766|NCT00991081|19305159|P3|NOT COMPLETED|Phase I, Formative Research||0
7843767|NCT00991081|19305160|P2|NOT COMPLETED|Phase I, Formative Research||0
7843768|NCT00991081|19305161|P1|NOT COMPLETED|Phase I, Formative Research||0
7843769|NCT00991081|19305159|P3|COMPLETED|Phase I, Formative Research||0
7843770|NCT00991081|19305160|P2|COMPLETED|Phase I, Formative Research||0
7843771|NCT00991081|19305161|P1|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20
7843772|NCT00991081|19305159|P3|STARTED|Phase I, Formative Research||0
7843773|NCT00991081|19305160|P2|STARTED|Phase I, Formative Research||0
7843774|NCT00991081|19305161|P1|STARTED|Phase I, Formative Research||20
7843775|NCT00991029|19305195|P2|NOT COMPLETED|Overall Study||168
7843776|NCT00991029|19305196|P1|NOT COMPLETED|Overall Study||156
7843777|NCT00991029|19305195|P2|COMPLETED|Overall Study||2281
7843778|NCT00991029|19305196|P1|COMPLETED|Overall Study||2276
7843779|NCT00991029|19305195|P2|STARTED|Overall Study||2449
7843780|NCT00991029|19305196|P1|STARTED|Overall Study||2432
7843781|NCT00990964|19305226|P1|NOT COMPLETED|Overall Study||212
7843782|NCT00990964|19305226|P1|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802
7843783|NCT00990964|19305226|P1|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917
7843784|NCT00990964|19305226|P1|STARTED|Overall Study|Total number of subjects enrolled|2014
7843785|NCT00990938|19305237|P6|NOT COMPLETED|Overall Study||0
7843786|NCT00990938|19305238|P5|NOT COMPLETED|Overall Study||0
7843787|NCT00990938|19305239|P4|NOT COMPLETED|Overall Study||0
7843788|NCT00990938|19305240|P3|NOT COMPLETED|Overall Study||0
7843789|NCT00990938|19305241|P2|NOT COMPLETED|Overall Study||0
7843790|NCT00990938|19305242|P1|NOT COMPLETED|Overall Study||0
7843791|NCT00990938|19305237|P6|COMPLETED|Overall Study||12
7843792|NCT00990938|19305238|P5|COMPLETED|Overall Study||12
7843793|NCT00990938|19305239|P4|COMPLETED|Overall Study||12
7843794|NCT00990938|19305240|P3|COMPLETED|Overall Study||12
7843795|NCT00990938|19305241|P2|COMPLETED|Overall Study||12
7843796|NCT00990938|19305242|P1|COMPLETED|Overall Study||3
7843797|NCT00990938|19305237|P6|STARTED|Overall Study||12
7843798|NCT00990938|19305238|P5|STARTED|Overall Study||12
7843799|NCT00990938|19305239|P4|STARTED|Overall Study||12
7843800|NCT00990938|19305240|P3|STARTED|Overall Study||12
7843801|NCT00990938|19305241|P2|STARTED|Overall Study||12
7843802|NCT00990938|19305242|P1|STARTED|Overall Study||3
7843803|NCT00990821|19305270|P14|NOT COMPLETED|Overall Study||1
7843804|NCT00990821|19305271|P13|NOT COMPLETED|Overall Study||2
7843805|NCT00990821|19305272|P12|NOT COMPLETED|Overall Study||5
7843806|NCT00990821|19305273|P11|NOT COMPLETED|Overall Study||3
7843807|NCT00990821|19305274|P10|NOT COMPLETED|Overall Study||1
7843808|NCT00990821|19305275|P9|NOT COMPLETED|Overall Study||0
7843809|NCT00990821|19305276|P8|NOT COMPLETED|Overall Study||0
7843810|NCT00990821|19305277|P7|NOT COMPLETED|Overall Study||1
7843811|NCT00990821|19305278|P6|NOT COMPLETED|Overall Study||3
7843812|NCT00990821|19305279|P5|NOT COMPLETED|Overall Study||3
7843813|NCT00990821|19305280|P4|NOT COMPLETED|Overall Study||0
7843814|NCT00990821|19305281|P3|NOT COMPLETED|Overall Study||0
7843815|NCT00990821|19305282|P2|NOT COMPLETED|Overall Study||2
7843816|NCT00990821|19305283|P1|NOT COMPLETED|Overall Study||0
7843817|NCT00990821|19305270|P14|COMPLETED|Overall Study||11
7843818|NCT00990821|19305271|P13|COMPLETED|Overall Study||10
7843819|NCT00990821|19305272|P12|COMPLETED|Overall Study||9
7843820|NCT00990821|19305273|P11|COMPLETED|Overall Study||9
7843821|NCT00990821|19305274|P10|COMPLETED|Overall Study||13
7843822|NCT00990821|19305275|P9|COMPLETED|Overall Study||12
7843823|NCT00990821|19305276|P8|COMPLETED|Overall Study||14
7843824|NCT00990821|19305277|P7|COMPLETED|Overall Study||11
7843825|NCT00990821|19305278|P6|COMPLETED|Overall Study||14
7843826|NCT00990821|19305279|P5|COMPLETED|Overall Study||14
7843827|NCT00990821|19305280|P4|COMPLETED|Overall Study||8
7843828|NCT00990821|19305281|P3|COMPLETED|Overall Study||14
7843829|NCT00990821|19305282|P2|COMPLETED|Overall Study||14
7843830|NCT00990821|19305283|P1|COMPLETED|Overall Study||14
7843831|NCT00990821|19305270|P14|STARTED|Overall Study||12
7843832|NCT00990821|19305271|P13|STARTED|Overall Study||12
7843833|NCT00990821|19305272|P12|STARTED|Overall Study||14
7843834|NCT00990821|19305273|P11|STARTED|Overall Study||12
7843835|NCT00990821|19305274|P10|STARTED|Overall Study||14
7843836|NCT00990821|19305275|P9|STARTED|Overall Study||12
7843837|NCT00990821|19305276|P8|STARTED|Overall Study||14
7843838|NCT00990821|19305277|P7|STARTED|Overall Study||12
7843839|NCT00990821|19305278|P6|STARTED|Overall Study||17
7843840|NCT00990821|19305279|P5|STARTED|Overall Study||17
7843841|NCT00990821|19305280|P4|STARTED|Overall Study||8
7843842|NCT00990821|19305281|P3|STARTED|Overall Study||14
7843843|NCT00990821|19305282|P2|STARTED|Overall Study||16
7843844|NCT00990821|19305283|P1|STARTED|Overall Study||14
7843845|NCT00990782|19305300|P1|NOT COMPLETED|Overall Study||5
7843846|NCT00990782|19305300|P1|COMPLETED|Overall Study||88
7843847|NCT00990782|19305300|P1|STARTED|Overall Study||93
7843848|NCT00990769|19305307|P2|NOT COMPLETED|Overall Study||0
7843849|NCT00990769|19305308|P1|NOT COMPLETED|Overall Study||0
7843850|NCT00990769|19305307|P2|COMPLETED|Overall Study||18
7843851|NCT00990769|19305308|P1|COMPLETED|Overall Study||22
7843852|NCT00990769|19305307|P2|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18
7843853|NCT00990769|19305308|P1|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22
7843854|NCT00990704|19305320|P2|NOT COMPLETED|Overall Study||2
7843855|NCT00990704|19305321|P1|NOT COMPLETED|Overall Study||1
7843856|NCT00990704|19305320|P2|COMPLETED|Overall Study||31
7843857|NCT00990704|19305321|P1|COMPLETED|Overall Study||13
7843858|NCT00990704|19305320|P2|STARTED|Overall Study||33
7843859|NCT00990704|19305321|P1|STARTED|Overall Study||14
7843860|NCT00990665|19305341|P1|NOT COMPLETED|Overall Study||48
7843861|NCT00990665|19305341|P1|COMPLETED|Overall Study||130
7843862|NCT00990665|19305341|P1|STARTED|Overall Study||178
7843863|NCT00990652|19305348|P1|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1
7843864|NCT00990652|19305348|P1|COMPLETED|Post-sugery Bortezomib + Temozolomide||8
7843865|NCT00990652|19305348|P1|STARTED|Post-sugery Bortezomib + Temozolomide||9
7843866|NCT00990652|19305348|P1|NOT COMPLETED|Surgical Resection||0
7843867|NCT00990652|19305348|P1|COMPLETED|Surgical Resection||9
7843868|NCT00990652|19305348|P1|STARTED|Surgical Resection||9
7843869|NCT00990652|19305348|P1|NOT COMPLETED|Pre-surgical Bortezomib||1
7843870|NCT00990652|19305348|P1|COMPLETED|Pre-surgical Bortezomib||9
7843871|NCT00990652|19305348|P1|STARTED|Pre-surgical Bortezomib||10
7843872|NCT00990561|19305358|P4|NOT COMPLETED|Period 2||2
7843873|NCT00990561|19305359|P3|NOT COMPLETED|Period 2||0
7843874|NCT00990561|19305360|P2|NOT COMPLETED|Period 2||0
7843875|NCT00990561|19305361|P1|NOT COMPLETED|Period 2||0
7843876|NCT00990561|19305358|P4|COMPLETED|Period 2||17
7843877|NCT00990561|19305359|P3|COMPLETED|Period 2||20
7843878|NCT00990561|19305360|P2|COMPLETED|Period 2||0
7843879|NCT00990561|19305361|P1|COMPLETED|Period 2||0
7843880|NCT00990561|19305358|P4|STARTED|Period 2||19
7843881|NCT00990561|19305359|P3|STARTED|Period 2||20
7843882|NCT00990561|19305360|P2|STARTED|Period 2||0
7843883|NCT00990561|19305361|P1|STARTED|Period 2||0
7843884|NCT00990561|19305358|P4|NOT COMPLETED|Period 1||0
7843885|NCT00990561|19305359|P3|NOT COMPLETED|Period 1||0
7843886|NCT00990561|19305360|P2|NOT COMPLETED|Period 1||1
7843887|NCT00990561|19305361|P1|NOT COMPLETED|Period 1||0
7843888|NCT00990561|19305358|P4|COMPLETED|Period 1||0
7843889|NCT00990561|19305359|P3|COMPLETED|Period 1||0
7843890|NCT00990561|19305360|P2|COMPLETED|Period 1||19
7843891|NCT00990561|19305361|P1|COMPLETED|Period 1||20
7843892|NCT00990561|19305358|P4|STARTED|Period 1||0
7843893|NCT00990561|19305359|P3|STARTED|Period 1||0
7843894|NCT00990561|19305360|P2|STARTED|Period 1||20
7843895|NCT00990561|19305361|P1|STARTED|Period 1||20
7843896|NCT00990509|19305369|P2|NOT COMPLETED|Overall Study||1
7843897|NCT00990509|19305370|P1|NOT COMPLETED|Overall Study||0
7843898|NCT00990509|19305369|P2|COMPLETED|Overall Study||8
7843899|NCT00990509|19305370|P1|COMPLETED|Overall Study||5
7843900|NCT00990509|19305369|P2|STARTED|Overall Study||9
7843901|NCT00990509|19305370|P1|STARTED|Overall Study||5
7843902|NCT00990340|19305382|P2|NOT COMPLETED|Second 14-day Treatment||0
7843903|NCT00990340|19305383|P1|NOT COMPLETED|Second 14-day Treatment||0
7843904|NCT00990340|19305382|P2|COMPLETED|Second 14-day Treatment||21
7843905|NCT00990340|19305383|P1|COMPLETED|Second 14-day Treatment||21
7843906|NCT00990340|19305382|P2|STARTED|Second 14-day Treatment||21
7843907|NCT00990340|19305383|P1|STARTED|Second 14-day Treatment||21
7843908|NCT00990340|19305382|P2|NOT COMPLETED|First 14-day Treatment||4
7843909|NCT00990340|19305383|P1|NOT COMPLETED|First 14-day Treatment||6
7843910|NCT00990340|19305382|P2|COMPLETED|First 14-day Treatment||21
7843911|NCT00990340|19305383|P1|COMPLETED|First 14-day Treatment||21
7843912|NCT00990340|19305382|P2|STARTED|First 14-day Treatment||25
7843913|NCT00990340|19305383|P1|STARTED|First 14-day Treatment||27
7843914|NCT00990314|19305397|P1|NOT COMPLETED|Overall Study||12
7843915|NCT00990314|19305397|P1|COMPLETED|Overall Study||19
7843916|NCT00990314|19305397|P1|STARTED|Overall Study||31
7843917|NCT00990288|19305408|P2|NOT COMPLETED|Overall Study||0
7843918|NCT00990288|19305409|P1|NOT COMPLETED|Overall Study||0
7843919|NCT00990288|19305408|P2|COMPLETED|Overall Study||99
7843920|NCT00990288|19305409|P1|COMPLETED|Overall Study||97
7843921|NCT00990288|19305408|P2|STARTED|Overall Study||99
7843922|NCT00990288|19305409|P1|STARTED|Overall Study||97
7843923|NCT00990249|19305439|P1|NOT COMPLETED|Overall Study||13
7843924|NCT00990249|19305439|P1|COMPLETED|Overall Study||107
7843925|NCT00990249|19305439|P1|STARTED|Overall Study||120
7843926|NCT00990236|19305445|P2|NOT COMPLETED|Overall Study||0
7843927|NCT00990236|19305446|P1|NOT COMPLETED|Overall Study||0
7843928|NCT00990236|19305445|P2|COMPLETED|Overall Study||96
7843929|NCT00990236|19305446|P1|COMPLETED|Overall Study||89
7843930|NCT00990236|19305445|P2|STARTED|Overall Study||96
7843931|NCT00990236|19305446|P1|STARTED|Overall Study||89
7843932|NCT00990184|19305454|P1|NOT COMPLETED|Overall Study||1
7843933|NCT00990184|19305454|P1|COMPLETED|Overall Study||20
7843934|NCT00990184|19305454|P1|STARTED|Overall Study||21
7843935|NCT00990106|19305462|P2|NOT COMPLETED|Overall Study||12
7843936|NCT00990106|19305463|P1|NOT COMPLETED|Overall Study||9
7843937|NCT00990106|19305462|P2|COMPLETED|Overall Study||23
7843938|NCT00990106|19305463|P1|COMPLETED|Overall Study||23
7843939|NCT00990106|19305462|P2|STARTED|Overall Study||35
7843940|NCT00990106|19305463|P1|STARTED|Overall Study||32
7843941|NCT00990093|19305473|P2|NOT COMPLETED|Test Period 2 (15-28 Days)||1
7843942|NCT00990093|19305474|P1|NOT COMPLETED|Test Period 2 (15-28 Days)||2
7843943|NCT00990093|19305473|P2|COMPLETED|Test Period 2 (15-28 Days)||14
7843944|NCT00990093|19305474|P1|COMPLETED|Test Period 2 (15-28 Days)||13
7843945|NCT00990093|19305473|P2|STARTED|Test Period 2 (15-28 Days)||15
7843946|NCT00990093|19305474|P1|STARTED|Test Period 2 (15-28 Days)||15
7843947|NCT00990093|19305473|P2|NOT COMPLETED|Test Period 1 (1-14 Days)||2
7843948|NCT00990093|19305474|P1|NOT COMPLETED|Test Period 1 (1-14 Days)||4
7843949|NCT00990093|19305473|P2|COMPLETED|Test Period 1 (1-14 Days)||15
7843950|NCT00990093|19305474|P1|COMPLETED|Test Period 1 (1-14 Days)||15
7843951|NCT00990093|19305473|P2|STARTED|Test Period 1 (1-14 Days)||17
7843952|NCT00990093|19305474|P1|STARTED|Test Period 1 (1-14 Days)||19
7843953|NCT00989989|19305483|P3|NOT COMPLETED|Overall Study||23
7843954|NCT00989989|19305484|P2|NOT COMPLETED|Overall Study||10
7843955|NCT00989989|19305485|P1|NOT COMPLETED|Overall Study||18
7843956|NCT00989989|19305483|P3|COMPLETED|Overall Study||108
7843957|NCT00989989|19305484|P2|COMPLETED|Overall Study||123
7843958|NCT00989989|19305485|P1|COMPLETED|Overall Study||114
7843959|NCT00989989|19305483|P3|STARTED|Overall Study||131
7843960|NCT00989989|19305484|P2|STARTED|Overall Study||133
7843961|NCT00989989|19305485|P1|STARTED|Overall Study||132
7843962|NCT00989963|19305526|P3|NOT COMPLETED|Overall Study||1
7843963|NCT00989963|19305527|P2|NOT COMPLETED|Overall Study||1
7843964|NCT00989963|19305528|P1|NOT COMPLETED|Overall Study||1
7843965|NCT00989963|19305526|P3|COMPLETED|Overall Study||11
7843966|NCT00989963|19305527|P2|COMPLETED|Overall Study||11
7843967|NCT00989963|19305528|P1|COMPLETED|Overall Study||11
7843968|NCT00989963|19305526|P3|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|10
7843969|NCT00989963|19305527|P2|Per-Protocol Population|Overall Study||11
7843970|NCT00989963|19305528|P1|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|12
7843971|NCT00989963|19305526|P3|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|11
7843972|NCT00989963|19305527|P2|Safety Population|Overall Study||12
7843973|NCT00989963|19305528|P1|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|13
7843974|NCT00989963|19305526|P3|STARTED|Overall Study||12
7843975|NCT00989963|19305527|P2|STARTED|Overall Study||12
7843976|NCT00989963|19305528|P1|STARTED|Overall Study||12
7843977|NCT00989950|19305564|P4|NOT COMPLETED|Randomized Phase||0
7843978|NCT00989950|19305565|P3|NOT COMPLETED|Randomized Phase||0
7843979|NCT00989950|19305566|P2|NOT COMPLETED|Randomized Phase||1
7843980|NCT00989950|19305567|P1|NOT COMPLETED|Randomized Phase||1
7843981|NCT00989950|19305564|P4|COMPLETED|Randomized Phase||7
7843982|NCT00989950|19305565|P3|COMPLETED|Randomized Phase||4
7843983|NCT00989950|19305566|P2|COMPLETED|Randomized Phase||8
7843984|NCT00989950|19305567|P1|COMPLETED|Randomized Phase||5
7843985|NCT00989950|19305564|P4|STARTED|Randomized Phase||7
7843986|NCT00989950|19305565|P3|STARTED|Randomized Phase||4
7843987|NCT00989950|19305566|P2|STARTED|Randomized Phase||9
7843988|NCT00989950|19305567|P1|STARTED|Randomized Phase||6
7843989|NCT00989950|19305564|P4|NOT COMPLETED|Open Label Dose Optimization||0
7843990|NCT00989950|19305565|P3|NOT COMPLETED|Open Label Dose Optimization||0
7843991|NCT00989950|19305566|P2|NOT COMPLETED|Open Label Dose Optimization||0
7843992|NCT00989950|19305567|P1|NOT COMPLETED|Open Label Dose Optimization||0
7843993|NCT00989950|19305564|P4|COMPLETED|Open Label Dose Optimization||7
7843994|NCT00989950|19305565|P3|COMPLETED|Open Label Dose Optimization||4
7843995|NCT00989950|19305566|P2|COMPLETED|Open Label Dose Optimization||9
7843996|NCT00989950|19305567|P1|COMPLETED|Open Label Dose Optimization||6
7843997|NCT00989950|19305564|P4|STARTED|Open Label Dose Optimization||7
7843998|NCT00989950|19305565|P3|STARTED|Open Label Dose Optimization||4
7843999|NCT00989950|19305566|P2|STARTED|Open Label Dose Optimization||9
7844000|NCT00989950|19305567|P1|STARTED|Open Label Dose Optimization||6
7844001|NCT00989937|19305577|P1|NOT COMPLETED|Overall Study||0
7844002|NCT00989937|19305577|P1|COMPLETED|Overall Study||0
7844003|NCT00989937|19305577|P1|STARTED|Overall Study||0
7844004|NCT00989911|19305592|P1|NOT COMPLETED|Overall Study||3
7844005|NCT00989911|19305592|P1|COMPLETED|Overall Study||7
7844006|NCT00989911|19305592|P1|STARTED|Overall Study||10
7844007|NCT00989833|19305599|P3|NOT COMPLETED|Overall Study||2
7844008|NCT00989833|19305600|P2|NOT COMPLETED|Overall Study||3
7844009|NCT00989833|19305601|P1|NOT COMPLETED|Overall Study||2
7844010|NCT00989833|19305599|P3|COMPLETED|Overall Study||21
7844011|NCT00989833|19305600|P2|COMPLETED|Overall Study||19
7844012|NCT00989833|19305601|P1|COMPLETED|Overall Study||19
7844013|NCT00989833|19305599|P3|STARTED|Overall Study||23
7844014|NCT00989833|19305600|P2|STARTED|Overall Study||22
7844015|NCT00989833|19305601|P1|STARTED|Overall Study||21
7844016|NCT00989781|19305632|P2|NOT COMPLETED|Adrenal Response ot ACTH||3
7844017|NCT00989781|19305633|P1|NOT COMPLETED|Adrenal Response ot ACTH||5
7844018|NCT00989781|19305632|P2|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented and completed study|15
7844019|NCT00989781|19305633|P1|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented. 2 dropped out and 13 completed study|13
7844020|NCT00989781|19305632|P2|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
7844021|NCT00989781|19305633|P1|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
7844022|NCT00989781|19305632|P2|NOT COMPLETED|Ovarian Response to hCG||2
7844023|NCT00989781|19305633|P1|NOT COMPLETED|Ovarian Response to hCG||3
7844024|NCT00989781|19305632|P2|COMPLETED|Ovarian Response to hCG||18
7844025|NCT00989781|19305633|P1|COMPLETED|Ovarian Response to hCG||18
7844026|NCT00989781|19305632|P2|STARTED|Ovarian Response to hCG||20
7844027|NCT00989781|19305633|P1|STARTED|Ovarian Response to hCG||21
7844028|NCT00989768|19305652|P1|NOT COMPLETED|Overall Study||1
7844029|NCT00989768|19305652|P1|COMPLETED|Overall Study||28
7844030|NCT00989768|19305652|P1|STARTED|Overall Study|All patients received both treatments. They are their own controls|29
7844031|NCT00989664|19305663|P1|NOT COMPLETED|Long-Term Follow-Up||3
7844032|NCT00989664|19305663|P1|COMPLETED|Long-Term Follow-Up||11
7844033|NCT00989664|19305663|P1|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14
7844034|NCT00989664|19305663|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61
7844035|NCT00989664|19305663|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
7844036|NCT00989664|19305663|P1|STARTED|Dosimetric and Therapeutic Treatment||61
7844037|NCT00989612|19305691|P1|NOT COMPLETED|Overall Study||0
7844038|NCT00989612|19305691|P1|COMPLETED|Overall Study||100
7844039|NCT00989612|19305691|P1|STARTED|Overall Study||100
7844040|NCT00989586|19305732|P2|NOT COMPLETED|Overall Study||0
7844041|NCT00989586|19305733|P1|NOT COMPLETED|Overall Study||0
7844042|NCT00989586|19305732|P2|COMPLETED|Overall Study||17
7844043|NCT00989586|19305733|P1|COMPLETED|Overall Study||18
7844044|NCT00989586|19305732|P2|STARTED|Overall Study||17
7844045|NCT00989586|19305733|P1|STARTED|Overall Study||18
7844046|NCT00989287|19305748|P2|NOT COMPLETED|Overall Study||1
7844047|NCT00989287|19305749|P1|NOT COMPLETED|Overall Study||1
7844048|NCT00989287|19305748|P2|COMPLETED|Overall Study||65
7844049|NCT00989287|19305749|P1|COMPLETED|Overall Study||64
7844050|NCT00989287|19305748|P2|STARTED|Overall Study||66
7844051|NCT00989287|19305749|P1|STARTED|Overall Study||65
7844052|NCT00989261|19305851|P2|NOT COMPLETED|Overall Study||22
7844053|NCT00989261|19305852|P1|NOT COMPLETED|Overall Study||15
7844054|NCT00989261|19305851|P2|COMPLETED|Overall Study||154
7844055|NCT00989261|19305852|P1|COMPLETED|Overall Study||142
7844056|NCT00989261|19305851|P2|STARTED|Overall Study||176
7844057|NCT00989261|19305852|P1|STARTED|Overall Study||157
7844058|NCT00989235|19305882|P2|NOT COMPLETED|Overall Study||6
7844059|NCT00989235|19305883|P1|NOT COMPLETED|Overall Study||3
7844060|NCT00989235|19305882|P2|COMPLETED|Overall Study||44
7844061|NCT00989235|19305883|P1|COMPLETED|Overall Study||55
7844062|NCT00989235|19305882|P2|Number Completing Double-Blind Treatment|Overall Study||41
7844063|NCT00989235|19305883|P1|Number Completing Double-Blind Treatment|Overall Study||51
7844064|NCT00989235|19305882|P2|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4
7844065|NCT00989235|19305883|P1|Number Rescued to Open-Label Treatment|Overall Study||4
7844066|NCT00989235|19305882|P2|STARTED|Overall Study||50
7844067|NCT00989235|19305883|P1|STARTED|Overall Study||58
7844068|NCT00989196|19305928|P2|NOT COMPLETED|Treatment Period||0
7844069|NCT00989196|19305929|P1|NOT COMPLETED|Treatment Period||1
7844070|NCT00989196|19305928|P2|COMPLETED|Treatment Period||12
7844071|NCT00989196|19305929|P1|COMPLETED|Treatment Period||9
7844072|NCT00989196|19305928|P2|STARTED|Treatment Period||12
7844073|NCT00989196|19305929|P1|STARTED|Treatment Period||10
7844074|NCT00989196|19305928|P2|NOT COMPLETED|PK Crossover Period||0
7844075|NCT00989196|19305929|P1|NOT COMPLETED|PK Crossover Period||0
7844076|NCT00989196|19305928|P2|COMPLETED|PK Crossover Period||12
7844077|NCT00989196|19305929|P1|COMPLETED|PK Crossover Period||10
7844078|NCT00989196|19305928|P2|STARTED|PK Crossover Period||12
7844079|NCT00989196|19305929|P1|STARTED|PK Crossover Period||10
7844080|NCT00989157|19305950|P2|NOT COMPLETED|Overall Study||0
7844081|NCT00989157|19305951|P1|NOT COMPLETED|Overall Study||0
7844082|NCT00989157|19305950|P2|COMPLETED|Overall Study||10
7844083|NCT00989157|19305951|P1|COMPLETED|Overall Study||10
7844084|NCT00989157|19305950|P2|STARTED|Overall Study||10
7844085|NCT00989157|19305951|P1|STARTED|Overall Study||10
7844086|NCT00989092|19305967|P2|NOT COMPLETED|Overall Study||28
7844087|NCT00989092|19305968|P1|NOT COMPLETED|Overall Study||90
7844088|NCT00989092|19305967|P2|COMPLETED|Overall Study||31
7844089|NCT00989092|19305968|P1|COMPLETED|Overall Study||138
7844090|NCT00989092|19305967|P2|Treated With Darbepoetin Alfa|Overall Study||33
7844091|NCT00989092|19305968|P1|Treated With Darbepoetin Alfa|Overall Study||226
7844092|NCT00989092|19305967|P2|STARTED|Overall Study||59
7844093|NCT00989092|19305968|P1|STARTED|Overall Study||228
7844094|NCT00989014|19306005|P4|NOT COMPLETED|Overall Study||0
7844095|NCT00989014|19306006|P3|NOT COMPLETED|Overall Study||0
7844096|NCT00989014|19306007|P2|NOT COMPLETED|Overall Study||0
7844097|NCT00989014|19306008|P1|NOT COMPLETED|Overall Study||0
7844098|NCT00989014|19306005|P4|COMPLETED|Overall Study||32
7844099|NCT00989014|19306006|P3|COMPLETED|Overall Study||28
7844100|NCT00989014|19306007|P2|COMPLETED|Overall Study||31
7844101|NCT00989014|19306008|P1|COMPLETED|Overall Study||31
7844102|NCT00989014|19306005|P4|STARTED|Overall Study||32
7844103|NCT00989014|19306006|P3|STARTED|Overall Study||28
7844104|NCT00989014|19306007|P2|STARTED|Overall Study||31
7844105|NCT00989014|19306008|P1|STARTED|Overall Study||31
7844106|NCT00988884|19306020|P2|NOT COMPLETED|Overall Study||36
7844107|NCT00988884|19306021|P1|NOT COMPLETED|Overall Study||35
7844108|NCT00988884|19306020|P2|COMPLETED|Overall Study||584
7844109|NCT00988884|19306021|P1|COMPLETED|Overall Study||586
7844110|NCT00988884|19306020|P2|STARTED|Overall Study||620
7844111|NCT00988884|19306021|P1|STARTED|Overall Study||621
7844112|NCT00988858|19306043|P1|NOT COMPLETED|Overall Study||10
7844113|NCT00988858|19306043|P1|COMPLETED|Overall Study||45
7844114|NCT00988858|19306043|P1|STARTED|Overall Study||55
7844115|NCT00988832|19306055|P1|NOT COMPLETED|Overall Study||0
7844116|NCT00988832|19306055|P1|COMPLETED|Overall Study||380
7844117|NCT00988832|19306055|P1|STARTED|Overall Study||380
7844118|NCT00988637|19306092|P2|NOT COMPLETED|Overall Study||3
7844119|NCT00988637|19306093|P1|NOT COMPLETED|Overall Study||3
7844120|NCT00988637|19306092|P2|COMPLETED|Overall Study||65
7844121|NCT00988637|19306093|P1|COMPLETED|Overall Study||67
7844122|NCT00988637|19306092|P2|STARTED|Overall Study||68
7844123|NCT00988637|19306093|P1|STARTED|Overall Study||70
7844124|NCT00988598|19306125|P2|NOT COMPLETED|Overall Study||0
7844125|NCT00988598|19306126|P1|NOT COMPLETED|Overall Study||2
7844126|NCT00988598|19306125|P2|COMPLETED|Overall Study||5
7844127|NCT00988598|19306126|P1|COMPLETED|Overall Study||8
7844128|NCT00988598|19306125|P2|STARTED|Overall Study||5
7844129|NCT00988598|19306126|P1|STARTED|Overall Study||10
7844130|NCT00988559|19306154|P4|NOT COMPLETED|Overall Study||1
7844131|NCT00988559|19306155|P3|NOT COMPLETED|Overall Study||2
7844132|NCT00988559|19306156|P2|NOT COMPLETED|Overall Study||2
7844133|NCT00988559|19306157|P1|NOT COMPLETED|Overall Study||1
7844134|NCT00988559|19306154|P4|COMPLETED|Overall Study||6
7844135|NCT00988559|19306155|P3|COMPLETED|Overall Study||9
7844136|NCT00988559|19306156|P2|COMPLETED|Overall Study||9
7844137|NCT00988559|19306157|P1|COMPLETED|Overall Study||9
7844138|NCT00988559|19306154|P4|STARTED|Overall Study||7
7844139|NCT00988559|19306155|P3|STARTED|Overall Study||11
7844140|NCT00988559|19306156|P2|STARTED|Overall Study||11
7844141|NCT00988559|19306157|P1|STARTED|Overall Study||10
7844142|NCT00988533|19306171|P1|NOT COMPLETED|Overall Study||3
7844143|NCT00988533|19306171|P1|COMPLETED|Overall Study||27
7844144|NCT00988533|19306171|P1|STARTED|Overall Study||30
7844145|NCT00988442|19306185|P2|NOT COMPLETED|Overall Study||28
7844146|NCT00988442|19306186|P1|NOT COMPLETED|Overall Study||30
7844147|NCT00988442|19306185|P2|COMPLETED|Overall Study||1
7844148|NCT00988442|19306186|P1|COMPLETED|Overall Study||0
7844149|NCT00988442|19306185|P2|STARTED|Overall Study||29
7844150|NCT00988442|19306186|P1|STARTED|Overall Study||30
7844151|NCT00988429|19306249|P3|NOT COMPLETED|Overall Study||69
7844152|NCT00988429|19306250|P2|NOT COMPLETED|Overall Study||43
7844153|NCT00988429|19306251|P1|NOT COMPLETED|Overall Study||37
7844154|NCT00988429|19306249|P3|COMPLETED|Overall Study||142
7844155|NCT00988429|19306250|P2|COMPLETED|Overall Study||173
7844156|NCT00988429|19306251|P1|COMPLETED|Overall Study||189
7844157|NCT00988429|19306249|P3|Intention-to-treat (ITT) Population|Overall Study||205
7844158|NCT00988429|19306250|P2|Intention-to-treat (ITT) Population|Overall Study||215
7844159|NCT00988429|19306251|P1|Intention-to-treat (ITT) Population|Overall Study||220
7844160|NCT00988429|19306249|P3|Safety Population|Overall Study||210
7844161|NCT00988429|19306250|P2|Safety Population|Overall Study||216
7844162|NCT00988429|19306251|P1|Safety Population|Overall Study||224
7844163|NCT00988429|19306249|P3|STARTED|Overall Study||211
7844164|NCT00988429|19306250|P2|STARTED|Overall Study||216
7844165|NCT00988429|19306251|P1|STARTED|Overall Study||226
7844166|NCT00988351|19306264|P2|NOT COMPLETED|Overall Study||12
7844167|NCT00988351|19306265|P1|NOT COMPLETED|Overall Study||19
7844168|NCT00988351|19306264|P2|COMPLETED|Overall Study||66
7844169|NCT00988351|19306265|P1|COMPLETED|Overall Study||59
7844170|NCT00988351|19306264|P2|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66
7844171|NCT00988351|19306265|P1|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59
7844172|NCT00988351|19306264|P2|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69
7844173|NCT00988351|19306265|P1|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64
7844174|NCT00988351|19306264|P2|PAP Setup|Overall Study|APAP treatment started|78
7844175|NCT00988351|19306265|P1|PAP Setup|Overall Study|CPAP treatment started|70
7844176|NCT00988351|19306264|P2|CPAP Titration|Overall Study|no titration needed|78
7844177|NCT00988351|19306265|P1|CPAP Titration|Overall Study|8 declined CPAP treatment|78
7844178|NCT00988351|19306264|P2|STARTED|Overall Study||78
7844179|NCT00988351|19306265|P1|STARTED|Overall Study||78
7844180|NCT00988325|19306282|P3|NOT COMPLETED|Overall Study||0
7844181|NCT00988325|19306283|P2|NOT COMPLETED|Overall Study||0
7844182|NCT00988325|19306284|P1|NOT COMPLETED|Overall Study||0
7844183|NCT00988325|19306282|P3|COMPLETED|Overall Study||5
7844184|NCT00988325|19306283|P2|COMPLETED|Overall Study||20
7844185|NCT00988325|19306284|P1|COMPLETED|Overall Study||40
7844186|NCT00988325|19306282|P3|STARTED|Overall Study||5
7844187|NCT00988325|19306283|P2|STARTED|Overall Study||20
7844188|NCT00988325|19306284|P1|STARTED|Overall Study||40
7844189|NCT00988247|19306342|P2|NOT COMPLETED|Overall Study||26
7844190|NCT00988247|19306343|P1|NOT COMPLETED|Overall Study||83
7844191|NCT00988247|19306342|P2|COMPLETED|Overall Study||85
7844192|NCT00988247|19306343|P1|COMPLETED|Overall Study||335
7844193|NCT00988247|19306342|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110
7844194|NCT00988247|19306343|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414
7844195|NCT00988247|19306342|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111
7844196|NCT00988247|19306343|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415
7844197|NCT00988247|19306342|P2|STARTED|Overall Study||111
7844198|NCT00988247|19306343|P1|STARTED|Overall Study||418
7844199|NCT00988221|19306362|P4|NOT COMPLETED|Part III||0
7844200|NCT00988221|19306363|P3|NOT COMPLETED|Part III||3
7844201|NCT00988221|19306364|P2|NOT COMPLETED|Part III||1
7844202|NCT00988221|19306365|P1|NOT COMPLETED|Part III||1
7844203|NCT00988221|19306362|P4|COMPLETED|Part III||0
7844204|NCT00988221|19306363|P3|COMPLETED|Part III||103
7844205|NCT00988221|19306364|P2|COMPLETED|Part III||23
7844206|NCT00988221|19306365|P1|COMPLETED|Part III||29
7844207|NCT00988221|19306362|P4|STARTED|Part III|No patients received placebo in Part III of this study.|0
7844208|NCT00988221|19306363|P3|STARTED|Part III||106
7844209|NCT00988221|19306364|P2|STARTED|Part III||24
7844210|NCT00988221|19306365|P1|STARTED|Part III||30
7844211|NCT00988221|19306362|P4|NOT COMPLETED|Part II||3
7844212|NCT00988221|19306363|P3|NOT COMPLETED|Part II||3
7844213|NCT00988221|19306364|P2|NOT COMPLETED|Part II||0
7844214|NCT00988221|19306365|P1|NOT COMPLETED|Part II||1
7844215|NCT00988221|19306362|P4|COMPLETED|Part II||81
7844216|NCT00988221|19306363|P3|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52
7844217|NCT00988221|19306364|P2|COMPLETED|Part II||11
7844218|NCT00988221|19306365|P1|COMPLETED|Part II||15
7844219|NCT00988221|19306362|P4|STARTED|Part II||84
7844220|NCT00988221|19306363|P3|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55
7844221|NCT00988221|19306364|P2|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11
7844222|NCT00988221|19306365|P1|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16
7844223|NCT00988221|19306362|P4|NOT COMPLETED|Part I||0
7844224|NCT00988221|19306363|P3|NOT COMPLETED|Part I||8
7844225|NCT00988221|19306364|P2|NOT COMPLETED|Part I||10
7844226|NCT00988221|19306365|P1|NOT COMPLETED|Part I||4
7844227|NCT00988221|19306362|P4|COMPLETED|Part I||0
7844228|NCT00988221|19306363|P3|COMPLETED|Part I||111
7844229|NCT00988221|19306364|P2|COMPLETED|Part I||24
7844230|NCT00988221|19306365|P1|COMPLETED|Part I||31
7844231|NCT00988221|19306362|P4|STARTED|Part I|No patients received placebo in Part I of this study.|0
7844232|NCT00988221|19306363|P3|STARTED|Part I||119
7844233|NCT00988221|19306364|P2|STARTED|Part I||34
7844234|NCT00988221|19306365|P1|STARTED|Part I||35
7844235|NCT00988208|19306538|P2|NOT COMPLETED|Overall Study||438
7844236|NCT00988208|19306539|P1|NOT COMPLETED|Overall Study||431
7844237|NCT00988208|19306538|P2|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95
7844238|NCT00988208|19306539|P1|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95
7844239|NCT00988208|19306538|P2|Treated|Overall Study||525
7844240|NCT00988208|19306539|P1|Treated|Overall Study||521
7844241|NCT00988208|19306538|P2|STARTED|Overall Study||533
7844242|NCT00988208|19306539|P1|STARTED|Overall Study||526
7844243|NCT00988169|19306557|P1|NOT COMPLETED|Overall Study||1
7844244|NCT00988169|19306557|P1|COMPLETED|Overall Study||5
7844245|NCT00988169|19306557|P1|STARTED|Overall Study||6
7844246|NCT00988156|19306563|P2|NOT COMPLETED|Overall Study||20
7844247|NCT00988156|19306564|P1|NOT COMPLETED|Overall Study||17
7844248|NCT00988156|19306563|P2|COMPLETED|Overall Study||135
7844249|NCT00988156|19306564|P1|COMPLETED|Overall Study||132
7844250|NCT00988156|19306563|P2|Safety Set|Overall Study||134
7844251|NCT00988156|19306564|P1|Safety Set|Overall Study||129
7844252|NCT00988156|19306563|P2|Per Protocol Set (PP)|Overall Study||97
7844253|NCT00988156|19306564|P1|Per Protocol Set (PP)|Overall Study||101
7844254|NCT00988156|19306563|P2|Intention-to-Treat Set (ITT)|Overall Study||134
7844255|NCT00988156|19306564|P1|Intention-to-Treat Set (ITT)|Overall Study||129
7844256|NCT00988156|19306563|P2|STARTED|Overall Study||155
7844257|NCT00988156|19306564|P1|STARTED|Overall Study||149
7844258|NCT00988143|19306575|P3|NOT COMPLETED|Overall Study||0
7844259|NCT00988143|19306576|P2|NOT COMPLETED|Overall Study||0
7844260|NCT00988143|19306577|P1|NOT COMPLETED|Overall Study||0
7844261|NCT00988143|19306575|P3|COMPLETED|Overall Study||190
7844262|NCT00988143|19306576|P2|COMPLETED|Overall Study||190
7844263|NCT00988143|19306577|P1|COMPLETED|Overall Study||220
7844264|NCT00988143|19306575|P3|STARTED|Overall Study||190
7844265|NCT00988143|19306576|P2|STARTED|Overall Study||190
7844266|NCT00988143|19306577|P1|STARTED|Overall Study||220
7844267|NCT00988117|19306609|P1|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2
7844268|NCT00988117|19306609|P1|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12
7844269|NCT00988117|19306609|P1|STARTED|9.5 mg/24 Hours From Week 4 to 12||14
7844270|NCT00988117|19306609|P1|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1
7844271|NCT00988117|19306609|P1|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14
7844272|NCT00988117|19306609|P1|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15
7844273|NCT00988091|19306618|P2|NOT COMPLETED|Open-label Period||33
7844274|NCT00988091|19306619|P1|NOT COMPLETED|Open-label Period||21
7844275|NCT00988091|19306618|P2|COMPLETED|Open-label Period||192
7844276|NCT00988091|19306619|P1|COMPLETED|Open-label Period||208
7844277|NCT00988091|19306618|P2|STARTED|Open-label Period|Participation in the Open-label period was optional.|225
7844278|NCT00988091|19306619|P1|STARTED|Open-label Period|Participation in the Open-label period was optional.|229
7844279|NCT00988091|19306618|P2|NOT COMPLETED|Double-blind Period||47
7844280|NCT00988091|19306619|P1|NOT COMPLETED|Double-blind Period||43
7844281|NCT00988091|19306618|P2|COMPLETED|Double-blind Period||251
7844282|NCT00988091|19306619|P1|COMPLETED|Double-blind Period||255
7844283|NCT00988091|19306618|P2|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295
7844284|NCT00988091|19306619|P1|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294
7844285|NCT00988091|19306618|P2|STARTED|Double-blind Period||298
7844286|NCT00988091|19306619|P1|STARTED|Double-blind Period||298
7844287|NCT00988065|19306641|P3|NOT COMPLETED|Overall Study||15
7844288|NCT00988065|19306642|P2|NOT COMPLETED|Overall Study||23
7844289|NCT00988065|19306643|P1|NOT COMPLETED|Overall Study||13
7844290|NCT00988065|19306641|P3|COMPLETED|Overall Study||135
7844291|NCT00988065|19306642|P2|COMPLETED|Overall Study||127
7844292|NCT00988065|19306643|P1|COMPLETED|Overall Study||135
7844293|NCT00988065|19306641|P3|Received Third Randomized Dose|Overall Study||135
7844294|NCT00988065|19306642|P2|Received Third Randomized Dose|Overall Study||127
7844295|NCT00988065|19306643|P1|Received Third Randomized Dose|Overall Study||135
7844296|NCT00988065|19306641|P3|Received Second Randomized Dose|Overall Study||145
7844297|NCT00988065|19306642|P2|Received Second Randomized Dose|Overall Study||135
7844298|NCT00988065|19306643|P1|Received Second Randomized Dose|Overall Study||139
7844299|NCT00988065|19306641|P3|Received First Randomized Dose|Overall Study||150
7844300|NCT00988065|19306642|P2|Received First Randomized Dose|Overall Study||150
7844301|NCT00988065|19306643|P1|Received First Randomized Dose|Overall Study||148
7844302|NCT00988065|19306641|P3|STARTED|Overall Study|Randomized to double-blind treatment|150
7844303|NCT00988065|19306642|P2|STARTED|Overall Study|Randomized to double-blind treatment|150
7844304|NCT00988065|19306643|P1|STARTED|Overall Study|Randomized to double-blind treatment|148
7844305|NCT00988052|19306665|P2|NOT COMPLETED|Overall Study||416
7844306|NCT00988052|19306666|P1|NOT COMPLETED|Overall Study||423
7844307|NCT00988052|19306665|P2|COMPLETED|Overall Study||0
7844308|NCT00988052|19306666|P1|COMPLETED|Overall Study||0
7844309|NCT00988052|19306665|P2|STARTED|Overall Study||416
7844310|NCT00988052|19306666|P1|STARTED|Overall Study||423
7844311|NCT00988000|19306683|P3|NOT COMPLETED|Overall Study||0
7844312|NCT00988000|19306684|P2|NOT COMPLETED|Overall Study||0
7844313|NCT00988000|19306685|P1|NOT COMPLETED|Overall Study||0
7844314|NCT00988000|19306683|P3|COMPLETED|Overall Study||57
7844315|NCT00988000|19306684|P2|COMPLETED|Overall Study||51
7844316|NCT00988000|19306685|P1|COMPLETED|Overall Study||49
7844317|NCT00988000|19306683|P3|STARTED|Overall Study||57
7844318|NCT00988000|19306684|P2|STARTED|Overall Study||51
7844319|NCT00988000|19306685|P1|STARTED|Overall Study||49
7844320|NCT00987948|19306696|P1|NOT COMPLETED|Overall Study||3
7844321|NCT00987948|19306696|P1|COMPLETED|Overall Study||12
7844322|NCT00987948|19306696|P1|STARTED|Overall Study||15
7844323|NCT00987935|19306710|P9|NOT COMPLETED|Overall Study||32
7844324|NCT00987935|19306711|P8|NOT COMPLETED|Overall Study||62
7844325|NCT00987935|19306712|P7|NOT COMPLETED|Overall Study||15
7844326|NCT00987935|19306713|P6|NOT COMPLETED|Overall Study||3
7844327|NCT00987935|19306714|P5|NOT COMPLETED|Overall Study||7
7844328|NCT00987935|19306715|P4|NOT COMPLETED|Overall Study||3
7844329|NCT00987935|19306716|P3|NOT COMPLETED|Overall Study||3
7844330|NCT00987935|19306717|P2|NOT COMPLETED|Overall Study||3
7844331|NCT00987935|19306718|P1|NOT COMPLETED|Overall Study||4
7844332|NCT00987935|19306710|P9|COMPLETED|Overall Study||0
7844333|NCT00987935|19306711|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
7844334|NCT00987935|19306712|P7|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
7844335|NCT00987935|19306713|P6|COMPLETED|Overall Study||0
7844336|NCT00987935|19306714|P5|COMPLETED|Overall Study||0
7844337|NCT00987935|19306715|P4|COMPLETED|Overall Study||0
7844338|NCT00987935|19306716|P3|COMPLETED|Overall Study||0
7844339|NCT00987935|19306717|P2|COMPLETED|Overall Study||0
7844340|NCT00987935|19306718|P1|COMPLETED|Overall Study||0
7844341|NCT00987935|19306710|P9|STARTED|Overall Study||32
7844342|NCT00987935|19306711|P8|STARTED|Overall Study||63
7844343|NCT00987935|19306712|P7|STARTED|Overall Study||16
7844344|NCT00987935|19306713|P6|STARTED|Overall Study||3
7844345|NCT00987935|19306714|P5|STARTED|Overall Study||7
7844346|NCT00987935|19306715|P4|STARTED|Overall Study||3
7844347|NCT00987935|19306716|P3|STARTED|Overall Study||3
7844348|NCT00987935|19306717|P2|STARTED|Overall Study||3
7844349|NCT00987935|19306718|P1|STARTED|Overall Study||4
7844350|NCT00987831|19306774|P3|NOT COMPLETED|Overall Study||0
7844351|NCT00987831|19306775|P2|NOT COMPLETED|Overall Study||3
7844352|NCT00987831|19306776|P1|NOT COMPLETED|Overall Study||1
7844353|NCT00987831|19306774|P3|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62
7844354|NCT00987831|19306775|P2|COMPLETED|Overall Study|all controls returned for two visits|52
7844355|NCT00987831|19306776|P1|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40
7844356|NCT00987831|19306774|P3|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62
7844357|NCT00987831|19306775|P2|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55
7844358|NCT00987831|19306776|P1|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41
7844359|NCT00987727|19306787|P2|NOT COMPLETED|Overall Study||7
7844360|NCT00987727|19306788|P1|NOT COMPLETED|Overall Study||5
7844361|NCT00987727|19306787|P2|COMPLETED|Overall Study||34
7844362|NCT00987727|19306788|P1|COMPLETED|Overall Study||36
7844363|NCT00987727|19306787|P2|STARTED|Overall Study||41
7844364|NCT00987727|19306788|P1|STARTED|Overall Study||41
7844365|NCT00987623|19306798|P2|NOT COMPLETED|Overall Study||3
7844366|NCT00987623|19306799|P1|NOT COMPLETED|Overall Study||5
7844367|NCT00987623|19306798|P2|COMPLETED|Overall Study||151
7844368|NCT00987623|19306799|P1|COMPLETED|Overall Study||140
7844369|NCT00987623|19306798|P2|STARTED|Overall Study||154
7844370|NCT00987623|19306799|P1|STARTED|Overall Study||145
7844371|NCT00987558|19306805|P2|NOT COMPLETED|Overall Study||5
7844372|NCT00987558|19306806|P1|NOT COMPLETED|Overall Study||1
7844373|NCT00987558|19306805|P2|COMPLETED|Overall Study||12
7844374|NCT00987558|19306806|P1|COMPLETED|Overall Study||12
7844375|NCT00987558|19306805|P2|Eslicarbazepine Acetate + Simvastatin|Overall Study||17
7844376|NCT00987558|19306806|P1|Eslicarbazepine Acetate + Simvastatin|Overall Study||13
7844377|NCT00987558|19306805|P2|Washout|Overall Study||12
7844378|NCT00987558|19306806|P1|Washout|Overall Study||13
7844379|NCT00987558|19306805|P2|Simvastatin|Overall Study||12
7844380|NCT00987558|19306806|P1|Simvastatin|Overall Study||13
7844381|NCT00987558|19306805|P2|STARTED|Overall Study||17
7844382|NCT00987558|19306806|P1|STARTED|Overall Study||13
7844383|NCT00987480|19306819|P1|NOT COMPLETED|Overall Study||0
7844384|NCT00987480|19306819|P1|COMPLETED|Overall Study||45
7844385|NCT00987480|19306819|P1|STARTED|Overall Study||45
7844386|NCT00987467|19306828|P1|NOT COMPLETED|Overall Study||2
7844387|NCT00987467|19306828|P1|COMPLETED|Overall Study||10
7844388|NCT00987467|19306828|P1|STARTED|Overall Study||12
7844389|NCT00987415|19306835|P2|NOT COMPLETED|Overall Study||9
7844390|NCT00987415|19306836|P1|NOT COMPLETED|Overall Study||9
7844391|NCT00987415|19306835|P2|COMPLETED|Overall Study||116
7844392|NCT00987415|19306836|P1|COMPLETED|Overall Study||119
7844393|NCT00987415|19306835|P2|STARTED|Overall Study||125
7844394|NCT00987415|19306836|P1|STARTED|Overall Study||128
7844395|NCT00987402|19306852|P2|NOT COMPLETED|Overall Study||98
7844396|NCT00987402|19306853|P1|NOT COMPLETED|Overall Study||86
7844397|NCT00987402|19306852|P2|COMPLETED|Overall Study|98 patients did not have sufficient data|1537
7844398|NCT00987402|19306853|P1|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596
7844399|NCT00987402|19306852|P2|STARTED|Overall Study|January 2007 with crossover every 2 months|1635
7844400|NCT00987402|19306853|P1|STARTED|Overall Study|January 2007, with crossover every 2 months|1682
7844401|NCT00987389|19306861|P4|NOT COMPLETED|Overall Study||3
7844402|NCT00987389|19306862|P3|NOT COMPLETED|Overall Study||8
7844403|NCT00987389|19306863|P2|NOT COMPLETED|Overall Study||8
7844404|NCT00987389|19306864|P1|NOT COMPLETED|Overall Study||9
7844405|NCT00987389|19306861|P4|COMPLETED|Overall Study||174
7844406|NCT00987389|19306862|P3|COMPLETED|Overall Study||167
7844407|NCT00987389|19306863|P2|COMPLETED|Overall Study||168
7844408|NCT00987389|19306864|P1|COMPLETED|Overall Study||167
7844409|NCT00987389|19306861|P4|STARTED|Overall Study||177
7844410|NCT00987389|19306862|P3|STARTED|Overall Study||175
7844411|NCT00987389|19306863|P2|STARTED|Overall Study||176
7844412|NCT00987389|19306864|P1|STARTED|Overall Study||176
7844413|NCT00987337|19306883|P3|NOT COMPLETED|Overall Study||51
7844414|NCT00987337|19306884|P2|NOT COMPLETED|Overall Study||55
7844415|NCT00987337|19306885|P1|NOT COMPLETED|Overall Study||57
7844416|NCT00987337|19306883|P3|COMPLETED|Overall Study||45
7844417|NCT00987337|19306884|P2|COMPLETED|Overall Study||41
7844418|NCT00987337|19306885|P1|COMPLETED|Overall Study||39
7844419|NCT00987337|19306883|P3|STARTED|Overall Study||96
7844420|NCT00987337|19306884|P2|STARTED|Overall Study||96
7844421|NCT00987337|19306885|P1|STARTED|Overall Study||96
7844422|NCT00986999|19306929|P1|NOT COMPLETED|Overall Study||1
7844423|NCT00986999|19306929|P1|COMPLETED|Overall Study||6
7844424|NCT00986999|19306929|P1|STARTED|Overall Study||7
7844425|NCT00986986|19306940|P2|NOT COMPLETED|Overall Study||1
7844426|NCT00986986|19306941|P1|NOT COMPLETED|Overall Study||0
7844427|NCT00986986|19306940|P2|COMPLETED|Overall Study||9
7844428|NCT00986986|19306941|P1|COMPLETED|Overall Study||10
7844429|NCT00986986|19306940|P2|STARTED|Overall Study||10
7844430|NCT00986986|19306941|P1|STARTED|Overall Study||10
7844431|NCT00986973|19306951|P1|NOT COMPLETED|Overall Study||1
7844432|NCT00986973|19306951|P1|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5
7844433|NCT00986973|19306951|P1|STARTED|Overall Study||6
7844434|NCT00986960|19306963|P2|NOT COMPLETED|Overall Study||0
7844435|NCT00986960|19306964|P1|NOT COMPLETED|Overall Study||0
7844436|NCT00986960|19306963|P2|COMPLETED|Overall Study||0
7844437|NCT00986960|19306964|P1|COMPLETED|Overall Study||0
7844438|NCT00986960|19306963|P2|STARTED|Overall Study||0
7844439|NCT00986960|19306964|P1|STARTED|Overall Study||0
7844440|NCT00986947|19306970|P1|NOT COMPLETED|Overall Study||20
7844441|NCT00986947|19306970|P1|COMPLETED|Overall Study||0
7844442|NCT00986947|19306970|P1|STARTED|Overall Study||20
7844443|NCT00986921|19306977|P2|NOT COMPLETED|Overall Study||0
7844444|NCT00986921|19306978|P1|NOT COMPLETED|Overall Study||1
7844445|NCT00986921|19306977|P2|COMPLETED|Overall Study||25
7844446|NCT00986921|19306978|P1|COMPLETED|Overall Study||24
7844447|NCT00986921|19306977|P2|STARTED|Overall Study||25
7844448|NCT00986921|19306978|P1|STARTED|Overall Study||25
7844449|NCT00986856|19306990|P2|NOT COMPLETED|Overall Study||0
7844450|NCT00986856|19306991|P1|NOT COMPLETED|Overall Study||0
7844451|NCT00986856|19306990|P2|COMPLETED|Overall Study||16
7844452|NCT00986856|19306991|P1|COMPLETED|Overall Study||42
7844453|NCT00986856|19306990|P2|STARTED|Overall Study||16
7844454|NCT00986856|19306991|P1|STARTED|Overall Study||42
7844455|NCT00986830|19307011|P1|NOT COMPLETED|Overall Study||8
7844456|NCT00986830|19307011|P1|COMPLETED|Overall Study||66
7844457|NCT00986830|19307011|P1|Treated|Overall Study||69
7844458|NCT00986830|19307011|P1|STARTED|Overall Study||74
7844459|NCT00986674|19307026|P3|NOT COMPLETED|Overall Study||48
7844460|NCT00986674|19307027|P2|NOT COMPLETED|Overall Study||45
7844461|NCT00986674|19307028|P1|NOT COMPLETED|Overall Study||47
7844462|NCT00986674|19307026|P3|COMPLETED|Overall Study||0
7844463|NCT00986674|19307027|P2|COMPLETED|Overall Study||0
7844464|NCT00986674|19307028|P1|COMPLETED|Overall Study||0
7844465|NCT00986674|19307026|P3|Eligible and Treated|Overall Study||47
7844466|NCT00986674|19307027|P2|Eligible and Treated|Overall Study||41
7844467|NCT00986674|19307028|P1|Eligible and Treated|Overall Study||39
7844468|NCT00986674|19307026|P3|Treated|Overall Study||47
7844469|NCT00986674|19307027|P2|Treated|Overall Study||42
7844470|NCT00986674|19307028|P1|Treated|Overall Study||43
7844471|NCT00986674|19307026|P3|STARTED|Overall Study||48
7844472|NCT00986674|19307027|P2|STARTED|Overall Study||45
7844473|NCT00986674|19307028|P1|STARTED|Overall Study||47
7844474|NCT00986583|19307044|P2|NOT COMPLETED|Overall Study||0
7844475|NCT00986583|19307045|P1|NOT COMPLETED|Overall Study||0
7844476|NCT00986583|19307044|P2|COMPLETED|Overall Study||32
7844477|NCT00986583|19307045|P1|COMPLETED|Overall Study||38
7844478|NCT00986583|19307044|P2|STARTED|Overall Study||32
7844479|NCT00986583|19307045|P1|STARTED|Overall Study||38
7844480|NCT00986570|19307061|P1|NOT COMPLETED|Overall Study||7
7844481|NCT00986570|19307061|P1|COMPLETED|Overall Study||114
7844482|NCT00986570|19307061|P1|STARTED|Overall Study||121
7844483|NCT00986544|19307067|P2|NOT COMPLETED|Overall Study||0
7844484|NCT00986544|19307068|P1|NOT COMPLETED|Overall Study||0
7844485|NCT00986544|19307067|P2|COMPLETED|Overall Study||53
7844486|NCT00986544|19307068|P1|COMPLETED|Overall Study||53
7844487|NCT00986544|19307067|P2|STARTED|Overall Study||53
7844488|NCT00986544|19307068|P1|STARTED|Overall Study||53
7844489|NCT00986479|19307078|P2|NOT COMPLETED|Period 2||0
7844490|NCT00986479|19307079|P1|NOT COMPLETED|Period 2||0
7844491|NCT00986479|19307078|P2|COMPLETED|Period 2||10
7844492|NCT00986479|19307079|P1|COMPLETED|Period 2||10
7844493|NCT00986479|19307078|P2|STARTED|Period 2||10
7844494|NCT00986479|19307079|P1|STARTED|Period 2||10
7844495|NCT00986479|19307078|P2|NOT COMPLETED|Period 1||0
7844496|NCT00986479|19307079|P1|NOT COMPLETED|Period 1||2
7844497|NCT00986479|19307078|P2|COMPLETED|Period 1||10
7844498|NCT00986479|19307079|P1|COMPLETED|Period 1||10
7844499|NCT00986479|19307078|P2|STARTED|Period 1||10
7844500|NCT00986479|19307079|P1|STARTED|Period 1||12
7844501|NCT00986453|19307109|P1|NOT COMPLETED|Overall Study||2
7844502|NCT00986453|19307109|P1|COMPLETED|Overall Study||43
7844503|NCT00986453|19307109|P1|STARTED|Overall Study||45
7844504|NCT00986440|19307125|P2|NOT COMPLETED|Overall Study||43
7844505|NCT00986440|19307126|P1|NOT COMPLETED|Overall Study||41
7844506|NCT00986440|19307125|P2|COMPLETED|Overall Study||0
7844507|NCT00986440|19307126|P1|COMPLETED|Overall Study||0
7844508|NCT00986440|19307125|P2|Randomized, But Not Dosed|Overall Study||1
7844509|NCT00986440|19307126|P1|Randomized, But Not Dosed|Overall Study||0
7844510|NCT00986440|19307125|P2|STARTED|Overall Study||43
7844511|NCT00986440|19307126|P1|STARTED|Overall Study||41
7844512|NCT00986427|19307144|P2|NOT COMPLETED|Overall Study||0
7844513|NCT00986427|19307145|P1|NOT COMPLETED|Overall Study||4
7844514|NCT00986427|19307144|P2|COMPLETED|Overall Study||12
7844515|NCT00986427|19307145|P1|COMPLETED|Overall Study||8
7844516|NCT00986427|19307144|P2|STARTED|Overall Study||12
7844517|NCT00986427|19307145|P1|STARTED|Overall Study||12
7844518|NCT00986401|19307161|P2|NOT COMPLETED|Period 2||0
7844519|NCT00986401|19307162|P1|NOT COMPLETED|Period 2||0
7844520|NCT00986401|19307161|P2|COMPLETED|Period 2||21
7844521|NCT00986401|19307162|P1|COMPLETED|Period 2||22
7844522|NCT00986401|19307161|P2|STARTED|Period 2||21
7844523|NCT00986401|19307162|P1|STARTED|Period 2||22
7844524|NCT00986401|19307161|P2|NOT COMPLETED|Period 1||1
7844525|NCT00986401|19307162|P1|NOT COMPLETED|Period 1||0
7844526|NCT00986401|19307161|P2|COMPLETED|Period 1||21
7844527|NCT00986401|19307162|P1|COMPLETED|Period 1||22
7844528|NCT00986401|19307161|P2|STARTED|Period 1||22
7844529|NCT00986401|19307162|P1|STARTED|Period 1||22
7844530|NCT00986362|19307173|P2|NOT COMPLETED|Overall Study||1
7844531|NCT00986362|19307174|P1|NOT COMPLETED|Overall Study||2
7844532|NCT00986362|19307173|P2|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7
7844533|NCT00986362|19307174|P1|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14
7844534|NCT00986362|19307173|P2|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8
7844535|NCT00986362|19307174|P1|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16
7844536|NCT00986349|19307180|P1|NOT COMPLETED|Overall Study||7
7844537|NCT00986349|19307180|P1|COMPLETED|Overall Study||16
7844538|NCT00986349|19307180|P1|Early Explant|Overall Study||4
7844539|NCT00986349|19307180|P1|Successful Implant Procedure|Overall Study|successful device implant procedure|20
7844540|NCT00986349|19307180|P1|STARTED|Overall Study|attempted implant procedures|23
7844541|NCT00986310|19307195|P2|NOT COMPLETED|Overall Study||0
7844542|NCT00986310|19307196|P1|NOT COMPLETED|Overall Study||0
7844543|NCT00986310|19307195|P2|COMPLETED|Overall Study||0
7844544|NCT00986310|19307196|P1|COMPLETED|Overall Study||0
7844545|NCT00986310|19307195|P2|STARTED|Overall Study||0
7844546|NCT00986310|19307196|P1|STARTED|Overall Study||0
7844547|NCT00986258|19307204|P1|NOT COMPLETED|Maintenance Period||9
7844548|NCT00986258|19307204|P1|COMPLETED|Maintenance Period||93
7844549|NCT00986258|19307204|P1|STARTED|Maintenance Period||102
7844550|NCT00986258|19307204|P1|NOT COMPLETED|Titration and Optimal Dose Period||23
7844551|NCT00986258|19307204|P1|COMPLETED|Titration and Optimal Dose Period||102
7844552|NCT00986258|19307204|P1|STARTED|Titration and Optimal Dose Period||125
7844553|NCT00986258|19307204|P1|NOT COMPLETED|Observation Period||11
7844554|NCT00986258|19307204|P1|COMPLETED|Observation Period||125
7844555|NCT00986258|19307204|P1|STARTED|Observation Period||136
7844556|NCT00986245|19307232|P2|NOT COMPLETED|Second Intervention||1
7844557|NCT00986245|19307233|P1|NOT COMPLETED|Second Intervention||2
7844558|NCT00986245|19307232|P2|COMPLETED|Second Intervention||32
7844559|NCT00986245|19307233|P1|COMPLETED|Second Intervention||29
7844560|NCT00986245|19307232|P2|STARTED|Second Intervention||33
7844561|NCT00986245|19307233|P1|STARTED|Second Intervention||31
7844562|NCT00986245|19307232|P2|NOT COMPLETED|First Intervention||8
7844563|NCT00986245|19307233|P1|NOT COMPLETED|First Intervention||10
7844564|NCT00986245|19307232|P2|COMPLETED|First Intervention||33
7844565|NCT00986245|19307233|P1|COMPLETED|First Intervention||31
7844566|NCT00986245|19307232|P2|STARTED|First Intervention||41
7844567|NCT00986245|19307233|P1|STARTED|First Intervention||41
7844568|NCT00986232|19307270|P4|NOT COMPLETED|Overall Study||20
7844569|NCT00986232|19307271|P3|NOT COMPLETED|Overall Study||35
7844570|NCT00986232|19307272|P2|NOT COMPLETED|Overall Study||50
7844571|NCT00986232|19307273|P1|NOT COMPLETED|Overall Study||51
7844572|NCT00986232|19307270|P4|COMPLETED|Overall Study||370
7844573|NCT00986232|19307271|P3|COMPLETED|Overall Study||346
7844574|NCT00986232|19307272|P2|COMPLETED|Overall Study||343
7844575|NCT00986232|19307273|P1|COMPLETED|Overall Study||336
7844576|NCT00986232|19307270|P4|Vaccination Visit 2|Overall Study||0
7844577|NCT00986232|19307271|P3|Vaccination Visit 2|Overall Study||360
7844578|NCT00986232|19307272|P2|Vaccination Visit 2|Overall Study||365
7844579|NCT00986232|19307273|P1|Vaccination Visit 2|Overall Study||360
7844580|NCT00986232|19307270|P4|Vaccination Visit 1|Overall Study||390
7844581|NCT00986232|19307271|P3|Vaccination Visit 1|Overall Study||381
7844582|NCT00986232|19307272|P2|Vaccination Visit 1|Overall Study||393
7844583|NCT00986232|19307273|P1|Vaccination Visit 1|Overall Study||387
7844584|NCT00986232|19307270|P4|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390
7844585|NCT00986232|19307271|P3|STARTED|Overall Study||381
7844586|NCT00986232|19307272|P2|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393
7844587|NCT00986232|19307273|P1|STARTED|Overall Study||387
7844588|NCT00986180|19307347|P2|NOT COMPLETED|Overall Study||56
7844589|NCT00986180|19307348|P1|NOT COMPLETED|Overall Study||44
7844590|NCT00986180|19307347|P2|COMPLETED|Overall Study||268
7844591|NCT00986180|19307348|P1|COMPLETED|Overall Study||277
7844592|NCT00986180|19307347|P2|STARTED|Overall Study||324
7844593|NCT00986180|19307348|P1|STARTED|Overall Study||321
7844594|NCT00986154|19307426|P2|NOT COMPLETED|Overall Study||194
7844595|NCT00986154|19307427|P1|NOT COMPLETED|Overall Study||206
7844596|NCT00986154|19307426|P2|COMPLETED|Overall Study||3955
7844597|NCT00986154|19307427|P1|COMPLETED|Overall Study||3937
7844598|NCT00986154|19307426|P2|Safety Analysis Set (Received Drug)|Overall Study||4122
7844599|NCT00986154|19307427|P1|Safety Analysis Set (Received Drug)|Overall Study||4118
7844600|NCT00986154|19307426|P2|STARTED|Overall Study||4149
7844601|NCT00986154|19307427|P1|STARTED|Overall Study||4143
7844602|NCT00986102|19307441|P4|NOT COMPLETED|Overall Study||1
7844603|NCT00986102|19307442|P3|NOT COMPLETED|Overall Study||0
7844604|NCT00986102|19307443|P2|NOT COMPLETED|Overall Study||2
7844605|NCT00986102|19307444|P1|NOT COMPLETED|Overall Study||1
7844606|NCT00986102|19307441|P4|COMPLETED|Overall Study||66
7844607|NCT00986102|19307442|P3|COMPLETED|Overall Study||19
7844608|NCT00986102|19307443|P2|COMPLETED|Overall Study||75
7844609|NCT00986102|19307444|P1|COMPLETED|Overall Study||52
7844610|NCT00986102|19307441|P4|STARTED|Overall Study|Number of participants who received study medication|67
7844611|NCT00986102|19307442|P3|STARTED|Overall Study|Number of participants who received study medication|19
7844612|NCT00986102|19307443|P2|STARTED|Overall Study|Number of participants who received study medication|77
7844613|NCT00986102|19307444|P1|STARTED|Overall Study|Number of participants who received study medication|53
7844614|NCT00985985|19307494|P4|NOT COMPLETED|Overall Study||13
7844615|NCT00985985|19307495|P3|NOT COMPLETED|Overall Study||11
7844616|NCT00985985|19307496|P2|NOT COMPLETED|Overall Study||24
7844617|NCT00985985|19307497|P1|NOT COMPLETED|Overall Study||24
7844618|NCT00985985|19307494|P4|COMPLETED|Overall Study||107
7844619|NCT00985985|19307495|P3|COMPLETED|Overall Study||109
7844620|NCT00985985|19307496|P2|COMPLETED|Overall Study||218
7844621|NCT00985985|19307497|P1|COMPLETED|Overall Study||217
7844622|NCT00985985|19307494|P4|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119
7844623|NCT00985985|19307495|P3|Full Analysis Set (FAS) Population|Overall Study||120
7844624|NCT00985985|19307496|P2|Full Analysis Set (FAS) Population|Overall Study||242
7844625|NCT00985985|19307497|P1|Full Analysis Set (FAS) Population|Overall Study||241
7844626|NCT00985985|19307494|P4|Safety Population|Overall Study||118
7844627|NCT00985985|19307495|P3|Safety Population|Overall Study||119
7844628|NCT00985985|19307496|P2|Safety Population|Overall Study||242
7844629|NCT00985985|19307497|P1|Safety Population|Overall Study||241
7844630|NCT00985985|19307494|P4|STARTED|Overall Study||120
7844631|NCT00985985|19307495|P3|STARTED|Overall Study||120
7844632|NCT00985985|19307496|P2|STARTED|Overall Study||242
7844633|NCT00985985|19307497|P1|STARTED|Overall Study||241
7844634|NCT00985959|19307538|P3|NOT COMPLETED|Overall Study||59
7844635|NCT00985959|19307539|P2|NOT COMPLETED|Overall Study||3
7844636|NCT00985959|19307540|P1|NOT COMPLETED|Overall Study||3
7844637|NCT00985959|19307538|P3|COMPLETED|Overall Study||28
7844638|NCT00985959|19307539|P2|COMPLETED|Overall Study|Completed all 9 cycles|3
7844639|NCT00985959|19307540|P1|COMPLETED|Overall Study|Completed all 9 cycles|3
7844640|NCT00985959|19307538|P3|STARTED|Overall Study|Number of participants treated|87
7844641|NCT00985959|19307539|P2|STARTED|Overall Study|Number of participants treated|6
7844642|NCT00985959|19307540|P1|STARTED|Overall Study|Number of participants treated|6
7844643|NCT00985946|19307563|P1|NOT COMPLETED|Overall Study||7
7844644|NCT00985946|19307563|P1|COMPLETED|Overall Study||8
7844645|NCT00985946|19307563|P1|STARTED|Overall Study|Eighty-seven percent (n=13) were evaluable for response.|15
7844646|NCT00985907|19307571|P1|NOT COMPLETED|Overall Study||13
7844647|NCT00985907|19307571|P1|COMPLETED|Overall Study||0
7844648|NCT00985907|19307571|P1|STARTED|Overall Study||13
7844649|NCT00985829|19307581|P1|NOT COMPLETED|Overall Study||0
7844650|NCT00985829|19307581|P1|COMPLETED|Overall Study||28
7844651|NCT00985829|19307581|P1|STARTED|Overall Study||28
7844652|NCT00985790|19307592|P2|NOT COMPLETED|Overall Study||8
7844653|NCT00985790|19307593|P1|NOT COMPLETED|Overall Study||7
7844654|NCT00985790|19307592|P2|COMPLETED|Overall Study||293
7844655|NCT00985790|19307593|P1|COMPLETED|Overall Study||291
7844656|NCT00985790|19307592|P2|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301
7844657|NCT00985790|19307593|P1|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298
7844658|NCT00985751|19307634|P5|NOT COMPLETED|Overall Study||1
7844659|NCT00985751|19307635|P4|NOT COMPLETED|Overall Study||0
7844660|NCT00985751|19307636|P3|NOT COMPLETED|Overall Study||0
7844661|NCT00985751|19307637|P2|NOT COMPLETED|Overall Study||0
7844662|NCT00985751|19307638|P1|NOT COMPLETED|Overall Study||0
7844663|NCT00985751|19307634|P5|COMPLETED|Overall Study||50
7844664|NCT00985751|19307635|P4|COMPLETED|Overall Study||51
7844665|NCT00985751|19307636|P3|COMPLETED|Overall Study||52
7844666|NCT00985751|19307637|P2|COMPLETED|Overall Study||52
7844667|NCT00985751|19307638|P1|COMPLETED|Overall Study||51
7844668|NCT00985751|19307634|P5|STARTED|Overall Study||51
7844669|NCT00985751|19307635|P4|STARTED|Overall Study||51
7844670|NCT00985751|19307636|P3|STARTED|Overall Study||52
7844671|NCT00985751|19307637|P2|STARTED|Overall Study||52
7844672|NCT00985751|19307638|P1|STARTED|Overall Study||51
7844673|NCT00985738|19307701|P2|NOT COMPLETED|Overall Study||8
7844674|NCT00985738|19307702|P1|NOT COMPLETED|Overall Study||8
7844675|NCT00985738|19307701|P2|COMPLETED|Overall Study||0
7844676|NCT00985738|19307702|P1|COMPLETED|Overall Study||0
7844677|NCT00985738|19307701|P2|STARTED|Overall Study||8
7844678|NCT00985738|19307702|P1|STARTED|Overall Study||8
7844679|NCT00985725|19307710|P2|NOT COMPLETED|Overall Study||13
7844680|NCT00985725|19307711|P1|NOT COMPLETED|Overall Study||11
7844681|NCT00985725|19307710|P2|COMPLETED|Overall Study||59
7844682|NCT00985725|19307711|P1|COMPLETED|Overall Study||60
7844683|NCT00985725|19307710|P2|STARTED|Overall Study||72
7844684|NCT00985725|19307711|P1|STARTED|Overall Study||71
7844685|NCT00985712|19307747|P2|NOT COMPLETED|Overall Study||7
7844686|NCT00985712|19307748|P1|NOT COMPLETED|Overall Study||6
7844687|NCT00985712|19307747|P2|COMPLETED|Overall Study||123
7844688|NCT00985712|19307748|P1|COMPLETED|Overall Study||127
7844689|NCT00985712|19307747|P2|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129
7844690|NCT00985712|19307748|P1|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128
7844691|NCT00985712|19307747|P2|Received at Least One Dose of Study Drug|Overall Study||130
7844692|NCT00985712|19307748|P1|Received at Least One Dose of Study Drug|Overall Study||131
7844693|NCT00985712|19307747|P2|STARTED|Overall Study||130
7844694|NCT00985712|19307748|P1|STARTED|Overall Study||133
7844695|NCT00985686|19307766|P4|NOT COMPLETED|Overall Study||2
7844696|NCT00985686|19307767|P3|NOT COMPLETED|Overall Study||0
7844697|NCT00985686|19307768|P2|NOT COMPLETED|Overall Study||1
7844698|NCT00985686|19307769|P1|NOT COMPLETED|Overall Study||1
7844699|NCT00985686|19307766|P4|COMPLETED|Overall Study||14
7844700|NCT00985686|19307767|P3|COMPLETED|Overall Study||13
7844701|NCT00985686|19307768|P2|COMPLETED|Overall Study||15
7844702|NCT00985686|19307769|P1|COMPLETED|Overall Study||17
7844703|NCT00985686|19307766|P4|Visit 4: Data Collection at 24 Weeks|Overall Study||14
7844704|NCT00985686|19307767|P3|Visit 4: Data Collection at 24 Weeks|Overall Study||13
7844705|NCT00985686|19307768|P2|Visit 4: Data Collection at 24 Weeks|Overall Study||15
7844706|NCT00985686|19307769|P1|Visit 4: Data Collection at 24 Weeks|Overall Study||17
7844707|NCT00985686|19307766|P4|Visit 3: Data Collection at 16 Weeks|Overall Study||16
7844708|NCT00985686|19307767|P3|Visit 3: Data Collection at 16 Weeks|Overall Study||13
7844709|NCT00985686|19307768|P2|Visit 3: Data Collection at 16 Weeks|Overall Study||15
7844710|NCT00985686|19307769|P1|Visit 3: Data Collection at 16 Weeks|Overall Study||17
7844711|NCT00985686|19307766|P4|Visit 2: Data Collection at 8 Weeks|Overall Study||16
7844712|NCT00985686|19307767|P3|Visit 2: Data Collection at 8 Weeks|Overall Study||13
7844713|NCT00985686|19307768|P2|Visit 2: Data Collection at 8 Weeks|Overall Study||15
7844714|NCT00985686|19307769|P1|Visit 2: Data Collection at 8 Weeks|Overall Study||18
7844715|NCT00985686|19307766|P4|Visit 1: Baseline Data Collection|Overall Study||16
7844716|NCT00985686|19307767|P3|Visit 1: Baseline Data Collection|Overall Study||13
7844717|NCT00985686|19307768|P2|Visit 1: Baseline Data Collection|Overall Study||15
7844718|NCT00985686|19307769|P1|Visit 1: Baseline Data Collection|Overall Study||18
7844719|NCT00985686|19307766|P4|STARTED|Overall Study||16
7844720|NCT00985686|19307767|P3|STARTED|Overall Study||13
7844721|NCT00985686|19307768|P2|STARTED|Overall Study||16
7844722|NCT00985686|19307769|P1|STARTED|Overall Study||18
7844723|NCT00985673|19307783|P6|NOT COMPLETED|Overall Study||6
7844724|NCT00985673|19307784|P5|NOT COMPLETED|Overall Study||8
7844725|NCT00985673|19307785|P4|NOT COMPLETED|Overall Study||12
7844726|NCT00985673|19307786|P3|NOT COMPLETED|Overall Study||12
7844727|NCT00985673|19307787|P2|NOT COMPLETED|Overall Study||11
7844728|NCT00985673|19307788|P1|NOT COMPLETED|Overall Study||7
7844729|NCT00985673|19307783|P6|COMPLETED|Overall Study||96
7844730|NCT00985673|19307784|P5|COMPLETED|Overall Study||93
7844731|NCT00985673|19307785|P4|COMPLETED|Overall Study||88
7844732|NCT00985673|19307786|P3|COMPLETED|Overall Study||90
7844733|NCT00985673|19307787|P2|COMPLETED|Overall Study||93
7844734|NCT00985673|19307788|P1|COMPLETED|Overall Study||95
7844735|NCT00985673|19307783|P6|STARTED|Overall Study||102
7844736|NCT00985673|19307784|P5|STARTED|Overall Study||101
7844737|NCT00985673|19307785|P4|STARTED|Overall Study||100
7844738|NCT00985673|19307786|P3|STARTED|Overall Study||102
7844739|NCT00985673|19307787|P2|STARTED|Overall Study||104
7844740|NCT00985673|19307788|P1|STARTED|Overall Study||102
7844741|NCT00985543|19308039|P1|NOT COMPLETED|Overall Study||0
7844742|NCT00985543|19308039|P1|COMPLETED|Overall Study||22
7844743|NCT00985543|19308039|P1|STARTED|Overall Study||22
7844744|NCT00985517|19308052|P4|NOT COMPLETED|Overall Study||3
7844745|NCT00985517|19308053|P3|NOT COMPLETED|Overall Study||1
7844746|NCT00985517|19308054|P2|NOT COMPLETED|Overall Study||0
7844747|NCT00985517|19308055|P1|NOT COMPLETED|Overall Study||0
7844748|NCT00985517|19308052|P4|COMPLETED|Overall Study||24
7844749|NCT00985517|19308053|P3|COMPLETED|Overall Study||23
7844750|NCT00985517|19308054|P2|COMPLETED|Overall Study||3
7844751|NCT00985517|19308055|P1|COMPLETED|Overall Study||3
7844752|NCT00985517|19308052|P4|STARTED|Overall Study||27
7844753|NCT00985517|19308053|P3|STARTED|Overall Study||24
7844754|NCT00985517|19308054|P2|STARTED|Overall Study||3
7844755|NCT00985517|19308055|P1|STARTED|Overall Study||3
7844756|NCT00985504|19308071|P2|NOT COMPLETED|Optimization Period||23
7844757|NCT00985504|19308072|P1|NOT COMPLETED|Optimization Period||26
7844758|NCT00985504|19308071|P2|COMPLETED|Optimization Period||204
7844759|NCT00985504|19308072|P1|COMPLETED|Optimization Period||203
7844760|NCT00985504|19308071|P2|STARTED|Optimization Period||227
7844761|NCT00985504|19308072|P1|STARTED|Optimization Period||229
7844762|NCT00985504|19308071|P2|NOT COMPLETED|Acute Treatment Period||12
7844763|NCT00985504|19308072|P1|NOT COMPLETED|Acute Treatment Period||15
7844764|NCT00985504|19308071|P2|COMPLETED|Acute Treatment Period||227
7844765|NCT00985504|19308072|P1|COMPLETED|Acute Treatment Period||229
7844766|NCT00985504|19308071|P2|STARTED|Acute Treatment Period||239
7844767|NCT00985504|19308072|P1|STARTED|Acute Treatment Period||244
7844768|NCT00985491|19308098|P1|NOT COMPLETED|Overall Study||19
7844769|NCT00985491|19308098|P1|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27
7844770|NCT00985491|19308098|P1|Received Device|Overall Study||43
7844771|NCT00985491|19308098|P1|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46
7844772|NCT00985465|19308105|P2|NOT COMPLETED|Overall Study||3
7844773|NCT00985465|19308106|P1|NOT COMPLETED|Overall Study||1
7844774|NCT00985465|19308105|P2|COMPLETED|Overall Study||66
7844775|NCT00985465|19308106|P1|COMPLETED|Overall Study||140
7844776|NCT00985465|19308105|P2|STARTED|Overall Study||69
7844777|NCT00985465|19308106|P1|STARTED|Overall Study||141
7844778|NCT00985439|19308133|P4|NOT COMPLETED|Overall Study||0
7844779|NCT00985439|19308134|P3|NOT COMPLETED|Overall Study||1
7844780|NCT00985439|19308135|P2|NOT COMPLETED|Overall Study||0
7844781|NCT00985439|19308136|P1|NOT COMPLETED|Overall Study||0
7844782|NCT00985439|19308133|P4|COMPLETED|Overall Study||51
7844783|NCT00985439|19308134|P3|COMPLETED|Overall Study||50
7844784|NCT00985439|19308135|P2|COMPLETED|Overall Study||51
7844785|NCT00985439|19308136|P1|COMPLETED|Overall Study||49
7844786|NCT00985439|19308133|P4|STARTED|Overall Study||51
7844787|NCT00985439|19308134|P3|STARTED|Overall Study||51
7844788|NCT00985439|19308135|P2|STARTED|Overall Study||51
7844789|NCT00985439|19308136|P1|STARTED|Overall Study||49
7844790|NCT00985426|19308148|P2|NOT COMPLETED|Overall Study||44
7844791|NCT00985426|19308149|P1|NOT COMPLETED|Overall Study||43
7844792|NCT00985426|19308148|P2|COMPLETED|Overall Study||219
7844793|NCT00985426|19308149|P1|COMPLETED|Overall Study||215
7844794|NCT00985426|19308148|P2|STARTED|Overall Study||263
7844795|NCT00985426|19308149|P1|STARTED|Overall Study||258
7844796|NCT00985257|19308165|P1|NOT COMPLETED|Overall Study||0
7844797|NCT00985257|19308165|P1|COMPLETED|Overall Study||123
7844798|NCT00985257|19308165|P1|STARTED|Overall Study||123
7844799|NCT00985231|19308171|P2|NOT COMPLETED|Overall Study||3
7844800|NCT00985231|19308172|P1|NOT COMPLETED|Overall Study||3
7844801|NCT00985231|19308171|P2|COMPLETED|Overall Study||129
7844802|NCT00985231|19308172|P1|COMPLETED|Overall Study||130
7844803|NCT00985231|19308171|P2|STARTED|Overall Study||132
7844804|NCT00985231|19308172|P1|STARTED|Overall Study||133
7844805|NCT00985192|19308180|P1|NOT COMPLETED|Overall Study||4
7844806|NCT00985192|19308180|P1|COMPLETED|Overall Study||45
7844807|NCT00985192|19308180|P1|STARTED|Overall Study||49
7844808|NCT00985166|19308192|P3|NOT COMPLETED|Overall Study||7
7844809|NCT00985166|19308193|P2|NOT COMPLETED|Overall Study||4
7844810|NCT00985166|19308194|P1|NOT COMPLETED|Overall Study||9
7844811|NCT00985166|19308192|P3|COMPLETED|Overall Study||188
7844812|NCT00985166|19308193|P2|COMPLETED|Overall Study||201
7844813|NCT00985166|19308194|P1|COMPLETED|Overall Study||392
7844814|NCT00985166|19308192|P3|Vaccinated at Visit 1|Overall Study||195
7844815|NCT00985166|19308193|P2|Vaccinated at Visit 1|Overall Study||205
7844816|NCT00985166|19308194|P1|Vaccinated at Visit 1|Overall Study||399
7844817|NCT00985166|19308192|P3|STARTED|Overall Study||195
7844818|NCT00985166|19308193|P2|STARTED|Overall Study||205
7844819|NCT00985166|19308194|P1|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401
7844820|NCT00985153|19308214|P4|NOT COMPLETED|Overall Study||47
7844821|NCT00985153|19308215|P3|NOT COMPLETED|Overall Study||44
7844822|NCT00985153|19308216|P2|NOT COMPLETED|Overall Study||44
7844823|NCT00985153|19308217|P1|NOT COMPLETED|Overall Study||35
7844824|NCT00985153|19308214|P4|COMPLETED|Overall Study||965
7844825|NCT00985153|19308215|P3|COMPLETED|Overall Study||918
7844826|NCT00985153|19308216|P2|COMPLETED|Overall Study||924
7844827|NCT00985153|19308217|P1|COMPLETED|Overall Study||950
7844828|NCT00985153|19308214|P4|Vaccinated at Visit 1|Overall Study||1012
7844829|NCT00985153|19308215|P3|Vaccinated at Visit 1|Overall Study||962
7844830|NCT00985153|19308216|P2|Vaccinated at Visit 1|Overall Study||968
7844831|NCT00985153|19308217|P1|Vaccinated at Visit 1|Overall Study||985
7844832|NCT00985153|19308214|P4|STARTED|Overall Study||1012
7844833|NCT00985153|19308215|P3|STARTED|Overall Study||962
7844834|NCT00985153|19308216|P2|STARTED|Overall Study||968
7844835|NCT00985153|19308217|P1|STARTED|Overall Study||985
7844836|NCT00985140|19308259|P1|NOT COMPLETED|Overall Study||0
7844837|NCT00985140|19308259|P1|COMPLETED|Overall Study||15
7844838|NCT00985140|19308259|P1|STARTED|Overall Study||15
7844839|NCT00985114|19308265|P2|NOT COMPLETED|Overall Study||2
7844840|NCT00985114|19308266|P1|NOT COMPLETED|Overall Study||1
7844841|NCT00985114|19308265|P2|COMPLETED|Overall Study||37
7844842|NCT00985114|19308266|P1|COMPLETED|Overall Study||33
7844843|NCT00985114|19308265|P2|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28
7844844|NCT00985114|19308266|P1|Diet + Lifestyle Counseling Cross-over|Overall Study||0
7844845|NCT00985114|19308265|P2|STARTED|Overall Study||39
7844846|NCT00985114|19308266|P1|STARTED|Overall Study|38 randomized, 34 received the device|34
7844847|NCT00985088|19308280|P8|NOT COMPLETED|Overall Study||6
7844848|NCT00985088|19308281|P7|NOT COMPLETED|Overall Study||4
7844849|NCT00985088|19308282|P6|NOT COMPLETED|Overall Study||7
7844850|NCT00985088|19308283|P5|NOT COMPLETED|Overall Study||9
7844851|NCT00985088|19308284|P4|NOT COMPLETED|Overall Study||7
7844852|NCT00985088|19308285|P3|NOT COMPLETED|Overall Study||4
7844853|NCT00985088|19308286|P2|NOT COMPLETED|Overall Study||2
7844854|NCT00985088|19308287|P1|NOT COMPLETED|Overall Study||11
7844855|NCT00985088|19308280|P8|COMPLETED|Overall Study||216
7844856|NCT00985088|19308281|P7|COMPLETED|Overall Study||107
7844857|NCT00985088|19308282|P6|COMPLETED|Overall Study||108
7844858|NCT00985088|19308283|P5|COMPLETED|Overall Study||214
7844859|NCT00985088|19308284|P4|COMPLETED|Overall Study||214
7844860|NCT00985088|19308285|P3|COMPLETED|Overall Study||108
7844861|NCT00985088|19308286|P2|COMPLETED|Overall Study||112
7844862|NCT00985088|19308287|P1|COMPLETED|Overall Study||211
7844863|NCT00985088|19308280|P8|STARTED|Overall Study||222
7844864|NCT00985088|19308281|P7|STARTED|Overall Study||111
7844865|NCT00985088|19308282|P6|STARTED|Overall Study||115
7844866|NCT00985088|19308283|P5|STARTED|Overall Study||223
7844867|NCT00985088|19308284|P4|STARTED|Overall Study||221
7844868|NCT00985088|19308285|P3|STARTED|Overall Study||112
7844869|NCT00985088|19308286|P2|STARTED|Overall Study||114
7844870|NCT00985088|19308287|P1|STARTED|Overall Study||222
7844871|NCT00985010|19308545|P2|NOT COMPLETED|Overall Study||0
7844872|NCT00985010|19308546|P1|NOT COMPLETED|Overall Study||0
7844873|NCT00985010|19308545|P2|COMPLETED|Overall Study||5
7844874|NCT00985010|19308546|P1|COMPLETED|Overall Study||4
7844875|NCT00985010|19308545|P2|STARTED|Overall Study||5
7844876|NCT00985010|19308546|P1|STARTED|Overall Study||4
7844877|NCT00984867|19308556|P2|NOT COMPLETED|Overall Study||17
7844878|NCT00984867|19308557|P1|NOT COMPLETED|Overall Study||23
7844879|NCT00984867|19308556|P2|COMPLETED|Overall Study||208
7844880|NCT00984867|19308557|P1|COMPLETED|Overall Study||203
7844881|NCT00984867|19308556|P2|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225
7844882|NCT00984867|19308557|P1|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226
7844883|NCT00984815|19308575|P1|NOT COMPLETED|Overall Study||30
7844884|NCT00984815|19308575|P1|COMPLETED|Overall Study||56
7844885|NCT00984815|19308575|P1|STARTED|Overall Study||86
7844886|NCT00984698|19308584|P2|NOT COMPLETED|Overall Study||8
7844887|NCT00984698|19308585|P1|NOT COMPLETED|Overall Study||3
7844888|NCT00984698|19308584|P2|COMPLETED|Overall Study||14
7844889|NCT00984698|19308585|P1|COMPLETED|Overall Study||18
7844890|NCT00984698|19308584|P2|STARTED|Overall Study||22
7844891|NCT00984698|19308585|P1|STARTED|Overall Study||21
7844892|NCT00984659|19308597|P4|NOT COMPLETED|6-week Double-blind Treatment Period||13
7844893|NCT00984659|19308598|P3|NOT COMPLETED|6-week Double-blind Treatment Period||11
7844894|NCT00984659|19308599|P2|NOT COMPLETED|6-week Double-blind Treatment Period||6
7844895|NCT00984659|19308600|P1|NOT COMPLETED|6-week Double-blind Treatment Period||0
7844896|NCT00984659|19308597|P4|COMPLETED|6-week Double-blind Treatment Period||126
7844897|NCT00984659|19308598|P3|COMPLETED|6-week Double-blind Treatment Period||141
7844898|NCT00984659|19308599|P2|COMPLETED|6-week Double-blind Treatment Period||69
7844899|NCT00984659|19308600|P1|COMPLETED|6-week Double-blind Treatment Period||0
7844900|NCT00984659|19308597|P4|STARTED|6-week Double-blind Treatment Period||139
7844901|NCT00984659|19308598|P3|STARTED|6-week Double-blind Treatment Period||152
7844902|NCT00984659|19308599|P2|STARTED|6-week Double-blind Treatment Period||75
7844903|NCT00984659|19308600|P1|STARTED|6-week Double-blind Treatment Period||0
7844904|NCT00984659|19308597|P4|NOT COMPLETED|2-week Run-in Period||0
7844905|NCT00984659|19308598|P3|NOT COMPLETED|2-week Run-in Period||0
7844906|NCT00984659|19308599|P2|NOT COMPLETED|2-week Run-in Period||0
7844907|NCT00984659|19308600|P1|NOT COMPLETED|2-week Run-in Period||52
7844908|NCT00984659|19308597|P4|COMPLETED|2-week Run-in Period||0
7844909|NCT00984659|19308598|P3|COMPLETED|2-week Run-in Period||0
7844910|NCT00984659|19308599|P2|COMPLETED|2-week Run-in Period||0
7844911|NCT00984659|19308600|P1|COMPLETED|2-week Run-in Period||366
7844912|NCT00984659|19308597|P4|STARTED|2-week Run-in Period||0
7844913|NCT00984659|19308598|P3|STARTED|2-week Run-in Period||0
7844914|NCT00984659|19308599|P2|STARTED|2-week Run-in Period||0
7844915|NCT00984659|19308600|P1|STARTED|2-week Run-in Period||418
7844916|NCT00984620|19308627|P2|NOT COMPLETED|Overall Study||12
7844917|NCT00984620|19308628|P1|NOT COMPLETED|Overall Study||6
7844918|NCT00984620|19308627|P2|COMPLETED|Overall Study||67
7844919|NCT00984620|19308628|P1|COMPLETED|Overall Study||75
7844920|NCT00984620|19308627|P2|STARTED|Overall Study||79
7844921|NCT00984620|19308628|P1|STARTED|Overall Study||81
7844922|NCT00984594|19308666|P2|NOT COMPLETED|Overall Study||1
7844923|NCT00984594|19308667|P1|NOT COMPLETED|Overall Study||1
7844924|NCT00984594|19308666|P2|COMPLETED|Overall Study||1
7844925|NCT00984594|19308667|P1|COMPLETED|Overall Study||1
7844926|NCT00984594|19308666|P2|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2
7844927|NCT00984594|19308667|P1|STARTED|Overall Study||2
7844928|NCT00984568|19308683|P2|NOT COMPLETED|Overall Study||6
7844929|NCT00984568|19308684|P1|NOT COMPLETED|Overall Study||8
7844930|NCT00984568|19308683|P2|COMPLETED|Overall Study||7
7844931|NCT00984568|19308684|P1|COMPLETED|Overall Study||7
7844932|NCT00984568|19308683|P2|STARTED|Overall Study||13
7844933|NCT00984568|19308684|P1|STARTED|Overall Study||15
7844934|NCT00984542|19308692|P1|NOT COMPLETED|Overall Study||41
7844935|NCT00984542|19308692|P1|COMPLETED|Overall Study||9
7844936|NCT00984542|19308692|P1|STARTED|Overall Study||50
7844937|NCT00984490|19308700|P1|NOT COMPLETED|Overall Study||0
7844938|NCT00984490|19308700|P1|COMPLETED|Overall Study||5
7844939|NCT00984490|19308700|P1|STARTED|Overall Study||5
7844940|NCT00984334|19308710|P5|NOT COMPLETED|Overall Study||1
7844941|NCT00984334|19308711|P4|NOT COMPLETED|Overall Study||1
7844942|NCT00984334|19308712|P3|NOT COMPLETED|Overall Study||0
7844943|NCT00984334|19308713|P2|NOT COMPLETED|Overall Study||1
7844944|NCT00984334|19308714|P1|NOT COMPLETED|Overall Study||1
7844945|NCT00984334|19308710|P5|COMPLETED|Overall Study||7
7844946|NCT00984334|19308711|P4|COMPLETED|Overall Study||7
7844947|NCT00984334|19308712|P3|COMPLETED|Overall Study||8
7844948|NCT00984334|19308713|P2|COMPLETED|Overall Study||7
7844949|NCT00984334|19308714|P1|COMPLETED|Overall Study||7
7844950|NCT00984334|19308710|P5|STARTED|Overall Study||8
7844951|NCT00984334|19308711|P4|STARTED|Overall Study||8
7844952|NCT00984334|19308712|P3|STARTED|Overall Study||8
7844953|NCT00984334|19308713|P2|STARTED|Overall Study||8
7844954|NCT00984334|19308714|P1|STARTED|Overall Study||8
7844955|NCT00984308|19308728|P2|NOT COMPLETED|Overall Study||6
7844956|NCT00984308|19308729|P1|NOT COMPLETED|Overall Study||18
7844957|NCT00984308|19308728|P2|COMPLETED|Overall Study||109
7844958|NCT00984308|19308729|P1|COMPLETED|Overall Study||92
7844959|NCT00984308|19308728|P2|STARTED|Overall Study||115
7844960|NCT00984308|19308729|P1|STARTED|Overall Study||110
7844961|NCT00984295|19308742|P3|NOT COMPLETED|Overall Study||37
7844962|NCT00984295|19308743|P2|NOT COMPLETED|Overall Study||32
7844963|NCT00984295|19308744|P1|NOT COMPLETED|Overall Study||65
7844964|NCT00984295|19308742|P3|COMPLETED|Overall Study||442
7844965|NCT00984295|19308743|P2|COMPLETED|Overall Study||453
7844966|NCT00984295|19308744|P1|COMPLETED|Overall Study||884
7844967|NCT00984295|19308742|P3|Visit 2|Overall Study||453
7844968|NCT00984295|19308743|P2|Visit 2|Overall Study||468
7844969|NCT00984295|19308744|P1|Visit 2|Overall Study||909
7844970|NCT00984295|19308742|P3|Visit 1|Overall Study||479
7844971|NCT00984295|19308743|P2|Visit 1|Overall Study||485
7844972|NCT00984295|19308744|P1|Visit 1|Overall Study||949
7844973|NCT00984295|19308742|P3|STARTED|Overall Study||479
7844974|NCT00984295|19308743|P2|STARTED|Overall Study||485
7844975|NCT00984295|19308744|P1|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949
7844976|NCT00984282|19308811|P2|NOT COMPLETED|Long Term Follow-up||120
7844977|NCT00984282|19308812|P1|NOT COMPLETED|Long Term Follow-up||69
7844978|NCT00984282|19308811|P2|COMPLETED|Long Term Follow-up||4
7844979|NCT00984282|19308812|P1|COMPLETED|Long Term Follow-up||3
7844980|NCT00984282|19308811|P2|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|124
7844981|NCT00984282|19308812|P1|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|72
7844982|NCT00984282|19308811|P2|NOT COMPLETED|Open-label Treatment||161
7844983|NCT00984282|19308812|P1|NOT COMPLETED|Open-label Treatment||86
7844984|NCT00984282|19308811|P2|COMPLETED|Open-label Treatment||0
7844985|NCT00984282|19308812|P1|COMPLETED|Open-label Treatment||0
7844986|NCT00984282|19308811|P2|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|161
7844987|NCT00984282|19308812|P1|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|86
7844988|NCT00984282|19308811|P2|STARTED|Open-label Treatment||161
7844989|NCT00984282|19308812|P1|STARTED|Open-label Treatment||86
7844990|NCT00984282|19308811|P2|NOT COMPLETED|Double Blind Treatment||38
7844991|NCT00984282|19308812|P1|NOT COMPLETED|Double Blind Treatment||104
7844992|NCT00984282|19308811|P2|COMPLETED|Double Blind Treatment||172
7844993|NCT00984282|19308812|P1|COMPLETED|Double Blind Treatment||103
7844994|NCT00984282|19308811|P2|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209
7844995|NCT00984282|19308812|P1|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207
7844996|NCT00984282|19308811|P2|STARTED|Double Blind Treatment||210
7844997|NCT00984282|19308812|P1|STARTED|Double Blind Treatment||207
7844998|NCT00984256|19308835|P2|NOT COMPLETED|Overall Study||1
7844999|NCT00984256|19308836|P1|NOT COMPLETED|Overall Study||0
7845000|NCT00984256|19308835|P2|COMPLETED|Overall Study||29
7845001|NCT00984256|19308836|P1|COMPLETED|Overall Study||6
7845002|NCT00984256|19308835|P2|STARTED|Overall Study||30
7845003|NCT00984256|19308836|P1|STARTED|Overall Study||6
7845004|NCT00984204|19308856|P1|NOT COMPLETED|Overall Study||15
7845005|NCT00984204|19308856|P1|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173
7845006|NCT00984204|19308856|P1|STARTED|Overall Study||188
7845007|NCT00984165|19308866|P4|NOT COMPLETED|Overall Study||4
7845008|NCT00984165|19308867|P3|NOT COMPLETED|Overall Study||0
7845009|NCT00984165|19308868|P2|NOT COMPLETED|Overall Study||1
7845010|NCT00984165|19308869|P1|NOT COMPLETED|Overall Study||7
7845011|NCT00984165|19308866|P4|COMPLETED|Overall Study||0
7845012|NCT00984165|19308867|P3|COMPLETED|Overall Study||4
7845013|NCT00984165|19308868|P2|COMPLETED|Overall Study||0
7845014|NCT00984165|19308869|P1|COMPLETED|Overall Study||2
7845015|NCT00984165|19308866|P4|STARTED|Overall Study||4
7845016|NCT00984165|19308867|P3|STARTED|Overall Study||4
7845017|NCT00984165|19308868|P2|STARTED|Overall Study||1
7845018|NCT00984165|19308869|P1|STARTED|Overall Study||9
7845019|NCT00984139|19308882|P1|NOT COMPLETED|Overall Study||0
7845020|NCT00984139|19308882|P1|COMPLETED|Overall Study||306
7845021|NCT00984139|19308882|P1|STARTED|Overall Study||306
7845022|NCT00984126|19308898|P4|NOT COMPLETED|Overall Study||59
7845023|NCT00984126|19308899|P3|NOT COMPLETED|Overall Study||7
7845024|NCT00984126|19308900|P2|NOT COMPLETED|Overall Study||8
7845025|NCT00984126|19308901|P1|NOT COMPLETED|Overall Study||7
7845026|NCT00984126|19308898|P4|COMPLETED|Overall Study||76
7845027|NCT00984126|19308899|P3|COMPLETED|Overall Study||16
7845028|NCT00984126|19308900|P2|COMPLETED|Overall Study||20
7845029|NCT00984126|19308901|P1|COMPLETED|Overall Study||20
7845030|NCT00984126|19308898|P4|STARTED|Overall Study||135
7845031|NCT00984126|19308899|P3|STARTED|Overall Study||23
7845032|NCT00984126|19308900|P2|STARTED|Overall Study||28
7845033|NCT00984126|19308901|P1|STARTED|Overall Study||27
7845034|NCT00984061|19308926|P1|NOT COMPLETED|Colchicine With Clarithromycin||0
7845035|NCT00984061|19308926|P1|COMPLETED|Colchicine With Clarithromycin||23
7845036|NCT00984061|19308926|P1|STARTED|Colchicine With Clarithromycin||23
7845037|NCT00984061|19308926|P1|NOT COMPLETED|Clarithromycin Alone||1
7845038|NCT00984061|19308926|P1|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23
7845039|NCT00984061|19308926|P1|STARTED|Clarithromycin Alone||24
7845040|NCT00984061|19308926|P1|NOT COMPLETED|21 Day Washout Period||0
7845041|NCT00984061|19308926|P1|COMPLETED|21 Day Washout Period||24
7845042|NCT00984061|19308926|P1|STARTED|21 Day Washout Period||24
7845043|NCT00984061|19308926|P1|NOT COMPLETED|Colchicine Alone||0
7845044|NCT00984061|19308926|P1|COMPLETED|Colchicine Alone||24
7845045|NCT00984061|19308926|P1|STARTED|Colchicine Alone||24
7845046|NCT00984022|19308939|P2|NOT COMPLETED|Overall Study||14
7845047|NCT00984022|19308940|P1|NOT COMPLETED|Overall Study||10
7845048|NCT00984022|19308939|P2|COMPLETED|Overall Study||35
7845049|NCT00984022|19308940|P1|COMPLETED|Overall Study||33
7845050|NCT00984022|19308939|P2|STARTED|Overall Study||49
7845051|NCT00984022|19308940|P1|STARTED|Overall Study||43
7845052|NCT00984009|19308950|P1|NOT COMPLETED|Colchicine With Grapefruit Juice||0
7845053|NCT00984009|19308950|P1|COMPLETED|Colchicine With Grapefruit Juice||21
7845054|NCT00984009|19308950|P1|STARTED|Colchicine With Grapefruit Juice||21
7845055|NCT00984009|19308950|P1|NOT COMPLETED|Grapefruit Juice Alone||1
7845056|NCT00984009|19308950|P1|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21
7845057|NCT00984009|19308950|P1|STARTED|Grapefruit Juice Alone||22
7845058|NCT00984009|19308950|P1|NOT COMPLETED|14 Day Washout Period||0
7845059|NCT00984009|19308950|P1|COMPLETED|14 Day Washout Period||22
7845060|NCT00984009|19308950|P1|STARTED|14 Day Washout Period||22
7845061|NCT00984009|19308950|P1|NOT COMPLETED|Colchicine Alone||0
7845062|NCT00984009|19308950|P1|COMPLETED|Colchicine Alone||22
7845063|NCT00984009|19308950|P1|STARTED|Colchicine Alone||22
7845064|NCT00983983|19308964|P3|NOT COMPLETED|Overall Study||1
7845065|NCT00983983|19308965|P2|NOT COMPLETED|Overall Study||1
7845066|NCT00983983|19308966|P1|NOT COMPLETED|Overall Study||2
7845067|NCT00983983|19308964|P3|COMPLETED|Overall Study||6
7845068|NCT00983983|19308965|P2|COMPLETED|Overall Study||8
7845069|NCT00983983|19308966|P1|COMPLETED|Overall Study||6
7845070|NCT00983983|19308964|P3|STARTED|Overall Study||7
7845071|NCT00983983|19308965|P2|STARTED|Overall Study||9
7845072|NCT00983983|19308966|P1|STARTED|Overall Study||8
7845073|NCT00983957|19308983|P1|NOT COMPLETED|Overall Study||2
7845074|NCT00983957|19308983|P1|COMPLETED|Overall Study||18
7845075|NCT00983957|19308983|P1|Treatment C|Overall Study||18
7845076|NCT00983957|19308983|P1|Treatment B|Overall Study||20
7845077|NCT00983957|19308983|P1|Treatment A|Overall Study||20
7845078|NCT00983957|19308983|P1|STARTED|Overall Study||20
7845079|NCT00983931|19309017|P1|NOT COMPLETED|Colchicine With Cyclosporine||0
7845080|NCT00983931|19309017|P1|COMPLETED|Colchicine With Cyclosporine||23
7845081|NCT00983931|19309017|P1|STARTED|Colchicine With Cyclosporine||23
7845082|NCT00983931|19309017|P1|NOT COMPLETED|14 Day Washout Period||1
7845083|NCT00983931|19309017|P1|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23
7845084|NCT00983931|19309017|P1|STARTED|14 Day Washout Period||24
7845085|NCT00983931|19309017|P1|NOT COMPLETED|Colchicine Alone||0
7845086|NCT00983931|19309017|P1|COMPLETED|Colchicine Alone||24
7845087|NCT00983931|19309017|P1|STARTED|Colchicine Alone||24
7845088|NCT00983918|19309031|P4|NOT COMPLETED|Overall Study||2
7845089|NCT00983918|19309032|P3|NOT COMPLETED|Overall Study||2
7845090|NCT00983918|19309033|P2|NOT COMPLETED|Overall Study||2
7845091|NCT00983918|19309034|P1|NOT COMPLETED|Overall Study||0
7845092|NCT00983918|19309031|P4|COMPLETED|Overall Study||18
7845093|NCT00983918|19309032|P3|COMPLETED|Overall Study||18
7845094|NCT00983918|19309033|P2|COMPLETED|Overall Study||18
7845095|NCT00983918|19309034|P1|COMPLETED|Overall Study||20
7845096|NCT00983918|19309031|P4|STARTED|Overall Study||20
7845097|NCT00983918|19309032|P3|STARTED|Overall Study||20
7845098|NCT00983918|19309033|P2|STARTED|Overall Study||20
7845099|NCT00983918|19309034|P1|STARTED|Overall Study||20
7845100|NCT00983905|19309044|P1|NOT COMPLETED|Theophylline With Colchicine||0
7845101|NCT00983905|19309044|P1|COMPLETED|Theophylline With Colchicine||27
7845102|NCT00983905|19309044|P1|STARTED|Theophylline With Colchicine||27
7845103|NCT00983905|19309044|P1|NOT COMPLETED|Colchicine Alone||2
7845104|NCT00983905|19309044|P1|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27
7845105|NCT00983905|19309044|P1|STARTED|Colchicine Alone||29
7845106|NCT00983905|19309044|P1|NOT COMPLETED|4 Day Washout Period||0
7845107|NCT00983905|19309044|P1|COMPLETED|4 Day Washout Period||29
7845108|NCT00983905|19309044|P1|STARTED|4 Day Washout Period||29
7845109|NCT00983905|19309044|P1|NOT COMPLETED|Theophylline Alone||1
7845110|NCT00983905|19309044|P1|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29
7845111|NCT00983905|19309044|P1|STARTED|Theophylline Alone||30
7845112|NCT00983892|19309057|P2|NOT COMPLETED|Overall Study||12
7845113|NCT00983892|19309058|P1|NOT COMPLETED|Overall Study||10
7845114|NCT00983892|19309057|P2|COMPLETED|Overall Study||56
7845115|NCT00983892|19309058|P1|COMPLETED|Overall Study||56
7845116|NCT00983892|19309057|P2|STARTED|Overall Study||68
7845117|NCT00983892|19309058|P1|STARTED|Overall Study||66
7845118|NCT00983853|19309070|P6|NOT COMPLETED|Overall Study||1
7845119|NCT00983853|19309071|P5|NOT COMPLETED|Overall Study||3
7845120|NCT00983853|19309072|P4|NOT COMPLETED|Overall Study||2
7845121|NCT00983853|19309073|P3|NOT COMPLETED|Overall Study||3
7845122|NCT00983853|19309074|P2|NOT COMPLETED|Overall Study||2
7845123|NCT00983853|19309075|P1|NOT COMPLETED|Overall Study||1
7845124|NCT00983853|19309070|P6|COMPLETED|Overall Study||7
7845125|NCT00983853|19309071|P5|COMPLETED|Overall Study||12
7845126|NCT00983853|19309072|P4|COMPLETED|Overall Study||6
7845127|NCT00983853|19309073|P3|COMPLETED|Overall Study||14
7845128|NCT00983853|19309074|P2|COMPLETED|Overall Study||5
7845129|NCT00983853|19309075|P1|COMPLETED|Overall Study||6
7845130|NCT00983853|19309070|P6|STARTED|Overall Study||8
7845131|NCT00983853|19309071|P5|STARTED|Overall Study||15
7845132|NCT00983853|19309072|P4|STARTED|Overall Study||8
7845133|NCT00983853|19309073|P3|STARTED|Overall Study|1 subject was randomized but not dosed|17
7845134|NCT00983853|19309074|P2|STARTED|Overall Study|1 subject was randomized but not dosed|7
7845135|NCT00983853|19309075|P1|STARTED|Overall Study||7
7845136|NCT00983827|19309103|P1|NOT COMPLETED|Overall Study||1
7845137|NCT00983827|19309103|P1|COMPLETED|Overall Study||7
7845138|NCT00983827|19309103|P1|STARTED|Overall Study||8
7845139|NCT00983801|19309107|P1|NOT COMPLETED|Overall Study||0
7845140|NCT00983801|19309107|P1|COMPLETED|Overall Study|Participants who were taken off treatment.|52
7845141|NCT00983801|19309107|P1|STARTED|Overall Study|Participants who received treatment.|52
7845142|NCT00983749|19309121|P2|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3
7845143|NCT00983749|19309122|P1|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1
7845144|NCT00983749|19309121|P2|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7
7845145|NCT00983749|19309122|P1|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12
7845146|NCT00983749|19309121|P2|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10
7845147|NCT00983749|19309122|P1|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13
7845148|NCT00983749|19309121|P2|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
7845149|NCT00983749|19309122|P1|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
7845150|NCT00983749|19309121|P2|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10
7845151|NCT00983749|19309122|P1|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13
7845152|NCT00983749|19309121|P2|STARTED|Acute Phase (Enrollment to Hospital DC)||10
7845153|NCT00983749|19309122|P1|STARTED|Acute Phase (Enrollment to Hospital DC)||13
7845154|NCT00983645|19309132|P2|NOT COMPLETED|Overall Study||0
7845155|NCT00983645|19309133|P1|NOT COMPLETED|Overall Study||0
7845156|NCT00983645|19309132|P2|COMPLETED|Overall Study||7
7845157|NCT00983645|19309133|P1|COMPLETED|Overall Study||8
7845158|NCT00983645|19309132|P2|STARTED|Overall Study||7
7845159|NCT00983645|19309133|P1|STARTED|Overall Study||8
7845160|NCT00983619|19309157|P12|NOT COMPLETED|Overall Study||11
7845161|NCT00983619|19309158|P11|NOT COMPLETED|Overall Study||11
7845162|NCT00983619|19309159|P10|NOT COMPLETED|Overall Study||3
7845163|NCT00983619|19309160|P9|NOT COMPLETED|Overall Study||1
7845164|NCT00983619|19309161|P8|NOT COMPLETED|Overall Study||2
7845165|NCT00983619|19309162|P7|NOT COMPLETED|Overall Study||3
7845166|NCT00983619|19309163|P6|NOT COMPLETED|Overall Study||67
7845167|NCT00983619|19309164|P5|NOT COMPLETED|Overall Study||3
7845168|NCT00983619|19309165|P4|NOT COMPLETED|Overall Study||5
7845169|NCT00983619|19309166|P3|NOT COMPLETED|Overall Study||3
7845170|NCT00983619|19309167|P2|NOT COMPLETED|Overall Study||4
7845171|NCT00983619|19309168|P1|NOT COMPLETED|Overall Study||3
7845172|NCT00983619|19309157|P12|COMPLETED|Overall Study||3
7845173|NCT00983619|19309158|P11|COMPLETED|Overall Study||6
7845174|NCT00983619|19309159|P10|COMPLETED|Overall Study||0
7845175|NCT00983619|19309160|P9|COMPLETED|Overall Study||0
7845176|NCT00983619|19309161|P8|COMPLETED|Overall Study||1
7845177|NCT00983619|19309162|P7|COMPLETED|Overall Study||0
7845178|NCT00983619|19309163|P6|COMPLETED|Overall Study||9
7845179|NCT00983619|19309164|P5|COMPLETED|Overall Study||0
7845180|NCT00983619|19309165|P4|COMPLETED|Overall Study||1
7845181|NCT00983619|19309166|P3|COMPLETED|Overall Study||0
7845182|NCT00983619|19309167|P2|COMPLETED|Overall Study||0
7845183|NCT00983619|19309168|P1|COMPLETED|Overall Study||0
7845184|NCT00983619|19309157|P12|STARTED|Overall Study||14
7845185|NCT00983619|19309158|P11|STARTED|Overall Study||17
7845186|NCT00983619|19309159|P10|STARTED|Overall Study||3
7845187|NCT00983619|19309160|P9|STARTED|Overall Study||1
7845188|NCT00983619|19309161|P8|STARTED|Overall Study||3
7845189|NCT00983619|19309162|P7|STARTED|Overall Study||3
7845190|NCT00983619|19309163|P6|STARTED|Overall Study||76
7845191|NCT00983619|19309164|P5|STARTED|Overall Study||3
7845192|NCT00983619|19309165|P4|STARTED|Overall Study||6
7845193|NCT00983619|19309166|P3|STARTED|Overall Study||3
7845194|NCT00983619|19309167|P2|STARTED|Overall Study||4
7845195|NCT00983619|19309168|P1|STARTED|Overall Study||3
7845196|NCT00983580|19309473|P2|NOT COMPLETED|Overall Study||4
7845197|NCT00983580|19309474|P1|NOT COMPLETED|Overall Study||5
7845198|NCT00983580|19309473|P2|COMPLETED|Overall Study||49
7845199|NCT00983580|19309474|P1|COMPLETED|Overall Study||49
7845200|NCT00983580|19309473|P2|STARTED|Overall Study||53
7845201|NCT00983580|19309474|P1|STARTED|Overall Study||54
7845202|NCT00983541|19309490|P1|NOT COMPLETED|Overall Study||0
7845203|NCT00983541|19309490|P1|COMPLETED|Overall Study||1
7845204|NCT00983541|19309490|P1|STARTED|Overall Study||1
7845205|NCT00983528|19309500|P1|NOT COMPLETED|Overall Study||6
7845206|NCT00983528|19309500|P1|COMPLETED|Overall Study||0
7845207|NCT00983528|19309500|P1|STARTED|Overall Study||6
7845208|NCT00983515|19309505|P1|NOT COMPLETED|Colchicine With Ritonavir||1
7845209|NCT00983515|19309505|P1|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17
7845210|NCT00983515|19309505|P1|STARTED|Colchicine With Ritonavir||18
7845211|NCT00983515|19309505|P1|NOT COMPLETED|Ritonavir Alone||6
7845212|NCT00983515|19309505|P1|COMPLETED|Ritonavir Alone||18
7845213|NCT00983515|19309505|P1|STARTED|Ritonavir Alone||24
7845214|NCT00983515|19309505|P1|NOT COMPLETED|14 Day Washout Period||0
7845215|NCT00983515|19309505|P1|COMPLETED|14 Day Washout Period||24
7845216|NCT00983515|19309505|P1|STARTED|14 Day Washout Period||24
7845217|NCT00983515|19309505|P1|NOT COMPLETED|Colchicine Alone||0
7845218|NCT00983515|19309505|P1|COMPLETED|Colchicine Alone||24
7845219|NCT00983515|19309505|P1|STARTED|Colchicine Alone||24
7845220|NCT00983489|19309519|P3|NOT COMPLETED|Overall Study||312
7845221|NCT00983489|19309520|P2|NOT COMPLETED|Overall Study||285
7845222|NCT00983489|19309521|P1|NOT COMPLETED|Overall Study||185
7845223|NCT00983489|19309519|P3|COMPLETED|Overall Study||135
7845224|NCT00983489|19309520|P2|COMPLETED|Overall Study||168
7845225|NCT00983489|19309521|P1|COMPLETED|Overall Study||326
7845226|NCT00983489|19309519|P3|STARTED|Overall Study||447
7845227|NCT00983489|19309520|P2|STARTED|Overall Study||453
7845228|NCT00983489|19309521|P1|STARTED|Overall Study||511
7845229|NCT00983476|19309532|P3|NOT COMPLETED|Overall Study||0
7845230|NCT00983476|19309533|P2|NOT COMPLETED|Overall Study||22
7845231|NCT00983476|19309534|P1|NOT COMPLETED|Overall Study||17
7845232|NCT00983476|19309532|P3|COMPLETED|Overall Study||88
7845233|NCT00983476|19309533|P2|COMPLETED|Overall Study||71
7845234|NCT00983476|19309534|P1|COMPLETED|Overall Study||78
7845235|NCT00983476|19309532|P3|6 Month Follow up Assessment|Overall Study||74
7845236|NCT00983476|19309533|P2|6 Month Follow up Assessment|Overall Study||62
7845237|NCT00983476|19309534|P1|6 Month Follow up Assessment|Overall Study||71
7845238|NCT00983476|19309532|P3|STARTED|Overall Study||88
7845239|NCT00983476|19309533|P2|STARTED|Overall Study||93
7845240|NCT00983476|19309534|P1|STARTED|Overall Study||95
7845241|NCT00983437|19309566|P1|NOT COMPLETED|Overall Study||47
7845242|NCT00983437|19309566|P1|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0
7845243|NCT00983437|19309566|P1|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45
7845244|NCT00983437|19309566|P1|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47
7845245|NCT00983437|19309566|P1|STARTED|Overall Study||47
7845246|NCT00983385|19309585|P1|NOT COMPLETED|Maintenance Period||23
7845247|NCT00983385|19309585|P1|COMPLETED|Maintenance Period||117
7845248|NCT00983385|19309585|P1|STARTED|Maintenance Period||140
7845249|NCT00983385|19309585|P1|NOT COMPLETED|Titration and Optimal Dose Period||36
7845250|NCT00983385|19309585|P1|COMPLETED|Titration and Optimal Dose Period||140
7845251|NCT00983385|19309585|P1|STARTED|Titration and Optimal Dose Period||176
7845252|NCT00983385|19309585|P1|NOT COMPLETED|Observation Period||32
7845253|NCT00983385|19309585|P1|COMPLETED|Observation Period||176
7845254|NCT00983385|19309585|P1|STARTED|Observation Period||208
7845255|NCT00983372|19309630|P1|NOT COMPLETED|Colchicine With Diltiazem ER||0
7845256|NCT00983372|19309630|P1|COMPLETED|Colchicine With Diltiazem ER||20
7845257|NCT00983372|19309630|P1|STARTED|Colchicine With Diltiazem ER||20
7845258|NCT00983372|19309630|P1|NOT COMPLETED|Diltiazem ER Alone||3
7845259|NCT00983372|19309630|P1|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20
7845260|NCT00983372|19309630|P1|STARTED|Diltiazem ER Alone||23
7845261|NCT00983372|19309630|P1|NOT COMPLETED|14 Day Washout Period||1
7845262|NCT00983372|19309630|P1|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23
7845263|NCT00983372|19309630|P1|STARTED|14 Day Washout Period||24
7845264|NCT00983372|19309630|P1|NOT COMPLETED|Colchicine Alone||0
7845265|NCT00983372|19309630|P1|COMPLETED|Colchicine Alone||24
7845266|NCT00983372|19309630|P1|STARTED|Colchicine Alone||24
7845267|NCT00983359|19309641|P1|NOT COMPLETED|Overall Study||1
7845268|NCT00983359|19309641|P1|COMPLETED|Overall Study||39
7845269|NCT00983359|19309641|P1|Not Eligible for Analysis|Overall Study||1
7845270|NCT00983359|19309641|P1|STARTED|Overall Study||40
7845271|NCT00983346|19309649|P1|NOT COMPLETED|Overall Study||0
7845272|NCT00983346|19309649|P1|COMPLETED|Overall Study||17
7845273|NCT00983346|19309649|P1|STARTED|Overall Study||17
7845274|NCT00983307|19309653|P1|NOT COMPLETED|Overall Study||0
7845275|NCT00983307|19309653|P1|COMPLETED|Overall Study||17
7845276|NCT00983307|19309653|P1|STARTED|Overall Study||17
7845277|NCT00983294|19309657|P1|NOT COMPLETED|Colchicine With Azithromycin||1
7845278|NCT00983294|19309657|P1|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21
7845279|NCT00983294|19309657|P1|STARTED|Colchicine With Azithromycin||22
7845280|NCT00983294|19309657|P1|NOT COMPLETED|Azithromycin Alone||0
7845281|NCT00983294|19309657|P1|COMPLETED|Azithromycin Alone||22
7845282|NCT00983294|19309657|P1|STARTED|Azithromycin Alone||22
7845283|NCT00983294|19309657|P1|NOT COMPLETED|14 Day Washout Period||2
7845284|NCT00983294|19309657|P1|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22
7845285|NCT00983294|19309657|P1|STARTED|14 Day Washout Period||24
7845286|NCT00983294|19309657|P1|NOT COMPLETED|Colchicine Alone||0
7845287|NCT00983294|19309657|P1|COMPLETED|Colchicine Alone||24
7845288|NCT00983294|19309657|P1|STARTED|Colchicine Alone||24
7845289|NCT00983281|19309670|P2|NOT COMPLETED|Overall Study||0
7845290|NCT00983281|19309671|P1|NOT COMPLETED|Overall Study||0
7845291|NCT00983281|19309670|P2|COMPLETED|Overall Study||909
7845292|NCT00983281|19309671|P1|COMPLETED|Overall Study||805
7845293|NCT00983281|19309670|P2|STARTED|Overall Study||909
7845294|NCT00983281|19309671|P1|STARTED|Overall Study||805
7845295|NCT00983242|19309677|P1|NOT COMPLETED|Colchicine With Verapamil HCl ER||0
7845296|NCT00983242|19309677|P1|COMPLETED|Colchicine With Verapamil HCl ER||24
7845297|NCT00983242|19309677|P1|STARTED|Colchicine With Verapamil HCl ER||24
7845298|NCT00983242|19309677|P1|NOT COMPLETED|Verapamil HCl ER Alone||0
7845299|NCT00983242|19309677|P1|COMPLETED|Verapamil HCl ER Alone||24
7845300|NCT00983242|19309677|P1|STARTED|Verapamil HCl ER Alone||24
7845301|NCT00983242|19309677|P1|NOT COMPLETED|14 Day Washout Period||0
7845302|NCT00983242|19309677|P1|COMPLETED|14 Day Washout Period||24
7845303|NCT00983242|19309677|P1|STARTED|14 Day Washout Period||24
7845304|NCT00983242|19309677|P1|NOT COMPLETED|Colchicine Alone||0
7845305|NCT00983242|19309677|P1|COMPLETED|Colchicine Alone||24
7845306|NCT00983242|19309677|P1|STARTED|Colchicine Alone||24
7845307|NCT00983216|19309688|P1|NOT COMPLETED|Colchicine With Ketoconazole||0
7845308|NCT00983216|19309688|P1|COMPLETED|Colchicine With Ketoconazole||24
7845309|NCT00983216|19309688|P1|STARTED|Colchicine With Ketoconazole||24
7845310|NCT00983216|19309688|P1|NOT COMPLETED|Ketoconazole Alone||0
7845311|NCT00983216|19309688|P1|COMPLETED|Ketoconazole Alone||24
7845312|NCT00983216|19309688|P1|STARTED|Ketoconazole Alone||24
7845313|NCT00983216|19309688|P1|NOT COMPLETED|14 Day Washout Period||0
7845314|NCT00983216|19309688|P1|COMPLETED|14 Day Washout Period||24
7845315|NCT00983216|19309688|P1|STARTED|14 Day Washout Period||24
7845316|NCT00983216|19309688|P1|NOT COMPLETED|Colchicine Alone||0
7845317|NCT00983216|19309688|P1|COMPLETED|Colchicine Alone||24
7845318|NCT00983216|19309688|P1|STARTED|Colchicine Alone||24
7845319|NCT00983073|19309699|P1|NOT COMPLETED|Maintenance Period||16
7845320|NCT00983073|19309699|P1|COMPLETED|Maintenance Period||144
7845321|NCT00983073|19309699|P1|STARTED|Maintenance Period||160
7845322|NCT00983073|19309699|P1|NOT COMPLETED|Titration and Optimal Dose Period||40
7845323|NCT00983073|19309699|P1|COMPLETED|Titration and Optimal Dose Period||160
7845324|NCT00983073|19309699|P1|STARTED|Titration and Optimal Dose Period||200
7845325|NCT00983073|19309699|P1|NOT COMPLETED|Observation Period||24
7845326|NCT00983073|19309699|P1|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200
7845327|NCT00983073|19309699|P1|STARTED|Observation Period||224
7845328|NCT00982995|19309720|P1|NOT COMPLETED|Overall Study||0
7845329|NCT00982995|19309720|P1|COMPLETED|Overall Study||3
7845330|NCT00982995|19309720|P1|STARTED|Overall Study||3
7845331|NCT00982878|19309725|P1|NOT COMPLETED|Overall Study||1
7845332|NCT00982878|19309725|P1|COMPLETED|Overall Study||12
7845333|NCT00982878|19309725|P1|STARTED|Overall Study||13
7845334|NCT00982865|19309734|P4|NOT COMPLETED|Overall Study||0
7845335|NCT00982865|19309735|P3|NOT COMPLETED|Overall Study||0
7845336|NCT00982865|19309736|P2|NOT COMPLETED|Overall Study||0
7845337|NCT00982865|19309737|P1|NOT COMPLETED|Overall Study||0
7845338|NCT00982865|19309734|P4|COMPLETED|Overall Study||34
7845339|NCT00982865|19309735|P3|COMPLETED|Overall Study||15
7845340|NCT00982865|19309736|P2|COMPLETED|Overall Study||82
7845341|NCT00982865|19309737|P1|COMPLETED|Overall Study||49
7845342|NCT00982865|19309734|P4|STARTED|Overall Study||34
7845343|NCT00982865|19309735|P3|STARTED|Overall Study||15
7845344|NCT00982865|19309736|P2|STARTED|Overall Study||82
7845345|NCT00982865|19309737|P1|STARTED|Overall Study||49
7845346|NCT00982735|19310023|P1|NOT COMPLETED|Overall Study||230
7845347|NCT00982735|19310023|P1|COMPLETED|Overall Study||757
7845348|NCT00982735|19310023|P1|STARTED|Overall Study||987
7845349|NCT00982657|19310033|P4|NOT COMPLETED|Overall Study||9
7845350|NCT00982657|19310034|P3|NOT COMPLETED|Overall Study||2
7845351|NCT00982657|19310035|P2|NOT COMPLETED|Overall Study||0
7845352|NCT00982657|19310036|P1|NOT COMPLETED|Overall Study||1
7845353|NCT00982657|19310033|P4|COMPLETED|Overall Study||7
7845354|NCT00982657|19310034|P3|COMPLETED|Overall Study||1
7845355|NCT00982657|19310035|P2|COMPLETED|Overall Study||3
7845356|NCT00982657|19310036|P1|COMPLETED|Overall Study||11
7845357|NCT00982657|19310033|P4|STARTED|Overall Study||16
7845358|NCT00982657|19310034|P3|STARTED|Overall Study||3
7845359|NCT00982657|19310035|P2|STARTED|Overall Study||3
7845360|NCT00982657|19310036|P1|STARTED|Overall Study||12
7845361|NCT00982644|19310077|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20
7845362|NCT00982644|19310078|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46
7845363|NCT00982644|19310077|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154
7845364|NCT00982644|19310078|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505
7845365|NCT00982644|19310077|P2|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174
7845366|NCT00982644|19310078|P1|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551
7845367|NCT00982644|19310077|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60
7845368|NCT00982644|19310078|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166
7845369|NCT00982644|19310077|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197
7845370|NCT00982644|19310078|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607
7845371|NCT00982644|19310077|P2|Exposed|Main: Week 0 to 52 (NN1250-3579)||257
7845372|NCT00982644|19310078|P1|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766
7845373|NCT00982644|19310077|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257
7845374|NCT00982644|19310078|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773
7845375|NCT00982644|19310077|P2|STARTED|Main: Week 0 to 52 (NN1250-3579)||257
7845376|NCT00982644|19310078|P1|STARTED|Main: Week 0 to 52 (NN1250-3579)||773
7845377|NCT00982592|19310102|P2|NOT COMPLETED|Overall Study||33
7845378|NCT00982592|19310103|P1|NOT COMPLETED|Overall Study||31
7845379|NCT00982592|19310102|P2|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27
7845380|NCT00982592|19310103|P1|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33
7845381|NCT00982592|19310102|P2|Treatment Received|Overall Study||52
7845382|NCT00982592|19310103|P1|Treatment Received|Overall Study||63
7845383|NCT00982592|19310102|P2|STARTED|Overall Study||60
7845384|NCT00982592|19310103|P1|STARTED|Overall Study||64
7845385|NCT00982553|19310117|P1|NOT COMPLETED|Phase3||0
7845386|NCT00982553|19310117|P1|COMPLETED|Phase3||14
7845387|NCT00982553|19310117|P1|STARTED|Phase3||14
7845388|NCT00982553|19310117|P1|NOT COMPLETED|Phase2||0
7845389|NCT00982553|19310117|P1|COMPLETED|Phase2||14
7845390|NCT00982553|19310117|P1|STARTED|Phase2||14
7845391|NCT00982553|19310117|P1|NOT COMPLETED|Phase1||0
7845392|NCT00982553|19310117|P1|COMPLETED|Phase1||14
7845393|NCT00982553|19310117|P1|STARTED|Phase1||14
7845394|NCT00982488|19310133|P5|NOT COMPLETED|Overall Study||1
7845395|NCT00982488|19310134|P4|NOT COMPLETED|Overall Study||3
7845396|NCT00982488|19310135|P3|NOT COMPLETED|Overall Study||34
7845397|NCT00982488|19310136|P2|NOT COMPLETED|Overall Study||14
7845398|NCT00982488|19310137|P1|NOT COMPLETED|Overall Study||185
7845399|NCT00982488|19310133|P5|COMPLETED|Overall Study|Still receiving treatment|0
7845400|NCT00982488|19310134|P4|COMPLETED|Overall Study|Still receiving treatment|0
7845401|NCT00982488|19310135|P3|COMPLETED|Overall Study|Still receiving treatment|0
7845402|NCT00982488|19310136|P2|COMPLETED|Overall Study|Still receiving treatment|0
7845403|NCT00982488|19310137|P1|COMPLETED|Overall Study|Still receiving treatment|0
7845404|NCT00982488|19310133|P5|STARTED|Overall Study|Received treatment|1
7845405|NCT00982488|19310134|P4|STARTED|Overall Study|Received treatment|3
7845406|NCT00982488|19310135|P3|STARTED|Overall Study|Received treatment|34
7845407|NCT00982488|19310136|P2|STARTED|Overall Study|Received treatment|14
7845408|NCT00982488|19310137|P1|STARTED|Overall Study|Received treatment|185
7845409|NCT00982423|19310151|P2|NOT COMPLETED|Overall Study||0
7845410|NCT00982423|19310152|P1|NOT COMPLETED|Overall Study||0
7845411|NCT00982423|19310151|P2|COMPLETED|Overall Study||19
7845412|NCT00982423|19310152|P1|COMPLETED|Overall Study||13
7845413|NCT00982423|19310151|P2|STARTED|Overall Study||19
7845414|NCT00982423|19310152|P1|STARTED|Overall Study||13
7845415|NCT00982410|19310170|P2|NOT COMPLETED|12-month Follow-up Assessment||9
7845416|NCT00982410|19310171|P1|NOT COMPLETED|12-month Follow-up Assessment||9
7845417|NCT00982410|19310170|P2|COMPLETED|12-month Follow-up Assessment||55
7845418|NCT00982410|19310171|P1|COMPLETED|12-month Follow-up Assessment||56
7845419|NCT00982410|19310170|P2|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
7845420|NCT00982410|19310171|P1|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
7845421|NCT00982410|19310170|P2|NOT COMPLETED|6-month Follow-up Assessment||11
7845422|NCT00982410|19310171|P1|NOT COMPLETED|6-month Follow-up Assessment||6
7845423|NCT00982410|19310170|P2|COMPLETED|6-month Follow-up Assessment||53
7845424|NCT00982410|19310171|P1|COMPLETED|6-month Follow-up Assessment||59
7845425|NCT00982410|19310170|P2|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
7845426|NCT00982410|19310171|P1|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
7845427|NCT00982410|19310170|P2|NOT COMPLETED|3-month Follow-up Assessment||13
7845428|NCT00982410|19310171|P1|NOT COMPLETED|3-month Follow-up Assessment||9
7845429|NCT00982410|19310170|P2|COMPLETED|3-month Follow-up Assessment||53
7845430|NCT00982410|19310171|P1|COMPLETED|3-month Follow-up Assessment||56
7845431|NCT00982410|19310170|P2|STARTED|3-month Follow-up Assessment||66
7845432|NCT00982410|19310171|P1|STARTED|3-month Follow-up Assessment||65
7845433|NCT00982397|19310195|P2|NOT COMPLETED|Phase II/Overall Study||0
7845434|NCT00982397|19310196|P1|NOT COMPLETED|Phase II/Overall Study||0
7845435|NCT00982397|19310195|P2|COMPLETED|Phase II/Overall Study||751
7845436|NCT00982397|19310196|P1|COMPLETED|Phase II/Overall Study||2019
7845437|NCT00982397|19310195|P2|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||131
7845438|NCT00982397|19310196|P1|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||221
7845439|NCT00982397|19310195|P2|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||122
7845440|NCT00982397|19310196|P1|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||231
7845441|NCT00982397|19310195|P2|STARTED|Phase II/Overall Study||751
7845442|NCT00982397|19310196|P1|STARTED|Phase II/Overall Study||2019
7845443|NCT00982397|19310195|P2|NOT COMPLETED|Phase I||0
7845444|NCT00982397|19310196|P1|NOT COMPLETED|Phase I||0
7845445|NCT00982397|19310195|P2|COMPLETED|Phase I||0
7845446|NCT00982397|19310196|P1|COMPLETED|Phase I||236
7845447|NCT00982397|19310195|P2|STARTED|Phase I||0
7845448|NCT00982397|19310196|P1|STARTED|Phase I||236
7845449|NCT00982345|19310206|P1|NOT COMPLETED|Overall Study||2
7845450|NCT00982345|19310206|P1|COMPLETED|Overall Study||18
7845451|NCT00982345|19310206|P1|STARTED|Overall Study||20
7845452|NCT00982319|19310212|P2|NOT COMPLETED|Overall Study||2
7845453|NCT00982319|19310213|P1|NOT COMPLETED|Overall Study||2
7845454|NCT00982319|19310212|P2|COMPLETED|Overall Study||15
7845455|NCT00982319|19310213|P1|COMPLETED|Overall Study||15
7845456|NCT00982319|19310212|P2|STARTED|Overall Study||17
7845457|NCT00982319|19310213|P1|STARTED|Overall Study||17
7845458|NCT00982280|19310221|P1|NOT COMPLETED|Maintenance Period||1
7845459|NCT00982280|19310221|P1|COMPLETED|Maintenance Period||54
7845460|NCT00982280|19310221|P1|STARTED|Maintenance Period||55
7845461|NCT00982280|19310221|P1|NOT COMPLETED|Titration and Optimal Dose Period||8
7845462|NCT00982280|19310221|P1|COMPLETED|Titration and Optimal Dose Period||55
7845463|NCT00982280|19310221|P1|STARTED|Titration and Optimal Dose Period||63
7845464|NCT00982280|19310221|P1|NOT COMPLETED|Observation Period||19
7845465|NCT00982280|19310221|P1|COMPLETED|Observation Period||63
7845466|NCT00982280|19310221|P1|STARTED|Observation Period||82
7845467|NCT00982228|19310246|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5
7845468|NCT00982228|19310247|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21
7845469|NCT00982228|19310246|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113
7845470|NCT00982228|19310247|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330
7845471|NCT00982228|19310246|P2|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118
7845472|NCT00982228|19310247|P1|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351
7845473|NCT00982228|19310246|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20
7845474|NCT00982228|19310247|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68
7845475|NCT00982228|19310246|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137
7845476|NCT00982228|19310247|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404
7845477|NCT00982228|19310246|P2|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154
7845478|NCT00982228|19310247|P1|Exposed|Main: Week 0 to 52 (NN1250-3583)||472
7845479|NCT00982228|19310246|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157
7845480|NCT00982228|19310247|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472
7845481|NCT00982228|19310246|P2|STARTED|Main: Week 0 to 52 (NN1250-3583)||157
7845482|NCT00982228|19310247|P1|STARTED|Main: Week 0 to 52 (NN1250-3583)||472
7845483|NCT00982189|19310275|P4|NOT COMPLETED|Overall Study||0
7845484|NCT00982189|19310276|P3|NOT COMPLETED|Overall Study||0
7845485|NCT00982189|19310277|P2|NOT COMPLETED|Overall Study||0
7845486|NCT00982189|19310278|P1|NOT COMPLETED|Overall Study||0
7845487|NCT00982189|19310275|P4|COMPLETED|Overall Study||9
7845488|NCT00982189|19310276|P3|COMPLETED|Overall Study||9
7845489|NCT00982189|19310277|P2|COMPLETED|Overall Study||9
7845490|NCT00982189|19310278|P1|COMPLETED|Overall Study||10
7845491|NCT00982189|19310275|P4|STARTED|Overall Study||9
7845492|NCT00982189|19310276|P3|STARTED|Overall Study||9
7845493|NCT00982189|19310277|P2|STARTED|Overall Study||9
7845494|NCT00982189|19310278|P1|STARTED|Overall Study||10
7845495|NCT00982137|19310306|P4|NOT COMPLETED|Overall Study||1
7845496|NCT00982137|19310307|P3|NOT COMPLETED|Overall Study||0
7845497|NCT00982137|19310308|P2|NOT COMPLETED|Overall Study||1
7845498|NCT00982137|19310309|P1|NOT COMPLETED|Overall Study||0
7845499|NCT00982137|19310306|P4|COMPLETED|Overall Study||17
7845500|NCT00982137|19310307|P3|COMPLETED|Overall Study||18
7845501|NCT00982137|19310308|P2|COMPLETED|Overall Study||35
7845502|NCT00982137|19310309|P1|COMPLETED|Overall Study||36
7845503|NCT00982137|19310306|P4|STARTED|Overall Study||18
7845504|NCT00982137|19310307|P3|STARTED|Overall Study||18
7845505|NCT00982137|19310308|P2|STARTED|Overall Study||36
7845506|NCT00982137|19310309|P1|STARTED|Overall Study||36
7845507|NCT00982111|19310341|P2|NOT COMPLETED|Overall Study||66
7845508|NCT00982111|19310342|P1|NOT COMPLETED|Overall Study||75
7845509|NCT00982111|19310341|P2|COMPLETED|Overall Study||252
7845510|NCT00982111|19310342|P1|COMPLETED|Overall Study||240
7845511|NCT00982111|19310341|P2|On Study at Conclusion, Off Treatment|Overall Study||6
7845512|NCT00982111|19310342|P1|On Study at Conclusion, Off Treatment|Overall Study||4
7845513|NCT00982111|19310341|P2|Death Due to Any Cause|Overall Study||246
7845514|NCT00982111|19310342|P1|Death Due to Any Cause|Overall Study||236
7845515|NCT00982111|19310341|P2|Received at Least 1 Dose of Study Drug|Overall Study||312
7845516|NCT00982111|19310342|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
7845517|NCT00982111|19310341|P2|STARTED|Overall Study||318
7845518|NCT00982111|19310342|P1|STARTED|Overall Study||315
7845519|NCT00982033|19310366|P2|NOT COMPLETED|Overall Study||0
7845520|NCT00982033|19310367|P1|NOT COMPLETED|Overall Study||0
7845521|NCT00982033|19310366|P2|COMPLETED|Overall Study||27
7845522|NCT00982033|19310367|P1|COMPLETED|Overall Study||25
7845523|NCT00982033|19310366|P2|STARTED|Overall Study||27
7845524|NCT00982033|19310367|P1|STARTED|Overall Study||25
7845525|NCT00982020|19310375|P2|NOT COMPLETED|Overall Study||64
7845526|NCT00982020|19310376|P1|NOT COMPLETED|Overall Study||57
7845527|NCT00982020|19310375|P2|COMPLETED|Overall Study||37
7845528|NCT00982020|19310376|P1|COMPLETED|Overall Study||45
7845529|NCT00982020|19310375|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
7845530|NCT00982020|19310376|P1|Received at Least 1 Dose of Study Drug|Overall Study||102
7845531|NCT00982020|19310375|P2|STARTED|Overall Study||101
7845532|NCT00982020|19310376|P1|STARTED|Overall Study||102
7845533|NCT00982007|19310400|P4|NOT COMPLETED|Overall Study||6
7845534|NCT00982007|19310401|P3|NOT COMPLETED|Overall Study||0
7845535|NCT00982007|19310402|P2|NOT COMPLETED|Overall Study||4
7845536|NCT00982007|19310403|P1|NOT COMPLETED|Overall Study||4
7845537|NCT00982007|19310400|P4|COMPLETED|Overall Study||245
7845538|NCT00982007|19310401|P3|COMPLETED|Overall Study||253
7845539|NCT00982007|19310402|P2|COMPLETED|Overall Study||253
7845540|NCT00982007|19310403|P1|COMPLETED|Overall Study||246
7845541|NCT00982007|19310400|P4|STARTED|Overall Study||251
7845542|NCT00982007|19310401|P3|STARTED|Overall Study||253
7845543|NCT00982007|19310402|P2|STARTED|Overall Study||257
7845544|NCT00982007|19310403|P1|STARTED|Overall Study||250
7845545|NCT00981825|19310415|P2|NOT COMPLETED|Second Intervention||0
7845546|NCT00981825|19310416|P1|NOT COMPLETED|Second Intervention||0
7845547|NCT00981825|19310415|P2|COMPLETED|Second Intervention||11
7845548|NCT00981825|19310416|P1|COMPLETED|Second Intervention||11
7845549|NCT00981825|19310415|P2|STARTED|Second Intervention||11
7845550|NCT00981825|19310416|P1|STARTED|Second Intervention||11
7845551|NCT00981825|19310415|P2|NOT COMPLETED|Washout After 1st Intervention||0
7845552|NCT00981825|19310416|P1|NOT COMPLETED|Washout After 1st Intervention||0
7845553|NCT00981825|19310415|P2|COMPLETED|Washout After 1st Intervention||11
7845554|NCT00981825|19310416|P1|COMPLETED|Washout After 1st Intervention||11
7845555|NCT00981825|19310415|P2|STARTED|Washout After 1st Intervention||11
7845556|NCT00981825|19310416|P1|STARTED|Washout After 1st Intervention||11
7845557|NCT00981825|19310415|P2|NOT COMPLETED|First Intervention||0
7845558|NCT00981825|19310416|P1|NOT COMPLETED|First Intervention||0
7845559|NCT00981825|19310415|P2|COMPLETED|First Intervention||11
7845560|NCT00981825|19310416|P1|COMPLETED|First Intervention||11
7845561|NCT00981825|19310415|P2|STARTED|First Intervention||11
7845562|NCT00981825|19310416|P1|STARTED|First Intervention||11
7845563|NCT00981812|19310422|P1|NOT COMPLETED|Overall Study||0
7845564|NCT00981812|19310422|P1|COMPLETED|Overall Study||20
7845565|NCT00981812|19310422|P1|STARTED|Overall Study||20
7845566|NCT00981799|19310430|P4|NOT COMPLETED|Overall Study||0
7845567|NCT00981799|19310431|P3|NOT COMPLETED|Overall Study||0
7845568|NCT00981799|19310432|P2|NOT COMPLETED|Overall Study||1
7845569|NCT00981799|19310433|P1|NOT COMPLETED|Overall Study||1
7845570|NCT00981799|19310430|P4|COMPLETED|Overall Study||0
7845571|NCT00981799|19310431|P3|COMPLETED|Overall Study||10
7845572|NCT00981799|19310432|P2|COMPLETED|Overall Study||6
7845573|NCT00981799|19310433|P1|COMPLETED|Overall Study||5
7845574|NCT00981799|19310430|P4|STARTED|Overall Study||0
7845575|NCT00981799|19310431|P3|STARTED|Overall Study||10
7845576|NCT00981799|19310432|P2|STARTED|Overall Study||7
7845577|NCT00981799|19310433|P1|STARTED|Overall Study||6
7845578|NCT00981747|19310447|P1|NOT COMPLETED|Sildenafil and Losartan||0
7845579|NCT00981747|19310447|P1|COMPLETED|Sildenafil and Losartan||9
7845580|NCT00981747|19310447|P1|Completed Sildenafil and Losartan|Sildenafil and Losartan||9
7845581|NCT00981747|19310447|P1|Started Sildenafil and Losartan|Sildenafil and Losartan||9
7845582|NCT00981747|19310447|P1|STARTED|Sildenafil and Losartan||9
7845583|NCT00981747|19310447|P1|NOT COMPLETED|Sildenafil||0
7845584|NCT00981747|19310447|P1|COMPLETED|Sildenafil||9
7845585|NCT00981747|19310447|P1|Completed Sildenafil|Sildenafil||9
7845586|NCT00981747|19310447|P1|Started Sildenafil|Sildenafil||9
7845587|NCT00981747|19310447|P1|STARTED|Sildenafil||9
7845588|NCT00981747|19310447|P1|NOT COMPLETED|Placebo Oral Tablet||1
7845589|NCT00981747|19310447|P1|COMPLETED|Placebo Oral Tablet||9
7845590|NCT00981747|19310447|P1|Completed Placebo Oral Tablet|Placebo Oral Tablet||9
7845591|NCT00981747|19310447|P1|Started Placebo Oral Tablet|Placebo Oral Tablet||10
7845592|NCT00981747|19310447|P1|STARTED|Placebo Oral Tablet||10
7845593|NCT00981747|19310447|P1|NOT COMPLETED|Losartan||2
7845594|NCT00981747|19310447|P1|COMPLETED|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
7845595|NCT00981747|19310447|P1|Completed Losartan|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
7845596|NCT00981747|19310447|P1|Started Losartan|Losartan||12
7845597|NCT00981747|19310447|P1|STARTED|Losartan||12
7845598|NCT00981669|19310467|P2|NOT COMPLETED|Overall Study||0
7845599|NCT00981669|19310468|P1|NOT COMPLETED|Overall Study||1
7845600|NCT00981669|19310467|P2|COMPLETED|Overall Study||40
7845601|NCT00981669|19310468|P1|COMPLETED|Overall Study||39
7845602|NCT00981669|19310467|P2|STARTED|Overall Study||40
7845603|NCT00981669|19310468|P1|STARTED|Overall Study||40
7845604|NCT00981630|19310480|P4|NOT COMPLETED|Overall Study||0
7845605|NCT00981630|19310481|P3|NOT COMPLETED|Overall Study||0
7845606|NCT00981630|19310482|P2|NOT COMPLETED|Overall Study||0
7845607|NCT00981630|19310483|P1|NOT COMPLETED|Overall Study||0
7845608|NCT00981630|19310480|P4|COMPLETED|Overall Study||32
7845609|NCT00981630|19310481|P3|COMPLETED|Overall Study||32
7845610|NCT00981630|19310482|P2|COMPLETED|Overall Study||32
7845611|NCT00981630|19310483|P1|COMPLETED|Overall Study||32
7845612|NCT00981630|19310480|P4|STARTED|Overall Study||32
7845613|NCT00981630|19310481|P3|STARTED|Overall Study||32
7845614|NCT00981630|19310482|P2|STARTED|Overall Study||32
7845615|NCT00981630|19310483|P1|STARTED|Overall Study||32
7845616|NCT00981578|19310513|P1|NOT COMPLETED|Overall Study||3
7845617|NCT00981578|19310513|P1|COMPLETED|Overall Study||14
7845618|NCT00981578|19310513|P1|STARTED|Overall Study||17
7845619|NCT00981526|19310521|P2|NOT COMPLETED|Overall Study||6
7845620|NCT00981526|19310522|P1|NOT COMPLETED|Overall Study||4
7845621|NCT00981526|19310521|P2|COMPLETED|Overall Study||22
7845622|NCT00981526|19310522|P1|COMPLETED|Overall Study||22
7845623|NCT00981526|19310521|P2|STARTED|Overall Study||28
7845624|NCT00981526|19310522|P1|STARTED|Overall Study||26
7845625|NCT00981461|19310540|P2|NOT COMPLETED|Overall Study||2
7845626|NCT00981461|19310541|P1|NOT COMPLETED|Overall Study||5
7845627|NCT00981461|19310540|P2|COMPLETED|Overall Study||22
7845628|NCT00981461|19310541|P1|COMPLETED|Overall Study||43
7845629|NCT00981461|19310540|P2|STARTED|Overall Study||24
7845630|NCT00981461|19310541|P1|STARTED|Overall Study||48
7845631|NCT00981435|19310550|P3|NOT COMPLETED|Overall Study||0
7845632|NCT00981435|19310551|P2|NOT COMPLETED|Overall Study||0
7845633|NCT00981435|19310552|P1|NOT COMPLETED|Overall Study||0
7845634|NCT00981435|19310550|P3|COMPLETED|Overall Study||37
7845635|NCT00981435|19310551|P2|COMPLETED|Overall Study||29
7845636|NCT00981435|19310552|P1|COMPLETED|Overall Study||31
7845637|NCT00981435|19310550|P3|STARTED|Overall Study||37
7845638|NCT00981435|19310551|P2|STARTED|Overall Study||29
7845639|NCT00981435|19310552|P1|STARTED|Overall Study||31
7845640|NCT00981409|19310565|P2|NOT COMPLETED|Overall Study||1
7845641|NCT00981409|19310566|P1|NOT COMPLETED|Overall Study||6
7845642|NCT00981409|19310565|P2|COMPLETED|Overall Study||10
7845643|NCT00981409|19310566|P1|COMPLETED|Overall Study||24
7845644|NCT00981409|19310565|P2|STARTED|Overall Study||11
7845645|NCT00981409|19310566|P1|STARTED|Overall Study||30
7845646|NCT00981370|19310580|P1|NOT COMPLETED|Overall Study||0
7845647|NCT00981370|19310580|P1|COMPLETED|Overall Study||0
7845648|NCT00981370|19310580|P1|STARTED|Overall Study||0
7845649|NCT00981305|19310586|P2|NOT COMPLETED|Overall Study||10
7845650|NCT00981305|19310587|P1|NOT COMPLETED|Overall Study||19
7845651|NCT00981305|19310586|P2|COMPLETED|Overall Study||57
7845652|NCT00981305|19310587|P1|COMPLETED|Overall Study||50
7845653|NCT00981305|19310586|P2|STARTED|Overall Study||67
7845654|NCT00981305|19310587|P1|STARTED|Overall Study||69
7845655|NCT00981292|19310605|P6|NOT COMPLETED|Day 3||1
7845656|NCT00981292|19310606|P5|NOT COMPLETED|Day 3||0
7845657|NCT00981292|19310607|P4|NOT COMPLETED|Day 3||0
7845658|NCT00981292|19310608|P3|NOT COMPLETED|Day 3||0
7845659|NCT00981292|19310609|P2|NOT COMPLETED|Day 3||0
7845660|NCT00981292|19310610|P1|NOT COMPLETED|Day 3||0
7845661|NCT00981292|19310605|P6|COMPLETED|Day 3||4
7845662|NCT00981292|19310606|P5|COMPLETED|Day 3||4
7845663|NCT00981292|19310607|P4|COMPLETED|Day 3||4
7845664|NCT00981292|19310608|P3|COMPLETED|Day 3||6
7845665|NCT00981292|19310609|P2|COMPLETED|Day 3||4
7845666|NCT00981292|19310610|P1|COMPLETED|Day 3||4
7845667|NCT00981292|19310605|P6|STARTED|Day 3||5
7845668|NCT00981292|19310606|P5|STARTED|Day 3||4
7845669|NCT00981292|19310607|P4|STARTED|Day 3||4
7845670|NCT00981292|19310608|P3|STARTED|Day 3||6
7845671|NCT00981292|19310609|P2|STARTED|Day 3||4
7845672|NCT00981292|19310610|P1|STARTED|Day 3||4
7845673|NCT00981292|19310605|P6|NOT COMPLETED|Day 2||0
7845674|NCT00981292|19310606|P5|NOT COMPLETED|Day 2||0
7845675|NCT00981292|19310607|P4|NOT COMPLETED|Day 2||0
7845676|NCT00981292|19310608|P3|NOT COMPLETED|Day 2||0
7845677|NCT00981292|19310609|P2|NOT COMPLETED|Day 2||0
7845678|NCT00981292|19310610|P1|NOT COMPLETED|Day 2||2
7845679|NCT00981292|19310605|P6|COMPLETED|Day 2||5
7845680|NCT00981292|19310606|P5|COMPLETED|Day 2||4
7845681|NCT00981292|19310607|P4|COMPLETED|Day 2||4
7845682|NCT00981292|19310608|P3|COMPLETED|Day 2||6
7845683|NCT00981292|19310609|P2|COMPLETED|Day 2||4
7845684|NCT00981292|19310610|P1|COMPLETED|Day 2||4
7845685|NCT00981292|19310605|P6|STARTED|Day 2||5
7845686|NCT00981292|19310606|P5|STARTED|Day 2||4
7845687|NCT00981292|19310607|P4|STARTED|Day 2||4
7845688|NCT00981292|19310608|P3|STARTED|Day 2||6
7845689|NCT00981292|19310609|P2|STARTED|Day 2||4
7845690|NCT00981292|19310610|P1|STARTED|Day 2||6
7845691|NCT00981292|19310605|P6|NOT COMPLETED|Day 1||2
7845692|NCT00981292|19310606|P5|NOT COMPLETED|Day 1||0
7845693|NCT00981292|19310607|P4|NOT COMPLETED|Day 1||0
7845694|NCT00981292|19310608|P3|NOT COMPLETED|Day 1||0
7845695|NCT00981292|19310609|P2|NOT COMPLETED|Day 1||0
7845696|NCT00981292|19310610|P1|NOT COMPLETED|Day 1||1
7845697|NCT00981292|19310605|P6|COMPLETED|Day 1||5
7845698|NCT00981292|19310606|P5|COMPLETED|Day 1||4
7845699|NCT00981292|19310607|P4|COMPLETED|Day 1||4
7845700|NCT00981292|19310608|P3|COMPLETED|Day 1||6
7845701|NCT00981292|19310609|P2|COMPLETED|Day 1||4
7845702|NCT00981292|19310610|P1|COMPLETED|Day 1||6
7845703|NCT00981292|19310605|P6|STARTED|Day 1||7
7845704|NCT00981292|19310606|P5|STARTED|Day 1||4
7845705|NCT00981292|19310607|P4|STARTED|Day 1||4
7845706|NCT00981292|19310608|P3|STARTED|Day 1||6
7845707|NCT00981292|19310609|P2|STARTED|Day 1||4
7845708|NCT00981292|19310610|P1|STARTED|Day 1||7
7845709|NCT00981253|19310629|P2|NOT COMPLETED|Overall Study||3
7845710|NCT00981253|19310630|P1|NOT COMPLETED|Overall Study||3
7845711|NCT00981253|19310629|P2|COMPLETED|Overall Study||72
7845712|NCT00981253|19310630|P1|COMPLETED|Overall Study||73
7845713|NCT00981253|19310629|P2|STARTED|Overall Study||75
7845714|NCT00981253|19310630|P1|STARTED|Overall Study||76
7845715|NCT00981227|19310654|P6|NOT COMPLETED|Overall Study||18
7845716|NCT00981227|19310655|P5|NOT COMPLETED|Overall Study||30
7845717|NCT00981227|19310656|P4|NOT COMPLETED|Overall Study||21
7845718|NCT00981227|19310657|P3|NOT COMPLETED|Overall Study||21
7845719|NCT00981227|19310658|P2|NOT COMPLETED|Overall Study||19
7845720|NCT00981227|19310659|P1|NOT COMPLETED|Overall Study||22
7845721|NCT00981227|19310654|P6|COMPLETED|Overall Study||75
7845722|NCT00981227|19310655|P5|COMPLETED|Overall Study||60
7845723|NCT00981227|19310656|P4|COMPLETED|Overall Study||73
7845724|NCT00981227|19310657|P3|COMPLETED|Overall Study||73
7845725|NCT00981227|19310658|P2|COMPLETED|Overall Study||75
7845726|NCT00981227|19310659|P1|COMPLETED|Overall Study||80
7845727|NCT00981227|19310654|P6|Per-Protocol|Overall Study||70
7845728|NCT00981227|19310655|P5|Per-Protocol|Overall Study||50
7845729|NCT00981227|19310656|P4|Per-Protocol|Overall Study||68
7845730|NCT00981227|19310657|P3|Per-Protocol|Overall Study||67
7845731|NCT00981227|19310658|P2|Per-Protocol|Overall Study||72
7845732|NCT00981227|19310659|P1|Per-Protocol|Overall Study||69
7845733|NCT00981227|19310654|P6|Safety Population|Overall Study||93
7845734|NCT00981227|19310655|P5|Safety Population|Overall Study||90
7845735|NCT00981227|19310656|P4|Safety Population|Overall Study||94
7845736|NCT00981227|19310657|P3|Safety Population|Overall Study||94
7845737|NCT00981227|19310658|P2|Safety Population|Overall Study||94
7845738|NCT00981227|19310659|P1|Safety Population|Overall Study||102
7845739|NCT00981227|19310654|P6|Randomized|Overall Study||93
7845740|NCT00981227|19310655|P5|Randomized|Overall Study||90
7845741|NCT00981227|19310656|P4|Randomized|Overall Study||94
7845742|NCT00981227|19310657|P3|Randomized|Overall Study||94
7845743|NCT00981227|19310658|P2|Randomized|Overall Study||94
7845744|NCT00981227|19310659|P1|Randomized|Overall Study||102
7845745|NCT00981227|19310654|P6|STARTED|Overall Study||93
7845746|NCT00981227|19310655|P5|STARTED|Overall Study||90
7845747|NCT00981227|19310656|P4|STARTED|Overall Study||94
7845748|NCT00981227|19310657|P3|STARTED|Overall Study||94
7845749|NCT00981227|19310658|P2|STARTED|Overall Study||94
7845750|NCT00981227|19310659|P1|STARTED|Overall Study||102
7845751|NCT00981214|19310677|P1|NOT COMPLETED|Overall Study||0
7845752|NCT00981214|19310677|P1|COMPLETED|Overall Study||19
7845753|NCT00981214|19310677|P1|STARTED|Overall Study||19
7845754|NCT00981175|19310694|P2|NOT COMPLETED|Booster Dose Vaccination||3
7845755|NCT00981175|19310695|P1|NOT COMPLETED|Booster Dose Vaccination||2
7845756|NCT00981175|19310694|P2|COMPLETED|Booster Dose Vaccination||40
7845757|NCT00981175|19310695|P1|COMPLETED|Booster Dose Vaccination||53
7845758|NCT00981175|19310694|P2|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43
7845759|NCT00981175|19310695|P1|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55
7845760|NCT00981175|19310694|P2|NOT COMPLETED|Primary Dose Vaccination||2
7845761|NCT00981175|19310695|P1|NOT COMPLETED|Primary Dose Vaccination||3
7845762|NCT00981175|19310694|P2|COMPLETED|Primary Dose Vaccination||99
7845763|NCT00981175|19310695|P1|COMPLETED|Primary Dose Vaccination||98
7845764|NCT00981175|19310694|P2|STARTED|Primary Dose Vaccination||101
7845765|NCT00981175|19310695|P1|STARTED|Primary Dose Vaccination||101
7845766|NCT00981149|19310720|P2|NOT COMPLETED|Overall Study||3
7845767|NCT00981149|19310721|P1|NOT COMPLETED|Overall Study||2
7845768|NCT00981149|19310720|P2|COMPLETED|Overall Study||9
7845769|NCT00981149|19310721|P1|COMPLETED|Overall Study||10
7845770|NCT00981149|19310720|P2|STARTED|Overall Study||12
7845771|NCT00981149|19310721|P1|STARTED|Overall Study||12
7845772|NCT00981084|19310731|P2|NOT COMPLETED|Post Intervention (Data Analysis)||1
7845773|NCT00981084|19310732|P1|NOT COMPLETED|Post Intervention (Data Analysis)||2
7845774|NCT00981084|19310731|P2|COMPLETED|Post Intervention (Data Analysis)||16
7845775|NCT00981084|19310732|P1|COMPLETED|Post Intervention (Data Analysis)||14
7845776|NCT00981084|19310731|P2|STARTED|Post Intervention (Data Analysis)||17
7845777|NCT00981084|19310732|P1|STARTED|Post Intervention (Data Analysis)||16
7845778|NCT00981084|19310731|P2|NOT COMPLETED|Second Intervention (One Day)||0
7845779|NCT00981084|19310732|P1|NOT COMPLETED|Second Intervention (One Day)||0
7845780|NCT00981084|19310731|P2|COMPLETED|Second Intervention (One Day)||17
7845781|NCT00981084|19310732|P1|COMPLETED|Second Intervention (One Day)||16
7845782|NCT00981084|19310731|P2|STARTED|Second Intervention (One Day)||17
7845783|NCT00981084|19310732|P1|STARTED|Second Intervention (One Day)||16
7845784|NCT00981084|19310731|P2|NOT COMPLETED|Washout Period (7 Days)||0
7845785|NCT00981084|19310732|P1|NOT COMPLETED|Washout Period (7 Days)||0
7845786|NCT00981084|19310731|P2|COMPLETED|Washout Period (7 Days)||17
7845787|NCT00981084|19310732|P1|COMPLETED|Washout Period (7 Days)||16
7845788|NCT00981084|19310731|P2|STARTED|Washout Period (7 Days)||17
7845789|NCT00981084|19310732|P1|STARTED|Washout Period (7 Days)||16
7845790|NCT00981084|19310731|P2|NOT COMPLETED|First Intervention (One Day)||0
7845791|NCT00981084|19310732|P1|NOT COMPLETED|First Intervention (One Day)||0
7845792|NCT00981084|19310731|P2|COMPLETED|First Intervention (One Day)||17
7845793|NCT00981084|19310732|P1|COMPLETED|First Intervention (One Day)||16
7845794|NCT00981084|19310731|P2|STARTED|First Intervention (One Day)||17
7845795|NCT00981084|19310732|P1|STARTED|First Intervention (One Day)||16
7845796|NCT00981058|19310748|P2|NOT COMPLETED|Overall Study||97
7845797|NCT00981058|19310749|P1|NOT COMPLETED|Overall Study||120
7845798|NCT00981058|19310748|P2|COMPLETED|Overall Study||451
7845799|NCT00981058|19310749|P1|COMPLETED|Overall Study||425
7845800|NCT00981058|19310748|P2|Death Due to Any Cause|Overall Study||442
7845801|NCT00981058|19310749|P1|Death Due to Any Cause|Overall Study||418
7845802|NCT00981058|19310748|P2|Received at Least 1 Dose of Study Drug|Overall Study||541
7845803|NCT00981058|19310749|P1|Received at Least 1 Dose of Study Drug|Overall Study||538
7845804|NCT00981058|19310748|P2|STARTED|Overall Study||548
7845805|NCT00981058|19310749|P1|STARTED|Overall Study||545
7845806|NCT00981045|19310771|P2|NOT COMPLETED|Overall Study||9
7845807|NCT00981045|19310772|P1|NOT COMPLETED|Overall Study||14
7845808|NCT00981045|19310771|P2|COMPLETED|Overall Study||1285
7845809|NCT00981045|19310772|P1|COMPLETED|Overall Study||1276
7845810|NCT00981045|19310771|P2|STARTED|Overall Study||1294
7845811|NCT00981045|19310772|P1|STARTED|Overall Study||1290
7845812|NCT00981019|19310780|P1|NOT COMPLETED|Overall Study||477
7845813|NCT00981019|19310780|P1|COMPLETED|Overall Study||301
7845814|NCT00981019|19310780|P1|STARTED|Overall Study||778
7845815|NCT00980980|19310787|P3|NOT COMPLETED|Overall Study||0
7845816|NCT00980980|19310788|P2|NOT COMPLETED|Overall Study||1
7845817|NCT00980980|19310789|P1|NOT COMPLETED|Overall Study||0
7845818|NCT00980980|19310787|P3|COMPLETED|Overall Study||13
7845819|NCT00980980|19310788|P2|COMPLETED|Overall Study||13
7845820|NCT00980980|19310789|P1|COMPLETED|Overall Study||16
7845821|NCT00980980|19310787|P3|STARTED|Overall Study||13
7845822|NCT00980980|19310788|P2|STARTED|Overall Study||14
7845823|NCT00980980|19310789|P1|STARTED|Overall Study||16
7845824|NCT00980798|19310820|P2|NOT COMPLETED|Overall Study||55
7845825|NCT00980798|19310821|P1|NOT COMPLETED|Overall Study||33
7845826|NCT00980798|19310820|P2|COMPLETED|Overall Study||84
7845827|NCT00980798|19310821|P1|COMPLETED|Overall Study||116
7845828|NCT00980798|19310820|P2|STARTED|Overall Study||139
7845829|NCT00980798|19310821|P1|STARTED|Overall Study||149
7845830|NCT00980785|19310831|P2|NOT COMPLETED|Overall Study||0
7845831|NCT00980785|19310832|P1|NOT COMPLETED|Overall Study||0
7845832|NCT00980785|19310831|P2|COMPLETED|Overall Study||8
7845833|NCT00980785|19310832|P1|COMPLETED|Overall Study||6
7845834|NCT00980785|19310831|P2|STARTED|Overall Study||8
7845835|NCT00980785|19310832|P1|STARTED|Overall Study||6
7845836|NCT00980746|19310850|P6|NOT COMPLETED|Overall Study||18
7845837|NCT00980746|19310851|P5|NOT COMPLETED|Overall Study||17
7845838|NCT00980746|19310852|P4|NOT COMPLETED|Overall Study||36
7845839|NCT00980746|19310853|P3|NOT COMPLETED|Overall Study||20
7845840|NCT00980746|19310854|P2|NOT COMPLETED|Overall Study||22
7845841|NCT00980746|19310855|P1|NOT COMPLETED|Overall Study||27
7845842|NCT00980746|19310850|P6|COMPLETED|Overall Study||78
7845843|NCT00980746|19310851|P5|COMPLETED|Overall Study||75
7845844|NCT00980746|19310852|P4|COMPLETED|Overall Study||64
7845845|NCT00980746|19310853|P3|COMPLETED|Overall Study||75
7845846|NCT00980746|19310854|P2|COMPLETED|Overall Study||67
7845847|NCT00980746|19310855|P1|COMPLETED|Overall Study||58
7845848|NCT00980746|19310850|P6|Per-protocol|Overall Study||74
7845849|NCT00980746|19310851|P5|Per-protocol|Overall Study||73
7845850|NCT00980746|19310852|P4|Per-protocol|Overall Study||62
7845851|NCT00980746|19310853|P3|Per-protocol|Overall Study||73
7845852|NCT00980746|19310854|P2|Per-protocol|Overall Study||66
7845853|NCT00980746|19310855|P1|Per-protocol|Overall Study||55
7845854|NCT00980746|19310850|P6|Safety Population|Overall Study||96
7845855|NCT00980746|19310851|P5|Safety Population|Overall Study||92
7845856|NCT00980746|19310852|P4|Safety Population|Overall Study||100
7845857|NCT00980746|19310853|P3|Safety Population|Overall Study||95
7845858|NCT00980746|19310854|P2|Safety Population|Overall Study||89
7845859|NCT00980746|19310855|P1|Safety Population|Overall Study||85
7845860|NCT00980746|19310850|P6|Randomized|Overall Study||96
7845861|NCT00980746|19310851|P5|Randomized|Overall Study||92
7845862|NCT00980746|19310852|P4|Randomized|Overall Study||100
7845863|NCT00980746|19310853|P3|Randomized|Overall Study||95
7845864|NCT00980746|19310854|P2|Randomized|Overall Study||89
7845865|NCT00980746|19310855|P1|Randomized|Overall Study||85
7845866|NCT00980746|19310850|P6|STARTED|Overall Study||96
7845867|NCT00980746|19310851|P5|STARTED|Overall Study||92
7845868|NCT00980746|19310852|P4|STARTED|Overall Study||100
7845869|NCT00980746|19310853|P3|STARTED|Overall Study||95
7845870|NCT00980746|19310854|P2|STARTED|Overall Study||89
7845871|NCT00980746|19310855|P1|STARTED|Overall Study||85
7845872|NCT00980681|19310869|P1|NOT COMPLETED|Dotarem MRA||0
7845873|NCT00980681|19310869|P1|COMPLETED|Dotarem MRA||10
7845874|NCT00980681|19310869|P1|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10
7845875|NCT00980681|19310869|P1|NOT COMPLETED|TOF MRA||0
7845876|NCT00980681|19310869|P1|COMPLETED|TOF MRA||10
7845877|NCT00980681|19310869|P1|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10
7845878|NCT00980655|19310877|P2|NOT COMPLETED|Overall Study||51
7845879|NCT00980655|19310878|P1|NOT COMPLETED|Overall Study||16
7845880|NCT00980655|19310877|P2|COMPLETED|Overall Study||139
7845881|NCT00980655|19310878|P1|COMPLETED|Overall Study||45
7845882|NCT00980655|19310877|P2|Vaccinated 23vPS Dose|Overall Study||140
7845883|NCT00980655|19310878|P1|Vaccinated 23vPS Dose|Overall Study||45
7845884|NCT00980655|19310877|P2|Vaccinated 13vPnC Dose 4|Overall Study||146
7845885|NCT00980655|19310878|P1|Vaccinated 13vPnC Dose 4|Overall Study||46
7845886|NCT00980655|19310877|P2|Vaccinated 13vPnC Dose 3|Overall Study||167
7845887|NCT00980655|19310878|P1|Vaccinated 13vPnC Dose 3|Overall Study||54
7845888|NCT00980655|19310877|P2|Vaccinated 13vPnC Dose 2|Overall Study||176
7845889|NCT00980655|19310878|P1|Vaccinated 13vPnC Dose 2|Overall Study||55
7845890|NCT00980655|19310877|P2|Vaccinated 13vPnC Dose 1|Overall Study||188
7845891|NCT00980655|19310878|P1|Vaccinated 13vPnC Dose 1|Overall Study||59
7845892|NCT00980655|19310877|P2|STARTED|Overall Study||190
7845893|NCT00980655|19310878|P1|STARTED|Overall Study||61
7845894|NCT00980642|19310926|P2|NOT COMPLETED|Overall Study||0
7845895|NCT00980642|19310927|P1|NOT COMPLETED|Overall Study||0
7845896|NCT00980642|19310926|P2|COMPLETED|Overall Study||20
7845897|NCT00980642|19310927|P1|COMPLETED|Overall Study||36
7845898|NCT00980642|19310926|P2|STARTED|Overall Study||20
7845899|NCT00980642|19310927|P1|STARTED|Overall Study||36
7845900|NCT00980590|19310939|P2|NOT COMPLETED|Overall Study||0
7845901|NCT00980590|19310940|P1|NOT COMPLETED|Overall Study||0
7845902|NCT00980590|19310939|P2|COMPLETED|Overall Study||50
7845903|NCT00980590|19310940|P1|COMPLETED|Overall Study||50
7845904|NCT00980590|19310939|P2|STARTED|Overall Study||50
7845905|NCT00980590|19310940|P1|STARTED|Overall Study||50
7845906|NCT00980395|19310952|P1|NOT COMPLETED|Overall Study||0
7845907|NCT00980395|19310952|P1|COMPLETED|Overall Study||24
7845908|NCT00980395|19310952|P1|STARTED|Overall Study||24
7845909|NCT00980343|19310961|P2|NOT COMPLETED|Overall Study||3
7845910|NCT00980343|19310962|P1|NOT COMPLETED|Overall Study||1
7845911|NCT00980343|19310961|P2|COMPLETED|Overall Study||20
7845912|NCT00980343|19310962|P1|COMPLETED|Overall Study||20
7845913|NCT00980343|19310961|P2|STARTED|Overall Study||23
7845914|NCT00980343|19310962|P1|STARTED|Overall Study||21
7845915|NCT00980330|19310986|P7|NOT COMPLETED|Overall Study||7
7845916|NCT00980330|19310987|P6|NOT COMPLETED|Overall Study||4
7845917|NCT00980330|19310988|P5|NOT COMPLETED|Overall Study||5
7845918|NCT00980330|19310989|P4|NOT COMPLETED|Overall Study||5
7845919|NCT00980330|19310990|P3|NOT COMPLETED|Overall Study||8
7845920|NCT00980330|19310991|P2|NOT COMPLETED|Overall Study||5
7845921|NCT00980330|19310992|P1|NOT COMPLETED|Overall Study||5
7845922|NCT00980330|19310986|P7|COMPLETED|Overall Study||59
7845923|NCT00980330|19310987|P6|COMPLETED|Overall Study||61
7845924|NCT00980330|19310988|P5|COMPLETED|Overall Study||63
7845925|NCT00980330|19310989|P4|COMPLETED|Overall Study||61
7845926|NCT00980330|19310990|P3|COMPLETED|Overall Study||58
7845927|NCT00980330|19310991|P2|COMPLETED|Overall Study||60
7845928|NCT00980330|19310992|P1|COMPLETED|Overall Study||61
7845929|NCT00980330|19310986|P7|STARTED|Overall Study||66
7845930|NCT00980330|19310987|P6|STARTED|Overall Study||65
7845931|NCT00980330|19310988|P5|STARTED|Overall Study||68
7845932|NCT00980330|19310989|P4|STARTED|Overall Study||66
7845933|NCT00980330|19310990|P3|STARTED|Overall Study||66
7845934|NCT00980330|19310991|P2|STARTED|Overall Study||65
7845935|NCT00980330|19310992|P1|STARTED|Overall Study||66
7845936|NCT00980278|19311092|P2|NOT COMPLETED|Overall Study||0
7845937|NCT00980278|19311093|P1|NOT COMPLETED|Overall Study||2
7845938|NCT00980278|19311092|P2|COMPLETED|Overall Study||13
7845939|NCT00980278|19311093|P1|COMPLETED|Overall Study||11
7845940|NCT00980278|19311092|P2|STARTED|Overall Study||13
7845941|NCT00980278|19311093|P1|STARTED|Overall Study||13
7845942|NCT00980200|19311107|P5|NOT COMPLETED|7-day Treatment Period 5||0
7845943|NCT00980200|19311108|P4|NOT COMPLETED|7-day Treatment Period 5||0
7845944|NCT00980200|19311109|P3|NOT COMPLETED|7-day Treatment Period 5||0
7845945|NCT00980200|19311110|P2|NOT COMPLETED|7-day Treatment Period 5||0
7845946|NCT00980200|19311111|P1|NOT COMPLETED|7-day Treatment Period 5||0
7845947|NCT00980200|19311107|P5|COMPLETED|7-day Treatment Period 5||14
7845948|NCT00980200|19311108|P4|COMPLETED|7-day Treatment Period 5||16
7845949|NCT00980200|19311109|P3|COMPLETED|7-day Treatment Period 5||15
7845950|NCT00980200|19311110|P2|COMPLETED|7-day Treatment Period 5||12
7845951|NCT00980200|19311111|P1|COMPLETED|7-day Treatment Period 5||15
7845952|NCT00980200|19311107|P5|STARTED|7-day Treatment Period 5||14
7845953|NCT00980200|19311108|P4|STARTED|7-day Treatment Period 5||16
7845954|NCT00980200|19311109|P3|STARTED|7-day Treatment Period 5||15
7845955|NCT00980200|19311110|P2|STARTED|7-day Treatment Period 5||12
7845956|NCT00980200|19311111|P1|STARTED|7-day Treatment Period 5||15
7845957|NCT00980200|19311107|P5|NOT COMPLETED|7-day Washout Period 4||0
7845958|NCT00980200|19311108|P4|NOT COMPLETED|7-day Washout Period 4||0
7845959|NCT00980200|19311109|P3|NOT COMPLETED|7-day Washout Period 4||0
7845960|NCT00980200|19311110|P2|NOT COMPLETED|7-day Washout Period 4||0
7845961|NCT00980200|19311111|P1|NOT COMPLETED|7-day Washout Period 4||0
7845962|NCT00980200|19311107|P5|COMPLETED|7-day Washout Period 4||14
7845963|NCT00980200|19311108|P4|COMPLETED|7-day Washout Period 4||16
7845964|NCT00980200|19311109|P3|COMPLETED|7-day Washout Period 4||15
7845965|NCT00980200|19311110|P2|COMPLETED|7-day Washout Period 4||12
7845966|NCT00980200|19311111|P1|COMPLETED|7-day Washout Period 4||15
7845967|NCT00980200|19311107|P5|STARTED|7-day Washout Period 4||14
7845968|NCT00980200|19311108|P4|STARTED|7-day Washout Period 4||16
7845969|NCT00980200|19311109|P3|STARTED|7-day Washout Period 4||15
7845970|NCT00980200|19311110|P2|STARTED|7-day Washout Period 4||12
7845971|NCT00980200|19311111|P1|STARTED|7-day Washout Period 4||15
7845972|NCT00980200|19311107|P5|NOT COMPLETED|7-day Treatment Period 4||0
7845973|NCT00980200|19311108|P4|NOT COMPLETED|7-day Treatment Period 4||0
7845974|NCT00980200|19311109|P3|NOT COMPLETED|7-day Treatment Period 4||0
7845975|NCT00980200|19311110|P2|NOT COMPLETED|7-day Treatment Period 4||0
7845976|NCT00980200|19311111|P1|NOT COMPLETED|7-day Treatment Period 4||0
7845977|NCT00980200|19311107|P5|COMPLETED|7-day Treatment Period 4||14
7845978|NCT00980200|19311108|P4|COMPLETED|7-day Treatment Period 4||16
7845979|NCT00980200|19311109|P3|COMPLETED|7-day Treatment Period 4||15
7845980|NCT00980200|19311110|P2|COMPLETED|7-day Treatment Period 4||12
7845981|NCT00980200|19311111|P1|COMPLETED|7-day Treatment Period 4||15
7845982|NCT00980200|19311107|P5|STARTED|7-day Treatment Period 4||14
7845983|NCT00980200|19311108|P4|STARTED|7-day Treatment Period 4||16
7845984|NCT00980200|19311109|P3|STARTED|7-day Treatment Period 4||15
7845985|NCT00980200|19311110|P2|STARTED|7-day Treatment Period 4||12
7845986|NCT00980200|19311111|P1|STARTED|7-day Treatment Period 4||15
7845987|NCT00980200|19311107|P5|NOT COMPLETED|7-day Washout Period 3||0
7845988|NCT00980200|19311108|P4|NOT COMPLETED|7-day Washout Period 3||0
7845989|NCT00980200|19311109|P3|NOT COMPLETED|7-day Washout Period 3||0
7845990|NCT00980200|19311110|P2|NOT COMPLETED|7-day Washout Period 3||0
7845991|NCT00980200|19311111|P1|NOT COMPLETED|7-day Washout Period 3||0
7845992|NCT00980200|19311107|P5|COMPLETED|7-day Washout Period 3||14
7845993|NCT00980200|19311108|P4|COMPLETED|7-day Washout Period 3||16
7845994|NCT00980200|19311109|P3|COMPLETED|7-day Washout Period 3||15
7845995|NCT00980200|19311110|P2|COMPLETED|7-day Washout Period 3||12
7845996|NCT00980200|19311111|P1|COMPLETED|7-day Washout Period 3||15
7845997|NCT00980200|19311107|P5|STARTED|7-day Washout Period 3||14
7845998|NCT00980200|19311108|P4|STARTED|7-day Washout Period 3||16
7845999|NCT00980200|19311109|P3|STARTED|7-day Washout Period 3||15
7846000|NCT00980200|19311110|P2|STARTED|7-day Washout Period 3||12
7846001|NCT00980200|19311111|P1|STARTED|7-day Washout Period 3||15
7846002|NCT00980200|19311107|P5|NOT COMPLETED|7-day Treatment Period 3||1
7846003|NCT00980200|19311108|P4|NOT COMPLETED|7-day Treatment Period 3||0
7846004|NCT00980200|19311109|P3|NOT COMPLETED|7-day Treatment Period 3||0
7846005|NCT00980200|19311110|P2|NOT COMPLETED|7-day Treatment Period 3||1
7846006|NCT00980200|19311111|P1|NOT COMPLETED|7-day Treatment Period 3||0
7846007|NCT00980200|19311107|P5|COMPLETED|7-day Treatment Period 3||14
7846008|NCT00980200|19311108|P4|COMPLETED|7-day Treatment Period 3||16
7846009|NCT00980200|19311109|P3|COMPLETED|7-day Treatment Period 3||15
7846010|NCT00980200|19311110|P2|COMPLETED|7-day Treatment Period 3||12
7846011|NCT00980200|19311111|P1|COMPLETED|7-day Treatment Period 3||15
7846012|NCT00980200|19311107|P5|STARTED|7-day Treatment Period 3||15
7846013|NCT00980200|19311108|P4|STARTED|7-day Treatment Period 3||16
7846014|NCT00980200|19311109|P3|STARTED|7-day Treatment Period 3||15
7846015|NCT00980200|19311110|P2|STARTED|7-day Treatment Period 3||13
7846016|NCT00980200|19311111|P1|STARTED|7-day Treatment Period 3||15
7846017|NCT00980200|19311107|P5|NOT COMPLETED|7-day Washout Period 2||0
7846018|NCT00980200|19311108|P4|NOT COMPLETED|7-day Washout Period 2||0
7846019|NCT00980200|19311109|P3|NOT COMPLETED|7-day Washout Period 2||0
7846020|NCT00980200|19311110|P2|NOT COMPLETED|7-day Washout Period 2||0
7846021|NCT00980200|19311111|P1|NOT COMPLETED|7-day Washout Period 2||0
7846022|NCT00980200|19311107|P5|COMPLETED|7-day Washout Period 2||15
7846023|NCT00980200|19311108|P4|COMPLETED|7-day Washout Period 2||16
7846024|NCT00980200|19311109|P3|COMPLETED|7-day Washout Period 2||15
7846025|NCT00980200|19311110|P2|COMPLETED|7-day Washout Period 2||13
7846026|NCT00980200|19311111|P1|COMPLETED|7-day Washout Period 2||15
7846027|NCT00980200|19311107|P5|STARTED|7-day Washout Period 2||15
7846028|NCT00980200|19311108|P4|STARTED|7-day Washout Period 2||16
7846029|NCT00980200|19311109|P3|STARTED|7-day Washout Period 2||15
7846030|NCT00980200|19311110|P2|STARTED|7-day Washout Period 2||13
7846031|NCT00980200|19311111|P1|STARTED|7-day Washout Period 2||15
7846032|NCT00980200|19311107|P5|NOT COMPLETED|7-day Treatment Period 2||0
7846033|NCT00980200|19311108|P4|NOT COMPLETED|7-day Treatment Period 2||0
7846034|NCT00980200|19311109|P3|NOT COMPLETED|7-day Treatment Period 2||0
7846035|NCT00980200|19311110|P2|NOT COMPLETED|7-day Treatment Period 2||0
7846036|NCT00980200|19311111|P1|NOT COMPLETED|7-day Treatment Period 2||0
7846037|NCT00980200|19311107|P5|COMPLETED|7-day Treatment Period 2||15
7846038|NCT00980200|19311108|P4|COMPLETED|7-day Treatment Period 2||16
7846039|NCT00980200|19311109|P3|COMPLETED|7-day Treatment Period 2||15
7846040|NCT00980200|19311110|P2|COMPLETED|7-day Treatment Period 2||13
7846041|NCT00980200|19311111|P1|COMPLETED|7-day Treatment Period 2||15
7846042|NCT00980200|19311107|P5|STARTED|7-day Treatment Period 2||15
7846043|NCT00980200|19311108|P4|STARTED|7-day Treatment Period 2||16
7846044|NCT00980200|19311109|P3|STARTED|7-day Treatment Period 2||15
7846045|NCT00980200|19311110|P2|STARTED|7-day Treatment Period 2||13
7846046|NCT00980200|19311111|P1|STARTED|7-day Treatment Period 2||15
7846047|NCT00980200|19311107|P5|NOT COMPLETED|7-day Washout Period 1||0
7846048|NCT00980200|19311108|P4|NOT COMPLETED|7-day Washout Period 1||0
7846049|NCT00980200|19311109|P3|NOT COMPLETED|7-day Washout Period 1||0
7846050|NCT00980200|19311110|P2|NOT COMPLETED|7-day Washout Period 1||0
7846051|NCT00980200|19311111|P1|NOT COMPLETED|7-day Washout Period 1||0
7846052|NCT00980200|19311107|P5|COMPLETED|7-day Washout Period 1||15
7846053|NCT00980200|19311108|P4|COMPLETED|7-day Washout Period 1||16
7846054|NCT00980200|19311109|P3|COMPLETED|7-day Washout Period 1||15
7846055|NCT00980200|19311110|P2|COMPLETED|7-day Washout Period 1||13
7846056|NCT00980200|19311111|P1|COMPLETED|7-day Washout Period 1||15
7846057|NCT00980200|19311107|P5|STARTED|7-day Washout Period 1||15
7846058|NCT00980200|19311108|P4|STARTED|7-day Washout Period 1||16
7846059|NCT00980200|19311109|P3|STARTED|7-day Washout Period 1||15
7846060|NCT00980200|19311110|P2|STARTED|7-day Washout Period 1||13
7846061|NCT00980200|19311111|P1|STARTED|7-day Washout Period 1||15
7846062|NCT00980200|19311107|P5|NOT COMPLETED|7-day Treatment Period 1||0
7846063|NCT00980200|19311108|P4|NOT COMPLETED|7-day Treatment Period 1||0
7846064|NCT00980200|19311109|P3|NOT COMPLETED|7-day Treatment Period 1||0
7846065|NCT00980200|19311110|P2|NOT COMPLETED|7-day Treatment Period 1||1
7846066|NCT00980200|19311111|P1|NOT COMPLETED|7-day Treatment Period 1||0
7846067|NCT00980200|19311107|P5|COMPLETED|7-day Treatment Period 1||15
7846068|NCT00980200|19311108|P4|COMPLETED|7-day Treatment Period 1||16
7846069|NCT00980200|19311109|P3|COMPLETED|7-day Treatment Period 1||15
7846070|NCT00980200|19311110|P2|COMPLETED|7-day Treatment Period 1||13
7846071|NCT00980200|19311111|P1|COMPLETED|7-day Treatment Period 1||15
7846072|NCT00980200|19311107|P5|STARTED|7-day Treatment Period 1||15
7846073|NCT00980200|19311108|P4|STARTED|7-day Treatment Period 1||16
7846074|NCT00980200|19311109|P3|STARTED|7-day Treatment Period 1||15
7846075|NCT00980200|19311110|P2|STARTED|7-day Treatment Period 1||14
7846076|NCT00980200|19311111|P1|STARTED|7-day Treatment Period 1||15
7846077|NCT00980174|19311130|P2|NOT COMPLETED|Overall Study||10
7846078|NCT00980174|19311131|P1|NOT COMPLETED|Overall Study||4
7846079|NCT00980174|19311130|P2|COMPLETED|Overall Study||111
7846080|NCT00980174|19311131|P1|COMPLETED|Overall Study||117
7846081|NCT00980174|19311130|P2|STARTED|Overall Study||121
7846082|NCT00980174|19311131|P1|STARTED|Overall Study||121
7846083|NCT00980148|19311149|P2|NOT COMPLETED|Overall Study||128
7846084|NCT00980148|19311150|P1|NOT COMPLETED|Overall Study||129
7846085|NCT00980148|19311149|P2|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
7846086|NCT00980148|19311150|P1|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
7846087|NCT00980148|19311149|P2|STARTED|Overall Study||283
7846088|NCT00980148|19311150|P1|STARTED|Overall Study||284
7846089|NCT00980057|19311158|P2|NOT COMPLETED|Overall Study||5
7846090|NCT00980057|19311159|P1|NOT COMPLETED|Overall Study||19
7846091|NCT00980057|19311158|P2|COMPLETED|Overall Study||155
7846092|NCT00980057|19311159|P1|COMPLETED|Overall Study||299
7846093|NCT00980057|19311158|P2|STARTED|Overall Study||160
7846094|NCT00980057|19311159|P1|STARTED|Overall Study||318
7846095|NCT00980044|19311182|P3|NOT COMPLETED|Overall Study||5
7846096|NCT00980044|19311183|P2|NOT COMPLETED|Overall Study||7
7846097|NCT00980044|19311184|P1|NOT COMPLETED|Overall Study||5
7846098|NCT00980044|19311182|P3|COMPLETED|Overall Study||12
7846099|NCT00980044|19311183|P2|COMPLETED|Overall Study||12
7846100|NCT00980044|19311184|P1|COMPLETED|Overall Study||12
7846101|NCT00980044|19311182|P3|STARTED|Overall Study||17
7846102|NCT00980044|19311183|P2|STARTED|Overall Study||19
7846103|NCT00980044|19311184|P1|STARTED|Overall Study||17
7846104|NCT00980005|19311203|P2|NOT COMPLETED|Overall Study||63
7846105|NCT00980005|19311204|P1|NOT COMPLETED|Overall Study||47
7846106|NCT00980005|19311203|P2|COMPLETED|Overall Study||998
7846107|NCT00980005|19311204|P1|COMPLETED|Overall Study||1008
7846108|NCT00980005|19311203|P2|STARTED|Overall Study||1061
7846109|NCT00980005|19311204|P1|STARTED|Overall Study||1055
7846110|NCT00979992|19311244|P1|NOT COMPLETED|Overall Study||5
7846111|NCT00979992|19311244|P1|COMPLETED|Overall Study||30
7846112|NCT00979992|19311244|P1|STARTED|Overall Study||35
7846113|NCT00979953|19311256|P4|NOT COMPLETED|Overall Study||7
7846114|NCT00979953|19311257|P3|NOT COMPLETED|Overall Study||22
7846115|NCT00979953|19311258|P2|NOT COMPLETED|Overall Study||5
7846116|NCT00979953|19311259|P1|NOT COMPLETED|Overall Study||8
7846117|NCT00979953|19311256|P4|COMPLETED|Overall Study||97
7846118|NCT00979953|19311257|P3|COMPLETED|Overall Study||82
7846119|NCT00979953|19311258|P2|COMPLETED|Overall Study||94
7846120|NCT00979953|19311259|P1|COMPLETED|Overall Study||93
7846121|NCT00979953|19311256|P4|Received at Least 1 Dose of Study Drug|Overall Study||104
7846122|NCT00979953|19311257|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
7846123|NCT00979953|19311258|P2|Received at Least 1 Dose of Study Drug|Overall Study||99
7846124|NCT00979953|19311259|P1|Received at Least 1 Dose of Study Drug|Overall Study||101
7846125|NCT00979953|19311256|P4|STARTED|Overall Study||104
7846126|NCT00979953|19311257|P3|STARTED|Overall Study||104
7846127|NCT00979953|19311258|P2|STARTED|Overall Study||99
7846128|NCT00979953|19311259|P1|STARTED|Overall Study||101
7846129|NCT00979940|19311271|P2|NOT COMPLETED|Overall Study||0
7846130|NCT00979940|19311272|P1|NOT COMPLETED|Overall Study||0
7846131|NCT00979940|19311271|P2|COMPLETED|Overall Study||28
7846132|NCT00979940|19311272|P1|COMPLETED|Overall Study||32
7846133|NCT00979940|19311271|P2|STARTED|Overall Study||28
7846134|NCT00979940|19311272|P1|STARTED|Overall Study||32
7846135|NCT00979901|19311282|P4|NOT COMPLETED|Overall Study||116
7846136|NCT00979901|19311283|P3|NOT COMPLETED|Overall Study||29
7846137|NCT00979901|19311284|P2|NOT COMPLETED|Overall Study||12
7846138|NCT00979901|19311285|P1|NOT COMPLETED|Overall Study||18
7846139|NCT00979901|19311282|P4|COMPLETED|Overall Study||159
7846140|NCT00979901|19311283|P3|COMPLETED|Overall Study||573
7846141|NCT00979901|19311284|P2|COMPLETED|Overall Study||336
7846142|NCT00979901|19311285|P1|COMPLETED|Overall Study||334
7846143|NCT00979901|19311282|P4|STARTED|Overall Study||275
7846144|NCT00979901|19311283|P3|STARTED|Overall Study||602
7846145|NCT00979901|19311284|P2|STARTED|Overall Study||348
7846146|NCT00979901|19311285|P1|STARTED|Overall Study||352
7846147|NCT00979875|19311309|P6|NOT COMPLETED|Intervention 3||0
7846148|NCT00979875|19311310|P5|NOT COMPLETED|Intervention 3||0
7846149|NCT00979875|19311311|P4|NOT COMPLETED|Intervention 3||0
7846150|NCT00979875|19311312|P3|NOT COMPLETED|Intervention 3||0
7846151|NCT00979875|19311313|P2|NOT COMPLETED|Intervention 3||0
7846152|NCT00979875|19311314|P1|NOT COMPLETED|Intervention 3||0
7846153|NCT00979875|19311309|P6|COMPLETED|Intervention 3||2
7846154|NCT00979875|19311310|P5|COMPLETED|Intervention 3||3
7846155|NCT00979875|19311311|P4|COMPLETED|Intervention 3||2
7846156|NCT00979875|19311312|P3|COMPLETED|Intervention 3||3
7846157|NCT00979875|19311313|P2|COMPLETED|Intervention 3||2
7846158|NCT00979875|19311314|P1|COMPLETED|Intervention 3||2
7846159|NCT00979875|19311309|P6|STARTED|Intervention 3||2
7846160|NCT00979875|19311310|P5|STARTED|Intervention 3||3
7846161|NCT00979875|19311311|P4|STARTED|Intervention 3||2
7846162|NCT00979875|19311312|P3|STARTED|Intervention 3||3
7846163|NCT00979875|19311313|P2|STARTED|Intervention 3||2
7846164|NCT00979875|19311314|P1|STARTED|Intervention 3||2
7846165|NCT00979875|19311309|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
7846166|NCT00979875|19311310|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
7846167|NCT00979875|19311311|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
7846168|NCT00979875|19311312|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
7846169|NCT00979875|19311313|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
7846170|NCT00979875|19311314|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
7846171|NCT00979875|19311309|P6|COMPLETED|Washout 2 (3 to 14 Days)||2
7846172|NCT00979875|19311310|P5|COMPLETED|Washout 2 (3 to 14 Days)||3
7846173|NCT00979875|19311311|P4|COMPLETED|Washout 2 (3 to 14 Days)||2
7846174|NCT00979875|19311312|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
7846175|NCT00979875|19311313|P2|COMPLETED|Washout 2 (3 to 14 Days)||2
7846176|NCT00979875|19311314|P1|COMPLETED|Washout 2 (3 to 14 Days)||2
7846177|NCT00979875|19311309|P6|STARTED|Washout 2 (3 to 14 Days)||2
7846178|NCT00979875|19311310|P5|STARTED|Washout 2 (3 to 14 Days)||3
7846179|NCT00979875|19311311|P4|STARTED|Washout 2 (3 to 14 Days)||2
7846180|NCT00979875|19311312|P3|STARTED|Washout 2 (3 to 14 Days)||3
7846181|NCT00979875|19311313|P2|STARTED|Washout 2 (3 to 14 Days)||2
7846182|NCT00979875|19311314|P1|STARTED|Washout 2 (3 to 14 Days)||2
7846183|NCT00979875|19311309|P6|NOT COMPLETED|Intervention 2||0
7846184|NCT00979875|19311310|P5|NOT COMPLETED|Intervention 2||0
7846185|NCT00979875|19311311|P4|NOT COMPLETED|Intervention 2||0
7846186|NCT00979875|19311312|P3|NOT COMPLETED|Intervention 2||0
7846187|NCT00979875|19311313|P2|NOT COMPLETED|Intervention 2||0
7846188|NCT00979875|19311314|P1|NOT COMPLETED|Intervention 2||0
7846189|NCT00979875|19311309|P6|COMPLETED|Intervention 2||2
7846190|NCT00979875|19311310|P5|COMPLETED|Intervention 2||3
7846191|NCT00979875|19311311|P4|COMPLETED|Intervention 2||2
7846192|NCT00979875|19311312|P3|COMPLETED|Intervention 2||3
7846193|NCT00979875|19311313|P2|COMPLETED|Intervention 2||2
7846194|NCT00979875|19311314|P1|COMPLETED|Intervention 2||2
7846195|NCT00979875|19311309|P6|STARTED|Intervention 2||2
7846196|NCT00979875|19311310|P5|STARTED|Intervention 2||3
7846197|NCT00979875|19311311|P4|STARTED|Intervention 2||2
7846198|NCT00979875|19311312|P3|STARTED|Intervention 2||3
7846199|NCT00979875|19311313|P2|STARTED|Intervention 2||2
7846200|NCT00979875|19311314|P1|STARTED|Intervention 2||2
7846201|NCT00979875|19311309|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
7846202|NCT00979875|19311310|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
7846203|NCT00979875|19311311|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
7846204|NCT00979875|19311312|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
7846205|NCT00979875|19311313|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
7846206|NCT00979875|19311314|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
7846207|NCT00979875|19311309|P6|COMPLETED|Washout 1 (3 to 14 Days)||2
7846208|NCT00979875|19311310|P5|COMPLETED|Washout 1 (3 to 14 Days)||3
7846209|NCT00979875|19311311|P4|COMPLETED|Washout 1 (3 to 14 Days)||2
7846210|NCT00979875|19311312|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
7846211|NCT00979875|19311313|P2|COMPLETED|Washout 1 (3 to 14 Days)||2
7846212|NCT00979875|19311314|P1|COMPLETED|Washout 1 (3 to 14 Days)||2
7846213|NCT00979875|19311309|P6|STARTED|Washout 1 (3 to 14 Days)||2
7846214|NCT00979875|19311310|P5|STARTED|Washout 1 (3 to 14 Days)||3
7846215|NCT00979875|19311311|P4|STARTED|Washout 1 (3 to 14 Days)||2
7846216|NCT00979875|19311312|P3|STARTED|Washout 1 (3 to 14 Days)||3
7846217|NCT00979875|19311313|P2|STARTED|Washout 1 (3 to 14 Days)||2
7846218|NCT00979875|19311314|P1|STARTED|Washout 1 (3 to 14 Days)||2
7846219|NCT00979875|19311309|P6|NOT COMPLETED|Intervention 1||0
7846220|NCT00979875|19311310|P5|NOT COMPLETED|Intervention 1||0
7846221|NCT00979875|19311311|P4|NOT COMPLETED|Intervention 1||0
7846222|NCT00979875|19311312|P3|NOT COMPLETED|Intervention 1||0
7846223|NCT00979875|19311313|P2|NOT COMPLETED|Intervention 1||0
7846224|NCT00979875|19311314|P1|NOT COMPLETED|Intervention 1||0
7846225|NCT00979875|19311309|P6|COMPLETED|Intervention 1||2
7846226|NCT00979875|19311310|P5|COMPLETED|Intervention 1||3
7846227|NCT00979875|19311311|P4|COMPLETED|Intervention 1||2
7846228|NCT00979875|19311312|P3|COMPLETED|Intervention 1||3
7846229|NCT00979875|19311313|P2|COMPLETED|Intervention 1||2
7846230|NCT00979875|19311314|P1|COMPLETED|Intervention 1||2
7846231|NCT00979875|19311309|P6|Received at Least 1 Dose of Study Drug|Intervention 1||2
7846232|NCT00979875|19311310|P5|Received at Least 1 Dose of Study Drug|Intervention 1||3
7846233|NCT00979875|19311311|P4|Received at Least 1 Dose of Study Drug|Intervention 1||2
7846234|NCT00979875|19311312|P3|Received at Least 1 Dose of Study Drug|Intervention 1||3
7846235|NCT00979875|19311313|P2|Received at Least 1 Dose of Study Drug|Intervention 1||2
7846236|NCT00979875|19311314|P1|Received at Least 1 Dose of Study Drug|Intervention 1||2
7846237|NCT00979875|19311309|P6|STARTED|Intervention 1||2
7846238|NCT00979875|19311310|P5|STARTED|Intervention 1||3
7846239|NCT00979875|19311311|P4|STARTED|Intervention 1||2
7846240|NCT00979875|19311312|P3|STARTED|Intervention 1||3
7846241|NCT00979875|19311313|P2|STARTED|Intervention 1||2
7846242|NCT00979875|19311314|P1|STARTED|Intervention 1||2
7846243|NCT00979810|19311358|P1|NOT COMPLETED|Overall Study||0
7846244|NCT00979810|19311358|P1|COMPLETED|Overall Study||11
7846245|NCT00979810|19311358|P1|STARTED|Overall Study||11
7846246|NCT00979654|19311365|P1|NOT COMPLETED|Overall Study||36
7846247|NCT00979654|19311365|P1|COMPLETED|Overall Study||67
7846248|NCT00979654|19311365|P1|STARTED|Overall Study||103
7846249|NCT00979628|19311380|P3|NOT COMPLETED|Overall Study||6
7846250|NCT00979628|19311381|P2|NOT COMPLETED|Overall Study||9
7846251|NCT00979628|19311382|P1|NOT COMPLETED|Overall Study||9
7846252|NCT00979628|19311380|P3|COMPLETED|Overall Study||74
7846253|NCT00979628|19311381|P2|COMPLETED|Overall Study||133
7846254|NCT00979628|19311382|P1|COMPLETED|Overall Study||144
7846255|NCT00979628|19311380|P3|STARTED|Overall Study||80
7846256|NCT00979628|19311381|P2|STARTED|Overall Study||142
7846257|NCT00979628|19311382|P1|STARTED|Overall Study||153
7846258|NCT00979615|19311395|P2|NOT COMPLETED|Overall Study||8
7846259|NCT00979615|19311396|P1|NOT COMPLETED|Overall Study||6
7846260|NCT00979615|19311395|P2|COMPLETED|Overall Study||58
7846261|NCT00979615|19311396|P1|COMPLETED|Overall Study||57
7846262|NCT00979615|19311395|P2|STARTED|Overall Study||66
7846263|NCT00979615|19311396|P1|STARTED|Overall Study||63
7846264|NCT00979602|19311412|P2|NOT COMPLETED|Overall Study||133
7846265|NCT00979602|19311413|P1|NOT COMPLETED|Overall Study||145
7846266|NCT00979602|19311412|P2|COMPLETED|Overall Study||1890
7846267|NCT00979602|19311413|P1|COMPLETED|Overall Study||1880
7846268|NCT00979602|19311412|P2|STARTED|Overall Study||2023
7846269|NCT00979602|19311413|P1|STARTED|Overall Study||2025
7846270|NCT00979576|19311584|P3|NOT COMPLETED|Combination Followed by Monotherapy||1
7846271|NCT00979576|19311585|P2|NOT COMPLETED|Combination Followed by Monotherapy||2
7846272|NCT00979576|19311586|P1|NOT COMPLETED|Combination Followed by Monotherapy||0
7846273|NCT00979576|19311584|P3|COMPLETED|Combination Followed by Monotherapy||0
7846274|NCT00979576|19311585|P2|COMPLETED|Combination Followed by Monotherapy||0
7846275|NCT00979576|19311586|P1|COMPLETED|Combination Followed by Monotherapy||0
7846276|NCT00979576|19311584|P3|STARTED|Combination Followed by Monotherapy||1
7846277|NCT00979576|19311585|P2|STARTED|Combination Followed by Monotherapy||2
7846278|NCT00979576|19311586|P1|STARTED|Combination Followed by Monotherapy||0
7846279|NCT00979576|19311584|P3|NOT COMPLETED|Combination Treatment Phase||9
7846280|NCT00979576|19311585|P2|NOT COMPLETED|Combination Treatment Phase||6
7846281|NCT00979576|19311586|P1|NOT COMPLETED|Combination Treatment Phase||3
7846282|NCT00979576|19311584|P3|COMPLETED|Combination Treatment Phase||0
7846283|NCT00979576|19311585|P2|COMPLETED|Combination Treatment Phase||0
7846284|NCT00979576|19311586|P1|COMPLETED|Combination Treatment Phase||0
7846285|NCT00979576|19311584|P3|STARTED|Combination Treatment Phase||9
7846286|NCT00979576|19311585|P2|STARTED|Combination Treatment Phase||6
7846287|NCT00979576|19311586|P1|STARTED|Combination Treatment Phase||3
7846288|NCT00979550|19311619|P2|NOT COMPLETED|Overall Study||0
7846289|NCT00979550|19311620|P1|NOT COMPLETED|Overall Study||0
7846290|NCT00979550|19311619|P2|COMPLETED|Overall Study||3
7846291|NCT00979550|19311620|P1|COMPLETED|Overall Study||4
7846292|NCT00979550|19311619|P2|STARTED|Overall Study||3
7846293|NCT00979550|19311620|P1|STARTED|Overall Study||4
7846294|NCT00979459|19311626|P2|NOT COMPLETED|Second Intervention||0
7846295|NCT00979459|19311627|P1|NOT COMPLETED|Second Intervention||0
7846296|NCT00979459|19311626|P2|COMPLETED|Second Intervention||6
7846297|NCT00979459|19311627|P1|COMPLETED|Second Intervention||6
7846298|NCT00979459|19311626|P2|STARTED|Second Intervention||6
7846299|NCT00979459|19311627|P1|STARTED|Second Intervention||6
7846300|NCT00979459|19311626|P2|NOT COMPLETED|7-day Washout Period||0
7846301|NCT00979459|19311627|P1|NOT COMPLETED|7-day Washout Period||0
7846302|NCT00979459|19311626|P2|COMPLETED|7-day Washout Period||6
7846303|NCT00979459|19311627|P1|COMPLETED|7-day Washout Period||6
7846304|NCT00979459|19311626|P2|STARTED|7-day Washout Period||6
7846305|NCT00979459|19311627|P1|STARTED|7-day Washout Period||6
7846306|NCT00979459|19311626|P2|NOT COMPLETED|First Intervention||0
7846307|NCT00979459|19311627|P1|NOT COMPLETED|First Intervention||0
7846308|NCT00979459|19311626|P2|COMPLETED|First Intervention||6
7846309|NCT00979459|19311627|P1|COMPLETED|First Intervention||6
7846310|NCT00979459|19311626|P2|STARTED|First Intervention||6
7846311|NCT00979459|19311627|P1|STARTED|First Intervention||6
7846312|NCT00979420|19311643|P4|NOT COMPLETED|Overall Study||2
7846313|NCT00979420|19311644|P3|NOT COMPLETED|Overall Study||1
7846314|NCT00979420|19311645|P2|NOT COMPLETED|Overall Study||0
7846315|NCT00979420|19311646|P1|NOT COMPLETED|Overall Study||7
7846316|NCT00979420|19311643|P4|COMPLETED|Overall Study||59
7846317|NCT00979420|19311644|P3|COMPLETED|Overall Study||59
7846318|NCT00979420|19311645|P2|COMPLETED|Overall Study||57
7846319|NCT00979420|19311646|P1|COMPLETED|Overall Study||171
7846320|NCT00979420|19311643|P4|STARTED|Overall Study||61
7846321|NCT00979420|19311644|P3|STARTED|Overall Study||60
7846322|NCT00979420|19311645|P2|STARTED|Overall Study||57
7846323|NCT00979420|19311646|P1|STARTED|Overall Study||178
7846324|NCT00979407|19311716|P2|NOT COMPLETED|Overall Study||7
7846325|NCT00979407|19311717|P1|NOT COMPLETED|Overall Study||6
7846326|NCT00979407|19311716|P2|COMPLETED|Overall Study||160
7846327|NCT00979407|19311717|P1|COMPLETED|Overall Study||161
7846328|NCT00979407|19311716|P2|STARTED|Overall Study||167
7846329|NCT00979407|19311717|P1|STARTED|Overall Study||167
7846330|NCT00979303|19311759|P2|NOT COMPLETED|Overall Study||0
7846331|NCT00979303|19311760|P1|NOT COMPLETED|Overall Study||0
7846332|NCT00979303|19311759|P2|COMPLETED|Overall Study||37
7846333|NCT00979303|19311760|P1|COMPLETED|Overall Study||37
7846334|NCT00979303|19311759|P2|STARTED|Overall Study||37
7846335|NCT00979303|19311760|P1|STARTED|Overall Study||37
7846336|NCT00979212|19311770|P2|NOT COMPLETED|Overall Study||8
7846337|NCT00979212|19311771|P1|NOT COMPLETED|Overall Study||2
7846338|NCT00979212|19311770|P2|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39
7846339|NCT00979212|19311771|P1|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22
7846340|NCT00979212|19311770|P2|STARTED|Overall Study||47
7846341|NCT00979212|19311771|P1|STARTED|Overall Study||24
7846342|NCT00979199|19311789|P1|NOT COMPLETED|Overall Study||222
7846343|NCT00979199|19311789|P1|COMPLETED|Overall Study||475
7846344|NCT00979199|19311789|P1|STARTED|Overall Study||697
7846345|NCT00979147|19311795|P2|NOT COMPLETED|Overall Study||0
7846346|NCT00979147|19311796|P1|NOT COMPLETED|Overall Study||0
7846347|NCT00979147|19311795|P2|COMPLETED|Overall Study||0
7846348|NCT00979147|19311796|P1|COMPLETED|Overall Study||0
7846349|NCT00979147|19311795|P2|STARTED|Overall Study||0
7846350|NCT00979147|19311796|P1|STARTED|Overall Study||0
7846351|NCT00979134|19311808|P3|NOT COMPLETED|Overall Study||40
7846352|NCT00979134|19311809|P2|NOT COMPLETED|Overall Study||6
7846353|NCT00979134|19311810|P1|NOT COMPLETED|Overall Study||33
7846354|NCT00979134|19311808|P3|COMPLETED|Overall Study|At DCO|5
7846355|NCT00979134|19311809|P2|COMPLETED|Overall Study|At DCO|0
7846356|NCT00979134|19311810|P1|COMPLETED|Overall Study|At DCO|10
7846357|NCT00979134|19311808|P3|STARTED|Overall Study||45
7846358|NCT00979134|19311809|P2|STARTED|Overall Study||6
7846359|NCT00979134|19311810|P1|STARTED|Overall Study||43
7846360|NCT00979121|19311862|P2|NOT COMPLETED|Overall Study||0
7846361|NCT00979121|19311863|P1|NOT COMPLETED|Overall Study||0
7846362|NCT00979121|19311862|P2|COMPLETED|Overall Study||366
7846363|NCT00979121|19311863|P1|COMPLETED|Overall Study||379
7846364|NCT00979121|19311862|P2|STARTED|Overall Study||366
7846365|NCT00979121|19311863|P1|STARTED|Overall Study||379
7846366|NCT00979069|19311881|P2|NOT COMPLETED|Overall Study||2
7846367|NCT00979069|19311882|P1|NOT COMPLETED|Overall Study||0
7846368|NCT00979069|19311881|P2|COMPLETED|Overall Study||8
7846369|NCT00979069|19311882|P1|COMPLETED|Overall Study||10
7846370|NCT00979069|19311881|P2|STARTED|Overall Study||10
7846371|NCT00979069|19311882|P1|STARTED|Overall Study||10
7846372|NCT00979017|19311888|P1|NOT COMPLETED|Overall Study||0
7846373|NCT00979017|19311888|P1|COMPLETED|Overall Study||41
7846374|NCT00979017|19311888|P1|STARTED|Overall Study||41
7846375|NCT00978757|19311898|P2|NOT COMPLETED|Overall Study||3
7846376|NCT00978757|19311899|P1|NOT COMPLETED|Overall Study||1
7846377|NCT00978757|19311898|P2|COMPLETED|Overall Study|June 2008|17
7846378|NCT00978757|19311899|P1|COMPLETED|Overall Study|June 2008|21
7846379|NCT00978757|19311898|P2|STARTED|Overall Study|June 2001|20
7846380|NCT00978757|19311899|P1|STARTED|Overall Study|June 2001|22
7846381|NCT00978731|19311909|P4|NOT COMPLETED|Overall Study||4
7846382|NCT00978731|19311910|P3|NOT COMPLETED|Overall Study||5
7846383|NCT00978731|19311911|P2|NOT COMPLETED|Overall Study||15
7846384|NCT00978731|19311912|P1|NOT COMPLETED|Overall Study||22
7846385|NCT00978731|19311909|P4|COMPLETED|Overall Study||0
7846386|NCT00978731|19311910|P3|COMPLETED|Overall Study||0
7846387|NCT00978731|19311911|P2|COMPLETED|Overall Study||0
7846388|NCT00978731|19311912|P1|COMPLETED|Overall Study||0
7846389|NCT00978731|19311909|P4|STARTED|Overall Study||4
7846390|NCT00978731|19311910|P3|STARTED|Overall Study||5
7846391|NCT00978731|19311911|P2|STARTED|Overall Study||15
7846392|NCT00978731|19311912|P1|STARTED|Overall Study||22
7846393|NCT00978627|19311952|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9
7846394|NCT00978627|19311953|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21
7846395|NCT00978627|19311952|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113
7846396|NCT00978627|19311953|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233
7846397|NCT00978627|19311952|P2|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122
7846398|NCT00978627|19311953|P1|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254
7846399|NCT00978627|19311952|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26
7846400|NCT00978627|19311953|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46
7846401|NCT00978627|19311952|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156
7846402|NCT00978627|19311953|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320
7846403|NCT00978627|19311952|P2|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180
7846404|NCT00978627|19311953|P1|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362
7846405|NCT00978627|19311952|P2|STARTED|Main: Week 0 to 26 (NN5401-3594)||182
7846406|NCT00978627|19311953|P1|STARTED|Main: Week 0 to 26 (NN5401-3594)||366
7846407|NCT00978562|19311975|P1|NOT COMPLETED|Overall Study||0
7846408|NCT00978562|19311975|P1|COMPLETED|Overall Study||7
7846409|NCT00978562|19311975|P1|STARTED|Overall Study||7
7846410|NCT00978445|19311980|P2|NOT COMPLETED|Overall Study||1
7846411|NCT00978445|19311981|P1|NOT COMPLETED|Overall Study||2
7846412|NCT00978445|19311980|P2|COMPLETED|Overall Study||12
7846413|NCT00978445|19311981|P1|COMPLETED|Overall Study||10
7846414|NCT00978445|19311980|P2|STARTED|Overall Study||13
7846415|NCT00978445|19311981|P1|STARTED|Overall Study||12
7846416|NCT00978432|19311991|P3|NOT COMPLETED|Overall Study||5
7846417|NCT00978432|19311992|P2|NOT COMPLETED|Overall Study||1
7846418|NCT00978432|19311993|P1|NOT COMPLETED|Overall Study||3
7846419|NCT00978432|19311991|P3|COMPLETED|Overall Study||13
7846420|NCT00978432|19311992|P2|COMPLETED|Overall Study||4
7846421|NCT00978432|19311993|P1|COMPLETED|Overall Study||7
7846422|NCT00978432|19311991|P3|STARTED|Overall Study||18
7846423|NCT00978432|19311992|P2|STARTED|Overall Study||5
7846424|NCT00978432|19311993|P1|STARTED|Overall Study||10
7846425|NCT00978419|19312015|P2|NOT COMPLETED|Overall Study||0
7846426|NCT00978419|19312016|P1|NOT COMPLETED|Overall Study||0
7846427|NCT00978419|19312015|P2|COMPLETED|Overall Study||0
7846428|NCT00978419|19312016|P1|COMPLETED|Overall Study||0
7846429|NCT00978419|19312015|P2|STARTED|Overall Study||0
7846430|NCT00978419|19312016|P1|STARTED|Overall Study||0
7846431|NCT00978380|19312044|P1|NOT COMPLETED|Overall Study||19
7846432|NCT00978380|19312044|P1|COMPLETED|Overall Study||44
7846433|NCT00978380|19312044|P1|STARTED|Overall Study||63
7846434|NCT00978341|19312050|P2|NOT COMPLETED|Second Intervention||0
7846435|NCT00978341|19312051|P1|NOT COMPLETED|Second Intervention||0
7846436|NCT00978341|19312050|P2|COMPLETED|Second Intervention||7
7846437|NCT00978341|19312051|P1|COMPLETED|Second Intervention||7
7846438|NCT00978341|19312050|P2|STARTED|Second Intervention||7
7846439|NCT00978341|19312051|P1|STARTED|Second Intervention||7
7846440|NCT00978341|19312050|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
7846441|NCT00978341|19312051|P1|NOT COMPLETED|Washout Period of 2 Weeks||1
7846442|NCT00978341|19312050|P2|COMPLETED|Washout Period of 2 Weeks||7
7846443|NCT00978341|19312051|P1|COMPLETED|Washout Period of 2 Weeks||7
7846444|NCT00978341|19312050|P2|STARTED|Washout Period of 2 Weeks||7
7846445|NCT00978341|19312051|P1|STARTED|Washout Period of 2 Weeks||8
7846446|NCT00978341|19312050|P2|NOT COMPLETED|First Intervention||0
7846447|NCT00978341|19312051|P1|NOT COMPLETED|First Intervention||0
7846448|NCT00978341|19312050|P2|COMPLETED|First Intervention||7
7846449|NCT00978341|19312051|P1|COMPLETED|First Intervention||8
7846450|NCT00978341|19312050|P2|STARTED|First Intervention||7
7846451|NCT00978341|19312051|P1|STARTED|First Intervention||8
7846452|NCT00978250|19312073|P4|NOT COMPLETED|Overall Study||1
7846453|NCT00978250|19312074|P3|NOT COMPLETED|Overall Study||0
7846454|NCT00978250|19312075|P2|NOT COMPLETED|Overall Study||1
7846455|NCT00978250|19312076|P1|NOT COMPLETED|Overall Study||0
7846456|NCT00978250|19312073|P4|COMPLETED|Overall Study||21
7846457|NCT00978250|19312074|P3|COMPLETED|Overall Study||18
7846458|NCT00978250|19312075|P2|COMPLETED|Overall Study||29
7846459|NCT00978250|19312076|P1|COMPLETED|Overall Study||25
7846460|NCT00978250|19312073|P4|STARTED|Overall Study||22
7846461|NCT00978250|19312074|P3|STARTED|Overall Study||18
7846462|NCT00978250|19312075|P2|STARTED|Overall Study||30
7846463|NCT00978250|19312076|P1|STARTED|Overall Study||25
7846464|NCT00978120|19312092|P4|NOT COMPLETED|Overall Study||2
7846465|NCT00978120|19312093|P3|NOT COMPLETED|Overall Study||3
7846466|NCT00978120|19312094|P2|NOT COMPLETED|Overall Study||0
7846467|NCT00978120|19312095|P1|NOT COMPLETED|Overall Study||2
7846468|NCT00978120|19312092|P4|COMPLETED|Overall Study||84
7846469|NCT00978120|19312093|P3|COMPLETED|Overall Study||84
7846470|NCT00978120|19312094|P2|COMPLETED|Overall Study||107
7846471|NCT00978120|19312095|P1|COMPLETED|Overall Study||108
7846472|NCT00978120|19312092|P4|STARTED|Overall Study||86
7846473|NCT00978120|19312093|P3|STARTED|Overall Study||87
7846474|NCT00978120|19312094|P2|STARTED|Overall Study||107
7846475|NCT00978120|19312095|P1|STARTED|Overall Study||110
7846476|NCT00978068|19312147|P2|NOT COMPLETED|Overall Study||9
7846477|NCT00978068|19312148|P1|NOT COMPLETED|Overall Study||4
7846478|NCT00978068|19312147|P2|COMPLETED|Overall Study||80
7846479|NCT00978068|19312148|P1|COMPLETED|Overall Study||83
7846480|NCT00978068|19312147|P2|Initiated Study Drugs|Overall Study||86
7846481|NCT00978068|19312148|P1|Initiated Study Drugs|Overall Study||84
7846482|NCT00978068|19312147|P2|STARTED|Overall Study||89
7846483|NCT00978068|19312148|P1|STARTED|Overall Study||87
7846484|NCT00978042|19312166|P2|NOT COMPLETED|Received Repeat Treatment||3
7846485|NCT00978042|19312167|P1|NOT COMPLETED|Received Repeat Treatment||43
7846486|NCT00978042|19312166|P2|COMPLETED|Received Repeat Treatment||23
7846487|NCT00978042|19312167|P1|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98
7846488|NCT00978042|19312166|P2|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26
7846489|NCT00978042|19312167|P1|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141
7846490|NCT00978042|19312166|P2|NOT COMPLETED|Initial Treatment Period||15
7846491|NCT00978042|19312167|P1|NOT COMPLETED|Initial Treatment Period||61
7846492|NCT00978042|19312166|P2|COMPLETED|Initial Treatment Period||32
7846493|NCT00978042|19312167|P1|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174
7846494|NCT00978042|19312166|P2|MITT_treated With VOLUMA XC|Initial Treatment Period||35
7846495|NCT00978042|19312167|P1|MITT_treated With VOLUMA XC|Initial Treatment Period||235
7846496|NCT00978042|19312166|P2|STARTED|Initial Treatment Period||47
7846497|NCT00978042|19312167|P1|STARTED|Initial Treatment Period||235
7846498|NCT00978029|19312180|P3|NOT COMPLETED|Overall Study||6
7846499|NCT00978029|19312181|P2|NOT COMPLETED|Overall Study||3
7846500|NCT00978029|19312182|P1|NOT COMPLETED|Overall Study||1
7846501|NCT00978029|19312180|P3|COMPLETED|Overall Study||59
7846502|NCT00978029|19312181|P2|COMPLETED|Overall Study||63
7846503|NCT00978029|19312182|P1|COMPLETED|Overall Study||64
7846504|NCT00978029|19312180|P3|STARTED|Overall Study||65
7846505|NCT00978029|19312181|P2|STARTED|Overall Study||66
7846506|NCT00978029|19312182|P1|STARTED|Overall Study||65
7846507|NCT00977938|19312209|P4|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3
7846508|NCT00977938|19312210|P3|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12
7846509|NCT00977938|19312211|P2|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58
7846510|NCT00977938|19312212|P1|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51
7846511|NCT00977938|19312209|P4|COMPLETED|Observation (30-33 mo. Post Procedure)||781
7846512|NCT00977938|19312210|P3|COMPLETED|Observation (30-33 mo. Post Procedure)||784
7846513|NCT00977938|19312211|P2|COMPLETED|Observation (30-33 mo. Post Procedure)||4658
7846514|NCT00977938|19312212|P1|COMPLETED|Observation (30-33 mo. Post Procedure)||4732
7846515|NCT00977938|19312209|P4|STARTED|Observation (30-33 mo. Post Procedure)||784
7846516|NCT00977938|19312210|P3|STARTED|Observation (30-33 mo. Post Procedure)||796
7846517|NCT00977938|19312211|P2|STARTED|Observation (30-33 mo. Post Procedure)||4716
7846518|NCT00977938|19312212|P1|STARTED|Observation (30-33 mo. Post Procedure)||4783
7846519|NCT00977938|19312209|P4|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61
7846520|NCT00977938|19312210|P3|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46
7846521|NCT00977938|19312211|P2|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225
7846522|NCT00977938|19312212|P1|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237
7846523|NCT00977938|19312209|P4|COMPLETED|Treatment (12-30 mo. Post Procedure)||784
7846524|NCT00977938|19312210|P3|COMPLETED|Treatment (12-30 mo. Post Procedure)||796
7846525|NCT00977938|19312211|P2|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716
7846526|NCT00977938|19312212|P1|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783
7846527|NCT00977938|19312209|P4|STARTED|Treatment (12-30 mo. Post Procedure)||845
7846528|NCT00977938|19312210|P3|STARTED|Treatment (12-30 mo. Post Procedure)||842
7846529|NCT00977938|19312211|P2|STARTED|Treatment (12-30 mo. Post Procedure)||4941
7846530|NCT00977938|19312212|P1|STARTED|Treatment (12-30 mo. Post Procedure)||5020
7846531|NCT00977808|19312246|P1|NOT COMPLETED|Overall Study||1
7846532|NCT00977808|19312246|P1|COMPLETED|Overall Study||11
7846533|NCT00977808|19312246|P1|Completion of Closed-Loop Admission|Overall Study||11
7846534|NCT00977808|19312246|P1|Completion of Open-Loop Admission|Overall Study||12
7846535|NCT00977808|19312246|P1|STARTED|Overall Study||12
7846536|NCT00977769|19312254|P3|NOT COMPLETED|Overall Study||0
7846537|NCT00977769|19312255|P2|NOT COMPLETED|Overall Study||0
7846538|NCT00977769|19312256|P1|NOT COMPLETED|Overall Study||0
7846539|NCT00977769|19312254|P3|COMPLETED|Overall Study||25
7846540|NCT00977769|19312255|P2|COMPLETED|Overall Study||26
7846541|NCT00977769|19312256|P1|COMPLETED|Overall Study||25
7846542|NCT00977769|19312254|P3|STARTED|Overall Study||25
7846543|NCT00977769|19312255|P2|STARTED|Overall Study||26
7846544|NCT00977769|19312256|P1|STARTED|Overall Study||25
7846545|NCT00977704|19312270|P1|NOT COMPLETED|Overall Study||0
7846546|NCT00977704|19312270|P1|COMPLETED|Overall Study||20
7846547|NCT00977704|19312270|P1|STARTED|Overall Study||20
7846548|NCT00977691|19312277|P3|NOT COMPLETED|Overall Study||0
7846549|NCT00977691|19312278|P2|NOT COMPLETED|Overall Study||1
7846550|NCT00977691|19312279|P1|NOT COMPLETED|Overall Study||0
7846551|NCT00977691|19312277|P3|COMPLETED|Overall Study||12
7846552|NCT00977691|19312278|P2|COMPLETED|Overall Study||7
7846553|NCT00977691|19312279|P1|COMPLETED|Overall Study||3
7846554|NCT00977691|19312277|P3|STARTED|Overall Study||12
7846555|NCT00977691|19312278|P2|STARTED|Overall Study||8
7846556|NCT00977691|19312279|P1|STARTED|Overall Study||3
7846557|NCT00977665|19312289|P2|NOT COMPLETED|Overall Study||15
7846558|NCT00977665|19312290|P1|NOT COMPLETED|Overall Study||21
7846559|NCT00977665|19312289|P2|COMPLETED|Overall Study||75
7846560|NCT00977665|19312290|P1|COMPLETED|Overall Study||63
7846561|NCT00977665|19312289|P2|STARTED|Overall Study||90
7846562|NCT00977665|19312290|P1|STARTED|Overall Study||84
7846563|NCT00977613|19312322|P1|NOT COMPLETED|Overall Study||16
7846564|NCT00977613|19312322|P1|COMPLETED|Overall Study||34
7846565|NCT00977613|19312322|P1|STARTED|Overall Study||50
7846566|NCT00977574|19312329|P3|NOT COMPLETED|Overall Study||4
7846567|NCT00977574|19312330|P2|NOT COMPLETED|Overall Study||2
7846568|NCT00977574|19312331|P1|NOT COMPLETED|Overall Study||4
7846569|NCT00977574|19312329|P3|COMPLETED|Overall Study||114
7846570|NCT00977574|19312330|P2|COMPLETED|Overall Study||113
7846571|NCT00977574|19312331|P1|COMPLETED|Overall Study||112
7846572|NCT00977574|19312329|P3|STARTED|Overall Study||118
7846573|NCT00977574|19312330|P2|STARTED|Overall Study||115
7846574|NCT00977574|19312331|P1|STARTED|Overall Study||116
7846575|NCT00977561|19312350|P2|NOT COMPLETED|Overall Study||4
7846576|NCT00977561|19312351|P1|NOT COMPLETED|Overall Study||5
7846577|NCT00977561|19312350|P2|COMPLETED|Overall Study||0
7846578|NCT00977561|19312351|P1|COMPLETED|Overall Study||0
7846579|NCT00977561|19312350|P2|STARTED|Overall Study||4
7846580|NCT00977561|19312351|P1|STARTED|Overall Study||5
7846581|NCT00977548|19312378|P1|NOT COMPLETED|Overall Study||13
7846582|NCT00977548|19312378|P1|COMPLETED|Overall Study||26
7846583|NCT00977548|19312378|P1|STARTED|Overall Study||39
7846584|NCT00977470|19312387|P2|NOT COMPLETED|Overall Study||38
7846585|NCT00977470|19312388|P1|NOT COMPLETED|Overall Study||38
7846586|NCT00977470|19312387|P2|COMPLETED|Overall Study||0
7846587|NCT00977470|19312388|P1|COMPLETED|Overall Study||0
7846588|NCT00977470|19312387|P2|STARTED|Overall Study||38
7846589|NCT00977470|19312388|P1|STARTED|Overall Study||38
7846590|NCT00977431|19312411|P5|NOT COMPLETED|Overall Study||13
7846591|NCT00977431|19312412|P4|NOT COMPLETED|Overall Study||3
7846592|NCT00977431|19312413|P3|NOT COMPLETED|Overall Study||7
7846593|NCT00977431|19312414|P2|NOT COMPLETED|Overall Study||6
7846594|NCT00977431|19312415|P1|NOT COMPLETED|Overall Study||7
7846595|NCT00977431|19312411|P5|COMPLETED|Overall Study||0
7846596|NCT00977431|19312412|P4|COMPLETED|Overall Study||0
7846597|NCT00977431|19312413|P3|COMPLETED|Overall Study||0
7846598|NCT00977431|19312414|P2|COMPLETED|Overall Study||0
7846599|NCT00977431|19312415|P1|COMPLETED|Overall Study||0
7846600|NCT00977431|19312411|P5|Discontinued Afatinib Before/on Day 42|Overall Study||3
7846601|NCT00977431|19312412|P4|Discontinued Afatinib Before/on Day 42|Overall Study||0
7846602|NCT00977431|19312413|P3|Discontinued Afatinib Before/on Day 42|Overall Study||4
7846603|NCT00977431|19312414|P2|Discontinued Afatinib Before/on Day 42|Overall Study||0
7846604|NCT00977431|19312415|P1|Discontinued Afatinib Before/on Day 42|Overall Study||1
7846605|NCT00977431|19312411|P5|STARTED|Overall Study||13
7846606|NCT00977431|19312412|P4|STARTED|Overall Study||3
7846607|NCT00977431|19312413|P3|STARTED|Overall Study||7
7846608|NCT00977431|19312414|P2|STARTED|Overall Study||6
7846609|NCT00977431|19312415|P1|STARTED|Overall Study||7
7846610|NCT00977379|19312448|P2|NOT COMPLETED|Overall Study||12
7846611|NCT00977379|19312449|P1|NOT COMPLETED|Overall Study||12
7846612|NCT00977379|19312448|P2|COMPLETED|Overall Study||0
7846613|NCT00977379|19312449|P1|COMPLETED|Overall Study||0
7846614|NCT00977379|19312448|P2|Treated|Overall Study||11
7846615|NCT00977379|19312449|P1|Treated|Overall Study||12
7846616|NCT00977379|19312448|P2|STARTED|Overall Study|Randomized|12
7846617|NCT00977379|19312449|P1|STARTED|Overall Study|Randomized|12
7846618|NCT00977314|19312485|P2|NOT COMPLETED|Overall Study||0
7846619|NCT00977314|19312486|P1|NOT COMPLETED|Overall Study||2
7846620|NCT00977314|19312485|P2|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
7846621|NCT00977314|19312486|P1|COMPLETED|Overall Study||28
7846622|NCT00977314|19312485|P2|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
7846623|NCT00977314|19312486|P1|STARTED|Overall Study||30
7846624|NCT00977197|19312494|P2|NOT COMPLETED|Overall Study||9
7846625|NCT00977197|19312495|P1|NOT COMPLETED|Overall Study||9
7846626|NCT00977197|19312494|P2|COMPLETED|Overall Study||35
7846627|NCT00977197|19312495|P1|COMPLETED|Overall Study||32
7846628|NCT00977197|19312494|P2|STARTED|Overall Study||44
7846629|NCT00977197|19312495|P1|STARTED|Overall Study||41
7846630|NCT00977184|19312525|P2|NOT COMPLETED|Overall Study||0
7846631|NCT00977184|19312526|P1|NOT COMPLETED|Overall Study||0
7846632|NCT00977184|19312525|P2|COMPLETED|Overall Study||13
7846633|NCT00977184|19312526|P1|COMPLETED|Overall Study||13
7846634|NCT00977184|19312525|P2|STARTED|Overall Study||13
7846635|NCT00977184|19312526|P1|STARTED|Overall Study||13
7846636|NCT00977171|19312552|P1|NOT COMPLETED|Overall Study||0
7846637|NCT00977171|19312552|P1|COMPLETED|Overall Study||3
7846638|NCT00977171|19312552|P1|STARTED|Overall Study||3
7846639|NCT00977106|19312558|P2|NOT COMPLETED|Overall Study||11
7846640|NCT00977106|19312559|P1|NOT COMPLETED|Overall Study||10
7846641|NCT00977106|19312558|P2|COMPLETED|Overall Study||45
7846642|NCT00977106|19312559|P1|COMPLETED|Overall Study||37
7846643|NCT00977106|19312558|P2|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56
7846644|NCT00977106|19312559|P1|STARTED|Overall Study||47
7846645|NCT00977080|19312651|P4|NOT COMPLETED|Overall Study||17
7846646|NCT00977080|19312652|P3|NOT COMPLETED|Overall Study||16
7846647|NCT00977080|19312653|P2|NOT COMPLETED|Overall Study||20
7846648|NCT00977080|19312654|P1|NOT COMPLETED|Overall Study||12
7846649|NCT00977080|19312651|P4|COMPLETED|Overall Study||53
7846650|NCT00977080|19312652|P3|COMPLETED|Overall Study||56
7846651|NCT00977080|19312653|P2|COMPLETED|Overall Study||44
7846652|NCT00977080|19312654|P1|COMPLETED|Overall Study||50
7846653|NCT00977080|19312651|P4|STARTED|Overall Study||70
7846654|NCT00977080|19312652|P3|STARTED|Overall Study||72
7846655|NCT00977080|19312653|P2|STARTED|Overall Study||64
7846656|NCT00977080|19312654|P1|STARTED|Overall Study||62
7846657|NCT00976989|19312687|P3|NOT COMPLETED|Overall Study||17
7846658|NCT00976989|19312688|P2|NOT COMPLETED|Overall Study||12
7846659|NCT00976989|19312689|P1|NOT COMPLETED|Overall Study||13
7846660|NCT00976989|19312687|P3|COMPLETED|Overall Study||60
7846661|NCT00976989|19312688|P2|COMPLETED|Overall Study||63
7846662|NCT00976989|19312689|P1|COMPLETED|Overall Study||60
7846663|NCT00976989|19312687|P3|STARTED|Overall Study||77
7846664|NCT00976989|19312688|P2|STARTED|Overall Study||75
7846665|NCT00976989|19312689|P1|STARTED|Overall Study||73
7846666|NCT00976950|19312730|P1|NOT COMPLETED|Overall Study||6
7846667|NCT00976950|19312730|P1|COMPLETED|Overall Study||36
7846668|NCT00976950|19312730|P1|STARTED|Overall Study||42
7846669|NCT00976937|19312738|P2|NOT COMPLETED|Overall Study||11
7846670|NCT00976937|19312739|P1|NOT COMPLETED|Overall Study||16
7846671|NCT00976937|19312738|P2|COMPLETED|Overall Study||150
7846672|NCT00976937|19312739|P1|COMPLETED|Overall Study||142
7846673|NCT00976937|19312738|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||161
7846674|NCT00976937|19312739|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158
7846675|NCT00976937|19312738|P2|Treated/Safety Population|Overall Study||161
7846676|NCT00976937|19312739|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158
7846677|NCT00976937|19312738|P2|STARTED|Overall Study||161
7846678|NCT00976937|19312739|P1|STARTED|Overall Study|Randomized|158
7846679|NCT00976911|19312781|P2|NOT COMPLETED|Overall Study||179
7846680|NCT00976911|19312782|P1|NOT COMPLETED|Overall Study||182
7846681|NCT00976911|19312781|P2|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
7846682|NCT00976911|19312782|P1|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
7846683|NCT00976911|19312781|P2|STARTED|Overall Study||179
7846684|NCT00976911|19312782|P1|STARTED|Overall Study||182
7846685|NCT00976898|19312800|P1|NOT COMPLETED|Overall Study||5
7846686|NCT00976898|19312800|P1|COMPLETED|Overall Study||78
7846687|NCT00976898|19312800|P1|STARTED|Overall Study||83
7846688|NCT00976820|19312811|P4|NOT COMPLETED|Overall Study||7
7846689|NCT00976820|19312812|P3|NOT COMPLETED|Overall Study||4
7846690|NCT00976820|19312813|P2|NOT COMPLETED|Overall Study||20
7846691|NCT00976820|19312814|P1|NOT COMPLETED|Overall Study||8
7846692|NCT00976820|19312811|P4|COMPLETED|Overall Study||56
7846693|NCT00976820|19312812|P3|COMPLETED|Overall Study||60
7846694|NCT00976820|19312813|P2|COMPLETED|Overall Study||108
7846695|NCT00976820|19312814|P1|COMPLETED|Overall Study||59
7846696|NCT00976820|19312811|P4|STARTED|Overall Study||63
7846697|NCT00976820|19312812|P3|STARTED|Overall Study||64
7846698|NCT00976820|19312813|P2|STARTED|Overall Study||128
7846699|NCT00976820|19312814|P1|STARTED|Overall Study||67
7846700|NCT00976716|19313150|P1|NOT COMPLETED|Overall Study||1
7846701|NCT00976716|19313150|P1|COMPLETED|Overall Study||79
7846702|NCT00976716|19313150|P1|STARTED|Overall Study||80
7846703|NCT00976703|19313168|P2|NOT COMPLETED|Overall Study||3
7846704|NCT00976703|19313169|P1|NOT COMPLETED|Overall Study||3
7846705|NCT00976703|19313168|P2|COMPLETED|Overall Study||95
7846706|NCT00976703|19313169|P1|COMPLETED|Overall Study||96
7846707|NCT00976703|19313168|P2|STARTED|Overall Study||98
7846708|NCT00976703|19313169|P1|STARTED|Overall Study||99
7846709|NCT00976677|19313183|P2|NOT COMPLETED|Overall Study||5
7846710|NCT00976677|19313184|P1|NOT COMPLETED|Overall Study||5
7846711|NCT00976677|19313183|P2|COMPLETED|Overall Study||0
7846712|NCT00976677|19313184|P1|COMPLETED|Overall Study||0
7846713|NCT00976677|19313183|P2|STARTED|Overall Study||5
7846714|NCT00976677|19313184|P1|STARTED|Overall Study||5
7846715|NCT00976664|19313192|P2|NOT COMPLETED|Overall Study||1
7846716|NCT00976664|19313193|P1|NOT COMPLETED|Overall Study||3
7846717|NCT00976664|19313192|P2|COMPLETED|Overall Study||24
7846718|NCT00976664|19313193|P1|COMPLETED|Overall Study||22
7846719|NCT00976664|19313192|P2|STARTED|Overall Study||25
7846720|NCT00976664|19313193|P1|STARTED|Overall Study||25
7846721|NCT00976599|19313203|P2|NOT COMPLETED|Overall Study||0
7846722|NCT00976599|19313204|P1|NOT COMPLETED|Overall Study||0
7846723|NCT00976599|19313203|P2|COMPLETED|Overall Study||14
7846724|NCT00976599|19313204|P1|COMPLETED|Overall Study||15
7846725|NCT00976599|19313203|P2|STARTED|Overall Study||14
7846726|NCT00976599|19313204|P1|STARTED|Overall Study||15
7846727|NCT00976573|19313392|P2|NOT COMPLETED|Overall Study||3
7846728|NCT00976573|19313393|P1|NOT COMPLETED|Overall Study||4
7846729|NCT00976573|19313392|P2|COMPLETED|Overall Study||71
7846730|NCT00976573|19313393|P1|COMPLETED|Overall Study||71
7846731|NCT00976573|19313392|P2|STARTED|Overall Study||74
7846732|NCT00976573|19313393|P1|STARTED|Overall Study||75
7846733|NCT00976560|19313407|P2|NOT COMPLETED|Overall Study||13
7846734|NCT00976560|19313408|P1|NOT COMPLETED|Overall Study||14
7846735|NCT00976560|19313407|P2|COMPLETED|Overall Study||51
7846736|NCT00976560|19313408|P1|COMPLETED|Overall Study||50
7846737|NCT00976560|19313407|P2|STARTED|Overall Study||64
7846738|NCT00976560|19313408|P1|STARTED|Overall Study||64
7846739|NCT00976521|19313460|P4|NOT COMPLETED|Overall Study||19
7846740|NCT00976521|19313461|P3|NOT COMPLETED|Overall Study||9
7846741|NCT00976521|19313462|P2|NOT COMPLETED|Overall Study||12
7846742|NCT00976521|19313463|P1|NOT COMPLETED|Overall Study||9
7846743|NCT00976521|19313460|P4|COMPLETED|Overall Study||93
7846744|NCT00976521|19313461|P3|COMPLETED|Overall Study||102
7846745|NCT00976521|19313462|P2|COMPLETED|Overall Study||99
7846746|NCT00976521|19313463|P1|COMPLETED|Overall Study||109
7846747|NCT00976521|19313460|P4|STARTED|Overall Study||112
7846748|NCT00976521|19313461|P3|STARTED|Overall Study||111
7846749|NCT00976521|19313462|P2|STARTED|Overall Study||111
7846750|NCT00976521|19313463|P1|STARTED|Overall Study||118
7846751|NCT00976508|19313477|P2|NOT COMPLETED|Overall Study||6
7846752|NCT00976508|19313478|P1|NOT COMPLETED|Overall Study||14
7846753|NCT00976508|19313477|P2|COMPLETED|Overall Study||0
7846754|NCT00976508|19313478|P1|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3
7846755|NCT00976508|19313477|P2|STARTED|Overall Study||6
7846756|NCT00976508|19313478|P1|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17
7846757|NCT00976495|19313511|P3|NOT COMPLETED|Overall Study||0
7846758|NCT00976495|19313512|P2|NOT COMPLETED|Overall Study||1
7846759|NCT00976495|19313513|P1|NOT COMPLETED|Overall Study||0
7846760|NCT00976495|19313511|P3|COMPLETED|Overall Study||26
7846761|NCT00976495|19313512|P2|COMPLETED|Overall Study||23
7846762|NCT00976495|19313513|P1|COMPLETED|Overall Study||25
7846763|NCT00976495|19313511|P3|STARTED|Overall Study||26
7846764|NCT00976495|19313512|P2|STARTED|Overall Study||24
7846765|NCT00976495|19313513|P1|STARTED|Overall Study||25
7846766|NCT00976482|19313530|P1|NOT COMPLETED|Overall Study||259
7846767|NCT00976482|19313530|P1|COMPLETED|Overall Study||1486
7846768|NCT00976482|19313530|P1|Eligible for Last Follow up|Overall Study||1487
7846769|NCT00976482|19313530|P1|STARTED|Overall Study||1745
7846770|NCT00976456|19313536|P2|NOT COMPLETED|Overall Study||38
7846771|NCT00976456|19313537|P1|NOT COMPLETED|Overall Study||43
7846772|NCT00976456|19313536|P2|COMPLETED|Overall Study||98
7846773|NCT00976456|19313537|P1|COMPLETED|Overall Study||92
7846774|NCT00976456|19313536|P2|STARTED|Overall Study||136
7846775|NCT00976456|19313537|P1|STARTED|Overall Study||135
7846776|NCT00976404|19313547|P2|NOT COMPLETED|Overall Study||0
7846777|NCT00976404|19313548|P1|NOT COMPLETED|Overall Study||0
7846778|NCT00976404|19313547|P2|COMPLETED|Overall Study||14
7846779|NCT00976404|19313548|P1|COMPLETED|Overall Study||14
7846780|NCT00976404|19313547|P2|STARTED|Overall Study||14
7846781|NCT00976404|19313548|P1|STARTED|Overall Study||14
7846782|NCT00976391|19313564|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||34
7846783|NCT00976391|19313565|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||29
7846784|NCT00976391|19313564|P2|COMPLETED|Follow-up Period (8 Weeks)||247
7846785|NCT00976391|19313565|P1|COMPLETED|Follow-up Period (8 Weeks)||256
7846786|NCT00976391|19313564|P2|STARTED|Follow-up Period (8 Weeks)||281
7846787|NCT00976391|19313565|P1|STARTED|Follow-up Period (8 Weeks)||285
7846788|NCT00976391|19313564|P2|NOT COMPLETED|Treatment Period (52 Weeks)||39
7846789|NCT00976391|19313565|P1|NOT COMPLETED|Treatment Period (52 Weeks)||42
7846790|NCT00976391|19313564|P2|COMPLETED|Treatment Period (52 Weeks)||242
7846791|NCT00976391|19313565|P1|COMPLETED|Treatment Period (52 Weeks)||243
7846792|NCT00976391|19313564|P2|STARTED|Treatment Period (52 Weeks)||281
7846793|NCT00976391|19313565|P1|STARTED|Treatment Period (52 Weeks)||285
7846794|NCT00976352|19313587|P2|NOT COMPLETED|Overall Study||4
7846795|NCT00976352|19313588|P1|NOT COMPLETED|Overall Study||0
7846796|NCT00976352|19313587|P2|COMPLETED|Overall Study|Last evaluation of last subject in cohort.|6
7846797|NCT00976352|19313588|P1|COMPLETED|Overall Study||3
7846798|NCT00976352|19313587|P2|STARTED|Overall Study||10
7846799|NCT00976352|19313588|P1|STARTED|Overall Study||3
7846800|NCT00976339|19313602|P2|NOT COMPLETED|Overall Study||0
7846801|NCT00976339|19313603|P1|NOT COMPLETED|Overall Study||0
7846802|NCT00976339|19313602|P2|COMPLETED|Overall Study||10
7846803|NCT00976339|19313603|P1|COMPLETED|Overall Study||10
7846804|NCT00976339|19313602|P2|STARTED|Overall Study||10
7846805|NCT00976339|19313603|P1|STARTED|Overall Study||10
7846806|NCT00976274|19313613|P2|NOT COMPLETED|Overall Study||8
7846807|NCT00976274|19313614|P1|NOT COMPLETED|Overall Study||7
7846808|NCT00976274|19313613|P2|COMPLETED|Overall Study||21
7846809|NCT00976274|19313614|P1|COMPLETED|Overall Study||24
7846810|NCT00976274|19313613|P2|STARTED|Overall Study||29
7846811|NCT00976274|19313614|P1|STARTED|Overall Study||31
7846812|NCT00976248|19313622|P1|NOT COMPLETED|Overall Study||0
7846813|NCT00976248|19313622|P1|COMPLETED|Overall Study||33
7846814|NCT00976248|19313622|P1|STARTED|Overall Study||33
7846815|NCT00976209|19313630|P2|NOT COMPLETED|Treatment Period 2||2
7846816|NCT00976209|19313631|P1|NOT COMPLETED|Treatment Period 2||0
7846817|NCT00976209|19313630|P2|COMPLETED|Treatment Period 2||161
7846818|NCT00976209|19313631|P1|COMPLETED|Treatment Period 2||158
7846819|NCT00976209|19313630|P2|STARTED|Treatment Period 2||163
7846820|NCT00976209|19313631|P1|STARTED|Treatment Period 2||158
7846821|NCT00976209|19313630|P2|NOT COMPLETED|Wash-out Period||2
7846822|NCT00976209|19313631|P1|NOT COMPLETED|Wash-out Period||4
7846823|NCT00976209|19313630|P2|COMPLETED|Wash-out Period||163
7846824|NCT00976209|19313631|P1|COMPLETED|Wash-out Period||158
7846825|NCT00976209|19313630|P2|STARTED|Wash-out Period||165
7846826|NCT00976209|19313631|P1|STARTED|Wash-out Period||162
7846827|NCT00976209|19313630|P2|NOT COMPLETED|Treatment Period 1||1
7846828|NCT00976209|19313631|P1|NOT COMPLETED|Treatment Period 1||3
7846829|NCT00976209|19313630|P2|COMPLETED|Treatment Period 1||165
7846830|NCT00976209|19313631|P1|COMPLETED|Treatment Period 1||162
7846831|NCT00976209|19313630|P2|STARTED|Treatment Period 1||166
7846832|NCT00976209|19313631|P1|STARTED|Treatment Period 1||165
7846833|NCT00976183|19313637|P1|NOT COMPLETED|Overall Study||0
7846834|NCT00976183|19313637|P1|COMPLETED|Overall Study|The study was closed on 05/30/12 due to adverse events. We did not complete enrollment|18
7846835|NCT00976183|19313637|P1|STARTED|Overall Study||18
7846836|NCT00976027|19313644|P2|NOT COMPLETED|Overall Study||215
7846837|NCT00976027|19313645|P1|NOT COMPLETED|Overall Study||411
7846838|NCT00976027|19313644|P2|COMPLETED|Overall Study||2835
7846839|NCT00976027|19313645|P1|COMPLETED|Overall Study||5697
7846840|NCT00976027|19313644|P2|STARTED|Overall Study||3050
7846841|NCT00976027|19313645|P1|STARTED|Overall Study||6108
7846842|NCT00975975|19313657|P1|NOT COMPLETED|Overall Study||6
7846843|NCT00975975|19313657|P1|COMPLETED|Overall Study||11
7846844|NCT00975975|19313657|P1|STARTED|Overall Study||17
7846845|NCT00975923|19313665|P2|NOT COMPLETED|Overall Study||1
7846846|NCT00975923|19313666|P1|NOT COMPLETED|Overall Study||0
7846847|NCT00975923|19313665|P2|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29
7846848|NCT00975923|19313666|P1|COMPLETED|Overall Study||30
7846849|NCT00975923|19313665|P2|STARTED|Overall Study||30
7846850|NCT00975923|19313666|P1|STARTED|Overall Study||30
7846851|NCT00975884|19313676|P2|NOT COMPLETED|Overall Study||15
7846852|NCT00975884|19313677|P1|NOT COMPLETED|Overall Study||16
7846853|NCT00975884|19313676|P2|COMPLETED|Overall Study||107
7846854|NCT00975884|19313677|P1|COMPLETED|Overall Study||168
7846855|NCT00975884|19313676|P2|STARTED|Overall Study||122
7846856|NCT00975884|19313677|P1|STARTED|Overall Study||184
7846857|NCT00975806|19313834|P3|NOT COMPLETED|Overall Study||4
7846858|NCT00975806|19313835|P2|NOT COMPLETED|Overall Study||7
7846859|NCT00975806|19313836|P1|NOT COMPLETED|Overall Study||5
7846860|NCT00975806|19313834|P3|COMPLETED|Overall Study|Participants were prematurely discontinued|0
7846861|NCT00975806|19313835|P2|COMPLETED|Overall Study|Participants were prematurely discontinued|0
7846862|NCT00975806|19313836|P1|COMPLETED|Overall Study|Participants were prematurely discontinued|0
7846863|NCT00975806|19313834|P3|STARTED|Overall Study||4
7846864|NCT00975806|19313835|P2|STARTED|Overall Study||7
7846865|NCT00975806|19313836|P1|STARTED|Overall Study||5
7846866|NCT00975780|19313860|P2|NOT COMPLETED|Follow Up||157
7846867|NCT00975780|19313861|P1|NOT COMPLETED|Follow Up||102
7846868|NCT00975780|19313860|P2|COMPLETED|Follow Up||277
7846869|NCT00975780|19313861|P1|COMPLETED|Follow Up||298
7846870|NCT00975780|19313860|P2|STARTED|Follow Up||434
7846871|NCT00975780|19313861|P1|STARTED|Follow Up||400
7846872|NCT00975780|19313860|P2|NOT COMPLETED|Allocation||0
7846873|NCT00975780|19313861|P1|NOT COMPLETED|Allocation||0
7846874|NCT00975780|19313860|P2|COMPLETED|Allocation||434
7846875|NCT00975780|19313861|P1|COMPLETED|Allocation||400
7846876|NCT00975780|19313860|P2|STARTED|Allocation||434
7846877|NCT00975780|19313861|P1|STARTED|Allocation||400
7846878|NCT00975715|19313871|P2|NOT COMPLETED|Maintenance Period||1
7846879|NCT00975715|19313872|P1|NOT COMPLETED|Maintenance Period||2
7846880|NCT00975715|19313871|P2|COMPLETED|Maintenance Period||50
7846881|NCT00975715|19313872|P1|COMPLETED|Maintenance Period||39
7846882|NCT00975715|19313871|P2|STARTED|Maintenance Period||51
7846883|NCT00975715|19313872|P1|STARTED|Maintenance Period||41
7846884|NCT00975715|19313871|P2|NOT COMPLETED|Titration Period||0
7846885|NCT00975715|19313872|P1|NOT COMPLETED|Titration Period||7
7846886|NCT00975715|19313871|P2|COMPLETED|Titration Period||51
7846887|NCT00975715|19313872|P1|COMPLETED|Titration Period||41
7846888|NCT00975715|19313871|P2|STARTED|Titration Period||51
7846889|NCT00975715|19313872|P1|STARTED|Titration Period||48
7846890|NCT00975689|19313888|P2|NOT COMPLETED|Overall Study||3
7846891|NCT00975689|19313889|P1|NOT COMPLETED|Overall Study||2
7846892|NCT00975689|19313888|P2|COMPLETED|Overall Study||15
7846893|NCT00975689|19313889|P1|COMPLETED|Overall Study||15
7846894|NCT00975689|19313888|P2|STARTED|Overall Study||18
7846895|NCT00975689|19313889|P1|STARTED|Overall Study||17
7846896|NCT00975650|19313895|P4|NOT COMPLETED|Period 4||0
7846897|NCT00975650|19313896|P3|NOT COMPLETED|Period 4||0
7846898|NCT00975650|19313897|P2|NOT COMPLETED|Period 4||0
7846899|NCT00975650|19313898|P1|NOT COMPLETED|Period 4||0
7846900|NCT00975650|19313895|P4|COMPLETED|Period 4||14
7846901|NCT00975650|19313896|P3|COMPLETED|Period 4||14
7846902|NCT00975650|19313897|P2|COMPLETED|Period 4||14
7846903|NCT00975650|19313898|P1|COMPLETED|Period 4||12
7846904|NCT00975650|19313895|P4|STARTED|Period 4||14
7846905|NCT00975650|19313896|P3|STARTED|Period 4||14
7846906|NCT00975650|19313897|P2|STARTED|Period 4||14
7846907|NCT00975650|19313898|P1|STARTED|Period 4||12
7846908|NCT00975650|19313895|P4|NOT COMPLETED|Period 3||0
7846909|NCT00975650|19313896|P3|NOT COMPLETED|Period 3||0
7846910|NCT00975650|19313897|P2|NOT COMPLETED|Period 3||0
7846911|NCT00975650|19313898|P1|NOT COMPLETED|Period 3||0
7846912|NCT00975650|19313895|P4|COMPLETED|Period 3||14
7846913|NCT00975650|19313896|P3|COMPLETED|Period 3||14
7846914|NCT00975650|19313897|P2|COMPLETED|Period 3||14
7846915|NCT00975650|19313898|P1|COMPLETED|Period 3||12
7846916|NCT00975650|19313895|P4|STARTED|Period 3||14
7846917|NCT00975650|19313896|P3|STARTED|Period 3||14
7846918|NCT00975650|19313897|P2|STARTED|Period 3||14
7846919|NCT00975650|19313898|P1|STARTED|Period 3||12
7846920|NCT00975650|19313895|P4|NOT COMPLETED|Period 2||0
7846921|NCT00975650|19313896|P3|NOT COMPLETED|Period 2||0
7846922|NCT00975650|19313897|P2|NOT COMPLETED|Period 2||2
7846923|NCT00975650|19313898|P1|NOT COMPLETED|Period 2||1
7846924|NCT00975650|19313895|P4|COMPLETED|Period 2||14
7846925|NCT00975650|19313896|P3|COMPLETED|Period 2||14
7846926|NCT00975650|19313897|P2|COMPLETED|Period 2||14
7846927|NCT00975650|19313898|P1|COMPLETED|Period 2||12
7846928|NCT00975650|19313895|P4|STARTED|Period 2||14
7846929|NCT00975650|19313896|P3|STARTED|Period 2||14
7846930|NCT00975650|19313897|P2|STARTED|Period 2||16
7846931|NCT00975650|19313898|P1|STARTED|Period 2||13
7846932|NCT00975650|19313895|P4|NOT COMPLETED|Period 1||0
7846933|NCT00975650|19313896|P3|NOT COMPLETED|Period 1||0
7846934|NCT00975650|19313897|P2|NOT COMPLETED|Period 1||0
7846935|NCT00975650|19313898|P1|NOT COMPLETED|Period 1||0
7846936|NCT00975650|19313895|P4|COMPLETED|Period 1||14
7846937|NCT00975650|19313896|P3|COMPLETED|Period 1||14
7846938|NCT00975650|19313897|P2|COMPLETED|Period 1||16
7846939|NCT00975650|19313898|P1|COMPLETED|Period 1||13
7846940|NCT00975650|19313895|P4|STARTED|Period 1||14
7846941|NCT00975650|19313896|P3|STARTED|Period 1||14
7846942|NCT00975650|19313897|P2|STARTED|Period 1||16
7846943|NCT00975650|19313898|P1|STARTED|Period 1||13
7846944|NCT00975637|19313937|P5|NOT COMPLETED|Overall Study||2
7846945|NCT00975637|19313938|P4|NOT COMPLETED|Overall Study||6
7846946|NCT00975637|19313939|P3|NOT COMPLETED|Overall Study||2
7846947|NCT00975637|19313940|P2|NOT COMPLETED|Overall Study||1
7846948|NCT00975637|19313941|P1|NOT COMPLETED|Overall Study||3
7846949|NCT00975637|19313937|P5|COMPLETED|Overall Study||37
7846950|NCT00975637|19313938|P4|COMPLETED|Overall Study||32
7846951|NCT00975637|19313939|P3|COMPLETED|Overall Study||40
7846952|NCT00975637|19313940|P2|COMPLETED|Overall Study||38
7846953|NCT00975637|19313941|P1|COMPLETED|Overall Study||37
7846954|NCT00975637|19313937|P5|STARTED|Overall Study||39
7846955|NCT00975637|19313938|P4|STARTED|Overall Study||38
7846956|NCT00975637|19313939|P3|STARTED|Overall Study||42
7846957|NCT00975637|19313940|P2|STARTED|Overall Study||39
7846958|NCT00975637|19313941|P1|STARTED|Overall Study||40
7846959|NCT00975611|19313958|P1|NOT COMPLETED|Overall Study||17
7846960|NCT00975611|19313958|P1|COMPLETED|Overall Study||5
7846961|NCT00975611|19313958|P1|STARTED|Overall Study||22
7846962|NCT00975585|19313964|P2|NOT COMPLETED|Overall Study||12
7846963|NCT00975585|19313965|P1|NOT COMPLETED|Overall Study||7
7846964|NCT00975585|19313964|P2|COMPLETED|Overall Study||183
7846965|NCT00975585|19313965|P1|COMPLETED|Overall Study||177
7846966|NCT00975585|19313964|P2|STARTED|Overall Study||195
7846967|NCT00975585|19313965|P1|STARTED|Overall Study||184
7846968|NCT00975507|19313985|P2|NOT COMPLETED|Overall Study||4
7846969|NCT00975507|19313986|P1|NOT COMPLETED|Overall Study||20
7846970|NCT00975507|19313985|P2|COMPLETED|Overall Study||153
7846971|NCT00975507|19313986|P1|COMPLETED|Overall Study||303
7846972|NCT00975507|19313985|P2|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0
7846973|NCT00975507|19313986|P1|Vaccinated at Visit 2|Overall Study||310
7846974|NCT00975507|19313985|P2|Vaccinated at Visit 1|Overall Study||157
7846975|NCT00975507|19313986|P1|Vaccinated at Visit 1|Overall Study||323
7846976|NCT00975507|19313985|P2|STARTED|Overall Study||157
7846977|NCT00975507|19313986|P1|STARTED|Overall Study||323
7846978|NCT00975481|19314006|P6|NOT COMPLETED|Sixth Intervention Period||0
7846979|NCT00975481|19314007|P5|NOT COMPLETED|Sixth Intervention Period||0
7846980|NCT00975481|19314008|P4|NOT COMPLETED|Sixth Intervention Period||0
7846981|NCT00975481|19314009|P3|NOT COMPLETED|Sixth Intervention Period||0
7846982|NCT00975481|19314010|P2|NOT COMPLETED|Sixth Intervention Period||0
7846983|NCT00975481|19314011|P1|NOT COMPLETED|Sixth Intervention Period||0
7846984|NCT00975481|19314006|P6|COMPLETED|Sixth Intervention Period||6
7846985|NCT00975481|19314007|P5|COMPLETED|Sixth Intervention Period||5
7846986|NCT00975481|19314008|P4|COMPLETED|Sixth Intervention Period||5
7846987|NCT00975481|19314009|P3|COMPLETED|Sixth Intervention Period||4
7846988|NCT00975481|19314010|P2|COMPLETED|Sixth Intervention Period||5
7846989|NCT00975481|19314011|P1|COMPLETED|Sixth Intervention Period||4
7846990|NCT00975481|19314006|P6|STARTED|Sixth Intervention Period||6
7846991|NCT00975481|19314007|P5|STARTED|Sixth Intervention Period||5
7846992|NCT00975481|19314008|P4|STARTED|Sixth Intervention Period||5
7846993|NCT00975481|19314009|P3|STARTED|Sixth Intervention Period||4
7846994|NCT00975481|19314010|P2|STARTED|Sixth Intervention Period||5
7846995|NCT00975481|19314011|P1|STARTED|Sixth Intervention Period||4
7846996|NCT00975481|19314006|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7846997|NCT00975481|19314007|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7846998|NCT00975481|19314008|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7846999|NCT00975481|19314009|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847000|NCT00975481|19314010|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847001|NCT00975481|19314011|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847002|NCT00975481|19314006|P6|COMPLETED|Washout Period (at Least 7 Days)||6
7847003|NCT00975481|19314007|P5|COMPLETED|Washout Period (at Least 7 Days)||5
7847004|NCT00975481|19314008|P4|COMPLETED|Washout Period (at Least 7 Days)||5
7847005|NCT00975481|19314009|P3|COMPLETED|Washout Period (at Least 7 Days)||4
7847006|NCT00975481|19314010|P2|COMPLETED|Washout Period (at Least 7 Days)||5
7847007|NCT00975481|19314011|P1|COMPLETED|Washout Period (at Least 7 Days)||4
7847008|NCT00975481|19314006|P6|STARTED|Washout Period (at Least 7 Days)||6
7847009|NCT00975481|19314007|P5|STARTED|Washout Period (at Least 7 Days)||5
7847010|NCT00975481|19314008|P4|STARTED|Washout Period (at Least 7 Days)||5
7847011|NCT00975481|19314009|P3|STARTED|Washout Period (at Least 7 Days)||4
7847012|NCT00975481|19314010|P2|STARTED|Washout Period (at Least 7 Days)||5
7847013|NCT00975481|19314011|P1|STARTED|Washout Period (at Least 7 Days)||4
7847014|NCT00975481|19314006|P6|NOT COMPLETED|Fifth Intervention Period||0
7847015|NCT00975481|19314007|P5|NOT COMPLETED|Fifth Intervention Period||1
7847016|NCT00975481|19314008|P4|NOT COMPLETED|Fifth Intervention Period||0
7847017|NCT00975481|19314009|P3|NOT COMPLETED|Fifth Intervention Period||0
7847018|NCT00975481|19314010|P2|NOT COMPLETED|Fifth Intervention Period||0
7847019|NCT00975481|19314011|P1|NOT COMPLETED|Fifth Intervention Period||0
7847020|NCT00975481|19314006|P6|COMPLETED|Fifth Intervention Period||6
7847021|NCT00975481|19314007|P5|COMPLETED|Fifth Intervention Period||5
7847022|NCT00975481|19314008|P4|COMPLETED|Fifth Intervention Period||5
7847023|NCT00975481|19314009|P3|COMPLETED|Fifth Intervention Period||4
7847024|NCT00975481|19314010|P2|COMPLETED|Fifth Intervention Period||5
7847025|NCT00975481|19314011|P1|COMPLETED|Fifth Intervention Period||4
7847026|NCT00975481|19314006|P6|STARTED|Fifth Intervention Period||6
7847027|NCT00975481|19314007|P5|STARTED|Fifth Intervention Period||6
7847028|NCT00975481|19314008|P4|STARTED|Fifth Intervention Period||5
7847029|NCT00975481|19314009|P3|STARTED|Fifth Intervention Period||4
7847030|NCT00975481|19314010|P2|STARTED|Fifth Intervention Period||5
7847031|NCT00975481|19314011|P1|STARTED|Fifth Intervention Period||4
7847032|NCT00975481|19314006|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847033|NCT00975481|19314007|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847034|NCT00975481|19314008|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847116|NCT00975481|19314006|P6|STARTED|Washout Period (at Least 7 Days)||6
7847035|NCT00975481|19314009|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847036|NCT00975481|19314010|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847037|NCT00975481|19314011|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847038|NCT00975481|19314006|P6|COMPLETED|Washout Period (at Least 7 Days)||6
7847039|NCT00975481|19314007|P5|COMPLETED|Washout Period (at Least 7 Days)||6
7847040|NCT00975481|19314008|P4|COMPLETED|Washout Period (at Least 7 Days)||5
7847041|NCT00975481|19314009|P3|COMPLETED|Washout Period (at Least 7 Days)||4
7847042|NCT00975481|19314010|P2|COMPLETED|Washout Period (at Least 7 Days)||5
7847043|NCT00975481|19314011|P1|COMPLETED|Washout Period (at Least 7 Days)||4
7847044|NCT00975481|19314006|P6|STARTED|Washout Period (at Least 7 Days)||6
7847045|NCT00975481|19314007|P5|STARTED|Washout Period (at Least 7 Days)||6
7847046|NCT00975481|19314008|P4|STARTED|Washout Period (at Least 7 Days)||5
7847047|NCT00975481|19314009|P3|STARTED|Washout Period (at Least 7 Days)||4
7847048|NCT00975481|19314010|P2|STARTED|Washout Period (at Least 7 Days)||5
7847049|NCT00975481|19314011|P1|STARTED|Washout Period (at Least 7 Days)||4
7847050|NCT00975481|19314006|P6|NOT COMPLETED|Fourth Intervention Period||0
7847051|NCT00975481|19314007|P5|NOT COMPLETED|Fourth Intervention Period||0
7847052|NCT00975481|19314008|P4|NOT COMPLETED|Fourth Intervention Period||1
7847053|NCT00975481|19314009|P3|NOT COMPLETED|Fourth Intervention Period||1
7847054|NCT00975481|19314010|P2|NOT COMPLETED|Fourth Intervention Period||0
7847055|NCT00975481|19314011|P1|NOT COMPLETED|Fourth Intervention Period||0
7847056|NCT00975481|19314006|P6|COMPLETED|Fourth Intervention Period||6
7847057|NCT00975481|19314007|P5|COMPLETED|Fourth Intervention Period||6
7847058|NCT00975481|19314008|P4|COMPLETED|Fourth Intervention Period||5
7847059|NCT00975481|19314009|P3|COMPLETED|Fourth Intervention Period||4
7847060|NCT00975481|19314010|P2|COMPLETED|Fourth Intervention Period||5
7847061|NCT00975481|19314011|P1|COMPLETED|Fourth Intervention Period||4
7847062|NCT00975481|19314006|P6|STARTED|Fourth Intervention Period||6
7847063|NCT00975481|19314007|P5|STARTED|Fourth Intervention Period||6
7847064|NCT00975481|19314008|P4|STARTED|Fourth Intervention Period||6
7847065|NCT00975481|19314009|P3|STARTED|Fourth Intervention Period||5
7847066|NCT00975481|19314010|P2|STARTED|Fourth Intervention Period||5
7847067|NCT00975481|19314011|P1|STARTED|Fourth Intervention Period||4
7847068|NCT00975481|19314006|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847069|NCT00975481|19314007|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847070|NCT00975481|19314008|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847071|NCT00975481|19314009|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847072|NCT00975481|19314010|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847073|NCT00975481|19314011|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847074|NCT00975481|19314006|P6|COMPLETED|Washout Period (at Least 7 Days)||6
7847075|NCT00975481|19314007|P5|COMPLETED|Washout Period (at Least 7 Days)||6
7847076|NCT00975481|19314008|P4|COMPLETED|Washout Period (at Least 7 Days)||6
7847077|NCT00975481|19314009|P3|COMPLETED|Washout Period (at Least 7 Days)||5
7847078|NCT00975481|19314010|P2|COMPLETED|Washout Period (at Least 7 Days)||5
7847079|NCT00975481|19314011|P1|COMPLETED|Washout Period (at Least 7 Days)||4
7847080|NCT00975481|19314006|P6|STARTED|Washout Period (at Least 7 Days)||6
7847081|NCT00975481|19314007|P5|STARTED|Washout Period (at Least 7 Days)||6
7847082|NCT00975481|19314008|P4|STARTED|Washout Period (at Least 7 Days)||6
7847083|NCT00975481|19314009|P3|STARTED|Washout Period (at Least 7 Days)||5
7847084|NCT00975481|19314010|P2|STARTED|Washout Period (at Least 7 Days)||5
7847085|NCT00975481|19314011|P1|STARTED|Washout Period (at Least 7 Days)||4
7847086|NCT00975481|19314006|P6|NOT COMPLETED|Third Intervention Period||0
7847087|NCT00975481|19314007|P5|NOT COMPLETED|Third Intervention Period||0
7847088|NCT00975481|19314008|P4|NOT COMPLETED|Third Intervention Period||0
7847089|NCT00975481|19314009|P3|NOT COMPLETED|Third Intervention Period||0
7847090|NCT00975481|19314010|P2|NOT COMPLETED|Third Intervention Period||0
7847091|NCT00975481|19314011|P1|NOT COMPLETED|Third Intervention Period||0
7847092|NCT00975481|19314006|P6|COMPLETED|Third Intervention Period||6
7847093|NCT00975481|19314007|P5|COMPLETED|Third Intervention Period||6
7847094|NCT00975481|19314008|P4|COMPLETED|Third Intervention Period||6
7847095|NCT00975481|19314009|P3|COMPLETED|Third Intervention Period||5
7847096|NCT00975481|19314010|P2|COMPLETED|Third Intervention Period||5
7847097|NCT00975481|19314011|P1|COMPLETED|Third Intervention Period||4
7847098|NCT00975481|19314006|P6|STARTED|Third Intervention Period||6
7847099|NCT00975481|19314007|P5|STARTED|Third Intervention Period||6
7847100|NCT00975481|19314008|P4|STARTED|Third Intervention Period||6
7847101|NCT00975481|19314009|P3|STARTED|Third Intervention Period||5
7847102|NCT00975481|19314010|P2|STARTED|Third Intervention Period||5
7847103|NCT00975481|19314011|P1|STARTED|Third Intervention Period||4
7847104|NCT00975481|19314006|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847105|NCT00975481|19314007|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847106|NCT00975481|19314008|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847107|NCT00975481|19314009|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847108|NCT00975481|19314010|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847109|NCT00975481|19314011|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847110|NCT00975481|19314006|P6|COMPLETED|Washout Period (at Least 7 Days)||6
7847111|NCT00975481|19314007|P5|COMPLETED|Washout Period (at Least 7 Days)||6
7847112|NCT00975481|19314008|P4|COMPLETED|Washout Period (at Least 7 Days)||6
7847113|NCT00975481|19314009|P3|COMPLETED|Washout Period (at Least 7 Days)||5
7847114|NCT00975481|19314010|P2|COMPLETED|Washout Period (at Least 7 Days)||5
7847115|NCT00975481|19314011|P1|COMPLETED|Washout Period (at Least 7 Days)||4
7847117|NCT00975481|19314007|P5|STARTED|Washout Period (at Least 7 Days)||6
7847118|NCT00975481|19314008|P4|STARTED|Washout Period (at Least 7 Days)||6
7847119|NCT00975481|19314009|P3|STARTED|Washout Period (at Least 7 Days)||5
7847120|NCT00975481|19314010|P2|STARTED|Washout Period (at Least 7 Days)||5
7847121|NCT00975481|19314011|P1|STARTED|Washout Period (at Least 7 Days)||4
7847122|NCT00975481|19314006|P6|NOT COMPLETED|Second Intervention Period||0
7847123|NCT00975481|19314007|P5|NOT COMPLETED|Second Intervention Period||0
7847124|NCT00975481|19314008|P4|NOT COMPLETED|Second Intervention Period||0
7847125|NCT00975481|19314009|P3|NOT COMPLETED|Second Intervention Period||1
7847126|NCT00975481|19314010|P2|NOT COMPLETED|Second Intervention Period||1
7847127|NCT00975481|19314011|P1|NOT COMPLETED|Second Intervention Period||2
7847128|NCT00975481|19314006|P6|COMPLETED|Second Intervention Period||6
7847129|NCT00975481|19314007|P5|COMPLETED|Second Intervention Period||6
7847130|NCT00975481|19314008|P4|COMPLETED|Second Intervention Period||6
7847131|NCT00975481|19314009|P3|COMPLETED|Second Intervention Period||5
7847132|NCT00975481|19314010|P2|COMPLETED|Second Intervention Period||5
7847133|NCT00975481|19314011|P1|COMPLETED|Second Intervention Period||4
7847134|NCT00975481|19314006|P6|STARTED|Second Intervention Period||6
7847135|NCT00975481|19314007|P5|STARTED|Second Intervention Period||6
7847136|NCT00975481|19314008|P4|STARTED|Second Intervention Period||6
7847137|NCT00975481|19314009|P3|STARTED|Second Intervention Period||6
7847138|NCT00975481|19314010|P2|STARTED|Second Intervention Period||6
7847139|NCT00975481|19314011|P1|STARTED|Second Intervention Period||6
7847140|NCT00975481|19314006|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847141|NCT00975481|19314007|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847142|NCT00975481|19314008|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847143|NCT00975481|19314009|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847144|NCT00975481|19314010|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847145|NCT00975481|19314011|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
7847146|NCT00975481|19314006|P6|COMPLETED|Washout Period (at Least 7 Days)||6
7847147|NCT00975481|19314007|P5|COMPLETED|Washout Period (at Least 7 Days)||6
7847148|NCT00975481|19314008|P4|COMPLETED|Washout Period (at Least 7 Days)||6
7847149|NCT00975481|19314009|P3|COMPLETED|Washout Period (at Least 7 Days)||6
7847150|NCT00975481|19314010|P2|COMPLETED|Washout Period (at Least 7 Days)||6
7847151|NCT00975481|19314011|P1|COMPLETED|Washout Period (at Least 7 Days)||6
7847152|NCT00975481|19314006|P6|STARTED|Washout Period (at Least 7 Days)||6
7847153|NCT00975481|19314007|P5|STARTED|Washout Period (at Least 7 Days)||6
7847154|NCT00975481|19314008|P4|STARTED|Washout Period (at Least 7 Days)||6
7847155|NCT00975481|19314009|P3|STARTED|Washout Period (at Least 7 Days)||6
7847156|NCT00975481|19314010|P2|STARTED|Washout Period (at Least 7 Days)||6
7847157|NCT00975481|19314011|P1|STARTED|Washout Period (at Least 7 Days)||6
7847158|NCT00975481|19314006|P6|NOT COMPLETED|First Intervention Period||0
7847159|NCT00975481|19314007|P5|NOT COMPLETED|First Intervention Period||0
7847160|NCT00975481|19314008|P4|NOT COMPLETED|First Intervention Period||0
7847161|NCT00975481|19314009|P3|NOT COMPLETED|First Intervention Period||0
7847162|NCT00975481|19314010|P2|NOT COMPLETED|First Intervention Period||0
7847163|NCT00975481|19314011|P1|NOT COMPLETED|First Intervention Period||0
7847164|NCT00975481|19314006|P6|COMPLETED|First Intervention Period||6
7847165|NCT00975481|19314007|P5|COMPLETED|First Intervention Period||6
7847166|NCT00975481|19314008|P4|COMPLETED|First Intervention Period||6
7847167|NCT00975481|19314009|P3|COMPLETED|First Intervention Period||6
7847168|NCT00975481|19314010|P2|COMPLETED|First Intervention Period||6
7847169|NCT00975481|19314011|P1|COMPLETED|First Intervention Period||6
7847170|NCT00975481|19314006|P6|STARTED|First Intervention Period||6
7847171|NCT00975481|19314007|P5|STARTED|First Intervention Period||6
7847172|NCT00975481|19314008|P4|STARTED|First Intervention Period||6
7847173|NCT00975481|19314009|P3|STARTED|First Intervention Period||6
7847174|NCT00975481|19314010|P2|STARTED|First Intervention Period||6
7847175|NCT00975481|19314011|P1|STARTED|First Intervention Period||6
7847176|NCT00975416|19314111|P2|NOT COMPLETED|Overall Study||5
7847177|NCT00975416|19314112|P1|NOT COMPLETED|Overall Study||3
7847178|NCT00975416|19314111|P2|COMPLETED|Overall Study||11
7847179|NCT00975416|19314112|P1|COMPLETED|Overall Study||11
7847180|NCT00975416|19314111|P2|STARTED|Overall Study||16
7847181|NCT00975416|19314112|P1|STARTED|Overall Study||14
7847182|NCT00975286|19314121|P2|NOT COMPLETED|Overall Study||29
7847183|NCT00975286|19314122|P1|NOT COMPLETED|Overall Study||12
7847184|NCT00975286|19314121|P2|COMPLETED|Overall Study||194
7847185|NCT00975286|19314122|P1|COMPLETED|Overall Study||211
7847186|NCT00975286|19314121|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||223
7847187|NCT00975286|19314122|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223
7847188|NCT00975286|19314121|P2|Safety Population|Overall Study||223
7847189|NCT00975286|19314122|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223
7847190|NCT00975286|19314121|P2|STARTED|Overall Study||223
7847191|NCT00975286|19314122|P1|STARTED|Overall Study|Randomized.|223
7847192|NCT00975221|19314154|P2|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1
7847193|NCT00975221|19314155|P1|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2
7847194|NCT00975221|19314154|P2|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
7847195|NCT00975221|19314155|P1|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
7847196|NCT00975221|19314154|P2|STARTED|Open-label Extension Phase (Weeks 29-52)||28
7847197|NCT00975221|19314155|P1|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29
7847198|NCT00975221|19314154|P2|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1
7847199|NCT00975221|19314155|P1|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0
7847200|NCT00975221|19314154|P2|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28
7847201|NCT00975221|19314155|P1|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30
7847202|NCT00975221|19314154|P2|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29
7847203|NCT00975221|19314155|P1|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30
7847204|NCT00975221|19314154|P2|NOT COMPLETED|Titration Phase (Weeks 1-12)||4
7847205|NCT00975221|19314155|P1|NOT COMPLETED|Titration Phase (Weeks 1-12)||3
7847206|NCT00975221|19314154|P2|COMPLETED|Titration Phase (Weeks 1-12)||29
7847207|NCT00975221|19314155|P1|COMPLETED|Titration Phase (Weeks 1-12)||31
7847208|NCT00975221|19314154|P2|Received Study Drug|Titration Phase (Weeks 1-12)||33
7847209|NCT00975221|19314155|P1|Received Study Drug|Titration Phase (Weeks 1-12)||34
7847210|NCT00975221|19314154|P2|STARTED|Titration Phase (Weeks 1-12)||33
7847211|NCT00975221|19314155|P1|STARTED|Titration Phase (Weeks 1-12)||34
7847212|NCT00975195|19314171|P2|NOT COMPLETED|Overall Study||233
7847213|NCT00975195|19314172|P1|NOT COMPLETED|Overall Study||228
7847214|NCT00975195|19314171|P2|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011
7847215|NCT00975195|19314172|P1|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016
7847216|NCT00975195|19314171|P2|STARTED|Overall Study||1244
7847217|NCT00975195|19314172|P1|STARTED|Overall Study||1244
7847218|NCT00975156|19314232|P2|NOT COMPLETED|Overall Study||1
7847219|NCT00975156|19314233|P1|NOT COMPLETED|Overall Study||0
7847220|NCT00975156|19314232|P2|COMPLETED|Overall Study||9
7847221|NCT00975156|19314233|P1|COMPLETED|Overall Study||11
7847222|NCT00975156|19314232|P2|STARTED|Overall Study||10
7847223|NCT00975156|19314233|P1|STARTED|Overall Study||11
7847224|NCT00975143|19314245|P2|NOT COMPLETED|Overall Study||60
7847225|NCT00975143|19314246|P1|NOT COMPLETED|Overall Study||70
7847226|NCT00975143|19314245|P2|COMPLETED|Overall Study||401
7847227|NCT00975143|19314246|P1|COMPLETED|Overall Study||394
7847228|NCT00975143|19314245|P2|Completed Treatment (Week 20)|Overall Study||410
7847229|NCT00975143|19314246|P1|Completed Treatment (Week 20)|Overall Study||403
7847230|NCT00975143|19314245|P2|STARTED|Overall Study||461
7847231|NCT00975143|19314246|P1|STARTED|Overall Study||464
7847232|NCT00975130|19314256|P3|NOT COMPLETED|Study Part 2||17
7847233|NCT00975130|19314257|P2|NOT COMPLETED|Study Part 2||38
7847234|NCT00975130|19314258|P1|NOT COMPLETED|Study Part 2||0
7847235|NCT00975130|19314256|P3|COMPLETED|Study Part 2||238
7847236|NCT00975130|19314257|P2|COMPLETED|Study Part 2||212
7847237|NCT00975130|19314258|P1|COMPLETED|Study Part 2||0
7847238|NCT00975130|19314256|P3|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255
7847239|NCT00975130|19314257|P2|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250
7847240|NCT00975130|19314258|P1|STARTED|Study Part 2||0
7847241|NCT00975130|19314256|P3|NOT COMPLETED|Study Part 1||0
7847242|NCT00975130|19314257|P2|NOT COMPLETED|Study Part 1||0
7847243|NCT00975130|19314258|P1|NOT COMPLETED|Study Part 1||280
7847244|NCT00975130|19314256|P3|COMPLETED|Study Part 1||0
7847245|NCT00975130|19314257|P2|COMPLETED|Study Part 1||0
7847246|NCT00975130|19314258|P1|COMPLETED|Study Part 1||3086
7847247|NCT00975130|19314256|P3|STARTED|Study Part 1||0
7847248|NCT00975130|19314257|P2|STARTED|Study Part 1||0
7847249|NCT00975130|19314258|P1|STARTED|Study Part 1||3366
7847250|NCT00975000|19314442|P2|NOT COMPLETED|Overall Study||5
7847251|NCT00975000|19314443|P1|NOT COMPLETED|Overall Study||5
7847252|NCT00975000|19314442|P2|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
7847253|NCT00975000|19314443|P1|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
7847254|NCT00975000|19314442|P2|Completed Maintenance Phase|Overall Study||52
7847255|NCT00975000|19314443|P1|Completed Maintenance Phase|Overall Study||52
7847256|NCT00975000|19314442|P2|Completed Efficacy Assessment Phase|Overall Study||54
7847257|NCT00975000|19314443|P1|Completed Efficacy Assessment Phase|Overall Study||54
7847258|NCT00975000|19314442|P2|Completed Titration Phase|Overall Study||55
7847259|NCT00975000|19314443|P1|Completed Titration Phase|Overall Study||54
7847260|NCT00975000|19314442|P2|STARTED|Overall Study||57
7847261|NCT00975000|19314443|P1|STARTED|Overall Study||57
7847262|NCT00974974|19314467|P2|NOT COMPLETED|Maintenance - Double Blind Treatment||10
7847263|NCT00974974|19314468|P1|NOT COMPLETED|Maintenance - Double Blind Treatment||15
7847264|NCT00974974|19314467|P2|COMPLETED|Maintenance - Double Blind Treatment||182
7847265|NCT00974974|19314468|P1|COMPLETED|Maintenance - Double Blind Treatment||186
7847266|NCT00974974|19314467|P2|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|192
7847267|NCT00974974|19314468|P1|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|201
7847268|NCT00974974|19314467|P2|NOT COMPLETED|IPX066 Dose Conversion||0
7847269|NCT00974974|19314468|P1|NOT COMPLETED|IPX066 Dose Conversion||57
7847270|NCT00974974|19314467|P2|COMPLETED|IPX066 Dose Conversion||0
7847271|NCT00974974|19314468|P1|COMPLETED|IPX066 Dose Conversion||393
7847272|NCT00974974|19314467|P2|STARTED|IPX066 Dose Conversion|IR is not applicable in IPX066 dose conversion.|0
7847273|NCT00974974|19314468|P1|STARTED|IPX066 Dose Conversion|All subjects who completed IR Dose adjustment entered into IPX066 dose conversion.|450
7847274|NCT00974974|19314467|P2|NOT COMPLETED|IR CD-LD Dose Adjustment||21
7847275|NCT00974974|19314468|P1|NOT COMPLETED|IR CD-LD Dose Adjustment||0
7847276|NCT00974974|19314467|P2|COMPLETED|IR CD-LD Dose Adjustment||450
7847277|NCT00974974|19314468|P1|COMPLETED|IR CD-LD Dose Adjustment||0
7847278|NCT00974974|19314467|P2|STARTED|IR CD-LD Dose Adjustment||471
7847279|NCT00974974|19314468|P1|STARTED|IR CD-LD Dose Adjustment||0
7847280|NCT00974922|19314478|P1|NOT COMPLETED|Overall Study||24
7847281|NCT00974922|19314478|P1|COMPLETED|Overall Study||16
7847282|NCT00974922|19314478|P1|STARTED|Overall Study||40
7847283|NCT00974818|19314485|P2|NOT COMPLETED|Overall Study||0
7847284|NCT00974818|19314486|P1|NOT COMPLETED|Overall Study||0
7847285|NCT00974818|19314485|P2|COMPLETED|Overall Study||25
7847286|NCT00974818|19314486|P1|COMPLETED|Overall Study||25
7847287|NCT00974818|19314485|P2|STARTED|Overall Study||25
7847288|NCT00974818|19314486|P1|STARTED|Overall Study||25
7847289|NCT00974675|19314496|P4|NOT COMPLETED|Overall Study||2
7847290|NCT00974675|19314497|P3|NOT COMPLETED|Overall Study||2
7847291|NCT00974675|19314498|P2|NOT COMPLETED|Overall Study||1
7847292|NCT00974675|19314499|P1|NOT COMPLETED|Overall Study||2
7847293|NCT00974675|19314496|P4|COMPLETED|Overall Study||2
7847294|NCT00974675|19314497|P3|COMPLETED|Overall Study||1
7847295|NCT00974675|19314498|P2|COMPLETED|Overall Study||7
7847296|NCT00974675|19314499|P1|COMPLETED|Overall Study||6
7847297|NCT00974675|19314496|P4|STARTED|Overall Study||4
7847298|NCT00974675|19314497|P3|STARTED|Overall Study||3
7847299|NCT00974675|19314498|P2|STARTED|Overall Study||8
7847300|NCT00974675|19314499|P1|STARTED|Overall Study||8
7847301|NCT00974571|19314548|P3|NOT COMPLETED|Overall Study||83
7847302|NCT00974571|19314549|P2|NOT COMPLETED|Overall Study||16
7847303|NCT00974571|19314550|P1|NOT COMPLETED|Overall Study||68
7847304|NCT00974571|19314548|P3|COMPLETED|Overall Study||530
7847305|NCT00974571|19314549|P2|COMPLETED|Overall Study||106
7847306|NCT00974571|19314550|P1|COMPLETED|Overall Study||562
7847307|NCT00974571|19314548|P3|STARTED|Overall Study||613
7847308|NCT00974571|19314549|P2|STARTED|Overall Study||122
7847309|NCT00974571|19314550|P1|STARTED|Overall Study||630
7847310|NCT00974493|19314572|P2|NOT COMPLETED|Overall Study||21
7847311|NCT00974493|19314573|P1|NOT COMPLETED|Overall Study||18
7847312|NCT00974493|19314572|P2|COMPLETED|Overall Study||506
7847313|NCT00974493|19314573|P1|COMPLETED|Overall Study||509
7847314|NCT00974493|19314572|P2|STARTED|Overall Study||527
7847315|NCT00974493|19314573|P1|STARTED|Overall Study||527
7847316|NCT00974480|19314582|P3|NOT COMPLETED|Overall Study||10
7847317|NCT00974480|19314583|P2|NOT COMPLETED|Overall Study||7
7847318|NCT00974480|19314584|P1|NOT COMPLETED|Overall Study||11
7847319|NCT00974480|19314582|P3|COMPLETED|Overall Study||30
7847320|NCT00974480|19314583|P2|COMPLETED|Overall Study||33
7847321|NCT00974480|19314584|P1|COMPLETED|Overall Study||29
7847322|NCT00974480|19314582|P3|STARTED|Overall Study||40
7847323|NCT00974480|19314583|P2|STARTED|Overall Study||40
7847324|NCT00974480|19314584|P1|STARTED|Overall Study||40
7847325|NCT00974376|19314624|P2|NOT COMPLETED|Overall Study||33
7847326|NCT00974376|19314625|P1|NOT COMPLETED|Overall Study||34
7847327|NCT00974376|19314624|P2|COMPLETED|Overall Study||42
7847328|NCT00974376|19314625|P1|COMPLETED|Overall Study||41
7847329|NCT00974376|19314624|P2|STARTED|Overall Study||75
7847330|NCT00974376|19314625|P1|STARTED|Overall Study||75
7847331|NCT00974363|19314633|P2|NOT COMPLETED|Overall Study||0
7847332|NCT00974363|19314634|P1|NOT COMPLETED|Overall Study||0
7847333|NCT00974363|19314633|P2|COMPLETED|Overall Study||168
7847334|NCT00974363|19314634|P1|COMPLETED|Overall Study||521
7847335|NCT00974363|19314633|P2|STARTED|Overall Study||168
7847336|NCT00974363|19314634|P1|STARTED|Overall Study||521
7847337|NCT00974311|19314656|P2|NOT COMPLETED|OLE Phase (up to 77 Months)||50
7847338|NCT00974311|19314657|P1|NOT COMPLETED|OLE Phase (up to 77 Months)||109
7847339|NCT00974311|19314656|P2|COMPLETED|OLE Phase (up to 77 Months)||0
7847340|NCT00974311|19314657|P1|COMPLETED|OLE Phase (up to 77 Months)||0
7847341|NCT00974311|19314656|P2|STARTED|OLE Phase (up to 77 Months)||50
7847342|NCT00974311|19314657|P1|STARTED|OLE Phase (up to 77 Months)||109
7847343|NCT00974311|19314656|P2|NOT COMPLETED|DB Phase (up to 24 Months)||349
7847344|NCT00974311|19314657|P1|NOT COMPLETED|DB Phase (up to 24 Months)||691
7847345|NCT00974311|19314656|P2|COMPLETED|DB Phase (up to 24 Months)||50
7847346|NCT00974311|19314657|P1|COMPLETED|DB Phase (up to 24 Months)||109
7847347|NCT00974311|19314656|P2|STARTED|DB Phase (up to 24 Months)||399
7847348|NCT00974311|19314657|P1|STARTED|DB Phase (up to 24 Months)||800
7847349|NCT00974259|19314695|P2|NOT COMPLETED|Overall Study||1
7847350|NCT00974259|19314696|P1|NOT COMPLETED|Overall Study||2
7847351|NCT00974259|19314695|P2|COMPLETED|Overall Study||62
7847352|NCT00974259|19314696|P1|COMPLETED|Overall Study||57
7847353|NCT00974259|19314695|P2|STARTED|Overall Study||63
7847354|NCT00974259|19314696|P1|STARTED|Overall Study||59
7847355|NCT00974246|19314708|P1|NOT COMPLETED|Overall Study||0
7847356|NCT00974246|19314708|P1|COMPLETED|Overall Study||27
7847357|NCT00974246|19314708|P1|STARTED|Overall Study||27
7847358|NCT00974233|19314714|P1|NOT COMPLETED|Maintenance Lenalidomide||13
7847359|NCT00974233|19314714|P1|COMPLETED|Maintenance Lenalidomide||6
7847360|NCT00974233|19314714|P1|STARTED|Maintenance Lenalidomide||19
7847361|NCT00974233|19314714|P1|NOT COMPLETED|Induction Chemoimmunotherapy||15
7847362|NCT00974233|19314714|P1|COMPLETED|Induction Chemoimmunotherapy||19
7847363|NCT00974233|19314714|P1|STARTED|Induction Chemoimmunotherapy||34
7847364|NCT00974220|19314729|P2|NOT COMPLETED|Treatment Period 2||0
7847365|NCT00974220|19314730|P1|NOT COMPLETED|Treatment Period 2||0
7847366|NCT00974220|19314729|P2|COMPLETED|Treatment Period 2||5
7847367|NCT00974220|19314730|P1|COMPLETED|Treatment Period 2||7
7847368|NCT00974220|19314729|P2|STARTED|Treatment Period 2||5
7847369|NCT00974220|19314730|P1|STARTED|Treatment Period 2||7
7847370|NCT00974220|19314729|P2|NOT COMPLETED|Treatment Period 1||2
7847371|NCT00974220|19314730|P1|NOT COMPLETED|Treatment Period 1||2
7847372|NCT00974220|19314729|P2|COMPLETED|Treatment Period 1||5
7847373|NCT00974220|19314730|P1|COMPLETED|Treatment Period 1||7
7847374|NCT00974220|19314729|P2|STARTED|Treatment Period 1||7
7847375|NCT00974220|19314730|P1|STARTED|Treatment Period 1||9
7847376|NCT00974142|19314740|P2|NOT COMPLETED|Overall Study||0
7847377|NCT00974142|19314741|P1|NOT COMPLETED|Overall Study||0
7847378|NCT00974142|19314740|P2|COMPLETED|Overall Study||9
7847379|NCT00974142|19314741|P1|COMPLETED|Overall Study||8
7847380|NCT00974142|19314740|P2|STARTED|Overall Study||9
7847381|NCT00974142|19314741|P1|STARTED|Overall Study||8
7847382|NCT00974090|19314775|P2|NOT COMPLETED|Period 2: Open-label Period||10
7847383|NCT00974090|19314776|P1|NOT COMPLETED|Period 2: Open-label Period||8
7847384|NCT00974090|19314775|P2|COMPLETED|Period 2: Open-label Period||85
7847385|NCT00974090|19314776|P1|COMPLETED|Period 2: Open-label Period||87
7847386|NCT00974090|19314775|P2|STARTED|Period 2: Open-label Period||95
7847387|NCT00974090|19314776|P1|STARTED|Period 2: Open-label Period||95
7847388|NCT00974090|19314775|P2|NOT COMPLETED|Period 1: Double Blind Period||1
7847389|NCT00974090|19314776|P1|NOT COMPLETED|Period 1: Double Blind Period||3
7847390|NCT00974090|19314775|P2|COMPLETED|Period 1: Double Blind Period||95
7847391|NCT00974090|19314776|P1|COMPLETED|Period 1: Double Blind Period||95
7847392|NCT00974090|19314775|P2|STARTED|Period 1: Double Blind Period||96
7847393|NCT00974090|19314776|P1|STARTED|Period 1: Double Blind Period||98
7847394|NCT00974051|19314790|P3|NOT COMPLETED|Overall Study||0
7847395|NCT00974051|19314791|P2|NOT COMPLETED|Overall Study||0
7847396|NCT00974051|19314792|P1|NOT COMPLETED|Overall Study||0
7847397|NCT00974051|19314790|P3|COMPLETED|Overall Study||6
7847398|NCT00974051|19314791|P2|COMPLETED|Overall Study||4
7847399|NCT00974051|19314792|P1|COMPLETED|Overall Study||6
7847400|NCT00974051|19314790|P3|STARTED|Overall Study||6
7847401|NCT00974051|19314791|P2|STARTED|Overall Study||4
7847402|NCT00974051|19314792|P1|STARTED|Overall Study||6
7847403|NCT00973973|19314812|P2|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||5
7847404|NCT00973973|19314813|P1|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||6
7847405|NCT00973973|19314812|P2|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||55
7847406|NCT00973973|19314813|P1|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||57
7847407|NCT00973973|19314812|P2|STARTED|Open-label Treatment Phase (Weeks 8-24)||60
7847408|NCT00973973|19314813|P1|STARTED|Open-label Treatment Phase (Weeks 8-24)||63
7847409|NCT00973973|19314812|P2|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||8
7847410|NCT00973973|19314813|P1|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||6
7847411|NCT00973973|19314812|P2|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||60
7847412|NCT00973973|19314813|P1|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||63
7847413|NCT00973973|19314812|P2|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||68
7847414|NCT00973973|19314813|P1|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||69
7847415|NCT00973973|19314812|P2|STARTED|Double-blind Treatment Phase (Weeks 1-8)||68
7847416|NCT00973973|19314813|P1|STARTED|Double-blind Treatment Phase (Weeks 1-8)||69
7847417|NCT00973921|19314873|P1|NOT COMPLETED|Overall Study||9
7847418|NCT00973921|19314873|P1|COMPLETED|Overall Study||31
7847419|NCT00973921|19314873|P1|STARTED|Overall Study||40
7847420|NCT00973856|19314882|P2|NOT COMPLETED|Overall Study||0
7847421|NCT00973856|19314883|P1|NOT COMPLETED|Overall Study||0
7847422|NCT00973856|19314882|P2|COMPLETED|Overall Study||2
7847423|NCT00973856|19314883|P1|COMPLETED|Overall Study||3
7847424|NCT00973856|19314882|P2|STARTED|Overall Study||2
7847425|NCT00973856|19314883|P1|STARTED|Overall Study||3
7847426|NCT00973765|19314890|P2|NOT COMPLETED|Overall Study||14
7847427|NCT00973765|19314891|P1|NOT COMPLETED|Overall Study||8
7847428|NCT00973765|19314890|P2|COMPLETED|Overall Study|102|102
7847429|NCT00973765|19314891|P1|COMPLETED|Overall Study|88|88
7847430|NCT00973765|19314890|P2|STARTED|Overall Study|116|116
7847431|NCT00973765|19314891|P1|STARTED|Overall Study|96|96
7847432|NCT00973752|19314897|P1|NOT COMPLETED|Overall Study||0
7847433|NCT00973752|19314897|P1|COMPLETED|Overall Study||30
7847434|NCT00973752|19314897|P1|STARTED|Overall Study||30
7847435|NCT00973739|19314901|P1|NOT COMPLETED|Overall Study||4
7847436|NCT00973739|19314901|P1|COMPLETED|Overall Study||17
7847437|NCT00973739|19314901|P1|STARTED|Overall Study||21
7847438|NCT00973700|19314913|P5|NOT COMPLETED|Overall Study||10
7847439|NCT00973700|19314914|P4|NOT COMPLETED|Overall Study||18
7847440|NCT00973700|19314915|P3|NOT COMPLETED|Overall Study||10
7847441|NCT00973700|19314916|P2|NOT COMPLETED|Overall Study||2
7847442|NCT00973700|19314917|P1|NOT COMPLETED|Overall Study||7
7847443|NCT00973700|19314913|P5|COMPLETED|Overall Study||158
7847444|NCT00973700|19314914|P4|COMPLETED|Overall Study||318
7847445|NCT00973700|19314915|P3|COMPLETED|Overall Study||158
7847446|NCT00973700|19314916|P2|COMPLETED|Overall Study||54
7847447|NCT00973700|19314917|P1|COMPLETED|Overall Study||49
7847448|NCT00973700|19314913|P5|STARTED|Overall Study||168
7847449|NCT00973700|19314914|P4|STARTED|Overall Study||336
7847450|NCT00973700|19314915|P3|STARTED|Overall Study||168
7847451|NCT00973700|19314916|P2|STARTED|Overall Study||56
7847452|NCT00973700|19314917|P1|STARTED|Overall Study||56
7847453|NCT00973674|19314966|P2|NOT COMPLETED|Overall Study||0
7847454|NCT00973674|19314967|P1|NOT COMPLETED|Overall Study||2
7847455|NCT00973674|19314966|P2|COMPLETED|Overall Study||26
7847456|NCT00973674|19314967|P1|COMPLETED|Overall Study||22
7847457|NCT00973674|19314966|P2|STARTED|Overall Study||26
7847458|NCT00973674|19314967|P1|STARTED|Overall Study||24
7847459|NCT00973622|19314981|P2|NOT COMPLETED|Overall Study||5
7847460|NCT00973622|19314982|P1|NOT COMPLETED|Overall Study||31
7847461|NCT00973622|19314981|P2|COMPLETED|Overall Study|Completed three sessions of rTMS|14
7847462|NCT00973622|19314982|P1|COMPLETED|Overall Study|Completed three sessions of rTMS|16
7847463|NCT00973622|19314981|P2|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19
7847464|NCT00973622|19314982|P1|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47
7847465|NCT00973479|19314990|P2|NOT COMPLETED|Overall Study||69
7847466|NCT00973479|19314991|P1|NOT COMPLETED|Overall Study||37
7847467|NCT00973479|19314990|P2|COMPLETED|Overall Study||326
7847468|NCT00973479|19314991|P1|COMPLETED|Overall Study||160
7847469|NCT00973479|19314990|P2|STARTED|Overall Study||395
7847470|NCT00973479|19314991|P1|STARTED|Overall Study||197
7847471|NCT00973362|19315009|P2|NOT COMPLETED|3-Year Follow-up||0
7847472|NCT00973362|19315010|P1|NOT COMPLETED|3-Year Follow-up||17
7847473|NCT00973362|19315009|P2|COMPLETED|3-Year Follow-up||0
7847474|NCT00973362|19315010|P1|COMPLETED|3-Year Follow-up||10854
7847475|NCT00973362|19315009|P2|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0
7847476|NCT00973362|19315010|P1|STARTED|3-Year Follow-up||10871
7847477|NCT00973362|19315009|P2|NOT COMPLETED|Baseline Evaluation||223
7847478|NCT00973362|19315010|P1|NOT COMPLETED|Baseline Evaluation||773
7847479|NCT00973362|19315009|P2|COMPLETED|Baseline Evaluation||1029
7847480|NCT00973362|19315010|P1|COMPLETED|Baseline Evaluation||10871
7847481|NCT00973362|19315009|P2|Conclusive Disease Status|Baseline Evaluation||939
7847482|NCT00973362|19315010|P1|Conclusive Disease Status|Baseline Evaluation||819
7847483|NCT00973362|19315009|P2|Evaluable for Analysis|Baseline Evaluation||958
7847484|NCT00973362|19315010|P1|Evaluable for Analysis|Baseline Evaluation||10871
7847485|NCT00973362|19315009|P2|STARTED|Baseline Evaluation||1252
7847486|NCT00973362|19315010|P1|STARTED|Baseline Evaluation||11644
7847487|NCT00973349|19315035|P16|NOT COMPLETED|Overall Study||2
7847488|NCT00973349|19315036|P15|NOT COMPLETED|Overall Study||2
7847489|NCT00973349|19315037|P14|NOT COMPLETED|Overall Study||0
7847490|NCT00973349|19315038|P13|NOT COMPLETED|Overall Study||1
7847491|NCT00973349|19315039|P12|NOT COMPLETED|Overall Study||2
7847492|NCT00973349|19315040|P11|NOT COMPLETED|Overall Study||0
7847493|NCT00973349|19315041|P10|NOT COMPLETED|Overall Study||6
7847494|NCT00973349|19315042|P9|NOT COMPLETED|Overall Study||4
7847495|NCT00973349|19315043|P8|NOT COMPLETED|Overall Study||3
7847496|NCT00973349|19315044|P7|NOT COMPLETED|Overall Study||2
7847497|NCT00973349|19315045|P6|NOT COMPLETED|Overall Study||4
7847498|NCT00973349|19315046|P5|NOT COMPLETED|Overall Study||5
7847499|NCT00973349|19315047|P4|NOT COMPLETED|Overall Study||5
7847500|NCT00973349|19315048|P3|NOT COMPLETED|Overall Study||5
7847501|NCT00973349|19315049|P2|NOT COMPLETED|Overall Study||3
7847502|NCT00973349|19315050|P1|NOT COMPLETED|Overall Study||4
7847503|NCT00973349|19315035|P16|COMPLETED|Overall Study||165
7847504|NCT00973349|19315036|P15|COMPLETED|Overall Study||168
7847505|NCT00973349|19315037|P14|COMPLETED|Overall Study||171
7847506|NCT00973349|19315038|P13|COMPLETED|Overall Study||168
7847507|NCT00973349|19315039|P12|COMPLETED|Overall Study||167
7847508|NCT00973349|19315040|P11|COMPLETED|Overall Study||174
7847509|NCT00973349|19315041|P10|COMPLETED|Overall Study||163
7847510|NCT00973349|19315042|P9|COMPLETED|Overall Study||167
7847511|NCT00973349|19315043|P8|COMPLETED|Overall Study||166
7847512|NCT00973349|19315044|P7|COMPLETED|Overall Study||172
7847513|NCT00973349|19315045|P6|COMPLETED|Overall Study||165
7847514|NCT00973349|19315046|P5|COMPLETED|Overall Study||165
7847515|NCT00973349|19315047|P4|COMPLETED|Overall Study||163
7847516|NCT00973349|19315048|P3|COMPLETED|Overall Study||166
7847517|NCT00973349|19315049|P2|COMPLETED|Overall Study||165
7847518|NCT00973349|19315050|P1|COMPLETED|Overall Study||166
7847519|NCT00973349|19315035|P16|STARTED|Overall Study||167
7847520|NCT00973349|19315036|P15|STARTED|Overall Study||170
7847521|NCT00973349|19315037|P14|STARTED|Overall Study||171
7847522|NCT00973349|19315038|P13|STARTED|Overall Study||169
7847523|NCT00973349|19315039|P12|STARTED|Overall Study||169
7847524|NCT00973349|19315040|P11|STARTED|Overall Study||174
7847525|NCT00973349|19315041|P10|STARTED|Overall Study||169
7847526|NCT00973349|19315042|P9|STARTED|Overall Study||171
7847527|NCT00973349|19315043|P8|STARTED|Overall Study||169
7847528|NCT00973349|19315044|P7|STARTED|Overall Study||174
7847529|NCT00973349|19315045|P6|STARTED|Overall Study||169
7847530|NCT00973349|19315046|P5|STARTED|Overall Study||170
7847531|NCT00973349|19315047|P4|STARTED|Overall Study||168
7847532|NCT00973349|19315048|P3|STARTED|Overall Study||171
7847533|NCT00973349|19315049|P2|STARTED|Overall Study||168
7847534|NCT00973349|19315050|P1|STARTED|Overall Study||170
7847535|NCT00973102|19315150|P2|NOT COMPLETED|Overall Study||1
7847536|NCT00973102|19315151|P1|NOT COMPLETED|Overall Study||1
7847537|NCT00973102|19315150|P2|COMPLETED|Overall Study||25
7847538|NCT00973102|19315151|P1|COMPLETED|Overall Study||23
7847539|NCT00973102|19315150|P2|STARTED|Overall Study||26
7847540|NCT00973102|19315151|P1|STARTED|Overall Study||24
7847541|NCT00972959|19315159|P1|NOT COMPLETED|Overall Study||0
7847542|NCT00972959|19315159|P1|COMPLETED|Overall Study||17
7847543|NCT00972959|19315159|P1|STARTED|Overall Study||17
7847544|NCT00972816|19315182|P8|NOT COMPLETED|Overall Study||9
7847545|NCT00972816|19315183|P7|NOT COMPLETED|Overall Study||10
7847546|NCT00972816|19315184|P6|NOT COMPLETED|Overall Study||11
7847547|NCT00972816|19315185|P5|NOT COMPLETED|Overall Study||12
7847548|NCT00972816|19315186|P4|NOT COMPLETED|Overall Study||8
7847549|NCT00972816|19315187|P3|NOT COMPLETED|Overall Study||9
7847550|NCT00972816|19315188|P2|NOT COMPLETED|Overall Study||11
7847551|NCT00972816|19315189|P1|NOT COMPLETED|Overall Study||17
7847552|NCT00972816|19315182|P8|COMPLETED|Overall Study||161
7847553|NCT00972816|19315183|P7|COMPLETED|Overall Study||159
7847554|NCT00972816|19315184|P6|COMPLETED|Overall Study||158
7847555|NCT00972816|19315185|P5|COMPLETED|Overall Study||157
7847556|NCT00972816|19315186|P4|COMPLETED|Overall Study||161
7847557|NCT00972816|19315187|P3|COMPLETED|Overall Study||160
7847558|NCT00972816|19315188|P2|COMPLETED|Overall Study||158
7847559|NCT00972816|19315189|P1|COMPLETED|Overall Study||156
7847560|NCT00972816|19315182|P8|STARTED|Overall Study||170
7847561|NCT00972816|19315183|P7|STARTED|Overall Study||169
7847562|NCT00972816|19315184|P6|STARTED|Overall Study||169
7847563|NCT00972816|19315185|P5|STARTED|Overall Study||169
7847564|NCT00972816|19315186|P4|STARTED|Overall Study||169
7847565|NCT00972816|19315187|P3|STARTED|Overall Study||169
7847566|NCT00972816|19315188|P2|STARTED|Overall Study||169
7847567|NCT00972816|19315189|P1|STARTED|Overall Study||173
7847568|NCT00972777|19315273|P2|NOT COMPLETED|Overall Study||14
7847569|NCT00972777|19315274|P1|NOT COMPLETED|Overall Study||14
7847570|NCT00972777|19315273|P2|COMPLETED|Overall Study||229
7847571|NCT00972777|19315274|P1|COMPLETED|Overall Study||217
7847572|NCT00972777|19315273|P2|STARTED|Overall Study||243
7847573|NCT00972777|19315274|P1|STARTED|Overall Study||231
7847574|NCT00972738|19315289|P3|NOT COMPLETED|Overall Study||29
7847575|NCT00972738|19315290|P2|NOT COMPLETED|Overall Study||6
7847576|NCT00972738|19315291|P1|NOT COMPLETED|Overall Study||21
7847577|NCT00972738|19315289|P3|COMPLETED|Overall Study||492
7847578|NCT00972738|19315290|P2|COMPLETED|Overall Study||165
7847579|NCT00972738|19315291|P1|COMPLETED|Overall Study||501
7847580|NCT00972738|19315289|P3|STARTED|Overall Study||521
7847581|NCT00972738|19315290|P2|STARTED|Overall Study||171
7847582|NCT00972738|19315291|P1|STARTED|Overall Study||522
7847583|NCT00972725|19315316|P2|NOT COMPLETED|Overall Study||0
7847584|NCT00972725|19315317|P1|NOT COMPLETED|Overall Study||0
7847585|NCT00972725|19315316|P2|COMPLETED|Overall Study||15
7847586|NCT00972725|19315317|P1|COMPLETED|Overall Study||13
7847587|NCT00972725|19315316|P2|STARTED|Overall Study||15
7847588|NCT00972725|19315317|P1|STARTED|Overall Study||13
7847589|NCT00972621|19315399|P2|NOT COMPLETED|Overall Study||1
7847590|NCT00972621|19315400|P1|NOT COMPLETED|Overall Study||0
7847591|NCT00972621|19315399|P2|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199
7847592|NCT00972621|19315400|P1|COMPLETED|Overall Study||200
7847593|NCT00972621|19315399|P2|STARTED|Overall Study||200
7847594|NCT00972621|19315400|P1|STARTED|Overall Study||200
7847595|NCT00972595|19315408|P2|NOT COMPLETED|Period 2||0
7847596|NCT00972595|19315409|P1|NOT COMPLETED|Period 2||0
7847597|NCT00972595|19315408|P2|COMPLETED|Period 2||22
7847598|NCT00972595|19315409|P1|COMPLETED|Period 2||22
7847599|NCT00972595|19315408|P2|STARTED|Period 2||22
7847600|NCT00972595|19315409|P1|STARTED|Period 2||22
7847601|NCT00972595|19315408|P2|NOT COMPLETED|Period 1||0
7847602|NCT00972595|19315409|P1|NOT COMPLETED|Period 1||1
7847603|NCT00972595|19315408|P2|COMPLETED|Period 1||22
7847604|NCT00972595|19315409|P1|COMPLETED|Period 1||22
7847605|NCT00972595|19315408|P2|STARTED|Period 1||22
7847606|NCT00972595|19315409|P1|STARTED|Period 1||23
7847607|NCT00972543|19315419|P2|NOT COMPLETED|Overall Study||1
7847608|NCT00972543|19315420|P1|NOT COMPLETED|Overall Study||5
7847609|NCT00972543|19315419|P2|COMPLETED|Overall Study||0
7847610|NCT00972543|19315420|P1|COMPLETED|Overall Study||0
7847611|NCT00972543|19315419|P2|STARTED|Overall Study||1
7847612|NCT00972543|19315420|P1|STARTED|Overall Study||5
7847613|NCT00972530|19315496|P2|NOT COMPLETED|Overall Study||0
7847614|NCT00972530|19315497|P1|NOT COMPLETED|Overall Study||0
7847615|NCT00972530|19315496|P2|COMPLETED|Overall Study||46
7847616|NCT00972530|19315497|P1|COMPLETED|Overall Study||44
7847617|NCT00972530|19315496|P2|STARTED|Overall Study||46
7847618|NCT00972530|19315497|P1|STARTED|Overall Study||44
7847619|NCT00972517|19315503|P6|NOT COMPLETED|Overall Study||0
7847620|NCT00972517|19315504|P5|NOT COMPLETED|Overall Study||1
7847621|NCT00972517|19315505|P4|NOT COMPLETED|Overall Study||3
7847622|NCT00972517|19315506|P3|NOT COMPLETED|Overall Study||0
7847623|NCT00972517|19315507|P2|NOT COMPLETED|Overall Study||1
7847624|NCT00972517|19315508|P1|NOT COMPLETED|Overall Study||0
7847625|NCT00972517|19315503|P6|COMPLETED|Overall Study||58
7847626|NCT00972517|19315504|P5|COMPLETED|Overall Study||33
7847627|NCT00972517|19315505|P4|COMPLETED|Overall Study||27
7847628|NCT00972517|19315506|P3|COMPLETED|Overall Study||60
7847629|NCT00972517|19315507|P2|COMPLETED|Overall Study||30
7847630|NCT00972517|19315508|P1|COMPLETED|Overall Study||31
7847631|NCT00972517|19315503|P6|STARTED|Overall Study||58
7847632|NCT00972517|19315504|P5|STARTED|Overall Study||34
7847633|NCT00972517|19315505|P4|STARTED|Overall Study||30
7847634|NCT00972517|19315506|P3|STARTED|Overall Study||60
7847635|NCT00972517|19315507|P2|STARTED|Overall Study||31
7847636|NCT00972517|19315508|P1|STARTED|Overall Study||31
7847637|NCT00972504|19315603|P1|NOT COMPLETED|Overall Study||3
7847638|NCT00972504|19315603|P1|COMPLETED|Overall Study||51
7847639|NCT00972504|19315603|P1|STARTED|Overall Study||54
7847640|NCT00972478|19315635|P2|NOT COMPLETED|Overall Study||38
7847641|NCT00972478|19315636|P1|NOT COMPLETED|Overall Study||7
7847642|NCT00972478|19315635|P2|COMPLETED|Overall Study||34
7847643|NCT00972478|19315636|P1|COMPLETED|Overall Study||4
7847644|NCT00972478|19315635|P2|Eligible and Began Protocol Therapy|Overall Study||63
7847645|NCT00972478|19315636|P1|Eligible and Began Protocol Therapy|Overall Study||9
7847646|NCT00972478|19315635|P2|STARTED|Overall Study||72
7847647|NCT00972478|19315636|P1|STARTED|Overall Study||11
7847648|NCT00972439|19315648|P2|NOT COMPLETED|Overall Study||0
7847649|NCT00972439|19315649|P1|NOT COMPLETED|Overall Study||0
7847650|NCT00972439|19315648|P2|COMPLETED|Overall Study||16
7847651|NCT00972439|19315649|P1|COMPLETED|Overall Study||17
7847652|NCT00972439|19315648|P2|STARTED|Overall Study||16
7847653|NCT00972439|19315649|P1|STARTED|Overall Study||17
7847654|NCT00972374|19315658|P3|NOT COMPLETED|Overall Study||1
7847655|NCT00972374|19315659|P2|NOT COMPLETED|Overall Study||0
7847656|NCT00972374|19315660|P1|NOT COMPLETED|Overall Study||2
7847657|NCT00972374|19315658|P3|COMPLETED|Overall Study||13
7847658|NCT00972374|19315659|P2|COMPLETED|Overall Study||15
7847659|NCT00972374|19315660|P1|COMPLETED|Overall Study||13
7847660|NCT00972374|19315658|P3|STARTED|Overall Study||14
7847661|NCT00972374|19315659|P2|STARTED|Overall Study||15
7847662|NCT00972374|19315660|P1|STARTED|Overall Study||15
7847663|NCT00972335|19315674|P1|NOT COMPLETED|Overall Study||17
7847664|NCT00972335|19315674|P1|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0
7847665|NCT00972335|19315674|P1|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17
7847666|NCT00972322|19315681|P2|NOT COMPLETED|Overall Study||3
7847667|NCT00972322|19315682|P1|NOT COMPLETED|Overall Study||3
7847668|NCT00972322|19315681|P2|COMPLETED|Overall Study||25
7847669|NCT00972322|19315682|P1|COMPLETED|Overall Study||25
7847670|NCT00972322|19315681|P2|STARTED|Overall Study||28
7847671|NCT00972322|19315682|P1|STARTED|Overall Study||28
7847672|NCT00972283|19315694|P2|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8
7847673|NCT00972283|19315695|P1|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27
7847674|NCT00972283|19315694|P2|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183
7847675|NCT00972283|19315695|P1|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539
7847676|NCT00972283|19315694|P2|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191
7847677|NCT00972283|19315695|P1|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566
7847678|NCT00972283|19315694|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40
7847679|NCT00972283|19315695|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137
7847680|NCT00972283|19315694|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211
7847681|NCT00972283|19315695|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618
7847682|NCT00972283|19315694|P2|Exposed|Main: Week 0 to 52 (NN1250-3582)||251
7847683|NCT00972283|19315695|P1|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753
7847684|NCT00972283|19315694|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248
7847685|NCT00972283|19315695|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744
7847686|NCT00972283|19315694|P2|STARTED|Main: Week 0 to 52 (NN1250-3582)||251
7847687|NCT00972283|19315695|P1|STARTED|Main: Week 0 to 52 (NN1250-3582)||755
7847688|NCT00972244|19315722|P5|NOT COMPLETED|Overall Study||9
7847689|NCT00972244|19315723|P4|NOT COMPLETED|Overall Study||0
7847690|NCT00972244|19315724|P3|NOT COMPLETED|Overall Study||2
7847691|NCT00972244|19315725|P2|NOT COMPLETED|Overall Study||5
7847692|NCT00972244|19315726|P1|NOT COMPLETED|Overall Study||5
7847693|NCT00972244|19315722|P5|COMPLETED|Overall Study||45
7847694|NCT00972244|19315723|P4|COMPLETED|Overall Study||52
7847695|NCT00972244|19315724|P3|COMPLETED|Overall Study||56
7847696|NCT00972244|19315725|P2|COMPLETED|Overall Study||51
7847697|NCT00972244|19315726|P1|COMPLETED|Overall Study||54
7847698|NCT00972244|19315722|P5|STARTED|Overall Study||54
7847699|NCT00972244|19315723|P4|STARTED|Overall Study||52
7847700|NCT00972244|19315724|P3|STARTED|Overall Study||58
7847701|NCT00972244|19315725|P2|STARTED|Overall Study||56
7847702|NCT00972244|19315726|P1|STARTED|Overall Study||59
7847703|NCT00972205|19315748|P1|NOT COMPLETED|Overall Study||0
7847704|NCT00972205|19315748|P1|COMPLETED|Overall Study||12
7847705|NCT00972205|19315748|P1|STARTED|Overall Study||12
7847706|NCT00972153|19315758|P3|NOT COMPLETED|Overall Study||0
7847707|NCT00972153|19315759|P2|NOT COMPLETED|Overall Study||1
7847708|NCT00972153|19315760|P1|NOT COMPLETED|Overall Study||0
7847709|NCT00972153|19315758|P3|COMPLETED|Overall Study||12
7847710|NCT00972153|19315759|P2|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11
7847711|NCT00972153|19315760|P1|COMPLETED|Overall Study||12
7847712|NCT00972153|19315758|P3|STARTED|Overall Study||12
7847713|NCT00972153|19315759|P2|STARTED|Overall Study||12
7847714|NCT00972153|19315760|P1|STARTED|Overall Study||12
7847715|NCT00972088|19315771|P1|NOT COMPLETED|Overall Study||0
7847716|NCT00972088|19315771|P1|COMPLETED|Overall Study||26
7847717|NCT00972088|19315771|P1|STARTED|Overall Study||26
7847718|NCT00972023|19315775|P1|NOT COMPLETED|Overall Study||1
7847719|NCT00972023|19315775|P1|COMPLETED|Overall Study||0
7847720|NCT00972023|19315775|P1|STARTED|Overall Study||1
7847721|NCT00971997|19315782|P1|NOT COMPLETED|Overall Study||19
7847722|NCT00971997|19315782|P1|COMPLETED|Overall Study||116
7847723|NCT00971997|19315782|P1|STARTED|Overall Study||135
7847724|NCT00971932|19315800|P1|NOT COMPLETED|Overall Study||7
7847725|NCT00971932|19315800|P1|COMPLETED|Overall Study||26
7847726|NCT00971932|19315800|P1|STARTED|Overall Study|Number of participants treated.|33
7847727|NCT00971841|19315810|P1|NOT COMPLETED|Overall Study||0
7847728|NCT00971841|19315810|P1|COMPLETED|Overall Study||1
7847729|NCT00971841|19315810|P1|STARTED|Overall Study||1
7847730|NCT00971789|19315815|P1|NOT COMPLETED|Overall Study||0
7847731|NCT00971789|19315815|P1|COMPLETED|Overall Study||18
7847732|NCT00971789|19315815|P1|STARTED|Overall Study||18
7847733|NCT00971750|19315820|P1|NOT COMPLETED|Overall Study||0
7847734|NCT00971750|19315820|P1|COMPLETED|Overall Study||253
7847735|NCT00971750|19315820|P1|STARTED|Overall Study||253
7847736|NCT00971737|19315831|P2|NOT COMPLETED|Overall Study||0
7847737|NCT00971737|19315832|P1|NOT COMPLETED|Overall Study||0
7847738|NCT00971737|19315831|P2|COMPLETED|Overall Study||30
7847739|NCT00971737|19315832|P1|COMPLETED|Overall Study||30
7847740|NCT00971737|19315831|P2|STARTED|Overall Study||30
7847741|NCT00971737|19315832|P1|STARTED|Overall Study||30
7847742|NCT00971633|19315850|P6|NOT COMPLETED|Period 3||0
7847743|NCT00971633|19315851|P5|NOT COMPLETED|Period 3||0
7847744|NCT00971633|19315852|P4|NOT COMPLETED|Period 3||0
7847745|NCT00971633|19315853|P3|NOT COMPLETED|Period 3||0
7847746|NCT00971633|19315854|P2|NOT COMPLETED|Period 3||0
7847747|NCT00971633|19315855|P1|NOT COMPLETED|Period 3||0
7847748|NCT00971633|19315850|P6|COMPLETED|Period 3||2
7847749|NCT00971633|19315851|P5|COMPLETED|Period 3||2
7847750|NCT00971633|19315852|P4|COMPLETED|Period 3||2
7847751|NCT00971633|19315853|P3|COMPLETED|Period 3||2
7847752|NCT00971633|19315854|P2|COMPLETED|Period 3||2
7847753|NCT00971633|19315855|P1|COMPLETED|Period 3||2
7847754|NCT00971633|19315850|P6|STARTED|Period 3||2
7847755|NCT00971633|19315851|P5|STARTED|Period 3||2
7847756|NCT00971633|19315852|P4|STARTED|Period 3||2
7847757|NCT00971633|19315853|P3|STARTED|Period 3||2
7847758|NCT00971633|19315854|P2|STARTED|Period 3||2
7847759|NCT00971633|19315855|P1|STARTED|Period 3||2
7847760|NCT00971633|19315850|P6|NOT COMPLETED|Period 2||0
7847761|NCT00971633|19315851|P5|NOT COMPLETED|Period 2||0
7847762|NCT00971633|19315852|P4|NOT COMPLETED|Period 2||0
7847763|NCT00971633|19315853|P3|NOT COMPLETED|Period 2||0
7847764|NCT00971633|19315854|P2|NOT COMPLETED|Period 2||0
7847765|NCT00971633|19315855|P1|NOT COMPLETED|Period 2||0
7847766|NCT00971633|19315850|P6|COMPLETED|Period 2||2
7847767|NCT00971633|19315851|P5|COMPLETED|Period 2||2
7847768|NCT00971633|19315852|P4|COMPLETED|Period 2||2
7847769|NCT00971633|19315853|P3|COMPLETED|Period 2||2
7847770|NCT00971633|19315854|P2|COMPLETED|Period 2||2
7847771|NCT00971633|19315855|P1|COMPLETED|Period 2||2
7847772|NCT00971633|19315850|P6|STARTED|Period 2||2
7847773|NCT00971633|19315851|P5|STARTED|Period 2||2
7847774|NCT00971633|19315852|P4|STARTED|Period 2||2
7847775|NCT00971633|19315853|P3|STARTED|Period 2||2
7847776|NCT00971633|19315854|P2|STARTED|Period 2||2
7847777|NCT00971633|19315855|P1|STARTED|Period 2||2
7847778|NCT00971633|19315850|P6|NOT COMPLETED|Period 1||0
7847779|NCT00971633|19315851|P5|NOT COMPLETED|Period 1||0
7847780|NCT00971633|19315852|P4|NOT COMPLETED|Period 1||0
7847781|NCT00971633|19315853|P3|NOT COMPLETED|Period 1||0
7847782|NCT00971633|19315854|P2|NOT COMPLETED|Period 1||0
7847783|NCT00971633|19315855|P1|NOT COMPLETED|Period 1||0
7847784|NCT00971633|19315850|P6|COMPLETED|Period 1||2
7847785|NCT00971633|19315851|P5|COMPLETED|Period 1||2
7847786|NCT00971633|19315852|P4|COMPLETED|Period 1||2
7847787|NCT00971633|19315853|P3|COMPLETED|Period 1||2
7847788|NCT00971633|19315854|P2|COMPLETED|Period 1||2
7847789|NCT00971633|19315855|P1|COMPLETED|Period 1||2
7847790|NCT00971633|19315850|P6|STARTED|Period 1||2
7847791|NCT00971633|19315851|P5|STARTED|Period 1||2
7847792|NCT00971633|19315852|P4|STARTED|Period 1||2
7847793|NCT00971633|19315853|P3|STARTED|Period 1||2
7847794|NCT00971633|19315854|P2|STARTED|Period 1||2
7847795|NCT00971633|19315855|P1|STARTED|Period 1||2
7847796|NCT00971620|19315868|P2|NOT COMPLETED|Overall Study||0
7847797|NCT00971620|19315869|P1|NOT COMPLETED|Overall Study||0
7847798|NCT00971620|19315868|P2|COMPLETED|Overall Study||9
7847799|NCT00971620|19315869|P1|COMPLETED|Overall Study||9
7847800|NCT00971620|19315868|P2|STARTED|Overall Study||9
7847801|NCT00971620|19315869|P1|STARTED|Overall Study||9
7847802|NCT00971425|19315901|P2|NOT COMPLETED|Overall Study||2
7847803|NCT00971425|19315902|P1|NOT COMPLETED|Overall Study||1
7847804|NCT00971425|19315901|P2|COMPLETED|Overall Study||71
7847805|NCT00971425|19315902|P1|COMPLETED|Overall Study||71
7847806|NCT00971425|19315901|P2|STARTED|Overall Study||73
7847807|NCT00971425|19315902|P1|STARTED|Overall Study||72
7847808|NCT00971321|19315938|P2|NOT COMPLETED|Up to Month 11-12||3
7847809|NCT00971321|19315939|P1|NOT COMPLETED|Up to Month 11-12||5
7847810|NCT00971321|19315938|P2|COMPLETED|Up to Month 11-12||50
7847811|NCT00971321|19315939|P1|COMPLETED|Up to Month 11-12||99
7847812|NCT00971321|19315938|P2|STARTED|Up to Month 11-12||53
7847813|NCT00971321|19315939|P1|STARTED|Up to Month 11-12||104
7847814|NCT00971321|19315938|P2|NOT COMPLETED|Up to Month 7||2
7847815|NCT00971321|19315939|P1|NOT COMPLETED|Up to Month 7||4
7847816|NCT00971321|19315938|P2|COMPLETED|Up to Month 7||51
7847817|NCT00971321|19315939|P1|COMPLETED|Up to Month 7||100
7847818|NCT00971321|19315938|P2|STARTED|Up to Month 7||53
7847819|NCT00971321|19315939|P1|STARTED|Up to Month 7||104
7847820|NCT00971321|19315938|P2|NOT COMPLETED|Up to Day 42||0
7847821|NCT00971321|19315939|P1|NOT COMPLETED|Up to Day 42||0
7847822|NCT00971321|19315938|P2|COMPLETED|Up to Day 42||53
7847823|NCT00971321|19315939|P1|COMPLETED|Up to Day 42||104
7847824|NCT00971321|19315938|P2|STARTED|Up to Day 42||53
7847825|NCT00971321|19315939|P1|STARTED|Up to Day 42||104
7847826|NCT00971295|19315989|P2|NOT COMPLETED|Overall Study||1
7847827|NCT00971295|19315990|P1|NOT COMPLETED|Overall Study||0
7847828|NCT00971295|19315989|P2|COMPLETED|Overall Study||9
7847829|NCT00971295|19315990|P1|COMPLETED|Overall Study||10
7847830|NCT00971295|19315989|P2|STARTED|Overall Study||10
7847831|NCT00971295|19315990|P1|STARTED|Overall Study||10
7847832|NCT00971282|19316000|P1|NOT COMPLETED|Overall Study||0
7847833|NCT00971282|19316000|P1|COMPLETED|Overall Study||30
7847834|NCT00971282|19316000|P1|STARTED|Overall Study||30
7847835|NCT00971243|19316019|P5|NOT COMPLETED|Open-label Period||6
7847836|NCT00971243|19316020|P4|NOT COMPLETED|Open-label Period||10
7847837|NCT00971243|19316021|P3|NOT COMPLETED|Open-label Period||5
7847838|NCT00971243|19316022|P2|NOT COMPLETED|Open-label Period||10
7847839|NCT00971243|19316023|P1|NOT COMPLETED|Open-label Period||8
7847840|NCT00971243|19316019|P5|COMPLETED|Open-label Period||64
7847841|NCT00971243|19316020|P4|COMPLETED|Open-label Period||64
7847842|NCT00971243|19316021|P3|COMPLETED|Open-label Period||66
7847843|NCT00971243|19316022|P2|COMPLETED|Open-label Period||71
7847844|NCT00971243|19316023|P1|COMPLETED|Open-label Period||60
7847845|NCT00971243|19316019|P5|STARTED|Open-label Period||70
7847846|NCT00971243|19316020|P4|STARTED|Open-label Period||74
7847847|NCT00971243|19316021|P3|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71
7847848|NCT00971243|19316022|P2|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81
7847849|NCT00971243|19316023|P1|STARTED|Open-label Period||68
7847850|NCT00971243|19316019|P5|NOT COMPLETED|Double Blind Period||18
7847851|NCT00971243|19316020|P4|NOT COMPLETED|Double Blind Period||14
7847852|NCT00971243|19316021|P3|NOT COMPLETED|Double Blind Period||19
7847853|NCT00971243|19316022|P2|NOT COMPLETED|Double Blind Period||11
7847854|NCT00971243|19316023|P1|NOT COMPLETED|Double Blind Period||19
7847855|NCT00971243|19316019|P5|COMPLETED|Double Blind Period||70
7847856|NCT00971243|19316020|P4|COMPLETED|Double Blind Period||74
7847857|NCT00971243|19316021|P3|COMPLETED|Double Blind Period||72
7847858|NCT00971243|19316022|P2|COMPLETED|Double Blind Period||82
7847859|NCT00971243|19316023|P1|COMPLETED|Double Blind Period||68
7847860|NCT00971243|19316019|P5|STARTED|Double Blind Period||88
7847861|NCT00971243|19316020|P4|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88
7847862|NCT00971243|19316021|P3|STARTED|Double Blind Period||91
7847863|NCT00971243|19316022|P2|STARTED|Double Blind Period||93
7847864|NCT00971243|19316023|P1|STARTED|Double Blind Period||87
7847865|NCT00971204|19316040|P1|NOT COMPLETED|Overall Study||24
7847866|NCT00971204|19316040|P1|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76
7847867|NCT00971204|19316040|P1|Treated|Overall Study||86
7847868|NCT00971204|19316040|P1|STARTED|Overall Study|100 enrolled participants|100
7847869|NCT00971178|19316047|P3|NOT COMPLETED|Overall Study||2
7847870|NCT00971178|19316048|P2|NOT COMPLETED|Overall Study||2
7847871|NCT00971178|19316049|P1|NOT COMPLETED|Overall Study||2
7847872|NCT00971178|19316047|P3|COMPLETED|Overall Study||33
7847873|NCT00971178|19316048|P2|COMPLETED|Overall Study||33
7847874|NCT00971178|19316049|P1|COMPLETED|Overall Study||33
7847875|NCT00971178|19316047|P3|STARTED|Overall Study||35
7847876|NCT00971178|19316048|P2|STARTED|Overall Study||35
7847877|NCT00971178|19316049|P1|STARTED|Overall Study||35
7847878|NCT00971048|19316061|P4|NOT COMPLETED|Overall Study||2
7847879|NCT00971048|19316062|P3|NOT COMPLETED|Overall Study||1
7847880|NCT00971048|19316063|P2|NOT COMPLETED|Overall Study||2
7847881|NCT00971048|19316064|P1|NOT COMPLETED|Overall Study||1
7847882|NCT00971048|19316061|P4|COMPLETED|Overall Study||11
7847883|NCT00971048|19316062|P3|COMPLETED|Overall Study||11
7847884|NCT00971048|19316063|P2|COMPLETED|Overall Study||31
7847885|NCT00971048|19316064|P1|COMPLETED|Overall Study||29
7847886|NCT00971048|19316061|P4|STARTED|Overall Study||13
7847887|NCT00971048|19316062|P3|STARTED|Overall Study||12
7847888|NCT00971048|19316063|P2|STARTED|Overall Study||33
7847889|NCT00971048|19316064|P1|STARTED|Overall Study||30
7847890|NCT00970944|19316088|P2|NOT COMPLETED|Overall Study||2
7847891|NCT00970944|19316089|P1|NOT COMPLETED|Overall Study||1
7847892|NCT00970944|19316088|P2|COMPLETED|Overall Study||95
7847893|NCT00970944|19316089|P1|COMPLETED|Overall Study||86
7847894|NCT00970944|19316088|P2|STARTED|Overall Study||97
7847895|NCT00970944|19316089|P1|STARTED|Overall Study||87
7847896|NCT00970853|19316099|P2|NOT COMPLETED|Overall Study||0
7847897|NCT00970853|19316100|P1|NOT COMPLETED|Overall Study||0
7847898|NCT00970853|19316099|P2|COMPLETED|Overall Study||98
7847899|NCT00970853|19316100|P1|COMPLETED|Overall Study||89
7847900|NCT00970853|19316099|P2|STARTED|Overall Study||98
7847901|NCT00970853|19316100|P1|STARTED|Overall Study||89
7847902|NCT00970814|19316124|P2|NOT COMPLETED|Overall Study||14
7847903|NCT00970814|19316125|P1|NOT COMPLETED|Overall Study||8
7847904|NCT00970814|19316124|P2|COMPLETED|Overall Study||50
7847905|NCT00970814|19316125|P1|COMPLETED|Overall Study||58
7847906|NCT00970814|19316124|P2|STARTED|Overall Study||64
7847907|NCT00970814|19316125|P1|STARTED|Overall Study||66
7847908|NCT00970736|19316135|P1|NOT COMPLETED|Overall Study||2
7847909|NCT00970736|19316135|P1|COMPLETED|Overall Study||18
7847910|NCT00970736|19316135|P1|STARTED|Overall Study||20
7847911|NCT00970684|19316141|P1|NOT COMPLETED|Overall Study||10
7847912|NCT00970684|19316141|P1|COMPLETED|Overall Study||3
7847913|NCT00970684|19316141|P1|STARTED|Overall Study||13
7847914|NCT00970632|19316150|P3|NOT COMPLETED|Overall Study||18
7847915|NCT00970632|19316151|P2|NOT COMPLETED|Overall Study||15
7847916|NCT00970632|19316152|P1|NOT COMPLETED|Overall Study||24
7847917|NCT00970632|19316150|P3|COMPLETED|Overall Study||150
7847918|NCT00970632|19316151|P2|COMPLETED|Overall Study||156
7847919|NCT00970632|19316152|P1|COMPLETED|Overall Study||148
7847920|NCT00970632|19316150|P3|STARTED|Overall Study||168
7847921|NCT00970632|19316151|P2|STARTED|Overall Study||171
7847922|NCT00970632|19316152|P1|STARTED|Overall Study||172
7847923|NCT00970606|19316210|P2|NOT COMPLETED|Overall Study||0
7847924|NCT00970606|19316211|P1|NOT COMPLETED|Overall Study||0
7847925|NCT00970606|19316210|P2|COMPLETED|Overall Study||3
7847926|NCT00970606|19316211|P1|COMPLETED|Overall Study||4
7847927|NCT00970606|19316210|P2|STARTED|Overall Study||3
7847928|NCT00970606|19316211|P1|STARTED|Overall Study||4
7847929|NCT00970593|19316224|P7|NOT COMPLETED|Overall Study||2
7847930|NCT00970593|19316225|P6|NOT COMPLETED|Overall Study||0
7847931|NCT00970593|19316226|P5|NOT COMPLETED|Overall Study||0
7847932|NCT00970593|19316227|P4|NOT COMPLETED|Overall Study||0
7847933|NCT00970593|19316228|P3|NOT COMPLETED|Overall Study||6
7847934|NCT00970593|19316229|P2|NOT COMPLETED|Overall Study||1
7847935|NCT00970593|19316230|P1|NOT COMPLETED|Overall Study||1
7847936|NCT00970593|19316224|P7|COMPLETED|Overall Study||14
7847937|NCT00970593|19316225|P6|COMPLETED|Overall Study||5
7847938|NCT00970593|19316226|P5|COMPLETED|Overall Study||20
7847939|NCT00970593|19316227|P4|COMPLETED|Overall Study||12
7847940|NCT00970593|19316228|P3|COMPLETED|Overall Study||7
7847941|NCT00970593|19316229|P2|COMPLETED|Overall Study||14
7847942|NCT00970593|19316230|P1|COMPLETED|Overall Study||10
7847943|NCT00970593|19316224|P7|STARTED|Overall Study||16
7847944|NCT00970593|19316225|P6|STARTED|Overall Study||5
7847945|NCT00970593|19316226|P5|STARTED|Overall Study||20
7847946|NCT00970593|19316227|P4|STARTED|Overall Study||12
7847947|NCT00970593|19316228|P3|STARTED|Overall Study||13
7847948|NCT00970593|19316229|P2|STARTED|Overall Study||15
7847949|NCT00970593|19316230|P1|STARTED|Overall Study||11
7847950|NCT00970502|19316312|P1|NOT COMPLETED|Overall Study||1
7847951|NCT00970502|19316312|P1|COMPLETED|Overall Study||14
7847952|NCT00970502|19316312|P1|STARTED|Overall Study||15
7847953|NCT00970489|19316323|P2|NOT COMPLETED|Overall Study||41
7847954|NCT00970489|19316324|P1|NOT COMPLETED|Overall Study||54
7847955|NCT00970489|19316323|P2|COMPLETED|Overall Study||717
7847956|NCT00970489|19316324|P1|COMPLETED|Overall Study||704
7847957|NCT00970489|19316323|P2|STARTED|Overall Study||758
7847958|NCT00970489|19316324|P1|STARTED|Overall Study||758
7847959|NCT00970359|19316336|P1|NOT COMPLETED|Overall Study||4
7847960|NCT00970359|19316336|P1|COMPLETED|Overall Study||20
7847961|NCT00970359|19316336|P1|STARTED|Overall Study||24
7847962|NCT00970320|19316347|P5|NOT COMPLETED|Overall Study||540
7847963|NCT00970320|19316348|P4|NOT COMPLETED|Overall Study||14
7847964|NCT00970320|19316349|P3|NOT COMPLETED|Overall Study||13
7847965|NCT00970320|19316350|P2|NOT COMPLETED|Overall Study||11
7847966|NCT00970320|19316351|P1|NOT COMPLETED|Overall Study||0
7847967|NCT00970320|19316347|P5|COMPLETED|Overall Study||1031
7847968|NCT00970320|19316348|P4|COMPLETED|Overall Study||36
7847969|NCT00970320|19316349|P3|COMPLETED|Overall Study||35
7847970|NCT00970320|19316350|P2|COMPLETED|Overall Study||13
7847971|NCT00970320|19316351|P1|COMPLETED|Overall Study||25
7847972|NCT00970320|19316347|P5|STARTED|Overall Study||1571
7847973|NCT00970320|19316348|P4|STARTED|Overall Study||50
7847974|NCT00970320|19316349|P3|STARTED|Overall Study||48
7847975|NCT00970320|19316350|P2|STARTED|Overall Study||24
7847976|NCT00970320|19316351|P1|STARTED|Overall Study||25
7847977|NCT00970307|19316366|P3|NOT COMPLETED|Overall Study||2
7847978|NCT00970307|19316367|P2|NOT COMPLETED|Overall Study||3
7847979|NCT00970307|19316368|P1|NOT COMPLETED|Overall Study||3
7847980|NCT00970307|19316366|P3|COMPLETED|Overall Study||139
7847981|NCT00970307|19316367|P2|COMPLETED|Overall Study||136
7847982|NCT00970307|19316368|P1|COMPLETED|Overall Study||138
7847983|NCT00970307|19316366|P3|STARTED|Overall Study||141
7847984|NCT00970307|19316367|P2|STARTED|Overall Study||139
7847985|NCT00970307|19316368|P1|STARTED|Overall Study||141
7847986|NCT00970294|19316442|P1|NOT COMPLETED|Overall Study||5
7847987|NCT00970294|19316442|P1|COMPLETED|Overall Study||6
7847988|NCT00970294|19316442|P1|STARTED|Overall Study||11
7847989|NCT00970281|19316450|P2|NOT COMPLETED|Overall Study||16
7847990|NCT00970281|19316451|P1|NOT COMPLETED|Overall Study||2
7847991|NCT00970281|19316450|P2|COMPLETED|Overall Study||29
7847992|NCT00970281|19316451|P1|COMPLETED|Overall Study||44
7847993|NCT00970281|19316450|P2|Full Analysis Set|Overall Study||45
7847994|NCT00970281|19316451|P1|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45
7847995|NCT00970281|19316450|P2|STARTED|Overall Study||45
7847996|NCT00970281|19316451|P1|STARTED|Overall Study||46
7847997|NCT00970268|19316469|P2|NOT COMPLETED|Overall Study||49
7847998|NCT00970268|19316470|P1|NOT COMPLETED|Overall Study||43
7847999|NCT00970268|19316469|P2|COMPLETED|Overall Study||103
7848000|NCT00970268|19316470|P1|COMPLETED|Overall Study||96
7848001|NCT00970268|19316469|P2|STARTED|Overall Study||152
7848002|NCT00970268|19316470|P1|STARTED|Overall Study||139
7848003|NCT00970216|19316484|P1|NOT COMPLETED|Overall Study||80
7848004|NCT00970216|19316484|P1|COMPLETED|Overall Study||80
7848005|NCT00970216|19316484|P1|STARTED|Overall Study||160
7848006|NCT00970203|19316490|P2|NOT COMPLETED|Overall Study||0
7848007|NCT00970203|19316491|P1|NOT COMPLETED|Overall Study||0
7848008|NCT00970203|19316490|P2|COMPLETED|Overall Study||6
7848009|NCT00970203|19316491|P1|COMPLETED|Overall Study||7
7848010|NCT00970203|19316490|P2|STARTED|Overall Study||6
7848011|NCT00970203|19316491|P1|STARTED|Overall Study||7
7848012|NCT00970073|19316514|P3|NOT COMPLETED|Overall Study||0
7848013|NCT00970073|19316515|P2|NOT COMPLETED|Overall Study||0
7848014|NCT00970073|19316516|P1|NOT COMPLETED|Overall Study||0
7848015|NCT00970073|19316514|P3|COMPLETED|Overall Study||10
7848016|NCT00970073|19316515|P2|COMPLETED|Overall Study||10
7848017|NCT00970073|19316516|P1|COMPLETED|Overall Study||10
7848018|NCT00970073|19316514|P3|STARTED|Overall Study||10
7848019|NCT00970073|19316515|P2|STARTED|Overall Study||10
7848020|NCT00970073|19316516|P1|STARTED|Overall Study||10
7848021|NCT00969878|19316535|P2|NOT COMPLETED|Overall Study||26
7848022|NCT00969878|19316536|P1|NOT COMPLETED|Overall Study||30
7848023|NCT00969878|19316535|P2|COMPLETED|Overall Study||126
7848024|NCT00969878|19316536|P1|COMPLETED|Overall Study||118
7848025|NCT00969878|19316535|P2|STARTED|Overall Study||152
7848026|NCT00969878|19316536|P1|STARTED|Overall Study||148
7848027|NCT00969761|19316556|P12|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
7848028|NCT00969761|19316557|P11|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
7848029|NCT00969761|19316558|P10|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
7848030|NCT00969761|19316559|P9|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||11
7848031|NCT00969761|19316560|P8|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||6
7848032|NCT00969761|19316561|P7|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
7848033|NCT00969761|19316562|P6|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
7848034|NCT00969761|19316563|P5|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
7848035|NCT00969761|19316564|P4|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||5
7848036|NCT00969761|19316565|P3|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||10
7848037|NCT00969761|19316566|P2|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
7848038|NCT00969761|19316567|P1|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
7848039|NCT00969761|19316556|P12|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
7848040|NCT00969761|19316557|P11|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
7848041|NCT00969761|19316558|P10|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
7848042|NCT00969761|19316559|P9|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
7848043|NCT00969761|19316560|P8|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
7848044|NCT00969761|19316561|P7|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
7848045|NCT00969761|19316562|P6|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
7848046|NCT00969761|19316563|P5|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
7848047|NCT00969761|19316564|P4|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
7848048|NCT00969761|19316565|P3|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
7848049|NCT00969761|19316566|P2|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
7848050|NCT00969761|19316567|P1|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
7848051|NCT00969761|19316556|P12|STARTED|Treated in and Beyond Treat. Cycle 2||3
7848052|NCT00969761|19316557|P11|STARTED|Treated in and Beyond Treat. Cycle 2||3
7848053|NCT00969761|19316558|P10|STARTED|Treated in and Beyond Treat. Cycle 2||2
7848054|NCT00969761|19316559|P9|STARTED|Treated in and Beyond Treat. Cycle 2||11
7848055|NCT00969761|19316560|P8|STARTED|Treated in and Beyond Treat. Cycle 2||6
7848056|NCT00969761|19316561|P7|STARTED|Treated in and Beyond Treat. Cycle 2||3
7848057|NCT00969761|19316562|P6|STARTED|Treated in and Beyond Treat. Cycle 2||3
7848058|NCT00969761|19316563|P5|STARTED|Treated in and Beyond Treat. Cycle 2||3
7848059|NCT00969761|19316564|P4|STARTED|Treated in and Beyond Treat. Cycle 2||5
7848060|NCT00969761|19316565|P3|STARTED|Treated in and Beyond Treat. Cycle 2||10
7848061|NCT00969761|19316566|P2|STARTED|Treated in and Beyond Treat. Cycle 2||3
7848062|NCT00969761|19316567|P1|STARTED|Treated in and Beyond Treat. Cycle 2||2
7848063|NCT00969761|19316556|P12|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
7848064|NCT00969761|19316557|P11|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
7848065|NCT00969761|19316558|P10|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
7848066|NCT00969761|19316559|P9|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
7848067|NCT00969761|19316560|P8|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
7848068|NCT00969761|19316561|P7|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
7848069|NCT00969761|19316562|P6|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
7848070|NCT00969761|19316563|P5|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
7848071|NCT00969761|19316564|P4|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
7848072|NCT00969761|19316565|P3|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
7848073|NCT00969761|19316566|P2|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
7848074|NCT00969761|19316567|P1|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
7848075|NCT00969761|19316556|P12|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
7848076|NCT00969761|19316557|P11|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
7848077|NCT00969761|19316558|P10|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
7848078|NCT00969761|19316559|P9|COMPLETED|Discont. Before Start of Treat. Cycle 2||11
7848079|NCT00969761|19316560|P8|COMPLETED|Discont. Before Start of Treat. Cycle 2||6
7848080|NCT00969761|19316561|P7|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
7848081|NCT00969761|19316562|P6|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
7848082|NCT00969761|19316563|P5|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
7848083|NCT00969761|19316564|P4|COMPLETED|Discont. Before Start of Treat. Cycle 2||5
7848084|NCT00969761|19316565|P3|COMPLETED|Discont. Before Start of Treat. Cycle 2||10
7848085|NCT00969761|19316566|P2|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
7848086|NCT00969761|19316567|P1|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
7848087|NCT00969761|19316556|P12|STARTED|Discont. Before Start of Treat. Cycle 2||3
7848088|NCT00969761|19316557|P11|STARTED|Discont. Before Start of Treat. Cycle 2||3
7848089|NCT00969761|19316558|P10|STARTED|Discont. Before Start of Treat. Cycle 2||3
7848090|NCT00969761|19316559|P9|STARTED|Discont. Before Start of Treat. Cycle 2||13
7848091|NCT00969761|19316560|P8|STARTED|Discont. Before Start of Treat. Cycle 2||6
7848092|NCT00969761|19316561|P7|STARTED|Discont. Before Start of Treat. Cycle 2||3
7848093|NCT00969761|19316562|P6|STARTED|Discont. Before Start of Treat. Cycle 2||3
7848094|NCT00969761|19316563|P5|STARTED|Discont. Before Start of Treat. Cycle 2||3
7848095|NCT00969761|19316564|P4|STARTED|Discont. Before Start of Treat. Cycle 2||6
7848096|NCT00969761|19316565|P3|STARTED|Discont. Before Start of Treat. Cycle 2||12
7848097|NCT00969761|19316566|P2|STARTED|Discont. Before Start of Treat. Cycle 2||3
7848098|NCT00969761|19316567|P1|STARTED|Discont. Before Start of Treat. Cycle 2||3
7848099|NCT00969709|19316873|P4|NOT COMPLETED|Overall Study||63
7848100|NCT00969709|19316874|P3|NOT COMPLETED|Overall Study||58
7848101|NCT00969709|19316875|P2|NOT COMPLETED|Overall Study||48
7848102|NCT00969709|19316876|P1|NOT COMPLETED|Overall Study||38
7848103|NCT00969709|19316873|P4|COMPLETED|Overall Study||117
7848104|NCT00969709|19316874|P3|COMPLETED|Overall Study||121
7848105|NCT00969709|19316875|P2|COMPLETED|Overall Study||130
7848106|NCT00969709|19316876|P1|COMPLETED|Overall Study||138
7848107|NCT00969709|19316873|P4|STARTED|Overall Study||180
7848108|NCT00969709|19316874|P3|STARTED|Overall Study||179
7848109|NCT00969709|19316875|P2|STARTED|Overall Study||178
7848110|NCT00969709|19316876|P1|STARTED|Overall Study||176
7848111|NCT00969618|19316890|P1|NOT COMPLETED|Overall Study||78
7848112|NCT00969618|19316890|P1|COMPLETED|Overall Study||133
7848113|NCT00969618|19316890|P1|STARTED|Overall Study||211
7848114|NCT00969553|19316910|P9|NOT COMPLETED|Overall Study||3
7848115|NCT00969553|19316911|P8|NOT COMPLETED|Overall Study||14
7848116|NCT00969553|19316912|P7|NOT COMPLETED|Overall Study||4
7848117|NCT00969553|19316913|P6|NOT COMPLETED|Overall Study||4
7848118|NCT00969553|19316914|P5|NOT COMPLETED|Overall Study||3
7848119|NCT00969553|19316915|P4|NOT COMPLETED|Overall Study||16
7848120|NCT00969553|19316916|P3|NOT COMPLETED|Overall Study||6
7848121|NCT00969553|19316917|P2|NOT COMPLETED|Overall Study||3
7848122|NCT00969553|19316918|P1|NOT COMPLETED|Overall Study||3
7848123|NCT00969553|19316910|P9|COMPLETED|Overall Study||0
7848124|NCT00969553|19316911|P8|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|2
7848125|NCT00969553|19316912|P7|COMPLETED|Overall Study||0
7848126|NCT00969553|19316913|P6|COMPLETED|Overall Study||0
7848127|NCT00969553|19316914|P5|COMPLETED|Overall Study||0
7848128|NCT00969553|19316915|P4|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|1
7848129|NCT00969553|19316916|P3|COMPLETED|Overall Study||0
7848130|NCT00969553|19316917|P2|COMPLETED|Overall Study||0
7848131|NCT00969553|19316918|P1|COMPLETED|Overall Study||0
7848132|NCT00969553|19316910|P9|STARTED|Overall Study||3
7848133|NCT00969553|19316911|P8|STARTED|Overall Study||16
7848134|NCT00969553|19316912|P7|STARTED|Overall Study||4
7848135|NCT00969553|19316913|P6|STARTED|Overall Study||4
7848136|NCT00969553|19316914|P5|STARTED|Overall Study||3
7848137|NCT00969553|19316915|P4|STARTED|Overall Study||17
7848138|NCT00969553|19316916|P3|STARTED|Overall Study||6
7848139|NCT00969553|19316917|P2|STARTED|Overall Study||3
7848140|NCT00969553|19316918|P1|STARTED|Overall Study||3
7848141|NCT00969540|19317061|P2|NOT COMPLETED|Overall Study||1
7848142|NCT00969540|19317062|P1|NOT COMPLETED|Overall Study||1
7848143|NCT00969540|19317061|P2|COMPLETED|Overall Study||3
7848144|NCT00969540|19317062|P1|COMPLETED|Overall Study||3
7848145|NCT00969540|19317061|P2|STARTED|Overall Study||4
7848146|NCT00969540|19317062|P1|STARTED|Overall Study||4
7848147|NCT00969501|19317080|P1|NOT COMPLETED|Overall Study||5
7848148|NCT00969501|19317080|P1|COMPLETED|Overall Study||27
7848149|NCT00969501|19317080|P1|STARTED|Overall Study||32
7848150|NCT00969436|19317087|P3|NOT COMPLETED|Overall Study||11
7848151|NCT00969436|19317088|P2|NOT COMPLETED|Overall Study||21
7848152|NCT00969436|19317089|P1|NOT COMPLETED|Overall Study||25
7848153|NCT00969436|19317087|P3|COMPLETED|Overall Study||79
7848154|NCT00969436|19317088|P2|COMPLETED|Overall Study||159
7848155|NCT00969436|19317089|P1|COMPLETED|Overall Study||155
7848156|NCT00969436|19317087|P3|STARTED|Overall Study||90
7848157|NCT00969436|19317088|P2|STARTED|Overall Study||180
7848158|NCT00969436|19317089|P1|STARTED|Overall Study||180
7848159|NCT00969332|19317121|P1|NOT COMPLETED|Overall Study||11
7848160|NCT00969332|19317121|P1|COMPLETED|Overall Study||51
7848161|NCT00969332|19317121|P1|STARTED|Overall Study||62
7848162|NCT00969280|19317137|P2|NOT COMPLETED|Overall Study||3
7848163|NCT00969280|19317138|P1|NOT COMPLETED|Overall Study||2
7848164|NCT00969280|19317137|P2|COMPLETED|Overall Study||18
7848165|NCT00969280|19317138|P1|COMPLETED|Overall Study||19
7848166|NCT00969280|19317137|P2|STARTED|Overall Study||21
7848167|NCT00969280|19317138|P1|STARTED|Overall Study||21
7848168|NCT00969228|19317146|P2|NOT COMPLETED|Overall Study||14
7848169|NCT00969228|19317147|P1|NOT COMPLETED|Overall Study||43
7848170|NCT00969228|19317146|P2|COMPLETED|Overall Study||162
7848171|NCT00969228|19317147|P1|COMPLETED|Overall Study||465
7848172|NCT00969228|19317146|P2|STARTED|Overall Study||176
7848173|NCT00969228|19317147|P1|STARTED|Overall Study||508
7848174|NCT00969150|19317165|P2|NOT COMPLETED|Overall Study||40
7848175|NCT00969150|19317166|P1|NOT COMPLETED|Overall Study||33
7848176|NCT00969150|19317165|P2|COMPLETED|Overall Study||135
7848177|NCT00969150|19317166|P1|COMPLETED|Overall Study||149
7848178|NCT00969150|19317165|P2|STARTED|Overall Study||175
7848179|NCT00969150|19317166|P1|STARTED|Overall Study||182
7848180|NCT00969124|19317174|P1|NOT COMPLETED|Overall Study||30
7848181|NCT00969124|19317174|P1|COMPLETED|Overall Study||298
7848182|NCT00969124|19317174|P1|STARTED|Overall Study||328
7848183|NCT00968981|19317183|P3|NOT COMPLETED|Overall Study||22
7848184|NCT00968981|19317184|P2|NOT COMPLETED|Overall Study||22
7848185|NCT00968981|19317185|P1|NOT COMPLETED|Overall Study||22
7848186|NCT00968981|19317183|P3|COMPLETED|Overall Study||0
7848187|NCT00968981|19317184|P2|COMPLETED|Overall Study||0
7848188|NCT00968981|19317185|P1|COMPLETED|Overall Study||1
7848280|NCT00968227|19317630|P1|STARTED|Overall Study||56
7848189|NCT00968981|19317183|P3|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22
7848190|NCT00968981|19317184|P2|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21
7848191|NCT00968981|19317185|P1|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20
7848192|NCT00968981|19317183|P3|STARTED|Overall Study||22
7848193|NCT00968981|19317184|P2|STARTED|Overall Study||22
7848194|NCT00968981|19317185|P1|STARTED|Overall Study||23
7848195|NCT00968968|19317223|P2|NOT COMPLETED|Overall Study||14
7848196|NCT00968968|19317224|P1|NOT COMPLETED|Overall Study||16
7848197|NCT00968968|19317223|P2|COMPLETED|Overall Study||3
7848198|NCT00968968|19317224|P1|COMPLETED|Overall Study||4
7848199|NCT00968968|19317223|P2|STARTED|Overall Study||17
7848200|NCT00968968|19317224|P1|STARTED|Overall Study||20
7848201|NCT00968890|19317241|P2|NOT COMPLETED|Overall Study||0
7848202|NCT00968890|19317242|P1|NOT COMPLETED|Overall Study||0
7848203|NCT00968890|19317241|P2|COMPLETED|Overall Study||84
7848204|NCT00968890|19317242|P1|COMPLETED|Overall Study||84
7848205|NCT00968890|19317241|P2|STARTED|Overall Study||84
7848206|NCT00968890|19317242|P1|STARTED|Overall Study||84
7848207|NCT00968864|19317270|P1|NOT COMPLETED|Overall Study||1
7848208|NCT00968864|19317270|P1|COMPLETED|Overall Study||52
7848209|NCT00968864|19317270|P1|STARTED|Overall Study|One patient, FDA and IRB approved to enroll as an exception, was not evaluable for study endpoints.|53
7848210|NCT00968838|19317288|P2|NOT COMPLETED|Overall Study||0
7848211|NCT00968838|19317289|P1|NOT COMPLETED|Overall Study||0
7848212|NCT00968838|19317288|P2|COMPLETED|Overall Study||58
7848213|NCT00968838|19317289|P1|COMPLETED|Overall Study||50
7848214|NCT00968838|19317288|P2|STARTED|Overall Study||58
7848215|NCT00968838|19317289|P1|STARTED|Overall Study||50
7848216|NCT00968812|19317298|P3|NOT COMPLETED|Overall Study||168
7848217|NCT00968812|19317299|P2|NOT COMPLETED|Overall Study||162
7848218|NCT00968812|19317300|P1|NOT COMPLETED|Overall Study||140
7848219|NCT00968812|19317298|P3|COMPLETED|Overall Study||314
7848220|NCT00968812|19317299|P2|COMPLETED|Overall Study||323
7848221|NCT00968812|19317300|P1|COMPLETED|Overall Study||343
7848222|NCT00968812|19317298|P3|STARTED|Overall Study||482
7848223|NCT00968812|19317299|P2|STARTED|Overall Study||485
7848224|NCT00968812|19317300|P1|STARTED|Overall Study||483
7848225|NCT00968799|19317320|P1|NOT COMPLETED|Overall Study||2
7848226|NCT00968799|19317320|P1|COMPLETED|Overall Study||4
7848227|NCT00968799|19317320|P1|STARTED|Overall Study||6
7848228|NCT00968708|19317330|P2|NOT COMPLETED|Overall Study||298
7848229|NCT00968708|19317331|P1|NOT COMPLETED|Overall Study||318
7848230|NCT00968708|19317330|P2|COMPLETED|Overall Study||2403
7848231|NCT00968708|19317331|P1|COMPLETED|Overall Study||2361
7848232|NCT00968708|19317330|P2|Treated|Overall Study||2698
7848233|NCT00968708|19317331|P1|Treated|Overall Study||2676
7848234|NCT00968708|19317330|P2|STARTED|Overall Study||2701
7848235|NCT00968708|19317331|P1|STARTED|Overall Study||2679
7848236|NCT00968669|19317343|P4|NOT COMPLETED|Overall Study||9
7848237|NCT00968669|19317344|P3|NOT COMPLETED|Overall Study||11
7848238|NCT00968669|19317345|P2|NOT COMPLETED|Overall Study||18
7848239|NCT00968669|19317346|P1|NOT COMPLETED|Overall Study||18
7848240|NCT00968669|19317343|P4|COMPLETED|Overall Study||72
7848241|NCT00968669|19317344|P3|COMPLETED|Overall Study||72
7848242|NCT00968669|19317345|P2|COMPLETED|Overall Study||63
7848243|NCT00968669|19317346|P1|COMPLETED|Overall Study||64
7848244|NCT00968669|19317343|P4|STARTED|Overall Study||81
7848245|NCT00968669|19317344|P3|STARTED|Overall Study||83
7848246|NCT00968669|19317345|P2|STARTED|Overall Study||81
7848247|NCT00968669|19317346|P1|STARTED|Overall Study||82
7848248|NCT00968617|19317436|P1|NOT COMPLETED|Overall Study||6
7848249|NCT00968617|19317436|P1|COMPLETED|Overall Study||1
7848250|NCT00968617|19317436|P1|STARTED|Overall Study||7
7848251|NCT00968539|19317450|P2|NOT COMPLETED|Overall Study||0
7848252|NCT00968539|19317451|P1|NOT COMPLETED|Overall Study||1
7848253|NCT00968539|19317450|P2|COMPLETED|Overall Study||66
7848254|NCT00968539|19317451|P1|COMPLETED|Overall Study||63
7848255|NCT00968539|19317450|P2|STARTED|Overall Study||66
7848256|NCT00968539|19317451|P1|STARTED|Overall Study||64
7848257|NCT00968526|19317511|P2|NOT COMPLETED|Overall Study||0
7848258|NCT00968526|19317512|P1|NOT COMPLETED|Overall Study||3
7848259|NCT00968526|19317511|P2|COMPLETED|Overall Study||102
7848260|NCT00968526|19317512|P1|COMPLETED|Overall Study||135
7848261|NCT00968526|19317511|P2|STARTED|Overall Study||102
7848262|NCT00968526|19317512|P1|STARTED|Overall Study||138
7848263|NCT00968344|19317604|P2|NOT COMPLETED|Overall Study||11
7848264|NCT00968344|19317605|P1|NOT COMPLETED|Overall Study||10
7848265|NCT00968344|19317604|P2|COMPLETED|Overall Study||9
7848266|NCT00968344|19317605|P1|COMPLETED|Overall Study||10
7848267|NCT00968344|19317604|P2|STARTED|Overall Study|Includes screen fails|20
7848268|NCT00968344|19317605|P1|STARTED|Overall Study|Includes screen fails|20
7848269|NCT00968253|19317614|P3|NOT COMPLETED|Overall Study||7
7848270|NCT00968253|19317615|P2|NOT COMPLETED|Overall Study||3
7848271|NCT00968253|19317616|P1|NOT COMPLETED|Overall Study||0
7848272|NCT00968253|19317614|P3|COMPLETED|Overall Study||5
7848273|NCT00968253|19317615|P2|COMPLETED|Overall Study||6
7848274|NCT00968253|19317616|P1|COMPLETED|Overall Study||3
7848275|NCT00968253|19317614|P3|STARTED|Overall Study||12
7848276|NCT00968253|19317615|P2|STARTED|Overall Study||9
7848277|NCT00968253|19317616|P1|STARTED|Overall Study||3
7848278|NCT00968227|19317630|P1|NOT COMPLETED|Overall Study||0
7848279|NCT00968227|19317630|P1|COMPLETED|Overall Study||56
7848281|NCT00968201|19317637|P3|NOT COMPLETED|Extension Study - (Period III)||280
7848282|NCT00968201|19317638|P2|NOT COMPLETED|Extension Study - (Period III)||124
7848283|NCT00968201|19317639|P1|NOT COMPLETED|Extension Study - (Period III)||0
7848284|NCT00968201|19317637|P3|COMPLETED|Extension Study - (Period III)||84
7848285|NCT00968201|19317638|P2|COMPLETED|Extension Study - (Period III)||33
7848286|NCT00968201|19317639|P1|COMPLETED|Extension Study - (Period III)||0
7848287|NCT00968201|19317637|P3|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364
7848288|NCT00968201|19317638|P2|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157
7848289|NCT00968201|19317639|P1|STARTED|Extension Study - (Period III)||0
7848290|NCT00968201|19317637|P3|NOT COMPLETED|Base Study - (Period II)||45
7848291|NCT00968201|19317638|P2|NOT COMPLETED|Base Study - (Period II)||0
7848292|NCT00968201|19317639|P1|NOT COMPLETED|Base Study - (Period II)||26
7848293|NCT00968201|19317637|P3|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416
7848294|NCT00968201|19317638|P2|COMPLETED|Base Study - (Period II)||0
7848295|NCT00968201|19317639|P1|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202
7848296|NCT00968201|19317637|P3|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461
7848297|NCT00968201|19317638|P2|STARTED|Base Study - (Period II)||0
7848298|NCT00968201|19317639|P1|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228
7848299|NCT00968149|19317700|P2|NOT COMPLETED|Overall Study||6
7848300|NCT00968149|19317701|P1|NOT COMPLETED|Overall Study||11
7848301|NCT00968149|19317700|P2|COMPLETED|Overall Study||127
7848302|NCT00968149|19317701|P1|COMPLETED|Overall Study||269
7848303|NCT00968149|19317700|P2|STARTED|Overall Study||133
7848304|NCT00968149|19317701|P1|STARTED|Overall Study||280
7848305|NCT00968071|19317721|P1|NOT COMPLETED|Overall Study||0
7848306|NCT00968071|19317721|P1|COMPLETED|Overall Study||71
7848307|NCT00968071|19317721|P1|STARTED|Overall Study||71
7848308|NCT00968032|19317725|P1|NOT COMPLETED|Overall Study||2
7848309|NCT00968032|19317725|P1|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage
~1 patient denied latest FU"|61
7848310|NCT00968032|19317725|P1|STARTED|Overall Study||63
7848311|NCT00968019|19317729|P1|NOT COMPLETED|Overall Study||15
7848312|NCT00968019|19317729|P1|COMPLETED|Overall Study||303
7848313|NCT00968019|19317729|P1|STARTED|Overall Study||318
7848314|NCT00967993|19317750|P1|NOT COMPLETED|Overall Study||4
7848315|NCT00967993|19317750|P1|COMPLETED|Overall Study||18
7848316|NCT00967993|19317750|P1|STARTED|Overall Study||22
7848317|NCT00967941|19317757|P3|NOT COMPLETED|Overall Study||4
7848318|NCT00967941|19317758|P2|NOT COMPLETED|Overall Study||3
7848319|NCT00967941|19317759|P1|NOT COMPLETED|Overall Study||5
7848320|NCT00967941|19317757|P3|COMPLETED|Overall Study||56
7848321|NCT00967941|19317758|P2|COMPLETED|Overall Study||51
7848322|NCT00967941|19317759|P1|COMPLETED|Overall Study||62
7848323|NCT00967941|19317757|P3|STARTED|Overall Study||60
7848324|NCT00967941|19317758|P2|STARTED|Overall Study||54
7848325|NCT00967941|19317759|P1|STARTED|Overall Study||67
7848326|NCT00967798|19317769|P2|NOT COMPLETED|Overall Study||3
7848327|NCT00967798|19317770|P1|NOT COMPLETED|Overall Study||9
7848328|NCT00967798|19317769|P2|COMPLETED|Overall Study||13
7848329|NCT00967798|19317770|P1|COMPLETED|Overall Study||8
7848330|NCT00967798|19317769|P2|STARTED|Overall Study||16
7848331|NCT00967798|19317770|P1|STARTED|Overall Study||17
7848332|NCT00967694|19317784|P1|NOT COMPLETED|Overall Study||6
7848333|NCT00967694|19317784|P1|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20
7848334|NCT00967694|19317784|P1|STARTED|Overall Study||26
7848335|NCT00967668|19317791|P3|NOT COMPLETED|Overall Study||69
7848336|NCT00967668|19317792|P2|NOT COMPLETED|Overall Study||56
7848337|NCT00967668|19317793|P1|NOT COMPLETED|Overall Study||71
7848338|NCT00967668|19317791|P3|COMPLETED|Overall Study||90
7848339|NCT00967668|19317792|P2|COMPLETED|Overall Study||104
7848340|NCT00967668|19317793|P1|COMPLETED|Overall Study||91
7848341|NCT00967668|19317791|P3|18-mo Assessment|Overall Study||92
7848342|NCT00967668|19317792|P2|18-mo Assessment|Overall Study||102
7848343|NCT00967668|19317793|P1|18-mo Assessment|Overall Study||95
7848344|NCT00967668|19317791|P3|Completed Year 1 - 12-mo Assessment|Overall Study||119
7848345|NCT00967668|19317792|P2|Completed Year 1 - 12-mo Assessment|Overall Study||122
7848346|NCT00967668|19317793|P1|Completed Year 1 - 12-mo Assessment|Overall Study||120
7848347|NCT00967668|19317791|P3|3-mo Assessment|Overall Study||115
7848348|NCT00967668|19317792|P2|3-mo Assessment|Overall Study||127
7848349|NCT00967668|19317793|P1|3-mo Assessment|Overall Study||131
7848350|NCT00967668|19317791|P3|STARTED|Overall Study||159
7848351|NCT00967668|19317792|P2|STARTED|Overall Study||160
7848352|NCT00967668|19317793|P1|STARTED|Overall Study||162
7848353|NCT00967616|19317806|P2|NOT COMPLETED|Overall Study||50
7848354|NCT00967616|19317807|P1|NOT COMPLETED|Overall Study||50
7848355|NCT00967616|19317806|P2|COMPLETED|Overall Study||0
7848356|NCT00967616|19317807|P1|COMPLETED|Overall Study||0
7848357|NCT00967616|19317806|P2|STARTED|Overall Study||50
7848358|NCT00967616|19317807|P1|STARTED|Overall Study||50
7848359|NCT00967551|19317823|P2|NOT COMPLETED|Overall Study||0
7848360|NCT00967551|19317824|P1|NOT COMPLETED|Overall Study||0
7848361|NCT00967551|19317823|P2|COMPLETED|Overall Study||75
7848362|NCT00967551|19317824|P1|COMPLETED|Overall Study||68
7848363|NCT00967551|19317823|P2|STARTED|Overall Study||75
7848364|NCT00967551|19317824|P1|STARTED|Overall Study||68
7848365|NCT00967486|19317834|P2|NOT COMPLETED|Overall Study||0
7848366|NCT00967486|19317835|P1|NOT COMPLETED|Overall Study||0
7848367|NCT00967486|19317834|P2|COMPLETED|Overall Study||102
7848368|NCT00967486|19317835|P1|COMPLETED|Overall Study||98
7848369|NCT00967486|19317834|P2|STARTED|Overall Study||102
7848370|NCT00967486|19317835|P1|STARTED|Overall Study||98
7848371|NCT00967473|19317841|P1|NOT COMPLETED|Overall Study||0
7848372|NCT00967473|19317841|P1|COMPLETED|Overall Study||15
7848373|NCT00967473|19317841|P1|STARTED|Overall Study||15
7848374|NCT00967447|19317847|P1|NOT COMPLETED|Overall Study||0
7848375|NCT00967447|19317847|P1|COMPLETED|Overall Study|there are no collected data in CRF|2
7848376|NCT00967447|19317847|P1|STARTED|Overall Study|there are no collected data in CRF|2
7848377|NCT00967369|19317856|P2|NOT COMPLETED|Overall Study||0
7848378|NCT00967369|19317857|P1|NOT COMPLETED|Overall Study||0
7848379|NCT00967369|19317856|P2|COMPLETED|Overall Study||10
7848380|NCT00967369|19317857|P1|COMPLETED|Overall Study||10
7848381|NCT00967369|19317856|P2|Refractory|Overall Study||3
7848382|NCT00967369|19317857|P1|Refractory|Overall Study||6
7848383|NCT00967369|19317856|P2|Relapsed|Overall Study||7
7848384|NCT00967369|19317857|P1|Relapsed|Overall Study||4
7848385|NCT00967369|19317856|P2|STARTED|Overall Study||10
7848386|NCT00967369|19317857|P1|STARTED|Overall Study||10
7848387|NCT00967330|19317875|P2|NOT COMPLETED|Overall Study||60
7848388|NCT00967330|19317876|P1|NOT COMPLETED|Overall Study||122
7848389|NCT00967330|19317875|P2|COMPLETED|Overall Study||0
7848390|NCT00967330|19317876|P1|COMPLETED|Overall Study||0
7848391|NCT00967330|19317875|P2|STARTED|Overall Study||60
7848392|NCT00967330|19317876|P1|STARTED|Overall Study||122
7848393|NCT00967226|19317906|P2|NOT COMPLETED|Overall Study||6
7848394|NCT00967226|19317907|P1|NOT COMPLETED|Overall Study||2
7848395|NCT00967226|19317906|P2|COMPLETED|Overall Study||2
7848396|NCT00967226|19317907|P1|COMPLETED|Overall Study||9
7848397|NCT00967226|19317906|P2|STARTED|Overall Study||8
7848398|NCT00967226|19317907|P1|STARTED|Overall Study||11
7848399|NCT00967044|19317937|P1|NOT COMPLETED|Overall Study||0
7848400|NCT00967044|19317937|P1|COMPLETED|Overall Study||30
7848401|NCT00967044|19317937|P1|STARTED|Overall Study||30
7848402|NCT00967018|19317941|P1|NOT COMPLETED|Overall Study||21
7848403|NCT00967018|19317941|P1|COMPLETED|Overall Study||56
7848404|NCT00967018|19317941|P1|STARTED|Overall Study||77
7848405|NCT00967005|19317950|P2|NOT COMPLETED|Overall Study||10
7848406|NCT00967005|19317951|P1|NOT COMPLETED|Overall Study||7
7848407|NCT00967005|19317950|P2|COMPLETED|Overall Study||5
7848408|NCT00967005|19317951|P1|COMPLETED|Overall Study||6
7848409|NCT00967005|19317950|P2|Treatment Completion|Overall Study||10
7848410|NCT00967005|19317951|P1|Treatment Completion|Overall Study||10
7848411|NCT00967005|19317950|P2|STARTED|Overall Study||15
7848412|NCT00967005|19317951|P1|STARTED|Overall Study||13
7848413|NCT00966992|19318005|P2|NOT COMPLETED|Overall Study||0
7848414|NCT00966992|19318006|P1|NOT COMPLETED|Overall Study||0
7848415|NCT00966992|19318005|P2|COMPLETED|Overall Study||0
7848416|NCT00966992|19318006|P1|COMPLETED|Overall Study||3
7848417|NCT00966992|19318005|P2|STARTED|Overall Study||0
7848418|NCT00966992|19318006|P1|STARTED|Overall Study||3
7848419|NCT00966953|19318026|P4|NOT COMPLETED|4th Intervention Order||0
7848420|NCT00966953|19318027|P3|NOT COMPLETED|4th Intervention Order||0
7848421|NCT00966953|19318028|P2|NOT COMPLETED|4th Intervention Order||0
7848422|NCT00966953|19318029|P1|NOT COMPLETED|4th Intervention Order||0
7848423|NCT00966953|19318026|P4|COMPLETED|4th Intervention Order||7
7848424|NCT00966953|19318027|P3|COMPLETED|4th Intervention Order||6
7848425|NCT00966953|19318028|P2|COMPLETED|4th Intervention Order||6
7848426|NCT00966953|19318029|P1|COMPLETED|4th Intervention Order||6
7848427|NCT00966953|19318026|P4|STARTED|4th Intervention Order||7
7848428|NCT00966953|19318027|P3|STARTED|4th Intervention Order||6
7848429|NCT00966953|19318028|P2|STARTED|4th Intervention Order||6
7848430|NCT00966953|19318029|P1|STARTED|4th Intervention Order||6
7848431|NCT00966953|19318026|P4|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
7848432|NCT00966953|19318027|P3|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
7848433|NCT00966953|19318028|P2|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
7848434|NCT00966953|19318029|P1|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
7848435|NCT00966953|19318026|P4|COMPLETED|1 Week Washout After 3rd Intervention||7
7848436|NCT00966953|19318027|P3|COMPLETED|1 Week Washout After 3rd Intervention||6
7848437|NCT00966953|19318028|P2|COMPLETED|1 Week Washout After 3rd Intervention||6
7848438|NCT00966953|19318029|P1|COMPLETED|1 Week Washout After 3rd Intervention||6
7848439|NCT00966953|19318026|P4|STARTED|1 Week Washout After 3rd Intervention||7
7848440|NCT00966953|19318027|P3|STARTED|1 Week Washout After 3rd Intervention||6
7848441|NCT00966953|19318028|P2|STARTED|1 Week Washout After 3rd Intervention||6
7848442|NCT00966953|19318029|P1|STARTED|1 Week Washout After 3rd Intervention||6
7848443|NCT00966953|19318026|P4|NOT COMPLETED|3rd Intervention Order||0
7848444|NCT00966953|19318027|P3|NOT COMPLETED|3rd Intervention Order||0
7848445|NCT00966953|19318028|P2|NOT COMPLETED|3rd Intervention Order||0
7848446|NCT00966953|19318029|P1|NOT COMPLETED|3rd Intervention Order||0
7848447|NCT00966953|19318026|P4|COMPLETED|3rd Intervention Order||7
7848448|NCT00966953|19318027|P3|COMPLETED|3rd Intervention Order||6
7848449|NCT00966953|19318028|P2|COMPLETED|3rd Intervention Order||6
7848450|NCT00966953|19318029|P1|COMPLETED|3rd Intervention Order||6
7848451|NCT00966953|19318026|P4|STARTED|3rd Intervention Order||7
7848452|NCT00966953|19318027|P3|STARTED|3rd Intervention Order||6
7848453|NCT00966953|19318028|P2|STARTED|3rd Intervention Order||6
7848454|NCT00966953|19318029|P1|STARTED|3rd Intervention Order||6
7848455|NCT00966953|19318026|P4|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
7848456|NCT00966953|19318027|P3|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
7848457|NCT00966953|19318028|P2|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
7848458|NCT00966953|19318029|P1|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
7848459|NCT00966953|19318026|P4|COMPLETED|1 Week Washout After 2nd Intervention||7
7848460|NCT00966953|19318027|P3|COMPLETED|1 Week Washout After 2nd Intervention||6
7848461|NCT00966953|19318028|P2|COMPLETED|1 Week Washout After 2nd Intervention||6
7848462|NCT00966953|19318029|P1|COMPLETED|1 Week Washout After 2nd Intervention||6
7848463|NCT00966953|19318026|P4|STARTED|1 Week Washout After 2nd Intervention||7
7848464|NCT00966953|19318027|P3|STARTED|1 Week Washout After 2nd Intervention||6
7848465|NCT00966953|19318028|P2|STARTED|1 Week Washout After 2nd Intervention||6
7848466|NCT00966953|19318029|P1|STARTED|1 Week Washout After 2nd Intervention||6
7848467|NCT00966953|19318026|P4|NOT COMPLETED|2nd Intervention||0
7848468|NCT00966953|19318027|P3|NOT COMPLETED|2nd Intervention||0
7848469|NCT00966953|19318028|P2|NOT COMPLETED|2nd Intervention||0
7848470|NCT00966953|19318029|P1|NOT COMPLETED|2nd Intervention||0
7848471|NCT00966953|19318026|P4|COMPLETED|2nd Intervention||7
7848472|NCT00966953|19318027|P3|COMPLETED|2nd Intervention||6
7848473|NCT00966953|19318028|P2|COMPLETED|2nd Intervention||6
7848474|NCT00966953|19318029|P1|COMPLETED|2nd Intervention||6
7848475|NCT00966953|19318026|P4|STARTED|2nd Intervention||7
7848476|NCT00966953|19318027|P3|STARTED|2nd Intervention||6
7848477|NCT00966953|19318028|P2|STARTED|2nd Intervention||6
7848478|NCT00966953|19318029|P1|STARTED|2nd Intervention||6
7848479|NCT00966953|19318026|P4|NOT COMPLETED|1 Week Washout After 1st Intervention||0
7848480|NCT00966953|19318027|P3|NOT COMPLETED|1 Week Washout After 1st Intervention||0
7848481|NCT00966953|19318028|P2|NOT COMPLETED|1 Week Washout After 1st Intervention||0
7848482|NCT00966953|19318029|P1|NOT COMPLETED|1 Week Washout After 1st Intervention||0
7848483|NCT00966953|19318026|P4|COMPLETED|1 Week Washout After 1st Intervention||7
7848484|NCT00966953|19318027|P3|COMPLETED|1 Week Washout After 1st Intervention||6
7848485|NCT00966953|19318028|P2|COMPLETED|1 Week Washout After 1st Intervention||6
7848486|NCT00966953|19318029|P1|COMPLETED|1 Week Washout After 1st Intervention||6
7848487|NCT00966953|19318026|P4|STARTED|1 Week Washout After 1st Intervention||7
7848488|NCT00966953|19318027|P3|STARTED|1 Week Washout After 1st Intervention||6
7848489|NCT00966953|19318028|P2|STARTED|1 Week Washout After 1st Intervention||6
7848490|NCT00966953|19318029|P1|STARTED|1 Week Washout After 1st Intervention||6
7848491|NCT00966953|19318026|P4|NOT COMPLETED|1st Intervention||0
7848492|NCT00966953|19318027|P3|NOT COMPLETED|1st Intervention||0
7848493|NCT00966953|19318028|P2|NOT COMPLETED|1st Intervention||0
7848494|NCT00966953|19318029|P1|NOT COMPLETED|1st Intervention||0
7848495|NCT00966953|19318026|P4|COMPLETED|1st Intervention||7
7848496|NCT00966953|19318027|P3|COMPLETED|1st Intervention||6
7848497|NCT00966953|19318028|P2|COMPLETED|1st Intervention||6
7848498|NCT00966953|19318029|P1|COMPLETED|1st Intervention||6
7848499|NCT00966953|19318026|P4|STARTED|1st Intervention||7
7848500|NCT00966953|19318027|P3|STARTED|1st Intervention||6
7848501|NCT00966953|19318028|P2|STARTED|1st Intervention||6
7848502|NCT00966953|19318029|P1|STARTED|1st Intervention||6
7848503|NCT00966940|19318037|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
7848504|NCT00966940|19318038|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
7848505|NCT00966940|19318037|P2|COMPLETED|Period 2, Second 6 Weeks||23
7848506|NCT00966940|19318038|P1|COMPLETED|Period 2, Second 6 Weeks||25
7848507|NCT00966940|19318037|P2|STARTED|Period 2, Second 6 Weeks||23
7848508|NCT00966940|19318038|P1|STARTED|Period 2, Second 6 Weeks||25
7848509|NCT00966940|19318037|P2|NOT COMPLETED|Period 1, First 6 Weeks||0
7848510|NCT00966940|19318038|P1|NOT COMPLETED|Period 1, First 6 Weeks||3
7848511|NCT00966940|19318037|P2|COMPLETED|Period 1, First 6 Weeks||23
7848512|NCT00966940|19318038|P1|COMPLETED|Period 1, First 6 Weeks||25
7848513|NCT00966940|19318037|P2|STARTED|Period 1, First 6 Weeks||23
7848514|NCT00966940|19318038|P1|STARTED|Period 1, First 6 Weeks||28
7848515|NCT00966875|19318065|P9|NOT COMPLETED|Part B||18
7848516|NCT00966875|19318066|P8|NOT COMPLETED|Part B||19
7848517|NCT00966875|19318067|P7|NOT COMPLETED|Part B||22
7848518|NCT00966875|19318068|P6|NOT COMPLETED|Part B||6
7848519|NCT00966875|19318069|P5|NOT COMPLETED|Part B||7
7848520|NCT00966875|19318070|P4|NOT COMPLETED|Part B||3
7848521|NCT00966875|19318071|P3|NOT COMPLETED|Part B||6
7848522|NCT00966875|19318072|P2|NOT COMPLETED|Part B||3
7848523|NCT00966875|19318073|P1|NOT COMPLETED|Part B||5
7848524|NCT00966875|19318065|P9|COMPLETED|Part B||32
7848525|NCT00966875|19318066|P8|COMPLETED|Part B||38
7848526|NCT00966875|19318067|P7|COMPLETED|Part B||29
7848527|NCT00966875|19318068|P6|COMPLETED|Part B||26
7848528|NCT00966875|19318069|P5|COMPLETED|Part B||44
7848529|NCT00966875|19318070|P4|COMPLETED|Part B||31
7848530|NCT00966875|19318071|P3|COMPLETED|Part B||27
7848531|NCT00966875|19318072|P2|COMPLETED|Part B||33
7848532|NCT00966875|19318073|P1|COMPLETED|Part B||41
7848533|NCT00966875|19318065|P9|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50
7848534|NCT00966875|19318066|P8|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57
7848535|NCT00966875|19318067|P7|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
7848536|NCT00966875|19318068|P6|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32
7848537|NCT00966875|19318069|P5|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
7848538|NCT00966875|19318070|P4|STARTED|Part B||34
7848539|NCT00966875|19318071|P3|STARTED|Part B||33
7848540|NCT00966875|19318072|P2|STARTED|Part B||36
7848541|NCT00966875|19318073|P1|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46
7848542|NCT00966875|19318065|P9|NOT COMPLETED|Part A||8
7848543|NCT00966875|19318066|P8|NOT COMPLETED|Part A||7
7848544|NCT00966875|19318067|P7|NOT COMPLETED|Part A||12
7848545|NCT00966875|19318068|P6|NOT COMPLETED|Part A||4
7848546|NCT00966875|19318069|P5|NOT COMPLETED|Part A||5
7848547|NCT00966875|19318070|P4|NOT COMPLETED|Part A||3
7848548|NCT00966875|19318071|P3|NOT COMPLETED|Part A||2
7848549|NCT00966875|19318072|P2|NOT COMPLETED|Part A||4
7848550|NCT00966875|19318073|P1|NOT COMPLETED|Part A||6
7848551|NCT00966875|19318065|P9|COMPLETED|Part A||51
7848552|NCT00966875|19318066|P8|COMPLETED|Part A||58
7848553|NCT00966875|19318067|P7|COMPLETED|Part A||52
7848554|NCT00966875|19318068|P6|COMPLETED|Part A||33
7848555|NCT00966875|19318069|P5|COMPLETED|Part A||52
7848556|NCT00966875|19318070|P4|COMPLETED|Part A||34
7848557|NCT00966875|19318071|P3|COMPLETED|Part A||33
7848558|NCT00966875|19318072|P2|COMPLETED|Part A||36
7848559|NCT00966875|19318073|P1|COMPLETED|Part A||48
7848560|NCT00966875|19318065|P9|Received ≥1 Doses of Study Drug|Part A||59
7848561|NCT00966875|19318066|P8|Received ≥1 Doses of Study Drug|Part A||65
7848562|NCT00966875|19318067|P7|Received ≥1 Doses of Study Drug|Part A||64
7848563|NCT00966875|19318068|P6|Received ≥1 Doses of Study Drug|Part A||37
7848564|NCT00966875|19318069|P5|Received ≥1 Doses of Study Drug|Part A||57
7848565|NCT00966875|19318070|P4|Received ≥1 Doses of Study Drug|Part A||37
7848566|NCT00966875|19318071|P3|Received ≥1 Doses of Study Drug|Part A||35
7848567|NCT00966875|19318072|P2|Received ≥1 Doses of Study Drug|Part A||40
7848568|NCT00966875|19318073|P1|Received ≥1 Doses of Study Drug|Part A||54
7848569|NCT00966875|19318065|P9|STARTED|Part A||59
7848570|NCT00966875|19318066|P8|STARTED|Part A||65
7848571|NCT00966875|19318067|P7|STARTED|Part A||64
7848572|NCT00966875|19318068|P6|STARTED|Part A||37
7848573|NCT00966875|19318069|P5|STARTED|Part A||57
7848574|NCT00966875|19318070|P4|STARTED|Part A||37
7848575|NCT00966875|19318071|P3|STARTED|Part A||35
7848576|NCT00966875|19318072|P2|STARTED|Part A||40
7848577|NCT00966875|19318073|P1|STARTED|Part A||54
7848578|NCT00966849|19318395|P3|NOT COMPLETED|Overall Study||1293
7848579|NCT00966849|19318396|P2|NOT COMPLETED|Overall Study||1478
7848580|NCT00966849|19318397|P1|NOT COMPLETED|Overall Study||1541
7848581|NCT00966849|19318395|P3|COMPLETED|Overall Study||1876
7848582|NCT00966849|19318396|P2|COMPLETED|Overall Study||2498
7848583|NCT00966849|19318397|P1|COMPLETED|Overall Study||2119
7848584|NCT00966849|19318395|P3|STARTED|Overall Study||3169
7848585|NCT00966849|19318396|P2|STARTED|Overall Study||3976
7848586|NCT00966849|19318397|P1|STARTED|Overall Study||3660
7848587|NCT00966823|19318414|P1|NOT COMPLETED|Overall Study||1
7848588|NCT00966823|19318414|P1|COMPLETED|Overall Study||2
7848589|NCT00966823|19318414|P1|STARTED|Overall Study||3
7848590|NCT00966719|19318424|P2|NOT COMPLETED|Overall Study||11
7848591|NCT00966719|19318425|P1|NOT COMPLETED|Overall Study||6
7848592|NCT00966719|19318424|P2|COMPLETED|Overall Study||38
7848593|NCT00966719|19318425|P1|COMPLETED|Overall Study||44
7848594|NCT00966719|19318424|P2|STARTED|Overall Study||49
7848595|NCT00966719|19318425|P1|STARTED|Overall Study||50
7848596|NCT00966693|19318449|P4|NOT COMPLETED|Overall Study||23
7848597|NCT00966693|19318450|P3|NOT COMPLETED|Overall Study||3
7848598|NCT00966693|19318451|P2|NOT COMPLETED|Overall Study||0
7848599|NCT00966693|19318452|P1|NOT COMPLETED|Overall Study||1
7848600|NCT00966693|19318449|P4|COMPLETED|Overall Study||26
7848601|NCT00966693|19318450|P3|COMPLETED|Overall Study||6
7848602|NCT00966693|19318451|P2|COMPLETED|Overall Study||3
7848603|NCT00966693|19318452|P1|COMPLETED|Overall Study||2
7848604|NCT00966693|19318449|P4|Phase 2 Completed|Overall Study||46
7848605|NCT00966693|19318450|P3|Phase 2 Completed|Overall Study||0
7848606|NCT00966693|19318451|P2|Phase 2 Completed|Overall Study||0
7848607|NCT00966693|19318452|P1|Phase 2 Completed|Overall Study||0
7848608|NCT00966693|19318449|P4|Phase 1 Completed|Overall Study||0
7848609|NCT00966693|19318450|P3|Phase 1 Completed|Overall Study||6
7848610|NCT00966693|19318451|P2|Phase 1 Completed|Overall Study||3
7848611|NCT00966693|19318452|P1|Phase 1 Completed|Overall Study||2
7848612|NCT00966693|19318449|P4|STARTED|Overall Study||49
7848613|NCT00966693|19318450|P3|STARTED|Overall Study||9
7848614|NCT00966693|19318451|P2|STARTED|Overall Study||3
7848615|NCT00966693|19318452|P1|STARTED|Overall Study||3
7848616|NCT00966654|19318486|P1|NOT COMPLETED|Overall Study||12
7848617|NCT00966654|19318486|P1|COMPLETED|Overall Study||0
7848618|NCT00966654|19318486|P1|STARTED|Overall Study||12
7848619|NCT00966641|19318494|P2|NOT COMPLETED|Second Intervention||0
7848620|NCT00966641|19318495|P1|NOT COMPLETED|Second Intervention||0
7848621|NCT00966641|19318494|P2|COMPLETED|Second Intervention||17
7848622|NCT00966641|19318495|P1|COMPLETED|Second Intervention||17
7848623|NCT00966641|19318494|P2|STARTED|Second Intervention||17
7848624|NCT00966641|19318495|P1|STARTED|Second Intervention||17
7848625|NCT00966641|19318494|P2|NOT COMPLETED|First Intervention||0
7848626|NCT00966641|19318495|P1|NOT COMPLETED|First Intervention||0
7848627|NCT00966641|19318494|P2|COMPLETED|First Intervention||17
7848628|NCT00966641|19318495|P1|COMPLETED|First Intervention||17
7848629|NCT00966641|19318494|P2|STARTED|First Intervention||17
7848630|NCT00966641|19318495|P1|STARTED|First Intervention||17
7848631|NCT00966550|19318503|P2|NOT COMPLETED|Overall Study||0
7848632|NCT00966550|19318504|P1|NOT COMPLETED|Overall Study||0
7848633|NCT00966550|19318503|P2|COMPLETED|Overall Study||12
7848634|NCT00966550|19318504|P1|COMPLETED|Overall Study||13
7848635|NCT00966550|19318503|P2|STARTED|Overall Study||12
7848636|NCT00966550|19318504|P1|STARTED|Overall Study||13
7848637|NCT00966446|19318513|P3|NOT COMPLETED|Overall Study||21
7848638|NCT00966446|19318514|P2|NOT COMPLETED|Overall Study||25
7848639|NCT00966446|19318515|P1|NOT COMPLETED|Overall Study||28
7848640|NCT00966446|19318513|P3|COMPLETED|Overall Study||52
7848641|NCT00966446|19318514|P2|COMPLETED|Overall Study||49
7848642|NCT00966446|19318515|P1|COMPLETED|Overall Study||48
7848643|NCT00966446|19318513|P3|STARTED|Overall Study||73
7848644|NCT00966446|19318514|P2|STARTED|Overall Study||74
7848645|NCT00966446|19318515|P1|STARTED|Overall Study||76
7848646|NCT00966433|19318532|P3|NOT COMPLETED|Overall Study||0
7848647|NCT00966433|19318533|P2|NOT COMPLETED|Overall Study||1
7848648|NCT00966433|19318534|P1|NOT COMPLETED|Overall Study||1
7848649|NCT00966433|19318532|P3|COMPLETED|Overall Study||11
7848650|NCT00966433|19318533|P2|COMPLETED|Overall Study||10
7848651|NCT00966433|19318534|P1|COMPLETED|Overall Study||10
7848652|NCT00966433|19318532|P3|STARTED|Overall Study||11
7848653|NCT00966433|19318533|P2|STARTED|Overall Study||11
7848654|NCT00966433|19318534|P1|STARTED|Overall Study||11
7848655|NCT00966355|19318560|P3|NOT COMPLETED|Overall Study||84
7848656|NCT00966355|19318561|P2|NOT COMPLETED|Overall Study||86
7848657|NCT00966355|19318562|P1|NOT COMPLETED|Overall Study||84
7848658|NCT00966355|19318560|P3|COMPLETED|Overall Study||261
7848659|NCT00966355|19318561|P2|COMPLETED|Overall Study||259
7848660|NCT00966355|19318562|P1|COMPLETED|Overall Study||260
7848661|NCT00966355|19318560|P3|STARTED|Overall Study||345
7848662|NCT00966355|19318561|P2|STARTED|Overall Study||345
7848663|NCT00966355|19318562|P1|STARTED|Overall Study||344
7848664|NCT00966277|19318575|P2|NOT COMPLETED|Overall Study||4
7848665|NCT00966277|19318576|P1|NOT COMPLETED|Overall Study||4
7848666|NCT00966277|19318575|P2|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33
7848667|NCT00966277|19318576|P1|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34
7848668|NCT00966277|19318575|P2|STARTED|Overall Study||37
7848669|NCT00966277|19318576|P1|STARTED|Overall Study||38
7848670|NCT00966264|19318584|P2|NOT COMPLETED|Overall Study||3
7848671|NCT00966264|19318585|P1|NOT COMPLETED|Overall Study||4
7848672|NCT00966264|19318584|P2|COMPLETED|Overall Study|5 years results|114
7848673|NCT00966264|19318585|P1|COMPLETED|Overall Study|5 years results|115
7848674|NCT00966264|19318584|P2|STARTED|Overall Study||117
7848675|NCT00966264|19318585|P1|STARTED|Overall Study||119
7848676|NCT00966238|19318597|P6|NOT COMPLETED|Overall Study||0
7848677|NCT00966238|19318598|P5|NOT COMPLETED|Overall Study||0
7848678|NCT00966238|19318599|P4|NOT COMPLETED|Overall Study||0
7848679|NCT00966238|19318600|P3|NOT COMPLETED|Overall Study||0
7848680|NCT00966238|19318601|P2|NOT COMPLETED|Overall Study||0
7848681|NCT00966238|19318602|P1|NOT COMPLETED|Overall Study||0
7848682|NCT00966238|19318597|P6|COMPLETED|Overall Study||20
7848683|NCT00966238|19318598|P5|COMPLETED|Overall Study||20
7848684|NCT00966238|19318599|P4|COMPLETED|Overall Study||20
7848685|NCT00966238|19318600|P3|COMPLETED|Overall Study||20
7848686|NCT00966238|19318601|P2|COMPLETED|Overall Study||20
7848687|NCT00966238|19318602|P1|COMPLETED|Overall Study||20
7848688|NCT00966238|19318597|P6|STARTED|Overall Study||20
7848689|NCT00966238|19318598|P5|STARTED|Overall Study||20
7848690|NCT00966238|19318599|P4|STARTED|Overall Study||20
7848691|NCT00966238|19318600|P3|STARTED|Overall Study||20
7848692|NCT00966238|19318601|P2|STARTED|Overall Study||20
7848693|NCT00966238|19318602|P1|STARTED|Overall Study||20
7848694|NCT00966186|19318624|P2|NOT COMPLETED|Overall Study||0
7848695|NCT00966186|19318625|P1|NOT COMPLETED|Overall Study||0
7848696|NCT00966186|19318624|P2|COMPLETED|Overall Study||60
7848697|NCT00966186|19318625|P1|COMPLETED|Overall Study||60
7848698|NCT00966186|19318624|P2|STARTED|Overall Study||60
7848699|NCT00966186|19318625|P1|STARTED|Overall Study||60
7848700|NCT00965848|19318631|P3|NOT COMPLETED|Overall Study||10
7848701|NCT00965848|19318632|P2|NOT COMPLETED|Overall Study||2
7848702|NCT00965848|19318633|P1|NOT COMPLETED|Overall Study||29
7848703|NCT00965848|19318631|P3|COMPLETED|Overall Study||117
7848704|NCT00965848|19318632|P2|COMPLETED|Overall Study||32
7848705|NCT00965848|19318633|P1|COMPLETED|Overall Study||78
7848706|NCT00965848|19318631|P3|STARTED|Overall Study||127
7848707|NCT00965848|19318632|P2|STARTED|Overall Study||34
7848708|NCT00965848|19318633|P1|STARTED|Overall Study||107
7848709|NCT00965757|19318652|P4|NOT COMPLETED|Extension Phase||24
7848710|NCT00965757|19318653|P3|NOT COMPLETED|Extension Phase||33
7848711|NCT00965757|19318654|P2|NOT COMPLETED|Extension Phase||0
7848712|NCT00965757|19318655|P1|NOT COMPLETED|Extension Phase||0
7848713|NCT00965757|19318652|P4|COMPLETED|Extension Phase||64
7848714|NCT00965757|19318653|P3|COMPLETED|Extension Phase||132
7848715|NCT00965757|19318654|P2|COMPLETED|Extension Phase||0
7848716|NCT00965757|19318655|P1|COMPLETED|Extension Phase||0
7848717|NCT00965757|19318652|P4|STARTED|Extension Phase||88
7848718|NCT00965757|19318653|P3|STARTED|Extension Phase||165
7848719|NCT00965757|19318654|P2|STARTED|Extension Phase||0
7848720|NCT00965757|19318655|P1|STARTED|Extension Phase||0
7848721|NCT00965757|19318652|P4|NOT COMPLETED|Double-blind Phase||0
7848722|NCT00965757|19318653|P3|NOT COMPLETED|Double-blind Phase||0
7848723|NCT00965757|19318654|P2|NOT COMPLETED|Double-blind Phase||18
7848724|NCT00965757|19318655|P1|NOT COMPLETED|Double-blind Phase||17
7848725|NCT00965757|19318652|P4|COMPLETED|Double-blind Phase||0
7848726|NCT00965757|19318653|P3|COMPLETED|Double-blind Phase||0
7848727|NCT00965757|19318654|P2|COMPLETED|Double-blind Phase||70
7848728|NCT00965757|19318655|P1|COMPLETED|Double-blind Phase||148
7848729|NCT00965757|19318652|P4|STARTED|Double-blind Phase||0
7848730|NCT00965757|19318653|P3|STARTED|Double-blind Phase||0
7848731|NCT00965757|19318654|P2|STARTED|Double-blind Phase||88
7848732|NCT00965757|19318655|P1|STARTED|Double-blind Phase||165
7848733|NCT00965731|19318689|P2|NOT COMPLETED|Overall Study||20
7848734|NCT00965731|19318690|P1|NOT COMPLETED|Overall Study||7
7848735|NCT00965731|19318689|P2|COMPLETED|Overall Study||0
7848736|NCT00965731|19318690|P1|COMPLETED|Overall Study||0
7848737|NCT00965731|19318689|P2|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20
7848738|NCT00965731|19318690|P1|STARTED|Overall Study||7
7848739|NCT00965718|19318754|P1|NOT COMPLETED|Overall Study||4
7848740|NCT00965718|19318754|P1|COMPLETED|Overall Study||16
7848741|NCT00965718|19318754|P1|STARTED|Overall Study||20
7848742|NCT00965575|19318766|P2|NOT COMPLETED|Overall Study||0
7848743|NCT00965575|19318767|P1|NOT COMPLETED|Overall Study||1
7848744|NCT00965575|19318766|P2|COMPLETED|Overall Study||5
7848745|NCT00965575|19318767|P1|COMPLETED|Overall Study||5
7848746|NCT00965575|19318766|P2|STARTED|Overall Study|cross over, total enrolled 11|5
7848747|NCT00965575|19318767|P1|STARTED|Overall Study|cross over, total enrolled 11|6
7848748|NCT00965562|19318778|P3|NOT COMPLETED|Overall Study||3
7848749|NCT00965562|19318779|P2|NOT COMPLETED|Overall Study||4
7848750|NCT00965562|19318780|P1|NOT COMPLETED|Overall Study||3
7848751|NCT00965562|19318778|P3|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
7848752|NCT00965562|19318779|P2|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
7848753|NCT00965562|19318780|P1|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
7848754|NCT00965562|19318778|P3|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11
7848755|NCT00965562|19318779|P2|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10
7848756|NCT00965562|19318780|P1|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6
7848757|NCT00965562|19318778|P3|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13
7848758|NCT00965562|19318779|P2|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13
7848759|NCT00965562|19318780|P1|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13
7848760|NCT00965562|19318778|P3|STARTED|Overall Study||16
7848761|NCT00965562|19318779|P2|STARTED|Overall Study||17
7848762|NCT00965562|19318780|P1|STARTED|Overall Study||16
7848763|NCT00965523|19318818|P1|NOT COMPLETED|Study 224||6
7848764|NCT00965523|19318818|P1|COMPLETED|Study 224||0
7848765|NCT00965523|19318818|P1|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6
7848766|NCT00965523|19318818|P1|NOT COMPLETED|Study 221||7
7848767|NCT00965523|19318818|P1|COMPLETED|Study 221||74
7848768|NCT00965523|19318818|P1|STARTED|Study 221|Study 221 (Safety Analysis Set).|81
7848769|NCT00965497|19318823|P1|NOT COMPLETED|Overall Study||1
7848770|NCT00965497|19318823|P1|COMPLETED|Overall Study||13
7848771|NCT00965497|19318823|P1|STARTED|Overall Study||14
7848772|NCT00965484|19318828|P1|NOT COMPLETED|Overall Study||2
7848773|NCT00965484|19318828|P1|COMPLETED|Overall Study||134
7848774|NCT00965484|19318828|P1|STARTED|Overall Study||136
7848775|NCT00965458|19318837|P2|NOT COMPLETED|Overall Study||4
7848776|NCT00965458|19318838|P1|NOT COMPLETED|Overall Study||2
7848777|NCT00965458|19318837|P2|COMPLETED|Overall Study||12
7848778|NCT00965458|19318838|P1|COMPLETED|Overall Study||31
7848779|NCT00965458|19318837|P2|STARTED|Overall Study||16
7848780|NCT00965458|19318838|P1|STARTED|Overall Study||33
7848781|NCT00965419|19318854|P1|NOT COMPLETED|Follow-up Phase||62
7848782|NCT00965419|19318854|P1|COMPLETED|Follow-up Phase||18
7848783|NCT00965419|19318854|P1|STARTED|Follow-up Phase||80
7848784|NCT00965419|19318854|P1|NOT COMPLETED|Open Label Treatment for Responders||247
7848785|NCT00965419|19318854|P1|COMPLETED|Open Label Treatment for Responders||20
7848786|NCT00965419|19318854|P1|Not Lost to f/u at First Post-baseline|Open Label Treatment for Responders||264
7848787|NCT00965419|19318854|P1|STARTED|Open Label Treatment for Responders||267
7848788|NCT00965341|19318900|P2|NOT COMPLETED|Overall Study||8
7848789|NCT00965341|19318901|P1|NOT COMPLETED|Overall Study||6
7848790|NCT00965341|19318900|P2|COMPLETED|Overall Study||16
7848791|NCT00965341|19318901|P1|COMPLETED|Overall Study||13
7848792|NCT00965341|19318900|P2|STARTED|Overall Study||24
7848793|NCT00965341|19318901|P1|STARTED|Overall Study||19
7848794|NCT00965263|19318911|P2|NOT COMPLETED|Overall Study||3
7848795|NCT00965263|19318912|P1|NOT COMPLETED|Overall Study||2
7848796|NCT00965263|19318911|P2|COMPLETED|Overall Study||6
7848797|NCT00965263|19318912|P1|COMPLETED|Overall Study||4
7848798|NCT00965263|19318911|P2|STARTED|Overall Study||9
7848799|NCT00965263|19318912|P1|STARTED|Overall Study||6
7848800|NCT00965250|19318944|P2|NOT COMPLETED|Overall Study||0
7848801|NCT00965250|19318945|P1|NOT COMPLETED|Overall Study||0
7848802|NCT00965250|19318944|P2|COMPLETED|Overall Study||12
7848803|NCT00965250|19318945|P1|COMPLETED|Overall Study||37
7848804|NCT00965250|19318944|P2|STARTED|Overall Study||12
7848805|NCT00965250|19318945|P1|STARTED|Overall Study||37
7848806|NCT00965237|19318963|P2|NOT COMPLETED|Period 2, One Week of Wear||0
7848807|NCT00965237|19318964|P1|NOT COMPLETED|Period 2, One Week of Wear||0
7848808|NCT00965237|19318963|P2|COMPLETED|Period 2, One Week of Wear||8
7848809|NCT00965237|19318964|P1|COMPLETED|Period 2, One Week of Wear||8
7848810|NCT00965237|19318963|P2|STARTED|Period 2, One Week of Wear||8
7848811|NCT00965237|19318964|P1|STARTED|Period 2, One Week of Wear||8
7848812|NCT00965237|19318963|P2|NOT COMPLETED|Period 1, One Week of Wear||0
7848813|NCT00965237|19318964|P1|NOT COMPLETED|Period 1, One Week of Wear||0
7848814|NCT00965237|19318963|P2|COMPLETED|Period 1, One Week of Wear||8
7848815|NCT00965237|19318964|P1|COMPLETED|Period 1, One Week of Wear||8
7848816|NCT00965237|19318963|P2|STARTED|Period 1, One Week of Wear||8
7848817|NCT00965237|19318964|P1|STARTED|Period 1, One Week of Wear||8
7848818|NCT00965185|19318972|P2|NOT COMPLETED|Overall Study||1
7848819|NCT00965185|19318973|P1|NOT COMPLETED|Overall Study||2
7848820|NCT00965185|19318972|P2|COMPLETED|Overall Study||20
7848821|NCT00965185|19318973|P1|COMPLETED|Overall Study||17
7848822|NCT00965185|19318972|P2|9 Month Visit|Overall Study||21
7848823|NCT00965185|19318973|P1|9 Month Visit|Overall Study||18
7848824|NCT00965185|19318972|P2|6 Month Visit|Overall Study||21
7848825|NCT00965185|19318973|P1|6 Month Visit|Overall Study||18
7848826|NCT00965185|19318972|P2|3 Month Visit|Overall Study||21
7848827|NCT00965185|19318973|P1|3 Month Visit|Overall Study||18
7848828|NCT00965185|19318972|P2|1 Month Visit|Overall Study||21
7848829|NCT00965185|19318973|P1|1 Month Visit|Overall Study||18
7848830|NCT00965185|19318972|P2|STARTED|Overall Study||21
7848831|NCT00965185|19318973|P1|STARTED|Overall Study||19
7848832|NCT00965146|19318993|P1|NOT COMPLETED|Overall Study||210
7848833|NCT00965146|19318993|P1|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0
7848834|NCT00965146|19318993|P1|STARTED|Overall Study||210
7848835|NCT00965094|19319000|P2|NOT COMPLETED|Overall Study||1
7848836|NCT00965094|19319001|P1|NOT COMPLETED|Overall Study||5
7848837|NCT00965094|19319000|P2|COMPLETED|Overall Study||16
7848838|NCT00965094|19319001|P1|COMPLETED|Overall Study||14
7848839|NCT00965094|19319000|P2|STARTED|Overall Study||17
7848840|NCT00965094|19319001|P1|STARTED|Overall Study||19
7848841|NCT00965081|19319017|P2|NOT COMPLETED|Overall Study||43
7848842|NCT00965081|19319018|P1|NOT COMPLETED|Overall Study||34
7848843|NCT00965081|19319017|P2|COMPLETED|Overall Study||110
7848844|NCT00965081|19319018|P1|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121
7848845|NCT00965081|19319017|P2|STARTED|Overall Study||153
7848846|NCT00965081|19319018|P1|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155
7848847|NCT00965055|19319041|P1|NOT COMPLETED|Overall Study||0
7848848|NCT00965055|19319041|P1|COMPLETED|Overall Study||2
7848849|NCT00965055|19319041|P1|STARTED|Overall Study||2
7848850|NCT00964886|19319050|P4|NOT COMPLETED|Overall Study||9
7848851|NCT00964886|19319051|P3|NOT COMPLETED|Overall Study||16
7848852|NCT00964886|19319052|P2|NOT COMPLETED|Overall Study||7
7848853|NCT00964886|19319053|P1|NOT COMPLETED|Overall Study||11
7848854|NCT00964886|19319050|P4|COMPLETED|Overall Study||24
7848855|NCT00964886|19319051|P3|COMPLETED|Overall Study||21
7848856|NCT00964886|19319052|P2|COMPLETED|Overall Study||27
7848857|NCT00964886|19319053|P1|COMPLETED|Overall Study||27
7848858|NCT00964886|19319050|P4|STARTED|Overall Study||33
7848859|NCT00964886|19319051|P3|STARTED|Overall Study||37
7848860|NCT00964886|19319052|P2|STARTED|Overall Study||34
7848861|NCT00964886|19319053|P1|STARTED|Overall Study||38
7848862|NCT00964860|19319069|P2|NOT COMPLETED|Overall Study||1
7848863|NCT00964860|19319070|P1|NOT COMPLETED|Overall Study||0
7848864|NCT00964860|19319069|P2|COMPLETED|Overall Study||29
7848865|NCT00964860|19319070|P1|COMPLETED|Overall Study||30
7848866|NCT00964860|19319069|P2|STARTED|Overall Study||30
7848867|NCT00964860|19319070|P1|STARTED|Overall Study||30
7848868|NCT00964795|19319078|P1|NOT COMPLETED|Overall Study||307
7848869|NCT00964795|19319078|P1|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16
7848870|NCT00964795|19319078|P1|Number of Participants Treated|Overall Study||320
7848871|NCT00964795|19319078|P1|STARTED|Overall Study|randomized|323
7848872|NCT00964782|19319087|P2|NOT COMPLETED|Overall Study||0
7848873|NCT00964782|19319088|P1|NOT COMPLETED|Overall Study||1
7848874|NCT00964782|19319087|P2|COMPLETED|Overall Study||8
7848875|NCT00964782|19319088|P1|COMPLETED|Overall Study||7
7848876|NCT00964782|19319087|P2|STARTED|Overall Study||8
7848877|NCT00964782|19319088|P1|STARTED|Overall Study||8
7848878|NCT00964743|19319102|P1|NOT COMPLETED|Overall Study||2
7848879|NCT00964743|19319102|P1|COMPLETED|Overall Study||0
7848880|NCT00964743|19319102|P1|STARTED|Overall Study||2
7848881|NCT00964678|19319110|P1|NOT COMPLETED|Overall Study||4
7848882|NCT00964678|19319110|P1|COMPLETED|Overall Study||6
7848883|NCT00964678|19319110|P1|STARTED|Overall Study||10
7848884|NCT00964548|19319119|P2|NOT COMPLETED|Overall Study||0
7848885|NCT00964548|19319120|P1|NOT COMPLETED|Overall Study||0
7848886|NCT00964548|19319119|P2|COMPLETED|Overall Study||5
7848887|NCT00964548|19319120|P1|COMPLETED|Overall Study||5
7848888|NCT00964548|19319119|P2|STARTED|Overall Study||5
7848889|NCT00964548|19319120|P1|STARTED|Overall Study||5
7848890|NCT00964496|19319132|P2|NOT COMPLETED|Overall Study||1
7848891|NCT00964496|19319133|P1|NOT COMPLETED|Overall Study||2
7848892|NCT00964496|19319132|P2|COMPLETED|Overall Study||26
7848893|NCT00964496|19319133|P1|COMPLETED|Overall Study||26
7848894|NCT00964496|19319132|P2|STARTED|Overall Study||27
7848895|NCT00964496|19319133|P1|STARTED|Overall Study||28
7848896|NCT00964444|19319151|P1|NOT COMPLETED|Overall Study||0
7848897|NCT00964444|19319151|P1|COMPLETED|Overall Study||10
7848898|NCT00964444|19319151|P1|STARTED|Overall Study||10
7848899|NCT00964431|19319159|P4|NOT COMPLETED|Overall Study||0
7848900|NCT00964431|19319160|P3|NOT COMPLETED|Overall Study||0
7848901|NCT00964431|19319161|P2|NOT COMPLETED|Overall Study||0
7848902|NCT00964431|19319162|P1|NOT COMPLETED|Overall Study||0
7848903|NCT00964431|19319159|P4|COMPLETED|Overall Study||51
7848904|NCT00964431|19319160|P3|COMPLETED|Overall Study||51
7848905|NCT00964431|19319161|P2|COMPLETED|Overall Study||51
7848906|NCT00964431|19319162|P1|COMPLETED|Overall Study||50
7848907|NCT00964431|19319159|P4|STARTED|Overall Study||51
7848908|NCT00964431|19319160|P3|STARTED|Overall Study||51
7848909|NCT00964431|19319161|P2|STARTED|Overall Study||51
7848910|NCT00964431|19319162|P1|STARTED|Overall Study||50
7848911|NCT00964392|19319174|P2|NOT COMPLETED|Overall Study||190
7848912|NCT00964392|19319175|P1|NOT COMPLETED|Overall Study||53
7848913|NCT00964392|19319174|P2|COMPLETED|Overall Study||92
7848914|NCT00964392|19319175|P1|COMPLETED|Overall Study||72
7848915|NCT00964392|19319174|P2|STARTED|Overall Study|Both safety and efficacy cohort: Total 292 (10 LEP Excluded)|282
7848916|NCT00964392|19319175|P1|STARTED|Overall Study|Both safety and efficacy cohort: Total 128 (3 MEP Excluded)|125
7848917|NCT00964366|19319185|P2|NOT COMPLETED|Overall Study||1
7848918|NCT00964366|19319186|P1|NOT COMPLETED|Overall Study||1
7848919|NCT00964366|19319185|P2|COMPLETED|Overall Study||24
7848920|NCT00964366|19319186|P1|COMPLETED|Overall Study||27
7848921|NCT00964366|19319185|P2|STARTED|Overall Study||25
7848922|NCT00964366|19319186|P1|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28
7848923|NCT00964353|19319202|P2|NOT COMPLETED|Overall Study||0
7848924|NCT00964353|19319203|P1|NOT COMPLETED|Overall Study||0
7848925|NCT00964353|19319202|P2|COMPLETED|Overall Study||178
7848926|NCT00964353|19319203|P1|COMPLETED|Overall Study||181
7848927|NCT00964353|19319202|P2|STARTED|Overall Study||178
7848928|NCT00964353|19319203|P1|STARTED|Overall Study||181
7848929|NCT00964223|19319211|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1
7848930|NCT00964223|19319211|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27
7848931|NCT00964223|19319211|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||28
7848932|NCT00964223|19319211|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
7848933|NCT00964223|19319211|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28
7848934|NCT00964223|19319211|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||28
7848935|NCT00964158|19319279|P3|NOT COMPLETED|Overall Study||8
7848936|NCT00964158|19319280|P2|NOT COMPLETED|Overall Study||1
7848937|NCT00964158|19319281|P1|NOT COMPLETED|Overall Study||0
7848938|NCT00964158|19319279|P3|COMPLETED|Overall Study||92
7848939|NCT00964158|19319280|P2|COMPLETED|Overall Study||56
7848940|NCT00964158|19319281|P1|COMPLETED|Overall Study||53
7848941|NCT00964158|19319279|P3|STARTED|Overall Study||100
7848942|NCT00964158|19319280|P2|STARTED|Overall Study||57
7848943|NCT00964158|19319281|P1|STARTED|Overall Study||53
7848944|NCT00964119|19319350|P1|NOT COMPLETED|Overall Study||0
7848945|NCT00964119|19319350|P1|COMPLETED|Overall Study||15
7848946|NCT00964119|19319350|P1|STARTED|Overall Study||15
7848947|NCT00964028|19319356|P2|NOT COMPLETED|Overall Study||1
7848948|NCT00964028|19319357|P1|NOT COMPLETED|Overall Study||0
7848949|NCT00964028|19319356|P2|COMPLETED|Overall Study||24
7848950|NCT00964028|19319357|P1|COMPLETED|Overall Study||25
7848951|NCT00964028|19319356|P2|STARTED|Overall Study||25
7848952|NCT00964028|19319357|P1|STARTED|Overall Study||25
7848953|NCT00963937|19319372|P3|NOT COMPLETED|Overall Study||4
7848954|NCT00963937|19319373|P2|NOT COMPLETED|Overall Study||11
7848955|NCT00963937|19319374|P1|NOT COMPLETED|Overall Study||19
7848956|NCT00963937|19319372|P3|COMPLETED|Overall Study||41
7848957|NCT00963937|19319373|P2|COMPLETED|Overall Study||33
7848958|NCT00963937|19319374|P1|COMPLETED|Overall Study||70
7848959|NCT00963937|19319372|P3|STARTED|Overall Study||45
7848960|NCT00963937|19319373|P2|STARTED|Overall Study||44
7848961|NCT00963937|19319374|P1|STARTED|Overall Study||89
7848962|NCT00963924|19319412|P2|NOT COMPLETED|Overall Study||3
7848963|NCT00963924|19319413|P1|NOT COMPLETED|Overall Study||1
7848964|NCT00963924|19319412|P2|COMPLETED|Overall Study||15
7848965|NCT00963924|19319413|P1|COMPLETED|Overall Study||17
7848966|NCT00963924|19319412|P2|STARTED|Overall Study||18
7848967|NCT00963924|19319413|P1|STARTED|Overall Study||18
7848968|NCT00963872|19319437|P2|NOT COMPLETED|Overall Study||1
7848969|NCT00963872|19319438|P1|NOT COMPLETED|Overall Study||1
7848970|NCT00963872|19319437|P2|COMPLETED|Overall Study||5
7848971|NCT00963872|19319438|P1|COMPLETED|Overall Study||24
7848972|NCT00963872|19319437|P2|STARTED|Overall Study||6
7848973|NCT00963872|19319438|P1|STARTED|Overall Study||25
7848974|NCT00963859|19319482|P1|NOT COMPLETED|Overall Study||0
7848975|NCT00963859|19319482|P1|COMPLETED|Overall Study||11
7848976|NCT00963859|19319482|P1|STARTED|Overall Study||11
7848977|NCT00963820|19319487|P12|NOT COMPLETED|Expansion Phase||4
7848978|NCT00963820|19319488|P11|NOT COMPLETED|Expansion Phase||5
7848979|NCT00963820|19319489|P10|NOT COMPLETED|Expansion Phase||9
7848980|NCT00963820|19319490|P9|NOT COMPLETED|Expansion Phase||10
7848981|NCT00963820|19319491|P8|NOT COMPLETED|Expansion Phase||0
7848982|NCT00963820|19319492|P7|NOT COMPLETED|Expansion Phase||0
7848983|NCT00963820|19319493|P6|NOT COMPLETED|Expansion Phase||0
7848984|NCT00963820|19319494|P5|NOT COMPLETED|Expansion Phase||0
7848985|NCT00963820|19319495|P4|NOT COMPLETED|Expansion Phase||0
7848986|NCT00963820|19319496|P3|NOT COMPLETED|Expansion Phase||0
7848987|NCT00963820|19319497|P2|NOT COMPLETED|Expansion Phase||0
7848988|NCT00963820|19319498|P1|NOT COMPLETED|Expansion Phase||0
7848989|NCT00963820|19319487|P12|COMPLETED|Expansion Phase||0
7848990|NCT00963820|19319488|P11|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
7848991|NCT00963820|19319489|P10|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
7848992|NCT00963820|19319490|P9|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
7848993|NCT00963820|19319491|P8|COMPLETED|Expansion Phase||0
7848994|NCT00963820|19319492|P7|COMPLETED|Expansion Phase||0
7848995|NCT00963820|19319493|P6|COMPLETED|Expansion Phase||0
7848996|NCT00963820|19319494|P5|COMPLETED|Expansion Phase||0
7848997|NCT00963820|19319495|P4|COMPLETED|Expansion Phase||0
7848998|NCT00963820|19319496|P3|COMPLETED|Expansion Phase||0
7848999|NCT00963820|19319497|P2|COMPLETED|Expansion Phase||0
7849000|NCT00963820|19319498|P1|COMPLETED|Expansion Phase||0
7849001|NCT00963820|19319487|P12|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4
7849002|NCT00963820|19319488|P11|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6
7849003|NCT00963820|19319489|P10|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10
7849004|NCT00963820|19319490|P9|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11
7849005|NCT00963820|19319491|P8|STARTED|Expansion Phase||0
7849006|NCT00963820|19319492|P7|STARTED|Expansion Phase||0
7849007|NCT00963820|19319493|P6|STARTED|Expansion Phase||0
7849008|NCT00963820|19319494|P5|STARTED|Expansion Phase||0
7849009|NCT00963820|19319495|P4|STARTED|Expansion Phase||0
7849010|NCT00963820|19319496|P3|STARTED|Expansion Phase||0
7849011|NCT00963820|19319497|P2|STARTED|Expansion Phase||0
7849012|NCT00963820|19319498|P1|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0
7849013|NCT00963820|19319487|P12|NOT COMPLETED|Dose Escalation Phase||0
7849014|NCT00963820|19319488|P11|NOT COMPLETED|Dose Escalation Phase||0
7849015|NCT00963820|19319489|P10|NOT COMPLETED|Dose Escalation Phase||0
7849016|NCT00963820|19319490|P9|NOT COMPLETED|Dose Escalation Phase||0
7849017|NCT00963820|19319491|P8|NOT COMPLETED|Dose Escalation Phase||5
7849018|NCT00963820|19319492|P7|NOT COMPLETED|Dose Escalation Phase||8
7849019|NCT00963820|19319493|P6|NOT COMPLETED|Dose Escalation Phase||3
7849020|NCT00963820|19319494|P5|NOT COMPLETED|Dose Escalation Phase||4
7849021|NCT00963820|19319495|P4|NOT COMPLETED|Dose Escalation Phase||3
7849022|NCT00963820|19319496|P3|NOT COMPLETED|Dose Escalation Phase||3
7849023|NCT00963820|19319497|P2|NOT COMPLETED|Dose Escalation Phase||3
7849024|NCT00963820|19319498|P1|NOT COMPLETED|Dose Escalation Phase||3
7849025|NCT00963820|19319487|P12|COMPLETED|Dose Escalation Phase||0
7849026|NCT00963820|19319488|P11|COMPLETED|Dose Escalation Phase||0
7849027|NCT00963820|19319489|P10|COMPLETED|Dose Escalation Phase||0
7849028|NCT00963820|19319490|P9|COMPLETED|Dose Escalation Phase||0
7849029|NCT00963820|19319491|P8|COMPLETED|Dose Escalation Phase||0
7849030|NCT00963820|19319492|P7|COMPLETED|Dose Escalation Phase||0
7849031|NCT00963820|19319493|P6|COMPLETED|Dose Escalation Phase||0
7849032|NCT00963820|19319494|P5|COMPLETED|Dose Escalation Phase||0
7849033|NCT00963820|19319495|P4|COMPLETED|Dose Escalation Phase||0
7849034|NCT00963820|19319496|P3|COMPLETED|Dose Escalation Phase||0
7849035|NCT00963820|19319497|P2|COMPLETED|Dose Escalation Phase||0
7849036|NCT00963820|19319498|P1|COMPLETED|Dose Escalation Phase||0
7849037|NCT00963820|19319487|P12|STARTED|Dose Escalation Phase||0
7849038|NCT00963820|19319488|P11|STARTED|Dose Escalation Phase||0
7849039|NCT00963820|19319489|P10|STARTED|Dose Escalation Phase||0
7849040|NCT00963820|19319490|P9|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0
7849041|NCT00963820|19319491|P8|STARTED|Dose Escalation Phase||5
7849042|NCT00963820|19319492|P7|STARTED|Dose Escalation Phase||8
7849043|NCT00963820|19319493|P6|STARTED|Dose Escalation Phase||3
7849044|NCT00963820|19319494|P5|STARTED|Dose Escalation Phase||4
7849045|NCT00963820|19319495|P4|STARTED|Dose Escalation Phase||3
7849046|NCT00963820|19319496|P3|STARTED|Dose Escalation Phase||3
7849047|NCT00963820|19319497|P2|STARTED|Dose Escalation Phase||3
7849048|NCT00963820|19319498|P1|STARTED|Dose Escalation Phase||3
7849049|NCT00963807|19319634|P1|NOT COMPLETED|Overall Study||18
7849050|NCT00963807|19319634|P1|COMPLETED|Overall Study||8
7849051|NCT00963807|19319634|P1|Completed Post-Cycle 2 FDG Imaging|Overall Study||8
7849052|NCT00963807|19319634|P1|Completed Post-Cycle 2 FLT Imaging|Overall Study||9
7849053|NCT00963807|19319634|P1|Completed Post-Cycle 1 Imaging|Overall Study||9
7849054|NCT00963807|19319634|P1|Completed Baseline Imaging|Overall Study||11
7849055|NCT00963807|19319634|P1|STARTED|Overall Study||26
7849056|NCT00963677|19319645|P2|NOT COMPLETED|Overall Study||2
7849057|NCT00963677|19319646|P1|NOT COMPLETED|Overall Study||0
7849058|NCT00963677|19319645|P2|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18
7849059|NCT00963677|19319646|P1|COMPLETED|Overall Study||35
7849060|NCT00963677|19319645|P2|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20
7849061|NCT00963677|19319646|P1|STARTED|Overall Study|Patients without predicted difficult intubation|35
7849062|NCT00963638|19319656|P2|NOT COMPLETED|Overall Study||0
7849063|NCT00963638|19319657|P1|NOT COMPLETED|Overall Study||0
7849064|NCT00963638|19319656|P2|COMPLETED|Overall Study||20
7849065|NCT00963638|19319657|P1|COMPLETED|Overall Study||20
7849066|NCT00963638|19319656|P2|STARTED|Overall Study||20
7849067|NCT00963638|19319657|P1|STARTED|Overall Study||20
7849068|NCT00963599|19319667|P4|NOT COMPLETED|Overall Study||14
7849069|NCT00963599|19319668|P3|NOT COMPLETED|Overall Study||9
7849070|NCT00963599|19319669|P2|NOT COMPLETED|Overall Study||6
7849071|NCT00963599|19319670|P1|NOT COMPLETED|Overall Study||6
7849072|NCT00963599|19319667|P4|COMPLETED|Overall Study||288
7849073|NCT00963599|19319668|P3|COMPLETED|Overall Study||292
7849074|NCT00963599|19319669|P2|COMPLETED|Overall Study||149
7849075|NCT00963599|19319670|P1|COMPLETED|Overall Study||143
7849076|NCT00963599|19319667|P4|STARTED|Overall Study||302
7849077|NCT00963599|19319668|P3|STARTED|Overall Study||301
7849078|NCT00963599|19319669|P2|STARTED|Overall Study||155
7849079|NCT00963599|19319670|P1|STARTED|Overall Study||149
7849080|NCT00963560|19319727|P3|NOT COMPLETED|Overall Study||0
7849081|NCT00963560|19319728|P2|NOT COMPLETED|Overall Study||3
7849082|NCT00963560|19319729|P1|NOT COMPLETED|Overall Study||3
7849083|NCT00963560|19319727|P3|COMPLETED|Overall Study||41
7849084|NCT00963560|19319728|P2|COMPLETED|Overall Study||41
7849085|NCT00963560|19319729|P1|COMPLETED|Overall Study||44
7849086|NCT00963560|19319727|P3|STARTED|Overall Study||41
7849087|NCT00963560|19319728|P2|STARTED|Overall Study||44
7849088|NCT00963560|19319729|P1|STARTED|Overall Study||47
7849089|NCT00963547|19319741|P7|NOT COMPLETED|Overall Study||0
7849090|NCT00963547|19319742|P6|NOT COMPLETED|Overall Study||0
7849091|NCT00963547|19319743|P5|NOT COMPLETED|Overall Study||0
7849092|NCT00963547|19319744|P4|NOT COMPLETED|Overall Study||6
7849093|NCT00963547|19319745|P3|NOT COMPLETED|Overall Study||12
7849094|NCT00963547|19319746|P2|NOT COMPLETED|Overall Study||11
7849095|NCT00963547|19319747|P1|NOT COMPLETED|Overall Study||4
7849096|NCT00963547|19319741|P7|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
7849097|NCT00963547|19319742|P6|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
7849098|NCT00963547|19319743|P5|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
7849099|NCT00963547|19319744|P4|COMPLETED|Overall Study||0
7849100|NCT00963547|19319745|P3|COMPLETED|Overall Study||0
7849101|NCT00963547|19319746|P2|COMPLETED|Overall Study||0
7849102|NCT00963547|19319747|P1|COMPLETED|Overall Study||0
7849103|NCT00963547|19319741|P7|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
7849104|NCT00963547|19319742|P6|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
7849105|NCT00963547|19319743|P5|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
7849106|NCT00963547|19319744|P4|Treated|Overall Study||6
7849107|NCT00963547|19319745|P3|Treated|Overall Study||11
7849108|NCT00963547|19319746|P2|Treated|Overall Study||11
7849109|NCT00963547|19319747|P1|Treated|Overall Study||3
7849110|NCT00963547|19319741|P7|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
7849111|NCT00963547|19319742|P6|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
7849112|NCT00963547|19319743|P5|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
7849113|NCT00963547|19319744|P4|STARTED|Overall Study||6
7849114|NCT00963547|19319745|P3|STARTED|Overall Study||12
7849115|NCT00963547|19319746|P2|STARTED|Overall Study||11
7849116|NCT00963547|19319747|P1|STARTED|Overall Study||4
7849117|NCT00963508|19319773|P2|NOT COMPLETED|Overall Study||28
7849118|NCT00963508|19319774|P1|NOT COMPLETED|Overall Study||10
7849119|NCT00963508|19319773|P2|COMPLETED|Overall Study||169
7849120|NCT00963508|19319774|P1|COMPLETED|Overall Study||196
7849121|NCT00963508|19319773|P2|STARTED|Overall Study||197
7849122|NCT00963508|19319774|P1|STARTED|Overall Study||206
7849123|NCT00963482|19319784|P2|NOT COMPLETED|Overall Study||17
7849124|NCT00963482|19319785|P1|NOT COMPLETED|Overall Study||28
7849125|NCT00963482|19319784|P2|COMPLETED|Overall Study||33
7849126|NCT00963482|19319785|P1|COMPLETED|Overall Study||25
7849127|NCT00963482|19319784|P2|STARTED|Overall Study||50
7849128|NCT00963482|19319785|P1|STARTED|Overall Study||53
7849129|NCT00963469|19319794|P3|NOT COMPLETED|Overall Study||10
7849130|NCT00963469|19319795|P2|NOT COMPLETED|Overall Study||28
7849131|NCT00963469|19319796|P1|NOT COMPLETED|Overall Study||41
7849132|NCT00963469|19319794|P3|COMPLETED|Overall Study||170
7849133|NCT00963469|19319795|P2|COMPLETED|Overall Study||420
7849134|NCT00963469|19319796|P1|COMPLETED|Overall Study||410
7849135|NCT00963469|19319794|P3|STARTED|Overall Study||180
7849136|NCT00963469|19319795|P2|STARTED|Overall Study||448
7849137|NCT00963469|19319796|P1|STARTED|Overall Study||451
7849138|NCT00963430|19319824|P2|NOT COMPLETED|Overall Study||3
7849139|NCT00963430|19319825|P1|NOT COMPLETED|Overall Study||1
7849140|NCT00963430|19319824|P2|COMPLETED|Overall Study||57
7849141|NCT00963430|19319825|P1|COMPLETED|Overall Study||59
7849142|NCT00963430|19319824|P2|STARTED|Overall Study||60
7849143|NCT00963430|19319825|P1|STARTED|Overall Study||60
7849144|NCT00963235|19319863|P1|NOT COMPLETED|Overall Study||60
7849145|NCT00963235|19319863|P1|COMPLETED|Overall Study||271
7849146|NCT00963235|19319863|P1|Completed Dose 3 1-month Blood Draw|Overall Study||277
7849147|NCT00963235|19319863|P1|Vaccinated Dose 3|Overall Study||279
7849148|NCT00963235|19319863|P1|Vaccinated Dose 2|Overall Study||300
7849149|NCT00963235|19319863|P1|Vaccinated Dose 1|Overall Study||329
7849150|NCT00963235|19319863|P1|STARTED|Overall Study||331
7849151|NCT00963157|19319887|P5|NOT COMPLETED|Overall Study||2
7849152|NCT00963157|19319888|P4|NOT COMPLETED|Overall Study||7
7849153|NCT00963157|19319889|P3|NOT COMPLETED|Overall Study||5
7849154|NCT00963157|19319890|P2|NOT COMPLETED|Overall Study||4
7849155|NCT00963157|19319891|P1|NOT COMPLETED|Overall Study||5
7849156|NCT00963157|19319887|P5|COMPLETED|Overall Study||151
7849157|NCT00963157|19319888|P4|COMPLETED|Overall Study||150
7849158|NCT00963157|19319889|P3|COMPLETED|Overall Study||155
7849159|NCT00963157|19319890|P2|COMPLETED|Overall Study||159
7849160|NCT00963157|19319891|P1|COMPLETED|Overall Study||151
7849161|NCT00963157|19319887|P5|STARTED|Overall Study||153
7849162|NCT00963157|19319888|P4|STARTED|Overall Study||157
7849163|NCT00963157|19319889|P3|STARTED|Overall Study||160
7849164|NCT00963157|19319890|P2|STARTED|Overall Study||163
7849165|NCT00963157|19319891|P1|STARTED|Overall Study||156
7849166|NCT00963105|19320086|P3|NOT COMPLETED|Overall Study||0
7849167|NCT00963105|19320087|P2|NOT COMPLETED|Overall Study||0
7849168|NCT00963105|19320088|P1|NOT COMPLETED|Overall Study||0
7849169|NCT00963105|19320086|P3|COMPLETED|Overall Study||35
7849170|NCT00963105|19320087|P2|COMPLETED|Overall Study||35
7849171|NCT00963105|19320088|P1|COMPLETED|Overall Study||34
7849172|NCT00963105|19320086|P3|Received Treatment|Overall Study||35
7849173|NCT00963105|19320087|P2|Received Treatment|Overall Study||34
7849174|NCT00963105|19320088|P1|Received Treatment|Overall Study||34
7849175|NCT00963105|19320086|P3|STARTED|Overall Study||35
7849176|NCT00963105|19320087|P2|STARTED|Overall Study||35
7849177|NCT00963105|19320088|P1|STARTED|Overall Study||34
7849178|NCT00962949|19320119|P2|NOT COMPLETED|Overall Study||0
7849179|NCT00962949|19320120|P1|NOT COMPLETED|Overall Study||0
7849180|NCT00962949|19320119|P2|COMPLETED|Overall Study||15
7849181|NCT00962949|19320120|P1|COMPLETED|Overall Study||13
7849182|NCT00962949|19320119|P2|STARTED|Overall Study||15
7849183|NCT00962949|19320120|P1|STARTED|Overall Study||13
7849184|NCT00962871|19320136|P4|NOT COMPLETED|Overall Study||0
7849185|NCT00962871|19320137|P3|NOT COMPLETED|Overall Study||0
7849186|NCT00962871|19320138|P2|NOT COMPLETED|Overall Study||0
7849187|NCT00962871|19320139|P1|NOT COMPLETED|Overall Study||0
7849188|NCT00962871|19320136|P4|COMPLETED|Overall Study||6
7849189|NCT00962871|19320137|P3|COMPLETED|Overall Study||12
7849190|NCT00962871|19320138|P2|COMPLETED|Overall Study||6
7849191|NCT00962871|19320139|P1|COMPLETED|Overall Study||6
7849192|NCT00962871|19320136|P4|STARTED|Overall Study||6
7849193|NCT00962871|19320137|P3|STARTED|Overall Study||12
7849194|NCT00962871|19320138|P2|STARTED|Overall Study||6
7849195|NCT00962871|19320139|P1|STARTED|Overall Study||6
7849196|NCT00962780|19320155|P2|NOT COMPLETED|Overall Study||14
7849197|NCT00962780|19320156|P1|NOT COMPLETED|Overall Study||10
7849198|NCT00962780|19320155|P2|COMPLETED|Overall Study||138
7849199|NCT00962780|19320156|P1|COMPLETED|Overall Study||141
7849200|NCT00962780|19320155|P2|Vaccinated 23vPS Dose|Overall Study||139
7849201|NCT00962780|19320156|P1|Vaccinated 23vPS Dose|Overall Study||143
7849202|NCT00962780|19320155|P2|Vaccinated 13vPnC Dose 3|Overall Study||142
7849203|NCT00962780|19320156|P1|Vaccinated 13vPnC Dose 3|Overall Study||144
7849204|NCT00962780|19320155|P2|Vaccinated 13vPnC Dose 2|Overall Study||145
7849205|NCT00962780|19320156|P1|Vaccinated 13vPnC Dose 2|Overall Study||145
7849206|NCT00962780|19320155|P2|Vaccinated 13vPnC Dose 1|Overall Study||151
7849207|NCT00962780|19320156|P1|Vaccinated 13vPnC Dose 1|Overall Study||150
7849208|NCT00962780|19320155|P2|STARTED|Overall Study||152
7849209|NCT00962780|19320156|P1|STARTED|Overall Study||151
7849210|NCT00962754|19320220|P2|NOT COMPLETED|Overall Study||0
7849211|NCT00962754|19320221|P1|NOT COMPLETED|Overall Study||0
7849212|NCT00962754|19320220|P2|COMPLETED|Overall Study||84
7849213|NCT00962754|19320221|P1|COMPLETED|Overall Study||86
7849214|NCT00962754|19320220|P2|STARTED|Overall Study||84
7849215|NCT00962754|19320221|P1|STARTED|Overall Study||86
7849216|NCT00962741|19320231|P1|NOT COMPLETED|Overall Study||8
7849217|NCT00962741|19320231|P1|COMPLETED|Overall Study||119
7849218|NCT00962741|19320231|P1|STARTED|Overall Study||127
7849219|NCT00962650|19320322|P1|NOT COMPLETED|Overall Study||2
7849220|NCT00962650|19320322|P1|COMPLETED|Overall Study||8
7849221|NCT00962650|19320322|P1|STARTED|Overall Study||10
7849222|NCT00962598|19320328|P2|NOT COMPLETED|Overall Study||0
7849223|NCT00962598|19320329|P1|NOT COMPLETED|Overall Study||0
7849224|NCT00962598|19320328|P2|COMPLETED|Overall Study||9
7849225|NCT00962598|19320329|P1|COMPLETED|Overall Study||7
7849226|NCT00962598|19320328|P2|STARTED|Overall Study||9
7849227|NCT00962598|19320329|P1|STARTED|Overall Study||7
7849228|NCT00962585|19320341|P4|NOT COMPLETED|Overall Study||0
7849229|NCT00962585|19320342|P3|NOT COMPLETED|Overall Study||3
7849230|NCT00962585|19320343|P2|NOT COMPLETED|Overall Study||2
7849231|NCT00962585|19320344|P1|NOT COMPLETED|Overall Study||6
7849232|NCT00962585|19320341|P4|COMPLETED|Overall Study||42
7849233|NCT00962585|19320342|P3|COMPLETED|Overall Study||39
7849234|NCT00962585|19320343|P2|COMPLETED|Overall Study||40
7849235|NCT00962585|19320344|P1|COMPLETED|Overall Study||37
7849236|NCT00962585|19320341|P4|STARTED|Overall Study||42
7849237|NCT00962585|19320342|P3|STARTED|Overall Study||42
7849238|NCT00962585|19320343|P2|STARTED|Overall Study||42
7849239|NCT00962585|19320344|P1|STARTED|Overall Study||43
7849240|NCT00962429|19320404|P2|NOT COMPLETED|Overall Study||0
7849241|NCT00962429|19320405|P1|NOT COMPLETED|Overall Study||0
7849242|NCT00962429|19320404|P2|COMPLETED|Overall Study||0
7849243|NCT00962429|19320405|P1|COMPLETED|Overall Study||0
7849244|NCT00962429|19320404|P2|STARTED|Overall Study||0
7849245|NCT00962429|19320405|P1|STARTED|Overall Study||0
7849246|NCT00962390|19320421|P4|NOT COMPLETED|Overall Study||1
7849247|NCT00962390|19320422|P3|NOT COMPLETED|Overall Study||4
7849248|NCT00962390|19320423|P2|NOT COMPLETED|Overall Study||3
7849249|NCT00962390|19320424|P1|NOT COMPLETED|Overall Study||4
7849250|NCT00962390|19320421|P4|COMPLETED|Overall Study||28
7849251|NCT00962390|19320422|P3|COMPLETED|Overall Study||25
7849252|NCT00962390|19320423|P2|COMPLETED|Overall Study||26
7849253|NCT00962390|19320424|P1|COMPLETED|Overall Study||25
7849254|NCT00962390|19320421|P4|STARTED|Overall Study||29
7849255|NCT00962390|19320422|P3|STARTED|Overall Study||29
7849256|NCT00962390|19320423|P2|STARTED|Overall Study||29
7849257|NCT00962390|19320424|P1|STARTED|Overall Study||29
7849258|NCT00962247|19320486|P1|NOT COMPLETED|50% Reduction of Sedentary Activity||0
7849259|NCT00962247|19320486|P1|COMPLETED|50% Reduction of Sedentary Activity||56
7849260|NCT00962247|19320486|P1|STARTED|50% Reduction of Sedentary Activity||56
7849261|NCT00962247|19320486|P1|NOT COMPLETED|25% Reduction of Sedentary Activity||5
7849262|NCT00962247|19320486|P1|COMPLETED|25% Reduction of Sedentary Activity||56
7849263|NCT00962247|19320486|P1|STARTED|25% Reduction of Sedentary Activity||61
7849264|NCT00962247|19320486|P1|NOT COMPLETED|Usual Sedentary||0
7849265|NCT00962247|19320486|P1|COMPLETED|Usual Sedentary||61
7849266|NCT00962247|19320486|P1|STARTED|Usual Sedentary||61
7849267|NCT00962208|19320497|P2|NOT COMPLETED|Overall Study||10
7849268|NCT00962208|19320498|P1|NOT COMPLETED|Overall Study||14
7849269|NCT00962208|19320497|P2|COMPLETED|Overall Study||41
7849270|NCT00962208|19320498|P1|COMPLETED|Overall Study||37
7849271|NCT00962208|19320497|P2|STARTED|Overall Study||51
7849272|NCT00962208|19320498|P1|STARTED|Overall Study||51
7849273|NCT00962104|19320506|P2|NOT COMPLETED|Overall Study||25
7849274|NCT00962104|19320507|P1|NOT COMPLETED|Overall Study||40
7849275|NCT00962104|19320506|P2|COMPLETED|Overall Study||171
7849276|NCT00962104|19320507|P1|COMPLETED|Overall Study||155
7849277|NCT00962104|19320506|P2|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195
7849278|NCT00962104|19320507|P1|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193
7849279|NCT00962104|19320506|P2|STARTED|Overall Study||196
7849280|NCT00962104|19320507|P1|STARTED|Overall Study||195
7849281|NCT00962091|19320540|P7|NOT COMPLETED|Overall Study||1
7849282|NCT00962091|19320541|P6|NOT COMPLETED|Overall Study||1
7849283|NCT00962091|19320542|P5|NOT COMPLETED|Overall Study||0
7849284|NCT00962091|19320543|P4|NOT COMPLETED|Overall Study||1
7849285|NCT00962091|19320544|P3|NOT COMPLETED|Overall Study||1
7849286|NCT00962091|19320545|P2|NOT COMPLETED|Overall Study||2
7849287|NCT00962091|19320546|P1|NOT COMPLETED|Overall Study||1
7849288|NCT00962091|19320540|P7|COMPLETED|Overall Study||11
7849289|NCT00962091|19320541|P6|COMPLETED|Overall Study||11
7849290|NCT00962091|19320542|P5|COMPLETED|Overall Study||3
7849291|NCT00962091|19320543|P4|COMPLETED|Overall Study||2
7849292|NCT00962091|19320544|P3|COMPLETED|Overall Study||9
7849293|NCT00962091|19320545|P2|COMPLETED|Overall Study||7
7849294|NCT00962091|19320546|P1|COMPLETED|Overall Study||3
7849295|NCT00962091|19320540|P7|STARTED|Overall Study||12
7849296|NCT00962091|19320541|P6|STARTED|Overall Study||12
7849297|NCT00962091|19320542|P5|STARTED|Overall Study||3
7849298|NCT00962091|19320543|P4|STARTED|Overall Study||3
7849299|NCT00962091|19320544|P3|STARTED|Overall Study||10
7849300|NCT00962091|19320545|P2|STARTED|Overall Study||9
7849301|NCT00962091|19320546|P1|STARTED|Overall Study||4
7849302|NCT00962078|19320593|P2|NOT COMPLETED|Overall Study||6
7849303|NCT00962078|19320594|P1|NOT COMPLETED|Overall Study||5
7849304|NCT00962078|19320593|P2|COMPLETED|Overall Study||30
7849305|NCT00962078|19320594|P1|COMPLETED|Overall Study||30
7849306|NCT00962078|19320593|P2|STARTED|Overall Study||36
7849307|NCT00962078|19320594|P1|STARTED|Overall Study||35
7849308|NCT00962065|19320605|P3|NOT COMPLETED|Overall Study||0
7849309|NCT00962065|19320606|P2|NOT COMPLETED|Overall Study||0
7849310|NCT00962065|19320607|P1|NOT COMPLETED|Overall Study||0
7849311|NCT00962065|19320605|P3|COMPLETED|Overall Study||12
7849312|NCT00962065|19320606|P2|COMPLETED|Overall Study||12
7849313|NCT00962065|19320607|P1|COMPLETED|Overall Study||12
7849314|NCT00962065|19320605|P3|STARTED|Overall Study||12
7849315|NCT00962065|19320606|P2|STARTED|Overall Study||12
7849316|NCT00962065|19320607|P1|STARTED|Overall Study||12
7849317|NCT00962039|19320632|P2|NOT COMPLETED|Overall Study||4
7849318|NCT00962039|19320633|P1|NOT COMPLETED|Overall Study||5
7849319|NCT00962039|19320632|P2|COMPLETED|Overall Study||37
7849320|NCT00962039|19320633|P1|COMPLETED|Overall Study||35
7849321|NCT00962039|19320632|P2|STARTED|Overall Study||41
7849322|NCT00962039|19320633|P1|STARTED|Overall Study||40
7849323|NCT00962013|19320649|P1|NOT COMPLETED|Overall Study||68
7849324|NCT00962013|19320649|P1|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52
7849325|NCT00962013|19320649|P1|STARTED|Overall Study||120
7849326|NCT00962000|19320658|P2|NOT COMPLETED|Period 4 - 1 Week||0
7849327|NCT00962000|19320659|P1|NOT COMPLETED|Period 4 - 1 Week||0
7849328|NCT00962000|19320658|P2|COMPLETED|Period 4 - 1 Week||21
7849329|NCT00962000|19320659|P1|COMPLETED|Period 4 - 1 Week||21
7849330|NCT00962000|19320658|P2|STARTED|Period 4 - 1 Week||21
7849331|NCT00962000|19320659|P1|STARTED|Period 4 - 1 Week||21
7849332|NCT00962000|19320658|P2|NOT COMPLETED|Period 3 - 1 Week||0
7849333|NCT00962000|19320659|P1|NOT COMPLETED|Period 3 - 1 Week||0
7849334|NCT00962000|19320658|P2|COMPLETED|Period 3 - 1 Week||21
7849335|NCT00962000|19320659|P1|COMPLETED|Period 3 - 1 Week||21
7849336|NCT00962000|19320658|P2|STARTED|Period 3 - 1 Week||21
7849337|NCT00962000|19320659|P1|STARTED|Period 3 - 1 Week||21
7849338|NCT00962000|19320658|P2|NOT COMPLETED|Period 2 - 1 Week||0
7849339|NCT00962000|19320659|P1|NOT COMPLETED|Period 2 - 1 Week||0
7849340|NCT00962000|19320658|P2|COMPLETED|Period 2 - 1 Week||21
7849341|NCT00962000|19320659|P1|COMPLETED|Period 2 - 1 Week||21
7849342|NCT00962000|19320658|P2|STARTED|Period 2 - 1 Week||21
7849343|NCT00962000|19320659|P1|STARTED|Period 2 - 1 Week||21
7849344|NCT00962000|19320658|P2|NOT COMPLETED|Period 1 - 1 Week||0
7849345|NCT00962000|19320659|P1|NOT COMPLETED|Period 1 - 1 Week||0
7849346|NCT00962000|19320658|P2|COMPLETED|Period 1 - 1 Week||21
7849347|NCT00962000|19320659|P1|COMPLETED|Period 1 - 1 Week||21
7849348|NCT00962000|19320658|P2|STARTED|Period 1 - 1 Week||21
7849349|NCT00962000|19320659|P1|STARTED|Period 1 - 1 Week||21
7849350|NCT00961961|19320673|P4|NOT COMPLETED|Phase II||8
7849351|NCT00961961|19320674|P3|NOT COMPLETED|Phase II||12
7849352|NCT00961961|19320675|P2|NOT COMPLETED|Phase II||0
7849353|NCT00961961|19320676|P1|NOT COMPLETED|Phase II||0
7849354|NCT00961961|19320673|P4|COMPLETED|Phase II||14
7849355|NCT00961961|19320674|P3|COMPLETED|Phase II||17
7849356|NCT00961961|19320675|P2|COMPLETED|Phase II||0
7849357|NCT00961961|19320676|P1|COMPLETED|Phase II||0
7849358|NCT00961961|19320673|P4|STARTED|Phase II||22
7849359|NCT00961961|19320674|P3|STARTED|Phase II||29
7849360|NCT00961961|19320675|P2|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
7849361|NCT00961961|19320676|P1|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
7849362|NCT00961961|19320673|P4|NOT COMPLETED|Phase I||0
7849363|NCT00961961|19320674|P3|NOT COMPLETED|Phase I||0
7849364|NCT00961961|19320675|P2|NOT COMPLETED|Phase I||0
7849365|NCT00961961|19320676|P1|NOT COMPLETED|Phase I||126
7849366|NCT00961961|19320673|P4|COMPLETED|Phase I||0
7849367|NCT00961961|19320674|P3|COMPLETED|Phase I||0
7849368|NCT00961961|19320675|P2|COMPLETED|Phase I||0
7849369|NCT00961961|19320676|P1|COMPLETED|Phase I||51
7849370|NCT00961961|19320673|P4|STARTED|Phase I||0
7849371|NCT00961961|19320674|P3|STARTED|Phase I||0
7849372|NCT00961961|19320675|P2|STARTED|Phase I||0
7849373|NCT00961961|19320676|P1|STARTED|Phase I||177
7849374|NCT00961896|19320701|P3|NOT COMPLETED|Overall Study||1
7849375|NCT00961896|19320702|P2|NOT COMPLETED|Overall Study||0
7849376|NCT00961896|19320703|P1|NOT COMPLETED|Overall Study||0
7849377|NCT00961896|19320701|P3|COMPLETED|Overall Study||6
7849378|NCT00961896|19320702|P2|COMPLETED|Overall Study||3
7849379|NCT00961896|19320703|P1|COMPLETED|Overall Study||8
7849380|NCT00961896|19320701|P3|STARTED|Overall Study||7
7849381|NCT00961896|19320702|P2|STARTED|Overall Study||3
7849382|NCT00961896|19320703|P1|STARTED|Overall Study||8
7849383|NCT00961805|19320724|P2|NOT COMPLETED|Overall Study||0
7849384|NCT00961805|19320725|P1|NOT COMPLETED|Overall Study||0
7849385|NCT00961805|19320724|P2|COMPLETED|Overall Study||40
7849386|NCT00961805|19320725|P1|COMPLETED|Overall Study||40
7849387|NCT00961805|19320724|P2|STARTED|Overall Study||40
7849388|NCT00961805|19320725|P1|STARTED|Overall Study||40
7849389|NCT00961662|19320756|P3|NOT COMPLETED|Overall Study||19
7849390|NCT00961662|19320757|P2|NOT COMPLETED|Overall Study||19
7849391|NCT00961662|19320758|P1|NOT COMPLETED|Overall Study||22
7849392|NCT00961662|19320756|P3|COMPLETED|Overall Study||34
7849393|NCT00961662|19320757|P2|COMPLETED|Overall Study||32
7849394|NCT00961662|19320758|P1|COMPLETED|Overall Study||35
7849395|NCT00961662|19320756|P3|STARTED|Overall Study||53
7849396|NCT00961662|19320757|P2|STARTED|Overall Study||51
7849397|NCT00961662|19320758|P1|STARTED|Overall Study||57
7849398|NCT00961649|19320770|P4|NOT COMPLETED|Overall Study||4
7849399|NCT00961649|19320771|P3|NOT COMPLETED|Overall Study||5
7849400|NCT00961649|19320772|P2|NOT COMPLETED|Overall Study||4
7849401|NCT00961649|19320773|P1|NOT COMPLETED|Overall Study||9
7849402|NCT00961649|19320770|P4|COMPLETED|Overall Study||37
7849403|NCT00961649|19320771|P3|COMPLETED|Overall Study||39
7849404|NCT00961649|19320772|P2|COMPLETED|Overall Study||40
7849405|NCT00961649|19320773|P1|COMPLETED|Overall Study||32
7849406|NCT00961649|19320770|P4|STARTED|Overall Study||41
7849407|NCT00961649|19320771|P3|STARTED|Overall Study||44
7849408|NCT00961649|19320772|P2|STARTED|Overall Study||44
7849409|NCT00961649|19320773|P1|STARTED|Overall Study||41
7849410|NCT00961636|19320787|P3|NOT COMPLETED|Overall Study||32
7849411|NCT00961636|19320788|P2|NOT COMPLETED|Overall Study||131
7849412|NCT00961636|19320789|P1|NOT COMPLETED|Overall Study||107
7849413|NCT00961636|19320787|P3|COMPLETED|Overall Study||201
7849414|NCT00961636|19320788|P2|COMPLETED|Overall Study||325
7849415|NCT00961636|19320789|P1|COMPLETED|Overall Study||356
7849416|NCT00961636|19320787|P3|STARTED|Overall Study||233
7849417|NCT00961636|19320788|P2|STARTED|Overall Study||456
7849418|NCT00961636|19320789|P1|STARTED|Overall Study||463
7849419|NCT00961571|19320800|P1|NOT COMPLETED|Overall Study||39
7849420|NCT00961571|19320800|P1|COMPLETED|Overall Study|high percentage of patient drop-off study prior cancer progression|11
7849421|NCT00961571|19320800|P1|STARTED|Overall Study||50
7849422|NCT00961532|19320804|P1|NOT COMPLETED|Overall Study||0
7849423|NCT00961532|19320804|P1|COMPLETED|Overall Study||14
7849424|NCT00961532|19320804|P1|STARTED|Overall Study||14
7849425|NCT00961441|19320811|P2|NOT COMPLETED|Overall Study||0
7849426|NCT00961441|19320812|P1|NOT COMPLETED|Overall Study||0
7849427|NCT00961441|19320811|P2|COMPLETED|Overall Study||13
7849428|NCT00961441|19320812|P1|COMPLETED|Overall Study||12
7849429|NCT00961441|19320811|P2|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10
7849430|NCT00961441|19320812|P1|Pharmacokinetic (PK-PP) Population|Overall Study||12
7849431|NCT00961441|19320811|P2|STARTED|Overall Study||13
7849432|NCT00961441|19320812|P1|STARTED|Overall Study||12
7849433|NCT00961415|19320828|P3|NOT COMPLETED|Maintenance Treatment Phase||45
7849434|NCT00961415|19320829|P2|NOT COMPLETED|Maintenance Treatment Phase||48
7849435|NCT00961415|19320830|P1|NOT COMPLETED|Maintenance Treatment Phase||0
7849436|NCT00961415|19320828|P3|COMPLETED|Maintenance Treatment Phase||83
7849437|NCT00961415|19320829|P2|COMPLETED|Maintenance Treatment Phase||77
7849438|NCT00961415|19320830|P1|COMPLETED|Maintenance Treatment Phase||0
7849439|NCT00961415|19320828|P3|STARTED|Maintenance Treatment Phase||128
7849440|NCT00961415|19320829|P2|STARTED|Maintenance Treatment Phase||125
7849441|NCT00961415|19320830|P1|STARTED|Maintenance Treatment Phase||0
7849442|NCT00961415|19320828|P3|NOT COMPLETED|Induction Treatment Phase||0
7849443|NCT00961415|19320829|P2|NOT COMPLETED|Induction Treatment Phase||0
7849444|NCT00961415|19320830|P1|NOT COMPLETED|Induction Treatment Phase||123
7849445|NCT00961415|19320828|P3|COMPLETED|Induction Treatment Phase||0
7849446|NCT00961415|19320829|P2|COMPLETED|Induction Treatment Phase||0
7849447|NCT00961415|19320830|P1|COMPLETED|Induction Treatment Phase||253
7849448|NCT00961415|19320828|P3|STARTED|Induction Treatment Phase||0
7849449|NCT00961415|19320829|P2|STARTED|Induction Treatment Phase||0
7849450|NCT00961415|19320830|P1|STARTED|Induction Treatment Phase||376
7849451|NCT00961402|19320855|P2|NOT COMPLETED|Overall Study||5
7849452|NCT00961402|19320856|P1|NOT COMPLETED|Overall Study||1
7849453|NCT00961402|19320855|P2|COMPLETED|Overall Study||61
7849454|NCT00961402|19320856|P1|COMPLETED|Overall Study||63
7849455|NCT00961402|19320855|P2|Randomized|Overall Study||66
7849456|NCT00961402|19320856|P1|Randomized|Overall Study||64
7849457|NCT00961402|19320855|P2|STARTED|Overall Study||66
7849458|NCT00961402|19320856|P1|STARTED|Overall Study||64
7849459|NCT00961350|19320870|P2|NOT COMPLETED|Overall Study||67
7849460|NCT00961350|19320871|P1|NOT COMPLETED|Overall Study||47
7849461|NCT00961350|19320870|P2|COMPLETED|Overall Study||198
7849462|NCT00961350|19320871|P1|COMPLETED|Overall Study||218
7849463|NCT00961350|19320870|P2|Safety Population|Overall Study||265
7849464|NCT00961350|19320871|P1|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264
7849465|NCT00961350|19320870|P2|Intent-to-Treat Population (ITT)|Overall Study||265
7849466|NCT00961350|19320871|P1|Intent-to-Treat Population (ITT)|Overall Study||265
7849467|NCT00961350|19320870|P2|STARTED|Overall Study||265
7849468|NCT00961350|19320871|P1|STARTED|Overall Study||265
7849469|NCT00961311|19320885|P1|NOT COMPLETED|Overall Study||0
7849470|NCT00961311|19320885|P1|COMPLETED|Overall Study||51
7849471|NCT00961311|19320885|P1|STARTED|Overall Study||51
7849472|NCT00961298|19320892|P1|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3
7849473|NCT00961298|19320892|P1|COMPLETED|12 Weeks Duloxetine Treatment Phase||11
7849474|NCT00961298|19320892|P1|STARTED|12 Weeks Duloxetine Treatment Phase||14
7849475|NCT00961298|19320892|P1|NOT COMPLETED|Two Week Placebo Run in||1
7849476|NCT00961298|19320892|P1|COMPLETED|Two Week Placebo Run in||14
7849477|NCT00961298|19320892|P1|STARTED|Two Week Placebo Run in||15
7849478|NCT00961259|19320899|P3|NOT COMPLETED|Third Intervention||0
7849479|NCT00961259|19320900|P2|NOT COMPLETED|Third Intervention||0
7849480|NCT00961259|19320901|P1|NOT COMPLETED|Third Intervention||0
7849481|NCT00961259|19320899|P3|COMPLETED|Third Intervention||18
7849482|NCT00961259|19320900|P2|COMPLETED|Third Intervention||17
7849483|NCT00961259|19320901|P1|COMPLETED|Third Intervention||18
7849484|NCT00961259|19320899|P3|STARTED|Third Intervention||18
7849485|NCT00961259|19320900|P2|STARTED|Third Intervention||17
7849486|NCT00961259|19320901|P1|STARTED|Third Intervention||18
7849487|NCT00961259|19320899|P3|NOT COMPLETED|Washout Period of 7 Days||0
7849488|NCT00961259|19320900|P2|NOT COMPLETED|Washout Period of 7 Days||0
7849489|NCT00961259|19320901|P1|NOT COMPLETED|Washout Period of 7 Days||0
7849490|NCT00961259|19320899|P3|COMPLETED|Washout Period of 7 Days||18
7849491|NCT00961259|19320900|P2|COMPLETED|Washout Period of 7 Days||17
7849492|NCT00961259|19320901|P1|COMPLETED|Washout Period of 7 Days||18
7849493|NCT00961259|19320899|P3|STARTED|Washout Period of 7 Days||18
7849494|NCT00961259|19320900|P2|STARTED|Washout Period of 7 Days||17
7849495|NCT00961259|19320901|P1|STARTED|Washout Period of 7 Days||18
7849496|NCT00961259|19320899|P3|NOT COMPLETED|Second Intervention||0
7849497|NCT00961259|19320900|P2|NOT COMPLETED|Second Intervention||0
7849498|NCT00961259|19320901|P1|NOT COMPLETED|Second Intervention||0
7849499|NCT00961259|19320899|P3|COMPLETED|Second Intervention||18
7849500|NCT00961259|19320900|P2|COMPLETED|Second Intervention||17
7849501|NCT00961259|19320901|P1|COMPLETED|Second Intervention||18
7849502|NCT00961259|19320899|P3|STARTED|Second Intervention||18
7849503|NCT00961259|19320900|P2|STARTED|Second Intervention||17
7849504|NCT00961259|19320901|P1|STARTED|Second Intervention||18
7849505|NCT00961259|19320899|P3|NOT COMPLETED|Washout Period of 7 Days||0
7849506|NCT00961259|19320900|P2|NOT COMPLETED|Washout Period of 7 Days||1
7849507|NCT00961259|19320901|P1|NOT COMPLETED|Washout Period of 7 Days||0
7849508|NCT00961259|19320899|P3|COMPLETED|Washout Period of 7 Days||18
7849509|NCT00961259|19320900|P2|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17
7849510|NCT00961259|19320901|P1|COMPLETED|Washout Period of 7 Days||18
7849511|NCT00961259|19320899|P3|STARTED|Washout Period of 7 Days||18
7849512|NCT00961259|19320900|P2|STARTED|Washout Period of 7 Days||18
7849513|NCT00961259|19320901|P1|STARTED|Washout Period of 7 Days||18
7849514|NCT00961259|19320899|P3|NOT COMPLETED|First Intervention||0
7849515|NCT00961259|19320900|P2|NOT COMPLETED|First Intervention||0
7849516|NCT00961259|19320901|P1|NOT COMPLETED|First Intervention||0
7849517|NCT00961259|19320899|P3|COMPLETED|First Intervention||18
7849518|NCT00961259|19320900|P2|COMPLETED|First Intervention||18
7849519|NCT00961259|19320901|P1|COMPLETED|First Intervention||18
7849520|NCT00961259|19320899|P3|STARTED|First Intervention||18
7849521|NCT00961259|19320900|P2|STARTED|First Intervention||18
7849522|NCT00961259|19320901|P1|STARTED|First Intervention||18
7849523|NCT00961233|19320920|P2|NOT COMPLETED|Overall Study||1
7849524|NCT00961233|19320921|P1|NOT COMPLETED|Overall Study||2
7849525|NCT00961233|19320920|P2|COMPLETED|Overall Study||11
7849526|NCT00961233|19320921|P1|COMPLETED|Overall Study||11
7849527|NCT00961233|19320920|P2|STARTED|Overall Study||12
7849528|NCT00961233|19320921|P1|STARTED|Overall Study||13
7849529|NCT00961220|19320929|P1|NOT COMPLETED|Overall Study||7
7849530|NCT00961220|19320929|P1|COMPLETED|Overall Study||10
7849531|NCT00961220|19320929|P1|STARTED|Overall Study||17
7849532|NCT00961181|19320945|P1|NOT COMPLETED|Overall Study||5
7849533|NCT00961181|19320945|P1|COMPLETED|Overall Study||76
7849534|NCT00961181|19320945|P1|STARTED|Overall Study||81
7849535|NCT00961116|19320958|P2|NOT COMPLETED|Second Intervention||0
7849536|NCT00961116|19320959|P1|NOT COMPLETED|Second Intervention||0
7849537|NCT00961116|19320958|P2|COMPLETED|Second Intervention||24
7849538|NCT00961116|19320959|P1|COMPLETED|Second Intervention||25
7849539|NCT00961116|19320958|P2|STARTED|Second Intervention||24
7849540|NCT00961116|19320959|P1|STARTED|Second Intervention||25
7849541|NCT00961116|19320958|P2|NOT COMPLETED|Washout Period of 7 Days||3
7849542|NCT00961116|19320959|P1|NOT COMPLETED|Washout Period of 7 Days||2
7849543|NCT00961116|19320958|P2|COMPLETED|Washout Period of 7 Days||24
7849544|NCT00961116|19320959|P1|COMPLETED|Washout Period of 7 Days||25
7849545|NCT00961116|19320958|P2|STARTED|Washout Period of 7 Days||27
7849546|NCT00961116|19320959|P1|STARTED|Washout Period of 7 Days||27
7849547|NCT00961116|19320958|P2|NOT COMPLETED|First Intervention||0
7849548|NCT00961116|19320959|P1|NOT COMPLETED|First Intervention||0
7849549|NCT00961116|19320958|P2|COMPLETED|First Intervention||27
7849550|NCT00961116|19320959|P1|COMPLETED|First Intervention||27
7849551|NCT00961116|19320958|P2|STARTED|First Intervention||27
7849552|NCT00961116|19320959|P1|STARTED|First Intervention||27
7849553|NCT00961064|19320969|P1|NOT COMPLETED|Overall Study||0
7849554|NCT00961064|19320969|P1|COMPLETED|Overall Study||30
7849555|NCT00961064|19320969|P1|STARTED|Overall Study||30
7849556|NCT00961051|19320975|P2|NOT COMPLETED|Overall Study||14
7849557|NCT00961051|19320976|P1|NOT COMPLETED|Overall Study||12
7849558|NCT00961051|19320975|P2|COMPLETED|Overall Study||79
7849559|NCT00961051|19320976|P1|COMPLETED|Overall Study||165
7849560|NCT00961051|19320975|P2|STARTED|Overall Study||93
7849561|NCT00961051|19320976|P1|STARTED|Overall Study||177
7849562|NCT00960999|19320986|P2|NOT COMPLETED|Overall Study||2
7849563|NCT00960999|19320987|P1|NOT COMPLETED|Overall Study||8
7849564|NCT00960999|19320986|P2|COMPLETED|Overall Study||45
7849565|NCT00960999|19320987|P1|COMPLETED|Overall Study||39
7849566|NCT00960999|19320986|P2|DLCO by Best Response|Overall Study||28
7849567|NCT00960999|19320987|P1|DLCO by Best Response|Overall Study||23
7849568|NCT00960999|19320986|P2|FEV1 by Best Response|Overall Study||33
7849569|NCT00960999|19320987|P1|FEV1 by Best Response|Overall Study||26
7849570|NCT00960999|19320986|P2|Normalized SUV at 1 Year|Overall Study||7
7849571|NCT00960999|19320987|P1|Normalized SUV at 1 Year|Overall Study||4
7849572|NCT00960999|19320986|P2|Normalized SUV at 8 Weeks|Overall Study||9
7849573|NCT00960999|19320987|P1|Normalized SUV at 8 Weeks|Overall Study||3
7849574|NCT00960999|19320986|P2|Peak SUV at 1 Year|Overall Study||7
7849575|NCT00960999|19320987|P1|Peak SUV at 1 Year|Overall Study||4
7849576|NCT00960999|19320986|P2|Peak SUV at 8 Weeks|Overall Study||11
7849577|NCT00960999|19320987|P1|Peak SUV at 8 Weeks|Overall Study||3
7849578|NCT00960999|19320986|P2|Primary Endpoint Population|Overall Study||38
7849579|NCT00960999|19320987|P1|Primary Endpoint Population|Overall Study||38
7849580|NCT00960999|19320986|P2|Started Protocol Treatment|Overall Study||45
7849581|NCT00960999|19320987|P1|Started Protocol Treatment|Overall Study||39
7849582|NCT00960999|19320986|P2|Eligible|Overall Study||45
7849583|NCT00960999|19320987|P1|Eligible|Overall Study||39
7849584|NCT00960999|19320986|P2|STARTED|Overall Study||47
7849585|NCT00960999|19320987|P1|STARTED|Overall Study||47
7849586|NCT00960986|19321019|P4|NOT COMPLETED|Period 3 (7-week Therapy Period)||25
7849587|NCT00960986|19321020|P3|NOT COMPLETED|Period 3 (7-week Therapy Period)||20
7849588|NCT00960986|19321021|P2|NOT COMPLETED|Period 3 (7-week Therapy Period)||23
7849589|NCT00960986|19321022|P1|NOT COMPLETED|Period 3 (7-week Therapy Period)||30
7849590|NCT00960986|19321019|P4|COMPLETED|Period 3 (7-week Therapy Period)||36
7849591|NCT00960986|19321020|P3|COMPLETED|Period 3 (7-week Therapy Period)||39
7849592|NCT00960986|19321021|P2|COMPLETED|Period 3 (7-week Therapy Period)||36
7849593|NCT00960986|19321022|P1|COMPLETED|Period 3 (7-week Therapy Period)||26
7849594|NCT00960986|19321019|P4|STARTED|Period 3 (7-week Therapy Period)||61
7849595|NCT00960986|19321020|P3|STARTED|Period 3 (7-week Therapy Period)||59
7849596|NCT00960986|19321021|P2|STARTED|Period 3 (7-week Therapy Period)||59
7849597|NCT00960986|19321022|P1|STARTED|Period 3 (7-week Therapy Period)||56
7849598|NCT00960986|19321019|P4|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
7849599|NCT00960986|19321020|P3|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
7849600|NCT00960986|19321021|P2|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
7849601|NCT00960986|19321022|P1|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
7849602|NCT00960986|19321019|P4|COMPLETED|Period 2 (1-week Initial Dosing Period)||61
7849603|NCT00960986|19321020|P3|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
7849604|NCT00960986|19321021|P2|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
7849605|NCT00960986|19321022|P1|COMPLETED|Period 2 (1-week Initial Dosing Period)||56
7849606|NCT00960986|19321019|P4|STARTED|Period 2 (1-week Initial Dosing Period)||61
7849607|NCT00960986|19321020|P3|STARTED|Period 2 (1-week Initial Dosing Period)||59
7849608|NCT00960986|19321021|P2|STARTED|Period 2 (1-week Initial Dosing Period)||59
7849609|NCT00960986|19321022|P1|STARTED|Period 2 (1-week Initial Dosing Period)||56
7849610|NCT00960986|19321019|P4|NOT COMPLETED|Period 1 (Screening and Washout)||3
7849611|NCT00960986|19321020|P3|NOT COMPLETED|Period 1 (Screening and Washout)||4
7849612|NCT00960986|19321021|P2|NOT COMPLETED|Period 1 (Screening and Washout)||4
7849613|NCT00960986|19321022|P1|NOT COMPLETED|Period 1 (Screening and Washout)||3
7849614|NCT00960986|19321019|P4|COMPLETED|Period 1 (Screening and Washout)||61
7849615|NCT00960986|19321020|P3|COMPLETED|Period 1 (Screening and Washout)||59
7849616|NCT00960986|19321021|P2|COMPLETED|Period 1 (Screening and Washout)||59
7849617|NCT00960986|19321022|P1|COMPLETED|Period 1 (Screening and Washout)||56
7849618|NCT00960986|19321019|P4|STARTED|Period 1 (Screening and Washout)||64
7849619|NCT00960986|19321020|P3|STARTED|Period 1 (Screening and Washout)||63
7849620|NCT00960986|19321021|P2|STARTED|Period 1 (Screening and Washout)||63
7849621|NCT00960986|19321022|P1|STARTED|Period 1 (Screening and Washout)||59
7849622|NCT00960934|19321098|P6|NOT COMPLETED|Overall Study||64
7849623|NCT00960934|19321099|P5|NOT COMPLETED|Overall Study||64
7849624|NCT00960934|19321100|P4|NOT COMPLETED|Overall Study||64
7849625|NCT00960934|19321101|P3|NOT COMPLETED|Overall Study||64
7849626|NCT00960934|19321102|P2|NOT COMPLETED|Overall Study||63
7849627|NCT00960934|19321103|P1|NOT COMPLETED|Overall Study||64
7849628|NCT00960934|19321098|P6|COMPLETED|Overall Study||0
7849629|NCT00960934|19321099|P5|COMPLETED|Overall Study||0
7849630|NCT00960934|19321100|P4|COMPLETED|Overall Study||0
7849631|NCT00960934|19321101|P3|COMPLETED|Overall Study||0
7849632|NCT00960934|19321102|P2|COMPLETED|Overall Study||0
7849633|NCT00960934|19321103|P1|COMPLETED|Overall Study||0
7849634|NCT00960934|19321098|P6|Number Treated|Overall Study|1 participant was randomized but not treated|63
7849635|NCT00960934|19321099|P5|Number Treated|Overall Study|1 participant was randomized but not treated|63
7849636|NCT00960934|19321100|P4|Number Treated|Overall Study||64
7849637|NCT00960934|19321101|P3|Number Treated|Overall Study||64
7849638|NCT00960934|19321102|P2|Number Treated|Overall Study|1 participant was randomized but not treated|62
7849639|NCT00960934|19321103|P1|Number Treated|Overall Study||64
7849640|NCT00960934|19321098|P6|STARTED|Overall Study||64
7849641|NCT00960934|19321099|P5|STARTED|Overall Study||64
7849642|NCT00960934|19321100|P4|STARTED|Overall Study||64
7849643|NCT00960934|19321101|P3|STARTED|Overall Study||64
7849644|NCT00960934|19321102|P2|STARTED|Overall Study||63
7849645|NCT00960934|19321103|P1|STARTED|Overall Study||64
7849646|NCT00960869|19321215|P2|NOT COMPLETED|Overall Study||62
7849647|NCT00960869|19321216|P1|NOT COMPLETED|Overall Study||53
7849648|NCT00960869|19321215|P2|COMPLETED|Overall Study||198
7849649|NCT00960869|19321216|P1|COMPLETED|Overall Study||206
7849650|NCT00960869|19321215|P2|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259
7849651|NCT00960869|19321216|P1|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257
7849652|NCT00960869|19321215|P2|Intent-to-Treat Population (ITT)|Overall Study||260
7849653|NCT00960869|19321216|P1|Intent-to-Treat Population (ITT)|Overall Study||259
7849654|NCT00960869|19321215|P2|STARTED|Overall Study||260
7849655|NCT00960869|19321216|P1|STARTED|Overall Study||259
7849656|NCT00960856|19321230|P4|NOT COMPLETED|Period IV||0
7849657|NCT00960856|19321231|P3|NOT COMPLETED|Period IV||0
7849658|NCT00960856|19321232|P2|NOT COMPLETED|Period IV||0
7849659|NCT00960856|19321233|P1|NOT COMPLETED|Period IV||0
7849660|NCT00960856|19321230|P4|COMPLETED|Period IV||9
7849661|NCT00960856|19321231|P3|COMPLETED|Period IV||8
7849662|NCT00960856|19321232|P2|COMPLETED|Period IV||7
7849663|NCT00960856|19321233|P1|COMPLETED|Period IV||10
7849664|NCT00960856|19321230|P4|STARTED|Period IV||9
7849665|NCT00960856|19321231|P3|STARTED|Period IV||8
7849666|NCT00960856|19321232|P2|STARTED|Period IV||7
7849667|NCT00960856|19321233|P1|STARTED|Period IV||10
7849668|NCT00960856|19321230|P4|NOT COMPLETED|Washout Period of 7 Days||0
7849669|NCT00960856|19321231|P3|NOT COMPLETED|Washout Period of 7 Days||1
7849670|NCT00960856|19321232|P2|NOT COMPLETED|Washout Period of 7 Days||0
7849671|NCT00960856|19321233|P1|NOT COMPLETED|Washout Period of 7 Days||0
7849672|NCT00960856|19321230|P4|COMPLETED|Washout Period of 7 Days||9
7849673|NCT00960856|19321231|P3|COMPLETED|Washout Period of 7 Days||8
7849674|NCT00960856|19321232|P2|COMPLETED|Washout Period of 7 Days||7
7849675|NCT00960856|19321233|P1|COMPLETED|Washout Period of 7 Days||10
7849676|NCT00960856|19321230|P4|STARTED|Washout Period of 7 Days||9
7849677|NCT00960856|19321231|P3|STARTED|Washout Period of 7 Days||9
7849678|NCT00960856|19321232|P2|STARTED|Washout Period of 7 Days||7
7849679|NCT00960856|19321233|P1|STARTED|Washout Period of 7 Days||10
7849680|NCT00960856|19321230|P4|NOT COMPLETED|Period III||0
7849681|NCT00960856|19321231|P3|NOT COMPLETED|Period III||0
7849682|NCT00960856|19321232|P2|NOT COMPLETED|Period III||0
7849683|NCT00960856|19321233|P1|NOT COMPLETED|Period III||0
7849684|NCT00960856|19321230|P4|COMPLETED|Period III||9
7849685|NCT00960856|19321231|P3|COMPLETED|Period III||9
7849686|NCT00960856|19321232|P2|COMPLETED|Period III||7
7849687|NCT00960856|19321233|P1|COMPLETED|Period III||10
7849688|NCT00960856|19321230|P4|STARTED|Period III||9
7849689|NCT00960856|19321231|P3|STARTED|Period III||9
7849690|NCT00960856|19321232|P2|STARTED|Period III||7
7849691|NCT00960856|19321233|P1|STARTED|Period III||10
7849692|NCT00960856|19321230|P4|NOT COMPLETED|Washout Period of 7 Days||0
7849693|NCT00960856|19321231|P3|NOT COMPLETED|Washout Period of 7 Days||0
7849694|NCT00960856|19321232|P2|NOT COMPLETED|Washout Period of 7 Days||0
7849695|NCT00960856|19321233|P1|NOT COMPLETED|Washout Period of 7 Days||0
7849696|NCT00960856|19321230|P4|COMPLETED|Washout Period of 7 Days||9
7849697|NCT00960856|19321231|P3|COMPLETED|Washout Period of 7 Days||9
7849698|NCT00960856|19321232|P2|COMPLETED|Washout Period of 7 Days||7
7849699|NCT00960856|19321233|P1|COMPLETED|Washout Period of 7 Days||10
7849700|NCT00960856|19321230|P4|STARTED|Washout Period of 7 Days||9
7849701|NCT00960856|19321231|P3|STARTED|Washout Period of 7 Days||9
7849702|NCT00960856|19321232|P2|STARTED|Washout Period of 7 Days||7
7849703|NCT00960856|19321233|P1|STARTED|Washout Period of 7 Days||10
7849704|NCT00960856|19321230|P4|NOT COMPLETED|Period II||0
7849705|NCT00960856|19321231|P3|NOT COMPLETED|Period II||0
7849706|NCT00960856|19321232|P2|NOT COMPLETED|Period II||0
7849707|NCT00960856|19321233|P1|NOT COMPLETED|Period II||0
7849708|NCT00960856|19321230|P4|COMPLETED|Period II||9
7849709|NCT00960856|19321231|P3|COMPLETED|Period II||9
7849710|NCT00960856|19321232|P2|COMPLETED|Period II||7
7849711|NCT00960856|19321233|P1|COMPLETED|Period II||10
7849712|NCT00960856|19321230|P4|STARTED|Period II||9
7849713|NCT00960856|19321231|P3|STARTED|Period II||9
7849714|NCT00960856|19321232|P2|STARTED|Period II||7
7849715|NCT00960856|19321233|P1|STARTED|Period II||10
7849716|NCT00960856|19321230|P4|NOT COMPLETED|Washout Period of 7 Days||0
7849717|NCT00960856|19321231|P3|NOT COMPLETED|Washout Period of 7 Days||0
7849718|NCT00960856|19321232|P2|NOT COMPLETED|Washout Period of 7 Days||2
7849719|NCT00960856|19321233|P1|NOT COMPLETED|Washout Period of 7 Days||0
7849720|NCT00960856|19321230|P4|COMPLETED|Washout Period of 7 Days||9
7849721|NCT00960856|19321231|P3|COMPLETED|Washout Period of 7 Days||9
7849722|NCT00960856|19321232|P2|COMPLETED|Washout Period of 7 Days|personal reasons|7
7849723|NCT00960856|19321233|P1|COMPLETED|Washout Period of 7 Days||10
7849724|NCT00960856|19321230|P4|STARTED|Washout Period of 7 Days||9
7849725|NCT00960856|19321231|P3|STARTED|Washout Period of 7 Days||9
7849726|NCT00960856|19321232|P2|STARTED|Washout Period of 7 Days||9
7849727|NCT00960856|19321233|P1|STARTED|Washout Period of 7 Days||10
7849728|NCT00960856|19321230|P4|NOT COMPLETED|Period I||0
7849729|NCT00960856|19321231|P3|NOT COMPLETED|Period I||0
7849730|NCT00960856|19321232|P2|NOT COMPLETED|Period I||0
7849731|NCT00960856|19321233|P1|NOT COMPLETED|Period I||0
7849732|NCT00960856|19321230|P4|COMPLETED|Period I||9
7849733|NCT00960856|19321231|P3|COMPLETED|Period I||9
7849734|NCT00960856|19321232|P2|COMPLETED|Period I||9
7849735|NCT00960856|19321233|P1|COMPLETED|Period I||10
7849736|NCT00960856|19321230|P4|STARTED|Period I||9
7849737|NCT00960856|19321231|P3|STARTED|Period I||9
7849738|NCT00960856|19321232|P2|STARTED|Period I||9
7849739|NCT00960856|19321233|P1|STARTED|Period I||10
7849740|NCT00960843|19321253|P2|NOT COMPLETED|Overall Study||5
7849741|NCT00960843|19321254|P1|NOT COMPLETED|Overall Study||2
7849742|NCT00960843|19321253|P2|COMPLETED|Overall Study||21
7849743|NCT00960843|19321254|P1|COMPLETED|Overall Study||23
7849744|NCT00960843|19321253|P2|STARTED|Overall Study||26
7849745|NCT00960843|19321254|P1|STARTED|Overall Study||25
7849746|NCT00960778|19321266|P2|NOT COMPLETED|Overall Study||3
7849747|NCT00960778|19321267|P1|NOT COMPLETED|Overall Study||9
7849748|NCT00960778|19321266|P2|COMPLETED|Overall Study||13
7849749|NCT00960778|19321267|P1|COMPLETED|Overall Study||8
7849750|NCT00960778|19321266|P2|STARTED|Overall Study||16
7849751|NCT00960778|19321267|P1|STARTED|Overall Study||17
7849752|NCT00960687|19321275|P2|NOT COMPLETED|Second Intervention||0
7849753|NCT00960687|19321276|P1|NOT COMPLETED|Second Intervention||0
7849754|NCT00960687|19321275|P2|COMPLETED|Second Intervention||24
7849755|NCT00960687|19321276|P1|COMPLETED|Second Intervention||23
7849756|NCT00960687|19321275|P2|STARTED|Second Intervention||24
7849757|NCT00960687|19321276|P1|STARTED|Second Intervention||23
7849758|NCT00960687|19321275|P2|NOT COMPLETED|Washout Period of 7 Days||3
7849759|NCT00960687|19321276|P1|NOT COMPLETED|Washout Period of 7 Days||4
7849760|NCT00960687|19321275|P2|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24
7849761|NCT00960687|19321276|P1|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23
7849762|NCT00960687|19321275|P2|STARTED|Washout Period of 7 Days||27
7849763|NCT00960687|19321276|P1|STARTED|Washout Period of 7 Days||27
7849764|NCT00960687|19321275|P2|NOT COMPLETED|First Intervention||0
7849765|NCT00960687|19321276|P1|NOT COMPLETED|First Intervention||0
7849766|NCT00960687|19321275|P2|COMPLETED|First Intervention||27
7849767|NCT00960687|19321276|P1|COMPLETED|First Intervention||27
7849768|NCT00960687|19321275|P2|STARTED|First Intervention||27
7849769|NCT00960687|19321276|P1|STARTED|First Intervention||27
7849770|NCT00960661|19321288|P3|NOT COMPLETED|Interventional Phase||46
7849771|NCT00960661|19321289|P2|NOT COMPLETED|Interventional Phase||52
7849772|NCT00960661|19321290|P1|NOT COMPLETED|Interventional Phase||0
7849773|NCT00960661|19321288|P3|COMPLETED|Interventional Phase||275
7849774|NCT00960661|19321289|P2|COMPLETED|Interventional Phase||264
7849775|NCT00960661|19321290|P1|COMPLETED|Interventional Phase||0
7849776|NCT00960661|19321288|P3|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263
7849777|NCT00960661|19321289|P2|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247
7849778|NCT00960661|19321290|P1|Per Protocol Population|Interventional Phase||0
7849779|NCT00960661|19321288|P3|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312
7849780|NCT00960661|19321289|P2|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315
7849781|NCT00960661|19321290|P1|Intent to Treat Population|Interventional Phase||0
7849782|NCT00960661|19321288|P3|STARTED|Interventional Phase||321
7849783|NCT00960661|19321289|P2|STARTED|Interventional Phase||316
7849784|NCT00960661|19321290|P1|STARTED|Interventional Phase||0
7849785|NCT00960661|19321288|P3|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
7849786|NCT00960661|19321289|P2|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
7849787|NCT00960661|19321290|P1|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399
7849788|NCT00960661|19321288|P3|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
7849789|NCT00960661|19321289|P2|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
7849790|NCT00960661|19321290|P1|COMPLETED|Basal Insulin Optimization Phase (BIO)||637
7849791|NCT00960661|19321288|P3|STARTED|Basal Insulin Optimization Phase (BIO)||0
7849792|NCT00960661|19321289|P2|STARTED|Basal Insulin Optimization Phase (BIO)||0
7849793|NCT00960661|19321290|P1|STARTED|Basal Insulin Optimization Phase (BIO)||1036
7849794|NCT00960622|19321322|P2|NOT COMPLETED|Overall Study||3
7849795|NCT00960622|19321323|P1|NOT COMPLETED|Overall Study||0
7849796|NCT00960622|19321322|P2|COMPLETED|Overall Study||7
7849797|NCT00960622|19321323|P1|COMPLETED|Overall Study||10
7849798|NCT00960622|19321322|P2|STARTED|Overall Study||10
7849799|NCT00960622|19321323|P1|STARTED|Overall Study||10
7849800|NCT00960570|19321329|P1|NOT COMPLETED|Efavirenz and Fenofibric Acid||0
7849801|NCT00960570|19321329|P1|COMPLETED|Efavirenz and Fenofibric Acid||25
7849802|NCT00960570|19321329|P1|STARTED|Efavirenz and Fenofibric Acid||25
7849803|NCT00960570|19321329|P1|NOT COMPLETED|1 Day Period Between Dosing||3
7849804|NCT00960570|19321329|P1|COMPLETED|1 Day Period Between Dosing||25
7849805|NCT00960570|19321329|P1|STARTED|1 Day Period Between Dosing||28
7849806|NCT00960570|19321329|P1|NOT COMPLETED|Fenofibric Acid Alone||0
7849807|NCT00960570|19321329|P1|COMPLETED|Fenofibric Acid Alone||28
7849808|NCT00960570|19321329|P1|STARTED|Fenofibric Acid Alone||28
7849809|NCT00960570|19321329|P1|NOT COMPLETED|21 Day Washout Period||2
7849810|NCT00960570|19321329|P1|COMPLETED|21 Day Washout Period||28
7849811|NCT00960570|19321329|P1|STARTED|21 Day Washout Period||30
7849812|NCT00960570|19321329|P1|NOT COMPLETED|Efavirenz Alone||0
7849813|NCT00960570|19321329|P1|COMPLETED|Efavirenz Alone||30
7849814|NCT00960570|19321329|P1|STARTED|Efavirenz Alone||30
7849815|NCT00960531|19321350|P10|NOT COMPLETED|Overall Study||1
7849816|NCT00960531|19321351|P9|NOT COMPLETED|Overall Study||14
7849817|NCT00960531|19321352|P8|NOT COMPLETED|Overall Study||4
7849818|NCT00960531|19321353|P7|NOT COMPLETED|Overall Study||24
7849819|NCT00960531|19321354|P6|NOT COMPLETED|Overall Study||3
7849820|NCT00960531|19321355|P5|NOT COMPLETED|Overall Study||2
7849821|NCT00960531|19321356|P4|NOT COMPLETED|Overall Study||8
7849822|NCT00960531|19321357|P3|NOT COMPLETED|Overall Study||26
7849823|NCT00960531|19321358|P2|NOT COMPLETED|Overall Study||1
7849824|NCT00960531|19321359|P1|NOT COMPLETED|Overall Study||10
7849825|NCT00960531|19321350|P10|COMPLETED|Overall Study|Completed study|3
7849826|NCT00960531|19321351|P9|COMPLETED|Overall Study|Completed study|2
7849827|NCT00960531|19321352|P8|COMPLETED|Overall Study|Completed study|2
7849828|NCT00960531|19321353|P7|COMPLETED|Overall Study|Completed study|3
7849829|NCT00960531|19321354|P6|COMPLETED|Overall Study|Completed study|6
7849830|NCT00960531|19321355|P5|COMPLETED|Overall Study|Completed study|3
7849831|NCT00960531|19321356|P4|COMPLETED|Overall Study|Completed study|17
7849832|NCT00960531|19321357|P3|COMPLETED|Overall Study|Completed study|15
7849833|NCT00960531|19321358|P2|COMPLETED|Overall Study|Completed study|5
7849834|NCT00960531|19321359|P1|COMPLETED|Overall Study|Completed study|11
7849835|NCT00960531|19321350|P10|Completed Treatment|Overall Study||4
7849836|NCT00960531|19321351|P9|Completed Treatment|Overall Study||2
7849837|NCT00960531|19321352|P8|Completed Treatment|Overall Study||3
7849838|NCT00960531|19321353|P7|Completed Treatment|Overall Study||4
7849839|NCT00960531|19321354|P6|Completed Treatment|Overall Study||7
7849840|NCT00960531|19321355|P5|Completed Treatment|Overall Study||3
7849841|NCT00960531|19321356|P4|Completed Treatment|Overall Study||17
7849842|NCT00960531|19321357|P3|Completed Treatment|Overall Study||15
7849843|NCT00960531|19321358|P2|Completed Treatment|Overall Study||5
7849844|NCT00960531|19321359|P1|Completed Treatment|Overall Study||12
7849845|NCT00960531|19321350|P10|Treated|Overall Study||4
7849846|NCT00960531|19321351|P9|Treated|Overall Study||16
7849847|NCT00960531|19321352|P8|Treated|Overall Study||6
7849848|NCT00960531|19321353|P7|Treated|Overall Study||27
7849849|NCT00960531|19321354|P6|Treated|Overall Study||9
7849850|NCT00960531|19321355|P5|Treated|Overall Study||5
7849851|NCT00960531|19321356|P4|Treated|Overall Study||24
7849852|NCT00960531|19321357|P3|Treated|Overall Study||41
7849853|NCT00960531|19321358|P2|Treated|Overall Study||6
7849854|NCT00960531|19321359|P1|Treated|Overall Study||21
7849855|NCT00960531|19321350|P10|STARTED|Overall Study|Started=Randomized|4
7849856|NCT00960531|19321351|P9|STARTED|Overall Study|Started=Randomized|16
7849857|NCT00960531|19321352|P8|STARTED|Overall Study|Started=Randomized|6
7849858|NCT00960531|19321353|P7|STARTED|Overall Study|Started=Randomized|27
7849859|NCT00960531|19321354|P6|STARTED|Overall Study|Started=Randomized|9
7849860|NCT00960531|19321355|P5|STARTED|Overall Study|Started=Randomized|5
7849861|NCT00960531|19321356|P4|STARTED|Overall Study|Started=Randomized.|25
7849862|NCT00960531|19321357|P3|STARTED|Overall Study|Started=Randomized|41
7849863|NCT00960531|19321358|P2|STARTED|Overall Study|Started=Randomized|6
7849864|NCT00960531|19321359|P1|STARTED|Overall Study|Started=Randomized|21
7849865|NCT00960505|19321406|P3|NOT COMPLETED|Overall Study||8
7849866|NCT00960505|19321407|P2|NOT COMPLETED|Overall Study||10
7849867|NCT00960505|19321408|P1|NOT COMPLETED|Overall Study||13
7849868|NCT00960505|19321406|P3|COMPLETED|Overall Study||23
7849869|NCT00960505|19321407|P2|COMPLETED|Overall Study||25
7849870|NCT00960505|19321408|P1|COMPLETED|Overall Study||21
7849871|NCT00960505|19321406|P3|STARTED|Overall Study||31
7849872|NCT00960505|19321407|P2|STARTED|Overall Study||35
7849873|NCT00960505|19321408|P1|STARTED|Overall Study||34
7849874|NCT00960440|19321441|P4|NOT COMPLETED|Overall Study||18
7849875|NCT00960440|19321442|P3|NOT COMPLETED|Overall Study||13
7849876|NCT00960440|19321443|P2|NOT COMPLETED|Overall Study||31
7849877|NCT00960440|19321444|P1|NOT COMPLETED|Overall Study||26
7849878|NCT00960440|19321441|P4|COMPLETED|Overall Study||48
7849879|NCT00960440|19321442|P3|COMPLETED|Overall Study||53
7849880|NCT00960440|19321443|P2|COMPLETED|Overall Study||103
7849881|NCT00960440|19321444|P1|COMPLETED|Overall Study||107
7849882|NCT00960440|19321441|P4|STARTED|Overall Study||66
7849883|NCT00960440|19321442|P3|STARTED|Overall Study||66
7849884|NCT00960440|19321443|P2|STARTED|Overall Study||134
7849885|NCT00960440|19321444|P1|STARTED|Overall Study||133
7849886|NCT00960375|19321616|P2|NOT COMPLETED|Overall Study||22
7849887|NCT00960375|19321617|P1|NOT COMPLETED|Overall Study||20
7849888|NCT00960375|19321616|P2|COMPLETED|Overall Study||65
7849889|NCT00960375|19321617|P1|COMPLETED|Overall Study||72
7849890|NCT00960375|19321616|P2|STARTED|Overall Study||87
7849891|NCT00960375|19321617|P1|STARTED|Overall Study||92
7849892|NCT00960323|19321625|P1|NOT COMPLETED|Colchicine and Atorvastatin||0
7849893|NCT00960323|19321625|P1|COMPLETED|Colchicine and Atorvastatin||23
7849894|NCT00960323|19321625|P1|STARTED|Colchicine and Atorvastatin||23
7849895|NCT00960323|19321625|P1|NOT COMPLETED|Atorvastatin Alone||1
7849896|NCT00960323|19321625|P1|COMPLETED|Atorvastatin Alone||23
7849897|NCT00960323|19321625|P1|STARTED|Atorvastatin Alone||24
7849898|NCT00960323|19321625|P1|NOT COMPLETED|14 Day Washout Period||0
7849899|NCT00960323|19321625|P1|COMPLETED|14 Day Washout Period||24
7849900|NCT00960323|19321625|P1|STARTED|14 Day Washout Period||24
7849901|NCT00960323|19321625|P1|NOT COMPLETED|Colchicine Alone||0
7849902|NCT00960323|19321625|P1|COMPLETED|Colchicine Alone||24
7849903|NCT00960323|19321625|P1|STARTED|Colchicine Alone||24
7849904|NCT00960297|19321636|P1|NOT COMPLETED|Overall Study||3
7849905|NCT00960297|19321636|P1|COMPLETED|Overall Study||1
7849906|NCT00960297|19321636|P1|STARTED|Overall Study||4
7849907|NCT00960206|19321643|P3|NOT COMPLETED|Overall Study||12
7849908|NCT00960206|19321644|P2|NOT COMPLETED|Overall Study||27
7849909|NCT00960206|19321645|P1|NOT COMPLETED|Overall Study||40
7849910|NCT00960206|19321643|P3|COMPLETED|Overall Study||77
7849911|NCT00960206|19321644|P2|COMPLETED|Overall Study||158
7849912|NCT00960206|19321645|P1|COMPLETED|Overall Study||150
7849913|NCT00960206|19321643|P3|STARTED|Overall Study||89
7849914|NCT00960206|19321644|P2|STARTED|Overall Study||185
7849915|NCT00960206|19321645|P1|STARTED|Overall Study||190
7849916|NCT00960193|19321663|P1|NOT COMPLETED|Colchicine With Seville Orange Juice||0
7849917|NCT00960193|19321663|P1|COMPLETED|Colchicine With Seville Orange Juice||23
7849918|NCT00960193|19321663|P1|STARTED|Colchicine With Seville Orange Juice||23
7849919|NCT00960193|19321663|P1|NOT COMPLETED|Seville Orange Juice Alone||0
7849920|NCT00960193|19321663|P1|COMPLETED|Seville Orange Juice Alone||23
7849921|NCT00960193|19321663|P1|STARTED|Seville Orange Juice Alone||23
7849922|NCT00960193|19321663|P1|NOT COMPLETED|14 Day Washout Period||1
7849923|NCT00960193|19321663|P1|COMPLETED|14 Day Washout Period||23
7849924|NCT00960193|19321663|P1|STARTED|14 Day Washout Period||24
7849925|NCT00960193|19321663|P1|NOT COMPLETED|Colchicine Alone||0
7849926|NCT00960193|19321663|P1|COMPLETED|Colchicine Alone||24
7849927|NCT00960193|19321663|P1|STARTED|Colchicine Alone||24
7849928|NCT00960154|19321676|P2|NOT COMPLETED|Overall Study||25
7849929|NCT00960154|19321677|P1|NOT COMPLETED|Overall Study||25
7849930|NCT00960154|19321676|P2|COMPLETED|Overall Study||0
7849931|NCT00960154|19321677|P1|COMPLETED|Overall Study||0
7849932|NCT00960154|19321676|P2|STARTED|Overall Study||25
7849933|NCT00960154|19321677|P1|STARTED|Overall Study||25
7849934|NCT00960141|19321688|P3|NOT COMPLETED|Overall Study||7
7849935|NCT00960141|19321689|P2|NOT COMPLETED|Overall Study||17
7849936|NCT00960141|19321690|P1|NOT COMPLETED|Overall Study||10
7849937|NCT00960141|19321688|P3|COMPLETED|Overall Study||163
7849938|NCT00960141|19321689|P2|COMPLETED|Overall Study||309
7849939|NCT00960141|19321690|P1|COMPLETED|Overall Study||323
7849940|NCT00960141|19321688|P3|STARTED|Overall Study||170
7849941|NCT00960141|19321689|P2|STARTED|Overall Study||326
7849942|NCT00960141|19321690|P1|STARTED|Overall Study||333
7849943|NCT00960115|19321715|P2|NOT COMPLETED|Overall Study||15
7849944|NCT00960115|19321716|P1|NOT COMPLETED|Overall Study||19
7849945|NCT00960115|19321715|P2|COMPLETED|Overall Study||43
7849946|NCT00960115|19321716|P1|COMPLETED|Overall Study||95
7849947|NCT00960115|19321715|P2|STARTED|Overall Study||58
7849948|NCT00960115|19321716|P1|STARTED|Overall Study||114
7849949|NCT00960076|19321730|P2|NOT COMPLETED|Overall Study||25
7849950|NCT00960076|19321731|P1|NOT COMPLETED|Overall Study||8
7849951|NCT00960076|19321730|P2|COMPLETED|Overall Study|Completing 18 weeks of treatment|119
7849952|NCT00960076|19321731|P1|COMPLETED|Overall Study|Completing 18 weeks of treatment|130
7849953|NCT00960076|19321730|P2|STARTED|Overall Study|Randomized and treated|144
7849954|NCT00960076|19321731|P1|STARTED|Overall Study|Randomized and treated|138
7849955|NCT00960063|19321746|P3|NOT COMPLETED|Overall Study||3
7849956|NCT00960063|19321747|P2|NOT COMPLETED|Overall Study||0
7849957|NCT00960063|19321748|P1|NOT COMPLETED|Overall Study||1
7849958|NCT00960063|19321746|P3|COMPLETED|Overall Study||0
7849959|NCT00960063|19321747|P2|COMPLETED|Overall Study||0
7849960|NCT00960063|19321748|P1|COMPLETED|Overall Study||0
7849961|NCT00960063|19321746|P3|STARTED|Overall Study||3
7849962|NCT00960063|19321747|P2|STARTED|Overall Study||0
7849963|NCT00960063|19321748|P1|STARTED|Overall Study||1
7849964|NCT00960011|19321788|P2|NOT COMPLETED|Overall Study||2
7849965|NCT00960011|19321789|P1|NOT COMPLETED|Overall Study||11
7849966|NCT00960011|19321788|P2|COMPLETED|Overall Study||23
7849967|NCT00960011|19321789|P1|COMPLETED|Overall Study||22
7849968|NCT00960011|19321788|P2|STARTED|Overall Study||25
7849969|NCT00960011|19321789|P1|STARTED|Overall Study||33
7849970|NCT00959985|19321833|P4|NOT COMPLETED|Overall Study||0
7849971|NCT00959985|19321834|P3|NOT COMPLETED|Overall Study||0
7849972|NCT00959985|19321835|P2|NOT COMPLETED|Overall Study||0
7849973|NCT00959985|19321836|P1|NOT COMPLETED|Overall Study||0
7849974|NCT00959985|19321833|P4|COMPLETED|Overall Study||4
7849975|NCT00959985|19321834|P3|COMPLETED|Overall Study||4
7849976|NCT00959985|19321835|P2|COMPLETED|Overall Study||7
7849977|NCT00959985|19321836|P1|COMPLETED|Overall Study||8
7849978|NCT00959985|19321833|P4|STARTED|Overall Study||4
7849979|NCT00959985|19321834|P3|STARTED|Overall Study||4
7849980|NCT00959985|19321835|P2|STARTED|Overall Study||7
7849981|NCT00959985|19321836|P1|STARTED|Overall Study||8
7849982|NCT00959946|19321882|P8|NOT COMPLETED|Overall Study||2
7849983|NCT00959946|19321883|P7|NOT COMPLETED|Overall Study||2
7849984|NCT00959946|19321884|P6|NOT COMPLETED|Overall Study||9
7849985|NCT00959946|19321885|P5|NOT COMPLETED|Overall Study||4
7849986|NCT00959946|19321886|P4|NOT COMPLETED|Overall Study||5
7849987|NCT00959946|19321887|P3|NOT COMPLETED|Overall Study||4
7849988|NCT00959946|19321888|P2|NOT COMPLETED|Overall Study||4
7849989|NCT00959946|19321889|P1|NOT COMPLETED|Overall Study||2
7849990|NCT00959946|19321882|P8|COMPLETED|Overall Study||0
7849991|NCT00959946|19321883|P7|COMPLETED|Overall Study||0
7849992|NCT00959946|19321884|P6|COMPLETED|Overall Study||0
7849993|NCT00959946|19321885|P5|COMPLETED|Overall Study||0
7849994|NCT00959946|19321886|P4|COMPLETED|Overall Study||0
7849995|NCT00959946|19321887|P3|COMPLETED|Overall Study||0
7849996|NCT00959946|19321888|P2|COMPLETED|Overall Study||0
7849997|NCT00959946|19321889|P1|COMPLETED|Overall Study||0
7849998|NCT00959946|19321882|P8|STARTED|Overall Study||2
7849999|NCT00959946|19321883|P7|STARTED|Overall Study||2
7850000|NCT00959946|19321884|P6|STARTED|Overall Study||9
7850001|NCT00959946|19321885|P5|STARTED|Overall Study||4
7850002|NCT00959946|19321886|P4|STARTED|Overall Study||5
7850003|NCT00959946|19321887|P3|STARTED|Overall Study||4
7850004|NCT00959946|19321888|P2|STARTED|Overall Study||4
7850005|NCT00959946|19321889|P1|STARTED|Overall Study||2
7850006|NCT00959920|19321942|P2|NOT COMPLETED|Overall Study||1
7850007|NCT00959920|19321943|P1|NOT COMPLETED|Overall Study||0
7850008|NCT00959920|19321942|P2|COMPLETED|Overall Study||66
7850009|NCT00959920|19321943|P1|COMPLETED|Overall Study||72
7850010|NCT00959920|19321942|P2|STARTED|Overall Study||67
7850011|NCT00959920|19321943|P1|STARTED|Overall Study||72
7850012|NCT00959907|19321953|P2|NOT COMPLETED|Overall Study||1
7850013|NCT00959907|19321954|P1|NOT COMPLETED|Overall Study||3
7850014|NCT00959907|19321953|P2|COMPLETED|Overall Study||28
7850015|NCT00959907|19321954|P1|COMPLETED|Overall Study||27
7850016|NCT00959907|19321953|P2|STARTED|Overall Study||29
7850017|NCT00959907|19321954|P1|STARTED|Overall Study||30
7850018|NCT00959894|19321964|P1|NOT COMPLETED|Overall Study||16
7850019|NCT00959894|19321964|P1|COMPLETED|Overall Study||63
7850020|NCT00959894|19321964|P1|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79
7850021|NCT00959764|19321995|P3|NOT COMPLETED|Overall Study||36
7850022|NCT00959764|19321996|P2|NOT COMPLETED|Overall Study||57
7850023|NCT00959764|19321997|P1|NOT COMPLETED|Overall Study||95
7850024|NCT00959764|19321995|P3|COMPLETED|Overall Study||73
7850025|NCT00959764|19321996|P2|COMPLETED|Overall Study||128
7850026|NCT00959764|19321997|P1|COMPLETED|Overall Study||176
7850027|NCT00959764|19321995|P3|STARTED|Overall Study||109
7850028|NCT00959764|19321996|P2|STARTED|Overall Study||185
7850029|NCT00959764|19321997|P1|STARTED|Overall Study||271
7850030|NCT00959751|19322013|P2|NOT COMPLETED|Overall Study||12
7850031|NCT00959751|19322014|P1|NOT COMPLETED|Overall Study||9
7850032|NCT00959751|19322013|P2|COMPLETED|Overall Study||86
7850033|NCT00959751|19322014|P1|COMPLETED|Overall Study||88
7850034|NCT00959751|19322013|P2|STARTED|Overall Study||98
7850035|NCT00959751|19322014|P1|STARTED|Overall Study||97
7850036|NCT00959699|19322036|P2|NOT COMPLETED|Follow-up Period||6
7850037|NCT00959699|19322037|P1|NOT COMPLETED|Follow-up Period||6
7850038|NCT00959699|19322036|P2|COMPLETED|Follow-up Period||56
7850039|NCT00959699|19322037|P1|COMPLETED|Follow-up Period||27
7850040|NCT00959699|19322036|P2|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62
7850041|NCT00959699|19322037|P1|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33
7850042|NCT00959699|19322036|P2|NOT COMPLETED|Treatment Period||25
7850043|NCT00959699|19322037|P1|NOT COMPLETED|Treatment Period||23
7850044|NCT00959699|19322036|P2|COMPLETED|Treatment Period||40
7850045|NCT00959699|19322037|P1|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11
7850046|NCT00959699|19322036|P2|Treated|Treatment Period||64
7850047|NCT00959699|19322037|P1|Treated|Treatment Period||34
7850048|NCT00959699|19322036|P2|STARTED|Treatment Period||65
7850049|NCT00959699|19322037|P1|STARTED|Treatment Period||34
7850050|NCT00959660|19322058|P4|NOT COMPLETED|Overall Study||3
7850051|NCT00959660|19322059|P3|NOT COMPLETED|Overall Study||3
7850052|NCT00959660|19322060|P2|NOT COMPLETED|Overall Study||0
7850053|NCT00959660|19322061|P1|NOT COMPLETED|Overall Study||2
7850054|NCT00959660|19322058|P4|COMPLETED|Overall Study||22
7850055|NCT00959660|19322059|P3|COMPLETED|Overall Study||22
7850056|NCT00959660|19322060|P2|COMPLETED|Overall Study||24
7850057|NCT00959660|19322061|P1|COMPLETED|Overall Study||24
7850058|NCT00959660|19322058|P4|STARTED|Overall Study||25
7850059|NCT00959660|19322059|P3|STARTED|Overall Study||25
7850060|NCT00959660|19322060|P2|STARTED|Overall Study||24
7850061|NCT00959660|19322061|P1|STARTED|Overall Study||26
7850062|NCT00959647|19322083|P1|NOT COMPLETED|Overall Study||19
7850063|NCT00959647|19322083|P1|COMPLETED|Overall Study||0
7850064|NCT00959647|19322083|P1|STARTED|Overall Study||19
7850065|NCT00959374|19322088|P1|NOT COMPLETED|Overall Study||23
7850066|NCT00959374|19322088|P1|COMPLETED|Overall Study||218
7850067|NCT00959374|19322088|P1|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241
7850068|NCT00959192|19322102|P4|NOT COMPLETED|Overall Study||1
7850069|NCT00959192|19322103|P3|NOT COMPLETED|Overall Study||3
7850070|NCT00959192|19322104|P2|NOT COMPLETED|Overall Study||1
7850071|NCT00959192|19322105|P1|NOT COMPLETED|Overall Study||2
7850072|NCT00959192|19322102|P4|COMPLETED|Overall Study||7
7850073|NCT00959192|19322103|P3|COMPLETED|Overall Study||6
7850074|NCT00959192|19322104|P2|COMPLETED|Overall Study||8
7850075|NCT00959192|19322105|P1|COMPLETED|Overall Study||4
7850076|NCT00959192|19322102|P4|STARTED|Overall Study||8
7850077|NCT00959192|19322103|P3|STARTED|Overall Study||9
7850078|NCT00959192|19322104|P2|STARTED|Overall Study||9
7850079|NCT00959192|19322105|P1|STARTED|Overall Study||6
7850080|NCT00959166|19322149|P2|NOT COMPLETED|Overall Study||0
7850081|NCT00959166|19322150|P1|NOT COMPLETED|Overall Study||0
7850082|NCT00959166|19322149|P2|COMPLETED|Overall Study||57
7850083|NCT00959166|19322150|P1|COMPLETED|Overall Study||24
7850084|NCT00959166|19322149|P2|STARTED|Overall Study||57
7850085|NCT00959166|19322150|P1|STARTED|Overall Study||24
7850086|NCT00959049|19322164|P6|NOT COMPLETED|Overall Study||1
7850087|NCT00959049|19322165|P5|NOT COMPLETED|Overall Study||9
7850088|NCT00959049|19322166|P4|NOT COMPLETED|Overall Study||11
7850089|NCT00959049|19322167|P3|NOT COMPLETED|Overall Study||1
7850090|NCT00959049|19322168|P2|NOT COMPLETED|Overall Study||7
7850091|NCT00959049|19322169|P1|NOT COMPLETED|Overall Study||18
7850092|NCT00959049|19322164|P6|COMPLETED|Overall Study||249
7850093|NCT00959049|19322165|P5|COMPLETED|Overall Study||248
7850094|NCT00959049|19322166|P4|COMPLETED|Overall Study||217
7850095|NCT00959049|19322167|P3|COMPLETED|Overall Study||253
7850096|NCT00959049|19322168|P2|COMPLETED|Overall Study||247
7850097|NCT00959049|19322169|P1|COMPLETED|Overall Study||213
7850098|NCT00959049|19322164|P6|STARTED|Overall Study||250
7850099|NCT00959049|19322165|P5|STARTED|Overall Study||257
7850100|NCT00959049|19322166|P4|STARTED|Overall Study||228
7850101|NCT00959049|19322167|P3|STARTED|Overall Study||254
7850102|NCT00959049|19322168|P2|STARTED|Overall Study||254
7850103|NCT00959049|19322169|P1|STARTED|Overall Study||231
7850104|NCT00958919|19322219|P2|NOT COMPLETED|Second Intervention||0
7850105|NCT00958919|19322220|P1|NOT COMPLETED|Second Intervention||0
7850106|NCT00958919|19322219|P2|COMPLETED|Second Intervention||7
7850107|NCT00958919|19322220|P1|COMPLETED|Second Intervention||7
7850108|NCT00958919|19322219|P2|STARTED|Second Intervention||7
7850109|NCT00958919|19322220|P1|STARTED|Second Intervention||7
7850110|NCT00958919|19322219|P2|NOT COMPLETED|First Intervention||0
7850111|NCT00958919|19322220|P1|NOT COMPLETED|First Intervention||0
7850112|NCT00958919|19322219|P2|COMPLETED|First Intervention||7
7850113|NCT00958919|19322220|P1|COMPLETED|First Intervention||7
7850114|NCT00958919|19322219|P2|STARTED|First Intervention||7
7850115|NCT00958919|19322220|P1|STARTED|First Intervention||7
7850116|NCT00958893|19322234|P1|NOT COMPLETED|Overall Study||4
7850117|NCT00958893|19322234|P1|COMPLETED|Overall Study||0
7850118|NCT00958893|19322234|P1|STARTED|Overall Study||4
7850119|NCT00958880|19322240|P2|NOT COMPLETED|Overall Study||2
7850120|NCT00958880|19322241|P1|NOT COMPLETED|Overall Study||2
7850121|NCT00958880|19322240|P2|COMPLETED|Overall Study||18
7850122|NCT00958880|19322241|P1|COMPLETED|Overall Study||18
7850123|NCT00958880|19322240|P2|STARTED|Overall Study||20
7850124|NCT00958880|19322241|P1|STARTED|Overall Study||20
7850125|NCT00958841|19322249|P1|NOT COMPLETED|Overall Study||96
7850126|NCT00958841|19322249|P1|COMPLETED|Overall Study|Completed = Completed extension|22
7850127|NCT00958841|19322249|P1|Entered in Extension|Overall Study||63
7850128|NCT00958841|19322249|P1|Completed Month 6 (M6)|Overall Study||90
7850129|NCT00958841|19322249|P1|STARTED|Overall Study||118
7850130|NCT00958828|19322267|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
7850131|NCT00958828|19322268|P1|NOT COMPLETED|Period 2, 1 Week of Wear||0
7850132|NCT00958828|19322267|P2|COMPLETED|Period 2, 1 Week of Wear||87
7850133|NCT00958828|19322268|P1|COMPLETED|Period 2, 1 Week of Wear||89
7850134|NCT00958828|19322267|P2|STARTED|Period 2, 1 Week of Wear||88
7850135|NCT00958828|19322268|P1|STARTED|Period 2, 1 Week of Wear||89
7850136|NCT00958828|19322267|P2|NOT COMPLETED|Period 1, 1 Week of Wear||1
7850137|NCT00958828|19322268|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
7850138|NCT00958828|19322267|P2|COMPLETED|Period 1, 1 Week of Wear||88
7850139|NCT00958828|19322268|P1|COMPLETED|Period 1, 1 Week of Wear||89
7850140|NCT00958828|19322267|P2|STARTED|Period 1, 1 Week of Wear||89
7850141|NCT00958828|19322268|P1|STARTED|Period 1, 1 Week of Wear||89
7850142|NCT00958789|19322274|P1|NOT COMPLETED|Overall Study||50
7850143|NCT00958789|19322274|P1|COMPLETED|Overall Study|Participant status at the 2 year primary outcome interval determined Completed/Not Completed counts.|130
7850144|NCT00958789|19322274|P1|STARTED|Overall Study||180
7850145|NCT00958776|19322294|P2|NOT COMPLETED|Overall Study||29
7850146|NCT00958776|19322295|P1|NOT COMPLETED|Overall Study||16
7850147|NCT00958776|19322294|P2|COMPLETED|Overall Study||239
7850148|NCT00958776|19322295|P1|COMPLETED|Overall Study||121
7850149|NCT00958776|19322294|P2|STARTED|Overall Study||268
7850150|NCT00958776|19322295|P1|STARTED|Overall Study||137
7850151|NCT00958724|19322325|P1|NOT COMPLETED|Overall Study||6
7850152|NCT00958724|19322325|P1|COMPLETED|Overall Study||0
7850153|NCT00958724|19322325|P1|STARTED|Overall Study||6
7850154|NCT00958711|19322337|P2|NOT COMPLETED|Overall Study||21
7850155|NCT00958711|19322338|P1|NOT COMPLETED|Overall Study||13
7850156|NCT00958711|19322337|P2|COMPLETED|Overall Study||27
7850157|NCT00958711|19322338|P1|COMPLETED|Overall Study||29
7850158|NCT00958711|19322337|P2|STARTED|Overall Study||48
7850159|NCT00958711|19322338|P1|STARTED|Overall Study||42
7850160|NCT00958581|19322367|P3|NOT COMPLETED|Overall Study||0
7850161|NCT00958581|19322368|P2|NOT COMPLETED|Overall Study||0
7850162|NCT00958581|19322369|P1|NOT COMPLETED|Overall Study||0
7850163|NCT00958581|19322367|P3|COMPLETED|Overall Study||55
7850164|NCT00958581|19322368|P2|COMPLETED|Overall Study||61
7850165|NCT00958581|19322369|P1|COMPLETED|Overall Study||61
7850166|NCT00958581|19322367|P3|STARTED|Overall Study||55
7850167|NCT00958581|19322368|P2|STARTED|Overall Study||61
7850168|NCT00958581|19322369|P1|STARTED|Overall Study||61
7850169|NCT00958568|19322383|P4|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106
7850170|NCT00958568|19322384|P3|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82
7850171|NCT00958568|19322385|P2|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
7850172|NCT00958568|19322386|P1|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
7850173|NCT00958568|19322383|P4|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117
7850174|NCT00958568|19322384|P3|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139
7850175|NCT00958568|19322385|P2|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
7850176|NCT00958568|19322386|P1|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
7850177|NCT00958568|19322383|P4|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223
7850178|NCT00958568|19322384|P3|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221
7850179|NCT00958568|19322385|P2|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
7850180|NCT00958568|19322386|P1|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
7850181|NCT00958568|19322383|P4|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
7850182|NCT00958568|19322384|P3|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
7850183|NCT00958568|19322385|P2|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211
7850184|NCT00958568|19322386|P1|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
7850185|NCT00958568|19322383|P4|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
7850186|NCT00958568|19322384|P3|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
7850187|NCT00958568|19322385|P2|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444
7850188|NCT00958568|19322386|P1|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
7850189|NCT00958568|19322383|P4|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
7850190|NCT00958568|19322384|P3|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
7850191|NCT00958568|19322385|P2|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655
7850192|NCT00958568|19322386|P1|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
7850193|NCT00958568|19322383|P4|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
7850194|NCT00958568|19322384|P3|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
7850195|NCT00958568|19322385|P2|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
7850196|NCT00958568|19322386|P1|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237
7850197|NCT00958568|19322383|P4|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
7850198|NCT00958568|19322384|P3|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
7850199|NCT00958568|19322385|P2|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
7850200|NCT00958568|19322386|P1|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655
7850201|NCT00958568|19322383|P4|STARTED|SPII (Wk 0-8, Acute Open-label)||0
7850202|NCT00958568|19322384|P3|STARTED|SPII (Wk 0-8, Acute Open-label)||0
7850203|NCT00958568|19322385|P2|STARTED|SPII (Wk 0-8, Acute Open-label)||0
7850204|NCT00958568|19322386|P1|STARTED|SPII (Wk 0-8, Acute Open-label)||892
7850205|NCT00958477|19322471|P4|NOT COMPLETED|Overall Study||0
7850206|NCT00958477|19322472|P3|NOT COMPLETED|Overall Study||0
7850207|NCT00958477|19322473|P2|NOT COMPLETED|Overall Study||0
7850208|NCT00958477|19322474|P1|NOT COMPLETED|Overall Study||0
7850209|NCT00958477|19322471|P4|COMPLETED|Overall Study||6
7850210|NCT00958477|19322472|P3|COMPLETED|Overall Study||6
7850211|NCT00958477|19322473|P2|COMPLETED|Overall Study||6
7850212|NCT00958477|19322474|P1|COMPLETED|Overall Study||8
7850213|NCT00958477|19322471|P4|STARTED|Overall Study||6
7850214|NCT00958477|19322472|P3|STARTED|Overall Study||6
7850215|NCT00958477|19322473|P2|STARTED|Overall Study||6
7850216|NCT00958477|19322474|P1|STARTED|Overall Study||8
7850217|NCT00958438|19322623|P3|NOT COMPLETED|Overall Study||6
7850218|NCT00958438|19322624|P2|NOT COMPLETED|Overall Study||10
7850219|NCT00958438|19322625|P1|NOT COMPLETED|Overall Study||10
7850220|NCT00958438|19322623|P3|COMPLETED|Overall Study||78
7850221|NCT00958438|19322624|P2|COMPLETED|Overall Study||72
7850222|NCT00958438|19322625|P1|COMPLETED|Overall Study||72
7850223|NCT00958438|19322623|P3|STARTED|Overall Study||84
7850224|NCT00958438|19322624|P2|STARTED|Overall Study||82
7850225|NCT00958438|19322625|P1|STARTED|Overall Study||82
7850226|NCT00958412|19322648|P1|NOT COMPLETED|Overall Study||18
7850227|NCT00958412|19322648|P1|COMPLETED|Overall Study||0
7850228|NCT00958412|19322648|P1|STARTED|Overall Study||18
7850229|NCT00958360|19322654|P2|NOT COMPLETED|Overall Study||10
7850230|NCT00958360|19322655|P1|NOT COMPLETED|Overall Study||11
7850231|NCT00958360|19322654|P2|COMPLETED|Overall Study||150
7850232|NCT00958360|19322655|P1|COMPLETED|Overall Study||152
7850233|NCT00958360|19322654|P2|STARTED|Overall Study||160
7850234|NCT00958360|19322655|P1|STARTED|Overall Study||163
7850235|NCT00958347|19322669|P1|NOT COMPLETED|Overall Study||226
7850236|NCT00958347|19322669|P1|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0
7850237|NCT00958347|19322669|P1|STARTED|Overall Study||226
7850238|NCT00958334|19322676|P3|NOT COMPLETED|Overall Study||13
7850239|NCT00958334|19322677|P2|NOT COMPLETED|Overall Study||17
7850240|NCT00958334|19322678|P1|NOT COMPLETED|Overall Study||14
7850241|NCT00958334|19322676|P3|COMPLETED|Overall Study||8
7850242|NCT00958334|19322677|P2|COMPLETED|Overall Study||5
7850243|NCT00958334|19322678|P1|COMPLETED|Overall Study||8
7850244|NCT00958334|19322676|P3|STARTED|Overall Study||21
7850245|NCT00958334|19322677|P2|STARTED|Overall Study||22
7850246|NCT00958334|19322678|P1|STARTED|Overall Study||22
7850247|NCT00958308|19322692|P3|NOT COMPLETED|Overall Study||0
7850248|NCT00958308|19322693|P2|NOT COMPLETED|Overall Study||0
7850249|NCT00958308|19322694|P1|NOT COMPLETED|Overall Study||0
7850250|NCT00958308|19322692|P3|COMPLETED|Overall Study||86
7850251|NCT00958308|19322693|P2|COMPLETED|Overall Study||85
7850252|NCT00958308|19322694|P1|COMPLETED|Overall Study||84
7850253|NCT00958308|19322692|P3|STARTED|Overall Study||86
7850254|NCT00958308|19322693|P2|STARTED|Overall Study||85
7850255|NCT00958308|19322694|P1|STARTED|Overall Study||84
7850256|NCT00958282|19322704|P2|NOT COMPLETED|Overall Study||6
7850257|NCT00958282|19322705|P1|NOT COMPLETED|Overall Study||10
7850258|NCT00958282|19322704|P2|COMPLETED|Overall Study||15
7850259|NCT00958282|19322705|P1|COMPLETED|Overall Study||12
7850260|NCT00958282|19322704|P2|STARTED|Overall Study||21
7850261|NCT00958282|19322705|P1|STARTED|Overall Study||22
7850262|NCT00958256|19322713|P1|NOT COMPLETED|Overall Study||3
7850263|NCT00958256|19322713|P1|COMPLETED|Overall Study||18
7850264|NCT00958256|19322713|P1|STARTED|Overall Study||21
7850265|NCT00958243|19322723|P6|NOT COMPLETED|Overall Study||10
7850266|NCT00958243|19322724|P5|NOT COMPLETED|Overall Study||9
7850267|NCT00958243|19322725|P4|NOT COMPLETED|Overall Study||3
7850268|NCT00958243|19322726|P3|NOT COMPLETED|Overall Study||14
7850269|NCT00958243|19322727|P2|NOT COMPLETED|Overall Study||6
7850270|NCT00958243|19322728|P1|NOT COMPLETED|Overall Study||2
7850271|NCT00958243|19322723|P6|COMPLETED|Overall Study||99
7850272|NCT00958243|19322724|P5|COMPLETED|Overall Study||100
7850273|NCT00958243|19322725|P4|COMPLETED|Overall Study||25
7850274|NCT00958243|19322726|P3|COMPLETED|Overall Study||82
7850275|NCT00958243|19322727|P2|COMPLETED|Overall Study||99
7850276|NCT00958243|19322728|P1|COMPLETED|Overall Study||24
7850277|NCT00958243|19322723|P6|STARTED|Overall Study||109
7850278|NCT00958243|19322724|P5|STARTED|Overall Study||109
7850279|NCT00958243|19322725|P4|STARTED|Overall Study||28
7850280|NCT00958243|19322726|P3|STARTED|Overall Study||96
7850281|NCT00958243|19322727|P2|STARTED|Overall Study||105
7850282|NCT00958243|19322728|P1|STARTED|Overall Study||26
7850283|NCT00958217|19322786|P2|NOT COMPLETED|Overall Study||25
7850284|NCT00958217|19322787|P1|NOT COMPLETED|Overall Study||24
7850285|NCT00958217|19322786|P2|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
7850286|NCT00958217|19322787|P1|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
7850287|NCT00958217|19322786|P2|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57
7850288|NCT00958217|19322787|P1|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56
7850289|NCT00958217|19322786|P2|STARTED|Overall Study||62
7850290|NCT00958217|19322787|P1|STARTED|Overall Study||61
7850291|NCT00958191|19322798|P1|NOT COMPLETED|Overall Study||111
7850292|NCT00958191|19322798|P1|COMPLETED|Overall Study||110
7850293|NCT00958191|19322798|P1|STARTED|Overall Study||221
7850294|NCT00958165|19322813|P1|NOT COMPLETED|Overall Study||14
7850295|NCT00958165|19322813|P1|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67
7850296|NCT00958165|19322813|P1|Treated|Overall Study||72
7850297|NCT00958165|19322813|P1|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81
7850298|NCT00958126|19322825|P8|NOT COMPLETED|Overall Study||0
7850299|NCT00958126|19322826|P7|NOT COMPLETED|Overall Study||1
7850300|NCT00958126|19322827|P6|NOT COMPLETED|Overall Study||1
7850301|NCT00958126|19322828|P5|NOT COMPLETED|Overall Study||0
7850302|NCT00958126|19322829|P4|NOT COMPLETED|Overall Study||11
7850303|NCT00958126|19322830|P3|NOT COMPLETED|Overall Study||10
7850304|NCT00958126|19322831|P2|NOT COMPLETED|Overall Study||9
7850305|NCT00958126|19322832|P1|NOT COMPLETED|Overall Study||1
7850306|NCT00958126|19322825|P8|COMPLETED|Overall Study||202
7850307|NCT00958126|19322826|P7|COMPLETED|Overall Study||199
7850308|NCT00958126|19322827|P6|COMPLETED|Overall Study||202
7850309|NCT00958126|19322828|P5|COMPLETED|Overall Study||50
7850310|NCT00958126|19322829|P4|COMPLETED|Overall Study||192
7850311|NCT00958126|19322830|P3|COMPLETED|Overall Study||191
7850312|NCT00958126|19322831|P2|COMPLETED|Overall Study||196
7850313|NCT00958126|19322832|P1|COMPLETED|Overall Study||48
7850314|NCT00958126|19322825|P8|STARTED|Overall Study||202
7850315|NCT00958126|19322826|P7|STARTED|Overall Study||200
7850316|NCT00958126|19322827|P6|STARTED|Overall Study||203
7850317|NCT00958126|19322828|P5|STARTED|Overall Study||50
7850318|NCT00958126|19322829|P4|STARTED|Overall Study||203
7850319|NCT00958126|19322830|P3|STARTED|Overall Study||201
7850320|NCT00958126|19322831|P2|STARTED|Overall Study||205
7850321|NCT00958126|19322832|P1|STARTED|Overall Study||49
7850322|NCT00958074|19322904|P2|NOT COMPLETED|Overall Study||1
7850323|NCT00958074|19322905|P1|NOT COMPLETED|Overall Study||0
7850324|NCT00958074|19322904|P2|COMPLETED|Overall Study||6
7850325|NCT00958074|19322905|P1|COMPLETED|Overall Study||4
7850326|NCT00958074|19322904|P2|STARTED|Overall Study||7
7850327|NCT00958074|19322905|P1|STARTED|Overall Study||4
7850328|NCT00958035|19322921|P2|NOT COMPLETED|Overall Study||4
7850329|NCT00958035|19322922|P1|NOT COMPLETED|Overall Study||3
7850330|NCT00958035|19322921|P2|COMPLETED|Overall Study||39
7850331|NCT00958035|19322922|P1|COMPLETED|Overall Study||43
7850332|NCT00958035|19322921|P2|STARTED|Overall Study||43
7850333|NCT00958035|19322922|P1|STARTED|Overall Study||46
7850334|NCT00958009|19322928|P1|NOT COMPLETED|Overall Study||2
7850335|NCT00958009|19322928|P1|COMPLETED|Overall Study||107
7850336|NCT00958009|19322928|P1|STARTED|Overall Study||109
7850337|NCT00957996|19322935|P2|NOT COMPLETED|Overall Study||28
7850338|NCT00957996|19322936|P1|NOT COMPLETED|Overall Study||26
7850339|NCT00957996|19322935|P2|COMPLETED|Overall Study||89
7850340|NCT00957996|19322936|P1|COMPLETED|Overall Study||91
7850341|NCT00957996|19322935|P2|STARTED|Overall Study||117
7850342|NCT00957996|19322936|P1|STARTED|Overall Study||117
7850343|NCT00957944|19322968|P2|NOT COMPLETED|Second Intervention- 24 Hours||0
7850344|NCT00957944|19322969|P1|NOT COMPLETED|Second Intervention- 24 Hours||0
7850345|NCT00957944|19322968|P2|COMPLETED|Second Intervention- 24 Hours||19
7850346|NCT00957944|19322969|P1|COMPLETED|Second Intervention- 24 Hours||20
7850347|NCT00957944|19322968|P2|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18
7850348|NCT00957944|19322969|P1|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20
7850349|NCT00957944|19322968|P2|STARTED|Second Intervention- 24 Hours||19
7850350|NCT00957944|19322969|P1|STARTED|Second Intervention- 24 Hours||20
7850351|NCT00957944|19322968|P2|NOT COMPLETED|Washout Period of at Least 5 Days||0
7850352|NCT00957944|19322969|P1|NOT COMPLETED|Washout Period of at Least 5 Days||0
7850353|NCT00957944|19322968|P2|COMPLETED|Washout Period of at Least 5 Days||19
7850354|NCT00957944|19322969|P1|COMPLETED|Washout Period of at Least 5 Days||20
7850355|NCT00957944|19322968|P2|STARTED|Washout Period of at Least 5 Days||19
7850356|NCT00957944|19322969|P1|STARTED|Washout Period of at Least 5 Days||20
7850357|NCT00957944|19322968|P2|NOT COMPLETED|First Intervention- 24 Hours||1
7850358|NCT00957944|19322969|P1|NOT COMPLETED|First Intervention- 24 Hours||0
7850359|NCT00957944|19322968|P2|COMPLETED|First Intervention- 24 Hours||19
7850360|NCT00957944|19322969|P1|COMPLETED|First Intervention- 24 Hours||20
7850361|NCT00957944|19322968|P2|STARTED|First Intervention- 24 Hours||20
7850362|NCT00957944|19322969|P1|STARTED|First Intervention- 24 Hours||20
7850363|NCT00957931|19323003|P1|NOT COMPLETED|Overall Study||4
7850364|NCT00957931|19323003|P1|COMPLETED|Overall Study||2
7850365|NCT00957931|19323003|P1|STARTED|Overall Study||6
7850366|NCT00957905|19323013|P2|NOT COMPLETED|Part B||4
7850367|NCT00957905|19323014|P1|NOT COMPLETED|Part B||0
7850368|NCT00957905|19323013|P2|COMPLETED|Part B||25
7850369|NCT00957905|19323014|P1|COMPLETED|Part B||0
7850370|NCT00957905|19323013|P2|STARTED|Part B||29
7850371|NCT00957905|19323014|P1|STARTED|Part B||0
7850372|NCT00957905|19323013|P2|NOT COMPLETED|Part A||0
7850373|NCT00957905|19323014|P1|NOT COMPLETED|Part A||0
7850374|NCT00957905|19323013|P2|COMPLETED|Part A||0
7850375|NCT00957905|19323014|P1|COMPLETED|Part A||7
7850376|NCT00957905|19323013|P2|STARTED|Part A||0
7850377|NCT00957905|19323014|P1|STARTED|Part A||7
7850378|NCT00957853|19323023|P3|NOT COMPLETED|Overall Study||0
7850379|NCT00957853|19323024|P2|NOT COMPLETED|Overall Study||0
7850380|NCT00957853|19323025|P1|NOT COMPLETED|Overall Study||1
7850381|NCT00957853|19323023|P3|COMPLETED|Overall Study||5
7850382|NCT00957853|19323024|P2|COMPLETED|Overall Study||6
7850383|NCT00957853|19323025|P1|COMPLETED|Overall Study||3
7850384|NCT00957853|19323023|P3|Neoadjuvant Tx Completion|Overall Study||5
7850385|NCT00957853|19323024|P2|Neoadjuvant Tx Completion|Overall Study||6
7850386|NCT00957853|19323025|P1|Neoadjuvant Tx Completion|Overall Study||3
7850387|NCT00957853|19323023|P3|Randomization|Overall Study||5
7850388|NCT00957853|19323024|P2|Randomization|Overall Study||6
7850389|NCT00957853|19323025|P1|Randomization|Overall Study||4
7850390|NCT00957853|19323023|P3|STARTED|Overall Study||5
7850391|NCT00957853|19323024|P2|STARTED|Overall Study||6
7850392|NCT00957853|19323025|P1|STARTED|Overall Study||4
7850393|NCT00957827|19323038|P2|NOT COMPLETED|Overall Study||0
7850394|NCT00957827|19323039|P1|NOT COMPLETED|Overall Study||0
7850395|NCT00957827|19323038|P2|COMPLETED|Overall Study||2
7850396|NCT00957827|19323039|P1|COMPLETED|Overall Study||2
7850397|NCT00957827|19323038|P2|STARTED|Overall Study||2
7850398|NCT00957827|19323039|P1|STARTED|Overall Study||2
7850399|NCT00957801|19323049|P4|NOT COMPLETED|Overall Study||1
7850400|NCT00957801|19323050|P3|NOT COMPLETED|Overall Study||0
7850401|NCT00957801|19323051|P2|NOT COMPLETED|Overall Study||0
7850402|NCT00957801|19323052|P1|NOT COMPLETED|Overall Study||0
7850403|NCT00957801|19323049|P4|COMPLETED|Overall Study||7
7850404|NCT00957801|19323050|P3|COMPLETED|Overall Study||7
7850405|NCT00957801|19323051|P2|COMPLETED|Overall Study||7
7850406|NCT00957801|19323052|P1|COMPLETED|Overall Study||7
7850407|NCT00957801|19323049|P4|STARTED|Overall Study||8
7850408|NCT00957801|19323050|P3|STARTED|Overall Study||7
7850409|NCT00957801|19323051|P2|STARTED|Overall Study||7
7850410|NCT00957801|19323052|P1|STARTED|Overall Study||7
7850411|NCT00957723|19323218|P1|NOT COMPLETED|Overall Study||113
7850412|NCT00957723|19323218|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298
7850413|NCT00957723|19323218|P1|STARTED|Overall Study||411
7850414|NCT00957684|19323236|P5|NOT COMPLETED|PART II||75
7850415|NCT00957684|19323237|P4|NOT COMPLETED|PART II||0
7850416|NCT00957684|19323238|P3|NOT COMPLETED|PART II||0
7850417|NCT00957684|19323239|P2|NOT COMPLETED|PART II||0
7850418|NCT00957684|19323240|P1|NOT COMPLETED|PART II||0
7850419|NCT00957684|19323236|P5|COMPLETED|PART II||239
7850420|NCT00957684|19323237|P4|COMPLETED|PART II||0
7850421|NCT00957684|19323238|P3|COMPLETED|PART II||0
7850422|NCT00957684|19323239|P2|COMPLETED|PART II||0
7850423|NCT00957684|19323240|P1|COMPLETED|PART II||0
7850424|NCT00957684|19323236|P5|Patients Entered Part II|PART II||314
7850425|NCT00957684|19323237|P4|Patients Entered Part II|PART II||0
7850426|NCT00957684|19323238|P3|Patients Entered Part II|PART II||0
7850427|NCT00957684|19323239|P2|Patients Entered Part II|PART II||0
7850428|NCT00957684|19323240|P1|Patients Entered Part II|PART II||0
7850429|NCT00957684|19323236|P5|STARTED|PART II||314
7850430|NCT00957684|19323237|P4|STARTED|PART II||0
7850431|NCT00957684|19323238|P3|STARTED|PART II||0
7850432|NCT00957684|19323239|P2|STARTED|PART II||0
7850433|NCT00957684|19323240|P1|STARTED|PART II||0
7850434|NCT00957684|19323236|P5|NOT COMPLETED|PART I||0
7850435|NCT00957684|19323237|P4|NOT COMPLETED|PART I||18
7850436|NCT00957684|19323238|P3|NOT COMPLETED|PART I||10
7850437|NCT00957684|19323239|P2|NOT COMPLETED|PART I||13
7850438|NCT00957684|19323240|P1|NOT COMPLETED|PART I||31
7850439|NCT00957684|19323236|P5|COMPLETED|PART I||0
7850440|NCT00957684|19323237|P4|COMPLETED|PART I||84
7850441|NCT00957684|19323238|P3|COMPLETED|PART I||90
7850442|NCT00957684|19323239|P2|COMPLETED|PART I||85
7850443|NCT00957684|19323240|P1|COMPLETED|PART I||71
7850444|NCT00957684|19323236|P5|Per-protocol (PP)Population|PART I||0
7850445|NCT00957684|19323237|P4|Per-protocol (PP)Population|PART I||91
7850446|NCT00957684|19323238|P3|Per-protocol (PP)Population|PART I||94
7850447|NCT00957684|19323239|P2|Per-protocol (PP)Population|PART I||86
7850448|NCT00957684|19323240|P1|Per-protocol (PP)Population|PART I||72
7850449|NCT00957684|19323236|P5|Intention-to-treat (ITT) Population|PART I||0
7850450|NCT00957684|19323237|P4|Intention-to-treat (ITT) Population|PART I||102
7850451|NCT00957684|19323238|P3|Intention-to-treat (ITT) Population|PART I||99
7850452|NCT00957684|19323239|P2|Intention-to-treat (ITT) Population|PART I||98
7850453|NCT00957684|19323240|P1|Intention-to-treat (ITT) Population|PART I||98
7850454|NCT00957684|19323236|P5|Randomised (Safety Population)|PART I||0
7850455|NCT00957684|19323237|P4|Randomised (Safety Population)|PART I||102
7850456|NCT00957684|19323238|P3|Randomised (Safety Population)|PART I||100
7850457|NCT00957684|19323239|P2|Randomised (Safety Population)|PART I||98
7850458|NCT00957684|19323240|P1|Randomised (Safety Population)|PART I||102
7850459|NCT00957684|19323236|P5|STARTED|PART I||0
7850460|NCT00957684|19323237|P4|STARTED|PART I||102
7850461|NCT00957684|19323238|P3|STARTED|PART I||100
7850462|NCT00957684|19323239|P2|STARTED|PART I||98
7850463|NCT00957684|19323240|P1|STARTED|PART I||102
7850464|NCT00957671|19323250|P1|NOT COMPLETED|Overall Study||0
7850465|NCT00957671|19323250|P1|COMPLETED|Overall Study|15 subjects completed the treatment phase of the study.|15
7850466|NCT00957671|19323250|P1|STARTED|Overall Study|15 subjects began the treatment phase.|15
7850467|NCT00957658|19323307|P1|NOT COMPLETED|Overall Study||65
7850468|NCT00957658|19323307|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169
7850469|NCT00957658|19323307|P1|STARTED|Overall Study||234
7850470|NCT00957593|19323322|P2|NOT COMPLETED|Overall Study||0
7850471|NCT00957593|19323323|P1|NOT COMPLETED|Overall Study||0
7850472|NCT00957593|19323322|P2|COMPLETED|Overall Study||125
7850473|NCT00957593|19323323|P1|COMPLETED|Overall Study||127
7850474|NCT00957593|19323322|P2|STARTED|Overall Study||125
7850475|NCT00957593|19323323|P1|STARTED|Overall Study||127
7850476|NCT00957580|19323334|P3|NOT COMPLETED|Overall Study||0
7850477|NCT00957580|19323335|P2|NOT COMPLETED|Overall Study||2
7850478|NCT00957580|19323336|P1|NOT COMPLETED|Overall Study||0
7850479|NCT00957580|19323334|P3|COMPLETED|Overall Study||15
7850480|NCT00957580|19323335|P2|COMPLETED|Overall Study||31
7850481|NCT00957580|19323336|P1|COMPLETED|Overall Study||33
7850482|NCT00957580|19323334|P3|Treated|Overall Study||15
7850483|NCT00957580|19323335|P2|Treated|Overall Study||32
7850484|NCT00957580|19323336|P1|Treated|Overall Study||33
7850485|NCT00957580|19323334|P3|STARTED|Overall Study||15
7850486|NCT00957580|19323335|P2|STARTED|Overall Study||33
7850487|NCT00957580|19323336|P1|STARTED|Overall Study||33
7850488|NCT00957528|19323483|P3|NOT COMPLETED|Overall Study||1
7850489|NCT00957528|19323484|P2|NOT COMPLETED|Overall Study||1
7850490|NCT00957528|19323485|P1|NOT COMPLETED|Overall Study||0
7850491|NCT00957528|19323483|P3|COMPLETED|Overall Study||8
7850492|NCT00957528|19323484|P2|COMPLETED|Overall Study||8
7850493|NCT00957528|19323485|P1|COMPLETED|Overall Study||8
7850494|NCT00957528|19323483|P3|STARTED|Overall Study||9
7850495|NCT00957528|19323484|P2|STARTED|Overall Study||9
7850496|NCT00957528|19323485|P1|STARTED|Overall Study||8
7850497|NCT00957424|19323508|P1|NOT COMPLETED|Overall Study||23
7850498|NCT00957424|19323508|P1|COMPLETED|Overall Study||44
7850499|NCT00957424|19323508|P1|Follow-up #2|Overall Study||50
7850500|NCT00957424|19323508|P1|Follow-up #1|Overall Study||59
7850501|NCT00957424|19323508|P1|STARTED|Overall Study||67
7850502|NCT00957372|19323518|P4|NOT COMPLETED|PART II||44
7850503|NCT00957372|19323519|P3|NOT COMPLETED|PART II||0
7850504|NCT00957372|19323520|P2|NOT COMPLETED|PART II||0
7850505|NCT00957372|19323521|P1|NOT COMPLETED|PART II||0
7850506|NCT00957372|19323518|P4|COMPLETED|PART II||150
7850507|NCT00957372|19323519|P3|COMPLETED|PART II||0
7850508|NCT00957372|19323520|P2|COMPLETED|PART II||0
7850509|NCT00957372|19323521|P1|COMPLETED|PART II||0
7850510|NCT00957372|19323518|P4|Per-Protocol Population|PART II||108
7850511|NCT00957372|19323519|P3|Per-Protocol Population|PART II||0
7850512|NCT00957372|19323520|P2|Per-Protocol Population|PART II||0
7850513|NCT00957372|19323521|P1|Per-Protocol Population|PART II||0
7850514|NCT00957372|19323518|P4|Intention-to-treat (ITT) Population|PART II||191
7850515|NCT00957372|19323519|P3|Intention-to-treat (ITT) Population|PART II||0
7850516|NCT00957372|19323520|P2|Intention-to-treat (ITT) Population|PART II||0
7850517|NCT00957372|19323521|P1|Intention-to-treat (ITT) Population|PART II||0
7850518|NCT00957372|19323518|P4|Safety Population|PART II||194
7850519|NCT00957372|19323519|P3|Safety Population|PART II||0
7850520|NCT00957372|19323520|P2|Safety Population|PART II||0
7850521|NCT00957372|19323521|P1|Safety Population|PART II||0
7850522|NCT00957372|19323518|P4|STARTED|PART II||194
7850523|NCT00957372|19323519|P3|STARTED|PART II||0
7850524|NCT00957372|19323520|P2|STARTED|PART II||0
7850525|NCT00957372|19323521|P1|STARTED|PART II||0
7850526|NCT00957372|19323518|P4|NOT COMPLETED|PART I||0
7850527|NCT00957372|19323519|P3|NOT COMPLETED|PART I||1
7850528|NCT00957372|19323520|P2|NOT COMPLETED|PART I||0
7850529|NCT00957372|19323521|P1|NOT COMPLETED|PART I||0
7850530|NCT00957372|19323518|P4|COMPLETED|PART I||0
7850531|NCT00957372|19323519|P3|COMPLETED|PART I||87
7850532|NCT00957372|19323520|P2|COMPLETED|PART I||85
7850533|NCT00957372|19323521|P1|COMPLETED|PART I||80
7850534|NCT00957372|19323518|P4|Randomized But Not Treated|PART I||0
7850535|NCT00957372|19323519|P3|Randomized But Not Treated|PART I||1
7850536|NCT00957372|19323520|P2|Randomized But Not Treated|PART I||0
7850537|NCT00957372|19323521|P1|Randomized But Not Treated|PART I||0
7850538|NCT00957372|19323518|P4|Per-Protocol Population|PART I||0
7850539|NCT00957372|19323519|P3|Per-Protocol Population|PART I||51
7850540|NCT00957372|19323520|P2|Per-Protocol Population|PART I||47
7850541|NCT00957372|19323521|P1|Per-Protocol Population|PART I||35
7850542|NCT00957372|19323518|P4|Intention-to-Treat Population|PART I||0
7850543|NCT00957372|19323519|P3|Intention-to-Treat Population|PART I||84
7850544|NCT00957372|19323520|P2|Intention-to-Treat Population|PART I||84
7850545|NCT00957372|19323521|P1|Intention-to-Treat Population|PART I||77
7850546|NCT00957372|19323518|P4|Safety Population|PART I||0
7850547|NCT00957372|19323519|P3|Safety Population|PART I||87
7850548|NCT00957372|19323520|P2|Safety Population|PART I||85
7850549|NCT00957372|19323521|P1|Safety Population|PART I||80
7850550|NCT00957372|19323518|P4|STARTED|PART I||0
7850551|NCT00957372|19323519|P3|STARTED|PART I||88
7850552|NCT00957372|19323520|P2|STARTED|PART I||85
7850553|NCT00957372|19323521|P1|STARTED|PART I||80
7850554|NCT00957359|19323539|P2|NOT COMPLETED|Overall Study||0
7850555|NCT00957359|19323540|P1|NOT COMPLETED|Overall Study||0
7850556|NCT00957359|19323539|P2|COMPLETED|Overall Study||15
7850557|NCT00957359|19323540|P1|COMPLETED|Overall Study||14
7850558|NCT00957359|19323539|P2|STARTED|Overall Study||15
7850559|NCT00957359|19323540|P1|STARTED|Overall Study||14
7850560|NCT00957333|19323652|P1|NOT COMPLETED|Overall Study||0
7850561|NCT00957333|19323652|P1|COMPLETED|Overall Study||44
7850562|NCT00957333|19323652|P1|STARTED|Overall Study||44
7850563|NCT00957268|19323661|P5|NOT COMPLETED|Overall Study||0
7850564|NCT00957268|19323662|P4|NOT COMPLETED|Overall Study||0
7850565|NCT00957268|19323663|P3|NOT COMPLETED|Overall Study||1
7850566|NCT00957268|19323664|P2|NOT COMPLETED|Overall Study||0
7850567|NCT00957268|19323665|P1|NOT COMPLETED|Overall Study||0
7850568|NCT00957268|19323661|P5|COMPLETED|Overall Study||22
7850569|NCT00957268|19323662|P4|COMPLETED|Overall Study||7
7850570|NCT00957268|19323663|P3|COMPLETED|Overall Study||7
7850571|NCT00957268|19323664|P2|COMPLETED|Overall Study||4
7850572|NCT00957268|19323665|P1|COMPLETED|Overall Study||5
7850573|NCT00957268|19323661|P5|STARTED|Overall Study||22
7850574|NCT00957268|19323662|P4|STARTED|Overall Study||7
7850575|NCT00957268|19323663|P3|STARTED|Overall Study||8
7850576|NCT00957268|19323664|P2|STARTED|Overall Study||4
7850577|NCT00957268|19323665|P1|STARTED|Overall Study||5
7850578|NCT00957242|19323729|P2|NOT COMPLETED|Overall Study||0
7850579|NCT00957242|19323730|P1|NOT COMPLETED|Overall Study||0
7850580|NCT00957242|19323729|P2|COMPLETED|Overall Study||72
7850581|NCT00957242|19323730|P1|COMPLETED|Overall Study||73
7850582|NCT00957242|19323729|P2|STARTED|Overall Study||72
7850583|NCT00957242|19323730|P1|STARTED|Overall Study||73
7850584|NCT00957047|19323762|P5|NOT COMPLETED|PART II||102
7850585|NCT00957047|19323763|P4|NOT COMPLETED|PART II||0
7850586|NCT00957047|19323764|P3|NOT COMPLETED|PART II||0
7850587|NCT00957047|19323765|P2|NOT COMPLETED|PART II||0
7850588|NCT00957047|19323766|P1|NOT COMPLETED|PART II||0
7850589|NCT00957047|19323762|P5|COMPLETED|PART II||223
7850590|NCT00957047|19323763|P4|COMPLETED|PART II||0
7850591|NCT00957047|19323764|P3|COMPLETED|PART II||0
7850592|NCT00957047|19323765|P2|COMPLETED|PART II||0
7850593|NCT00957047|19323766|P1|COMPLETED|PART II||0
7850594|NCT00957047|19323762|P5|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102
7850595|NCT00957047|19323763|P4|Terminated Prematurely|PART II||0
7850596|NCT00957047|19323764|P3|Terminated Prematurely|PART II||0
7850597|NCT00957047|19323765|P2|Terminated Prematurely|PART II||0
7850598|NCT00957047|19323766|P1|Terminated Prematurely|PART II||0
7850599|NCT00957047|19323762|P5|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325
7850600|NCT00957047|19323763|P4|STARTED|PART II||0
7850601|NCT00957047|19323764|P3|STARTED|PART II||0
7850602|NCT00957047|19323765|P2|STARTED|PART II||0
7850603|NCT00957047|19323766|P1|STARTED|PART II||0
7850604|NCT00957047|19323762|P5|NOT COMPLETED|PART I||0
7850605|NCT00957047|19323763|P4|NOT COMPLETED|PART I||30
7850606|NCT00957047|19323764|P3|NOT COMPLETED|PART I||21
7850607|NCT00957047|19323765|P2|NOT COMPLETED|PART I||13
7850608|NCT00957047|19323766|P1|NOT COMPLETED|PART I||6
7850609|NCT00957047|19323762|P5|COMPLETED|PART I||0
7850610|NCT00957047|19323763|P4|COMPLETED|PART I||68
7850611|NCT00957047|19323764|P3|COMPLETED|PART I||80
7850612|NCT00957047|19323765|P2|COMPLETED|PART I||83
7850613|NCT00957047|19323766|P1|COMPLETED|PART I||94
7850614|NCT00957047|19323762|P5|Per-Protocol Population|PART I||0
7850615|NCT00957047|19323763|P4|Per-Protocol Population|PART I||54
7850616|NCT00957047|19323764|P3|Per-Protocol Population|PART I||75
7850617|NCT00957047|19323765|P2|Per-Protocol Population|PART I||70
7850618|NCT00957047|19323766|P1|Per-Protocol Population|PART I||81
7850619|NCT00957047|19323762|P5|Intention-to-treat (ITT) Population|PART I||0
7850620|NCT00957047|19323763|P4|Intention-to-treat (ITT) Population|PART I||97
7850621|NCT00957047|19323764|P3|Intention-to-treat (ITT) Population|PART I||100
7850622|NCT00957047|19323765|P2|Intention-to-treat (ITT) Population|PART I||96
7850623|NCT00957047|19323766|P1|Intention-to-treat (ITT) Population|PART I||100
7850624|NCT00957047|19323762|P5|Randomized/Safety Population|PART I||0
7850625|NCT00957047|19323763|P4|Randomized/Safety Population|PART I||98
7850626|NCT00957047|19323764|P3|Randomized/Safety Population|PART I||101
7850627|NCT00957047|19323765|P2|Randomized/Safety Population|PART I||96
7850628|NCT00957047|19323766|P1|Randomized/Safety Population|PART I||100
7850629|NCT00957047|19323762|P5|STARTED|PART I||0
7850630|NCT00957047|19323763|P4|STARTED|PART I||98
7850631|NCT00957047|19323764|P3|STARTED|PART I||101
7850632|NCT00957047|19323765|P2|STARTED|PART I||96
7850633|NCT00957047|19323766|P1|STARTED|PART I||100
7850634|NCT00957034|19323787|P3|NOT COMPLETED|Overall Study||6
7850635|NCT00957034|19323788|P2|NOT COMPLETED|Overall Study||4
7850636|NCT00957034|19323789|P1|NOT COMPLETED|Overall Study||6
7850637|NCT00957034|19323787|P3|COMPLETED|Overall Study||1
7850638|NCT00957034|19323788|P2|COMPLETED|Overall Study||0
7850639|NCT00957034|19323789|P1|COMPLETED|Overall Study||0
7850640|NCT00957034|19323787|P3|STARTED|Overall Study||7
7850641|NCT00957034|19323788|P2|STARTED|Overall Study||4
7850642|NCT00957034|19323789|P1|STARTED|Overall Study||6
7850643|NCT00957021|19323812|P1|NOT COMPLETED|Overall Study||117
7850644|NCT00957021|19323812|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237
7850645|NCT00957021|19323812|P1|STARTED|Overall Study||354
7850646|NCT00957008|19323825|P4|NOT COMPLETED|Overall Study||24
7850647|NCT00957008|19323826|P3|NOT COMPLETED|Overall Study||17
7850648|NCT00957008|19323827|P2|NOT COMPLETED|Overall Study||12
7850649|NCT00957008|19323828|P1|NOT COMPLETED|Overall Study||21
7850650|NCT00957008|19323825|P4|COMPLETED|Overall Study||26
7850651|NCT00957008|19323826|P3|COMPLETED|Overall Study||32
7850652|NCT00957008|19323827|P2|COMPLETED|Overall Study||37
7850653|NCT00957008|19323828|P1|COMPLETED|Overall Study||28
7850654|NCT00957008|19323825|P4|STARTED|Overall Study||50
7850655|NCT00957008|19323826|P3|STARTED|Overall Study||49
7850656|NCT00957008|19323827|P2|STARTED|Overall Study||49
7850657|NCT00957008|19323828|P1|STARTED|Overall Study||49
7850658|NCT00956943|19323856|P2|NOT COMPLETED|Overall Study||10
7850659|NCT00956943|19323857|P1|NOT COMPLETED|Overall Study||9
7850660|NCT00956943|19323856|P2|COMPLETED|Overall Study||34
7850661|NCT00956943|19323857|P1|COMPLETED|Overall Study||34
7850662|NCT00956943|19323856|P2|Baseline|Overall Study||44
7850663|NCT00956943|19323857|P1|Baseline|Overall Study||43
7850664|NCT00956943|19323856|P2|STARTED|Overall Study||44
7850665|NCT00956943|19323857|P1|STARTED|Overall Study||43
7850666|NCT00956930|19323867|P2|NOT COMPLETED|Overall Study||0
7850667|NCT00956930|19323868|P1|NOT COMPLETED|Overall Study||0
7850668|NCT00956930|19323867|P2|COMPLETED|Overall Study||21
7850669|NCT00956930|19323868|P1|COMPLETED|Overall Study||24
7850670|NCT00956930|19323867|P2|STARTED|Overall Study||21
7850671|NCT00956930|19323868|P1|STARTED|Overall Study||24
7850672|NCT00956839|19323881|P3|NOT COMPLETED|Overall Study||3
7850673|NCT00956839|19323882|P2|NOT COMPLETED|Overall Study||0
7850674|NCT00956839|19323883|P1|NOT COMPLETED|Overall Study||3
7850675|NCT00956839|19323881|P3|COMPLETED|Overall Study||10
7850676|NCT00956839|19323882|P2|COMPLETED|Overall Study||13
7850677|NCT00956839|19323883|P1|COMPLETED|Overall Study||11
7850678|NCT00956839|19323881|P3|STARTED|Overall Study||13
7850679|NCT00956839|19323882|P2|STARTED|Overall Study||13
7850680|NCT00956839|19323883|P1|STARTED|Overall Study||14
7850681|NCT00956813|19323896|P2|NOT COMPLETED|Continuation Phase||0
7850682|NCT00956813|19323897|P1|NOT COMPLETED|Continuation Phase||0
7850683|NCT00956813|19323896|P2|COMPLETED|Continuation Phase||0
7850684|NCT00956813|19323897|P1|COMPLETED|Continuation Phase||80
7850685|NCT00956813|19323896|P2|STARTED|Continuation Phase||0
7850686|NCT00956813|19323897|P1|STARTED|Continuation Phase||80
7850687|NCT00956813|19323896|P2|NOT COMPLETED|Flaxseed and Placebo||5
7850688|NCT00956813|19323897|P1|NOT COMPLETED|Flaxseed and Placebo||8
7850689|NCT00956813|19323896|P2|COMPLETED|Flaxseed and Placebo||100
7850690|NCT00956813|19323897|P1|COMPLETED|Flaxseed and Placebo||97
7850691|NCT00956813|19323896|P2|STARTED|Flaxseed and Placebo||105
7850692|NCT00956813|19323897|P1|STARTED|Flaxseed and Placebo||105
7850693|NCT00956761|19323912|P1|NOT COMPLETED|Overall Study||0
7850694|NCT00956761|19323912|P1|COMPLETED|Overall Study||63
7850695|NCT00956761|19323912|P1|STARTED|Overall Study||63
7850696|NCT00956709|19323921|P2|NOT COMPLETED|Overall Study||0
7850697|NCT00956709|19323922|P1|NOT COMPLETED|Overall Study||0
7850698|NCT00956709|19323921|P2|COMPLETED|Overall Study||19
7850699|NCT00956709|19323922|P1|COMPLETED|Overall Study||16
7850700|NCT00956709|19323921|P2|STARTED|Overall Study||19
7850701|NCT00956709|19323922|P1|STARTED|Overall Study||16
7850702|NCT00956657|19323934|P2|NOT COMPLETED|Overall Study||0
7850703|NCT00956657|19323935|P1|NOT COMPLETED|Overall Study||0
7850704|NCT00956657|19323934|P2|COMPLETED|Overall Study||13
7850705|NCT00956657|19323935|P1|COMPLETED|Overall Study||18
7850706|NCT00956657|19323934|P2|STARTED|Overall Study||13
7850707|NCT00956657|19323935|P1|STARTED|Overall Study||18
7850708|NCT00956631|19323941|P1|NOT COMPLETED|Overall Study||16
7850709|NCT00956631|19323941|P1|COMPLETED|Overall Study||62
7850710|NCT00956631|19323941|P1|STARTED|Overall Study||78
7850711|NCT00956592|19323949|P2|NOT COMPLETED|Overall Study||3
7850712|NCT00956592|19323950|P1|NOT COMPLETED|Overall Study||1
7850713|NCT00956592|19323949|P2|COMPLETED|Overall Study||147
7850714|NCT00956592|19323950|P1|COMPLETED|Overall Study||149
7850715|NCT00956592|19323949|P2|STARTED|Overall Study||150
7850716|NCT00956592|19323950|P1|STARTED|Overall Study||150
7850717|NCT00956540|19323970|P4|NOT COMPLETED|Overall Study||4
7850718|NCT00956540|19323971|P3|NOT COMPLETED|Overall Study||3
7850719|NCT00956540|19323972|P2|NOT COMPLETED|Overall Study||4
7850720|NCT00956540|19323973|P1|NOT COMPLETED|Overall Study||3
7850721|NCT00956540|19323970|P4|COMPLETED|Overall Study||41
7850722|NCT00956540|19323971|P3|COMPLETED|Overall Study||43
7850723|NCT00956540|19323972|P2|COMPLETED|Overall Study||46
7850724|NCT00956540|19323973|P1|COMPLETED|Overall Study||51
7850725|NCT00956540|19323970|P4|STARTED|Overall Study||45
7850726|NCT00956540|19323971|P3|STARTED|Overall Study||46
7850727|NCT00956540|19323972|P2|STARTED|Overall Study||50
7850728|NCT00956540|19323973|P1|STARTED|Overall Study||54
7850729|NCT00956293|19323985|P3|NOT COMPLETED|Follow-up Period||0
7850730|NCT00956293|19323986|P2|NOT COMPLETED|Follow-up Period||32
7850731|NCT00956293|19323987|P1|NOT COMPLETED|Follow-up Period||20
7850732|NCT00956293|19323985|P3|COMPLETED|Follow-up Period||0
7850733|NCT00956293|19323986|P2|COMPLETED|Follow-up Period||0
7850734|NCT00956293|19323987|P1|COMPLETED|Follow-up Period||0
7850735|NCT00956293|19323985|P3|STARTED|Follow-up Period||0
7850736|NCT00956293|19323986|P2|STARTED|Follow-up Period||32
7850737|NCT00956293|19323987|P1|STARTED|Follow-up Period||20
7850738|NCT00956293|19323985|P3|NOT COMPLETED|Main Period (Randomization)||0
7850739|NCT00956293|19323986|P2|NOT COMPLETED|Main Period (Randomization)||27
7850740|NCT00956293|19323987|P1|NOT COMPLETED|Main Period (Randomization)||1
7850741|NCT00956293|19323985|P3|COMPLETED|Main Period (Randomization)||0
7850742|NCT00956293|19323986|P2|COMPLETED|Main Period (Randomization)||26
7850743|NCT00956293|19323987|P1|COMPLETED|Main Period (Randomization)||23
7850744|NCT00956293|19323985|P3|Randomized Safety Set|Main Period (Randomization)||0
7850745|NCT00956293|19323986|P2|Randomized Safety Set|Main Period (Randomization)||51
7850746|NCT00956293|19323987|P1|Randomized Safety Set|Main Period (Randomization)||24
7850747|NCT00956293|19323985|P3|Full Analysis Set|Main Period (Randomization)||0
7850748|NCT00956293|19323986|P2|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51
7850749|NCT00956293|19323987|P1|Full Analysis Set|Main Period (Randomization)||24
7850750|NCT00956293|19323985|P3|STARTED|Main Period (Randomization)||0
7850751|NCT00956293|19323986|P2|STARTED|Main Period (Randomization)||53
7850752|NCT00956293|19323987|P1|STARTED|Main Period (Randomization)||24
7850753|NCT00956293|19323985|P3|NOT COMPLETED|Main Period (Pre-randomization)||130
7850754|NCT00956293|19323986|P2|NOT COMPLETED|Main Period (Pre-randomization)||0
7850755|NCT00956293|19323987|P1|NOT COMPLETED|Main Period (Pre-randomization)||0
7850756|NCT00956293|19323985|P3|COMPLETED|Main Period (Pre-randomization)||77
7850757|NCT00956293|19323986|P2|COMPLETED|Main Period (Pre-randomization)||0
7850758|NCT00956293|19323987|P1|COMPLETED|Main Period (Pre-randomization)||0
7850759|NCT00956293|19323985|P3|Enrolled Safety Set|Main Period (Pre-randomization)||203
7850760|NCT00956293|19323986|P2|Enrolled Safety Set|Main Period (Pre-randomization)||0
7850761|NCT00956293|19323987|P1|Enrolled Safety Set|Main Period (Pre-randomization)||0
7850762|NCT00956293|19323985|P3|STARTED|Main Period (Pre-randomization)||207
7850763|NCT00956293|19323986|P2|STARTED|Main Period (Pre-randomization)||0
7850764|NCT00956293|19323987|P1|STARTED|Main Period (Pre-randomization)||0
7850765|NCT00956254|19324011|P1|NOT COMPLETED|Overall Study||0
7850766|NCT00956254|19324011|P1|COMPLETED|Overall Study||18
7850767|NCT00956254|19324011|P1|STARTED|Overall Study||18
7850768|NCT00956085|19324021|P1|NOT COMPLETED|Overall Study||0
7850769|NCT00956085|19324021|P1|COMPLETED|Overall Study||12
7850770|NCT00956085|19324021|P1|STARTED|Overall Study||12
7850771|NCT00956020|19324025|P1|NOT COMPLETED|Overall Study||0
7850772|NCT00956020|19324025|P1|COMPLETED|Overall Study||4
7850773|NCT00956020|19324025|P1|STARTED|Overall Study||4
7850774|NCT00955968|19324042|P2|NOT COMPLETED|Overall Study||126
7850775|NCT00955968|19324043|P1|NOT COMPLETED|Overall Study||137
7850776|NCT00955968|19324042|P2|COMPLETED|Overall Study||699
7850777|NCT00955968|19324043|P1|COMPLETED|Overall Study||691
7850778|NCT00955968|19324042|P2|STARTED|Overall Study||825
7850779|NCT00955968|19324043|P1|STARTED|Overall Study||828
7850780|NCT00955955|19324085|P3|NOT COMPLETED|Overall Study||0
7850781|NCT00955955|19324086|P2|NOT COMPLETED|Overall Study||0
7850782|NCT00955955|19324087|P1|NOT COMPLETED|Overall Study||2
7850783|NCT00955955|19324085|P3|COMPLETED|Overall Study||28
7850784|NCT00955955|19324086|P2|COMPLETED|Overall Study||28
7850785|NCT00955955|19324087|P1|COMPLETED|Overall Study||17
7850786|NCT00955955|19324085|P3|STARTED|Overall Study||28
7850787|NCT00955955|19324086|P2|STARTED|Overall Study||28
7850788|NCT00955955|19324087|P1|STARTED|Overall Study||19
7850789|NCT00955916|19324101|P1|NOT COMPLETED|Overall Study||0
7850790|NCT00955916|19324101|P1|COMPLETED|Overall Study||38
7850791|NCT00955916|19324101|P1|STARTED|Overall Study||38
7850792|NCT00955903|19324110|P3|NOT COMPLETED|Overall Study||7
7850793|NCT00955903|19324111|P2|NOT COMPLETED|Overall Study||3
7850794|NCT00955903|19324112|P1|NOT COMPLETED|Overall Study||6
7850795|NCT00955903|19324110|P3|COMPLETED|Overall Study||48
7850796|NCT00955903|19324111|P2|COMPLETED|Overall Study||51
7850797|NCT00955903|19324112|P1|COMPLETED|Overall Study||49
7850798|NCT00955903|19324110|P3|STARTED|Overall Study||55
7850799|NCT00955903|19324111|P2|STARTED|Overall Study||54
7850800|NCT00955903|19324112|P1|STARTED|Overall Study||55
7850801|NCT00955877|19324129|P3|NOT COMPLETED|Overall Study||0
7850802|NCT00955877|19324130|P2|NOT COMPLETED|Overall Study||0
7850803|NCT00955877|19324131|P1|NOT COMPLETED|Overall Study||0
7850804|NCT00955877|19324129|P3|COMPLETED|Overall Study||7
7850805|NCT00955877|19324130|P2|COMPLETED|Overall Study||0
7850806|NCT00955877|19324131|P1|COMPLETED|Overall Study||6
7850807|NCT00955877|19324129|P3|STARTED|Overall Study||7
7850808|NCT00955877|19324130|P2|STARTED|Overall Study|No patients were enrolled because analysis of previous arm wasn't completed.|0
7850809|NCT00955877|19324131|P1|STARTED|Overall Study|Drug manufacturer ceased producing the drug prior to completion of 10 enrolled in this arm.|6
7850810|NCT00955825|19324171|P2|NOT COMPLETED|Overall Study||17
7850811|NCT00955825|19324172|P1|NOT COMPLETED|Overall Study||26
7850812|NCT00955825|19324171|P2|COMPLETED|Overall Study||223
7850813|NCT00955825|19324172|P1|COMPLETED|Overall Study||207
7850814|NCT00955825|19324171|P2|STARTED|Overall Study||240
7850815|NCT00955825|19324172|P1|STARTED|Overall Study||233
7850816|NCT00955747|19324180|P2|NOT COMPLETED|Overall Study||69
7850817|NCT00955747|19324181|P1|NOT COMPLETED|Overall Study||69
7850818|NCT00955747|19324180|P2|COMPLETED|Overall Study||172
7850819|NCT00955747|19324181|P1|COMPLETED|Overall Study||184
7850820|NCT00955747|19324180|P2|STARTED|Overall Study||241
7850821|NCT00955747|19324181|P1|STARTED|Overall Study||253
7850822|NCT00955721|19324189|P2|NOT COMPLETED|Overall Study||0
7850823|NCT00955721|19324190|P1|NOT COMPLETED|Overall Study||3
7850824|NCT00955721|19324189|P2|COMPLETED|Overall Study||0
7850825|NCT00955721|19324190|P1|COMPLETED|Overall Study||6
7850826|NCT00955721|19324189|P2|STARTED|Overall Study||0
7850827|NCT00955721|19324190|P1|STARTED|Overall Study||9
7850828|NCT00955708|19324200|P1|NOT COMPLETED|Overall Study||1058
7850829|NCT00955708|19324200|P1|COMPLETED|Overall Study||250
7850830|NCT00955708|19324200|P1|STARTED|Overall Study||1308
7850831|NCT00955682|19324206|P2|NOT COMPLETED|Year 5 Period||0
7850832|NCT00955682|19324207|P1|NOT COMPLETED|Year 5 Period||0
7850833|NCT00955682|19324206|P2|COMPLETED|Year 5 Period||47
7850834|NCT00955682|19324207|P1|COMPLETED|Year 5 Period||239
7850835|NCT00955682|19324206|P2|STARTED|Year 5 Period||47
7850836|NCT00955682|19324207|P1|STARTED|Year 5 Period||239
7850837|NCT00955682|19324206|P2|NOT COMPLETED|Booster Period (Month 49)||1
7850838|NCT00955682|19324207|P1|NOT COMPLETED|Booster Period (Month 49)||1
7850839|NCT00955682|19324206|P2|COMPLETED|Booster Period (Month 49)||47
7850840|NCT00955682|19324207|P1|COMPLETED|Booster Period (Month 49)||244
7850841|NCT00955682|19324206|P2|STARTED|Booster Period (Month 49)||48
7850842|NCT00955682|19324207|P1|STARTED|Booster Period (Month 49)||245
7850843|NCT00955682|19324206|P2|NOT COMPLETED|Year 4 Period||0
7850844|NCT00955682|19324207|P1|NOT COMPLETED|Year 4 Period||0
7850845|NCT00955682|19324206|P2|COMPLETED|Year 4 Period||48
7850846|NCT00955682|19324207|P1|COMPLETED|Year 4 Period||246
7850847|NCT00955682|19324206|P2|STARTED|Year 4 Period||48
7850848|NCT00955682|19324207|P1|STARTED|Year 4 Period||246
7850849|NCT00955682|19324206|P2|NOT COMPLETED|Year 3 Period||0
7850850|NCT00955682|19324207|P1|NOT COMPLETED|Year 3 Period||0
7850851|NCT00955682|19324206|P2|COMPLETED|Year 3 Period||47
7850852|NCT00955682|19324207|P1|COMPLETED|Year 3 Period||273
7850853|NCT00955682|19324206|P2|STARTED|Year 3 Period||47
7850854|NCT00955682|19324207|P1|STARTED|Year 3 Period||273
7850855|NCT00955682|19324206|P2|NOT COMPLETED|Year 2 Period||0
7850856|NCT00955682|19324207|P1|NOT COMPLETED|Year 2 Period||0
7850857|NCT00955682|19324206|P2|COMPLETED|Year 2 Period||42
7850858|NCT00955682|19324207|P1|COMPLETED|Year 2 Period||253
7850859|NCT00955682|19324206|P2|STARTED|Year 2 Period||42
7850860|NCT00955682|19324207|P1|STARTED|Year 2 Period||253
7850861|NCT00955617|19324317|P2|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
7850862|NCT00955617|19324318|P1|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
7850863|NCT00955617|19324317|P2|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
7850864|NCT00955617|19324318|P1|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
7850865|NCT00955617|19324317|P2|STARTED|Second MRA (Between Day 1 and Day 51)||10
7850866|NCT00955617|19324318|P1|STARTED|Second MRA (Between Day 1 and Day 51)||10
7850867|NCT00955617|19324317|P2|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
7850868|NCT00955617|19324318|P1|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
7850869|NCT00955617|19324317|P2|COMPLETED|First MRA (Between Day0 and Day21)||10
7850870|NCT00955617|19324318|P1|COMPLETED|First MRA (Between Day0 and Day21)||10
7850871|NCT00955617|19324317|P2|STARTED|First MRA (Between Day0 and Day21)||10
7850872|NCT00955617|19324318|P1|STARTED|First MRA (Between Day0 and Day21)||10
7850873|NCT00955513|19324331|P3|NOT COMPLETED|Overall Study||3
7850874|NCT00955513|19324332|P2|NOT COMPLETED|Overall Study||2
7850875|NCT00955513|19324333|P1|NOT COMPLETED|Overall Study||1
7850876|NCT00955513|19324331|P3|COMPLETED|Overall Study||79
7850877|NCT00955513|19324332|P2|COMPLETED|Overall Study||78
7850878|NCT00955513|19324333|P1|COMPLETED|Overall Study||79
7850879|NCT00955513|19324331|P3|STARTED|Overall Study||82
7850880|NCT00955513|19324332|P2|STARTED|Overall Study||80
7850881|NCT00955513|19324333|P1|STARTED|Overall Study||80
7850882|NCT00955487|19324343|P6|NOT COMPLETED|Overall Study||0
7850883|NCT00955487|19324344|P5|NOT COMPLETED|Overall Study||0
7850884|NCT00955487|19324345|P4|NOT COMPLETED|Overall Study||0
7850885|NCT00955487|19324346|P3|NOT COMPLETED|Overall Study||0
7850886|NCT00955487|19324347|P2|NOT COMPLETED|Overall Study||0
7850887|NCT00955487|19324348|P1|NOT COMPLETED|Overall Study||0
7850888|NCT00955487|19324343|P6|COMPLETED|Overall Study||35
7850889|NCT00955487|19324344|P5|COMPLETED|Overall Study||32
7850890|NCT00955487|19324345|P4|COMPLETED|Overall Study||21
7850891|NCT00955487|19324346|P3|COMPLETED|Overall Study||17
7850892|NCT00955487|19324347|P2|COMPLETED|Overall Study||9
7850893|NCT00955487|19324348|P1|COMPLETED|Overall Study||10
7850894|NCT00955487|19324343|P6|STARTED|Overall Study||35
7850895|NCT00955487|19324344|P5|STARTED|Overall Study||32
7850896|NCT00955487|19324345|P4|STARTED|Overall Study||21
7850897|NCT00955487|19324346|P3|STARTED|Overall Study||17
7850898|NCT00955487|19324347|P2|STARTED|Overall Study||9
7850899|NCT00955487|19324348|P1|STARTED|Overall Study||10
7850900|NCT00955474|19324382|P2|NOT COMPLETED|Overall Study||5
7850901|NCT00955474|19324383|P1|NOT COMPLETED|Overall Study||7
7850902|NCT00955474|19324382|P2|COMPLETED|Overall Study||8
7850903|NCT00955474|19324383|P1|COMPLETED|Overall Study||5
7850904|NCT00955474|19324382|P2|STARTED|Overall Study||13
7850905|NCT00955474|19324383|P1|STARTED|Overall Study||12
7850906|NCT00955357|19324419|P2|NOT COMPLETED|Maintenance Phase||45
7850907|NCT00955357|19324420|P1|NOT COMPLETED|Maintenance Phase||12
7850908|NCT00955357|19324419|P2|COMPLETED|Maintenance Phase||249
7850909|NCT00955357|19324420|P1|COMPLETED|Maintenance Phase||68
7850910|NCT00955357|19324419|P2|STARTED|Maintenance Phase||294
7850911|NCT00955357|19324420|P1|STARTED|Maintenance Phase||80
7850912|NCT00955357|19324419|P2|NOT COMPLETED|Titration Phase||66
7850913|NCT00955357|19324420|P1|NOT COMPLETED|Titration Phase||16
7850914|NCT00955357|19324419|P2|COMPLETED|Titration Phase||294
7850915|NCT00955357|19324420|P1|COMPLETED|Titration Phase||80
7850916|NCT00955357|19324419|P2|STARTED|Titration Phase||360
7850917|NCT00955357|19324420|P1|STARTED|Titration Phase||96
7850918|NCT00955305|19324428|P2|NOT COMPLETED|Overall Study||87
7850919|NCT00955305|19324429|P1|NOT COMPLETED|Overall Study||88
7850920|NCT00955305|19324428|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
7850921|NCT00955305|19324429|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
7850922|NCT00955305|19324428|P2|Eligible and Treated|Overall Study||75
7850923|NCT00955305|19324429|P1|Eligible and Treated|Overall Study||78
7850924|NCT00955305|19324428|P2|Treated|Overall Study||82
7850925|NCT00955305|19324429|P1|Treated|Overall Study||83
7850926|NCT00955305|19324428|P2|STARTED|Overall Study||87
7850927|NCT00955305|19324429|P1|STARTED|Overall Study||88
7850928|NCT00955279|19324442|P3|NOT COMPLETED|Overall Study||8
7850929|NCT00955279|19324443|P2|NOT COMPLETED|Overall Study||4
7850930|NCT00955279|19324444|P1|NOT COMPLETED|Overall Study||3
7850931|NCT00955279|19324442|P3|COMPLETED|Overall Study||52
7850932|NCT00955279|19324443|P2|COMPLETED|Overall Study||51
7850933|NCT00955279|19324444|P1|COMPLETED|Overall Study||55
7850934|NCT00955279|19324442|P3|STARTED|Overall Study||60
7850935|NCT00955279|19324443|P2|STARTED|Overall Study||55
7850936|NCT00955279|19324444|P1|STARTED|Overall Study||58
7850937|NCT00955266|19324466|P2|NOT COMPLETED|Overall Study||0
7850938|NCT00955266|19324467|P1|NOT COMPLETED|Overall Study||0
7850939|NCT00955266|19324466|P2|COMPLETED|Overall Study||4
7850940|NCT00955266|19324467|P1|COMPLETED|Overall Study||4
7850941|NCT00955266|19324466|P2|STARTED|Overall Study||4
7850942|NCT00955266|19324467|P1|STARTED|Overall Study||4
7850943|NCT00955253|19324481|P2|NOT COMPLETED|Second Intervention (Day 4)||0
7850944|NCT00955253|19324482|P1|NOT COMPLETED|Second Intervention (Day 4)||0
7850945|NCT00955253|19324481|P2|COMPLETED|Second Intervention (Day 4)||6
7850946|NCT00955253|19324482|P1|COMPLETED|Second Intervention (Day 4)||7
7850947|NCT00955253|19324481|P2|STARTED|Second Intervention (Day 4)||6
7850948|NCT00955253|19324482|P1|STARTED|Second Intervention (Day 4)||7
7850949|NCT00955253|19324481|P2|NOT COMPLETED|First Intervention (Day 2)||0
7850950|NCT00955253|19324482|P1|NOT COMPLETED|First Intervention (Day 2)||0
7850951|NCT00955253|19324481|P2|COMPLETED|First Intervention (Day 2)||6
7850952|NCT00955253|19324482|P1|COMPLETED|First Intervention (Day 2)||7
7850953|NCT00955253|19324481|P2|STARTED|First Intervention (Day 2)||6
7850954|NCT00955253|19324482|P1|STARTED|First Intervention (Day 2)||7
7850955|NCT00955201|19324491|P4|NOT COMPLETED|Overall Study||4
7850956|NCT00955201|19324492|P3|NOT COMPLETED|Overall Study||1
7850957|NCT00955201|19324493|P2|NOT COMPLETED|Overall Study||0
7850958|NCT00955201|19324494|P1|NOT COMPLETED|Overall Study||4
7850959|NCT00955201|19324491|P4|COMPLETED|Overall Study||7
7850960|NCT00955201|19324492|P3|COMPLETED|Overall Study||10
7850961|NCT00955201|19324493|P2|COMPLETED|Overall Study||11
7850962|NCT00955201|19324494|P1|COMPLETED|Overall Study||8
7850963|NCT00955201|19324491|P4|STARTED|Overall Study||11
7850964|NCT00955201|19324492|P3|STARTED|Overall Study||11
7850965|NCT00955201|19324493|P2|STARTED|Overall Study||11
7850966|NCT00955201|19324494|P1|STARTED|Overall Study||12
7850967|NCT00955110|19324652|P1|NOT COMPLETED|Treatment Phase||6
7850968|NCT00955110|19324652|P1|COMPLETED|Treatment Phase||35
7850969|NCT00955110|19324652|P1|Oxycodone CR 60 mg|Treatment Phase||40
7850970|NCT00955110|19324652|P1|Oxycodone CR 30 mg|Treatment Phase||40
7850971|NCT00955110|19324652|P1|Oxymorphone ER 30 mg|Treatment Phase||38
7850972|NCT00955110|19324652|P1|Oxymorphone ER 15 mg|Treatment Phase||37
7850973|NCT00955110|19324652|P1|Placebo|Treatment Phase||38
7850974|NCT00955110|19324652|P1|STARTED|Treatment Phase||41
7850975|NCT00955110|19324652|P1|NOT COMPLETED|Qualification Phase||24
7850976|NCT00955110|19324652|P1|COMPLETED|Qualification Phase||54
7850977|NCT00955110|19324652|P1|STARTED|Qualification Phase||78
7850978|NCT00955032|19324666|P2|NOT COMPLETED|Overall Study||0
7850979|NCT00955032|19324667|P1|NOT COMPLETED|Overall Study||0
7850980|NCT00955032|19324666|P2|COMPLETED|Overall Study||8
7850981|NCT00955032|19324667|P1|COMPLETED|Overall Study||16
7850982|NCT00955032|19324666|P2|STARTED|Overall Study||8
7850983|NCT00955032|19324667|P1|STARTED|Overall Study||16
7850984|NCT00954993|19324687|P1|NOT COMPLETED|Period 2||0
7850985|NCT00954993|19324687|P1|COMPLETED|Period 2||3
7850986|NCT00954993|19324687|P1|STARTED|Period 2||3
7850987|NCT00954993|19324687|P1|NOT COMPLETED|Washout||0
7850988|NCT00954993|19324687|P1|COMPLETED|Washout||3
7850989|NCT00954993|19324687|P1|STARTED|Washout||3
7850990|NCT00954993|19324687|P1|NOT COMPLETED|Period 1||0
7850991|NCT00954993|19324687|P1|COMPLETED|Period 1||3
7850992|NCT00954993|19324687|P1|STARTED|Period 1||3
7850993|NCT00954941|19324699|P2|NOT COMPLETED|Overall Study||7
7850994|NCT00954941|19324700|P1|NOT COMPLETED|Overall Study||8
7850995|NCT00954941|19324699|P2|COMPLETED|Overall Study||41
7850996|NCT00954941|19324700|P1|COMPLETED|Overall Study||42
7850997|NCT00954941|19324699|P2|STARTED|Overall Study||48
7850998|NCT00954941|19324700|P1|STARTED|Overall Study||50
7850999|NCT00954915|19324708|P1|NOT COMPLETED|Overall Study||0
7851000|NCT00954915|19324708|P1|COMPLETED|Overall Study||1
7851001|NCT00954915|19324708|P1|STARTED|Overall Study||1
7851002|NCT00954824|19324712|P1|NOT COMPLETED|Overall Study||50
7851003|NCT00954824|19324712|P1|COMPLETED|Overall Study||50
7851004|NCT00954824|19324712|P1|STARTED|Overall Study||100
7851005|NCT00954733|19324716|P1|NOT COMPLETED|Overall Study||1
7851006|NCT00954733|19324716|P1|COMPLETED|Overall Study||39
7851007|NCT00954733|19324716|P1|STARTED|Overall Study||40
7851008|NCT00954707|19324720|P1|NOT COMPLETED|Overall Study||167
7851009|NCT00954707|19324720|P1|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342
7851010|NCT00954707|19324720|P1|STARTED|Overall Study||2509
7851011|NCT00954681|19324736|P1|NOT COMPLETED|Overall Study||5
7851012|NCT00954681|19324736|P1|COMPLETED|Overall Study||10
7851013|NCT00954681|19324736|P1|STARTED|Overall Study||15
7851014|NCT00954538|19324742|P6|NOT COMPLETED|Part III||0
7851015|NCT00954538|19324743|P5|NOT COMPLETED|Part III||1
7851016|NCT00954538|19324744|P4|NOT COMPLETED|Part III||0
7851017|NCT00954538|19324745|P3|NOT COMPLETED|Part III||0
7851018|NCT00954538|19324746|P2|NOT COMPLETED|Part III||0
7851019|NCT00954538|19324747|P1|NOT COMPLETED|Part III||0
7851020|NCT00954538|19324742|P6|COMPLETED|Part III||2
7851021|NCT00954538|19324743|P5|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5
7851022|NCT00954538|19324744|P4|COMPLETED|Part III||4
7851023|NCT00954538|19324745|P3|COMPLETED|Part III||0
7851024|NCT00954538|19324746|P2|COMPLETED|Part III||0
7851025|NCT00954538|19324747|P1|COMPLETED|Part III||0
7851026|NCT00954538|19324742|P6|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2
7851027|NCT00954538|19324743|P5|STARTED|Part III|These subjects did not participate in Part I or II|6
7851028|NCT00954538|19324744|P4|STARTED|Part III|These subjects did not participate in Part I or II|4
7851029|NCT00954538|19324745|P3|STARTED|Part III||0
7851030|NCT00954538|19324746|P2|STARTED|Part III||0
7851031|NCT00954538|19324747|P1|STARTED|Part III||0
7851032|NCT00954538|19324742|P6|NOT COMPLETED|Part II||0
7851033|NCT00954538|19324743|P5|NOT COMPLETED|Part II||0
7851034|NCT00954538|19324744|P4|NOT COMPLETED|Part II||0
7851035|NCT00954538|19324745|P3|NOT COMPLETED|Part II||0
7851036|NCT00954538|19324746|P2|NOT COMPLETED|Part II||0
7851037|NCT00954538|19324747|P1|NOT COMPLETED|Part II||0
7851038|NCT00954538|19324742|P6|COMPLETED|Part II||2
7851039|NCT00954538|19324743|P5|COMPLETED|Part II||0
7851040|NCT00954538|19324744|P4|COMPLETED|Part II||0
7851041|NCT00954538|19324745|P3|COMPLETED|Part II||3
7851042|NCT00954538|19324746|P2|COMPLETED|Part II||1
7851043|NCT00954538|19324747|P1|COMPLETED|Part II||0
7851044|NCT00954538|19324742|P6|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2
7851045|NCT00954538|19324743|P5|STARTED|Part II||0
7851046|NCT00954538|19324744|P4|STARTED|Part II||0
7851047|NCT00954538|19324745|P3|STARTED|Part II|These subjects did not participate in Part I or III|3
7851048|NCT00954538|19324746|P2|STARTED|Part II|This subject did not participate in Part I or III|1
7851049|NCT00954538|19324747|P1|STARTED|Part II||0
7851050|NCT00954538|19324742|P6|NOT COMPLETED|Part I||0
7851051|NCT00954538|19324743|P5|NOT COMPLETED|Part I||0
7851052|NCT00954538|19324744|P4|NOT COMPLETED|Part I||0
7851053|NCT00954538|19324745|P3|NOT COMPLETED|Part I||0
7851054|NCT00954538|19324746|P2|NOT COMPLETED|Part I||0
7851055|NCT00954538|19324747|P1|NOT COMPLETED|Part I||0
7851056|NCT00954538|19324742|P6|COMPLETED|Part I||0
7851057|NCT00954538|19324743|P5|COMPLETED|Part I||0
7851058|NCT00954538|19324744|P4|COMPLETED|Part I||0
7851059|NCT00954538|19324745|P3|COMPLETED|Part I||0
7851060|NCT00954538|19324746|P2|COMPLETED|Part I||0
7851061|NCT00954538|19324747|P1|COMPLETED|Part I||3
7851062|NCT00954538|19324742|P6|STARTED|Part I||0
7851063|NCT00954538|19324743|P5|STARTED|Part I||0
7851064|NCT00954538|19324744|P4|STARTED|Part I||0
7851065|NCT00954538|19324745|P3|STARTED|Part I||0
7851066|NCT00954538|19324746|P2|STARTED|Part I||0
7851067|NCT00954538|19324747|P1|STARTED|Part I|These subjects did not participate in Part II or III|3
7851068|NCT00954512|19324764|P6|NOT COMPLETED|Overall Study||4
7851069|NCT00954512|19324765|P5|NOT COMPLETED|Overall Study||4
7851070|NCT00954512|19324766|P4|NOT COMPLETED|Overall Study||2
7851071|NCT00954512|19324767|P3|NOT COMPLETED|Overall Study||0
7851072|NCT00954512|19324768|P2|NOT COMPLETED|Overall Study||3
7851073|NCT00954512|19324769|P1|NOT COMPLETED|Overall Study||2
7851074|NCT00954512|19324764|P6|COMPLETED|Overall Study||0
7851075|NCT00954512|19324765|P5|COMPLETED|Overall Study||0
7851076|NCT00954512|19324766|P4|COMPLETED|Overall Study||0
7851077|NCT00954512|19324767|P3|COMPLETED|Overall Study||0
7851078|NCT00954512|19324768|P2|COMPLETED|Overall Study||0
7851079|NCT00954512|19324769|P1|COMPLETED|Overall Study||0
7851080|NCT00954512|19324764|P6|STARTED|Overall Study||4
7851081|NCT00954512|19324765|P5|STARTED|Overall Study||4
7851082|NCT00954512|19324766|P4|STARTED|Overall Study||2
7851083|NCT00954512|19324767|P3|STARTED|Overall Study||0
7851084|NCT00954512|19324768|P2|STARTED|Overall Study||3
7851085|NCT00954512|19324769|P1|STARTED|Overall Study||2
7851086|NCT00954447|19324790|P2|NOT COMPLETED|Overall Study||88
7851087|NCT00954447|19324791|P1|NOT COMPLETED|Overall Study||110
7851088|NCT00954447|19324790|P2|COMPLETED|Overall Study||543
7851089|NCT00954447|19324791|P1|COMPLETED|Overall Study||520
7851090|NCT00954447|19324790|P2|STARTED|Overall Study||631
7851091|NCT00954447|19324791|P1|STARTED|Overall Study||630
7851092|NCT00954421|19324827|P1|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1
7851093|NCT00954421|19324827|P1|COMPLETED|VIM=ON VO=OFF at 6 Months||11
7851094|NCT00954421|19324827|P1|STARTED|VIM=ON VO=OFF at 6 Months||12
7851095|NCT00954421|19324827|P1|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0
7851096|NCT00954421|19324827|P1|COMPLETED|VIM=OFF VO=ON at 6 Months||12
7851097|NCT00954421|19324827|P1|STARTED|VIM=OFF VO=ON at 6 Months||12
7851098|NCT00954421|19324827|P1|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0
7851099|NCT00954421|19324827|P1|COMPLETED|VIM=OFF VO=OFF at 6 Months||12
7851100|NCT00954421|19324827|P1|STARTED|VIM=OFF VO=OFF at 6 Months||12
7851101|NCT00954421|19324827|P1|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0
7851102|NCT00954421|19324827|P1|COMPLETED|VIM=ON VO=ON at 6 Months||12
7851103|NCT00954421|19324827|P1|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12
7851104|NCT00954421|19324827|P1|NOT COMPLETED|6 Months of DBS||1
7851105|NCT00954421|19324827|P1|COMPLETED|6 Months of DBS||12
7851106|NCT00954421|19324827|P1|STARTED|6 Months of DBS||13
7851107|NCT00954421|19324827|P1|NOT COMPLETED|Baseline||0
7851108|NCT00954421|19324827|P1|COMPLETED|Baseline||13
7851109|NCT00954421|19324827|P1|STARTED|Baseline||13
7851110|NCT00954421|19324827|P1|NOT COMPLETED|Screening||3
7851111|NCT00954421|19324827|P1|COMPLETED|Screening||13
7851112|NCT00954421|19324827|P1|STARTED|Screening||16
7851113|NCT00954356|19324835|P2|NOT COMPLETED|Overall Study||0
7851114|NCT00954356|19324836|P1|NOT COMPLETED|Overall Study||0
7851115|NCT00954356|19324835|P2|COMPLETED|Overall Study||20
7851116|NCT00954356|19324836|P1|COMPLETED|Overall Study||41
7851117|NCT00954356|19324835|P2|STARTED|Overall Study||20
7851118|NCT00954356|19324836|P1|STARTED|Overall Study||41
7851119|NCT00954187|19324866|P2|NOT COMPLETED|Overall Study||0
7851120|NCT00954187|19324867|P1|NOT COMPLETED|Overall Study||0
7851121|NCT00954187|19324866|P2|COMPLETED|Overall Study||0
7851122|NCT00954187|19324867|P1|COMPLETED|Overall Study||0
7851123|NCT00954187|19324866|P2|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
7851124|NCT00954187|19324867|P1|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
7851125|NCT00954174|19324877|P4|NOT COMPLETED|Overall Study||25
7851126|NCT00954174|19324878|P3|NOT COMPLETED|Overall Study||24
7851127|NCT00954174|19324879|P2|NOT COMPLETED|Overall Study||123
7851128|NCT00954174|19324880|P1|NOT COMPLETED|Overall Study||126
7851129|NCT00954174|19324877|P4|COMPLETED|Overall Study||25
7851130|NCT00954174|19324878|P3|COMPLETED|Overall Study||27
7851131|NCT00954174|19324879|P2|COMPLETED|Overall Study||145
7851132|NCT00954174|19324880|P1|COMPLETED|Overall Study||142
7851133|NCT00954174|19324877|P4|STARTED|Overall Study||50
7851134|NCT00954174|19324878|P3|STARTED|Overall Study||51
7851135|NCT00954174|19324879|P2|STARTED|Overall Study||268
7851136|NCT00954174|19324880|P1|STARTED|Overall Study||268
7851137|NCT00954122|19324900|P1|NOT COMPLETED|Overall Study||7
7851138|NCT00954122|19324900|P1|COMPLETED|Overall Study||28
7851139|NCT00954122|19324900|P1|STARTED|Overall Study||35
7851140|NCT00954109|19324910|P1|NOT COMPLETED|Overall Study||0
7851141|NCT00954109|19324910|P1|COMPLETED|Overall Study||11
7851142|NCT00954109|19324910|P1|STARTED|Overall Study||11
7851143|NCT00953927|19324917|P2|NOT COMPLETED|Overall Study||95
7851144|NCT00953927|19324918|P1|NOT COMPLETED|Overall Study||105
7851145|NCT00953927|19324917|P2|COMPLETED|Overall Study||1303
7851146|NCT00953927|19324918|P1|COMPLETED|Overall Study||1294
7851147|NCT00953927|19324917|P2|STARTED|Overall Study||1398
7851148|NCT00953927|19324918|P1|STARTED|Overall Study||1399
7851149|NCT00953862|19324936|P1|NOT COMPLETED|Overall Study||6
7851150|NCT00953862|19324936|P1|COMPLETED|Overall Study||12
7851151|NCT00953862|19324936|P1|STARTED|Overall Study||18
7851152|NCT00953849|19324946|P4|NOT COMPLETED|Overall Study||0
7851153|NCT00953849|19324947|P3|NOT COMPLETED|Overall Study||0
7851154|NCT00953849|19324948|P2|NOT COMPLETED|Overall Study||0
7851155|NCT00953849|19324949|P1|NOT COMPLETED|Overall Study||0
7851156|NCT00953849|19324946|P4|COMPLETED|Overall Study||5
7851157|NCT00953849|19324947|P3|COMPLETED|Overall Study||4
7851158|NCT00953849|19324948|P2|COMPLETED|Overall Study||6
7851159|NCT00953849|19324949|P1|COMPLETED|Overall Study||6
7851160|NCT00953849|19324946|P4|STARTED|Overall Study||5
7851161|NCT00953849|19324947|P3|STARTED|Overall Study||4
7851162|NCT00953849|19324948|P2|STARTED|Overall Study||6
7851163|NCT00953849|19324949|P1|STARTED|Overall Study||6
7851164|NCT00953745|19324973|P2|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
7851165|NCT00953745|19324974|P1|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
7851166|NCT00953745|19324973|P2|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
7851167|NCT00953745|19324974|P1|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||17
7851168|NCT00953745|19324973|P2|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||0
7851169|NCT00953745|19324974|P1|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||17
7851170|NCT00953745|19324973|P2|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
7851171|NCT00953745|19324974|P1|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||1
7851172|NCT00953745|19324973|P2|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
7851173|NCT00953745|19324974|P1|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||17
7851174|NCT00953745|19324973|P2|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||0
7851175|NCT00953745|19324974|P1|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||18
7851176|NCT00953745|19324973|P2|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||0
7851177|NCT00953745|19324974|P1|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||13
7851178|NCT00953745|19324973|P2|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||6
7851179|NCT00953745|19324974|P1|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||24
7851180|NCT00953745|19324973|P2|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||6
7851181|NCT00953745|19324974|P1|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||37
7851182|NCT00953719|19324984|P2|NOT COMPLETED|Overall Study||5
7851183|NCT00953719|19324985|P1|NOT COMPLETED|Overall Study||19
7851184|NCT00953719|19324984|P2|COMPLETED|Overall Study||69
7851185|NCT00953719|19324985|P1|COMPLETED|Overall Study||150
7851186|NCT00953719|19324984|P2|STARTED|Overall Study||74
7851187|NCT00953719|19324985|P1|STARTED|Overall Study||169
7851188|NCT00953706|19325007|P4|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33
7851189|NCT00953706|19325008|P3|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5
7851190|NCT00953706|19325009|P2|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
7851191|NCT00953706|19325010|P1|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
7851192|NCT00953706|19325007|P4|COMPLETED|Part B (96-Week Open-Label Extension)||0
7851193|NCT00953706|19325008|P3|COMPLETED|Part B (96-Week Open-Label Extension)||0
7851194|NCT00953706|19325009|P2|COMPLETED|Part B (96-Week Open-Label Extension)||0
7851195|NCT00953706|19325010|P1|COMPLETED|Part B (96-Week Open-Label Extension)||0
7851196|NCT00953706|19325007|P4|STARTED|Part B (96-Week Open-Label Extension)||33
7851197|NCT00953706|19325008|P3|STARTED|Part B (96-Week Open-Label Extension)||5
7851198|NCT00953706|19325009|P2|STARTED|Part B (96-Week Open-Label Extension)||0
7851199|NCT00953706|19325010|P1|STARTED|Part B (96-Week Open-Label Extension)||0
7851200|NCT00953706|19325007|P4|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
7851201|NCT00953706|19325008|P3|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
7851202|NCT00953706|19325009|P2|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8
7851203|NCT00953706|19325010|P1|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2
7851204|NCT00953706|19325007|P4|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
7851205|NCT00953706|19325008|P3|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
7851206|NCT00953706|19325009|P2|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104
7851207|NCT00953706|19325010|P1|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26
7851208|NCT00953706|19325007|P4|STARTED|Part A (16-Week Double-Blind Treatment)||0
7851209|NCT00953706|19325008|P3|STARTED|Part A (16-Week Double-Blind Treatment)||0
7851210|NCT00953706|19325009|P2|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112
7851211|NCT00953706|19325010|P1|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28
7851212|NCT00953680|19325042|P2|NOT COMPLETED|Period 2||0
7851213|NCT00953680|19325043|P1|NOT COMPLETED|Period 2||0
7851214|NCT00953680|19325042|P2|COMPLETED|Period 2||38
7851215|NCT00953680|19325043|P1|COMPLETED|Period 2||38
7851216|NCT00953680|19325042|P2|STARTED|Period 2||38
7851217|NCT00953680|19325043|P1|STARTED|Period 2||38
7851218|NCT00953680|19325042|P2|NOT COMPLETED|Period 1||1
7851219|NCT00953680|19325043|P1|NOT COMPLETED|Period 1||0
7851220|NCT00953680|19325042|P2|COMPLETED|Period 1||38
7851221|NCT00953680|19325043|P1|COMPLETED|Period 1||38
7851222|NCT00953680|19325042|P2|STARTED|Period 1||39
7851223|NCT00953680|19325043|P1|STARTED|Period 1||38
7851224|NCT00953667|19325055|P1|NOT COMPLETED|Overall Study||123
7851225|NCT00953667|19325055|P1|COMPLETED|Overall Study||277
7851226|NCT00953667|19325055|P1|STARTED|Overall Study||400
7851227|NCT00953654|19325063|P3|NOT COMPLETED|Overall Study||0
7851228|NCT00953654|19325064|P2|NOT COMPLETED|Overall Study||0
7851229|NCT00953654|19325065|P1|NOT COMPLETED|Overall Study||0
7851230|NCT00953654|19325063|P3|COMPLETED|Overall Study||10
7851231|NCT00953654|19325064|P2|COMPLETED|Overall Study||10
7851232|NCT00953654|19325065|P1|COMPLETED|Overall Study||10
7851233|NCT00953654|19325063|P3|STARTED|Overall Study||10
7851234|NCT00953654|19325064|P2|STARTED|Overall Study||10
7851235|NCT00953654|19325065|P1|STARTED|Overall Study||10
7851236|NCT00953615|19325076|P1|NOT COMPLETED|Overall Study||1
7851237|NCT00953615|19325076|P1|COMPLETED|Overall Study||0
7851238|NCT00953615|19325076|P1|STARTED|Overall Study||1
7851239|NCT00953576|19325085|P2|NOT COMPLETED|Overall Study||1
7851240|NCT00953576|19325086|P1|NOT COMPLETED|Overall Study||2
7851241|NCT00953576|19325085|P2|COMPLETED|Overall Study||4
7851242|NCT00953576|19325086|P1|COMPLETED|Overall Study|One participant enrolled on dose level 1 did not receive full dose ketoconazole and was replaced.|4
7851243|NCT00953576|19325085|P2|Pharmacokinetic (PK) Evaluable|Overall Study||3
7851244|NCT00953576|19325086|P1|Pharmacokinetic (PK) Evaluable|Overall Study||4
7851245|NCT00953576|19325085|P2|Treated|Overall Study||5
7851246|NCT00953576|19325086|P1|Treated|Overall Study||4
7851247|NCT00953576|19325085|P2|DLT Evaluable|Overall Study||5
7851248|NCT00953576|19325086|P1|DLT Evaluable|Overall Study||3
7851249|NCT00953576|19325085|P2|STARTED|Overall Study||5
7851250|NCT00953576|19325086|P1|STARTED|Overall Study||6
7851251|NCT00953524|19325101|P4|NOT COMPLETED|Overall Study||8
7851252|NCT00953524|19325102|P3|NOT COMPLETED|Overall Study||14
7851253|NCT00953524|19325103|P2|NOT COMPLETED|Overall Study||15
7851254|NCT00953524|19325104|P1|NOT COMPLETED|Overall Study||22
7851255|NCT00953524|19325101|P4|COMPLETED|Overall Study||91
7851256|NCT00953524|19325102|P3|COMPLETED|Overall Study||233
7851257|NCT00953524|19325103|P2|COMPLETED|Overall Study||239
7851258|NCT00953524|19325104|P1|COMPLETED|Overall Study||227
7851259|NCT00953524|19325101|P4|STARTED|Overall Study||99
7851260|NCT00953524|19325102|P3|STARTED|Overall Study||247
7851261|NCT00953524|19325103|P2|STARTED|Overall Study||254
7851262|NCT00953524|19325104|P1|STARTED|Overall Study||249
7851263|NCT00953407|19325147|P5|NOT COMPLETED|Overall Study||1
7851264|NCT00953407|19325148|P4|NOT COMPLETED|Overall Study||2
7851265|NCT00953407|19325149|P3|NOT COMPLETED|Overall Study||1
7851266|NCT00953407|19325150|P2|NOT COMPLETED|Overall Study||1
7851267|NCT00953407|19325151|P1|NOT COMPLETED|Overall Study||1
7851268|NCT00953407|19325147|P5|COMPLETED|Overall Study||23
7851269|NCT00953407|19325148|P4|COMPLETED|Overall Study||23
7851270|NCT00953407|19325149|P3|COMPLETED|Overall Study||25
7851271|NCT00953407|19325150|P2|COMPLETED|Overall Study||24
7851272|NCT00953407|19325151|P1|COMPLETED|Overall Study||25
7851273|NCT00953407|19325147|P5|STARTED|Overall Study||24
7851274|NCT00953407|19325148|P4|STARTED|Overall Study||25
7851275|NCT00953407|19325149|P3|STARTED|Overall Study||26
7851276|NCT00953407|19325150|P2|STARTED|Overall Study||25
7851277|NCT00953407|19325151|P1|STARTED|Overall Study||26
7851278|NCT00953329|19325163|P1|NOT COMPLETED|Overall Study||1
7851279|NCT00953329|19325163|P1|COMPLETED|Overall Study||0
7851280|NCT00953329|19325163|P1|STARTED|Overall Study||1
7851281|NCT00953290|19325167|P1|NOT COMPLETED|Overall Study||0
7851282|NCT00953290|19325167|P1|COMPLETED|Overall Study||4
7851283|NCT00953290|19325167|P1|STARTED|Overall Study||4
7851284|NCT00953225|19325176|P2|NOT COMPLETED|Overall Study||0
7851285|NCT00953225|19325177|P1|NOT COMPLETED|Overall Study||2
7851286|NCT00953225|19325176|P2|COMPLETED|Overall Study||37
7851287|NCT00953225|19325177|P1|COMPLETED|Overall Study||44
7851288|NCT00953225|19325176|P2|STARTED|Overall Study||37
7851289|NCT00953225|19325177|P1|STARTED|Overall Study||46
7851290|NCT00953212|19325189|P4|NOT COMPLETED|Overall Study||0
7851291|NCT00953212|19325190|P3|NOT COMPLETED|Overall Study||0
7851292|NCT00953212|19325191|P2|NOT COMPLETED|Overall Study||0
7851293|NCT00953212|19325192|P1|NOT COMPLETED|Overall Study||0
7851294|NCT00953212|19325189|P4|COMPLETED|Overall Study||76
7851295|NCT00953212|19325190|P3|COMPLETED|Overall Study||78
7851296|NCT00953212|19325191|P2|COMPLETED|Overall Study||74
7851297|NCT00953212|19325192|P1|COMPLETED|Overall Study||76
7851298|NCT00953212|19325189|P4|STARTED|Overall Study||76
7851299|NCT00953212|19325190|P3|STARTED|Overall Study||78
7851300|NCT00953212|19325191|P2|STARTED|Overall Study||74
7851301|NCT00953212|19325192|P1|STARTED|Overall Study||76
7851302|NCT00953199|19325248|P2|NOT COMPLETED|Overall Study||0
7851303|NCT00953199|19325249|P1|NOT COMPLETED|Overall Study||0
7851304|NCT00953199|19325248|P2|COMPLETED|Overall Study||252
7851305|NCT00953199|19325249|P1|COMPLETED|Overall Study||254
7851306|NCT00953199|19325248|P2|STARTED|Overall Study||252
7851307|NCT00953199|19325249|P1|STARTED|Overall Study||254
7851308|NCT00953173|19325257|P1|NOT COMPLETED|Overall Study||282
7851309|NCT00953173|19325257|P1|COMPLETED|Overall Study||389
7851310|NCT00953173|19325257|P1|STARTED|Overall Study||671
7851311|NCT00953160|19325261|P1|NOT COMPLETED|Overall Study||27
7851312|NCT00953160|19325261|P1|COMPLETED|Overall Study||49
7851313|NCT00953160|19325261|P1|STARTED|Overall Study||76
7851314|NCT00953147|19325270|P3|NOT COMPLETED|Overall Study||42
7851315|NCT00953147|19325271|P2|NOT COMPLETED|Overall Study||66
7851316|NCT00953147|19325272|P1|NOT COMPLETED|Overall Study||37
7851317|NCT00953147|19325270|P3|COMPLETED|Overall Study||265
7851318|NCT00953147|19325271|P2|COMPLETED|Overall Study||439
7851319|NCT00953147|19325272|P1|COMPLETED|Overall Study||261
7851320|NCT00953147|19325270|P3|STARTED|Overall Study||307
7851321|NCT00953147|19325271|P2|STARTED|Overall Study||505
7851322|NCT00953147|19325272|P1|STARTED|Overall Study||298
7851323|NCT00953121|19325322|P3|NOT COMPLETED|Overall Study||0
7851324|NCT00953121|19325323|P2|NOT COMPLETED|Overall Study||0
7851325|NCT00953121|19325324|P1|NOT COMPLETED|Overall Study||0
7851326|NCT00953121|19325322|P3|COMPLETED|Overall Study||25
7851327|NCT00953121|19325323|P2|COMPLETED|Overall Study||39
7851328|NCT00953121|19325324|P1|COMPLETED|Overall Study||40
7851329|NCT00953121|19325322|P3|STARTED|Overall Study||25
7851330|NCT00953121|19325323|P2|STARTED|Overall Study||39
7851331|NCT00953121|19325324|P1|STARTED|Overall Study||40
7851332|NCT00953056|19325350|P6|NOT COMPLETED|Overall Study||4
7851333|NCT00953056|19325351|P5|NOT COMPLETED|Overall Study||2
7851334|NCT00953056|19325352|P4|NOT COMPLETED|Overall Study||0
7851335|NCT00953056|19325353|P3|NOT COMPLETED|Overall Study||0
7851336|NCT00953056|19325354|P2|NOT COMPLETED|Overall Study||0
7851337|NCT00953056|19325355|P1|NOT COMPLETED|Overall Study||0
7851338|NCT00953056|19325350|P6|COMPLETED|Overall Study||20
7851339|NCT00953056|19325351|P5|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22
7851340|NCT00953056|19325352|P4|COMPLETED|Overall Study||24
7851341|NCT00953056|19325353|P3|COMPLETED|Overall Study||24
7851342|NCT00953056|19325354|P2|COMPLETED|Overall Study||24
7851343|NCT00953056|19325355|P1|COMPLETED|Overall Study||24
7851344|NCT00953056|19325350|P6|STARTED|Overall Study||24
7851345|NCT00953056|19325351|P5|STARTED|Overall Study||24
7851346|NCT00953056|19325352|P4|STARTED|Overall Study||24
7851347|NCT00953056|19325353|P3|STARTED|Overall Study||24
7851348|NCT00953056|19325354|P2|STARTED|Overall Study||24
7851349|NCT00953056|19325355|P1|STARTED|Overall Study||24
7851350|NCT00953043|19325379|P2|NOT COMPLETED|Overall Study||2
7851351|NCT00953043|19325380|P1|NOT COMPLETED|Overall Study||4
7851352|NCT00953043|19325379|P2|COMPLETED|Overall Study||28
7851353|NCT00953043|19325380|P1|COMPLETED|Overall Study||26
7851354|NCT00953043|19325379|P2|STARTED|Overall Study||30
7851355|NCT00953043|19325380|P1|STARTED|Overall Study||30
7851356|NCT00953017|19325404|P4|NOT COMPLETED|Overall Study||5
7851357|NCT00953017|19325405|P3|NOT COMPLETED|Overall Study||6
7851358|NCT00953017|19325406|P2|NOT COMPLETED|Overall Study||6
7851359|NCT00953017|19325407|P1|NOT COMPLETED|Overall Study||5
7851360|NCT00953017|19325404|P4|COMPLETED|Overall Study||101
7851361|NCT00953017|19325405|P3|COMPLETED|Overall Study||100
7851362|NCT00953017|19325406|P2|COMPLETED|Overall Study||101
7851363|NCT00953017|19325407|P1|COMPLETED|Overall Study||101
7851364|NCT00953017|19325404|P4|STARTED|Overall Study||106
7851365|NCT00953017|19325405|P3|STARTED|Overall Study||106
7851366|NCT00953017|19325406|P2|STARTED|Overall Study||107
7851367|NCT00953017|19325407|P1|STARTED|Overall Study||106
7851368|NCT00952848|19325429|P1|NOT COMPLETED|Overall Study||4
7851369|NCT00952848|19325429|P1|COMPLETED|Overall Study||14
7851370|NCT00952848|19325429|P1|STARTED|Overall Study||18
7851371|NCT00952822|19325436|P4|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
7851372|NCT00952822|19325437|P3|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1
7851373|NCT00952822|19325438|P2|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
7851374|NCT00952822|19325439|P1|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
7851375|NCT00952822|19325436|P4|COMPLETED|2nd Pharmacokinetic Evaluation||4
7851376|NCT00952822|19325437|P3|COMPLETED|2nd Pharmacokinetic Evaluation||10
7851377|NCT00952822|19325438|P2|COMPLETED|2nd Pharmacokinetic Evaluation||17
7851378|NCT00952822|19325439|P1|COMPLETED|2nd Pharmacokinetic Evaluation||9
7851379|NCT00952822|19325436|P4|STARTED|2nd Pharmacokinetic Evaluation||4
7851380|NCT00952822|19325437|P3|STARTED|2nd Pharmacokinetic Evaluation||11
7851381|NCT00952822|19325438|P2|STARTED|2nd Pharmacokinetic Evaluation||17
7851382|NCT00952822|19325439|P1|STARTED|2nd Pharmacokinetic Evaluation||9
7851383|NCT00952822|19325436|P4|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
7851384|NCT00952822|19325437|P3|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
7851385|NCT00952822|19325438|P2|NOT COMPLETED|1st Pharmacokinetic Evaluation||1
7851386|NCT00952822|19325439|P1|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
7851387|NCT00952822|19325436|P4|COMPLETED|1st Pharmacokinetic Evaluation||4
7851388|NCT00952822|19325437|P3|COMPLETED|1st Pharmacokinetic Evaluation||11
7851389|NCT00952822|19325438|P2|COMPLETED|1st Pharmacokinetic Evaluation||17
7851390|NCT00952822|19325439|P1|COMPLETED|1st Pharmacokinetic Evaluation||9
7851391|NCT00952822|19325436|P4|STARTED|1st Pharmacokinetic Evaluation||4
7851392|NCT00952822|19325437|P3|STARTED|1st Pharmacokinetic Evaluation||11
7851393|NCT00952822|19325438|P2|STARTED|1st Pharmacokinetic Evaluation||18
7851394|NCT00952822|19325439|P1|STARTED|1st Pharmacokinetic Evaluation||9
7851395|NCT00952731|19325471|P2|NOT COMPLETED|Overall Study||0
7851396|NCT00952731|19325472|P1|NOT COMPLETED|Overall Study||1
7851397|NCT00952731|19325471|P2|COMPLETED|Overall Study||14
7851398|NCT00952731|19325472|P1|COMPLETED|Overall Study||12
7851399|NCT00952731|19325471|P2|Follow-up|Overall Study||14
7851400|NCT00952731|19325472|P1|Follow-up|Overall Study||12
7851401|NCT00952731|19325471|P2|Surgery|Overall Study||14
7851402|NCT00952731|19325472|P1|Surgery|Overall Study||12
7851403|NCT00952731|19325471|P2|Treatment & Pre-Surgery|Overall Study||14
7851404|NCT00952731|19325472|P1|Treatment & Pre-Surgery|Overall Study||12
7851405|NCT00952731|19325471|P2|Randomization|Overall Study||14
7851406|NCT00952731|19325472|P1|Randomization|Overall Study||13
7851407|NCT00952731|19325471|P2|STARTED|Overall Study||14
7851408|NCT00952731|19325472|P1|STARTED|Overall Study||13
7851409|NCT00952718|19325490|P2|NOT COMPLETED|Overall Study||6
7851410|NCT00952718|19325491|P1|NOT COMPLETED|Overall Study||6
7851411|NCT00952718|19325490|P2|COMPLETED|Overall Study||13
7851412|NCT00952718|19325491|P1|COMPLETED|Overall Study||13
7851413|NCT00952718|19325490|P2|STARTED|Overall Study||19
7851414|NCT00952718|19325491|P1|STARTED|Overall Study||19
7851415|NCT00952705|19325504|P3|NOT COMPLETED|Overall Study||10
7851416|NCT00952705|19325505|P2|NOT COMPLETED|Overall Study||10
7851417|NCT00952705|19325506|P1|NOT COMPLETED|Overall Study||33
7851418|NCT00952705|19325504|P3|COMPLETED|Overall Study||288
7851419|NCT00952705|19325505|P2|COMPLETED|Overall Study||290
7851420|NCT00952705|19325506|P1|COMPLETED|Overall Study||1169
7851421|NCT00952705|19325504|P3|STARTED|Overall Study||298
7851422|NCT00952705|19325505|P2|STARTED|Overall Study||300
7851423|NCT00952705|19325506|P1|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202
7851424|NCT00952653|19325568|P1|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0
7851425|NCT00952653|19325568|P1|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28
7851426|NCT00952653|19325568|P1|STARTED|Period 2: Coadministration DVS SR, MDZ||28
7851427|NCT00952653|19325568|P1|NOT COMPLETED|Period 1: MDZ Alone||0
7851428|NCT00952653|19325568|P1|COMPLETED|Period 1: MDZ Alone||28
7851429|NCT00952653|19325568|P1|STARTED|Period 1: MDZ Alone||28
7851430|NCT00952614|19325593|P1|NOT COMPLETED|Overall Study||7
7851431|NCT00952614|19325593|P1|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23
7851432|NCT00952614|19325593|P1|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30
7851433|NCT00952614|19325593|P1|STARTED|Overall Study||30
7851434|NCT00952588|19325600|P2|NOT COMPLETED|Overall Study||24
7851435|NCT00952588|19325601|P1|NOT COMPLETED|Overall Study||36
7851436|NCT00952588|19325600|P2|COMPLETED|Overall Study||2
7851437|NCT00952588|19325601|P1|COMPLETED|Overall Study||12
7851438|NCT00952588|19325600|P2|STARTED|Overall Study||26
7851439|NCT00952588|19325601|P1|STARTED|Overall Study||48
7851440|NCT00952523|19325619|P1|NOT COMPLETED|Overall Study||7
7851441|NCT00952523|19325619|P1|COMPLETED|Overall Study||155
7851442|NCT00952523|19325619|P1|STARTED|Overall Study||162
7851443|NCT00952484|19325628|P3|NOT COMPLETED|Overall Study||0
7851444|NCT00952484|19325629|P2|NOT COMPLETED|Overall Study||1
7851445|NCT00952484|19325630|P1|NOT COMPLETED|Overall Study||0
7851446|NCT00952484|19325628|P3|COMPLETED|Overall Study||16
7851447|NCT00952484|19325629|P2|COMPLETED|Overall Study||6
7851448|NCT00952484|19325630|P1|COMPLETED|Overall Study||6
7851449|NCT00952484|19325628|P3|STARTED|Overall Study||16
7851450|NCT00952484|19325629|P2|STARTED|Overall Study||7
7851451|NCT00952484|19325630|P1|STARTED|Overall Study||6
7851452|NCT00952419|19325657|P3|NOT COMPLETED|Overall Study||0
7851453|NCT00952419|19325658|P2|NOT COMPLETED|Overall Study||10
7851454|NCT00952419|19325659|P1|NOT COMPLETED|Overall Study||6
7851455|NCT00952419|19325657|P3|COMPLETED|Overall Study||51
7851456|NCT00952419|19325658|P2|COMPLETED|Overall Study||198
7851457|NCT00952419|19325659|P1|COMPLETED|Overall Study||209
7851458|NCT00952419|19325657|P3|STARTED|Overall Study||51
7851459|NCT00952419|19325658|P2|STARTED|Overall Study||208
7851460|NCT00952419|19325659|P1|STARTED|Overall Study||215
7851461|NCT00952393|19325691|P1|NOT COMPLETED|Overall Study||0
7851462|NCT00952393|19325691|P1|COMPLETED|Overall Study||10
7851463|NCT00952393|19325691|P1|STARTED|Overall Study|10|10
7851464|NCT00952380|19325700|P5|NOT COMPLETED|Overall Study||6
7851465|NCT00952380|19325701|P4|NOT COMPLETED|Overall Study||3
7851466|NCT00952380|19325702|P3|NOT COMPLETED|Overall Study||2
7851467|NCT00952380|19325703|P2|NOT COMPLETED|Overall Study||1
7851468|NCT00952380|19325704|P1|NOT COMPLETED|Overall Study||0
7851469|NCT00952380|19325700|P5|COMPLETED|Overall Study||14
7851470|NCT00952380|19325701|P4|COMPLETED|Overall Study||4
7851471|NCT00952380|19325702|P3|COMPLETED|Overall Study||6
7851472|NCT00952380|19325703|P2|COMPLETED|Overall Study||1
7851473|NCT00952380|19325704|P1|COMPLETED|Overall Study||1
7851474|NCT00952380|19325700|P5|STARTED|Overall Study||20
7851475|NCT00952380|19325701|P4|STARTED|Overall Study||7
7851476|NCT00952380|19325702|P3|STARTED|Overall Study||8
7851477|NCT00952380|19325703|P2|STARTED|Overall Study||2
7851478|NCT00952380|19325704|P1|STARTED|Overall Study||1
7851479|NCT00952367|19325805|P1|NOT COMPLETED|Overall Study||6
7851480|NCT00952367|19325805|P1|COMPLETED|Overall Study||3635
7851481|NCT00952367|19325805|P1|STARTED|Overall Study||3641
7851482|NCT00952341|19325820|P2|NOT COMPLETED|Cycle 2||12
7851483|NCT00952341|19325821|P1|NOT COMPLETED|Cycle 2||9
7851484|NCT00952341|19325820|P2|COMPLETED|Cycle 2||118
7851485|NCT00952341|19325821|P1|COMPLETED|Cycle 2||101
7851486|NCT00952341|19325820|P2|STARTED|Cycle 2||130
7851487|NCT00952341|19325821|P1|STARTED|Cycle 2||110
7851488|NCT00952341|19325820|P2|NOT COMPLETED|Cycle 1||13
7851489|NCT00952341|19325821|P1|NOT COMPLETED|Cycle 1||20
7851490|NCT00952341|19325820|P2|COMPLETED|Cycle 1||199
7851491|NCT00952341|19325821|P1|COMPLETED|Cycle 1||189
7851492|NCT00952341|19325820|P2|STARTED|Cycle 1||212
7851493|NCT00952341|19325821|P1|STARTED|Cycle 1||209
7851494|NCT00952315|19325844|P3|NOT COMPLETED|Overall Study||19
7851495|NCT00952315|19325845|P2|NOT COMPLETED|Overall Study||24
7851496|NCT00952315|19325846|P1|NOT COMPLETED|Overall Study||26
7851497|NCT00952315|19325844|P3|COMPLETED|Overall Study||71
7851498|NCT00952315|19325845|P2|COMPLETED|Overall Study||66
7851499|NCT00952315|19325846|P1|COMPLETED|Overall Study||64
7851500|NCT00952315|19325844|P3|STARTED|Overall Study||90
7851501|NCT00952315|19325845|P2|STARTED|Overall Study||90
7851502|NCT00952315|19325846|P1|STARTED|Overall Study||90
7851503|NCT00952289|19325883|P2|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54
7851504|NCT00952289|19325884|P1|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
7851505|NCT00952289|19325883|P2|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57
7851506|NCT00952289|19325884|P1|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
7851507|NCT00952289|19325883|P2|STARTED|Patients Who Crossed Over to Ruxolitinib||111
7851508|NCT00952289|19325884|P1|STARTED|Patients Who Crossed Over to Ruxolitinib||0
7851509|NCT00952289|19325883|P2|NOT COMPLETED|All Participants||40
7851510|NCT00952289|19325884|P1|NOT COMPLETED|All Participants||21
7851511|NCT00952289|19325883|P2|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114
7851512|NCT00952289|19325884|P1|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134
7851513|NCT00952289|19325883|P2|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151
7851514|NCT00952289|19325884|P1|Safety Population|All Participants||155
7851515|NCT00952289|19325883|P2|STARTED|All Participants||154
7851516|NCT00952289|19325884|P1|STARTED|All Participants||155
7851517|NCT00952276|19325913|P5|NOT COMPLETED|Overall Study||0
7851518|NCT00952276|19325914|P4|NOT COMPLETED|Overall Study||1
7851519|NCT00952276|19325915|P3|NOT COMPLETED|Overall Study||0
7851520|NCT00952276|19325916|P2|NOT COMPLETED|Overall Study||0
7851521|NCT00952276|19325917|P1|NOT COMPLETED|Overall Study||1
7851522|NCT00952276|19325913|P5|COMPLETED|Overall Study||63
7851523|NCT00952276|19325914|P4|COMPLETED|Overall Study||120
7851524|NCT00952276|19325915|P3|COMPLETED|Overall Study||122
7851525|NCT00952276|19325916|P2|COMPLETED|Overall Study||115
7851526|NCT00952276|19325917|P1|COMPLETED|Overall Study||126
7851527|NCT00952276|19325913|P5|STARTED|Overall Study||63
7851528|NCT00952276|19325914|P4|STARTED|Overall Study||121
7851529|NCT00952276|19325915|P3|STARTED|Overall Study||122
7851530|NCT00952276|19325916|P2|STARTED|Overall Study||115
7851531|NCT00952276|19325917|P1|STARTED|Overall Study||127
7851532|NCT00952211|19325966|P2|NOT COMPLETED|Overall Study||0
7851533|NCT00952211|19325967|P1|NOT COMPLETED|Overall Study||0
7851534|NCT00952211|19325966|P2|COMPLETED|Overall Study||0
7851535|NCT00952211|19325967|P1|COMPLETED|Overall Study||3
7851536|NCT00952211|19325966|P2|STARTED|Overall Study||0
7851537|NCT00952211|19325967|P1|STARTED|Overall Study||3
7851538|NCT00952133|19325977|P2|NOT COMPLETED|Overall Study||0
7851539|NCT00952133|19325978|P1|NOT COMPLETED|Overall Study||0
7851540|NCT00952133|19325977|P2|COMPLETED|Overall Study||59
7851541|NCT00952133|19325978|P1|COMPLETED|Overall Study||59
7851542|NCT00952133|19325977|P2|STARTED|Overall Study||59
7851543|NCT00952133|19325978|P1|STARTED|Overall Study||59
7851544|NCT00952120|19325989|P3|NOT COMPLETED|Overall Study||0
7851545|NCT00952120|19325990|P2|NOT COMPLETED|Overall Study||0
7851546|NCT00952120|19325991|P1|NOT COMPLETED|Overall Study||0
7851547|NCT00952120|19325989|P3|COMPLETED|Overall Study||5
7851548|NCT00952120|19325990|P2|COMPLETED|Overall Study||47
7851549|NCT00952120|19325991|P1|COMPLETED|Overall Study||52
7851550|NCT00952120|19325989|P3|STARTED|Overall Study||5
7851551|NCT00952120|19325990|P2|STARTED|Overall Study||47
7851552|NCT00952120|19325991|P1|STARTED|Overall Study||52
7851553|NCT00952081|19325999|P1|NOT COMPLETED|Overall Study||0
7851554|NCT00952081|19325999|P1|COMPLETED|Overall Study||22
7851555|NCT00952081|19325999|P1|STARTED|Overall Study||22
7851556|NCT00952068|19326003|P1|NOT COMPLETED|Overall Study||7
7851557|NCT00952068|19326003|P1|COMPLETED|Overall Study||40
7851558|NCT00952068|19326003|P1|STARTED|Overall Study||47
7851559|NCT00951912|19326014|P3|NOT COMPLETED|Overall Study||2
7851560|NCT00951912|19326015|P2|NOT COMPLETED|Overall Study||5
7851561|NCT00951912|19326016|P1|NOT COMPLETED|Overall Study||7
7851562|NCT00951912|19326014|P3|COMPLETED|Overall Study||54
7851563|NCT00951912|19326015|P2|COMPLETED|Overall Study||50
7851564|NCT00951912|19326016|P1|COMPLETED|Overall Study||47
7851565|NCT00951912|19326014|P3|STARTED|Overall Study||56
7851566|NCT00951912|19326015|P2|STARTED|Overall Study||55
7851567|NCT00951912|19326016|P1|STARTED|Overall Study||54
7851568|NCT00951899|19326068|P2|NOT COMPLETED|Overall Study||0
7851569|NCT00951899|19326069|P1|NOT COMPLETED|Overall Study||0
7851570|NCT00951899|19326068|P2|COMPLETED|Overall Study||19
7851571|NCT00951899|19326069|P1|COMPLETED|Overall Study||19
7851572|NCT00951899|19326068|P2|STARTED|Overall Study||19
7851573|NCT00951899|19326069|P1|STARTED|Overall Study||19
7851574|NCT00951821|19326093|P2|NOT COMPLETED|Overall Study||0
7851575|NCT00951821|19326094|P1|NOT COMPLETED|Overall Study||0
7851576|NCT00951821|19326093|P2|COMPLETED|Overall Study||8
7851577|NCT00951821|19326094|P1|COMPLETED|Overall Study||16
7851578|NCT00951821|19326093|P2|STARTED|Overall Study||8
7851579|NCT00951821|19326094|P1|STARTED|Overall Study||16
7851580|NCT00951808|19326102|P3|NOT COMPLETED|Overall Study||4
7851581|NCT00951808|19326103|P2|NOT COMPLETED|Overall Study||0
7851582|NCT00951808|19326104|P1|NOT COMPLETED|Overall Study||0
7851583|NCT00951808|19326102|P3|COMPLETED|Overall Study|Four subjects withdrew from the study.|223
7851584|NCT00951808|19326103|P2|COMPLETED|Overall Study||6
7851585|NCT00951808|19326104|P1|COMPLETED|Overall Study||4
7851586|NCT00951808|19326102|P3|STARTED|Overall Study||227
7851587|NCT00951808|19326103|P2|STARTED|Overall Study||6
7851588|NCT00951808|19326104|P1|STARTED|Overall Study||4
7851589|NCT00951665|19326116|P6|NOT COMPLETED|Phase 2a||7
7851590|NCT00951665|19326117|P5|NOT COMPLETED|Phase 2a||12
7851591|NCT00951665|19326118|P4|NOT COMPLETED|Phase 2a||0
7851592|NCT00951665|19326119|P3|NOT COMPLETED|Phase 2a||0
7851593|NCT00951665|19326120|P2|NOT COMPLETED|Phase 2a||0
7851594|NCT00951665|19326121|P1|NOT COMPLETED|Phase 2a||0
7851595|NCT00951665|19326116|P6|COMPLETED|Phase 2a||15
7851596|NCT00951665|19326117|P5|COMPLETED|Phase 2a||10
7851597|NCT00951665|19326118|P4|COMPLETED|Phase 2a||0
7851598|NCT00951665|19326119|P3|COMPLETED|Phase 2a||0
7851599|NCT00951665|19326120|P2|COMPLETED|Phase 2a||0
7851600|NCT00951665|19326121|P1|COMPLETED|Phase 2a||0
7851601|NCT00951665|19326116|P6|STARTED|Phase 2a||22
7851602|NCT00951665|19326117|P5|STARTED|Phase 2a||22
7851603|NCT00951665|19326118|P4|STARTED|Phase 2a||0
7851604|NCT00951665|19326119|P3|STARTED|Phase 2a||0
7851605|NCT00951665|19326120|P2|STARTED|Phase 2a||0
7851606|NCT00951665|19326121|P1|STARTED|Phase 2a||0
7851607|NCT00951665|19326116|P6|NOT COMPLETED|Phase 1b||0
7851608|NCT00951665|19326117|P5|NOT COMPLETED|Phase 1b||0
7851609|NCT00951665|19326118|P4|NOT COMPLETED|Phase 1b||1
7851610|NCT00951665|19326119|P3|NOT COMPLETED|Phase 1b||17
7851611|NCT00951665|19326120|P2|NOT COMPLETED|Phase 1b||4
7851612|NCT00951665|19326121|P1|NOT COMPLETED|Phase 1b||22
7851613|NCT00951665|19326116|P6|COMPLETED|Phase 1b||0
7851614|NCT00951665|19326117|P5|COMPLETED|Phase 1b||0
7851615|NCT00951665|19326118|P4|COMPLETED|Phase 1b||2
7851616|NCT00951665|19326119|P3|COMPLETED|Phase 1b||4
7851617|NCT00951665|19326120|P2|COMPLETED|Phase 1b||6
7851618|NCT00951665|19326121|P1|COMPLETED|Phase 1b||7
7851619|NCT00951665|19326116|P6|Started Treatment|Phase 1b||0
7851620|NCT00951665|19326117|P5|Started Treatment|Phase 1b||0
7851621|NCT00951665|19326118|P4|Started Treatment|Phase 1b||3
7851622|NCT00951665|19326119|P3|Started Treatment|Phase 1b||21
7851623|NCT00951665|19326120|P2|Started Treatment|Phase 1b||10
7851624|NCT00951665|19326121|P1|Started Treatment|Phase 1b||26
7851625|NCT00951665|19326116|P6|STARTED|Phase 1b||0
7851626|NCT00951665|19326117|P5|STARTED|Phase 1b||0
7851627|NCT00951665|19326118|P4|STARTED|Phase 1b||3
7851628|NCT00951665|19326119|P3|STARTED|Phase 1b||21
7851629|NCT00951665|19326120|P2|STARTED|Phase 1b||10
7851630|NCT00951665|19326121|P1|STARTED|Phase 1b||29
7851631|NCT00951561|19326222|P4|NOT COMPLETED|Overall Study||1
7851632|NCT00951561|19326223|P3|NOT COMPLETED|Overall Study||3
7851633|NCT00951561|19326224|P2|NOT COMPLETED|Overall Study||0
7851634|NCT00951561|19326225|P1|NOT COMPLETED|Overall Study||0
7851635|NCT00951561|19326222|P4|COMPLETED|Overall Study|1 subject dropped after period 2|26
7851636|NCT00951561|19326223|P3|COMPLETED|Overall Study|3 subjects dropped after period 2|18
7851637|NCT00951561|19326224|P2|COMPLETED|Overall Study||29
7851638|NCT00951561|19326225|P1|COMPLETED|Overall Study||25
7851639|NCT00951561|19326222|P4|STARTED|Overall Study||27
7851640|NCT00951561|19326223|P3|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21
7851641|NCT00951561|19326224|P2|STARTED|Overall Study||29
7851642|NCT00951561|19326225|P1|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25
7851643|NCT00951509|19326230|P1|NOT COMPLETED|Overall Study||2
7851644|NCT00951509|19326230|P1|COMPLETED|Overall Study||29
7851645|NCT00951509|19326230|P1|Driving Condition 5|Overall Study||30
7851646|NCT00951509|19326230|P1|Driving Condition 4|Overall Study||28
7851647|NCT00951509|19326230|P1|Driving Condition 3|Overall Study||25
7851648|NCT00951509|19326230|P1|Driving Condition 2|Overall Study||29
7851649|NCT00951509|19326230|P1|Driving Condition 1|Overall Study||29
7851650|NCT00951509|19326230|P1|STARTED|Overall Study||31
7851651|NCT00951496|19326241|P3|NOT COMPLETED|Overall Study||13
7851652|NCT00951496|19326242|P2|NOT COMPLETED|Overall Study||8
7851653|NCT00951496|19326243|P1|NOT COMPLETED|Overall Study||10
7851654|NCT00951496|19326241|P3|COMPLETED|Overall Study||508
7851655|NCT00951496|19326242|P2|COMPLETED|Overall Study||510
7851656|NCT00951496|19326243|P1|COMPLETED|Overall Study||511
7851657|NCT00951496|19326241|P3|STARTED|Overall Study||521
7851658|NCT00951496|19326242|P2|STARTED|Overall Study||518
7851659|NCT00951496|19326243|P1|STARTED|Overall Study||521
7851660|NCT00951483|19326271|P2|NOT COMPLETED|Overall Study||0
7851661|NCT00951483|19326272|P1|NOT COMPLETED|Overall Study||19
7851662|NCT00951483|19326271|P2|COMPLETED|Overall Study||44
7851663|NCT00951483|19326272|P1|COMPLETED|Overall Study||28
7851664|NCT00951483|19326271|P2|STARTED|Overall Study||44
7851665|NCT00951483|19326272|P1|STARTED|Overall Study||47
7851666|NCT00951379|19326292|P2|NOT COMPLETED|Overall Study||2
7851667|NCT00951379|19326293|P1|NOT COMPLETED|Overall Study||6
7851668|NCT00951379|19326292|P2|COMPLETED|Overall Study||23
7851669|NCT00951379|19326293|P1|COMPLETED|Overall Study||21
7851670|NCT00951379|19326292|P2|STARTED|Overall Study||25
7851671|NCT00951379|19326293|P1|STARTED|Overall Study||27
7851672|NCT00951275|19326335|P1|NOT COMPLETED|Overall Study||13
7851673|NCT00951275|19326335|P1|COMPLETED|Overall Study||92
7851674|NCT00951275|19326335|P1|STARTED|Overall Study||105
7851675|NCT00951171|19326367|P2|NOT COMPLETED|Overall Study||0
7851676|NCT00951171|19326368|P1|NOT COMPLETED|Overall Study||2
7851677|NCT00951171|19326367|P2|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55
7851678|NCT00951171|19326368|P1|COMPLETED|Overall Study||38
7851679|NCT00951171|19326367|P2|Pregnancy|Overall Study||7
7851680|NCT00951171|19326368|P1|Pregnancy|Overall Study||1
7851681|NCT00951171|19326367|P2|STARTED|Overall Study||55
7851682|NCT00951171|19326368|P1|STARTED|Overall Study||40
7851683|NCT00951093|19326374|P1|NOT COMPLETED|6 Months After GBP||0
7851684|NCT00951093|19326374|P1|COMPLETED|6 Months After GBP||53
7851685|NCT00951093|19326374|P1|STARTED|6 Months After GBP||53
7851686|NCT00951093|19326374|P1|NOT COMPLETED|Before GBP||0
7851687|NCT00951093|19326374|P1|COMPLETED|Before GBP||53
7851688|NCT00951093|19326374|P1|STARTED|Before GBP||53
7851689|NCT00951080|19326400|P2|NOT COMPLETED|Overall Study||27
7851690|NCT00951080|19326401|P1|NOT COMPLETED|Overall Study||26
7851691|NCT00951080|19326400|P2|COMPLETED|Overall Study||41
7851692|NCT00951080|19326401|P1|COMPLETED|Overall Study||38
7851693|NCT00951080|19326400|P2|STARTED|Overall Study||68
7851694|NCT00951080|19326401|P1|STARTED|Overall Study||64
7851695|NCT00951041|19326409|P2|NOT COMPLETED|Overall Study||1
7851696|NCT00951041|19326410|P1|NOT COMPLETED|Overall Study||5
7851697|NCT00951041|19326409|P2|COMPLETED|Overall Study||65
7851698|NCT00951041|19326410|P1|COMPLETED|Overall Study||59
7851699|NCT00951041|19326409|P2|STARTED|Overall Study||66
7851700|NCT00951041|19326410|P1|STARTED|Overall Study||64
7851701|NCT00951015|19326465|P5|NOT COMPLETED|Open-label Phase||50
7851702|NCT00951015|19326466|P4|NOT COMPLETED|Open-label Phase||0
7851703|NCT00951015|19326467|P3|NOT COMPLETED|Open-label Phase||0
7851704|NCT00951015|19326468|P2|NOT COMPLETED|Open-label Phase||0
7851705|NCT00951015|19326469|P1|NOT COMPLETED|Open-label Phase||0
7851706|NCT00951015|19326465|P5|COMPLETED|Open-label Phase||88
7851707|NCT00951015|19326466|P4|COMPLETED|Open-label Phase||0
7851708|NCT00951015|19326467|P3|COMPLETED|Open-label Phase||0
7851709|NCT00951015|19326468|P2|COMPLETED|Open-label Phase||0
7851710|NCT00951015|19326469|P1|COMPLETED|Open-label Phase||0
7851711|NCT00951015|19326465|P5|STARTED|Open-label Phase||138
7851712|NCT00951015|19326466|P4|STARTED|Open-label Phase||0
7851713|NCT00951015|19326467|P3|STARTED|Open-label Phase||0
7851714|NCT00951015|19326468|P2|STARTED|Open-label Phase||0
7851715|NCT00951015|19326469|P1|STARTED|Open-label Phase||0
7851716|NCT00951015|19326465|P5|NOT COMPLETED|Randomization Phase 96 Week||0
7851717|NCT00951015|19326466|P4|NOT COMPLETED|Randomization Phase 96 Week||10
7851718|NCT00951015|19326467|P3|NOT COMPLETED|Randomization Phase 96 Week||5
7851719|NCT00951015|19326468|P2|NOT COMPLETED|Randomization Phase 96 Week||7
7851720|NCT00951015|19326469|P1|NOT COMPLETED|Randomization Phase 96 Week||5
7851721|NCT00951015|19326465|P5|COMPLETED|Randomization Phase 96 Week||0
7851722|NCT00951015|19326466|P4|COMPLETED|Randomization Phase 96 Week||40
7851723|NCT00951015|19326467|P3|COMPLETED|Randomization Phase 96 Week||46
7851724|NCT00951015|19326468|P2|COMPLETED|Randomization Phase 96 Week||44
7851725|NCT00951015|19326469|P1|COMPLETED|Randomization Phase 96 Week||48
7851726|NCT00951015|19326465|P5|STARTED|Randomization Phase 96 Week||0
7851727|NCT00951015|19326466|P4|STARTED|Randomization Phase 96 Week||50
7851728|NCT00951015|19326467|P3|STARTED|Randomization Phase 96 Week||51
7851729|NCT00951015|19326468|P2|STARTED|Randomization Phase 96 Week||51
7851730|NCT00951015|19326469|P1|STARTED|Randomization Phase 96 Week||53
7851731|NCT00950963|19326566|P2|NOT COMPLETED|Overall Study||24
7851732|NCT00950963|19326567|P1|NOT COMPLETED|Overall Study||29
7851733|NCT00950963|19326566|P2|COMPLETED|Overall Study||357
7851734|NCT00950963|19326567|P1|COMPLETED|Overall Study||352
7851735|NCT00950963|19326566|P2|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
7851736|NCT00950963|19326567|P1|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
7851737|NCT00950950|19326583|P2|NOT COMPLETED|Overall Study||1
7851738|NCT00950950|19326584|P1|NOT COMPLETED|Overall Study||1
7851739|NCT00950950|19326583|P2|COMPLETED|Overall Study||11
7851740|NCT00950950|19326584|P1|COMPLETED|Overall Study||11
7851741|NCT00950950|19326583|P2|STARTED|Overall Study||12
7851742|NCT00950950|19326584|P1|STARTED|Overall Study||12
7851743|NCT00950937|19326647|P2|NOT COMPLETED|Overall Study||0
7851744|NCT00950937|19326648|P1|NOT COMPLETED|Overall Study||0
7851745|NCT00950937|19326647|P2|COMPLETED|Overall Study||14
7851746|NCT00950937|19326648|P1|COMPLETED|Overall Study||14
7851747|NCT00950937|19326647|P2|STARTED|Overall Study||14
7851748|NCT00950937|19326648|P1|STARTED|Overall Study||14
7851749|NCT00950911|19326666|P2|NOT COMPLETED|Overall Study||15
7851750|NCT00950911|19326667|P1|NOT COMPLETED|Overall Study||12
7851751|NCT00950911|19326666|P2|COMPLETED|Overall Study||3
7851752|NCT00950911|19326667|P1|COMPLETED|Overall Study||5
7851753|NCT00950911|19326666|P2|STARTED|Overall Study||18
7851754|NCT00950911|19326667|P1|STARTED|Overall Study||17
7851755|NCT00950872|19326673|P1|NOT COMPLETED|Overall Study||3
7851756|NCT00950872|19326673|P1|COMPLETED|Overall Study||26
7851757|NCT00950872|19326673|P1|STARTED|Overall Study||29
7851758|NCT00950859|19326682|P2|NOT COMPLETED|Overall Study||10
7851759|NCT00950859|19326683|P1|NOT COMPLETED|Overall Study||16
7851760|NCT00950859|19326682|P2|COMPLETED|Overall Study||14
7851761|NCT00950859|19326683|P1|COMPLETED|Overall Study||11
7851762|NCT00950859|19326682|P2|STARTED|Overall Study||24
7851763|NCT00950859|19326683|P1|STARTED|Overall Study||27
7851764|NCT00950833|19326726|P3|NOT COMPLETED|Overall Study||0
7851765|NCT00950833|19326727|P2|NOT COMPLETED|Overall Study||0
7851766|NCT00950833|19326728|P1|NOT COMPLETED|Overall Study||0
7851767|NCT00950833|19326726|P3|COMPLETED|Overall Study||223
7851768|NCT00950833|19326727|P2|COMPLETED|Overall Study||108
7851769|NCT00950833|19326728|P1|COMPLETED|Overall Study||112
7851770|NCT00950833|19326726|P3|STARTED|Overall Study||223
7851771|NCT00950833|19326727|P2|STARTED|Overall Study||108
7851772|NCT00950833|19326728|P1|STARTED|Overall Study||112
7851773|NCT00950807|19326782|P10|NOT COMPLETED|Treatment Period 3||1
7851774|NCT00950807|19326783|P9|NOT COMPLETED|Treatment Period 3||0
7851775|NCT00950807|19326784|P8|NOT COMPLETED|Treatment Period 3||1
7851776|NCT00950807|19326785|P7|NOT COMPLETED|Treatment Period 3||1
7851777|NCT00950807|19326786|P6|NOT COMPLETED|Treatment Period 3||0
7851778|NCT00950807|19326787|P5|NOT COMPLETED|Treatment Period 3||0
7851779|NCT00950807|19326788|P4|NOT COMPLETED|Treatment Period 3||0
7851780|NCT00950807|19326789|P3|NOT COMPLETED|Treatment Period 3||0
7851781|NCT00950807|19326790|P2|NOT COMPLETED|Treatment Period 3||0
7851782|NCT00950807|19326791|P1|NOT COMPLETED|Treatment Period 3||1
7851783|NCT00950807|19326782|P10|COMPLETED|Treatment Period 3||10
7851784|NCT00950807|19326783|P9|COMPLETED|Treatment Period 3||9
7851785|NCT00950807|19326784|P8|COMPLETED|Treatment Period 3||9
7851786|NCT00950807|19326785|P7|COMPLETED|Treatment Period 3||11
7851787|NCT00950807|19326786|P6|COMPLETED|Treatment Period 3||9
7851788|NCT00950807|19326787|P5|COMPLETED|Treatment Period 3||12
7851789|NCT00950807|19326788|P4|COMPLETED|Treatment Period 3||11
7851790|NCT00950807|19326789|P3|COMPLETED|Treatment Period 3||10
7851791|NCT00950807|19326790|P2|COMPLETED|Treatment Period 3||9
7851792|NCT00950807|19326791|P1|COMPLETED|Treatment Period 3||45
7851793|NCT00950807|19326782|P10|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
7851794|NCT00950807|19326783|P9|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
7851795|NCT00950807|19326784|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
7851796|NCT00950807|19326785|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
7851797|NCT00950807|19326786|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
7851798|NCT00950807|19326787|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
7851799|NCT00950807|19326788|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
7851800|NCT00950807|19326789|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
7851801|NCT00950807|19326790|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
7851802|NCT00950807|19326791|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46
7851803|NCT00950807|19326782|P10|NOT COMPLETED|Washout Period 2||0
7851804|NCT00950807|19326783|P9|NOT COMPLETED|Washout Period 2||0
7851805|NCT00950807|19326784|P8|NOT COMPLETED|Washout Period 2||1
7851806|NCT00950807|19326785|P7|NOT COMPLETED|Washout Period 2||1
7851807|NCT00950807|19326786|P6|NOT COMPLETED|Washout Period 2||0
7851808|NCT00950807|19326787|P5|NOT COMPLETED|Washout Period 2||1
7851809|NCT00950807|19326788|P4|NOT COMPLETED|Washout Period 2||1
7851810|NCT00950807|19326789|P3|NOT COMPLETED|Washout Period 2||0
7851811|NCT00950807|19326790|P2|NOT COMPLETED|Washout Period 2||1
7851812|NCT00950807|19326791|P1|NOT COMPLETED|Washout Period 2||4
7851813|NCT00950807|19326782|P10|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
7851814|NCT00950807|19326783|P9|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
7851815|NCT00950807|19326784|P8|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
7851816|NCT00950807|19326785|P7|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8
7851817|NCT00950807|19326786|P6|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
7851818|NCT00950807|19326787|P5|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12
7851819|NCT00950807|19326788|P4|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
7851820|NCT00950807|19326789|P3|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10
7851821|NCT00950807|19326790|P2|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
7851822|NCT00950807|19326791|P1|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47
7851823|NCT00950807|19326782|P10|STARTED|Washout Period 2||11
7851824|NCT00950807|19326783|P9|STARTED|Washout Period 2||11
7851825|NCT00950807|19326784|P8|STARTED|Washout Period 2||10
7851826|NCT00950807|19326785|P7|STARTED|Washout Period 2||9
7851827|NCT00950807|19326786|P6|STARTED|Washout Period 2||9
7851828|NCT00950807|19326787|P5|STARTED|Washout Period 2||13
7851829|NCT00950807|19326788|P4|STARTED|Washout Period 2||12
7851830|NCT00950807|19326789|P3|STARTED|Washout Period 2||10
7851831|NCT00950807|19326790|P2|STARTED|Washout Period 2||12
7851832|NCT00950807|19326791|P1|STARTED|Washout Period 2||51
7851833|NCT00950807|19326782|P10|NOT COMPLETED|Treatment Period 2||0
7851834|NCT00950807|19326783|P9|NOT COMPLETED|Treatment Period 2||0
7851835|NCT00950807|19326784|P8|NOT COMPLETED|Treatment Period 2||3
7851836|NCT00950807|19326785|P7|NOT COMPLETED|Treatment Period 2||1
7851837|NCT00950807|19326786|P6|NOT COMPLETED|Treatment Period 2||1
7851838|NCT00950807|19326787|P5|NOT COMPLETED|Treatment Period 2||0
7851839|NCT00950807|19326788|P4|NOT COMPLETED|Treatment Period 2||1
7851840|NCT00950807|19326789|P3|NOT COMPLETED|Treatment Period 2||0
7851841|NCT00950807|19326790|P2|NOT COMPLETED|Treatment Period 2||1
7851842|NCT00950807|19326791|P1|NOT COMPLETED|Treatment Period 2||2
7851843|NCT00950807|19326782|P10|COMPLETED|Treatment Period 2||11
7851844|NCT00950807|19326783|P9|COMPLETED|Treatment Period 2||11
7851845|NCT00950807|19326784|P8|COMPLETED|Treatment Period 2||10
7851846|NCT00950807|19326785|P7|COMPLETED|Treatment Period 2||9
7851847|NCT00950807|19326786|P6|COMPLETED|Treatment Period 2||9
7851848|NCT00950807|19326787|P5|COMPLETED|Treatment Period 2||13
7851849|NCT00950807|19326788|P4|COMPLETED|Treatment Period 2||12
7851850|NCT00950807|19326789|P3|COMPLETED|Treatment Period 2||10
7851851|NCT00950807|19326790|P2|COMPLETED|Treatment Period 2||12
7851852|NCT00950807|19326791|P1|COMPLETED|Treatment Period 2||51
7851853|NCT00950807|19326782|P10|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
7851854|NCT00950807|19326783|P9|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
7851855|NCT00950807|19326784|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
7851856|NCT00950807|19326785|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
7851857|NCT00950807|19326786|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
7851858|NCT00950807|19326787|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
7851859|NCT00950807|19326788|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
7851860|NCT00950807|19326789|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
7851861|NCT00950807|19326790|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
7851941|NCT00950729|19326876|P1|NOT COMPLETED|Driving With Running Shoes||0
7851862|NCT00950807|19326791|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53
7851863|NCT00950807|19326782|P10|NOT COMPLETED|Washout Period 1||0
7851864|NCT00950807|19326783|P9|NOT COMPLETED|Washout Period 1||1
7851865|NCT00950807|19326784|P8|NOT COMPLETED|Washout Period 1||1
7851866|NCT00950807|19326785|P7|NOT COMPLETED|Washout Period 1||2
7851867|NCT00950807|19326786|P6|NOT COMPLETED|Washout Period 1||0
7851868|NCT00950807|19326787|P5|NOT COMPLETED|Washout Period 1||1
7851869|NCT00950807|19326788|P4|NOT COMPLETED|Washout Period 1||1
7851870|NCT00950807|19326789|P3|NOT COMPLETED|Washout Period 1||0
7851871|NCT00950807|19326790|P2|NOT COMPLETED|Washout Period 1||0
7851872|NCT00950807|19326791|P1|NOT COMPLETED|Washout Period 1||5
7851873|NCT00950807|19326782|P10|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
7851874|NCT00950807|19326783|P9|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
7851875|NCT00950807|19326784|P8|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
7851876|NCT00950807|19326785|P7|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10
7851877|NCT00950807|19326786|P6|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
7851878|NCT00950807|19326787|P5|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
7851879|NCT00950807|19326788|P4|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
7851880|NCT00950807|19326789|P3|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
7851881|NCT00950807|19326790|P2|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
7851882|NCT00950807|19326791|P1|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51
7851883|NCT00950807|19326782|P10|STARTED|Washout Period 1||13
7851884|NCT00950807|19326783|P9|STARTED|Washout Period 1||12
7851885|NCT00950807|19326784|P8|STARTED|Washout Period 1||14
7851886|NCT00950807|19326785|P7|STARTED|Washout Period 1||12
7851887|NCT00950807|19326786|P6|STARTED|Washout Period 1||11
7851888|NCT00950807|19326787|P5|STARTED|Washout Period 1||12
7851889|NCT00950807|19326788|P4|STARTED|Washout Period 1||12
7851890|NCT00950807|19326789|P3|STARTED|Washout Period 1||13
7851891|NCT00950807|19326790|P2|STARTED|Washout Period 1||13
7851892|NCT00950807|19326791|P1|STARTED|Washout Period 1||56
7851893|NCT00950807|19326782|P10|NOT COMPLETED|Treatment Period 1||0
7851894|NCT00950807|19326783|P9|NOT COMPLETED|Treatment Period 1||1
7851895|NCT00950807|19326784|P8|NOT COMPLETED|Treatment Period 1||0
7851896|NCT00950807|19326785|P7|NOT COMPLETED|Treatment Period 1||0
7851897|NCT00950807|19326786|P6|NOT COMPLETED|Treatment Period 1||2
7851898|NCT00950807|19326787|P5|NOT COMPLETED|Treatment Period 1||1
7851899|NCT00950807|19326788|P4|NOT COMPLETED|Treatment Period 1||0
7851900|NCT00950807|19326789|P3|NOT COMPLETED|Treatment Period 1||1
7851901|NCT00950807|19326790|P2|NOT COMPLETED|Treatment Period 1||0
7851902|NCT00950807|19326791|P1|NOT COMPLETED|Treatment Period 1||3
7851903|NCT00950807|19326782|P10|COMPLETED|Treatment Period 1||13
7851904|NCT00950807|19326783|P9|COMPLETED|Treatment Period 1||12
7851905|NCT00950807|19326784|P8|COMPLETED|Treatment Period 1||14
7851906|NCT00950807|19326785|P7|COMPLETED|Treatment Period 1||12
7851907|NCT00950807|19326786|P6|COMPLETED|Treatment Period 1||11
7851908|NCT00950807|19326787|P5|COMPLETED|Treatment Period 1||12
7851909|NCT00950807|19326788|P4|COMPLETED|Treatment Period 1||12
7851910|NCT00950807|19326789|P3|COMPLETED|Treatment Period 1||13
7851911|NCT00950807|19326790|P2|COMPLETED|Treatment Period 1||13
7851912|NCT00950807|19326791|P1|COMPLETED|Treatment Period 1||56
7851913|NCT00950807|19326782|P10|STARTED|Treatment Period 1||13
7851914|NCT00950807|19326783|P9|STARTED|Treatment Period 1||13
7851915|NCT00950807|19326784|P8|STARTED|Treatment Period 1||14
7851916|NCT00950807|19326785|P7|STARTED|Treatment Period 1||12
7851917|NCT00950807|19326786|P6|STARTED|Treatment Period 1||13
7851918|NCT00950807|19326787|P5|STARTED|Treatment Period 1||13
7851919|NCT00950807|19326788|P4|STARTED|Treatment Period 1||12
7851920|NCT00950807|19326789|P3|STARTED|Treatment Period 1||14
7851921|NCT00950807|19326790|P2|STARTED|Treatment Period 1||13
7851922|NCT00950807|19326791|P1|STARTED|Treatment Period 1||59
7851923|NCT00950755|19326833|P1|NOT COMPLETED|Long-Term Follow-Up||9
7851924|NCT00950755|19326833|P1|COMPLETED|Long-Term Follow-Up||9
7851925|NCT00950755|19326833|P1|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18
7851926|NCT00950755|19326833|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41
7851927|NCT00950755|19326833|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
7851928|NCT00950755|19326833|P1|STARTED|Dosimetric and Therapeutic Treatment||41
7851929|NCT00950742|19326859|P2|NOT COMPLETED|Overall Study||2
7851930|NCT00950742|19326860|P1|NOT COMPLETED|Overall Study||16
7851931|NCT00950742|19326859|P2|COMPLETED|Overall Study||0
7851932|NCT00950742|19326860|P1|COMPLETED|Overall Study||0
7851933|NCT00950742|19326859|P2|STARTED|Overall Study|entered and treated|2
7851934|NCT00950742|19326860|P1|STARTED|Overall Study|entered and treated|16
7851935|NCT00950729|19326876|P1|NOT COMPLETED|Driving With Aircast||0
7851936|NCT00950729|19326876|P1|COMPLETED|Driving With Aircast||48
7851937|NCT00950729|19326876|P1|STARTED|Driving With Aircast||48
7851938|NCT00950729|19326876|P1|NOT COMPLETED|Driving With Plaster Cast||0
7851939|NCT00950729|19326876|P1|COMPLETED|Driving With Plaster Cast||48
7851940|NCT00950729|19326876|P1|STARTED|Driving With Plaster Cast||48
7851942|NCT00950729|19326876|P1|COMPLETED|Driving With Running Shoes|June 2007|48
7851943|NCT00950729|19326876|P1|STARTED|Driving With Running Shoes|March 2007|48
7851944|NCT00950690|19326881|P1|NOT COMPLETED|Overall Study||244
7851945|NCT00950690|19326881|P1|COMPLETED|Overall Study||1105
7851946|NCT00950690|19326881|P1|STARTED|Overall Study||1349
7851947|NCT00950664|19326888|P2|NOT COMPLETED|Second Intervention||48
7851948|NCT00950664|19326889|P1|NOT COMPLETED|Second Intervention||46
7851949|NCT00950664|19326888|P2|COMPLETED|Second Intervention||0
7851950|NCT00950664|19326889|P1|COMPLETED|Second Intervention||0
7851951|NCT00950664|19326888|P2|STARTED|Second Intervention||48
7851952|NCT00950664|19326889|P1|STARTED|Second Intervention||46
7851953|NCT00950664|19326888|P2|NOT COMPLETED|Washout Period of 4 Weeks||0
7851954|NCT00950664|19326889|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
7851955|NCT00950664|19326888|P2|COMPLETED|Washout Period of 4 Weeks||48
7851956|NCT00950664|19326889|P1|COMPLETED|Washout Period of 4 Weeks||46
7851957|NCT00950664|19326888|P2|STARTED|Washout Period of 4 Weeks||48
7851958|NCT00950664|19326889|P1|STARTED|Washout Period of 4 Weeks||46
7851959|NCT00950664|19326888|P2|NOT COMPLETED|First Intervention||5
7851960|NCT00950664|19326889|P1|NOT COMPLETED|First Intervention||3
7851961|NCT00950664|19326888|P2|COMPLETED|First Intervention||48
7851962|NCT00950664|19326889|P1|COMPLETED|First Intervention||46
7851963|NCT00950664|19326888|P2|STARTED|First Intervention||53
7851964|NCT00950664|19326889|P1|STARTED|First Intervention||49
7851965|NCT00950651|19326909|P2|NOT COMPLETED|Overall Study||35
7851966|NCT00950651|19326910|P1|NOT COMPLETED|Overall Study||31
7851967|NCT00950651|19326909|P2|COMPLETED|Overall Study||181
7851968|NCT00950651|19326910|P1|COMPLETED|Overall Study||184
7851969|NCT00950651|19326909|P2|STARTED|Overall Study|216 patients randomized but one never took study medication|216
7851970|NCT00950651|19326910|P1|STARTED|Overall Study||215
7851971|NCT00950612|19326958|P2|NOT COMPLETED|Overall Study||0
7851972|NCT00950612|19326959|P1|NOT COMPLETED|Overall Study||0
7851973|NCT00950612|19326958|P2|COMPLETED|Overall Study||20
7851974|NCT00950612|19326959|P1|COMPLETED|Overall Study||40
7851975|NCT00950612|19326958|P2|STARTED|Overall Study||20
7851976|NCT00950612|19326959|P1|STARTED|Overall Study||40
7851977|NCT00950599|19327003|P10|NOT COMPLETED|Follow-Up Period||2
7851978|NCT00950599|19327004|P9|NOT COMPLETED|Follow-Up Period||13
7851979|NCT00950599|19327005|P8|NOT COMPLETED|Follow-Up Period||0
7851980|NCT00950599|19327006|P7|NOT COMPLETED|Follow-Up Period||0
7851981|NCT00950599|19327007|P6|NOT COMPLETED|Follow-Up Period||0
7851982|NCT00950599|19327008|P5|NOT COMPLETED|Follow-Up Period||0
7851983|NCT00950599|19327009|P4|NOT COMPLETED|Follow-Up Period||0
7851984|NCT00950599|19327010|P3|NOT COMPLETED|Follow-Up Period||0
7851985|NCT00950599|19327011|P2|NOT COMPLETED|Follow-Up Period||0
7851986|NCT00950599|19327012|P1|NOT COMPLETED|Follow-Up Period||0
7851987|NCT00950599|19327003|P10|COMPLETED|Follow-Up Period||78
7851988|NCT00950599|19327004|P9|COMPLETED|Follow-Up Period||296
7851989|NCT00950599|19327005|P8|COMPLETED|Follow-Up Period||0
7851990|NCT00950599|19327006|P7|COMPLETED|Follow-Up Period||0
7851991|NCT00950599|19327007|P6|COMPLETED|Follow-Up Period||0
7851992|NCT00950599|19327008|P5|COMPLETED|Follow-Up Period||0
7851993|NCT00950599|19327009|P4|COMPLETED|Follow-Up Period||0
7851994|NCT00950599|19327010|P3|COMPLETED|Follow-Up Period||0
7851995|NCT00950599|19327011|P2|COMPLETED|Follow-Up Period||0
7851996|NCT00950599|19327012|P1|COMPLETED|Follow-Up Period||0
7851997|NCT00950599|19327003|P10|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80
7851998|NCT00950599|19327004|P9|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309
7851999|NCT00950599|19327005|P8|STARTED|Follow-Up Period||0
7852000|NCT00950599|19327006|P7|STARTED|Follow-Up Period||0
7852001|NCT00950599|19327007|P6|STARTED|Follow-Up Period||0
7852002|NCT00950599|19327008|P5|STARTED|Follow-Up Period||0
7852003|NCT00950599|19327009|P4|STARTED|Follow-Up Period||0
7852004|NCT00950599|19327010|P3|STARTED|Follow-Up Period||0
7852005|NCT00950599|19327011|P2|STARTED|Follow-Up Period||0
7852006|NCT00950599|19327012|P1|STARTED|Follow-Up Period||0
7852007|NCT00950599|19327003|P10|NOT COMPLETED|Double-Blind Treatment Period||0
7852008|NCT00950599|19327004|P9|NOT COMPLETED|Double-Blind Treatment Period||0
7852009|NCT00950599|19327005|P8|NOT COMPLETED|Double-Blind Treatment Period||6
7852010|NCT00950599|19327006|P7|NOT COMPLETED|Double-Blind Treatment Period||0
7852011|NCT00950599|19327007|P6|NOT COMPLETED|Double-Blind Treatment Period||12
7852012|NCT00950599|19327008|P5|NOT COMPLETED|Double-Blind Treatment Period||7
7852013|NCT00950599|19327009|P4|NOT COMPLETED|Double-Blind Treatment Period||11
7852014|NCT00950599|19327010|P3|NOT COMPLETED|Double-Blind Treatment Period||9
7852015|NCT00950599|19327011|P2|NOT COMPLETED|Double-Blind Treatment Period||10
7852016|NCT00950599|19327012|P1|NOT COMPLETED|Double-Blind Treatment Period||7
7852017|NCT00950599|19327003|P10|COMPLETED|Double-Blind Treatment Period||0
7852018|NCT00950599|19327004|P9|COMPLETED|Double-Blind Treatment Period||0
7852019|NCT00950599|19327005|P8|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35
7852020|NCT00950599|19327006|P7|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44
7852021|NCT00950599|19327007|P6|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55
7852022|NCT00950599|19327008|P5|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45
7852023|NCT00950599|19327009|P4|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43
7852024|NCT00950599|19327010|P3|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54
7852025|NCT00950599|19327011|P2|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37
7852026|NCT00950599|19327012|P1|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48
7852027|NCT00950599|19327003|P10|STARTED|Double-Blind Treatment Period||0
7852028|NCT00950599|19327004|P9|STARTED|Double-Blind Treatment Period||0
7852029|NCT00950599|19327005|P8|STARTED|Double-Blind Treatment Period||41
7852030|NCT00950599|19327006|P7|STARTED|Double-Blind Treatment Period||44
7852031|NCT00950599|19327007|P6|STARTED|Double-Blind Treatment Period||67
7852032|NCT00950599|19327008|P5|STARTED|Double-Blind Treatment Period||52
7852033|NCT00950599|19327009|P4|STARTED|Double-Blind Treatment Period||54
7852034|NCT00950599|19327010|P3|STARTED|Double-Blind Treatment Period||63
7852035|NCT00950599|19327011|P2|STARTED|Double-Blind Treatment Period||47
7852036|NCT00950599|19327012|P1|STARTED|Double-Blind Treatment Period||55
7852037|NCT00950365|19327576|P2|NOT COMPLETED|Overall Study||2
7852038|NCT00950365|19327577|P1|NOT COMPLETED|Overall Study||2
7852039|NCT00950365|19327576|P2|COMPLETED|Overall Study||50
7852040|NCT00950365|19327577|P1|COMPLETED|Overall Study||25
7852041|NCT00950365|19327576|P2|STARTED|Overall Study||52
7852042|NCT00950365|19327577|P1|STARTED|Overall Study||27
7852043|NCT00950352|19327589|P2|NOT COMPLETED|Overall Study||11
7852044|NCT00950352|19327590|P1|NOT COMPLETED|Overall Study||42
7852045|NCT00950352|19327589|P2|COMPLETED|Overall Study||21
7852046|NCT00950352|19327590|P1|COMPLETED|Overall Study||30
7852047|NCT00950352|19327589|P2|STARTED|Overall Study||32
7852048|NCT00950352|19327590|P1|STARTED|Overall Study||72
7852049|NCT00950300|19327598|P2|NOT COMPLETED|SFU Period||78
7852050|NCT00950300|19327599|P1|NOT COMPLETED|SFU Period||78
7852051|NCT00950300|19327598|P2|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|45
7852052|NCT00950300|19327599|P1|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|40
7852053|NCT00950300|19327598|P2|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|123
7852054|NCT00950300|19327599|P1|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|118
7852055|NCT00950300|19327598|P2|NOT COMPLETED|TFFU Period||107
7852056|NCT00950300|19327599|P1|NOT COMPLETED|TFFU Period||100
7852057|NCT00950300|19327598|P2|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|161
7852058|NCT00950300|19327599|P1|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|165
7852059|NCT00950300|19327598|P2|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268
7852060|NCT00950300|19327599|P1|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265
7852061|NCT00950300|19327598|P2|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
7852062|NCT00950300|19327599|P1|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
7852063|NCT00950300|19327598|P2|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255
7852064|NCT00950300|19327599|P1|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257
7852065|NCT00950300|19327598|P2|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274
7852066|NCT00950300|19327599|P1|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277
7852067|NCT00950300|19327598|P2|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273
7852068|NCT00950300|19327599|P1|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||277
7852069|NCT00950300|19327598|P2|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||297
7852070|NCT00950300|19327599|P1|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||298
7852071|NCT00950300|19327598|P2|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297
7852072|NCT00950300|19327599|P1|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299
7852073|NCT00950248|19327648|P3|NOT COMPLETED|Year 2&3 Treatment Randomization||5
7852074|NCT00950248|19327649|P2|NOT COMPLETED|Year 2&3 Treatment Randomization||6
7852075|NCT00950248|19327650|P1|NOT COMPLETED|Year 2&3 Treatment Randomization||0
7852076|NCT00950248|19327648|P3|COMPLETED|Year 2&3 Treatment Randomization||33
7852077|NCT00950248|19327649|P2|COMPLETED|Year 2&3 Treatment Randomization||33
7852078|NCT00950248|19327650|P1|COMPLETED|Year 2&3 Treatment Randomization||0
7852079|NCT00950248|19327648|P3|STARTED|Year 2&3 Treatment Randomization||38
7852080|NCT00950248|19327649|P2|STARTED|Year 2&3 Treatment Randomization||39
7852081|NCT00950248|19327650|P1|STARTED|Year 2&3 Treatment Randomization||0
7852082|NCT00950248|19327648|P3|NOT COMPLETED|Year 1: Baseline||0
7852083|NCT00950248|19327649|P2|NOT COMPLETED|Year 1: Baseline||0
7852084|NCT00950248|19327650|P1|NOT COMPLETED|Year 1: Baseline||8
7852085|NCT00950248|19327648|P3|COMPLETED|Year 1: Baseline||0
7852086|NCT00950248|19327649|P2|COMPLETED|Year 1: Baseline||0
7852087|NCT00950248|19327650|P1|COMPLETED|Year 1: Baseline||77
7852088|NCT00950248|19327648|P3|STARTED|Year 1: Baseline||0
7852089|NCT00950248|19327649|P2|STARTED|Year 1: Baseline||0
7852090|NCT00950248|19327650|P1|STARTED|Year 1: Baseline||85
7852091|NCT00950235|19327671|P2|NOT COMPLETED|Overall Study||4
7852092|NCT00950235|19327672|P1|NOT COMPLETED|Overall Study||2
7852093|NCT00950235|19327671|P2|COMPLETED|Overall Study||54
7852094|NCT00950235|19327672|P1|COMPLETED|Overall Study||58
7852095|NCT00950235|19327671|P2|STARTED|Overall Study||58
7852096|NCT00950235|19327672|P1|STARTED|Overall Study||60
7852097|NCT00950183|19327682|P1|NOT COMPLETED|Overall Study||36
7852098|NCT00950183|19327682|P1|COMPLETED|Overall Study||0
7852099|NCT00950183|19327682|P1|STARTED|Overall Study||36
7852100|NCT00950170|19327690|P1|NOT COMPLETED|Overall Study||4
7852101|NCT00950170|19327690|P1|COMPLETED|Overall Study||19
7852102|NCT00950170|19327690|P1|STARTED|Overall Study||23
7852103|NCT00949988|19327741|P1|NOT COMPLETED|Overall Study||3
7852104|NCT00949988|19327741|P1|COMPLETED|Overall Study||0
7852105|NCT00949988|19327741|P1|STARTED|Overall Study||3
7852106|NCT00949975|19327756|P4|NOT COMPLETED|Overall Study||28
7852107|NCT00949975|19327757|P3|NOT COMPLETED|Overall Study||19
7852108|NCT00949975|19327758|P2|NOT COMPLETED|Overall Study||29
7852109|NCT00949975|19327759|P1|NOT COMPLETED|Overall Study||27
7852110|NCT00949975|19327756|P4|COMPLETED|Overall Study||190
7852111|NCT00949975|19327757|P3|COMPLETED|Overall Study||183
7852112|NCT00949975|19327758|P2|COMPLETED|Overall Study||177
7852113|NCT00949975|19327759|P1|COMPLETED|Overall Study||185
7852114|NCT00949975|19327756|P4|STARTED|Overall Study||218
7852115|NCT00949975|19327757|P3|STARTED|Overall Study||202
7852116|NCT00949975|19327758|P2|STARTED|Overall Study||206
7852117|NCT00949975|19327759|P1|STARTED|Overall Study||212
7852118|NCT00949910|19327877|P1|NOT COMPLETED|Overall Study||6576
7852119|NCT00949910|19327877|P1|COMPLETED|Overall Study||10
7852120|NCT00949910|19327877|P1|STARTED|Overall Study||6586
7852121|NCT00949884|19327890|P3|NOT COMPLETED|Overall Study||58
7852122|NCT00949884|19327891|P2|NOT COMPLETED|Overall Study||15
7852123|NCT00949884|19327892|P1|NOT COMPLETED|Overall Study||50
7852124|NCT00949884|19327890|P3|COMPLETED|Overall Study||411
7852125|NCT00949884|19327891|P2|COMPLETED|Overall Study||37
7852126|NCT00949884|19327892|P1|COMPLETED|Overall Study||370
7852127|NCT00949884|19327890|P3|STARTED|Overall Study||469
7852128|NCT00949884|19327891|P2|STARTED|Overall Study||52
7852129|NCT00949884|19327892|P1|STARTED|Overall Study||420
7852130|NCT00949715|19327947|P2|NOT COMPLETED|Overall Study||0
7852131|NCT00949715|19327948|P1|NOT COMPLETED|Overall Study||4
7852132|NCT00949715|19327947|P2|COMPLETED|Overall Study||33
7852133|NCT00949715|19327948|P1|COMPLETED|Overall Study||28
7852134|NCT00949715|19327947|P2|STARTED|Overall Study||33
7852135|NCT00949715|19327948|P1|STARTED|Overall Study||32
7852136|NCT00949702|19327959|P1|NOT COMPLETED|Overall Study||48
7852137|NCT00949702|19327959|P1|COMPLETED|Overall Study||84
7852138|NCT00949702|19327959|P1|STARTED|Overall Study||132
7852139|NCT00949650|19327976|P2|NOT COMPLETED|Overall Study||115
7852140|NCT00949650|19327977|P1|NOT COMPLETED|Overall Study||230
7852141|NCT00949650|19327976|P2|COMPLETED|Overall Study||0
7852142|NCT00949650|19327977|P1|COMPLETED|Overall Study|On treatment at the cut-off date 17MAR2017.|0
7852143|NCT00949650|19327976|P2|STARTED|Overall Study|Treated patients.|115
7852144|NCT00949650|19327977|P1|STARTED|Overall Study|Treated patients.|230
7852145|NCT00949533|19328015|P2|NOT COMPLETED|Overall Study||1
7852146|NCT00949533|19328016|P1|NOT COMPLETED|Overall Study||0
7852147|NCT00949533|19328015|P2|COMPLETED|Overall Study||17
7852148|NCT00949533|19328016|P1|COMPLETED|Overall Study||19
7852149|NCT00949533|19328015|P2|STARTED|Overall Study||18
7852150|NCT00949533|19328016|P1|STARTED|Overall Study||19
7852151|NCT00949403|19328028|P1|NOT COMPLETED|Overall Study||0
7852152|NCT00949403|19328028|P1|COMPLETED|Overall Study||9
7852153|NCT00949403|19328028|P1|STARTED|Overall Study||9
7852154|NCT00949325|19328032|P3|NOT COMPLETED|Overall Study||0
7852155|NCT00949325|19328033|P2|NOT COMPLETED|Overall Study||2
7852156|NCT00949325|19328034|P1|NOT COMPLETED|Overall Study||0
7852157|NCT00949325|19328032|P3|COMPLETED|Overall Study||3
7852158|NCT00949325|19328033|P2|COMPLETED|Overall Study||16
7852159|NCT00949325|19328034|P1|COMPLETED|Overall Study||3
7852160|NCT00949325|19328032|P3|STARTED|Overall Study||3
7852161|NCT00949325|19328033|P2|STARTED|Overall Study||18
7852162|NCT00949325|19328034|P1|STARTED|Overall Study||3
7852163|NCT00949234|19328052|P1|NOT COMPLETED|Overall Study||42
7852164|NCT00949234|19328052|P1|COMPLETED|Overall Study||225
7852165|NCT00949234|19328052|P1|STARTED|Overall Study||267
7852166|NCT00949117|19328058|P2|NOT COMPLETED|Overall Study||5
7852167|NCT00949117|19328059|P1|NOT COMPLETED|Overall Study||3
7852168|NCT00949117|19328058|P2|COMPLETED|Overall Study||0
7852169|NCT00949117|19328059|P1|COMPLETED|Overall Study||1
7852170|NCT00949117|19328058|P2|STARTED|Overall Study||5
7852171|NCT00949117|19328059|P1|STARTED|Overall Study||4
7852172|NCT00949078|19328075|P2|NOT COMPLETED|Overall Study||0
7852173|NCT00949078|19328076|P1|NOT COMPLETED|Overall Study||0
7852174|NCT00949078|19328075|P2|COMPLETED|Overall Study||9
7852175|NCT00949078|19328076|P1|COMPLETED|Overall Study||5
7852176|NCT00949078|19328075|P2|STARTED|Overall Study||9
7852177|NCT00949078|19328076|P1|STARTED|Overall Study||5
7852178|NCT00948974|19328100|P2|NOT COMPLETED|Overall Study||20
7852179|NCT00948974|19328101|P1|NOT COMPLETED|Overall Study||23
7852180|NCT00948974|19328100|P2|COMPLETED|Overall Study||28
7852181|NCT00948974|19328101|P1|COMPLETED|Overall Study||17
7852182|NCT00948974|19328100|P2|STARTED|Overall Study||48
7852183|NCT00948974|19328101|P1|STARTED|Overall Study||40
7852184|NCT00948935|19328111|P1|NOT COMPLETED|Overall Study||0
7852185|NCT00948935|19328111|P1|COMPLETED|Overall Study||35
7852186|NCT00948935|19328111|P1|STARTED|Overall Study||35
7852187|NCT00948922|19328119|P3|NOT COMPLETED|Overall Study||1
7852188|NCT00948922|19328120|P2|NOT COMPLETED|Overall Study||14
7852189|NCT00948922|19328121|P1|NOT COMPLETED|Overall Study||8
7852190|NCT00948922|19328119|P3|COMPLETED|Overall Study||38
7852191|NCT00948922|19328120|P2|COMPLETED|Overall Study||37
7852192|NCT00948922|19328121|P1|COMPLETED|Overall Study||26
7852193|NCT00948922|19328119|P3|STARTED|Overall Study||39
7852194|NCT00948922|19328120|P2|STARTED|Overall Study||51
7852195|NCT00948922|19328121|P1|STARTED|Overall Study||34
7852196|NCT00948896|19328144|P8|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
7852197|NCT00948896|19328145|P7|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
7852198|NCT00948896|19328146|P6|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
7852199|NCT00948896|19328147|P5|NOT COMPLETED|24 Months of Age to 36 Months of Age||1
7852200|NCT00948896|19328148|P4|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
7852201|NCT00948896|19328149|P3|NOT COMPLETED|24 Months of Age to 36 Months of Age||5
7852202|NCT00948896|19328150|P2|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
7852203|NCT00948896|19328151|P1|NOT COMPLETED|24 Months of Age to 36 Months of Age||3
7852204|NCT00948896|19328144|P8|COMPLETED|24 Months of Age to 36 Months of Age||45
7852205|NCT00948896|19328145|P7|COMPLETED|24 Months of Age to 36 Months of Age||43
7852206|NCT00948896|19328146|P6|COMPLETED|24 Months of Age to 36 Months of Age||40
7852207|NCT00948896|19328147|P5|COMPLETED|24 Months of Age to 36 Months of Age||43
7852208|NCT00948896|19328148|P4|COMPLETED|24 Months of Age to 36 Months of Age||85
7852209|NCT00948896|19328149|P3|COMPLETED|24 Months of Age to 36 Months of Age||85
7852210|NCT00948896|19328150|P2|COMPLETED|24 Months of Age to 36 Months of Age||83
7852211|NCT00948896|19328151|P1|COMPLETED|24 Months of Age to 36 Months of Age||87
7852212|NCT00948896|19328144|P8|STARTED|24 Months of Age to 36 Months of Age||45
7852213|NCT00948896|19328145|P7|STARTED|24 Months of Age to 36 Months of Age||43
7852214|NCT00948896|19328146|P6|STARTED|24 Months of Age to 36 Months of Age||42
7852215|NCT00948896|19328147|P5|STARTED|24 Months of Age to 36 Months of Age||44
7852216|NCT00948896|19328148|P4|STARTED|24 Months of Age to 36 Months of Age||87
7852217|NCT00948896|19328149|P3|STARTED|24 Months of Age to 36 Months of Age||90
7852218|NCT00948896|19328150|P2|STARTED|24 Months of Age to 36 Months of Age||85
7852219|NCT00948896|19328151|P1|STARTED|24 Months of Age to 36 Months of Age||90
7852220|NCT00948896|19328144|P8|NOT COMPLETED|Randomization to 24 Months of Age||2
7852221|NCT00948896|19328145|P7|NOT COMPLETED|Randomization to 24 Months of Age||4
7852222|NCT00948896|19328146|P6|NOT COMPLETED|Randomization to 24 Months of Age||4
7852223|NCT00948896|19328147|P5|NOT COMPLETED|Randomization to 24 Months of Age||2
7852224|NCT00948896|19328148|P4|NOT COMPLETED|Randomization to 24 Months of Age||11
7852225|NCT00948896|19328149|P3|NOT COMPLETED|Randomization to 24 Months of Age||9
7852226|NCT00948896|19328150|P2|NOT COMPLETED|Randomization to 24 Months of Age||13
7852227|NCT00948896|19328151|P1|NOT COMPLETED|Randomization to 24 Months of Age||8
7852228|NCT00948896|19328144|P8|COMPLETED|Randomization to 24 Months of Age||45
7852229|NCT00948896|19328145|P7|COMPLETED|Randomization to 24 Months of Age||43
7852230|NCT00948896|19328146|P6|COMPLETED|Randomization to 24 Months of Age||42
7852231|NCT00948896|19328147|P5|COMPLETED|Randomization to 24 Months of Age||44
7852232|NCT00948896|19328148|P4|COMPLETED|Randomization to 24 Months of Age||87
7852233|NCT00948896|19328149|P3|COMPLETED|Randomization to 24 Months of Age||90
7852234|NCT00948896|19328150|P2|COMPLETED|Randomization to 24 Months of Age||85
7852235|NCT00948896|19328151|P1|COMPLETED|Randomization to 24 Months of Age||90
7852236|NCT00948896|19328144|P8|STARTED|Randomization to 24 Months of Age||47
7852237|NCT00948896|19328145|P7|STARTED|Randomization to 24 Months of Age||47
7852238|NCT00948896|19328146|P6|STARTED|Randomization to 24 Months of Age||46
7852239|NCT00948896|19328147|P5|STARTED|Randomization to 24 Months of Age||46
7852240|NCT00948896|19328148|P4|STARTED|Randomization to 24 Months of Age||98
7852241|NCT00948896|19328149|P3|STARTED|Randomization to 24 Months of Age||99
7852242|NCT00948896|19328150|P2|STARTED|Randomization to 24 Months of Age||98
7852243|NCT00948896|19328151|P1|STARTED|Randomization to 24 Months of Age||98
7852244|NCT00948857|19328187|P2|NOT COMPLETED|Overall Study||0
7852245|NCT00948857|19328188|P1|NOT COMPLETED|Overall Study||1
7852246|NCT00948857|19328187|P2|COMPLETED|Overall Study||2
7852247|NCT00948857|19328188|P1|COMPLETED|Overall Study|3 completed and 1 dropped out.|2
7852248|NCT00948857|19328187|P2|STARTED|Overall Study||2
7852249|NCT00948857|19328188|P1|STARTED|Overall Study||3
7852250|NCT00948818|19328196|P2|NOT COMPLETED|Overall Study||94
7852251|NCT00948818|19328197|P1|NOT COMPLETED|Overall Study||62
7852252|NCT00948818|19328196|P2|COMPLETED|Overall Study||312
7852253|NCT00948818|19328197|P1|COMPLETED|Overall Study||335
7852254|NCT00948818|19328196|P2|STARTED|Overall Study||406
7852255|NCT00948818|19328197|P1|STARTED|Overall Study||397
7852256|NCT00948792|19328232|P1|NOT COMPLETED|Overall Study||0
7852257|NCT00948792|19328232|P1|COMPLETED|Overall Study||21
7852258|NCT00948792|19328232|P1|STARTED|Overall Study||21
7852259|NCT00948766|19328244|P2|NOT COMPLETED|Extension Study||0
7852260|NCT00948766|19328245|P1|NOT COMPLETED|Extension Study||91
7852261|NCT00948766|19328244|P2|COMPLETED|Extension Study||0
7852262|NCT00948766|19328245|P1|COMPLETED|Extension Study||306
7852263|NCT00948766|19328244|P2|Exposed to Study Medication|Extension Study||0
7852264|NCT00948766|19328245|P1|Exposed to Study Medication|Extension Study||396
7852265|NCT00948766|19328244|P2|STARTED|Extension Study|No patients received this treatment in the extension study.|0
7852266|NCT00948766|19328245|P1|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397
7852267|NCT00948766|19328244|P2|NOT COMPLETED|Core Study||126
7852268|NCT00948766|19328245|P1|NOT COMPLETED|Core Study||127
7852269|NCT00948766|19328244|P2|COMPLETED|Core Study||234
7852270|NCT00948766|19328245|P1|COMPLETED|Core Study||229
7852271|NCT00948766|19328244|P2|Exposed to Study Medication|Core Study||359
7852272|NCT00948766|19328245|P1|Exposed to Study Medication|Core Study||355
7852273|NCT00948766|19328244|P2|STARTED|Core Study||360
7852274|NCT00948766|19328245|P1|STARTED|Core Study||356
7852275|NCT00948688|19328261|P2|NOT COMPLETED|Period 2: 100 mg Vorinostat||1
7852276|NCT00948688|19328262|P1|NOT COMPLETED|Period 2: 100 mg Vorinostat||0
7852277|NCT00948688|19328261|P2|COMPLETED|Period 2: 100 mg Vorinostat||5
7852278|NCT00948688|19328262|P1|COMPLETED|Period 2: 100 mg Vorinostat||0
7852279|NCT00948688|19328261|P2|STARTED|Period 2: 100 mg Vorinostat||6
7852280|NCT00948688|19328262|P1|STARTED|Period 2: 100 mg Vorinostat||0
7852281|NCT00948688|19328261|P2|NOT COMPLETED|Period 1: 200 mg Vorinostat||0
7852282|NCT00948688|19328262|P1|NOT COMPLETED|Period 1: 200 mg Vorinostat||2
7852283|NCT00948688|19328261|P2|COMPLETED|Period 1: 200 mg Vorinostat||0
7852284|NCT00948688|19328262|P1|COMPLETED|Period 1: 200 mg Vorinostat||2
7852285|NCT00948688|19328261|P2|STARTED|Period 1: 200 mg Vorinostat||0
7852286|NCT00948688|19328262|P1|STARTED|Period 1: 200 mg Vorinostat||4
7852287|NCT00948675|19328276|P2|NOT COMPLETED|Overall Study||4
7852288|NCT00948675|19328277|P1|NOT COMPLETED|Overall Study||7
7852289|NCT00948675|19328276|P2|COMPLETED|Overall Study||175
7852290|NCT00948675|19328277|P1|COMPLETED|Overall Study||175
7852291|NCT00948675|19328276|P2|STARTED|Overall Study||179
7852292|NCT00948675|19328277|P1|STARTED|Overall Study||182
7852293|NCT00948610|19328293|P2|NOT COMPLETED|Overall Study||1
7852294|NCT00948610|19328294|P1|NOT COMPLETED|Overall Study||1
7852295|NCT00948610|19328293|P2|COMPLETED|Overall Study||9
7852296|NCT00948610|19328294|P1|COMPLETED|Overall Study||9
7852297|NCT00948610|19328293|P2|STARTED|Overall Study||10
7852298|NCT00948610|19328294|P1|STARTED|Overall Study||10
7852299|NCT00948506|19328304|P2|NOT COMPLETED|Overall Study||1
7852300|NCT00948506|19328305|P1|NOT COMPLETED|Overall Study||3
7852301|NCT00948506|19328304|P2|COMPLETED|Overall Study||8
7852302|NCT00948506|19328305|P1|COMPLETED|Overall Study||8
7852303|NCT00948506|19328304|P2|STARTED|Overall Study||9
7852304|NCT00948506|19328305|P1|STARTED|Overall Study||11
7852305|NCT00948441|19328316|P2|NOT COMPLETED|Overall Study||4
7852306|NCT00948441|19328317|P1|NOT COMPLETED|Overall Study||1
7852307|NCT00948441|19328316|P2|COMPLETED|Overall Study||4
7852308|NCT00948441|19328317|P1|COMPLETED|Overall Study||7
7852309|NCT00948441|19328316|P2|STARTED|Overall Study||8
7852310|NCT00948441|19328317|P1|STARTED|Overall Study||8
7852311|NCT00948428|19328328|P3|NOT COMPLETED|Overall Study||8
7852312|NCT00948428|19328329|P2|NOT COMPLETED|Overall Study||18
7852313|NCT00948428|19328330|P1|NOT COMPLETED|Overall Study||18
7852314|NCT00948428|19328328|P3|COMPLETED|Overall Study||84
7852315|NCT00948428|19328329|P2|COMPLETED|Overall Study||167
7852316|NCT00948428|19328330|P1|COMPLETED|Overall Study||167
7852317|NCT00948428|19328328|P3|STARTED|Overall Study||92
7852318|NCT00948428|19328329|P2|STARTED|Overall Study||185
7852319|NCT00948428|19328330|P1|STARTED|Overall Study||185
7852320|NCT00948389|19328349|P5|NOT COMPLETED|Overall Study||1
7852321|NCT00948389|19328350|P4|NOT COMPLETED|Overall Study||9
7852322|NCT00948389|19328351|P3|NOT COMPLETED|Overall Study||7
7852323|NCT00948389|19328352|P2|NOT COMPLETED|Overall Study||3
7852324|NCT00948389|19328353|P1|NOT COMPLETED|Overall Study||6
7852325|NCT00948389|19328349|P5|COMPLETED|Overall Study||0
7852326|NCT00948389|19328350|P4|COMPLETED|Overall Study||0
7852327|NCT00948389|19328351|P3|COMPLETED|Overall Study||0
7852328|NCT00948389|19328352|P2|COMPLETED|Overall Study||0
7852329|NCT00948389|19328353|P1|COMPLETED|Overall Study||0
7852330|NCT00948389|19328349|P5|STARTED|Overall Study||1
7852331|NCT00948389|19328350|P4|STARTED|Overall Study||9
7852332|NCT00948389|19328351|P3|STARTED|Overall Study||7
7852333|NCT00948389|19328352|P2|STARTED|Overall Study||3
7852334|NCT00948389|19328353|P1|STARTED|Overall Study||6
7852335|NCT00948298|19328392|P2|NOT COMPLETED|Overall Study||5
7852336|NCT00948298|19328393|P1|NOT COMPLETED|Overall Study||10
7852337|NCT00948298|19328392|P2|COMPLETED|Overall Study||60
7852338|NCT00948298|19328393|P1|COMPLETED|Overall Study||55
7852339|NCT00948298|19328392|P2|STARTED|Overall Study||65
7852340|NCT00948298|19328393|P1|STARTED|Overall Study||65
7852341|NCT00948246|19328401|P1|NOT COMPLETED|Overall Study||24
7852342|NCT00948246|19328401|P1|COMPLETED|Overall Study||86
7852343|NCT00948246|19328401|P1|STARTED|Overall Study||110
7852344|NCT00948155|19328410|P2|NOT COMPLETED|Second Intervention 21 Days||3
7852345|NCT00948155|19328411|P1|NOT COMPLETED|Second Intervention 21 Days||2
7852346|NCT00948155|19328410|P2|COMPLETED|Second Intervention 21 Days||8
7852347|NCT00948155|19328411|P1|COMPLETED|Second Intervention 21 Days||9
7852348|NCT00948155|19328410|P2|STARTED|Second Intervention 21 Days||11
7852349|NCT00948155|19328411|P1|STARTED|Second Intervention 21 Days||11
7852350|NCT00948155|19328410|P2|NOT COMPLETED|Washout 14 Days||2
7852351|NCT00948155|19328411|P1|NOT COMPLETED|Washout 14 Days||1
7852352|NCT00948155|19328410|P2|COMPLETED|Washout 14 Days||11
7852353|NCT00948155|19328411|P1|COMPLETED|Washout 14 Days||11
7852354|NCT00948155|19328410|P2|STARTED|Washout 14 Days||13
7852355|NCT00948155|19328411|P1|STARTED|Washout 14 Days||12
7852356|NCT00948155|19328410|P2|NOT COMPLETED|First Intervention 21 Days||2
7852357|NCT00948155|19328411|P1|NOT COMPLETED|First Intervention 21 Days||2
7852358|NCT00948155|19328410|P2|COMPLETED|First Intervention 21 Days||13
7852359|NCT00948155|19328411|P1|COMPLETED|First Intervention 21 Days||12
7852360|NCT00948155|19328410|P2|STARTED|First Intervention 21 Days||15
7852361|NCT00948155|19328411|P1|STARTED|First Intervention 21 Days||14
7852362|NCT00948090|19328433|P4|NOT COMPLETED|Overall Study||11
7852363|NCT00948090|19328434|P3|NOT COMPLETED|Overall Study||56
7852364|NCT00948090|19328435|P2|NOT COMPLETED|Overall Study||1
7852365|NCT00948090|19328436|P1|NOT COMPLETED|Overall Study||43
7852366|NCT00948090|19328433|P4|COMPLETED|Overall Study||7
7852367|NCT00948090|19328434|P3|COMPLETED|Overall Study||67
7852368|NCT00948090|19328435|P2|COMPLETED|Overall Study||0
7852369|NCT00948090|19328436|P1|COMPLETED|Overall Study||22
7852370|NCT00948090|19328433|P4|STARTED|Overall Study||18
7852371|NCT00948090|19328434|P3|STARTED|Overall Study||123
7852372|NCT00948090|19328435|P2|STARTED|Overall Study||1
7852373|NCT00948090|19328436|P1|STARTED|Overall Study||65
7852374|NCT00948064|19328458|P3|NOT COMPLETED|Phase II||1
7852375|NCT00948064|19328459|P2|NOT COMPLETED|Phase II||1
7852376|NCT00948064|19328460|P1|NOT COMPLETED|Phase II||0
7852377|NCT00948064|19328458|P3|COMPLETED|Phase II||26
7852378|NCT00948064|19328459|P2|COMPLETED|Phase II||51
7852379|NCT00948064|19328460|P1|COMPLETED|Phase II||0
7852380|NCT00948064|19328458|P3|STARTED|Phase II||27
7852381|NCT00948064|19328459|P2|STARTED|Phase II||52
7852382|NCT00948064|19328460|P1|STARTED|Phase II||0
7852383|NCT00948064|19328458|P3|NOT COMPLETED|Phase I||0
7852384|NCT00948064|19328459|P2|NOT COMPLETED|Phase I||0
7852385|NCT00948064|19328460|P1|NOT COMPLETED|Phase I||1
7852386|NCT00948064|19328458|P3|COMPLETED|Phase I||0
7852387|NCT00948064|19328459|P2|COMPLETED|Phase I||0
7852388|NCT00948064|19328460|P1|COMPLETED|Phase I||30
7852389|NCT00948064|19328458|P3|STARTED|Phase I||0
7852390|NCT00948064|19328459|P2|STARTED|Phase I||0
7852391|NCT00948064|19328460|P1|STARTED|Phase I||31
7852392|NCT00948025|19328473|P2|NOT COMPLETED|Phase 2 (Comparative Phase)||0
7852393|NCT00948025|19328474|P1|NOT COMPLETED|Phase 2 (Comparative Phase)||0
7852394|NCT00948025|19328473|P2|COMPLETED|Phase 2 (Comparative Phase)||0
7852395|NCT00948025|19328474|P1|COMPLETED|Phase 2 (Comparative Phase)||0
7852396|NCT00948025|19328473|P2|STARTED|Phase 2 (Comparative Phase)||0
7852397|NCT00948025|19328474|P1|STARTED|Phase 2 (Comparative Phase)||0
7852398|NCT00948025|19328473|P2|NOT COMPLETED|Phase 1 (Pilot Phase)||3
7852399|NCT00948025|19328474|P1|NOT COMPLETED|Phase 1 (Pilot Phase)||9
7852400|NCT00948025|19328473|P2|COMPLETED|Phase 1 (Pilot Phase)||6
7852401|NCT00948025|19328474|P1|COMPLETED|Phase 1 (Pilot Phase)||5
7852402|NCT00948025|19328473|P2|STARTED|Phase 1 (Pilot Phase)||9
7852403|NCT00948025|19328474|P1|STARTED|Phase 1 (Pilot Phase)||14
7852404|NCT00947882|19328502|P4|NOT COMPLETED|Overall Study||82
7852405|NCT00947882|19328503|P3|NOT COMPLETED|Overall Study||79
7852406|NCT00947882|19328504|P2|NOT COMPLETED|Overall Study||77
7852407|NCT00947882|19328505|P1|NOT COMPLETED|Overall Study||74
7852408|NCT00947882|19328502|P4|COMPLETED|Overall Study||20
7852409|NCT00947882|19328503|P3|COMPLETED|Overall Study||22
7852410|NCT00947882|19328504|P2|COMPLETED|Overall Study||24
7852411|NCT00947882|19328505|P1|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26
7852412|NCT00947882|19328502|P4|Visit 12, Month 6|Overall Study||95
7852413|NCT00947882|19328503|P3|Visit 12, Month 6|Overall Study||90
7852414|NCT00947882|19328504|P2|Visit 12, Month 6|Overall Study||91
7852415|NCT00947882|19328505|P1|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93
7852416|NCT00947882|19328502|P4|Safety Analysis Set|Overall Study||105
7852417|NCT00947882|19328503|P3|Safety Analysis Set|Overall Study||100
7852418|NCT00947882|19328504|P2|Safety Analysis Set|Overall Study||101
7852419|NCT00947882|19328505|P1|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98
7852420|NCT00947882|19328502|P4|Actual Treatment|Overall Study||105
7852421|NCT00947882|19328503|P3|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100
7852422|NCT00947882|19328504|P2|Actual Treatment|Overall Study||101
7852423|NCT00947882|19328505|P1|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98
7852424|NCT00947882|19328502|P4|Full Analysis Set (FAS)|Overall Study||102
7852425|NCT00947882|19328503|P3|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100
7852426|NCT00947882|19328504|P2|Full Analysis Set (FAS)|Overall Study||101
7852427|NCT00947882|19328505|P1|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100
7852428|NCT00947882|19328502|P4|STARTED|Overall Study||102
7852429|NCT00947882|19328503|P3|STARTED|Overall Study||101
7852430|NCT00947882|19328504|P2|STARTED|Overall Study||101
7852431|NCT00947882|19328505|P1|STARTED|Overall Study|Started: Randomised.|100
7852432|NCT00947856|19328533|P2|NOT COMPLETED|Follow-up Period||23
7852433|NCT00947856|19328534|P1|NOT COMPLETED|Follow-up Period||51
7852434|NCT00947856|19328533|P2|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9
7852435|NCT00947856|19328534|P1|COMPLETED|Follow-up Period||27
7852436|NCT00947856|19328533|P2|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32
7852437|NCT00947856|19328534|P1|STARTED|Follow-up Period||78
7852438|NCT00947856|19328533|P2|NOT COMPLETED|Treatment Period||32
7852439|NCT00947856|19328534|P1|NOT COMPLETED|Treatment Period||78
7852440|NCT00947856|19328533|P2|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0
7852441|NCT00947856|19328534|P1|COMPLETED|Treatment Period||0
7852442|NCT00947856|19328533|P2|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32
7852443|NCT00947856|19328534|P1|STARTED|Treatment Period||78
7852444|NCT00947791|19328563|P2|NOT COMPLETED|Overall Study||0
7852445|NCT00947791|19328564|P1|NOT COMPLETED|Overall Study||0
7852446|NCT00947791|19328563|P2|COMPLETED|Overall Study||1
7852447|NCT00947791|19328564|P1|COMPLETED|Overall Study||0
7852448|NCT00947791|19328563|P2|STARTED|Overall Study||1
7852449|NCT00947791|19328564|P1|STARTED|Overall Study||0
7852450|NCT00947765|19328582|P2|NOT COMPLETED|Overall Study||0
7852451|NCT00947765|19328583|P1|NOT COMPLETED|Overall Study||0
7852452|NCT00947765|19328582|P2|COMPLETED|Overall Study||30
7852453|NCT00947765|19328583|P1|COMPLETED|Overall Study||30
7852454|NCT00947765|19328582|P2|STARTED|Overall Study||30
7852455|NCT00947765|19328583|P1|STARTED|Overall Study||30
7852456|NCT00947752|19328605|P2|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
7852457|NCT00947752|19328606|P1|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
7852458|NCT00947752|19328605|P2|COMPLETED|Crossover to 2nd 14-day Treatment Period||76
7852459|NCT00947752|19328606|P1|COMPLETED|Crossover to 2nd 14-day Treatment Period||71
7852460|NCT00947752|19328605|P2|STARTED|Crossover to 2nd 14-day Treatment Period||76
7852461|NCT00947752|19328606|P1|STARTED|Crossover to 2nd 14-day Treatment Period||71
7852462|NCT00947752|19328605|P2|NOT COMPLETED|1st 14-day Treatment Period||0
7852463|NCT00947752|19328606|P1|NOT COMPLETED|1st 14-day Treatment Period||0
7852464|NCT00947752|19328605|P2|COMPLETED|1st 14-day Treatment Period||71
7852465|NCT00947752|19328606|P1|COMPLETED|1st 14-day Treatment Period||76
7852466|NCT00947752|19328605|P2|STARTED|1st 14-day Treatment Period||71
7852467|NCT00947752|19328606|P1|STARTED|1st 14-day Treatment Period||76
7852468|NCT00947752|19328605|P2|NOT COMPLETED|7-Day Run-in Treatment Period||0
7852469|NCT00947752|19328606|P1|NOT COMPLETED|7-Day Run-in Treatment Period||0
7852470|NCT00947752|19328605|P2|COMPLETED|7-Day Run-in Treatment Period||0
7852471|NCT00947752|19328606|P1|COMPLETED|7-Day Run-in Treatment Period||147
7852472|NCT00947752|19328605|P2|STARTED|7-Day Run-in Treatment Period||0
7852473|NCT00947752|19328606|P1|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147
7852474|NCT00947661|19328616|P2|NOT COMPLETED|Overall Study||15
7852475|NCT00947661|19328617|P1|NOT COMPLETED|Overall Study||13
7852476|NCT00947661|19328616|P2|COMPLETED|Overall Study||274
7852477|NCT00947661|19328617|P1|COMPLETED|Overall Study||276
7852478|NCT00947661|19328616|P2|STARTED|Overall Study||289
7852479|NCT00947661|19328617|P1|STARTED|Overall Study||289
7852480|NCT00947544|19328623|P2|NOT COMPLETED|Safety-Extension Period (12 Months)||0
7852481|NCT00947544|19328624|P1|NOT COMPLETED|Safety-Extension Period (12 Months)||1
7852482|NCT00947544|19328623|P2|COMPLETED|Safety-Extension Period (12 Months)||6
7852483|NCT00947544|19328624|P1|COMPLETED|Safety-Extension Period (12 Months)||10
7852484|NCT00947544|19328623|P2|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6
7852485|NCT00947544|19328624|P1|STARTED|Safety-Extension Period (12 Months)||11
7852486|NCT00947544|19328623|P2|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
7852487|NCT00947544|19328624|P1|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
7852488|NCT00947544|19328623|P2|COMPLETED|Switch-Over Period (2 Weeks)||0
7852489|NCT00947544|19328624|P1|COMPLETED|Switch-Over Period (2 Weeks)||11
7852490|NCT00947544|19328623|P2|STARTED|Switch-Over Period (2 Weeks)||0
7852491|NCT00947544|19328624|P1|STARTED|Switch-Over Period (2 Weeks)||11
7852492|NCT00947531|19328650|P2|NOT COMPLETED|Overall Study||11
7852493|NCT00947531|19328651|P1|NOT COMPLETED|Overall Study||14
7852494|NCT00947531|19328650|P2|COMPLETED|Overall Study||110
7852495|NCT00947531|19328651|P1|COMPLETED|Overall Study||107
7852496|NCT00947531|19328650|P2|STARTED|Overall Study||121
7852497|NCT00947531|19328651|P1|STARTED|Overall Study||121
7852498|NCT00947518|19328662|P3|NOT COMPLETED|Overall Study||0
7852499|NCT00947518|19328663|P2|NOT COMPLETED|Overall Study||0
7852500|NCT00947518|19328664|P1|NOT COMPLETED|Overall Study||0
7852501|NCT00947518|19328662|P3|COMPLETED|Overall Study||20
7852502|NCT00947518|19328663|P2|COMPLETED|Overall Study||20
7852503|NCT00947518|19328664|P1|COMPLETED|Overall Study||20
7852504|NCT00947518|19328662|P3|STARTED|Overall Study||20
7852505|NCT00947518|19328663|P2|STARTED|Overall Study||20
7852506|NCT00947518|19328664|P1|STARTED|Overall Study||20
7852507|NCT00947505|19328680|P2|NOT COMPLETED|Overall Study||2
7852508|NCT00947505|19328681|P1|NOT COMPLETED|Overall Study||9
7852509|NCT00947505|19328680|P2|COMPLETED|Overall Study||14
7852510|NCT00947505|19328681|P1|COMPLETED|Overall Study||24
7852511|NCT00947505|19328680|P2|STARTED|Overall Study||16
7852512|NCT00947505|19328681|P1|STARTED|Overall Study||33
7852513|NCT00947427|19328689|P2|NOT COMPLETED|Overall Study||4
7852514|NCT00947427|19328690|P1|NOT COMPLETED|Overall Study||1
7852515|NCT00947427|19328689|P2|COMPLETED|Overall Study||45
7852516|NCT00947427|19328690|P1|COMPLETED|Overall Study||21
7852517|NCT00947427|19328689|P2|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49
7852518|NCT00947427|19328690|P1|STARTED|Overall Study||22
7852519|NCT00947349|19328700|P4|NOT COMPLETED|Overall Study Standard of Care||2
7852520|NCT00947349|19328701|P3|NOT COMPLETED|Overall Study Standard of Care||2
7852521|NCT00947349|19328702|P2|NOT COMPLETED|Overall Study Standard of Care||0
7852522|NCT00947349|19328703|P1|NOT COMPLETED|Overall Study Standard of Care||0
7852523|NCT00947349|19328700|P4|COMPLETED|Overall Study Standard of Care||4
7852524|NCT00947349|19328701|P3|COMPLETED|Overall Study Standard of Care||4
7852525|NCT00947349|19328702|P2|COMPLETED|Overall Study Standard of Care||5
7852526|NCT00947349|19328703|P1|COMPLETED|Overall Study Standard of Care||4
7852527|NCT00947349|19328700|P4|STARTED|Overall Study Standard of Care||6
7852528|NCT00947349|19328701|P3|STARTED|Overall Study Standard of Care||6
7852529|NCT00947349|19328702|P2|STARTED|Overall Study Standard of Care||5
7852530|NCT00947349|19328703|P1|STARTED|Overall Study Standard of Care||4
7852531|NCT00947349|19328700|P4|NOT COMPLETED|Triple Treatment Combination Period||0
7852532|NCT00947349|19328701|P3|NOT COMPLETED|Triple Treatment Combination Period||0
7852533|NCT00947349|19328702|P2|NOT COMPLETED|Triple Treatment Combination Period||1
7852534|NCT00947349|19328703|P1|NOT COMPLETED|Triple Treatment Combination Period||0
7852535|NCT00947349|19328700|P4|COMPLETED|Triple Treatment Combination Period||6
7852536|NCT00947349|19328701|P3|COMPLETED|Triple Treatment Combination Period||6
7852537|NCT00947349|19328702|P2|COMPLETED|Triple Treatment Combination Period||5
7852538|NCT00947349|19328703|P1|COMPLETED|Triple Treatment Combination Period||4
7852539|NCT00947349|19328700|P4|STARTED|Triple Treatment Combination Period||6
7852540|NCT00947349|19328701|P3|STARTED|Triple Treatment Combination Period||6
7852541|NCT00947349|19328702|P2|STARTED|Triple Treatment Combination Period||6
7852542|NCT00947349|19328703|P1|STARTED|Triple Treatment Combination Period||4
7852543|NCT00947310|19328838|P3|NOT COMPLETED|Overall Study||0
7852544|NCT00947310|19328839|P2|NOT COMPLETED|Overall Study||0
7852545|NCT00947310|19328840|P1|NOT COMPLETED|Overall Study||0
7852546|NCT00947310|19328838|P3|COMPLETED|Overall Study||486
7852547|NCT00947310|19328839|P2|COMPLETED|Overall Study||500
7852548|NCT00947310|19328840|P1|COMPLETED|Overall Study||514
7852549|NCT00947310|19328838|P3|STARTED|Overall Study||486
7852550|NCT00947310|19328839|P2|STARTED|Overall Study||500
7852551|NCT00947310|19328840|P1|STARTED|Overall Study||514
7852552|NCT00947297|19328854|P1|NOT COMPLETED|Overall Study||7
7852553|NCT00947297|19328854|P1|COMPLETED|Overall Study||53
7852554|NCT00947297|19328854|P1|STARTED|Overall Study||60
7852555|NCT00947284|19328861|P2|NOT COMPLETED|Overall Study||3
7852556|NCT00947284|19328862|P1|NOT COMPLETED|Overall Study||0
7852557|NCT00947284|19328861|P2|COMPLETED|Overall Study||0
7852558|NCT00947284|19328862|P1|COMPLETED|Overall Study||0
7852559|NCT00947284|19328861|P2|STARTED|Overall Study||3
7852560|NCT00947284|19328862|P1|STARTED|Overall Study||0
7852561|NCT00947271|19328870|P4|NOT COMPLETED|12 Months Post Intervention||62
7852562|NCT00947271|19328871|P3|NOT COMPLETED|12 Months Post Intervention||59
7852563|NCT00947271|19328872|P2|NOT COMPLETED|12 Months Post Intervention||60
7852564|NCT00947271|19328873|P1|NOT COMPLETED|12 Months Post Intervention||71
7852565|NCT00947271|19328870|P4|COMPLETED|12 Months Post Intervention||188
7852566|NCT00947271|19328871|P3|COMPLETED|12 Months Post Intervention||195
7852567|NCT00947271|19328872|P2|COMPLETED|12 Months Post Intervention||192
7852568|NCT00947271|19328873|P1|COMPLETED|12 Months Post Intervention||183
7852569|NCT00947271|19328870|P4|STARTED|12 Months Post Intervention||250
7852570|NCT00947271|19328871|P3|STARTED|12 Months Post Intervention||254
7852571|NCT00947271|19328872|P2|STARTED|12 Months Post Intervention||252
7852572|NCT00947271|19328873|P1|STARTED|12 Months Post Intervention||254
7852573|NCT00947271|19328870|P4|NOT COMPLETED|9 Months Post Intervention||59
7852574|NCT00947271|19328871|P3|NOT COMPLETED|9 Months Post Intervention||61
7852575|NCT00947271|19328872|P2|NOT COMPLETED|9 Months Post Intervention||60
7852576|NCT00947271|19328873|P1|NOT COMPLETED|9 Months Post Intervention||70
7852577|NCT00947271|19328870|P4|COMPLETED|9 Months Post Intervention||191
7852578|NCT00947271|19328871|P3|COMPLETED|9 Months Post Intervention||193
7852579|NCT00947271|19328872|P2|COMPLETED|9 Months Post Intervention||192
7852580|NCT00947271|19328873|P1|COMPLETED|9 Months Post Intervention||184
7852581|NCT00947271|19328870|P4|STARTED|9 Months Post Intervention||250
7852582|NCT00947271|19328871|P3|STARTED|9 Months Post Intervention||254
7852583|NCT00947271|19328872|P2|STARTED|9 Months Post Intervention||252
7852584|NCT00947271|19328873|P1|STARTED|9 Months Post Intervention||254
7852585|NCT00947271|19328870|P4|NOT COMPLETED|6 Months Post Intervention||54
7852586|NCT00947271|19328871|P3|NOT COMPLETED|6 Months Post Intervention||58
7852587|NCT00947271|19328872|P2|NOT COMPLETED|6 Months Post Intervention||53
7852588|NCT00947271|19328873|P1|NOT COMPLETED|6 Months Post Intervention||55
7852589|NCT00947271|19328870|P4|COMPLETED|6 Months Post Intervention||196
7852590|NCT00947271|19328871|P3|COMPLETED|6 Months Post Intervention||196
7852591|NCT00947271|19328872|P2|COMPLETED|6 Months Post Intervention||199
7852592|NCT00947271|19328873|P1|COMPLETED|6 Months Post Intervention||199
7852593|NCT00947271|19328870|P4|STARTED|6 Months Post Intervention||250
7852594|NCT00947271|19328871|P3|STARTED|6 Months Post Intervention||254
7852595|NCT00947271|19328872|P2|STARTED|6 Months Post Intervention||252
7852596|NCT00947271|19328873|P1|STARTED|6 Months Post Intervention||254
7852597|NCT00947271|19328870|P4|NOT COMPLETED|3 Months Post Intervention||44
7852598|NCT00947271|19328871|P3|NOT COMPLETED|3 Months Post Intervention||36
7852599|NCT00947271|19328872|P2|NOT COMPLETED|3 Months Post Intervention||48
7852600|NCT00947271|19328873|P1|NOT COMPLETED|3 Months Post Intervention||52
7852601|NCT00947271|19328870|P4|COMPLETED|3 Months Post Intervention||206
7852602|NCT00947271|19328871|P3|COMPLETED|3 Months Post Intervention||218
7852603|NCT00947271|19328872|P2|COMPLETED|3 Months Post Intervention||204
7852604|NCT00947271|19328873|P1|COMPLETED|3 Months Post Intervention||202
7852605|NCT00947271|19328870|P4|STARTED|3 Months Post Intervention||250
7852606|NCT00947271|19328871|P3|STARTED|3 Months Post Intervention||254
7852607|NCT00947271|19328872|P2|STARTED|3 Months Post Intervention||252
7852608|NCT00947271|19328873|P1|STARTED|3 Months Post Intervention||254
7852609|NCT00947219|19328902|P3|NOT COMPLETED|Overall Study||4
7852610|NCT00947219|19328903|P2|NOT COMPLETED|Overall Study||4
7852611|NCT00947219|19328904|P1|NOT COMPLETED|Overall Study||6
7852612|NCT00947219|19328902|P3|COMPLETED|Overall Study||22
7852613|NCT00947219|19328903|P2|COMPLETED|Overall Study||21
7852614|NCT00947219|19328904|P1|COMPLETED|Overall Study||22
7852615|NCT00947219|19328902|P3|STARTED|Overall Study||26
7852616|NCT00947219|19328903|P2|STARTED|Overall Study||25
7852617|NCT00947219|19328904|P1|STARTED|Overall Study||28
7852618|NCT00947193|19328912|P2|NOT COMPLETED|Overall Study||0
7852619|NCT00947193|19328913|P1|NOT COMPLETED|Overall Study||3
7852620|NCT00947193|19328912|P2|COMPLETED|Overall Study||10
7852621|NCT00947193|19328913|P1|COMPLETED|Overall Study||0
7852622|NCT00947193|19328912|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
7852623|NCT00947193|19328913|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
7852624|NCT00947193|19328912|P2|STARTED|Overall Study||10
7852625|NCT00947193|19328913|P1|STARTED|Overall Study||3
7852626|NCT00947167|19328923|P1|NOT COMPLETED|Erlotinib Added to Pertuzumab||0
7852627|NCT00947167|19328923|P1|COMPLETED|Erlotinib Added to Pertuzumab||3
7852628|NCT00947167|19328923|P1|STARTED|Erlotinib Added to Pertuzumab||3
7852629|NCT00947167|19328923|P1|NOT COMPLETED|Pertuzumab Alone||0
7852630|NCT00947167|19328923|P1|COMPLETED|Pertuzumab Alone||4
7852631|NCT00947167|19328923|P1|STARTED|Pertuzumab Alone||4
7852632|NCT00947154|19328928|P1|NOT COMPLETED|Overall Study||1
7852633|NCT00947154|19328928|P1|COMPLETED|Overall Study||11
7852634|NCT00947154|19328928|P1|STARTED|Overall Study||12
7852635|NCT00947115|19328938|P3|NOT COMPLETED|Overall Study||15
7852636|NCT00947115|19328939|P2|NOT COMPLETED|Overall Study||22
7852637|NCT00947115|19328940|P1|NOT COMPLETED|Overall Study||17
7852638|NCT00947115|19328938|P3|COMPLETED|Overall Study||156
7852639|NCT00947115|19328939|P2|COMPLETED|Overall Study||172
7852640|NCT00947115|19328940|P1|COMPLETED|Overall Study||142
7852641|NCT00947115|19328938|P3|STARTED|Overall Study||171
7852642|NCT00947115|19328939|P2|STARTED|Overall Study||194
7852643|NCT00947115|19328940|P1|STARTED|Overall Study||159
7852644|NCT00947011|19329002|P1|NOT COMPLETED|Overall Study||12
7852645|NCT00947011|19329002|P1|COMPLETED|Overall Study||0
7852646|NCT00947011|19329002|P1|STARTED|Overall Study||12
7852647|NCT00946998|19329012|P2|NOT COMPLETED|Overall Study||3
7852648|NCT00946998|19329013|P1|NOT COMPLETED|Overall Study||5
7852649|NCT00946998|19329012|P2|COMPLETED|Overall Study||96
7852650|NCT00946998|19329013|P1|COMPLETED|Overall Study||97
7852651|NCT00946998|19329012|P2|Received Treatment as Randomized|Overall Study||99
7852652|NCT00946998|19329013|P1|Received Treatment as Randomized|Overall Study||102
7852653|NCT00946998|19329012|P2|STARTED|Overall Study||99
7852654|NCT00946998|19329013|P1|STARTED|Overall Study||102
7852655|NCT00946985|19329027|P1|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2
7852656|NCT00946985|19329027|P1|COMPLETED|Relapse Prevention Phase (24 Months)||0
7852657|NCT00946985|19329027|P1|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2
7852658|NCT00946985|19329027|P1|NOT COMPLETED|Stabilization Phase (25 Weeks)||160
7852659|NCT00946985|19329027|P1|COMPLETED|Stabilization Phase (25 Weeks)||2
7852660|NCT00946985|19329027|P1|STARTED|Stabilization Phase (25 Weeks)||162
7852661|NCT00946920|19329033|P2|NOT COMPLETED|Overall Study||44
7852662|NCT00946920|19329034|P1|NOT COMPLETED|Overall Study||110
7852663|NCT00946920|19329033|P2|COMPLETED|Overall Study||239
7852664|NCT00946920|19329034|P1|COMPLETED|Overall Study||455
7852665|NCT00946920|19329033|P2|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282
7852666|NCT00946920|19329034|P1|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565
7852667|NCT00946920|19329033|P2|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283
7852668|NCT00946920|19329034|P1|STARTED|Overall Study|Received at least one dose of degarelix.|565
7852669|NCT00946881|19329049|P1|NOT COMPLETED|Retreatment||1
7852670|NCT00946881|19329049|P1|COMPLETED|Retreatment||7
7852671|NCT00946881|19329049|P1|STARTED|Retreatment||8
7852672|NCT00946881|19329049|P1|NOT COMPLETED|First Treatment||2
7852673|NCT00946881|19329049|P1|COMPLETED|First Treatment||28
7852674|NCT00946881|19329049|P1|STARTED|First Treatment||30
7852675|NCT00946712|19329080|P2|NOT COMPLETED|Overall Study||662
7852676|NCT00946712|19329081|P1|NOT COMPLETED|Overall Study||547
7852677|NCT00946712|19329080|P2|COMPLETED|Overall Study||0
7852678|NCT00946712|19329081|P1|COMPLETED|Overall Study||124
7852679|NCT00946712|19329080|P2|STARTED|Overall Study||662
7852680|NCT00946712|19329081|P1|STARTED|Overall Study||671
7852681|NCT00946647|19329100|P5|NOT COMPLETED|Phase ll Part||42
7852682|NCT00946647|19329101|P4|NOT COMPLETED|Phase ll Part||40
7852683|NCT00946647|19329102|P3|NOT COMPLETED|Phase ll Part||0
7852684|NCT00946647|19329103|P2|NOT COMPLETED|Phase ll Part||0
7852685|NCT00946647|19329104|P1|NOT COMPLETED|Phase ll Part||0
7852686|NCT00946647|19329100|P5|COMPLETED|Phase ll Part||0
7852687|NCT00946647|19329101|P4|COMPLETED|Phase ll Part||0
7852688|NCT00946647|19329102|P3|COMPLETED|Phase ll Part||0
7852689|NCT00946647|19329103|P2|COMPLETED|Phase ll Part||0
7852690|NCT00946647|19329104|P1|COMPLETED|Phase ll Part||0
7852691|NCT00946647|19329100|P5|Safety Set|Phase ll Part|2 pts rand. to PAN+5AZA, did not receive PAN but received 5AZA|42
7852692|NCT00946647|19329101|P4|Safety Set|Phase ll Part|2 pts rand. to this grp did not receive PAN|38
7852693|NCT00946647|19329102|P3|Safety Set|Phase ll Part||0
7852694|NCT00946647|19329103|P2|Safety Set|Phase ll Part||0
7852695|NCT00946647|19329104|P1|Safety Set|Phase ll Part||0
7852696|NCT00946647|19329100|P5|STARTED|Phase ll Part||42
7852697|NCT00946647|19329101|P4|STARTED|Phase ll Part||40
7852698|NCT00946647|19329102|P3|STARTED|Phase ll Part||0
7852699|NCT00946647|19329103|P2|STARTED|Phase ll Part||0
7852700|NCT00946647|19329104|P1|STARTED|Phase ll Part||0
7852701|NCT00946647|19329100|P5|NOT COMPLETED|Phase 1 Part||0
7852702|NCT00946647|19329101|P4|NOT COMPLETED|Phase 1 Part||0
7852703|NCT00946647|19329102|P3|NOT COMPLETED|Phase 1 Part||7
7852704|NCT00946647|19329103|P2|NOT COMPLETED|Phase 1 Part||18
7852705|NCT00946647|19329104|P1|NOT COMPLETED|Phase 1 Part||6
7852706|NCT00946647|19329100|P5|COMPLETED|Phase 1 Part||0
7852707|NCT00946647|19329101|P4|COMPLETED|Phase 1 Part||0
7852708|NCT00946647|19329102|P3|COMPLETED|Phase 1 Part||0
7852709|NCT00946647|19329103|P2|COMPLETED|Phase 1 Part||0
7852710|NCT00946647|19329104|P1|COMPLETED|Phase 1 Part||0
7852711|NCT00946647|19329100|P5|STARTED|Phase 1 Part||0
7852712|NCT00946647|19329101|P4|STARTED|Phase 1 Part||0
7852713|NCT00946647|19329102|P3|STARTED|Phase 1 Part||7
7852714|NCT00946647|19329103|P2|STARTED|Phase 1 Part||18
7852715|NCT00946647|19329104|P1|STARTED|Phase 1 Part||6
7852716|NCT00946530|19329138|P4|NOT COMPLETED|Overall Study||4
7852717|NCT00946530|19329139|P3|NOT COMPLETED|Overall Study||1
7852718|NCT00946530|19329140|P2|NOT COMPLETED|Overall Study||4
7852719|NCT00946530|19329141|P1|NOT COMPLETED|Overall Study||1
7852720|NCT00946530|19329138|P4|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|23
7852721|NCT00946530|19329139|P3|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
7852722|NCT00946530|19329140|P2|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver completed to the Dim Light (Control) arm|23
7852723|NCT00946530|19329141|P1|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
7852724|NCT00946530|19329138|P4|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
7852725|NCT00946530|19329139|P3|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
7852726|NCT00946530|19329140|P2|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
7852727|NCT00946530|19329141|P1|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
7852728|NCT00946478|19329157|P2|NOT COMPLETED|Overall Study||0
7852729|NCT00946478|19329158|P1|NOT COMPLETED|Overall Study||0
7852730|NCT00946478|19329157|P2|COMPLETED|Overall Study||20
7852731|NCT00946478|19329158|P1|COMPLETED|Overall Study||20
7852732|NCT00946478|19329157|P2|STARTED|Overall Study||20
7852733|NCT00946478|19329158|P1|STARTED|Overall Study||20
7852734|NCT00946348|19329166|P2|NOT COMPLETED|Overall Study||0
7852735|NCT00946348|19329167|P1|NOT COMPLETED|Overall Study||0
7852736|NCT00946348|19329166|P2|COMPLETED|Overall Study||6
7852737|NCT00946348|19329167|P1|COMPLETED|Overall Study||6
7852738|NCT00946348|19329166|P2|STARTED|Overall Study||6
7852739|NCT00946348|19329167|P1|STARTED|Overall Study||6
7852740|NCT00946322|19329173|P1|NOT COMPLETED|Post-treatment||2
7852741|NCT00946322|19329173|P1|COMPLETED|Post-treatment||9
7852742|NCT00946322|19329173|P1|STARTED|Post-treatment||11
7852743|NCT00946322|19329173|P1|NOT COMPLETED|Pre-treatment||1
7852744|NCT00946322|19329173|P1|COMPLETED|Pre-treatment||11
7852745|NCT00946322|19329173|P1|STARTED|Pre-treatment||12
7852746|NCT00946309|19329186|P2|NOT COMPLETED|Overall Study||4
7852747|NCT00946309|19329187|P1|NOT COMPLETED|Overall Study||1
7852748|NCT00946309|19329186|P2|COMPLETED|Overall Study||19
7852749|NCT00946309|19329187|P1|COMPLETED|Overall Study||21
7852750|NCT00946309|19329186|P2|STARTED|Overall Study||23
7852751|NCT00946309|19329187|P1|STARTED|Overall Study||22
7852752|NCT00946296|19329205|P2|NOT COMPLETED|Overall Study||0
7852753|NCT00946296|19329206|P1|NOT COMPLETED|Overall Study||3
7852754|NCT00946296|19329205|P2|COMPLETED|Overall Study||15
7852755|NCT00946296|19329206|P1|COMPLETED|Overall Study||18
7852756|NCT00946296|19329205|P2|STARTED|Overall Study||15
7852757|NCT00946296|19329206|P1|STARTED|Overall Study||21
7852758|NCT00946270|19329215|P3|NOT COMPLETED|Overall Study||0
7852759|NCT00946270|19329216|P2|NOT COMPLETED|Overall Study||0
7852760|NCT00946270|19329217|P1|NOT COMPLETED|Overall Study||0
7852761|NCT00946270|19329215|P3|COMPLETED|Overall Study||29
7852762|NCT00946270|19329216|P2|COMPLETED|Overall Study||20
7852763|NCT00946270|19329217|P1|COMPLETED|Overall Study||21
7852764|NCT00946270|19329215|P3|STARTED|Overall Study||29
7852765|NCT00946270|19329216|P2|STARTED|Overall Study||20
7852766|NCT00946270|19329217|P1|STARTED|Overall Study||21
7852767|NCT00946192|19329228|P3|NOT COMPLETED|Overall Study||12
7852768|NCT00946192|19329229|P2|NOT COMPLETED|Overall Study||18
7852769|NCT00946192|19329230|P1|NOT COMPLETED|Overall Study||18
7852770|NCT00946192|19329228|P3|COMPLETED|Overall Study||26
7852771|NCT00946192|19329229|P2|COMPLETED|Overall Study||22
7852772|NCT00946192|19329230|P1|COMPLETED|Overall Study||25
7852773|NCT00946192|19329228|P3|STARTED|Overall Study||38
7852774|NCT00946192|19329229|P2|STARTED|Overall Study||40
7852775|NCT00946192|19329230|P1|STARTED|Overall Study||43
7852776|NCT00946153|19329246|P5|NOT COMPLETED|Phase 2||13
7852777|NCT00946153|19329247|P4|NOT COMPLETED|Phase 2||0
7852778|NCT00946153|19329248|P3|NOT COMPLETED|Phase 2||0
7852779|NCT00946153|19329249|P2|NOT COMPLETED|Phase 2||0
7852780|NCT00946153|19329250|P1|NOT COMPLETED|Phase 2||0
7852781|NCT00946153|19329246|P5|COMPLETED|Phase 2||33
7852782|NCT00946153|19329247|P4|COMPLETED|Phase 2||0
7852783|NCT00946153|19329248|P3|COMPLETED|Phase 2||0
7852784|NCT00946153|19329249|P2|COMPLETED|Phase 2||0
7852785|NCT00946153|19329250|P1|COMPLETED|Phase 2||0
7852786|NCT00946153|19329246|P5|STARTED|Phase 2||46
7852787|NCT00946153|19329247|P4|STARTED|Phase 2||0
7852788|NCT00946153|19329248|P3|STARTED|Phase 2||0
7852789|NCT00946153|19329249|P2|STARTED|Phase 2||0
7852790|NCT00946153|19329250|P1|STARTED|Phase 2||0
7852791|NCT00946153|19329246|P5|NOT COMPLETED|Phase 1||0
7852792|NCT00946153|19329247|P4|NOT COMPLETED|Phase 1||0
7852793|NCT00946153|19329248|P3|NOT COMPLETED|Phase 1||0
7852794|NCT00946153|19329249|P2|NOT COMPLETED|Phase 1||0
7852795|NCT00946153|19329250|P1|NOT COMPLETED|Phase 1||0
7852796|NCT00946153|19329246|P5|COMPLETED|Phase 1||0
7852797|NCT00946153|19329247|P4|COMPLETED|Phase 1||5
7852798|NCT00946153|19329248|P3|COMPLETED|Phase 1||6
7852799|NCT00946153|19329249|P2|COMPLETED|Phase 1||3
7852800|NCT00946153|19329250|P1|COMPLETED|Phase 1||6
7852801|NCT00946153|19329246|P5|STARTED|Phase 1||0
7852802|NCT00946153|19329247|P4|STARTED|Phase 1||5
7852803|NCT00946153|19329248|P3|STARTED|Phase 1||6
7852804|NCT00946153|19329249|P2|STARTED|Phase 1||3
7852805|NCT00946153|19329250|P1|STARTED|Phase 1||6
7852806|NCT00946114|19329278|P2|NOT COMPLETED|Overall Study||2
7852807|NCT00946114|19329279|P1|NOT COMPLETED|Overall Study||8
7852808|NCT00946114|19329278|P2|COMPLETED|Overall Study||10
7852809|NCT00946114|19329279|P1|COMPLETED|Overall Study||12
7852810|NCT00946114|19329278|P2|STARTED|Overall Study||12
7852811|NCT00946114|19329279|P1|STARTED|Overall Study||20
7852812|NCT00946101|19329287|P2|NOT COMPLETED|Overall Study||2
7852813|NCT00946101|19329288|P1|NOT COMPLETED|Overall Study||4
7852814|NCT00946101|19329287|P2|COMPLETED|Overall Study||63
7852815|NCT00946101|19329288|P1|COMPLETED|Overall Study||257
7852816|NCT00946101|19329287|P2|Day 15 Post Dose 2|Overall Study||63
7852817|NCT00946101|19329288|P1|Day 15 Post Dose 2|Overall Study||254
7852818|NCT00946101|19329287|P2|Day 15 Post Dose 1|Overall Study||64
7852819|NCT00946101|19329288|P1|Day 15 Post Dose 1|Overall Study||260
7852820|NCT00946101|19329287|P2|STARTED|Overall Study||65
7852821|NCT00946101|19329288|P1|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261
7852822|NCT00946088|19329354|P2|NOT COMPLETED|Overall Study||1
7852823|NCT00946088|19329355|P1|NOT COMPLETED|Overall Study||0
7852824|NCT00946088|19329354|P2|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2
7852825|NCT00946088|19329355|P1|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4
7852826|NCT00946088|19329354|P2|STARTED|Overall Study||3
7852827|NCT00946088|19329355|P1|STARTED|Overall Study||4
7852828|NCT00946023|19329377|P1|NOT COMPLETED|Overall Study||0
7852829|NCT00946023|19329377|P1|COMPLETED|Overall Study||83
7852830|NCT00946023|19329377|P1|STARTED|Overall Study||83
7852831|NCT00945958|19329392|P1|NOT COMPLETED|Overall Study||12
7852832|NCT00945958|19329392|P1|COMPLETED|Overall Study||149
7852833|NCT00945958|19329392|P1|STARTED|Overall Study||161
7852834|NCT00945945|19329399|P2|NOT COMPLETED|Overall Study||55
7852835|NCT00945945|19329400|P1|NOT COMPLETED|Overall Study||36
7852836|NCT00945945|19329399|P2|COMPLETED|Overall Study||162
7852837|NCT00945945|19329400|P1|COMPLETED|Overall Study||171
7852838|NCT00945945|19329399|P2|STARTED|Overall Study||217
7852839|NCT00945945|19329400|P1|STARTED|Overall Study||207
7852840|NCT00945906|19329426|P1|NOT COMPLETED|Overall Study||7
7852841|NCT00945906|19329426|P1|COMPLETED|Overall Study||54
7852842|NCT00945906|19329426|P1|STARTED|Overall Study||61
7852843|NCT00945893|19329437|P2|NOT COMPLETED|Overall Study||10
7852844|NCT00945893|19329438|P1|NOT COMPLETED|Overall Study||3
7852845|NCT00945893|19329437|P2|COMPLETED|Overall Study||230
7852846|NCT00945893|19329438|P1|COMPLETED|Overall Study||57
7852847|NCT00945893|19329437|P2|Day 15 Post Dose 2|Overall Study||226
7852848|NCT00945893|19329438|P1|Day 15 Post Dose 2|Overall Study||54
7852849|NCT00945893|19329437|P2|Day 15 Post Dose 1|Overall Study||238
7852850|NCT00945893|19329438|P1|Day 15 Post Dose 1|Overall Study||60
7852851|NCT00945893|19329437|P2|STARTED|Overall Study||240
7852852|NCT00945893|19329438|P1|STARTED|Overall Study||60
7852853|NCT00945854|19329504|P2|NOT COMPLETED|Overall Study||4
7852854|NCT00945854|19329505|P1|NOT COMPLETED|Overall Study||2
7852855|NCT00945854|19329504|P2|COMPLETED|Overall Study||26
7852856|NCT00945854|19329505|P1|COMPLETED|Overall Study||28
7852857|NCT00945854|19329504|P2|STARTED|Overall Study||30
7852858|NCT00945854|19329505|P1|STARTED|Overall Study||30
7852859|NCT00945815|19329515|P1|NOT COMPLETED|Overall Study||8
7852860|NCT00945815|19329515|P1|COMPLETED|Overall Study||27
7852861|NCT00945815|19329515|P1|Eligible and Began Protocol Therapy|Overall Study||31
7852862|NCT00945815|19329515|P1|Eligible|Overall Study||32
7852863|NCT00945815|19329515|P1|STARTED|Overall Study||35
7852864|NCT00945750|19329526|P6|NOT COMPLETED|Period III||0
7852865|NCT00945750|19329527|P5|NOT COMPLETED|Period III||0
7852866|NCT00945750|19329528|P4|NOT COMPLETED|Period III||0
7852867|NCT00945750|19329529|P3|NOT COMPLETED|Period III||0
7852868|NCT00945750|19329530|P2|NOT COMPLETED|Period III||0
7852869|NCT00945750|19329531|P1|NOT COMPLETED|Period III||0
7852870|NCT00945750|19329526|P6|COMPLETED|Period III||5
7852871|NCT00945750|19329527|P5|COMPLETED|Period III||5
7852872|NCT00945750|19329528|P4|COMPLETED|Period III||5
7852873|NCT00945750|19329529|P3|COMPLETED|Period III||5
7852874|NCT00945750|19329530|P2|COMPLETED|Period III||5
7852875|NCT00945750|19329531|P1|COMPLETED|Period III||5
7852876|NCT00945750|19329526|P6|STARTED|Period III||5
7852877|NCT00945750|19329527|P5|STARTED|Period III||5
7852878|NCT00945750|19329528|P4|STARTED|Period III||5
7852879|NCT00945750|19329529|P3|STARTED|Period III||5
7852880|NCT00945750|19329530|P2|STARTED|Period III||5
7852881|NCT00945750|19329531|P1|STARTED|Period III||5
7852882|NCT00945750|19329526|P6|NOT COMPLETED|Period II||0
7852883|NCT00945750|19329527|P5|NOT COMPLETED|Period II||0
7852884|NCT00945750|19329528|P4|NOT COMPLETED|Period II||0
7852885|NCT00945750|19329529|P3|NOT COMPLETED|Period II||0
7852886|NCT00945750|19329530|P2|NOT COMPLETED|Period II||0
7852887|NCT00945750|19329531|P1|NOT COMPLETED|Period II||0
7852888|NCT00945750|19329526|P6|COMPLETED|Period II||5
7852889|NCT00945750|19329527|P5|COMPLETED|Period II||5
7852890|NCT00945750|19329528|P4|COMPLETED|Period II||5
7852891|NCT00945750|19329529|P3|COMPLETED|Period II||5
7852892|NCT00945750|19329530|P2|COMPLETED|Period II||5
7852893|NCT00945750|19329531|P1|COMPLETED|Period II||5
7852894|NCT00945750|19329526|P6|STARTED|Period II||5
7852895|NCT00945750|19329527|P5|STARTED|Period II||5
7852896|NCT00945750|19329528|P4|STARTED|Period II||5
7852897|NCT00945750|19329529|P3|STARTED|Period II||5
7852898|NCT00945750|19329530|P2|STARTED|Period II||5
7852899|NCT00945750|19329531|P1|STARTED|Period II||5
7852900|NCT00945750|19329526|P6|NOT COMPLETED|Period I||0
7852901|NCT00945750|19329527|P5|NOT COMPLETED|Period I||0
7852902|NCT00945750|19329528|P4|NOT COMPLETED|Period I||0
7852903|NCT00945750|19329529|P3|NOT COMPLETED|Period I||0
7852904|NCT00945750|19329530|P2|NOT COMPLETED|Period I||0
7852905|NCT00945750|19329531|P1|NOT COMPLETED|Period I||0
7852906|NCT00945750|19329526|P6|COMPLETED|Period I||5
7852907|NCT00945750|19329527|P5|COMPLETED|Period I||5
7852908|NCT00945750|19329528|P4|COMPLETED|Period I||5
7852909|NCT00945750|19329529|P3|COMPLETED|Period I||5
7852910|NCT00945750|19329530|P2|COMPLETED|Period I||5
7852911|NCT00945750|19329531|P1|COMPLETED|Period I||5
7852912|NCT00945750|19329526|P6|STARTED|Period I||5
7852913|NCT00945750|19329527|P5|STARTED|Period I||5
7852914|NCT00945750|19329528|P4|STARTED|Period I||5
7852915|NCT00945750|19329529|P3|STARTED|Period I||5
7852916|NCT00945750|19329530|P2|STARTED|Period I||5
7852917|NCT00945750|19329531|P1|STARTED|Period I||5
7852918|NCT00945659|19329547|P3|NOT COMPLETED|Overall Study||17
7852919|NCT00945659|19329548|P2|NOT COMPLETED|Overall Study||20
7852920|NCT00945659|19329549|P1|NOT COMPLETED|Overall Study||7
7852921|NCT00945659|19329547|P3|COMPLETED|Overall Study||20
7852922|NCT00945659|19329548|P2|COMPLETED|Overall Study||20
7852923|NCT00945659|19329549|P1|COMPLETED|Overall Study||32
7852924|NCT00945659|19329547|P3|12-Months|Overall Study||20
7852925|NCT00945659|19329548|P2|12-Months|Overall Study||20
7852926|NCT00945659|19329549|P1|12-Months|Overall Study||32
7852927|NCT00945659|19329547|P3|9-Months|Overall Study||20
7852928|NCT00945659|19329548|P2|9-Months|Overall Study||20
7852929|NCT00945659|19329549|P1|9-Months|Overall Study||32
7852930|NCT00945659|19329547|P3|6-Months|Overall Study||25
7852931|NCT00945659|19329548|P2|6-Months|Overall Study||29
7852932|NCT00945659|19329549|P1|6-Months|Overall Study||31
7852933|NCT00945659|19329547|P3|3-Months|Overall Study||35
7852934|NCT00945659|19329548|P2|3-Months|Overall Study||39
7852935|NCT00945659|19329549|P1|3-Months|Overall Study||38
7852936|NCT00945659|19329547|P3|Baseline|Overall Study||37
7852937|NCT00945659|19329548|P2|Baseline|Overall Study||40
7852938|NCT00945659|19329549|P1|Baseline|Overall Study||39
7852939|NCT00945659|19329547|P3|STARTED|Overall Study||37
7852940|NCT00945659|19329548|P2|STARTED|Overall Study||40
7852941|NCT00945659|19329549|P1|STARTED|Overall Study||39
7852942|NCT00945594|19329595|P2|NOT COMPLETED|Overall Study||0
7852943|NCT00945594|19329596|P1|NOT COMPLETED|Overall Study||0
7852944|NCT00945594|19329595|P2|COMPLETED|Overall Study||50
7852945|NCT00945594|19329596|P1|COMPLETED|Overall Study||50
7852946|NCT00945594|19329595|P2|STARTED|Overall Study||50
7852947|NCT00945594|19329596|P1|STARTED|Overall Study||50
7852948|NCT00945555|19329606|P1|NOT COMPLETED|Overall Study||28
7852949|NCT00945555|19329606|P1|COMPLETED|Overall Study||236
7852950|NCT00945555|19329606|P1|STARTED|Overall Study||264
7852951|NCT00945477|19329617|P1|NOT COMPLETED|Overall Study||6
7852952|NCT00945477|19329617|P1|COMPLETED|Overall Study||5
7852953|NCT00945477|19329617|P1|STARTED|Overall Study||11
7852954|NCT00945334|19329624|P2|NOT COMPLETED|Overall Study||3
7852955|NCT00945334|19329625|P1|NOT COMPLETED|Overall Study||3
7852956|NCT00945334|19329624|P2|COMPLETED|Overall Study||15
7852957|NCT00945334|19329625|P1|COMPLETED|Overall Study||16
7852958|NCT00945334|19329624|P2|STARTED|Overall Study||18
7852959|NCT00945334|19329625|P1|STARTED|Overall Study||19
7852960|NCT00945321|19329633|P6|NOT COMPLETED|Period 4||1
7852961|NCT00945321|19329634|P5|NOT COMPLETED|Period 4||0
7852962|NCT00945321|19329635|P4|NOT COMPLETED|Period 4||0
7852963|NCT00945321|19329636|P3|NOT COMPLETED|Period 4||0
7852964|NCT00945321|19329637|P2|NOT COMPLETED|Period 4||0
7852965|NCT00945321|19329638|P1|NOT COMPLETED|Period 4||0
7852966|NCT00945321|19329633|P6|COMPLETED|Period 4||6
7852967|NCT00945321|19329634|P5|COMPLETED|Period 4||6
7852968|NCT00945321|19329635|P4|COMPLETED|Period 4||7
7852969|NCT00945321|19329636|P3|COMPLETED|Period 4||7
7852970|NCT00945321|19329637|P2|COMPLETED|Period 4||7
7852971|NCT00945321|19329638|P1|COMPLETED|Period 4||7
7852972|NCT00945321|19329633|P6|STARTED|Period 4||7
7852973|NCT00945321|19329634|P5|STARTED|Period 4||6
7852974|NCT00945321|19329635|P4|STARTED|Period 4||7
7852975|NCT00945321|19329636|P3|STARTED|Period 4||7
7852976|NCT00945321|19329637|P2|STARTED|Period 4||7
7852977|NCT00945321|19329638|P1|STARTED|Period 4||7
7852978|NCT00945321|19329633|P6|NOT COMPLETED|Period 3||0
7852979|NCT00945321|19329634|P5|NOT COMPLETED|Period 3||0
7852980|NCT00945321|19329635|P4|NOT COMPLETED|Period 3||0
7852981|NCT00945321|19329636|P3|NOT COMPLETED|Period 3||0
7852982|NCT00945321|19329637|P2|NOT COMPLETED|Period 3||0
7852983|NCT00945321|19329638|P1|NOT COMPLETED|Period 3||0
7852984|NCT00945321|19329633|P6|COMPLETED|Period 3||7
7852985|NCT00945321|19329634|P5|COMPLETED|Period 3||6
7852986|NCT00945321|19329635|P4|COMPLETED|Period 3||7
7852987|NCT00945321|19329636|P3|COMPLETED|Period 3||7
7852988|NCT00945321|19329637|P2|COMPLETED|Period 3||7
7852989|NCT00945321|19329638|P1|COMPLETED|Period 3||7
7852990|NCT00945321|19329633|P6|STARTED|Period 3||7
7852991|NCT00945321|19329634|P5|STARTED|Period 3||6
7852992|NCT00945321|19329635|P4|STARTED|Period 3||7
7852993|NCT00945321|19329636|P3|STARTED|Period 3||7
7852994|NCT00945321|19329637|P2|STARTED|Period 3||7
7852995|NCT00945321|19329638|P1|STARTED|Period 3||7
7852996|NCT00945321|19329633|P6|NOT COMPLETED|Period 2||0
7852997|NCT00945321|19329634|P5|NOT COMPLETED|Period 2||0
7852998|NCT00945321|19329635|P4|NOT COMPLETED|Period 2||0
7852999|NCT00945321|19329636|P3|NOT COMPLETED|Period 2||0
7853000|NCT00945321|19329637|P2|NOT COMPLETED|Period 2||0
7853001|NCT00945321|19329638|P1|NOT COMPLETED|Period 2||0
7853002|NCT00945321|19329633|P6|COMPLETED|Period 2||7
7853003|NCT00945321|19329634|P5|COMPLETED|Period 2||6
7853004|NCT00945321|19329635|P4|COMPLETED|Period 2||7
7853005|NCT00945321|19329636|P3|COMPLETED|Period 2||7
7853006|NCT00945321|19329637|P2|COMPLETED|Period 2||7
7853007|NCT00945321|19329638|P1|COMPLETED|Period 2||7
7853008|NCT00945321|19329633|P6|STARTED|Period 2||7
7853009|NCT00945321|19329634|P5|STARTED|Period 2||6
7853010|NCT00945321|19329635|P4|STARTED|Period 2||7
7853011|NCT00945321|19329636|P3|STARTED|Period 2||7
7853012|NCT00945321|19329637|P2|STARTED|Period 2||7
7853013|NCT00945321|19329638|P1|STARTED|Period 2||7
7853014|NCT00945321|19329633|P6|NOT COMPLETED|Period 1||0
7853015|NCT00945321|19329634|P5|NOT COMPLETED|Period 1||1
7853016|NCT00945321|19329635|P4|NOT COMPLETED|Period 1||0
7853017|NCT00945321|19329636|P3|NOT COMPLETED|Period 1||0
7853018|NCT00945321|19329637|P2|NOT COMPLETED|Period 1||0
7853019|NCT00945321|19329638|P1|NOT COMPLETED|Period 1||0
7853020|NCT00945321|19329633|P6|COMPLETED|Period 1||7
7853021|NCT00945321|19329634|P5|COMPLETED|Period 1||6
7853022|NCT00945321|19329635|P4|COMPLETED|Period 1||7
7853023|NCT00945321|19329636|P3|COMPLETED|Period 1||7
7853024|NCT00945321|19329637|P2|COMPLETED|Period 1||7
7853025|NCT00945321|19329638|P1|COMPLETED|Period 1||7
7853026|NCT00945321|19329633|P6|STARTED|Period 1||7
7853027|NCT00945321|19329634|P5|STARTED|Period 1||7
7853028|NCT00945321|19329635|P4|STARTED|Period 1||7
7853029|NCT00945321|19329636|P3|STARTED|Period 1||7
7853030|NCT00945321|19329637|P2|STARTED|Period 1||7
7853031|NCT00945321|19329638|P1|STARTED|Period 1||7
7853032|NCT00945295|19329660|P2|NOT COMPLETED|Overall Study||2
7853033|NCT00945295|19329661|P1|NOT COMPLETED|Overall Study||0
7853034|NCT00945295|19329660|P2|COMPLETED|Overall Study||14
7853035|NCT00945295|19329661|P1|COMPLETED|Overall Study||15
7853036|NCT00945295|19329660|P2|STARTED|Overall Study||16
7853037|NCT00945295|19329661|P1|STARTED|Overall Study||15
7853038|NCT00945282|19329671|P2|NOT COMPLETED|Overall Study||0
7853039|NCT00945282|19329672|P1|NOT COMPLETED|Overall Study||0
7853040|NCT00945282|19329671|P2|COMPLETED|Overall Study||2
7853041|NCT00945282|19329672|P1|COMPLETED|Overall Study||6
7853042|NCT00945282|19329671|P2|STARTED|Overall Study||2
7853043|NCT00945282|19329672|P1|STARTED|Overall Study||6
7853044|NCT00945256|19329755|P5|NOT COMPLETED|Overall Study||1
7853045|NCT00945256|19329756|P4|NOT COMPLETED|Overall Study||9
7853046|NCT00945256|19329757|P3|NOT COMPLETED|Overall Study||8
7853047|NCT00945256|19329758|P2|NOT COMPLETED|Overall Study||2
7853048|NCT00945256|19329759|P1|NOT COMPLETED|Overall Study||4
7853049|NCT00945256|19329755|P5|COMPLETED|Overall Study||7
7853050|NCT00945256|19329756|P4|COMPLETED|Overall Study||7
7853051|NCT00945256|19329757|P3|COMPLETED|Overall Study||7
7853052|NCT00945256|19329758|P2|COMPLETED|Overall Study||8
7853053|NCT00945256|19329759|P1|COMPLETED|Overall Study||9
7853054|NCT00945256|19329755|P5|STARTED|Overall Study||8
7853055|NCT00945256|19329756|P4|STARTED|Overall Study||16
7853056|NCT00945256|19329757|P3|STARTED|Overall Study||15
7853057|NCT00945256|19329758|P2|STARTED|Overall Study||10
7853058|NCT00945256|19329759|P1|STARTED|Overall Study||13
7853059|NCT00945243|19329771|P1|NOT COMPLETED|Overall Study||3
7853060|NCT00945243|19329771|P1|COMPLETED|Overall Study||8
7853061|NCT00945243|19329771|P1|STARTED|Overall Study|Enrolled and Treated Per Protocol|11
7853062|NCT00945191|19329777|P1|NOT COMPLETED|Overall Study||24
7853063|NCT00945191|19329777|P1|COMPLETED|Overall Study||0
7853064|NCT00945191|19329777|P1|STARTED|Overall Study||24
7853065|NCT00945139|19329783|P1|NOT COMPLETED|Overall Study||0
7853066|NCT00945139|19329783|P1|COMPLETED|Overall Study||46
7853067|NCT00945139|19329783|P1|STARTED|Overall Study||46
7853068|NCT00945100|19329794|P2|NOT COMPLETED|Post-10 Week Primary Outcome||7
7853069|NCT00945100|19329795|P1|NOT COMPLETED|Post-10 Week Primary Outcome||4
7853070|NCT00945100|19329794|P2|COMPLETED|Post-10 Week Primary Outcome||56
7853071|NCT00945100|19329795|P1|COMPLETED|Post-10 Week Primary Outcome||51
7853072|NCT00945100|19329794|P2|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63
7853073|NCT00945100|19329795|P1|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55
7853074|NCT00945100|19329794|P2|NOT COMPLETED|10-week Primary Outcome||3
7853075|NCT00945100|19329795|P1|NOT COMPLETED|10-week Primary Outcome||1
7853076|NCT00945100|19329794|P2|COMPLETED|10-week Primary Outcome||83
7853077|NCT00945100|19329795|P1|COMPLETED|10-week Primary Outcome||82
7853078|NCT00945100|19329794|P2|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20
7853079|NCT00945100|19329795|P1|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27
7853080|NCT00945100|19329794|P2|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63
7853081|NCT00945100|19329795|P1|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55
7853082|NCT00945100|19329794|P2|STARTED|10-week Primary Outcome||86
7853083|NCT00945100|19329795|P1|STARTED|10-week Primary Outcome||83
7853084|NCT00945061|19329861|P2|NOT COMPLETED|Overall Study||0
7853085|NCT00945061|19329862|P1|NOT COMPLETED|Overall Study||0
7853086|NCT00945061|19329861|P2|COMPLETED|Overall Study||1
7853087|NCT00945061|19329862|P1|COMPLETED|Overall Study||12
7853088|NCT00945061|19329861|P2|STARTED|Overall Study||1
7853089|NCT00945061|19329862|P1|STARTED|Overall Study||12
7853090|NCT00945035|19329961|P2|NOT COMPLETED|Period 2||0
7853091|NCT00945035|19329962|P1|NOT COMPLETED|Period 2||0
7853092|NCT00945035|19329961|P2|COMPLETED|Period 2||18
7853093|NCT00945035|19329962|P1|COMPLETED|Period 2||18
7853094|NCT00945035|19329961|P2|STARTED|Period 2||18
7853095|NCT00945035|19329962|P1|STARTED|Period 2||18
7853096|NCT00945035|19329961|P2|NOT COMPLETED|Period 1||0
7853097|NCT00945035|19329962|P1|NOT COMPLETED|Period 1||0
7853098|NCT00945035|19329961|P2|COMPLETED|Period 1||18
7853099|NCT00945035|19329962|P1|COMPLETED|Period 1||18
7853100|NCT00945035|19329961|P2|STARTED|Period 1||18
7853101|NCT00945035|19329962|P1|STARTED|Period 1||18
7853102|NCT00945009|19329973|P3|NOT COMPLETED|Overall Study||3
7853103|NCT00945009|19329974|P2|NOT COMPLETED|Overall Study||7
7853104|NCT00945009|19329975|P1|NOT COMPLETED|Overall Study||45
7853105|NCT00945009|19329973|P3|COMPLETED|Overall Study||6
7853106|NCT00945009|19329974|P2|COMPLETED|Overall Study||32
7853107|NCT00945009|19329975|P1|COMPLETED|Overall Study||156
7853108|NCT00945009|19329973|P3|STARTED|Overall Study||9
7853109|NCT00945009|19329974|P2|STARTED|Overall Study||39
7853110|NCT00945009|19329975|P1|STARTED|Overall Study||201
7853111|NCT00944749|19329985|P1|NOT COMPLETED|Overall Study||1
7853112|NCT00944749|19329985|P1|COMPLETED|Overall Study||22
7853113|NCT00944749|19329985|P1|STARTED|Overall Study||23
7853114|NCT00944710|19329992|P2|NOT COMPLETED|Additional Post 10-week Primary Outcome||11
7853115|NCT00944710|19329993|P1|NOT COMPLETED|Additional Post 10-week Primary Outcome||17
7853116|NCT00944710|19329992|P2|COMPLETED|Additional Post 10-week Primary Outcome||22
7853117|NCT00944710|19329993|P1|COMPLETED|Additional Post 10-week Primary Outcome||23
7853118|NCT00944710|19329992|P2|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26
7853119|NCT00944710|19329993|P1|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24
7853120|NCT00944710|19329992|P2|STARTED|Additional Post 10-week Primary Outcome||33
7853121|NCT00944710|19329993|P1|STARTED|Additional Post 10-week Primary Outcome||40
7853122|NCT00944710|19329992|P2|NOT COMPLETED|12-week Visit (Off-treatment)||0
7853123|NCT00944710|19329993|P1|NOT COMPLETED|12-week Visit (Off-treatment)||0
7853124|NCT00944710|19329992|P2|COMPLETED|12-week Visit (Off-treatment)||33
7853125|NCT00944710|19329993|P1|COMPLETED|12-week Visit (Off-treatment)||40
7853126|NCT00944710|19329992|P2|STARTED|12-week Visit (Off-treatment)||33
7853127|NCT00944710|19329993|P1|STARTED|12-week Visit (Off-treatment)||40
7853128|NCT00944710|19329992|P2|NOT COMPLETED|10-week Primary Outcome||0
7853129|NCT00944710|19329993|P1|NOT COMPLETED|10-week Primary Outcome||0
7853130|NCT00944710|19329992|P2|COMPLETED|10-week Primary Outcome||33
7853131|NCT00944710|19329993|P1|COMPLETED|10-week Primary Outcome||40
7853132|NCT00944710|19329992|P2|STARTED|10-week Primary Outcome||33
7853133|NCT00944710|19329993|P1|STARTED|10-week Primary Outcome||40
7853134|NCT00944697|19330051|P2|NOT COMPLETED|Overall Study||5
7853135|NCT00944697|19330052|P1|NOT COMPLETED|Overall Study||2
7853136|NCT00944697|19330051|P2|COMPLETED|Overall Study||43
7853137|NCT00944697|19330052|P1|COMPLETED|Overall Study||48
7853138|NCT00944697|19330051|P2|STARTED|Overall Study||48
7853139|NCT00944697|19330052|P1|STARTED|Overall Study||50
7853140|NCT00944671|19330064|P6|NOT COMPLETED|Period III||0
7853141|NCT00944671|19330065|P5|NOT COMPLETED|Period III||0
7853142|NCT00944671|19330066|P4|NOT COMPLETED|Period III||0
7853143|NCT00944671|19330067|P3|NOT COMPLETED|Period III||0
7853144|NCT00944671|19330068|P2|NOT COMPLETED|Period III||0
7853145|NCT00944671|19330069|P1|NOT COMPLETED|Period III||0
7853146|NCT00944671|19330064|P6|COMPLETED|Period III||4
7853147|NCT00944671|19330065|P5|COMPLETED|Period III||4
7853148|NCT00944671|19330066|P4|COMPLETED|Period III||4
7853149|NCT00944671|19330067|P3|COMPLETED|Period III||4
7853150|NCT00944671|19330068|P2|COMPLETED|Period III||4
7853151|NCT00944671|19330069|P1|COMPLETED|Period III||4
7853152|NCT00944671|19330064|P6|STARTED|Period III||4
7853153|NCT00944671|19330065|P5|STARTED|Period III||4
7853154|NCT00944671|19330066|P4|STARTED|Period III||4
7853155|NCT00944671|19330067|P3|STARTED|Period III||4
7853156|NCT00944671|19330068|P2|STARTED|Period III||4
7853157|NCT00944671|19330069|P1|STARTED|Period III||4
7853158|NCT00944671|19330064|P6|NOT COMPLETED|Period II||0
7853159|NCT00944671|19330065|P5|NOT COMPLETED|Period II||0
7853160|NCT00944671|19330066|P4|NOT COMPLETED|Period II||0
7853161|NCT00944671|19330067|P3|NOT COMPLETED|Period II||0
7853162|NCT00944671|19330068|P2|NOT COMPLETED|Period II||0
7853163|NCT00944671|19330069|P1|NOT COMPLETED|Period II||0
7853164|NCT00944671|19330064|P6|COMPLETED|Period II||4
7853165|NCT00944671|19330065|P5|COMPLETED|Period II||4
7853166|NCT00944671|19330066|P4|COMPLETED|Period II||4
7853167|NCT00944671|19330067|P3|COMPLETED|Period II||4
7853168|NCT00944671|19330068|P2|COMPLETED|Period II||4
7853169|NCT00944671|19330069|P1|COMPLETED|Period II||4
7853170|NCT00944671|19330064|P6|STARTED|Period II||4
7853171|NCT00944671|19330065|P5|STARTED|Period II||4
7853172|NCT00944671|19330066|P4|STARTED|Period II||4
7853173|NCT00944671|19330067|P3|STARTED|Period II||4
7853174|NCT00944671|19330068|P2|STARTED|Period II||4
7853175|NCT00944671|19330069|P1|STARTED|Period II||4
7853176|NCT00944671|19330064|P6|NOT COMPLETED|Period I||0
7853177|NCT00944671|19330065|P5|NOT COMPLETED|Period I||0
7853178|NCT00944671|19330066|P4|NOT COMPLETED|Period I||0
7853179|NCT00944671|19330067|P3|NOT COMPLETED|Period I||0
7853180|NCT00944671|19330068|P2|NOT COMPLETED|Period I||0
7853181|NCT00944671|19330069|P1|NOT COMPLETED|Period I||0
7853182|NCT00944671|19330064|P6|COMPLETED|Period I||4
7853183|NCT00944671|19330065|P5|COMPLETED|Period I||4
7853184|NCT00944671|19330066|P4|COMPLETED|Period I||4
7853185|NCT00944671|19330067|P3|COMPLETED|Period I||4
7853186|NCT00944671|19330068|P2|COMPLETED|Period I||4
7853187|NCT00944671|19330069|P1|COMPLETED|Period I||4
7853188|NCT00944671|19330064|P6|STARTED|Period I||4
7853189|NCT00944671|19330065|P5|STARTED|Period I||4
7853190|NCT00944671|19330066|P4|STARTED|Period I||4
7853191|NCT00944671|19330067|P3|STARTED|Period I||4
7853192|NCT00944671|19330068|P2|STARTED|Period I||4
7853193|NCT00944671|19330069|P1|STARTED|Period I||4
7853194|NCT00944658|19330084|P2|NOT COMPLETED|Follow up 4 Weeks||0
7853195|NCT00944658|19330085|P1|NOT COMPLETED|Follow up 4 Weeks||0
7853196|NCT00944658|19330084|P2|COMPLETED|Follow up 4 Weeks||17
7853197|NCT00944658|19330085|P1|COMPLETED|Follow up 4 Weeks||19
7853198|NCT00944658|19330084|P2|STARTED|Follow up 4 Weeks||17
7853199|NCT00944658|19330085|P1|STARTED|Follow up 4 Weeks||19
7853200|NCT00944658|19330084|P2|NOT COMPLETED|Treatment 12 Weeks||2
7853201|NCT00944658|19330085|P1|NOT COMPLETED|Treatment 12 Weeks||0
7853202|NCT00944658|19330084|P2|COMPLETED|Treatment 12 Weeks||17
7853203|NCT00944658|19330085|P1|COMPLETED|Treatment 12 Weeks||19
7853204|NCT00944658|19330084|P2|STARTED|Treatment 12 Weeks||19
7853205|NCT00944658|19330085|P1|STARTED|Treatment 12 Weeks||19
7853206|NCT00944645|19330097|P2|NOT COMPLETED|Period 2||9
7853207|NCT00944645|19330098|P1|NOT COMPLETED|Period 2||8
7853208|NCT00944645|19330097|P2|COMPLETED|Period 2||85
7853209|NCT00944645|19330098|P1|COMPLETED|Period 2||86
7853210|NCT00944645|19330097|P2|STARTED|Period 2||94
7853211|NCT00944645|19330098|P1|STARTED|Period 2||94
7853212|NCT00944645|19330097|P2|NOT COMPLETED|Period 1||0
7853213|NCT00944645|19330098|P1|NOT COMPLETED|Period 1||0
7853214|NCT00944645|19330097|P2|COMPLETED|Period 1||94
7853215|NCT00944645|19330098|P1|COMPLETED|Period 1||94
7853216|NCT00944645|19330097|P2|STARTED|Period 1||94
7853217|NCT00944645|19330098|P1|STARTED|Period 1||94
7853218|NCT00944554|19330112|P2|NOT COMPLETED|Overall Study||29
7853219|NCT00944554|19330113|P1|NOT COMPLETED|Overall Study||28
7853220|NCT00944554|19330112|P2|COMPLETED|Overall Study||25
7853221|NCT00944554|19330113|P1|COMPLETED|Overall Study||22
7853222|NCT00944554|19330112|P2|STARTED|Overall Study||54
7853223|NCT00944554|19330113|P1|STARTED|Overall Study||50
7853224|NCT00944528|19330122|P3|NOT COMPLETED|Overall Study||0
7853225|NCT00944528|19330123|P2|NOT COMPLETED|Overall Study||2
7853226|NCT00944528|19330124|P1|NOT COMPLETED|Overall Study||1
7853227|NCT00944528|19330122|P3|COMPLETED|Overall Study||16
7853228|NCT00944528|19330123|P2|COMPLETED|Overall Study||8
7853229|NCT00944528|19330124|P1|COMPLETED|Overall Study||8
7853230|NCT00944528|19330122|P3|STARTED|Overall Study||16
7853231|NCT00944528|19330123|P2|STARTED|Overall Study||10
7853232|NCT00944528|19330124|P1|STARTED|Overall Study||9
7853233|NCT00944450|19330136|P2|NOT COMPLETED|Period 2||0
7853234|NCT00944450|19330137|P1|NOT COMPLETED|Period 2||0
7853235|NCT00944450|19330136|P2|COMPLETED|Period 2||6
7853236|NCT00944450|19330137|P1|COMPLETED|Period 2||6
7853237|NCT00944450|19330136|P2|STARTED|Period 2||6
7853238|NCT00944450|19330137|P1|STARTED|Period 2||6
7853239|NCT00944450|19330136|P2|NOT COMPLETED|Period 1||0
7853240|NCT00944450|19330137|P1|NOT COMPLETED|Period 1||0
7853241|NCT00944450|19330136|P2|COMPLETED|Period 1||6
7853242|NCT00944450|19330137|P1|COMPLETED|Period 1||6
7853243|NCT00944450|19330136|P2|STARTED|Period 1||6
7853244|NCT00944450|19330137|P1|STARTED|Period 1||6
7853245|NCT00944229|19330145|P1|NOT COMPLETED|Overall Study||25
7853246|NCT00944229|19330145|P1|COMPLETED|Overall Study||33
7853247|NCT00944229|19330145|P1|STARTED|Overall Study||58
7853248|NCT00944125|19330151|P2|NOT COMPLETED|6 Months to Study Completion||2
7853249|NCT00944125|19330152|P1|NOT COMPLETED|6 Months to Study Completion||0
7853250|NCT00944125|19330151|P2|COMPLETED|6 Months to Study Completion||18
7853251|NCT00944125|19330152|P1|COMPLETED|6 Months to Study Completion||19
7853252|NCT00944125|19330151|P2|STARTED|6 Months to Study Completion||20
7853253|NCT00944125|19330152|P1|STARTED|6 Months to Study Completion||19
7853254|NCT00944125|19330151|P2|NOT COMPLETED|3 to 6 Months||2
7853255|NCT00944125|19330152|P1|NOT COMPLETED|3 to 6 Months||0
7853256|NCT00944125|19330151|P2|COMPLETED|3 to 6 Months||20
7853257|NCT00944125|19330152|P1|COMPLETED|3 to 6 Months||19
7853258|NCT00944125|19330151|P2|STARTED|3 to 6 Months||22
7853259|NCT00944125|19330152|P1|STARTED|3 to 6 Months||19
7853260|NCT00944125|19330151|P2|NOT COMPLETED|Baseline to 3 Months||0
7853261|NCT00944125|19330152|P1|NOT COMPLETED|Baseline to 3 Months||0
7853262|NCT00944125|19330151|P2|COMPLETED|Baseline to 3 Months||22
7853263|NCT00944125|19330152|P1|COMPLETED|Baseline to 3 Months||19
7853264|NCT00944125|19330151|P2|STARTED|Baseline to 3 Months||22
7853265|NCT00944125|19330152|P1|STARTED|Baseline to 3 Months||19
7853266|NCT00944073|19330160|P2|NOT COMPLETED|Overall Study||4
7853267|NCT00944073|19330161|P1|NOT COMPLETED|Overall Study||5
7853268|NCT00944073|19330160|P2|COMPLETED|Overall Study||287
7853269|NCT00944073|19330161|P1|COMPLETED|Overall Study||287
7853270|NCT00944073|19330160|P2|STARTED|Overall Study||291
7853271|NCT00944073|19330161|P1|STARTED|Overall Study||292
7853272|NCT00944047|19330239|P1|NOT COMPLETED|Overall Study||5
7853273|NCT00944047|19330239|P1|COMPLETED|Overall Study||27
7853274|NCT00944047|19330239|P1|STARTED|Overall Study||32
7853275|NCT00944034|19330255|P12|NOT COMPLETED|Overall Study||4
7853276|NCT00944034|19330256|P11|NOT COMPLETED|Overall Study||1
7853277|NCT00944034|19330257|P10|NOT COMPLETED|Overall Study||10
7853278|NCT00944034|19330258|P9|NOT COMPLETED|Overall Study||10
7853279|NCT00944034|19330259|P8|NOT COMPLETED|Overall Study||5
7853280|NCT00944034|19330260|P7|NOT COMPLETED|Overall Study||4
7853281|NCT00944034|19330261|P6|NOT COMPLETED|Overall Study||20
7853282|NCT00944034|19330262|P5|NOT COMPLETED|Overall Study||14
7853283|NCT00944034|19330263|P4|NOT COMPLETED|Overall Study||4
7853284|NCT00944034|19330264|P3|NOT COMPLETED|Overall Study||9
7853285|NCT00944034|19330265|P2|NOT COMPLETED|Overall Study||7
7853286|NCT00944034|19330266|P1|NOT COMPLETED|Overall Study||5
7853287|NCT00944034|19330255|P12|COMPLETED|Overall Study||52
7853288|NCT00944034|19330256|P11|COMPLETED|Overall Study||50
7853289|NCT00944034|19330257|P10|COMPLETED|Overall Study||236
7853290|NCT00944034|19330258|P9|COMPLETED|Overall Study||63
7853291|NCT00944034|19330259|P8|COMPLETED|Overall Study||73
7853292|NCT00944034|19330260|P7|COMPLETED|Overall Study||102
7853293|NCT00944034|19330261|P6|COMPLETED|Overall Study||123
7853294|NCT00944034|19330262|P5|COMPLETED|Overall Study||150
7853295|NCT00944034|19330263|P4|COMPLETED|Overall Study||170
7853296|NCT00944034|19330264|P3|COMPLETED|Overall Study||143
7853297|NCT00944034|19330265|P2|COMPLETED|Overall Study||150
7853298|NCT00944034|19330266|P1|COMPLETED|Overall Study||183
7853299|NCT00944034|19330255|P12|STARTED|Overall Study||56
7853300|NCT00944034|19330256|P11|STARTED|Overall Study||51
7853301|NCT00944034|19330257|P10|STARTED|Overall Study||246
7853302|NCT00944034|19330258|P9|STARTED|Overall Study||73
7853303|NCT00944034|19330259|P8|STARTED|Overall Study||78
7853304|NCT00944034|19330260|P7|STARTED|Overall Study||106
7853305|NCT00944034|19330261|P6|STARTED|Overall Study||143
7853306|NCT00944034|19330262|P5|STARTED|Overall Study||164
7853307|NCT00944034|19330263|P4|STARTED|Overall Study||174
7853308|NCT00944034|19330264|P3|STARTED|Overall Study||152
7853309|NCT00944034|19330265|P2|STARTED|Overall Study||157
7853310|NCT00944034|19330266|P1|STARTED|Overall Study||188
7853311|NCT00944021|19330336|P5|NOT COMPLETED|Overall Study||0
7853312|NCT00944021|19330337|P4|NOT COMPLETED|Overall Study||0
7853313|NCT00944021|19330338|P3|NOT COMPLETED|Overall Study||0
7853314|NCT00944021|19330339|P2|NOT COMPLETED|Overall Study||0
7853315|NCT00944021|19330340|P1|NOT COMPLETED|Overall Study||1
7853316|NCT00944021|19330336|P5|COMPLETED|Overall Study||8
7853317|NCT00944021|19330337|P4|COMPLETED|Overall Study||16
7853318|NCT00944021|19330338|P3|COMPLETED|Overall Study||15
7853319|NCT00944021|19330339|P2|COMPLETED|Overall Study||15
7853320|NCT00944021|19330340|P1|COMPLETED|Overall Study||14
7853321|NCT00944021|19330336|P5|STARTED|Overall Study||8
7853322|NCT00944021|19330337|P4|STARTED|Overall Study||16
7853323|NCT00944021|19330338|P3|STARTED|Overall Study||15
7853324|NCT00944021|19330339|P2|STARTED|Overall Study||15
7853325|NCT00944021|19330340|P1|STARTED|Overall Study||15
7853326|NCT00943917|19330412|P15|NOT COMPLETED|Stage II Continuation||4
7853327|NCT00943917|19330413|P14|NOT COMPLETED|Stage II Continuation||3
7853328|NCT00943917|19330414|P13|NOT COMPLETED|Stage II Continuation||3
7853329|NCT00943917|19330415|P12|NOT COMPLETED|Stage II Continuation||2
7853330|NCT00943917|19330416|P11|NOT COMPLETED|Stage II Continuation||0
7853331|NCT00943917|19330417|P10|NOT COMPLETED|Stage II Continuation||1
7853332|NCT00943917|19330418|P9|NOT COMPLETED|Stage II Continuation||0
7853333|NCT00943917|19330419|P8|NOT COMPLETED|Stage II Continuation||0
7853334|NCT00943917|19330420|P7|NOT COMPLETED|Stage II Continuation||0
7853335|NCT00943917|19330421|P6|NOT COMPLETED|Stage II Continuation||0
7853336|NCT00943917|19330422|P5|NOT COMPLETED|Stage II Continuation||0
7853337|NCT00943917|19330423|P4|NOT COMPLETED|Stage II Continuation||0
7853338|NCT00943917|19330424|P3|NOT COMPLETED|Stage II Continuation||0
7853339|NCT00943917|19330425|P2|NOT COMPLETED|Stage II Continuation||0
7853340|NCT00943917|19330426|P1|NOT COMPLETED|Stage II Continuation||0
7853341|NCT00943917|19330412|P15|COMPLETED|Stage II Continuation||8
7853342|NCT00943917|19330413|P14|COMPLETED|Stage II Continuation||12
7853343|NCT00943917|19330414|P13|COMPLETED|Stage II Continuation||13
7853344|NCT00943917|19330415|P12|COMPLETED|Stage II Continuation||11
7853345|NCT00943917|19330416|P11|COMPLETED|Stage II Continuation||15
7853346|NCT00943917|19330417|P10|COMPLETED|Stage II Continuation||14
7853347|NCT00943917|19330418|P9|COMPLETED|Stage II Continuation||0
7853348|NCT00943917|19330419|P8|COMPLETED|Stage II Continuation||0
7853349|NCT00943917|19330420|P7|COMPLETED|Stage II Continuation||0
7853350|NCT00943917|19330421|P6|COMPLETED|Stage II Continuation||0
7853351|NCT00943917|19330422|P5|COMPLETED|Stage II Continuation||0
7853352|NCT00943917|19330423|P4|COMPLETED|Stage II Continuation||0
7853353|NCT00943917|19330424|P3|COMPLETED|Stage II Continuation||0
7853354|NCT00943917|19330425|P2|COMPLETED|Stage II Continuation||0
7853355|NCT00943917|19330426|P1|COMPLETED|Stage II Continuation||0
7853356|NCT00943917|19330412|P15|STARTED|Stage II Continuation||12
7853357|NCT00943917|19330413|P14|STARTED|Stage II Continuation||15
7853358|NCT00943917|19330414|P13|STARTED|Stage II Continuation||16
7853359|NCT00943917|19330415|P12|STARTED|Stage II Continuation||13
7853360|NCT00943917|19330416|P11|STARTED|Stage II Continuation||15
7853361|NCT00943917|19330417|P10|STARTED|Stage II Continuation||15
7853362|NCT00943917|19330418|P9|STARTED|Stage II Continuation||0
7853363|NCT00943917|19330419|P8|STARTED|Stage II Continuation||0
7853364|NCT00943917|19330420|P7|STARTED|Stage II Continuation||0
7853365|NCT00943917|19330421|P6|STARTED|Stage II Continuation||0
7853366|NCT00943917|19330422|P5|STARTED|Stage II Continuation||0
7853367|NCT00943917|19330423|P4|STARTED|Stage II Continuation||0
7853368|NCT00943917|19330424|P3|STARTED|Stage II Continuation||0
7853369|NCT00943917|19330425|P2|STARTED|Stage II Continuation||0
7853370|NCT00943917|19330426|P1|STARTED|Stage II Continuation||0
7853371|NCT00943917|19330412|P15|NOT COMPLETED|Stage II||0
7853372|NCT00943917|19330413|P14|NOT COMPLETED|Stage II||0
7853373|NCT00943917|19330414|P13|NOT COMPLETED|Stage II||0
7853374|NCT00943917|19330415|P12|NOT COMPLETED|Stage II||0
7853375|NCT00943917|19330416|P11|NOT COMPLETED|Stage II||0
7853376|NCT00943917|19330417|P10|NOT COMPLETED|Stage II||0
7853377|NCT00943917|19330418|P9|NOT COMPLETED|Stage II||1
7853378|NCT00943917|19330419|P8|NOT COMPLETED|Stage II||0
7853379|NCT00943917|19330420|P7|NOT COMPLETED|Stage II||3
7853380|NCT00943917|19330421|P6|NOT COMPLETED|Stage II||3
7853381|NCT00943917|19330422|P5|NOT COMPLETED|Stage II||0
7853382|NCT00943917|19330423|P4|NOT COMPLETED|Stage II||0
7853383|NCT00943917|19330424|P3|NOT COMPLETED|Stage II||0
7853384|NCT00943917|19330425|P2|NOT COMPLETED|Stage II||0
7853385|NCT00943917|19330426|P1|NOT COMPLETED|Stage II||0
7853386|NCT00943917|19330412|P15|COMPLETED|Stage II||0
7853387|NCT00943917|19330413|P14|COMPLETED|Stage II||0
7853388|NCT00943917|19330414|P13|COMPLETED|Stage II||0
7853389|NCT00943917|19330415|P12|COMPLETED|Stage II||0
7853390|NCT00943917|19330416|P11|COMPLETED|Stage II||0
7853391|NCT00943917|19330417|P10|COMPLETED|Stage II||0
7853392|NCT00943917|19330418|P9|COMPLETED|Stage II||20
7853393|NCT00943917|19330419|P8|COMPLETED|Stage II||23
7853394|NCT00943917|19330420|P7|COMPLETED|Stage II||20
7853395|NCT00943917|19330421|P6|COMPLETED|Stage II||20
7853396|NCT00943917|19330422|P5|COMPLETED|Stage II||21
7853397|NCT00943917|19330423|P4|COMPLETED|Stage II||20
7853398|NCT00943917|19330424|P3|COMPLETED|Stage II||0
7853399|NCT00943917|19330425|P2|COMPLETED|Stage II||0
7853400|NCT00943917|19330426|P1|COMPLETED|Stage II||0
7853401|NCT00943917|19330412|P15|STARTED|Stage II||0
7853402|NCT00943917|19330413|P14|STARTED|Stage II||0
7853403|NCT00943917|19330414|P13|STARTED|Stage II||0
7853404|NCT00943917|19330415|P12|STARTED|Stage II||0
7853405|NCT00943917|19330416|P11|STARTED|Stage II||0
7853406|NCT00943917|19330417|P10|STARTED|Stage II||0
7853407|NCT00943917|19330418|P9|STARTED|Stage II||21
7853408|NCT00943917|19330419|P8|STARTED|Stage II||23
7853409|NCT00943917|19330420|P7|STARTED|Stage II||23
7853410|NCT00943917|19330421|P6|STARTED|Stage II||23
7853411|NCT00943917|19330422|P5|STARTED|Stage II||21
7853412|NCT00943917|19330423|P4|STARTED|Stage II||20
7853413|NCT00943917|19330424|P3|STARTED|Stage II||0
7853414|NCT00943917|19330425|P2|STARTED|Stage II||0
7853415|NCT00943917|19330426|P1|STARTED|Stage II||0
7853416|NCT00943917|19330412|P15|NOT COMPLETED|Stage I||0
7853417|NCT00943917|19330413|P14|NOT COMPLETED|Stage I||0
7853418|NCT00943917|19330414|P13|NOT COMPLETED|Stage I||0
7853419|NCT00943917|19330415|P12|NOT COMPLETED|Stage I||0
7853420|NCT00943917|19330416|P11|NOT COMPLETED|Stage I||0
7853421|NCT00943917|19330417|P10|NOT COMPLETED|Stage I||0
7853422|NCT00943917|19330418|P9|NOT COMPLETED|Stage I||0
7853423|NCT00943917|19330419|P8|NOT COMPLETED|Stage I||0
7853424|NCT00943917|19330420|P7|NOT COMPLETED|Stage I||0
7853425|NCT00943917|19330421|P6|NOT COMPLETED|Stage I||0
7853426|NCT00943917|19330422|P5|NOT COMPLETED|Stage I||0
7853427|NCT00943917|19330423|P4|NOT COMPLETED|Stage I||0
7853428|NCT00943917|19330424|P3|NOT COMPLETED|Stage I||6
7853429|NCT00943917|19330425|P2|NOT COMPLETED|Stage I||3
7853430|NCT00943917|19330426|P1|NOT COMPLETED|Stage I||4
7853431|NCT00943917|19330412|P15|COMPLETED|Stage I||0
7853432|NCT00943917|19330413|P14|COMPLETED|Stage I||0
7853433|NCT00943917|19330414|P13|COMPLETED|Stage I||0
7853434|NCT00943917|19330415|P12|COMPLETED|Stage I||0
7853435|NCT00943917|19330416|P11|COMPLETED|Stage I||0
7853436|NCT00943917|19330417|P10|COMPLETED|Stage I||0
7853437|NCT00943917|19330418|P9|COMPLETED|Stage I||0
7853438|NCT00943917|19330419|P8|COMPLETED|Stage I||0
7853439|NCT00943917|19330420|P7|COMPLETED|Stage I||0
7853440|NCT00943917|19330421|P6|COMPLETED|Stage I||0
7853441|NCT00943917|19330422|P5|COMPLETED|Stage I||0
7853442|NCT00943917|19330423|P4|COMPLETED|Stage I||0
7853443|NCT00943917|19330424|P3|COMPLETED|Stage I||47
7853444|NCT00943917|19330425|P2|COMPLETED|Stage I||48
7853445|NCT00943917|19330426|P1|COMPLETED|Stage I||47
7853446|NCT00943917|19330412|P15|STARTED|Stage I||0
7853447|NCT00943917|19330413|P14|STARTED|Stage I||0
7853448|NCT00943917|19330414|P13|STARTED|Stage I||0
7853449|NCT00943917|19330415|P12|STARTED|Stage I||0
7853450|NCT00943917|19330416|P11|STARTED|Stage I||0
7853451|NCT00943917|19330417|P10|STARTED|Stage I||0
7853452|NCT00943917|19330418|P9|STARTED|Stage I||0
7853453|NCT00943917|19330419|P8|STARTED|Stage I||0
7853454|NCT00943917|19330420|P7|STARTED|Stage I||0
7853455|NCT00943917|19330421|P6|STARTED|Stage I||0
7853456|NCT00943917|19330422|P5|STARTED|Stage I||0
7853457|NCT00943917|19330423|P4|STARTED|Stage I||0
7853458|NCT00943917|19330424|P3|STARTED|Stage I||53
7853459|NCT00943917|19330425|P2|STARTED|Stage I||51
7853460|NCT00943917|19330426|P1|STARTED|Stage I||51
7853461|NCT00943878|19330477|P4|NOT COMPLETED|Overall Study||2
7853462|NCT00943878|19330478|P3|NOT COMPLETED|Overall Study||6
7853463|NCT00943878|19330479|P2|NOT COMPLETED|Overall Study||2
7853464|NCT00943878|19330480|P1|NOT COMPLETED|Overall Study||2
7853465|NCT00943878|19330477|P4|COMPLETED|Overall Study||198
7853466|NCT00943878|19330478|P3|COMPLETED|Overall Study||197
7853467|NCT00943878|19330479|P2|COMPLETED|Overall Study||198
7853468|NCT00943878|19330480|P1|COMPLETED|Overall Study||200
7853469|NCT00943878|19330477|P4|STARTED|Overall Study||200
7853470|NCT00943878|19330478|P3|STARTED|Overall Study||203
7853471|NCT00943878|19330479|P2|STARTED|Overall Study||200
7853472|NCT00943878|19330480|P1|STARTED|Overall Study||202
7853473|NCT00943852|19330602|P10|NOT COMPLETED|Fifth Period of Treatment Intervention||0
7853474|NCT00943852|19330603|P9|NOT COMPLETED|Fifth Period of Treatment Intervention||0
7853475|NCT00943852|19330604|P8|NOT COMPLETED|Fifth Period of Treatment Intervention||0
7853476|NCT00943852|19330605|P7|NOT COMPLETED|Fifth Period of Treatment Intervention||0
7853477|NCT00943852|19330606|P6|NOT COMPLETED|Fifth Period of Treatment Intervention||0
7853478|NCT00943852|19330607|P5|NOT COMPLETED|Fifth Period of Treatment Intervention||0
7853479|NCT00943852|19330608|P4|NOT COMPLETED|Fifth Period of Treatment Intervention||0
7853480|NCT00943852|19330609|P3|NOT COMPLETED|Fifth Period of Treatment Intervention||0
7853481|NCT00943852|19330610|P2|NOT COMPLETED|Fifth Period of Treatment Intervention||0
7853482|NCT00943852|19330611|P1|NOT COMPLETED|Fifth Period of Treatment Intervention||0
7853483|NCT00943852|19330602|P10|COMPLETED|Fifth Period of Treatment Intervention||1
7853484|NCT00943852|19330603|P9|COMPLETED|Fifth Period of Treatment Intervention||1
7853485|NCT00943852|19330604|P8|COMPLETED|Fifth Period of Treatment Intervention||0
7853486|NCT00943852|19330605|P7|COMPLETED|Fifth Period of Treatment Intervention||0
7853487|NCT00943852|19330606|P6|COMPLETED|Fifth Period of Treatment Intervention||0
7853488|NCT00943852|19330607|P5|COMPLETED|Fifth Period of Treatment Intervention||1
7853489|NCT00943852|19330608|P4|COMPLETED|Fifth Period of Treatment Intervention||0
7853490|NCT00943852|19330609|P3|COMPLETED|Fifth Period of Treatment Intervention||0
7853491|NCT00943852|19330610|P2|COMPLETED|Fifth Period of Treatment Intervention||1
7853492|NCT00943852|19330611|P1|COMPLETED|Fifth Period of Treatment Intervention||1
7853493|NCT00943852|19330602|P10|STARTED|Fifth Period of Treatment Intervention||1
7853494|NCT00943852|19330603|P9|STARTED|Fifth Period of Treatment Intervention||1
7853495|NCT00943852|19330604|P8|STARTED|Fifth Period of Treatment Intervention||0
7853496|NCT00943852|19330605|P7|STARTED|Fifth Period of Treatment Intervention||0
7853497|NCT00943852|19330606|P6|STARTED|Fifth Period of Treatment Intervention||0
7853498|NCT00943852|19330607|P5|STARTED|Fifth Period of Treatment Intervention||1
7853499|NCT00943852|19330608|P4|STARTED|Fifth Period of Treatment Intervention||0
7853500|NCT00943852|19330609|P3|STARTED|Fifth Period of Treatment Intervention||0
7853501|NCT00943852|19330610|P2|STARTED|Fifth Period of Treatment Intervention||1
7853502|NCT00943852|19330611|P1|STARTED|Fifth Period of Treatment Intervention||1
7853503|NCT00943852|19330602|P10|NOT COMPLETED|Washout Period After Period 4 Treatment||0
7853504|NCT00943852|19330603|P9|NOT COMPLETED|Washout Period After Period 4 Treatment||0
7853505|NCT00943852|19330604|P8|NOT COMPLETED|Washout Period After Period 4 Treatment||1
7853506|NCT00943852|19330605|P7|NOT COMPLETED|Washout Period After Period 4 Treatment||1
7853507|NCT00943852|19330606|P6|NOT COMPLETED|Washout Period After Period 4 Treatment||0
7853508|NCT00943852|19330607|P5|NOT COMPLETED|Washout Period After Period 4 Treatment||0
7853509|NCT00943852|19330608|P4|NOT COMPLETED|Washout Period After Period 4 Treatment||1
7853510|NCT00943852|19330609|P3|NOT COMPLETED|Washout Period After Period 4 Treatment||1
7853511|NCT00943852|19330610|P2|NOT COMPLETED|Washout Period After Period 4 Treatment||0
7853512|NCT00943852|19330611|P1|NOT COMPLETED|Washout Period After Period 4 Treatment||1
7853513|NCT00943852|19330602|P10|COMPLETED|Washout Period After Period 4 Treatment||1
7853514|NCT00943852|19330603|P9|COMPLETED|Washout Period After Period 4 Treatment||1
7853515|NCT00943852|19330604|P8|COMPLETED|Washout Period After Period 4 Treatment||0
7853516|NCT00943852|19330605|P7|COMPLETED|Washout Period After Period 4 Treatment||0
7853517|NCT00943852|19330606|P6|COMPLETED|Washout Period After Period 4 Treatment||0
7853518|NCT00943852|19330607|P5|COMPLETED|Washout Period After Period 4 Treatment||1
7853519|NCT00943852|19330608|P4|COMPLETED|Washout Period After Period 4 Treatment||0
7853520|NCT00943852|19330609|P3|COMPLETED|Washout Period After Period 4 Treatment||0
7853521|NCT00943852|19330610|P2|COMPLETED|Washout Period After Period 4 Treatment||1
7853522|NCT00943852|19330611|P1|COMPLETED|Washout Period After Period 4 Treatment||1
7853523|NCT00943852|19330602|P10|STARTED|Washout Period After Period 4 Treatment||1
7853524|NCT00943852|19330603|P9|STARTED|Washout Period After Period 4 Treatment||1
7853525|NCT00943852|19330604|P8|STARTED|Washout Period After Period 4 Treatment||1
7853526|NCT00943852|19330605|P7|STARTED|Washout Period After Period 4 Treatment||1
7853527|NCT00943852|19330606|P6|STARTED|Washout Period After Period 4 Treatment||0
7853528|NCT00943852|19330607|P5|STARTED|Washout Period After Period 4 Treatment||1
7853529|NCT00943852|19330608|P4|STARTED|Washout Period After Period 4 Treatment||1
7853530|NCT00943852|19330609|P3|STARTED|Washout Period After Period 4 Treatment||1
7853531|NCT00943852|19330610|P2|STARTED|Washout Period After Period 4 Treatment||1
7853532|NCT00943852|19330611|P1|STARTED|Washout Period After Period 4 Treatment||2
7853533|NCT00943852|19330602|P10|NOT COMPLETED|Fourth Period of Treatment Intervention||0
7853534|NCT00943852|19330603|P9|NOT COMPLETED|Fourth Period of Treatment Intervention||0
7853535|NCT00943852|19330604|P8|NOT COMPLETED|Fourth Period of Treatment Intervention||0
7853536|NCT00943852|19330605|P7|NOT COMPLETED|Fourth Period of Treatment Intervention||0
7853537|NCT00943852|19330606|P6|NOT COMPLETED|Fourth Period of Treatment Intervention||0
7853538|NCT00943852|19330607|P5|NOT COMPLETED|Fourth Period of Treatment Intervention||0
7853539|NCT00943852|19330608|P4|NOT COMPLETED|Fourth Period of Treatment Intervention||0
7853540|NCT00943852|19330609|P3|NOT COMPLETED|Fourth Period of Treatment Intervention||0
7853541|NCT00943852|19330610|P2|NOT COMPLETED|Fourth Period of Treatment Intervention||0
7853542|NCT00943852|19330611|P1|NOT COMPLETED|Fourth Period of Treatment Intervention||0
7853543|NCT00943852|19330602|P10|COMPLETED|Fourth Period of Treatment Intervention||1
7853544|NCT00943852|19330603|P9|COMPLETED|Fourth Period of Treatment Intervention||1
7853545|NCT00943852|19330604|P8|COMPLETED|Fourth Period of Treatment Intervention||1
7853546|NCT00943852|19330605|P7|COMPLETED|Fourth Period of Treatment Intervention||1
7853547|NCT00943852|19330606|P6|COMPLETED|Fourth Period of Treatment Intervention||0
7853548|NCT00943852|19330607|P5|COMPLETED|Fourth Period of Treatment Intervention||1
7853549|NCT00943852|19330608|P4|COMPLETED|Fourth Period of Treatment Intervention||1
7853550|NCT00943852|19330609|P3|COMPLETED|Fourth Period of Treatment Intervention||1
7853551|NCT00943852|19330610|P2|COMPLETED|Fourth Period of Treatment Intervention||1
7853552|NCT00943852|19330611|P1|COMPLETED|Fourth Period of Treatment Intervention||2
7853553|NCT00943852|19330602|P10|STARTED|Fourth Period of Treatment Intervention||1
7853554|NCT00943852|19330603|P9|STARTED|Fourth Period of Treatment Intervention||1
7853555|NCT00943852|19330604|P8|STARTED|Fourth Period of Treatment Intervention||1
7853556|NCT00943852|19330605|P7|STARTED|Fourth Period of Treatment Intervention||1
7853557|NCT00943852|19330606|P6|STARTED|Fourth Period of Treatment Intervention||0
7853558|NCT00943852|19330607|P5|STARTED|Fourth Period of Treatment Intervention||1
7853559|NCT00943852|19330608|P4|STARTED|Fourth Period of Treatment Intervention||1
7853560|NCT00943852|19330609|P3|STARTED|Fourth Period of Treatment Intervention||1
7853561|NCT00943852|19330610|P2|STARTED|Fourth Period of Treatment Intervention||1
7853562|NCT00943852|19330611|P1|STARTED|Fourth Period of Treatment Intervention||2
7853563|NCT00943852|19330602|P10|NOT COMPLETED|Washout Period After Period 3 Treatment||0
7853564|NCT00943852|19330603|P9|NOT COMPLETED|Washout Period After Period 3 Treatment||0
7853565|NCT00943852|19330604|P8|NOT COMPLETED|Washout Period After Period 3 Treatment||0
7853566|NCT00943852|19330605|P7|NOT COMPLETED|Washout Period After Period 3 Treatment||1
7853567|NCT00943852|19330606|P6|NOT COMPLETED|Washout Period After Period 3 Treatment||0
7853568|NCT00943852|19330607|P5|NOT COMPLETED|Washout Period After Period 3 Treatment||0
7853569|NCT00943852|19330608|P4|NOT COMPLETED|Washout Period After Period 3 Treatment||0
7853570|NCT00943852|19330609|P3|NOT COMPLETED|Washout Period After Period 3 Treatment||0
7853571|NCT00943852|19330610|P2|NOT COMPLETED|Washout Period After Period 3 Treatment||0
7853572|NCT00943852|19330611|P1|NOT COMPLETED|Washout Period After Period 3 Treatment||0
7853573|NCT00943852|19330602|P10|COMPLETED|Washout Period After Period 3 Treatment||1
7853574|NCT00943852|19330603|P9|COMPLETED|Washout Period After Period 3 Treatment||1
7853575|NCT00943852|19330604|P8|COMPLETED|Washout Period After Period 3 Treatment||1
7853576|NCT00943852|19330605|P7|COMPLETED|Washout Period After Period 3 Treatment||1
7853577|NCT00943852|19330606|P6|COMPLETED|Washout Period After Period 3 Treatment||0
7853578|NCT00943852|19330607|P5|COMPLETED|Washout Period After Period 3 Treatment||1
7853579|NCT00943852|19330608|P4|COMPLETED|Washout Period After Period 3 Treatment||1
7853580|NCT00943852|19330609|P3|COMPLETED|Washout Period After Period 3 Treatment||1
7853581|NCT00943852|19330610|P2|COMPLETED|Washout Period After Period 3 Treatment||1
7853582|NCT00943852|19330611|P1|COMPLETED|Washout Period After Period 3 Treatment||2
7853583|NCT00943852|19330602|P10|STARTED|Washout Period After Period 3 Treatment||1
7853584|NCT00943852|19330603|P9|STARTED|Washout Period After Period 3 Treatment||1
7853585|NCT00943852|19330604|P8|STARTED|Washout Period After Period 3 Treatment||1
7853586|NCT00943852|19330605|P7|STARTED|Washout Period After Period 3 Treatment||2
7853587|NCT00943852|19330606|P6|STARTED|Washout Period After Period 3 Treatment||0
7853588|NCT00943852|19330607|P5|STARTED|Washout Period After Period 3 Treatment||1
7853589|NCT00943852|19330608|P4|STARTED|Washout Period After Period 3 Treatment||1
7853590|NCT00943852|19330609|P3|STARTED|Washout Period After Period 3 Treatment||1
7853591|NCT00943852|19330610|P2|STARTED|Washout Period After Period 3 Treatment||1
7853592|NCT00943852|19330611|P1|STARTED|Washout Period After Period 3 Treatment||2
7853593|NCT00943852|19330602|P10|NOT COMPLETED|Third Period of Treatment Intervention||0
7853594|NCT00943852|19330603|P9|NOT COMPLETED|Third Period of Treatment Intervention||0
7853595|NCT00943852|19330604|P8|NOT COMPLETED|Third Period of Treatment Intervention||0
7853596|NCT00943852|19330605|P7|NOT COMPLETED|Third Period of Treatment Intervention||0
7853597|NCT00943852|19330606|P6|NOT COMPLETED|Third Period of Treatment Intervention||0
7853598|NCT00943852|19330607|P5|NOT COMPLETED|Third Period of Treatment Intervention||0
7853599|NCT00943852|19330608|P4|NOT COMPLETED|Third Period of Treatment Intervention||0
7853600|NCT00943852|19330609|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
7853601|NCT00943852|19330610|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
7853602|NCT00943852|19330611|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
7853603|NCT00943852|19330602|P10|COMPLETED|Third Period of Treatment Intervention||1
7853604|NCT00943852|19330603|P9|COMPLETED|Third Period of Treatment Intervention||1
7853605|NCT00943852|19330604|P8|COMPLETED|Third Period of Treatment Intervention||1
7853606|NCT00943852|19330605|P7|COMPLETED|Third Period of Treatment Intervention||2
7853607|NCT00943852|19330606|P6|COMPLETED|Third Period of Treatment Intervention||0
7853608|NCT00943852|19330607|P5|COMPLETED|Third Period of Treatment Intervention||1
7853609|NCT00943852|19330608|P4|COMPLETED|Third Period of Treatment Intervention||1
7853610|NCT00943852|19330609|P3|COMPLETED|Third Period of Treatment Intervention||1
7853611|NCT00943852|19330610|P2|COMPLETED|Third Period of Treatment Intervention||1
7853612|NCT00943852|19330611|P1|COMPLETED|Third Period of Treatment Intervention||2
7853613|NCT00943852|19330602|P10|STARTED|Third Period of Treatment Intervention||1
7853614|NCT00943852|19330603|P9|STARTED|Third Period of Treatment Intervention||1
7853615|NCT00943852|19330604|P8|STARTED|Third Period of Treatment Intervention||1
7853616|NCT00943852|19330605|P7|STARTED|Third Period of Treatment Intervention||2
7853617|NCT00943852|19330606|P6|STARTED|Third Period of Treatment Intervention||0
7853618|NCT00943852|19330607|P5|STARTED|Third Period of Treatment Intervention||1
7853619|NCT00943852|19330608|P4|STARTED|Third Period of Treatment Intervention||1
7853620|NCT00943852|19330609|P3|STARTED|Third Period of Treatment Intervention||1
7853621|NCT00943852|19330610|P2|STARTED|Third Period of Treatment Intervention||1
7853622|NCT00943852|19330611|P1|STARTED|Third Period of Treatment Intervention||2
7853623|NCT00943852|19330602|P10|NOT COMPLETED|Washout Period After Period 2 Treatment||0
7853624|NCT00943852|19330603|P9|NOT COMPLETED|Washout Period After Period 2 Treatment||0
7853625|NCT00943852|19330604|P8|NOT COMPLETED|Washout Period After Period 2 Treatment||0
7853626|NCT00943852|19330605|P7|NOT COMPLETED|Washout Period After Period 2 Treatment||0
7853627|NCT00943852|19330606|P6|NOT COMPLETED|Washout Period After Period 2 Treatment||1
7853628|NCT00943852|19330607|P5|NOT COMPLETED|Washout Period After Period 2 Treatment||0
7853629|NCT00943852|19330608|P4|NOT COMPLETED|Washout Period After Period 2 Treatment||0
7853630|NCT00943852|19330609|P3|NOT COMPLETED|Washout Period After Period 2 Treatment||0
7853631|NCT00943852|19330610|P2|NOT COMPLETED|Washout Period After Period 2 Treatment||0
7853632|NCT00943852|19330611|P1|NOT COMPLETED|Washout Period After Period 2 Treatment||0
7853633|NCT00943852|19330602|P10|COMPLETED|Washout Period After Period 2 Treatment||1
7853634|NCT00943852|19330603|P9|COMPLETED|Washout Period After Period 2 Treatment||1
7853635|NCT00943852|19330604|P8|COMPLETED|Washout Period After Period 2 Treatment||1
7853636|NCT00943852|19330605|P7|COMPLETED|Washout Period After Period 2 Treatment||2
7853637|NCT00943852|19330606|P6|COMPLETED|Washout Period After Period 2 Treatment||0
7853638|NCT00943852|19330607|P5|COMPLETED|Washout Period After Period 2 Treatment||1
7853639|NCT00943852|19330608|P4|COMPLETED|Washout Period After Period 2 Treatment||1
7853640|NCT00943852|19330609|P3|COMPLETED|Washout Period After Period 2 Treatment||1
7853641|NCT00943852|19330610|P2|COMPLETED|Washout Period After Period 2 Treatment||1
7853642|NCT00943852|19330611|P1|COMPLETED|Washout Period After Period 2 Treatment||2
7853643|NCT00943852|19330602|P10|STARTED|Washout Period After Period 2 Treatment||1
7853644|NCT00943852|19330603|P9|STARTED|Washout Period After Period 2 Treatment||1
7853645|NCT00943852|19330604|P8|STARTED|Washout Period After Period 2 Treatment||1
7853646|NCT00943852|19330605|P7|STARTED|Washout Period After Period 2 Treatment||2
7853647|NCT00943852|19330606|P6|STARTED|Washout Period After Period 2 Treatment||1
7853648|NCT00943852|19330607|P5|STARTED|Washout Period After Period 2 Treatment||1
7853649|NCT00943852|19330608|P4|STARTED|Washout Period After Period 2 Treatment||1
7853650|NCT00943852|19330609|P3|STARTED|Washout Period After Period 2 Treatment||1
7853651|NCT00943852|19330610|P2|STARTED|Washout Period After Period 2 Treatment||1
7853652|NCT00943852|19330611|P1|STARTED|Washout Period After Period 2 Treatment||2
7853653|NCT00943852|19330602|P10|NOT COMPLETED|Second Period of Treatment Intervention||0
7853654|NCT00943852|19330603|P9|NOT COMPLETED|Second Period of Treatment Intervention||0
7853655|NCT00943852|19330604|P8|NOT COMPLETED|Second Period of Treatment Intervention||0
7853656|NCT00943852|19330605|P7|NOT COMPLETED|Second Period of Treatment Intervention||0
7853657|NCT00943852|19330606|P6|NOT COMPLETED|Second Period of Treatment Intervention||0
7853658|NCT00943852|19330607|P5|NOT COMPLETED|Second Period of Treatment Intervention||0
7853659|NCT00943852|19330608|P4|NOT COMPLETED|Second Period of Treatment Intervention||0
7853660|NCT00943852|19330609|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
7853661|NCT00943852|19330610|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
7853662|NCT00943852|19330611|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
7853663|NCT00943852|19330602|P10|COMPLETED|Second Period of Treatment Intervention||1
7853664|NCT00943852|19330603|P9|COMPLETED|Second Period of Treatment Intervention||1
7853665|NCT00943852|19330604|P8|COMPLETED|Second Period of Treatment Intervention||1
7853666|NCT00943852|19330605|P7|COMPLETED|Second Period of Treatment Intervention||2
7853667|NCT00943852|19330606|P6|COMPLETED|Second Period of Treatment Intervention||1
7853668|NCT00943852|19330607|P5|COMPLETED|Second Period of Treatment Intervention||1
7853669|NCT00943852|19330608|P4|COMPLETED|Second Period of Treatment Intervention||1
7853670|NCT00943852|19330609|P3|COMPLETED|Second Period of Treatment Intervention||1
7853671|NCT00943852|19330610|P2|COMPLETED|Second Period of Treatment Intervention||1
7853672|NCT00943852|19330611|P1|COMPLETED|Second Period of Treatment Intervention||2
7853673|NCT00943852|19330602|P10|STARTED|Second Period of Treatment Intervention||1
7853674|NCT00943852|19330603|P9|STARTED|Second Period of Treatment Intervention||1
7853675|NCT00943852|19330604|P8|STARTED|Second Period of Treatment Intervention||1
7853676|NCT00943852|19330605|P7|STARTED|Second Period of Treatment Intervention||2
7853677|NCT00943852|19330606|P6|STARTED|Second Period of Treatment Intervention||1
7853678|NCT00943852|19330607|P5|STARTED|Second Period of Treatment Intervention||1
7853679|NCT00943852|19330608|P4|STARTED|Second Period of Treatment Intervention||1
7853680|NCT00943852|19330609|P3|STARTED|Second Period of Treatment Intervention||1
7853681|NCT00943852|19330610|P2|STARTED|Second Period of Treatment Intervention||1
7853682|NCT00943852|19330611|P1|STARTED|Second Period of Treatment Intervention||2
7853683|NCT00943852|19330602|P10|NOT COMPLETED|Washout Period After Period 1 Treatment||0
7853684|NCT00943852|19330603|P9|NOT COMPLETED|Washout Period After Period 1 Treatment||0
7853685|NCT00943852|19330604|P8|NOT COMPLETED|Washout Period After Period 1 Treatment||0
7853686|NCT00943852|19330605|P7|NOT COMPLETED|Washout Period After Period 1 Treatment||0
7853687|NCT00943852|19330606|P6|NOT COMPLETED|Washout Period After Period 1 Treatment||0
7853688|NCT00943852|19330607|P5|NOT COMPLETED|Washout Period After Period 1 Treatment||0
7853689|NCT00943852|19330608|P4|NOT COMPLETED|Washout Period After Period 1 Treatment||1
7853690|NCT00943852|19330609|P3|NOT COMPLETED|Washout Period After Period 1 Treatment||0
7853691|NCT00943852|19330610|P2|NOT COMPLETED|Washout Period After Period 1 Treatment||0
7853692|NCT00943852|19330611|P1|NOT COMPLETED|Washout Period After Period 1 Treatment||0
7853693|NCT00943852|19330602|P10|COMPLETED|Washout Period After Period 1 Treatment||1
7853694|NCT00943852|19330603|P9|COMPLETED|Washout Period After Period 1 Treatment||1
7853695|NCT00943852|19330604|P8|COMPLETED|Washout Period After Period 1 Treatment||1
7853696|NCT00943852|19330605|P7|COMPLETED|Washout Period After Period 1 Treatment||2
7853697|NCT00943852|19330606|P6|COMPLETED|Washout Period After Period 1 Treatment||1
7853698|NCT00943852|19330607|P5|COMPLETED|Washout Period After Period 1 Treatment||1
7853699|NCT00943852|19330608|P4|COMPLETED|Washout Period After Period 1 Treatment||1
7853700|NCT00943852|19330609|P3|COMPLETED|Washout Period After Period 1 Treatment||1
7853701|NCT00943852|19330610|P2|COMPLETED|Washout Period After Period 1 Treatment||1
7853702|NCT00943852|19330611|P1|COMPLETED|Washout Period After Period 1 Treatment||2
7853703|NCT00943852|19330602|P10|STARTED|Washout Period After Period 1 Treatment||1
7853704|NCT00943852|19330603|P9|STARTED|Washout Period After Period 1 Treatment||1
7853705|NCT00943852|19330604|P8|STARTED|Washout Period After Period 1 Treatment||1
7853706|NCT00943852|19330605|P7|STARTED|Washout Period After Period 1 Treatment||2
7853707|NCT00943852|19330606|P6|STARTED|Washout Period After Period 1 Treatment||1
7853708|NCT00943852|19330607|P5|STARTED|Washout Period After Period 1 Treatment||1
7853709|NCT00943852|19330608|P4|STARTED|Washout Period After Period 1 Treatment||2
7853710|NCT00943852|19330609|P3|STARTED|Washout Period After Period 1 Treatment||1
7853711|NCT00943852|19330610|P2|STARTED|Washout Period After Period 1 Treatment||1
7853712|NCT00943852|19330611|P1|STARTED|Washout Period After Period 1 Treatment||2
7853713|NCT00943852|19330602|P10|NOT COMPLETED|First Period of Treatment Intervention||0
7853714|NCT00943852|19330603|P9|NOT COMPLETED|First Period of Treatment Intervention||0
7853715|NCT00943852|19330604|P8|NOT COMPLETED|First Period of Treatment Intervention||0
7853716|NCT00943852|19330605|P7|NOT COMPLETED|First Period of Treatment Intervention||0
7853717|NCT00943852|19330606|P6|NOT COMPLETED|First Period of Treatment Intervention||0
7853718|NCT00943852|19330607|P5|NOT COMPLETED|First Period of Treatment Intervention||0
7853719|NCT00943852|19330608|P4|NOT COMPLETED|First Period of Treatment Intervention||0
7853720|NCT00943852|19330609|P3|NOT COMPLETED|First Period of Treatment Intervention||0
7853721|NCT00943852|19330610|P2|NOT COMPLETED|First Period of Treatment Intervention||0
7853722|NCT00943852|19330611|P1|NOT COMPLETED|First Period of Treatment Intervention||0
7853723|NCT00943852|19330602|P10|COMPLETED|First Period of Treatment Intervention||1
7853724|NCT00943852|19330603|P9|COMPLETED|First Period of Treatment Intervention||1
7853725|NCT00943852|19330604|P8|COMPLETED|First Period of Treatment Intervention||1
7853726|NCT00943852|19330605|P7|COMPLETED|First Period of Treatment Intervention||2
7853727|NCT00943852|19330606|P6|COMPLETED|First Period of Treatment Intervention||1
7853728|NCT00943852|19330607|P5|COMPLETED|First Period of Treatment Intervention||1
7853729|NCT00943852|19330608|P4|COMPLETED|First Period of Treatment Intervention||2
7853730|NCT00943852|19330609|P3|COMPLETED|First Period of Treatment Intervention||1
7853731|NCT00943852|19330610|P2|COMPLETED|First Period of Treatment Intervention||1
7853732|NCT00943852|19330611|P1|COMPLETED|First Period of Treatment Intervention||2
7853733|NCT00943852|19330602|P10|STARTED|First Period of Treatment Intervention||1
7853734|NCT00943852|19330603|P9|STARTED|First Period of Treatment Intervention||1
7853735|NCT00943852|19330604|P8|STARTED|First Period of Treatment Intervention||1
7853736|NCT00943852|19330605|P7|STARTED|First Period of Treatment Intervention||2
7853737|NCT00943852|19330606|P6|STARTED|First Period of Treatment Intervention||1
7853738|NCT00943852|19330607|P5|STARTED|First Period of Treatment Intervention||1
7853739|NCT00943852|19330608|P4|STARTED|First Period of Treatment Intervention||2
7853740|NCT00943852|19330609|P3|STARTED|First Period of Treatment Intervention||1
7853741|NCT00943852|19330610|P2|STARTED|First Period of Treatment Intervention||1
7853742|NCT00943852|19330611|P1|STARTED|First Period of Treatment Intervention||2
7853743|NCT00943826|19330624|P2|NOT COMPLETED|After Primary Overall Survival Analysis||20
7853744|NCT00943826|19330625|P1|NOT COMPLETED|After Primary Overall Survival Analysis||27
7853745|NCT00943826|19330624|P2|COMPLETED|After Primary Overall Survival Analysis||0
7853746|NCT00943826|19330625|P1|COMPLETED|After Primary Overall Survival Analysis||0
7853747|NCT00943826|19330624|P2|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|20
7853748|NCT00943826|19330625|P1|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|27
7853749|NCT00943826|19330624|P2|NOT COMPLETED|Monotherapy Phase||16
7853750|NCT00943826|19330625|P1|NOT COMPLETED|Monotherapy Phase||65
7853751|NCT00943826|19330624|P2|COMPLETED|Monotherapy Phase||143
7853752|NCT00943826|19330625|P1|COMPLETED|Monotherapy Phase||204
7853753|NCT00943826|19330624|P2|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|159
7853754|NCT00943826|19330625|P1|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|269
7853755|NCT00943826|19330624|P2|NOT COMPLETED|Maintenance Phase||39
7853756|NCT00943826|19330625|P1|NOT COMPLETED|Maintenance Phase||43
7853757|NCT00943826|19330624|P2|COMPLETED|Maintenance Phase||331
7853758|NCT00943826|19330625|P1|COMPLETED|Maintenance Phase||353
7853759|NCT00943826|19330624|P2|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|370
7853760|NCT00943826|19330625|P1|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|396
7853761|NCT00943826|19330624|P2|NOT COMPLETED|Concurrent Phase||42
7853762|NCT00943826|19330625|P1|NOT COMPLETED|Concurrent Phase||61
7853763|NCT00943826|19330624|P2|COMPLETED|Concurrent Phase||421
7853764|NCT00943826|19330625|P1|COMPLETED|Concurrent Phase||397
7853765|NCT00943826|19330624|P2|Treated|Concurrent Phase||459
7853766|NCT00943826|19330625|P1|Treated|Concurrent Phase||452
7853767|NCT00943826|19330624|P2|STARTED|Concurrent Phase||463
7853768|NCT00943826|19330625|P1|STARTED|Concurrent Phase||458
7853769|NCT00943800|19330643|P1|NOT COMPLETED|Overall Study||0
7853770|NCT00943800|19330643|P1|COMPLETED|Overall Study||87
7853771|NCT00943800|19330643|P1|STARTED|Overall Study||87
7853772|NCT00943787|19330649|P1|NOT COMPLETED|Overall Study||7
7853773|NCT00943787|19330649|P1|COMPLETED|Overall Study||34
7853774|NCT00943787|19330649|P1|STARTED|Overall Study||41
7853775|NCT00943761|19330656|P2|NOT COMPLETED|Overall Study||1
7853776|NCT00943761|19330657|P1|NOT COMPLETED|Overall Study||4
7853777|NCT00943761|19330656|P2|COMPLETED|Overall Study||23
7853778|NCT00943761|19330657|P1|COMPLETED|Overall Study||17
7853779|NCT00943761|19330656|P2|STARTED|Overall Study||24
7853780|NCT00943761|19330657|P1|STARTED|Overall Study||21
7853781|NCT00943735|19330669|P1|NOT COMPLETED|Overall Study||32
7853782|NCT00943735|19330669|P1|COMPLETED|Overall Study||742
7853783|NCT00943735|19330669|P1|Per Protocol Population|Overall Study||500
7853784|NCT00943735|19330669|P1|STARTED|Overall Study||774
7853785|NCT00943722|19330707|P5|NOT COMPLETED|Overall Study||22
7853786|NCT00943722|19330708|P4|NOT COMPLETED|Overall Study||22
7853787|NCT00943722|19330709|P3|NOT COMPLETED|Overall Study||13
7853788|NCT00943722|19330710|P2|NOT COMPLETED|Overall Study||22
7853789|NCT00943722|19330711|P1|NOT COMPLETED|Overall Study||25
7853790|NCT00943722|19330707|P5|COMPLETED|Overall Study|Includes 4 participants for whom completion status is unknown|448
7853791|NCT00943722|19330708|P4|COMPLETED|Overall Study||647
7853792|NCT00943722|19330709|P3|COMPLETED|Overall Study||631
7853793|NCT00943722|19330710|P2|COMPLETED|Overall Study||621
7853794|NCT00943722|19330711|P1|COMPLETED|Overall Study||623
7853795|NCT00943722|19330707|P5|Vaccination 3|Overall Study||455
7853796|NCT00943722|19330708|P4|Vaccination 3|Overall Study||653
7853797|NCT00943722|19330709|P3|Vaccination 3|Overall Study||637
7853798|NCT00943722|19330710|P2|Vaccination 3|Overall Study||627
7853799|NCT00943722|19330711|P1|Vaccination 3|Overall Study||635
7853800|NCT00943722|19330707|P5|Vaccination 2|Overall Study||462
7853801|NCT00943722|19330708|P4|Vaccination 2|Overall Study||658
7853802|NCT00943722|19330709|P3|Vaccination 2|Overall Study||638
7853803|NCT00943722|19330710|P2|Vaccination 2|Overall Study||633
7853804|NCT00943722|19330711|P1|Vaccination 2|Overall Study||637
7853805|NCT00943722|19330707|P5|Vaccination 1|Overall Study||468
7853806|NCT00943722|19330708|P4|Vaccination 1|Overall Study||666
7853807|NCT00943722|19330709|P3|Vaccination 1|Overall Study||644
7853808|NCT00943722|19330710|P2|Vaccination 1|Overall Study||642
7853809|NCT00943722|19330711|P1|Vaccination 1|Overall Study||646
7853810|NCT00943722|19330707|P5|STARTED|Overall Study||470
7853811|NCT00943722|19330708|P4|STARTED|Overall Study||669
7853812|NCT00943722|19330709|P3|STARTED|Overall Study||644
7853813|NCT00943722|19330710|P2|STARTED|Overall Study||643
7853814|NCT00943722|19330711|P1|STARTED|Overall Study||648
7853815|NCT00943683|19330741|P2|NOT COMPLETED|Overall Study||6
7853816|NCT00943683|19330742|P1|NOT COMPLETED|Overall Study||7
7853817|NCT00943683|19330741|P2|COMPLETED|Overall Study||169
7853818|NCT00943683|19330742|P1|COMPLETED|Overall Study||74
7853819|NCT00943683|19330741|P2|STARTED|Overall Study||175
7853820|NCT00943683|19330742|P1|STARTED|Overall Study||81
7853821|NCT00943670|19330748|P1|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18
7853822|NCT00943670|19330748|P1|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2
7853823|NCT00943670|19330748|P1|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20
7853824|NCT00943670|19330748|P1|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42
7853825|NCT00943670|19330748|P1|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9
7853826|NCT00943670|19330748|P1|Treated|Single-agent Trastuzumab Emtansine||51
7853827|NCT00943670|19330748|P1|STARTED|Single-agent Trastuzumab Emtansine||51
7853828|NCT00943631|19330784|P2|NOT COMPLETED|Overall Study||2
7853829|NCT00943631|19330785|P1|NOT COMPLETED|Overall Study||4
7853830|NCT00943631|19330784|P2|COMPLETED|Overall Study||202
7853831|NCT00943631|19330785|P1|COMPLETED|Overall Study||198
7853832|NCT00943631|19330784|P2|STARTED|Overall Study||204
7853833|NCT00943631|19330785|P1|STARTED|Overall Study||202
7853834|NCT00943605|19330837|P2|NOT COMPLETED|Overall Study||30
7853835|NCT00943605|19330838|P1|NOT COMPLETED|Overall Study||30
7853836|NCT00943605|19330837|P2|COMPLETED|Overall Study||0
7853837|NCT00943605|19330838|P1|COMPLETED|Overall Study||0
7853838|NCT00943605|19330837|P2|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
7853839|NCT00943605|19330838|P1|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
7853840|NCT00943592|19330848|P1|NOT COMPLETED|Overall Study||3
7853841|NCT00943592|19330848|P1|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79
7853842|NCT00943592|19330848|P1|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74
7853843|NCT00943592|19330848|P1|STARTED|Overall Study||82
7853844|NCT00943579|19330861|P2|NOT COMPLETED|Overall Study||5
7853845|NCT00943579|19330862|P1|NOT COMPLETED|Overall Study||6
7853846|NCT00943579|19330861|P2|COMPLETED|Overall Study||15
7853847|NCT00943579|19330862|P1|COMPLETED|Overall Study||15
7853848|NCT00943579|19330861|P2|STARTED|Overall Study||20
7853849|NCT00943579|19330862|P1|STARTED|Overall Study||21
7853850|NCT00943488|19330883|P2|NOT COMPLETED|Overall Study||2
7853851|NCT00943488|19330884|P1|NOT COMPLETED|Overall Study||1
7853852|NCT00943488|19330883|P2|COMPLETED|Overall Study||202
7853853|NCT00943488|19330884|P1|COMPLETED|Overall Study||203
7853854|NCT00943488|19330883|P2|STARTED|Overall Study||204
7853855|NCT00943488|19330884|P1|STARTED|Overall Study||204
7853856|NCT00943436|19330940|P2|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
7853857|NCT00943436|19330941|P1|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
7853858|NCT00943436|19330940|P2|COMPLETED|Rest Session: 45 Minutes of Reading||10
7853859|NCT00943436|19330941|P1|COMPLETED|Rest Session: 45 Minutes of Reading||10
7853860|NCT00943436|19330940|P2|STARTED|Rest Session: 45 Minutes of Reading||10
7853861|NCT00943436|19330941|P1|STARTED|Rest Session: 45 Minutes of Reading||10
7853862|NCT00943436|19330940|P2|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
7853863|NCT00943436|19330941|P1|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
7853864|NCT00943436|19330940|P2|COMPLETED|Exercise Session: 45 Minutes of Activity||10
7853865|NCT00943436|19330941|P1|COMPLETED|Exercise Session: 45 Minutes of Activity||10
7853866|NCT00943436|19330940|P2|STARTED|Exercise Session: 45 Minutes of Activity||10
7853867|NCT00943436|19330941|P1|STARTED|Exercise Session: 45 Minutes of Activity||10
7853868|NCT00943397|19330963|P2|NOT COMPLETED|Overall Study||72
7853869|NCT00943397|19330964|P1|NOT COMPLETED|Overall Study||15
7853870|NCT00943397|19330963|P2|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86
7853871|NCT00943397|19330964|P1|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17
7853872|NCT00943397|19330963|P2|STARTED|Overall Study||158
7853873|NCT00943397|19330964|P1|STARTED|Overall Study||32
7853874|NCT00943384|19330970|P1|NOT COMPLETED|Overall Study||49
7853875|NCT00943384|19330970|P1|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55
7853876|NCT00943384|19330970|P1|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76
7853877|NCT00943384|19330970|P1|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81
7853878|NCT00943384|19330970|P1|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104
7853879|NCT00943319|19330984|P1|NOT COMPLETED|Overall Study||1
7853880|NCT00943319|19330984|P1|COMPLETED|Overall Study||49
7853881|NCT00943319|19330984|P1|STARTED|Overall Study||50
7853882|NCT00943306|19330990|P1|NOT COMPLETED|Overall Study||3
7853883|NCT00943306|19330990|P1|COMPLETED|Overall Study||16
7853884|NCT00943306|19330990|P1|STARTED|Overall Study||19
7853885|NCT00943202|19331051|P4|NOT COMPLETED|Overall Study||1
7853886|NCT00943202|19331052|P3|NOT COMPLETED|Overall Study||0
7853887|NCT00943202|19331053|P2|NOT COMPLETED|Overall Study||2
7853888|NCT00943202|19331054|P1|NOT COMPLETED|Overall Study||1
7853889|NCT00943202|19331051|P4|COMPLETED|Overall Study||131
7853890|NCT00943202|19331052|P3|COMPLETED|Overall Study||133
7853891|NCT00943202|19331053|P2|COMPLETED|Overall Study||131
7853892|NCT00943202|19331054|P1|COMPLETED|Overall Study||132
7853893|NCT00943202|19331051|P4|STARTED|Overall Study||132
7853894|NCT00943202|19331052|P3|STARTED|Overall Study||133
7853895|NCT00943202|19331053|P2|STARTED|Overall Study||133
7853896|NCT00943202|19331054|P1|STARTED|Overall Study||133
7853897|NCT00943150|19331270|P2|NOT COMPLETED|Overall Study||0
7853898|NCT00943150|19331271|P1|NOT COMPLETED|Overall Study||0
7853899|NCT00943150|19331270|P2|COMPLETED|Overall Study||10
7853900|NCT00943150|19331271|P1|COMPLETED|Overall Study||10
7853901|NCT00943150|19331270|P2|STARTED|Overall Study||10
7853902|NCT00943150|19331271|P1|STARTED|Overall Study||10
7853903|NCT00943124|19331292|P2|NOT COMPLETED|Period 2||0
7853904|NCT00943124|19331293|P1|NOT COMPLETED|Period 2||0
7853905|NCT00943124|19331292|P2|COMPLETED|Period 2||108
7853906|NCT00943124|19331293|P1|COMPLETED|Period 2||108
7853907|NCT00943124|19331292|P2|STARTED|Period 2||108
7853908|NCT00943124|19331293|P1|STARTED|Period 2||108
7853909|NCT00943124|19331292|P2|NOT COMPLETED|Period 1||2
7853910|NCT00943124|19331293|P1|NOT COMPLETED|Period 1||2
7853911|NCT00943124|19331292|P2|COMPLETED|Period 1||108
7853912|NCT00943124|19331293|P1|COMPLETED|Period 1||108
7853913|NCT00943124|19331292|P2|STARTED|Period 1||110
7853914|NCT00943124|19331293|P1|STARTED|Period 1||110
7853915|NCT00943111|19331315|P3|NOT COMPLETED|5 Years Long-term Treatment Period||75
7853916|NCT00943111|19331316|P2|NOT COMPLETED|5 Years Long-term Treatment Period||0
7853917|NCT00943111|19331317|P1|NOT COMPLETED|5 Years Long-term Treatment Period||0
7853918|NCT00943111|19331315|P3|COMPLETED|5 Years Long-term Treatment Period||77
7853919|NCT00943111|19331316|P2|COMPLETED|5 Years Long-term Treatment Period||0
7853920|NCT00943111|19331317|P1|COMPLETED|5 Years Long-term Treatment Period||0
7853921|NCT00943111|19331315|P3|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152
7853922|NCT00943111|19331316|P2|STARTED|5 Years Long-term Treatment Period||0
7853923|NCT00943111|19331317|P1|STARTED|5 Years Long-term Treatment Period||0
7853924|NCT00943111|19331315|P3|NOT COMPLETED|52-Weeks Primary Analysis Period||0
7853925|NCT00943111|19331316|P2|NOT COMPLETED|52-Weeks Primary Analysis Period||2
7853926|NCT00943111|19331317|P1|NOT COMPLETED|52-Weeks Primary Analysis Period||2
7853927|NCT00943111|19331315|P3|COMPLETED|52-Weeks Primary Analysis Period||0
7853928|NCT00943111|19331316|P2|COMPLETED|52-Weeks Primary Analysis Period||52
7853929|NCT00943111|19331317|P1|COMPLETED|52-Weeks Primary Analysis Period||104
7853930|NCT00943111|19331315|P3|Treated|52-Weeks Primary Analysis Period||0
7853931|NCT00943111|19331316|P2|Treated|52-Weeks Primary Analysis Period||53
7853932|NCT00943111|19331317|P1|Treated|52-Weeks Primary Analysis Period||106
7853933|NCT00943111|19331315|P3|STARTED|52-Weeks Primary Analysis Period||0
7853934|NCT00943111|19331316|P2|STARTED|52-Weeks Primary Analysis Period||54
7853935|NCT00943111|19331317|P1|STARTED|52-Weeks Primary Analysis Period||106
7853936|NCT00943098|19331350|P2|NOT COMPLETED|Overall Study||0
7853937|NCT00943098|19331351|P1|NOT COMPLETED|Overall Study||0
7853938|NCT00943098|19331350|P2|COMPLETED|Overall Study||72
7853939|NCT00943098|19331351|P1|COMPLETED|Overall Study||70
7854030|NCT00942422|19331620|P1|STARTED|Overall Study||8
7853940|NCT00943098|19331350|P2|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72
7853941|NCT00943098|19331351|P1|STARTED|Overall Study||70
7853942|NCT00943072|19331385|P2|NOT COMPLETED|Overall Study||14
7853943|NCT00943072|19331386|P1|NOT COMPLETED|Overall Study||5
7853944|NCT00943072|19331385|P2|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60
7853945|NCT00943072|19331386|P1|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110
7853946|NCT00943072|19331385|P2|Full Analysis Set (FAS) Population|Overall Study||73
7853947|NCT00943072|19331386|P1|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114
7853948|NCT00943072|19331385|P2|Participants Received Treatment|Overall Study||74
7853949|NCT00943072|19331386|P1|Participants Received Treatment|Overall Study|Safety population (SAF)|114
7853950|NCT00943072|19331385|P2|STARTED|Overall Study||74
7853951|NCT00943072|19331386|P1|STARTED|Overall Study||115
7853952|NCT00942994|19331404|P2|NOT COMPLETED|Overall Study||19
7853953|NCT00942994|19331405|P1|NOT COMPLETED|Overall Study||16
7853954|NCT00942994|19331404|P2|COMPLETED|Overall Study||190
7853955|NCT00942994|19331405|P1|COMPLETED|Overall Study||187
7853956|NCT00942994|19331404|P2|STARTED|Overall Study||209
7853957|NCT00942994|19331405|P1|STARTED|Overall Study||203
7853958|NCT00942968|19331421|P1|NOT COMPLETED|Overall Study||229
7853959|NCT00942968|19331421|P1|COMPLETED|Overall Study||109
7853960|NCT00942968|19331421|P1|Treated|Overall Study||334
7853961|NCT00942968|19331421|P1|STARTED|Overall Study||338
7853962|NCT00942903|19331442|P1|NOT COMPLETED|Overall Study||0
7853963|NCT00942903|19331442|P1|COMPLETED|Overall Study||20
7853964|NCT00942903|19331442|P1|STARTED|Overall Study||20
7853965|NCT00942890|19331449|P2|NOT COMPLETED|Overall Study||0
7853966|NCT00942890|19331450|P1|NOT COMPLETED|Overall Study||0
7853967|NCT00942890|19331449|P2|COMPLETED|Overall Study||23
7853968|NCT00942890|19331450|P1|COMPLETED|Overall Study||21
7853969|NCT00942890|19331449|P2|STARTED|Overall Study||23
7853970|NCT00942890|19331450|P1|STARTED|Overall Study||21
7853971|NCT00942851|19331472|P2|NOT COMPLETED|Overall Study||1
7853972|NCT00942851|19331473|P1|NOT COMPLETED|Overall Study||0
7853973|NCT00942851|19331472|P2|COMPLETED|Overall Study||11
7853974|NCT00942851|19331473|P1|COMPLETED|Overall Study||12
7853975|NCT00942851|19331472|P2|STARTED|Overall Study||12
7853976|NCT00942851|19331473|P1|STARTED|Overall Study||12
7853977|NCT00942825|19331485|P2|NOT COMPLETED|Overall Study||0
7853978|NCT00942825|19331486|P1|NOT COMPLETED|Overall Study||0
7853979|NCT00942825|19331485|P2|COMPLETED|Overall Study||98
7853980|NCT00942825|19331486|P1|COMPLETED|Overall Study||97
7853981|NCT00942825|19331485|P2|STARTED|Overall Study||98
7853982|NCT00942825|19331486|P1|STARTED|Overall Study||97
7853983|NCT00942786|19331492|P1|NOT COMPLETED|Overall Study||0
7853984|NCT00942786|19331492|P1|COMPLETED|Overall Study|date of last follow-up|297
7853985|NCT00942786|19331492|P1|STARTED|Overall Study||297
7853986|NCT00942734|19331499|P1|NOT COMPLETED|Overall Study||8
7853987|NCT00942734|19331499|P1|COMPLETED|Overall Study||35
7853988|NCT00942734|19331499|P1|STARTED|Overall Study||43
7853989|NCT00942708|19331503|P1|NOT COMPLETED|Overall Study||1
7853990|NCT00942708|19331503|P1|COMPLETED|Overall Study||5
7853991|NCT00942708|19331503|P1|STARTED|Overall Study||6
7853992|NCT00942604|19331511|P2|NOT COMPLETED|Overall Study||4
7853993|NCT00942604|19331512|P1|NOT COMPLETED|Overall Study||2
7853994|NCT00942604|19331511|P2|COMPLETED|Overall Study||99
7853995|NCT00942604|19331512|P1|COMPLETED|Overall Study||98
7853996|NCT00942604|19331511|P2|STARTED|Overall Study||103
7853997|NCT00942604|19331512|P1|STARTED|Overall Study||100
7853998|NCT00942578|19331523|P3|NOT COMPLETED|Expansion Phase||0
7853999|NCT00942578|19331524|P2|NOT COMPLETED|Expansion Phase||0
7854000|NCT00942578|19331525|P1|NOT COMPLETED|Expansion Phase||0
7854001|NCT00942578|19331523|P3|COMPLETED|Expansion Phase||43
7854002|NCT00942578|19331524|P2|COMPLETED|Expansion Phase||0
7854003|NCT00942578|19331525|P1|COMPLETED|Expansion Phase||11
7854004|NCT00942578|19331523|P3|STARTED|Expansion Phase||43
7854005|NCT00942578|19331524|P2|STARTED|Expansion Phase||0
7854006|NCT00942578|19331525|P1|STARTED|Expansion Phase||11
7854007|NCT00942578|19331523|P3|NOT COMPLETED|Dose Escalation Phase||0
7854008|NCT00942578|19331524|P2|NOT COMPLETED|Dose Escalation Phase||0
7854009|NCT00942578|19331525|P1|NOT COMPLETED|Dose Escalation Phase||0
7854010|NCT00942578|19331523|P3|COMPLETED|Dose Escalation Phase||3
7854011|NCT00942578|19331524|P2|COMPLETED|Dose Escalation Phase||3
7854012|NCT00942578|19331525|P1|COMPLETED|Dose Escalation Phase||3
7854013|NCT00942578|19331523|P3|STARTED|Dose Escalation Phase||3
7854014|NCT00942578|19331524|P2|STARTED|Dose Escalation Phase||3
7854015|NCT00942578|19331525|P1|STARTED|Dose Escalation Phase||3
7854016|NCT00942448|19331555|P4|NOT COMPLETED|Overall Study||0
7854017|NCT00942448|19331556|P3|NOT COMPLETED|Overall Study||0
7854018|NCT00942448|19331557|P2|NOT COMPLETED|Overall Study||0
7854019|NCT00942448|19331558|P1|NOT COMPLETED|Overall Study||0
7854020|NCT00942448|19331555|P4|COMPLETED|Overall Study||75
7854021|NCT00942448|19331556|P3|COMPLETED|Overall Study||78
7854022|NCT00942448|19331557|P2|COMPLETED|Overall Study||76
7854023|NCT00942448|19331558|P1|COMPLETED|Overall Study||77
7854024|NCT00942448|19331555|P4|STARTED|Overall Study||75
7854025|NCT00942448|19331556|P3|STARTED|Overall Study||78
7854026|NCT00942448|19331557|P2|STARTED|Overall Study||76
7854027|NCT00942448|19331558|P1|STARTED|Overall Study||77
7854028|NCT00942422|19331620|P1|NOT COMPLETED|Overall Study||3
7854029|NCT00942422|19331620|P1|COMPLETED|Overall Study||5
7854031|NCT00942409|19331624|P1|NOT COMPLETED|Overall Study||3
7854032|NCT00942409|19331624|P1|COMPLETED|Overall Study||2
7854033|NCT00942409|19331624|P1|STARTED|Overall Study||5
7854034|NCT00942357|19331630|P2|NOT COMPLETED|Overall Study||40
7854035|NCT00942357|19331631|P1|NOT COMPLETED|Overall Study||37
7854036|NCT00942357|19331630|P2|COMPLETED|Overall Study||366
7854037|NCT00942357|19331631|P1|COMPLETED|Overall Study||370
7854038|NCT00942357|19331630|P2|STARTED|Overall Study||406
7854039|NCT00942357|19331631|P1|STARTED|Overall Study||407
7854040|NCT00942331|19331647|P2|NOT COMPLETED|Overall Study||22
7854041|NCT00942331|19331648|P1|NOT COMPLETED|Overall Study||15
7854042|NCT00942331|19331647|P2|COMPLETED|Overall Study||232
7854043|NCT00942331|19331648|P1|COMPLETED|Overall Study||237
7854044|NCT00942331|19331647|P2|STARTED|Overall Study||254
7854045|NCT00942331|19331648|P1|STARTED|Overall Study||252
7854046|NCT00942266|19331660|P2|NOT COMPLETED|Overall Study||15
7854047|NCT00942266|19331661|P1|NOT COMPLETED|Overall Study||43
7854048|NCT00942266|19331660|P2|COMPLETED|Overall Study||0
7854049|NCT00942266|19331661|P1|COMPLETED|Overall Study||0
7854050|NCT00942266|19331660|P2|STARTED|Overall Study||15
7854051|NCT00942266|19331661|P1|STARTED|Overall Study||43
7854052|NCT00942188|19331683|P4|NOT COMPLETED|Overall Study||4
7854053|NCT00942188|19331684|P3|NOT COMPLETED|Overall Study||9
7854054|NCT00942188|19331685|P2|NOT COMPLETED|Overall Study||10
7854055|NCT00942188|19331686|P1|NOT COMPLETED|Overall Study||4
7854056|NCT00942188|19331683|P4|COMPLETED|Overall Study||23
7854057|NCT00942188|19331684|P3|COMPLETED|Overall Study||18
7854058|NCT00942188|19331685|P2|COMPLETED|Overall Study||16
7854059|NCT00942188|19331686|P1|COMPLETED|Overall Study||22
7854060|NCT00942188|19331683|P4|STARTED|Overall Study||27
7854061|NCT00942188|19331684|P3|STARTED|Overall Study||27
7854062|NCT00942188|19331685|P2|STARTED|Overall Study||26
7854063|NCT00942188|19331686|P1|STARTED|Overall Study||26
7854064|NCT00942175|19331725|P4|NOT COMPLETED|Overall Study||2
7854065|NCT00942175|19331726|P3|NOT COMPLETED|Overall Study||2
7854066|NCT00942175|19331727|P2|NOT COMPLETED|Overall Study||4
7854067|NCT00942175|19331728|P1|NOT COMPLETED|Overall Study||2
7854068|NCT00942175|19331725|P4|COMPLETED|Overall Study||38
7854069|NCT00942175|19331726|P3|COMPLETED|Overall Study||38
7854070|NCT00942175|19331727|P2|COMPLETED|Overall Study||36
7854071|NCT00942175|19331728|P1|COMPLETED|Overall Study||38
7854072|NCT00942175|19331725|P4|STARTED|Overall Study||40
7854073|NCT00942175|19331726|P3|STARTED|Overall Study||40
7854074|NCT00942175|19331727|P2|STARTED|Overall Study||40
7854075|NCT00942175|19331728|P1|STARTED|Overall Study||40
7854076|NCT00942162|19331781|P3|NOT COMPLETED|Overall Study||2
7854077|NCT00942162|19331782|P2|NOT COMPLETED|Overall Study||50
7854078|NCT00942162|19331783|P1|NOT COMPLETED|Overall Study||70
7854079|NCT00942162|19331781|P3|COMPLETED|Overall Study||0
7854080|NCT00942162|19331782|P2|COMPLETED|Overall Study||0
7854081|NCT00942162|19331783|P1|COMPLETED|Overall Study||1
7854082|NCT00942162|19331781|P3|STARTED|Overall Study||2
7854083|NCT00942162|19331782|P2|STARTED|Overall Study||50
7854084|NCT00942162|19331783|P1|STARTED|Overall Study||71
7854085|NCT00942149|19331850|P1|NOT COMPLETED|Overall Study||0
7854086|NCT00942149|19331850|P1|COMPLETED|Overall Study||20
7854087|NCT00942149|19331850|P1|STARTED|Overall Study||20
7854088|NCT00942084|19331854|P1|NOT COMPLETED|Overall Study||2
7854089|NCT00942084|19331854|P1|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30
7854090|NCT00942084|19331854|P1|STARTED|Overall Study||32
7854091|NCT00941993|19331863|P1|NOT COMPLETED|Overall Study||0
7854092|NCT00941993|19331863|P1|COMPLETED|Overall Study||109
7854093|NCT00941993|19331863|P1|STARTED|Overall Study||109
7854094|NCT00941928|19331871|P1|NOT COMPLETED|Overall Study||2
7854095|NCT00941928|19331871|P1|COMPLETED|Overall Study||0
7854096|NCT00941928|19331871|P1|STARTED|Overall Study||2
7854097|NCT00941889|19331877|P2|NOT COMPLETED|Overall Study||12
7854098|NCT00941889|19331878|P1|NOT COMPLETED|Overall Study||12
7854099|NCT00941889|19331877|P2|COMPLETED|Overall Study||3
7854100|NCT00941889|19331878|P1|COMPLETED|Overall Study||5
7854101|NCT00941889|19331877|P2|STARTED|Overall Study||15
7854102|NCT00941889|19331878|P1|STARTED|Overall Study||17
7854103|NCT00941863|19331889|P5|NOT COMPLETED|Continued After PCD||19
7854104|NCT00941863|19331890|P4|NOT COMPLETED|Continued After PCD||0
7854105|NCT00941863|19331891|P3|NOT COMPLETED|Continued After PCD||0
7854106|NCT00941863|19331892|P2|NOT COMPLETED|Continued After PCD||0
7854107|NCT00941863|19331893|P1|NOT COMPLETED|Continued After PCD||0
7854108|NCT00941863|19331889|P5|COMPLETED|Continued After PCD||6
7854109|NCT00941863|19331890|P4|COMPLETED|Continued After PCD||0
7854110|NCT00941863|19331891|P3|COMPLETED|Continued After PCD||0
7854111|NCT00941863|19331892|P2|COMPLETED|Continued After PCD||0
7854112|NCT00941863|19331893|P1|COMPLETED|Continued After PCD||0
7854113|NCT00941863|19331889|P5|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25
7854114|NCT00941863|19331890|P4|STARTED|Continued After PCD||0
7854115|NCT00941863|19331891|P3|STARTED|Continued After PCD||0
7854116|NCT00941863|19331892|P2|STARTED|Continued After PCD||0
7854117|NCT00941863|19331893|P1|STARTED|Continued After PCD||0
7854118|NCT00941863|19331889|P5|NOT COMPLETED|Until Primary Completion Date (PCD)||94
7854119|NCT00941863|19331890|P4|NOT COMPLETED|Until Primary Completion Date (PCD)||17
7854120|NCT00941863|19331891|P3|NOT COMPLETED|Until Primary Completion Date (PCD)||12
7854121|NCT00941863|19331892|P2|NOT COMPLETED|Until Primary Completion Date (PCD)||3
7854122|NCT00941863|19331893|P1|NOT COMPLETED|Until Primary Completion Date (PCD)||7
7854123|NCT00941863|19331889|P5|COMPLETED|Until Primary Completion Date (PCD)||25
7854124|NCT00941863|19331890|P4|COMPLETED|Until Primary Completion Date (PCD)||0
7854125|NCT00941863|19331891|P3|COMPLETED|Until Primary Completion Date (PCD)||0
7854126|NCT00941863|19331892|P2|COMPLETED|Until Primary Completion Date (PCD)||0
7854127|NCT00941863|19331893|P1|COMPLETED|Until Primary Completion Date (PCD)||0
7854128|NCT00941863|19331889|P5|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94
7854129|NCT00941863|19331890|P4|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17
7854130|NCT00941863|19331891|P3|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12
7854131|NCT00941863|19331892|P2|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3
7854132|NCT00941863|19331893|P1|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7
7854133|NCT00941863|19331889|P5|STARTED|Until Primary Completion Date (PCD)||119
7854134|NCT00941863|19331890|P4|STARTED|Until Primary Completion Date (PCD)||17
7854135|NCT00941863|19331891|P3|STARTED|Until Primary Completion Date (PCD)||12
7854136|NCT00941863|19331892|P2|STARTED|Until Primary Completion Date (PCD)||3
7854137|NCT00941863|19331893|P1|STARTED|Until Primary Completion Date (PCD)||7
7854138|NCT00941798|19331920|P2|NOT COMPLETED|Overall Study||185
7854139|NCT00941798|19331921|P1|NOT COMPLETED|Overall Study||194
7854140|NCT00941798|19331920|P2|COMPLETED|Overall Study||578
7854141|NCT00941798|19331921|P1|COMPLETED|Overall Study||561
7854142|NCT00941798|19331920|P2|Full Analysis Set|Overall Study||759
7854143|NCT00941798|19331921|P1|Full Analysis Set|Overall Study||749
7854144|NCT00941798|19331920|P2|STARTED|Overall Study||763
7854145|NCT00941798|19331921|P1|STARTED|Overall Study||755
7854146|NCT00941733|19331951|P2|NOT COMPLETED|Overall Study||28
7854147|NCT00941733|19331952|P1|NOT COMPLETED|Overall Study||74
7854148|NCT00941733|19331951|P2|COMPLETED|Overall Study|1 year follow-up|91
7854149|NCT00941733|19331952|P1|COMPLETED|Overall Study|1 year follow-up|165
7854150|NCT00941733|19331951|P2|STARTED|Overall Study||119
7854151|NCT00941733|19331952|P1|STARTED|Overall Study||239
7854152|NCT00941720|19331992|P1|NOT COMPLETED|Overall Study||14
7854153|NCT00941720|19331992|P1|COMPLETED|Overall Study||57
7854154|NCT00941720|19331992|P1|STARTED|Overall Study||71
7854155|NCT00941681|19332001|P3|NOT COMPLETED|Overall Study||0
7854156|NCT00941681|19332002|P2|NOT COMPLETED|Overall Study||1
7854157|NCT00941681|19332003|P1|NOT COMPLETED|Overall Study||0
7854158|NCT00941681|19332001|P3|COMPLETED|Overall Study||12
7854159|NCT00941681|19332002|P2|COMPLETED|Overall Study||10
7854160|NCT00941681|19332003|P1|COMPLETED|Overall Study||12
7854161|NCT00941681|19332001|P3|STARTED|Overall Study||12
7854162|NCT00941681|19332002|P2|STARTED|Overall Study||11
7854163|NCT00941681|19332003|P1|STARTED|Overall Study||12
7854164|NCT00941668|19332028|P2|NOT COMPLETED|Overall Study||25
7854165|NCT00941668|19332029|P1|NOT COMPLETED|Overall Study||24
7854166|NCT00941668|19332028|P2|COMPLETED|Overall Study||0
7854167|NCT00941668|19332029|P1|COMPLETED|Overall Study||0
7854168|NCT00941668|19332028|P2|STARTED|Overall Study||25
7854169|NCT00941668|19332029|P1|STARTED|Overall Study||24
7854170|NCT00941655|19332039|P2|NOT COMPLETED|Overall Study||5
7854171|NCT00941655|19332040|P1|NOT COMPLETED|Overall Study||5
7854172|NCT00941655|19332039|P2|COMPLETED|Overall Study||2
7854173|NCT00941655|19332040|P1|COMPLETED|Overall Study||3
7854174|NCT00941655|19332039|P2|STARTED|Overall Study||7
7854175|NCT00941655|19332040|P1|STARTED|Overall Study||8
7854176|NCT00941603|19332065|P6|NOT COMPLETED|Overall Study||3
7854177|NCT00941603|19332066|P5|NOT COMPLETED|Overall Study||4
7854178|NCT00941603|19332067|P4|NOT COMPLETED|Overall Study||4
7854179|NCT00941603|19332068|P3|NOT COMPLETED|Overall Study||5
7854180|NCT00941603|19332069|P2|NOT COMPLETED|Overall Study||16
7854181|NCT00941603|19332070|P1|NOT COMPLETED|Overall Study||11
7854182|NCT00941603|19332065|P6|COMPLETED|Overall Study||94
7854183|NCT00941603|19332066|P5|COMPLETED|Overall Study||101
7854184|NCT00941603|19332067|P4|COMPLETED|Overall Study||100
7854185|NCT00941603|19332068|P3|COMPLETED|Overall Study||99
7854186|NCT00941603|19332069|P2|COMPLETED|Overall Study||89
7854187|NCT00941603|19332070|P1|COMPLETED|Overall Study||93
7854188|NCT00941603|19332065|P6|STARTED|Overall Study||97
7854189|NCT00941603|19332066|P5|STARTED|Overall Study||105
7854190|NCT00941603|19332067|P4|STARTED|Overall Study||104
7854191|NCT00941603|19332068|P3|STARTED|Overall Study||104
7854192|NCT00941603|19332069|P2|STARTED|Overall Study||105
7854193|NCT00941603|19332070|P1|STARTED|Overall Study||104
7854194|NCT00941330|19332092|P2|NOT COMPLETED|Overall Study||2
7854195|NCT00941330|19332093|P1|NOT COMPLETED|Overall Study||1
7854196|NCT00941330|19332092|P2|COMPLETED|Overall Study||9
7854197|NCT00941330|19332093|P1|COMPLETED|Overall Study||14
7854198|NCT00941330|19332092|P2|STARTED|Overall Study||11
7854199|NCT00941330|19332093|P1|STARTED|Overall Study||15
7854200|NCT00941304|19332106|P5|NOT COMPLETED|Overall Study||0
7854201|NCT00941304|19332107|P4|NOT COMPLETED|Overall Study||0
7854202|NCT00941304|19332108|P3|NOT COMPLETED|Overall Study||0
7854203|NCT00941304|19332109|P2|NOT COMPLETED|Overall Study||0
7854204|NCT00941304|19332110|P1|NOT COMPLETED|Overall Study||1
7854205|NCT00941304|19332106|P5|COMPLETED|Overall Study||31
7854206|NCT00941304|19332107|P4|COMPLETED|Overall Study||30
7854207|NCT00941304|19332108|P3|COMPLETED|Overall Study||31
7854208|NCT00941304|19332109|P2|COMPLETED|Overall Study||30
7854209|NCT00941304|19332110|P1|COMPLETED|Overall Study||30
7854210|NCT00941304|19332106|P5|STARTED|Overall Study||31
7854211|NCT00941304|19332107|P4|STARTED|Overall Study||30
7854212|NCT00941304|19332108|P3|STARTED|Overall Study||31
7854213|NCT00941304|19332109|P2|STARTED|Overall Study||30
7854214|NCT00941304|19332110|P1|STARTED|Overall Study||31
7854215|NCT00941070|19332172|P1|NOT COMPLETED|Overall Study||1
7854216|NCT00941070|19332172|P1|COMPLETED|Overall Study||25
7854217|NCT00941070|19332172|P1|STARTED|Overall Study||26
7854218|NCT00941031|19332192|P7|NOT COMPLETED|Maintenance Period||43
7854219|NCT00941031|19332193|P6|NOT COMPLETED|Maintenance Period||6
7854220|NCT00941031|19332194|P5|NOT COMPLETED|Maintenance Period||9
7854221|NCT00941031|19332195|P4|NOT COMPLETED|Maintenance Period||0
7854222|NCT00941031|19332196|P3|NOT COMPLETED|Maintenance Period||0
7854223|NCT00941031|19332197|P2|NOT COMPLETED|Maintenance Period||0
7854224|NCT00941031|19332198|P1|NOT COMPLETED|Maintenance Period||0
7854225|NCT00941031|19332192|P7|COMPLETED|Maintenance Period||204
7854226|NCT00941031|19332193|P6|COMPLETED|Maintenance Period||61
7854227|NCT00941031|19332194|P5|COMPLETED|Maintenance Period||56
7854228|NCT00941031|19332195|P4|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0
7854229|NCT00941031|19332196|P3|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
7854230|NCT00941031|19332197|P2|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
7854231|NCT00941031|19332198|P1|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
7854232|NCT00941031|19332192|P7|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247
7854233|NCT00941031|19332193|P6|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67
7854234|NCT00941031|19332194|P5|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65
7854235|NCT00941031|19332195|P4|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0
7854236|NCT00941031|19332196|P3|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
7854237|NCT00941031|19332197|P2|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
7854238|NCT00941031|19332198|P1|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
7854239|NCT00941031|19332192|P7|NOT COMPLETED|Induction Period||0
7854240|NCT00941031|19332193|P6|NOT COMPLETED|Induction Period||0
7854241|NCT00941031|19332194|P5|NOT COMPLETED|Induction Period||0
7854242|NCT00941031|19332195|P4|NOT COMPLETED|Induction Period||9
7854243|NCT00941031|19332196|P3|NOT COMPLETED|Induction Period||6
7854244|NCT00941031|19332197|P2|NOT COMPLETED|Induction Period||4
7854245|NCT00941031|19332198|P1|NOT COMPLETED|Induction Period||5
7854246|NCT00941031|19332192|P7|COMPLETED|Induction Period||0
7854247|NCT00941031|19332193|P6|COMPLETED|Induction Period||0
7854248|NCT00941031|19332194|P5|COMPLETED|Induction Period||0
7854249|NCT00941031|19332195|P4|COMPLETED|Induction Period||58
7854250|NCT00941031|19332196|P3|COMPLETED|Induction Period||127
7854251|NCT00941031|19332197|P2|COMPLETED|Induction Period||134
7854252|NCT00941031|19332198|P1|COMPLETED|Induction Period||61
7854253|NCT00941031|19332192|P7|STARTED|Induction Period||0
7854254|NCT00941031|19332193|P6|STARTED|Induction Period||0
7854255|NCT00941031|19332194|P5|STARTED|Induction Period||0
7854256|NCT00941031|19332195|P4|STARTED|Induction Period||67
7854257|NCT00941031|19332196|P3|STARTED|Induction Period||133
7854258|NCT00941031|19332197|P2|STARTED|Induction Period||138
7854259|NCT00941031|19332198|P1|STARTED|Induction Period||66
7854260|NCT00941005|19332223|P2|NOT COMPLETED|Overall Study||0
7854261|NCT00941005|19332224|P1|NOT COMPLETED|Overall Study||0
7854262|NCT00941005|19332223|P2|COMPLETED|Overall Study||61
7854263|NCT00941005|19332224|P1|COMPLETED|Overall Study||61
7854264|NCT00941005|19332223|P2|STARTED|Overall Study||61
7854265|NCT00941005|19332224|P1|STARTED|Overall Study||61
7854266|NCT00940992|19332245|P3|NOT COMPLETED|Overall Study||2
7854267|NCT00940992|19332246|P2|NOT COMPLETED|Overall Study||2
7854268|NCT00940992|19332247|P1|NOT COMPLETED|Overall Study||4
7854269|NCT00940992|19332245|P3|COMPLETED|Overall Study||28
7854270|NCT00940992|19332246|P2|COMPLETED|Overall Study||28
7854271|NCT00940992|19332247|P1|COMPLETED|Overall Study||28
7854272|NCT00940992|19332245|P3|STARTED|Overall Study||30
7854273|NCT00940992|19332246|P2|STARTED|Overall Study||30
7854274|NCT00940992|19332247|P1|STARTED|Overall Study||32
7854275|NCT00940927|19332258|P1|NOT COMPLETED|Overall Study||0
7854276|NCT00940927|19332258|P1|COMPLETED|Overall Study||81
7854277|NCT00940927|19332258|P1|STARTED|Overall Study||81
7854278|NCT00940901|19332265|P2|NOT COMPLETED|Week 9-16 (Phase 2)||3
7854279|NCT00940901|19332266|P1|NOT COMPLETED|Week 9-16 (Phase 2)||2
7854280|NCT00940901|19332265|P2|COMPLETED|Week 9-16 (Phase 2)||4
7854281|NCT00940901|19332266|P1|COMPLETED|Week 9-16 (Phase 2)||4
7854282|NCT00940901|19332265|P2|STARTED|Week 9-16 (Phase 2)||7
7854283|NCT00940901|19332266|P1|STARTED|Week 9-16 (Phase 2)||6
7854284|NCT00940901|19332265|P2|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
7854285|NCT00940901|19332266|P1|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
7854286|NCT00940901|19332265|P2|COMPLETED|Weeks 1-8 (Phase 1)||7
7854287|NCT00940901|19332266|P1|COMPLETED|Weeks 1-8 (Phase 1)||6
7854288|NCT00940901|19332265|P2|STARTED|Weeks 1-8 (Phase 1)||7
7854289|NCT00940901|19332266|P1|STARTED|Weeks 1-8 (Phase 1)||6
7854290|NCT00940888|19332276|P1|NOT COMPLETED|Overall Study||835
7854291|NCT00940888|19332276|P1|COMPLETED|Overall Study|Subjects that completed the 60 month follow up visit|866
7854292|NCT00940888|19332276|P1|STARTED|Overall Study|Total number of subjects consented|1701
7854293|NCT00940875|19332283|P2|NOT COMPLETED|Post-Study Treatment||3
7854294|NCT00940875|19332284|P1|NOT COMPLETED|Post-Study Treatment||0
7854295|NCT00940875|19332283|P2|COMPLETED|Post-Study Treatment||1
7854296|NCT00940875|19332284|P1|COMPLETED|Post-Study Treatment||0
7854297|NCT00940875|19332283|P2|STARTED|Post-Study Treatment||4
7854298|NCT00940875|19332284|P1|STARTED|Post-Study Treatment||0
7854299|NCT00940875|19332283|P2|NOT COMPLETED|Treatment Phase||19
7854300|NCT00940875|19332284|P1|NOT COMPLETED|Treatment Phase||26
7854301|NCT00940875|19332283|P2|COMPLETED|Treatment Phase||4
7854302|NCT00940875|19332284|P1|COMPLETED|Treatment Phase||5
7854303|NCT00940875|19332283|P2|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23
7854304|NCT00940875|19332284|P1|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31
7854305|NCT00940823|19332304|P2|NOT COMPLETED|Overall Study||32
7854306|NCT00940823|19332305|P1|NOT COMPLETED|Overall Study||35
7854307|NCT00940823|19332304|P2|COMPLETED|Overall Study||82
7854308|NCT00940823|19332305|P1|COMPLETED|Overall Study||89
7854309|NCT00940823|19332304|P2|STARTED|Overall Study||114
7854310|NCT00940823|19332305|P1|STARTED|Overall Study||124
7854311|NCT00940771|19332321|P1|NOT COMPLETED|24 Weeks||0
7854312|NCT00940771|19332321|P1|COMPLETED|24 Weeks||10
7854313|NCT00940771|19332321|P1|STARTED|24 Weeks||10
7854314|NCT00940771|19332321|P1|NOT COMPLETED|12 Weeks||0
7854315|NCT00940771|19332321|P1|COMPLETED|12 Weeks||10
7854316|NCT00940771|19332321|P1|STARTED|12 Weeks||10
7854317|NCT00940771|19332321|P1|NOT COMPLETED|4 Weeks||0
7854318|NCT00940771|19332321|P1|COMPLETED|4 Weeks||10
7854319|NCT00940771|19332321|P1|STARTED|4 Weeks||10
7854320|NCT00940771|19332321|P1|NOT COMPLETED|Pre-Entry||0
7854321|NCT00940771|19332321|P1|COMPLETED|Pre-Entry||10
7854322|NCT00940771|19332321|P1|STARTED|Pre-Entry||10
7854323|NCT00940602|19332330|P2|NOT COMPLETED|Overall Study||76
7854324|NCT00940602|19332331|P1|NOT COMPLETED|Overall Study||149
7854325|NCT00940602|19332330|P2|COMPLETED|Overall Study||0
7854326|NCT00940602|19332331|P1|COMPLETED|Overall Study||0
7854327|NCT00940602|19332330|P2|Untreated|Overall Study||0
7854328|NCT00940602|19332331|P1|Untreated|Overall Study||1
7854329|NCT00940602|19332330|P2|Treated|Overall Study||76
7854330|NCT00940602|19332331|P1|Treated|Overall Study||148
7854331|NCT00940602|19332330|P2|Full Analysis Set|Overall Study||76
7854332|NCT00940602|19332331|P1|Full Analysis Set|Overall Study||149
7854333|NCT00940602|19332330|P2|Safety Analysis Set|Overall Study||76
7854334|NCT00940602|19332331|P1|Safety Analysis Set|Overall Study||148
7854335|NCT00940602|19332330|P2|STARTED|Overall Study||76
7854336|NCT00940602|19332331|P1|STARTED|Overall Study||149
7854337|NCT00940589|19332370|P2|NOT COMPLETED|Overall Study||5
7854338|NCT00940589|19332371|P1|NOT COMPLETED|Overall Study||8
7854339|NCT00940589|19332370|P2|COMPLETED|Overall Study||29
7854340|NCT00940589|19332371|P1|COMPLETED|Overall Study||31
7854341|NCT00940589|19332370|P2|STARTED|Overall Study||34
7854342|NCT00940589|19332371|P1|STARTED|Overall Study||39
7854343|NCT00940576|19332381|P2|NOT COMPLETED|Overall Study||0
7854344|NCT00940576|19332382|P1|NOT COMPLETED|Overall Study||0
7854345|NCT00940576|19332381|P2|COMPLETED|Overall Study||9
7854346|NCT00940576|19332382|P1|COMPLETED|Overall Study||8
7854347|NCT00940576|19332381|P2|STARTED|Overall Study||9
7854348|NCT00940576|19332382|P1|STARTED|Overall Study||8
7854349|NCT00940537|19332391|P2|NOT COMPLETED|Overall Study||0
7854350|NCT00940537|19332392|P1|NOT COMPLETED|Overall Study||0
7854351|NCT00940537|19332391|P2|COMPLETED|Overall Study||9
7854352|NCT00940537|19332392|P1|COMPLETED|Overall Study||5
7854353|NCT00940537|19332391|P2|STARTED|Overall Study||9
7854354|NCT00940537|19332392|P1|STARTED|Overall Study||5
7854355|NCT00940498|19332409|P8|NOT COMPLETED|Overall Study||1
7854356|NCT00940498|19332410|P7|NOT COMPLETED|Overall Study||1
7854357|NCT00940498|19332411|P6|NOT COMPLETED|Overall Study||1
7854358|NCT00940498|19332412|P5|NOT COMPLETED|Overall Study||9
7854359|NCT00940498|19332413|P4|NOT COMPLETED|Overall Study||2
7854360|NCT00940498|19332414|P3|NOT COMPLETED|Overall Study||3
7854361|NCT00940498|19332415|P2|NOT COMPLETED|Overall Study||1
7854362|NCT00940498|19332416|P1|NOT COMPLETED|Overall Study||3
7854363|NCT00940498|19332409|P8|COMPLETED|Overall Study||3
7854364|NCT00940498|19332410|P7|COMPLETED|Overall Study||7
7854365|NCT00940498|19332411|P6|COMPLETED|Overall Study||6
7854366|NCT00940498|19332412|P5|COMPLETED|Overall Study||34
7854367|NCT00940498|19332413|P4|COMPLETED|Overall Study||2
7854368|NCT00940498|19332414|P3|COMPLETED|Overall Study||1
7854369|NCT00940498|19332415|P2|COMPLETED|Overall Study||3
7854370|NCT00940498|19332416|P1|COMPLETED|Overall Study||1
7854371|NCT00940498|19332409|P8|STARTED|Overall Study||4
7854372|NCT00940498|19332410|P7|STARTED|Overall Study||8
7854373|NCT00940498|19332411|P6|STARTED|Overall Study||7
7854374|NCT00940498|19332412|P5|STARTED|Overall Study||43
7854375|NCT00940498|19332413|P4|STARTED|Overall Study||4
7854376|NCT00940498|19332414|P3|STARTED|Overall Study||4
7854377|NCT00940498|19332415|P2|STARTED|Overall Study||4
7854378|NCT00940498|19332416|P1|STARTED|Overall Study||4
7854379|NCT00940485|19332534|P2|NOT COMPLETED|Overall Study||7
7854380|NCT00940485|19332535|P1|NOT COMPLETED|Overall Study||15
7854381|NCT00940485|19332534|P2|COMPLETED|Overall Study||93
7854382|NCT00940485|19332535|P1|COMPLETED|Overall Study||82
7854383|NCT00940485|19332534|P2|STARTED|Overall Study||100
7854384|NCT00940485|19332535|P1|STARTED|Overall Study||97
7854385|NCT00940446|19332561|P2|NOT COMPLETED|Overall Study||0
7854386|NCT00940446|19332562|P1|NOT COMPLETED|Overall Study||0
7854387|NCT00940446|19332561|P2|COMPLETED|Overall Study||30
7854388|NCT00940446|19332562|P1|COMPLETED|Overall Study||30
7854389|NCT00940446|19332561|P2|STARTED|Overall Study||30
7854390|NCT00940446|19332562|P1|STARTED|Overall Study||30
7854391|NCT00940342|19332573|P3|NOT COMPLETED|Overall Study||1
7854392|NCT00940342|19332574|P2|NOT COMPLETED|Overall Study||2
7854393|NCT00940342|19332575|P1|NOT COMPLETED|Overall Study||0
7854394|NCT00940342|19332573|P3|COMPLETED|Overall Study||39
7854395|NCT00940342|19332574|P2|COMPLETED|Overall Study||38
7854396|NCT00940342|19332575|P1|COMPLETED|Overall Study||50
7854397|NCT00940342|19332573|P3|STARTED|Overall Study||40
7854398|NCT00940342|19332574|P2|STARTED|Overall Study||40
7854399|NCT00940342|19332575|P1|STARTED|Overall Study||50
7854400|NCT00940316|19332586|P3|NOT COMPLETED|Follow up Every 3 Months||0
7854401|NCT00940316|19332587|P2|NOT COMPLETED|Follow up Every 3 Months||0
7854402|NCT00940316|19332588|P1|NOT COMPLETED|Follow up Every 3 Months||0
7854403|NCT00940316|19332586|P3|COMPLETED|Follow up Every 3 Months||2
7854404|NCT00940316|19332587|P2|COMPLETED|Follow up Every 3 Months||13
7854405|NCT00940316|19332588|P1|COMPLETED|Follow up Every 3 Months||13
7854406|NCT00940316|19332586|P3|STARTED|Follow up Every 3 Months||2
7854407|NCT00940316|19332587|P2|STARTED|Follow up Every 3 Months||13
7854408|NCT00940316|19332588|P1|STARTED|Follow up Every 3 Months||13
7854409|NCT00940316|19332586|P3|NOT COMPLETED|Crossed Over to Arm A After Progression||0
7854410|NCT00940316|19332587|P2|NOT COMPLETED|Crossed Over to Arm A After Progression||0
7854411|NCT00940316|19332588|P1|NOT COMPLETED|Crossed Over to Arm A After Progression||0
7854412|NCT00940316|19332586|P3|COMPLETED|Crossed Over to Arm A After Progression||0
7854413|NCT00940316|19332587|P2|COMPLETED|Crossed Over to Arm A After Progression||3
7854414|NCT00940316|19332588|P1|COMPLETED|Crossed Over to Arm A After Progression||0
7854415|NCT00940316|19332586|P3|Treated for Cycle One|Crossed Over to Arm A After Progression||0
7854416|NCT00940316|19332587|P2|Treated for Cycle One|Crossed Over to Arm A After Progression||3
7854417|NCT00940316|19332588|P1|Treated for Cycle One|Crossed Over to Arm A After Progression||0
7854418|NCT00940316|19332586|P3|STARTED|Crossed Over to Arm A After Progression||0
7854419|NCT00940316|19332587|P2|STARTED|Crossed Over to Arm A After Progression||3
7854420|NCT00940316|19332588|P1|STARTED|Crossed Over to Arm A After Progression||0
7854421|NCT00940316|19332586|P3|NOT COMPLETED|Treated After Cycle 5||1
7854422|NCT00940316|19332587|P2|NOT COMPLETED|Treated After Cycle 5||1
7854423|NCT00940316|19332588|P1|NOT COMPLETED|Treated After Cycle 5||0
7854424|NCT00940316|19332586|P3|COMPLETED|Treated After Cycle 5||1
7854425|NCT00940316|19332587|P2|COMPLETED|Treated After Cycle 5||8
7854426|NCT00940316|19332588|P1|COMPLETED|Treated After Cycle 5||8
7854427|NCT00940316|19332586|P3|STARTED|Treated After Cycle 5||2
7854428|NCT00940316|19332587|P2|STARTED|Treated After Cycle 5||9
7854429|NCT00940316|19332588|P1|STARTED|Treated After Cycle 5||8
7854430|NCT00940316|19332586|P3|NOT COMPLETED|Moved on to be Treated Cycle 5||0
7854431|NCT00940316|19332587|P2|NOT COMPLETED|Moved on to be Treated Cycle 5||0
7854432|NCT00940316|19332588|P1|NOT COMPLETED|Moved on to be Treated Cycle 5||2
7854433|NCT00940316|19332586|P3|COMPLETED|Moved on to be Treated Cycle 5||2
7854434|NCT00940316|19332587|P2|COMPLETED|Moved on to be Treated Cycle 5||9
7854435|NCT00940316|19332588|P1|COMPLETED|Moved on to be Treated Cycle 5||8
7854436|NCT00940316|19332586|P3|STARTED|Moved on to be Treated Cycle 5||2
7854437|NCT00940316|19332587|P2|STARTED|Moved on to be Treated Cycle 5||9
7854438|NCT00940316|19332588|P1|STARTED|Moved on to be Treated Cycle 5||10
7854439|NCT00940316|19332586|P3|NOT COMPLETED|Reached First Response at 8 Weeks||0
7854440|NCT00940316|19332587|P2|NOT COMPLETED|Reached First Response at 8 Weeks||4
7854441|NCT00940316|19332588|P1|NOT COMPLETED|Reached First Response at 8 Weeks||3
7854442|NCT00940316|19332586|P3|COMPLETED|Reached First Response at 8 Weeks||2
7854443|NCT00940316|19332587|P2|COMPLETED|Reached First Response at 8 Weeks||9
7854444|NCT00940316|19332588|P1|COMPLETED|Reached First Response at 8 Weeks||10
7854445|NCT00940316|19332586|P3|STARTED|Reached First Response at 8 Weeks||2
7854446|NCT00940316|19332587|P2|STARTED|Reached First Response at 8 Weeks||13
7854447|NCT00940316|19332588|P1|STARTED|Reached First Response at 8 Weeks||13
7854448|NCT00940290|19332614|P4|NOT COMPLETED|Overall Study||0
7854449|NCT00940290|19332615|P3|NOT COMPLETED|Overall Study||0
7854450|NCT00940290|19332616|P2|NOT COMPLETED|Overall Study||0
7854451|NCT00940290|19332617|P1|NOT COMPLETED|Overall Study||0
7854452|NCT00940290|19332614|P4|COMPLETED|Overall Study||54
7854453|NCT00940290|19332615|P3|COMPLETED|Overall Study||55
7854454|NCT00940290|19332616|P2|COMPLETED|Overall Study||53
7854455|NCT00940290|19332617|P1|COMPLETED|Overall Study||54
7854456|NCT00940290|19332614|P4|STARTED|Overall Study||54
7854457|NCT00940290|19332615|P3|STARTED|Overall Study||55
7854458|NCT00940290|19332616|P2|STARTED|Overall Study||53
7854459|NCT00940290|19332617|P1|STARTED|Overall Study||54
7854460|NCT00940108|19332631|P4|NOT COMPLETED|Overall Study||5
7854461|NCT00940108|19332632|P3|NOT COMPLETED|Overall Study||3
7854462|NCT00940108|19332633|P2|NOT COMPLETED|Overall Study||9
7854463|NCT00940108|19332634|P1|NOT COMPLETED|Overall Study||5
7854464|NCT00940108|19332631|P4|COMPLETED|Overall Study||99
7854465|NCT00940108|19332632|P3|COMPLETED|Overall Study||100
7854466|NCT00940108|19332633|P2|COMPLETED|Overall Study||71
7854467|NCT00940108|19332634|P1|COMPLETED|Overall Study||77
7854468|NCT00940108|19332631|P4|STARTED|Overall Study||104
7854469|NCT00940108|19332632|P3|STARTED|Overall Study||103
7854470|NCT00940108|19332633|P2|STARTED|Overall Study||80
7854471|NCT00940108|19332634|P1|STARTED|Overall Study||82
7854472|NCT00940017|19332684|P1|NOT COMPLETED|Overall Study||4
7854473|NCT00940017|19332684|P1|COMPLETED|Overall Study||20
7854474|NCT00940017|19332684|P1|Subjects Treated|Overall Study||21
7854475|NCT00940017|19332684|P1|STARTED|Overall Study||24
7854476|NCT00939991|19332705|P2|NOT COMPLETED|Overall Study||0
7854477|NCT00939991|19332706|P1|NOT COMPLETED|Overall Study||0
7854478|NCT00939991|19332705|P2|COMPLETED|Overall Study||39
7854479|NCT00939991|19332706|P1|COMPLETED|Overall Study||9
7854480|NCT00939991|19332705|P2|STARTED|Overall Study||39
7854481|NCT00939991|19332706|P1|STARTED|Overall Study||9
7854482|NCT00939952|19332716|P1|NOT COMPLETED|Overall Study||0
7854483|NCT00939952|19332716|P1|COMPLETED|Overall Study||7
7854484|NCT00939952|19332716|P1|STARTED|Overall Study||7
7854485|NCT00939900|19332728|P2|NOT COMPLETED|Overall Study||7
7854486|NCT00939900|19332729|P1|NOT COMPLETED|Overall Study||2
7854487|NCT00939900|19332728|P2|COMPLETED|Overall Study||48
7854488|NCT00939900|19332729|P1|COMPLETED|Overall Study||53
7854489|NCT00939900|19332728|P2|STARTED|Overall Study||55
7854490|NCT00939900|19332729|P1|STARTED|Overall Study||55
7854491|NCT00939874|19332735|P1|NOT COMPLETED|Overall Study||20
7854492|NCT00939874|19332735|P1|COMPLETED|Overall Study||32
7854493|NCT00939874|19332735|P1|Completed Week 48|Overall Study||37
7854494|NCT00939874|19332735|P1|STARTED|Overall Study||52
7854495|NCT00939822|19332742|P2|NOT COMPLETED|Overall Study||3
7854496|NCT00939822|19332743|P1|NOT COMPLETED|Overall Study||2
7854497|NCT00939822|19332742|P2|COMPLETED|Overall Study||41
7854498|NCT00939822|19332743|P1|COMPLETED|Overall Study||42
7854499|NCT00939822|19332742|P2|STARTED|Overall Study||44
7854500|NCT00939822|19332743|P1|STARTED|Overall Study||44
7854501|NCT00939809|19332755|P1|NOT COMPLETED|Overall Study||3
7854502|NCT00939809|19332755|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28
7854503|NCT00939809|19332755|P1|STARTED|Overall Study||31
7854504|NCT00939796|19332764|P1|NOT COMPLETED|Overall Study||0
7854505|NCT00939796|19332764|P1|COMPLETED|Overall Study||16
7854506|NCT00939796|19332764|P1|STARTED|Overall Study||16
7854507|NCT00939783|19332770|P1|NOT COMPLETED|Overall Study||649
7854508|NCT00939783|19332770|P1|COMPLETED|Overall Study||0
7854509|NCT00939783|19332770|P1|Treated|Overall Study||648
7854510|NCT00939783|19332770|P1|STARTED|Overall Study||649
7854511|NCT00939770|19332785|P8|NOT COMPLETED|Overall Study||10
7854512|NCT00939770|19332786|P7|NOT COMPLETED|Overall Study||14
7854513|NCT00939770|19332787|P6|NOT COMPLETED|Overall Study||11
7854514|NCT00939770|19332788|P5|NOT COMPLETED|Overall Study||37
7854515|NCT00939770|19332789|P4|NOT COMPLETED|Overall Study||11
7854516|NCT00939770|19332790|P3|NOT COMPLETED|Overall Study||20
7854517|NCT00939770|19332791|P2|NOT COMPLETED|Overall Study||8
7854518|NCT00939770|19332792|P1|NOT COMPLETED|Overall Study||5
7854519|NCT00939770|19332785|P8|COMPLETED|Overall Study||0
7854520|NCT00939770|19332786|P7|COMPLETED|Overall Study||0
7854521|NCT00939770|19332787|P6|COMPLETED|Overall Study||0
7854522|NCT00939770|19332788|P5|COMPLETED|Overall Study||1
7854523|NCT00939770|19332789|P4|COMPLETED|Overall Study||1
7854524|NCT00939770|19332790|P3|COMPLETED|Overall Study||3
7854525|NCT00939770|19332791|P2|COMPLETED|Overall Study||0
7854526|NCT00939770|19332792|P1|COMPLETED|Overall Study||1
7854527|NCT00939770|19332785|P8|STARTED|Overall Study||10
7854528|NCT00939770|19332786|P7|STARTED|Overall Study||14
7854529|NCT00939770|19332787|P6|STARTED|Overall Study||11
7854530|NCT00939770|19332788|P5|STARTED|Overall Study||38
7854531|NCT00939770|19332789|P4|STARTED|Overall Study||12
7854532|NCT00939770|19332790|P3|STARTED|Overall Study||23
7854533|NCT00939770|19332791|P2|STARTED|Overall Study||8
7854534|NCT00939770|19332792|P1|STARTED|Overall Study||6
7854535|NCT00939731|19332843|P2|NOT COMPLETED|Second Intervention Period||0
7854536|NCT00939731|19332844|P1|NOT COMPLETED|Second Intervention Period||0
7854537|NCT00939731|19332843|P2|COMPLETED|Second Intervention Period||12
7854538|NCT00939731|19332844|P1|COMPLETED|Second Intervention Period||12
7854539|NCT00939731|19332843|P2|STARTED|Second Intervention Period||12
7854540|NCT00939731|19332844|P1|STARTED|Second Intervention Period||12
7854541|NCT00939731|19332843|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7854542|NCT00939731|19332844|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7854543|NCT00939731|19332843|P2|COMPLETED|Washout Period (at Least 14 Days)||12
7854544|NCT00939731|19332844|P1|COMPLETED|Washout Period (at Least 14 Days)||12
7854545|NCT00939731|19332843|P2|STARTED|Washout Period (at Least 14 Days)||12
7854546|NCT00939731|19332844|P1|STARTED|Washout Period (at Least 14 Days)||12
7854547|NCT00939731|19332843|P2|NOT COMPLETED|First Intervention Period||0
7854548|NCT00939731|19332844|P1|NOT COMPLETED|First Intervention Period||0
7854549|NCT00939731|19332843|P2|COMPLETED|First Intervention Period||12
7854550|NCT00939731|19332844|P1|COMPLETED|First Intervention Period||12
7854551|NCT00939731|19332843|P2|STARTED|First Intervention Period||12
7854552|NCT00939731|19332844|P1|STARTED|First Intervention Period||12
7854553|NCT00939705|19332864|P2|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
7854554|NCT00939705|19332865|P1|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
7854555|NCT00939705|19332864|P2|COMPLETED|Period 3 - Second Intervent - 5 Days||9
7854556|NCT00939705|19332865|P1|COMPLETED|Period 3 - Second Intervent - 5 Days||9
7854557|NCT00939705|19332864|P2|STARTED|Period 3 - Second Intervent - 5 Days||9
7854558|NCT00939705|19332865|P1|STARTED|Period 3 - Second Intervent - 5 Days||9
7854559|NCT00939705|19332864|P2|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
7854560|NCT00939705|19332865|P1|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
7854561|NCT00939705|19332864|P2|COMPLETED|Period 2 - Washout Period - 21 Days||9
7854562|NCT00939705|19332865|P1|COMPLETED|Period 2 - Washout Period - 21 Days||9
7854563|NCT00939705|19332864|P2|STARTED|Period 2 - Washout Period - 21 Days||9
7854564|NCT00939705|19332865|P1|STARTED|Period 2 - Washout Period - 21 Days||9
7854565|NCT00939705|19332864|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
7854566|NCT00939705|19332865|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
7854567|NCT00939705|19332864|P2|COMPLETED|Period 1 - First Intervention - 5 Days||9
7854568|NCT00939705|19332865|P1|COMPLETED|Period 1 - First Intervention - 5 Days||9
7854569|NCT00939705|19332864|P2|STARTED|Period 1 - First Intervention - 5 Days||9
7854570|NCT00939705|19332865|P1|STARTED|Period 1 - First Intervention - 5 Days||9
7854571|NCT00939692|19332877|P2|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1
7854572|NCT00939692|19332878|P1|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0
7854573|NCT00939692|19332877|P2|COMPLETED|Period 2 - Second Intervent - 5 Days||12
7854574|NCT00939692|19332878|P1|COMPLETED|Period 2 - Second Intervent - 5 Days||12
7854575|NCT00939692|19332877|P2|STARTED|Period 2 - Second Intervent - 5 Days||13
7854576|NCT00939692|19332878|P1|STARTED|Period 2 - Second Intervent - 5 Days||12
7854577|NCT00939692|19332877|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
7854578|NCT00939692|19332878|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1
7854579|NCT00939692|19332877|P2|COMPLETED|Period 1 - First Intervention - 5 Days||13
7854580|NCT00939692|19332878|P1|COMPLETED|Period 1 - First Intervention - 5 Days||12
7854581|NCT00939692|19332877|P2|STARTED|Period 1 - First Intervention - 5 Days||13
7854582|NCT00939692|19332878|P1|STARTED|Period 1 - First Intervention - 5 Days||13
7854583|NCT00939653|19332888|P1|NOT COMPLETED|Treatment Course 4||0
7854584|NCT00939653|19332888|P1|COMPLETED|Treatment Course 4||0
7854585|NCT00939653|19332888|P1|STARTED|Treatment Course 4||0
7854586|NCT00939653|19332888|P1|NOT COMPLETED|Treatment Course 3||0
7854587|NCT00939653|19332888|P1|COMPLETED|Treatment Course 3||0
7854588|NCT00939653|19332888|P1|STARTED|Treatment Course 3||0
7854589|NCT00939653|19332888|P1|NOT COMPLETED|Treatment Course 2||0
7854590|NCT00939653|19332888|P1|COMPLETED|Treatment Course 2||2
7854591|NCT00939653|19332888|P1|STARTED|Treatment Course 2||2
7854592|NCT00939653|19332888|P1|NOT COMPLETED|Treatment Course 1||0
7854593|NCT00939653|19332888|P1|COMPLETED|Treatment Course 1||6
7854594|NCT00939653|19332888|P1|STARTED|Treatment Course 1||6
7854595|NCT00939640|19332893|P1|NOT COMPLETED|Overall Study||1
7854596|NCT00939640|19332893|P1|COMPLETED|Overall Study||13
7854597|NCT00939640|19332893|P1|STARTED|Overall Study||14
7854598|NCT00939627|19332914|P3|NOT COMPLETED|Overall Study||0
7854599|NCT00939627|19332915|P2|NOT COMPLETED|Overall Study||28
7854600|NCT00939627|19332916|P1|NOT COMPLETED|Overall Study||27
7854601|NCT00939627|19332914|P3|COMPLETED|Overall Study||0
7854602|NCT00939627|19332915|P2|COMPLETED|Overall Study||0
7854603|NCT00939627|19332916|P1|COMPLETED|Overall Study||0
7854604|NCT00939627|19332914|P3|STARTED|Overall Study||0
7854605|NCT00939627|19332915|P2|STARTED|Overall Study||28
7854606|NCT00939627|19332916|P1|STARTED|Overall Study||27
7854607|NCT00939562|19332934|P2|NOT COMPLETED|Period 2||0
7854608|NCT00939562|19332935|P1|NOT COMPLETED|Period 2||0
7854609|NCT00939562|19332934|P2|COMPLETED|Period 2||12
7854610|NCT00939562|19332935|P1|COMPLETED|Period 2||12
7854611|NCT00939562|19332934|P2|STARTED|Period 2||12
7854612|NCT00939562|19332935|P1|STARTED|Period 2||12
7854613|NCT00939562|19332934|P2|NOT COMPLETED|Period 1||0
7854614|NCT00939562|19332935|P1|NOT COMPLETED|Period 1||0
7854615|NCT00939562|19332934|P2|COMPLETED|Period 1||12
7854616|NCT00939562|19332935|P1|COMPLETED|Period 1||12
7854617|NCT00939562|19332934|P2|STARTED|Period 1||12
7854618|NCT00939562|19332935|P1|STARTED|Period 1||12
7854619|NCT00939536|19332945|P2|NOT COMPLETED|Second Intervention||0
7854620|NCT00939536|19332946|P1|NOT COMPLETED|Second Intervention||0
7854621|NCT00939536|19332945|P2|COMPLETED|Second Intervention||12
7854622|NCT00939536|19332946|P1|COMPLETED|Second Intervention||12
7854623|NCT00939536|19332945|P2|STARTED|Second Intervention||12
7854624|NCT00939536|19332946|P1|STARTED|Second Intervention||12
7854625|NCT00939536|19332945|P2|NOT COMPLETED|First Intervention||0
7854626|NCT00939536|19332946|P1|NOT COMPLETED|First Intervention||0
7854627|NCT00939536|19332945|P2|COMPLETED|First Intervention||12
7854628|NCT00939536|19332946|P1|COMPLETED|First Intervention||12
7854629|NCT00939536|19332945|P2|STARTED|First Intervention||12
7854630|NCT00939536|19332946|P1|STARTED|First Intervention||12
7854631|NCT00939523|19332956|P1|NOT COMPLETED|Overall Study||3
7854632|NCT00939523|19332956|P1|COMPLETED|Overall Study||6
7854633|NCT00939523|19332956|P1|STARTED|Overall Study||9
7854634|NCT00939510|19332963|P1|NOT COMPLETED|Overall Study||1
7854635|NCT00939510|19332963|P1|COMPLETED|Overall Study||31
7854636|NCT00939510|19332963|P1|STARTED|Overall Study||32
7854637|NCT00939484|19332972|P3|NOT COMPLETED|Overall Study||3
7854638|NCT00939484|19332973|P2|NOT COMPLETED|Overall Study||20
7854639|NCT00939484|19332974|P1|NOT COMPLETED|Overall Study||8
7854640|NCT00939484|19332972|P3|COMPLETED|Overall Study||0
7854641|NCT00939484|19332973|P2|COMPLETED|Overall Study||0
7854642|NCT00939484|19332974|P1|COMPLETED|Overall Study||0
7854643|NCT00939484|19332972|P3|STARTED|Overall Study||3
7854644|NCT00939484|19332973|P2|STARTED|Overall Study||20
7854645|NCT00939484|19332974|P1|STARTED|Overall Study||8
7854646|NCT00939471|19332987|P1|NOT COMPLETED|Overall Study||11
7854647|NCT00939471|19332987|P1|COMPLETED|Overall Study||33
7854648|NCT00939471|19332987|P1|STARTED|Overall Study||44
7854649|NCT00939393|19333000|P2|NOT COMPLETED|Overall Study||0
7854650|NCT00939393|19333001|P1|NOT COMPLETED|Overall Study||4
7854651|NCT00939393|19333000|P2|COMPLETED|Overall Study||35
7854652|NCT00939393|19333001|P1|COMPLETED|Overall Study||33
7854653|NCT00939393|19333000|P2|STARTED|Overall Study||35
7854654|NCT00939393|19333001|P1|STARTED|Overall Study||37
7854655|NCT00939367|19333021|P2|NOT COMPLETED|Second Intervention||0
7854656|NCT00939367|19333022|P1|NOT COMPLETED|Second Intervention||0
7854657|NCT00939367|19333021|P2|COMPLETED|Second Intervention||15
7854658|NCT00939367|19333022|P1|COMPLETED|Second Intervention||15
7854659|NCT00939367|19333021|P2|STARTED|Second Intervention||15
7854660|NCT00939367|19333022|P1|STARTED|Second Intervention||15
7854661|NCT00939367|19333021|P2|NOT COMPLETED|First Intervention||0
7854662|NCT00939367|19333022|P1|NOT COMPLETED|First Intervention||0
7854663|NCT00939367|19333021|P2|COMPLETED|First Intervention||15
7854664|NCT00939367|19333022|P1|COMPLETED|First Intervention||15
7854665|NCT00939367|19333021|P2|STARTED|First Intervention||15
7854666|NCT00939367|19333022|P1|STARTED|First Intervention||15
7854667|NCT00939341|19333032|P1|NOT COMPLETED|Overall Study||66
7854668|NCT00939341|19333032|P1|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796
7854669|NCT00939341|19333032|P1|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862
7854670|NCT00939211|19333052|P1|NOT COMPLETED|Placebo||0
7854671|NCT00939211|19333052|P1|COMPLETED|Placebo||28
7854672|NCT00939211|19333052|P1|STARTED|Placebo||28
7854673|NCT00939211|19333052|P1|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0
7854674|NCT00939211|19333052|P1|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28
7854675|NCT00939211|19333052|P1|STARTED|Spiriva 18 Mcg First, Then Placebo||28
7854676|NCT00939211|19333052|P1|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0
7854677|NCT00939211|19333052|P1|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28
7854678|NCT00939211|19333052|P1|STARTED|AZD9164 1200 Mcg First, Then Placebo||28
7854679|NCT00939211|19333052|P1|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0
7854680|NCT00939211|19333052|P1|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28
7854681|NCT00939211|19333052|P1|STARTED|AZD9164 400 Mcg First, Then Placebo||28
7854682|NCT00939211|19333052|P1|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0
7854683|NCT00939211|19333052|P1|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28
7854684|NCT00939211|19333052|P1|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28
7854685|NCT00939198|19333114|P1|NOT COMPLETED|Overall Study||0
7854686|NCT00939198|19333114|P1|COMPLETED|Overall Study||87
7854687|NCT00939198|19333114|P1|STARTED|Overall Study||87
7854688|NCT00939185|19333119|P1|NOT COMPLETED|Overall Study||25
7854689|NCT00939185|19333119|P1|COMPLETED|Overall Study||375
7854690|NCT00939185|19333119|P1|Received Treatment|Overall Study||390
7854691|NCT00939185|19333119|P1|STARTED|Overall Study||400
7854692|NCT00939159|19333126|P1|NOT COMPLETED|Overall Study||0
7854693|NCT00939159|19333126|P1|COMPLETED|Overall Study||13
7854694|NCT00939159|19333126|P1|STARTED|Overall Study||13
7854695|NCT00939120|19333132|P2|NOT COMPLETED|Overall Study||5
7854696|NCT00939120|19333133|P1|NOT COMPLETED|Overall Study||8
7854697|NCT00939120|19333132|P2|COMPLETED|Overall Study||18
7854698|NCT00939120|19333133|P1|COMPLETED|Overall Study||15
7854699|NCT00939120|19333132|P2|STARTED|Overall Study||23
7854700|NCT00939120|19333133|P1|STARTED|Overall Study||23
7854701|NCT00939107|19333157|P2|NOT COMPLETED|Overall Study||12
7854702|NCT00939107|19333158|P1|NOT COMPLETED|Overall Study||14
7854703|NCT00939107|19333157|P2|COMPLETED|Overall Study||163
7854704|NCT00939107|19333158|P1|COMPLETED|Overall Study||161
7854705|NCT00939107|19333157|P2|12 Months Follow-up|Overall Study||163
7854706|NCT00939107|19333158|P1|12 Months Follow-up|Overall Study||161
7854707|NCT00939107|19333157|P2|STARTED|Overall Study||175
7854708|NCT00939107|19333158|P1|STARTED|Overall Study||175
7854709|NCT00939094|19333172|P2|NOT COMPLETED|Overall Study||10
7854710|NCT00939094|19333173|P1|NOT COMPLETED|Overall Study||14
7854711|NCT00939094|19333172|P2|COMPLETED|Overall Study||35
7854712|NCT00939094|19333173|P1|COMPLETED|Overall Study||28
7854713|NCT00939094|19333172|P2|STARTED|Overall Study||45
7854714|NCT00939094|19333173|P1|STARTED|Overall Study||42
7854715|NCT00939055|19333195|P2|NOT COMPLETED|Overall Study||0
7854716|NCT00939055|19333196|P1|NOT COMPLETED|Overall Study||4
7854717|NCT00939055|19333195|P2|COMPLETED|Overall Study||39
7854718|NCT00939055|19333196|P1|COMPLETED|Overall Study||69
7854719|NCT00939055|19333195|P2|STARTED|Overall Study||39
7854720|NCT00939055|19333196|P1|STARTED|Overall Study||73
7854721|NCT00939029|19333206|P2|NOT COMPLETED|Overall Study||12
7854722|NCT00939029|19333207|P1|NOT COMPLETED|Overall Study||6
7854723|NCT00939029|19333206|P2|COMPLETED|Overall Study||15
7854724|NCT00939029|19333207|P1|COMPLETED|Overall Study||19
7854725|NCT00939029|19333206|P2|STARTED|Overall Study||27
7854726|NCT00939029|19333207|P1|STARTED|Overall Study||25
7854727|NCT00939003|19333219|P2|NOT COMPLETED|Open-label Treatment Period||29
7854728|NCT00939003|19333220|P1|NOT COMPLETED|Open-label Treatment Period||29
7854729|NCT00939003|19333219|P2|COMPLETED|Open-label Treatment Period||62
7854730|NCT00939003|19333220|P1|COMPLETED|Open-label Treatment Period||66
7854731|NCT00939003|19333219|P2|STARTED|Open-label Treatment Period||91
7854732|NCT00939003|19333220|P1|STARTED|Open-label Treatment Period||95
7854733|NCT00939003|19333219|P2|NOT COMPLETED|Double-blind Treatment Period||4
7854734|NCT00939003|19333220|P1|NOT COMPLETED|Double-blind Treatment Period||2
7854735|NCT00939003|19333219|P2|COMPLETED|Double-blind Treatment Period||91
7854736|NCT00939003|19333220|P1|COMPLETED|Double-blind Treatment Period||95
7854737|NCT00939003|19333219|P2|STARTED|Double-blind Treatment Period||95
7854738|NCT00939003|19333220|P1|STARTED|Double-blind Treatment Period||97
7854739|NCT00938964|19333257|P2|NOT COMPLETED|Overall Study||28
7854740|NCT00938964|19333258|P1|NOT COMPLETED|Overall Study||30
7854741|NCT00938964|19333257|P2|COMPLETED|Overall Study||209
7854742|NCT00938964|19333258|P1|COMPLETED|Overall Study||211
7854743|NCT00938964|19333257|P2|STARTED|Overall Study||237
7854744|NCT00938964|19333258|P1|STARTED|Overall Study||241
7854745|NCT00938886|19333322|P2|NOT COMPLETED|Overall Study||10
7854746|NCT00938886|19333323|P1|NOT COMPLETED|Overall Study||7
7854747|NCT00938886|19333322|P2|COMPLETED|Overall Study||65
7854748|NCT00938886|19333323|P1|COMPLETED|Overall Study||68
7854749|NCT00938886|19333322|P2|Attended 1 Counseling Session|Overall Study||70
7854750|NCT00938886|19333323|P1|Attended 1 Counseling Session|Overall Study||70
7854751|NCT00938886|19333322|P2|STARTED|Overall Study||75
7854752|NCT00938886|19333323|P1|STARTED|Overall Study||75
7854753|NCT00938860|19333333|P2|NOT COMPLETED|Overall Study||17
7854754|NCT00938860|19333334|P1|NOT COMPLETED|Overall Study||25
7854755|NCT00938860|19333333|P2|COMPLETED|Overall Study||25
7854756|NCT00938860|19333334|P1|COMPLETED|Overall Study||25
7854757|NCT00938860|19333333|P2|Efficacy Population|Overall Study||41
7854758|NCT00938860|19333334|P1|Efficacy Population|Overall Study||40
7854759|NCT00938860|19333333|P2|STARTED|Overall Study||42
7854760|NCT00938860|19333334|P1|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50
7854761|NCT00938782|19333358|P2|NOT COMPLETED|Overall Study||0
7854762|NCT00938782|19333359|P1|NOT COMPLETED|Overall Study||0
7854763|NCT00938782|19333358|P2|COMPLETED|Overall Study|Upon discharge from PACU|35
7854764|NCT00938782|19333359|P1|COMPLETED|Overall Study|Upon discharge from PACU|32
7854765|NCT00938782|19333358|P2|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35
7854766|NCT00938782|19333359|P1|STARTED|Overall Study|Pre-induction of anesthesia|32
7854767|NCT00938717|19333367|P2|NOT COMPLETED|Overall Study||108
7854768|NCT00938717|19333368|P1|NOT COMPLETED|Overall Study||98
7854769|NCT00938717|19333367|P2|COMPLETED|Overall Study||294
7854770|NCT00938717|19333368|P1|COMPLETED|Overall Study||305
7854771|NCT00938717|19333367|P2|STARTED|Overall Study||402
7854772|NCT00938717|19333368|P1|STARTED|Overall Study||403
7854773|NCT00938704|19333402|P2|NOT COMPLETED|Overall Study||0
7854774|NCT00938704|19333403|P1|NOT COMPLETED|Overall Study||0
7854775|NCT00938704|19333402|P2|COMPLETED|Overall Study||37
7854776|NCT00938704|19333403|P1|COMPLETED|Overall Study||33
7854777|NCT00938704|19333402|P2|STARTED|Overall Study||37
7854778|NCT00938704|19333403|P1|STARTED|Overall Study||33
7854779|NCT00938639|19333419|P2|NOT COMPLETED|Overall Study||4
7854780|NCT00938639|19333420|P1|NOT COMPLETED|Overall Study||3
7854781|NCT00938639|19333419|P2|COMPLETED|Overall Study||116
7854782|NCT00938639|19333420|P1|COMPLETED|Overall Study||117
7854783|NCT00938639|19333419|P2|STARTED|Overall Study||120
7854784|NCT00938639|19333420|P1|STARTED|Overall Study||120
7854785|NCT00938548|19333490|P2|NOT COMPLETED|Overall Study||0
7854786|NCT00938548|19333491|P1|NOT COMPLETED|Overall Study||0
7854787|NCT00938548|19333490|P2|COMPLETED|Overall Study||35
7854788|NCT00938548|19333491|P1|COMPLETED|Overall Study||35
7854789|NCT00938548|19333490|P2|STARTED|Overall Study||35
7854790|NCT00938548|19333491|P1|STARTED|Overall Study||35
7854791|NCT00938470|19333503|P2|NOT COMPLETED|Overall Study||3
7854792|NCT00938470|19333504|P1|NOT COMPLETED|Overall Study||7
7854793|NCT00938470|19333503|P2|COMPLETED|Overall Study||25
7854794|NCT00938470|19333504|P1|COMPLETED|Overall Study||27
7854795|NCT00938470|19333503|P2|STARTED|Overall Study||28
7854796|NCT00938470|19333504|P1|STARTED|Overall Study||34
7854797|NCT00938457|19333518|P1|NOT COMPLETED|Overall Study||0
7854798|NCT00938457|19333518|P1|COMPLETED|Overall Study||3
7854799|NCT00938457|19333518|P1|STARTED|Overall Study||3
7854800|NCT00938431|19333534|P3|NOT COMPLETED|Overall Study||8
7854801|NCT00938431|19333535|P2|NOT COMPLETED|Overall Study||9
7854802|NCT00938431|19333536|P1|NOT COMPLETED|Overall Study||6
7854803|NCT00938431|19333534|P3|COMPLETED|Overall Study||1
7854804|NCT00938431|19333535|P2|COMPLETED|Overall Study||14
7854805|NCT00938431|19333536|P1|COMPLETED|Overall Study||9
7854806|NCT00938431|19333534|P3|STARTED|Overall Study||9
7854807|NCT00938431|19333535|P2|STARTED|Overall Study||23
7854808|NCT00938431|19333536|P1|STARTED|Overall Study||15
7854809|NCT00938392|19333563|P2|NOT COMPLETED|Overall Study||4
7854810|NCT00938392|19333564|P1|NOT COMPLETED|Overall Study||2
7854811|NCT00938392|19333563|P2|COMPLETED|Overall Study||358
7854812|NCT00938392|19333564|P1|COMPLETED|Overall Study||360
7854813|NCT00938392|19333563|P2|STARTED|Overall Study||362
7854814|NCT00938392|19333564|P1|STARTED|Overall Study||362
7854815|NCT00938366|19333590|P2|NOT COMPLETED|Overall Study||0
7854816|NCT00938366|19333591|P1|NOT COMPLETED|Overall Study||1
7854817|NCT00938366|19333590|P2|COMPLETED|Overall Study||9
7854818|NCT00938366|19333591|P1|COMPLETED|Overall Study||8
7854819|NCT00938366|19333590|P2|STARTED|Overall Study||9
7854820|NCT00938366|19333591|P1|STARTED|Overall Study||9
7854821|NCT00938340|19333611|P1|NOT COMPLETED|Overall Study||5
7854822|NCT00938340|19333611|P1|COMPLETED|Overall Study||15
7854823|NCT00938340|19333611|P1|Received Walnut Oil Intervention|Overall Study||15
7854824|NCT00938340|19333611|P1|Received Walnut Skins Intervention|Overall Study||15
7854825|NCT00938340|19333611|P1|Received Walnut Nutmeat Intervention|Overall Study||19
7854826|NCT00938340|19333611|P1|Received Whole Walnut Intervention|Overall Study||16
7854827|NCT00938340|19333611|P1|STARTED|Overall Study||20
7854828|NCT00938327|19333741|P1|NOT COMPLETED|Overall Study||60
7854829|NCT00938327|19333741|P1|COMPLETED|Overall Study||272
7854830|NCT00938327|19333741|P1|STARTED|Overall Study||332
7854831|NCT00938314|19333752|P4|NOT COMPLETED|Cohort 3||1
7854832|NCT00938314|19333753|P3|NOT COMPLETED|Cohort 3||4
7854833|NCT00938314|19333754|P2|NOT COMPLETED|Cohort 3||0
7854834|NCT00938314|19333755|P1|NOT COMPLETED|Cohort 3||0
7854835|NCT00938314|19333752|P4|COMPLETED|Cohort 3||7
7854836|NCT00938314|19333753|P3|COMPLETED|Cohort 3||20
7854837|NCT00938314|19333754|P2|COMPLETED|Cohort 3||0
7854838|NCT00938314|19333755|P1|COMPLETED|Cohort 3||0
7854839|NCT00938314|19333752|P4|STARTED|Cohort 3||8
7854840|NCT00938314|19333753|P3|STARTED|Cohort 3||24
7854841|NCT00938314|19333754|P2|STARTED|Cohort 3||0
7854842|NCT00938314|19333755|P1|STARTED|Cohort 3||0
7854843|NCT00938314|19333752|P4|NOT COMPLETED|Cohort 2||2
7854844|NCT00938314|19333753|P3|NOT COMPLETED|Cohort 2||0
7854845|NCT00938314|19333754|P2|NOT COMPLETED|Cohort 2||6
7854846|NCT00938314|19333755|P1|NOT COMPLETED|Cohort 2||0
7854847|NCT00938314|19333752|P4|COMPLETED|Cohort 2||6
7854848|NCT00938314|19333753|P3|COMPLETED|Cohort 2||0
7854849|NCT00938314|19333754|P2|COMPLETED|Cohort 2||18
7854850|NCT00938314|19333755|P1|COMPLETED|Cohort 2||0
7854851|NCT00938314|19333752|P4|STARTED|Cohort 2||8
7854852|NCT00938314|19333753|P3|STARTED|Cohort 2||0
7854853|NCT00938314|19333754|P2|STARTED|Cohort 2||24
7854854|NCT00938314|19333755|P1|STARTED|Cohort 2||0
7854855|NCT00938314|19333752|P4|NOT COMPLETED|Cohort 1||2
7854856|NCT00938314|19333753|P3|NOT COMPLETED|Cohort 1||0
7854857|NCT00938314|19333754|P2|NOT COMPLETED|Cohort 1||0
7854858|NCT00938314|19333755|P1|NOT COMPLETED|Cohort 1||2
7854859|NCT00938314|19333752|P4|COMPLETED|Cohort 1||6
7854860|NCT00938314|19333753|P3|COMPLETED|Cohort 1||0
7854861|NCT00938314|19333754|P2|COMPLETED|Cohort 1||0
7854862|NCT00938314|19333755|P1|COMPLETED|Cohort 1||22
7854863|NCT00938314|19333752|P4|STARTED|Cohort 1||8
7854864|NCT00938314|19333753|P3|STARTED|Cohort 1||0
7854865|NCT00938314|19333754|P2|STARTED|Cohort 1||0
7854866|NCT00938314|19333755|P1|STARTED|Cohort 1||24
7854867|NCT00938041|19333809|P1|NOT COMPLETED|Overall Study||27
7854868|NCT00938041|19333809|P1|COMPLETED|Overall Study||5
7854869|NCT00938041|19333809|P1|STARTED|Overall Study||32
7854870|NCT00938015|19333818|P1|NOT COMPLETED|Overall Study||147
7854871|NCT00938015|19333818|P1|COMPLETED|Overall Study||156
7854872|NCT00938015|19333818|P1|STARTED|Overall Study||303
7854873|NCT00937950|19333834|P1|NOT COMPLETED|Overall Study||216
7854874|NCT00937950|19333834|P1|COMPLETED|Overall Study||1787
7854875|NCT00937950|19333834|P1|STARTED|Overall Study||2003
7854876|NCT00937937|19333850|P1|NOT COMPLETED|Overall Study||72
7854877|NCT00937937|19333850|P1|COMPLETED|Overall Study||0
7854878|NCT00937937|19333850|P1|STARTED|Overall Study||72
7854879|NCT00937859|19333859|P2|NOT COMPLETED|Overall Study||19
7854880|NCT00937859|19333860|P1|NOT COMPLETED|Overall Study||19
7854881|NCT00937859|19333859|P2|COMPLETED|Overall Study||134
7854882|NCT00937859|19333860|P1|COMPLETED|Overall Study||129
7854883|NCT00937859|19333859|P2|STARTED|Overall Study||153
7854884|NCT00937859|19333860|P1|STARTED|Overall Study||148
7854885|NCT00937833|19333870|P2|NOT COMPLETED|Overall Study||17
7854886|NCT00937833|19333871|P1|NOT COMPLETED|Overall Study||15
7854887|NCT00937833|19333870|P2|COMPLETED|Overall Study||60
7854888|NCT00937833|19333871|P1|COMPLETED|Overall Study||58
7854889|NCT00937833|19333870|P2|STARTED|Overall Study||77
7854890|NCT00937833|19333871|P1|STARTED|Overall Study||73
7854891|NCT00937794|19333877|P1|NOT COMPLETED|Overall Study||0
7854892|NCT00937794|19333877|P1|COMPLETED|Overall Study||33
7854893|NCT00937794|19333877|P1|STARTED|Overall Study||33
7854894|NCT00937768|19333884|P2|NOT COMPLETED|Overall Study||8
7854895|NCT00937768|19333885|P1|NOT COMPLETED|Overall Study||8
7854896|NCT00937768|19333884|P2|COMPLETED|Overall Study||0
7854897|NCT00937768|19333885|P1|COMPLETED|Overall Study||0
7854898|NCT00937768|19333884|P2|STARTED|Overall Study||8
7854899|NCT00937768|19333885|P1|STARTED|Overall Study||8
7854900|NCT00937560|19333905|P1|NOT COMPLETED|Maintenance Treatment||18
7854901|NCT00937560|19333905|P1|COMPLETED|Maintenance Treatment||150
7854902|NCT00937560|19333905|P1|STARTED|Maintenance Treatment||168
7854903|NCT00937560|19333905|P1|NOT COMPLETED|Initial Treatment||21
7854904|NCT00937560|19333905|P1|COMPLETED|Initial Treatment||168
7854905|NCT00937560|19333905|P1|Received Treatment|Initial Treatment||189
7854906|NCT00937560|19333905|P1|STARTED|Initial Treatment||189
7854907|NCT00937547|19333916|P3|NOT COMPLETED|Overall Study||7
7854908|NCT00937547|19333917|P2|NOT COMPLETED|Overall Study||6
7854909|NCT00937547|19333918|P1|NOT COMPLETED|Overall Study||1
7854910|NCT00937547|19333916|P3|COMPLETED|Overall Study||142
7854911|NCT00937547|19333917|P2|COMPLETED|Overall Study||78
7854912|NCT00937547|19333918|P1|COMPLETED|Overall Study||95
7854913|NCT00937547|19333916|P3|Histological Samples|Overall Study||142
7854914|NCT00937547|19333917|P2|Histological Samples|Overall Study||78
7854915|NCT00937547|19333918|P1|Histological Samples|Overall Study||95
7854916|NCT00937547|19333916|P3|STARTED|Overall Study||149
7854917|NCT00937547|19333917|P2|STARTED|Overall Study||84
7854918|NCT00937547|19333918|P1|STARTED|Overall Study||96
7854919|NCT00937521|19333955|P8|NOT COMPLETED|Booster Phase||2
7854920|NCT00937521|19333956|P7|NOT COMPLETED|Booster Phase||5
7854921|NCT00937521|19333957|P6|NOT COMPLETED|Booster Phase||5
7854922|NCT00937521|19333958|P5|NOT COMPLETED|Booster Phase||5
7854923|NCT00937521|19333959|P4|NOT COMPLETED|Booster Phase||3
7854924|NCT00937521|19333960|P3|NOT COMPLETED|Booster Phase||5
7854925|NCT00937521|19333961|P2|NOT COMPLETED|Booster Phase||2
7854926|NCT00937521|19333962|P1|NOT COMPLETED|Booster Phase||3
7854927|NCT00937521|19333955|P8|COMPLETED|Booster Phase||159
7854928|NCT00937521|19333956|P7|COMPLETED|Booster Phase||160
7854929|NCT00937521|19333957|P6|COMPLETED|Booster Phase||160
7854930|NCT00937521|19333958|P5|COMPLETED|Booster Phase||163
7854931|NCT00937521|19333959|P4|COMPLETED|Booster Phase||167
7854932|NCT00937521|19333960|P3|COMPLETED|Booster Phase||164
7854933|NCT00937521|19333961|P2|COMPLETED|Booster Phase||161
7854934|NCT00937521|19333962|P1|COMPLETED|Booster Phase||152
7854935|NCT00937521|19333955|P8|Premature Withdrawal|Booster Phase||2
7854936|NCT00937521|19333956|P7|Premature Withdrawal|Booster Phase||5
7854937|NCT00937521|19333957|P6|Premature Withdrawal|Booster Phase||5
7854938|NCT00937521|19333958|P5|Premature Withdrawal|Booster Phase||5
7854939|NCT00937521|19333959|P4|Premature Withdrawal|Booster Phase||3
7854940|NCT00937521|19333960|P3|Premature Withdrawal|Booster Phase||5
7854941|NCT00937521|19333961|P2|Premature Withdrawal|Booster Phase||2
7854942|NCT00937521|19333962|P1|Premature Withdrawal|Booster Phase||3
7854943|NCT00937521|19333955|P8|STARTED|Booster Phase||161
7854944|NCT00937521|19333956|P7|STARTED|Booster Phase||165
7854945|NCT00937521|19333957|P6|STARTED|Booster Phase||165
7854946|NCT00937521|19333958|P5|STARTED|Booster Phase||168
7854947|NCT00937521|19333959|P4|STARTED|Booster Phase||170
7854948|NCT00937521|19333960|P3|STARTED|Booster Phase||169
7854949|NCT00937521|19333961|P2|STARTED|Booster Phase||163
7854950|NCT00937521|19333962|P1|STARTED|Booster Phase||155
7854951|NCT00937521|19333955|P8|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
7854952|NCT00937521|19333956|P7|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
7854953|NCT00937521|19333957|P6|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
7854954|NCT00937521|19333958|P5|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
7854955|NCT00937521|19333959|P4|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
7854956|NCT00937521|19333960|P3|NOT COMPLETED|Overall Study - Prior to Booster Dose||6
7854957|NCT00937521|19333961|P2|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
7854958|NCT00937521|19333962|P1|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
7854959|NCT00937521|19333955|P8|COMPLETED|Overall Study - Prior to Booster Dose||183
7854960|NCT00937521|19333956|P7|COMPLETED|Overall Study - Prior to Booster Dose||181
7854961|NCT00937521|19333957|P6|COMPLETED|Overall Study - Prior to Booster Dose||187
7854962|NCT00937521|19333958|P5|COMPLETED|Overall Study - Prior to Booster Dose||188
7854963|NCT00937521|19333959|P4|COMPLETED|Overall Study - Prior to Booster Dose||187
7854964|NCT00937521|19333960|P3|COMPLETED|Overall Study - Prior to Booster Dose||186
7854965|NCT00937521|19333961|P2|COMPLETED|Overall Study - Prior to Booster Dose||185
7854966|NCT00937521|19333962|P1|COMPLETED|Overall Study - Prior to Booster Dose||185
7854967|NCT00937521|19333955|P8|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
7854968|NCT00937521|19333956|P7|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
7854969|NCT00937521|19333957|P6|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
7854970|NCT00937521|19333958|P5|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
7854971|NCT00937521|19333959|P4|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
7854972|NCT00937521|19333960|P3|Premature Withdrawal|Overall Study - Prior to Booster Dose||6
7854973|NCT00937521|19333961|P2|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
7854974|NCT00937521|19333962|P1|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
7854975|NCT00937521|19333955|P8|STARTED|Overall Study - Prior to Booster Dose||184
7854976|NCT00937521|19333956|P7|STARTED|Overall Study - Prior to Booster Dose||186
7854977|NCT00937521|19333957|P6|STARTED|Overall Study - Prior to Booster Dose||188
7854978|NCT00937521|19333958|P5|STARTED|Overall Study - Prior to Booster Dose||191
7854979|NCT00937521|19333959|P4|STARTED|Overall Study - Prior to Booster Dose||188
7854980|NCT00937521|19333960|P3|STARTED|Overall Study - Prior to Booster Dose||192
7854981|NCT00937521|19333961|P2|STARTED|Overall Study - Prior to Booster Dose||190
7854982|NCT00937521|19333962|P1|STARTED|Overall Study - Prior to Booster Dose||188
7854983|NCT00937495|19334068|P1|NOT COMPLETED|Overall Study||2
7854984|NCT00937495|19334068|P1|COMPLETED|Overall Study||14
7854985|NCT00937495|19334068|P1|STARTED|Overall Study||16
7854986|NCT00937404|19334074|P1|NOT COMPLETED|Overall Study||2
7854987|NCT00937404|19334074|P1|COMPLETED|Overall Study||23
7854988|NCT00937404|19334074|P1|STARTED|Overall Study||25
7854989|NCT00937391|19334083|P1|NOT COMPLETED|Stage 2||1
7854990|NCT00937391|19334083|P1|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33
7854991|NCT00937391|19334083|P1|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34
7854992|NCT00937391|19334083|P1|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34
7854993|NCT00937391|19334083|P1|NOT COMPLETED|Stage 1||0
7854994|NCT00937391|19334083|P1|COMPLETED|Stage 1||20
7854995|NCT00937391|19334083|P1|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20
7854996|NCT00937391|19334083|P1|STARTED|Stage 1||20
7854997|NCT00937378|19334136|P2|NOT COMPLETED|Overall Study||18
7854998|NCT00937378|19334137|P1|NOT COMPLETED|Overall Study||18
7854999|NCT00937378|19334136|P2|COMPLETED|Overall Study||141
7855000|NCT00937378|19334137|P1|COMPLETED|Overall Study||149
7855001|NCT00937378|19334136|P2|STARTED|Overall Study||159
7855002|NCT00937378|19334137|P1|STARTED|Overall Study||167
7855003|NCT00937326|19334150|P5|NOT COMPLETED|Overall Study||5
7855004|NCT00937326|19334151|P4|NOT COMPLETED|Overall Study||5
7855005|NCT00937326|19334152|P3|NOT COMPLETED|Overall Study||4
7855006|NCT00937326|19334153|P2|NOT COMPLETED|Overall Study||7
7855007|NCT00937326|19334154|P1|NOT COMPLETED|Overall Study||3
7855008|NCT00937326|19334150|P5|COMPLETED|Overall Study||40
7855009|NCT00937326|19334151|P4|COMPLETED|Overall Study||40
7855010|NCT00937326|19334152|P3|COMPLETED|Overall Study||42
7855011|NCT00937326|19334153|P2|COMPLETED|Overall Study||38
7855012|NCT00937326|19334154|P1|COMPLETED|Overall Study||43
7855013|NCT00937326|19334150|P5|STARTED|Overall Study||45
7855014|NCT00937326|19334151|P4|STARTED|Overall Study||45
7855015|NCT00937326|19334152|P3|STARTED|Overall Study||46
7855016|NCT00937326|19334153|P2|STARTED|Overall Study||45
7855017|NCT00937326|19334154|P1|STARTED|Overall Study||46
7855018|NCT00937235|19334382|P2|NOT COMPLETED|Overall Study||0
7855019|NCT00937235|19334383|P1|NOT COMPLETED|Overall Study||0
7855020|NCT00937235|19334382|P2|COMPLETED|Overall Study||70
7855021|NCT00937235|19334383|P1|COMPLETED|Overall Study||72
7855022|NCT00937235|19334382|P2|STARTED|Overall Study||70
7855023|NCT00937235|19334383|P1|STARTED|Overall Study||72
7855024|NCT00937157|19334403|P1|NOT COMPLETED|Overall Study||4
7855025|NCT00937157|19334403|P1|COMPLETED|Overall Study||8
7855026|NCT00937157|19334403|P1|STARTED|Overall Study||12
7855027|NCT00937118|19334407|P1|NOT COMPLETED|Overall Study||0
7855028|NCT00937118|19334407|P1|COMPLETED|Overall Study||41
7855029|NCT00937118|19334407|P1|STARTED|Overall Study||41
7855030|NCT00937105|19334416|P2|NOT COMPLETED|Overall Study||39
7855031|NCT00937105|19334417|P1|NOT COMPLETED|Overall Study||40
7855032|NCT00937105|19334416|P2|COMPLETED|Overall Study||70
7855033|NCT00937105|19334417|P1|COMPLETED|Overall Study||69
7855034|NCT00937105|19334416|P2|STARTED|Overall Study||109
7855035|NCT00937105|19334417|P1|STARTED|Overall Study||109
7855036|NCT00937040|19334434|P2|NOT COMPLETED|Overall Study||37
7855037|NCT00937040|19334435|P1|NOT COMPLETED|Overall Study||41
7855038|NCT00937040|19334434|P2|COMPLETED|Overall Study||141
7855039|NCT00937040|19334435|P1|COMPLETED|Overall Study||138
7855040|NCT00937040|19334434|P2|STARTED|Overall Study||178
7855041|NCT00937040|19334435|P1|STARTED|Overall Study||179
7855042|NCT00936975|19334477|P1|NOT COMPLETED|Overall Study||6
7855043|NCT00936975|19334477|P1|COMPLETED|Overall Study||12
7855044|NCT00936975|19334477|P1|STARTED|Overall Study||18
7855045|NCT00936910|19334486|P1|NOT COMPLETED|Overall Study||3
7855046|NCT00936910|19334486|P1|COMPLETED|Overall Study|The primary endpt. of 2 (-) cultures within 5 d of lock therapy was met for 10 patients|10
7855047|NCT00936910|19334486|P1|STARTED|Overall Study||13
7855048|NCT00936897|19334495|P2|NOT COMPLETED|Overall Study||60
7855049|NCT00936897|19334496|P1|NOT COMPLETED|Overall Study||19
7855050|NCT00936897|19334495|P2|COMPLETED|Overall Study||356
7855051|NCT00936897|19334496|P1|COMPLETED|Overall Study||398
7855052|NCT00936897|19334495|P2|STARTED|Overall Study|Randomized|416
7855053|NCT00936897|19334496|P1|STARTED|Overall Study|Randomized|417
7855054|NCT00936884|19334510|P3|NOT COMPLETED|Open-label||19
7855055|NCT00936884|19334511|P2|NOT COMPLETED|Open-label||0
7855056|NCT00936884|19334512|P1|NOT COMPLETED|Open-label||0
7855057|NCT00936884|19334510|P3|COMPLETED|Open-label||12
7855058|NCT00936884|19334511|P2|COMPLETED|Open-label||0
7855059|NCT00936884|19334512|P1|COMPLETED|Open-label||0
7855060|NCT00936884|19334510|P3|STARTED|Open-label||31
7855061|NCT00936884|19334511|P2|STARTED|Open-label||0
7855062|NCT00936884|19334512|P1|STARTED|Open-label||0
7855063|NCT00936884|19334510|P3|NOT COMPLETED|Double-blind||0
7855064|NCT00936884|19334511|P2|NOT COMPLETED|Double-blind||7
7855065|NCT00936884|19334512|P1|NOT COMPLETED|Double-blind||12
7855066|NCT00936884|19334510|P3|COMPLETED|Double-blind||0
7855067|NCT00936884|19334511|P2|COMPLETED|Double-blind||18
7855068|NCT00936884|19334512|P1|COMPLETED|Double-blind||13
7855069|NCT00936884|19334510|P3|STARTED|Double-blind|Thirteen subjects from the MNTX group and 18 from the placebo group entered the 12-week extension.|0
7855070|NCT00936884|19334511|P2|STARTED|Double-blind|Twenty-four subjects received placebo, and 23 had ≥ 1 post baseline diary assessment.|25
7855071|NCT00936884|19334512|P1|STARTED|Double-blind|Twenty-five subjects received MNTX, and 24 had ≥ 1 post baseline diary assessment.|25
7855072|NCT00936741|19334523|P1|NOT COMPLETED|Overall Study||9
7855073|NCT00936741|19334523|P1|COMPLETED|Overall Study||21
7855074|NCT00936741|19334523|P1|STARTED|Overall Study||30
7855075|NCT00936715|19334528|P1|NOT COMPLETED|Overall Study||6
7855076|NCT00936715|19334528|P1|COMPLETED|Overall Study||18
7855077|NCT00936715|19334528|P1|STARTED|Overall Study||24
7855078|NCT00936702|19334532|P1|NOT COMPLETED|Overall Study||46
7855079|NCT00936702|19334532|P1|COMPLETED|Overall Study||0
7855080|NCT00936702|19334532|P1|STARTED|Overall Study||46
7855081|NCT00936663|19334542|P2|NOT COMPLETED|Overall Study||0
7855082|NCT00936663|19334543|P1|NOT COMPLETED|Overall Study||0
7855083|NCT00936663|19334542|P2|COMPLETED|Overall Study||2
7855084|NCT00936663|19334543|P1|COMPLETED|Overall Study||1
7855085|NCT00936663|19334542|P2|STARTED|Overall Study||2
7855086|NCT00936663|19334543|P1|STARTED|Overall Study||1
7855087|NCT00936598|19334565|P2|NOT COMPLETED|Overall Study||0
7855088|NCT00936598|19334566|P1|NOT COMPLETED|Overall Study||2
7855089|NCT00936598|19334565|P2|COMPLETED|Overall Study||1
7855090|NCT00936598|19334566|P1|COMPLETED|Overall Study||2
7855091|NCT00936598|19334565|P2|STARTED|Overall Study||1
7855092|NCT00936598|19334566|P1|STARTED|Overall Study||4
7855093|NCT00936585|19334576|P1|NOT COMPLETED|Overall Study||0
7855094|NCT00936585|19334576|P1|COMPLETED|Overall Study||2
7855095|NCT00936585|19334576|P1|STARTED|Overall Study||2
7855096|NCT00936481|19334582|P2|NOT COMPLETED|Overall Study||0
7855097|NCT00936481|19334583|P1|NOT COMPLETED|Overall Study||0
7855098|NCT00936481|19334582|P2|COMPLETED|Overall Study||17
7855099|NCT00936481|19334583|P1|COMPLETED|Overall Study||17
7855100|NCT00936481|19334582|P2|STARTED|Overall Study||17
7855101|NCT00936481|19334583|P1|STARTED|Overall Study||17
7855102|NCT00936455|19334593|P2|NOT COMPLETED|Overall Study||0
7855103|NCT00936455|19334594|P1|NOT COMPLETED|Overall Study||0
7855104|NCT00936455|19334593|P2|COMPLETED|Overall Study||38
7855105|NCT00936455|19334594|P1|COMPLETED|Overall Study||37
7855106|NCT00936455|19334593|P2|STARTED|Overall Study||38
7855107|NCT00936455|19334594|P1|STARTED|Overall Study||37
7855108|NCT00936377|19334609|P3|NOT COMPLETED|Overall Study||0
7855109|NCT00936377|19334610|P2|NOT COMPLETED|Overall Study||0
7855110|NCT00936377|19334611|P1|NOT COMPLETED|Overall Study||0
7855111|NCT00936377|19334609|P3|COMPLETED|Overall Study||8
7855112|NCT00936377|19334610|P2|COMPLETED|Overall Study||8
7855113|NCT00936377|19334611|P1|COMPLETED|Overall Study||8
7855114|NCT00936377|19334609|P3|STARTED|Overall Study||8
7855115|NCT00936377|19334610|P2|STARTED|Overall Study||8
7855116|NCT00936377|19334611|P1|STARTED|Overall Study||8
7855117|NCT00936351|19334642|P2|NOT COMPLETED|Overall Study||2
7855118|NCT00936351|19334643|P1|NOT COMPLETED|Overall Study||3
7855119|NCT00936351|19334642|P2|COMPLETED|Overall Study||14
7855120|NCT00936351|19334643|P1|COMPLETED|Overall Study||15
7855121|NCT00936351|19334642|P2|STARTED|Overall Study||16
7855122|NCT00936351|19334643|P1|STARTED|Overall Study||18
7855123|NCT00936299|19334655|P2|NOT COMPLETED|Overall Study||12
7855124|NCT00936299|19334656|P1|NOT COMPLETED|Overall Study||13
7855125|NCT00936299|19334655|P2|COMPLETED|Overall Study||40
7855126|NCT00936299|19334656|P1|COMPLETED|Overall Study||40
7855127|NCT00936299|19334655|P2|STARTED|Overall Study||52
7855128|NCT00936299|19334656|P1|STARTED|Overall Study||53
7855129|NCT00936221|19334668|P2|NOT COMPLETED|Overall Study||1
7855130|NCT00936221|19334669|P1|NOT COMPLETED|Overall Study||1
7855131|NCT00936221|19334668|P2|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45
7855132|NCT00936221|19334669|P1|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44
7855133|NCT00936221|19334668|P2|Received Treatment|Overall Study||45
7855134|NCT00936221|19334669|P1|Received Treatment|Overall Study||44
7855135|NCT00936221|19334668|P2|STARTED|Overall Study||46
7855136|NCT00936221|19334669|P1|STARTED|Overall Study||45
7855137|NCT00936208|19334683|P2|NOT COMPLETED|Overall Study||22
7855138|NCT00936208|19334684|P1|NOT COMPLETED|Overall Study||37
7855139|NCT00936208|19334683|P2|COMPLETED|Overall Study||1574
7855140|NCT00936208|19334684|P1|COMPLETED|Overall Study||1462
7855141|NCT00936208|19334683|P2|STARTED|Overall Study||1596
7855142|NCT00936208|19334684|P1|STARTED|Overall Study||1499
7855143|NCT00936117|19334702|P1|NOT COMPLETED|Overall Study||10
7855144|NCT00936117|19334702|P1|COMPLETED|Overall Study|Completed 42 days on study drug|10
7855145|NCT00936117|19334702|P1|STARTED|Overall Study||20
7855146|NCT00936065|19334710|P3|NOT COMPLETED|Overall Study||7
7855147|NCT00936065|19334711|P2|NOT COMPLETED|Overall Study||4
7855148|NCT00936065|19334712|P1|NOT COMPLETED|Overall Study||4
7855149|NCT00936065|19334710|P3|COMPLETED|Overall Study||12
7855150|NCT00936065|19334711|P2|COMPLETED|Overall Study||16
7855151|NCT00936065|19334712|P1|COMPLETED|Overall Study||17
7855152|NCT00936065|19334710|P3|Study Assessments Performed|Overall Study||18
7855153|NCT00936065|19334711|P2|Study Assessments Performed|Overall Study||19
7855154|NCT00936065|19334712|P1|Study Assessments Performed|Overall Study||21
7855155|NCT00936065|19334710|P3|Received Treatment|Overall Study||18
7855156|NCT00936065|19334711|P2|Received Treatment|Overall Study||20
7855157|NCT00936065|19334712|P1|Received Treatment|Overall Study||21
7855158|NCT00936065|19334710|P3|STARTED|Overall Study||19
7855159|NCT00936065|19334711|P2|STARTED|Overall Study||20
7855160|NCT00936065|19334712|P1|STARTED|Overall Study||21
7855161|NCT00935883|19334818|P2|NOT COMPLETED|Follow-Up Period||0
7855162|NCT00935883|19334819|P1|NOT COMPLETED|Follow-Up Period||0
7855163|NCT00935883|19334818|P2|COMPLETED|Follow-Up Period||38
7855164|NCT00935883|19334819|P1|COMPLETED|Follow-Up Period||19
7855165|NCT00935883|19334818|P2|STARTED|Follow-Up Period||38
7855166|NCT00935883|19334819|P1|STARTED|Follow-Up Period||19
7855167|NCT00935883|19334818|P2|NOT COMPLETED|Treatment Period||2
7855168|NCT00935883|19334819|P1|NOT COMPLETED|Treatment Period||1
7855169|NCT00935883|19334818|P2|COMPLETED|Treatment Period||38
7855170|NCT00935883|19334819|P1|COMPLETED|Treatment Period||19
7855171|NCT00935883|19334818|P2|STARTED|Treatment Period||40
7855172|NCT00935883|19334819|P1|STARTED|Treatment Period||20
7855173|NCT00935857|19334833|P2|NOT COMPLETED|Overall Study||0
7855174|NCT00935857|19334834|P1|NOT COMPLETED|Overall Study||0
7855175|NCT00935857|19334833|P2|COMPLETED|Overall Study||16
7855176|NCT00935857|19334834|P1|COMPLETED|Overall Study||14
7855177|NCT00935857|19334833|P2|STARTED|Overall Study||16
7855178|NCT00935857|19334834|P1|STARTED|Overall Study||14
7855179|NCT00935818|19334846|P2|NOT COMPLETED|Overall Study||100
7855180|NCT00935818|19334847|P1|NOT COMPLETED|Overall Study||91
7855181|NCT00935818|19334846|P2|COMPLETED|Overall Study||157
7855182|NCT00935818|19334847|P1|COMPLETED|Overall Study||158
7855183|NCT00935818|19334846|P2|End of Medication Phase|Overall Study||184
7855184|NCT00935818|19334847|P1|End of Medication Phase|Overall Study||182
7855185|NCT00935818|19334846|P2|STARTED|Overall Study||257
7855186|NCT00935818|19334847|P1|STARTED|Overall Study||249
7855187|NCT00935792|19334868|P3|NOT COMPLETED|Overall Study||0
7855188|NCT00935792|19334869|P2|NOT COMPLETED|Overall Study||3
7855189|NCT00935792|19334870|P1|NOT COMPLETED|Overall Study||1
7855190|NCT00935792|19334868|P3|COMPLETED|Overall Study||12
7855191|NCT00935792|19334869|P2|COMPLETED|Overall Study||6
7855192|NCT00935792|19334870|P1|COMPLETED|Overall Study||6
7855193|NCT00935792|19334868|P3|STARTED|Overall Study||12
7855194|NCT00935792|19334869|P2|STARTED|Overall Study||9
7855195|NCT00935792|19334870|P1|STARTED|Overall Study||7
7855196|NCT00935766|19334887|P2|NOT COMPLETED|Overall Study||7
7855197|NCT00935766|19334888|P1|NOT COMPLETED|Overall Study||7
7855198|NCT00935766|19334887|P2|COMPLETED|Overall Study||27
7855199|NCT00935766|19334888|P1|COMPLETED|Overall Study||35
7855200|NCT00935766|19334887|P2|STARTED|Overall Study||34
7855201|NCT00935766|19334888|P1|STARTED|Overall Study||42
7855202|NCT00935701|19334898|P1|NOT COMPLETED|Overall Study||1
7855203|NCT00935701|19334898|P1|COMPLETED|Overall Study||9
7855204|NCT00935701|19334898|P1|Transition Acupressure to Acupuncture|Overall Study||9
7855205|NCT00935701|19334898|P1|STARTED|Overall Study||10
7855206|NCT00935649|19334905|P1|NOT COMPLETED|Overall Study||5
7855207|NCT00935649|19334905|P1|COMPLETED|Overall Study||134
7855208|NCT00935649|19334905|P1|STARTED|Overall Study||139
7855209|NCT00935584|19334915|P2|NOT COMPLETED|Overall Study||4
7855210|NCT00935584|19334916|P1|NOT COMPLETED|Overall Study||49
7855211|NCT00935584|19334915|P2|COMPLETED|Overall Study||19
7855212|NCT00935584|19334916|P1|COMPLETED|Overall Study||77
7855213|NCT00935584|19334915|P2|STARTED|Overall Study||23
7855214|NCT00935584|19334916|P1|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126
7855215|NCT00935532|19334928|P2|NOT COMPLETED|Overall Study||11
7855216|NCT00935532|19334929|P1|NOT COMPLETED|Overall Study||22
7855217|NCT00935532|19334928|P2|COMPLETED|Overall Study||201
7855218|NCT00935532|19334929|P1|COMPLETED|Overall Study||193
7855219|NCT00935532|19334928|P2|STARTED|Overall Study||212
7855220|NCT00935532|19334929|P1|STARTED|Overall Study||215
7855221|NCT00935493|19334958|P3|NOT COMPLETED|Overall Study||1
7855222|NCT00935493|19334959|P2|NOT COMPLETED|Overall Study||2
7855223|NCT00935493|19334960|P1|NOT COMPLETED|Overall Study||1
7855224|NCT00935493|19334958|P3|COMPLETED|Overall Study||40
7855225|NCT00935493|19334959|P2|COMPLETED|Overall Study||39
7855226|NCT00935493|19334960|P1|COMPLETED|Overall Study||40
7855227|NCT00935493|19334958|P3|STARTED|Overall Study||41
7855228|NCT00935493|19334959|P2|STARTED|Overall Study||41
7855229|NCT00935493|19334960|P1|STARTED|Overall Study||41
7855230|NCT00935428|19334974|P1|NOT COMPLETED|Overall Study||0
7855231|NCT00935428|19334974|P1|COMPLETED|Overall Study||231
7855232|NCT00935428|19334974|P1|STARTED|Overall Study||231
7855233|NCT00935311|19334988|P3|NOT COMPLETED|Overall Study||0
7855234|NCT00935311|19334989|P2|NOT COMPLETED|Overall Study||0
7855235|NCT00935311|19334990|P1|NOT COMPLETED|Overall Study||0
7855236|NCT00935311|19334988|P3|COMPLETED|Overall Study||40
7855237|NCT00935311|19334989|P2|COMPLETED|Overall Study||39
7855238|NCT00935311|19334990|P1|COMPLETED|Overall Study||43
7855239|NCT00935311|19334988|P3|STARTED|Overall Study||40
7855240|NCT00935311|19334989|P2|STARTED|Overall Study||39
7855241|NCT00935311|19334990|P1|STARTED|Overall Study||43
7855242|NCT00935272|19335009|P2|NOT COMPLETED|Overall Study||6
7855243|NCT00935272|19335010|P1|NOT COMPLETED|Overall Study||19
7855244|NCT00935272|19335009|P2|COMPLETED|Overall Study||39
7855245|NCT00935272|19335010|P1|COMPLETED|Overall Study||116
7855246|NCT00935272|19335009|P2|STARTED|Overall Study||45
7855247|NCT00935272|19335010|P1|STARTED|Overall Study||135
7855248|NCT00935259|19335019|P2|NOT COMPLETED|Period 2||0
7855249|NCT00935259|19335020|P1|NOT COMPLETED|Period 2||0
7855250|NCT00935259|19335019|P2|COMPLETED|Period 2||14
7855251|NCT00935259|19335020|P1|COMPLETED|Period 2||15
7855252|NCT00935259|19335019|P2|STARTED|Period 2||14
7855253|NCT00935259|19335020|P1|STARTED|Period 2||15
7855254|NCT00935259|19335019|P2|NOT COMPLETED|Period 1||1
7855255|NCT00935259|19335020|P1|NOT COMPLETED|Period 1||1
7855256|NCT00935259|19335019|P2|COMPLETED|Period 1||14
7855257|NCT00935259|19335020|P1|COMPLETED|Period 1||15
7855258|NCT00935259|19335019|P2|STARTED|Period 1||15
7855259|NCT00935259|19335020|P1|STARTED|Period 1||16
7855260|NCT00935220|19335034|P1|NOT COMPLETED|Overall Study||2
7855261|NCT00935220|19335034|P1|COMPLETED|Overall Study||39
7855262|NCT00935220|19335034|P1|STARTED|Overall Study||41
7855263|NCT00935064|19335048|P2|NOT COMPLETED|Overall Study||0
7855264|NCT00935064|19335049|P1|NOT COMPLETED|Overall Study||0
7855265|NCT00935064|19335048|P2|COMPLETED|Overall Study||30
7855266|NCT00935064|19335049|P1|COMPLETED|Overall Study||30
7855267|NCT00935064|19335048|P2|STARTED|Overall Study||30
7855268|NCT00935064|19335049|P1|STARTED|Overall Study||30
7855269|NCT00934947|19335065|P2|NOT COMPLETED|Overall Study||2
7855270|NCT00934947|19335066|P1|NOT COMPLETED|Overall Study||0
7855271|NCT00934947|19335065|P2|COMPLETED|Overall Study||20
7855272|NCT00934947|19335066|P1|COMPLETED|Overall Study||23
7855273|NCT00934947|19335065|P2|STARTED|Overall Study||22
7855274|NCT00934947|19335066|P1|STARTED|Overall Study||23
7855275|NCT00934921|19335080|P2|NOT COMPLETED|Second Intervention||0
7855276|NCT00934921|19335081|P1|NOT COMPLETED|Second Intervention||0
7855277|NCT00934921|19335080|P2|COMPLETED|Second Intervention||12
7855278|NCT00934921|19335081|P1|COMPLETED|Second Intervention||12
7855279|NCT00934921|19335080|P2|STARTED|Second Intervention||12
7855280|NCT00934921|19335081|P1|STARTED|Second Intervention||12
7855281|NCT00934921|19335080|P2|NOT COMPLETED|First Intervention||0
7855282|NCT00934921|19335081|P1|NOT COMPLETED|First Intervention||0
7855283|NCT00934921|19335080|P2|COMPLETED|First Intervention||12
7855284|NCT00934921|19335081|P1|COMPLETED|First Intervention||12
7855285|NCT00934921|19335080|P2|STARTED|First Intervention||12
7855286|NCT00934921|19335081|P1|STARTED|First Intervention||12
7855287|NCT00934856|19335095|P6|NOT COMPLETED|Extension Part||5
7855288|NCT00934856|19335096|P5|NOT COMPLETED|Extension Part||4
7855289|NCT00934856|19335097|P4|NOT COMPLETED|Extension Part||2
7855290|NCT00934856|19335098|P3|NOT COMPLETED|Extension Part||0
7855291|NCT00934856|19335099|P2|NOT COMPLETED|Extension Part||0
7855292|NCT00934856|19335100|P1|NOT COMPLETED|Extension Part||0
7855293|NCT00934856|19335095|P6|COMPLETED|Extension Part||19
7855294|NCT00934856|19335096|P5|COMPLETED|Extension Part||24
7855295|NCT00934856|19335097|P4|COMPLETED|Extension Part||2
7855296|NCT00934856|19335098|P3|COMPLETED|Extension Part||0
7855297|NCT00934856|19335099|P2|COMPLETED|Extension Part||0
7855298|NCT00934856|19335100|P1|COMPLETED|Extension Part||0
7855299|NCT00934856|19335095|P6|STARTED|Extension Part|New participants were enrolled in the extension part.|24
7855300|NCT00934856|19335096|P5|STARTED|Extension Part|New participants were enrolled in the extension part.|28
7855301|NCT00934856|19335097|P4|STARTED|Extension Part|New participants were enrolled in the extension part.|4
7855302|NCT00934856|19335098|P3|STARTED|Extension Part||0
7855303|NCT00934856|19335099|P2|STARTED|Extension Part||0
7855304|NCT00934856|19335100|P1|STARTED|Extension Part||0
7855305|NCT00934856|19335095|P6|NOT COMPLETED|Feasibility Part||3
7855306|NCT00934856|19335096|P5|NOT COMPLETED|Feasibility Part||0
7855307|NCT00934856|19335097|P4|NOT COMPLETED|Feasibility Part||5
7855308|NCT00934856|19335098|P3|NOT COMPLETED|Feasibility Part||3
7855309|NCT00934856|19335099|P2|NOT COMPLETED|Feasibility Part||5
7855310|NCT00934856|19335100|P1|NOT COMPLETED|Feasibility Part||5
7855311|NCT00934856|19335095|P6|COMPLETED|Feasibility Part||6
7855312|NCT00934856|19335096|P5|COMPLETED|Feasibility Part||12
7855313|NCT00934856|19335097|P4|COMPLETED|Feasibility Part||1
7855314|NCT00934856|19335098|P3|COMPLETED|Feasibility Part||0
7855315|NCT00934856|19335099|P2|COMPLETED|Feasibility Part||1
7855316|NCT00934856|19335100|P1|COMPLETED|Feasibility Part||1
7855317|NCT00934856|19335095|P6|STARTED|Feasibility Part||9
7855318|NCT00934856|19335096|P5|STARTED|Feasibility Part||12
7855319|NCT00934856|19335097|P4|STARTED|Feasibility Part||6
7855320|NCT00934856|19335098|P3|STARTED|Feasibility Part||3
7855321|NCT00934856|19335099|P2|STARTED|Feasibility Part||6
7855322|NCT00934856|19335100|P1|STARTED|Feasibility Part||6
7855323|NCT00934843|19335198|P2|NOT COMPLETED|Overall Study||1
7855324|NCT00934843|19335199|P1|NOT COMPLETED|Overall Study||0
7855325|NCT00934843|19335198|P2|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39
7855326|NCT00934843|19335199|P1|COMPLETED|Overall Study||37
7855327|NCT00934843|19335198|P2|STARTED|Overall Study||40
7855328|NCT00934843|19335199|P1|STARTED|Overall Study||37
7855329|NCT00934791|19335215|P2|NOT COMPLETED|Overall Study||0
7855330|NCT00934791|19335216|P1|NOT COMPLETED|Overall Study||1
7855331|NCT00934791|19335215|P2|COMPLETED|Overall Study||0
7855332|NCT00934791|19335216|P1|COMPLETED|Overall Study||0
7855333|NCT00934791|19335215|P2|STARTED|Overall Study||0
7855334|NCT00934791|19335216|P1|STARTED|Overall Study||1
7855335|NCT00934661|19335224|P2|NOT COMPLETED|Overall Study||0
7855336|NCT00934661|19335225|P1|NOT COMPLETED|Overall Study||1
7855337|NCT00934661|19335224|P2|COMPLETED|Overall Study||20
7855338|NCT00934661|19335225|P1|COMPLETED|Overall Study||19
7855339|NCT00934661|19335224|P2|STARTED|Overall Study||20
7855340|NCT00934661|19335225|P1|STARTED|Overall Study||20
7855341|NCT00934648|19335245|P1|NOT COMPLETED|Overall Study||9
7855342|NCT00934648|19335245|P1|COMPLETED|Overall Study||6
7855343|NCT00934648|19335245|P1|STARTED|Overall Study||15
7855344|NCT00934635|19335261|P9|NOT COMPLETED|Overall Study||0
7855345|NCT00934635|19335262|P8|NOT COMPLETED|Overall Study||0
7855346|NCT00934635|19335263|P7|NOT COMPLETED|Overall Study||0
7855347|NCT00934635|19335264|P6|NOT COMPLETED|Overall Study||0
7855348|NCT00934635|19335265|P5|NOT COMPLETED|Overall Study||0
7855349|NCT00934635|19335266|P4|NOT COMPLETED|Overall Study||0
7855350|NCT00934635|19335267|P3|NOT COMPLETED|Overall Study||0
7855351|NCT00934635|19335268|P2|NOT COMPLETED|Overall Study||0
7855352|NCT00934635|19335269|P1|NOT COMPLETED|Overall Study||0
7855353|NCT00934635|19335261|P9|COMPLETED|Overall Study||1
7855354|NCT00934635|19335262|P8|COMPLETED|Overall Study||0
7855355|NCT00934635|19335263|P7|COMPLETED|Overall Study||0
7855356|NCT00934635|19335264|P6|COMPLETED|Overall Study||0
7855357|NCT00934635|19335265|P5|COMPLETED|Overall Study||0
7855358|NCT00934635|19335266|P4|COMPLETED|Overall Study||0
7855359|NCT00934635|19335267|P3|COMPLETED|Overall Study||0
7855360|NCT00934635|19335268|P2|COMPLETED|Overall Study||1
7855361|NCT00934635|19335269|P1|COMPLETED|Overall Study||0
7855362|NCT00934635|19335261|P9|STARTED|Overall Study||1
7855363|NCT00934635|19335262|P8|STARTED|Overall Study||0
7855364|NCT00934635|19335263|P7|STARTED|Overall Study||0
7855365|NCT00934635|19335264|P6|STARTED|Overall Study||0
7855366|NCT00934635|19335265|P5|STARTED|Overall Study||0
7855367|NCT00934635|19335266|P4|STARTED|Overall Study||0
7855368|NCT00934635|19335267|P3|STARTED|Overall Study||0
7855369|NCT00934635|19335268|P2|STARTED|Overall Study||1
7855370|NCT00934635|19335269|P1|STARTED|Overall Study||0
7855371|NCT00934622|19335289|P1|NOT COMPLETED|Overall Study||8
7855372|NCT00934622|19335289|P1|COMPLETED|Overall Study||68
7855373|NCT00934622|19335289|P1|STARTED|Overall Study||76
7855374|NCT00934596|19335296|P2|NOT COMPLETED|Overall Study||0
7855375|NCT00934596|19335297|P1|NOT COMPLETED|Overall Study||0
7855376|NCT00934596|19335296|P2|COMPLETED|Overall Study||10
7855377|NCT00934596|19335297|P1|COMPLETED|Overall Study||10
7855378|NCT00934596|19335296|P2|STARTED|Overall Study||10
7855379|NCT00934596|19335297|P1|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10
7855380|NCT00934544|19335327|P3|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||34
7855381|NCT00934544|19335328|P2|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||28
7855382|NCT00934544|19335329|P1|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||107
7855383|NCT00934544|19335327|P3|COMPLETED|Overall Disposition at 5 Year Follow-up||11
7855384|NCT00934544|19335328|P2|COMPLETED|Overall Disposition at 5 Year Follow-up||0
7855385|NCT00934544|19335329|P1|COMPLETED|Overall Disposition at 5 Year Follow-up||39
7855386|NCT00934544|19335327|P3|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||6
7855387|NCT00934544|19335328|P2|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
7855388|NCT00934544|19335329|P1|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
7855389|NCT00934544|19335327|P3|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||12
7855390|NCT00934544|19335328|P2|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
7855391|NCT00934544|19335329|P1|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
7855392|NCT00934544|19335327|P3|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||27
7855393|NCT00934544|19335328|P2|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
7855394|NCT00934544|19335329|P1|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
7855395|NCT00934544|19335327|P3|STARTED|Overall Disposition at 5 Year Follow-up||45
7855396|NCT00934544|19335328|P2|STARTED|Overall Disposition at 5 Year Follow-up||28
7855397|NCT00934544|19335329|P1|STARTED|Overall Disposition at 5 Year Follow-up||146
7855398|NCT00934544|19335327|P3|NOT COMPLETED|Primary Endpoint Analysis (Interim)||0
7855399|NCT00934544|19335328|P2|NOT COMPLETED|Primary Endpoint Analysis (Interim)||42
7855400|NCT00934544|19335329|P1|NOT COMPLETED|Primary Endpoint Analysis (Interim)||55
7855401|NCT00934544|19335327|P3|COMPLETED|Primary Endpoint Analysis (Interim)||0
7855402|NCT00934544|19335328|P2|COMPLETED|Primary Endpoint Analysis (Interim)||31
7855403|NCT00934544|19335329|P1|COMPLETED|Primary Endpoint Analysis (Interim)||91
7855404|NCT00934544|19335327|P3|STARTED|Primary Endpoint Analysis (Interim)||0
7855405|NCT00934544|19335328|P2|STARTED|Primary Endpoint Analysis (Interim)||73
7855406|NCT00934544|19335329|P1|STARTED|Primary Endpoint Analysis (Interim)||146
7855407|NCT00934440|19335365|P1|NOT COMPLETED|Overall Study||1
7855408|NCT00934440|19335365|P1|COMPLETED|Overall Study||10
7855409|NCT00934440|19335365|P1|STARTED|Overall Study||11
7855410|NCT00934375|19335372|P2|NOT COMPLETED|Overall Study||22
7855411|NCT00934375|19335373|P1|NOT COMPLETED|Overall Study||13
7855412|NCT00934375|19335372|P2|COMPLETED|Overall Study||55
7855413|NCT00934375|19335373|P1|COMPLETED|Overall Study||55
7855414|NCT00934375|19335372|P2|STARTED|Overall Study||77
7855415|NCT00934375|19335373|P1|STARTED|Overall Study||68
7855416|NCT00934362|19335381|P2|NOT COMPLETED|Overall Study||0
7855417|NCT00934362|19335382|P1|NOT COMPLETED|Overall Study||1
7855418|NCT00934362|19335381|P2|COMPLETED|Overall Study||8
7855419|NCT00934362|19335382|P1|COMPLETED|Overall Study||7
7855420|NCT00934362|19335381|P2|STARTED|Overall Study||8
7855421|NCT00934362|19335382|P1|STARTED|Overall Study||8
7855422|NCT00934180|19335392|P2|NOT COMPLETED|Second Intervention||0
7855423|NCT00934180|19335393|P1|NOT COMPLETED|Second Intervention||0
7855424|NCT00934180|19335392|P2|COMPLETED|Second Intervention||12
7855425|NCT00934180|19335393|P1|COMPLETED|Second Intervention||12
7855426|NCT00934180|19335392|P2|STARTED|Second Intervention||12
7855427|NCT00934180|19335393|P1|STARTED|Second Intervention||12
7855428|NCT00934180|19335392|P2|NOT COMPLETED|First Intervention||0
7855429|NCT00934180|19335393|P1|NOT COMPLETED|First Intervention||0
7855430|NCT00934180|19335392|P2|COMPLETED|First Intervention||12
7855431|NCT00934180|19335393|P1|COMPLETED|First Intervention||12
7855432|NCT00934180|19335392|P2|STARTED|First Intervention||12
7855433|NCT00934180|19335393|P1|STARTED|First Intervention||12
7855434|NCT00934141|19335405|P4|NOT COMPLETED|Overall Study||3
7855435|NCT00934141|19335406|P3|NOT COMPLETED|Overall Study||0
7855436|NCT00934141|19335407|P2|NOT COMPLETED|Overall Study||3
7855437|NCT00934141|19335408|P1|NOT COMPLETED|Overall Study||4
7855438|NCT00934141|19335405|P4|COMPLETED|Overall Study||51
7855439|NCT00934141|19335406|P3|COMPLETED|Overall Study||48
7855440|NCT00934141|19335407|P2|COMPLETED|Overall Study||47
7855441|NCT00934141|19335408|P1|COMPLETED|Overall Study||45
7855442|NCT00934141|19335405|P4|STARTED|Overall Study||54
7855443|NCT00934141|19335406|P3|STARTED|Overall Study||48
7855444|NCT00934141|19335407|P2|STARTED|Overall Study||50
7855445|NCT00934141|19335408|P1|STARTED|Overall Study||49
7855446|NCT00934128|19335432|P2|NOT COMPLETED|Second Intervention (2 Hours)||3
7855447|NCT00934128|19335433|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
7855448|NCT00934128|19335432|P2|COMPLETED|Second Intervention (2 Hours)||5
7855449|NCT00934128|19335433|P1|COMPLETED|Second Intervention (2 Hours)||3
7855450|NCT00934128|19335432|P2|STARTED|Second Intervention (2 Hours)||8
7855451|NCT00934128|19335433|P1|STARTED|Second Intervention (2 Hours)||3
7855452|NCT00934128|19335432|P2|NOT COMPLETED|Washout Period (1 Hour)||5
7855453|NCT00934128|19335433|P1|NOT COMPLETED|Washout Period (1 Hour)||7
7855454|NCT00934128|19335432|P2|COMPLETED|Washout Period (1 Hour)||8
7855455|NCT00934128|19335433|P1|COMPLETED|Washout Period (1 Hour)||3
7855456|NCT00934128|19335432|P2|STARTED|Washout Period (1 Hour)||13
7855457|NCT00934128|19335433|P1|STARTED|Washout Period (1 Hour)||10
7855458|NCT00934128|19335432|P2|NOT COMPLETED|First Intervention (2 Hours)||2
7855459|NCT00934128|19335433|P1|NOT COMPLETED|First Intervention (2 Hours)||5
7855460|NCT00934128|19335432|P2|COMPLETED|First Intervention (2 Hours)||13
7855461|NCT00934128|19335433|P1|COMPLETED|First Intervention (2 Hours)||10
7855462|NCT00934128|19335432|P2|STARTED|First Intervention (2 Hours)||15
7855463|NCT00934128|19335433|P1|STARTED|First Intervention (2 Hours)||15
7855464|NCT00934102|19335441|P3|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
7855465|NCT00934102|19335442|P2|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
7855466|NCT00934102|19335443|P1|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
7855467|NCT00934102|19335441|P3|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
7855468|NCT00934102|19335442|P2|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
7855469|NCT00934102|19335443|P1|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
7855470|NCT00934102|19335441|P3|STARTED|Period 2, 7 Days/6 Nights of Wear||15
7855471|NCT00934102|19335442|P2|STARTED|Period 2, 7 Days/6 Nights of Wear||15
7855472|NCT00934102|19335443|P1|STARTED|Period 2, 7 Days/6 Nights of Wear||15
7855473|NCT00934102|19335441|P3|NOT COMPLETED|Period 1, One Night of Wear||0
7855474|NCT00934102|19335442|P2|NOT COMPLETED|Period 1, One Night of Wear||0
7855475|NCT00934102|19335443|P1|NOT COMPLETED|Period 1, One Night of Wear||1
7855476|NCT00934102|19335441|P3|COMPLETED|Period 1, One Night of Wear||15
7855477|NCT00934102|19335442|P2|COMPLETED|Period 1, One Night of Wear||15
7855478|NCT00934102|19335443|P1|COMPLETED|Period 1, One Night of Wear||15
7855479|NCT00934102|19335441|P3|STARTED|Period 1, One Night of Wear||15
7855480|NCT00934102|19335442|P2|STARTED|Period 1, One Night of Wear||15
7855481|NCT00934102|19335443|P1|STARTED|Period 1, One Night of Wear||16
7855482|NCT00934050|19335457|P6|NOT COMPLETED|Enrolled After 15 Dec 2009||4
7855483|NCT00934050|19335458|P5|NOT COMPLETED|Enrolled After 15 Dec 2009||7
7855484|NCT00934050|19335459|P4|NOT COMPLETED|Enrolled After 15 Dec 2009||0
7855485|NCT00934050|19335460|P3|NOT COMPLETED|Enrolled After 15 Dec 2009||0
7855486|NCT00934050|19335461|P2|NOT COMPLETED|Enrolled After 15 Dec 2009||0
7855487|NCT00934050|19335462|P1|NOT COMPLETED|Enrolled After 15 Dec 2009||0
7855488|NCT00934050|19335457|P6|COMPLETED|Enrolled After 15 Dec 2009||23
7855489|NCT00934050|19335458|P5|COMPLETED|Enrolled After 15 Dec 2009||19
7855490|NCT00934050|19335459|P4|COMPLETED|Enrolled After 15 Dec 2009||0
7855491|NCT00934050|19335460|P3|COMPLETED|Enrolled After 15 Dec 2009||0
7855492|NCT00934050|19335461|P2|COMPLETED|Enrolled After 15 Dec 2009||0
7855493|NCT00934050|19335462|P1|COMPLETED|Enrolled After 15 Dec 2009||0
7855494|NCT00934050|19335457|P6|STARTED|Enrolled After 15 Dec 2009||27
7855495|NCT00934050|19335458|P5|STARTED|Enrolled After 15 Dec 2009||26
7855496|NCT00934050|19335459|P4|STARTED|Enrolled After 15 Dec 2009||0
7855497|NCT00934050|19335460|P3|STARTED|Enrolled After 15 Dec 2009||0
7855498|NCT00934050|19335461|P2|STARTED|Enrolled After 15 Dec 2009||0
7855499|NCT00934050|19335462|P1|STARTED|Enrolled After 15 Dec 2009||0
7855500|NCT00934050|19335457|P6|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
7855501|NCT00934050|19335458|P5|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
7855502|NCT00934050|19335459|P4|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14
7855503|NCT00934050|19335460|P3|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
7855504|NCT00934050|19335461|P2|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
7855505|NCT00934050|19335462|P1|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
7855506|NCT00934050|19335457|P6|COMPLETED|Enrolled Prior to 15 Dec 2009||0
7855507|NCT00934050|19335458|P5|COMPLETED|Enrolled Prior to 15 Dec 2009||0
7855508|NCT00934050|19335459|P4|COMPLETED|Enrolled Prior to 15 Dec 2009||0
7855509|NCT00934050|19335460|P3|COMPLETED|Enrolled Prior to 15 Dec 2009||0
7855510|NCT00934050|19335461|P2|COMPLETED|Enrolled Prior to 15 Dec 2009||0
7855511|NCT00934050|19335462|P1|COMPLETED|Enrolled Prior to 15 Dec 2009||0
7855512|NCT00934050|19335457|P6|STARTED|Enrolled Prior to 15 Dec 2009||0
7855513|NCT00934050|19335458|P5|STARTED|Enrolled Prior to 15 Dec 2009||0
7855514|NCT00934050|19335459|P4|STARTED|Enrolled Prior to 15 Dec 2009||14
7855515|NCT00934050|19335460|P3|STARTED|Enrolled Prior to 15 Dec 2009||12
7855516|NCT00934050|19335461|P2|STARTED|Enrolled Prior to 15 Dec 2009||12
7855517|NCT00934050|19335462|P1|STARTED|Enrolled Prior to 15 Dec 2009||12
7855518|NCT00934024|19335474|P2|NOT COMPLETED|Overall Study||5
7855519|NCT00934024|19335475|P1|NOT COMPLETED|Overall Study||0
7855520|NCT00934024|19335474|P2|COMPLETED|Overall Study||6
7855521|NCT00934024|19335475|P1|COMPLETED|Overall Study||10
7855522|NCT00934024|19335474|P2|STARTED|Overall Study||11
7855523|NCT00934024|19335475|P1|STARTED|Overall Study||10
7855524|NCT00933933|19335485|P3|NOT COMPLETED|Pediatric From 2 to 21 Years||0
7855525|NCT00933933|19335486|P2|NOT COMPLETED|Pediatric From 2 to 21 Years||0
7855526|NCT00933933|19335487|P1|NOT COMPLETED|Pediatric From 2 to 21 Years||0
7855527|NCT00933933|19335485|P3|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0
7855528|NCT00933933|19335486|P2|COMPLETED|Pediatric From 2 to 21 Years||64
7855529|NCT00933933|19335487|P1|COMPLETED|Pediatric From 2 to 21 Years||588
7855530|NCT00933933|19335485|P3|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0
7855531|NCT00933933|19335486|P2|STARTED|Pediatric From 2 to 21 Years||64
7855532|NCT00933933|19335487|P1|STARTED|Pediatric From 2 to 21 Years||588
7855533|NCT00933933|19335485|P3|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
7855534|NCT00933933|19335486|P2|NOT COMPLETED|Pregnant Females Between 16-44 Years||2
7855535|NCT00933933|19335487|P1|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
7855536|NCT00933933|19335485|P3|COMPLETED|Pregnant Females Between 16-44 Years||203
7855537|NCT00933933|19335486|P2|COMPLETED|Pregnant Females Between 16-44 Years||65
7855538|NCT00933933|19335487|P1|COMPLETED|Pregnant Females Between 16-44 Years||448
7855539|NCT00933933|19335485|P3|STARTED|Pregnant Females Between 16-44 Years||203
7855540|NCT00933933|19335486|P2|STARTED|Pregnant Females Between 16-44 Years||67
7855541|NCT00933933|19335487|P1|STARTED|Pregnant Females Between 16-44 Years||448
7855542|NCT00933933|19335485|P3|NOT COMPLETED|General Population From 16 to 89 Years||0
7855543|NCT00933933|19335486|P2|NOT COMPLETED|General Population From 16 to 89 Years||20
7855544|NCT00933933|19335487|P1|NOT COMPLETED|General Population From 16 to 89 Years||0
7855545|NCT00933933|19335485|P3|COMPLETED|General Population From 16 to 89 Years||1206
7855546|NCT00933933|19335486|P2|COMPLETED|General Population From 16 to 89 Years||1267
7855547|NCT00933933|19335487|P1|COMPLETED|General Population From 16 to 89 Years||6164
7855548|NCT00933933|19335485|P3|STARTED|General Population From 16 to 89 Years||1206
7855549|NCT00933933|19335486|P2|STARTED|General Population From 16 to 89 Years||1287
7855550|NCT00933933|19335487|P1|STARTED|General Population From 16 to 89 Years||6164
7855551|NCT00933686|19335505|P2|NOT COMPLETED|Overall Study||11
7855552|NCT00933686|19335506|P1|NOT COMPLETED|Overall Study||10
7855553|NCT00933686|19335505|P2|COMPLETED|Overall Study||47
7855554|NCT00933686|19335506|P1|COMPLETED|Overall Study||45
7855555|NCT00933686|19335505|P2|STARTED|Overall Study||58
7855556|NCT00933686|19335506|P1|STARTED|Overall Study||55
7855557|NCT00933608|19335526|P2|NOT COMPLETED|Overall Study||2
7855558|NCT00933608|19335527|P1|NOT COMPLETED|Overall Study||5
7855559|NCT00933608|19335526|P2|COMPLETED|Overall Study||8
7855560|NCT00933608|19335527|P1|COMPLETED|Overall Study||2
7855561|NCT00933608|19335526|P2|STARTED|Overall Study||10
7855562|NCT00933608|19335527|P1|STARTED|Overall Study||7
7855563|NCT00933543|19335535|P2|NOT COMPLETED|Overall Study||7
7855564|NCT00933543|19335536|P1|NOT COMPLETED|Overall Study||3
7855565|NCT00933543|19335535|P2|COMPLETED|Overall Study||46
7855566|NCT00933543|19335536|P1|COMPLETED|Overall Study||51
7855567|NCT00933543|19335535|P2|STARTED|Overall Study||53
7855568|NCT00933543|19335536|P1|STARTED|Overall Study||54
7855569|NCT00933491|19335594|P2|NOT COMPLETED|Overall Study||0
7855570|NCT00933491|19335595|P1|NOT COMPLETED|Overall Study||0
7855571|NCT00933491|19335594|P2|COMPLETED|Overall Study||18
7855572|NCT00933491|19335595|P1|COMPLETED|Overall Study||14
7855573|NCT00933491|19335594|P2|STARTED|Overall Study||18
7855574|NCT00933491|19335595|P1|STARTED|Overall Study||14
7855575|NCT00933335|19335605|P2|NOT COMPLETED|Overall Study||16
7855576|NCT00933335|19335606|P1|NOT COMPLETED|Overall Study||2
7855577|NCT00933335|19335605|P2|COMPLETED|Overall Study||20
7855578|NCT00933335|19335606|P1|COMPLETED|Overall Study||0
7855579|NCT00933335|19335605|P2|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36
7855580|NCT00933335|19335606|P1|STARTED|Overall Study||2
7855581|NCT00933270|19335676|P1|NOT COMPLETED|Overall Study||87
7855582|NCT00933270|19335676|P1|COMPLETED|Overall Study||177
7855583|NCT00933270|19335676|P1|STARTED|Overall Study|ITT population|264
7855584|NCT00933244|19335770|P3|NOT COMPLETED|Overall Study||3
7855585|NCT00933244|19335771|P2|NOT COMPLETED|Overall Study||1
7855586|NCT00933244|19335772|P1|NOT COMPLETED|Overall Study||5
7855587|NCT00933244|19335770|P3|COMPLETED|Overall Study||73
7855588|NCT00933244|19335771|P2|COMPLETED|Overall Study||74
7855589|NCT00933244|19335772|P1|COMPLETED|Overall Study||74
7855590|NCT00933244|19335770|P3|STARTED|Overall Study||76
7855591|NCT00933244|19335771|P2|STARTED|Overall Study||75
7855592|NCT00933244|19335772|P1|STARTED|Overall Study||79
7855593|NCT00933166|19335789|P1|NOT COMPLETED|Overall Study||18
7855594|NCT00933166|19335789|P1|COMPLETED|Overall Study||151
7855595|NCT00933166|19335789|P1|STARTED|Overall Study||169
7855596|NCT00932893|19335795|P2|NOT COMPLETED|Overall Study||170
7855597|NCT00932893|19335796|P1|NOT COMPLETED|Overall Study||133
7855598|NCT00932893|19335795|P2|COMPLETED|Overall Study||4
7855599|NCT00932893|19335796|P1|COMPLETED|Overall Study||40
7855600|NCT00932893|19335795|P2|Treated|Overall Study||171
7855601|NCT00932893|19335796|P1|Treated|Overall Study||172
7855602|NCT00932893|19335795|P2|STARTED|Overall Study||174
7855603|NCT00932893|19335796|P1|STARTED|Overall Study||173
7855604|NCT00932828|19335827|P1|NOT COMPLETED|Overall Study||5
7855605|NCT00932828|19335827|P1|COMPLETED|Overall Study|5 subjects who did not complete the protocol were considered in an ITT analysis.|32
7855606|NCT00932828|19335827|P1|STARTED|Overall Study||37
7855607|NCT00932698|19335844|P11|NOT COMPLETED|Part 2 (Dose Expansion)||2
7855608|NCT00932698|19335845|P10|NOT COMPLETED|Part 2 (Dose Expansion)||6
7855609|NCT00932698|19335846|P9|NOT COMPLETED|Part 2 (Dose Expansion)||12
7855610|NCT00932698|19335847|P8|NOT COMPLETED|Part 2 (Dose Expansion)||20
7855611|NCT00932698|19335848|P7|NOT COMPLETED|Part 2 (Dose Expansion)||0
7855612|NCT00932698|19335849|P6|NOT COMPLETED|Part 2 (Dose Expansion)||0
7855613|NCT00932698|19335850|P5|NOT COMPLETED|Part 2 (Dose Expansion)||0
7855614|NCT00932698|19335851|P4|NOT COMPLETED|Part 2 (Dose Expansion)||0
7855615|NCT00932698|19335852|P3|NOT COMPLETED|Part 2 (Dose Expansion)||0
7855616|NCT00932698|19335853|P2|NOT COMPLETED|Part 2 (Dose Expansion)||0
7855617|NCT00932698|19335854|P1|NOT COMPLETED|Part 2 (Dose Expansion)||0
7855618|NCT00932698|19335844|P11|COMPLETED|Part 2 (Dose Expansion)||0
7855619|NCT00932698|19335845|P10|COMPLETED|Part 2 (Dose Expansion)||0
7855620|NCT00932698|19335846|P9|COMPLETED|Part 2 (Dose Expansion)||0
7855621|NCT00932698|19335847|P8|COMPLETED|Part 2 (Dose Expansion)||0
7855622|NCT00932698|19335848|P7|COMPLETED|Part 2 (Dose Expansion)||0
7855623|NCT00932698|19335849|P6|COMPLETED|Part 2 (Dose Expansion)||0
7855624|NCT00932698|19335850|P5|COMPLETED|Part 2 (Dose Expansion)||0
7855625|NCT00932698|19335851|P4|COMPLETED|Part 2 (Dose Expansion)||0
7855626|NCT00932698|19335852|P3|COMPLETED|Part 2 (Dose Expansion)||0
7855627|NCT00932698|19335853|P2|COMPLETED|Part 2 (Dose Expansion)||0
7855628|NCT00932698|19335854|P1|COMPLETED|Part 2 (Dose Expansion)||0
7855629|NCT00932698|19335844|P11|STARTED|Part 2 (Dose Expansion)||2
7855630|NCT00932698|19335845|P10|STARTED|Part 2 (Dose Expansion)||6
7855631|NCT00932698|19335846|P9|STARTED|Part 2 (Dose Expansion)||12
7855632|NCT00932698|19335847|P8|STARTED|Part 2 (Dose Expansion)||20
7855633|NCT00932698|19335848|P7|STARTED|Part 2 (Dose Expansion)||0
7855634|NCT00932698|19335849|P6|STARTED|Part 2 (Dose Expansion)||0
7855635|NCT00932698|19335850|P5|STARTED|Part 2 (Dose Expansion)||0
7855636|NCT00932698|19335851|P4|STARTED|Part 2 (Dose Expansion)||0
7855637|NCT00932698|19335852|P3|STARTED|Part 2 (Dose Expansion)||0
7855638|NCT00932698|19335853|P2|STARTED|Part 2 (Dose Expansion)||0
7855639|NCT00932698|19335854|P1|STARTED|Part 2 (Dose Expansion)||0
7855640|NCT00932698|19335844|P11|NOT COMPLETED|Part 1 (Dose Escalation)||0
7855641|NCT00932698|19335845|P10|NOT COMPLETED|Part 1 (Dose Escalation)||0
7855642|NCT00932698|19335846|P9|NOT COMPLETED|Part 1 (Dose Escalation)||0
7855643|NCT00932698|19335847|P8|NOT COMPLETED|Part 1 (Dose Escalation)||0
7855644|NCT00932698|19335848|P7|NOT COMPLETED|Part 1 (Dose Escalation)||4
7855645|NCT00932698|19335849|P6|NOT COMPLETED|Part 1 (Dose Escalation)||7
7855646|NCT00932698|19335850|P5|NOT COMPLETED|Part 1 (Dose Escalation)||3
7855647|NCT00932698|19335851|P4|NOT COMPLETED|Part 1 (Dose Escalation)||3
7855648|NCT00932698|19335852|P3|NOT COMPLETED|Part 1 (Dose Escalation)||3
7855649|NCT00932698|19335853|P2|NOT COMPLETED|Part 1 (Dose Escalation)||3
7855650|NCT00932698|19335854|P1|NOT COMPLETED|Part 1 (Dose Escalation)||3
7855651|NCT00932698|19335844|P11|COMPLETED|Part 1 (Dose Escalation)||0
7855652|NCT00932698|19335845|P10|COMPLETED|Part 1 (Dose Escalation)||0
7855653|NCT00932698|19335846|P9|COMPLETED|Part 1 (Dose Escalation)||0
7855654|NCT00932698|19335847|P8|COMPLETED|Part 1 (Dose Escalation)||0
7855655|NCT00932698|19335848|P7|COMPLETED|Part 1 (Dose Escalation)||0
7855656|NCT00932698|19335849|P6|COMPLETED|Part 1 (Dose Escalation)|6 participants from 2.0 mg/m^2 dose cohort transitioned to dose expansion cohort: 5 in RR, 1 in VR.|0
7855657|NCT00932698|19335850|P5|COMPLETED|Part 1 (Dose Escalation)||0
7855658|NCT00932698|19335851|P4|COMPLETED|Part 1 (Dose Escalation)||0
7855659|NCT00932698|19335852|P3|COMPLETED|Part 1 (Dose Escalation)||0
7855660|NCT00932698|19335853|P2|COMPLETED|Part 1 (Dose Escalation)||0
7855661|NCT00932698|19335854|P1|COMPLETED|Part 1 (Dose Escalation)||0
7855662|NCT00932698|19335844|P11|STARTED|Part 1 (Dose Escalation)||0
7855663|NCT00932698|19335845|P10|STARTED|Part 1 (Dose Escalation)||0
7855664|NCT00932698|19335846|P9|STARTED|Part 1 (Dose Escalation)||0
7855665|NCT00932698|19335847|P8|STARTED|Part 1 (Dose Escalation)||0
7855666|NCT00932698|19335848|P7|STARTED|Part 1 (Dose Escalation)||4
7855667|NCT00932698|19335849|P6|STARTED|Part 1 (Dose Escalation)||7
7855668|NCT00932698|19335850|P5|STARTED|Part 1 (Dose Escalation)||3
7855669|NCT00932698|19335851|P4|STARTED|Part 1 (Dose Escalation)||3
7855670|NCT00932698|19335852|P3|STARTED|Part 1 (Dose Escalation)||3
7855671|NCT00932698|19335853|P2|STARTED|Part 1 (Dose Escalation)||3
7855672|NCT00932698|19335854|P1|STARTED|Part 1 (Dose Escalation)||3
7855673|NCT00932659|19336023|P1|NOT COMPLETED|Overall Study||0
7855674|NCT00932659|19336023|P1|COMPLETED|Overall Study||8
7855675|NCT00932659|19336023|P1|STARTED|Overall Study||8
7855676|NCT00932646|19336028|P4|NOT COMPLETED|Overall Study||1
7855677|NCT00932646|19336029|P3|NOT COMPLETED|Overall Study||4
7855678|NCT00932646|19336030|P2|NOT COMPLETED|Overall Study||3
7855679|NCT00932646|19336031|P1|NOT COMPLETED|Overall Study||5
7855680|NCT00932646|19336028|P4|COMPLETED|Overall Study||24
7855681|NCT00932646|19336029|P3|COMPLETED|Overall Study||21
7855682|NCT00932646|19336030|P2|COMPLETED|Overall Study||22
7855683|NCT00932646|19336031|P1|COMPLETED|Overall Study||20
7855684|NCT00932646|19336028|P4|STARTED|Overall Study||25
7855685|NCT00932646|19336029|P3|STARTED|Overall Study||25
7855686|NCT00932646|19336030|P2|STARTED|Overall Study||25
7855687|NCT00932646|19336031|P1|STARTED|Overall Study||25
7855688|NCT00932620|19336087|P2|NOT COMPLETED|Overall Study||0
7855689|NCT00932620|19336088|P1|NOT COMPLETED|Overall Study||0
7855690|NCT00932620|19336087|P2|COMPLETED|Overall Study||50
7855691|NCT00932620|19336088|P1|COMPLETED|Overall Study||50
7855692|NCT00932620|19336087|P2|STARTED|Overall Study||50
7855693|NCT00932620|19336088|P1|STARTED|Overall Study||50
7855694|NCT00932477|19336096|P6|NOT COMPLETED|Treatment 3||0
7855695|NCT00932477|19336097|P5|NOT COMPLETED|Treatment 3||0
7855696|NCT00932477|19336098|P4|NOT COMPLETED|Treatment 3||0
7855697|NCT00932477|19336099|P3|NOT COMPLETED|Treatment 3||0
7855698|NCT00932477|19336100|P2|NOT COMPLETED|Treatment 3||0
7855699|NCT00932477|19336101|P1|NOT COMPLETED|Treatment 3||0
7855700|NCT00932477|19336096|P6|COMPLETED|Treatment 3||8
7855701|NCT00932477|19336097|P5|COMPLETED|Treatment 3||8
7855702|NCT00932477|19336098|P4|COMPLETED|Treatment 3||7
7855703|NCT00932477|19336099|P3|COMPLETED|Treatment 3||9
7855704|NCT00932477|19336100|P2|COMPLETED|Treatment 3||8
7855705|NCT00932477|19336101|P1|COMPLETED|Treatment 3||7
7855706|NCT00932477|19336096|P6|STARTED|Treatment 3||8
7855707|NCT00932477|19336097|P5|STARTED|Treatment 3||8
7855708|NCT00932477|19336098|P4|STARTED|Treatment 3||7
7855709|NCT00932477|19336099|P3|STARTED|Treatment 3||9
7855710|NCT00932477|19336100|P2|STARTED|Treatment 3||8
7855711|NCT00932477|19336101|P1|STARTED|Treatment 3||7
7855712|NCT00932477|19336096|P6|NOT COMPLETED|Treatment 2||0
7855713|NCT00932477|19336097|P5|NOT COMPLETED|Treatment 2||0
7855714|NCT00932477|19336098|P4|NOT COMPLETED|Treatment 2||0
7855715|NCT00932477|19336099|P3|NOT COMPLETED|Treatment 2||0
7855716|NCT00932477|19336100|P2|NOT COMPLETED|Treatment 2||0
7855717|NCT00932477|19336101|P1|NOT COMPLETED|Treatment 2||0
7855718|NCT00932477|19336096|P6|COMPLETED|Treatment 2||8
7855719|NCT00932477|19336097|P5|COMPLETED|Treatment 2||8
7855720|NCT00932477|19336098|P4|COMPLETED|Treatment 2||7
7855721|NCT00932477|19336099|P3|COMPLETED|Treatment 2||9
7855722|NCT00932477|19336100|P2|COMPLETED|Treatment 2||8
7855723|NCT00932477|19336101|P1|COMPLETED|Treatment 2||7
7855724|NCT00932477|19336096|P6|STARTED|Treatment 2||8
7855725|NCT00932477|19336097|P5|STARTED|Treatment 2||8
7855726|NCT00932477|19336098|P4|STARTED|Treatment 2||7
7855727|NCT00932477|19336099|P3|STARTED|Treatment 2||9
7855728|NCT00932477|19336100|P2|STARTED|Treatment 2||8
7855729|NCT00932477|19336101|P1|STARTED|Treatment 2||7
7855730|NCT00932477|19336096|P6|NOT COMPLETED|Treatment 1||0
7855731|NCT00932477|19336097|P5|NOT COMPLETED|Treatment 1||0
7855732|NCT00932477|19336098|P4|NOT COMPLETED|Treatment 1||0
7855733|NCT00932477|19336099|P3|NOT COMPLETED|Treatment 1||0
7855734|NCT00932477|19336100|P2|NOT COMPLETED|Treatment 1||0
7855735|NCT00932477|19336101|P1|NOT COMPLETED|Treatment 1||0
7855736|NCT00932477|19336096|P6|COMPLETED|Treatment 1||8
7855737|NCT00932477|19336097|P5|COMPLETED|Treatment 1||8
7855738|NCT00932477|19336098|P4|COMPLETED|Treatment 1||7
7855739|NCT00932477|19336099|P3|COMPLETED|Treatment 1||9
7855740|NCT00932477|19336100|P2|COMPLETED|Treatment 1||8
7855741|NCT00932477|19336101|P1|COMPLETED|Treatment 1||7
7855742|NCT00932477|19336096|P6|STARTED|Treatment 1||8
7855743|NCT00932477|19336097|P5|STARTED|Treatment 1||8
7855744|NCT00932477|19336098|P4|STARTED|Treatment 1||7
7855745|NCT00932477|19336099|P3|STARTED|Treatment 1||9
7855746|NCT00932477|19336100|P2|STARTED|Treatment 1||8
7855747|NCT00932477|19336101|P1|STARTED|Treatment 1||7
7855748|NCT00932451|19336118|P1|NOT COMPLETED|Overall Study||822
7855749|NCT00932451|19336118|P1|COMPLETED|Overall Study||244
7855750|NCT00932451|19336118|P1|STARTED|Overall Study||1066
7855751|NCT00932425|19336142|P2|NOT COMPLETED|Overall Study||2
7855752|NCT00932425|19336143|P1|NOT COMPLETED|Overall Study||0
7855753|NCT00932425|19336142|P2|COMPLETED|Overall Study||18
7855754|NCT00932425|19336143|P1|COMPLETED|Overall Study||20
7855755|NCT00932425|19336142|P2|STARTED|Overall Study||20
7855756|NCT00932425|19336143|P1|STARTED|Overall Study||20
7855757|NCT00932399|19336158|P2|NOT COMPLETED|Overall Study||0
7855758|NCT00932399|19336159|P1|NOT COMPLETED|Overall Study||0
7855759|NCT00932399|19336158|P2|COMPLETED|Overall Study||3790
7855760|NCT00932399|19336159|P1|COMPLETED|Overall Study||759
7855761|NCT00932399|19336158|P2|STARTED|Overall Study||3790
7855762|NCT00932399|19336159|P1|STARTED|Overall Study||759
7855763|NCT00932373|19336176|P11|NOT COMPLETED|Overall Study||3
7855764|NCT00932373|19336177|P10|NOT COMPLETED|Overall Study||13
7855765|NCT00932373|19336178|P9|NOT COMPLETED|Overall Study||2
7855766|NCT00932373|19336179|P8|NOT COMPLETED|Overall Study||3
7855767|NCT00932373|19336180|P7|NOT COMPLETED|Overall Study||1
7855768|NCT00932373|19336181|P6|NOT COMPLETED|Overall Study||3
7855769|NCT00932373|19336182|P5|NOT COMPLETED|Overall Study||14
7855770|NCT00932373|19336183|P4|NOT COMPLETED|Overall Study||0
7855771|NCT00932373|19336184|P3|NOT COMPLETED|Overall Study||1
7855772|NCT00932373|19336185|P2|NOT COMPLETED|Overall Study||1
7855773|NCT00932373|19336186|P1|NOT COMPLETED|Overall Study||3
7855774|NCT00932373|19336176|P11|COMPLETED|Overall Study||0
7855775|NCT00932373|19336177|P10|COMPLETED|Overall Study||3
7855776|NCT00932373|19336178|P9|COMPLETED|Overall Study||1
7855777|NCT00932373|19336179|P8|COMPLETED|Overall Study||0
7855778|NCT00932373|19336180|P7|COMPLETED|Overall Study||2
7855779|NCT00932373|19336181|P6|COMPLETED|Overall Study||0
7855780|NCT00932373|19336182|P5|COMPLETED|Overall Study||1
7855781|NCT00932373|19336183|P4|COMPLETED|Overall Study||1
7855782|NCT00932373|19336184|P3|COMPLETED|Overall Study||0
7855783|NCT00932373|19336185|P2|COMPLETED|Overall Study||0
7855784|NCT00932373|19336186|P1|COMPLETED|Overall Study||0
7855785|NCT00932373|19336176|P11|STARTED|Overall Study||3
7855786|NCT00932373|19336177|P10|STARTED|Overall Study||16
7855787|NCT00932373|19336178|P9|STARTED|Overall Study||3
7855788|NCT00932373|19336179|P8|STARTED|Overall Study||3
7855789|NCT00932373|19336180|P7|STARTED|Overall Study||3
7855790|NCT00932373|19336181|P6|STARTED|Overall Study||3
7855791|NCT00932373|19336182|P5|STARTED|Overall Study||15
7855792|NCT00932373|19336183|P4|STARTED|Overall Study||1
7855793|NCT00932373|19336184|P3|STARTED|Overall Study||1
7855794|NCT00932373|19336185|P2|STARTED|Overall Study||1
7855795|NCT00932373|19336186|P1|STARTED|Overall Study||3
7855796|NCT00932360|19336286|P6|NOT COMPLETED|Visit 3/Week 3||0
7855797|NCT00932360|19336287|P5|NOT COMPLETED|Visit 3/Week 3||0
7855798|NCT00932360|19336288|P4|NOT COMPLETED|Visit 3/Week 3||0
7855799|NCT00932360|19336289|P3|NOT COMPLETED|Visit 3/Week 3||0
7855800|NCT00932360|19336290|P2|NOT COMPLETED|Visit 3/Week 3||0
7855801|NCT00932360|19336291|P1|NOT COMPLETED|Visit 3/Week 3||0
7855802|NCT00932360|19336286|P6|COMPLETED|Visit 3/Week 3||7
7855803|NCT00932360|19336287|P5|COMPLETED|Visit 3/Week 3||2
7855804|NCT00932360|19336288|P4|COMPLETED|Visit 3/Week 3||13
7855805|NCT00932360|19336289|P3|COMPLETED|Visit 3/Week 3||3
7855806|NCT00932360|19336290|P2|COMPLETED|Visit 3/Week 3||6
7855807|NCT00932360|19336291|P1|COMPLETED|Visit 3/Week 3||10
7855808|NCT00932360|19336286|P6|STARTED|Visit 3/Week 3||7
7855809|NCT00932360|19336287|P5|STARTED|Visit 3/Week 3||2
7855810|NCT00932360|19336288|P4|STARTED|Visit 3/Week 3||13
7855811|NCT00932360|19336289|P3|STARTED|Visit 3/Week 3||3
7855812|NCT00932360|19336290|P2|STARTED|Visit 3/Week 3||6
7855813|NCT00932360|19336291|P1|STARTED|Visit 3/Week 3||10
7855814|NCT00932360|19336286|P6|NOT COMPLETED|Washout (One Week)||0
7855815|NCT00932360|19336287|P5|NOT COMPLETED|Washout (One Week)||0
7855816|NCT00932360|19336288|P4|NOT COMPLETED|Washout (One Week)||0
7855817|NCT00932360|19336289|P3|NOT COMPLETED|Washout (One Week)||0
7855818|NCT00932360|19336290|P2|NOT COMPLETED|Washout (One Week)||0
7855819|NCT00932360|19336291|P1|NOT COMPLETED|Washout (One Week)||0
7855820|NCT00932360|19336286|P6|COMPLETED|Washout (One Week)||7
7855821|NCT00932360|19336287|P5|COMPLETED|Washout (One Week)||2
7855822|NCT00932360|19336288|P4|COMPLETED|Washout (One Week)||13
7855823|NCT00932360|19336289|P3|COMPLETED|Washout (One Week)||3
7855824|NCT00932360|19336290|P2|COMPLETED|Washout (One Week)||6
7855825|NCT00932360|19336291|P1|COMPLETED|Washout (One Week)||10
7855826|NCT00932360|19336286|P6|STARTED|Washout (One Week)||7
7855827|NCT00932360|19336287|P5|STARTED|Washout (One Week)||2
7855828|NCT00932360|19336288|P4|STARTED|Washout (One Week)||13
7855829|NCT00932360|19336289|P3|STARTED|Washout (One Week)||3
7855830|NCT00932360|19336290|P2|STARTED|Washout (One Week)||6
7855831|NCT00932360|19336291|P1|STARTED|Washout (One Week)||10
7855832|NCT00932360|19336286|P6|NOT COMPLETED|Visit 2/Week 2||0
7855833|NCT00932360|19336287|P5|NOT COMPLETED|Visit 2/Week 2||0
7855834|NCT00932360|19336288|P4|NOT COMPLETED|Visit 2/Week 2||0
7855835|NCT00932360|19336289|P3|NOT COMPLETED|Visit 2/Week 2||0
7855836|NCT00932360|19336290|P2|NOT COMPLETED|Visit 2/Week 2||0
7855837|NCT00932360|19336291|P1|NOT COMPLETED|Visit 2/Week 2||0
7855838|NCT00932360|19336286|P6|COMPLETED|Visit 2/Week 2||7
7855839|NCT00932360|19336287|P5|COMPLETED|Visit 2/Week 2||2
7855840|NCT00932360|19336288|P4|COMPLETED|Visit 2/Week 2||13
7855841|NCT00932360|19336289|P3|COMPLETED|Visit 2/Week 2||3
7855842|NCT00932360|19336290|P2|COMPLETED|Visit 2/Week 2||6
7855843|NCT00932360|19336291|P1|COMPLETED|Visit 2/Week 2||10
7855844|NCT00932360|19336286|P6|STARTED|Visit 2/Week 2||7
7855845|NCT00932360|19336287|P5|STARTED|Visit 2/Week 2||2
7855846|NCT00932360|19336288|P4|STARTED|Visit 2/Week 2||13
7855847|NCT00932360|19336289|P3|STARTED|Visit 2/Week 2||3
7855848|NCT00932360|19336290|P2|STARTED|Visit 2/Week 2||6
7855849|NCT00932360|19336291|P1|STARTED|Visit 2/Week 2||10
7855850|NCT00932360|19336286|P6|NOT COMPLETED|Washout (One Week)||0
7855851|NCT00932360|19336287|P5|NOT COMPLETED|Washout (One Week)||2
7855852|NCT00932360|19336288|P4|NOT COMPLETED|Washout (One Week)||0
7855853|NCT00932360|19336289|P3|NOT COMPLETED|Washout (One Week)||0
7855854|NCT00932360|19336290|P2|NOT COMPLETED|Washout (One Week)||0
7855855|NCT00932360|19336291|P1|NOT COMPLETED|Washout (One Week)||0
7855856|NCT00932360|19336286|P6|COMPLETED|Washout (One Week)||7
7855857|NCT00932360|19336287|P5|COMPLETED|Washout (One Week)||2
7855858|NCT00932360|19336288|P4|COMPLETED|Washout (One Week)||13
7855859|NCT00932360|19336289|P3|COMPLETED|Washout (One Week)||3
7855860|NCT00932360|19336290|P2|COMPLETED|Washout (One Week)||6
7855861|NCT00932360|19336291|P1|COMPLETED|Washout (One Week)||10
7855862|NCT00932360|19336286|P6|STARTED|Washout (One Week)||7
7855863|NCT00932360|19336287|P5|STARTED|Washout (One Week)||4
7855864|NCT00932360|19336288|P4|STARTED|Washout (One Week)||13
7855865|NCT00932360|19336289|P3|STARTED|Washout (One Week)||3
7855866|NCT00932360|19336290|P2|STARTED|Washout (One Week)||6
7855867|NCT00932360|19336291|P1|STARTED|Washout (One Week)||10
7855868|NCT00932360|19336286|P6|NOT COMPLETED|1: Visit 1/Week1||0
7855869|NCT00932360|19336287|P5|NOT COMPLETED|1: Visit 1/Week1||0
7855870|NCT00932360|19336288|P4|NOT COMPLETED|1: Visit 1/Week1||0
7855871|NCT00932360|19336289|P3|NOT COMPLETED|1: Visit 1/Week1||0
7855872|NCT00932360|19336290|P2|NOT COMPLETED|1: Visit 1/Week1||0
7855873|NCT00932360|19336291|P1|NOT COMPLETED|1: Visit 1/Week1||0
7855874|NCT00932360|19336286|P6|COMPLETED|1: Visit 1/Week1||7
7855875|NCT00932360|19336287|P5|COMPLETED|1: Visit 1/Week1||4
7855876|NCT00932360|19336288|P4|COMPLETED|1: Visit 1/Week1||13
7855877|NCT00932360|19336289|P3|COMPLETED|1: Visit 1/Week1||3
7855878|NCT00932360|19336290|P2|COMPLETED|1: Visit 1/Week1||6
7855879|NCT00932360|19336291|P1|COMPLETED|1: Visit 1/Week1||10
7855880|NCT00932360|19336286|P6|STARTED|1: Visit 1/Week1||7
7855881|NCT00932360|19336287|P5|STARTED|1: Visit 1/Week1||4
7855882|NCT00932360|19336288|P4|STARTED|1: Visit 1/Week1||13
7855883|NCT00932360|19336289|P3|STARTED|1: Visit 1/Week1||3
7855884|NCT00932360|19336290|P2|STARTED|1: Visit 1/Week1||6
7855885|NCT00932360|19336291|P1|STARTED|1: Visit 1/Week1||10
7855886|NCT00932321|19336322|P2|NOT COMPLETED|Overall Study||46
7855887|NCT00932321|19336323|P1|NOT COMPLETED|Overall Study||171
7855888|NCT00932321|19336322|P2|COMPLETED|Overall Study||141
7855889|NCT00932321|19336323|P1|COMPLETED|Overall Study||580
7855890|NCT00932321|19336322|P2|MITT Population|Overall Study||181
7855891|NCT00932321|19336323|P1|MITT Population|Overall Study||705
7855892|NCT00932321|19336322|P2|STARTED|Overall Study||187
7855893|NCT00932321|19336323|P1|STARTED|Overall Study||751
7855894|NCT00932282|19336333|P2|NOT COMPLETED|OIT Maintenance Phase||2
7855895|NCT00932282|19336334|P1|NOT COMPLETED|OIT Maintenance Phase||1
7855896|NCT00932282|19336333|P2|COMPLETED|OIT Maintenance Phase||2
7855897|NCT00932282|19336334|P1|COMPLETED|OIT Maintenance Phase||4
7855898|NCT00932282|19336333|P2|STARTED|OIT Maintenance Phase||4
7855899|NCT00932282|19336334|P1|STARTED|OIT Maintenance Phase||5
7855900|NCT00932282|19336333|P2|NOT COMPLETED|Biweekly OIT Buildup Phase||1
7855901|NCT00932282|19336334|P1|NOT COMPLETED|Biweekly OIT Buildup Phase||1
7855902|NCT00932282|19336333|P2|COMPLETED|Biweekly OIT Buildup Phase||4
7855903|NCT00932282|19336334|P1|COMPLETED|Biweekly OIT Buildup Phase||5
7855904|NCT00932282|19336333|P2|STARTED|Biweekly OIT Buildup Phase||5
7855905|NCT00932282|19336334|P1|STARTED|Biweekly OIT Buildup Phase||6
7855906|NCT00932282|19336333|P2|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
7855907|NCT00932282|19336334|P1|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
7855908|NCT00932282|19336333|P2|COMPLETED|Modified OIT Rush Desensitization Phase||5
7855909|NCT00932282|19336334|P1|COMPLETED|Modified OIT Rush Desensitization Phase||6
7855910|NCT00932282|19336333|P2|STARTED|Modified OIT Rush Desensitization Phase||5
7855911|NCT00932282|19336334|P1|STARTED|Modified OIT Rush Desensitization Phase||6
7855912|NCT00932282|19336333|P2|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
7855913|NCT00932282|19336334|P1|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
7855914|NCT00932282|19336333|P2|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||5
7855915|NCT00932282|19336334|P1|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||6
7855916|NCT00932282|19336333|P2|STARTED|Pre-OIT Anti-IgE Therapy Phase||6
7855917|NCT00932282|19336334|P1|STARTED|Pre-OIT Anti-IgE Therapy Phase||7
7855918|NCT00932165|19336348|P1|NOT COMPLETED|Overall Study||1
7855919|NCT00932165|19336348|P1|COMPLETED|Overall Study||450
7855920|NCT00932165|19336348|P1|STARTED|Overall Study||451
7855921|NCT00932152|19336361|P2|NOT COMPLETED|Overall Study||2
7855922|NCT00932152|19336362|P1|NOT COMPLETED|Overall Study||1
7855923|NCT00932152|19336361|P2|COMPLETED|Overall Study||0
7855924|NCT00932152|19336362|P1|COMPLETED|Overall Study||0
7855925|NCT00932152|19336361|P2|STARTED|Overall Study||2
7855926|NCT00932152|19336362|P1|STARTED|Overall Study||1
7855927|NCT00932126|19336372|P8|NOT COMPLETED|Overall Study||10
7855928|NCT00932126|19336373|P7|NOT COMPLETED|Overall Study||5
7855929|NCT00932126|19336374|P6|NOT COMPLETED|Overall Study||3
7855930|NCT00932126|19336375|P5|NOT COMPLETED|Overall Study||5
7855931|NCT00932126|19336376|P4|NOT COMPLETED|Overall Study||3
7855932|NCT00932126|19336377|P3|NOT COMPLETED|Overall Study||3
7855933|NCT00932126|19336378|P2|NOT COMPLETED|Overall Study||3
7855934|NCT00932126|19336379|P1|NOT COMPLETED|Overall Study||3
7855935|NCT00932126|19336372|P8|COMPLETED|Overall Study||0
7855936|NCT00932126|19336373|P7|COMPLETED|Overall Study||0
7855937|NCT00932126|19336374|P6|COMPLETED|Overall Study||0
7855938|NCT00932126|19336375|P5|COMPLETED|Overall Study||0
7855939|NCT00932126|19336376|P4|COMPLETED|Overall Study||0
7855940|NCT00932126|19336377|P3|COMPLETED|Overall Study||0
7855941|NCT00932126|19336378|P2|COMPLETED|Overall Study||0
7855942|NCT00932126|19336379|P1|COMPLETED|Overall Study||0
7855943|NCT00932126|19336372|P8|STARTED|Overall Study||10
7855944|NCT00932126|19336373|P7|STARTED|Overall Study||5
7855945|NCT00932126|19336374|P6|STARTED|Overall Study||3
7855946|NCT00932126|19336375|P5|STARTED|Overall Study||5
7855947|NCT00932126|19336376|P4|STARTED|Overall Study||3
7855948|NCT00932126|19336377|P3|STARTED|Overall Study||3
7855949|NCT00932126|19336378|P2|STARTED|Overall Study||3
7855950|NCT00932126|19336379|P1|STARTED|Overall Study||3
7855951|NCT00932113|19336417|P2|NOT COMPLETED|Overall Study||0
7855952|NCT00932113|19336418|P1|NOT COMPLETED|Overall Study||1
7855953|NCT00932113|19336417|P2|COMPLETED|Overall Study||15
7855954|NCT00932113|19336418|P1|COMPLETED|Overall Study||14
7855955|NCT00932113|19336417|P2|STARTED|Overall Study||15
7855956|NCT00932113|19336418|P1|STARTED|Overall Study||15
7855957|NCT00932035|19336436|P2|NOT COMPLETED|Overall Study||0
7855958|NCT00932035|19336437|P1|NOT COMPLETED|Overall Study||0
7855959|NCT00932035|19336436|P2|COMPLETED|Overall Study||21
7855960|NCT00932035|19336437|P1|COMPLETED|Overall Study||18
7855961|NCT00932035|19336436|P2|STARTED|Overall Study||21
7855962|NCT00932035|19336437|P1|STARTED|Overall Study||18
7855963|NCT00932022|19336449|P2|NOT COMPLETED|Overall Study||4
7855964|NCT00932022|19336450|P1|NOT COMPLETED|Overall Study||5
7855965|NCT00932022|19336449|P2|COMPLETED|Overall Study||59
7855966|NCT00932022|19336450|P1|COMPLETED|Overall Study||59
7855967|NCT00932022|19336449|P2|STARTED|Overall Study||63
7855968|NCT00932022|19336450|P1|STARTED|Overall Study||64
7855969|NCT00931996|19336464|P1|NOT COMPLETED|Overall Study||7
7855970|NCT00931996|19336464|P1|COMPLETED|Overall Study||5
7855971|NCT00931996|19336464|P1|STARTED|Overall Study||12
7855972|NCT00931918|19336470|P2|NOT COMPLETED|Overall Study||17
7855973|NCT00931918|19336471|P1|NOT COMPLETED|Overall Study||17
7855974|NCT00931918|19336470|P2|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
7855975|NCT00931918|19336471|P1|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
7855976|NCT00931918|19336470|P2|Safety Population: Received Study Drug|Overall Study||101
7855977|NCT00931918|19336471|P1|Safety Population: Received Study Drug|Overall Study||100
7855978|NCT00931918|19336470|P2|STARTED|Overall Study||103
7855979|NCT00931918|19336471|P1|STARTED|Overall Study||103
7855980|NCT00931879|19336497|P2|NOT COMPLETED|Overall Study||3
7855981|NCT00931879|19336498|P1|NOT COMPLETED|Overall Study||3
7855982|NCT00931879|19336497|P2|COMPLETED|Overall Study||19
7855983|NCT00931879|19336498|P1|COMPLETED|Overall Study||19
7855984|NCT00931879|19336497|P2|STARTED|Overall Study||22
7855985|NCT00931879|19336498|P1|STARTED|Overall Study||22
7855986|NCT00931801|19336523|P3|NOT COMPLETED|Overall Study||4
7855987|NCT00931801|19336524|P2|NOT COMPLETED|Overall Study||1
7855988|NCT00931801|19336525|P1|NOT COMPLETED|Overall Study||1
7855989|NCT00931801|19336523|P3|COMPLETED|Overall Study||10
7855990|NCT00931801|19336524|P2|COMPLETED|Overall Study||14
7855991|NCT00931801|19336525|P1|COMPLETED|Overall Study||13
7855992|NCT00931801|19336523|P3|STARTED|Overall Study||14
7855993|NCT00931801|19336524|P2|STARTED|Overall Study||15
7855994|NCT00931801|19336525|P1|STARTED|Overall Study||14
7855995|NCT00931723|19336548|P2|NOT COMPLETED|Overall Study||39
7855996|NCT00931723|19336549|P1|NOT COMPLETED|Overall Study||26
7855997|NCT00931723|19336548|P2|COMPLETED|Overall Study||144
7855998|NCT00931723|19336549|P1|COMPLETED|Overall Study||147
7855999|NCT00931723|19336548|P2|STARTED|Overall Study||183
7856000|NCT00931723|19336549|P1|STARTED|Overall Study||173
7856001|NCT00931710|19336597|P2|NOT COMPLETED|Overall Study||38
7856002|NCT00931710|19336598|P1|NOT COMPLETED|Overall Study||34
7856003|NCT00931710|19336597|P2|COMPLETED|Overall Study||209
7856004|NCT00931710|19336598|P1|COMPLETED|Overall Study||207
7856005|NCT00931710|19336597|P2|STARTED|Overall Study||247
7856006|NCT00931710|19336598|P1|STARTED|Overall Study||241
7856007|NCT00931632|19336616|P2|NOT COMPLETED|Overall Study||18
7856008|NCT00931632|19336617|P1|NOT COMPLETED|Overall Study||21
7856009|NCT00931632|19336616|P2|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204
7856010|NCT00931632|19336617|P1|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208
7856011|NCT00931632|19336616|P2|STARTED|Overall Study|Randomized|222
7856012|NCT00931632|19336617|P1|STARTED|Overall Study|Randomized|229
7856013|NCT00931528|19336639|P2|NOT COMPLETED|Overall Study||60
7856014|NCT00931528|19336640|P1|NOT COMPLETED|Overall Study||41
7856015|NCT00931528|19336639|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61
7856016|NCT00931528|19336640|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80
7856017|NCT00931528|19336639|P2|STARTED|Overall Study||121
7856018|NCT00931528|19336640|P1|STARTED|Overall Study||121
7856019|NCT00931515|19336660|P2|NOT COMPLETED|Overall Study||5
7856020|NCT00931515|19336661|P1|NOT COMPLETED|Overall Study||2
7856021|NCT00931515|19336660|P2|COMPLETED|Overall Study||10
7856022|NCT00931515|19336661|P1|COMPLETED|Overall Study||13
7856023|NCT00931515|19336660|P2|STARTED|Overall Study||15
7856024|NCT00931515|19336661|P1|STARTED|Overall Study||15
7856025|NCT00931489|19336672|P5|NOT COMPLETED|Overall Study||0
7856026|NCT00931489|19336673|P4|NOT COMPLETED|Overall Study||0
7856027|NCT00931489|19336674|P3|NOT COMPLETED|Overall Study||0
7856028|NCT00931489|19336675|P2|NOT COMPLETED|Overall Study||0
7856029|NCT00931489|19336676|P1|NOT COMPLETED|Overall Study||0
7856030|NCT00931489|19336672|P5|COMPLETED|Overall Study||7
7856031|NCT00931489|19336673|P4|COMPLETED|Overall Study||39
7856032|NCT00931489|19336674|P3|COMPLETED|Overall Study|3 subjects enrolled in Group 1 (responders) were moved to Group 3 (non-responders)|5
7856033|NCT00931489|19336675|P2|COMPLETED|Overall Study||40
7856034|NCT00931489|19336676|P1|COMPLETED|Overall Study||40
7856035|NCT00931489|19336672|P5|STARTED|Overall Study||7
7856036|NCT00931489|19336673|P4|STARTED|Overall Study||39
7856037|NCT00931489|19336674|P3|STARTED|Overall Study||5
7856038|NCT00931489|19336675|P2|STARTED|Overall Study||40
7856039|NCT00931489|19336676|P1|STARTED|Overall Study||40
7856040|NCT00931463|19336691|P2|NOT COMPLETED|Overall Study||5
7856041|NCT00931463|19336692|P1|NOT COMPLETED|Overall Study||17
7856042|NCT00931463|19336691|P2|COMPLETED|Overall Study||265
7856043|NCT00931463|19336692|P1|COMPLETED|Overall Study||254
7856044|NCT00931463|19336691|P2|STARTED|Overall Study||270
7856045|NCT00931463|19336692|P1|STARTED|Overall Study||271
7856046|NCT00931411|19336708|P2|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1
7856047|NCT00931411|19336709|P1|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0
7856048|NCT00931411|19336708|P2|COMPLETED|After Crossover - 14 Days (up to Day 56)||34
7856049|NCT00931411|19336709|P1|COMPLETED|After Crossover - 14 Days (up to Day 56)||31
7856050|NCT00931411|19336708|P2|STARTED|After Crossover - 14 Days (up to Day 56)||35
7856051|NCT00931411|19336709|P1|STARTED|After Crossover - 14 Days (up to Day 56)||31
7856052|NCT00931411|19336708|P2|NOT COMPLETED|First Intervention - 42 Days||3
7856053|NCT00931411|19336709|P1|NOT COMPLETED|First Intervention - 42 Days||4
7856054|NCT00931411|19336708|P2|COMPLETED|First Intervention - 42 Days||35
7856055|NCT00931411|19336709|P1|COMPLETED|First Intervention - 42 Days||31
7856056|NCT00931411|19336708|P2|STARTED|First Intervention - 42 Days||38
7856057|NCT00931411|19336709|P1|STARTED|First Intervention - 42 Days||35
7856058|NCT00931385|19336730|P4|NOT COMPLETED|Overall Study||5
7856059|NCT00931385|19336731|P3|NOT COMPLETED|Overall Study||1
7856060|NCT00931385|19336732|P2|NOT COMPLETED|Overall Study||2
7856061|NCT00931385|19336733|P1|NOT COMPLETED|Overall Study||2
7856062|NCT00931385|19336730|P4|COMPLETED|Overall Study||21
7856063|NCT00931385|19336731|P3|COMPLETED|Overall Study||24
7856064|NCT00931385|19336732|P2|COMPLETED|Overall Study||21
7856065|NCT00931385|19336733|P1|COMPLETED|Overall Study||23
7856066|NCT00931385|19336730|P4|STARTED|Overall Study||26
7856067|NCT00931385|19336731|P3|STARTED|Overall Study||25
7856068|NCT00931385|19336732|P2|STARTED|Overall Study||23
7856069|NCT00931385|19336733|P1|STARTED|Overall Study||25
7856070|NCT00931359|19336789|P2|NOT COMPLETED|Overall Study||13
7856071|NCT00931359|19336790|P1|NOT COMPLETED|Overall Study||6
7856072|NCT00931359|19336789|P2|COMPLETED|Overall Study||68
7856073|NCT00931359|19336790|P1|COMPLETED|Overall Study||33
7856074|NCT00931359|19336789|P2|STARTED|Overall Study||81
7856075|NCT00931359|19336790|P1|STARTED|Overall Study||39
7856076|NCT00931307|19336802|P1|NOT COMPLETED|Overall Study||13
7856077|NCT00931307|19336802|P1|COMPLETED|Overall Study||9
7856078|NCT00931307|19336802|P1|STARTED|Overall Study||22
7856079|NCT00931268|19336806|P1|NOT COMPLETED|Overall Study||6
7856080|NCT00931268|19336806|P1|COMPLETED|Overall Study||4
7856081|NCT00931268|19336806|P1|STARTED|Overall Study||10
7856082|NCT00931255|19336818|P2|NOT COMPLETED|Overall Study||3
7856083|NCT00931255|19336819|P1|NOT COMPLETED|Overall Study||2
7856084|NCT00931255|19336818|P2|COMPLETED|Overall Study||12
7856085|NCT00931255|19336819|P1|COMPLETED|Overall Study||15
7856086|NCT00931255|19336818|P2|STARTED|Overall Study||15
7856087|NCT00931255|19336819|P1|STARTED|Overall Study||17
7856088|NCT00931242|19336843|P2|NOT COMPLETED|Overall Study||2
7856089|NCT00931242|19336844|P1|NOT COMPLETED|Overall Study||5
7856090|NCT00931242|19336843|P2|COMPLETED|Overall Study||0
7856091|NCT00931242|19336844|P1|COMPLETED|Overall Study||5
7856092|NCT00931242|19336843|P2|STARTED|Overall Study||2
7856093|NCT00931242|19336844|P1|STARTED|Overall Study||10
7856094|NCT00931164|19336850|P1|NOT COMPLETED|Overall Study||0
7856095|NCT00931164|19336850|P1|COMPLETED|Overall Study||6
7856096|NCT00931164|19336850|P1|STARTED|Overall Study||6
7856097|NCT00930982|19336856|P2|NOT COMPLETED|Overall Study||29
7856098|NCT00930982|19336857|P1|NOT COMPLETED|Overall Study||21
7856099|NCT00930982|19336856|P2|COMPLETED|Overall Study||35
7856100|NCT00930982|19336857|P1|COMPLETED|Overall Study||39
7856101|NCT00930982|19336856|P2|STARTED|Overall Study||64
7856102|NCT00930982|19336857|P1|STARTED|Overall Study||60
7856103|NCT00930969|19336891|P1|NOT COMPLETED|Overall Study||38
7856104|NCT00930969|19336891|P1|COMPLETED|Overall Study||137
7856105|NCT00930969|19336891|P1|STARTED|Overall Study||175
7856106|NCT00930930|19336901|P2|NOT COMPLETED|Overall Study||9
7856107|NCT00930930|19336902|P1|NOT COMPLETED|Overall Study||21
7856108|NCT00930930|19336901|P2|COMPLETED|Overall Study||40
7856109|NCT00930930|19336902|P1|COMPLETED|Overall Study||75
7856110|NCT00930930|19336901|P2|STARTED|Overall Study||49
7856111|NCT00930930|19336902|P1|STARTED|Overall Study||96
7856112|NCT00930813|19336916|P2|NOT COMPLETED|Overall Study||14
7856113|NCT00930813|19336917|P1|NOT COMPLETED|Overall Study||8
7856114|NCT00930813|19336916|P2|COMPLETED|Overall Study||38
7856115|NCT00930813|19336917|P1|COMPLETED|Overall Study||41
7856116|NCT00930813|19336916|P2|STARTED|Overall Study||52
7856117|NCT00930813|19336917|P1|STARTED|Overall Study||49
7856118|NCT00930787|19336927|P2|NOT COMPLETED|Overall Study||0
7856119|NCT00930787|19336928|P1|NOT COMPLETED|Overall Study||0
7856120|NCT00930787|19336927|P2|COMPLETED|Overall Study||9
7856121|NCT00930787|19336928|P1|COMPLETED|Overall Study||14
7856122|NCT00930787|19336927|P2|STARTED|Overall Study||9
7856123|NCT00930787|19336928|P1|STARTED|Overall Study||14
7856124|NCT00930774|19336938|P4|NOT COMPLETED|Overall Study||0
7856125|NCT00930774|19336939|P3|NOT COMPLETED|Overall Study||2
7856126|NCT00930774|19336940|P2|NOT COMPLETED|Overall Study||9
7856127|NCT00930774|19336941|P1|NOT COMPLETED|Overall Study||1
7856128|NCT00930774|19336938|P4|COMPLETED|Overall Study||25
7856129|NCT00930774|19336939|P3|COMPLETED|Overall Study||22
7856130|NCT00930774|19336940|P2|COMPLETED|Overall Study||16
7856131|NCT00930774|19336941|P1|COMPLETED|Overall Study||24
7856132|NCT00930774|19336938|P4|STARTED|Overall Study||25
7856133|NCT00930774|19336939|P3|STARTED|Overall Study||24
7856134|NCT00930774|19336940|P2|STARTED|Overall Study||25
7856135|NCT00930774|19336941|P1|STARTED|Overall Study||25
7856136|NCT00930761|19336981|P2|NOT COMPLETED|Overall Study||3
7856137|NCT00930761|19336982|P1|NOT COMPLETED|Overall Study||4
7856138|NCT00930761|19336981|P2|COMPLETED|Overall Study||48
7856139|NCT00930761|19336982|P1|COMPLETED|Overall Study||46
7856140|NCT00930761|19336981|P2|STARTED|Overall Study||51
7856141|NCT00930761|19336982|P1|STARTED|Overall Study||50
7856142|NCT00930722|19336994|P1|NOT COMPLETED|Overall Study||27
7856143|NCT00930722|19336994|P1|COMPLETED|Overall Study||302
7856144|NCT00930722|19336994|P1|STARTED|Overall Study||329
7856145|NCT00930644|19337009|P1|NOT COMPLETED|Overall Study||23
7856146|NCT00930644|19337009|P1|COMPLETED|Overall Study||65
7856147|NCT00930644|19337009|P1|STARTED|Overall Study||88
7856148|NCT00930553|19337022|P1|NOT COMPLETED|Overall Study||223
7856149|NCT00930553|19337022|P1|COMPLETED|Overall Study||1091
7856150|NCT00930553|19337022|P1|Participants Entered From CAMMS324|Overall Study||685
7856151|NCT00930553|19337022|P1|Participants Entered From CAMMS323|Overall Study||488
7856152|NCT00930553|19337022|P1|Participants Entered From CAMMS223|Overall Study||141
7856153|NCT00930553|19337022|P1|STARTED|Overall Study||1314
7856154|NCT00930293|19337090|P2|NOT COMPLETED|Overall Study||7
7856155|NCT00930293|19337091|P1|NOT COMPLETED|Overall Study||7
7856156|NCT00930293|19337090|P2|COMPLETED|Overall Study||19
7856157|NCT00930293|19337091|P1|COMPLETED|Overall Study||17
7856158|NCT00930293|19337090|P2|STARTED|Overall Study||26
7856159|NCT00930293|19337091|P1|STARTED|Overall Study||24
7856160|NCT00930176|19337099|P1|NOT COMPLETED|Overall Study||1
7856161|NCT00930176|19337099|P1|COMPLETED|Overall Study||15
7856162|NCT00930176|19337099|P1|STARTED|Overall Study||16
7856163|NCT00930059|19337106|P2|NOT COMPLETED|Overall Study||12
7856164|NCT00930059|19337107|P1|NOT COMPLETED|Overall Study||8
7856165|NCT00930059|19337106|P2|COMPLETED|Overall Study||79
7856166|NCT00930059|19337107|P1|COMPLETED|Overall Study||92
7856167|NCT00930059|19337106|P2|STARTED|Overall Study||91
7856168|NCT00930059|19337107|P1|STARTED|Overall Study||100
7856169|NCT00930046|19337137|P2|NOT COMPLETED|Overall Study||2
7856170|NCT00930046|19337138|P1|NOT COMPLETED|Overall Study||1
7856171|NCT00930046|19337137|P2|COMPLETED|Overall Study||5
7856172|NCT00930046|19337138|P1|COMPLETED|Overall Study||7
7856173|NCT00930046|19337137|P2|STARTED|Overall Study||7
7856174|NCT00930046|19337138|P1|STARTED|Overall Study||8
7856175|NCT00929994|19337146|P1|NOT COMPLETED|Overall Study||6
7856176|NCT00929994|19337146|P1|COMPLETED|Overall Study||14
7856177|NCT00929994|19337146|P1|STARTED|Overall Study||20
7856178|NCT00929981|19337153|P1|NOT COMPLETED|Overall Study||0
7856179|NCT00929981|19337153|P1|COMPLETED|Overall Study||80
7856180|NCT00929981|19337153|P1|STARTED|Overall Study||80
7856181|NCT00929864|19337165|P2|NOT COMPLETED|Overall Study||83
7856182|NCT00929864|19337166|P1|NOT COMPLETED|Overall Study||66
7856183|NCT00929864|19337165|P2|COMPLETED|Overall Study||245
7856184|NCT00929864|19337166|P1|COMPLETED|Overall Study||252
7856185|NCT00929864|19337165|P2|STARTED|Overall Study||328
7856186|NCT00929864|19337166|P1|STARTED|Overall Study||318
7856187|NCT00929838|19337188|P4|NOT COMPLETED|Overall Study||9
7856188|NCT00929838|19337189|P3|NOT COMPLETED|Overall Study||10
7856189|NCT00929838|19337190|P2|NOT COMPLETED|Overall Study||9
7856190|NCT00929838|19337191|P1|NOT COMPLETED|Overall Study||10
7856191|NCT00929838|19337188|P4|COMPLETED|Overall Study||55
7856192|NCT00929838|19337189|P3|COMPLETED|Overall Study||53
7856193|NCT00929838|19337190|P2|COMPLETED|Overall Study||56
7856194|NCT00929838|19337191|P1|COMPLETED|Overall Study||53
7856195|NCT00929838|19337188|P4|STARTED|Overall Study||64
7856196|NCT00929838|19337189|P3|STARTED|Overall Study||63
7856197|NCT00929838|19337190|P2|STARTED|Overall Study||65
7856198|NCT00929838|19337191|P1|STARTED|Overall Study||63
7856199|NCT00929773|19337203|P2|NOT COMPLETED|Overall Study||0
7856200|NCT00929773|19337204|P1|NOT COMPLETED|Overall Study||0
7856201|NCT00929773|19337203|P2|COMPLETED|Overall Study||50
7856202|NCT00929773|19337204|P1|COMPLETED|Overall Study||50
7856203|NCT00929773|19337203|P2|STARTED|Overall Study||50
7856204|NCT00929773|19337204|P1|STARTED|Overall Study||50
7856205|NCT00929734|19337222|P2|NOT COMPLETED|Overall Study||3
7856206|NCT00929734|19337223|P1|NOT COMPLETED|Overall Study||2
7856207|NCT00929734|19337222|P2|COMPLETED|Overall Study||47
7856208|NCT00929734|19337223|P1|COMPLETED|Overall Study||47
7856209|NCT00929734|19337222|P2|STARTED|Overall Study||50
7856210|NCT00929734|19337223|P1|STARTED|Overall Study||49
7856211|NCT00929708|19337240|P5|NOT COMPLETED|Overall Study||6
7856212|NCT00929708|19337241|P4|NOT COMPLETED|Overall Study||6
7856213|NCT00929708|19337242|P3|NOT COMPLETED|Overall Study||3
7856214|NCT00929708|19337243|P2|NOT COMPLETED|Overall Study||3
7856215|NCT00929708|19337244|P1|NOT COMPLETED|Overall Study||4
7856216|NCT00929708|19337240|P5|COMPLETED|Overall Study||57
7856217|NCT00929708|19337241|P4|COMPLETED|Overall Study||61
7856218|NCT00929708|19337242|P3|COMPLETED|Overall Study||62
7856219|NCT00929708|19337243|P2|COMPLETED|Overall Study||66
7856220|NCT00929708|19337244|P1|COMPLETED|Overall Study||61
7856221|NCT00929708|19337240|P5|STARTED|Overall Study||63
7856222|NCT00929708|19337241|P4|STARTED|Overall Study||67
7856223|NCT00929708|19337242|P3|STARTED|Overall Study||65
7856224|NCT00929708|19337243|P2|STARTED|Overall Study||69
7856225|NCT00929708|19337244|P1|STARTED|Overall Study||65
7856226|NCT00929695|19337298|P2|NOT COMPLETED|Overall Study||6
7856227|NCT00929695|19337299|P1|NOT COMPLETED|Overall Study||8
7856228|NCT00929695|19337298|P2|COMPLETED|Overall Study||77
7856229|NCT00929695|19337299|P1|COMPLETED|Overall Study||73
7856230|NCT00929695|19337298|P2|STARTED|Overall Study||83
7856231|NCT00929695|19337299|P1|STARTED|Overall Study||81
7856232|NCT00929669|19337329|P1|NOT COMPLETED|Overall Study||1
7856233|NCT00929669|19337329|P1|COMPLETED|Overall Study||1
7856234|NCT00929669|19337329|P1|STARTED|Overall Study||2
7856235|NCT00929656|19337336|P2|NOT COMPLETED|Overall Study||1
7856236|NCT00929656|19337337|P1|NOT COMPLETED|Overall Study||0
7856237|NCT00929656|19337336|P2|COMPLETED|Overall Study||8
7856238|NCT00929656|19337337|P1|COMPLETED|Overall Study||13
7856239|NCT00929656|19337336|P2|STARTED|Overall Study||9
7856240|NCT00929656|19337337|P1|STARTED|Overall Study||13
7856241|NCT00929643|19337351|P1|NOT COMPLETED|Overall Study||2
7856242|NCT00929643|19337351|P1|COMPLETED|Overall Study||201
7856243|NCT00929643|19337351|P1|STARTED|Overall Study||203
7856244|NCT00929578|19337360|P1|NOT COMPLETED|Overall Study||0
7856245|NCT00929578|19337360|P1|COMPLETED|Overall Study||15
7856246|NCT00929578|19337360|P1|STARTED|Overall Study||15
7856247|NCT00929526|19337373|P2|NOT COMPLETED|Overall Study||29
7856248|NCT00929526|19337374|P1|NOT COMPLETED|Overall Study||17
7856249|NCT00929526|19337373|P2|COMPLETED|Overall Study||348
7856250|NCT00929526|19337374|P1|COMPLETED|Overall Study||358
7856251|NCT00929526|19337373|P2|STARTED|Overall Study||377
7856252|NCT00929526|19337374|P1|STARTED|Overall Study||375
7856253|NCT00929500|19337410|P2|NOT COMPLETED|Overall Study||0
7856254|NCT00929500|19337411|P1|NOT COMPLETED|Overall Study||4
7856255|NCT00929500|19337410|P2|COMPLETED|Overall Study||4
7856256|NCT00929500|19337411|P1|COMPLETED|Overall Study||4
7856257|NCT00929500|19337410|P2|STARTED|Overall Study||4
7856258|NCT00929500|19337411|P1|STARTED|Overall Study||8
7856259|NCT00929474|19337425|P2|NOT COMPLETED|Overall Study||9
7856260|NCT00929474|19337426|P1|NOT COMPLETED|Overall Study||8
7856261|NCT00929474|19337425|P2|COMPLETED|Overall Study||0
7856262|NCT00929474|19337426|P1|COMPLETED|Overall Study||0
7856263|NCT00929474|19337425|P2|STARTED|Overall Study||9
7856264|NCT00929474|19337426|P1|STARTED|Overall Study||8
7856265|NCT00929383|19337432|P1|NOT COMPLETED|Overall Study||15
7856266|NCT00929383|19337432|P1|COMPLETED|Overall Study||67
7856267|NCT00929383|19337432|P1|STARTED|Overall Study||82
7856268|NCT00929357|19337442|P2|NOT COMPLETED|Overall Study||0
7856269|NCT00929357|19337443|P1|NOT COMPLETED|Overall Study||0
7856270|NCT00929357|19337442|P2|COMPLETED|Overall Study||64
7856271|NCT00929357|19337443|P1|COMPLETED|Overall Study||92
7856272|NCT00929357|19337442|P2|STARTED|Overall Study||64
7856273|NCT00929357|19337443|P1|STARTED|Overall Study||92
7856274|NCT00929344|19337466|P3|NOT COMPLETED|Overall Study||21
7856275|NCT00929344|19337467|P2|NOT COMPLETED|Overall Study||13
7856276|NCT00929344|19337468|P1|NOT COMPLETED|Overall Study||22
7856277|NCT00929344|19337466|P3|COMPLETED|Overall Study||29
7856278|NCT00929344|19337467|P2|COMPLETED|Overall Study||37
7856279|NCT00929344|19337468|P1|COMPLETED|Overall Study||28
7856280|NCT00929344|19337466|P3|STARTED|Overall Study||50
7856281|NCT00929344|19337467|P2|STARTED|Overall Study||50
7856282|NCT00929344|19337468|P1|STARTED|Overall Study||50
7856283|NCT00929331|19337484|P2|NOT COMPLETED|Overall Study||0
7856284|NCT00929331|19337485|P1|NOT COMPLETED|Overall Study||0
7856285|NCT00929331|19337484|P2|COMPLETED|Overall Study||55
7856286|NCT00929331|19337485|P1|COMPLETED|Overall Study||55
7856287|NCT00929331|19337484|P2|STARTED|Overall Study||55
7856288|NCT00929331|19337485|P1|STARTED|Overall Study||55
7856289|NCT00929305|19337519|P2|NOT COMPLETED|Overall Study||0
7856290|NCT00929305|19337520|P1|NOT COMPLETED|Overall Study||0
7856291|NCT00929305|19337519|P2|COMPLETED|Overall Study||43
7856292|NCT00929305|19337520|P1|COMPLETED|Overall Study||43
7856293|NCT00929305|19337519|P2|STARTED|Overall Study||43
7856294|NCT00929305|19337520|P1|STARTED|Overall Study||43
7856295|NCT00929240|19337528|P3|NOT COMPLETED|Maintenance Phase||91
7856296|NCT00929240|19337529|P2|NOT COMPLETED|Maintenance Phase||94
7856297|NCT00929240|19337530|P1|NOT COMPLETED|Maintenance Phase||0
7856298|NCT00929240|19337528|P3|COMPLETED|Maintenance Phase||0
7856299|NCT00929240|19337529|P2|COMPLETED|Maintenance Phase||0
7856300|NCT00929240|19337530|P1|COMPLETED|Maintenance Phase||0
7856301|NCT00929240|19337528|P3|STARTED|Maintenance Phase||91
7856302|NCT00929240|19337529|P2|STARTED|Maintenance Phase||94
7856303|NCT00929240|19337530|P1|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
7856304|NCT00929240|19337528|P3|NOT COMPLETED|Initial Treatment Phase||0
7856305|NCT00929240|19337529|P2|NOT COMPLETED|Initial Treatment Phase||0
7856306|NCT00929240|19337530|P1|NOT COMPLETED|Initial Treatment Phase||99
7856307|NCT00929240|19337528|P3|COMPLETED|Initial Treatment Phase||0
7856308|NCT00929240|19337529|P2|COMPLETED|Initial Treatment Phase||0
7856309|NCT00929240|19337530|P1|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185
7856310|NCT00929240|19337528|P3|STARTED|Initial Treatment Phase||0
7856311|NCT00929240|19337529|P2|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
7856312|NCT00929240|19337530|P1|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284
7856313|NCT00929201|19337557|P2|NOT COMPLETED|Period 2||0
7856314|NCT00929201|19337558|P1|NOT COMPLETED|Period 2||0
7856315|NCT00929201|19337557|P2|COMPLETED|Period 2||30
7856316|NCT00929201|19337558|P1|COMPLETED|Period 2||30
7856317|NCT00929201|19337557|P2|STARTED|Period 2||30
7856318|NCT00929201|19337558|P1|STARTED|Period 2||30
7856319|NCT00929201|19337557|P2|NOT COMPLETED|7-day Washout||0
7856320|NCT00929201|19337558|P1|NOT COMPLETED|7-day Washout||0
7856321|NCT00929201|19337557|P2|COMPLETED|7-day Washout||30
7856322|NCT00929201|19337558|P1|COMPLETED|7-day Washout||30
7856323|NCT00929201|19337557|P2|STARTED|7-day Washout||30
7856324|NCT00929201|19337558|P1|STARTED|7-day Washout||30
7856325|NCT00929201|19337557|P2|NOT COMPLETED|Period 1||1
7856326|NCT00929201|19337558|P1|NOT COMPLETED|Period 1||0
7856327|NCT00929201|19337557|P2|COMPLETED|Period 1||30
7856328|NCT00929201|19337558|P1|COMPLETED|Period 1||30
7856329|NCT00929201|19337557|P2|STARTED|Period 1||31
7856330|NCT00929201|19337558|P1|STARTED|Period 1||30
7856331|NCT00929162|19337568|P2|NOT COMPLETED|Overall Study||42
7856332|NCT00929162|19337569|P1|NOT COMPLETED|Overall Study||48
7856333|NCT00929162|19337568|P2|COMPLETED|Overall Study||19
7856334|NCT00929162|19337569|P1|COMPLETED|Overall Study||11
7856335|NCT00929162|19337568|P2|Patients Who Received Treatment|Overall Study||58
7856336|NCT00929162|19337569|P1|Patients Who Received Treatment|Overall Study||58
7856337|NCT00929162|19337568|P2|STARTED|Overall Study||61
7856338|NCT00929162|19337569|P1|STARTED|Overall Study||59
7856339|NCT00929110|19337582|P3|NOT COMPLETED|Overall Study||62
7856340|NCT00929110|19337583|P2|NOT COMPLETED|Overall Study||76
7856341|NCT00929110|19337584|P1|NOT COMPLETED|Overall Study||118
7856342|NCT00929110|19337582|P3|COMPLETED|Overall Study||206
7856343|NCT00929110|19337583|P2|COMPLETED|Overall Study||193
7856344|NCT00929110|19337584|P1|COMPLETED|Overall Study||411
7856345|NCT00929110|19337582|P3|STARTED|Overall Study||268
7856346|NCT00929110|19337583|P2|STARTED|Overall Study||269
7856347|NCT00929110|19337584|P1|STARTED|Overall Study||529
7856348|NCT00929071|19337649|P1|NOT COMPLETED|Overall Study||0
7856349|NCT00929071|19337649|P1|COMPLETED|Overall Study||10
7856350|NCT00929071|19337649|P1|STARTED|Overall Study||10
7856351|NCT00928954|19337656|P2|NOT COMPLETED|Overall Study||0
7856352|NCT00928954|19337657|P1|NOT COMPLETED|Overall Study||0
7856353|NCT00928954|19337656|P2|COMPLETED|Overall Study||6
7856354|NCT00928954|19337657|P1|COMPLETED|Overall Study||4
7856355|NCT00928954|19337656|P2|STARTED|Overall Study||6
7856356|NCT00928954|19337657|P1|STARTED|Overall Study||4
7856357|NCT00928889|19337667|P2|NOT COMPLETED|Overall Study||2
7856358|NCT00928889|19337668|P1|NOT COMPLETED|Overall Study||5
7856359|NCT00928889|19337667|P2|COMPLETED|Overall Study||78
7856360|NCT00928889|19337668|P1|COMPLETED|Overall Study||75
7856361|NCT00928889|19337667|P2|STARTED|Overall Study||80
7856362|NCT00928889|19337668|P1|STARTED|Overall Study||80
7856363|NCT00928772|19337695|P3|NOT COMPLETED|Overall Study||0
7856364|NCT00928772|19337696|P2|NOT COMPLETED|Overall Study||0
7856365|NCT00928772|19337697|P1|NOT COMPLETED|Overall Study||0
7856366|NCT00928772|19337695|P3|COMPLETED|Overall Study||38
7856367|NCT00928772|19337696|P2|COMPLETED|Overall Study||38
7856368|NCT00928772|19337697|P1|COMPLETED|Overall Study||39
7856369|NCT00928772|19337695|P3|STARTED|Overall Study||38
7856370|NCT00928772|19337696|P2|STARTED|Overall Study||38
7856371|NCT00928772|19337697|P1|STARTED|Overall Study||39
7856372|NCT00928746|19337714|P1|NOT COMPLETED|Overall Study||6
7856373|NCT00928746|19337714|P1|COMPLETED|Overall Study||136
7856374|NCT00928746|19337714|P1|STARTED|Overall Study||142
7856375|NCT00928720|19337737|P3|NOT COMPLETED|Overall Study||3
7856376|NCT00928720|19337738|P2|NOT COMPLETED|Overall Study||6
7856377|NCT00928720|19337739|P1|NOT COMPLETED|Overall Study||2
7856378|NCT00928720|19337737|P3|COMPLETED|Overall Study||15
7856379|NCT00928720|19337738|P2|COMPLETED|Overall Study||14
7856380|NCT00928720|19337739|P1|COMPLETED|Overall Study||17
7856381|NCT00928720|19337737|P3|STARTED|Overall Study||18
7856382|NCT00928720|19337738|P2|STARTED|Overall Study||20
7856383|NCT00928720|19337739|P1|STARTED|Overall Study||19
7856384|NCT00928707|19337764|P2|NOT COMPLETED|Overall Study||0
7856385|NCT00928707|19337765|P1|NOT COMPLETED|Overall Study||1
7856386|NCT00928707|19337764|P2|COMPLETED|Overall Study||22
7856387|NCT00928707|19337765|P1|COMPLETED|Overall Study||22
7856388|NCT00928707|19337764|P2|STARTED|Overall Study||22
7856389|NCT00928707|19337765|P1|STARTED|Overall Study||23
7856390|NCT00928694|19337777|P2|NOT COMPLETED|Second Intervention||0
7856391|NCT00928694|19337778|P1|NOT COMPLETED|Second Intervention||0
7856392|NCT00928694|19337777|P2|COMPLETED|Second Intervention||7
7856393|NCT00928694|19337778|P1|COMPLETED|Second Intervention||7
7856394|NCT00928694|19337777|P2|STARTED|Second Intervention||7
7856395|NCT00928694|19337778|P1|STARTED|Second Intervention||7
7856396|NCT00928694|19337777|P2|NOT COMPLETED|First Intervention||0
7856397|NCT00928694|19337778|P1|NOT COMPLETED|First Intervention||0
7856398|NCT00928694|19337777|P2|COMPLETED|First Intervention||7
7856399|NCT00928694|19337778|P1|COMPLETED|First Intervention||7
7856400|NCT00928694|19337777|P2|STARTED|First Intervention||7
7856401|NCT00928694|19337778|P1|STARTED|First Intervention||7
7856402|NCT00928668|19337786|P5|NOT COMPLETED|Overall Study||1
7856403|NCT00928668|19337787|P4|NOT COMPLETED|Overall Study||1
7856404|NCT00928668|19337788|P3|NOT COMPLETED|Overall Study||1
7856405|NCT00928668|19337789|P2|NOT COMPLETED|Overall Study||1
7856406|NCT00928668|19337790|P1|NOT COMPLETED|Overall Study||1
7856407|NCT00928668|19337786|P5|COMPLETED|Overall Study||5
7856408|NCT00928668|19337787|P4|COMPLETED|Overall Study||3
7856409|NCT00928668|19337788|P3|COMPLETED|Overall Study||6
7856410|NCT00928668|19337789|P2|COMPLETED|Overall Study||6
7856411|NCT00928668|19337790|P1|COMPLETED|Overall Study||6
7856412|NCT00928668|19337786|P5|STARTED|Overall Study||6
7856413|NCT00928668|19337787|P4|STARTED|Overall Study||4
7856414|NCT00928668|19337788|P3|STARTED|Overall Study||7
7856415|NCT00928668|19337789|P2|STARTED|Overall Study||7
7856416|NCT00928668|19337790|P1|STARTED|Overall Study||7
7856417|NCT00928642|19337832|P1|NOT COMPLETED|Overall Study||0
7856418|NCT00928642|19337832|P1|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8
7856419|NCT00928642|19337832|P1|STARTED|Overall Study||8
7856420|NCT00928512|19337846|P5|NOT COMPLETED|Overall Study||15
7856421|NCT00928512|19337847|P4|NOT COMPLETED|Overall Study||21
7856422|NCT00928512|19337848|P3|NOT COMPLETED|Overall Study||11
7856423|NCT00928512|19337849|P2|NOT COMPLETED|Overall Study||6
7856424|NCT00928512|19337850|P1|NOT COMPLETED|Overall Study||10
7856425|NCT00928512|19337846|P5|COMPLETED|Overall Study||35
7856426|NCT00928512|19337847|P4|COMPLETED|Overall Study||33
7856427|NCT00928512|19337848|P3|COMPLETED|Overall Study||38
7856428|NCT00928512|19337849|P2|COMPLETED|Overall Study||37
7856429|NCT00928512|19337850|P1|COMPLETED|Overall Study||31
7856430|NCT00928512|19337846|P5|Entered/Continued to Week 20 (All)|Overall Study||45
7856431|NCT00928512|19337847|P4|Entered/Continued to Week 20 (All)|Overall Study||45
7856432|NCT00928512|19337848|P3|Entered/Continued to Week 20 (All)|Overall Study||46
7856433|NCT00928512|19337849|P2|Entered/Continued to Week 20 (All)|Overall Study||43
7856434|NCT00928512|19337850|P1|Entered/Continued to Week 20 (All)|Overall Study||37
7856435|NCT00928512|19337846|P5|Completed Week 16|Overall Study||45
7856436|NCT00928512|19337847|P4|Completed Week 16|Overall Study||48
7856437|NCT00928512|19337848|P3|Completed Week 16|Overall Study||47
7856438|NCT00928512|19337849|P2|Completed Week 16|Overall Study||43
7856439|NCT00928512|19337850|P1|Completed Week 16|Overall Study||38
7856440|NCT00928512|19337846|P5|New Groups After Reassignment|Overall Study||0
7856441|NCT00928512|19337847|P4|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18
7856442|NCT00928512|19337848|P3|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23
7856443|NCT00928512|19337849|P2|New Groups After Reassignment|Overall Study||115
7856444|NCT00928512|19337850|P1|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60
7856445|NCT00928512|19337846|P5|Not Reassigned at Week 20 (Responders)|Overall Study||0
7856446|NCT00928512|19337847|P4|Not Reassigned at Week 20 (Responders)|Overall Study||18
7856447|NCT00928512|19337848|P3|Not Reassigned at Week 20 (Responders)|Overall Study||23
7856448|NCT00928512|19337849|P2|Not Reassigned at Week 20 (Responders)|Overall Study||20
7856449|NCT00928512|19337850|P1|Not Reassigned at Week 20 (Responders)|Overall Study||37
7856450|NCT00928512|19337846|P5|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45
7856451|NCT00928512|19337847|P4|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27
7856452|NCT00928512|19337848|P3|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23
7856453|NCT00928512|19337849|P2|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23
7856454|NCT00928512|19337850|P1|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0
7856455|NCT00928512|19337846|P5|Discontinued Prior to Week 16|Overall Study||5
7856456|NCT00928512|19337847|P4|Discontinued Prior to Week 16|Overall Study||6
7856457|NCT00928512|19337848|P3|Discontinued Prior to Week 16|Overall Study||2
7856458|NCT00928512|19337849|P2|Discontinued Prior to Week 16|Overall Study||0
7856459|NCT00928512|19337850|P1|Discontinued Prior to Week 16|Overall Study||3
7856460|NCT00928512|19337846|P5|STARTED|Overall Study||50
7856461|NCT00928512|19337847|P4|STARTED|Overall Study||54
7856462|NCT00928512|19337848|P3|STARTED|Overall Study||49
7856463|NCT00928512|19337849|P2|STARTED|Overall Study||43
7856464|NCT00928512|19337850|P1|STARTED|Overall Study||41
7856465|NCT00928486|19337951|P1|NOT COMPLETED|Overall Study||10
7856466|NCT00928486|19337951|P1|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15
7856467|NCT00928486|19337951|P1|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24
7856468|NCT00928486|19337951|P1|STARTED|Overall Study||25
7856469|NCT00928434|19337960|P3|NOT COMPLETED|Overall Study||44
7856470|NCT00928434|19337961|P2|NOT COMPLETED|Overall Study||14
7856471|NCT00928434|19337962|P1|NOT COMPLETED|Overall Study||44
7856472|NCT00928434|19337960|P3|COMPLETED|Overall Study||134
7856473|NCT00928434|19337961|P2|COMPLETED|Overall Study||36
7856474|NCT00928434|19337962|P1|COMPLETED|Overall Study||131
7856475|NCT00928434|19337960|P3|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150
7856476|NCT00928434|19337961|P2|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41
7856477|NCT00928434|19337962|P1|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137
7856478|NCT00928434|19337960|P3|STARTED|Overall Study|Full Analysis Set Patients|178
7856479|NCT00928434|19337961|P2|STARTED|Overall Study|Full Analysis Set Patients|50
7856480|NCT00928434|19337962|P1|STARTED|Overall Study|Full Analysis Set Patients|175
7856481|NCT00928421|19338034|P1|NOT COMPLETED|Overall Study||0
7856482|NCT00928421|19338034|P1|COMPLETED|Overall Study||16
7856483|NCT00928421|19338034|P1|Treated With Study Drug|Overall Study||16
7856484|NCT00928421|19338034|P1|STARTED|Overall Study||16
7856485|NCT00928408|19338038|P1|NOT COMPLETED|Overall Study||23
7856486|NCT00928408|19338038|P1|COMPLETED|Overall Study||282
7856487|NCT00928408|19338038|P1|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303
7856488|NCT00928408|19338038|P1|STARTED|Overall Study|Number Enrolled|305
7856489|NCT00928395|19338067|P1|NOT COMPLETED|Overall Study||21
7856490|NCT00928395|19338067|P1|COMPLETED|Overall Study||29
7856491|NCT00928395|19338067|P1|STARTED|Overall Study||50
7856492|NCT00928304|19338071|P2|NOT COMPLETED|Overall Study||0
7856493|NCT00928304|19338072|P1|NOT COMPLETED|Overall Study||0
7856494|NCT00928304|19338071|P2|COMPLETED|Overall Study||70
7856495|NCT00928304|19338072|P1|COMPLETED|Overall Study||39
7856496|NCT00928304|19338071|P2|STARTED|Overall Study||70
7856497|NCT00928304|19338072|P1|STARTED|Overall Study||39
7856498|NCT00928252|19338084|P1|NOT COMPLETED|Overall Study||3
7856499|NCT00928252|19338084|P1|COMPLETED|Overall Study||42
7856500|NCT00928252|19338084|P1|STARTED|Overall Study||45
7856501|NCT00928226|19338094|P4|NOT COMPLETED|Overall Study||0
7856502|NCT00928226|19338095|P3|NOT COMPLETED|Overall Study||0
7856503|NCT00928226|19338096|P2|NOT COMPLETED|Overall Study||0
7856504|NCT00928226|19338097|P1|NOT COMPLETED|Overall Study||0
7856505|NCT00928226|19338094|P4|COMPLETED|Overall Study||12
7856506|NCT00928226|19338095|P3|COMPLETED|Overall Study||12
7856507|NCT00928226|19338096|P2|COMPLETED|Overall Study||12
7856508|NCT00928226|19338097|P1|COMPLETED|Overall Study||20
7856509|NCT00928226|19338094|P4|Strata D: Large Tumor, Not Resected|Overall Study||0
7856510|NCT00928226|19338095|P3|Strata D: Large Tumor, Not Resected|Overall Study||0
7856511|NCT00928226|19338096|P2|Strata D: Large Tumor, Not Resected|Overall Study||0
7856512|NCT00928226|19338097|P1|Strata D: Large Tumor, Not Resected|Overall Study||1
7856513|NCT00928226|19338094|P4|Strata C: Large Tumor, Resected|Overall Study||6
7856514|NCT00928226|19338095|P3|Strata C: Large Tumor, Resected|Overall Study||6
7856515|NCT00928226|19338096|P2|Strata C: Large Tumor, Resected|Overall Study||6
7856516|NCT00928226|19338097|P1|Strata C: Large Tumor, Resected|Overall Study||8
7856517|NCT00928226|19338094|P4|Strata B: Small Tumor, Not Resected|Overall Study||0
7856518|NCT00928226|19338095|P3|Strata B: Small Tumor, Not Resected|Overall Study||0
7856519|NCT00928226|19338096|P2|Strata B: Small Tumor, Not Resected|Overall Study||0
7856520|NCT00928226|19338097|P1|Strata B: Small Tumor, Not Resected|Overall Study||5
7856521|NCT00928226|19338094|P4|Strata A: Small Tumor, Resected|Overall Study||6
7856522|NCT00928226|19338095|P3|Strata A: Small Tumor, Resected|Overall Study||6
7856523|NCT00928226|19338096|P2|Strata A: Small Tumor, Resected|Overall Study||6
7856524|NCT00928226|19338097|P1|Strata A: Small Tumor, Resected|Overall Study||6
7856525|NCT00928226|19338094|P4|STARTED|Overall Study||12
7856526|NCT00928226|19338095|P3|STARTED|Overall Study||12
7856527|NCT00928226|19338096|P2|STARTED|Overall Study||12
7856528|NCT00928226|19338097|P1|STARTED|Overall Study||20
7856529|NCT00928200|19338135|P1|NOT COMPLETED|Overall Study||0
7856530|NCT00928200|19338135|P1|COMPLETED|Overall Study||1
7856531|NCT00928200|19338135|P1|STARTED|Overall Study||1
7856532|NCT00928187|19338144|P3|NOT COMPLETED|Overall Study||5
7856533|NCT00928187|19338145|P2|NOT COMPLETED|Overall Study||6
7856534|NCT00928187|19338146|P1|NOT COMPLETED|Overall Study||2
7856535|NCT00928187|19338144|P3|COMPLETED|Overall Study||150
7856536|NCT00928187|19338145|P2|COMPLETED|Overall Study||141
7856537|NCT00928187|19338146|P1|COMPLETED|Overall Study||150
7856538|NCT00928187|19338144|P3|Analysed|Overall Study||154
7856539|NCT00928187|19338145|P2|Analysed|Overall Study||145
7856540|NCT00928187|19338146|P1|Analysed|Overall Study||152
7856541|NCT00928187|19338144|P3|STARTED|Overall Study||155
7856542|NCT00928187|19338145|P2|STARTED|Overall Study||147
7856543|NCT00928187|19338146|P1|STARTED|Overall Study||152
7856544|NCT00928174|19338190|P1|NOT COMPLETED|Overall Study||5
7856545|NCT00928174|19338190|P1|COMPLETED|Overall Study|3 withdrawn before start of participation|22
7856546|NCT00928174|19338190|P1|STARTED|Overall Study||27
7856547|NCT00928083|19338197|P9|NOT COMPLETED|Overall Study||0
7856548|NCT00928083|19338198|P8|NOT COMPLETED|Overall Study||0
7856549|NCT00928083|19338199|P7|NOT COMPLETED|Overall Study||0
7856550|NCT00928083|19338200|P6|NOT COMPLETED|Overall Study||0
7856551|NCT00928083|19338201|P5|NOT COMPLETED|Overall Study||1
7856552|NCT00928083|19338202|P4|NOT COMPLETED|Overall Study||1
7856553|NCT00928083|19338203|P3|NOT COMPLETED|Overall Study||0
7856554|NCT00928083|19338204|P2|NOT COMPLETED|Overall Study||0
7856555|NCT00928083|19338205|P1|NOT COMPLETED|Overall Study||4
7856556|NCT00928083|19338197|P9|COMPLETED|Overall Study||6
7856557|NCT00928083|19338198|P8|COMPLETED|Overall Study||6
7856558|NCT00928083|19338199|P7|COMPLETED|Overall Study||6
7856559|NCT00928083|19338200|P6|COMPLETED|Overall Study||6
7856560|NCT00928083|19338201|P5|COMPLETED|Overall Study||6
7856561|NCT00928083|19338202|P4|COMPLETED|Overall Study||5
7856562|NCT00928083|19338203|P3|COMPLETED|Overall Study||8
7856563|NCT00928083|19338204|P2|COMPLETED|Overall Study||8
7856564|NCT00928083|19338205|P1|COMPLETED|Overall Study||6
7856565|NCT00928083|19338197|P9|STARTED|Overall Study||6
7856566|NCT00928083|19338198|P8|STARTED|Overall Study||6
7856567|NCT00928083|19338199|P7|STARTED|Overall Study||6
7856568|NCT00928083|19338200|P6|STARTED|Overall Study||6
7856569|NCT00928083|19338201|P5|STARTED|Overall Study||7
7856570|NCT00928083|19338202|P4|STARTED|Overall Study||6
7856571|NCT00928083|19338203|P3|STARTED|Overall Study||8
7856572|NCT00928083|19338204|P2|STARTED|Overall Study||8
7856573|NCT00928083|19338205|P1|STARTED|Overall Study||10
7856574|NCT00928070|19338316|P2|NOT COMPLETED|Overall Study||57
7856575|NCT00928070|19338317|P1|NOT COMPLETED|Overall Study||63
7856576|NCT00928070|19338316|P2|COMPLETED|Overall Study||226
7856577|NCT00928070|19338317|P1|COMPLETED|Overall Study||220
7856578|NCT00928070|19338316|P2|Treated|Overall Study||281
7856579|NCT00928070|19338317|P1|Treated|Overall Study||281
7856580|NCT00928070|19338316|P2|STARTED|Overall Study||283
7856581|NCT00928070|19338317|P1|STARTED|Overall Study||283
7856582|NCT00928057|19338375|P2|NOT COMPLETED|Overall Study||4
7856583|NCT00928057|19338376|P1|NOT COMPLETED|Overall Study||2
7856584|NCT00928057|19338375|P2|COMPLETED|Overall Study||85
7856585|NCT00928057|19338376|P1|COMPLETED|Overall Study||82
7856586|NCT00928057|19338375|P2|STARTED|Overall Study||89
7856587|NCT00928057|19338376|P1|STARTED|Overall Study||84
7856588|NCT00928018|19338401|P2|NOT COMPLETED|Overall Study||0
7856589|NCT00928018|19338402|P1|NOT COMPLETED|Overall Study||1
7856590|NCT00928018|19338401|P2|COMPLETED|Overall Study||73
7856591|NCT00928018|19338402|P1|COMPLETED|Overall Study||65
7856592|NCT00928018|19338401|P2|STARTED|Overall Study||73
7856593|NCT00928018|19338402|P1|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66
7856594|NCT00927992|19338420|P1|NOT COMPLETED|Overall Study||0
7856595|NCT00927992|19338420|P1|COMPLETED|Overall Study||11
7856596|NCT00927992|19338420|P1|STARTED|Overall Study||11
7856597|NCT00927953|19338432|P2|NOT COMPLETED|Overall Study||1
7856598|NCT00927953|19338433|P1|NOT COMPLETED|Overall Study||2
7856599|NCT00927953|19338432|P2|COMPLETED|Overall Study||6
7856600|NCT00927953|19338433|P1|COMPLETED|Overall Study||4
7856601|NCT00927953|19338432|P2|STARTED|Overall Study||7
7856602|NCT00927953|19338433|P1|STARTED|Overall Study||6
7856603|NCT00927940|19338447|P1|NOT COMPLETED|Overall Study||1
7856604|NCT00927940|19338447|P1|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99
7856605|NCT00927940|19338447|P1|STARTED|Overall Study||100
7856606|NCT00927927|19338467|P15|NOT COMPLETED|Overall Study||0
7856607|NCT00927927|19338468|P14|NOT COMPLETED|Overall Study||0
7856608|NCT00927927|19338469|P13|NOT COMPLETED|Overall Study||0
7856609|NCT00927927|19338470|P12|NOT COMPLETED|Overall Study||2
7856610|NCT00927927|19338471|P11|NOT COMPLETED|Overall Study||0
7856611|NCT00927927|19338472|P10|NOT COMPLETED|Overall Study||0
7856612|NCT00927927|19338473|P9|NOT COMPLETED|Overall Study||0
7856613|NCT00927927|19338474|P8|NOT COMPLETED|Overall Study||2
7856614|NCT00927927|19338475|P7|NOT COMPLETED|Overall Study||0
7856615|NCT00927927|19338476|P6|NOT COMPLETED|Overall Study||0
7856616|NCT00927927|19338477|P5|NOT COMPLETED|Overall Study||0
7856617|NCT00927927|19338478|P4|NOT COMPLETED|Overall Study||0
7856618|NCT00927927|19338479|P3|NOT COMPLETED|Overall Study||0
7856619|NCT00927927|19338480|P2|NOT COMPLETED|Overall Study||0
7856620|NCT00927927|19338481|P1|NOT COMPLETED|Overall Study||0
7856621|NCT00927927|19338467|P15|COMPLETED|Overall Study||9
7856622|NCT00927927|19338468|P14|COMPLETED|Overall Study||5
7856623|NCT00927927|19338469|P13|COMPLETED|Overall Study||5
7856624|NCT00927927|19338470|P12|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4
7856625|NCT00927927|19338471|P11|COMPLETED|Overall Study||5
7856626|NCT00927927|19338472|P10|COMPLETED|Overall Study||3
7856627|NCT00927927|19338473|P9|COMPLETED|Overall Study||8
7856628|NCT00927927|19338474|P8|COMPLETED|Overall Study||1
7856629|NCT00927927|19338475|P7|COMPLETED|Overall Study||3
7856630|NCT00927927|19338476|P6|COMPLETED|Overall Study||3
7856631|NCT00927927|19338477|P5|COMPLETED|Overall Study||3
7856632|NCT00927927|19338478|P4|COMPLETED|Overall Study||3
7856633|NCT00927927|19338479|P3|COMPLETED|Overall Study||3
7856634|NCT00927927|19338480|P2|COMPLETED|Overall Study||3
7856635|NCT00927927|19338481|P1|COMPLETED|Overall Study||3
7856636|NCT00927927|19338467|P15|Exposed|Overall Study||9
7856637|NCT00927927|19338468|P14|Exposed|Overall Study||5
7856638|NCT00927927|19338469|P13|Exposed|Overall Study||5
7856639|NCT00927927|19338470|P12|Exposed|Overall Study||5
7856640|NCT00927927|19338471|P11|Exposed|Overall Study||5
7856641|NCT00927927|19338472|P10|Exposed|Overall Study||3
7856642|NCT00927927|19338473|P9|Exposed|Overall Study||8
7856643|NCT00927927|19338474|P8|Exposed|Overall Study||3
7856644|NCT00927927|19338475|P7|Exposed|Overall Study||3
7856645|NCT00927927|19338476|P6|Exposed|Overall Study||3
7856646|NCT00927927|19338477|P5|Exposed|Overall Study||3
7856647|NCT00927927|19338478|P4|Exposed|Overall Study||3
7856648|NCT00927927|19338479|P3|Exposed|Overall Study||3
7856649|NCT00927927|19338480|P2|Exposed|Overall Study||3
7856650|NCT00927927|19338481|P1|Exposed|Overall Study||3
7856651|NCT00927927|19338467|P15|STARTED|Overall Study||9
7856652|NCT00927927|19338468|P14|STARTED|Overall Study||5
7856653|NCT00927927|19338469|P13|STARTED|Overall Study||5
7856654|NCT00927927|19338470|P12|STARTED|Overall Study||6
7856655|NCT00927927|19338471|P11|STARTED|Overall Study||5
7856656|NCT00927927|19338472|P10|STARTED|Overall Study||3
7856657|NCT00927927|19338473|P9|STARTED|Overall Study||8
7856658|NCT00927927|19338474|P8|STARTED|Overall Study||3
7856659|NCT00927927|19338475|P7|STARTED|Overall Study||3
7856660|NCT00927927|19338476|P6|STARTED|Overall Study||3
7856661|NCT00927927|19338477|P5|STARTED|Overall Study||3
7856662|NCT00927927|19338478|P4|STARTED|Overall Study||3
7856663|NCT00927927|19338479|P3|STARTED|Overall Study||3
7856664|NCT00927927|19338480|P2|STARTED|Overall Study||3
7856665|NCT00927927|19338481|P1|STARTED|Overall Study||3
7856666|NCT00927901|19338528|P4|NOT COMPLETED|Treatment Period 4||1
7856667|NCT00927901|19338529|P3|NOT COMPLETED|Treatment Period 4||1
7856668|NCT00927901|19338530|P2|NOT COMPLETED|Treatment Period 4||0
7856669|NCT00927901|19338531|P1|NOT COMPLETED|Treatment Period 4||0
7856670|NCT00927901|19338528|P4|COMPLETED|Treatment Period 4||8
7856671|NCT00927901|19338529|P3|COMPLETED|Treatment Period 4||5
7856672|NCT00927901|19338530|P2|COMPLETED|Treatment Period 4||7
7856673|NCT00927901|19338531|P1|COMPLETED|Treatment Period 4||7
7856674|NCT00927901|19338528|P4|STARTED|Treatment Period 4||9
7856675|NCT00927901|19338529|P3|STARTED|Treatment Period 4||6
7856676|NCT00927901|19338530|P2|STARTED|Treatment Period 4||7
7856677|NCT00927901|19338531|P1|STARTED|Treatment Period 4||7
7856678|NCT00927901|19338528|P4|NOT COMPLETED|Treatment Period 3||0
7856679|NCT00927901|19338529|P3|NOT COMPLETED|Treatment Period 3||0
7856680|NCT00927901|19338530|P2|NOT COMPLETED|Treatment Period 3||0
7856681|NCT00927901|19338531|P1|NOT COMPLETED|Treatment Period 3||0
7856682|NCT00927901|19338528|P4|COMPLETED|Treatment Period 3||9
7856683|NCT00927901|19338529|P3|COMPLETED|Treatment Period 3||6
7856684|NCT00927901|19338530|P2|COMPLETED|Treatment Period 3||7
7856685|NCT00927901|19338531|P1|COMPLETED|Treatment Period 3||7
7856686|NCT00927901|19338528|P4|STARTED|Treatment Period 3||9
7856687|NCT00927901|19338529|P3|STARTED|Treatment Period 3||6
7856688|NCT00927901|19338530|P2|STARTED|Treatment Period 3||7
7856689|NCT00927901|19338531|P1|STARTED|Treatment Period 3||7
7856690|NCT00927901|19338528|P4|NOT COMPLETED|Treatment Period 2||0
7856691|NCT00927901|19338529|P3|NOT COMPLETED|Treatment Period 2||0
7856692|NCT00927901|19338530|P2|NOT COMPLETED|Treatment Period 2||0
7856693|NCT00927901|19338531|P1|NOT COMPLETED|Treatment Period 2||0
7856694|NCT00927901|19338528|P4|COMPLETED|Treatment Period 2||9
7856695|NCT00927901|19338529|P3|COMPLETED|Treatment Period 2||6
7856696|NCT00927901|19338530|P2|COMPLETED|Treatment Period 2||7
7856697|NCT00927901|19338531|P1|COMPLETED|Treatment Period 2||7
7856698|NCT00927901|19338528|P4|STARTED|Treatment Period 2||9
7856699|NCT00927901|19338529|P3|STARTED|Treatment Period 2||6
7856700|NCT00927901|19338530|P2|STARTED|Treatment Period 2||7
7856701|NCT00927901|19338531|P1|STARTED|Treatment Period 2||7
7856702|NCT00927901|19338528|P4|NOT COMPLETED|Treatment Period 1||0
7856703|NCT00927901|19338529|P3|NOT COMPLETED|Treatment Period 1||1
7856704|NCT00927901|19338530|P2|NOT COMPLETED|Treatment Period 1||0
7856705|NCT00927901|19338531|P1|NOT COMPLETED|Treatment Period 1||0
7856706|NCT00927901|19338528|P4|COMPLETED|Treatment Period 1||9
7856707|NCT00927901|19338529|P3|COMPLETED|Treatment Period 1||6
7856708|NCT00927901|19338530|P2|COMPLETED|Treatment Period 1||7
7856709|NCT00927901|19338531|P1|COMPLETED|Treatment Period 1||7
7856710|NCT00927901|19338528|P4|STARTED|Treatment Period 1||9
7856711|NCT00927901|19338529|P3|STARTED|Treatment Period 1||7
7856712|NCT00927901|19338530|P2|STARTED|Treatment Period 1||7
7856713|NCT00927901|19338531|P1|STARTED|Treatment Period 1||7
7856714|NCT00927888|19338561|P2|NOT COMPLETED|Overall Study||0
7856715|NCT00927888|19338562|P1|NOT COMPLETED|Overall Study||0
7856716|NCT00927888|19338561|P2|COMPLETED|Overall Study||27
7856717|NCT00927888|19338562|P1|COMPLETED|Overall Study||29
7856718|NCT00927888|19338561|P2|STARTED|Overall Study||27
7856719|NCT00927888|19338562|P1|STARTED|Overall Study||29
7856720|NCT00927862|19338572|P2|NOT COMPLETED|Overall Study||45
7856721|NCT00927862|19338573|P1|NOT COMPLETED|Overall Study||27
7856722|NCT00927862|19338572|P2|COMPLETED|Overall Study||1866
7856723|NCT00927862|19338573|P1|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477
7856724|NCT00927862|19338572|P2|STARTED|Overall Study||1911
7856725|NCT00927862|19338573|P1|STARTED|Overall Study||504
7856726|NCT00927849|19338598|P3|NOT COMPLETED|Overall Study||0
7856727|NCT00927849|19338599|P2|NOT COMPLETED|Overall Study||0
7856728|NCT00927849|19338600|P1|NOT COMPLETED|Overall Study||0
7856729|NCT00927849|19338598|P3|COMPLETED|Overall Study||21
7856730|NCT00927849|19338599|P2|COMPLETED|Overall Study||21
7856731|NCT00927849|19338600|P1|COMPLETED|Overall Study||21
7856732|NCT00927849|19338598|P3|STARTED|Overall Study||21
7856733|NCT00927849|19338599|P2|STARTED|Overall Study||21
7856734|NCT00927849|19338600|P1|STARTED|Overall Study||21
7856735|NCT00927823|19338608|P4|NOT COMPLETED|Continuous Dosing Period||5
7856736|NCT00927823|19338609|P3|NOT COMPLETED|Continuous Dosing Period||26
7856737|NCT00927823|19338610|P2|NOT COMPLETED|Continuous Dosing Period||3
7856738|NCT00927823|19338611|P1|NOT COMPLETED|Continuous Dosing Period||3
7856739|NCT00927823|19338608|P4|COMPLETED|Continuous Dosing Period||0
7856740|NCT00927823|19338609|P3|COMPLETED|Continuous Dosing Period||0
7856741|NCT00927823|19338610|P2|COMPLETED|Continuous Dosing Period||0
7856742|NCT00927823|19338611|P1|COMPLETED|Continuous Dosing Period||0
7856743|NCT00927823|19338608|P4|Treated|Continuous Dosing Period||5
7856744|NCT00927823|19338609|P3|Treated|Continuous Dosing Period||23
7856745|NCT00927823|19338610|P2|Treated|Continuous Dosing Period||3
7856746|NCT00927823|19338611|P1|Treated|Continuous Dosing Period||3
7856747|NCT00927823|19338608|P4|STARTED|Continuous Dosing Period||5
7856748|NCT00927823|19338609|P3|STARTED|Continuous Dosing Period||26
7856749|NCT00927823|19338610|P2|STARTED|Continuous Dosing Period||3
7856750|NCT00927823|19338611|P1|STARTED|Continuous Dosing Period||3
7856751|NCT00927823|19338608|P4|NOT COMPLETED|Lead-In Period||0
7856752|NCT00927823|19338609|P3|NOT COMPLETED|Lead-In Period||0
7856753|NCT00927823|19338610|P2|NOT COMPLETED|Lead-In Period||0
7856754|NCT00927823|19338611|P1|NOT COMPLETED|Lead-In Period||0
7856755|NCT00927823|19338608|P4|COMPLETED|Lead-In Period||5
7856756|NCT00927823|19338609|P3|COMPLETED|Lead-In Period||26
7856757|NCT00927823|19338610|P2|COMPLETED|Lead-In Period||3
7856758|NCT00927823|19338611|P1|COMPLETED|Lead-In Period||3
7856759|NCT00927823|19338608|P4|STARTED|Lead-In Period||5
7856760|NCT00927823|19338609|P3|STARTED|Lead-In Period||26
7856761|NCT00927823|19338610|P2|STARTED|Lead-In Period||3
7856762|NCT00927823|19338611|P1|STARTED|Lead-In Period||3
7856763|NCT00927784|19338677|P2|NOT COMPLETED|Overall Study||0
7856764|NCT00927784|19338678|P1|NOT COMPLETED|Overall Study||2
7856765|NCT00927784|19338677|P2|COMPLETED|Overall Study||2
7856766|NCT00927784|19338678|P1|COMPLETED|Overall Study||6
7856767|NCT00927784|19338677|P2|STARTED|Overall Study||2
7856768|NCT00927784|19338678|P1|STARTED|Overall Study||8
7856769|NCT00927758|19338708|P6|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
7856770|NCT00927758|19338709|P5|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
7856771|NCT00927758|19338710|P4|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
7856772|NCT00927758|19338711|P3|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
7856773|NCT00927758|19338712|P2|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
7856774|NCT00927758|19338713|P1|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
7856775|NCT00927758|19338708|P6|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2
7856776|NCT00927758|19338709|P5|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
7856777|NCT00927758|19338710|P4|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1
7856778|NCT00927758|19338711|P3|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
7856779|NCT00927758|19338712|P2|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
7856780|NCT00927758|19338713|P1|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
7856781|NCT00927758|19338708|P6|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2
7856782|NCT00927758|19338709|P5|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
7856783|NCT00927758|19338710|P4|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1
7856784|NCT00927758|19338711|P3|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
7856785|NCT00927758|19338712|P2|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
7856786|NCT00927758|19338713|P1|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
7856787|NCT00927758|19338708|P6|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
7856788|NCT00927758|19338709|P5|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
7856789|NCT00927758|19338710|P4|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
7856790|NCT00927758|19338711|P3|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
7856791|NCT00927758|19338712|P2|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
7856792|NCT00927758|19338713|P1|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
7856793|NCT00927758|19338708|P6|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2
7856794|NCT00927758|19338709|P5|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
7856795|NCT00927758|19338710|P4|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
7856796|NCT00927758|19338711|P3|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
7856797|NCT00927758|19338712|P2|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
7856798|NCT00927758|19338713|P1|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
7856799|NCT00927758|19338708|P6|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2
7856800|NCT00927758|19338709|P5|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
7856801|NCT00927758|19338710|P4|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1
7856802|NCT00927758|19338711|P3|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
7856803|NCT00927758|19338712|P2|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
7856804|NCT00927758|19338713|P1|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
7856805|NCT00927758|19338708|P6|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
7856806|NCT00927758|19338709|P5|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
7856807|NCT00927758|19338710|P4|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2
7856808|NCT00927758|19338711|P3|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
7856809|NCT00927758|19338712|P2|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
7856810|NCT00927758|19338713|P1|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
7856811|NCT00927758|19338708|P6|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
7856812|NCT00927758|19338709|P5|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
7856813|NCT00927758|19338710|P4|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
7856814|NCT00927758|19338711|P3|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
7856815|NCT00927758|19338712|P2|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
7856816|NCT00927758|19338713|P1|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
7856817|NCT00927758|19338708|P6|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
7856818|NCT00927758|19338709|P5|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
7856819|NCT00927758|19338710|P4|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2
7856820|NCT00927758|19338711|P3|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
7856821|NCT00927758|19338712|P2|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
7856822|NCT00927758|19338713|P1|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
7856823|NCT00927758|19338708|P6|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
7856824|NCT00927758|19338709|P5|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
7856825|NCT00927758|19338710|P4|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2
7856826|NCT00927758|19338711|P3|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
7856827|NCT00927758|19338712|P2|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
7856828|NCT00927758|19338713|P1|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
7856829|NCT00927758|19338708|P6|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
7856830|NCT00927758|19338709|P5|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
7856831|NCT00927758|19338710|P4|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
7856832|NCT00927758|19338711|P3|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
7856833|NCT00927758|19338712|P2|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
7856834|NCT00927758|19338713|P1|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4
7856835|NCT00927589|19338721|P1|NOT COMPLETED|Overall Study||16
7856836|NCT00927589|19338721|P1|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43
7856837|NCT00927589|19338721|P1|STARTED|Overall Study||59
7856838|NCT00927576|19338745|P2|NOT COMPLETED|Overall Study||0
7856839|NCT00927576|19338746|P1|NOT COMPLETED|Overall Study||0
7856840|NCT00927576|19338745|P2|COMPLETED|Overall Study||28
7856841|NCT00927576|19338746|P1|COMPLETED|Overall Study||237
7856842|NCT00927576|19338745|P2|Cognitive Testing|Overall Study||28
7856843|NCT00927576|19338746|P1|Cognitive Testing|Overall Study||237
7856844|NCT00927576|19338745|P2|STARTED|Overall Study||28
7856845|NCT00927576|19338746|P1|STARTED|Overall Study||237
7856846|NCT00927563|19338751|P1|NOT COMPLETED|Overall Study||2
7856847|NCT00927563|19338751|P1|COMPLETED|Overall Study||22
7856848|NCT00927563|19338751|P1|STARTED|Overall Study||24
7856849|NCT00927485|19338759|P2|NOT COMPLETED|Overall Study||4
7856850|NCT00927485|19338760|P1|NOT COMPLETED|Overall Study||6
7856851|NCT00927485|19338759|P2|COMPLETED|Overall Study||19
7856852|NCT00927485|19338760|P1|COMPLETED|Overall Study||15
7856853|NCT00927485|19338759|P2|STARTED|Overall Study||23
7856854|NCT00927485|19338760|P1|STARTED|Overall Study||21
7856855|NCT00927472|19338770|P2|NOT COMPLETED|Overall Study||22
7856856|NCT00927472|19338771|P1|NOT COMPLETED|Overall Study||11
7856857|NCT00927472|19338770|P2|COMPLETED|Overall Study||106
7856858|NCT00927472|19338771|P1|COMPLETED|Overall Study||115
7856859|NCT00927472|19338770|P2|STARTED|Overall Study||128
7856860|NCT00927472|19338771|P1|STARTED|Overall Study||126
7856861|NCT00927394|19338797|P2|NOT COMPLETED|Overall Study||85
7856862|NCT00927394|19338798|P1|NOT COMPLETED|Overall Study||77
7856863|NCT00927394|19338797|P2|COMPLETED|Overall Study||483
7856864|NCT00927394|19338798|P1|COMPLETED|Overall Study||498
7856865|NCT00927394|19338797|P2|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562
7856866|NCT00927394|19338798|P1|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574
7856867|NCT00927394|19338797|P2|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323
7856868|NCT00927394|19338798|P1|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342
7856869|NCT00927394|19338797|P2|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398
7856870|NCT00927394|19338798|P1|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417
7856871|NCT00927394|19338797|P2|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164
7856872|NCT00927394|19338798|P1|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157
7856873|NCT00927394|19338797|P2|Combined Safety Set (Cohort 1 and 2)|Overall Study||565
7856874|NCT00927394|19338798|P1|Combined Safety Set (Cohort 1 and 2)|Overall Study||574
7856875|NCT00927394|19338797|P2|Cohort 2 (Randomized)|Overall Study||403
7856876|NCT00927394|19338798|P1|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418
7856877|NCT00927394|19338797|P2|Cohort 1 (Randomized)|Overall Study||165
7856878|NCT00927394|19338798|P1|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157
7856879|NCT00927394|19338797|P2|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568
7856880|NCT00927394|19338798|P1|STARTED|Overall Study||575
7856881|NCT00927368|19338829|P3|NOT COMPLETED|Overall Study||5
7856882|NCT00927368|19338830|P2|NOT COMPLETED|Overall Study||5
7856883|NCT00927368|19338831|P1|NOT COMPLETED|Overall Study||6
7856884|NCT00927368|19338829|P3|COMPLETED|Overall Study||138
7856885|NCT00927368|19338830|P2|COMPLETED|Overall Study||152
7856886|NCT00927368|19338831|P1|COMPLETED|Overall Study||147
7856887|NCT00927368|19338829|P3|STARTED|Overall Study||143
7856888|NCT00927368|19338830|P2|STARTED|Overall Study||157
7856889|NCT00927368|19338831|P1|STARTED|Overall Study||153
7856890|NCT00927355|19338850|P2|NOT COMPLETED|Overall Study||1
7856891|NCT00927355|19338851|P1|NOT COMPLETED|Overall Study||1
7856892|NCT00927355|19338850|P2|COMPLETED|Overall Study||4
7856893|NCT00927355|19338851|P1|COMPLETED|Overall Study||4
7856894|NCT00927355|19338850|P2|STARTED|Overall Study||5
7856895|NCT00927355|19338851|P1|STARTED|Overall Study||5
7856896|NCT00927264|19338871|P2|NOT COMPLETED|Overall Study||25
7856897|NCT00927264|19338872|P1|NOT COMPLETED|Overall Study||56
7856898|NCT00927264|19338871|P2|COMPLETED|Overall Study||140
7856899|NCT00927264|19338872|P1|COMPLETED|Overall Study||109
7856900|NCT00927264|19338871|P2|STARTED|Overall Study||165
7856901|NCT00927264|19338872|P1|STARTED|Overall Study||165
7856902|NCT00927251|19338886|P1|NOT COMPLETED|Overall Study||8
7856903|NCT00927251|19338886|P1|COMPLETED|Overall Study||82
7856904|NCT00927251|19338886|P1|STARTED|Overall Study||90
7856905|NCT00927186|19338892|P2|NOT COMPLETED|12 - 24 Months Extension Treatment||0
7856906|NCT00927186|19338893|P1|NOT COMPLETED|12 - 24 Months Extension Treatment||0
7856907|NCT00927186|19338892|P2|COMPLETED|12 - 24 Months Extension Treatment||11
7856908|NCT00927186|19338893|P1|COMPLETED|12 - 24 Months Extension Treatment||10
7856909|NCT00927186|19338892|P2|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11
7856910|NCT00927186|19338893|P1|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10
7856911|NCT00927186|19338892|P2|NOT COMPLETED|12 Months Primary Study||4
7856912|NCT00927186|19338893|P1|NOT COMPLETED|12 Months Primary Study||7
7856913|NCT00927186|19338892|P2|COMPLETED|12 Months Primary Study||31
7856914|NCT00927186|19338893|P1|COMPLETED|12 Months Primary Study||27
7856915|NCT00927186|19338892|P2|Completed 6 Months Double Blind Phase|12 Months Primary Study||31
7856916|NCT00927186|19338893|P1|Completed 6 Months Double Blind Phase|12 Months Primary Study||28
7856917|NCT00927186|19338892|P2|STARTED|12 Months Primary Study||35
7856918|NCT00927186|19338893|P1|STARTED|12 Months Primary Study||34
7856919|NCT00927160|19339011|P2|NOT COMPLETED|Overall Study||0
7856920|NCT00927160|19339012|P1|NOT COMPLETED|Overall Study||0
7856921|NCT00927160|19339011|P2|COMPLETED|Overall Study||173
7856922|NCT00927160|19339012|P1|COMPLETED|Overall Study||173
7856923|NCT00927160|19339011|P2|STARTED|Overall Study||173
7856924|NCT00927160|19339012|P1|STARTED|Overall Study||173
7856925|NCT00927095|19339023|P3|NOT COMPLETED|Overall Study||2
7856926|NCT00927095|19339024|P2|NOT COMPLETED|Overall Study||4
7856927|NCT00927095|19339025|P1|NOT COMPLETED|Overall Study||6
7856928|NCT00927095|19339023|P3|COMPLETED|Overall Study||22
7856929|NCT00927095|19339024|P2|COMPLETED|Overall Study||17
7856930|NCT00927095|19339025|P1|COMPLETED|Overall Study||16
7856931|NCT00927095|19339023|P3|STARTED|Overall Study||24
7856932|NCT00927095|19339024|P2|STARTED|Overall Study||21
7856933|NCT00927095|19339025|P1|STARTED|Overall Study||22
7856934|NCT00927082|19339037|P4|NOT COMPLETED|Overall Study||19
7856935|NCT00927082|19339038|P3|NOT COMPLETED|Overall Study||22
7856936|NCT00927082|19339039|P2|NOT COMPLETED|Overall Study||10
7856937|NCT00927082|19339040|P1|NOT COMPLETED|Overall Study||12
7856938|NCT00927082|19339037|P4|COMPLETED|Overall Study||78
7856939|NCT00927082|19339038|P3|COMPLETED|Overall Study||86
7856940|NCT00927082|19339039|P2|COMPLETED|Overall Study||77
7856941|NCT00927082|19339040|P1|COMPLETED|Overall Study||79
7856942|NCT00927082|19339037|P4|STARTED|Overall Study||97
7856943|NCT00927082|19339038|P3|STARTED|Overall Study||108
7856944|NCT00927082|19339039|P2|STARTED|Overall Study||87
7856945|NCT00927082|19339040|P1|STARTED|Overall Study||91
7856946|NCT00927069|19339104|P4|NOT COMPLETED|Week 12 to Week 24||3
7856947|NCT00927069|19339105|P3|NOT COMPLETED|Week 12 to Week 24||3
7856948|NCT00927069|19339106|P2|NOT COMPLETED|Week 12 to Week 24||0
7856949|NCT00927069|19339107|P1|NOT COMPLETED|Week 12 to Week 24||2
7856950|NCT00927069|19339104|P4|COMPLETED|Week 12 to Week 24||20
7856951|NCT00927069|19339105|P3|COMPLETED|Week 12 to Week 24||28
7856952|NCT00927069|19339106|P2|COMPLETED|Week 12 to Week 24||11
7856953|NCT00927069|19339107|P1|COMPLETED|Week 12 to Week 24||16
7856954|NCT00927069|19339104|P4|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23
7856955|NCT00927069|19339105|P3|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31
7856956|NCT00927069|19339106|P2|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11
7856957|NCT00927069|19339107|P1|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18
7856958|NCT00927069|19339104|P4|NOT COMPLETED|Week 0 to Week 12||0
7856959|NCT00927069|19339105|P3|NOT COMPLETED|Week 0 to Week 12||0
7856960|NCT00927069|19339106|P2|NOT COMPLETED|Week 0 to Week 12||1
7856961|NCT00927069|19339107|P1|NOT COMPLETED|Week 0 to Week 12||1
7856962|NCT00927069|19339104|P4|COMPLETED|Week 0 to Week 12||0
7856963|NCT00927069|19339105|P3|COMPLETED|Week 0 to Week 12||0
7856964|NCT00927069|19339106|P2|COMPLETED|Week 0 to Week 12||34
7856965|NCT00927069|19339107|P1|COMPLETED|Week 0 to Week 12||49
7856966|NCT00927069|19339104|P4|STARTED|Week 0 to Week 12||0
7856967|NCT00927069|19339105|P3|STARTED|Week 0 to Week 12||0
7856968|NCT00927069|19339106|P2|STARTED|Week 0 to Week 12||35
7856969|NCT00927069|19339107|P1|STARTED|Week 0 to Week 12||50
7856970|NCT00926952|19339117|P1|NOT COMPLETED|Overall Study||0
7856971|NCT00926952|19339117|P1|COMPLETED|Overall Study||20
7856972|NCT00926952|19339117|P1|STARTED|Overall Study||20
7856973|NCT00926887|19339131|P2|NOT COMPLETED|Overall Study||0
7856974|NCT00926887|19339132|P1|NOT COMPLETED|Overall Study||0
7856975|NCT00926887|19339131|P2|COMPLETED|Overall Study||50
7856976|NCT00926887|19339132|P1|COMPLETED|Overall Study||54
7856977|NCT00926887|19339131|P2|STARTED|Overall Study||50
7856978|NCT00926887|19339132|P1|STARTED|Overall Study||54
7856979|NCT00926848|19339144|P2|NOT COMPLETED|Overall Study||0
7856980|NCT00926848|19339145|P1|NOT COMPLETED|Overall Study||0
7856981|NCT00926848|19339144|P2|COMPLETED|Overall Study||34
7856982|NCT00926848|19339145|P1|COMPLETED|Overall Study||34
7856983|NCT00926848|19339144|P2|STARTED|Overall Study||34
7856984|NCT00926848|19339145|P1|STARTED|Overall Study||34
7856985|NCT00926796|19339163|P2|NOT COMPLETED|Overall Study||106
7856986|NCT00926796|19339164|P1|NOT COMPLETED|Overall Study||107
7856987|NCT00926796|19339163|P2|COMPLETED|Overall Study|Number eligible and in the full analysis set|199
7856988|NCT00926796|19339164|P1|COMPLETED|Overall Study|Number eligible and in the full analysis set|202
7856989|NCT00926796|19339163|P2|STARTED|Overall Study|Number randomized|305
7856990|NCT00926796|19339164|P1|STARTED|Overall Study|Number randomized|309
7856991|NCT00926783|19339185|P2|NOT COMPLETED|Overall Study||3
7856992|NCT00926783|19339186|P1|NOT COMPLETED|Overall Study||3
7856993|NCT00926783|19339185|P2|COMPLETED|Overall Study||38
7856994|NCT00926783|19339186|P1|COMPLETED|Overall Study||39
7856995|NCT00926783|19339185|P2|STARTED|Overall Study||41
7856996|NCT00926783|19339186|P1|STARTED|Overall Study||42
7856997|NCT00926588|19339204|P2|NOT COMPLETED|Overall Study||4
7856998|NCT00926588|19339205|P1|NOT COMPLETED|Overall Study||8
7856999|NCT00926588|19339204|P2|COMPLETED|Overall Study||122
7857000|NCT00926588|19339205|P1|COMPLETED|Overall Study||116
7857001|NCT00926588|19339204|P2|STARTED|Overall Study||126
7857002|NCT00926588|19339205|P1|STARTED|Overall Study||124
7857003|NCT00926575|19339213|P2|NOT COMPLETED|Overall Study||17
7857004|NCT00926575|19339214|P1|NOT COMPLETED|Overall Study||16
7857005|NCT00926575|19339213|P2|COMPLETED|Overall Study||53
7857006|NCT00926575|19339214|P1|COMPLETED|Overall Study||54
7857007|NCT00926575|19339213|P2|STARTED|Overall Study||70
7857008|NCT00926575|19339214|P1|STARTED|Overall Study||70
7857009|NCT00926536|19339226|P2|NOT COMPLETED|Overall Study||2
7857010|NCT00926536|19339227|P1|NOT COMPLETED|Overall Study||1
7857011|NCT00926536|19339226|P2|COMPLETED|Overall Study||41
7857012|NCT00926536|19339227|P1|COMPLETED|Overall Study||43
7857013|NCT00926536|19339226|P2|STARTED|Overall Study||43
7857014|NCT00926536|19339227|P1|STARTED|Overall Study||44
7857015|NCT00926497|19339237|P2|NOT COMPLETED|Overall Study||0
7857016|NCT00926497|19339238|P1|NOT COMPLETED|Overall Study||0
7857017|NCT00926497|19339237|P2|COMPLETED|Overall Study||61
7857018|NCT00926497|19339238|P1|COMPLETED|Overall Study||60
7857019|NCT00926497|19339237|P2|STARTED|Overall Study||61
7857020|NCT00926497|19339238|P1|STARTED|Overall Study||60
7857021|NCT00926393|19339248|P2|NOT COMPLETED|Overall Study||3
7857022|NCT00926393|19339249|P1|NOT COMPLETED|Overall Study||2
7857023|NCT00926393|19339248|P2|COMPLETED|Overall Study||67
7857024|NCT00926393|19339249|P1|COMPLETED|Overall Study||67
7857025|NCT00926393|19339248|P2|STARTED|Overall Study||70
7857026|NCT00926393|19339249|P1|STARTED|Overall Study||69
7857027|NCT00926380|19339282|P3|NOT COMPLETED|Year 2||5
7857028|NCT00926380|19339283|P2|NOT COMPLETED|Year 2||2
7857029|NCT00926380|19339284|P1|NOT COMPLETED|Year 2||2
7857030|NCT00926380|19339282|P3|COMPLETED|Year 2||24
7857031|NCT00926380|19339283|P2|COMPLETED|Year 2||28
7857032|NCT00926380|19339284|P1|COMPLETED|Year 2||31
7857033|NCT00926380|19339282|P3|STARTED|Year 2||29
7857034|NCT00926380|19339283|P2|STARTED|Year 2||30
7857035|NCT00926380|19339284|P1|STARTED|Year 2||33
7857036|NCT00926380|19339282|P3|NOT COMPLETED|Year 1||1
7857037|NCT00926380|19339283|P2|NOT COMPLETED|Year 1||1
7857038|NCT00926380|19339284|P1|NOT COMPLETED|Year 1||0
7857039|NCT00926380|19339282|P3|COMPLETED|Year 1||29
7857040|NCT00926380|19339283|P2|COMPLETED|Year 1||30
7857041|NCT00926380|19339284|P1|COMPLETED|Year 1||33
7857042|NCT00926380|19339282|P3|STARTED|Year 1||30
7857043|NCT00926380|19339283|P2|STARTED|Year 1||31
7857044|NCT00926380|19339284|P1|STARTED|Year 1||33
7857045|NCT00926367|19339294|P2|NOT COMPLETED|Overall Study||3
7857046|NCT00926367|19339295|P1|NOT COMPLETED|Overall Study||2
7857047|NCT00926367|19339294|P2|COMPLETED|Overall Study||24
7857048|NCT00926367|19339295|P1|COMPLETED|Overall Study||23
7857049|NCT00926367|19339294|P2|STARTED|Overall Study||27
7857050|NCT00926367|19339295|P1|STARTED|Overall Study||25
7857051|NCT00926328|19339337|P2|NOT COMPLETED|Overall Study||14
7857052|NCT00926328|19339338|P1|NOT COMPLETED|Overall Study||12
7857053|NCT00926328|19339337|P2|COMPLETED|Overall Study||46
7857054|NCT00926328|19339338|P1|COMPLETED|Overall Study||48
7857055|NCT00926328|19339337|P2|STARTED|Overall Study||60
7857056|NCT00926328|19339338|P1|STARTED|Overall Study||60
7857057|NCT00926289|19339348|P2|NOT COMPLETED|Overall Study||36
7857058|NCT00926289|19339349|P1|NOT COMPLETED|Overall Study||25
7857059|NCT00926289|19339348|P2|COMPLETED|Overall Study||558
7857060|NCT00926289|19339349|P1|COMPLETED|Overall Study||269
7857061|NCT00926289|19339348|P2|STARTED|Overall Study|Number of treated patients|594
7857062|NCT00926289|19339349|P1|STARTED|Overall Study|Number of treated patients|294
7857063|NCT00926263|19339385|P2|NOT COMPLETED|Overall Study||0
7857064|NCT00926263|19339386|P1|NOT COMPLETED|Overall Study||0
7857065|NCT00926263|19339385|P2|COMPLETED|Overall Study||12
7857066|NCT00926263|19339386|P1|COMPLETED|Overall Study||16
7857067|NCT00926263|19339385|P2|STARTED|Overall Study||12
7857068|NCT00926263|19339386|P1|STARTED|Overall Study||16
7857069|NCT00926237|19339417|P2|NOT COMPLETED|Overall Study||1
7857070|NCT00926237|19339418|P1|NOT COMPLETED|Overall Study||2
7857071|NCT00926237|19339417|P2|COMPLETED|Overall Study||19
7857072|NCT00926237|19339418|P1|COMPLETED|Overall Study||17
7857073|NCT00926237|19339417|P2|STARTED|Overall Study|One subjects withdrew after receiving sham rTMS but before receiving active rTMS.|20
7857162|NCT00925782|19339546|P1|COMPLETED|Study Period (Day -3 to Day 0)||12
7857074|NCT00926237|19339418|P1|STARTED|Overall Study|Two subjects withdrew after receiving sham rTMS but before receiving active rTMS.|19
7857075|NCT00926211|19339428|P1|NOT COMPLETED|Overall Study||1
7857076|NCT00926211|19339428|P1|COMPLETED|Overall Study||35
7857077|NCT00926211|19339428|P1|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36
7857078|NCT00926185|19339439|P4|NOT COMPLETED|Overall Study||10
7857079|NCT00926185|19339440|P3|NOT COMPLETED|Overall Study||10
7857080|NCT00926185|19339441|P2|NOT COMPLETED|Overall Study||6
7857081|NCT00926185|19339442|P1|NOT COMPLETED|Overall Study||3
7857082|NCT00926185|19339439|P4|COMPLETED|Overall Study||48
7857083|NCT00926185|19339440|P3|COMPLETED|Overall Study||48
7857084|NCT00926185|19339441|P2|COMPLETED|Overall Study||51
7857085|NCT00926185|19339442|P1|COMPLETED|Overall Study||54
7857086|NCT00926185|19339439|P4|STARTED|Overall Study||58
7857087|NCT00926185|19339440|P3|STARTED|Overall Study||58
7857088|NCT00926185|19339441|P2|STARTED|Overall Study||57
7857089|NCT00926185|19339442|P1|STARTED|Overall Study||57
7857090|NCT00926029|19339459|P3|NOT COMPLETED|Overall Study||1
7857091|NCT00926029|19339460|P2|NOT COMPLETED|Overall Study||1
7857092|NCT00926029|19339461|P1|NOT COMPLETED|Overall Study||2
7857093|NCT00926029|19339459|P3|COMPLETED|Overall Study||33
7857094|NCT00926029|19339460|P2|COMPLETED|Overall Study||33
7857095|NCT00926029|19339461|P1|COMPLETED|Overall Study||32
7857096|NCT00926029|19339459|P3|STARTED|Overall Study||34
7857097|NCT00926029|19339460|P2|STARTED|Overall Study||34
7857098|NCT00926029|19339461|P1|STARTED|Overall Study||34
7857099|NCT00926003|19339475|P3|NOT COMPLETED|Post-Training 3-month Follow-up||0
7857100|NCT00926003|19339476|P2|NOT COMPLETED|Post-Training 3-month Follow-up||0
7857101|NCT00926003|19339477|P1|NOT COMPLETED|Post-Training 3-month Follow-up||1
7857102|NCT00926003|19339475|P3|COMPLETED|Post-Training 3-month Follow-up||52
7857103|NCT00926003|19339476|P2|COMPLETED|Post-Training 3-month Follow-up||54
7857104|NCT00926003|19339477|P1|COMPLETED|Post-Training 3-month Follow-up||51
7857105|NCT00926003|19339475|P3|STARTED|Post-Training 3-month Follow-up||52
7857106|NCT00926003|19339476|P2|STARTED|Post-Training 3-month Follow-up||54
7857107|NCT00926003|19339477|P1|STARTED|Post-Training 3-month Follow-up||52
7857108|NCT00926003|19339475|P3|NOT COMPLETED|Post-Training Evaluation||0
7857109|NCT00926003|19339476|P2|NOT COMPLETED|Post-Training Evaluation||0
7857110|NCT00926003|19339477|P1|NOT COMPLETED|Post-Training Evaluation||1
7857111|NCT00926003|19339475|P3|COMPLETED|Post-Training Evaluation||52
7857112|NCT00926003|19339476|P2|COMPLETED|Post-Training Evaluation||54
7857113|NCT00926003|19339477|P1|COMPLETED|Post-Training Evaluation||52
7857114|NCT00926003|19339475|P3|STARTED|Post-Training Evaluation||52
7857115|NCT00926003|19339476|P2|STARTED|Post-Training Evaluation||54
7857116|NCT00926003|19339477|P1|STARTED|Post-Training Evaluation||53
7857117|NCT00926003|19339475|P3|NOT COMPLETED|Baseline||0
7857118|NCT00926003|19339476|P2|NOT COMPLETED|Baseline||0
7857119|NCT00926003|19339477|P1|NOT COMPLETED|Baseline||0
7857120|NCT00926003|19339475|P3|COMPLETED|Baseline||52
7857121|NCT00926003|19339476|P2|COMPLETED|Baseline||54
7857122|NCT00926003|19339477|P1|COMPLETED|Baseline||53
7857123|NCT00926003|19339475|P3|STARTED|Baseline||52
7857124|NCT00926003|19339476|P2|STARTED|Baseline||54
7857125|NCT00926003|19339477|P1|STARTED|Baseline||53
7857126|NCT00925990|19339490|P2|NOT COMPLETED|Overall Study||11
7857127|NCT00925990|19339491|P1|NOT COMPLETED|Overall Study||5
7857128|NCT00925990|19339490|P2|COMPLETED|Overall Study||24
7857129|NCT00925990|19339491|P1|COMPLETED|Overall Study||30
7857130|NCT00925990|19339490|P2|STARTED|Overall Study||35
7857131|NCT00925990|19339491|P1|STARTED|Overall Study||35
7857132|NCT00925938|19339502|P3|NOT COMPLETED|Overall Study||0
7857133|NCT00925938|19339503|P2|NOT COMPLETED|Overall Study||0
7857134|NCT00925938|19339504|P1|NOT COMPLETED|Overall Study||0
7857135|NCT00925938|19339502|P3|COMPLETED|Overall Study||17
7857136|NCT00925938|19339503|P2|COMPLETED|Overall Study||25
7857137|NCT00925938|19339504|P1|COMPLETED|Overall Study||9
7857138|NCT00925938|19339502|P3|STARTED|Overall Study||17
7857139|NCT00925938|19339503|P2|STARTED|Overall Study||25
7857140|NCT00925938|19339504|P1|STARTED|Overall Study||9
7857141|NCT00925899|19339526|P2|NOT COMPLETED|Part 2||12
7857142|NCT00925899|19339527|P1|NOT COMPLETED|Part 2||6
7857143|NCT00925899|19339526|P2|COMPLETED|Part 2||9
7857144|NCT00925899|19339527|P1|COMPLETED|Part 2||9
7857145|NCT00925899|19339526|P2|STARTED|Part 2|Nine patients withdrew because they did not wish to continue in the study|21
7857146|NCT00925899|19339527|P1|STARTED|Part 2|All patients received the same intervention in the second part of the study (20 mg melatonin)|15
7857147|NCT00925899|19339526|P2|NOT COMPLETED|Part 1||11
7857148|NCT00925899|19339527|P1|NOT COMPLETED|Part 1||11
7857149|NCT00925899|19339526|P2|COMPLETED|Part 1||27
7857150|NCT00925899|19339527|P1|COMPLETED|Part 1||23
7857151|NCT00925899|19339526|P2|STARTED|Part 1||38
7857152|NCT00925899|19339527|P1|STARTED|Part 1||34
7857153|NCT00925782|19339545|P2|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
7857154|NCT00925782|19339546|P1|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
7857155|NCT00925782|19339545|P2|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
7857156|NCT00925782|19339546|P1|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
7857157|NCT00925782|19339545|P2|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
7857158|NCT00925782|19339546|P1|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
7857159|NCT00925782|19339545|P2|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
7857160|NCT00925782|19339546|P1|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
7857161|NCT00925782|19339545|P2|COMPLETED|Study Period (Day -3 to Day 0)||12
7857163|NCT00925782|19339545|P2|STARTED|Study Period (Day -3 to Day 0)||12
7857164|NCT00925782|19339546|P1|STARTED|Study Period (Day -3 to Day 0)||12
7857165|NCT00925782|19339545|P2|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
7857166|NCT00925782|19339546|P1|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
7857167|NCT00925782|19339545|P2|COMPLETED|Pretreatment (Day -30 to Day -3)||12
7857168|NCT00925782|19339546|P1|COMPLETED|Pretreatment (Day -30 to Day -3)||12
7857169|NCT00925782|19339545|P2|STARTED|Pretreatment (Day -30 to Day -3)||12
7857170|NCT00925782|19339546|P1|STARTED|Pretreatment (Day -30 to Day -3)||12
7857171|NCT00925769|19339555|P6|NOT COMPLETED|Overall Study||3
7857172|NCT00925769|19339556|P5|NOT COMPLETED|Overall Study||3
7857173|NCT00925769|19339557|P4|NOT COMPLETED|Overall Study||6
7857174|NCT00925769|19339558|P3|NOT COMPLETED|Overall Study||6
7857175|NCT00925769|19339559|P2|NOT COMPLETED|Overall Study||6
7857176|NCT00925769|19339560|P1|NOT COMPLETED|Overall Study||6
7857177|NCT00925769|19339555|P6|COMPLETED|Overall Study||0
7857178|NCT00925769|19339556|P5|COMPLETED|Overall Study||0
7857179|NCT00925769|19339557|P4|COMPLETED|Overall Study||0
7857180|NCT00925769|19339558|P3|COMPLETED|Overall Study||0
7857181|NCT00925769|19339559|P2|COMPLETED|Overall Study||0
7857182|NCT00925769|19339560|P1|COMPLETED|Overall Study||0
7857183|NCT00925769|19339555|P6|STARTED|Overall Study||3
7857184|NCT00925769|19339556|P5|STARTED|Overall Study||3
7857185|NCT00925769|19339557|P4|STARTED|Overall Study||6
7857186|NCT00925769|19339558|P3|STARTED|Overall Study||6
7857187|NCT00925769|19339559|P2|STARTED|Overall Study||6
7857188|NCT00925769|19339560|P1|STARTED|Overall Study||6
7857189|NCT00925756|19339622|P1|NOT COMPLETED|Overall Study||0
7857190|NCT00925756|19339622|P1|COMPLETED|Overall Study||32
7857191|NCT00925756|19339622|P1|STARTED|Overall Study||32
7857192|NCT00925704|19339634|P6|NOT COMPLETED|Third Intervention||1
7857193|NCT00925704|19339635|P5|NOT COMPLETED|Third Intervention||0
7857194|NCT00925704|19339636|P4|NOT COMPLETED|Third Intervention||0
7857195|NCT00925704|19339637|P3|NOT COMPLETED|Third Intervention||0
7857196|NCT00925704|19339638|P2|NOT COMPLETED|Third Intervention||0
7857197|NCT00925704|19339639|P1|NOT COMPLETED|Third Intervention||0
7857198|NCT00925704|19339634|P6|COMPLETED|Third Intervention||6
7857199|NCT00925704|19339635|P5|COMPLETED|Third Intervention||5
7857200|NCT00925704|19339636|P4|COMPLETED|Third Intervention||6
7857201|NCT00925704|19339637|P3|COMPLETED|Third Intervention||7
7857202|NCT00925704|19339638|P2|COMPLETED|Third Intervention||7
7857203|NCT00925704|19339639|P1|COMPLETED|Third Intervention||5
7857204|NCT00925704|19339634|P6|STARTED|Third Intervention||7
7857205|NCT00925704|19339635|P5|STARTED|Third Intervention||5
7857206|NCT00925704|19339636|P4|STARTED|Third Intervention||6
7857207|NCT00925704|19339637|P3|STARTED|Third Intervention||7
7857208|NCT00925704|19339638|P2|STARTED|Third Intervention||7
7857209|NCT00925704|19339639|P1|STARTED|Third Intervention||5
7857210|NCT00925704|19339634|P6|NOT COMPLETED|Washout||0
7857211|NCT00925704|19339635|P5|NOT COMPLETED|Washout||0
7857212|NCT00925704|19339636|P4|NOT COMPLETED|Washout||0
7857213|NCT00925704|19339637|P3|NOT COMPLETED|Washout||0
7857214|NCT00925704|19339638|P2|NOT COMPLETED|Washout||0
7857215|NCT00925704|19339639|P1|NOT COMPLETED|Washout||0
7857216|NCT00925704|19339634|P6|COMPLETED|Washout||7
7857217|NCT00925704|19339635|P5|COMPLETED|Washout||5
7857218|NCT00925704|19339636|P4|COMPLETED|Washout||6
7857219|NCT00925704|19339637|P3|COMPLETED|Washout||7
7857220|NCT00925704|19339638|P2|COMPLETED|Washout||7
7857221|NCT00925704|19339639|P1|COMPLETED|Washout||5
7857222|NCT00925704|19339634|P6|STARTED|Washout||7
7857223|NCT00925704|19339635|P5|STARTED|Washout||5
7857224|NCT00925704|19339636|P4|STARTED|Washout||6
7857225|NCT00925704|19339637|P3|STARTED|Washout||7
7857226|NCT00925704|19339638|P2|STARTED|Washout||7
7857227|NCT00925704|19339639|P1|STARTED|Washout||5
7857228|NCT00925704|19339634|P6|NOT COMPLETED|Second Intervention||0
7857229|NCT00925704|19339635|P5|NOT COMPLETED|Second Intervention||1
7857230|NCT00925704|19339636|P4|NOT COMPLETED|Second Intervention||0
7857231|NCT00925704|19339637|P3|NOT COMPLETED|Second Intervention||0
7857232|NCT00925704|19339638|P2|NOT COMPLETED|Second Intervention||0
7857233|NCT00925704|19339639|P1|NOT COMPLETED|Second Intervention||1
7857234|NCT00925704|19339634|P6|COMPLETED|Second Intervention||7
7857235|NCT00925704|19339635|P5|COMPLETED|Second Intervention||5
7857236|NCT00925704|19339636|P4|COMPLETED|Second Intervention||6
7857237|NCT00925704|19339637|P3|COMPLETED|Second Intervention||7
7857238|NCT00925704|19339638|P2|COMPLETED|Second Intervention||7
7857239|NCT00925704|19339639|P1|COMPLETED|Second Intervention||5
7857240|NCT00925704|19339634|P6|STARTED|Second Intervention||7
7857241|NCT00925704|19339635|P5|STARTED|Second Intervention||6
7857242|NCT00925704|19339636|P4|STARTED|Second Intervention||6
7857243|NCT00925704|19339637|P3|STARTED|Second Intervention||7
7857244|NCT00925704|19339638|P2|STARTED|Second Intervention||7
7857245|NCT00925704|19339639|P1|STARTED|Second Intervention||6
7857246|NCT00925704|19339634|P6|NOT COMPLETED|Washout||0
7857247|NCT00925704|19339635|P5|NOT COMPLETED|Washout||0
7857248|NCT00925704|19339636|P4|NOT COMPLETED|Washout||0
7857249|NCT00925704|19339637|P3|NOT COMPLETED|Washout||0
7857250|NCT00925704|19339638|P2|NOT COMPLETED|Washout||0
7857251|NCT00925704|19339639|P1|NOT COMPLETED|Washout||0
7857252|NCT00925704|19339634|P6|COMPLETED|Washout||7
7857253|NCT00925704|19339635|P5|COMPLETED|Washout||6
7857254|NCT00925704|19339636|P4|COMPLETED|Washout||6
7857255|NCT00925704|19339637|P3|COMPLETED|Washout||7
7857256|NCT00925704|19339638|P2|COMPLETED|Washout||7
7857257|NCT00925704|19339639|P1|COMPLETED|Washout||6
7857258|NCT00925704|19339634|P6|STARTED|Washout||7
7857259|NCT00925704|19339635|P5|STARTED|Washout||6
7857260|NCT00925704|19339636|P4|STARTED|Washout||6
7857261|NCT00925704|19339637|P3|STARTED|Washout||7
7857262|NCT00925704|19339638|P2|STARTED|Washout||7
7857263|NCT00925704|19339639|P1|STARTED|Washout||6
7857264|NCT00925704|19339634|P6|NOT COMPLETED|First Intervention||0
7857265|NCT00925704|19339635|P5|NOT COMPLETED|First Intervention||1
7857266|NCT00925704|19339636|P4|NOT COMPLETED|First Intervention||1
7857267|NCT00925704|19339637|P3|NOT COMPLETED|First Intervention||0
7857268|NCT00925704|19339638|P2|NOT COMPLETED|First Intervention||0
7857269|NCT00925704|19339639|P1|NOT COMPLETED|First Intervention||0
7857270|NCT00925704|19339634|P6|COMPLETED|First Intervention||7
7857271|NCT00925704|19339635|P5|COMPLETED|First Intervention||6
7857272|NCT00925704|19339636|P4|COMPLETED|First Intervention||6
7857273|NCT00925704|19339637|P3|COMPLETED|First Intervention||7
7857274|NCT00925704|19339638|P2|COMPLETED|First Intervention||7
7857275|NCT00925704|19339639|P1|COMPLETED|First Intervention||6
7857276|NCT00925704|19339634|P6|STARTED|First Intervention||7
7857277|NCT00925704|19339635|P5|STARTED|First Intervention||7
7857278|NCT00925704|19339636|P4|STARTED|First Intervention||7
7857279|NCT00925704|19339637|P3|STARTED|First Intervention||7
7857280|NCT00925704|19339638|P2|STARTED|First Intervention||7
7857281|NCT00925704|19339639|P1|STARTED|First Intervention||6
7857282|NCT00925600|19339652|P2|NOT COMPLETED|Overall Study||28
7857283|NCT00925600|19339653|P1|NOT COMPLETED|Overall Study||32
7857284|NCT00925600|19339652|P2|COMPLETED|Overall Study||355
7857285|NCT00925600|19339653|P1|COMPLETED|Overall Study||354
7857286|NCT00925600|19339652|P2|Received Treatment|Overall Study||382
7857287|NCT00925600|19339653|P1|Received Treatment|Overall Study|Three participants received at least 1 dose of denosumab in error|383
7857288|NCT00925600|19339652|P2|STARTED|Overall Study||383
7857289|NCT00925600|19339653|P1|STARTED|Overall Study||386
7857290|NCT00925587|19339675|P2|NOT COMPLETED|Overall Study||25
7857291|NCT00925587|19339676|P1|NOT COMPLETED|Overall Study||36
7857292|NCT00925587|19339675|P2|COMPLETED|Overall Study||155
7857293|NCT00925587|19339676|P1|COMPLETED|Overall Study||142
7857294|NCT00925587|19339675|P2|STARTED|Overall Study||180
7857295|NCT00925587|19339676|P1|STARTED|Overall Study||178
7857296|NCT00925548|19339790|P2|NOT COMPLETED|Overall Study||5
7857297|NCT00925548|19339791|P1|NOT COMPLETED|Overall Study||10
7857298|NCT00925548|19339790|P2|COMPLETED|Overall Study||0
7857299|NCT00925548|19339791|P1|COMPLETED|Overall Study||1
7857300|NCT00925548|19339790|P2|STARTED|Overall Study||5
7857301|NCT00925548|19339791|P1|STARTED|Overall Study||11
7857302|NCT00925522|19339817|P1|NOT COMPLETED|Overall Study||20
7857303|NCT00925522|19339817|P1|COMPLETED|Overall Study||0
7857304|NCT00925522|19339817|P1|STARTED|Overall Study||20
7857305|NCT00925353|19339821|P1|NOT COMPLETED|Overall Study||3
7857306|NCT00925353|19339821|P1|COMPLETED|Overall Study||10
7857307|NCT00925353|19339821|P1|STARTED|Overall Study||13
7857308|NCT00925301|19339827|P4|NOT COMPLETED|12-Month Open-label Extension (Optional)||3
7857309|NCT00925301|19339828|P3|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
7857310|NCT00925301|19339829|P2|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
7857311|NCT00925301|19339830|P1|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
7857312|NCT00925301|19339827|P4|COMPLETED|12-Month Open-label Extension (Optional)||54
7857313|NCT00925301|19339828|P3|COMPLETED|12-Month Open-label Extension (Optional)||0
7857314|NCT00925301|19339829|P2|COMPLETED|12-Month Open-label Extension (Optional)||0
7857315|NCT00925301|19339830|P1|COMPLETED|12-Month Open-label Extension (Optional)||0
7857316|NCT00925301|19339827|P4|ITT-amenable|12-Month Open-label Extension (Optional)||42
7857317|NCT00925301|19339828|P3|ITT-amenable|12-Month Open-label Extension (Optional)||0
7857318|NCT00925301|19339829|P2|ITT-amenable|12-Month Open-label Extension (Optional)||0
7857319|NCT00925301|19339830|P1|ITT-amenable|12-Month Open-label Extension (Optional)||0
7857320|NCT00925301|19339827|P4|STARTED|12-Month Open-label Extension (Optional)|The OLE was optional for those who completed Stage 2. Reasons for not entering were not recorded.|57
7857321|NCT00925301|19339828|P3|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 2.|0
7857322|NCT00925301|19339829|P2|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
7857323|NCT00925301|19339830|P1|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
7857324|NCT00925301|19339827|P4|NOT COMPLETED|6-Month Open-label (Stage 2)||0
7857325|NCT00925301|19339828|P3|NOT COMPLETED|6-Month Open-label (Stage 2)||3
7857326|NCT00925301|19339829|P2|NOT COMPLETED|6-Month Open-label (Stage 2)||0
7857327|NCT00925301|19339830|P1|NOT COMPLETED|6-Month Open-label (Stage 2)||0
7857328|NCT00925301|19339827|P4|COMPLETED|6-Month Open-label (Stage 2)||0
7857329|NCT00925301|19339828|P3|COMPLETED|6-Month Open-label (Stage 2)||60
7857330|NCT00925301|19339829|P2|COMPLETED|6-Month Open-label (Stage 2)||0
7857331|NCT00925301|19339830|P1|COMPLETED|6-Month Open-label (Stage 2)||0
7857332|NCT00925301|19339827|P4|ITT-amenable|6-Month Open-label (Stage 2)||0
7857333|NCT00925301|19339828|P3|ITT-amenable|6-Month Open-label (Stage 2)||47
7857334|NCT00925301|19339829|P2|ITT-amenable|6-Month Open-label (Stage 2)||0
7857335|NCT00925301|19339830|P1|ITT-amenable|6-Month Open-label (Stage 2)||0
7857336|NCT00925301|19339827|P4|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants did not start the OLE yet.|0
7857337|NCT00925301|19339828|P3|STARTED|6-Month Open-label (Stage 2)|One participant (Migalastat [0-6 Months]) withdrew consent after completing Month 6.|63
7857423|NCT00924885|19340035|P1|STARTED|Overall Study||129
7857338|NCT00925301|19339829|P2|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
7857339|NCT00925301|19339830|P1|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
7857340|NCT00925301|19339827|P4|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
7857341|NCT00925301|19339828|P3|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
7857342|NCT00925301|19339829|P2|NOT COMPLETED|6-Month Double-blind (Stage 1)||3
7857343|NCT00925301|19339830|P1|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
7857344|NCT00925301|19339827|P4|COMPLETED|6-Month Double-blind (Stage 1)||0
7857345|NCT00925301|19339828|P3|COMPLETED|6-Month Double-blind (Stage 1)||0
7857346|NCT00925301|19339829|P2|COMPLETED|6-Month Double-blind (Stage 1)||30
7857347|NCT00925301|19339830|P1|COMPLETED|6-Month Double-blind (Stage 1)||34
7857348|NCT00925301|19339827|P4|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
7857349|NCT00925301|19339828|P3|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
7857350|NCT00925301|19339829|P2|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
7857351|NCT00925301|19339830|P1|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
7857352|NCT00925301|19339827|P4|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
7857353|NCT00925301|19339828|P3|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
7857354|NCT00925301|19339829|P2|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||33
7857355|NCT00925301|19339830|P1|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||34
7857356|NCT00925301|19339827|P4|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
7857357|NCT00925301|19339828|P3|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
7857358|NCT00925301|19339829|P2|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||33
7857359|NCT00925301|19339830|P1|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||34
7857360|NCT00925301|19339827|P4|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start the OLE yet.|0
7857361|NCT00925301|19339828|P3|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start Stage 2 yet.|0
7857362|NCT00925301|19339829|P2|STARTED|6-Month Double-blind (Stage 1)||33
7857363|NCT00925301|19339830|P1|STARTED|6-Month Double-blind (Stage 1)||34
7857364|NCT00925288|19339846|P2|NOT COMPLETED|Overall Study||7
7857365|NCT00925288|19339847|P1|NOT COMPLETED|Overall Study||9
7857366|NCT00925288|19339846|P2|COMPLETED|Overall Study||93
7857367|NCT00925288|19339847|P1|COMPLETED|Overall Study||91
7857368|NCT00925288|19339846|P2|STARTED|Overall Study||100
7857369|NCT00925288|19339847|P1|STARTED|Overall Study||100
7857370|NCT00925132|19339859|P5|NOT COMPLETED|Overall Study||5
7857371|NCT00925132|19339860|P4|NOT COMPLETED|Overall Study||0
7857372|NCT00925132|19339861|P3|NOT COMPLETED|Overall Study||0
7857373|NCT00925132|19339862|P2|NOT COMPLETED|Overall Study||0
7857374|NCT00925132|19339863|P1|NOT COMPLETED|Overall Study||2
7857375|NCT00925132|19339859|P5|COMPLETED|Overall Study||17
7857376|NCT00925132|19339860|P4|COMPLETED|Overall Study||4
7857377|NCT00925132|19339861|P3|COMPLETED|Overall Study||4
7857378|NCT00925132|19339862|P2|COMPLETED|Overall Study||4
7857379|NCT00925132|19339863|P1|COMPLETED|Overall Study||3
7857380|NCT00925132|19339859|P5|STARTED|Overall Study||22
7857381|NCT00925132|19339860|P4|STARTED|Overall Study||4
7857382|NCT00925132|19339861|P3|STARTED|Overall Study||4
7857383|NCT00925132|19339862|P2|STARTED|Overall Study||4
7857384|NCT00925132|19339863|P1|STARTED|Overall Study||5
7857385|NCT00925119|19339869|P1|NOT COMPLETED|Overall Study||12
7857386|NCT00925119|19339869|P1|COMPLETED|Overall Study||19
7857387|NCT00925119|19339869|P1|STARTED|Overall Study||31
7857388|NCT00925054|19339884|P5|NOT COMPLETED|Overall Study||0
7857389|NCT00925054|19339885|P4|NOT COMPLETED|Overall Study||1
7857390|NCT00925054|19339886|P3|NOT COMPLETED|Overall Study||1
7857391|NCT00925054|19339887|P2|NOT COMPLETED|Overall Study||1
7857392|NCT00925054|19339888|P1|NOT COMPLETED|Overall Study||0
7857393|NCT00925054|19339884|P5|COMPLETED|Overall Study||10
7857394|NCT00925054|19339885|P4|COMPLETED|Overall Study||0
7857395|NCT00925054|19339886|P3|COMPLETED|Overall Study||12
7857396|NCT00925054|19339887|P2|COMPLETED|Overall Study||8
7857397|NCT00925054|19339888|P1|COMPLETED|Overall Study||7
7857398|NCT00925054|19339884|P5|STARTED|Overall Study||10
7857399|NCT00925054|19339885|P4|STARTED|Overall Study||1
7857400|NCT00925054|19339886|P3|STARTED|Overall Study||13
7857401|NCT00925054|19339887|P2|STARTED|Overall Study||9
7857402|NCT00925054|19339888|P1|STARTED|Overall Study||7
7857403|NCT00925015|19339958|P3|NOT COMPLETED|Overall Study||6
7857404|NCT00925015|19339959|P2|NOT COMPLETED|Overall Study||6
7857405|NCT00925015|19339960|P1|NOT COMPLETED|Overall Study||8
7857406|NCT00925015|19339958|P3|COMPLETED|Overall Study||0
7857407|NCT00925015|19339959|P2|COMPLETED|Overall Study||0
7857408|NCT00925015|19339960|P1|COMPLETED|Overall Study||0
7857409|NCT00925015|19339958|P3|STARTED|Overall Study||6
7857410|NCT00925015|19339959|P2|STARTED|Overall Study||6
7857411|NCT00925015|19339960|P1|STARTED|Overall Study||8
7857412|NCT00924950|19340016|P1|NOT COMPLETED|Overall Study||2
7857413|NCT00924950|19340016|P1|COMPLETED|Overall Study||28
7857414|NCT00924950|19340016|P1|STARTED|Overall Study||30
7857415|NCT00924898|19340023|P1|NOT COMPLETED|Overall Study||2
7857416|NCT00924898|19340023|P1|COMPLETED|Overall Study||90
7857417|NCT00924898|19340023|P1|STARTED|Overall Study||92
7857418|NCT00924885|19340034|P2|NOT COMPLETED|Overall Study||4
7857419|NCT00924885|19340035|P1|NOT COMPLETED|Overall Study||3
7857420|NCT00924885|19340034|P2|COMPLETED|Overall Study||124
7857421|NCT00924885|19340035|P1|COMPLETED|Overall Study||126
7857422|NCT00924885|19340034|P2|STARTED|Overall Study||128
7857424|NCT00924833|19340046|P3|NOT COMPLETED|Overall Study||0
7857425|NCT00924833|19340047|P2|NOT COMPLETED|Overall Study||0
7857426|NCT00924833|19340048|P1|NOT COMPLETED|Overall Study||0
7857427|NCT00924833|19340046|P3|COMPLETED|Overall Study|1 subject was excluded from the analysis for medical problems unrelated to the study.|9
7857428|NCT00924833|19340047|P2|COMPLETED|Overall Study|1 subject was excluded from the analysis for incomplete data.|9
7857429|NCT00924833|19340048|P1|COMPLETED|Overall Study|7 subjects analyzed (2 were excluded for poor cardiopulmonary exercise stress test quality).|9
7857430|NCT00924833|19340046|P3|STARTED|Overall Study||9
7857431|NCT00924833|19340047|P2|STARTED|Overall Study||9
7857432|NCT00924833|19340048|P1|STARTED|Overall Study||9
7857433|NCT00924820|19340062|P1|NOT COMPLETED|Overall Study||7
7857434|NCT00924820|19340062|P1|COMPLETED|Overall Study||13
7857435|NCT00924820|19340062|P1|STARTED|Overall Study||20
7857436|NCT00924807|19340068|P1|NOT COMPLETED|Overall Study||0
7857437|NCT00924807|19340068|P1|COMPLETED|Overall Study||4
7857438|NCT00924807|19340068|P1|STARTED|Overall Study||4
7857439|NCT00924781|19340077|P2|NOT COMPLETED|Overall Study||10
7857440|NCT00924781|19340078|P1|NOT COMPLETED|Overall Study||12
7857441|NCT00924781|19340077|P2|COMPLETED|Overall Study||9
7857442|NCT00924781|19340078|P1|COMPLETED|Overall Study||8
7857443|NCT00924781|19340077|P2|STARTED|Overall Study||19
7857444|NCT00924781|19340078|P1|STARTED|Overall Study||20
7857445|NCT00924729|19340112|P2|NOT COMPLETED|Overall Study||0
7857446|NCT00924729|19340113|P1|NOT COMPLETED|Overall Study||2
7857447|NCT00924729|19340112|P2|COMPLETED|Overall Study||25
7857448|NCT00924729|19340113|P1|COMPLETED|Overall Study||23
7857449|NCT00924729|19340112|P2|STARTED|Overall Study||25
7857450|NCT00924729|19340113|P1|STARTED|Overall Study||25
7857451|NCT00924651|19340123|P2|NOT COMPLETED|Overall Study||25
7857452|NCT00924651|19340124|P1|NOT COMPLETED|Overall Study||25
7857453|NCT00924651|19340123|P2|COMPLETED|Overall Study||312
7857454|NCT00924651|19340124|P1|COMPLETED|Overall Study||331
7857455|NCT00924651|19340123|P2|STARTED|Overall Study||337
7857456|NCT00924651|19340124|P1|STARTED|Overall Study||356
7857457|NCT00924638|19340132|P2|NOT COMPLETED|Overall Study||13
7857458|NCT00924638|19340133|P1|NOT COMPLETED|Overall Study||12
7857459|NCT00924638|19340132|P2|COMPLETED|Overall Study|Completed 6 months of follow-up|207
7857460|NCT00924638|19340133|P1|COMPLETED|Overall Study|Completed 6 months of follow-up|209
7857461|NCT00924638|19340132|P2|STARTED|Overall Study|Randomized to Control Arm|220
7857462|NCT00924638|19340133|P1|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221
7857463|NCT00924612|19340152|P4|NOT COMPLETED|Overall Study||0
7857464|NCT00924612|19340153|P3|NOT COMPLETED|Overall Study||0
7857465|NCT00924612|19340154|P2|NOT COMPLETED|Overall Study||0
7857466|NCT00924612|19340155|P1|NOT COMPLETED|Overall Study||0
7857467|NCT00924612|19340152|P4|COMPLETED|Overall Study||4
7857468|NCT00924612|19340153|P3|COMPLETED|Overall Study||4
7857469|NCT00924612|19340154|P2|COMPLETED|Overall Study||4
7857470|NCT00924612|19340155|P1|COMPLETED|Overall Study||4
7857471|NCT00924612|19340152|P4|STARTED|Overall Study||4
7857472|NCT00924612|19340153|P3|STARTED|Overall Study||4
7857473|NCT00924612|19340154|P2|STARTED|Overall Study||4
7857474|NCT00924612|19340155|P1|STARTED|Overall Study||4
7857475|NCT00924560|19340170|P3|NOT COMPLETED|Overall Study||83
7857476|NCT00924560|19340171|P2|NOT COMPLETED|Overall Study||208
7857477|NCT00924560|19340172|P1|NOT COMPLETED|Overall Study||211
7857478|NCT00924560|19340170|P3|COMPLETED|Overall Study||372
7857479|NCT00924560|19340171|P2|COMPLETED|Overall Study||240
7857480|NCT00924560|19340172|P1|COMPLETED|Overall Study||247
7857481|NCT00924560|19340170|P3|Received Treatment|Overall Study||0
7857482|NCT00924560|19340171|P2|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411
7857483|NCT00924560|19340172|P1|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422
7857484|NCT00924560|19340170|P3|STARTED|Overall Study||455
7857485|NCT00924560|19340171|P2|STARTED|Overall Study||448
7857486|NCT00924560|19340172|P1|STARTED|Overall Study||458
7857487|NCT00924508|19340216|P1|NOT COMPLETED|Overall Study||3
7857488|NCT00924508|19340216|P1|COMPLETED|Overall Study||20
7857489|NCT00924508|19340216|P1|STARTED|Overall Study||23
7857490|NCT00924482|19340223|P1|NOT COMPLETED|Overall Study||0
7857491|NCT00924482|19340223|P1|COMPLETED|Overall Study||261
7857492|NCT00924482|19340223|P1|STARTED|Overall Study||261
7857493|NCT00924469|19340230|P2|NOT COMPLETED|Overall Study||2
7857494|NCT00924469|19340231|P1|NOT COMPLETED|Overall Study||2
7857495|NCT00924469|19340230|P2|COMPLETED|Overall Study||26
7857496|NCT00924469|19340231|P1|COMPLETED|Overall Study||28
7857497|NCT00924469|19340230|P2|STARTED|Overall Study||28
7857498|NCT00924469|19340231|P1|STARTED|Overall Study||30
7857499|NCT00924443|19340253|P1|NOT COMPLETED|Overall Study||3
7857500|NCT00924443|19340253|P1|COMPLETED|Overall Study||66
7857501|NCT00924443|19340253|P1|Full Analysis Set (Received Study Drug)|Overall Study||66
7857502|NCT00924443|19340253|P1|STARTED|Overall Study||69
7857503|NCT00924404|19340263|P2|NOT COMPLETED|Overall Study||4
7857504|NCT00924404|19340264|P1|NOT COMPLETED|Overall Study||6
7857505|NCT00924404|19340263|P2|COMPLETED|Overall Study||22
7857506|NCT00924404|19340264|P1|COMPLETED|Overall Study||21
7857507|NCT00924404|19340263|P2|STARTED|Overall Study||26
7857508|NCT00924404|19340264|P1|STARTED|Overall Study||27
7857509|NCT00924352|19340272|P2|NOT COMPLETED|Overall Study||0
7857510|NCT00924352|19340273|P1|NOT COMPLETED|Overall Study||0
7857511|NCT00924352|19340272|P2|COMPLETED|Overall Study||44
7857512|NCT00924352|19340273|P1|COMPLETED|Overall Study||12
7857513|NCT00924352|19340272|P2|STARTED|Overall Study||44
7857514|NCT00924352|19340273|P1|STARTED|Overall Study||12
7857515|NCT00924326|19340295|P9|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
7857516|NCT00924326|19340296|P8|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
7857517|NCT00924326|19340297|P7|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
7857518|NCT00924326|19340298|P6|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
7857519|NCT00924326|19340299|P5|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
7857520|NCT00924326|19340300|P4|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
7857521|NCT00924326|19340301|P3|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
7857522|NCT00924326|19340302|P2|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
7857523|NCT00924326|19340303|P1|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
7857524|NCT00924326|19340295|P9|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
7857525|NCT00924326|19340296|P8|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
7857526|NCT00924326|19340297|P7|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
7857527|NCT00924326|19340298|P6|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
7857528|NCT00924326|19340299|P5|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
7857529|NCT00924326|19340300|P4|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
7857530|NCT00924326|19340301|P3|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
7857531|NCT00924326|19340302|P2|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
7857532|NCT00924326|19340303|P1|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||3
7857533|NCT00924326|19340295|P9|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
7857534|NCT00924326|19340296|P8|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
7857535|NCT00924326|19340297|P7|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
7857536|NCT00924326|19340298|P6|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
7857537|NCT00924326|19340299|P5|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
7857538|NCT00924326|19340300|P4|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
7857539|NCT00924326|19340301|P3|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
7857540|NCT00924326|19340302|P2|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
7857541|NCT00924326|19340303|P1|STARTED|1x10^9-1x10^10 + High Dose Retreat||3
7857542|NCT00924326|19340295|P9|NOT COMPLETED|Dose Administration||0
7857543|NCT00924326|19340296|P8|NOT COMPLETED|Dose Administration||0
7857544|NCT00924326|19340297|P7|NOT COMPLETED|Dose Administration||0
7857545|NCT00924326|19340298|P6|NOT COMPLETED|Dose Administration||0
7857546|NCT00924326|19340299|P5|NOT COMPLETED|Dose Administration||0
7857547|NCT00924326|19340300|P4|NOT COMPLETED|Dose Administration||0
7857548|NCT00924326|19340301|P3|NOT COMPLETED|Dose Administration||0
7857549|NCT00924326|19340302|P2|NOT COMPLETED|Dose Administration||0
7857550|NCT00924326|19340303|P1|NOT COMPLETED|Dose Administration||0
7857551|NCT00924326|19340295|P9|COMPLETED|Dose Administration||2
7857552|NCT00924326|19340296|P8|COMPLETED|Dose Administration||2
7857553|NCT00924326|19340297|P7|COMPLETED|Dose Administration||1
7857554|NCT00924326|19340298|P6|COMPLETED|Dose Administration||10
7857555|NCT00924326|19340299|P5|COMPLETED|Dose Administration||7
7857556|NCT00924326|19340300|P4|COMPLETED|Dose Administration||6
7857557|NCT00924326|19340301|P3|COMPLETED|Dose Administration||5
7857558|NCT00924326|19340302|P2|COMPLETED|Dose Administration||2
7857559|NCT00924326|19340303|P1|COMPLETED|Dose Administration||8
7857560|NCT00924326|19340295|P9|STARTED|Dose Administration||2
7857561|NCT00924326|19340296|P8|STARTED|Dose Administration||2
7857562|NCT00924326|19340297|P7|STARTED|Dose Administration||1
7857563|NCT00924326|19340298|P6|STARTED|Dose Administration||10
7857564|NCT00924326|19340299|P5|STARTED|Dose Administration||7
7857565|NCT00924326|19340300|P4|STARTED|Dose Administration||6
7857566|NCT00924326|19340301|P3|STARTED|Dose Administration||5
7857567|NCT00924326|19340302|P2|STARTED|Dose Administration||2
7857568|NCT00924326|19340303|P1|STARTED|Dose Administration||8
7857569|NCT00924313|19340335|P1|NOT COMPLETED|Overall Study||1
7857570|NCT00924313|19340335|P1|COMPLETED|Overall Study||39
7857571|NCT00924313|19340335|P1|STARTED|Overall Study||40
7857572|NCT00924287|19340347|P1|NOT COMPLETED|Overall Study||1
7857573|NCT00924287|19340347|P1|COMPLETED|Overall Study||0
7857574|NCT00924287|19340347|P1|STARTED|Overall Study||1
7857575|NCT00924209|19340353|P1|NOT COMPLETED|Overall Study||0
7857576|NCT00924209|19340353|P1|COMPLETED|Overall Study||7
7857577|NCT00924209|19340353|P1|STARTED|Overall Study||7
7857578|NCT00924170|19340363|P2|NOT COMPLETED|Overall Study||8
7857579|NCT00924170|19340364|P1|NOT COMPLETED|Overall Study||7
7857580|NCT00924170|19340363|P2|COMPLETED|Overall Study||0
7857581|NCT00924170|19340364|P1|COMPLETED|Overall Study||3
7857582|NCT00924170|19340363|P2|STARTED|Overall Study||8
7857583|NCT00924170|19340364|P1|STARTED|Overall Study||10
7857584|NCT00924118|19340404|P2|NOT COMPLETED|Overall Study||0
7857585|NCT00924118|19340405|P1|NOT COMPLETED|Overall Study||0
7857586|NCT00924118|19340404|P2|COMPLETED|Overall Study||15
7857587|NCT00924118|19340405|P1|COMPLETED|Overall Study||15
7857588|NCT00924118|19340404|P2|STARTED|Overall Study||15
7857589|NCT00924118|19340405|P1|STARTED|Overall Study||15
7857590|NCT00924066|19340413|P1|NOT COMPLETED|Overall Study||0
7857591|NCT00924066|19340413|P1|COMPLETED|Overall Study||41
7857592|NCT00924066|19340413|P1|STARTED|Overall Study||41
7857593|NCT00924053|19340422|P4|NOT COMPLETED|Overall Study||0
7857594|NCT00924053|19340423|P3|NOT COMPLETED|Overall Study||0
7857595|NCT00924053|19340424|P2|NOT COMPLETED|Overall Study||0
7857596|NCT00924053|19340425|P1|NOT COMPLETED|Overall Study||0
7857597|NCT00924053|19340422|P4|COMPLETED|Overall Study||6
7857598|NCT00924053|19340423|P3|COMPLETED|Overall Study||6
7857599|NCT00924053|19340424|P2|COMPLETED|Overall Study||6
7857600|NCT00924053|19340425|P1|COMPLETED|Overall Study||6
7857601|NCT00924053|19340422|P4|STARTED|Overall Study||6
7857602|NCT00924053|19340423|P3|STARTED|Overall Study||6
7857603|NCT00924053|19340424|P2|STARTED|Overall Study||6
7857604|NCT00924053|19340425|P1|STARTED|Overall Study||6
7857605|NCT00924040|19340471|P1|NOT COMPLETED|Overall Study||0
7857606|NCT00924040|19340471|P1|COMPLETED|Overall Study||1
7857607|NCT00924040|19340471|P1|STARTED|Overall Study||1
7857608|NCT00924001|19340483|P1|NOT COMPLETED|Overall Study||0
7857609|NCT00924001|19340483|P1|COMPLETED|Overall Study||1
7857610|NCT00924001|19340483|P1|STARTED|Overall Study||1
7857611|NCT00923975|19340489|P1|NOT COMPLETED|Overall Study||1
7857612|NCT00923975|19340489|P1|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50
7857613|NCT00923975|19340489|P1|STARTED|Overall Study||51
7857614|NCT00923949|19340496|P1|NOT COMPLETED|Overall Study||0
7857615|NCT00923949|19340496|P1|COMPLETED|Overall Study||1
7857616|NCT00923949|19340496|P1|STARTED|Overall Study||1
7857617|NCT00923936|19340508|P2|NOT COMPLETED|Overall Study||3
7857618|NCT00923936|19340509|P1|NOT COMPLETED|Overall Study||8
7857619|NCT00923936|19340508|P2|COMPLETED|Overall Study||3
7857620|NCT00923936|19340509|P1|COMPLETED|Overall Study||2
7857621|NCT00923936|19340508|P2|STARTED|Overall Study||6
7857622|NCT00923936|19340509|P1|STARTED|Overall Study||10
7857623|NCT00923910|19340525|P2|NOT COMPLETED|Period 2||0
7857624|NCT00923910|19340526|P1|NOT COMPLETED|Period 2||0
7857625|NCT00923910|19340525|P2|COMPLETED|Period 2||5
7857626|NCT00923910|19340526|P1|COMPLETED|Period 2||5
7857627|NCT00923910|19340525|P2|STARTED|Period 2||5
7857628|NCT00923910|19340526|P1|STARTED|Period 2||5
7857629|NCT00923910|19340525|P2|NOT COMPLETED|Period 1||0
7857630|NCT00923910|19340526|P1|NOT COMPLETED|Period 1||0
7857631|NCT00923910|19340525|P2|COMPLETED|Period 1||5
7857632|NCT00923910|19340526|P1|COMPLETED|Period 1||5
7857633|NCT00923910|19340525|P2|STARTED|Period 1||5
7857634|NCT00923910|19340526|P1|STARTED|Period 1||5
7857635|NCT00923845|19340538|P2|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
7857636|NCT00923845|19340539|P1|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
7857637|NCT00923845|19340538|P2|COMPLETED|Allogeneic Stem Cell Therapy||10
7857638|NCT00923845|19340539|P1|COMPLETED|Allogeneic Stem Cell Therapy||0
7857639|NCT00923845|19340538|P2|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6
7857640|NCT00923845|19340539|P1|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0
7857641|NCT00923845|19340538|P2|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8
7857642|NCT00923845|19340539|P1|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0
7857643|NCT00923845|19340538|P2|STARTED|Allogeneic Stem Cell Therapy||10
7857644|NCT00923845|19340539|P1|STARTED|Allogeneic Stem Cell Therapy||0
7857645|NCT00923845|19340538|P2|NOT COMPLETED|Induction Therapy||2
7857646|NCT00923845|19340539|P1|NOT COMPLETED|Induction Therapy||0
7857647|NCT00923845|19340538|P2|COMPLETED|Induction Therapy||10
7857648|NCT00923845|19340539|P1|COMPLETED|Induction Therapy||0
7857649|NCT00923845|19340538|P2|STARTED|Induction Therapy||12
7857650|NCT00923845|19340539|P1|STARTED|Induction Therapy||0
7857651|NCT00923845|19340538|P2|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
7857652|NCT00923845|19340539|P1|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
7857653|NCT00923845|19340538|P2|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
7857654|NCT00923845|19340539|P1|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13
7857655|NCT00923845|19340538|P2|STARTED|Donor Hematopoietic Stem Cell Harvest||0
7857656|NCT00923845|19340539|P1|STARTED|Donor Hematopoietic Stem Cell Harvest||13
7857657|NCT00923845|19340538|P2|NOT COMPLETED|Donor Lymphocyte Harvest||0
7857658|NCT00923845|19340539|P1|NOT COMPLETED|Donor Lymphocyte Harvest||0
7857659|NCT00923845|19340538|P2|COMPLETED|Donor Lymphocyte Harvest||0
7857660|NCT00923845|19340539|P1|COMPLETED|Donor Lymphocyte Harvest||13
7857661|NCT00923845|19340538|P2|STARTED|Donor Lymphocyte Harvest||0
7857662|NCT00923845|19340539|P1|STARTED|Donor Lymphocyte Harvest||13
7857663|NCT00923598|19340562|P2|NOT COMPLETED|Overall Study||5
7857664|NCT00923598|19340563|P1|NOT COMPLETED|Overall Study||4
7857665|NCT00923598|19340562|P2|COMPLETED|Overall Study||17
7857666|NCT00923598|19340563|P1|COMPLETED|Overall Study||19
7857667|NCT00923598|19340562|P2|STARTED|Overall Study||22
7857668|NCT00923598|19340563|P1|STARTED|Overall Study||23
7857669|NCT00923481|19340569|P1|NOT COMPLETED|Overall Study||0
7857670|NCT00923481|19340569|P1|COMPLETED|Overall Study||37
7857671|NCT00923481|19340569|P1|STARTED|Overall Study||37
7857672|NCT00923364|19340574|P2|NOT COMPLETED|Overall Study||0
7857673|NCT00923364|19340575|P1|NOT COMPLETED|Overall Study||4
7857674|NCT00923364|19340574|P2|COMPLETED|Overall Study||5
7857675|NCT00923364|19340575|P1|COMPLETED|Overall Study||10
7857676|NCT00923364|19340574|P2|STARTED|Overall Study||5
7857677|NCT00923364|19340575|P1|STARTED|Overall Study||14
7857678|NCT00923351|19340587|P3|NOT COMPLETED|Overall Study||12
7857679|NCT00923351|19340588|P2|NOT COMPLETED|Overall Study||0
7857680|NCT00923351|19340589|P1|NOT COMPLETED|Overall Study||0
7857681|NCT00923351|19340587|P3|COMPLETED|Overall Study||0
7857682|NCT00923351|19340588|P2|COMPLETED|Overall Study||26
7857683|NCT00923351|19340589|P1|COMPLETED|Overall Study||6
7857684|NCT00923351|19340587|P3|STARTED|Overall Study||12
7857685|NCT00923351|19340588|P2|STARTED|Overall Study||26
7857686|NCT00923351|19340589|P1|STARTED|Overall Study||6
7857687|NCT00923273|19340604|P5|NOT COMPLETED|Phase II Treatment Period||0
7857688|NCT00923273|19340605|P4|NOT COMPLETED|Phase II Treatment Period||7
7857689|NCT00923273|19340606|P3|NOT COMPLETED|Phase II Treatment Period||0
7857690|NCT00923273|19340607|P2|NOT COMPLETED|Phase II Treatment Period||0
7857691|NCT00923273|19340608|P1|NOT COMPLETED|Phase II Treatment Period||0
7857692|NCT00923273|19340604|P5|COMPLETED|Phase II Treatment Period||0
7857693|NCT00923273|19340605|P4|COMPLETED|Phase II Treatment Period||20
7857694|NCT00923273|19340606|P3|COMPLETED|Phase II Treatment Period||0
7857695|NCT00923273|19340607|P2|COMPLETED|Phase II Treatment Period||0
7857696|NCT00923273|19340608|P1|COMPLETED|Phase II Treatment Period||0
7857697|NCT00923273|19340604|P5|STARTED|Phase II Treatment Period||0
7857698|NCT00923273|19340605|P4|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27
7857699|NCT00923273|19340606|P3|STARTED|Phase II Treatment Period||0
7857700|NCT00923273|19340607|P2|STARTED|Phase II Treatment Period||0
7857701|NCT00923273|19340608|P1|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0
7857702|NCT00923273|19340604|P5|NOT COMPLETED|Phase I Treatment Period||0
7857703|NCT00923273|19340605|P4|NOT COMPLETED|Phase I Treatment Period||0
7857704|NCT00923273|19340606|P3|NOT COMPLETED|Phase I Treatment Period||0
7857705|NCT00923273|19340607|P2|NOT COMPLETED|Phase I Treatment Period||0
7857706|NCT00923273|19340608|P1|NOT COMPLETED|Phase I Treatment Period||0
7857707|NCT00923273|19340604|P5|COMPLETED|Phase I Treatment Period||5
7857708|NCT00923273|19340605|P4|COMPLETED|Phase I Treatment Period||7
7857709|NCT00923273|19340606|P3|COMPLETED|Phase I Treatment Period||3
7857710|NCT00923273|19340607|P2|COMPLETED|Phase I Treatment Period||3
7857711|NCT00923273|19340608|P1|COMPLETED|Phase I Treatment Period||4
7857712|NCT00923273|19340604|P5|STARTED|Phase I Treatment Period|5 subjects peme naive.|5
7857713|NCT00923273|19340605|P4|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7
7857714|NCT00923273|19340606|P3|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
7857715|NCT00923273|19340607|P2|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
7857716|NCT00923273|19340608|P1|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4
7857717|NCT00923260|19340633|P2|NOT COMPLETED|Overall Study||1
7857718|NCT00923260|19340634|P1|NOT COMPLETED|Overall Study||1
7857719|NCT00923260|19340633|P2|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
7857720|NCT00923260|19340634|P1|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
7857721|NCT00923260|19340633|P2|STARTED|Overall Study||12
7857722|NCT00923260|19340634|P1|STARTED|Overall Study||12
7857723|NCT00923247|19340768|P2|NOT COMPLETED|Overall Study||0
7857724|NCT00923247|19340769|P1|NOT COMPLETED|Overall Study||0
7857725|NCT00923247|19340768|P2|COMPLETED|Overall Study||1
7857726|NCT00923247|19340769|P1|COMPLETED|Overall Study||21
7857727|NCT00923247|19340768|P2|STARTED|Overall Study||1
7857728|NCT00923247|19340769|P1|STARTED|Overall Study||21
7857729|NCT00923195|19340797|P2|NOT COMPLETED|Overall Study||1
7857730|NCT00923195|19340798|P1|NOT COMPLETED|Overall Study||0
7857731|NCT00923195|19340797|P2|COMPLETED|Overall Study||1
7857732|NCT00923195|19340798|P1|COMPLETED|Overall Study||2
7857733|NCT00923195|19340797|P2|STARTED|Overall Study||2
7857734|NCT00923195|19340798|P1|STARTED|Overall Study||2
7857735|NCT00923156|19340809|P3|NOT COMPLETED|Overall Study||3
7857736|NCT00923156|19340810|P2|NOT COMPLETED|Overall Study||4
7857737|NCT00923156|19340811|P1|NOT COMPLETED|Overall Study||0
7857738|NCT00923156|19340809|P3|COMPLETED|Overall Study||38
7857739|NCT00923156|19340810|P2|COMPLETED|Overall Study||38
7857740|NCT00923156|19340811|P1|COMPLETED|Overall Study||40
7857741|NCT00923156|19340809|P3|STARTED|Overall Study||41
7857742|NCT00923156|19340810|P2|STARTED|Overall Study||42
7857743|NCT00923156|19340811|P1|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40
7857744|NCT00923130|19340837|P1|NOT COMPLETED|Overall Study||25
7857745|NCT00923130|19340837|P1|COMPLETED|Overall Study||5
7857746|NCT00923130|19340837|P1|STARTED|Overall Study||30
7857747|NCT00923117|19340855|P2|NOT COMPLETED|Overall Study||0
7857748|NCT00923117|19340856|P1|NOT COMPLETED|Overall Study||0
7857749|NCT00923117|19340855|P2|COMPLETED|Overall Study||43
7857750|NCT00923117|19340856|P1|COMPLETED|Overall Study||44
7857751|NCT00923117|19340855|P2|STARTED|Overall Study||43
7857752|NCT00923117|19340856|P1|STARTED|Overall Study||44
7857753|NCT00923091|19340872|P13|NOT COMPLETED|Period VI (Open-Label)||0
7857754|NCT00923091|19340873|P12|NOT COMPLETED|Period VI (Open-Label)||0
7857755|NCT00923091|19340874|P11|NOT COMPLETED|Period VI (Open-Label)||0
7857756|NCT00923091|19340875|P10|NOT COMPLETED|Period VI (Open-Label)||0
7857757|NCT00923091|19340876|P9|NOT COMPLETED|Period VI (Open-Label)||0
7857758|NCT00923091|19340877|P8|NOT COMPLETED|Period VI (Open-Label)||0
7857759|NCT00923091|19340878|P7|NOT COMPLETED|Period VI (Open-Label)||0
7857760|NCT00923091|19340879|P6|NOT COMPLETED|Period VI (Open-Label)||0
7857761|NCT00923091|19340880|P5|NOT COMPLETED|Period VI (Open-Label)||7
7857762|NCT00923091|19340881|P4|NOT COMPLETED|Period VI (Open-Label)||3
7857763|NCT00923091|19340882|P3|NOT COMPLETED|Period VI (Open-Label)||13
7857764|NCT00923091|19340883|P2|NOT COMPLETED|Period VI (Open-Label)||8
7857765|NCT00923091|19340884|P1|NOT COMPLETED|Period VI (Open-Label)||39
7857766|NCT00923091|19340872|P13|COMPLETED|Period VI (Open-Label)||0
7857767|NCT00923091|19340873|P12|COMPLETED|Period VI (Open-Label)||0
7857768|NCT00923091|19340874|P11|COMPLETED|Period VI (Open-Label)||0
7857769|NCT00923091|19340875|P10|COMPLETED|Period VI (Open-Label)||0
7857770|NCT00923091|19340876|P9|COMPLETED|Period VI (Open-Label)||0
7857771|NCT00923091|19340877|P8|COMPLETED|Period VI (Open-Label)||0
7857772|NCT00923091|19340878|P7|COMPLETED|Period VI (Open-Label)||0
7857773|NCT00923091|19340879|P6|COMPLETED|Period VI (Open-Label)||0
7857774|NCT00923091|19340880|P5|COMPLETED|Period VI (Open-Label)||157
7857775|NCT00923091|19340881|P4|COMPLETED|Period VI (Open-Label)||143
7857776|NCT00923091|19340882|P3|COMPLETED|Period VI (Open-Label)||467
7857777|NCT00923091|19340883|P2|COMPLETED|Period VI (Open-Label)||264
7857778|NCT00923091|19340884|P1|COMPLETED|Period VI (Open-Label)||1408
7857779|NCT00923091|19340872|P13|STARTED|Period VI (Open-Label)||0
7857780|NCT00923091|19340873|P12|STARTED|Period VI (Open-Label)||0
7857781|NCT00923091|19340874|P11|STARTED|Period VI (Open-Label)||0
7857782|NCT00923091|19340875|P10|STARTED|Period VI (Open-Label)||0
7857783|NCT00923091|19340876|P9|STARTED|Period VI (Open-Label)||0
7857784|NCT00923091|19340877|P8|STARTED|Period VI (Open-Label)||0
7857785|NCT00923091|19340878|P7|STARTED|Period VI (Open-Label)||0
7857786|NCT00923091|19340879|P6|STARTED|Period VI (Open-Label)||0
7857787|NCT00923091|19340880|P5|STARTED|Period VI (Open-Label)||164
7857788|NCT00923091|19340881|P4|STARTED|Period VI (Open-Label)||146
7857789|NCT00923091|19340882|P3|STARTED|Period VI (Open-Label)||480
7857790|NCT00923091|19340883|P2|STARTED|Period VI (Open-Label)||272
7857791|NCT00923091|19340884|P1|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447
7857792|NCT00923091|19340872|P13|NOT COMPLETED|Period V (Double -Blind)||2
7857793|NCT00923091|19340873|P12|NOT COMPLETED|Period V (Double -Blind)||0
7857794|NCT00923091|19340874|P11|NOT COMPLETED|Period V (Double -Blind)||1
7857795|NCT00923091|19340875|P10|NOT COMPLETED|Period V (Double -Blind)||0
7857796|NCT00923091|19340876|P9|NOT COMPLETED|Period V (Double -Blind)||1
7857797|NCT00923091|19340877|P8|NOT COMPLETED|Period V (Double -Blind)||0
7857798|NCT00923091|19340878|P7|NOT COMPLETED|Period V (Double -Blind)||0
7857799|NCT00923091|19340879|P6|NOT COMPLETED|Period V (Double -Blind)||0
7857800|NCT00923091|19340880|P5|NOT COMPLETED|Period V (Double -Blind)||0
7857801|NCT00923091|19340881|P4|NOT COMPLETED|Period V (Double -Blind)||0
7857802|NCT00923091|19340882|P3|NOT COMPLETED|Period V (Double -Blind)||0
7857803|NCT00923091|19340883|P2|NOT COMPLETED|Period V (Double -Blind)||0
7857804|NCT00923091|19340884|P1|NOT COMPLETED|Period V (Double -Blind)||0
7857805|NCT00923091|19340872|P13|COMPLETED|Period V (Double -Blind)||73
7857806|NCT00923091|19340873|P12|COMPLETED|Period V (Double -Blind)||151
7857807|NCT00923091|19340874|P11|COMPLETED|Period V (Double -Blind)||193
7857808|NCT00923091|19340875|P10|COMPLETED|Period V (Double -Blind)||119
7857809|NCT00923091|19340876|P9|COMPLETED|Period V (Double -Blind)||134
7857810|NCT00923091|19340877|P8|COMPLETED|Period V (Double -Blind)||0
7857811|NCT00923091|19340878|P7|COMPLETED|Period V (Double -Blind)||0
7857812|NCT00923091|19340879|P6|COMPLETED|Period V (Double -Blind)||0
7857813|NCT00923091|19340880|P5|COMPLETED|Period V (Double -Blind)||0
7857814|NCT00923091|19340881|P4|COMPLETED|Period V (Double -Blind)||0
7857815|NCT00923091|19340882|P3|COMPLETED|Period V (Double -Blind)||0
7857816|NCT00923091|19340883|P2|COMPLETED|Period V (Double -Blind)||0
7857817|NCT00923091|19340884|P1|COMPLETED|Period V (Double -Blind)||0
7857818|NCT00923091|19340872|P13|STARTED|Period V (Double -Blind)||75
7857819|NCT00923091|19340873|P12|STARTED|Period V (Double -Blind)||151
7857820|NCT00923091|19340874|P11|STARTED|Period V (Double -Blind)||194
7857821|NCT00923091|19340875|P10|STARTED|Period V (Double -Blind)||119
7857822|NCT00923091|19340876|P9|STARTED|Period V (Double -Blind)||135
7857823|NCT00923091|19340877|P8|STARTED|Period V (Double -Blind)||0
7857824|NCT00923091|19340878|P7|STARTED|Period V (Double -Blind)||0
7857825|NCT00923091|19340879|P6|STARTED|Period V (Double -Blind)||0
7857826|NCT00923091|19340880|P5|STARTED|Period V (Double -Blind)||0
7857827|NCT00923091|19340881|P4|STARTED|Period V (Double -Blind)||0
7857828|NCT00923091|19340882|P3|STARTED|Period V (Double -Blind)||0
7857829|NCT00923091|19340883|P2|STARTED|Period V (Double -Blind)||0
7857830|NCT00923091|19340884|P1|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0
7857831|NCT00923091|19340872|P13|NOT COMPLETED|Period IV (Double-Blind)||0
7857832|NCT00923091|19340873|P12|NOT COMPLETED|Period IV (Double-Blind)||0
7857833|NCT00923091|19340874|P11|NOT COMPLETED|Period IV (Double-Blind)||0
7857834|NCT00923091|19340875|P10|NOT COMPLETED|Period IV (Double-Blind)||0
7857835|NCT00923091|19340876|P9|NOT COMPLETED|Period IV (Double-Blind)||0
7857836|NCT00923091|19340877|P8|NOT COMPLETED|Period IV (Double-Blind)||0
7857837|NCT00923091|19340878|P7|NOT COMPLETED|Period IV (Double-Blind)||0
7857838|NCT00923091|19340879|P6|NOT COMPLETED|Period IV (Double-Blind)||0
7857839|NCT00923091|19340880|P5|NOT COMPLETED|Period IV (Double-Blind)||0
7857840|NCT00923091|19340881|P4|NOT COMPLETED|Period IV (Double-Blind)||0
7857841|NCT00923091|19340882|P3|NOT COMPLETED|Period IV (Double-Blind)||0
7857842|NCT00923091|19340883|P2|NOT COMPLETED|Period IV (Double-Blind)||2
7857843|NCT00923091|19340884|P1|NOT COMPLETED|Period IV (Double-Blind)||2
7857844|NCT00923091|19340872|P13|COMPLETED|Period IV (Double-Blind)||0
7857845|NCT00923091|19340873|P12|COMPLETED|Period IV (Double-Blind)||0
7857846|NCT00923091|19340874|P11|COMPLETED|Period IV (Double-Blind)||0
7857847|NCT00923091|19340875|P10|COMPLETED|Period IV (Double-Blind)||0
7857848|NCT00923091|19340876|P9|COMPLETED|Period IV (Double-Blind)||0
7857849|NCT00923091|19340877|P8|COMPLETED|Period IV (Double-Blind)||0
7857850|NCT00923091|19340878|P7|COMPLETED|Period IV (Double-Blind)||0
7857851|NCT00923091|19340879|P6|COMPLETED|Period IV (Double-Blind)||0
7857852|NCT00923091|19340880|P5|COMPLETED|Period IV (Double-Blind)||0
7857853|NCT00923091|19340881|P4|COMPLETED|Period IV (Double-Blind)||0
7857854|NCT00923091|19340882|P3|COMPLETED|Period IV (Double-Blind)||0
7857855|NCT00923091|19340883|P2|COMPLETED|Period IV (Double-Blind)||451
7857856|NCT00923091|19340884|P1|COMPLETED|Period IV (Double-Blind)||226
7857857|NCT00923091|19340872|P13|STARTED|Period IV (Double-Blind)||0
7857858|NCT00923091|19340873|P12|STARTED|Period IV (Double-Blind)||0
7857859|NCT00923091|19340874|P11|STARTED|Period IV (Double-Blind)||0
7857860|NCT00923091|19340875|P10|STARTED|Period IV (Double-Blind)||0
7857861|NCT00923091|19340876|P9|STARTED|Period IV (Double-Blind)||0
7857862|NCT00923091|19340877|P8|STARTED|Period IV (Double-Blind)||0
7857863|NCT00923091|19340878|P7|STARTED|Period IV (Double-Blind)||0
7857864|NCT00923091|19340879|P6|STARTED|Period IV (Double-Blind)||0
7857865|NCT00923091|19340880|P5|STARTED|Period IV (Double-Blind)||0
7857866|NCT00923091|19340881|P4|STARTED|Period IV (Double-Blind)||0
7857867|NCT00923091|19340882|P3|STARTED|Period IV (Double-Blind)||0
7857868|NCT00923091|19340883|P2|STARTED|Period IV (Double-Blind)||453
7857869|NCT00923091|19340884|P1|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228
7857870|NCT00923091|19340872|P13|NOT COMPLETED|Period III (Single-Blind)||0
7857871|NCT00923091|19340873|P12|NOT COMPLETED|Period III (Single-Blind)||0
7857872|NCT00923091|19340874|P11|NOT COMPLETED|Period III (Single-Blind)||0
7857873|NCT00923091|19340875|P10|NOT COMPLETED|Period III (Single-Blind)||0
7857874|NCT00923091|19340876|P9|NOT COMPLETED|Period III (Single-Blind)||0
7857875|NCT00923091|19340877|P8|NOT COMPLETED|Period III (Single-Blind)||0
7857876|NCT00923091|19340878|P7|NOT COMPLETED|Period III (Single-Blind)||0
7857877|NCT00923091|19340879|P6|NOT COMPLETED|Period III (Single-Blind)||0
7857878|NCT00923091|19340880|P5|NOT COMPLETED|Period III (Single-Blind)||0
7857879|NCT00923091|19340881|P4|NOT COMPLETED|Period III (Single-Blind)||0
7857880|NCT00923091|19340882|P3|NOT COMPLETED|Period III (Single-Blind)||0
7857881|NCT00923091|19340883|P2|NOT COMPLETED|Period III (Single-Blind)||0
7857882|NCT00923091|19340884|P1|NOT COMPLETED|Period III (Single-Blind)||20
7857883|NCT00923091|19340872|P13|COMPLETED|Period III (Single-Blind)||0
7857884|NCT00923091|19340873|P12|COMPLETED|Period III (Single-Blind)||0
7857885|NCT00923091|19340874|P11|COMPLETED|Period III (Single-Blind)||0
7857886|NCT00923091|19340875|P10|COMPLETED|Period III (Single-Blind)||0
7857887|NCT00923091|19340876|P9|COMPLETED|Period III (Single-Blind)||0
7857888|NCT00923091|19340877|P8|COMPLETED|Period III (Single-Blind)||0
7857889|NCT00923091|19340878|P7|COMPLETED|Period III (Single-Blind)||0
7857890|NCT00923091|19340879|P6|COMPLETED|Period III (Single-Blind)||0
7857891|NCT00923091|19340880|P5|COMPLETED|Period III (Single-Blind)||0
7857892|NCT00923091|19340881|P4|COMPLETED|Period III (Single-Blind)||0
7857893|NCT00923091|19340882|P3|COMPLETED|Period III (Single-Blind)||0
7857894|NCT00923091|19340883|P2|COMPLETED|Period III (Single-Blind)||0
7857895|NCT00923091|19340884|P1|COMPLETED|Period III (Single-Blind)||2520
7857896|NCT00923091|19340872|P13|STARTED|Period III (Single-Blind)||0
7857897|NCT00923091|19340873|P12|STARTED|Period III (Single-Blind)||0
7857898|NCT00923091|19340874|P11|STARTED|Period III (Single-Blind)||0
7857899|NCT00923091|19340875|P10|STARTED|Period III (Single-Blind)||0
7857900|NCT00923091|19340876|P9|STARTED|Period III (Single-Blind)||0
7857901|NCT00923091|19340877|P8|STARTED|Period III (Single-Blind)||0
7857902|NCT00923091|19340878|P7|STARTED|Period III (Single-Blind)||0
7857903|NCT00923091|19340879|P6|STARTED|Period III (Single-Blind)||0
7857904|NCT00923091|19340880|P5|STARTED|Period III (Single-Blind)||0
7857905|NCT00923091|19340881|P4|STARTED|Period III (Single-Blind)||0
7857906|NCT00923091|19340882|P3|STARTED|Period III (Single-Blind)||0
7857907|NCT00923091|19340883|P2|STARTED|Period III (Single-Blind)||0
7857908|NCT00923091|19340884|P1|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540
7857909|NCT00923091|19340872|P13|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
7857910|NCT00923091|19340873|P12|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
7857911|NCT00923091|19340874|P11|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
7857912|NCT00923091|19340875|P10|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
7857913|NCT00923091|19340876|P9|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
7857914|NCT00923091|19340877|P8|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25
7857915|NCT00923091|19340878|P7|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18
7857916|NCT00923091|19340879|P6|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15
7857917|NCT00923091|19340880|P5|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21
7857918|NCT00923091|19340881|P4|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27
7857919|NCT00923091|19340882|P3|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13
7857920|NCT00923091|19340883|P2|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11
7857921|NCT00923091|19340884|P1|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16
7857922|NCT00923091|19340872|P13|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
7857923|NCT00923091|19340873|P12|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
7857924|NCT00923091|19340874|P11|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
7857925|NCT00923091|19340875|P10|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
7857926|NCT00923091|19340876|P9|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
7857927|NCT00923091|19340877|P8|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311
7857928|NCT00923091|19340878|P7|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
7857929|NCT00923091|19340879|P6|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322
7857930|NCT00923091|19340880|P5|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315
7857931|NCT00923091|19340881|P4|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309
7857932|NCT00923091|19340882|P3|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323
7857933|NCT00923091|19340883|P2|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325
7857934|NCT00923091|19340884|P1|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
7857935|NCT00923091|19340872|P13|STARTED|PeriodI-II (Randomized, Double-Blind)||0
7857936|NCT00923091|19340873|P12|STARTED|PeriodI-II (Randomized, Double-Blind)||0
7857937|NCT00923091|19340874|P11|STARTED|PeriodI-II (Randomized, Double-Blind)||0
7858020|NCT00922636|19341027|P3|NOT COMPLETED|Overall Study||20
7857938|NCT00923091|19340875|P10|STARTED|PeriodI-II (Randomized, Double-Blind)||0
7857939|NCT00923091|19340876|P9|STARTED|PeriodI-II (Randomized, Double-Blind)||0
7857940|NCT00923091|19340877|P8|STARTED|PeriodI-II (Randomized, Double-Blind)||336
7857941|NCT00923091|19340878|P7|STARTED|PeriodI-II (Randomized, Double-Blind)||337
7857942|NCT00923091|19340879|P6|STARTED|PeriodI-II (Randomized, Double-Blind)||337
7857943|NCT00923091|19340880|P5|STARTED|PeriodI-II (Randomized, Double-Blind)||336
7857944|NCT00923091|19340881|P4|STARTED|PeriodI-II (Randomized, Double-Blind)||336
7857945|NCT00923091|19340882|P3|STARTED|PeriodI-II (Randomized, Double-Blind)||336
7857946|NCT00923091|19340883|P2|STARTED|PeriodI-II (Randomized, Double-Blind)||336
7857947|NCT00923091|19340884|P1|STARTED|PeriodI-II (Randomized, Double-Blind)||335
7857948|NCT00923078|19340934|P3|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
7857949|NCT00923078|19340935|P2|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
7857950|NCT00923078|19340936|P1|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
7857951|NCT00923078|19340934|P3|COMPLETED|Second Intervention (Weeks 5-8)||0
7857952|NCT00923078|19340935|P2|COMPLETED|Second Intervention (Weeks 5-8)||19
7857953|NCT00923078|19340936|P1|COMPLETED|Second Intervention (Weeks 5-8)||19
7857954|NCT00923078|19340934|P3|STARTED|Second Intervention (Weeks 5-8)|Healthy Comparison sample subjects completed only a single test session (baseline)|0
7857955|NCT00923078|19340935|P2|STARTED|Second Intervention (Weeks 5-8)||19
7857956|NCT00923078|19340936|P1|STARTED|Second Intervention (Weeks 5-8)||19
7857957|NCT00923078|19340934|P3|NOT COMPLETED|First Intervention (Weeks 1-4)||20
7857958|NCT00923078|19340935|P2|NOT COMPLETED|First Intervention (Weeks 1-4)||1
7857959|NCT00923078|19340936|P1|NOT COMPLETED|First Intervention (Weeks 1-4)||1
7857960|NCT00923078|19340934|P3|COMPLETED|First Intervention (Weeks 1-4)||0
7857961|NCT00923078|19340935|P2|COMPLETED|First Intervention (Weeks 1-4)||19
7857962|NCT00923078|19340936|P1|COMPLETED|First Intervention (Weeks 1-4)||19
7857963|NCT00923078|19340934|P3|STARTED|First Intervention (Weeks 1-4)||20
7857964|NCT00923078|19340935|P2|STARTED|First Intervention (Weeks 1-4)||20
7857965|NCT00923078|19340936|P1|STARTED|First Intervention (Weeks 1-4)||20
7857966|NCT00922987|19340955|P1|NOT COMPLETED|Overall Study||4
7857967|NCT00922987|19340955|P1|COMPLETED|Overall Study||277
7857968|NCT00922987|19340955|P1|STARTED|Overall Study||281
7857969|NCT00922974|19340970|P2|NOT COMPLETED|Phase III Component||6
7857970|NCT00922974|19340971|P1|NOT COMPLETED|Phase III Component||8
7857971|NCT00922974|19340970|P2|COMPLETED|Phase III Component||130
7857972|NCT00922974|19340971|P1|COMPLETED|Phase III Component||209
7857973|NCT00922974|19340970|P2|Eligible, Treated, Adverse Event Data|Phase III Component||83
7857974|NCT00922974|19340971|P1|Eligible, Treated, Adverse Event Data|Phase III Component||148
7857975|NCT00922974|19340970|P2|Eligible With Adverse Event Data|Phase III Component||117
7857976|NCT00922974|19340971|P1|Eligible With Adverse Event Data|Phase III Component||202
7857977|NCT00922974|19340970|P2|Eligible With 3 mo. FACT-G Data|Phase III Component||58
7857978|NCT00922974|19340971|P1|Eligible With 3 mo. FACT-G Data|Phase III Component||87
7857979|NCT00922974|19340970|P2|Eligible With 3 mo. NRPS Data|Phase III Component||76
7857980|NCT00922974|19340971|P1|Eligible With 3 mo. NRPS Data|Phase III Component||139
7857981|NCT00922974|19340970|P2|Eligible|Phase III Component||130
7857982|NCT00922974|19340971|P1|Eligible|Phase III Component||209
7857983|NCT00922974|19340970|P2|STARTED|Phase III Component||136
7857984|NCT00922974|19340971|P1|STARTED|Phase III Component|The phase III component accrues new subjects; these are not continuing phase II subjects.|217
7857985|NCT00922974|19340970|P2|NOT COMPLETED|Phase II Component||0
7857986|NCT00922974|19340971|P1|NOT COMPLETED|Phase II Component||7
7857987|NCT00922974|19340970|P2|COMPLETED|Phase II Component||0
7857988|NCT00922974|19340971|P1|COMPLETED|Phase II Component|These subjects do not participate in the phase III component.|39
7857989|NCT00922974|19340970|P2|Eligible, Treated, Adverse Event Data|Phase II Component||0
7857990|NCT00922974|19340971|P1|Eligible, Treated, Adverse Event Data|Phase II Component||34
7857991|NCT00922974|19340970|P2|Eligible and Started Treatment|Phase II Component||0
7857992|NCT00922974|19340971|P1|Eligible and Started Treatment|Phase II Component||39
7857993|NCT00922974|19340970|P2|Eligible|Phase II Component||0
7857994|NCT00922974|19340971|P1|Eligible|Phase II Component||44
7857995|NCT00922974|19340970|P2|STARTED|Phase II Component||0
7857996|NCT00922974|19340971|P1|STARTED|Phase II Component||46
7857997|NCT00922935|19340986|P3|NOT COMPLETED|Overall Study||0
7857998|NCT00922935|19340987|P2|NOT COMPLETED|Overall Study||5
7857999|NCT00922935|19340988|P1|NOT COMPLETED|Overall Study||1
7858000|NCT00922935|19340986|P3|COMPLETED|Overall Study||10
7858001|NCT00922935|19340987|P2|COMPLETED|Overall Study||11
7858002|NCT00922935|19340988|P1|COMPLETED|Overall Study||9
7858003|NCT00922935|19340986|P3|STARTED|Overall Study||10
7858004|NCT00922935|19340987|P2|STARTED|Overall Study||16
7858005|NCT00922935|19340988|P1|STARTED|Overall Study||10
7858006|NCT00922883|19340996|P1|NOT COMPLETED|Overall Study||0
7858007|NCT00922883|19340996|P1|COMPLETED|Overall Study||43
7858008|NCT00922883|19340996|P1|STARTED|Overall Study||43
7858009|NCT00922779|19341000|P1|NOT COMPLETED|Overall Study||2327
7858010|NCT00922779|19341000|P1|COMPLETED|Overall Study||4334
7858011|NCT00922779|19341000|P1|STARTED|Overall Study||6661
7858012|NCT00922766|19341007|P1|NOT COMPLETED|Overall Study||7
7858013|NCT00922766|19341007|P1|COMPLETED|Overall Study||610
7858014|NCT00922766|19341007|P1|STARTED|Overall Study||617
7858015|NCT00922701|19341016|P1|NOT COMPLETED|Overall Study||0
7858016|NCT00922701|19341016|P1|COMPLETED|Overall Study||4
7858017|NCT00922701|19341016|P1|STARTED|Overall Study||4
7858018|NCT00922636|19341025|P5|NOT COMPLETED|Overall Study||16
7858019|NCT00922636|19341026|P4|NOT COMPLETED|Overall Study||17
7858021|NCT00922636|19341028|P2|NOT COMPLETED|Overall Study||16
7858022|NCT00922636|19341029|P1|NOT COMPLETED|Overall Study||7
7858023|NCT00922636|19341025|P5|COMPLETED|Overall Study||59
7858024|NCT00922636|19341026|P4|COMPLETED|Overall Study||58
7858025|NCT00922636|19341027|P3|COMPLETED|Overall Study||56
7858026|NCT00922636|19341028|P2|COMPLETED|Overall Study||62
7858027|NCT00922636|19341029|P1|COMPLETED|Overall Study||29
7858028|NCT00922636|19341025|P5|Entered Optional Taper Phase|Overall Study||12
7858029|NCT00922636|19341026|P4|Entered Optional Taper Phase|Overall Study||7
7858030|NCT00922636|19341027|P3|Entered Optional Taper Phase|Overall Study||15
7858031|NCT00922636|19341028|P2|Entered Optional Taper Phase|Overall Study||10
7858032|NCT00922636|19341029|P1|Entered Optional Taper Phase|Overall Study||4
7858033|NCT00922636|19341025|P5|STARTED|Overall Study||75
7858034|NCT00922636|19341026|P4|STARTED|Overall Study||75
7858035|NCT00922636|19341027|P3|STARTED|Overall Study||76
7858036|NCT00922636|19341028|P2|STARTED|Overall Study||78
7858037|NCT00922636|19341029|P1|STARTED|Overall Study||36
7858038|NCT00922623|19341176|P1|NOT COMPLETED|Overall Study||5
7858039|NCT00922623|19341176|P1|COMPLETED|Overall Study||88
7858040|NCT00922623|19341176|P1|STARTED|Overall Study||93
7858041|NCT00922480|19341184|P2|NOT COMPLETED|Extension Study||3
7858042|NCT00922480|19341185|P1|NOT COMPLETED|Extension Study||5
7858043|NCT00922480|19341184|P2|COMPLETED|Extension Study||82
7858044|NCT00922480|19341185|P1|COMPLETED|Extension Study||68
7858045|NCT00922480|19341184|P2|STARTED|Extension Study||85
7858046|NCT00922480|19341185|P1|STARTED|Extension Study||73
7858047|NCT00922480|19341184|P2|NOT COMPLETED|Main Study||29
7858048|NCT00922480|19341185|P1|NOT COMPLETED|Main Study||37
7858049|NCT00922480|19341184|P2|COMPLETED|Main Study||226
7858050|NCT00922480|19341185|P1|COMPLETED|Main Study||213
7858051|NCT00922480|19341184|P2|STARTED|Main Study||255
7858052|NCT00922480|19341185|P1|STARTED|Main Study||250
7858053|NCT00922441|19341196|P3|NOT COMPLETED|Overall Study||3
7858054|NCT00922441|19341197|P2|NOT COMPLETED|Overall Study||0
7858055|NCT00922441|19341198|P1|NOT COMPLETED|Overall Study||0
7858056|NCT00922441|19341196|P3|COMPLETED|Overall Study||29
7858057|NCT00922441|19341197|P2|COMPLETED|Overall Study||30
7858058|NCT00922441|19341198|P1|COMPLETED|Overall Study||30
7858059|NCT00922441|19341196|P3|STARTED|Overall Study||32
7858060|NCT00922441|19341197|P2|STARTED|Overall Study||30
7858061|NCT00922441|19341198|P1|STARTED|Overall Study||30
7858062|NCT00922428|19341206|P1|NOT COMPLETED|Overall Study||15
7858063|NCT00922428|19341206|P1|COMPLETED|Overall Study|for 11 participants no gender was given|1374
7858064|NCT00922428|19341206|P1|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389
7858065|NCT00922272|19341235|P2|NOT COMPLETED|Double-blind Phase||6
7858066|NCT00922272|19341236|P1|NOT COMPLETED|Double-blind Phase||7
7858067|NCT00922272|19341235|P2|COMPLETED|Double-blind Phase||29
7858068|NCT00922272|19341236|P1|COMPLETED|Double-blind Phase||27
7858069|NCT00922272|19341235|P2|STARTED|Double-blind Phase||35
7858070|NCT00922272|19341236|P1|STARTED|Double-blind Phase||34
7858071|NCT00922272|19341235|P2|NOT COMPLETED|Open-label Phase||0
7858072|NCT00922272|19341236|P1|NOT COMPLETED|Open-label Phase||23
7858073|NCT00922272|19341235|P2|COMPLETED|Open-label Phase||0
7858074|NCT00922272|19341236|P1|COMPLETED|Open-label Phase||69
7858075|NCT00922272|19341235|P2|STARTED|Open-label Phase||0
7858076|NCT00922272|19341236|P1|STARTED|Open-label Phase||92
7858077|NCT00922233|19341292|P1|NOT COMPLETED|Overall Study||4
7858078|NCT00922233|19341292|P1|COMPLETED|Overall Study||68
7858079|NCT00922233|19341292|P1|STARTED|Overall Study||72
7858080|NCT00922207|19341301|P3|NOT COMPLETED|Overall Study||4
7858081|NCT00922207|19341302|P2|NOT COMPLETED|Overall Study||7
7858082|NCT00922207|19341303|P1|NOT COMPLETED|Overall Study||6
7858083|NCT00922207|19341301|P3|COMPLETED|Overall Study||90
7858084|NCT00922207|19341302|P2|COMPLETED|Overall Study||88
7858085|NCT00922207|19341303|P1|COMPLETED|Overall Study||85
7858086|NCT00922207|19341301|P3|STARTED|Overall Study||94
7858087|NCT00922207|19341302|P2|STARTED|Overall Study||95
7858088|NCT00922207|19341303|P1|STARTED|Overall Study||91
7858089|NCT00922194|19341329|P1|NOT COMPLETED|Metformin for 12 Months or More||0
7858090|NCT00922194|19341329|P1|COMPLETED|Metformin for 12 Months or More||102
7858091|NCT00922194|19341329|P1|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102
7858092|NCT00922194|19341329|P1|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0
7858093|NCT00922194|19341329|P1|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102
7858094|NCT00922194|19341329|P1|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102
7858095|NCT00922116|19341339|P1|NOT COMPLETED|Overall Study||15
7858096|NCT00922116|19341339|P1|COMPLETED|Overall Study||176
7858097|NCT00922116|19341339|P1|STARTED|Overall Study||191
7858098|NCT00921947|19341350|P2|NOT COMPLETED|Day 28||0
7858099|NCT00921947|19341351|P1|NOT COMPLETED|Day 28||0
7858100|NCT00921947|19341350|P2|COMPLETED|Day 28||30
7858101|NCT00921947|19341351|P1|COMPLETED|Day 28||28
7858102|NCT00921947|19341350|P2|STARTED|Day 28||30
7858103|NCT00921947|19341351|P1|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28
7858104|NCT00921947|19341350|P2|NOT COMPLETED|Day 0||0
7858105|NCT00921947|19341351|P1|NOT COMPLETED|Day 0||0
7858106|NCT00921947|19341350|P2|COMPLETED|Day 0||30
7858107|NCT00921947|19341351|P1|COMPLETED|Day 0||30
7858108|NCT00921947|19341350|P2|STARTED|Day 0||30
7858109|NCT00921947|19341351|P1|STARTED|Day 0||30
7858110|NCT00921934|19341361|P1|NOT COMPLETED|Overall Study||0
7858111|NCT00921934|19341361|P1|COMPLETED|Overall Study||68
7858112|NCT00921934|19341361|P1|STARTED|Overall Study||68
7858113|NCT00921895|19341365|P1|NOT COMPLETED|Overall Study||0
7858114|NCT00921895|19341365|P1|COMPLETED|Overall Study||128
7858115|NCT00921895|19341365|P1|STARTED|Overall Study||128
7858116|NCT00921843|19341374|P4|NOT COMPLETED|Overall Study||0
7858117|NCT00921843|19341375|P3|NOT COMPLETED|Overall Study||0
7858118|NCT00921843|19341376|P2|NOT COMPLETED|Overall Study||0
7858119|NCT00921843|19341377|P1|NOT COMPLETED|Overall Study||0
7858120|NCT00921843|19341374|P4|COMPLETED|Overall Study||30
7858121|NCT00921843|19341375|P3|COMPLETED|Overall Study||11
7858122|NCT00921843|19341376|P2|COMPLETED|Overall Study||10
7858123|NCT00921843|19341377|P1|COMPLETED|Overall Study||10
7858124|NCT00921843|19341374|P4|STARTED|Overall Study||30
7858125|NCT00921843|19341375|P3|STARTED|Overall Study||11
7858126|NCT00921843|19341376|P2|STARTED|Overall Study||10
7858127|NCT00921843|19341377|P1|STARTED|Overall Study||10
7858128|NCT00921687|19341389|P2|NOT COMPLETED|Overall Study||0
7858129|NCT00921687|19341390|P1|NOT COMPLETED|Overall Study||0
7858130|NCT00921687|19341389|P2|COMPLETED|Overall Study||363
7858131|NCT00921687|19341390|P1|COMPLETED|Overall Study||418
7858132|NCT00921687|19341389|P2|STARTED|Overall Study||363
7858133|NCT00921687|19341390|P1|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418
7858134|NCT00921557|19341401|P3|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
7858135|NCT00921557|19341402|P2|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
7858136|NCT00921557|19341403|P1|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3
7858137|NCT00921557|19341401|P3|COMPLETED|Weeks 96-144 (Off Study Treatment)||16
7858138|NCT00921557|19341402|P2|COMPLETED|Weeks 96-144 (Off Study Treatment)||15
7858139|NCT00921557|19341403|P1|COMPLETED|Weeks 96-144 (Off Study Treatment)||12
7858140|NCT00921557|19341401|P3|STARTED|Weeks 96-144 (Off Study Treatment)||17
7858141|NCT00921557|19341402|P2|STARTED|Weeks 96-144 (Off Study Treatment)||16
7858142|NCT00921557|19341403|P1|STARTED|Weeks 96-144 (Off Study Treatment)||15
7858143|NCT00921557|19341401|P3|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
7858144|NCT00921557|19341402|P2|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
7858145|NCT00921557|19341403|P1|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0
7858146|NCT00921557|19341401|P3|COMPLETED|Weeks 48-96 (on Study Treatment)||17
7858147|NCT00921557|19341402|P2|COMPLETED|Weeks 48-96 (on Study Treatment)||16
7858148|NCT00921557|19341403|P1|COMPLETED|Weeks 48-96 (on Study Treatment)||15
7858149|NCT00921557|19341401|P3|STARTED|Weeks 48-96 (on Study Treatment)||18
7858150|NCT00921557|19341402|P2|STARTED|Weeks 48-96 (on Study Treatment)||17
7858151|NCT00921557|19341403|P1|STARTED|Weeks 48-96 (on Study Treatment)||15
7858152|NCT00921557|19341401|P3|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
7858153|NCT00921557|19341402|P2|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
7858154|NCT00921557|19341403|P1|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2
7858155|NCT00921557|19341401|P3|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|18
7858156|NCT00921557|19341402|P2|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|17
7858157|NCT00921557|19341403|P1|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|15
7858158|NCT00921557|19341401|P3|STARTED|Weeks 0-48 (on Study Treatment)||18
7858159|NCT00921557|19341402|P2|STARTED|Weeks 0-48 (on Study Treatment)||17
7858160|NCT00921557|19341403|P1|STARTED|Weeks 0-48 (on Study Treatment)||17
7858161|NCT00921518|19341463|P2|NOT COMPLETED|Overall Study||0
7858162|NCT00921518|19341464|P1|NOT COMPLETED|Overall Study||0
7858163|NCT00921518|19341463|P2|COMPLETED|Overall Study||44
7858164|NCT00921518|19341464|P1|COMPLETED|Overall Study||48
7858165|NCT00921518|19341463|P2|STARTED|Overall Study||44
7858166|NCT00921518|19341464|P1|STARTED|Overall Study||48
7858167|NCT00921310|19341472|P3|NOT COMPLETED|Overall Study||0
7858168|NCT00921310|19341473|P2|NOT COMPLETED|Overall Study||0
7858169|NCT00921310|19341474|P1|NOT COMPLETED|Overall Study||0
7858170|NCT00921310|19341472|P3|COMPLETED|Overall Study||4
7858171|NCT00921310|19341473|P2|COMPLETED|Overall Study||6
7858172|NCT00921310|19341474|P1|COMPLETED|Overall Study||2
7858173|NCT00921310|19341472|P3|STARTED|Overall Study||4
7858174|NCT00921310|19341473|P2|STARTED|Overall Study||6
7858175|NCT00921310|19341474|P1|STARTED|Overall Study||2
7858176|NCT00921115|19341499|P1|NOT COMPLETED|Overall Study||0
7858177|NCT00921115|19341499|P1|COMPLETED|Overall Study||42
7858178|NCT00921115|19341499|P1|STARTED|Overall Study||42
7858179|NCT00921024|19341505|P2|NOT COMPLETED|Overall Study||3
7858180|NCT00921024|19341506|P1|NOT COMPLETED|Overall Study||4
7858181|NCT00921024|19341505|P2|COMPLETED|Overall Study||39
7858182|NCT00921024|19341506|P1|COMPLETED|Overall Study||81
7858183|NCT00921024|19341505|P2|STARTED|Overall Study||42
7858184|NCT00921024|19341506|P1|STARTED|Overall Study||85
7858185|NCT00920907|19341516|P2|NOT COMPLETED|Maintenance Period||13
7858186|NCT00920907|19341517|P1|NOT COMPLETED|Maintenance Period||12
7858187|NCT00920907|19341516|P2|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2
7858188|NCT00920907|19341517|P1|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3
7858189|NCT00920907|19341516|P2|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15
7858190|NCT00920907|19341517|P1|STARTED|Maintenance Period||15
7858191|NCT00920907|19341516|P2|NOT COMPLETED|Induction Period||22
7858192|NCT00920907|19341517|P1|NOT COMPLETED|Induction Period||22
7858193|NCT00920907|19341516|P2|COMPLETED|Induction Period||16
7858194|NCT00920907|19341517|P1|COMPLETED|Induction Period||15
7858195|NCT00920907|19341516|P2|STARTED|Induction Period||38
7858196|NCT00920907|19341517|P1|STARTED|Induction Period||37
7858197|NCT00920855|19341558|P3|NOT COMPLETED|Overall Study||22
7858198|NCT00920855|19341559|P2|NOT COMPLETED|Overall Study||3
7858199|NCT00920855|19341560|P1|NOT COMPLETED|Overall Study||5
7858200|NCT00920855|19341558|P3|COMPLETED|Overall Study|completed eight cycles of treatment|9
7858201|NCT00920855|19341559|P2|COMPLETED|Overall Study|completed eight cycles of treatment|1
7858202|NCT00920855|19341560|P1|COMPLETED|Overall Study|completed eight cycles of treatment|0
7858203|NCT00920855|19341558|P3|Safety and Efficacy Populations|Overall Study||31
7858204|NCT00920855|19341559|P2|Safety and Efficacy Populations|Overall Study||4
7858205|NCT00920855|19341560|P1|Safety and Efficacy Populations|Overall Study||5
7858206|NCT00920855|19341558|P3|STARTED|Overall Study||31
7858207|NCT00920855|19341559|P2|STARTED|Overall Study||4
7858208|NCT00920855|19341560|P1|STARTED|Overall Study||5
7858209|NCT00920829|19341586|P4|NOT COMPLETED|Available for Analysis||11
7858210|NCT00920829|19341587|P3|NOT COMPLETED|Available for Analysis||10
7858211|NCT00920829|19341588|P2|NOT COMPLETED|Available for Analysis||11
7858212|NCT00920829|19341589|P1|NOT COMPLETED|Available for Analysis||8
7858213|NCT00920829|19341586|P4|COMPLETED|Available for Analysis||24
7858214|NCT00920829|19341587|P3|COMPLETED|Available for Analysis||28
7858215|NCT00920829|19341588|P2|COMPLETED|Available for Analysis||27
7858216|NCT00920829|19341589|P1|COMPLETED|Available for Analysis||27
7858217|NCT00920829|19341586|P4|STARTED|Available for Analysis||35
7858218|NCT00920829|19341587|P3|STARTED|Available for Analysis||38
7858219|NCT00920829|19341588|P2|STARTED|Available for Analysis||38
7858220|NCT00920829|19341589|P1|STARTED|Available for Analysis||35
7858221|NCT00920829|19341586|P4|NOT COMPLETED|Allocation||2
7858222|NCT00920829|19341587|P3|NOT COMPLETED|Allocation||0
7858223|NCT00920829|19341588|P2|NOT COMPLETED|Allocation||1
7858224|NCT00920829|19341589|P1|NOT COMPLETED|Allocation||3
7858225|NCT00920829|19341586|P4|COMPLETED|Allocation||35
7858226|NCT00920829|19341587|P3|COMPLETED|Allocation||38
7858227|NCT00920829|19341588|P2|COMPLETED|Allocation||38
7858228|NCT00920829|19341589|P1|COMPLETED|Allocation||35
7858229|NCT00920829|19341586|P4|STARTED|Allocation||37
7858230|NCT00920829|19341587|P3|STARTED|Allocation||38
7858231|NCT00920829|19341588|P2|STARTED|Allocation||39
7858232|NCT00920829|19341589|P1|STARTED|Allocation||38
7858233|NCT00920816|19341603|P4|NOT COMPLETED|Overall Study||69
7858234|NCT00920816|19341604|P3|NOT COMPLETED|Overall Study||135
7858235|NCT00920816|19341605|P2|NOT COMPLETED|Overall Study||96
7858236|NCT00920816|19341606|P1|NOT COMPLETED|Overall Study||192
7858237|NCT00920816|19341603|P4|COMPLETED|Overall Study||0
7858238|NCT00920816|19341604|P3|COMPLETED|Overall Study||0
7858239|NCT00920816|19341605|P2|COMPLETED|Overall Study||0
7858240|NCT00920816|19341606|P1|COMPLETED|Overall Study||0
7858241|NCT00920816|19341603|P4|Treated|Overall Study||69
7858242|NCT00920816|19341604|P3|Treated|Overall Study||135
7858243|NCT00920816|19341605|P2|Treated|Overall Study||96
7858244|NCT00920816|19341606|P1|Treated|Overall Study||189
7858245|NCT00920816|19341603|P4|STARTED|Overall Study||69
7858246|NCT00920816|19341604|P3|STARTED|Overall Study||135
7858247|NCT00920816|19341605|P2|STARTED|Overall Study||96
7858248|NCT00920816|19341606|P1|STARTED|Overall Study||192
7858249|NCT00920790|19341644|P1|NOT COMPLETED|Overall Study||14
7858250|NCT00920790|19341644|P1|COMPLETED|Overall Study||13
7858251|NCT00920790|19341644|P1|STARTED|Overall Study||27
7858252|NCT00920699|19341656|P3|NOT COMPLETED|Overall Study||4
7858253|NCT00920699|19341657|P2|NOT COMPLETED|Overall Study||1
7858254|NCT00920699|19341658|P1|NOT COMPLETED|Overall Study||2
7858255|NCT00920699|19341656|P3|COMPLETED|Overall Study||28
7858256|NCT00920699|19341657|P2|COMPLETED|Overall Study||29
7858257|NCT00920699|19341658|P1|COMPLETED|Overall Study||27
7858258|NCT00920699|19341656|P3|STARTED|Overall Study||32
7858259|NCT00920699|19341657|P2|STARTED|Overall Study||30
7858260|NCT00920699|19341658|P1|STARTED|Overall Study||29
7858261|NCT00920686|19341675|P3|NOT COMPLETED|Overall Study||13
7858262|NCT00920686|19341676|P2|NOT COMPLETED|Overall Study||22
7858263|NCT00920686|19341677|P1|NOT COMPLETED|Overall Study||19
7858264|NCT00920686|19341675|P3|COMPLETED|Overall Study||62
7858265|NCT00920686|19341676|P2|COMPLETED|Overall Study||60
7858266|NCT00920686|19341677|P1|COMPLETED|Overall Study||63
7858267|NCT00920686|19341675|P3|STARTED|Overall Study||75
7858268|NCT00920686|19341676|P2|STARTED|Overall Study||82
7858269|NCT00920686|19341677|P1|STARTED|Overall Study||82
7858270|NCT00920647|19341701|P4|NOT COMPLETED|Overall Study||0
7858271|NCT00920647|19341702|P3|NOT COMPLETED|Overall Study||0
7858272|NCT00920647|19341703|P2|NOT COMPLETED|Overall Study||0
7858273|NCT00920647|19341704|P1|NOT COMPLETED|Overall Study||0
7858274|NCT00920647|19341701|P4|COMPLETED|Overall Study||4
7858275|NCT00920647|19341702|P3|COMPLETED|Overall Study||4
7858276|NCT00920647|19341703|P2|COMPLETED|Overall Study||4
7858277|NCT00920647|19341704|P1|COMPLETED|Overall Study||4
7858278|NCT00920647|19341701|P4|STARTED|Overall Study||4
7858279|NCT00920647|19341702|P3|STARTED|Overall Study||4
7858280|NCT00920647|19341703|P2|STARTED|Overall Study||4
7858281|NCT00920647|19341704|P1|STARTED|Overall Study||4
7858282|NCT00920621|19341756|P4|NOT COMPLETED|Overall Study||35
7858283|NCT00920621|19341757|P3|NOT COMPLETED|Overall Study||35
7858284|NCT00920621|19341758|P2|NOT COMPLETED|Overall Study||45
7858285|NCT00920621|19341759|P1|NOT COMPLETED|Overall Study||54
7858286|NCT00920621|19341756|P4|COMPLETED|Overall Study||401
7858287|NCT00920621|19341757|P3|COMPLETED|Overall Study||405
7858288|NCT00920621|19341758|P2|COMPLETED|Overall Study||391
7858289|NCT00920621|19341759|P1|COMPLETED|Overall Study||386
7858290|NCT00920621|19341756|P4|STARTED|Overall Study||436
7858291|NCT00920621|19341757|P3|STARTED|Overall Study||440
7858292|NCT00920621|19341758|P2|STARTED|Overall Study||436
7858293|NCT00920621|19341759|P1|STARTED|Overall Study||440
7858294|NCT00920556|19341789|P1|NOT COMPLETED|Overall Study||24
7858295|NCT00920556|19341789|P1|COMPLETED|Overall Study||0
7858296|NCT00920556|19341789|P1|STARTED|Overall Study||24
7858297|NCT00920439|19341828|P1|NOT COMPLETED|Overall Study||0
7858298|NCT00920439|19341828|P1|COMPLETED|Overall Study||25
7858299|NCT00920439|19341828|P1|STARTED|Overall Study||25
7858300|NCT00920426|19341838|P4|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
7858301|NCT00920426|19341839|P3|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
7858302|NCT00920426|19341840|P2|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
7858303|NCT00920426|19341841|P1|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
7858304|NCT00920426|19341838|P4|COMPLETED|ITZ112929: Optimized Therapy (OT)||8
7858305|NCT00920426|19341839|P3|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
7858306|NCT00920426|19341840|P2|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
7858307|NCT00920426|19341841|P1|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
7858308|NCT00920426|19341838|P4|STARTED|ITZ112929: Optimized Therapy (OT)|Out of 9 participants receiving randomized regimen, 8 participants continued to receive OT.|8
7858309|NCT00920426|19341839|P3|STARTED|ITZ112929: Optimized Therapy (OT)||0
7858310|NCT00920426|19341840|P2|STARTED|ITZ112929: Optimized Therapy (OT)||0
7858311|NCT00920426|19341841|P1|STARTED|ITZ112929: Optimized Therapy (OT)||0
7858312|NCT00920426|19341838|P4|NOT COMPLETED|ITZ112929: Randomized Regimen||0
7858313|NCT00920426|19341839|P3|NOT COMPLETED|ITZ112929: Randomized Regimen||0
7858314|NCT00920426|19341840|P2|NOT COMPLETED|ITZ112929: Randomized Regimen||0
7858315|NCT00920426|19341841|P1|NOT COMPLETED|ITZ112929: Randomized Regimen||0
7858316|NCT00920426|19341838|P4|COMPLETED|ITZ112929: Randomized Regimen||0
7858317|NCT00920426|19341839|P3|COMPLETED|ITZ112929: Randomized Regimen||2
7858318|NCT00920426|19341840|P2|COMPLETED|ITZ112929: Randomized Regimen||7
7858319|NCT00920426|19341841|P1|COMPLETED|ITZ112929: Randomized Regimen||0
7858320|NCT00920426|19341838|P4|STARTED|ITZ112929: Randomized Regimen||0
7858321|NCT00920426|19341839|P3|STARTED|ITZ112929: Randomized Regimen||2
7858322|NCT00920426|19341840|P2|STARTED|ITZ112929: Randomized Regimen||7
7858323|NCT00920426|19341841|P1|STARTED|ITZ112929: Randomized Regimen||0
7858324|NCT00920426|19341838|P4|NOT COMPLETED|ITZ111451||0
7858325|NCT00920426|19341839|P3|NOT COMPLETED|ITZ111451||0
7858326|NCT00920426|19341840|P2|NOT COMPLETED|ITZ111451||0
7858327|NCT00920426|19341841|P1|NOT COMPLETED|ITZ111451||1
7858328|NCT00920426|19341838|P4|COMPLETED|ITZ111451||0
7858329|NCT00920426|19341839|P3|COMPLETED|ITZ111451||0
7858330|NCT00920426|19341840|P2|COMPLETED|ITZ111451||0
7858331|NCT00920426|19341841|P1|COMPLETED|ITZ111451||7
7858332|NCT00920426|19341838|P4|STARTED|ITZ111451||0
7858333|NCT00920426|19341839|P3|STARTED|ITZ111451||0
7858334|NCT00920426|19341840|P2|STARTED|ITZ111451||0
7858335|NCT00920426|19341841|P1|STARTED|ITZ111451||8
7858336|NCT00920374|19341910|P2|NOT COMPLETED|Overall Study||0
7858337|NCT00920374|19341911|P1|NOT COMPLETED|Overall Study||0
7858338|NCT00920374|19341910|P2|COMPLETED|Overall Study||57
7858339|NCT00920374|19341911|P1|COMPLETED|Overall Study||61
7858340|NCT00920374|19341910|P2|STARTED|Overall Study||57
7858341|NCT00920374|19341911|P1|STARTED|Overall Study||61
7858342|NCT00920309|19341937|P2|NOT COMPLETED|Overall Study||0
7858343|NCT00920309|19341938|P1|NOT COMPLETED|Overall Study||0
7858344|NCT00920309|19341937|P2|COMPLETED|Overall Study||7
7858345|NCT00920309|19341938|P1|COMPLETED|Overall Study||14
7858346|NCT00920309|19341937|P2|STARTED|Overall Study||7
7858347|NCT00920309|19341938|P1|STARTED|Overall Study||14
7858348|NCT00920231|19341948|P2|NOT COMPLETED|Overall Study||0
7858349|NCT00920231|19341949|P1|NOT COMPLETED|Overall Study||0
7858350|NCT00920231|19341948|P2|COMPLETED|Overall Study||8
7858351|NCT00920231|19341949|P1|COMPLETED|Overall Study||8
7858352|NCT00920231|19341948|P2|STARTED|Overall Study||8
7858353|NCT00920231|19341949|P1|STARTED|Overall Study||8
7858354|NCT00920218|19341961|P4|NOT COMPLETED|Overall Study||7
7858355|NCT00920218|19341962|P3|NOT COMPLETED|Overall Study||8
7858356|NCT00920218|19341963|P2|NOT COMPLETED|Overall Study||5
7858357|NCT00920218|19341964|P1|NOT COMPLETED|Overall Study||2
7858358|NCT00920218|19341961|P4|COMPLETED|Overall Study||23
7858359|NCT00920218|19341962|P3|COMPLETED|Overall Study||23
7858360|NCT00920218|19341963|P2|COMPLETED|Overall Study||24
7858361|NCT00920218|19341964|P1|COMPLETED|Overall Study||28
7858362|NCT00920218|19341961|P4|STARTED|Overall Study||30
7858363|NCT00920218|19341962|P3|STARTED|Overall Study||31
7858364|NCT00920218|19341963|P2|STARTED|Overall Study||29
7858365|NCT00920218|19341964|P1|STARTED|Overall Study||30
7858366|NCT00920140|19342067|P5|NOT COMPLETED|Phase 2||11
7858367|NCT00920140|19342068|P4|NOT COMPLETED|Phase 2||22
7858368|NCT00920140|19342069|P3|NOT COMPLETED|Phase 2||50
7858369|NCT00920140|19342070|P2|NOT COMPLETED|Phase 2||0
7858370|NCT00920140|19342071|P1|NOT COMPLETED|Phase 2||0
7858371|NCT00920140|19342067|P5|COMPLETED|Phase 2||0
7858372|NCT00920140|19342068|P4|COMPLETED|Phase 2||0
7858373|NCT00920140|19342069|P3|COMPLETED|Phase 2||0
7858374|NCT00920140|19342070|P2|COMPLETED|Phase 2||0
7858375|NCT00920140|19342071|P1|COMPLETED|Phase 2||0
7858376|NCT00920140|19342067|P5|STARTED|Phase 2||11
7858377|NCT00920140|19342068|P4|STARTED|Phase 2||22
7858378|NCT00920140|19342069|P3|STARTED|Phase 2||50
7858379|NCT00920140|19342070|P2|STARTED|Phase 2||0
7858380|NCT00920140|19342071|P1|STARTED|Phase 2||0
7858381|NCT00920140|19342067|P5|NOT COMPLETED|Phase 1 (Dose Escalation)||0
7858382|NCT00920140|19342068|P4|NOT COMPLETED|Phase 1 (Dose Escalation)||0
7858383|NCT00920140|19342069|P3|NOT COMPLETED|Phase 1 (Dose Escalation)||0
7858384|NCT00920140|19342070|P2|NOT COMPLETED|Phase 1 (Dose Escalation)||9
7858385|NCT00920140|19342071|P1|NOT COMPLETED|Phase 1 (Dose Escalation)||5
7858386|NCT00920140|19342067|P5|COMPLETED|Phase 1 (Dose Escalation)||0
7858387|NCT00920140|19342068|P4|COMPLETED|Phase 1 (Dose Escalation)||0
7858388|NCT00920140|19342069|P3|COMPLETED|Phase 1 (Dose Escalation)||0
7858389|NCT00920140|19342070|P2|COMPLETED|Phase 1 (Dose Escalation)||0
7858390|NCT00920140|19342071|P1|COMPLETED|Phase 1 (Dose Escalation)||0
7858391|NCT00920140|19342067|P5|STARTED|Phase 1 (Dose Escalation)||0
7858392|NCT00920140|19342068|P4|STARTED|Phase 1 (Dose Escalation)||0
7858393|NCT00920140|19342069|P3|STARTED|Phase 1 (Dose Escalation)||0
7858394|NCT00920140|19342070|P2|STARTED|Phase 1 (Dose Escalation)||9
7858395|NCT00920140|19342071|P1|STARTED|Phase 1 (Dose Escalation)||5
7858396|NCT00920075|19342109|P1|NOT COMPLETED|Post Study, 11 Pts Responded||0
7858397|NCT00920075|19342109|P1|COMPLETED|Post Study, 11 Pts Responded||11
7858398|NCT00920075|19342109|P1|STARTED|Post Study, 11 Pts Responded||11
7858399|NCT00920075|19342109|P1|NOT COMPLETED|Last Study, 25 Pts Invited,11 Responded||0
7858400|NCT00920075|19342109|P1|COMPLETED|Last Study, 25 Pts Invited,11 Responded||11
7858401|NCT00920075|19342109|P1|STARTED|Last Study, 25 Pts Invited,11 Responded||11
7858402|NCT00920023|19342115|P1|NOT COMPLETED|Overall Study||0
7858403|NCT00920023|19342115|P1|COMPLETED|Overall Study||15
7858404|NCT00920023|19342115|P1|STARTED|Overall Study||15
7858405|NCT00919932|19342122|P2|NOT COMPLETED|Overall Study||0
7858406|NCT00919932|19342123|P1|NOT COMPLETED|Overall Study||0
7858407|NCT00919932|19342122|P2|COMPLETED|Overall Study||5
7858408|NCT00919932|19342123|P1|COMPLETED|Overall Study||4
7858409|NCT00919932|19342122|P2|STARTED|Overall Study||5
7858410|NCT00919932|19342123|P1|STARTED|Overall Study||4
7858411|NCT00919893|19342133|P2|NOT COMPLETED|Overall Study||9
7858412|NCT00919893|19342134|P1|NOT COMPLETED|Overall Study||19
7858413|NCT00919893|19342133|P2|COMPLETED|Overall Study||60
7858414|NCT00919893|19342134|P1|COMPLETED|Overall Study||51
7858415|NCT00919893|19342133|P2|STARTED|Overall Study||69
7858416|NCT00919893|19342134|P1|STARTED|Overall Study||70
7858417|NCT00919867|19342146|P6|NOT COMPLETED|Third Intervention||0
7858418|NCT00919867|19342147|P5|NOT COMPLETED|Third Intervention||0
7858419|NCT00919867|19342148|P4|NOT COMPLETED|Third Intervention||0
7858420|NCT00919867|19342149|P3|NOT COMPLETED|Third Intervention||0
7858421|NCT00919867|19342150|P2|NOT COMPLETED|Third Intervention||0
7858422|NCT00919867|19342151|P1|NOT COMPLETED|Third Intervention||0
7858423|NCT00919867|19342146|P6|COMPLETED|Third Intervention||6
7858424|NCT00919867|19342147|P5|COMPLETED|Third Intervention||7
7858425|NCT00919867|19342148|P4|COMPLETED|Third Intervention||7
7858426|NCT00919867|19342149|P3|COMPLETED|Third Intervention||6
7858427|NCT00919867|19342150|P2|COMPLETED|Third Intervention||7
7858428|NCT00919867|19342151|P1|COMPLETED|Third Intervention||7
7858429|NCT00919867|19342146|P6|STARTED|Third Intervention||6
7858430|NCT00919867|19342147|P5|STARTED|Third Intervention||7
7858431|NCT00919867|19342148|P4|STARTED|Third Intervention||7
7858432|NCT00919867|19342149|P3|STARTED|Third Intervention||6
7858433|NCT00919867|19342150|P2|STARTED|Third Intervention||7
7858434|NCT00919867|19342151|P1|STARTED|Third Intervention||7
7858435|NCT00919867|19342146|P6|NOT COMPLETED|Washout||0
7858436|NCT00919867|19342147|P5|NOT COMPLETED|Washout||0
7858437|NCT00919867|19342148|P4|NOT COMPLETED|Washout||0
7858438|NCT00919867|19342149|P3|NOT COMPLETED|Washout||0
7858439|NCT00919867|19342150|P2|NOT COMPLETED|Washout||0
7858440|NCT00919867|19342151|P1|NOT COMPLETED|Washout||0
7858441|NCT00919867|19342146|P6|COMPLETED|Washout||6
7858442|NCT00919867|19342147|P5|COMPLETED|Washout||7
7858443|NCT00919867|19342148|P4|COMPLETED|Washout||7
7858444|NCT00919867|19342149|P3|COMPLETED|Washout||6
7858445|NCT00919867|19342150|P2|COMPLETED|Washout||7
7858446|NCT00919867|19342151|P1|COMPLETED|Washout||7
7858447|NCT00919867|19342146|P6|STARTED|Washout||6
7858448|NCT00919867|19342147|P5|STARTED|Washout||7
7858449|NCT00919867|19342148|P4|STARTED|Washout||7
7858450|NCT00919867|19342149|P3|STARTED|Washout||6
7858451|NCT00919867|19342150|P2|STARTED|Washout||7
7858452|NCT00919867|19342151|P1|STARTED|Washout||7
7858453|NCT00919867|19342146|P6|NOT COMPLETED|Second Intervention||0
7858454|NCT00919867|19342147|P5|NOT COMPLETED|Second Intervention||0
7858455|NCT00919867|19342148|P4|NOT COMPLETED|Second Intervention||0
7858456|NCT00919867|19342149|P3|NOT COMPLETED|Second Intervention||0
7858457|NCT00919867|19342150|P2|NOT COMPLETED|Second Intervention||0
7858458|NCT00919867|19342151|P1|NOT COMPLETED|Second Intervention||0
7858459|NCT00919867|19342146|P6|COMPLETED|Second Intervention||6
7858460|NCT00919867|19342147|P5|COMPLETED|Second Intervention||7
7858461|NCT00919867|19342148|P4|COMPLETED|Second Intervention||7
7858462|NCT00919867|19342149|P3|COMPLETED|Second Intervention||6
7858463|NCT00919867|19342150|P2|COMPLETED|Second Intervention||7
7858464|NCT00919867|19342151|P1|COMPLETED|Second Intervention||7
7858465|NCT00919867|19342146|P6|STARTED|Second Intervention||6
7858466|NCT00919867|19342147|P5|STARTED|Second Intervention||7
7858467|NCT00919867|19342148|P4|STARTED|Second Intervention||7
7858468|NCT00919867|19342149|P3|STARTED|Second Intervention||6
7858469|NCT00919867|19342150|P2|STARTED|Second Intervention||7
7858470|NCT00919867|19342151|P1|STARTED|Second Intervention||7
7858471|NCT00919867|19342146|P6|NOT COMPLETED|Washout||0
7858472|NCT00919867|19342147|P5|NOT COMPLETED|Washout||0
7858473|NCT00919867|19342148|P4|NOT COMPLETED|Washout||0
7858474|NCT00919867|19342149|P3|NOT COMPLETED|Washout||0
7858475|NCT00919867|19342150|P2|NOT COMPLETED|Washout||0
7858476|NCT00919867|19342151|P1|NOT COMPLETED|Washout||0
7858477|NCT00919867|19342146|P6|COMPLETED|Washout||6
7858478|NCT00919867|19342147|P5|COMPLETED|Washout||7
7858479|NCT00919867|19342148|P4|COMPLETED|Washout||7
7858480|NCT00919867|19342149|P3|COMPLETED|Washout||6
7858481|NCT00919867|19342150|P2|COMPLETED|Washout||7
7858482|NCT00919867|19342151|P1|COMPLETED|Washout||7
7858483|NCT00919867|19342146|P6|STARTED|Washout||6
7858484|NCT00919867|19342147|P5|STARTED|Washout||7
7858485|NCT00919867|19342148|P4|STARTED|Washout||7
7858486|NCT00919867|19342149|P3|STARTED|Washout||6
7858487|NCT00919867|19342150|P2|STARTED|Washout||7
7858488|NCT00919867|19342151|P1|STARTED|Washout||7
7858489|NCT00919867|19342146|P6|NOT COMPLETED|First Intervention||1
7858490|NCT00919867|19342147|P5|NOT COMPLETED|First Intervention||0
7858491|NCT00919867|19342148|P4|NOT COMPLETED|First Intervention||0
7858492|NCT00919867|19342149|P3|NOT COMPLETED|First Intervention||1
7858493|NCT00919867|19342150|P2|NOT COMPLETED|First Intervention||0
7858494|NCT00919867|19342151|P1|NOT COMPLETED|First Intervention||0
7858495|NCT00919867|19342146|P6|COMPLETED|First Intervention||6
7858496|NCT00919867|19342147|P5|COMPLETED|First Intervention||7
7858497|NCT00919867|19342148|P4|COMPLETED|First Intervention||7
7858498|NCT00919867|19342149|P3|COMPLETED|First Intervention||6
7858499|NCT00919867|19342150|P2|COMPLETED|First Intervention||7
7858500|NCT00919867|19342151|P1|COMPLETED|First Intervention||7
7858501|NCT00919867|19342146|P6|STARTED|First Intervention||7
7858502|NCT00919867|19342147|P5|STARTED|First Intervention||7
7858503|NCT00919867|19342148|P4|STARTED|First Intervention||7
7858504|NCT00919867|19342149|P3|STARTED|First Intervention||7
7858505|NCT00919867|19342150|P2|STARTED|First Intervention||7
7858506|NCT00919867|19342151|P1|STARTED|First Intervention||7
7858507|NCT00919854|19342172|P1|NOT COMPLETED|Overall Study||1
7858508|NCT00919854|19342172|P1|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20
7858509|NCT00919854|19342172|P1|STARTED|Overall Study||21
7858510|NCT00919802|19342181|P2|NOT COMPLETED|Second Intervention - (24 Hours)||0
7858511|NCT00919802|19342182|P1|NOT COMPLETED|Second Intervention - (24 Hours)||0
7858512|NCT00919802|19342181|P2|COMPLETED|Second Intervention - (24 Hours)||13
7858513|NCT00919802|19342182|P1|COMPLETED|Second Intervention - (24 Hours)||12
7858514|NCT00919802|19342181|P2|STARTED|Second Intervention - (24 Hours)||13
7858515|NCT00919802|19342182|P1|STARTED|Second Intervention - (24 Hours)||12
7858516|NCT00919802|19342181|P2|NOT COMPLETED|First Intervention - (24 Hours)||0
7858517|NCT00919802|19342182|P1|NOT COMPLETED|First Intervention - (24 Hours)||0
7858518|NCT00919802|19342181|P2|COMPLETED|First Intervention - (24 Hours)||13
7858519|NCT00919802|19342182|P1|COMPLETED|First Intervention - (24 Hours)||12
7858520|NCT00919802|19342181|P2|STARTED|First Intervention - (24 Hours)||13
7858521|NCT00919802|19342182|P1|STARTED|First Intervention - (24 Hours)||12
7858522|NCT00919763|19342192|P2|NOT COMPLETED|Overall Study||4
7858523|NCT00919763|19342193|P1|NOT COMPLETED|Overall Study||12
7858524|NCT00919763|19342192|P2|COMPLETED|Overall Study||45
7858525|NCT00919763|19342193|P1|COMPLETED|Overall Study||41
7858526|NCT00919763|19342192|P2|STARTED|Overall Study||49
7858527|NCT00919763|19342193|P1|STARTED|Overall Study||53
7858528|NCT00919724|19342201|P2|NOT COMPLETED|Overall Study||0
7858529|NCT00919724|19342202|P1|NOT COMPLETED|Overall Study||0
7858530|NCT00919724|19342201|P2|COMPLETED|Overall Study||44
7858531|NCT00919724|19342202|P1|COMPLETED|Overall Study||45
7858532|NCT00919724|19342201|P2|STARTED|Overall Study||44
7858533|NCT00919724|19342202|P1|STARTED|Overall Study||45
7858534|NCT00919711|19342210|P2|NOT COMPLETED|Overall Study||13
7858535|NCT00919711|19342211|P1|NOT COMPLETED|Overall Study||33
7858536|NCT00919711|19342210|P2|COMPLETED|Overall Study||422
7858537|NCT00919711|19342211|P1|COMPLETED|Overall Study||402
7858538|NCT00919711|19342210|P2|STARTED|Overall Study||435
7858539|NCT00919711|19342211|P1|STARTED|Overall Study||435
7858540|NCT00919633|19342227|P4|NOT COMPLETED|Overall Study||21
7858541|NCT00919633|19342228|P3|NOT COMPLETED|Overall Study||23
7858542|NCT00919633|19342229|P2|NOT COMPLETED|Overall Study||15
7858543|NCT00919633|19342230|P1|NOT COMPLETED|Overall Study||22
7858544|NCT00919633|19342227|P4|COMPLETED|Overall Study||5
7858545|NCT00919633|19342228|P3|COMPLETED|Overall Study||4
7858546|NCT00919633|19342229|P2|COMPLETED|Overall Study||10
7858547|NCT00919633|19342230|P1|COMPLETED|Overall Study||6
7858548|NCT00919633|19342227|P4|STARTED|Overall Study||26
7858549|NCT00919633|19342228|P3|STARTED|Overall Study||27
7858550|NCT00919633|19342229|P2|STARTED|Overall Study||25
7858551|NCT00919633|19342230|P1|STARTED|Overall Study||28
7858552|NCT00919191|19342248|P1|NOT COMPLETED|Overall Study||0
7858553|NCT00919191|19342248|P1|COMPLETED|Overall Study||26
7858554|NCT00919191|19342248|P1|STARTED|Overall Study||26
7858555|NCT00919126|19342258|P3|NOT COMPLETED|Overall Study||1
7858556|NCT00919126|19342259|P2|NOT COMPLETED|Overall Study||5
7858557|NCT00919126|19342260|P1|NOT COMPLETED|Overall Study||1
7858558|NCT00919126|19342258|P3|COMPLETED|Overall Study||32
7858559|NCT00919126|19342259|P2|COMPLETED|Overall Study||32
7858560|NCT00919126|19342260|P1|COMPLETED|Overall Study||31
7858561|NCT00919126|19342258|P3|STARTED|Overall Study||33
7858562|NCT00919126|19342259|P2|STARTED|Overall Study||37
7858563|NCT00919126|19342260|P1|STARTED|Overall Study||32
7858564|NCT00919113|19342306|P2|NOT COMPLETED|Overall Study||8
7858565|NCT00919113|19342307|P1|NOT COMPLETED|Overall Study||9
7858566|NCT00919113|19342306|P2|COMPLETED|Overall Study||40
7858567|NCT00919113|19342307|P1|COMPLETED|Overall Study||41
7858568|NCT00919113|19342306|P2|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
7858569|NCT00919113|19342307|P1|Received Placebo|Overall Study||0
7858570|NCT00919113|19342306|P2|Received Uracyst|Overall Study||0
7858571|NCT00919113|19342307|P1|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
7858572|NCT00919113|19342306|P2|STARTED|Overall Study||48
7858573|NCT00919113|19342307|P1|STARTED|Overall Study||50
7858574|NCT00919100|19342317|P2|NOT COMPLETED|Overall Study||0
7858575|NCT00919100|19342318|P1|NOT COMPLETED|Overall Study||0
7858576|NCT00919100|19342317|P2|COMPLETED|Overall Study||41
7858577|NCT00919100|19342318|P1|COMPLETED|Overall Study||40
7858578|NCT00919100|19342317|P2|STARTED|Overall Study||41
7858579|NCT00919100|19342318|P1|STARTED|Overall Study||40
7858580|NCT00919061|19342328|P1|NOT COMPLETED|Overall Study||2
7858581|NCT00919061|19342328|P1|COMPLETED|Overall Study||37
7858582|NCT00919061|19342328|P1|STARTED|Overall Study||39
7858583|NCT00919035|19342333|P1|NOT COMPLETED|Overall Study||0
7858584|NCT00919035|19342333|P1|COMPLETED|Overall Study||21
7858585|NCT00919035|19342333|P1|STARTED|Overall Study||21
7858586|NCT00918957|19342341|P2|NOT COMPLETED|Overall Study||0
7858587|NCT00918957|19342342|P1|NOT COMPLETED|Overall Study||3
7858588|NCT00918957|19342341|P2|COMPLETED|Overall Study||30
7858589|NCT00918957|19342342|P1|COMPLETED|Overall Study||29
7858590|NCT00918957|19342341|P2|STARTED|Overall Study||30
7858591|NCT00918957|19342342|P1|STARTED|Overall Study||32
7858592|NCT00918931|19342369|P1|NOT COMPLETED|Overall Study||0
7858593|NCT00918931|19342369|P1|COMPLETED|Overall Study||3
7858594|NCT00918931|19342369|P1|STARTED|Overall Study||3
7858595|NCT00918879|19342375|P2|NOT COMPLETED|Overall Study||6
7858596|NCT00918879|19342376|P1|NOT COMPLETED|Overall Study||6
7858597|NCT00918879|19342375|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|100
7858598|NCT00918879|19342376|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|101
7858599|NCT00918879|19342375|P2|STARTED|Overall Study|Randomized and treated|106
7858600|NCT00918879|19342376|P1|STARTED|Overall Study|Randomized and treated|107
7858601|NCT00918866|19342390|P2|NOT COMPLETED|Overall Study||0
7858602|NCT00918866|19342391|P1|NOT COMPLETED|Overall Study||0
7858603|NCT00918866|19342390|P2|COMPLETED|Overall Study||16
7858604|NCT00918866|19342391|P1|COMPLETED|Overall Study||16
7858605|NCT00918866|19342390|P2|STARTED|Overall Study||16
7858606|NCT00918866|19342391|P1|STARTED|Overall Study||16
7858607|NCT00918749|19342408|P3|NOT COMPLETED|Overall Study||7
7858608|NCT00918749|19342409|P2|NOT COMPLETED|Overall Study||3
7858609|NCT00918749|19342410|P1|NOT COMPLETED|Overall Study||7
7858610|NCT00918749|19342408|P3|COMPLETED|Overall Study||62
7858611|NCT00918749|19342409|P2|COMPLETED|Overall Study||63
7858612|NCT00918749|19342410|P1|COMPLETED|Overall Study||63
7858613|NCT00918749|19342408|P3|ITT (Intent to Treat) Population|Overall Study||69
7858614|NCT00918749|19342409|P2|ITT (Intent to Treat) Population|Overall Study||66
7858615|NCT00918749|19342410|P1|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69
7858616|NCT00918749|19342408|P3|STARTED|Overall Study||69
7858617|NCT00918749|19342409|P2|STARTED|Overall Study||66
7858618|NCT00918749|19342410|P1|STARTED|Overall Study||70
7858619|NCT00918736|19342442|P1|NOT COMPLETED|Overall Study||4
7858620|NCT00918736|19342442|P1|COMPLETED|Overall Study|October, 2008|46
7858621|NCT00918736|19342442|P1|STARTED|Overall Study|October, 2007|50
7858622|NCT00918723|19342446|P1|NOT COMPLETED|Overall Study||0
7858623|NCT00918723|19342446|P1|COMPLETED|Overall Study||40
7858624|NCT00918723|19342446|P1|STARTED|Overall Study||40
7858625|NCT00918684|19342455|P1|NOT COMPLETED|Treatment Phase||25
7858626|NCT00918684|19342455|P1|COMPLETED|Treatment Phase||65
7858627|NCT00918684|19342455|P1|STARTED|Treatment Phase||90
7858628|NCT00918684|19342455|P1|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16
7858629|NCT00918684|19342455|P1|COMPLETED|Two Week Drug Washout and Placebo Phase||90
7858630|NCT00918684|19342455|P1|STARTED|Two Week Drug Washout and Placebo Phase||106
7858631|NCT00918671|19342461|P1|NOT COMPLETED|Overall Study||0
7858632|NCT00918671|19342461|P1|COMPLETED|Overall Study||60
7858633|NCT00918671|19342461|P1|STARTED|Overall Study||60
7858634|NCT00918645|19342466|P1|NOT COMPLETED|Overall Study||1
7858635|NCT00918645|19342466|P1|COMPLETED|Overall Study||12
7858636|NCT00918645|19342466|P1|STARTED|Overall Study||13
7858637|NCT00918580|19342472|P1|NOT COMPLETED|After 6-month FU to 1-year FU||60
7858638|NCT00918580|19342472|P1|COMPLETED|After 6-month FU to 1-year FU||87
7858639|NCT00918580|19342472|P1|Continued After 6-Month FU|After 6-month FU to 1-year FU||89
7858640|NCT00918580|19342472|P1|STARTED|After 6-month FU to 1-year FU||147
7858641|NCT00918580|19342472|P1|NOT COMPLETED|Up to 6-month Follow-up(FU)||11
7858642|NCT00918580|19342472|P1|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147
7858643|NCT00918580|19342472|P1|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146
7858644|NCT00918580|19342472|P1|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158
7858645|NCT00918580|19342472|P1|STARTED|Up to 6-month Follow-up(FU)||158
7858646|NCT00918567|19342492|P2|NOT COMPLETED|Overall Study||2
7858647|NCT00918567|19342493|P1|NOT COMPLETED|Overall Study||5
7858648|NCT00918567|19342492|P2|COMPLETED|Overall Study||25
7858649|NCT00918567|19342493|P1|COMPLETED|Overall Study||24
7858650|NCT00918567|19342492|P2|STARTED|Overall Study||27
7858651|NCT00918567|19342493|P1|STARTED|Overall Study||29
7858652|NCT00918463|19342519|P1|NOT COMPLETED|Overall Study||2
7858653|NCT00918463|19342519|P1|COMPLETED|Overall Study||0
7858654|NCT00918463|19342519|P1|STARTED|Overall Study||2
7858655|NCT00918385|19342527|P2|NOT COMPLETED|Combination Nilutamide and Dasatinib||8
7858656|NCT00918385|19342528|P1|NOT COMPLETED|Combination Nilutamide and Dasatinib||6
7858657|NCT00918385|19342527|P2|COMPLETED|Combination Nilutamide and Dasatinib||3
7858658|NCT00918385|19342528|P1|COMPLETED|Combination Nilutamide and Dasatinib||6
7858659|NCT00918385|19342527|P2|STARTED|Combination Nilutamide and Dasatinib||11
7858660|NCT00918385|19342528|P1|STARTED|Combination Nilutamide and Dasatinib||12
7858661|NCT00918385|19342527|P2|NOT COMPLETED|Monotherapy||6
7858662|NCT00918385|19342528|P1|NOT COMPLETED|Monotherapy||2
7858663|NCT00918385|19342527|P2|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11
7858664|NCT00918385|19342528|P1|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12
7858665|NCT00918385|19342527|P2|STARTED|Monotherapy||17
7858666|NCT00918385|19342528|P1|STARTED|Monotherapy||14
7858667|NCT00918346|19342537|P2|NOT COMPLETED|Post Study Period||0
7858668|NCT00918346|19342538|P1|NOT COMPLETED|Post Study Period||0
7858669|NCT00918346|19342537|P2|COMPLETED|Post Study Period||21
7858670|NCT00918346|19342538|P1|COMPLETED|Post Study Period||21
7858671|NCT00918346|19342537|P2|STARTED|Post Study Period||21
7858672|NCT00918346|19342538|P1|STARTED|Post Study Period||21
7858673|NCT00918346|19342537|P2|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
7858674|NCT00918346|19342538|P1|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
7858675|NCT00918346|19342537|P2|COMPLETED|Second Treatment Period (4 Weeks)||21
7858676|NCT00918346|19342538|P1|COMPLETED|Second Treatment Period (4 Weeks)||21
7858677|NCT00918346|19342537|P2|STARTED|Second Treatment Period (4 Weeks)||21
7858678|NCT00918346|19342538|P1|STARTED|Second Treatment Period (4 Weeks)||21
7858679|NCT00918346|19342537|P2|NOT COMPLETED|Washout (at Least 4 Weeks)||0
7858680|NCT00918346|19342538|P1|NOT COMPLETED|Washout (at Least 4 Weeks)||0
7858681|NCT00918346|19342537|P2|COMPLETED|Washout (at Least 4 Weeks)||21
7858682|NCT00918346|19342538|P1|COMPLETED|Washout (at Least 4 Weeks)||21
7858683|NCT00918346|19342537|P2|STARTED|Washout (at Least 4 Weeks)||21
7858684|NCT00918346|19342538|P1|STARTED|Washout (at Least 4 Weeks)||21
7858685|NCT00918346|19342537|P2|NOT COMPLETED|First Treatment Period (4 Weeks)||1
7858686|NCT00918346|19342538|P1|NOT COMPLETED|First Treatment Period (4 Weeks)||0
7858687|NCT00918346|19342537|P2|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21
7858688|NCT00918346|19342538|P1|COMPLETED|First Treatment Period (4 Weeks)||21
7858689|NCT00918346|19342537|P2|STARTED|First Treatment Period (4 Weeks)||22
7858690|NCT00918346|19342538|P1|STARTED|First Treatment Period (4 Weeks)||21
7858691|NCT00918333|19342554|P2|NOT COMPLETED|Overall Study||5
7858692|NCT00918333|19342555|P1|NOT COMPLETED|Overall Study||3
7858693|NCT00918333|19342554|P2|COMPLETED|Overall Study||93
7858694|NCT00918333|19342555|P1|COMPLETED|Overall Study||23
7858695|NCT00918333|19342554|P2|STARTED|Overall Study||98
7858696|NCT00918333|19342555|P1|STARTED|Overall Study||26
7858697|NCT00918281|19342575|P1|NOT COMPLETED|Overall Study||29
7858698|NCT00918281|19342575|P1|COMPLETED|Overall Study||41
7858699|NCT00918281|19342575|P1|STARTED|Overall Study||70
7858700|NCT00918255|19342585|P3|NOT COMPLETED|Overall Study||5
7858701|NCT00918255|19342586|P2|NOT COMPLETED|Overall Study||0
7858702|NCT00918255|19342587|P1|NOT COMPLETED|Overall Study||6
7858703|NCT00918255|19342585|P3|COMPLETED|Overall Study||46
7858704|NCT00918255|19342586|P2|COMPLETED|Overall Study||52
7858705|NCT00918255|19342587|P1|COMPLETED|Overall Study||45
7858706|NCT00918255|19342585|P3|STARTED|Overall Study||51
7858707|NCT00918255|19342586|P2|STARTED|Overall Study||52
7858708|NCT00918255|19342587|P1|STARTED|Overall Study||51
7858709|NCT00918229|19342613|P1|NOT COMPLETED|Overall Study||0
7858710|NCT00918229|19342613|P1|COMPLETED|Overall Study||24
7858711|NCT00918229|19342613|P1|STARTED|Overall Study||24
7858712|NCT00918203|19342620|P3|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
7858713|NCT00918203|19342621|P2|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
7858714|NCT00918203|19342622|P1|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
7858715|NCT00918203|19342620|P3|COMPLETED|Crossover to Olaratumab Monotherapy||18
7858716|NCT00918203|19342621|P2|COMPLETED|Crossover to Olaratumab Monotherapy||0
7858717|NCT00918203|19342622|P1|COMPLETED|Crossover to Olaratumab Monotherapy||0
7858718|NCT00918203|19342620|P3|STARTED|Crossover to Olaratumab Monotherapy|18 participants who had progressive disease crossed over to monotherapy.|18
7858719|NCT00918203|19342621|P2|STARTED|Crossover to Olaratumab Monotherapy||0
7858720|NCT00918203|19342622|P1|STARTED|Crossover to Olaratumab Monotherapy||0
7858721|NCT00918203|19342620|P3|NOT COMPLETED|Treatment With or Without Olaratumab||0
7858722|NCT00918203|19342621|P2|NOT COMPLETED|Treatment With or Without Olaratumab||10
7858723|NCT00918203|19342622|P1|NOT COMPLETED|Treatment With or Without Olaratumab||6
7858724|NCT00918203|19342620|P3|COMPLETED|Treatment With or Without Olaratumab||0
7858725|NCT00918203|19342621|P2|COMPLETED|Treatment With or Without Olaratumab||57
7858726|NCT00918203|19342622|P1|COMPLETED|Treatment With or Without Olaratumab||64
7858727|NCT00918203|19342620|P3|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||0
7858728|NCT00918203|19342621|P2|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||10
7858729|NCT00918203|19342622|P1|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||11
7858730|NCT00918203|19342620|P3|Death Due to Any Cause|Treatment With or Without Olaratumab||0
7858731|NCT00918203|19342621|P2|Death Due to Any Cause|Treatment With or Without Olaratumab||47
7858732|NCT00918203|19342622|P1|Death Due to Any Cause|Treatment With or Without Olaratumab||53
7858733|NCT00918203|19342620|P3|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0
7858734|NCT00918203|19342621|P2|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64
7858735|NCT00918203|19342622|P1|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67
7858736|NCT00918203|19342620|P3|STARTED|Treatment With or Without Olaratumab||0
7858737|NCT00918203|19342621|P2|STARTED|Treatment With or Without Olaratumab||67
7858738|NCT00918203|19342622|P1|STARTED|Treatment With or Without Olaratumab||70
7858739|NCT00918138|19342653|P2|NOT COMPLETED|Overall Study||1
7858740|NCT00918138|19342654|P1|NOT COMPLETED|Overall Study||2
7858741|NCT00918138|19342653|P2|COMPLETED|Overall Study||46
7858742|NCT00918138|19342654|P1|COMPLETED|Overall Study||44
7858743|NCT00918138|19342653|P2|STARTED|Overall Study||47
7858744|NCT00918138|19342654|P1|STARTED|Overall Study||46
7858745|NCT00918125|19342670|P2|NOT COMPLETED|Overall Study||0
7858746|NCT00918125|19342671|P1|NOT COMPLETED|Overall Study||0
7858747|NCT00918125|19342670|P2|COMPLETED|Overall Study||39
7858748|NCT00918125|19342671|P1|COMPLETED|Overall Study||20
7858749|NCT00918125|19342670|P2|STARTED|Overall Study||39
7858750|NCT00918125|19342671|P1|STARTED|Overall Study||20
7858751|NCT00917865|19342682|P1|NOT COMPLETED|Overall Study||0
7858752|NCT00917865|19342682|P1|COMPLETED|Overall Study||11
7858753|NCT00917865|19342682|P1|STARTED|Overall Study||11
7858754|NCT00917852|19342693|P1|NOT COMPLETED|Overall Study||6
7858755|NCT00917852|19342693|P1|COMPLETED|Overall Study||45
7858756|NCT00917852|19342693|P1|STARTED|Overall Study||51
7858757|NCT00917735|19342700|P2|NOT COMPLETED|Overall Study||63
7858758|NCT00917735|19342701|P1|NOT COMPLETED|Overall Study||75
7858759|NCT00917735|19342700|P2|COMPLETED|Overall Study||474
7858760|NCT00917735|19342701|P1|COMPLETED|Overall Study||463
7858761|NCT00917735|19342700|P2|STARTED|Overall Study||537
7858762|NCT00917735|19342701|P1|STARTED|Overall Study||538
7858763|NCT00917644|19342711|P2|NOT COMPLETED|Period 2: Second Intervention||0
7858764|NCT00917644|19342712|P1|NOT COMPLETED|Period 2: Second Intervention||1
7858765|NCT00917644|19342711|P2|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37
7858766|NCT00917644|19342712|P1|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36
7858767|NCT00917644|19342711|P2|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37
7858768|NCT00917644|19342712|P1|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37
7858769|NCT00917644|19342711|P2|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0
7858770|NCT00917644|19342712|P1|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2
7858771|NCT00917644|19342711|P2|COMPLETED|Period: Washout Period of > = 2 Weeks||37
7858772|NCT00917644|19342712|P1|COMPLETED|Period: Washout Period of > = 2 Weeks||37
7858773|NCT00917644|19342711|P2|STARTED|Period: Washout Period of > = 2 Weeks||37
7858774|NCT00917644|19342712|P1|STARTED|Period: Washout Period of > = 2 Weeks||39
7858775|NCT00917644|19342711|P2|NOT COMPLETED|Period 1: First Intervention||0
7858776|NCT00917644|19342712|P1|NOT COMPLETED|Period 1: First Intervention||0
7858777|NCT00917644|19342711|P2|COMPLETED|Period 1: First Intervention||37
7858778|NCT00917644|19342712|P1|COMPLETED|Period 1: First Intervention||39
7858779|NCT00917644|19342711|P2|STARTED|Period 1: First Intervention||37
7858780|NCT00917644|19342712|P1|STARTED|Period 1: First Intervention||39
7858781|NCT00917579|19342726|P2|NOT COMPLETED|Period 2: 2nd Intervention||0
7858782|NCT00917579|19342727|P1|NOT COMPLETED|Period 2: 2nd Intervention||0
7858783|NCT00917579|19342726|P2|COMPLETED|Period 2: 2nd Intervention||37
7858784|NCT00917579|19342727|P1|COMPLETED|Period 2: 2nd Intervention||37
7858785|NCT00917579|19342726|P2|STARTED|Period 2: 2nd Intervention||37
7858786|NCT00917579|19342727|P1|STARTED|Period 2: 2nd Intervention||37
7858787|NCT00917579|19342726|P2|NOT COMPLETED|Washout >= 2 Weeks||0
7858788|NCT00917579|19342727|P1|NOT COMPLETED|Washout >= 2 Weeks||2
7858789|NCT00917579|19342726|P2|COMPLETED|Washout >= 2 Weeks||37
7858790|NCT00917579|19342727|P1|COMPLETED|Washout >= 2 Weeks||37
7858791|NCT00917579|19342726|P2|STARTED|Washout >= 2 Weeks||37
7858792|NCT00917579|19342727|P1|STARTED|Washout >= 2 Weeks||39
7858793|NCT00917579|19342726|P2|NOT COMPLETED|Period 1: 1st Intervention||0
7858794|NCT00917579|19342727|P1|NOT COMPLETED|Period 1: 1st Intervention||0
7858795|NCT00917579|19342726|P2|COMPLETED|Period 1: 1st Intervention||37
7858796|NCT00917579|19342727|P1|COMPLETED|Period 1: 1st Intervention||39
7858797|NCT00917579|19342726|P2|STARTED|Period 1: 1st Intervention||37
7858798|NCT00917579|19342727|P1|STARTED|Period 1: 1st Intervention||39
7858799|NCT00917553|19342743|P2|NOT COMPLETED|Overall Study||1
7858800|NCT00917553|19342744|P1|NOT COMPLETED|Overall Study||2
7858801|NCT00917553|19342743|P2|COMPLETED|Overall Study||15
7858802|NCT00917553|19342744|P1|COMPLETED|Overall Study||15
7858803|NCT00917553|19342743|P2|STARTED|Overall Study||16
7858804|NCT00917553|19342744|P1|STARTED|Overall Study||17
7858805|NCT00917501|19342760|P2|NOT COMPLETED|Overall Study||5
7858806|NCT00917501|19342761|P1|NOT COMPLETED|Overall Study||8
7858807|NCT00917501|19342760|P2|COMPLETED|Overall Study||21
7858808|NCT00917501|19342761|P1|COMPLETED|Overall Study||21
7858809|NCT00917501|19342760|P2|STARTED|Overall Study||26
7858810|NCT00917501|19342761|P1|STARTED|Overall Study||29
7858811|NCT00917462|19342767|P1|NOT COMPLETED|Overall Study||1
7858812|NCT00917462|19342767|P1|COMPLETED|Overall Study||34
7858813|NCT00917462|19342767|P1|STARTED|Overall Study||35
7858814|NCT00917384|19342777|P2|NOT COMPLETED|Overall Study||4
7858815|NCT00917384|19342778|P1|NOT COMPLETED|Overall Study||14
7858816|NCT00917384|19342777|P2|COMPLETED|Overall Study||113
7858817|NCT00917384|19342778|P1|COMPLETED|Overall Study||224
7858818|NCT00917384|19342777|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
7858819|NCT00917384|19342778|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
7858820|NCT00917384|19342777|P2|STARTED|Overall Study||117
7858821|NCT00917384|19342778|P1|STARTED|Overall Study||238
7858822|NCT00917267|19342802|P2|NOT COMPLETED|Overall Study||79
7858823|NCT00917267|19342803|P1|NOT COMPLETED|Overall Study||39
7858824|NCT00917267|19342802|P2|COMPLETED|Overall Study||266
7858825|NCT00917267|19342803|P1|COMPLETED|Overall Study||307
7858826|NCT00917267|19342802|P2|Intent to Treat (ITT)|Overall Study||338
7858827|NCT00917267|19342803|P1|Intent to Treat (ITT)|Overall Study||340
7858828|NCT00917267|19342802|P2|STARTED|Overall Study||345
7858829|NCT00917267|19342803|P1|STARTED|Overall Study||346
7858830|NCT00917124|19342831|P2|NOT COMPLETED|Overall Study||6
7858831|NCT00917124|19342832|P1|NOT COMPLETED|Overall Study||4
7858832|NCT00917124|19342831|P2|COMPLETED|Overall Study||94
7858833|NCT00917124|19342832|P1|COMPLETED|Overall Study||96
7858834|NCT00917124|19342831|P2|STARTED|Overall Study||100
7858835|NCT00917124|19342832|P1|STARTED|Overall Study||100
7858836|NCT00916929|19342842|P2|NOT COMPLETED|Overall Study||29
7858837|NCT00916929|19342843|P1|NOT COMPLETED|Overall Study||10
7858838|NCT00916929|19342842|P2|COMPLETED|Overall Study||53
7858839|NCT00916929|19342843|P1|COMPLETED|Overall Study||70
7858840|NCT00916929|19342842|P2|STARTED|Overall Study||82
7858841|NCT00916929|19342843|P1|STARTED|Overall Study||80
7858842|NCT00916721|19342853|P2|NOT COMPLETED|Overall Study||10
7858843|NCT00916721|19342854|P1|NOT COMPLETED|Overall Study||10
7858844|NCT00916721|19342853|P2|COMPLETED|Overall Study||29
7858845|NCT00916721|19342854|P1|COMPLETED|Overall Study||25
7858846|NCT00916721|19342853|P2|STARTED|Overall Study||39
7858847|NCT00916721|19342854|P1|STARTED|Overall Study||35
7858848|NCT00916643|19342866|P1|NOT COMPLETED|Overall Study||0
7858849|NCT00916643|19342866|P1|COMPLETED|Overall Study||113
7858850|NCT00916643|19342866|P1|STARTED|Overall Study||113
7858851|NCT00916617|19342877|P4|NOT COMPLETED|Overall Study||7
7858852|NCT00916617|19342878|P3|NOT COMPLETED|Overall Study||10
7858853|NCT00916617|19342879|P2|NOT COMPLETED|Overall Study||21
7858854|NCT00916617|19342880|P1|NOT COMPLETED|Overall Study||23
7858855|NCT00916617|19342877|P4|COMPLETED|Overall Study||0
7858856|NCT00916617|19342878|P3|COMPLETED|Overall Study||0
7858857|NCT00916617|19342879|P2|COMPLETED|Overall Study||0
7858858|NCT00916617|19342880|P1|COMPLETED|Overall Study||1
7858859|NCT00916617|19342877|P4|STARTED|Overall Study||7
7858860|NCT00916617|19342878|P3|STARTED|Overall Study||10
7858861|NCT00916617|19342879|P2|STARTED|Overall Study||21
7858862|NCT00916617|19342880|P1|STARTED|Overall Study||24
7858863|NCT00916578|19342894|P1|NOT COMPLETED|Overall Study||7
7858864|NCT00916578|19342894|P1|COMPLETED|Overall Study||26
7858865|NCT00916578|19342894|P1|STARTED|Overall Study||33
7858866|NCT00916539|19342900|P2|NOT COMPLETED|Overall Study||0
7858867|NCT00916539|19342901|P1|NOT COMPLETED|Overall Study||0
7858868|NCT00916539|19342900|P2|COMPLETED|Overall Study||31
7858869|NCT00916539|19342901|P1|COMPLETED|Overall Study||31
7858870|NCT00916539|19342900|P2|STARTED|Overall Study||31
7858871|NCT00916539|19342901|P1|STARTED|Overall Study||31
7858872|NCT00916383|19342923|P1|NOT COMPLETED|Overall Study||3
7858873|NCT00916383|19342923|P1|COMPLETED|Overall Study||46
7858874|NCT00916383|19342923|P1|STARTED|Overall Study||49
7858875|NCT00916370|19342951|P2|NOT COMPLETED|Overall Study||2
7858876|NCT00916370|19342952|P1|NOT COMPLETED|Overall Study||5
7858877|NCT00916370|19342951|P2|COMPLETED|Overall Study||102
7858878|NCT00916370|19342952|P1|COMPLETED|Overall Study||396
7858879|NCT00916370|19342951|P2|STARTED|Overall Study||104
7858880|NCT00916370|19342952|P1|STARTED|Overall Study||401
7858881|NCT00916357|19343126|P6|NOT COMPLETED|Period 3||0
7858882|NCT00916357|19343127|P5|NOT COMPLETED|Period 3||0
7858883|NCT00916357|19343128|P4|NOT COMPLETED|Period 3||0
7858884|NCT00916357|19343129|P3|NOT COMPLETED|Period 3||0
7858885|NCT00916357|19343130|P2|NOT COMPLETED|Period 3||0
7858886|NCT00916357|19343131|P1|NOT COMPLETED|Period 3||0
7858887|NCT00916357|19343126|P6|COMPLETED|Period 3||4
7858888|NCT00916357|19343127|P5|COMPLETED|Period 3||3
7858889|NCT00916357|19343128|P4|COMPLETED|Period 3||3
7858890|NCT00916357|19343129|P3|COMPLETED|Period 3||4
7858891|NCT00916357|19343130|P2|COMPLETED|Period 3||4
7858892|NCT00916357|19343131|P1|COMPLETED|Period 3||3
7858893|NCT00916357|19343126|P6|STARTED|Period 3||4
7858894|NCT00916357|19343127|P5|STARTED|Period 3||3
7858895|NCT00916357|19343128|P4|STARTED|Period 3||3
7858896|NCT00916357|19343129|P3|STARTED|Period 3||4
7858897|NCT00916357|19343130|P2|STARTED|Period 3||4
7858898|NCT00916357|19343131|P1|STARTED|Period 3||3
7858899|NCT00916357|19343126|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
7858900|NCT00916357|19343127|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
7858901|NCT00916357|19343128|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
7858902|NCT00916357|19343129|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
7858903|NCT00916357|19343130|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
7858904|NCT00916357|19343131|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
7858905|NCT00916357|19343126|P6|COMPLETED|Washout (3 to 14 Days)||4
7858906|NCT00916357|19343127|P5|COMPLETED|Washout (3 to 14 Days)||3
7858907|NCT00916357|19343128|P4|COMPLETED|Washout (3 to 14 Days)||3
7858908|NCT00916357|19343129|P3|COMPLETED|Washout (3 to 14 Days)||4
7858909|NCT00916357|19343130|P2|COMPLETED|Washout (3 to 14 Days)||4
7858910|NCT00916357|19343131|P1|COMPLETED|Washout (3 to 14 Days)||3
7858911|NCT00916357|19343126|P6|STARTED|Washout (3 to 14 Days)||4
7858912|NCT00916357|19343127|P5|STARTED|Washout (3 to 14 Days)||3
7858913|NCT00916357|19343128|P4|STARTED|Washout (3 to 14 Days)||3
7858914|NCT00916357|19343129|P3|STARTED|Washout (3 to 14 Days)||4
7858915|NCT00916357|19343130|P2|STARTED|Washout (3 to 14 Days)||4
7858916|NCT00916357|19343131|P1|STARTED|Washout (3 to 14 Days)||3
7858917|NCT00916357|19343126|P6|NOT COMPLETED|Period 2||0
7858918|NCT00916357|19343127|P5|NOT COMPLETED|Period 2||0
7858919|NCT00916357|19343128|P4|NOT COMPLETED|Period 2||1
7858920|NCT00916357|19343129|P3|NOT COMPLETED|Period 2||0
7858921|NCT00916357|19343130|P2|NOT COMPLETED|Period 2||0
7858922|NCT00916357|19343131|P1|NOT COMPLETED|Period 2||0
7858923|NCT00916357|19343126|P6|COMPLETED|Period 2||4
7858924|NCT00916357|19343127|P5|COMPLETED|Period 2||3
7858925|NCT00916357|19343128|P4|COMPLETED|Period 2||3
7858926|NCT00916357|19343129|P3|COMPLETED|Period 2||4
7858927|NCT00916357|19343130|P2|COMPLETED|Period 2||4
7858928|NCT00916357|19343131|P1|COMPLETED|Period 2||3
7858929|NCT00916357|19343126|P6|STARTED|Period 2||4
7858930|NCT00916357|19343127|P5|STARTED|Period 2||3
7858931|NCT00916357|19343128|P4|STARTED|Period 2||4
7858932|NCT00916357|19343129|P3|STARTED|Period 2||4
7858933|NCT00916357|19343130|P2|STARTED|Period 2||4
7858934|NCT00916357|19343131|P1|STARTED|Period 2||3
7858935|NCT00916357|19343126|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
7858936|NCT00916357|19343127|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
7858937|NCT00916357|19343128|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
7858938|NCT00916357|19343129|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
7858939|NCT00916357|19343130|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
7858940|NCT00916357|19343131|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
7858941|NCT00916357|19343126|P6|COMPLETED|Washout (3 to 14 Days)||4
7858942|NCT00916357|19343127|P5|COMPLETED|Washout (3 to 14 Days)||3
7858943|NCT00916357|19343128|P4|COMPLETED|Washout (3 to 14 Days)||4
7858944|NCT00916357|19343129|P3|COMPLETED|Washout (3 to 14 Days)||4
7858945|NCT00916357|19343130|P2|COMPLETED|Washout (3 to 14 Days)||4
7858946|NCT00916357|19343131|P1|COMPLETED|Washout (3 to 14 Days)||3
7858947|NCT00916357|19343126|P6|STARTED|Washout (3 to 14 Days)||4
7858948|NCT00916357|19343127|P5|STARTED|Washout (3 to 14 Days)||3
7858949|NCT00916357|19343128|P4|STARTED|Washout (3 to 14 Days)||4
7858950|NCT00916357|19343129|P3|STARTED|Washout (3 to 14 Days)||4
7858951|NCT00916357|19343130|P2|STARTED|Washout (3 to 14 Days)||4
7858952|NCT00916357|19343131|P1|STARTED|Washout (3 to 14 Days)||3
7858953|NCT00916357|19343126|P6|NOT COMPLETED|Period 1||0
7858954|NCT00916357|19343127|P5|NOT COMPLETED|Period 1||0
7858955|NCT00916357|19343128|P4|NOT COMPLETED|Period 1||0
7858956|NCT00916357|19343129|P3|NOT COMPLETED|Period 1||0
7858957|NCT00916357|19343130|P2|NOT COMPLETED|Period 1||0
7858958|NCT00916357|19343131|P1|NOT COMPLETED|Period 1||1
7858959|NCT00916357|19343126|P6|COMPLETED|Period 1||4
7858960|NCT00916357|19343127|P5|COMPLETED|Period 1||3
7858961|NCT00916357|19343128|P4|COMPLETED|Period 1||4
7858962|NCT00916357|19343129|P3|COMPLETED|Period 1||4
7858963|NCT00916357|19343130|P2|COMPLETED|Period 1||4
7858964|NCT00916357|19343131|P1|COMPLETED|Period 1||3
7858965|NCT00916357|19343126|P6|Received at Least 1 Dose of Study Drug|Period 1||4
7858966|NCT00916357|19343127|P5|Received at Least 1 Dose of Study Drug|Period 1||3
7858967|NCT00916357|19343128|P4|Received at Least 1 Dose of Study Drug|Period 1||4
7858968|NCT00916357|19343129|P3|Received at Least 1 Dose of Study Drug|Period 1||4
7858969|NCT00916357|19343130|P2|Received at Least 1 Dose of Study Drug|Period 1||4
7858970|NCT00916357|19343131|P1|Received at Least 1 Dose of Study Drug|Period 1||4
7858971|NCT00916357|19343126|P6|STARTED|Period 1||4
7858972|NCT00916357|19343127|P5|STARTED|Period 1||3
7858973|NCT00916357|19343128|P4|STARTED|Period 1||4
7858974|NCT00916357|19343129|P3|STARTED|Period 1||4
7858975|NCT00916357|19343130|P2|STARTED|Period 1||4
7858976|NCT00916357|19343131|P1|STARTED|Period 1||4
7858977|NCT00916344|19343169|P1|NOT COMPLETED|Overall Study||8
7858978|NCT00916344|19343169|P1|COMPLETED|Overall Study||167
7858979|NCT00916344|19343169|P1|STARTED|Overall Study||175
7858980|NCT00916305|19343176|P2|NOT COMPLETED|Overall Study||28
7858981|NCT00916305|19343177|P1|NOT COMPLETED|Overall Study||21
7858982|NCT00916305|19343176|P2|COMPLETED|Overall Study||9
7858983|NCT00916305|19343177|P1|COMPLETED|Overall Study||7
7858984|NCT00916305|19343176|P2|STARTED|Overall Study||37
7858985|NCT00916305|19343177|P1|STARTED|Overall Study||28
7858986|NCT00916279|19343185|P1|NOT COMPLETED|Overall Study||4
7858987|NCT00916279|19343185|P1|COMPLETED|Overall Study||37
7858988|NCT00916279|19343185|P1|24 Months|Overall Study||37
7858989|NCT00916279|19343185|P1|6 Months|Overall Study||41
7858990|NCT00916279|19343185|P1|30 Days|Overall Study||41
7858991|NCT00916279|19343185|P1|STARTED|Overall Study||41
7858992|NCT00916149|19343196|P3|NOT COMPLETED|Overall Study||0
7858993|NCT00916149|19343197|P2|NOT COMPLETED|Overall Study||2
7858994|NCT00916149|19343198|P1|NOT COMPLETED|Overall Study||4
7858995|NCT00916149|19343196|P3|COMPLETED|Overall Study||5
7858996|NCT00916149|19343197|P2|COMPLETED|Overall Study||8
7858997|NCT00916149|19343198|P1|COMPLETED|Overall Study||12
7858998|NCT00916149|19343196|P3|STARTED|Overall Study||5
7858999|NCT00916149|19343197|P2|STARTED|Overall Study||10
7859000|NCT00916149|19343198|P1|STARTED|Overall Study||16
7859001|NCT00916136|19343269|P2|NOT COMPLETED|Overall Study||0
7859002|NCT00916136|19343270|P1|NOT COMPLETED|Overall Study||0
7859003|NCT00916136|19343269|P2|COMPLETED|Overall Study||29
7859004|NCT00916136|19343270|P1|COMPLETED|Overall Study||37
7859005|NCT00916136|19343269|P2|STARTED|Overall Study||29
7859006|NCT00916136|19343270|P1|STARTED|Overall Study||37
7859007|NCT00916058|19343285|P7|NOT COMPLETED|Phase 2||3
7859008|NCT00916058|19343286|P6|NOT COMPLETED|Phase 2||0
7859009|NCT00916058|19343287|P5|NOT COMPLETED|Phase 2||0
7859010|NCT00916058|19343288|P4|NOT COMPLETED|Phase 2||0
7859011|NCT00916058|19343289|P3|NOT COMPLETED|Phase 2||0
7859012|NCT00916058|19343290|P2|NOT COMPLETED|Phase 2||0
7859013|NCT00916058|19343291|P1|NOT COMPLETED|Phase 2||0
7859014|NCT00916058|19343285|P7|COMPLETED|Phase 2||28
7859015|NCT00916058|19343286|P6|COMPLETED|Phase 2||0
7859016|NCT00916058|19343287|P5|COMPLETED|Phase 2||0
7859017|NCT00916058|19343288|P4|COMPLETED|Phase 2||0
7859018|NCT00916058|19343289|P3|COMPLETED|Phase 2||0
7859019|NCT00916058|19343290|P2|COMPLETED|Phase 2||0
7859020|NCT00916058|19343291|P1|COMPLETED|Phase 2||0
7859021|NCT00916058|19343285|P7|STARTED|Phase 2||31
7859022|NCT00916058|19343286|P6|STARTED|Phase 2||0
7859023|NCT00916058|19343287|P5|STARTED|Phase 2||0
7859024|NCT00916058|19343288|P4|STARTED|Phase 2||0
7859025|NCT00916058|19343289|P3|STARTED|Phase 2||0
7859026|NCT00916058|19343290|P2|STARTED|Phase 2||0
7859027|NCT00916058|19343291|P1|STARTED|Phase 2||0
7859028|NCT00916058|19343285|P7|NOT COMPLETED|Phase 1||0
7859029|NCT00916058|19343286|P6|NOT COMPLETED|Phase 1||1
7859030|NCT00916058|19343287|P5|NOT COMPLETED|Phase 1||0
7859031|NCT00916058|19343288|P4|NOT COMPLETED|Phase 1||0
7859032|NCT00916058|19343289|P3|NOT COMPLETED|Phase 1||0
7859033|NCT00916058|19343290|P2|NOT COMPLETED|Phase 1||0
7859034|NCT00916058|19343291|P1|NOT COMPLETED|Phase 1||0
7859035|NCT00916058|19343285|P7|COMPLETED|Phase 1||0
7859036|NCT00916058|19343286|P6|COMPLETED|Phase 1||7
7859037|NCT00916058|19343287|P5|COMPLETED|Phase 1||3
7859038|NCT00916058|19343288|P4|COMPLETED|Phase 1||3
7859039|NCT00916058|19343289|P3|COMPLETED|Phase 1||3
7859040|NCT00916058|19343290|P2|COMPLETED|Phase 1||6
7859041|NCT00916058|19343291|P1|COMPLETED|Phase 1||3
7859042|NCT00916058|19343285|P7|STARTED|Phase 1||0
7859043|NCT00916058|19343286|P6|STARTED|Phase 1||8
7859044|NCT00916058|19343287|P5|STARTED|Phase 1||3
7859045|NCT00916058|19343288|P4|STARTED|Phase 1||3
7859046|NCT00916058|19343289|P3|STARTED|Phase 1||3
7859047|NCT00916058|19343290|P2|STARTED|Phase 1||6
7859048|NCT00916058|19343291|P1|STARTED|Phase 1||3
7859049|NCT00916032|19343311|P2|NOT COMPLETED|Overall Study||0
7859050|NCT00916032|19343312|P1|NOT COMPLETED|Overall Study||0
7859051|NCT00916032|19343311|P2|COMPLETED|Overall Study||11
7859052|NCT00916032|19343312|P1|COMPLETED|Overall Study||12
7859053|NCT00916032|19343311|P2|STARTED|Overall Study||11
7859054|NCT00916032|19343312|P1|STARTED|Overall Study||12
7859055|NCT00916006|19343354|P2|NOT COMPLETED|Overall Study||7
7859056|NCT00916006|19343355|P1|NOT COMPLETED|Overall Study||3
7859057|NCT00916006|19343354|P2|COMPLETED|Overall Study||127
7859058|NCT00916006|19343355|P1|COMPLETED|Overall Study||132
7859059|NCT00916006|19343354|P2|STARTED|Overall Study||134
7859060|NCT00916006|19343355|P1|STARTED|Overall Study||135
7859061|NCT00915967|19343365|P2|NOT COMPLETED|Overall Study||2
7859062|NCT00915967|19343366|P1|NOT COMPLETED|Overall Study||1
7859063|NCT00915967|19343365|P2|COMPLETED|Overall Study||98
7859064|NCT00915967|19343366|P1|COMPLETED|Overall Study||97
7859065|NCT00915967|19343365|P2|STARTED|Overall Study||100
7859066|NCT00915967|19343366|P1|STARTED|Overall Study||98
7859067|NCT00915954|19343375|P3|NOT COMPLETED|Overall Study||0
7859068|NCT00915954|19343376|P2|NOT COMPLETED|Overall Study||0
7859069|NCT00915954|19343377|P1|NOT COMPLETED|Overall Study||0
7859070|NCT00915954|19343375|P3|COMPLETED|Overall Study||10
7859071|NCT00915954|19343376|P2|COMPLETED|Overall Study||8
7859072|NCT00915954|19343377|P1|COMPLETED|Overall Study||10
7859073|NCT00915954|19343375|P3|STARTED|Overall Study||10
7859074|NCT00915954|19343376|P2|STARTED|Overall Study||8
7859075|NCT00915954|19343377|P1|STARTED|Overall Study||10
7859076|NCT00915928|19343396|P2|NOT COMPLETED|Overall Study||0
7859077|NCT00915928|19343397|P1|NOT COMPLETED|Overall Study||0
7859078|NCT00915928|19343396|P2|COMPLETED|Overall Study||22
7859079|NCT00915928|19343397|P1|COMPLETED|Overall Study||25
7859080|NCT00915928|19343396|P2|STARTED|Overall Study||22
7859081|NCT00915928|19343397|P1|STARTED|Overall Study||25
7859082|NCT00915902|19343406|P2|NOT COMPLETED|2nd Treatment Period||1
7859083|NCT00915902|19343407|P1|NOT COMPLETED|2nd Treatment Period||0
7859084|NCT00915902|19343406|P2|COMPLETED|2nd Treatment Period||20
7859085|NCT00915902|19343407|P1|COMPLETED|2nd Treatment Period||19
7859086|NCT00915902|19343406|P2|STARTED|2nd Treatment Period||21
7859087|NCT00915902|19343407|P1|STARTED|2nd Treatment Period||19
7859088|NCT00915902|19343406|P2|NOT COMPLETED|Washout (4 Weeks)||1
7859089|NCT00915902|19343407|P1|NOT COMPLETED|Washout (4 Weeks)||0
7859090|NCT00915902|19343406|P2|COMPLETED|Washout (4 Weeks)||21
7859091|NCT00915902|19343407|P1|COMPLETED|Washout (4 Weeks)||19
7859092|NCT00915902|19343406|P2|STARTED|Washout (4 Weeks)||22
7859093|NCT00915902|19343407|P1|STARTED|Washout (4 Weeks)||19
7859094|NCT00915902|19343406|P2|NOT COMPLETED|1st Treatment Period||0
7859095|NCT00915902|19343407|P1|NOT COMPLETED|1st Treatment Period||1
7859096|NCT00915902|19343406|P2|COMPLETED|1st Treatment Period||22
7859097|NCT00915902|19343407|P1|COMPLETED|1st Treatment Period||19
7859098|NCT00915902|19343406|P2|STARTED|1st Treatment Period||22
7859099|NCT00915902|19343407|P1|STARTED|1st Treatment Period||20
7859100|NCT00915876|19343417|P2|NOT COMPLETED|Overall Study||1
7859101|NCT00915876|19343418|P1|NOT COMPLETED|Overall Study||0
7859102|NCT00915876|19343417|P2|COMPLETED|Overall Study||20
7859103|NCT00915876|19343418|P1|COMPLETED|Overall Study||20
7859104|NCT00915876|19343417|P2|Moving Beyond First Dose|Overall Study||20
7859105|NCT00915876|19343418|P1|Moving Beyond First Dose|Overall Study||20
7859106|NCT00915876|19343417|P2|STARTED|Overall Study||21
7859107|NCT00915876|19343418|P1|STARTED|Overall Study||20
7859108|NCT00915798|19343428|P4|NOT COMPLETED|Overall Study||0
7859109|NCT00915798|19343429|P3|NOT COMPLETED|Overall Study||0
7859110|NCT00915798|19343430|P2|NOT COMPLETED|Overall Study||0
7859111|NCT00915798|19343431|P1|NOT COMPLETED|Overall Study||0
7859112|NCT00915798|19343428|P4|COMPLETED|Overall Study||26
7859113|NCT00915798|19343429|P3|COMPLETED|Overall Study||23
7859114|NCT00915798|19343430|P2|COMPLETED|Overall Study||21
7859115|NCT00915798|19343431|P1|COMPLETED|Overall Study||19
7859116|NCT00915798|19343428|P4|STARTED|Overall Study||26
7859117|NCT00915798|19343429|P3|STARTED|Overall Study||23
7859118|NCT00915798|19343430|P2|STARTED|Overall Study||21
7859119|NCT00915798|19343431|P1|STARTED|Overall Study||19
7859120|NCT00915772|19343454|P3|NOT COMPLETED|Overall Study||29
7859121|NCT00915772|19343455|P2|NOT COMPLETED|Overall Study||46
7859122|NCT00915772|19343456|P1|NOT COMPLETED|Overall Study||36
7859123|NCT00915772|19343454|P3|COMPLETED|Overall Study||142
7859124|NCT00915772|19343455|P2|COMPLETED|Overall Study||179
7859125|NCT00915772|19343456|P1|COMPLETED|Overall Study||134
7859126|NCT00915772|19343454|P3|STARTED|Overall Study||171
7859127|NCT00915772|19343455|P2|STARTED|Overall Study||225
7859128|NCT00915772|19343456|P1|STARTED|Overall Study||170
7859129|NCT00915759|19343501|P1|NOT COMPLETED|Overall Study||0
7859130|NCT00915759|19343501|P1|COMPLETED|Overall Study|number of participants|40
7859131|NCT00915759|19343501|P1|STARTED|Overall Study|number of participants|40
7859132|NCT00915655|19343511|P1|NOT COMPLETED|Overall Study||0
7859133|NCT00915655|19343511|P1|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12
7859134|NCT00915655|19343511|P1|STARTED|Overall Study||12
7859135|NCT00915603|19343518|P2|NOT COMPLETED|Overall Study||55
7859136|NCT00915603|19343519|P1|NOT COMPLETED|Overall Study||56
7859137|NCT00915603|19343518|P2|COMPLETED|Overall Study||0
7859138|NCT00915603|19343519|P1|COMPLETED|Overall Study||0
7859139|NCT00915603|19343518|P2|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55
7859140|NCT00915603|19343519|P1|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56
7859141|NCT00915590|19343535|P2|NOT COMPLETED|Overall Study||1
7859142|NCT00915590|19343536|P1|NOT COMPLETED|Overall Study||2
7859143|NCT00915590|19343535|P2|COMPLETED|Overall Study||4
7859144|NCT00915590|19343536|P1|COMPLETED|Overall Study||3
7859145|NCT00915590|19343535|P2|STARTED|Overall Study||5
7859146|NCT00915590|19343536|P1|STARTED|Overall Study||5
7859147|NCT00915551|19343555|P2|NOT COMPLETED|Overall Study||1
7859148|NCT00915551|19343556|P1|NOT COMPLETED|Overall Study||0
7859149|NCT00915551|19343555|P2|COMPLETED|Overall Study||135
7859150|NCT00915551|19343556|P1|COMPLETED|Overall Study||142
7859151|NCT00915551|19343555|P2|STARTED|Overall Study||136
7859152|NCT00915551|19343556|P1|STARTED|Overall Study||142
7859153|NCT00915538|19343566|P2|NOT COMPLETED|Overall Study||0
7859154|NCT00915538|19343567|P1|NOT COMPLETED|Overall Study||0
7859155|NCT00915538|19343566|P2|COMPLETED|Overall Study||8
7859156|NCT00915538|19343567|P1|COMPLETED|Overall Study||8
7859157|NCT00915538|19343566|P2|STARTED|Overall Study||8
7859158|NCT00915538|19343567|P1|STARTED|Overall Study||8
7859159|NCT00915525|19343577|P2|NOT COMPLETED|Overall Study||135
7859160|NCT00915525|19343578|P1|NOT COMPLETED|Overall Study||265
7859161|NCT00915525|19343577|P2|COMPLETED|Overall Study||151
7859162|NCT00915525|19343578|P1|COMPLETED|Overall Study||278
7859163|NCT00915525|19343577|P2|STARTED|Overall Study||286
7859164|NCT00915525|19343578|P1|STARTED|Overall Study||543
7859165|NCT00915499|19343681|P2|NOT COMPLETED|Overall Study||2
7859166|NCT00915499|19343682|P1|NOT COMPLETED|Overall Study||4
7859167|NCT00915499|19343681|P2|COMPLETED|Overall Study||31
7859168|NCT00915499|19343682|P1|COMPLETED|Overall Study||29
7859169|NCT00915499|19343681|P2|STARTED|Overall Study||33
7859170|NCT00915499|19343682|P1|STARTED|Overall Study||33
7859171|NCT00915473|19343692|P2|NOT COMPLETED|4-week Follow Up||5
7859172|NCT00915473|19343693|P1|NOT COMPLETED|4-week Follow Up||1
7859173|NCT00915473|19343692|P2|COMPLETED|4-week Follow Up||30
7859174|NCT00915473|19343693|P1|COMPLETED|4-week Follow Up||33
7859175|NCT00915473|19343692|P2|STARTED|4-week Follow Up||35
7859176|NCT00915473|19343693|P1|STARTED|4-week Follow Up||34
7859177|NCT00915473|19343692|P2|NOT COMPLETED|Injection||0
7859178|NCT00915473|19343693|P1|NOT COMPLETED|Injection||0
7859179|NCT00915473|19343692|P2|COMPLETED|Injection||35
7859180|NCT00915473|19343693|P1|COMPLETED|Injection||34
7859181|NCT00915473|19343692|P2|STARTED|Injection||35
7859182|NCT00915473|19343693|P1|STARTED|Injection||34
7859183|NCT00915473|19343692|P2|NOT COMPLETED|Screening||0
7859184|NCT00915473|19343693|P1|NOT COMPLETED|Screening||1
7859185|NCT00915473|19343692|P2|COMPLETED|Screening||35
7859186|NCT00915473|19343693|P1|COMPLETED|Screening||34
7859187|NCT00915473|19343692|P2|STARTED|Screening||35
7859188|NCT00915473|19343693|P1|STARTED|Screening||35
7859189|NCT00915356|19343710|P5|NOT COMPLETED|Overall Study||0
7859190|NCT00915356|19343711|P4|NOT COMPLETED|Overall Study||0
7859191|NCT00915356|19343712|P3|NOT COMPLETED|Overall Study||0
7859192|NCT00915356|19343713|P2|NOT COMPLETED|Overall Study||0
7859193|NCT00915356|19343714|P1|NOT COMPLETED|Overall Study||1
7859194|NCT00915356|19343710|P5|COMPLETED|Overall Study||43
7859195|NCT00915356|19343711|P4|COMPLETED|Overall Study||12
7859196|NCT00915356|19343712|P3|COMPLETED|Overall Study||45
7859197|NCT00915356|19343713|P2|COMPLETED|Overall Study||45
7859198|NCT00915356|19343714|P1|COMPLETED|Overall Study||25
7859199|NCT00915356|19343710|P5|STARTED|Overall Study||43
7859200|NCT00915356|19343711|P4|STARTED|Overall Study||12
7859201|NCT00915356|19343712|P3|STARTED|Overall Study||45
7859202|NCT00915356|19343713|P2|STARTED|Overall Study||45
7859203|NCT00915356|19343714|P1|STARTED|Overall Study||26
7859204|NCT00915343|19343776|P3|NOT COMPLETED|Part B - Open Label Period||2
7859205|NCT00915343|19343777|P2|NOT COMPLETED|Part B - Open Label Period||0
7859206|NCT00915343|19343778|P1|NOT COMPLETED|Part B - Open Label Period||0
7859207|NCT00915343|19343776|P3|COMPLETED|Part B - Open Label Period||57
7859208|NCT00915343|19343777|P2|COMPLETED|Part B - Open Label Period||0
7859209|NCT00915343|19343778|P1|COMPLETED|Part B - Open Label Period||0
7859210|NCT00915343|19343776|P3|STARTED|Part B - Open Label Period||59
7859211|NCT00915343|19343777|P2|STARTED|Part B - Open Label Period||0
7859212|NCT00915343|19343778|P1|STARTED|Part B - Open Label Period||0
7859213|NCT00915343|19343776|P3|NOT COMPLETED|Part A - Second Intervention Period||0
7859214|NCT00915343|19343777|P2|NOT COMPLETED|Part A - Second Intervention Period||0
7859215|NCT00915343|19343778|P1|NOT COMPLETED|Part A - Second Intervention Period||0
7859216|NCT00915343|19343776|P3|COMPLETED|Part A - Second Intervention Period||0
7859217|NCT00915343|19343777|P2|COMPLETED|Part A - Second Intervention Period||32
7859218|NCT00915343|19343778|P1|COMPLETED|Part A - Second Intervention Period||32
7859219|NCT00915343|19343776|P3|STARTED|Part A - Second Intervention Period||0
7859220|NCT00915343|19343777|P2|STARTED|Part A - Second Intervention Period||32
7859221|NCT00915343|19343778|P1|STARTED|Part A - Second Intervention Period||32
7859222|NCT00915343|19343776|P3|NOT COMPLETED|Part A - First Intervention Period||0
7859223|NCT00915343|19343777|P2|NOT COMPLETED|Part A - First Intervention Period||0
7859224|NCT00915343|19343778|P1|NOT COMPLETED|Part A - First Intervention Period||0
7859225|NCT00915343|19343776|P3|COMPLETED|Part A - First Intervention Period||0
7859226|NCT00915343|19343777|P2|COMPLETED|Part A - First Intervention Period||32
7859227|NCT00915343|19343778|P1|COMPLETED|Part A - First Intervention Period||32
7859228|NCT00915343|19343776|P3|STARTED|Part A - First Intervention Period||0
7859229|NCT00915343|19343777|P2|STARTED|Part A - First Intervention Period||32
7859230|NCT00915343|19343778|P1|STARTED|Part A - First Intervention Period||32
7859231|NCT00915278|19343863|P6|NOT COMPLETED|Overall Study||8
7859232|NCT00915278|19343864|P5|NOT COMPLETED|Overall Study||2
7859233|NCT00915278|19343865|P4|NOT COMPLETED|Overall Study||3
7859234|NCT00915278|19343866|P3|NOT COMPLETED|Overall Study||1
7859235|NCT00915278|19343867|P2|NOT COMPLETED|Overall Study||3
7859236|NCT00915278|19343868|P1|NOT COMPLETED|Overall Study||5
7859237|NCT00915278|19343863|P6|COMPLETED|Overall Study||1
7859238|NCT00915278|19343864|P5|COMPLETED|Overall Study||1
7859239|NCT00915278|19343865|P4|COMPLETED|Overall Study||2
7859240|NCT00915278|19343866|P3|COMPLETED|Overall Study||2
7859241|NCT00915278|19343867|P2|COMPLETED|Overall Study||2
7859242|NCT00915278|19343868|P1|COMPLETED|Overall Study||3
7859243|NCT00915278|19343863|P6|STARTED|Overall Study||9
7859244|NCT00915278|19343864|P5|STARTED|Overall Study||3
7859245|NCT00915278|19343865|P4|STARTED|Overall Study||5
7859246|NCT00915278|19343866|P3|STARTED|Overall Study||3
7859247|NCT00915278|19343867|P2|STARTED|Overall Study||5
7859248|NCT00915278|19343868|P1|STARTED|Overall Study||8
7859249|NCT00915148|19344014|P1|NOT COMPLETED|Overall Study||0
7859250|NCT00915148|19344014|P1|COMPLETED|Overall Study|August 2010|110
7859251|NCT00915148|19344014|P1|STARTED|Overall Study|October 2009|110
7859252|NCT00915031|19344021|P2|NOT COMPLETED|Overall Study||0
7859253|NCT00915031|19344022|P1|NOT COMPLETED|Overall Study||0
7859254|NCT00915031|19344021|P2|COMPLETED|Overall Study||24
7859255|NCT00915031|19344022|P1|COMPLETED|Overall Study||714
7859256|NCT00915031|19344021|P2|STARTED|Overall Study||24
7859257|NCT00915031|19344022|P1|STARTED|Overall Study||714
7859258|NCT00915018|19344029|P2|NOT COMPLETED|Overall Study||207
7859259|NCT00915018|19344030|P1|NOT COMPLETED|Overall Study||215
7859260|NCT00915018|19344029|P2|COMPLETED|Overall Study||30
7859261|NCT00915018|19344030|P1|COMPLETED|Overall Study||27
7859262|NCT00915018|19344029|P2|Received Treatment|Overall Study||234
7859263|NCT00915018|19344030|P1|Received Treatment|Overall Study||240
7859264|NCT00915018|19344029|P2|STARTED|Overall Study||237
7859265|NCT00915018|19344030|P1|STARTED|Overall Study||242
7859266|NCT00915005|19344046|P2|NOT COMPLETED|Overall Study||19
7859267|NCT00915005|19344047|P1|NOT COMPLETED|Overall Study||13
7859268|NCT00915005|19344046|P2|COMPLETED|Overall Study||57
7859269|NCT00915005|19344047|P1|COMPLETED|Overall Study||92
7859270|NCT00915005|19344046|P2|STARTED|Overall Study||76
7859271|NCT00915005|19344047|P1|STARTED|Overall Study||105
7859272|NCT00914966|19344055|P1|NOT COMPLETED|Step 3: 2500 Units||0
7859273|NCT00914966|19344055|P1|COMPLETED|Step 3: 2500 Units||12
7859274|NCT00914966|19344055|P1|STARTED|Step 3: 2500 Units||12
7859275|NCT00914966|19344055|P1|NOT COMPLETED|Step 2: 2000 Units||1
7859276|NCT00914966|19344055|P1|COMPLETED|Step 2: 2000 Units||12
7859277|NCT00914966|19344055|P1|STARTED|Step 2: 2000 Units||13
7859278|NCT00914966|19344055|P1|NOT COMPLETED|Step 1: 1500 Units||2
7859279|NCT00914966|19344055|P1|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18
7859280|NCT00914966|19344055|P1|STARTED|Step 1: 1500 Units||20
7859281|NCT00914940|19344067|P1|NOT COMPLETED|2 Years to 5 Years Post-transplant||3
7859282|NCT00914940|19344067|P1|COMPLETED|2 Years to 5 Years Post-transplant||28
7859283|NCT00914940|19344067|P1|STARTED|2 Years to 5 Years Post-transplant||31
7859284|NCT00914940|19344067|P1|NOT COMPLETED|D101 to 2 Years Post-transplant||8
7859285|NCT00914940|19344067|P1|COMPLETED|D101 to 2 Years Post-transplant||31
7859286|NCT00914940|19344067|P1|STARTED|D101 to 2 Years Post-transplant||39
7859287|NCT00914940|19344067|P1|NOT COMPLETED|D0 to D100 Post-transplant||2
7859288|NCT00914940|19344067|P1|COMPLETED|D0 to D100 Post-transplant||39
7859289|NCT00914940|19344067|P1|STARTED|D0 to D100 Post-transplant||41
7859290|NCT00914927|19344082|P7|NOT COMPLETED|Overall Study||0
7859291|NCT00914927|19344083|P6|NOT COMPLETED|Overall Study||0
7859292|NCT00914927|19344084|P5|NOT COMPLETED|Overall Study||2
7859293|NCT00914927|19344085|P4|NOT COMPLETED|Overall Study||2
7859294|NCT00914927|19344086|P3|NOT COMPLETED|Overall Study||0
7859295|NCT00914927|19344087|P2|NOT COMPLETED|Overall Study||2
7859296|NCT00914927|19344088|P1|NOT COMPLETED|Overall Study||2
7859297|NCT00914927|19344082|P7|COMPLETED|Overall Study||21
7859298|NCT00914927|19344083|P6|COMPLETED|Overall Study||21
7859299|NCT00914927|19344084|P5|COMPLETED|Overall Study||19
7859300|NCT00914927|19344085|P4|COMPLETED|Overall Study||14
7859301|NCT00914927|19344086|P3|COMPLETED|Overall Study||17
7859302|NCT00914927|19344087|P2|COMPLETED|Overall Study||14
7859303|NCT00914927|19344088|P1|COMPLETED|Overall Study||16
7859304|NCT00914927|19344082|P7|STARTED|Overall Study||21
7859305|NCT00914927|19344083|P6|STARTED|Overall Study||21
7859306|NCT00914927|19344084|P5|STARTED|Overall Study||21
7859307|NCT00914927|19344085|P4|STARTED|Overall Study||16
7859308|NCT00914927|19344086|P3|STARTED|Overall Study||17
7859309|NCT00914927|19344087|P2|STARTED|Overall Study||16
7859310|NCT00914927|19344088|P1|STARTED|Overall Study||18
7859311|NCT00914862|19344137|P5|NOT COMPLETED|Overall Study||0
7859312|NCT00914862|19344138|P4|NOT COMPLETED|Overall Study||0
7859313|NCT00914862|19344139|P3|NOT COMPLETED|Overall Study||0
7859314|NCT00914862|19344140|P2|NOT COMPLETED|Overall Study||0
7859315|NCT00914862|19344141|P1|NOT COMPLETED|Overall Study||0
7859316|NCT00914862|19344137|P5|COMPLETED|Overall Study||28
7859317|NCT00914862|19344138|P4|COMPLETED|Overall Study||8
7859318|NCT00914862|19344139|P3|COMPLETED|Overall Study||8
7859319|NCT00914862|19344140|P2|COMPLETED|Overall Study||6
7859320|NCT00914862|19344141|P1|COMPLETED|Overall Study||6
7859321|NCT00914862|19344137|P5|STARTED|Overall Study||28
7859322|NCT00914862|19344138|P4|STARTED|Overall Study||8
7859323|NCT00914862|19344139|P3|STARTED|Overall Study||8
7859324|NCT00914862|19344140|P2|STARTED|Overall Study||6
7859325|NCT00914862|19344141|P1|STARTED|Overall Study||6
7859326|NCT00914849|19344215|P2|NOT COMPLETED|Overall Study||1
7859327|NCT00914849|19344216|P1|NOT COMPLETED|Overall Study||1
7859328|NCT00914849|19344215|P2|COMPLETED|Overall Study||33
7859329|NCT00914849|19344216|P1|COMPLETED|Overall Study||33
7859330|NCT00914849|19344215|P2|STARTED|Overall Study||34
7859331|NCT00914849|19344216|P1|STARTED|Overall Study||34
7859332|NCT00914810|19344250|P2|NOT COMPLETED|Overall Study||1
7859333|NCT00914810|19344251|P1|NOT COMPLETED|Overall Study||2
7859334|NCT00914810|19344250|P2|COMPLETED|Overall Study||18
7859335|NCT00914810|19344251|P1|COMPLETED|Overall Study||18
7859336|NCT00914810|19344250|P2|STARTED|Overall Study||19
7859337|NCT00914810|19344251|P1|STARTED|Overall Study||20
7859338|NCT00914589|19344262|P3|NOT COMPLETED|Overall Study||12
7859339|NCT00914589|19344263|P2|NOT COMPLETED|Overall Study||16
7859340|NCT00914589|19344264|P1|NOT COMPLETED|Overall Study||25
7859341|NCT00914589|19344262|P3|COMPLETED|Overall Study||126
7859342|NCT00914589|19344263|P2|COMPLETED|Overall Study||127
7859343|NCT00914589|19344264|P1|COMPLETED|Overall Study||103
7859344|NCT00914589|19344262|P3|STARTED|Overall Study||138
7859345|NCT00914589|19344263|P2|STARTED|Overall Study||143
7859346|NCT00914589|19344264|P1|STARTED|Overall Study||128
7859347|NCT00914485|19344284|P1|NOT COMPLETED|Overall Study||0
7859348|NCT00914485|19344284|P1|COMPLETED|Overall Study||369
7859349|NCT00914485|19344284|P1|STARTED|Overall Study||369
7859350|NCT00914459|19344290|P2|NOT COMPLETED|Overall Study||1
7859351|NCT00914459|19344291|P1|NOT COMPLETED|Overall Study||1
7859352|NCT00914459|19344290|P2|COMPLETED|Overall Study||18
7859353|NCT00914459|19344291|P1|COMPLETED|Overall Study||17
7859354|NCT00914459|19344290|P2|STARTED|Overall Study||19
7859355|NCT00914459|19344291|P1|STARTED|Overall Study||18
7859356|NCT00914316|19344321|P4|NOT COMPLETED|Phase 2||0
7859357|NCT00914316|19344322|P3|NOT COMPLETED|Phase 2||1
7859358|NCT00914316|19344323|P2|NOT COMPLETED|Phase 2||0
7859359|NCT00914316|19344324|P1|NOT COMPLETED|Phase 2||1
7859360|NCT00914316|19344321|P4|COMPLETED|Phase 2||6
7859361|NCT00914316|19344322|P3|COMPLETED|Phase 2||2
7859362|NCT00914316|19344323|P2|COMPLETED|Phase 2||4
7859363|NCT00914316|19344324|P1|COMPLETED|Phase 2||1
7859364|NCT00914316|19344321|P4|STARTED|Phase 2||6
7859365|NCT00914316|19344322|P3|STARTED|Phase 2||3
7859366|NCT00914316|19344323|P2|STARTED|Phase 2||4
7859367|NCT00914316|19344324|P1|STARTED|Phase 2||2
7859368|NCT00914316|19344321|P4|NOT COMPLETED|Phase 1||2
7859369|NCT00914316|19344322|P3|NOT COMPLETED|Phase 1||5
7859370|NCT00914316|19344323|P2|NOT COMPLETED|Phase 1||2
7859371|NCT00914316|19344324|P1|NOT COMPLETED|Phase 1||5
7859372|NCT00914316|19344321|P4|COMPLETED|Phase 1||6
7859373|NCT00914316|19344322|P3|COMPLETED|Phase 1||3
7859374|NCT00914316|19344323|P2|COMPLETED|Phase 1||4
7859375|NCT00914316|19344324|P1|COMPLETED|Phase 1||2
7859376|NCT00914316|19344321|P4|STARTED|Phase 1||8
7859377|NCT00914316|19344322|P3|STARTED|Phase 1||8
7859378|NCT00914316|19344323|P2|STARTED|Phase 1||6
7859379|NCT00914316|19344324|P1|STARTED|Phase 1||7
7859380|NCT00914186|19344342|P4|NOT COMPLETED|Overall Study||10
7859381|NCT00914186|19344343|P3|NOT COMPLETED|Overall Study||2
7859382|NCT00914186|19344344|P2|NOT COMPLETED|Overall Study||2
7859383|NCT00914186|19344345|P1|NOT COMPLETED|Overall Study||3
7859384|NCT00914186|19344342|P4|COMPLETED|Overall Study||20
7859385|NCT00914186|19344343|P3|COMPLETED|Overall Study||29
7859386|NCT00914186|19344344|P2|COMPLETED|Overall Study||28
7859387|NCT00914186|19344345|P1|COMPLETED|Overall Study||28
7859388|NCT00914186|19344342|P4|STARTED|Overall Study||30
7859389|NCT00914186|19344343|P3|STARTED|Overall Study||31
7859390|NCT00914186|19344344|P2|STARTED|Overall Study||30
7859391|NCT00914186|19344345|P1|STARTED|Overall Study||31
7859392|NCT00914069|19344379|P2|NOT COMPLETED|Overall Study||0
7859393|NCT00914069|19344380|P1|NOT COMPLETED|Overall Study||0
7859394|NCT00914069|19344379|P2|COMPLETED|Overall Study||88
7859395|NCT00914069|19344380|P1|COMPLETED|Overall Study||84
7859396|NCT00914069|19344379|P2|STARTED|Overall Study||88
7859397|NCT00914069|19344380|P1|STARTED|Overall Study||84
7859398|NCT00913978|19344396|P2|NOT COMPLETED|Overall Study||3
7859399|NCT00913978|19344397|P1|NOT COMPLETED|Overall Study||1
7859400|NCT00913978|19344396|P2|COMPLETED|Overall Study||21
7859401|NCT00913978|19344397|P1|COMPLETED|Overall Study||25
7859402|NCT00913978|19344396|P2|STARTED|Overall Study||24
7859403|NCT00913978|19344397|P1|STARTED|Overall Study||26
7859404|NCT00913913|19344405|P1|NOT COMPLETED|Overall Study||8
7859405|NCT00913913|19344405|P1|COMPLETED|Overall Study||0
7859406|NCT00913913|19344405|P1|STARTED|Overall Study||8
7859407|NCT00913835|19344414|P2|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3
7859408|NCT00913835|19344415|P1|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0
7859409|NCT00913835|19344414|P2|COMPLETED|Lip Dox: Olaratumab Monotherapy||25
7859410|NCT00913835|19344415|P1|COMPLETED|Lip Dox: Olaratumab Monotherapy||0
7859411|NCT00913835|19344414|P2|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28
7859412|NCT00913835|19344415|P1|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0
7859413|NCT00913835|19344414|P2|STARTED|Lip Dox: Olaratumab Monotherapy||28
7859414|NCT00913835|19344415|P1|STARTED|Lip Dox: Olaratumab Monotherapy||0
7859415|NCT00913835|19344414|P2|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7
7859416|NCT00913835|19344415|P1|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8
7859417|NCT00913835|19344414|P2|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
7859418|NCT00913835|19344415|P1|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
7859419|NCT00913835|19344414|P2|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61
7859420|NCT00913835|19344415|P1|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62
7859421|NCT00913835|19344414|P2|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62
7859422|NCT00913835|19344415|P1|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63
7859423|NCT00913770|19344454|P3|NOT COMPLETED|Overall Study||21
7859424|NCT00913770|19344455|P2|NOT COMPLETED|Overall Study||29
7859425|NCT00913770|19344456|P1|NOT COMPLETED|Overall Study||35
7859426|NCT00913770|19344454|P3|COMPLETED|Overall Study||93
7859427|NCT00913770|19344455|P2|COMPLETED|Overall Study||82
7859428|NCT00913770|19344456|P1|COMPLETED|Overall Study||69
7859429|NCT00913770|19344454|P3|STARTED|Overall Study||114
7859430|NCT00913770|19344455|P2|STARTED|Overall Study||111
7859431|NCT00913770|19344456|P1|STARTED|Overall Study||104
7859432|NCT00913744|19344469|P2|NOT COMPLETED|Overall Study||1
7859433|NCT00913744|19344470|P1|NOT COMPLETED|Overall Study||5
7859434|NCT00913744|19344469|P2|COMPLETED|Overall Study||24
7859435|NCT00913744|19344470|P1|COMPLETED|Overall Study||70
7859436|NCT00913744|19344469|P2|STARTED|Overall Study||25
7859437|NCT00913744|19344470|P1|STARTED|Overall Study||75
7859438|NCT00913692|19344476|P1|NOT COMPLETED|Treatment Phase 2 (5 Months)||0
7859439|NCT00913692|19344476|P1|COMPLETED|Treatment Phase 2 (5 Months)||1
7859440|NCT00913692|19344476|P1|STARTED|Treatment Phase 2 (5 Months)||1
7859441|NCT00913692|19344476|P1|NOT COMPLETED|Washout (2 Weeks)||0
7859442|NCT00913692|19344476|P1|COMPLETED|Washout (2 Weeks)||1
7859443|NCT00913692|19344476|P1|STARTED|Washout (2 Weeks)||1
7859444|NCT00913692|19344476|P1|NOT COMPLETED|Treatment Phase 1 (5 Months)||1
7859445|NCT00913692|19344476|P1|COMPLETED|Treatment Phase 1 (5 Months)||1
7859446|NCT00913692|19344476|P1|STARTED|Treatment Phase 1 (5 Months)||2
7859447|NCT00913692|19344476|P1|NOT COMPLETED|Screening (4 Months)||9
7859448|NCT00913692|19344476|P1|COMPLETED|Screening (4 Months)||2
7859449|NCT00913692|19344476|P1|STARTED|Screening (4 Months)||11
7859450|NCT00913627|19344490|P4|NOT COMPLETED|Overall Study||0
7859451|NCT00913627|19344491|P3|NOT COMPLETED|Overall Study||0
7859452|NCT00913627|19344492|P2|NOT COMPLETED|Overall Study||0
7859453|NCT00913627|19344493|P1|NOT COMPLETED|Overall Study||0
7859454|NCT00913627|19344490|P4|COMPLETED|Overall Study||58
7859455|NCT00913627|19344491|P3|COMPLETED|Overall Study||56
7859456|NCT00913627|19344492|P2|COMPLETED|Overall Study||53
7859457|NCT00913627|19344493|P1|COMPLETED|Overall Study||29
7859458|NCT00913627|19344490|P4|STARTED|Overall Study||58
7859459|NCT00913627|19344491|P3|STARTED|Overall Study||56
7859460|NCT00913627|19344492|P2|STARTED|Overall Study||53
7859461|NCT00913627|19344493|P1|STARTED|Overall Study||29
7859462|NCT00913523|19344570|P3|NOT COMPLETED|Overall Study||14
7859463|NCT00913523|19344571|P2|NOT COMPLETED|Overall Study||16
7859464|NCT00913523|19344572|P1|NOT COMPLETED|Overall Study||18
7859465|NCT00913523|19344570|P3|COMPLETED|Overall Study||147
7859466|NCT00913523|19344571|P2|COMPLETED|Overall Study||143
7859467|NCT00913523|19344572|P1|COMPLETED|Overall Study||144
7859468|NCT00913523|19344570|P3|STARTED|Overall Study||161
7859469|NCT00913523|19344571|P2|STARTED|Overall Study||159
7859470|NCT00913523|19344572|P1|STARTED|Overall Study||162
7859471|NCT00913510|19344597|P2|NOT COMPLETED|Overall Study||4
7859472|NCT00913510|19344598|P1|NOT COMPLETED|Overall Study||8
7859473|NCT00913510|19344597|P2|COMPLETED|Overall Study||3
7859474|NCT00913510|19344598|P1|COMPLETED|Overall Study||5
7859475|NCT00913510|19344597|P2|STARTED|Overall Study||7
7859476|NCT00913510|19344598|P1|STARTED|Overall Study||13
7859477|NCT00913458|19344604|P7|NOT COMPLETED|Phase 3||8
7859478|NCT00913458|19344605|P6|NOT COMPLETED|Phase 3||18
7859479|NCT00913458|19344606|P5|NOT COMPLETED|Phase 3||22
7859480|NCT00913458|19344607|P4|NOT COMPLETED|Phase 3||0
7859481|NCT00913458|19344608|P3|NOT COMPLETED|Phase 3||0
7859482|NCT00913458|19344609|P2|NOT COMPLETED|Phase 3||0
7859483|NCT00913458|19344610|P1|NOT COMPLETED|Phase 3||0
7859484|NCT00913458|19344604|P7|COMPLETED|Phase 3||24
7859485|NCT00913458|19344605|P6|COMPLETED|Phase 3||28
7859486|NCT00913458|19344606|P5|COMPLETED|Phase 3||31
7859487|NCT00913458|19344607|P4|COMPLETED|Phase 3||0
7859488|NCT00913458|19344608|P3|COMPLETED|Phase 3||0
7859489|NCT00913458|19344609|P2|COMPLETED|Phase 3||0
7859490|NCT00913458|19344610|P1|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0
7859491|NCT00913458|19344604|P7|STARTED|Phase 3|Participants who completed Phase 2 study|32
7859492|NCT00913458|19344605|P6|STARTED|Phase 3|Participants who completed Phase 2 study|46
7859493|NCT00913458|19344606|P5|STARTED|Phase 3|Participants who completed Phase 2 study|53
7859494|NCT00913458|19344607|P4|STARTED|Phase 3||0
7859495|NCT00913458|19344608|P3|STARTED|Phase 3||0
7859496|NCT00913458|19344609|P2|STARTED|Phase 3||0
7859497|NCT00913458|19344610|P1|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0
7859498|NCT00913458|19344604|P7|NOT COMPLETED|Phase 2||0
7859499|NCT00913458|19344605|P6|NOT COMPLETED|Phase 2||0
7859500|NCT00913458|19344606|P5|NOT COMPLETED|Phase 2||0
7859501|NCT00913458|19344607|P4|NOT COMPLETED|Phase 2||33
7859502|NCT00913458|19344608|P3|NOT COMPLETED|Phase 2||19
7859503|NCT00913458|19344609|P2|NOT COMPLETED|Phase 2||10
7859504|NCT00913458|19344610|P1|NOT COMPLETED|Phase 2||0
7859505|NCT00913458|19344604|P7|COMPLETED|Phase 2||0
7859506|NCT00913458|19344605|P6|COMPLETED|Phase 2||0
7859507|NCT00913458|19344606|P5|COMPLETED|Phase 2||0
7859508|NCT00913458|19344607|P4|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32
7859509|NCT00913458|19344608|P3|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46
7859510|NCT00913458|19344609|P2|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53
7859511|NCT00913458|19344610|P1|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0
7859512|NCT00913458|19344604|P7|STARTED|Phase 2||0
7859513|NCT00913458|19344605|P6|STARTED|Phase 2||0
7859514|NCT00913458|19344606|P5|STARTED|Phase 2||0
7859515|NCT00913458|19344607|P4|STARTED|Phase 2||65
7859516|NCT00913458|19344608|P3|STARTED|Phase 2||65
7859517|NCT00913458|19344609|P2|STARTED|Phase 2||63
7859518|NCT00913458|19344610|P1|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0
7859519|NCT00913458|19344604|P7|NOT COMPLETED|Phase 1||0
7859520|NCT00913458|19344605|P6|NOT COMPLETED|Phase 1||0
7859521|NCT00913458|19344606|P5|NOT COMPLETED|Phase 1||0
7859522|NCT00913458|19344607|P4|NOT COMPLETED|Phase 1||0
7859523|NCT00913458|19344608|P3|NOT COMPLETED|Phase 1||0
7859524|NCT00913458|19344609|P2|NOT COMPLETED|Phase 1||0
7859525|NCT00913458|19344610|P1|NOT COMPLETED|Phase 1||112
7859526|NCT00913458|19344604|P7|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
7859527|NCT00913458|19344605|P6|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
7859528|NCT00913458|19344606|P5|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
7859529|NCT00913458|19344607|P4|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
7859530|NCT00913458|19344608|P3|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
7859531|NCT00913458|19344609|P2|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
7859532|NCT00913458|19344610|P1|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194
7859533|NCT00913458|19344604|P7|STARTED|Phase 1|This arm is part of Phase 3 study|0
7859534|NCT00913458|19344605|P6|STARTED|Phase 1|This arm is part of Phase 3 study|0
7859535|NCT00913458|19344606|P5|STARTED|Phase 1|This arm is part of Phase 3 study|0
7859536|NCT00913458|19344607|P4|STARTED|Phase 1|This arm is part of Phase 2 study|0
7859537|NCT00913458|19344608|P3|STARTED|Phase 1|This arm is part of Phase 2 study|0
7859538|NCT00913458|19344609|P2|STARTED|Phase 1|This arm is part of Phase 2 study|0
7859539|NCT00913458|19344610|P1|STARTED|Phase 1||306
7859540|NCT00913380|19344703|P2|NOT COMPLETED|Clinical Outcomes||6
7859541|NCT00913380|19344704|P1|NOT COMPLETED|Clinical Outcomes||6
7859542|NCT00913380|19344703|P2|COMPLETED|Clinical Outcomes||441
7859543|NCT00913380|19344704|P1|COMPLETED|Clinical Outcomes||438
7859544|NCT00913380|19344703|P2|STARTED|Clinical Outcomes||447
7859545|NCT00913380|19344704|P1|STARTED|Clinical Outcomes||444
7859546|NCT00913380|19344703|P2|NOT COMPLETED|CT Examination||0
7859547|NCT00913380|19344704|P1|NOT COMPLETED|CT Examination||0
7859548|NCT00913380|19344703|P2|COMPLETED|CT Examination||447
7859549|NCT00913380|19344704|P1|COMPLETED|CT Examination||444
7859550|NCT00913380|19344703|P2|STARTED|CT Examination||447
7859551|NCT00913380|19344704|P1|STARTED|CT Examination||444
7859552|NCT00913263|19344730|P1|NOT COMPLETED|Overall Study||0
7859553|NCT00913263|19344730|P1|COMPLETED|Overall Study||24
7859554|NCT00913263|19344730|P1|STARTED|Overall Study||24
7859555|NCT00913133|19344739|P1|NOT COMPLETED|Overall Study||0
7859556|NCT00913133|19344739|P1|COMPLETED|Overall Study||516
7859557|NCT00913133|19344739|P1|STARTED|Overall Study||516
7859558|NCT00913081|19344744|P1|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0
7859559|NCT00913081|19344744|P1|COMPLETED|Placebo + Niacin 500 mg (1day)||17
7859560|NCT00913081|19344744|P1|STARTED|Placebo + Niacin 500 mg (1day)||17
7859561|NCT00913081|19344744|P1|NOT COMPLETED|Washout #3 (7days)||0
7859562|NCT00913081|19344744|P1|COMPLETED|Washout #3 (7days)||17
7859563|NCT00913081|19344744|P1|STARTED|Washout #3 (7days)||17
7859564|NCT00913081|19344744|P1|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0
7859565|NCT00913081|19344744|P1|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
7859566|NCT00913081|19344744|P1|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
7859567|NCT00913081|19344744|P1|NOT COMPLETED|Washout #2 (7 Days)||0
7859568|NCT00913081|19344744|P1|COMPLETED|Washout #2 (7 Days)||17
7859569|NCT00913081|19344744|P1|STARTED|Washout #2 (7 Days)||17
7859570|NCT00913081|19344744|P1|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0
7859571|NCT00913081|19344744|P1|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
7859572|NCT00913081|19344744|P1|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
7859573|NCT00913081|19344744|P1|NOT COMPLETED|Washout #1 (7 Days)||0
7859574|NCT00913081|19344744|P1|COMPLETED|Washout #1 (7 Days)||17
7859575|NCT00913081|19344744|P1|STARTED|Washout #1 (7 Days)||17
7859576|NCT00913081|19344744|P1|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0
7859577|NCT00913081|19344744|P1|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17
7859578|NCT00913081|19344744|P1|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17
7859579|NCT00913003|19344756|P2|NOT COMPLETED|Overall Study||0
7859580|NCT00913003|19344757|P1|NOT COMPLETED|Overall Study||0
7859581|NCT00913003|19344756|P2|COMPLETED|Overall Study||11
7859582|NCT00913003|19344757|P1|COMPLETED|Overall Study||11
7859583|NCT00913003|19344756|P2|STARTED|Overall Study||11
7859584|NCT00913003|19344757|P1|STARTED|Overall Study||11
7859585|NCT00912990|19344769|P2|NOT COMPLETED|Overall Study||0
7859586|NCT00912990|19344770|P1|NOT COMPLETED|Overall Study||0
7859587|NCT00912990|19344769|P2|COMPLETED|Overall Study||18
7859588|NCT00912990|19344770|P1|COMPLETED|Overall Study||16
7859589|NCT00912990|19344769|P2|STARTED|Overall Study||18
7859590|NCT00912990|19344770|P1|STARTED|Overall Study||16
7859591|NCT00912964|19344783|P3|NOT COMPLETED|Overall Study||54
7859592|NCT00912964|19344784|P2|NOT COMPLETED|Overall Study||46
7859593|NCT00912964|19344785|P1|NOT COMPLETED|Overall Study||66
7859594|NCT00912964|19344783|P3|COMPLETED|Overall Study||386
7859595|NCT00912964|19344784|P2|COMPLETED|Overall Study||387
7859596|NCT00912964|19344785|P1|COMPLETED|Overall Study||367
7859597|NCT00912964|19344783|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257
7859598|NCT00912964|19344784|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254
7859599|NCT00912964|19344785|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262
7859600|NCT00912964|19344783|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426
7859601|NCT00912964|19344784|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410
7859602|NCT00912964|19344785|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415
7859603|NCT00912964|19344783|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440
7859604|NCT00912964|19344784|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432
7859605|NCT00912964|19344785|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
7859606|NCT00912964|19344783|P3|STARTED|Overall Study||440
7859607|NCT00912964|19344784|P2|STARTED|Overall Study||433
7859608|NCT00912964|19344785|P1|STARTED|Overall Study||433
7859609|NCT00912925|19344909|P2|NOT COMPLETED|Overall Study||0
7859610|NCT00912925|19344910|P1|NOT COMPLETED|Overall Study||0
7859611|NCT00912925|19344909|P2|COMPLETED|Overall Study||22
7859612|NCT00912925|19344910|P1|COMPLETED|Overall Study||23
7859613|NCT00912925|19344909|P2|STARTED|Overall Study||22
7859614|NCT00912925|19344910|P1|STARTED|Overall Study||23
7859615|NCT00912912|19344928|P1|NOT COMPLETED|Overall Study||4
7859616|NCT00912912|19344928|P1|COMPLETED|Overall Study||1
7859617|NCT00912912|19344928|P1|STARTED|Overall Study||5
7859618|NCT00912808|19344934|P2|NOT COMPLETED|Second Intervention (6 Weeks)||1
7859619|NCT00912808|19344935|P1|NOT COMPLETED|Second Intervention (6 Weeks)||1
7859620|NCT00912808|19344934|P2|COMPLETED|Second Intervention (6 Weeks)||9
7859621|NCT00912808|19344935|P1|COMPLETED|Second Intervention (6 Weeks)||8
7859622|NCT00912808|19344934|P2|Received Intervention|Second Intervention (6 Weeks)||10
7859623|NCT00912808|19344935|P1|Received Intervention|Second Intervention (6 Weeks)||9
7859624|NCT00912808|19344934|P2|STARTED|Second Intervention (6 Weeks)||10
7859625|NCT00912808|19344935|P1|STARTED|Second Intervention (6 Weeks)||9
7859626|NCT00912808|19344934|P2|NOT COMPLETED|Washout||1
7859627|NCT00912808|19344935|P1|NOT COMPLETED|Washout||0
7859628|NCT00912808|19344934|P2|COMPLETED|Washout||10
7859629|NCT00912808|19344935|P1|COMPLETED|Washout||9
7859630|NCT00912808|19344934|P2|STARTED|Washout||11
7859631|NCT00912808|19344935|P1|STARTED|Washout||9
7859632|NCT00912808|19344934|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
7859633|NCT00912808|19344935|P1|NOT COMPLETED|First Intervention (6 Weeks)||2
7859634|NCT00912808|19344934|P2|COMPLETED|First Intervention (6 Weeks)||11
7859635|NCT00912808|19344935|P1|COMPLETED|First Intervention (6 Weeks)||9
7859636|NCT00912808|19344934|P2|Received Intervention|First Intervention (6 Weeks)||12
7859637|NCT00912808|19344935|P1|Received Intervention|First Intervention (6 Weeks)||11
7859638|NCT00912808|19344934|P2|STARTED|First Intervention (6 Weeks)||12
7859639|NCT00912808|19344935|P1|STARTED|First Intervention (6 Weeks)||11
7859640|NCT00912795|19344945|P2|NOT COMPLETED|Overall Study||58
7859641|NCT00912795|19344946|P1|NOT COMPLETED|Overall Study||47
7859642|NCT00912795|19344945|P2|COMPLETED|Overall Study||17
7859643|NCT00912795|19344946|P1|COMPLETED|Overall Study||29
7859644|NCT00912795|19344945|P2|STARTED|Overall Study||75
7859645|NCT00912795|19344946|P1|STARTED|Overall Study||76
7859646|NCT00912782|19344960|P2|NOT COMPLETED|Overall Study||5
7859647|NCT00912782|19344961|P1|NOT COMPLETED|Overall Study||3
7859648|NCT00912782|19344960|P2|COMPLETED|Overall Study||20
7859649|NCT00912782|19344961|P1|COMPLETED|Overall Study||24
7859650|NCT00912782|19344960|P2|STARTED|Overall Study||25
7859651|NCT00912782|19344961|P1|STARTED|Overall Study||27
7859652|NCT00912743|19344971|P2|NOT COMPLETED|Overall Study||20
7859653|NCT00912743|19344972|P1|NOT COMPLETED|Overall Study||13
7859654|NCT00912743|19344971|P2|COMPLETED|Overall Study||0
7859655|NCT00912743|19344972|P1|COMPLETED|Overall Study||0
7859656|NCT00912743|19344971|P2|STARTED|Overall Study||20
7859657|NCT00912743|19344972|P1|STARTED|Overall Study||13
7859658|NCT00912509|19344984|P2|NOT COMPLETED|Overall Study||3
7859659|NCT00912509|19344985|P1|NOT COMPLETED|Overall Study||5
7859660|NCT00912509|19344984|P2|COMPLETED|Overall Study||7
7859661|NCT00912509|19344985|P1|COMPLETED|Overall Study||15
7859662|NCT00912509|19344984|P2|STARTED|Overall Study||10
7859663|NCT00912509|19344985|P1|STARTED|Overall Study||20
7859664|NCT00912405|19344993|P1|NOT COMPLETED|Overall Study||5
7859665|NCT00912405|19344993|P1|COMPLETED|Overall Study||45
7859666|NCT00912405|19344993|P1|STARTED|Overall Study||50
7859667|NCT00912340|19345003|P3|NOT COMPLETED|Overall Study||4
7859668|NCT00912340|19345004|P2|NOT COMPLETED|Overall Study||4
7859669|NCT00912340|19345005|P1|NOT COMPLETED|Overall Study||2
7859670|NCT00912340|19345003|P3|COMPLETED|Overall Study||0
7859671|NCT00912340|19345004|P2|COMPLETED|Overall Study||26
7859672|NCT00912340|19345005|P1|COMPLETED|Overall Study||22
7859673|NCT00912340|19345003|P3|STARTED|Overall Study||4
7859674|NCT00912340|19345004|P2|STARTED|Overall Study||30
7859675|NCT00912340|19345005|P1|STARTED|Overall Study||24
7859676|NCT00912301|19345019|P3|NOT COMPLETED|Overall Study||0
7859677|NCT00912301|19345020|P2|NOT COMPLETED|Overall Study||0
7859678|NCT00912301|19345021|P1|NOT COMPLETED|Overall Study||0
7859679|NCT00912301|19345019|P3|COMPLETED|Overall Study||13
7859680|NCT00912301|19345020|P2|COMPLETED|Overall Study||12
7859681|NCT00912301|19345021|P1|COMPLETED|Overall Study||11
7859682|NCT00912301|19345019|P3|STARTED|Overall Study||13
7859683|NCT00912301|19345020|P2|STARTED|Overall Study||12
7859684|NCT00912301|19345021|P1|STARTED|Overall Study||11
7859685|NCT00912288|19345043|P2|NOT COMPLETED|Overall Study||40
7859686|NCT00912288|19345044|P1|NOT COMPLETED|Overall Study||41
7859687|NCT00912288|19345043|P2|COMPLETED|Overall Study||2
7859688|NCT00912288|19345044|P1|COMPLETED|Overall Study||3
7859689|NCT00912288|19345043|P2|STARTED|Overall Study||42
7859690|NCT00912288|19345044|P1|STARTED|Overall Study||44
7859691|NCT00912223|19345066|P1|NOT COMPLETED|Overall Study||3
7859692|NCT00912223|19345066|P1|COMPLETED|Overall Study||62
7859693|NCT00912223|19345066|P1|STARTED|Overall Study||65
7859694|NCT00912197|19345084|P2|NOT COMPLETED|Overall Study||3
7859695|NCT00912197|19345085|P1|NOT COMPLETED|Overall Study||3
7859696|NCT00912197|19345084|P2|COMPLETED|Overall Study||10
7859697|NCT00912197|19345085|P1|COMPLETED|Overall Study||12
7859698|NCT00912197|19345084|P2|STARTED|Overall Study||13
7859699|NCT00912197|19345085|P1|STARTED|Overall Study||15
7859700|NCT00912158|19345112|P3|NOT COMPLETED|Overall Study||0
7859701|NCT00912158|19345113|P2|NOT COMPLETED|Overall Study||0
7859702|NCT00912158|19345114|P1|NOT COMPLETED|Overall Study||0
7859703|NCT00912158|19345112|P3|COMPLETED|Overall Study||41
7859704|NCT00912158|19345113|P2|COMPLETED|Overall Study||44
7859705|NCT00912158|19345114|P1|COMPLETED|Overall Study||44
7859706|NCT00912158|19345112|P3|STARTED|Overall Study||41
7859707|NCT00912158|19345113|P2|STARTED|Overall Study||44
7859708|NCT00912158|19345114|P1|STARTED|Overall Study||44
7859709|NCT00912093|19345124|P5|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
7859710|NCT00912093|19345125|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
7859711|NCT00912093|19345126|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
7859712|NCT00912093|19345127|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
7859713|NCT00912093|19345128|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
7859714|NCT00912093|19345124|P5|COMPLETED|The Open Label Extension (OLE) Phase||4
7859715|NCT00912093|19345125|P4|COMPLETED|The Open Label Extension (OLE) Phase||2
7859716|NCT00912093|19345126|P3|COMPLETED|The Open Label Extension (OLE) Phase||3
7859717|NCT00912093|19345127|P2|COMPLETED|The Open Label Extension (OLE) Phase||35
7859718|NCT00912093|19345128|P1|COMPLETED|The Open Label Extension (OLE) Phase||38
7859719|NCT00912093|19345124|P5|STARTED|The Open Label Extension (OLE) Phase||4
7859720|NCT00912093|19345125|P4|STARTED|The Open Label Extension (OLE) Phase||2
7859721|NCT00912093|19345126|P3|STARTED|The Open Label Extension (OLE) Phase||3
7859722|NCT00912093|19345127|P2|STARTED|The Open Label Extension (OLE) Phase||35
7859723|NCT00912093|19345128|P1|STARTED|The Open Label Extension (OLE) Phase||38
7859724|NCT00912093|19345124|P5|NOT COMPLETED|The Controlled Phase||1
7859725|NCT00912093|19345125|P4|NOT COMPLETED|The Controlled Phase||0
7859726|NCT00912093|19345126|P3|NOT COMPLETED|The Controlled Phase||0
7859727|NCT00912093|19345127|P2|NOT COMPLETED|The Controlled Phase||2
7859728|NCT00912093|19345128|P1|NOT COMPLETED|The Controlled Phase||0
7859729|NCT00912093|19345124|P5|COMPLETED|The Controlled Phase||4
7859730|NCT00912093|19345125|P4|COMPLETED|The Controlled Phase||2
7859731|NCT00912093|19345126|P3|COMPLETED|The Controlled Phase||3
7859732|NCT00912093|19345127|P2|COMPLETED|The Controlled Phase||43
7859733|NCT00912093|19345128|P1|COMPLETED|The Controlled Phase||43
7859734|NCT00912093|19345124|P5|STARTED|The Controlled Phase||5
7859735|NCT00912093|19345125|P4|STARTED|The Controlled Phase||2
7859736|NCT00912093|19345126|P3|STARTED|The Controlled Phase||3
7859737|NCT00912093|19345127|P2|STARTED|The Controlled Phase||45
7859738|NCT00912093|19345128|P1|STARTED|The Controlled Phase||43
7859739|NCT00912028|19345147|P5|NOT COMPLETED|Overall Study||3
7859740|NCT00912028|19345148|P4|NOT COMPLETED|Overall Study||1
7859741|NCT00912028|19345149|P3|NOT COMPLETED|Overall Study||0
7859742|NCT00912028|19345150|P2|NOT COMPLETED|Overall Study||3
7859743|NCT00912028|19345151|P1|NOT COMPLETED|Overall Study||5
7859744|NCT00912028|19345147|P5|COMPLETED|Overall Study||0
7859745|NCT00912028|19345148|P4|COMPLETED|Overall Study||16
7859746|NCT00912028|19345149|P3|COMPLETED|Overall Study||13
7859747|NCT00912028|19345150|P2|COMPLETED|Overall Study||0
7859748|NCT00912028|19345151|P1|COMPLETED|Overall Study||30
7859749|NCT00912028|19345147|P5|STARTED|Overall Study||3
7859750|NCT00912028|19345148|P4|STARTED|Overall Study||17
7859751|NCT00912028|19345149|P3|STARTED|Overall Study||13
7859752|NCT00912028|19345150|P2|STARTED|Overall Study||3
7859753|NCT00912028|19345151|P1|STARTED|Overall Study||35
7859754|NCT00912015|19345180|P4|NOT COMPLETED|Overall Study||2
7859755|NCT00912015|19345181|P3|NOT COMPLETED|Overall Study||3
7859756|NCT00912015|19345182|P2|NOT COMPLETED|Overall Study||8
7859757|NCT00912015|19345183|P1|NOT COMPLETED|Overall Study||16
7859758|NCT00912015|19345180|P4|COMPLETED|Overall Study||0
7859759|NCT00912015|19345181|P3|COMPLETED|Overall Study||22
7859760|NCT00912015|19345182|P2|COMPLETED|Overall Study||62
7859761|NCT00912015|19345183|P1|COMPLETED|Overall Study||125
7859762|NCT00912015|19345180|P4|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2
7859763|NCT00912015|19345181|P3|STARTED|Overall Study|Dose at which a patient spent the longest time.|25
7859764|NCT00912015|19345182|P2|STARTED|Overall Study|Dose at which a patient spent the longest time.|70
7859765|NCT00912015|19345183|P1|STARTED|Overall Study|Dose at which a patient spent the longest time.|141
7859766|NCT00912002|19345193|P1|NOT COMPLETED|Overall Study||0
7859767|NCT00912002|19345193|P1|COMPLETED|Overall Study||6
7859768|NCT00912002|19345193|P1|STARTED|Overall Study||6
7859769|NCT00911989|19345199|P1|NOT COMPLETED|Overall Study||1
7859770|NCT00911989|19345199|P1|COMPLETED|Overall Study||3
7859771|NCT00911989|19345199|P1|STARTED|Overall Study||4
7859772|NCT00911937|19345205|P2|NOT COMPLETED|Overall Study||95
7859773|NCT00911937|19345206|P1|NOT COMPLETED|Overall Study||87
7859774|NCT00911937|19345205|P2|COMPLETED|Overall Study||381
7859775|NCT00911937|19345206|P1|COMPLETED|Overall Study||400
7859776|NCT00911937|19345205|P2|Treated|Overall Study||463
7859777|NCT00911937|19345206|P1|Treated|Overall Study||474
7859778|NCT00911937|19345205|P2|STARTED|Overall Study||476
7859779|NCT00911937|19345206|P1|STARTED|Overall Study||487
7859780|NCT00911898|19345266|P1|NOT COMPLETED|Overall Study||0
7859781|NCT00911898|19345266|P1|COMPLETED|Overall Study||20
7859782|NCT00911898|19345266|P1|STARTED|Overall Study||20
7859783|NCT00911859|19345273|P3|NOT COMPLETED|Follow-up Period||41
7859784|NCT00911859|19345274|P2|NOT COMPLETED|Follow-up Period||46
7859785|NCT00911859|19345275|P1|NOT COMPLETED|Follow-up Period||11
7859786|NCT00911859|19345273|P3|COMPLETED|Follow-up Period||11
7859787|NCT00911859|19345274|P2|COMPLETED|Follow-up Period||7
7859788|NCT00911859|19345275|P1|COMPLETED|Follow-up Period||1
7859789|NCT00911859|19345273|P3|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52
7859790|NCT00911859|19345274|P2|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53
7859791|NCT00911859|19345275|P1|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12
7859792|NCT00911859|19345273|P3|NOT COMPLETED|Maintainance Period||21
7859793|NCT00911859|19345274|P2|NOT COMPLETED|Maintainance Period||0
7859794|NCT00911859|19345275|P1|NOT COMPLETED|Maintainance Period||0
7859795|NCT00911859|19345273|P3|COMPLETED|Maintainance Period||0
7859796|NCT00911859|19345274|P2|COMPLETED|Maintainance Period||0
7859797|NCT00911859|19345275|P1|COMPLETED|Maintainance Period||0
7859798|NCT00911859|19345273|P3|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21
7859799|NCT00911859|19345274|P2|STARTED|Maintainance Period||0
7859800|NCT00911859|19345275|P1|STARTED|Maintainance Period||0
7859801|NCT00911859|19345273|P3|NOT COMPLETED|Treatment Period||25
7859802|NCT00911859|19345274|P2|NOT COMPLETED|Treatment Period||21
7859803|NCT00911859|19345275|P1|NOT COMPLETED|Treatment Period||8
7859804|NCT00911859|19345273|P3|COMPLETED|Treatment Period||27
7859805|NCT00911859|19345274|P2|COMPLETED|Treatment Period||33
7859806|NCT00911859|19345275|P1|COMPLETED|Treatment Period||4
7859807|NCT00911859|19345273|P3|Received Treatment|Treatment Period||52
7859808|NCT00911859|19345274|P2|Received Treatment|Treatment Period||53
7859809|NCT00911859|19345275|P1|Received Treatment|Treatment Period||12
7859810|NCT00911859|19345273|P3|STARTED|Treatment Period||52
7859811|NCT00911859|19345274|P2|STARTED|Treatment Period||54
7859812|NCT00911859|19345275|P1|STARTED|Treatment Period||12
7859813|NCT00911820|19345301|P2|NOT COMPLETED|Overall Study||43
7859814|NCT00911820|19345302|P1|NOT COMPLETED|Overall Study||45
7859815|NCT00911820|19345301|P2|COMPLETED|Overall Study||0
7859816|NCT00911820|19345302|P1|COMPLETED|Overall Study||0
7859817|NCT00911820|19345301|P2|Treated|Overall Study|Randomized patients not treated: withdrew consent (n=2)|41
7859818|NCT00911820|19345302|P1|Treated|Overall Study|Randomized patients not treated: unable to confirm pathology (n=1)|44
7859819|NCT00911820|19345301|P2|STARTED|Overall Study||43
7859820|NCT00911820|19345302|P1|STARTED|Overall Study||45
7859821|NCT00911807|19345319|P3|NOT COMPLETED|Overall Study||23
7859822|NCT00911807|19345320|P2|NOT COMPLETED|Overall Study||18
7859823|NCT00911807|19345321|P1|NOT COMPLETED|Overall Study||17
7859824|NCT00911807|19345319|P3|COMPLETED|Overall Study||52
7859825|NCT00911807|19345320|P2|COMPLETED|Overall Study||52
7859826|NCT00911807|19345321|P1|COMPLETED|Overall Study||55
7859827|NCT00911807|19345319|P3|STARTED|Overall Study||75
7859828|NCT00911807|19345320|P2|STARTED|Overall Study||70
7859829|NCT00911807|19345321|P1|STARTED|Overall Study||72
7859830|NCT00911768|19345331|P2|NOT COMPLETED|Overall Study||4
7859831|NCT00911768|19345332|P1|NOT COMPLETED|Overall Study||6
7859832|NCT00911768|19345331|P2|COMPLETED|Overall Study||46
7859833|NCT00911768|19345332|P1|COMPLETED|Overall Study||44
7859834|NCT00911768|19345331|P2|STARTED|Overall Study||50
7859835|NCT00911768|19345332|P1|STARTED|Overall Study||50
7859836|NCT00911742|19345344|P2|NOT COMPLETED|Treatment Phase II||0
7859837|NCT00911742|19345345|P1|NOT COMPLETED|Treatment Phase II||0
7859838|NCT00911742|19345344|P2|COMPLETED|Treatment Phase II||13
7859839|NCT00911742|19345345|P1|COMPLETED|Treatment Phase II||13
7859840|NCT00911742|19345344|P2|STARTED|Treatment Phase II||13
7859841|NCT00911742|19345345|P1|STARTED|Treatment Phase II||13
7859842|NCT00911742|19345344|P2|NOT COMPLETED|Treatment Phase I||0
7859843|NCT00911742|19345345|P1|NOT COMPLETED|Treatment Phase I||0
7859844|NCT00911742|19345344|P2|COMPLETED|Treatment Phase I||13
7859845|NCT00911742|19345345|P1|COMPLETED|Treatment Phase I||13
7859846|NCT00911742|19345344|P2|STARTED|Treatment Phase I||13
7859847|NCT00911742|19345345|P1|STARTED|Treatment Phase I||13
7859848|NCT00911625|19345361|P2|NOT COMPLETED|Overall Study||0
7859849|NCT00911625|19345362|P1|NOT COMPLETED|Overall Study||7
7859850|NCT00911625|19345361|P2|COMPLETED|Overall Study||57
7859851|NCT00911625|19345362|P1|COMPLETED|Overall Study||50
7859852|NCT00911625|19345361|P2|STARTED|Overall Study||57
7859853|NCT00911625|19345362|P1|STARTED|Overall Study||57
7859854|NCT00911612|19345372|P2|NOT COMPLETED|Overall Study||0
7859855|NCT00911612|19345373|P1|NOT COMPLETED|Overall Study||0
7859856|NCT00911612|19345372|P2|COMPLETED|Overall Study||12
7859857|NCT00911612|19345373|P1|COMPLETED|Overall Study||12
7859858|NCT00911612|19345372|P2|STARTED|Overall Study||12
7859859|NCT00911612|19345373|P1|STARTED|Overall Study||12
7859860|NCT00911586|19345387|P1|NOT COMPLETED|Overall Study||0
7859861|NCT00911586|19345387|P1|COMPLETED|Overall Study||15
7859862|NCT00911586|19345387|P1|STARTED|Overall Study||15
7859863|NCT00911547|19345396|P4|NOT COMPLETED|Overall Study||16
7859864|NCT00911547|19345397|P3|NOT COMPLETED|Overall Study||22
7859865|NCT00911547|19345398|P2|NOT COMPLETED|Overall Study||42
7859866|NCT00911547|19345399|P1|NOT COMPLETED|Overall Study||11
7859867|NCT00911547|19345396|P4|COMPLETED|Overall Study||177
7859868|NCT00911547|19345397|P3|COMPLETED|Overall Study||178
7859869|NCT00911547|19345398|P2|COMPLETED|Overall Study||159
7859870|NCT00911547|19345399|P1|COMPLETED|Overall Study||37
7859871|NCT00911547|19345396|P4|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193
7859872|NCT00911547|19345397|P3|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200
7859873|NCT00911547|19345398|P2|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201
7859874|NCT00911547|19345399|P1|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48
7859875|NCT00911534|19345427|P2|NOT COMPLETED|Overall Study||16
7859876|NCT00911534|19345428|P1|NOT COMPLETED|Overall Study||15
7859877|NCT00911534|19345427|P2|COMPLETED|Overall Study||137
7859878|NCT00911534|19345428|P1|COMPLETED|Overall Study||132
7859879|NCT00911534|19345427|P2|STARTED|Overall Study|Randomized (treated)|153
7859880|NCT00911534|19345428|P1|STARTED|Overall Study|Randomized (treated)|147
7859881|NCT00911508|19345442|P2|NOT COMPLETED|Overall Study||130
7859882|NCT00911508|19345443|P1|NOT COMPLETED|Overall Study||106
7859883|NCT00911508|19345442|P2|COMPLETED|Overall Study||966
7859884|NCT00911508|19345443|P1|COMPLETED|Overall Study||1002
7859885|NCT00911508|19345442|P2|STARTED|Overall Study||1096
7859886|NCT00911508|19345443|P1|STARTED|Overall Study||1108
7859887|NCT00911495|19345475|P1|NOT COMPLETED|Overall Study||1
7859888|NCT00911495|19345475|P1|COMPLETED|Overall Study||14
7859889|NCT00911495|19345475|P1|STARTED|Overall Study||15
7859890|NCT00911443|19345488|P5|NOT COMPLETED|Overall Study||0
7859891|NCT00911443|19345489|P4|NOT COMPLETED|Overall Study||0
7859892|NCT00911443|19345490|P3|NOT COMPLETED|Overall Study||0
7859893|NCT00911443|19345491|P2|NOT COMPLETED|Overall Study||0
7859894|NCT00911443|19345492|P1|NOT COMPLETED|Overall Study||0
7859895|NCT00911443|19345488|P5|COMPLETED|Overall Study||97
7859896|NCT00911443|19345489|P4|COMPLETED|Overall Study||99
7859897|NCT00911443|19345490|P3|COMPLETED|Overall Study||98
7859898|NCT00911443|19345491|P2|COMPLETED|Overall Study||97
7859899|NCT00911443|19345492|P1|COMPLETED|Overall Study||97
7859900|NCT00911443|19345488|P5|STARTED|Overall Study||97
7859901|NCT00911443|19345489|P4|STARTED|Overall Study||99
7859902|NCT00911443|19345490|P3|STARTED|Overall Study||98
7859903|NCT00911443|19345491|P2|STARTED|Overall Study||97
7859904|NCT00911443|19345492|P1|STARTED|Overall Study||97
7859905|NCT00911326|19345509|P1|NOT COMPLETED|Overall Study||16
7859906|NCT00911326|19345509|P1|COMPLETED|Overall Study||85
7859907|NCT00911326|19345509|P1|STARTED|Overall Study||101
7859908|NCT00911300|19345518|P2|NOT COMPLETED|Overall Study||43
7859909|NCT00911300|19345519|P1|NOT COMPLETED|Overall Study||35
7859910|NCT00911300|19345518|P2|COMPLETED|Overall Study||131
7859911|NCT00911300|19345519|P1|COMPLETED|Overall Study||140
7859912|NCT00911300|19345518|P2|STARTED|Overall Study||174
7859913|NCT00911300|19345519|P1|STARTED|Overall Study||175
7859914|NCT00911274|19345545|P2|NOT COMPLETED|Period 2||0
7859915|NCT00911274|19345546|P1|NOT COMPLETED|Period 2||0
7859916|NCT00911274|19345545|P2|COMPLETED|Period 2||26
7859917|NCT00911274|19345546|P1|COMPLETED|Period 2||27
7859918|NCT00911274|19345545|P2|STARTED|Period 2||26
7859919|NCT00911274|19345546|P1|STARTED|Period 2||27
7859920|NCT00911274|19345545|P2|NOT COMPLETED|Period 1||0
7859921|NCT00911274|19345546|P1|NOT COMPLETED|Period 1||0
7859922|NCT00911274|19345545|P2|COMPLETED|Period 1||26
7859923|NCT00911274|19345546|P1|COMPLETED|Period 1||27
7859924|NCT00911274|19345545|P2|STARTED|Period 1||26
7859925|NCT00911274|19345546|P1|STARTED|Period 1||27
7859926|NCT00911170|19345556|P2|NOT COMPLETED|Long Term Follow-Up||422
7859927|NCT00911170|19345557|P1|NOT COMPLETED|Long Term Follow-Up||423
7859928|NCT00911170|19345556|P2|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
7859929|NCT00911170|19345557|P1|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
7859930|NCT00911170|19345556|P2|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422
7859931|NCT00911170|19345557|P1|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423
7859932|NCT00911170|19345556|P2|NOT COMPLETED|Treatment Period||37
7859933|NCT00911170|19345557|P1|NOT COMPLETED|Treatment Period||27
7859934|NCT00911170|19345556|P2|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386
7859935|NCT00911170|19345557|P1|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397
7859936|NCT00911170|19345556|P2|Received Investigational Product|Treatment Period||419
7859937|NCT00911170|19345557|P1|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422
7859938|NCT00911170|19345556|P2|Received Bevacizumab|Treatment Period||420
7859939|NCT00911170|19345557|P1|Received Bevacizumab|Treatment Period||423
7859940|NCT00911170|19345556|P2|Received Chemotherapy|Treatment Period|Primary Analysis Set|422
7859941|NCT00911170|19345557|P1|Received Chemotherapy|Treatment Period|Primary Analysis Set|423
7859942|NCT00911170|19345556|P2|STARTED|Treatment Period||423
7859943|NCT00911170|19345557|P1|STARTED|Treatment Period||424
7859944|NCT00911157|19345581|P2|NOT COMPLETED|Overall Study||2
7859945|NCT00911157|19345582|P1|NOT COMPLETED|Overall Study||7
7859946|NCT00911157|19345581|P2|COMPLETED|Overall Study||8
7859947|NCT00911157|19345582|P1|COMPLETED|Overall Study||22
7859948|NCT00911157|19345581|P2|STARTED|Overall Study||10
7859949|NCT00911157|19345582|P1|STARTED|Overall Study||29
7859950|NCT00911144|19345598|P2|NOT COMPLETED|Overall Study||5
7859951|NCT00911144|19345599|P1|NOT COMPLETED|Overall Study||16
7859952|NCT00911144|19345598|P2|COMPLETED|Overall Study||108
7859953|NCT00911144|19345599|P1|COMPLETED|Overall Study||319
7859954|NCT00911144|19345598|P2|STARTED|Overall Study||113
7859955|NCT00911144|19345599|P1|STARTED|Overall Study||335
7859956|NCT00911053|19345628|P5|NOT COMPLETED|Overall Study||0
7859957|NCT00911053|19345629|P4|NOT COMPLETED|Overall Study||0
7859958|NCT00911053|19345630|P3|NOT COMPLETED|Overall Study||0
7859959|NCT00911053|19345631|P2|NOT COMPLETED|Overall Study||0
7859960|NCT00911053|19345632|P1|NOT COMPLETED|Overall Study||0
7859961|NCT00911053|19345628|P5|COMPLETED|Overall Study||0
7859962|NCT00911053|19345629|P4|COMPLETED|Overall Study||0
7859963|NCT00911053|19345630|P3|COMPLETED|Overall Study||0
7859964|NCT00911053|19345631|P2|COMPLETED|Overall Study||0
7859965|NCT00911053|19345632|P1|COMPLETED|Overall Study||0
7859966|NCT00911053|19345628|P5|STARTED|Overall Study||0
7859967|NCT00911053|19345629|P4|STARTED|Overall Study||0
7859968|NCT00911053|19345630|P3|STARTED|Overall Study||0
7859969|NCT00911053|19345631|P2|STARTED|Overall Study||0
7859970|NCT00911053|19345632|P1|STARTED|Overall Study||0
7859971|NCT00910988|19345653|P4|NOT COMPLETED|Overall Study||0
7859972|NCT00910988|19345654|P3|NOT COMPLETED|Overall Study||3
7859973|NCT00910988|19345655|P2|NOT COMPLETED|Overall Study||4
7859974|NCT00910988|19345656|P1|NOT COMPLETED|Overall Study||2
7859975|NCT00910988|19345653|P4|COMPLETED|Overall Study||6
7859976|NCT00910988|19345654|P3|COMPLETED|Overall Study||5
7859977|NCT00910988|19345655|P2|COMPLETED|Overall Study||12
7859978|NCT00910988|19345656|P1|COMPLETED|Overall Study||14
7859979|NCT00910988|19345653|P4|STARTED|Overall Study||6
7859980|NCT00910988|19345654|P3|STARTED|Overall Study||8
7859981|NCT00910988|19345655|P2|STARTED|Overall Study||16
7859982|NCT00910988|19345656|P1|STARTED|Overall Study||16
7859983|NCT00910962|19345701|P3|NOT COMPLETED|Overall Study||76
7859984|NCT00910962|19345702|P2|NOT COMPLETED|Overall Study||78
7859985|NCT00910962|19345703|P1|NOT COMPLETED|Overall Study||43
7859986|NCT00910962|19345701|P3|COMPLETED|Overall Study||116
7859987|NCT00910962|19345702|P2|COMPLETED|Overall Study||121
7859988|NCT00910962|19345703|P1|COMPLETED|Overall Study||92
7859989|NCT00910962|19345701|P3|STARTED|Overall Study||192
7859990|NCT00910962|19345702|P2|STARTED|Overall Study||199
7859991|NCT00910962|19345703|P1|STARTED|Overall Study||135
7859992|NCT00910910|19345795|P2|NOT COMPLETED|Overall Study||224
7859993|NCT00910910|19345796|P1|NOT COMPLETED|Overall Study||225
7859994|NCT00910910|19345795|P2|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|1
7859995|NCT00910910|19345796|P1|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|0
7859996|NCT00910910|19345795|P2|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223
7859997|NCT00910910|19345796|P1|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224
7859998|NCT00910910|19345795|P2|STARTED|Overall Study||225
7859999|NCT00910910|19345796|P1|STARTED|Overall Study||225
7860000|NCT00910871|19345832|P1|NOT COMPLETED|Overall Study||54
7860001|NCT00910871|19345832|P1|COMPLETED|Overall Study||179
7860002|NCT00910871|19345832|P1|STARTED|Overall Study||233
7860003|NCT00910858|19345840|P3|NOT COMPLETED|Combined Treatment Phase||4
7860004|NCT00910858|19345841|P2|NOT COMPLETED|Combined Treatment Phase||10
7860005|NCT00910858|19345842|P1|NOT COMPLETED|Combined Treatment Phase||9
7860006|NCT00910858|19345840|P3|COMPLETED|Combined Treatment Phase||0
7860007|NCT00910858|19345841|P2|COMPLETED|Combined Treatment Phase||0
7860008|NCT00910858|19345842|P1|COMPLETED|Combined Treatment Phase||0
7860009|NCT00910858|19345840|P3|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4
7860010|NCT00910858|19345841|P2|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10
7860011|NCT00910858|19345842|P1|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9
7860012|NCT00910858|19345840|P3|NOT COMPLETED|Monotherapy Phase||7
7860013|NCT00910858|19345841|P2|NOT COMPLETED|Monotherapy Phase||15
7860014|NCT00910858|19345842|P1|NOT COMPLETED|Monotherapy Phase||17
7860015|NCT00910858|19345840|P3|COMPLETED|Monotherapy Phase||0
7860016|NCT00910858|19345841|P2|COMPLETED|Monotherapy Phase||0
7860017|NCT00910858|19345842|P1|COMPLETED|Monotherapy Phase||0
7860018|NCT00910858|19345840|P3|Pharmacokinetic Population|Monotherapy Phase||7
7860019|NCT00910858|19345841|P2|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0
7860020|NCT00910858|19345842|P1|Pharmacokinetic Population|Monotherapy Phase||17
7860021|NCT00910858|19345840|P3|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7
7860022|NCT00910858|19345841|P2|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15
7860023|NCT00910858|19345842|P1|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17
7860024|NCT00910858|19345840|P3|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7
7860025|NCT00910858|19345841|P2|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15
7860026|NCT00910858|19345842|P1|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17
7860027|NCT00910858|19345840|P3|NOT COMPLETED|Pharmacokinetic Phase||0
7860028|NCT00910858|19345841|P2|NOT COMPLETED|Pharmacokinetic Phase||0
7860029|NCT00910858|19345842|P1|NOT COMPLETED|Pharmacokinetic Phase||1
7860030|NCT00910858|19345840|P3|COMPLETED|Pharmacokinetic Phase||3
7860031|NCT00910858|19345841|P2|COMPLETED|Pharmacokinetic Phase||0
7860032|NCT00910858|19345842|P1|COMPLETED|Pharmacokinetic Phase||8
7860033|NCT00910858|19345840|P3|STARTED|Pharmacokinetic Phase||3
7860034|NCT00910858|19345841|P2|STARTED|Pharmacokinetic Phase||0
7860035|NCT00910858|19345842|P1|STARTED|Pharmacokinetic Phase||9
7860036|NCT00910845|19345867|P2|NOT COMPLETED|Treatment Cycle 2||9
7860037|NCT00910845|19345868|P1|NOT COMPLETED|Treatment Cycle 2||5
7860038|NCT00910845|19345867|P2|COMPLETED|Treatment Cycle 2||203
7860039|NCT00910845|19345868|P1|COMPLETED|Treatment Cycle 2||136
7860040|NCT00910845|19345867|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212
7860041|NCT00910845|19345868|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141
7860042|NCT00910845|19345867|P2|NOT COMPLETED|Treatment Cycle 1||34
7860043|NCT00910845|19345868|P1|NOT COMPLETED|Treatment Cycle 1||31
7860044|NCT00910845|19345867|P2|COMPLETED|Treatment Cycle 1||243
7860045|NCT00910845|19345868|P1|COMPLETED|Treatment Cycle 1||249
7860046|NCT00910845|19345867|P2|STARTED|Treatment Cycle 1||277
7860047|NCT00910845|19345868|P1|STARTED|Treatment Cycle 1||280
7860048|NCT00910728|19345887|P9|NOT COMPLETED|Overall Study||3
7860049|NCT00910728|19345888|P8|NOT COMPLETED|Overall Study||3
7860050|NCT00910728|19345889|P7|NOT COMPLETED|Overall Study||6
7860051|NCT00910728|19345890|P6|NOT COMPLETED|Overall Study||1
7860052|NCT00910728|19345891|P5|NOT COMPLETED|Overall Study||5
7860053|NCT00910728|19345892|P4|NOT COMPLETED|Overall Study||3
7860054|NCT00910728|19345893|P3|NOT COMPLETED|Overall Study||3
7860055|NCT00910728|19345894|P2|NOT COMPLETED|Overall Study||3
7860056|NCT00910728|19345895|P1|NOT COMPLETED|Overall Study||6
7860057|NCT00910728|19345887|P9|COMPLETED|Overall Study||0
7860058|NCT00910728|19345888|P8|COMPLETED|Overall Study||1
7860059|NCT00910728|19345889|P7|COMPLETED|Overall Study||0
7860060|NCT00910728|19345890|P6|COMPLETED|Overall Study||0
7860061|NCT00910728|19345891|P5|COMPLETED|Overall Study||1
7860062|NCT00910728|19345892|P4|COMPLETED|Overall Study||0
7860063|NCT00910728|19345893|P3|COMPLETED|Overall Study||0
7860064|NCT00910728|19345894|P2|COMPLETED|Overall Study||0
7860065|NCT00910728|19345895|P1|COMPLETED|Overall Study||0
7860066|NCT00910728|19345887|P9|STARTED|Overall Study||3
7860067|NCT00910728|19345888|P8|STARTED|Overall Study||4
7860068|NCT00910728|19345889|P7|STARTED|Overall Study||6
7860069|NCT00910728|19345890|P6|STARTED|Overall Study||1
7860070|NCT00910728|19345891|P5|STARTED|Overall Study||6
7860071|NCT00910728|19345892|P4|STARTED|Overall Study||3
7860072|NCT00910728|19345893|P3|STARTED|Overall Study||3
7860073|NCT00910728|19345894|P2|STARTED|Overall Study||3
7860074|NCT00910728|19345895|P1|STARTED|Overall Study||6
7860075|NCT00910715|19346017|P3|NOT COMPLETED|Overall Study||0
7860076|NCT00910715|19346018|P2|NOT COMPLETED|Overall Study||26
7860077|NCT00910715|19346019|P1|NOT COMPLETED|Overall Study||22
7860078|NCT00910715|19346017|P3|COMPLETED|Overall Study||81
7860079|NCT00910715|19346018|P2|COMPLETED|Overall Study||91
7860080|NCT00910715|19346019|P1|COMPLETED|Overall Study||86
7860081|NCT00910715|19346017|P3|STARTED|Overall Study||81
7860082|NCT00910715|19346018|P2|STARTED|Overall Study||117
7860083|NCT00910715|19346019|P1|STARTED|Overall Study||108
7860084|NCT00910689|19346033|P4|NOT COMPLETED|Months 11- 16: Evaluation Period II||6
7860085|NCT00910689|19346034|P3|NOT COMPLETED|Months 11- 16: Evaluation Period II||7
7860086|NCT00910689|19346035|P2|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
7860087|NCT00910689|19346036|P1|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
7860088|NCT00910689|19346033|P4|COMPLETED|Months 11- 16: Evaluation Period II||35
7860089|NCT00910689|19346034|P3|COMPLETED|Months 11- 16: Evaluation Period II||28
7860090|NCT00910689|19346035|P2|COMPLETED|Months 11- 16: Evaluation Period II||25
7860091|NCT00910689|19346036|P1|COMPLETED|Months 11- 16: Evaluation Period II||30
7860092|NCT00910689|19346033|P4|STARTED|Months 11- 16: Evaluation Period II||41
7860093|NCT00910689|19346034|P3|STARTED|Months 11- 16: Evaluation Period II||35
7860094|NCT00910689|19346035|P2|STARTED|Months 11- 16: Evaluation Period II||35
7860095|NCT00910689|19346036|P1|STARTED|Months 11- 16: Evaluation Period II||40
7860096|NCT00910689|19346033|P4|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
7860097|NCT00910689|19346034|P3|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
7860098|NCT00910689|19346035|P2|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
7860099|NCT00910689|19346036|P1|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4
7860100|NCT00910689|19346033|P4|COMPLETED|Months 5 - 10: Evaluation Period I||41
7860101|NCT00910689|19346034|P3|COMPLETED|Months 5 - 10: Evaluation Period I||35
7860102|NCT00910689|19346035|P2|COMPLETED|Months 5 - 10: Evaluation Period I||35
7860103|NCT00910689|19346036|P1|COMPLETED|Months 5 - 10: Evaluation Period I||40
7860104|NCT00910689|19346033|P4|STARTED|Months 5 - 10: Evaluation Period I||48
7860105|NCT00910689|19346034|P3|STARTED|Months 5 - 10: Evaluation Period I||42
7860106|NCT00910689|19346035|P2|STARTED|Months 5 - 10: Evaluation Period I||42
7860107|NCT00910689|19346036|P1|STARTED|Months 5 - 10: Evaluation Period I||44
7860108|NCT00910689|19346033|P4|NOT COMPLETED|Month 2- 4: Treatment Period||11
7860109|NCT00910689|19346034|P3|NOT COMPLETED|Month 2- 4: Treatment Period||8
7860110|NCT00910689|19346035|P2|NOT COMPLETED|Month 2- 4: Treatment Period||10
7860111|NCT00910689|19346036|P1|NOT COMPLETED|Month 2- 4: Treatment Period||9
7860112|NCT00910689|19346033|P4|COMPLETED|Month 2- 4: Treatment Period||48
7860113|NCT00910689|19346034|P3|COMPLETED|Month 2- 4: Treatment Period||42
7860114|NCT00910689|19346035|P2|COMPLETED|Month 2- 4: Treatment Period||42
7860115|NCT00910689|19346036|P1|COMPLETED|Month 2- 4: Treatment Period||44
7860116|NCT00910689|19346033|P4|STARTED|Month 2- 4: Treatment Period||59
7860117|NCT00910689|19346034|P3|STARTED|Month 2- 4: Treatment Period||50
7860118|NCT00910689|19346035|P2|STARTED|Month 2- 4: Treatment Period||52
7860119|NCT00910689|19346036|P1|STARTED|Month 2- 4: Treatment Period||53
7860120|NCT00910689|19346033|P4|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10
7860121|NCT00910689|19346034|P3|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5
7860122|NCT00910689|19346035|P2|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1
7860123|NCT00910689|19346036|P1|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2
7860124|NCT00910689|19346033|P4|COMPLETED|Month 1: Optimal Acute Therapy Run in||59
7860125|NCT00910689|19346034|P3|COMPLETED|Month 1: Optimal Acute Therapy Run in||50
7860126|NCT00910689|19346035|P2|COMPLETED|Month 1: Optimal Acute Therapy Run in||52
7860127|NCT00910689|19346036|P1|COMPLETED|Month 1: Optimal Acute Therapy Run in||53
7860128|NCT00910689|19346033|P4|STARTED|Month 1: Optimal Acute Therapy Run in||69
7860129|NCT00910689|19346034|P3|STARTED|Month 1: Optimal Acute Therapy Run in||55
7860130|NCT00910689|19346035|P2|STARTED|Month 1: Optimal Acute Therapy Run in||53
7860131|NCT00910689|19346036|P1|STARTED|Month 1: Optimal Acute Therapy Run in||55
7860132|NCT00910663|19346068|P2|NOT COMPLETED|Period 2||0
7860133|NCT00910663|19346069|P1|NOT COMPLETED|Period 2||0
7860134|NCT00910663|19346068|P2|COMPLETED|Period 2||29
7860135|NCT00910663|19346069|P1|COMPLETED|Period 2||30
7860136|NCT00910663|19346068|P2|STARTED|Period 2||29
7860137|NCT00910663|19346069|P1|STARTED|Period 2||30
7860138|NCT00910663|19346068|P2|NOT COMPLETED|Period 1||1
7860139|NCT00910663|19346069|P1|NOT COMPLETED|Period 1||0
7860140|NCT00910663|19346068|P2|COMPLETED|Period 1||29
7860141|NCT00910663|19346069|P1|COMPLETED|Period 1||30
7860142|NCT00910663|19346068|P2|STARTED|Period 1||30
7860143|NCT00910663|19346069|P1|STARTED|Period 1||30
7860144|NCT00910624|19346083|P4|NOT COMPLETED|Follow-Up Phase||0
7860145|NCT00910624|19346084|P3|NOT COMPLETED|Follow-Up Phase||4
7860146|NCT00910624|19346085|P2|NOT COMPLETED|Follow-Up Phase||4
7860147|NCT00910624|19346086|P1|NOT COMPLETED|Follow-Up Phase||6
7860148|NCT00910624|19346083|P4|COMPLETED|Follow-Up Phase||2
7860149|NCT00910624|19346084|P3|COMPLETED|Follow-Up Phase||25
7860150|NCT00910624|19346085|P2|COMPLETED|Follow-Up Phase||76
7860151|NCT00910624|19346086|P1|COMPLETED|Follow-Up Phase||42
7860152|NCT00910624|19346083|P4|STARTED|Follow-Up Phase||2
7860153|NCT00910624|19346084|P3|STARTED|Follow-Up Phase||29
7860154|NCT00910624|19346085|P2|STARTED|Follow-Up Phase||80
7860155|NCT00910624|19346086|P1|STARTED|Follow-Up Phase||48
7860156|NCT00910624|19346083|P4|NOT COMPLETED|Treatment Phase||0
7860157|NCT00910624|19346084|P3|NOT COMPLETED|Treatment Phase||9
7860158|NCT00910624|19346085|P2|NOT COMPLETED|Treatment Phase||21
7860159|NCT00910624|19346086|P1|NOT COMPLETED|Treatment Phase||30
7860160|NCT00910624|19346083|P4|COMPLETED|Treatment Phase||2
7860161|NCT00910624|19346084|P3|COMPLETED|Treatment Phase||20
7860162|NCT00910624|19346085|P2|COMPLETED|Treatment Phase||64
7860163|NCT00910624|19346086|P1|COMPLETED|Treatment Phase||22
7860164|NCT00910624|19346083|P4|STARTED|Treatment Phase||2
7860165|NCT00910624|19346084|P3|STARTED|Treatment Phase||29
7860166|NCT00910624|19346085|P2|STARTED|Treatment Phase||85
7860167|NCT00910624|19346086|P1|STARTED|Treatment Phase||52
7860168|NCT00910520|19346100|P2|NOT COMPLETED|Treatment Cycle 2||8
7860169|NCT00910520|19346101|P1|NOT COMPLETED|Treatment Cycle 2||7
7860170|NCT00910520|19346100|P2|COMPLETED|Treatment Cycle 2||215
7860171|NCT00910520|19346101|P1|COMPLETED|Treatment Cycle 2||156
7860172|NCT00910520|19346100|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223
7860173|NCT00910520|19346101|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163
7860174|NCT00910520|19346100|P2|NOT COMPLETED|Treatment Cycle 1||24
7860175|NCT00910520|19346101|P1|NOT COMPLETED|Treatment Cycle 1||20
7860176|NCT00910520|19346100|P2|COMPLETED|Treatment Cycle 1||247
7860177|NCT00910520|19346101|P1|COMPLETED|Treatment Cycle 1||257
7860178|NCT00910520|19346100|P2|STARTED|Treatment Cycle 1||271
7860179|NCT00910520|19346101|P1|STARTED|Treatment Cycle 1||277
7860180|NCT00910429|19346113|P2|NOT COMPLETED|Overall Study||21
7860181|NCT00910429|19346114|P1|NOT COMPLETED|Overall Study||39
7860182|NCT00910429|19346113|P2|COMPLETED|Overall Study|Completed treatment|61
7860183|NCT00910429|19346114|P1|COMPLETED|Overall Study|Completed treatment|116
7860184|NCT00910429|19346113|P2|STARTED|Overall Study||82
7860185|NCT00910429|19346114|P1|STARTED|Overall Study||155
7860186|NCT00910299|19346176|P2|NOT COMPLETED|Overall Study||74
7860187|NCT00910299|19346177|P1|NOT COMPLETED|Overall Study||76
7860188|NCT00910299|19346176|P2|COMPLETED|Overall Study|"1 participant died of sepsis while on study drug and was considered a protocol completer."|137
7860189|NCT00910299|19346177|P1|COMPLETED|Overall Study||136
7860190|NCT00910299|19346176|P2|Received at Least 1 Dose of Study Drug|Overall Study||210
7860191|NCT00910299|19346177|P1|Received at Least 1 Dose of Study Drug|Overall Study||210
7860192|NCT00910299|19346176|P2|STARTED|Overall Study||211
7860193|NCT00910299|19346177|P1|STARTED|Overall Study||212
7860194|NCT00910273|19346189|P2|NOT COMPLETED|Overall Study||13
7860195|NCT00910273|19346190|P1|NOT COMPLETED|Overall Study||18
7860196|NCT00910273|19346189|P2|COMPLETED|Overall Study||3
7860197|NCT00910273|19346190|P1|COMPLETED|Overall Study||0
7860198|NCT00910273|19346189|P2|STARTED|Overall Study||16
7860199|NCT00910273|19346190|P1|STARTED|Overall Study||18
7860200|NCT00910247|19346240|P1|NOT COMPLETED|Overall Study||69
7860201|NCT00910247|19346240|P1|COMPLETED|Overall Study||205
7860202|NCT00910247|19346240|P1|STARTED|Overall Study||274
7860203|NCT00910208|19346263|P3|NOT COMPLETED|Overall Study||1
7860204|NCT00910208|19346264|P2|NOT COMPLETED|Overall Study||2
7860205|NCT00910208|19346265|P1|NOT COMPLETED|Overall Study||2
7860206|NCT00910208|19346263|P3|COMPLETED|Overall Study||69
7860207|NCT00910208|19346264|P2|COMPLETED|Overall Study||70
7860208|NCT00910208|19346265|P1|COMPLETED|Overall Study||67
7860209|NCT00910208|19346263|P3|STARTED|Overall Study||70
7860210|NCT00910208|19346264|P2|STARTED|Overall Study||72
7860211|NCT00910208|19346265|P1|STARTED|Overall Study||69
7860212|NCT00910091|19346290|P2|NOT COMPLETED|Treatment and Survival||4
7860213|NCT00910091|19346291|P1|NOT COMPLETED|Treatment and Survival||4
7860214|NCT00910091|19346290|P2|COMPLETED|Treatment and Survival||31
7860215|NCT00910091|19346291|P1|COMPLETED|Treatment and Survival||32
7860216|NCT00910091|19346290|P2|STARTED|Treatment and Survival||35
7860217|NCT00910091|19346291|P1|STARTED|Treatment and Survival||36
7860218|NCT00910091|19346290|P2|NOT COMPLETED|Pre-assignment||2
7860219|NCT00910091|19346291|P1|NOT COMPLETED|Pre-assignment||0
7860220|NCT00910091|19346290|P2|COMPLETED|Pre-assignment||35
7860221|NCT00910091|19346291|P1|COMPLETED|Pre-assignment||36
7860222|NCT00910091|19346290|P2|STARTED|Pre-assignment||37
7860223|NCT00910091|19346291|P1|STARTED|Pre-assignment||36
7860224|NCT00910039|19346319|P1|NOT COMPLETED|Overall Study||1
7860225|NCT00910039|19346319|P1|COMPLETED|Overall Study||13
7860226|NCT00910039|19346319|P1|STARTED|Overall Study||14
7860227|NCT00910000|19346336|P6|NOT COMPLETED|Overall Study||1
7860228|NCT00910000|19346337|P5|NOT COMPLETED|Overall Study||1
7860229|NCT00910000|19346338|P4|NOT COMPLETED|Overall Study||2
7860230|NCT00910000|19346339|P3|NOT COMPLETED|Overall Study||3
7860231|NCT00910000|19346340|P2|NOT COMPLETED|Overall Study||3
7860232|NCT00910000|19346341|P1|NOT COMPLETED|Overall Study||0
7860233|NCT00910000|19346336|P6|COMPLETED|Overall Study||0
7860234|NCT00910000|19346337|P5|COMPLETED|Overall Study||2
7860235|NCT00910000|19346338|P4|COMPLETED|Overall Study||0
7860236|NCT00910000|19346339|P3|COMPLETED|Overall Study||0
7860237|NCT00910000|19346340|P2|COMPLETED|Overall Study||0
7860238|NCT00910000|19346341|P1|COMPLETED|Overall Study||3
7860239|NCT00910000|19346336|P6|STARTED|Overall Study||1
7860240|NCT00910000|19346337|P5|STARTED|Overall Study||3
7860241|NCT00910000|19346338|P4|STARTED|Overall Study||2
7860242|NCT00910000|19346339|P3|STARTED|Overall Study||3
7860243|NCT00910000|19346340|P2|STARTED|Overall Study||3
7860244|NCT00910000|19346341|P1|STARTED|Overall Study||3
7860245|NCT00909870|19346359|P2|NOT COMPLETED|Overall Study||27
7860246|NCT00909870|19346360|P1|NOT COMPLETED|Overall Study||23
7860247|NCT00909870|19346359|P2|COMPLETED|Overall Study||236
7860248|NCT00909870|19346360|P1|COMPLETED|Overall Study||251
7860249|NCT00909870|19346359|P2|STARTED|Overall Study||263
7860250|NCT00909870|19346360|P1|STARTED|Overall Study||274
7860251|NCT00909857|19346372|P2|NOT COMPLETED|Overall Study||45
7860252|NCT00909857|19346373|P1|NOT COMPLETED|Overall Study||36
7860253|NCT00909857|19346372|P2|COMPLETED|Overall Study||209
7860254|NCT00909857|19346373|P1|COMPLETED|Overall Study||217
7860255|NCT00909857|19346372|P2|Treated|Overall Study||230
7860256|NCT00909857|19346373|P1|Treated|Overall Study||234
7860257|NCT00909857|19346372|P2|STARTED|Overall Study||254
7860258|NCT00909857|19346373|P1|STARTED|Overall Study||253
7860259|NCT00909844|19346513|P1|NOT COMPLETED|Overall Study||4
7860260|NCT00909844|19346513|P1|COMPLETED|Overall Study||31
7860261|NCT00909844|19346513|P1|STARTED|Overall Study||35
7860262|NCT00909792|19346531|P2|NOT COMPLETED|Period 2||1
7860263|NCT00909792|19346532|P1|NOT COMPLETED|Period 2||1
7860264|NCT00909792|19346531|P2|COMPLETED|Period 2||124
7860265|NCT00909792|19346532|P1|COMPLETED|Period 2||128
7860266|NCT00909792|19346531|P2|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125
7860267|NCT00909792|19346532|P1|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129
7860268|NCT00909792|19346531|P2|NOT COMPLETED|Period 1||1
7860269|NCT00909792|19346532|P1|NOT COMPLETED|Period 1||0
7860270|NCT00909792|19346531|P2|COMPLETED|Period 1||127
7860271|NCT00909792|19346532|P1|COMPLETED|Period 1||130
7860272|NCT00909792|19346531|P2|STARTED|Period 1||128
7860273|NCT00909792|19346532|P1|STARTED|Period 1||130
7860274|NCT00909779|19346540|P2|NOT COMPLETED|Overall Study||165
7860275|NCT00909779|19346541|P1|NOT COMPLETED|Overall Study||210
7860276|NCT00909779|19346540|P2|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255
7860277|NCT00909779|19346541|P1|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211
7860278|NCT00909779|19346540|P2|STARTED|Overall Study||420
7860279|NCT00909779|19346541|P1|STARTED|Overall Study||421
7860280|NCT00909753|19346565|P2|NOT COMPLETED|Period: Second Intervention||0
7860281|NCT00909753|19346566|P1|NOT COMPLETED|Period: Second Intervention||1
7860282|NCT00909753|19346565|P2|COMPLETED|Period: Second Intervention||43
7860283|NCT00909753|19346566|P1|COMPLETED|Period: Second Intervention||43
7860284|NCT00909753|19346565|P2|STARTED|Period: Second Intervention||43
7860285|NCT00909753|19346566|P1|STARTED|Period: Second Intervention||44
7860286|NCT00909753|19346565|P2|NOT COMPLETED|Period: Washout of 28 Days||3
7860287|NCT00909753|19346566|P1|NOT COMPLETED|Period: Washout of 28 Days||2
7860288|NCT00909753|19346565|P2|COMPLETED|Period: Washout of 28 Days||43
7860289|NCT00909753|19346566|P1|COMPLETED|Period: Washout of 28 Days||44
7860290|NCT00909753|19346565|P2|STARTED|Period: Washout of 28 Days||46
7860291|NCT00909753|19346566|P1|STARTED|Period: Washout of 28 Days||46
7860292|NCT00909753|19346565|P2|NOT COMPLETED|Period: First Intervention||0
7860293|NCT00909753|19346566|P1|NOT COMPLETED|Period: First Intervention||0
7860294|NCT00909753|19346565|P2|COMPLETED|Period: First Intervention||46
7860295|NCT00909753|19346566|P1|COMPLETED|Period: First Intervention||46
7860296|NCT00909753|19346565|P2|STARTED|Period: First Intervention||46
7860297|NCT00909753|19346566|P1|STARTED|Period: First Intervention||46
7860298|NCT00909727|19346586|P2|NOT COMPLETED|Overall Study||0
7860299|NCT00909727|19346587|P1|NOT COMPLETED|Overall Study||4
7860300|NCT00909727|19346586|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26
7860301|NCT00909727|19346587|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22
7860302|NCT00909727|19346586|P2|Completed Treatment Period, Week 24|Overall Study||26
7860303|NCT00909727|19346587|P1|Completed Treatment Period, Week 24|Overall Study||23
7860304|NCT00909727|19346586|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26
7860305|NCT00909727|19346587|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26
7860306|NCT00909649|19346603|P2|NOT COMPLETED|Overall Study||0
7860307|NCT00909649|19346604|P1|NOT COMPLETED|Overall Study||0
7860308|NCT00909649|19346603|P2|COMPLETED|Overall Study||25
7860309|NCT00909649|19346604|P1|COMPLETED|Overall Study||25
7860310|NCT00909649|19346603|P2|STARTED|Overall Study||25
7860311|NCT00909649|19346604|P1|STARTED|Overall Study||25
7860312|NCT00909610|19346610|P2|NOT COMPLETED|Period: Second Intervention||0
7860313|NCT00909610|19346611|P1|NOT COMPLETED|Period: Second Intervention||1
7860314|NCT00909610|19346610|P2|COMPLETED|Period: Second Intervention||33
7860315|NCT00909610|19346611|P1|COMPLETED|Period: Second Intervention||36
7860316|NCT00909610|19346610|P2|STARTED|Period: Second Intervention||33
7860317|NCT00909610|19346611|P1|STARTED|Period: Second Intervention||37
7860318|NCT00909610|19346610|P2|NOT COMPLETED|Period: Washout of 28 Days||6
7860319|NCT00909610|19346611|P1|NOT COMPLETED|Period: Washout of 28 Days||3
7860320|NCT00909610|19346610|P2|COMPLETED|Period: Washout of 28 Days||33
7860321|NCT00909610|19346611|P1|COMPLETED|Period: Washout of 28 Days||37
7860322|NCT00909610|19346610|P2|STARTED|Period: Washout of 28 Days||39
7860323|NCT00909610|19346611|P1|STARTED|Period: Washout of 28 Days||40
7860324|NCT00909610|19346610|P2|NOT COMPLETED|Period: First Intervention||1
7860325|NCT00909610|19346611|P1|NOT COMPLETED|Period: First Intervention||0
7860326|NCT00909610|19346610|P2|COMPLETED|Period: First Intervention||39
7860327|NCT00909610|19346611|P1|COMPLETED|Period: First Intervention||40
7860328|NCT00909610|19346610|P2|STARTED|Period: First Intervention||40
7860329|NCT00909610|19346611|P1|STARTED|Period: First Intervention||40
7860330|NCT00909545|19346633|P4|NOT COMPLETED|Overall Study||5
7860331|NCT00909545|19346634|P3|NOT COMPLETED|Overall Study||1
7860332|NCT00909545|19346635|P2|NOT COMPLETED|Overall Study||1
7860333|NCT00909545|19346636|P1|NOT COMPLETED|Overall Study||1
7860334|NCT00909545|19346633|P4|COMPLETED|Overall Study||19
7860335|NCT00909545|19346634|P3|COMPLETED|Overall Study||25
7860336|NCT00909545|19346635|P2|COMPLETED|Overall Study||22
7860337|NCT00909545|19346636|P1|COMPLETED|Overall Study||25
7860338|NCT00909545|19346633|P4|STARTED|Overall Study||24
7860339|NCT00909545|19346634|P3|STARTED|Overall Study||26
7860340|NCT00909545|19346635|P2|STARTED|Overall Study||23
7860341|NCT00909545|19346636|P1|STARTED|Overall Study||26
7860342|NCT00909532|19346772|P2|NOT COMPLETED|Overall Study||6
7860343|NCT00909532|19346773|P1|NOT COMPLETED|Overall Study||10
7860344|NCT00909532|19346772|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77
7860345|NCT00909532|19346773|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68
7860346|NCT00909532|19346772|P2|Completed Treatment Period, Week 24|Overall Study||80
7860347|NCT00909532|19346773|P1|Completed Treatment Period, Week 24|Overall Study||71
7860348|NCT00909532|19346772|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83
7860349|NCT00909532|19346773|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78
7860350|NCT00909480|19346791|P2|NOT COMPLETED|Overall Study||41
7860351|NCT00909480|19346792|P1|NOT COMPLETED|Overall Study||38
7860352|NCT00909480|19346791|P2|COMPLETED|Overall Study||188
7860353|NCT00909480|19346792|P1|COMPLETED|Overall Study||190
7860354|NCT00909480|19346791|P2|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227
7860355|NCT00909480|19346792|P1|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226
7860356|NCT00909480|19346791|P2|STARTED|Overall Study||229
7860357|NCT00909480|19346792|P1|STARTED|Overall Study||228
7860358|NCT00909428|19346827|P3|NOT COMPLETED|Overall Study||9
7860359|NCT00909428|19346828|P2|NOT COMPLETED|Overall Study||10
7860360|NCT00909428|19346829|P1|NOT COMPLETED|Overall Study||13
7860361|NCT00909428|19346827|P3|COMPLETED|Overall Study||0
7860362|NCT00909428|19346828|P2|COMPLETED|Overall Study||5
7860363|NCT00909428|19346829|P1|COMPLETED|Overall Study||5
7860364|NCT00909428|19346827|P3|STARTED|Overall Study||9
7860365|NCT00909428|19346828|P2|STARTED|Overall Study||15
7860366|NCT00909428|19346829|P1|STARTED|Overall Study||18
7860367|NCT00909389|19346836|P1|NOT COMPLETED|Overall Study||133
7860368|NCT00909389|19346836|P1|COMPLETED|Overall Study||4615
7860369|NCT00909389|19346836|P1|STARTED|Overall Study||4748
7860370|NCT00909363|19346843|P3|NOT COMPLETED|Overall Study||0
7860371|NCT00909363|19346844|P2|NOT COMPLETED|Overall Study||0
7860372|NCT00909363|19346845|P1|NOT COMPLETED|Overall Study||2
7860373|NCT00909363|19346843|P3|COMPLETED|Overall Study||5
7860374|NCT00909363|19346844|P2|COMPLETED|Overall Study||8
7860375|NCT00909363|19346845|P1|COMPLETED|Overall Study|1 patient started bleeding 3 days after starting eltrombopag; he underwent bone marrow transplant|9
7860376|NCT00909363|19346843|P3|STARTED|Overall Study||5
7860377|NCT00909363|19346844|P2|STARTED|Overall Study||8
7860378|NCT00909363|19346845|P1|STARTED|Overall Study||11
7860379|NCT00909324|19346864|P2|NOT COMPLETED|Overall Study||0
7860380|NCT00909324|19346865|P1|NOT COMPLETED|Overall Study||0
7860381|NCT00909324|19346864|P2|COMPLETED|Overall Study||90
7860382|NCT00909324|19346865|P1|COMPLETED|Overall Study||72
7860383|NCT00909324|19346864|P2|STARTED|Overall Study||90
7860384|NCT00909324|19346865|P1|STARTED|Overall Study||72
7860385|NCT00909220|19346877|P2|NOT COMPLETED|Overall Study||0
7860386|NCT00909220|19346878|P1|NOT COMPLETED|Overall Study||0
7860387|NCT00909220|19346877|P2|COMPLETED|Overall Study||36
7860388|NCT00909220|19346878|P1|COMPLETED|Overall Study||41
7860389|NCT00909220|19346877|P2|Submission for Publication|Overall Study||36
7860390|NCT00909220|19346878|P1|Submission for Publication|Overall Study||41
7860391|NCT00909220|19346877|P2|Data Analyses|Overall Study||36
7860392|NCT00909220|19346878|P1|Data Analyses|Overall Study||41
7860393|NCT00909220|19346877|P2|Data Entry|Overall Study||36
7860394|NCT00909220|19346878|P1|Data Entry|Overall Study||41
7860395|NCT00909220|19346877|P2|STARTED|Overall Study|Started enrolling participants May 2009|36
7860396|NCT00909220|19346878|P1|STARTED|Overall Study|Started enrolling participants May 2009|41
7860397|NCT00909181|19346892|P3|NOT COMPLETED|Overall Study||33
7860398|NCT00909181|19346893|P2|NOT COMPLETED|Overall Study||18
7860399|NCT00909181|19346894|P1|NOT COMPLETED|Overall Study||39
7860400|NCT00909181|19346892|P3|COMPLETED|Overall Study||169
7860401|NCT00909181|19346893|P2|COMPLETED|Overall Study||196
7860402|NCT00909181|19346894|P1|COMPLETED|Overall Study||171
7860403|NCT00909181|19346892|P3|STARTED|Overall Study||202
7860404|NCT00909181|19346893|P2|STARTED|Overall Study||214
7860405|NCT00909181|19346894|P1|STARTED|Overall Study||210
7860406|NCT00909155|19346905|P3|NOT COMPLETED|Overall Study||7
7860407|NCT00909155|19346906|P2|NOT COMPLETED|Overall Study||5
7860408|NCT00909155|19346907|P1|NOT COMPLETED|Overall Study||3
7860409|NCT00909155|19346905|P3|COMPLETED|Overall Study||14
7860410|NCT00909155|19346906|P2|COMPLETED|Overall Study||9
7860411|NCT00909155|19346907|P1|COMPLETED|Overall Study||12
7860412|NCT00909155|19346905|P3|STARTED|Overall Study||21
7860413|NCT00909155|19346906|P2|STARTED|Overall Study||14
7860414|NCT00909155|19346907|P1|STARTED|Overall Study||15
7860415|NCT00909090|19346920|P2|NOT COMPLETED|Overall Study||17
7860416|NCT00909090|19346921|P1|NOT COMPLETED|Overall Study||17
7860417|NCT00909090|19346920|P2|COMPLETED|Overall Study||39
7860418|NCT00909090|19346921|P1|COMPLETED|Overall Study||36
7860419|NCT00909090|19346920|P2|STARTED|Overall Study||56
7860420|NCT00909090|19346921|P1|STARTED|Overall Study||53
7860421|NCT00909064|19346933|P1|NOT COMPLETED|Overall Study||0
7860422|NCT00909064|19346933|P1|COMPLETED|Overall Study||114
7860423|NCT00909064|19346933|P1|STARTED|Overall Study||114
7860424|NCT00909038|19346939|P1|NOT COMPLETED|Overall Study||417
7860425|NCT00909038|19346939|P1|COMPLETED|Overall Study||1994
7860426|NCT00909038|19346939|P1|STARTED|Overall Study||2411
7860427|NCT00908960|19346951|P3|NOT COMPLETED|Overall Study||2
7860428|NCT00908960|19346952|P2|NOT COMPLETED|Overall Study||1
7860429|NCT00908960|19346953|P1|NOT COMPLETED|Overall Study||1
7860430|NCT00908960|19346951|P3|COMPLETED|Overall Study||32
7860431|NCT00908960|19346952|P2|COMPLETED|Overall Study||11
7860432|NCT00908960|19346953|P1|COMPLETED|Overall Study||23
7860433|NCT00908960|19346951|P3|Evaluable|Overall Study||32
7860434|NCT00908960|19346952|P2|Evaluable|Overall Study||11
7860435|NCT00908960|19346953|P1|Evaluable|Overall Study||23
7860436|NCT00908960|19346951|P3|STARTED|Overall Study||34
7860437|NCT00908960|19346952|P2|STARTED|Overall Study||12
7860438|NCT00908960|19346953|P1|STARTED|Overall Study||24
7860439|NCT00908947|19346967|P1|NOT COMPLETED|Overall Study||90
7860440|NCT00908947|19346967|P1|COMPLETED|Overall Study||83
7860441|NCT00908947|19346967|P1|STARTED|Overall Study||173
7860442|NCT00908908|19346989|P1|NOT COMPLETED|Overall Study||0
7860443|NCT00908908|19346989|P1|COMPLETED|Overall Study||6
7860444|NCT00908908|19346989|P1|Physician Decision|Overall Study||0
7860445|NCT00908908|19346989|P1|Administrative/Other|Overall Study||0
7860446|NCT00908908|19346989|P1|Withdrawl by Subject|Overall Study||0
7860447|NCT00908908|19346989|P1|Adverse Event|Overall Study||0
7860448|NCT00908908|19346989|P1|STARTED|Overall Study||6
7860449|NCT00908895|19346997|P2|NOT COMPLETED|Overall Study||6
7860450|NCT00908895|19346998|P1|NOT COMPLETED|Overall Study||4
7860451|NCT00908895|19346997|P2|COMPLETED|Overall Study||57
7860452|NCT00908895|19346998|P1|COMPLETED|Overall Study||53
7860453|NCT00908895|19346997|P2|STARTED|Overall Study||63
7860454|NCT00908895|19346998|P1|STARTED|Overall Study||57
7860455|NCT00908882|19347008|P2|NOT COMPLETED|Overall Study||30
7860456|NCT00908882|19347009|P1|NOT COMPLETED|Overall Study||28
7860457|NCT00908882|19347008|P2|COMPLETED|Overall Study||59
7860458|NCT00908882|19347009|P1|COMPLETED|Overall Study||61
7860459|NCT00908882|19347008|P2|STARTED|Overall Study||89
7860460|NCT00908882|19347009|P1|STARTED|Overall Study||89
7860461|NCT00908830|19347035|P2|NOT COMPLETED|Overall Study||0
7860462|NCT00908830|19347036|P1|NOT COMPLETED|Overall Study||0
7860463|NCT00908830|19347035|P2|COMPLETED|Overall Study||5
7860464|NCT00908830|19347036|P1|COMPLETED|Overall Study||5
7860465|NCT00908830|19347035|P2|STARTED|Overall Study||5
7860466|NCT00908830|19347036|P1|STARTED|Overall Study||5
7860467|NCT00908791|19347044|P1|NOT COMPLETED|Overall Study||0
7860468|NCT00908791|19347044|P1|COMPLETED|Overall Study||24
7860469|NCT00908791|19347044|P1|STARTED|Overall Study||24
7860470|NCT00908687|19347067|P6|NOT COMPLETED|Overall Study||6
7860471|NCT00908687|19347068|P5|NOT COMPLETED|Overall Study||4
7860472|NCT00908687|19347069|P4|NOT COMPLETED|Overall Study||3
7860473|NCT00908687|19347070|P3|NOT COMPLETED|Overall Study||3
7860474|NCT00908687|19347071|P2|NOT COMPLETED|Overall Study||1
7860475|NCT00908687|19347072|P1|NOT COMPLETED|Overall Study||1
7860476|NCT00908687|19347067|P6|COMPLETED|Overall Study||94
7860477|NCT00908687|19347068|P5|COMPLETED|Overall Study||94
7860478|NCT00908687|19347069|P4|COMPLETED|Overall Study||47
7860479|NCT00908687|19347070|P3|COMPLETED|Overall Study||99
7860480|NCT00908687|19347071|P2|COMPLETED|Overall Study||99
7860481|NCT00908687|19347072|P1|COMPLETED|Overall Study||49
7860482|NCT00908687|19347067|P6|STARTED|Overall Study||100
7860483|NCT00908687|19347068|P5|STARTED|Overall Study||98
7860484|NCT00908687|19347069|P4|STARTED|Overall Study||50
7860485|NCT00908687|19347070|P3|STARTED|Overall Study||102
7860486|NCT00908687|19347071|P2|STARTED|Overall Study||100
7860487|NCT00908687|19347072|P1|STARTED|Overall Study||50
7860488|NCT00908648|19347088|P2|NOT COMPLETED|Overall Study||0
7860489|NCT00908648|19347089|P1|NOT COMPLETED|Overall Study||0
7860490|NCT00908648|19347088|P2|COMPLETED|Overall Study||103
7860491|NCT00908648|19347089|P1|COMPLETED|Overall Study||108
7860492|NCT00908648|19347088|P2|STARTED|Overall Study||103
7860493|NCT00908648|19347089|P1|STARTED|Overall Study||108
7860494|NCT00908596|19347099|P4|NOT COMPLETED|Overall Study||37
7860495|NCT00908596|19347100|P3|NOT COMPLETED|Overall Study||74
7860496|NCT00908596|19347101|P2|NOT COMPLETED|Overall Study||13
7860497|NCT00908596|19347102|P1|NOT COMPLETED|Overall Study||47
7860498|NCT00908596|19347099|P4|COMPLETED|Overall Study||48
7860499|NCT00908596|19347100|P3|COMPLETED|Overall Study||119
7860500|NCT00908596|19347101|P2|COMPLETED|Overall Study||19
7860501|NCT00908596|19347102|P1|COMPLETED|Overall Study||0
7860502|NCT00908596|19347099|P4|STARTED|Overall Study||85
7860503|NCT00908596|19347100|P3|STARTED|Overall Study||193
7860504|NCT00908596|19347101|P2|STARTED|Overall Study||32
7860505|NCT00908596|19347102|P1|STARTED|Overall Study||47
7860506|NCT00908583|19347132|P1|NOT COMPLETED|Phase 5||3
7860507|NCT00908583|19347132|P1|COMPLETED|Phase 5||2
7860508|NCT00908583|19347132|P1|STARTED|Phase 5||5
7860509|NCT00908583|19347132|P1|NOT COMPLETED|Phase 4||2
7860510|NCT00908583|19347132|P1|COMPLETED|Phase 4||3
7860511|NCT00908583|19347132|P1|STARTED|Phase 4||5
7860512|NCT00908583|19347132|P1|NOT COMPLETED|Phase 3||2
7860513|NCT00908583|19347132|P1|COMPLETED|Phase 3||8
7860514|NCT00908583|19347132|P1|STARTED|Phase 3||10
7860515|NCT00908583|19347132|P1|NOT COMPLETED|Phase 2||2
7860516|NCT00908583|19347132|P1|COMPLETED|Phase 2||10
7860517|NCT00908583|19347132|P1|STARTED|Phase 2||12
7860518|NCT00908583|19347132|P1|NOT COMPLETED|Phase 1||5
7860519|NCT00908583|19347132|P1|COMPLETED|Phase 1||15
7860520|NCT00908583|19347132|P1|STARTED|Phase 1||20
7860521|NCT00908544|19347152|P2|NOT COMPLETED|Overall Study||6
7860522|NCT00908544|19347153|P1|NOT COMPLETED|Overall Study||5
7860523|NCT00908544|19347152|P2|COMPLETED|Overall Study||16
7860524|NCT00908544|19347153|P1|COMPLETED|Overall Study||15
7860525|NCT00908544|19347152|P2|STARTED|Overall Study||22
7860526|NCT00908544|19347153|P1|STARTED|Overall Study||20
7860527|NCT00908466|19347195|P2|NOT COMPLETED|Overall Study||1
7860528|NCT00908466|19347196|P1|NOT COMPLETED|Overall Study||1
7860529|NCT00908466|19347195|P2|COMPLETED|Overall Study||14
7860530|NCT00908466|19347196|P1|COMPLETED|Overall Study||14
7860531|NCT00908466|19347195|P2|STARTED|Overall Study||15
7860532|NCT00908466|19347196|P1|STARTED|Overall Study||15
7860533|NCT00908388|19347202|P1|NOT COMPLETED|Overall Study||10
7860534|NCT00908388|19347202|P1|COMPLETED|Overall Study||40
7860535|NCT00908388|19347202|P1|STARTED|Overall Study||50
7860536|NCT00908375|19347212|P2|NOT COMPLETED|Overall Study||10
7860537|NCT00908375|19347213|P1|NOT COMPLETED|Overall Study||10
7860538|NCT00908375|19347212|P2|COMPLETED|Overall Study||9
7860539|NCT00908375|19347213|P1|COMPLETED|Overall Study||10
7860540|NCT00908375|19347212|P2|STARTED|Overall Study||19
7860541|NCT00908375|19347213|P1|STARTED|Overall Study||20
7860542|NCT00908349|19347223|P1|NOT COMPLETED|Overall Study||35
7860543|NCT00908349|19347223|P1|COMPLETED|Overall Study||179
7860544|NCT00908349|19347223|P1|STARTED|Overall Study||214
7860545|NCT00908310|19347227|P1|NOT COMPLETED|Overall Study||60
7860546|NCT00908310|19347227|P1|COMPLETED|Overall Study||153
7860547|NCT00908310|19347227|P1|STARTED|Overall Study||213
7860548|NCT00908232|19347231|P4|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0
7860549|NCT00908232|19347232|P3|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1
7860550|NCT00908232|19347233|P2|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3
7860551|NCT00908232|19347234|P1|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35
7860552|NCT00908232|19347231|P4|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
7860553|NCT00908232|19347232|P3|COMPLETED|Randomization (Cycle 5) to Cycle 8||7
7860554|NCT00908232|19347233|P2|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
7860555|NCT00908232|19347234|P1|COMPLETED|Randomization (Cycle 5) to Cycle 8||63
7860556|NCT00908232|19347231|P4|STARTED|Randomization (Cycle 5) to Cycle 8||4
7860557|NCT00908232|19347232|P3|STARTED|Randomization (Cycle 5) to Cycle 8||8
7860558|NCT00908232|19347233|P2|STARTED|Randomization (Cycle 5) to Cycle 8||7
7860559|NCT00908232|19347234|P1|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98
7860560|NCT00908232|19347231|P4|NOT COMPLETED|Cycle 1 to 4||0
7860561|NCT00908232|19347232|P3|NOT COMPLETED|Cycle 1 to 4||0
7860562|NCT00908232|19347233|P2|NOT COMPLETED|Cycle 1 to 4||0
7860563|NCT00908232|19347234|P1|NOT COMPLETED|Cycle 1 to 4||28
7860564|NCT00908232|19347231|P4|COMPLETED|Cycle 1 to 4||0
7860565|NCT00908232|19347232|P3|COMPLETED|Cycle 1 to 4||0
7860566|NCT00908232|19347233|P2|COMPLETED|Cycle 1 to 4||0
7860567|NCT00908232|19347234|P1|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135
7860568|NCT00908232|19347231|P4|STARTED|Cycle 1 to 4||0
7860569|NCT00908232|19347232|P3|STARTED|Cycle 1 to 4||0
7860570|NCT00908232|19347233|P2|STARTED|Cycle 1 to 4||0
7860571|NCT00908232|19347234|P1|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163
7860572|NCT00908141|19347252|P2|NOT COMPLETED|Overall Study||1
7860573|NCT00908141|19347253|P1|NOT COMPLETED|Overall Study||0
7860574|NCT00908141|19347252|P2|COMPLETED|Overall Study||8
7860575|NCT00908141|19347253|P1|COMPLETED|Overall Study||8
7860576|NCT00908141|19347252|P2|STARTED|Overall Study||9
7860577|NCT00908141|19347253|P1|STARTED|Overall Study||8
7860578|NCT00908128|19347261|P2|NOT COMPLETED|Period 4||0
7860579|NCT00908128|19347262|P1|NOT COMPLETED|Period 4||0
7860580|NCT00908128|19347261|P2|COMPLETED|Period 4||19
7860581|NCT00908128|19347262|P1|COMPLETED|Period 4||20
7860582|NCT00908128|19347261|P2|STARTED|Period 4|One subject withdrew prior to Period 4 dosing due to adverse events|19
7860583|NCT00908128|19347262|P1|STARTED|Period 4||20
7860584|NCT00908128|19347261|P2|NOT COMPLETED|Period 3||0
7860585|NCT00908128|19347262|P1|NOT COMPLETED|Period 3||0
7860586|NCT00908128|19347261|P2|COMPLETED|Period 3||20
7860587|NCT00908128|19347262|P1|COMPLETED|Period 3||20
7860588|NCT00908128|19347261|P2|STARTED|Period 3||20
7860589|NCT00908128|19347262|P1|STARTED|Period 3||20
7860590|NCT00908128|19347261|P2|NOT COMPLETED|Period 2||0
7860591|NCT00908128|19347262|P1|NOT COMPLETED|Period 2||0
7860592|NCT00908128|19347261|P2|COMPLETED|Period 2||20
7860593|NCT00908128|19347262|P1|COMPLETED|Period 2||20
7860594|NCT00908128|19347261|P2|STARTED|Period 2||20
7860595|NCT00908128|19347262|P1|STARTED|Period 2||20
7860596|NCT00908128|19347261|P2|NOT COMPLETED|Period 1||0
7860597|NCT00908128|19347262|P1|NOT COMPLETED|Period 1||0
7860598|NCT00908128|19347261|P2|COMPLETED|Period 1||20
7860599|NCT00908128|19347262|P1|COMPLETED|Period 1||20
7860600|NCT00908128|19347261|P2|STARTED|Period 1||20
7860601|NCT00908128|19347262|P1|STARTED|Period 1||20
7860602|NCT00908115|19347270|P1|NOT COMPLETED|Overall Study||14
7860603|NCT00908115|19347270|P1|COMPLETED|Overall Study||1244
7860604|NCT00908115|19347270|P1|STARTED|Overall Study||1258
7860605|NCT00908076|19347278|P2|NOT COMPLETED|Overall Study||1
7860606|NCT00908076|19347279|P1|NOT COMPLETED|Overall Study||1
7860607|NCT00908076|19347278|P2|COMPLETED|Overall Study||26
7860608|NCT00908076|19347279|P1|COMPLETED|Overall Study||26
7860609|NCT00908076|19347278|P2|STARTED|Overall Study||27
7860610|NCT00908076|19347279|P1|STARTED|Overall Study||27
7860611|NCT00908037|19347292|P12|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
7860612|NCT00908037|19347293|P11|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4
7860613|NCT00908037|19347294|P10|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
7860614|NCT00908037|19347295|P9|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
7860615|NCT00908037|19347296|P8|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
7860616|NCT00908037|19347297|P7|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
7860617|NCT00908037|19347298|P6|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
7860618|NCT00908037|19347299|P5|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
7860619|NCT00908037|19347300|P4|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
7860620|NCT00908037|19347301|P3|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
7860621|NCT00908037|19347302|P2|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
7860622|NCT00908037|19347303|P1|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
7860623|NCT00908037|19347292|P12|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12
7860624|NCT00908037|19347293|P11|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24
7860625|NCT00908037|19347294|P10|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21
7860626|NCT00908037|19347295|P9|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
7860627|NCT00908037|19347296|P8|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
7860628|NCT00908037|19347297|P7|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
7860629|NCT00908037|19347298|P6|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
7860630|NCT00908037|19347299|P5|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
7860631|NCT00908037|19347300|P4|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
7860632|NCT00908037|19347301|P3|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
7860633|NCT00908037|19347302|P2|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
7860634|NCT00908037|19347303|P1|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
7860635|NCT00908037|19347292|P12|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15
7860636|NCT00908037|19347293|P11|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28
7860637|NCT00908037|19347294|P10|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24
7860638|NCT00908037|19347295|P9|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
7860639|NCT00908037|19347296|P8|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
7860640|NCT00908037|19347297|P7|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
7860641|NCT00908037|19347298|P6|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
7860642|NCT00908037|19347299|P5|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
7860643|NCT00908037|19347300|P4|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
7860644|NCT00908037|19347301|P3|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
7860645|NCT00908037|19347302|P2|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
7860646|NCT00908037|19347303|P1|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
7860647|NCT00908037|19347292|P12|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
7860648|NCT00908037|19347293|P11|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
7860649|NCT00908037|19347294|P10|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
7860650|NCT00908037|19347295|P9|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5
7860651|NCT00908037|19347296|P8|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
7860652|NCT00908037|19347297|P7|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4
7860653|NCT00908037|19347298|P6|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
7860654|NCT00908037|19347299|P5|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3
7860655|NCT00908037|19347300|P4|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1
7860656|NCT00908037|19347301|P3|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
7860657|NCT00908037|19347302|P2|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
7860658|NCT00908037|19347303|P1|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
7860659|NCT00908037|19347292|P12|COMPLETED|Part 2 (7 Week Randomized Period)||0
7860660|NCT00908037|19347293|P11|COMPLETED|Part 2 (7 Week Randomized Period)||0
7860661|NCT00908037|19347294|P10|COMPLETED|Part 2 (7 Week Randomized Period)||0
7860662|NCT00908037|19347295|P9|COMPLETED|Part 2 (7 Week Randomized Period)||5
7860663|NCT00908037|19347296|P8|COMPLETED|Part 2 (7 Week Randomized Period)||5
7860664|NCT00908037|19347297|P7|COMPLETED|Part 2 (7 Week Randomized Period)||15
7860665|NCT00908037|19347298|P6|COMPLETED|Part 2 (7 Week Randomized Period)||9
7860666|NCT00908037|19347299|P5|COMPLETED|Part 2 (7 Week Randomized Period)||13
7860667|NCT00908037|19347300|P4|COMPLETED|Part 2 (7 Week Randomized Period)||7
7860668|NCT00908037|19347301|P3|COMPLETED|Part 2 (7 Week Randomized Period)||0
7860669|NCT00908037|19347302|P2|COMPLETED|Part 2 (7 Week Randomized Period)||0
7860670|NCT00908037|19347303|P1|COMPLETED|Part 2 (7 Week Randomized Period)||0
7860671|NCT00908037|19347292|P12|STARTED|Part 2 (7 Week Randomized Period)||0
7860672|NCT00908037|19347293|P11|STARTED|Part 2 (7 Week Randomized Period)||0
7860673|NCT00908037|19347294|P10|STARTED|Part 2 (7 Week Randomized Period)||0
7860674|NCT00908037|19347295|P9|STARTED|Part 2 (7 Week Randomized Period)||10
7860675|NCT00908037|19347296|P8|STARTED|Part 2 (7 Week Randomized Period)||5
7860676|NCT00908037|19347297|P7|STARTED|Part 2 (7 Week Randomized Period)||19
7860677|NCT00908037|19347298|P6|STARTED|Part 2 (7 Week Randomized Period)||9
7860678|NCT00908037|19347299|P5|STARTED|Part 2 (7 Week Randomized Period)||16
7860679|NCT00908037|19347300|P4|STARTED|Part 2 (7 Week Randomized Period)||8
7860680|NCT00908037|19347301|P3|STARTED|Part 2 (7 Week Randomized Period)||0
7860681|NCT00908037|19347302|P2|STARTED|Part 2 (7 Week Randomized Period)||0
7860682|NCT00908037|19347303|P1|STARTED|Part 2 (7 Week Randomized Period)||0
7860683|NCT00908037|19347292|P12|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
7860684|NCT00908037|19347293|P11|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
7860685|NCT00908037|19347294|P10|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
7860686|NCT00908037|19347295|P9|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
7860687|NCT00908037|19347296|P8|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
7860688|NCT00908037|19347297|P7|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
7860689|NCT00908037|19347298|P6|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
7860690|NCT00908037|19347299|P5|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
7860691|NCT00908037|19347300|P4|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
7860692|NCT00908037|19347301|P3|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
7860693|NCT00908037|19347302|P2|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
7860694|NCT00908037|19347303|P1|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
7860695|NCT00908037|19347292|P12|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
7860696|NCT00908037|19347293|P11|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
7860697|NCT00908037|19347294|P10|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
7860698|NCT00908037|19347295|P9|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
7860699|NCT00908037|19347296|P8|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
7860700|NCT00908037|19347297|P7|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
7860701|NCT00908037|19347298|P6|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
7860702|NCT00908037|19347299|P5|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
7860703|NCT00908037|19347300|P4|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
7860704|NCT00908037|19347301|P3|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
7860705|NCT00908037|19347302|P2|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
7860706|NCT00908037|19347303|P1|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
7860707|NCT00908037|19347292|P12|STARTED|Part1 (24 Week Dose-Finding Period)||0
7860708|NCT00908037|19347293|P11|STARTED|Part1 (24 Week Dose-Finding Period)||0
7860709|NCT00908037|19347294|P10|STARTED|Part1 (24 Week Dose-Finding Period)||0
7860710|NCT00908037|19347295|P9|STARTED|Part1 (24 Week Dose-Finding Period)||0
7860711|NCT00908037|19347296|P8|STARTED|Part1 (24 Week Dose-Finding Period)||0
7860712|NCT00908037|19347297|P7|STARTED|Part1 (24 Week Dose-Finding Period)||0
7860713|NCT00908037|19347298|P6|STARTED|Part1 (24 Week Dose-Finding Period)||0
7860714|NCT00908037|19347299|P5|STARTED|Part1 (24 Week Dose-Finding Period)||0
7860715|NCT00908037|19347300|P4|STARTED|Part1 (24 Week Dose-Finding Period)||0
7860716|NCT00908037|19347301|P3|STARTED|Part1 (24 Week Dose-Finding Period)||5
7860717|NCT00908037|19347302|P2|STARTED|Part1 (24 Week Dose-Finding Period)||5
7860718|NCT00908037|19347303|P1|STARTED|Part1 (24 Week Dose-Finding Period)||5
7860719|NCT00908011|19347452|P2|NOT COMPLETED|Overall Study||2
7860720|NCT00908011|19347453|P1|NOT COMPLETED|Overall Study||2
7860721|NCT00908011|19347452|P2|COMPLETED|Overall Study||18
7860722|NCT00908011|19347453|P1|COMPLETED|Overall Study||21
7860723|NCT00908011|19347452|P2|STARTED|Overall Study||20
7860724|NCT00908011|19347453|P1|STARTED|Overall Study||23
7860725|NCT00907907|19347461|P2|NOT COMPLETED|Period 4||0
7860726|NCT00907907|19347462|P1|NOT COMPLETED|Period 4||0
7860727|NCT00907907|19347461|P2|COMPLETED|Period 4||18
7860728|NCT00907907|19347462|P1|COMPLETED|Period 4||19
7860729|NCT00907907|19347461|P2|STARTED|Period 4|two subjects were withdrawn prior to Period 4 dosing|18
7860730|NCT00907907|19347462|P1|STARTED|Period 4|one subject withdrew prior to Period 4 dosing|19
7860731|NCT00907907|19347461|P2|NOT COMPLETED|Period 3||0
7860732|NCT00907907|19347462|P1|NOT COMPLETED|Period 3||0
7860733|NCT00907907|19347461|P2|COMPLETED|Period 3||20
7860734|NCT00907907|19347462|P1|COMPLETED|Period 3||20
7860735|NCT00907907|19347461|P2|STARTED|Period 3||20
7860736|NCT00907907|19347462|P1|STARTED|Period 3||20
7860737|NCT00907907|19347461|P2|NOT COMPLETED|Period 2||0
7860738|NCT00907907|19347462|P1|NOT COMPLETED|Period 2||0
7860739|NCT00907907|19347461|P2|COMPLETED|Period 2||20
7860740|NCT00907907|19347462|P1|COMPLETED|Period 2||20
7860741|NCT00907907|19347461|P2|STARTED|Period 2||20
7860742|NCT00907907|19347462|P1|STARTED|Period 2||20
7860743|NCT00907907|19347461|P2|NOT COMPLETED|Period 1||0
7860744|NCT00907907|19347462|P1|NOT COMPLETED|Period 1||0
7860745|NCT00907907|19347461|P2|COMPLETED|Period 1||20
7860746|NCT00907907|19347462|P1|COMPLETED|Period 1||20
7860747|NCT00907907|19347461|P2|STARTED|Period 1||20
7860748|NCT00907907|19347462|P1|STARTED|Period 1||20
7860749|NCT00907881|19347470|P1|NOT COMPLETED|Overall Study||85
7860750|NCT00907881|19347470|P1|COMPLETED|Overall Study||984
7860751|NCT00907881|19347470|P1|STARTED|Overall Study||1069
7860752|NCT00907803|19347480|P3|NOT COMPLETED|Overall Study||0
7860753|NCT00907803|19347481|P2|NOT COMPLETED|Overall Study||3
7860754|NCT00907803|19347482|P1|NOT COMPLETED|Overall Study||3
7860755|NCT00907803|19347480|P3|COMPLETED|Overall Study||16
7860756|NCT00907803|19347481|P2|COMPLETED|Overall Study||43
7860757|NCT00907803|19347482|P1|COMPLETED|Overall Study||42
7860758|NCT00907803|19347480|P3|STARTED|Overall Study||16
7860759|NCT00907803|19347481|P2|STARTED|Overall Study||46
7860760|NCT00907803|19347482|P1|STARTED|Overall Study||45
7860761|NCT00907777|19347513|P2|NOT COMPLETED|Overall Study||1
7860762|NCT00907777|19347514|P1|NOT COMPLETED|Overall Study||0
7860763|NCT00907777|19347513|P2|COMPLETED|Overall Study||26
7860764|NCT00907777|19347514|P1|COMPLETED|Overall Study||25
7860765|NCT00907777|19347513|P2|STARTED|Overall Study||27
7860766|NCT00907777|19347514|P1|STARTED|Overall Study||25
7860767|NCT00907738|19347541|P5|NOT COMPLETED|Overall Study||2
7860768|NCT00907738|19347542|P4|NOT COMPLETED|Overall Study||4
7860769|NCT00907738|19347543|P3|NOT COMPLETED|Overall Study||7
7860770|NCT00907738|19347544|P2|NOT COMPLETED|Overall Study||1
7860771|NCT00907738|19347545|P1|NOT COMPLETED|Overall Study||13
7860772|NCT00907738|19347541|P5|COMPLETED|Overall Study||0
7860773|NCT00907738|19347542|P4|COMPLETED|Overall Study||0
7860774|NCT00907738|19347543|P3|COMPLETED|Overall Study||0
7860775|NCT00907738|19347544|P2|COMPLETED|Overall Study||0
7860776|NCT00907738|19347545|P1|COMPLETED|Overall Study||0
7860777|NCT00907738|19347541|P5|STARTED|Overall Study||2
7860778|NCT00907738|19347542|P4|STARTED|Overall Study||4
7860779|NCT00907738|19347543|P3|STARTED|Overall Study||7
7860780|NCT00907738|19347544|P2|STARTED|Overall Study||1
7860781|NCT00907738|19347545|P1|STARTED|Overall Study||13
7860782|NCT00907621|19347563|P2|NOT COMPLETED|Overall Study||4
7860783|NCT00907621|19347564|P1|NOT COMPLETED|Overall Study||7
7860784|NCT00907621|19347563|P2|COMPLETED|Overall Study||41
7860785|NCT00907621|19347564|P1|COMPLETED|Overall Study||38
7860786|NCT00907621|19347563|P2|STARTED|Overall Study||45
7860787|NCT00907621|19347564|P1|STARTED|Overall Study||45
7860788|NCT00907517|19347577|P5|NOT COMPLETED|Overall Study||5
7860789|NCT00907517|19347578|P4|NOT COMPLETED|Overall Study||4
7860790|NCT00907517|19347579|P3|NOT COMPLETED|Overall Study||4
7860791|NCT00907517|19347580|P2|NOT COMPLETED|Overall Study||3
7860792|NCT00907517|19347581|P1|NOT COMPLETED|Overall Study||3
7860793|NCT00907517|19347577|P5|COMPLETED|Overall Study||1
7860794|NCT00907517|19347578|P4|COMPLETED|Overall Study||2
7860795|NCT00907517|19347579|P3|COMPLETED|Overall Study||2
7860796|NCT00907517|19347580|P2|COMPLETED|Overall Study||0
7860797|NCT00907517|19347581|P1|COMPLETED|Overall Study||0
7860798|NCT00907517|19347577|P5|STARTED|Overall Study||6
7860799|NCT00907517|19347578|P4|STARTED|Overall Study||6
7860800|NCT00907517|19347579|P3|STARTED|Overall Study||6
7860801|NCT00907517|19347580|P2|STARTED|Overall Study||3
7860802|NCT00907517|19347581|P1|STARTED|Overall Study||3
7860803|NCT00907478|19347606|P3|NOT COMPLETED|Overall Study||22
7860804|NCT00907478|19347607|P2|NOT COMPLETED|Overall Study||17
7860805|NCT00907478|19347608|P1|NOT COMPLETED|Overall Study||27
7860806|NCT00907478|19347606|P3|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47
7860807|NCT00907478|19347607|P2|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33
7860808|NCT00907478|19347608|P1|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23
7860809|NCT00907478|19347606|P3|STARTED|Overall Study||69
7860810|NCT00907478|19347607|P2|STARTED|Overall Study||50
7860811|NCT00907478|19347608|P1|STARTED|Overall Study||50
7860812|NCT00907426|19347639|P3|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7
7860813|NCT00907426|19347640|P2|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3
7860814|NCT00907426|19347641|P1|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11
7860815|NCT00907426|19347639|P3|COMPLETED|Treatment Period 2 (6 to 12 Months)||77
7860816|NCT00907426|19347640|P2|COMPLETED|Treatment Period 2 (6 to 12 Months)||52
7860817|NCT00907426|19347641|P1|COMPLETED|Treatment Period 2 (6 to 12 Months)||184
7860818|NCT00907426|19347639|P3|STARTED|Treatment Period 2 (6 to 12 Months)||84
7860819|NCT00907426|19347640|P2|STARTED|Treatment Period 2 (6 to 12 Months)||55
7860820|NCT00907426|19347641|P1|STARTED|Treatment Period 2 (6 to 12 Months)||195
7860821|NCT00907426|19347639|P3|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9
7860822|NCT00907426|19347640|P2|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5
7860823|NCT00907426|19347641|P1|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20
7860824|NCT00907426|19347639|P3|COMPLETED|Treatment Period 1 (0 to 6 Months)||84
7860825|NCT00907426|19347640|P2|COMPLETED|Treatment Period 1 (0 to 6 Months)||55
7860826|NCT00907426|19347641|P1|COMPLETED|Treatment Period 1 (0 to 6 Months)||195
7860827|NCT00907426|19347639|P3|STARTED|Treatment Period 1 (0 to 6 Months)||93
7860828|NCT00907426|19347640|P2|STARTED|Treatment Period 1 (0 to 6 Months)||60
7860829|NCT00907426|19347641|P1|STARTED|Treatment Period 1 (0 to 6 Months)||215
7860830|NCT00907374|19347658|P2|NOT COMPLETED|Overall Study||2
7860831|NCT00907374|19347659|P1|NOT COMPLETED|Overall Study||2
7860832|NCT00907374|19347658|P2|COMPLETED|Overall Study||11
7860833|NCT00907374|19347659|P1|COMPLETED|Overall Study||12
7860834|NCT00907374|19347658|P2|STARTED|Overall Study||13
7860835|NCT00907374|19347659|P1|STARTED|Overall Study||14
7860836|NCT00907335|19347673|P2|NOT COMPLETED|Overall Study||1
7860837|NCT00907335|19347674|P1|NOT COMPLETED|Overall Study||8
7860838|NCT00907335|19347673|P2|COMPLETED|Overall Study||54
7860839|NCT00907335|19347674|P1|COMPLETED|Overall Study||47
7860840|NCT00907335|19347673|P2|STARTED|Overall Study||55
7860841|NCT00907335|19347674|P1|STARTED|Overall Study||55
7860842|NCT00907296|19347700|P10|NOT COMPLETED|Overall Study||7
7860843|NCT00907296|19347701|P9|NOT COMPLETED|Overall Study||4
7860844|NCT00907296|19347702|P8|NOT COMPLETED|Overall Study||7
7860845|NCT00907296|19347703|P7|NOT COMPLETED|Overall Study||6
7860846|NCT00907296|19347704|P6|NOT COMPLETED|Overall Study||9
7860847|NCT00907296|19347705|P5|NOT COMPLETED|Overall Study||1
7860848|NCT00907296|19347706|P4|NOT COMPLETED|Overall Study||4
7860849|NCT00907296|19347707|P3|NOT COMPLETED|Overall Study||2
7860850|NCT00907296|19347708|P2|NOT COMPLETED|Overall Study||5
7860851|NCT00907296|19347709|P1|NOT COMPLETED|Overall Study||20
7860852|NCT00907296|19347700|P10|COMPLETED|Overall Study||28
7860853|NCT00907296|19347701|P9|COMPLETED|Overall Study||27
7860854|NCT00907296|19347702|P8|COMPLETED|Overall Study||26
7860855|NCT00907296|19347703|P7|COMPLETED|Overall Study||27
7860856|NCT00907296|19347704|P6|COMPLETED|Overall Study||24
7860857|NCT00907296|19347705|P5|COMPLETED|Overall Study||32
7860858|NCT00907296|19347706|P4|COMPLETED|Overall Study||29
7860859|NCT00907296|19347707|P3|COMPLETED|Overall Study||32
7860860|NCT00907296|19347708|P2|COMPLETED|Overall Study||29
7860861|NCT00907296|19347709|P1|COMPLETED|Overall Study||83
7860862|NCT00907296|19347700|P10|Received Treatment|Overall Study||35
7860863|NCT00907296|19347701|P9|Received Treatment|Overall Study||30
7860864|NCT00907296|19347702|P8|Received Treatment|Overall Study||32
7860865|NCT00907296|19347703|P7|Received Treatment|Overall Study||31
7860866|NCT00907296|19347704|P6|Received Treatment|Overall Study||32
7860867|NCT00907296|19347705|P5|Received Treatment|Overall Study||33
7860868|NCT00907296|19347706|P4|Received Treatment|Overall Study||32
7860869|NCT00907296|19347707|P3|Received Treatment|Overall Study||34
7860870|NCT00907296|19347708|P2|Received Treatment|Overall Study||34
7860871|NCT00907296|19347709|P1|Received Treatment|Overall Study||100
7860872|NCT00907296|19347700|P10|STARTED|Overall Study||35
7860873|NCT00907296|19347701|P9|STARTED|Overall Study||31
7860874|NCT00907296|19347702|P8|STARTED|Overall Study||33
7860875|NCT00907296|19347703|P7|STARTED|Overall Study||33
7860876|NCT00907296|19347704|P6|STARTED|Overall Study||33
7860877|NCT00907296|19347705|P5|STARTED|Overall Study||33
7860878|NCT00907296|19347706|P4|STARTED|Overall Study||33
7860879|NCT00907296|19347707|P3|STARTED|Overall Study||34
7860880|NCT00907296|19347708|P2|STARTED|Overall Study||34
7860881|NCT00907296|19347709|P1|STARTED|Overall Study||103
7860882|NCT00907257|19347763|P2|NOT COMPLETED|Overall Study||12
7860883|NCT00907257|19347764|P1|NOT COMPLETED|Overall Study||13
7860884|NCT00907257|19347763|P2|COMPLETED|Overall Study||112
7860885|NCT00907257|19347764|P1|COMPLETED|Overall Study||110
7860886|NCT00907257|19347763|P2|STARTED|Overall Study||124
7860887|NCT00907257|19347764|P1|STARTED|Overall Study||123
7860888|NCT00907218|19347774|P1|NOT COMPLETED|Overall Study||0
7860889|NCT00907218|19347774|P1|COMPLETED|Overall Study||2
7860890|NCT00907218|19347774|P1|STARTED|Overall Study||2
7860891|NCT00907153|19347786|P2|NOT COMPLETED|Overall Study||4
7860892|NCT00907153|19347787|P1|NOT COMPLETED|Overall Study||2
7860893|NCT00907153|19347786|P2|COMPLETED|Overall Study||11
7860894|NCT00907153|19347787|P1|COMPLETED|Overall Study||11
7860895|NCT00907153|19347786|P2|STARTED|Overall Study||15
7860896|NCT00907153|19347787|P1|STARTED|Overall Study||13
7860897|NCT00907101|19347829|P1|NOT COMPLETED|Overall Study||0
7860898|NCT00907101|19347829|P1|COMPLETED|Overall Study||30
7860899|NCT00907101|19347829|P1|STARTED|Overall Study||30
7860900|NCT00907088|19347839|P2|NOT COMPLETED|Overall Study||30
7860901|NCT00907088|19347840|P1|NOT COMPLETED|Overall Study||20
7860902|NCT00907088|19347839|P2|COMPLETED|Overall Study||99
7860903|NCT00907088|19347840|P1|COMPLETED|Overall Study||102
7860904|NCT00907088|19347839|P2|STARTED|Overall Study||129
7860905|NCT00907088|19347840|P1|STARTED|Overall Study||122
7860906|NCT00906971|19347848|P2|NOT COMPLETED|Overall Study||3
7860907|NCT00906971|19347849|P1|NOT COMPLETED|Overall Study||8
7860908|NCT00906971|19347848|P2|COMPLETED|Overall Study||33
7860909|NCT00906971|19347849|P1|COMPLETED|Overall Study||28
7860910|NCT00906971|19347848|P2|STARTED|Overall Study||36
7860911|NCT00906971|19347849|P1|STARTED|Overall Study||36
7860912|NCT00906945|19347862|P6|NOT COMPLETED|Overall Study||2
7860913|NCT00906945|19347863|P5|NOT COMPLETED|Overall Study||1
7860914|NCT00906945|19347864|P4|NOT COMPLETED|Overall Study||1
7860915|NCT00906945|19347865|P3|NOT COMPLETED|Overall Study||0
7860916|NCT00906945|19347866|P2|NOT COMPLETED|Overall Study||0
7860917|NCT00906945|19347867|P1|NOT COMPLETED|Overall Study||0
7860918|NCT00906945|19347862|P6|COMPLETED|Overall Study||14
7860919|NCT00906945|19347863|P5|COMPLETED|Overall Study||6
7860920|NCT00906945|19347864|P4|COMPLETED|Overall Study||6
7860921|NCT00906945|19347865|P3|COMPLETED|Overall Study||3
7860922|NCT00906945|19347866|P2|COMPLETED|Overall Study||3
7860923|NCT00906945|19347867|P1|COMPLETED|Overall Study||3
7860924|NCT00906945|19347862|P6|STARTED|Overall Study||16
7860925|NCT00906945|19347863|P5|STARTED|Overall Study||7
7860926|NCT00906945|19347864|P4|STARTED|Overall Study||7
7860927|NCT00906945|19347865|P3|STARTED|Overall Study||3
7860928|NCT00906945|19347866|P2|STARTED|Overall Study||3
7860929|NCT00906945|19347867|P1|STARTED|Overall Study||3
7860930|NCT00906789|19347894|P1|NOT COMPLETED|Overall Study||0
7860931|NCT00906789|19347894|P1|COMPLETED|Overall Study||15
7860932|NCT00906789|19347894|P1|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15
7860933|NCT00906776|19347904|P2|NOT COMPLETED|Overall Study||0
7860934|NCT00906776|19347905|P1|NOT COMPLETED|Overall Study||0
7860935|NCT00906776|19347904|P2|COMPLETED|Overall Study||8
7860936|NCT00906776|19347905|P1|COMPLETED|Overall Study||11
7860937|NCT00906776|19347904|P2|STARTED|Overall Study||8
7860938|NCT00906776|19347905|P1|STARTED|Overall Study||11
7860939|NCT00906698|19347927|P6|NOT COMPLETED|Overall Study||5
7860940|NCT00906698|19347928|P5|NOT COMPLETED|Overall Study||18
7860941|NCT00906698|19347929|P4|NOT COMPLETED|Overall Study||4
7860942|NCT00906698|19347930|P3|NOT COMPLETED|Overall Study||6
7860943|NCT00906698|19347931|P2|NOT COMPLETED|Overall Study||19
7860944|NCT00906698|19347932|P1|NOT COMPLETED|Overall Study||3
7860945|NCT00906698|19347927|P6|COMPLETED|Overall Study||0
7860946|NCT00906698|19347928|P5|COMPLETED|Overall Study||0
7860947|NCT00906698|19347929|P4|COMPLETED|Overall Study||0
7860948|NCT00906698|19347930|P3|COMPLETED|Overall Study||0
7860949|NCT00906698|19347931|P2|COMPLETED|Overall Study||0
7860950|NCT00906698|19347932|P1|COMPLETED|Overall Study||0
7860951|NCT00906698|19347927|P6|STARTED|Overall Study||5
7860952|NCT00906698|19347928|P5|STARTED|Overall Study||18
7860953|NCT00906698|19347929|P4|STARTED|Overall Study||4
7860954|NCT00906698|19347930|P3|STARTED|Overall Study||6
7860955|NCT00906698|19347931|P2|STARTED|Overall Study||19
7860956|NCT00906698|19347932|P1|STARTED|Overall Study||3
7860957|NCT00906503|19348014|P1|NOT COMPLETED|Overall Study||0
7860958|NCT00906503|19348014|P1|COMPLETED|Overall Study||9
7860959|NCT00906503|19348014|P1|STARTED|Overall Study||9
7860960|NCT00906425|19348020|P2|NOT COMPLETED|Overall Study||72
7860961|NCT00906425|19348021|P1|NOT COMPLETED|Overall Study||73
7860962|NCT00906425|19348020|P2|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
7860963|NCT00906425|19348021|P1|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
7860964|NCT00906425|19348020|P2|2 Year|Overall Study|ITT population|58
7860965|NCT00906425|19348021|P1|2 Year|Overall Study|ITT population|62
7860966|NCT00906425|19348020|P2|1 Year|Overall Study|ITT population|60
7860967|NCT00906425|19348021|P1|1 Year|Overall Study|ITT population|67
7860968|NCT00906425|19348020|P2|6 Months|Overall Study|ITT population|64
7860969|NCT00906425|19348021|P1|6 Months|Overall Study|ITT population|69
7860970|NCT00906425|19348020|P2|STARTED|Overall Study||72
7860971|NCT00906425|19348021|P1|STARTED|Overall Study||73
7860972|NCT00906399|19348034|P7|NOT COMPLETED|Year 2||29
7860973|NCT00906399|19348035|P6|NOT COMPLETED|Year 2||47
7860974|NCT00906399|19348036|P5|NOT COMPLETED|Year 2||35
7860975|NCT00906399|19348037|P4|NOT COMPLETED|Year 2||30
7860976|NCT00906399|19348038|P3|NOT COMPLETED|Year 2||0
7860977|NCT00906399|19348039|P2|NOT COMPLETED|Year 2||0
7860978|NCT00906399|19348040|P1|NOT COMPLETED|Year 2||0
7860979|NCT00906399|19348034|P7|COMPLETED|Year 2||409
7860980|NCT00906399|19348035|P6|COMPLETED|Year 2||391
7860981|NCT00906399|19348036|P5|COMPLETED|Year 2||193
7860982|NCT00906399|19348037|P4|COMPLETED|Year 2||198
7860983|NCT00906399|19348038|P3|COMPLETED|Year 2||0
7860984|NCT00906399|19348039|P2|COMPLETED|Year 2||0
7860985|NCT00906399|19348040|P1|COMPLETED|Year 2||0
7860986|NCT00906399|19348034|P7|Completed Year 2 Study Treatment|Year 2||411
7860987|NCT00906399|19348035|P6|Completed Year 2 Study Treatment|Year 2||391
7860988|NCT00906399|19348036|P5|Completed Year 2 Study Treatment|Year 2||196
7860989|NCT00906399|19348037|P4|Completed Year 2 Study Treatment|Year 2||200
7860990|NCT00906399|19348038|P3|Completed Year 2 Study Treatment|Year 2||0
7860991|NCT00906399|19348039|P2|Completed Year 2 Study Treatment|Year 2||0
7860992|NCT00906399|19348040|P1|Completed Year 2 Study Treatment|Year 2||0
7860993|NCT00906399|19348034|P7|STARTED|Year 2||438
7860994|NCT00906399|19348035|P6|STARTED|Year 2||438
7860995|NCT00906399|19348036|P5|STARTED|Year 2||228
7860996|NCT00906399|19348037|P4|STARTED|Year 2||228
7860997|NCT00906399|19348038|P3|STARTED|Year 2||0
7860998|NCT00906399|19348039|P2|STARTED|Year 2||0
7860999|NCT00906399|19348040|P1|STARTED|Year 2||0
7861000|NCT00906399|19348034|P7|NOT COMPLETED|Year 1||0
7861001|NCT00906399|19348035|P6|NOT COMPLETED|Year 1||0
7861002|NCT00906399|19348036|P5|NOT COMPLETED|Year 1||0
7861003|NCT00906399|19348037|P4|NOT COMPLETED|Year 1||0
7861004|NCT00906399|19348038|P3|NOT COMPLETED|Year 1||76
7861005|NCT00906399|19348039|P2|NOT COMPLETED|Year 1||63
7861006|NCT00906399|19348040|P1|NOT COMPLETED|Year 1||44
7861007|NCT00906399|19348034|P7|COMPLETED|Year 1||0
7861008|NCT00906399|19348035|P6|COMPLETED|Year 1||0
7861009|NCT00906399|19348036|P5|COMPLETED|Year 1||0
7861010|NCT00906399|19348037|P4|COMPLETED|Year 1||0
7861011|NCT00906399|19348038|P3|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439
7861012|NCT00906399|19348039|P2|COMPLETED|Year 1||438
7861013|NCT00906399|19348040|P1|COMPLETED|Year 1||456
7861014|NCT00906399|19348034|P7|Completed Year 1 Study Treatment|Year 1||0
7861015|NCT00906399|19348035|P6|Completed Year 1 Study Treatment|Year 1||0
7861016|NCT00906399|19348036|P5|Completed Year 1 Study Treatment|Year 1||0
7861017|NCT00906399|19348037|P4|Completed Year 1 Study Treatment|Year 1||0
7861018|NCT00906399|19348038|P3|Completed Year 1 Study Treatment|Year 1||438
7861019|NCT00906399|19348039|P2|Completed Year 1 Study Treatment|Year 1||438
7861020|NCT00906399|19348040|P1|Completed Year 1 Study Treatment|Year 1||456
7861021|NCT00906399|19348034|P7|STARTED|Year 1||0
7861022|NCT00906399|19348035|P6|STARTED|Year 1||0
7861023|NCT00906399|19348036|P5|STARTED|Year 1||0
7861024|NCT00906399|19348037|P4|STARTED|Year 1||0
7861025|NCT00906399|19348038|P3|STARTED|Year 1||515
7861026|NCT00906399|19348039|P2|STARTED|Year 1||501
7861027|NCT00906399|19348040|P1|STARTED|Year 1||500
7861028|NCT00906373|19348063|P2|NOT COMPLETED|Overall Study||8
7861029|NCT00906373|19348064|P1|NOT COMPLETED|Overall Study||0
7861030|NCT00906373|19348063|P2|COMPLETED|Overall Study||33
7861031|NCT00906373|19348064|P1|COMPLETED|Overall Study||6
7861032|NCT00906373|19348063|P2|Received Any Amount of Study Drug|Overall Study||41
7861033|NCT00906373|19348064|P1|Received Any Amount of Study Drug|Overall Study||6
7861034|NCT00906373|19348063|P2|STARTED|Overall Study||41
7861035|NCT00906373|19348064|P1|STARTED|Overall Study||6
7861036|NCT00906347|19348103|P2|NOT COMPLETED|Received Study Drug||31
7861037|NCT00906347|19348104|P1|NOT COMPLETED|Received Study Drug||40
7861038|NCT00906347|19348103|P2|COMPLETED|Received Study Drug||143
7861039|NCT00906347|19348104|P1|COMPLETED|Received Study Drug||136
7861040|NCT00906347|19348103|P2|STARTED|Received Study Drug||174
7861041|NCT00906347|19348104|P1|STARTED|Received Study Drug||176
7861042|NCT00906347|19348103|P2|NOT COMPLETED|Randomized||0
7861043|NCT00906347|19348104|P1|NOT COMPLETED|Randomized||0
7861044|NCT00906347|19348103|P2|COMPLETED|Randomized||174
7861045|NCT00906347|19348104|P1|COMPLETED|Randomized||176
7861046|NCT00906347|19348103|P2|STARTED|Randomized||174
7861047|NCT00906347|19348104|P1|STARTED|Randomized||176
7861048|NCT00906282|19348124|P1|NOT COMPLETED|Surgical Resection||0
7861049|NCT00906282|19348124|P1|COMPLETED|Surgical Resection||27
7861050|NCT00906282|19348124|P1|STARTED|Surgical Resection||27
7861051|NCT00906282|19348124|P1|NOT COMPLETED|Preoperative Chemotherapy||19
7861052|NCT00906282|19348124|P1|COMPLETED|Preoperative Chemotherapy|2 of 27 patients completed less than 4 cycles and were deemed surgical candidates.|27
7861053|NCT00906282|19348124|P1|STARTED|Preoperative Chemotherapy||46
7861054|NCT00906243|19348132|P1|NOT COMPLETED|Overall Study||0
7861055|NCT00906243|19348132|P1|COMPLETED|Overall Study||6
7861056|NCT00906243|19348132|P1|STARTED|Overall Study||6
7861057|NCT00906204|19348138|P2|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3
7861058|NCT00906204|19348139|P1|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2
7861059|NCT00906204|19348138|P2|COMPLETED|Secondary Endpoints (Long-term Safety)||48
7861060|NCT00906204|19348139|P1|COMPLETED|Secondary Endpoints (Long-term Safety)||41
7861061|NCT00906204|19348138|P2|STARTED|Secondary Endpoints (Long-term Safety)||51
7861062|NCT00906204|19348139|P1|STARTED|Secondary Endpoints (Long-term Safety)||43
7861063|NCT00906204|19348138|P2|NOT COMPLETED|Primary Endpoint (Early Safety)||1
7861064|NCT00906204|19348139|P1|NOT COMPLETED|Primary Endpoint (Early Safety)||2
7861065|NCT00906204|19348138|P2|COMPLETED|Primary Endpoint (Early Safety)||51
7861066|NCT00906204|19348139|P1|COMPLETED|Primary Endpoint (Early Safety)||43
7861067|NCT00906204|19348138|P2|STARTED|Primary Endpoint (Early Safety)||52
7861068|NCT00906204|19348139|P1|STARTED|Primary Endpoint (Early Safety)||45
7861069|NCT00906178|19348157|P2|NOT COMPLETED|Overall Study||16
7861070|NCT00906178|19348158|P1|NOT COMPLETED|Overall Study||15
7861071|NCT00906178|19348157|P2|COMPLETED|Overall Study||167
7861072|NCT00906178|19348158|P1|COMPLETED|Overall Study||168
7861073|NCT00906178|19348157|P2|STARTED|Overall Study||183
7861074|NCT00906178|19348158|P1|STARTED|Overall Study||183
7861075|NCT00906165|19348172|P2|NOT COMPLETED|Overall Study||0
7861076|NCT00906165|19348173|P1|NOT COMPLETED|Overall Study||4
7861077|NCT00906165|19348172|P2|COMPLETED|Overall Study||14
7861078|NCT00906165|19348173|P1|COMPLETED|Overall Study||10
7861079|NCT00906165|19348172|P2|STARTED|Overall Study||14
7861080|NCT00906165|19348173|P1|STARTED|Overall Study||14
7861081|NCT00906087|19348193|P1|NOT COMPLETED|Final Washout Period 4 Weeks||0
7861082|NCT00906087|19348193|P1|COMPLETED|Final Washout Period 4 Weeks||12
7861083|NCT00906087|19348193|P1|STARTED|Final Washout Period 4 Weeks||12
7861084|NCT00906087|19348193|P1|NOT COMPLETED|Cosopt Treatment 6 Weeks||0
7861085|NCT00906087|19348193|P1|COMPLETED|Cosopt Treatment 6 Weeks||12
7861086|NCT00906087|19348193|P1|STARTED|Cosopt Treatment 6 Weeks||12
7861087|NCT00906087|19348193|P1|NOT COMPLETED|Initial Washout||2
7861088|NCT00906087|19348193|P1|COMPLETED|Initial Washout||12
7861089|NCT00906087|19348193|P1|Completed Washout and Continue Protocol|Initial Washout||12
7861090|NCT00906087|19348193|P1|Begin Washout|Initial Washout||13
7861091|NCT00906087|19348193|P1|Completed Screening|Initial Washout||14
7861092|NCT00906087|19348193|P1|STARTED|Initial Washout||14
7861093|NCT00906074|19348202|P2|NOT COMPLETED|Overall Study||0
7861094|NCT00906074|19348203|P1|NOT COMPLETED|Overall Study||0
7861095|NCT00906074|19348202|P2|COMPLETED|Overall Study||90
7861096|NCT00906074|19348203|P1|COMPLETED|Overall Study||90
7861097|NCT00906074|19348202|P2|STARTED|Overall Study||90
7861098|NCT00906074|19348203|P1|STARTED|Overall Study||90
7861099|NCT00906035|19348230|P3|NOT COMPLETED|Overall Study||0
7861100|NCT00906035|19348231|P2|NOT COMPLETED|Overall Study||3
7861101|NCT00906035|19348232|P1|NOT COMPLETED|Overall Study||2
7861102|NCT00906035|19348230|P3|COMPLETED|Overall Study||8
7861103|NCT00906035|19348231|P2|COMPLETED|Overall Study|2 subjects Withdrew after Visit 1 and 1 subject Withdrew shortly after Visit 1due to an AE|6
7861104|NCT00906035|19348232|P1|COMPLETED|Overall Study|One Drop-Out; SAE day before Visit 1 and One subject Withrew prior to visit 1|6
7861105|NCT00906035|19348230|P3|STARTED|Overall Study||8
7861106|NCT00906035|19348231|P2|STARTED|Overall Study||9
7861107|NCT00906035|19348232|P1|STARTED|Overall Study||8
7861108|NCT00905840|19348246|P1|NOT COMPLETED|Overall Study||16
7861109|NCT00905840|19348246|P1|COMPLETED|Overall Study||75
7861110|NCT00905840|19348246|P1|STARTED|Overall Study||91
7861111|NCT00905827|19348258|P3|NOT COMPLETED|Overall Study||0
7861112|NCT00905827|19348259|P2|NOT COMPLETED|Overall Study||0
7861113|NCT00905827|19348260|P1|NOT COMPLETED|Overall Study||0
7861114|NCT00905827|19348258|P3|COMPLETED|Overall Study||73
7861115|NCT00905827|19348259|P2|COMPLETED|Overall Study||69
7861116|NCT00905827|19348260|P1|COMPLETED|Overall Study||70
7861117|NCT00905827|19348258|P3|STARTED|Overall Study||73
7861118|NCT00905827|19348259|P2|STARTED|Overall Study||69
7861119|NCT00905827|19348260|P1|STARTED|Overall Study||70
7861120|NCT00905632|19348277|P7|NOT COMPLETED|Overall Study||4
7861121|NCT00905632|19348278|P6|NOT COMPLETED|Overall Study||1
7861122|NCT00905632|19348279|P5|NOT COMPLETED|Overall Study||0
7861123|NCT00905632|19348280|P4|NOT COMPLETED|Overall Study||0
7861124|NCT00905632|19348281|P3|NOT COMPLETED|Overall Study||0
7861125|NCT00905632|19348282|P2|NOT COMPLETED|Overall Study||0
7861126|NCT00905632|19348283|P1|NOT COMPLETED|Overall Study||0
7861127|NCT00905632|19348277|P7|COMPLETED|Overall Study||7
7861128|NCT00905632|19348278|P6|COMPLETED|Overall Study||8
7861129|NCT00905632|19348279|P5|COMPLETED|Overall Study||10
7861130|NCT00905632|19348280|P4|COMPLETED|Overall Study||6
7861131|NCT00905632|19348281|P3|COMPLETED|Overall Study||7
7861132|NCT00905632|19348282|P2|COMPLETED|Overall Study||6
7861133|NCT00905632|19348283|P1|COMPLETED|Overall Study||8
7861134|NCT00905632|19348277|P7|STARTED|Overall Study||11
7861135|NCT00905632|19348278|P6|STARTED|Overall Study||9
7861136|NCT00905632|19348279|P5|STARTED|Overall Study||10
7861137|NCT00905632|19348280|P4|STARTED|Overall Study||6
7861138|NCT00905632|19348281|P3|STARTED|Overall Study||7
7861139|NCT00905632|19348282|P2|STARTED|Overall Study||6
7861140|NCT00905632|19348283|P1|STARTED|Overall Study||8
7861141|NCT00905606|19348421|P2|NOT COMPLETED|Period 2||0
7861142|NCT00905606|19348422|P1|NOT COMPLETED|Period 2||0
7861143|NCT00905606|19348421|P2|COMPLETED|Period 2||14
7861144|NCT00905606|19348422|P1|COMPLETED|Period 2||14
7861145|NCT00905606|19348421|P2|STARTED|Period 2||14
7861146|NCT00905606|19348422|P1|STARTED|Period 2||14
7861147|NCT00905606|19348421|P2|NOT COMPLETED|Washout||0
7861148|NCT00905606|19348422|P1|NOT COMPLETED|Washout||1
7861149|NCT00905606|19348421|P2|COMPLETED|Washout||14
7861150|NCT00905606|19348422|P1|COMPLETED|Washout||14
7861151|NCT00905606|19348421|P2|STARTED|Washout||14
7861152|NCT00905606|19348422|P1|STARTED|Washout||15
7861153|NCT00905606|19348421|P2|NOT COMPLETED|Period 1||1
7861154|NCT00905606|19348422|P1|NOT COMPLETED|Period 1||0
7861155|NCT00905606|19348421|P2|COMPLETED|Period 1||14
7861156|NCT00905606|19348422|P1|COMPLETED|Period 1||15
7861157|NCT00905606|19348421|P2|STARTED|Period 1||15
7861158|NCT00905606|19348422|P1|STARTED|Period 1||15
7861159|NCT00905580|19348432|P2|NOT COMPLETED|Overall Study||3
7861160|NCT00905580|19348433|P1|NOT COMPLETED|Overall Study||2
7861161|NCT00905580|19348432|P2|COMPLETED|Overall Study||47
7861162|NCT00905580|19348433|P1|COMPLETED|Overall Study||47
7861163|NCT00905580|19348432|P2|STARTED|Overall Study||50
7861164|NCT00905580|19348433|P1|STARTED|Overall Study||49
7861165|NCT00905567|19348447|P2|NOT COMPLETED|Period 2||0
7861166|NCT00905567|19348448|P1|NOT COMPLETED|Period 2||0
7861167|NCT00905567|19348447|P2|COMPLETED|Period 2||11
7861168|NCT00905567|19348448|P1|COMPLETED|Period 2||12
7861169|NCT00905567|19348447|P2|STARTED|Period 2||11
7861170|NCT00905567|19348448|P1|STARTED|Period 2||12
7861171|NCT00905567|19348447|P2|NOT COMPLETED|Washout||1
7861172|NCT00905567|19348448|P1|NOT COMPLETED|Washout||0
7861173|NCT00905567|19348447|P2|COMPLETED|Washout||11
7861174|NCT00905567|19348448|P1|COMPLETED|Washout||12
7861175|NCT00905567|19348447|P2|STARTED|Washout||12
7861176|NCT00905567|19348448|P1|STARTED|Washout||12
7861177|NCT00905567|19348447|P2|NOT COMPLETED|Period 1||0
7861178|NCT00905567|19348448|P1|NOT COMPLETED|Period 1||0
7861179|NCT00905567|19348447|P2|COMPLETED|Period 1||12
7861180|NCT00905567|19348448|P1|COMPLETED|Period 1||12
7861181|NCT00905567|19348447|P2|STARTED|Period 1||12
7861182|NCT00905567|19348448|P1|STARTED|Period 1||12
7861183|NCT00905554|19348458|P2|NOT COMPLETED|Overall Study||0
7861184|NCT00905554|19348459|P1|NOT COMPLETED|Overall Study||0
7861185|NCT00905554|19348458|P2|COMPLETED|Overall Study||114
7861186|NCT00905554|19348459|P1|COMPLETED|Overall Study||116
7861187|NCT00905554|19348458|P2|STARTED|Overall Study||114
7861188|NCT00905554|19348459|P1|STARTED|Overall Study||116
7861189|NCT00905515|19348470|P3|NOT COMPLETED|Overall Study||2
7861190|NCT00905515|19348471|P2|NOT COMPLETED|Overall Study||0
7861191|NCT00905515|19348472|P1|NOT COMPLETED|Overall Study||2
7861192|NCT00905515|19348470|P3|COMPLETED|Overall Study||20
7861193|NCT00905515|19348471|P2|COMPLETED|Overall Study||20
7861194|NCT00905515|19348472|P1|COMPLETED|Overall Study||19
7861195|NCT00905515|19348470|P3|STARTED|Overall Study||22
7861196|NCT00905515|19348471|P2|STARTED|Overall Study||20
7861197|NCT00905515|19348472|P1|STARTED|Overall Study||21
7861198|NCT00905489|19348480|P1|NOT COMPLETED|Optional Extension Phase (OEP)||1
7861199|NCT00905489|19348480|P1|COMPLETED|Optional Extension Phase (OEP)||39
7861200|NCT00905489|19348480|P1|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40
7861201|NCT00905489|19348480|P1|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5
7861202|NCT00905489|19348480|P1|COMPLETED|Pharmaco-kinetic (PK) Phase||80
7861203|NCT00905489|19348480|P1|STARTED|Pharmaco-kinetic (PK) Phase||85
7861204|NCT00905450|19348535|P8|NOT COMPLETED|Overall Study||1
7861205|NCT00905450|19348536|P7|NOT COMPLETED|Overall Study||2
7861206|NCT00905450|19348537|P6|NOT COMPLETED|Overall Study||2
7861207|NCT00905450|19348538|P5|NOT COMPLETED|Overall Study||0
7861208|NCT00905450|19348539|P4|NOT COMPLETED|Overall Study||0
7861209|NCT00905450|19348540|P3|NOT COMPLETED|Overall Study||0
7861210|NCT00905450|19348541|P2|NOT COMPLETED|Overall Study||1
7861211|NCT00905450|19348542|P1|NOT COMPLETED|Overall Study||1
7861212|NCT00905450|19348535|P8|COMPLETED|Overall Study||59
7861213|NCT00905450|19348536|P7|COMPLETED|Overall Study||58
7861214|NCT00905450|19348537|P6|COMPLETED|Overall Study||58
7861215|NCT00905450|19348538|P5|COMPLETED|Overall Study||59
7861216|NCT00905450|19348539|P4|COMPLETED|Overall Study||60
7861217|NCT00905450|19348540|P3|COMPLETED|Overall Study||28
7861218|NCT00905450|19348541|P2|COMPLETED|Overall Study||27
7861219|NCT00905450|19348542|P1|COMPLETED|Overall Study||59
7861220|NCT00905450|19348535|P8|STARTED|Overall Study||60
7861221|NCT00905450|19348536|P7|STARTED|Overall Study||60
7861222|NCT00905450|19348537|P6|STARTED|Overall Study||60
7861223|NCT00905450|19348538|P5|STARTED|Overall Study||59
7861224|NCT00905450|19348539|P4|STARTED|Overall Study||60
7861225|NCT00905450|19348540|P3|STARTED|Overall Study||28
7861226|NCT00905450|19348541|P2|STARTED|Overall Study||28
7861227|NCT00905450|19348542|P1|STARTED|Overall Study||60
7861228|NCT00905437|19348570|P2|NOT COMPLETED|Overall Study||10
7861229|NCT00905437|19348571|P1|NOT COMPLETED|Overall Study||8
7861230|NCT00905437|19348570|P2|COMPLETED|Overall Study||27
7861231|NCT00905437|19348571|P1|COMPLETED|Overall Study||27
7861232|NCT00905437|19348570|P2|STARTED|Overall Study||37
7861233|NCT00905437|19348571|P1|STARTED|Overall Study||35
7861234|NCT00905424|19348591|P2|NOT COMPLETED|Overall Study||9
7861235|NCT00905424|19348592|P1|NOT COMPLETED|Overall Study||11
7861236|NCT00905424|19348591|P2|COMPLETED|Overall Study||79
7861237|NCT00905424|19348592|P1|COMPLETED|Overall Study||78
7861238|NCT00905424|19348591|P2|STARTED|Overall Study||88
7861239|NCT00905424|19348592|P1|STARTED|Overall Study||89
7861240|NCT00905359|19348634|P2|NOT COMPLETED|Overall Study||16
7861241|NCT00905359|19348635|P1|NOT COMPLETED|Overall Study||24
7861242|NCT00905359|19348634|P2|COMPLETED|Overall Study||65
7861243|NCT00905359|19348635|P1|COMPLETED|Overall Study||58
7861244|NCT00905359|19348634|P2|24 Months Follow up|Overall Study||65
7861245|NCT00905359|19348635|P1|24 Months Follow up|Overall Study||58
7861246|NCT00905359|19348634|P2|12 Months Follow up|Overall Study||72
7861247|NCT00905359|19348635|P1|12 Months Follow up|Overall Study||68
7861248|NCT00905359|19348634|P2|STARTED|Overall Study||81
7861249|NCT00905359|19348635|P1|STARTED|Overall Study||82
7861250|NCT00905346|19348671|P2|NOT COMPLETED|Period 2||0
7861251|NCT00905346|19348672|P1|NOT COMPLETED|Period 2||0
7861252|NCT00905346|19348671|P2|COMPLETED|Period 2||11
7861253|NCT00905346|19348672|P1|COMPLETED|Period 2||10
7861254|NCT00905346|19348671|P2|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|11
7861255|NCT00905346|19348672|P1|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|10
7861256|NCT00905346|19348671|P2|NOT COMPLETED|Period 1||0
7861257|NCT00905346|19348672|P1|NOT COMPLETED|Period 1||1
7861258|NCT00905346|19348671|P2|COMPLETED|Period 1||12
7861259|NCT00905346|19348672|P1|COMPLETED|Period 1||11
7861260|NCT00905346|19348671|P2|STARTED|Period 1||12
7861261|NCT00905346|19348672|P1|STARTED|Period 1||12
7861262|NCT00905307|19348686|P6|NOT COMPLETED|Overall Study||42
7861263|NCT00905307|19348687|P5|NOT COMPLETED|Overall Study||16
7861264|NCT00905307|19348688|P4|NOT COMPLETED|Overall Study||37
7861265|NCT00905307|19348689|P3|NOT COMPLETED|Overall Study||37
7861266|NCT00905307|19348690|P2|NOT COMPLETED|Overall Study||37
7861267|NCT00905307|19348691|P1|NOT COMPLETED|Overall Study||22
7861268|NCT00905307|19348686|P6|COMPLETED|Overall Study||53
7861269|NCT00905307|19348687|P5|COMPLETED|Overall Study||34
7861270|NCT00905307|19348688|P4|COMPLETED|Overall Study||56
7861271|NCT00905307|19348689|P3|COMPLETED|Overall Study||53
7861272|NCT00905307|19348690|P2|COMPLETED|Overall Study||52
7861273|NCT00905307|19348691|P1|COMPLETED|Overall Study||20
7861274|NCT00905307|19348686|P6|STARTED|Overall Study||95
7861275|NCT00905307|19348687|P5|STARTED|Overall Study||50
7861276|NCT00905307|19348688|P4|STARTED|Overall Study||93
7861277|NCT00905307|19348689|P3|STARTED|Overall Study||90
7861278|NCT00905307|19348690|P2|STARTED|Overall Study||89
7861279|NCT00905307|19348691|P1|STARTED|Overall Study||42
7861280|NCT00905268|19348751|P4|NOT COMPLETED|Overall Study||2
7861281|NCT00905268|19348752|P3|NOT COMPLETED|Overall Study||0
7861282|NCT00905268|19348753|P2|NOT COMPLETED|Overall Study||1
7861283|NCT00905268|19348754|P1|NOT COMPLETED|Overall Study||4
7861284|NCT00905268|19348751|P4|COMPLETED|Overall Study||57
7861285|NCT00905268|19348752|P3|COMPLETED|Overall Study||59
7861286|NCT00905268|19348753|P2|COMPLETED|Overall Study||56
7861287|NCT00905268|19348754|P1|COMPLETED|Overall Study||53
7861288|NCT00905268|19348751|P4|STARTED|Overall Study||59
7861289|NCT00905268|19348752|P3|STARTED|Overall Study||59
7861290|NCT00905268|19348753|P2|STARTED|Overall Study||57
7861291|NCT00905268|19348754|P1|STARTED|Overall Study||57
7861292|NCT00905255|19348786|P2|NOT COMPLETED|Overall Study||9
7861293|NCT00905255|19348787|P1|NOT COMPLETED|Overall Study||13
7861294|NCT00905255|19348786|P2|COMPLETED|Overall Study||27
7861295|NCT00905255|19348787|P1|COMPLETED|Overall Study||20
7861296|NCT00905255|19348786|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||36
7861297|NCT00905255|19348787|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33
7861298|NCT00905255|19348786|P2|Safety Population|Overall Study||36
7861299|NCT00905255|19348787|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33
7861300|NCT00905255|19348786|P2|STARTED|Overall Study||36
7861301|NCT00905255|19348787|P1|STARTED|Overall Study|Randomized.|33
7861302|NCT00905164|19348805|P2|NOT COMPLETED|Period 2||0
7861303|NCT00905164|19348806|P1|NOT COMPLETED|Period 2||0
7861304|NCT00905164|19348805|P2|COMPLETED|Period 2||11
7861305|NCT00905164|19348806|P1|COMPLETED|Period 2||12
7861306|NCT00905164|19348805|P2|STARTED|Period 2||11
7861307|NCT00905164|19348806|P1|STARTED|Period 2||12
7861308|NCT00905164|19348805|P2|NOT COMPLETED|Period 1||1
7861309|NCT00905164|19348806|P1|NOT COMPLETED|Period 1||0
7861310|NCT00905164|19348805|P2|COMPLETED|Period 1||11
7861311|NCT00905164|19348806|P1|COMPLETED|Period 1||12
7861312|NCT00905164|19348805|P2|STARTED|Period 1||12
7861313|NCT00905164|19348806|P1|STARTED|Period 1||12
7861314|NCT00905151|19348814|P1|NOT COMPLETED|Overall Study||6
7861315|NCT00905151|19348814|P1|COMPLETED|Overall Study||200
7861316|NCT00905151|19348814|P1|STARTED|Overall Study||206
7861317|NCT00905125|19348820|P2|NOT COMPLETED|Overall Study||3
7861318|NCT00905125|19348821|P1|NOT COMPLETED|Overall Study||4
7861319|NCT00905125|19348820|P2|COMPLETED|Overall Study||53
7861320|NCT00905125|19348821|P1|COMPLETED|Overall Study||42
7861321|NCT00905125|19348820|P2|STARTED|Overall Study||56
7861322|NCT00905125|19348821|P1|STARTED|Overall Study||46
7861323|NCT00905034|19348853|P1|NOT COMPLETED|Overall Study||1
7861324|NCT00905034|19348853|P1|COMPLETED|Overall Study||36
7861325|NCT00905034|19348853|P1|STARTED|Overall Study||37
7861326|NCT00905021|19348857|P1|NOT COMPLETED|Overall Study||2
7861327|NCT00905021|19348857|P1|COMPLETED|Overall Study|2 patients were off study due to AE.|2
7861328|NCT00905021|19348857|P1|STARTED|Overall Study||4
7861329|NCT00904995|19348866|P2|NOT COMPLETED|Overall Study||0
7861330|NCT00904995|19348867|P1|NOT COMPLETED|Overall Study||0
7861331|NCT00904995|19348866|P2|COMPLETED|Overall Study||11
7861332|NCT00904995|19348867|P1|COMPLETED|Overall Study||10
7861333|NCT00904995|19348866|P2|STARTED|Overall Study||11
7861334|NCT00904995|19348867|P1|STARTED|Overall Study||10
7861335|NCT00904982|19348877|P4|NOT COMPLETED|Overall Study||0
7861336|NCT00904982|19348878|P3|NOT COMPLETED|Overall Study||0
7861337|NCT00904982|19348879|P2|NOT COMPLETED|Overall Study||0
7861338|NCT00904982|19348880|P1|NOT COMPLETED|Overall Study||2
7861339|NCT00904982|19348877|P4|COMPLETED|Overall Study||68
7861340|NCT00904982|19348878|P3|COMPLETED|Overall Study||67
7861341|NCT00904982|19348879|P2|COMPLETED|Overall Study||67
7861342|NCT00904982|19348880|P1|COMPLETED|Overall Study||66
7861343|NCT00904982|19348877|P4|STARTED|Overall Study||68
7861344|NCT00904982|19348878|P3|STARTED|Overall Study||67
7861345|NCT00904982|19348879|P2|STARTED|Overall Study||67
7861346|NCT00904982|19348880|P1|STARTED|Overall Study||68
7861347|NCT00904969|19348890|P1|NOT COMPLETED|Overall Study||19
7861348|NCT00904969|19348890|P1|COMPLETED|Overall Study|# of Implanted Subjects Who Completed the Study|31
7861349|NCT00904969|19348890|P1|STARTED|Overall Study|Number of patients with an attempted implant; 1 subject with procedure aborted|50
7861350|NCT00904943|19348942|P2|NOT COMPLETED|Period 2||0
7861351|NCT00904943|19348943|P1|NOT COMPLETED|Period 2||0
7861352|NCT00904943|19348942|P2|COMPLETED|Period 2||8
7861353|NCT00904943|19348943|P1|COMPLETED|Period 2||9
7861354|NCT00904943|19348942|P2|STARTED|Period 2|one subject was withdrawn prior to Pd. 2 dosing|8
7861355|NCT00904943|19348943|P1|STARTED|Period 2||9
7861356|NCT00904943|19348942|P2|NOT COMPLETED|Period 1||0
7861357|NCT00904943|19348943|P1|NOT COMPLETED|Period 1||0
7861358|NCT00904943|19348942|P2|COMPLETED|Period 1||9
7861359|NCT00904943|19348943|P1|COMPLETED|Period 1||9
7861360|NCT00904943|19348942|P2|STARTED|Period 1||9
7861361|NCT00904943|19348943|P1|STARTED|Period 1||9
7861362|NCT00904917|19348955|P4|NOT COMPLETED|Overall Study||2
7861363|NCT00904917|19348956|P3|NOT COMPLETED|Overall Study||2
7861364|NCT00904917|19348957|P2|NOT COMPLETED|Overall Study||2
7861365|NCT00904917|19348958|P1|NOT COMPLETED|Overall Study||2
7861366|NCT00904917|19348955|P4|COMPLETED|Overall Study||6
7861367|NCT00904917|19348956|P3|COMPLETED|Overall Study||6
7861368|NCT00904917|19348957|P2|COMPLETED|Overall Study||9
7861369|NCT00904917|19348958|P1|COMPLETED|Overall Study||5
7861370|NCT00904917|19348955|P4|STARTED|Overall Study||8
7861371|NCT00904917|19348956|P3|STARTED|Overall Study||8
7861372|NCT00904917|19348957|P2|STARTED|Overall Study||11
7861373|NCT00904917|19348958|P1|STARTED|Overall Study||7
7861374|NCT00904839|19348976|P3|NOT COMPLETED|Overall Study||15
7861375|NCT00904839|19348977|P2|NOT COMPLETED|Overall Study||18
7861376|NCT00904839|19348978|P1|NOT COMPLETED|Overall Study||1
7861377|NCT00904839|19348976|P3|COMPLETED|Overall Study||27
7861378|NCT00904839|19348977|P2|COMPLETED|Overall Study||64
7861379|NCT00904839|19348978|P1|COMPLETED|Overall Study||3
7861380|NCT00904839|19348976|P3|STARTED|Overall Study|Randomised|42
7861381|NCT00904839|19348977|P2|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82
7861382|NCT00904839|19348978|P1|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4
7861383|NCT00904826|19349012|P1|NOT COMPLETED|Overall Study||0
7861384|NCT00904826|19349012|P1|COMPLETED|Overall Study||14
7861385|NCT00904826|19349012|P1|STARTED|Overall Study||14
7861386|NCT00904748|19349024|P6|NOT COMPLETED|Overall Study||0
7861387|NCT00904748|19349025|P5|NOT COMPLETED|Overall Study||1
7861388|NCT00904748|19349026|P4|NOT COMPLETED|Overall Study||2
7861389|NCT00904748|19349027|P3|NOT COMPLETED|Overall Study||1
7861390|NCT00904748|19349028|P2|NOT COMPLETED|Overall Study||1
7861391|NCT00904748|19349029|P1|NOT COMPLETED|Overall Study||1
7861392|NCT00904748|19349024|P6|COMPLETED|Overall Study||8
7861393|NCT00904748|19349025|P5|COMPLETED|Overall Study||7
7861394|NCT00904748|19349026|P4|COMPLETED|Overall Study||6
7861395|NCT00904748|19349027|P3|COMPLETED|Overall Study||7
7861396|NCT00904748|19349028|P2|COMPLETED|Overall Study||7
7861397|NCT00904748|19349029|P1|COMPLETED|Overall Study||7
7861398|NCT00904748|19349024|P6|Received Treatment|Overall Study||8
7861399|NCT00904748|19349025|P5|Received Treatment|Overall Study||7
7861400|NCT00904748|19349026|P4|Received Treatment|Overall Study||8
7861401|NCT00904748|19349027|P3|Received Treatment|Overall Study||8
7861402|NCT00904748|19349028|P2|Received Treatment|Overall Study||8
7861403|NCT00904748|19349029|P1|Received Treatment|Overall Study||8
7861404|NCT00904748|19349024|P6|STARTED|Overall Study||8
7861405|NCT00904748|19349025|P5|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8
7861406|NCT00904748|19349026|P4|STARTED|Overall Study||8
7861407|NCT00904748|19349027|P3|STARTED|Overall Study||8
7861408|NCT00904748|19349028|P2|STARTED|Overall Study||8
7861409|NCT00904748|19349029|P1|STARTED|Overall Study||8
7861410|NCT00904722|19349053|P1|NOT COMPLETED|Overall Study||1
7861411|NCT00904722|19349053|P1|COMPLETED|Overall Study||29
7861412|NCT00904722|19349053|P1|STARTED|Overall Study||30
7861413|NCT00904670|19349058|P2|NOT COMPLETED|Second Intervention Period||0
7861414|NCT00904670|19349059|P1|NOT COMPLETED|Second Intervention Period||0
7861415|NCT00904670|19349058|P2|COMPLETED|Second Intervention Period||22
7861416|NCT00904670|19349059|P1|COMPLETED|Second Intervention Period||17
7861417|NCT00904670|19349058|P2|STARTED|Second Intervention Period||22
7861418|NCT00904670|19349059|P1|STARTED|Second Intervention Period||17
7861419|NCT00904670|19349058|P2|NOT COMPLETED|First Intervention Period||0
7861420|NCT00904670|19349059|P1|NOT COMPLETED|First Intervention Period||0
7861421|NCT00904670|19349058|P2|COMPLETED|First Intervention Period||22
7861422|NCT00904670|19349059|P1|COMPLETED|First Intervention Period||17
7861423|NCT00904670|19349058|P2|STARTED|First Intervention Period||22
7861424|NCT00904670|19349059|P1|STARTED|First Intervention Period||17
7861425|NCT00904670|19349058|P2|NOT COMPLETED|Open Label Phase||0
7861426|NCT00904670|19349059|P1|NOT COMPLETED|Open Label Phase||6
7861427|NCT00904670|19349058|P2|COMPLETED|Open Label Phase||22
7861428|NCT00904670|19349059|P1|COMPLETED|Open Label Phase||17
7861429|NCT00904670|19349058|P2|STARTED|Open Label Phase||22
7861430|NCT00904670|19349059|P1|STARTED|Open Label Phase||23
7861431|NCT00904618|19349080|P1|NOT COMPLETED|Overall Study||0
7861432|NCT00904618|19349080|P1|COMPLETED|Overall Study||48
7861433|NCT00904618|19349080|P1|STARTED|Overall Study||48
7861434|NCT00904488|19349090|P2|NOT COMPLETED|Overall Study||0
7861435|NCT00904488|19349091|P1|NOT COMPLETED|Overall Study||0
7861436|NCT00904488|19349090|P2|COMPLETED|Overall Study||6
7861437|NCT00904488|19349091|P1|COMPLETED|Overall Study||5
7861438|NCT00904488|19349090|P2|STARTED|Overall Study||6
7861439|NCT00904488|19349091|P1|STARTED|Overall Study||5
7861440|NCT00904423|19349121|P1|NOT COMPLETED|Overall Study||0
7861441|NCT00904423|19349121|P1|COMPLETED|Overall Study||8
7861442|NCT00904423|19349121|P1|STARTED|Overall Study||8
7861443|NCT00904371|19349129|P1|NOT COMPLETED|Overall Study||9
7861444|NCT00904371|19349129|P1|COMPLETED|Overall Study||202
7861445|NCT00904371|19349129|P1|STARTED|Overall Study||211
7861446|NCT00904215|19349143|P1|NOT COMPLETED|Overall Study||135
7861447|NCT00904215|19349143|P1|COMPLETED|Overall Study||960
7861448|NCT00904215|19349143|P1|STARTED|Overall Study||1095
7861449|NCT00904189|19349150|P1|NOT COMPLETED|Overall Study||0
7861450|NCT00904189|19349150|P1|COMPLETED|Overall Study||2
7861451|NCT00904189|19349150|P1|STARTED|Overall Study||2
7861452|NCT00904150|19349157|P2|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
7861453|NCT00904150|19349158|P1|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
7861454|NCT00904150|19349157|P2|COMPLETED|Blood Samples (RNA): Luteal Phase||30
7861455|NCT00904150|19349158|P1|COMPLETED|Blood Samples (RNA): Luteal Phase||34
7861456|NCT00904150|19349157|P2|STARTED|Blood Samples (RNA): Luteal Phase||30
7861457|NCT00904150|19349158|P1|STARTED|Blood Samples (RNA): Luteal Phase||34
7861458|NCT00904150|19349157|P2|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
7861459|NCT00904150|19349158|P1|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
7861460|NCT00904150|19349157|P2|COMPLETED|Blood Samples (RNA): Follicular Phase||32
7861461|NCT00904150|19349158|P1|COMPLETED|Blood Samples (RNA): Follicular Phase||37
7861462|NCT00904150|19349157|P2|STARTED|Blood Samples (RNA): Follicular Phase||32
7861463|NCT00904150|19349158|P1|STARTED|Blood Samples (RNA): Follicular Phase||37
7861464|NCT00904150|19349157|P2|NOT COMPLETED|Saliva Samples (DNA)||145
7861465|NCT00904150|19349158|P1|NOT COMPLETED|Saliva Samples (DNA)||3
7861466|NCT00904150|19349157|P2|COMPLETED|Saliva Samples (DNA)||155
7861467|NCT00904150|19349158|P1|COMPLETED|Saliva Samples (DNA)||282
7861468|NCT00904150|19349157|P2|STARTED|Saliva Samples (DNA)||300
7861469|NCT00904150|19349158|P1|STARTED|Saliva Samples (DNA)||285
7861470|NCT00904033|19349180|P4|NOT COMPLETED|Overall Study||2
7861471|NCT00904033|19349181|P3|NOT COMPLETED|Overall Study||1
7861472|NCT00904033|19349182|P2|NOT COMPLETED|Overall Study||1
7861473|NCT00904033|19349183|P1|NOT COMPLETED|Overall Study||1
7861474|NCT00904033|19349180|P4|COMPLETED|Overall Study||9
7861475|NCT00904033|19349181|P3|COMPLETED|Overall Study||9
7861476|NCT00904033|19349182|P2|COMPLETED|Overall Study||9
7861477|NCT00904033|19349183|P1|COMPLETED|Overall Study||9
7861478|NCT00904033|19349180|P4|STARTED|Overall Study||11
7861479|NCT00904033|19349181|P3|STARTED|Overall Study||10
7861480|NCT00904033|19349182|P2|STARTED|Overall Study||10
7861481|NCT00904033|19349183|P1|STARTED|Overall Study||10
7861482|NCT00904007|19349207|P2|NOT COMPLETED|Overall Study||0
7861483|NCT00904007|19349208|P1|NOT COMPLETED|Overall Study||0
7861484|NCT00904007|19349207|P2|COMPLETED|Overall Study||56
7861485|NCT00904007|19349208|P1|COMPLETED|Overall Study||55
7861486|NCT00904007|19349207|P2|STARTED|Overall Study||56
7861487|NCT00904007|19349208|P1|STARTED|Overall Study||55
7861488|NCT00903968|19349248|P8|NOT COMPLETED|Overall Study||33
7861489|NCT00903968|19349249|P7|NOT COMPLETED|Overall Study||3
7861490|NCT00903968|19349250|P6|NOT COMPLETED|Overall Study||6
7861491|NCT00903968|19349251|P5|NOT COMPLETED|Overall Study||4
7861492|NCT00903968|19349252|P4|NOT COMPLETED|Overall Study||3
7861493|NCT00903968|19349253|P3|NOT COMPLETED|Overall Study||3
7861494|NCT00903968|19349254|P2|NOT COMPLETED|Overall Study||3
7861495|NCT00903968|19349255|P1|NOT COMPLETED|Overall Study||3
7861496|NCT00903968|19349248|P8|COMPLETED|Overall Study||0
7861497|NCT00903968|19349249|P7|COMPLETED|Overall Study||0
7861498|NCT00903968|19349250|P6|COMPLETED|Overall Study||0
7861499|NCT00903968|19349251|P5|COMPLETED|Overall Study||0
7861500|NCT00903968|19349252|P4|COMPLETED|Overall Study||0
7861501|NCT00903968|19349253|P3|COMPLETED|Overall Study||0
7861502|NCT00903968|19349254|P2|COMPLETED|Overall Study||0
7861503|NCT00903968|19349255|P1|COMPLETED|Overall Study||0
7861504|NCT00903968|19349248|P8|STARTED|Overall Study||33
7861505|NCT00903968|19349249|P7|STARTED|Overall Study||3
7861506|NCT00903968|19349250|P6|STARTED|Overall Study||6
7861507|NCT00903968|19349251|P5|STARTED|Overall Study||4
7861508|NCT00903968|19349252|P4|STARTED|Overall Study||3
7861509|NCT00903968|19349253|P3|STARTED|Overall Study||3
7861510|NCT00903968|19349254|P2|STARTED|Overall Study||3
7861511|NCT00903968|19349255|P1|STARTED|Overall Study||3
7861512|NCT00903929|19349285|P4|NOT COMPLETED|Overall Study||3
7861513|NCT00903929|19349286|P3|NOT COMPLETED|Overall Study||1
7861514|NCT00903929|19349287|P2|NOT COMPLETED|Overall Study||0
7861515|NCT00903929|19349288|P1|NOT COMPLETED|Overall Study||0
7861516|NCT00903929|19349285|P4|COMPLETED|Overall Study||6
7861517|NCT00903929|19349286|P3|COMPLETED|Overall Study||3
7861518|NCT00903929|19349287|P2|COMPLETED|Overall Study||3
7861519|NCT00903929|19349288|P1|COMPLETED|Overall Study||3
7861520|NCT00903929|19349285|P4|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9
7861521|NCT00903929|19349286|P3|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4
7861522|NCT00903929|19349287|P2|STARTED|Overall Study||3
7861523|NCT00903929|19349288|P1|STARTED|Overall Study||3
7861524|NCT00903877|19349294|P1|NOT COMPLETED|Overall Study||43
7861525|NCT00903877|19349294|P1|COMPLETED|Overall Study||8
7861526|NCT00903877|19349294|P1|STARTED|Overall Study||51
7861527|NCT00903786|19349298|P1|NOT COMPLETED|Overall Study||15
7861528|NCT00903786|19349298|P1|COMPLETED|Overall Study||6
7861529|NCT00903786|19349298|P1|STARTED|Overall Study||21
7861530|NCT00903760|19349308|P2|NOT COMPLETED|Overall Study||16
7861531|NCT00903760|19349309|P1|NOT COMPLETED|Overall Study||19
7861532|NCT00903760|19349308|P2|COMPLETED|Overall Study|Completed all 24 courses|2
7861533|NCT00903760|19349309|P1|COMPLETED|Overall Study|Completed all 24 courses|0
7861534|NCT00903760|19349308|P2|STARTED|Overall Study||18
7861535|NCT00903760|19349309|P1|STARTED|Overall Study||19
7861536|NCT00903695|19349319|P2|NOT COMPLETED|Overall Study||0
7861537|NCT00903695|19349320|P1|NOT COMPLETED|Overall Study||2
7861538|NCT00903695|19349319|P2|COMPLETED|Overall Study||2
7861539|NCT00903695|19349320|P1|COMPLETED|Overall Study||6
7861540|NCT00903695|19349319|P2|STARTED|Overall Study||2
7861541|NCT00903695|19349320|P1|STARTED|Overall Study||8
7861542|NCT00903682|19349342|P2|NOT COMPLETED|Overall Study||15
7861543|NCT00903682|19349343|P1|NOT COMPLETED|Overall Study||16
7861544|NCT00903682|19349342|P2|COMPLETED|Overall Study||63
7861545|NCT00903682|19349343|P1|COMPLETED|Overall Study||63
7861546|NCT00903682|19349342|P2|STARTED|Overall Study||78
7861547|NCT00903682|19349343|P1|STARTED|Overall Study||79
7861548|NCT00903630|19349364|P3|NOT COMPLETED|Phase 2||1
7861549|NCT00903630|19349365|P2|NOT COMPLETED|Phase 2||0
7861550|NCT00903630|19349366|P1|NOT COMPLETED|Phase 2||0
7861551|NCT00903630|19349364|P3|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3
7861552|NCT00903630|19349365|P2|COMPLETED|Phase 2||0
7861553|NCT00903630|19349366|P1|COMPLETED|Phase 2||6
7861554|NCT00903630|19349364|P3|STARTED|Phase 2||4
7861555|NCT00903630|19349365|P2|STARTED|Phase 2||0
7861556|NCT00903630|19349366|P1|STARTED|Phase 2||6
7861557|NCT00903630|19349364|P3|NOT COMPLETED|Phase l||0
7861558|NCT00903630|19349365|P2|NOT COMPLETED|Phase l||0
7861559|NCT00903630|19349366|P1|NOT COMPLETED|Phase l||0
7861560|NCT00903630|19349364|P3|COMPLETED|Phase l||0
7861561|NCT00903630|19349365|P2|COMPLETED|Phase l||5
7861562|NCT00903630|19349366|P1|COMPLETED|Phase l||6
7861563|NCT00903630|19349364|P3|STARTED|Phase l||0
7861564|NCT00903630|19349365|P2|STARTED|Phase l||5
7861565|NCT00903630|19349366|P1|STARTED|Phase l||6
7861566|NCT00903617|19349384|P4|NOT COMPLETED|Overall Study||1
7861567|NCT00903617|19349385|P3|NOT COMPLETED|Overall Study||5
7861568|NCT00903617|19349386|P2|NOT COMPLETED|Overall Study||5
7861569|NCT00903617|19349387|P1|NOT COMPLETED|Overall Study||3
7861570|NCT00903617|19349384|P4|COMPLETED|Overall Study||20
7861571|NCT00903617|19349385|P3|COMPLETED|Overall Study||15
7861572|NCT00903617|19349386|P2|COMPLETED|Overall Study||15
7861573|NCT00903617|19349387|P1|COMPLETED|Overall Study||16
7861574|NCT00903617|19349384|P4|STARTED|Overall Study||21
7861575|NCT00903617|19349385|P3|STARTED|Overall Study||20
7861576|NCT00903617|19349386|P2|STARTED|Overall Study||20
7861577|NCT00903617|19349387|P1|STARTED|Overall Study||19
7861578|NCT00903448|19349481|P2|NOT COMPLETED|Period 3: 5 Days||0
7861579|NCT00903448|19349482|P1|NOT COMPLETED|Period 3: 5 Days||0
7861580|NCT00903448|19349481|P2|COMPLETED|Period 3: 5 Days||20
7861581|NCT00903448|19349482|P1|COMPLETED|Period 3: 5 Days||20
7861582|NCT00903448|19349481|P2|STARTED|Period 3: 5 Days||20
7861583|NCT00903448|19349482|P1|STARTED|Period 3: 5 Days||20
7861584|NCT00903448|19349481|P2|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
7861585|NCT00903448|19349482|P1|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
7861586|NCT00903448|19349481|P2|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
7861587|NCT00903448|19349482|P1|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
7861588|NCT00903448|19349481|P2|STARTED|Period 2: 5 Days Then 10 Day Washout||20
7861589|NCT00903448|19349482|P1|STARTED|Period 2: 5 Days Then 10 Day Washout||20
7861590|NCT00903448|19349481|P2|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
7861591|NCT00903448|19349482|P1|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
7861592|NCT00903448|19349481|P2|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
7861593|NCT00903448|19349482|P1|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
7861594|NCT00903448|19349481|P2|STARTED|Period 1: 5 Days Then 10 Day Washout||20
7861595|NCT00903448|19349482|P1|STARTED|Period 1: 5 Days Then 10 Day Washout||20
7861596|NCT00903409|19349490|P2|NOT COMPLETED|Overall Study||27
7861597|NCT00903409|19349491|P1|NOT COMPLETED|Overall Study||26
7861598|NCT00903409|19349490|P2|COMPLETED|Overall Study||73
7861599|NCT00903409|19349491|P1|COMPLETED|Overall Study||62
7861600|NCT00903409|19349490|P2|STARTED|Overall Study||100
7861601|NCT00903409|19349491|P1|STARTED|Overall Study||88
7861602|NCT00903396|19349509|P4|NOT COMPLETED|Overall Study||0
7861603|NCT00903396|19349510|P3|NOT COMPLETED|Overall Study||0
7861604|NCT00903396|19349511|P2|NOT COMPLETED|Overall Study||0
7861605|NCT00903396|19349512|P1|NOT COMPLETED|Overall Study||0
7861606|NCT00903396|19349509|P4|COMPLETED|Overall Study||1
7861607|NCT00903396|19349510|P3|COMPLETED|Overall Study||3
7861608|NCT00903396|19349511|P2|COMPLETED|Overall Study||1
7861609|NCT00903396|19349512|P1|COMPLETED|Overall Study||2
7861610|NCT00903396|19349509|P4|STARTED|Overall Study||1
7861611|NCT00903396|19349510|P3|STARTED|Overall Study||3
7861612|NCT00903396|19349511|P2|STARTED|Overall Study||1
7861613|NCT00903396|19349512|P1|STARTED|Overall Study||2
7861614|NCT00903383|19349542|P4|NOT COMPLETED|Overall Study||5
7861615|NCT00903383|19349543|P3|NOT COMPLETED|Overall Study||3
7861616|NCT00903383|19349544|P2|NOT COMPLETED|Overall Study||6
7861617|NCT00903383|19349545|P1|NOT COMPLETED|Overall Study||7
7861618|NCT00903383|19349542|P4|COMPLETED|Overall Study||44
7861619|NCT00903383|19349543|P3|COMPLETED|Overall Study||47
7861620|NCT00903383|19349544|P2|COMPLETED|Overall Study||48
7861621|NCT00903383|19349545|P1|COMPLETED|Overall Study||48
7861622|NCT00903383|19349542|P4|STARTED|Overall Study||49
7861623|NCT00903383|19349543|P3|STARTED|Overall Study||50
7861624|NCT00903383|19349544|P2|STARTED|Overall Study||54
7861625|NCT00903383|19349545|P1|STARTED|Overall Study||55
7861626|NCT00903370|19349577|P2|NOT COMPLETED|Overall Study||24
7861627|NCT00903370|19349578|P1|NOT COMPLETED|Overall Study||28
7861628|NCT00903370|19349577|P2|COMPLETED|Overall Study||109
7861629|NCT00903370|19349578|P1|COMPLETED|Overall Study||99
7861630|NCT00903370|19349577|P2|STARTED|Overall Study||133
7861631|NCT00903370|19349578|P1|STARTED|Overall Study||127
7861632|NCT00903357|19349586|P2|NOT COMPLETED|Second Intervention||0
7861633|NCT00903357|19349587|P1|NOT COMPLETED|Second Intervention||1
7861634|NCT00903357|19349586|P2|COMPLETED|Second Intervention||22
7861635|NCT00903357|19349587|P1|COMPLETED|Second Intervention||21
7861636|NCT00903357|19349586|P2|STARTED|Second Intervention||22
7861637|NCT00903357|19349587|P1|STARTED|Second Intervention||22
7861638|NCT00903357|19349586|P2|NOT COMPLETED|Wash Out Period of 2 Weeks||1
7861639|NCT00903357|19349587|P1|NOT COMPLETED|Wash Out Period of 2 Weeks||0
7861640|NCT00903357|19349586|P2|COMPLETED|Wash Out Period of 2 Weeks||22
7861641|NCT00903357|19349587|P1|COMPLETED|Wash Out Period of 2 Weeks||22
7861642|NCT00903357|19349586|P2|STARTED|Wash Out Period of 2 Weeks||23
7861643|NCT00903357|19349587|P1|STARTED|Wash Out Period of 2 Weeks||22
7861644|NCT00903357|19349586|P2|NOT COMPLETED|First Intervention||4
7861645|NCT00903357|19349587|P1|NOT COMPLETED|First Intervention||5
7861646|NCT00903357|19349586|P2|COMPLETED|First Intervention||23
7861647|NCT00903357|19349587|P1|COMPLETED|First Intervention||22
7861648|NCT00903357|19349586|P2|STARTED|First Intervention||27
7861649|NCT00903357|19349587|P1|STARTED|First Intervention||27
7861650|NCT00903344|19349599|P2|NOT COMPLETED|Overall Study||3
7861651|NCT00903344|19349600|P1|NOT COMPLETED|Overall Study||5
7861652|NCT00903344|19349599|P2|COMPLETED|Overall Study||7
7861653|NCT00903344|19349600|P1|COMPLETED|Overall Study||7
7861654|NCT00903344|19349599|P2|6 Month Visit|Overall Study||10
7861655|NCT00903344|19349600|P1|6 Month Visit|Overall Study||9
7861656|NCT00903344|19349599|P2|3 Month Visit|Overall Study||10
7861657|NCT00903344|19349600|P1|3 Month Visit|Overall Study||10
7861658|NCT00903344|19349599|P2|STARTED|Overall Study||10
7861659|NCT00903344|19349600|P1|STARTED|Overall Study||12
7861660|NCT00903331|19349618|P2|NOT COMPLETED|Overall Study||18
7861661|NCT00903331|19349619|P1|NOT COMPLETED|Overall Study||5
7861662|NCT00903331|19349618|P2|COMPLETED|Overall Study||101
7861663|NCT00903331|19349619|P1|COMPLETED|Overall Study||54
7861664|NCT00903331|19349618|P2|STARTED|Overall Study||119
7861665|NCT00903331|19349619|P1|STARTED|Overall Study||59
7861666|NCT00903201|19349630|P3|NOT COMPLETED|Overall Study||2
7861667|NCT00903201|19349631|P2|NOT COMPLETED|Overall Study||6
7861668|NCT00903201|19349632|P1|NOT COMPLETED|Overall Study||5
7861669|NCT00903201|19349630|P3|COMPLETED|Overall Study||39
7861670|NCT00903201|19349631|P2|COMPLETED|Overall Study||38
7861671|NCT00903201|19349632|P1|COMPLETED|Overall Study||56
7861672|NCT00903201|19349630|P3|STARTED|Overall Study||41
7861673|NCT00903201|19349631|P2|STARTED|Overall Study||44
7861674|NCT00903201|19349632|P1|STARTED|Overall Study||61
7861675|NCT00903175|19349690|P2|NOT COMPLETED|Period 2 - Second Line||36
7861676|NCT00903175|19349691|P1|NOT COMPLETED|Period 2 - Second Line||49
7861677|NCT00903175|19349690|P2|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80
7861678|NCT00903175|19349691|P1|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79
7861679|NCT00903175|19349690|P2|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116
7861680|NCT00903175|19349691|P1|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128
7861681|NCT00903175|19349690|P2|NOT COMPLETED|Period 1 - First Line||89
7861682|NCT00903175|19349691|P1|NOT COMPLETED|Period 1 - First Line||77
7861683|NCT00903175|19349690|P2|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142
7861684|NCT00903175|19349691|P1|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161
7861685|NCT00903175|19349690|P2|STARTED|Period 1 - First Line||231
7861686|NCT00903175|19349691|P1|STARTED|Period 1 - First Line||238
7861687|NCT00903162|19349721|P1|NOT COMPLETED|Overall Study||4
7861688|NCT00903162|19349721|P1|COMPLETED|Overall Study||12
7861689|NCT00903162|19349721|P1|STARTED|Overall Study||16
7861690|NCT00903032|19349729|P2|NOT COMPLETED|Overall Study||5
7861691|NCT00903032|19349730|P1|NOT COMPLETED|Overall Study||7
7861692|NCT00903032|19349729|P2|COMPLETED|Overall Study||119
7861693|NCT00903032|19349730|P1|COMPLETED|Overall Study||122
7861694|NCT00903032|19349729|P2|STARTED|Overall Study||124
7861695|NCT00903032|19349730|P1|STARTED|Overall Study||129
7861696|NCT00903006|19349740|P4|NOT COMPLETED|Overall Study||0
7861697|NCT00903006|19349741|P3|NOT COMPLETED|Overall Study||1
7861698|NCT00903006|19349742|P2|NOT COMPLETED|Overall Study||3
7861699|NCT00903006|19349743|P1|NOT COMPLETED|Overall Study||2
7861700|NCT00903006|19349740|P4|COMPLETED|Overall Study||0
7861701|NCT00903006|19349741|P3|COMPLETED|Overall Study||0
7861702|NCT00903006|19349742|P2|COMPLETED|Overall Study||0
7861703|NCT00903006|19349743|P1|COMPLETED|Overall Study||0
7861704|NCT00903006|19349740|P4|STARTED|Overall Study|Zero participants started due to smaller sample size.|0
7861705|NCT00903006|19349741|P3|STARTED|Overall Study||1
7861706|NCT00903006|19349742|P2|STARTED|Overall Study||3
7861707|NCT00903006|19349743|P1|STARTED|Overall Study||2
7861708|NCT00902850|19349755|P2|NOT COMPLETED|Overall Study||2
7861709|NCT00902850|19349756|P1|NOT COMPLETED|Overall Study||2
7861710|NCT00902850|19349755|P2|COMPLETED|Overall Study||12
7861711|NCT00902850|19349756|P1|COMPLETED|Overall Study||12
7861712|NCT00902850|19349755|P2|STARTED|Overall Study||14
7861713|NCT00902850|19349756|P1|STARTED|Overall Study||14
7861714|NCT00902746|19349762|P1|NOT COMPLETED|Overall Study||36
7861715|NCT00902746|19349762|P1|COMPLETED|Overall Study||113
7861716|NCT00902746|19349762|P1|Transfer to Step 2|Overall Study||133
7861717|NCT00902746|19349762|P1|Initiation of Study Drug Administration|Overall Study||148
7861718|NCT00902746|19349762|P1|STARTED|Overall Study||149
7861719|NCT00902668|19349767|P1|NOT COMPLETED|Overall Study||3
7861720|NCT00902668|19349767|P1|COMPLETED|Overall Study||0
7861721|NCT00902668|19349767|P1|STARTED|Overall Study||3
7861722|NCT00902577|19349771|P1|NOT COMPLETED|Overall Study||8
7861723|NCT00902577|19349771|P1|COMPLETED|Overall Study||42
7861724|NCT00902577|19349771|P1|DWI MRI|Overall Study||39
7861725|NCT00902577|19349771|P1|DSE MRI|Overall Study||37
7861726|NCT00902577|19349771|P1|DCE MRI|Overall Study||31
7861727|NCT00902577|19349771|P1|FMISO/PET|Overall Study||38
7861728|NCT00902577|19349771|P1|STARTED|Overall Study||50
7861729|NCT00902564|19349800|P1|NOT COMPLETED|Overall Study||2
7861730|NCT00902564|19349800|P1|COMPLETED|Overall Study||28
7861731|NCT00902564|19349800|P1|STARTED|Overall Study||30
7861732|NCT00902538|19349815|P6|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1
7861733|NCT00902538|19349816|P5|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2
7861734|NCT00902538|19349817|P4|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9
7861735|NCT00902538|19349818|P3|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
7861736|NCT00902538|19349819|P2|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
7861737|NCT00902538|19349820|P1|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
7861738|NCT00902538|19349815|P6|COMPLETED|4-Randomized Double-blind 2 Treatments||196
7861739|NCT00902538|19349816|P5|COMPLETED|4-Randomized Double-blind 2 Treatments||95
7861740|NCT00902538|19349817|P4|COMPLETED|4-Randomized Double-blind 2 Treatments||458
7861741|NCT00902538|19349818|P3|COMPLETED|4-Randomized Double-blind 2 Treatments||0
7861742|NCT00902538|19349819|P2|COMPLETED|4-Randomized Double-blind 2 Treatments||0
7861743|NCT00902538|19349820|P1|COMPLETED|4-Randomized Double-blind 2 Treatments||0
7861744|NCT00902538|19349815|P6|STARTED|4-Randomized Double-blind 2 Treatments||197
7861745|NCT00902538|19349816|P5|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97
7861746|NCT00902538|19349817|P4|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467
7861747|NCT00902538|19349818|P3|STARTED|4-Randomized Double-blind 2 Treatments||0
7861748|NCT00902538|19349819|P2|STARTED|4-Randomized Double-blind 2 Treatments||0
7861749|NCT00902538|19349820|P1|STARTED|4-Randomized Double-blind 2 Treatments||0
7861750|NCT00902538|19349815|P6|NOT COMPLETED|3-Single-blind, Single Treatment||0
7861751|NCT00902538|19349816|P5|NOT COMPLETED|3-Single-blind, Single Treatment||0
7861752|NCT00902538|19349817|P4|NOT COMPLETED|3-Single-blind, Single Treatment||0
7861753|NCT00902538|19349818|P3|NOT COMPLETED|3-Single-blind, Single Treatment||0
7861754|NCT00902538|19349819|P2|NOT COMPLETED|3-Single-blind, Single Treatment||15
7861755|NCT00902538|19349820|P1|NOT COMPLETED|3-Single-blind, Single Treatment||0
7861756|NCT00902538|19349815|P6|COMPLETED|3-Single-blind, Single Treatment||0
7861757|NCT00902538|19349816|P5|COMPLETED|3-Single-blind, Single Treatment||0
7861758|NCT00902538|19349817|P4|COMPLETED|3-Single-blind, Single Treatment||0
7861759|NCT00902538|19349818|P3|COMPLETED|3-Single-blind, Single Treatment||0
7861760|NCT00902538|19349819|P2|COMPLETED|3-Single-blind, Single Treatment||767
7861761|NCT00902538|19349820|P1|COMPLETED|3-Single-blind, Single Treatment||0
7861762|NCT00902538|19349815|P6|STARTED|3-Single-blind, Single Treatment||0
7861763|NCT00902538|19349816|P5|STARTED|3-Single-blind, Single Treatment||0
7861764|NCT00902538|19349817|P4|STARTED|3-Single-blind, Single Treatment||0
7861765|NCT00902538|19349818|P3|STARTED|3-Single-blind, Single Treatment||0
7861766|NCT00902538|19349819|P2|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782
7861767|NCT00902538|19349820|P1|STARTED|3-Single-blind, Single Treatment||0
7861768|NCT00902538|19349815|P6|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
7861769|NCT00902538|19349816|P5|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
7861770|NCT00902538|19349817|P4|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
7861771|NCT00902538|19349818|P3|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8
7861772|NCT00902538|19349819|P2|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6
7861773|NCT00902538|19349820|P1|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9
7861774|NCT00902538|19349815|P6|COMPLETED|2-Randomized Double-blind 3 Treatments||0
7861775|NCT00902538|19349816|P5|COMPLETED|2-Randomized Double-blind 3 Treatments||0
7861776|NCT00902538|19349817|P4|COMPLETED|2-Randomized Double-blind 3 Treatments||0
7861777|NCT00902538|19349818|P3|COMPLETED|2-Randomized Double-blind 3 Treatments||262
7861778|NCT00902538|19349819|P2|COMPLETED|2-Randomized Double-blind 3 Treatments||263
7861779|NCT00902538|19349820|P1|COMPLETED|2-Randomized Double-blind 3 Treatments||260
7861780|NCT00902538|19349815|P6|STARTED|2-Randomized Double-blind 3 Treatments||0
7861781|NCT00902538|19349816|P5|STARTED|2-Randomized Double-blind 3 Treatments||0
7861782|NCT00902538|19349817|P4|STARTED|2-Randomized Double-blind 3 Treatments||0
7861783|NCT00902538|19349818|P3|STARTED|2-Randomized Double-blind 3 Treatments||270
7861784|NCT00902538|19349819|P2|STARTED|2-Randomized Double-blind 3 Treatments||269
7861785|NCT00902538|19349820|P1|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269
7861786|NCT00902538|19349815|P6|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
7861787|NCT00902538|19349816|P5|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
7861788|NCT00902538|19349817|P4|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
7861789|NCT00902538|19349818|P3|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
7861790|NCT00902538|19349819|P2|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
7861791|NCT00902538|19349820|P1|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118
7861792|NCT00902538|19349815|P6|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
7861793|NCT00902538|19349816|P5|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
7861794|NCT00902538|19349817|P4|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
7861795|NCT00902538|19349818|P3|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
7861796|NCT00902538|19349819|P2|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
7861797|NCT00902538|19349820|P1|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086
7861798|NCT00902538|19349815|P6|STARTED|1-Single-blind, Run-in, Single-Treatment||0
7861799|NCT00902538|19349816|P5|STARTED|1-Single-blind, Run-in, Single-Treatment||0
7861800|NCT00902538|19349817|P4|STARTED|1-Single-blind, Run-in, Single-Treatment||0
7861801|NCT00902538|19349818|P3|STARTED|1-Single-blind, Run-in, Single-Treatment||0
7861802|NCT00902538|19349819|P2|STARTED|1-Single-blind, Run-in, Single-Treatment||0
7861803|NCT00902538|19349820|P1|STARTED|1-Single-blind, Run-in, Single-Treatment||2204
7861804|NCT00902486|19349854|P6|NOT COMPLETED|Follow-up (After Week 24)||0
7861805|NCT00902486|19349855|P5|NOT COMPLETED|Follow-up (After Week 24)||0
7861806|NCT00902486|19349856|P4|NOT COMPLETED|Follow-up (After Week 24)||1
7861807|NCT00902486|19349857|P3|NOT COMPLETED|Follow-up (After Week 24)||0
7861808|NCT00902486|19349858|P2|NOT COMPLETED|Follow-up (After Week 24)||0
7861809|NCT00902486|19349859|P1|NOT COMPLETED|Follow-up (After Week 24)||0
7861810|NCT00902486|19349854|P6|COMPLETED|Follow-up (After Week 24)||24
7861811|NCT00902486|19349855|P5|COMPLETED|Follow-up (After Week 24)||29
7861812|NCT00902486|19349856|P4|COMPLETED|Follow-up (After Week 24)||26
7861813|NCT00902486|19349857|P3|COMPLETED|Follow-up (After Week 24)||13
7861814|NCT00902486|19349858|P2|COMPLETED|Follow-up (After Week 24)||14
7861815|NCT00902486|19349859|P1|COMPLETED|Follow-up (After Week 24)||0
7861816|NCT00902486|19349854|P6|Safety Evaluable Participants|Follow-up (After Week 24)||27
7861817|NCT00902486|19349855|P5|Safety Evaluable Participants|Follow-up (After Week 24)||30
7861818|NCT00902486|19349856|P4|Safety Evaluable Participants|Follow-up (After Week 24)||29
7861819|NCT00902486|19349857|P3|Safety Evaluable Participants|Follow-up (After Week 24)||15
7861820|NCT00902486|19349858|P2|Safety Evaluable Participants|Follow-up (After Week 24)||14
7861821|NCT00902486|19349859|P1|Safety Evaluable Participants|Follow-up (After Week 24)||0
7861822|NCT00902486|19349854|P6|STARTED|Follow-up (After Week 24)||24
7861823|NCT00902486|19349855|P5|STARTED|Follow-up (After Week 24)||29
7861824|NCT00902486|19349856|P4|STARTED|Follow-up (After Week 24)||27
7861825|NCT00902486|19349857|P3|STARTED|Follow-up (After Week 24)||13
7861826|NCT00902486|19349858|P2|STARTED|Follow-up (After Week 24)||14
7861827|NCT00902486|19349859|P1|STARTED|Follow-up (After Week 24)||0
7861828|NCT00902486|19349854|P6|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||3
7861829|NCT00902486|19349855|P5|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||1
7861830|NCT00902486|19349856|P4|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
7861831|NCT00902486|19349857|P3|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
7861832|NCT00902486|19349858|P2|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
7861833|NCT00902486|19349859|P1|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
7861834|NCT00902486|19349854|P6|COMPLETED|Extension Period (Weeks 12 Through 24)||24
7861835|NCT00902486|19349855|P5|COMPLETED|Extension Period (Weeks 12 Through 24)||29
7861836|NCT00902486|19349856|P4|COMPLETED|Extension Period (Weeks 12 Through 24)||27
7861837|NCT00902486|19349857|P3|COMPLETED|Extension Period (Weeks 12 Through 24)||13
7861838|NCT00902486|19349858|P2|COMPLETED|Extension Period (Weeks 12 Through 24)||14
7861839|NCT00902486|19349859|P1|COMPLETED|Extension Period (Weeks 12 Through 24)||0
7861840|NCT00902486|19349854|P6|STARTED|Extension Period (Weeks 12 Through 24)||27
7861841|NCT00902486|19349855|P5|STARTED|Extension Period (Weeks 12 Through 24)||30
7861842|NCT00902486|19349856|P4|STARTED|Extension Period (Weeks 12 Through 24)||29
7861843|NCT00902486|19349857|P3|STARTED|Extension Period (Weeks 12 Through 24)||15
7861844|NCT00902486|19349858|P2|STARTED|Extension Period (Weeks 12 Through 24)||14
7861845|NCT00902486|19349859|P1|STARTED|Extension Period (Weeks 12 Through 24)||0
7861846|NCT00902486|19349854|P6|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||5
7861847|NCT00902486|19349855|P5|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
7861848|NCT00902486|19349856|P4|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||3
7861849|NCT00902486|19349857|P3|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
7861850|NCT00902486|19349858|P2|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
7861851|NCT00902486|19349859|P1|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
7861852|NCT00902486|19349854|P6|COMPLETED|Treatment Period (Weeks 0 Through 12)||27
7861853|NCT00902486|19349855|P5|COMPLETED|Treatment Period (Weeks 0 Through 12)||30
7861854|NCT00902486|19349856|P4|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
7861855|NCT00902486|19349857|P3|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
7861856|NCT00902486|19349858|P2|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
7861857|NCT00902486|19349859|P1|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
7861858|NCT00902486|19349854|P6|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||30
7861859|NCT00902486|19349855|P5|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||32
7861860|NCT00902486|19349856|P4|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
7861861|NCT00902486|19349857|P3|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
7861862|NCT00902486|19349858|P2|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
7861863|NCT00902486|19349859|P1|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
7861864|NCT00902486|19349854|P6|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
7861865|NCT00902486|19349855|P5|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||32
7861866|NCT00902486|19349856|P4|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
7861867|NCT00902486|19349857|P3|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
7861868|NCT00902486|19349858|P2|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
7861869|NCT00902486|19349859|P1|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
7861870|NCT00902486|19349854|P6|STARTED|Treatment Period (Weeks 0 Through 12)||32
7861871|NCT00902486|19349855|P5|STARTED|Treatment Period (Weeks 0 Through 12)||32
7861872|NCT00902486|19349856|P4|STARTED|Treatment Period (Weeks 0 Through 12)||32
7861873|NCT00902486|19349857|P3|STARTED|Treatment Period (Weeks 0 Through 12)||0
7861874|NCT00902486|19349858|P2|STARTED|Treatment Period (Weeks 0 Through 12)||0
7861875|NCT00902486|19349859|P1|STARTED|Treatment Period (Weeks 0 Through 12)||31
7861876|NCT00902330|19349997|P2|NOT COMPLETED|Overall Study||5
7861877|NCT00902330|19349998|P1|NOT COMPLETED|Overall Study||4
7861878|NCT00902330|19349997|P2|COMPLETED|Overall Study||75
7861879|NCT00902330|19349998|P1|COMPLETED|Overall Study||77
7861880|NCT00902330|19349997|P2|STARTED|Overall Study||80
7861881|NCT00902330|19349998|P1|STARTED|Overall Study||81
7861882|NCT00902304|19350035|P3|NOT COMPLETED|Overall Study||110
7861883|NCT00902304|19350036|P2|NOT COMPLETED|Overall Study||71
7861884|NCT00902304|19350037|P1|NOT COMPLETED|Overall Study||58
7861885|NCT00902304|19350035|P3|COMPLETED|Overall Study||568
7861886|NCT00902304|19350036|P2|COMPLETED|Overall Study||289
7861887|NCT00902304|19350037|P1|COMPLETED|Overall Study||466
7861888|NCT00902304|19350035|P3|STARTED|Overall Study||678
7861889|NCT00902304|19350036|P2|STARTED|Overall Study||360
7861890|NCT00902304|19350037|P1|STARTED|Overall Study||524
7861891|NCT00902278|19350087|P5|NOT COMPLETED|Overall Study||2
7861892|NCT00902278|19350088|P4|NOT COMPLETED|Overall Study||0
7861893|NCT00902278|19350089|P3|NOT COMPLETED|Overall Study||5
7861894|NCT00902278|19350090|P2|NOT COMPLETED|Overall Study||2
7861895|NCT00902278|19350091|P1|NOT COMPLETED|Overall Study||4
7861896|NCT00902278|19350087|P5|COMPLETED|Overall Study||35
7861897|NCT00902278|19350088|P4|COMPLETED|Overall Study||12
7861898|NCT00902278|19350089|P3|COMPLETED|Overall Study||49
7861899|NCT00902278|19350090|P2|COMPLETED|Overall Study||34
7861900|NCT00902278|19350091|P1|COMPLETED|Overall Study||50
7861901|NCT00902278|19350087|P5|STARTED|Overall Study||37
7861902|NCT00902278|19350088|P4|STARTED|Overall Study||12
7861903|NCT00902278|19350089|P3|STARTED|Overall Study||54
7861904|NCT00902278|19350090|P2|STARTED|Overall Study||36
7861905|NCT00902278|19350091|P1|STARTED|Overall Study||54
7861906|NCT00902265|19350108|P1|NOT COMPLETED|Overall Study||6
7861907|NCT00902265|19350108|P1|COMPLETED|Overall Study||132
7861908|NCT00902265|19350108|P1|Participants Who Received Treatment|Overall Study||137
7861909|NCT00902265|19350108|P1|STARTED|Overall Study||138
7861910|NCT00902226|19350120|P1|NOT COMPLETED|Overall Study||0
7861911|NCT00902226|19350120|P1|COMPLETED|Overall Study||30
7861912|NCT00902226|19350120|P1|STARTED|Overall Study||30
7861913|NCT00902174|19350132|P2|NOT COMPLETED|Overall Study||18
7861914|NCT00902174|19350133|P1|NOT COMPLETED|Overall Study||34
7861915|NCT00902174|19350132|P2|COMPLETED|Overall Study||81
7861916|NCT00902174|19350133|P1|COMPLETED|Overall Study||69
7861917|NCT00902174|19350132|P2|STARTED|Overall Study||99
7861918|NCT00902174|19350133|P1|STARTED|Overall Study||103
7861919|NCT00902161|19350171|P3|NOT COMPLETED|Period 2||0
7861920|NCT00902161|19350172|P2|NOT COMPLETED|Period 2||0
7861921|NCT00902161|19350173|P1|NOT COMPLETED|Period 2||0
7861922|NCT00902161|19350171|P3|COMPLETED|Period 2||0
7861923|NCT00902161|19350172|P2|COMPLETED|Period 2||9
7861924|NCT00902161|19350173|P1|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8
7861925|NCT00902161|19350171|P3|STARTED|Period 2||0
7861926|NCT00902161|19350172|P2|STARTED|Period 2||9
7861927|NCT00902161|19350173|P1|STARTED|Period 2||8
7861928|NCT00902161|19350171|P3|NOT COMPLETED|Post-clamp Washout||0
7861929|NCT00902161|19350172|P2|NOT COMPLETED|Post-clamp Washout||0
7861930|NCT00902161|19350173|P1|NOT COMPLETED|Post-clamp Washout||0
7861931|NCT00902161|19350171|P3|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22
7861932|NCT00902161|19350172|P2|COMPLETED|Post-clamp Washout||0
7861933|NCT00902161|19350173|P1|COMPLETED|Post-clamp Washout||0
7861934|NCT00902161|19350171|P3|STARTED|Post-clamp Washout||22
7861935|NCT00902161|19350172|P2|STARTED|Post-clamp Washout||0
7861936|NCT00902161|19350173|P1|STARTED|Post-clamp Washout||0
7861937|NCT00902161|19350171|P3|NOT COMPLETED|Period 1||0
7861938|NCT00902161|19350172|P2|NOT COMPLETED|Period 1||0
7861939|NCT00902161|19350173|P1|NOT COMPLETED|Period 1||0
7861940|NCT00902161|19350171|P3|COMPLETED|Period 1||0
7861941|NCT00902161|19350172|P2|COMPLETED|Period 1||10
7861942|NCT00902161|19350173|P1|COMPLETED|Period 1||12
7861943|NCT00902161|19350171|P3|STARTED|Period 1||0
7861944|NCT00902161|19350172|P2|STARTED|Period 1||10
7861945|NCT00902161|19350173|P1|STARTED|Period 1||12
7861946|NCT00902161|19350171|P3|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
7861947|NCT00902161|19350172|P2|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
7861948|NCT00902161|19350173|P1|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
7861949|NCT00902161|19350171|P3|COMPLETED|Pre-study Washout/Propanolol Run-in||22
7861950|NCT00902161|19350172|P2|COMPLETED|Pre-study Washout/Propanolol Run-in||0
7861951|NCT00902161|19350173|P1|COMPLETED|Pre-study Washout/Propanolol Run-in||0
7861952|NCT00902161|19350171|P3|STARTED|Pre-study Washout/Propanolol Run-in||22
7861953|NCT00902161|19350172|P2|STARTED|Pre-study Washout/Propanolol Run-in||0
7861954|NCT00902161|19350173|P1|STARTED|Pre-study Washout/Propanolol Run-in||0
7861955|NCT00902018|19350191|P3|NOT COMPLETED|Overall Study||0
7861956|NCT00902018|19350192|P2|NOT COMPLETED|Overall Study||0
7861957|NCT00902018|19350193|P1|NOT COMPLETED|Overall Study||0
7861958|NCT00902018|19350191|P3|COMPLETED|Overall Study||10
7861959|NCT00902018|19350192|P2|COMPLETED|Overall Study||3
7861960|NCT00902018|19350193|P1|COMPLETED|Overall Study||7
7861961|NCT00902018|19350191|P3|STARTED|Overall Study||10
7861962|NCT00902018|19350192|P2|STARTED|Overall Study||3
7861963|NCT00902018|19350193|P1|STARTED|Overall Study||7
7861964|NCT00901927|19350208|P1|NOT COMPLETED|Overall Study||6
7861965|NCT00901927|19350208|P1|COMPLETED|Overall Study||8
7861966|NCT00901927|19350208|P1|STARTED|Overall Study||14
7861967|NCT00901901|19350216|P2|NOT COMPLETED|Follow-up Period||341
7861968|NCT00901901|19350217|P1|NOT COMPLETED|Follow-up Period||340
7861969|NCT00901901|19350216|P2|COMPLETED|Follow-up Period||0
7861970|NCT00901901|19350217|P1|COMPLETED|Follow-up Period||0
7861971|NCT00901901|19350216|P2|STARTED|Follow-up Period||341
7861972|NCT00901901|19350217|P1|STARTED|Follow-up Period||340
7861973|NCT00901901|19350216|P2|NOT COMPLETED|Treatment Period||177
7861974|NCT00901901|19350217|P1|NOT COMPLETED|Treatment Period||169
7861975|NCT00901901|19350216|P2|COMPLETED|Treatment Period||181
7861976|NCT00901901|19350217|P1|COMPLETED|Treatment Period||193
7861977|NCT00901901|19350216|P2|Participants Received Treatment|Treatment Period||355
7861978|NCT00901901|19350217|P1|Participants Received Treatment|Treatment Period||362
7861979|NCT00901901|19350216|P2|STARTED|Treatment Period||358
7861980|NCT00901901|19350217|P1|STARTED|Treatment Period||362
7861981|NCT00901628|19350239|P2|NOT COMPLETED|Overall Study||10
7861982|NCT00901628|19350240|P1|NOT COMPLETED|Overall Study||4
7861983|NCT00901628|19350239|P2|COMPLETED|Overall Study||42
7861984|NCT00901628|19350240|P1|COMPLETED|Overall Study||45
7861985|NCT00901628|19350239|P2|STARTED|Overall Study||52
7861986|NCT00901628|19350240|P1|STARTED|Overall Study||49
7861987|NCT00901576|19350262|P6|NOT COMPLETED|Third Intervention||0
7861988|NCT00901576|19350263|P5|NOT COMPLETED|Third Intervention||0
7861989|NCT00901576|19350264|P4|NOT COMPLETED|Third Intervention||0
7861990|NCT00901576|19350265|P3|NOT COMPLETED|Third Intervention||0
7861991|NCT00901576|19350266|P2|NOT COMPLETED|Third Intervention||0
7861992|NCT00901576|19350267|P1|NOT COMPLETED|Third Intervention||0
7861993|NCT00901576|19350262|P6|COMPLETED|Third Intervention||5
7861994|NCT00901576|19350263|P5|COMPLETED|Third Intervention||6
7861995|NCT00901576|19350264|P4|COMPLETED|Third Intervention||5
7861996|NCT00901576|19350265|P3|COMPLETED|Third Intervention||7
7861997|NCT00901576|19350266|P2|COMPLETED|Third Intervention||7
7861998|NCT00901576|19350267|P1|COMPLETED|Third Intervention||5
7861999|NCT00901576|19350262|P6|STARTED|Third Intervention||5
7862000|NCT00901576|19350263|P5|STARTED|Third Intervention||6
7862001|NCT00901576|19350264|P4|STARTED|Third Intervention||5
7862002|NCT00901576|19350265|P3|STARTED|Third Intervention||7
7862003|NCT00901576|19350266|P2|STARTED|Third Intervention||7
7862004|NCT00901576|19350267|P1|STARTED|Third Intervention||5
7862005|NCT00901576|19350262|P6|NOT COMPLETED|Washout||0
7862006|NCT00901576|19350263|P5|NOT COMPLETED|Washout||0
7862007|NCT00901576|19350264|P4|NOT COMPLETED|Washout||0
7862008|NCT00901576|19350265|P3|NOT COMPLETED|Washout||0
7862009|NCT00901576|19350266|P2|NOT COMPLETED|Washout||0
7862010|NCT00901576|19350267|P1|NOT COMPLETED|Washout||0
7862011|NCT00901576|19350262|P6|COMPLETED|Washout||5
7862012|NCT00901576|19350263|P5|COMPLETED|Washout||6
7862013|NCT00901576|19350264|P4|COMPLETED|Washout||5
7862014|NCT00901576|19350265|P3|COMPLETED|Washout||7
7862015|NCT00901576|19350266|P2|COMPLETED|Washout||7
7862016|NCT00901576|19350267|P1|COMPLETED|Washout||5
7862017|NCT00901576|19350262|P6|STARTED|Washout||5
7862018|NCT00901576|19350263|P5|STARTED|Washout||6
7862019|NCT00901576|19350264|P4|STARTED|Washout||5
7862020|NCT00901576|19350265|P3|STARTED|Washout||7
7862021|NCT00901576|19350266|P2|STARTED|Washout||7
7862022|NCT00901576|19350267|P1|STARTED|Washout||5
7862023|NCT00901576|19350262|P6|NOT COMPLETED|Second Intervention||1
7862024|NCT00901576|19350263|P5|NOT COMPLETED|Second Intervention||0
7862025|NCT00901576|19350264|P4|NOT COMPLETED|Second Intervention||1
7862026|NCT00901576|19350265|P3|NOT COMPLETED|Second Intervention||0
7862027|NCT00901576|19350266|P2|NOT COMPLETED|Second Intervention||0
7862028|NCT00901576|19350267|P1|NOT COMPLETED|Second Intervention||1
7862029|NCT00901576|19350262|P6|COMPLETED|Second Intervention||5
7862030|NCT00901576|19350263|P5|COMPLETED|Second Intervention||6
7862031|NCT00901576|19350264|P4|COMPLETED|Second Intervention||5
7862032|NCT00901576|19350265|P3|COMPLETED|Second Intervention||7
7862033|NCT00901576|19350266|P2|COMPLETED|Second Intervention||7
7862034|NCT00901576|19350267|P1|COMPLETED|Second Intervention||5
7862035|NCT00901576|19350262|P6|STARTED|Second Intervention||6
7862036|NCT00901576|19350263|P5|STARTED|Second Intervention||6
7862037|NCT00901576|19350264|P4|STARTED|Second Intervention||6
7862038|NCT00901576|19350265|P3|STARTED|Second Intervention||7
7862039|NCT00901576|19350266|P2|STARTED|Second Intervention||7
7862040|NCT00901576|19350267|P1|STARTED|Second Intervention||6
7862041|NCT00901576|19350262|P6|NOT COMPLETED|Washout||0
7862042|NCT00901576|19350263|P5|NOT COMPLETED|Washout||0
7862043|NCT00901576|19350264|P4|NOT COMPLETED|Washout||0
7862044|NCT00901576|19350265|P3|NOT COMPLETED|Washout||0
7862045|NCT00901576|19350266|P2|NOT COMPLETED|Washout||0
7862046|NCT00901576|19350267|P1|NOT COMPLETED|Washout||0
7862047|NCT00901576|19350262|P6|COMPLETED|Washout||6
7862048|NCT00901576|19350263|P5|COMPLETED|Washout||6
7862049|NCT00901576|19350264|P4|COMPLETED|Washout||6
7862050|NCT00901576|19350265|P3|COMPLETED|Washout||7
7862051|NCT00901576|19350266|P2|COMPLETED|Washout||7
7862052|NCT00901576|19350267|P1|COMPLETED|Washout||6
7862053|NCT00901576|19350262|P6|STARTED|Washout||6
7862054|NCT00901576|19350263|P5|STARTED|Washout||6
7862055|NCT00901576|19350264|P4|STARTED|Washout||6
7862056|NCT00901576|19350265|P3|STARTED|Washout||7
7862057|NCT00901576|19350266|P2|STARTED|Washout||7
7862058|NCT00901576|19350267|P1|STARTED|Washout||6
7862059|NCT00901576|19350262|P6|NOT COMPLETED|First Intervention||0
7862060|NCT00901576|19350263|P5|NOT COMPLETED|First Intervention||0
7862061|NCT00901576|19350264|P4|NOT COMPLETED|First Intervention||0
7862062|NCT00901576|19350265|P3|NOT COMPLETED|First Intervention||0
7862063|NCT00901576|19350266|P2|NOT COMPLETED|First Intervention||0
7862064|NCT00901576|19350267|P1|NOT COMPLETED|First Intervention||0
7862065|NCT00901576|19350262|P6|COMPLETED|First Intervention||6
7862066|NCT00901576|19350263|P5|COMPLETED|First Intervention||6
7862067|NCT00901576|19350264|P4|COMPLETED|First Intervention||6
7862068|NCT00901576|19350265|P3|COMPLETED|First Intervention||7
7862069|NCT00901576|19350266|P2|COMPLETED|First Intervention||7
7862070|NCT00901576|19350267|P1|COMPLETED|First Intervention||6
7862071|NCT00901576|19350262|P6|STARTED|First Intervention||6
7862072|NCT00901576|19350263|P5|STARTED|First Intervention||6
7862073|NCT00901576|19350264|P4|STARTED|First Intervention||6
7862074|NCT00901576|19350265|P3|STARTED|First Intervention||7
7862075|NCT00901576|19350266|P2|STARTED|First Intervention||7
7862076|NCT00901576|19350267|P1|STARTED|First Intervention||6
7862077|NCT00901459|19350288|P1|NOT COMPLETED|Overall Study||6
7862078|NCT00901459|19350288|P1|COMPLETED|Overall Study||15
7862079|NCT00901459|19350288|P1|STARTED|Overall Study||21
7862080|NCT00901394|19350302|P3|NOT COMPLETED|Overall Study||2
7862081|NCT00901394|19350303|P2|NOT COMPLETED|Overall Study||1
7862082|NCT00901394|19350304|P1|NOT COMPLETED|Overall Study||1
7862083|NCT00901394|19350302|P3|COMPLETED|Overall Study||20
7862084|NCT00901394|19350303|P2|COMPLETED|Overall Study||19
7862085|NCT00901394|19350304|P1|COMPLETED|Overall Study||20
7862086|NCT00901394|19350302|P3|STARTED|Overall Study||22
7862087|NCT00901394|19350303|P2|STARTED|Overall Study||20
7862088|NCT00901394|19350304|P1|STARTED|Overall Study||21
7862089|NCT00901342|19350312|P1|NOT COMPLETED|Overall Study||15
7862090|NCT00901342|19350312|P1|COMPLETED|Overall Study|89 subjects completed the study completion visit|89
7862091|NCT00901342|19350312|P1|Received at Least 1 Infusion|Overall Study||98
7862092|NCT00901342|19350312|P1|STARTED|Overall Study||104
7862093|NCT00901316|19350318|P2|NOT COMPLETED|Overall Study||0
7862094|NCT00901316|19350319|P1|NOT COMPLETED|Overall Study||0
7862095|NCT00901316|19350318|P2|COMPLETED|Overall Study||495
7862096|NCT00901316|19350319|P1|COMPLETED|Overall Study||492
7862097|NCT00901316|19350318|P2|STARTED|Overall Study||495
7862098|NCT00901316|19350319|P1|STARTED|Overall Study||492
7862099|NCT00901303|19350327|P2|NOT COMPLETED|Overall Study||0
7862100|NCT00901303|19350328|P1|NOT COMPLETED|Overall Study||0
7862101|NCT00901303|19350327|P2|COMPLETED|Overall Study||1
7862102|NCT00901303|19350328|P1|COMPLETED|Overall Study||5
7862103|NCT00901303|19350327|P2|STARTED|Overall Study||1
7862104|NCT00901303|19350328|P1|STARTED|Overall Study||5
7862105|NCT00901225|19350334|P1|NOT COMPLETED|Overall Study||1
7862106|NCT00901225|19350334|P1|COMPLETED|Overall Study||20
7862107|NCT00901225|19350334|P1|STARTED|Overall Study||21
7862108|NCT00901186|19350345|P2|NOT COMPLETED|Overall Study||11
7862109|NCT00901186|19350346|P1|NOT COMPLETED|Overall Study||9
7862110|NCT00901186|19350345|P2|COMPLETED|Overall Study||32
7862111|NCT00901186|19350346|P1|COMPLETED|Overall Study||31
7862112|NCT00901186|19350345|P2|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38
7862113|NCT00901186|19350346|P1|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35
7862114|NCT00901186|19350345|P2|Safety Set|Overall Study||43
7862115|NCT00901186|19350346|P1|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39
7862116|NCT00901186|19350345|P2|STARTED|Overall Study||43
7862117|NCT00901186|19350346|P1|STARTED|Overall Study||40
7862118|NCT00901017|19350362|P1|NOT COMPLETED|Overall Study||0
7862119|NCT00901017|19350362|P1|COMPLETED|Overall Study||14
7862120|NCT00901017|19350362|P1|STARTED|Overall Study||14
7862121|NCT00900822|19350376|P1|NOT COMPLETED|12 Months Clinical Evaluation||0
7862122|NCT00900822|19350376|P1|COMPLETED|12 Months Clinical Evaluation||11
7862123|NCT00900822|19350376|P1|STARTED|12 Months Clinical Evaluation||11
7862124|NCT00900822|19350376|P1|NOT COMPLETED|9 Months Histological Evaluation||0
7862125|NCT00900822|19350376|P1|COMPLETED|9 Months Histological Evaluation||11
7862126|NCT00900822|19350376|P1|STARTED|9 Months Histological Evaluation||11
7862127|NCT00900796|19350386|P1|NOT COMPLETED|Phase 2||5
7862128|NCT00900796|19350386|P1|COMPLETED|Phase 2||6
7862129|NCT00900796|19350386|P1|STARTED|Phase 2||11
7862130|NCT00900796|19350386|P1|NOT COMPLETED|Between Phase 1 and Phase 2||110
7862131|NCT00900796|19350386|P1|COMPLETED|Between Phase 1 and Phase 2||11
7862132|NCT00900796|19350386|P1|STARTED|Between Phase 1 and Phase 2||121
7862133|NCT00900796|19350386|P1|NOT COMPLETED|Phase 1||11
7862134|NCT00900796|19350386|P1|COMPLETED|Phase 1||121
7862135|NCT00900796|19350386|P1|STARTED|Phase 1||132
7862136|NCT00900757|19350396|P1|NOT COMPLETED|Overall Study||19
7862137|NCT00900757|19350396|P1|COMPLETED|Overall Study||38
7862138|NCT00900757|19350396|P1|STARTED|Overall Study||57
7862139|NCT00900731|19350406|P2|NOT COMPLETED|Overall Study||61
7862140|NCT00900731|19350407|P1|NOT COMPLETED|Overall Study||60
7862141|NCT00900731|19350406|P2|COMPLETED|Overall Study||740
7862142|NCT00900731|19350407|P1|COMPLETED|Overall Study||737
7862143|NCT00900731|19350406|P2|Safety Set: Received Study Drug|Overall Study||799
7862144|NCT00900731|19350407|P1|Safety Set: Received Study Drug|Overall Study||794
7862145|NCT00900731|19350406|P2|STARTED|Overall Study||801
7862146|NCT00900731|19350407|P1|STARTED|Overall Study|Randomized participants|797
7862147|NCT00900666|19350429|P2|NOT COMPLETED|Overall Study||0
7862148|NCT00900666|19350430|P1|NOT COMPLETED|Overall Study||0
7862149|NCT00900666|19350429|P2|COMPLETED|Overall Study||9
7862150|NCT00900666|19350430|P1|COMPLETED|Overall Study||10
7862151|NCT00900666|19350429|P2|STARTED|Overall Study||9
7862152|NCT00900666|19350430|P1|STARTED|Overall Study||10
7862153|NCT00900627|19350444|P6|NOT COMPLETED|Overall Study||26
7862154|NCT00900627|19350445|P5|NOT COMPLETED|Overall Study||29
7862155|NCT00900627|19350446|P4|NOT COMPLETED|Overall Study||6
7862156|NCT00900627|19350447|P3|NOT COMPLETED|Overall Study||6
7862157|NCT00900627|19350448|P2|NOT COMPLETED|Overall Study||2
7862158|NCT00900627|19350449|P1|NOT COMPLETED|Overall Study||6
7862159|NCT00900627|19350444|P6|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70
7862160|NCT00900627|19350445|P5|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65
7862161|NCT00900627|19350446|P4|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
7862162|NCT00900627|19350447|P3|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
7862163|NCT00900627|19350448|P2|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
7862164|NCT00900627|19350449|P1|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
7862165|NCT00900627|19350444|P6|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96
7862166|NCT00900627|19350445|P5|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94
7862167|NCT00900627|19350446|P4|STARTED|Overall Study||6
7862168|NCT00900627|19350447|P3|STARTED|Overall Study||6
7862169|NCT00900627|19350448|P2|STARTED|Overall Study||2
7862170|NCT00900627|19350449|P1|STARTED|Overall Study||6
7862171|NCT00900601|19350467|P1|NOT COMPLETED|Overall Study||1
7862172|NCT00900601|19350467|P1|COMPLETED|Overall Study||8
7862173|NCT00900601|19350467|P1|STARTED|Overall Study||9
7862174|NCT00900237|19350475|P2|NOT COMPLETED|Overall Study||0
7862175|NCT00900237|19350476|P1|NOT COMPLETED|Overall Study||0
7862176|NCT00900237|19350475|P2|COMPLETED|Overall Study||7
7862177|NCT00900237|19350476|P1|COMPLETED|Overall Study||7
7862178|NCT00900237|19350475|P2|STARTED|Overall Study||7
7862179|NCT00900237|19350476|P1|STARTED|Overall Study||7
7862180|NCT00900159|19350486|P2|NOT COMPLETED|Second Intervention||0
7862181|NCT00900159|19350487|P1|NOT COMPLETED|Second Intervention||1
7862182|NCT00900159|19350486|P2|COMPLETED|Second Intervention||13
7862183|NCT00900159|19350487|P1|COMPLETED|Second Intervention||10
7862184|NCT00900159|19350486|P2|STARTED|Second Intervention||13
7862185|NCT00900159|19350487|P1|STARTED|Second Intervention||11
7862186|NCT00900159|19350486|P2|NOT COMPLETED|Washout||0
7862187|NCT00900159|19350487|P1|NOT COMPLETED|Washout||0
7862188|NCT00900159|19350486|P2|COMPLETED|Washout||13
7862189|NCT00900159|19350487|P1|COMPLETED|Washout||11
7862190|NCT00900159|19350486|P2|STARTED|Washout||13
7862191|NCT00900159|19350487|P1|STARTED|Washout||11
7862192|NCT00900159|19350486|P2|NOT COMPLETED|First Intervention||0
7862193|NCT00900159|19350487|P1|NOT COMPLETED|First Intervention||0
7862194|NCT00900159|19350486|P2|COMPLETED|First Intervention||13
7862195|NCT00900159|19350487|P1|COMPLETED|First Intervention||11
7862196|NCT00900159|19350486|P2|STARTED|First Intervention||13
7862197|NCT00900159|19350487|P1|STARTED|First Intervention||11
7862198|NCT00900146|19350506|P5|NOT COMPLETED|Intermediate: Period III||167
7862199|NCT00900146|19350507|P4|NOT COMPLETED|Intermediate: Period III||90
7862200|NCT00900146|19350508|P3|NOT COMPLETED|Intermediate: Period III||84
7862201|NCT00900146|19350509|P2|NOT COMPLETED|Intermediate: Period III||93
7862202|NCT00900146|19350510|P1|NOT COMPLETED|Intermediate: Period III||87
7862203|NCT00900146|19350506|P5|COMPLETED|Intermediate: Period III||0
7862204|NCT00900146|19350507|P4|COMPLETED|Intermediate: Period III||0
7862205|NCT00900146|19350508|P3|COMPLETED|Intermediate: Period III||0
7862206|NCT00900146|19350509|P2|COMPLETED|Intermediate: Period III||0
7862207|NCT00900146|19350510|P1|COMPLETED|Intermediate: Period III||0
7862208|NCT00900146|19350506|P5|Safety Set|Intermediate: Period III||166
7862209|NCT00900146|19350507|P4|Safety Set|Intermediate: Period III||90
7862210|NCT00900146|19350508|P3|Safety Set|Intermediate: Period III||84
7862211|NCT00900146|19350509|P2|Safety Set|Intermediate: Period III||92
7862212|NCT00900146|19350510|P1|Safety Set|Intermediate: Period III||86
7862213|NCT00900146|19350506|P5|STARTED|Intermediate: Period III||167
7862214|NCT00900146|19350507|P4|STARTED|Intermediate: Period III||90
7862215|NCT00900146|19350508|P3|STARTED|Intermediate: Period III||84
7862216|NCT00900146|19350509|P2|STARTED|Intermediate: Period III||93
7862217|NCT00900146|19350510|P1|STARTED|Intermediate: Period III||87
7862218|NCT00900146|19350506|P5|NOT COMPLETED|Dose Finding: Period II (4 Months)||12
7862219|NCT00900146|19350507|P4|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
7862220|NCT00900146|19350508|P3|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
7862221|NCT00900146|19350509|P2|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
7862222|NCT00900146|19350510|P1|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
7862223|NCT00900146|19350506|P5|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167
7862224|NCT00900146|19350507|P4|COMPLETED|Dose Finding: Period II (4 Months)||90
7862225|NCT00900146|19350508|P3|COMPLETED|Dose Finding: Period II (4 Months)||87
7862226|NCT00900146|19350509|P2|COMPLETED|Dose Finding: Period II (4 Months)||93
7862227|NCT00900146|19350510|P1|COMPLETED|Dose Finding: Period II (4 Months)||88
7862228|NCT00900146|19350506|P5|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179
7862229|NCT00900146|19350507|P4|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
7862230|NCT00900146|19350508|P3|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
7862231|NCT00900146|19350509|P2|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95
7862232|NCT00900146|19350510|P1|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93
7862233|NCT00900146|19350506|P5|STARTED|Dose Finding: Period II (4 Months)||179
7862234|NCT00900146|19350507|P4|STARTED|Dose Finding: Period II (4 Months)||92
7862235|NCT00900146|19350508|P3|STARTED|Dose Finding: Period II (4 Months)||92
7862236|NCT00900146|19350509|P2|STARTED|Dose Finding: Period II (4 Months)||95
7862237|NCT00900146|19350510|P1|STARTED|Dose Finding: Period II (4 Months)||93
7862238|NCT00900029|19350627|P5|NOT COMPLETED|Overall Study||6
7862239|NCT00900029|19350628|P4|NOT COMPLETED|Overall Study||7
7862240|NCT00900029|19350629|P3|NOT COMPLETED|Overall Study||3
7862241|NCT00900029|19350630|P2|NOT COMPLETED|Overall Study||4
7862242|NCT00900029|19350631|P1|NOT COMPLETED|Overall Study||3
7862243|NCT00900029|19350627|P5|COMPLETED|Overall Study||38
7862244|NCT00900029|19350628|P4|COMPLETED|Overall Study||35
7862245|NCT00900029|19350629|P3|COMPLETED|Overall Study||38
7862246|NCT00900029|19350630|P2|COMPLETED|Overall Study||37
7862247|NCT00900029|19350631|P1|COMPLETED|Overall Study||35
7862248|NCT00900029|19350627|P5|STARTED|Overall Study||44
7862249|NCT00900029|19350628|P4|STARTED|Overall Study||42
7862250|NCT00900029|19350629|P3|STARTED|Overall Study||41
7862251|NCT00900029|19350630|P2|STARTED|Overall Study||41
7862252|NCT00900029|19350631|P1|STARTED|Overall Study||38
7862253|NCT00899847|19350648|P1|NOT COMPLETED|Overall Study||2
7862254|NCT00899847|19350648|P1|COMPLETED|Overall Study||7
7862255|NCT00899847|19350648|P1|STARTED|Overall Study||9
7862256|NCT00899717|19350661|P2|NOT COMPLETED|Overall Study||0
7862257|NCT00899717|19350662|P1|NOT COMPLETED|Overall Study||0
7862258|NCT00899717|19350661|P2|COMPLETED|Overall Study||11
7862259|NCT00899717|19350662|P1|COMPLETED|Overall Study||10
7862260|NCT00899717|19350661|P2|STARTED|Overall Study||11
7862261|NCT00899717|19350662|P1|STARTED|Overall Study||10
7862262|NCT00899678|19350679|P3|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28
7862263|NCT00899678|19350680|P2|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25
7862264|NCT00899678|19350681|P1|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0
7862265|NCT00899678|19350679|P3|COMPLETED|Maintenance Period (Weeks 8 to 62)||7
7862266|NCT00899678|19350680|P2|COMPLETED|Maintenance Period (Weeks 8 to 62)||12
7862267|NCT00899678|19350681|P1|COMPLETED|Maintenance Period (Weeks 8 to 62)||0
7862268|NCT00899678|19350679|P3|STARTED|Maintenance Period (Weeks 8 to 62)||35
7862269|NCT00899678|19350680|P2|STARTED|Maintenance Period (Weeks 8 to 62)||37
7862270|NCT00899678|19350681|P1|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0
7862271|NCT00899678|19350679|P3|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
7862272|NCT00899678|19350680|P2|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
7862273|NCT00899678|19350681|P1|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25
7862274|NCT00899678|19350679|P3|COMPLETED|Induction Period (Weeks 0 to 6)||35
7862275|NCT00899678|19350680|P2|COMPLETED|Induction Period (Weeks 0 to 6)||37
7862276|NCT00899678|19350681|P1|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2
7862277|NCT00899678|19350679|P3|STARTED|Induction Period (Weeks 0 to 6)||35
7862278|NCT00899678|19350680|P2|STARTED|Induction Period (Weeks 0 to 6)||37
7862279|NCT00899678|19350681|P1|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27
7862280|NCT00899600|19350711|P2|NOT COMPLETED|Overall Study||0
7862281|NCT00899600|19350712|P1|NOT COMPLETED|Overall Study||0
7862282|NCT00899600|19350711|P2|COMPLETED|Overall Study||52
7862283|NCT00899600|19350712|P1|COMPLETED|Overall Study||50
7862284|NCT00899600|19350711|P2|STARTED|Overall Study||52
7862285|NCT00899600|19350712|P1|STARTED|Overall Study||50
7862286|NCT00899574|19350726|P1|NOT COMPLETED|Overall Study||0
7862287|NCT00899574|19350726|P1|COMPLETED|Overall Study||10
7862288|NCT00899574|19350726|P1|STARTED|Overall Study||10
7862289|NCT00899548|19350731|P1|NOT COMPLETED|Overall Study||3
7862290|NCT00899548|19350731|P1|COMPLETED|Overall Study||179
7862291|NCT00899548|19350731|P1|STARTED|Overall Study||182
7862292|NCT00899470|19350743|P4|NOT COMPLETED|Fourth Therapy||0
7862293|NCT00899470|19350744|P3|NOT COMPLETED|Fourth Therapy||0
7862294|NCT00899470|19350745|P2|NOT COMPLETED|Fourth Therapy||0
7862295|NCT00899470|19350746|P1|NOT COMPLETED|Fourth Therapy||0
7862296|NCT00899470|19350743|P4|COMPLETED|Fourth Therapy||6
7862297|NCT00899470|19350744|P3|COMPLETED|Fourth Therapy||6
7862298|NCT00899470|19350745|P2|COMPLETED|Fourth Therapy||6
7862299|NCT00899470|19350746|P1|COMPLETED|Fourth Therapy||6
7862300|NCT00899470|19350743|P4|STARTED|Fourth Therapy||6
7862301|NCT00899470|19350744|P3|STARTED|Fourth Therapy||6
7862302|NCT00899470|19350745|P2|STARTED|Fourth Therapy||6
7862303|NCT00899470|19350746|P1|STARTED|Fourth Therapy||6
7862304|NCT00899470|19350743|P4|NOT COMPLETED|Third Washout||0
7862305|NCT00899470|19350744|P3|NOT COMPLETED|Third Washout||0
7862306|NCT00899470|19350745|P2|NOT COMPLETED|Third Washout||0
7862307|NCT00899470|19350746|P1|NOT COMPLETED|Third Washout||0
7862308|NCT00899470|19350743|P4|COMPLETED|Third Washout||6
7862309|NCT00899470|19350744|P3|COMPLETED|Third Washout||6
7862310|NCT00899470|19350745|P2|COMPLETED|Third Washout||6
7862311|NCT00899470|19350746|P1|COMPLETED|Third Washout||6
7862312|NCT00899470|19350743|P4|STARTED|Third Washout||6
7862313|NCT00899470|19350744|P3|STARTED|Third Washout||6
7862314|NCT00899470|19350745|P2|STARTED|Third Washout||6
7862315|NCT00899470|19350746|P1|STARTED|Third Washout||6
7862316|NCT00899470|19350743|P4|NOT COMPLETED|Third Therapy||0
7862317|NCT00899470|19350744|P3|NOT COMPLETED|Third Therapy||0
7862318|NCT00899470|19350745|P2|NOT COMPLETED|Third Therapy||0
7862319|NCT00899470|19350746|P1|NOT COMPLETED|Third Therapy||0
7862320|NCT00899470|19350743|P4|COMPLETED|Third Therapy||6
7862321|NCT00899470|19350744|P3|COMPLETED|Third Therapy||6
7862322|NCT00899470|19350745|P2|COMPLETED|Third Therapy||6
7862323|NCT00899470|19350746|P1|COMPLETED|Third Therapy||6
7862324|NCT00899470|19350743|P4|STARTED|Third Therapy||6
7862325|NCT00899470|19350744|P3|STARTED|Third Therapy||6
7862326|NCT00899470|19350745|P2|STARTED|Third Therapy||6
7862327|NCT00899470|19350746|P1|STARTED|Third Therapy||6
7862328|NCT00899470|19350743|P4|NOT COMPLETED|Second Washout||0
7862329|NCT00899470|19350744|P3|NOT COMPLETED|Second Washout||0
7862330|NCT00899470|19350745|P2|NOT COMPLETED|Second Washout||0
7862331|NCT00899470|19350746|P1|NOT COMPLETED|Second Washout||0
7862332|NCT00899470|19350743|P4|COMPLETED|Second Washout||6
7862333|NCT00899470|19350744|P3|COMPLETED|Second Washout||6
7862334|NCT00899470|19350745|P2|COMPLETED|Second Washout||6
7862335|NCT00899470|19350746|P1|COMPLETED|Second Washout||6
7862336|NCT00899470|19350743|P4|STARTED|Second Washout||6
7862337|NCT00899470|19350744|P3|STARTED|Second Washout||6
7862338|NCT00899470|19350745|P2|STARTED|Second Washout||6
7862339|NCT00899470|19350746|P1|STARTED|Second Washout||6
7862340|NCT00899470|19350743|P4|NOT COMPLETED|Second Therapy||0
7862341|NCT00899470|19350744|P3|NOT COMPLETED|Second Therapy||0
7862342|NCT00899470|19350745|P2|NOT COMPLETED|Second Therapy||0
7862343|NCT00899470|19350746|P1|NOT COMPLETED|Second Therapy||0
7862344|NCT00899470|19350743|P4|COMPLETED|Second Therapy||6
7862345|NCT00899470|19350744|P3|COMPLETED|Second Therapy||6
7862346|NCT00899470|19350745|P2|COMPLETED|Second Therapy||6
7862347|NCT00899470|19350746|P1|COMPLETED|Second Therapy||6
7862348|NCT00899470|19350743|P4|STARTED|Second Therapy||6
7862349|NCT00899470|19350744|P3|STARTED|Second Therapy||6
7862350|NCT00899470|19350745|P2|STARTED|Second Therapy||6
7862351|NCT00899470|19350746|P1|STARTED|Second Therapy||6
7862352|NCT00899470|19350743|P4|NOT COMPLETED|First Washout Period||0
7862353|NCT00899470|19350744|P3|NOT COMPLETED|First Washout Period||0
7862354|NCT00899470|19350745|P2|NOT COMPLETED|First Washout Period||0
7862355|NCT00899470|19350746|P1|NOT COMPLETED|First Washout Period||0
7862356|NCT00899470|19350743|P4|COMPLETED|First Washout Period||6
7862357|NCT00899470|19350744|P3|COMPLETED|First Washout Period||6
7862358|NCT00899470|19350745|P2|COMPLETED|First Washout Period||6
7862359|NCT00899470|19350746|P1|COMPLETED|First Washout Period||6
7862360|NCT00899470|19350743|P4|STARTED|First Washout Period||6
7862361|NCT00899470|19350744|P3|STARTED|First Washout Period||6
7862362|NCT00899470|19350745|P2|STARTED|First Washout Period||6
7862363|NCT00899470|19350746|P1|STARTED|First Washout Period||6
7862364|NCT00899470|19350743|P4|NOT COMPLETED|First Therapy||0
7862365|NCT00899470|19350744|P3|NOT COMPLETED|First Therapy||0
7862366|NCT00899470|19350745|P2|NOT COMPLETED|First Therapy||0
7862367|NCT00899470|19350746|P1|NOT COMPLETED|First Therapy||0
7862368|NCT00899470|19350743|P4|COMPLETED|First Therapy||6
7862369|NCT00899470|19350744|P3|COMPLETED|First Therapy||6
7862370|NCT00899470|19350745|P2|COMPLETED|First Therapy||6
7862371|NCT00899470|19350746|P1|COMPLETED|First Therapy||6
7862372|NCT00899470|19350743|P4|STARTED|First Therapy||6
7862373|NCT00899470|19350744|P3|STARTED|First Therapy||6
7862374|NCT00899470|19350745|P2|STARTED|First Therapy||6
7862375|NCT00899470|19350746|P1|STARTED|First Therapy||6
7862376|NCT00899431|19350825|P3|NOT COMPLETED|Overall Study||0
7862377|NCT00899431|19350826|P2|NOT COMPLETED|Overall Study||0
7862378|NCT00899431|19350827|P1|NOT COMPLETED|Overall Study||1
7862379|NCT00899431|19350825|P3|COMPLETED|Overall Study||9
7862380|NCT00899431|19350826|P2|COMPLETED|Overall Study||8
7862381|NCT00899431|19350827|P1|COMPLETED|Overall Study||21
7862382|NCT00899431|19350825|P3|STARTED|Overall Study||9
7862383|NCT00899431|19350826|P2|STARTED|Overall Study||8
7862384|NCT00899431|19350827|P1|STARTED|Overall Study||22
7862385|NCT00899392|19350840|P2|NOT COMPLETED|Overall Study||24
7862386|NCT00899392|19350841|P1|NOT COMPLETED|Overall Study||21
7862387|NCT00899392|19350840|P2|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50
7862388|NCT00899392|19350841|P1|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47
7862389|NCT00899392|19350840|P2|STARTED|Overall Study||74
7862390|NCT00899392|19350841|P1|STARTED|Overall Study||68
7862391|NCT00899379|19350858|P5|NOT COMPLETED|Overall Study||31
7862392|NCT00899379|19350859|P4|NOT COMPLETED|Overall Study||37
7862393|NCT00899379|19350860|P3|NOT COMPLETED|Overall Study||29
7862394|NCT00899379|19350861|P2|NOT COMPLETED|Overall Study||29
7862395|NCT00899379|19350862|P1|NOT COMPLETED|Overall Study||34
7862396|NCT00899379|19350858|P5|COMPLETED|Overall Study|Patients who took study drug and completed the study|63
7862397|NCT00899379|19350859|P4|COMPLETED|Overall Study|Patients who took study drug and completed the study|57
7862398|NCT00899379|19350860|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
7862399|NCT00899379|19350861|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
7862400|NCT00899379|19350862|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|61
7862401|NCT00899379|19350858|P5|Patients Not Treated|Overall Study|Patients who did not take study drug|13
7862402|NCT00899379|19350859|P4|Patients Not Treated|Overall Study|Patients who did not take study drug|17
7862403|NCT00899379|19350860|P3|Patients Not Treated|Overall Study|Patients who did not take study drug|11
7862404|NCT00899379|19350861|P2|Patients Not Treated|Overall Study|Patients who did not take study drug|13
7862405|NCT00899379|19350862|P1|Patients Not Treated|Overall Study|Patients who did not take study drug|12
7862406|NCT00899379|19350858|P5|Patients Treated|Overall Study|Patients who took study drug|81
7862407|NCT00899379|19350859|P4|Patients Treated|Overall Study|Patients who took study drug|77
7862408|NCT00899379|19350860|P3|Patients Treated|Overall Study|Patients who took study drug|84
7862409|NCT00899379|19350861|P2|Patients Treated|Overall Study|Patients who took study drug|82
7862410|NCT00899379|19350862|P1|Patients Treated|Overall Study|Patients who took study drug|83
7862411|NCT00899379|19350858|P5|STARTED|Overall Study|Patients who were allocated study drug|94
7862412|NCT00899379|19350859|P4|STARTED|Overall Study|Patients who were allocated study drug|94
7862413|NCT00899379|19350860|P3|STARTED|Overall Study|Patients who were allocated study drug|95
7862414|NCT00899379|19350861|P2|STARTED|Overall Study|Patients who were allocated study drug|95
7862415|NCT00899379|19350862|P1|STARTED|Overall Study|Patients who were allocated study drug|95
7862416|NCT00899353|19350874|P1|NOT COMPLETED|Overall Study||5
7862417|NCT00899353|19350874|P1|COMPLETED|Overall Study||11
7862418|NCT00899353|19350874|P1|STARTED|Overall Study||16
7862419|NCT00898937|19350898|P3|NOT COMPLETED|Overall Study||0
7862420|NCT00898937|19350899|P2|NOT COMPLETED|Overall Study||0
7862421|NCT00898937|19350900|P1|NOT COMPLETED|Overall Study||0
7862422|NCT00898937|19350898|P3|COMPLETED|Overall Study||9
7862423|NCT00898937|19350899|P2|COMPLETED|Overall Study||21
7862424|NCT00898937|19350900|P1|COMPLETED|Overall Study||25
7862425|NCT00898937|19350898|P3|STARTED|Overall Study||9
7862426|NCT00898937|19350899|P2|STARTED|Overall Study||21
7862427|NCT00898937|19350900|P1|STARTED|Overall Study||25
7862428|NCT00898807|19350910|P2|NOT COMPLETED|Overall Study||9
7862429|NCT00898807|19350911|P1|NOT COMPLETED|Overall Study||8
7862430|NCT00898807|19350910|P2|COMPLETED|Overall Study||83
7862431|NCT00898807|19350911|P1|COMPLETED|Overall Study||86
7862432|NCT00898807|19350910|P2|STARTED|Overall Study||92
7862433|NCT00898807|19350911|P1|STARTED|Overall Study||94
7862434|NCT00898677|19350927|P4|NOT COMPLETED|Overall Study||19
7862435|NCT00898677|19350928|P3|NOT COMPLETED|Overall Study||72
7862436|NCT00898677|19350929|P2|NOT COMPLETED|Overall Study||69
7862437|NCT00898677|19350930|P1|NOT COMPLETED|Overall Study||17
7862438|NCT00898677|19350927|P4|COMPLETED|Overall Study||159
7862439|NCT00898677|19350928|P3|COMPLETED|Overall Study||383
7862440|NCT00898677|19350929|P2|COMPLETED|Overall Study||386
7862441|NCT00898677|19350930|P1|COMPLETED|Overall Study||163
7862442|NCT00898677|19350927|P4|Patients Treated|Overall Study|Patients Not Treated: 18|160
7862443|NCT00898677|19350928|P3|Patients Treated|Overall Study|Patients Not Treated: 67|388
7862444|NCT00898677|19350929|P2|Patients Treated|Overall Study|Patients Not Treated: 68|387
7862445|NCT00898677|19350930|P1|Patients Treated|Overall Study|Patients Not Treated: 16|164
7862446|NCT00898677|19350927|P4|STARTED|Overall Study||178
7862447|NCT00898677|19350928|P3|STARTED|Overall Study||455
7862448|NCT00898677|19350929|P2|STARTED|Overall Study||455
7862449|NCT00898677|19350930|P1|STARTED|Overall Study||180
7862450|NCT00898560|19350956|P1|NOT COMPLETED|Overall Study||1
7862451|NCT00898560|19350956|P1|COMPLETED|Overall Study||19
7862452|NCT00898560|19350956|P1|STARTED|Overall Study||20
7862453|NCT00898443|19350968|P2|NOT COMPLETED|Overall Study||0
7862454|NCT00898443|19350969|P1|NOT COMPLETED|Overall Study||1
7862455|NCT00898443|19350968|P2|COMPLETED|Overall Study||8
7862456|NCT00898443|19350969|P1|COMPLETED|Overall Study||9
7862457|NCT00898443|19350968|P2|STARTED|Overall Study||8
7862458|NCT00898443|19350969|P1|STARTED|Overall Study||10
7862459|NCT00898222|19350977|P1|NOT COMPLETED|Overall Study||0
7862460|NCT00898222|19350977|P1|COMPLETED|Overall Study||4
7862461|NCT00898222|19350977|P1|STARTED|Overall Study||4
7862462|NCT00897949|19350984|P3|NOT COMPLETED|Overall Study||69
7862463|NCT00897949|19350985|P2|NOT COMPLETED|Overall Study||103
7862464|NCT00897949|19350986|P1|NOT COMPLETED|Overall Study||104
7862465|NCT00897949|19350984|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|301
7862466|NCT00897949|19350985|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|446
7862467|NCT00897949|19350986|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|450
7862468|NCT00897949|19350984|P3|Patients Treated|Overall Study|Patients who took study drug|304
7862469|NCT00897949|19350985|P2|Patients Treated|Overall Study|Patients who took study drug|456
7862470|NCT00897949|19350986|P1|Patients Treated|Overall Study|Patients who took study drug|458
7862471|NCT00897949|19350984|P3|STARTED|Overall Study|Patients who were allocated study drug|370
7862472|NCT00897949|19350985|P2|STARTED|Overall Study|Patients who were allocated study drug|549
7862473|NCT00897949|19350986|P1|STARTED|Overall Study|Patients who were allocated study drug|554
7862474|NCT00897910|19351009|P1|NOT COMPLETED|Overall Study||0
7862475|NCT00897910|19351009|P1|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6
7862476|NCT00897910|19351009|P1|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6
7862477|NCT00897897|19351013|P1|NOT COMPLETED|Overall Study||0
7862478|NCT00897897|19351013|P1|COMPLETED|Overall Study||33
7862479|NCT00897897|19351013|P1|STARTED|Overall Study||33
7862480|NCT00897715|19351020|P2|NOT COMPLETED|Overall Study||1
7862481|NCT00897715|19351021|P1|NOT COMPLETED|Overall Study||2
7862482|NCT00897715|19351020|P2|COMPLETED|Overall Study||6
7862483|NCT00897715|19351021|P1|COMPLETED|Overall Study||6
7862484|NCT00897715|19351020|P2|STARTED|Overall Study||7
7862485|NCT00897715|19351021|P1|STARTED|Overall Study||8
7862486|NCT00897676|19351029|P2|NOT COMPLETED|Intervention 2(6 Hours)||0
7862487|NCT00897676|19351030|P1|NOT COMPLETED|Intervention 2(6 Hours)||0
7862488|NCT00897676|19351029|P2|COMPLETED|Intervention 2(6 Hours)||7
7862489|NCT00897676|19351030|P1|COMPLETED|Intervention 2(6 Hours)||9
7862490|NCT00897676|19351029|P2|STARTED|Intervention 2(6 Hours)||7
7862491|NCT00897676|19351030|P1|STARTED|Intervention 2(6 Hours)||9
7862492|NCT00897676|19351029|P2|NOT COMPLETED|Intervention 1(6 Hours)||0
7862493|NCT00897676|19351030|P1|NOT COMPLETED|Intervention 1(6 Hours)||0
7862494|NCT00897676|19351029|P2|COMPLETED|Intervention 1(6 Hours)||7
7862495|NCT00897676|19351030|P1|COMPLETED|Intervention 1(6 Hours)||9
7862496|NCT00897676|19351029|P2|STARTED|Intervention 1(6 Hours)||7
7862497|NCT00897676|19351030|P1|STARTED|Intervention 1(6 Hours)||9
7862498|NCT00897390|19351046|P1|NOT COMPLETED|Overall Study||6
7862499|NCT00897390|19351046|P1|COMPLETED|Overall Study||18
7862500|NCT00897390|19351046|P1|STARTED|Overall Study||24
7862501|NCT00897104|19351136|P3|NOT COMPLETED|Overall Study||8
7862502|NCT00897104|19351137|P2|NOT COMPLETED|Overall Study||71
7862503|NCT00897104|19351138|P1|NOT COMPLETED|Overall Study||64
7862504|NCT00897104|19351136|P3|COMPLETED|Overall Study|Participants who took study drug and completed the study|79
7862505|NCT00897104|19351137|P2|COMPLETED|Overall Study|Participants who took study drug and completed the study|357
7862506|NCT00897104|19351138|P1|COMPLETED|Overall Study|Participants who took study drug and completed the study|354
7862507|NCT00897104|19351136|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|7
7862508|NCT00897104|19351137|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|71
7862509|NCT00897104|19351138|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|63
7862510|NCT00897104|19351136|P3|Participants Treated|Overall Study|Participants who took study drug|80
7862511|NCT00897104|19351137|P2|Participants Treated|Overall Study|Participants who took study drug|357
7862512|NCT00897104|19351138|P1|Participants Treated|Overall Study|Participants who took study drug|355
7862513|NCT00897104|19351136|P3|STARTED|Overall Study|Participants who were allocated study drug|87
7862514|NCT00897104|19351137|P2|STARTED|Overall Study|Participants who were allocated study drug|428
7862515|NCT00897104|19351138|P1|STARTED|Overall Study|Participants who were allocated study drug|418
7862516|NCT00896779|19351166|P2|NOT COMPLETED|Overall Study||1
7862517|NCT00896779|19351167|P1|NOT COMPLETED|Overall Study||0
7862518|NCT00896779|19351166|P2|COMPLETED|Overall Study||11
7862519|NCT00896779|19351167|P1|COMPLETED|Overall Study||8
7862520|NCT00896779|19351166|P2|STARTED|Overall Study||12
7862521|NCT00896779|19351167|P1|STARTED|Overall Study||8
7862522|NCT00896649|19351173|P1|NOT COMPLETED|Overall Study||5
7862523|NCT00896649|19351173|P1|COMPLETED|Overall Study||188
7862524|NCT00896649|19351173|P1|STARTED|Overall Study||193
7862525|NCT00896532|19351186|P23|NOT COMPLETED|Months 48-72: Follow-on Phase||0
7862526|NCT00896532|19351187|P22|NOT COMPLETED|Months 48-72: Follow-on Phase||2
7862527|NCT00896532|19351188|P21|NOT COMPLETED|Months 48-72: Follow-on Phase||0
7862528|NCT00896532|19351189|P20|NOT COMPLETED|Months 48-72: Follow-on Phase||0
7862529|NCT00896532|19351190|P19|NOT COMPLETED|Months 48-72: Follow-on Phase||1
7862530|NCT00896532|19351191|P18|NOT COMPLETED|Months 48-72: Follow-on Phase||0
7862531|NCT00896532|19351192|P17|NOT COMPLETED|Months 48-72: Follow-on Phase||0
7862532|NCT00896532|19351193|P16|NOT COMPLETED|Months 48-72: Follow-on Phase||0
7862533|NCT00896532|19351194|P15|NOT COMPLETED|Months 48-72: Follow-on Phase||0
7862534|NCT00896532|19351195|P14|NOT COMPLETED|Months 48-72: Follow-on Phase||0
7862535|NCT00896532|19351196|P13|NOT COMPLETED|Months 48-72: Follow-on Phase||0
7862536|NCT00896532|19351197|P12|NOT COMPLETED|Months 48-72: Follow-on Phase||0
7862537|NCT00896532|19351198|P11|NOT COMPLETED|Months 48-72: Follow-on Phase||0
7862538|NCT00896532|19351199|P10|NOT COMPLETED|Months 48-72: Follow-on Phase||0
7862539|NCT00896532|19351200|P9|NOT COMPLETED|Months 48-72: Follow-on Phase||0
7862540|NCT00896532|19351201|P8|NOT COMPLETED|Months 48-72: Follow-on Phase||0
7862541|NCT00896532|19351202|P7|NOT COMPLETED|Months 48-72: Follow-on Phase||0
7862542|NCT00896532|19351203|P6|NOT COMPLETED|Months 48-72: Follow-on Phase||0
7862543|NCT00896532|19351204|P5|NOT COMPLETED|Months 48-72: Follow-on Phase||0
7862544|NCT00896532|19351205|P4|NOT COMPLETED|Months 48-72: Follow-on Phase||0
7862545|NCT00896532|19351206|P3|NOT COMPLETED|Months 48-72: Follow-on Phase||0
7862546|NCT00896532|19351207|P2|NOT COMPLETED|Months 48-72: Follow-on Phase||0
7862547|NCT00896532|19351208|P1|NOT COMPLETED|Months 48-72: Follow-on Phase||0
7862548|NCT00896532|19351186|P23|COMPLETED|Months 48-72: Follow-on Phase||8
7862549|NCT00896532|19351187|P22|COMPLETED|Months 48-72: Follow-on Phase||57
7862550|NCT00896532|19351188|P21|COMPLETED|Months 48-72: Follow-on Phase||12
7862551|NCT00896532|19351189|P20|COMPLETED|Months 48-72: Follow-on Phase||11
7862552|NCT00896532|19351190|P19|COMPLETED|Months 48-72: Follow-on Phase||50
7862553|NCT00896532|19351191|P18|COMPLETED|Months 48-72: Follow-on Phase||0
7862554|NCT00896532|19351192|P17|COMPLETED|Months 48-72: Follow-on Phase||0
7862555|NCT00896532|19351193|P16|COMPLETED|Months 48-72: Follow-on Phase||0
7862556|NCT00896532|19351194|P15|COMPLETED|Months 48-72: Follow-on Phase||0
7862557|NCT00896532|19351195|P14|COMPLETED|Months 48-72: Follow-on Phase||0
7862558|NCT00896532|19351196|P13|COMPLETED|Months 48-72: Follow-on Phase||0
7862559|NCT00896532|19351197|P12|COMPLETED|Months 48-72: Follow-on Phase||0
7862560|NCT00896532|19351198|P11|COMPLETED|Months 48-72: Follow-on Phase||0
7862561|NCT00896532|19351199|P10|COMPLETED|Months 48-72: Follow-on Phase||0
7862562|NCT00896532|19351200|P9|COMPLETED|Months 48-72: Follow-on Phase||0
7862563|NCT00896532|19351201|P8|COMPLETED|Months 48-72: Follow-on Phase||0
7862564|NCT00896532|19351202|P7|COMPLETED|Months 48-72: Follow-on Phase||0
7862565|NCT00896532|19351203|P6|COMPLETED|Months 48-72: Follow-on Phase||0
7862566|NCT00896532|19351204|P5|COMPLETED|Months 48-72: Follow-on Phase||0
7862567|NCT00896532|19351205|P4|COMPLETED|Months 48-72: Follow-on Phase||0
7862568|NCT00896532|19351206|P3|COMPLETED|Months 48-72: Follow-on Phase||0
7862569|NCT00896532|19351207|P2|COMPLETED|Months 48-72: Follow-on Phase||0
7862570|NCT00896532|19351208|P1|COMPLETED|Months 48-72: Follow-on Phase||0
7862571|NCT00896532|19351186|P23|Received Zoledronic Acid|Months 48-72: Follow-on Phase||8
7862572|NCT00896532|19351187|P22|Received Zoledronic Acid|Months 48-72: Follow-on Phase||56
7862573|NCT00896532|19351188|P21|Received Zoledronic Acid|Months 48-72: Follow-on Phase||12
7862574|NCT00896532|19351189|P20|Received Zoledronic Acid|Months 48-72: Follow-on Phase||11
7862575|NCT00896532|19351190|P19|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
7862576|NCT00896532|19351191|P18|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
7862577|NCT00896532|19351192|P17|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
7862578|NCT00896532|19351193|P16|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
7862579|NCT00896532|19351194|P15|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
7862580|NCT00896532|19351195|P14|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
7862581|NCT00896532|19351196|P13|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
7862582|NCT00896532|19351197|P12|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
7862583|NCT00896532|19351198|P11|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
7862584|NCT00896532|19351199|P10|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
7862585|NCT00896532|19351200|P9|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
7862586|NCT00896532|19351201|P8|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
7862587|NCT00896532|19351202|P7|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
7862588|NCT00896532|19351203|P6|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
7862589|NCT00896532|19351204|P5|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
7862590|NCT00896532|19351205|P4|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
7862591|NCT00896532|19351206|P3|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
7862592|NCT00896532|19351207|P2|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
7862593|NCT00896532|19351208|P1|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
7862594|NCT00896532|19351186|P23|STARTED|Months 48-72: Follow-on Phase||8
7862595|NCT00896532|19351187|P22|STARTED|Months 48-72: Follow-on Phase||59
7862596|NCT00896532|19351188|P21|STARTED|Months 48-72: Follow-on Phase||12
7862597|NCT00896532|19351189|P20|STARTED|Months 48-72: Follow-on Phase||11
7862598|NCT00896532|19351190|P19|STARTED|Months 48-72: Follow-on Phase||51
7862599|NCT00896532|19351191|P18|STARTED|Months 48-72: Follow-on Phase||0
7862600|NCT00896532|19351192|P17|STARTED|Months 48-72: Follow-on Phase||0
7862601|NCT00896532|19351193|P16|STARTED|Months 48-72: Follow-on Phase||0
7862602|NCT00896532|19351194|P15|STARTED|Months 48-72: Follow-on Phase||0
7862603|NCT00896532|19351195|P14|STARTED|Months 48-72: Follow-on Phase||0
7862604|NCT00896532|19351196|P13|STARTED|Months 48-72: Follow-on Phase||0
7862605|NCT00896532|19351197|P12|STARTED|Months 48-72: Follow-on Phase||0
7862606|NCT00896532|19351198|P11|STARTED|Months 48-72: Follow-on Phase||0
7862607|NCT00896532|19351199|P10|STARTED|Months 48-72: Follow-on Phase||0
7862608|NCT00896532|19351200|P9|STARTED|Months 48-72: Follow-on Phase||0
7862609|NCT00896532|19351201|P8|STARTED|Months 48-72: Follow-on Phase||0
7862610|NCT00896532|19351202|P7|STARTED|Months 48-72: Follow-on Phase||0
7862611|NCT00896532|19351203|P6|STARTED|Months 48-72: Follow-on Phase||0
7862612|NCT00896532|19351204|P5|STARTED|Months 48-72: Follow-on Phase||0
7862613|NCT00896532|19351205|P4|STARTED|Months 48-72: Follow-on Phase||0
7862614|NCT00896532|19351206|P3|STARTED|Months 48-72: Follow-on Phase||0
7862615|NCT00896532|19351207|P2|STARTED|Months 48-72: Follow-on Phase||0
7862616|NCT00896532|19351208|P1|STARTED|Months 48-72: Follow-on Phase||0
7862617|NCT00896532|19351186|P23|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862618|NCT00896532|19351187|P22|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862619|NCT00896532|19351188|P21|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862620|NCT00896532|19351189|P20|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862621|NCT00896532|19351190|P19|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862622|NCT00896532|19351191|P18|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||3
7862623|NCT00896532|19351192|P17|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||7
7862624|NCT00896532|19351193|P16|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||2
7862625|NCT00896532|19351194|P15|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862626|NCT00896532|19351195|P14|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862627|NCT00896532|19351196|P13|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862628|NCT00896532|19351197|P12|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862629|NCT00896532|19351198|P11|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862630|NCT00896532|19351199|P10|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862631|NCT00896532|19351200|P9|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862632|NCT00896532|19351201|P8|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862633|NCT00896532|19351202|P7|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862634|NCT00896532|19351203|P6|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862635|NCT00896532|19351204|P5|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862636|NCT00896532|19351205|P4|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862637|NCT00896532|19351206|P3|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862638|NCT00896532|19351207|P2|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862639|NCT00896532|19351208|P1|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862640|NCT00896532|19351186|P23|COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862641|NCT00896532|19351187|P22|COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862642|NCT00896532|19351188|P21|COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862643|NCT00896532|19351189|P20|COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862644|NCT00896532|19351190|P19|COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862645|NCT00896532|19351191|P18|COMPLETED|Months 36-48: Romosozumab Retreatment||64
7862646|NCT00896532|19351192|P17|COMPLETED|Months 36-48: Romosozumab Retreatment||65
7862647|NCT00896532|19351193|P16|COMPLETED|Months 36-48: Romosozumab Retreatment||14
7862648|NCT00896532|19351194|P15|COMPLETED|Months 36-48: Romosozumab Retreatment||12
7862649|NCT00896532|19351195|P14|COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862650|NCT00896532|19351196|P13|COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862651|NCT00896532|19351197|P12|COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862652|NCT00896532|19351198|P11|COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862653|NCT00896532|19351199|P10|COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862654|NCT00896532|19351200|P9|COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862655|NCT00896532|19351201|P8|COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862656|NCT00896532|19351202|P7|COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862657|NCT00896532|19351203|P6|COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862658|NCT00896532|19351204|P5|COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862659|NCT00896532|19351205|P4|COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862660|NCT00896532|19351206|P3|COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862661|NCT00896532|19351207|P2|COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862662|NCT00896532|19351208|P1|COMPLETED|Months 36-48: Romosozumab Retreatment||0
7862663|NCT00896532|19351186|P23|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
7862664|NCT00896532|19351187|P22|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
7862665|NCT00896532|19351188|P21|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
7862666|NCT00896532|19351189|P20|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
7862667|NCT00896532|19351190|P19|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
7862668|NCT00896532|19351191|P18|Received Romosozumab|Months 36-48: Romosozumab Retreatment||67
7862669|NCT00896532|19351192|P17|Received Romosozumab|Months 36-48: Romosozumab Retreatment||72
7862670|NCT00896532|19351193|P16|Received Romosozumab|Months 36-48: Romosozumab Retreatment|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|16
7862671|NCT00896532|19351194|P15|Received Romosozumab|Months 36-48: Romosozumab Retreatment||12
7862672|NCT00896532|19351195|P14|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
7862673|NCT00896532|19351196|P13|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
7862674|NCT00896532|19351197|P12|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
7862675|NCT00896532|19351198|P11|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
7862676|NCT00896532|19351199|P10|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
7862677|NCT00896532|19351200|P9|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
7862678|NCT00896532|19351201|P8|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
7862679|NCT00896532|19351202|P7|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
7862680|NCT00896532|19351203|P6|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
7862681|NCT00896532|19351204|P5|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
7862682|NCT00896532|19351205|P4|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
7862683|NCT00896532|19351206|P3|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
7862684|NCT00896532|19351207|P2|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
7862685|NCT00896532|19351208|P1|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
7862686|NCT00896532|19351186|P23|STARTED|Months 36-48: Romosozumab Retreatment||0
7862687|NCT00896532|19351187|P22|STARTED|Months 36-48: Romosozumab Retreatment||0
7862688|NCT00896532|19351188|P21|STARTED|Months 36-48: Romosozumab Retreatment||0
7862689|NCT00896532|19351189|P20|STARTED|Months 36-48: Romosozumab Retreatment||0
7862690|NCT00896532|19351190|P19|STARTED|Months 36-48: Romosozumab Retreatment||0
7862691|NCT00896532|19351191|P18|STARTED|Months 36-48: Romosozumab Retreatment||67
7862692|NCT00896532|19351192|P17|STARTED|Months 36-48: Romosozumab Retreatment||72
7862693|NCT00896532|19351193|P16|STARTED|Months 36-48: Romosozumab Retreatment||16
7862694|NCT00896532|19351194|P15|STARTED|Months 36-48: Romosozumab Retreatment||12
7862695|NCT00896532|19351195|P14|STARTED|Months 36-48: Romosozumab Retreatment||0
7862696|NCT00896532|19351196|P13|STARTED|Months 36-48: Romosozumab Retreatment||0
7862697|NCT00896532|19351197|P12|STARTED|Months 36-48: Romosozumab Retreatment||0
7862698|NCT00896532|19351198|P11|STARTED|Months 36-48: Romosozumab Retreatment||0
7862699|NCT00896532|19351199|P10|STARTED|Months 36-48: Romosozumab Retreatment||0
7862700|NCT00896532|19351200|P9|STARTED|Months 36-48: Romosozumab Retreatment||0
7862701|NCT00896532|19351201|P8|STARTED|Months 36-48: Romosozumab Retreatment||0
7862702|NCT00896532|19351202|P7|STARTED|Months 36-48: Romosozumab Retreatment||0
7862703|NCT00896532|19351203|P6|STARTED|Months 36-48: Romosozumab Retreatment||0
7862704|NCT00896532|19351204|P5|STARTED|Months 36-48: Romosozumab Retreatment||0
7862705|NCT00896532|19351205|P4|STARTED|Months 36-48: Romosozumab Retreatment||0
7862706|NCT00896532|19351206|P3|STARTED|Months 36-48: Romosozumab Retreatment||0
7862707|NCT00896532|19351207|P2|STARTED|Months 36-48: Romosozumab Retreatment||0
7862708|NCT00896532|19351208|P1|STARTED|Months 36-48: Romosozumab Retreatment||0
7862709|NCT00896532|19351186|P23|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862710|NCT00896532|19351187|P22|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862711|NCT00896532|19351188|P21|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862712|NCT00896532|19351189|P20|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862713|NCT00896532|19351190|P19|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862714|NCT00896532|19351191|P18|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862715|NCT00896532|19351192|P17|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862716|NCT00896532|19351193|P16|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862717|NCT00896532|19351194|P15|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862718|NCT00896532|19351195|P14|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
7862719|NCT00896532|19351196|P13|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||5
7862720|NCT00896532|19351197|P12|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
7862721|NCT00896532|19351198|P11|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
7862722|NCT00896532|19351199|P10|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862723|NCT00896532|19351200|P9|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||1
7862724|NCT00896532|19351201|P8|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862725|NCT00896532|19351202|P7|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862726|NCT00896532|19351203|P6|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862727|NCT00896532|19351204|P5|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862728|NCT00896532|19351205|P4|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862729|NCT00896532|19351206|P3|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862730|NCT00896532|19351207|P2|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862731|NCT00896532|19351208|P1|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862732|NCT00896532|19351186|P23|COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862733|NCT00896532|19351187|P22|COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862734|NCT00896532|19351188|P21|COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862735|NCT00896532|19351189|P20|COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862736|NCT00896532|19351190|P19|COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862737|NCT00896532|19351191|P18|COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862738|NCT00896532|19351192|P17|COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862739|NCT00896532|19351193|P16|COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862740|NCT00896532|19351194|P15|COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862741|NCT00896532|19351195|P14|COMPLETED|Months 24-36: Denosumab Extension Phase||88
7862742|NCT00896532|19351196|P13|COMPLETED|Months 24-36: Denosumab Extension Phase||88
7862743|NCT00896532|19351197|P12|COMPLETED|Months 24-36: Denosumab Extension Phase||19
7862744|NCT00896532|19351198|P11|COMPLETED|Months 24-36: Denosumab Extension Phase||18
7862745|NCT00896532|19351199|P10|COMPLETED|Months 24-36: Denosumab Extension Phase||18
7862746|NCT00896532|19351200|P9|COMPLETED|Months 24-36: Denosumab Extension Phase||17
7862747|NCT00896532|19351201|P8|COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862748|NCT00896532|19351202|P7|COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862749|NCT00896532|19351203|P6|COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862750|NCT00896532|19351204|P5|COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862751|NCT00896532|19351205|P4|COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862752|NCT00896532|19351206|P3|COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862753|NCT00896532|19351207|P2|COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862754|NCT00896532|19351208|P1|COMPLETED|Months 24-36: Denosumab Extension Phase||0
7862755|NCT00896532|19351186|P23|Received Treatment|Months 24-36: Denosumab Extension Phase||0
7862756|NCT00896532|19351187|P22|Received Treatment|Months 24-36: Denosumab Extension Phase||0
7862757|NCT00896532|19351188|P21|Received Treatment|Months 24-36: Denosumab Extension Phase||0
7862758|NCT00896532|19351189|P20|Received Treatment|Months 24-36: Denosumab Extension Phase||0
7862759|NCT00896532|19351190|P19|Received Treatment|Months 24-36: Denosumab Extension Phase||0
7862760|NCT00896532|19351191|P18|Received Treatment|Months 24-36: Denosumab Extension Phase||0
7862761|NCT00896532|19351192|P17|Received Treatment|Months 24-36: Denosumab Extension Phase||0
7862762|NCT00896532|19351193|P16|Received Treatment|Months 24-36: Denosumab Extension Phase||0
7862763|NCT00896532|19351194|P15|Received Treatment|Months 24-36: Denosumab Extension Phase||0
7862764|NCT00896532|19351195|P14|Received Treatment|Months 24-36: Denosumab Extension Phase||88
7862765|NCT00896532|19351196|P13|Received Treatment|Months 24-36: Denosumab Extension Phase||90
7862766|NCT00896532|19351197|P12|Received Treatment|Months 24-36: Denosumab Extension Phase||19
7862767|NCT00896532|19351198|P11|Received Treatment|Months 24-36: Denosumab Extension Phase||19
7862768|NCT00896532|19351199|P10|Received Treatment|Months 24-36: Denosumab Extension Phase|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|18
7862769|NCT00896532|19351200|P9|Received Treatment|Months 24-36: Denosumab Extension Phase||18
7862770|NCT00896532|19351201|P8|Received Treatment|Months 24-36: Denosumab Extension Phase||0
7862771|NCT00896532|19351202|P7|Received Treatment|Months 24-36: Denosumab Extension Phase||0
7862772|NCT00896532|19351203|P6|Received Treatment|Months 24-36: Denosumab Extension Phase||0
7862773|NCT00896532|19351204|P5|Received Treatment|Months 24-36: Denosumab Extension Phase||0
7862774|NCT00896532|19351205|P4|Received Treatment|Months 24-36: Denosumab Extension Phase||0
7862775|NCT00896532|19351206|P3|Received Treatment|Months 24-36: Denosumab Extension Phase||0
7862776|NCT00896532|19351207|P2|Received Treatment|Months 24-36: Denosumab Extension Phase||0
7862777|NCT00896532|19351208|P1|Received Treatment|Months 24-36: Denosumab Extension Phase||0
7862778|NCT00896532|19351186|P23|STARTED|Months 24-36: Denosumab Extension Phase||0
7862779|NCT00896532|19351187|P22|STARTED|Months 24-36: Denosumab Extension Phase||0
7862780|NCT00896532|19351188|P21|STARTED|Months 24-36: Denosumab Extension Phase||0
7862781|NCT00896532|19351189|P20|STARTED|Months 24-36: Denosumab Extension Phase||0
7862782|NCT00896532|19351190|P19|STARTED|Months 24-36: Denosumab Extension Phase||0
7862783|NCT00896532|19351191|P18|STARTED|Months 24-36: Denosumab Extension Phase||0
7862784|NCT00896532|19351192|P17|STARTED|Months 24-36: Denosumab Extension Phase||0
7862785|NCT00896532|19351193|P16|STARTED|Months 24-36: Denosumab Extension Phase||0
7862786|NCT00896532|19351194|P15|STARTED|Months 24-36: Denosumab Extension Phase||0
7862787|NCT00896532|19351195|P14|STARTED|Months 24-36: Denosumab Extension Phase||90
7862788|NCT00896532|19351196|P13|STARTED|Months 24-36: Denosumab Extension Phase||93
7862789|NCT00896532|19351197|P12|STARTED|Months 24-36: Denosumab Extension Phase||21
7862790|NCT00896532|19351198|P11|STARTED|Months 24-36: Denosumab Extension Phase||20
7862791|NCT00896532|19351199|P10|STARTED|Months 24-36: Denosumab Extension Phase||18
7862792|NCT00896532|19351200|P9|STARTED|Months 24-36: Denosumab Extension Phase||18
7862793|NCT00896532|19351201|P8|STARTED|Months 24-36: Denosumab Extension Phase||0
7862794|NCT00896532|19351202|P7|STARTED|Months 24-36: Denosumab Extension Phase||0
7862795|NCT00896532|19351203|P6|STARTED|Months 24-36: Denosumab Extension Phase||0
7862796|NCT00896532|19351204|P5|STARTED|Months 24-36: Denosumab Extension Phase||0
7862797|NCT00896532|19351205|P4|STARTED|Months 24-36: Denosumab Extension Phase||0
7862798|NCT00896532|19351206|P3|STARTED|Months 24-36: Denosumab Extension Phase||0
7862799|NCT00896532|19351207|P2|STARTED|Months 24-36: Denosumab Extension Phase||0
7862800|NCT00896532|19351208|P1|STARTED|Months 24-36: Denosumab Extension Phase||0
7862801|NCT00896532|19351186|P23|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862802|NCT00896532|19351187|P22|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862803|NCT00896532|19351188|P21|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862804|NCT00896532|19351189|P20|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862805|NCT00896532|19351190|P19|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862806|NCT00896532|19351191|P18|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862807|NCT00896532|19351192|P17|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862808|NCT00896532|19351193|P16|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862809|NCT00896532|19351194|P15|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862810|NCT00896532|19351195|P14|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862811|NCT00896532|19351196|P13|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862812|NCT00896532|19351197|P12|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862813|NCT00896532|19351198|P11|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862814|NCT00896532|19351199|P10|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862815|NCT00896532|19351200|P9|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862816|NCT00896532|19351201|P8|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||4
7862817|NCT00896532|19351202|P7|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||5
7862818|NCT00896532|19351203|P6|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
7862819|NCT00896532|19351204|P5|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
7862820|NCT00896532|19351205|P4|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||12
7862821|NCT00896532|19351206|P3|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||9
7862822|NCT00896532|19351207|P2|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
7862823|NCT00896532|19351208|P1|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
7862824|NCT00896532|19351186|P23|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862825|NCT00896532|19351187|P22|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862826|NCT00896532|19351188|P21|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862827|NCT00896532|19351189|P20|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862828|NCT00896532|19351190|P19|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862829|NCT00896532|19351191|P18|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862830|NCT00896532|19351192|P17|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862831|NCT00896532|19351193|P16|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862832|NCT00896532|19351194|P15|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862833|NCT00896532|19351195|P14|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862834|NCT00896532|19351196|P13|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862835|NCT00896532|19351197|P12|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862836|NCT00896532|19351198|P11|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862837|NCT00896532|19351199|P10|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862838|NCT00896532|19351200|P9|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
7862839|NCT00896532|19351201|P8|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
7862840|NCT00896532|19351202|P7|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
7862841|NCT00896532|19351203|P6|COMPLETED|Months 1-24: Romosozumab Treatment Phase||43
7862842|NCT00896532|19351204|P5|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
7862843|NCT00896532|19351205|P4|COMPLETED|Months 1-24: Romosozumab Treatment Phase||39
7862844|NCT00896532|19351206|P3|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
7862845|NCT00896532|19351207|P2|COMPLETED|Months 1-24: Romosozumab Treatment Phase||45
7862846|NCT00896532|19351208|P1|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
7862847|NCT00896532|19351186|P23|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
7862848|NCT00896532|19351187|P22|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
7862849|NCT00896532|19351188|P21|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
7862850|NCT00896532|19351189|P20|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
7862851|NCT00896532|19351190|P19|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
7862852|NCT00896532|19351191|P18|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
7862853|NCT00896532|19351192|P17|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
7862854|NCT00896532|19351193|P16|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
7862855|NCT00896532|19351194|P15|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
7862856|NCT00896532|19351195|P14|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
7862857|NCT00896532|19351196|P13|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
7862858|NCT00896532|19351197|P12|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
7862859|NCT00896532|19351198|P11|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
7862860|NCT00896532|19351199|P10|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
7862861|NCT00896532|19351200|P9|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
7862862|NCT00896532|19351201|P8|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
7862863|NCT00896532|19351202|P7|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||51
7862864|NCT00896532|19351203|P6|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
7862865|NCT00896532|19351204|P5|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||50
7862866|NCT00896532|19351205|P4|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||45
7862867|NCT00896532|19351206|P3|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
7862868|NCT00896532|19351207|P2|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
7862869|NCT00896532|19351208|P1|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||47
7862870|NCT00896532|19351186|P23|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
7862871|NCT00896532|19351187|P22|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
7862872|NCT00896532|19351188|P21|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
7862873|NCT00896532|19351189|P20|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
7862874|NCT00896532|19351190|P19|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
7862875|NCT00896532|19351191|P18|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
7862876|NCT00896532|19351192|P17|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
7862877|NCT00896532|19351193|P16|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
7862878|NCT00896532|19351194|P15|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
7862879|NCT00896532|19351195|P14|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
7862880|NCT00896532|19351196|P13|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
7862881|NCT00896532|19351197|P12|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
7862882|NCT00896532|19351198|P11|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
7862883|NCT00896532|19351199|P10|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
7862884|NCT00896532|19351200|P9|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
7862885|NCT00896532|19351201|P8|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
7862886|NCT00896532|19351202|P7|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
7862887|NCT00896532|19351203|P6|Received Treatment|Months 1-24: Romosozumab Treatment Phase||48
7862888|NCT00896532|19351204|P5|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
7862889|NCT00896532|19351205|P4|Received Treatment|Months 1-24: Romosozumab Treatment Phase||49
7862890|NCT00896532|19351206|P3|Received Treatment|Months 1-24: Romosozumab Treatment Phase||54
7862891|NCT00896532|19351207|P2|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
7862892|NCT00896532|19351208|P1|Received Treatment|Months 1-24: Romosozumab Treatment Phase|One participant received 1 dose of romosozumab 70 mg in error|51
7862893|NCT00896532|19351186|P23|STARTED|Months 1-24: Romosozumab Treatment Phase||0
7862894|NCT00896532|19351187|P22|STARTED|Months 1-24: Romosozumab Treatment Phase||0
7862895|NCT00896532|19351188|P21|STARTED|Months 1-24: Romosozumab Treatment Phase||0
7862896|NCT00896532|19351189|P20|STARTED|Months 1-24: Romosozumab Treatment Phase||0
7862897|NCT00896532|19351190|P19|STARTED|Months 1-24: Romosozumab Treatment Phase||0
7862898|NCT00896532|19351191|P18|STARTED|Months 1-24: Romosozumab Treatment Phase||0
7862899|NCT00896532|19351192|P17|STARTED|Months 1-24: Romosozumab Treatment Phase||0
7862900|NCT00896532|19351193|P16|STARTED|Months 1-24: Romosozumab Treatment Phase||0
7862901|NCT00896532|19351194|P15|STARTED|Months 1-24: Romosozumab Treatment Phase||0
7862902|NCT00896532|19351195|P14|STARTED|Months 1-24: Romosozumab Treatment Phase||0
7862903|NCT00896532|19351196|P13|STARTED|Months 1-24: Romosozumab Treatment Phase||0
7862904|NCT00896532|19351197|P12|STARTED|Months 1-24: Romosozumab Treatment Phase||0
7862905|NCT00896532|19351198|P11|STARTED|Months 1-24: Romosozumab Treatment Phase||0
7862906|NCT00896532|19351199|P10|STARTED|Months 1-24: Romosozumab Treatment Phase||0
7862907|NCT00896532|19351200|P9|STARTED|Months 1-24: Romosozumab Treatment Phase||0
7862908|NCT00896532|19351201|P8|STARTED|Months 1-24: Romosozumab Treatment Phase||52
7862909|NCT00896532|19351202|P7|STARTED|Months 1-24: Romosozumab Treatment Phase||53
7862910|NCT00896532|19351203|P6|STARTED|Months 1-24: Romosozumab Treatment Phase||51
7862911|NCT00896532|19351204|P5|STARTED|Months 1-24: Romosozumab Treatment Phase||54
7862912|NCT00896532|19351205|P4|STARTED|Months 1-24: Romosozumab Treatment Phase||51
7862913|NCT00896532|19351206|P3|STARTED|Months 1-24: Romosozumab Treatment Phase||55
7862914|NCT00896532|19351207|P2|STARTED|Months 1-24: Romosozumab Treatment Phase||51
7862915|NCT00896532|19351208|P1|STARTED|Months 1-24: Romosozumab Treatment Phase||52
7862916|NCT00896480|19351335|P1|NOT COMPLETED|Overall Study||21
7862917|NCT00896480|19351335|P1|COMPLETED|Overall Study||3
7862918|NCT00896480|19351335|P1|STARTED|Overall Study||24
7862919|NCT00896454|19351383|P1|NOT COMPLETED|Overall Study||33
7862920|NCT00896454|19351383|P1|COMPLETED|Overall Study||0
7862921|NCT00896454|19351383|P1|STARTED|Overall Study||33
7862922|NCT00896441|19351397|P2|NOT COMPLETED|Overall Study||0
7862923|NCT00896441|19351398|P1|NOT COMPLETED|Overall Study||2
7862924|NCT00896441|19351397|P2|COMPLETED|Overall Study||9
7862925|NCT00896441|19351398|P1|COMPLETED|Overall Study||15
7862926|NCT00896441|19351397|P2|STARTED|Overall Study||9
7862927|NCT00896441|19351398|P1|STARTED|Overall Study||17
7862928|NCT00896389|19351405|P1|NOT COMPLETED|HCTZ High Dose||0
7862929|NCT00896389|19351405|P1|COMPLETED|HCTZ High Dose||25
7862930|NCT00896389|19351405|P1|STARTED|HCTZ High Dose||25
7862931|NCT00896389|19351405|P1|NOT COMPLETED|HCTZ Low Dose||0
7862932|NCT00896389|19351405|P1|COMPLETED|HCTZ Low Dose||28
7862933|NCT00896389|19351405|P1|STARTED|HCTZ Low Dose|Only subjects with SBP > 120 mmHg and agreeable to the HCTZ protocol continued to the next period.|28
7862934|NCT00896389|19351405|P1|NOT COMPLETED|Salt Loading||0
7862935|NCT00896389|19351405|P1|COMPLETED|Salt Loading||124
7862936|NCT00896389|19351405|P1|STARTED|Salt Loading||124
7862937|NCT00896363|19351422|P3|NOT COMPLETED|Overall Study||8
7862938|NCT00896363|19351423|P2|NOT COMPLETED|Overall Study||11
7862939|NCT00896363|19351424|P1|NOT COMPLETED|Overall Study||6
7862940|NCT00896363|19351422|P3|COMPLETED|Overall Study||24
7862941|NCT00896363|19351423|P2|COMPLETED|Overall Study||25
7862942|NCT00896363|19351424|P1|COMPLETED|Overall Study||25
7862943|NCT00896363|19351422|P3|STARTED|Overall Study||32
7862944|NCT00896363|19351423|P2|STARTED|Overall Study||36
7862945|NCT00896363|19351424|P1|STARTED|Overall Study||31
7862946|NCT00896337|19351476|P1|NOT COMPLETED|Overall Study||25
7862947|NCT00896337|19351476|P1|COMPLETED|Overall Study||100
7862948|NCT00896337|19351476|P1|STARTED|Overall Study||125
7862949|NCT00896298|19351545|P2|NOT COMPLETED|Overall Study||3
7862950|NCT00896298|19351546|P1|NOT COMPLETED|Overall Study||3
7862951|NCT00896298|19351545|P2|COMPLETED|Overall Study||9
7862952|NCT00896298|19351546|P1|COMPLETED|Overall Study||10
7862953|NCT00896298|19351545|P2|STARTED|Overall Study||12
7862954|NCT00896298|19351546|P1|STARTED|Overall Study||13
7862955|NCT00896233|19351558|P1|NOT COMPLETED|Overall Study||1
7862956|NCT00896233|19351558|P1|COMPLETED|Overall Study||9
7862957|NCT00896233|19351558|P1|STARTED|Overall Study||10
7862958|NCT00896168|19351571|P2|NOT COMPLETED|Overall Study||19
7862959|NCT00896168|19351572|P1|NOT COMPLETED|Overall Study||14
7862960|NCT00896168|19351571|P2|COMPLETED|Overall Study||111
7862961|NCT00896168|19351572|P1|COMPLETED|Overall Study||90
7862962|NCT00896168|19351571|P2|STARTED|Overall Study||130
7862963|NCT00896168|19351572|P1|STARTED|Overall Study||104
7862964|NCT00896064|19351602|P2|NOT COMPLETED|Overall Study||0
7862965|NCT00896064|19351603|P1|NOT COMPLETED|Overall Study||0
7862966|NCT00896064|19351602|P2|COMPLETED|Overall Study||21
7862967|NCT00896064|19351603|P1|COMPLETED|Overall Study||22
7862968|NCT00896064|19351602|P2|STARTED|Overall Study||21
7862969|NCT00896064|19351603|P1|STARTED|Overall Study||22
7862970|NCT00896051|19351633|P2|NOT COMPLETED|Overall Study||9
7862971|NCT00896051|19351634|P1|NOT COMPLETED|Overall Study||10
7862972|NCT00896051|19351633|P2|COMPLETED|Overall Study||16
7862973|NCT00896051|19351634|P1|COMPLETED|Overall Study||15
7862974|NCT00896051|19351633|P2|STARTED|Overall Study||25
7862975|NCT00896051|19351634|P1|STARTED|Overall Study||25
7862976|NCT00896038|19351676|P2|NOT COMPLETED|Overall Study||1
7862977|NCT00896038|19351677|P1|NOT COMPLETED|Overall Study||4
7862978|NCT00896038|19351676|P2|COMPLETED|Overall Study||27
7862979|NCT00896038|19351677|P1|COMPLETED|Overall Study||26
7862980|NCT00896038|19351676|P2|STARTED|Overall Study||28
7862981|NCT00896038|19351677|P1|STARTED|Overall Study||30
7862982|NCT00896025|19351715|P1|NOT COMPLETED|Overall Study||0
7862983|NCT00896025|19351715|P1|COMPLETED|Overall Study||8
7862984|NCT00896025|19351715|P1|STARTED|Overall Study||8
7862985|NCT00896012|19351729|P2|NOT COMPLETED|Overall Study||11
7862986|NCT00896012|19351730|P1|NOT COMPLETED|Overall Study||11
7862987|NCT00896012|19351729|P2|COMPLETED|Overall Study||12
7862988|NCT00896012|19351730|P1|COMPLETED|Overall Study||18
7862989|NCT00896012|19351729|P2|STARTED|Overall Study||23
7862990|NCT00896012|19351730|P1|STARTED|Overall Study||29
7862991|NCT00895947|19351742|P2|NOT COMPLETED|Overall Study||10
7862992|NCT00895947|19351743|P1|NOT COMPLETED|Overall Study||12
7862993|NCT00895947|19351742|P2|COMPLETED|Overall Study||90
7862994|NCT00895947|19351743|P1|COMPLETED|Overall Study||88
7862995|NCT00895947|19351742|P2|STARTED|Overall Study||100
7862996|NCT00895947|19351743|P1|STARTED|Overall Study||100
7862997|NCT00895934|19351761|P4|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
7862998|NCT00895934|19351762|P3|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
7862999|NCT00895934|19351763|P2|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
7863000|NCT00895934|19351764|P1|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
7863001|NCT00895934|19351761|P4|COMPLETED|Efficacy of Most Tolerated Dose||37
7863002|NCT00895934|19351762|P3|COMPLETED|Efficacy of Most Tolerated Dose||0
7863003|NCT00895934|19351763|P2|COMPLETED|Efficacy of Most Tolerated Dose||0
7863004|NCT00895934|19351764|P1|COMPLETED|Efficacy of Most Tolerated Dose||0
7863005|NCT00895934|19351761|P4|STARTED|Efficacy of Most Tolerated Dose||37
7863006|NCT00895934|19351762|P3|STARTED|Efficacy of Most Tolerated Dose||0
7863007|NCT00895934|19351763|P2|STARTED|Efficacy of Most Tolerated Dose||0
7863008|NCT00895934|19351764|P1|STARTED|Efficacy of Most Tolerated Dose||0
7863009|NCT00895934|19351761|P4|NOT COMPLETED|Dose Escalation||0
7863010|NCT00895934|19351762|P3|NOT COMPLETED|Dose Escalation||0
7863011|NCT00895934|19351763|P2|NOT COMPLETED|Dose Escalation||0
7863012|NCT00895934|19351764|P1|NOT COMPLETED|Dose Escalation||0
7863013|NCT00895934|19351761|P4|COMPLETED|Dose Escalation||6
7863014|NCT00895934|19351762|P3|COMPLETED|Dose Escalation||3
7863015|NCT00895934|19351763|P2|COMPLETED|Dose Escalation||3
7863016|NCT00895934|19351764|P1|COMPLETED|Dose Escalation||3
7863017|NCT00895934|19351761|P4|STARTED|Dose Escalation||6
7863018|NCT00895934|19351762|P3|STARTED|Dose Escalation||3
7863019|NCT00895934|19351763|P2|STARTED|Dose Escalation||3
7863020|NCT00895934|19351764|P1|STARTED|Dose Escalation||3
7863021|NCT00895921|19351778|P2|NOT COMPLETED|Overall Study||0
7863022|NCT00895921|19351779|P1|NOT COMPLETED|Overall Study||0
7863023|NCT00895921|19351778|P2|COMPLETED|Overall Study||15
7863024|NCT00895921|19351779|P1|COMPLETED|Overall Study||15
7863025|NCT00895921|19351778|P2|STARTED|Overall Study||15
7863026|NCT00895921|19351779|P1|STARTED|Overall Study||15
7863027|NCT00895895|19351794|P5|NOT COMPLETED|Period 2||49
7863028|NCT00895895|19351795|P4|NOT COMPLETED|Period 2||54
7863029|NCT00895895|19351796|P3|NOT COMPLETED|Period 2||49
7863030|NCT00895895|19351797|P2|NOT COMPLETED|Period 2||53
7863031|NCT00895895|19351798|P1|NOT COMPLETED|Period 2||56
7863032|NCT00895895|19351794|P5|COMPLETED|Period 2||35
7863033|NCT00895895|19351795|P4|COMPLETED|Period 2||37
7863034|NCT00895895|19351796|P3|COMPLETED|Period 2||33
7863035|NCT00895895|19351797|P2|COMPLETED|Period 2||31
7863036|NCT00895895|19351798|P1|COMPLETED|Period 2||30
7863037|NCT00895895|19351794|P5|STARTED|Period 2||84
7863038|NCT00895895|19351795|P4|STARTED|Period 2||91
7863039|NCT00895895|19351796|P3|STARTED|Period 2||82
7863040|NCT00895895|19351797|P2|STARTED|Period 2||84
7863041|NCT00895895|19351798|P1|STARTED|Period 2||86
7863042|NCT00895895|19351794|P5|NOT COMPLETED|After Period 1, Prior to Period 2||2
7863043|NCT00895895|19351795|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
7863044|NCT00895895|19351796|P3|NOT COMPLETED|After Period 1, Prior to Period 2||2
7863045|NCT00895895|19351797|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
7863046|NCT00895895|19351798|P1|NOT COMPLETED|After Period 1, Prior to Period 2||0
7863047|NCT00895895|19351794|P5|COMPLETED|After Period 1, Prior to Period 2||84
7863048|NCT00895895|19351795|P4|COMPLETED|After Period 1, Prior to Period 2||91
7863049|NCT00895895|19351796|P3|COMPLETED|After Period 1, Prior to Period 2||82
7863050|NCT00895895|19351797|P2|COMPLETED|After Period 1, Prior to Period 2||84
7863051|NCT00895895|19351798|P1|COMPLETED|After Period 1, Prior to Period 2||86
7863052|NCT00895895|19351794|P5|STARTED|After Period 1, Prior to Period 2||86
7863053|NCT00895895|19351795|P4|STARTED|After Period 1, Prior to Period 2||91
7863054|NCT00895895|19351796|P3|STARTED|After Period 1, Prior to Period 2||84
7863055|NCT00895895|19351797|P2|STARTED|After Period 1, Prior to Period 2||84
7863056|NCT00895895|19351798|P1|STARTED|After Period 1, Prior to Period 2||86
7863057|NCT00895895|19351794|P5|NOT COMPLETED|Period 1||20
7863058|NCT00895895|19351795|P4|NOT COMPLETED|Period 1||13
7863059|NCT00895895|19351796|P3|NOT COMPLETED|Period 1||20
7863060|NCT00895895|19351797|P2|NOT COMPLETED|Period 1||21
7863061|NCT00895895|19351798|P1|NOT COMPLETED|Period 1||21
7863062|NCT00895895|19351794|P5|COMPLETED|Period 1||86
7863063|NCT00895895|19351795|P4|COMPLETED|Period 1||91
7863064|NCT00895895|19351796|P3|COMPLETED|Period 1||84
7863065|NCT00895895|19351797|P2|COMPLETED|Period 1||84
7863066|NCT00895895|19351798|P1|COMPLETED|Period 1||86
7863067|NCT00895895|19351794|P5|Randomized But Not Treated|Period 1||2
7863068|NCT00895895|19351795|P4|Randomized But Not Treated|Period 1||1
7863069|NCT00895895|19351796|P3|Randomized But Not Treated|Period 1||1
7863070|NCT00895895|19351797|P2|Randomized But Not Treated|Period 1||3
7863071|NCT00895895|19351798|P1|Randomized But Not Treated|Period 1||1
7863072|NCT00895895|19351794|P5|STARTED|Period 1||106
7863073|NCT00895895|19351795|P4|STARTED|Period 1||104
7863074|NCT00895895|19351796|P3|STARTED|Period 1||104
7863075|NCT00895895|19351797|P2|STARTED|Period 1||105
7863076|NCT00895895|19351798|P1|STARTED|Period 1||107
7863077|NCT00895843|19351912|P2|NOT COMPLETED|Overall Study||12
7863078|NCT00895843|19351913|P1|NOT COMPLETED|Overall Study||12
7863079|NCT00895843|19351912|P2|COMPLETED|Overall Study||50
7863080|NCT00895843|19351913|P1|COMPLETED|Overall Study||48
7863081|NCT00895843|19351912|P2|STARTED|Overall Study||62
7863082|NCT00895843|19351913|P1|STARTED|Overall Study||60
7863083|NCT00895830|19351924|P5|NOT COMPLETED|Overall Study||0
7863084|NCT00895830|19351925|P4|NOT COMPLETED|Overall Study||0
7863085|NCT00895830|19351926|P3|NOT COMPLETED|Overall Study||0
7863086|NCT00895830|19351927|P2|NOT COMPLETED|Overall Study||0
7863087|NCT00895830|19351928|P1|NOT COMPLETED|Overall Study||0
7863088|NCT00895830|19351924|P5|COMPLETED|Overall Study||55
7863089|NCT00895830|19351925|P4|COMPLETED|Overall Study||52
7863090|NCT00895830|19351926|P3|COMPLETED|Overall Study||49
7863091|NCT00895830|19351927|P2|COMPLETED|Overall Study||50
7863092|NCT00895830|19351928|P1|COMPLETED|Overall Study||51
7863093|NCT00895830|19351924|P5|STARTED|Overall Study||55
7863094|NCT00895830|19351925|P4|STARTED|Overall Study||52
7863095|NCT00895830|19351926|P3|STARTED|Overall Study||49
7863096|NCT00895830|19351927|P2|STARTED|Overall Study||50
7863097|NCT00895830|19351928|P1|STARTED|Overall Study||51
7863098|NCT00895817|19351942|P2|NOT COMPLETED|Overall Study||0
7863099|NCT00895817|19351943|P1|NOT COMPLETED|Overall Study||0
7863100|NCT00895817|19351942|P2|COMPLETED|Overall Study||21
7863101|NCT00895817|19351943|P1|COMPLETED|Overall Study||21
7863102|NCT00895817|19351942|P2|STARTED|Overall Study||21
7863103|NCT00895817|19351943|P1|STARTED|Overall Study||21
7863104|NCT00895752|19351949|P1|NOT COMPLETED|Overall Study||0
7863105|NCT00895752|19351949|P1|COMPLETED|Overall Study||6
7863106|NCT00895752|19351949|P1|STARTED|Overall Study||6
7863107|NCT00895661|19351960|P1|NOT COMPLETED|Overall Study||3
7863108|NCT00895661|19351960|P1|COMPLETED|Overall Study||37
7863109|NCT00895661|19351960|P1|STARTED|Overall Study||40
7863110|NCT00895622|19351970|P3|NOT COMPLETED|Overall Study||4
7863111|NCT00895622|19351971|P2|NOT COMPLETED|Overall Study||4
7863112|NCT00895622|19351972|P1|NOT COMPLETED|Overall Study||5
7863113|NCT00895622|19351970|P3|COMPLETED|Overall Study||53
7863114|NCT00895622|19351971|P2|COMPLETED|Overall Study||52
7863115|NCT00895622|19351972|P1|COMPLETED|Overall Study||60
7863116|NCT00895622|19351970|P3|STARTED|Overall Study||57
7863117|NCT00895622|19351971|P2|STARTED|Overall Study||56
7863118|NCT00895622|19351972|P1|STARTED|Overall Study||65
7863119|NCT00895583|19351999|P2|NOT COMPLETED|Overall Study||12
7863120|NCT00895583|19352000|P1|NOT COMPLETED|Overall Study||44
7863121|NCT00895583|19351999|P2|COMPLETED|Overall Study||111
7863122|NCT00895583|19352000|P1|COMPLETED|Overall Study||87
7863123|NCT00895583|19351999|P2|STARTED|Overall Study||123
7863124|NCT00895583|19352000|P1|STARTED|Overall Study||131
7863125|NCT00895531|19352080|P2|NOT COMPLETED|Overall Study||0
7863126|NCT00895531|19352081|P1|NOT COMPLETED|Overall Study||0
7863127|NCT00895531|19352080|P2|COMPLETED|Overall Study||37
7863128|NCT00895531|19352081|P1|COMPLETED|Overall Study||38
7863129|NCT00895531|19352080|P2|STARTED|Overall Study||37
7863130|NCT00895531|19352081|P1|STARTED|Overall Study||38
7863131|NCT00895453|19352090|P3|NOT COMPLETED|Overall Study||23
7863132|NCT00895453|19352091|P2|NOT COMPLETED|Overall Study||25
7863133|NCT00895453|19352092|P1|NOT COMPLETED|Overall Study||25
7863134|NCT00895453|19352090|P3|COMPLETED|Overall Study||23
7863135|NCT00895453|19352091|P2|COMPLETED|Overall Study||25
7863136|NCT00895453|19352092|P1|COMPLETED|Overall Study||23
7863137|NCT00895453|19352090|P3|STARTED|Overall Study||46
7863138|NCT00895453|19352091|P2|STARTED|Overall Study||50
7863139|NCT00895453|19352092|P1|STARTED|Overall Study||48
7863140|NCT00895414|19352100|P2|NOT COMPLETED|Second Intervention (14 Days)||0
7863141|NCT00895414|19352101|P1|NOT COMPLETED|Second Intervention (14 Days)||0
7863142|NCT00895414|19352100|P2|COMPLETED|Second Intervention (14 Days)||9
7863143|NCT00895414|19352101|P1|COMPLETED|Second Intervention (14 Days)||8
7863144|NCT00895414|19352100|P2|STARTED|Second Intervention (14 Days)||9
7863145|NCT00895414|19352101|P1|STARTED|Second Intervention (14 Days)||8
7863146|NCT00895414|19352100|P2|NOT COMPLETED|First Intervention (14 Days)||1
7863147|NCT00895414|19352101|P1|NOT COMPLETED|First Intervention (14 Days)||1
7863148|NCT00895414|19352100|P2|COMPLETED|First Intervention (14 Days)||9
7863149|NCT00895414|19352101|P1|COMPLETED|First Intervention (14 Days)||8
7863150|NCT00895414|19352100|P2|STARTED|First Intervention (14 Days)||10
7863151|NCT00895414|19352101|P1|STARTED|First Intervention (14 Days)||9
7863152|NCT00895310|19352111|P1|NOT COMPLETED|Overall Study||1
7863153|NCT00895310|19352111|P1|COMPLETED|Overall Study||29
7863154|NCT00895310|19352111|P1|STARTED|Overall Study||30
7863155|NCT00895284|19352120|P2|NOT COMPLETED|Overall Study||0
7863156|NCT00895284|19352121|P1|NOT COMPLETED|Overall Study||0
7863157|NCT00895284|19352120|P2|COMPLETED|Overall Study||0
7863158|NCT00895284|19352121|P1|COMPLETED|Overall Study||3
7863159|NCT00895284|19352120|P2|STARTED|Overall Study||0
7863160|NCT00895284|19352121|P1|STARTED|Overall Study||3
7863161|NCT00895245|19352127|P1|NOT COMPLETED|Overall Study||6
7863162|NCT00895245|19352127|P1|COMPLETED|Overall Study||0
7863163|NCT00895245|19352127|P1|STARTED|Overall Study||6
7863164|NCT00895232|19352137|P3|NOT COMPLETED|Overall Study||5
7863165|NCT00895232|19352138|P2|NOT COMPLETED|Overall Study||4
7863166|NCT00895232|19352139|P1|NOT COMPLETED|Overall Study||3
7863167|NCT00895232|19352137|P3|COMPLETED|Overall Study||3
7863168|NCT00895232|19352138|P2|COMPLETED|Overall Study||2
7863169|NCT00895232|19352139|P1|COMPLETED|Overall Study||4
7863170|NCT00895232|19352137|P3|STARTED|Overall Study||8
7863171|NCT00895232|19352138|P2|STARTED|Overall Study||6
7863172|NCT00895232|19352139|P1|STARTED|Overall Study||7
7863173|NCT00895193|19352157|P4|NOT COMPLETED|Overall Study||0
7863174|NCT00895193|19352158|P3|NOT COMPLETED|Overall Study||0
7863175|NCT00895193|19352159|P2|NOT COMPLETED|Overall Study||0
7863176|NCT00895193|19352160|P1|NOT COMPLETED|Overall Study||0
7863177|NCT00895193|19352157|P4|COMPLETED|Overall Study||25
7863178|NCT00895193|19352158|P3|COMPLETED|Overall Study||25
7863179|NCT00895193|19352159|P2|COMPLETED|Overall Study||25
7863180|NCT00895193|19352160|P1|COMPLETED|Overall Study||25
7863181|NCT00895193|19352157|P4|STARTED|Overall Study||25
7863182|NCT00895193|19352158|P3|STARTED|Overall Study||25
7863183|NCT00895193|19352159|P2|STARTED|Overall Study||25
7863184|NCT00895193|19352160|P1|STARTED|Overall Study||25
7863185|NCT00895180|19352184|P2|NOT COMPLETED|Overall Study||0
7863186|NCT00895180|19352185|P1|NOT COMPLETED|Overall Study||0
7863187|NCT00895180|19352184|P2|COMPLETED|Overall Study||40
7863188|NCT00895180|19352185|P1|COMPLETED|Overall Study||40
7863189|NCT00895180|19352184|P2|Received at Least 1 Dose of Study Drug|Overall Study||40
7863190|NCT00895180|19352185|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
7863191|NCT00895180|19352184|P2|STARTED|Overall Study||40
7863192|NCT00895180|19352185|P1|STARTED|Overall Study||40
7863193|NCT00895154|19352205|P2|NOT COMPLETED|Overall Study||2
7863194|NCT00895154|19352206|P1|NOT COMPLETED|Overall Study||1
7863195|NCT00895154|19352205|P2|COMPLETED|Overall Study||8
7863196|NCT00895154|19352206|P1|COMPLETED|Overall Study||7
7863197|NCT00895154|19352205|P2|Follow Up|Overall Study||8
7863198|NCT00895154|19352206|P1|Follow Up|Overall Study||7
7863199|NCT00895154|19352205|P2|STARTED|Overall Study||10
7863200|NCT00895154|19352206|P1|STARTED|Overall Study||8
7863201|NCT00895037|19352241|P3|NOT COMPLETED|Overall Study||1
7863202|NCT00895037|19352242|P2|NOT COMPLETED|Overall Study||2
7863203|NCT00895037|19352243|P1|NOT COMPLETED|Overall Study||0
7863204|NCT00895037|19352241|P3|COMPLETED|Overall Study||1
7863205|NCT00895037|19352242|P2|COMPLETED|Overall Study||75
7863206|NCT00895037|19352243|P1|COMPLETED|Overall Study||22
7863207|NCT00895037|19352241|P3|STARTED|Overall Study||2
7863208|NCT00895037|19352242|P2|STARTED|Overall Study||77
7863209|NCT00895037|19352243|P1|STARTED|Overall Study||22
7863210|NCT00895011|19352274|P3|NOT COMPLETED|Overall Study||8
7863211|NCT00895011|19352275|P2|NOT COMPLETED|Overall Study||14
7863212|NCT00895011|19352276|P1|NOT COMPLETED|Overall Study||24
7863213|NCT00895011|19352274|P3|COMPLETED|Overall Study||91
7863214|NCT00895011|19352275|P2|COMPLETED|Overall Study||85
7863215|NCT00895011|19352276|P1|COMPLETED|Overall Study||76
7863216|NCT00895011|19352274|P3|STARTED|Overall Study||99
7863217|NCT00895011|19352275|P2|STARTED|Overall Study||99
7863218|NCT00895011|19352276|P1|STARTED|Overall Study||100
7863219|NCT00894933|19352290|P1|NOT COMPLETED|Overall Study||4
7863220|NCT00894933|19352290|P1|COMPLETED|Overall Study||29
7863221|NCT00894933|19352290|P1|STARTED|Overall Study||33
7863222|NCT00894803|19352308|P2|NOT COMPLETED|Overall Study||5
7863223|NCT00894803|19352309|P1|NOT COMPLETED|Overall Study||20
7863224|NCT00894803|19352308|P2|COMPLETED|Overall Study||20
7863225|NCT00894803|19352309|P1|COMPLETED|Overall Study||81
7863226|NCT00894803|19352308|P2|STARTED|Overall Study||25
7863227|NCT00894803|19352309|P1|STARTED|Overall Study||101
7863228|NCT00894790|19352345|P2|NOT COMPLETED|Overall Study||2
7863229|NCT00894790|19352346|P1|NOT COMPLETED|Overall Study||1
7863230|NCT00894790|19352345|P2|COMPLETED|Overall Study||2
7863231|NCT00894790|19352346|P1|COMPLETED|Overall Study||3
7863232|NCT00894790|19352345|P2|STARTED|Overall Study||4
7863233|NCT00894790|19352346|P1|STARTED|Overall Study||4
7863234|NCT00894738|19352370|P2|NOT COMPLETED|Overall Study||0
7863235|NCT00894738|19352371|P1|NOT COMPLETED|Overall Study||0
7863236|NCT00894738|19352370|P2|COMPLETED|Overall Study||19
7863237|NCT00894738|19352371|P1|COMPLETED|Overall Study||25
7863238|NCT00894738|19352370|P2|STARTED|Overall Study||19
7863239|NCT00894738|19352371|P1|STARTED|Overall Study||25
7863240|NCT00894699|19352381|P2|NOT COMPLETED|Overall Study||0
7863241|NCT00894699|19352382|P1|NOT COMPLETED|Overall Study||0
7863242|NCT00894699|19352381|P2|COMPLETED|Overall Study||19
7863243|NCT00894699|19352382|P1|COMPLETED|Overall Study||21
7863244|NCT00894699|19352381|P2|STARTED|Overall Study||19
7863245|NCT00894699|19352382|P1|STARTED|Overall Study||21
7863246|NCT00894686|19352388|P1|NOT COMPLETED|Overall Study||56
7863247|NCT00894686|19352388|P1|COMPLETED|Overall Study||123
7863248|NCT00894686|19352388|P1|STARTED|Overall Study||179
7863249|NCT00894647|19352412|P2|NOT COMPLETED|Overall Study||14
7863250|NCT00894647|19352413|P1|NOT COMPLETED|Overall Study||10
7863251|NCT00894647|19352412|P2|COMPLETED|Overall Study||112
7863252|NCT00894647|19352413|P1|COMPLETED|Overall Study||111
7863253|NCT00894647|19352412|P2|STARTED|Overall Study||126
7863254|NCT00894647|19352413|P1|STARTED|Overall Study||121
7863255|NCT00894556|19352426|P4|NOT COMPLETED|Treatment Phase||0
7863256|NCT00894556|19352427|P3|NOT COMPLETED|Treatment Phase||1
7863257|NCT00894556|19352428|P2|NOT COMPLETED|Treatment Phase||4
7863258|NCT00894556|19352429|P1|NOT COMPLETED|Treatment Phase||4
7863259|NCT00894556|19352426|P4|COMPLETED|Treatment Phase||0
7863260|NCT00894556|19352427|P3|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35
7863261|NCT00894556|19352428|P2|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32
7863262|NCT00894556|19352429|P1|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33
7863263|NCT00894556|19352426|P4|STARTED|Treatment Phase||0
7863264|NCT00894556|19352427|P3|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
7863265|NCT00894556|19352428|P2|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
7863266|NCT00894556|19352429|P1|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37
7863267|NCT00894556|19352426|P4|NOT COMPLETED|Baseline Phase||85
7863268|NCT00894556|19352427|P3|NOT COMPLETED|Baseline Phase||0
7863269|NCT00894556|19352428|P2|NOT COMPLETED|Baseline Phase||0
7863270|NCT00894556|19352429|P1|NOT COMPLETED|Baseline Phase||0
7863271|NCT00894556|19352426|P4|COMPLETED|Baseline Phase||109
7863272|NCT00894556|19352427|P3|COMPLETED|Baseline Phase||0
7863273|NCT00894556|19352428|P2|COMPLETED|Baseline Phase||0
7863274|NCT00894556|19352429|P1|COMPLETED|Baseline Phase||0
7863275|NCT00894556|19352426|P4|STARTED|Baseline Phase||194
7863276|NCT00894556|19352427|P3|STARTED|Baseline Phase||0
7863277|NCT00894556|19352428|P2|STARTED|Baseline Phase||0
7863278|NCT00894556|19352429|P1|STARTED|Baseline Phase||0
7863279|NCT00894543|19352440|P2|NOT COMPLETED|Week 4 to Week 8||2
7863280|NCT00894543|19352441|P1|NOT COMPLETED|Week 4 to Week 8||4
7863281|NCT00894543|19352440|P2|COMPLETED|Week 4 to Week 8||97
7863282|NCT00894543|19352441|P1|COMPLETED|Week 4 to Week 8||97
7863283|NCT00894543|19352440|P2|STARTED|Week 4 to Week 8||99
7863284|NCT00894543|19352441|P1|STARTED|Week 4 to Week 8||101
7863285|NCT00894543|19352440|P2|NOT COMPLETED|Baseline to Week 4||2
7863286|NCT00894543|19352441|P1|NOT COMPLETED|Baseline to Week 4||3
7863287|NCT00894543|19352440|P2|COMPLETED|Baseline to Week 4||99
7863288|NCT00894543|19352441|P1|COMPLETED|Baseline to Week 4||101
7863289|NCT00894543|19352440|P2|STARTED|Baseline to Week 4||101
7863290|NCT00894543|19352441|P1|STARTED|Baseline to Week 4||104
7863291|NCT00894543|19352440|P2|NOT COMPLETED|Baseline||0
7863292|NCT00894543|19352441|P1|NOT COMPLETED|Baseline||0
7863293|NCT00894543|19352440|P2|COMPLETED|Baseline||101
7863294|NCT00894543|19352441|P1|COMPLETED|Baseline||104
7863295|NCT00894543|19352440|P2|STARTED|Baseline||101
7863296|NCT00894543|19352441|P1|STARTED|Baseline||104
7863297|NCT00894517|19352465|P2|NOT COMPLETED|Overall Study||5
7863298|NCT00894517|19352466|P1|NOT COMPLETED|Overall Study||2
7863299|NCT00894517|19352465|P2|COMPLETED|Overall Study||26
7863300|NCT00894517|19352466|P1|COMPLETED|Overall Study||28
7863301|NCT00894517|19352465|P2|STARTED|Overall Study||31
7863302|NCT00894517|19352466|P1|STARTED|Overall Study||30
7863303|NCT00894504|19352480|P1|NOT COMPLETED|Overall Study||71
7863304|NCT00894504|19352480|P1|COMPLETED|Overall Study||0
7863305|NCT00894504|19352480|P1|STARTED|Overall Study||71
7863306|NCT00894465|19352496|P2|NOT COMPLETED|Overall Study||0
7863307|NCT00894465|19352497|P1|NOT COMPLETED|Overall Study||0
7863308|NCT00894465|19352496|P2|COMPLETED|Overall Study||22
7863309|NCT00894465|19352497|P1|COMPLETED|Overall Study||22
7863310|NCT00894465|19352496|P2|STARTED|Overall Study||22
7863311|NCT00894465|19352497|P1|STARTED|Overall Study||22
7863312|NCT00894413|19352507|P2|NOT COMPLETED|Overall Study||8
7863313|NCT00894413|19352508|P1|NOT COMPLETED|Overall Study||0
7863314|NCT00894413|19352507|P2|COMPLETED|Overall Study||17
7863315|NCT00894413|19352508|P1|COMPLETED|Overall Study||15
7863316|NCT00894413|19352507|P2|STARTED|Overall Study||25
7863317|NCT00894413|19352508|P1|STARTED|Overall Study||15
7863318|NCT00894387|19352516|P2|NOT COMPLETED|Overall Study||175
7863319|NCT00894387|19352517|P1|NOT COMPLETED|Overall Study||175
7863320|NCT00894387|19352516|P2|COMPLETED|Overall Study||643
7863321|NCT00894387|19352517|P1|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646
7863322|NCT00894387|19352516|P2|Completed Secondary Efficacy Phase (12m)|Overall Study||640
7863323|NCT00894387|19352517|P1|Completed Secondary Efficacy Phase (12m)|Overall Study||654
7863324|NCT00894387|19352516|P2|Completed Primary Efficacy Phase (6 m)|Overall Study||707
7863325|NCT00894387|19352517|P1|Completed Primary Efficacy Phase (6 m)|Overall Study||717
7863326|NCT00894387|19352516|P2|Full Analysis Set|Overall Study||807
7863327|NCT00894387|19352517|P1|Full Analysis Set|Overall Study||808
7863328|NCT00894387|19352516|P2|Safety Set|Overall Study||810
7863329|NCT00894387|19352517|P1|Safety Set|Overall Study||808
7863330|NCT00894387|19352516|P2|STARTED|Overall Study||818
7863331|NCT00894387|19352517|P1|STARTED|Overall Study|"Started indicates all randomized patients"|821
7863332|NCT00894361|19352537|P2|NOT COMPLETED|Overall Study||64
7863333|NCT00894361|19352538|P1|NOT COMPLETED|Overall Study||24
7863334|NCT00894361|19352537|P2|COMPLETED|Overall Study||136
7863335|NCT00894361|19352538|P1|COMPLETED|Overall Study||176
7863336|NCT00894361|19352537|P2|STARTED|Overall Study||200
7863337|NCT00894361|19352538|P1|STARTED|Overall Study||200
7863338|NCT00894322|19352549|P3|NOT COMPLETED|Overall Study||0
7863339|NCT00894322|19352550|P2|NOT COMPLETED|Overall Study||0
7863340|NCT00894322|19352551|P1|NOT COMPLETED|Overall Study||1
7863341|NCT00894322|19352549|P3|COMPLETED|Overall Study||12
7863342|NCT00894322|19352550|P2|COMPLETED|Overall Study||23
7863343|NCT00894322|19352551|P1|COMPLETED|Overall Study||29
7863344|NCT00894322|19352549|P3|STARTED|Overall Study||12
7863345|NCT00894322|19352550|P2|STARTED|Overall Study||23
7863346|NCT00894322|19352551|P1|STARTED|Overall Study||30
7863347|NCT00894244|19352590|P1|NOT COMPLETED|Overall Study||1
7863348|NCT00894244|19352590|P1|COMPLETED|Overall Study||24
7863349|NCT00894244|19352590|P1|STARTED|Overall Study||25
7863350|NCT00894166|19352602|P8|NOT COMPLETED|Overall Study||34
7863351|NCT00894166|19352603|P7|NOT COMPLETED|Overall Study||16
7863352|NCT00894166|19352604|P6|NOT COMPLETED|Overall Study||16
7863353|NCT00894166|19352605|P5|NOT COMPLETED|Overall Study||24
7863354|NCT00894166|19352606|P4|NOT COMPLETED|Overall Study||69
7863355|NCT00894166|19352607|P3|NOT COMPLETED|Overall Study||62
7863356|NCT00894166|19352608|P2|NOT COMPLETED|Overall Study||63
7863357|NCT00894166|19352609|P1|NOT COMPLETED|Overall Study||61
7863358|NCT00894166|19352602|P8|COMPLETED|Overall Study||0
7863359|NCT00894166|19352603|P7|COMPLETED|Overall Study||19
7863360|NCT00894166|19352604|P6|COMPLETED|Overall Study||20
7863361|NCT00894166|19352605|P5|COMPLETED|Overall Study||10
7863362|NCT00894166|19352606|P4|COMPLETED|Overall Study||45
7863363|NCT00894166|19352607|P3|COMPLETED|Overall Study||50
7863364|NCT00894166|19352608|P2|COMPLETED|Overall Study||46
7863365|NCT00894166|19352609|P1|COMPLETED|Overall Study||71
7863366|NCT00894166|19352602|P8|STARTED|Overall Study||34
7863367|NCT00894166|19352603|P7|STARTED|Overall Study||35
7863368|NCT00894166|19352604|P6|STARTED|Overall Study||36
7863369|NCT00894166|19352605|P5|STARTED|Overall Study||34
7863370|NCT00894166|19352606|P4|STARTED|Overall Study||114
7863371|NCT00894166|19352607|P3|STARTED|Overall Study||112
7863372|NCT00894166|19352608|P2|STARTED|Overall Study||109
7863373|NCT00894166|19352609|P1|STARTED|Overall Study||132
7863374|NCT00894127|19352639|P1|NOT COMPLETED|Overall Study||0
7863375|NCT00894127|19352639|P1|COMPLETED|Overall Study||128
7863376|NCT00894127|19352639|P1|STARTED|Overall Study||128
7863377|NCT00893997|19352643|P1|NOT COMPLETED|Overall Study||0
7863378|NCT00893997|19352643|P1|COMPLETED|Overall Study||10
7863379|NCT00893997|19352643|P1|STARTED|Overall Study||10
7863380|NCT00893984|19352648|P1|NOT COMPLETED|Overall Study||6
7863381|NCT00893984|19352648|P1|COMPLETED|Overall Study||0
7863382|NCT00893984|19352648|P1|STARTED|Overall Study||6
7863383|NCT00893971|19352655|P1|NOT COMPLETED|Overall Study||3
7863384|NCT00893971|19352655|P1|COMPLETED|Overall Study||13
7863385|NCT00893971|19352655|P1|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16
7863386|NCT00893971|19352655|P1|Placebo + FF MDI (PT005)|Overall Study||13
7863387|NCT00893971|19352655|P1|Placebo + GFF MDI (PT003)|Overall Study||15
7863388|NCT00893971|19352655|P1|Placebo + GP MDI (PT001)|Overall Study||15
7863389|NCT00893971|19352655|P1|STARTED|Overall Study||16
7863390|NCT00893789|19352773|P4|NOT COMPLETED|Overall Study||13
7863391|NCT00893789|19352774|P3|NOT COMPLETED|Overall Study||7
7863392|NCT00893789|19352775|P2|NOT COMPLETED|Overall Study||4
7863393|NCT00893789|19352776|P1|NOT COMPLETED|Overall Study||6
7863394|NCT00893789|19352773|P4|COMPLETED|Overall Study||16
7863395|NCT00893789|19352774|P3|COMPLETED|Overall Study||22
7863396|NCT00893789|19352775|P2|COMPLETED|Overall Study||26
7863397|NCT00893789|19352776|P1|COMPLETED|Overall Study||23
7863398|NCT00893789|19352773|P4|Full Analysis Set (FAS)|Overall Study||27
7863399|NCT00893789|19352774|P3|Full Analysis Set (FAS)|Overall Study||28
7863400|NCT00893789|19352775|P2|Full Analysis Set (FAS)|Overall Study||29
7863401|NCT00893789|19352776|P1|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29
7863402|NCT00893789|19352773|P4|Safety Analysis Set (SAS)|Overall Study||29
7863403|NCT00893789|19352774|P3|Safety Analysis Set (SAS)|Overall Study||29
7863404|NCT00893789|19352775|P2|Safety Analysis Set (SAS)|Overall Study||30
7863405|NCT00893789|19352776|P1|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29
7863406|NCT00893789|19352773|P4|STARTED|Overall Study||29
7863407|NCT00893789|19352774|P3|STARTED|Overall Study||29
7863408|NCT00893789|19352775|P2|STARTED|Overall Study||30
7863409|NCT00893789|19352776|P1|STARTED|Overall Study||29
7863410|NCT00893763|19352860|P2|NOT COMPLETED|Overall Study||110
7863411|NCT00893763|19352861|P1|NOT COMPLETED|Overall Study||110
7863412|NCT00893763|19352860|P2|COMPLETED|Overall Study||47
7863413|NCT00893763|19352861|P1|COMPLETED|Overall Study||47
7863414|NCT00893763|19352860|P2|STARTED|Overall Study||157
7863415|NCT00893763|19352861|P1|STARTED|Overall Study||157
7863416|NCT00893737|19352869|P1|NOT COMPLETED|Overall Study||12
7863417|NCT00893737|19352869|P1|COMPLETED|Overall Study||135
7863418|NCT00893737|19352869|P1|STARTED|Overall Study||147
7863419|NCT00893464|19352883|P8|NOT COMPLETED|Overall Study||2
7863420|NCT00893464|19352884|P7|NOT COMPLETED|Overall Study||2
7863421|NCT00893464|19352885|P6|NOT COMPLETED|Overall Study||0
7863422|NCT00893464|19352886|P5|NOT COMPLETED|Overall Study||0
7863423|NCT00893464|19352887|P4|NOT COMPLETED|Overall Study||0
7863424|NCT00893464|19352888|P3|NOT COMPLETED|Overall Study||0
7863425|NCT00893464|19352889|P2|NOT COMPLETED|Overall Study||0
7863426|NCT00893464|19352890|P1|NOT COMPLETED|Overall Study||0
7863427|NCT00893464|19352883|P8|COMPLETED|Overall Study||3
7863428|NCT00893464|19352884|P7|COMPLETED|Overall Study||8
7863429|NCT00893464|19352885|P6|COMPLETED|Overall Study||7
7863430|NCT00893464|19352886|P5|COMPLETED|Overall Study||4
7863431|NCT00893464|19352887|P4|COMPLETED|Overall Study||1
7863432|NCT00893464|19352888|P3|COMPLETED|Overall Study||1
7863433|NCT00893464|19352889|P2|COMPLETED|Overall Study||1
7863434|NCT00893464|19352890|P1|COMPLETED|Overall Study||1
7863435|NCT00893464|19352883|P8|STARTED|Overall Study||5
7863436|NCT00893464|19352884|P7|STARTED|Overall Study||10
7863437|NCT00893464|19352885|P6|STARTED|Overall Study||7
7863438|NCT00893464|19352886|P5|STARTED|Overall Study||4
7863439|NCT00893464|19352887|P4|STARTED|Overall Study||1
7863440|NCT00893464|19352888|P3|STARTED|Overall Study||1
7863441|NCT00893464|19352889|P2|STARTED|Overall Study||1
7863442|NCT00893464|19352890|P1|STARTED|Overall Study||1
7863443|NCT00893152|19353008|P2|NOT COMPLETED|Overall Study||0
7863444|NCT00893152|19353009|P1|NOT COMPLETED|Overall Study||0
7863445|NCT00893152|19353008|P2|COMPLETED|Overall Study||36
7863446|NCT00893152|19353009|P1|COMPLETED|Overall Study||47
7863447|NCT00893152|19353008|P2|STARTED|Overall Study||36
7863448|NCT00893152|19353009|P1|STARTED|Overall Study||47
7863449|NCT00893113|19353017|P2|NOT COMPLETED|Overall Study||16
7863450|NCT00893113|19353018|P1|NOT COMPLETED|Overall Study||13
7863451|NCT00893113|19353017|P2|COMPLETED|Overall Study||22
7863452|NCT00893113|19353018|P1|COMPLETED|Overall Study||23
7863453|NCT00893113|19353017|P2|STARTED|Overall Study||38
7863454|NCT00893113|19353018|P1|STARTED|Overall Study||36
7863455|NCT00893074|19353028|P1|NOT COMPLETED|Overall Study||11
7863456|NCT00893074|19353028|P1|COMPLETED|Overall Study||13
7863457|NCT00893074|19353028|P1|STARTED|Overall Study||24
7863458|NCT00892957|19353048|P2|NOT COMPLETED|Postoperative Day 30 Assessment||0
7863459|NCT00892957|19353049|P1|NOT COMPLETED|Postoperative Day 30 Assessment||0
7863460|NCT00892957|19353048|P2|COMPLETED|Postoperative Day 30 Assessment||66
7863461|NCT00892957|19353049|P1|COMPLETED|Postoperative Day 30 Assessment||70
7863462|NCT00892957|19353048|P2|STARTED|Postoperative Day 30 Assessment||66
7863463|NCT00892957|19353049|P1|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70
7863464|NCT00892957|19353048|P2|NOT COMPLETED|Postoperative Day 14 Assessment||0
7863465|NCT00892957|19353049|P1|NOT COMPLETED|Postoperative Day 14 Assessment||0
7863466|NCT00892957|19353048|P2|COMPLETED|Postoperative Day 14 Assessment||66
7863467|NCT00892957|19353049|P1|COMPLETED|Postoperative Day 14 Assessment||68
7863468|NCT00892957|19353048|P2|STARTED|Postoperative Day 14 Assessment||66
7863469|NCT00892957|19353049|P1|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68
7863470|NCT00892957|19353048|P2|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4
7863471|NCT00892957|19353049|P1|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0
7863472|NCT00892957|19353048|P2|COMPLETED|Between Postoperative Day 1 and Day 14||66
7863473|NCT00892957|19353049|P1|COMPLETED|Between Postoperative Day 1 and Day 14||70
7863474|NCT00892957|19353048|P2|STARTED|Between Postoperative Day 1 and Day 14||70
7863475|NCT00892957|19353049|P1|STARTED|Between Postoperative Day 1 and Day 14||70
7863476|NCT00892957|19353048|P2|NOT COMPLETED|Postoperative Day 1 Assessment||0
7863477|NCT00892957|19353049|P1|NOT COMPLETED|Postoperative Day 1 Assessment||0
7863478|NCT00892957|19353048|P2|COMPLETED|Postoperative Day 1 Assessment||70
7863479|NCT00892957|19353049|P1|COMPLETED|Postoperative Day 1 Assessment||70
7863480|NCT00892957|19353048|P2|STARTED|Postoperative Day 1 Assessment||70
7863481|NCT00892957|19353049|P1|STARTED|Postoperative Day 1 Assessment||70
7863482|NCT00892957|19353048|P2|NOT COMPLETED|Intraoperative Day 0||0
7863483|NCT00892957|19353049|P1|NOT COMPLETED|Intraoperative Day 0||0
7863484|NCT00892957|19353048|P2|COMPLETED|Intraoperative Day 0||70
7863485|NCT00892957|19353049|P1|COMPLETED|Intraoperative Day 0||70
7863486|NCT00892957|19353048|P2|STARTED|Intraoperative Day 0||70
7863487|NCT00892957|19353049|P1|STARTED|Intraoperative Day 0||70
7863488|NCT00892775|19353137|P2|NOT COMPLETED|Overall Study||1
7863489|NCT00892775|19353138|P1|NOT COMPLETED|Overall Study||5
7863490|NCT00892775|19353137|P2|COMPLETED|Overall Study||165
7863491|NCT00892775|19353138|P1|COMPLETED|Overall Study||327
7863492|NCT00892775|19353137|P2|STARTED|Overall Study||166
7863493|NCT00892775|19353138|P1|STARTED|Overall Study||332
7863494|NCT00892723|19353165|P3|NOT COMPLETED|Overall Study||2
7863495|NCT00892723|19353166|P2|NOT COMPLETED|Overall Study||4
7863496|NCT00892723|19353167|P1|NOT COMPLETED|Overall Study||2
7863497|NCT00892723|19353165|P3|COMPLETED|Overall Study||17
7863498|NCT00892723|19353166|P2|COMPLETED|Overall Study||15
7863499|NCT00892723|19353167|P1|COMPLETED|Overall Study||19
7863500|NCT00892723|19353165|P3|STARTED|Overall Study||19
7863501|NCT00892723|19353166|P2|STARTED|Overall Study||19
7863502|NCT00892723|19353167|P1|STARTED|Overall Study||21
7863503|NCT00892710|19353211|P3|NOT COMPLETED|Overall Study||55
7863504|NCT00892710|19353212|P2|NOT COMPLETED|Overall Study||59
7863505|NCT00892710|19353213|P1|NOT COMPLETED|Overall Study||48
7863506|NCT00892710|19353211|P3|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
7863507|NCT00892710|19353212|P2|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
7863508|NCT00892710|19353213|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
7863509|NCT00892710|19353211|P3|STARTED|Overall Study||55
7863510|NCT00892710|19353212|P2|STARTED|Overall Study||59
7863511|NCT00892710|19353213|P1|STARTED|Overall Study||48
7863512|NCT00892697|19353236|P1|NOT COMPLETED|Overall Study||0
7863513|NCT00892697|19353236|P1|COMPLETED|Overall Study||15
7863514|NCT00892697|19353236|P1|STARTED|Overall Study||15
7863515|NCT00892606|19353243|P2|NOT COMPLETED|Overall Study||4
7863516|NCT00892606|19353244|P1|NOT COMPLETED|Overall Study||5
7863517|NCT00892606|19353243|P2|COMPLETED|Overall Study||33
7863518|NCT00892606|19353244|P1|COMPLETED|Overall Study||33
7863519|NCT00892606|19353243|P2|STARTED|Overall Study||37
7863520|NCT00892606|19353244|P1|STARTED|Overall Study||38
7863521|NCT00892437|19353256|P2|NOT COMPLETED|Open-Label Extension Phase||4
7863522|NCT00892437|19353257|P1|NOT COMPLETED|Open-Label Extension Phase||12
7863523|NCT00892437|19353256|P2|COMPLETED|Open-Label Extension Phase||15
7863524|NCT00892437|19353257|P1|COMPLETED|Open-Label Extension Phase||32
7863525|NCT00892437|19353256|P2|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19
7863526|NCT00892437|19353257|P1|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44
7863527|NCT00892437|19353256|P2|NOT COMPLETED|Randomized Phase||5
7863528|NCT00892437|19353257|P1|NOT COMPLETED|Randomized Phase||11
7863529|NCT00892437|19353256|P2|COMPLETED|Randomized Phase||24
7863530|NCT00892437|19353257|P1|COMPLETED|Randomized Phase||45
7863531|NCT00892437|19353256|P2|Randomized and Treated|Randomized Phase||29
7863532|NCT00892437|19353257|P1|Randomized and Treated|Randomized Phase||50
7863533|NCT00892437|19353256|P2|STARTED|Randomized Phase||29
7863534|NCT00892437|19353257|P1|STARTED|Randomized Phase||56
7863535|NCT00892281|19353276|P2|NOT COMPLETED|Overall Study||37
7863536|NCT00892281|19353277|P1|NOT COMPLETED|Overall Study||267
7863537|NCT00892281|19353276|P2|COMPLETED|Overall Study||187
7863538|NCT00892281|19353277|P1|COMPLETED|Overall Study||930
7863539|NCT00892281|19353276|P2|STARTED|Overall Study||224
7863540|NCT00892281|19353277|P1|STARTED|Overall Study||1197
7863541|NCT00892177|19353290|P6|NOT COMPLETED|Phase II||2
7863542|NCT00892177|19353291|P5|NOT COMPLETED|Phase II||5
7863543|NCT00892177|19353292|P4|NOT COMPLETED|Phase II||0
7863544|NCT00892177|19353293|P3|NOT COMPLETED|Phase II||0
7863545|NCT00892177|19353294|P2|NOT COMPLETED|Phase II||0
7863546|NCT00892177|19353295|P1|NOT COMPLETED|Phase II||0
7863547|NCT00892177|19353290|P6|COMPLETED|Phase II||38
7863548|NCT00892177|19353291|P5|COMPLETED|Phase II||83
7863549|NCT00892177|19353292|P4|COMPLETED|Phase II||0
7863550|NCT00892177|19353293|P3|COMPLETED|Phase II||0
7863551|NCT00892177|19353294|P2|COMPLETED|Phase II||0
7863552|NCT00892177|19353295|P1|COMPLETED|Phase II||0
7863553|NCT00892177|19353290|P6|STARTED|Phase II||40
7863554|NCT00892177|19353291|P5|STARTED|Phase II||88
7863555|NCT00892177|19353292|P4|STARTED|Phase II||0
7863556|NCT00892177|19353293|P3|STARTED|Phase II||0
7863557|NCT00892177|19353294|P2|STARTED|Phase II||0
7863558|NCT00892177|19353295|P1|STARTED|Phase II||0
7863559|NCT00892177|19353290|P6|NOT COMPLETED|Phase I: Dose Level 3||0
7863560|NCT00892177|19353291|P5|NOT COMPLETED|Phase I: Dose Level 3||0
7863561|NCT00892177|19353292|P4|NOT COMPLETED|Phase I: Dose Level 3||0
7863562|NCT00892177|19353293|P3|NOT COMPLETED|Phase I: Dose Level 3||0
7863563|NCT00892177|19353294|P2|NOT COMPLETED|Phase I: Dose Level 3||0
7863564|NCT00892177|19353295|P1|NOT COMPLETED|Phase I: Dose Level 3||0
7863565|NCT00892177|19353290|P6|COMPLETED|Phase I: Dose Level 3||0
7863566|NCT00892177|19353291|P5|COMPLETED|Phase I: Dose Level 3||0
7863567|NCT00892177|19353292|P4|COMPLETED|Phase I: Dose Level 3||6
7863568|NCT00892177|19353293|P3|COMPLETED|Phase I: Dose Level 3||0
7863569|NCT00892177|19353294|P2|COMPLETED|Phase I: Dose Level 3||0
7863570|NCT00892177|19353295|P1|COMPLETED|Phase I: Dose Level 3||0
7863571|NCT00892177|19353290|P6|STARTED|Phase I: Dose Level 3||0
7863572|NCT00892177|19353291|P5|STARTED|Phase I: Dose Level 3||0
7863573|NCT00892177|19353292|P4|STARTED|Phase I: Dose Level 3||6
7863574|NCT00892177|19353293|P3|STARTED|Phase I: Dose Level 3||0
7863575|NCT00892177|19353294|P2|STARTED|Phase I: Dose Level 3||0
7863576|NCT00892177|19353295|P1|STARTED|Phase I: Dose Level 3||0
7863577|NCT00892177|19353290|P6|NOT COMPLETED|Phase I: Dose Level 2||0
7863578|NCT00892177|19353291|P5|NOT COMPLETED|Phase I: Dose Level 2||0
7863579|NCT00892177|19353292|P4|NOT COMPLETED|Phase I: Dose Level 2||0
7863580|NCT00892177|19353293|P3|NOT COMPLETED|Phase I: Dose Level 2||0
7863581|NCT00892177|19353294|P2|NOT COMPLETED|Phase I: Dose Level 2||0
7863582|NCT00892177|19353295|P1|NOT COMPLETED|Phase I: Dose Level 2||0
7863583|NCT00892177|19353290|P6|COMPLETED|Phase I: Dose Level 2||0
7863584|NCT00892177|19353291|P5|COMPLETED|Phase I: Dose Level 2||0
7863585|NCT00892177|19353292|P4|COMPLETED|Phase I: Dose Level 2||0
7863586|NCT00892177|19353293|P3|COMPLETED|Phase I: Dose Level 2||3
7863587|NCT00892177|19353294|P2|COMPLETED|Phase I: Dose Level 2||0
7863588|NCT00892177|19353295|P1|COMPLETED|Phase I: Dose Level 2||0
7863589|NCT00892177|19353290|P6|STARTED|Phase I: Dose Level 2||0
7863590|NCT00892177|19353291|P5|STARTED|Phase I: Dose Level 2||0
7863591|NCT00892177|19353292|P4|STARTED|Phase I: Dose Level 2||0
7863592|NCT00892177|19353293|P3|STARTED|Phase I: Dose Level 2||3
7863593|NCT00892177|19353294|P2|STARTED|Phase I: Dose Level 2||0
7863594|NCT00892177|19353295|P1|STARTED|Phase I: Dose Level 2||0
7863595|NCT00892177|19353290|P6|NOT COMPLETED|Phase I: Dose Level 1||0
7863596|NCT00892177|19353291|P5|NOT COMPLETED|Phase I: Dose Level 1||0
7863597|NCT00892177|19353292|P4|NOT COMPLETED|Phase I: Dose Level 1||0
7863598|NCT00892177|19353293|P3|NOT COMPLETED|Phase I: Dose Level 1||0
7863599|NCT00892177|19353294|P2|NOT COMPLETED|Phase I: Dose Level 1||0
7863600|NCT00892177|19353295|P1|NOT COMPLETED|Phase I: Dose Level 1||0
7863601|NCT00892177|19353290|P6|COMPLETED|Phase I: Dose Level 1||0
7863602|NCT00892177|19353291|P5|COMPLETED|Phase I: Dose Level 1||0
7863603|NCT00892177|19353292|P4|COMPLETED|Phase I: Dose Level 1||0
7863604|NCT00892177|19353293|P3|COMPLETED|Phase I: Dose Level 1||0
7863605|NCT00892177|19353294|P2|COMPLETED|Phase I: Dose Level 1||4
7863606|NCT00892177|19353295|P1|COMPLETED|Phase I: Dose Level 1||0
7863607|NCT00892177|19353290|P6|STARTED|Phase I: Dose Level 1||0
7863608|NCT00892177|19353291|P5|STARTED|Phase I: Dose Level 1||0
7863609|NCT00892177|19353292|P4|STARTED|Phase I: Dose Level 1||0
7863610|NCT00892177|19353293|P3|STARTED|Phase I: Dose Level 1||0
7863611|NCT00892177|19353294|P2|STARTED|Phase I: Dose Level 1||4
7863612|NCT00892177|19353295|P1|STARTED|Phase I: Dose Level 1||0
7863613|NCT00892177|19353290|P6|NOT COMPLETED|Phase I: Dose Level 0||0
7863614|NCT00892177|19353291|P5|NOT COMPLETED|Phase I: Dose Level 0||0
7863615|NCT00892177|19353292|P4|NOT COMPLETED|Phase I: Dose Level 0||0
7863616|NCT00892177|19353293|P3|NOT COMPLETED|Phase I: Dose Level 0||0
7863617|NCT00892177|19353294|P2|NOT COMPLETED|Phase I: Dose Level 0||0
7863618|NCT00892177|19353295|P1|NOT COMPLETED|Phase I: Dose Level 0||0
7863619|NCT00892177|19353290|P6|COMPLETED|Phase I: Dose Level 0||0
7863620|NCT00892177|19353291|P5|COMPLETED|Phase I: Dose Level 0||0
7863621|NCT00892177|19353292|P4|COMPLETED|Phase I: Dose Level 0||0
7863622|NCT00892177|19353293|P3|COMPLETED|Phase I: Dose Level 0||0
7863623|NCT00892177|19353294|P2|COMPLETED|Phase I: Dose Level 0||0
7863624|NCT00892177|19353295|P1|COMPLETED|Phase I: Dose Level 0||3
7863625|NCT00892177|19353290|P6|STARTED|Phase I: Dose Level 0||0
7863626|NCT00892177|19353291|P5|STARTED|Phase I: Dose Level 0||0
7863627|NCT00892177|19353292|P4|STARTED|Phase I: Dose Level 0||0
7863628|NCT00892177|19353293|P3|STARTED|Phase I: Dose Level 0||0
7863629|NCT00892177|19353294|P2|STARTED|Phase I: Dose Level 0||0
7863630|NCT00892177|19353295|P1|STARTED|Phase I: Dose Level 0||3
7863631|NCT00892151|19353320|P1|NOT COMPLETED|Overall Study||1
7863632|NCT00892151|19353320|P1|COMPLETED|Overall Study||50
7863633|NCT00892151|19353320|P1|STARTED|Overall Study||51
7863634|NCT00892099|19353329|P3|NOT COMPLETED|Overall Study||7
7863635|NCT00892099|19353330|P2|NOT COMPLETED|Overall Study||1
7863636|NCT00892099|19353331|P1|NOT COMPLETED|Overall Study||5
7863637|NCT00892099|19353329|P3|COMPLETED|Overall Study||29
7863638|NCT00892099|19353330|P2|COMPLETED|Overall Study||32
7863639|NCT00892099|19353331|P1|COMPLETED|Overall Study||31
7863640|NCT00892099|19353329|P3|STARTED|Overall Study||36
7863641|NCT00892099|19353330|P2|STARTED|Overall Study||33
7863642|NCT00892099|19353331|P1|STARTED|Overall Study||36
7863643|NCT00892047|19353356|P2|NOT COMPLETED|Overall Study||7
7863644|NCT00892047|19353357|P1|NOT COMPLETED|Overall Study||4
7863645|NCT00892047|19353356|P2|COMPLETED|Overall Study||83
7863646|NCT00892047|19353357|P1|COMPLETED|Overall Study||87
7863647|NCT00892047|19353356|P2|STARTED|Overall Study||90
7863648|NCT00892047|19353357|P1|STARTED|Overall Study||91
7863649|NCT00892008|19353373|P1|NOT COMPLETED|Overall Study||565
7863650|NCT00892008|19353373|P1|COMPLETED|Overall Study||1713
7863651|NCT00892008|19353373|P1|STARTED|Overall Study||2278
7863652|NCT00891995|19353389|P2|NOT COMPLETED|Overall Study||0
7863653|NCT00891995|19353390|P1|NOT COMPLETED|Overall Study||0
7863654|NCT00891995|19353389|P2|COMPLETED|Overall Study||21
7863655|NCT00891995|19353390|P1|COMPLETED|Overall Study||50
7863656|NCT00891995|19353389|P2|STARTED|Overall Study||21
7863657|NCT00891995|19353390|P1|STARTED|Overall Study||50
7863658|NCT00891982|19353414|P2|NOT COMPLETED|Overall Study||1
7863659|NCT00891982|19353415|P1|NOT COMPLETED|Overall Study||2
7863660|NCT00891982|19353414|P2|COMPLETED|Overall Study||30
7863661|NCT00891982|19353415|P1|COMPLETED|Overall Study||28
7863662|NCT00891982|19353414|P2|STARTED|Overall Study||31
7863663|NCT00891982|19353415|P1|STARTED|Overall Study||30
7863664|NCT00891930|19353459|P1|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31
7863665|NCT00891930|19353459|P1|COMPLETED|Part 2: Panitumumab + Ganitumab||5
7863666|NCT00891930|19353459|P1|STARTED|Part 2: Panitumumab + Ganitumab||36
7863667|NCT00891930|19353459|P1|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40
7863668|NCT00891930|19353459|P1|COMPLETED|Part 1: Panitumumab +Irinotecan||36
7863669|NCT00891930|19353459|P1|Received Treatment|Part 1: Panitumumab +Irinotecan||74
7863670|NCT00891930|19353459|P1|STARTED|Part 1: Panitumumab +Irinotecan||76
7863671|NCT00891904|19353480|P1|NOT COMPLETED|Overall Study||2
7863672|NCT00891904|19353480|P1|COMPLETED|Overall Study||0
7863673|NCT00891904|19353480|P1|STARTED|Overall Study||2
7863674|NCT00891878|19353489|P2|NOT COMPLETED|Overall Study||0
7863675|NCT00891878|19353490|P1|NOT COMPLETED|Overall Study||0
7863676|NCT00891878|19353489|P2|COMPLETED|Overall Study||6
7863677|NCT00891878|19353490|P1|COMPLETED|Overall Study||6
7863678|NCT00891878|19353489|P2|STARTED|Overall Study||6
7863679|NCT00891878|19353490|P1|STARTED|Overall Study||6
7863680|NCT00891839|19353506|P1|NOT COMPLETED|Overall Study||7
7863681|NCT00891839|19353506|P1|COMPLETED|Overall Study|completed treatment|38
7863682|NCT00891839|19353506|P1|STARTED|Overall Study||45
7863683|NCT00891813|19353515|P1|NOT COMPLETED|Overall Study||12
7863684|NCT00891813|19353515|P1|COMPLETED|Overall Study||88
7863685|NCT00891813|19353515|P1|STARTED|Overall Study||100
7863686|NCT00891774|19353521|P1|NOT COMPLETED|Overall Study||14
7863687|NCT00891774|19353521|P1|COMPLETED|Overall Study||158
7863688|NCT00891774|19353521|P1|STARTED|Overall Study||172
7863689|NCT00891735|19353532|P4|NOT COMPLETED|Overall Study||15
7863690|NCT00891735|19353533|P3|NOT COMPLETED|Overall Study||12
7863691|NCT00891735|19353534|P2|NOT COMPLETED|Overall Study||16
7863692|NCT00891735|19353535|P1|NOT COMPLETED|Overall Study||17
7863693|NCT00891735|19353532|P4|COMPLETED|Overall Study||258
7863694|NCT00891735|19353533|P3|COMPLETED|Overall Study||263
7863695|NCT00891735|19353534|P2|COMPLETED|Overall Study||258
7863696|NCT00891735|19353535|P1|COMPLETED|Overall Study||258
7863697|NCT00891735|19353532|P4|STARTED|Overall Study||273
7863698|NCT00891735|19353533|P3|STARTED|Overall Study||275
7863699|NCT00891735|19353534|P2|STARTED|Overall Study||274
7863700|NCT00891735|19353535|P1|STARTED|Overall Study||275
7863701|NCT00891657|19353575|P2|NOT COMPLETED|Overall Study||1
7863702|NCT00891657|19353576|P1|NOT COMPLETED|Overall Study||1
7863703|NCT00891657|19353575|P2|COMPLETED|Overall Study||5
7863704|NCT00891657|19353576|P1|COMPLETED|Overall Study||8
7863705|NCT00891657|19353575|P2|STARTED|Overall Study||6
7863706|NCT00891657|19353576|P1|STARTED|Overall Study||9
7863707|NCT00891618|19353588|P1|NOT COMPLETED|Overall Study||1
7863708|NCT00891618|19353588|P1|COMPLETED|Overall Study||20
7863709|NCT00891618|19353588|P1|STARTED|Overall Study||21
7863710|NCT00891527|19353592|P1|NOT COMPLETED|Overall Study||2
7863711|NCT00891527|19353592|P1|COMPLETED|Overall Study||48
7863712|NCT00891527|19353592|P1|STARTED|Overall Study||50
7863713|NCT00891462|19353601|P3|NOT COMPLETED|Overall Study||24
7863714|NCT00891462|19353602|P2|NOT COMPLETED|Overall Study||33
7863715|NCT00891462|19353603|P1|NOT COMPLETED|Overall Study||37
7863716|NCT00891462|19353601|P3|COMPLETED|Overall Study||166
7863717|NCT00891462|19353602|P2|COMPLETED|Overall Study||152
7863718|NCT00891462|19353603|P1|COMPLETED|Overall Study||149
7863719|NCT00891462|19353601|P3|STARTED|Overall Study||190
7863720|NCT00891462|19353602|P2|STARTED|Overall Study||185
7863721|NCT00891462|19353603|P1|STARTED|Overall Study||186
7863722|NCT00891436|19353616|P2|NOT COMPLETED|Overall Study||0
7863723|NCT00891436|19353617|P1|NOT COMPLETED|Overall Study||0
7863724|NCT00891436|19353616|P2|COMPLETED|Overall Study||10
7863725|NCT00891436|19353617|P1|COMPLETED|Overall Study||10
7863726|NCT00891436|19353616|P2|STARTED|Overall Study||10
7863727|NCT00891436|19353617|P1|STARTED|Overall Study||10
7863728|NCT00891371|19353625|P1|NOT COMPLETED|Treatment||9
7863729|NCT00891371|19353625|P1|COMPLETED|Treatment||27
7863730|NCT00891371|19353625|P1|STARTED|Treatment||36
7863731|NCT00891371|19353625|P1|NOT COMPLETED|Pre-assignment||6
7863732|NCT00891371|19353625|P1|COMPLETED|Pre-assignment||36
7863733|NCT00891371|19353625|P1|STARTED|Pre-assignment||42
7863734|NCT00891319|19353636|P2|NOT COMPLETED|Overall Study||0
7863735|NCT00891319|19353637|P1|NOT COMPLETED|Overall Study||8
7863736|NCT00891319|19353636|P2|COMPLETED|Overall Study||40
7863737|NCT00891319|19353637|P1|COMPLETED|Overall Study||32
7863738|NCT00891319|19353636|P2|STARTED|Overall Study||40
7863739|NCT00891319|19353637|P1|STARTED|Overall Study||40
7863740|NCT00891293|19353647|P1|NOT COMPLETED|Overall Study||84
7863741|NCT00891293|19353647|P1|COMPLETED|Overall Study||9
7863742|NCT00891293|19353647|P1|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93
7863743|NCT00891228|19353662|P3|NOT COMPLETED|Overall Study||15
7863744|NCT00891228|19353663|P2|NOT COMPLETED|Overall Study||13
7863745|NCT00891228|19353664|P1|NOT COMPLETED|Overall Study||11
7863746|NCT00891228|19353662|P3|COMPLETED|Overall Study||19
7863747|NCT00891228|19353663|P2|COMPLETED|Overall Study||20
7863748|NCT00891228|19353664|P1|COMPLETED|Overall Study||21
7863749|NCT00891228|19353662|P3|STARTED|Overall Study||34
7863750|NCT00891228|19353663|P2|STARTED|Overall Study||33
7863751|NCT00891228|19353664|P1|STARTED|Overall Study||32
7863752|NCT00891202|19353686|P4|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5
7863753|NCT00891202|19353687|P3|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7
7863754|NCT00891202|19353688|P2|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
7863755|NCT00891202|19353689|P1|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
7863756|NCT00891202|19353686|P4|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15
7863757|NCT00891202|19353687|P3|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12
7863758|NCT00891202|19353688|P2|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
7863759|NCT00891202|19353689|P1|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
7863760|NCT00891202|19353686|P4|STARTED|LTTP (Post-Week 39 up to Week 312)||20
7863761|NCT00891202|19353687|P3|STARTED|LTTP (Post-Week 39 up to Week 312)||19
7863762|NCT00891202|19353688|P2|STARTED|LTTP (Post-Week 39 up to Week 312)||0
7863763|NCT00891202|19353689|P1|STARTED|LTTP (Post-Week 39 up to Week 312)||0
7863764|NCT00891202|19353686|P4|NOT COMPLETED|PAP (Up To Week 39)||0
7863765|NCT00891202|19353687|P3|NOT COMPLETED|PAP (Up To Week 39)||0
7863766|NCT00891202|19353688|P2|NOT COMPLETED|PAP (Up To Week 39)||0
7863767|NCT00891202|19353689|P1|NOT COMPLETED|PAP (Up To Week 39)||1
7863768|NCT00891202|19353686|P4|COMPLETED|PAP (Up To Week 39)||0
7863769|NCT00891202|19353687|P3|COMPLETED|PAP (Up To Week 39)||0
7863770|NCT00891202|19353688|P2|COMPLETED|PAP (Up To Week 39)||20
7863771|NCT00891202|19353689|P1|COMPLETED|PAP (Up To Week 39)||19
7863772|NCT00891202|19353686|P4|STARTED|PAP (Up To Week 39)||0
7863773|NCT00891202|19353687|P3|STARTED|PAP (Up To Week 39)||0
7863774|NCT00891202|19353688|P2|STARTED|PAP (Up To Week 39)||20
7863775|NCT00891202|19353689|P1|STARTED|PAP (Up To Week 39)||20
7863776|NCT00891176|19353715|P4|NOT COMPLETED|At 6 Years of Age||0
7863777|NCT00891176|19353716|P3|NOT COMPLETED|At 6 Years of Age||0
7863778|NCT00891176|19353717|P2|NOT COMPLETED|At 6 Years of Age||0
7863779|NCT00891176|19353718|P1|NOT COMPLETED|At 6 Years of Age||0
7863780|NCT00891176|19353715|P4|COMPLETED|At 6 Years of Age||135
7863781|NCT00891176|19353716|P3|COMPLETED|At 6 Years of Age||135
7863782|NCT00891176|19353717|P2|COMPLETED|At 6 Years of Age||138
7863783|NCT00891176|19353718|P1|COMPLETED|At 6 Years of Age||131
7863784|NCT00891176|19353715|P4|STARTED|At 6 Years of Age||135
7863785|NCT00891176|19353716|P3|STARTED|At 6 Years of Age||135
7863786|NCT00891176|19353717|P2|STARTED|At 6 Years of Age||138
7863787|NCT00891176|19353718|P1|STARTED|At 6 Years of Age||131
7863788|NCT00891176|19353715|P4|NOT COMPLETED|At 4 Years of Age||0
7863789|NCT00891176|19353716|P3|NOT COMPLETED|At 4 Years of Age||0
7863790|NCT00891176|19353717|P2|NOT COMPLETED|At 4 Years of Age||0
7863791|NCT00891176|19353718|P1|NOT COMPLETED|At 4 Years of Age||0
7863792|NCT00891176|19353715|P4|COMPLETED|At 4 Years of Age||137
7863793|NCT00891176|19353716|P3|COMPLETED|At 4 Years of Age||142
7863794|NCT00891176|19353717|P2|COMPLETED|At 4 Years of Age||142
7863795|NCT00891176|19353718|P1|COMPLETED|At 4 Years of Age||140
7863796|NCT00891176|19353715|P4|STARTED|At 4 Years of Age||137
7863797|NCT00891176|19353716|P3|STARTED|At 4 Years of Age||142
7863798|NCT00891176|19353717|P2|STARTED|At 4 Years of Age||142
7863799|NCT00891176|19353718|P1|STARTED|At 4 Years of Age||140
7863800|NCT00891176|19353715|P4|NOT COMPLETED|At 3 Years of Age||0
7863801|NCT00891176|19353716|P3|NOT COMPLETED|At 3 Years of Age||0
7863802|NCT00891176|19353717|P2|NOT COMPLETED|At 3 Years of Age||0
7863803|NCT00891176|19353718|P1|NOT COMPLETED|At 3 Years of Age||0
7863804|NCT00891176|19353715|P4|COMPLETED|At 3 Years of Age||141
7863805|NCT00891176|19353716|P3|COMPLETED|At 3 Years of Age||149
7863806|NCT00891176|19353717|P2|COMPLETED|At 3 Years of Age||147
7863807|NCT00891176|19353718|P1|COMPLETED|At 3 Years of Age||144
7863808|NCT00891176|19353715|P4|STARTED|At 3 Years of Age||141
7863809|NCT00891176|19353716|P3|STARTED|At 3 Years of Age||149
7863810|NCT00891176|19353717|P2|STARTED|At 3 Years of Age||147
7863811|NCT00891176|19353718|P1|STARTED|At 3 Years of Age||144
7863812|NCT00891046|19353865|P5|NOT COMPLETED|Overall Study||39
7863813|NCT00891046|19353866|P4|NOT COMPLETED|Overall Study||3
7863814|NCT00891046|19353867|P3|NOT COMPLETED|Overall Study||23
7863815|NCT00891046|19353868|P2|NOT COMPLETED|Overall Study||9
7863816|NCT00891046|19353869|P1|NOT COMPLETED|Overall Study||12
7863817|NCT00891046|19353865|P5|COMPLETED|Overall Study||84
7863818|NCT00891046|19353866|P4|COMPLETED|Overall Study||8
7863819|NCT00891046|19353867|P3|COMPLETED|Overall Study||17
7863820|NCT00891046|19353868|P2|COMPLETED|Overall Study||54
7863821|NCT00891046|19353869|P1|COMPLETED|Overall Study||21
7863822|NCT00891046|19353865|P5|STARTED|Overall Study||123
7863823|NCT00891046|19353866|P4|STARTED|Overall Study||11
7863824|NCT00891046|19353867|P3|STARTED|Overall Study||40
7863825|NCT00891046|19353868|P2|STARTED|Overall Study||63
7863826|NCT00891046|19353869|P1|STARTED|Overall Study||33
7863827|NCT00891020|19353945|P3|NOT COMPLETED|Long-term Extension Period||23
7863828|NCT00891020|19353946|P2|NOT COMPLETED|Long-term Extension Period||24
7863829|NCT00891020|19353947|P1|NOT COMPLETED|Long-term Extension Period||6
7863830|NCT00891020|19353945|P3|COMPLETED|Long-term Extension Period||170
7863831|NCT00891020|19353946|P2|COMPLETED|Long-term Extension Period||172
7863832|NCT00891020|19353947|P1|COMPLETED|Long-term Extension Period||49
7863833|NCT00891020|19353945|P3|STARTED|Long-term Extension Period||193
7863834|NCT00891020|19353946|P2|STARTED|Long-term Extension Period||196
7863835|NCT00891020|19353947|P1|STARTED|Long-term Extension Period||55
7863836|NCT00891020|19353945|P3|NOT COMPLETED|24 Week Treatment Period||58
7863837|NCT00891020|19353946|P2|NOT COMPLETED|24 Week Treatment Period||60
7863838|NCT00891020|19353947|P1|NOT COMPLETED|24 Week Treatment Period||37
7863839|NCT00891020|19353945|P3|COMPLETED|24 Week Treatment Period||302
7863840|NCT00891020|19353946|P2|COMPLETED|24 Week Treatment Period||303
7863841|NCT00891020|19353947|P1|COMPLETED|24 Week Treatment Period||126
7863842|NCT00891020|19353945|P3|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381
7863843|NCT00891020|19353946|P2|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364
7863844|NCT00891020|19353947|P1|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138
7863845|NCT00891020|19353945|P3|Intent-to-Treat (ITT)|24 Week Treatment Period||358
7863846|NCT00891020|19353946|P2|Intent-to-Treat (ITT)|24 Week Treatment Period||362
7863847|NCT00891020|19353947|P1|Intent-to-Treat (ITT)|24 Week Treatment Period||163
7863848|NCT00891020|19353945|P3|STARTED|24 Week Treatment Period||360
7863849|NCT00891020|19353946|P2|STARTED|24 Week Treatment Period||363
7863850|NCT00891020|19353947|P1|STARTED|24 Week Treatment Period||163
7863851|NCT00890981|19353980|P2|NOT COMPLETED|Overall Study||0
7863852|NCT00890981|19353981|P1|NOT COMPLETED|Overall Study||0
7863853|NCT00890981|19353980|P2|COMPLETED|Overall Study||40
7863854|NCT00890981|19353981|P1|COMPLETED|Overall Study||39
7863855|NCT00890981|19353980|P2|STARTED|Overall Study||40
7863856|NCT00890981|19353981|P1|STARTED|Overall Study||39
7863857|NCT00890929|19354011|P1|NOT COMPLETED|Overall Study||6
7863858|NCT00890929|19354011|P1|COMPLETED|Overall Study||39
7863859|NCT00890929|19354011|P1|Initiated Treatment|Overall Study||43
7863860|NCT00890929|19354011|P1|Consented & Enrolled|Overall Study||45
7863861|NCT00890929|19354011|P1|STARTED|Overall Study||45
7863862|NCT00890916|19354023|P1|NOT COMPLETED|"Rehab - NP Off"||0
7863863|NCT00890916|19354023|P1|COMPLETED|"Rehab - NP Off"||10
7863864|NCT00890916|19354023|P1|"Grasp Release Pre-Test OFF"|"Rehab - NP Off"||10
7863865|NCT00890916|19354023|P1|STARTED|"Rehab - NP Off"||10
7863866|NCT00890916|19354023|P1|NOT COMPLETED|"Rehab - Neuroprosthesis (NP) On"||0
7863867|NCT00890916|19354023|P1|COMPLETED|"Rehab - Neuroprosthesis (NP) On"||10
7863868|NCT00890916|19354023|P1|"Grasp Release Pre-Test ON"|"Rehab - Neuroprosthesis (NP) On"||10
7863869|NCT00890916|19354023|P1|STARTED|"Rehab - Neuroprosthesis (NP) On"|First Implanted Stimulator-Telemeter (IST-12) Implant.|10
7863870|NCT00890825|19354029|P2|NOT COMPLETED|Overall Study||14
7863871|NCT00890825|19354030|P1|NOT COMPLETED|Overall Study||14
7863872|NCT00890825|19354029|P2|COMPLETED|Overall Study||29
7863873|NCT00890825|19354030|P1|COMPLETED|Overall Study||30
7863874|NCT00890825|19354029|P2|STARTED|Overall Study|A patient randomized to this arm was excluded from the safety population for not receiving treatment|43
7863875|NCT00890825|19354030|P1|STARTED|Overall Study||44
7863876|NCT00890721|19354050|P2|NOT COMPLETED|Overall Study||1
7863877|NCT00890721|19354051|P1|NOT COMPLETED|Overall Study||1
7863878|NCT00890721|19354050|P2|COMPLETED|Overall Study||93
7863879|NCT00890721|19354051|P1|COMPLETED|Overall Study||94
7863880|NCT00890721|19354050|P2|STARTED|Overall Study||94
7863881|NCT00890721|19354051|P1|STARTED|Overall Study||95
7863882|NCT00890695|19354059|P2|NOT COMPLETED|Overall Study||0
7863883|NCT00890695|19354060|P1|NOT COMPLETED|Overall Study||1
7863884|NCT00890695|19354059|P2|COMPLETED|Overall Study||33
7863885|NCT00890695|19354060|P1|COMPLETED|Overall Study||31
7863886|NCT00890695|19354059|P2|STARTED|Overall Study||33
7863887|NCT00890695|19354060|P1|STARTED|Overall Study||32
7863888|NCT00890682|19354078|P2|NOT COMPLETED|Overall Study||2
7863889|NCT00890682|19354079|P1|NOT COMPLETED|Overall Study||4
7863890|NCT00890682|19354078|P2|COMPLETED|Overall Study||94
7863891|NCT00890682|19354079|P1|COMPLETED|Overall Study||93
7863892|NCT00890682|19354078|P2|STARTED|Overall Study||96
7863893|NCT00890682|19354079|P1|STARTED|Overall Study||97
7863894|NCT00890656|19354085|P1|NOT COMPLETED|Overall Study||0
7863895|NCT00890656|19354085|P1|COMPLETED|Overall Study||90
7863896|NCT00890656|19354085|P1|STARTED|Overall Study||90
7863897|NCT00890617|19354089|P1|NOT COMPLETED|Overall Study||0
7863898|NCT00890617|19354089|P1|COMPLETED|Overall Study||9
7863899|NCT00890617|19354089|P1|STARTED|Overall Study||9
7863900|NCT00890591|19354094|P1|NOT COMPLETED|Overall Study||20
7863901|NCT00890591|19354094|P1|COMPLETED|Overall Study||124
7863902|NCT00890591|19354094|P1|STARTED|Overall Study||144
7863903|NCT00890552|19354100|P1|NOT COMPLETED|On-treatment||10
7863904|NCT00890552|19354100|P1|COMPLETED|On-treatment||14
7863905|NCT00890552|19354100|P1|STARTED|On-treatment||24
7863906|NCT00890552|19354100|P1|NOT COMPLETED|Enrollment and Pre-treatment||1
7863907|NCT00890552|19354100|P1|COMPLETED|Enrollment and Pre-treatment||24
7863908|NCT00890552|19354100|P1|STARTED|Enrollment and Pre-treatment||25
7863909|NCT00890409|19354109|P2|NOT COMPLETED|Overall Study||21
7863910|NCT00890409|19354110|P1|NOT COMPLETED|Overall Study||20
7863911|NCT00890409|19354109|P2|COMPLETED|Overall Study||119
7863912|NCT00890409|19354110|P1|COMPLETED|Overall Study||96
7863913|NCT00890409|19354109|P2|STARTED|Overall Study||140
7863914|NCT00890409|19354110|P1|STARTED|Overall Study||116
7863915|NCT00890396|19354120|P2|NOT COMPLETED|Overall Study||2
7863916|NCT00890396|19354121|P1|NOT COMPLETED|Overall Study||5
7863917|NCT00890396|19354120|P2|COMPLETED|Overall Study||34
7863918|NCT00890396|19354121|P1|COMPLETED|Overall Study||122
7863919|NCT00890396|19354120|P2|STARTED|Overall Study||36
7863920|NCT00890396|19354121|P1|STARTED|Overall Study||127
7863921|NCT00890201|19354147|P2|NOT COMPLETED|Overall Study||56
7863922|NCT00890201|19354148|P1|NOT COMPLETED|Overall Study||5
7863923|NCT00890201|19354147|P2|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103
7863924|NCT00890201|19354148|P1|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33
7863925|NCT00890201|19354147|P2|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159
7863926|NCT00890201|19354148|P1|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38
7863927|NCT00890162|19354156|P2|NOT COMPLETED|Overall Study||1
7863928|NCT00890162|19354157|P1|NOT COMPLETED|Overall Study||2
7863929|NCT00890162|19354156|P2|COMPLETED|Overall Study||7
7863930|NCT00890162|19354157|P1|COMPLETED|Overall Study||6
7863931|NCT00890162|19354156|P2|STARTED|Overall Study||8
7863932|NCT00890162|19354157|P1|STARTED|Overall Study||8
7863933|NCT00890097|19354166|P3|NOT COMPLETED|Overall Study||77
7863934|NCT00890097|19354167|P2|NOT COMPLETED|Overall Study||86
7863935|NCT00890097|19354168|P1|NOT COMPLETED|Overall Study||68
7863936|NCT00890097|19354166|P3|COMPLETED|Overall Study||184
7863937|NCT00890097|19354167|P2|COMPLETED|Overall Study||173
7863938|NCT00890097|19354168|P1|COMPLETED|Overall Study||184
7863939|NCT00890097|19354166|P3|STARTED|Overall Study||261
7863940|NCT00890097|19354167|P2|STARTED|Overall Study||259
7863941|NCT00890097|19354168|P1|STARTED|Overall Study||252
7863942|NCT00890084|19354176|P1|NOT COMPLETED|Overall Study||142
7863943|NCT00890084|19354176|P1|COMPLETED|Overall Study||2771
7863944|NCT00890084|19354176|P1|STARTED|Overall Study||2913
7863945|NCT00889928|19354187|P1|NOT COMPLETED|Overall Study||0
7863946|NCT00889928|19354187|P1|COMPLETED|Overall Study||7
7863947|NCT00889928|19354187|P1|STARTED|Overall Study||7
7863948|NCT00889915|19354195|P4|NOT COMPLETED|Overall Study||8
7863949|NCT00889915|19354196|P3|NOT COMPLETED|Overall Study||13
7863950|NCT00889915|19354197|P2|NOT COMPLETED|Overall Study||5
7863951|NCT00889915|19354198|P1|NOT COMPLETED|Overall Study||2
7863952|NCT00889915|19354195|P4|COMPLETED|Overall Study||40
7863953|NCT00889915|19354196|P3|COMPLETED|Overall Study||54
7863954|NCT00889915|19354197|P2|COMPLETED|Overall Study||71
7863955|NCT00889915|19354198|P1|COMPLETED|Overall Study||35
7863956|NCT00889915|19354195|P4|STARTED|Overall Study||48
7863957|NCT00889915|19354196|P3|STARTED|Overall Study||67
7863958|NCT00889915|19354197|P2|STARTED|Overall Study||76
7863959|NCT00889915|19354198|P1|STARTED|Overall Study||37
7863960|NCT00889863|19354216|P2|NOT COMPLETED|Part II: Randomized Double Blind||26
7863961|NCT00889863|19354217|P1|NOT COMPLETED|Part II: Randomized Double Blind||11
7863962|NCT00889863|19354216|P2|COMPLETED|Part II: Randomized Double Blind||24
7863963|NCT00889863|19354217|P1|COMPLETED|Part II: Randomized Double Blind||39
7863964|NCT00889863|19354216|P2|STARTED|Part II: Randomized Double Blind||50
7863965|NCT00889863|19354217|P1|STARTED|Part II: Randomized Double Blind||50
7863966|NCT00889863|19354216|P2|NOT COMPLETED|Part I: Open Label||0
7863967|NCT00889863|19354217|P1|NOT COMPLETED|Part I: Open Label||77
7863968|NCT00889863|19354216|P2|COMPLETED|Part I: Open Label||0
7863969|NCT00889863|19354217|P1|COMPLETED|Part I: Open Label||100
7863970|NCT00889863|19354216|P2|Entered Part 1d|Part I: Open Label||0
7863971|NCT00889863|19354217|P1|Entered Part 1d|Part I: Open Label||103
7863972|NCT00889863|19354216|P2|Entered Part Ic|Part I: Open Label||0
7863973|NCT00889863|19354217|P1|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92
7863974|NCT00889863|19354216|P2|Entered Part Ib|Part I: Open Label||0
7863975|NCT00889863|19354217|P1|Entered Part Ib|Part I: Open Label||142
7863976|NCT00889863|19354216|P2|Entered Part Ia|Part I: Open Label||0
7863977|NCT00889863|19354217|P1|Entered Part Ia|Part I: Open Label||145
7863978|NCT00889863|19354216|P2|STARTED|Part I: Open Label|No participants received placebo in Part I.|0
7863979|NCT00889863|19354217|P1|STARTED|Part I: Open Label||177
7863980|NCT00889824|19354239|P1|NOT COMPLETED|Overall Study||0
7863981|NCT00889824|19354239|P1|COMPLETED|Overall Study||5
7863982|NCT00889824|19354239|P1|STARTED|Overall Study||5
7863983|NCT00889720|19354243|P1|NOT COMPLETED|Overall Study||8
7863984|NCT00889720|19354243|P1|COMPLETED|Overall Study||8
7863985|NCT00889720|19354243|P1|Surgical Population|Overall Study||12
7863986|NCT00889720|19354243|P1|STARTED|Overall Study||16
7863987|NCT00889707|19354270|P2|NOT COMPLETED|Overall Study||10
7863988|NCT00889707|19354271|P1|NOT COMPLETED|Overall Study||7
7863989|NCT00889707|19354270|P2|COMPLETED|Overall Study||21
7863990|NCT00889707|19354271|P1|COMPLETED|Overall Study||54
7863991|NCT00889707|19354270|P2|STARTED|Overall Study||31
7863992|NCT00889707|19354271|P1|STARTED|Overall Study||61
7863993|NCT00889681|19354279|P1|NOT COMPLETED|Overall Study||3
7863994|NCT00889681|19354279|P1|COMPLETED|Overall Study||78
7863995|NCT00889681|19354279|P1|Received Treatment|Overall Study||78
7863996|NCT00889681|19354279|P1|STARTED|Overall Study||81
7863997|NCT00889603|19354286|P1|NOT COMPLETED|Overall Study||37
7863998|NCT00889603|19354286|P1|COMPLETED|Overall Study||333
7863999|NCT00889603|19354286|P1|STARTED|Overall Study||370
7864000|NCT00889512|19354301|P2|NOT COMPLETED|Overall Study||0
7864001|NCT00889512|19354302|P1|NOT COMPLETED|Overall Study||0
7864002|NCT00889512|19354301|P2|COMPLETED|Overall Study||9
7864003|NCT00889512|19354302|P1|COMPLETED|Overall Study||5
7864004|NCT00889512|19354301|P2|STARTED|Overall Study||9
7864005|NCT00889512|19354302|P1|STARTED|Overall Study||5
7864006|NCT00889421|19354308|P1|NOT COMPLETED|Overall Study||3
7864007|NCT00889421|19354308|P1|COMPLETED|Overall Study||0
7864008|NCT00889421|19354308|P1|STARTED|Overall Study||3
7864009|NCT00889330|19354318|P2|NOT COMPLETED|Overall Study||0
7864010|NCT00889330|19354319|P1|NOT COMPLETED|Overall Study||0
7864011|NCT00889330|19354318|P2|COMPLETED|Overall Study||30
7864012|NCT00889330|19354319|P1|COMPLETED|Overall Study||30
7864013|NCT00889330|19354318|P2|STARTED|Overall Study||30
7864014|NCT00889330|19354319|P1|STARTED|Overall Study||30
7864015|NCT00889265|19354349|P1|NOT COMPLETED|Overall Study||7
7864016|NCT00889265|19354349|P1|COMPLETED|Overall Study||44
7864017|NCT00889265|19354349|P1|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51
7864018|NCT00889252|19354356|P2|NOT COMPLETED|Overall Study||4
7864019|NCT00889252|19354357|P1|NOT COMPLETED|Overall Study||7
7864020|NCT00889252|19354356|P2|COMPLETED|Overall Study||78
7864021|NCT00889252|19354357|P1|COMPLETED|Overall Study||161
7864022|NCT00889252|19354356|P2|STARTED|Overall Study||82
7864023|NCT00889252|19354357|P1|STARTED|Overall Study||168
7864024|NCT00889226|19354401|P2|NOT COMPLETED|Overall Study||35
7864025|NCT00889226|19354402|P1|NOT COMPLETED|Overall Study||25
7864026|NCT00889226|19354401|P2|COMPLETED|Overall Study||43
7864027|NCT00889226|19354402|P1|COMPLETED|Overall Study||58
7864028|NCT00889226|19354401|P2|STARTED|Overall Study||78
7864029|NCT00889226|19354402|P1|STARTED|Overall Study||83
7864030|NCT00889200|19354410|P1|NOT COMPLETED|Overall Study||0
7864031|NCT00889200|19354410|P1|COMPLETED|Overall Study||12
7864032|NCT00889200|19354410|P1|STARTED|Overall Study||12
7864033|NCT00889187|19354414|P4|NOT COMPLETED|Overall Study||0
7864034|NCT00889187|19354415|P3|NOT COMPLETED|Overall Study||0
7864035|NCT00889187|19354416|P2|NOT COMPLETED|Overall Study||0
7864036|NCT00889187|19354417|P1|NOT COMPLETED|Overall Study||0
7864037|NCT00889187|19354414|P4|COMPLETED|Overall Study||0
7864038|NCT00889187|19354415|P3|COMPLETED|Overall Study||4
7864039|NCT00889187|19354416|P2|COMPLETED|Overall Study||3
7864040|NCT00889187|19354417|P1|COMPLETED|Overall Study||3
7864041|NCT00889187|19354414|P4|STARTED|Overall Study||0
7864042|NCT00889187|19354415|P3|STARTED|Overall Study||4
7864043|NCT00889187|19354416|P2|STARTED|Overall Study||3
7864044|NCT00889187|19354417|P1|STARTED|Overall Study||3
7864045|NCT00889005|19354434|P2|NOT COMPLETED|Overall Study||2
7864046|NCT00889005|19354435|P1|NOT COMPLETED|Overall Study||8
7864047|NCT00889005|19354434|P2|COMPLETED|Overall Study||72
7864048|NCT00889005|19354435|P1|COMPLETED|Overall Study||57
7864049|NCT00889005|19354434|P2|STARTED|Overall Study||74
7864050|NCT00889005|19354435|P1|STARTED|Overall Study||65
7864051|NCT00888979|19354441|P1|NOT COMPLETED|Overall Study||4
7864052|NCT00888979|19354441|P1|COMPLETED|Overall Study||6
7864053|NCT00888979|19354441|P1|Received the Inhaler/Counseling|Overall Study||8
7864054|NCT00888979|19354441|P1|STARTED|Overall Study||10
7864055|NCT00888940|19354449|P2|NOT COMPLETED|Overall Study||21
7864056|NCT00888940|19354450|P1|NOT COMPLETED|Overall Study||28
7864057|NCT00888940|19354449|P2|COMPLETED|Overall Study||101
7864058|NCT00888940|19354450|P1|COMPLETED|Overall Study||92
7864059|NCT00888940|19354449|P2|Completed Therapy|Overall Study||106
7864060|NCT00888940|19354450|P1|Completed Therapy|Overall Study||107
7864061|NCT00888940|19354449|P2|STARTED|Overall Study||122
7864062|NCT00888940|19354450|P1|STARTED|Overall Study||120
7864063|NCT00888927|19354462|P4|NOT COMPLETED|Overall Study||2
7864064|NCT00888927|19354463|P3|NOT COMPLETED|Overall Study||0
7864065|NCT00888927|19354464|P2|NOT COMPLETED|Overall Study||0
7864066|NCT00888927|19354465|P1|NOT COMPLETED|Overall Study||0
7864067|NCT00888927|19354462|P4|COMPLETED|Overall Study||31
7864068|NCT00888927|19354463|P3|COMPLETED|Overall Study||3
7864069|NCT00888927|19354464|P2|COMPLETED|Overall Study||3
7864070|NCT00888927|19354465|P1|COMPLETED|Overall Study||3
7864071|NCT00888927|19354462|P4|STARTED|Overall Study||33
7864072|NCT00888927|19354463|P3|STARTED|Overall Study||3
7864073|NCT00888927|19354464|P2|STARTED|Overall Study||3
7864074|NCT00888927|19354465|P1|STARTED|Overall Study||3
7864075|NCT00888849|19354481|P2|NOT COMPLETED|Overall Study||9
7864076|NCT00888849|19354482|P1|NOT COMPLETED|Overall Study||5
7864077|NCT00888849|19354481|P2|COMPLETED|Overall Study||129
7864078|NCT00888849|19354482|P1|COMPLETED|Overall Study||137
7864079|NCT00888849|19354481|P2|STARTED|Overall Study||138
7864080|NCT00888849|19354482|P1|STARTED|Overall Study||142
7864081|NCT00888654|19354492|P1|NOT COMPLETED|Overall Study||10
7864082|NCT00888654|19354492|P1|COMPLETED|Overall Study||31
7864083|NCT00888654|19354492|P1|STARTED|Overall Study||41
7864084|NCT00888628|19354498|P1|NOT COMPLETED|Overall Study||3
7864085|NCT00888628|19354498|P1|COMPLETED|Overall Study||4
7864086|NCT00888628|19354498|P1|Transplanted|Overall Study||4
7864087|NCT00888628|19354498|P1|Withdrawn|Overall Study||1
7864088|NCT00888628|19354498|P1|Screen Failure|Overall Study||2
7864089|NCT00888628|19354498|P1|Enrolled|Overall Study||7
7864090|NCT00888628|19354498|P1|STARTED|Overall Study||7
7864091|NCT00888615|19354510|P1|NOT COMPLETED|Overall Study||2
7864092|NCT00888615|19354510|P1|COMPLETED|Overall Study||56
7864093|NCT00888615|19354510|P1|STARTED|Overall Study||58
7864094|NCT00888511|19354519|P1|NOT COMPLETED|Overall Study||0
7864095|NCT00888511|19354519|P1|COMPLETED|Overall Study||15
7864096|NCT00888511|19354519|P1|STARTED|Overall Study||15
7864097|NCT00888459|19354525|P2|NOT COMPLETED|Overall Study||0
7864098|NCT00888459|19354526|P1|NOT COMPLETED|Overall Study||0
7864099|NCT00888459|19354525|P2|COMPLETED|Overall Study||30
7864100|NCT00888459|19354526|P1|COMPLETED|Overall Study||30
7864101|NCT00888459|19354525|P2|STARTED|Overall Study||30
7864102|NCT00888459|19354526|P1|STARTED|Overall Study||30
7864103|NCT00888433|19354534|P2|NOT COMPLETED|Overall Study||3
7864104|NCT00888433|19354535|P1|NOT COMPLETED|Overall Study||3
7864105|NCT00888433|19354534|P2|COMPLETED|Overall Study||51
7864106|NCT00888433|19354535|P1|COMPLETED|Overall Study||49
7864107|NCT00888433|19354534|P2|STARTED|Overall Study||54
7864108|NCT00888433|19354535|P1|STARTED|Overall Study||52
7864109|NCT00888381|19354543|P2|NOT COMPLETED|Overall Study||1
7864110|NCT00888381|19354544|P1|NOT COMPLETED|Overall Study||0
7864111|NCT00888381|19354543|P2|COMPLETED|Overall Study||59
7864112|NCT00888381|19354544|P1|COMPLETED|Overall Study||60
7864113|NCT00888381|19354543|P2|STARTED|Overall Study||60
7864114|NCT00888381|19354544|P1|STARTED|Overall Study||60
7864115|NCT00888355|19354564|P4|NOT COMPLETED|Overall Study||10
7864116|NCT00888355|19354565|P3|NOT COMPLETED|Overall Study||12
7864117|NCT00888355|19354566|P2|NOT COMPLETED|Overall Study||9
7864118|NCT00888355|19354567|P1|NOT COMPLETED|Overall Study||22
7864119|NCT00888355|19354564|P4|COMPLETED|Overall Study||96
7864120|NCT00888355|19354565|P3|COMPLETED|Overall Study||94
7864121|NCT00888355|19354566|P2|COMPLETED|Overall Study||99
7864122|NCT00888355|19354567|P1|COMPLETED|Overall Study||86
7864123|NCT00888355|19354564|P4|STARTED|Overall Study||106
7864124|NCT00888355|19354565|P3|STARTED|Overall Study||106
7864125|NCT00888355|19354566|P2|STARTED|Overall Study||108
7864126|NCT00888355|19354567|P1|STARTED|Overall Study||108
7864127|NCT00888329|19354623|P2|NOT COMPLETED|Overall Study||9
7864128|NCT00888329|19354624|P1|NOT COMPLETED|Overall Study||6
7864129|NCT00888329|19354623|P2|COMPLETED|Overall Study||122
7864130|NCT00888329|19354624|P1|COMPLETED|Overall Study||119
7864131|NCT00888329|19354623|P2|STARTED|Overall Study||131
7864132|NCT00888329|19354624|P1|STARTED|Overall Study||125
7864133|NCT00888238|19354630|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
7864134|NCT00888238|19354631|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
7864135|NCT00888238|19354632|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
7864136|NCT00888238|19354630|P3|COMPLETED|Third Period of Treatment Intervention||3
7864137|NCT00888238|19354631|P2|COMPLETED|Third Period of Treatment Intervention||4
7864138|NCT00888238|19354632|P1|COMPLETED|Third Period of Treatment Intervention||4
7864139|NCT00888238|19354630|P3|STARTED|Third Period of Treatment Intervention||3
7864140|NCT00888238|19354631|P2|STARTED|Third Period of Treatment Intervention||4
7864141|NCT00888238|19354632|P1|STARTED|Third Period of Treatment Intervention||4
7864142|NCT00888238|19354630|P3|NOT COMPLETED|Washout Period After Period 2||1
7864143|NCT00888238|19354631|P2|NOT COMPLETED|Washout Period After Period 2||0
7864144|NCT00888238|19354632|P1|NOT COMPLETED|Washout Period After Period 2||0
7864145|NCT00888238|19354630|P3|COMPLETED|Washout Period After Period 2||3
7864146|NCT00888238|19354631|P2|COMPLETED|Washout Period After Period 2||4
7864147|NCT00888238|19354632|P1|COMPLETED|Washout Period After Period 2||4
7864148|NCT00888238|19354630|P3|STARTED|Washout Period After Period 2||4
7864149|NCT00888238|19354631|P2|STARTED|Washout Period After Period 2||4
7864150|NCT00888238|19354632|P1|STARTED|Washout Period After Period 2||4
7864151|NCT00888238|19354630|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
7864152|NCT00888238|19354631|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
7864153|NCT00888238|19354632|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
7864154|NCT00888238|19354630|P3|COMPLETED|Second Period of Treatment Intervention||4
7864155|NCT00888238|19354631|P2|COMPLETED|Second Period of Treatment Intervention||4
7864156|NCT00888238|19354632|P1|COMPLETED|Second Period of Treatment Intervention||4
7864157|NCT00888238|19354630|P3|STARTED|Second Period of Treatment Intervention||4
7864158|NCT00888238|19354631|P2|STARTED|Second Period of Treatment Intervention||4
7864159|NCT00888238|19354632|P1|STARTED|Second Period of Treatment Intervention||4
7864160|NCT00888238|19354630|P3|NOT COMPLETED|Washout Period After Period 1||0
7864161|NCT00888238|19354631|P2|NOT COMPLETED|Washout Period After Period 1||0
7864162|NCT00888238|19354632|P1|NOT COMPLETED|Washout Period After Period 1||0
7864163|NCT00888238|19354630|P3|COMPLETED|Washout Period After Period 1||4
7864164|NCT00888238|19354631|P2|COMPLETED|Washout Period After Period 1||4
7864165|NCT00888238|19354632|P1|COMPLETED|Washout Period After Period 1||4
7864166|NCT00888238|19354630|P3|STARTED|Washout Period After Period 1||4
7864167|NCT00888238|19354631|P2|STARTED|Washout Period After Period 1||4
7864168|NCT00888238|19354632|P1|STARTED|Washout Period After Period 1||4
7864169|NCT00888238|19354630|P3|NOT COMPLETED|First Period of Treatment Intervention||0
7864170|NCT00888238|19354631|P2|NOT COMPLETED|First Period of Treatment Intervention||0
7864260|NCT00887588|19354855|P1|STARTED|Core Period||149
7864171|NCT00888238|19354632|P1|NOT COMPLETED|First Period of Treatment Intervention||0
7864172|NCT00888238|19354630|P3|COMPLETED|First Period of Treatment Intervention||4
7864173|NCT00888238|19354631|P2|COMPLETED|First Period of Treatment Intervention||4
7864174|NCT00888238|19354632|P1|COMPLETED|First Period of Treatment Intervention||4
7864175|NCT00888238|19354630|P3|STARTED|First Period of Treatment Intervention||4
7864176|NCT00888238|19354631|P2|STARTED|First Period of Treatment Intervention||4
7864177|NCT00888238|19354632|P1|STARTED|First Period of Treatment Intervention||4
7864178|NCT00888173|19354640|P1|NOT COMPLETED|Overall Study||2
7864179|NCT00888173|19354640|P1|COMPLETED|Overall Study||43
7864180|NCT00888173|19354640|P1|STARTED|Overall Study||45
7864181|NCT00888134|19354648|P1|NOT COMPLETED|Follow-up||1
7864182|NCT00888134|19354648|P1|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26
7864183|NCT00888134|19354648|P1|STARTED|Follow-up||27
7864184|NCT00888134|19354648|P1|NOT COMPLETED|Treatment With Study Drug||1
7864185|NCT00888134|19354648|P1|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27
7864186|NCT00888134|19354648|P1|STARTED|Treatment With Study Drug||28
7864187|NCT00887978|19354658|P2|NOT COMPLETED|Overall Study||15
7864188|NCT00887978|19354659|P1|NOT COMPLETED|Overall Study||25
7864189|NCT00887978|19354658|P2|COMPLETED|Overall Study||138
7864190|NCT00887978|19354659|P1|COMPLETED|Overall Study||132
7864191|NCT00887978|19354658|P2|STARTED|Overall Study||153
7864192|NCT00887978|19354659|P1|STARTED|Overall Study||157
7864193|NCT00887965|19354695|P1|NOT COMPLETED|Overall Study||0
7864194|NCT00887965|19354695|P1|COMPLETED|Overall Study||15
7864195|NCT00887965|19354695|P1|STARTED|Overall Study||15
7864196|NCT00887926|19354729|P4|NOT COMPLETED|Overall Study||0
7864197|NCT00887926|19354730|P3|NOT COMPLETED|Overall Study||0
7864198|NCT00887926|19354731|P2|NOT COMPLETED|Overall Study||1
7864199|NCT00887926|19354732|P1|NOT COMPLETED|Overall Study||0
7864200|NCT00887926|19354729|P4|COMPLETED|Overall Study||5
7864201|NCT00887926|19354730|P3|COMPLETED|Overall Study||3
7864202|NCT00887926|19354731|P2|COMPLETED|Overall Study||13
7864203|NCT00887926|19354732|P1|COMPLETED|Overall Study||3
7864204|NCT00887926|19354729|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
7864205|NCT00887926|19354730|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
7864206|NCT00887926|19354731|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
7864207|NCT00887926|19354732|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
7864208|NCT00887926|19354729|P4|STARTED|Overall Study||5
7864209|NCT00887926|19354730|P3|STARTED|Overall Study||3
7864210|NCT00887926|19354731|P2|STARTED|Overall Study||14
7864211|NCT00887926|19354732|P1|STARTED|Overall Study||3
7864212|NCT00887913|19354767|P1|NOT COMPLETED|Overall Study||6
7864213|NCT00887913|19354767|P1|COMPLETED|Overall Study||63
7864214|NCT00887913|19354767|P1|STARTED|Overall Study||69
7864215|NCT00887822|19354775|P2|NOT COMPLETED|Overall Study||102
7864216|NCT00887822|19354776|P1|NOT COMPLETED|Overall Study||97
7864217|NCT00887822|19354775|P2|COMPLETED|Overall Study||0
7864218|NCT00887822|19354776|P1|COMPLETED|Overall Study||3
7864219|NCT00887822|19354775|P2|Treated (Safety Population)|Overall Study||101
7864220|NCT00887822|19354776|P1|Treated (Safety Population)|Overall Study||100
7864221|NCT00887822|19354775|P2|STARTED|Overall Study||102
7864222|NCT00887822|19354776|P1|STARTED|Overall Study||100
7864223|NCT00887809|19354808|P2|NOT COMPLETED|Overall Study||0
7864224|NCT00887809|19354809|P1|NOT COMPLETED|Overall Study||4
7864225|NCT00887809|19354808|P2|COMPLETED|Overall Study||10
7864226|NCT00887809|19354809|P1|COMPLETED|Overall Study||33
7864227|NCT00887809|19354808|P2|STARTED|Overall Study||10
7864228|NCT00887809|19354809|P1|STARTED|Overall Study||37
7864229|NCT00887744|19354815|P1|NOT COMPLETED|Overall Study||34
7864230|NCT00887744|19354815|P1|COMPLETED|Overall Study||128
7864231|NCT00887744|19354815|P1|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162
7864232|NCT00887679|19354824|P1|NOT COMPLETED|Overall Study||10
7864233|NCT00887679|19354824|P1|COMPLETED|Overall Study|20 subjects completed the study.|20
7864234|NCT00887679|19354824|P1|STARTED|Overall Study||30
7864235|NCT00887653|19354833|P1|NOT COMPLETED|Overall Study||0
7864236|NCT00887653|19354833|P1|COMPLETED|Overall Study||20
7864237|NCT00887653|19354833|P1|STARTED|Overall Study||20
7864238|NCT00887640|19354839|P1|NOT COMPLETED|Overall Study||0
7864239|NCT00887640|19354839|P1|COMPLETED|Overall Study||11
7864240|NCT00887640|19354839|P1|STARTED|Overall Study||11
7864241|NCT00887588|19354854|P2|NOT COMPLETED|Extension Period||5
7864242|NCT00887588|19354855|P1|NOT COMPLETED|Extension Period||6
7864243|NCT00887588|19354854|P2|COMPLETED|Extension Period||120
7864244|NCT00887588|19354855|P1|COMPLETED|Extension Period||121
7864245|NCT00887588|19354854|P2|Arterial Stiffness Set|Extension Period||94
7864246|NCT00887588|19354855|P1|Arterial Stiffness Set|Extension Period||86
7864247|NCT00887588|19354854|P2|STARTED|Extension Period||125
7864248|NCT00887588|19354855|P1|STARTED|Extension Period||127
7864249|NCT00887588|19354854|P2|NOT COMPLETED|Core Period||21
7864250|NCT00887588|19354855|P1|NOT COMPLETED|Core Period||19
7864251|NCT00887588|19354854|P2|COMPLETED|Core Period||131
7864252|NCT00887588|19354855|P1|COMPLETED|Core Period||130
7864253|NCT00887588|19354854|P2|Arterial Stiffness Set|Core Period||94
7864254|NCT00887588|19354855|P1|Arterial Stiffness Set|Core Period||86
7864255|NCT00887588|19354854|P2|Full Analysis Set|Core Period||146
7864256|NCT00887588|19354855|P1|Full Analysis Set|Core Period||148
7864257|NCT00887588|19354854|P2|Extension Efficacy Set|Core Period||125
7864258|NCT00887588|19354855|P1|Extension Efficacy Set|Core Period||127
7864259|NCT00887588|19354854|P2|STARTED|Core Period||152
7864261|NCT00887575|19354907|P3|NOT COMPLETED|Phase II - Maintenance Therapy||0
7864262|NCT00887575|19354908|P2|NOT COMPLETED|Phase II - Maintenance Therapy||0
7864263|NCT00887575|19354909|P1|NOT COMPLETED|Phase II - Maintenance Therapy||2
7864264|NCT00887575|19354907|P3|COMPLETED|Phase II - Maintenance Therapy||0
7864265|NCT00887575|19354908|P2|COMPLETED|Phase II - Maintenance Therapy||0
7864266|NCT00887575|19354909|P1|COMPLETED|Phase II - Maintenance Therapy||6
7864267|NCT00887575|19354907|P3|STARTED|Phase II - Maintenance Therapy||0
7864268|NCT00887575|19354908|P2|STARTED|Phase II - Maintenance Therapy||0
7864269|NCT00887575|19354909|P1|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8
7864270|NCT00887575|19354907|P3|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
7864271|NCT00887575|19354908|P2|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
7864272|NCT00887575|19354909|P1|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25
7864273|NCT00887575|19354907|P3|COMPLETED|Phase II - Neoadjuvant Therapy||0
7864274|NCT00887575|19354908|P2|COMPLETED|Phase II - Neoadjuvant Therapy||0
7864275|NCT00887575|19354909|P1|COMPLETED|Phase II - Neoadjuvant Therapy||16
7864276|NCT00887575|19354907|P3|STARTED|Phase II - Neoadjuvant Therapy||0
7864277|NCT00887575|19354908|P2|STARTED|Phase II - Neoadjuvant Therapy||0
7864278|NCT00887575|19354909|P1|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41
7864279|NCT00887575|19354907|P3|NOT COMPLETED|Phase I||3
7864280|NCT00887575|19354908|P2|NOT COMPLETED|Phase I||6
7864281|NCT00887575|19354909|P1|NOT COMPLETED|Phase I||0
7864282|NCT00887575|19354907|P3|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
7864283|NCT00887575|19354908|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
7864284|NCT00887575|19354909|P1|COMPLETED|Phase I||6
7864285|NCT00887575|19354907|P3|STARTED|Phase I||3
7864286|NCT00887575|19354908|P2|STARTED|Phase I||6
7864287|NCT00887575|19354909|P1|STARTED|Phase I||6
7864288|NCT00887562|19354920|P3|NOT COMPLETED|Overall Study||1
7864289|NCT00887562|19354921|P2|NOT COMPLETED|Overall Study||2
7864290|NCT00887562|19354922|P1|NOT COMPLETED|Overall Study||3
7864291|NCT00887562|19354920|P3|COMPLETED|Overall Study||7
7864292|NCT00887562|19354921|P2|COMPLETED|Overall Study||7
7864293|NCT00887562|19354922|P1|COMPLETED|Overall Study||7
7864294|NCT00887562|19354920|P3|STARTED|Overall Study||8
7864295|NCT00887562|19354921|P2|STARTED|Overall Study||9
7864296|NCT00887562|19354922|P1|STARTED|Overall Study||10
7864297|NCT00887549|19354936|P1|NOT COMPLETED|Maintenance Therapy||43
7864298|NCT00887549|19354936|P1|COMPLETED|Maintenance Therapy||0
7864299|NCT00887549|19354936|P1|STARTED|Maintenance Therapy||43
7864300|NCT00887549|19354936|P1|NOT COMPLETED|Induction Therapy||27
7864301|NCT00887549|19354936|P1|COMPLETED|Induction Therapy||43
7864302|NCT00887549|19354936|P1|STARTED|Induction Therapy||70
7864303|NCT00887510|19354945|P2|NOT COMPLETED|Overall Study||0
7864304|NCT00887510|19354946|P1|NOT COMPLETED|Overall Study||0
7864305|NCT00887510|19354945|P2|COMPLETED|Overall Study||12
7864306|NCT00887510|19354946|P1|COMPLETED|Overall Study||12
7864307|NCT00887510|19354945|P2|STARTED|Overall Study||12
7864308|NCT00887510|19354946|P1|STARTED|Overall Study||12
7864309|NCT00887484|19354954|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3
7864310|NCT00887484|19354954|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45
7864311|NCT00887484|19354954|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||48
7864312|NCT00887484|19354954|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
7864313|NCT00887484|19354954|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48
7864314|NCT00887484|19354954|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||48
7864315|NCT00887471|19355020|P2|NOT COMPLETED|Overall Study||0
7864316|NCT00887471|19355021|P1|NOT COMPLETED|Overall Study||0
7864317|NCT00887471|19355020|P2|COMPLETED|Overall Study||15
7864318|NCT00887471|19355021|P1|COMPLETED|Overall Study||15
7864319|NCT00887471|19355020|P2|STARTED|Overall Study||15
7864320|NCT00887471|19355021|P1|STARTED|Overall Study||15
7864321|NCT00887458|19355031|P2|NOT COMPLETED|Overall Study||4
7864322|NCT00887458|19355032|P1|NOT COMPLETED|Overall Study||0
7864323|NCT00887458|19355031|P2|COMPLETED|Overall Study||25
7864324|NCT00887458|19355032|P1|COMPLETED|Overall Study||17
7864325|NCT00887458|19355031|P2|STARTED|Overall Study||29
7864326|NCT00887458|19355032|P1|STARTED|Overall Study||17
7864327|NCT00887354|19355042|P2|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6
7864328|NCT00887354|19355043|P1|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3
7864329|NCT00887354|19355042|P2|COMPLETED|Open Label Phase (Week 26 to Week 78)||59
7864330|NCT00887354|19355043|P1|COMPLETED|Open Label Phase (Week 26 to Week 78)||57
7864331|NCT00887354|19355042|P2|STARTED|Open Label Phase (Week 26 to Week 78)||65
7864332|NCT00887354|19355043|P1|STARTED|Open Label Phase (Week 26 to Week 78)||60
7864333|NCT00887354|19355042|P2|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48
7864334|NCT00887354|19355043|P1|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51
7864335|NCT00887354|19355042|P2|COMPLETED|Treatment Phase (Week 0 to Week 26)||65
7864336|NCT00887354|19355043|P1|COMPLETED|Treatment Phase (Week 0 to Week 26)||60
7864337|NCT00887354|19355042|P2|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85
7864338|NCT00887354|19355043|P1|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86
7864339|NCT00887354|19355042|P2|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110
7864340|NCT00887354|19355043|P1|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106
7864341|NCT00887354|19355042|P2|STARTED|Treatment Phase (Week 0 to Week 26)||113
7864342|NCT00887354|19355043|P1|STARTED|Treatment Phase (Week 0 to Week 26)||111
7864343|NCT00887341|19355063|P2|NOT COMPLETED|Overall Study||3
7864344|NCT00887341|19355064|P1|NOT COMPLETED|Overall Study||2
7864345|NCT00887341|19355063|P2|COMPLETED|Overall Study||36
7864346|NCT00887341|19355064|P1|COMPLETED|Overall Study||35
7864347|NCT00887341|19355063|P2|STARTED|Overall Study||39
7864348|NCT00887341|19355064|P1|STARTED|Overall Study||37
7864349|NCT00887315|19355100|P2|NOT COMPLETED|Overall Study||4
7864350|NCT00887315|19355101|P1|NOT COMPLETED|Overall Study||7
7864351|NCT00887315|19355100|P2|COMPLETED|Overall Study||0
7864352|NCT00887315|19355101|P1|COMPLETED|Overall Study||0
7864353|NCT00887315|19355100|P2|STARTED|Overall Study||4
7864354|NCT00887315|19355101|P1|STARTED|Overall Study||7
7864355|NCT00887289|19355109|P1|NOT COMPLETED|Overall Study||95
7864356|NCT00887289|19355109|P1|COMPLETED|Overall Study||1409
7864357|NCT00887289|19355109|P1|STARTED|Overall Study||1504
7864358|NCT00887250|19355121|P3|NOT COMPLETED|Overall Study||13
7864359|NCT00887250|19355122|P2|NOT COMPLETED|Overall Study||12
7864360|NCT00887250|19355123|P1|NOT COMPLETED|Overall Study||18
7864361|NCT00887250|19355121|P3|COMPLETED|Overall Study||110
7864362|NCT00887250|19355122|P2|COMPLETED|Overall Study||115
7864363|NCT00887250|19355123|P1|COMPLETED|Overall Study||98
7864364|NCT00887250|19355121|P3|STARTED|Overall Study||123
7864365|NCT00887250|19355122|P2|STARTED|Overall Study||127
7864366|NCT00887250|19355123|P1|STARTED|Overall Study||116
7864367|NCT00887224|19355146|P3|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30
7864368|NCT00887224|19355147|P2|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41
7864369|NCT00887224|19355148|P1|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0
7864370|NCT00887224|19355146|P3|COMPLETED|DB Taper Phase / Post Study Follow Up||235
7864371|NCT00887224|19355147|P2|COMPLETED|DB Taper Phase / Post Study Follow Up||226
7864372|NCT00887224|19355148|P1|COMPLETED|DB Taper Phase / Post Study Follow Up||0
7864373|NCT00887224|19355146|P3|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30
7864374|NCT00887224|19355147|P2|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41
7864375|NCT00887224|19355148|P1|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0
7864376|NCT00887224|19355146|P3|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7
7864377|NCT00887224|19355147|P2|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9
7864378|NCT00887224|19355148|P1|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0
7864379|NCT00887224|19355146|P3|STARTED|DB Taper Phase / Post Study Follow Up||265
7864380|NCT00887224|19355147|P2|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267
7864381|NCT00887224|19355148|P1|STARTED|DB Taper Phase / Post Study Follow Up||0
7864382|NCT00887224|19355146|P3|NOT COMPLETED|Double-blind (DB) Phase||62
7864383|NCT00887224|19355147|P2|NOT COMPLETED|Double-blind (DB) Phase||100
7864384|NCT00887224|19355148|P1|NOT COMPLETED|Double-blind (DB) Phase||0
7864385|NCT00887224|19355146|P3|COMPLETED|Double-blind (DB) Phase||210
7864386|NCT00887224|19355147|P2|COMPLETED|Double-blind (DB) Phase||176
7864387|NCT00887224|19355148|P1|COMPLETED|Double-blind (DB) Phase||0
7864388|NCT00887224|19355146|P3|STARTED|Double-blind (DB) Phase||272
7864389|NCT00887224|19355147|P2|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276
7864390|NCT00887224|19355148|P1|STARTED|Double-blind (DB) Phase||0
7864391|NCT00887224|19355146|P3|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
7864392|NCT00887224|19355147|P2|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
7864393|NCT00887224|19355148|P1|NOT COMPLETED|OL Taper Phase / OL Follow Up||144
7864394|NCT00887224|19355146|P3|COMPLETED|OL Taper Phase / OL Follow Up||0
7864395|NCT00887224|19355147|P2|COMPLETED|OL Taper Phase / OL Follow Up||0
7864396|NCT00887224|19355148|P1|COMPLETED|OL Taper Phase / OL Follow Up||163
7864397|NCT00887224|19355146|P3|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
7864398|NCT00887224|19355147|P2|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
7864399|NCT00887224|19355148|P1|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144
7864400|NCT00887224|19355146|P3|STARTED|OL Taper Phase / OL Follow Up||0
7864401|NCT00887224|19355147|P2|STARTED|OL Taper Phase / OL Follow Up||0
7864402|NCT00887224|19355148|P1|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307
7864403|NCT00887224|19355146|P3|NOT COMPLETED|Between OLS and DB Phases||0
7864404|NCT00887224|19355147|P2|NOT COMPLETED|Between OLS and DB Phases||0
7864405|NCT00887224|19355148|P1|NOT COMPLETED|Between OLS and DB Phases||28
7864406|NCT00887224|19355146|P3|COMPLETED|Between OLS and DB Phases||0
7864407|NCT00887224|19355147|P2|COMPLETED|Between OLS and DB Phases||0
7864408|NCT00887224|19355148|P1|COMPLETED|Between OLS and DB Phases||548
7864409|NCT00887224|19355146|P3|STARTED|Between OLS and DB Phases||0
7864410|NCT00887224|19355147|P2|STARTED|Between OLS and DB Phases||0
7864411|NCT00887224|19355148|P1|STARTED|Between OLS and DB Phases||576
7864412|NCT00887224|19355146|P3|NOT COMPLETED|Open-label Stability (OLS) Phase||0
7864413|NCT00887224|19355147|P2|NOT COMPLETED|Open-label Stability (OLS) Phase||0
7864414|NCT00887224|19355148|P1|NOT COMPLETED|Open-label Stability (OLS) Phase||83
7864415|NCT00887224|19355146|P3|COMPLETED|Open-label Stability (OLS) Phase||0
7864416|NCT00887224|19355147|P2|COMPLETED|Open-label Stability (OLS) Phase||0
7864417|NCT00887224|19355148|P1|COMPLETED|Open-label Stability (OLS) Phase||576
7864418|NCT00887224|19355146|P3|STARTED|Open-label Stability (OLS) Phase||0
7864419|NCT00887224|19355147|P2|STARTED|Open-label Stability (OLS) Phase||0
7864420|NCT00887224|19355148|P1|STARTED|Open-label Stability (OLS) Phase||659
7864421|NCT00887224|19355146|P3|NOT COMPLETED|Between OLR and OLS Phases||0
7864422|NCT00887224|19355147|P2|NOT COMPLETED|Between OLR and OLS Phases||0
7864423|NCT00887224|19355148|P1|NOT COMPLETED|Between OLR and OLS Phases||93
7864424|NCT00887224|19355146|P3|COMPLETED|Between OLR and OLS Phases||0
7864425|NCT00887224|19355147|P2|COMPLETED|Between OLR and OLS Phases||0
7864426|NCT00887224|19355148|P1|COMPLETED|Between OLR and OLS Phases||659
7864427|NCT00887224|19355146|P3|STARTED|Between OLR and OLS Phases||0
7864428|NCT00887224|19355147|P2|STARTED|Between OLR and OLS Phases||0
7864429|NCT00887224|19355148|P1|STARTED|Between OLR and OLS Phases||752
7864430|NCT00887224|19355146|P3|NOT COMPLETED|Open-label Response (OLR) Phase||0
7864431|NCT00887224|19355147|P2|NOT COMPLETED|Open-label Response (OLR) Phase||0
7864432|NCT00887224|19355148|P1|NOT COMPLETED|Open-label Response (OLR) Phase||122
7864433|NCT00887224|19355146|P3|COMPLETED|Open-label Response (OLR) Phase||0
7864434|NCT00887224|19355147|P2|COMPLETED|Open-label Response (OLR) Phase||0
7864435|NCT00887224|19355148|P1|COMPLETED|Open-label Response (OLR) Phase||752
7864436|NCT00887224|19355146|P3|STARTED|Open-label Response (OLR) Phase||0
7864437|NCT00887224|19355147|P2|STARTED|Open-label Response (OLR) Phase||0
7864438|NCT00887224|19355148|P1|STARTED|Open-label Response (OLR) Phase||874
7864439|NCT00887198|19355175|P3|NOT COMPLETED|Cross Over (Placebo to AA)||93
7864440|NCT00887198|19355176|P2|NOT COMPLETED|Cross Over (Placebo to AA)||0
7864441|NCT00887198|19355177|P1|NOT COMPLETED|Cross Over (Placebo to AA)||0
7864442|NCT00887198|19355175|P3|COMPLETED|Cross Over (Placebo to AA)||0
7864443|NCT00887198|19355176|P2|COMPLETED|Cross Over (Placebo to AA)||0
7864444|NCT00887198|19355177|P1|COMPLETED|Cross Over (Placebo to AA)||0
7864445|NCT00887198|19355175|P3|STARTED|Cross Over (Placebo to AA)|93= 51 participants(crossed over under amendment 3)+42 participants (crossed over under amendment 4)|93
7864446|NCT00887198|19355176|P2|STARTED|Cross Over (Placebo to AA)||0
7864447|NCT00887198|19355177|P1|STARTED|Cross Over (Placebo to AA)||0
7864448|NCT00887198|19355175|P3|NOT COMPLETED|Randomized Period||0
7864449|NCT00887198|19355176|P2|NOT COMPLETED|Randomized Period||542
7864450|NCT00887198|19355177|P1|NOT COMPLETED|Randomized Period||546
7864451|NCT00887198|19355175|P3|COMPLETED|Randomized Period||0
7864452|NCT00887198|19355176|P2|COMPLETED|Randomized Period||0
7864453|NCT00887198|19355177|P1|COMPLETED|Randomized Period||0
7864454|NCT00887198|19355175|P3|Treated|Randomized Period||0
7864455|NCT00887198|19355176|P2|Treated|Randomized Period||540
7864456|NCT00887198|19355177|P1|Treated|Randomized Period||542
7864457|NCT00887198|19355175|P3|STARTED|Randomized Period||0
7864458|NCT00887198|19355176|P2|STARTED|Randomized Period||542
7864459|NCT00887198|19355177|P1|STARTED|Randomized Period||546
7864460|NCT00887159|19355208|P3|NOT COMPLETED|Overall Study||56
7864461|NCT00887159|19355209|P2|NOT COMPLETED|Overall Study||56
7864462|NCT00887159|19355210|P1|NOT COMPLETED|Overall Study||29
7864463|NCT00887159|19355208|P3|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
7864464|NCT00887159|19355209|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
7864465|NCT00887159|19355210|P1|COMPLETED|Overall Study||27
7864466|NCT00887159|19355208|P3|Eligible/Treated Pts With CTCs Results|Overall Study||38
7864467|NCT00887159|19355209|P2|Eligible/Treated Pts With CTCs Results|Overall Study||42
7864468|NCT00887159|19355210|P1|Eligible/Treated Pts With CTCs Results|Overall Study||40
7864469|NCT00887159|19355208|P3|Eligible and Treated Patients|Overall Study||52
7864470|NCT00887159|19355209|P2|Eligible and Treated Patients|Overall Study||52
7864471|NCT00887159|19355210|P1|Eligible and Treated Patients|Overall Study||48
7864472|NCT00887159|19355208|P3|Patients Who Started Assigned Treatment|Overall Study||52
7864473|NCT00887159|19355209|P2|Patients Who Started Assigned Treatment|Overall Study||53
7864474|NCT00887159|19355210|P1|Patients Who Started Assigned Treatment|Overall Study||53
7864475|NCT00887159|19355208|P3|STARTED|Overall Study||56
7864476|NCT00887159|19355209|P2|STARTED|Overall Study||56
7864477|NCT00887159|19355210|P1|STARTED|Overall Study||56
7864478|NCT00887068|19355228|P2|NOT COMPLETED|Overall Study||0
7864479|NCT00887068|19355229|P1|NOT COMPLETED|Overall Study||6
7864480|NCT00887068|19355228|P2|COMPLETED|Overall Study||94
7864481|NCT00887068|19355229|P1|COMPLETED|Overall Study||87
7864482|NCT00887068|19355228|P2|STARTED|Overall Study||94
7864483|NCT00887068|19355229|P1|STARTED|Overall Study||93
7864484|NCT00886938|19355237|P1|NOT COMPLETED|Overall Study||2
7864485|NCT00886938|19355237|P1|COMPLETED|Overall Study||10
7864486|NCT00886938|19355237|P1|STARTED|Overall Study||12
7864487|NCT00886899|19355241|P1|NOT COMPLETED|Overall Study||0
7864488|NCT00886899|19355241|P1|COMPLETED|Overall Study||147
7864489|NCT00886899|19355241|P1|STARTED|Overall Study||147
7864490|NCT00886834|19355250|P2|NOT COMPLETED|Overall Study||3
7864491|NCT00886834|19355251|P1|NOT COMPLETED|Overall Study||0
7864492|NCT00886834|19355250|P2|COMPLETED|Overall Study||51
7864493|NCT00886834|19355251|P1|COMPLETED|Overall Study||54
7864494|NCT00886834|19355250|P2|STARTED|Overall Study||54
7864495|NCT00886834|19355251|P1|STARTED|Overall Study||54
7864496|NCT00886821|19355273|P14|NOT COMPLETED|Stage 2||1
7864497|NCT00886821|19355274|P13|NOT COMPLETED|Stage 2||5
7864498|NCT00886821|19355275|P12|NOT COMPLETED|Stage 2||1
7864499|NCT00886821|19355276|P11|NOT COMPLETED|Stage 2||0
7864500|NCT00886821|19355277|P10|NOT COMPLETED|Stage 2||0
7864501|NCT00886821|19355278|P9|NOT COMPLETED|Stage 2||0
7864502|NCT00886821|19355279|P8|NOT COMPLETED|Stage 2||0
7864503|NCT00886821|19355280|P7|NOT COMPLETED|Stage 2||0
7864504|NCT00886821|19355281|P6|NOT COMPLETED|Stage 2||0
7864505|NCT00886821|19355282|P5|NOT COMPLETED|Stage 2||0
7864506|NCT00886821|19355283|P4|NOT COMPLETED|Stage 2||0
7864507|NCT00886821|19355284|P3|NOT COMPLETED|Stage 2||0
7864508|NCT00886821|19355285|P2|NOT COMPLETED|Stage 2||0
7864509|NCT00886821|19355286|P1|NOT COMPLETED|Stage 2||0
7864510|NCT00886821|19355273|P14|COMPLETED|Stage 2||8
7864511|NCT00886821|19355274|P13|COMPLETED|Stage 2||8
7864512|NCT00886821|19355275|P12|COMPLETED|Stage 2||8
7864513|NCT00886821|19355276|P11|COMPLETED|Stage 2||9
7864514|NCT00886821|19355277|P10|COMPLETED|Stage 2||0
7864515|NCT00886821|19355278|P9|COMPLETED|Stage 2||0
7864516|NCT00886821|19355279|P8|COMPLETED|Stage 2||0
7864517|NCT00886821|19355280|P7|COMPLETED|Stage 2||0
7864518|NCT00886821|19355281|P6|COMPLETED|Stage 2||0
7864519|NCT00886821|19355282|P5|COMPLETED|Stage 2||0
7864520|NCT00886821|19355283|P4|COMPLETED|Stage 2||0
7864521|NCT00886821|19355284|P3|COMPLETED|Stage 2||0
7864522|NCT00886821|19355285|P2|COMPLETED|Stage 2||0
7864523|NCT00886821|19355286|P1|COMPLETED|Stage 2||0
7864524|NCT00886821|19355273|P14|STARTED|Stage 2||9
7864525|NCT00886821|19355274|P13|STARTED|Stage 2||13
7864526|NCT00886821|19355275|P12|STARTED|Stage 2||9
7864527|NCT00886821|19355276|P11|STARTED|Stage 2||9
7864528|NCT00886821|19355277|P10|STARTED|Stage 2||0
7864529|NCT00886821|19355278|P9|STARTED|Stage 2||0
7864530|NCT00886821|19355279|P8|STARTED|Stage 2||0
7864531|NCT00886821|19355280|P7|STARTED|Stage 2||0
7864532|NCT00886821|19355281|P6|STARTED|Stage 2||0
7864533|NCT00886821|19355282|P5|STARTED|Stage 2||0
7864534|NCT00886821|19355283|P4|STARTED|Stage 2||0
7864535|NCT00886821|19355284|P3|STARTED|Stage 2||0
7864536|NCT00886821|19355285|P2|STARTED|Stage 2||0
7864537|NCT00886821|19355286|P1|STARTED|Stage 2||0
7864538|NCT00886821|19355273|P14|NOT COMPLETED|Stage 1||0
7864539|NCT00886821|19355274|P13|NOT COMPLETED|Stage 1||0
7864540|NCT00886821|19355275|P12|NOT COMPLETED|Stage 1||0
7864541|NCT00886821|19355276|P11|NOT COMPLETED|Stage 1||0
7864542|NCT00886821|19355277|P10|NOT COMPLETED|Stage 1||0
7864543|NCT00886821|19355278|P9|NOT COMPLETED|Stage 1||0
7864544|NCT00886821|19355279|P8|NOT COMPLETED|Stage 1||0
7864545|NCT00886821|19355280|P7|NOT COMPLETED|Stage 1||0
7864546|NCT00886821|19355281|P6|NOT COMPLETED|Stage 1||0
7864547|NCT00886821|19355282|P5|NOT COMPLETED|Stage 1||0
7864548|NCT00886821|19355283|P4|NOT COMPLETED|Stage 1||0
7864549|NCT00886821|19355284|P3|NOT COMPLETED|Stage 1||0
7864550|NCT00886821|19355285|P2|NOT COMPLETED|Stage 1||0
7864551|NCT00886821|19355286|P1|NOT COMPLETED|Stage 1||0
7864552|NCT00886821|19355273|P14|COMPLETED|Stage 1||0
7864553|NCT00886821|19355274|P13|COMPLETED|Stage 1||0
7864554|NCT00886821|19355275|P12|COMPLETED|Stage 1||0
7864555|NCT00886821|19355276|P11|COMPLETED|Stage 1||0
7864556|NCT00886821|19355277|P10|COMPLETED|Stage 1||18
7864557|NCT00886821|19355278|P9|COMPLETED|Stage 1||6
7864558|NCT00886821|19355279|P8|COMPLETED|Stage 1||6
7864559|NCT00886821|19355280|P7|COMPLETED|Stage 1||6
7864560|NCT00886821|19355281|P6|COMPLETED|Stage 1||6
7864561|NCT00886821|19355282|P5|COMPLETED|Stage 1||6
7864562|NCT00886821|19355283|P4|COMPLETED|Stage 1||7
7864563|NCT00886821|19355284|P3|COMPLETED|Stage 1||6
7864564|NCT00886821|19355285|P2|COMPLETED|Stage 1||6
7864565|NCT00886821|19355286|P1|COMPLETED|Stage 1||7
7864566|NCT00886821|19355273|P14|STARTED|Stage 1||0
7864567|NCT00886821|19355274|P13|STARTED|Stage 1||0
7864568|NCT00886821|19355275|P12|STARTED|Stage 1||0
7864569|NCT00886821|19355276|P11|STARTED|Stage 1||0
7864570|NCT00886821|19355277|P10|STARTED|Stage 1||18
7864571|NCT00886821|19355278|P9|STARTED|Stage 1||6
7864572|NCT00886821|19355279|P8|STARTED|Stage 1||6
7864573|NCT00886821|19355280|P7|STARTED|Stage 1||6
7864574|NCT00886821|19355281|P6|STARTED|Stage 1||6
7864575|NCT00886821|19355282|P5|STARTED|Stage 1||6
7864576|NCT00886821|19355283|P4|STARTED|Stage 1||7
7864577|NCT00886821|19355284|P3|STARTED|Stage 1||6
7864578|NCT00886821|19355285|P2|STARTED|Stage 1||6
7864579|NCT00886821|19355286|P1|STARTED|Stage 1||7
7864580|NCT00886795|19355511|P1|NOT COMPLETED|Overall Study||1
7864581|NCT00886795|19355511|P1|COMPLETED|Overall Study||3
7864582|NCT00886795|19355511|P1|STARTED|Overall Study||4
7864583|NCT00886769|19355518|P2|NOT COMPLETED|Overall Study||37
7864584|NCT00886769|19355519|P1|NOT COMPLETED|Overall Study||6
7864585|NCT00886769|19355518|P2|COMPLETED|Overall Study||4
7864586|NCT00886769|19355519|P1|COMPLETED|Overall Study||37
7864587|NCT00886769|19355518|P2|STARTED|Overall Study||41
7864588|NCT00886769|19355519|P1|STARTED|Overall Study||43
7864589|NCT00886743|19355543|P1|NOT COMPLETED|Overall Study||4
7864590|NCT00886743|19355543|P1|COMPLETED|Overall Study||15
7864591|NCT00886743|19355543|P1|STARTED|Overall Study|Received treatment|19
7864592|NCT00886704|19355553|P2|NOT COMPLETED|Overall Study||0
7864593|NCT00886704|19355554|P1|NOT COMPLETED|Overall Study||0
7864594|NCT00886704|19355553|P2|COMPLETED|Overall Study||10
7864595|NCT00886704|19355554|P1|COMPLETED|Overall Study||40
7864596|NCT00886704|19355553|P2|STARTED|Overall Study||10
7864597|NCT00886704|19355554|P1|STARTED|Overall Study||40
7864598|NCT00886691|19355564|P2|NOT COMPLETED|Overall Study||0
7864599|NCT00886691|19355565|P1|NOT COMPLETED|Overall Study||0
7864600|NCT00886691|19355564|P2|COMPLETED|Overall Study||75
7864601|NCT00886691|19355565|P1|COMPLETED|Overall Study||75
7864602|NCT00886691|19355564|P2|STARTED|Overall Study||75
7864603|NCT00886691|19355565|P1|STARTED|Overall Study||75
7864604|NCT00886639|19355581|P1|NOT COMPLETED|Overall Study||16
7864605|NCT00886639|19355581|P1|COMPLETED|Overall Study||111
7864606|NCT00886639|19355581|P1|STARTED|Overall Study||127
7864607|NCT00886626|19355585|P2|NOT COMPLETED|Period 2 (90 Days)||0
7864608|NCT00886626|19355586|P1|NOT COMPLETED|Period 2 (90 Days)||0
7864609|NCT00886626|19355585|P2|COMPLETED|Period 2 (90 Days)||6
7864610|NCT00886626|19355586|P1|COMPLETED|Period 2 (90 Days)||5
7864611|NCT00886626|19355585|P2|STARTED|Period 2 (90 Days)||6
7864612|NCT00886626|19355586|P1|STARTED|Period 2 (90 Days)||5
7864613|NCT00886626|19355585|P2|NOT COMPLETED|Period 1 (90 Days)||0
7864614|NCT00886626|19355586|P1|NOT COMPLETED|Period 1 (90 Days)||1
7864615|NCT00886626|19355585|P2|COMPLETED|Period 1 (90 Days)||6
7864616|NCT00886626|19355586|P1|COMPLETED|Period 1 (90 Days)||5
7864617|NCT00886626|19355585|P2|STARTED|Period 1 (90 Days)||6
7864618|NCT00886626|19355586|P1|STARTED|Period 1 (90 Days)||6
7864619|NCT00886613|19355595|P3|NOT COMPLETED|Overall Study||3
7864620|NCT00886613|19355596|P2|NOT COMPLETED|Overall Study||0
7864621|NCT00886613|19355597|P1|NOT COMPLETED|Overall Study||2
7864622|NCT00886613|19355595|P3|COMPLETED|Overall Study||37
7864623|NCT00886613|19355596|P2|COMPLETED|Overall Study||39
7864624|NCT00886613|19355597|P1|COMPLETED|Overall Study||39
7864625|NCT00886613|19355595|P3|STARTED|Overall Study||40
7864626|NCT00886613|19355596|P2|STARTED|Overall Study||39
7864627|NCT00886613|19355597|P1|STARTED|Overall Study||41
7864628|NCT00886600|19355619|P4|NOT COMPLETED|Combination Therapy Period||0
7864629|NCT00886600|19355620|P3|NOT COMPLETED|Combination Therapy Period||2
7864630|NCT00886600|19355621|P2|NOT COMPLETED|Combination Therapy Period||0
7864631|NCT00886600|19355622|P1|NOT COMPLETED|Combination Therapy Period||0
7864632|NCT00886600|19355619|P4|COMPLETED|Combination Therapy Period||23
7864633|NCT00886600|19355620|P3|COMPLETED|Combination Therapy Period||19
7864634|NCT00886600|19355621|P2|COMPLETED|Combination Therapy Period||21
7864635|NCT00886600|19355622|P1|COMPLETED|Combination Therapy Period||28
7864636|NCT00886600|19355619|P4|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 5-(SiDBP <85); 1-(SiDBP ≥85)|23
7864637|NCT00886600|19355620|P3|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 7-(SiDBP <85); 1-(SiDBP ≥85)|21
7864638|NCT00886600|19355621|P2|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 4-(SiDBP <85); 3-(SiDBP ≥85)|21
7864639|NCT00886600|19355622|P1|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 2-(Sitting Diastolic Blood Pressure (SiDBP) <85)|28
7864640|NCT00886600|19355619|P4|NOT COMPLETED|Double-blind Monotherapy||2
7864641|NCT00886600|19355620|P3|NOT COMPLETED|Double-blind Monotherapy||1
7864642|NCT00886600|19355621|P2|NOT COMPLETED|Double-blind Monotherapy||1
7864643|NCT00886600|19355622|P1|NOT COMPLETED|Double-blind Monotherapy||2
7864644|NCT00886600|19355619|P4|COMPLETED|Double-blind Monotherapy||29
7864645|NCT00886600|19355620|P3|COMPLETED|Double-blind Monotherapy||29
7864646|NCT00886600|19355621|P2|COMPLETED|Double-blind Monotherapy|1 pt discontinued after Wk 4 due to AE starting in placebo baseline and continuing into double-blind|28
7864647|NCT00886600|19355622|P1|COMPLETED|Double-blind Monotherapy||30
7864648|NCT00886600|19355619|P4|STARTED|Double-blind Monotherapy||31
7864649|NCT00886600|19355620|P3|STARTED|Double-blind Monotherapy||30
7864650|NCT00886600|19355621|P2|STARTED|Double-blind Monotherapy||29
7864651|NCT00886600|19355622|P1|STARTED|Double-blind Monotherapy||32
7864652|NCT00886587|19355646|P2|NOT COMPLETED|Overall Study||2
7864653|NCT00886587|19355647|P1|NOT COMPLETED|Overall Study||4
7864654|NCT00886587|19355646|P2|COMPLETED|Overall Study||39
7864655|NCT00886587|19355647|P1|COMPLETED|Overall Study||37
7864656|NCT00886587|19355646|P2|STARTED|Overall Study||41
7864657|NCT00886587|19355647|P1|STARTED|Overall Study||41
7864658|NCT00886483|19355661|P2|NOT COMPLETED|Overall Study||3
7864659|NCT00886483|19355662|P1|NOT COMPLETED|Overall Study||2
7864660|NCT00886483|19355661|P2|COMPLETED|Overall Study||10
7864661|NCT00886483|19355662|P1|COMPLETED|Overall Study||24
7864662|NCT00886483|19355661|P2|Completed 20 Treatments|Overall Study||11
7864663|NCT00886483|19355662|P1|Completed 20 Treatments|Overall Study||25
7864664|NCT00886483|19355661|P2|STARTED|Overall Study||13
7864665|NCT00886483|19355662|P1|STARTED|Overall Study||26
7864666|NCT00886340|19355680|P2|NOT COMPLETED|Overall Study||7
7864667|NCT00886340|19355681|P1|NOT COMPLETED|Overall Study||0
7864668|NCT00886340|19355680|P2|COMPLETED|Overall Study||24
7864669|NCT00886340|19355681|P1|COMPLETED|Overall Study||27
7864670|NCT00886340|19355680|P2|STARTED|Overall Study||31
7864671|NCT00886340|19355681|P1|STARTED|Overall Study||27
7864672|NCT00886288|19355689|P2|NOT COMPLETED|Overall Study||227
7864673|NCT00886288|19355690|P1|NOT COMPLETED|Overall Study||743
7864674|NCT00886288|19355689|P2|COMPLETED|Overall Study||457
7864675|NCT00886288|19355690|P1|COMPLETED|Overall Study||1284
7864676|NCT00886288|19355689|P2|STARTED|Overall Study|Baseline Population|684
7864677|NCT00886288|19355690|P1|STARTED|Overall Study|Baseline Population|2027
7864678|NCT00886262|19355708|P2|NOT COMPLETED|Overall Study||3
7864679|NCT00886262|19355709|P1|NOT COMPLETED|Overall Study||0
7864680|NCT00886262|19355708|P2|COMPLETED|Overall Study||7
7864681|NCT00886262|19355709|P1|COMPLETED|Overall Study||8
7864682|NCT00886262|19355708|P2|STARTED|Overall Study||10
7864683|NCT00886262|19355709|P1|STARTED|Overall Study||8
7864684|NCT00886236|19355724|P3|NOT COMPLETED|Overall Study||4
7864685|NCT00886236|19355725|P2|NOT COMPLETED|Overall Study||4
7864686|NCT00886236|19355726|P1|NOT COMPLETED|Overall Study||2
7864687|NCT00886236|19355724|P3|COMPLETED|Overall Study||17
7864688|NCT00886236|19355725|P2|COMPLETED|Overall Study||17
7864689|NCT00886236|19355726|P1|COMPLETED|Overall Study||18
7864690|NCT00886236|19355724|P3|STARTED|Overall Study||21
7864691|NCT00886236|19355725|P2|STARTED|Overall Study||21
7864692|NCT00886236|19355726|P1|STARTED|Overall Study||20
7864693|NCT00886145|19355740|P1|NOT COMPLETED|Overall Study||0
7864694|NCT00886145|19355740|P1|COMPLETED|Overall Study||1
7864695|NCT00886145|19355740|P1|STARTED|Overall Study||1
7864696|NCT00886119|19355746|P2|NOT COMPLETED|Period 2||0
7864697|NCT00886119|19355747|P1|NOT COMPLETED|Period 2||0
7864698|NCT00886119|19355746|P2|COMPLETED|Period 2||22
7864699|NCT00886119|19355747|P1|COMPLETED|Period 2||23
7864700|NCT00886119|19355746|P2|STARTED|Period 2||22
7864701|NCT00886119|19355747|P1|STARTED|Period 2||23
7864702|NCT00886119|19355746|P2|NOT COMPLETED|Period 1||0
7864703|NCT00886119|19355747|P1|NOT COMPLETED|Period 1||1
7864704|NCT00886119|19355746|P2|COMPLETED|Period 1||22
7864705|NCT00886119|19355747|P1|COMPLETED|Period 1||23
7864706|NCT00886119|19355746|P2|STARTED|Period 1||22
7864707|NCT00886119|19355747|P1|STARTED|Period 1||24
7864708|NCT00886015|19355755|P2|NOT COMPLETED|Overall Study||2
7864709|NCT00886015|19355756|P1|NOT COMPLETED|Overall Study||0
7864710|NCT00886015|19355755|P2|COMPLETED|Overall Study|1669 eyes; 956 participants|1669
7864711|NCT00886015|19355756|P1|COMPLETED|Overall Study|1674 eyes; 960 participants|1674
7864712|NCT00886015|19355755|P2|STARTED|Overall Study|1671 eyes; 957 participants|1671
7864713|NCT00886015|19355756|P1|STARTED|Overall Study|1674 eyes; 960 participants|1674
7864714|NCT00885846|19355775|P3|NOT COMPLETED|Overall Study||2
7864715|NCT00885846|19355776|P2|NOT COMPLETED|Overall Study||5
7864716|NCT00885846|19355777|P1|NOT COMPLETED|Overall Study||2
7864717|NCT00885846|19355775|P3|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8
7864718|NCT00885846|19355776|P2|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6
7864719|NCT00885846|19355777|P1|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9
7864720|NCT00885846|19355775|P3|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10
7864721|NCT00885846|19355776|P2|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11
7864722|NCT00885846|19355777|P1|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11
7864723|NCT00885768|19355785|P1|NOT COMPLETED|Overall Study||0
7864724|NCT00885768|19355785|P1|COMPLETED|Overall Study|all patients with including criteria completed the study|146
7864725|NCT00885768|19355785|P1|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146
7864726|NCT00885755|19355792|P3|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
7864727|NCT00885755|19355793|P2|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
7864728|NCT00885755|19355794|P1|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5
7864729|NCT00885755|19355792|P3|COMPLETED|Part II: Trastuzumab + Capecitabine.||0
7864730|NCT00885755|19355793|P2|COMPLETED|Part II: Trastuzumab + Capecitabine.||1
7864731|NCT00885755|19355794|P1|COMPLETED|Part II: Trastuzumab + Capecitabine.||8
7864732|NCT00885755|19355792|P3|STARTED|Part II: Trastuzumab + Capecitabine.||0
7864733|NCT00885755|19355793|P2|STARTED|Part II: Trastuzumab + Capecitabine.||1
7864734|NCT00885755|19355794|P1|STARTED|Part II: Trastuzumab + Capecitabine.||13
7864735|NCT00885755|19355792|P3|NOT COMPLETED|Part I: Trastuzumab+Taxane||1
7864736|NCT00885755|19355793|P2|NOT COMPLETED|Part I: Trastuzumab+Taxane||0
7864737|NCT00885755|19355794|P1|NOT COMPLETED|Part I: Trastuzumab+Taxane||18
7864738|NCT00885755|19355792|P3|COMPLETED|Part I: Trastuzumab+Taxane||0
7864739|NCT00885755|19355793|P2|COMPLETED|Part I: Trastuzumab+Taxane||1
7864740|NCT00885755|19355794|P1|COMPLETED|Part I: Trastuzumab+Taxane||13
7864741|NCT00885755|19355792|P3|STARTED|Part I: Trastuzumab+Taxane||1
7864742|NCT00885755|19355793|P2|STARTED|Part I: Trastuzumab+Taxane||1
7864743|NCT00885755|19355794|P1|STARTED|Part I: Trastuzumab+Taxane||31
7864744|NCT00885742|19355819|P1|NOT COMPLETED|Overall Study||0
7864745|NCT00885742|19355819|P1|COMPLETED|Overall Study||41
7864746|NCT00885742|19355819|P1|STARTED|Overall Study||41
7864747|NCT00885703|19355837|P7|NOT COMPLETED|Overall Study||6
7864748|NCT00885703|19355838|P6|NOT COMPLETED|Overall Study||13
7864749|NCT00885703|19355839|P5|NOT COMPLETED|Overall Study||12
7864750|NCT00885703|19355840|P4|NOT COMPLETED|Overall Study||9
7864751|NCT00885703|19355841|P3|NOT COMPLETED|Overall Study||11
7864752|NCT00885703|19355842|P2|NOT COMPLETED|Overall Study||10
7864753|NCT00885703|19355843|P1|NOT COMPLETED|Overall Study||10
7864754|NCT00885703|19355837|P7|COMPLETED|Overall Study||18
7864755|NCT00885703|19355838|P6|COMPLETED|Overall Study||11
7864756|NCT00885703|19355839|P5|COMPLETED|Overall Study||12
7864757|NCT00885703|19355840|P4|COMPLETED|Overall Study||15
7864758|NCT00885703|19355841|P3|COMPLETED|Overall Study||13
7864759|NCT00885703|19355842|P2|COMPLETED|Overall Study||16
7864760|NCT00885703|19355843|P1|COMPLETED|Overall Study||12
7864761|NCT00885703|19355837|P7|STARTED|Overall Study||24
7864762|NCT00885703|19355838|P6|STARTED|Overall Study||24
7864763|NCT00885703|19355839|P5|STARTED|Overall Study||24
7864764|NCT00885703|19355840|P4|STARTED|Overall Study||24
7864765|NCT00885703|19355841|P3|STARTED|Overall Study||24
7864766|NCT00885703|19355842|P2|STARTED|Overall Study||26
7864767|NCT00885703|19355843|P1|STARTED|Overall Study||22
7864768|NCT00885677|19355901|P2|NOT COMPLETED|Overall Study||178
7864769|NCT00885677|19355902|P1|NOT COMPLETED|Overall Study||183
7864770|NCT00885677|19355901|P2|COMPLETED|Overall Study||277
7864771|NCT00885677|19355902|P1|COMPLETED|Overall Study||279
7864772|NCT00885677|19355901|P2|Intention To Treat|Overall Study||428
7864773|NCT00885677|19355902|P1|Intention To Treat|Overall Study||437
7864774|NCT00885677|19355901|P2|STARTED|Overall Study||455
7864775|NCT00885677|19355902|P1|STARTED|Overall Study||462
7864776|NCT00885638|19355910|P2|NOT COMPLETED|Overall Study||0
7864777|NCT00885638|19355911|P1|NOT COMPLETED|Overall Study||0
7864778|NCT00885638|19355910|P2|COMPLETED|Overall Study||6
7864779|NCT00885638|19355911|P1|COMPLETED|Overall Study||6
7864780|NCT00885638|19355910|P2|STARTED|Overall Study||6
7864781|NCT00885638|19355911|P1|STARTED|Overall Study||6
7864782|NCT00885534|19355918|P1|NOT COMPLETED|Overall Study||1
7864783|NCT00885534|19355918|P1|COMPLETED|Overall Study||6
7864784|NCT00885534|19355918|P1|STARTED|Overall Study||7
7864785|NCT00885482|19355922|P1|NOT COMPLETED|Overall Study||4
7864786|NCT00885482|19355922|P1|COMPLETED|Overall Study||36
7864787|NCT00885482|19355922|P1|STARTED|Overall Study||40
7864788|NCT00885378|19355928|P2|NOT COMPLETED|Overall Study||8
7864789|NCT00885378|19355929|P1|NOT COMPLETED|Overall Study||8
7864790|NCT00885378|19355928|P2|COMPLETED|Overall Study||78
7864791|NCT00885378|19355929|P1|COMPLETED|Overall Study||66
7864792|NCT00885378|19355928|P2|STARTED|Overall Study|Number randomized.|86
7864793|NCT00885378|19355929|P1|STARTED|Overall Study|Number randomized.|74
7864794|NCT00885365|19355959|P2|NOT COMPLETED|4 Weeks OFF Treatment||0
7864795|NCT00885365|19355960|P1|NOT COMPLETED|4 Weeks OFF Treatment||0
7864796|NCT00885365|19355959|P2|COMPLETED|4 Weeks OFF Treatment||159
7864797|NCT00885365|19355960|P1|COMPLETED|4 Weeks OFF Treatment||155
7864798|NCT00885365|19355959|P2|STARTED|4 Weeks OFF Treatment||159
7864799|NCT00885365|19355960|P1|STARTED|4 Weeks OFF Treatment||155
7864800|NCT00885365|19355959|P2|NOT COMPLETED|4 Weeks ON Treatment||6
7864801|NCT00885365|19355960|P1|NOT COMPLETED|4 Weeks ON Treatment||4
7864802|NCT00885365|19355959|P2|COMPLETED|4 Weeks ON Treatment||159
7864803|NCT00885365|19355960|P1|COMPLETED|4 Weeks ON Treatment||155
7864804|NCT00885365|19355959|P2|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168
7864805|NCT00885365|19355960|P1|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156
7864806|NCT00885365|19355959|P2|Intent-to-Treat Population|4 Weeks ON Treatment||163
7864807|NCT00885365|19355960|P1|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158
7864808|NCT00885365|19355959|P2|STARTED|4 Weeks ON Treatment||165
7864809|NCT00885365|19355960|P1|STARTED|4 Weeks ON Treatment||159
7864810|NCT00885352|19355996|P2|NOT COMPLETED|Overall Study||20
7864811|NCT00885352|19355997|P1|NOT COMPLETED|Overall Study||8
7864812|NCT00885352|19355996|P2|COMPLETED|Overall Study||136
7864813|NCT00885352|19355997|P1|COMPLETED|Overall Study||149
7864814|NCT00885352|19355996|P2|STARTED|Overall Study||156
7864815|NCT00885352|19355997|P1|STARTED|Overall Study||157
7864816|NCT00885170|19356009|P2|NOT COMPLETED|Overall Study||23
7864817|NCT00885170|19356010|P1|NOT COMPLETED|Overall Study||38
7864818|NCT00885170|19356009|P2|COMPLETED|Overall Study||99
7864819|NCT00885170|19356010|P1|COMPLETED|Overall Study||86
7864820|NCT00885170|19356009|P2|Treated|Overall Study||121
7864821|NCT00885170|19356010|P1|Treated|Overall Study||122
7864822|NCT00885170|19356009|P2|STARTED|Overall Study||122
7864823|NCT00885170|19356010|P1|STARTED|Overall Study||124
7864824|NCT00885118|19356069|P5|NOT COMPLETED|Overall Study||1
7864825|NCT00885118|19356070|P4|NOT COMPLETED|Overall Study||0
7864826|NCT00885118|19356071|P3|NOT COMPLETED|Overall Study||1
7864827|NCT00885118|19356072|P2|NOT COMPLETED|Overall Study||0
7864828|NCT00885118|19356073|P1|NOT COMPLETED|Overall Study||1
7864829|NCT00885118|19356069|P5|COMPLETED|Overall Study||18
7864830|NCT00885118|19356070|P4|COMPLETED|Overall Study||20
7864831|NCT00885118|19356071|P3|COMPLETED|Overall Study||20
7864832|NCT00885118|19356072|P2|COMPLETED|Overall Study||19
7864833|NCT00885118|19356073|P1|COMPLETED|Overall Study||20
7864834|NCT00885118|19356069|P5|STARTED|Overall Study||19
7864835|NCT00885118|19356070|P4|STARTED|Overall Study||20
7864836|NCT00885118|19356071|P3|STARTED|Overall Study||21
7864837|NCT00885118|19356072|P2|STARTED|Overall Study||19
7864838|NCT00885118|19356073|P1|STARTED|Overall Study||21
7864839|NCT00885105|19356212|P2|NOT COMPLETED|Overall Study||10
7864840|NCT00885105|19356213|P1|NOT COMPLETED|Overall Study||1
7864841|NCT00885105|19356212|P2|COMPLETED|Overall Study||120
7864842|NCT00885105|19356213|P1|COMPLETED|Overall Study||111
7864843|NCT00885105|19356212|P2|STARTED|Overall Study||130
7864844|NCT00885105|19356213|P1|STARTED|Overall Study||112
7864845|NCT00885092|19356231|P2|NOT COMPLETED|Period 2, 7 Days||0
7864846|NCT00885092|19356232|P1|NOT COMPLETED|Period 2, 7 Days||0
7864847|NCT00885092|19356231|P2|COMPLETED|Period 2, 7 Days||20
7864848|NCT00885092|19356232|P1|COMPLETED|Period 2, 7 Days||20
7864849|NCT00885092|19356231|P2|STARTED|Period 2, 7 Days||20
7864850|NCT00885092|19356232|P1|STARTED|Period 2, 7 Days||20
7864851|NCT00885092|19356231|P2|NOT COMPLETED|Period 1, 7 Days||0
7864852|NCT00885092|19356232|P1|NOT COMPLETED|Period 1, 7 Days||0
7864853|NCT00885092|19356231|P2|COMPLETED|Period 1, 7 Days||20
7864854|NCT00885092|19356232|P1|COMPLETED|Period 1, 7 Days||20
7864855|NCT00885092|19356231|P2|STARTED|Period 1, 7 Days||20
7864856|NCT00885092|19356232|P1|STARTED|Period 1, 7 Days||20
7864857|NCT00885079|19356244|P2|NOT COMPLETED|Overall Study||4
7864858|NCT00885079|19356245|P1|NOT COMPLETED|Overall Study||2
7864859|NCT00885079|19356244|P2|COMPLETED|Overall Study||91
7864860|NCT00885079|19356245|P1|COMPLETED|Overall Study||91
7864861|NCT00885079|19356244|P2|STARTED|Overall Study||95
7864862|NCT00885079|19356245|P1|STARTED|Overall Study||93
7864863|NCT00884949|19356253|P1|NOT COMPLETED|Continuation Period||0
7864864|NCT00884949|19356253|P1|COMPLETED|Continuation Period||18
7864865|NCT00884949|19356253|P1|STARTED|Continuation Period||18
7864866|NCT00884949|19356253|P1|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0
7864867|NCT00884949|19356253|P1|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18
7864868|NCT00884949|19356253|P1|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18
7864869|NCT00884949|19356253|P1|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0
7864870|NCT00884949|19356253|P1|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18
7864871|NCT00884949|19356253|P1|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18
7864872|NCT00884949|19356253|P1|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2
7864873|NCT00884949|19356253|P1|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18
7864874|NCT00884949|19356253|P1|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20
7864875|NCT00884910|19356270|P1|NOT COMPLETED|Overall Study||1
7864876|NCT00884910|19356270|P1|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32
7864877|NCT00884910|19356270|P1|STARTED|Overall Study||33
7864878|NCT00884897|19356277|P2|NOT COMPLETED|Overall Study||0
7864879|NCT00884897|19356278|P1|NOT COMPLETED|Overall Study||0
7864880|NCT00884897|19356277|P2|COMPLETED|Overall Study||15
7864881|NCT00884897|19356278|P1|COMPLETED|Overall Study||13
7864882|NCT00884897|19356277|P2|STARTED|Overall Study||15
7864883|NCT00884897|19356278|P1|STARTED|Overall Study||13
7864884|NCT00884832|19356288|P2|NOT COMPLETED|Overall Study||1
7864885|NCT00884832|19356289|P1|NOT COMPLETED|Overall Study||0
7864886|NCT00884832|19356288|P2|COMPLETED|Overall Study||21
7864887|NCT00884832|19356289|P1|COMPLETED|Overall Study||22
7864888|NCT00884832|19356288|P2|STARTED|Overall Study||22
7864889|NCT00884832|19356289|P1|STARTED|Overall Study||22
7864890|NCT00884806|19356319|P1|NOT COMPLETED|Overall Study||0
7864891|NCT00884806|19356319|P1|COMPLETED|Overall Study||110
7864892|NCT00884806|19356319|P1|STARTED|Overall Study||110
7864893|NCT00884793|19356324|P1|NOT COMPLETED|Overall Study||1
7864894|NCT00884793|19356324|P1|COMPLETED|Overall Study||7
7864895|NCT00884793|19356324|P1|STARTED|Overall Study||8
7864896|NCT00884754|19356333|P2|NOT COMPLETED|Overall Study||0
7864897|NCT00884754|19356334|P1|NOT COMPLETED|Overall Study||0
7864898|NCT00884754|19356333|P2|COMPLETED|Overall Study||30
7864899|NCT00884754|19356334|P1|COMPLETED|Overall Study||30
7864900|NCT00884754|19356333|P2|STARTED|Overall Study||30
7864901|NCT00884754|19356334|P1|STARTED|Overall Study||30
7864902|NCT00884741|19356343|P4|NOT COMPLETED|Randomization||8
7864903|NCT00884741|19356344|P3|NOT COMPLETED|Randomization||8
7864904|NCT00884741|19356345|P2|NOT COMPLETED|Randomization||0
7864905|NCT00884741|19356346|P1|NOT COMPLETED|Randomization||0
7864906|NCT00884741|19356343|P4|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312
7864907|NCT00884741|19356344|P3|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309
7864908|NCT00884741|19356345|P2|COMPLETED|Randomization||0
7864909|NCT00884741|19356346|P1|COMPLETED|Randomization||0
7864910|NCT00884741|19356343|P4|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320
7864911|NCT00884741|19356344|P3|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317
7864912|NCT00884741|19356345|P2|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0
7864913|NCT00884741|19356346|P1|STARTED|Randomization||0
7864914|NCT00884741|19356343|P4|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
7864915|NCT00884741|19356344|P3|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
7864916|NCT00884741|19356345|P2|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29
7864917|NCT00884741|19356346|P1|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
7864918|NCT00884741|19356343|P4|COMPLETED|Step 2 Registration: Tissue Analysis||0
7864919|NCT00884741|19356344|P3|COMPLETED|Step 2 Registration: Tissue Analysis||0
7864920|NCT00884741|19356345|P2|COMPLETED|Step 2 Registration: Tissue Analysis||637
7864921|NCT00884741|19356346|P1|COMPLETED|Step 2 Registration: Tissue Analysis||0
7864922|NCT00884741|19356343|P4|STARTED|Step 2 Registration: Tissue Analysis||0
7864923|NCT00884741|19356344|P3|STARTED|Step 2 Registration: Tissue Analysis||0
7864924|NCT00884741|19356345|P2|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666
7864925|NCT00884741|19356346|P1|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0
7864926|NCT00884741|19356343|P4|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
7864927|NCT00884741|19356344|P3|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
7864928|NCT00884741|19356345|P2|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
7864929|NCT00884741|19356346|P1|NOT COMPLETED|Step 1 Registration: Tissue Screening||312
7864930|NCT00884741|19356343|P4|COMPLETED|Step 1 Registration: Tissue Screening||0
7864931|NCT00884741|19356344|P3|COMPLETED|Step 1 Registration: Tissue Screening||0
7864932|NCT00884741|19356345|P2|COMPLETED|Step 1 Registration: Tissue Screening||0
7864933|NCT00884741|19356346|P1|COMPLETED|Step 1 Registration: Tissue Screening||666
7864934|NCT00884741|19356343|P4|STARTED|Step 1 Registration: Tissue Screening||0
7864935|NCT00884741|19356344|P3|STARTED|Step 1 Registration: Tissue Screening||0
7864936|NCT00884741|19356345|P2|STARTED|Step 1 Registration: Tissue Screening||0
7864937|NCT00884741|19356346|P1|STARTED|Step 1 Registration: Tissue Screening||978
7864938|NCT00884611|19356357|P1|NOT COMPLETED|Overall Study||1
7864939|NCT00884611|19356357|P1|COMPLETED|Overall Study||19
7864940|NCT00884611|19356357|P1|Enrolled, Not Treated|Overall Study||1
7864941|NCT00884611|19356357|P1|STARTED|Overall Study||20
7864942|NCT00884585|19356381|P2|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0
7864943|NCT00884585|19356382|P1|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3
7864944|NCT00884585|19356381|P2|COMPLETED|Open-Label Maintenance (Months 9-12)||0
7864945|NCT00884585|19356382|P1|COMPLETED|Open-Label Maintenance (Months 9-12)||144
7864946|NCT00884585|19356381|P2|STARTED|Open-Label Maintenance (Months 9-12)||0
7864947|NCT00884585|19356382|P1|STARTED|Open-Label Maintenance (Months 9-12)||147
7864948|NCT00884585|19356381|P2|NOT COMPLETED|Open-Label Phase (Months 3-9)||0
7864949|NCT00884585|19356382|P1|NOT COMPLETED|Open-Label Phase (Months 3-9)||15
7864950|NCT00884585|19356381|P2|COMPLETED|Open-Label Phase (Months 3-9)||0
7864951|NCT00884585|19356382|P1|COMPLETED|Open-Label Phase (Months 3-9)||147
7864952|NCT00884585|19356381|P2|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0
7864953|NCT00884585|19356382|P1|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162
7864954|NCT00884585|19356381|P2|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4
7864955|NCT00884585|19356382|P1|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10
7864956|NCT00884585|19356381|P2|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83
7864957|NCT00884585|19356382|P1|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79
7864958|NCT00884585|19356381|P2|STARTED|Double-Masked Phase (Day 1-Month 3)||87
7864959|NCT00884585|19356382|P1|STARTED|Double-Masked Phase (Day 1-Month 3)||89
7864960|NCT00884390|19356396|P2|NOT COMPLETED|Overall Study||8
7864961|NCT00884390|19356397|P1|NOT COMPLETED|Overall Study||23
7864962|NCT00884390|19356396|P2|COMPLETED|Overall Study||54
7864963|NCT00884390|19356397|P1|COMPLETED|Overall Study||123
7864964|NCT00884390|19356396|P2|STARTED|Overall Study||62
7864965|NCT00884390|19356397|P1|STARTED|Overall Study||146
7864966|NCT00884377|19356415|P2|NOT COMPLETED|Overall Study||1
7864967|NCT00884377|19356416|P1|NOT COMPLETED|Overall Study||2
7864968|NCT00884377|19356415|P2|COMPLETED|Overall Study||27
7864969|NCT00884377|19356416|P1|COMPLETED|Overall Study|1 received full course of therapy,withdrew consent before completion of the 12 month follow up|26
7864970|NCT00884377|19356415|P2|STARTED|Overall Study|1 was not treated due to concerns arising from the location of cutaneous leishmaniasis lesion|28
7864971|NCT00884377|19356416|P1|STARTED|Overall Study|1 not treated because infecting parasite could not be confirmed as L. major on rapid PCR testing,|28
7864972|NCT00884325|19356438|P2|NOT COMPLETED|Overall Study||4
7864973|NCT00884325|19356439|P1|NOT COMPLETED|Overall Study||3
7864974|NCT00884325|19356438|P2|COMPLETED|Overall Study||16
7864975|NCT00884325|19356439|P1|COMPLETED|Overall Study||17
7864976|NCT00884325|19356438|P2|STARTED|Overall Study||20
7864977|NCT00884325|19356439|P1|STARTED|Overall Study||20
7864978|NCT00884312|19356449|P2|NOT COMPLETED|Overall Study||25
7864979|NCT00884312|19356450|P1|NOT COMPLETED|Overall Study||2
7864980|NCT00884312|19356449|P2|COMPLETED|Overall Study||67
7864981|NCT00884312|19356450|P1|COMPLETED|Overall Study||7
7864982|NCT00884312|19356449|P2|Received Treatment|Overall Study||91
7864983|NCT00884312|19356450|P1|Received Treatment|Overall Study||9
7864984|NCT00884312|19356449|P2|STARTED|Overall Study||92
7864985|NCT00884312|19356450|P1|STARTED|Overall Study||9
7864986|NCT00884286|19356466|P2|NOT COMPLETED|Overall Study||33
7864987|NCT00884286|19356467|P1|NOT COMPLETED|Overall Study||32
7864988|NCT00884286|19356466|P2|COMPLETED|Overall Study||0
7864989|NCT00884286|19356467|P1|COMPLETED|Overall Study||2
7864990|NCT00884286|19356466|P2|STARTED|Overall Study||33
7864991|NCT00884286|19356467|P1|STARTED|Overall Study||34
7864992|NCT00884273|19356481|P2|NOT COMPLETED|Overall Study||5
7864993|NCT00884273|19356482|P1|NOT COMPLETED|Overall Study||2
7864994|NCT00884273|19356481|P2|COMPLETED|Overall Study||93
7864995|NCT00884273|19356482|P1|COMPLETED|Overall Study||82
7864996|NCT00884273|19356481|P2|Safety Analysis Set|Overall Study||98
7864997|NCT00884273|19356482|P1|Safety Analysis Set|Overall Study||84
7864998|NCT00884273|19356481|P2|Per Protocol (PP) Analysis Set|Overall Study||92
7864999|NCT00884273|19356482|P1|Per Protocol (PP) Analysis Set|Overall Study||81
7865000|NCT00884273|19356481|P2|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97
7865001|NCT00884273|19356482|P1|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82
7865002|NCT00884273|19356481|P2|STARTED|Overall Study|ITT population.|98
7865003|NCT00884273|19356482|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|84
7865004|NCT00884221|19356508|P2|NOT COMPLETED|Overall Study||32
7865005|NCT00884221|19356509|P1|NOT COMPLETED|Overall Study||34
7865006|NCT00884221|19356508|P2|COMPLETED|Overall Study||343
7865007|NCT00884221|19356509|P1|COMPLETED|Overall Study||340
7865008|NCT00884221|19356508|P2|STARTED|Overall Study||375
7865009|NCT00884221|19356509|P1|STARTED|Overall Study||374
7865010|NCT00884117|19356545|P1|NOT COMPLETED|Overall Study||249
7865011|NCT00884117|19356545|P1|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312
7865012|NCT00884117|19356545|P1|STARTED|Overall Study||4561
7865013|NCT00884065|19356589|P2|NOT COMPLETED|Overall Study||0
7865014|NCT00884065|19356590|P1|NOT COMPLETED|Overall Study||0
7865015|NCT00884065|19356589|P2|COMPLETED|Overall Study||25
7865016|NCT00884065|19356590|P1|COMPLETED|Overall Study||25
7865017|NCT00884065|19356589|P2|STARTED|Overall Study||25
7865018|NCT00884065|19356590|P1|STARTED|Overall Study||25
7865019|NCT00884052|19356606|P2|NOT COMPLETED|Overall Study||0
7865020|NCT00884052|19356607|P1|NOT COMPLETED|Overall Study||0
7865021|NCT00884052|19356606|P2|COMPLETED|Overall Study||12
7865022|NCT00884052|19356607|P1|COMPLETED|Overall Study||6
7865023|NCT00884052|19356606|P2|STARTED|Overall Study||12
7865024|NCT00884052|19356607|P1|STARTED|Overall Study||6
7865025|NCT00884039|19356616|P2|NOT COMPLETED|Overall Study||1
7865026|NCT00884039|19356617|P1|NOT COMPLETED|Overall Study||2
7865027|NCT00884039|19356616|P2|COMPLETED|Overall Study||1
7865028|NCT00884039|19356617|P1|COMPLETED|Overall Study||3
7865029|NCT00884039|19356616|P2|STARTED|Overall Study||2
7865030|NCT00884039|19356617|P1|STARTED|Overall Study||5
7865031|NCT00883779|19356625|P2|NOT COMPLETED|Off-study Phase||202
7865032|NCT00883779|19356626|P1|NOT COMPLETED|Off-study Phase||209
7865033|NCT00883779|19356625|P2|COMPLETED|Off-study Phase||0
7865034|NCT00883779|19356626|P1|COMPLETED|Off-study Phase||0
7865035|NCT00883779|19356625|P2|STARTED|Off-study Phase||202
7865036|NCT00883779|19356626|P1|STARTED|Off-study Phase||209
7865037|NCT00883779|19356625|P2|NOT COMPLETED|Post-Study Treatment Phase||135
7865038|NCT00883779|19356626|P1|NOT COMPLETED|Post-Study Treatment Phase||112
7865039|NCT00883779|19356625|P2|COMPLETED|Post-Study Treatment Phase||0
7865040|NCT00883779|19356626|P1|COMPLETED|Post-Study Treatment Phase||0
7865041|NCT00883779|19356625|P2|STARTED|Post-Study Treatment Phase||135
7865042|NCT00883779|19356626|P1|STARTED|Post-Study Treatment Phase||112
7865043|NCT00883779|19356625|P2|NOT COMPLETED|Primary Study Treatment Phase||86
7865044|NCT00883779|19356626|P1|NOT COMPLETED|Primary Study Treatment Phase||105
7865045|NCT00883779|19356625|P2|COMPLETED|Primary Study Treatment Phase||140
7865046|NCT00883779|19356626|P1|COMPLETED|Primary Study Treatment Phase||120
7865047|NCT00883779|19356625|P2|STARTED|Primary Study Treatment Phase||226
7865048|NCT00883779|19356626|P1|STARTED|Primary Study Treatment Phase||225
7865049|NCT00883753|19356662|P1|NOT COMPLETED|Overall Study||107
7865050|NCT00883753|19356662|P1|COMPLETED|Overall Study||827
7865051|NCT00883753|19356662|P1|STARTED|Overall Study||934
7865052|NCT00883740|19356702|P2|NOT COMPLETED|Second Intervention||1
7865053|NCT00883740|19356703|P1|NOT COMPLETED|Second Intervention||1
7865054|NCT00883740|19356702|P2|COMPLETED|Second Intervention||50
7865055|NCT00883740|19356703|P1|COMPLETED|Second Intervention||52
7865056|NCT00883740|19356702|P2|STARTED|Second Intervention||51
7865057|NCT00883740|19356703|P1|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
7865058|NCT00883740|19356702|P2|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
7865059|NCT00883740|19356703|P1|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
7865060|NCT00883740|19356702|P2|COMPLETED|Taper and Washout Period (2 Weeks)||51
7865061|NCT00883740|19356703|P1|COMPLETED|Taper and Washout Period (2 Weeks)||54
7865062|NCT00883740|19356702|P2|STARTED|Taper and Washout Period (2 Weeks)||51
7865063|NCT00883740|19356703|P1|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54
7865064|NCT00883740|19356702|P2|NOT COMPLETED|First Intervention||8
7865065|NCT00883740|19356703|P1|NOT COMPLETED|First Intervention||7
7865066|NCT00883740|19356702|P2|COMPLETED|First Intervention||51
7865067|NCT00883740|19356703|P1|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
7865068|NCT00883740|19356702|P2|STARTED|First Intervention||59
7865069|NCT00883740|19356703|P1|STARTED|First Intervention||60
7865070|NCT00883688|19356743|P1|NOT COMPLETED|Overall Study||2
7865071|NCT00883688|19356743|P1|COMPLETED|Overall Study||22
7865072|NCT00883688|19356743|P1|STARTED|Overall Study||24
7865073|NCT00883675|19356747|P1|NOT COMPLETED|Overall Study||0
7865074|NCT00883675|19356747|P1|COMPLETED|Overall Study||133
7865075|NCT00883675|19356747|P1|STARTED|Overall Study||133
7865076|NCT00883558|19356751|P3|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1
7865077|NCT00883558|19356752|P2|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
7865078|NCT00883558|19356753|P1|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
7865079|NCT00883558|19356751|P3|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22
7865080|NCT00883558|19356752|P2|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19
7865081|NCT00883558|19356753|P1|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
7865082|NCT00883558|19356751|P3|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23
7865083|NCT00883558|19356752|P2|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19
7865084|NCT00883558|19356753|P1|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0
7865085|NCT00883558|19356751|P3|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23
7865086|NCT00883558|19356752|P2|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19
7865087|NCT00883558|19356753|P1|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0
7865088|NCT00883558|19356751|P3|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1
7865089|NCT00883558|19356752|P2|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3
7865090|NCT00883558|19356753|P1|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
7865091|NCT00883558|19356751|P3|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23
7865092|NCT00883558|19356752|P2|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19
7865093|NCT00883558|19356753|P1|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
7865094|NCT00883558|19356751|P3|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24
7865095|NCT00883558|19356752|P2|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22
7865096|NCT00883558|19356753|P1|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0
7865097|NCT00883558|19356751|P3|STARTED|First Treatment Cycle (Weeks 4 to 16)||24
7865098|NCT00883558|19356752|P2|STARTED|First Treatment Cycle (Weeks 4 to 16)||22
7865099|NCT00883558|19356753|P1|STARTED|First Treatment Cycle (Weeks 4 to 16)||0
7865100|NCT00883558|19356751|P3|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
7865101|NCT00883558|19356752|P2|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
7865102|NCT00883558|19356753|P1|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2
7865103|NCT00883558|19356751|P3|COMPLETED|Titration Period (Weeks 0 to 4)||0
7865104|NCT00883558|19356752|P2|COMPLETED|Titration Period (Weeks 0 to 4)||0
7865105|NCT00883558|19356753|P1|COMPLETED|Titration Period (Weeks 0 to 4)||46
7865106|NCT00883558|19356751|P3|STARTED|Titration Period (Weeks 0 to 4)||0
7865107|NCT00883558|19356752|P2|STARTED|Titration Period (Weeks 0 to 4)||0
7865108|NCT00883558|19356753|P1|STARTED|Titration Period (Weeks 0 to 4)||48
7865109|NCT00883493|19356765|P2|NOT COMPLETED|Overall Study||50
7865110|NCT00883493|19356766|P1|NOT COMPLETED|Overall Study||46
7865111|NCT00883493|19356765|P2|COMPLETED|Overall Study||159
7865112|NCT00883493|19356766|P1|COMPLETED|Overall Study||166
7865113|NCT00883493|19356765|P2|Per Protocol Analysis Population|Overall Study||155
7865114|NCT00883493|19356766|P1|Per Protocol Analysis Population|Overall Study||162
7865115|NCT00883493|19356765|P2|Intention To Treat Analysis Population|Overall Study||195
7865116|NCT00883493|19356766|P1|Intention To Treat Analysis Population|Overall Study||204
7865117|NCT00883493|19356765|P2|STARTED|Overall Study||209
7865118|NCT00883493|19356766|P1|STARTED|Overall Study||212
7865119|NCT00883415|19356790|P1|NOT COMPLETED|Overall Study||2
7865120|NCT00883415|19356790|P1|COMPLETED|Overall Study||18
7865121|NCT00883415|19356790|P1|STARTED|Overall Study||20
7865122|NCT00883389|19356794|P1|NOT COMPLETED|Overall Study||0
7865123|NCT00883389|19356794|P1|COMPLETED|Overall Study||26
7865124|NCT00883389|19356794|P1|STARTED|Overall Study||26
7865125|NCT00883337|19356801|P3|NOT COMPLETED|Extension Treatment Period||19
7865126|NCT00883337|19356802|P2|NOT COMPLETED|Extension Treatment Period||23
7865127|NCT00883337|19356803|P1|NOT COMPLETED|Extension Treatment Period||28
7865128|NCT00883337|19356801|P3|COMPLETED|Extension Treatment Period||40
7865129|NCT00883337|19356802|P2|COMPLETED|Extension Treatment Period||66
7865130|NCT00883337|19356803|P1|COMPLETED|Extension Treatment Period||61
7865131|NCT00883337|19356801|P3|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59
7865132|NCT00883337|19356802|P2|STARTED|Extension Treatment Period||89
7865133|NCT00883337|19356803|P1|STARTED|Extension Treatment Period||89
7865134|NCT00883337|19356801|P3|NOT COMPLETED|Core Treatment Period||33
7865135|NCT00883337|19356802|P2|NOT COMPLETED|Core Treatment Period||22
7865136|NCT00883337|19356803|P1|NOT COMPLETED|Core Treatment Period||20
7865137|NCT00883337|19356801|P3|COMPLETED|Core Treatment Period||71
7865138|NCT00883337|19356802|P2|COMPLETED|Core Treatment Period||89
7865139|NCT00883337|19356803|P1|COMPLETED|Core Treatment Period||89
7865140|NCT00883337|19356801|P3|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101
7865141|NCT00883337|19356802|P2|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111
7865142|NCT00883337|19356803|P1|Treated|Core Treatment Period||109
7865143|NCT00883337|19356801|P3|STARTED|Core Treatment Period||104
7865144|NCT00883337|19356802|P2|STARTED|Core Treatment Period||111
7865145|NCT00883337|19356803|P1|STARTED|Core Treatment Period||109
7865146|NCT00883246|19356835|P1|NOT COMPLETED|Overall Study||173
7865147|NCT00883246|19356835|P1|COMPLETED|Overall Study||626
7865148|NCT00883246|19356835|P1|STARTED|Overall Study||799
7865149|NCT00883233|19356857|P4|NOT COMPLETED|Overall Study||5
7865150|NCT00883233|19356858|P3|NOT COMPLETED|Overall Study||4
7865151|NCT00883233|19356859|P2|NOT COMPLETED|Overall Study||4
7865152|NCT00883233|19356860|P1|NOT COMPLETED|Overall Study||5
7865153|NCT00883233|19356857|P4|COMPLETED|Overall Study||25
7865154|NCT00883233|19356858|P3|COMPLETED|Overall Study||25
7865155|NCT00883233|19356859|P2|COMPLETED|Overall Study||28
7865156|NCT00883233|19356860|P1|COMPLETED|Overall Study||27
7865157|NCT00883233|19356857|P4|STARTED|Overall Study||30
7865158|NCT00883233|19356858|P3|STARTED|Overall Study||29
7865159|NCT00883233|19356859|P2|STARTED|Overall Study||32
7865160|NCT00883233|19356860|P1|STARTED|Overall Study||32
7865161|NCT00883181|19356870|P1|NOT COMPLETED|Overall Study||278
7865162|NCT00883181|19356870|P1|COMPLETED|Overall Study|Completed planned chemotherapy|1069
7865163|NCT00883181|19356870|P1|STARTED|Overall Study|Full analysis set|1347
7865164|NCT00883168|19357083|P4|NOT COMPLETED|Overall Study||15
7865165|NCT00883168|19357084|P3|NOT COMPLETED|Overall Study||19
7865166|NCT00883168|19357085|P2|NOT COMPLETED|Overall Study||15
7865167|NCT00883168|19357086|P1|NOT COMPLETED|Overall Study||14
7865168|NCT00883168|19357083|P4|COMPLETED|Overall Study||433
7865169|NCT00883168|19357084|P3|COMPLETED|Overall Study||431
7865170|NCT00883168|19357085|P2|COMPLETED|Overall Study||430
7865171|NCT00883168|19357086|P1|COMPLETED|Overall Study||434
7865172|NCT00883168|19357083|P4|STARTED|Overall Study||448
7865173|NCT00883168|19357084|P3|STARTED|Overall Study||450
7865174|NCT00883168|19357085|P2|STARTED|Overall Study||445
7865175|NCT00883168|19357086|P1|STARTED|Overall Study||448
7865176|NCT00883129|19357106|P2|NOT COMPLETED|Overall Study||36
7865177|NCT00883129|19357107|P1|NOT COMPLETED|Overall Study||20
7865178|NCT00883129|19357106|P2|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37
7865179|NCT00883129|19357107|P1|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49
7865180|NCT00883129|19357106|P2|STARTED|Overall Study||73
7865181|NCT00883129|19357107|P1|STARTED|Overall Study||69
7865182|NCT00883116|19357131|P2|NOT COMPLETED|Overall Study||219
7865183|NCT00883116|19357132|P1|NOT COMPLETED|Overall Study||209
7865184|NCT00883116|19357131|P2|COMPLETED|Overall Study||29
7865185|NCT00883116|19357132|P1|COMPLETED|Overall Study||39
7865186|NCT00883116|19357131|P2|Received Treatment|Overall Study||239
7865187|NCT00883116|19357132|P1|Received Treatment|Overall Study||248
7865188|NCT00883116|19357131|P2|STARTED|Overall Study||248
7865189|NCT00883116|19357132|P1|STARTED|Overall Study||248
7865190|NCT00883103|19357147|P2|NOT COMPLETED|Overall Study||0
7865191|NCT00883103|19357148|P1|NOT COMPLETED|Overall Study||0
7865192|NCT00883103|19357147|P2|COMPLETED|Overall Study||68
7865193|NCT00883103|19357148|P1|COMPLETED|Overall Study||69
7865194|NCT00883103|19357147|P2|STARTED|Overall Study||68
7865195|NCT00883103|19357148|P1|STARTED|Overall Study||69
7865196|NCT00883090|19357154|P1|NOT COMPLETED|Overall Study||2
7865197|NCT00883090|19357154|P1|COMPLETED|Overall Study||13
7865198|NCT00883090|19357154|P1|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15
7865199|NCT00883051|19357174|P5|NOT COMPLETED|Overall Study||18
7865200|NCT00883051|19357175|P4|NOT COMPLETED|Overall Study||29
7865201|NCT00883051|19357176|P3|NOT COMPLETED|Overall Study||29
7865202|NCT00883051|19357177|P2|NOT COMPLETED|Overall Study||22
7865203|NCT00883051|19357178|P1|NOT COMPLETED|Overall Study||24
7865204|NCT00883051|19357174|P5|COMPLETED|Overall Study|One participant was lost to follow up and did not provide adverse event data.|85
7865205|NCT00883051|19357175|P4|COMPLETED|Overall Study||70
7865206|NCT00883051|19357176|P3|COMPLETED|Overall Study||71
7865207|NCT00883051|19357177|P2|COMPLETED|Overall Study||82
7865208|NCT00883051|19357178|P1|COMPLETED|Overall Study||82
7865209|NCT00883051|19357174|P5|Received at Least 1 Dose of Study Drug|Overall Study||86
7865210|NCT00883051|19357175|P4|Received at Least 1 Dose of Study Drug|Overall Study||70
7865211|NCT00883051|19357176|P3|Received at Least 1 Dose of Study Drug|Overall Study||71
7865212|NCT00883051|19357177|P2|Received at Least 1 Dose of Study Drug|Overall Study||82
7865213|NCT00883051|19357178|P1|Received at Least 1 Dose of Study Drug|Overall Study||82
7865214|NCT00883051|19357174|P5|No Study Medication Used|Overall Study||17
7865215|NCT00883051|19357175|P4|No Study Medication Used|Overall Study||29
7865216|NCT00883051|19357176|P3|No Study Medication Used|Overall Study||29
7865217|NCT00883051|19357177|P2|No Study Medication Used|Overall Study||22
7865218|NCT00883051|19357178|P1|No Study Medication Used|Overall Study||24
7865219|NCT00883051|19357174|P5|STARTED|Overall Study||103
7865220|NCT00883051|19357175|P4|STARTED|Overall Study||99
7865221|NCT00883051|19357176|P3|STARTED|Overall Study||100
7865222|NCT00883051|19357177|P2|STARTED|Overall Study||104
7865223|NCT00883051|19357178|P1|STARTED|Overall Study||106
7865224|NCT00882999|19357282|P7|NOT COMPLETED|Overall Study||8
7865225|NCT00882999|19357283|P6|NOT COMPLETED|Overall Study||7
7865226|NCT00882999|19357284|P5|NOT COMPLETED|Overall Study||8
7865227|NCT00882999|19357285|P4|NOT COMPLETED|Overall Study||5
7865228|NCT00882999|19357286|P3|NOT COMPLETED|Overall Study||4
7865229|NCT00882999|19357287|P2|NOT COMPLETED|Overall Study||8
7865230|NCT00882999|19357288|P1|NOT COMPLETED|Overall Study||8
7865231|NCT00882999|19357282|P7|COMPLETED|Overall Study||27
7865232|NCT00882999|19357283|P6|COMPLETED|Overall Study||28
7865233|NCT00882999|19357284|P5|COMPLETED|Overall Study||28
7865234|NCT00882999|19357285|P4|COMPLETED|Overall Study||31
7865235|NCT00882999|19357286|P3|COMPLETED|Overall Study||30
7865236|NCT00882999|19357287|P2|COMPLETED|Overall Study||26
7865237|NCT00882999|19357288|P1|COMPLETED|Overall Study||27
7865238|NCT00882999|19357282|P7|Completed Study Treatment|Overall Study||31
7865239|NCT00882999|19357283|P6|Completed Study Treatment|Overall Study||30
7865240|NCT00882999|19357284|P5|Completed Study Treatment|Overall Study||29
7865241|NCT00882999|19357285|P4|Completed Study Treatment|Overall Study||33
7865242|NCT00882999|19357286|P3|Completed Study Treatment|Overall Study||31
7865243|NCT00882999|19357287|P2|Completed Study Treatment|Overall Study||29
7865244|NCT00882999|19357288|P1|Completed Study Treatment|Overall Study||29
7865245|NCT00882999|19357282|P7|Received Any Amount of Study Drug|Overall Study||35
7865246|NCT00882999|19357283|P6|Received Any Amount of Study Drug|Overall Study||35
7865247|NCT00882999|19357284|P5|Received Any Amount of Study Drug|Overall Study||36
7865248|NCT00882999|19357285|P4|Received Any Amount of Study Drug|Overall Study||36
7865249|NCT00882999|19357286|P3|Received Any Amount of Study Drug|Overall Study||34
7865250|NCT00882999|19357287|P2|Received Any Amount of Study Drug|Overall Study||34
7865251|NCT00882999|19357288|P1|Received Any Amount of Study Drug|Overall Study||35
7865252|NCT00882999|19357282|P7|STARTED|Overall Study||35
7865253|NCT00882999|19357283|P6|STARTED|Overall Study||35
7865254|NCT00882999|19357284|P5|STARTED|Overall Study||36
7865255|NCT00882999|19357285|P4|STARTED|Overall Study||36
7865256|NCT00882999|19357286|P3|STARTED|Overall Study||34
7865257|NCT00882999|19357287|P2|STARTED|Overall Study||34
7865258|NCT00882999|19357288|P1|STARTED|Overall Study||35
7865259|NCT00882921|19357415|P1|NOT COMPLETED|Overall Study||11
7865260|NCT00882921|19357415|P1|COMPLETED|Overall Study||15
7865261|NCT00882921|19357415|P1|STARTED|Overall Study||26
7865262|NCT00882908|19357425|P5|NOT COMPLETED|Overall Study||6
7865263|NCT00882908|19357426|P4|NOT COMPLETED|Overall Study||7
7865264|NCT00882908|19357427|P3|NOT COMPLETED|Overall Study||7
7865265|NCT00882908|19357428|P2|NOT COMPLETED|Overall Study||6
7865266|NCT00882908|19357429|P1|NOT COMPLETED|Overall Study||3
7865267|NCT00882908|19357425|P5|COMPLETED|Overall Study||71
7865268|NCT00882908|19357426|P4|COMPLETED|Overall Study||72
7865269|NCT00882908|19357427|P3|COMPLETED|Overall Study||70
7865270|NCT00882908|19357428|P2|COMPLETED|Overall Study||69
7865271|NCT00882908|19357429|P1|COMPLETED|Overall Study||75
7865272|NCT00882908|19357425|P5|STARTED|Overall Study||77
7865273|NCT00882908|19357426|P4|STARTED|Overall Study||79
7865274|NCT00882908|19357427|P3|STARTED|Overall Study||77
7865275|NCT00882908|19357428|P2|STARTED|Overall Study||75
7865276|NCT00882908|19357429|P1|STARTED|Overall Study||78
7865277|NCT00882778|19357504|P1|NOT COMPLETED|Overall Study||0
7865278|NCT00882778|19357504|P1|COMPLETED|Overall Study||86
7865279|NCT00882778|19357504|P1|STARTED|Overall Study||86
7865280|NCT00882713|19357535|P1|NOT COMPLETED|Overall Study||22
7865281|NCT00882713|19357535|P1|COMPLETED|Overall Study||172
7865282|NCT00882713|19357535|P1|STARTED|Overall Study||194
7865283|NCT00882687|19357561|P4|NOT COMPLETED|Overall Study||2
7865284|NCT00882687|19357562|P3|NOT COMPLETED|Overall Study||3
7865285|NCT00882687|19357563|P2|NOT COMPLETED|Overall Study||2
7865286|NCT00882687|19357564|P1|NOT COMPLETED|Overall Study||2
7865287|NCT00882687|19357561|P4|COMPLETED|Overall Study||13
7865288|NCT00882687|19357562|P3|COMPLETED|Overall Study||12
7865289|NCT00882687|19357563|P2|COMPLETED|Overall Study||13
7865290|NCT00882687|19357564|P1|COMPLETED|Overall Study||13
7865291|NCT00882687|19357561|P4|STARTED|Overall Study||15
7865292|NCT00882687|19357562|P3|STARTED|Overall Study||15
7865293|NCT00882687|19357563|P2|STARTED|Overall Study||15
7865294|NCT00882687|19357564|P1|STARTED|Overall Study||15
7865295|NCT00882661|19357597|P2|NOT COMPLETED|Treatment||26
7865296|NCT00882661|19357598|P1|NOT COMPLETED|Treatment||10
7865297|NCT00882661|19357597|P2|COMPLETED|Treatment||114
7865298|NCT00882661|19357598|P1|COMPLETED|Treatment||141
7865299|NCT00882661|19357597|P2|STARTED|Treatment||140
7865300|NCT00882661|19357598|P1|STARTED|Treatment||151
7865301|NCT00882661|19357597|P2|NOT COMPLETED|Investigational Training||0
7865302|NCT00882661|19357598|P1|NOT COMPLETED|Investigational Training||10
7865303|NCT00882661|19357597|P2|COMPLETED|Investigational Training||0
7865304|NCT00882661|19357598|P1|COMPLETED|Investigational Training||79
7865305|NCT00882661|19357597|P2|STARTED|Investigational Training||0
7865306|NCT00882661|19357598|P1|STARTED|Investigational Training||89
7865307|NCT00882583|19357628|P2|NOT COMPLETED|Overall Study||1
7865308|NCT00882583|19357629|P1|NOT COMPLETED|Overall Study||1
7865309|NCT00882583|19357628|P2|COMPLETED|Overall Study||11
7865310|NCT00882583|19357629|P1|COMPLETED|Overall Study||6
7865311|NCT00882583|19357628|P2|STARTED|Overall Study||12
7865312|NCT00882583|19357629|P1|STARTED|Overall Study||7
7865313|NCT00882557|19357637|P2|NOT COMPLETED|Overall Study||1
7865314|NCT00882557|19357638|P1|NOT COMPLETED|Overall Study||2
7865315|NCT00882557|19357637|P2|COMPLETED|Overall Study||7
7865316|NCT00882557|19357638|P1|COMPLETED|Overall Study||6
7865317|NCT00882557|19357637|P2|Completed Dose 2|Overall Study||7
7865318|NCT00882557|19357638|P1|Completed Dose 2|Overall Study||6
7865319|NCT00882557|19357637|P2|Completed Dose 1|Overall Study||7
7865320|NCT00882557|19357638|P1|Completed Dose 1|Overall Study||8
7865321|NCT00882557|19357637|P2|STARTED|Overall Study||8
7865322|NCT00882557|19357638|P1|STARTED|Overall Study||8
7865323|NCT00882518|19357658|P2|NOT COMPLETED|Overall Study||44
7865324|NCT00882518|19357659|P1|NOT COMPLETED|Overall Study||38
7865325|NCT00882518|19357658|P2|COMPLETED|Overall Study||148
7865326|NCT00882518|19357659|P1|COMPLETED|Overall Study||158
7865327|NCT00882518|19357658|P2|STARTED|Overall Study||192
7865328|NCT00882518|19357659|P1|STARTED|Overall Study||196
7865329|NCT00882440|19357688|P7|NOT COMPLETED|Overall Study||4
7865330|NCT00882440|19357689|P6|NOT COMPLETED|Overall Study||7
7865331|NCT00882440|19357690|P5|NOT COMPLETED|Overall Study||10
7865332|NCT00882440|19357691|P4|NOT COMPLETED|Overall Study||3
7865333|NCT00882440|19357692|P3|NOT COMPLETED|Overall Study||7
7865334|NCT00882440|19357693|P2|NOT COMPLETED|Overall Study||8
7865335|NCT00882440|19357694|P1|NOT COMPLETED|Overall Study||11
7865336|NCT00882440|19357688|P7|COMPLETED|Overall Study||79
7865337|NCT00882440|19357689|P6|COMPLETED|Overall Study||77
7865338|NCT00882440|19357690|P5|COMPLETED|Overall Study||80
7865339|NCT00882440|19357691|P4|COMPLETED|Overall Study||76
7865340|NCT00882440|19357692|P3|COMPLETED|Overall Study||75
7865341|NCT00882440|19357693|P2|COMPLETED|Overall Study||72
7865342|NCT00882440|19357694|P1|COMPLETED|Overall Study||67
7865343|NCT00882440|19357688|P7|STARTED|Overall Study||83
7865344|NCT00882440|19357689|P6|STARTED|Overall Study||84
7865345|NCT00882440|19357690|P5|STARTED|Overall Study||90
7865346|NCT00882440|19357691|P4|STARTED|Overall Study||79
7865347|NCT00882440|19357692|P3|STARTED|Overall Study||82
7865348|NCT00882440|19357693|P2|STARTED|Overall Study||80
7865349|NCT00882440|19357694|P1|STARTED|Overall Study||78
7865350|NCT00882362|19357719|P2|NOT COMPLETED|Overall Study||23
7865351|NCT00882362|19357720|P1|NOT COMPLETED|Overall Study||49
7865352|NCT00882362|19357719|P2|COMPLETED|Overall Study||10
7865353|NCT00882362|19357720|P1|COMPLETED|Overall Study||73
7865354|NCT00882362|19357719|P2|STARTED|Overall Study||33
7865355|NCT00882362|19357720|P1|STARTED|Overall Study||122
7865356|NCT00882310|19357726|P1|NOT COMPLETED|Overall Study||22
7865357|NCT00882310|19357726|P1|COMPLETED|Overall Study||15
7865358|NCT00882310|19357726|P1|STARTED|Overall Study||37
7865359|NCT00882206|19357732|P1|NOT COMPLETED|Overall Study||0
7865360|NCT00882206|19357732|P1|COMPLETED|Overall Study||13
7865361|NCT00882206|19357732|P1|STARTED|Overall Study||13
7865362|NCT00882115|19357739|P1|NOT COMPLETED|Overall Study||9
7865363|NCT00882115|19357739|P1|COMPLETED|Overall Study||29
7865364|NCT00882115|19357739|P1|STARTED|Overall Study||38
7865365|NCT00882102|19357743|P1|NOT COMPLETED|Overall Study||0
7865366|NCT00882102|19357743|P1|COMPLETED|Overall Study||40
7865367|NCT00882102|19357743|P1|STARTED|Overall Study||40
7865368|NCT00881959|19357749|P2|NOT COMPLETED|Overall Study||4
7865369|NCT00881959|19357750|P1|NOT COMPLETED|Overall Study||2
7865370|NCT00881959|19357749|P2|COMPLETED|Overall Study||38
7865371|NCT00881959|19357750|P1|COMPLETED|Overall Study||36
7865372|NCT00881959|19357749|P2|STARTED|Overall Study||42
7865373|NCT00881959|19357750|P1|STARTED|Overall Study||38
7865374|NCT00881894|19357758|P2|NOT COMPLETED|Overall Study||3
7865375|NCT00881894|19357759|P1|NOT COMPLETED|Overall Study||1
7865376|NCT00881894|19357758|P2|COMPLETED|Overall Study||23
7865377|NCT00881894|19357759|P1|COMPLETED|Overall Study||25
7865378|NCT00881894|19357758|P2|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21
7865379|NCT00881894|19357759|P1|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23
7865380|NCT00881894|19357758|P2|STARTED|Overall Study||26
7865381|NCT00881894|19357759|P1|STARTED|Overall Study||26
7865382|NCT00881868|19357791|P2|NOT COMPLETED|Overall Study||2
7865383|NCT00881868|19357792|P1|NOT COMPLETED|Overall Study||8
7865384|NCT00881868|19357791|P2|COMPLETED|Overall Study||38
7865385|NCT00881868|19357792|P1|COMPLETED|Overall Study||33
7865386|NCT00881868|19357791|P2|STARTED|Overall Study||40
7865387|NCT00881868|19357792|P1|STARTED|Overall Study||41
7865388|NCT00881751|19357806|P2|NOT COMPLETED|Overall Study||5
7865389|NCT00881751|19357807|P1|NOT COMPLETED|Overall Study||0
7865390|NCT00881751|19357806|P2|COMPLETED|Overall Study||43
7865391|NCT00881751|19357807|P1|COMPLETED|Overall Study||47
7865392|NCT00881751|19357806|P2|STARTED|Overall Study||48
7865393|NCT00881751|19357807|P1|STARTED|Overall Study||47
7865394|NCT00881712|19357822|P3|NOT COMPLETED|Overall Study||0
7865395|NCT00881712|19357823|P2|NOT COMPLETED|Overall Study||0
7865396|NCT00881712|19357824|P1|NOT COMPLETED|Overall Study||2
7865397|NCT00881712|19357822|P3|COMPLETED|Overall Study||0
7865398|NCT00881712|19357823|P2|COMPLETED|Overall Study||0
7865399|NCT00881712|19357824|P1|COMPLETED|Overall Study||13
7865400|NCT00881712|19357822|P3|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
7865401|NCT00881712|19357823|P2|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
7865402|NCT00881712|19357824|P1|STARTED|Overall Study||15
7865403|NCT00881647|19357846|P2|NOT COMPLETED|Overall Study||1
7865404|NCT00881647|19357847|P1|NOT COMPLETED|Overall Study||2
7865405|NCT00881647|19357846|P2|COMPLETED|Overall Study||15
7865406|NCT00881647|19357847|P1|COMPLETED|Overall Study||27
7865407|NCT00881647|19357846|P2|STARTED|Overall Study||16
7865408|NCT00881647|19357847|P1|STARTED|Overall Study||29
7865409|NCT00881621|19357857|P1|NOT COMPLETED|Overall Study||34
7865410|NCT00881621|19357857|P1|COMPLETED|Overall Study||17
7865411|NCT00881621|19357857|P1|STARTED|Overall Study||51
7865412|NCT00881608|19357869|P1|NOT COMPLETED|Overall Study||11
7865413|NCT00881608|19357869|P1|COMPLETED|Overall Study||0
7865414|NCT00881608|19357869|P1|STARTED|Overall Study||11
7865415|NCT00881569|19357888|P2|NOT COMPLETED|Overall Study||1
7865416|NCT00881569|19357889|P1|NOT COMPLETED|Overall Study||1
7865417|NCT00881569|19357888|P2|COMPLETED|Overall Study||0
7865418|NCT00881569|19357889|P1|COMPLETED|Overall Study||0
7865419|NCT00881569|19357888|P2|STARTED|Overall Study||1
7865420|NCT00881569|19357889|P1|STARTED|Overall Study||1
7865421|NCT00881530|19357905|P6|NOT COMPLETED|Overall Study||5
7865422|NCT00881530|19357906|P5|NOT COMPLETED|Overall Study||14
7865423|NCT00881530|19357907|P4|NOT COMPLETED|Overall Study||9
7865424|NCT00881530|19357908|P3|NOT COMPLETED|Overall Study||5
7865425|NCT00881530|19357909|P2|NOT COMPLETED|Overall Study||5
7865426|NCT00881530|19357910|P1|NOT COMPLETED|Overall Study||14
7865427|NCT00881530|19357905|P6|COMPLETED|Overall Study||51
7865428|NCT00881530|19357906|P5|COMPLETED|Overall Study||152
7865429|NCT00881530|19357907|P4|COMPLETED|Overall Study||157
7865430|NCT00881530|19357908|P3|COMPLETED|Overall Study||51
7865431|NCT00881530|19357909|P2|COMPLETED|Overall Study||104
7865432|NCT00881530|19357910|P1|COMPLETED|Overall Study||92
7865433|NCT00881530|19357905|P6|STARTED|Overall Study||56
7865434|NCT00881530|19357906|P5|STARTED|Overall Study||166
7865435|NCT00881530|19357907|P4|STARTED|Overall Study||166
7865436|NCT00881530|19357908|P3|STARTED|Overall Study||56
7865437|NCT00881530|19357909|P2|STARTED|Overall Study||109
7865438|NCT00881530|19357910|P1|STARTED|Overall Study||106
7865439|NCT00881504|19357966|P1|NOT COMPLETED|Overall Study||1
7865440|NCT00881504|19357966|P1|COMPLETED|Overall Study||8
7865441|NCT00881504|19357966|P1|STARTED|Overall Study||9
7865442|NCT00881465|19357973|P2|NOT COMPLETED|Overall Study||0
7865443|NCT00881465|19357974|P1|NOT COMPLETED|Overall Study||2
7865444|NCT00881465|19357973|P2|COMPLETED|Overall Study||15
7865445|NCT00881465|19357974|P1|COMPLETED|Overall Study||14
7865446|NCT00881465|19357973|P2|STARTED|Overall Study||15
7865447|NCT00881465|19357974|P1|STARTED|Overall Study||16
7865448|NCT00881361|19357986|P3|NOT COMPLETED|Overall Study||2
7865449|NCT00881361|19357987|P2|NOT COMPLETED|Overall Study||9
7865450|NCT00881361|19357988|P1|NOT COMPLETED|Overall Study||44
7865451|NCT00881361|19357986|P3|COMPLETED|Overall Study||0
7865452|NCT00881361|19357987|P2|COMPLETED|Overall Study||38
7865453|NCT00881361|19357988|P1|COMPLETED|Overall Study||663
7865454|NCT00881361|19357986|P3|STARTED|Overall Study||2
7865455|NCT00881361|19357987|P2|STARTED|Overall Study||47
7865456|NCT00881361|19357988|P1|STARTED|Overall Study||707
7865457|NCT00881335|19358003|P2|NOT COMPLETED|Overall Study||2
7865458|NCT00881335|19358004|P1|NOT COMPLETED|Overall Study||3
7865459|NCT00881335|19358003|P2|COMPLETED|Overall Study|2 participants did not complete the period|28
7865460|NCT00881335|19358004|P1|COMPLETED|Overall Study|3 participants did not complete the period|27
7865461|NCT00881335|19358003|P2|STARTED|Overall Study||30
7865462|NCT00881335|19358004|P1|STARTED|Overall Study||30
7865463|NCT00881205|19358024|P2|NOT COMPLETED|Overall Study||7
7865464|NCT00881205|19358025|P1|NOT COMPLETED|Overall Study||11
7865465|NCT00881205|19358024|P2|COMPLETED|Overall Study||34
7865466|NCT00881205|19358025|P1|COMPLETED|Overall Study||34
7865467|NCT00881205|19358024|P2|STARTED|Overall Study||41
7865468|NCT00881205|19358025|P1|STARTED|Overall Study||45
7865469|NCT00880997|19358035|P3|NOT COMPLETED|Overall Study||8
7865470|NCT00880997|19358036|P2|NOT COMPLETED|Overall Study||2
7865471|NCT00880997|19358037|P1|NOT COMPLETED|Overall Study||3
7865472|NCT00880997|19358035|P3|COMPLETED|Overall Study||5
7865473|NCT00880997|19358036|P2|COMPLETED|Overall Study||6
7865474|NCT00880997|19358037|P1|COMPLETED|Overall Study||6
7865475|NCT00880997|19358035|P3|STARTED|Overall Study||13
7865476|NCT00880997|19358036|P2|STARTED|Overall Study||8
7865477|NCT00880997|19358037|P1|STARTED|Overall Study||9
7865478|NCT00880919|19358057|P3|NOT COMPLETED|Overall Study||6
7865479|NCT00880919|19358058|P2|NOT COMPLETED|Overall Study||14
7865480|NCT00880919|19358059|P1|NOT COMPLETED|Overall Study||15
7865481|NCT00880919|19358057|P3|COMPLETED|Overall Study||23
7865482|NCT00880919|19358058|P2|COMPLETED|Overall Study||19
7865483|NCT00880919|19358059|P1|COMPLETED|Overall Study||18
7865484|NCT00880919|19358057|P3|STARTED|Overall Study||29
7865485|NCT00880919|19358058|P2|STARTED|Overall Study||33
7865486|NCT00880919|19358059|P1|STARTED|Overall Study||33
7865487|NCT00880906|19358093|P2|NOT COMPLETED|Overall Study||7
7865488|NCT00880906|19358094|P1|NOT COMPLETED|Overall Study||12
7865489|NCT00880906|19358093|P2|COMPLETED|Overall Study||14
7865490|NCT00880906|19358094|P1|COMPLETED|Overall Study||17
7865491|NCT00880906|19358093|P2|STARTED|Overall Study||21
7865492|NCT00880906|19358094|P1|STARTED|Overall Study||29
7865493|NCT00880893|19358104|P2|NOT COMPLETED|Overall Study||45
7865494|NCT00880893|19358105|P1|NOT COMPLETED|Overall Study||107
7865495|NCT00880893|19358104|P2|COMPLETED|Overall Study||255
7865496|NCT00880893|19358105|P1|COMPLETED|Overall Study||791
7865497|NCT00880893|19358104|P2|STARTED|Overall Study||300
7865498|NCT00880893|19358105|P1|STARTED|Overall Study||898
7865499|NCT00880763|19358157|P4|NOT COMPLETED|Extension Period (Part 2)||3
7865500|NCT00880763|19358158|P3|NOT COMPLETED|Extension Period (Part 2)||3
7865501|NCT00880763|19358159|P2|NOT COMPLETED|Extension Period (Part 2)||3
7865502|NCT00880763|19358160|P1|NOT COMPLETED|Extension Period (Part 2)||0
7865503|NCT00880763|19358157|P4|COMPLETED|Extension Period (Part 2)||19
7865504|NCT00880763|19358158|P3|COMPLETED|Extension Period (Part 2)||20
7865505|NCT00880763|19358159|P2|COMPLETED|Extension Period (Part 2)||19
7865506|NCT00880763|19358160|P1|COMPLETED|Extension Period (Part 2)||23
7865507|NCT00880763|19358157|P4|STARTED|Extension Period (Part 2)||22
7865508|NCT00880763|19358158|P3|STARTED|Extension Period (Part 2)||23
7865509|NCT00880763|19358159|P2|STARTED|Extension Period (Part 2)||22
7865510|NCT00880763|19358160|P1|STARTED|Extension Period (Part 2)||23
7865511|NCT00880763|19358157|P4|NOT COMPLETED|Initial Treatment Period (Part 1)||0
7865512|NCT00880763|19358158|P3|NOT COMPLETED|Initial Treatment Period (Part 1)||0
7865513|NCT00880763|19358159|P2|NOT COMPLETED|Initial Treatment Period (Part 1)||0
7865514|NCT00880763|19358160|P1|NOT COMPLETED|Initial Treatment Period (Part 1)||0
7865515|NCT00880763|19358157|P4|COMPLETED|Initial Treatment Period (Part 1)||22
7865516|NCT00880763|19358158|P3|COMPLETED|Initial Treatment Period (Part 1)||23
7865517|NCT00880763|19358159|P2|COMPLETED|Initial Treatment Period (Part 1)||22
7865518|NCT00880763|19358160|P1|COMPLETED|Initial Treatment Period (Part 1)||23
7865519|NCT00880763|19358157|P4|STARTED|Initial Treatment Period (Part 1)||22
7865520|NCT00880763|19358158|P3|STARTED|Initial Treatment Period (Part 1)||23
7865521|NCT00880763|19358159|P2|STARTED|Initial Treatment Period (Part 1)||22
7865522|NCT00880763|19358160|P1|STARTED|Initial Treatment Period (Part 1)||23
7865523|NCT00880750|19358192|P2|NOT COMPLETED|Second Intervention||2
7865524|NCT00880750|19358193|P1|NOT COMPLETED|Second Intervention||4
7865525|NCT00880750|19358192|P2|COMPLETED|Second Intervention||30
7865526|NCT00880750|19358193|P1|COMPLETED|Second Intervention||26
7865527|NCT00880750|19358192|P2|STARTED|Second Intervention||32
7865528|NCT00880750|19358193|P1|STARTED|Second Intervention||30
7865529|NCT00880750|19358192|P2|NOT COMPLETED|Washout Period||0
7865530|NCT00880750|19358193|P1|NOT COMPLETED|Washout Period||0
7865531|NCT00880750|19358192|P2|COMPLETED|Washout Period||32
7865532|NCT00880750|19358193|P1|COMPLETED|Washout Period||30
7865533|NCT00880750|19358192|P2|STARTED|Washout Period||32
7865534|NCT00880750|19358193|P1|STARTED|Washout Period||30
7865535|NCT00880750|19358192|P2|NOT COMPLETED|First Intervention||1
7865536|NCT00880750|19358193|P1|NOT COMPLETED|First Intervention||9
7865537|NCT00880750|19358192|P2|COMPLETED|First Intervention||32
7865538|NCT00880750|19358193|P1|COMPLETED|First Intervention||30
7865539|NCT00880750|19358192|P2|STARTED|First Intervention||33
7865540|NCT00880750|19358193|P1|STARTED|First Intervention||39
7865541|NCT00880698|19358211|P4|NOT COMPLETED|Overall Study||3
7865542|NCT00880698|19358212|P3|NOT COMPLETED|Overall Study||1
7865543|NCT00880698|19358213|P2|NOT COMPLETED|Overall Study||3
7865544|NCT00880698|19358214|P1|NOT COMPLETED|Overall Study||1
7865545|NCT00880698|19358211|P4|COMPLETED|Overall Study||36
7865546|NCT00880698|19358212|P3|COMPLETED|Overall Study||36
7865547|NCT00880698|19358213|P2|COMPLETED|Overall Study||61
7865548|NCT00880698|19358214|P1|COMPLETED|Overall Study||61
7865549|NCT00880698|19358211|P4|STARTED|Overall Study||39
7865550|NCT00880698|19358212|P3|STARTED|Overall Study||37
7865551|NCT00880698|19358213|P2|STARTED|Overall Study||64
7865552|NCT00880698|19358214|P1|STARTED|Overall Study||62
7865553|NCT00880685|19358240|P1|NOT COMPLETED|Memantine 30mg||0
7865554|NCT00880685|19358240|P1|COMPLETED|Memantine 30mg||9
7865555|NCT00880685|19358240|P1|STARTED|Memantine 30mg||9
7865556|NCT00880685|19358240|P1|NOT COMPLETED|Memantine 20mg||1
7865557|NCT00880685|19358240|P1|COMPLETED|Memantine 20mg||9
7865558|NCT00880685|19358240|P1|STARTED|Memantine 20mg||10
7865559|NCT00880685|19358240|P1|NOT COMPLETED|Memantine 10mg||2
7865560|NCT00880685|19358240|P1|COMPLETED|Memantine 10mg||10
7865561|NCT00880685|19358240|P1|STARTED|Memantine 10mg||12
7865562|NCT00880620|19358252|P4|NOT COMPLETED|Overall Study||24
7865563|NCT00880620|19358253|P3|NOT COMPLETED|Overall Study||21
7865564|NCT00880620|19358254|P2|NOT COMPLETED|Overall Study||15
7865565|NCT00880620|19358255|P1|NOT COMPLETED|Overall Study||21
7865566|NCT00880620|19358252|P4|COMPLETED|Overall Study||74
7865567|NCT00880620|19358253|P3|COMPLETED|Overall Study||83
7865568|NCT00880620|19358254|P2|COMPLETED|Overall Study||72
7865569|NCT00880620|19358255|P1|COMPLETED|Overall Study||71
7865570|NCT00880620|19358252|P4|Week 23|Overall Study||74
7865571|NCT00880620|19358253|P3|Week 23|Overall Study||85
7865572|NCT00880620|19358254|P2|Week 23|Overall Study||72
7865573|NCT00880620|19358255|P1|Week 23|Overall Study||71
7865574|NCT00880620|19358252|P4|Week 16|Overall Study||74
7865575|NCT00880620|19358253|P3|Week 16|Overall Study||87
7865576|NCT00880620|19358254|P2|Week 16|Overall Study||73
7865577|NCT00880620|19358255|P1|Week 16|Overall Study||74
7865578|NCT00880620|19358252|P4|Week 9|Overall Study||78
7865579|NCT00880620|19358253|P3|Week 9|Overall Study||88
7865580|NCT00880620|19358254|P2|Week 9|Overall Study||73
7865581|NCT00880620|19358255|P1|Week 9|Overall Study||80
7865582|NCT00880620|19358252|P4|Week 4|Overall Study||86
7865583|NCT00880620|19358253|P3|Week 4|Overall Study||94
7865584|NCT00880620|19358254|P2|Week 4|Overall Study||79
7865585|NCT00880620|19358255|P1|Week 4|Overall Study||88
7865586|NCT00880620|19358252|P4|STARTED|Overall Study||98
7865587|NCT00880620|19358253|P3|STARTED|Overall Study||104
7865588|NCT00880620|19358254|P2|STARTED|Overall Study||87
7865589|NCT00880620|19358255|P1|STARTED|Overall Study||92
7865590|NCT00880607|19358271|P2|NOT COMPLETED|Overall Study||3
7865591|NCT00880607|19358272|P1|NOT COMPLETED|Overall Study||7
7865592|NCT00880607|19358271|P2|COMPLETED|Overall Study||34
7865593|NCT00880607|19358272|P1|COMPLETED|Overall Study||37
7865594|NCT00880607|19358271|P2|Observation After Receiving Medication|Overall Study||35
7865595|NCT00880607|19358272|P1|Observation After Receiving Medication|Overall Study||42
7865596|NCT00880607|19358271|P2|STARTED|Overall Study||37
7865597|NCT00880607|19358272|P1|STARTED|Overall Study||44
7865598|NCT00880581|19358290|P1|NOT COMPLETED|Cycle 2 Re-treatment||0
7865599|NCT00880581|19358290|P1|COMPLETED|Cycle 2 Re-treatment||24
7865600|NCT00880581|19358290|P1|STARTED|Cycle 2 Re-treatment|6 subjects with progessive disease were not treated and evaluated in Cycle 2|24
7865601|NCT00880581|19358290|P1|NOT COMPLETED|Cycle 1||0
7865602|NCT00880581|19358290|P1|COMPLETED|Cycle 1||30
7865603|NCT00880581|19358290|P1|STARTED|Cycle 1||30
7865604|NCT00880568|19358304|P9|NOT COMPLETED|Overall Study||3
7865605|NCT00880568|19358305|P8|NOT COMPLETED|Overall Study||2
7865606|NCT00880568|19358306|P7|NOT COMPLETED|Overall Study||6
7865607|NCT00880568|19358307|P6|NOT COMPLETED|Overall Study||3
7865608|NCT00880568|19358308|P5|NOT COMPLETED|Overall Study||3
7865609|NCT00880568|19358309|P4|NOT COMPLETED|Overall Study||1
7865610|NCT00880568|19358310|P3|NOT COMPLETED|Overall Study||3
7865611|NCT00880568|19358311|P2|NOT COMPLETED|Overall Study||3
7865612|NCT00880568|19358312|P1|NOT COMPLETED|Overall Study||3
7865613|NCT00880568|19358304|P9|COMPLETED|Overall Study||0
7865614|NCT00880568|19358305|P8|COMPLETED|Overall Study||0
7865615|NCT00880568|19358306|P7|COMPLETED|Overall Study||0
7865616|NCT00880568|19358307|P6|COMPLETED|Overall Study||0
7865617|NCT00880568|19358308|P5|COMPLETED|Overall Study||0
7865618|NCT00880568|19358309|P4|COMPLETED|Overall Study||0
7865619|NCT00880568|19358310|P3|COMPLETED|Overall Study||0
7865620|NCT00880568|19358311|P2|COMPLETED|Overall Study||0
7865621|NCT00880568|19358312|P1|COMPLETED|Overall Study||0
7865622|NCT00880568|19358304|P9|STARTED|Overall Study||3
7865623|NCT00880568|19358305|P8|STARTED|Overall Study||2
7865624|NCT00880568|19358306|P7|STARTED|Overall Study||6
7865625|NCT00880568|19358307|P6|STARTED|Overall Study||3
7865626|NCT00880568|19358308|P5|STARTED|Overall Study||3
7865627|NCT00880568|19358309|P4|STARTED|Overall Study||1
7865628|NCT00880568|19358310|P3|STARTED|Overall Study||3
7865629|NCT00880568|19358311|P2|STARTED|Overall Study||3
7865630|NCT00880568|19358312|P1|STARTED|Overall Study||3
7865631|NCT00880555|19358358|P6|NOT COMPLETED|Overall Study||1
7865632|NCT00880555|19358359|P5|NOT COMPLETED|Overall Study||1
7865633|NCT00880555|19358360|P4|NOT COMPLETED|Overall Study||2
7865634|NCT00880555|19358361|P3|NOT COMPLETED|Overall Study||5
7865635|NCT00880555|19358362|P2|NOT COMPLETED|Overall Study||17
7865636|NCT00880555|19358363|P1|NOT COMPLETED|Overall Study||10
7865637|NCT00880555|19358358|P6|COMPLETED|Overall Study||0
7865638|NCT00880555|19358359|P5|COMPLETED|Overall Study||0
7865639|NCT00880555|19358360|P4|COMPLETED|Overall Study||0
7865640|NCT00880555|19358361|P3|COMPLETED|Overall Study||6
7865641|NCT00880555|19358362|P2|COMPLETED|Overall Study||23
7865642|NCT00880555|19358363|P1|COMPLETED|Overall Study||13
7865643|NCT00880555|19358358|P6|STARTED|Overall Study||1
7865644|NCT00880555|19358359|P5|STARTED|Overall Study||1
7865645|NCT00880555|19358360|P4|STARTED|Overall Study||2
7865646|NCT00880555|19358361|P3|STARTED|Overall Study||11
7865647|NCT00880555|19358362|P2|STARTED|Overall Study||40
7865648|NCT00880555|19358363|P1|STARTED|Overall Study||23
7865649|NCT00880542|19358374|P1|NOT COMPLETED|Follow-up Period||0
7865650|NCT00880542|19358374|P1|COMPLETED|Follow-up Period||7
7865651|NCT00880542|19358374|P1|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7
7865652|NCT00880542|19358374|P1|NOT COMPLETED|Continued Treatment Period||0
7865653|NCT00880542|19358374|P1|COMPLETED|Continued Treatment Period||0
7865654|NCT00880542|19358374|P1|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0
7865655|NCT00880542|19358374|P1|NOT COMPLETED|Post Surgical Evaluation||0
7865656|NCT00880542|19358374|P1|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3
7865657|NCT00880542|19358374|P1|STARTED|Post Surgical Evaluation||3
7865658|NCT00880542|19358374|P1|NOT COMPLETED|REP: Surgical Resection||1
7865659|NCT00880542|19358374|P1|COMPLETED|REP: Surgical Resection||3
7865660|NCT00880542|19358374|P1|STARTED|REP: Surgical Resection||4
7865661|NCT00880542|19358374|P1|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0
7865662|NCT00880542|19358374|P1|COMPLETED|Response Evaluation Period(REP): PET/CT||4
7865663|NCT00880542|19358374|P1|STARTED|Response Evaluation Period(REP): PET/CT||4
7865664|NCT00880542|19358374|P1|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3
7865665|NCT00880542|19358374|P1|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4
7865666|NCT00880542|19358374|P1|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7
7865667|NCT00880425|19358379|P2|NOT COMPLETED|Overall Study||0
7865668|NCT00880425|19358380|P1|NOT COMPLETED|Overall Study||0
7865669|NCT00880425|19358379|P2|COMPLETED|Overall Study||27
7865670|NCT00880425|19358380|P1|COMPLETED|Overall Study||18
7865671|NCT00880425|19358379|P2|STARTED|Overall Study||27
7865672|NCT00880425|19358380|P1|STARTED|Overall Study||18
7865673|NCT00880399|19358391|P3|NOT COMPLETED|Overall Study||26
7865674|NCT00880399|19358392|P2|NOT COMPLETED|Overall Study||29
7865675|NCT00880399|19358393|P1|NOT COMPLETED|Overall Study||31
7865676|NCT00880399|19358391|P3|COMPLETED|Overall Study||81
7865677|NCT00880399|19358392|P2|COMPLETED|Overall Study||84
7865678|NCT00880399|19358393|P1|COMPLETED|Overall Study||77
7865679|NCT00880399|19358391|P3|STARTED|Overall Study||107
7865680|NCT00880399|19358392|P2|STARTED|Overall Study||113
7865681|NCT00880399|19358393|P1|STARTED|Overall Study||108
7865682|NCT00880360|19358449|P1|NOT COMPLETED|Overall Study||0
7865683|NCT00880360|19358449|P1|COMPLETED|Overall Study||19
7865684|NCT00880360|19358449|P1|STARTED|Overall Study||19
7865685|NCT00880334|19358456|P2|NOT COMPLETED|Crossover Phase||0
7865686|NCT00880334|19358457|P1|NOT COMPLETED|Crossover Phase||0
7865687|NCT00880334|19358456|P2|COMPLETED|Crossover Phase||37
7865688|NCT00880334|19358457|P1|COMPLETED|Crossover Phase||0
7865689|NCT00880334|19358456|P2|STARTED|Crossover Phase|Only participants randomized to placebo and docetaxel potentially received crossover treatment.|37
7865690|NCT00880334|19358457|P1|STARTED|Crossover Phase||0
7865691|NCT00880334|19358456|P2|NOT COMPLETED|Randomized Phase||40
7865692|NCT00880334|19358457|P1|NOT COMPLETED|Randomized Phase||4
7865693|NCT00880334|19358456|P2|COMPLETED|Randomized Phase||35
7865694|NCT00880334|19358457|P1|COMPLETED|Randomized Phase||70
7865695|NCT00880334|19358456|P2|Eligible & Treated|Randomized Phase||72
7865696|NCT00880334|19358457|P1|Eligible & Treated|Randomized Phase||70
7865697|NCT00880334|19358456|P2|STARTED|Randomized Phase||75
7865698|NCT00880334|19358457|P1|STARTED|Randomized Phase||74
7865699|NCT00880269|19358474|P2|NOT COMPLETED|Overall Study||27
7865700|NCT00880269|19358475|P1|NOT COMPLETED|Overall Study||32
7865701|NCT00880269|19358474|P2|COMPLETED|Overall Study||0
7865702|NCT00880269|19358475|P1|COMPLETED|Overall Study||0
7865703|NCT00880269|19358474|P2|Discontinued Treatment|Overall Study||27
7865704|NCT00880269|19358475|P1|Discontinued Treatment|Overall Study||32
7865705|NCT00880269|19358474|P2|STARTED|Overall Study||27
7865706|NCT00880269|19358475|P1|STARTED|Overall Study||32
7865707|NCT00880256|19358491|P1|NOT COMPLETED|Overall Study||28
7865708|NCT00880256|19358491|P1|COMPLETED|Overall Study||65
7865709|NCT00880256|19358491|P1|STARTED|Overall Study||93
7865710|NCT00880230|19358496|P1|NOT COMPLETED|Overall Study||7
7865711|NCT00880230|19358496|P1|COMPLETED|Overall Study||134
7865712|NCT00880230|19358496|P1|STARTED|Overall Study||141
7865713|NCT00880191|19358518|P2|NOT COMPLETED|Overall Study||8
7865714|NCT00880191|19358519|P1|NOT COMPLETED|Overall Study||13
7865715|NCT00880191|19358518|P2|COMPLETED|Overall Study||198
7865716|NCT00880191|19358519|P1|COMPLETED|Overall Study||194
7865717|NCT00880191|19358518|P2|Available for Primary Endpoint Analysis|Overall Study||206
7865718|NCT00880191|19358519|P1|Available for Primary Endpoint Analysis|Overall Study||207
7865719|NCT00880191|19358518|P2|STARTED|Overall Study||206
7865720|NCT00880191|19358519|P1|STARTED|Overall Study||207
7865721|NCT00880165|19358539|P2|NOT COMPLETED|Overall Study||50
7865722|NCT00880165|19358540|P1|NOT COMPLETED|Overall Study||62
7865723|NCT00880165|19358539|P2|COMPLETED|Overall Study||98
7865724|NCT00880165|19358540|P1|COMPLETED|Overall Study||86
7865725|NCT00880165|19358539|P2|STARTED|Overall Study||148
7865726|NCT00880165|19358540|P1|STARTED|Overall Study||148
7865727|NCT00880100|19358550|P1|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3
7865728|NCT00880100|19358550|P1|COMPLETED|Treatment Phase With Ultrase® MT12||45
7865729|NCT00880100|19358550|P1|STARTED|Treatment Phase With Ultrase® MT12||48
7865730|NCT00880100|19358550|P1|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1
7865731|NCT00880100|19358550|P1|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48
7865732|NCT00880100|19358550|P1|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49
7865733|NCT00880087|19358563|P2|NOT COMPLETED|Overall Study||2
7865734|NCT00880087|19358564|P1|NOT COMPLETED|Overall Study||0
7865735|NCT00880087|19358563|P2|COMPLETED|Overall Study|Of 161 with 1-year vital status, 158 had received Therapeutic Normothermia, 3 received no treatment.|161
7865736|NCT00880087|19358564|P1|COMPLETED|Overall Study|1-year vital status available for all 166 Started patients.|166
7865737|NCT00880087|19358563|P2|STARTED|Overall Study|Among the 163 Started, 160 received Therapeutic Normothermia and 3 received no treatment.|163
7865738|NCT00880087|19358564|P1|STARTED|Overall Study|Among the 166 Started, 161 received Therapeutic Hypothermia and 5 received no treatment.|166
7865739|NCT00880048|19358579|P3|NOT COMPLETED|Overall Study||35
7865740|NCT00880048|19358580|P2|NOT COMPLETED|Overall Study||33
7865741|NCT00880048|19358581|P1|NOT COMPLETED|Overall Study||28
7865742|NCT00880048|19358579|P3|COMPLETED|Overall Study||77
7865743|NCT00880048|19358580|P2|COMPLETED|Overall Study||82
7865744|NCT00880048|19358581|P1|COMPLETED|Overall Study||88
7865745|NCT00880048|19358579|P3|STARTED|Overall Study||112
7865746|NCT00880048|19358580|P2|STARTED|Overall Study||115
7865747|NCT00880048|19358581|P1|STARTED|Overall Study||116
7865748|NCT00880022|19358639|P2|NOT COMPLETED|Overall Study||3
7865749|NCT00880022|19358640|P1|NOT COMPLETED|Overall Study||2
7865750|NCT00880022|19358639|P2|COMPLETED|Overall Study||21
7865751|NCT00880022|19358640|P1|COMPLETED|Overall Study||21
7865752|NCT00880022|19358639|P2|STARTED|Overall Study||24
7865753|NCT00880022|19358640|P1|STARTED|Overall Study||23
7865754|NCT00880009|19358648|P1|NOT COMPLETED|Overall Study||16
7865755|NCT00880009|19358648|P1|COMPLETED|Overall Study||0
7865756|NCT00880009|19358648|P1|STARTED|Overall Study||16
7865757|NCT00879996|19358672|P2|NOT COMPLETED|Overall Study||13
7865758|NCT00879996|19358673|P1|NOT COMPLETED|Overall Study||15
7865759|NCT00879996|19358672|P2|COMPLETED|Overall Study||13
7865760|NCT00879996|19358673|P1|COMPLETED|Overall Study||13
7865761|NCT00879996|19358672|P2|STARTED|Overall Study||26
7865762|NCT00879996|19358673|P1|STARTED|Overall Study||28
7865763|NCT00879970|19358688|P5|NOT COMPLETED|Period 2 Vitamin D Randomization||7
7865764|NCT00879970|19358689|P4|NOT COMPLETED|Period 2 Vitamin D Randomization||4
7865765|NCT00879970|19358690|P3|NOT COMPLETED|Period 2 Vitamin D Randomization||0
7865766|NCT00879970|19358691|P2|NOT COMPLETED|Period 2 Vitamin D Randomization||0
7865767|NCT00879970|19358692|P1|NOT COMPLETED|Period 2 Vitamin D Randomization||0
7865768|NCT00879970|19358688|P5|COMPLETED|Period 2 Vitamin D Randomization||600
7865769|NCT00879970|19358689|P4|COMPLETED|Period 2 Vitamin D Randomization||610
7865770|NCT00879970|19358690|P3|COMPLETED|Period 2 Vitamin D Randomization||0
7865771|NCT00879970|19358691|P2|COMPLETED|Period 2 Vitamin D Randomization||0
7865772|NCT00879970|19358692|P1|COMPLETED|Period 2 Vitamin D Randomization||0
7865773|NCT00879970|19358688|P5|STARTED|Period 2 Vitamin D Randomization||607
7865774|NCT00879970|19358689|P4|STARTED|Period 2 Vitamin D Randomization||614
7865775|NCT00879970|19358690|P3|STARTED|Period 2 Vitamin D Randomization||0
7865776|NCT00879970|19358691|P2|STARTED|Period 2 Vitamin D Randomization||0
7865777|NCT00879970|19358692|P1|STARTED|Period 2 Vitamin D Randomization||0
7865778|NCT00879970|19358688|P5|NOT COMPLETED|Period 1 TZD Randomization||0
7865779|NCT00879970|19358689|P4|NOT COMPLETED|Period 1 TZD Randomization||0
7865780|NCT00879970|19358690|P3|NOT COMPLETED|Period 1 TZD Randomization||6
7865781|NCT00879970|19358691|P2|NOT COMPLETED|Period 1 TZD Randomization||4
7865782|NCT00879970|19358692|P1|NOT COMPLETED|Period 1 TZD Randomization||8
7865783|NCT00879970|19358688|P5|COMPLETED|Period 1 TZD Randomization||0
7865784|NCT00879970|19358689|P4|COMPLETED|Period 1 TZD Randomization||0
7865785|NCT00879970|19358690|P3|COMPLETED|Period 1 TZD Randomization||393
7865786|NCT00879970|19358691|P2|COMPLETED|Period 1 TZD Randomization||388
7865787|NCT00879970|19358692|P1|COMPLETED|Period 1 TZD Randomization||533
7865788|NCT00879970|19358688|P5|STARTED|Period 1 TZD Randomization||0
7865789|NCT00879970|19358689|P4|STARTED|Period 1 TZD Randomization||0
7865790|NCT00879970|19358690|P3|STARTED|Period 1 TZD Randomization||399
7865791|NCT00879970|19358691|P2|STARTED|Period 1 TZD Randomization||392
7865792|NCT00879970|19358692|P1|STARTED|Period 1 TZD Randomization||541
7865793|NCT00879879|19358774|P1|NOT COMPLETED|Overall Study||3
7865794|NCT00879879|19358774|P1|COMPLETED|Overall Study||17
7865795|NCT00879879|19358774|P1|STARTED|Overall Study||20
7865796|NCT00879814|19358782|P4|NOT COMPLETED|Overall Study||5
7865797|NCT00879814|19358783|P3|NOT COMPLETED|Overall Study||3
7865798|NCT00879814|19358784|P2|NOT COMPLETED|Overall Study||2
7865799|NCT00879814|19358785|P1|NOT COMPLETED|Overall Study||4
7865800|NCT00879814|19358782|P4|COMPLETED|Overall Study||7
7865801|NCT00879814|19358783|P3|COMPLETED|Overall Study||9
7865802|NCT00879814|19358784|P2|COMPLETED|Overall Study||10
7865803|NCT00879814|19358785|P1|COMPLETED|Overall Study||8
7865804|NCT00879814|19358782|P4|STARTED|Overall Study||12
7865805|NCT00879814|19358783|P3|STARTED|Overall Study||12
7865806|NCT00879814|19358784|P2|STARTED|Overall Study||12
7865807|NCT00879814|19358785|P1|STARTED|Overall Study||12
7865808|NCT00879775|19358893|P2|NOT COMPLETED|Overall Study||1
7865809|NCT00879775|19358894|P1|NOT COMPLETED|Overall Study||2
7865810|NCT00879775|19358893|P2|COMPLETED|Overall Study||20
7865811|NCT00879775|19358894|P1|COMPLETED|Overall Study||18
7865812|NCT00879775|19358893|P2|STARTED|Overall Study||21
7865813|NCT00879775|19358894|P1|STARTED|Overall Study||20
7865814|NCT00879710|19358910|P4|NOT COMPLETED|Phase 2 6 Weeks||0
7865815|NCT00879710|19358911|P3|NOT COMPLETED|Phase 2 6 Weeks||0
7865816|NCT00879710|19358912|P2|NOT COMPLETED|Phase 2 6 Weeks||0
7865817|NCT00879710|19358913|P1|NOT COMPLETED|Phase 2 6 Weeks||0
7865818|NCT00879710|19358910|P4|COMPLETED|Phase 2 6 Weeks||13
7865819|NCT00879710|19358911|P3|COMPLETED|Phase 2 6 Weeks||10
7865820|NCT00879710|19358912|P2|COMPLETED|Phase 2 6 Weeks||14
7865821|NCT00879710|19358913|P1|COMPLETED|Phase 2 6 Weeks||10
7865822|NCT00879710|19358910|P4|STARTED|Phase 2 6 Weeks||13
7865823|NCT00879710|19358911|P3|STARTED|Phase 2 6 Weeks||10
7865824|NCT00879710|19358912|P2|STARTED|Phase 2 6 Weeks||14
7865825|NCT00879710|19358913|P1|STARTED|Phase 2 6 Weeks||10
7865826|NCT00879710|19358910|P4|NOT COMPLETED|Wash Out Period of 4 Weeks||0
7865827|NCT00879710|19358911|P3|NOT COMPLETED|Wash Out Period of 4 Weeks||0
7865828|NCT00879710|19358912|P2|NOT COMPLETED|Wash Out Period of 4 Weeks||0
7865829|NCT00879710|19358913|P1|NOT COMPLETED|Wash Out Period of 4 Weeks||0
7865830|NCT00879710|19358910|P4|COMPLETED|Wash Out Period of 4 Weeks||13
7865831|NCT00879710|19358911|P3|COMPLETED|Wash Out Period of 4 Weeks||10
7865832|NCT00879710|19358912|P2|COMPLETED|Wash Out Period of 4 Weeks||14
7865833|NCT00879710|19358913|P1|COMPLETED|Wash Out Period of 4 Weeks||10
7865834|NCT00879710|19358910|P4|STARTED|Wash Out Period of 4 Weeks||13
7865920|NCT00879645|19359098|P3|NOT COMPLETED|Overall Study||0
7865835|NCT00879710|19358911|P3|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10
7865836|NCT00879710|19358912|P2|STARTED|Wash Out Period of 4 Weeks||14
7865837|NCT00879710|19358913|P1|STARTED|Wash Out Period of 4 Weeks||10
7865838|NCT00879710|19358910|P4|NOT COMPLETED|Phase 1 - 6 Weeks||4
7865839|NCT00879710|19358911|P3|NOT COMPLETED|Phase 1 - 6 Weeks||2
7865840|NCT00879710|19358912|P2|NOT COMPLETED|Phase 1 - 6 Weeks||3
7865841|NCT00879710|19358913|P1|NOT COMPLETED|Phase 1 - 6 Weeks||2
7865842|NCT00879710|19358910|P4|COMPLETED|Phase 1 - 6 Weeks||13
7865843|NCT00879710|19358911|P3|COMPLETED|Phase 1 - 6 Weeks||9
7865844|NCT00879710|19358912|P2|COMPLETED|Phase 1 - 6 Weeks||14
7865845|NCT00879710|19358913|P1|COMPLETED|Phase 1 - 6 Weeks||10
7865846|NCT00879710|19358910|P4|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17
7865847|NCT00879710|19358911|P3|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11
7865848|NCT00879710|19358912|P2|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17
7865849|NCT00879710|19358913|P1|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12
7865850|NCT00879697|19358923|P2|NOT COMPLETED|Overall Study||2
7865851|NCT00879697|19358924|P1|NOT COMPLETED|Overall Study||2
7865852|NCT00879697|19358923|P2|COMPLETED|Overall Study|Two patients did not finish the trial|15
7865853|NCT00879697|19358924|P1|COMPLETED|Overall Study|Two patients did not finish the trial|15
7865854|NCT00879697|19358923|P2|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
7865855|NCT00879697|19358924|P1|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
7865856|NCT00879684|19358930|P7|NOT COMPLETED|Stage 2: Expanded Cohort||13
7865857|NCT00879684|19358931|P6|NOT COMPLETED|Stage 2: Expanded Cohort||0
7865858|NCT00879684|19358932|P5|NOT COMPLETED|Stage 2: Expanded Cohort||0
7865859|NCT00879684|19358933|P4|NOT COMPLETED|Stage 2: Expanded Cohort||0
7865860|NCT00879684|19358934|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
7865861|NCT00879684|19358935|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
7865862|NCT00879684|19358936|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
7865863|NCT00879684|19358930|P7|COMPLETED|Stage 2: Expanded Cohort||0
7865864|NCT00879684|19358931|P6|COMPLETED|Stage 2: Expanded Cohort||0
7865865|NCT00879684|19358932|P5|COMPLETED|Stage 2: Expanded Cohort||0
7865866|NCT00879684|19358933|P4|COMPLETED|Stage 2: Expanded Cohort||0
7865867|NCT00879684|19358934|P3|COMPLETED|Stage 2: Expanded Cohort||0
7865868|NCT00879684|19358935|P2|COMPLETED|Stage 2: Expanded Cohort||0
7865869|NCT00879684|19358936|P1|COMPLETED|Stage 2: Expanded Cohort||0
7865870|NCT00879684|19358930|P7|STARTED|Stage 2: Expanded Cohort||13
7865871|NCT00879684|19358931|P6|STARTED|Stage 2: Expanded Cohort||0
7865872|NCT00879684|19358932|P5|STARTED|Stage 2: Expanded Cohort||0
7865873|NCT00879684|19358933|P4|STARTED|Stage 2: Expanded Cohort||0
7865874|NCT00879684|19358934|P3|STARTED|Stage 2: Expanded Cohort||0
7865875|NCT00879684|19358935|P2|STARTED|Stage 2: Expanded Cohort||0
7865876|NCT00879684|19358936|P1|STARTED|Stage 2: Expanded Cohort||0
7865877|NCT00879684|19358930|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
7865878|NCT00879684|19358931|P6|NOT COMPLETED|Stage 1: Dose Escalation||3
7865879|NCT00879684|19358932|P5|NOT COMPLETED|Stage 1: Dose Escalation||3
7865880|NCT00879684|19358933|P4|NOT COMPLETED|Stage 1: Dose Escalation||6
7865881|NCT00879684|19358934|P3|NOT COMPLETED|Stage 1: Dose Escalation||3
7865882|NCT00879684|19358935|P2|NOT COMPLETED|Stage 1: Dose Escalation||3
7865883|NCT00879684|19358936|P1|NOT COMPLETED|Stage 1: Dose Escalation||3
7865884|NCT00879684|19358930|P7|COMPLETED|Stage 1: Dose Escalation||0
7865885|NCT00879684|19358931|P6|COMPLETED|Stage 1: Dose Escalation||0
7865886|NCT00879684|19358932|P5|COMPLETED|Stage 1: Dose Escalation||0
7865887|NCT00879684|19358933|P4|COMPLETED|Stage 1: Dose Escalation||0
7865888|NCT00879684|19358934|P3|COMPLETED|Stage 1: Dose Escalation||0
7865889|NCT00879684|19358935|P2|COMPLETED|Stage 1: Dose Escalation||0
7865890|NCT00879684|19358936|P1|COMPLETED|Stage 1: Dose Escalation||0
7865891|NCT00879684|19358930|P7|STARTED|Stage 1: Dose Escalation||0
7865892|NCT00879684|19358931|P6|STARTED|Stage 1: Dose Escalation||3
7865893|NCT00879684|19358932|P5|STARTED|Stage 1: Dose Escalation||3
7865894|NCT00879684|19358933|P4|STARTED|Stage 1: Dose Escalation||6
7865895|NCT00879684|19358934|P3|STARTED|Stage 1: Dose Escalation||3
7865896|NCT00879684|19358935|P2|STARTED|Stage 1: Dose Escalation||3
7865897|NCT00879684|19358936|P1|STARTED|Stage 1: Dose Escalation||3
7865898|NCT00879658|19359005|P7|NOT COMPLETED|Overall Study||0
7865899|NCT00879658|19359006|P6|NOT COMPLETED|Overall Study||1
7865900|NCT00879658|19359007|P5|NOT COMPLETED|Overall Study||2
7865901|NCT00879658|19359008|P4|NOT COMPLETED|Overall Study||4
7865902|NCT00879658|19359009|P3|NOT COMPLETED|Overall Study||7
7865903|NCT00879658|19359010|P2|NOT COMPLETED|Overall Study||5
7865904|NCT00879658|19359011|P1|NOT COMPLETED|Overall Study||15
7865905|NCT00879658|19359005|P7|COMPLETED|Overall Study||16
7865906|NCT00879658|19359006|P6|COMPLETED|Overall Study||50
7865907|NCT00879658|19359007|P5|COMPLETED|Overall Study||40
7865908|NCT00879658|19359008|P4|COMPLETED|Overall Study||42
7865909|NCT00879658|19359009|P3|COMPLETED|Overall Study||36
7865910|NCT00879658|19359010|P2|COMPLETED|Overall Study||44
7865911|NCT00879658|19359011|P1|COMPLETED|Overall Study||35
7865912|NCT00879658|19359005|P7|STARTED|Overall Study||16
7865913|NCT00879658|19359006|P6|STARTED|Overall Study||51
7865914|NCT00879658|19359007|P5|STARTED|Overall Study||42
7865915|NCT00879658|19359008|P4|STARTED|Overall Study||46
7865916|NCT00879658|19359009|P3|STARTED|Overall Study||43
7865917|NCT00879658|19359010|P2|STARTED|Overall Study||49
7865918|NCT00879658|19359011|P1|STARTED|Overall Study||50
7865919|NCT00879645|19359097|P4|NOT COMPLETED|Overall Study||0
7865921|NCT00879645|19359099|P2|NOT COMPLETED|Overall Study||0
7865922|NCT00879645|19359100|P1|NOT COMPLETED|Overall Study||1
7865923|NCT00879645|19359097|P4|COMPLETED|Overall Study||7
7865924|NCT00879645|19359098|P3|COMPLETED|Overall Study||6
7865925|NCT00879645|19359099|P2|COMPLETED|Overall Study||6
7865926|NCT00879645|19359100|P1|COMPLETED|Overall Study||8
7865927|NCT00879645|19359097|P4|STARTED|Overall Study||7
7865928|NCT00879645|19359098|P3|STARTED|Overall Study||6
7865929|NCT00879645|19359099|P2|STARTED|Overall Study||6
7865930|NCT00879645|19359100|P1|STARTED|Overall Study||9
7865931|NCT00879619|19359118|P1|NOT COMPLETED|Overall Study||0
7865932|NCT00879619|19359118|P1|COMPLETED|Overall Study||4
7865933|NCT00879619|19359118|P1|STARTED|Overall Study||4
7865934|NCT00879411|19359127|P1|NOT COMPLETED|Overall Study||162
7865935|NCT00879411|19359127|P1|COMPLETED|Overall Study||539
7865936|NCT00879411|19359127|P1|STARTED|Overall Study||701
7865937|NCT00879398|19359133|P1|NOT COMPLETED|Overall Study||675
7865938|NCT00879398|19359133|P1|COMPLETED|Overall Study||2434
7865939|NCT00879398|19359133|P1|STARTED|Overall Study||3109
7865940|NCT00879359|19359143|P1|NOT COMPLETED|Overall Study||0
7865941|NCT00879359|19359143|P1|COMPLETED|Overall Study||15
7865942|NCT00879359|19359143|P1|STARTED|Overall Study||15
7865943|NCT00879333|19359151|P2|NOT COMPLETED|Overall Study||217
7865944|NCT00879333|19359152|P1|NOT COMPLETED|Overall Study||428
7865945|NCT00879333|19359151|P2|COMPLETED|Overall Study||0
7865946|NCT00879333|19359152|P1|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11
7865947|NCT00879333|19359151|P2|Discontinued Study Treatment|Overall Study||217
7865948|NCT00879333|19359152|P1|Discontinued Study Treatment|Overall Study||428
7865949|NCT00879333|19359151|P2|STARTED|Overall Study||217
7865950|NCT00879333|19359152|P1|STARTED|Overall Study||439
7865951|NCT00879255|19359172|P2|NOT COMPLETED|Overall Study||19
7865952|NCT00879255|19359173|P1|NOT COMPLETED|Overall Study||16
7865953|NCT00879255|19359172|P2|COMPLETED|Overall Study|Completed 6-mo follow-up|45
7865954|NCT00879255|19359173|P1|COMPLETED|Overall Study|Completed 6-mo follow-up|45
7865955|NCT00879255|19359172|P2|Completed 3-mo Follow-up|Overall Study||49
7865956|NCT00879255|19359173|P1|Completed 3-mo Follow-up|Overall Study||48
7865957|NCT00879255|19359172|P2|Completed Posttreatment Follow-up|Overall Study||55
7865958|NCT00879255|19359173|P1|Completed Posttreatment Follow-up|Overall Study||50
7865959|NCT00879255|19359172|P2|Received Allocated Intervention:|Overall Study||56
7865960|NCT00879255|19359173|P1|Received Allocated Intervention:|Overall Study||51
7865961|NCT00879255|19359172|P2|STARTED|Overall Study||64
7865962|NCT00879255|19359173|P1|STARTED|Overall Study||61
7865963|NCT00879229|19359185|P2|NOT COMPLETED|Overall Study||14
7865964|NCT00879229|19359186|P1|NOT COMPLETED|Overall Study||22
7865965|NCT00879229|19359185|P2|COMPLETED|Overall Study||1
7865966|NCT00879229|19359186|P1|COMPLETED|Overall Study||3
7865967|NCT00879229|19359185|P2|STARTED|Overall Study||15
7865968|NCT00879229|19359186|P1|STARTED|Overall Study||25
7865969|NCT00879190|19359212|P2|NOT COMPLETED|Overall Study||0
7865970|NCT00879190|19359213|P1|NOT COMPLETED|Overall Study||0
7865971|NCT00879190|19359212|P2|COMPLETED|Overall Study||49
7865972|NCT00879190|19359213|P1|COMPLETED|Overall Study||43
7865973|NCT00879190|19359212|P2|STARTED|Overall Study||49
7865974|NCT00879190|19359213|P1|STARTED|Overall Study||43
7865975|NCT00879034|19359223|P1|NOT COMPLETED|Overall Study||0
7865976|NCT00879034|19359223|P1|COMPLETED|Overall Study||5
7865977|NCT00879034|19359223|P1|Received Treatment|Overall Study||4
7865978|NCT00879034|19359223|P1|STARTED|Overall Study||5
7865979|NCT00878995|19359234|P2|NOT COMPLETED|Midpoint Study - Post Study||0
7865980|NCT00878995|19359235|P1|NOT COMPLETED|Midpoint Study - Post Study||0
7865981|NCT00878995|19359234|P2|COMPLETED|Midpoint Study - Post Study||10
7865982|NCT00878995|19359235|P1|COMPLETED|Midpoint Study - Post Study||12
7865983|NCT00878995|19359234|P2|STARTED|Midpoint Study - Post Study||10
7865984|NCT00878995|19359235|P1|STARTED|Midpoint Study - Post Study||12
7865985|NCT00878995|19359234|P2|NOT COMPLETED|Baseline Study - Midpoint Study||2
7865986|NCT00878995|19359235|P1|NOT COMPLETED|Baseline Study - Midpoint Study||0
7865987|NCT00878995|19359234|P2|COMPLETED|Baseline Study - Midpoint Study|2 subjects dropped after the baseline study. They decided to seek treatment closer to home.|10
7865988|NCT00878995|19359235|P1|COMPLETED|Baseline Study - Midpoint Study||12
7865989|NCT00878995|19359234|P2|Baseline Study|Baseline Study - Midpoint Study||12
7865990|NCT00878995|19359235|P1|Baseline Study|Baseline Study - Midpoint Study||12
7865991|NCT00878995|19359234|P2|STARTED|Baseline Study - Midpoint Study||12
7865992|NCT00878995|19359235|P1|STARTED|Baseline Study - Midpoint Study||12
7865993|NCT00878969|19359336|P3|NOT COMPLETED|Overall Study||11
7865994|NCT00878969|19359337|P2|NOT COMPLETED|Overall Study||15
7865995|NCT00878969|19359338|P1|NOT COMPLETED|Overall Study||15
7865996|NCT00878969|19359336|P3|COMPLETED|Overall Study||15
7865997|NCT00878969|19359337|P2|COMPLETED|Overall Study||12
7865998|NCT00878969|19359338|P1|COMPLETED|Overall Study||10
7865999|NCT00878969|19359336|P3|STARTED|Overall Study||26
7866000|NCT00878969|19359337|P2|STARTED|Overall Study||27
7866001|NCT00878969|19359338|P1|STARTED|Overall Study||25
7866002|NCT00878878|19359348|P2|NOT COMPLETED|Overall Study||0
7866003|NCT00878878|19359349|P1|NOT COMPLETED|Overall Study||0
7866004|NCT00878878|19359348|P2|COMPLETED|Overall Study||15
7866005|NCT00878878|19359349|P1|COMPLETED|Overall Study||15
7866006|NCT00878878|19359348|P2|STARTED|Overall Study||15
7866007|NCT00878878|19359349|P1|STARTED|Overall Study||15
7866008|NCT00878826|19359362|P3|NOT COMPLETED|Overall Study||0
7866009|NCT00878826|19359363|P2|NOT COMPLETED|Overall Study||0
7866010|NCT00878826|19359364|P1|NOT COMPLETED|Overall Study||0
7866011|NCT00878826|19359362|P3|COMPLETED|Overall Study||2
7866012|NCT00878826|19359363|P2|COMPLETED|Overall Study||6
7866013|NCT00878826|19359364|P1|COMPLETED|Overall Study||3
7866014|NCT00878826|19359362|P3|STARTED|Overall Study||2
7866015|NCT00878826|19359363|P2|STARTED|Overall Study||6
7866016|NCT00878826|19359364|P1|STARTED|Overall Study||3
7866017|NCT00878800|19359386|P5|NOT COMPLETED|Overall Study||16
7866018|NCT00878800|19359387|P4|NOT COMPLETED|Overall Study||6
7866019|NCT00878800|19359388|P3|NOT COMPLETED|Overall Study||9
7866020|NCT00878800|19359389|P2|NOT COMPLETED|Overall Study||7
7866021|NCT00878800|19359390|P1|NOT COMPLETED|Overall Study||3
7866022|NCT00878800|19359386|P5|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0
7866023|NCT00878800|19359387|P4|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0
7866024|NCT00878800|19359388|P3|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0
7866025|NCT00878800|19359389|P2|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0
7866026|NCT00878800|19359390|P1|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0
7866027|NCT00878800|19359386|P5|STARTED|Overall Study||16
7866028|NCT00878800|19359387|P4|STARTED|Overall Study||6
7866029|NCT00878800|19359388|P3|STARTED|Overall Study||9
7866030|NCT00878800|19359389|P2|STARTED|Overall Study||7
7866031|NCT00878800|19359390|P1|STARTED|Overall Study||3
7866032|NCT00878722|19359425|P8|NOT COMPLETED|Overall Study||7
7866033|NCT00878722|19359426|P7|NOT COMPLETED|Overall Study||6
7866034|NCT00878722|19359427|P6|NOT COMPLETED|Overall Study||2
7866035|NCT00878722|19359428|P5|NOT COMPLETED|Overall Study||7
7866036|NCT00878722|19359429|P4|NOT COMPLETED|Overall Study||9
7866037|NCT00878722|19359430|P3|NOT COMPLETED|Overall Study||3
7866038|NCT00878722|19359431|P2|NOT COMPLETED|Overall Study||3
7866039|NCT00878722|19359432|P1|NOT COMPLETED|Overall Study||3
7866040|NCT00878722|19359425|P8|COMPLETED|Overall Study||0
7866041|NCT00878722|19359426|P7|COMPLETED|Overall Study||0
7866042|NCT00878722|19359427|P6|COMPLETED|Overall Study||1
7866043|NCT00878722|19359428|P5|COMPLETED|Overall Study||0
7866044|NCT00878722|19359429|P4|COMPLETED|Overall Study||0
7866045|NCT00878722|19359430|P3|COMPLETED|Overall Study||0
7866046|NCT00878722|19359431|P2|COMPLETED|Overall Study||0
7866047|NCT00878722|19359432|P1|COMPLETED|Overall Study||0
7866048|NCT00878722|19359425|P8|STARTED|Overall Study||7
7866049|NCT00878722|19359426|P7|STARTED|Overall Study||6
7866050|NCT00878722|19359427|P6|STARTED|Overall Study||3
7866051|NCT00878722|19359428|P5|STARTED|Overall Study||7
7866052|NCT00878722|19359429|P4|STARTED|Overall Study||9
7866053|NCT00878722|19359430|P3|STARTED|Overall Study||3
7866054|NCT00878722|19359431|P2|STARTED|Overall Study||3
7866055|NCT00878722|19359432|P1|STARTED|Overall Study||3
7866056|NCT00878709|19359517|P2|NOT COMPLETED|Overall Study||237
7866057|NCT00878709|19359518|P1|NOT COMPLETED|Overall Study||325
7866058|NCT00878709|19359517|P2|COMPLETED|Overall Study||1183
7866059|NCT00878709|19359518|P1|COMPLETED|Overall Study||1095
7866060|NCT00878709|19359517|P2|STARTED|Overall Study||1420
7866061|NCT00878709|19359518|P1|STARTED|Overall Study||1420
7866062|NCT00878644|19359558|P2|NOT COMPLETED|Overall Study||4
7866063|NCT00878644|19359559|P1|NOT COMPLETED|Overall Study||4
7866064|NCT00878644|19359558|P2|COMPLETED|Overall Study||136
7866065|NCT00878644|19359559|P1|COMPLETED|Overall Study||151
7866066|NCT00878644|19359558|P2|STARTED|Overall Study||140
7866067|NCT00878644|19359559|P1|STARTED|Overall Study||155
7866068|NCT00878605|19359575|P4|NOT COMPLETED|Overall Study||3
7866069|NCT00878605|19359576|P3|NOT COMPLETED|Overall Study||1
7866070|NCT00878605|19359577|P2|NOT COMPLETED|Overall Study||3
7866071|NCT00878605|19359578|P1|NOT COMPLETED|Overall Study||3
7866072|NCT00878605|19359575|P4|COMPLETED|Overall Study||6
7866073|NCT00878605|19359576|P3|COMPLETED|Overall Study||8
7866074|NCT00878605|19359577|P2|COMPLETED|Overall Study||7
7866075|NCT00878605|19359578|P1|COMPLETED|Overall Study||7
7866076|NCT00878605|19359575|P4|STARTED|Overall Study||9
7866077|NCT00878605|19359576|P3|STARTED|Overall Study||9
7866078|NCT00878605|19359577|P2|STARTED|Overall Study||10
7866079|NCT00878605|19359578|P1|STARTED|Overall Study||10
7866080|NCT00878553|19359592|P5|NOT COMPLETED|PK Study||0
7866081|NCT00878553|19359593|P4|NOT COMPLETED|PK Study||1
7866082|NCT00878553|19359594|P3|NOT COMPLETED|PK Study||0
7866083|NCT00878553|19359595|P2|NOT COMPLETED|PK Study||0
7866084|NCT00878553|19359596|P1|NOT COMPLETED|PK Study||0
7866085|NCT00878553|19359592|P5|COMPLETED|PK Study||15
7866086|NCT00878553|19359593|P4|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13
7866087|NCT00878553|19359594|P3|COMPLETED|PK Study||17
7866088|NCT00878553|19359595|P2|COMPLETED|PK Study||16
7866089|NCT00878553|19359596|P1|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0
7866090|NCT00878553|19359592|P5|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15
7866091|NCT00878553|19359593|P4|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14
7866092|NCT00878553|19359594|P3|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17
7866093|NCT00878553|19359595|P2|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16
7866094|NCT00878553|19359596|P1|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0
7866095|NCT00878553|19359592|P5|NOT COMPLETED|Sleep Study||0
7866096|NCT00878553|19359593|P4|NOT COMPLETED|Sleep Study||0
7866097|NCT00878553|19359594|P3|NOT COMPLETED|Sleep Study||0
7866098|NCT00878553|19359595|P2|NOT COMPLETED|Sleep Study||0
7866099|NCT00878553|19359596|P1|NOT COMPLETED|Sleep Study||5
7866100|NCT00878553|19359592|P5|COMPLETED|Sleep Study||0
7866101|NCT00878553|19359593|P4|COMPLETED|Sleep Study||0
7866102|NCT00878553|19359594|P3|COMPLETED|Sleep Study||0
7866103|NCT00878553|19359595|P2|COMPLETED|Sleep Study||0
7866104|NCT00878553|19359596|P1|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62
7866105|NCT00878553|19359592|P5|Number of Patients Receiving 20mg|Sleep Study||0
7866106|NCT00878553|19359593|P4|Number of Patients Receiving 20mg|Sleep Study||0
7866107|NCT00878553|19359594|P3|Number of Patients Receiving 20mg|Sleep Study||0
7866108|NCT00878553|19359595|P2|Number of Patients Receiving 20mg|Sleep Study||0
7866109|NCT00878553|19359596|P1|Number of Patients Receiving 20mg|Sleep Study||65
7866110|NCT00878553|19359592|P5|Number of Patients Receiving 15mg|Sleep Study||0
7866111|NCT00878553|19359593|P4|Number of Patients Receiving 15mg|Sleep Study||0
7866112|NCT00878553|19359594|P3|Number of Patients Receiving 15mg|Sleep Study||0
7866113|NCT00878553|19359595|P2|Number of Patients Receiving 15mg|Sleep Study||0
7866114|NCT00878553|19359596|P1|Number of Patients Receiving 15mg|Sleep Study||65
7866115|NCT00878553|19359592|P5|Number of Patients Receiving 10mg|Sleep Study||0
7866116|NCT00878553|19359593|P4|Number of Patients Receiving 10mg|Sleep Study||0
7866117|NCT00878553|19359594|P3|Number of Patients Receiving 10mg|Sleep Study||0
7866118|NCT00878553|19359595|P2|Number of Patients Receiving 10mg|Sleep Study||0
7866119|NCT00878553|19359596|P1|Number of Patients Receiving 10mg|Sleep Study||65
7866120|NCT00878553|19359592|P5|Number of Patients Receiving Placebo|Sleep Study||0
7866121|NCT00878553|19359593|P4|Number of Patients Receiving Placebo|Sleep Study||0
7866122|NCT00878553|19359594|P3|Number of Patients Receiving Placebo|Sleep Study||0
7866123|NCT00878553|19359595|P2|Number of Patients Receiving Placebo|Sleep Study||0
7866124|NCT00878553|19359596|P1|Number of Patients Receiving Placebo|Sleep Study||66
7866125|NCT00878553|19359592|P5|STARTED|Sleep Study||0
7866126|NCT00878553|19359593|P4|STARTED|Sleep Study||0
7866127|NCT00878553|19359594|P3|STARTED|Sleep Study||0
7866128|NCT00878553|19359595|P2|STARTED|Sleep Study||0
7866129|NCT00878553|19359596|P1|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67
7866130|NCT00878501|19359655|P3|NOT COMPLETED|Overall Study||8
7866131|NCT00878501|19359656|P2|NOT COMPLETED|Overall Study||7
7866132|NCT00878501|19359657|P1|NOT COMPLETED|Overall Study||17
7866133|NCT00878501|19359655|P3|COMPLETED|Overall Study||85
7866134|NCT00878501|19359656|P2|COMPLETED|Overall Study||37
7866135|NCT00878501|19359657|P1|COMPLETED|Overall Study||87
7866136|NCT00878501|19359655|P3|Interim Analysis|Overall Study||81
7866137|NCT00878501|19359656|P2|Interim Analysis|Overall Study||37
7866138|NCT00878501|19359657|P1|Interim Analysis|Overall Study||83
7866139|NCT00878501|19359655|P3|STARTED|Overall Study||93
7866140|NCT00878501|19359656|P2|STARTED|Overall Study||44
7866141|NCT00878501|19359657|P1|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104
7866142|NCT00878436|19359676|P2|NOT COMPLETED|Overall Study||24
7866143|NCT00878436|19359677|P1|NOT COMPLETED|Overall Study||23
7866144|NCT00878436|19359676|P2|COMPLETED|Overall Study||0
7866145|NCT00878436|19359677|P1|COMPLETED|Overall Study||5
7866146|NCT00878436|19359676|P2|6 Months|Overall Study||0
7866147|NCT00878436|19359677|P1|6 Months|Overall Study||8
7866148|NCT00878436|19359676|P2|Completed 2 Cycles|Overall Study||20
7866149|NCT00878436|19359677|P1|Completed 2 Cycles|Overall Study||21
7866150|NCT00878436|19359676|P2|STARTED|Overall Study||24
7866151|NCT00878436|19359677|P1|STARTED|Overall Study||28
7866152|NCT00878228|19359691|P2|NOT COMPLETED|Overall Study||12
7866153|NCT00878228|19359692|P1|NOT COMPLETED|Overall Study||10
7866154|NCT00878228|19359691|P2|COMPLETED|Overall Study||37
7866155|NCT00878228|19359692|P1|COMPLETED|Overall Study||39
7866156|NCT00878228|19359691|P2|STARTED|Overall Study||49
7866157|NCT00878228|19359692|P1|STARTED|Overall Study||49
7866158|NCT00878215|19359706|P4|NOT COMPLETED|Overall Study||0
7866159|NCT00878215|19359707|P3|NOT COMPLETED|Overall Study||0
7866160|NCT00878215|19359708|P2|NOT COMPLETED|Overall Study||10
7866161|NCT00878215|19359709|P1|NOT COMPLETED|Overall Study||0
7866162|NCT00878215|19359706|P4|COMPLETED|Overall Study||0
7866163|NCT00878215|19359707|P3|COMPLETED|Overall Study||0
7866164|NCT00878215|19359708|P2|COMPLETED|Overall Study||9
7866165|NCT00878215|19359709|P1|COMPLETED|Overall Study||21
7866166|NCT00878215|19359706|P4|STARTED|Overall Study|Phase 4 not performed because the liver imaging system became commercially available|0
7866167|NCT00878215|19359707|P3|STARTED|Overall Study|Phase 3 not performed because the liver imaging system became commercially available|0
7866168|NCT00878215|19359708|P2|STARTED|Overall Study||19
7866169|NCT00878215|19359709|P1|STARTED|Overall Study||21
7866170|NCT00878189|19359721|P9|NOT COMPLETED|Overall Study||8
7866171|NCT00878189|19359722|P8|NOT COMPLETED|Overall Study||3
7866172|NCT00878189|19359723|P7|NOT COMPLETED|Overall Study||16
7866173|NCT00878189|19359724|P6|NOT COMPLETED|Overall Study||23
7866174|NCT00878189|19359725|P5|NOT COMPLETED|Overall Study||4
7866175|NCT00878189|19359726|P4|NOT COMPLETED|Overall Study||8
7866176|NCT00878189|19359727|P3|NOT COMPLETED|Overall Study||4
7866177|NCT00878189|19359728|P2|NOT COMPLETED|Overall Study||3
7866178|NCT00878189|19359729|P1|NOT COMPLETED|Overall Study||3
7866179|NCT00878189|19359721|P9|COMPLETED|Overall Study||0
7866180|NCT00878189|19359722|P8|COMPLETED|Overall Study||0
7866181|NCT00878189|19359723|P7|COMPLETED|Overall Study||0
7866182|NCT00878189|19359724|P6|COMPLETED|Overall Study||0
7866183|NCT00878189|19359725|P5|COMPLETED|Overall Study||0
7866184|NCT00878189|19359726|P4|COMPLETED|Overall Study||0
7866185|NCT00878189|19359727|P3|COMPLETED|Overall Study||0
7866186|NCT00878189|19359728|P2|COMPLETED|Overall Study||0
7866187|NCT00878189|19359729|P1|COMPLETED|Overall Study||0
7866188|NCT00878189|19359721|P9|STARTED|Overall Study||8
7866189|NCT00878189|19359722|P8|STARTED|Overall Study||3
7866190|NCT00878189|19359723|P7|STARTED|Overall Study||16
7866191|NCT00878189|19359724|P6|STARTED|Overall Study||23
7866192|NCT00878189|19359725|P5|STARTED|Overall Study||4
7866193|NCT00878189|19359726|P4|STARTED|Overall Study||8
7866194|NCT00878189|19359727|P3|STARTED|Overall Study||4
7866195|NCT00878189|19359728|P2|STARTED|Overall Study||3
7866196|NCT00878189|19359729|P1|STARTED|Overall Study||3
7866197|NCT00877929|19359997|P2|NOT COMPLETED|Overall Study||35
7866198|NCT00877929|19359998|P1|NOT COMPLETED|Overall Study||20
7866199|NCT00877929|19359997|P2|COMPLETED|Overall Study||319
7866200|NCT00877929|19359998|P1|COMPLETED|Overall Study||332
7866201|NCT00877929|19359997|P2|STARTED|Overall Study||354
7866202|NCT00877929|19359998|P1|STARTED|Overall Study||352
7866203|NCT00877890|19360086|P2|NOT COMPLETED|Overall Study||30
7866204|NCT00877890|19360087|P1|NOT COMPLETED|Overall Study||20
7866205|NCT00877890|19360086|P2|COMPLETED|Overall Study||95
7866206|NCT00877890|19360087|P1|COMPLETED|Overall Study||109
7866207|NCT00877890|19360086|P2|Intent to Treat (ITT)|Overall Study||123
7866208|NCT00877890|19360087|P1|Intent to Treat (ITT)|Overall Study||129
7866209|NCT00877890|19360086|P2|STARTED|Overall Study||125
7866210|NCT00877890|19360087|P1|STARTED|Overall Study||129
7866211|NCT00877877|19360121|P1|NOT COMPLETED|Year 10||0
7866212|NCT00877877|19360121|P1|COMPLETED|Year 10||495
7866213|NCT00877877|19360121|P1|STARTED|Year 10||495
7866214|NCT00877877|19360121|P1|NOT COMPLETED|Year 9||0
7866215|NCT00877877|19360121|P1|COMPLETED|Year 9||507
7866216|NCT00877877|19360121|P1|STARTED|Year 9||507
7866217|NCT00877877|19360121|P1|NOT COMPLETED|Year 8||0
7866218|NCT00877877|19360121|P1|COMPLETED|Year 8||522
7866219|NCT00877877|19360121|P1|STARTED|Year 8||522
7866220|NCT00877877|19360121|P1|NOT COMPLETED|Year 7||0
7866221|NCT00877877|19360121|P1|COMPLETED|Year 7||523
7866222|NCT00877877|19360121|P1|STARTED|Year 7||523
7866223|NCT00877877|19360121|P1|NOT COMPLETED|Year 6||0
7866224|NCT00877877|19360121|P1|COMPLETED|Year 6||529
7866225|NCT00877877|19360121|P1|STARTED|Year 6||529
7866226|NCT00877877|19360121|P1|NOT COMPLETED|Year 5||0
7866227|NCT00877877|19360121|P1|COMPLETED|Year 5||397
7866228|NCT00877877|19360121|P1|STARTED|Year 5||397
7866229|NCT00877799|19360152|P5|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1
7866230|NCT00877799|19360153|P4|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2
7866231|NCT00877799|19360154|P3|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
7866232|NCT00877799|19360155|P2|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
7866233|NCT00877799|19360156|P1|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
7866234|NCT00877799|19360152|P5|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19
7866235|NCT00877799|19360153|P4|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24
7866236|NCT00877799|19360154|P3|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
7866237|NCT00877799|19360155|P2|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
7866238|NCT00877799|19360156|P1|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
7866239|NCT00877799|19360152|P5|STARTED|Cohort 2: Immediately Post-op (Day 0)||20
7866240|NCT00877799|19360153|P4|STARTED|Cohort 2: Immediately Post-op (Day 0)||26
7866241|NCT00877799|19360154|P3|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
7866242|NCT00877799|19360155|P2|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
7866243|NCT00877799|19360156|P1|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
7866244|NCT00877799|19360152|P5|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
7866245|NCT00877799|19360153|P4|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
7866246|NCT00877799|19360154|P3|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
7866247|NCT00877799|19360155|P2|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5
7866248|NCT00877799|19360156|P1|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
7866249|NCT00877799|19360152|P5|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
7866250|NCT00877799|19360153|P4|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
7866251|NCT00877799|19360154|P3|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18
7866252|NCT00877799|19360155|P2|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17
7866253|NCT00877799|19360156|P1|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22
7866254|NCT00877799|19360152|P5|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
7866255|NCT00877799|19360153|P4|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
7866256|NCT00877799|19360154|P3|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21
7866257|NCT00877799|19360155|P2|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22
7866258|NCT00877799|19360156|P1|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25
7866259|NCT00877773|19360171|P1|NOT COMPLETED|Overall Study||44
7866260|NCT00877773|19360171|P1|COMPLETED|Overall Study|No participant reached to first restaging.|0
7866261|NCT00877773|19360171|P1|STARTED|Overall Study||44
7866262|NCT00877604|19360177|P2|NOT COMPLETED|Overall Study||3
7866263|NCT00877604|19360178|P1|NOT COMPLETED|Overall Study||2
7866264|NCT00877604|19360177|P2|COMPLETED|Overall Study||14
7866265|NCT00877604|19360178|P1|COMPLETED|Overall Study||15
7866266|NCT00877604|19360177|P2|STARTED|Overall Study||17
7866267|NCT00877604|19360178|P1|STARTED|Overall Study||17
7866268|NCT00877487|19360184|P2|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47
7866269|NCT00877487|19360185|P1|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6
7866270|NCT00877487|19360184|P2|COMPLETED|Double-blind Randomized Withdrawal Phase||13
7866271|NCT00877487|19360185|P1|COMPLETED|Double-blind Randomized Withdrawal Phase||50
7866272|NCT00877487|19360184|P2|STARTED|Double-blind Randomized Withdrawal Phase||60
7866273|NCT00877487|19360185|P1|STARTED|Double-blind Randomized Withdrawal Phase||56
7866274|NCT00877487|19360184|P2|NOT COMPLETED|Open-label Treatment Phase||0
7866275|NCT00877487|19360185|P1|NOT COMPLETED|Open-label Treatment Phase||7
7866276|NCT00877487|19360184|P2|COMPLETED|Open-label Treatment Phase||0
7866277|NCT00877487|19360185|P1|COMPLETED|Open-label Treatment Phase||116
7866278|NCT00877487|19360184|P2|STARTED|Open-label Treatment Phase||0
7866279|NCT00877487|19360185|P1|STARTED|Open-label Treatment Phase||123
7866280|NCT00877448|19360202|P7|NOT COMPLETED|Overall Study||0
7866281|NCT00877448|19360203|P6|NOT COMPLETED|Overall Study||1
7866282|NCT00877448|19360204|P5|NOT COMPLETED|Overall Study||0
7866283|NCT00877448|19360205|P4|NOT COMPLETED|Overall Study||1
7866284|NCT00877448|19360206|P3|NOT COMPLETED|Overall Study||0
7866285|NCT00877448|19360207|P2|NOT COMPLETED|Overall Study||1
7866286|NCT00877448|19360208|P1|NOT COMPLETED|Overall Study||0
7866287|NCT00877448|19360202|P7|COMPLETED|Overall Study||3
7866288|NCT00877448|19360203|P6|COMPLETED|Overall Study||9
7866289|NCT00877448|19360204|P5|COMPLETED|Overall Study||10
7866290|NCT00877448|19360205|P4|COMPLETED|Overall Study||9
7866291|NCT00877448|19360206|P3|COMPLETED|Overall Study||10
7866292|NCT00877448|19360207|P2|COMPLETED|Overall Study||9
7866293|NCT00877448|19360208|P1|COMPLETED|Overall Study||10
7866294|NCT00877448|19360202|P7|STARTED|Overall Study||3
7866295|NCT00877448|19360203|P6|STARTED|Overall Study||10
7866296|NCT00877448|19360204|P5|STARTED|Overall Study||10
7866297|NCT00877448|19360205|P4|STARTED|Overall Study||10
7866298|NCT00877448|19360206|P3|STARTED|Overall Study||10
7866299|NCT00877448|19360207|P2|STARTED|Overall Study||10
7866300|NCT00877448|19360208|P1|STARTED|Overall Study||10
7866301|NCT00877383|19360233|P2|NOT COMPLETED|Overall Study||37
7866302|NCT00877383|19360234|P1|NOT COMPLETED|Overall Study||29
7866303|NCT00877383|19360233|P2|COMPLETED|Overall Study||533
7866304|NCT00877383|19360234|P1|COMPLETED|Overall Study||543
7866305|NCT00877383|19360233|P2|STARTED|Overall Study||570
7866306|NCT00877383|19360234|P1|STARTED|Overall Study||572
7866307|NCT00877370|19360250|P1|NOT COMPLETED|Overall Study||0
7866308|NCT00877370|19360250|P1|COMPLETED|Overall Study||8
7866309|NCT00877370|19360250|P1|STARTED|Overall Study||8
7866310|NCT00877071|19360254|P1|NOT COMPLETED|Overall Study||2
7866311|NCT00877071|19360254|P1|COMPLETED|Overall Study||0
7866312|NCT00877071|19360254|P1|STARTED|Overall Study||2
7866313|NCT00877058|19360264|P3|NOT COMPLETED|Overall Study||39
7866314|NCT00877058|19360265|P2|NOT COMPLETED|Overall Study||40
7866315|NCT00877058|19360266|P1|NOT COMPLETED|Overall Study||37
7866316|NCT00877058|19360264|P3|COMPLETED|Overall Study||75
7866317|NCT00877058|19360265|P2|COMPLETED|Overall Study||131
7866318|NCT00877058|19360266|P1|COMPLETED|Overall Study||137
7866319|NCT00877058|19360264|P3|STARTED|Overall Study||114
7866320|NCT00877058|19360265|P2|STARTED|Overall Study||171
7866321|NCT00877058|19360266|P1|STARTED|Overall Study||174
7866322|NCT00877032|19360287|P7|NOT COMPLETED|Overall Study||2
7866323|NCT00877032|19360288|P6|NOT COMPLETED|Overall Study||0
7866324|NCT00877032|19360289|P5|NOT COMPLETED|Overall Study||0
7866325|NCT00877032|19360290|P4|NOT COMPLETED|Overall Study||1
7866326|NCT00877032|19360291|P3|NOT COMPLETED|Overall Study||0
7866327|NCT00877032|19360292|P2|NOT COMPLETED|Overall Study||0
7866328|NCT00877032|19360293|P1|NOT COMPLETED|Overall Study||0
7866329|NCT00877032|19360287|P7|COMPLETED|Overall Study||18
7866330|NCT00877032|19360288|P6|COMPLETED|Overall Study||6
7866331|NCT00877032|19360289|P5|COMPLETED|Overall Study||6
7866332|NCT00877032|19360290|P4|COMPLETED|Overall Study||6
7866333|NCT00877032|19360291|P3|COMPLETED|Overall Study||6
7866334|NCT00877032|19360292|P2|COMPLETED|Overall Study||6
7866335|NCT00877032|19360293|P1|COMPLETED|Overall Study||6
7866336|NCT00877032|19360287|P7|Treated|Overall Study||18
7866337|NCT00877032|19360288|P6|Treated|Overall Study||6
7866338|NCT00877032|19360289|P5|Treated|Overall Study||6
7866339|NCT00877032|19360290|P4|Treated|Overall Study||6
7866340|NCT00877032|19360291|P3|Treated|Overall Study||6
7866341|NCT00877032|19360292|P2|Treated|Overall Study||6
7866342|NCT00877032|19360293|P1|Treated|Overall Study||6
7866343|NCT00877032|19360287|P7|STARTED|Overall Study||20
7866344|NCT00877032|19360288|P6|STARTED|Overall Study||6
7866345|NCT00877032|19360289|P5|STARTED|Overall Study||6
7866346|NCT00877032|19360290|P4|STARTED|Overall Study||7
7866347|NCT00877032|19360291|P3|STARTED|Overall Study||6
7866348|NCT00877032|19360292|P2|STARTED|Overall Study||6
7866349|NCT00877032|19360293|P1|STARTED|Overall Study||6
7866350|NCT00877006|19360394|P2|NOT COMPLETED|Long-Term Follow-up Period||55
7866351|NCT00877006|19360395|P1|NOT COMPLETED|Long-Term Follow-up Period||53
7866352|NCT00877006|19360394|P2|COMPLETED|Long-Term Follow-up Period||154
7866353|NCT00877006|19360395|P1|COMPLETED|Long-Term Follow-up Period||157
7866354|NCT00877006|19360394|P2|STARTED|Long-Term Follow-up Period||209
7866355|NCT00877006|19360395|P1|STARTED|Long-Term Follow-up Period||210
7866356|NCT00877006|19360394|P2|NOT COMPLETED|Treatment Period||27
7866357|NCT00877006|19360395|P1|NOT COMPLETED|Treatment Period||25
7866358|NCT00877006|19360394|P2|COMPLETED|Treatment Period||196
7866359|NCT00877006|19360395|P1|COMPLETED|Treatment Period||199
7866360|NCT00877006|19360394|P2|STARTED|Treatment Period||223
7866361|NCT00877006|19360395|P1|STARTED|Treatment Period||224
7866362|NCT00876993|19360438|P5|NOT COMPLETED|Overall Study||2
7866363|NCT00876993|19360439|P4|NOT COMPLETED|Overall Study||0
7866364|NCT00876993|19360440|P3|NOT COMPLETED|Overall Study||2
7866365|NCT00876993|19360441|P2|NOT COMPLETED|Overall Study||0
7866366|NCT00876993|19360442|P1|NOT COMPLETED|Overall Study||1
7866367|NCT00876993|19360438|P5|COMPLETED|Overall Study||3
7866368|NCT00876993|19360439|P4|COMPLETED|Overall Study||5
7866369|NCT00876993|19360440|P3|COMPLETED|Overall Study||3
7866370|NCT00876993|19360441|P2|COMPLETED|Overall Study||6
7866371|NCT00876993|19360442|P1|COMPLETED|Overall Study||4
7866372|NCT00876993|19360438|P5|STARTED|Overall Study||5
7866373|NCT00876993|19360439|P4|STARTED|Overall Study||5
7866374|NCT00876993|19360440|P3|STARTED|Overall Study||5
7866375|NCT00876993|19360441|P2|STARTED|Overall Study||6
7866376|NCT00876993|19360442|P1|STARTED|Overall Study||5
7866377|NCT00876928|19360471|P2|NOT COMPLETED|Overall Study||5
7866378|NCT00876928|19360472|P1|NOT COMPLETED|Overall Study||3
7866379|NCT00876928|19360471|P2|COMPLETED|Overall Study||56
7866380|NCT00876928|19360472|P1|COMPLETED|Overall Study||53
7866381|NCT00876928|19360471|P2|STARTED|Overall Study||61
7866382|NCT00876928|19360472|P1|STARTED|Overall Study||56
7866383|NCT00876915|19360483|P3|NOT COMPLETED|Overall Study||0
7866384|NCT00876915|19360484|P2|NOT COMPLETED|Overall Study||14
7866385|NCT00876915|19360485|P1|NOT COMPLETED|Overall Study||19
7866386|NCT00876915|19360483|P3|COMPLETED|Overall Study||101
7866387|NCT00876915|19360484|P2|COMPLETED|Overall Study||34
7866388|NCT00876915|19360485|P1|COMPLETED|Overall Study||31
7866389|NCT00876915|19360483|P3|Week 8|Overall Study||0
7866390|NCT00876915|19360484|P2|Week 8|Overall Study||36
7866391|NCT00876915|19360485|P1|Week 8|Overall Study||33
7866392|NCT00876915|19360483|P3|Week 4|Overall Study||0
7866393|NCT00876915|19360484|P2|Week 4|Overall Study||45
7866394|NCT00876915|19360485|P1|Week 4|Overall Study||38
7866395|NCT00876915|19360483|P3|STARTED|Overall Study||101
7866396|NCT00876915|19360484|P2|STARTED|Overall Study||48
7866397|NCT00876915|19360485|P1|STARTED|Overall Study||50
7866398|NCT00876733|19360509|P4|NOT COMPLETED|Overall Study||7
7866399|NCT00876733|19360510|P3|NOT COMPLETED|Overall Study||30
7866400|NCT00876733|19360511|P2|NOT COMPLETED|Overall Study||42
7866401|NCT00876733|19360512|P1|NOT COMPLETED|Overall Study||91
7866402|NCT00876733|19360509|P4|COMPLETED|Overall Study||14
7866403|NCT00876733|19360510|P3|COMPLETED|Overall Study||63
7866404|NCT00876733|19360511|P2|COMPLETED|Overall Study||161
7866405|NCT00876733|19360512|P1|COMPLETED|Overall Study||197
7866406|NCT00876733|19360509|P4|STARTED|Overall Study||21
7866407|NCT00876733|19360510|P3|STARTED|Overall Study||93
7866408|NCT00876733|19360511|P2|STARTED|Overall Study||203
7866409|NCT00876733|19360512|P1|STARTED|Overall Study||288
7866410|NCT00876694|19360620|P2|NOT COMPLETED|Overall Study||12
7866411|NCT00876694|19360621|P1|NOT COMPLETED|Overall Study||21
7866412|NCT00876694|19360620|P2|COMPLETED|Overall Study||49
7866413|NCT00876694|19360621|P1|COMPLETED|Overall Study||104
7866414|NCT00876694|19360620|P2|STARTED|Overall Study||61
7866415|NCT00876694|19360621|P1|STARTED|Overall Study||125
7866416|NCT00876460|19360647|P8|NOT COMPLETED|Mono Therapy Phase||3
7866417|NCT00876460|19360648|P7|NOT COMPLETED|Mono Therapy Phase||1
7866418|NCT00876460|19360649|P6|NOT COMPLETED|Mono Therapy Phase||0
7866419|NCT00876460|19360650|P5|NOT COMPLETED|Mono Therapy Phase||2
7866420|NCT00876460|19360651|P4|NOT COMPLETED|Mono Therapy Phase||1
7866421|NCT00876460|19360652|P3|NOT COMPLETED|Mono Therapy Phase||0
7866422|NCT00876460|19360653|P2|NOT COMPLETED|Mono Therapy Phase||1
7866423|NCT00876460|19360654|P1|NOT COMPLETED|Mono Therapy Phase||0
7866424|NCT00876460|19360647|P8|COMPLETED|Mono Therapy Phase||0
7866425|NCT00876460|19360648|P7|COMPLETED|Mono Therapy Phase||0
7866426|NCT00876460|19360649|P6|COMPLETED|Mono Therapy Phase||0
7866427|NCT00876460|19360650|P5|COMPLETED|Mono Therapy Phase||0
7866428|NCT00876460|19360651|P4|COMPLETED|Mono Therapy Phase||0
7866429|NCT00876460|19360652|P3|COMPLETED|Mono Therapy Phase||0
7866430|NCT00876460|19360653|P2|COMPLETED|Mono Therapy Phase||0
7866431|NCT00876460|19360654|P1|COMPLETED|Mono Therapy Phase||0
7866432|NCT00876460|19360647|P8|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3
7866433|NCT00876460|19360648|P7|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
7866434|NCT00876460|19360649|P6|STARTED|Mono Therapy Phase||0
7866435|NCT00876460|19360650|P5|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2
7866436|NCT00876460|19360651|P4|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
7866437|NCT00876460|19360652|P3|STARTED|Mono Therapy Phase||0
7866438|NCT00876460|19360653|P2|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
7866439|NCT00876460|19360654|P1|STARTED|Mono Therapy Phase||0
7866440|NCT00876460|19360647|P8|NOT COMPLETED|Combination Therapy Phase||6
7866441|NCT00876460|19360648|P7|NOT COMPLETED|Combination Therapy Phase||8
7866442|NCT00876460|19360649|P6|NOT COMPLETED|Combination Therapy Phase||3
7866443|NCT00876460|19360650|P5|NOT COMPLETED|Combination Therapy Phase||7
7866444|NCT00876460|19360651|P4|NOT COMPLETED|Combination Therapy Phase||6
7866445|NCT00876460|19360652|P3|NOT COMPLETED|Combination Therapy Phase||3
7866446|NCT00876460|19360653|P2|NOT COMPLETED|Combination Therapy Phase||7
7866447|NCT00876460|19360654|P1|NOT COMPLETED|Combination Therapy Phase||3
7866448|NCT00876460|19360647|P8|COMPLETED|Combination Therapy Phase||0
7866449|NCT00876460|19360648|P7|COMPLETED|Combination Therapy Phase||0
7866450|NCT00876460|19360649|P6|COMPLETED|Combination Therapy Phase||0
7866451|NCT00876460|19360650|P5|COMPLETED|Combination Therapy Phase||0
7866452|NCT00876460|19360651|P4|COMPLETED|Combination Therapy Phase||0
7866453|NCT00876460|19360652|P3|COMPLETED|Combination Therapy Phase||0
7866454|NCT00876460|19360653|P2|COMPLETED|Combination Therapy Phase||0
7866455|NCT00876460|19360654|P1|COMPLETED|Combination Therapy Phase||0
7866456|NCT00876460|19360647|P8|STARTED|Combination Therapy Phase||6
7866457|NCT00876460|19360648|P7|STARTED|Combination Therapy Phase||8
7866458|NCT00876460|19360649|P6|STARTED|Combination Therapy Phase||3
7866459|NCT00876460|19360650|P5|STARTED|Combination Therapy Phase||7
7866460|NCT00876460|19360651|P4|STARTED|Combination Therapy Phase||6
7866461|NCT00876460|19360652|P3|STARTED|Combination Therapy Phase||3
7866462|NCT00876460|19360653|P2|STARTED|Combination Therapy Phase||7
7866463|NCT00876460|19360654|P1|STARTED|Combination Therapy Phase||3
7866464|NCT00876447|19360726|P2|NOT COMPLETED|Overall Study||81
7866465|NCT00876447|19360727|P1|NOT COMPLETED|Overall Study||80
7866466|NCT00876447|19360726|P2|COMPLETED|Overall Study||122
7866467|NCT00876447|19360727|P1|COMPLETED|Overall Study||105
7866468|NCT00876447|19360726|P2|STARTED|Overall Study||203
7866469|NCT00876447|19360727|P1|STARTED|Overall Study||185
7866470|NCT00876395|19360787|P2|NOT COMPLETED|Overall Study||239
7866471|NCT00876395|19360788|P1|NOT COMPLETED|Overall Study||480
7866472|NCT00876395|19360787|P2|COMPLETED|Overall Study||0
7866473|NCT00876395|19360788|P1|COMPLETED|Overall Study||0
7866474|NCT00876395|19360787|P2|Untreated|Overall Study||1
7866475|NCT00876395|19360788|P1|Untreated|Overall Study||8
7866476|NCT00876395|19360787|P2|STARTED|Overall Study||239
7866477|NCT00876395|19360788|P1|STARTED|Overall Study||480
7866478|NCT00876343|19360829|P3|NOT COMPLETED|Overall Study||12
7866479|NCT00876343|19360830|P2|NOT COMPLETED|Overall Study||17
7866480|NCT00876343|19360831|P1|NOT COMPLETED|Overall Study||17
7866481|NCT00876343|19360829|P3|COMPLETED|Overall Study||183
7866482|NCT00876343|19360830|P2|COMPLETED|Overall Study||180
7866483|NCT00876343|19360831|P1|COMPLETED|Overall Study||177
7866484|NCT00876343|19360829|P3|STARTED|Overall Study||195
7866485|NCT00876343|19360830|P2|STARTED|Overall Study||197
7866486|NCT00876343|19360831|P1|STARTED|Overall Study||194
7866487|NCT00876265|19360845|P1|NOT COMPLETED|Overall Study||12
7866488|NCT00876265|19360845|P1|COMPLETED|Overall Study||106
7866489|NCT00876265|19360845|P1|STARTED|Overall Study||118
7866490|NCT00876200|19360853|P2|NOT COMPLETED|Overall Study||3
7866491|NCT00876200|19360854|P1|NOT COMPLETED|Overall Study||1
7866492|NCT00876200|19360853|P2|COMPLETED|Overall Study||9
7866493|NCT00876200|19360854|P1|COMPLETED|Overall Study||8
7866494|NCT00876200|19360853|P2|STARTED|Overall Study||12
7866495|NCT00876200|19360854|P1|STARTED|Overall Study||9
7866496|NCT00876018|19360863|P3|NOT COMPLETED|Overall Study||3
7866497|NCT00876018|19360864|P2|NOT COMPLETED|Overall Study||5
7866498|NCT00876018|19360865|P1|NOT COMPLETED|Overall Study||5
7866499|NCT00876018|19360863|P3|COMPLETED|Overall Study||97
7866500|NCT00876018|19360864|P2|COMPLETED|Overall Study||95
7866501|NCT00876018|19360865|P1|COMPLETED|Overall Study||95
7866502|NCT00876018|19360863|P3|STARTED|Overall Study||100
7866503|NCT00876018|19360864|P2|STARTED|Overall Study||100
7866504|NCT00876018|19360865|P1|STARTED|Overall Study||100
7866505|NCT00875979|19360920|P2|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47
7866506|NCT00875979|19360921|P1|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
7866507|NCT00875979|19360920|P2|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11
7866508|NCT00875979|19360921|P1|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
7866509|NCT00875979|19360920|P2|STARTED|Dose Expansion Phase - 3.6 mg/kg||58
7866510|NCT00875979|19360921|P1|STARTED|Dose Expansion Phase - 3.6 mg/kg||0
7866511|NCT00875979|19360920|P2|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6
7866512|NCT00875979|19360921|P1|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
7866513|NCT00875979|19360920|P2|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
7866514|NCT00875979|19360921|P1|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
7866515|NCT00875979|19360920|P2|STARTED|Dose Escalation Phase - 3.6 mg/kg||6
7866516|NCT00875979|19360921|P1|STARTED|Dose Escalation Phase - 3.6 mg/kg||0
7866517|NCT00875979|19360920|P2|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
7866518|NCT00875979|19360921|P1|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3
7866519|NCT00875979|19360920|P2|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
7866520|NCT00875979|19360921|P1|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
7866521|NCT00875979|19360920|P2|STARTED|Dose Escalation Phase - 3.0 mg/kg||0
7866522|NCT00875979|19360921|P1|STARTED|Dose Escalation Phase - 3.0 mg/kg||3
7866523|NCT00875836|19360933|P2|NOT COMPLETED|Overall Study||40
7866524|NCT00875836|19360934|P1|NOT COMPLETED|Overall Study||43
7866525|NCT00875836|19360933|P2|COMPLETED|Overall Study||47
7866526|NCT00875836|19360934|P1|COMPLETED|Overall Study||45
7866527|NCT00875836|19360933|P2|STARTED|Overall Study||87
7866528|NCT00875836|19360934|P1|STARTED|Overall Study||88
7866529|NCT00875810|19360944|P1|NOT COMPLETED|Overall Study||46
7866530|NCT00875810|19360944|P1|COMPLETED|Overall Study||148
7866531|NCT00875810|19360944|P1|24 Months Follow up|Overall Study||148
7866532|NCT00875810|19360944|P1|12 Months Follow up|Overall Study||112
7866533|NCT00875810|19360944|P1|6 Months Follow up|Overall Study||80
7866534|NCT00875810|19360944|P1|3 Months Follow up|Overall Study||175
7866535|NCT00875810|19360944|P1|Discharged|Overall Study||177
7866536|NCT00875810|19360944|P1|Implanted|Overall Study||190
7866537|NCT00875810|19360944|P1|STARTED|Overall Study||194
7866538|NCT00875797|19360953|P2|NOT COMPLETED|Overall Study||3
7866539|NCT00875797|19360954|P1|NOT COMPLETED|Overall Study||6
7866540|NCT00875797|19360953|P2|COMPLETED|Overall Study||42
7866541|NCT00875797|19360954|P1|COMPLETED|Overall Study||39
7866542|NCT00875797|19360953|P2|STARTED|Overall Study||45
7866543|NCT00875797|19360954|P1|STARTED|Overall Study||45
7866544|NCT00875706|19360967|P3|NOT COMPLETED|Overall Study||0
7866545|NCT00875706|19360968|P2|NOT COMPLETED|Overall Study||0
7866546|NCT00875706|19360969|P1|NOT COMPLETED|Overall Study||1
7866547|NCT00875706|19360967|P3|COMPLETED|Overall Study||13
7866548|NCT00875706|19360968|P2|COMPLETED|Overall Study||24
7866549|NCT00875706|19360969|P1|COMPLETED|Overall Study||7
7866550|NCT00875706|19360967|P3|STARTED|Overall Study||13
7866551|NCT00875706|19360968|P2|STARTED|Overall Study||24
7866552|NCT00875706|19360969|P1|STARTED|Overall Study||8
7866553|NCT00875667|19360988|P2|NOT COMPLETED|Overall Study||73
7866554|NCT00875667|19360989|P1|NOT COMPLETED|Overall Study||170
7866555|NCT00875667|19360988|P2|COMPLETED|Overall Study|Participants completed 6 cycles of IC single agent cytarabine, fludarabine, or gemcitabine.|11
7866556|NCT00875667|19360989|P1|COMPLETED|Overall Study||0
7866557|NCT00875667|19360988|P2|Participants Treated|Overall Study||83
7866558|NCT00875667|19360989|P1|Participants Treated|Overall Study||167
7866559|NCT00875667|19360988|P2|Crossover From IC to Lenalidomide|Overall Study|Upon disease progression, participants crossed over to lenalidomide|40
7866560|NCT00875667|19360989|P1|Crossover From IC to Lenalidomide|Overall Study|NA = Participants in the IC arm were able to crossover to lenalidomide|0
7866561|NCT00875667|19360988|P2|STARTED|Overall Study||84
7866562|NCT00875667|19360989|P1|STARTED|Overall Study||170
7866563|NCT00875641|19361090|P3|NOT COMPLETED|Overall Study||0
7866564|NCT00875641|19361091|P2|NOT COMPLETED|Overall Study||0
7866565|NCT00875641|19361092|P1|NOT COMPLETED|Overall Study||0
7866566|NCT00875641|19361090|P3|COMPLETED|Overall Study||159344
7866567|NCT00875641|19361091|P2|COMPLETED|Overall Study||173384
7866568|NCT00875641|19361092|P1|COMPLETED|Overall Study||57931
7866569|NCT00875641|19361090|P3|STARTED|Overall Study||159344
7866570|NCT00875641|19361091|P2|STARTED|Overall Study||173384
7866571|NCT00875641|19361092|P1|STARTED|Overall Study||57931
7866572|NCT00875615|19361124|P1|NOT COMPLETED|Overall Study||1
7866573|NCT00875615|19361124|P1|COMPLETED|Overall Study||10
7866574|NCT00875615|19361124|P1|STARTED|Overall Study||11
7866575|NCT00875589|19361131|P2|NOT COMPLETED|Overall Study||0
7866576|NCT00875589|19361132|P1|NOT COMPLETED|Overall Study||0
7866577|NCT00875589|19361131|P2|COMPLETED|Overall Study||11
7866578|NCT00875589|19361132|P1|COMPLETED|Overall Study||15
7866579|NCT00875589|19361131|P2|STARTED|Overall Study||11
7866580|NCT00875589|19361132|P1|STARTED|Overall Study||15
7866581|NCT00875563|19361138|P1|NOT COMPLETED|Overall Study||24
7866582|NCT00875563|19361138|P1|COMPLETED|Overall Study||18
7866583|NCT00875563|19361138|P1|STARTED|Overall Study||42
7866584|NCT00875550|19361144|P2|NOT COMPLETED|Overall Study||10
7866585|NCT00875550|19361145|P1|NOT COMPLETED|Overall Study||12
7866586|NCT00875550|19361144|P2|COMPLETED|Overall Study||76
7866587|NCT00875550|19361145|P1|COMPLETED|Overall Study||77
7866588|NCT00875550|19361144|P2|STARTED|Overall Study||86
7866589|NCT00875550|19361145|P1|STARTED|Overall Study||89
7866590|NCT00875524|19361163|P2|NOT COMPLETED|Overall Study||6
7866591|NCT00875524|19361164|P1|NOT COMPLETED|Overall Study||8
7866592|NCT00875524|19361163|P2|COMPLETED|Overall Study||54
7866593|NCT00875524|19361164|P1|COMPLETED|Overall Study||112
7866594|NCT00875524|19361163|P2|Received Vaccination 3|Overall Study||58
7866595|NCT00875524|19361164|P1|Received Vaccination 3|Overall Study||114
7866596|NCT00875524|19361163|P2|Received Vaccination 2|Overall Study||58
7866597|NCT00875524|19361164|P1|Received Vaccination 2|Overall Study||116
7866598|NCT00875524|19361163|P2|Received Vaccination 1|Overall Study||60
7866599|NCT00875524|19361164|P1|Received Vaccination 1|Overall Study||120
7866600|NCT00875524|19361163|P2|STARTED|Overall Study||60
7866601|NCT00875524|19361164|P1|STARTED|Overall Study||120
7866602|NCT00875485|19361182|P2|NOT COMPLETED|Challenge Dose Epoch||0
7866603|NCT00875485|19361183|P1|NOT COMPLETED|Challenge Dose Epoch||1
7866604|NCT00875485|19361182|P2|COMPLETED|Challenge Dose Epoch||11
7866605|NCT00875485|19361183|P1|COMPLETED|Challenge Dose Epoch||7
7866606|NCT00875485|19361182|P2|STARTED|Challenge Dose Epoch||11
7866607|NCT00875485|19361183|P1|STARTED|Challenge Dose Epoch||8
7866608|NCT00875485|19361182|P2|NOT COMPLETED|Year 15||0
7866609|NCT00875485|19361183|P1|NOT COMPLETED|Year 15||0
7866610|NCT00875485|19361182|P2|COMPLETED|Year 15||111
7866611|NCT00875485|19361183|P1|COMPLETED|Year 15||98
7866612|NCT00875485|19361182|P2|STARTED|Year 15||111
7866613|NCT00875485|19361183|P1|STARTED|Year 15||98
7866614|NCT00875485|19361182|P2|NOT COMPLETED|Year 14||0
7866615|NCT00875485|19361183|P1|NOT COMPLETED|Year 14||0
7866616|NCT00875485|19361182|P2|COMPLETED|Year 14||113
7866617|NCT00875485|19361183|P1|COMPLETED|Year 14||100
7866618|NCT00875485|19361182|P2|STARTED|Year 14||113
7866619|NCT00875485|19361183|P1|STARTED|Year 14||100
7866620|NCT00875485|19361182|P2|NOT COMPLETED|Year 13||0
7866621|NCT00875485|19361183|P1|NOT COMPLETED|Year 13||0
7866622|NCT00875485|19361182|P2|COMPLETED|Year 13||113
7866623|NCT00875485|19361183|P1|COMPLETED|Year 13||102
7866624|NCT00875485|19361182|P2|STARTED|Year 13||113
7866625|NCT00875485|19361183|P1|STARTED|Year 13||102
7866626|NCT00875485|19361182|P2|NOT COMPLETED|Year 12||0
7866627|NCT00875485|19361183|P1|NOT COMPLETED|Year 12||0
7866628|NCT00875485|19361182|P2|COMPLETED|Year 12||109
7866629|NCT00875485|19361183|P1|COMPLETED|Year 12||101
7866630|NCT00875485|19361182|P2|STARTED|Year 12||109
7866631|NCT00875485|19361183|P1|STARTED|Year 12||101
7866632|NCT00875485|19361182|P2|NOT COMPLETED|Year 11||0
7866633|NCT00875485|19361183|P1|NOT COMPLETED|Year 11||0
7866634|NCT00875485|19361182|P2|COMPLETED|Year 11||111
7866635|NCT00875485|19361183|P1|COMPLETED|Year 11||99
7866636|NCT00875485|19361182|P2|STARTED|Year 11||111
7866637|NCT00875485|19361183|P1|STARTED|Year 11||99
7866638|NCT00875433|19361223|P1|NOT COMPLETED|Overall Study||60
7866639|NCT00875433|19361223|P1|COMPLETED|Overall Study||0
7866640|NCT00875433|19361223|P1|STARTED|Overall Study|Treated|60
7866641|NCT00875420|19361253|P5|NOT COMPLETED|Overall Study||2
7866642|NCT00875420|19361254|P4|NOT COMPLETED|Overall Study||2
7866643|NCT00875420|19361255|P3|NOT COMPLETED|Overall Study||3
7866644|NCT00875420|19361256|P2|NOT COMPLETED|Overall Study||2
7866645|NCT00875420|19361257|P1|NOT COMPLETED|Overall Study||2
7866646|NCT00875420|19361253|P5|COMPLETED|Overall Study||17
7866647|NCT00875420|19361254|P4|COMPLETED|Overall Study||16
7866648|NCT00875420|19361255|P3|COMPLETED|Overall Study||18
7866649|NCT00875420|19361256|P2|COMPLETED|Overall Study||18
7866650|NCT00875420|19361257|P1|COMPLETED|Overall Study||20
7866651|NCT00875420|19361253|P5|STARTED|Overall Study||19
7866652|NCT00875420|19361254|P4|STARTED|Overall Study||18
7866653|NCT00875420|19361255|P3|STARTED|Overall Study||21
7866654|NCT00875420|19361256|P2|STARTED|Overall Study||20
7866655|NCT00875420|19361257|P1|STARTED|Overall Study||22
7866656|NCT00875394|19361287|P3|NOT COMPLETED|Overall Study||0
7866657|NCT00875394|19361288|P2|NOT COMPLETED|Overall Study||0
7866658|NCT00875394|19361289|P1|NOT COMPLETED|Overall Study||0
7866659|NCT00875394|19361287|P3|COMPLETED|Overall Study||9
7866660|NCT00875394|19361288|P2|COMPLETED|Overall Study||23
7866661|NCT00875394|19361289|P1|COMPLETED|Overall Study||36
7866662|NCT00875394|19361287|P3|STARTED|Overall Study||9
7866663|NCT00875394|19361288|P2|STARTED|Overall Study||23
7866664|NCT00875394|19361289|P1|STARTED|Overall Study||36
7866665|NCT00875329|19361297|P1|NOT COMPLETED|Overall Study||0
7866666|NCT00875329|19361297|P1|COMPLETED|Overall Study||97
7866667|NCT00875329|19361297|P1|STARTED|Overall Study||97
7866668|NCT00875277|19361301|P1|NOT COMPLETED|Overall Study||0
7866669|NCT00875277|19361301|P1|COMPLETED|Overall Study||24
7866670|NCT00875277|19361301|P1|STARTED|Overall Study||24
7866671|NCT00875212|19361382|P1|NOT COMPLETED|CaGP and Fluoride Dentifrice||0
7866672|NCT00875212|19361382|P1|COMPLETED|CaGP and Fluoride Dentifrice||12
7866673|NCT00875212|19361382|P1|STARTED|CaGP and Fluoride Dentifrice||12
7866674|NCT00875212|19361382|P1|NOT COMPLETED|Fluoride Only Dentifrice||0
7866675|NCT00875212|19361382|P1|COMPLETED|Fluoride Only Dentifrice||12
7866676|NCT00875212|19361382|P1|STARTED|Fluoride Only Dentifrice||12
7866677|NCT00875212|19361382|P1|NOT COMPLETED|CaGP Only Dentifrice||0
7866678|NCT00875212|19361382|P1|COMPLETED|CaGP Only Dentifrice||12
7866679|NCT00875212|19361382|P1|STARTED|CaGP Only Dentifrice||12
7866680|NCT00875212|19361382|P1|NOT COMPLETED|Placebo Dentifrice||0
7866681|NCT00875212|19361382|P1|COMPLETED|Placebo Dentifrice|all participants completed this group|12
7866682|NCT00875212|19361382|P1|STARTED|Placebo Dentifrice||12
7866683|NCT00875056|19361396|P3|NOT COMPLETED|Overall Study||6
7866684|NCT00875056|19361397|P2|NOT COMPLETED|Overall Study||9
7866685|NCT00875056|19361398|P1|NOT COMPLETED|Overall Study||23
7866686|NCT00875056|19361396|P3|COMPLETED|Overall Study||0
7866687|NCT00875056|19361397|P2|COMPLETED|Overall Study||2
7866688|NCT00875056|19361398|P1|COMPLETED|Overall Study||16
7866689|NCT00875056|19361396|P3|STARTED|Overall Study||6
7866690|NCT00875056|19361397|P2|STARTED|Overall Study||11
7866691|NCT00875056|19361398|P1|STARTED|Overall Study||39
7866692|NCT00875017|19361424|P6|NOT COMPLETED|Fourth Intervention||1
7866693|NCT00875017|19361425|P5|NOT COMPLETED|Fourth Intervention||0
7866694|NCT00875017|19361426|P4|NOT COMPLETED|Fourth Intervention||0
7866695|NCT00875017|19361427|P3|NOT COMPLETED|Fourth Intervention||0
7866696|NCT00875017|19361428|P2|NOT COMPLETED|Fourth Intervention||0
7866697|NCT00875017|19361429|P1|NOT COMPLETED|Fourth Intervention||0
7866698|NCT00875017|19361424|P6|COMPLETED|Fourth Intervention||4
7866699|NCT00875017|19361425|P5|COMPLETED|Fourth Intervention||3
7866700|NCT00875017|19361426|P4|COMPLETED|Fourth Intervention||4
7866701|NCT00875017|19361427|P3|COMPLETED|Fourth Intervention||2
7866702|NCT00875017|19361428|P2|COMPLETED|Fourth Intervention||3
7866703|NCT00875017|19361429|P1|COMPLETED|Fourth Intervention||3
7866704|NCT00875017|19361424|P6|STARTED|Fourth Intervention||5
7866705|NCT00875017|19361425|P5|STARTED|Fourth Intervention||3
7866706|NCT00875017|19361426|P4|STARTED|Fourth Intervention||4
7866707|NCT00875017|19361427|P3|STARTED|Fourth Intervention||2
7866708|NCT00875017|19361428|P2|STARTED|Fourth Intervention||3
7866709|NCT00875017|19361429|P1|STARTED|Fourth Intervention||3
7866710|NCT00875017|19361424|P6|NOT COMPLETED|Washout||0
7866711|NCT00875017|19361425|P5|NOT COMPLETED|Washout||1
7866712|NCT00875017|19361426|P4|NOT COMPLETED|Washout||0
7866713|NCT00875017|19361427|P3|NOT COMPLETED|Washout||0
7866714|NCT00875017|19361428|P2|NOT COMPLETED|Washout||0
7866715|NCT00875017|19361429|P1|NOT COMPLETED|Washout||0
7866716|NCT00875017|19361424|P6|COMPLETED|Washout||5
7866717|NCT00875017|19361425|P5|COMPLETED|Washout||3
7866718|NCT00875017|19361426|P4|COMPLETED|Washout||4
7866719|NCT00875017|19361427|P3|COMPLETED|Washout||2
7866720|NCT00875017|19361428|P2|COMPLETED|Washout||3
7866721|NCT00875017|19361429|P1|COMPLETED|Washout||3
7866722|NCT00875017|19361424|P6|STARTED|Washout||5
7866723|NCT00875017|19361425|P5|STARTED|Washout||4
7866724|NCT00875017|19361426|P4|STARTED|Washout||4
7866725|NCT00875017|19361427|P3|STARTED|Washout||2
7866726|NCT00875017|19361428|P2|STARTED|Washout||3
7866727|NCT00875017|19361429|P1|STARTED|Washout||3
7866728|NCT00875017|19361424|P6|NOT COMPLETED|Third Intervention||0
7866729|NCT00875017|19361425|P5|NOT COMPLETED|Third Intervention||0
7866730|NCT00875017|19361426|P4|NOT COMPLETED|Third Intervention||0
7866731|NCT00875017|19361427|P3|NOT COMPLETED|Third Intervention||1
7866732|NCT00875017|19361428|P2|NOT COMPLETED|Third Intervention||1
7866733|NCT00875017|19361429|P1|NOT COMPLETED|Third Intervention||0
7866734|NCT00875017|19361424|P6|COMPLETED|Third Intervention||5
7866735|NCT00875017|19361425|P5|COMPLETED|Third Intervention||4
7866736|NCT00875017|19361426|P4|COMPLETED|Third Intervention||4
7866737|NCT00875017|19361427|P3|COMPLETED|Third Intervention||2
7866738|NCT00875017|19361428|P2|COMPLETED|Third Intervention||3
7866739|NCT00875017|19361429|P1|COMPLETED|Third Intervention||3
7866740|NCT00875017|19361424|P6|STARTED|Third Intervention||5
7866741|NCT00875017|19361425|P5|STARTED|Third Intervention||4
7866742|NCT00875017|19361426|P4|STARTED|Third Intervention||4
7866743|NCT00875017|19361427|P3|STARTED|Third Intervention||3
7866744|NCT00875017|19361428|P2|STARTED|Third Intervention||4
7866745|NCT00875017|19361429|P1|STARTED|Third Intervention||3
7866746|NCT00875017|19361424|P6|NOT COMPLETED|Washout||0
7866747|NCT00875017|19361425|P5|NOT COMPLETED|Washout||0
7866748|NCT00875017|19361426|P4|NOT COMPLETED|Washout||0
7866749|NCT00875017|19361427|P3|NOT COMPLETED|Washout||0
7866750|NCT00875017|19361428|P2|NOT COMPLETED|Washout||1
7866751|NCT00875017|19361429|P1|NOT COMPLETED|Washout||0
7866752|NCT00875017|19361424|P6|COMPLETED|Washout||5
7866753|NCT00875017|19361425|P5|COMPLETED|Washout||4
7866754|NCT00875017|19361426|P4|COMPLETED|Washout||4
7866755|NCT00875017|19361427|P3|COMPLETED|Washout||3
7866756|NCT00875017|19361428|P2|COMPLETED|Washout||4
7866757|NCT00875017|19361429|P1|COMPLETED|Washout||3
7866758|NCT00875017|19361424|P6|STARTED|Washout||5
7866759|NCT00875017|19361425|P5|STARTED|Washout||4
7866760|NCT00875017|19361426|P4|STARTED|Washout||4
7866761|NCT00875017|19361427|P3|STARTED|Washout||3
7866762|NCT00875017|19361428|P2|STARTED|Washout||5
7866763|NCT00875017|19361429|P1|STARTED|Washout||3
7866764|NCT00875017|19361424|P6|NOT COMPLETED|Second Intervention||0
7866765|NCT00875017|19361425|P5|NOT COMPLETED|Second Intervention||0
7866766|NCT00875017|19361426|P4|NOT COMPLETED|Second Intervention||1
7866767|NCT00875017|19361427|P3|NOT COMPLETED|Second Intervention||0
7866768|NCT00875017|19361428|P2|NOT COMPLETED|Second Intervention||0
7866769|NCT00875017|19361429|P1|NOT COMPLETED|Second Intervention||0
7866770|NCT00875017|19361424|P6|COMPLETED|Second Intervention||5
7866771|NCT00875017|19361425|P5|COMPLETED|Second Intervention||4
7866772|NCT00875017|19361426|P4|COMPLETED|Second Intervention||4
7866773|NCT00875017|19361427|P3|COMPLETED|Second Intervention||3
7866774|NCT00875017|19361428|P2|COMPLETED|Second Intervention||5
7866775|NCT00875017|19361429|P1|COMPLETED|Second Intervention||3
7866776|NCT00875017|19361424|P6|STARTED|Second Intervention||5
7866777|NCT00875017|19361425|P5|STARTED|Second Intervention||4
7866778|NCT00875017|19361426|P4|STARTED|Second Intervention||5
7866779|NCT00875017|19361427|P3|STARTED|Second Intervention||3
7866780|NCT00875017|19361428|P2|STARTED|Second Intervention||5
7866781|NCT00875017|19361429|P1|STARTED|Second Intervention||3
7866782|NCT00875017|19361424|P6|NOT COMPLETED|Washout||0
7866783|NCT00875017|19361425|P5|NOT COMPLETED|Washout||0
7866784|NCT00875017|19361426|P4|NOT COMPLETED|Washout||0
7866785|NCT00875017|19361427|P3|NOT COMPLETED|Washout||1
7866786|NCT00875017|19361428|P2|NOT COMPLETED|Washout||0
7866787|NCT00875017|19361429|P1|NOT COMPLETED|Washout||0
7866788|NCT00875017|19361424|P6|COMPLETED|Washout||5
7866789|NCT00875017|19361425|P5|COMPLETED|Washout||4
7866790|NCT00875017|19361426|P4|COMPLETED|Washout||5
7866791|NCT00875017|19361427|P3|COMPLETED|Washout||3
7866792|NCT00875017|19361428|P2|COMPLETED|Washout||5
7866793|NCT00875017|19361429|P1|COMPLETED|Washout||3
7866794|NCT00875017|19361424|P6|STARTED|Washout||5
7866795|NCT00875017|19361425|P5|STARTED|Washout||4
7866796|NCT00875017|19361426|P4|STARTED|Washout||5
7866797|NCT00875017|19361427|P3|STARTED|Washout||4
7866798|NCT00875017|19361428|P2|STARTED|Washout||5
7866799|NCT00875017|19361429|P1|STARTED|Washout||3
7866800|NCT00875017|19361424|P6|NOT COMPLETED|First Intervention||0
7866801|NCT00875017|19361425|P5|NOT COMPLETED|First Intervention||1
7866802|NCT00875017|19361426|P4|NOT COMPLETED|First Intervention||1
7866803|NCT00875017|19361427|P3|NOT COMPLETED|First Intervention||1
7866804|NCT00875017|19361428|P2|NOT COMPLETED|First Intervention||0
7866805|NCT00875017|19361429|P1|NOT COMPLETED|First Intervention||2
7866806|NCT00875017|19361424|P6|COMPLETED|First Intervention||5
7866807|NCT00875017|19361425|P5|COMPLETED|First Intervention||4
7866808|NCT00875017|19361426|P4|COMPLETED|First Intervention||5
7866809|NCT00875017|19361427|P3|COMPLETED|First Intervention||4
7866810|NCT00875017|19361428|P2|COMPLETED|First Intervention||5
7866811|NCT00875017|19361429|P1|COMPLETED|First Intervention||3
7866812|NCT00875017|19361424|P6|STARTED|First Intervention||5
7866813|NCT00875017|19361425|P5|STARTED|First Intervention||5
7866814|NCT00875017|19361426|P4|STARTED|First Intervention||6
7866815|NCT00875017|19361427|P3|STARTED|First Intervention||5
7866816|NCT00875017|19361428|P2|STARTED|First Intervention||5
7866817|NCT00875017|19361429|P1|STARTED|First Intervention||5
7866818|NCT00874939|19361443|P1|NOT COMPLETED|Overall Study||4
7866819|NCT00874939|19361443|P1|COMPLETED|Overall Study||0
7866820|NCT00874939|19361443|P1|Treated|Overall Study||0
7866821|NCT00874939|19361443|P1|STARTED|Overall Study||4
7866822|NCT00874887|19361459|P2|NOT COMPLETED|Overall Study||0
7866823|NCT00874887|19361460|P1|NOT COMPLETED|Overall Study||0
7866824|NCT00874887|19361459|P2|COMPLETED|Overall Study||34
7866825|NCT00874887|19361460|P1|COMPLETED|Overall Study||32
7866826|NCT00874887|19361459|P2|STARTED|Overall Study||34
7866827|NCT00874887|19361460|P1|STARTED|Overall Study||32
7866828|NCT00874848|19361476|P2|NOT COMPLETED|Overall Study||28
7866829|NCT00874848|19361477|P1|NOT COMPLETED|Overall Study||59
7866830|NCT00874848|19361476|P2|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1
7866831|NCT00874848|19361477|P1|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0
7866832|NCT00874848|19361476|P2|Discontinued|Overall Study||28
7866833|NCT00874848|19361477|P1|Discontinued|Overall Study||59
7866834|NCT00874848|19361476|P2|STARTED|Overall Study||29
7866835|NCT00874848|19361477|P1|STARTED|Overall Study||59
7866836|NCT00874822|19361493|P1|NOT COMPLETED|Overall Study||8
7866837|NCT00874822|19361493|P1|COMPLETED|Overall Study||208
7866838|NCT00874822|19361493|P1|STARTED|Overall Study||216
7866839|NCT00874770|19361501|P4|NOT COMPLETED|Overall Study||5
7866840|NCT00874770|19361502|P3|NOT COMPLETED|Overall Study||4
7866841|NCT00874770|19361503|P2|NOT COMPLETED|Overall Study||1
7866842|NCT00874770|19361504|P1|NOT COMPLETED|Overall Study||5
7866843|NCT00874770|19361501|P4|COMPLETED|Overall Study||7
7866844|NCT00874770|19361502|P3|COMPLETED|Overall Study||8
7866845|NCT00874770|19361503|P2|COMPLETED|Overall Study||11
7866846|NCT00874770|19361504|P1|COMPLETED|Overall Study||7
7866847|NCT00874770|19361501|P4|STARTED|Overall Study||12
7866848|NCT00874770|19361502|P3|STARTED|Overall Study||12
7866849|NCT00874770|19361503|P2|STARTED|Overall Study||12
7866850|NCT00874770|19361504|P1|STARTED|Overall Study||12
7866851|NCT00874731|19361538|P3|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||22
7866852|NCT00874731|19361539|P2|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
7866853|NCT00874731|19361540|P1|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
7866854|NCT00874731|19361538|P3|COMPLETED|Part 2: Ridaforolimus 40 mg||0
7866855|NCT00874731|19361539|P2|COMPLETED|Part 2: Ridaforolimus 40 mg||0
7866856|NCT00874731|19361540|P1|COMPLETED|Part 2: Ridaforolimus 40 mg||0
7866857|NCT00874731|19361538|P3|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, started this period in Pt 2. Ridaforolimus 40 mg arm."|22
7866858|NCT00874731|19361539|P2|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, enter into the Pt 2. Ridaforolimus 40 mg arm."|0
7866859|NCT00874731|19361540|P1|STARTED|Part 2: Ridaforolimus 40 mg||0
7866860|NCT00874731|19361538|P3|NOT COMPLETED|Washout Period||0
7866861|NCT00874731|19361539|P2|NOT COMPLETED|Washout Period||0
7866862|NCT00874731|19361540|P1|NOT COMPLETED|Washout Period||0
7866863|NCT00874731|19361538|P3|COMPLETED|Washout Period||0
7866864|NCT00874731|19361539|P2|COMPLETED|Washout Period||22
7866865|NCT00874731|19361540|P1|COMPLETED|Washout Period||0
7866866|NCT00874731|19361538|P3|STARTED|Washout Period||0
7866867|NCT00874731|19361539|P2|STARTED|Washout Period||22
7866868|NCT00874731|19361540|P1|STARTED|Washout Period||0
7866869|NCT00874731|19361538|P3|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
7866870|NCT00874731|19361539|P2|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
7866871|NCT00874731|19361540|P1|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
7866872|NCT00874731|19361538|P3|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
7866873|NCT00874731|19361539|P2|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||22
7866874|NCT00874731|19361540|P1|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
7866875|NCT00874731|19361538|P3|STARTED|Part 1, Day 2: Ridaforolimus 100 mg||0
7866876|NCT00874731|19361539|P2|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, started this period in Pt 1, Day 2. Ridaforolimus 100 mg arm."|22
7866877|NCT00874731|19361540|P1|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, enter into the Pt 1, Day 2. Ridaforolimus 100 mg arm."|0
7866878|NCT00874731|19361538|P3|NOT COMPLETED|Part 1, Day 1: Placebo||0
7866879|NCT00874731|19361539|P2|NOT COMPLETED|Part 1, Day 1: Placebo||0
7866880|NCT00874731|19361540|P1|NOT COMPLETED|Part 1, Day 1: Placebo||1
7866881|NCT00874731|19361538|P3|COMPLETED|Part 1, Day 1: Placebo||0
7866882|NCT00874731|19361539|P2|COMPLETED|Part 1, Day 1: Placebo||0
7866883|NCT00874731|19361540|P1|COMPLETED|Part 1, Day 1: Placebo||22
7866884|NCT00874731|19361538|P3|STARTED|Part 1, Day 1: Placebo||0
7866885|NCT00874731|19361539|P2|STARTED|Part 1, Day 1: Placebo||0
7866886|NCT00874731|19361540|P1|STARTED|Part 1, Day 1: Placebo||23
7866887|NCT00874614|19361569|P1|NOT COMPLETED|Overall Study||58
7866888|NCT00874614|19361569|P1|COMPLETED|Overall Study|As of December 2017|16
7866889|NCT00874614|19361569|P1|Received Two Therapeutic Doses|Overall Study||50
7866890|NCT00874614|19361569|P1|Received at Least One Therapeutic Dose|Overall Study||68
7866891|NCT00874614|19361569|P1|STARTED|Overall Study||74
7866892|NCT00874549|19361581|P4|NOT COMPLETED|Overall Study||2
7866893|NCT00874549|19361582|P3|NOT COMPLETED|Overall Study||4
7866894|NCT00874549|19361583|P2|NOT COMPLETED|Overall Study||1
7866895|NCT00874549|19361584|P1|NOT COMPLETED|Overall Study||1
7866896|NCT00874549|19361581|P4|COMPLETED|Overall Study||56
7866897|NCT00874549|19361582|P3|COMPLETED|Overall Study||47
7866898|NCT00874549|19361583|P2|COMPLETED|Overall Study||55
7866899|NCT00874549|19361584|P1|COMPLETED|Overall Study||50
7866900|NCT00874549|19361581|P4|STARTED|Overall Study||58
7866901|NCT00874549|19361582|P3|STARTED|Overall Study||51
7866902|NCT00874549|19361583|P2|STARTED|Overall Study||56
7866903|NCT00874549|19361584|P1|STARTED|Overall Study||51
7866904|NCT00874510|19361652|P2|NOT COMPLETED|Year 2||0
7866905|NCT00874510|19361653|P1|NOT COMPLETED|Year 2||0
7866906|NCT00874510|19361652|P2|COMPLETED|Year 2||87
7866907|NCT00874510|19361653|P1|COMPLETED|Year 2||92
7866908|NCT00874510|19361652|P2|STARTED|Year 2||87
7866909|NCT00874510|19361653|P1|STARTED|Year 2||92
7866910|NCT00874510|19361652|P2|NOT COMPLETED|Year 1||0
7866911|NCT00874510|19361653|P1|NOT COMPLETED|Year 1||0
7866912|NCT00874510|19361652|P2|COMPLETED|Year 1||85
7866913|NCT00874510|19361653|P1|COMPLETED|Year 1||88
7866914|NCT00874510|19361652|P2|STARTED|Year 1||85
7866915|NCT00874510|19361653|P1|STARTED|Year 1||88
7866916|NCT00874497|19361661|P2|NOT COMPLETED|Overall Study||18
7866917|NCT00874497|19361662|P1|NOT COMPLETED|Overall Study||28
7866918|NCT00874497|19361661|P2|COMPLETED|Overall Study||15
7866919|NCT00874497|19361662|P1|COMPLETED|Overall Study||23
7866920|NCT00874497|19361661|P2|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|33
7866921|NCT00874497|19361662|P1|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|51
7866922|NCT00874432|19361704|P4|NOT COMPLETED|Overall Study||3
7866923|NCT00874432|19361705|P3|NOT COMPLETED|Overall Study||8
7866924|NCT00874432|19361706|P2|NOT COMPLETED|Overall Study||2
7866925|NCT00874432|19361707|P1|NOT COMPLETED|Overall Study||3
7866926|NCT00874432|19361704|P4|COMPLETED|Overall Study||11
7866927|NCT00874432|19361705|P3|COMPLETED|Overall Study||9
7866928|NCT00874432|19361706|P2|COMPLETED|Overall Study||2
7866929|NCT00874432|19361707|P1|COMPLETED|Overall Study||5
7866930|NCT00874432|19361704|P4|STARTED|Overall Study||14
7866931|NCT00874432|19361705|P3|STARTED|Overall Study||17
7866932|NCT00874432|19361706|P2|STARTED|Overall Study||4
7866933|NCT00874432|19361707|P1|STARTED|Overall Study||8
7866934|NCT00874276|19361725|P2|NOT COMPLETED|Overall Study||1
7866935|NCT00874276|19361726|P1|NOT COMPLETED|Overall Study||1
7866936|NCT00874276|19361725|P2|COMPLETED|Overall Study||7
7866937|NCT00874276|19361726|P1|COMPLETED|Overall Study||5
7866938|NCT00874276|19361725|P2|STARTED|Overall Study||8
7866939|NCT00874276|19361726|P1|STARTED|Overall Study||6
7866940|NCT00874250|19361734|P1|NOT COMPLETED|Overall Study||51
7866941|NCT00874250|19361734|P1|COMPLETED|Overall Study||0
7866942|NCT00874250|19361734|P1|STARTED|Overall Study||51
7866943|NCT00874237|19361746|P6|NOT COMPLETED|Overall Study||0
7866944|NCT00874237|19361747|P5|NOT COMPLETED|Overall Study||0
7866945|NCT00874237|19361748|P4|NOT COMPLETED|Overall Study||0
7866946|NCT00874237|19361749|P3|NOT COMPLETED|Overall Study||1
7866947|NCT00874237|19361750|P2|NOT COMPLETED|Overall Study||1
7866948|NCT00874237|19361751|P1|NOT COMPLETED|Overall Study||0
7866949|NCT00874237|19361746|P6|COMPLETED|Overall Study||8
7866950|NCT00874237|19361747|P5|COMPLETED|Overall Study||8
7866951|NCT00874237|19361748|P4|COMPLETED|Overall Study||8
7866952|NCT00874237|19361749|P3|COMPLETED|Overall Study||7
7866953|NCT00874237|19361750|P2|COMPLETED|Overall Study||7
7866954|NCT00874237|19361751|P1|COMPLETED|Overall Study||8
7866955|NCT00874237|19361746|P6|STARTED|Overall Study||8
7866956|NCT00874237|19361747|P5|STARTED|Overall Study||8
7866957|NCT00874237|19361748|P4|STARTED|Overall Study||8
7866958|NCT00874237|19361749|P3|STARTED|Overall Study||8
7866959|NCT00874237|19361750|P2|STARTED|Overall Study||8
7866960|NCT00874237|19361751|P1|STARTED|Overall Study||8
7866961|NCT00874120|19361769|P2|NOT COMPLETED|Second Intervention||0
7866962|NCT00874120|19361770|P1|NOT COMPLETED|Second Intervention||2
7866963|NCT00874120|19361769|P2|COMPLETED|Second Intervention||56
7866964|NCT00874120|19361770|P1|COMPLETED|Second Intervention||50
7866965|NCT00874120|19361769|P2|STARTED|Second Intervention||56
7866966|NCT00874120|19361770|P1|STARTED|Second Intervention||52
7866967|NCT00874120|19361769|P2|NOT COMPLETED|Wash-out Period||0
7866968|NCT00874120|19361770|P1|NOT COMPLETED|Wash-out Period||0
7866969|NCT00874120|19361769|P2|COMPLETED|Wash-out Period||56
7866970|NCT00874120|19361770|P1|COMPLETED|Wash-out Period||52
7866971|NCT00874120|19361769|P2|STARTED|Wash-out Period||56
7866972|NCT00874120|19361770|P1|STARTED|Wash-out Period||52
7866973|NCT00874120|19361769|P2|NOT COMPLETED|First Intervention||2
7866974|NCT00874120|19361770|P1|NOT COMPLETED|First Intervention||6
7866975|NCT00874120|19361769|P2|COMPLETED|First Intervention||56
7866976|NCT00874120|19361770|P1|COMPLETED|First Intervention||52
7866977|NCT00874120|19361769|P2|STARTED|First Intervention||58
7866978|NCT00874120|19361770|P1|STARTED|First Intervention||58
7866979|NCT00874094|19361776|P1|NOT COMPLETED|Overall Study||0
7866980|NCT00874094|19361776|P1|COMPLETED|Overall Study||15
7866981|NCT00874094|19361776|P1|STARTED|Overall Study||15
7866982|NCT00874029|19361783|P1|NOT COMPLETED|Overall Study||21
7866983|NCT00874029|19361783|P1|COMPLETED|Overall Study||116
7866984|NCT00874029|19361783|P1|STARTED|Overall Study||137
7866985|NCT00873912|19361799|P2|NOT COMPLETED|Overall Study||0
7866986|NCT00873912|19361800|P1|NOT COMPLETED|Overall Study||3
7866987|NCT00873912|19361799|P2|COMPLETED|Overall Study||60
7866988|NCT00873912|19361800|P1|COMPLETED|Overall Study||237
7866989|NCT00873912|19361799|P2|STARTED|Overall Study||60
7866990|NCT00873912|19361800|P1|STARTED|Overall Study||240
7866991|NCT00873873|19361818|P4|NOT COMPLETED|Overall Study||0
7866992|NCT00873873|19361819|P3|NOT COMPLETED|Overall Study||0
7866993|NCT00873873|19361820|P2|NOT COMPLETED|Overall Study||0
7866994|NCT00873873|19361821|P1|NOT COMPLETED|Overall Study||0
7866995|NCT00873873|19361818|P4|COMPLETED|Overall Study||18
7866996|NCT00873873|19361819|P3|COMPLETED|Overall Study||9
7866997|NCT00873873|19361820|P2|COMPLETED|Overall Study||8
7866998|NCT00873873|19361821|P1|COMPLETED|Overall Study||20
7866999|NCT00873873|19361818|P4|STARTED|Overall Study||18
7867000|NCT00873873|19361819|P3|STARTED|Overall Study||9
7867001|NCT00873873|19361820|P2|STARTED|Overall Study||8
7867002|NCT00873873|19361821|P1|STARTED|Overall Study||20
7867003|NCT00873860|19361839|P4|NOT COMPLETED|Overall Study||1
7867004|NCT00873860|19361840|P3|NOT COMPLETED|Overall Study||3
7867005|NCT00873860|19361841|P2|NOT COMPLETED|Overall Study||0
7867006|NCT00873860|19361842|P1|NOT COMPLETED|Overall Study||4
7867007|NCT00873860|19361839|P4|COMPLETED|Overall Study||47
7867008|NCT00873860|19361840|P3|COMPLETED|Overall Study||48
7867009|NCT00873860|19361841|P2|COMPLETED|Overall Study||47
7867010|NCT00873860|19361842|P1|COMPLETED|Overall Study||44
7867011|NCT00873860|19361839|P4|Treated|Overall Study||48
7867012|NCT00873860|19361840|P3|Treated|Overall Study||51
7867013|NCT00873860|19361841|P2|Treated|Overall Study||47
7867014|NCT00873860|19361842|P1|Treated|Overall Study||47
7867015|NCT00873860|19361839|P4|STARTED|Overall Study||48
7867016|NCT00873860|19361840|P3|STARTED|Overall Study||51
7867017|NCT00873860|19361841|P2|STARTED|Overall Study||47
7867018|NCT00873860|19361842|P1|STARTED|Overall Study||48
7867019|NCT00873821|19361913|P2|NOT COMPLETED|Overall Study||0
7867020|NCT00873821|19361914|P1|NOT COMPLETED|Overall Study||0
7867021|NCT00873821|19361913|P2|COMPLETED|Overall Study||22
7867022|NCT00873821|19361914|P1|COMPLETED|Overall Study||22
7867023|NCT00873821|19361913|P2|STARTED|Overall Study||22
7867024|NCT00873821|19361914|P1|STARTED|Overall Study||22
7867025|NCT00873782|19361924|P1|NOT COMPLETED|Overall Study||0
7867026|NCT00873782|19361924|P1|COMPLETED|Overall Study||16
7867027|NCT00873782|19361924|P1|STARTED|Overall Study||16
7867028|NCT00873730|19361930|P2|NOT COMPLETED|Overall Study||5
7867029|NCT00873730|19361931|P1|NOT COMPLETED|Overall Study||6
7867030|NCT00873730|19361930|P2|COMPLETED|Overall Study||49
7867031|NCT00873730|19361931|P1|COMPLETED|Overall Study||48
7867032|NCT00873730|19361930|P2|STARTED|Overall Study||54
7867033|NCT00873730|19361931|P1|STARTED|Overall Study||54
7867034|NCT00873457|19361967|P1|NOT COMPLETED|Overall Study||0
7867035|NCT00873457|19361967|P1|COMPLETED|Overall Study||16
7867036|NCT00873457|19361967|P1|STARTED|Overall Study||16
7867037|NCT00873366|19361974|P1|NOT COMPLETED|Overall Study||6
7867038|NCT00873366|19361974|P1|COMPLETED|Overall Study||71
7867039|NCT00873366|19361974|P1|STARTED|Overall Study||77
7867040|NCT00873327|19361993|P1|NOT COMPLETED|Overall Study||0
7867041|NCT00873327|19361993|P1|COMPLETED|Overall Study||32
7867042|NCT00873327|19361993|P1|STARTED|Overall Study||32
7867043|NCT00873119|19361999|P2|NOT COMPLETED|Overall Study||26
7867044|NCT00873119|19362000|P1|NOT COMPLETED|Overall Study||44
7867045|NCT00873119|19361999|P2|COMPLETED|Overall Study||19
7867046|NCT00873119|19362000|P1|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0
7867047|NCT00873119|19361999|P2|STARTED|Overall Study||45
7867048|NCT00873119|19362000|P1|STARTED|Overall Study||44
7867049|NCT00873093|19362021|P5|NOT COMPLETED|Overall Study||2
7867050|NCT00873093|19362022|P4|NOT COMPLETED|Overall Study||11
7867051|NCT00873093|19362023|P3|NOT COMPLETED|Overall Study||16
7867052|NCT00873093|19362024|P2|NOT COMPLETED|Overall Study||27
7867053|NCT00873093|19362025|P1|NOT COMPLETED|Overall Study||1
7867054|NCT00873093|19362021|P5|COMPLETED|Overall Study||8
7867055|NCT00873093|19362022|P4|COMPLETED|Overall Study||12
7867056|NCT00873093|19362023|P3|COMPLETED|Overall Study||33
7867057|NCT00873093|19362024|P2|COMPLETED|Overall Study||35
7867058|NCT00873093|19362025|P1|COMPLETED|Overall Study||3
7867059|NCT00873093|19362021|P5|STARTED|Overall Study||10
7867060|NCT00873093|19362022|P4|STARTED|Overall Study||23
7867061|NCT00873093|19362023|P3|STARTED|Overall Study||49
7867062|NCT00873093|19362024|P2|STARTED|Overall Study||62
7867063|NCT00873093|19362025|P1|STARTED|Overall Study||4
7867064|NCT00873041|19362082|P3|NOT COMPLETED|Extension Study||2
7867065|NCT00873041|19362083|P2|NOT COMPLETED|Extension Study||0
7867066|NCT00873041|19362084|P1|NOT COMPLETED|Extension Study||1
7867067|NCT00873041|19362082|P3|COMPLETED|Extension Study||46
7867068|NCT00873041|19362083|P2|COMPLETED|Extension Study||44
7867069|NCT00873041|19362084|P1|COMPLETED|Extension Study||40
7867070|NCT00873041|19362082|P3|STARTED|Extension Study||48
7867071|NCT00873041|19362083|P2|STARTED|Extension Study||44
7867072|NCT00873041|19362084|P1|STARTED|Extension Study||41
7867073|NCT00873041|19362082|P3|NOT COMPLETED|Core Study||5
7867074|NCT00873041|19362083|P2|NOT COMPLETED|Core Study||6
7867075|NCT00873041|19362084|P1|NOT COMPLETED|Core Study||7
7867076|NCT00873041|19362082|P3|COMPLETED|Core Study||51
7867077|NCT00873041|19362083|P2|COMPLETED|Core Study||49
7867078|NCT00873041|19362084|P1|COMPLETED|Core Study||48
7867079|NCT00873041|19362082|P3|STARTED|Core Study||56
7867080|NCT00873041|19362083|P2|STARTED|Core Study||55
7867081|NCT00873041|19362084|P1|STARTED|Core Study||55
7867082|NCT00873015|19362142|P4|NOT COMPLETED|Overall Study||0
7867083|NCT00873015|19362143|P3|NOT COMPLETED|Overall Study||0
7867084|NCT00873015|19362144|P2|NOT COMPLETED|Overall Study||1
7867085|NCT00873015|19362145|P1|NOT COMPLETED|Overall Study||0
7867086|NCT00873015|19362142|P4|COMPLETED|Overall Study||3
7867087|NCT00873015|19362143|P3|COMPLETED|Overall Study||3
7867088|NCT00873015|19362144|P2|COMPLETED|Overall Study||3
7867089|NCT00873015|19362145|P1|COMPLETED|Overall Study||9
7867090|NCT00873015|19362142|P4|STARTED|Overall Study||3
7867091|NCT00873015|19362143|P3|STARTED|Overall Study||3
7867092|NCT00873015|19362144|P2|STARTED|Overall Study||4
7867093|NCT00873015|19362145|P1|STARTED|Overall Study||9
7867094|NCT00872989|19362162|P2|NOT COMPLETED|Overall Study||63
7867095|NCT00872989|19362163|P1|NOT COMPLETED|Overall Study||65
7867096|NCT00872989|19362162|P2|COMPLETED|Overall Study||0
7867097|NCT00872989|19362163|P1|COMPLETED|Overall Study||1
7867098|NCT00872989|19362162|P2|STARTED|Overall Study||63
7867099|NCT00872989|19362163|P1|STARTED|Overall Study||66
7867100|NCT00872898|19362182|P2|NOT COMPLETED|Part Two - Double Blind||6
7867101|NCT00872898|19362183|P1|NOT COMPLETED|Part Two - Double Blind||11
7867102|NCT00872898|19362182|P2|COMPLETED|Part Two - Double Blind||54
7867103|NCT00872898|19362183|P1|COMPLETED|Part Two - Double Blind||50
7867104|NCT00872898|19362182|P2|STARTED|Part Two - Double Blind||60
7867105|NCT00872898|19362183|P1|STARTED|Part Two - Double Blind||61
7867106|NCT00872898|19362182|P2|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
7867107|NCT00872898|19362183|P1|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
7867108|NCT00872898|19362182|P2|COMPLETED|Part One - Open Label, Pharmacokinetics||4
7867109|NCT00872898|19362183|P1|COMPLETED|Part One - Open Label, Pharmacokinetics||0
7867110|NCT00872898|19362182|P2|STARTED|Part One - Open Label, Pharmacokinetics||4
7867111|NCT00872898|19362183|P1|STARTED|Part One - Open Label, Pharmacokinetics||0
7867112|NCT00872833|19362217|P2|NOT COMPLETED|Overall Study||0
7867113|NCT00872833|19362218|P1|NOT COMPLETED|Overall Study||0
7867114|NCT00872833|19362217|P2|COMPLETED|Overall Study||17
7867115|NCT00872833|19362218|P1|COMPLETED|Overall Study||15
7867116|NCT00872833|19362217|P2|STARTED|Overall Study||17
7867117|NCT00872833|19362218|P1|STARTED|Overall Study||15
7867118|NCT00872729|19362227|P1|NOT COMPLETED|Overall Study||0
7867119|NCT00872729|19362227|P1|COMPLETED|Overall Study||9
7867120|NCT00872729|19362227|P1|STARTED|Overall Study||9
7867121|NCT00872599|19362257|P2|NOT COMPLETED|Second Drug During High Salt Intake||0
7867122|NCT00872599|19362258|P1|NOT COMPLETED|Second Drug During High Salt Intake||0
7867123|NCT00872599|19362257|P2|COMPLETED|Second Drug During High Salt Intake||16
7867124|NCT00872599|19362258|P1|COMPLETED|Second Drug During High Salt Intake||15
7867125|NCT00872599|19362257|P2|STARTED|Second Drug During High Salt Intake||16
7867126|NCT00872599|19362258|P1|STARTED|Second Drug During High Salt Intake||15
7867127|NCT00872599|19362257|P2|NOT COMPLETED|Second Washout Period||1
7867128|NCT00872599|19362258|P1|NOT COMPLETED|Second Washout Period||1
7867129|NCT00872599|19362257|P2|COMPLETED|Second Washout Period||16
7867130|NCT00872599|19362258|P1|COMPLETED|Second Washout Period||15
7867131|NCT00872599|19362257|P2|STARTED|Second Washout Period||17
7867132|NCT00872599|19362258|P1|STARTED|Second Washout Period||16
7867133|NCT00872599|19362257|P2|NOT COMPLETED|First Drug During High Salt Intake||0
7867134|NCT00872599|19362258|P1|NOT COMPLETED|First Drug During High Salt Intake||0
7867135|NCT00872599|19362257|P2|COMPLETED|First Drug During High Salt Intake||17
7867136|NCT00872599|19362258|P1|COMPLETED|First Drug During High Salt Intake||16
7867137|NCT00872599|19362257|P2|STARTED|First Drug During High Salt Intake||17
7867138|NCT00872599|19362258|P1|STARTED|First Drug During High Salt Intake||16
7867139|NCT00872599|19362257|P2|NOT COMPLETED|First Washout Period After Low Salt||0
7867140|NCT00872599|19362258|P1|NOT COMPLETED|First Washout Period After Low Salt||0
7867141|NCT00872599|19362257|P2|COMPLETED|First Washout Period After Low Salt||17
7867142|NCT00872599|19362258|P1|COMPLETED|First Washout Period After Low Salt||16
7867143|NCT00872599|19362257|P2|STARTED|First Washout Period After Low Salt||17
7867144|NCT00872599|19362258|P1|STARTED|First Washout Period After Low Salt||16
7867145|NCT00872534|19362268|P2|NOT COMPLETED|Overall Study||3
7867146|NCT00872534|19362269|P1|NOT COMPLETED|Overall Study||3
7867147|NCT00872534|19362268|P2|COMPLETED|Overall Study||101
7867148|NCT00872534|19362269|P1|COMPLETED|Overall Study||97
7867149|NCT00872534|19362268|P2|STARTED|Overall Study||104
7867150|NCT00872534|19362269|P1|STARTED|Overall Study||100
7867151|NCT00872521|19362278|P3|NOT COMPLETED|Secondary Endpoint Analysis||1
7867152|NCT00872521|19362279|P2|NOT COMPLETED|Secondary Endpoint Analysis||2
7867153|NCT00872521|19362280|P1|NOT COMPLETED|Secondary Endpoint Analysis||0
7867154|NCT00872521|19362278|P3|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7
7867155|NCT00872521|19362279|P2|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58
7867156|NCT00872521|19362280|P1|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20
7867157|NCT00872521|19362278|P3|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8
7867158|NCT00872521|19362279|P2|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60
7867159|NCT00872521|19362280|P1|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20
7867160|NCT00872521|19362278|P3|NOT COMPLETED|Completed 3-month Follow up||0
7867161|NCT00872521|19362279|P2|NOT COMPLETED|Completed 3-month Follow up||3
7867162|NCT00872521|19362280|P1|NOT COMPLETED|Completed 3-month Follow up||0
7867163|NCT00872521|19362278|P3|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8
7867164|NCT00872521|19362279|P2|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60
7867165|NCT00872521|19362280|P1|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20
7867166|NCT00872521|19362278|P3|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8
7867167|NCT00872521|19362279|P2|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63
7867168|NCT00872521|19362280|P1|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20
7867169|NCT00872521|19362278|P3|NOT COMPLETED|Primary Endpoint Analysis||1
7867170|NCT00872521|19362279|P2|NOT COMPLETED|Primary Endpoint Analysis||5
7867171|NCT00872521|19362280|P1|NOT COMPLETED|Primary Endpoint Analysis||1
7867172|NCT00872521|19362278|P3|COMPLETED|Primary Endpoint Analysis|participants analyzed|8
7867173|NCT00872521|19362279|P2|COMPLETED|Primary Endpoint Analysis|participants analyzed|63
7867174|NCT00872521|19362280|P1|COMPLETED|Primary Endpoint Analysis|participants analyzed|20
7867175|NCT00872521|19362278|P3|STARTED|Primary Endpoint Analysis|Completed PAD induction|9
7867176|NCT00872521|19362279|P2|STARTED|Primary Endpoint Analysis|Completed PAD induction|68
7867177|NCT00872521|19362280|P1|STARTED|Primary Endpoint Analysis|Completed PAD induction|21
7867178|NCT00872521|19362278|P3|NOT COMPLETED|Completed PAD Induction||0
7867179|NCT00872521|19362279|P2|NOT COMPLETED|Completed PAD Induction||4
7867180|NCT00872521|19362280|P1|NOT COMPLETED|Completed PAD Induction||5
7867181|NCT00872521|19362278|P3|COMPLETED|Completed PAD Induction|Completed PAD induction|9
7867182|NCT00872521|19362279|P2|COMPLETED|Completed PAD Induction|Completed PAD induction|68
7867183|NCT00872521|19362280|P1|COMPLETED|Completed PAD Induction|Completed PAD induction|21
7867184|NCT00872521|19362278|P3|STARTED|Completed PAD Induction|Received allocated treatment|9
7867185|NCT00872521|19362279|P2|STARTED|Completed PAD Induction|Received allocated treatment|72
7867186|NCT00872521|19362280|P1|STARTED|Completed PAD Induction|Received allocated treatment|26
7867187|NCT00872430|19362328|P2|NOT COMPLETED|Second Intervention||0
7867188|NCT00872430|19362329|P1|NOT COMPLETED|Second Intervention||0
7867189|NCT00872430|19362328|P2|COMPLETED|Second Intervention||10
7867190|NCT00872430|19362329|P1|COMPLETED|Second Intervention||10
7867191|NCT00872430|19362328|P2|STARTED|Second Intervention||10
7867192|NCT00872430|19362329|P1|STARTED|Second Intervention||10
7867193|NCT00872430|19362328|P2|NOT COMPLETED|Washout Period||0
7867194|NCT00872430|19362329|P1|NOT COMPLETED|Washout Period||0
7867195|NCT00872430|19362328|P2|COMPLETED|Washout Period||10
7867196|NCT00872430|19362329|P1|COMPLETED|Washout Period||10
7867197|NCT00872430|19362328|P2|STARTED|Washout Period||10
7867198|NCT00872430|19362329|P1|STARTED|Washout Period||10
7867199|NCT00872430|19362328|P2|NOT COMPLETED|First Intervention||0
7867200|NCT00872430|19362329|P1|NOT COMPLETED|First Intervention||0
7867201|NCT00872430|19362328|P2|COMPLETED|First Intervention||10
7867202|NCT00872430|19362329|P1|COMPLETED|First Intervention||10
7867203|NCT00872430|19362328|P2|STARTED|First Intervention||10
7867204|NCT00872430|19362329|P1|STARTED|First Intervention||10
7867205|NCT00872339|19362338|P3|NOT COMPLETED|Overall Study||0
7867206|NCT00872339|19362339|P2|NOT COMPLETED|Overall Study||0
7867207|NCT00872339|19362340|P1|NOT COMPLETED|Overall Study||0
7867208|NCT00872339|19362338|P3|COMPLETED|Overall Study||37
7867209|NCT00872339|19362339|P2|COMPLETED|Overall Study||14
7867210|NCT00872339|19362340|P1|COMPLETED|Overall Study||201
7867211|NCT00872339|19362338|P3|STARTED|Overall Study||37
7867212|NCT00872339|19362339|P2|STARTED|Overall Study||14
7867213|NCT00872339|19362340|P1|STARTED|Overall Study||201
7867214|NCT00872170|19362351|P2|NOT COMPLETED|Overall Study||0
7867215|NCT00872170|19362352|P1|NOT COMPLETED|Overall Study||1
7867216|NCT00872170|19362351|P2|COMPLETED|Overall Study||13
7867217|NCT00872170|19362352|P1|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13
7867218|NCT00872170|19362351|P2|STARTED|Overall Study||13
7867219|NCT00872170|19362352|P1|STARTED|Overall Study||14
7867220|NCT00872079|19362367|P1|NOT COMPLETED|Overall Study||0
7867221|NCT00872079|19362367|P1|COMPLETED|Overall Study||175
7867222|NCT00872079|19362367|P1|STARTED|Overall Study||175
7867223|NCT00872027|19362373|P2|NOT COMPLETED|Overall Study||0
7867224|NCT00872027|19362374|P1|NOT COMPLETED|Overall Study||0
7867225|NCT00872027|19362373|P2|COMPLETED|Overall Study||8
7867226|NCT00872027|19362374|P1|COMPLETED|Overall Study||7
7867227|NCT00872027|19362373|P2|STARTED|Overall Study||8
7867228|NCT00872027|19362374|P1|STARTED|Overall Study||7
7867229|NCT00872001|19362382|P2|NOT COMPLETED|Overall Study||131
7867230|NCT00872001|19362383|P1|NOT COMPLETED|Overall Study||136
7867231|NCT00872001|19362382|P2|COMPLETED|Overall Study||1413
7867232|NCT00872001|19362383|P1|COMPLETED|Overall Study||1400
7867233|NCT00872001|19362382|P2|STARTED|Overall Study||1544
7867234|NCT00872001|19362383|P1|STARTED|Overall Study||1536
7867235|NCT00871975|19362391|P1|NOT COMPLETED|Overall Study||22
7867236|NCT00871975|19362391|P1|COMPLETED|Overall Study||133
7867237|NCT00871975|19362391|P1|STARTED|Overall Study||155
7867238|NCT00871871|19362397|P4|NOT COMPLETED|Part II||4
7867239|NCT00871871|19362398|P3|NOT COMPLETED|Part II||4
7867240|NCT00871871|19362399|P2|NOT COMPLETED|Part II||0
7867241|NCT00871871|19362400|P1|NOT COMPLETED|Part II||0
7867242|NCT00871871|19362397|P4|COMPLETED|Part II||11
7867243|NCT00871871|19362398|P3|COMPLETED|Part II||9
7867244|NCT00871871|19362399|P2|COMPLETED|Part II||0
7867245|NCT00871871|19362400|P1|COMPLETED|Part II||0
7867246|NCT00871871|19362397|P4|STARTED|Part II||15
7867247|NCT00871871|19362398|P3|STARTED|Part II||13
7867248|NCT00871871|19362399|P2|STARTED|Part II||0
7867249|NCT00871871|19362400|P1|STARTED|Part II||0
7867250|NCT00871871|19362397|P4|NOT COMPLETED|Part I||0
7867251|NCT00871871|19362398|P3|NOT COMPLETED|Part I||0
7867252|NCT00871871|19362399|P2|NOT COMPLETED|Part I||3
7867253|NCT00871871|19362400|P1|NOT COMPLETED|Part I||3
7867254|NCT00871871|19362397|P4|COMPLETED|Part I||0
7867255|NCT00871871|19362398|P3|COMPLETED|Part I||0
7867256|NCT00871871|19362399|P2|COMPLETED|Part I||15
7867257|NCT00871871|19362400|P1|COMPLETED|Part I||15
7867258|NCT00871871|19362397|P4|STARTED|Part I||0
7867259|NCT00871871|19362398|P3|STARTED|Part I||0
7867260|NCT00871871|19362399|P2|STARTED|Part I||18
7867261|NCT00871871|19362400|P1|STARTED|Part I||18
7867262|NCT00871845|19362422|P2|NOT COMPLETED|Overall Study||0
7867263|NCT00871845|19362423|P1|NOT COMPLETED|Overall Study||0
7867264|NCT00871845|19362422|P2|COMPLETED|Overall Study||25
7867265|NCT00871845|19362423|P1|COMPLETED|Overall Study||11
7867266|NCT00871845|19362422|P2|STARTED|Overall Study||25
7867267|NCT00871845|19362423|P1|STARTED|Overall Study||11
7867268|NCT00871819|19362433|P1|NOT COMPLETED|Overall Study||0
7867269|NCT00871819|19362433|P1|COMPLETED|Overall Study||20
7867270|NCT00871819|19362433|P1|STARTED|Overall Study||20
7867271|NCT00871780|19362437|P1|NOT COMPLETED|Overall Study||27
7867272|NCT00871780|19362437|P1|COMPLETED|Overall Study||197
7867273|NCT00871780|19362437|P1|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215
7867274|NCT00871780|19362437|P1|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218
7867275|NCT00871780|19362437|P1|STARTED|Overall Study|number enrolled|224
7867276|NCT00871741|19362457|P2|NOT COMPLETED|Overall Study||7
7867277|NCT00871741|19362458|P1|NOT COMPLETED|Overall Study||9
7867278|NCT00871741|19362457|P2|COMPLETED|Overall Study||0
7867279|NCT00871741|19362458|P1|COMPLETED|Overall Study||0
7867280|NCT00871741|19362457|P2|STARTED|Overall Study||7
7867281|NCT00871741|19362458|P1|STARTED|Overall Study||9
7867282|NCT00871728|19362472|P1|NOT COMPLETED|Overall Study||20
7867283|NCT00871728|19362472|P1|COMPLETED|Overall Study||112
7867284|NCT00871728|19362472|P1|Treated|Overall Study||130
7867285|NCT00871728|19362472|P1|STARTED|Overall Study||132
7867286|NCT00871715|19362485|P3|NOT COMPLETED|Overall Study||26
7867287|NCT00871715|19362486|P2|NOT COMPLETED|Overall Study||16
7867288|NCT00871715|19362487|P1|NOT COMPLETED|Overall Study||15
7867289|NCT00871715|19362485|P3|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96
7867290|NCT00871715|19362486|P2|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
7867291|NCT00871715|19362487|P1|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
7867292|NCT00871715|19362485|P3|6-mo Follow-up|Overall Study||112
7867293|NCT00871715|19362486|P2|6-mo Follow-up|Overall Study||113
7867294|NCT00871715|19362487|P1|6-mo Follow-up|Overall Study||110
7867295|NCT00871715|19362485|P3|Post-Intervention|Overall Study||115
7867296|NCT00871715|19362486|P2|Post-Intervention|Overall Study||115
7867297|NCT00871715|19362487|P1|Post-Intervention|Overall Study||112
7867298|NCT00871715|19362485|P3|STARTED|Overall Study||122
7867299|NCT00871715|19362486|P2|STARTED|Overall Study||120
7867300|NCT00871715|19362487|P1|STARTED|Overall Study||119
7867301|NCT00871689|19362538|P1|NOT COMPLETED|Overall Study||0
7867302|NCT00871689|19362538|P1|COMPLETED|Overall Study||2
7867303|NCT00871689|19362538|P1|STARTED|Overall Study||2
7867304|NCT00871624|19362551|P2|NOT COMPLETED|Overall Study||1
7867305|NCT00871624|19362552|P1|NOT COMPLETED|Overall Study||2
7867306|NCT00871624|19362551|P2|COMPLETED|Overall Study||17
7867307|NCT00871624|19362552|P1|COMPLETED|Overall Study||16
7867308|NCT00871624|19362551|P2|STARTED|Overall Study||18
7867309|NCT00871624|19362552|P1|STARTED|Overall Study||18
7867310|NCT00871572|19362564|P4|NOT COMPLETED|Overall Study||7
7867311|NCT00871572|19362565|P3|NOT COMPLETED|Overall Study||4
7867312|NCT00871572|19362566|P2|NOT COMPLETED|Overall Study||6
7867313|NCT00871572|19362567|P1|NOT COMPLETED|Overall Study||2
7867314|NCT00871572|19362564|P4|COMPLETED|Overall Study||19
7867315|NCT00871572|19362565|P3|COMPLETED|Overall Study||30
7867316|NCT00871572|19362566|P2|COMPLETED|Overall Study||11
7867317|NCT00871572|19362567|P1|COMPLETED|Overall Study||8
7867318|NCT00871572|19362564|P4|Received at Least 1 Dose of Study Drug|Overall Study||25
7867319|NCT00871572|19362565|P3|Received at Least 1 Dose of Study Drug|Overall Study||34
7867320|NCT00871572|19362566|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
7867321|NCT00871572|19362567|P1|Received at Least 1 Dose of Study Drug|Overall Study||9
7867322|NCT00871572|19362564|P4|≥1 Post Baseline Value by Assigned Group|Overall Study||25
7867323|NCT00871572|19362565|P3|≥1 Post Baseline Value by Assigned Group|Overall Study||34
7867324|NCT00871572|19362566|P2|≥1 Post Baseline Value by Assigned Group|Overall Study||17
7867325|NCT00871572|19362567|P1|≥1 Post Baseline Value by Assigned Group|Overall Study||9
7867326|NCT00871572|19362564|P4|STARTED|Overall Study||26
7867327|NCT00871572|19362565|P3|STARTED|Overall Study||34
7867328|NCT00871572|19362566|P2|STARTED|Overall Study||17
7867329|NCT00871572|19362567|P1|STARTED|Overall Study||10
7867330|NCT00871494|19362637|P1|NOT COMPLETED|Overall Study||14
7867331|NCT00871494|19362637|P1|COMPLETED|Overall Study||62
7867332|NCT00871494|19362637|P1|STARTED|Overall Study||76
7867333|NCT00871429|19362644|P1|NOT COMPLETED|Overall Study||24
7867334|NCT00871429|19362644|P1|COMPLETED|Overall Study||75
7867335|NCT00871429|19362644|P1|STARTED|Overall Study||99
7867336|NCT00871403|19362655|P3|NOT COMPLETED|Monotherapy Treatment Phase||1
7867337|NCT00871403|19362656|P2|NOT COMPLETED|Monotherapy Treatment Phase||13
7867338|NCT00871403|19362657|P1|NOT COMPLETED|Monotherapy Treatment Phase||0
7867339|NCT00871403|19362655|P3|COMPLETED|Monotherapy Treatment Phase||0
7867340|NCT00871403|19362656|P2|COMPLETED|Monotherapy Treatment Phase||0
7867341|NCT00871403|19362657|P1|COMPLETED|Monotherapy Treatment Phase||0
7867342|NCT00871403|19362655|P3|STARTED|Monotherapy Treatment Phase||1
7867343|NCT00871403|19362656|P2|STARTED|Monotherapy Treatment Phase||13
7867344|NCT00871403|19362657|P1|STARTED|Monotherapy Treatment Phase||0
7867345|NCT00871403|19362655|P3|NOT COMPLETED|Combination Treatment Phase||12
7867346|NCT00871403|19362656|P2|NOT COMPLETED|Combination Treatment Phase||49
7867347|NCT00871403|19362657|P1|NOT COMPLETED|Combination Treatment Phase||9
7867348|NCT00871403|19362655|P3|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23
7867349|NCT00871403|19362656|P2|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13
7867350|NCT00871403|19362657|P1|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0
7867351|NCT00871403|19362655|P3|STARTED|Combination Treatment Phase||35
7867352|NCT00871403|19362656|P2|STARTED|Combination Treatment Phase||62
7867353|NCT00871403|19362657|P1|STARTED|Combination Treatment Phase||9
7867354|NCT00871377|19362670|P6|NOT COMPLETED|Third Intervention (10 Weeks)||0
7867355|NCT00871377|19362671|P5|NOT COMPLETED|Third Intervention (10 Weeks)||0
7867356|NCT00871377|19362672|P4|NOT COMPLETED|Third Intervention (10 Weeks)||1
7867357|NCT00871377|19362673|P3|NOT COMPLETED|Third Intervention (10 Weeks)||0
7867358|NCT00871377|19362674|P2|NOT COMPLETED|Third Intervention (10 Weeks)||0
7867359|NCT00871377|19362675|P1|NOT COMPLETED|Third Intervention (10 Weeks)||0
7867360|NCT00871377|19362670|P6|COMPLETED|Third Intervention (10 Weeks)||3
7867361|NCT00871377|19362671|P5|COMPLETED|Third Intervention (10 Weeks)||4
7867362|NCT00871377|19362672|P4|COMPLETED|Third Intervention (10 Weeks)||3
7867363|NCT00871377|19362673|P3|COMPLETED|Third Intervention (10 Weeks)||3
7867364|NCT00871377|19362674|P2|COMPLETED|Third Intervention (10 Weeks)||4
7867365|NCT00871377|19362675|P1|COMPLETED|Third Intervention (10 Weeks)||2
7867366|NCT00871377|19362670|P6|STARTED|Third Intervention (10 Weeks)||3
7867367|NCT00871377|19362671|P5|STARTED|Third Intervention (10 Weeks)||4
7867368|NCT00871377|19362672|P4|STARTED|Third Intervention (10 Weeks)||4
7867369|NCT00871377|19362673|P3|STARTED|Third Intervention (10 Weeks)||3
7867370|NCT00871377|19362674|P2|STARTED|Third Intervention (10 Weeks)||4
7867371|NCT00871377|19362675|P1|STARTED|Third Intervention (10 Weeks)||2
7867372|NCT00871377|19362670|P6|NOT COMPLETED|Washout (6 Weeks)||1
7867373|NCT00871377|19362671|P5|NOT COMPLETED|Washout (6 Weeks)||0
7867374|NCT00871377|19362672|P4|NOT COMPLETED|Washout (6 Weeks)||0
7867375|NCT00871377|19362673|P3|NOT COMPLETED|Washout (6 Weeks)||0
7867376|NCT00871377|19362674|P2|NOT COMPLETED|Washout (6 Weeks)||0
7867377|NCT00871377|19362675|P1|NOT COMPLETED|Washout (6 Weeks)||0
7867378|NCT00871377|19362670|P6|COMPLETED|Washout (6 Weeks)||3
7867379|NCT00871377|19362671|P5|COMPLETED|Washout (6 Weeks)||4
7867380|NCT00871377|19362672|P4|COMPLETED|Washout (6 Weeks)||4
7867381|NCT00871377|19362673|P3|COMPLETED|Washout (6 Weeks)||3
7867382|NCT00871377|19362674|P2|COMPLETED|Washout (6 Weeks)||4
7867383|NCT00871377|19362675|P1|COMPLETED|Washout (6 Weeks)||2
7867384|NCT00871377|19362670|P6|STARTED|Washout (6 Weeks)||4
7867385|NCT00871377|19362671|P5|STARTED|Washout (6 Weeks)||4
7867386|NCT00871377|19362672|P4|STARTED|Washout (6 Weeks)||4
7867387|NCT00871377|19362673|P3|STARTED|Washout (6 Weeks)||3
7867388|NCT00871377|19362674|P2|STARTED|Washout (6 Weeks)||4
7867389|NCT00871377|19362675|P1|STARTED|Washout (6 Weeks)||2
7867390|NCT00871377|19362670|P6|NOT COMPLETED|Second Intervention (10 Weeks)||0
7867391|NCT00871377|19362671|P5|NOT COMPLETED|Second Intervention (10 Weeks)||0
7867392|NCT00871377|19362672|P4|NOT COMPLETED|Second Intervention (10 Weeks)||0
7867393|NCT00871377|19362673|P3|NOT COMPLETED|Second Intervention (10 Weeks)||0
7867394|NCT00871377|19362674|P2|NOT COMPLETED|Second Intervention (10 Weeks)||0
7867395|NCT00871377|19362675|P1|NOT COMPLETED|Second Intervention (10 Weeks)||0
7867396|NCT00871377|19362670|P6|COMPLETED|Second Intervention (10 Weeks)||4
7867397|NCT00871377|19362671|P5|COMPLETED|Second Intervention (10 Weeks)||4
7867398|NCT00871377|19362672|P4|COMPLETED|Second Intervention (10 Weeks)||4
7867399|NCT00871377|19362673|P3|COMPLETED|Second Intervention (10 Weeks)||3
7867400|NCT00871377|19362674|P2|COMPLETED|Second Intervention (10 Weeks)||4
7867401|NCT00871377|19362675|P1|COMPLETED|Second Intervention (10 Weeks)||2
7867402|NCT00871377|19362670|P6|STARTED|Second Intervention (10 Weeks)||4
7867403|NCT00871377|19362671|P5|STARTED|Second Intervention (10 Weeks)||4
7867404|NCT00871377|19362672|P4|STARTED|Second Intervention (10 Weeks)||4
7867405|NCT00871377|19362673|P3|STARTED|Second Intervention (10 Weeks)||3
7867406|NCT00871377|19362674|P2|STARTED|Second Intervention (10 Weeks)||4
7867407|NCT00871377|19362675|P1|STARTED|Second Intervention (10 Weeks)||2
7867408|NCT00871377|19362670|P6|NOT COMPLETED|Washout (6 Weeks)||0
7867409|NCT00871377|19362671|P5|NOT COMPLETED|Washout (6 Weeks)||0
7867410|NCT00871377|19362672|P4|NOT COMPLETED|Washout (6 Weeks)||0
7867411|NCT00871377|19362673|P3|NOT COMPLETED|Washout (6 Weeks)||0
7867412|NCT00871377|19362674|P2|NOT COMPLETED|Washout (6 Weeks)||0
7867413|NCT00871377|19362675|P1|NOT COMPLETED|Washout (6 Weeks)||1
7867414|NCT00871377|19362670|P6|COMPLETED|Washout (6 Weeks)||4
7867415|NCT00871377|19362671|P5|COMPLETED|Washout (6 Weeks)||4
7867416|NCT00871377|19362672|P4|COMPLETED|Washout (6 Weeks)||4
7867417|NCT00871377|19362673|P3|COMPLETED|Washout (6 Weeks)||3
7867418|NCT00871377|19362674|P2|COMPLETED|Washout (6 Weeks)||4
7867419|NCT00871377|19362675|P1|COMPLETED|Washout (6 Weeks)||2
7867420|NCT00871377|19362670|P6|STARTED|Washout (6 Weeks)||4
7867421|NCT00871377|19362671|P5|STARTED|Washout (6 Weeks)||4
7867422|NCT00871377|19362672|P4|STARTED|Washout (6 Weeks)||4
7867423|NCT00871377|19362673|P3|STARTED|Washout (6 Weeks)||3
7867424|NCT00871377|19362674|P2|STARTED|Washout (6 Weeks)||4
7867425|NCT00871377|19362675|P1|STARTED|Washout (6 Weeks)||3
7867426|NCT00871377|19362670|P6|NOT COMPLETED|First Intervention (10 Weeks)||1
7867427|NCT00871377|19362671|P5|NOT COMPLETED|First Intervention (10 Weeks)||0
7867428|NCT00871377|19362672|P4|NOT COMPLETED|First Intervention (10 Weeks)||0
7867429|NCT00871377|19362673|P3|NOT COMPLETED|First Intervention (10 Weeks)||1
7867430|NCT00871377|19362674|P2|NOT COMPLETED|First Intervention (10 Weeks)||0
7867431|NCT00871377|19362675|P1|NOT COMPLETED|First Intervention (10 Weeks)||0
7867432|NCT00871377|19362670|P6|COMPLETED|First Intervention (10 Weeks)||4
7867433|NCT00871377|19362671|P5|COMPLETED|First Intervention (10 Weeks)||4
7867434|NCT00871377|19362672|P4|COMPLETED|First Intervention (10 Weeks)||4
7867435|NCT00871377|19362673|P3|COMPLETED|First Intervention (10 Weeks)||3
7867436|NCT00871377|19362674|P2|COMPLETED|First Intervention (10 Weeks)||4
7867437|NCT00871377|19362675|P1|COMPLETED|First Intervention (10 Weeks)||3
7867438|NCT00871377|19362670|P6|STARTED|First Intervention (10 Weeks)||5
7867439|NCT00871377|19362671|P5|STARTED|First Intervention (10 Weeks)||4
7867440|NCT00871377|19362672|P4|STARTED|First Intervention (10 Weeks)||4
7867441|NCT00871377|19362673|P3|STARTED|First Intervention (10 Weeks)||4
7867442|NCT00871377|19362674|P2|STARTED|First Intervention (10 Weeks)||4
7867443|NCT00871377|19362675|P1|STARTED|First Intervention (10 Weeks)||3
7867444|NCT00871351|19362686|P3|NOT COMPLETED|Overall Study||0
7867445|NCT00871351|19362687|P2|NOT COMPLETED|Overall Study||1
7867446|NCT00871351|19362688|P1|NOT COMPLETED|Overall Study||4
7867447|NCT00871351|19362686|P3|COMPLETED|Overall Study||32
7867448|NCT00871351|19362687|P2|COMPLETED|Overall Study||45
7867449|NCT00871351|19362688|P1|COMPLETED|Overall Study||43
7867450|NCT00871351|19362686|P3|STARTED|Overall Study||32
7867451|NCT00871351|19362687|P2|STARTED|Overall Study||46
7867452|NCT00871351|19362688|P1|STARTED|Overall Study||47
7867453|NCT00871338|19362710|P2|NOT COMPLETED|After Booster||0
7867454|NCT00871338|19362711|P1|NOT COMPLETED|After Booster||0
7867455|NCT00871338|19362710|P2|COMPLETED|After Booster||135
7867456|NCT00871338|19362711|P1|COMPLETED|After Booster||139
7867457|NCT00871338|19362710|P2|STARTED|After Booster||135
7867458|NCT00871338|19362711|P1|STARTED|After Booster||139
7867459|NCT00871338|19362710|P2|NOT COMPLETED|Prior to Booster||3
7867460|NCT00871338|19362711|P1|NOT COMPLETED|Prior to Booster||2
7867461|NCT00871338|19362710|P2|COMPLETED|Prior to Booster||139
7867462|NCT00871338|19362711|P1|COMPLETED|Prior to Booster||140
7867463|NCT00871338|19362710|P2|STARTED|Prior to Booster||142
7867464|NCT00871338|19362711|P1|STARTED|Prior to Booster||142
7867465|NCT00871286|19362791|P2|NOT COMPLETED|Overall Study||6
7867466|NCT00871286|19362792|P1|NOT COMPLETED|Overall Study||0
7867467|NCT00871286|19362791|P2|COMPLETED|Overall Study||14
7867468|NCT00871286|19362792|P1|COMPLETED|Overall Study||20
7867469|NCT00871286|19362791|P2|STARTED|Overall Study||20
7867470|NCT00871286|19362792|P1|STARTED|Overall Study||20
7867471|NCT00871234|19362800|P1|NOT COMPLETED|Overall Study||5
7867472|NCT00871234|19362800|P1|COMPLETED|Overall Study||23
7867473|NCT00871234|19362800|P1|STARTED|Overall Study||28
7867474|NCT00871169|19362804|P1|NOT COMPLETED|Overall Study||3
7867475|NCT00871169|19362804|P1|COMPLETED|Overall Study||58
7867476|NCT00871169|19362804|P1|STARTED|Overall Study||61
7867477|NCT00871143|19362811|P2|NOT COMPLETED|Overall Study||0
7867478|NCT00871143|19362812|P1|NOT COMPLETED|Overall Study||0
7867479|NCT00871143|19362811|P2|COMPLETED|Overall Study||25
7867480|NCT00871143|19362812|P1|COMPLETED|Overall Study||21
7867481|NCT00871143|19362811|P2|STARTED|Overall Study||25
7867482|NCT00871143|19362812|P1|STARTED|Overall Study||21
7867483|NCT00871117|19362832|P2|NOT COMPLETED|Overall Study||10
7867484|NCT00871117|19362833|P1|NOT COMPLETED|Overall Study||5
7867485|NCT00871117|19362832|P2|COMPLETED|Overall Study||227
7867486|NCT00871117|19362833|P1|COMPLETED|Overall Study||234
7867487|NCT00871117|19362832|P2|STARTED|Overall Study||237
7867488|NCT00871117|19362833|P1|STARTED|Overall Study||239
7867489|NCT00871000|19362867|P2|NOT COMPLETED|Overall Study||0
7867490|NCT00871000|19362868|P1|NOT COMPLETED|Overall Study||1
7867491|NCT00871000|19362867|P2|COMPLETED|Overall Study||152
7867492|NCT00871000|19362868|P1|COMPLETED|Overall Study||150
7867493|NCT00871000|19362867|P2|STARTED|Overall Study||152
7867494|NCT00871000|19362868|P1|STARTED|Overall Study||151
7867495|NCT00870896|19362910|P1|NOT COMPLETED|Overall Study||0
7867496|NCT00870896|19362910|P1|COMPLETED|Overall Study||5
7867497|NCT00870896|19362910|P1|STARTED|Overall Study||5
7867498|NCT00870870|19362920|P4|NOT COMPLETED|Overall Study||5
7867499|NCT00870870|19362921|P3|NOT COMPLETED|Overall Study||3
7867500|NCT00870870|19362922|P2|NOT COMPLETED|Overall Study||1
7867501|NCT00870870|19362923|P1|NOT COMPLETED|Overall Study||0
7867502|NCT00870870|19362920|P4|COMPLETED|Overall Study||20
7867503|NCT00870870|19362921|P3|COMPLETED|Overall Study||26
7867504|NCT00870870|19362922|P2|COMPLETED|Overall Study||5
7867505|NCT00870870|19362923|P1|COMPLETED|Overall Study||4
7867506|NCT00870870|19362920|P4|STARTED|Overall Study||25
7867507|NCT00870870|19362921|P3|STARTED|Overall Study||29
7867508|NCT00870870|19362922|P2|STARTED|Overall Study||6
7867509|NCT00870870|19362923|P1|STARTED|Overall Study||4
7867510|NCT00870740|19362967|P6|NOT COMPLETED|Overall Study||17
7867511|NCT00870740|19362968|P5|NOT COMPLETED|Overall Study||11
7867512|NCT00870740|19362969|P4|NOT COMPLETED|Overall Study||12
7867513|NCT00870740|19362970|P3|NOT COMPLETED|Overall Study||10
7867514|NCT00870740|19362971|P2|NOT COMPLETED|Overall Study||9
7867515|NCT00870740|19362972|P1|NOT COMPLETED|Overall Study||12
7867516|NCT00870740|19362967|P6|COMPLETED|Overall Study||70
7867517|NCT00870740|19362968|P5|COMPLETED|Overall Study||77
7867518|NCT00870740|19362969|P4|COMPLETED|Overall Study||74
7867519|NCT00870740|19362970|P3|COMPLETED|Overall Study||76
7867520|NCT00870740|19362971|P2|COMPLETED|Overall Study||75
7867521|NCT00870740|19362972|P1|COMPLETED|Overall Study||74
7867522|NCT00870740|19362967|P6|STARTED|Overall Study|number randomized and dosed|87
7867523|NCT00870740|19362968|P5|STARTED|Overall Study|number randomized and dosed|88
7867524|NCT00870740|19362969|P4|STARTED|Overall Study|number randomized and dosed|86
7867525|NCT00870740|19362970|P3|STARTED|Overall Study|number randomized and dosed|86
7867526|NCT00870740|19362971|P2|STARTED|Overall Study|number randomized and dosed|84
7867527|NCT00870740|19362972|P1|STARTED|Overall Study|number randomized and dosed|86
7867528|NCT00870727|19363048|P2|NOT COMPLETED|Overall Study||5
7867529|NCT00870727|19363049|P1|NOT COMPLETED|Overall Study||1
7867530|NCT00870727|19363048|P2|COMPLETED|Overall Study||11
7867531|NCT00870727|19363049|P1|COMPLETED|Overall Study||16
7867532|NCT00870727|19363048|P2|STARTED|Overall Study||16
7867533|NCT00870727|19363049|P1|STARTED|Overall Study||17
7867534|NCT00870688|19363065|P1|NOT COMPLETED|Overall Study||4
7867535|NCT00870688|19363065|P1|COMPLETED|Overall Study||78
7867536|NCT00870688|19363065|P1|STARTED|Overall Study||82
7867537|NCT00870584|19363070|P2|NOT COMPLETED|Overall Study||13
7867538|NCT00870584|19363071|P1|NOT COMPLETED|Overall Study||16
7867539|NCT00870584|19363070|P2|COMPLETED|Overall Study||122
7867540|NCT00870584|19363071|P1|COMPLETED|Overall Study||120
7867541|NCT00870584|19363070|P2|STARTED|Overall Study||135
7867542|NCT00870584|19363071|P1|STARTED|Overall Study||136
7867543|NCT00870545|19363079|P1|NOT COMPLETED|Overall Study||17
7867544|NCT00870545|19363079|P1|COMPLETED|Overall Study||69
7867545|NCT00870545|19363079|P1|STARTED|Overall Study||86
7867546|NCT00870467|19363090|P6|NOT COMPLETED|Open-label||3
7867547|NCT00870467|19363091|P5|NOT COMPLETED|Open-label||5
7867548|NCT00870467|19363092|P4|NOT COMPLETED|Open-label||7
7867549|NCT00870467|19363093|P3|NOT COMPLETED|Open-label||13
7867550|NCT00870467|19363094|P2|NOT COMPLETED|Open-label||0
7867551|NCT00870467|19363095|P1|NOT COMPLETED|Open-label||0
7867552|NCT00870467|19363090|P6|COMPLETED|Open-label||21
7867553|NCT00870467|19363091|P5|COMPLETED|Open-label||5
7867554|NCT00870467|19363092|P4|COMPLETED|Open-label||120
7867555|NCT00870467|19363093|P3|COMPLETED|Open-label||132
7867556|NCT00870467|19363094|P2|COMPLETED|Open-label||0
7867557|NCT00870467|19363095|P1|COMPLETED|Open-label||0
7867558|NCT00870467|19363090|P6|STARTED|Open-label||24
7867559|NCT00870467|19363091|P5|STARTED|Open-label||10
7867560|NCT00870467|19363092|P4|STARTED|Open-label||127
7867561|NCT00870467|19363093|P3|STARTED|Open-label||145
7867562|NCT00870467|19363094|P2|STARTED|Open-label||0
7867563|NCT00870467|19363095|P1|STARTED|Open-label||0
7867564|NCT00870467|19363090|P6|NOT COMPLETED|Double-blind||0
7867565|NCT00870467|19363091|P5|NOT COMPLETED|Double-blind||0
7867566|NCT00870467|19363092|P4|NOT COMPLETED|Double-blind||0
7867567|NCT00870467|19363093|P3|NOT COMPLETED|Double-blind||0
7867568|NCT00870467|19363094|P2|NOT COMPLETED|Double-blind||12
7867569|NCT00870467|19363095|P1|NOT COMPLETED|Double-blind||16
7867570|NCT00870467|19363090|P6|COMPLETED|Double-blind||0
7867571|NCT00870467|19363091|P5|COMPLETED|Double-blind||0
7867572|NCT00870467|19363092|P4|COMPLETED|Double-blind||0
7867573|NCT00870467|19363093|P3|COMPLETED|Double-blind||0
7867574|NCT00870467|19363094|P2|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151
7867575|NCT00870467|19363095|P1|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155
7867576|NCT00870467|19363090|P6|STARTED|Double-blind||0
7867577|NCT00870467|19363091|P5|STARTED|Double-blind||0
7867578|NCT00870467|19363092|P4|STARTED|Double-blind||0
7867579|NCT00870467|19363093|P3|STARTED|Double-blind||0
7867580|NCT00870467|19363094|P2|STARTED|Double-blind||163
7867581|NCT00870467|19363095|P1|STARTED|Double-blind||171
7867582|NCT00870363|19363143|P4|NOT COMPLETED|Overall Study||0
7867583|NCT00870363|19363144|P3|NOT COMPLETED|Overall Study||3
7867584|NCT00870363|19363145|P2|NOT COMPLETED|Overall Study||3
7867585|NCT00870363|19363146|P1|NOT COMPLETED|Overall Study||0
7867586|NCT00870363|19363143|P4|COMPLETED|Overall Study||12
7867587|NCT00870363|19363144|P3|COMPLETED|Overall Study||8
7867588|NCT00870363|19363145|P2|COMPLETED|Overall Study||8
7867589|NCT00870363|19363146|P1|COMPLETED|Overall Study||10
7867590|NCT00870363|19363143|P4|STARTED|Overall Study||12
7867591|NCT00870363|19363144|P3|STARTED|Overall Study||11
7867592|NCT00870363|19363145|P2|STARTED|Overall Study||11
7867593|NCT00870363|19363146|P1|STARTED|Overall Study||10
7867594|NCT00870233|19363180|P1|NOT COMPLETED|Overall Study||24
7867595|NCT00870233|19363180|P1|COMPLETED|Overall Study||96
7867596|NCT00870233|19363180|P1|STARTED|Overall Study||120
7867597|NCT00870194|19363189|P2|NOT COMPLETED|Overall Study||14
7867598|NCT00870194|19363190|P1|NOT COMPLETED|Overall Study||26
7867599|NCT00870194|19363189|P2|COMPLETED|Overall Study||114
7867600|NCT00870194|19363190|P1|COMPLETED|Overall Study||101
7867601|NCT00870194|19363189|P2|Per Protocol Set|Overall Study||111
7867602|NCT00870194|19363190|P1|Per Protocol Set|Overall Study||97
7867603|NCT00870194|19363189|P2|STARTED|Overall Study||128
7867604|NCT00870194|19363190|P1|STARTED|Overall Study||127
7867605|NCT00870103|19363228|P1|NOT COMPLETED|Overall Study||4
7867606|NCT00870103|19363228|P1|COMPLETED|Overall Study||60
7867607|NCT00870103|19363228|P1|STARTED|Overall Study||64
7867608|NCT00869999|19363233|P1|NOT COMPLETED|Overall Study||2
7867609|NCT00869999|19363233|P1|COMPLETED|Overall Study||24
7867610|NCT00869999|19363233|P1|STARTED|Overall Study||26
7867611|NCT00869960|19363239|P1|NOT COMPLETED|Overall Study||2
7867612|NCT00869960|19363239|P1|COMPLETED|Overall Study||22
7867613|NCT00869960|19363239|P1|STARTED|Overall Study||24
7867614|NCT00869947|19363252|P2|NOT COMPLETED|Overall Study||0
7867615|NCT00869947|19363253|P1|NOT COMPLETED|Overall Study||0
7867616|NCT00869947|19363252|P2|COMPLETED|Overall Study||8
7867617|NCT00869947|19363253|P1|COMPLETED|Overall Study||8
7867618|NCT00869947|19363252|P2|STARTED|Overall Study||8
7867619|NCT00869947|19363253|P1|STARTED|Overall Study||8
7867620|NCT00869791|19363266|P2|NOT COMPLETED|Period 2 Treatment for 7 Days||0
7867621|NCT00869791|19363267|P1|NOT COMPLETED|Period 2 Treatment for 7 Days||0
7867622|NCT00869791|19363266|P2|COMPLETED|Period 2 Treatment for 7 Days||13
7867623|NCT00869791|19363267|P1|COMPLETED|Period 2 Treatment for 7 Days||14
7867624|NCT00869791|19363266|P2|STARTED|Period 2 Treatment for 7 Days||13
7867625|NCT00869791|19363267|P1|STARTED|Period 2 Treatment for 7 Days||14
7867626|NCT00869791|19363266|P2|NOT COMPLETED|Period 1 Treatment for 7 Days||0
7867627|NCT00869791|19363267|P1|NOT COMPLETED|Period 1 Treatment for 7 Days||0
7867628|NCT00869791|19363266|P2|COMPLETED|Period 1 Treatment for 7 Days||13
7867629|NCT00869791|19363267|P1|COMPLETED|Period 1 Treatment for 7 Days||14
7867630|NCT00869791|19363266|P2|STARTED|Period 1 Treatment for 7 Days||13
7867631|NCT00869791|19363267|P1|STARTED|Period 1 Treatment for 7 Days||14
7867632|NCT00869778|19363288|P3|NOT COMPLETED|Overall Study||10
7867633|NCT00869778|19363289|P2|NOT COMPLETED|Overall Study||7
7867634|NCT00869778|19363290|P1|NOT COMPLETED|Overall Study||12
7867635|NCT00869778|19363288|P3|COMPLETED|Overall Study||110
7867636|NCT00869778|19363289|P2|COMPLETED|Overall Study||113
7867637|NCT00869778|19363290|P1|COMPLETED|Overall Study||108
7867638|NCT00869778|19363288|P3|STARTED|Overall Study||120
7867639|NCT00869778|19363289|P2|STARTED|Overall Study||120
7867640|NCT00869778|19363290|P1|STARTED|Overall Study||120
7867641|NCT00869622|19363327|P2|NOT COMPLETED|Overall Study||14
7867642|NCT00869622|19363328|P1|NOT COMPLETED|Overall Study||13
7867643|NCT00869622|19363327|P2|COMPLETED|Overall Study||26
7867644|NCT00869622|19363328|P1|COMPLETED|Overall Study||27
7867645|NCT00869622|19363327|P2|STARTED|Overall Study||40
7867646|NCT00869622|19363328|P1|STARTED|Overall Study||40
7867647|NCT00869609|19363338|P2|NOT COMPLETED|Overall Study||3
7867648|NCT00869609|19363339|P1|NOT COMPLETED|Overall Study||6
7867649|NCT00869609|19363338|P2|COMPLETED|Overall Study||26
7867650|NCT00869609|19363339|P1|COMPLETED|Overall Study||25
7867651|NCT00869609|19363338|P2|STARTED|Overall Study||29
7867652|NCT00869609|19363339|P1|STARTED|Overall Study||31
7867653|NCT00869557|19363365|P2|NOT COMPLETED|Extension Phase||3
7867654|NCT00869557|19363366|P1|NOT COMPLETED|Extension Phase||10
7867655|NCT00869557|19363365|P2|COMPLETED|Extension Phase||11
7867656|NCT00869557|19363366|P1|COMPLETED|Extension Phase||35
7867657|NCT00869557|19363365|P2|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14
7867658|NCT00869557|19363366|P1|STARTED|Extension Phase||45
7867659|NCT00869557|19363365|P2|NOT COMPLETED|Randomized Phase||2
7867660|NCT00869557|19363366|P1|NOT COMPLETED|Randomized Phase||3
7867661|NCT00869557|19363365|P2|COMPLETED|Randomized Phase||21
7867662|NCT00869557|19363366|P1|COMPLETED|Randomized Phase||45
7867663|NCT00869557|19363365|P2|STARTED|Randomized Phase||23
7867664|NCT00869557|19363366|P1|STARTED|Randomized Phase||48
7867665|NCT00869518|19363385|P2|NOT COMPLETED|Overall Study||1
7867666|NCT00869518|19363386|P1|NOT COMPLETED|Overall Study||1
7867667|NCT00869518|19363385|P2|COMPLETED|Overall Study||5
7867668|NCT00869518|19363386|P1|COMPLETED|Overall Study||5
7867669|NCT00869518|19363385|P2|STARTED|Overall Study||6
7867670|NCT00869518|19363386|P1|STARTED|Overall Study||6
7867671|NCT00869440|19363402|P4|NOT COMPLETED|Overall Study||0
7867672|NCT00869440|19363403|P3|NOT COMPLETED|Overall Study||0
7867673|NCT00869440|19363404|P2|NOT COMPLETED|Overall Study||1
7867674|NCT00869440|19363405|P1|NOT COMPLETED|Overall Study||2
7867675|NCT00869440|19363402|P4|COMPLETED|Overall Study||25
7867676|NCT00869440|19363403|P3|COMPLETED|Overall Study||25
7867677|NCT00869440|19363404|P2|COMPLETED|Overall Study||24
7867678|NCT00869440|19363405|P1|COMPLETED|Overall Study||23
7867679|NCT00869440|19363402|P4|STARTED|Overall Study||25
7867680|NCT00869440|19363403|P3|STARTED|Overall Study||25
7867681|NCT00869440|19363404|P2|STARTED|Overall Study||25
7867682|NCT00869440|19363405|P1|STARTED|Overall Study||25
7867683|NCT00869414|19363423|P3|NOT COMPLETED|Overall Study||0
7867684|NCT00869414|19363424|P2|NOT COMPLETED|Overall Study||0
7867685|NCT00869414|19363425|P1|NOT COMPLETED|Overall Study||0
7867686|NCT00869414|19363423|P3|COMPLETED|Overall Study||0
7867687|NCT00869414|19363424|P2|COMPLETED|Overall Study||0
7867688|NCT00869414|19363425|P1|COMPLETED|Overall Study||0
7867689|NCT00869414|19363423|P3|STARTED|Overall Study||0
7867690|NCT00869414|19363424|P2|STARTED|Overall Study||0
7867691|NCT00869414|19363425|P1|STARTED|Overall Study||0
7867692|NCT00869401|19363439|P5|NOT COMPLETED|Overall Study||3
7867693|NCT00869401|19363440|P4|NOT COMPLETED|Overall Study||5
7867694|NCT00869401|19363441|P3|NOT COMPLETED|Overall Study||0
7867695|NCT00869401|19363442|P2|NOT COMPLETED|Overall Study||0
7867696|NCT00869401|19363443|P1|NOT COMPLETED|Overall Study||0
7867697|NCT00869401|19363439|P5|COMPLETED|Overall Study||63
7867698|NCT00869401|19363440|P4|COMPLETED|Overall Study||133
7867699|NCT00869401|19363441|P3|COMPLETED|Overall Study||7
7867700|NCT00869401|19363442|P2|COMPLETED|Overall Study||3
7867701|NCT00869401|19363443|P1|COMPLETED|Overall Study||3
7867702|NCT00869401|19363439|P5|STARTED|Overall Study||66
7867703|NCT00869401|19363440|P4|STARTED|Overall Study||138
7867704|NCT00869401|19363441|P3|STARTED|Overall Study||7
7867705|NCT00869401|19363442|P2|STARTED|Overall Study||3
7867706|NCT00869401|19363443|P1|STARTED|Overall Study||3
7867707|NCT00869375|19363461|P2|NOT COMPLETED|Overall Study||0
7867708|NCT00869375|19363462|P1|NOT COMPLETED|Overall Study||0
7867709|NCT00869375|19363461|P2|COMPLETED|Overall Study||3
7867710|NCT00869375|19363462|P1|COMPLETED|Overall Study||3
7867711|NCT00869375|19363461|P2|STARTED|Overall Study||3
7867712|NCT00869375|19363462|P1|STARTED|Overall Study||3
7867713|NCT00869362|19363472|P2|NOT COMPLETED|Overall Study||5
7867714|NCT00869362|19363473|P1|NOT COMPLETED|Overall Study||1
7867715|NCT00869362|19363472|P2|COMPLETED|Overall Study||11
7867716|NCT00869362|19363473|P1|COMPLETED|Overall Study||14
7867717|NCT00869362|19363472|P2|STARTED|Overall Study||16
7867718|NCT00869362|19363473|P1|STARTED|Overall Study||15
7867719|NCT00869349|19363483|P2|NOT COMPLETED|Overall Study||4
7867720|NCT00869349|19363484|P1|NOT COMPLETED|Overall Study||7
7867721|NCT00869349|19363483|P2|COMPLETED|Overall Study||36
7867722|NCT00869349|19363484|P1|COMPLETED|Overall Study||32
7867723|NCT00869349|19363483|P2|STARTED|Overall Study||40
7867724|NCT00869349|19363484|P1|STARTED|Overall Study||39
7867725|NCT00869323|19363494|P1|NOT COMPLETED|Maintenance Therapy||1
7867726|NCT00869323|19363494|P1|COMPLETED|Maintenance Therapy||1
7867727|NCT00869323|19363494|P1|STARTED|Maintenance Therapy|One participant removed from study after completing induction therapy due to progressive disease.|2
7867728|NCT00869323|19363494|P1|NOT COMPLETED|Induction Therapy||0
7867729|NCT00869323|19363494|P1|COMPLETED|Induction Therapy||3
7867730|NCT00869323|19363494|P1|STARTED|Induction Therapy||3
7867731|NCT00869258|19363502|P1|NOT COMPLETED|Overall Study||1
7867732|NCT00869258|19363502|P1|COMPLETED|Overall Study||31
7867733|NCT00869258|19363502|P1|STARTED|Overall Study||32
7867734|NCT00869206|19363508|P2|NOT COMPLETED|Overall Study||27
7867735|NCT00869206|19363509|P1|NOT COMPLETED|Overall Study||29
7867736|NCT00869206|19363508|P2|COMPLETED|Overall Study||884
7867737|NCT00869206|19363509|P1|COMPLETED|Overall Study||882
7867738|NCT00869206|19363508|P2|STARTED|Overall Study||911
7867739|NCT00869206|19363509|P1|STARTED|Overall Study||911
7867740|NCT00869167|19363539|P2|NOT COMPLETED|Overall Study||1
7867741|NCT00869167|19363540|P1|NOT COMPLETED|Overall Study||0
7867742|NCT00869167|19363539|P2|COMPLETED|Overall Study||0
7867743|NCT00869167|19363540|P1|COMPLETED|Overall Study||2
7867744|NCT00869167|19363539|P2|STARTED|Overall Study||1
7867745|NCT00869167|19363540|P1|STARTED|Overall Study||2
7867746|NCT00869141|19363556|P2|NOT COMPLETED|Overall Study||0
7867747|NCT00869141|19363557|P1|NOT COMPLETED|Overall Study||0
7867748|NCT00869141|19363556|P2|COMPLETED|Overall Study||26
7867749|NCT00869141|19363557|P1|COMPLETED|Overall Study||26
7867750|NCT00869141|19363556|P2|STARTED|Overall Study||26
7867751|NCT00869141|19363557|P1|STARTED|Overall Study||26
7867752|NCT00869128|19363567|P2|NOT COMPLETED|Overall Study||6
7867753|NCT00869128|19363568|P1|NOT COMPLETED|Overall Study||6
7867754|NCT00869128|19363567|P2|COMPLETED|Overall Study||12
7867755|NCT00869128|19363568|P1|COMPLETED|Overall Study||12
7867756|NCT00869128|19363567|P2|STARTED|Overall Study||18
7867757|NCT00869128|19363568|P1|STARTED|Overall Study||18
7867758|NCT00869089|19363572|P1|NOT COMPLETED|Overall Study||3
7867759|NCT00869089|19363572|P1|COMPLETED|Overall Study||2
7867760|NCT00869089|19363572|P1|STARTED|Overall Study||5
7867761|NCT00869050|19363576|P1|NOT COMPLETED|Overall Study||3
7867762|NCT00869050|19363576|P1|COMPLETED|Overall Study||38
7867763|NCT00869050|19363576|P1|STARTED|Overall Study||41
7867764|NCT00869024|19363583|P2|NOT COMPLETED|Overall Study||5
7867765|NCT00869024|19363584|P1|NOT COMPLETED|Overall Study||2
7867766|NCT00869024|19363583|P2|COMPLETED|Overall Study||4
7867767|NCT00869024|19363584|P1|COMPLETED|Overall Study||14
7867768|NCT00869024|19363583|P2|STARTED|Overall Study|One patient intent to treat, did not receive study product|9
7867769|NCT00869024|19363584|P1|STARTED|Overall Study||16
7867770|NCT00868998|19363600|P1|NOT COMPLETED|Overall Study||5
7867771|NCT00868998|19363600|P1|COMPLETED|Overall Study||0
7867772|NCT00868998|19363600|P1|STARTED|Overall Study||5
7867773|NCT00868959|19363605|P1|NOT COMPLETED|Overall Study||258
7867774|NCT00868959|19363605|P1|COMPLETED|Overall Study||559
7867775|NCT00868959|19363605|P1|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817
7867776|NCT00868790|19363611|P14|NOT COMPLETED|Post-study||0
7867777|NCT00868790|19363612|P13|NOT COMPLETED|Post-study||0
7867778|NCT00868790|19363613|P12|NOT COMPLETED|Post-study||0
7867779|NCT00868790|19363614|P11|NOT COMPLETED|Post-study||0
7867780|NCT00868790|19363615|P10|NOT COMPLETED|Post-study||1
7867781|NCT00868790|19363616|P9|NOT COMPLETED|Post-study||0
7867782|NCT00868790|19363617|P8|NOT COMPLETED|Post-study||2
7867783|NCT00868790|19363618|P7|NOT COMPLETED|Post-study||0
7867784|NCT00868790|19363619|P6|NOT COMPLETED|Post-study||0
7867785|NCT00868790|19363620|P5|NOT COMPLETED|Post-study||1
7867786|NCT00868790|19363621|P4|NOT COMPLETED|Post-study||0
7867787|NCT00868790|19363622|P3|NOT COMPLETED|Post-study||0
7867788|NCT00868790|19363623|P2|NOT COMPLETED|Post-study||0
7867789|NCT00868790|19363624|P1|NOT COMPLETED|Post-study||0
7867790|NCT00868790|19363611|P14|COMPLETED|Post-study||7
7867791|NCT00868790|19363612|P13|COMPLETED|Post-study||6
7867792|NCT00868790|19363613|P12|COMPLETED|Post-study||3
7867793|NCT00868790|19363614|P11|COMPLETED|Post-study||5
7867794|NCT00868790|19363615|P10|COMPLETED|Post-study||1
7867795|NCT00868790|19363616|P9|COMPLETED|Post-study||6
7867796|NCT00868790|19363617|P8|COMPLETED|Post-study||12
7867797|NCT00868790|19363618|P7|COMPLETED|Post-study||4
7867798|NCT00868790|19363619|P6|COMPLETED|Post-study||1
7867799|NCT00868790|19363620|P5|COMPLETED|Post-study||17
7867800|NCT00868790|19363621|P4|COMPLETED|Post-study||3
7867801|NCT00868790|19363622|P3|COMPLETED|Post-study||3
7867802|NCT00868790|19363623|P2|COMPLETED|Post-study||6
7867803|NCT00868790|19363624|P1|COMPLETED|Post-study||7
7867804|NCT00868790|19363611|P14|STARTED|Post-study||7
7867805|NCT00868790|19363612|P13|STARTED|Post-study||6
7867806|NCT00868790|19363613|P12|STARTED|Post-study||3
7867807|NCT00868790|19363614|P11|STARTED|Post-study||5
7867808|NCT00868790|19363615|P10|STARTED|Post-study||2
7867809|NCT00868790|19363616|P9|STARTED|Post-study||6
7867810|NCT00868790|19363617|P8|STARTED|Post-study||14
7867811|NCT00868790|19363618|P7|STARTED|Post-study||4
7867812|NCT00868790|19363619|P6|STARTED|Post-study||1
7867813|NCT00868790|19363620|P5|STARTED|Post-study||18
7867814|NCT00868790|19363621|P4|STARTED|Post-study||3
7867815|NCT00868790|19363622|P3|STARTED|Post-study||3
7867816|NCT00868790|19363623|P2|STARTED|Post-study||6
7867817|NCT00868790|19363624|P1|STARTED|Post-study||7
7867818|NCT00868790|19363611|P14|NOT COMPLETED|Period 4||1
7867819|NCT00868790|19363612|P13|NOT COMPLETED|Period 4||1
7867820|NCT00868790|19363613|P12|NOT COMPLETED|Period 4||1
7867821|NCT00868790|19363614|P11|NOT COMPLETED|Period 4||3
7867822|NCT00868790|19363615|P10|NOT COMPLETED|Period 4||0
7867823|NCT00868790|19363616|P9|NOT COMPLETED|Period 4||2
7867824|NCT00868790|19363617|P8|NOT COMPLETED|Period 4||3
7867825|NCT00868790|19363618|P7|NOT COMPLETED|Period 4||0
7867826|NCT00868790|19363619|P6|NOT COMPLETED|Period 4||0
7867827|NCT00868790|19363620|P5|NOT COMPLETED|Period 4||0
7867828|NCT00868790|19363621|P4|NOT COMPLETED|Period 4||0
7867829|NCT00868790|19363622|P3|NOT COMPLETED|Period 4||1
7867830|NCT00868790|19363623|P2|NOT COMPLETED|Period 4||0
7867831|NCT00868790|19363624|P1|NOT COMPLETED|Period 4||2
7867832|NCT00868790|19363611|P14|COMPLETED|Period 4||7
7867833|NCT00868790|19363612|P13|COMPLETED|Period 4||6
7867834|NCT00868790|19363613|P12|COMPLETED|Period 4||3
7867835|NCT00868790|19363614|P11|COMPLETED|Period 4||5
7867836|NCT00868790|19363615|P10|COMPLETED|Period 4||2
7867837|NCT00868790|19363616|P9|COMPLETED|Period 4||6
7867838|NCT00868790|19363617|P8|COMPLETED|Period 4||14
7867839|NCT00868790|19363618|P7|COMPLETED|Period 4||4
7867840|NCT00868790|19363619|P6|COMPLETED|Period 4||1
7867841|NCT00868790|19363620|P5|COMPLETED|Period 4||18
7867842|NCT00868790|19363621|P4|COMPLETED|Period 4||3
7867843|NCT00868790|19363622|P3|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3
7867844|NCT00868790|19363623|P2|COMPLETED|Period 4||6
7867845|NCT00868790|19363624|P1|COMPLETED|Period 4||7
7867846|NCT00868790|19363611|P14|STARTED|Period 4||8
7867847|NCT00868790|19363612|P13|STARTED|Period 4||7
7867848|NCT00868790|19363613|P12|STARTED|Period 4||4
7867849|NCT00868790|19363614|P11|STARTED|Period 4||8
7867850|NCT00868790|19363615|P10|STARTED|Period 4||2
7867851|NCT00868790|19363616|P9|STARTED|Period 4||8
7867852|NCT00868790|19363617|P8|STARTED|Period 4||17
7867853|NCT00868790|19363618|P7|STARTED|Period 4||4
7867854|NCT00868790|19363619|P6|STARTED|Period 4||1
7867855|NCT00868790|19363620|P5|STARTED|Period 4||18
7867856|NCT00868790|19363621|P4|STARTED|Period 4||3
7867857|NCT00868790|19363622|P3|STARTED|Period 4||4
7867858|NCT00868790|19363623|P2|STARTED|Period 4||6
7867859|NCT00868790|19363624|P1|STARTED|Period 4||9
7867860|NCT00868790|19363611|P14|NOT COMPLETED|Period 3||0
7867861|NCT00868790|19363612|P13|NOT COMPLETED|Period 3||0
7867862|NCT00868790|19363613|P12|NOT COMPLETED|Period 3||0
7867863|NCT00868790|19363614|P11|NOT COMPLETED|Period 3||1
7867864|NCT00868790|19363615|P10|NOT COMPLETED|Period 3||1
7867865|NCT00868790|19363616|P9|NOT COMPLETED|Period 3||0
7867866|NCT00868790|19363617|P8|NOT COMPLETED|Period 3||0
7867867|NCT00868790|19363618|P7|NOT COMPLETED|Period 3||0
7867868|NCT00868790|19363619|P6|NOT COMPLETED|Period 3||0
7867869|NCT00868790|19363620|P5|NOT COMPLETED|Period 3||0
7867870|NCT00868790|19363621|P4|NOT COMPLETED|Period 3||1
7867871|NCT00868790|19363622|P3|NOT COMPLETED|Period 3||0
7867872|NCT00868790|19363623|P2|NOT COMPLETED|Period 3||0
7867873|NCT00868790|19363624|P1|NOT COMPLETED|Period 3||0
7867874|NCT00868790|19363611|P14|COMPLETED|Period 3||8
7867875|NCT00868790|19363612|P13|COMPLETED|Period 3||7
7867876|NCT00868790|19363613|P12|COMPLETED|Period 3||4
7867877|NCT00868790|19363614|P11|COMPLETED|Period 3||8
7867878|NCT00868790|19363615|P10|COMPLETED|Period 3||2
7867879|NCT00868790|19363616|P9|COMPLETED|Period 3||8
7867880|NCT00868790|19363617|P8|COMPLETED|Period 3||17
7867881|NCT00868790|19363618|P7|COMPLETED|Period 3||4
7867882|NCT00868790|19363619|P6|COMPLETED|Period 3||1
7867883|NCT00868790|19363620|P5|COMPLETED|Period 3||18
7867884|NCT00868790|19363621|P4|COMPLETED|Period 3||3
7867885|NCT00868790|19363622|P3|COMPLETED|Period 3||4
7867886|NCT00868790|19363623|P2|COMPLETED|Period 3||6
7867887|NCT00868790|19363624|P1|COMPLETED|Period 3||9
7867888|NCT00868790|19363611|P14|STARTED|Period 3||8
7867889|NCT00868790|19363612|P13|STARTED|Period 3||7
7867890|NCT00868790|19363613|P12|STARTED|Period 3||4
7867891|NCT00868790|19363614|P11|STARTED|Period 3||9
7867892|NCT00868790|19363615|P10|STARTED|Period 3||3
7867893|NCT00868790|19363616|P9|STARTED|Period 3||8
7867894|NCT00868790|19363617|P8|STARTED|Period 3||17
7867895|NCT00868790|19363618|P7|STARTED|Period 3||4
7867896|NCT00868790|19363619|P6|STARTED|Period 3||1
7867897|NCT00868790|19363620|P5|STARTED|Period 3||18
7867898|NCT00868790|19363621|P4|STARTED|Period 3||4
7867899|NCT00868790|19363622|P3|STARTED|Period 3||4
7867900|NCT00868790|19363623|P2|STARTED|Period 3||6
7867901|NCT00868790|19363624|P1|STARTED|Period 3||9
7867902|NCT00868790|19363611|P14|NOT COMPLETED|Period 2||1
7867903|NCT00868790|19363612|P13|NOT COMPLETED|Period 2||0
7867904|NCT00868790|19363613|P12|NOT COMPLETED|Period 2||0
7867905|NCT00868790|19363614|P11|NOT COMPLETED|Period 2||0
7867906|NCT00868790|19363615|P10|NOT COMPLETED|Period 2||0
7867907|NCT00868790|19363616|P9|NOT COMPLETED|Period 2||2
7867908|NCT00868790|19363617|P8|NOT COMPLETED|Period 2||0
7867909|NCT00868790|19363618|P7|NOT COMPLETED|Period 2||0
7867910|NCT00868790|19363619|P6|NOT COMPLETED|Period 2||1
7867911|NCT00868790|19363620|P5|NOT COMPLETED|Period 2||0
7867912|NCT00868790|19363621|P4|NOT COMPLETED|Period 2||0
7867913|NCT00868790|19363622|P3|NOT COMPLETED|Period 2||0
7867914|NCT00868790|19363623|P2|NOT COMPLETED|Period 2||1
7867915|NCT00868790|19363624|P1|NOT COMPLETED|Period 2||0
7867916|NCT00868790|19363611|P14|COMPLETED|Period 2||8
7867917|NCT00868790|19363612|P13|COMPLETED|Period 2||7
7867918|NCT00868790|19363613|P12|COMPLETED|Period 2||4
7867919|NCT00868790|19363614|P11|COMPLETED|Period 2||9
7867920|NCT00868790|19363615|P10|COMPLETED|Period 2||3
7867921|NCT00868790|19363616|P9|COMPLETED|Period 2||8
7867922|NCT00868790|19363617|P8|COMPLETED|Period 2||17
7867923|NCT00868790|19363618|P7|COMPLETED|Period 2||4
7867924|NCT00868790|19363619|P6|COMPLETED|Period 2||1
7867925|NCT00868790|19363620|P5|COMPLETED|Period 2||18
7867926|NCT00868790|19363621|P4|COMPLETED|Period 2||4
7867927|NCT00868790|19363622|P3|COMPLETED|Period 2||4
7867928|NCT00868790|19363623|P2|COMPLETED|Period 2||6
7867929|NCT00868790|19363624|P1|COMPLETED|Period 2||9
7867930|NCT00868790|19363611|P14|STARTED|Period 2||9
7867931|NCT00868790|19363612|P13|STARTED|Period 2||7
7867932|NCT00868790|19363613|P12|STARTED|Period 2||4
7867933|NCT00868790|19363614|P11|STARTED|Period 2||9
7867934|NCT00868790|19363615|P10|STARTED|Period 2||3
7867935|NCT00868790|19363616|P9|STARTED|Period 2||10
7867936|NCT00868790|19363617|P8|STARTED|Period 2||17
7867937|NCT00868790|19363618|P7|STARTED|Period 2||4
7867938|NCT00868790|19363619|P6|STARTED|Period 2||2
7867939|NCT00868790|19363620|P5|STARTED|Period 2||18
7867940|NCT00868790|19363621|P4|STARTED|Period 2||4
7867941|NCT00868790|19363622|P3|STARTED|Period 2||4
7867942|NCT00868790|19363623|P2|STARTED|Period 2||7
7867943|NCT00868790|19363624|P1|STARTED|Period 2||9
7867944|NCT00868790|19363611|P14|NOT COMPLETED|Period 1||2
7867945|NCT00868790|19363612|P13|NOT COMPLETED|Period 1||0
7867946|NCT00868790|19363613|P12|NOT COMPLETED|Period 1||0
7867947|NCT00868790|19363614|P11|NOT COMPLETED|Period 1||0
7867948|NCT00868790|19363615|P10|NOT COMPLETED|Period 1||0
7867949|NCT00868790|19363616|P9|NOT COMPLETED|Period 1||1
7867950|NCT00868790|19363617|P8|NOT COMPLETED|Period 1||3
7867951|NCT00868790|19363618|P7|NOT COMPLETED|Period 1||0
7867952|NCT00868790|19363619|P6|NOT COMPLETED|Period 1||1
7867953|NCT00868790|19363620|P5|NOT COMPLETED|Period 1||1
7867954|NCT00868790|19363621|P4|NOT COMPLETED|Period 1||0
7867955|NCT00868790|19363622|P3|NOT COMPLETED|Period 1||0
7867956|NCT00868790|19363623|P2|NOT COMPLETED|Period 1||1
7867957|NCT00868790|19363624|P1|NOT COMPLETED|Period 1||2
7867958|NCT00868790|19363611|P14|COMPLETED|Period 1||9
7867959|NCT00868790|19363612|P13|COMPLETED|Period 1||7
7867960|NCT00868790|19363613|P12|COMPLETED|Period 1||4
7867961|NCT00868790|19363614|P11|COMPLETED|Period 1||9
7867962|NCT00868790|19363615|P10|COMPLETED|Period 1||3
7867963|NCT00868790|19363616|P9|COMPLETED|Period 1||10
7867964|NCT00868790|19363617|P8|COMPLETED|Period 1||17
7867965|NCT00868790|19363618|P7|COMPLETED|Period 1||4
7867966|NCT00868790|19363619|P6|COMPLETED|Period 1||2
7867967|NCT00868790|19363620|P5|COMPLETED|Period 1||18
7867968|NCT00868790|19363621|P4|COMPLETED|Period 1||4
7867969|NCT00868790|19363622|P3|COMPLETED|Period 1||4
7867970|NCT00868790|19363623|P2|COMPLETED|Period 1||7
7867971|NCT00868790|19363624|P1|COMPLETED|Period 1||9
7867972|NCT00868790|19363611|P14|STARTED|Period 1||11
7867973|NCT00868790|19363612|P13|STARTED|Period 1||7
7867974|NCT00868790|19363613|P12|STARTED|Period 1||4
7867975|NCT00868790|19363614|P11|STARTED|Period 1||9
7867976|NCT00868790|19363615|P10|STARTED|Period 1||3
7867977|NCT00868790|19363616|P9|STARTED|Period 1||11
7867978|NCT00868790|19363617|P8|STARTED|Period 1||20
7867979|NCT00868790|19363618|P7|STARTED|Period 1||4
7867980|NCT00868790|19363619|P6|STARTED|Period 1||3
7867981|NCT00868790|19363620|P5|STARTED|Period 1||19
7867982|NCT00868790|19363621|P4|STARTED|Period 1||4
7867983|NCT00868790|19363622|P3|STARTED|Period 1||4
7867984|NCT00868790|19363623|P2|STARTED|Period 1||8
7867985|NCT00868790|19363624|P1|STARTED|Period 1||11
7867986|NCT00868751|19363661|P1|NOT COMPLETED|Overall Study||1
7867987|NCT00868751|19363661|P1|COMPLETED|Overall Study||0
7867988|NCT00868751|19363661|P1|STARTED|Overall Study||1
7867989|NCT00868712|19363672|P3|NOT COMPLETED|Overall Study||0
7867990|NCT00868712|19363673|P2|NOT COMPLETED|Overall Study||0
7867991|NCT00868712|19363674|P1|NOT COMPLETED|Overall Study||0
7867992|NCT00868712|19363672|P3|COMPLETED|Overall Study||28
7867993|NCT00868712|19363673|P2|COMPLETED|Overall Study||11
7867994|NCT00868712|19363674|P1|COMPLETED|Overall Study||31
7867995|NCT00868712|19363672|P3|STARTED|Overall Study||28
7867996|NCT00868712|19363673|P2|STARTED|Overall Study||11
7867997|NCT00868712|19363674|P1|STARTED|Overall Study||31
7867998|NCT00868699|19363688|P3|NOT COMPLETED|Overall Study||43
7867999|NCT00868699|19363689|P2|NOT COMPLETED|Overall Study||45
7868000|NCT00868699|19363690|P1|NOT COMPLETED|Overall Study||43
7868001|NCT00868699|19363688|P3|COMPLETED|Overall Study||123
7868002|NCT00868699|19363689|P2|COMPLETED|Overall Study||124
7868003|NCT00868699|19363690|P1|COMPLETED|Overall Study||127
7868004|NCT00868699|19363688|P3|Safety Population|Overall Study||164
7868005|NCT00868699|19363689|P2|Safety Population|Overall Study||167
7868006|NCT00868699|19363690|P1|Safety Population|Overall Study||168
7868007|NCT00868699|19363688|P3|Intent-to-Treat Population|Overall Study||161
7868008|NCT00868699|19363689|P2|Intent-to-Treat Population|Overall Study||162
7868009|NCT00868699|19363690|P1|Intent-to-Treat Population|Overall Study||162
7868010|NCT00868699|19363688|P3|STARTED|Overall Study||166
7868011|NCT00868699|19363689|P2|STARTED|Overall Study||169
7868012|NCT00868699|19363690|P1|STARTED|Overall Study||170
7868013|NCT00868608|19363707|P3|NOT COMPLETED|Overall Study||5
7868014|NCT00868608|19363708|P2|NOT COMPLETED|Overall Study||3
7868015|NCT00868608|19363709|P1|NOT COMPLETED|Overall Study||23
7868016|NCT00868608|19363707|P3|COMPLETED|Overall Study||0
7868017|NCT00868608|19363708|P2|COMPLETED|Overall Study||1
7868018|NCT00868608|19363709|P1|COMPLETED|Overall Study||49
7868019|NCT00868608|19363707|P3|STARTED|Overall Study||5
7868020|NCT00868608|19363708|P2|STARTED|Overall Study||4
7868021|NCT00868608|19363709|P1|STARTED|Overall Study||72
7868022|NCT00868530|19363733|P1|NOT COMPLETED|Overall Study||4
7868023|NCT00868530|19363733|P1|COMPLETED|Overall Study||49
7868024|NCT00868530|19363733|P1|STARTED|Overall Study||53
7868025|NCT00868517|19363748|P3|NOT COMPLETED|Overall Study||2
7868026|NCT00868517|19363749|P2|NOT COMPLETED|Overall Study||4
7868027|NCT00868517|19363750|P1|NOT COMPLETED|Overall Study||4
7868028|NCT00868517|19363748|P3|COMPLETED|Overall Study||9
7868029|NCT00868517|19363749|P2|COMPLETED|Overall Study||8
7868030|NCT00868517|19363750|P1|COMPLETED|Overall Study||8
7868031|NCT00868517|19363748|P3|STARTED|Overall Study||11
7868032|NCT00868517|19363749|P2|STARTED|Overall Study||12
7868033|NCT00868517|19363750|P1|STARTED|Overall Study||12
7868034|NCT00868452|19363775|P2|NOT COMPLETED|Overall Study||29
7868035|NCT00868452|19363776|P1|NOT COMPLETED|Overall Study||40
7868036|NCT00868452|19363775|P2|COMPLETED|Overall Study||136
7868037|NCT00868452|19363776|P1|COMPLETED|Overall Study||143
7868038|NCT00868452|19363775|P2|STARTED|Overall Study||165
7868039|NCT00868452|19363776|P1|STARTED|Overall Study||183
7868040|NCT00868439|19363788|P2|NOT COMPLETED|Overall Study||9
7868041|NCT00868439|19363789|P1|NOT COMPLETED|Overall Study||8
7868042|NCT00868439|19363788|P2|COMPLETED|Overall Study||40
7868043|NCT00868439|19363789|P1|COMPLETED|Overall Study||48
7868044|NCT00868439|19363788|P2|STARTED|Overall Study||49
7868045|NCT00868439|19363789|P1|STARTED|Overall Study||56
7868046|NCT00868374|19363807|P2|NOT COMPLETED|Overall Study||7
7868047|NCT00868374|19363808|P1|NOT COMPLETED|Overall Study||7
7868048|NCT00868374|19363807|P2|COMPLETED|Overall Study||4
7868049|NCT00868374|19363808|P1|COMPLETED|Overall Study||5
7868050|NCT00868374|19363807|P2|STARTED|Overall Study||11
7868051|NCT00868374|19363808|P1|STARTED|Overall Study||12
7868052|NCT00868348|19363816|P2|NOT COMPLETED|Overall Study||0
7868053|NCT00868348|19363817|P1|NOT COMPLETED|Overall Study||0
7868054|NCT00868348|19363816|P2|COMPLETED|Overall Study||30
7868055|NCT00868348|19363817|P1|COMPLETED|Overall Study||30
7868056|NCT00868348|19363816|P2|STARTED|Overall Study||30
7868057|NCT00868348|19363817|P1|STARTED|Overall Study||30
7868058|NCT00868309|19363835|P2|NOT COMPLETED|Overall Study||0
7868059|NCT00868309|19363836|P1|NOT COMPLETED|Overall Study||0
7868060|NCT00868309|19363835|P2|COMPLETED|Overall Study||6
7868061|NCT00868309|19363836|P1|COMPLETED|Overall Study||6
7868062|NCT00868309|19363835|P2|STARTED|Overall Study||6
7868063|NCT00868309|19363836|P1|STARTED|Overall Study||6
7868064|NCT00868296|19363846|P2|NOT COMPLETED|Overall Study||3
7868065|NCT00868296|19363847|P1|NOT COMPLETED|Overall Study||0
7868066|NCT00868296|19363846|P2|COMPLETED|Overall Study||43
7868067|NCT00868296|19363847|P1|COMPLETED|Overall Study||12
7868068|NCT00868296|19363846|P2|STARTED|Overall Study||46
7868069|NCT00868296|19363847|P1|STARTED|Overall Study||12
7868070|NCT00868231|19363855|P6|NOT COMPLETED|Treatment Period 3||0
7868071|NCT00868231|19363856|P5|NOT COMPLETED|Treatment Period 3||0
7868072|NCT00868231|19363857|P4|NOT COMPLETED|Treatment Period 3||0
7868073|NCT00868231|19363858|P3|NOT COMPLETED|Treatment Period 3||1
7868074|NCT00868231|19363859|P2|NOT COMPLETED|Treatment Period 3||0
7868075|NCT00868231|19363860|P1|NOT COMPLETED|Treatment Period 3||0
7868076|NCT00868231|19363855|P6|COMPLETED|Treatment Period 3||5
7868077|NCT00868231|19363856|P5|COMPLETED|Treatment Period 3||4
7868078|NCT00868231|19363857|P4|COMPLETED|Treatment Period 3||5
7868079|NCT00868231|19363858|P3|COMPLETED|Treatment Period 3||4
7868080|NCT00868231|19363859|P2|COMPLETED|Treatment Period 3||5
7868081|NCT00868231|19363860|P1|COMPLETED|Treatment Period 3||4
7868082|NCT00868231|19363855|P6|STARTED|Treatment Period 3||5
7868083|NCT00868231|19363856|P5|STARTED|Treatment Period 3||4
7868084|NCT00868231|19363857|P4|STARTED|Treatment Period 3||5
7868085|NCT00868231|19363858|P3|STARTED|Treatment Period 3||5
7868086|NCT00868231|19363859|P2|STARTED|Treatment Period 3||5
7868087|NCT00868231|19363860|P1|STARTED|Treatment Period 3||4
7868088|NCT00868231|19363855|P6|NOT COMPLETED|Treatment Period 2||0
7868089|NCT00868231|19363856|P5|NOT COMPLETED|Treatment Period 2||0
7868090|NCT00868231|19363857|P4|NOT COMPLETED|Treatment Period 2||0
7868091|NCT00868231|19363858|P3|NOT COMPLETED|Treatment Period 2||0
7868092|NCT00868231|19363859|P2|NOT COMPLETED|Treatment Period 2||0
7868093|NCT00868231|19363860|P1|NOT COMPLETED|Treatment Period 2||1
7868094|NCT00868231|19363855|P6|COMPLETED|Treatment Period 2||5
7868095|NCT00868231|19363856|P5|COMPLETED|Treatment Period 2||4
7868096|NCT00868231|19363857|P4|COMPLETED|Treatment Period 2||5
7868097|NCT00868231|19363858|P3|COMPLETED|Treatment Period 2||5
7868098|NCT00868231|19363859|P2|COMPLETED|Treatment Period 2||5
7868099|NCT00868231|19363860|P1|COMPLETED|Treatment Period 2||4
7868100|NCT00868231|19363855|P6|STARTED|Treatment Period 2||5
7868101|NCT00868231|19363856|P5|STARTED|Treatment Period 2||4
7868102|NCT00868231|19363857|P4|STARTED|Treatment Period 2||5
7868103|NCT00868231|19363858|P3|STARTED|Treatment Period 2||5
7868104|NCT00868231|19363859|P2|STARTED|Treatment Period 2||5
7868105|NCT00868231|19363860|P1|STARTED|Treatment Period 2||5
7868106|NCT00868231|19363855|P6|NOT COMPLETED|Treatment Period 1||0
7868107|NCT00868231|19363856|P5|NOT COMPLETED|Treatment Period 1||1
7868108|NCT00868231|19363857|P4|NOT COMPLETED|Treatment Period 1||0
7868109|NCT00868231|19363858|P3|NOT COMPLETED|Treatment Period 1||0
7868110|NCT00868231|19363859|P2|NOT COMPLETED|Treatment Period 1||0
7868111|NCT00868231|19363860|P1|NOT COMPLETED|Treatment Period 1||0
7868112|NCT00868231|19363855|P6|COMPLETED|Treatment Period 1||5
7868113|NCT00868231|19363856|P5|COMPLETED|Treatment Period 1||4
7868114|NCT00868231|19363857|P4|COMPLETED|Treatment Period 1||5
7868115|NCT00868231|19363858|P3|COMPLETED|Treatment Period 1||5
7868116|NCT00868231|19363859|P2|COMPLETED|Treatment Period 1||5
7868117|NCT00868231|19363860|P1|COMPLETED|Treatment Period 1||5
7868118|NCT00868231|19363855|P6|STARTED|Treatment Period 1||5
7868119|NCT00868231|19363856|P5|STARTED|Treatment Period 1||5
7868120|NCT00868231|19363857|P4|STARTED|Treatment Period 1||5
7868121|NCT00868231|19363858|P3|STARTED|Treatment Period 1||5
7868122|NCT00868231|19363859|P2|STARTED|Treatment Period 1||5
7868123|NCT00868231|19363860|P1|STARTED|Treatment Period 1||5
7868124|NCT00868218|19363905|P4|NOT COMPLETED|Overall Study||0
7868125|NCT00868218|19363906|P3|NOT COMPLETED|Overall Study||0
7868126|NCT00868218|19363907|P2|NOT COMPLETED|Overall Study||0
7868127|NCT00868218|19363908|P1|NOT COMPLETED|Overall Study||0
7868128|NCT00868218|19363905|P4|COMPLETED|Overall Study||15
7868129|NCT00868218|19363906|P3|COMPLETED|Overall Study||15
7868130|NCT00868218|19363907|P2|COMPLETED|Overall Study||15
7868131|NCT00868218|19363908|P1|COMPLETED|Overall Study||15
7868132|NCT00868218|19363905|P4|STARTED|Overall Study||15
7868133|NCT00868218|19363906|P3|STARTED|Overall Study||15
7868134|NCT00868218|19363907|P2|STARTED|Overall Study||15
7868135|NCT00868218|19363908|P1|STARTED|Overall Study||15
7868136|NCT00868192|19363926|P1|NOT COMPLETED|Overall Study||4
7868137|NCT00868192|19363926|P1|COMPLETED|Overall Study||34
7868138|NCT00868192|19363926|P1|STARTED|Overall Study||38
7868139|NCT00868166|19363943|P2|NOT COMPLETED|Overall Study||114
7868140|NCT00868166|19363944|P1|NOT COMPLETED|Overall Study||112
7868141|NCT00868166|19363943|P2|COMPLETED|Overall Study||139
7868142|NCT00868166|19363944|P1|COMPLETED|Overall Study||147
7868143|NCT00868166|19363943|P2|STARTED|Overall Study||253
7868144|NCT00868166|19363944|P1|STARTED|Overall Study||259
7868145|NCT00868140|19363966|P2|NOT COMPLETED|Overall Study||0
7868146|NCT00868140|19363967|P1|NOT COMPLETED|Overall Study||0
7868147|NCT00868140|19363966|P2|COMPLETED|Overall Study||25
7868148|NCT00868140|19363967|P1|COMPLETED|Overall Study||26
7868149|NCT00868140|19363966|P2|STARTED|Overall Study||25
7868150|NCT00868140|19363967|P1|STARTED|Overall Study||26
7868151|NCT00868101|19363985|P2|NOT COMPLETED|Overall Study||0
7868152|NCT00868101|19363986|P1|NOT COMPLETED|Overall Study||0
7868153|NCT00868101|19363985|P2|COMPLETED|Overall Study||10
7868154|NCT00868101|19363986|P1|COMPLETED|Overall Study||12
7868155|NCT00868101|19363985|P2|STARTED|Overall Study||10
7868156|NCT00868101|19363986|P1|STARTED|Overall Study||12
7868157|NCT00867932|19363998|P1|NOT COMPLETED|Overall Study||0
7868158|NCT00867932|19363998|P1|COMPLETED|Overall Study||7
7868159|NCT00867932|19363998|P1|Intent-to-Treat (ITT) Population|Overall Study||7
7868160|NCT00867932|19363998|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
7868161|NCT00867932|19363998|P1|Maintenance Phase|Overall Study||7
7868162|NCT00867932|19363998|P1|Induction Phase|Overall Study||7
7868163|NCT00867932|19363998|P1|STARTED|Overall Study||7
7868164|NCT00867815|19364006|P1|NOT COMPLETED|Overall Study||1
7868165|NCT00867815|19364006|P1|COMPLETED|Overall Study||9
7868166|NCT00867815|19364006|P1|STARTED|Overall Study||10
7868167|NCT00867659|19364012|P1|NOT COMPLETED|Overall Study||0
7868168|NCT00867659|19364012|P1|COMPLETED|Overall Study|January 2010|20
7868169|NCT00867659|19364012|P1|STARTED|Overall Study|October 2009|20
7868170|NCT00867568|19364017|P1|NOT COMPLETED|Overall Study||15
7868171|NCT00867568|19364017|P1|COMPLETED|Overall Study||3
7868172|NCT00867568|19364017|P1|STARTED|Overall Study||18
7868173|NCT00867529|19364026|P1|NOT COMPLETED|Overall Study||0
7868174|NCT00867529|19364026|P1|COMPLETED|Overall Study||63
7868175|NCT00867529|19364026|P1|STARTED|Overall Study||63
7868176|NCT00867503|19364034|P1|NOT COMPLETED|Overall Study||1
7868177|NCT00867503|19364034|P1|COMPLETED|Overall Study||9
7868178|NCT00867503|19364034|P1|STARTED|Overall Study||10
7868179|NCT00867490|19364040|P1|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0
7868180|NCT00867490|19364040|P1|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61
7868181|NCT00867490|19364040|P1|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61
7868182|NCT00867490|19364040|P1|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3
7868183|NCT00867490|19364040|P1|COMPLETED|Phase 2 - Aliskiren+HCTZ||120
7868184|NCT00867490|19364040|P1|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123
7868185|NCT00867490|19364040|P1|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10
7868186|NCT00867490|19364040|P1|COMPLETED|Phase 1 - Candesartan+HCTZ||176
7868187|NCT00867490|19364040|P1|STARTED|Phase 1 - Candesartan+HCTZ||186
7868188|NCT00867451|19364059|P2|NOT COMPLETED|Overall Study||0
7868189|NCT00867451|19364060|P1|NOT COMPLETED|Overall Study||0
7868190|NCT00867451|19364059|P2|COMPLETED|Overall Study||4
7868191|NCT00867451|19364060|P1|COMPLETED|Overall Study||4
7868192|NCT00867451|19364059|P2|STARTED|Overall Study||4
7868193|NCT00867451|19364060|P1|STARTED|Overall Study||4
7868194|NCT00867360|19364082|P2|NOT COMPLETED|Overall Study||1
7868195|NCT00867360|19364083|P1|NOT COMPLETED|Overall Study||1
7868196|NCT00867360|19364082|P2|COMPLETED|Overall Study||5
7868197|NCT00867360|19364083|P1|COMPLETED|Overall Study||3
7868198|NCT00867360|19364082|P2|STARTED|Overall Study||6
7868199|NCT00867360|19364083|P1|STARTED|Overall Study||4
7868200|NCT00867334|19364095|P2|NOT COMPLETED|Overall Study||1
7868201|NCT00867334|19364096|P1|NOT COMPLETED|Overall Study||2
7868202|NCT00867334|19364095|P2|COMPLETED|Overall Study||0
7868203|NCT00867334|19364096|P1|COMPLETED|Overall Study||4
7868204|NCT00867334|19364095|P2|STARTED|Overall Study||1
7868205|NCT00867334|19364096|P1|STARTED|Overall Study||6
7868206|NCT00867321|19364107|P6|NOT COMPLETED|Overall Study||0
7868207|NCT00867321|19364108|P5|NOT COMPLETED|Overall Study||0
7868208|NCT00867321|19364109|P4|NOT COMPLETED|Overall Study||0
7868209|NCT00867321|19364110|P3|NOT COMPLETED|Overall Study||0
7868210|NCT00867321|19364111|P2|NOT COMPLETED|Overall Study||1
7868211|NCT00867321|19364112|P1|NOT COMPLETED|Overall Study||0
7868212|NCT00867321|19364107|P6|COMPLETED|Overall Study||3
7868213|NCT00867321|19364108|P5|COMPLETED|Overall Study||5
7868214|NCT00867321|19364109|P4|COMPLETED|Overall Study||6
7868215|NCT00867321|19364110|P3|COMPLETED|Overall Study||3
7868216|NCT00867321|19364111|P2|COMPLETED|Overall Study||2
7868217|NCT00867321|19364112|P1|COMPLETED|Overall Study||4
7868218|NCT00867321|19364107|P6|STARTED|Overall Study||3
7868219|NCT00867321|19364108|P5|STARTED|Overall Study||5
7868220|NCT00867321|19364109|P4|STARTED|Overall Study||6
7868221|NCT00867321|19364110|P3|STARTED|Overall Study||3
7868222|NCT00867321|19364111|P2|STARTED|Overall Study||3
7868223|NCT00867321|19364112|P1|STARTED|Overall Study||4
7868224|NCT00867308|19364132|P2|NOT COMPLETED|Overall Study||18
7868225|NCT00867308|19364133|P1|NOT COMPLETED|Overall Study||9
7868226|NCT00867308|19364132|P2|COMPLETED|Overall Study||0
7868227|NCT00867308|19364133|P1|COMPLETED|Overall Study||0
7868228|NCT00867308|19364132|P2|STARTED|Overall Study||18
7868229|NCT00867308|19364133|P1|STARTED|Overall Study||9
7868230|NCT00867217|19364143|P2|NOT COMPLETED|Overall Study||10
7868231|NCT00867217|19364144|P1|NOT COMPLETED|Overall Study||3
7868232|NCT00867217|19364143|P2|COMPLETED|Overall Study||70
7868233|NCT00867217|19364144|P1|COMPLETED|Overall Study||77
7868234|NCT00867217|19364143|P2|STARTED|Overall Study||80
7868235|NCT00867217|19364144|P1|STARTED|Overall Study||80
7868236|NCT00867165|19364152|P2|NOT COMPLETED|Overall Study||0
7868237|NCT00867165|19364153|P1|NOT COMPLETED|Overall Study||4
7868238|NCT00867165|19364152|P2|COMPLETED|Overall Study||45
7868239|NCT00867165|19364153|P1|COMPLETED|Overall Study||89
7868240|NCT00867165|19364152|P2|STARTED|Overall Study||45
7868241|NCT00867165|19364153|P1|STARTED|Overall Study||93
7868242|NCT00867139|19364258|P3|NOT COMPLETED|Overall Study||1
7868243|NCT00867139|19364259|P2|NOT COMPLETED|Overall Study||0
7868244|NCT00867139|19364260|P1|NOT COMPLETED|Overall Study||0
7868245|NCT00867139|19364258|P3|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3
7868246|NCT00867139|19364259|P2|COMPLETED|Overall Study||1
7868247|NCT00867139|19364260|P1|COMPLETED|Overall Study||2
7868248|NCT00867139|19364258|P3|STARTED|Overall Study||4
7868249|NCT00867139|19364259|P2|STARTED|Overall Study||1
7868250|NCT00867139|19364260|P1|STARTED|Overall Study||2
7868251|NCT00867113|19364301|P1|NOT COMPLETED|Post Treatment After Survival Follow-up||11
7868252|NCT00867113|19364301|P1|COMPLETED|Post Treatment After Survival Follow-up||57
7868253|NCT00867113|19364301|P1|STARTED|Post Treatment After Survival Follow-up||68
7868254|NCT00867113|19364301|P1|NOT COMPLETED|Treatment Period||45
7868255|NCT00867113|19364301|P1|COMPLETED|Treatment Period||46
7868256|NCT00867113|19364301|P1|Full Analysis Set (FAS)|Treatment Period||91
7868257|NCT00867113|19364301|P1|Safety Set|Treatment Period||91
7868258|NCT00867113|19364301|P1|STARTED|Treatment Period||91
7868259|NCT00867100|19364321|P13|NOT COMPLETED|Overall Study||0
7868260|NCT00867100|19364322|P12|NOT COMPLETED|Overall Study||0
7868261|NCT00867100|19364323|P11|NOT COMPLETED|Overall Study||1
7868262|NCT00867100|19364324|P10|NOT COMPLETED|Overall Study||0
7868263|NCT00867100|19364325|P9|NOT COMPLETED|Overall Study||0
7868264|NCT00867100|19364326|P8|NOT COMPLETED|Overall Study||0
7868265|NCT00867100|19364327|P7|NOT COMPLETED|Overall Study||1
7868266|NCT00867100|19364328|P6|NOT COMPLETED|Overall Study||0
7868267|NCT00867100|19364329|P5|NOT COMPLETED|Overall Study||0
7868268|NCT00867100|19364330|P4|NOT COMPLETED|Overall Study||0
7868269|NCT00867100|19364331|P3|NOT COMPLETED|Overall Study||0
7868270|NCT00867100|19364332|P2|NOT COMPLETED|Overall Study||1
7868271|NCT00867100|19364333|P1|NOT COMPLETED|Overall Study||0
7868272|NCT00867100|19364321|P13|COMPLETED|Overall Study||6
7868273|NCT00867100|19364322|P12|COMPLETED|Overall Study||6
7868274|NCT00867100|19364323|P11|COMPLETED|Overall Study||3
7868275|NCT00867100|19364324|P10|COMPLETED|Overall Study||6
7868276|NCT00867100|19364325|P9|COMPLETED|Overall Study||6
7868277|NCT00867100|19364326|P8|COMPLETED|Overall Study||3
7868278|NCT00867100|19364327|P7|COMPLETED|Overall Study||6
7868279|NCT00867100|19364328|P6|COMPLETED|Overall Study||6
7868280|NCT00867100|19364329|P5|COMPLETED|Overall Study||14
7868281|NCT00867100|19364330|P4|COMPLETED|Overall Study||8
7868282|NCT00867100|19364331|P3|COMPLETED|Overall Study||8
7868283|NCT00867100|19364332|P2|COMPLETED|Overall Study||4
7868284|NCT00867100|19364333|P1|COMPLETED|Overall Study||5
7868285|NCT00867100|19364321|P13|STARTED|Overall Study||6
7868286|NCT00867100|19364322|P12|STARTED|Overall Study||6
7868287|NCT00867100|19364323|P11|STARTED|Overall Study||4
7868288|NCT00867100|19364324|P10|STARTED|Overall Study||6
7868289|NCT00867100|19364325|P9|STARTED|Overall Study||6
7868290|NCT00867100|19364326|P8|STARTED|Overall Study||3
7868291|NCT00867100|19364327|P7|STARTED|Overall Study||7
7868292|NCT00867100|19364328|P6|STARTED|Overall Study||6
7868293|NCT00867100|19364329|P5|STARTED|Overall Study||14
7868294|NCT00867100|19364330|P4|STARTED|Overall Study||8
7868295|NCT00867100|19364331|P3|STARTED|Overall Study||8
7868296|NCT00867100|19364332|P2|STARTED|Overall Study||5
7868297|NCT00867100|19364333|P1|STARTED|Overall Study||5
7868298|NCT00867087|19364365|P1|NOT COMPLETED|Overall Study||42
7868299|NCT00867087|19364365|P1|COMPLETED|Overall Study||21
7868300|NCT00867087|19364365|P1|STARTED|Overall Study||63
7868301|NCT00867035|19364381|P2|NOT COMPLETED|Baseline to 1 Week||0
7868302|NCT00867035|19364382|P1|NOT COMPLETED|Baseline to 1 Week||1
7868303|NCT00867035|19364381|P2|COMPLETED|Baseline to 1 Week||8
7868304|NCT00867035|19364382|P1|COMPLETED|Baseline to 1 Week||11
7868305|NCT00867035|19364381|P2|STARTED|Baseline to 1 Week||8
7868306|NCT00867035|19364382|P1|STARTED|Baseline to 1 Week||12
7868307|NCT00867035|19364381|P2|NOT COMPLETED|Baseline to 4 Hours||0
7868308|NCT00867035|19364382|P1|NOT COMPLETED|Baseline to 4 Hours||0
7868309|NCT00867035|19364381|P2|COMPLETED|Baseline to 4 Hours||8
7868310|NCT00867035|19364382|P1|COMPLETED|Baseline to 4 Hours||12
7868311|NCT00867035|19364381|P2|STARTED|Baseline to 4 Hours||8
7868312|NCT00867035|19364382|P1|STARTED|Baseline to 4 Hours||12
7868313|NCT00867035|19364381|P2|NOT COMPLETED|Baseline to 2 Hours||0
7868314|NCT00867035|19364382|P1|NOT COMPLETED|Baseline to 2 Hours||0
7868315|NCT00867035|19364381|P2|COMPLETED|Baseline to 2 Hours||8
7868316|NCT00867035|19364382|P1|COMPLETED|Baseline to 2 Hours||12
7868317|NCT00867035|19364381|P2|STARTED|Baseline to 2 Hours||8
7868318|NCT00867035|19364382|P1|STARTED|Baseline to 2 Hours||12
7868319|NCT00867035|19364381|P2|NOT COMPLETED|Baseline to 1 Hour||1
7868320|NCT00867035|19364382|P1|NOT COMPLETED|Baseline to 1 Hour||1
7868321|NCT00867035|19364381|P2|COMPLETED|Baseline to 1 Hour||8
7868322|NCT00867035|19364382|P1|COMPLETED|Baseline to 1 Hour||12
7868323|NCT00867035|19364381|P2|STARTED|Baseline to 1 Hour||9
7868324|NCT00867035|19364382|P1|STARTED|Baseline to 1 Hour||13
7868325|NCT00867009|19364408|P1|NOT COMPLETED|Maintenance Period||4
7868326|NCT00867009|19364408|P1|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47
7868327|NCT00867009|19364408|P1|STARTED|Maintenance Period||51
7868328|NCT00867009|19364408|P1|NOT COMPLETED|Induction Period||62
7868329|NCT00867009|19364408|P1|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51
7868330|NCT00867009|19364408|P1|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109
7868331|NCT00867009|19364408|P1|Received at Least 1 Dose of Study Drug|Induction Period||113
7868332|NCT00867009|19364408|P1|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113
7868333|NCT00866918|19364417|P2|NOT COMPLETED|Overall Study||12
7868334|NCT00866918|19364418|P1|NOT COMPLETED|Overall Study||16
7868335|NCT00866918|19364417|P2|COMPLETED|Overall Study||27
7868336|NCT00866918|19364418|P1|COMPLETED|Overall Study||53
7868337|NCT00866918|19364417|P2|STARTED|Overall Study||39
7868338|NCT00866918|19364418|P1|STARTED|Overall Study||69
7868339|NCT00866905|19364430|P1|NOT COMPLETED|Overall Study||33
7868340|NCT00866905|19364430|P1|COMPLETED|Overall Study||135
7868341|NCT00866905|19364430|P1|STARTED|Overall Study||168
7868342|NCT00866879|19364437|P2|NOT COMPLETED|Overall Study||0
7868343|NCT00866879|19364438|P1|NOT COMPLETED|Overall Study||0
7868344|NCT00866879|19364437|P2|COMPLETED|Overall Study||185
7868345|NCT00866879|19364438|P1|COMPLETED|Overall Study||90
7868346|NCT00866879|19364437|P2|STARTED|Overall Study||185
7868347|NCT00866879|19364438|P1|STARTED|Overall Study||90
7868348|NCT00866814|19364452|P1|NOT COMPLETED|Overall Study||20
7868349|NCT00866814|19364452|P1|COMPLETED|Overall Study||99
7868350|NCT00866814|19364452|P1|STARTED|Overall Study||119
7868351|NCT00866788|19364465|P4|NOT COMPLETED|Overall Study||5
7868352|NCT00866788|19364466|P3|NOT COMPLETED|Overall Study||2
7868353|NCT00866788|19364467|P2|NOT COMPLETED|Overall Study||6
7868354|NCT00866788|19364468|P1|NOT COMPLETED|Overall Study||6
7868355|NCT00866788|19364465|P4|COMPLETED|Overall Study||16
7868356|NCT00866788|19364466|P3|COMPLETED|Overall Study||23
7868357|NCT00866788|19364467|P2|COMPLETED|Overall Study||17
7868358|NCT00866788|19364468|P1|COMPLETED|Overall Study||15
7868359|NCT00866788|19364465|P4|STARTED|Overall Study||21
7868360|NCT00866788|19364466|P3|STARTED|Overall Study||25
7868361|NCT00866788|19364467|P2|STARTED|Overall Study||23
7868362|NCT00866788|19364468|P1|STARTED|Overall Study||21
7868363|NCT00866775|19364516|P2|NOT COMPLETED|Overall Study||52
7868364|NCT00866775|19364517|P1|NOT COMPLETED|Overall Study||36
7868365|NCT00866775|19364516|P2|COMPLETED|Overall Study||76
7868366|NCT00866775|19364517|P1|COMPLETED|Overall Study||29
7868367|NCT00866775|19364516|P2|STARTED|Overall Study||128
7868368|NCT00866775|19364517|P1|STARTED|Overall Study||65
7868369|NCT00866749|19364553|P1|NOT COMPLETED|Overall Study||0
7868370|NCT00866749|19364553|P1|COMPLETED|Overall Study||120
7868371|NCT00866749|19364553|P1|STARTED|Overall Study||120
7868372|NCT00866723|19364560|P1|NOT COMPLETED|Overall Study||5
7868373|NCT00866723|19364560|P1|COMPLETED|Overall Study||0
7868374|NCT00866723|19364560|P1|STARTED|Overall Study||5
7868375|NCT00866697|19364567|P2|NOT COMPLETED|Overall Study||228
7868376|NCT00866697|19364568|P1|NOT COMPLETED|Overall Study||214
7868377|NCT00866697|19364567|P2|COMPLETED|Overall Study||244
7868378|NCT00866697|19364568|P1|COMPLETED|Overall Study||254
7868379|NCT00866697|19364567|P2|STARTED|Overall Study||472
7868380|NCT00866697|19364568|P1|STARTED|Overall Study||468
7868381|NCT00866658|19364610|P2|NOT COMPLETED|Overall Study||21
7868382|NCT00866658|19364611|P1|NOT COMPLETED|Overall Study||13
7868383|NCT00866658|19364610|P2|COMPLETED|Overall Study||133
7868384|NCT00866658|19364611|P1|COMPLETED|Overall Study||144
7868385|NCT00866658|19364610|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||154
7868386|NCT00866658|19364611|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157
7868387|NCT00866658|19364610|P2|Safety Population|Overall Study||154
7868388|NCT00866658|19364611|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157
7868389|NCT00866658|19364610|P2|STARTED|Overall Study||154
7868390|NCT00866658|19364611|P1|STARTED|Overall Study|Randomized.|157
7868391|NCT00866619|19364643|P4|NOT COMPLETED|Overall Study||630
7868392|NCT00866619|19364644|P3|NOT COMPLETED|Overall Study||889
7868393|NCT00866619|19364645|P2|NOT COMPLETED|Overall Study||1270
7868394|NCT00866619|19364646|P1|NOT COMPLETED|Overall Study||1846
7868395|NCT00866619|19364643|P4|COMPLETED|Overall Study||1549
7868396|NCT00866619|19364644|P3|COMPLETED|Overall Study||2085
7868397|NCT00866619|19364645|P2|COMPLETED|Overall Study||3088
7868398|NCT00866619|19364646|P1|COMPLETED|Overall Study||4102
7868399|NCT00866619|19364643|P4|STARTED|Overall Study||2179
7868400|NCT00866619|19364644|P3|STARTED|Overall Study||2974
7868401|NCT00866619|19364645|P2|STARTED|Overall Study||4358
7868402|NCT00866619|19364646|P1|STARTED|Overall Study||5948
7868403|NCT00866606|19364966|P1|NOT COMPLETED|Overall Study||4
7868404|NCT00866606|19364966|P1|COMPLETED|Overall Study||31
7868405|NCT00866606|19364966|P1|STARTED|Overall Study||35
7868406|NCT00866359|19364980|P4|NOT COMPLETED|Observational Follow-Up Phase||0
7868407|NCT00866359|19364981|P3|NOT COMPLETED|Observational Follow-Up Phase||0
7868408|NCT00866359|19364982|P2|NOT COMPLETED|Observational Follow-Up Phase||0
7868409|NCT00866359|19364983|P1|NOT COMPLETED|Observational Follow-Up Phase||0
7868410|NCT00866359|19364980|P4|COMPLETED|Observational Follow-Up Phase||54
7868411|NCT00866359|19364981|P3|COMPLETED|Observational Follow-Up Phase||54
7868412|NCT00866359|19364982|P2|COMPLETED|Observational Follow-Up Phase||0
7868413|NCT00866359|19364983|P1|COMPLETED|Observational Follow-Up Phase||0
7868414|NCT00866359|19364980|P4|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
7868415|NCT00866359|19364981|P3|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
7868416|NCT00866359|19364982|P2|STARTED|Observational Follow-Up Phase||0
7868417|NCT00866359|19364983|P1|STARTED|Observational Follow-Up Phase||0
7868418|NCT00866359|19364980|P4|NOT COMPLETED|Extension Phase (Day 86 to 169)||3
7868419|NCT00866359|19364981|P3|NOT COMPLETED|Extension Phase (Day 86 to 169)||1
7868420|NCT00866359|19364982|P2|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
7868421|NCT00866359|19364983|P1|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
7868422|NCT00866359|19364980|P4|COMPLETED|Extension Phase (Day 86 to 169)||47
7868423|NCT00866359|19364981|P3|COMPLETED|Extension Phase (Day 86 to 169)||44
7868424|NCT00866359|19364982|P2|COMPLETED|Extension Phase (Day 86 to 169)||0
7868425|NCT00866359|19364983|P1|COMPLETED|Extension Phase (Day 86 to 169)||0
7868426|NCT00866359|19364980|P4|STARTED|Extension Phase (Day 86 to 169)||50
7868427|NCT00866359|19364981|P3|STARTED|Extension Phase (Day 86 to 169)||45
7868428|NCT00866359|19364982|P2|STARTED|Extension Phase (Day 86 to 169)||0
7868429|NCT00866359|19364983|P1|STARTED|Extension Phase (Day 86 to 169)||0
7868430|NCT00866359|19364980|P4|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
7868431|NCT00866359|19364981|P3|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
7868432|NCT00866359|19364982|P2|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5
7868433|NCT00866359|19364983|P1|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11
7868434|NCT00866359|19364980|P4|COMPLETED|Treatment Phase (Days 1 to 85)||0
7868435|NCT00866359|19364981|P3|COMPLETED|Treatment Phase (Days 1 to 85)||0
7868436|NCT00866359|19364982|P2|COMPLETED|Treatment Phase (Days 1 to 85)||50
7868437|NCT00866359|19364983|P1|COMPLETED|Treatment Phase (Days 1 to 85)||45
7868438|NCT00866359|19364980|P4|STARTED|Treatment Phase (Days 1 to 85)||0
7868439|NCT00866359|19364981|P3|STARTED|Treatment Phase (Days 1 to 85)||0
7868440|NCT00866359|19364982|P2|STARTED|Treatment Phase (Days 1 to 85)||55
7868441|NCT00866359|19364983|P1|STARTED|Treatment Phase (Days 1 to 85)||56
7868442|NCT00866333|19365039|P3|NOT COMPLETED|Overall Study||12
7868443|NCT00866333|19365040|P2|NOT COMPLETED|Overall Study||7
7868444|NCT00866333|19365041|P1|NOT COMPLETED|Overall Study||5
7868445|NCT00866333|19365039|P3|COMPLETED|Overall Study||4
7868446|NCT00866333|19365040|P2|COMPLETED|Overall Study||10
7868447|NCT00866333|19365041|P1|COMPLETED|Overall Study||11
7868448|NCT00866333|19365039|P3|STARTED|Overall Study||16
7868449|NCT00866333|19365040|P2|STARTED|Overall Study||17
7868450|NCT00866333|19365041|P1|STARTED|Overall Study||16
7868451|NCT00866320|19365058|P1|NOT COMPLETED|Overall Study||6
7868452|NCT00866320|19365058|P1|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43
7868453|NCT00866320|19365058|P1|STARTED|Overall Study||49
7868454|NCT00866307|19365065|P3|NOT COMPLETED|Consolidation/Maintenance||16
7868455|NCT00866307|19365066|P2|NOT COMPLETED|Consolidation/Maintenance||9
7868456|NCT00866307|19365067|P1|NOT COMPLETED|Consolidation/Maintenance||0
7868457|NCT00866307|19365065|P3|COMPLETED|Consolidation/Maintenance||14
7868458|NCT00866307|19365066|P2|COMPLETED|Consolidation/Maintenance||45
7868459|NCT00866307|19365067|P1|COMPLETED|Consolidation/Maintenance||0
7868460|NCT00866307|19365065|P3|STARTED|Consolidation/Maintenance||30
7868461|NCT00866307|19365066|P2|STARTED|Consolidation/Maintenance||54
7868462|NCT00866307|19365067|P1|STARTED|Consolidation/Maintenance||0
7868463|NCT00866307|19365065|P3|NOT COMPLETED|Induction||0
7868464|NCT00866307|19365066|P2|NOT COMPLETED|Induction||0
7868465|NCT00866307|19365067|P1|NOT COMPLETED|Induction||20
7868466|NCT00866307|19365065|P3|COMPLETED|Induction||0
7868467|NCT00866307|19365066|P2|COMPLETED|Induction||0
7868468|NCT00866307|19365067|P1|COMPLETED|Induction||84
7868469|NCT00866307|19365065|P3|STARTED|Induction||0
7868470|NCT00866307|19365066|P2|STARTED|Induction||0
7868471|NCT00866307|19365067|P1|STARTED|Induction||104
7868472|NCT00866294|19365077|P3|NOT COMPLETED|Overall Study||11
7868473|NCT00866294|19365078|P2|NOT COMPLETED|Overall Study||20
7868474|NCT00866294|19365079|P1|NOT COMPLETED|Overall Study||33
7868475|NCT00866294|19365077|P3|COMPLETED|Overall Study||72
7868476|NCT00866294|19365078|P2|COMPLETED|Overall Study||141
7868477|NCT00866294|19365079|P1|COMPLETED|Overall Study||139
7868478|NCT00866294|19365077|P3|STARTED|Overall Study||83
7868479|NCT00866294|19365078|P2|STARTED|Overall Study||161
7868480|NCT00866294|19365079|P1|STARTED|Overall Study||172
7868481|NCT00866281|19365108|P2|NOT COMPLETED|Overall Study||15
7868482|NCT00866281|19365109|P1|NOT COMPLETED|Overall Study||7
7868483|NCT00866281|19365108|P2|COMPLETED|Overall Study||0
7868484|NCT00866281|19365109|P1|COMPLETED|Overall Study||0
7868485|NCT00866281|19365108|P2|STARTED|Overall Study||15
7868486|NCT00866281|19365109|P1|STARTED|Overall Study||7
7868487|NCT00866177|19365125|P1|NOT COMPLETED|Overall Study||152
7868488|NCT00866177|19365125|P1|COMPLETED|Overall Study||15
7868489|NCT00866177|19365125|P1|STARTED|Overall Study||167
7868490|NCT00866047|19365129|P1|NOT COMPLETED|Follow-up Period||5
7868491|NCT00866047|19365129|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [25] or study completion [28]|53
7868492|NCT00866047|19365129|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|58
7868493|NCT00866047|19365129|P1|NOT COMPLETED|Treatment Period||48
7868494|NCT00866047|19365129|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|10
7868495|NCT00866047|19365129|P1|STARTED|Treatment Period||58
7868496|NCT00866034|19365147|P2|NOT COMPLETED|Overall Study||8
7868497|NCT00866034|19365148|P1|NOT COMPLETED|Overall Study||16
7868498|NCT00866034|19365147|P2|COMPLETED|Overall Study||301
7868499|NCT00866034|19365148|P1|COMPLETED|Overall Study||292
7868500|NCT00866034|19365147|P2|STARTED|Overall Study||309
7868501|NCT00866034|19365148|P1|STARTED|Overall Study||308
7868502|NCT00865904|19365161|P5|NOT COMPLETED|Overall Study||1
7868503|NCT00865904|19365162|P4|NOT COMPLETED|Overall Study||1
7868504|NCT00865904|19365163|P3|NOT COMPLETED|Overall Study||0
7868505|NCT00865904|19365164|P2|NOT COMPLETED|Overall Study||0
7868506|NCT00865904|19365165|P1|NOT COMPLETED|Overall Study||2
7868507|NCT00865904|19365161|P5|COMPLETED|Overall Study|Completed 14-day follow-up.|19
7868508|NCT00865904|19365162|P4|COMPLETED|Overall Study|Completed 14-day follow-up.|17
7868509|NCT00865904|19365163|P3|COMPLETED|Overall Study|Completed 14-day follow-up.|18
7868510|NCT00865904|19365164|P2|COMPLETED|Overall Study|Completed 14-day follow-up.|18
7868511|NCT00865904|19365165|P1|COMPLETED|Overall Study|Completed 14-day follow-up.|17
7868512|NCT00865904|19365161|P5|STARTED|Overall Study|Randomized.|20
7868513|NCT00865904|19365162|P4|STARTED|Overall Study|Randomized.|18
7868514|NCT00865904|19365163|P3|STARTED|Overall Study|Randomized.|18
7868515|NCT00865904|19365164|P2|STARTED|Overall Study|Randomized.|18
7868516|NCT00865904|19365165|P1|STARTED|Overall Study|Randomized.|19
7868517|NCT00865709|19365222|P2|NOT COMPLETED|Long Term Follow-up||49
7868518|NCT00865709|19365223|P1|NOT COMPLETED|Long Term Follow-up||46
7868519|NCT00865709|19365222|P2|COMPLETED|Long Term Follow-up||33
7868520|NCT00865709|19365223|P1|COMPLETED|Long Term Follow-up||24
7868521|NCT00865709|19365222|P2|STARTED|Long Term Follow-up||82
7868522|NCT00865709|19365223|P1|STARTED|Long Term Follow-up||70
7868523|NCT00865709|19365222|P2|NOT COMPLETED|Active Follow-up||1
7868524|NCT00865709|19365223|P1|NOT COMPLETED|Active Follow-up||8
7868525|NCT00865709|19365222|P2|COMPLETED|Active Follow-up||15
7868526|NCT00865709|19365223|P1|COMPLETED|Active Follow-up||17
7868527|NCT00865709|19365222|P2|STARTED|Active Follow-up||16
7868528|NCT00865709|19365223|P1|STARTED|Active Follow-up||25
7868529|NCT00865709|19365222|P2|NOT COMPLETED|Treatment||18
7868530|NCT00865709|19365223|P1|NOT COMPLETED|Treatment||30
7868531|NCT00865709|19365222|P2|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83
7868532|NCT00865709|19365223|P1|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67
7868533|NCT00865709|19365222|P2|Received Treatment|Treatment|Safety population|101
7868534|NCT00865709|19365223|P1|Received Treatment|Treatment|Safety population|97
7868535|NCT00865709|19365222|P2|STARTED|Treatment||101
7868536|NCT00865709|19365223|P1|STARTED|Treatment||97
7868537|NCT00865566|19365241|P2|NOT COMPLETED|Overall Study||687
7868538|NCT00865566|19365242|P1|NOT COMPLETED|Overall Study||624
7868539|NCT00865566|19365241|P2|COMPLETED|Overall Study||564
7868540|NCT00865566|19365242|P1|COMPLETED|Overall Study||629
7868541|NCT00865566|19365241|P2|Modified Intent-to-Treat Population|Overall Study||1245
7868542|NCT00865566|19365242|P1|Modified Intent-to-Treat Population|Overall Study||1251
7868543|NCT00865566|19365241|P2|STARTED|Overall Study||1251
7868544|NCT00865566|19365242|P1|STARTED|Overall Study||1253
7868545|NCT00865514|19365262|P1|NOT COMPLETED|Overall Study||2
7868546|NCT00865514|19365262|P1|COMPLETED|Overall Study||0
7868547|NCT00865514|19365262|P1|STARTED|Overall Study||2
7868548|NCT00865345|19365267|P1|NOT COMPLETED|Overall Study||2
7868549|NCT00865345|19365267|P1|COMPLETED|Overall Study||61
7868550|NCT00865345|19365267|P1|STARTED|Overall Study||63
7868551|NCT00865306|19365274|P2|NOT COMPLETED|One-Year Follow-Up||0
7868552|NCT00865306|19365275|P1|NOT COMPLETED|One-Year Follow-Up||0
7868553|NCT00865306|19365274|P2|COMPLETED|One-Year Follow-Up||15
7868554|NCT00865306|19365275|P1|COMPLETED|One-Year Follow-Up||29
7868555|NCT00865306|19365274|P2|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15
7868556|NCT00865306|19365275|P1|STARTED|One-Year Follow-Up||29
7868557|NCT00865306|19365274|P2|NOT COMPLETED|Controlled Trial||2
7868558|NCT00865306|19365275|P1|NOT COMPLETED|Controlled Trial||5
7868559|NCT00865306|19365274|P2|COMPLETED|Controlled Trial||28
7868560|NCT00865306|19365275|P1|COMPLETED|Controlled Trial||29
7868561|NCT00865306|19365274|P2|STARTED|Controlled Trial||30
7868562|NCT00865306|19365275|P1|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34
7868563|NCT00865202|19365287|P2|NOT COMPLETED|Overall Study||0
7868564|NCT00865202|19365288|P1|NOT COMPLETED|Overall Study||0
7868565|NCT00865202|19365287|P2|COMPLETED|Overall Study||149
7868566|NCT00865202|19365288|P1|COMPLETED|Overall Study||152
7868567|NCT00865202|19365287|P2|STARTED|Overall Study||149
7868568|NCT00865202|19365288|P1|STARTED|Overall Study||152
7868569|NCT00865189|19365304|P2|NOT COMPLETED|Overall Study||19
7868570|NCT00865189|19365305|P1|NOT COMPLETED|Overall Study||12
7868571|NCT00865189|19365304|P2|COMPLETED|Overall Study||26
7868572|NCT00865189|19365305|P1|COMPLETED|Overall Study||34
7868573|NCT00865189|19365304|P2|STARTED|Overall Study||45
7868574|NCT00865189|19365305|P1|STARTED|Overall Study||46
7868575|NCT00865124|19365333|P3|NOT COMPLETED|Overall Study||0
7868576|NCT00865124|19365334|P2|NOT COMPLETED|Overall Study||1
7868577|NCT00865124|19365335|P1|NOT COMPLETED|Overall Study||4
7868578|NCT00865124|19365333|P3|COMPLETED|Overall Study||17
7868579|NCT00865124|19365334|P2|COMPLETED|Overall Study||24
7868580|NCT00865124|19365335|P1|COMPLETED|Overall Study||23
7868581|NCT00865124|19365333|P3|STARTED|Overall Study||17
7868582|NCT00865124|19365334|P2|STARTED|Overall Study||25
7868583|NCT00865124|19365335|P1|STARTED|Overall Study||27
7868584|NCT00865098|19365352|P1|NOT COMPLETED|Overall Study||1
7868585|NCT00865098|19365352|P1|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21
7868586|NCT00865098|19365352|P1|STARTED|Overall Study||22
7868587|NCT00865046|19365364|P3|NOT COMPLETED|Overall Study||1
7868588|NCT00865046|19365365|P2|NOT COMPLETED|Overall Study||5
7868589|NCT00865046|19365366|P1|NOT COMPLETED|Overall Study||6
7868590|NCT00865046|19365364|P3|COMPLETED|Overall Study||62
7868591|NCT00865046|19365365|P2|COMPLETED|Overall Study||59
7868592|NCT00865046|19365366|P1|COMPLETED|Overall Study||57
7868593|NCT00865046|19365364|P3|STARTED|Overall Study||63
7868594|NCT00865046|19365365|P2|STARTED|Overall Study||64
7868595|NCT00865046|19365366|P1|STARTED|Overall Study||63
7868596|NCT00865020|19365376|P2|NOT COMPLETED|Overall Study||51
7868597|NCT00865020|19365377|P1|NOT COMPLETED|Overall Study||49
7868598|NCT00865020|19365376|P2|COMPLETED|Overall Study||357
7868599|NCT00865020|19365377|P1|COMPLETED|Overall Study||365
7868600|NCT00865020|19365376|P2|STARTED|Overall Study||408
7868601|NCT00865020|19365377|P1|STARTED|Overall Study||414
7868602|NCT00864916|19365393|P2|NOT COMPLETED|Overall Study||4
7868603|NCT00864916|19365394|P1|NOT COMPLETED|Overall Study||6
7868604|NCT00864916|19365393|P2|COMPLETED|Overall Study||5
7868605|NCT00864916|19365394|P1|COMPLETED|Overall Study||4
7868606|NCT00864916|19365393|P2|STARTED|Overall Study||9
7868607|NCT00864916|19365394|P1|STARTED|Overall Study||10
7868608|NCT00864851|19365403|P3|NOT COMPLETED|Overall Study||0
7868609|NCT00864851|19365404|P2|NOT COMPLETED|Overall Study||1
7868610|NCT00864851|19365405|P1|NOT COMPLETED|Overall Study||3
7868611|NCT00864851|19365403|P3|COMPLETED|Overall Study||5
7868612|NCT00864851|19365404|P2|COMPLETED|Overall Study||18
7868613|NCT00864851|19365405|P1|COMPLETED|Overall Study||17
7868614|NCT00864851|19365403|P3|STARTED|Overall Study||5
7868615|NCT00864851|19365404|P2|STARTED|Overall Study||19
7868616|NCT00864851|19365405|P1|STARTED|Overall Study||20
7868617|NCT00864721|19365439|P1|NOT COMPLETED|Overall Study||34
7868618|NCT00864721|19365439|P1|COMPLETED|Overall Study||29
7868619|NCT00864721|19365439|P1|STARTED|Overall Study||63
7868620|NCT00864708|19365447|P1|NOT COMPLETED|Overall Study||0
7868621|NCT00864708|19365447|P1|COMPLETED|Overall Study||1
7868622|NCT00864708|19365447|P1|STARTED|Overall Study||1
7868623|NCT00864682|19365459|P3|NOT COMPLETED|Overall Study||2
7868624|NCT00864682|19365460|P2|NOT COMPLETED|Overall Study||1
7868625|NCT00864682|19365461|P1|NOT COMPLETED|Overall Study||2
7868626|NCT00864682|19365459|P3|COMPLETED|Overall Study||51
7868627|NCT00864682|19365460|P2|COMPLETED|Overall Study||50
7868628|NCT00864682|19365461|P1|COMPLETED|Overall Study||50
7868629|NCT00864682|19365459|P3|STARTED|Overall Study||53
7868630|NCT00864682|19365460|P2|STARTED|Overall Study||51
7868631|NCT00864682|19365461|P1|STARTED|Overall Study||52
7868632|NCT00864539|19365481|P6|NOT COMPLETED|Overall Study||14
7868633|NCT00864539|19365482|P5|NOT COMPLETED|Overall Study||22
7868634|NCT00864539|19365483|P4|NOT COMPLETED|Overall Study||7
7868635|NCT00864539|19365484|P3|NOT COMPLETED|Overall Study||10
7868636|NCT00864539|19365485|P2|NOT COMPLETED|Overall Study||23
7868637|NCT00864539|19365486|P1|NOT COMPLETED|Overall Study||9
7868638|NCT00864539|19365481|P6|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71
7868639|NCT00864539|19365482|P5|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81
7868640|NCT00864539|19365483|P4|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89
7868641|NCT00864539|19365484|P3|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92
7868642|NCT00864539|19365485|P2|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72
7868643|NCT00864539|19365486|P1|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95
7868644|NCT00864539|19365481|P6|STARTED|Overall Study||85
7868645|NCT00864539|19365482|P5|STARTED|Overall Study||103
7868646|NCT00864539|19365483|P4|STARTED|Overall Study||96
7868647|NCT00864539|19365484|P3|STARTED|Overall Study||102
7868648|NCT00864539|19365485|P2|STARTED|Overall Study||95
7868649|NCT00864539|19365486|P1|STARTED|Overall Study||104
7868650|NCT00864513|19365500|P1|NOT COMPLETED|Overall Study||3
7868651|NCT00864513|19365500|P1|COMPLETED|Overall Study||12
7868652|NCT00864513|19365500|P1|STARTED|Overall Study||15
7868653|NCT00864474|19365507|P1|NOT COMPLETED|Overall Study||0
7868654|NCT00864474|19365507|P1|COMPLETED|Overall Study||68
7868655|NCT00864474|19365507|P1|STARTED|Overall Study||68
7868656|NCT00864383|19365548|P3|NOT COMPLETED|Modified Intent to Treat||85
7868657|NCT00864383|19365549|P2|NOT COMPLETED|Modified Intent to Treat||87
7868658|NCT00864383|19365550|P1|NOT COMPLETED|Modified Intent to Treat||85
7868659|NCT00864383|19365548|P3|COMPLETED|Modified Intent to Treat||551
7868660|NCT00864383|19365549|P2|COMPLETED|Modified Intent to Treat||568
7868661|NCT00864383|19365550|P1|COMPLETED|Modified Intent to Treat||555
7868662|NCT00864383|19365548|P3|STARTED|Modified Intent to Treat||636
7868663|NCT00864383|19365549|P2|STARTED|Modified Intent to Treat||655
7868664|NCT00864383|19365550|P1|STARTED|Modified Intent to Treat||640
7868665|NCT00864383|19365548|P3|NOT COMPLETED|Per- Protocol||112
7868666|NCT00864383|19365549|P2|NOT COMPLETED|Per- Protocol||141
7868667|NCT00864383|19365550|P1|NOT COMPLETED|Per- Protocol||130
7868668|NCT00864383|19365548|P3|COMPLETED|Per- Protocol||524
7868669|NCT00864383|19365549|P2|COMPLETED|Per- Protocol||514
7868670|NCT00864383|19365550|P1|COMPLETED|Per- Protocol||510
7868671|NCT00864383|19365548|P3|STARTED|Per- Protocol||636
7868672|NCT00864383|19365549|P2|STARTED|Per- Protocol||655
7868673|NCT00864383|19365550|P1|STARTED|Per- Protocol||640
7868674|NCT00864253|19365584|P2|NOT COMPLETED|Overall Study||58
7868675|NCT00864253|19365585|P1|NOT COMPLETED|Overall Study||99
7868676|NCT00864253|19365584|P2|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207
7868677|NCT00864253|19365585|P1|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165
7868678|NCT00864253|19365584|P2|Treated|Overall Study||258
7868679|NCT00864253|19365585|P1|Treated|Overall Study||257
7868680|NCT00864253|19365584|P2|STARTED|Overall Study||265
7868681|NCT00864253|19365585|P1|STARTED|Overall Study||264
7868682|NCT00864227|19365615|P1|NOT COMPLETED|Overall Study||4
7868683|NCT00864227|19365615|P1|COMPLETED|Overall Study||50
7868684|NCT00864227|19365615|P1|STARTED|Overall Study||54
7868685|NCT00864123|19365632|P2|NOT COMPLETED|Overall Study||0
7868686|NCT00864123|19365633|P1|NOT COMPLETED|Overall Study||0
7868687|NCT00864123|19365632|P2|COMPLETED|Overall Study||15
7868688|NCT00864123|19365633|P1|COMPLETED|Overall Study||15
7868689|NCT00864123|19365632|P2|STARTED|Overall Study||15
7868690|NCT00864123|19365633|P1|STARTED|Overall Study||15
7868691|NCT00864084|19365643|P1|NOT COMPLETED|Overall Study||3
7868692|NCT00864084|19365643|P1|COMPLETED|Overall Study||11
7868693|NCT00864084|19365643|P1|STARTED|Overall Study||14
7868694|NCT00864032|19365666|P3|NOT COMPLETED|Overall Study||0
7868695|NCT00864032|19365667|P2|NOT COMPLETED|Overall Study||0
7868696|NCT00864032|19365668|P1|NOT COMPLETED|Overall Study||0
7868697|NCT00864032|19365666|P3|COMPLETED|Overall Study||0
7868698|NCT00864032|19365667|P2|COMPLETED|Overall Study||5
7868699|NCT00864032|19365668|P1|COMPLETED|Overall Study||3
7868700|NCT00864032|19365666|P3|STARTED|Overall Study||0
7868701|NCT00864032|19365667|P2|STARTED|Overall Study||5
7868702|NCT00864032|19365668|P1|STARTED|Overall Study||3
7868703|NCT00863928|19365676|P2|NOT COMPLETED|Overall Study||0
7868704|NCT00863928|19365677|P1|NOT COMPLETED|Overall Study||36
7868705|NCT00863928|19365676|P2|COMPLETED|Overall Study||41
7868706|NCT00863928|19365677|P1|COMPLETED|Overall Study||58
7868707|NCT00863928|19365676|P2|STARTED|Overall Study||41
7868708|NCT00863928|19365677|P1|STARTED|Overall Study||94
7868709|NCT00863798|19365686|P3|NOT COMPLETED|Overall Study||25
7868710|NCT00863798|19365687|P2|NOT COMPLETED|Overall Study||30
7868711|NCT00863798|19365688|P1|NOT COMPLETED|Overall Study||32
7868712|NCT00863798|19365686|P3|COMPLETED|Overall Study||202
7868713|NCT00863798|19365687|P2|COMPLETED|Overall Study||198
7868714|NCT00863798|19365688|P1|COMPLETED|Overall Study||195
7868715|NCT00863798|19365686|P3|Treated|Overall Study||224
7868716|NCT00863798|19365687|P2|Treated|Overall Study||226
7868717|NCT00863798|19365688|P1|Treated|Overall Study||223
7868718|NCT00863798|19365686|P3|STARTED|Overall Study||227
7868719|NCT00863798|19365687|P2|STARTED|Overall Study||228
7868720|NCT00863798|19365688|P1|STARTED|Overall Study||227
7868721|NCT00863746|19365740|P2|NOT COMPLETED|Survival Follow up||280
7868722|NCT00863746|19365741|P1|NOT COMPLETED|Survival Follow up||253
7868723|NCT00863746|19365740|P2|COMPLETED|Survival Follow up||51
7868724|NCT00863746|19365741|P1|COMPLETED|Survival Follow up||45
7868725|NCT00863746|19365740|P2|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331
7868726|NCT00863746|19365741|P1|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298
7868727|NCT00863746|19365740|P2|NOT COMPLETED|Treatment||35
7868728|NCT00863746|19365741|P1|NOT COMPLETED|Treatment||71
7868729|NCT00863746|19365740|P2|COMPLETED|Treatment||318
7868730|NCT00863746|19365741|P1|COMPLETED|Treatment||279
7868731|NCT00863746|19365740|P2|Participants Received Treatment|Treatment|Safety population|351
7868732|NCT00863746|19365741|P1|Participants Received Treatment|Treatment|Safety population|346
7868733|NCT00863746|19365740|P2|STARTED|Treatment||353
7868734|NCT00863746|19365741|P1|STARTED|Treatment||350
7868735|NCT00863707|19365767|P2|NOT COMPLETED|Overall Study||3
7868736|NCT00863707|19365768|P1|NOT COMPLETED|Overall Study||4
7868737|NCT00863707|19365767|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334
7868738|NCT00863707|19365768|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170
7868739|NCT00863707|19365767|P2|STARTED|Overall Study||337
7868740|NCT00863707|19365768|P1|STARTED|Overall Study||174
7868741|NCT00863681|19365777|P3|NOT COMPLETED|Overall Study||18
7868742|NCT00863681|19365778|P2|NOT COMPLETED|Overall Study||43
7868743|NCT00863681|19365779|P1|NOT COMPLETED|Overall Study||91
7868744|NCT00863681|19365777|P3|COMPLETED|Overall Study|Completed treatment|38
7868745|NCT00863681|19365778|P2|COMPLETED|Overall Study|Completed treatment|66
7868746|NCT00863681|19365779|P1|COMPLETED|Overall Study|Completed treatment|140
7868747|NCT00863681|19365777|P3|STARTED|Overall Study||56
7868748|NCT00863681|19365778|P2|STARTED|Overall Study||109
7868749|NCT00863681|19365779|P1|STARTED|Overall Study||231
7868750|NCT00863655|19365864|P2|NOT COMPLETED|Overall Study||239
7868751|NCT00863655|19365865|P1|NOT COMPLETED|Overall Study||485
7868752|NCT00863655|19365864|P2|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
7868753|NCT00863655|19365865|P1|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
7868754|NCT00863655|19365864|P2|STARTED|Overall Study||239
7868755|NCT00863655|19365865|P1|STARTED|Overall Study||485
7868756|NCT00863551|19365892|P1|NOT COMPLETED|Overall Study||0
7868757|NCT00863551|19365892|P1|COMPLETED|Overall Study||12
7868758|NCT00863551|19365892|P1|STARTED|Overall Study||12
7868759|NCT00863512|19365902|P2|NOT COMPLETED|Overall Study||0
7868760|NCT00863512|19365903|P1|NOT COMPLETED|Overall Study||14
7868761|NCT00863512|19365902|P2|COMPLETED|Overall Study||17
7868762|NCT00863512|19365903|P1|COMPLETED|Overall Study||3
7868763|NCT00863512|19365902|P2|STARTED|Overall Study||17
7868764|NCT00863512|19365903|P1|STARTED|Overall Study||17
7868765|NCT00863434|19365909|P1|NOT COMPLETED|Overall Study||0
7868766|NCT00863434|19365909|P1|COMPLETED|Overall Study||2
7868767|NCT00863434|19365909|P1|STARTED|Overall Study||2
7868768|NCT00863356|19365915|P1|NOT COMPLETED|Overall Study||0
7868769|NCT00863356|19365915|P1|COMPLETED|Overall Study||20
7868770|NCT00863356|19365915|P1|STARTED|Overall Study||20
7868771|NCT00863343|19365921|P2|NOT COMPLETED|Overall Study||0
7868772|NCT00863343|19365922|P1|NOT COMPLETED|Overall Study||0
7868773|NCT00863343|19365921|P2|COMPLETED|Overall Study||374
7868774|NCT00863343|19365922|P1|COMPLETED|Overall Study||17
7868775|NCT00863343|19365921|P2|STARTED|Overall Study||374
7868776|NCT00863343|19365922|P1|STARTED|Overall Study||17
7868777|NCT00863330|19365934|P1|NOT COMPLETED|Overall Study||6
7868778|NCT00863330|19365934|P1|COMPLETED|Overall Study||0
7868779|NCT00863330|19365934|P1|STARTED|Overall Study||6
7868780|NCT00863317|19365940|P2|NOT COMPLETED|Overall Study||9
7868781|NCT00863317|19365941|P1|NOT COMPLETED|Overall Study||8
7868782|NCT00863317|19365940|P2|COMPLETED|Overall Study||64
7868783|NCT00863317|19365941|P1|COMPLETED|Overall Study||60
7868784|NCT00863317|19365940|P2|STARTED|Overall Study||73
7868785|NCT00863317|19365941|P1|STARTED|Overall Study||68
7868786|NCT00863265|19365947|P6|NOT COMPLETED|Overall Study||0
7868787|NCT00863265|19365948|P5|NOT COMPLETED|Overall Study||1
7868788|NCT00863265|19365949|P4|NOT COMPLETED|Overall Study||0
7868789|NCT00863265|19365950|P3|NOT COMPLETED|Overall Study||0
7868790|NCT00863265|19365951|P2|NOT COMPLETED|Overall Study||0
7868791|NCT00863265|19365952|P1|NOT COMPLETED|Overall Study||0
7868792|NCT00863265|19365947|P6|COMPLETED|Overall Study||3
7868793|NCT00863265|19365948|P5|COMPLETED|Overall Study||3
7868794|NCT00863265|19365949|P4|COMPLETED|Overall Study||4
7868795|NCT00863265|19365950|P3|COMPLETED|Overall Study||4
7868796|NCT00863265|19365951|P2|COMPLETED|Overall Study||3
7868797|NCT00863265|19365952|P1|COMPLETED|Overall Study||4
7868798|NCT00863265|19365947|P6|STARTED|Overall Study||3
7868799|NCT00863265|19365948|P5|STARTED|Overall Study||4
7868800|NCT00863265|19365949|P4|STARTED|Overall Study||4
7868801|NCT00863265|19365950|P3|STARTED|Overall Study||4
7868802|NCT00863265|19365951|P2|STARTED|Overall Study||3
7868803|NCT00863265|19365952|P1|STARTED|Overall Study||4
7868804|NCT00863122|19365968|P2|NOT COMPLETED|Overall Study||0
7868805|NCT00863122|19365969|P1|NOT COMPLETED|Overall Study||0
7868806|NCT00863122|19365968|P2|COMPLETED|Overall Study||7
7868807|NCT00863122|19365969|P1|COMPLETED|Overall Study||19
7868808|NCT00863122|19365968|P2|STARTED|Overall Study||7
7868809|NCT00863122|19365969|P1|STARTED|Overall Study||19
7868810|NCT00863109|19365980|P1|NOT COMPLETED|Follow-up Period||11
7868811|NCT00863109|19365980|P1|COMPLETED|Follow-up Period||48
7868812|NCT00863109|19365980|P1|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59
7868813|NCT00863109|19365980|P1|NOT COMPLETED|Treatment Period||77
7868814|NCT00863109|19365980|P1|COMPLETED|Treatment Period||53
7868815|NCT00863109|19365980|P1|STARTED|Treatment Period||130
7868816|NCT00863057|19365997|P4|NOT COMPLETED|Period 4 (Weeks 16-20)||0
7868817|NCT00863057|19365998|P3|NOT COMPLETED|Period 4 (Weeks 16-20)||0
7868818|NCT00863057|19365999|P2|NOT COMPLETED|Period 4 (Weeks 16-20)||0
7868819|NCT00863057|19366000|P1|NOT COMPLETED|Period 4 (Weeks 16-20)||0
7868820|NCT00863057|19365997|P4|COMPLETED|Period 4 (Weeks 16-20)||2
7868821|NCT00863057|19365998|P3|COMPLETED|Period 4 (Weeks 16-20)||2
7868822|NCT00863057|19365999|P2|COMPLETED|Period 4 (Weeks 16-20)||1
7868823|NCT00863057|19366000|P1|COMPLETED|Period 4 (Weeks 16-20)||3
7868824|NCT00863057|19365997|P4|STARTED|Period 4 (Weeks 16-20)||2
7868825|NCT00863057|19365998|P3|STARTED|Period 4 (Weeks 16-20)||2
7868826|NCT00863057|19365999|P2|STARTED|Period 4 (Weeks 16-20)||1
7868827|NCT00863057|19366000|P1|STARTED|Period 4 (Weeks 16-20)||3
7868828|NCT00863057|19365997|P4|NOT COMPLETED|Period 3 (Weeks 11-15)||0
7868829|NCT00863057|19365998|P3|NOT COMPLETED|Period 3 (Weeks 11-15)||0
7868830|NCT00863057|19365999|P2|NOT COMPLETED|Period 3 (Weeks 11-15)||0
7868831|NCT00863057|19366000|P1|NOT COMPLETED|Period 3 (Weeks 11-15)||0
7868832|NCT00863057|19365997|P4|COMPLETED|Period 3 (Weeks 11-15)||2
7868833|NCT00863057|19365998|P3|COMPLETED|Period 3 (Weeks 11-15)||2
7868834|NCT00863057|19365999|P2|COMPLETED|Period 3 (Weeks 11-15)||1
7868835|NCT00863057|19366000|P1|COMPLETED|Period 3 (Weeks 11-15)||3
7868836|NCT00863057|19365997|P4|STARTED|Period 3 (Weeks 11-15)||2
7868837|NCT00863057|19365998|P3|STARTED|Period 3 (Weeks 11-15)||2
7868838|NCT00863057|19365999|P2|STARTED|Period 3 (Weeks 11-15)||1
7868839|NCT00863057|19366000|P1|STARTED|Period 3 (Weeks 11-15)||3
7868840|NCT00863057|19365997|P4|NOT COMPLETED|Period 2 (Weeks 6-10)||1
7868841|NCT00863057|19365998|P3|NOT COMPLETED|Period 2 (Weeks 6-10)||1
7868842|NCT00863057|19365999|P2|NOT COMPLETED|Period 2 (Weeks 6-10)||1
7868843|NCT00863057|19366000|P1|NOT COMPLETED|Period 2 (Weeks 6-10)||0
7868844|NCT00863057|19365997|P4|COMPLETED|Period 2 (Weeks 6-10)||2
7868845|NCT00863057|19365998|P3|COMPLETED|Period 2 (Weeks 6-10)||2
7868846|NCT00863057|19365999|P2|COMPLETED|Period 2 (Weeks 6-10)||1
7868847|NCT00863057|19366000|P1|COMPLETED|Period 2 (Weeks 6-10)||3
7868848|NCT00863057|19365997|P4|STARTED|Period 2 (Weeks 6-10)||3
7868849|NCT00863057|19365998|P3|STARTED|Period 2 (Weeks 6-10)||3
7868850|NCT00863057|19365999|P2|STARTED|Period 2 (Weeks 6-10)||2
7868851|NCT00863057|19366000|P1|STARTED|Period 2 (Weeks 6-10)||3
7868852|NCT00863057|19365997|P4|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
7868853|NCT00863057|19365998|P3|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0
7868854|NCT00863057|19365999|P2|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2
7868855|NCT00863057|19366000|P1|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
7868856|NCT00863057|19365997|P4|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
7868857|NCT00863057|19365998|P3|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
7868858|NCT00863057|19365999|P2|COMPLETED|Milestones Period 1 (Weeks 0-5)||2
7868859|NCT00863057|19366000|P1|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
7868860|NCT00863057|19365997|P4|STARTED|Milestones Period 1 (Weeks 0-5)||4
7868861|NCT00863057|19365998|P3|STARTED|Milestones Period 1 (Weeks 0-5)||3
7868862|NCT00863057|19365999|P2|STARTED|Milestones Period 1 (Weeks 0-5)||4
7868863|NCT00863057|19366000|P1|STARTED|Milestones Period 1 (Weeks 0-5)||4
7868864|NCT00862979|19366058|P2|NOT COMPLETED|Overall Study||7
7868865|NCT00862979|19366059|P1|NOT COMPLETED|Overall Study||8
7868866|NCT00862979|19366058|P2|COMPLETED|Overall Study||71
7868867|NCT00862979|19366059|P1|COMPLETED|Overall Study||76
7868868|NCT00862979|19366058|P2|Full Analysis Set (FAS)|Overall Study||71
7868869|NCT00862979|19366059|P1|Full Analysis Set (FAS)|Overall Study||74
7868870|NCT00862979|19366058|P2|STARTED|Overall Study||78
7868871|NCT00862979|19366059|P1|STARTED|Overall Study||84
7868872|NCT00862940|19366077|P2|NOT COMPLETED|Overall Study||30
7868873|NCT00862940|19366078|P1|NOT COMPLETED|Overall Study||30
7868874|NCT00862940|19366077|P2|COMPLETED|Overall Study||114
7868875|NCT00862940|19366078|P1|COMPLETED|Overall Study||103
7868876|NCT00862940|19366077|P2|STARTED|Overall Study||144
7868877|NCT00862940|19366078|P1|STARTED|Overall Study||133
7868878|NCT00862849|19366090|P6|NOT COMPLETED|Intervention 6||0
7868879|NCT00862849|19366091|P5|NOT COMPLETED|Intervention 6||0
7868880|NCT00862849|19366092|P4|NOT COMPLETED|Intervention 6||0
7868881|NCT00862849|19366093|P3|NOT COMPLETED|Intervention 6||0
7868882|NCT00862849|19366094|P2|NOT COMPLETED|Intervention 6||0
7868883|NCT00862849|19366095|P1|NOT COMPLETED|Intervention 6||0
7868884|NCT00862849|19366090|P6|COMPLETED|Intervention 6||3
7868885|NCT00862849|19366091|P5|COMPLETED|Intervention 6||4
7868886|NCT00862849|19366092|P4|COMPLETED|Intervention 6||4
7868887|NCT00862849|19366093|P3|COMPLETED|Intervention 6||3
7868888|NCT00862849|19366094|P2|COMPLETED|Intervention 6||3
7868889|NCT00862849|19366095|P1|COMPLETED|Intervention 6||3
7868890|NCT00862849|19366090|P6|STARTED|Intervention 6||3
7868891|NCT00862849|19366091|P5|STARTED|Intervention 6||4
7868892|NCT00862849|19366092|P4|STARTED|Intervention 6||4
7868893|NCT00862849|19366093|P3|STARTED|Intervention 6||3
7868894|NCT00862849|19366094|P2|STARTED|Intervention 6||3
7868895|NCT00862849|19366095|P1|STARTED|Intervention 6||3
7868896|NCT00862849|19366090|P6|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
7868897|NCT00862849|19366091|P5|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
7868898|NCT00862849|19366092|P4|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
7868899|NCT00862849|19366093|P3|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
7868900|NCT00862849|19366094|P2|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
7868901|NCT00862849|19366095|P1|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
7868902|NCT00862849|19366090|P6|COMPLETED|Washout 5 (3 to 14 Days)||3
7868903|NCT00862849|19366091|P5|COMPLETED|Washout 5 (3 to 14 Days)||4
7868904|NCT00862849|19366092|P4|COMPLETED|Washout 5 (3 to 14 Days)||4
7868905|NCT00862849|19366093|P3|COMPLETED|Washout 5 (3 to 14 Days)||3
7868906|NCT00862849|19366094|P2|COMPLETED|Washout 5 (3 to 14 Days)||3
7868907|NCT00862849|19366095|P1|COMPLETED|Washout 5 (3 to 14 Days)||3
7868908|NCT00862849|19366090|P6|STARTED|Washout 5 (3 to 14 Days)||3
7868909|NCT00862849|19366091|P5|STARTED|Washout 5 (3 to 14 Days)||4
7868910|NCT00862849|19366092|P4|STARTED|Washout 5 (3 to 14 Days)||4
7868911|NCT00862849|19366093|P3|STARTED|Washout 5 (3 to 14 Days)||3
7868912|NCT00862849|19366094|P2|STARTED|Washout 5 (3 to 14 Days)||3
7868913|NCT00862849|19366095|P1|STARTED|Washout 5 (3 to 14 Days)||3
7868914|NCT00862849|19366090|P6|NOT COMPLETED|Intervention 5||0
7868915|NCT00862849|19366091|P5|NOT COMPLETED|Intervention 5||0
7868916|NCT00862849|19366092|P4|NOT COMPLETED|Intervention 5||0
7868917|NCT00862849|19366093|P3|NOT COMPLETED|Intervention 5||0
7868918|NCT00862849|19366094|P2|NOT COMPLETED|Intervention 5||0
7868919|NCT00862849|19366095|P1|NOT COMPLETED|Intervention 5||0
7868920|NCT00862849|19366090|P6|COMPLETED|Intervention 5||3
7868921|NCT00862849|19366091|P5|COMPLETED|Intervention 5||4
7868922|NCT00862849|19366092|P4|COMPLETED|Intervention 5||4
7868923|NCT00862849|19366093|P3|COMPLETED|Intervention 5||3
7868924|NCT00862849|19366094|P2|COMPLETED|Intervention 5||3
7868925|NCT00862849|19366095|P1|COMPLETED|Intervention 5||3
7868926|NCT00862849|19366090|P6|STARTED|Intervention 5||3
7868927|NCT00862849|19366091|P5|STARTED|Intervention 5||4
7868928|NCT00862849|19366092|P4|STARTED|Intervention 5||4
7868929|NCT00862849|19366093|P3|STARTED|Intervention 5||3
7868930|NCT00862849|19366094|P2|STARTED|Intervention 5||3
7868931|NCT00862849|19366095|P1|STARTED|Intervention 5||3
7868932|NCT00862849|19366090|P6|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
7868933|NCT00862849|19366091|P5|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
7868934|NCT00862849|19366092|P4|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
7868935|NCT00862849|19366093|P3|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
7868936|NCT00862849|19366094|P2|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
7868937|NCT00862849|19366095|P1|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
7868938|NCT00862849|19366090|P6|COMPLETED|Washout 4 (3 to 14 Days)||3
7868939|NCT00862849|19366091|P5|COMPLETED|Washout 4 (3 to 14 Days)||4
7868940|NCT00862849|19366092|P4|COMPLETED|Washout 4 (3 to 14 Days)||4
7868941|NCT00862849|19366093|P3|COMPLETED|Washout 4 (3 to 14 Days)||3
7868942|NCT00862849|19366094|P2|COMPLETED|Washout 4 (3 to 14 Days)||3
7868943|NCT00862849|19366095|P1|COMPLETED|Washout 4 (3 to 14 Days)||3
7868944|NCT00862849|19366090|P6|STARTED|Washout 4 (3 to 14 Days)||3
7868945|NCT00862849|19366091|P5|STARTED|Washout 4 (3 to 14 Days)||4
7868946|NCT00862849|19366092|P4|STARTED|Washout 4 (3 to 14 Days)||4
7868947|NCT00862849|19366093|P3|STARTED|Washout 4 (3 to 14 Days)||3
7868948|NCT00862849|19366094|P2|STARTED|Washout 4 (3 to 14 Days)||3
7868949|NCT00862849|19366095|P1|STARTED|Washout 4 (3 to 14 Days)||3
7868950|NCT00862849|19366090|P6|NOT COMPLETED|Intervention 4||0
7868951|NCT00862849|19366091|P5|NOT COMPLETED|Intervention 4||0
7868952|NCT00862849|19366092|P4|NOT COMPLETED|Intervention 4||0
7868953|NCT00862849|19366093|P3|NOT COMPLETED|Intervention 4||0
7868954|NCT00862849|19366094|P2|NOT COMPLETED|Intervention 4||0
7868955|NCT00862849|19366095|P1|NOT COMPLETED|Intervention 4||0
7868956|NCT00862849|19366090|P6|COMPLETED|Intervention 4||3
7868957|NCT00862849|19366091|P5|COMPLETED|Intervention 4||4
7868958|NCT00862849|19366092|P4|COMPLETED|Intervention 4||4
7868959|NCT00862849|19366093|P3|COMPLETED|Intervention 4||3
7868960|NCT00862849|19366094|P2|COMPLETED|Intervention 4||3
7868961|NCT00862849|19366095|P1|COMPLETED|Intervention 4||3
7868962|NCT00862849|19366090|P6|STARTED|Intervention 4||3
7868963|NCT00862849|19366091|P5|STARTED|Intervention 4||4
7868964|NCT00862849|19366092|P4|STARTED|Intervention 4||4
7868965|NCT00862849|19366093|P3|STARTED|Intervention 4||3
7868966|NCT00862849|19366094|P2|STARTED|Intervention 4||3
7868967|NCT00862849|19366095|P1|STARTED|Intervention 4||3
7868968|NCT00862849|19366090|P6|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
7868969|NCT00862849|19366091|P5|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
7868970|NCT00862849|19366092|P4|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
7868971|NCT00862849|19366093|P3|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
7868972|NCT00862849|19366094|P2|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
7868973|NCT00862849|19366095|P1|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
7868974|NCT00862849|19366090|P6|COMPLETED|Washout 3 (3 to 14 Days)||3
7868975|NCT00862849|19366091|P5|COMPLETED|Washout 3 (3 to 14 Days)||4
7868976|NCT00862849|19366092|P4|COMPLETED|Washout 3 (3 to 14 Days)||4
7868977|NCT00862849|19366093|P3|COMPLETED|Washout 3 (3 to 14 Days)||3
7868978|NCT00862849|19366094|P2|COMPLETED|Washout 3 (3 to 14 Days)||3
7868979|NCT00862849|19366095|P1|COMPLETED|Washout 3 (3 to 14 Days)||3
7868980|NCT00862849|19366090|P6|STARTED|Washout 3 (3 to 14 Days)||3
7868981|NCT00862849|19366091|P5|STARTED|Washout 3 (3 to 14 Days)||4
7868982|NCT00862849|19366092|P4|STARTED|Washout 3 (3 to 14 Days)||4
7868983|NCT00862849|19366093|P3|STARTED|Washout 3 (3 to 14 Days)||3
7868984|NCT00862849|19366094|P2|STARTED|Washout 3 (3 to 14 Days)||3
7868985|NCT00862849|19366095|P1|STARTED|Washout 3 (3 to 14 Days)||3
7868986|NCT00862849|19366090|P6|NOT COMPLETED|Intervention 3||0
7868987|NCT00862849|19366091|P5|NOT COMPLETED|Intervention 3||0
7868988|NCT00862849|19366092|P4|NOT COMPLETED|Intervention 3||0
7868989|NCT00862849|19366093|P3|NOT COMPLETED|Intervention 3||0
7868990|NCT00862849|19366094|P2|NOT COMPLETED|Intervention 3||0
7868991|NCT00862849|19366095|P1|NOT COMPLETED|Intervention 3||0
7868992|NCT00862849|19366090|P6|COMPLETED|Intervention 3||3
7868993|NCT00862849|19366091|P5|COMPLETED|Intervention 3||4
7868994|NCT00862849|19366092|P4|COMPLETED|Intervention 3||4
7868995|NCT00862849|19366093|P3|COMPLETED|Intervention 3||3
7868996|NCT00862849|19366094|P2|COMPLETED|Intervention 3||3
7868997|NCT00862849|19366095|P1|COMPLETED|Intervention 3||3
7868998|NCT00862849|19366090|P6|STARTED|Intervention 3||3
7868999|NCT00862849|19366091|P5|STARTED|Intervention 3||4
7869000|NCT00862849|19366092|P4|STARTED|Intervention 3||4
7869001|NCT00862849|19366093|P3|STARTED|Intervention 3||3
7869002|NCT00862849|19366094|P2|STARTED|Intervention 3||3
7869003|NCT00862849|19366095|P1|STARTED|Intervention 3||3
7869004|NCT00862849|19366090|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
7869005|NCT00862849|19366091|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
7869006|NCT00862849|19366092|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
7869007|NCT00862849|19366093|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
7869008|NCT00862849|19366094|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||1
7869009|NCT00862849|19366095|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
7869010|NCT00862849|19366090|P6|COMPLETED|Washout 2 (3 to 14 Days)||3
7869011|NCT00862849|19366091|P5|COMPLETED|Washout 2 (3 to 14 Days)||4
7869012|NCT00862849|19366092|P4|COMPLETED|Washout 2 (3 to 14 Days)||4
7869013|NCT00862849|19366093|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
7869014|NCT00862849|19366094|P2|COMPLETED|Washout 2 (3 to 14 Days)||3
7869015|NCT00862849|19366095|P1|COMPLETED|Washout 2 (3 to 14 Days)||3
7869016|NCT00862849|19366090|P6|STARTED|Washout 2 (3 to 14 Days)||3
7869017|NCT00862849|19366091|P5|STARTED|Washout 2 (3 to 14 Days)||4
7869018|NCT00862849|19366092|P4|STARTED|Washout 2 (3 to 14 Days)||4
7869019|NCT00862849|19366093|P3|STARTED|Washout 2 (3 to 14 Days)||3
7869020|NCT00862849|19366094|P2|STARTED|Washout 2 (3 to 14 Days)||4
7869021|NCT00862849|19366095|P1|STARTED|Washout 2 (3 to 14 Days)||3
7869022|NCT00862849|19366090|P6|NOT COMPLETED|Intervention 2||0
7869023|NCT00862849|19366091|P5|NOT COMPLETED|Intervention 2||0
7869024|NCT00862849|19366092|P4|NOT COMPLETED|Intervention 2||0
7869025|NCT00862849|19366093|P3|NOT COMPLETED|Intervention 2||0
7869026|NCT00862849|19366094|P2|NOT COMPLETED|Intervention 2||0
7869027|NCT00862849|19366095|P1|NOT COMPLETED|Intervention 2||0
7869028|NCT00862849|19366090|P6|COMPLETED|Intervention 2||3
7869029|NCT00862849|19366091|P5|COMPLETED|Intervention 2||4
7869030|NCT00862849|19366092|P4|COMPLETED|Intervention 2||4
7869031|NCT00862849|19366093|P3|COMPLETED|Intervention 2||3
7869032|NCT00862849|19366094|P2|COMPLETED|Intervention 2||4
7869033|NCT00862849|19366095|P1|COMPLETED|Intervention 2||3
7869034|NCT00862849|19366090|P6|STARTED|Intervention 2||3
7869035|NCT00862849|19366091|P5|STARTED|Intervention 2||4
7869036|NCT00862849|19366092|P4|STARTED|Intervention 2||4
7869037|NCT00862849|19366093|P3|STARTED|Intervention 2||3
7869038|NCT00862849|19366094|P2|STARTED|Intervention 2||4
7869039|NCT00862849|19366095|P1|STARTED|Intervention 2||3
7869040|NCT00862849|19366090|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
7869041|NCT00862849|19366091|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
7869042|NCT00862849|19366092|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
7869043|NCT00862849|19366093|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
7869044|NCT00862849|19366094|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||1
7869045|NCT00862849|19366095|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
7869046|NCT00862849|19366090|P6|COMPLETED|Washout 1 (3 to 14 Days)||3
7869047|NCT00862849|19366091|P5|COMPLETED|Washout 1 (3 to 14 Days)||4
7869048|NCT00862849|19366092|P4|COMPLETED|Washout 1 (3 to 14 Days)||4
7869049|NCT00862849|19366093|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
7869050|NCT00862849|19366094|P2|COMPLETED|Washout 1 (3 to 14 Days)||4
7869051|NCT00862849|19366095|P1|COMPLETED|Washout 1 (3 to 14 Days)||3
7869052|NCT00862849|19366090|P6|STARTED|Washout 1 (3 to 14 Days)||3
7869053|NCT00862849|19366091|P5|STARTED|Washout 1 (3 to 14 Days)||4
7869054|NCT00862849|19366092|P4|STARTED|Washout 1 (3 to 14 Days)||4
7869055|NCT00862849|19366093|P3|STARTED|Washout 1 (3 to 14 Days)||3
7869056|NCT00862849|19366094|P2|STARTED|Washout 1 (3 to 14 Days)||5
7869057|NCT00862849|19366095|P1|STARTED|Washout 1 (3 to 14 Days)||3
7869058|NCT00862849|19366090|P6|NOT COMPLETED|Intervention 1||0
7869059|NCT00862849|19366091|P5|NOT COMPLETED|Intervention 1||0
7869060|NCT00862849|19366092|P4|NOT COMPLETED|Intervention 1||0
7869061|NCT00862849|19366093|P3|NOT COMPLETED|Intervention 1||0
7869062|NCT00862849|19366094|P2|NOT COMPLETED|Intervention 1||0
7869063|NCT00862849|19366095|P1|NOT COMPLETED|Intervention 1||0
7869064|NCT00862849|19366090|P6|COMPLETED|Intervention 1||3
7869065|NCT00862849|19366091|P5|COMPLETED|Intervention 1||4
7869066|NCT00862849|19366092|P4|COMPLETED|Intervention 1||4
7869067|NCT00862849|19366093|P3|COMPLETED|Intervention 1||3
7869068|NCT00862849|19366094|P2|COMPLETED|Intervention 1||5
7869069|NCT00862849|19366095|P1|COMPLETED|Intervention 1||3
7869070|NCT00862849|19366090|P6|Received at Least One Dose of Study Drug|Intervention 1||3
7869071|NCT00862849|19366091|P5|Received at Least One Dose of Study Drug|Intervention 1||4
7869072|NCT00862849|19366092|P4|Received at Least One Dose of Study Drug|Intervention 1||4
7869073|NCT00862849|19366093|P3|Received at Least One Dose of Study Drug|Intervention 1||3
7869074|NCT00862849|19366094|P2|Received at Least One Dose of Study Drug|Intervention 1||5
7869075|NCT00862849|19366095|P1|Received at Least One Dose of Study Drug|Intervention 1||3
7869076|NCT00862849|19366090|P6|STARTED|Intervention 1||3
7869077|NCT00862849|19366091|P5|STARTED|Intervention 1||4
7869078|NCT00862849|19366092|P4|STARTED|Intervention 1||4
7869079|NCT00862849|19366093|P3|STARTED|Intervention 1||3
7869080|NCT00862849|19366094|P2|STARTED|Intervention 1||5
7869081|NCT00862849|19366095|P1|STARTED|Intervention 1||3
7869082|NCT00862836|19366118|P1|NOT COMPLETED|Overall Study||1
7869083|NCT00862836|19366118|P1|COMPLETED|Overall Study||14
7869084|NCT00862836|19366118|P1|Evaluable for Activity (Tumour Response)|Overall Study||10
7869085|NCT00862836|19366118|P1|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14
7869086|NCT00862836|19366118|P1|STARTED|Overall Study||15
7869087|NCT00862823|19366129|P2|NOT COMPLETED|Second Intervention||0
7869088|NCT00862823|19366130|P1|NOT COMPLETED|Second Intervention||0
7869089|NCT00862823|19366129|P2|COMPLETED|Second Intervention||9
7869090|NCT00862823|19366130|P1|COMPLETED|Second Intervention||5
7869091|NCT00862823|19366129|P2|STARTED|Second Intervention||9
7869092|NCT00862823|19366130|P1|STARTED|Second Intervention||5
7869093|NCT00862823|19366129|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
7869094|NCT00862823|19366130|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
7869095|NCT00862823|19366129|P2|COMPLETED|Washout Period of 2 Weeks||9
7869096|NCT00862823|19366130|P1|COMPLETED|Washout Period of 2 Weeks||5
7869097|NCT00862823|19366129|P2|STARTED|Washout Period of 2 Weeks||9
7869098|NCT00862823|19366130|P1|STARTED|Washout Period of 2 Weeks||5
7869099|NCT00862823|19366129|P2|NOT COMPLETED|First Intervention||1
7869100|NCT00862823|19366130|P1|NOT COMPLETED|First Intervention||1
7869101|NCT00862823|19366129|P2|COMPLETED|First Intervention||9
7869102|NCT00862823|19366130|P1|COMPLETED|First Intervention||5
7869103|NCT00862823|19366129|P2|STARTED|First Intervention||10
7869104|NCT00862823|19366130|P1|STARTED|First Intervention||6
7869105|NCT00862810|19366139|P2|NOT COMPLETED|Overall Study||4
7869106|NCT00862810|19366140|P1|NOT COMPLETED|Overall Study||4
7869107|NCT00862810|19366139|P2|COMPLETED|Overall Study||35
7869108|NCT00862810|19366140|P1|COMPLETED|Overall Study||29
7869109|NCT00862810|19366139|P2|STARTED|Overall Study||39
7869110|NCT00862810|19366140|P1|STARTED|Overall Study||33
7869111|NCT00862784|19366146|P1|NOT COMPLETED|Overall Study||0
7869112|NCT00862784|19366146|P1|COMPLETED|Overall Study||48
7869113|NCT00862784|19366146|P1|Received Any Amount of Study Drug|Overall Study||48
7869114|NCT00862784|19366146|P1|STARTED|Overall Study||48
7869115|NCT00862745|19366168|P2|NOT COMPLETED|Open-label Follow-up||49
7869116|NCT00862745|19366169|P1|NOT COMPLETED|Open-label Follow-up||39
7869117|NCT00862745|19366168|P2|COMPLETED|Open-label Follow-up||225
7869118|NCT00862745|19366169|P1|COMPLETED|Open-label Follow-up||229
7869119|NCT00862745|19366168|P2|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274
7869120|NCT00862745|19366169|P1|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268
7869121|NCT00862745|19366168|P2|NOT COMPLETED|Randomized Control Trial||39
7869122|NCT00862745|19366169|P1|NOT COMPLETED|Randomized Control Trial||38
7869123|NCT00862745|19366168|P2|COMPLETED|Randomized Control Trial||284
7869124|NCT00862745|19366169|P1|COMPLETED|Randomized Control Trial||284
7869125|NCT00862745|19366168|P2|STARTED|Randomized Control Trial||323
7869126|NCT00862745|19366169|P1|STARTED|Randomized Control Trial||322
7869127|NCT00862719|19366179|P4|NOT COMPLETED|Overall Study||1
7869128|NCT00862719|19366180|P3|NOT COMPLETED|Overall Study||4
7869129|NCT00862719|19366181|P2|NOT COMPLETED|Overall Study||6
7869130|NCT00862719|19366182|P1|NOT COMPLETED|Overall Study||10
7869131|NCT00862719|19366179|P4|COMPLETED|Overall Study||0
7869132|NCT00862719|19366180|P3|COMPLETED|Overall Study||0
7869133|NCT00862719|19366181|P2|COMPLETED|Overall Study||1
7869134|NCT00862719|19366182|P1|COMPLETED|Overall Study||7
7869135|NCT00862719|19366179|P4|STARTED|Overall Study||1
7869136|NCT00862719|19366180|P3|STARTED|Overall Study||4
7869137|NCT00862719|19366181|P2|STARTED|Overall Study||7
7869138|NCT00862719|19366182|P1|STARTED|Overall Study||17
7869139|NCT00862654|19366205|P4|NOT COMPLETED|Overall Study||6
7869140|NCT00862654|19366206|P3|NOT COMPLETED|Overall Study||6
7869141|NCT00862654|19366207|P2|NOT COMPLETED|Overall Study||8
7869142|NCT00862654|19366208|P1|NOT COMPLETED|Overall Study||6
7869143|NCT00862654|19366205|P4|COMPLETED|Overall Study||74
7869144|NCT00862654|19366206|P3|COMPLETED|Overall Study||76
7869145|NCT00862654|19366207|P2|COMPLETED|Overall Study||74
7869146|NCT00862654|19366208|P1|COMPLETED|Overall Study||76
7869147|NCT00862654|19366205|P4|STARTED|Overall Study||80
7869148|NCT00862654|19366206|P3|STARTED|Overall Study||82
7869149|NCT00862654|19366207|P2|STARTED|Overall Study||82
7869150|NCT00862654|19366208|P1|STARTED|Overall Study||82
7869151|NCT00862641|19366222|P4|NOT COMPLETED|Overall Study||4
7869152|NCT00862641|19366223|P3|NOT COMPLETED|Overall Study||1
7869153|NCT00862641|19366224|P2|NOT COMPLETED|Overall Study||4
7869154|NCT00862641|19366225|P1|NOT COMPLETED|Overall Study||1
7869155|NCT00862641|19366222|P4|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316
7869156|NCT00862641|19366223|P3|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151
7869157|NCT00862641|19366224|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356
7869158|NCT00862641|19366225|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176
7869159|NCT00862641|19366222|P4|STARTED|Overall Study||320
7869160|NCT00862641|19366223|P3|STARTED|Overall Study||152
7869161|NCT00862641|19366224|P2|STARTED|Overall Study||360
7869162|NCT00862641|19366225|P1|STARTED|Overall Study||177
7869163|NCT00862563|19366271|P4|NOT COMPLETED|Overall Study||5
7869164|NCT00862563|19366272|P3|NOT COMPLETED|Overall Study||6
7869165|NCT00862563|19366273|P2|NOT COMPLETED|Overall Study||4
7869166|NCT00862563|19366274|P1|NOT COMPLETED|Overall Study||4
7869167|NCT00862563|19366271|P4|COMPLETED|Overall Study||19
7869168|NCT00862563|19366272|P3|COMPLETED|Overall Study||15
7869169|NCT00862563|19366273|P2|COMPLETED|Overall Study||17
7869170|NCT00862563|19366274|P1|COMPLETED|Overall Study||15
7869171|NCT00862563|19366271|P4|STARTED|Overall Study||24
7869172|NCT00862563|19366272|P3|STARTED|Overall Study||21
7869173|NCT00862563|19366273|P2|STARTED|Overall Study||21
7869174|NCT00862563|19366274|P1|STARTED|Overall Study||19
7869175|NCT00862537|19366312|P1|NOT COMPLETED|Overall Study||7
7869176|NCT00862537|19366312|P1|COMPLETED|Overall Study||11
7869177|NCT00862537|19366312|P1|STARTED|Overall Study||18
7869178|NCT00862459|19366319|P3|NOT COMPLETED|Overall Study||6
7869179|NCT00862459|19366320|P2|NOT COMPLETED|Overall Study||8
7869180|NCT00862459|19366321|P1|NOT COMPLETED|Overall Study||6
7869181|NCT00862459|19366319|P3|COMPLETED|Overall Study||66
7869182|NCT00862459|19366320|P2|COMPLETED|Overall Study||85
7869183|NCT00862459|19366321|P1|COMPLETED|Overall Study||66
7869184|NCT00862459|19366319|P3|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69
7869185|NCT00862459|19366320|P2|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90
7869186|NCT00862459|19366321|P1|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70
7869187|NCT00862459|19366319|P3|STARTED|Overall Study||72
7869188|NCT00862459|19366320|P2|STARTED|Overall Study||93
7869189|NCT00862459|19366321|P1|STARTED|Overall Study||72
7869190|NCT00862446|19366465|P1|NOT COMPLETED|Overall Study||0
7869191|NCT00862446|19366465|P1|COMPLETED|Overall Study||48
7869192|NCT00862446|19366465|P1|STARTED|Overall Study||48
7869193|NCT00862277|19366472|P3|NOT COMPLETED|Overall Study||5
7869194|NCT00862277|19366473|P2|NOT COMPLETED|Overall Study||2
7869195|NCT00862277|19366474|P1|NOT COMPLETED|Overall Study||1
7869196|NCT00862277|19366472|P3|COMPLETED|Overall Study||100
7869197|NCT00862277|19366473|P2|COMPLETED|Overall Study||94
7869198|NCT00862277|19366474|P1|COMPLETED|Overall Study||560
7869199|NCT00862277|19366472|P3|STARTED|Overall Study||105
7869200|NCT00862277|19366473|P2|STARTED|Overall Study||96
7869201|NCT00862277|19366474|P1|STARTED|Overall Study||561
7869202|NCT00862251|19366488|P3|NOT COMPLETED|Overall Study||9
7869203|NCT00862251|19366489|P2|NOT COMPLETED|Overall Study||5
7869204|NCT00862251|19366490|P1|NOT COMPLETED|Overall Study||19
7869205|NCT00862251|19366488|P3|COMPLETED|Overall Study||315
7869206|NCT00862251|19366489|P2|COMPLETED|Overall Study||157
7869207|NCT00862251|19366490|P1|COMPLETED|Overall Study||303
7869208|NCT00862251|19366488|P3|STARTED|Overall Study||324
7869209|NCT00862251|19366489|P2|STARTED|Overall Study||162
7869210|NCT00862251|19366490|P1|STARTED|Overall Study||322
7869211|NCT00862186|19366543|P1|NOT COMPLETED|Overall Study||0
7869212|NCT00862186|19366543|P1|COMPLETED|Overall Study||15
7869213|NCT00862186|19366543|P1|STARTED|Overall Study||15
7869214|NCT00862134|19366550|P2|NOT COMPLETED|Overall Study||12
7869215|NCT00862134|19366551|P1|NOT COMPLETED|Overall Study||11
7869216|NCT00862134|19366550|P2|COMPLETED|Overall Study||11
7869217|NCT00862134|19366551|P1|COMPLETED|Overall Study||8
7869218|NCT00862134|19366550|P2|STARTED|Overall Study||23
7869219|NCT00862134|19366551|P1|STARTED|Overall Study||19
7869220|NCT00862121|19366563|P2|NOT COMPLETED|Overall Study||8
7869221|NCT00862121|19366564|P1|NOT COMPLETED|Overall Study||1
7869222|NCT00862121|19366563|P2|COMPLETED|Overall Study||4
7869223|NCT00862121|19366564|P1|COMPLETED|Overall Study||7
7869224|NCT00862121|19366563|P2|Safety Analysis Set|Overall Study||11
7869225|NCT00862121|19366564|P1|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8
7869226|NCT00862121|19366563|P2|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11
7869227|NCT00862121|19366564|P1|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7
7869228|NCT00862121|19366563|P2|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12
7869229|NCT00862121|19366564|P1|STARTED|Overall Study||8
7869230|NCT00862082|19366582|P2|NOT COMPLETED|Overall Study||1
7869231|NCT00862082|19366583|P1|NOT COMPLETED|Overall Study||5
7869232|NCT00862082|19366582|P2|COMPLETED|Overall Study||5
7869233|NCT00862082|19366583|P1|COMPLETED|Overall Study||3
7869234|NCT00862082|19366582|P2|STARTED|Overall Study||6
7869235|NCT00862082|19366583|P1|STARTED|Overall Study||8
7869236|NCT00861913|19366626|P1|NOT COMPLETED|Overall Study||0
7869237|NCT00861913|19366626|P1|COMPLETED|Overall Study||13
7869238|NCT00861913|19366626|P1|STARTED|Overall Study||13
7869239|NCT00861757|19366638|P4|NOT COMPLETED|Overall Study||9
7869240|NCT00861757|19366639|P3|NOT COMPLETED|Overall Study||18
7869241|NCT00861757|19366640|P2|NOT COMPLETED|Overall Study||15
7869242|NCT00861757|19366641|P1|NOT COMPLETED|Overall Study||9
7869243|NCT00861757|19366638|P4|COMPLETED|Overall Study||143
7869244|NCT00861757|19366639|P3|COMPLETED|Overall Study||137
7869245|NCT00861757|19366640|P2|COMPLETED|Overall Study||136
7869246|NCT00861757|19366641|P1|COMPLETED|Overall Study||145
7869247|NCT00861757|19366638|P4|STARTED|Overall Study||152
7869248|NCT00861757|19366639|P3|STARTED|Overall Study||155
7869249|NCT00861757|19366640|P2|STARTED|Overall Study||151
7869250|NCT00861757|19366641|P1|STARTED|Overall Study||154
7869251|NCT00861744|19366699|P4|NOT COMPLETED|Overall Study||33
7869252|NCT00861744|19366700|P3|NOT COMPLETED|Overall Study||24
7869253|NCT00861744|19366701|P2|NOT COMPLETED|Overall Study||29
7869254|NCT00861744|19366702|P1|NOT COMPLETED|Overall Study||17
7869255|NCT00861744|19366699|P4|COMPLETED|Overall Study||275
7869256|NCT00861744|19366700|P3|COMPLETED|Overall Study||280
7869257|NCT00861744|19366701|P2|COMPLETED|Overall Study||275
7869258|NCT00861744|19366702|P1|COMPLETED|Overall Study||287
7869259|NCT00861744|19366699|P4|STARTED|Overall Study||308
7869260|NCT00861744|19366700|P3|STARTED|Overall Study||304
7869261|NCT00861744|19366701|P2|STARTED|Overall Study||304
7869262|NCT00861744|19366702|P1|STARTED|Overall Study||304
7869263|NCT00861705|19366884|P4|NOT COMPLETED|Overall Study||1
7869264|NCT00861705|19366885|P3|NOT COMPLETED|Overall Study||0
7869265|NCT00861705|19366886|P2|NOT COMPLETED|Overall Study||3
7869266|NCT00861705|19366887|P1|NOT COMPLETED|Overall Study||7
7869267|NCT00861705|19366884|P4|COMPLETED|Overall Study||112
7869268|NCT00861705|19366885|P3|COMPLETED|Overall Study||113
7869269|NCT00861705|19366886|P2|COMPLETED|Overall Study||110
7869270|NCT00861705|19366887|P1|COMPLETED|Overall Study||108
7869271|NCT00861705|19366884|P4|STARTED|Overall Study||113
7869272|NCT00861705|19366885|P3|STARTED|Overall Study||113
7869273|NCT00861705|19366886|P2|STARTED|Overall Study||113
7869274|NCT00861705|19366887|P1|STARTED|Overall Study||115
7869275|NCT00861692|19366927|P1|NOT COMPLETED|Overall Study||6
7869276|NCT00861692|19366927|P1|COMPLETED|Overall Study||14
7869277|NCT00861692|19366927|P1|STARTED|Overall Study||20
7869278|NCT00861614|19366939|P2|NOT COMPLETED|Overall Study||368
7869279|NCT00861614|19366940|P1|NOT COMPLETED|Overall Study||371
7869280|NCT00861614|19366939|P2|COMPLETED|Overall Study||28
7869281|NCT00861614|19366940|P1|COMPLETED|Overall Study||22
7869282|NCT00861614|19366939|P2|STARTED|Overall Study||396
7869283|NCT00861614|19366940|P1|STARTED|Overall Study||393
7869284|NCT00861601|19366973|P3|NOT COMPLETED|Overall Study||0
7869285|NCT00861601|19366974|P2|NOT COMPLETED|Overall Study||0
7869286|NCT00861601|19366975|P1|NOT COMPLETED|Overall Study||0
7869287|NCT00861601|19366973|P3|COMPLETED|Overall Study||12
7869288|NCT00861601|19366974|P2|COMPLETED|Overall Study||14
7869289|NCT00861601|19366975|P1|COMPLETED|Overall Study||12
7869290|NCT00861601|19366973|P3|STARTED|Overall Study||12
7869291|NCT00861601|19366974|P2|STARTED|Overall Study||14
7869292|NCT00861601|19366975|P1|STARTED|Overall Study||12
7869293|NCT00861471|19367025|P1|NOT COMPLETED|Overall Study||9
7869294|NCT00861471|19367025|P1|COMPLETED|Overall Study||3
7869295|NCT00861471|19367025|P1|STARTED|Overall Study||12
7869296|NCT00861380|19367040|P7|NOT COMPLETED|Overall Study||3020
7869297|NCT00861380|19367041|P6|NOT COMPLETED|Overall Study||6249
7869298|NCT00861380|19367042|P5|NOT COMPLETED|Overall Study||1812
7869299|NCT00861380|19367043|P4|NOT COMPLETED|Overall Study||3689
7869300|NCT00861380|19367044|P3|NOT COMPLETED|Overall Study||8872
7869301|NCT00861380|19367045|P2|NOT COMPLETED|Overall Study||9112
7869302|NCT00861380|19367046|P1|NOT COMPLETED|Overall Study||8427
7869303|NCT00861380|19367040|P7|COMPLETED|Overall Study||0
7869304|NCT00861380|19367041|P6|COMPLETED|Overall Study||0
7869305|NCT00861380|19367042|P5|COMPLETED|Overall Study||0
7869306|NCT00861380|19367043|P4|COMPLETED|Overall Study||0
7869307|NCT00861380|19367044|P3|COMPLETED|Overall Study||0
7869308|NCT00861380|19367045|P2|COMPLETED|Overall Study||0
7869309|NCT00861380|19367046|P1|COMPLETED|Overall Study||0
7869310|NCT00861380|19367040|P7|STARTED|Overall Study||3020
7869311|NCT00861380|19367041|P6|STARTED|Overall Study||6249
7869312|NCT00861380|19367042|P5|STARTED|Overall Study||1812
7869313|NCT00861380|19367043|P4|STARTED|Overall Study||3689
7869314|NCT00861380|19367044|P3|STARTED|Overall Study||8872
7869315|NCT00861380|19367045|P2|STARTED|Overall Study||9112
7869316|NCT00861380|19367046|P1|STARTED|Overall Study||8427
7869317|NCT00861341|19367142|P1|NOT COMPLETED|Overall Study||2
7869318|NCT00861341|19367142|P1|COMPLETED|Overall Study||38
7869319|NCT00861341|19367142|P1|STARTED|Overall Study||40
7869320|NCT00861263|19367147|P1|NOT COMPLETED|Overall Study||0
7869321|NCT00861263|19367147|P1|COMPLETED|Overall Study||193
7869322|NCT00861263|19367147|P1|STARTED|Overall Study||193
7869323|NCT00861198|19367151|P1|NOT COMPLETED|Overall Study||5
7869324|NCT00861198|19367151|P1|COMPLETED|Overall Study||70
7869325|NCT00861198|19367151|P1|STARTED|Overall Study||75
7869326|NCT00861146|19367157|P2|NOT COMPLETED|Overall Study||8
7869327|NCT00861146|19367158|P1|NOT COMPLETED|Overall Study||20
7869328|NCT00861146|19367157|P2|COMPLETED|Overall Study||38
7869329|NCT00861146|19367158|P1|COMPLETED|Overall Study||85
7869330|NCT00861146|19367157|P2|Week 13 Assessment|Overall Study||38
7869331|NCT00861146|19367158|P1|Week 13 Assessment|Overall Study||85
7869332|NCT00861146|19367157|P2|Week 2 Assessment|Overall Study||45
7869333|NCT00861146|19367158|P1|Week 2 Assessment|Overall Study||97
7869334|NCT00861146|19367157|P2|STARTED|Overall Study||46
7869335|NCT00861146|19367158|P1|STARTED|Overall Study||105
7869336|NCT00860951|19367168|P1|NOT COMPLETED|Overall Study||7
7869337|NCT00860951|19367168|P1|COMPLETED|Overall Study||22
7869338|NCT00860951|19367168|P1|STARTED|Overall Study||29
7869339|NCT00860938|19367176|P2|NOT COMPLETED|Overall Study||8
7869340|NCT00860938|19367177|P1|NOT COMPLETED|Overall Study||14
7869341|NCT00860938|19367176|P2|COMPLETED|Overall Study||37
7869342|NCT00860938|19367177|P1|COMPLETED|Overall Study||31
7869343|NCT00860938|19367176|P2|STARTED|Overall Study||45
7869344|NCT00860938|19367177|P1|STARTED|Overall Study||45
7869345|NCT00860847|19367191|P2|NOT COMPLETED|Overall Study||5
7869346|NCT00860847|19367192|P1|NOT COMPLETED|Overall Study||4
7869347|NCT00860847|19367191|P2|COMPLETED|Overall Study||28
7869348|NCT00860847|19367192|P1|COMPLETED|Overall Study||28
7869349|NCT00860847|19367191|P2|STARTED|Overall Study||33
7869350|NCT00860847|19367192|P1|STARTED|Overall Study||32
7869351|NCT00860795|19367200|P2|NOT COMPLETED|Overall Study||0
7869352|NCT00860795|19367201|P1|NOT COMPLETED|Overall Study||0
7869353|NCT00860795|19367200|P2|COMPLETED|Overall Study||10
7869354|NCT00860795|19367201|P1|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10
7869355|NCT00860795|19367200|P2|Number to Complete Study Medication|Overall Study||10
7869356|NCT00860795|19367201|P1|Number to Complete Study Medication|Overall Study||9
7869357|NCT00860795|19367200|P2|STARTED|Overall Study||10
7869358|NCT00860795|19367201|P1|STARTED|Overall Study||10
7869359|NCT00860743|19367225|P2|NOT COMPLETED|Overall Study||0
7869360|NCT00860743|19367226|P1|NOT COMPLETED|Overall Study||3
7869361|NCT00860743|19367225|P2|COMPLETED|Overall Study||23
7869362|NCT00860743|19367226|P1|COMPLETED|Overall Study||37
7869363|NCT00860743|19367225|P2|STARTED|Overall Study||23
7869364|NCT00860743|19367226|P1|STARTED|Overall Study||40
7869365|NCT00860535|19367232|P1|NOT COMPLETED|Overall Study||1
7869366|NCT00860535|19367232|P1|COMPLETED|Overall Study||8
7869367|NCT00860535|19367232|P1|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1
7869368|NCT00860535|19367232|P1|STARTED|Overall Study||9
7869369|NCT00860470|19367239|P2|NOT COMPLETED|Overall Study||59
7869370|NCT00860470|19367240|P1|NOT COMPLETED|Overall Study||48
7869371|NCT00860470|19367239|P2|COMPLETED|Overall Study||22346
7869372|NCT00860470|19367240|P1|COMPLETED|Overall Study||22114
7869373|NCT00860470|19367239|P2|STARTED|Overall Study||22405
7869374|NCT00860470|19367240|P1|STARTED|Overall Study||22162
7869375|NCT00860457|19367264|P1|NOT COMPLETED|Overall Study||11
7869376|NCT00860457|19367264|P1|COMPLETED|Overall Study||11
7869377|NCT00860457|19367264|P1|STARTED|Overall Study||22
7869378|NCT00860405|19367270|P2|NOT COMPLETED|Overall Study||4
7869379|NCT00860405|19367271|P1|NOT COMPLETED|Overall Study||5
7869380|NCT00860405|19367270|P2|COMPLETED|Overall Study||26
7869381|NCT00860405|19367271|P1|COMPLETED|Overall Study|completed overall study|26
7869382|NCT00860405|19367270|P2|Day 28 Follow-up Performed|Overall Study||29
7869383|NCT00860405|19367271|P1|Day 28 Follow-up Performed|Overall Study||31
7869384|NCT00860405|19367270|P2|Completed Treatment|Overall Study||29
7869385|NCT00860405|19367271|P1|Completed Treatment|Overall Study||31
7869386|NCT00860405|19367270|P2|STARTED|Overall Study||30
7869387|NCT00860405|19367271|P1|STARTED|Overall Study||31
7869388|NCT00860314|19367295|P2|NOT COMPLETED|Overall Study||0
7869389|NCT00860314|19367296|P1|NOT COMPLETED|Overall Study||0
7869390|NCT00860314|19367295|P2|COMPLETED|Overall Study||48
7869391|NCT00860314|19367296|P1|COMPLETED|Overall Study||48
7869392|NCT00860314|19367295|P2|STARTED|Overall Study||48
7869393|NCT00860314|19367296|P1|STARTED|Overall Study||48
7869394|NCT00860262|19367311|P3|NOT COMPLETED|Overall Study||18
7869395|NCT00860262|19367312|P2|NOT COMPLETED|Overall Study||22
7869396|NCT00860262|19367313|P1|NOT COMPLETED|Overall Study||20
7869397|NCT00860262|19367311|P3|COMPLETED|Overall Study||202
7869398|NCT00860262|19367312|P2|COMPLETED|Overall Study||195
7869399|NCT00860262|19367313|P1|COMPLETED|Overall Study||401
7869400|NCT00860262|19367311|P3|STARTED|Overall Study||220
7869401|NCT00860262|19367312|P2|STARTED|Overall Study||217
7869402|NCT00860262|19367313|P1|STARTED|Overall Study||421
7869403|NCT00860249|19367426|P3|NOT COMPLETED|Overall Study||21
7869404|NCT00860249|19367427|P2|NOT COMPLETED|Overall Study||18
7869405|NCT00860249|19367428|P1|NOT COMPLETED|Overall Study||21
7869406|NCT00860249|19367426|P3|COMPLETED|Overall Study||0
7869407|NCT00860249|19367427|P2|COMPLETED|Overall Study||0
7869408|NCT00860249|19367428|P1|COMPLETED|Overall Study||0
7869409|NCT00860249|19367426|P3|STARTED|Overall Study||21
7869410|NCT00860249|19367427|P2|STARTED|Overall Study||18
7869411|NCT00860249|19367428|P1|STARTED|Overall Study||21
7869412|NCT00860171|19367439|P1|NOT COMPLETED|Overall Study||0
7869413|NCT00860171|19367439|P1|COMPLETED|Overall Study||16
7869414|NCT00860171|19367439|P1|STARTED|Overall Study||16
7869415|NCT00860158|19367448|P1|NOT COMPLETED|Overall Study||1
7869416|NCT00860158|19367448|P1|COMPLETED|Overall Study||0
7869417|NCT00860158|19367448|P1|STARTED|Overall Study||1
7869418|NCT00860067|19367460|P3|NOT COMPLETED|Overall Study||9
7869419|NCT00860067|19367461|P2|NOT COMPLETED|Overall Study||9
7869420|NCT00860067|19367462|P1|NOT COMPLETED|Overall Study||51
7869421|NCT00860067|19367460|P3|COMPLETED|Overall Study||292
7869422|NCT00860067|19367461|P2|COMPLETED|Overall Study||290
7869423|NCT00860067|19367462|P1|COMPLETED|Overall Study||1149
7869424|NCT00860067|19367460|P3|STARTED|Overall Study||301
7869425|NCT00860067|19367461|P2|STARTED|Overall Study||299
7869426|NCT00860067|19367462|P1|STARTED|Overall Study||1200
7869427|NCT00860028|19367522|P2|NOT COMPLETED|Smoking Cessation Phase||2
7869428|NCT00860028|19367523|P1|NOT COMPLETED|Smoking Cessation Phase||0
7869429|NCT00860028|19367522|P2|COMPLETED|Smoking Cessation Phase||12
7869430|NCT00860028|19367523|P1|COMPLETED|Smoking Cessation Phase||13
7869431|NCT00860028|19367522|P2|STARTED|Smoking Cessation Phase||14
7869432|NCT00860028|19367523|P1|STARTED|Smoking Cessation Phase||13
7869433|NCT00860028|19367522|P2|NOT COMPLETED|Placebo Controlled Pretreatment Period||1
7869434|NCT00860028|19367523|P1|NOT COMPLETED|Placebo Controlled Pretreatment Period||2
7869435|NCT00860028|19367522|P2|COMPLETED|Placebo Controlled Pretreatment Period||14
7869436|NCT00860028|19367523|P1|COMPLETED|Placebo Controlled Pretreatment Period||13
7869437|NCT00860028|19367522|P2|STARTED|Placebo Controlled Pretreatment Period||15
7869438|NCT00860028|19367523|P1|STARTED|Placebo Controlled Pretreatment Period||15
7869439|NCT00860015|19367533|P1|NOT COMPLETED|Overall Study||0
7869440|NCT00860015|19367533|P1|COMPLETED|Overall Study||12
7869441|NCT00860015|19367533|P1|STARTED|Overall Study||12
7869442|NCT00859976|19367539|P2|NOT COMPLETED|Overall Study||18
7869443|NCT00859976|19367540|P1|NOT COMPLETED|Overall Study||16
7869444|NCT00859976|19367539|P2|COMPLETED|Overall Study||67
7869445|NCT00859976|19367540|P1|COMPLETED|Overall Study||66
7869446|NCT00859976|19367539|P2|STARTED|Overall Study||85
7869447|NCT00859976|19367540|P1|STARTED|Overall Study||82
7869448|NCT00859950|19367556|P2|NOT COMPLETED|Overall Study||0
7869449|NCT00859950|19367557|P1|NOT COMPLETED|Overall Study||0
7869450|NCT00859950|19367556|P2|COMPLETED|Overall Study||21
7869451|NCT00859950|19367557|P1|COMPLETED|Overall Study||49
7869452|NCT00859950|19367556|P2|STARTED|Overall Study||21
7869453|NCT00859950|19367557|P1|STARTED|Overall Study||49
7869454|NCT00859937|19367565|P2|NOT COMPLETED|Overall Study||0
7869455|NCT00859937|19367566|P1|NOT COMPLETED|Overall Study||1
7869456|NCT00859937|19367565|P2|COMPLETED|Overall Study||14
7869457|NCT00859937|19367566|P1|COMPLETED|Overall Study||40
7869458|NCT00859937|19367565|P2|STARTED|Overall Study||14
7869459|NCT00859937|19367566|P1|STARTED|Overall Study||41
7869460|NCT00859898|19367581|P3|NOT COMPLETED|Overall Study||27
7869461|NCT00859898|19367582|P2|NOT COMPLETED|Overall Study||31
7869462|NCT00859898|19367583|P1|NOT COMPLETED|Overall Study||28
7869463|NCT00859898|19367581|P3|COMPLETED|Overall Study||181
7869464|NCT00859898|19367582|P2|COMPLETED|Overall Study||188
7869465|NCT00859898|19367583|P1|COMPLETED|Overall Study||183
7869466|NCT00859898|19367581|P3|STARTED|Overall Study||208
7869467|NCT00859898|19367582|P2|STARTED|Overall Study||219
7869468|NCT00859898|19367583|P1|STARTED|Overall Study||211
7869469|NCT00859833|19367624|P1|NOT COMPLETED|Overall Study||0
7869470|NCT00859833|19367624|P1|COMPLETED|Overall Study||30
7869471|NCT00859833|19367624|P1|STARTED|Overall Study||30
7869472|NCT00859651|19367631|P2|NOT COMPLETED|Overall Study||0
7869473|NCT00859651|19367632|P1|NOT COMPLETED|Overall Study||0
7869474|NCT00859651|19367631|P2|COMPLETED|Overall Study||22
7869475|NCT00859651|19367632|P1|COMPLETED|Overall Study||18
7869476|NCT00859651|19367631|P2|STARTED|Overall Study||22
7869477|NCT00859651|19367632|P1|STARTED|Overall Study||18
7869478|NCT00859638|19367642|P2|NOT COMPLETED|Overall Study||4
7869479|NCT00859638|19367643|P1|NOT COMPLETED|Overall Study||10
7869480|NCT00859638|19367642|P2|COMPLETED|Overall Study||55
7869481|NCT00859638|19367643|P1|COMPLETED|Overall Study||55
7869482|NCT00859638|19367642|P2|STARTED|Overall Study||59
7869483|NCT00859638|19367643|P1|STARTED|Overall Study||65
7869484|NCT00859586|19367649|P1|NOT COMPLETED|Overall Study||4
7869485|NCT00859586|19367649|P1|COMPLETED|Overall Study||4
7869486|NCT00859586|19367649|P1|STARTED|Overall Study||8
7869487|NCT00859573|19367665|P2|NOT COMPLETED|Overall Study||2
7869488|NCT00859573|19367666|P1|NOT COMPLETED|Overall Study||5
7869489|NCT00859573|19367665|P2|COMPLETED|Overall Study||1
7869490|NCT00859573|19367666|P1|COMPLETED|Overall Study||1
7869491|NCT00859573|19367665|P2|STARTED|Overall Study||3
7869492|NCT00859573|19367666|P1|STARTED|Overall Study||6
7869493|NCT00859547|19367672|P1|NOT COMPLETED|Overall Study||2
7869494|NCT00859547|19367672|P1|COMPLETED|Overall Study||28
7869495|NCT00859547|19367672|P1|STARTED|Overall Study||30
7869496|NCT00859521|19367685|P2|NOT COMPLETED|Second Intervention||0
7869497|NCT00859521|19367686|P1|NOT COMPLETED|Second Intervention||0
7869498|NCT00859521|19367685|P2|COMPLETED|Second Intervention||14
7869499|NCT00859521|19367686|P1|COMPLETED|Second Intervention||15
7869500|NCT00859521|19367685|P2|STARTED|Second Intervention||14
7869501|NCT00859521|19367686|P1|STARTED|Second Intervention||15
7869502|NCT00859521|19367685|P2|NOT COMPLETED|Washout||1
7869503|NCT00859521|19367686|P1|NOT COMPLETED|Washout||0
7869504|NCT00859521|19367685|P2|COMPLETED|Washout||14
7869505|NCT00859521|19367686|P1|COMPLETED|Washout||15
7869506|NCT00859521|19367685|P2|STARTED|Washout||15
7869507|NCT00859521|19367686|P1|STARTED|Washout||15
7869508|NCT00859521|19367685|P2|NOT COMPLETED|First Intervention||0
7869509|NCT00859521|19367686|P1|NOT COMPLETED|First Intervention||0
7869510|NCT00859521|19367685|P2|COMPLETED|First Intervention||15
7869511|NCT00859521|19367686|P1|COMPLETED|First Intervention||15
7869512|NCT00859521|19367685|P2|STARTED|First Intervention||15
7869513|NCT00859521|19367686|P1|STARTED|First Intervention||15
7869514|NCT00859508|19367696|P2|NOT COMPLETED|Overall Study||0
7869515|NCT00859508|19367697|P1|NOT COMPLETED|Overall Study||6
7869516|NCT00859508|19367696|P2|COMPLETED|Overall Study||37
7869517|NCT00859508|19367697|P1|COMPLETED|Overall Study||62
7869518|NCT00859508|19367696|P2|STARTED|Overall Study||37
7869519|NCT00859508|19367697|P1|STARTED|Overall Study||68
7869520|NCT00859495|19367703|P1|NOT COMPLETED|Overall Study||0
7869521|NCT00859495|19367703|P1|COMPLETED|Overall Study||9
7869522|NCT00859495|19367703|P1|STARTED|Overall Study||9
7869523|NCT00859469|19367707|P1|NOT COMPLETED|Overall Study||28
7869524|NCT00859469|19367707|P1|COMPLETED|Overall Study||1
7869525|NCT00859469|19367707|P1|6 Cycles|Overall Study||16
7869526|NCT00859469|19367707|P1|STARTED|Overall Study||29
7869527|NCT00859456|19367713|P1|NOT COMPLETED|Overall Study||8
7869528|NCT00859456|19367713|P1|COMPLETED|Overall Study||1
7869529|NCT00859456|19367713|P1|STARTED|Overall Study||9
7869530|NCT00859430|19367719|P2|NOT COMPLETED|Second Intervention||0
7869531|NCT00859430|19367720|P1|NOT COMPLETED|Second Intervention||0
7869532|NCT00859430|19367719|P2|COMPLETED|Second Intervention||10
7869533|NCT00859430|19367720|P1|COMPLETED|Second Intervention||11
7869534|NCT00859430|19367719|P2|STARTED|Second Intervention||10
7869535|NCT00859430|19367720|P1|STARTED|Second Intervention||11
7869536|NCT00859430|19367719|P2|NOT COMPLETED|First Intervention||1
7869537|NCT00859430|19367720|P1|NOT COMPLETED|First Intervention||0
7869538|NCT00859430|19367719|P2|COMPLETED|First Intervention||10
7869539|NCT00859430|19367720|P1|COMPLETED|First Intervention||11
7869540|NCT00859430|19367719|P2|STARTED|First Intervention||11
7869541|NCT00859430|19367720|P1|STARTED|First Intervention||11
7869542|NCT00859339|19367728|P1|NOT COMPLETED|Overall Study||0
7869543|NCT00859339|19367728|P1|COMPLETED|Overall Study||9
7869544|NCT00859339|19367728|P1|STARTED|Overall Study||9
7869545|NCT00859313|19367736|P1|NOT COMPLETED|Overall Study||4
7869546|NCT00859313|19367736|P1|COMPLETED|Overall Study||26
7869547|NCT00859313|19367736|P1|STARTED|Overall Study||30
7869548|NCT00859222|19367743|P5|NOT COMPLETED|Overall Study||15
7869549|NCT00859222|19367744|P4|NOT COMPLETED|Overall Study||24
7869550|NCT00859222|19367745|P3|NOT COMPLETED|Overall Study||6
7869551|NCT00859222|19367746|P2|NOT COMPLETED|Overall Study||3
7869552|NCT00859222|19367747|P1|NOT COMPLETED|Overall Study||3
7869553|NCT00859222|19367743|P5|COMPLETED|Overall Study||0
7869554|NCT00859222|19367744|P4|COMPLETED|Overall Study||0
7869555|NCT00859222|19367745|P3|COMPLETED|Overall Study||0
7869556|NCT00859222|19367746|P2|COMPLETED|Overall Study||0
7869557|NCT00859222|19367747|P1|COMPLETED|Overall Study||0
7869558|NCT00859222|19367743|P5|STARTED|Overall Study||15
7869559|NCT00859222|19367744|P4|STARTED|Overall Study||24
7869560|NCT00859222|19367745|P3|STARTED|Overall Study||6
7869561|NCT00859222|19367746|P2|STARTED|Overall Study||3
7869562|NCT00859222|19367747|P1|STARTED|Overall Study||3
7869563|NCT00859131|19367774|P2|NOT COMPLETED|Overall Study||0
7869564|NCT00859131|19367775|P1|NOT COMPLETED|Overall Study||0
7869565|NCT00859131|19367774|P2|COMPLETED|Overall Study||98
7869566|NCT00859131|19367775|P1|COMPLETED|Overall Study||102
7869567|NCT00859131|19367774|P2|STARTED|Overall Study||98
7869568|NCT00859131|19367775|P1|STARTED|Overall Study||102
7869569|NCT00859053|19367797|P4|NOT COMPLETED|Overall Study||0
7869570|NCT00859053|19367798|P3|NOT COMPLETED|Overall Study||0
7869571|NCT00859053|19367799|P2|NOT COMPLETED|Overall Study||0
7869572|NCT00859053|19367800|P1|NOT COMPLETED|Overall Study||0
7869573|NCT00859053|19367797|P4|COMPLETED|Overall Study||12
7869574|NCT00859053|19367798|P3|COMPLETED|Overall Study||6
7869575|NCT00859053|19367799|P2|COMPLETED|Overall Study||6
7869576|NCT00859053|19367800|P1|COMPLETED|Overall Study||6
7869577|NCT00859053|19367797|P4|STARTED|Overall Study||12
7869578|NCT00859053|19367798|P3|STARTED|Overall Study||6
7869579|NCT00859053|19367799|P2|STARTED|Overall Study||6
7869580|NCT00859053|19367800|P1|STARTED|Overall Study||6
7869581|NCT00859040|19367844|P2|NOT COMPLETED|Overall Study||0
7869582|NCT00859040|19367845|P1|NOT COMPLETED|Overall Study||0
7869583|NCT00859040|19367844|P2|COMPLETED|Overall Study||16
7869584|NCT00859040|19367845|P1|COMPLETED|Overall Study||18
7869585|NCT00859040|19367844|P2|STARTED|Overall Study||16
7869586|NCT00859040|19367845|P1|STARTED|Overall Study||18
7869587|NCT00859027|19367860|P2|NOT COMPLETED|Overall Study||5
7869588|NCT00859027|19367861|P1|NOT COMPLETED|Overall Study||5
7869589|NCT00859027|19367860|P2|COMPLETED|Overall Study||20
7869590|NCT00859027|19367861|P1|COMPLETED|Overall Study||20
7869591|NCT00859027|19367860|P2|STARTED|Overall Study||25
7869592|NCT00859027|19367861|P1|STARTED|Overall Study||25
7869593|NCT00859014|19367869|P1|NOT COMPLETED|Overall Study||5
7869594|NCT00859014|19367869|P1|COMPLETED|Overall Study||20
7869595|NCT00859014|19367869|P1|STARTED|Overall Study||25
7869596|NCT00858988|19367876|P2|NOT COMPLETED|Analysis||1
7869597|NCT00858988|19367877|P1|NOT COMPLETED|Analysis||2
7869598|NCT00858988|19367876|P2|COMPLETED|Analysis||72
7869599|NCT00858988|19367877|P1|COMPLETED|Analysis||72
7869600|NCT00858988|19367876|P2|STARTED|Analysis||73
7869601|NCT00858988|19367877|P1|STARTED|Analysis||74
7869602|NCT00858988|19367876|P2|NOT COMPLETED|Randomized and Allocation||0
7869603|NCT00858988|19367877|P1|NOT COMPLETED|Randomized and Allocation||0
7869604|NCT00858988|19367876|P2|COMPLETED|Randomized and Allocation||73
7869605|NCT00858988|19367877|P1|COMPLETED|Randomized and Allocation||74
7869606|NCT00858988|19367876|P2|STARTED|Randomized and Allocation||73
7869607|NCT00858988|19367877|P1|STARTED|Randomized and Allocation||74
7869608|NCT00858962|19367883|P1|NOT COMPLETED|Overall Study||0
7869609|NCT00858962|19367883|P1|COMPLETED|Overall Study||12
7869610|NCT00858962|19367883|P1|STARTED|Overall Study||12
7869611|NCT00858858|19367887|P1|NOT COMPLETED|Overall Study||18
7869612|NCT00858858|19367887|P1|COMPLETED|Overall Study||42
7869613|NCT00858858|19367887|P1|STARTED|Overall Study||60
7869614|NCT00858845|19367893|P2|NOT COMPLETED|Overall Study||1
7869615|NCT00858845|19367894|P1|NOT COMPLETED|Overall Study||0
7869616|NCT00858845|19367893|P2|COMPLETED|Overall Study||5
7869617|NCT00858845|19367894|P1|COMPLETED|Overall Study||5
7869618|NCT00858845|19367893|P2|STARTED|Overall Study||6
7869619|NCT00858845|19367894|P1|STARTED|Overall Study||5
7869620|NCT00858832|19367906|P2|NOT COMPLETED|Overall Study||1
7869621|NCT00858832|19367907|P1|NOT COMPLETED|Overall Study||1
7869622|NCT00858832|19367906|P2|COMPLETED|Overall Study||22
7869623|NCT00858832|19367907|P1|COMPLETED|Overall Study||20
7869624|NCT00858832|19367906|P2|STARTED|Overall Study||23
7869625|NCT00858832|19367907|P1|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21
7869626|NCT00858780|19367913|P5|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2
7869627|NCT00858780|19367914|P4|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
7869628|NCT00858780|19367915|P3|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
7869629|NCT00858780|19367916|P2|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
7869630|NCT00858780|19367917|P1|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
7869631|NCT00858780|19367913|P5|COMPLETED|OL Re-Treatment (Failure to Week 48)||41
7869632|NCT00858780|19367914|P4|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
7869633|NCT00858780|19367915|P3|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
7869634|NCT00858780|19367916|P2|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
7869635|NCT00858780|19367917|P1|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
7869636|NCT00858780|19367913|P5|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43
7869637|NCT00858780|19367914|P4|STARTED|OL Re-Treatment (Failure to Week 48)||0
7869638|NCT00858780|19367915|P3|STARTED|OL Re-Treatment (Failure to Week 48)||0
7869639|NCT00858780|19367916|P2|STARTED|OL Re-Treatment (Failure to Week 48)||0
7869640|NCT00858780|19367917|P1|STARTED|OL Re-Treatment (Failure to Week 48)||0
7869641|NCT00858780|19367913|P5|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
7869642|NCT00858780|19367914|P4|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1
7869643|NCT00858780|19367915|P3|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
7869644|NCT00858780|19367916|P2|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
7869645|NCT00858780|19367917|P1|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
7869646|NCT00858780|19367913|P5|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
7869647|NCT00858780|19367914|P4|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22
7869648|NCT00858780|19367915|P3|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25
7869649|NCT00858780|19367916|P2|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21
7869650|NCT00858780|19367917|P1|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
7869651|NCT00858780|19367913|P5|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
7869652|NCT00858780|19367914|P4|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
7869653|NCT00858780|19367915|P3|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27
7869654|NCT00858780|19367916|P2|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
7869655|NCT00858780|19367917|P1|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
7869656|NCT00858780|19367913|P5|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
7869657|NCT00858780|19367914|P4|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
7869658|NCT00858780|19367915|P3|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
7869659|NCT00858780|19367916|P2|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
7869660|NCT00858780|19367917|P1|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18
7869661|NCT00858780|19367913|P5|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
7869662|NCT00858780|19367914|P4|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
7869663|NCT00858780|19367915|P3|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
7869664|NCT00858780|19367916|P2|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
7869665|NCT00858780|19367917|P1|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73
7869666|NCT00858780|19367913|P5|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
7869667|NCT00858780|19367914|P4|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
7869668|NCT00858780|19367915|P3|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
7869669|NCT00858780|19367916|P2|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
7869670|NCT00858780|19367917|P1|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91
7869671|NCT00858702|19367992|P2|NOT COMPLETED|Overall Study||2
7869672|NCT00858702|19367993|P1|NOT COMPLETED|Overall Study||5
7869673|NCT00858702|19367992|P2|COMPLETED|Overall Study||50
7869674|NCT00858702|19367993|P1|COMPLETED|Overall Study||48
7869675|NCT00858702|19367992|P2|STARTED|Overall Study||52
7869676|NCT00858702|19367993|P1|STARTED|Overall Study||53
7869677|NCT00858689|19368001|P1|NOT COMPLETED|Overall Study||1
7869678|NCT00858689|19368001|P1|COMPLETED|Overall Study||19
7869679|NCT00858689|19368001|P1|STARTED|Overall Study||20
7869680|NCT00858637|19368008|P6|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
7869681|NCT00858637|19368009|P5|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
7869682|NCT00858637|19368010|P4|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
7869683|NCT00858637|19368011|P3|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
7869684|NCT00858637|19368012|P2|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
7869685|NCT00858637|19368013|P1|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
7869686|NCT00858637|19368008|P6|COMPLETED|Placebo-controlled Withdrawal Phase||58
7869687|NCT00858637|19368009|P5|COMPLETED|Placebo-controlled Withdrawal Phase||55
7869688|NCT00858637|19368010|P4|COMPLETED|Placebo-controlled Withdrawal Phase||0
7869689|NCT00858637|19368011|P3|COMPLETED|Placebo-controlled Withdrawal Phase||53
7869690|NCT00858637|19368012|P2|COMPLETED|Placebo-controlled Withdrawal Phase||49
7869691|NCT00858637|19368013|P1|COMPLETED|Placebo-controlled Withdrawal Phase||0
7869692|NCT00858637|19368008|P6|STARTED|Placebo-controlled Withdrawal Phase||59
7869693|NCT00858637|19368009|P5|STARTED|Placebo-controlled Withdrawal Phase||56
7869694|NCT00858637|19368010|P4|STARTED|Placebo-controlled Withdrawal Phase||0
7869695|NCT00858637|19368011|P3|STARTED|Placebo-controlled Withdrawal Phase||54
7869696|NCT00858637|19368012|P2|STARTED|Placebo-controlled Withdrawal Phase||49
7869697|NCT00858637|19368013|P1|STARTED|Placebo-controlled Withdrawal Phase||0
7869698|NCT00858637|19368008|P6|NOT COMPLETED|Active Comparison Phase||0
7869699|NCT00858637|19368009|P5|NOT COMPLETED|Active Comparison Phase||0
7869700|NCT00858637|19368010|P4|NOT COMPLETED|Active Comparison Phase||18
7869701|NCT00858637|19368011|P3|NOT COMPLETED|Active Comparison Phase||0
7869702|NCT00858637|19368012|P2|NOT COMPLETED|Active Comparison Phase||0
7869703|NCT00858637|19368013|P1|NOT COMPLETED|Active Comparison Phase||24
7869704|NCT00858637|19368008|P6|COMPLETED|Active Comparison Phase||0
7869705|NCT00858637|19368009|P5|COMPLETED|Active Comparison Phase||0
7869706|NCT00858637|19368010|P4|COMPLETED|Active Comparison Phase||115
7869707|NCT00858637|19368011|P3|COMPLETED|Active Comparison Phase||0
7869708|NCT00858637|19368012|P2|COMPLETED|Active Comparison Phase||0
7869709|NCT00858637|19368013|P1|COMPLETED|Active Comparison Phase||103
7869710|NCT00858637|19368008|P6|STARTED|Active Comparison Phase||0
7869711|NCT00858637|19368009|P5|STARTED|Active Comparison Phase||0
7869712|NCT00858637|19368010|P4|STARTED|Active Comparison Phase||133
7869713|NCT00858637|19368011|P3|STARTED|Active Comparison Phase||0
7869714|NCT00858637|19368012|P2|STARTED|Active Comparison Phase||0
7869715|NCT00858637|19368013|P1|STARTED|Active Comparison Phase||127
7869716|NCT00858507|19368025|P2|NOT COMPLETED|Overall Study||15
7869717|NCT00858507|19368026|P1|NOT COMPLETED|Overall Study||22
7869718|NCT00858507|19368025|P2|COMPLETED|Overall Study||101
7869719|NCT00858507|19368026|P1|COMPLETED|Overall Study||83
7869720|NCT00858507|19368025|P2|STARTED|Overall Study||116
7869721|NCT00858507|19368026|P1|STARTED|Overall Study||105
7869722|NCT00858494|19368032|P1|NOT COMPLETED|Overall Study||4
7869723|NCT00858494|19368032|P1|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45
7869724|NCT00858494|19368032|P1|STARTED|Overall Study||49
7869725|NCT00858468|19368039|P2|NOT COMPLETED|Overall Study||0
7869726|NCT00858468|19368040|P1|NOT COMPLETED|Overall Study||0
7869727|NCT00858468|19368039|P2|COMPLETED|Overall Study||192
7869728|NCT00858468|19368040|P1|COMPLETED|Overall Study||201
7869729|NCT00858468|19368039|P2|STARTED|Overall Study||192
7869730|NCT00858468|19368040|P1|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201
7869731|NCT00858442|19368054|P2|NOT COMPLETED|Compression:Start to Finish||3
7869732|NCT00858442|19368055|P1|NOT COMPLETED|Compression:Start to Finish||1
7869733|NCT00858442|19368054|P2|COMPLETED|Compression:Start to Finish||20
7869734|NCT00858442|19368055|P1|COMPLETED|Compression:Start to Finish||20
7869735|NCT00858442|19368054|P2|STARTED|Compression:Start to Finish||23
7869736|NCT00858442|19368055|P1|STARTED|Compression:Start to Finish||21
7869737|NCT00858442|19368054|P2|NOT COMPLETED|From Surgery to Start Compression;||0
7869738|NCT00858442|19368055|P1|NOT COMPLETED|From Surgery to Start Compression;||0
7869739|NCT00858442|19368054|P2|COMPLETED|From Surgery to Start Compression;||23
7869740|NCT00858442|19368055|P1|COMPLETED|From Surgery to Start Compression;||21
7869741|NCT00858442|19368054|P2|STARTED|From Surgery to Start Compression;||23
7869742|NCT00858442|19368055|P1|STARTED|From Surgery to Start Compression;||21
7869743|NCT00858403|19368065|P1|NOT COMPLETED|Overall Study||5
7869744|NCT00858403|19368065|P1|COMPLETED|Overall Study||2
7869745|NCT00858403|19368065|P1|STARTED|Overall Study||7
7869746|NCT00858390|19368077|P2|NOT COMPLETED|Overall Study||0
7869747|NCT00858390|19368078|P1|NOT COMPLETED|Overall Study||0
7869748|NCT00858390|19368077|P2|COMPLETED|Overall Study||18
7869749|NCT00858390|19368078|P1|COMPLETED|Overall Study||18
7869750|NCT00858390|19368077|P2|STARTED|Overall Study||18
7869751|NCT00858390|19368078|P1|STARTED|Overall Study||18
7869752|NCT00858364|19368086|P2|NOT COMPLETED|Overall Study||457
7869753|NCT00858364|19368087|P1|NOT COMPLETED|Overall Study||204
7869754|NCT00858364|19368086|P2|COMPLETED|Overall Study||1246
7869755|NCT00858364|19368087|P1|COMPLETED|Overall Study||642
7869756|NCT00858364|19368086|P2|Received Study Drug|Overall Study||1681
7869757|NCT00858364|19368087|P1|Received Study Drug|Overall Study||837
7869758|NCT00858364|19368086|P2|STARTED|Overall Study||1703
7869759|NCT00858364|19368087|P1|STARTED|Overall Study||846
7869760|NCT00858247|19368109|P2|NOT COMPLETED|Week 12 Follow-up||1
7869761|NCT00858247|19368110|P1|NOT COMPLETED|Week 12 Follow-up||0
7869762|NCT00858247|19368109|P2|COMPLETED|Week 12 Follow-up||23
7869763|NCT00858247|19368110|P1|COMPLETED|Week 12 Follow-up||23
7869764|NCT00858247|19368109|P2|STARTED|Week 12 Follow-up||24
7869765|NCT00858247|19368110|P1|STARTED|Week 12 Follow-up||23
7869766|NCT00858247|19368109|P2|NOT COMPLETED|Baseline Assessment||2
7869767|NCT00858247|19368110|P1|NOT COMPLETED|Baseline Assessment||2
7869768|NCT00858247|19368109|P2|COMPLETED|Baseline Assessment||24
7869769|NCT00858247|19368110|P1|COMPLETED|Baseline Assessment||23
7869770|NCT00858247|19368109|P2|STARTED|Baseline Assessment||26
7869771|NCT00858247|19368110|P1|STARTED|Baseline Assessment||25
7869772|NCT00858208|19368126|P1|NOT COMPLETED|Overall Study||79
7869773|NCT00858208|19368126|P1|COMPLETED|Overall Study||6
7869774|NCT00858208|19368126|P1|STARTED|Overall Study||85
7869775|NCT00858143|19368143|P1|NOT COMPLETED|Overall Study||50
7869776|NCT00858143|19368143|P1|COMPLETED|Overall Study||261
7869777|NCT00858143|19368143|P1|STARTED|Overall Study|Baseline|311
7869778|NCT00858130|19368192|P1|NOT COMPLETED|Overall Study||0
7869779|NCT00858130|19368192|P1|COMPLETED|Overall Study||12
7869780|NCT00858130|19368192|P1|STARTED|Overall Study||12
7869781|NCT00858117|19368200|P1|NOT COMPLETED|Follow up for 5 Years||13
7869782|NCT00858117|19368200|P1|COMPLETED|Follow up for 5 Years||17
7869783|NCT00858117|19368200|P1|STARTED|Follow up for 5 Years|All patients who receive at least one dose of drug under the protocol go into follow up for survival|30
7869784|NCT00858117|19368200|P1|NOT COMPLETED|Treatment on Study||2
7869785|NCT00858117|19368200|P1|COMPLETED|Treatment on Study||28
7869786|NCT00858117|19368200|P1|Completed 18 Weeks of Treatment|Treatment on Study||28
7869787|NCT00858117|19368200|P1|STARTED|Treatment on Study||30
7869788|NCT00858013|19368210|P2|NOT COMPLETED|Overall Study||19
7869789|NCT00858013|19368211|P1|NOT COMPLETED|Overall Study||22
7869790|NCT00858013|19368210|P2|COMPLETED|Overall Study||23
7869791|NCT00858013|19368211|P1|COMPLETED|Overall Study||24
7869792|NCT00858013|19368210|P2|STARTED|Overall Study||42
7869793|NCT00858013|19368211|P1|STARTED|Overall Study||46
7869794|NCT00857961|19368225|P1|NOT COMPLETED|Overall Study||0
7869795|NCT00857961|19368225|P1|COMPLETED|Overall Study||21
7869796|NCT00857961|19368225|P1|STARTED|Overall Study||21
7869797|NCT00857948|19368263|P4|NOT COMPLETED|Overall Study||0
7869798|NCT00857948|19368264|P3|NOT COMPLETED|Overall Study||1
7869799|NCT00857948|19368265|P2|NOT COMPLETED|Overall Study||0
7869800|NCT00857948|19368266|P1|NOT COMPLETED|Overall Study||3
7869801|NCT00857948|19368263|P4|COMPLETED|Overall Study||23
7869802|NCT00857948|19368264|P3|COMPLETED|Overall Study||18
7869803|NCT00857948|19368265|P2|COMPLETED|Overall Study||18
7869804|NCT00857948|19368266|P1|COMPLETED|Overall Study||15
7869805|NCT00857948|19368263|P4|STARTED|Overall Study||23
7869806|NCT00857948|19368264|P3|STARTED|Overall Study||19
7869807|NCT00857948|19368265|P2|STARTED|Overall Study||18
7869808|NCT00857948|19368266|P1|STARTED|Overall Study||18
7869809|NCT00857896|19368288|P1|NOT COMPLETED|Week 5 to Week 8||0
7869810|NCT00857896|19368288|P1|COMPLETED|Week 5 to Week 8||20
7869811|NCT00857896|19368288|P1|STARTED|Week 5 to Week 8||20
7869812|NCT00857896|19368288|P1|NOT COMPLETED|Baseline to Week 4||1
7869813|NCT00857896|19368288|P1|COMPLETED|Baseline to Week 4||20
7869814|NCT00857896|19368288|P1|STARTED|Baseline to Week 4||21
7869815|NCT00857857|19368300|P1|NOT COMPLETED|Overall Study||0
7869816|NCT00857857|19368300|P1|COMPLETED|Overall Study||24
7869817|NCT00857857|19368300|P1|STARTED|Overall Study||24
7869818|NCT00857818|19368444|P2|NOT COMPLETED|Overall Study||8
7869819|NCT00857818|19368445|P1|NOT COMPLETED|Overall Study||11
7869820|NCT00857818|19368444|P2|COMPLETED|Overall Study||6
7869821|NCT00857818|19368445|P1|COMPLETED|Overall Study||3
7869822|NCT00857818|19368444|P2|Received Treatment|Overall Study||12
7869823|NCT00857818|19368445|P1|Received Treatment|Overall Study||14
7869824|NCT00857818|19368444|P2|STARTED|Overall Study||14
7869825|NCT00857818|19368445|P1|STARTED|Overall Study||14
7869826|NCT00857792|19368473|P1|NOT COMPLETED|Overall Study||12
7869827|NCT00857792|19368473|P1|COMPLETED|Overall Study||108
7869828|NCT00857792|19368473|P1|STARTED|Overall Study||120
7869829|NCT00857766|19368479|P2|NOT COMPLETED|Overall Study||30
7869830|NCT00857766|19368480|P1|NOT COMPLETED|Overall Study||31
7869831|NCT00857766|19368479|P2|COMPLETED|Overall Study||96
7869832|NCT00857766|19368480|P1|COMPLETED|Overall Study||92
7869833|NCT00857766|19368479|P2|STARTED|Overall Study||126
7869834|NCT00857766|19368480|P1|STARTED|Overall Study||123
7869835|NCT00857727|19368492|P2|NOT COMPLETED|Overall Study||0
7869836|NCT00857727|19368493|P1|NOT COMPLETED|Overall Study||0
7869837|NCT00857727|19368492|P2|COMPLETED|Overall Study||14
7869838|NCT00857727|19368493|P1|COMPLETED|Overall Study||14
7869839|NCT00857727|19368492|P2|STARTED|Overall Study||14
7869840|NCT00857727|19368493|P1|STARTED|Overall Study||14
7869841|NCT00857714|19368515|P1|NOT COMPLETED|Overall Study||0
7869842|NCT00857714|19368515|P1|COMPLETED|Overall Study||1
7869843|NCT00857714|19368515|P1|STARTED|Overall Study||1
7869844|NCT00857649|19368522|P2|NOT COMPLETED|Overall Study||32
7869845|NCT00857649|19368523|P1|NOT COMPLETED|Overall Study||31
7869846|NCT00857649|19368522|P2|COMPLETED|Overall Study||155
7869847|NCT00857649|19368523|P1|COMPLETED|Overall Study||151
7869848|NCT00857649|19368522|P2|STARTED|Overall Study||187
7869849|NCT00857649|19368523|P1|STARTED|Overall Study||182
7869850|NCT00857623|19368539|P2|NOT COMPLETED|Overall Study||10
7869851|NCT00857623|19368540|P1|NOT COMPLETED|Overall Study||14
7869852|NCT00857623|19368539|P2|COMPLETED|Overall Study||55
7869853|NCT00857623|19368540|P1|COMPLETED|Overall Study||48
7869854|NCT00857623|19368539|P2|STARTED|Overall Study||65
7869855|NCT00857623|19368540|P1|STARTED|Overall Study||62
7869856|NCT00857584|19368564|P2|NOT COMPLETED|Overall Study||5
7869857|NCT00857584|19368565|P1|NOT COMPLETED|Overall Study||4
7869858|NCT00857584|19368564|P2|COMPLETED|Overall Study||8
7869859|NCT00857584|19368565|P1|COMPLETED|Overall Study||10
7869860|NCT00857584|19368564|P2|Week 8|Overall Study||8
7869861|NCT00857584|19368565|P1|Week 8|Overall Study||10
7869862|NCT00857584|19368564|P2|Week 4|Overall Study||9
7869863|NCT00857584|19368565|P1|Week 4|Overall Study||11
7869864|NCT00857584|19368564|P2|Week 2|Overall Study||11
7869865|NCT00857584|19368565|P1|Week 2|Overall Study||14
7869866|NCT00857584|19368564|P2|Week 1|Overall Study||13
7869867|NCT00857584|19368565|P1|Week 1|Overall Study||14
7869868|NCT00857584|19368564|P2|STARTED|Overall Study||13
7869869|NCT00857584|19368565|P1|STARTED|Overall Study||14
7869870|NCT00857545|19368607|P2|NOT COMPLETED|Overall Study||0
7869871|NCT00857545|19368608|P1|NOT COMPLETED|Overall Study||0
7869872|NCT00857545|19368607|P2|COMPLETED|Overall Study||85
7869873|NCT00857545|19368608|P1|COMPLETED|Overall Study|Enrolled and randomized participants.|86
7869874|NCT00857545|19368607|P2|STARTED|Overall Study||85
7869875|NCT00857545|19368608|P1|STARTED|Overall Study||86
7869876|NCT00857532|19368618|P1|NOT COMPLETED|Overall Study||0
7869877|NCT00857532|19368618|P1|COMPLETED|Overall Study||31
7869878|NCT00857532|19368618|P1|STARTED|Overall Study||31
7869879|NCT00857506|19368629|P3|NOT COMPLETED|Overall Study||18
7869880|NCT00857506|19368630|P2|NOT COMPLETED|Overall Study||15
7869881|NCT00857506|19368631|P1|NOT COMPLETED|Overall Study||15
7869882|NCT00857506|19368629|P3|COMPLETED|Overall Study||51
7869883|NCT00857506|19368630|P2|COMPLETED|Overall Study||37
7869884|NCT00857506|19368631|P1|COMPLETED|Overall Study||16
7869885|NCT00857506|19368629|P3|STARTED|Overall Study||69
7869886|NCT00857506|19368630|P2|STARTED|Overall Study||52
7869887|NCT00857506|19368631|P1|STARTED|Overall Study||31
7869888|NCT00857493|19368659|P2|NOT COMPLETED|Overall Study||0
7869889|NCT00857493|19368660|P1|NOT COMPLETED|Overall Study||3
7869890|NCT00857493|19368659|P2|COMPLETED|Overall Study||58
7869891|NCT00857493|19368660|P1|COMPLETED|Overall Study||59
7869892|NCT00857493|19368659|P2|STARTED|Overall Study||58
7869893|NCT00857493|19368660|P1|STARTED|Overall Study||62
7869894|NCT00857454|19368692|P1|NOT COMPLETED|Overall Study||20
7869895|NCT00857454|19368692|P1|COMPLETED|Overall Study||51
7869896|NCT00857454|19368692|P1|STARTED|Overall Study||71
7869897|NCT00857415|19368705|P2|NOT COMPLETED|Overall Study||0
7869898|NCT00857415|19368706|P1|NOT COMPLETED|Overall Study||117
7869899|NCT00857415|19368705|P2|COMPLETED|Overall Study||74
7869900|NCT00857415|19368706|P1|COMPLETED|Overall Study||35
7869901|NCT00857415|19368705|P2|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0
7869902|NCT00857415|19368706|P1|Deceased Within One Year of AV-45 Scan|Overall Study||37
7869903|NCT00857415|19368705|P2|STARTED|Overall Study||74
7869904|NCT00857415|19368706|P1|STARTED|Overall Study||152
7869905|NCT00857389|19368713|P1|NOT COMPLETED|Overall Study||2
7869906|NCT00857389|19368713|P1|COMPLETED|Overall Study||58
7869907|NCT00857389|19368713|P1|STARTED|Overall Study||60
7869908|NCT00857311|19368727|P4|NOT COMPLETED|Overall Study||0
7869909|NCT00857311|19368728|P3|NOT COMPLETED|Overall Study||0
7869910|NCT00857311|19368729|P2|NOT COMPLETED|Overall Study||0
7869911|NCT00857311|19368730|P1|NOT COMPLETED|Overall Study||1
7869912|NCT00857311|19368727|P4|COMPLETED|Overall Study||0
7869913|NCT00857311|19368728|P3|COMPLETED|Overall Study||8
7869914|NCT00857311|19368729|P2|COMPLETED|Overall Study||0
7869915|NCT00857311|19368730|P1|COMPLETED|Overall Study||8
7869916|NCT00857311|19368727|P4|STARTED|Overall Study||0
7869917|NCT00857311|19368728|P3|STARTED|Overall Study||8
7869918|NCT00857311|19368729|P2|STARTED|Overall Study||0
7869919|NCT00857311|19368730|P1|STARTED|Overall Study||9
7869920|NCT00857285|19368742|P2|NOT COMPLETED|Overall Study||6
7869921|NCT00857285|19368743|P1|NOT COMPLETED|Overall Study||12
7869922|NCT00857285|19368742|P2|COMPLETED|Overall Study||59
7869923|NCT00857285|19368743|P1|COMPLETED|Overall Study||53
7869924|NCT00857285|19368742|P2|STARTED|Overall Study||65
7869925|NCT00857285|19368743|P1|STARTED|Overall Study||65
7869926|NCT00857272|19368749|P2|NOT COMPLETED|Overall Study||9
7869927|NCT00857272|19368750|P1|NOT COMPLETED|Overall Study||9
7869928|NCT00857272|19368749|P2|COMPLETED|Overall Study||145
7869929|NCT00857272|19368750|P1|COMPLETED|Overall Study||145
7869930|NCT00857272|19368749|P2|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154
7869931|NCT00857272|19368750|P1|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154
7869932|NCT00857259|19368759|P3|NOT COMPLETED|Overall Study||1
7869933|NCT00857259|19368760|P2|NOT COMPLETED|Overall Study||0
7869934|NCT00857259|19368761|P1|NOT COMPLETED|Overall Study||1
7869935|NCT00857259|19368759|P3|COMPLETED|Overall Study||6
7869936|NCT00857259|19368760|P2|COMPLETED|Overall Study||1
7869937|NCT00857259|19368761|P1|COMPLETED|Overall Study||7
7869938|NCT00857259|19368759|P3|STARTED|Overall Study||7
7869939|NCT00857259|19368760|P2|STARTED|Overall Study||1
7869940|NCT00857259|19368761|P1|STARTED|Overall Study||8
7869941|NCT00857246|19368771|P1|NOT COMPLETED|ChemoRT||3
7869942|NCT00857246|19368771|P1|COMPLETED|ChemoRT||12
7869943|NCT00857246|19368771|P1|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15
7869944|NCT00857246|19368771|P1|NOT COMPLETED|Surgery (Curative)||6
7869945|NCT00857246|19368771|P1|COMPLETED|Surgery (Curative)||21
7869946|NCT00857246|19368771|P1|STARTED|Surgery (Curative)||27
7869947|NCT00857246|19368771|P1|NOT COMPLETED|Induction Regimen||3
7869948|NCT00857246|19368771|P1|COMPLETED|Induction Regimen||27
7869949|NCT00857246|19368771|P1|STARTED|Induction Regimen||30
7869950|NCT00857233|19368781|P1|NOT COMPLETED|Overall Study||55
7869951|NCT00857233|19368781|P1|COMPLETED|Overall Study||242
7869952|NCT00857233|19368781|P1|STARTED|Overall Study||297
7869953|NCT00857220|19368790|P1|NOT COMPLETED|Overall Study||183
7869954|NCT00857220|19368790|P1|COMPLETED|Overall Study||121
7869955|NCT00857220|19368790|P1|STARTED|Overall Study||304
7869956|NCT00856999|19368807|P1|NOT COMPLETED|Overall Study||5
7869957|NCT00856999|19368807|P1|COMPLETED|Overall Study||45
7869958|NCT00856999|19368807|P1|STARTED|Overall Study||50
7869959|NCT00856986|19368817|P5|NOT COMPLETED|Extension Period, Weeks 26-52||0
7869960|NCT00856986|19368818|P4|NOT COMPLETED|Extension Period, Weeks 26-52||0
7869961|NCT00856986|19368819|P3|NOT COMPLETED|Extension Period, Weeks 26-52||38
7869962|NCT00856986|19368820|P2|NOT COMPLETED|Extension Period, Weeks 26-52||14
7869963|NCT00856986|19368821|P1|NOT COMPLETED|Extension Period, Weeks 26-52||19
7869964|NCT00856986|19368817|P5|COMPLETED|Extension Period, Weeks 26-52||0
7869965|NCT00856986|19368818|P4|COMPLETED|Extension Period, Weeks 26-52||0
7869966|NCT00856986|19368819|P3|COMPLETED|Extension Period, Weeks 26-52||432
7869967|NCT00856986|19368820|P2|COMPLETED|Extension Period, Weeks 26-52||130
7869968|NCT00856986|19368821|P1|COMPLETED|Extension Period, Weeks 26-52||108
7869969|NCT00856986|19368817|P5|Enrolled in Extension|Extension Period, Weeks 26-52||0
7869970|NCT00856986|19368818|P4|Enrolled in Extension|Extension Period, Weeks 26-52||0
7869971|NCT00856986|19368819|P3|Enrolled in Extension|Extension Period, Weeks 26-52||461
7869972|NCT00856986|19368820|P2|Enrolled in Extension|Extension Period, Weeks 26-52||140
7869973|NCT00856986|19368821|P1|Enrolled in Extension|Extension Period, Weeks 26-52||122
7869974|NCT00856986|19368817|P5|STARTED|Extension Period, Weeks 26-52||0
7869975|NCT00856986|19368818|P4|STARTED|Extension Period, Weeks 26-52||0
7869976|NCT00856986|19368819|P3|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470
7869977|NCT00856986|19368820|P2|STARTED|Extension Period, Weeks 26-52||144
7869978|NCT00856986|19368821|P1|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127
7869979|NCT00856986|19368817|P5|NOT COMPLETED|Main Period, Weeks 0-26||0
7869980|NCT00856986|19368818|P4|NOT COMPLETED|Main Period, Weeks 0-26||0
7869981|NCT00856986|19368819|P3|NOT COMPLETED|Main Period, Weeks 0-26||28
7869982|NCT00856986|19368820|P2|NOT COMPLETED|Main Period, Weeks 0-26||18
7869983|NCT00856986|19368821|P1|NOT COMPLETED|Main Period, Weeks 0-26||34
7869984|NCT00856986|19368817|P5|COMPLETED|Main Period, Weeks 0-26||0
7869985|NCT00856986|19368818|P4|COMPLETED|Main Period, Weeks 0-26||0
7869986|NCT00856986|19368819|P3|COMPLETED|Main Period, Weeks 0-26||470
7869987|NCT00856986|19368820|P2|COMPLETED|Main Period, Weeks 0-26||144
7869988|NCT00856986|19368821|P1|COMPLETED|Main Period, Weeks 0-26||127
7869989|NCT00856986|19368817|P5|STARTED|Main Period, Weeks 0-26||0
7869990|NCT00856986|19368818|P4|STARTED|Main Period, Weeks 0-26||0
7869991|NCT00856986|19368819|P3|STARTED|Main Period, Weeks 0-26||498
7869992|NCT00856986|19368820|P2|STARTED|Main Period, Weeks 0-26||162
7869993|NCT00856986|19368821|P1|STARTED|Main Period, Weeks 0-26||161
7869994|NCT00856986|19368817|P5|NOT COMPLETED|Run-in Period, Weeks -12-0||0
7869995|NCT00856986|19368818|P4|NOT COMPLETED|Run-in Period, Weeks -12-0||167
7869996|NCT00856986|19368819|P3|NOT COMPLETED|Run-in Period, Weeks -12-0||0
7869997|NCT00856986|19368820|P2|NOT COMPLETED|Run-in Period, Weeks -12-0||0
7869998|NCT00856986|19368821|P1|NOT COMPLETED|Run-in Period, Weeks -12-0||0
7869999|NCT00856986|19368817|P5|COMPLETED|Run-in Period, Weeks -12-0||0
7870000|NCT00856986|19368818|P4|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0
7870001|NCT00856986|19368819|P3|COMPLETED|Run-in Period, Weeks -12-0||498
7870002|NCT00856986|19368820|P2|COMPLETED|Run-in Period, Weeks -12-0||162
7870003|NCT00856986|19368821|P1|COMPLETED|Run-in Period, Weeks -12-0||161
7870004|NCT00856986|19368817|P5|STARTED|Run-in Period, Weeks -12-0||0
7870005|NCT00856986|19368818|P4|STARTED|Run-in Period, Weeks -12-0||167
7870006|NCT00856986|19368819|P3|STARTED|Run-in Period, Weeks -12-0||498
7870007|NCT00856986|19368820|P2|STARTED|Run-in Period, Weeks -12-0||162
7870008|NCT00856986|19368821|P1|STARTED|Run-in Period, Weeks -12-0||161
7870009|NCT00856973|19368991|P3|NOT COMPLETED|Overall Study||38
7870010|NCT00856973|19368992|P2|NOT COMPLETED|Overall Study||41
7870011|NCT00856973|19368993|P1|NOT COMPLETED|Overall Study||36
7870012|NCT00856973|19368991|P3|COMPLETED|Overall Study||123
7870013|NCT00856973|19368992|P2|COMPLETED|Overall Study||122
7870014|NCT00856973|19368993|P1|COMPLETED|Overall Study||126
7870015|NCT00856973|19368991|P3|STARTED|Overall Study||161
7870016|NCT00856973|19368992|P2|STARTED|Overall Study||163
7870017|NCT00856973|19368993|P1|STARTED|Overall Study||162
7870018|NCT00856934|19369061|P3|NOT COMPLETED|Overall Study||0
7870019|NCT00856934|19369062|P2|NOT COMPLETED|Overall Study||0
7870020|NCT00856934|19369063|P1|NOT COMPLETED|Overall Study||0
7870021|NCT00856934|19369061|P3|COMPLETED|Overall Study||15
7870022|NCT00856934|19369062|P2|COMPLETED|Overall Study||15
7870023|NCT00856934|19369063|P1|COMPLETED|Overall Study||15
7870024|NCT00856934|19369061|P3|STARTED|Overall Study||15
7870025|NCT00856934|19369062|P2|STARTED|Overall Study||15
7870026|NCT00856934|19369063|P1|STARTED|Overall Study||15
7870027|NCT00856908|19369073|P2|NOT COMPLETED|Overall Study||0
7870028|NCT00856908|19369074|P1|NOT COMPLETED|Overall Study||1
7870029|NCT00856908|19369073|P2|COMPLETED|Overall Study||5
7870030|NCT00856908|19369074|P1|COMPLETED|Overall Study||14
7870031|NCT00856908|19369073|P2|STARTED|Overall Study||5
7870032|NCT00856908|19369074|P1|STARTED|Overall Study||15
7870033|NCT00856856|19369099|P1|NOT COMPLETED|5-year Clinical Follow-up||0
7870034|NCT00856856|19369099|P1|COMPLETED|5-year Clinical Follow-up|One patient missed the 4-year clinical follow-up but returned at 5 year.|100
7870035|NCT00856856|19369099|P1|STARTED|5-year Clinical Follow-up||100
7870036|NCT00856856|19369099|P1|NOT COMPLETED|4-year Clinical Follow-up||1
7870037|NCT00856856|19369099|P1|COMPLETED|4-year Clinical Follow-up||99
7870038|NCT00856856|19369099|P1|STARTED|4-year Clinical Follow-up||100
7870039|NCT00856856|19369099|P1|NOT COMPLETED|3-year Clinical Follow-up||0
7870040|NCT00856856|19369099|P1|COMPLETED|3-year Clinical Follow-up||100
7870041|NCT00856856|19369099|P1|STARTED|3-year Clinical Follow-up||100
7870042|NCT00856856|19369099|P1|NOT COMPLETED|2-year Clinical Follow-up||1
7870043|NCT00856856|19369099|P1|COMPLETED|2-year Clinical Follow-up||100
7870044|NCT00856856|19369099|P1|STARTED|2-year Clinical Follow-up||101
7870045|NCT00856856|19369099|P1|NOT COMPLETED|1-year Clinical Follow-up||0
7870046|NCT00856856|19369099|P1|COMPLETED|1-year Clinical Follow-up||101
7870047|NCT00856856|19369099|P1|STARTED|1-year Clinical Follow-up||101
7870048|NCT00856856|19369099|P1|NOT COMPLETED|270-day Clinical Follow-up||0
7870049|NCT00856856|19369099|P1|COMPLETED|270-day Clinical Follow-up||101
7870050|NCT00856856|19369099|P1|STARTED|270-day Clinical Follow-up||101
7870051|NCT00856856|19369099|P1|NOT COMPLETED|180-day Clinical Follow-up||0
7870052|NCT00856856|19369099|P1|COMPLETED|180-day Clinical Follow-up||101
7870053|NCT00856856|19369099|P1|STARTED|180-day Clinical Follow-up||101
7870054|NCT00856856|19369099|P1|NOT COMPLETED|30-day Clinical Follow-up||0
7870055|NCT00856856|19369099|P1|COMPLETED|30-day Clinical Follow-up||101
7870056|NCT00856856|19369099|P1|STARTED|30-day Clinical Follow-up||101
7870057|NCT00856856|19369099|P1|NOT COMPLETED|Baseline||0
7870058|NCT00856856|19369099|P1|COMPLETED|Baseline||101
7870059|NCT00856856|19369099|P1|STARTED|Baseline||101
7870060|NCT00856843|19369298|P2|NOT COMPLETED|Overall Study||5
7870061|NCT00856843|19369299|P1|NOT COMPLETED|Overall Study||2
7870062|NCT00856843|19369298|P2|COMPLETED|Overall Study||63
7870063|NCT00856843|19369299|P1|COMPLETED|Overall Study||66
7870064|NCT00856843|19369298|P2|STARTED|Overall Study||68
7870065|NCT00856843|19369299|P1|STARTED|Overall Study||68
7870066|NCT00856830|19369335|P4|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
7870067|NCT00856830|19369336|P3|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
7870068|NCT00856830|19369337|P2|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
7870069|NCT00856830|19369338|P1|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
7870070|NCT00856830|19369335|P4|COMPLETED|Regimen - B (Carboplatin & Etoposide)||12
7870071|NCT00856830|19369336|P3|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
7870072|NCT00856830|19369337|P2|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
7870073|NCT00856830|19369338|P1|COMPLETED|Regimen - B (Carboplatin & Etoposide)||3
7870074|NCT00856830|19369335|P4|STARTED|Regimen - B (Carboplatin & Etoposide)||12
7870075|NCT00856830|19369336|P3|STARTED|Regimen - B (Carboplatin & Etoposide)||6
7870076|NCT00856830|19369337|P2|STARTED|Regimen - B (Carboplatin & Etoposide)||6
7870077|NCT00856830|19369338|P1|STARTED|Regimen - B (Carboplatin & Etoposide)||3
7870078|NCT00856830|19369335|P4|NOT COMPLETED|Irinotecan & Bendamustine||3
7870079|NCT00856830|19369336|P3|NOT COMPLETED|Irinotecan & Bendamustine||0
7870080|NCT00856830|19369337|P2|NOT COMPLETED|Irinotecan & Bendamustine||0
7870081|NCT00856830|19369338|P1|NOT COMPLETED|Irinotecan & Bendamustine||0
7870082|NCT00856830|19369335|P4|COMPLETED|Irinotecan & Bendamustine||12
7870083|NCT00856830|19369336|P3|COMPLETED|Irinotecan & Bendamustine||6
7870084|NCT00856830|19369337|P2|COMPLETED|Irinotecan & Bendamustine||6
7870085|NCT00856830|19369338|P1|COMPLETED|Irinotecan & Bendamustine||3
7870086|NCT00856830|19369335|P4|Maximum Tolerated Dose|Irinotecan & Bendamustine||12
7870087|NCT00856830|19369336|P3|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
7870088|NCT00856830|19369337|P2|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
7870089|NCT00856830|19369338|P1|Maximum Tolerated Dose|Irinotecan & Bendamustine||3
7870090|NCT00856830|19369335|P4|STARTED|Irinotecan & Bendamustine||15
7870091|NCT00856830|19369336|P3|STARTED|Irinotecan & Bendamustine||6
7870092|NCT00856830|19369337|P2|STARTED|Irinotecan & Bendamustine||6
7870093|NCT00856830|19369338|P1|STARTED|Irinotecan & Bendamustine||3
7870094|NCT00856791|19369344|P1|NOT COMPLETED|Overall Study||0
7870095|NCT00856791|19369344|P1|COMPLETED|Overall Study||1
7870096|NCT00856791|19369344|P1|STARTED|Overall Study||1
7870097|NCT00856778|19369349|P1|NOT COMPLETED|Overall Study||24
7870098|NCT00856778|19369349|P1|COMPLETED|Overall Study||74
7870099|NCT00856778|19369349|P1|STARTED|Overall Study||98
7870100|NCT00856739|19369368|P3|NOT COMPLETED|Overall Study||0
7870101|NCT00856739|19369369|P2|NOT COMPLETED|Overall Study||0
7870102|NCT00856739|19369370|P1|NOT COMPLETED|Overall Study||0
7870103|NCT00856739|19369368|P3|COMPLETED|Overall Study||55
7870104|NCT00856739|19369369|P2|COMPLETED|Overall Study||52
7870105|NCT00856739|19369370|P1|COMPLETED|Overall Study||70
7870106|NCT00856739|19369368|P3|STARTED|Overall Study||55
7870107|NCT00856739|19369369|P2|STARTED|Overall Study||52
7870108|NCT00856739|19369370|P1|STARTED|Overall Study||70
7870109|NCT00856726|19369381|P1|NOT COMPLETED|Overall Study||0
7870110|NCT00856726|19369381|P1|COMPLETED|Overall Study||26
7870111|NCT00856726|19369381|P1|STARTED|Overall Study||26
7870112|NCT00856661|19369392|P2|NOT COMPLETED|Overall Study||29
7870113|NCT00856661|19369393|P1|NOT COMPLETED|Overall Study||27
7870114|NCT00856661|19369392|P2|COMPLETED|Overall Study||106
7870115|NCT00856661|19369393|P1|COMPLETED|Overall Study||108
7870116|NCT00856661|19369392|P2|Randomized Not Treated|Overall Study||4
7870117|NCT00856661|19369393|P1|Randomized Not Treated|Overall Study||9
7870118|NCT00856661|19369392|P2|Treated|Overall Study||131
7870119|NCT00856661|19369393|P1|Treated|Overall Study||126
7870120|NCT00856661|19369392|P2|STARTED|Overall Study|Randomised|135
7870121|NCT00856661|19369393|P1|STARTED|Overall Study|Randomised|135
7870122|NCT00856635|19369407|P2|NOT COMPLETED|Overall Study||8
7870123|NCT00856635|19369408|P1|NOT COMPLETED|Overall Study||10
7870124|NCT00856635|19369407|P2|COMPLETED|Overall Study||14
7870125|NCT00856635|19369408|P1|COMPLETED|Overall Study||12
7870126|NCT00856635|19369407|P2|Received Study Drug|Overall Study||20
7870127|NCT00856635|19369408|P1|Received Study Drug|Overall Study||20
7870128|NCT00856635|19369407|P2|STARTED|Overall Study||22
7870129|NCT00856635|19369408|P1|STARTED|Overall Study||22
7870130|NCT00856609|19369418|P2|NOT COMPLETED|Overall Study||0
7870131|NCT00856609|19369419|P1|NOT COMPLETED|Overall Study||1
7870132|NCT00856609|19369418|P2|COMPLETED|Overall Study||39
7870133|NCT00856609|19369419|P1|COMPLETED|Overall Study||40
7870134|NCT00856609|19369418|P2|STARTED|Overall Study||39
7870135|NCT00856609|19369419|P1|STARTED|Overall Study||41
7870136|NCT00856583|19369431|P2|NOT COMPLETED|Overall Study||2597
7870137|NCT00856583|19369432|P1|NOT COMPLETED|Overall Study||3137
7870138|NCT00856583|19369431|P2|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307
7870139|NCT00856583|19369432|P1|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768
7870140|NCT00856583|19369431|P2|STARTED|Overall Study|Patients treated|4904
7870141|NCT00856583|19369432|P1|STARTED|Overall Study|Patients treated|4905
7870142|NCT00856557|19369462|P2|NOT COMPLETED|Overall Study||16
7870143|NCT00856557|19369463|P1|NOT COMPLETED|Overall Study||12
7870144|NCT00856557|19369462|P2|COMPLETED|Overall Study||60
7870145|NCT00856557|19369463|P1|COMPLETED|Overall Study||50
7870146|NCT00856557|19369462|P2|With Patients With Contextual Flags|Overall Study||60
7870147|NCT00856557|19369463|P1|With Patients With Contextual Flags|Overall Study||50
7870148|NCT00856557|19369462|P2|Tested With Standardized Patients|Overall Study||76
7870149|NCT00856557|19369463|P1|Tested With Standardized Patients|Overall Study||62
7870150|NCT00856557|19369462|P2|Received Intervention/Control|Overall Study||76
7870151|NCT00856557|19369463|P1|Received Intervention/Control|Overall Study||62
7870152|NCT00856557|19369462|P2|STARTED|Overall Study||76
7870153|NCT00856557|19369463|P1|STARTED|Overall Study||62
7870154|NCT00856544|19369477|P4|NOT COMPLETED|Overall Study||13
7870155|NCT00856544|19369478|P3|NOT COMPLETED|Overall Study||8
7870156|NCT00856544|19369479|P2|NOT COMPLETED|Overall Study||66
7870157|NCT00856544|19369480|P1|NOT COMPLETED|Overall Study||57
7870158|NCT00856544|19369477|P4|COMPLETED|Overall Study||67
7870159|NCT00856544|19369478|P3|COMPLETED|Overall Study||71
7870160|NCT00856544|19369479|P2|COMPLETED|Overall Study||252
7870161|NCT00856544|19369480|P1|COMPLETED|Overall Study||261
7870162|NCT00856544|19369477|P4|Treated|Overall Study||80
7870163|NCT00856544|19369478|P3|Treated|Overall Study||79
7870164|NCT00856544|19369479|P2|Treated|Overall Study||318
7870165|NCT00856544|19369480|P1|Treated|Overall Study||315
7870166|NCT00856544|19369477|P4|STARTED|Overall Study||80
7870167|NCT00856544|19369478|P3|STARTED|Overall Study||79
7870168|NCT00856544|19369479|P2|STARTED|Overall Study||318
7870169|NCT00856544|19369480|P1|STARTED|Overall Study||318
7870170|NCT00856518|19369659|P2|NOT COMPLETED|Overall Study||2
7870171|NCT00856518|19369660|P1|NOT COMPLETED|Overall Study||4
7870172|NCT00856518|19369659|P2|COMPLETED|Overall Study||16
7870173|NCT00856518|19369660|P1|COMPLETED|Overall Study||20
7870174|NCT00856518|19369659|P2|STARTED|Overall Study||18
7870175|NCT00856518|19369660|P1|STARTED|Overall Study||24
7870176|NCT00856492|19369673|P3|NOT COMPLETED|Overall Study||2
7870177|NCT00856492|19369674|P2|NOT COMPLETED|Overall Study||1
7870178|NCT00856492|19369675|P1|NOT COMPLETED|Overall Study||1
7870179|NCT00856492|19369673|P3|COMPLETED|Overall Study||51
7870180|NCT00856492|19369674|P2|COMPLETED|Overall Study||62
7870181|NCT00856492|19369675|P1|COMPLETED|Overall Study||98
7870182|NCT00856492|19369673|P3|Toxicity Eval|Overall Study||51
7870183|NCT00856492|19369674|P2|Toxicity Eval|Overall Study||60
7870184|NCT00856492|19369675|P1|Toxicity Eval|Overall Study||96
7870185|NCT00856492|19369673|P3|STARTED|Overall Study||53
7870186|NCT00856492|19369674|P2|STARTED|Overall Study||63
7870187|NCT00856492|19369675|P1|STARTED|Overall Study||99
7870188|NCT00856414|19369689|P1|NOT COMPLETED|Overall Study||0
7870189|NCT00856414|19369689|P1|COMPLETED|Overall Study||45
7870190|NCT00856414|19369689|P1|STARTED|Overall Study||45
7870191|NCT00856388|19369697|P1|NOT COMPLETED|Overall Study||1
7870192|NCT00856388|19369697|P1|COMPLETED|Overall Study||61
7870193|NCT00856388|19369697|P1|STARTED|Overall Study||62
7870194|NCT00856349|19369708|P1|NOT COMPLETED|Overall Study||1021
7870195|NCT00856349|19369708|P1|COMPLETED|Overall Study||3111
7870196|NCT00856349|19369708|P1|24 Month Follow-up|Overall Study||1698
7870197|NCT00856349|19369708|P1|18 Month Follow-up|Overall Study||2467
7870198|NCT00856349|19369708|P1|12 Month Follow-up|Overall Study||3228
7870199|NCT00856349|19369708|P1|STARTED|Overall Study||4132
7870200|NCT00856323|19369717|P1|NOT COMPLETED|Overall Study||2
7870201|NCT00856323|19369717|P1|COMPLETED|Overall Study||51
7870202|NCT00856323|19369717|P1|STARTED|Overall Study||53
7870203|NCT00856297|19369729|P5|NOT COMPLETED|Overall Study||0
7870204|NCT00856297|19369730|P4|NOT COMPLETED|Overall Study||0
7870205|NCT00856297|19369731|P3|NOT COMPLETED|Overall Study||0
7870206|NCT00856297|19369732|P2|NOT COMPLETED|Overall Study||0
7870207|NCT00856297|19369733|P1|NOT COMPLETED|Overall Study||2
7870208|NCT00856297|19369729|P5|COMPLETED|Overall Study||31
7870209|NCT00856297|19369730|P4|COMPLETED|Overall Study||44
7870210|NCT00856297|19369731|P3|COMPLETED|Overall Study||107
7870211|NCT00856297|19369732|P2|COMPLETED|Overall Study||76
7870212|NCT00856297|19369733|P1|COMPLETED|Overall Study||129
7870213|NCT00856297|19369729|P5|STARTED|Overall Study||31
7870214|NCT00856297|19369730|P4|STARTED|Overall Study||44
7870215|NCT00856297|19369731|P3|STARTED|Overall Study||107
7870216|NCT00856297|19369732|P2|STARTED|Overall Study||76
7870217|NCT00856297|19369733|P1|STARTED|Overall Study||131
7870218|NCT00856284|19369766|P3|NOT COMPLETED|Overall Study||447
7870219|NCT00856284|19369767|P2|NOT COMPLETED|Overall Study||392
7870220|NCT00856284|19369768|P1|NOT COMPLETED|Overall Study||408
7870221|NCT00856284|19369766|P3|COMPLETED|Overall Study||427
7870222|NCT00856284|19369767|P2|COMPLETED|Overall Study||493
7870223|NCT00856284|19369768|P1|COMPLETED|Overall Study||472
7870224|NCT00856284|19369766|P3|Received Study Drug|Overall Study||869
7870225|NCT00856284|19369767|P2|Received Study Drug|Overall Study||878
7870226|NCT00856284|19369768|P1|Received Study Drug|Overall Study||873
7870227|NCT00856284|19369766|P3|STARTED|Overall Study||874
7870228|NCT00856284|19369767|P2|STARTED|Overall Study||885
7870229|NCT00856284|19369768|P1|STARTED|Overall Study||880
7870230|NCT00856245|19369794|P1|NOT COMPLETED|Overall Study||5
7870231|NCT00856245|19369794|P1|COMPLETED|Overall Study||14
7870232|NCT00856245|19369794|P1|STARTED|Overall Study||19
7870233|NCT00856232|19369802|P3|NOT COMPLETED|Overall Study||0
7870234|NCT00856232|19369803|P2|NOT COMPLETED|Overall Study||0
7870235|NCT00856232|19369804|P1|NOT COMPLETED|Overall Study||0
7870236|NCT00856232|19369802|P3|COMPLETED|Overall Study||36
7870237|NCT00856232|19369803|P2|COMPLETED|Overall Study||29
7870238|NCT00856232|19369804|P1|COMPLETED|Overall Study||26
7870239|NCT00856232|19369802|P3|STARTED|Overall Study||36
7870240|NCT00856232|19369803|P2|STARTED|Overall Study||29
7870241|NCT00856232|19369804|P1|STARTED|Overall Study||26
7870242|NCT00856206|19369817|P2|NOT COMPLETED|Overall Study||161
7870243|NCT00856206|19369818|P1|NOT COMPLETED|Overall Study||54
7870244|NCT00856206|19369817|P2|COMPLETED|Overall Study||824
7870245|NCT00856206|19369818|P1|COMPLETED|Overall Study||276
7870246|NCT00856206|19369817|P2|STARTED|Overall Study||985
7870247|NCT00856206|19369818|P1|STARTED|Overall Study||330
7870248|NCT00856193|19369832|P2|NOT COMPLETED|Period 2||2
7870249|NCT00856193|19369833|P1|NOT COMPLETED|Period 2||0
7870250|NCT00856193|19369832|P2|COMPLETED|Period 2||15
7870251|NCT00856193|19369833|P1|COMPLETED|Period 2||16
7870252|NCT00856193|19369832|P2|STARTED|Period 2||17
7870253|NCT00856193|19369833|P1|STARTED|Period 2||16
7870254|NCT00856193|19369832|P2|NOT COMPLETED|Period 1||0
7870255|NCT00856193|19369833|P1|NOT COMPLETED|Period 1||0
7870256|NCT00856193|19369832|P2|COMPLETED|Period 1||17
7870257|NCT00856193|19369833|P1|COMPLETED|Period 1||16
7870258|NCT00856193|19369832|P2|STARTED|Period 1||17
7870259|NCT00856193|19369833|P1|STARTED|Period 1||16
7870260|NCT00856180|19369845|P1|NOT COMPLETED|Overall Study||20
7870261|NCT00856180|19369845|P1|COMPLETED|Overall Study||0
7870262|NCT00856180|19369845|P1|STARTED|Overall Study||20
7870263|NCT00856050|19369854|P1|NOT COMPLETED|Overall Study||0
7870264|NCT00856050|19369854|P1|COMPLETED|Overall Study||26
7870265|NCT00856050|19369854|P1|STARTED|Overall Study||26
7870266|NCT00856024|19369858|P1|NOT COMPLETED|Overall Study||0
7870267|NCT00856024|19369858|P1|COMPLETED|Overall Study||902
7870268|NCT00856024|19369858|P1|STARTED|Overall Study||902
7870269|NCT00855959|19369870|P1|NOT COMPLETED|Overall Study||9
7870270|NCT00855959|19369870|P1|COMPLETED|Overall Study||99
7870271|NCT00855959|19369870|P1|Patients Who Received Pulmicort Respules|Overall Study||105
7870272|NCT00855959|19369870|P1|STARTED|Overall Study||108
7870273|NCT00855933|19369887|P2|NOT COMPLETED|Overall Study||1
7870274|NCT00855933|19369888|P1|NOT COMPLETED|Overall Study||0
7870275|NCT00855933|19369887|P2|COMPLETED|Overall Study||29
7870276|NCT00855933|19369888|P1|COMPLETED|Overall Study||30
7870277|NCT00855933|19369887|P2|STARTED|Overall Study||30
7870278|NCT00855933|19369888|P1|STARTED|Overall Study||30
7870279|NCT00855920|19369897|P3|NOT COMPLETED|Overall Study||11
7870280|NCT00855920|19369898|P2|NOT COMPLETED|Overall Study||9
7870281|NCT00855920|19369899|P1|NOT COMPLETED|Overall Study||8
7870282|NCT00855920|19369897|P3|COMPLETED|Overall Study||64
7870283|NCT00855920|19369898|P2|COMPLETED|Overall Study||65
7870284|NCT00855920|19369899|P1|COMPLETED|Overall Study||68
7870285|NCT00855920|19369897|P3|Safety Population|Overall Study||75
7870286|NCT00855920|19369898|P2|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|73
7870287|NCT00855920|19369899|P1|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|77
7870288|NCT00855920|19369897|P3|STARTED|Overall Study||75
7870289|NCT00855920|19369898|P2|STARTED|Overall Study||74
7870290|NCT00855920|19369899|P1|STARTED|Overall Study||76
7870291|NCT00855894|19369916|P1|NOT COMPLETED|Overall Study||33
7870292|NCT00855894|19369916|P1|COMPLETED|Overall Study||8
7870293|NCT00855894|19369916|P1|STARTED|Overall Study||41
7870294|NCT00855868|19369926|P2|NOT COMPLETED|Overall Study||1
7870295|NCT00855868|19369927|P1|NOT COMPLETED|Overall Study||1
7870296|NCT00855868|19369926|P2|COMPLETED|Overall Study||14
7870297|NCT00855868|19369927|P1|COMPLETED|Overall Study||12
7870298|NCT00855868|19369926|P2|STARTED|Overall Study||15
7870299|NCT00855868|19369927|P1|STARTED|Overall Study||13
7870300|NCT00855842|19369933|P1|NOT COMPLETED|Overall Study||0
7870301|NCT00855842|19369933|P1|COMPLETED|Overall Study||4
7870302|NCT00855842|19369933|P1|STARTED|Overall Study||4
7870303|NCT00855816|19369939|P2|NOT COMPLETED|Overall Study||21
7870304|NCT00855816|19369940|P1|NOT COMPLETED|Overall Study||26
7870305|NCT00855816|19369939|P2|COMPLETED|Overall Study||12
7870306|NCT00855816|19369940|P1|COMPLETED|Overall Study||21
7870307|NCT00855816|19369939|P2|STARTED|Overall Study||33
7870308|NCT00855816|19369940|P1|STARTED|Overall Study||47
7870309|NCT00855738|19369946|P1|NOT COMPLETED|Overall Study||5
7870310|NCT00855738|19369946|P1|COMPLETED|Overall Study||106
7870311|NCT00855738|19369946|P1|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108
7870312|NCT00855738|19369946|P1|STARTED|Overall Study||111
7870313|NCT00855595|19369974|P2|NOT COMPLETED|Overall Study||7
7870314|NCT00855595|19369975|P1|NOT COMPLETED|Overall Study||6
7870315|NCT00855595|19369974|P2|COMPLETED|Overall Study||94
7870316|NCT00855595|19369975|P1|COMPLETED|Overall Study||100
7870317|NCT00855595|19369974|P2|STARTED|Overall Study||101
7870318|NCT00855595|19369975|P1|STARTED|Overall Study||106
7870319|NCT00855582|19370014|P3|NOT COMPLETED|Overall Study||30
7870320|NCT00855582|19370015|P2|NOT COMPLETED|Overall Study||24
7870321|NCT00855582|19370016|P1|NOT COMPLETED|Overall Study||26
7870322|NCT00855582|19370014|P3|COMPLETED|Overall Study||170
7870323|NCT00855582|19370015|P2|COMPLETED|Overall Study||184
7870324|NCT00855582|19370016|P1|COMPLETED|Overall Study||172
7870325|NCT00855582|19370014|P3|STARTED|Overall Study||200
7870326|NCT00855582|19370015|P2|STARTED|Overall Study||208
7870327|NCT00855582|19370016|P1|STARTED|Overall Study||198
7870328|NCT00855465|19370105|P2|NOT COMPLETED|Follow-up Period (FUP)||2
7870329|NCT00855465|19370106|P1|NOT COMPLETED|Follow-up Period (FUP)||8
7870330|NCT00855465|19370105|P2|COMPLETED|Follow-up Period (FUP)||2
7870331|NCT00855465|19370106|P1|COMPLETED|Follow-up Period (FUP)||9
7870332|NCT00855465|19370105|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4
7870333|NCT00855465|19370106|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17
7870334|NCT00855465|19370105|P2|NOT COMPLETED|Treatment Period||5
7870335|NCT00855465|19370106|P1|NOT COMPLETED|Treatment Period||14
7870336|NCT00855465|19370105|P2|COMPLETED|Treatment Period||83
7870337|NCT00855465|19370106|P1|COMPLETED|Treatment Period||160
7870338|NCT00855465|19370105|P2|Participants Received Treatment|Treatment Period||88
7870339|NCT00855465|19370106|P1|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173
7870340|NCT00855465|19370105|P2|STARTED|Treatment Period||88
7870341|NCT00855465|19370106|P1|STARTED|Treatment Period||174
7870342|NCT00855439|19370196|P2|NOT COMPLETED|Overall Study||0
7870343|NCT00855439|19370197|P1|NOT COMPLETED|Overall Study||3
7870344|NCT00855439|19370196|P2|COMPLETED|Overall Study||24
7870345|NCT00855439|19370197|P1|COMPLETED|Overall Study||19
7870346|NCT00855439|19370196|P2|STARTED|Overall Study||24
7870347|NCT00855439|19370197|P1|STARTED|Overall Study||22
7870348|NCT00855413|19370209|P1|NOT COMPLETED|Overall Study||0
7870349|NCT00855413|19370209|P1|COMPLETED|Overall Study||15
7870350|NCT00855413|19370209|P1|STARTED|Overall Study||15
7870351|NCT00855335|19370255|P5|NOT COMPLETED|Overall Study||1
7870352|NCT00855335|19370256|P4|NOT COMPLETED|Overall Study||7
7870353|NCT00855335|19370257|P3|NOT COMPLETED|Overall Study||5
7870354|NCT00855335|19370258|P2|NOT COMPLETED|Overall Study||2
7870355|NCT00855335|19370259|P1|NOT COMPLETED|Overall Study||5
7870356|NCT00855335|19370255|P5|COMPLETED|Overall Study||6
7870357|NCT00855335|19370256|P4|COMPLETED|Overall Study||12
7870358|NCT00855335|19370257|P3|COMPLETED|Overall Study||10
7870359|NCT00855335|19370258|P2|COMPLETED|Overall Study||16
7870360|NCT00855335|19370259|P1|COMPLETED|Overall Study||13
7870361|NCT00855335|19370255|P5|STARTED|Overall Study||7
7870362|NCT00855335|19370256|P4|STARTED|Overall Study||19
7870363|NCT00855335|19370257|P3|STARTED|Overall Study||15
7870364|NCT00855335|19370258|P2|STARTED|Overall Study||18
7870365|NCT00855335|19370259|P1|STARTED|Overall Study||18
7870366|NCT00855309|19370346|P2|NOT COMPLETED|Overall Study||0
7870367|NCT00855309|19370347|P1|NOT COMPLETED|Overall Study||1
7870368|NCT00855309|19370346|P2|COMPLETED|Overall Study||55
7870369|NCT00855309|19370347|P1|COMPLETED|Overall Study||56
7870370|NCT00855309|19370346|P2|STARTED|Overall Study||55
7870371|NCT00855309|19370347|P1|STARTED|Overall Study||57
7870372|NCT00855218|19370355|P2|NOT COMPLETED|Overall Study||153
7870373|NCT00855218|19370356|P1|NOT COMPLETED|Overall Study||154
7870374|NCT00855218|19370355|P2|COMPLETED|Overall Study||0
7870375|NCT00855218|19370356|P1|COMPLETED|Overall Study||0
7870376|NCT00855218|19370355|P2|Participants Received Treatment|Overall Study||151
7870377|NCT00855218|19370356|P1|Participants Received Treatment|Overall Study||153
7870378|NCT00855218|19370355|P2|STARTED|Overall Study||153
7870379|NCT00855218|19370356|P1|STARTED|Overall Study||154
7870380|NCT00855166|19370374|P2|NOT COMPLETED|Overall Study||8
7870381|NCT00855166|19370375|P1|NOT COMPLETED|Overall Study||5
7870382|NCT00855166|19370374|P2|COMPLETED|Overall Study||83
7870383|NCT00855166|19370375|P1|COMPLETED|Overall Study||86
7870384|NCT00855166|19370374|P2|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91
7870385|NCT00855166|19370375|P1|STARTED|Overall Study||91
7870386|NCT00855062|19370395|P2|NOT COMPLETED|Step2||6
7870387|NCT00855062|19370396|P1|NOT COMPLETED|Step2||6
7870388|NCT00855062|19370395|P2|COMPLETED|Step2||15
7870389|NCT00855062|19370396|P1|COMPLETED|Step2||13
7870390|NCT00855062|19370395|P2|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21
7870391|NCT00855062|19370396|P1|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19
7870392|NCT00855062|19370395|P2|NOT COMPLETED|Step1||11
7870393|NCT00855062|19370396|P1|NOT COMPLETED|Step1||10
7870394|NCT00855062|19370395|P2|COMPLETED|Step1||26
7870395|NCT00855062|19370396|P1|COMPLETED|Step1||26
7870396|NCT00855062|19370395|P2|STARTED|Step1||37
7870397|NCT00855062|19370396|P1|STARTED|Step1||36
7870398|NCT00855010|19370422|P2|NOT COMPLETED|Overall Study||1
7870399|NCT00855010|19370423|P1|NOT COMPLETED|Overall Study||4
7870400|NCT00855010|19370422|P2|COMPLETED|Overall Study||18
7870401|NCT00855010|19370423|P1|COMPLETED|Overall Study||19
7870402|NCT00855010|19370422|P2|STARTED|Overall Study||19
7870403|NCT00855010|19370423|P1|STARTED|Overall Study||23
7870404|NCT00854906|19370445|P1|NOT COMPLETED|Overall Study||1
7870405|NCT00854906|19370445|P1|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25
7870406|NCT00854906|19370445|P1|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26
7870407|NCT00854724|19370454|P2|NOT COMPLETED|Second Intervention||1
7870408|NCT00854724|19370455|P1|NOT COMPLETED|Second Intervention||1
7870409|NCT00854724|19370454|P2|COMPLETED|Second Intervention||5
7870410|NCT00854724|19370455|P1|COMPLETED|Second Intervention||5
7870411|NCT00854724|19370454|P2|STARTED|Second Intervention||6
7870412|NCT00854724|19370455|P1|STARTED|Second Intervention||6
7870413|NCT00854724|19370454|P2|NOT COMPLETED|Washout||1
7870414|NCT00854724|19370455|P1|NOT COMPLETED|Washout||1
7870415|NCT00854724|19370454|P2|COMPLETED|Washout||6
7870416|NCT00854724|19370455|P1|COMPLETED|Washout||6
7870417|NCT00854724|19370454|P2|STARTED|Washout||7
7870418|NCT00854724|19370455|P1|STARTED|Washout||7
7870419|NCT00854724|19370454|P2|NOT COMPLETED|First Intervention||1
7870420|NCT00854724|19370455|P1|NOT COMPLETED|First Intervention||1
7870421|NCT00854724|19370454|P2|COMPLETED|First Intervention||7
7870422|NCT00854724|19370455|P1|COMPLETED|First Intervention||7
7870423|NCT00854724|19370454|P2|STARTED|First Intervention||8
7870424|NCT00854724|19370455|P1|STARTED|First Intervention||8
7870425|NCT00854620|19370461|P1|NOT COMPLETED|Overall Study||1
7870426|NCT00854620|19370461|P1|COMPLETED|Overall Study||8
7870427|NCT00854620|19370461|P1|STARTED|Overall Study||9
7870428|NCT00854607|19370465|P1|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65
7870429|NCT00854607|19370465|P1|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51
7870430|NCT00854607|19370465|P1|STARTED|2 Weeks After Start Anti-fungal Therapy||116
7870431|NCT00854607|19370465|P1|NOT COMPLETED|Enrollment||0
7870432|NCT00854607|19370465|P1|COMPLETED|Enrollment||116
7870433|NCT00854607|19370465|P1|STARTED|Enrollment||116
7870434|NCT00854594|19370500|P2|NOT COMPLETED|Overall Study||0
7870435|NCT00854594|19370501|P1|NOT COMPLETED|Overall Study||0
7870436|NCT00854594|19370500|P2|COMPLETED|Overall Study||69
7870437|NCT00854594|19370501|P1|COMPLETED|Overall Study||48
7870438|NCT00854594|19370500|P2|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69
7870439|NCT00854594|19370501|P1|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48
7870440|NCT00854581|19370513|P1|NOT COMPLETED|Part 2 Maintenance (Up to 12 Months)||3
7870441|NCT00854581|19370513|P1|COMPLETED|Part 2 Maintenance (Up to 12 Months)||2
7870442|NCT00854581|19370513|P1|STARTED|Part 2 Maintenance (Up to 12 Months)||5
7870443|NCT00854581|19370513|P1|NOT COMPLETED|Part 1 Maintenance (Up to Day 60)||2
7870444|NCT00854581|19370513|P1|COMPLETED|Part 1 Maintenance (Up to Day 60)||5
7870445|NCT00854581|19370513|P1|STARTED|Part 1 Maintenance (Up to Day 60)||7
7870446|NCT00854581|19370513|P1|NOT COMPLETED|Induction (Up to Day 21)||6
7870447|NCT00854581|19370513|P1|COMPLETED|Induction (Up to Day 21)||7
7870448|NCT00854581|19370513|P1|STARTED|Induction (Up to Day 21)||13
7870449|NCT00854373|19370528|P2|NOT COMPLETED|Overall Study||4
7870450|NCT00854373|19370529|P1|NOT COMPLETED|Overall Study||2
7870451|NCT00854373|19370528|P2|COMPLETED|Overall Study||89
7870452|NCT00854373|19370529|P1|COMPLETED|Overall Study||93
7870453|NCT00854373|19370528|P2|STARTED|Overall Study||93
7870454|NCT00854373|19370529|P1|STARTED|Overall Study||95
7870455|NCT00854360|19370543|P4|NOT COMPLETED|Overall Study||10
7870456|NCT00854360|19370544|P3|NOT COMPLETED|Overall Study||2
7870457|NCT00854360|19370545|P2|NOT COMPLETED|Overall Study||3
7870458|NCT00854360|19370546|P1|NOT COMPLETED|Overall Study||2
7870459|NCT00854360|19370543|P4|COMPLETED|Overall Study||114
7870460|NCT00854360|19370544|P3|COMPLETED|Overall Study||120
7870461|NCT00854360|19370545|P2|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120
7870462|NCT00854360|19370546|P1|COMPLETED|Overall Study||116
7870463|NCT00854360|19370543|P4|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123
7870464|NCT00854360|19370544|P3|Intent to Treat / Safety Population|Overall Study||122
7870465|NCT00854360|19370545|P2|Intent to Treat / Safety Population|Overall Study||123
7870466|NCT00854360|19370546|P1|Intent to Treat / Safety Population|Overall Study||118
7870467|NCT00854360|19370543|P4|STARTED|Overall Study||124
7870468|NCT00854360|19370544|P3|STARTED|Overall Study||122
7870469|NCT00854360|19370545|P2|STARTED|Overall Study||123
7870470|NCT00854360|19370546|P1|STARTED|Overall Study||118
7870471|NCT00854308|19370578|P2|NOT COMPLETED|Overall Study||67
7870472|NCT00854308|19370579|P1|NOT COMPLETED|Overall Study||62
7870473|NCT00854308|19370578|P2|COMPLETED|Overall Study||1
7870474|NCT00854308|19370579|P1|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7
7870475|NCT00854308|19370578|P2|Received Study Drug|Overall Study||67
7870476|NCT00854308|19370579|P1|Received Study Drug|Overall Study||69
7870477|NCT00854308|19370578|P2|STARTED|Overall Study||68
7870478|NCT00854308|19370579|P1|STARTED|Overall Study||69
7870479|NCT00854113|19370604|P11|NOT COMPLETED|Overall Study||0
7870480|NCT00854113|19370605|P10|NOT COMPLETED|Overall Study||0
7870481|NCT00854113|19370606|P9|NOT COMPLETED|Overall Study||1
7870482|NCT00854113|19370607|P8|NOT COMPLETED|Overall Study||3
7870483|NCT00854113|19370608|P7|NOT COMPLETED|Overall Study||0
7870484|NCT00854113|19370609|P6|NOT COMPLETED|Overall Study||0
7870485|NCT00854113|19370610|P5|NOT COMPLETED|Overall Study||0
7870486|NCT00854113|19370611|P4|NOT COMPLETED|Overall Study||0
7870487|NCT00854113|19370612|P3|NOT COMPLETED|Overall Study||0
7870488|NCT00854113|19370613|P2|NOT COMPLETED|Overall Study||0
7870489|NCT00854113|19370614|P1|NOT COMPLETED|Overall Study||0
7870490|NCT00854113|19370604|P11|COMPLETED|Overall Study||6
7870491|NCT00854113|19370605|P10|COMPLETED|Overall Study||8
7870492|NCT00854113|19370606|P9|COMPLETED|Overall Study||7
7870493|NCT00854113|19370607|P8|COMPLETED|Overall Study||5
7870494|NCT00854113|19370608|P7|COMPLETED|Overall Study||12
7870495|NCT00854113|19370609|P6|COMPLETED|Overall Study||6
7870496|NCT00854113|19370610|P5|COMPLETED|Overall Study||6
7870497|NCT00854113|19370611|P4|COMPLETED|Overall Study||6
7870498|NCT00854113|19370612|P3|COMPLETED|Overall Study||6
7870499|NCT00854113|19370613|P2|COMPLETED|Overall Study||6
7870500|NCT00854113|19370614|P1|COMPLETED|Overall Study||6
7870501|NCT00854113|19370604|P11|STARTED|Overall Study||6
7870502|NCT00854113|19370605|P10|STARTED|Overall Study||8
7870503|NCT00854113|19370606|P9|STARTED|Overall Study||8
7870504|NCT00854113|19370607|P8|STARTED|Overall Study||8
7870505|NCT00854113|19370608|P7|STARTED|Overall Study||12
7870506|NCT00854113|19370609|P6|STARTED|Overall Study||6
7870507|NCT00854113|19370610|P5|STARTED|Overall Study||6
7870508|NCT00854113|19370611|P4|STARTED|Overall Study||6
7870509|NCT00854113|19370612|P3|STARTED|Overall Study||6
7870510|NCT00854113|19370613|P2|STARTED|Overall Study||6
7870511|NCT00854113|19370614|P1|STARTED|Overall Study||6
7870512|NCT00854100|19370718|P3|NOT COMPLETED|Overall Study||11
7870513|NCT00854100|19370719|P2|NOT COMPLETED|Overall Study||6
7870514|NCT00854100|19370720|P1|NOT COMPLETED|Overall Study||9
7870515|NCT00854100|19370718|P3|COMPLETED|Overall Study||63
7870516|NCT00854100|19370719|P2|COMPLETED|Overall Study||70
7870517|NCT00854100|19370720|P1|COMPLETED|Overall Study||72
7870518|NCT00854100|19370718|P3|STARTED|Overall Study||74
7870519|NCT00854100|19370719|P2|STARTED|Overall Study||76
7870520|NCT00854100|19370720|P1|STARTED|Overall Study||81
7870521|NCT00854087|19370734|P2|NOT COMPLETED|Overall Study||19
7870522|NCT00854087|19370735|P1|NOT COMPLETED|Overall Study||19
7870523|NCT00854087|19370734|P2|COMPLETED|Overall Study||40
7870524|NCT00854087|19370735|P1|COMPLETED|Overall Study||40
7870525|NCT00854087|19370734|P2|STARTED|Overall Study||59
7870526|NCT00854087|19370735|P1|STARTED|Overall Study||59
7870527|NCT00854061|19370741|P1|NOT COMPLETED|Overall Study||23
7870528|NCT00854061|19370741|P1|COMPLETED|Overall Study||149
7870529|NCT00854061|19370741|P1|Completed 2nd Surgery (T-PRED and Pred Forte in Opposite Eyes Compared to 1st Surgery)|Overall Study||149
7870530|NCT00854061|19370741|P1|Completed 1st Surgery (T-PRED in One Eye and Pred Forte in the Other Eye)|Overall Study||162
7870531|NCT00854061|19370741|P1|STARTED|Overall Study||172
7870532|NCT00853996|19370747|P1|NOT COMPLETED|Overall Study||0
7870533|NCT00853996|19370747|P1|COMPLETED|Overall Study||25
7870534|NCT00853996|19370747|P1|STARTED|Overall Study||25
7870535|NCT00853970|19370759|P2|NOT COMPLETED|Overall Study||3
7870536|NCT00853970|19370760|P1|NOT COMPLETED|Overall Study||6
7870537|NCT00853970|19370759|P2|COMPLETED|Overall Study||144
7870538|NCT00853970|19370760|P1|COMPLETED|Overall Study||146
7870539|NCT00853970|19370759|P2|STARTED|Overall Study||147
7870540|NCT00853970|19370760|P1|STARTED|Overall Study||152
7870541|NCT00853957|19370770|P2|NOT COMPLETED|Overall Study||19
7870542|NCT00853957|19370771|P1|NOT COMPLETED|Overall Study||14
7870543|NCT00853957|19370770|P2|COMPLETED|Overall Study||204
7870544|NCT00853957|19370771|P1|COMPLETED|Overall Study||206
7870545|NCT00853957|19370770|P2|STARTED|Overall Study||223
7870546|NCT00853957|19370771|P1|STARTED|Overall Study||220
7870547|NCT00853905|19370789|P2|NOT COMPLETED|Overall Study||4
7870548|NCT00853905|19370790|P1|NOT COMPLETED|Overall Study||2
7870549|NCT00853905|19370789|P2|COMPLETED|Overall Study||36
7870550|NCT00853905|19370790|P1|COMPLETED|Overall Study||35
7870551|NCT00853905|19370789|P2|STARTED|Overall Study||40
7870552|NCT00853905|19370790|P1|STARTED|Overall Study||37
7870553|NCT00853840|19370804|P2|NOT COMPLETED|Period 2||0
7870554|NCT00853840|19370805|P1|NOT COMPLETED|Period 2||0
7870555|NCT00853840|19370804|P2|COMPLETED|Period 2||9
7870556|NCT00853840|19370805|P1|COMPLETED|Period 2||9
7870557|NCT00853840|19370804|P2|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
7870558|NCT00853840|19370805|P1|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
7870559|NCT00853840|19370804|P2|Maraviroc (Days 1 - 3)|Period 2||9
7870560|NCT00853840|19370805|P1|Maraviroc (Days 1 - 3)|Period 2||9
7870561|NCT00853840|19370804|P2|STARTED|Period 2||9
7870562|NCT00853840|19370805|P1|STARTED|Period 2||9
7870563|NCT00853840|19370804|P2|NOT COMPLETED|Period 1||0
7870564|NCT00853840|19370805|P1|NOT COMPLETED|Period 1||0
7870565|NCT00853840|19370804|P2|COMPLETED|Period 1||9
7870566|NCT00853840|19370805|P1|COMPLETED|Period 1||9
7870567|NCT00853840|19370804|P2|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
7870568|NCT00853840|19370805|P1|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
7870569|NCT00853840|19370804|P2|Maraviroc (Days 1 - 4)|Period 1||9
7870570|NCT00853840|19370805|P1|Maraviroc (Days 1 - 4)|Period 1||9
7870571|NCT00853840|19370804|P2|STARTED|Period 1||9
7870572|NCT00853840|19370805|P1|STARTED|Period 1||9
7870573|NCT00853827|19370822|P2|NOT COMPLETED|Double Blind Period (103 Weeks)||109
7870574|NCT00853827|19370823|P1|NOT COMPLETED|Double Blind Period (103 Weeks)||104
7870575|NCT00853827|19370822|P2|COMPLETED|Double Blind Period (103 Weeks)||199
7870576|NCT00853827|19370823|P1|COMPLETED|Double Blind Period (103 Weeks)||201
7870577|NCT00853827|19370822|P2|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233
7870578|NCT00853827|19370823|P1|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225
7870579|NCT00853827|19370822|P2|STARTED|Double Blind Period (103 Weeks)||308
7870580|NCT00853827|19370823|P1|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305
7870581|NCT00853827|19370822|P2|NOT COMPLETED|Single Blind Period (1 Week)||0
7870582|NCT00853827|19370823|P1|NOT COMPLETED|Single Blind Period (1 Week)||39
7870583|NCT00853827|19370822|P2|COMPLETED|Single Blind Period (1 Week)||0
7870584|NCT00853827|19370823|P1|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613
7870585|NCT00853827|19370822|P2|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0
7870586|NCT00853827|19370823|P1|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652
7870587|NCT00853762|19370839|P4|NOT COMPLETED|Overall Study||22
7870588|NCT00853762|19370840|P3|NOT COMPLETED|Overall Study||17
7870589|NCT00853762|19370841|P2|NOT COMPLETED|Overall Study||19
7870590|NCT00853762|19370842|P1|NOT COMPLETED|Overall Study||16
7870591|NCT00853762|19370839|P4|COMPLETED|Overall Study||0
7870592|NCT00853762|19370840|P3|COMPLETED|Overall Study||0
7870593|NCT00853762|19370841|P2|COMPLETED|Overall Study||0
7870594|NCT00853762|19370842|P1|COMPLETED|Overall Study||0
7870595|NCT00853762|19370839|P4|STARTED|Overall Study||22
7870596|NCT00853762|19370840|P3|STARTED|Overall Study||17
7870597|NCT00853762|19370841|P2|STARTED|Overall Study||19
7870598|NCT00853762|19370842|P1|STARTED|Overall Study||16
7870599|NCT00853749|19370910|P2|NOT COMPLETED|Overall Study||1
7870600|NCT00853749|19370911|P1|NOT COMPLETED|Overall Study||0
7870601|NCT00853749|19370910|P2|COMPLETED|Overall Study||38
7870602|NCT00853749|19370911|P1|COMPLETED|Overall Study||50
7870603|NCT00853749|19370910|P2|Vaccinated|Overall Study||39
7870604|NCT00853749|19370911|P1|Vaccinated|Overall Study||50
7870605|NCT00853749|19370910|P2|STARTED|Overall Study||39
7870606|NCT00853749|19370911|P1|STARTED|Overall Study||50
7870607|NCT00853723|19370932|P3|NOT COMPLETED|Overall Study||2
7870608|NCT00853723|19370933|P2|NOT COMPLETED|Overall Study||7
7870609|NCT00853723|19370934|P1|NOT COMPLETED|Overall Study||6
7870610|NCT00853723|19370932|P3|COMPLETED|Overall Study||33
7870611|NCT00853723|19370933|P2|COMPLETED|Overall Study||28
7870612|NCT00853723|19370934|P1|COMPLETED|Overall Study||29
7870613|NCT00853723|19370932|P3|STARTED|Overall Study||35
7870614|NCT00853723|19370933|P2|STARTED|Overall Study||35
7870615|NCT00853723|19370934|P1|STARTED|Overall Study||35
7870616|NCT00853671|19370978|P1|NOT COMPLETED|Overall Study||0
7870617|NCT00853671|19370978|P1|COMPLETED|Overall Study||50
7870618|NCT00853671|19370978|P1|STARTED|Overall Study||50
7870619|NCT00853658|19370988|P3|NOT COMPLETED|Overall Study||815
7870620|NCT00853658|19370989|P2|NOT COMPLETED|Overall Study||832
7870621|NCT00853658|19370990|P1|NOT COMPLETED|Overall Study||787
7870622|NCT00853658|19370988|P3|COMPLETED|Overall Study||1539
7870623|NCT00853658|19370989|P2|COMPLETED|Overall Study||1524
7870624|NCT00853658|19370990|P1|COMPLETED|Overall Study||1567
7870625|NCT00853658|19370988|P3|Safety Set|Overall Study||2345
7870626|NCT00853658|19370989|P2|Safety Set|Overall Study||2348
7870627|NCT00853658|19370990|P1|Safety Set|Overall Study||2347
7870628|NCT00853658|19370988|P3|Full Analysis Set (FAS)|Overall Study||2336
7870629|NCT00853658|19370989|P2|Full Analysis Set (FAS)|Overall Study||2340
7870630|NCT00853658|19370990|P1|Full Analysis Set (FAS)|Overall Study||2340
7870631|NCT00853658|19370988|P3|STARTED|Overall Study||2354
7870632|NCT00853658|19370989|P2|STARTED|Overall Study||2356
7870633|NCT00853658|19370990|P1|STARTED|Overall Study||2354
7870634|NCT00853606|19371004|P1|NOT COMPLETED|Overall Study||220
7870635|NCT00853606|19371004|P1|COMPLETED|Overall Study||492
7870636|NCT00853606|19371004|P1|STARTED|Overall Study||712
7870637|NCT00853593|19371010|P1|NOT COMPLETED|Overall Study||45
7870638|NCT00853593|19371010|P1|COMPLETED|Overall Study||152
7870639|NCT00853593|19371010|P1|Model 4396 Lead Attempted|Overall Study||164
7870640|NCT00853593|19371010|P1|Implant Attempted|Overall Study||193
7870641|NCT00853593|19371010|P1|STARTED|Overall Study||197
7870642|NCT00853580|19371037|P2|NOT COMPLETED|Overall Study||16
7870643|NCT00853580|19371038|P1|NOT COMPLETED|Overall Study||7
7870644|NCT00853580|19371037|P2|COMPLETED|Overall Study||56
7870645|NCT00853580|19371038|P1|COMPLETED|Overall Study||67
7870646|NCT00853580|19371037|P2|STARTED|Overall Study||72
7870647|NCT00853580|19371038|P1|STARTED|Overall Study||74
7870648|NCT00853567|19371085|P1|NOT COMPLETED|Overall Study||71
7870649|NCT00853567|19371085|P1|COMPLETED|Overall Study||0
7870650|NCT00853567|19371085|P1|STARTED|Overall Study||71
7870651|NCT00853489|19371095|P2|NOT COMPLETED|Overall Study||2
7870652|NCT00853489|19371096|P1|NOT COMPLETED|Overall Study||5
7870653|NCT00853489|19371095|P2|COMPLETED|Overall Study||12
7870654|NCT00853489|19371096|P1|COMPLETED|Overall Study||11
7870655|NCT00853489|19371095|P2|STARTED|Overall Study||14
7870656|NCT00853489|19371096|P1|STARTED|Overall Study||16
7870657|NCT00853385|19371111|P5|NOT COMPLETED|Overall Study||42
7870658|NCT00853385|19371112|P4|NOT COMPLETED|Overall Study||13
7870659|NCT00853385|19371113|P3|NOT COMPLETED|Overall Study||9
7870660|NCT00853385|19371114|P2|NOT COMPLETED|Overall Study||43
7870661|NCT00853385|19371115|P1|NOT COMPLETED|Overall Study||54
7870662|NCT00853385|19371111|P5|COMPLETED|Overall Study||162
7870663|NCT00853385|19371112|P4|COMPLETED|Overall Study||39
7870664|NCT00853385|19371113|P3|COMPLETED|Overall Study||47
7870665|NCT00853385|19371114|P2|COMPLETED|Overall Study||158
7870666|NCT00853385|19371115|P1|COMPLETED|Overall Study||150
7870667|NCT00853385|19371111|P5|STARTED|Overall Study||204
7870668|NCT00853385|19371112|P4|STARTED|Overall Study||52
7870669|NCT00853385|19371113|P3|STARTED|Overall Study||56
7870670|NCT00853385|19371114|P2|STARTED|Overall Study||201
7870671|NCT00853385|19371115|P1|STARTED|Overall Study||204
7870672|NCT00853372|19371330|P2|NOT COMPLETED|Overall Study||29
7870673|NCT00853372|19371331|P1|NOT COMPLETED|Overall Study||32
7870674|NCT00853372|19371330|P2|COMPLETED|Overall Study||13
7870675|NCT00853372|19371331|P1|COMPLETED|Overall Study||11
7870676|NCT00853372|19371330|P2|STARTED|Overall Study||42
7870677|NCT00853372|19371331|P1|STARTED|Overall Study||43
7870678|NCT00853333|19371368|P3|NOT COMPLETED|Overall Study||0
7870679|NCT00853333|19371369|P2|NOT COMPLETED|Overall Study||0
7870680|NCT00853333|19371370|P1|NOT COMPLETED|Overall Study||0
7870681|NCT00853333|19371368|P3|COMPLETED|Overall Study||31
7870682|NCT00853333|19371369|P2|COMPLETED|Overall Study||27
7870683|NCT00853333|19371370|P1|COMPLETED|Overall Study||28
7870684|NCT00853333|19371368|P3|STARTED|Overall Study||31
7870685|NCT00853333|19371369|P2|STARTED|Overall Study||27
7870686|NCT00853333|19371370|P1|STARTED|Overall Study||28
7870687|NCT00853307|19371380|P2|NOT COMPLETED|Overall Study||5
7870688|NCT00853307|19371381|P1|NOT COMPLETED|Overall Study||2
7870689|NCT00853307|19371380|P2|COMPLETED|Overall Study||20
7870690|NCT00853307|19371381|P1|COMPLETED|Overall Study|Completed = participants who completed the study treatment.|4
7870691|NCT00853307|19371380|P2|STARTED|Overall Study||25
7870692|NCT00853307|19371381|P1|STARTED|Overall Study||6
7870693|NCT00853242|19371408|P7|NOT COMPLETED|Overall Study||5
7870694|NCT00853242|19371409|P6|NOT COMPLETED|Overall Study||2
7870695|NCT00853242|19371410|P5|NOT COMPLETED|Overall Study||4
7870696|NCT00853242|19371411|P4|NOT COMPLETED|Overall Study||4
7870697|NCT00853242|19371412|P3|NOT COMPLETED|Overall Study||3
7870698|NCT00853242|19371413|P2|NOT COMPLETED|Overall Study||3
7870699|NCT00853242|19371414|P1|NOT COMPLETED|Overall Study||3
7870700|NCT00853242|19371408|P7|COMPLETED|Overall Study||44
7870701|NCT00853242|19371409|P6|COMPLETED|Overall Study||49
7870702|NCT00853242|19371410|P5|COMPLETED|Overall Study||46
7870703|NCT00853242|19371411|P4|COMPLETED|Overall Study||46
7870704|NCT00853242|19371412|P3|COMPLETED|Overall Study||46
7870705|NCT00853242|19371413|P2|COMPLETED|Overall Study||47
7870706|NCT00853242|19371414|P1|COMPLETED|Overall Study||47
7870707|NCT00853242|19371408|P7|Treated|Overall Study||48
7870708|NCT00853242|19371409|P6|Treated|Overall Study||51
7870709|NCT00853242|19371410|P5|Treated|Overall Study||50
7870710|NCT00853242|19371411|P4|Treated|Overall Study||50
7870711|NCT00853242|19371412|P3|Treated|Overall Study||48
7870712|NCT00853242|19371413|P2|Treated|Overall Study||49
7870713|NCT00853242|19371414|P1|Treated|Overall Study||50
7870714|NCT00853242|19371408|P7|STARTED|Overall Study||49
7870715|NCT00853242|19371409|P6|STARTED|Overall Study||51
7870716|NCT00853242|19371410|P5|STARTED|Overall Study||50
7870717|NCT00853242|19371411|P4|STARTED|Overall Study||50
7870718|NCT00853242|19371412|P3|STARTED|Overall Study||49
7870719|NCT00853242|19371413|P2|STARTED|Overall Study||50
7870720|NCT00853242|19371414|P1|STARTED|Overall Study||50
7870721|NCT00853229|19371456|P2|NOT COMPLETED|Phase 2: Cross Over||0
7870722|NCT00853229|19371457|P1|NOT COMPLETED|Phase 2: Cross Over||0
7870723|NCT00853229|19371456|P2|COMPLETED|Phase 2: Cross Over||0
7870724|NCT00853229|19371457|P1|COMPLETED|Phase 2: Cross Over||0
7870725|NCT00853229|19371456|P2|STARTED|Phase 2: Cross Over||0
7870726|NCT00853229|19371457|P1|STARTED|Phase 2: Cross Over||0
7870727|NCT00853229|19371456|P2|NOT COMPLETED|Phase 1: Initial Intervention||8
7870728|NCT00853229|19371457|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
7870729|NCT00853229|19371456|P2|COMPLETED|Phase 1: Initial Intervention||0
7870730|NCT00853229|19371457|P1|COMPLETED|Phase 1: Initial Intervention||0
7870731|NCT00853229|19371456|P2|STARTED|Phase 1: Initial Intervention||8
7870732|NCT00853229|19371457|P1|STARTED|Phase 1: Initial Intervention||8
7870733|NCT00853151|19371467|P4|NOT COMPLETED|Overall Study||3
7870734|NCT00853151|19371468|P3|NOT COMPLETED|Overall Study||8
7870735|NCT00853151|19371469|P2|NOT COMPLETED|Overall Study||13
7870736|NCT00853151|19371470|P1|NOT COMPLETED|Overall Study||10
7870737|NCT00853151|19371467|P4|COMPLETED|Overall Study||15
7870738|NCT00853151|19371468|P3|COMPLETED|Overall Study||30
7870739|NCT00853151|19371469|P2|COMPLETED|Overall Study||24
7870740|NCT00853151|19371470|P1|COMPLETED|Overall Study||28
7870741|NCT00853151|19371467|P4|STARTED|Overall Study||18
7870742|NCT00853151|19371468|P3|STARTED|Overall Study||38
7870743|NCT00853151|19371469|P2|STARTED|Overall Study||37
7870744|NCT00853151|19371470|P1|STARTED|Overall Study||38
7870745|NCT00853125|19371612|P1|NOT COMPLETED|Overall Study||1
7870746|NCT00853125|19371612|P1|COMPLETED|Overall Study||9
7870747|NCT00853125|19371612|P1|STARTED|Overall Study||10
7870748|NCT00853112|19371624|P7|NOT COMPLETED|Overall Study||1
7870749|NCT00853112|19371625|P6|NOT COMPLETED|Overall Study||0
7870750|NCT00853112|19371626|P5|NOT COMPLETED|Overall Study||0
7870751|NCT00853112|19371627|P4|NOT COMPLETED|Overall Study||2
7870752|NCT00853112|19371628|P3|NOT COMPLETED|Overall Study||0
7870753|NCT00853112|19371629|P2|NOT COMPLETED|Overall Study||1
7870754|NCT00853112|19371630|P1|NOT COMPLETED|Overall Study||0
7870755|NCT00853112|19371624|P7|COMPLETED|Overall Study||6
7870756|NCT00853112|19371625|P6|COMPLETED|Overall Study||7
7870757|NCT00853112|19371626|P5|COMPLETED|Overall Study||6
7870758|NCT00853112|19371627|P4|COMPLETED|Overall Study||6
7870759|NCT00853112|19371628|P3|COMPLETED|Overall Study||7
7870760|NCT00853112|19371629|P2|COMPLETED|Overall Study||6
7870761|NCT00853112|19371630|P1|COMPLETED|Overall Study||6
7870762|NCT00853112|19371624|P7|Treated|Overall Study||6
7870763|NCT00853112|19371625|P6|Treated|Overall Study||7
7870764|NCT00853112|19371626|P5|Treated|Overall Study||6
7870765|NCT00853112|19371627|P4|Treated|Overall Study||6
7870766|NCT00853112|19371628|P3|Treated|Overall Study||7
7870767|NCT00853112|19371629|P2|Treated|Overall Study||6
7870768|NCT00853112|19371630|P1|Treated|Overall Study||6
7870769|NCT00853112|19371624|P7|STARTED|Overall Study||7
7870770|NCT00853112|19371625|P6|STARTED|Overall Study||7
7870771|NCT00853112|19371626|P5|STARTED|Overall Study||6
7870772|NCT00853112|19371627|P4|STARTED|Overall Study||8
7870773|NCT00853112|19371628|P3|STARTED|Overall Study||7
7870774|NCT00853112|19371629|P2|STARTED|Overall Study||7
7870775|NCT00853112|19371630|P1|STARTED|Overall Study||6
7870776|NCT00853099|19371740|P4|NOT COMPLETED|Double-blind + Open-label Periods||147
7870777|NCT00853099|19371741|P3|NOT COMPLETED|Double-blind + Open-label Periods||0
7870778|NCT00853099|19371742|P2|NOT COMPLETED|Double-blind + Open-label Periods||0
7870779|NCT00853099|19371743|P1|NOT COMPLETED|Double-blind + Open-label Periods||0
7870780|NCT00853099|19371740|P4|COMPLETED|Double-blind + Open-label Periods||119
7870781|NCT00853099|19371741|P3|COMPLETED|Double-blind + Open-label Periods||0
7870782|NCT00853099|19371742|P2|COMPLETED|Double-blind + Open-label Periods||0
7870783|NCT00853099|19371743|P1|COMPLETED|Double-blind + Open-label Periods||0
7870784|NCT00853099|19371740|P4|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266
7870785|NCT00853099|19371741|P3|STARTED|Double-blind + Open-label Periods||0
7870786|NCT00853099|19371742|P2|STARTED|Double-blind + Open-label Periods||0
7870787|NCT00853099|19371743|P1|STARTED|Double-blind + Open-label Periods||0
7870788|NCT00853099|19371740|P4|NOT COMPLETED|Double-blind Period||0
7870789|NCT00853099|19371741|P3|NOT COMPLETED|Double-blind Period||31
7870790|NCT00853099|19371742|P2|NOT COMPLETED|Double-blind Period||29
7870791|NCT00853099|19371743|P1|NOT COMPLETED|Double-blind Period||23
7870792|NCT00853099|19371740|P4|COMPLETED|Double-blind Period||0
7870793|NCT00853099|19371741|P3|COMPLETED|Double-blind Period|Participants who completed Week 52.|60
7870794|NCT00853099|19371742|P2|COMPLETED|Double-blind Period|Participants who completed Week 52.|58
7870795|NCT00853099|19371743|P1|COMPLETED|Double-blind Period|Participants who completed Week 52.|73
7870796|NCT00853099|19371740|P4|Completed Week 8|Double-blind Period||0
7870797|NCT00853099|19371741|P3|Completed Week 8|Double-blind Period||86
7870798|NCT00853099|19371742|P2|Completed Week 8|Double-blind Period||85
7870799|NCT00853099|19371743|P1|Completed Week 8|Double-blind Period||92
7870800|NCT00853099|19371740|P4|Treated|Double-blind Period||0
7870801|NCT00853099|19371741|P3|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90
7870802|NCT00853099|19371742|P2|Treated|Double-blind Period||87
7870803|NCT00853099|19371743|P1|Treated|Double-blind Period||96
7870804|NCT00853099|19371740|P4|STARTED|Double-blind Period||0
7870805|NCT00853099|19371741|P3|STARTED|Double-blind Period||91
7870806|NCT00853099|19371742|P2|STARTED|Double-blind Period||87
7870807|NCT00853099|19371743|P1|STARTED|Double-blind Period||96
7870808|NCT00853073|19371785|P2|NOT COMPLETED|Overall Study||2
7870809|NCT00853073|19371786|P1|NOT COMPLETED|Overall Study||3
7870810|NCT00853073|19371785|P2|COMPLETED|Overall Study||29
7870811|NCT00853073|19371786|P1|COMPLETED|Overall Study||29
7870812|NCT00853073|19371785|P2|STARTED|Overall Study||31
7870813|NCT00853073|19371786|P1|STARTED|Overall Study||32
7870814|NCT00853047|19371799|P6|NOT COMPLETED|Open-Label Extension Phase||17
7870815|NCT00853047|19371800|P5|NOT COMPLETED|Open-Label Extension Phase||0
7870816|NCT00853047|19371801|P4|NOT COMPLETED|Open-Label Extension Phase||0
7870817|NCT00853047|19371802|P3|NOT COMPLETED|Open-Label Extension Phase||0
7870818|NCT00853047|19371803|P2|NOT COMPLETED|Open-Label Extension Phase||0
7870819|NCT00853047|19371804|P1|NOT COMPLETED|Open-Label Extension Phase||0
7870820|NCT00853047|19371799|P6|COMPLETED|Open-Label Extension Phase||2
7870821|NCT00853047|19371800|P5|COMPLETED|Open-Label Extension Phase||0
7870822|NCT00853047|19371801|P4|COMPLETED|Open-Label Extension Phase||0
7870823|NCT00853047|19371802|P3|COMPLETED|Open-Label Extension Phase||0
7870824|NCT00853047|19371803|P2|COMPLETED|Open-Label Extension Phase||0
7870825|NCT00853047|19371804|P1|COMPLETED|Open-Label Extension Phase||0
7870826|NCT00853047|19371799|P6|Completed 8-week Extension Period|Open-Label Extension Phase||16
7870827|NCT00853047|19371800|P5|Completed 8-week Extension Period|Open-Label Extension Phase||0
7870828|NCT00853047|19371801|P4|Completed 8-week Extension Period|Open-Label Extension Phase||0
7870829|NCT00853047|19371802|P3|Completed 8-week Extension Period|Open-Label Extension Phase||0
7870830|NCT00853047|19371803|P2|Completed 8-week Extension Period|Open-Label Extension Phase||0
7870831|NCT00853047|19371804|P1|Completed 8-week Extension Period|Open-Label Extension Phase||0
7870832|NCT00853047|19371799|P6|STARTED|Open-Label Extension Phase|19 of the 22 participants who completed the Core Phase entered the optional Open-Label Extension.|19
7870833|NCT00853047|19371800|P5|STARTED|Open-Label Extension Phase||0
7870834|NCT00853047|19371801|P4|STARTED|Open-Label Extension Phase||0
7870835|NCT00853047|19371802|P3|STARTED|Open-Label Extension Phase||0
7870836|NCT00853047|19371803|P2|STARTED|Open-Label Extension Phase||0
7870837|NCT00853047|19371804|P1|STARTED|Open-Label Extension Phase||0
7870838|NCT00853047|19371799|P6|NOT COMPLETED|Core Phase||0
7870839|NCT00853047|19371800|P5|NOT COMPLETED|Core Phase||0
7870840|NCT00853047|19371801|P4|NOT COMPLETED|Core Phase||1
7870841|NCT00853047|19371802|P3|NOT COMPLETED|Core Phase||0
7870842|NCT00853047|19371803|P2|NOT COMPLETED|Core Phase||0
7870843|NCT00853047|19371804|P1|NOT COMPLETED|Core Phase||0
7870844|NCT00853047|19371799|P6|COMPLETED|Core Phase||0
7870845|NCT00853047|19371800|P5|COMPLETED|Core Phase||9
7870846|NCT00853047|19371801|P4|COMPLETED|Core Phase||2
7870847|NCT00853047|19371802|P3|COMPLETED|Core Phase||3
7870848|NCT00853047|19371803|P2|COMPLETED|Core Phase||3
7870849|NCT00853047|19371804|P1|COMPLETED|Core Phase||5
7870850|NCT00853047|19371799|P6|STARTED|Core Phase||0
7870851|NCT00853047|19371800|P5|STARTED|Core Phase||9
7870852|NCT00853047|19371801|P4|STARTED|Core Phase||3
7870853|NCT00853047|19371802|P3|STARTED|Core Phase||3
7870854|NCT00853047|19371803|P2|STARTED|Core Phase||3
7870855|NCT00853047|19371804|P1|STARTED|Core Phase||5
7870856|NCT00853021|19371870|P1|NOT COMPLETED|Overall Study||5
7870857|NCT00853021|19371870|P1|COMPLETED|Overall Study||21
7870858|NCT00853021|19371870|P1|STARTED|Overall Study||26
7870859|NCT00852995|19371882|P5|NOT COMPLETED|Overall Study||4
7870860|NCT00852995|19371883|P4|NOT COMPLETED|Overall Study||5
7870861|NCT00852995|19371884|P3|NOT COMPLETED|Overall Study||5
7870862|NCT00852995|19371885|P2|NOT COMPLETED|Overall Study||1
7870863|NCT00852995|19371886|P1|NOT COMPLETED|Overall Study||8
7870864|NCT00852995|19371882|P5|COMPLETED|Overall Study||46
7870865|NCT00852995|19371883|P4|COMPLETED|Overall Study||40
7870866|NCT00852995|19371884|P3|COMPLETED|Overall Study||39
7870867|NCT00852995|19371885|P2|COMPLETED|Overall Study||42
7870868|NCT00852995|19371886|P1|COMPLETED|Overall Study||38
7870869|NCT00852995|19371882|P5|STARTED|Overall Study||50
7870870|NCT00852995|19371883|P4|STARTED|Overall Study||45
7870871|NCT00852995|19371884|P3|STARTED|Overall Study||44
7870872|NCT00852995|19371885|P2|STARTED|Overall Study||43
7870873|NCT00852995|19371886|P1|STARTED|Overall Study||46
7870874|NCT00852969|19371930|P2|NOT COMPLETED|Overall Study||2
7870875|NCT00852969|19371931|P1|NOT COMPLETED|Overall Study||0
7870876|NCT00852969|19371930|P2|COMPLETED|Overall Study||13
7870877|NCT00852969|19371931|P1|COMPLETED|Overall Study||15
7870878|NCT00852969|19371930|P2|STARTED|Overall Study||15
7870879|NCT00852969|19371931|P1|STARTED|Overall Study||15
7870880|NCT00852930|19371942|P3|NOT COMPLETED|Overall Study||2
7870881|NCT00852930|19371943|P2|NOT COMPLETED|Overall Study||1
7870882|NCT00852930|19371944|P1|NOT COMPLETED|Overall Study||1
7870883|NCT00852930|19371942|P3|COMPLETED|Overall Study||15
7870884|NCT00852930|19371943|P2|COMPLETED|Overall Study||16
7870885|NCT00852930|19371944|P1|COMPLETED|Overall Study||15
7870886|NCT00852930|19371942|P3|STARTED|Overall Study||17
7870887|NCT00852930|19371943|P2|STARTED|Overall Study||17
7870888|NCT00852930|19371944|P1|STARTED|Overall Study||16
7870889|NCT00852917|19371965|P4|NOT COMPLETED|Overall Study||93
7870890|NCT00852917|19371966|P3|NOT COMPLETED|Overall Study||58
7870891|NCT00852917|19371967|P2|NOT COMPLETED|Overall Study||46
7870892|NCT00852917|19371968|P1|NOT COMPLETED|Overall Study||44
7870893|NCT00852917|19371965|P4|COMPLETED|Overall Study||134
7870894|NCT00852917|19371966|P3|COMPLETED|Overall Study||50
7870895|NCT00852917|19371967|P2|COMPLETED|Overall Study||65
7870896|NCT00852917|19371968|P1|COMPLETED|Overall Study||62
7870897|NCT00852917|19371965|P4|STARTED|Overall Study||227
7870898|NCT00852917|19371966|P3|STARTED|Overall Study||108
7870899|NCT00852917|19371967|P2|STARTED|Overall Study||111
7870900|NCT00852917|19371968|P1|STARTED|Overall Study||106
7870901|NCT00852761|19372008|P2|NOT COMPLETED|Overall Study||0
7870902|NCT00852761|19372009|P1|NOT COMPLETED|Overall Study||0
7870903|NCT00852761|19372008|P2|COMPLETED|Overall Study||17
7870904|NCT00852761|19372009|P1|COMPLETED|Overall Study||17
7870905|NCT00852761|19372008|P2|STARTED|Overall Study||17
7870906|NCT00852761|19372009|P1|STARTED|Overall Study||17
7870907|NCT00852644|19372051|P6|NOT COMPLETED|Overall Study||0
7870908|NCT00852644|19372052|P5|NOT COMPLETED|Overall Study||0
7870909|NCT00852644|19372053|P4|NOT COMPLETED|Overall Study||0
7870910|NCT00852644|19372054|P3|NOT COMPLETED|Overall Study||0
7870911|NCT00852644|19372055|P2|NOT COMPLETED|Overall Study||0
7870912|NCT00852644|19372056|P1|NOT COMPLETED|Overall Study||0
7870913|NCT00852644|19372051|P6|COMPLETED|Overall Study||0
7870914|NCT00852644|19372052|P5|COMPLETED|Overall Study||0
7870915|NCT00852644|19372053|P4|COMPLETED|Overall Study||3
7870916|NCT00852644|19372054|P3|COMPLETED|Overall Study||0
7870917|NCT00852644|19372055|P2|COMPLETED|Overall Study||3
7870918|NCT00852644|19372056|P1|COMPLETED|Overall Study||3
7870919|NCT00852644|19372051|P6|STARTED|Overall Study||0
7870920|NCT00852644|19372052|P5|STARTED|Overall Study||0
7870921|NCT00852644|19372053|P4|STARTED|Overall Study||3
7870922|NCT00852644|19372054|P3|STARTED|Overall Study||0
7870923|NCT00852644|19372055|P2|STARTED|Overall Study||3
7870924|NCT00852644|19372056|P1|STARTED|Overall Study||3
7870925|NCT00852631|19372077|P1|NOT COMPLETED|Overall Study||11
7870926|NCT00852631|19372077|P1|COMPLETED|Overall Study||17
7870927|NCT00852631|19372077|P1|STARTED|Overall Study||28
7870928|NCT00852592|19372085|P2|NOT COMPLETED|Overall Study||4
7870929|NCT00852592|19372086|P1|NOT COMPLETED|Overall Study||3
7870930|NCT00852592|19372085|P2|COMPLETED|Overall Study||19
7870931|NCT00852592|19372086|P1|COMPLETED|Overall Study||20
7870932|NCT00852592|19372085|P2|STARTED|Overall Study||23
7870933|NCT00852592|19372086|P1|STARTED|Overall Study||23
7870934|NCT00852540|19372096|P2|NOT COMPLETED|Overall Study||18
7870935|NCT00852540|19372097|P1|NOT COMPLETED|Overall Study||36
7870936|NCT00852540|19372096|P2|COMPLETED|Overall Study||122
7870937|NCT00852540|19372097|P1|COMPLETED|Overall Study||234
7870938|NCT00852540|19372096|P2|STARTED|Overall Study||140
7870939|NCT00852540|19372097|P1|STARTED|Overall Study||270
7870940|NCT00852527|19372123|P2|NOT COMPLETED|Overall Study||0
7870941|NCT00852527|19372124|P1|NOT COMPLETED|Overall Study||0
7870942|NCT00852527|19372123|P2|COMPLETED|Overall Study||242
7870943|NCT00852527|19372124|P1|COMPLETED|Overall Study||196
7870944|NCT00852527|19372123|P2|STARTED|Overall Study||242
7870945|NCT00852527|19372124|P1|STARTED|Overall Study||196
7870946|NCT00852475|19372131|P2|NOT COMPLETED|Overall Study||4
7870947|NCT00852475|19372132|P1|NOT COMPLETED|Overall Study||3
7870948|NCT00852475|19372131|P2|COMPLETED|Overall Study||16
7870949|NCT00852475|19372132|P1|COMPLETED|Overall Study||23
7870950|NCT00852475|19372131|P2|STARTED|Overall Study||20
7870951|NCT00852475|19372132|P1|STARTED|Overall Study||26
7870952|NCT00852397|19372143|P3|NOT COMPLETED|Overall Study||14
7870953|NCT00852397|19372144|P2|NOT COMPLETED|Overall Study||8
7870954|NCT00852397|19372145|P1|NOT COMPLETED|Overall Study||11
7870955|NCT00852397|19372143|P3|COMPLETED|Overall Study||36
7870956|NCT00852397|19372144|P2|COMPLETED|Overall Study||41
7870957|NCT00852397|19372145|P1|COMPLETED|Overall Study||41
7870958|NCT00852397|19372143|P3|Treated Participants|Overall Study||49
7870959|NCT00852397|19372144|P2|Treated Participants|Overall Study||49
7870960|NCT00852397|19372145|P1|Treated Participants|Overall Study||51
7870961|NCT00852397|19372143|P3|STARTED|Overall Study||50
7870962|NCT00852397|19372144|P2|STARTED|Overall Study||49
7870963|NCT00852397|19372145|P1|STARTED|Overall Study||52
7870964|NCT00852241|19372174|P1|NOT COMPLETED|Overall Study||18
7870965|NCT00852241|19372174|P1|COMPLETED|Overall Study||0
7870966|NCT00852241|19372174|P1|STARTED|Overall Study||18
7870967|NCT00852202|19372181|P3|NOT COMPLETED|Overall Study||26
7870968|NCT00852202|19372182|P2|NOT COMPLETED|Overall Study||12
7870969|NCT00852202|19372183|P1|NOT COMPLETED|Overall Study||17
7870970|NCT00852202|19372181|P3|COMPLETED|Overall Study||49
7870971|NCT00852202|19372182|P2|COMPLETED|Overall Study||63
7870972|NCT00852202|19372183|P1|COMPLETED|Overall Study||60
7870973|NCT00852202|19372181|P3|STARTED|Overall Study||75
7870974|NCT00852202|19372182|P2|STARTED|Overall Study||75
7870975|NCT00852202|19372183|P1|STARTED|Overall Study||77
7870976|NCT00852137|19372196|P2|NOT COMPLETED|Overall Study||0
7870977|NCT00852137|19372197|P1|NOT COMPLETED|Overall Study||0
7870978|NCT00852137|19372196|P2|COMPLETED|Overall Study||3
7870979|NCT00852137|19372197|P1|COMPLETED|Overall Study||13
7870980|NCT00852137|19372196|P2|STARTED|Overall Study||3
7870981|NCT00852137|19372197|P1|STARTED|Overall Study||13
7870982|NCT00852124|19372219|P2|NOT COMPLETED|Overall Study||0
7870983|NCT00852124|19372220|P1|NOT COMPLETED|Overall Study||0
7870984|NCT00852124|19372219|P2|COMPLETED|Overall Study||0
7870985|NCT00852124|19372220|P1|COMPLETED|Overall Study||3
7870986|NCT00852124|19372219|P2|STARTED|Overall Study||0
7870987|NCT00852124|19372220|P1|STARTED|Overall Study||3
7870988|NCT00851903|19372225|P1|NOT COMPLETED|Overall Study||2
7870989|NCT00851903|19372225|P1|COMPLETED|Overall Study||110
7870990|NCT00851903|19372225|P1|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111
7870991|NCT00851903|19372225|P1|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111
7870992|NCT00851903|19372225|P1|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112
7870993|NCT00851903|19372225|P1|STARTED|Overall Study||112
7870994|NCT00851890|19372239|P4|NOT COMPLETED|Overall Study||1
7870995|NCT00851890|19372240|P3|NOT COMPLETED|Overall Study||0
7870996|NCT00851890|19372241|P2|NOT COMPLETED|Overall Study||1
7870997|NCT00851890|19372242|P1|NOT COMPLETED|Overall Study||0
7870998|NCT00851890|19372239|P4|COMPLETED|Overall Study||5
7870999|NCT00851890|19372240|P3|COMPLETED|Overall Study||8
7871000|NCT00851890|19372241|P2|COMPLETED|Overall Study||7
7871001|NCT00851890|19372242|P1|COMPLETED|Overall Study||8
7871002|NCT00851890|19372239|P4|STARTED|Overall Study||6
7871003|NCT00851890|19372240|P3|STARTED|Overall Study||8
7871004|NCT00851890|19372241|P2|STARTED|Overall Study||8
7871005|NCT00851890|19372242|P1|STARTED|Overall Study||8
7871006|NCT00851877|19372299|P3|NOT COMPLETED|Phase II||3
7871007|NCT00851877|19372300|P2|NOT COMPLETED|Phase II||0
7871008|NCT00851877|19372301|P1|NOT COMPLETED|Phase II||0
7871009|NCT00851877|19372299|P3|COMPLETED|Phase II||22
7871010|NCT00851877|19372300|P2|COMPLETED|Phase II||0
7871011|NCT00851877|19372301|P1|COMPLETED|Phase II||0
7871012|NCT00851877|19372299|P3|STARTED|Phase II||25
7871013|NCT00851877|19372300|P2|STARTED|Phase II||0
7871014|NCT00851877|19372301|P1|STARTED|Phase II||0
7871015|NCT00851877|19372299|P3|NOT COMPLETED|Phase I-2||0
7871016|NCT00851877|19372300|P2|NOT COMPLETED|Phase I-2||0
7871017|NCT00851877|19372301|P1|NOT COMPLETED|Phase I-2||0
7871018|NCT00851877|19372299|P3|COMPLETED|Phase I-2||0
7871019|NCT00851877|19372300|P2|COMPLETED|Phase I-2||5
7871020|NCT00851877|19372301|P1|COMPLETED|Phase I-2||0
7871021|NCT00851877|19372299|P3|STARTED|Phase I-2||0
7871022|NCT00851877|19372300|P2|STARTED|Phase I-2||5
7871023|NCT00851877|19372301|P1|STARTED|Phase I-2||0
7871024|NCT00851877|19372299|P3|NOT COMPLETED|Phase I-1||0
7871025|NCT00851877|19372300|P2|NOT COMPLETED|Phase I-1||0
7871026|NCT00851877|19372301|P1|NOT COMPLETED|Phase I-1||1
7871027|NCT00851877|19372299|P3|COMPLETED|Phase I-1||0
7871028|NCT00851877|19372300|P2|COMPLETED|Phase I-1||0
7871029|NCT00851877|19372301|P1|COMPLETED|Phase I-1||6
7871030|NCT00851877|19372299|P3|STARTED|Phase I-1||0
7871031|NCT00851877|19372300|P2|STARTED|Phase I-1||0
7871032|NCT00851877|19372301|P1|STARTED|Phase I-1||7
7871033|NCT00851799|19372311|P3|NOT COMPLETED|Overall Study||24
7871034|NCT00851799|19372312|P2|NOT COMPLETED|Overall Study||13
7871035|NCT00851799|19372313|P1|NOT COMPLETED|Overall Study||16
7871036|NCT00851799|19372311|P3|COMPLETED|Overall Study||89
7871037|NCT00851799|19372312|P2|COMPLETED|Overall Study||93
7871038|NCT00851799|19372313|P1|COMPLETED|Overall Study||93
7871039|NCT00851799|19372311|P3|STARTED|Overall Study||113
7871040|NCT00851799|19372312|P2|STARTED|Overall Study||106
7871041|NCT00851799|19372313|P1|STARTED|Overall Study||109
7871042|NCT00851786|19372401|P2|NOT COMPLETED|Overall Study||2
7871043|NCT00851786|19372402|P1|NOT COMPLETED|Overall Study||5
7871044|NCT00851786|19372401|P2|COMPLETED|Overall Study||97
7871045|NCT00851786|19372402|P1|COMPLETED|Overall Study||291
7871046|NCT00851786|19372401|P2|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99
7871047|NCT00851786|19372402|P1|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296
7871048|NCT00851747|19372415|P3|NOT COMPLETED|Overall Study||6
7871049|NCT00851747|19372416|P2|NOT COMPLETED|Overall Study||6
7871050|NCT00851747|19372417|P1|NOT COMPLETED|Overall Study||6
7871051|NCT00851747|19372415|P3|COMPLETED|Overall Study||0
7871052|NCT00851747|19372416|P2|COMPLETED|Overall Study||0
7871053|NCT00851747|19372417|P1|COMPLETED|Overall Study||0
7871054|NCT00851747|19372415|P3|STARTED|Overall Study||6
7871055|NCT00851747|19372416|P2|STARTED|Overall Study||6
7871056|NCT00851747|19372417|P1|STARTED|Overall Study||6
7871057|NCT00851721|19372426|P2|NOT COMPLETED|Overall Study||1
7871058|NCT00851721|19372427|P1|NOT COMPLETED|Overall Study||2
7871059|NCT00851721|19372426|P2|COMPLETED|Overall Study||16
7871060|NCT00851721|19372427|P1|COMPLETED|Overall Study||17
7871061|NCT00851721|19372426|P2|STARTED|Overall Study||17
7871062|NCT00851721|19372427|P1|STARTED|Overall Study||19
7871063|NCT00851682|19372517|P2|NOT COMPLETED|Overall Study||0
7871064|NCT00851682|19372518|P1|NOT COMPLETED|Overall Study||5
7871065|NCT00851682|19372517|P2|COMPLETED|Overall Study||5
7871066|NCT00851682|19372518|P1|COMPLETED|Overall Study||55
7871067|NCT00851682|19372517|P2|STARTED|Overall Study||5
7871068|NCT00851682|19372518|P1|STARTED|Overall Study||60
7871069|NCT00851643|19372532|P6|NOT COMPLETED|Extension Study (Up to 36 Months)||1
7871070|NCT00851643|19372533|P5|NOT COMPLETED|Extension Study (Up to 36 Months)||2
7871071|NCT00851643|19372534|P4|NOT COMPLETED|Extension Study (Up to 36 Months)||2
7871072|NCT00851643|19372535|P3|NOT COMPLETED|Extension Study (Up to 36 Months)||5
7871073|NCT00851643|19372536|P2|NOT COMPLETED|Extension Study (Up to 36 Months)||4
7871074|NCT00851643|19372537|P1|NOT COMPLETED|Extension Study (Up to 36 Months)||4
7871075|NCT00851643|19372532|P6|COMPLETED|Extension Study (Up to 36 Months)||14
7871076|NCT00851643|19372533|P5|COMPLETED|Extension Study (Up to 36 Months)||19
7871077|NCT00851643|19372534|P4|COMPLETED|Extension Study (Up to 36 Months)||5
7871078|NCT00851643|19372535|P3|COMPLETED|Extension Study (Up to 36 Months)||14
7871079|NCT00851643|19372536|P2|COMPLETED|Extension Study (Up to 36 Months)||15
7871080|NCT00851643|19372537|P1|COMPLETED|Extension Study (Up to 36 Months)||6
7871081|NCT00851643|19372532|P6|STARTED|Extension Study (Up to 36 Months)||15
7871082|NCT00851643|19372533|P5|STARTED|Extension Study (Up to 36 Months)||21
7871083|NCT00851643|19372534|P4|STARTED|Extension Study (Up to 36 Months)||7
7871084|NCT00851643|19372535|P3|STARTED|Extension Study (Up to 36 Months)||19
7871085|NCT00851643|19372536|P2|STARTED|Extension Study (Up to 36 Months)||19
7871086|NCT00851643|19372537|P1|STARTED|Extension Study (Up to 36 Months)||10
7871087|NCT00851643|19372532|P6|NOT COMPLETED|Base Study (Up to 12 Months)||1
7871088|NCT00851643|19372533|P5|NOT COMPLETED|Base Study (Up to 12 Months)||0
7871089|NCT00851643|19372534|P4|NOT COMPLETED|Base Study (Up to 12 Months)||0
7871090|NCT00851643|19372535|P3|NOT COMPLETED|Base Study (Up to 12 Months)||0
7871091|NCT00851643|19372536|P2|NOT COMPLETED|Base Study (Up to 12 Months)||0
7871092|NCT00851643|19372537|P1|NOT COMPLETED|Base Study (Up to 12 Months)||1
7871093|NCT00851643|19372532|P6|COMPLETED|Base Study (Up to 12 Months)||29
7871094|NCT00851643|19372533|P5|COMPLETED|Base Study (Up to 12 Months)||30
7871095|NCT00851643|19372534|P4|COMPLETED|Base Study (Up to 12 Months)||15
7871096|NCT00851643|19372535|P3|COMPLETED|Base Study (Up to 12 Months)||30
7871097|NCT00851643|19372536|P2|COMPLETED|Base Study (Up to 12 Months)||30
7871098|NCT00851643|19372537|P1|COMPLETED|Base Study (Up to 12 Months)||14
7871099|NCT00851643|19372532|P6|STARTED|Base Study (Up to 12 Months)||30
7871100|NCT00851643|19372533|P5|STARTED|Base Study (Up to 12 Months)||30
7871101|NCT00851643|19372534|P4|STARTED|Base Study (Up to 12 Months)||15
7871102|NCT00851643|19372535|P3|STARTED|Base Study (Up to 12 Months)||30
7871103|NCT00851643|19372536|P2|STARTED|Base Study (Up to 12 Months)||30
7871104|NCT00851643|19372537|P1|STARTED|Base Study (Up to 12 Months)||15
7871105|NCT00851630|19372558|P2|NOT COMPLETED|Overall Study||2
7871106|NCT00851630|19372559|P1|NOT COMPLETED|Overall Study||2
7871107|NCT00851630|19372558|P2|COMPLETED|Overall Study||33
7871108|NCT00851630|19372559|P1|COMPLETED|Overall Study||33
7871109|NCT00851630|19372558|P2|STARTED|Overall Study||35
7871110|NCT00851630|19372559|P1|STARTED|Overall Study||35
7871111|NCT00851591|19372573|P2|NOT COMPLETED|Overall Study||0
7871112|NCT00851591|19372574|P1|NOT COMPLETED|Overall Study||2
7871113|NCT00851591|19372573|P2|COMPLETED|Overall Study||1
7871114|NCT00851591|19372574|P1|COMPLETED|Overall Study||0
7871115|NCT00851591|19372573|P2|STARTED|Overall Study|One received treatment.|1
7871116|NCT00851591|19372574|P1|STARTED|Overall Study|These 2 participants did not receive treatment.|2
7871117|NCT00851552|19372580|P1|NOT COMPLETED|Overall Study||7
7871118|NCT00851552|19372580|P1|COMPLETED|Overall Study||2
7871119|NCT00851552|19372580|P1|STARTED|Overall Study||9
7871120|NCT00851409|19372585|P1|NOT COMPLETED|Overall Study||0
7871121|NCT00851409|19372585|P1|COMPLETED|Overall Study||25
7871122|NCT00851409|19372585|P1|STARTED|Overall Study||25
7871123|NCT00851357|19372593|P3|NOT COMPLETED|Overall Study||0
7871124|NCT00851357|19372594|P2|NOT COMPLETED|Overall Study||0
7871125|NCT00851357|19372595|P1|NOT COMPLETED|Overall Study||0
7871126|NCT00851357|19372593|P3|COMPLETED|Overall Study||1799
7871127|NCT00851357|19372594|P2|COMPLETED|Overall Study||1201
7871128|NCT00851357|19372595|P1|COMPLETED|Overall Study||1200
7871129|NCT00851357|19372593|P3|STARTED|Overall Study||1799
7871130|NCT00851357|19372594|P2|STARTED|Overall Study||1201
7871131|NCT00851357|19372595|P1|STARTED|Overall Study||1200
7871132|NCT00851318|19372610|P4|NOT COMPLETED|Overall Study||19
7871133|NCT00851318|19372611|P3|NOT COMPLETED|Overall Study||21
7871134|NCT00851318|19372612|P2|NOT COMPLETED|Overall Study||5
7871135|NCT00851318|19372613|P1|NOT COMPLETED|Overall Study||30
7871136|NCT00851318|19372610|P4|COMPLETED|Overall Study||73
7871137|NCT00851318|19372611|P3|COMPLETED|Overall Study||72
7871138|NCT00851318|19372612|P2|COMPLETED|Overall Study||14
7871139|NCT00851318|19372613|P1|COMPLETED|Overall Study||51
7871140|NCT00851318|19372610|P4|Completed Week 52|Overall Study||85
7871141|NCT00851318|19372611|P3|Completed Week 52|Overall Study||87
7871142|NCT00851318|19372612|P2|Completed Week 52|Overall Study||16
7871143|NCT00851318|19372613|P1|Completed Week 52|Overall Study||64
7871144|NCT00851318|19372610|P4|Completed Week 24|Overall Study||87
7871145|NCT00851318|19372611|P3|Completed Week 24|Overall Study||90
7871146|NCT00851318|19372612|P2|Completed Week 24|Overall Study||17
7871147|NCT00851318|19372613|P1|Completed Week 24|Overall Study||69
7871148|NCT00851318|19372610|P4|STARTED|Overall Study||92
7871149|NCT00851318|19372611|P3|STARTED|Overall Study||93
7871150|NCT00851318|19372612|P2|STARTED|Overall Study||19
7871151|NCT00851318|19372613|P1|STARTED|Overall Study||81
7871152|NCT00851279|19372643|P1|NOT COMPLETED|Overall Study||0
7871153|NCT00851279|19372643|P1|COMPLETED|Overall Study||53
7871154|NCT00851279|19372643|P1|STARTED|Overall Study||53
7871155|NCT00851253|19372649|P2|NOT COMPLETED|Overall Study||0
7871156|NCT00851253|19372650|P1|NOT COMPLETED|Overall Study||1
7871157|NCT00851253|19372649|P2|COMPLETED|Overall Study||10
7871158|NCT00851253|19372650|P1|COMPLETED|Overall Study||1
7871159|NCT00851253|19372649|P2|STARTED|Overall Study||10
7871160|NCT00851253|19372650|P1|STARTED|Overall Study||2
7871161|NCT00851084|19372660|P2|NOT COMPLETED|Overall Study||119
7871162|NCT00851084|19372661|P1|NOT COMPLETED|Overall Study||117
7871163|NCT00851084|19372660|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
7871164|NCT00851084|19372661|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
7871165|NCT00851084|19372660|P2|STARTED|Overall Study||119
7871166|NCT00851084|19372661|P1|STARTED|Overall Study||117
7871167|NCT00851006|19372677|P2|NOT COMPLETED|Overall Study||0
7871168|NCT00851006|19372678|P1|NOT COMPLETED|Overall Study||0
7871169|NCT00851006|19372677|P2|COMPLETED|Overall Study||6
7871170|NCT00851006|19372678|P1|COMPLETED|Overall Study||7
7871171|NCT00851006|19372677|P2|STARTED|Overall Study||6
7871172|NCT00851006|19372678|P1|STARTED|Overall Study||7
7871173|NCT00850993|19372689|P4|NOT COMPLETED|Overall Study||1
7871174|NCT00850993|19372690|P3|NOT COMPLETED|Overall Study||0
7871175|NCT00850993|19372691|P2|NOT COMPLETED|Overall Study||0
7871176|NCT00850993|19372692|P1|NOT COMPLETED|Overall Study||1
7871177|NCT00850993|19372689|P4|COMPLETED|Overall Study||14
7871178|NCT00850993|19372690|P3|COMPLETED|Overall Study||8
7871179|NCT00850993|19372691|P2|COMPLETED|Overall Study||18
7871180|NCT00850993|19372692|P1|COMPLETED|Overall Study||16
7871181|NCT00850993|19372689|P4|Per Protocol|Overall Study||13
7871182|NCT00850993|19372690|P3|Per Protocol|Overall Study||5
7871183|NCT00850993|19372691|P2|Per Protocol|Overall Study||13
7871184|NCT00850993|19372692|P1|Per Protocol|Overall Study||10
7871185|NCT00850993|19372689|P4|Received Phototherapy|Overall Study||8
7871186|NCT00850993|19372690|P3|Received Phototherapy|Overall Study||2
7871187|NCT00850993|19372691|P2|Received Phototherapy|Overall Study||6
7871188|NCT00850993|19372692|P1|Received Phototherapy|Overall Study||3
7871189|NCT00850993|19372689|P4|Intent-to-treat|Overall Study||15
7871190|NCT00850993|19372690|P3|Intent-to-treat|Overall Study||8
7871191|NCT00850993|19372691|P2|Intent-to-treat|Overall Study||18
7871192|NCT00850993|19372692|P1|Intent-to-treat|Overall Study||17
7871193|NCT00850993|19372689|P4|Safety|Overall Study||15
7871194|NCT00850993|19372690|P3|Safety|Overall Study||8
7871195|NCT00850993|19372691|P2|Safety|Overall Study||18
7871196|NCT00850993|19372692|P1|Safety|Overall Study||17
7871197|NCT00850993|19372689|P4|STARTED|Overall Study||15
7871198|NCT00850993|19372690|P3|STARTED|Overall Study||8
7871199|NCT00850993|19372691|P2|STARTED|Overall Study||18
7871200|NCT00850993|19372692|P1|STARTED|Overall Study||17
7871201|NCT00850889|19372706|P1|NOT COMPLETED|Overall Study||0
7871202|NCT00850889|19372706|P1|COMPLETED|Overall Study||32
7871203|NCT00850889|19372706|P1|STARTED|Overall Study||32
7871204|NCT00850759|19372721|P4|NOT COMPLETED|Overall Study||3
7871205|NCT00850759|19372722|P3|NOT COMPLETED|Overall Study||5
7871206|NCT00850759|19372723|P2|NOT COMPLETED|Overall Study||5
7871207|NCT00850759|19372724|P1|NOT COMPLETED|Overall Study||7
7871208|NCT00850759|19372721|P4|COMPLETED|Overall Study||55
7871209|NCT00850759|19372722|P3|COMPLETED|Overall Study||52
7871210|NCT00850759|19372723|P2|COMPLETED|Overall Study||52
7871211|NCT00850759|19372724|P1|COMPLETED|Overall Study||52
7871212|NCT00850759|19372721|P4|STARTED|Overall Study||58
7871213|NCT00850759|19372722|P3|STARTED|Overall Study||57
7871214|NCT00850759|19372723|P2|STARTED|Overall Study||57
7871215|NCT00850759|19372724|P1|STARTED|Overall Study||59
7871216|NCT00850720|19372734|P1|NOT COMPLETED|Overall Study||0
7871217|NCT00850720|19372734|P1|COMPLETED|Overall Study||0
7871218|NCT00850720|19372734|P1|STARTED|Overall Study||0
7871219|NCT00850642|19372740|P2|NOT COMPLETED|Overall Study||0
7871220|NCT00850642|19372741|P1|NOT COMPLETED|Overall Study||0
7871221|NCT00850642|19372740|P2|COMPLETED|Overall Study||4
7871222|NCT00850642|19372741|P1|COMPLETED|Overall Study||3
7871223|NCT00850642|19372740|P2|STARTED|Overall Study||4
7871224|NCT00850642|19372741|P1|STARTED|Overall Study||3
7871225|NCT00850603|19372779|P5|NOT COMPLETED|Overall Study||0
7871226|NCT00850603|19372780|P4|NOT COMPLETED|Overall Study||0
7871227|NCT00850603|19372781|P3|NOT COMPLETED|Overall Study||0
7871228|NCT00850603|19372782|P2|NOT COMPLETED|Overall Study||0
7871229|NCT00850603|19372783|P1|NOT COMPLETED|Overall Study||0
7871230|NCT00850603|19372779|P5|COMPLETED|Overall Study||34
7871231|NCT00850603|19372780|P4|COMPLETED|Overall Study||34
7871232|NCT00850603|19372781|P3|COMPLETED|Overall Study||34
7871233|NCT00850603|19372782|P2|COMPLETED|Overall Study||34
7871234|NCT00850603|19372783|P1|COMPLETED|Overall Study||34
7871235|NCT00850603|19372779|P5|STARTED|Overall Study||34
7871236|NCT00850603|19372780|P4|STARTED|Overall Study||34
7871237|NCT00850603|19372781|P3|STARTED|Overall Study||34
7871238|NCT00850603|19372782|P2|STARTED|Overall Study||34
7871239|NCT00850603|19372783|P1|STARTED|Overall Study||34
7871240|NCT00850564|19372805|P1|NOT COMPLETED|Overall Study||2
7871241|NCT00850564|19372805|P1|COMPLETED|Overall Study||13
7871242|NCT00850564|19372805|P1|STARTED|Overall Study||15
7871243|NCT00850538|19372810|P1|NOT COMPLETED|Overall Study||41
7871244|NCT00850538|19372810|P1|COMPLETED|Overall Study||60
7871245|NCT00850538|19372810|P1|STARTED|Overall Study||101
7871246|NCT00850499|19372816|P2|NOT COMPLETED|Overall Study||2
7871247|NCT00850499|19372817|P1|NOT COMPLETED|Overall Study||3
7871248|NCT00850499|19372816|P2|COMPLETED|Overall Study||6
7871249|NCT00850499|19372817|P1|COMPLETED|Overall Study||1
7871250|NCT00850499|19372816|P2|STARTED|Overall Study||8
7871251|NCT00850499|19372817|P1|STARTED|Overall Study||4
7871252|NCT00850473|19372825|P1|NOT COMPLETED|Overall Study||0
7871253|NCT00850473|19372825|P1|COMPLETED|Overall Study||3
7871254|NCT00850473|19372825|P1|STARTED|Overall Study||3
7871255|NCT00850460|19372831|P2|NOT COMPLETED|Overall Study||4
7871256|NCT00850460|19372832|P1|NOT COMPLETED|Overall Study||4
7871257|NCT00850460|19372831|P2|COMPLETED|Overall Study||3
7871258|NCT00850460|19372832|P1|COMPLETED|Overall Study||3
7871259|NCT00850460|19372831|P2|Completion - Week 8|Overall Study||3
7871260|NCT00850460|19372832|P1|Completion - Week 8|Overall Study||3
7871261|NCT00850460|19372831|P2|Started - Week 0|Overall Study||7
7871262|NCT00850460|19372832|P1|Started - Week 0|Overall Study||7
7871263|NCT00850460|19372831|P2|STARTED|Overall Study||7
7871264|NCT00850460|19372832|P1|STARTED|Overall Study||7
7871265|NCT00850421|19372840|P1|NOT COMPLETED|Overall Study||17
7871266|NCT00850421|19372840|P1|COMPLETED|Overall Study||18
7871267|NCT00850421|19372840|P1|STARTED|Overall Study||35
7871268|NCT00850395|19372846|P1|NOT COMPLETED|Overall Study||10
7871269|NCT00850395|19372846|P1|COMPLETED|Overall Study||69
7871270|NCT00850395|19372846|P1|STARTED|Overall Study||79
7871271|NCT00850343|19372866|P4|NOT COMPLETED|Overall Study||13
7871272|NCT00850343|19372867|P3|NOT COMPLETED|Overall Study||14
7871273|NCT00850343|19372868|P2|NOT COMPLETED|Overall Study||3
7871274|NCT00850343|19372869|P1|NOT COMPLETED|Overall Study||46
7871275|NCT00850343|19372866|P4|COMPLETED|Overall Study||30
7871276|NCT00850343|19372867|P3|COMPLETED|Overall Study||29
7871277|NCT00850343|19372868|P2|COMPLETED|Overall Study||9
7871278|NCT00850343|19372869|P1|COMPLETED|Overall Study||64
7871279|NCT00850343|19372866|P4|Completed Week 52|Overall Study||37
7871280|NCT00850343|19372867|P3|Completed Week 52|Overall Study||37
7871281|NCT00850343|19372868|P2|Completed Week 52|Overall Study||11
7871282|NCT00850343|19372869|P1|Completed Week 52|Overall Study||88
7871283|NCT00850343|19372866|P4|Completed Week 24|Overall Study||39
7871284|NCT00850343|19372867|P3|Completed Week 24|Overall Study||39
7871285|NCT00850343|19372868|P2|Completed Week 24|Overall Study||12
7871286|NCT00850343|19372869|P1|Completed Week 24|Overall Study||94
7871287|NCT00850343|19372866|P4|STARTED|Overall Study||43
7871288|NCT00850343|19372867|P3|STARTED|Overall Study||43
7871289|NCT00850343|19372868|P2|STARTED|Overall Study||12
7871290|NCT00850343|19372869|P1|STARTED|Overall Study||110
7871291|NCT00850200|19372899|P1|NOT COMPLETED|Overall Study||5
7871292|NCT00850200|19372899|P1|COMPLETED|Overall Study||15
7871293|NCT00850200|19372899|P1|STARTED|Overall Study||20
7871294|NCT00850174|19372909|P2|NOT COMPLETED|Second Intervention||0
7871295|NCT00850174|19372910|P1|NOT COMPLETED|Second Intervention||1
7871296|NCT00850174|19372909|P2|COMPLETED|Second Intervention||28
7871297|NCT00850174|19372910|P1|COMPLETED|Second Intervention||29
7871298|NCT00850174|19372909|P2|STARTED|Second Intervention||28
7871299|NCT00850174|19372910|P1|STARTED|Second Intervention||30
7871300|NCT00850174|19372909|P2|NOT COMPLETED|Washout: One Week||2
7871301|NCT00850174|19372910|P1|NOT COMPLETED|Washout: One Week||0
7871302|NCT00850174|19372909|P2|COMPLETED|Washout: One Week||28
7871303|NCT00850174|19372910|P1|COMPLETED|Washout: One Week||30
7871304|NCT00850174|19372909|P2|STARTED|Washout: One Week||30
7871305|NCT00850174|19372910|P1|STARTED|Washout: One Week||30
7871306|NCT00850174|19372909|P2|NOT COMPLETED|First Intervention||0
7871307|NCT00850174|19372910|P1|NOT COMPLETED|First Intervention||0
7871308|NCT00850174|19372909|P2|COMPLETED|First Intervention||30
7871309|NCT00850174|19372910|P1|COMPLETED|First Intervention||30
7871310|NCT00850174|19372909|P2|STARTED|First Intervention||30
7871311|NCT00850174|19372910|P1|STARTED|First Intervention||30
7871312|NCT00850135|19372924|P1|NOT COMPLETED|Overall Study||1
7871313|NCT00850135|19372924|P1|COMPLETED|Overall Study||56
7871314|NCT00850135|19372924|P1|STARTED|Overall Study||57
7871315|NCT00850096|19372932|P2|NOT COMPLETED|Overall Study||2
7871316|NCT00850096|19372933|P1|NOT COMPLETED|Overall Study||3
7871317|NCT00850096|19372932|P2|COMPLETED|Overall Study||45
7871318|NCT00850096|19372933|P1|COMPLETED|Overall Study||44
7871319|NCT00850096|19372932|P2|STARTED|Overall Study||47
7871320|NCT00850096|19372933|P1|STARTED|Overall Study||47
7871321|NCT00850070|19372943|P2|NOT COMPLETED|Overall Study||1
7871322|NCT00850070|19372944|P1|NOT COMPLETED|Overall Study||3
7871323|NCT00850070|19372943|P2|COMPLETED|Overall Study||22
7871324|NCT00850070|19372944|P1|COMPLETED|Overall Study||20
7871325|NCT00850070|19372943|P2|STARTED|Overall Study||23
7871326|NCT00850070|19372944|P1|STARTED|Overall Study||23
7871327|NCT00850031|19372968|P1|NOT COMPLETED|Overall Study||17
7871328|NCT00850031|19372968|P1|COMPLETED|Overall Study||101
7871329|NCT00850031|19372968|P1|STARTED|Overall Study||118
7871330|NCT00849940|19372973|P1|NOT COMPLETED|Overall Study||4
7871331|NCT00849940|19372973|P1|COMPLETED|Overall Study||68
7871332|NCT00849940|19372973|P1|STARTED|Overall Study||72
7871333|NCT00849901|19372984|P3|NOT COMPLETED|Extension Phase||17
7871334|NCT00849901|19372985|P2|NOT COMPLETED|Extension Phase||26
7871335|NCT00849901|19372986|P1|NOT COMPLETED|Extension Phase||27
7871336|NCT00849901|19372984|P3|COMPLETED|Extension Phase||69
7871337|NCT00849901|19372985|P2|COMPLETED|Extension Phase||65
7871338|NCT00849901|19372986|P1|COMPLETED|Extension Phase||56
7871339|NCT00849901|19372984|P3|STARTED|Extension Phase||86
7871340|NCT00849901|19372985|P2|STARTED|Extension Phase||91
7871341|NCT00849901|19372986|P1|STARTED|Extension Phase||83
7871342|NCT00849901|19372984|P3|NOT COMPLETED|Acute Treatment Phase||16
7871343|NCT00849901|19372985|P2|NOT COMPLETED|Acute Treatment Phase||26
7871344|NCT00849901|19372986|P1|NOT COMPLETED|Acute Treatment Phase||30
7871345|NCT00849901|19372984|P3|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87
7871346|NCT00849901|19372985|P2|COMPLETED|Acute Treatment Phase||91
7871347|NCT00849901|19372986|P1|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87
7871348|NCT00849901|19372984|P3|STARTED|Acute Treatment Phase||103
7871349|NCT00849901|19372985|P2|STARTED|Acute Treatment Phase||117
7871350|NCT00849901|19372986|P1|STARTED|Acute Treatment Phase||117
7871351|NCT00849875|19373033|P1|NOT COMPLETED|Overall Study||47
7871352|NCT00849875|19373033|P1|COMPLETED|Overall Study||1
7871353|NCT00849875|19373033|P1|STARTED|Overall Study||48
7871354|NCT00849862|19373115|P2|NOT COMPLETED|Second Intervention||0
7871355|NCT00849862|19373116|P1|NOT COMPLETED|Second Intervention||0
7871356|NCT00849862|19373115|P2|COMPLETED|Second Intervention||11
7871357|NCT00849862|19373116|P1|COMPLETED|Second Intervention||11
7871358|NCT00849862|19373115|P2|STARTED|Second Intervention||11
7871359|NCT00849862|19373116|P1|STARTED|Second Intervention||11
7871360|NCT00849862|19373115|P2|NOT COMPLETED|Washout: 7 Days||0
7871361|NCT00849862|19373116|P1|NOT COMPLETED|Washout: 7 Days||0
7871362|NCT00849862|19373115|P2|COMPLETED|Washout: 7 Days||11
7871363|NCT00849862|19373116|P1|COMPLETED|Washout: 7 Days||11
7871364|NCT00849862|19373115|P2|STARTED|Washout: 7 Days||11
7871365|NCT00849862|19373116|P1|STARTED|Washout: 7 Days||11
7871366|NCT00849862|19373115|P2|NOT COMPLETED|First Intervention||0
7871367|NCT00849862|19373116|P1|NOT COMPLETED|First Intervention||0
7871368|NCT00849862|19373115|P2|COMPLETED|First Intervention||11
7871369|NCT00849862|19373116|P1|COMPLETED|First Intervention||11
7871370|NCT00849862|19373115|P2|STARTED|First Intervention||11
7871371|NCT00849862|19373116|P1|STARTED|First Intervention||11
7871372|NCT00849810|19373124|P1|NOT COMPLETED|Overall Study||0
7871373|NCT00849810|19373124|P1|COMPLETED|Overall Study||1
7871374|NCT00849810|19373124|P1|STARTED|Overall Study||1
7871375|NCT00849797|19373130|P2|NOT COMPLETED|Second Intervention||0
7871376|NCT00849797|19373131|P1|NOT COMPLETED|Second Intervention||0
7871377|NCT00849797|19373130|P2|COMPLETED|Second Intervention||57
7871378|NCT00849797|19373131|P1|COMPLETED|Second Intervention||59
7871379|NCT00849797|19373130|P2|STARTED|Second Intervention||57
7871380|NCT00849797|19373131|P1|STARTED|Second Intervention||59
7871381|NCT00849797|19373130|P2|NOT COMPLETED|Washout: One Week||2
7871382|NCT00849797|19373131|P1|NOT COMPLETED|Washout: One Week||0
7871383|NCT00849797|19373130|P2|COMPLETED|Washout: One Week||57
7871384|NCT00849797|19373131|P1|COMPLETED|Washout: One Week||59
7871385|NCT00849797|19373130|P2|STARTED|Washout: One Week||59
7871386|NCT00849797|19373131|P1|STARTED|Washout: One Week||59
7871387|NCT00849797|19373130|P2|NOT COMPLETED|First Intervention||1
7871388|NCT00849797|19373131|P1|NOT COMPLETED|First Intervention||1
7871389|NCT00849797|19373130|P2|COMPLETED|First Intervention||59
7871390|NCT00849797|19373131|P1|COMPLETED|First Intervention||59
7871391|NCT00849797|19373130|P2|STARTED|First Intervention||60
7871392|NCT00849797|19373131|P1|STARTED|First Intervention||60
7871393|NCT00849693|19373149|P4|NOT COMPLETED|Extension Phase||38
7871394|NCT00849693|19373150|P3|NOT COMPLETED|Extension Phase||35
7871395|NCT00849693|19373151|P2|NOT COMPLETED|Extension Phase||30
7871396|NCT00849693|19373152|P1|NOT COMPLETED|Extension Phase||30
7871397|NCT00849693|19373149|P4|COMPLETED|Extension Phase||44
7871398|NCT00849693|19373150|P3|COMPLETED|Extension Phase||49
7871399|NCT00849693|19373151|P2|COMPLETED|Extension Phase||50
7871400|NCT00849693|19373152|P1|COMPLETED|Extension Phase||43
7871401|NCT00849693|19373149|P4|STARTED|Extension Phase||82
7871402|NCT00849693|19373150|P3|STARTED|Extension Phase||84
7871403|NCT00849693|19373151|P2|STARTED|Extension Phase||80
7871404|NCT00849693|19373152|P1|STARTED|Extension Phase||73
7871405|NCT00849693|19373149|P4|NOT COMPLETED|Acute Treatment Phase||37
7871406|NCT00849693|19373150|P3|NOT COMPLETED|Acute Treatment Phase||33
7871407|NCT00849693|19373151|P2|NOT COMPLETED|Acute Treatment Phase||35
7871408|NCT00849693|19373152|P1|NOT COMPLETED|Acute Treatment Phase||33
7871409|NCT00849693|19373149|P4|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85
7871410|NCT00849693|19373150|P3|COMPLETED|Acute Treatment Phase||84
7871411|NCT00849693|19373151|P2|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81
7871412|NCT00849693|19373152|P1|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75
7871413|NCT00849693|19373149|P4|STARTED|Acute Treatment Phase||122
7871414|NCT00849693|19373150|P3|STARTED|Acute Treatment Phase||117
7871415|NCT00849693|19373151|P2|STARTED|Acute Treatment Phase||116
7871416|NCT00849693|19373152|P1|STARTED|Acute Treatment Phase||108
7871417|NCT00849680|19373219|P8|NOT COMPLETED|Overall Study||8
7871418|NCT00849680|19373220|P7|NOT COMPLETED|Overall Study||17
7871419|NCT00849680|19373221|P6|NOT COMPLETED|Overall Study||15
7871420|NCT00849680|19373222|P5|NOT COMPLETED|Overall Study||10
7871421|NCT00849680|19373223|P4|NOT COMPLETED|Overall Study||14
7871422|NCT00849680|19373224|P3|NOT COMPLETED|Overall Study||15
7871423|NCT00849680|19373225|P2|NOT COMPLETED|Overall Study||3
7871424|NCT00849680|19373226|P1|NOT COMPLETED|Overall Study||11
7871425|NCT00849680|19373219|P8|COMPLETED|Overall Study||23
7871426|NCT00849680|19373220|P7|COMPLETED|Overall Study||61
7871427|NCT00849680|19373221|P6|COMPLETED|Overall Study||27
7871428|NCT00849680|19373222|P5|COMPLETED|Overall Study||32
7871429|NCT00849680|19373223|P4|COMPLETED|Overall Study||28
7871430|NCT00849680|19373224|P3|COMPLETED|Overall Study||27
7871431|NCT00849680|19373225|P2|COMPLETED|Overall Study||10
7871432|NCT00849680|19373226|P1|COMPLETED|Overall Study||16
7871433|NCT00849680|19373219|P8|STARTED|Overall Study||31
7871434|NCT00849680|19373220|P7|STARTED|Overall Study||78
7871435|NCT00849680|19373221|P6|STARTED|Overall Study||42
7871436|NCT00849680|19373222|P5|STARTED|Overall Study||42
7871437|NCT00849680|19373223|P4|STARTED|Overall Study||42
7871438|NCT00849680|19373224|P3|STARTED|Overall Study||42
7871439|NCT00849680|19373225|P2|STARTED|Overall Study||13
7871440|NCT00849680|19373226|P1|STARTED|Overall Study||27
7871441|NCT00849524|19373268|P1|NOT COMPLETED|Overall Study||3
7871442|NCT00849524|19373268|P1|COMPLETED|Overall Study||3
7871443|NCT00849524|19373268|P1|STARTED|Overall Study||6
7871444|NCT00849485|19373276|P2|NOT COMPLETED|Second Intervention||0
7871445|NCT00849485|19373277|P1|NOT COMPLETED|Second Intervention||0
7871446|NCT00849485|19373276|P2|COMPLETED|Second Intervention||11
7871447|NCT00849485|19373277|P1|COMPLETED|Second Intervention||11
7871448|NCT00849485|19373276|P2|STARTED|Second Intervention||11
7871449|NCT00849485|19373277|P1|STARTED|Second Intervention||11
7871450|NCT00849485|19373276|P2|NOT COMPLETED|Washout: 7 Days||0
7871451|NCT00849485|19373277|P1|NOT COMPLETED|Washout: 7 Days||0
7871452|NCT00849485|19373276|P2|COMPLETED|Washout: 7 Days||11
7871453|NCT00849485|19373277|P1|COMPLETED|Washout: 7 Days||11
7871454|NCT00849485|19373276|P2|STARTED|Washout: 7 Days||11
7871455|NCT00849485|19373277|P1|STARTED|Washout: 7 Days||11
7871456|NCT00849485|19373276|P2|NOT COMPLETED|First Intervention||0
7871457|NCT00849485|19373277|P1|NOT COMPLETED|First Intervention||0
7871458|NCT00849485|19373276|P2|COMPLETED|First Intervention||11
7871459|NCT00849485|19373277|P1|COMPLETED|First Intervention||11
7871460|NCT00849485|19373276|P2|STARTED|First Intervention||11
7871461|NCT00849485|19373277|P1|STARTED|First Intervention||11
7871462|NCT00849472|19373285|P1|NOT COMPLETED|Pazopanib Postsurgery Treatment||26
7871463|NCT00849472|19373285|P1|COMPLETED|Pazopanib Postsurgery Treatment||16
7871464|NCT00849472|19373285|P1|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42
7871465|NCT00849472|19373285|P1|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58
7871466|NCT00849472|19373285|P1|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36
7871467|NCT00849472|19373285|P1|STARTED|Pazopanib Presurgery Treatment (PPT)||94
7871468|NCT00849472|19373285|P1|NOT COMPLETED|Weekly Paclitaxel||16
7871469|NCT00849472|19373285|P1|COMPLETED|Weekly Paclitaxel||78
7871470|NCT00849472|19373285|P1|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94
7871471|NCT00849472|19373285|P1|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6
7871472|NCT00849472|19373285|P1|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95
7871473|NCT00849472|19373285|P1|STARTED|Doxorubicin and Cyclophosphamide (AC)||101
7871474|NCT00849381|19373299|P1|NOT COMPLETED|Overall Study||145
7871475|NCT00849381|19373299|P1|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092
7871476|NCT00849381|19373299|P1|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237
7871477|NCT00849290|19373305|P1|NOT COMPLETED|Overall Study||55
7871478|NCT00849290|19373305|P1|COMPLETED|Overall Study||58
7871479|NCT00849290|19373305|P1|STARTED|Overall Study||113
7871480|NCT00849251|19373309|P2|NOT COMPLETED|Overall Study||1
7871481|NCT00849251|19373310|P1|NOT COMPLETED|Overall Study||1
7871482|NCT00849251|19373309|P2|COMPLETED|Overall Study||24
7871483|NCT00849251|19373310|P1|COMPLETED|Overall Study||5
7871484|NCT00849251|19373309|P2|STARTED|Overall Study||25
7871485|NCT00849251|19373310|P1|STARTED|Overall Study||6
7871486|NCT00849212|19373316|P1|NOT COMPLETED|Overall Study||7
7871487|NCT00849212|19373316|P1|COMPLETED|Overall Study||23
7871488|NCT00849212|19373316|P1|STARTED|Overall Study||30
7871489|NCT00849186|19373321|P1|NOT COMPLETED|Overall Study||10
7871490|NCT00849186|19373321|P1|COMPLETED|Overall Study||16
7871491|NCT00849186|19373321|P1|STARTED|Overall Study||26
7871492|NCT00849147|19373327|P1|NOT COMPLETED|Overall Study||5
7871493|NCT00849147|19373327|P1|COMPLETED|Overall Study||50
7871494|NCT00849147|19373327|P1|STARTED|Overall Study||55
7871495|NCT00849121|19373344|P2|NOT COMPLETED|Overall Study||0
7871496|NCT00849121|19373345|P1|NOT COMPLETED|Overall Study||0
7871497|NCT00849121|19373344|P2|COMPLETED|Overall Study||9
7871498|NCT00849121|19373345|P1|COMPLETED|Overall Study||8
7871499|NCT00849121|19373344|P2|STARTED|Overall Study||9
7871500|NCT00849121|19373345|P1|STARTED|Overall Study||8
7871501|NCT00849108|19373360|P2|NOT COMPLETED|Cohort 2 Efficacy||10
7871502|NCT00849108|19373361|P1|NOT COMPLETED|Cohort 2 Efficacy||0
7871503|NCT00849108|19373360|P2|COMPLETED|Cohort 2 Efficacy||133
7871504|NCT00849108|19373361|P1|COMPLETED|Cohort 2 Efficacy||0
7871505|NCT00849108|19373360|P2|STARTED|Cohort 2 Efficacy||143
7871506|NCT00849108|19373361|P1|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0
7871507|NCT00849108|19373360|P2|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
7871508|NCT00849108|19373361|P1|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1
7871509|NCT00849108|19373360|P2|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
7871510|NCT00849108|19373361|P1|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32
7871511|NCT00849108|19373360|P2|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0
7871512|NCT00849108|19373361|P1|STARTED|Cohort 1 Dose Ranging and Dose Interval||33
7871513|NCT00849056|19373371|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25
7871514|NCT00849056|19373372|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27
7871515|NCT00849056|19373371|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124
7871516|NCT00849056|19373372|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122
7871517|NCT00849056|19373371|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149
7871518|NCT00849056|19373372|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149
7871519|NCT00849056|19373371|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50
7871520|NCT00849056|19373372|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63
7871521|NCT00849056|19373371|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||100
7871522|NCT00849056|19373372|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||88
7871523|NCT00849056|19373371|P2|STARTED|Treatment Period (TP) (156 Weeks)||150
7871524|NCT00849056|19373372|P1|STARTED|Treatment Period (TP) (156 Weeks)||151
7871525|NCT00849017|19373397|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||25
7871526|NCT00849017|19373398|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||18
7871527|NCT00849017|19373399|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||25
7871528|NCT00849017|19373397|P3|COMPLETED|Follow-up Period (8 Weeks)||74
7871529|NCT00849017|19373398|P2|COMPLETED|Follow-up Period (8 Weeks)||83
7871530|NCT00849017|19373399|P1|COMPLETED|Follow-up Period (8 Weeks)||76
7871789|NCT00848042|19374120|P2|Month 2|Overall Study||5
7871531|NCT00849017|19373397|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99
7871532|NCT00849017|19373398|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
7871533|NCT00849017|19373399|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
7871534|NCT00849017|19373397|P3|NOT COMPLETED|Treatment Period (156 Weeks)||42
7871535|NCT00849017|19373398|P2|NOT COMPLETED|Treatment Period (156 Weeks)||33
7871536|NCT00849017|19373399|P1|NOT COMPLETED|Treatment Period (156 Weeks)||43
7871537|NCT00849017|19373397|P3|COMPLETED|Treatment Period (156 Weeks)||57
7871538|NCT00849017|19373398|P2|COMPLETED|Treatment Period (156 Weeks)||68
7871539|NCT00849017|19373399|P1|COMPLETED|Treatment Period (156 Weeks)||58
7871540|NCT00849017|19373397|P3|STARTED|Treatment Period (156 Weeks)||99
7871541|NCT00849017|19373398|P2|STARTED|Treatment Period (156 Weeks)||101
7871542|NCT00849017|19373399|P1|STARTED|Treatment Period (156 Weeks)||101
7871543|NCT00848965|19373442|P1|NOT COMPLETED|Overall Study||2
7871544|NCT00848965|19373442|P1|COMPLETED|Overall Study||57
7871545|NCT00848965|19373442|P1|STARTED|Overall Study||59
7871546|NCT00848926|19373484|P1|NOT COMPLETED|Follow-up Period||12
7871547|NCT00848926|19373484|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90
7871548|NCT00848926|19373484|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|102
7871549|NCT00848926|19373484|P1|NOT COMPLETED|Treatment Period||84
7871550|NCT00848926|19373484|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18
7871551|NCT00848926|19373484|P1|STARTED|Treatment Period||102
7871552|NCT00848783|19373503|P3|NOT COMPLETED|Overall Study||0
7871553|NCT00848783|19373504|P2|NOT COMPLETED|Overall Study||2
7871554|NCT00848783|19373505|P1|NOT COMPLETED|Overall Study||3
7871555|NCT00848783|19373503|P3|COMPLETED|Overall Study||1
7871556|NCT00848783|19373504|P2|COMPLETED|Overall Study||1
7871557|NCT00848783|19373505|P1|COMPLETED|Overall Study||1
7871558|NCT00848783|19373503|P3|STARTED|Overall Study||1
7871559|NCT00848783|19373504|P2|STARTED|Overall Study||3
7871560|NCT00848783|19373505|P1|STARTED|Overall Study||4
7871561|NCT00848744|19373514|P1|NOT COMPLETED|Overall Study||0
7871562|NCT00848744|19373514|P1|COMPLETED|Overall Study||10
7871563|NCT00848744|19373514|P1|STARTED|Overall Study||10
7871564|NCT00848718|19373534|P13|NOT COMPLETED|Overall Study||8
7871565|NCT00848718|19373535|P12|NOT COMPLETED|Overall Study||6
7871566|NCT00848718|19373536|P11|NOT COMPLETED|Overall Study||4
7871567|NCT00848718|19373537|P10|NOT COMPLETED|Overall Study||9
7871568|NCT00848718|19373538|P9|NOT COMPLETED|Overall Study||4
7871569|NCT00848718|19373539|P8|NOT COMPLETED|Overall Study||5
7871570|NCT00848718|19373540|P7|NOT COMPLETED|Overall Study||3
7871571|NCT00848718|19373541|P6|NOT COMPLETED|Overall Study||5
7871572|NCT00848718|19373542|P5|NOT COMPLETED|Overall Study||6
7871573|NCT00848718|19373543|P4|NOT COMPLETED|Overall Study||5
7871574|NCT00848718|19373544|P3|NOT COMPLETED|Overall Study||6
7871575|NCT00848718|19373545|P2|NOT COMPLETED|Overall Study||9
7871576|NCT00848718|19373546|P1|NOT COMPLETED|Overall Study||7
7871577|NCT00848718|19373534|P13|COMPLETED|Overall Study||0
7871578|NCT00848718|19373535|P12|COMPLETED|Overall Study||0
7871579|NCT00848718|19373536|P11|COMPLETED|Overall Study||0
7871580|NCT00848718|19373537|P10|COMPLETED|Overall Study||0
7871581|NCT00848718|19373538|P9|COMPLETED|Overall Study||0
7871582|NCT00848718|19373539|P8|COMPLETED|Overall Study||0
7871583|NCT00848718|19373540|P7|COMPLETED|Overall Study||0
7871584|NCT00848718|19373541|P6|COMPLETED|Overall Study||0
7871585|NCT00848718|19373542|P5|COMPLETED|Overall Study||0
7871586|NCT00848718|19373543|P4|COMPLETED|Overall Study||0
7871587|NCT00848718|19373544|P3|COMPLETED|Overall Study||0
7871588|NCT00848718|19373545|P2|COMPLETED|Overall Study||0
7871589|NCT00848718|19373546|P1|COMPLETED|Overall Study||0
7871590|NCT00848718|19373534|P13|Treated|Overall Study|2 participants were allocated but did not receive treatment due to progression of disease|6
7871591|NCT00848718|19373535|P12|Treated|Overall Study||6
7871592|NCT00848718|19373536|P11|Treated|Overall Study||4
7871593|NCT00848718|19373537|P10|Treated|Overall Study||9
7871594|NCT00848718|19373538|P9|Treated|Overall Study||4
7871595|NCT00848718|19373539|P8|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|4
7871596|NCT00848718|19373540|P7|Treated|Overall Study||3
7871597|NCT00848718|19373541|P6|Treated|Overall Study||5
7871598|NCT00848718|19373542|P5|Treated|Overall Study||6
7871599|NCT00848718|19373543|P4|Treated|Overall Study||5
7871600|NCT00848718|19373544|P3|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|5
7871601|NCT00848718|19373545|P2|Treated|Overall Study||9
7871602|NCT00848718|19373546|P1|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|6
7871603|NCT00848718|19373534|P13|STARTED|Overall Study||8
7871604|NCT00848718|19373535|P12|STARTED|Overall Study||6
7871605|NCT00848718|19373536|P11|STARTED|Overall Study||4
7871606|NCT00848718|19373537|P10|STARTED|Overall Study||9
7871607|NCT00848718|19373538|P9|STARTED|Overall Study||4
7871608|NCT00848718|19373539|P8|STARTED|Overall Study||5
7871609|NCT00848718|19373540|P7|STARTED|Overall Study||3
7871610|NCT00848718|19373541|P6|STARTED|Overall Study||5
7871611|NCT00848718|19373542|P5|STARTED|Overall Study||6
7871612|NCT00848718|19373543|P4|STARTED|Overall Study||5
7871613|NCT00848718|19373544|P3|STARTED|Overall Study||6
7871614|NCT00848718|19373545|P2|STARTED|Overall Study||9
7871615|NCT00848718|19373546|P1|STARTED|Overall Study||7
7871616|NCT00848549|19373647|P2|NOT COMPLETED|E2090-E044-314 (Extension Study)||24
7871617|NCT00848549|19373648|P1|NOT COMPLETED|E2090-E044-314 (Extension Study)||17
7871618|NCT00848549|19373647|P2|COMPLETED|E2090-E044-314 (Extension Study)||134
7871619|NCT00848549|19373648|P1|COMPLETED|E2090-E044-314 (Extension Study)||120
7871620|NCT00848549|19373647|P2|STARTED|E2090-E044-314 (Extension Study)||158
7871621|NCT00848549|19373648|P1|STARTED|E2090-E044-314 (Extension Study)||137
7871622|NCT00848549|19373647|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34
7871623|NCT00848549|19373648|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24
7871624|NCT00848549|19373647|P2|COMPLETED|E2090-E044-310 (Base Study) Transition||158
7871625|NCT00848549|19373648|P1|COMPLETED|E2090-E044-310 (Base Study) Transition||137
7871626|NCT00848549|19373647|P2|STARTED|E2090-E044-310 (Base Study) Transition||192
7871627|NCT00848549|19373648|P1|STARTED|E2090-E044-310 (Base Study) Transition||161
7871628|NCT00848549|19373647|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109
7871629|NCT00848549|19373648|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121
7871630|NCT00848549|19373647|P2|COMPLETED|E2090-E044-310 (Base Study) Disposition||192
7871631|NCT00848549|19373648|P1|COMPLETED|E2090-E044-310 (Base Study) Disposition||161
7871632|NCT00848549|19373647|P2|STARTED|E2090-E044-310 (Base Study) Disposition||301
7871633|NCT00848549|19373648|P1|STARTED|E2090-E044-310 (Base Study) Disposition||282
7871634|NCT00848536|19373666|P2|NOT COMPLETED|Overall Study||7
7871635|NCT00848536|19373667|P1|NOT COMPLETED|Overall Study||4
7871636|NCT00848536|19373666|P2|COMPLETED|Overall Study||179
7871637|NCT00848536|19373667|P1|COMPLETED|Overall Study||181
7871638|NCT00848536|19373666|P2|STARTED|Overall Study||186
7871639|NCT00848536|19373667|P1|STARTED|Overall Study||185
7871640|NCT00848510|19373681|P4|NOT COMPLETED|Overall Study||0
7871641|NCT00848510|19373682|P3|NOT COMPLETED|Overall Study||0
7871642|NCT00848510|19373683|P2|NOT COMPLETED|Overall Study||0
7871643|NCT00848510|19373684|P1|NOT COMPLETED|Overall Study||0
7871644|NCT00848510|19373681|P4|COMPLETED|Overall Study||10
7871645|NCT00848510|19373682|P3|COMPLETED|Overall Study||8
7871646|NCT00848510|19373683|P2|COMPLETED|Overall Study||13
7871647|NCT00848510|19373684|P1|COMPLETED|Overall Study||10
7871648|NCT00848510|19373681|P4|STARTED|Overall Study||10
7871649|NCT00848510|19373682|P3|STARTED|Overall Study||8
7871650|NCT00848510|19373683|P2|STARTED|Overall Study||13
7871651|NCT00848510|19373684|P1|STARTED|Overall Study||10
7871652|NCT00848497|19373732|P2|NOT COMPLETED|Overall Study||1
7871653|NCT00848497|19373733|P1|NOT COMPLETED|Overall Study||2
7871654|NCT00848497|19373732|P2|COMPLETED|Overall Study||0
7871655|NCT00848497|19373733|P1|COMPLETED|Overall Study||0
7871656|NCT00848497|19373732|P2|STARTED|Overall Study|Completed Visit 4|1
7871657|NCT00848497|19373733|P1|STARTED|Overall Study||2
7871658|NCT00848484|19373747|P2|NOT COMPLETED|Second Intervention (Treatment Period 2)||1
7871659|NCT00848484|19373748|P1|NOT COMPLETED|Second Intervention (Treatment Period 2)||0
7871660|NCT00848484|19373747|P2|COMPLETED|Second Intervention (Treatment Period 2)||20
7871661|NCT00848484|19373748|P1|COMPLETED|Second Intervention (Treatment Period 2)||25
7871662|NCT00848484|19373747|P2|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
7871663|NCT00848484|19373748|P1|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
7871664|NCT00848484|19373747|P2|STARTED|Second Intervention (Treatment Period 2)||21
7871665|NCT00848484|19373748|P1|STARTED|Second Intervention (Treatment Period 2)||25
7871666|NCT00848484|19373747|P2|NOT COMPLETED|Washout Period of Two Weeks||3
7871667|NCT00848484|19373748|P1|NOT COMPLETED|Washout Period of Two Weeks||0
7871668|NCT00848484|19373747|P2|COMPLETED|Washout Period of Two Weeks||21
7871669|NCT00848484|19373748|P1|COMPLETED|Washout Period of Two Weeks||25
7871670|NCT00848484|19373747|P2|STARTED|Washout Period of Two Weeks||24
7871671|NCT00848484|19373748|P1|STARTED|Washout Period of Two Weeks||25
7871672|NCT00848484|19373747|P2|NOT COMPLETED|First Intervention (Treatment Period 1)||3
7871673|NCT00848484|19373748|P1|NOT COMPLETED|First Intervention (Treatment Period 1)||2
7871674|NCT00848484|19373747|P2|COMPLETED|First Intervention (Treatment Period 1)||24
7871675|NCT00848484|19373748|P1|COMPLETED|First Intervention (Treatment Period 1)||25
7871676|NCT00848484|19373747|P2|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1
7871677|NCT00848484|19373748|P1|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2
7871678|NCT00848484|19373747|P2|STARTED|First Intervention (Treatment Period 1)||27
7871679|NCT00848484|19373748|P1|STARTED|First Intervention (Treatment Period 1)||27
7871680|NCT00848393|19373767|P3|NOT COMPLETED|Overall Study||3
7871681|NCT00848393|19373768|P2|NOT COMPLETED|Overall Study||0
7871682|NCT00848393|19373769|P1|NOT COMPLETED|Overall Study||0
7871683|NCT00848393|19373767|P3|COMPLETED|Overall Study||15
7871684|NCT00848393|19373768|P2|COMPLETED|Overall Study||16
7871685|NCT00848393|19373769|P1|COMPLETED|Overall Study||17
7871686|NCT00848393|19373767|P3|STARTED|Overall Study||18
7871687|NCT00848393|19373768|P2|STARTED|Overall Study||16
7871688|NCT00848393|19373769|P1|STARTED|Overall Study||17
7871689|NCT00848367|19373797|P2|NOT COMPLETED|Overall Study||9
7871690|NCT00848367|19373798|P1|NOT COMPLETED|Overall Study||9
7871691|NCT00848367|19373797|P2|COMPLETED|Overall Study||41
7871692|NCT00848367|19373798|P1|COMPLETED|Overall Study||43
7871693|NCT00848367|19373797|P2|STARTED|Overall Study||50
7871694|NCT00848367|19373798|P1|STARTED|Overall Study||52
7871695|NCT00848354|19373808|P2|NOT COMPLETED|Phase 2 Year 2||7
7871696|NCT00848354|19373809|P1|NOT COMPLETED|Phase 2 Year 2||23
7871697|NCT00848354|19373808|P2|COMPLETED|Phase 2 Year 2||113
7871698|NCT00848354|19373809|P1|COMPLETED|Phase 2 Year 2||218
7871790|NCT00848042|19374121|P1|Month 2|Overall Study||1
7871699|NCT00848354|19373808|P2|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120
7871700|NCT00848354|19373809|P1|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.
~1 participant discontinued between Year 1 and Year 2."|241
7871701|NCT00848354|19373808|P2|NOT COMPLETED|Phase 2 Year 1||6
7871702|NCT00848354|19373809|P1|NOT COMPLETED|Phase 2 Year 1||18
7871703|NCT00848354|19373808|P2|COMPLETED|Phase 2 Year 1||120
7871704|NCT00848354|19373809|P1|COMPLETED|Phase 2 Year 1||242
7871705|NCT00848354|19373808|P2|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126
7871706|NCT00848354|19373809|P1|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260
7871707|NCT00848354|19373808|P2|NOT COMPLETED|Phase 1||14
7871708|NCT00848354|19373809|P1|NOT COMPLETED|Phase 1||12
7871709|NCT00848354|19373808|P2|COMPLETED|Phase 1||129
7871710|NCT00848354|19373809|P1|COMPLETED|Phase 1||269
7871711|NCT00848354|19373808|P2|STARTED|Phase 1||143
7871712|NCT00848354|19373809|P1|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281
7871713|NCT00848250|19373961|P2|NOT COMPLETED|Overall Study||1
7871714|NCT00848250|19373962|P1|NOT COMPLETED|Overall Study||0
7871715|NCT00848250|19373961|P2|COMPLETED|Overall Study||9
7871716|NCT00848250|19373962|P1|COMPLETED|Overall Study||11
7871717|NCT00848250|19373961|P2|STARTED|Overall Study||10
7871718|NCT00848250|19373962|P1|STARTED|Overall Study||11
7871719|NCT00848237|19373980|P1|NOT COMPLETED|Overall Study||539
7871720|NCT00848237|19373980|P1|COMPLETED|Overall Study||4982
7871721|NCT00848237|19373980|P1|STARTED|Overall Study||5521
7871722|NCT00848211|19373993|P4|NOT COMPLETED|Overall Study||0
7871723|NCT00848211|19373994|P3|NOT COMPLETED|Overall Study||1
7871724|NCT00848211|19373995|P2|NOT COMPLETED|Overall Study||1
7871725|NCT00848211|19373996|P1|NOT COMPLETED|Overall Study||0
7871726|NCT00848211|19373993|P4|COMPLETED|Overall Study||5
7871727|NCT00848211|19373994|P3|COMPLETED|Overall Study||5
7871728|NCT00848211|19373995|P2|COMPLETED|Overall Study||6
7871729|NCT00848211|19373996|P1|COMPLETED|Overall Study||6
7871730|NCT00848211|19373993|P4|STARTED|Overall Study||5
7871731|NCT00848211|19373994|P3|STARTED|Overall Study||6
7871732|NCT00848211|19373995|P2|STARTED|Overall Study||7
7871733|NCT00848211|19373996|P1|STARTED|Overall Study||6
7871734|NCT00848198|19374014|P1|NOT COMPLETED|Overall Study||15
7871735|NCT00848198|19374014|P1|COMPLETED|Overall Study||299
7871736|NCT00848198|19374014|P1|STARTED|Overall Study||314
7871737|NCT00848185|19374055|P3|NOT COMPLETED|Overall Study||0
7871738|NCT00848185|19374056|P2|NOT COMPLETED|Overall Study||0
7871739|NCT00848185|19374057|P1|NOT COMPLETED|Overall Study||0
7871740|NCT00848185|19374055|P3|COMPLETED|Overall Study||32
7871741|NCT00848185|19374056|P2|COMPLETED|Overall Study||32
7871742|NCT00848185|19374057|P1|COMPLETED|Overall Study||32
7871743|NCT00848185|19374055|P3|STARTED|Overall Study||32
7871744|NCT00848185|19374056|P2|STARTED|Overall Study||32
7871745|NCT00848185|19374057|P1|STARTED|Overall Study||32
7871746|NCT00848172|19374067|P2|NOT COMPLETED|Visit 3 - Follow Up||0
7871747|NCT00848172|19374068|P1|NOT COMPLETED|Visit 3 - Follow Up||0
7871748|NCT00848172|19374067|P2|COMPLETED|Visit 3 - Follow Up||8
7871749|NCT00848172|19374068|P1|COMPLETED|Visit 3 - Follow Up||10
7871750|NCT00848172|19374067|P2|STARTED|Visit 3 - Follow Up||8
7871751|NCT00848172|19374068|P1|STARTED|Visit 3 - Follow Up||10
7871752|NCT00848172|19374067|P2|NOT COMPLETED|Visit 2 - Drug Administration||1
7871753|NCT00848172|19374068|P1|NOT COMPLETED|Visit 2 - Drug Administration||0
7871754|NCT00848172|19374067|P2|COMPLETED|Visit 2 - Drug Administration||8
7871755|NCT00848172|19374068|P1|COMPLETED|Visit 2 - Drug Administration||10
7871756|NCT00848172|19374067|P2|STARTED|Visit 2 - Drug Administration||9
7871757|NCT00848172|19374068|P1|STARTED|Visit 2 - Drug Administration||10
7871758|NCT00848120|19374079|P1|NOT COMPLETED|Overall Study||1
7871759|NCT00848120|19374079|P1|COMPLETED|Overall Study||28
7871760|NCT00848120|19374079|P1|STARTED|Overall Study||29
7871761|NCT00848107|19374091|P1|NOT COMPLETED|Overall Study||21
7871762|NCT00848107|19374091|P1|COMPLETED|Overall Study||94
7871763|NCT00848107|19374091|P1|STARTED|Overall Study||115
7871764|NCT00848081|19374101|P2|NOT COMPLETED|Overall Study||18
7871765|NCT00848081|19374102|P1|NOT COMPLETED|Overall Study||20
7871766|NCT00848081|19374101|P2|COMPLETED|Overall Study||140
7871767|NCT00848081|19374102|P1|COMPLETED|Overall Study||140
7871768|NCT00848081|19374101|P2|STARTED|Overall Study||158
7871769|NCT00848081|19374102|P1|STARTED|Overall Study||160
7871770|NCT00848042|19374119|P3|NOT COMPLETED|Overall Study||0
7871771|NCT00848042|19374120|P2|NOT COMPLETED|Overall Study||2
7871772|NCT00848042|19374121|P1|NOT COMPLETED|Overall Study||4
7871773|NCT00848042|19374119|P3|COMPLETED|Overall Study||1
7871774|NCT00848042|19374120|P2|COMPLETED|Overall Study||3
7871775|NCT00848042|19374121|P1|COMPLETED|Overall Study||1
7871776|NCT00848042|19374119|P3|Month 6|Overall Study||1
7871777|NCT00848042|19374120|P2|Month 6|Overall Study||3
7871778|NCT00848042|19374121|P1|Month 6|Overall Study||1
7871779|NCT00848042|19374119|P3|Month 5|Overall Study||1
7871780|NCT00848042|19374120|P2|Month 5|Overall Study||3
7871781|NCT00848042|19374121|P1|Month 5|Overall Study||1
7871782|NCT00848042|19374119|P3|Month 4|Overall Study||1
7871783|NCT00848042|19374120|P2|Month 4|Overall Study||4
7871784|NCT00848042|19374121|P1|Month 4|Overall Study||1
7871785|NCT00848042|19374119|P3|Month 3|Overall Study||1
7871786|NCT00848042|19374120|P2|Month 3|Overall Study||4
7871787|NCT00848042|19374121|P1|Month 3|Overall Study||1
7871788|NCT00848042|19374119|P3|Month 2|Overall Study||1
7871791|NCT00848042|19374119|P3|Month 1|Overall Study||1
7871792|NCT00848042|19374120|P2|Month 1|Overall Study||5
7871793|NCT00848042|19374121|P1|Month 1|Overall Study||4
7871794|NCT00848042|19374119|P3|Day 15|Overall Study||1
7871795|NCT00848042|19374120|P2|Day 15|Overall Study||5
7871796|NCT00848042|19374121|P1|Day 15|Overall Study||4
7871797|NCT00848042|19374119|P3|Day 8|Overall Study||1
7871798|NCT00848042|19374120|P2|Day 8|Overall Study||5
7871799|NCT00848042|19374121|P1|Day 8|Overall Study||5
7871800|NCT00848042|19374119|P3|Day 3|Overall Study||1
7871801|NCT00848042|19374120|P2|Day 3|Overall Study||5
7871802|NCT00848042|19374121|P1|Day 3|Overall Study||5
7871803|NCT00848042|19374119|P3|Day 2|Overall Study||1
7871804|NCT00848042|19374120|P2|Day 2|Overall Study||5
7871805|NCT00848042|19374121|P1|Day 2|Overall Study||5
7871806|NCT00848042|19374119|P3|Day 1|Overall Study||1
7871807|NCT00848042|19374120|P2|Day 1|Overall Study||5
7871808|NCT00848042|19374121|P1|Day 1|Overall Study||5
7871809|NCT00848042|19374119|P3|STARTED|Overall Study||1
7871810|NCT00848042|19374120|P2|STARTED|Overall Study||5
7871811|NCT00848042|19374121|P1|STARTED|Overall Study||5
7871812|NCT00848016|19374132|P1|NOT COMPLETED|Overall Study||0
7871813|NCT00848016|19374132|P1|COMPLETED|Overall Study||29
7871814|NCT00848016|19374132|P1|STARTED|Overall Study||29
7871815|NCT00847938|19374142|P4|NOT COMPLETED|Overall Study||0
7871816|NCT00847938|19374143|P3|NOT COMPLETED|Overall Study||1
7871817|NCT00847938|19374144|P2|NOT COMPLETED|Overall Study||1
7871818|NCT00847938|19374145|P1|NOT COMPLETED|Overall Study||0
7871819|NCT00847938|19374142|P4|COMPLETED|Overall Study||15
7871820|NCT00847938|19374143|P3|COMPLETED|Overall Study||15
7871821|NCT00847938|19374144|P2|COMPLETED|Overall Study||14
7871822|NCT00847938|19374145|P1|COMPLETED|Overall Study||16
7871823|NCT00847938|19374142|P4|STARTED|Overall Study||15
7871824|NCT00847938|19374143|P3|STARTED|Overall Study||16
7871825|NCT00847938|19374144|P2|STARTED|Overall Study||15
7871826|NCT00847938|19374145|P1|STARTED|Overall Study||16
7871827|NCT00847912|19374157|P2|NOT COMPLETED|Overall Study||13
7871828|NCT00847912|19374158|P1|NOT COMPLETED|Overall Study||9
7871829|NCT00847912|19374157|P2|COMPLETED|Overall Study||464
7871830|NCT00847912|19374158|P1|COMPLETED|Overall Study||468
7871831|NCT00847912|19374157|P2|STARTED|Overall Study||477
7871832|NCT00847912|19374158|P1|STARTED|Overall Study||477
7871833|NCT00847886|19374168|P2|NOT COMPLETED|Overall Study||1
7871834|NCT00847886|19374169|P1|NOT COMPLETED|Overall Study||0
7871835|NCT00847886|19374168|P2|COMPLETED|Overall Study||3
7871836|NCT00847886|19374169|P1|COMPLETED|Overall Study||12
7871837|NCT00847886|19374168|P2|STARTED|Overall Study||4
7871838|NCT00847886|19374169|P1|STARTED|Overall Study||12
7871839|NCT00847808|19374195|P1|NOT COMPLETED|Overall Study||15
7871840|NCT00847808|19374195|P1|COMPLETED|Overall Study||163
7871841|NCT00847808|19374195|P1|STARTED|Overall Study||178
7871842|NCT00847730|19374212|P1|NOT COMPLETED|Overall Study||8
7871843|NCT00847730|19374212|P1|COMPLETED|Overall Study||25
7871844|NCT00847730|19374212|P1|STARTED|Overall Study||33
7871845|NCT00847704|19374216|P1|NOT COMPLETED|Overall Study||1
7871846|NCT00847704|19374216|P1|COMPLETED|Overall Study||2
7871847|NCT00847704|19374216|P1|STARTED|Overall Study||3
7871848|NCT00847665|19374227|P2|NOT COMPLETED|Overall Study||0
7871849|NCT00847665|19374228|P1|NOT COMPLETED|Overall Study||1
7871850|NCT00847665|19374227|P2|COMPLETED|Overall Study||165
7871851|NCT00847665|19374228|P1|COMPLETED|Overall Study||164
7871852|NCT00847665|19374227|P2|STARTED|Overall Study||165
7871853|NCT00847665|19374228|P1|STARTED|Overall Study||165
7871854|NCT00847626|19374251|P11|NOT COMPLETED|Overall Study||20
7871855|NCT00847626|19374252|P10|NOT COMPLETED|Overall Study||14
7871856|NCT00847626|19374253|P9|NOT COMPLETED|Overall Study||14
7871857|NCT00847626|19374254|P8|NOT COMPLETED|Overall Study||19
7871858|NCT00847626|19374255|P7|NOT COMPLETED|Overall Study||22
7871859|NCT00847626|19374256|P6|NOT COMPLETED|Overall Study||37
7871860|NCT00847626|19374257|P5|NOT COMPLETED|Overall Study||28
7871861|NCT00847626|19374258|P4|NOT COMPLETED|Overall Study||31
7871862|NCT00847626|19374259|P3|NOT COMPLETED|Overall Study||16
7871863|NCT00847626|19374260|P2|NOT COMPLETED|Overall Study||23
7871864|NCT00847626|19374261|P1|NOT COMPLETED|Overall Study||21
7871865|NCT00847626|19374251|P11|COMPLETED|Overall Study||142
7871866|NCT00847626|19374252|P10|COMPLETED|Overall Study||139
7871867|NCT00847626|19374253|P9|COMPLETED|Overall Study||141
7871868|NCT00847626|19374254|P8|COMPLETED|Overall Study||141
7871869|NCT00847626|19374255|P7|COMPLETED|Overall Study||135
7871870|NCT00847626|19374256|P6|COMPLETED|Overall Study||125
7871871|NCT00847626|19374257|P5|COMPLETED|Overall Study||125
7871872|NCT00847626|19374258|P4|COMPLETED|Overall Study||125
7871873|NCT00847626|19374259|P3|COMPLETED|Overall Study||131
7871874|NCT00847626|19374260|P2|COMPLETED|Overall Study||131
7871875|NCT00847626|19374261|P1|COMPLETED|Overall Study||135
7871876|NCT00847626|19374251|P11|STARTED|Overall Study||162
7871877|NCT00847626|19374252|P10|STARTED|Overall Study||153
7871878|NCT00847626|19374253|P9|STARTED|Overall Study||155
7871879|NCT00847626|19374254|P8|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160
7871880|NCT00847626|19374255|P7|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157
7871881|NCT00847626|19374256|P6|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162
7871882|NCT00847626|19374257|P5|STARTED|Overall Study||153
7871883|NCT00847626|19374258|P4|STARTED|Overall Study||156
7871884|NCT00847626|19374259|P3|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147
7871885|NCT00847626|19374260|P2|STARTED|Overall Study||154
7871886|NCT00847626|19374261|P1|STARTED|Overall Study||156
7871887|NCT00847613|19374460|P4|NOT COMPLETED|Overall Study||79
7871888|NCT00847613|19374461|P3|NOT COMPLETED|Overall Study||81
7871889|NCT00847613|19374462|P2|NOT COMPLETED|Overall Study||319
7871890|NCT00847613|19374463|P1|NOT COMPLETED|Overall Study||321
7871891|NCT00847613|19374460|P4|COMPLETED|Overall Study||0
7871892|NCT00847613|19374461|P3|COMPLETED|Overall Study||0
7871893|NCT00847613|19374462|P2|COMPLETED|Overall Study||0
7871894|NCT00847613|19374463|P1|COMPLETED|Overall Study||0
7871895|NCT00847613|19374460|P4|Treated|Overall Study||79
7871896|NCT00847613|19374461|P3|Treated|Overall Study||81
7871897|NCT00847613|19374462|P2|Treated|Overall Study||316
7871898|NCT00847613|19374463|P1|Treated|Overall Study||321
7871899|NCT00847613|19374460|P4|STARTED|Overall Study||79
7871900|NCT00847613|19374461|P3|STARTED|Overall Study||81
7871901|NCT00847613|19374462|P2|STARTED|Overall Study||319
7871902|NCT00847613|19374463|P1|STARTED|Overall Study||321
7871903|NCT00847587|19374703|P2|NOT COMPLETED|Overall Study||0
7871904|NCT00847587|19374704|P1|NOT COMPLETED|Overall Study||1
7871905|NCT00847587|19374703|P2|COMPLETED|Overall Study||34
7871906|NCT00847587|19374704|P1|COMPLETED|Overall Study|Patient declined study after randomization.|34
7871907|NCT00847587|19374703|P2|STARTED|Overall Study||34
7871908|NCT00847587|19374704|P1|STARTED|Overall Study||35
7871909|NCT00847561|19374714|P2|NOT COMPLETED|Overall Study||4
7871910|NCT00847561|19374715|P1|NOT COMPLETED|Overall Study||13
7871911|NCT00847561|19374714|P2|COMPLETED|Overall Study||62
7871912|NCT00847561|19374715|P1|COMPLETED|Overall Study||57
7871913|NCT00847561|19374714|P2|STARTED|Overall Study||66
7871914|NCT00847561|19374715|P1|STARTED|Overall Study||70
7871915|NCT00847535|19374721|P3|NOT COMPLETED|Overall Study||1
7871916|NCT00847535|19374722|P2|NOT COMPLETED|Overall Study||2
7871917|NCT00847535|19374723|P1|NOT COMPLETED|Overall Study||2
7871918|NCT00847535|19374721|P3|COMPLETED|Overall Study||15
7871919|NCT00847535|19374722|P2|COMPLETED|Overall Study||22
7871920|NCT00847535|19374723|P1|COMPLETED|Overall Study||22
7871921|NCT00847535|19374721|P3|200 Million AMDC|Overall Study||8
7871922|NCT00847535|19374722|P2|200 Million AMDC|Overall Study||0
7871923|NCT00847535|19374723|P1|200 Million AMDC|Overall Study||0
7871924|NCT00847535|19374721|P3|100 Million AMDC|Overall Study||8
7871925|NCT00847535|19374722|P2|100 Million AMDC|Overall Study||8
7871926|NCT00847535|19374723|P1|100 Million AMDC|Overall Study||8
7871927|NCT00847535|19374721|P3|50 Million AMDC|Overall Study||0
7871928|NCT00847535|19374722|P2|50 Million AMDC|Overall Study||8
7871929|NCT00847535|19374723|P1|50 Million AMDC|Overall Study||8
7871930|NCT00847535|19374721|P3|10 Million AMDC|Overall Study||0
7871931|NCT00847535|19374722|P2|10 Million AMDC|Overall Study||8
7871932|NCT00847535|19374723|P1|10 Million AMDC|Overall Study||8
7871933|NCT00847535|19374721|P3|STARTED|Overall Study||16
7871934|NCT00847535|19374722|P2|STARTED|Overall Study||24
7871935|NCT00847535|19374723|P1|STARTED|Overall Study||24
7871936|NCT00847522|19374731|P1|NOT COMPLETED|Overall Study||0
7871937|NCT00847522|19374731|P1|COMPLETED|Overall Study||90
7871938|NCT00847522|19374731|P1|Phase II|Overall Study||80
7871939|NCT00847522|19374731|P1|Phase I|Overall Study||10
7871940|NCT00847522|19374731|P1|STARTED|Overall Study||90
7871941|NCT00847509|19374736|P1|NOT COMPLETED|Overall Study||11
7871942|NCT00847509|19374736|P1|COMPLETED|Overall Study||38
7871943|NCT00847509|19374736|P1|STARTED|Overall Study||49
7871944|NCT00847405|19374742|P2|NOT COMPLETED|Second Intervention||0
7871945|NCT00847405|19374743|P1|NOT COMPLETED|Second Intervention||0
7871946|NCT00847405|19374742|P2|COMPLETED|Second Intervention||13
7871947|NCT00847405|19374743|P1|COMPLETED|Second Intervention||13
7871948|NCT00847405|19374742|P2|STARTED|Second Intervention||13
7871949|NCT00847405|19374743|P1|STARTED|Second Intervention||13
7871950|NCT00847405|19374742|P2|NOT COMPLETED|Washout of 7 Days||0
7871951|NCT00847405|19374743|P1|NOT COMPLETED|Washout of 7 Days||1
7871952|NCT00847405|19374742|P2|COMPLETED|Washout of 7 Days||13
7871953|NCT00847405|19374743|P1|COMPLETED|Washout of 7 Days||13
7871954|NCT00847405|19374742|P2|STARTED|Washout of 7 Days||13
7871955|NCT00847405|19374743|P1|STARTED|Washout of 7 Days||14
7871956|NCT00847405|19374742|P2|NOT COMPLETED|First Intervention||1
7871957|NCT00847405|19374743|P1|NOT COMPLETED|First Intervention||0
7871958|NCT00847405|19374742|P2|COMPLETED|First Intervention||13
7871959|NCT00847405|19374743|P1|COMPLETED|First Intervention||14
7871960|NCT00847405|19374742|P2|STARTED|First Intervention||14
7871961|NCT00847405|19374743|P1|STARTED|First Intervention||14
7871962|NCT00847379|19374754|P3|NOT COMPLETED|Overall Study||57
7871963|NCT00847379|19374755|P2|NOT COMPLETED|Overall Study||57
7871964|NCT00847379|19374756|P1|NOT COMPLETED|Overall Study||59
7871965|NCT00847379|19374754|P3|COMPLETED|Overall Study||0
7871966|NCT00847379|19374755|P2|COMPLETED|Overall Study||0
7871967|NCT00847379|19374756|P1|COMPLETED|Overall Study||0
7871968|NCT00847379|19374754|P3|As-treated Population|Overall Study||57
7871969|NCT00847379|19374755|P2|As-treated Population|Overall Study||57
7871970|NCT00847379|19374756|P1|As-treated Population|Overall Study||59
7871971|NCT00847379|19374754|P3|STARTED|Overall Study||57
7871972|NCT00847379|19374755|P2|STARTED|Overall Study||57
7871973|NCT00847379|19374756|P1|STARTED|Overall Study||59
7871974|NCT00847301|19374854|P1|NOT COMPLETED|Overall Study||54
7871975|NCT00847301|19374854|P1|COMPLETED|Overall Study||374
7871976|NCT00847301|19374854|P1|STARTED|Overall Study||428
7871977|NCT00847288|19374864|P2|NOT COMPLETED|Overall Study||47
7871978|NCT00847288|19374865|P1|NOT COMPLETED|Overall Study||30
7871979|NCT00847288|19374864|P2|COMPLETED|Overall Study||780
7871980|NCT00847288|19374865|P1|COMPLETED|Overall Study||811
7871981|NCT00847288|19374864|P2|STARTED|Overall Study||827
7871982|NCT00847288|19374865|P1|STARTED|Overall Study||841
7871983|NCT00847210|19374879|P2|NOT COMPLETED|Overall Study||0
7871984|NCT00847210|19374880|P1|NOT COMPLETED|Overall Study||0
7871985|NCT00847210|19374879|P2|COMPLETED|Overall Study||18
7871986|NCT00847210|19374880|P1|COMPLETED|Overall Study||18
7871987|NCT00847210|19374879|P2|STARTED|Overall Study||18
7871988|NCT00847210|19374880|P1|STARTED|Overall Study||18
7871989|NCT00847197|19374902|P2|NOT COMPLETED|Overall Study||5
7871990|NCT00847197|19374903|P1|NOT COMPLETED|Overall Study||24
7871991|NCT00847197|19374902|P2|COMPLETED|Overall Study||70
7871992|NCT00847197|19374903|P1|COMPLETED|Overall Study||92
7871993|NCT00847197|19374902|P2|STARTED|Overall Study||75
7871994|NCT00847197|19374903|P1|STARTED|Overall Study||116
7871995|NCT00847171|19374913|P1|NOT COMPLETED|Overall Study||0
7871996|NCT00847171|19374913|P1|COMPLETED|Overall Study||20
7871997|NCT00847171|19374913|P1|STARTED|Overall Study||20
7871998|NCT00847145|19374927|P8|NOT COMPLETED|Overall Study||4
7871999|NCT00847145|19374928|P7|NOT COMPLETED|Overall Study||9
7872000|NCT00847145|19374929|P6|NOT COMPLETED|Overall Study||4
7872001|NCT00847145|19374930|P5|NOT COMPLETED|Overall Study||6
7872002|NCT00847145|19374931|P4|NOT COMPLETED|Overall Study||1
7872003|NCT00847145|19374932|P3|NOT COMPLETED|Overall Study||11
7872004|NCT00847145|19374933|P2|NOT COMPLETED|Overall Study||6
7872005|NCT00847145|19374934|P1|NOT COMPLETED|Overall Study||6
7872006|NCT00847145|19374927|P8|COMPLETED|Overall Study||136
7872007|NCT00847145|19374928|P7|COMPLETED|Overall Study||143
7872008|NCT00847145|19374929|P6|COMPLETED|Overall Study||152
7872009|NCT00847145|19374930|P5|COMPLETED|Overall Study||131
7872010|NCT00847145|19374931|P4|COMPLETED|Overall Study||116
7872011|NCT00847145|19374932|P3|COMPLETED|Overall Study||274
7872012|NCT00847145|19374933|P2|COMPLETED|Overall Study||627
7872013|NCT00847145|19374934|P1|COMPLETED|Overall Study||623
7872014|NCT00847145|19374927|P8|STARTED|Overall Study||140
7872015|NCT00847145|19374928|P7|STARTED|Overall Study||152
7872016|NCT00847145|19374929|P6|STARTED|Overall Study||156
7872017|NCT00847145|19374930|P5|STARTED|Overall Study||137
7872018|NCT00847145|19374931|P4|STARTED|Overall Study||117
7872019|NCT00847145|19374932|P3|STARTED|Overall Study||285
7872020|NCT00847145|19374933|P2|STARTED|Overall Study||633
7872021|NCT00847145|19374934|P1|STARTED|Overall Study||629
7872022|NCT00847132|19374984|P2|NOT COMPLETED|Overall Study||1
7872023|NCT00847132|19374985|P1|NOT COMPLETED|Overall Study||1
7872024|NCT00847132|19374984|P2|COMPLETED|Overall Study||84
7872025|NCT00847132|19374985|P1|COMPLETED|Overall Study||89
7872026|NCT00847132|19374984|P2|STARTED|Overall Study||85
7872027|NCT00847132|19374985|P1|STARTED|Overall Study||90
7872028|NCT00847015|19374993|P1|NOT COMPLETED|Overall Study||3
7872029|NCT00847015|19374993|P1|COMPLETED|Overall Study||15
7872030|NCT00847015|19374993|P1|STARTED|Overall Study||18
7872031|NCT00847002|19375001|P2|NOT COMPLETED|Overall Study||0
7872032|NCT00847002|19375002|P1|NOT COMPLETED|Overall Study||0
7872033|NCT00847002|19375001|P2|COMPLETED|Overall Study||4
7872034|NCT00847002|19375002|P1|COMPLETED|Overall Study||4
7872035|NCT00847002|19375001|P2|STARTED|Overall Study||4
7872036|NCT00847002|19375002|P1|STARTED|Overall Study||4
7872037|NCT00846885|19375012|P2|NOT COMPLETED|Second Intervention||0
7872038|NCT00846885|19375013|P1|NOT COMPLETED|Second Intervention||0
7872039|NCT00846885|19375012|P2|COMPLETED|Second Intervention||14
7872040|NCT00846885|19375013|P1|COMPLETED|Second Intervention||14
7872041|NCT00846885|19375012|P2|STARTED|Second Intervention||14
7872042|NCT00846885|19375013|P1|STARTED|Second Intervention||14
7872043|NCT00846885|19375012|P2|NOT COMPLETED|Washout of 7 Days||0
7872044|NCT00846885|19375013|P1|NOT COMPLETED|Washout of 7 Days||0
7872045|NCT00846885|19375012|P2|COMPLETED|Washout of 7 Days||14
7872046|NCT00846885|19375013|P1|COMPLETED|Washout of 7 Days||14
7872047|NCT00846885|19375012|P2|STARTED|Washout of 7 Days||14
7872048|NCT00846885|19375013|P1|STARTED|Washout of 7 Days||14
7872049|NCT00846885|19375012|P2|NOT COMPLETED|First Intervention||0
7872050|NCT00846885|19375013|P1|NOT COMPLETED|First Intervention||0
7872051|NCT00846885|19375012|P2|COMPLETED|First Intervention||14
7872052|NCT00846885|19375013|P1|COMPLETED|First Intervention||14
7872053|NCT00846885|19375012|P2|STARTED|First Intervention||14
7872054|NCT00846885|19375013|P1|STARTED|First Intervention||14
7872055|NCT00846846|19375021|P1|NOT COMPLETED|Overall Study||75
7872056|NCT00846846|19375021|P1|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943
7872057|NCT00846846|19375021|P1|STARTED|Overall Study||1018
7872058|NCT00846807|19375026|P1|NOT COMPLETED|Overall Study||632
7872059|NCT00846807|19375026|P1|COMPLETED|Overall Study|Completed treatment.|4660
7872060|NCT00846807|19375026|P1|STARTED|Overall Study|Entered and treated.|5292
7872061|NCT00846768|19375034|P4|NOT COMPLETED|Overall Study||0
7872062|NCT00846768|19375035|P3|NOT COMPLETED|Overall Study||0
7872063|NCT00846768|19375036|P2|NOT COMPLETED|Overall Study||1
7872064|NCT00846768|19375037|P1|NOT COMPLETED|Overall Study||0
7872065|NCT00846768|19375034|P4|COMPLETED|Overall Study||12
7872066|NCT00846768|19375035|P3|COMPLETED|Overall Study||12
7872067|NCT00846768|19375036|P2|COMPLETED|Overall Study||11
7872068|NCT00846768|19375037|P1|COMPLETED|Overall Study||11
7872069|NCT00846768|19375034|P4|STARTED|Overall Study||12
7872070|NCT00846768|19375035|P3|STARTED|Overall Study||12
7872071|NCT00846768|19375036|P2|STARTED|Overall Study||12
7872072|NCT00846768|19375037|P1|STARTED|Overall Study||11
7872073|NCT00846742|19375107|P1|NOT COMPLETED|Overall Study||1
7872074|NCT00846742|19375107|P1|COMPLETED|Overall Study||84
7872075|NCT00846742|19375107|P1|Without Radiation Therapy (RT)|Overall Study||68
7872076|NCT00846742|19375107|P1|With Radiation Therapy (RT)|Overall Study||17
7872077|NCT00846742|19375107|P1|STARTED|Overall Study||85
7872078|NCT00846651|19375115|P2|NOT COMPLETED|Overall Study||4
7872079|NCT00846651|19375116|P1|NOT COMPLETED|Overall Study||4
7872080|NCT00846651|19375115|P2|COMPLETED|Overall Study||37
7872081|NCT00846651|19375116|P1|COMPLETED|Overall Study||37
7872082|NCT00846651|19375115|P2|STARTED|Overall Study||41
7872083|NCT00846651|19375116|P1|STARTED|Overall Study||41
7872084|NCT00846586|19375134|P2|NOT COMPLETED|Overall Study||35
7872085|NCT00846586|19375135|P1|NOT COMPLETED|Overall Study||39
7872086|NCT00846586|19375134|P2|COMPLETED|Overall Study||529
7872087|NCT00846586|19375135|P1|COMPLETED|Overall Study||531
7872088|NCT00846586|19375134|P2|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561
7872089|NCT00846586|19375135|P1|Received Study Drug|Overall Study||570
7872090|NCT00846586|19375134|P2|STARTED|Overall Study||564
7872091|NCT00846586|19375135|P1|STARTED|Overall Study||570
7872092|NCT00846573|19375154|P4|NOT COMPLETED|Overall Study||0
7872093|NCT00846573|19375155|P3|NOT COMPLETED|Overall Study||0
7872094|NCT00846573|19375156|P2|NOT COMPLETED|Overall Study||0
7872095|NCT00846573|19375157|P1|NOT COMPLETED|Overall Study||0
7872096|NCT00846573|19375154|P4|COMPLETED|Overall Study||0
7872097|NCT00846573|19375155|P3|COMPLETED|Overall Study||7
7872098|NCT00846573|19375156|P2|COMPLETED|Overall Study||2
7872099|NCT00846573|19375157|P1|COMPLETED|Overall Study||5
7872100|NCT00846573|19375154|P4|STARTED|Overall Study||0
7872101|NCT00846573|19375155|P3|STARTED|Overall Study||7
7872102|NCT00846573|19375156|P2|STARTED|Overall Study||2
7872103|NCT00846573|19375157|P1|STARTED|Overall Study||5
7872104|NCT00846547|19375165|P1|NOT COMPLETED|Overall Study||7
7872105|NCT00846547|19375165|P1|COMPLETED|Overall Study||25
7872106|NCT00846547|19375165|P1|STARTED|Overall Study||32
7872107|NCT00846521|19375169|P1|NOT COMPLETED|Overall Study||11
7872108|NCT00846521|19375169|P1|COMPLETED|Overall Study||12
7872109|NCT00846521|19375169|P1|STARTED|Overall Study||23
7872110|NCT00846495|19375176|P2|NOT COMPLETED|Overall Study||3
7872111|NCT00846495|19375177|P1|NOT COMPLETED|Overall Study||8
7872112|NCT00846495|19375176|P2|COMPLETED|Overall Study||24
7872113|NCT00846495|19375177|P1|COMPLETED|Overall Study||20
7872114|NCT00846495|19375176|P2|STARTED|Overall Study||27
7872115|NCT00846495|19375177|P1|STARTED|Overall Study||28
7872116|NCT00846482|19375197|P1|NOT COMPLETED|Overall Study||10
7872117|NCT00846482|19375197|P1|COMPLETED|Overall Study||54
7872118|NCT00846482|19375197|P1|STARTED|Overall Study||64
7872119|NCT00846391|19375205|P3|NOT COMPLETED|Overall Study||3
7872120|NCT00846391|19375206|P2|NOT COMPLETED|Overall Study||2
7872121|NCT00846391|19375207|P1|NOT COMPLETED|Overall Study||1
7872122|NCT00846391|19375205|P3|COMPLETED|Overall Study||3
7872123|NCT00846391|19375206|P2|COMPLETED|Overall Study||2
7872124|NCT00846391|19375207|P1|COMPLETED|Overall Study||3
7872125|NCT00846391|19375205|P3|STARTED|Overall Study||6
7872126|NCT00846391|19375206|P2|STARTED|Overall Study||4
7872127|NCT00846391|19375207|P1|STARTED|Overall Study||4
7872128|NCT00846365|19375218|P3|NOT COMPLETED|Overall Study||33
7872129|NCT00846365|19375219|P2|NOT COMPLETED|Overall Study||49
7872130|NCT00846365|19375220|P1|NOT COMPLETED|Overall Study||55
7872131|NCT00846365|19375218|P3|COMPLETED|Overall Study||323
7872132|NCT00846365|19375219|P2|COMPLETED|Overall Study||308
7872133|NCT00846365|19375220|P1|COMPLETED|Overall Study||317
7872134|NCT00846365|19375218|P3|STARTED|Overall Study||356
7872135|NCT00846365|19375219|P2|STARTED|Overall Study||357
7872136|NCT00846365|19375220|P1|STARTED|Overall Study||372
7872137|NCT00846287|19375275|P2|NOT COMPLETED|Overall Study||5
7872138|NCT00846287|19375276|P1|NOT COMPLETED|Overall Study||10
7872139|NCT00846287|19375275|P2|COMPLETED|Overall Study||10
7872140|NCT00846287|19375276|P1|COMPLETED|Overall Study||6
7872141|NCT00846287|19375275|P2|STARTED|Overall Study||15
7872142|NCT00846287|19375276|P1|STARTED|Overall Study||16
7872143|NCT00846066|19375286|P2|NOT COMPLETED|Overall Study||0
7872144|NCT00846066|19375287|P1|NOT COMPLETED|Overall Study||0
7872145|NCT00846066|19375286|P2|COMPLETED|Overall Study||29
7872146|NCT00846066|19375287|P1|COMPLETED|Overall Study||27
7872147|NCT00846066|19375286|P2|STARTED|Overall Study||29
7872148|NCT00846066|19375287|P1|STARTED|Overall Study||27
7872149|NCT00846053|19375301|P2|NOT COMPLETED|Overall Study||0
7872150|NCT00846053|19375302|P1|NOT COMPLETED|Overall Study||3
7872151|NCT00846053|19375301|P2|COMPLETED|Overall Study||8
7872152|NCT00846053|19375302|P1|COMPLETED|Overall Study|No milestones. Enrollment continued until end of study. 21 subjects enrolled.|10
7872153|NCT00846053|19375301|P2|STARTED|Overall Study||8
7872154|NCT00846053|19375302|P1|STARTED|Overall Study|No milestones. Enrollment continued until end of study.|13
7872155|NCT00846027|19375310|P1|NOT COMPLETED|Overall Study||90
7872156|NCT00846027|19375310|P1|COMPLETED|Overall Study||0
7872157|NCT00846027|19375310|P1|Received Treatment|Overall Study||83
7872158|NCT00846027|19375310|P1|STARTED|Overall Study||90
7872159|NCT00845975|19375319|P2|NOT COMPLETED|Overall Study||0
7872160|NCT00845975|19375320|P1|NOT COMPLETED|Overall Study||0
7872161|NCT00845975|19375319|P2|COMPLETED|Overall Study||9
7872162|NCT00845975|19375320|P1|COMPLETED|Overall Study||9
7872163|NCT00845975|19375319|P2|STARTED|Overall Study||9
7872164|NCT00845975|19375320|P1|STARTED|Overall Study||9
7872165|NCT00845897|19375333|P3|NOT COMPLETED|Overall Study||3
7872166|NCT00845897|19375334|P2|NOT COMPLETED|Overall Study||5
7872167|NCT00845897|19375335|P1|NOT COMPLETED|Overall Study||2
7872168|NCT00845897|19375333|P3|COMPLETED|Overall Study||2
7872169|NCT00845897|19375334|P2|COMPLETED|Overall Study||2
7872170|NCT00845897|19375335|P1|COMPLETED|Overall Study||3
7872171|NCT00845897|19375333|P3|STARTED|Overall Study||5
7872172|NCT00845897|19375334|P2|STARTED|Overall Study||7
7872173|NCT00845897|19375335|P1|STARTED|Overall Study||5
7872174|NCT00845858|19375349|P3|NOT COMPLETED|Overall Study||8
7872175|NCT00845858|19375350|P2|NOT COMPLETED|Overall Study||12
7872176|NCT00845858|19375351|P1|NOT COMPLETED|Overall Study||8
7872177|NCT00845858|19375349|P3|COMPLETED|Overall Study||87
7872178|NCT00845858|19375350|P2|COMPLETED|Overall Study||84
7872179|NCT00845858|19375351|P1|COMPLETED|Overall Study||88
7872180|NCT00845858|19375349|P3|STARTED|Overall Study||95
7872181|NCT00845858|19375350|P2|STARTED|Overall Study|"95 subjects received allocated intervention.
~1 subject was not eligible and was not dosed."|96
7872182|NCT00845858|19375351|P1|STARTED|Overall Study|"95 subjects received allocated intervention.
~1 subject withdrew consent and was not dosed."|96
7872183|NCT00845845|19375364|P2|NOT COMPLETED|Overall Study||4
7872184|NCT00845845|19375365|P1|NOT COMPLETED|Overall Study||0
7872185|NCT00845845|19375364|P2|COMPLETED|Overall Study||2
7872186|NCT00845845|19375365|P1|COMPLETED|Overall Study||3
7872187|NCT00845845|19375364|P2|STARTED|Overall Study||6
7872188|NCT00845845|19375365|P1|STARTED|Overall Study||3
7872189|NCT00845832|19375376|P3|NOT COMPLETED|Extended Safety Follow-Up||7
7872190|NCT00845832|19375377|P2|NOT COMPLETED|Extended Safety Follow-Up||0
7872191|NCT00845832|19375378|P1|NOT COMPLETED|Extended Safety Follow-Up||0
7872192|NCT00845832|19375376|P3|COMPLETED|Extended Safety Follow-Up||0
7872193|NCT00845832|19375377|P2|COMPLETED|Extended Safety Follow-Up||5
7872194|NCT00845832|19375378|P1|COMPLETED|Extended Safety Follow-Up||2
7872195|NCT00845832|19375376|P3|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7
7872196|NCT00845832|19375377|P2|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5
7872197|NCT00845832|19375378|P1|STARTED|Extended Safety Follow-Up||2
7872198|NCT00845832|19375376|P3|NOT COMPLETED|Safety Follow-Up||0
7872199|NCT00845832|19375377|P2|NOT COMPLETED|Safety Follow-Up||0
7872200|NCT00845832|19375378|P1|NOT COMPLETED|Safety Follow-Up||1
7872201|NCT00845832|19375376|P3|COMPLETED|Safety Follow-Up||12
7872202|NCT00845832|19375377|P2|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9
7872203|NCT00845832|19375378|P1|COMPLETED|Safety Follow-Up||2
7872204|NCT00845832|19375376|P3|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12
7872205|NCT00845832|19375377|P2|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9
7872206|NCT00845832|19375378|P1|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3
7872207|NCT00845832|19375376|P3|NOT COMPLETED|Treatment Period||0
7872208|NCT00845832|19375377|P2|NOT COMPLETED|Treatment Period||3
7872209|NCT00845832|19375378|P1|NOT COMPLETED|Treatment Period||1
7872210|NCT00845832|19375376|P3|COMPLETED|Treatment Period||10
7872211|NCT00845832|19375377|P2|COMPLETED|Treatment Period||7
7872212|NCT00845832|19375378|P1|COMPLETED|Treatment Period||3
7872213|NCT00845832|19375376|P3|STARTED|Treatment Period||10
7872214|NCT00845832|19375377|P2|STARTED|Treatment Period||10
7872215|NCT00845832|19375378|P1|STARTED|Treatment Period||4
7872216|NCT00845728|19375424|P2|NOT COMPLETED|Overall Study||342
7872217|NCT00845728|19375425|P1|NOT COMPLETED|Overall Study||386
7872218|NCT00845728|19375424|P2|COMPLETED|Overall Study||1379
7872219|NCT00845728|19375425|P1|COMPLETED|Overall Study||1337
7872220|NCT00845728|19375424|P2|Exposed|Overall Study||1718
7872221|NCT00845728|19375425|P1|Exposed|Overall Study||1721
7872222|NCT00845728|19375424|P2|STARTED|Overall Study||1721
7872223|NCT00845728|19375425|P1|STARTED|Overall Study||1723
7872224|NCT00845702|19375433|P1|NOT COMPLETED|Dotarem MRA||0
7872225|NCT00845702|19375433|P1|COMPLETED|Dotarem MRA||32
7872226|NCT00845702|19375433|P1|STARTED|Dotarem MRA||32
7872227|NCT00845702|19375433|P1|NOT COMPLETED|TOF MRA||1
7872228|NCT00845702|19375433|P1|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32
7872229|NCT00845702|19375433|P1|STARTED|TOF MRA||33
7872230|NCT00845676|19375439|P1|NOT COMPLETED|Overall Study||2
7872231|NCT00845676|19375439|P1|COMPLETED|Overall Study||19
7872232|NCT00845676|19375439|P1|STARTED|Overall Study||21
7872233|NCT00845663|19375447|P2|NOT COMPLETED|Overall Study||0
7872234|NCT00845663|19375448|P1|NOT COMPLETED|Overall Study||0
7872235|NCT00845663|19375447|P2|COMPLETED|Overall Study||49
7872236|NCT00845663|19375448|P1|COMPLETED|Overall Study||49
7872237|NCT00845663|19375447|P2|STARTED|Overall Study||49
7872238|NCT00845663|19375448|P1|STARTED|Overall Study||49
7872239|NCT00845650|19375502|P6|NOT COMPLETED|Overall Study||2
7872240|NCT00845650|19375503|P5|NOT COMPLETED|Overall Study||3
7872241|NCT00845650|19375504|P4|NOT COMPLETED|Overall Study||1
7872242|NCT00845650|19375505|P3|NOT COMPLETED|Overall Study||3
7872243|NCT00845650|19375506|P2|NOT COMPLETED|Overall Study||0
7872244|NCT00845650|19375507|P1|NOT COMPLETED|Overall Study||1
7872245|NCT00845650|19375502|P6|COMPLETED|Overall Study||15
7872246|NCT00845650|19375503|P5|COMPLETED|Overall Study||28
7872247|NCT00845650|19375504|P4|COMPLETED|Overall Study||13
7872248|NCT00845650|19375505|P3|COMPLETED|Overall Study||28
7872249|NCT00845650|19375506|P2|COMPLETED|Overall Study||5
7872250|NCT00845650|19375507|P1|COMPLETED|Overall Study||30
7872251|NCT00845650|19375502|P6|STARTED|Overall Study|1 subject not dosed|17
7872252|NCT00845650|19375503|P5|STARTED|Overall Study|2 subjects not dosed|31
7872253|NCT00845650|19375504|P4|STARTED|Overall Study||14
7872254|NCT00845650|19375505|P3|STARTED|Overall Study||31
7872255|NCT00845650|19375506|P2|STARTED|Overall Study||5
7872256|NCT00845650|19375507|P1|STARTED|Overall Study|1 subject not dosed|31
7872257|NCT00845520|19375545|P3|NOT COMPLETED|Overall Study||1
7872258|NCT00845520|19375546|P2|NOT COMPLETED|Overall Study||2
7872259|NCT00845520|19375547|P1|NOT COMPLETED|Overall Study||2
7872260|NCT00845520|19375545|P3|COMPLETED|Overall Study||23
7872261|NCT00845520|19375546|P2|COMPLETED|Overall Study||23
7872262|NCT00845520|19375547|P1|COMPLETED|Overall Study||23
7872263|NCT00845520|19375545|P3|STARTED|Overall Study||24
7872264|NCT00845520|19375546|P2|STARTED|Overall Study||25
7872265|NCT00845520|19375547|P1|STARTED|Overall Study||25
7872266|NCT00845507|19375563|P2|NOT COMPLETED|Overall Study||1
7872267|NCT00845507|19375564|P1|NOT COMPLETED|Overall Study||2
7872268|NCT00845507|19375563|P2|COMPLETED|Overall Study||29
7872269|NCT00845507|19375564|P1|COMPLETED|Overall Study||22
7872270|NCT00845507|19375563|P2|STARTED|Overall Study||30
7872271|NCT00845507|19375564|P1|STARTED|Overall Study||24
7872272|NCT00845481|19375572|P1|NOT COMPLETED|Overall Study||0
7872273|NCT00845481|19375572|P1|COMPLETED|Overall Study||24
7872274|NCT00845481|19375572|P1|STARTED|Overall Study||24
7872275|NCT00845429|19375584|P3|NOT COMPLETED|Overall Study||20
7872276|NCT00845429|19375585|P2|NOT COMPLETED|Overall Study||15
7872277|NCT00845429|19375586|P1|NOT COMPLETED|Overall Study||14
7872278|NCT00845429|19375584|P3|COMPLETED|Overall Study||224
7872279|NCT00845429|19375585|P2|COMPLETED|Overall Study||226
7872280|NCT00845429|19375586|P1|COMPLETED|Overall Study||230
7872281|NCT00845429|19375584|P3|STARTED|Overall Study||244
7872282|NCT00845429|19375585|P2|STARTED|Overall Study||241
7872283|NCT00845429|19375586|P1|STARTED|Overall Study||244
7872284|NCT00845195|19375605|P2|NOT COMPLETED|Overall Study||0
7872285|NCT00845195|19375606|P1|NOT COMPLETED|Overall Study||0
7872286|NCT00845195|19375605|P2|COMPLETED|Overall Study||75
7872287|NCT00845195|19375606|P1|COMPLETED|Overall Study||75
7872288|NCT00845195|19375605|P2|STARTED|Overall Study||75
7872289|NCT00845195|19375606|P1|STARTED|Overall Study||75
7872290|NCT00845182|19375621|P3|NOT COMPLETED|Overall Study||6
7872291|NCT00845182|19375622|P2|NOT COMPLETED|Overall Study||4
7872292|NCT00845182|19375623|P1|NOT COMPLETED|Overall Study||3
7872293|NCT00845182|19375621|P3|COMPLETED|Overall Study||9
7872294|NCT00845182|19375622|P2|COMPLETED|Overall Study||11
7872295|NCT00845182|19375623|P1|COMPLETED|Overall Study||10
7872296|NCT00845182|19375621|P3|STARTED|Overall Study||15
7872297|NCT00845182|19375622|P2|STARTED|Overall Study||15
7872298|NCT00845182|19375623|P1|STARTED|Overall Study||13
7872299|NCT00845130|19375637|P2|NOT COMPLETED|Overall Study||3
7872300|NCT00845130|19375638|P1|NOT COMPLETED|Overall Study||4
7872301|NCT00845130|19375637|P2|COMPLETED|Overall Study||19
7872302|NCT00845130|19375638|P1|COMPLETED|Overall Study||16
7872303|NCT00845130|19375637|P2|STARTED|Overall Study||22
7872304|NCT00845130|19375638|P1|STARTED|Overall Study||20
7872305|NCT00845065|19375648|P2|NOT COMPLETED|Overall Study||55
7872306|NCT00845065|19375649|P1|NOT COMPLETED|Overall Study||47
7872307|NCT00845065|19375648|P2|COMPLETED|Overall Study||79
7872308|NCT00845065|19375649|P1|COMPLETED|Overall Study||20
7872309|NCT00845065|19375648|P2|STARTED|Overall Study||134
7872310|NCT00845065|19375649|P1|STARTED|Overall Study||67
7872311|NCT00845039|19375665|P2|NOT COMPLETED|Overall Study||0
7872312|NCT00845039|19375666|P1|NOT COMPLETED|Overall Study||0
7872313|NCT00845039|19375665|P2|COMPLETED|Overall Study||2
7872314|NCT00845039|19375666|P1|COMPLETED|Overall Study||2
7872315|NCT00845039|19375665|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
7872316|NCT00845039|19375666|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
7872317|NCT00845039|19375665|P2|STARTED|Overall Study||2
7872318|NCT00845039|19375666|P1|STARTED|Overall Study||2
7872319|NCT00845000|19375693|P6|NOT COMPLETED|Period 3||0
7872320|NCT00845000|19375694|P5|NOT COMPLETED|Period 3||0
7872321|NCT00845000|19375695|P4|NOT COMPLETED|Period 3||0
7872322|NCT00845000|19375696|P3|NOT COMPLETED|Period 3||0
7872323|NCT00845000|19375697|P2|NOT COMPLETED|Period 3||0
7872324|NCT00845000|19375698|P1|NOT COMPLETED|Period 3||0
7872325|NCT00845000|19375693|P6|COMPLETED|Period 3||2
7872326|NCT00845000|19375694|P5|COMPLETED|Period 3||2
7872327|NCT00845000|19375695|P4|COMPLETED|Period 3||2
7872328|NCT00845000|19375696|P3|COMPLETED|Period 3||2
7872329|NCT00845000|19375697|P2|COMPLETED|Period 3||2
7872330|NCT00845000|19375698|P1|COMPLETED|Period 3||2
7872331|NCT00845000|19375693|P6|STARTED|Period 3||2
7872332|NCT00845000|19375694|P5|STARTED|Period 3||2
7872333|NCT00845000|19375695|P4|STARTED|Period 3||2
7872334|NCT00845000|19375696|P3|STARTED|Period 3||2
7872335|NCT00845000|19375697|P2|STARTED|Period 3||2
7872336|NCT00845000|19375698|P1|STARTED|Period 3||2
7872337|NCT00845000|19375693|P6|NOT COMPLETED|Period 2||0
7872338|NCT00845000|19375694|P5|NOT COMPLETED|Period 2||0
7872339|NCT00845000|19375695|P4|NOT COMPLETED|Period 2||0
7872340|NCT00845000|19375696|P3|NOT COMPLETED|Period 2||0
7872341|NCT00845000|19375697|P2|NOT COMPLETED|Period 2||0
7872342|NCT00845000|19375698|P1|NOT COMPLETED|Period 2||0
7872343|NCT00845000|19375693|P6|COMPLETED|Period 2||2
7872344|NCT00845000|19375694|P5|COMPLETED|Period 2||2
7872345|NCT00845000|19375695|P4|COMPLETED|Period 2||2
7872346|NCT00845000|19375696|P3|COMPLETED|Period 2||2
7872347|NCT00845000|19375697|P2|COMPLETED|Period 2||2
7872348|NCT00845000|19375698|P1|COMPLETED|Period 2||2
7872349|NCT00845000|19375693|P6|STARTED|Period 2||2
7872350|NCT00845000|19375694|P5|STARTED|Period 2||2
7872351|NCT00845000|19375695|P4|STARTED|Period 2||2
7872352|NCT00845000|19375696|P3|STARTED|Period 2||2
7872353|NCT00845000|19375697|P2|STARTED|Period 2||2
7872354|NCT00845000|19375698|P1|STARTED|Period 2||2
7872355|NCT00845000|19375693|P6|NOT COMPLETED|Period 1||0
7872356|NCT00845000|19375694|P5|NOT COMPLETED|Period 1||0
7872357|NCT00845000|19375695|P4|NOT COMPLETED|Period 1||0
7872358|NCT00845000|19375696|P3|NOT COMPLETED|Period 1||0
7872359|NCT00845000|19375697|P2|NOT COMPLETED|Period 1||0
7872360|NCT00845000|19375698|P1|NOT COMPLETED|Period 1||0
7872361|NCT00845000|19375693|P6|COMPLETED|Period 1||2
7872362|NCT00845000|19375694|P5|COMPLETED|Period 1||2
7872363|NCT00845000|19375695|P4|COMPLETED|Period 1||2
7872364|NCT00845000|19375696|P3|COMPLETED|Period 1||2
7872365|NCT00845000|19375697|P2|COMPLETED|Period 1||2
7872366|NCT00845000|19375698|P1|COMPLETED|Period 1||2
7872367|NCT00845000|19375693|P6|STARTED|Period 1||2
7872368|NCT00845000|19375694|P5|STARTED|Period 1||2
7872369|NCT00845000|19375695|P4|STARTED|Period 1||2
7872370|NCT00845000|19375696|P3|STARTED|Period 1||2
7872371|NCT00845000|19375697|P2|STARTED|Period 1||2
7872372|NCT00845000|19375698|P1|STARTED|Period 1||2
7872373|NCT00844896|19375717|P2|NOT COMPLETED|Overall Study||17
7872374|NCT00844896|19375718|P1|NOT COMPLETED|Overall Study||12
7872375|NCT00844896|19375717|P2|COMPLETED|Overall Study||11
7872376|NCT00844896|19375718|P1|COMPLETED|Overall Study||17
7872377|NCT00844896|19375717|P2|STARTED|Overall Study||28
7872378|NCT00844896|19375718|P1|STARTED|Overall Study||29
7872379|NCT00844883|19375740|P1|NOT COMPLETED|Overall Study||4
7872380|NCT00844883|19375740|P1|COMPLETED|Overall Study||46
7872381|NCT00844883|19375740|P1|Patients Who Received TACE|Overall Study|2 patients withdrawn at Week 1 prior to TACE for intolerance to sorafenib|48
7872382|NCT00844883|19375740|P1|STARTED|Overall Study||50
7872383|NCT00844857|19375752|P2|NOT COMPLETED|Overall Study||37
7872384|NCT00844857|19375753|P1|NOT COMPLETED|Overall Study||78
7872385|NCT00844857|19375752|P2|COMPLETED|Overall Study||60
7872386|NCT00844857|19375753|P1|COMPLETED|Overall Study||116
7872387|NCT00844857|19375752|P2|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85
7872388|NCT00844857|19375753|P1|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170
7872389|NCT00844857|19375752|P2|STARTED|Overall Study||97
7872390|NCT00844857|19375753|P1|STARTED|Overall Study||194
7872391|NCT00844844|19375797|P1|NOT COMPLETED|Post Treatment Period||1
7872392|NCT00844844|19375797|P1|COMPLETED|Post Treatment Period||5
7872393|NCT00844844|19375797|P1|STARTED|Post Treatment Period||6
7872394|NCT00844844|19375797|P1|NOT COMPLETED|Extension Treatment Period||2
7872395|NCT00844844|19375797|P1|COMPLETED|Extension Treatment Period||11
7872396|NCT00844844|19375797|P1|STARTED|Extension Treatment Period||13
7872397|NCT00844844|19375797|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
7872398|NCT00844844|19375797|P1|COMPLETED|Treatment Period (26 Weeks)||15
7872399|NCT00844844|19375797|P1|STARTED|Treatment Period (26 Weeks)||17
7872400|NCT00844844|19375797|P1|NOT COMPLETED|Screening Period||0
7872401|NCT00844844|19375797|P1|COMPLETED|Screening Period||17
7872402|NCT00844844|19375797|P1|STARTED|Screening Period||17
7872403|NCT00844831|19375811|P1|NOT COMPLETED|Overall Study||6
7872404|NCT00844831|19375811|P1|COMPLETED|Overall Study||19
7872405|NCT00844831|19375811|P1|STARTED|Overall Study||25
7872406|NCT00844805|19375821|P4|NOT COMPLETED|Follow-Up Phase||9
7872407|NCT00844805|19375822|P3|NOT COMPLETED|Follow-Up Phase||9
7872408|NCT00844805|19375823|P2|NOT COMPLETED|Follow-Up Phase||0
7872409|NCT00844805|19375824|P1|NOT COMPLETED|Follow-Up Phase||0
7872410|NCT00844805|19375821|P4|COMPLETED|Follow-Up Phase||32
7872411|NCT00844805|19375822|P3|COMPLETED|Follow-Up Phase||32
7872412|NCT00844805|19375823|P2|COMPLETED|Follow-Up Phase||0
7872413|NCT00844805|19375824|P1|COMPLETED|Follow-Up Phase||0
7872414|NCT00844805|19375821|P4|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
7872415|NCT00844805|19375822|P3|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
7872416|NCT00844805|19375823|P2|STARTED|Follow-Up Phase||0
7872417|NCT00844805|19375824|P1|STARTED|Follow-Up Phase||0
7872418|NCT00844805|19375821|P4|NOT COMPLETED|Treatment Phase||0
7872419|NCT00844805|19375822|P3|NOT COMPLETED|Treatment Phase||0
7872420|NCT00844805|19375823|P2|NOT COMPLETED|Treatment Phase||7
7872421|NCT00844805|19375824|P1|NOT COMPLETED|Treatment Phase||10
7872422|NCT00844805|19375821|P4|COMPLETED|Treatment Phase||0
7872423|NCT00844805|19375822|P3|COMPLETED|Treatment Phase||0
7872424|NCT00844805|19375823|P2|COMPLETED|Treatment Phase||45
7872425|NCT00844805|19375824|P1|COMPLETED|Treatment Phase||96
7872426|NCT00844805|19375821|P4|STARTED|Treatment Phase||0
7872427|NCT00844805|19375822|P3|STARTED|Treatment Phase||0
7872428|NCT00844805|19375823|P2|STARTED|Treatment Phase||52
7872429|NCT00844805|19375824|P1|STARTED|Treatment Phase||106
7872430|NCT00844753|19375868|P4|NOT COMPLETED|Overall Study||11
7872431|NCT00844753|19375869|P3|NOT COMPLETED|Overall Study||7
7872432|NCT00844753|19375870|P2|NOT COMPLETED|Overall Study||3
7872433|NCT00844753|19375871|P1|NOT COMPLETED|Overall Study||8
7872434|NCT00844753|19375868|P4|COMPLETED|Overall Study||21
7872435|NCT00844753|19375869|P3|COMPLETED|Overall Study||25
7872436|NCT00844753|19375870|P2|COMPLETED|Overall Study||29
7872437|NCT00844753|19375871|P1|COMPLETED|Overall Study||24
7872438|NCT00844753|19375868|P4|STARTED|Overall Study||32
7872439|NCT00844753|19375869|P3|STARTED|Overall Study||32
7872440|NCT00844753|19375870|P2|STARTED|Overall Study||32
7872441|NCT00844753|19375871|P1|STARTED|Overall Study||32
7872442|NCT00844714|19375883|P1|NOT COMPLETED|Overall Study||0
7872443|NCT00844714|19375883|P1|COMPLETED|Overall Study||20
7872444|NCT00844714|19375883|P1|STARTED|Overall Study||20
7872445|NCT00844649|19375889|P2|NOT COMPLETED|Overall Study||418
7872446|NCT00844649|19375890|P1|NOT COMPLETED|Overall Study||405
7872447|NCT00844649|19375889|P2|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12
7872448|NCT00844649|19375890|P1|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26
7872449|NCT00844649|19375889|P2|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402
7872450|NCT00844649|19375890|P1|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421
7872451|NCT00844649|19375889|P2|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430
7872452|NCT00844649|19375890|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431
7872453|NCT00844597|19375914|P6|NOT COMPLETED|Overall Study||0
7872454|NCT00844597|19375915|P5|NOT COMPLETED|Overall Study||0
7872455|NCT00844597|19375916|P4|NOT COMPLETED|Overall Study||1
7872456|NCT00844597|19375917|P3|NOT COMPLETED|Overall Study||0
7872457|NCT00844597|19375918|P2|NOT COMPLETED|Overall Study||0
7872458|NCT00844597|19375919|P1|NOT COMPLETED|Overall Study||0
7872459|NCT00844597|19375914|P6|COMPLETED|Overall Study||4
7872460|NCT00844597|19375915|P5|COMPLETED|Overall Study||4
7872461|NCT00844597|19375916|P4|COMPLETED|Overall Study||2
7872462|NCT00844597|19375917|P3|COMPLETED|Overall Study||2
7872463|NCT00844597|19375918|P2|COMPLETED|Overall Study||2
7872464|NCT00844597|19375919|P1|COMPLETED|Overall Study||4
7872465|NCT00844597|19375914|P6|STARTED|Overall Study||4
7872466|NCT00844597|19375915|P5|STARTED|Overall Study||4
7872467|NCT00844597|19375916|P4|STARTED|Overall Study||3
7872468|NCT00844597|19375917|P3|STARTED|Overall Study||2
7872469|NCT00844597|19375918|P2|STARTED|Overall Study||2
7872470|NCT00844597|19375919|P1|STARTED|Overall Study||4
7872471|NCT00844558|19375939|P2|NOT COMPLETED|Overall Study||4
7872472|NCT00844558|19375940|P1|NOT COMPLETED|Overall Study||12
7872473|NCT00844558|19375939|P2|COMPLETED|Overall Study||18
7872474|NCT00844558|19375940|P1|COMPLETED|Overall Study||24
7872475|NCT00844558|19375939|P2|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18
7872476|NCT00844558|19375940|P1|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24
7872477|NCT00844558|19375939|P2|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18
7872478|NCT00844558|19375940|P1|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28
7872479|NCT00844558|19375939|P2|3 Month Visit|Overall Study|"Lost to follow-up (n=1)
~Discontinued Intervention (n=1)"|19
7872480|NCT00844558|19375940|P1|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29
7872481|NCT00844558|19375939|P2|Received Allocated Intervention|Overall Study||21
7872482|NCT00844558|19375940|P1|Received Allocated Intervention|Overall Study||33
7872483|NCT00844558|19375939|P2|STARTED|Overall Study|"Received allocated intervention (n=21)
~Did not receive allocated intervention (n=1)"|22
7872484|NCT00844558|19375940|P1|STARTED|Overall Study|"Received allocated intervention (n=33)
~Did not receive allocated intervention (n=3)"|36
7872485|NCT00844545|19375956|P1|NOT COMPLETED|Post Treatment Period||1
7872486|NCT00844545|19375956|P1|COMPLETED|Post Treatment Period||5
7872487|NCT00844545|19375956|P1|STARTED|Post Treatment Period||6
7872488|NCT00844545|19375956|P1|NOT COMPLETED|Extension Treatment Period||2
7872489|NCT00844545|19375956|P1|COMPLETED|Extension Treatment Period||11
7872490|NCT00844545|19375956|P1|STARTED|Extension Treatment Period||13
7872491|NCT00844545|19375956|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
7872492|NCT00844545|19375956|P1|COMPLETED|Treatment Period (26 Weeks)||15
7872493|NCT00844545|19375956|P1|STARTED|Treatment Period (26 Weeks)||17
7872494|NCT00844545|19375956|P1|NOT COMPLETED|Screening Period||0
7872495|NCT00844545|19375956|P1|COMPLETED|Screening Period||17
7872496|NCT00844545|19375956|P1|STARTED|Screening Period||17
7872497|NCT00844532|19375970|P1|NOT COMPLETED|Overall Study||39
7872498|NCT00844532|19375970|P1|COMPLETED|Overall Study||112
7872499|NCT00844532|19375970|P1|STARTED|Overall Study||151
7872500|NCT00844519|19376056|P2|NOT COMPLETED|Overall Study||1
7872501|NCT00844519|19376057|P1|NOT COMPLETED|Overall Study||2
7872502|NCT00844519|19376056|P2|COMPLETED|Overall Study||25
7872503|NCT00844519|19376057|P1|COMPLETED|Overall Study||24
7872504|NCT00844519|19376056|P2|STARTED|Overall Study||26
7872505|NCT00844519|19376057|P1|STARTED|Overall Study||26
7872506|NCT00844480|19376065|P2|NOT COMPLETED|Overall Study||3
7872507|NCT00844480|19376066|P1|NOT COMPLETED|Overall Study||2
7872508|NCT00844480|19376065|P2|COMPLETED|Overall Study||6
7872509|NCT00844480|19376066|P1|COMPLETED|Overall Study||6
7872510|NCT00844480|19376065|P2|STARTED|Overall Study||9
7872511|NCT00844480|19376066|P1|STARTED|Overall Study||8
7872512|NCT00844428|19376074|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
7872513|NCT00844428|19376074|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
7872514|NCT00844428|19376074|P1|STARTED|Post Treatment Period (Patients Who Disc||5
7872515|NCT00844428|19376074|P1|NOT COMPLETED|Extension Treatment Period||1
7872516|NCT00844428|19376074|P1|COMPLETED|Extension Treatment Period||18
7872517|NCT00844428|19376074|P1|STARTED|Extension Treatment Period||19
7872518|NCT00844428|19376074|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
7872519|NCT00844428|19376074|P1|COMPLETED|Treatment Period (26 Weeks)||20
7872520|NCT00844428|19376074|P1|STARTED|Treatment Period (26 Weeks)||20
7872521|NCT00844428|19376074|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
7872522|NCT00844428|19376074|P1|COMPLETED|Observation Period (8 Weeks)||20
7872523|NCT00844428|19376074|P1|STARTED|Observation Period (8 Weeks)||20
7872524|NCT00844428|19376074|P1|NOT COMPLETED|Screening Period||3
7872525|NCT00844428|19376074|P1|COMPLETED|Screening Period||20
7872526|NCT00844428|19376074|P1|STARTED|Screening Period||23
7872527|NCT00844415|19376090|P1|NOT COMPLETED|Overall Study||1
7872528|NCT00844415|19376090|P1|COMPLETED|Overall Study|Completed.|8
7872529|NCT00844415|19376090|P1|Pat. Received Single Dose 75mg|Overall Study||1
7872530|NCT00844415|19376090|P1|Pat. Received 125mg Followed by 150mg|Overall Study||2
7872531|NCT00844415|19376090|P1|Pat. Received 100mg Followed by 125mg|Overall Study||3
7872532|NCT00844415|19376090|P1|Pat. Received 75mg Followed by 100mg|Overall Study||3
7872533|NCT00844415|19376090|P1|STARTED|Overall Study|Entered and treated.|9
7872534|NCT00844376|19376104|P2|NOT COMPLETED|Period 2: Second Intervention||0
7872535|NCT00844376|19376105|P1|NOT COMPLETED|Period 2: Second Intervention||0
7872536|NCT00844376|19376104|P2|COMPLETED|Period 2: Second Intervention||6
7872537|NCT00844376|19376105|P1|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5
7872538|NCT00844376|19376104|P2|STARTED|Period 2: Second Intervention||6
7872539|NCT00844376|19376105|P1|STARTED|Period 2: Second Intervention||5
7872540|NCT00844376|19376104|P2|NOT COMPLETED|Period 1: First Intervention||0
7872541|NCT00844376|19376105|P1|NOT COMPLETED|Period 1: First Intervention||1
7872542|NCT00844376|19376104|P2|COMPLETED|Period 1: First Intervention||6
7872543|NCT00844376|19376105|P1|COMPLETED|Period 1: First Intervention||5
7872544|NCT00844376|19376104|P2|STARTED|Period 1: First Intervention||6
7872545|NCT00844376|19376105|P1|STARTED|Period 1: First Intervention||6
7872546|NCT00844298|19376123|P1|NOT COMPLETED|Overall Study||0
7872547|NCT00844298|19376123|P1|COMPLETED|Overall Study||91
7872548|NCT00844298|19376123|P1|STARTED|Overall Study||91
7872549|NCT00844194|19376129|P2|NOT COMPLETED|Overall Study||8
7872550|NCT00844194|19376130|P1|NOT COMPLETED|Overall Study||25
7872551|NCT00844194|19376129|P2|COMPLETED|Overall Study||22
7872552|NCT00844194|19376130|P1|COMPLETED|Overall Study||53
7872553|NCT00844194|19376129|P2|STARTED|Overall Study||30
7872554|NCT00844194|19376130|P1|STARTED|Overall Study||78
7872555|NCT00844090|19376336|P2|NOT COMPLETED|Overall Study||8
7872556|NCT00844090|19376337|P1|NOT COMPLETED|Overall Study||6
7872557|NCT00844090|19376336|P2|COMPLETED|Overall Study||46
7872558|NCT00844090|19376337|P1|COMPLETED|Overall Study||46
7872559|NCT00844090|19376336|P2|STARTED|Overall Study||54
7872560|NCT00844090|19376337|P1|STARTED|Overall Study||52
7872561|NCT00844051|19376345|P2|NOT COMPLETED|Overall Study||0
7872562|NCT00844051|19376346|P1|NOT COMPLETED|Overall Study||0
7872563|NCT00844051|19376345|P2|COMPLETED|Overall Study||2368
7872564|NCT00844051|19376346|P1|COMPLETED|Overall Study||2087
7872565|NCT00844051|19376345|P2|STARTED|Overall Study||2368
7872566|NCT00844051|19376346|P1|STARTED|Overall Study||2087
7872567|NCT00843986|19376356|P2|NOT COMPLETED|Overall Study||1
7872568|NCT00843986|19376357|P1|NOT COMPLETED|Overall Study||1
7872569|NCT00843986|19376356|P2|COMPLETED|Overall Study||5
7872570|NCT00843986|19376357|P1|COMPLETED|Overall Study||2
7872571|NCT00843986|19376356|P2|Completed Treatment (Infusion)|Overall Study||6
7872572|NCT00843986|19376357|P1|Completed Treatment (Infusion)|Overall Study||2
7872573|NCT00843986|19376356|P2|STARTED|Overall Study||6
7872574|NCT00843986|19376357|P1|STARTED|Overall Study||3
7872575|NCT00843856|19376385|P2|NOT COMPLETED|Overall Study||2
7872576|NCT00843856|19376386|P1|NOT COMPLETED|Overall Study||1
7872577|NCT00843856|19376385|P2|COMPLETED|Overall Study||18
7872578|NCT00843856|19376386|P1|COMPLETED|Overall Study||19
7872579|NCT00843856|19376385|P2|STARTED|Overall Study||20
7872580|NCT00843856|19376386|P1|STARTED|Overall Study||20
7872581|NCT00843843|19376396|P2|NOT COMPLETED|Overall Study||2
7872582|NCT00843843|19376397|P1|NOT COMPLETED|Overall Study||2
7872583|NCT00843843|19376396|P2|COMPLETED|Overall Study||6
7872584|NCT00843843|19376397|P1|COMPLETED|Overall Study||6
7872585|NCT00843843|19376396|P2|STARTED|Overall Study||8
7872586|NCT00843843|19376397|P1|STARTED|Overall Study||8
7872587|NCT00843830|19376405|P1|NOT COMPLETED|Overall Study||0
7872588|NCT00843830|19376405|P1|COMPLETED|Overall Study||4
7872589|NCT00843830|19376405|P1|STARTED|Overall Study||4
7872590|NCT00843778|19376410|P1|NOT COMPLETED|Overall Study||35
7872591|NCT00843778|19376410|P1|COMPLETED|Overall Study||96
7872592|NCT00843778|19376410|P1|STARTED|Overall Study||131
7872593|NCT00843713|19376445|P2|NOT COMPLETED|Overall Study||0
7872594|NCT00843713|19376446|P1|NOT COMPLETED|Overall Study||0
7872595|NCT00843713|19376445|P2|COMPLETED|Overall Study||26
7872596|NCT00843713|19376446|P1|COMPLETED|Overall Study||30
7872597|NCT00843713|19376445|P2|STARTED|Overall Study||26
7872598|NCT00843713|19376446|P1|STARTED|Overall Study||30
7872599|NCT00843635|19376455|P3|NOT COMPLETED|Overall Study||0
7872600|NCT00843635|19376456|P2|NOT COMPLETED|Overall Study||2
7872601|NCT00843635|19376457|P1|NOT COMPLETED|Overall Study||2
7872602|NCT00843635|19376455|P3|COMPLETED|Overall Study||5
7872603|NCT00843635|19376456|P2|COMPLETED|Overall Study||13
7872604|NCT00843635|19376457|P1|COMPLETED|Overall Study||13
7872605|NCT00843635|19376455|P3|STARTED|Overall Study||5
7872606|NCT00843635|19376456|P2|STARTED|Overall Study||15
7872607|NCT00843635|19376457|P1|STARTED|Overall Study||15
7872608|NCT00843622|19376477|P2|NOT COMPLETED|Overall Study||55
7872609|NCT00843622|19376478|P1|NOT COMPLETED|Overall Study||43
7872610|NCT00843622|19376477|P2|COMPLETED|Overall Study||70
7872611|NCT00843622|19376478|P1|COMPLETED|Overall Study||82
7872612|NCT00843622|19376477|P2|STARTED|Overall Study||125
7872613|NCT00843622|19376478|P1|STARTED|Overall Study||125
7872614|NCT00843531|19376484|P1|NOT COMPLETED|Overall Study||0
7872615|NCT00843531|19376484|P1|COMPLETED|Overall Study||17
7872616|NCT00843531|19376484|P1|STARTED|Overall Study||17
7872617|NCT00843518|19376496|P2|NOT COMPLETED|Period 3 (Single-blind Washout)||0
7872618|NCT00843518|19376497|P1|NOT COMPLETED|Period 3 (Single-blind Washout)||0
7872619|NCT00843518|19376496|P2|COMPLETED|Period 3 (Single-blind Washout)||49
7872620|NCT00843518|19376497|P1|COMPLETED|Period 3 (Single-blind Washout)||42
7872621|NCT00843518|19376496|P2|STARTED|Period 3 (Single-blind Washout)||49
7872622|NCT00843518|19376497|P1|STARTED|Period 3 (Single-blind Washout)|1 LY451395 participant completed double-blind treatment, but did not enter washout period.|42
7872623|NCT00843518|19376496|P2|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
7872624|NCT00843518|19376497|P1|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
7872625|NCT00843518|19376496|P2|COMPLETED|Period 2 (Double-blind Treatment)||49
7872626|NCT00843518|19376497|P1|COMPLETED|Period 2 (Double-blind Treatment)||43
7872627|NCT00843518|19376496|P2|STARTED|Period 2 (Double-blind Treatment)||69
7872628|NCT00843518|19376497|P1|STARTED|Period 2 (Double-blind Treatment)||63
7872629|NCT00843492|19376527|P2|NOT COMPLETED|Overall Study||14
7872630|NCT00843492|19376528|P1|NOT COMPLETED|Overall Study||8
7872631|NCT00843492|19376527|P2|COMPLETED|Overall Study||607
7872632|NCT00843492|19376528|P1|COMPLETED|Overall Study||614
7872633|NCT00843492|19376527|P2|STARTED|Overall Study||621
7872634|NCT00843492|19376528|P1|STARTED|Overall Study||622
7872635|NCT00843479|19376548|P2|NOT COMPLETED|Overall Study||0
7872636|NCT00843479|19376549|P1|NOT COMPLETED|Overall Study||0
7872637|NCT00843479|19376548|P2|COMPLETED|Overall Study||12
7872638|NCT00843479|19376549|P1|COMPLETED|Overall Study||12
7872639|NCT00843479|19376548|P2|STARTED|Overall Study||12
7872640|NCT00843479|19376549|P1|STARTED|Overall Study||12
7872641|NCT00843466|19376567|P2|NOT COMPLETED|Overall Study||0
7872642|NCT00843466|19376568|P1|NOT COMPLETED|Overall Study||0
7872643|NCT00843466|19376567|P2|COMPLETED|Overall Study||18
7872644|NCT00843466|19376568|P1|COMPLETED|Overall Study||24
7872645|NCT00843466|19376567|P2|STARTED|Overall Study||18
7872646|NCT00843466|19376568|P1|STARTED|Overall Study||24
7872647|NCT00843349|19376578|P4|NOT COMPLETED|Overall Study||1
7872648|NCT00843349|19376579|P3|NOT COMPLETED|Overall Study||0
7872649|NCT00843349|19376580|P2|NOT COMPLETED|Overall Study||0
7872650|NCT00843349|19376581|P1|NOT COMPLETED|Overall Study||3
7872651|NCT00843349|19376578|P4|COMPLETED|Overall Study||10
7872652|NCT00843349|19376579|P3|COMPLETED|Overall Study||10
7872653|NCT00843349|19376580|P2|COMPLETED|Overall Study||11
7872654|NCT00843349|19376581|P1|COMPLETED|Overall Study||8
7872655|NCT00843349|19376578|P4|STARTED|Overall Study||11
7872656|NCT00843349|19376579|P3|STARTED|Overall Study||10
7872657|NCT00843349|19376580|P2|STARTED|Overall Study||11
7872658|NCT00843349|19376581|P1|STARTED|Overall Study||11
7872659|NCT00843310|19376595|P1|NOT COMPLETED|Overall Study||7
7872660|NCT00843310|19376595|P1|COMPLETED|Overall Study||1
7872661|NCT00843310|19376595|P1|STARTED|Overall Study||8
7872662|NCT00843284|19376599|P1|NOT COMPLETED|Overall Study||72
7872663|NCT00843284|19376599|P1|COMPLETED|Overall Study||619
7872664|NCT00843284|19376599|P1|STARTED|Overall Study||691
7872665|NCT00843193|19376609|P2|NOT COMPLETED|Overall Study||11
7872666|NCT00843193|19376610|P1|NOT COMPLETED|Overall Study||8
7872667|NCT00843193|19376609|P2|COMPLETED|Overall Study||88
7872668|NCT00843193|19376610|P1|COMPLETED|Overall Study||91
7872669|NCT00843193|19376609|P2|STARTED|Overall Study||99
7872670|NCT00843193|19376610|P1|STARTED|Overall Study||99
7872671|NCT00843180|19376646|P2|NOT COMPLETED|Overall Study||0
7872672|NCT00843180|19376647|P1|NOT COMPLETED|Overall Study||0
7872673|NCT00843180|19376646|P2|COMPLETED|Overall Study||7
7872674|NCT00843180|19376647|P1|COMPLETED|Overall Study||16
7872675|NCT00843180|19376646|P2|STARTED|Overall Study||7
7872676|NCT00843180|19376647|P1|STARTED|Overall Study||16
7872677|NCT00843167|19376661|P2|NOT COMPLETED|Follow-up||0
7872678|NCT00843167|19376662|P1|NOT COMPLETED|Follow-up||0
7872679|NCT00843167|19376661|P2|COMPLETED|Follow-up||24
7872680|NCT00843167|19376662|P1|COMPLETED|Follow-up||24
7872681|NCT00843167|19376661|P2|Completed Final Visit|Follow-up||24
7872682|NCT00843167|19376662|P1|Completed Final Visit|Follow-up||24
7872683|NCT00843167|19376661|P2|STARTED|Follow-up||24
7872684|NCT00843167|19376662|P1|STARTED|Follow-up||24
7872685|NCT00843167|19376661|P2|NOT COMPLETED|Treatment Period||8
7872686|NCT00843167|19376662|P1|NOT COMPLETED|Treatment Period||3
7872687|NCT00843167|19376661|P2|COMPLETED|Treatment Period||19
7872688|NCT00843167|19376662|P1|COMPLETED|Treatment Period||24
7872689|NCT00843167|19376661|P2|STARTED|Treatment Period||27
7872690|NCT00843167|19376662|P1|STARTED|Treatment Period||27
7872691|NCT00843115|19376675|P1|NOT COMPLETED|Overall Study||66
7872692|NCT00843115|19376675|P1|COMPLETED|Overall Study||304
7872693|NCT00843115|19376675|P1|STARTED|Overall Study||370
7872694|NCT00843050|19376721|P1|NOT COMPLETED|Overall Study||13
7872695|NCT00843050|19376721|P1|COMPLETED|Overall Study||0
7872696|NCT00843050|19376721|P1|STARTED|Overall Study||13
7872697|NCT00843024|19376731|P6|NOT COMPLETED|Double-blind Treatment Phase||25
7872698|NCT00843024|19376732|P5|NOT COMPLETED|Double-blind Treatment Phase||20
7872699|NCT00843024|19376733|P4|NOT COMPLETED|Double-blind Treatment Phase||23
7872700|NCT00843024|19376734|P3|NOT COMPLETED|Double-blind Treatment Phase||31
7872701|NCT00843024|19376735|P2|NOT COMPLETED|Double-blind Treatment Phase||0
7872702|NCT00843024|19376736|P1|NOT COMPLETED|Double-blind Treatment Phase||0
7872703|NCT00843024|19376731|P6|COMPLETED|Double-blind Treatment Phase||152
7872704|NCT00843024|19376732|P5|COMPLETED|Double-blind Treatment Phase||97
7872705|NCT00843024|19376733|P4|COMPLETED|Double-blind Treatment Phase||96
7872706|NCT00843024|19376734|P3|COMPLETED|Double-blind Treatment Phase||145
7872707|NCT00843024|19376735|P2|COMPLETED|Double-blind Treatment Phase||0
7872708|NCT00843024|19376736|P1|COMPLETED|Double-blind Treatment Phase||0
7872709|NCT00843024|19376731|P6|STARTED|Double-blind Treatment Phase||177
7872710|NCT00843024|19376732|P5|STARTED|Double-blind Treatment Phase||117
7872711|NCT00843024|19376733|P4|STARTED|Double-blind Treatment Phase||119
7872712|NCT00843024|19376734|P3|STARTED|Double-blind Treatment Phase||176
7872713|NCT00843024|19376735|P2|STARTED|Double-blind Treatment Phase||0
7872714|NCT00843024|19376736|P1|STARTED|Double-blind Treatment Phase||0
7872715|NCT00843024|19376731|P6|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
7872716|NCT00843024|19376732|P5|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
7872717|NCT00843024|19376733|P4|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
7872718|NCT00843024|19376734|P3|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
7872719|NCT00843024|19376735|P2|NOT COMPLETED|Single-blind Placebo Run-In Phase||136
7872720|NCT00843024|19376736|P1|NOT COMPLETED|Single-blind Placebo Run-In Phase||140
7872721|NCT00843024|19376731|P6|COMPLETED|Single-blind Placebo Run-In Phase||0
7872722|NCT00843024|19376732|P5|COMPLETED|Single-blind Placebo Run-In Phase||0
7872723|NCT00843024|19376733|P4|COMPLETED|Single-blind Placebo Run-In Phase||0
7872724|NCT00843024|19376734|P3|COMPLETED|Single-blind Placebo Run-In Phase||0
7872725|NCT00843024|19376735|P2|COMPLETED|Single-blind Placebo Run-In Phase||321
7872726|NCT00843024|19376736|P1|COMPLETED|Single-blind Placebo Run-In Phase||268
7872727|NCT00843024|19376731|P6|STARTED|Single-blind Placebo Run-In Phase||0
7872728|NCT00843024|19376732|P5|STARTED|Single-blind Placebo Run-In Phase||0
7872729|NCT00843024|19376733|P4|STARTED|Single-blind Placebo Run-In Phase||0
7872730|NCT00843024|19376734|P3|STARTED|Single-blind Placebo Run-In Phase||0
7872731|NCT00843024|19376735|P2|STARTED|Single-blind Placebo Run-In Phase||457
7872732|NCT00843024|19376736|P1|STARTED|Single-blind Placebo Run-In Phase||408
7872733|NCT00842985|19376801|P1|NOT COMPLETED|Fourth Intervention||0
7872734|NCT00842985|19376801|P1|COMPLETED|Fourth Intervention||15
7872735|NCT00842985|19376801|P1|STARTED|Fourth Intervention||15
7872736|NCT00842985|19376801|P1|NOT COMPLETED|Washout Period of GE 4 Days||0
7872737|NCT00842985|19376801|P1|COMPLETED|Washout Period of GE 4 Days||15
7872738|NCT00842985|19376801|P1|STARTED|Washout Period of GE 4 Days||15
7872739|NCT00842985|19376801|P1|NOT COMPLETED|Third Intervention||0
7872740|NCT00842985|19376801|P1|COMPLETED|Third Intervention||15
7872741|NCT00842985|19376801|P1|STARTED|Third Intervention||15
7872742|NCT00842985|19376801|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
7872743|NCT00842985|19376801|P1|COMPLETED|Washout Period of GE 4 Days||15
7872744|NCT00842985|19376801|P1|STARTED|Washout Period of GE 4 Days||17
7872745|NCT00842985|19376801|P1|NOT COMPLETED|Second Intervention||1
7872746|NCT00842985|19376801|P1|COMPLETED|Second Intervention||17
7872747|NCT00842985|19376801|P1|STARTED|Second Intervention||18
7872748|NCT00842985|19376801|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
7872749|NCT00842985|19376801|P1|COMPLETED|Washout Period of GE 4 Days||18
7872750|NCT00842985|19376801|P1|STARTED|Washout Period of GE 4 Days||20
7872751|NCT00842985|19376801|P1|NOT COMPLETED|First Intervention||6
7872752|NCT00842985|19376801|P1|COMPLETED|First Intervention|Completed 1st Intervention|20
7872753|NCT00842985|19376801|P1|STARTED|First Intervention|Signed Consent|26
7872754|NCT00842985|19376801|P1|NOT COMPLETED|Screening||27
7872755|NCT00842985|19376801|P1|COMPLETED|Screening||26
7872756|NCT00842985|19376801|P1|STARTED|Screening||53
7872757|NCT00842946|19376810|P2|NOT COMPLETED|Overall Study||5
7872758|NCT00842946|19376811|P1|NOT COMPLETED|Overall Study||5
7872759|NCT00842946|19376810|P2|COMPLETED|Overall Study||19
7872760|NCT00842946|19376811|P1|COMPLETED|Overall Study||16
7872761|NCT00842946|19376810|P2|STARTED|Overall Study||24
7872762|NCT00842946|19376811|P1|STARTED|Overall Study||21
7872763|NCT00842829|19376819|P3|NOT COMPLETED|Continuation Period||61
7872764|NCT00842829|19376820|P2|NOT COMPLETED|Continuation Period||0
7872765|NCT00842829|19376821|P1|NOT COMPLETED|Continuation Period||0
7872766|NCT00842829|19376819|P3|COMPLETED|Continuation Period||27
7872767|NCT00842829|19376820|P2|COMPLETED|Continuation Period||0
7872768|NCT00842829|19376821|P1|COMPLETED|Continuation Period||0
7872769|NCT00842829|19376819|P3|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87
7872770|NCT00842829|19376820|P2|Continuation Safety Analysis Set|Continuation Period||0
7872771|NCT00842829|19376821|P1|Continuation Safety Analysis Set|Continuation Period||0
7872772|NCT00842829|19376819|P3|STARTED|Continuation Period|Eligible for Continuation Period|88
7872773|NCT00842829|19376820|P2|STARTED|Continuation Period||0
7872774|NCT00842829|19376821|P1|STARTED|Continuation Period||0
7872775|NCT00842829|19376819|P3|NOT COMPLETED|Treatment Period||63
7872776|NCT00842829|19376820|P2|NOT COMPLETED|Treatment Period||0
7872777|NCT00842829|19376821|P1|NOT COMPLETED|Treatment Period||0
7872778|NCT00842829|19376819|P3|COMPLETED|Treatment Period||218
7872779|NCT00842829|19376820|P2|COMPLETED|Treatment Period||0
7872780|NCT00842829|19376821|P1|COMPLETED|Treatment Period||0
7872781|NCT00842829|19376819|P3|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223
7872782|NCT00842829|19376820|P2|Safety Analysis Set|Treatment Period||0
7872783|NCT00842829|19376821|P1|Safety Analysis Set|Treatment Period||0
7872784|NCT00842829|19376819|P3|STARTED|Treatment Period||281
7872785|NCT00842829|19376820|P2|STARTED|Treatment Period||0
7872786|NCT00842829|19376821|P1|STARTED|Treatment Period||0
7872787|NCT00842829|19376819|P3|NOT COMPLETED|Dose Titration Period||0
7872788|NCT00842829|19376820|P2|NOT COMPLETED|Dose Titration Period||23
7872789|NCT00842829|19376821|P1|NOT COMPLETED|Dose Titration Period||26
7872790|NCT00842829|19376819|P3|COMPLETED|Dose Titration Period||0
7872791|NCT00842829|19376820|P2|COMPLETED|Dose Titration Period||151
7872792|NCT00842829|19376821|P1|COMPLETED|Dose Titration Period||130
7872793|NCT00842829|19376819|P3|Titration Safety Analysis Set|Dose Titration Period||0
7872794|NCT00842829|19376820|P2|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167
7872795|NCT00842829|19376821|P1|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145
7872796|NCT00842829|19376819|P3|STARTED|Dose Titration Period||0
7872797|NCT00842829|19376820|P2|STARTED|Dose Titration Period||174
7872798|NCT00842829|19376821|P1|STARTED|Dose Titration Period||156
7872799|NCT00842764|19376855|P1|NOT COMPLETED|Overall Study||2
7872800|NCT00842764|19376855|P1|COMPLETED|Overall Study||5
7872801|NCT00842764|19376855|P1|STARTED|Overall Study||7
7872802|NCT00842751|19376859|P1|NOT COMPLETED|Overall Study||0
7872803|NCT00842751|19376859|P1|COMPLETED|Overall Study||11
7872804|NCT00842751|19376859|P1|STARTED|Overall Study||11
7872805|NCT00842712|19376880|P7|NOT COMPLETED|Randomized Part||6
7872806|NCT00842712|19376881|P6|NOT COMPLETED|Randomized Part||1
7872807|NCT00842712|19376882|P5|NOT COMPLETED|Randomized Part||0
7872808|NCT00842712|19376883|P4|NOT COMPLETED|Randomized Part||0
7872809|NCT00842712|19376884|P3|NOT COMPLETED|Randomized Part||0
7872810|NCT00842712|19376885|P2|NOT COMPLETED|Randomized Part||0
7872811|NCT00842712|19376886|P1|NOT COMPLETED|Randomized Part||0
7872812|NCT00842712|19376880|P7|COMPLETED|Randomized Part||78
7872813|NCT00842712|19376881|P6|COMPLETED|Randomized Part||50
7872814|NCT00842712|19376882|P5|COMPLETED|Randomized Part||85
7872815|NCT00842712|19376883|P4|COMPLETED|Randomized Part||0
7872816|NCT00842712|19376884|P3|COMPLETED|Randomized Part||0
7872817|NCT00842712|19376885|P2|COMPLETED|Randomized Part||0
7872818|NCT00842712|19376886|P1|COMPLETED|Randomized Part||0
7872819|NCT00842712|19376880|P7|Treated|Randomized Part||80
7872820|NCT00842712|19376881|P6|Treated|Randomized Part||50
7872821|NCT00842712|19376882|P5|Treated|Randomized Part||85
7872822|NCT00842712|19376883|P4|Treated|Randomized Part||0
7872823|NCT00842712|19376884|P3|Treated|Randomized Part||0
7872824|NCT00842712|19376885|P2|Treated|Randomized Part||0
7872825|NCT00842712|19376886|P1|Treated|Randomized Part||0
7872826|NCT00842712|19376880|P7|STARTED|Randomized Part||84
7872827|NCT00842712|19376881|P6|STARTED|Randomized Part||51
7872828|NCT00842712|19376882|P5|STARTED|Randomized Part||85
7872829|NCT00842712|19376883|P4|STARTED|Randomized Part||0
7872830|NCT00842712|19376884|P3|STARTED|Randomized Part||0
7872831|NCT00842712|19376885|P2|STARTED|Randomized Part||0
7872832|NCT00842712|19376886|P1|STARTED|Randomized Part||0
7872833|NCT00842712|19376880|P7|NOT COMPLETED|Safety Run-in Part||0
7872834|NCT00842712|19376881|P6|NOT COMPLETED|Safety Run-in Part||0
7872835|NCT00842712|19376882|P5|NOT COMPLETED|Safety Run-in Part||0
7872836|NCT00842712|19376883|P4|NOT COMPLETED|Safety Run-in Part||1
7872837|NCT00842712|19376884|P3|NOT COMPLETED|Safety Run-in Part||0
7872838|NCT00842712|19376885|P2|NOT COMPLETED|Safety Run-in Part||2
7872839|NCT00842712|19376886|P1|NOT COMPLETED|Safety Run-in Part||3
7872840|NCT00842712|19376880|P7|COMPLETED|Safety Run-in Part||0
7872841|NCT00842712|19376881|P6|COMPLETED|Safety Run-in Part||0
7872842|NCT00842712|19376882|P5|COMPLETED|Safety Run-in Part||0
7872843|NCT00842712|19376883|P4|COMPLETED|Safety Run-in Part||2
7872844|NCT00842712|19376884|P3|COMPLETED|Safety Run-in Part||3
7872845|NCT00842712|19376885|P2|COMPLETED|Safety Run-in Part||1
7872846|NCT00842712|19376886|P1|COMPLETED|Safety Run-in Part||0
7872847|NCT00842712|19376880|P7|STARTED|Safety Run-in Part||0
7872848|NCT00842712|19376881|P6|STARTED|Safety Run-in Part||0
7872849|NCT00842712|19376882|P5|STARTED|Safety Run-in Part||0
7872850|NCT00842712|19376883|P4|STARTED|Safety Run-in Part||3
7872851|NCT00842712|19376884|P3|STARTED|Safety Run-in Part||3
7872852|NCT00842712|19376885|P2|STARTED|Safety Run-in Part||3
7872853|NCT00842712|19376886|P1|STARTED|Safety Run-in Part||3
7872854|NCT00842608|19376918|P4|NOT COMPLETED|Overall Study||1
7872855|NCT00842608|19376919|P3|NOT COMPLETED|Overall Study||0
7872856|NCT00842608|19376920|P2|NOT COMPLETED|Overall Study||1
7872857|NCT00842608|19376921|P1|NOT COMPLETED|Overall Study||4
7872858|NCT00842608|19376918|P4|COMPLETED|Overall Study||100
7872859|NCT00842608|19376919|P3|COMPLETED|Overall Study||99
7872860|NCT00842608|19376920|P2|COMPLETED|Overall Study||176
7872861|NCT00842608|19376921|P1|COMPLETED|Overall Study||170
7872862|NCT00842608|19376918|P4|STARTED|Overall Study||101
7872863|NCT00842608|19376919|P3|STARTED|Overall Study||99
7872864|NCT00842608|19376920|P2|STARTED|Overall Study||177
7872865|NCT00842608|19376921|P1|STARTED|Overall Study||174
7872866|NCT00842543|19376943|P4|NOT COMPLETED|Overall Study||4
7872867|NCT00842543|19376944|P3|NOT COMPLETED|Overall Study||3
7872868|NCT00842543|19376945|P2|NOT COMPLETED|Overall Study||0
7872869|NCT00842543|19376946|P1|NOT COMPLETED|Overall Study||2
7872870|NCT00842543|19376943|P4|COMPLETED|Overall Study||4
7872871|NCT00842543|19376944|P3|COMPLETED|Overall Study||10
7872872|NCT00842543|19376945|P2|COMPLETED|Overall Study||5
7872873|NCT00842543|19376946|P1|COMPLETED|Overall Study||11
7872874|NCT00842543|19376943|P4|STARTED|Overall Study||8
7872875|NCT00842543|19376944|P3|STARTED|Overall Study||13
7872876|NCT00842543|19376945|P2|STARTED|Overall Study||5
7872877|NCT00842543|19376946|P1|STARTED|Overall Study||13
7872878|NCT00842530|19376960|P2|NOT COMPLETED|Overall Study||57
7872879|NCT00842530|19376961|P1|NOT COMPLETED|Overall Study||117
7872880|NCT00842530|19376960|P2|COMPLETED|Overall Study||1276
7872881|NCT00842530|19376961|P1|COMPLETED|Overall Study||2552
7872882|NCT00842530|19376960|P2|Received Vaccination 3|Overall Study||1282
7872883|NCT00842530|19376961|P1|Received Vaccination 3|Overall Study||2557
7872884|NCT00842530|19376960|P2|Received Vaccination 2|Overall Study||1300
7872885|NCT00842530|19376961|P1|Received Vaccination 2|Overall Study||2584
7872886|NCT00842530|19376960|P2|Received Vaccination 1|Overall Study||1331
7872887|NCT00842530|19376961|P1|Received Vaccination 1|Overall Study||2666
7872888|NCT00842530|19376960|P2|STARTED|Overall Study||1333
7872889|NCT00842530|19376961|P1|STARTED|Overall Study||2669
7872890|NCT00842361|19376991|P2|NOT COMPLETED|Overall Study||2
7872891|NCT00842361|19376992|P1|NOT COMPLETED|Overall Study||1
7872892|NCT00842361|19376991|P2|COMPLETED|Overall Study||31
7872893|NCT00842361|19376992|P1|COMPLETED|Overall Study||32
7872894|NCT00842361|19376991|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32
7872895|NCT00842361|19376992|P1|Exposed|Overall Study||33
7872896|NCT00842361|19376991|P2|STARTED|Overall Study||33
7872897|NCT00842361|19376992|P1|STARTED|Overall Study||33
7872898|NCT00842348|19377012|P2|NOT COMPLETED|Study 729||38
7872899|NCT00842348|19377013|P1|NOT COMPLETED|Study 729||26
7872900|NCT00842348|19377012|P2|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9
7872901|NCT00842348|19377013|P1|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16
7872902|NCT00842348|19377012|P2|STARTED|Study 729||47
7872903|NCT00842348|19377013|P1|STARTED|Study 729||42
7872904|NCT00842348|19377012|P2|NOT COMPLETED|Patients Randomised in Study 726||56
7872905|NCT00842348|19377013|P1|NOT COMPLETED|Patients Randomised in Study 726||59
7872906|NCT00842348|19377012|P2|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47
7872907|NCT00842348|19377013|P1|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42
7872908|NCT00842348|19377012|P2|STARTED|Patients Randomised in Study 726||103
7872909|NCT00842348|19377013|P1|STARTED|Patients Randomised in Study 726||101
7872910|NCT00842335|19377023|P1|NOT COMPLETED|Overall Study||0
7872911|NCT00842335|19377023|P1|COMPLETED|Overall Study||18
7872912|NCT00842335|19377023|P1|STARTED|Overall Study||18
7872913|NCT00842309|19377032|P2|NOT COMPLETED|Overall Study||1
7872914|NCT00842309|19377033|P1|NOT COMPLETED|Overall Study||3
7872915|NCT00842309|19377032|P2|COMPLETED|Overall Study||13
7872916|NCT00842309|19377033|P1|COMPLETED|Overall Study||11
7872917|NCT00842309|19377032|P2|STARTED|Overall Study||14
7872918|NCT00842309|19377033|P1|STARTED|Overall Study|14 randomized. 2 withdrew prior to initiating DCS-not included in modified intent-to-treat analyses.|14
7872919|NCT00842296|19377041|P1|NOT COMPLETED|Overall Study||0
7872920|NCT00842296|19377041|P1|COMPLETED|Overall Study||326
7872921|NCT00842296|19377041|P1|STARTED|Overall Study||326
7872922|NCT00842257|19377067|P1|NOT COMPLETED|Overall Study||1
7872923|NCT00842257|19377067|P1|COMPLETED|Overall Study||19
7872924|NCT00842257|19377067|P1|STARTED|Overall Study||20
7872925|NCT00842244|19377074|P1|NOT COMPLETED|Overall Study||21
7872926|NCT00842244|19377074|P1|COMPLETED|Overall Study||1
7872927|NCT00842244|19377074|P1|STARTED|Overall Study||22
7872928|NCT00842231|19377093|P1|NOT COMPLETED|Overall Study||0
7872929|NCT00842231|19377093|P1|COMPLETED|Overall Study||40
7872930|NCT00842231|19377093|P1|STARTED|Overall Study||40
7872931|NCT00842153|19377101|P2|NOT COMPLETED|Overall Study||3
7872932|NCT00842153|19377102|P1|NOT COMPLETED|Overall Study||1
7872933|NCT00842153|19377101|P2|COMPLETED|Overall Study||27
7872934|NCT00842153|19377102|P1|COMPLETED|Overall Study||27
7872935|NCT00842153|19377101|P2|STARTED|Overall Study||30
7872936|NCT00842153|19377102|P1|STARTED|Overall Study||28
7872937|NCT00842075|19377142|P2|NOT COMPLETED|Overall Study||0
7872938|NCT00842075|19377143|P1|NOT COMPLETED|Overall Study||0
7872939|NCT00842075|19377142|P2|COMPLETED|Overall Study||5
7872940|NCT00842075|19377143|P1|COMPLETED|Overall Study||5
7872941|NCT00842075|19377142|P2|STARTED|Overall Study||5
7872942|NCT00842075|19377143|P1|STARTED|Overall Study||5
7872943|NCT00842023|19377153|P2|NOT COMPLETED|Overall Study||0
7872944|NCT00842023|19377154|P1|NOT COMPLETED|Overall Study||0
7872945|NCT00842023|19377153|P2|COMPLETED|Overall Study||44
7872946|NCT00842023|19377154|P1|COMPLETED|Overall Study||45
7872947|NCT00842023|19377153|P2|STARTED|Overall Study||44
7872948|NCT00842023|19377154|P1|STARTED|Overall Study||45
7872949|NCT00841971|19377166|P2|NOT COMPLETED|Overall Study||1
7872950|NCT00841971|19377167|P1|NOT COMPLETED|Overall Study||2
7872951|NCT00841971|19377166|P2|COMPLETED|Overall Study||99
7872952|NCT00841971|19377167|P1|COMPLETED|Overall Study||98
7872953|NCT00841971|19377166|P2|STARTED|Overall Study||100
7872954|NCT00841971|19377167|P1|STARTED|Overall Study||100
7872955|NCT00841906|19377177|P2|NOT COMPLETED|Overall Study||0
7872956|NCT00841906|19377178|P1|NOT COMPLETED|Overall Study||2
7872957|NCT00841906|19377177|P2|COMPLETED|Overall Study||14
7872958|NCT00841906|19377178|P1|COMPLETED|Overall Study||16
7872959|NCT00841906|19377177|P2|STARTED|Overall Study||14
7872960|NCT00841906|19377178|P1|STARTED|Overall Study||18
7872961|NCT00841828|19377192|P2|NOT COMPLETED|Overall Study||2
7872962|NCT00841828|19377193|P1|NOT COMPLETED|Overall Study||10
7872963|NCT00841828|19377192|P2|COMPLETED|Overall Study||48
7872964|NCT00841828|19377193|P1|COMPLETED|Overall Study||42
7872965|NCT00841828|19377192|P2|STARTED|Overall Study||50
7872966|NCT00841828|19377193|P1|STARTED|Overall Study||52
7872967|NCT00841815|19377203|P2|NOT COMPLETED|Period 2||0
7872968|NCT00841815|19377204|P1|NOT COMPLETED|Period 2||0
7872969|NCT00841815|19377203|P2|COMPLETED|Period 2||13
7872970|NCT00841815|19377204|P1|COMPLETED|Period 2||14
7872971|NCT00841815|19377203|P2|STARTED|Period 2||13
7872972|NCT00841815|19377204|P1|STARTED|Period 2||14
7872973|NCT00841815|19377203|P2|NOT COMPLETED|Washout||1
7872974|NCT00841815|19377204|P1|NOT COMPLETED|Washout||0
7872975|NCT00841815|19377203|P2|COMPLETED|Washout||13
7872976|NCT00841815|19377204|P1|COMPLETED|Washout||14
7872977|NCT00841815|19377203|P2|STARTED|Washout||14
7872978|NCT00841815|19377204|P1|STARTED|Washout||14
7872979|NCT00841815|19377203|P2|NOT COMPLETED|Period 1||0
7872980|NCT00841815|19377204|P1|NOT COMPLETED|Period 1||0
7872981|NCT00841815|19377203|P2|COMPLETED|Period 1||14
7872982|NCT00841815|19377204|P1|COMPLETED|Period 1||14
7872983|NCT00841815|19377203|P2|STARTED|Period 1||14
7872984|NCT00841815|19377204|P1|STARTED|Period 1||14
7872985|NCT00841776|19377214|P2|NOT COMPLETED|Overall Study||3
7872986|NCT00841776|19377215|P1|NOT COMPLETED|Overall Study||2
7872987|NCT00841776|19377214|P2|COMPLETED|Overall Study||24
7872988|NCT00841776|19377215|P1|COMPLETED|Overall Study||25
7872989|NCT00841776|19377214|P2|STARTED|Overall Study||27
7872990|NCT00841776|19377215|P1|STARTED|Overall Study||27
7872991|NCT00841763|19377233|P4|NOT COMPLETED|Overall Study||3
7872992|NCT00841763|19377234|P3|NOT COMPLETED|Overall Study||8
7872993|NCT00841763|19377235|P2|NOT COMPLETED|Overall Study||57
7872994|NCT00841763|19377236|P1|NOT COMPLETED|Overall Study||162
7872995|NCT00841763|19377233|P4|COMPLETED|Overall Study||53
7872996|NCT00841763|19377234|P3|COMPLETED|Overall Study||211
7872997|NCT00841763|19377235|P2|COMPLETED|Overall Study||624
7872998|NCT00841763|19377236|P1|COMPLETED|Overall Study||2529
7872999|NCT00841763|19377233|P4|STARTED|Overall Study||56
7873000|NCT00841763|19377234|P3|STARTED|Overall Study||219
7873001|NCT00841763|19377235|P2|STARTED|Overall Study||681
7873002|NCT00841763|19377236|P1|STARTED|Overall Study||2691
7873003|NCT00841698|19377298|P2|NOT COMPLETED|Second Intervention||0
7873004|NCT00841698|19377299|P1|NOT COMPLETED|Second Intervention||0
7873005|NCT00841698|19377298|P2|COMPLETED|Second Intervention||25
7873006|NCT00841698|19377299|P1|COMPLETED|Second Intervention||24
7873007|NCT00841698|19377298|P2|STARTED|Second Intervention||25
7873008|NCT00841698|19377299|P1|STARTED|Second Intervention||24
7873009|NCT00841698|19377298|P2|NOT COMPLETED|Washout: 2 Weeks||0
7873010|NCT00841698|19377299|P1|NOT COMPLETED|Washout: 2 Weeks||0
7873011|NCT00841698|19377298|P2|COMPLETED|Washout: 2 Weeks||25
7873012|NCT00841698|19377299|P1|COMPLETED|Washout: 2 Weeks||24
7873013|NCT00841698|19377298|P2|STARTED|Washout: 2 Weeks||25
7873014|NCT00841698|19377299|P1|STARTED|Washout: 2 Weeks||24
7873015|NCT00841698|19377298|P2|NOT COMPLETED|First Intervention||0
7873016|NCT00841698|19377299|P1|NOT COMPLETED|First Intervention||1
7873017|NCT00841698|19377298|P2|COMPLETED|First Intervention||25
7873018|NCT00841698|19377299|P1|COMPLETED|First Intervention||24
7873019|NCT00841698|19377298|P2|STARTED|First Intervention||25
7873020|NCT00841698|19377299|P1|STARTED|First Intervention||25
7873021|NCT00841672|19377309|P2|NOT COMPLETED|Overall Study||32
7873022|NCT00841672|19377310|P1|NOT COMPLETED|Overall Study||20
7873023|NCT00841672|19377309|P2|COMPLETED|Overall Study||209
7873024|NCT00841672|19377310|P1|COMPLETED|Overall Study||224
7873025|NCT00841672|19377309|P2|STARTED|Overall Study||241
7873026|NCT00841672|19377310|P1|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244
7873027|NCT00841659|19377326|P2|NOT COMPLETED|Second Intervention||0
7873028|NCT00841659|19377327|P1|NOT COMPLETED|Second Intervention||0
7873029|NCT00841659|19377326|P2|COMPLETED|Second Intervention||12
7873030|NCT00841659|19377327|P1|COMPLETED|Second Intervention||11
7873031|NCT00841659|19377326|P2|STARTED|Second Intervention||12
7873032|NCT00841659|19377327|P1|STARTED|Second Intervention||11
7873033|NCT00841659|19377326|P2|NOT COMPLETED|Washout: 2 Weeks||0
7873034|NCT00841659|19377327|P1|NOT COMPLETED|Washout: 2 Weeks||1
7873035|NCT00841659|19377326|P2|COMPLETED|Washout: 2 Weeks||12
7873036|NCT00841659|19377327|P1|COMPLETED|Washout: 2 Weeks||11
7873037|NCT00841659|19377326|P2|STARTED|Washout: 2 Weeks||12
7873038|NCT00841659|19377327|P1|STARTED|Washout: 2 Weeks||12
7873039|NCT00841659|19377326|P2|NOT COMPLETED|First Intervention||0
7873040|NCT00841659|19377327|P1|NOT COMPLETED|First Intervention||0
7873041|NCT00841659|19377326|P2|COMPLETED|First Intervention||12
7873042|NCT00841659|19377327|P1|COMPLETED|First Intervention||12
7873043|NCT00841659|19377326|P2|STARTED|First Intervention||12
7873044|NCT00841659|19377327|P1|STARTED|First Intervention||12
7873045|NCT00841568|19377335|P1|NOT COMPLETED|Overall Study||5
7873046|NCT00841568|19377335|P1|COMPLETED|Overall Study||12
7873047|NCT00841568|19377335|P1|STARTED|Overall Study||17
7873048|NCT00841555|19377351|P3|NOT COMPLETED|Overall Study||0
7873049|NCT00841555|19377352|P2|NOT COMPLETED|Overall Study||0
7873050|NCT00841555|19377353|P1|NOT COMPLETED|Overall Study||0
7873051|NCT00841555|19377351|P3|COMPLETED|Overall Study||3
7873052|NCT00841555|19377352|P2|COMPLETED|Overall Study||3
7873053|NCT00841555|19377353|P1|COMPLETED|Overall Study||3
7873054|NCT00841555|19377351|P3|STARTED|Overall Study||3
7873055|NCT00841555|19377352|P2|STARTED|Overall Study||3
7873056|NCT00841555|19377353|P1|STARTED|Overall Study||3
7873057|NCT00841542|19377363|P2|NOT COMPLETED|Period 2||0
7873058|NCT00841542|19377364|P1|NOT COMPLETED|Period 2||0
7873059|NCT00841542|19377363|P2|COMPLETED|Period 2||14
7873060|NCT00841542|19377364|P1|COMPLETED|Period 2||13
7873061|NCT00841542|19377363|P2|STARTED|Period 2||14
7873062|NCT00841542|19377364|P1|STARTED|Period 2||13
7873063|NCT00841542|19377363|P2|NOT COMPLETED|Period 1||0
7873064|NCT00841542|19377364|P1|NOT COMPLETED|Period 1||1
7873065|NCT00841542|19377363|P2|COMPLETED|Period 1||14
7873066|NCT00841542|19377364|P1|COMPLETED|Period 1||13
7873067|NCT00841542|19377363|P2|STARTED|Period 1||14
7873068|NCT00841542|19377364|P1|STARTED|Period 1||14
7873069|NCT00841412|19377372|P2|NOT COMPLETED|Overall Study||30
7873070|NCT00841412|19377373|P1|NOT COMPLETED|Overall Study||40
7873071|NCT00841412|19377372|P2|COMPLETED|Overall Study||50
7873072|NCT00841412|19377373|P1|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80
7873073|NCT00841412|19377372|P2|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80
7873074|NCT00841412|19377373|P1|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120
7873075|NCT00841321|19377379|P2|NOT COMPLETED|Overall Study||3
7873076|NCT00841321|19377380|P1|NOT COMPLETED|Overall Study||1
7873077|NCT00841321|19377379|P2|COMPLETED|Overall Study||58
7873078|NCT00841321|19377380|P1|COMPLETED|Overall Study||58
7873079|NCT00841321|19377379|P2|STARTED|Overall Study||61
7873080|NCT00841321|19377380|P1|STARTED|Overall Study||59
7873081|NCT00841269|19377394|P2|NOT COMPLETED|Overall Study||9
7873082|NCT00841269|19377395|P1|NOT COMPLETED|Overall Study||8
7873083|NCT00841269|19377394|P2|COMPLETED|Overall Study||13
7873084|NCT00841269|19377395|P1|COMPLETED|Overall Study||12
7873085|NCT00841269|19377394|P2|STARTED|Overall Study||22
7873086|NCT00841269|19377395|P1|STARTED|Overall Study||20
7873087|NCT00841204|19377406|P2|NOT COMPLETED|Overall Study||0
7873088|NCT00841204|19377407|P1|NOT COMPLETED|Overall Study||0
7873089|NCT00841204|19377406|P2|COMPLETED|Overall Study||25
7873090|NCT00841204|19377407|P1|COMPLETED|Overall Study||25
7873091|NCT00841204|19377406|P2|STARTED|Overall Study||25
7873092|NCT00841204|19377407|P1|STARTED|Overall Study||25
7873093|NCT00841100|19377427|P1|NOT COMPLETED|Phase 3 (28 Days)||0
7873094|NCT00841100|19377427|P1|COMPLETED|Phase 3 (28 Days)||4
7873095|NCT00841100|19377427|P1|STARTED|Phase 3 (28 Days)|Participants who achieved a fasting blood phenylalanine of <600 umol/l can continue to Phase 3.|4
7873096|NCT00841100|19377427|P1|NOT COMPLETED|Phase 2 (2 Weeks)||0
7873097|NCT00841100|19377427|P1|COMPLETED|Phase 2 (2 Weeks)||5
7873098|NCT00841100|19377427|P1|STARTED|Phase 2 (2 Weeks)|Participants who were non-responsive on the Phase 1 component of the study continued on to Phase 2.|5
7873099|NCT00841100|19377427|P1|NOT COMPLETED|Phase 1 (28 Days)||3
7873100|NCT00841100|19377427|P1|COMPLETED|Phase 1 (28 Days)||15
7873101|NCT00841100|19377427|P1|STARTED|Phase 1 (28 Days)|3 participants from the acute phase elected not to continue to the Phase 1 component of the study.|18
7873102|NCT00841100|19377427|P1|NOT COMPLETED|Acute Component (24 Hours)||0
7873103|NCT00841100|19377427|P1|COMPLETED|Acute Component (24 Hours)||21
7873104|NCT00841100|19377427|P1|STARTED|Acute Component (24 Hours)||21
7873105|NCT00841087|19377433|P2|NOT COMPLETED|Overall Study||0
7873106|NCT00841087|19377434|P1|NOT COMPLETED|Overall Study||0
7873107|NCT00841087|19377433|P2|COMPLETED|Overall Study||32
7873108|NCT00841087|19377434|P1|COMPLETED|Overall Study||33
7873109|NCT00841087|19377433|P2|STARTED|Overall Study||32
7873110|NCT00841087|19377434|P1|STARTED|Overall Study||33
7873111|NCT00841035|19377452|P1|NOT COMPLETED|Phase 2 of Overall Study||0
7873112|NCT00841035|19377452|P1|COMPLETED|Phase 2 of Overall Study||6
7873113|NCT00841035|19377452|P1|STARTED|Phase 2 of Overall Study||6
7873114|NCT00841035|19377452|P1|NOT COMPLETED|Phase 1 Overall Study||13
7873115|NCT00841035|19377452|P1|COMPLETED|Phase 1 Overall Study||6
7873116|NCT00841035|19377452|P1|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19
7873117|NCT00840996|19377459|P2|NOT COMPLETED|Overall Study||0
7873118|NCT00840996|19377460|P1|NOT COMPLETED|Overall Study||1
7873119|NCT00840996|19377459|P2|COMPLETED|Overall Study||58
7873120|NCT00840996|19377460|P1|COMPLETED|Overall Study||57
7873121|NCT00840996|19377459|P2|STARTED|Overall Study||58
7873122|NCT00840996|19377460|P1|STARTED|Overall Study||58
7873123|NCT00840970|19377478|P3|NOT COMPLETED|Overall Study||1
7873124|NCT00840970|19377479|P2|NOT COMPLETED|Overall Study||0
7873125|NCT00840970|19377480|P1|NOT COMPLETED|Overall Study||0
7873126|NCT00840970|19377478|P3|COMPLETED|Overall Study||4
7873127|NCT00840970|19377479|P2|COMPLETED|Overall Study||38
7873128|NCT00840970|19377480|P1|COMPLETED|Overall Study||7
7873129|NCT00840970|19377478|P3|STARTED|Overall Study||5
7873130|NCT00840970|19377479|P2|STARTED|Overall Study||38
7873131|NCT00840970|19377480|P1|STARTED|Overall Study||7
7873132|NCT00840879|19377500|P2|NOT COMPLETED|Second Intervention||0
7873133|NCT00840879|19377501|P1|NOT COMPLETED|Second Intervention||1
7873134|NCT00840879|19377500|P2|COMPLETED|Second Intervention||14
7873135|NCT00840879|19377501|P1|COMPLETED|Second Intervention||13
7873136|NCT00840879|19377500|P2|STARTED|Second Intervention||14
7873137|NCT00840879|19377501|P1|STARTED|Second Intervention||14
7873138|NCT00840879|19377500|P2|NOT COMPLETED|Washout: 14 Days||0
7873139|NCT00840879|19377501|P1|NOT COMPLETED|Washout: 14 Days||0
7873140|NCT00840879|19377500|P2|COMPLETED|Washout: 14 Days||14
7873141|NCT00840879|19377501|P1|COMPLETED|Washout: 14 Days||14
7873142|NCT00840879|19377500|P2|STARTED|Washout: 14 Days||14
7873143|NCT00840879|19377501|P1|STARTED|Washout: 14 Days||14
7873144|NCT00840879|19377500|P2|NOT COMPLETED|First Intervention||0
7873145|NCT00840879|19377501|P1|NOT COMPLETED|First Intervention||0
7873146|NCT00840879|19377500|P2|COMPLETED|First Intervention||14
7873147|NCT00840879|19377501|P1|COMPLETED|First Intervention||14
7873148|NCT00840879|19377500|P2|STARTED|First Intervention||14
7873149|NCT00840879|19377501|P1|STARTED|First Intervention||14
7873150|NCT00840866|19377511|P2|NOT COMPLETED|Second Intervention||0
7873151|NCT00840866|19377512|P1|NOT COMPLETED|Second Intervention||0
7873152|NCT00840866|19377511|P2|COMPLETED|Second Intervention||19
7873153|NCT00840866|19377512|P1|COMPLETED|Second Intervention||20
7873154|NCT00840866|19377511|P2|STARTED|Second Intervention||19
7873155|NCT00840866|19377512|P1|STARTED|Second Intervention||20
7873156|NCT00840866|19377511|P2|NOT COMPLETED|Washout of 7 Days||0
7873157|NCT00840866|19377512|P1|NOT COMPLETED|Washout of 7 Days||0
7873158|NCT00840866|19377511|P2|COMPLETED|Washout of 7 Days||19
7873159|NCT00840866|19377512|P1|COMPLETED|Washout of 7 Days||20
7873160|NCT00840866|19377511|P2|STARTED|Washout of 7 Days||19
7873161|NCT00840866|19377512|P1|STARTED|Washout of 7 Days||20
7873162|NCT00840866|19377511|P2|NOT COMPLETED|First Intervention||0
7873163|NCT00840866|19377512|P1|NOT COMPLETED|First Intervention||0
7873164|NCT00840866|19377511|P2|COMPLETED|First Intervention||19
7873165|NCT00840866|19377512|P1|COMPLETED|First Intervention||20
7873166|NCT00840866|19377511|P2|STARTED|First Intervention||19
7873167|NCT00840866|19377512|P1|STARTED|First Intervention||20
7873168|NCT00840840|19377522|P2|NOT COMPLETED|Period 2||0
7873169|NCT00840840|19377523|P1|NOT COMPLETED|Period 2||0
7873170|NCT00840840|19377522|P2|COMPLETED|Period 2||24
7873171|NCT00840840|19377523|P1|COMPLETED|Period 2||23
7873172|NCT00840840|19377522|P2|STARTED|Period 2||24
7873173|NCT00840840|19377523|P1|STARTED|Period 2|One subject was withdrawn due to AE after Period 1|23
7873174|NCT00840840|19377522|P2|NOT COMPLETED|Period 1||0
7873175|NCT00840840|19377523|P1|NOT COMPLETED|Period 1||0
7873176|NCT00840840|19377522|P2|COMPLETED|Period 1||24
7873177|NCT00840840|19377523|P1|COMPLETED|Period 1||24
7873178|NCT00840840|19377522|P2|STARTED|Period 1||24
7873179|NCT00840840|19377523|P1|STARTED|Period 1||24
7873180|NCT00840827|19377537|P1|NOT COMPLETED|Overall Study||6
7873181|NCT00840827|19377537|P1|COMPLETED|Overall Study||0
7873182|NCT00840827|19377537|P1|STARTED|Overall Study||6
7873183|NCT00840749|19377552|P2|NOT COMPLETED|Overall Study||27
7873184|NCT00840749|19377553|P1|NOT COMPLETED|Overall Study||31
7873185|NCT00840749|19377552|P2|COMPLETED|Overall Study||0
7873186|NCT00840749|19377553|P1|COMPLETED|Overall Study||0
7873187|NCT00840749|19377552|P2|36 Months Post tx|Overall Study||0
7873188|NCT00840749|19377553|P1|36 Months Post tx|Overall Study||1
7873189|NCT00840749|19377552|P2|24 Months Post tx|Overall Study||3
7873190|NCT00840749|19377553|P1|24 Months Post tx|Overall Study||9
7873191|NCT00840749|19377552|P2|18 Months Post tx|Overall Study||6
7873192|NCT00840749|19377553|P1|18 Months Post tx|Overall Study||12
7873193|NCT00840749|19377552|P2|12 Months Post tx|Overall Study||7
7873194|NCT00840749|19377553|P1|12 Months Post tx|Overall Study||14
7873195|NCT00840749|19377552|P2|6 Months Post tx|Overall Study||10
7873196|NCT00840749|19377553|P1|6 Months Post tx|Overall Study||16
7873197|NCT00840749|19377552|P2|1 Month Post tx|Overall Study||15
7873198|NCT00840749|19377553|P1|1 Month Post tx|Overall Study||19
7873199|NCT00840749|19377552|P2|Treatment|Overall Study||16
7873200|NCT00840749|19377553|P1|Treatment|Overall Study||20
7873201|NCT00840749|19377552|P2|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|27
7873202|NCT00840749|19377553|P1|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|31
7873203|NCT00840658|19377565|P4|NOT COMPLETED|Overall Study||4
7873204|NCT00840658|19377566|P3|NOT COMPLETED|Overall Study||5
7873205|NCT00840658|19377567|P2|NOT COMPLETED|Overall Study||3
7873206|NCT00840658|19377568|P1|NOT COMPLETED|Overall Study||5
7873207|NCT00840658|19377565|P4|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142
7873208|NCT00840658|19377566|P3|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
7873209|NCT00840658|19377567|P2|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
7873210|NCT00840658|19377568|P1|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139
7873211|NCT00840658|19377565|P4|STARTED|Overall Study||146
7873212|NCT00840658|19377566|P3|STARTED|Overall Study||148
7873213|NCT00840658|19377567|P2|STARTED|Overall Study||146
7873214|NCT00840658|19377568|P1|STARTED|Overall Study||144
7873215|NCT00840632|19377586|P2|NOT COMPLETED|Second Intervention||0
7873216|NCT00840632|19377587|P1|NOT COMPLETED|Second Intervention||0
7873217|NCT00840632|19377586|P2|COMPLETED|Second Intervention||18
7873218|NCT00840632|19377587|P1|COMPLETED|Second Intervention||19
7873219|NCT00840632|19377586|P2|STARTED|Second Intervention||18
7873220|NCT00840632|19377587|P1|STARTED|Second Intervention||19
7873221|NCT00840632|19377586|P2|NOT COMPLETED|Washout||1
7873222|NCT00840632|19377587|P1|NOT COMPLETED|Washout||1
7873223|NCT00840632|19377586|P2|COMPLETED|Washout||18
7873224|NCT00840632|19377587|P1|COMPLETED|Washout||19
7873225|NCT00840632|19377586|P2|STARTED|Washout||19
7873226|NCT00840632|19377587|P1|STARTED|Washout||20
7873227|NCT00840632|19377586|P2|NOT COMPLETED|First Intervention||1
7873228|NCT00840632|19377587|P1|NOT COMPLETED|First Intervention||0
7873229|NCT00840632|19377586|P2|COMPLETED|First Intervention||19
7873230|NCT00840632|19377587|P1|COMPLETED|First Intervention||20
7873231|NCT00840632|19377586|P2|STARTED|First Intervention||20
7873232|NCT00840632|19377587|P1|STARTED|First Intervention||20
7873233|NCT00840476|19377603|P2|NOT COMPLETED|Second Intervention||0
7873234|NCT00840476|19377604|P1|NOT COMPLETED|Second Intervention||0
7873235|NCT00840476|19377603|P2|COMPLETED|Second Intervention||14
7873236|NCT00840476|19377604|P1|COMPLETED|Second Intervention||14
7873237|NCT00840476|19377603|P2|STARTED|Second Intervention||14
7873238|NCT00840476|19377604|P1|STARTED|Second Intervention||14
7873239|NCT00840476|19377603|P2|NOT COMPLETED|Washout: 14 Days||0
7873240|NCT00840476|19377604|P1|NOT COMPLETED|Washout: 14 Days||0
7873241|NCT00840476|19377603|P2|COMPLETED|Washout: 14 Days||14
7873242|NCT00840476|19377604|P1|COMPLETED|Washout: 14 Days||14
7873243|NCT00840476|19377603|P2|STARTED|Washout: 14 Days||14
7873244|NCT00840476|19377604|P1|STARTED|Washout: 14 Days||14
7873245|NCT00840476|19377603|P2|NOT COMPLETED|First Intervention||0
7873246|NCT00840476|19377604|P1|NOT COMPLETED|First Intervention||0
7873247|NCT00840476|19377603|P2|COMPLETED|First Intervention||14
7873248|NCT00840476|19377604|P1|COMPLETED|First Intervention||14
7873249|NCT00840476|19377603|P2|STARTED|First Intervention||14
7873250|NCT00840476|19377604|P1|STARTED|First Intervention||14
7873251|NCT00840463|19377614|P2|NOT COMPLETED|Overall Study||0
7873252|NCT00840463|19377615|P1|NOT COMPLETED|Overall Study||1
7873253|NCT00840463|19377614|P2|COMPLETED|Overall Study||1
7873254|NCT00840463|19377615|P1|COMPLETED|Overall Study||2
7873255|NCT00840463|19377614|P2|STARTED|Overall Study||1
7873256|NCT00840463|19377615|P1|STARTED|Overall Study||3
7873257|NCT00840450|19377629|P1|NOT COMPLETED|Overall Study||3
7873258|NCT00840450|19377629|P1|COMPLETED|Overall Study||9
7873259|NCT00840450|19377629|P1|STARTED|Overall Study||12
7873260|NCT00840411|19377637|P2|NOT COMPLETED|Second Intervention||0
7873261|NCT00840411|19377638|P1|NOT COMPLETED|Second Intervention||0
7873262|NCT00840411|19377637|P2|COMPLETED|Second Intervention||33
7873263|NCT00840411|19377638|P1|COMPLETED|Second Intervention||31
7873264|NCT00840411|19377637|P2|STARTED|Second Intervention||33
7873265|NCT00840411|19377638|P1|STARTED|Second Intervention||31
7873266|NCT00840411|19377637|P2|NOT COMPLETED|Washout||0
7873267|NCT00840411|19377638|P1|NOT COMPLETED|Washout||1
7873268|NCT00840411|19377637|P2|COMPLETED|Washout||33
7873269|NCT00840411|19377638|P1|COMPLETED|Washout||31
7873270|NCT00840411|19377637|P2|STARTED|Washout||33
7873271|NCT00840411|19377638|P1|STARTED|Washout||32
7873272|NCT00840411|19377637|P2|NOT COMPLETED|First Intervention||0
7873273|NCT00840411|19377638|P1|NOT COMPLETED|First Intervention||1
7873274|NCT00840411|19377637|P2|COMPLETED|First Intervention||33
7873275|NCT00840411|19377638|P1|COMPLETED|First Intervention||32
7873276|NCT00840411|19377637|P2|STARTED|First Intervention||33
7873277|NCT00840411|19377638|P1|STARTED|First Intervention||33
7873278|NCT00840307|19377646|P1|NOT COMPLETED|Overall Study||4
7873279|NCT00840307|19377646|P1|COMPLETED|Overall Study||16
7873280|NCT00840307|19377646|P1|STARTED|Overall Study||20
7873281|NCT00840294|19377652|P2|NOT COMPLETED|Overall Study||5
7873282|NCT00840294|19377653|P1|NOT COMPLETED|Overall Study||3
7873283|NCT00840294|19377652|P2|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38
7873284|NCT00840294|19377653|P1|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39
7873285|NCT00840294|19377652|P2|STARTED|Overall Study||43
7873286|NCT00840294|19377653|P1|STARTED|Overall Study||42
7873287|NCT00840281|19377663|P2|NOT COMPLETED|Second Intervention||0
7873288|NCT00840281|19377664|P1|NOT COMPLETED|Second Intervention||0
7873289|NCT00840281|19377663|P2|COMPLETED|Second Intervention||19
7873290|NCT00840281|19377664|P1|COMPLETED|Second Intervention||19
7873291|NCT00840281|19377663|P2|STARTED|Second Intervention||19
7873292|NCT00840281|19377664|P1|STARTED|Second Intervention||19
7873293|NCT00840281|19377663|P2|NOT COMPLETED|Washout of 7 Days||0
7873294|NCT00840281|19377664|P1|NOT COMPLETED|Washout of 7 Days||0
7873295|NCT00840281|19377663|P2|COMPLETED|Washout of 7 Days||19
7873296|NCT00840281|19377664|P1|COMPLETED|Washout of 7 Days||19
7873297|NCT00840281|19377663|P2|STARTED|Washout of 7 Days||19
7873298|NCT00840281|19377664|P1|STARTED|Washout of 7 Days||19
7873299|NCT00840281|19377663|P2|NOT COMPLETED|First Intervention||0
7873300|NCT00840281|19377664|P1|NOT COMPLETED|First Intervention||0
7873301|NCT00840281|19377663|P2|COMPLETED|First Intervention||19
7873302|NCT00840281|19377664|P1|COMPLETED|First Intervention||19
7873303|NCT00840281|19377663|P2|STARTED|First Intervention||19
7873304|NCT00840281|19377664|P1|STARTED|First Intervention||19
7873305|NCT00840216|19377674|P2|NOT COMPLETED|Second Intervention||0
7873306|NCT00840216|19377675|P1|NOT COMPLETED|Second Intervention||0
7873307|NCT00840216|19377674|P2|COMPLETED|Second Intervention||11
7873308|NCT00840216|19377675|P1|COMPLETED|Second Intervention||10
7873309|NCT00840216|19377674|P2|STARTED|Second Intervention||11
7873310|NCT00840216|19377675|P1|STARTED|Second Intervention||10
7873311|NCT00840216|19377674|P2|NOT COMPLETED|Washout: 7 Days||0
7873312|NCT00840216|19377675|P1|NOT COMPLETED|Washout: 7 Days||1
7873313|NCT00840216|19377674|P2|COMPLETED|Washout: 7 Days||11
7873314|NCT00840216|19377675|P1|COMPLETED|Washout: 7 Days||10
7873315|NCT00840216|19377674|P2|STARTED|Washout: 7 Days||11
7873316|NCT00840216|19377675|P1|STARTED|Washout: 7 Days||11
7873317|NCT00840216|19377674|P2|NOT COMPLETED|First Intervention||0
7873318|NCT00840216|19377675|P1|NOT COMPLETED|First Intervention||0
7873319|NCT00840216|19377674|P2|COMPLETED|First Intervention||11
7873320|NCT00840216|19377675|P1|COMPLETED|First Intervention||11
7873321|NCT00840216|19377674|P2|STARTED|First Intervention||11
7873322|NCT00840216|19377675|P1|STARTED|First Intervention||11
7873323|NCT00840203|19377685|P2|NOT COMPLETED|Second Intervention||0
7873324|NCT00840203|19377686|P1|NOT COMPLETED|Second Intervention||0
7873325|NCT00840203|19377685|P2|COMPLETED|Second Intervention||34
7873326|NCT00840203|19377686|P1|COMPLETED|Second Intervention||35
7873327|NCT00840203|19377685|P2|STARTED|Second Intervention||34
7873328|NCT00840203|19377686|P1|STARTED|Second Intervention||35
7873329|NCT00840203|19377685|P2|NOT COMPLETED|Washout||0
7873330|NCT00840203|19377686|P1|NOT COMPLETED|Washout||1
7873331|NCT00840203|19377685|P2|COMPLETED|Washout||34
7873332|NCT00840203|19377686|P1|COMPLETED|Washout||35
7873333|NCT00840203|19377685|P2|STARTED|Washout||34
7873334|NCT00840203|19377686|P1|STARTED|Washout||36
7873335|NCT00840203|19377685|P2|NOT COMPLETED|First Intervention||1
7873336|NCT00840203|19377686|P1|NOT COMPLETED|First Intervention||1
7873337|NCT00840203|19377685|P2|COMPLETED|First Intervention||34
7873338|NCT00840203|19377686|P1|COMPLETED|First Intervention||36
7873339|NCT00840203|19377685|P2|STARTED|First Intervention||35
7873340|NCT00840203|19377686|P1|STARTED|First Intervention||37
7873341|NCT00840177|19377703|P3|NOT COMPLETED|Overall Study||11
7873342|NCT00840177|19377704|P2|NOT COMPLETED|Overall Study||9
7873343|NCT00840177|19377705|P1|NOT COMPLETED|Overall Study||18
7873344|NCT00840177|19377703|P3|COMPLETED|Overall Study||39
7873345|NCT00840177|19377704|P2|COMPLETED|Overall Study||20
7873346|NCT00840177|19377705|P1|COMPLETED|Overall Study||18
7873347|NCT00840177|19377703|P3|Assessed for AEs|Overall Study||46
7873348|NCT00840177|19377704|P2|Assessed for AEs|Overall Study||29
7873349|NCT00840177|19377705|P1|Assessed for AEs|Overall Study||35
7873350|NCT00840177|19377703|P3|Treated|Overall Study||46
7873351|NCT00840177|19377704|P2|Treated|Overall Study||29
7873352|NCT00840177|19377705|P1|Treated|Overall Study||36
7873353|NCT00840177|19377703|P3|STARTED|Overall Study||50
7873354|NCT00840177|19377704|P2|STARTED|Overall Study||29
7873355|NCT00840177|19377705|P1|STARTED|Overall Study||36
7873356|NCT00840099|19377724|P2|NOT COMPLETED|Period 2||0
7873357|NCT00840099|19377725|P1|NOT COMPLETED|Period 2||0
7873358|NCT00840099|19377724|P2|COMPLETED|Period 2||24
7873359|NCT00840099|19377725|P1|COMPLETED|Period 2||21
7873360|NCT00840099|19377724|P2|STARTED|Period 2||24
7873361|NCT00840099|19377725|P1|STARTED|Period 2|3 subjects were dismissed from study prior to period 2 dosing|21
7873362|NCT00840099|19377724|P2|NOT COMPLETED|Period 1||0
7873363|NCT00840099|19377725|P1|NOT COMPLETED|Period 1||0
7873364|NCT00840099|19377724|P2|COMPLETED|Period 1||24
7873365|NCT00840099|19377725|P1|COMPLETED|Period 1||24
7873366|NCT00840099|19377724|P2|STARTED|Period 1||24
7873367|NCT00840099|19377725|P1|STARTED|Period 1||24
7873368|NCT00840086|19377739|P1|NOT COMPLETED|Overall Study||4
7873369|NCT00840086|19377739|P1|COMPLETED|Overall Study||146
7873370|NCT00840086|19377739|P1|STARTED|Overall Study||150
7873371|NCT00840073|19377748|P2|NOT COMPLETED|Second Intervention||1
7873372|NCT00840073|19377749|P1|NOT COMPLETED|Second Intervention||1
7873373|NCT00840073|19377748|P2|COMPLETED|Second Intervention||24
7873374|NCT00840073|19377749|P1|COMPLETED|Second Intervention||24
7873375|NCT00840073|19377748|P2|STARTED|Second Intervention||25
7873376|NCT00840073|19377749|P1|STARTED|Second Intervention||25
7873377|NCT00840073|19377748|P2|NOT COMPLETED|First Intervention||0
7873378|NCT00840073|19377749|P1|NOT COMPLETED|First Intervention||0
7873379|NCT00840073|19377748|P2|COMPLETED|First Intervention||25
7873380|NCT00840073|19377749|P1|COMPLETED|First Intervention||25
7873381|NCT00840073|19377748|P2|STARTED|First Intervention||25
7873382|NCT00840073|19377749|P1|STARTED|First Intervention||25
7873383|NCT00840060|19377763|P2|NOT COMPLETED|Overall Study||1
7873384|NCT00840060|19377764|P1|NOT COMPLETED|Overall Study||1
7873385|NCT00840060|19377763|P2|COMPLETED|Overall Study||19
7873386|NCT00840060|19377764|P1|COMPLETED|Overall Study||19
7873387|NCT00840060|19377763|P2|STARTED|Overall Study||20
7873388|NCT00840060|19377764|P1|STARTED|Overall Study||20
7873389|NCT00840034|19377774|P2|NOT COMPLETED|Taper Phase||2
7873390|NCT00840034|19377775|P1|NOT COMPLETED|Taper Phase||3
7873391|NCT00840034|19377774|P2|COMPLETED|Taper Phase||80
7873392|NCT00840034|19377775|P1|COMPLETED|Taper Phase||87
7873393|NCT00840034|19377774|P2|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|82
7873394|NCT00840034|19377775|P1|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|90
7873395|NCT00840034|19377774|P2|NOT COMPLETED|Acute Treatment Phase||36
7873396|NCT00840034|19377775|P1|NOT COMPLETED|Acute Treatment Phase||21
7873397|NCT00840034|19377774|P2|COMPLETED|Acute Treatment Phase||80
7873398|NCT00840034|19377775|P1|COMPLETED|Acute Treatment Phase||90
7873399|NCT00840034|19377774|P2|STARTED|Acute Treatment Phase||116
7873400|NCT00840034|19377775|P1|STARTED|Acute Treatment Phase||111
7873401|NCT00839982|19377811|P4|NOT COMPLETED|Overall Study||0
7873402|NCT00839982|19377812|P3|NOT COMPLETED|Overall Study||0
7873403|NCT00839982|19377813|P2|NOT COMPLETED|Overall Study||0
7873404|NCT00839982|19377814|P1|NOT COMPLETED|Overall Study||0
7873405|NCT00839982|19377811|P4|COMPLETED|Overall Study||3
7873406|NCT00839982|19377812|P3|COMPLETED|Overall Study||2
7873407|NCT00839982|19377813|P2|COMPLETED|Overall Study||26
7873408|NCT00839982|19377814|P1|COMPLETED|Overall Study||4
7873409|NCT00839982|19377811|P4|STARTED|Overall Study||3
7873410|NCT00839982|19377812|P3|STARTED|Overall Study||2
7873411|NCT00839982|19377813|P2|STARTED|Overall Study||26
7873412|NCT00839982|19377814|P1|STARTED|Overall Study||4
7873413|NCT00839956|19377828|P1|NOT COMPLETED|Overall Study||12
7873414|NCT00839956|19377828|P1|COMPLETED|Overall Study||19
7873415|NCT00839956|19377828|P1|STARTED|Overall Study||31
7873416|NCT00839930|19377837|P2|NOT COMPLETED|Second Intervention||0
7873417|NCT00839930|19377838|P1|NOT COMPLETED|Second Intervention||0
7873418|NCT00839930|19377837|P2|COMPLETED|Second Intervention||15
7873419|NCT00839930|19377838|P1|COMPLETED|Second Intervention||15
7873420|NCT00839930|19377837|P2|STARTED|Second Intervention||15
7873421|NCT00839930|19377838|P1|STARTED|Second Intervention||15
7873422|NCT00839930|19377837|P2|NOT COMPLETED|Washout: 7 Days||0
7873423|NCT00839930|19377838|P1|NOT COMPLETED|Washout: 7 Days||0
7873424|NCT00839930|19377837|P2|COMPLETED|Washout: 7 Days||15
7873425|NCT00839930|19377838|P1|COMPLETED|Washout: 7 Days||15
7873426|NCT00839930|19377837|P2|STARTED|Washout: 7 Days||15
7873427|NCT00839930|19377838|P1|STARTED|Washout: 7 Days||15
7873428|NCT00839930|19377837|P2|NOT COMPLETED|First Intervention||0
7873429|NCT00839930|19377838|P1|NOT COMPLETED|First Intervention||0
7873430|NCT00839930|19377837|P2|COMPLETED|First Intervention||15
7873431|NCT00839930|19377838|P1|COMPLETED|First Intervention||15
7873432|NCT00839930|19377837|P2|STARTED|First Intervention||15
7873433|NCT00839930|19377838|P1|STARTED|First Intervention||15
7873434|NCT00839917|19377848|P2|NOT COMPLETED|Overall Study||1
7873435|NCT00839917|19377849|P1|NOT COMPLETED|Overall Study||1
7873436|NCT00839917|19377848|P2|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16
7873437|NCT00839917|19377849|P1|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12
7873438|NCT00839917|19377848|P2|STARTED|Overall Study||17
7873439|NCT00839917|19377849|P1|STARTED|Overall Study||13
7873440|NCT00839852|19377885|P1|NOT COMPLETED|Overall Study||47
7873441|NCT00839852|19377885|P1|COMPLETED|Overall Study||46
7873442|NCT00839852|19377885|P1|STARTED|Overall Study||93
7873443|NCT00839800|19377892|P2|NOT COMPLETED|Overall Study||110
7873444|NCT00839800|19377893|P1|NOT COMPLETED|Overall Study||93
7873445|NCT00839800|19377892|P2|COMPLETED|Overall Study||932
7873446|NCT00839800|19377893|P1|COMPLETED|Overall Study||956
7873447|NCT00839800|19377892|P2|STARTED|Overall Study||1042
7873448|NCT00839800|19377893|P1|STARTED|Overall Study||1049
7873449|NCT00839540|19377926|P3|NOT COMPLETED|Overall Study||0
7873450|NCT00839540|19377927|P2|NOT COMPLETED|Overall Study||0
7873451|NCT00839540|19377928|P1|NOT COMPLETED|Overall Study||0
7873452|NCT00839540|19377926|P3|COMPLETED|Overall Study||5
7873453|NCT00839540|19377927|P2|COMPLETED|Overall Study||8
7873454|NCT00839540|19377928|P1|COMPLETED|Overall Study||8
7873455|NCT00839540|19377926|P3|STARTED|Overall Study||5
7873456|NCT00839540|19377927|P2|STARTED|Overall Study||8
7873457|NCT00839540|19377928|P1|STARTED|Overall Study||8
7873458|NCT00839527|19377939|P3|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62
7873459|NCT00839527|19377940|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56
7873460|NCT00839527|19377941|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28
7873461|NCT00839527|19377939|P3|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204
7873462|NCT00839527|19377940|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217
7873463|NCT00839527|19377941|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86
7873464|NCT00839527|19377939|P3|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266
7873465|NCT00839527|19377940|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273
7873466|NCT00839527|19377941|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114
7873467|NCT00839527|19377939|P3|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119
7873468|NCT00839527|19377940|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118
7873469|NCT00839527|19377941|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60
7873470|NCT00839527|19377939|P3|COMPLETED|Treatment Period (TP) (156 Weeks)||152
7873471|NCT00839527|19377940|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||159
7873472|NCT00839527|19377941|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||55
7873473|NCT00839527|19377939|P3|STARTED|Treatment Period (TP) (156 Weeks)||271
7873474|NCT00839527|19377940|P2|STARTED|Treatment Period (TP) (156 Weeks)||277
7873475|NCT00839527|19377941|P1|STARTED|Treatment Period (TP) (156 Weeks)||115
7873476|NCT00839436|19377976|P3|NOT COMPLETED|Overall Study||1
7873477|NCT00839436|19377977|P2|NOT COMPLETED|Overall Study||1
7873478|NCT00839436|19377978|P1|NOT COMPLETED|Overall Study||1
7873479|NCT00839436|19377976|P3|COMPLETED|Overall Study||0
7873480|NCT00839436|19377977|P2|COMPLETED|Overall Study||4
7873481|NCT00839436|19377978|P1|COMPLETED|Overall Study||2
7873482|NCT00839436|19377976|P3|STARTED|Overall Study||1
7873483|NCT00839436|19377977|P2|STARTED|Overall Study||5
7873484|NCT00839436|19377978|P1|STARTED|Overall Study||3
7873485|NCT00839423|19377990|P4|NOT COMPLETED|Overall Study||20
7873486|NCT00839423|19377991|P3|NOT COMPLETED|Overall Study||18
7873487|NCT00839423|19377992|P2|NOT COMPLETED|Overall Study||10
7873488|NCT00839423|19377993|P1|NOT COMPLETED|Overall Study||18
7873489|NCT00839423|19377990|P4|COMPLETED|Overall Study||93
7873490|NCT00839423|19377991|P3|COMPLETED|Overall Study||82
7873491|NCT00839423|19377992|P2|COMPLETED|Overall Study||98
7873492|NCT00839423|19377993|P1|COMPLETED|Overall Study||87
7873493|NCT00839423|19377990|P4|STARTED|Overall Study||113
7873494|NCT00839423|19377991|P3|STARTED|Overall Study||100
7873495|NCT00839423|19377992|P2|STARTED|Overall Study||108
7873496|NCT00839423|19377993|P1|STARTED|Overall Study||105
7873497|NCT00839332|19378034|P3|NOT COMPLETED|Phase 2||39
7873498|NCT00839332|19378035|P2|NOT COMPLETED|Phase 2||68
7873499|NCT00839332|19378036|P1|NOT COMPLETED|Phase 2||0
7873500|NCT00839332|19378034|P3|COMPLETED|Phase 2||0
7873501|NCT00839332|19378035|P2|COMPLETED|Phase 2||0
7873502|NCT00839332|19378036|P1|COMPLETED|Phase 2||0
7873503|NCT00839332|19378034|P3|Received at Least 1 Dose of Study Drug|Phase 2||34
7873504|NCT00839332|19378035|P2|Received at Least 1 Dose of Study Drug|Phase 2||65
7873505|NCT00839332|19378036|P1|Received at Least 1 Dose of Study Drug|Phase 2||0
7873506|NCT00839332|19378034|P3|STARTED|Phase 2||39
7873507|NCT00839332|19378035|P2|STARTED|Phase 2||68
7873508|NCT00839332|19378036|P1|STARTED|Phase 2|Participants in Phase 1 did not participate in Phase 2.|0
7873509|NCT00839332|19378034|P3|NOT COMPLETED|Phase 1||0
7873510|NCT00839332|19378035|P2|NOT COMPLETED|Phase 1||0
7873511|NCT00839332|19378036|P1|NOT COMPLETED|Phase 1||50
7873512|NCT00839332|19378034|P3|COMPLETED|Phase 1||0
7873513|NCT00839332|19378035|P2|COMPLETED|Phase 1||0
7873514|NCT00839332|19378036|P1|COMPLETED|Phase 1||0
7873515|NCT00839332|19378034|P3|Received at Least 1 Dose of Study Drug|Phase 1||0
7873516|NCT00839332|19378035|P2|Received at Least 1 Dose of Study Drug|Phase 1||0
7873517|NCT00839332|19378036|P1|Received at Least 1 Dose of Study Drug|Phase 1||50
7873518|NCT00839332|19378034|P3|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
7873519|NCT00839332|19378035|P2|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
7873520|NCT00839332|19378036|P1|STARTED|Phase 1||50
7873521|NCT00839319|19378064|P5|NOT COMPLETED|Overall Study||0
7873522|NCT00839319|19378065|P4|NOT COMPLETED|Overall Study||3
7873523|NCT00839319|19378066|P3|NOT COMPLETED|Overall Study||3
7873524|NCT00839319|19378067|P2|NOT COMPLETED|Overall Study||1
7873525|NCT00839319|19378068|P1|NOT COMPLETED|Overall Study||2
7873526|NCT00839319|19378064|P5|COMPLETED|Overall Study||8
7873527|NCT00839319|19378065|P4|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5
7873528|NCT00839319|19378066|P3|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5
7873529|NCT00839319|19378067|P2|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7
7873530|NCT00839319|19378068|P1|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6
7873531|NCT00839319|19378064|P5|STARTED|Overall Study||8
7873532|NCT00839319|19378065|P4|STARTED|Overall Study||8
7873533|NCT00839319|19378066|P3|STARTED|Overall Study||8
7873534|NCT00839319|19378067|P2|STARTED|Overall Study||8
7873535|NCT00839319|19378068|P1|STARTED|Overall Study||8
7873536|NCT00839306|19378097|P2|NOT COMPLETED|Overall Study||43
7873537|NCT00839306|19378098|P1|NOT COMPLETED|Overall Study||25
7873538|NCT00839306|19378097|P2|COMPLETED|Overall Study||134
7873539|NCT00839306|19378098|P1|COMPLETED|Overall Study||35
7873540|NCT00839306|19378097|P2|STARTED|Overall Study|Treated|177
7873541|NCT00839306|19378098|P1|STARTED|Overall Study|Treated|60
7873542|NCT00839254|19378114|P8|NOT COMPLETED|Overall Study||15
7873543|NCT00839254|19378115|P7|NOT COMPLETED|Overall Study||28
7873544|NCT00839254|19378116|P6|NOT COMPLETED|Overall Study||26
7873545|NCT00839254|19378117|P5|NOT COMPLETED|Overall Study||37
7873546|NCT00839254|19378118|P4|NOT COMPLETED|Overall Study||62
7873547|NCT00839254|19378119|P3|NOT COMPLETED|Overall Study||90
7873548|NCT00839254|19378120|P2|NOT COMPLETED|Overall Study||92
7873549|NCT00839254|19378121|P1|NOT COMPLETED|Overall Study||153
7873550|NCT00839254|19378114|P8|COMPLETED|Overall Study||256
7873551|NCT00839254|19378115|P7|COMPLETED|Overall Study||340
7873552|NCT00839254|19378116|P6|COMPLETED|Overall Study||178
7873553|NCT00839254|19378117|P5|COMPLETED|Overall Study||204
7873554|NCT00839254|19378118|P4|COMPLETED|Overall Study||797
7873555|NCT00839254|19378119|P3|COMPLETED|Overall Study||979
7873556|NCT00839254|19378120|P2|COMPLETED|Overall Study||1224
7873557|NCT00839254|19378121|P1|COMPLETED|Overall Study||1696
7873558|NCT00839254|19378114|P8|STARTED|Overall Study||271
7873559|NCT00839254|19378115|P7|STARTED|Overall Study||368
7873560|NCT00839254|19378116|P6|STARTED|Overall Study||204
7873561|NCT00839254|19378117|P5|STARTED|Overall Study||241
7873562|NCT00839254|19378118|P4|STARTED|Overall Study||859
7873563|NCT00839254|19378119|P3|STARTED|Overall Study||1069
7873564|NCT00839254|19378120|P2|STARTED|Overall Study||1316
7873565|NCT00839254|19378121|P1|STARTED|Overall Study||1849
7873566|NCT00839241|19378357|P2|NOT COMPLETED|Overall Study||17
7873567|NCT00839241|19378358|P1|NOT COMPLETED|Overall Study||5
7873568|NCT00839241|19378357|P2|COMPLETED|Overall Study||8
7873569|NCT00839241|19378358|P1|COMPLETED|Overall Study||15
7873570|NCT00839241|19378357|P2|STARTED|Overall Study||25
7873571|NCT00839241|19378358|P1|STARTED|Overall Study||20
7873572|NCT00839098|19378445|P3|NOT COMPLETED|Overall Study||7
7873573|NCT00839098|19378446|P2|NOT COMPLETED|Overall Study||1
7873574|NCT00839098|19378447|P1|NOT COMPLETED|Overall Study||2
7873575|NCT00839098|19378445|P3|COMPLETED|Overall Study||6
7873576|NCT00839098|19378446|P2|COMPLETED|Overall Study||11
7873577|NCT00839098|19378447|P1|COMPLETED|Overall Study||1
7873578|NCT00839098|19378445|P3|STARTED|Overall Study||13
7873579|NCT00839098|19378446|P2|STARTED|Overall Study||12
7873580|NCT00839098|19378447|P1|STARTED|Overall Study||3
7873581|NCT00839072|19378473|P2|NOT COMPLETED|Second Intervention Period||0
7873582|NCT00839072|19378474|P1|NOT COMPLETED|Second Intervention Period||1
7873583|NCT00839072|19378473|P2|COMPLETED|Second Intervention Period||11
7873584|NCT00839072|19378474|P1|COMPLETED|Second Intervention Period||9
7873585|NCT00839072|19378473|P2|STARTED|Second Intervention Period||11
7873586|NCT00839072|19378474|P1|STARTED|Second Intervention Period||10
7873587|NCT00839072|19378473|P2|NOT COMPLETED|Washout Period of 7 Days||0
7873588|NCT00839072|19378474|P1|NOT COMPLETED|Washout Period of 7 Days||0
7873589|NCT00839072|19378473|P2|COMPLETED|Washout Period of 7 Days||11
7873590|NCT00839072|19378474|P1|COMPLETED|Washout Period of 7 Days||10
7873591|NCT00839072|19378473|P2|STARTED|Washout Period of 7 Days||11
7873592|NCT00839072|19378474|P1|STARTED|Washout Period of 7 Days||10
7873593|NCT00839072|19378473|P2|NOT COMPLETED|First Intervention Period||1
7873594|NCT00839072|19378474|P1|NOT COMPLETED|First Intervention Period||2
7873595|NCT00839072|19378473|P2|COMPLETED|First Intervention Period||11
7873596|NCT00839072|19378474|P1|COMPLETED|First Intervention Period||10
7873597|NCT00839072|19378473|P2|STARTED|First Intervention Period||12
7873598|NCT00839072|19378474|P1|STARTED|First Intervention Period||12
7873599|NCT00838981|19378494|P4|NOT COMPLETED|Day 4 to Week 11||7
7873600|NCT00838981|19378495|P3|NOT COMPLETED|Day 4 to Week 11||11
7873601|NCT00838981|19378496|P2|NOT COMPLETED|Day 4 to Week 11||8
7873602|NCT00838981|19378497|P1|NOT COMPLETED|Day 4 to Week 11||7
7873603|NCT00838981|19378494|P4|COMPLETED|Day 4 to Week 11||12
7873604|NCT00838981|19378495|P3|COMPLETED|Day 4 to Week 11||16
7873605|NCT00838981|19378496|P2|COMPLETED|Day 4 to Week 11||11
7873606|NCT00838981|19378497|P1|COMPLETED|Day 4 to Week 11||19
7873607|NCT00838981|19378494|P4|Completed Main Treatment on 400mg|Day 4 to Week 11||14
7873608|NCT00838981|19378495|P3|Completed Main Treatment on 400mg|Day 4 to Week 11||17
7873609|NCT00838981|19378496|P2|Completed Main Treatment on 400mg|Day 4 to Week 11||13
7873610|NCT00838981|19378497|P1|Completed Main Treatment on 400mg|Day 4 to Week 11||22
7873611|NCT00838981|19378494|P4|STARTED|Day 4 to Week 11||19
7873612|NCT00838981|19378495|P3|STARTED|Day 4 to Week 11||27
7873613|NCT00838981|19378496|P2|STARTED|Day 4 to Week 11||19
7873614|NCT00838981|19378497|P1|STARTED|Day 4 to Week 11||26
7873615|NCT00838981|19378494|P4|NOT COMPLETED|Week 1 Days 1-3||0
7873616|NCT00838981|19378495|P3|NOT COMPLETED|Week 1 Days 1-3||0
7873617|NCT00838981|19378496|P2|NOT COMPLETED|Week 1 Days 1-3||0
7873618|NCT00838981|19378497|P1|NOT COMPLETED|Week 1 Days 1-3||0
7873619|NCT00838981|19378494|P4|COMPLETED|Week 1 Days 1-3||19
7873620|NCT00838981|19378495|P3|COMPLETED|Week 1 Days 1-3||27
7873621|NCT00838981|19378496|P2|COMPLETED|Week 1 Days 1-3||19
7873622|NCT00838981|19378497|P1|COMPLETED|Week 1 Days 1-3||26
7873623|NCT00838981|19378494|P4|STARTED|Week 1 Days 1-3||19
7873624|NCT00838981|19378495|P3|STARTED|Week 1 Days 1-3||27
7873625|NCT00838981|19378496|P2|STARTED|Week 1 Days 1-3||19
7873626|NCT00838981|19378497|P1|STARTED|Week 1 Days 1-3||26
7873627|NCT00838929|19378518|P3|NOT COMPLETED|Overall Study||1
7873628|NCT00838929|19378519|P2|NOT COMPLETED|Overall Study||3
7873629|NCT00838929|19378520|P1|NOT COMPLETED|Overall Study||0
7873630|NCT00838929|19378518|P3|COMPLETED|Overall Study||5
7873631|NCT00838929|19378519|P2|COMPLETED|Overall Study||5
7873632|NCT00838929|19378520|P1|COMPLETED|Overall Study||3
7873633|NCT00838929|19378518|P3|STARTED|Overall Study||6
7873634|NCT00838929|19378519|P2|STARTED|Overall Study||8
7873635|NCT00838929|19378520|P1|STARTED|Overall Study||3
7873636|NCT00838916|19378528|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||51
7873637|NCT00838916|19378529|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||96
7873638|NCT00838916|19378528|P2|COMPLETED|Follow-up Period (8 Weeks)||190
7873639|NCT00838916|19378529|P1|COMPLETED|Follow-up Period (8 Weeks)||408
7873640|NCT00838916|19378528|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241
7873641|NCT00838916|19378529|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504
7873642|NCT00838916|19378528|P2|NOT COMPLETED|Treatment Period (156 Weeks)||77
7873643|NCT00838916|19378529|P1|NOT COMPLETED|Treatment Period (156 Weeks)||196
7873644|NCT00838916|19378528|P2|COMPLETED|Treatment Period (156 Weeks)||164
7873645|NCT00838916|19378529|P1|COMPLETED|Treatment Period (156 Weeks)||308
7873646|NCT00838916|19378528|P2|STARTED|Treatment Period (156 Weeks)||241
7873647|NCT00838916|19378529|P1|STARTED|Treatment Period (156 Weeks)||504
7873648|NCT00838903|19378558|P4|NOT COMPLETED|Follow-up Period (8 Weeks)||58
7873649|NCT00838903|19378559|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||64
7873650|NCT00838903|19378560|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||65
7873651|NCT00838903|19378561|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||26
7873652|NCT00838903|19378558|P4|COMPLETED|Follow-up Period (8 Weeks)||244
7873653|NCT00838903|19378559|P3|COMPLETED|Follow-up Period (8 Weeks)||243
7873654|NCT00838903|19378560|P2|COMPLETED|Follow-up Period (8 Weeks)||237
7873655|NCT00838903|19378561|P1|COMPLETED|Follow-up Period (8 Weeks)||75
7873656|NCT00838903|19378558|P4|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
7873657|NCT00838903|19378559|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307
7873658|NCT00838903|19378560|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
7873659|NCT00838903|19378561|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
7873660|NCT00838903|19378558|P4|NOT COMPLETED|Treatment Period (156 Weeks)||110
7873661|NCT00838903|19378559|P3|NOT COMPLETED|Treatment Period (156 Weeks)||116
7873662|NCT00838903|19378560|P2|NOT COMPLETED|Treatment Period (156 Weeks)||112
7873663|NCT00838903|19378561|P1|NOT COMPLETED|Treatment Period (156 Weeks)||46
7873664|NCT00838903|19378558|P4|COMPLETED|Treatment Period (156 Weeks)||192
7873665|NCT00838903|19378559|P3|COMPLETED|Treatment Period (156 Weeks)||191
7873666|NCT00838903|19378560|P2|COMPLETED|Treatment Period (156 Weeks)||190
7873667|NCT00838903|19378561|P1|COMPLETED|Treatment Period (156 Weeks)||55
7873668|NCT00838903|19378558|P4|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
7873669|NCT00838903|19378559|P3|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
7873670|NCT00838903|19378560|P2|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
7873671|NCT00838903|19378561|P1|Missing Active Treatment Status|Treatment Period (156 Weeks)||1
7873672|NCT00838903|19378558|P4|STARTED|Treatment Period (156 Weeks)||302
7873673|NCT00838903|19378559|P3|STARTED|Treatment Period (156 Weeks)||307
7873674|NCT00838903|19378560|P2|STARTED|Treatment Period (156 Weeks)||302
7873675|NCT00838903|19378561|P1|STARTED|Treatment Period (156 Weeks)||101
7873676|NCT00838695|19378605|P2|NOT COMPLETED|Overall Study||0
7873677|NCT00838695|19378606|P1|NOT COMPLETED|Overall Study||0
7873678|NCT00838695|19378605|P2|COMPLETED|Overall Study||64
7873679|NCT00838695|19378606|P1|COMPLETED|Overall Study||42
7873680|NCT00838695|19378605|P2|STARTED|Overall Study||64
7873681|NCT00838695|19378606|P1|STARTED|Overall Study||42
7873682|NCT00838682|19378616|P2|NOT COMPLETED|Overall Study||19
7873683|NCT00838682|19378617|P1|NOT COMPLETED|Overall Study||25
7873684|NCT00838682|19378616|P2|COMPLETED|Overall Study||33
7873685|NCT00838682|19378617|P1|COMPLETED|Overall Study||29
7873686|NCT00838682|19378616|P2|STARTED|Overall Study||52
7873687|NCT00838682|19378617|P1|STARTED|Overall Study||54
7873688|NCT00838630|19378635|P2|NOT COMPLETED|Second Intervention||0
7873689|NCT00838630|19378636|P1|NOT COMPLETED|Second Intervention||0
7873690|NCT00838630|19378635|P2|COMPLETED|Second Intervention||18
7873691|NCT00838630|19378636|P1|COMPLETED|Second Intervention||16
7873692|NCT00838630|19378635|P2|STARTED|Second Intervention||18
7873693|NCT00838630|19378636|P1|STARTED|Second Intervention||16
7873694|NCT00838630|19378635|P2|NOT COMPLETED|Washout: 7 Days||0
7873695|NCT00838630|19378636|P1|NOT COMPLETED|Washout: 7 Days||1
7873696|NCT00838630|19378635|P2|COMPLETED|Washout: 7 Days||18
7873697|NCT00838630|19378636|P1|COMPLETED|Washout: 7 Days||16
7873698|NCT00838630|19378635|P2|STARTED|Washout: 7 Days||18
7873699|NCT00838630|19378636|P1|STARTED|Washout: 7 Days||17
7873700|NCT00838630|19378635|P2|NOT COMPLETED|First Intervention||0
7873701|NCT00838630|19378636|P1|NOT COMPLETED|First Intervention||1
7873702|NCT00838630|19378635|P2|COMPLETED|First Intervention||18
7873703|NCT00838630|19378636|P1|COMPLETED|First Intervention||17
7873704|NCT00838630|19378635|P2|STARTED|First Intervention||18
7873705|NCT00838630|19378636|P1|STARTED|First Intervention||18
7873706|NCT00838578|19378644|P1|NOT COMPLETED|Overall Study||2
7873707|NCT00838578|19378644|P1|COMPLETED|Overall Study||63
7873708|NCT00838578|19378644|P1|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65
7873709|NCT00838565|19378658|P6|NOT COMPLETED|Overall Study||2
7873710|NCT00838565|19378659|P5|NOT COMPLETED|Overall Study||0
7873711|NCT00838565|19378660|P4|NOT COMPLETED|Overall Study||0
7873712|NCT00838565|19378661|P3|NOT COMPLETED|Overall Study||1
7873713|NCT00838565|19378662|P2|NOT COMPLETED|Overall Study||3
7873714|NCT00838565|19378663|P1|NOT COMPLETED|Overall Study||0
7873715|NCT00838565|19378658|P6|COMPLETED|Overall Study||5
7873716|NCT00838565|19378659|P5|COMPLETED|Overall Study||6
7873717|NCT00838565|19378660|P4|COMPLETED|Overall Study||6
7873718|NCT00838565|19378661|P3|COMPLETED|Overall Study||5
7873719|NCT00838565|19378662|P2|COMPLETED|Overall Study||4
7873720|NCT00838565|19378663|P1|COMPLETED|Overall Study||9
7873721|NCT00838565|19378658|P6|Treated|Overall Study||7
7873722|NCT00838565|19378659|P5|Treated|Overall Study||6
7873723|NCT00838565|19378660|P4|Treated|Overall Study||6
7873724|NCT00838565|19378661|P3|Treated|Overall Study||6
7873725|NCT00838565|19378662|P2|Treated|Overall Study||6
7873726|NCT00838565|19378663|P1|Treated|Overall Study||9
7873727|NCT00838565|19378658|P6|STARTED|Overall Study||7
7873728|NCT00838565|19378659|P5|STARTED|Overall Study||6
7873729|NCT00838565|19378660|P4|STARTED|Overall Study||6
7873730|NCT00838565|19378661|P3|STARTED|Overall Study||6
7873731|NCT00838565|19378662|P2|STARTED|Overall Study||7
7873732|NCT00838565|19378663|P1|STARTED|Overall Study||9
7873733|NCT00838539|19378768|P12|NOT COMPLETED|Overall Study||4
7873734|NCT00838539|19378769|P11|NOT COMPLETED|Overall Study||5
7873735|NCT00838539|19378770|P10|NOT COMPLETED|Overall Study||8
7873736|NCT00838539|19378771|P9|NOT COMPLETED|Overall Study||5
7873737|NCT00838539|19378772|P8|NOT COMPLETED|Overall Study||6
7873738|NCT00838539|19378773|P7|NOT COMPLETED|Overall Study||5
7873739|NCT00838539|19378774|P6|NOT COMPLETED|Overall Study||4
7873740|NCT00838539|19378775|P5|NOT COMPLETED|Overall Study||6
7873741|NCT00838539|19378776|P4|NOT COMPLETED|Overall Study||4
7873742|NCT00838539|19378777|P3|NOT COMPLETED|Overall Study||5
7873743|NCT00838539|19378778|P2|NOT COMPLETED|Overall Study||6
7873744|NCT00838539|19378779|P1|NOT COMPLETED|Overall Study||3
7873745|NCT00838539|19378768|P12|COMPLETED|Overall Study||0
7873746|NCT00838539|19378769|P11|COMPLETED|Overall Study||0
7873747|NCT00838539|19378770|P10|COMPLETED|Overall Study||0
7873748|NCT00838539|19378771|P9|COMPLETED|Overall Study||0
7873749|NCT00838539|19378772|P8|COMPLETED|Overall Study||0
7873750|NCT00838539|19378773|P7|COMPLETED|Overall Study||2
7873751|NCT00838539|19378774|P6|COMPLETED|Overall Study||0
7873752|NCT00838539|19378775|P5|COMPLETED|Overall Study||0
7873753|NCT00838539|19378776|P4|COMPLETED|Overall Study||0
7873754|NCT00838539|19378777|P3|COMPLETED|Overall Study||0
7873755|NCT00838539|19378778|P2|COMPLETED|Overall Study||0
7873756|NCT00838539|19378779|P1|COMPLETED|Overall Study||0
7873757|NCT00838539|19378768|P12|Received Treatment|Overall Study||4
7873758|NCT00838539|19378769|P11|Received Treatment|Overall Study||5
7873759|NCT00838539|19378770|P10|Received Treatment|Overall Study||8
7873760|NCT00838539|19378771|P9|Received Treatment|Overall Study||5
7873761|NCT00838539|19378772|P8|Received Treatment|Overall Study||6
7873762|NCT00838539|19378773|P7|Received Treatment|Overall Study||7
7873763|NCT00838539|19378774|P6|Received Treatment|Overall Study||4
7873764|NCT00838539|19378775|P5|Received Treatment|Overall Study||4
7873765|NCT00838539|19378776|P4|Received Treatment|Overall Study||4
7873766|NCT00838539|19378777|P3|Received Treatment|Overall Study||5
7873767|NCT00838539|19378778|P2|Received Treatment|Overall Study||5
7873768|NCT00838539|19378779|P1|Received Treatment|Overall Study||3
7873769|NCT00838539|19378768|P12|STARTED|Overall Study||4
7873770|NCT00838539|19378769|P11|STARTED|Overall Study||5
7873771|NCT00838539|19378770|P10|STARTED|Overall Study||8
7873772|NCT00838539|19378771|P9|STARTED|Overall Study||5
7873773|NCT00838539|19378772|P8|STARTED|Overall Study||6
7873774|NCT00838539|19378773|P7|STARTED|Overall Study||7
7873775|NCT00838539|19378774|P6|STARTED|Overall Study||4
7873776|NCT00838539|19378775|P5|STARTED|Overall Study||6
7873777|NCT00838539|19378776|P4|STARTED|Overall Study||4
7873778|NCT00838539|19378777|P3|STARTED|Overall Study||5
7873779|NCT00838539|19378778|P2|STARTED|Overall Study||6
7873780|NCT00838539|19378779|P1|STARTED|Overall Study||3
7873781|NCT00838526|19378829|P2|NOT COMPLETED|Overall Study||39
7873782|NCT00838526|19378830|P1|NOT COMPLETED|Overall Study||24
7873783|NCT00838526|19378829|P2|COMPLETED|Overall Study||137
7873784|NCT00838526|19378830|P1|COMPLETED|Overall Study||35
7873785|NCT00838526|19378829|P2|STARTED|Overall Study|Treated|176
7873786|NCT00838526|19378830|P1|STARTED|Overall Study|Treated|59
7873787|NCT00838513|19378838|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
7873788|NCT00838513|19378838|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
7873789|NCT00838513|19378838|P1|STARTED|Post Treatment Period (Patients Who Disc||5
7873790|NCT00838513|19378838|P1|NOT COMPLETED|Extension Treatment Period||1
7873791|NCT00838513|19378838|P1|COMPLETED|Extension Treatment Period||18
7873792|NCT00838513|19378838|P1|STARTED|Extension Treatment Period||19
7873793|NCT00838513|19378838|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
7873794|NCT00838513|19378838|P1|COMPLETED|Treatment Period (26 Weeks)||20
7873795|NCT00838513|19378838|P1|STARTED|Treatment Period (26 Weeks)||20
7873796|NCT00838513|19378838|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
7873797|NCT00838513|19378838|P1|COMPLETED|Observation Period (8 Weeks)||20
7873798|NCT00838513|19378838|P1|STARTED|Observation Period (8 Weeks)||20
7873799|NCT00838513|19378838|P1|NOT COMPLETED|Screening Period||3
7873800|NCT00838513|19378838|P1|COMPLETED|Screening Period||20
7873801|NCT00838513|19378838|P1|STARTED|Screening Period||23
7873802|NCT00838435|19378854|P1|NOT COMPLETED|Part 2 (7 Years)||16
7873803|NCT00838435|19378854|P1|COMPLETED|Part 2 (7 Years)||49
7873804|NCT00838435|19378854|P1|STARTED|Part 2 (7 Years)|65 of 95 subjects in Part 1 were determined responders & eligible for the Part 2 of the study.|65
7873805|NCT00838435|19378854|P1|NOT COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||2
7873806|NCT00838435|19378854|P1|COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||63
7873807|NCT00838435|19378854|P1|STARTED|Safety/Efficacy Sub-Study 1 (6 Months)|65 of 95 subjects in Part 1 were determined responders & eligible for the Safety/Efficacy Sub-study.|65
7873808|NCT00838435|19378854|P1|NOT COMPLETED|PK Sub-Study 2 (4 Weeks)||1
7873809|NCT00838435|19378854|P1|COMPLETED|PK Sub-Study 2 (4 Weeks)||93
7873810|NCT00838435|19378854|P1|STARTED|PK Sub-Study 2 (4 Weeks)|1 subject declined participation in the PK Sub-Study.|94
7873811|NCT00838435|19378854|P1|NOT COMPLETED|Part 1 (4 Weeks)||0
7873812|NCT00838435|19378854|P1|COMPLETED|Part 1 (4 Weeks)||95
7873813|NCT00838435|19378854|P1|STARTED|Part 1 (4 Weeks)||95
7873814|NCT00838331|19378867|P1|NOT COMPLETED|Aged Blood Transfusion||9
7873815|NCT00838331|19378867|P1|COMPLETED|Aged Blood Transfusion||8
7873816|NCT00838331|19378867|P1|STARTED|Aged Blood Transfusion||17
7873817|NCT00838331|19378867|P1|NOT COMPLETED|Fresh Blood Transfusion||0
7873818|NCT00838331|19378867|P1|COMPLETED|Fresh Blood Transfusion||17
7873819|NCT00838331|19378867|P1|STARTED|Fresh Blood Transfusion||17
7873820|NCT00838279|19378873|P2|NOT COMPLETED|Second Intervention||0
7873821|NCT00838279|19378874|P1|NOT COMPLETED|Second Intervention||0
7873822|NCT00838279|19378873|P2|COMPLETED|Second Intervention||15
7873823|NCT00838279|19378874|P1|COMPLETED|Second Intervention||15
7873824|NCT00838279|19378873|P2|STARTED|Second Intervention||15
7873825|NCT00838279|19378874|P1|STARTED|Second Intervention||15
7873826|NCT00838279|19378873|P2|NOT COMPLETED|Washout||1
7873827|NCT00838279|19378874|P1|NOT COMPLETED|Washout||1
7873828|NCT00838279|19378873|P2|COMPLETED|Washout||15
7873829|NCT00838279|19378874|P1|COMPLETED|Washout||15
7873830|NCT00838279|19378873|P2|STARTED|Washout||16
7873831|NCT00838279|19378874|P1|STARTED|Washout||16
7873832|NCT00838279|19378873|P2|NOT COMPLETED|First Intervention||0
7873833|NCT00838279|19378874|P1|NOT COMPLETED|First Intervention||0
7873834|NCT00838279|19378873|P2|COMPLETED|First Intervention||16
7873835|NCT00838279|19378874|P1|COMPLETED|First Intervention||16
7873836|NCT00838279|19378873|P2|STARTED|First Intervention||16
7873837|NCT00838279|19378874|P1|STARTED|First Intervention||16
7873838|NCT00838201|19378884|P2|NOT COMPLETED|Overall Study||53
7873839|NCT00838201|19378885|P1|NOT COMPLETED|Overall Study||42
7873840|NCT00838201|19378884|P2|COMPLETED|Overall Study||145
7873841|NCT00838201|19378885|P1|COMPLETED|Overall Study||144
7873842|NCT00838201|19378884|P2|STARTED|Overall Study||198
7873843|NCT00838201|19378885|P1|STARTED|Overall Study||186
7873844|NCT00838162|19378895|P4|NOT COMPLETED|Overall Study||0
7873845|NCT00838162|19378896|P3|NOT COMPLETED|Overall Study||0
7873846|NCT00838162|19378897|P2|NOT COMPLETED|Overall Study||0
7873847|NCT00838162|19378898|P1|NOT COMPLETED|Overall Study||0
7873848|NCT00838162|19378895|P4|COMPLETED|Overall Study||8
7873849|NCT00838162|19378896|P3|COMPLETED|Overall Study||8
7873850|NCT00838162|19378897|P2|COMPLETED|Overall Study||8
7873851|NCT00838162|19378898|P1|COMPLETED|Overall Study||9
7873852|NCT00838162|19378895|P4|STARTED|Overall Study||8
7873853|NCT00838162|19378896|P3|STARTED|Overall Study||8
7873854|NCT00838162|19378897|P2|STARTED|Overall Study||8
7873855|NCT00838162|19378898|P1|STARTED|Overall Study||9
7873856|NCT00838136|19378942|P2|NOT COMPLETED|Second Intervention||1
7873857|NCT00838136|19378943|P1|NOT COMPLETED|Second Intervention||0
7873858|NCT00838136|19378942|P2|COMPLETED|Second Intervention||15
7873859|NCT00838136|19378943|P1|COMPLETED|Second Intervention||16
7873860|NCT00838136|19378942|P2|STARTED|Second Intervention||16
7873861|NCT00838136|19378943|P1|STARTED|Second Intervention||16
7873862|NCT00838136|19378942|P2|NOT COMPLETED|First Intervention||0
7873863|NCT00838136|19378943|P1|NOT COMPLETED|First Intervention||0
7873864|NCT00838136|19378942|P2|COMPLETED|First Intervention||16
7873865|NCT00838136|19378943|P1|COMPLETED|First Intervention||16
7873866|NCT00838136|19378942|P2|STARTED|First Intervention||16
7873867|NCT00838136|19378943|P1|STARTED|First Intervention||16
7873868|NCT00838110|19378953|P4|NOT COMPLETED|Overall Study||18
7873869|NCT00838110|19378954|P3|NOT COMPLETED|Overall Study||17
7873870|NCT00838110|19378955|P2|NOT COMPLETED|Overall Study||22
7873871|NCT00838110|19378956|P1|NOT COMPLETED|Overall Study||22
7873872|NCT00838110|19378953|P4|COMPLETED|Overall Study||226
7873873|NCT00838110|19378954|P3|COMPLETED|Overall Study||226
7873874|NCT00838110|19378955|P2|COMPLETED|Overall Study||106
7873875|NCT00838110|19378956|P1|COMPLETED|Overall Study||105
7873876|NCT00838110|19378953|P4|Treated|Overall Study||244
7873877|NCT00838110|19378954|P3|Treated|Overall Study||243
7873878|NCT00838110|19378955|P2|Treated|Overall Study||127
7873879|NCT00838110|19378956|P1|Treated|Overall Study||127
7873880|NCT00838110|19378953|P4|STARTED|Overall Study||244
7873881|NCT00838110|19378954|P3|STARTED|Overall Study||243
7873882|NCT00838110|19378955|P2|STARTED|Overall Study||128
7873883|NCT00838110|19378956|P1|STARTED|Overall Study||127
7873884|NCT00838097|19378976|P1|NOT COMPLETED|Overall Study||176
7873885|NCT00838097|19378976|P1|COMPLETED|Overall Study||145
7873886|NCT00838097|19378976|P1|Received Darbepoetin Alfa|Overall Study||319
7873887|NCT00838097|19378976|P1|STARTED|Overall Study||321
7873888|NCT00838006|19378987|P3|NOT COMPLETED|Overall Study||48
7873889|NCT00838006|19378988|P2|NOT COMPLETED|Overall Study||26
7873890|NCT00838006|19378989|P1|NOT COMPLETED|Overall Study||34
7873891|NCT00838006|19378987|P3|COMPLETED|Overall Study||94
7873892|NCT00838006|19378988|P2|COMPLETED|Overall Study||72
7873893|NCT00838006|19378989|P1|COMPLETED|Overall Study||68
7873894|NCT00838006|19378987|P3|3-month Post-deployment Follow-up|Overall Study||135
7873895|NCT00838006|19378988|P2|3-month Post-deployment Follow-up|Overall Study||80
7873896|NCT00838006|19378989|P1|3-month Post-deployment Follow-up|Overall Study||92
7873897|NCT00838006|19378987|P3|STARTED|Overall Study||142
7873898|NCT00838006|19378988|P2|STARTED|Overall Study||98
7873899|NCT00838006|19378989|P1|STARTED|Overall Study||102
7873900|NCT00837967|19379000|P2|NOT COMPLETED|Second Intervention||0
7873901|NCT00837967|19379001|P1|NOT COMPLETED|Second Intervention||0
7873902|NCT00837967|19379000|P2|COMPLETED|Second Intervention||12
7873903|NCT00837967|19379001|P1|COMPLETED|Second Intervention||11
7873904|NCT00837967|19379000|P2|STARTED|Second Intervention||12
7873905|NCT00837967|19379001|P1|STARTED|Second Intervention||11
7873906|NCT00837967|19379000|P2|NOT COMPLETED|Washout Period of 7 - 14 Days||0
7873907|NCT00837967|19379001|P1|NOT COMPLETED|Washout Period of 7 - 14 Days||2
7873908|NCT00837967|19379000|P2|COMPLETED|Washout Period of 7 - 14 Days||12
7873909|NCT00837967|19379001|P1|COMPLETED|Washout Period of 7 - 14 Days||11
7873910|NCT00837967|19379000|P2|STARTED|Washout Period of 7 - 14 Days||12
7873911|NCT00837967|19379001|P1|STARTED|Washout Period of 7 - 14 Days||13
7873912|NCT00837967|19379000|P2|NOT COMPLETED|First Intervention||0
7873913|NCT00837967|19379001|P1|NOT COMPLETED|First Intervention||0
7873914|NCT00837967|19379000|P2|COMPLETED|First Intervention||12
7873915|NCT00837967|19379001|P1|COMPLETED|First Intervention||13
7873916|NCT00837967|19379000|P2|STARTED|First Intervention||12
7873917|NCT00837967|19379001|P1|STARTED|First Intervention||13
7873918|NCT00837902|19379019|P2|NOT COMPLETED|Overall Study||0
7873919|NCT00837902|19379020|P1|NOT COMPLETED|Overall Study||0
7873920|NCT00837902|19379019|P2|COMPLETED|Overall Study||69
7873921|NCT00837902|19379020|P1|COMPLETED|Overall Study||85
7873922|NCT00837902|19379019|P2|STARTED|Overall Study||69
7873923|NCT00837902|19379020|P1|STARTED|Overall Study||85
7873924|NCT00837876|19379027|P1|NOT COMPLETED|Overall Study||37
7873925|NCT00837876|19379027|P1|COMPLETED|Overall Study||0
7873926|NCT00837876|19379027|P1|STARTED|Overall Study||37
7873927|NCT00837824|19379036|P2|NOT COMPLETED|Overall Study||0
7873928|NCT00837824|19379037|P1|NOT COMPLETED|Overall Study||0
7873929|NCT00837824|19379036|P2|COMPLETED|Overall Study||9
7873930|NCT00837824|19379037|P1|COMPLETED|Overall Study||11
7873931|NCT00837824|19379036|P2|STARTED|Overall Study||9
7873932|NCT00837824|19379037|P1|STARTED|Overall Study||11
7873933|NCT00837811|19379049|P3|NOT COMPLETED|Overall Study||1
7873934|NCT00837811|19379050|P2|NOT COMPLETED|Overall Study||34
7873935|NCT00837811|19379051|P1|NOT COMPLETED|Overall Study||7
7873936|NCT00837811|19379049|P3|COMPLETED|Overall Study||0
7873937|NCT00837811|19379050|P2|COMPLETED|Overall Study||87
7873938|NCT00837811|19379051|P1|COMPLETED|Overall Study||53
7873939|NCT00837811|19379049|P3|Included in Efficacy Analyses|Overall Study||1
7873940|NCT00837811|19379050|P2|Included in Efficacy Analyses|Overall Study|Excludes participant from site with Good Clinical Practice (GCP) violations.|120
7873941|NCT00837811|19379051|P1|Included in Efficacy Analyses|Overall Study||59
7873942|NCT00837811|19379049|P3|Had at Least 1 Efficacy Assessment|Overall Study||1
7873943|NCT00837811|19379050|P2|Had at Least 1 Efficacy Assessment|Overall Study||121
7873944|NCT00837811|19379051|P1|Had at Least 1 Efficacy Assessment|Overall Study||59
7873945|NCT00837811|19379049|P3|Received Any Amount of Study Drug|Overall Study||1
7873946|NCT00837811|19379050|P2|Received Any Amount of Study Drug|Overall Study||121
7873947|NCT00837811|19379051|P1|Received Any Amount of Study Drug|Overall Study||60
7873948|NCT00837811|19379049|P3|STARTED|Overall Study||1
7873949|NCT00837811|19379050|P2|STARTED|Overall Study||121
7873950|NCT00837811|19379051|P1|STARTED|Overall Study||60
7873951|NCT00837759|19379136|P1|NOT COMPLETED|Overall Study||4
7873952|NCT00837759|19379136|P1|COMPLETED|Overall Study||3
7873953|NCT00837759|19379136|P1|STARTED|Overall Study||7
7873954|NCT00837694|19379151|P6|NOT COMPLETED|Overall Study||1
7873955|NCT00837694|19379152|P5|NOT COMPLETED|Overall Study||1
7873956|NCT00837694|19379153|P4|NOT COMPLETED|Overall Study||1
7873957|NCT00837694|19379154|P3|NOT COMPLETED|Overall Study||2
7873958|NCT00837694|19379155|P2|NOT COMPLETED|Overall Study||0
7873959|NCT00837694|19379156|P1|NOT COMPLETED|Overall Study||2
7873960|NCT00837694|19379151|P6|COMPLETED|Overall Study||10
7873961|NCT00837694|19379152|P5|COMPLETED|Overall Study||11
7873962|NCT00837694|19379153|P4|COMPLETED|Overall Study||10
7873963|NCT00837694|19379154|P3|COMPLETED|Overall Study||8
7873964|NCT00837694|19379155|P2|COMPLETED|Overall Study||11
7873965|NCT00837694|19379156|P1|COMPLETED|Overall Study||8
7873966|NCT00837694|19379151|P6|STARTED|Overall Study||11
7873967|NCT00837694|19379152|P5|STARTED|Overall Study||12
7873968|NCT00837694|19379153|P4|STARTED|Overall Study||11
7873969|NCT00837694|19379154|P3|STARTED|Overall Study||10
7873970|NCT00837694|19379155|P2|STARTED|Overall Study||11
7873971|NCT00837694|19379156|P1|STARTED|Overall Study||10
7873972|NCT00837616|19379172|P2|NOT COMPLETED|Overall Study||1
7873973|NCT00837616|19379173|P1|NOT COMPLETED|Overall Study||0
7873974|NCT00837616|19379172|P2|COMPLETED|Overall Study||20
7873975|NCT00837616|19379173|P1|COMPLETED|Overall Study||20
7873976|NCT00837616|19379172|P2|STARTED|Overall Study||21
7873977|NCT00837616|19379173|P1|STARTED|Overall Study||20
7873978|NCT00837590|19379200|P3|NOT COMPLETED|Overall Study||1
7873979|NCT00837590|19379201|P2|NOT COMPLETED|Overall Study||1
7873980|NCT00837590|19379202|P1|NOT COMPLETED|Overall Study||0
7873981|NCT00837590|19379200|P3|COMPLETED|Overall Study||4
7873982|NCT00837590|19379201|P2|COMPLETED|Overall Study||4
7873983|NCT00837590|19379202|P1|COMPLETED|Overall Study||6
7873984|NCT00837590|19379200|P3|STARTED|Overall Study||5
7873985|NCT00837590|19379201|P2|STARTED|Overall Study||5
7873986|NCT00837590|19379202|P1|STARTED|Overall Study||6
7873987|NCT00837577|19379212|P2|NOT COMPLETED|Open-label Period||9
7873988|NCT00837577|19379213|P1|NOT COMPLETED|Open-label Period||8
7873989|NCT00837577|19379212|P2|COMPLETED|Open-label Period||54
7873990|NCT00837577|19379213|P1|COMPLETED|Open-label Period||60
7873991|NCT00837577|19379212|P2|STARTED|Open-label Period||63
7873992|NCT00837577|19379213|P1|STARTED|Open-label Period||68
7873993|NCT00837577|19379212|P2|NOT COMPLETED|Double-blind Period||0
7873994|NCT00837577|19379213|P1|NOT COMPLETED|Double-blind Period||2
7873995|NCT00837577|19379212|P2|COMPLETED|Double-blind Period||63
7873996|NCT00837577|19379213|P1|COMPLETED|Double-blind Period||68
7873997|NCT00837577|19379212|P2|STARTED|Double-blind Period||63
7873998|NCT00837577|19379213|P1|STARTED|Double-blind Period||70
7873999|NCT00837512|19379224|P2|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
7874000|NCT00837512|19379225|P1|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
7874001|NCT00837512|19379224|P2|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
7874002|NCT00837512|19379225|P1|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
7874003|NCT00837512|19379224|P2|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
7874004|NCT00837512|19379225|P1|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
7874005|NCT00837512|19379224|P2|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
7874006|NCT00837512|19379225|P1|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
7874007|NCT00837512|19379224|P2|COMPLETED|Both Arms: Washout (7-28 Days)||8
7874008|NCT00837512|19379225|P1|COMPLETED|Both Arms: Washout (7-28 Days)||8
7874009|NCT00837512|19379224|P2|STARTED|Both Arms: Washout (7-28 Days)||8
7874010|NCT00837512|19379225|P1|STARTED|Both Arms: Washout (7-28 Days)||8
7874011|NCT00837512|19379224|P2|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
7874012|NCT00837512|19379225|P1|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
7874013|NCT00837512|19379224|P2|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
7874014|NCT00837512|19379225|P1|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
7874015|NCT00837512|19379224|P2|STARTED|First Intervention (6hrs) - RANDOMIZED||8
7874016|NCT00837512|19379225|P1|STARTED|First Intervention (6hrs) - RANDOMIZED||8
7874017|NCT00837486|19379233|P2|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0
7874018|NCT00837486|19379234|P1|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5
7874019|NCT00837486|19379233|P2|COMPLETED|Long-term Follow-up Phase - Open Label||0
7874020|NCT00837486|19379234|P1|COMPLETED|Long-term Follow-up Phase - Open Label||24
7874021|NCT00837486|19379233|P2|STARTED|Long-term Follow-up Phase - Open Label||0
7874022|NCT00837486|19379234|P1|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29
7874023|NCT00837486|19379233|P2|NOT COMPLETED|Blinded-treatment Phase||0
7874024|NCT00837486|19379234|P1|NOT COMPLETED|Blinded-treatment Phase||1
7874025|NCT00837486|19379233|P2|COMPLETED|Blinded-treatment Phase||14
7874026|NCT00837486|19379234|P1|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15
7874027|NCT00837486|19379233|P2|STARTED|Blinded-treatment Phase||14
7874028|NCT00837486|19379234|P1|STARTED|Blinded-treatment Phase||16
7874029|NCT00837473|19379246|P1|NOT COMPLETED|Overall Study||3
7874030|NCT00837473|19379246|P1|COMPLETED|Overall Study||12
7874031|NCT00837473|19379246|P1|STARTED|Overall Study||15
7874032|NCT00837447|19379259|P1|NOT COMPLETED|Overall Study||0
7874033|NCT00837447|19379259|P1|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
7874034|NCT00837447|19379259|P1|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
7874035|NCT00837434|19379266|P2|NOT COMPLETED|Overall Study||1
7874036|NCT00837434|19379267|P1|NOT COMPLETED|Overall Study||9
7874037|NCT00837434|19379266|P2|COMPLETED|Overall Study||19
7874038|NCT00837434|19379267|P1|COMPLETED|Overall Study||34
7874039|NCT00837434|19379266|P2|STARTED|Overall Study||20
7874040|NCT00837434|19379267|P1|STARTED|Overall Study||43
7874041|NCT00837330|19379287|P2|NOT COMPLETED|Overall Study||3
7874042|NCT00837330|19379288|P1|NOT COMPLETED|Overall Study||1
7874043|NCT00837330|19379287|P2|COMPLETED|Overall Study||7
7874044|NCT00837330|19379288|P1|COMPLETED|Overall Study||9
7874045|NCT00837330|19379287|P2|STARTED|Overall Study||10
7874046|NCT00837330|19379288|P1|STARTED|Overall Study||10
7874047|NCT00837252|19379294|P1|NOT COMPLETED|Overall Study||0
7874048|NCT00837252|19379294|P1|COMPLETED|Overall Study||5
7874049|NCT00837252|19379294|P1|STARTED|Overall Study||5
7874050|NCT00837213|19379311|P2|NOT COMPLETED|Overall Study||5
7874051|NCT00837213|19379312|P1|NOT COMPLETED|Overall Study||6
7874052|NCT00837213|19379311|P2|COMPLETED|Overall Study||12
7874053|NCT00837213|19379312|P1|COMPLETED|Overall Study||10
7874054|NCT00837213|19379311|P2|STARTED|Overall Study||17
7874055|NCT00837213|19379312|P1|STARTED|Overall Study||16
7874056|NCT00837200|19379332|P1|NOT COMPLETED|Overall Study||0
7874057|NCT00837200|19379332|P1|COMPLETED|Overall Study||13
7874058|NCT00837200|19379332|P1|STARTED|Overall Study||13
7874059|NCT00837161|19379338|P1|NOT COMPLETED|Overall Study||2
7874060|NCT00837161|19379338|P1|COMPLETED|Overall Study||9
7874061|NCT00837161|19379338|P1|STARTED|Overall Study||11
7874062|NCT00837148|19379346|P1|NOT COMPLETED|Overall Study||2
7874063|NCT00837148|19379346|P1|COMPLETED|Overall Study||35
7874064|NCT00837148|19379346|P1|STARTED|Overall Study||37
7874065|NCT00837096|19379352|P2|NOT COMPLETED|Overall Study||9
7874066|NCT00837096|19379353|P1|NOT COMPLETED|Overall Study||10
7874067|NCT00837096|19379352|P2|COMPLETED|Overall Study||0
7874068|NCT00837096|19379353|P1|COMPLETED|Overall Study||0
7874069|NCT00837096|19379352|P2|STARTED|Overall Study||9
7874070|NCT00837096|19379353|P1|STARTED|Overall Study||10
7874071|NCT00837031|19379359|P1|NOT COMPLETED|Overall Study||0
7874072|NCT00837031|19379359|P1|COMPLETED|Overall Study||72
7874073|NCT00837031|19379359|P1|STARTED|Overall Study||72
7874074|NCT00836953|19379365|P1|NOT COMPLETED|Overall Study||2
7874075|NCT00836953|19379365|P1|COMPLETED|Overall Study||31
7874076|NCT00836953|19379365|P1|STARTED|Overall Study||33
7874077|NCT00836927|19379376|P5|NOT COMPLETED|Overall Study||1
7874078|NCT00836927|19379377|P4|NOT COMPLETED|Overall Study||1
7874079|NCT00836927|19379378|P3|NOT COMPLETED|Overall Study||0
7874080|NCT00836927|19379379|P2|NOT COMPLETED|Overall Study||0
7874081|NCT00836927|19379380|P1|NOT COMPLETED|Overall Study||3
7874082|NCT00836927|19379376|P5|COMPLETED|Overall Study||0
7874083|NCT00836927|19379377|P4|COMPLETED|Overall Study||0
7874084|NCT00836927|19379378|P3|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
7874085|NCT00836927|19379379|P2|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
7874086|NCT00836927|19379380|P1|COMPLETED|Overall Study||0
7874087|NCT00836927|19379376|P5|Completed Dosing Through 03 Apr 2017|Overall Study||0
7874088|NCT00836927|19379377|P4|Completed Dosing Through 03 Apr 2017|Overall Study||0
7874089|NCT00836927|19379378|P3|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
7874090|NCT00836927|19379379|P2|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
7874091|NCT00836927|19379380|P1|Completed Dosing Through 03 Apr 2017|Overall Study||0
7874092|NCT00836927|19379376|P5|STARTED|Overall Study||1
7874093|NCT00836927|19379377|P4|STARTED|Overall Study||1
7874094|NCT00836927|19379378|P3|STARTED|Overall Study|One participant received ridaforolimus 3 mg IV infusion before being switched to the oral tablet.|1
7874095|NCT00836927|19379379|P2|STARTED|Overall Study||1
7874096|NCT00836927|19379380|P1|STARTED|Overall Study||3
7874097|NCT00836901|19379416|P2|NOT COMPLETED|Second Intervention||0
7874098|NCT00836901|19379417|P1|NOT COMPLETED|Second Intervention||0
7874099|NCT00836901|19379416|P2|COMPLETED|Second Intervention||28
7874100|NCT00836901|19379417|P1|COMPLETED|Second Intervention||23
7874101|NCT00836901|19379416|P2|STARTED|Second Intervention||28
7874102|NCT00836901|19379417|P1|STARTED|Second Intervention||23
7874103|NCT00836901|19379416|P2|NOT COMPLETED|First Intervention||0
7874104|NCT00836901|19379417|P1|NOT COMPLETED|First Intervention||1
7874105|NCT00836901|19379416|P2|COMPLETED|First Intervention||28
7874106|NCT00836901|19379417|P1|COMPLETED|First Intervention||23
7874107|NCT00836901|19379416|P2|STARTED|First Intervention||28
7874108|NCT00836901|19379417|P1|STARTED|First Intervention||24
7874109|NCT00836888|19379435|P4|NOT COMPLETED|Overall Study||3
7874110|NCT00836888|19379436|P3|NOT COMPLETED|Overall Study||6
7874111|NCT00836888|19379437|P2|NOT COMPLETED|Overall Study||3
7874112|NCT00836888|19379438|P1|NOT COMPLETED|Overall Study||3
7874113|NCT00836888|19379435|P4|COMPLETED|Overall Study||0
7874114|NCT00836888|19379436|P3|COMPLETED|Overall Study||0
7874115|NCT00836888|19379437|P2|COMPLETED|Overall Study||2
7874116|NCT00836888|19379438|P1|COMPLETED|Overall Study||0
7874117|NCT00836888|19379435|P4|STARTED|Overall Study||3
7874118|NCT00836888|19379436|P3|STARTED|Overall Study||6
7874119|NCT00836888|19379437|P2|STARTED|Overall Study||5
7874120|NCT00836888|19379438|P1|STARTED|Overall Study||3
7874121|NCT00836875|19379466|P2|NOT COMPLETED|Overall Study||3
7874122|NCT00836875|19379467|P1|NOT COMPLETED|Overall Study||3
7874123|NCT00836875|19379466|P2|COMPLETED|Overall Study||17
7874124|NCT00836875|19379467|P1|COMPLETED|Overall Study||8
7874125|NCT00836875|19379466|P2|STARTED|Overall Study||20
7874126|NCT00836875|19379467|P1|STARTED|Overall Study||11
7874127|NCT00836810|19379483|P2|NOT COMPLETED|Overall Study||0
7874128|NCT00836810|19379484|P1|NOT COMPLETED|Overall Study||1
7874129|NCT00836810|19379483|P2|COMPLETED|Overall Study||6
7874130|NCT00836810|19379484|P1|COMPLETED|Overall Study|1 patient was subsequently diagnosed with SLE and, per protocol, was not included.|4
7874131|NCT00836810|19379483|P2|STARTED|Overall Study||6
7874132|NCT00836810|19379484|P1|STARTED|Overall Study||5
7874133|NCT00836758|19379500|P1|NOT COMPLETED|Overall Study||0
7874134|NCT00836758|19379500|P1|COMPLETED|Overall Study||115
7874135|NCT00836758|19379500|P1|STARTED|Overall Study||115
7874136|NCT00836745|19379506|P1|NOT COMPLETED|Overall Study||21
7874137|NCT00836745|19379506|P1|COMPLETED|Overall Study||15
7874138|NCT00836745|19379506|P1|STARTED|Overall Study||36
7874139|NCT00836719|19379513|P1|NOT COMPLETED|Overall Study||0
7874140|NCT00836719|19379513|P1|COMPLETED|Overall Study||10
7874141|NCT00836719|19379513|P1|STARTED|Overall Study||10
7874142|NCT00836706|19379520|P2|NOT COMPLETED|Second Intervention||0
7874143|NCT00836706|19379521|P1|NOT COMPLETED|Second Intervention||0
7874144|NCT00836706|19379520|P2|COMPLETED|Second Intervention||11
7874145|NCT00836706|19379521|P1|COMPLETED|Second Intervention||11
7874146|NCT00836706|19379520|P2|STARTED|Second Intervention||11
7874147|NCT00836706|19379521|P1|STARTED|Second Intervention||11
7874148|NCT00836706|19379520|P2|NOT COMPLETED|Washout: 7 Days||1
7874149|NCT00836706|19379521|P1|NOT COMPLETED|Washout: 7 Days||0
7874150|NCT00836706|19379520|P2|COMPLETED|Washout: 7 Days||11
7874151|NCT00836706|19379521|P1|COMPLETED|Washout: 7 Days||11
7874152|NCT00836706|19379520|P2|STARTED|Washout: 7 Days||12
7874153|NCT00836706|19379521|P1|STARTED|Washout: 7 Days||11
7874154|NCT00836706|19379520|P2|NOT COMPLETED|First Intervention||0
7874155|NCT00836706|19379521|P1|NOT COMPLETED|First Intervention||0
7874156|NCT00836706|19379520|P2|COMPLETED|First Intervention||12
7874157|NCT00836706|19379521|P1|COMPLETED|First Intervention||11
7874158|NCT00836706|19379520|P2|STARTED|First Intervention||12
7874159|NCT00836706|19379521|P1|STARTED|First Intervention||11
7874160|NCT00836693|19379531|P2|NOT COMPLETED|Overall Study||6
7874161|NCT00836693|19379532|P1|NOT COMPLETED|Overall Study||17
7874162|NCT00836693|19379531|P2|COMPLETED|Overall Study||64
7874163|NCT00836693|19379532|P1|COMPLETED|Overall Study||130
7874164|NCT00836693|19379531|P2|STARTED|Overall Study||70
7874165|NCT00836693|19379532|P1|STARTED|Overall Study||147
7874166|NCT00836641|19379574|P2|NOT COMPLETED|Overall Study||0
7874167|NCT00836641|19379575|P1|NOT COMPLETED|Overall Study||0
7874168|NCT00836641|19379574|P2|COMPLETED|Overall Study||34
7874169|NCT00836641|19379575|P1|COMPLETED|Overall Study||36
7874170|NCT00836641|19379574|P2|STARTED|Overall Study||34
7874171|NCT00836641|19379575|P1|STARTED|Overall Study||36
7874172|NCT00836589|19379582|P1|NOT COMPLETED|Overall Study||1266
7874173|NCT00836589|19379582|P1|COMPLETED|Overall Study||731
7874174|NCT00836589|19379582|P1|STARTED|Overall Study||1997
7874175|NCT00836498|19379615|P2|NOT COMPLETED|Overall Study||1
7874176|NCT00836498|19379616|P1|NOT COMPLETED|Overall Study||4
7874177|NCT00836498|19379615|P2|COMPLETED|Overall Study||21
7874178|NCT00836498|19379616|P1|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40
7874179|NCT00836498|19379615|P2|STARTED|Overall Study||22
7874180|NCT00836498|19379616|P1|STARTED|Overall Study||44
7874181|NCT00836472|19379648|P2|NOT COMPLETED|Second Intervention||0
7874182|NCT00836472|19379649|P1|NOT COMPLETED|Second Intervention||0
7874183|NCT00836472|19379648|P2|COMPLETED|Second Intervention||27
7874184|NCT00836472|19379649|P1|COMPLETED|Second Intervention||28
7874185|NCT00836472|19379648|P2|STARTED|Second Intervention||27
7874186|NCT00836472|19379649|P1|STARTED|Second Intervention||28
7874187|NCT00836472|19379648|P2|NOT COMPLETED|Washout||3
7874188|NCT00836472|19379649|P1|NOT COMPLETED|Washout||2
7874189|NCT00836472|19379648|P2|COMPLETED|Washout||27
7874190|NCT00836472|19379649|P1|COMPLETED|Washout||28
7874191|NCT00836472|19379648|P2|STARTED|Washout||30
7874192|NCT00836472|19379649|P1|STARTED|Washout||30
7874193|NCT00836472|19379648|P2|NOT COMPLETED|First Intervention||0
7874194|NCT00836472|19379649|P1|NOT COMPLETED|First Intervention||0
7874195|NCT00836472|19379648|P2|COMPLETED|First Intervention||30
7874196|NCT00836472|19379649|P1|COMPLETED|First Intervention||30
7874197|NCT00836472|19379648|P2|STARTED|First Intervention||30
7874198|NCT00836472|19379649|P1|STARTED|First Intervention||30
7874199|NCT00836433|19379665|P2|NOT COMPLETED|Overall Study||7
7874200|NCT00836433|19379666|P1|NOT COMPLETED|Overall Study||12
7874201|NCT00836433|19379665|P2|COMPLETED|Overall Study||321
7874202|NCT00836433|19379666|P1|COMPLETED|Overall Study||349
7874203|NCT00836433|19379665|P2|STARTED|Overall Study||328
7874204|NCT00836433|19379666|P1|STARTED|Overall Study||361
7874205|NCT00836407|19379676|P2|NOT COMPLETED|Overall Study||8
7874206|NCT00836407|19379677|P1|NOT COMPLETED|Overall Study||11
7874207|NCT00836407|19379676|P2|COMPLETED|Overall Study||7
7874208|NCT00836407|19379677|P1|COMPLETED|Overall Study||4
7874209|NCT00836407|19379676|P2|STARTED|Overall Study||15
7874210|NCT00836407|19379677|P1|STARTED|Overall Study||15
7874211|NCT00836355|19379689|P4|NOT COMPLETED|Overall Study||0
7874212|NCT00836355|19379690|P3|NOT COMPLETED|Overall Study||0
7874213|NCT00836355|19379691|P2|NOT COMPLETED|Overall Study||0
7874214|NCT00836355|19379692|P1|NOT COMPLETED|Overall Study||0
7874215|NCT00836355|19379689|P4|COMPLETED|Overall Study||2
7874216|NCT00836355|19379690|P3|COMPLETED|Overall Study||0
7874217|NCT00836355|19379691|P2|COMPLETED|Overall Study||4
7874218|NCT00836355|19379692|P1|COMPLETED|Overall Study||0
7874219|NCT00836355|19379689|P4|STARTED|Overall Study||2
7874220|NCT00836355|19379690|P3|STARTED|Overall Study||0
7874221|NCT00836355|19379691|P2|STARTED|Overall Study||4
7874222|NCT00836355|19379692|P1|STARTED|Overall Study||0
7874223|NCT00836342|19379713|P3|NOT COMPLETED|Overall Study||0
7874224|NCT00836342|19379714|P2|NOT COMPLETED|Overall Study||0
7874225|NCT00836342|19379715|P1|NOT COMPLETED|Overall Study||0
7874226|NCT00836342|19379713|P3|COMPLETED|Overall Study||36
7874227|NCT00836342|19379714|P2|COMPLETED|Overall Study||23
7874228|NCT00836342|19379715|P1|COMPLETED|Overall Study||22
7874229|NCT00836342|19379713|P3|STARTED|Overall Study||36
7874230|NCT00836342|19379714|P2|STARTED|Overall Study||23
7874231|NCT00836342|19379715|P1|STARTED|Overall Study||22
7874232|NCT00836277|19379726|P1|NOT COMPLETED|Overall Study||6
7874233|NCT00836277|19379726|P1|COMPLETED|Overall Study||18
7874234|NCT00836277|19379726|P1|STARTED|Overall Study||24
7874235|NCT00836186|19379734|P1|NOT COMPLETED|Overall Study||1
7874236|NCT00836186|19379734|P1|COMPLETED|Overall Study||81
7874237|NCT00836186|19379734|P1|STARTED|Overall Study||82
7874238|NCT00836095|19379742|P2|NOT COMPLETED|Overall Study||3
7874239|NCT00836095|19379743|P1|NOT COMPLETED|Overall Study||0
7874240|NCT00836095|19379742|P2|COMPLETED|Overall Study||27
7874241|NCT00836095|19379743|P1|COMPLETED|Overall Study||22
7874242|NCT00836095|19379742|P2|STARTED|Overall Study||30
7874243|NCT00836095|19379743|P1|STARTED|Overall Study||22
7874244|NCT00836056|19379753|P2|NOT COMPLETED|Second Intervention||0
7874245|NCT00836056|19379754|P1|NOT COMPLETED|Second Intervention||0
7874246|NCT00836056|19379753|P2|COMPLETED|Second Intervention||12
7874247|NCT00836056|19379754|P1|COMPLETED|Second Intervention||11
7874248|NCT00836056|19379753|P2|STARTED|Second Intervention||12
7874249|NCT00836056|19379754|P1|STARTED|Second Intervention||11
7874250|NCT00836056|19379753|P2|NOT COMPLETED|Washout: 7 Days||0
7874251|NCT00836056|19379754|P1|NOT COMPLETED|Washout: 7 Days||0
7874252|NCT00836056|19379753|P2|COMPLETED|Washout: 7 Days||12
7874253|NCT00836056|19379754|P1|COMPLETED|Washout: 7 Days||11
7874254|NCT00836056|19379753|P2|STARTED|Washout: 7 Days||12
7874255|NCT00836056|19379754|P1|STARTED|Washout: 7 Days||11
7874256|NCT00836056|19379753|P2|NOT COMPLETED|First Intervention||0
7874257|NCT00836056|19379754|P1|NOT COMPLETED|First Intervention||1
7874258|NCT00836056|19379753|P2|COMPLETED|First Intervention||12
7874259|NCT00836056|19379754|P1|COMPLETED|First Intervention||11
7874260|NCT00836056|19379753|P2|STARTED|First Intervention||12
7874261|NCT00836056|19379754|P1|STARTED|First Intervention||12
7874262|NCT00836017|19379762|P1|NOT COMPLETED|Overall Study||544
7874263|NCT00836017|19379762|P1|COMPLETED|Overall Study||502
7874264|NCT00836017|19379762|P1|STARTED|Overall Study||1046
7874265|NCT00836004|19379772|P2|NOT COMPLETED|Second Intervention||0
7874266|NCT00836004|19379773|P1|NOT COMPLETED|Second Intervention||0
7874267|NCT00836004|19379772|P2|COMPLETED|Second Intervention||12
7874268|NCT00836004|19379773|P1|COMPLETED|Second Intervention||12
7874269|NCT00836004|19379772|P2|STARTED|Second Intervention||12
7874270|NCT00836004|19379773|P1|STARTED|Second Intervention||12
7874271|NCT00836004|19379772|P2|NOT COMPLETED|Washout: 7 Days||0
7874272|NCT00836004|19379773|P1|NOT COMPLETED|Washout: 7 Days||0
7874273|NCT00836004|19379772|P2|COMPLETED|Washout: 7 Days||12
7874274|NCT00836004|19379773|P1|COMPLETED|Washout: 7 Days||12
7874275|NCT00836004|19379772|P2|STARTED|Washout: 7 Days||12
7874276|NCT00836004|19379773|P1|STARTED|Washout: 7 Days||12
7874277|NCT00836004|19379772|P2|NOT COMPLETED|First Intervention||0
7874278|NCT00836004|19379773|P1|NOT COMPLETED|First Intervention||0
7874279|NCT00836004|19379772|P2|COMPLETED|First Intervention||12
7874280|NCT00836004|19379773|P1|COMPLETED|First Intervention||12
7874281|NCT00836004|19379772|P2|STARTED|First Intervention||12
7874282|NCT00836004|19379773|P1|STARTED|First Intervention||12
7874283|NCT00835991|19379783|P2|NOT COMPLETED|Second Intervention||0
7874284|NCT00835991|19379784|P1|NOT COMPLETED|Second Intervention||0
7874285|NCT00835991|19379783|P2|COMPLETED|Second Intervention||26
7874286|NCT00835991|19379784|P1|COMPLETED|Second Intervention||27
7874287|NCT00835991|19379783|P2|STARTED|Second Intervention||26
7874288|NCT00835991|19379784|P1|STARTED|Second Intervention||27
7874289|NCT00835991|19379783|P2|NOT COMPLETED|Washout||3
7874290|NCT00835991|19379784|P1|NOT COMPLETED|Washout||3
7874291|NCT00835991|19379783|P2|COMPLETED|Washout||26
7874292|NCT00835991|19379784|P1|COMPLETED|Washout||27
7874293|NCT00835991|19379783|P2|STARTED|Washout||29
7874294|NCT00835991|19379784|P1|STARTED|Washout||30
7874295|NCT00835991|19379783|P2|NOT COMPLETED|First Intervention||1
7874296|NCT00835991|19379784|P1|NOT COMPLETED|First Intervention||0
7874297|NCT00835991|19379783|P2|COMPLETED|First Intervention||29
7874298|NCT00835991|19379784|P1|COMPLETED|First Intervention||30
7874299|NCT00835991|19379783|P2|STARTED|First Intervention||30
7874300|NCT00835991|19379784|P1|STARTED|First Intervention||30
7874301|NCT00835978|19379802|P4|NOT COMPLETED|Overall Study||10
7874302|NCT00835978|19379803|P3|NOT COMPLETED|Overall Study||91
7874303|NCT00835978|19379804|P2|NOT COMPLETED|Overall Study||56
7874304|NCT00835978|19379805|P1|NOT COMPLETED|Overall Study||56
7874305|NCT00835978|19379802|P4|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
7874306|NCT00835978|19379803|P3|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
7874307|NCT00835978|19379804|P2|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
7874308|NCT00835978|19379805|P1|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
7874309|NCT00835978|19379802|P4|Treated|Overall Study||10
7874310|NCT00835978|19379803|P3|Treated|Overall Study||91
7874311|NCT00835978|19379804|P2|Treated|Overall Study||56
7874312|NCT00835978|19379805|P1|Treated|Overall Study||56
7874313|NCT00835978|19379802|P4|STARTED|Overall Study||10
7874314|NCT00835978|19379803|P3|STARTED|Overall Study||91
7874315|NCT00835978|19379804|P2|STARTED|Overall Study||56
7874316|NCT00835978|19379805|P1|STARTED|Overall Study||56
7874317|NCT00835926|19379865|P2|NOT COMPLETED|Overall Study||0
7874318|NCT00835926|19379866|P1|NOT COMPLETED|Overall Study||0
7874319|NCT00835926|19379865|P2|COMPLETED|Overall Study||60
7874320|NCT00835926|19379866|P1|COMPLETED|Overall Study||61
7874321|NCT00835926|19379865|P2|STARTED|Overall Study||60
7874322|NCT00835926|19379866|P1|STARTED|Overall Study||61
7874323|NCT00835900|19379880|P2|NOT COMPLETED|Overall Study||6
7874324|NCT00835900|19379881|P1|NOT COMPLETED|Overall Study||5
7874325|NCT00835900|19379880|P2|COMPLETED|Overall Study||22
7874326|NCT00835900|19379881|P1|COMPLETED|Overall Study||27
7874327|NCT00835900|19379880|P2|STARTED|Overall Study||28
7874328|NCT00835900|19379881|P1|STARTED|Overall Study||32
7874329|NCT00835861|19379891|P2|NOT COMPLETED|Overall Study||2
7874330|NCT00835861|19379892|P1|NOT COMPLETED|Overall Study||1
7874331|NCT00835861|19379891|P2|COMPLETED|Overall Study||14
7874332|NCT00835861|19379892|P1|COMPLETED|Overall Study||14
7874333|NCT00835861|19379891|P2|STARTED|Overall Study||16
7874334|NCT00835861|19379892|P1|STARTED|Overall Study||15
7874335|NCT00835796|19379916|P2|NOT COMPLETED|Second Intervention||0
7874336|NCT00835796|19379917|P1|NOT COMPLETED|Second Intervention||0
7874337|NCT00835796|19379916|P2|COMPLETED|Second Intervention||9
7874338|NCT00835796|19379917|P1|COMPLETED|Second Intervention||10
7874339|NCT00835796|19379916|P2|STARTED|Second Intervention||9
7874340|NCT00835796|19379917|P1|STARTED|Second Intervention||10
7874341|NCT00835796|19379916|P2|NOT COMPLETED|Washout||0
7874342|NCT00835796|19379917|P1|NOT COMPLETED|Washout||0
7874343|NCT00835796|19379916|P2|COMPLETED|Washout||9
7874344|NCT00835796|19379917|P1|COMPLETED|Washout||10
7874345|NCT00835796|19379916|P2|STARTED|Washout||9
7874346|NCT00835796|19379917|P1|STARTED|Washout||10
7874347|NCT00835796|19379916|P2|NOT COMPLETED|First Intervention||1
7874348|NCT00835796|19379917|P1|NOT COMPLETED|First Intervention||0
7874349|NCT00835796|19379916|P2|COMPLETED|First Intervention||9
7874350|NCT00835796|19379917|P1|COMPLETED|First Intervention||10
7874351|NCT00835796|19379916|P2|STARTED|First Intervention||10
7874352|NCT00835796|19379917|P1|STARTED|First Intervention||10
7874353|NCT00835770|19379927|P2|NOT COMPLETED|Overall Study||493
7874354|NCT00835770|19379928|P1|NOT COMPLETED|Overall Study||484
7874355|NCT00835770|19379927|P2|COMPLETED|Overall Study||375
7874356|NCT00835770|19379928|P1|COMPLETED|Overall Study||384
7874357|NCT00835770|19379927|P2|STARTED|Overall Study||868
7874358|NCT00835770|19379928|P1|STARTED|Overall Study||868
7874359|NCT00835731|19380026|P2|NOT COMPLETED|Overall Study||1
7874360|NCT00835731|19380027|P1|NOT COMPLETED|Overall Study||2
7874361|NCT00835731|19380026|P2|COMPLETED|Overall Study||60
7874362|NCT00835731|19380027|P1|COMPLETED|Overall Study||62
7874363|NCT00835731|19380026|P2|STARTED|Overall Study||61
7874364|NCT00835731|19380027|P1|STARTED|Overall Study||64
7874365|NCT00835705|19380047|P2|NOT COMPLETED|Second Intervention||0
7874366|NCT00835705|19380048|P1|NOT COMPLETED|Second Intervention||1
7874367|NCT00835705|19380047|P2|COMPLETED|Second Intervention||28
7874368|NCT00835705|19380048|P1|COMPLETED|Second Intervention||22
7874369|NCT00835705|19380047|P2|STARTED|Second Intervention||28
7874370|NCT00835705|19380048|P1|STARTED|Second Intervention||23
7874371|NCT00835705|19380047|P2|NOT COMPLETED|First Intervention||0
7874372|NCT00835705|19380048|P1|NOT COMPLETED|First Intervention||1
7874373|NCT00835705|19380047|P2|COMPLETED|First Intervention||28
7874374|NCT00835705|19380048|P1|COMPLETED|First Intervention||23
7874375|NCT00835705|19380047|P2|STARTED|First Intervention||28
7874376|NCT00835705|19380048|P1|STARTED|First Intervention||24
7874377|NCT00835692|19380064|P2|NOT COMPLETED|Second Intervention||0
7874378|NCT00835692|19380065|P1|NOT COMPLETED|Second Intervention||0
7874379|NCT00835692|19380064|P2|COMPLETED|Second Intervention||28
7874380|NCT00835692|19380065|P1|COMPLETED|Second Intervention||27
7874381|NCT00835692|19380064|P2|STARTED|Second Intervention||28
7874382|NCT00835692|19380065|P1|STARTED|Second Intervention||27
7874383|NCT00835692|19380064|P2|NOT COMPLETED|Washout||0
7874384|NCT00835692|19380065|P1|NOT COMPLETED|Washout||0
7874385|NCT00835692|19380064|P2|COMPLETED|Washout||28
7874386|NCT00835692|19380065|P1|COMPLETED|Washout||27
7874387|NCT00835692|19380064|P2|STARTED|Washout||28
7874388|NCT00835692|19380065|P1|STARTED|Washout||27
7874389|NCT00835692|19380064|P2|NOT COMPLETED|First Intervention||0
7874390|NCT00835692|19380065|P1|NOT COMPLETED|First Intervention||1
7874391|NCT00835692|19380064|P2|COMPLETED|First Intervention||28
7874392|NCT00835692|19380065|P1|COMPLETED|First Intervention||27
7874393|NCT00835692|19380064|P2|STARTED|First Intervention||28
7874394|NCT00835692|19380065|P1|STARTED|First Intervention||28
7874395|NCT00835679|19380077|P4|NOT COMPLETED|Overall Study||0
7874396|NCT00835679|19380078|P3|NOT COMPLETED|Overall Study||0
7874397|NCT00835679|19380079|P2|NOT COMPLETED|Overall Study||0
7874398|NCT00835679|19380080|P1|NOT COMPLETED|Overall Study||1
7874399|NCT00835679|19380077|P4|COMPLETED|Overall Study||0
7874400|NCT00835679|19380078|P3|COMPLETED|Overall Study||0
7874401|NCT00835679|19380079|P2|COMPLETED|Overall Study||0
7874402|NCT00835679|19380080|P1|COMPLETED|Overall Study||8
7874403|NCT00835679|19380077|P4|STARTED|Overall Study||0
7874404|NCT00835679|19380078|P3|STARTED|Overall Study||0
7874405|NCT00835679|19380079|P2|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0
7874406|NCT00835679|19380080|P1|STARTED|Overall Study||9
7874407|NCT00835666|19380104|P2|NOT COMPLETED|Second Intervention||0
7874408|NCT00835666|19380105|P1|NOT COMPLETED|Second Intervention||0
7874409|NCT00835666|19380104|P2|COMPLETED|Second Intervention||16
7874410|NCT00835666|19380105|P1|COMPLETED|Second Intervention||14
7874411|NCT00835666|19380104|P2|STARTED|Second Intervention||16
7874412|NCT00835666|19380105|P1|STARTED|Second Intervention||14
7874413|NCT00835666|19380104|P2|NOT COMPLETED|Washout||0
7874414|NCT00835666|19380105|P1|NOT COMPLETED|Washout||2
7874415|NCT00835666|19380104|P2|COMPLETED|Washout||16
7874416|NCT00835666|19380105|P1|COMPLETED|Washout||14
7874417|NCT00835666|19380104|P2|STARTED|Washout||16
7874418|NCT00835666|19380105|P1|STARTED|Washout||16
7874419|NCT00835666|19380104|P2|NOT COMPLETED|First Intervention||0
7874420|NCT00835666|19380105|P1|NOT COMPLETED|First Intervention||0
7874421|NCT00835666|19380104|P2|COMPLETED|First Intervention||16
7874422|NCT00835666|19380105|P1|COMPLETED|First Intervention||16
7874423|NCT00835666|19380104|P2|STARTED|First Intervention||16
7874424|NCT00835666|19380105|P1|STARTED|First Intervention||16
7874425|NCT00835640|19380115|P2|NOT COMPLETED|Second Intervention||0
7874426|NCT00835640|19380116|P1|NOT COMPLETED|Second Intervention||1
7874427|NCT00835640|19380115|P2|COMPLETED|Second Intervention||12
7874428|NCT00835640|19380116|P1|COMPLETED|Second Intervention||11
7874429|NCT00835640|19380115|P2|STARTED|Second Intervention||12
7874430|NCT00835640|19380116|P1|STARTED|Second Intervention||12
7874431|NCT00835640|19380115|P2|NOT COMPLETED|Washout of 7 Days||0
7874432|NCT00835640|19380116|P1|NOT COMPLETED|Washout of 7 Days||0
7874433|NCT00835640|19380115|P2|COMPLETED|Washout of 7 Days||12
7874434|NCT00835640|19380116|P1|COMPLETED|Washout of 7 Days||12
7874435|NCT00835640|19380115|P2|STARTED|Washout of 7 Days||12
7874436|NCT00835640|19380116|P1|STARTED|Washout of 7 Days||12
7874437|NCT00835640|19380115|P2|NOT COMPLETED|First Intervention||0
7874438|NCT00835640|19380116|P1|NOT COMPLETED|First Intervention||0
7874439|NCT00835640|19380115|P2|COMPLETED|First Intervention||12
7874440|NCT00835640|19380116|P1|COMPLETED|First Intervention||12
7874441|NCT00835640|19380115|P2|STARTED|First Intervention||12
7874442|NCT00835640|19380116|P1|STARTED|First Intervention||12
7874443|NCT00835614|19380126|P2|NOT COMPLETED|Second Intervention||0
7874444|NCT00835614|19380127|P1|NOT COMPLETED|Second Intervention||0
7874445|NCT00835614|19380126|P2|COMPLETED|Second Intervention||13
7874446|NCT00835614|19380127|P1|COMPLETED|Second Intervention||13
7874447|NCT00835614|19380126|P2|STARTED|Second Intervention||13
7874448|NCT00835614|19380127|P1|STARTED|Second Intervention||13
7874449|NCT00835614|19380126|P2|NOT COMPLETED|Washout of 7 Days||0
7874450|NCT00835614|19380127|P1|NOT COMPLETED|Washout of 7 Days||0
7874451|NCT00835614|19380126|P2|COMPLETED|Washout of 7 Days||13
7874452|NCT00835614|19380127|P1|COMPLETED|Washout of 7 Days||13
7874453|NCT00835614|19380126|P2|STARTED|Washout of 7 Days||13
7874454|NCT00835614|19380127|P1|STARTED|Washout of 7 Days||13
7874455|NCT00835614|19380126|P2|NOT COMPLETED|First Intervention||0
7874456|NCT00835614|19380127|P1|NOT COMPLETED|First Intervention||0
7874457|NCT00835614|19380126|P2|COMPLETED|First Intervention||13
7874458|NCT00835614|19380127|P1|COMPLETED|First Intervention||13
7874459|NCT00835614|19380126|P2|STARTED|First Intervention||13
7874460|NCT00835614|19380127|P1|STARTED|First Intervention||13
7874461|NCT00835588|19380137|P2|NOT COMPLETED|Second Intervention||0
7874462|NCT00835588|19380138|P1|NOT COMPLETED|Second Intervention||0
7874463|NCT00835588|19380137|P2|COMPLETED|Second Intervention||50
7874464|NCT00835588|19380138|P1|COMPLETED|Second Intervention||50
7874465|NCT00835588|19380137|P2|STARTED|Second Intervention||50
7874466|NCT00835588|19380138|P1|STARTED|Second Intervention||50
7874467|NCT00835588|19380137|P2|NOT COMPLETED|Washout: 5 Days||0
7874468|NCT00835588|19380138|P1|NOT COMPLETED|Washout: 5 Days||0
7874469|NCT00835588|19380137|P2|COMPLETED|Washout: 5 Days||50
7874470|NCT00835588|19380138|P1|COMPLETED|Washout: 5 Days||50
7874471|NCT00835588|19380137|P2|STARTED|Washout: 5 Days||50
7874472|NCT00835588|19380138|P1|STARTED|Washout: 5 Days||50
7874473|NCT00835588|19380137|P2|NOT COMPLETED|First Intervention||0
7874474|NCT00835588|19380138|P1|NOT COMPLETED|First Intervention||0
7874475|NCT00835588|19380137|P2|COMPLETED|First Intervention||50
7874476|NCT00835588|19380138|P1|COMPLETED|First Intervention||50
7874477|NCT00835588|19380137|P2|STARTED|First Intervention||50
7874478|NCT00835588|19380138|P1|STARTED|First Intervention||50
7874479|NCT00835575|19380148|P2|NOT COMPLETED|Second Intervention||0
7874480|NCT00835575|19380149|P1|NOT COMPLETED|Second Intervention||0
7874481|NCT00835575|19380148|P2|COMPLETED|Second Intervention||16
7874482|NCT00835575|19380149|P1|COMPLETED|Second Intervention||15
7874483|NCT00835575|19380148|P2|STARTED|Second Intervention||16
7874484|NCT00835575|19380149|P1|STARTED|Second Intervention||15
7874485|NCT00835575|19380148|P2|NOT COMPLETED|Washout of 14 Days||0
7874486|NCT00835575|19380149|P1|NOT COMPLETED|Washout of 14 Days||1
7874487|NCT00835575|19380148|P2|COMPLETED|Washout of 14 Days||16
7874488|NCT00835575|19380149|P1|COMPLETED|Washout of 14 Days||15
7874489|NCT00835575|19380148|P2|STARTED|Washout of 14 Days||16
7874490|NCT00835575|19380149|P1|STARTED|Washout of 14 Days||16
7874491|NCT00835575|19380148|P2|NOT COMPLETED|First Intervention||0
7874492|NCT00835575|19380149|P1|NOT COMPLETED|First Intervention||0
7874493|NCT00835575|19380148|P2|COMPLETED|First Intervention||16
7874494|NCT00835575|19380149|P1|COMPLETED|First Intervention||16
7874495|NCT00835575|19380148|P2|STARTED|First Intervention||16
7874496|NCT00835575|19380149|P1|STARTED|First Intervention||16
7874497|NCT00835549|19380159|P2|NOT COMPLETED|Second Intervention||0
7874498|NCT00835549|19380160|P1|NOT COMPLETED|Second Intervention||0
7874499|NCT00835549|19380159|P2|COMPLETED|Second Intervention||16
7874500|NCT00835549|19380160|P1|COMPLETED|Second Intervention||14
7874501|NCT00835549|19380159|P2|STARTED|Second Intervention||16
7874502|NCT00835549|19380160|P1|STARTED|Second Intervention||14
7874503|NCT00835549|19380159|P2|NOT COMPLETED|Washout of 7 Days||0
7874504|NCT00835549|19380160|P1|NOT COMPLETED|Washout of 7 Days||2
7874505|NCT00835549|19380159|P2|COMPLETED|Washout of 7 Days||16
7874506|NCT00835549|19380160|P1|COMPLETED|Washout of 7 Days||14
7874507|NCT00835549|19380159|P2|STARTED|Washout of 7 Days||16
7874508|NCT00835549|19380160|P1|STARTED|Washout of 7 Days||16
7874509|NCT00835549|19380159|P2|NOT COMPLETED|First Intervention||0
7874510|NCT00835549|19380160|P1|NOT COMPLETED|First Intervention||0
7874511|NCT00835549|19380159|P2|COMPLETED|First Intervention||16
7874512|NCT00835549|19380160|P1|COMPLETED|First Intervention||16
7874513|NCT00835549|19380159|P2|STARTED|First Intervention||16
7874514|NCT00835549|19380160|P1|STARTED|First Intervention||16
7874515|NCT00835536|19380170|P2|NOT COMPLETED|Second Intervention||0
7874516|NCT00835536|19380171|P1|NOT COMPLETED|Second Intervention||0
7874517|NCT00835536|19380170|P2|COMPLETED|Second Intervention||14
7874518|NCT00835536|19380171|P1|COMPLETED|Second Intervention||12
7874519|NCT00835536|19380170|P2|STARTED|Second Intervention||14
7874520|NCT00835536|19380171|P1|STARTED|Second Intervention||12
7874521|NCT00835536|19380170|P2|NOT COMPLETED|Washout of 5 Weeks||0
7874522|NCT00835536|19380171|P1|NOT COMPLETED|Washout of 5 Weeks||1
7874523|NCT00835536|19380170|P2|COMPLETED|Washout of 5 Weeks||14
7874524|NCT00835536|19380171|P1|COMPLETED|Washout of 5 Weeks||12
7874525|NCT00835536|19380170|P2|STARTED|Washout of 5 Weeks||14
7874526|NCT00835536|19380171|P1|STARTED|Washout of 5 Weeks||13
7874527|NCT00835536|19380170|P2|NOT COMPLETED|First Intervention||0
7874528|NCT00835536|19380171|P1|NOT COMPLETED|First Intervention||0
7874529|NCT00835536|19380170|P2|COMPLETED|First Intervention||14
7874530|NCT00835536|19380171|P1|COMPLETED|First Intervention||13
7874531|NCT00835536|19380170|P2|STARTED|First Intervention||14
7874532|NCT00835536|19380171|P1|STARTED|First Intervention||13
7874533|NCT00835510|19380180|P3|NOT COMPLETED|Overall Study||38
7874534|NCT00835510|19380181|P2|NOT COMPLETED|Overall Study||69
7874535|NCT00835510|19380182|P1|NOT COMPLETED|Overall Study||76
7874536|NCT00835510|19380180|P3|COMPLETED|Overall Study||70
7874537|NCT00835510|19380181|P2|COMPLETED|Overall Study||152
7874538|NCT00835510|19380182|P1|COMPLETED|Overall Study||143
7874539|NCT00835510|19380180|P3|Positive Fungal Culture|Overall Study||71
7874540|NCT00835510|19380181|P2|Positive Fungal Culture|Overall Study||155
7874541|NCT00835510|19380182|P1|Positive Fungal Culture|Overall Study||149
7874542|NCT00835510|19380180|P3|STARTED|Overall Study||108
7874543|NCT00835510|19380181|P2|STARTED|Overall Study||221
7874544|NCT00835510|19380182|P1|STARTED|Overall Study||219
7874545|NCT00835497|19380204|P2|NOT COMPLETED|Second Intervention||0
7874546|NCT00835497|19380205|P1|NOT COMPLETED|Second Intervention||0
7874547|NCT00835497|19380204|P2|COMPLETED|Second Intervention||20
7874548|NCT00835497|19380205|P1|COMPLETED|Second Intervention||20
7874549|NCT00835497|19380204|P2|STARTED|Second Intervention||20
7874550|NCT00835497|19380205|P1|STARTED|Second Intervention||20
7874551|NCT00835497|19380204|P2|NOT COMPLETED|Washout: 7 Days||0
7874552|NCT00835497|19380205|P1|NOT COMPLETED|Washout: 7 Days||0
7874553|NCT00835497|19380204|P2|COMPLETED|Washout: 7 Days||20
7874554|NCT00835497|19380205|P1|COMPLETED|Washout: 7 Days||20
7874555|NCT00835497|19380204|P2|STARTED|Washout: 7 Days||20
7874556|NCT00835497|19380205|P1|STARTED|Washout: 7 Days||20
7874557|NCT00835497|19380204|P2|NOT COMPLETED|First Intervention||0
7874558|NCT00835497|19380205|P1|NOT COMPLETED|First Intervention||0
7874559|NCT00835497|19380204|P2|COMPLETED|First Intervention||20
7874560|NCT00835497|19380205|P1|COMPLETED|First Intervention||20
7874561|NCT00835497|19380204|P2|STARTED|First Intervention||20
7874562|NCT00835497|19380205|P1|STARTED|First Intervention||20
7874563|NCT00835484|19380221|P2|NOT COMPLETED|Second Intervention||0
7874564|NCT00835484|19380222|P1|NOT COMPLETED|Second Intervention||0
7874565|NCT00835484|19380221|P2|COMPLETED|Second Intervention||16
7874566|NCT00835484|19380222|P1|COMPLETED|Second Intervention||16
7874567|NCT00835484|19380221|P2|STARTED|Second Intervention||16
7874568|NCT00835484|19380222|P1|STARTED|Second Intervention||16
7874569|NCT00835484|19380221|P2|NOT COMPLETED|Washout of 7 Days||0
7874570|NCT00835484|19380222|P1|NOT COMPLETED|Washout of 7 Days||0
7874571|NCT00835484|19380221|P2|COMPLETED|Washout of 7 Days||16
7874572|NCT00835484|19380222|P1|COMPLETED|Washout of 7 Days||16
7874573|NCT00835484|19380221|P2|STARTED|Washout of 7 Days||16
7874574|NCT00835484|19380222|P1|STARTED|Washout of 7 Days||16
7874575|NCT00835484|19380221|P2|NOT COMPLETED|First Intervention||0
7874576|NCT00835484|19380222|P1|NOT COMPLETED|First Intervention||0
7874577|NCT00835484|19380221|P2|COMPLETED|First Intervention||16
7874578|NCT00835484|19380222|P1|COMPLETED|First Intervention||16
7874579|NCT00835484|19380221|P2|STARTED|First Intervention||16
7874580|NCT00835484|19380222|P1|STARTED|First Intervention||16
7874581|NCT00835406|19380232|P2|NOT COMPLETED|Period: Second Intervention||0
7874582|NCT00835406|19380233|P1|NOT COMPLETED|Period: Second Intervention||0
7874583|NCT00835406|19380232|P2|COMPLETED|Period: Second Intervention||67
7874584|NCT00835406|19380233|P1|COMPLETED|Period: Second Intervention||68
7874585|NCT00835406|19380232|P2|STARTED|Period: Second Intervention||67
7874586|NCT00835406|19380233|P1|STARTED|Period: Second Intervention||68
7874587|NCT00835406|19380232|P2|NOT COMPLETED|Period: Washout of 7 Days||2
7874588|NCT00835406|19380233|P1|NOT COMPLETED|Period: Washout of 7 Days||0
7874589|NCT00835406|19380232|P2|COMPLETED|Period: Washout of 7 Days||67
7874590|NCT00835406|19380233|P1|COMPLETED|Period: Washout of 7 Days||68
7874591|NCT00835406|19380232|P2|STARTED|Period: Washout of 7 Days||69
7874592|NCT00835406|19380233|P1|STARTED|Period: Washout of 7 Days||68
7874593|NCT00835406|19380232|P2|NOT COMPLETED|Period: First Intervention||1
7874594|NCT00835406|19380233|P1|NOT COMPLETED|Period: First Intervention||2
7874595|NCT00835406|19380232|P2|COMPLETED|Period: First Intervention||69
7874596|NCT00835406|19380233|P1|COMPLETED|Period: First Intervention||68
7874597|NCT00835406|19380232|P2|STARTED|Period: First Intervention||70
7874598|NCT00835406|19380233|P1|STARTED|Period: First Intervention||70
7874599|NCT00835380|19380239|P1|NOT COMPLETED|Overall Study||2
7874600|NCT00835380|19380239|P1|COMPLETED|Overall Study||78
7874601|NCT00835380|19380239|P1|STARTED|Overall Study||80
7874602|NCT00835367|19380246|P2|NOT COMPLETED|Second Intervention||1
7874603|NCT00835367|19380247|P1|NOT COMPLETED|Second Intervention||1
7874604|NCT00835367|19380246|P2|COMPLETED|Second Intervention||33
7874605|NCT00835367|19380247|P1|COMPLETED|Second Intervention||30
7874606|NCT00835367|19380246|P2|STARTED|Second Intervention||34
7874607|NCT00835367|19380247|P1|STARTED|Second Intervention||31
7874608|NCT00835367|19380246|P2|NOT COMPLETED|Washout||0
7874609|NCT00835367|19380247|P1|NOT COMPLETED|Washout||3
7874610|NCT00835367|19380246|P2|COMPLETED|Washout||34
7874611|NCT00835367|19380247|P1|COMPLETED|Washout||31
7874612|NCT00835367|19380246|P2|STARTED|Washout||34
7874613|NCT00835367|19380247|P1|STARTED|Washout||34
7874614|NCT00835367|19380246|P2|NOT COMPLETED|First Intervention||0
7874615|NCT00835367|19380247|P1|NOT COMPLETED|First Intervention||0
7874616|NCT00835367|19380246|P2|COMPLETED|First Intervention||34
7874617|NCT00835367|19380247|P1|COMPLETED|First Intervention||34
7874618|NCT00835367|19380246|P2|STARTED|First Intervention||34
7874619|NCT00835367|19380247|P1|STARTED|First Intervention||34
7874620|NCT00835354|19380269|P2|NOT COMPLETED|Second Intervention||0
7874621|NCT00835354|19380270|P1|NOT COMPLETED|Second Intervention||0
7874622|NCT00835354|19380269|P2|COMPLETED|Second Intervention||12
7874623|NCT00835354|19380270|P1|COMPLETED|Second Intervention||13
7874624|NCT00835354|19380269|P2|STARTED|Second Intervention||12
7874625|NCT00835354|19380270|P1|STARTED|Second Intervention||13
7874626|NCT00835354|19380269|P2|NOT COMPLETED|Washout of 7 Days||0
7874627|NCT00835354|19380270|P1|NOT COMPLETED|Washout of 7 Days||0
7874628|NCT00835354|19380269|P2|COMPLETED|Washout of 7 Days||12
7874629|NCT00835354|19380270|P1|COMPLETED|Washout of 7 Days||13
7874630|NCT00835354|19380269|P2|STARTED|Washout of 7 Days||12
7874631|NCT00835354|19380270|P1|STARTED|Washout of 7 Days||13
7874632|NCT00835354|19380269|P2|NOT COMPLETED|First Intervention||1
7874633|NCT00835354|19380270|P1|NOT COMPLETED|First Intervention||0
7874634|NCT00835354|19380269|P2|COMPLETED|First Intervention||12
7874635|NCT00835354|19380270|P1|COMPLETED|First Intervention||13
7874636|NCT00835354|19380269|P2|STARTED|First Intervention||13
7874637|NCT00835354|19380270|P1|STARTED|First Intervention||13
7874638|NCT00835341|19380280|P2|NOT COMPLETED|Overall Study||12
7874639|NCT00835341|19380281|P1|NOT COMPLETED|Overall Study||3
7874640|NCT00835341|19380280|P2|COMPLETED|Overall Study||46
7874641|NCT00835341|19380281|P1|COMPLETED|Overall Study||32
7874642|NCT00835341|19380280|P2|STARTED|Overall Study||58
7874643|NCT00835341|19380281|P1|STARTED|Overall Study||35
7874644|NCT00835328|19380291|P4|NOT COMPLETED|Cohort 4: Dose Level 4||0
7874645|NCT00835328|19380292|P3|NOT COMPLETED|Cohort 4: Dose Level 4||0
7874646|NCT00835328|19380293|P2|NOT COMPLETED|Cohort 4: Dose Level 4||0
7874647|NCT00835328|19380294|P1|NOT COMPLETED|Cohort 4: Dose Level 4||0
7874648|NCT00835328|19380291|P4|COMPLETED|Cohort 4: Dose Level 4||4
7874649|NCT00835328|19380292|P3|COMPLETED|Cohort 4: Dose Level 4||0
7874650|NCT00835328|19380293|P2|COMPLETED|Cohort 4: Dose Level 4||0
7874651|NCT00835328|19380294|P1|COMPLETED|Cohort 4: Dose Level 4||0
7874652|NCT00835328|19380291|P4|STARTED|Cohort 4: Dose Level 4||4
7874653|NCT00835328|19380292|P3|STARTED|Cohort 4: Dose Level 4||0
7874654|NCT00835328|19380293|P2|STARTED|Cohort 4: Dose Level 4||0
7874655|NCT00835328|19380294|P1|STARTED|Cohort 4: Dose Level 4|Cohort#4 enrolled 4 subsequent subjects|0
7874656|NCT00835328|19380291|P4|NOT COMPLETED|Cohort 3: Dose Level 3||0
7874657|NCT00835328|19380292|P3|NOT COMPLETED|Cohort 3: Dose Level 3||0
7874658|NCT00835328|19380293|P2|NOT COMPLETED|Cohort 3: Dose Level 3||0
7874659|NCT00835328|19380294|P1|NOT COMPLETED|Cohort 3: Dose Level 3||0
7874660|NCT00835328|19380291|P4|COMPLETED|Cohort 3: Dose Level 3||0
7874661|NCT00835328|19380292|P3|COMPLETED|Cohort 3: Dose Level 3||2
7874662|NCT00835328|19380293|P2|COMPLETED|Cohort 3: Dose Level 3||0
7874663|NCT00835328|19380294|P1|COMPLETED|Cohort 3: Dose Level 3||0
7874664|NCT00835328|19380291|P4|STARTED|Cohort 3: Dose Level 3||0
7874665|NCT00835328|19380292|P3|STARTED|Cohort 3: Dose Level 3||2
7874666|NCT00835328|19380293|P2|STARTED|Cohort 3: Dose Level 3||0
7874667|NCT00835328|19380294|P1|STARTED|Cohort 3: Dose Level 3||0
7874668|NCT00835328|19380291|P4|NOT COMPLETED|Cohort 2: Dose Level 2||0
7874669|NCT00835328|19380292|P3|NOT COMPLETED|Cohort 2: Dose Level 2||0
7874670|NCT00835328|19380293|P2|NOT COMPLETED|Cohort 2: Dose Level 2||0
7874671|NCT00835328|19380294|P1|NOT COMPLETED|Cohort 2: Dose Level 2||0
7874672|NCT00835328|19380291|P4|COMPLETED|Cohort 2: Dose Level 2||0
7874673|NCT00835328|19380292|P3|COMPLETED|Cohort 2: Dose Level 2||0
7874674|NCT00835328|19380293|P2|COMPLETED|Cohort 2: Dose Level 2||2
7874675|NCT00835328|19380294|P1|COMPLETED|Cohort 2: Dose Level 2||0
7874676|NCT00835328|19380291|P4|STARTED|Cohort 2: Dose Level 2||0
7874677|NCT00835328|19380292|P3|STARTED|Cohort 2: Dose Level 2||0
7874678|NCT00835328|19380293|P2|STARTED|Cohort 2: Dose Level 2||2
7874679|NCT00835328|19380294|P1|STARTED|Cohort 2: Dose Level 2||0
7874680|NCT00835328|19380291|P4|NOT COMPLETED|Cohort 1: Dose Level 1||0
7874681|NCT00835328|19380292|P3|NOT COMPLETED|Cohort 1: Dose Level 1||0
7874682|NCT00835328|19380293|P2|NOT COMPLETED|Cohort 1: Dose Level 1||0
7874683|NCT00835328|19380294|P1|NOT COMPLETED|Cohort 1: Dose Level 1||0
7874684|NCT00835328|19380291|P4|COMPLETED|Cohort 1: Dose Level 1||0
7874685|NCT00835328|19380292|P3|COMPLETED|Cohort 1: Dose Level 1||0
7874686|NCT00835328|19380293|P2|COMPLETED|Cohort 1: Dose Level 1||0
7874687|NCT00835328|19380294|P1|COMPLETED|Cohort 1: Dose Level 1||5
7874688|NCT00835328|19380291|P4|STARTED|Cohort 1: Dose Level 1||0
7874689|NCT00835328|19380292|P3|STARTED|Cohort 1: Dose Level 1||0
7874690|NCT00835328|19380293|P2|STARTED|Cohort 1: Dose Level 1||0
7874691|NCT00835328|19380294|P1|STARTED|Cohort 1: Dose Level 1||5
7874692|NCT00835276|19380333|P2|NOT COMPLETED|Second Intervention||0
7874693|NCT00835276|19380334|P1|NOT COMPLETED|Second Intervention||0
7874694|NCT00835276|19380333|P2|COMPLETED|Second Intervention||24
7874695|NCT00835276|19380334|P1|COMPLETED|Second Intervention||24
7874696|NCT00835276|19380333|P2|STARTED|Second Intervention||24
7874697|NCT00835276|19380334|P1|STARTED|Second Intervention||24
7874698|NCT00835276|19380333|P2|NOT COMPLETED|Washout of 7 Days||0
7874699|NCT00835276|19380334|P1|NOT COMPLETED|Washout of 7 Days||0
7874700|NCT00835276|19380333|P2|COMPLETED|Washout of 7 Days||24
7874701|NCT00835276|19380334|P1|COMPLETED|Washout of 7 Days||24
7874702|NCT00835276|19380333|P2|STARTED|Washout of 7 Days||24
7874703|NCT00835276|19380334|P1|STARTED|Washout of 7 Days||24
7874704|NCT00835276|19380333|P2|NOT COMPLETED|First Intervention||0
7874705|NCT00835276|19380334|P1|NOT COMPLETED|First Intervention||0
7874706|NCT00835276|19380333|P2|COMPLETED|First Intervention||24
7874707|NCT00835276|19380334|P1|COMPLETED|First Intervention||24
7874708|NCT00835276|19380333|P2|STARTED|First Intervention||24
7874709|NCT00835276|19380334|P1|STARTED|First Intervention||24
7874710|NCT00835263|19380344|P2|NOT COMPLETED|Second Intervention||0
7874711|NCT00835263|19380345|P1|NOT COMPLETED|Second Intervention||1
7874712|NCT00835263|19380344|P2|COMPLETED|Second Intervention||16
7874713|NCT00835263|19380345|P1|COMPLETED|Second Intervention||15
7874714|NCT00835263|19380344|P2|STARTED|Second Intervention||16
7874715|NCT00835263|19380345|P1|STARTED|Second Intervention||16
7874716|NCT00835263|19380344|P2|NOT COMPLETED|First Intervention||0
7874717|NCT00835263|19380345|P1|NOT COMPLETED|First Intervention||0
7874718|NCT00835263|19380344|P2|COMPLETED|First Intervention||16
7874719|NCT00835263|19380345|P1|COMPLETED|First Intervention||16
7874720|NCT00835263|19380344|P2|STARTED|First Intervention||16
7874721|NCT00835263|19380345|P1|STARTED|First Intervention||16
7874722|NCT00835237|19380355|P2|NOT COMPLETED|Overall Study||0
7874723|NCT00835237|19380356|P1|NOT COMPLETED|Overall Study||6
7874724|NCT00835237|19380355|P2|COMPLETED|Overall Study||445
7874725|NCT00835237|19380356|P1|COMPLETED|Overall Study||881
7874726|NCT00835237|19380355|P2|STARTED|Overall Study||445
7874727|NCT00835237|19380356|P1|STARTED|Overall Study||887
7874728|NCT00835224|19380380|P1|NOT COMPLETED|Overall Study||10
7874729|NCT00835224|19380380|P1|COMPLETED|Overall Study||24
7874730|NCT00835224|19380380|P1|STARTED|Overall Study||34
7874731|NCT00835211|19380396|P2|NOT COMPLETED|Second Intervention||0
7874732|NCT00835211|19380397|P1|NOT COMPLETED|Second Intervention||0
7874733|NCT00835211|19380396|P2|COMPLETED|Second Intervention||22
7874734|NCT00835211|19380397|P1|COMPLETED|Second Intervention||21
7874735|NCT00835211|19380396|P2|STARTED|Second Intervention||22
7874736|NCT00835211|19380397|P1|STARTED|Second Intervention||21
7874737|NCT00835211|19380396|P2|NOT COMPLETED|Washout: 7 Days||1
7874738|NCT00835211|19380397|P1|NOT COMPLETED|Washout: 7 Days||3
7874739|NCT00835211|19380396|P2|COMPLETED|Washout: 7 Days||22
7874740|NCT00835211|19380397|P1|COMPLETED|Washout: 7 Days||21
7874741|NCT00835211|19380396|P2|STARTED|Washout: 7 Days||23
7874742|NCT00835211|19380397|P1|STARTED|Washout: 7 Days||24
7874743|NCT00835211|19380396|P2|NOT COMPLETED|First Intervention||1
7874744|NCT00835211|19380397|P1|NOT COMPLETED|First Intervention||0
7874745|NCT00835211|19380396|P2|COMPLETED|First Intervention||23
7874746|NCT00835211|19380397|P1|COMPLETED|First Intervention||24
7874747|NCT00835211|19380396|P2|STARTED|First Intervention||24
7874748|NCT00835211|19380397|P1|STARTED|First Intervention||24
7874749|NCT00835198|19380407|P2|NOT COMPLETED|Overall Study||7
7874750|NCT00835198|19380408|P1|NOT COMPLETED|Overall Study||8
7874751|NCT00835198|19380407|P2|COMPLETED|Overall Study||74
7874752|NCT00835198|19380408|P1|COMPLETED|Overall Study||74
7874753|NCT00835198|19380407|P2|STARTED|Overall Study||81
7874754|NCT00835198|19380408|P1|STARTED|Overall Study||82
7874755|NCT00835185|19380420|P1|NOT COMPLETED|Overall Study||0
7874756|NCT00835185|19380420|P1|COMPLETED|Overall Study||44
7874757|NCT00835185|19380420|P1|Received at Least 1 Dose of Study Drug|Overall Study||44
7874758|NCT00835185|19380420|P1|STARTED|Overall Study||44
7874759|NCT00835172|19380443|P2|NOT COMPLETED|Second Intervention||0
7874760|NCT00835172|19380444|P1|NOT COMPLETED|Second Intervention||0
7874761|NCT00835172|19380443|P2|COMPLETED|Second Intervention||15
7874762|NCT00835172|19380444|P1|COMPLETED|Second Intervention||16
7874763|NCT00835172|19380443|P2|STARTED|Second Intervention||15
7874764|NCT00835172|19380444|P1|STARTED|Second Intervention||16
7874765|NCT00835172|19380443|P2|NOT COMPLETED|Washout||1
7874766|NCT00835172|19380444|P1|NOT COMPLETED|Washout||0
7874767|NCT00835172|19380443|P2|COMPLETED|Washout||15
7874768|NCT00835172|19380444|P1|COMPLETED|Washout||16
7874769|NCT00835172|19380443|P2|STARTED|Washout||16
7874770|NCT00835172|19380444|P1|STARTED|Washout||16
7874771|NCT00835172|19380443|P2|NOT COMPLETED|First Intervention||0
7874772|NCT00835172|19380444|P1|NOT COMPLETED|First Intervention||0
7874773|NCT00835172|19380443|P2|COMPLETED|First Intervention||16
7874774|NCT00835172|19380444|P1|COMPLETED|First Intervention||16
7874775|NCT00835172|19380443|P2|STARTED|First Intervention||16
7874776|NCT00835172|19380444|P1|STARTED|First Intervention||16
7874777|NCT00835159|19380454|P2|NOT COMPLETED|Overall Study||0
7874778|NCT00835159|19380455|P1|NOT COMPLETED|Overall Study||0
7874779|NCT00835159|19380454|P2|COMPLETED|Overall Study||17
7874780|NCT00835159|19380455|P1|COMPLETED|Overall Study||11
7874781|NCT00835159|19380454|P2|STARTED|Overall Study||17
7874782|NCT00835159|19380455|P1|STARTED|Overall Study||11
7874783|NCT00835146|19380463|P2|NOT COMPLETED|Second Intervention||0
7874784|NCT00835146|19380464|P1|NOT COMPLETED|Second Intervention||0
7874785|NCT00835146|19380463|P2|COMPLETED|Second Intervention||14
7874786|NCT00835146|19380464|P1|COMPLETED|Second Intervention||14
7874787|NCT00835146|19380463|P2|STARTED|Second Intervention||14
7874788|NCT00835146|19380464|P1|STARTED|Second Intervention||14
7874789|NCT00835146|19380463|P2|NOT COMPLETED|Washout of 5 Weeks||0
7874790|NCT00835146|19380464|P1|NOT COMPLETED|Washout of 5 Weeks||0
7874791|NCT00835146|19380463|P2|COMPLETED|Washout of 5 Weeks||14
7874792|NCT00835146|19380464|P1|COMPLETED|Washout of 5 Weeks||14
7874793|NCT00835146|19380463|P2|STARTED|Washout of 5 Weeks||14
7874794|NCT00835146|19380464|P1|STARTED|Washout of 5 Weeks||14
7874795|NCT00835146|19380463|P2|NOT COMPLETED|First Intervention||0
7874796|NCT00835146|19380464|P1|NOT COMPLETED|First Intervention||0
7874797|NCT00835146|19380463|P2|COMPLETED|First Intervention||14
7874798|NCT00835146|19380464|P1|COMPLETED|First Intervention||14
7874799|NCT00835146|19380463|P2|STARTED|First Intervention||14
7874800|NCT00835146|19380464|P1|STARTED|First Intervention||14
7874801|NCT00835120|19380470|P1|NOT COMPLETED|Overall Study||8
7874802|NCT00835120|19380470|P1|COMPLETED|Overall Study||26
7874803|NCT00835120|19380470|P1|STARTED|Overall Study||34
7874804|NCT00835081|19380480|P2|NOT COMPLETED|Second Intervention||0
7874805|NCT00835081|19380481|P1|NOT COMPLETED|Second Intervention||0
7874806|NCT00835081|19380480|P2|COMPLETED|Second Intervention||13
7874807|NCT00835081|19380481|P1|COMPLETED|Second Intervention||12
7874808|NCT00835081|19380480|P2|STARTED|Second Intervention||13
7874809|NCT00835081|19380481|P1|STARTED|Second Intervention||12
7874810|NCT00835081|19380480|P2|NOT COMPLETED|Washout of 7 Days||0
7874811|NCT00835081|19380481|P1|NOT COMPLETED|Washout of 7 Days||1
7874812|NCT00835081|19380480|P2|COMPLETED|Washout of 7 Days||13
7874813|NCT00835081|19380481|P1|COMPLETED|Washout of 7 Days||12
7874814|NCT00835081|19380480|P2|STARTED|Washout of 7 Days||13
7874815|NCT00835081|19380481|P1|STARTED|Washout of 7 Days||13
7874816|NCT00835081|19380480|P2|NOT COMPLETED|First Intervention||0
7874817|NCT00835081|19380481|P1|NOT COMPLETED|First Intervention||0
7874818|NCT00835081|19380480|P2|COMPLETED|First Intervention||13
7874819|NCT00835081|19380481|P1|COMPLETED|First Intervention||13
7874820|NCT00835081|19380480|P2|STARTED|First Intervention||13
7874821|NCT00835081|19380481|P1|STARTED|First Intervention||13
7874822|NCT00835068|19380491|P2|NOT COMPLETED|Overall Study||1
7874823|NCT00835068|19380492|P1|NOT COMPLETED|Overall Study||10
7874824|NCT00835068|19380491|P2|COMPLETED|Overall Study||0
7874825|NCT00835068|19380492|P1|COMPLETED|Overall Study||47
7874826|NCT00835068|19380491|P2|STARTED|Overall Study||1
7874827|NCT00835068|19380492|P1|STARTED|Overall Study||57
7874828|NCT00835042|19380512|P2|NOT COMPLETED|Second Intervention||0
7874829|NCT00835042|19380513|P1|NOT COMPLETED|Second Intervention||0
7874830|NCT00835042|19380512|P2|COMPLETED|Second Intervention||24
7874831|NCT00835042|19380513|P1|COMPLETED|Second Intervention||26
7874832|NCT00835042|19380512|P2|STARTED|Second Intervention||24
7874833|NCT00835042|19380513|P1|STARTED|Second Intervention||26
7874834|NCT00835042|19380512|P2|NOT COMPLETED|Washout of 21 Days||2
7874835|NCT00835042|19380513|P1|NOT COMPLETED|Washout of 21 Days||0
7874836|NCT00835042|19380512|P2|COMPLETED|Washout of 21 Days||24
7874837|NCT00835042|19380513|P1|COMPLETED|Washout of 21 Days||26
7874838|NCT00835042|19380512|P2|STARTED|Washout of 21 Days||26
7874839|NCT00835042|19380513|P1|STARTED|Washout of 21 Days||26
7874840|NCT00835042|19380512|P2|NOT COMPLETED|First Intervention||2
7874841|NCT00835042|19380513|P1|NOT COMPLETED|First Intervention||4
7874842|NCT00835042|19380512|P2|COMPLETED|First Intervention||26
7874843|NCT00835042|19380513|P1|COMPLETED|First Intervention||26
7874844|NCT00835042|19380512|P2|STARTED|First Intervention||28
7874845|NCT00835042|19380513|P1|STARTED|First Intervention||30
7874846|NCT00835003|19380535|P2|NOT COMPLETED|Overall Study||0
7874847|NCT00835003|19380536|P1|NOT COMPLETED|Overall Study||0
7874848|NCT00835003|19380535|P2|COMPLETED|Overall Study||638
7874849|NCT00835003|19380536|P1|COMPLETED|Overall Study||636
7874850|NCT00835003|19380535|P2|STARTED|Overall Study||638
7874851|NCT00835003|19380536|P1|STARTED|Overall Study||636
7874852|NCT00834990|19380544|P2|NOT COMPLETED|Second Intervention||0
7874853|NCT00834990|19380545|P1|NOT COMPLETED|Second Intervention||0
7874854|NCT00834990|19380544|P2|COMPLETED|Second Intervention||11
7874855|NCT00834990|19380545|P1|COMPLETED|Second Intervention||12
7874856|NCT00834990|19380544|P2|STARTED|Second Intervention||11
7874857|NCT00834990|19380545|P1|STARTED|Second Intervention||12
7874858|NCT00834990|19380544|P2|NOT COMPLETED|Washout of 7 Days||0
7874859|NCT00834990|19380545|P1|NOT COMPLETED|Washout of 7 Days||0
7874860|NCT00834990|19380544|P2|COMPLETED|Washout of 7 Days||11
7874861|NCT00834990|19380545|P1|COMPLETED|Washout of 7 Days||12
7874862|NCT00834990|19380544|P2|STARTED|Washout of 7 Days||11
7874863|NCT00834990|19380545|P1|STARTED|Washout of 7 Days||12
7874864|NCT00834990|19380544|P2|NOT COMPLETED|First Intervention||0
7874865|NCT00834990|19380545|P1|NOT COMPLETED|First Intervention||0
7874866|NCT00834990|19380544|P2|COMPLETED|First Intervention||11
7874867|NCT00834990|19380545|P1|COMPLETED|First Intervention||12
7874868|NCT00834990|19380544|P2|STARTED|First Intervention||11
7874869|NCT00834990|19380545|P1|STARTED|First Intervention||12
7874870|NCT00834977|19380555|P2|NOT COMPLETED|Second Intervention||0
7874871|NCT00834977|19380556|P1|NOT COMPLETED|Second Intervention||0
7874872|NCT00834977|19380555|P2|COMPLETED|Second Intervention||24
7874873|NCT00834977|19380556|P1|COMPLETED|Second Intervention||24
7874874|NCT00834977|19380555|P2|STARTED|Second Intervention||24
7874875|NCT00834977|19380556|P1|STARTED|Second Intervention||24
7874876|NCT00834977|19380555|P2|NOT COMPLETED|First Intervention||0
7874877|NCT00834977|19380556|P1|NOT COMPLETED|First Intervention||0
7874878|NCT00834977|19380555|P2|COMPLETED|First Intervention||24
7874879|NCT00834977|19380556|P1|COMPLETED|First Intervention||24
7874880|NCT00834977|19380555|P2|STARTED|First Intervention||24
7874881|NCT00834977|19380556|P1|STARTED|First Intervention||24
7874882|NCT00834964|19380578|P2|NOT COMPLETED|Second Intervention||0
7874883|NCT00834964|19380579|P1|NOT COMPLETED|Second Intervention||0
7874884|NCT00834964|19380578|P2|COMPLETED|Second Intervention||15
7874885|NCT00834964|19380579|P1|COMPLETED|Second Intervention||15
7874886|NCT00834964|19380578|P2|STARTED|Second Intervention||15
7874887|NCT00834964|19380579|P1|STARTED|Second Intervention||15
7874888|NCT00834964|19380578|P2|NOT COMPLETED|Washout: 7 Days||0
7874889|NCT00834964|19380579|P1|NOT COMPLETED|Washout: 7 Days||0
7874890|NCT00834964|19380578|P2|COMPLETED|Washout: 7 Days||15
7874891|NCT00834964|19380579|P1|COMPLETED|Washout: 7 Days||15
7874892|NCT00834964|19380578|P2|STARTED|Washout: 7 Days||15
7874893|NCT00834964|19380579|P1|STARTED|Washout: 7 Days||15
7874894|NCT00834964|19380578|P2|NOT COMPLETED|First Intervention||0
7874895|NCT00834964|19380579|P1|NOT COMPLETED|First Intervention||0
7874896|NCT00834964|19380578|P2|COMPLETED|First Intervention||15
7874897|NCT00834964|19380579|P1|COMPLETED|First Intervention||15
7874898|NCT00834964|19380578|P2|STARTED|First Intervention||15
7874899|NCT00834964|19380579|P1|STARTED|First Intervention||15
7874900|NCT00834912|19380599|P6|NOT COMPLETED|Treatment Period 3||0
7874901|NCT00834912|19380600|P5|NOT COMPLETED|Treatment Period 3||0
7874902|NCT00834912|19380601|P4|NOT COMPLETED|Treatment Period 3||0
7874903|NCT00834912|19380602|P3|NOT COMPLETED|Treatment Period 3||0
7874904|NCT00834912|19380603|P2|NOT COMPLETED|Treatment Period 3||0
7874905|NCT00834912|19380604|P1|NOT COMPLETED|Treatment Period 3||0
7874906|NCT00834912|19380599|P6|COMPLETED|Treatment Period 3||6
7874907|NCT00834912|19380600|P5|COMPLETED|Treatment Period 3||5
7874908|NCT00834912|19380601|P4|COMPLETED|Treatment Period 3||5
7874909|NCT00834912|19380602|P3|COMPLETED|Treatment Period 3||5
7874910|NCT00834912|19380603|P2|COMPLETED|Treatment Period 3||5
7874911|NCT00834912|19380604|P1|COMPLETED|Treatment Period 3||6
7874912|NCT00834912|19380599|P6|STARTED|Treatment Period 3||6
7874913|NCT00834912|19380600|P5|STARTED|Treatment Period 3||5
7874914|NCT00834912|19380601|P4|STARTED|Treatment Period 3||5
7874915|NCT00834912|19380602|P3|STARTED|Treatment Period 3||5
7874916|NCT00834912|19380603|P2|STARTED|Treatment Period 3||5
7874917|NCT00834912|19380604|P1|STARTED|Treatment Period 3||6
7874918|NCT00834912|19380599|P6|NOT COMPLETED|Treatment Period 2||0
7874919|NCT00834912|19380600|P5|NOT COMPLETED|Treatment Period 2||1
7874920|NCT00834912|19380601|P4|NOT COMPLETED|Treatment Period 2||0
7874921|NCT00834912|19380602|P3|NOT COMPLETED|Treatment Period 2||1
7874922|NCT00834912|19380603|P2|NOT COMPLETED|Treatment Period 2||0
7874923|NCT00834912|19380604|P1|NOT COMPLETED|Treatment Period 2||0
7874924|NCT00834912|19380599|P6|COMPLETED|Treatment Period 2||6
7874925|NCT00834912|19380600|P5|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
7874926|NCT00834912|19380601|P4|COMPLETED|Treatment Period 2||5
7874927|NCT00834912|19380602|P3|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
7874928|NCT00834912|19380603|P2|COMPLETED|Treatment Period 2||5
7874929|NCT00834912|19380604|P1|COMPLETED|Treatment Period 2||6
7874930|NCT00834912|19380599|P6|STARTED|Treatment Period 2||6
7874931|NCT00834912|19380600|P5|STARTED|Treatment Period 2||6
7874932|NCT00834912|19380601|P4|STARTED|Treatment Period 2||5
7874933|NCT00834912|19380602|P3|STARTED|Treatment Period 2||6
7874934|NCT00834912|19380603|P2|STARTED|Treatment Period 2||5
7874935|NCT00834912|19380604|P1|STARTED|Treatment Period 2||6
7874936|NCT00834912|19380599|P6|NOT COMPLETED|Treatment Period 1||0
7874937|NCT00834912|19380600|P5|NOT COMPLETED|Treatment Period 1||0
7874938|NCT00834912|19380601|P4|NOT COMPLETED|Treatment Period 1||1
7874939|NCT00834912|19380602|P3|NOT COMPLETED|Treatment Period 1||0
7874940|NCT00834912|19380603|P2|NOT COMPLETED|Treatment Period 1||1
7874941|NCT00834912|19380604|P1|NOT COMPLETED|Treatment Period 1||0
7874942|NCT00834912|19380599|P6|COMPLETED|Treatment Period 1||6
7874943|NCT00834912|19380600|P5|COMPLETED|Treatment Period 1||6
7874944|NCT00834912|19380601|P4|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
7874945|NCT00834912|19380602|P3|COMPLETED|Treatment Period 1||6
7874946|NCT00834912|19380603|P2|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
7874947|NCT00834912|19380604|P1|COMPLETED|Treatment Period 1||6
7874948|NCT00834912|19380599|P6|STARTED|Treatment Period 1||6
7874949|NCT00834912|19380600|P5|STARTED|Treatment Period 1||6
7874950|NCT00834912|19380601|P4|STARTED|Treatment Period 1||6
7874951|NCT00834912|19380602|P3|STARTED|Treatment Period 1||6
7874952|NCT00834912|19380603|P2|STARTED|Treatment Period 1||6
7874953|NCT00834912|19380604|P1|STARTED|Treatment Period 1||6
7874954|NCT00834899|19380626|P2|NOT COMPLETED|Overall Study||1
7874955|NCT00834899|19380627|P1|NOT COMPLETED|Overall Study||1
7874956|NCT00834899|19380626|P2|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3
7874957|NCT00834899|19380627|P1|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8
7874958|NCT00834899|19380626|P2|STARTED|Overall Study||4
7874959|NCT00834899|19380627|P1|STARTED|Overall Study||9
7874960|NCT00834886|19380643|P4|NOT COMPLETED|Overall Study||0
7874961|NCT00834886|19380644|P3|NOT COMPLETED|Overall Study||1
7874962|NCT00834886|19380645|P2|NOT COMPLETED|Overall Study||1
7874963|NCT00834886|19380646|P1|NOT COMPLETED|Overall Study||0
7874964|NCT00834886|19380643|P4|COMPLETED|Overall Study||10
7874965|NCT00834886|19380644|P3|COMPLETED|Overall Study||9
7874966|NCT00834886|19380645|P2|COMPLETED|Overall Study||9
7874967|NCT00834886|19380646|P1|COMPLETED|Overall Study||10
7874968|NCT00834886|19380643|P4|STARTED|Overall Study||10
7874969|NCT00834886|19380644|P3|STARTED|Overall Study||10
7874970|NCT00834886|19380645|P2|STARTED|Overall Study||10
7874971|NCT00834886|19380646|P1|STARTED|Overall Study||10
7874972|NCT00834873|19380666|P2|NOT COMPLETED|Second Intervention||0
7874973|NCT00834873|19380667|P1|NOT COMPLETED|Second Intervention||0
7874974|NCT00834873|19380666|P2|COMPLETED|Second Intervention||11
7874975|NCT00834873|19380667|P1|COMPLETED|Second Intervention||12
7874976|NCT00834873|19380666|P2|STARTED|Second Intervention||11
7874977|NCT00834873|19380667|P1|STARTED|Second Intervention||12
7874978|NCT00834873|19380666|P2|NOT COMPLETED|Washout: 7 Days||0
7874979|NCT00834873|19380667|P1|NOT COMPLETED|Washout: 7 Days||0
7874980|NCT00834873|19380666|P2|COMPLETED|Washout: 7 Days||11
7874981|NCT00834873|19380667|P1|COMPLETED|Washout: 7 Days||12
7874982|NCT00834873|19380666|P2|STARTED|Washout: 7 Days||11
7874983|NCT00834873|19380667|P1|STARTED|Washout: 7 Days||12
7874984|NCT00834873|19380666|P2|NOT COMPLETED|First Intervention||1
7874985|NCT00834873|19380667|P1|NOT COMPLETED|First Intervention||0
7874986|NCT00834873|19380666|P2|COMPLETED|First Intervention||11
7874987|NCT00834873|19380667|P1|COMPLETED|First Intervention||12
7874988|NCT00834873|19380666|P2|STARTED|First Intervention||12
7874989|NCT00834873|19380667|P1|STARTED|First Intervention||12
7874990|NCT00834834|19380677|P2|NOT COMPLETED|Overall Study||3
7874991|NCT00834834|19380678|P1|NOT COMPLETED|Overall Study||4
7874992|NCT00834834|19380677|P2|COMPLETED|Overall Study||39
7874993|NCT00834834|19380678|P1|COMPLETED|Overall Study||38
7874994|NCT00834834|19380677|P2|STARTED|Overall Study||42
7874995|NCT00834834|19380678|P1|STARTED|Overall Study||42
7874996|NCT00834808|19380689|P3|NOT COMPLETED|Treatment Period 3 (Day 15)||0
7874997|NCT00834808|19380690|P2|NOT COMPLETED|Treatment Period 3 (Day 15)||0
7874998|NCT00834808|19380691|P1|NOT COMPLETED|Treatment Period 3 (Day 15)||0
7874999|NCT00834808|19380689|P3|COMPLETED|Treatment Period 3 (Day 15)||9
7875000|NCT00834808|19380690|P2|COMPLETED|Treatment Period 3 (Day 15)||9
7875001|NCT00834808|19380691|P1|COMPLETED|Treatment Period 3 (Day 15)||9
7875002|NCT00834808|19380689|P3|STARTED|Treatment Period 3 (Day 15)||9
7875003|NCT00834808|19380690|P2|STARTED|Treatment Period 3 (Day 15)||9
7875004|NCT00834808|19380691|P1|STARTED|Treatment Period 3 (Day 15)||9
7875005|NCT00834808|19380689|P3|NOT COMPLETED|Treatment Period 2 (Day 8)||0
7875006|NCT00834808|19380690|P2|NOT COMPLETED|Treatment Period 2 (Day 8)||0
7875007|NCT00834808|19380691|P1|NOT COMPLETED|Treatment Period 2 (Day 8)||0
7875008|NCT00834808|19380689|P3|COMPLETED|Treatment Period 2 (Day 8)||9
7875009|NCT00834808|19380690|P2|COMPLETED|Treatment Period 2 (Day 8)||9
7875010|NCT00834808|19380691|P1|COMPLETED|Treatment Period 2 (Day 8)||9
7875011|NCT00834808|19380689|P3|STARTED|Treatment Period 2 (Day 8)||9
7875012|NCT00834808|19380690|P2|STARTED|Treatment Period 2 (Day 8)||9
7875013|NCT00834808|19380691|P1|STARTED|Treatment Period 2 (Day 8)||9
7875014|NCT00834808|19380689|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
7875015|NCT00834808|19380690|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
7875016|NCT00834808|19380691|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
7875017|NCT00834808|19380689|P3|COMPLETED|Treatment Period 1 (Day 1)||9
7875018|NCT00834808|19380690|P2|COMPLETED|Treatment Period 1 (Day 1)||9
7875019|NCT00834808|19380691|P1|COMPLETED|Treatment Period 1 (Day 1)||9
7875020|NCT00834808|19380689|P3|STARTED|Treatment Period 1 (Day 1)||9
7875021|NCT00834808|19380690|P2|STARTED|Treatment Period 1 (Day 1)||9
7875022|NCT00834808|19380691|P1|STARTED|Treatment Period 1 (Day 1)||9
7875023|NCT00834795|19380713|P2|NOT COMPLETED|Second Intervention||0
7875024|NCT00834795|19380714|P1|NOT COMPLETED|Second Intervention||1
7875025|NCT00834795|19380713|P2|COMPLETED|Second Intervention||17
7875026|NCT00834795|19380714|P1|COMPLETED|Second Intervention||17
7875027|NCT00834795|19380713|P2|STARTED|Second Intervention||17
7875028|NCT00834795|19380714|P1|STARTED|Second Intervention||18
7875029|NCT00834795|19380713|P2|NOT COMPLETED|Washout: 7 Days||1
7875030|NCT00834795|19380714|P1|NOT COMPLETED|Washout: 7 Days||0
7875031|NCT00834795|19380713|P2|COMPLETED|Washout: 7 Days||17
7875032|NCT00834795|19380714|P1|COMPLETED|Washout: 7 Days||18
7875033|NCT00834795|19380713|P2|STARTED|Washout: 7 Days||18
7875034|NCT00834795|19380714|P1|STARTED|Washout: 7 Days||18
7875035|NCT00834795|19380713|P2|NOT COMPLETED|First Intervention||0
7875036|NCT00834795|19380714|P1|NOT COMPLETED|First Intervention||0
7875037|NCT00834795|19380713|P2|COMPLETED|First Intervention||18
7875038|NCT00834795|19380714|P1|COMPLETED|First Intervention||18
7875039|NCT00834795|19380713|P2|STARTED|First Intervention||18
7875040|NCT00834795|19380714|P1|STARTED|First Intervention||18
7875041|NCT00834756|19380724|P2|NOT COMPLETED|Second Intervention||0
7875042|NCT00834756|19380725|P1|NOT COMPLETED|Second Intervention||0
7875043|NCT00834756|19380724|P2|COMPLETED|Second Intervention||18
7875044|NCT00834756|19380725|P1|COMPLETED|Second Intervention||16
7875045|NCT00834756|19380724|P2|STARTED|Second Intervention||18
7875046|NCT00834756|19380725|P1|STARTED|Second Intervention||16
7875047|NCT00834756|19380724|P2|NOT COMPLETED|Washout: 21 Days||0
7875048|NCT00834756|19380725|P1|NOT COMPLETED|Washout: 21 Days||1
7875049|NCT00834756|19380724|P2|COMPLETED|Washout: 21 Days||18
7875050|NCT00834756|19380725|P1|COMPLETED|Washout: 21 Days||16
7875051|NCT00834756|19380724|P2|STARTED|Washout: 21 Days||18
7875052|NCT00834756|19380725|P1|STARTED|Washout: 21 Days||17
7875053|NCT00834756|19380724|P2|NOT COMPLETED|First Intervention||0
7875054|NCT00834756|19380725|P1|NOT COMPLETED|First Intervention||1
7875055|NCT00834756|19380724|P2|COMPLETED|First Intervention||18
7875056|NCT00834756|19380725|P1|COMPLETED|First Intervention||17
7875057|NCT00834756|19380724|P2|STARTED|First Intervention||18
7875058|NCT00834756|19380725|P1|STARTED|First Intervention||18
7875059|NCT00834743|19380735|P2|NOT COMPLETED|Second Intervention||0
7875060|NCT00834743|19380736|P1|NOT COMPLETED|Second Intervention||1
7875061|NCT00834743|19380735|P2|COMPLETED|Second Intervention||16
7875062|NCT00834743|19380736|P1|COMPLETED|Second Intervention||15
7875063|NCT00834743|19380735|P2|STARTED|Second Intervention||16
7875064|NCT00834743|19380736|P1|STARTED|Second Intervention||16
7875065|NCT00834743|19380735|P2|NOT COMPLETED|Washout of 7 Days||0
7875066|NCT00834743|19380736|P1|NOT COMPLETED|Washout of 7 Days||0
7875067|NCT00834743|19380735|P2|COMPLETED|Washout of 7 Days||16
7875068|NCT00834743|19380736|P1|COMPLETED|Washout of 7 Days||16
7875069|NCT00834743|19380735|P2|STARTED|Washout of 7 Days||16
7875070|NCT00834743|19380736|P1|STARTED|Washout of 7 Days||16
7875071|NCT00834743|19380735|P2|NOT COMPLETED|First Intervention||0
7875072|NCT00834743|19380736|P1|NOT COMPLETED|First Intervention||0
7875073|NCT00834743|19380735|P2|COMPLETED|First Intervention||16
7875074|NCT00834743|19380736|P1|COMPLETED|First Intervention||16
7875075|NCT00834743|19380735|P2|STARTED|First Intervention||16
7875076|NCT00834743|19380736|P1|STARTED|First Intervention||16
7875077|NCT00834717|19380746|P2|NOT COMPLETED|Second Intervention||0
7875078|NCT00834717|19380747|P1|NOT COMPLETED|Second Intervention||0
7875079|NCT00834717|19380746|P2|COMPLETED|Second Intervention||19
7875080|NCT00834717|19380747|P1|COMPLETED|Second Intervention||19
7875081|NCT00834717|19380746|P2|STARTED|Second Intervention||19
7875082|NCT00834717|19380747|P1|STARTED|Second Intervention||19
7875083|NCT00834717|19380746|P2|NOT COMPLETED|First Intervention||1
7875084|NCT00834717|19380747|P1|NOT COMPLETED|First Intervention||1
7875085|NCT00834717|19380746|P2|COMPLETED|First Intervention||19
7875086|NCT00834717|19380747|P1|COMPLETED|First Intervention||19
7875087|NCT00834717|19380746|P2|STARTED|First Intervention||20
7875088|NCT00834717|19380747|P1|STARTED|First Intervention||20
7875089|NCT00834678|19380755|P1|NOT COMPLETED|Overall Study||0
7875090|NCT00834678|19380755|P1|COMPLETED|Overall Study||11
7875091|NCT00834678|19380755|P1|STARTED|Overall Study||11
7875092|NCT00834652|19380769|P2|NOT COMPLETED|Overall Study||40
7875093|NCT00834652|19380770|P1|NOT COMPLETED|Overall Study||38
7875094|NCT00834652|19380769|P2|COMPLETED|Overall Study||62
7875095|NCT00834652|19380770|P1|COMPLETED|Overall Study||66
7875096|NCT00834652|19380769|P2|STARTED|Overall Study||102
7875097|NCT00834652|19380770|P1|STARTED|Overall Study||104
7875098|NCT00834639|19380778|P2|NOT COMPLETED|Second Intervention||2
7875099|NCT00834639|19380779|P1|NOT COMPLETED|Second Intervention||0
7875100|NCT00834639|19380778|P2|COMPLETED|Second Intervention||10
7875101|NCT00834639|19380779|P1|COMPLETED|Second Intervention||12
7875102|NCT00834639|19380778|P2|STARTED|Second Intervention||12
7875103|NCT00834639|19380779|P1|STARTED|Second Intervention||12
7875104|NCT00834639|19380778|P2|NOT COMPLETED|Washout of 7 Days||0
7875105|NCT00834639|19380779|P1|NOT COMPLETED|Washout of 7 Days||0
7875106|NCT00834639|19380778|P2|COMPLETED|Washout of 7 Days||12
7875107|NCT00834639|19380779|P1|COMPLETED|Washout of 7 Days||12
7875108|NCT00834639|19380778|P2|STARTED|Washout of 7 Days||12
7875109|NCT00834639|19380779|P1|STARTED|Washout of 7 Days||12
7875110|NCT00834639|19380778|P2|NOT COMPLETED|First Intervention||0
7875111|NCT00834639|19380779|P1|NOT COMPLETED|First Intervention||0
7875112|NCT00834639|19380778|P2|COMPLETED|First Intervention||12
7875113|NCT00834639|19380779|P1|COMPLETED|First Intervention||12
7875114|NCT00834639|19380778|P2|STARTED|First Intervention||12
7875115|NCT00834639|19380779|P1|STARTED|First Intervention||12
7875116|NCT00834626|19380787|P1|NOT COMPLETED|Overall Study||0
7875117|NCT00834626|19380787|P1|COMPLETED|Overall Study||30
7875118|NCT00834626|19380787|P1|1 Year Follow-up|Overall Study||30
7875119|NCT00834626|19380787|P1|STARTED|Overall Study||30
7875120|NCT00834613|19380796|P2|NOT COMPLETED|Second Intervention||0
7875121|NCT00834613|19380797|P1|NOT COMPLETED|Second Intervention||0
7875122|NCT00834613|19380796|P2|COMPLETED|Second Intervention||16
7875123|NCT00834613|19380797|P1|COMPLETED|Second Intervention||15
7875124|NCT00834613|19380796|P2|STARTED|Second Intervention||16
7875125|NCT00834613|19380797|P1|STARTED|Second Intervention||15
7875126|NCT00834613|19380796|P2|NOT COMPLETED|Washout of 7 Days||0
7875127|NCT00834613|19380797|P1|NOT COMPLETED|Washout of 7 Days||0
7875128|NCT00834613|19380796|P2|COMPLETED|Washout of 7 Days||16
7875129|NCT00834613|19380797|P1|COMPLETED|Washout of 7 Days||15
7875130|NCT00834613|19380796|P2|STARTED|Washout of 7 Days||16
7875131|NCT00834613|19380797|P1|STARTED|Washout of 7 Days||15
7875132|NCT00834613|19380796|P2|NOT COMPLETED|First Intervention||0
7875133|NCT00834613|19380797|P1|NOT COMPLETED|First Intervention||1
7875134|NCT00834613|19380796|P2|COMPLETED|First Intervention||16
7875135|NCT00834613|19380797|P1|COMPLETED|First Intervention||15
7875136|NCT00834613|19380796|P2|STARTED|First Intervention||16
7875137|NCT00834613|19380797|P1|STARTED|First Intervention||16
7875138|NCT00834587|19380807|P2|NOT COMPLETED|Second Intervention||0
7875139|NCT00834587|19380808|P1|NOT COMPLETED|Second Intervention||0
7875140|NCT00834587|19380807|P2|COMPLETED|Second Intervention||20
7875141|NCT00834587|19380808|P1|COMPLETED|Second Intervention||19
7875142|NCT00834587|19380807|P2|STARTED|Second Intervention||20
7875143|NCT00834587|19380808|P1|STARTED|Second Intervention||19
7875144|NCT00834587|19380807|P2|NOT COMPLETED|Washout: 7 Days||0
7875145|NCT00834587|19380808|P1|NOT COMPLETED|Washout: 7 Days||1
7875146|NCT00834587|19380807|P2|COMPLETED|Washout: 7 Days||20
7875147|NCT00834587|19380808|P1|COMPLETED|Washout: 7 Days||19
7875148|NCT00834587|19380807|P2|STARTED|Washout: 7 Days||20
7875149|NCT00834587|19380808|P1|STARTED|Washout: 7 Days||20
7875150|NCT00834587|19380807|P2|NOT COMPLETED|First Intervention||0
7875151|NCT00834587|19380808|P1|NOT COMPLETED|First Intervention||0
7875152|NCT00834587|19380807|P2|COMPLETED|First Intervention||20
7875153|NCT00834587|19380808|P1|COMPLETED|First Intervention||20
7875154|NCT00834587|19380807|P2|STARTED|First Intervention||20
7875155|NCT00834587|19380808|P1|STARTED|First Intervention||20
7875156|NCT00834574|19380824|P2|NOT COMPLETED|Second Intervention||0
7875157|NCT00834574|19380825|P1|NOT COMPLETED|Second Intervention||0
7875158|NCT00834574|19380824|P2|COMPLETED|Second Intervention||16
7875159|NCT00834574|19380825|P1|COMPLETED|Second Intervention||16
7875160|NCT00834574|19380824|P2|STARTED|Second Intervention||16
7875161|NCT00834574|19380825|P1|STARTED|Second Intervention||16
7875162|NCT00834574|19380824|P2|NOT COMPLETED|Washout of 7 Days||0
7875163|NCT00834574|19380825|P1|NOT COMPLETED|Washout of 7 Days||0
7875164|NCT00834574|19380824|P2|COMPLETED|Washout of 7 Days||16
7875165|NCT00834574|19380825|P1|COMPLETED|Washout of 7 Days||16
7875166|NCT00834574|19380824|P2|STARTED|Washout of 7 Days||16
7875167|NCT00834574|19380825|P1|STARTED|Washout of 7 Days||16
7875168|NCT00834574|19380824|P2|NOT COMPLETED|First Intervention||0
7875169|NCT00834574|19380825|P1|NOT COMPLETED|First Intervention||0
7875170|NCT00834574|19380824|P2|COMPLETED|First Intervention||16
7875171|NCT00834574|19380825|P1|COMPLETED|First Intervention||16
7875172|NCT00834574|19380824|P2|STARTED|First Intervention||16
7875173|NCT00834574|19380825|P1|STARTED|First Intervention||16
7875174|NCT00834561|19380835|P2|NOT COMPLETED|Second Intervention||0
7875175|NCT00834561|19380836|P1|NOT COMPLETED|Second Intervention||0
7875176|NCT00834561|19380835|P2|COMPLETED|Second Intervention||16
7875177|NCT00834561|19380836|P1|COMPLETED|Second Intervention||16
7875178|NCT00834561|19380835|P2|STARTED|Second Intervention||16
7875179|NCT00834561|19380836|P1|STARTED|Second Intervention||16
7875180|NCT00834561|19380835|P2|NOT COMPLETED|First Intervention||0
7875181|NCT00834561|19380836|P1|NOT COMPLETED|First Intervention||0
7875182|NCT00834561|19380835|P2|COMPLETED|First Intervention||16
7875183|NCT00834561|19380836|P1|COMPLETED|First Intervention||16
7875184|NCT00834561|19380835|P2|STARTED|First Intervention||16
7875185|NCT00834561|19380836|P1|STARTED|First Intervention||16
7875186|NCT00834535|19380846|P2|NOT COMPLETED|Second Intervention||0
7875187|NCT00834535|19380847|P1|NOT COMPLETED|Second Intervention||0
7875188|NCT00834535|19380846|P2|COMPLETED|Second Intervention||16
7875189|NCT00834535|19380847|P1|COMPLETED|Second Intervention||16
7875190|NCT00834535|19380846|P2|STARTED|Second Intervention||16
7875191|NCT00834535|19380847|P1|STARTED|Second Intervention||16
7875192|NCT00834535|19380846|P2|NOT COMPLETED|Washout of 7 Days||0
7875193|NCT00834535|19380847|P1|NOT COMPLETED|Washout of 7 Days||0
7875194|NCT00834535|19380846|P2|COMPLETED|Washout of 7 Days||16
7875195|NCT00834535|19380847|P1|COMPLETED|Washout of 7 Days||16
7875196|NCT00834535|19380846|P2|STARTED|Washout of 7 Days||16
7875197|NCT00834535|19380847|P1|STARTED|Washout of 7 Days||16
7875198|NCT00834535|19380846|P2|NOT COMPLETED|First Intervention||0
7875199|NCT00834535|19380847|P1|NOT COMPLETED|First Intervention||0
7875200|NCT00834535|19380846|P2|COMPLETED|First Intervention||16
7875201|NCT00834535|19380847|P1|COMPLETED|First Intervention||16
7875202|NCT00834535|19380846|P2|STARTED|First Intervention||16
7875203|NCT00834535|19380847|P1|STARTED|First Intervention||16
7875204|NCT00834522|19380857|P2|NOT COMPLETED|Second Intervention||0
7875205|NCT00834522|19380858|P1|NOT COMPLETED|Second Intervention||0
7875206|NCT00834522|19380857|P2|COMPLETED|Second Intervention||39
7875207|NCT00834522|19380858|P1|COMPLETED|Second Intervention||37
7875208|NCT00834522|19380857|P2|STARTED|Second Intervention||39
7875209|NCT00834522|19380858|P1|STARTED|Second Intervention||37
7875210|NCT00834522|19380857|P2|NOT COMPLETED|Washout||1
7875211|NCT00834522|19380858|P1|NOT COMPLETED|Washout||3
7875212|NCT00834522|19380857|P2|COMPLETED|Washout||39
7875213|NCT00834522|19380858|P1|COMPLETED|Washout||37
7875214|NCT00834522|19380857|P2|STARTED|Washout||40
7875215|NCT00834522|19380858|P1|STARTED|Washout||40
7875216|NCT00834522|19380857|P2|NOT COMPLETED|First Intervention||0
7875217|NCT00834522|19380858|P1|NOT COMPLETED|First Intervention||0
7875218|NCT00834522|19380857|P2|COMPLETED|First Intervention||40
7875219|NCT00834522|19380858|P1|COMPLETED|First Intervention||40
7875220|NCT00834522|19380857|P2|STARTED|First Intervention||40
7875221|NCT00834522|19380858|P1|STARTED|First Intervention||40
7875222|NCT00834483|19380868|P2|NOT COMPLETED|Overall Study||0
7875223|NCT00834483|19380869|P1|NOT COMPLETED|Overall Study||0
7875224|NCT00834483|19380868|P2|COMPLETED|Overall Study||29
7875225|NCT00834483|19380869|P1|COMPLETED|Overall Study||31
7875226|NCT00834483|19380868|P2|STARTED|Overall Study||29
7875227|NCT00834483|19380869|P1|STARTED|Overall Study||31
7875228|NCT00834444|19380881|P2|NOT COMPLETED|Second Intervention||0
7875229|NCT00834444|19380882|P1|NOT COMPLETED|Second Intervention||1
7875230|NCT00834444|19380881|P2|COMPLETED|Second Intervention||16
7875231|NCT00834444|19380882|P1|COMPLETED|Second Intervention||16
7875232|NCT00834444|19380881|P2|STARTED|Second Intervention||16
7875233|NCT00834444|19380882|P1|STARTED|Second Intervention||17
7875234|NCT00834444|19380881|P2|NOT COMPLETED|Washout of 7 Days||1
7875235|NCT00834444|19380882|P1|NOT COMPLETED|Washout of 7 Days||0
7875236|NCT00834444|19380881|P2|COMPLETED|Washout of 7 Days||16
7875237|NCT00834444|19380882|P1|COMPLETED|Washout of 7 Days||17
7875238|NCT00834444|19380881|P2|STARTED|Washout of 7 Days||17
7875239|NCT00834444|19380882|P1|STARTED|Washout of 7 Days||17
7875240|NCT00834444|19380881|P2|NOT COMPLETED|First Intervention||1
7875241|NCT00834444|19380882|P1|NOT COMPLETED|First Intervention||1
7875242|NCT00834444|19380881|P2|COMPLETED|First Intervention||17
7875243|NCT00834444|19380882|P1|COMPLETED|First Intervention||17
7875244|NCT00834444|19380881|P2|STARTED|First Intervention||18
7875245|NCT00834444|19380882|P1|STARTED|First Intervention||18
7875246|NCT00834431|19380892|P2|NOT COMPLETED|Second Intervention||0
7875247|NCT00834431|19380893|P1|NOT COMPLETED|Second Intervention||0
7875248|NCT00834431|19380892|P2|COMPLETED|Second Intervention||16
7875249|NCT00834431|19380893|P1|COMPLETED|Second Intervention||18
7875250|NCT00834431|19380892|P2|STARTED|Second Intervention||16
7875251|NCT00834431|19380893|P1|STARTED|Second Intervention||18
7875252|NCT00834431|19380892|P2|NOT COMPLETED|Washout of 7 Days||1
7875253|NCT00834431|19380893|P1|NOT COMPLETED|Washout of 7 Days||0
7875254|NCT00834431|19380892|P2|COMPLETED|Washout of 7 Days||16
7875255|NCT00834431|19380893|P1|COMPLETED|Washout of 7 Days||18
7875256|NCT00834431|19380892|P2|STARTED|Washout of 7 Days||17
7875257|NCT00834431|19380893|P1|STARTED|Washout of 7 Days||18
7875258|NCT00834431|19380892|P2|NOT COMPLETED|First Intervention||1
7875259|NCT00834431|19380893|P1|NOT COMPLETED|First Intervention||0
7875260|NCT00834431|19380892|P2|COMPLETED|First Intervention||17
7875261|NCT00834431|19380893|P1|COMPLETED|First Intervention||18
7875262|NCT00834431|19380892|P2|STARTED|First Intervention||18
7875263|NCT00834431|19380893|P1|STARTED|First Intervention||18
7875264|NCT00834418|19380903|P2|NOT COMPLETED|Overall Study||2
7875265|NCT00834418|19380904|P1|NOT COMPLETED|Overall Study||0
7875266|NCT00834418|19380903|P2|COMPLETED|Overall Study||40
7875267|NCT00834418|19380904|P1|COMPLETED|Overall Study||42
7875268|NCT00834418|19380903|P2|STARTED|Overall Study||42
7875269|NCT00834418|19380904|P1|STARTED|Overall Study||42
7875270|NCT00834405|19380912|P2|NOT COMPLETED|Overall Study||0
7875271|NCT00834405|19380913|P1|NOT COMPLETED|Overall Study||0
7875272|NCT00834405|19380912|P2|COMPLETED|Overall Study||17
7875273|NCT00834405|19380913|P1|COMPLETED|Overall Study||20
7875274|NCT00834405|19380912|P2|STARTED|Overall Study||17
7875275|NCT00834405|19380913|P1|STARTED|Overall Study||20
7875276|NCT00834366|19380921|P2|NOT COMPLETED|Treatment Period 2||0
7875277|NCT00834366|19380922|P1|NOT COMPLETED|Treatment Period 2||0
7875278|NCT00834366|19380921|P2|COMPLETED|Treatment Period 2||12
7875279|NCT00834366|19380922|P1|COMPLETED|Treatment Period 2||12
7875280|NCT00834366|19380921|P2|STARTED|Treatment Period 2||12
7875281|NCT00834366|19380922|P1|STARTED|Treatment Period 2||12
7875282|NCT00834366|19380921|P2|NOT COMPLETED|Treatment Period 1||1
7875283|NCT00834366|19380922|P1|NOT COMPLETED|Treatment Period 1||1
7875284|NCT00834366|19380921|P2|COMPLETED|Treatment Period 1||12
7875285|NCT00834366|19380922|P1|COMPLETED|Treatment Period 1||12
7875286|NCT00834366|19380921|P2|STARTED|Treatment Period 1||13
7875287|NCT00834366|19380922|P1|STARTED|Treatment Period 1||13
7875288|NCT00834340|19380938|P2|NOT COMPLETED|Second Intervention||0
7875289|NCT00834340|19380939|P1|NOT COMPLETED|Second Intervention||0
7875290|NCT00834340|19380938|P2|COMPLETED|Second Intervention||16
7875291|NCT00834340|19380939|P1|COMPLETED|Second Intervention||14
7875292|NCT00834340|19380938|P2|STARTED|Second Intervention||16
7875293|NCT00834340|19380939|P1|STARTED|Second Intervention||14
7875294|NCT00834340|19380938|P2|NOT COMPLETED|Washout||0
7875295|NCT00834340|19380939|P1|NOT COMPLETED|Washout||2
7875296|NCT00834340|19380938|P2|COMPLETED|Washout||16
7875297|NCT00834340|19380939|P1|COMPLETED|Washout||14
7875298|NCT00834340|19380938|P2|STARTED|Washout||16
7875299|NCT00834340|19380939|P1|STARTED|Washout||16
7875300|NCT00834340|19380938|P2|NOT COMPLETED|First Intervention||0
7875301|NCT00834340|19380939|P1|NOT COMPLETED|First Intervention||0
7875302|NCT00834340|19380938|P2|COMPLETED|First Intervention||16
7875303|NCT00834340|19380939|P1|COMPLETED|First Intervention||16
7875304|NCT00834340|19380938|P2|STARTED|First Intervention||16
7875305|NCT00834340|19380939|P1|STARTED|First Intervention||16
7875306|NCT00834288|19380949|P2|NOT COMPLETED|Treatment Phase II||0
7875307|NCT00834288|19380950|P1|NOT COMPLETED|Treatment Phase II||0
7875308|NCT00834288|19380949|P2|COMPLETED|Treatment Phase II||13
7875309|NCT00834288|19380950|P1|COMPLETED|Treatment Phase II||13
7875310|NCT00834288|19380949|P2|STARTED|Treatment Phase II||13
7875311|NCT00834288|19380950|P1|STARTED|Treatment Phase II||13
7875312|NCT00834288|19380949|P2|NOT COMPLETED|Treatment Phase I||0
7875313|NCT00834288|19380950|P1|NOT COMPLETED|Treatment Phase I||0
7875314|NCT00834288|19380949|P2|COMPLETED|Treatment Phase I||13
7875315|NCT00834288|19380950|P1|COMPLETED|Treatment Phase I||13
7875316|NCT00834288|19380949|P2|STARTED|Treatment Phase I||13
7875317|NCT00834288|19380950|P1|STARTED|Treatment Phase I||13
7875318|NCT00834275|19380972|P2|NOT COMPLETED|Second Intervention||0
7875319|NCT00834275|19380973|P1|NOT COMPLETED|Second Intervention||0
7875320|NCT00834275|19380972|P2|COMPLETED|Second Intervention||13
7875321|NCT00834275|19380973|P1|COMPLETED|Second Intervention||13
7875322|NCT00834275|19380972|P2|STARTED|Second Intervention||13
7875323|NCT00834275|19380973|P1|STARTED|Second Intervention||13
7875324|NCT00834275|19380972|P2|NOT COMPLETED|Washout of 7 Days||0
7875325|NCT00834275|19380973|P1|NOT COMPLETED|Washout of 7 Days||0
7875326|NCT00834275|19380972|P2|COMPLETED|Washout of 7 Days||13
7875327|NCT00834275|19380973|P1|COMPLETED|Washout of 7 Days||13
7875328|NCT00834275|19380972|P2|STARTED|Washout of 7 Days||13
7875329|NCT00834275|19380973|P1|STARTED|Washout of 7 Days||13
7875330|NCT00834275|19380972|P2|NOT COMPLETED|First Intervention||0
7875331|NCT00834275|19380973|P1|NOT COMPLETED|First Intervention||0
7875332|NCT00834275|19380972|P2|COMPLETED|First Intervention||13
7875333|NCT00834275|19380973|P1|COMPLETED|First Intervention||13
7875334|NCT00834275|19380972|P2|STARTED|First Intervention||13
7875335|NCT00834275|19380973|P1|STARTED|First Intervention||13
7875336|NCT00834249|19380983|P2|NOT COMPLETED|Second Intervention||0
7875337|NCT00834249|19380984|P1|NOT COMPLETED|Second Intervention||1
7875338|NCT00834249|19380983|P2|COMPLETED|Second Intervention||8
7875339|NCT00834249|19380984|P1|COMPLETED|Second Intervention||7
7875340|NCT00834249|19380983|P2|STARTED|Second Intervention||8
7875341|NCT00834249|19380984|P1|STARTED|Second Intervention||8
7875342|NCT00834249|19380983|P2|NOT COMPLETED|Washout: 7 Days||1
7875343|NCT00834249|19380984|P1|NOT COMPLETED|Washout: 7 Days||1
7875344|NCT00834249|19380983|P2|COMPLETED|Washout: 7 Days||8
7875345|NCT00834249|19380984|P1|COMPLETED|Washout: 7 Days||8
7875346|NCT00834249|19380983|P2|STARTED|Washout: 7 Days||9
7875347|NCT00834249|19380984|P1|STARTED|Washout: 7 Days||9
7875348|NCT00834249|19380983|P2|NOT COMPLETED|First Intervention||0
7875349|NCT00834249|19380984|P1|NOT COMPLETED|First Intervention||0
7875350|NCT00834249|19380983|P2|COMPLETED|First Intervention||9
7875351|NCT00834249|19380984|P1|COMPLETED|First Intervention||9
7875352|NCT00834249|19380983|P2|STARTED|First Intervention||9
7875353|NCT00834249|19380984|P1|STARTED|First Intervention||9
7875354|NCT00834236|19381000|P2|NOT COMPLETED|Overall Study||0
7875355|NCT00834236|19381001|P1|NOT COMPLETED|Overall Study||0
7875356|NCT00834236|19381000|P2|COMPLETED|Overall Study||47
7875357|NCT00834236|19381001|P1|COMPLETED|Overall Study||29
7875358|NCT00834236|19381000|P2|STARTED|Overall Study||47
7875359|NCT00834236|19381001|P1|STARTED|Overall Study||29
7875360|NCT00834210|19381009|P2|NOT COMPLETED|Overall Study||8
7875361|NCT00834210|19381010|P1|NOT COMPLETED|Overall Study||3
7875362|NCT00834210|19381009|P2|COMPLETED|Overall Study||77
7875363|NCT00834210|19381010|P1|COMPLETED|Overall Study||83
7875364|NCT00834210|19381009|P2|STARTED|Overall Study||85
7875365|NCT00834210|19381010|P1|STARTED|Overall Study||86
7875366|NCT00834197|19381024|P2|NOT COMPLETED|Second Intervention||0
7875367|NCT00834197|19381025|P1|NOT COMPLETED|Second Intervention||0
7875368|NCT00834197|19381024|P2|COMPLETED|Second Intervention||16
7875369|NCT00834197|19381025|P1|COMPLETED|Second Intervention||16
7875370|NCT00834197|19381024|P2|STARTED|Second Intervention||16
7875371|NCT00834197|19381025|P1|STARTED|Second Intervention||16
7875372|NCT00834197|19381024|P2|NOT COMPLETED|Washout of 14 Days||0
7875373|NCT00834197|19381025|P1|NOT COMPLETED|Washout of 14 Days||0
7875374|NCT00834197|19381024|P2|COMPLETED|Washout of 14 Days||16
7875375|NCT00834197|19381025|P1|COMPLETED|Washout of 14 Days||16
7875376|NCT00834197|19381024|P2|STARTED|Washout of 14 Days||16
7875377|NCT00834197|19381025|P1|STARTED|Washout of 14 Days||16
7875378|NCT00834197|19381024|P2|NOT COMPLETED|First Intervention||0
7875379|NCT00834197|19381025|P1|NOT COMPLETED|First Intervention||0
7875380|NCT00834197|19381024|P2|COMPLETED|First Intervention||16
7875381|NCT00834197|19381025|P1|COMPLETED|First Intervention||16
7875382|NCT00834197|19381024|P2|STARTED|First Intervention||16
7875383|NCT00834197|19381025|P1|STARTED|First Intervention||16
7875384|NCT00834171|19381035|P2|NOT COMPLETED|Overall Study||0
7875385|NCT00834171|19381036|P1|NOT COMPLETED|Overall Study||0
7875386|NCT00834171|19381035|P2|COMPLETED|Overall Study||7
7875387|NCT00834171|19381036|P1|COMPLETED|Overall Study||43
7875388|NCT00834171|19381035|P2|STARTED|Overall Study||7
7875389|NCT00834171|19381036|P1|STARTED|Overall Study||43
7875390|NCT00834132|19381044|P2|NOT COMPLETED|Second Intervention||0
7875391|NCT00834132|19381045|P1|NOT COMPLETED|Second Intervention||0
7875392|NCT00834132|19381044|P2|COMPLETED|Second Intervention||12
7875393|NCT00834132|19381045|P1|COMPLETED|Second Intervention||12
7875394|NCT00834132|19381044|P2|STARTED|Second Intervention||12
7875395|NCT00834132|19381045|P1|STARTED|Second Intervention||12
7875396|NCT00834132|19381044|P2|NOT COMPLETED|Washout: 21 Days||0
7875397|NCT00834132|19381045|P1|NOT COMPLETED|Washout: 21 Days||0
7875398|NCT00834132|19381044|P2|COMPLETED|Washout: 21 Days||12
7875399|NCT00834132|19381045|P1|COMPLETED|Washout: 21 Days||12
7875400|NCT00834132|19381044|P2|STARTED|Washout: 21 Days||12
7875401|NCT00834132|19381045|P1|STARTED|Washout: 21 Days||12
7875402|NCT00834132|19381044|P2|NOT COMPLETED|First Intervention||0
7875403|NCT00834132|19381045|P1|NOT COMPLETED|First Intervention||0
7875404|NCT00834132|19381044|P2|COMPLETED|First Intervention||12
7875405|NCT00834132|19381045|P1|COMPLETED|First Intervention||12
7875406|NCT00834132|19381044|P2|STARTED|First Intervention||12
7875407|NCT00834132|19381045|P1|STARTED|First Intervention||12
7875408|NCT00834106|19381055|P2|NOT COMPLETED|Extension Study (Month 42 to Month 90)||74
7875409|NCT00834106|19381056|P1|NOT COMPLETED|Extension Study (Month 42 to Month 90)||96
7875410|NCT00834106|19381055|P2|COMPLETED|Extension Study (Month 42 to Month 90)||1294
7875411|NCT00834106|19381056|P1|COMPLETED|Extension Study (Month 42 to Month 90)||1308
7875412|NCT00834106|19381055|P2|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1368
7875413|NCT00834106|19381056|P1|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1404
7875414|NCT00834106|19381055|P2|NOT COMPLETED|Base Study (Day 1 to Month 30)||145
7875415|NCT00834106|19381056|P1|NOT COMPLETED|Base Study (Day 1 to Month 30)||102
7875416|NCT00834106|19381055|P2|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1358
7875417|NCT00834106|19381056|P1|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1401
7875418|NCT00834106|19381055|P2|Completed Vaccinations|Base Study (Day 1 to Month 30)||1463
7875419|NCT00834106|19381056|P1|Completed Vaccinations|Base Study (Day 1 to Month 30)||1473
7875420|NCT00834106|19381055|P2|Vaccinated|Base Study (Day 1 to Month 30)||1503
7875421|NCT00834106|19381056|P1|Vaccinated|Base Study (Day 1 to Month 30)||1503
7875422|NCT00834106|19381055|P2|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
7875423|NCT00834106|19381056|P1|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
7875424|NCT00834080|19381080|P1|NOT COMPLETED|Overall Study||23
7875425|NCT00834080|19381080|P1|COMPLETED|Overall Study||15
7875426|NCT00834080|19381080|P1|STARTED|Overall Study||38
7875427|NCT00834067|19381086|P2|NOT COMPLETED|Second Intervention||0
7875428|NCT00834067|19381087|P1|NOT COMPLETED|Second Intervention||0
7875429|NCT00834067|19381086|P2|COMPLETED|Second Intervention||29
7875430|NCT00834067|19381087|P1|COMPLETED|Second Intervention||30
7875431|NCT00834067|19381086|P2|STARTED|Second Intervention||29
7875432|NCT00834067|19381087|P1|STARTED|Second Intervention||30
7875433|NCT00834067|19381086|P2|NOT COMPLETED|Washout of 21 Days||1
7875434|NCT00834067|19381087|P1|NOT COMPLETED|Washout of 21 Days||0
7875435|NCT00834067|19381086|P2|COMPLETED|Washout of 21 Days||29
7875436|NCT00834067|19381087|P1|COMPLETED|Washout of 21 Days||30
7875437|NCT00834067|19381086|P2|STARTED|Washout of 21 Days||30
7875438|NCT00834067|19381087|P1|STARTED|Washout of 21 Days||30
7875439|NCT00834067|19381086|P2|NOT COMPLETED|First Intervention||0
7875440|NCT00834067|19381087|P1|NOT COMPLETED|First Intervention||0
7875441|NCT00834067|19381086|P2|COMPLETED|First Intervention||30
7875442|NCT00834067|19381087|P1|COMPLETED|First Intervention||30
7875443|NCT00834067|19381086|P2|STARTED|First Intervention||30
7875444|NCT00834067|19381087|P1|STARTED|First Intervention||30
7875445|NCT00834041|19381109|P2|NOT COMPLETED|Overall Study||1
7875446|NCT00834041|19381110|P1|NOT COMPLETED|Overall Study||1
7875447|NCT00834041|19381109|P2|COMPLETED|Overall Study||19
7875448|NCT00834041|19381110|P1|COMPLETED|Overall Study||18
7875449|NCT00834041|19381109|P2|STARTED|Overall Study||20
7875450|NCT00834041|19381110|P1|STARTED|Overall Study||19
7875451|NCT00833989|19381128|P4|NOT COMPLETED|Overall Study||2
7875452|NCT00833989|19381129|P3|NOT COMPLETED|Overall Study||1
7875453|NCT00833989|19381130|P2|NOT COMPLETED|Overall Study||0
7875454|NCT00833989|19381131|P1|NOT COMPLETED|Overall Study||3
7875455|NCT00833989|19381128|P4|COMPLETED|Overall Study||6
7875456|NCT00833989|19381129|P3|COMPLETED|Overall Study||8
7875457|NCT00833989|19381130|P2|COMPLETED|Overall Study||8
7875458|NCT00833989|19381131|P1|COMPLETED|Overall Study||14
7875459|NCT00833989|19381128|P4|STARTED|Overall Study||8
7875460|NCT00833989|19381129|P3|STARTED|Overall Study||9
7875461|NCT00833989|19381130|P2|STARTED|Overall Study||8
7875462|NCT00833989|19381131|P1|STARTED|Overall Study||17
7875463|NCT00833976|19381235|P1|NOT COMPLETED|Overall Study||51
7875464|NCT00833976|19381235|P1|COMPLETED|Overall Study||14
7875465|NCT00833976|19381235|P1|STARTED|Overall Study||65
7875466|NCT00833937|19381243|P2|NOT COMPLETED|Second Intervention||0
7875467|NCT00833937|19381244|P1|NOT COMPLETED|Second Intervention||0
7875468|NCT00833937|19381243|P2|COMPLETED|Second Intervention||12
7875469|NCT00833937|19381244|P1|COMPLETED|Second Intervention||11
7875470|NCT00833937|19381243|P2|STARTED|Second Intervention||12
7875471|NCT00833937|19381244|P1|STARTED|Second Intervention||11
7875472|NCT00833937|19381243|P2|NOT COMPLETED|Washout||0
7875473|NCT00833937|19381244|P1|NOT COMPLETED|Washout||1
7875474|NCT00833937|19381243|P2|COMPLETED|Washout||12
7875475|NCT00833937|19381244|P1|COMPLETED|Washout||11
7875476|NCT00833937|19381243|P2|STARTED|Washout||12
7875477|NCT00833937|19381244|P1|STARTED|Washout||12
7875478|NCT00833937|19381243|P2|NOT COMPLETED|First Intervention||0
7875479|NCT00833937|19381244|P1|NOT COMPLETED|First Intervention||0
7875480|NCT00833937|19381243|P2|COMPLETED|First Intervention||12
7875481|NCT00833937|19381244|P1|COMPLETED|First Intervention||12
7875482|NCT00833937|19381243|P2|STARTED|First Intervention||12
7875483|NCT00833937|19381244|P1|STARTED|First Intervention||12
7875484|NCT00833924|19381252|P1|NOT COMPLETED|Overall Study||109
7875485|NCT00833924|19381252|P1|COMPLETED|Overall Study||11
7875486|NCT00833924|19381252|P1|12-month|Overall Study||113
7875487|NCT00833924|19381252|P1|30-day|Overall Study||120
7875488|NCT00833924|19381252|P1|STARTED|Overall Study||120
7875489|NCT00833911|19381257|P1|NOT COMPLETED|Maintenance Phase II||10
7875490|NCT00833911|19381257|P1|COMPLETED|Maintenance Phase II||166
7875491|NCT00833911|19381257|P1|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176
7875492|NCT00833911|19381257|P1|NOT COMPLETED|Maintenance Phase I||98
7875493|NCT00833911|19381257|P1|COMPLETED|Maintenance Phase I||273
7875494|NCT00833911|19381257|P1|STARTED|Maintenance Phase I||371
7875495|NCT00833911|19381257|P1|NOT COMPLETED|Titration||21
7875496|NCT00833911|19381257|P1|COMPLETED|Titration||371
7875497|NCT00833911|19381257|P1|STARTED|Titration||392
7875498|NCT00833898|19381267|P2|NOT COMPLETED|Overall Study||36
7875499|NCT00833898|19381268|P1|NOT COMPLETED|Overall Study||40
7875500|NCT00833898|19381267|P2|COMPLETED|Overall Study||38
7875501|NCT00833898|19381268|P1|COMPLETED|Overall Study||34
7875502|NCT00833898|19381267|P2|Month 12 (Post Transplantation)|Overall Study||50
7875503|NCT00833898|19381268|P1|Month 12 (Post Transplantation)|Overall Study||50
7875504|NCT00833898|19381267|P2|Month 6 (Post Transplantation)|Overall Study||54
7875505|NCT00833898|19381268|P1|Month 6 (Post Transplantation)|Overall Study||59
7875506|NCT00833898|19381267|P2|Month 3 (Post Transplantation)|Overall Study||64
7875507|NCT00833898|19381268|P1|Month 3 (Post Transplantation)|Overall Study||66
7875508|NCT00833898|19381267|P2|Month 1 (Post Transplantation)|Overall Study||74
7875509|NCT00833898|19381268|P1|Month 1 (Post Transplantation)|Overall Study||72
7875510|NCT00833898|19381267|P2|STARTED|Overall Study||74
7875511|NCT00833898|19381268|P1|STARTED|Overall Study||74
7875512|NCT00833859|19381314|P1|NOT COMPLETED|Overall Study||0
7875513|NCT00833859|19381314|P1|COMPLETED|Overall Study||2
7875514|NCT00833859|19381314|P1|STARTED|Overall Study||2
7875515|NCT00833833|19381327|P6|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61
7875516|NCT00833833|19381328|P5|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55
7875517|NCT00833833|19381329|P4|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
7875518|NCT00833833|19381330|P3|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
7875519|NCT00833833|19381331|P2|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
7875520|NCT00833833|19381332|P1|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
7875521|NCT00833833|19381327|P6|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47
7875522|NCT00833833|19381328|P5|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58
7875523|NCT00833833|19381329|P4|COMPLETED|Phase 2 (as of 01 April 2011)||0
7875524|NCT00833833|19381330|P3|COMPLETED|Phase 2 (as of 01 April 2011)||0
7875525|NCT00833833|19381331|P2|COMPLETED|Phase 2 (as of 01 April 2011)||0
7875526|NCT00833833|19381332|P1|COMPLETED|Phase 2 (as of 01 April 2011)||0
7875527|NCT00833833|19381327|P6|Safety Population|Phase 2 (as of 01 April 2011)||107
7875528|NCT00833833|19381328|P5|Safety Population|Phase 2 (as of 01 April 2011)||112
7875529|NCT00833833|19381329|P4|Safety Population|Phase 2 (as of 01 April 2011)||0
7875530|NCT00833833|19381330|P3|Safety Population|Phase 2 (as of 01 April 2011)||0
7875531|NCT00833833|19381331|P2|Safety Population|Phase 2 (as of 01 April 2011)||0
7875532|NCT00833833|19381332|P1|Safety Population|Phase 2 (as of 01 April 2011)||0
7875533|NCT00833833|19381327|P6|STARTED|Phase 2 (as of 01 April 2011)||108
7875534|NCT00833833|19381328|P5|STARTED|Phase 2 (as of 01 April 2011)||113
7875535|NCT00833833|19381329|P4|STARTED|Phase 2 (as of 01 April 2011)||0
7875536|NCT00833833|19381330|P3|STARTED|Phase 2 (as of 01 April 2011)||0
7875537|NCT00833833|19381331|P2|STARTED|Phase 2 (as of 01 April 2011)||0
7875538|NCT00833833|19381332|P1|STARTED|Phase 2 (as of 01 April 2011)||0
7875539|NCT00833833|19381327|P6|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
7875540|NCT00833833|19381328|P5|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
7875541|NCT00833833|19381329|P4|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6
7875542|NCT00833833|19381330|P3|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9
7875543|NCT00833833|19381331|P2|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5
7875544|NCT00833833|19381332|P1|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4
7875545|NCT00833833|19381327|P6|COMPLETED|Phase 1 (as of 01 April 2011)||0
7875546|NCT00833833|19381328|P5|COMPLETED|Phase 1 (as of 01 April 2011)||0
7875547|NCT00833833|19381329|P4|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4
7875548|NCT00833833|19381330|P3|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5
7875549|NCT00833833|19381331|P2|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3
7875550|NCT00833833|19381332|P1|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2
7875551|NCT00833833|19381327|P6|STARTED|Phase 1 (as of 01 April 2011)||0
7875552|NCT00833833|19381328|P5|STARTED|Phase 1 (as of 01 April 2011)||0
7875553|NCT00833833|19381329|P4|STARTED|Phase 1 (as of 01 April 2011)||10
7875554|NCT00833833|19381330|P3|STARTED|Phase 1 (as of 01 April 2011)||14
7875555|NCT00833833|19381331|P2|STARTED|Phase 1 (as of 01 April 2011)||8
7875556|NCT00833833|19381332|P1|STARTED|Phase 1 (as of 01 April 2011)||6
7875557|NCT00833794|19381372|P2|NOT COMPLETED|Double-blind Phase||49
7875558|NCT00833794|19381373|P1|NOT COMPLETED|Double-blind Phase||106
7875559|NCT00833794|19381372|P2|COMPLETED|Double-blind Phase||165
7875560|NCT00833794|19381373|P1|COMPLETED|Double-blind Phase||326
7875561|NCT00833794|19381372|P2|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214
7875562|NCT00833794|19381373|P1|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432
7875563|NCT00833794|19381372|P2|NOT COMPLETED|Open-label Phase||0
7875564|NCT00833794|19381373|P1|NOT COMPLETED|Open-label Phase||382
7875565|NCT00833794|19381372|P2|COMPLETED|Open-label Phase||0
7875566|NCT00833794|19381373|P1|COMPLETED|Open-label Phase|Randomized in double-blind phase|646
7875567|NCT00833794|19381372|P2|Received Open-Label Treatment|Open-label Phase||0
7875568|NCT00833794|19381373|P1|Received Open-Label Treatment|Open-label Phase||1023
7875569|NCT00833794|19381372|P2|Entered run-in Period|Open-label Phase||0
7875570|NCT00833794|19381373|P1|Entered run-in Period|Open-label Phase||1027
7875571|NCT00833794|19381372|P2|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0
7875572|NCT00833794|19381373|P1|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028
7875573|NCT00833781|19381401|P2|NOT COMPLETED|Overall Study||0
7875574|NCT00833781|19381402|P1|NOT COMPLETED|Overall Study||0
7875575|NCT00833781|19381401|P2|COMPLETED|Overall Study||5
7875576|NCT00833781|19381402|P1|COMPLETED|Overall Study||10
7875577|NCT00833781|19381401|P2|STARTED|Overall Study||5
7875578|NCT00833781|19381402|P1|STARTED|Overall Study||10
7875579|NCT00833755|19381417|P4|NOT COMPLETED|Overall Study||6
7875580|NCT00833755|19381418|P3|NOT COMPLETED|Overall Study||2
7875581|NCT00833755|19381419|P2|NOT COMPLETED|Overall Study||5
7875582|NCT00833755|19381420|P1|NOT COMPLETED|Overall Study||4
7875583|NCT00833755|19381417|P4|COMPLETED|Overall Study||17
7875584|NCT00833755|19381418|P3|COMPLETED|Overall Study||20
7875585|NCT00833755|19381419|P2|COMPLETED|Overall Study||13
7875586|NCT00833755|19381420|P1|COMPLETED|Overall Study||12
7875587|NCT00833755|19381417|P4|STARTED|Overall Study||23
7875588|NCT00833755|19381418|P3|STARTED|Overall Study||22
7875589|NCT00833755|19381419|P2|STARTED|Overall Study||18
7875590|NCT00833755|19381420|P1|STARTED|Overall Study||16
7875591|NCT00833703|19381440|P2|NOT COMPLETED|Overall Study||1
7875592|NCT00833703|19381441|P1|NOT COMPLETED|Overall Study||0
7875593|NCT00833703|19381440|P2|COMPLETED|Overall Study|Completed follow-up|25
7875594|NCT00833703|19381441|P1|COMPLETED|Overall Study|Completed follow-up|23
7875595|NCT00833703|19381440|P2|Completed Treatment|Overall Study||24
7875596|NCT00833703|19381441|P1|Completed Treatment|Overall Study||22
7875597|NCT00833703|19381440|P2|Treated|Overall Study||26
7875598|NCT00833703|19381441|P1|Treated|Overall Study||23
7875599|NCT00833703|19381440|P2|STARTED|Overall Study|Included|26
7875600|NCT00833703|19381441|P1|STARTED|Overall Study|Included|23
7875601|NCT00833690|19381454|P3|NOT COMPLETED|Overall Study||0
7875602|NCT00833690|19381455|P2|NOT COMPLETED|Overall Study||2
7875603|NCT00833690|19381456|P1|NOT COMPLETED|Overall Study||4
7875604|NCT00833690|19381454|P3|COMPLETED|Overall Study||26
7875605|NCT00833690|19381455|P2|COMPLETED|Overall Study||22
7875606|NCT00833690|19381456|P1|COMPLETED|Overall Study||21
7875607|NCT00833690|19381454|P3|STARTED|Overall Study||26
7875608|NCT00833690|19381455|P2|STARTED|Overall Study||24
7875609|NCT00833690|19381456|P1|STARTED|Overall Study||25
7875610|NCT00833664|19381580|P2|NOT COMPLETED|Second Intervention||0
7875611|NCT00833664|19381581|P1|NOT COMPLETED|Second Intervention||0
7875612|NCT00833664|19381580|P2|COMPLETED|Second Intervention||11
7875613|NCT00833664|19381581|P1|COMPLETED|Second Intervention||10
7875614|NCT00833664|19381580|P2|STARTED|Second Intervention||11
7875615|NCT00833664|19381581|P1|STARTED|Second Intervention||10
7875616|NCT00833664|19381580|P2|NOT COMPLETED|Washout: 14 Days||0
7875617|NCT00833664|19381581|P1|NOT COMPLETED|Washout: 14 Days||1
7875618|NCT00833664|19381580|P2|COMPLETED|Washout: 14 Days||11
7875619|NCT00833664|19381581|P1|COMPLETED|Washout: 14 Days||10
7875620|NCT00833664|19381580|P2|STARTED|Washout: 14 Days||11
7875621|NCT00833664|19381581|P1|STARTED|Washout: 14 Days||11
7875622|NCT00833664|19381580|P2|NOT COMPLETED|First Intervention||0
7875623|NCT00833664|19381581|P1|NOT COMPLETED|First Intervention||0
7875624|NCT00833664|19381580|P2|COMPLETED|First Intervention||11
7875625|NCT00833664|19381581|P1|COMPLETED|First Intervention||11
7875626|NCT00833664|19381580|P2|STARTED|First Intervention||11
7875627|NCT00833664|19381581|P1|STARTED|First Intervention||11
7875628|NCT00833638|19381592|P3|NOT COMPLETED|Phase 3: Open-label Extension Phase||2
7875629|NCT00833638|19381593|P2|NOT COMPLETED|Phase 3: Open-label Extension Phase||3
7875630|NCT00833638|19381594|P1|NOT COMPLETED|Phase 3: Open-label Extension Phase||1
7875631|NCT00833638|19381592|P3|COMPLETED|Phase 3: Open-label Extension Phase||122
7875632|NCT00833638|19381593|P2|COMPLETED|Phase 3: Open-label Extension Phase||105
7875633|NCT00833638|19381594|P1|COMPLETED|Phase 3: Open-label Extension Phase||110
7875634|NCT00833638|19381592|P3|STARTED|Phase 3: Open-label Extension Phase||124
7875635|NCT00833638|19381593|P2|STARTED|Phase 3: Open-label Extension Phase||108
7875636|NCT00833638|19381594|P1|STARTED|Phase 3: Open-label Extension Phase||111
7875637|NCT00833638|19381592|P3|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9
7875638|NCT00833638|19381593|P2|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
7875639|NCT00833638|19381594|P1|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
7875640|NCT00833638|19381592|P3|COMPLETED|Phase 2: Double-blind Treatment Phase||124
7875641|NCT00833638|19381593|P2|COMPLETED|Phase 2: Double-blind Treatment Phase||108
7875642|NCT00833638|19381594|P1|COMPLETED|Phase 2: Double-blind Treatment Phase||111
7875643|NCT00833638|19381592|P3|STARTED|Phase 2: Double-blind Treatment Phase||133
7875644|NCT00833638|19381593|P2|STARTED|Phase 2: Double-blind Treatment Phase||118
7875645|NCT00833638|19381594|P1|STARTED|Phase 2: Double-blind Treatment Phase||121
7875646|NCT00833586|19381636|P2|NOT COMPLETED|Second Intervention||0
7875647|NCT00833586|19381637|P1|NOT COMPLETED|Second Intervention||0
7875648|NCT00833586|19381636|P2|COMPLETED|Second Intervention||14
7875649|NCT00833586|19381637|P1|COMPLETED|Second Intervention||14
7875650|NCT00833586|19381636|P2|STARTED|Second Intervention||14
7875651|NCT00833586|19381637|P1|STARTED|Second Intervention||14
7875652|NCT00833586|19381636|P2|NOT COMPLETED|Washout: 14 Days||0
7875653|NCT00833586|19381637|P1|NOT COMPLETED|Washout: 14 Days||0
7875654|NCT00833586|19381636|P2|COMPLETED|Washout: 14 Days||14
7875655|NCT00833586|19381637|P1|COMPLETED|Washout: 14 Days||14
7875656|NCT00833586|19381636|P2|STARTED|Washout: 14 Days||14
7875657|NCT00833586|19381637|P1|STARTED|Washout: 14 Days||14
7875658|NCT00833586|19381636|P2|NOT COMPLETED|First Intervention||0
7875659|NCT00833586|19381637|P1|NOT COMPLETED|First Intervention||0
7875660|NCT00833586|19381636|P2|COMPLETED|First Intervention||14
7875661|NCT00833586|19381637|P1|COMPLETED|First Intervention||14
7875662|NCT00833586|19381636|P2|STARTED|First Intervention||14
7875663|NCT00833586|19381637|P1|STARTED|First Intervention||14
7875664|NCT00833560|19381645|P1|NOT COMPLETED|Overall Study||42
7875665|NCT00833560|19381645|P1|COMPLETED|Overall Study||353
7875666|NCT00833560|19381645|P1|STARTED|Overall Study||395
7875667|NCT00833547|19381654|P2|NOT COMPLETED|Overall Study||2
7875668|NCT00833547|19381655|P1|NOT COMPLETED|Overall Study||2
7875669|NCT00833547|19381654|P2|COMPLETED|Overall Study||10
7875670|NCT00833547|19381655|P1|COMPLETED|Overall Study||11
7875671|NCT00833547|19381654|P2|STARTED|Overall Study||12
7875672|NCT00833547|19381655|P1|STARTED|Overall Study||13
7875673|NCT00833521|19381665|P2|NOT COMPLETED|Second Intervention||0
7875674|NCT00833521|19381666|P1|NOT COMPLETED|Second Intervention||0
7875675|NCT00833521|19381665|P2|COMPLETED|Second Intervention||19
7875676|NCT00833521|19381666|P1|COMPLETED|Second Intervention||19
7875677|NCT00833521|19381665|P2|STARTED|Second Intervention||19
7875678|NCT00833521|19381666|P1|STARTED|Second Intervention||19
7875679|NCT00833521|19381665|P2|NOT COMPLETED|First Intervention||0
7875680|NCT00833521|19381666|P1|NOT COMPLETED|First Intervention||0
7875681|NCT00833521|19381665|P2|COMPLETED|First Intervention||19
7875682|NCT00833521|19381666|P1|COMPLETED|First Intervention||19
7875683|NCT00833521|19381665|P2|STARTED|First Intervention||19
7875684|NCT00833521|19381666|P1|STARTED|First Intervention||19
7875685|NCT00833482|19381676|P6|NOT COMPLETED|Days 21-30||0
7875686|NCT00833482|19381677|P5|NOT COMPLETED|Days 21-30||1
7875687|NCT00833482|19381678|P4|NOT COMPLETED|Days 21-30||0
7875688|NCT00833482|19381679|P3|NOT COMPLETED|Days 21-30||1
7875689|NCT00833482|19381680|P2|NOT COMPLETED|Days 21-30||0
7875690|NCT00833482|19381681|P1|NOT COMPLETED|Days 21-30||0
7875691|NCT00833482|19381676|P6|COMPLETED|Days 21-30||0
7875692|NCT00833482|19381677|P5|COMPLETED|Days 21-30||7
7875693|NCT00833482|19381678|P4|COMPLETED|Days 21-30||0
7875694|NCT00833482|19381679|P3|COMPLETED|Days 21-30||20
7875695|NCT00833482|19381680|P2|COMPLETED|Days 21-30||0
7875696|NCT00833482|19381681|P1|COMPLETED|Days 21-30||0
7875697|NCT00833482|19381676|P6|STARTED|Days 21-30||0
7875698|NCT00833482|19381677|P5|STARTED|Days 21-30||8
7875699|NCT00833482|19381678|P4|STARTED|Days 21-30||0
7875700|NCT00833482|19381679|P3|STARTED|Days 21-30||21
7875701|NCT00833482|19381680|P2|STARTED|Days 21-30||0
7875702|NCT00833482|19381681|P1|STARTED|Days 21-30||0
7875703|NCT00833482|19381676|P6|NOT COMPLETED|Days 11-20||0
7875704|NCT00833482|19381677|P5|NOT COMPLETED|Days 11-20||0
7875705|NCT00833482|19381678|P4|NOT COMPLETED|Days 11-20||0
7875706|NCT00833482|19381679|P3|NOT COMPLETED|Days 11-20||0
7875707|NCT00833482|19381680|P2|NOT COMPLETED|Days 11-20||3
7875708|NCT00833482|19381681|P1|NOT COMPLETED|Days 11-20||0
7875709|NCT00833482|19381676|P6|COMPLETED|Days 11-20||8
7875710|NCT00833482|19381677|P5|COMPLETED|Days 11-20||0
7875711|NCT00833482|19381678|P4|COMPLETED|Days 11-20||0
7875712|NCT00833482|19381679|P3|COMPLETED|Days 11-20||0
7875713|NCT00833482|19381680|P2|COMPLETED|Days 11-20||21
7875714|NCT00833482|19381681|P1|COMPLETED|Days 11-20||0
7875715|NCT00833482|19381676|P6|STARTED|Days 11-20|Participants who received treatment.|8
7875716|NCT00833482|19381677|P5|STARTED|Days 11-20||0
7875717|NCT00833482|19381678|P4|STARTED|Days 11-20||0
7875718|NCT00833482|19381679|P3|STARTED|Days 11-20||0
7875719|NCT00833482|19381680|P2|STARTED|Days 11-20|Participants who received treatment.|24
7875720|NCT00833482|19381681|P1|STARTED|Days 11-20||0
7875721|NCT00833482|19381676|P6|NOT COMPLETED|Days 1-3||0
7875722|NCT00833482|19381677|P5|NOT COMPLETED|Days 1-3||0
7875723|NCT00833482|19381678|P4|NOT COMPLETED|Days 1-3||0
7875724|NCT00833482|19381679|P3|NOT COMPLETED|Days 1-3||0
7875725|NCT00833482|19381680|P2|NOT COMPLETED|Days 1-3||0
7875726|NCT00833482|19381681|P1|NOT COMPLETED|Days 1-3||0
7875727|NCT00833482|19381676|P6|COMPLETED|Days 1-3||0
7875728|NCT00833482|19381677|P5|COMPLETED|Days 1-3||0
7875729|NCT00833482|19381678|P4|COMPLETED|Days 1-3||8
7875730|NCT00833482|19381679|P3|COMPLETED|Days 1-3||0
7875731|NCT00833482|19381680|P2|COMPLETED|Days 1-3||0
7875732|NCT00833482|19381681|P1|COMPLETED|Days 1-3||24
7875733|NCT00833482|19381676|P6|STARTED|Days 1-3||0
7875734|NCT00833482|19381677|P5|STARTED|Days 1-3||0
7875735|NCT00833482|19381678|P4|STARTED|Days 1-3||8
7875736|NCT00833482|19381679|P3|STARTED|Days 1-3||0
7875737|NCT00833482|19381680|P2|STARTED|Days 1-3|Participants who received treatment|0
7875738|NCT00833482|19381681|P1|STARTED|Days 1-3|Participants who received treatment|24
7875739|NCT00833469|19381737|P1|NOT COMPLETED|Overall Study||2
7875740|NCT00833469|19381737|P1|COMPLETED|Overall Study||3
7875741|NCT00833469|19381737|P1|STARTED|Overall Study||5
7875742|NCT00833443|19381745|P2|NOT COMPLETED|Overall Study||28
7875743|NCT00833443|19381746|P1|NOT COMPLETED|Overall Study||20
7875744|NCT00833443|19381745|P2|COMPLETED|Overall Study||15
7875745|NCT00833443|19381746|P1|COMPLETED|Overall Study||21
7875746|NCT00833443|19381745|P2|STARTED|Overall Study||43
7875747|NCT00833443|19381746|P1|STARTED|Overall Study||41
7875748|NCT00833417|19381760|P2|NOT COMPLETED|Overall Study||71
7875749|NCT00833417|19381761|P1|NOT COMPLETED|Overall Study||33
7875750|NCT00833417|19381760|P2|COMPLETED|Overall Study||0
7875751|NCT00833417|19381761|P1|COMPLETED|Overall Study||0
7875752|NCT00833417|19381760|P2|STARTED|Overall Study||71
7875753|NCT00833417|19381761|P1|STARTED|Overall Study||33
7875754|NCT00833365|19381776|P2|NOT COMPLETED|Overall Study||0
7875755|NCT00833365|19381777|P1|NOT COMPLETED|Overall Study||0
7875756|NCT00833365|19381776|P2|COMPLETED|Overall Study||6
7875757|NCT00833365|19381777|P1|COMPLETED|Overall Study||9
7875758|NCT00833365|19381776|P2|STARTED|Overall Study||6
7875759|NCT00833365|19381777|P1|STARTED|Overall Study||9
7875760|NCT00833261|19381785|P1|NOT COMPLETED|Overall Study||4
7875761|NCT00833261|19381785|P1|COMPLETED|Overall Study|3 patients withdrew from the study prior to treatment & 1 receiving it did not complete the course.|33
7875762|NCT00833261|19381785|P1|STARTED|Overall Study||37
7875763|NCT00833248|19381792|P2|NOT COMPLETED|Overall Study||3
7875764|NCT00833248|19381793|P1|NOT COMPLETED|Overall Study||4
7875765|NCT00833248|19381792|P2|COMPLETED|Overall Study||62
7875766|NCT00833248|19381793|P1|COMPLETED|Overall Study||177
7875767|NCT00833248|19381792|P2|Safety Analysis Set|Overall Study||64
7875768|NCT00833248|19381793|P1|Safety Analysis Set|Overall Study||181
7875769|NCT00833248|19381792|P2|Per Protocol (PP) Analysis Set|Overall Study||57
7875770|NCT00833248|19381793|P1|Per Protocol (PP) Analysis Set|Overall Study||164
7875771|NCT00833248|19381792|P2|Full Analysis Set (FAS)|Overall Study||64
7875772|NCT00833248|19381793|P1|Full Analysis Set (FAS)|Overall Study||180
7875773|NCT00833248|19381792|P2|STARTED|Overall Study||65
7875774|NCT00833248|19381793|P1|STARTED|Overall Study||181
7875775|NCT00833105|19381815|P1|NOT COMPLETED|Overall Study||3
7875776|NCT00833105|19381815|P1|COMPLETED|Overall Study||10
7875777|NCT00833105|19381815|P1|STARTED|Overall Study||13
7875778|NCT00833092|19381833|P2|NOT COMPLETED|Overall Study||7
7875779|NCT00833092|19381834|P1|NOT COMPLETED|Overall Study||4
7875780|NCT00833092|19381833|P2|COMPLETED|Overall Study||50
7875781|NCT00833092|19381834|P1|COMPLETED|Overall Study||50
7875782|NCT00833092|19381833|P2|STARTED|Overall Study||57
7875783|NCT00833092|19381834|P1|STARTED|Overall Study||54
7875784|NCT00833053|19381842|P2|NOT COMPLETED|Overall Study||3
7875785|NCT00833053|19381843|P1|NOT COMPLETED|Overall Study||9
7875786|NCT00833053|19381842|P2|COMPLETED|Overall Study||17
7875787|NCT00833053|19381843|P1|COMPLETED|Overall Study||10
7875788|NCT00833053|19381842|P2|STARTED|Overall Study||20
7875789|NCT00833053|19381843|P1|STARTED|Overall Study||19
7875790|NCT00833040|19381861|P6|NOT COMPLETED|Overall Study||1
7875791|NCT00833040|19381862|P5|NOT COMPLETED|Overall Study||0
7875792|NCT00833040|19381863|P4|NOT COMPLETED|Overall Study||0
7875793|NCT00833040|19381864|P3|NOT COMPLETED|Overall Study||0
7875794|NCT00833040|19381865|P2|NOT COMPLETED|Overall Study||0
7875795|NCT00833040|19381866|P1|NOT COMPLETED|Overall Study||0
7875796|NCT00833040|19381861|P6|COMPLETED|Overall Study||4
7875797|NCT00833040|19381862|P5|COMPLETED|Overall Study||5
7875798|NCT00833040|19381863|P4|COMPLETED|Overall Study||6
7875799|NCT00833040|19381864|P3|COMPLETED|Overall Study||6
7875800|NCT00833040|19381865|P2|COMPLETED|Overall Study||6
7875801|NCT00833040|19381866|P1|COMPLETED|Overall Study||6
7875802|NCT00833040|19381861|P6|STARTED|Overall Study||5
7875803|NCT00833040|19381862|P5|STARTED|Overall Study||5
7875804|NCT00833040|19381863|P4|STARTED|Overall Study||6
7875805|NCT00833040|19381864|P3|STARTED|Overall Study||6
7875806|NCT00833040|19381865|P2|STARTED|Overall Study||6
7875807|NCT00833040|19381866|P1|STARTED|Overall Study||6
7875808|NCT00833027|19381871|P1|NOT COMPLETED|Overall Study||211
7875809|NCT00833027|19381871|P1|COMPLETED|Overall Study||397
7875810|NCT00833027|19381871|P1|STARTED|Overall Study||608
7875811|NCT00832975|19381876|P1|NOT COMPLETED|Overall Study||39
7875812|NCT00832975|19381876|P1|COMPLETED|Overall Study||118
7875813|NCT00832975|19381876|P1|STARTED|Overall Study||157
7875814|NCT00832871|19381881|P1|NOT COMPLETED|Overall Study||0
7875815|NCT00832871|19381881|P1|COMPLETED|Overall Study||4
7875816|NCT00832871|19381881|P1|STARTED|Overall Study||4
7875817|NCT00832819|19381890|P3|NOT COMPLETED|Overall Study||1
7875818|NCT00832819|19381891|P2|NOT COMPLETED|Overall Study||1
7875819|NCT00832819|19381892|P1|NOT COMPLETED|Overall Study||0
7875820|NCT00832819|19381890|P3|COMPLETED|Overall Study||15
7875821|NCT00832819|19381891|P2|COMPLETED|Overall Study||5
7875822|NCT00832819|19381892|P1|COMPLETED|Overall Study||6
7875823|NCT00832819|19381890|P3|STARTED|Overall Study||16
7875824|NCT00832819|19381891|P2|STARTED|Overall Study||6
7875825|NCT00832819|19381892|P1|STARTED|Overall Study||6
7875826|NCT00832780|19381898|P1|NOT COMPLETED|Overall Study||25
7875827|NCT00832780|19381898|P1|COMPLETED|Overall Study||19
7875828|NCT00832780|19381898|P1|STARTED|Overall Study||44
7875829|NCT00832767|19381908|P2|NOT COMPLETED|Overall Study||18
7875830|NCT00832767|19381909|P1|NOT COMPLETED|Overall Study||22
7875831|NCT00832767|19381908|P2|COMPLETED|Overall Study||63
7875832|NCT00832767|19381909|P1|COMPLETED|Overall Study||99
7875833|NCT00832767|19381908|P2|STARTED|Overall Study||81
7875834|NCT00832767|19381909|P1|STARTED|Overall Study||121
7875835|NCT00832650|19381940|P3|NOT COMPLETED|Overall Study||1
7875836|NCT00832650|19381941|P2|NOT COMPLETED|Overall Study||0
7875837|NCT00832650|19381942|P1|NOT COMPLETED|Overall Study||0
7875838|NCT00832650|19381940|P3|COMPLETED|Overall Study||22
7875839|NCT00832650|19381941|P2|COMPLETED|Overall Study||12
7875840|NCT00832650|19381942|P1|COMPLETED|Overall Study||25
7875841|NCT00832650|19381940|P3|Treated|Overall Study||22
7875842|NCT00832650|19381941|P2|Treated|Overall Study||12
7875843|NCT00832650|19381942|P1|Treated|Overall Study||25
7875844|NCT00832650|19381940|P3|STARTED|Overall Study||23
7875845|NCT00832650|19381941|P2|STARTED|Overall Study||12
7875846|NCT00832650|19381942|P1|STARTED|Overall Study||25
7875847|NCT00832637|19381974|P1|NOT COMPLETED|Overall Study||0
7875848|NCT00832637|19381974|P1|COMPLETED|Overall Study||33
7875849|NCT00832637|19381974|P1|STARTED|Overall Study||33
7875850|NCT00832624|19381982|P1|NOT COMPLETED|Overall Study||10
7875851|NCT00832624|19381982|P1|COMPLETED|Overall Study||0
7875852|NCT00832624|19381982|P1|STARTED|Overall Study||10
7875853|NCT00832598|19381986|P1|NOT COMPLETED|Overall Study||0
7875854|NCT00832598|19381986|P1|COMPLETED|Overall Study||13
7875855|NCT00832598|19381986|P1|STARTED|Overall Study||13
7875856|NCT00832585|19381992|P1|NOT COMPLETED|Overall Study||2
7875857|NCT00832585|19381992|P1|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3
7875858|NCT00832585|19381992|P1|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5
7875859|NCT00832572|19381999|P2|NOT COMPLETED|Period 2||0
7875860|NCT00832572|19382000|P1|NOT COMPLETED|Period 2||0
7875861|NCT00832572|19381999|P2|COMPLETED|Period 2||2
7875862|NCT00832572|19382000|P1|COMPLETED|Period 2||3
7875863|NCT00832572|19381999|P2|STARTED|Period 2||2
7875864|NCT00832572|19382000|P1|STARTED|Period 2||3
7875865|NCT00832572|19381999|P2|NOT COMPLETED|Period 1||0
7875866|NCT00832572|19382000|P1|NOT COMPLETED|Period 1||0
7875867|NCT00832572|19381999|P2|COMPLETED|Period 1||2
7875868|NCT00832572|19382000|P1|COMPLETED|Period 1||3
7875869|NCT00832572|19381999|P2|STARTED|Period 1||2
7875870|NCT00832572|19382000|P1|STARTED|Period 1||3
7875871|NCT00832520|19382012|P1|NOT COMPLETED|Overall Study||0
7875872|NCT00832520|19382012|P1|COMPLETED|Overall Study||13
7875873|NCT00832520|19382012|P1|STARTED|Overall Study||13
7875874|NCT00832455|19382017|P1|NOT COMPLETED|Overall Study||72
7875875|NCT00832455|19382017|P1|COMPLETED|Overall Study||373
7875876|NCT00832455|19382017|P1|Week 12|Overall Study||373
7875877|NCT00832455|19382017|P1|Week 8 (Optional)|Overall Study||247
7875878|NCT00832455|19382017|P1|Week 4|Overall Study||411
7875879|NCT00832455|19382017|P1|Baseline|Overall Study|420 -patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420
7875880|NCT00832455|19382017|P1|STARTED|Overall Study|445 - number of patients that signed the informed consent form (Safety population)|445
7875881|NCT00832416|19382041|P4|NOT COMPLETED|Overall Study||83
7875882|NCT00832416|19382042|P3|NOT COMPLETED|Overall Study||61
7875883|NCT00832416|19382043|P2|NOT COMPLETED|Overall Study||53
7875884|NCT00832416|19382044|P1|NOT COMPLETED|Overall Study||46
7875885|NCT00832416|19382041|P4|COMPLETED|Overall Study||144
7875886|NCT00832416|19382042|P3|COMPLETED|Overall Study||54
7875887|NCT00832416|19382043|P2|COMPLETED|Overall Study||60
7875888|NCT00832416|19382044|P1|COMPLETED|Overall Study||64
7875889|NCT00832416|19382041|P4|STARTED|Overall Study||227
7875890|NCT00832416|19382042|P3|STARTED|Overall Study||115
7875891|NCT00832416|19382043|P2|STARTED|Overall Study||113
7875892|NCT00832416|19382044|P1|STARTED|Overall Study||110
7875893|NCT00832390|19382085|P3|NOT COMPLETED|Overall Study||0
7875894|NCT00832390|19382086|P2|NOT COMPLETED|Overall Study||0
7875895|NCT00832390|19382087|P1|NOT COMPLETED|Overall Study||0
7875896|NCT00832390|19382085|P3|COMPLETED|Overall Study||1
7875897|NCT00832390|19382086|P2|COMPLETED|Overall Study||16
7875898|NCT00832390|19382087|P1|COMPLETED|Overall Study||12
7875899|NCT00832390|19382085|P3|STARTED|Overall Study||1
7875900|NCT00832390|19382086|P2|STARTED|Overall Study||16
7875901|NCT00832390|19382087|P1|STARTED|Overall Study||12
7875902|NCT00832377|19382095|P1|NOT COMPLETED|Overall Study||1
7875903|NCT00832377|19382095|P1|COMPLETED|Overall Study||36
7875904|NCT00832377|19382095|P1|STARTED|Overall Study||37
7875905|NCT00832338|19382102|P1|NOT COMPLETED|Overall Study||0
7875906|NCT00832338|19382102|P1|COMPLETED|Overall Study||23
7875907|NCT00832338|19382102|P1|STARTED|Overall Study||23
7875908|NCT00832299|19382106|P1|NOT COMPLETED|Overall Study||0
7875909|NCT00832299|19382106|P1|COMPLETED|Overall Study||2
7875910|NCT00832299|19382106|P1|STARTED|Overall Study||2
7875911|NCT00832260|19382111|P1|NOT COMPLETED|Overall Study||0
7875912|NCT00832260|19382111|P1|COMPLETED|Overall Study||70
7875913|NCT00832260|19382111|P1|STARTED|Overall Study||70
7875914|NCT00832130|19382118|P2|NOT COMPLETED|Overall Study||0
7875915|NCT00832130|19382119|P1|NOT COMPLETED|Overall Study||0
7875916|NCT00832130|19382118|P2|COMPLETED|Overall Study||70
7875917|NCT00832130|19382119|P1|COMPLETED|Overall Study||69
7875918|NCT00832130|19382118|P2|STARTED|Overall Study||70
7875919|NCT00832130|19382119|P1|STARTED|Overall Study||69
7875920|NCT00832117|19382141|P1|NOT COMPLETED|Overall Study||12
7875921|NCT00832117|19382141|P1|COMPLETED|Overall Study||17
7875922|NCT00832117|19382141|P1|STARTED|Overall Study||29
7875923|NCT00832091|19382160|P2|NOT COMPLETED|Overall Study||2
7875924|NCT00832091|19382161|P1|NOT COMPLETED|Overall Study||5
7875925|NCT00832091|19382160|P2|COMPLETED|Overall Study||53
7875926|NCT00832091|19382161|P1|COMPLETED|Overall Study||12
7875927|NCT00832091|19382160|P2|STARTED|Overall Study||55
7875928|NCT00832091|19382161|P1|STARTED|Overall Study||17
7875929|NCT00832078|19382169|P2|NOT COMPLETED|Test Day 2 - 2 Period||0
7875930|NCT00832078|19382170|P1|NOT COMPLETED|Test Day 2 - 2 Period||1
7875931|NCT00832078|19382169|P2|COMPLETED|Test Day 2 - 2 Period||10
7875932|NCT00832078|19382170|P1|COMPLETED|Test Day 2 - 2 Period||12
7875933|NCT00832078|19382169|P2|STARTED|Test Day 2 - 2 Period||10
7875934|NCT00832078|19382170|P1|STARTED|Test Day 2 - 2 Period||13
7875935|NCT00832078|19382169|P2|NOT COMPLETED|Test Day 2 - 1 Period||0
7875936|NCT00832078|19382170|P1|NOT COMPLETED|Test Day 2 - 1 Period||0
7875937|NCT00832078|19382169|P2|COMPLETED|Test Day 2 - 1 Period||10
7875938|NCT00832078|19382170|P1|COMPLETED|Test Day 2 - 1 Period||13
7875939|NCT00832078|19382169|P2|STARTED|Test Day 2 - 1 Period||10
7875940|NCT00832078|19382170|P1|STARTED|Test Day 2 - 1 Period||13
7875941|NCT00832078|19382169|P2|NOT COMPLETED|Test Day 1-2 Period||2
7875942|NCT00832078|19382170|P1|NOT COMPLETED|Test Day 1-2 Period||0
7875943|NCT00832078|19382169|P2|COMPLETED|Test Day 1-2 Period||10
7875944|NCT00832078|19382170|P1|COMPLETED|Test Day 1-2 Period||13
7875945|NCT00832078|19382169|P2|STARTED|Test Day 1-2 Period||12
7875946|NCT00832078|19382170|P1|STARTED|Test Day 1-2 Period||13
7875947|NCT00832078|19382169|P2|NOT COMPLETED|Test Day 1- 1 Period||0
7875948|NCT00832078|19382170|P1|NOT COMPLETED|Test Day 1- 1 Period||0
7875949|NCT00832078|19382169|P2|COMPLETED|Test Day 1- 1 Period||12
7875950|NCT00832078|19382170|P1|COMPLETED|Test Day 1- 1 Period||13
7875951|NCT00832078|19382169|P2|STARTED|Test Day 1- 1 Period||12
7875952|NCT00832078|19382170|P1|STARTED|Test Day 1- 1 Period||13
7875953|NCT00832000|19382176|P2|NOT COMPLETED|Overall Study||1
7875954|NCT00832000|19382177|P1|NOT COMPLETED|Overall Study||6
7875955|NCT00832000|19382176|P2|COMPLETED|Overall Study||29
7875956|NCT00832000|19382177|P1|COMPLETED|Overall Study||23
7875957|NCT00832000|19382176|P2|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29
7875958|NCT00832000|19382177|P1|Crossed Over to Opposite Intervention|Overall Study|Placebo|25
7875959|NCT00832000|19382176|P2|STARTED|Overall Study|Placebo|30
7875960|NCT00832000|19382177|P1|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29
7875961|NCT00831987|19382215|P2|NOT COMPLETED|Overall Study||0
7875962|NCT00831987|19382216|P1|NOT COMPLETED|Overall Study||0
7875963|NCT00831987|19382215|P2|COMPLETED|Overall Study||60
7875964|NCT00831987|19382216|P1|COMPLETED|Overall Study||60
7875965|NCT00831987|19382215|P2|STARTED|Overall Study||60
7875966|NCT00831987|19382216|P1|STARTED|Overall Study||60
7875967|NCT00831844|19382238|P10|NOT COMPLETED|Overall Study||0
7875968|NCT00831844|19382239|P9|NOT COMPLETED|Overall Study||9
7875969|NCT00831844|19382240|P8|NOT COMPLETED|Overall Study||10
7875970|NCT00831844|19382241|P7|NOT COMPLETED|Overall Study||10
7875971|NCT00831844|19382242|P6|NOT COMPLETED|Overall Study||19
7875972|NCT00831844|19382243|P5|NOT COMPLETED|Overall Study||14
7875973|NCT00831844|19382244|P4|NOT COMPLETED|Overall Study||10
7875974|NCT00831844|19382245|P3|NOT COMPLETED|Overall Study||20
7875975|NCT00831844|19382246|P2|NOT COMPLETED|Overall Study||12
7875976|NCT00831844|19382247|P1|NOT COMPLETED|Overall Study||10
7875977|NCT00831844|19382238|P10|COMPLETED|Overall Study||0
7875978|NCT00831844|19382239|P9|COMPLETED|Overall Study||0
7875979|NCT00831844|19382240|P8|COMPLETED|Overall Study||0
7875980|NCT00831844|19382241|P7|COMPLETED|Overall Study||0
7875981|NCT00831844|19382242|P6|COMPLETED|Overall Study||1
7875982|NCT00831844|19382243|P5|COMPLETED|Overall Study||0
7875983|NCT00831844|19382244|P4|COMPLETED|Overall Study||0
7875984|NCT00831844|19382245|P3|COMPLETED|Overall Study||1
7875985|NCT00831844|19382246|P2|COMPLETED|Overall Study||0
7875986|NCT00831844|19382247|P1|COMPLETED|Overall Study||0
7875987|NCT00831844|19382238|P10|STARTED|Overall Study||0
7875988|NCT00831844|19382239|P9|STARTED|Overall Study||9
7875989|NCT00831844|19382240|P8|STARTED|Overall Study||10
7875990|NCT00831844|19382241|P7|STARTED|Overall Study||10
7875991|NCT00831844|19382242|P6|STARTED|Overall Study||20
7875992|NCT00831844|19382243|P5|STARTED|Overall Study||14
7875993|NCT00831844|19382244|P4|STARTED|Overall Study||10
7875994|NCT00831844|19382245|P3|STARTED|Overall Study||21
7875995|NCT00831844|19382246|P2|STARTED|Overall Study||12
7875996|NCT00831844|19382247|P1|STARTED|Overall Study||10
7875997|NCT00831792|19382269|P1|NOT COMPLETED|Overall Study||6
7875998|NCT00831792|19382269|P1|COMPLETED|Overall Study||40
7875999|NCT00831792|19382269|P1|STARTED|Overall Study||46
7876000|NCT00831779|19382275|P2|NOT COMPLETED|Overall Study||1
7876001|NCT00831779|19382276|P1|NOT COMPLETED|Overall Study||1
7876002|NCT00831779|19382275|P2|COMPLETED|Overall Study||22
7876003|NCT00831779|19382276|P1|COMPLETED|Overall Study||20
7876004|NCT00831779|19382275|P2|STARTED|Overall Study||23
7876005|NCT00831779|19382276|P1|STARTED|Overall Study||21
7876006|NCT00831766|19382286|P2|NOT COMPLETED|Overall Study||0
7876007|NCT00831766|19382287|P1|NOT COMPLETED|Overall Study||0
7876008|NCT00831766|19382286|P2|COMPLETED|Overall Study||28
7876009|NCT00831766|19382287|P1|COMPLETED|Overall Study||23
7876010|NCT00831766|19382286|P2|STARTED|Overall Study||28
7876011|NCT00831766|19382287|P1|STARTED|Overall Study||23
7876012|NCT00831753|19382298|P2|NOT COMPLETED|Overall Study||0
7876013|NCT00831753|19382299|P1|NOT COMPLETED|Overall Study||0
7876014|NCT00831753|19382298|P2|COMPLETED|Overall Study||131
7876015|NCT00831753|19382299|P1|COMPLETED|Overall Study||132
7876016|NCT00831753|19382298|P2|STARTED|Overall Study||131
7876017|NCT00831753|19382299|P1|STARTED|Overall Study||132
7876018|NCT00831701|19382313|P2|NOT COMPLETED|Overall Study||5
7876019|NCT00831701|19382314|P1|NOT COMPLETED|Overall Study||5
7876020|NCT00831701|19382313|P2|COMPLETED|Overall Study||45
7876021|NCT00831701|19382314|P1|COMPLETED|Overall Study||45
7876022|NCT00831701|19382313|P2|STARTED|Overall Study||50
7876023|NCT00831701|19382314|P1|STARTED|Overall Study||50
7876024|NCT00831675|19382330|P2|NOT COMPLETED|Overall Study||0
7876025|NCT00831675|19382331|P1|NOT COMPLETED|Overall Study||0
7876026|NCT00831675|19382330|P2|COMPLETED|Overall Study||18
7876027|NCT00831675|19382331|P1|COMPLETED|Overall Study||12
7876028|NCT00831675|19382330|P2|STARTED|Overall Study||18
7876029|NCT00831675|19382331|P1|STARTED|Overall Study||12
7876030|NCT00831493|19382343|P1|NOT COMPLETED|Overall Study||1
7876031|NCT00831493|19382343|P1|COMPLETED|Overall Study||2
7876032|NCT00831493|19382343|P1|STARTED|Overall Study||3
7876033|NCT00831480|19382347|P1|NOT COMPLETED|Overall Study||2
7876034|NCT00831480|19382347|P1|COMPLETED|Overall Study||7
7876035|NCT00831480|19382347|P1|STARTED|Overall Study||9
7876036|NCT00831441|19382353|P2|NOT COMPLETED|Follow Up (30 Days)||174
7876037|NCT00831441|19382354|P1|NOT COMPLETED|Follow Up (30 Days)||133
7876038|NCT00831441|19382353|P2|COMPLETED|Follow Up (30 Days)||3355
7876039|NCT00831441|19382354|P1|COMPLETED|Follow Up (30 Days)||3375
7876040|NCT00831441|19382353|P2|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529
7876041|NCT00831441|19382354|P1|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508
7876042|NCT00831441|19382353|P2|NOT COMPLETED|Randomized||3705
7876043|NCT00831441|19382354|P1|NOT COMPLETED|Randomized||3687
7876044|NCT00831441|19382353|P2|COMPLETED|Randomized||0
7876045|NCT00831441|19382354|P1|COMPLETED|Randomized||0
7876046|NCT00831441|19382353|P2|Treated|Randomized||3672
7876047|NCT00831441|19382354|P1|Treated|Randomized||3643
7876048|NCT00831441|19382353|P2|STARTED|Randomized||3705
7876049|NCT00831441|19382354|P1|STARTED|Randomized||3687
7876050|NCT00831428|19382382|P1|NOT COMPLETED|Overall Study||0
7876051|NCT00831428|19382382|P1|COMPLETED|Overall Study||97
7876052|NCT00831428|19382382|P1|STARTED|Overall Study||97
7876053|NCT00831415|19382386|P1|NOT COMPLETED|Overall Study||75
7876054|NCT00831415|19382386|P1|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229
7876055|NCT00831415|19382386|P1|"Study Completers"|Overall Study|"Defined as participants whose conclusion of study participation status was study completed."|227
7876056|NCT00831415|19382386|P1|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227
7876057|NCT00831415|19382386|P1|STARTED|Overall Study||304
7876058|NCT00831389|19382395|P2|NOT COMPLETED|Overall Study||1
7876059|NCT00831389|19382396|P1|NOT COMPLETED|Overall Study||0
7876060|NCT00831389|19382395|P2|COMPLETED|Overall Study||6
7876061|NCT00831389|19382396|P1|COMPLETED|Overall Study||6
7876062|NCT00831389|19382395|P2|STARTED|Overall Study||7
7876063|NCT00831389|19382396|P1|STARTED|Overall Study||6
7876064|NCT00831311|19382422|P2|NOT COMPLETED|Overall Study||8
7876065|NCT00831311|19382423|P1|NOT COMPLETED|Overall Study||12
7876066|NCT00831311|19382422|P2|COMPLETED|Overall Study||304
7876067|NCT00831311|19382423|P1|COMPLETED|Overall Study||300
7876068|NCT00831311|19382422|P2|STARTED|Overall Study||312
7876069|NCT00831311|19382423|P1|STARTED|Overall Study||312
7876070|NCT00831272|19382445|P4|NOT COMPLETED|Overall Study||10
7876071|NCT00831272|19382446|P3|NOT COMPLETED|Overall Study||10
7876072|NCT00831272|19382447|P2|NOT COMPLETED|Overall Study||7
7876073|NCT00831272|19382448|P1|NOT COMPLETED|Overall Study||8
7876074|NCT00831272|19382445|P4|COMPLETED|Overall Study||56
7876075|NCT00831272|19382446|P3|COMPLETED|Overall Study||63
7876076|NCT00831272|19382447|P2|COMPLETED|Overall Study||37
7876077|NCT00831272|19382448|P1|COMPLETED|Overall Study||30
7876078|NCT00831272|19382445|P4|STARTED|Overall Study||66
7876079|NCT00831272|19382446|P3|STARTED|Overall Study||73
7876080|NCT00831272|19382447|P2|STARTED|Overall Study||44
7876081|NCT00831272|19382448|P1|STARTED|Overall Study||38
7876082|NCT00831233|19382460|P2|NOT COMPLETED|Overall Study||1
7876083|NCT00831233|19382461|P1|NOT COMPLETED|Overall Study||3
7876084|NCT00831233|19382460|P2|COMPLETED|Overall Study||12
7876085|NCT00831233|19382461|P1|COMPLETED|Overall Study||26
7876086|NCT00831233|19382460|P2|Per Protocol (PP) Analysis Set|Overall Study||11
7876087|NCT00831233|19382461|P1|Per Protocol (PP) Analysis Set|Overall Study||26
7876088|NCT00831233|19382460|P2|Full Analysis Set (FAS)|Overall Study||13
7876089|NCT00831233|19382461|P1|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27
7876090|NCT00831233|19382460|P2|STARTED|Overall Study|ITT population.|13
7876091|NCT00831233|19382461|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|29
7876092|NCT00831181|19382485|P1|NOT COMPLETED|Overall Study||12
7876093|NCT00831181|19382485|P1|COMPLETED|Overall Study||15
7876094|NCT00831181|19382485|P1|STARTED|Overall Study||27
7876095|NCT00831129|19382498|P2|NOT COMPLETED|Overall Study||10
7876096|NCT00831129|19382499|P1|NOT COMPLETED|Overall Study||0
7876097|NCT00831129|19382498|P2|COMPLETED|Overall Study||23
7876098|NCT00831129|19382499|P1|COMPLETED|Overall Study||20
7876099|NCT00831129|19382498|P2|STARTED|Overall Study||33
7876100|NCT00831129|19382499|P1|STARTED|Overall Study||20
7876101|NCT00830960|19382541|P6|NOT COMPLETED|Overall Study||37
7876102|NCT00830960|19382542|P5|NOT COMPLETED|Overall Study||32
7876103|NCT00830960|19382543|P4|NOT COMPLETED|Overall Study||32
7876104|NCT00830960|19382544|P3|NOT COMPLETED|Overall Study||29
7876105|NCT00830960|19382545|P2|NOT COMPLETED|Overall Study||28
7876106|NCT00830960|19382546|P1|NOT COMPLETED|Overall Study||33
7876107|NCT00830960|19382541|P6|COMPLETED|Overall Study||63
7876108|NCT00830960|19382542|P5|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64
7876109|NCT00830960|19382543|P4|COMPLETED|Overall Study||106
7876110|NCT00830960|19382544|P3|COMPLETED|Overall Study||108
7876111|NCT00830960|19382545|P2|COMPLETED|Overall Study||96
7876112|NCT00830960|19382546|P1|COMPLETED|Overall Study||91
7876113|NCT00830960|19382541|P6|Received at Least 1 Dose of Study Drug|Overall Study||93
7876114|NCT00830960|19382542|P5|Received at Least 1 Dose of Study Drug|Overall Study||91
7876115|NCT00830960|19382543|P4|Received at Least 1 Dose of Study Drug|Overall Study||135
7876116|NCT00830960|19382544|P3|Received at Least 1 Dose of Study Drug|Overall Study||133
7876117|NCT00830960|19382545|P2|Received at Least 1 Dose of Study Drug|Overall Study||122
7876118|NCT00830960|19382546|P1|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117
7876119|NCT00830960|19382541|P6|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100
7876120|NCT00830960|19382542|P5|STARTED|Overall Study||96
7876121|NCT00830960|19382543|P4|STARTED|Overall Study||138
7876122|NCT00830960|19382544|P3|STARTED|Overall Study||137
7876123|NCT00830960|19382545|P2|STARTED|Overall Study||124
7876124|NCT00830960|19382546|P1|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124
7876125|NCT00830947|19382662|P2|NOT COMPLETED|Overall Study||4
7876126|NCT00830947|19382663|P1|NOT COMPLETED|Overall Study||4
7876127|NCT00830947|19382662|P2|COMPLETED|Overall Study||18
7876128|NCT00830947|19382663|P1|COMPLETED|Overall Study||19
7876129|NCT00830947|19382662|P2|STARTED|Overall Study||22
7876130|NCT00830947|19382663|P1|STARTED|Overall Study||23
7876131|NCT00830869|19382681|P12|NOT COMPLETED|Period 2: Part 2||20
7876132|NCT00830869|19382682|P11|NOT COMPLETED|Period 2: Part 2||11
7876133|NCT00830869|19382683|P10|NOT COMPLETED|Period 2: Part 2||20
7876134|NCT00830869|19382684|P9|NOT COMPLETED|Period 2: Part 2||22
7876135|NCT00830869|19382685|P8|NOT COMPLETED|Period 2: Part 2||20
7876136|NCT00830869|19382686|P7|NOT COMPLETED|Period 2: Part 2||0
7876137|NCT00830869|19382687|P6|NOT COMPLETED|Period 2: Part 2||0
7876138|NCT00830869|19382688|P5|NOT COMPLETED|Period 2: Part 2||0
7876139|NCT00830869|19382689|P4|NOT COMPLETED|Period 2: Part 2||0
7876140|NCT00830869|19382690|P3|NOT COMPLETED|Period 2: Part 2||0
7876141|NCT00830869|19382691|P2|NOT COMPLETED|Period 2: Part 2||0
7876142|NCT00830869|19382692|P1|NOT COMPLETED|Period 2: Part 2||0
7876143|NCT00830869|19382681|P12|COMPLETED|Period 2: Part 2||0
7876144|NCT00830869|19382682|P11|COMPLETED|Period 2: Part 2||0
7876145|NCT00830869|19382683|P10|COMPLETED|Period 2: Part 2||0
7876146|NCT00830869|19382684|P9|COMPLETED|Period 2: Part 2||0
7876147|NCT00830869|19382685|P8|COMPLETED|Period 2: Part 2||0
7876148|NCT00830869|19382686|P7|COMPLETED|Period 2: Part 2||0
7876149|NCT00830869|19382687|P6|COMPLETED|Period 2: Part 2||0
7876150|NCT00830869|19382688|P5|COMPLETED|Period 2: Part 2||0
7876151|NCT00830869|19382689|P4|COMPLETED|Period 2: Part 2||0
7876152|NCT00830869|19382690|P3|COMPLETED|Period 2: Part 2||0
7876153|NCT00830869|19382691|P2|COMPLETED|Period 2: Part 2||0
7876154|NCT00830869|19382692|P1|COMPLETED|Period 2: Part 2||0
7876155|NCT00830869|19382681|P12|STARTED|Period 2: Part 2||20
7876156|NCT00830869|19382682|P11|STARTED|Period 2: Part 2||11
7876157|NCT00830869|19382683|P10|STARTED|Period 2: Part 2||20
7876158|NCT00830869|19382684|P9|STARTED|Period 2: Part 2||22
7876159|NCT00830869|19382685|P8|STARTED|Period 2: Part 2||20
7876160|NCT00830869|19382686|P7|STARTED|Period 2: Part 2||0
7876161|NCT00830869|19382687|P6|STARTED|Period 2: Part 2||0
7876162|NCT00830869|19382688|P5|STARTED|Period 2: Part 2||0
7876163|NCT00830869|19382689|P4|STARTED|Period 2: Part 2||0
7876164|NCT00830869|19382690|P3|STARTED|Period 2: Part 2||0
7876165|NCT00830869|19382691|P2|STARTED|Period 2: Part 2||0
7876166|NCT00830869|19382692|P1|STARTED|Period 2: Part 2||0
7876167|NCT00830869|19382681|P12|NOT COMPLETED|Period 1: Part 1||0
7876168|NCT00830869|19382682|P11|NOT COMPLETED|Period 1: Part 1||0
7876169|NCT00830869|19382683|P10|NOT COMPLETED|Period 1: Part 1||0
7876170|NCT00830869|19382684|P9|NOT COMPLETED|Period 1: Part 1||0
7876171|NCT00830869|19382685|P8|NOT COMPLETED|Period 1: Part 1||0
7876172|NCT00830869|19382686|P7|NOT COMPLETED|Period 1: Part 1||3
7876173|NCT00830869|19382687|P6|NOT COMPLETED|Period 1: Part 1||6
7876174|NCT00830869|19382688|P5|NOT COMPLETED|Period 1: Part 1||4
7876175|NCT00830869|19382689|P4|NOT COMPLETED|Period 1: Part 1||7
7876176|NCT00830869|19382690|P3|NOT COMPLETED|Period 1: Part 1||1
7876177|NCT00830869|19382691|P2|NOT COMPLETED|Period 1: Part 1||1
7876178|NCT00830869|19382692|P1|NOT COMPLETED|Period 1: Part 1||1
7876179|NCT00830869|19382681|P12|COMPLETED|Period 1: Part 1||0
7876180|NCT00830869|19382682|P11|COMPLETED|Period 1: Part 1||0
7876181|NCT00830869|19382683|P10|COMPLETED|Period 1: Part 1||0
7876182|NCT00830869|19382684|P9|COMPLETED|Period 1: Part 1||0
7876183|NCT00830869|19382685|P8|COMPLETED|Period 1: Part 1||0
7876184|NCT00830869|19382686|P7|COMPLETED|Period 1: Part 1||0
7876185|NCT00830869|19382687|P6|COMPLETED|Period 1: Part 1||0
7876186|NCT00830869|19382688|P5|COMPLETED|Period 1: Part 1||0
7876187|NCT00830869|19382689|P4|COMPLETED|Period 1: Part 1||0
7876188|NCT00830869|19382690|P3|COMPLETED|Period 1: Part 1||0
7876189|NCT00830869|19382691|P2|COMPLETED|Period 1: Part 1||0
7876190|NCT00830869|19382692|P1|COMPLETED|Period 1: Part 1||0
7876191|NCT00830869|19382681|P12|STARTED|Period 1: Part 1||0
7876192|NCT00830869|19382682|P11|STARTED|Period 1: Part 1||0
7876193|NCT00830869|19382683|P10|STARTED|Period 1: Part 1||0
7876194|NCT00830869|19382684|P9|STARTED|Period 1: Part 1||0
7876195|NCT00830869|19382685|P8|STARTED|Period 1: Part 1||0
7876196|NCT00830869|19382686|P7|STARTED|Period 1: Part 1||3
7876197|NCT00830869|19382687|P6|STARTED|Period 1: Part 1||6
7876198|NCT00830869|19382688|P5|STARTED|Period 1: Part 1||4
7876199|NCT00830869|19382689|P4|STARTED|Period 1: Part 1||7
7876200|NCT00830869|19382690|P3|STARTED|Period 1: Part 1||1
7876201|NCT00830869|19382691|P2|STARTED|Period 1: Part 1||1
7876202|NCT00830869|19382692|P1|STARTED|Period 1: Part 1||1
7876203|NCT00830804|19382828|P1|NOT COMPLETED|Overall Study||15
7876204|NCT00830804|19382828|P1|COMPLETED|Overall Study||97
7876205|NCT00830804|19382828|P1|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112
7876206|NCT00830791|19382854|P6|NOT COMPLETED|Overall Study||0
7876207|NCT00830791|19382855|P5|NOT COMPLETED|Overall Study||0
7876208|NCT00830791|19382856|P4|NOT COMPLETED|Overall Study||0
7876209|NCT00830791|19382857|P3|NOT COMPLETED|Overall Study||0
7876210|NCT00830791|19382858|P2|NOT COMPLETED|Overall Study||0
7876211|NCT00830791|19382859|P1|NOT COMPLETED|Overall Study||0
7876212|NCT00830791|19382854|P6|COMPLETED|Overall Study||0
7876213|NCT00830791|19382855|P5|COMPLETED|Overall Study||0
7876214|NCT00830791|19382856|P4|COMPLETED|Overall Study||8
7876215|NCT00830791|19382857|P3|COMPLETED|Overall Study||8
7876216|NCT00830791|19382858|P2|COMPLETED|Overall Study||8
7876217|NCT00830791|19382859|P1|COMPLETED|Overall Study||8
7876218|NCT00830791|19382854|P6|STARTED|Overall Study||0
7876219|NCT00830791|19382855|P5|STARTED|Overall Study||0
7876220|NCT00830791|19382856|P4|STARTED|Overall Study||8
7876221|NCT00830791|19382857|P3|STARTED|Overall Study||8
7876222|NCT00830791|19382858|P2|STARTED|Overall Study||8
7876223|NCT00830791|19382859|P1|STARTED|Overall Study||8
7876224|NCT00830765|19382908|P2|NOT COMPLETED|Overall Study||2
7876225|NCT00830765|19382909|P1|NOT COMPLETED|Overall Study||3
7876226|NCT00830765|19382908|P2|COMPLETED|Overall Study||69
7876227|NCT00830765|19382909|P1|COMPLETED|Overall Study||70
7876228|NCT00830765|19382908|P2|STARTED|Overall Study||71
7876229|NCT00830765|19382909|P1|STARTED|Overall Study||73
7876230|NCT00830596|19382918|P3|NOT COMPLETED|Overall Study||6
7876231|NCT00830596|19382919|P2|NOT COMPLETED|Overall Study||2
7876232|NCT00830596|19382920|P1|NOT COMPLETED|Overall Study||2
7876233|NCT00830596|19382918|P3|COMPLETED|Overall Study||67
7876234|NCT00830596|19382919|P2|COMPLETED|Overall Study||72
7876235|NCT00830596|19382920|P1|COMPLETED|Overall Study||72
7876236|NCT00830596|19382918|P3|STARTED|Overall Study||73
7876237|NCT00830596|19382919|P2|STARTED|Overall Study||74
7876238|NCT00830596|19382920|P1|STARTED|Overall Study||74
7876239|NCT00830518|19382942|P2|NOT COMPLETED|Overall Study||11
7876240|NCT00830518|19382943|P1|NOT COMPLETED|Overall Study||46
7876241|NCT00830518|19382942|P2|COMPLETED|Overall Study||0
7876242|NCT00830518|19382943|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
7876243|NCT00830518|19382942|P2|STARTED|Overall Study||11
7876244|NCT00830518|19382943|P1|STARTED|Overall Study||46
7876245|NCT00830440|19382962|P2|NOT COMPLETED|Overall Study||0
7876246|NCT00830440|19382963|P1|NOT COMPLETED|Overall Study||8
7876247|NCT00830440|19382962|P2|COMPLETED|Overall Study||11
7876248|NCT00830440|19382963|P1|COMPLETED|Overall Study||24
7876249|NCT00830440|19382962|P2|Completed 24 Week Follow up|Overall Study||0
7876250|NCT00830440|19382963|P1|Completed 24 Week Follow up|Overall Study||3
7876251|NCT00830440|19382962|P2|Completed 16 Week Follow up|Overall Study||0
7876252|NCT00830440|19382963|P1|Completed 16 Week Follow up|Overall Study||4
7876253|NCT00830440|19382962|P2|Completed 12 Week Follow up|Overall Study||11
7876254|NCT00830440|19382963|P1|Completed 12 Week Follow up|Overall Study||24
7876255|NCT00830440|19382962|P2|Received Device|Overall Study||0
7876256|NCT00830440|19382963|P1|Received Device|Overall Study||26
7876257|NCT00830440|19382962|P2|STARTED|Overall Study||11
7876258|NCT00830440|19382963|P1|STARTED|Overall Study||32
7876259|NCT00830388|19382973|P1|NOT COMPLETED|Overall Study||0
7876260|NCT00830388|19382973|P1|COMPLETED|Overall Study||11
7876261|NCT00830388|19382973|P1|STARTED|Overall Study||11
7876262|NCT00830375|19382978|P1|NOT COMPLETED|Overall Study||1
7876263|NCT00830375|19382978|P1|COMPLETED|Overall Study||9
7876264|NCT00830375|19382978|P1|STARTED|Overall Study||10
7876265|NCT00830362|19382984|P2|NOT COMPLETED|Overall Study||4
7876266|NCT00830362|19382985|P1|NOT COMPLETED|Overall Study||4
7876267|NCT00830362|19382984|P2|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20
7876268|NCT00830362|19382985|P1|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23
7876269|NCT00830362|19382984|P2|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24
7876270|NCT00830362|19382985|P1|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26
7876271|NCT00830362|19382984|P2|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24
7876272|NCT00830362|19382985|P1|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27
7876273|NCT00830336|19382993|P2|NOT COMPLETED|Second Intervention||0
7876274|NCT00830336|19382994|P1|NOT COMPLETED|Second Intervention||0
7876275|NCT00830336|19382993|P2|COMPLETED|Second Intervention||40
7876276|NCT00830336|19382994|P1|COMPLETED|Second Intervention||39
7876277|NCT00830336|19382993|P2|STARTED|Second Intervention||40
7876278|NCT00830336|19382994|P1|STARTED|Second Intervention||39
7876279|NCT00830336|19382993|P2|NOT COMPLETED|Washout: 21 Days||0
7876280|NCT00830336|19382994|P1|NOT COMPLETED|Washout: 21 Days||1
7876281|NCT00830336|19382993|P2|COMPLETED|Washout: 21 Days||40
7876282|NCT00830336|19382994|P1|COMPLETED|Washout: 21 Days||39
7876283|NCT00830336|19382993|P2|STARTED|Washout: 21 Days||40
7876284|NCT00830336|19382994|P1|STARTED|Washout: 21 Days||40
7876285|NCT00830336|19382993|P2|NOT COMPLETED|First Intervention||0
7876286|NCT00830336|19382994|P1|NOT COMPLETED|First Intervention||0
7876287|NCT00830336|19382993|P2|COMPLETED|First Intervention||40
7876288|NCT00830336|19382994|P1|COMPLETED|First Intervention||40
7876289|NCT00830336|19382993|P2|STARTED|First Intervention||40
7876290|NCT00830336|19382994|P1|STARTED|First Intervention||40
7876291|NCT00830310|19383002|P1|NOT COMPLETED|Overall Study||13
7876292|NCT00830310|19383002|P1|COMPLETED|Overall Study||30
7876293|NCT00830310|19383002|P1|STARTED|Overall Study||43
7876294|NCT00830284|19383014|P1|NOT COMPLETED|Overall Study||2
7876295|NCT00830284|19383014|P1|COMPLETED|Overall Study||10
7876296|NCT00830284|19383014|P1|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12
7876297|NCT00830258|19383021|P2|NOT COMPLETED|Second Intervention||0
7876298|NCT00830258|19383022|P1|NOT COMPLETED|Second Intervention||0
7876299|NCT00830258|19383021|P2|COMPLETED|Second Intervention||30
7876300|NCT00830258|19383022|P1|COMPLETED|Second Intervention||28
7876301|NCT00830258|19383021|P2|STARTED|Second Intervention||30
7876302|NCT00830258|19383022|P1|STARTED|Second Intervention||28
7876303|NCT00830258|19383021|P2|NOT COMPLETED|Washout: 7 Days||0
7876304|NCT00830258|19383022|P1|NOT COMPLETED|Washout: 7 Days||1
7876305|NCT00830258|19383021|P2|COMPLETED|Washout: 7 Days||30
7876306|NCT00830258|19383022|P1|COMPLETED|Washout: 7 Days||28
7876307|NCT00830258|19383021|P2|STARTED|Washout: 7 Days||30
7876308|NCT00830258|19383022|P1|STARTED|Washout: 7 Days||29
7876309|NCT00830258|19383021|P2|NOT COMPLETED|First Intervention||0
7876310|NCT00830258|19383022|P1|NOT COMPLETED|First Intervention||1
7876311|NCT00830258|19383021|P2|COMPLETED|First Intervention||30
7876312|NCT00830258|19383022|P1|COMPLETED|First Intervention||29
7876313|NCT00830258|19383021|P2|STARTED|First Intervention||30
7876314|NCT00830258|19383022|P1|STARTED|First Intervention||30
7876315|NCT00830232|19383032|P2|NOT COMPLETED|Overall Study||0
7876316|NCT00830232|19383033|P1|NOT COMPLETED|Overall Study||0
7876317|NCT00830232|19383032|P2|COMPLETED|Overall Study||20
7876318|NCT00830232|19383033|P1|COMPLETED|Overall Study||20
7876319|NCT00830232|19383032|P2|STARTED|Overall Study||20
7876320|NCT00830232|19383033|P1|STARTED|Overall Study||20
7876321|NCT00830219|19383041|P2|NOT COMPLETED|Second Intervention||0
7876322|NCT00830219|19383042|P1|NOT COMPLETED|Second Intervention||0
7876323|NCT00830219|19383041|P2|COMPLETED|Second Intervention||22
7876324|NCT00830219|19383042|P1|COMPLETED|Second Intervention||22
7876325|NCT00830219|19383041|P2|STARTED|Second Intervention||22
7876326|NCT00830219|19383042|P1|STARTED|Second Intervention||22
7876327|NCT00830219|19383041|P2|NOT COMPLETED|Washout of 7 Days||1
7876328|NCT00830219|19383042|P1|NOT COMPLETED|Washout of 7 Days||1
7876329|NCT00830219|19383041|P2|COMPLETED|Washout of 7 Days||22
7876330|NCT00830219|19383042|P1|COMPLETED|Washout of 7 Days||22
7876331|NCT00830219|19383041|P2|STARTED|Washout of 7 Days||23
7876332|NCT00830219|19383042|P1|STARTED|Washout of 7 Days||23
7876333|NCT00830219|19383041|P2|NOT COMPLETED|First Intervention||0
7876334|NCT00830219|19383042|P1|NOT COMPLETED|First Intervention||0
7876335|NCT00830219|19383041|P2|COMPLETED|First Intervention||23
7876336|NCT00830219|19383042|P1|COMPLETED|First Intervention||23
7876337|NCT00830219|19383041|P2|STARTED|First Intervention||23
7876338|NCT00830219|19383042|P1|STARTED|First Intervention||23
7876339|NCT00830206|19383052|P2|NOT COMPLETED|Second Intervention||0
7876340|NCT00830206|19383053|P1|NOT COMPLETED|Second Intervention||0
7876341|NCT00830206|19383052|P2|COMPLETED|Second Intervention||39
7876342|NCT00830206|19383053|P1|COMPLETED|Second Intervention||39
7876343|NCT00830206|19383052|P2|STARTED|Second Intervention||39
7876344|NCT00830206|19383053|P1|STARTED|Second Intervention||39
7876345|NCT00830206|19383052|P2|NOT COMPLETED|Washout: 21 Days||1
7876346|NCT00830206|19383053|P1|NOT COMPLETED|Washout: 21 Days||1
7876347|NCT00830206|19383052|P2|COMPLETED|Washout: 21 Days||39
7876348|NCT00830206|19383053|P1|COMPLETED|Washout: 21 Days||39
7876349|NCT00830206|19383052|P2|STARTED|Washout: 21 Days||40
7876350|NCT00830206|19383053|P1|STARTED|Washout: 21 Days||40
7876351|NCT00830206|19383052|P2|NOT COMPLETED|First Intervention||0
7876352|NCT00830206|19383053|P1|NOT COMPLETED|First Intervention||0
7876353|NCT00830206|19383052|P2|COMPLETED|First Intervention||40
7876354|NCT00830206|19383053|P1|COMPLETED|First Intervention||40
7876355|NCT00830206|19383052|P2|STARTED|First Intervention||40
7876356|NCT00830206|19383053|P1|STARTED|First Intervention||40
7876357|NCT00830167|19383063|P2|NOT COMPLETED|Overall Study||43
7876358|NCT00830167|19383064|P1|NOT COMPLETED|Overall Study||40
7876359|NCT00830167|19383063|P2|COMPLETED|Overall Study||207
7876360|NCT00830167|19383064|P1|COMPLETED|Overall Study||208
7876361|NCT00830167|19383063|P2|STARTED|Overall Study|Treated|250
7876362|NCT00830167|19383064|P1|STARTED|Overall Study|Treated|248
7876363|NCT00830128|19383134|P1|NOT COMPLETED|Overall Study||19
7876364|NCT00830128|19383134|P1|COMPLETED|Overall Study||87
7876365|NCT00830128|19383134|P1|STARTED|Overall Study||106
7876366|NCT00830115|19383149|P1|NOT COMPLETED|Overall Study||3
7876367|NCT00830115|19383149|P1|COMPLETED|Overall Study||1042
7876368|NCT00830115|19383149|P1|STARTED|Overall Study||1045
7876369|NCT00830076|19383165|P1|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0
7876370|NCT00830076|19383165|P1|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18
7876371|NCT00830076|19383165|P1|STARTED|Placebo Sitagliptin + Placebo Metformin||18
7876372|NCT00830076|19383165|P1|NOT COMPLETED|7-day Washout||0
7876373|NCT00830076|19383165|P1|COMPLETED|7-day Washout||18
7876374|NCT00830076|19383165|P1|STARTED|7-day Washout||18
7876375|NCT00830076|19383165|P1|NOT COMPLETED|Sitagliptin + Metformin||0
7876376|NCT00830076|19383165|P1|COMPLETED|Sitagliptin + Metformin||18
7876377|NCT00830076|19383165|P1|STARTED|Sitagliptin + Metformin||18
7876378|NCT00830076|19383165|P1|NOT COMPLETED|7-day Washout||0
7876379|NCT00830076|19383165|P1|COMPLETED|7-day Washout||18
7876380|NCT00830076|19383165|P1|STARTED|7-day Washout||18
7876381|NCT00830076|19383165|P1|NOT COMPLETED|Metformin + Placebo Sitagliptin||0
7876382|NCT00830076|19383165|P1|COMPLETED|Metformin + Placebo Sitagliptin||18
7876383|NCT00830076|19383165|P1|STARTED|Metformin + Placebo Sitagliptin||18
7876384|NCT00830076|19383165|P1|NOT COMPLETED|7-day Washout||0
7876385|NCT00830076|19383165|P1|COMPLETED|7-day Washout||18
7876386|NCT00830076|19383165|P1|STARTED|7-day Washout||18
7876387|NCT00830076|19383165|P1|NOT COMPLETED|Sitagliptin + Placebo Metformin||0
7876388|NCT00830076|19383165|P1|COMPLETED|Sitagliptin + Placebo Metformin||18
7876389|NCT00830076|19383165|P1|STARTED|Sitagliptin + Placebo Metformin||18
7876390|NCT00830037|19383176|P2|NOT COMPLETED|Overall Study||19
7876391|NCT00830037|19383177|P1|NOT COMPLETED|Overall Study||18
7876392|NCT00830037|19383176|P2|COMPLETED|Overall Study||50
7876393|NCT00830037|19383177|P1|COMPLETED|Overall Study||49
7876394|NCT00830037|19383176|P2|STARTED|Overall Study||69
7876395|NCT00830037|19383177|P1|STARTED|Overall Study||67
7876396|NCT00830024|19383187|P2|NOT COMPLETED|Second Intervention||0
7876397|NCT00830024|19383188|P1|NOT COMPLETED|Second Intervention||0
7876398|NCT00830024|19383187|P2|COMPLETED|Second Intervention||18
7876399|NCT00830024|19383188|P1|COMPLETED|Second Intervention||17
7876400|NCT00830024|19383187|P2|STARTED|Second Intervention||18
7876401|NCT00830024|19383188|P1|STARTED|Second Intervention||17
7876402|NCT00830024|19383187|P2|NOT COMPLETED|Washout: 7 Days||0
7876403|NCT00830024|19383188|P1|NOT COMPLETED|Washout: 7 Days||1
7876404|NCT00830024|19383187|P2|COMPLETED|Washout: 7 Days||18
7876405|NCT00830024|19383188|P1|COMPLETED|Washout: 7 Days||17
7876406|NCT00830024|19383187|P2|STARTED|Washout: 7 Days||18
7876407|NCT00830024|19383188|P1|STARTED|Washout: 7 Days||18
7876408|NCT00830024|19383187|P2|NOT COMPLETED|First Intervention||0
7876409|NCT00830024|19383188|P1|NOT COMPLETED|First Intervention||0
7876410|NCT00830024|19383187|P2|COMPLETED|First Intervention||18
7876411|NCT00830024|19383188|P1|COMPLETED|First Intervention||18
7876412|NCT00830024|19383187|P2|STARTED|First Intervention||18
7876413|NCT00830024|19383188|P1|STARTED|First Intervention||18
7876414|NCT00829998|19383198|P2|NOT COMPLETED|Second Intervention||0
7876415|NCT00829998|19383199|P1|NOT COMPLETED|Second Intervention||0
7876416|NCT00829998|19383198|P2|COMPLETED|Second Intervention||19
7876417|NCT00829998|19383199|P1|COMPLETED|Second Intervention||21
7876418|NCT00829998|19383198|P2|STARTED|Second Intervention||19
7876419|NCT00829998|19383199|P1|STARTED|Second Intervention||21
7876420|NCT00829998|19383198|P2|NOT COMPLETED|Washout||1
7876421|NCT00829998|19383199|P1|NOT COMPLETED|Washout||0
7876422|NCT00829998|19383198|P2|COMPLETED|Washout||19
7876423|NCT00829998|19383199|P1|COMPLETED|Washout||21
7876424|NCT00829998|19383198|P2|STARTED|Washout||20
7876425|NCT00829998|19383199|P1|STARTED|Washout||21
7876426|NCT00829998|19383198|P2|NOT COMPLETED|First Intervention||0
7876427|NCT00829998|19383199|P1|NOT COMPLETED|First Intervention||0
7876428|NCT00829998|19383198|P2|COMPLETED|First Intervention||20
7876429|NCT00829998|19383199|P1|COMPLETED|First Intervention||21
7876430|NCT00829998|19383198|P2|STARTED|First Intervention||20
7876431|NCT00829998|19383199|P1|STARTED|First Intervention||21
7876432|NCT00829985|19383209|P2|NOT COMPLETED|Overall Study||4
7876433|NCT00829985|19383210|P1|NOT COMPLETED|Overall Study||9
7876434|NCT00829985|19383209|P2|COMPLETED|Overall Study||22
7876435|NCT00829985|19383210|P1|COMPLETED|Overall Study||19
7876436|NCT00829985|19383209|P2|STARTED|Overall Study||26
7876437|NCT00829985|19383210|P1|STARTED|Overall Study||28
7876438|NCT00829933|19383228|P4|NOT COMPLETED|Overall Study||14
7876439|NCT00829933|19383229|P3|NOT COMPLETED|Overall Study||13
7876440|NCT00829933|19383230|P2|NOT COMPLETED|Overall Study||13
7876441|NCT00829933|19383231|P1|NOT COMPLETED|Overall Study||14
7876442|NCT00829933|19383228|P4|COMPLETED|Overall Study||120
7876443|NCT00829933|19383229|P3|COMPLETED|Overall Study||119
7876444|NCT00829933|19383230|P2|COMPLETED|Overall Study||122
7876445|NCT00829933|19383231|P1|COMPLETED|Overall Study||121
7876446|NCT00829933|19383228|P4|Baseline Analysis Population|Overall Study||129
7876447|NCT00829933|19383229|P3|Baseline Analysis Population|Overall Study||131
7876448|NCT00829933|19383230|P2|Baseline Analysis Population|Overall Study||134
7876449|NCT00829933|19383231|P1|Baseline Analysis Population|Overall Study||131
7876450|NCT00829933|19383228|P4|STARTED|Overall Study||134
7876451|NCT00829933|19383229|P3|STARTED|Overall Study||132
7876452|NCT00829933|19383230|P2|STARTED|Overall Study||135
7876453|NCT00829933|19383231|P1|STARTED|Overall Study||135
7876454|NCT00829868|19383243|P2|NOT COMPLETED|Second Intervention||0
7876455|NCT00829868|19383244|P1|NOT COMPLETED|Second Intervention||0
7876456|NCT00829868|19383243|P2|COMPLETED|Second Intervention||21
7876457|NCT00829868|19383244|P1|COMPLETED|Second Intervention||20
7876458|NCT00829868|19383243|P2|STARTED|Second Intervention||21
7876459|NCT00829868|19383244|P1|STARTED|Second Intervention||20
7876460|NCT00829868|19383243|P2|NOT COMPLETED|Washout||0
7876461|NCT00829868|19383244|P1|NOT COMPLETED|Washout||1
7876462|NCT00829868|19383243|P2|COMPLETED|Washout||21
7876463|NCT00829868|19383244|P1|COMPLETED|Washout||20
7876464|NCT00829868|19383243|P2|STARTED|Washout||21
7876465|NCT00829868|19383244|P1|STARTED|Washout||21
7876466|NCT00829868|19383243|P2|NOT COMPLETED|First Intervention||0
7876467|NCT00829868|19383244|P1|NOT COMPLETED|First Intervention||0
7876468|NCT00829868|19383243|P2|COMPLETED|First Intervention||21
7876469|NCT00829868|19383244|P1|COMPLETED|First Intervention||21
7876470|NCT00829868|19383243|P2|STARTED|First Intervention||21
7876471|NCT00829868|19383244|P1|STARTED|First Intervention||21
7876472|NCT00829829|19383255|P3|NOT COMPLETED|Overall Study||11
7876473|NCT00829829|19383256|P2|NOT COMPLETED|Overall Study||16
7876474|NCT00829829|19383257|P1|NOT COMPLETED|Overall Study||22
7876475|NCT00829829|19383255|P3|COMPLETED|Overall Study||70
7876476|NCT00829829|19383256|P2|COMPLETED|Overall Study||64
7876477|NCT00829829|19383257|P1|COMPLETED|Overall Study||58
7876478|NCT00829829|19383255|P3|Treated|Overall Study||81
7876479|NCT00829829|19383256|P2|Treated|Overall Study||80
7876480|NCT00829829|19383257|P1|Treated|Overall Study||79
7876481|NCT00829829|19383255|P3|STARTED|Overall Study||81
7876482|NCT00829829|19383256|P2|STARTED|Overall Study||80
7876483|NCT00829829|19383257|P1|STARTED|Overall Study||80
7876484|NCT00829790|19383282|P2|NOT COMPLETED|Second Intervention||0
7876485|NCT00829790|19383283|P1|NOT COMPLETED|Second Intervention||0
7876486|NCT00829790|19383282|P2|COMPLETED|Second Intervention||14
7876487|NCT00829790|19383283|P1|COMPLETED|Second Intervention||15
7876488|NCT00829790|19383282|P2|STARTED|Second Intervention||14
7876489|NCT00829790|19383283|P1|STARTED|Second Intervention||15
7876490|NCT00829790|19383282|P2|NOT COMPLETED|Washout of 14 Days||1
7876491|NCT00829790|19383283|P1|NOT COMPLETED|Washout of 14 Days||0
7876492|NCT00829790|19383282|P2|COMPLETED|Washout of 14 Days||14
7876493|NCT00829790|19383283|P1|COMPLETED|Washout of 14 Days||15
7876494|NCT00829790|19383282|P2|STARTED|Washout of 14 Days||15
7876495|NCT00829790|19383283|P1|STARTED|Washout of 14 Days||15
7876496|NCT00829790|19383282|P2|NOT COMPLETED|First Intervention||0
7876497|NCT00829790|19383283|P1|NOT COMPLETED|First Intervention||0
7876498|NCT00829790|19383282|P2|COMPLETED|First Intervention||15
7876499|NCT00829790|19383283|P1|COMPLETED|First Intervention||15
7876500|NCT00829790|19383282|P2|STARTED|First Intervention||15
7876501|NCT00829790|19383283|P1|STARTED|First Intervention||15
7876502|NCT00829764|19383293|P2|NOT COMPLETED|Second Intervention||0
7876503|NCT00829764|19383294|P1|NOT COMPLETED|Second Intervention||0
7876504|NCT00829764|19383293|P2|COMPLETED|Second Intervention||14
7876505|NCT00829764|19383294|P1|COMPLETED|Second Intervention||13
7876506|NCT00829764|19383293|P2|STARTED|Second Intervention||14
7876507|NCT00829764|19383294|P1|STARTED|Second Intervention||13
7876508|NCT00829764|19383293|P2|NOT COMPLETED|Washout of 14 Days||0
7876509|NCT00829764|19383294|P1|NOT COMPLETED|Washout of 14 Days||0
7876510|NCT00829764|19383293|P2|COMPLETED|Washout of 14 Days||14
7876511|NCT00829764|19383294|P1|COMPLETED|Washout of 14 Days||13
7876512|NCT00829764|19383293|P2|STARTED|Washout of 14 Days||14
7876513|NCT00829764|19383294|P1|STARTED|Washout of 14 Days||13
7876514|NCT00829764|19383293|P2|NOT COMPLETED|First Intervention||1
7876515|NCT00829764|19383294|P1|NOT COMPLETED|First Intervention||2
7876516|NCT00829764|19383293|P2|COMPLETED|First Intervention||14
7876517|NCT00829764|19383294|P1|COMPLETED|First Intervention||13
7876518|NCT00829764|19383293|P2|STARTED|First Intervention||15
7876519|NCT00829764|19383294|P1|STARTED|First Intervention||15
7876520|NCT00829738|19383302|P1|NOT COMPLETED|Overall Study||8
7876521|NCT00829738|19383302|P1|COMPLETED|Overall Study||4180
7876522|NCT00829738|19383302|P1|STARTED|Overall Study||4188
7876523|NCT00829712|19383320|P2|NOT COMPLETED|Second Intervention||0
7876524|NCT00829712|19383321|P1|NOT COMPLETED|Second Intervention||0
7876525|NCT00829712|19383320|P2|COMPLETED|Second Intervention||11
7876526|NCT00829712|19383321|P1|COMPLETED|Second Intervention||12
7876527|NCT00829712|19383320|P2|STARTED|Second Intervention||11
7876528|NCT00829712|19383321|P1|STARTED|Second Intervention||12
7876529|NCT00829712|19383320|P2|NOT COMPLETED|Washout of 7 Days||1
7876530|NCT00829712|19383321|P1|NOT COMPLETED|Washout of 7 Days||0
7876531|NCT00829712|19383320|P2|COMPLETED|Washout of 7 Days||11
7876532|NCT00829712|19383321|P1|COMPLETED|Washout of 7 Days||12
7876533|NCT00829712|19383320|P2|STARTED|Washout of 7 Days||12
7876534|NCT00829712|19383321|P1|STARTED|Washout of 7 Days||12
7876535|NCT00829712|19383320|P2|NOT COMPLETED|First Intervention||0
7876536|NCT00829712|19383321|P1|NOT COMPLETED|First Intervention||0
7876537|NCT00829712|19383320|P2|COMPLETED|First Intervention||12
7876538|NCT00829712|19383321|P1|COMPLETED|First Intervention||12
7876539|NCT00829712|19383320|P2|STARTED|First Intervention||12
7876540|NCT00829712|19383321|P1|STARTED|First Intervention||12
7876541|NCT00829686|19383331|P2|NOT COMPLETED|Overall Study||0
7876542|NCT00829686|19383332|P1|NOT COMPLETED|Overall Study||0
7876543|NCT00829686|19383331|P2|COMPLETED|Overall Study||18
7876544|NCT00829686|19383332|P1|COMPLETED|Overall Study||13
7876545|NCT00829686|19383331|P2|STARTED|Overall Study||18
7876546|NCT00829686|19383332|P1|STARTED|Overall Study||13
7876547|NCT00829673|19383340|P2|NOT COMPLETED|Second Intervention||0
7876548|NCT00829673|19383341|P1|NOT COMPLETED|Second Intervention||0
7876549|NCT00829673|19383340|P2|COMPLETED|Second Intervention||12
7876550|NCT00829673|19383341|P1|COMPLETED|Second Intervention||11
7876551|NCT00829673|19383340|P2|STARTED|Second Intervention||12
7876552|NCT00829673|19383341|P1|STARTED|Second Intervention||11
7876553|NCT00829673|19383340|P2|NOT COMPLETED|Washout of 7 Days||0
7876554|NCT00829673|19383341|P1|NOT COMPLETED|Washout of 7 Days||1
7876555|NCT00829673|19383340|P2|COMPLETED|Washout of 7 Days||12
7876556|NCT00829673|19383341|P1|COMPLETED|Washout of 7 Days||11
7876557|NCT00829673|19383340|P2|STARTED|Washout of 7 Days||12
7876558|NCT00829673|19383341|P1|STARTED|Washout of 7 Days||12
7876559|NCT00829673|19383340|P2|NOT COMPLETED|First Intervention||0
7876560|NCT00829673|19383341|P1|NOT COMPLETED|First Intervention||0
7876561|NCT00829673|19383340|P2|COMPLETED|First Intervention||12
7876562|NCT00829673|19383341|P1|COMPLETED|First Intervention||12
7876563|NCT00829673|19383340|P2|STARTED|First Intervention||12
7876564|NCT00829673|19383341|P1|STARTED|First Intervention||12
7876565|NCT00829621|19383351|P2|NOT COMPLETED|Overall Study||4
7876566|NCT00829621|19383352|P1|NOT COMPLETED|Overall Study||4
7876567|NCT00829621|19383351|P2|COMPLETED|Overall Study||8
7876568|NCT00829621|19383352|P1|COMPLETED|Overall Study||4
7876569|NCT00829621|19383351|P2|STARTED|Overall Study||12
7876570|NCT00829621|19383352|P1|STARTED|Overall Study||8
7876571|NCT00829530|19383360|P2|NOT COMPLETED|Second Intervention||0
7876572|NCT00829530|19383361|P1|NOT COMPLETED|Second Intervention||1
7876573|NCT00829530|19383360|P2|COMPLETED|Second Intervention||18
7876574|NCT00829530|19383361|P1|COMPLETED|Second Intervention||19
7876575|NCT00829530|19383360|P2|STARTED|Second Intervention||18
7876576|NCT00829530|19383361|P1|STARTED|Second Intervention||20
7876577|NCT00829530|19383360|P2|NOT COMPLETED|Washout of 42 Days||0
7876578|NCT00829530|19383361|P1|NOT COMPLETED|Washout of 42 Days||0
7876579|NCT00829530|19383360|P2|COMPLETED|Washout of 42 Days||18
7876580|NCT00829530|19383361|P1|COMPLETED|Washout of 42 Days||20
7876581|NCT00829530|19383360|P2|STARTED|Washout of 42 Days||18
7876582|NCT00829530|19383361|P1|STARTED|Washout of 42 Days||20
7876583|NCT00829530|19383360|P2|NOT COMPLETED|First Intervention||2
7876584|NCT00829530|19383361|P1|NOT COMPLETED|First Intervention||0
7876585|NCT00829530|19383360|P2|COMPLETED|First Intervention||18
7876586|NCT00829530|19383361|P1|COMPLETED|First Intervention||20
7876587|NCT00829530|19383360|P2|STARTED|First Intervention||20
7876588|NCT00829530|19383361|P1|STARTED|First Intervention||20
7876589|NCT00829504|19383375|P2|NOT COMPLETED|Second Intervention||0
7876590|NCT00829504|19383376|P1|NOT COMPLETED|Second Intervention||1
7876591|NCT00829504|19383375|P2|COMPLETED|Second Intervention||22
7876592|NCT00829504|19383376|P1|COMPLETED|Second Intervention||19
7876593|NCT00829504|19383375|P2|STARTED|Second Intervention||22
7876594|NCT00829504|19383376|P1|STARTED|Second Intervention||20
7876595|NCT00829504|19383375|P2|NOT COMPLETED|Washout of 7 Days||0
7876596|NCT00829504|19383376|P1|NOT COMPLETED|Washout of 7 Days||1
7876597|NCT00829504|19383375|P2|COMPLETED|Washout of 7 Days||22
7876598|NCT00829504|19383376|P1|COMPLETED|Washout of 7 Days||20
7876599|NCT00829504|19383375|P2|STARTED|Washout of 7 Days||22
7876600|NCT00829504|19383376|P1|STARTED|Washout of 7 Days||21
7876601|NCT00829504|19383375|P2|NOT COMPLETED|First Intervention||0
7876602|NCT00829504|19383376|P1|NOT COMPLETED|First Intervention||1
7876603|NCT00829504|19383375|P2|COMPLETED|First Intervention||22
7876604|NCT00829504|19383376|P1|COMPLETED|First Intervention||21
7876605|NCT00829504|19383375|P2|STARTED|First Intervention||22
7876606|NCT00829504|19383376|P1|STARTED|First Intervention||22
7876607|NCT00829452|19383386|P2|NOT COMPLETED|Second Intervention||1
7876608|NCT00829452|19383387|P1|NOT COMPLETED|Second Intervention||0
7876609|NCT00829452|19383386|P2|COMPLETED|Second Intervention||17
7876610|NCT00829452|19383387|P1|COMPLETED|Second Intervention||20
7876611|NCT00829452|19383386|P2|STARTED|Second Intervention||18
7876612|NCT00829452|19383387|P1|STARTED|Second Intervention||20
7876613|NCT00829452|19383386|P2|NOT COMPLETED|Washout of 42 Days||1
7876614|NCT00829452|19383387|P1|NOT COMPLETED|Washout of 42 Days||0
7876615|NCT00829452|19383386|P2|COMPLETED|Washout of 42 Days||18
7876616|NCT00829452|19383387|P1|COMPLETED|Washout of 42 Days||20
7876617|NCT00829452|19383386|P2|STARTED|Washout of 42 Days||19
7876618|NCT00829452|19383387|P1|STARTED|Washout of 42 Days||20
7876619|NCT00829452|19383386|P2|NOT COMPLETED|First Intervention||1
7876620|NCT00829452|19383387|P1|NOT COMPLETED|First Intervention||0
7876621|NCT00829452|19383386|P2|COMPLETED|First Intervention||19
7876622|NCT00829452|19383387|P1|COMPLETED|First Intervention||20
7876623|NCT00829452|19383386|P2|STARTED|First Intervention||20
7876624|NCT00829452|19383387|P1|STARTED|First Intervention||20
7876625|NCT00829439|19383399|P4|NOT COMPLETED|Overall Study||0
7876626|NCT00829439|19383400|P3|NOT COMPLETED|Overall Study||1
7876627|NCT00829439|19383401|P2|NOT COMPLETED|Overall Study||0
7876628|NCT00829439|19383402|P1|NOT COMPLETED|Overall Study||0
7876629|NCT00829439|19383399|P4|COMPLETED|Overall Study||4
7876630|NCT00829439|19383400|P3|COMPLETED|Overall Study||5
7876631|NCT00829439|19383401|P2|COMPLETED|Overall Study||3
7876632|NCT00829439|19383402|P1|COMPLETED|Overall Study||3
7876633|NCT00829439|19383399|P4|STARTED|Overall Study||4
7876634|NCT00829439|19383400|P3|STARTED|Overall Study||6
7876635|NCT00829439|19383401|P2|STARTED|Overall Study||3
7876636|NCT00829439|19383402|P1|STARTED|Overall Study||3
7876637|NCT00829426|19383408|P2|NOT COMPLETED|Second Intervention||0
7876638|NCT00829426|19383409|P1|NOT COMPLETED|Second Intervention||0
7876639|NCT00829426|19383408|P2|COMPLETED|Second Intervention||16
7876640|NCT00829426|19383409|P1|COMPLETED|Second Intervention||15
7876641|NCT00829426|19383408|P2|STARTED|Second Intervention||16
7876642|NCT00829426|19383409|P1|STARTED|Second Intervention||15
7876643|NCT00829426|19383408|P2|NOT COMPLETED|Washout: 7 Days||0
7876644|NCT00829426|19383409|P1|NOT COMPLETED|Washout: 7 Days||1
7876645|NCT00829426|19383408|P2|COMPLETED|Washout: 7 Days||16
7876646|NCT00829426|19383409|P1|COMPLETED|Washout: 7 Days||15
7876647|NCT00829426|19383408|P2|STARTED|Washout: 7 Days||16
7876648|NCT00829426|19383409|P1|STARTED|Washout: 7 Days||16
7876649|NCT00829426|19383408|P2|NOT COMPLETED|First Intervention||0
7876650|NCT00829426|19383409|P1|NOT COMPLETED|First Intervention||0
7876651|NCT00829426|19383408|P2|COMPLETED|First Intervention||16
7876652|NCT00829426|19383409|P1|COMPLETED|First Intervention||16
7876653|NCT00829426|19383408|P2|STARTED|First Intervention||16
7876654|NCT00829426|19383409|P1|STARTED|First Intervention||16
7876655|NCT00829413|19383417|P1|NOT COMPLETED|Overall Study||94
7876656|NCT00829413|19383417|P1|COMPLETED|Overall Study||259
7876657|NCT00829413|19383417|P1|STARTED|Overall Study||353
7876658|NCT00829387|19383466|P2|NOT COMPLETED|Overall Study||3
7876659|NCT00829387|19383467|P1|NOT COMPLETED|Overall Study||3
7876660|NCT00829387|19383466|P2|COMPLETED|Overall Study||21
7876661|NCT00829387|19383467|P1|COMPLETED|Overall Study||20
7876662|NCT00829387|19383466|P2|STARTED|Overall Study||24
7876663|NCT00829387|19383467|P1|STARTED|Overall Study||23
7876664|NCT00829309|19383485|P2|NOT COMPLETED|Second Intervention||0
7876665|NCT00829309|19383486|P1|NOT COMPLETED|Second Intervention||0
7876666|NCT00829309|19383485|P2|COMPLETED|Second Intervention||8
7876667|NCT00829309|19383486|P1|COMPLETED|Second Intervention||7
7876668|NCT00829309|19383485|P2|STARTED|Second Intervention||8
7876669|NCT00829309|19383486|P1|STARTED|Second Intervention||7
7876670|NCT00829309|19383485|P2|NOT COMPLETED|Washout: 7 Days||0
7876671|NCT00829309|19383486|P1|NOT COMPLETED|Washout: 7 Days||1
7876672|NCT00829309|19383485|P2|COMPLETED|Washout: 7 Days||8
7876673|NCT00829309|19383486|P1|COMPLETED|Washout: 7 Days||7
7876674|NCT00829309|19383485|P2|STARTED|Washout: 7 Days||8
7876675|NCT00829309|19383486|P1|STARTED|Washout: 7 Days||8
7876676|NCT00829309|19383485|P2|NOT COMPLETED|First Intervention||0
7876677|NCT00829309|19383486|P1|NOT COMPLETED|First Intervention||0
7876678|NCT00829309|19383485|P2|COMPLETED|First Intervention||8
7876679|NCT00829309|19383486|P1|COMPLETED|First Intervention||8
7876680|NCT00829309|19383485|P2|STARTED|First Intervention||8
7876681|NCT00829309|19383486|P1|STARTED|First Intervention||8
7876682|NCT00829296|19383496|P2|NOT COMPLETED|Overall Study||4
7876683|NCT00829296|19383497|P1|NOT COMPLETED|Overall Study||5
7876684|NCT00829296|19383496|P2|COMPLETED|Overall Study||32
7876685|NCT00829296|19383497|P1|COMPLETED|Overall Study||29
7876686|NCT00829296|19383496|P2|STARTED|Overall Study||36
7876687|NCT00829296|19383497|P1|STARTED|Overall Study||34
7876688|NCT00829283|19383511|P2|NOT COMPLETED|Overall Study||25
7876689|NCT00829283|19383512|P1|NOT COMPLETED|Overall Study||7
7876690|NCT00829283|19383511|P2|COMPLETED|Overall Study||127
7876691|NCT00829283|19383512|P1|COMPLETED|Overall Study||32
7876692|NCT00829283|19383511|P2|STARTED|Overall Study||152
7876693|NCT00829283|19383512|P1|STARTED|Overall Study||39
7876694|NCT00829244|19383522|P2|NOT COMPLETED|Overall Study||21
7876695|NCT00829244|19383523|P1|NOT COMPLETED|Overall Study||14
7876696|NCT00829244|19383522|P2|COMPLETED|Overall Study||83
7876697|NCT00829244|19383523|P1|COMPLETED|Overall Study||82
7876698|NCT00829244|19383522|P2|STARTED|Overall Study||104
7876699|NCT00829244|19383523|P1|STARTED|Overall Study||96
7876700|NCT00829179|19383553|P1|NOT COMPLETED|Overall Study||1
7876701|NCT00829179|19383553|P1|COMPLETED|Overall Study||19
7876702|NCT00829179|19383553|P1|STARTED|Overall Study||20
7876703|NCT00829166|19383559|P2|NOT COMPLETED|Overall Study||496
7876704|NCT00829166|19383560|P1|NOT COMPLETED|Overall Study||495
7876705|NCT00829166|19383559|P2|COMPLETED|Overall Study||0
7876706|NCT00829166|19383560|P1|COMPLETED|Overall Study||0
7876707|NCT00829166|19383559|P2|Treated|Overall Study||488
7876708|NCT00829166|19383560|P1|Treated|Overall Study||490
7876709|NCT00829166|19383559|P2|STARTED|Overall Study||496
7876710|NCT00829166|19383560|P1|STARTED|Overall Study||495
7876711|NCT00829049|19383601|P2|NOT COMPLETED|Overall Study||20
7876712|NCT00829049|19383602|P1|NOT COMPLETED|Overall Study||17
7876713|NCT00829049|19383601|P2|COMPLETED|Overall Study||68
7876714|NCT00829049|19383602|P1|COMPLETED|Overall Study||60
7876715|NCT00829049|19383601|P2|STARTED|Overall Study||88
7876716|NCT00829049|19383602|P1|STARTED|Overall Study||77
7876717|NCT00829036|19383614|P1|NOT COMPLETED|Overall Study||0
7876718|NCT00829036|19383614|P1|COMPLETED|Overall Study||24
7876719|NCT00829036|19383614|P1|STARTED|Overall Study||24
7876720|NCT00829010|19383623|P5|NOT COMPLETED|Overall Study||2
7876721|NCT00829010|19383624|P4|NOT COMPLETED|Overall Study||8
7876722|NCT00829010|19383625|P3|NOT COMPLETED|Overall Study||3
7876723|NCT00829010|19383626|P2|NOT COMPLETED|Overall Study||9
7876724|NCT00829010|19383627|P1|NOT COMPLETED|Overall Study||10
7876725|NCT00829010|19383623|P5|COMPLETED|Overall Study||98
7876726|NCT00829010|19383624|P4|COMPLETED|Overall Study||92
7876727|NCT00829010|19383625|P3|COMPLETED|Overall Study||97
7876728|NCT00829010|19383626|P2|COMPLETED|Overall Study||92
7876729|NCT00829010|19383627|P1|COMPLETED|Overall Study||73
7876730|NCT00829010|19383623|P5|STARTED|Overall Study||100
7876731|NCT00829010|19383624|P4|STARTED|Overall Study||100
7876732|NCT00829010|19383625|P3|STARTED|Overall Study||100
7876733|NCT00829010|19383626|P2|STARTED|Overall Study||101
7876734|NCT00829010|19383627|P1|STARTED|Overall Study||83
7876735|NCT00828984|19383792|P3|NOT COMPLETED|Overall Study||9
7876736|NCT00828984|19383793|P2|NOT COMPLETED|Overall Study||16
7876737|NCT00828984|19383794|P1|NOT COMPLETED|Overall Study||14
7876738|NCT00828984|19383792|P3|COMPLETED|Overall Study||19
7876739|NCT00828984|19383793|P2|COMPLETED|Overall Study||15
7876740|NCT00828984|19383794|P1|COMPLETED|Overall Study||14
7876741|NCT00828984|19383792|P3|Post Intervention Follow-Up|Overall Study||19
7876742|NCT00828984|19383793|P2|Post Intervention Follow-Up|Overall Study||16
7876743|NCT00828984|19383794|P1|Post Intervention Follow-Up|Overall Study||15
7876744|NCT00828984|19383792|P3|Flexible Sigmoidoscopy|Overall Study||19
7876745|NCT00828984|19383793|P2|Flexible Sigmoidoscopy|Overall Study||19
7876746|NCT00828984|19383794|P1|Flexible Sigmoidoscopy|Overall Study||20
7876747|NCT00828984|19383792|P3|Treatment|Overall Study||24
7876748|NCT00828984|19383793|P2|Treatment|Overall Study||26
7876749|NCT00828984|19383794|P1|Treatment|Overall Study||24
7876750|NCT00828984|19383792|P3|Randomization|Overall Study||28
7876751|NCT00828984|19383793|P2|Randomization|Overall Study||31
7876752|NCT00828984|19383794|P1|Randomization|Overall Study||28
7876753|NCT00828984|19383792|P3|STARTED|Overall Study||28
7876754|NCT00828984|19383793|P2|STARTED|Overall Study||31
7876755|NCT00828984|19383794|P1|STARTED|Overall Study||28
7876756|NCT00828945|19383817|P1|NOT COMPLETED|Overall Study||41
7876757|NCT00828945|19383817|P1|COMPLETED|Overall Study||216
7876758|NCT00828945|19383817|P1|STARTED|Overall Study||257
7876759|NCT00828841|19383834|P3|NOT COMPLETED|Overall Study||4
7876760|NCT00828841|19383835|P2|NOT COMPLETED|Overall Study||4
7876761|NCT00828841|19383836|P1|NOT COMPLETED|Overall Study||4
7876762|NCT00828841|19383834|P3|COMPLETED|Overall Study||126
7876763|NCT00828841|19383835|P2|COMPLETED|Overall Study||232
7876764|NCT00828841|19383836|P1|COMPLETED|Overall Study||231
7876765|NCT00828841|19383834|P3|STARTED|Overall Study||130
7876766|NCT00828841|19383835|P2|STARTED|Overall Study||236
7876767|NCT00828841|19383836|P1|STARTED|Overall Study||235
7876768|NCT00828750|19383849|P1|NOT COMPLETED|Overall Study||4
7876769|NCT00828750|19383849|P1|COMPLETED|Overall Study||15
7876770|NCT00828750|19383849|P1|STARTED|Overall Study||19
7876771|NCT00828711|19383863|P3|NOT COMPLETED|Overall Study||0
7876772|NCT00828711|19383864|P2|NOT COMPLETED|Overall Study||0
7876773|NCT00828711|19383865|P1|NOT COMPLETED|Overall Study||1
7876774|NCT00828711|19383863|P3|COMPLETED|Overall Study||131
7876775|NCT00828711|19383864|P2|COMPLETED|Overall Study||125
7876776|NCT00828711|19383865|P1|COMPLETED|Overall Study||117
7876777|NCT00828711|19383863|P3|STARTED|Overall Study||131
7876778|NCT00828711|19383864|P2|STARTED|Overall Study||125
7876779|NCT00828711|19383865|P1|STARTED|Overall Study||118
7876780|NCT00828672|19383896|P2|NOT COMPLETED|Follow-up||0
7876781|NCT00828672|19383897|P1|NOT COMPLETED|Follow-up||0
7876782|NCT00828672|19383896|P2|COMPLETED|Follow-up||41
7876783|NCT00828672|19383897|P1|COMPLETED|Follow-up||42
7876784|NCT00828672|19383896|P2|STARTED|Follow-up|Patients with no central review material and with adverse event are in followup (joined this period)|41
7876785|NCT00828672|19383897|P1|STARTED|Follow-up|Patient in Arm 1 with clinical complete response and no surgery is in follow up (joined this period)|42
7876786|NCT00828672|19383896|P2|NOT COMPLETED|Post-surgery (<30 Days)||1
7876787|NCT00828672|19383897|P1|NOT COMPLETED|Post-surgery (<30 Days)||0
7876788|NCT00828672|19383896|P2|COMPLETED|Post-surgery (<30 Days)||38
7876789|NCT00828672|19383897|P1|COMPLETED|Post-surgery (<30 Days)||41
7876790|NCT00828672|19383896|P2|STARTED|Post-surgery (<30 Days)||39
7876791|NCT00828672|19383897|P1|STARTED|Post-surgery (<30 Days)||41
7876792|NCT00828672|19383896|P2|NOT COMPLETED|Study Treatment||2
7876793|NCT00828672|19383897|P1|NOT COMPLETED|Study Treatment||2
7876794|NCT00828672|19383896|P2|COMPLETED|Study Treatment||39
7876795|NCT00828672|19383897|P1|COMPLETED|Study Treatment||41
7876796|NCT00828672|19383896|P2|STARTED|Study Treatment||41
7876797|NCT00828672|19383897|P1|STARTED|Study Treatment||43
7876798|NCT00828672|19383896|P2|NOT COMPLETED|Pre-treatment (Baseline)||0
7876799|NCT00828672|19383897|P1|NOT COMPLETED|Pre-treatment (Baseline)||0
7876800|NCT00828672|19383896|P2|COMPLETED|Pre-treatment (Baseline)||41
7876801|NCT00828672|19383897|P1|COMPLETED|Pre-treatment (Baseline)||43
7876802|NCT00828672|19383896|P2|STARTED|Pre-treatment (Baseline)||41
7876803|NCT00828672|19383897|P1|STARTED|Pre-treatment (Baseline)||43
7876804|NCT00828568|19383918|P3|NOT COMPLETED|Treated - Received at Least One Dose||5
7876805|NCT00828568|19383919|P2|NOT COMPLETED|Treated - Received at Least One Dose||29
7876806|NCT00828568|19383920|P1|NOT COMPLETED|Treated - Received at Least One Dose||30
7876807|NCT00828568|19383918|P3|COMPLETED|Treated - Received at Least One Dose||55
7876808|NCT00828568|19383919|P2|COMPLETED|Treated - Received at Least One Dose||150
7876809|NCT00828568|19383920|P1|COMPLETED|Treated - Received at Least One Dose||153
7876810|NCT00828568|19383918|P3|STARTED|Treated - Received at Least One Dose||60
7876811|NCT00828568|19383919|P2|STARTED|Treated - Received at Least One Dose||179
7876812|NCT00828568|19383920|P1|STARTED|Treated - Received at Least One Dose||183
7876813|NCT00828568|19383918|P3|NOT COMPLETED|Randomized||2
7876814|NCT00828568|19383919|P2|NOT COMPLETED|Randomized||0
7876815|NCT00828568|19383920|P1|NOT COMPLETED|Randomized||1
7876816|NCT00828568|19383918|P3|COMPLETED|Randomized||60
7876817|NCT00828568|19383919|P2|COMPLETED|Randomized||179
7876818|NCT00828568|19383920|P1|COMPLETED|Randomized||183
7876819|NCT00828568|19383918|P3|STARTED|Randomized||62
7876820|NCT00828568|19383919|P2|STARTED|Randomized||179
7876821|NCT00828568|19383920|P1|STARTED|Randomized||184
7876822|NCT00828542|19383935|P2|NOT COMPLETED|Overall Study||3
7876823|NCT00828542|19383936|P1|NOT COMPLETED|Overall Study||3
7876824|NCT00828542|19383935|P2|COMPLETED|Overall Study||20
7876825|NCT00828542|19383936|P1|COMPLETED|Overall Study||20
7876826|NCT00828542|19383935|P2|STARTED|Overall Study||23
7876827|NCT00828542|19383936|P1|STARTED|Overall Study||23
7876828|NCT00828516|19383942|P1|NOT COMPLETED|Clinical Phase: Series 2||0
7876829|NCT00828516|19383942|P1|COMPLETED|Clinical Phase: Series 2||30
7876830|NCT00828516|19383942|P1|STARTED|Clinical Phase: Series 2||30
7876831|NCT00828516|19383942|P1|NOT COMPLETED|Clinical Phase: Series 1||2
7876832|NCT00828516|19383942|P1|COMPLETED|Clinical Phase: Series 1||33
7876833|NCT00828516|19383942|P1|STARTED|Clinical Phase: Series 1||35
7876834|NCT00828464|19383947|P1|NOT COMPLETED|Overall Study||1
7876835|NCT00828464|19383947|P1|COMPLETED|Overall Study||29
7876836|NCT00828464|19383947|P1|STARTED|Overall Study||30
7876837|NCT00828451|19383964|P1|NOT COMPLETED|Overall Study||11
7876838|NCT00828451|19383964|P1|COMPLETED|Overall Study||18
7876839|NCT00828451|19383964|P1|STARTED|Overall Study||29
7876840|NCT00828412|19383972|P2|NOT COMPLETED|Overall Study||2
7876841|NCT00828412|19383973|P1|NOT COMPLETED|Overall Study||9
7876842|NCT00828412|19383972|P2|COMPLETED|Overall Study||48
7876843|NCT00828412|19383973|P1|COMPLETED|Overall Study||41
7876844|NCT00828412|19383972|P2|STARTED|Overall Study||50
7876845|NCT00828412|19383973|P1|STARTED|Overall Study||50
7876846|NCT00828347|19383981|P2|NOT COMPLETED|Overall Study||0
7876847|NCT00828347|19383982|P1|NOT COMPLETED|Overall Study||0
7876848|NCT00828347|19383981|P2|COMPLETED|Overall Study||11
7876849|NCT00828347|19383982|P1|COMPLETED|Overall Study||12
7876850|NCT00828347|19383981|P2|STARTED|Overall Study||11
7876851|NCT00828347|19383982|P1|STARTED|Overall Study||12
7876852|NCT00828321|19383990|P2|NOT COMPLETED|Second Intervention||1
7876853|NCT00828321|19383991|P1|NOT COMPLETED|Second Intervention||0
7876854|NCT00828321|19383990|P2|COMPLETED|Second Intervention||19
7876855|NCT00828321|19383991|P1|COMPLETED|Second Intervention||18
7876856|NCT00828321|19383990|P2|STARTED|Second Intervention||20
7876857|NCT00828321|19383991|P1|STARTED|Second Intervention||18
7876858|NCT00828321|19383990|P2|NOT COMPLETED|Washout of 42 Days||0
7876859|NCT00828321|19383991|P1|NOT COMPLETED|Washout of 42 Days||2
7876860|NCT00828321|19383990|P2|COMPLETED|Washout of 42 Days||20
7876861|NCT00828321|19383991|P1|COMPLETED|Washout of 42 Days||18
7876862|NCT00828321|19383990|P2|STARTED|Washout of 42 Days||20
7876863|NCT00828321|19383991|P1|STARTED|Washout of 42 Days||20
7876864|NCT00828321|19383990|P2|NOT COMPLETED|First Intervention||0
7876865|NCT00828321|19383991|P1|NOT COMPLETED|First Intervention||0
7876866|NCT00828321|19383990|P2|COMPLETED|First Intervention||20
7876867|NCT00828321|19383991|P1|COMPLETED|First Intervention||20
7876868|NCT00828321|19383990|P2|STARTED|First Intervention||20
7876869|NCT00828321|19383991|P1|STARTED|First Intervention||20
7876870|NCT00828308|19384003|P1|NOT COMPLETED|Overall Study||0
7876871|NCT00828308|19384003|P1|COMPLETED|Overall Study||16
7876872|NCT00828308|19384003|P1|STARTED|Overall Study||16
7876873|NCT00828295|19384009|P2|NOT COMPLETED|Overall Study||0
7876874|NCT00828295|19384010|P1|NOT COMPLETED|Overall Study||0
7876875|NCT00828295|19384009|P2|COMPLETED|Overall Study||75
7876876|NCT00828295|19384010|P1|COMPLETED|Overall Study||75
7876877|NCT00828295|19384009|P2|STARTED|Overall Study||75
7876878|NCT00828295|19384010|P1|STARTED|Overall Study||75
7876879|NCT00828204|19384020|P2|NOT COMPLETED|Extension Study||3
7876880|NCT00828204|19384021|P1|NOT COMPLETED|Extension Study||0
7876881|NCT00828204|19384020|P2|COMPLETED|Extension Study||61
7876882|NCT00828204|19384021|P1|COMPLETED|Extension Study||0
7876883|NCT00828204|19384020|P2|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64
7876884|NCT00828204|19384021|P1|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0
7876885|NCT00828204|19384020|P2|NOT COMPLETED|Main Study: After Study Restart||3
7876886|NCT00828204|19384021|P1|NOT COMPLETED|Main Study: After Study Restart||0
7876887|NCT00828204|19384020|P2|COMPLETED|Main Study: After Study Restart||71
7876888|NCT00828204|19384021|P1|COMPLETED|Main Study: After Study Restart||0
7876889|NCT00828204|19384020|P2|Continued With Autoinjector Injections|Main Study: After Study Restart||72
7876890|NCT00828204|19384021|P1|Continued With Autoinjector Injections|Main Study: After Study Restart||0
7876891|NCT00828204|19384020|P2|Completed Manual Injection|Main Study: After Study Restart||74
7876892|NCT00828204|19384021|P1|Completed Manual Injection|Main Study: After Study Restart||0
7876893|NCT00828204|19384020|P2|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74
7876894|NCT00828204|19384021|P1|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0
7876895|NCT00828204|19384020|P2|NOT COMPLETED|Main Study: Prior to Study Suspension||0
7876896|NCT00828204|19384021|P1|NOT COMPLETED|Main Study: Prior to Study Suspension||14
7876897|NCT00828204|19384020|P2|COMPLETED|Main Study: Prior to Study Suspension||0
7876898|NCT00828204|19384021|P1|COMPLETED|Main Study: Prior to Study Suspension||7
7876899|NCT00828204|19384020|P2|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0
7876900|NCT00828204|19384021|P1|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19
7876901|NCT00828204|19384020|P2|Completed Manual Injection|Main Study: Prior to Study Suspension||0
7876902|NCT00828204|19384021|P1|Completed Manual Injection|Main Study: Prior to Study Suspension||21
7876903|NCT00828204|19384020|P2|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0
7876904|NCT00828204|19384021|P1|STARTED|Main Study: Prior to Study Suspension||21
7876905|NCT00828191|19384040|P2|NOT COMPLETED|Overall Study||10
7876906|NCT00828191|19384041|P1|NOT COMPLETED|Overall Study||8
7876907|NCT00828191|19384040|P2|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390
7876908|NCT00828191|19384041|P1|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392
7876909|NCT00828191|19384040|P2|STARTED|Overall Study|Randomized patients|400
7876910|NCT00828191|19384041|P1|STARTED|Overall Study|Randomized patients|400
7876911|NCT00828178|19384053|P2|NOT COMPLETED|Overall Study||2
7876912|NCT00828178|19384054|P1|NOT COMPLETED|Overall Study||0
7876913|NCT00828178|19384053|P2|COMPLETED|Overall Study|Two patients did not complete the study.|43
7876914|NCT00828178|19384054|P1|COMPLETED|Overall Study||42
7876915|NCT00828178|19384053|P2|STARTED|Overall Study|Eighty seven participants were randomized.|45
7876916|NCT00828178|19384054|P1|STARTED|Overall Study||42
7876917|NCT00828139|19384068|P4|NOT COMPLETED|Overall Study||51
7876918|NCT00828139|19384069|P3|NOT COMPLETED|Overall Study||55
7876919|NCT00828139|19384070|P2|NOT COMPLETED|Overall Study||41
7876920|NCT00828139|19384071|P1|NOT COMPLETED|Overall Study||41
7876921|NCT00828139|19384068|P4|COMPLETED|Overall Study||0
7876922|NCT00828139|19384069|P3|COMPLETED|Overall Study||0
7876923|NCT00828139|19384070|P2|COMPLETED|Overall Study||0
7876924|NCT00828139|19384071|P1|COMPLETED|Overall Study||1
7876925|NCT00828139|19384068|P4|STARTED|Overall Study||51
7876926|NCT00828139|19384069|P3|STARTED|Overall Study||55
7876927|NCT00828139|19384070|P2|STARTED|Overall Study||41
7876928|NCT00828139|19384071|P1|STARTED|Overall Study||42
7876929|NCT00828113|19384091|P2|NOT COMPLETED|Overall Study||31
7876930|NCT00828113|19384092|P1|NOT COMPLETED|Overall Study||30
7876931|NCT00828113|19384091|P2|COMPLETED|Overall Study||20
7876932|NCT00828113|19384092|P1|COMPLETED|Overall Study||20
7876933|NCT00828113|19384091|P2|STARTED|Overall Study||51
7876934|NCT00828113|19384092|P1|STARTED|Overall Study||50
7876935|NCT00828074|19384100|P3|NOT COMPLETED|Overall Study||0
7876936|NCT00828074|19384101|P2|NOT COMPLETED|Overall Study||0
7876937|NCT00828074|19384102|P1|NOT COMPLETED|Overall Study||0
7876938|NCT00828074|19384100|P3|COMPLETED|Overall Study||35
7876939|NCT00828074|19384101|P2|COMPLETED|Overall Study||5
7876940|NCT00828074|19384102|P1|COMPLETED|Overall Study||6
7876941|NCT00828074|19384100|P3|STARTED|Overall Study||35
7876942|NCT00828074|19384101|P2|STARTED|Overall Study||5
7876943|NCT00828074|19384102|P1|STARTED|Overall Study||6
7876944|NCT00828061|19384114|P6|NOT COMPLETED|Period 3||0
7876945|NCT00828061|19384115|P5|NOT COMPLETED|Period 3||0
7876946|NCT00828061|19384116|P4|NOT COMPLETED|Period 3||0
7876947|NCT00828061|19384117|P3|NOT COMPLETED|Period 3||0
7876948|NCT00828061|19384118|P2|NOT COMPLETED|Period 3||0
7876949|NCT00828061|19384119|P1|NOT COMPLETED|Period 3||0
7876950|NCT00828061|19384114|P6|COMPLETED|Period 3||3
7876951|NCT00828061|19384115|P5|COMPLETED|Period 3||3
7876952|NCT00828061|19384116|P4|COMPLETED|Period 3||3
7876953|NCT00828061|19384117|P3|COMPLETED|Period 3||3
7876954|NCT00828061|19384118|P2|COMPLETED|Period 3||3
7876955|NCT00828061|19384119|P1|COMPLETED|Period 3||4
7876956|NCT00828061|19384114|P6|STARTED|Period 3||3
7876957|NCT00828061|19384115|P5|STARTED|Period 3||3
7876958|NCT00828061|19384116|P4|STARTED|Period 3||3
7876959|NCT00828061|19384117|P3|STARTED|Period 3||3
7876960|NCT00828061|19384118|P2|STARTED|Period 3||3
7876961|NCT00828061|19384119|P1|STARTED|Period 3||4
7876962|NCT00828061|19384114|P6|NOT COMPLETED|Period 2||0
7876963|NCT00828061|19384115|P5|NOT COMPLETED|Period 2||0
7876964|NCT00828061|19384116|P4|NOT COMPLETED|Period 2||0
7876965|NCT00828061|19384117|P3|NOT COMPLETED|Period 2||0
7876966|NCT00828061|19384118|P2|NOT COMPLETED|Period 2||0
7876967|NCT00828061|19384119|P1|NOT COMPLETED|Period 2||0
7876968|NCT00828061|19384114|P6|COMPLETED|Period 2||3
7876969|NCT00828061|19384115|P5|COMPLETED|Period 2||3
7876970|NCT00828061|19384116|P4|COMPLETED|Period 2||3
7876971|NCT00828061|19384117|P3|COMPLETED|Period 2||3
7876972|NCT00828061|19384118|P2|COMPLETED|Period 2||3
7876973|NCT00828061|19384119|P1|COMPLETED|Period 2||4
7876974|NCT00828061|19384114|P6|STARTED|Period 2||3
7876975|NCT00828061|19384115|P5|STARTED|Period 2||3
7876976|NCT00828061|19384116|P4|STARTED|Period 2||3
7876977|NCT00828061|19384117|P3|STARTED|Period 2||3
7876978|NCT00828061|19384118|P2|STARTED|Period 2||3
7876979|NCT00828061|19384119|P1|STARTED|Period 2||4
7876980|NCT00828061|19384114|P6|NOT COMPLETED|Period 1||0
7876981|NCT00828061|19384115|P5|NOT COMPLETED|Period 1||0
7876982|NCT00828061|19384116|P4|NOT COMPLETED|Period 1||0
7876983|NCT00828061|19384117|P3|NOT COMPLETED|Period 1||0
7876984|NCT00828061|19384118|P2|NOT COMPLETED|Period 1||0
7876985|NCT00828061|19384119|P1|NOT COMPLETED|Period 1||0
7876986|NCT00828061|19384114|P6|COMPLETED|Period 1||3
7876987|NCT00828061|19384115|P5|COMPLETED|Period 1||3
7876988|NCT00828061|19384116|P4|COMPLETED|Period 1||3
7876989|NCT00828061|19384117|P3|COMPLETED|Period 1||3
7876990|NCT00828061|19384118|P2|COMPLETED|Period 1||3
7876991|NCT00828061|19384119|P1|COMPLETED|Period 1||4
7876992|NCT00828061|19384114|P6|STARTED|Period 1||3
7876993|NCT00828061|19384115|P5|STARTED|Period 1||3
7876994|NCT00828061|19384116|P4|STARTED|Period 1||3
7876995|NCT00828061|19384117|P3|STARTED|Period 1||3
7876996|NCT00828061|19384118|P2|STARTED|Period 1||3
7876997|NCT00828061|19384119|P1|STARTED|Period 1||4
7876998|NCT00828009|19384130|P1|NOT COMPLETED|Step 2 - Maintenance Therapy||33
7876999|NCT00828009|19384130|P1|COMPLETED|Step 2 - Maintenance Therapy|Max maintenance therapy was 34 cycles. No patients were off treatment due to completion of 34 cycles|0
7877000|NCT00828009|19384130|P1|STARTED|Step 2 - Maintenance Therapy|Among 39 pts with tx completion, 4 did not register to step 2 and 2 had PD at the end of step 1.|33
7877001|NCT00828009|19384130|P1|NOT COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||31
7877002|NCT00828009|19384130|P1|COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||39
7877003|NCT00828009|19384130|P1|Started Treatment|Step 1 - Chemo RT/Consolidation Chemo||68
7877004|NCT00828009|19384130|P1|STARTED|Step 1 - Chemo RT/Consolidation Chemo||70
7877005|NCT00827983|19384139|P2|NOT COMPLETED|Overall Study||16
7877006|NCT00827983|19384140|P1|NOT COMPLETED|Overall Study||18
7877007|NCT00827983|19384139|P2|COMPLETED|Overall Study|patients who performed the pregnancy test|328
7877008|NCT00827983|19384140|P1|COMPLETED|Overall Study|patients who performed the pregnancy test|321
7877009|NCT00827983|19384139|P2|STARTED|Overall Study|all randomised patients|344
7877010|NCT00827983|19384140|P1|STARTED|Overall Study|All randomised patients|339
7877011|NCT00827944|19384152|P2|NOT COMPLETED|Overall Study||59
7877012|NCT00827944|19384153|P1|NOT COMPLETED|Overall Study||63
7877013|NCT00827944|19384152|P2|COMPLETED|Overall Study||240
7877014|NCT00827944|19384153|P1|COMPLETED|Overall Study||241
7877015|NCT00827944|19384152|P2|STARTED|Overall Study||299
7877016|NCT00827944|19384153|P1|STARTED|Overall Study||304
7877017|NCT00827931|19384173|P2|NOT COMPLETED|Overall Study||6
7877018|NCT00827931|19384174|P1|NOT COMPLETED|Overall Study||6
7877019|NCT00827931|19384173|P2|COMPLETED|Overall Study||39
7877020|NCT00827931|19384174|P1|COMPLETED|Overall Study||43
7877021|NCT00827931|19384173|P2|STARTED|Overall Study||45
7877022|NCT00827931|19384174|P1|STARTED|Overall Study||49
7877023|NCT00827918|19384195|P3|NOT COMPLETED|Overall Study||21
7877024|NCT00827918|19384196|P2|NOT COMPLETED|Overall Study||9
7877025|NCT00827918|19384197|P1|NOT COMPLETED|Overall Study||28
7877026|NCT00827918|19384195|P3|COMPLETED|Overall Study||62
7877027|NCT00827918|19384196|P2|COMPLETED|Overall Study||38
7877028|NCT00827918|19384197|P1|COMPLETED|Overall Study||58
7877029|NCT00827918|19384195|P3|STARTED|Overall Study||83
7877030|NCT00827918|19384196|P2|STARTED|Overall Study||47
7877031|NCT00827918|19384197|P1|STARTED|Overall Study||86
7877032|NCT00827827|19384225|P2|NOT COMPLETED|Overall Study||0
7877033|NCT00827827|19384226|P1|NOT COMPLETED|Overall Study||8
7877034|NCT00827827|19384225|P2|COMPLETED|Overall Study||16
7877035|NCT00827827|19384226|P1|COMPLETED|Overall Study||14
7877036|NCT00827827|19384225|P2|STARTED|Overall Study||16
7877037|NCT00827827|19384226|P1|STARTED|Overall Study||22
7877038|NCT00827775|19384270|P2|NOT COMPLETED|Overall Study||5
7877039|NCT00827775|19384271|P1|NOT COMPLETED|Overall Study||0
7877040|NCT00827775|19384270|P2|COMPLETED|Overall Study||25
7877041|NCT00827775|19384271|P1|COMPLETED|Overall Study||25
7877042|NCT00827775|19384270|P2|STARTED|Overall Study||30
7877043|NCT00827775|19384271|P1|STARTED|Overall Study||25
7877044|NCT00827632|19384281|P2|NOT COMPLETED|Overall Study||23
7877045|NCT00827632|19384282|P1|NOT COMPLETED|Overall Study||22
7877046|NCT00827632|19384281|P2|COMPLETED|Overall Study||75
7877047|NCT00827632|19384282|P1|COMPLETED|Overall Study||106
7877048|NCT00827632|19384281|P2|STARTED|Overall Study||98
7877049|NCT00827632|19384282|P1|STARTED|Overall Study||128
7877050|NCT00827606|19384294|P2|NOT COMPLETED|Overall Study||38
7877051|NCT00827606|19384295|P1|NOT COMPLETED|Overall Study||27
7877052|NCT00827606|19384294|P2|COMPLETED|Overall Study||94
7877053|NCT00827606|19384295|P1|COMPLETED|Overall Study||112
7877054|NCT00827606|19384294|P2|STARTED|Overall Study||132
7877055|NCT00827606|19384295|P1|STARTED|Overall Study||139
7877056|NCT00827567|19384356|P1|NOT COMPLETED|Overall Study||4
7877057|NCT00827567|19384356|P1|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0
7877058|NCT00827567|19384356|P1|STARTED|Overall Study||4
7877059|NCT00827541|19384362|P2|NOT COMPLETED|Overall Study||11
7877060|NCT00827541|19384363|P1|NOT COMPLETED|Overall Study||4
7877061|NCT00827541|19384362|P2|COMPLETED|Overall Study||85
7877062|NCT00827541|19384363|P1|COMPLETED|Overall Study||15
7877063|NCT00827541|19384362|P2|STARTED|Overall Study||96
7877064|NCT00827541|19384363|P1|STARTED|Overall Study||19
7877065|NCT00827502|19384375|P1|NOT COMPLETED|Overall Study||21
7877066|NCT00827502|19384375|P1|COMPLETED|Overall Study||400
7877067|NCT00827502|19384375|P1|Received Treatment (Number Treated)|Overall Study||410
7877068|NCT00827502|19384375|P1|STARTED|Overall Study||421
7877069|NCT00827372|19384381|P1|NOT COMPLETED|Overall Study||8
7877070|NCT00827372|19384381|P1|COMPLETED|Overall Study||2
7877071|NCT00827372|19384381|P1|STARTED|Overall Study||10
7877072|NCT00827255|19384389|P1|NOT COMPLETED|Overall Study||0
7877073|NCT00827255|19384389|P1|COMPLETED|Overall Study||35
7877074|NCT00827255|19384389|P1|STARTED|Overall Study||35
7877075|NCT00827242|19384396|P2|NOT COMPLETED|Overall Study||12
7877076|NCT00827242|19384397|P1|NOT COMPLETED|Overall Study||13
7877077|NCT00827242|19384396|P2|COMPLETED|Overall Study||152
7877078|NCT00827242|19384397|P1|COMPLETED|Overall Study||148
7877079|NCT00827242|19384396|P2|STARTED|Overall Study||164
7877080|NCT00827242|19384397|P1|STARTED|Overall Study||161
7877081|NCT00827112|19384435|P2|NOT COMPLETED|Overall Study||12
7877082|NCT00827112|19384436|P1|NOT COMPLETED|Overall Study||15
7877083|NCT00827112|19384435|P2|COMPLETED|Overall Study||52
7877084|NCT00827112|19384436|P1|COMPLETED|Overall Study||50
7877085|NCT00827112|19384435|P2|Treated|Overall Study||61
7877086|NCT00827112|19384436|P1|Treated|Overall Study||60
7877087|NCT00827112|19384435|P2|STARTED|Overall Study||64
7877088|NCT00827112|19384436|P1|STARTED|Overall Study||65
7877089|NCT00827099|19384469|P1|NOT COMPLETED|Overall Study||0
7877090|NCT00827099|19384469|P1|COMPLETED|Overall Study||5
7877091|NCT00827099|19384469|P1|STARTED|Overall Study||5
7877092|NCT00827073|19384480|P2|NOT COMPLETED|Overall Study||0
7877093|NCT00827073|19384481|P1|NOT COMPLETED|Overall Study||0
7877094|NCT00827073|19384480|P2|COMPLETED|Overall Study||20
7877095|NCT00827073|19384481|P1|COMPLETED|Overall Study||20
7877096|NCT00827073|19384480|P2|STARTED|Overall Study||20
7877097|NCT00827073|19384481|P1|STARTED|Overall Study||20
7877098|NCT00826943|19384489|P6|NOT COMPLETED|Overall Study||0
7877099|NCT00826943|19384490|P5|NOT COMPLETED|Overall Study||1
7877100|NCT00826943|19384491|P4|NOT COMPLETED|Overall Study||0
7877101|NCT00826943|19384492|P3|NOT COMPLETED|Overall Study||0
7877102|NCT00826943|19384493|P2|NOT COMPLETED|Overall Study||0
7877103|NCT00826943|19384494|P1|NOT COMPLETED|Overall Study||0
7877104|NCT00826943|19384489|P6|COMPLETED|Overall Study||2
7877105|NCT00826943|19384490|P5|COMPLETED|Overall Study||6
7877106|NCT00826943|19384491|P4|COMPLETED|Overall Study||5
7877107|NCT00826943|19384492|P3|COMPLETED|Overall Study||4
7877108|NCT00826943|19384493|P2|COMPLETED|Overall Study||6
7877109|NCT00826943|19384494|P1|COMPLETED|Overall Study||6
7877110|NCT00826943|19384489|P6|STARTED|Overall Study||2
7877111|NCT00826943|19384490|P5|STARTED|Overall Study||7
7877112|NCT00826943|19384491|P4|STARTED|Overall Study||5
7877113|NCT00826943|19384492|P3|STARTED|Overall Study||4
7877114|NCT00826943|19384493|P2|STARTED|Overall Study||6
7877115|NCT00826943|19384494|P1|STARTED|Overall Study||6
7877116|NCT00826800|19384508|P1|NOT COMPLETED|Overall Study||0
7877117|NCT00826800|19384508|P1|COMPLETED|Overall Study||2
7877118|NCT00826800|19384508|P1|STARTED|Overall Study||2
7877119|NCT00826748|19384515|P3|NOT COMPLETED|Overall Study||4
7877120|NCT00826748|19384516|P2|NOT COMPLETED|Overall Study||0
7877121|NCT00826748|19384517|P1|NOT COMPLETED|Overall Study||0
7877122|NCT00826748|19384515|P3|COMPLETED|Overall Study||8
7877123|NCT00826748|19384516|P2|COMPLETED|Overall Study||4
7877124|NCT00826748|19384517|P1|COMPLETED|Overall Study||6
7877125|NCT00826748|19384515|P3|STARTED|Overall Study||12
7877126|NCT00826748|19384516|P2|STARTED|Overall Study||4
7877127|NCT00826748|19384517|P1|STARTED|Overall Study||6
7877128|NCT00826618|19384525|P1|NOT COMPLETED|Overall Study||1
7877129|NCT00826618|19384525|P1|COMPLETED|Overall Study||5
7877130|NCT00826618|19384525|P1|STARTED|Overall Study||6
7877131|NCT00826540|19384529|P1|NOT COMPLETED|Overall Study||4
7877132|NCT00826540|19384529|P1|COMPLETED|Overall Study||79
7877133|NCT00826540|19384529|P1|STARTED|Overall Study||83
7877134|NCT00826449|19384535|P1|NOT COMPLETED|Overall Study||5
7877135|NCT00826449|19384535|P1|COMPLETED|Overall Study||42
7877136|NCT00826449|19384535|P1|Phase II|Overall Study||35
7877137|NCT00826449|19384535|P1|Phase I|Overall Study||12
7877138|NCT00826449|19384535|P1|STARTED|Overall Study||47
7877139|NCT00826280|19384544|P3|NOT COMPLETED|Overall Study||46
7877140|NCT00826280|19384545|P2|NOT COMPLETED|Overall Study||46
7877141|NCT00826280|19384546|P1|NOT COMPLETED|Overall Study||48
7877142|NCT00826280|19384544|P3|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71
7877143|NCT00826280|19384545|P2|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70
7877144|NCT00826280|19384546|P1|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66
7877145|NCT00826280|19384544|P3|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72
7877146|NCT00826280|19384545|P2|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71
7877147|NCT00826280|19384546|P1|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66
7877148|NCT00826280|19384544|P3|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
7877149|NCT00826280|19384545|P2|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
7877150|NCT00826280|19384546|P1|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113
7877151|NCT00826280|19384544|P3|STARTED|Overall Study||117
7877152|NCT00826280|19384545|P2|STARTED|Overall Study||116
7877153|NCT00826280|19384546|P1|STARTED|Overall Study||114
7877154|NCT00826267|19384575|P3|NOT COMPLETED|Overall Study||0
7877155|NCT00826267|19384576|P2|NOT COMPLETED|Overall Study||0
7877156|NCT00826267|19384577|P1|NOT COMPLETED|Overall Study||1
7877157|NCT00826267|19384575|P3|COMPLETED|Overall Study||11
7877158|NCT00826267|19384576|P2|COMPLETED|Overall Study||8
7877159|NCT00826267|19384577|P1|COMPLETED|Overall Study||9
7877160|NCT00826267|19384575|P3|STARTED|Overall Study||11
7877161|NCT00826267|19384576|P2|STARTED|Overall Study||8
7877162|NCT00826267|19384577|P1|STARTED|Overall Study||10
7877163|NCT00826241|19384595|P1|NOT COMPLETED|Overall Study||27
7877164|NCT00826241|19384595|P1|COMPLETED|Overall Study||31
7877165|NCT00826241|19384595|P1|STARTED|Overall Study||58
7877166|NCT00826228|19384601|P1|NOT COMPLETED|Overall Study||1
7877167|NCT00826228|19384601|P1|COMPLETED|Overall Study||11
7877168|NCT00826228|19384601|P1|STARTED|Overall Study||12
7877169|NCT00826202|19384608|P2|NOT COMPLETED|Overall Study||13
7877170|NCT00826202|19384609|P1|NOT COMPLETED|Overall Study||10
7877171|NCT00826202|19384608|P2|COMPLETED|Overall Study||11
7877172|NCT00826202|19384609|P1|COMPLETED|Overall Study||10
7877173|NCT00826202|19384608|P2|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20
7877174|NCT00826202|19384609|P1|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15
7877175|NCT00826202|19384608|P2|STARTED|Overall Study||24
7877176|NCT00826202|19384609|P1|STARTED|Overall Study||20
7877177|NCT00826176|19384623|P2|NOT COMPLETED|Overall Study||0
7877178|NCT00826176|19384624|P1|NOT COMPLETED|Overall Study||13
7877179|NCT00826176|19384623|P2|COMPLETED|Overall Study|treated and completed|36
7877180|NCT00826176|19384624|P1|COMPLETED|Overall Study|treated and completed|115
7877181|NCT00826176|19384623|P2|STARTED|Overall Study|enrolled|36
7877182|NCT00826176|19384624|P1|STARTED|Overall Study|enrolled|128
7877183|NCT00826150|19384637|P3|NOT COMPLETED|Overall Study||3
7877184|NCT00826150|19384638|P2|NOT COMPLETED|Overall Study||2
7877185|NCT00826150|19384639|P1|NOT COMPLETED|Overall Study||6
7877186|NCT00826150|19384637|P3|COMPLETED|Overall Study||0
7877187|NCT00826150|19384638|P2|COMPLETED|Overall Study||1
7877188|NCT00826150|19384639|P1|COMPLETED|Overall Study||2
7877189|NCT00826150|19384637|P3|STARTED|Overall Study||3
7877190|NCT00826150|19384638|P2|STARTED|Overall Study||3
7877191|NCT00826150|19384639|P1|STARTED|Overall Study||8
7877192|NCT00826111|19384673|P2|NOT COMPLETED|Overall Study||2
7877193|NCT00826111|19384674|P1|NOT COMPLETED|Overall Study||7
7877194|NCT00826111|19384673|P2|COMPLETED|Overall Study||3
7877195|NCT00826111|19384674|P1|COMPLETED|Overall Study||7
7877196|NCT00826111|19384673|P2|STARTED|Overall Study||5
7877197|NCT00826111|19384674|P1|STARTED|Overall Study||14
7877198|NCT00826020|19384696|P1|NOT COMPLETED|Overall Study||0
7877199|NCT00826020|19384696|P1|COMPLETED|Overall Study||72
7877200|NCT00826020|19384696|P1|STARTED|Overall Study||72
7877201|NCT00826007|19384703|P2|NOT COMPLETED|Overall Study||0
7877202|NCT00826007|19384704|P1|NOT COMPLETED|Overall Study||0
7877203|NCT00826007|19384703|P2|COMPLETED|Overall Study||279
7877204|NCT00826007|19384704|P1|COMPLETED|Overall Study|Retrospective review|308
7877205|NCT00826007|19384703|P2|STARTED|Overall Study||279
7877206|NCT00826007|19384704|P1|STARTED|Overall Study|Retrospective review|308
7877207|NCT00825994|19384709|P1|NOT COMPLETED|Overall Study||5
7877208|NCT00825994|19384709|P1|COMPLETED|Overall Study||19
7877209|NCT00825994|19384709|P1|STARTED|Overall Study||24
7877210|NCT00825916|19384717|P3|NOT COMPLETED|Overall Study||1
7877211|NCT00825916|19384718|P2|NOT COMPLETED|Overall Study||2
7877212|NCT00825916|19384719|P1|NOT COMPLETED|Overall Study||4
7877213|NCT00825916|19384717|P3|COMPLETED|Overall Study||19
7877214|NCT00825916|19384718|P2|COMPLETED|Overall Study||18
7877215|NCT00825916|19384719|P1|COMPLETED|Overall Study||15
7877216|NCT00825916|19384717|P3|STARTED|Overall Study||20
7877217|NCT00825916|19384718|P2|STARTED|Overall Study||20
7877218|NCT00825916|19384719|P1|STARTED|Overall Study||19
7877219|NCT00825825|19384760|P6|NOT COMPLETED|Third Medication Period (14 Days)||2
7877220|NCT00825825|19384761|P5|NOT COMPLETED|Third Medication Period (14 Days)||0
7877221|NCT00825825|19384762|P4|NOT COMPLETED|Third Medication Period (14 Days)||0
7877222|NCT00825825|19384763|P3|NOT COMPLETED|Third Medication Period (14 Days)||0
7877223|NCT00825825|19384764|P2|NOT COMPLETED|Third Medication Period (14 Days)||2
7877224|NCT00825825|19384765|P1|NOT COMPLETED|Third Medication Period (14 Days)||0
7877225|NCT00825825|19384760|P6|COMPLETED|Third Medication Period (14 Days)||1
7877226|NCT00825825|19384761|P5|COMPLETED|Third Medication Period (14 Days)||3
7877227|NCT00825825|19384762|P4|COMPLETED|Third Medication Period (14 Days)||3
7877228|NCT00825825|19384763|P3|COMPLETED|Third Medication Period (14 Days)||2
7877229|NCT00825825|19384764|P2|COMPLETED|Third Medication Period (14 Days)||2
7877230|NCT00825825|19384765|P1|COMPLETED|Third Medication Period (14 Days)||1
7877231|NCT00825825|19384760|P6|STARTED|Third Medication Period (14 Days)||3
7877232|NCT00825825|19384761|P5|STARTED|Third Medication Period (14 Days)||3
7877233|NCT00825825|19384762|P4|STARTED|Third Medication Period (14 Days)||3
7877234|NCT00825825|19384763|P3|STARTED|Third Medication Period (14 Days)||2
7877235|NCT00825825|19384764|P2|STARTED|Third Medication Period (14 Days)||4
7877236|NCT00825825|19384765|P1|STARTED|Third Medication Period (14 Days)||1
7877237|NCT00825825|19384760|P6|NOT COMPLETED|Second Washout Period (14 Days)||0
7877238|NCT00825825|19384761|P5|NOT COMPLETED|Second Washout Period (14 Days)||0
7877239|NCT00825825|19384762|P4|NOT COMPLETED|Second Washout Period (14 Days)||0
7877240|NCT00825825|19384763|P3|NOT COMPLETED|Second Washout Period (14 Days)||0
7877241|NCT00825825|19384764|P2|NOT COMPLETED|Second Washout Period (14 Days)||0
7877242|NCT00825825|19384765|P1|NOT COMPLETED|Second Washout Period (14 Days)||0
7877243|NCT00825825|19384760|P6|COMPLETED|Second Washout Period (14 Days)||3
7877244|NCT00825825|19384761|P5|COMPLETED|Second Washout Period (14 Days)||3
7877245|NCT00825825|19384762|P4|COMPLETED|Second Washout Period (14 Days)||3
7877246|NCT00825825|19384763|P3|COMPLETED|Second Washout Period (14 Days)||2
7877247|NCT00825825|19384764|P2|COMPLETED|Second Washout Period (14 Days)||4
7877248|NCT00825825|19384765|P1|COMPLETED|Second Washout Period (14 Days)||1
7877249|NCT00825825|19384760|P6|STARTED|Second Washout Period (14 Days)||3
7877250|NCT00825825|19384761|P5|STARTED|Second Washout Period (14 Days)||3
7877251|NCT00825825|19384762|P4|STARTED|Second Washout Period (14 Days)||3
7877252|NCT00825825|19384763|P3|STARTED|Second Washout Period (14 Days)||2
7877253|NCT00825825|19384764|P2|STARTED|Second Washout Period (14 Days)||4
7877254|NCT00825825|19384765|P1|STARTED|Second Washout Period (14 Days)||1
7877255|NCT00825825|19384760|P6|NOT COMPLETED|Second Medication Period (14 Days)||0
7877256|NCT00825825|19384761|P5|NOT COMPLETED|Second Medication Period (14 Days)||1
7877257|NCT00825825|19384762|P4|NOT COMPLETED|Second Medication Period (14 Days)||2
7877258|NCT00825825|19384763|P3|NOT COMPLETED|Second Medication Period (14 Days)||0
7877259|NCT00825825|19384764|P2|NOT COMPLETED|Second Medication Period (14 Days)||0
7877260|NCT00825825|19384765|P1|NOT COMPLETED|Second Medication Period (14 Days)||2
7877261|NCT00825825|19384760|P6|COMPLETED|Second Medication Period (14 Days)||3
7877262|NCT00825825|19384761|P5|COMPLETED|Second Medication Period (14 Days)||3
7877263|NCT00825825|19384762|P4|COMPLETED|Second Medication Period (14 Days)||3
7877264|NCT00825825|19384763|P3|COMPLETED|Second Medication Period (14 Days)||2
7877265|NCT00825825|19384764|P2|COMPLETED|Second Medication Period (14 Days)||4
7877266|NCT00825825|19384765|P1|COMPLETED|Second Medication Period (14 Days)||1
7877267|NCT00825825|19384760|P6|STARTED|Second Medication Period (14 Days)||3
7877268|NCT00825825|19384761|P5|STARTED|Second Medication Period (14 Days)||4
7877269|NCT00825825|19384762|P4|STARTED|Second Medication Period (14 Days)||5
7877270|NCT00825825|19384763|P3|STARTED|Second Medication Period (14 Days)||2
7877271|NCT00825825|19384764|P2|STARTED|Second Medication Period (14 Days)||4
7877272|NCT00825825|19384765|P1|STARTED|Second Medication Period (14 Days)||3
7877273|NCT00825825|19384760|P6|NOT COMPLETED|First Washout Period (14 Days)||0
7877274|NCT00825825|19384761|P5|NOT COMPLETED|First Washout Period (14 Days)||0
7877275|NCT00825825|19384762|P4|NOT COMPLETED|First Washout Period (14 Days)||0
7877276|NCT00825825|19384763|P3|NOT COMPLETED|First Washout Period (14 Days)||0
7877277|NCT00825825|19384764|P2|NOT COMPLETED|First Washout Period (14 Days)||0
7877278|NCT00825825|19384765|P1|NOT COMPLETED|First Washout Period (14 Days)||0
7877279|NCT00825825|19384760|P6|COMPLETED|First Washout Period (14 Days)||3
7877280|NCT00825825|19384761|P5|COMPLETED|First Washout Period (14 Days)||4
7877281|NCT00825825|19384762|P4|COMPLETED|First Washout Period (14 Days)||5
7877282|NCT00825825|19384763|P3|COMPLETED|First Washout Period (14 Days)||2
7877283|NCT00825825|19384764|P2|COMPLETED|First Washout Period (14 Days)||4
7877284|NCT00825825|19384765|P1|COMPLETED|First Washout Period (14 Days)||3
7877285|NCT00825825|19384760|P6|STARTED|First Washout Period (14 Days)||3
7877286|NCT00825825|19384761|P5|STARTED|First Washout Period (14 Days)||4
7877287|NCT00825825|19384762|P4|STARTED|First Washout Period (14 Days)||5
7877288|NCT00825825|19384763|P3|STARTED|First Washout Period (14 Days)||2
7877289|NCT00825825|19384764|P2|STARTED|First Washout Period (14 Days)||4
7877290|NCT00825825|19384765|P1|STARTED|First Washout Period (14 Days)||3
7877291|NCT00825825|19384760|P6|NOT COMPLETED|First Medication Period (14 Days)||2
7877292|NCT00825825|19384761|P5|NOT COMPLETED|First Medication Period (14 Days)||0
7877293|NCT00825825|19384762|P4|NOT COMPLETED|First Medication Period (14 Days)||0
7877294|NCT00825825|19384763|P3|NOT COMPLETED|First Medication Period (14 Days)||1
7877295|NCT00825825|19384764|P2|NOT COMPLETED|First Medication Period (14 Days)||0
7877296|NCT00825825|19384765|P1|NOT COMPLETED|First Medication Period (14 Days)||3
7877297|NCT00825825|19384760|P6|COMPLETED|First Medication Period (14 Days)||3
7877298|NCT00825825|19384761|P5|COMPLETED|First Medication Period (14 Days)||4
7877299|NCT00825825|19384762|P4|COMPLETED|First Medication Period (14 Days)||5
7877300|NCT00825825|19384763|P3|COMPLETED|First Medication Period (14 Days)||2
7877301|NCT00825825|19384764|P2|COMPLETED|First Medication Period (14 Days)||4
7877302|NCT00825825|19384765|P1|COMPLETED|First Medication Period (14 Days)||3
7877303|NCT00825825|19384760|P6|STARTED|First Medication Period (14 Days)||5
7877304|NCT00825825|19384761|P5|STARTED|First Medication Period (14 Days)||4
7877305|NCT00825825|19384762|P4|STARTED|First Medication Period (14 Days)||5
7877306|NCT00825825|19384763|P3|STARTED|First Medication Period (14 Days)||3
7877307|NCT00825825|19384764|P2|STARTED|First Medication Period (14 Days)||4
7877308|NCT00825825|19384765|P1|STARTED|First Medication Period (14 Days)||6
7877309|NCT00825812|19384781|P4|NOT COMPLETED|Overall Study||10
7877310|NCT00825812|19384782|P3|NOT COMPLETED|Overall Study||6
7877311|NCT00825812|19384783|P2|NOT COMPLETED|Overall Study||1
7877312|NCT00825812|19384784|P1|NOT COMPLETED|Overall Study||0
7877313|NCT00825812|19384781|P4|COMPLETED|Overall Study||111
7877314|NCT00825812|19384782|P3|COMPLETED|Overall Study||120
7877315|NCT00825812|19384783|P2|COMPLETED|Overall Study||31
7877316|NCT00825812|19384784|P1|COMPLETED|Overall Study||29
7877317|NCT00825812|19384781|P4|TREATED|Overall Study||111
7877318|NCT00825812|19384782|P3|TREATED|Overall Study||120
7877319|NCT00825812|19384783|P2|TREATED|Overall Study||31
7877320|NCT00825812|19384784|P1|TREATED|Overall Study||29
7877321|NCT00825812|19384781|P4|STARTED|Overall Study||121
7877322|NCT00825812|19384782|P3|STARTED|Overall Study||126
7877323|NCT00825812|19384783|P2|STARTED|Overall Study||32
7877324|NCT00825812|19384784|P1|STARTED|Overall Study||29
7877325|NCT00825786|19384800|P2|NOT COMPLETED|Overall Study||0
7877326|NCT00825786|19384801|P1|NOT COMPLETED|Overall Study||0
7877327|NCT00825786|19384800|P2|COMPLETED|Overall Study||51
7877328|NCT00825786|19384801|P1|COMPLETED|Overall Study||52
7877329|NCT00825786|19384800|P2|STARTED|Overall Study||51
7877330|NCT00825786|19384801|P1|STARTED|Overall Study||52
7877331|NCT00825734|19384819|P3|NOT COMPLETED|Phase II||76
7877332|NCT00825734|19384820|P2|NOT COMPLETED|Phase II||0
7877333|NCT00825734|19384821|P1|NOT COMPLETED|Phase II||0
7877334|NCT00825734|19384819|P3|COMPLETED|Phase II||0
7877335|NCT00825734|19384820|P2|COMPLETED|Phase II||0
7877336|NCT00825734|19384821|P1|COMPLETED|Phase II||0
7877337|NCT00825734|19384819|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76
7877338|NCT00825734|19384820|P2|STARTED|Phase II||0
7877339|NCT00825734|19384821|P1|STARTED|Phase II||0
7877340|NCT00825734|19384819|P3|NOT COMPLETED|Phase I||0
7877341|NCT00825734|19384820|P2|NOT COMPLETED|Phase I||3
7877342|NCT00825734|19384821|P1|NOT COMPLETED|Phase I||4
7877343|NCT00825734|19384819|P3|COMPLETED|Phase I||3
7877344|NCT00825734|19384820|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
7877345|NCT00825734|19384821|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
7877346|NCT00825734|19384819|P3|STARTED|Phase I||3
7877347|NCT00825734|19384820|P2|STARTED|Phase I||3
7877348|NCT00825734|19384821|P1|STARTED|Phase I||4
7877349|NCT00825682|19384831|P2|NOT COMPLETED|Overall Study||5
7877350|NCT00825682|19384832|P1|NOT COMPLETED|Overall Study||13
7877351|NCT00825682|19384831|P2|COMPLETED|Overall Study||20
7877352|NCT00825682|19384832|P1|COMPLETED|Overall Study||34
7877353|NCT00825682|19384831|P2|STARTED|Overall Study||25
7877354|NCT00825682|19384832|P1|STARTED|Overall Study||47
7877355|NCT00825630|19384846|P4|NOT COMPLETED|Overall Study||0
7877356|NCT00825630|19384847|P3|NOT COMPLETED|Overall Study||0
7877357|NCT00825630|19384848|P2|NOT COMPLETED|Overall Study||0
7877358|NCT00825630|19384849|P1|NOT COMPLETED|Overall Study||0
7877359|NCT00825630|19384846|P4|COMPLETED|Overall Study||13
7877360|NCT00825630|19384847|P3|COMPLETED|Overall Study||19
7877361|NCT00825630|19384848|P2|COMPLETED|Overall Study||62
7877362|NCT00825630|19384849|P1|COMPLETED|Overall Study||29
7877363|NCT00825630|19384846|P4|STARTED|Overall Study||13
7877364|NCT00825630|19384847|P3|STARTED|Overall Study||19
7877365|NCT00825630|19384848|P2|STARTED|Overall Study||62
7877366|NCT00825630|19384849|P1|STARTED|Overall Study||29
7877367|NCT00825565|19384859|P1|NOT COMPLETED|Overall Study||0
7877368|NCT00825565|19384859|P1|COMPLETED|Overall Study||8
7877369|NCT00825565|19384859|P1|STARTED|Overall Study||8
7877370|NCT00825500|19384872|P3|NOT COMPLETED|Overall Study||0
7877371|NCT00825500|19384873|P2|NOT COMPLETED|Overall Study||0
7877372|NCT00825500|19384874|P1|NOT COMPLETED|Overall Study||0
7877373|NCT00825500|19384872|P3|COMPLETED|Overall Study||120
7877374|NCT00825500|19384873|P2|COMPLETED|Overall Study||121
7877375|NCT00825500|19384874|P1|COMPLETED|Overall Study||125
7877376|NCT00825500|19384872|P3|STARTED|Overall Study||120
7877377|NCT00825500|19384873|P2|STARTED|Overall Study||121
7877378|NCT00825500|19384874|P1|STARTED|Overall Study||125
7877379|NCT00825370|19384887|P2|NOT COMPLETED|Overall Study||0
7877380|NCT00825370|19384888|P1|NOT COMPLETED|Overall Study||0
7877381|NCT00825370|19384887|P2|COMPLETED|Overall Study||175
7877382|NCT00825370|19384888|P1|COMPLETED|Overall Study||175
7877383|NCT00825370|19384887|P2|STARTED|Overall Study||175
7877384|NCT00825370|19384888|P1|STARTED|Overall Study||175
7877385|NCT00825344|19384902|P2|NOT COMPLETED|Overall Study||1
7877386|NCT00825344|19384903|P1|NOT COMPLETED|Overall Study||1
7877387|NCT00825344|19384902|P2|COMPLETED|Overall Study||42
7877388|NCT00825344|19384903|P1|COMPLETED|Overall Study||33
7877389|NCT00825344|19384902|P2|STARTED|Overall Study||43
7877390|NCT00825344|19384903|P1|STARTED|Overall Study||34
7877391|NCT00825318|19384913|P1|NOT COMPLETED|Overall Study||1
7877392|NCT00825318|19384913|P1|COMPLETED|Overall Study||12
7877393|NCT00825318|19384913|P1|STARTED|Overall Study||13
7877394|NCT00825305|19384923|P2|NOT COMPLETED|Overall Study||23
7877395|NCT00825305|19384924|P1|NOT COMPLETED|Overall Study||17
7877396|NCT00825305|19384923|P2|COMPLETED|Overall Study||252
7877397|NCT00825305|19384924|P1|COMPLETED|Overall Study||533
7877398|NCT00825305|19384923|P2|STARTED|Overall Study||275
7877399|NCT00825305|19384924|P1|STARTED|Overall Study||550
7877400|NCT00825266|19384938|P2|NOT COMPLETED|Overall Study||0
7877401|NCT00825266|19384939|P1|NOT COMPLETED|Overall Study||0
7877402|NCT00825266|19384938|P2|COMPLETED|Overall Study||1
7877403|NCT00825266|19384939|P1|COMPLETED|Overall Study||1
7877404|NCT00825266|19384938|P2|STARTED|Overall Study||1
7877405|NCT00825266|19384939|P1|STARTED|Overall Study||1
7877406|NCT00825227|19384951|P2|NOT COMPLETED|Overall Study||0
7877407|NCT00825227|19384952|P1|NOT COMPLETED|Overall Study||0
7877408|NCT00825227|19384951|P2|COMPLETED|Overall Study||4
7877409|NCT00825227|19384952|P1|COMPLETED|Overall Study||6
7877410|NCT00825227|19384951|P2|STARTED|Overall Study||4
7877411|NCT00825227|19384952|P1|STARTED|Overall Study||6
7877412|NCT00825175|19384964|P2|NOT COMPLETED|Overall Study||5
7877413|NCT00825175|19384965|P1|NOT COMPLETED|Overall Study||0
7877414|NCT00825175|19384964|P2|COMPLETED|Overall Study||7
7877415|NCT00825175|19384965|P1|COMPLETED|Overall Study||10
7877416|NCT00825175|19384964|P2|STARTED|Overall Study||12
7877417|NCT00825175|19384965|P1|STARTED|Overall Study||10
7877418|NCT00825162|19384974|P3|NOT COMPLETED|Overall Study||6
7877419|NCT00825162|19384975|P2|NOT COMPLETED|Overall Study||21
7877420|NCT00825162|19384976|P1|NOT COMPLETED|Overall Study||28
7877421|NCT00825162|19384974|P3|COMPLETED|Overall Study||396
7877422|NCT00825162|19384975|P2|COMPLETED|Overall Study||859
7877423|NCT00825162|19384976|P1|COMPLETED|Overall Study||682
7877424|NCT00825162|19384974|P3|STARTED|Overall Study||402
7877425|NCT00825162|19384975|P2|STARTED|Overall Study||880
7877426|NCT00825162|19384976|P1|STARTED|Overall Study||710
7877427|NCT00824993|19385002|P2|NOT COMPLETED|Overall Study||17
7877428|NCT00824993|19385003|P1|NOT COMPLETED|Overall Study||14
7877429|NCT00824993|19385002|P2|COMPLETED|Overall Study||22
7877430|NCT00824993|19385003|P1|COMPLETED|Overall Study||25
7877431|NCT00824993|19385002|P2|6 Month Follow up|Overall Study||27
7877432|NCT00824993|19385003|P1|6 Month Follow up|Overall Study||33
7877433|NCT00824993|19385002|P2|STARTED|Overall Study||39
7877434|NCT00824993|19385003|P1|STARTED|Overall Study||39
7877435|NCT00824850|19385011|P2|NOT COMPLETED|Overall Study||1
7877436|NCT00824850|19385012|P1|NOT COMPLETED|Overall Study||0
7877437|NCT00824850|19385011|P2|COMPLETED|Overall Study||36
7877438|NCT00824850|19385012|P1|COMPLETED|Overall Study||38
7877439|NCT00824850|19385011|P2|Received Vaccination 13vPnC|Overall Study||36
7877440|NCT00824850|19385012|P1|Received Vaccination 13vPnC|Overall Study||38
7877441|NCT00824850|19385011|P2|STARTED|Overall Study||37
7877442|NCT00824850|19385012|P1|STARTED|Overall Study||38
7877443|NCT00824824|19385058|P2|NOT COMPLETED|Overall Study||0
7877444|NCT00824824|19385059|P1|NOT COMPLETED|Overall Study||0
7877445|NCT00824824|19385058|P2|COMPLETED|Overall Study||3
7877446|NCT00824824|19385059|P1|COMPLETED|Overall Study||4
7877447|NCT00824824|19385058|P2|STARTED|Overall Study||3
7877448|NCT00824824|19385059|P1|STARTED|Overall Study||4
7877449|NCT00824772|19385065|P1|NOT COMPLETED|Overall Study||8
7877450|NCT00824772|19385065|P1|COMPLETED|Overall Study||196
7877451|NCT00824772|19385065|P1|STARTED|Overall Study||204
7877452|NCT00824746|19385070|P1|NOT COMPLETED|Overall Study||0
7877453|NCT00824746|19385070|P1|COMPLETED|Overall Study||23
7877454|NCT00824746|19385070|P1|STARTED|Overall Study||23
7877455|NCT00824733|19385076|P1|NOT COMPLETED|Overall Study||0
7877456|NCT00824733|19385076|P1|COMPLETED|Overall Study||6
7877457|NCT00824733|19385076|P1|STARTED|Overall Study||6
7877458|NCT00824720|19385085|P3|NOT COMPLETED|Overall Study||1
7877459|NCT00824720|19385086|P2|NOT COMPLETED|Overall Study||1
7877460|NCT00824720|19385087|P1|NOT COMPLETED|Overall Study||3
7877461|NCT00824720|19385085|P3|COMPLETED|Overall Study||19
7877462|NCT00824720|19385086|P2|COMPLETED|Overall Study||15
7877463|NCT00824720|19385087|P1|COMPLETED|Overall Study||16
7877464|NCT00824720|19385085|P3|STARTED|Overall Study||20
7877465|NCT00824720|19385086|P2|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16
7877466|NCT00824720|19385087|P1|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19
7877467|NCT00824655|19385103|P2|NOT COMPLETED|Toddler Dose (12 Months of Age)||0
7877468|NCT00824655|19385104|P1|NOT COMPLETED|Toddler Dose (12 Months of Age)||2
7877469|NCT00824655|19385103|P2|COMPLETED|Toddler Dose (12 Months of Age)||116
7877470|NCT00824655|19385104|P1|COMPLETED|Toddler Dose (12 Months of Age)||116
7877471|NCT00824655|19385103|P2|STARTED|Toddler Dose (12 Months of Age)||116
7877472|NCT00824655|19385104|P1|STARTED|Toddler Dose (12 Months of Age)||118
7877473|NCT00824655|19385103|P2|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
7877474|NCT00824655|19385104|P1|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
7877475|NCT00824655|19385103|P2|COMPLETED|After Infant Dose (6 Months of Age)||0
7877476|NCT00824655|19385104|P1|COMPLETED|After Infant Dose (6 Months of Age)||118
7877477|NCT00824655|19385103|P2|STARTED|After Infant Dose (6 Months of Age)||0
7877478|NCT00824655|19385104|P1|STARTED|After Infant Dose (6 Months of Age)||118
7877479|NCT00824655|19385103|P2|NOT COMPLETED|Infant Series (5 Months of Age)||0
7877480|NCT00824655|19385104|P1|NOT COMPLETED|Infant Series (5 Months of Age)||0
7877481|NCT00824655|19385103|P2|COMPLETED|Infant Series (5 Months of Age)||0
7877482|NCT00824655|19385104|P1|COMPLETED|Infant Series (5 Months of Age)||118
7877483|NCT00824655|19385103|P2|STARTED|Infant Series (5 Months of Age)||0
7877484|NCT00824655|19385104|P1|STARTED|Infant Series (5 Months of Age)||118
7877485|NCT00824616|19385124|P2|NOT COMPLETED|Overall Study||7
7877486|NCT00824616|19385125|P1|NOT COMPLETED|Overall Study||6
7877487|NCT00824616|19385124|P2|COMPLETED|Overall Study||27
7877488|NCT00824616|19385125|P1|COMPLETED|Overall Study||28
7877489|NCT00824616|19385124|P2|STARTED|Overall Study||34
7877490|NCT00824616|19385125|P1|STARTED|Overall Study||34
7877491|NCT00824564|19385135|P2|NOT COMPLETED|Overall Study||10
7877492|NCT00824564|19385136|P1|NOT COMPLETED|Overall Study||8
7877493|NCT00824564|19385135|P2|COMPLETED|Overall Study||30
7877494|NCT00824564|19385136|P1|COMPLETED|Overall Study||34
7877495|NCT00824564|19385135|P2|Treated|Overall Study||40
7877496|NCT00824564|19385136|P1|Treated|Overall Study||41
7877497|NCT00824564|19385135|P2|STARTED|Overall Study||40
7877498|NCT00824564|19385136|P1|STARTED|Overall Study||42
7877499|NCT00824538|19385154|P1|NOT COMPLETED|Overall Study||2
7877500|NCT00824538|19385154|P1|COMPLETED|Overall Study||11
7877501|NCT00824538|19385154|P1|STARTED|Overall Study|13 patients entered the study|13
7877502|NCT00824512|19385164|P2|NOT COMPLETED|Overall Study||0
7877503|NCT00824512|19385165|P1|NOT COMPLETED|Overall Study||0
7877504|NCT00824512|19385164|P2|COMPLETED|Overall Study||11
7877505|NCT00824512|19385165|P1|COMPLETED|Overall Study||11
7877506|NCT00824512|19385164|P2|STARTED|Overall Study||11
7877507|NCT00824512|19385165|P1|STARTED|Overall Study||11
7877508|NCT00824473|19385215|P2|NOT COMPLETED|Overall Study||13
7877509|NCT00824473|19385216|P1|NOT COMPLETED|Overall Study||15
7877510|NCT00824473|19385215|P2|COMPLETED|Overall Study||238
7877511|NCT00824473|19385216|P1|COMPLETED|Overall Study||240
7877512|NCT00824473|19385215|P2|STARTED|Overall Study||251
7877513|NCT00824473|19385216|P1|STARTED|Overall Study|1 subject was randomized in error|255
7877514|NCT00824460|19385238|P6|NOT COMPLETED|Overall Study||8
7877515|NCT00824460|19385239|P5|NOT COMPLETED|Overall Study||9
7877516|NCT00824460|19385240|P4|NOT COMPLETED|Overall Study||12
7877517|NCT00824460|19385241|P3|NOT COMPLETED|Overall Study||5
7877518|NCT00824460|19385242|P2|NOT COMPLETED|Overall Study||9
7877519|NCT00824460|19385243|P1|NOT COMPLETED|Overall Study||8
7877520|NCT00824460|19385238|P6|COMPLETED|Overall Study||18
7877521|NCT00824460|19385239|P5|COMPLETED|Overall Study||15
7877522|NCT00824460|19385240|P4|COMPLETED|Overall Study||15
7877523|NCT00824460|19385241|P3|COMPLETED|Overall Study||20
7877524|NCT00824460|19385242|P2|COMPLETED|Overall Study||17
7877525|NCT00824460|19385243|P1|COMPLETED|Overall Study||18
7877526|NCT00824460|19385238|P6|STARTED|Overall Study||26
7877527|NCT00824460|19385239|P5|STARTED|Overall Study||24
7877528|NCT00824460|19385240|P4|STARTED|Overall Study||27
7877529|NCT00824460|19385241|P3|STARTED|Overall Study||25
7877530|NCT00824460|19385242|P2|STARTED|Overall Study||26
7877531|NCT00824460|19385243|P1|STARTED|Overall Study||26
7877532|NCT00824434|19385275|P1|NOT COMPLETED|Overall Study||0
7877533|NCT00824434|19385275|P1|COMPLETED|Overall Study||100
7877534|NCT00824434|19385275|P1|STARTED|Overall Study||100
7877535|NCT00824421|19385297|P3|NOT COMPLETED|Overall Study||14
7877536|NCT00824421|19385298|P2|NOT COMPLETED|Overall Study||22
7877537|NCT00824421|19385299|P1|NOT COMPLETED|Overall Study||17
7877538|NCT00824421|19385297|P3|COMPLETED|Overall Study||49
7877539|NCT00824421|19385298|P2|COMPLETED|Overall Study||44
7877540|NCT00824421|19385299|P1|COMPLETED|Overall Study||49
7877541|NCT00824421|19385297|P3|Treated|Overall Study||63
7877542|NCT00824421|19385298|P2|Treated|Overall Study||65
7877543|NCT00824421|19385299|P1|Treated|Overall Study||65
7877544|NCT00824421|19385297|P3|STARTED|Overall Study||63
7877545|NCT00824421|19385298|P2|STARTED|Overall Study||66
7877546|NCT00824421|19385299|P1|STARTED|Overall Study||66
7877547|NCT00824408|19385350|P5|NOT COMPLETED|Randomized Phase||46
7877548|NCT00824408|19385351|P4|NOT COMPLETED|Randomized Phase||46
7877549|NCT00824408|19385352|P3|NOT COMPLETED|Randomized Phase||36
7877550|NCT00824408|19385353|P2|NOT COMPLETED|Randomized Phase||0
7877551|NCT00824408|19385354|P1|NOT COMPLETED|Randomized Phase||0
7877552|NCT00824408|19385350|P5|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
7877553|NCT00824408|19385351|P4|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
7877554|NCT00824408|19385352|P3|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
7877555|NCT00824408|19385353|P2|COMPLETED|Randomized Phase||0
7877556|NCT00824408|19385354|P1|COMPLETED|Randomized Phase||0
7877557|NCT00824408|19385350|P5|STARTED|Randomized Phase||47
7877558|NCT00824408|19385351|P4|STARTED|Randomized Phase||47
7877559|NCT00824408|19385352|P3|STARTED|Randomized Phase||37
7877560|NCT00824408|19385353|P2|STARTED|Randomized Phase||0
7877561|NCT00824408|19385354|P1|STARTED|Randomized Phase||0
7877562|NCT00824408|19385350|P5|NOT COMPLETED|Run-in Phase||0
7877563|NCT00824408|19385351|P4|NOT COMPLETED|Run-in Phase||0
7877564|NCT00824408|19385352|P3|NOT COMPLETED|Run-in Phase||0
7877565|NCT00824408|19385353|P2|NOT COMPLETED|Run-in Phase||6
7877566|NCT00824408|19385354|P1|NOT COMPLETED|Run-in Phase||6
7877567|NCT00824408|19385350|P5|COMPLETED|Run-in Phase||0
7877568|NCT00824408|19385351|P4|COMPLETED|Run-in Phase||0
7877569|NCT00824408|19385352|P3|COMPLETED|Run-in Phase||0
7877570|NCT00824408|19385353|P2|COMPLETED|Run-in Phase||0
7877571|NCT00824408|19385354|P1|COMPLETED|Run-in Phase||0
7877572|NCT00824408|19385350|P5|STARTED|Run-in Phase||0
7877573|NCT00824408|19385351|P4|STARTED|Run-in Phase||0
7877574|NCT00824408|19385352|P3|STARTED|Run-in Phase||0
7877575|NCT00824408|19385353|P2|STARTED|Run-in Phase||6
7877576|NCT00824408|19385354|P1|STARTED|Run-in Phase||6
7877577|NCT00824382|19385406|P4|NOT COMPLETED|Overall Study||5
7877578|NCT00824382|19385407|P3|NOT COMPLETED|Overall Study||3
7877579|NCT00824382|19385408|P2|NOT COMPLETED|Overall Study||2
7877580|NCT00824382|19385409|P1|NOT COMPLETED|Overall Study||5
7877581|NCT00824382|19385406|P4|COMPLETED|Overall Study||81
7877582|NCT00824382|19385407|P3|COMPLETED|Overall Study||76
7877583|NCT00824382|19385408|P2|COMPLETED|Overall Study||82
7877584|NCT00824382|19385409|P1|COMPLETED|Overall Study||74
7877585|NCT00824382|19385406|P4|STARTED|Overall Study||86
7877586|NCT00824382|19385407|P3|STARTED|Overall Study||79
7877587|NCT00824382|19385408|P2|STARTED|Overall Study||84
7877588|NCT00824382|19385409|P1|STARTED|Overall Study||79
7877589|NCT00824369|19385485|P6|NOT COMPLETED|Overall Study||1
7877590|NCT00824369|19385486|P5|NOT COMPLETED|Overall Study||1
7877591|NCT00824369|19385487|P4|NOT COMPLETED|Overall Study||2
7877592|NCT00824369|19385488|P3|NOT COMPLETED|Overall Study||1
7877593|NCT00824369|19385489|P2|NOT COMPLETED|Overall Study||0
7877594|NCT00824369|19385490|P1|NOT COMPLETED|Overall Study||1
7877595|NCT00824369|19385485|P6|COMPLETED|Overall Study||16
7877596|NCT00824369|19385486|P5|COMPLETED|Overall Study||11
7877597|NCT00824369|19385487|P4|COMPLETED|Overall Study||9
7877598|NCT00824369|19385488|P3|COMPLETED|Overall Study||2
7877599|NCT00824369|19385489|P2|COMPLETED|Overall Study||4
7877600|NCT00824369|19385490|P1|COMPLETED|Overall Study||4
7877601|NCT00824369|19385485|P6|STARTED|Overall Study||17
7877602|NCT00824369|19385486|P5|STARTED|Overall Study||12
7877603|NCT00824369|19385487|P4|STARTED|Overall Study||11
7877604|NCT00824369|19385488|P3|STARTED|Overall Study||3
7877605|NCT00824369|19385489|P2|STARTED|Overall Study||4
7877606|NCT00824369|19385490|P1|STARTED|Overall Study||5
7877607|NCT00824291|19385530|P2|NOT COMPLETED|Overall Study||35
7877608|NCT00824291|19385531|P1|NOT COMPLETED|Overall Study||54
7877609|NCT00824291|19385530|P2|COMPLETED|Overall Study||107
7877610|NCT00824291|19385531|P1|COMPLETED|Overall Study||231
7877611|NCT00824291|19385530|P2|STARTED|Overall Study||142
7877612|NCT00824291|19385531|P1|STARTED|Overall Study||285
7877613|NCT00824265|19385553|P2|NOT COMPLETED|Survival Follow-up Phase||16
7877614|NCT00824265|19385554|P1|NOT COMPLETED|Survival Follow-up Phase||9
7877615|NCT00824265|19385553|P2|COMPLETED|Survival Follow-up Phase||73
7877616|NCT00824265|19385554|P1|COMPLETED|Survival Follow-up Phase||87
7877617|NCT00824265|19385553|P2|STARTED|Survival Follow-up Phase||89
7877618|NCT00824265|19385554|P1|STARTED|Survival Follow-up Phase||96
7877619|NCT00824265|19385553|P2|NOT COMPLETED|Follow-up Phase||31
7877620|NCT00824265|19385554|P1|NOT COMPLETED|Follow-up Phase||18
7877621|NCT00824265|19385553|P2|COMPLETED|Follow-up Phase||129
7877622|NCT00824265|19385554|P1|COMPLETED|Follow-up Phase||154
7877623|NCT00824265|19385553|P2|STARTED|Follow-up Phase||160
7877624|NCT00824265|19385554|P1|STARTED|Follow-up Phase||172
7877625|NCT00824265|19385553|P2|NOT COMPLETED|Treatment Phase||80
7877626|NCT00824265|19385554|P1|NOT COMPLETED|Treatment Phase||64
7877627|NCT00824265|19385553|P2|COMPLETED|Treatment Phase||102
7877628|NCT00824265|19385554|P1|COMPLETED|Treatment Phase||119
7877629|NCT00824265|19385553|P2|STARTED|Treatment Phase||182
7877630|NCT00824265|19385554|P1|STARTED|Treatment Phase||183
7877631|NCT00824161|19385615|P1|NOT COMPLETED|Overall Study||2
7877632|NCT00824161|19385615|P1|COMPLETED|Overall Study||26
7877633|NCT00824161|19385615|P1|STARTED|Overall Study||28
7877634|NCT00824070|19385624|P3|NOT COMPLETED|Overall Study||0
7877635|NCT00824070|19385625|P2|NOT COMPLETED|Overall Study||0
7877636|NCT00824070|19385626|P1|NOT COMPLETED|Overall Study||0
7877637|NCT00824070|19385624|P3|COMPLETED|Overall Study||36
7877638|NCT00824070|19385625|P2|COMPLETED|Overall Study||35
7877639|NCT00824070|19385626|P1|COMPLETED|Overall Study||34
7877640|NCT00824070|19385624|P3|STARTED|Overall Study||36
7877641|NCT00824070|19385625|P2|STARTED|Overall Study||35
7877642|NCT00824070|19385626|P1|STARTED|Overall Study||34
7877643|NCT00824044|19385636|P2|NOT COMPLETED|Overall Study||6
7877644|NCT00824044|19385637|P1|NOT COMPLETED|Overall Study||9
7877645|NCT00824044|19385636|P2|COMPLETED|Overall Study||10
7877646|NCT00824044|19385637|P1|COMPLETED|Overall Study||14
7877647|NCT00824044|19385636|P2|STARTED|Overall Study||16
7877648|NCT00824044|19385637|P1|STARTED|Overall Study||23
7877649|NCT00824005|19385681|P2|NOT COMPLETED|Overall Study||2
7877650|NCT00824005|19385682|P1|NOT COMPLETED|Overall Study||0
7877651|NCT00824005|19385681|P2|COMPLETED|Overall Study||59
7877652|NCT00824005|19385682|P1|COMPLETED|Overall Study||31
7877653|NCT00824005|19385681|P2|STARTED|Overall Study||61
7877654|NCT00824005|19385682|P1|STARTED|Overall Study||31
7877655|NCT00823979|19385717|P3|NOT COMPLETED|Overall Study||24
7877656|NCT00823979|19385718|P2|NOT COMPLETED|Overall Study||32
7877657|NCT00823979|19385719|P1|NOT COMPLETED|Overall Study||29
7877658|NCT00823979|19385717|P3|COMPLETED|Overall Study||11
7877659|NCT00823979|19385718|P2|COMPLETED|Overall Study||3
7877660|NCT00823979|19385719|P1|COMPLETED|Overall Study||6
7877661|NCT00823979|19385717|P3|Treated|Overall Study||34
7877662|NCT00823979|19385718|P2|Treated|Overall Study||32
7877663|NCT00823979|19385719|P1|Treated|Overall Study||31
7877664|NCT00823979|19385717|P3|STARTED|Overall Study||35
7877665|NCT00823979|19385718|P2|STARTED|Overall Study||35
7877666|NCT00823979|19385719|P1|STARTED|Overall Study||35
7877667|NCT00823966|19385757|P1|NOT COMPLETED|Overall Study||0
7877668|NCT00823966|19385757|P1|COMPLETED|Overall Study||3
7877669|NCT00823966|19385757|P1|STARTED|Overall Study||3
7877670|NCT00823901|19385764|P2|NOT COMPLETED|Overall Study||2
7877671|NCT00823901|19385765|P1|NOT COMPLETED|Overall Study||4
7877672|NCT00823901|19385764|P2|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38
7877673|NCT00823901|19385765|P1|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39
7877674|NCT00823901|19385764|P2|STARTED|Overall Study|Randomized to placebo gel|40
7877675|NCT00823901|19385765|P1|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43
7877676|NCT00823836|19385773|P2|NOT COMPLETED|Long-term Phase||5
7877677|NCT00823836|19385774|P1|NOT COMPLETED|Long-term Phase||5
7877678|NCT00823836|19385773|P2|COMPLETED|Long-term Phase||79
7877679|NCT00823836|19385774|P1|COMPLETED|Long-term Phase||68
7877680|NCT00823836|19385773|P2|STARTED|Long-term Phase||84
7877681|NCT00823836|19385774|P1|STARTED|Long-term Phase||73
7877682|NCT00823836|19385773|P2|NOT COMPLETED|NV and PR/XR Switching Phases||29
7877683|NCT00823836|19385774|P1|NOT COMPLETED|NV and PR/XR Switching Phases||32
7877684|NCT00823836|19385773|P2|COMPLETED|NV and PR/XR Switching Phases||117
7877685|NCT00823836|19385774|P1|COMPLETED|NV and PR/XR Switching Phases||124
7877686|NCT00823836|19385773|P2|STARTED|NV and PR/XR Switching Phases||146
7877687|NCT00823836|19385774|P1|STARTED|NV and PR/XR Switching Phases||156
7877688|NCT00823823|19385880|P2|NOT COMPLETED|Overall Study||6
7877689|NCT00823823|19385881|P1|NOT COMPLETED|Overall Study||8
7877690|NCT00823823|19385880|P2|COMPLETED|Overall Study||101
7877691|NCT00823823|19385881|P1|COMPLETED|Overall Study||101
7877692|NCT00823823|19385880|P2|STARTED|Overall Study||107
7877693|NCT00823823|19385881|P1|STARTED|Overall Study||109
7877694|NCT00823797|19385891|P2|NOT COMPLETED|Overall Study||0
7877695|NCT00823797|19385892|P1|NOT COMPLETED|Overall Study||0
7877696|NCT00823797|19385891|P2|COMPLETED|Overall Study||16
7877697|NCT00823797|19385892|P1|COMPLETED|Overall Study||29
7877698|NCT00823797|19385891|P2|STARTED|Overall Study||16
7877699|NCT00823797|19385892|P1|STARTED|Overall Study||29
7877700|NCT00823719|19385905|P2|NOT COMPLETED|Overall Study||11
7877701|NCT00823719|19385906|P1|NOT COMPLETED|Overall Study||6
7877702|NCT00823719|19385905|P2|COMPLETED|Overall Study||24
7877703|NCT00823719|19385906|P1|COMPLETED|Overall Study||20
7877704|NCT00823719|19385905|P2|STARTED|Overall Study||35
7877705|NCT00823719|19385906|P1|STARTED|Overall Study||26
7877706|NCT00823615|19385959|P2|NOT COMPLETED|Period 2||2
7877707|NCT00823615|19385960|P1|NOT COMPLETED|Period 2||3
7877708|NCT00823615|19385959|P2|COMPLETED|Period 2||17
7877709|NCT00823615|19385960|P1|COMPLETED|Period 2||16
7877710|NCT00823615|19385959|P2|STARTED|Period 2||19
7877711|NCT00823615|19385960|P1|STARTED|Period 2||19
7877712|NCT00823615|19385959|P2|NOT COMPLETED|Period 1||0
7877713|NCT00823615|19385960|P1|NOT COMPLETED|Period 1||0
7877714|NCT00823615|19385959|P2|COMPLETED|Period 1||19
7877715|NCT00823615|19385960|P1|COMPLETED|Period 1||19
7877716|NCT00823615|19385959|P2|STARTED|Period 1||19
7877717|NCT00823615|19385960|P1|STARTED|Period 1||19
7877718|NCT00823472|19385970|P2|NOT COMPLETED|Overall Study||28
7877719|NCT00823472|19385971|P1|NOT COMPLETED|Overall Study||24
7877720|NCT00823472|19385970|P2|COMPLETED|Overall Study||39
7877721|NCT00823472|19385971|P1|COMPLETED|Overall Study||56
7877722|NCT00823472|19385970|P2|STARTED|Overall Study||67
7877723|NCT00823472|19385971|P1|STARTED|Overall Study||80
7877724|NCT00823459|19385979|P1|NOT COMPLETED|Overall Study||0
7877725|NCT00823459|19385979|P1|COMPLETED|Overall Study||58
7877726|NCT00823459|19385979|P1|STARTED|Overall Study||58
7877727|NCT00823303|19385989|P2|NOT COMPLETED|Overall Study||11
7877728|NCT00823303|19385990|P1|NOT COMPLETED|Overall Study||9
7877729|NCT00823303|19385989|P2|COMPLETED|Overall Study||45
7877730|NCT00823303|19385990|P1|COMPLETED|Overall Study||45
7877731|NCT00823303|19385989|P2|STARTED|Overall Study||56
7877732|NCT00823303|19385990|P1|STARTED|Overall Study||54
7877733|NCT00823264|19385998|P2|NOT COMPLETED|Overall Study||0
7877734|NCT00823264|19385999|P1|NOT COMPLETED|Overall Study||2
7877735|NCT00823264|19385998|P2|COMPLETED|Overall Study||7
7877736|NCT00823264|19385999|P1|COMPLETED|Overall Study||8
7877737|NCT00823264|19385998|P2|STARTED|Overall Study||7
7877738|NCT00823264|19385999|P1|STARTED|Overall Study||10
7877739|NCT00823212|19386007|P2|NOT COMPLETED|Overall Study||33
7877740|NCT00823212|19386008|P1|NOT COMPLETED|Overall Study||35
7877741|NCT00823212|19386007|P2|COMPLETED|Overall Study|12-month follow-up|735
7877742|NCT00823212|19386008|P1|COMPLETED|Overall Study|12-month follow-up|727
7877743|NCT00823212|19386007|P2|STARTED|Overall Study||768
7877744|NCT00823212|19386008|P1|STARTED|Overall Study||762
7877745|NCT00823199|19386090|P1|NOT COMPLETED|Overall Study||2
7877746|NCT00823199|19386090|P1|COMPLETED|Overall Study||8
7877747|NCT00823199|19386090|P1|STARTED|Overall Study||10
7877748|NCT00823134|19386096|P1|NOT COMPLETED|Overall Study||1
7877749|NCT00823134|19386096|P1|COMPLETED|Overall Study||22
7877750|NCT00823134|19386096|P1|STARTED|Overall Study||23
7877751|NCT00823095|19386106|P1|NOT COMPLETED|Overall Study||0
7877752|NCT00823095|19386106|P1|COMPLETED|Overall Study||7
7877753|NCT00823095|19386106|P1|STARTED|Overall Study||7
7877754|NCT00823082|19386113|P2|NOT COMPLETED|Overall Study||1
7877755|NCT00823082|19386114|P1|NOT COMPLETED|Overall Study||0
7877756|NCT00823082|19386113|P2|COMPLETED|Overall Study||99
7877757|NCT00823082|19386114|P1|COMPLETED|Overall Study||100
7877758|NCT00823082|19386113|P2|Intent-to-Treat/Per Protocol Populations|Overall Study||94
7877759|NCT00823082|19386114|P1|Intent-to-Treat/Per Protocol Populations|Overall Study||100
7877760|NCT00823082|19386113|P2|Safety Population|Overall Study||99
7877761|NCT00823082|19386114|P1|Safety Population|Overall Study||100
7877762|NCT00823082|19386113|P2|STARTED|Overall Study||100
7877763|NCT00823082|19386114|P1|STARTED|Overall Study||100
7877764|NCT00823069|19386148|P1|NOT COMPLETED|Overall Study||0
7877765|NCT00823069|19386148|P1|COMPLETED|Overall Study||60
7877766|NCT00823069|19386148|P1|STARTED|Overall Study||60
7877767|NCT00823043|19386155|P2|NOT COMPLETED|Overall Study||0
7877768|NCT00823043|19386156|P1|NOT COMPLETED|Overall Study||0
7877769|NCT00823043|19386155|P2|COMPLETED|Overall Study||39
7877770|NCT00823043|19386156|P1|COMPLETED|Overall Study||64
7877771|NCT00823043|19386155|P2|STARTED|Overall Study||39
7877772|NCT00823043|19386156|P1|STARTED|Overall Study||64
7877773|NCT00822926|19386169|P2|NOT COMPLETED|Second Injection Visit||1
7877774|NCT00822926|19386170|P1|NOT COMPLETED|Second Injection Visit||1
7877775|NCT00822926|19386169|P2|COMPLETED|Second Injection Visit||2
7877776|NCT00822926|19386170|P1|COMPLETED|Second Injection Visit||1
7877777|NCT00822926|19386169|P2|STARTED|Second Injection Visit||3
7877778|NCT00822926|19386170|P1|STARTED|Second Injection Visit||2
7877779|NCT00822926|19386169|P2|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
7877780|NCT00822926|19386170|P1|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
7877781|NCT00822926|19386169|P2|COMPLETED|Washout (Varies Based on Scheduling)||3
7877782|NCT00822926|19386170|P1|COMPLETED|Washout (Varies Based on Scheduling)||2
7877783|NCT00822926|19386169|P2|STARTED|Washout (Varies Based on Scheduling)||3
7877784|NCT00822926|19386170|P1|STARTED|Washout (Varies Based on Scheduling)||2
7877785|NCT00822926|19386169|P2|NOT COMPLETED|First Injection Visit||0
7877786|NCT00822926|19386170|P1|NOT COMPLETED|First Injection Visit||0
7877787|NCT00822926|19386169|P2|COMPLETED|First Injection Visit||3
7877788|NCT00822926|19386170|P1|COMPLETED|First Injection Visit||2
7877789|NCT00822926|19386169|P2|STARTED|First Injection Visit||3
7877790|NCT00822926|19386170|P1|STARTED|First Injection Visit||2
7877791|NCT00822900|19386184|P2|NOT COMPLETED|Overall Study||93
7877792|NCT00822900|19386185|P1|NOT COMPLETED|Overall Study||108
7877793|NCT00822900|19386184|P2|COMPLETED|Overall Study||347
7877794|NCT00822900|19386185|P1|COMPLETED|Overall Study||334
7877795|NCT00822900|19386184|P2|STARTED|Overall Study||440
7877796|NCT00822900|19386185|P1|STARTED|Overall Study||442
7877797|NCT00822770|19386215|P2|NOT COMPLETED|Overall Study||1
7877798|NCT00822770|19386216|P1|NOT COMPLETED|Overall Study||3
7877799|NCT00822770|19386215|P2|COMPLETED|Overall Study||28
7877800|NCT00822770|19386216|P1|COMPLETED|Overall Study||15
7877801|NCT00822770|19386215|P2|STARTED|Overall Study||29
7877802|NCT00822770|19386216|P1|STARTED|Overall Study||18
7877803|NCT00822757|19386225|P2|NOT COMPLETED|Overall Study||0
7877804|NCT00822757|19386226|P1|NOT COMPLETED|Overall Study||0
7877805|NCT00822757|19386225|P2|COMPLETED|Overall Study||10
7877806|NCT00822757|19386226|P1|COMPLETED|Overall Study||41
7877807|NCT00822757|19386225|P2|STARTED|Overall Study||10
7877808|NCT00822757|19386226|P1|STARTED|Overall Study||41
7877809|NCT00822692|19386238|P2|NOT COMPLETED|Overall Study||25
7877810|NCT00822692|19386239|P1|NOT COMPLETED|Overall Study||17
7877811|NCT00822692|19386238|P2|COMPLETED|Overall Study|June 1 , 2009|51
7877812|NCT00822692|19386239|P1|COMPLETED|Overall Study|June 1, 2009|46
7877813|NCT00822692|19386238|P2|STARTED|Overall Study|July 1, 2008|76
7877814|NCT00822692|19386239|P1|STARTED|Overall Study|July 1, 2008|63
7877815|NCT00822679|19386247|P2|NOT COMPLETED|Overall Study||0
7877816|NCT00822679|19386248|P1|NOT COMPLETED|Overall Study||0
7877817|NCT00822679|19386247|P2|COMPLETED|Overall Study||0
7877818|NCT00822679|19386248|P1|COMPLETED|Overall Study||0
7877819|NCT00822679|19386247|P2|STARTED|Overall Study||0
7877820|NCT00822679|19386248|P1|STARTED|Overall Study||0
7877821|NCT00822588|19386256|P2|NOT COMPLETED|Overall Study||4
7877822|NCT00822588|19386257|P1|NOT COMPLETED|Overall Study||7
7877823|NCT00822588|19386256|P2|COMPLETED|Overall Study|APT/ITT analysis set|110
7877824|NCT00822588|19386257|P1|COMPLETED|Overall Study|APT/ITT analysis set|106
7877825|NCT00822588|19386256|P2|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114
7877826|NCT00822588|19386257|P1|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113
7877827|NCT00822523|19386266|P3|NOT COMPLETED|Overall Study||0
7877828|NCT00822523|19386267|P2|NOT COMPLETED|Overall Study||0
7877829|NCT00822523|19386268|P1|NOT COMPLETED|Overall Study||0
7877830|NCT00822523|19386266|P3|COMPLETED|Overall Study||4
7877831|NCT00822523|19386267|P2|COMPLETED|Overall Study||4
7877832|NCT00822523|19386268|P1|COMPLETED|Overall Study||5
7877833|NCT00822523|19386266|P3|STARTED|Overall Study||4
7877834|NCT00822523|19386267|P2|STARTED|Overall Study||4
7877835|NCT00822523|19386268|P1|STARTED|Overall Study||5
7877836|NCT00822510|19386314|P2|NOT COMPLETED|Overall Study||5
7877837|NCT00822510|19386315|P1|NOT COMPLETED|Overall Study||3
7877838|NCT00822510|19386314|P2|COMPLETED|Overall Study||36
7877839|NCT00822510|19386315|P1|COMPLETED|Overall Study||35
7877840|NCT00822510|19386314|P2|STARTED|Overall Study||41
7877841|NCT00822510|19386315|P1|STARTED|Overall Study||38
7877842|NCT00822354|19386335|P2|NOT COMPLETED|Second Intervention (28 Days)||0
7877843|NCT00822354|19386336|P1|NOT COMPLETED|Second Intervention (28 Days)||1
7877844|NCT00822354|19386335|P2|COMPLETED|Second Intervention (28 Days)||5
7877845|NCT00822354|19386336|P1|COMPLETED|Second Intervention (28 Days)||3
7877846|NCT00822354|19386335|P2|STARTED|Second Intervention (28 Days)||5
7877847|NCT00822354|19386336|P1|STARTED|Second Intervention (28 Days)||4
7877848|NCT00822354|19386335|P2|NOT COMPLETED|Washout (7 Days)||0
7877849|NCT00822354|19386336|P1|NOT COMPLETED|Washout (7 Days)||0
7877850|NCT00822354|19386335|P2|COMPLETED|Washout (7 Days)||5
7877851|NCT00822354|19386336|P1|COMPLETED|Washout (7 Days)||4
7877852|NCT00822354|19386335|P2|STARTED|Washout (7 Days)||5
7877853|NCT00822354|19386336|P1|STARTED|Washout (7 Days)||4
7877854|NCT00822354|19386335|P2|NOT COMPLETED|First Intervention (28 Days)||0
7877855|NCT00822354|19386336|P1|NOT COMPLETED|First Intervention (28 Days)||1
7877856|NCT00822354|19386335|P2|COMPLETED|First Intervention (28 Days)||5
7877857|NCT00822354|19386336|P1|COMPLETED|First Intervention (28 Days)||4
7877858|NCT00822354|19386335|P2|STARTED|First Intervention (28 Days)||5
7877859|NCT00822354|19386336|P1|STARTED|First Intervention (28 Days)||5
7877860|NCT00822328|19386366|P2|NOT COMPLETED|Overall Study||0
7877861|NCT00822328|19386367|P1|NOT COMPLETED|Overall Study||0
7877862|NCT00822328|19386366|P2|COMPLETED|Overall Study||12
7877863|NCT00822328|19386367|P1|COMPLETED|Overall Study||12
7877864|NCT00822328|19386366|P2|STARTED|Overall Study||12
7877865|NCT00822328|19386367|P1|STARTED|Overall Study||12
7877866|NCT00822237|19386377|P2|NOT COMPLETED|Dose 2 Vaccination||11
7877867|NCT00822237|19386378|P1|NOT COMPLETED|Dose 2 Vaccination||4
7877868|NCT00822237|19386377|P2|COMPLETED|Dose 2 Vaccination||262
7877869|NCT00822237|19386378|P1|COMPLETED|Dose 2 Vaccination||270
7877870|NCT00822237|19386377|P2|STARTED|Dose 2 Vaccination|Number who received second dose|273
7877871|NCT00822237|19386378|P1|STARTED|Dose 2 Vaccination|Number who received second dose|274
7877872|NCT00822237|19386377|P2|NOT COMPLETED|Dose 1 Vaccination||26
7877873|NCT00822237|19386378|P1|NOT COMPLETED|Dose 1 Vaccination||25
7877874|NCT00822237|19386377|P2|COMPLETED|Dose 1 Vaccination||273
7877875|NCT00822237|19386378|P1|COMPLETED|Dose 1 Vaccination||274
7877876|NCT00822237|19386377|P2|STARTED|Dose 1 Vaccination|Number randomized|299
7877877|NCT00822237|19386378|P1|STARTED|Dose 1 Vaccination|Number randomized|299
7877878|NCT00822185|19386388|P5|NOT COMPLETED|Overall Study||0
7877879|NCT00822185|19386389|P4|NOT COMPLETED|Overall Study||0
7877880|NCT00822185|19386390|P3|NOT COMPLETED|Overall Study||0
7877881|NCT00822185|19386391|P2|NOT COMPLETED|Overall Study||0
7877882|NCT00822185|19386392|P1|NOT COMPLETED|Overall Study||0
7877883|NCT00822185|19386388|P5|COMPLETED|Overall Study||8
7877884|NCT00822185|19386389|P4|COMPLETED|Overall Study||6
7877885|NCT00822185|19386390|P3|COMPLETED|Overall Study||6
7877886|NCT00822185|19386391|P2|COMPLETED|Overall Study||6
7877887|NCT00822185|19386392|P1|COMPLETED|Overall Study||6
7877888|NCT00822185|19386388|P5|STARTED|Overall Study||8
7877889|NCT00822185|19386389|P4|STARTED|Overall Study||6
7877890|NCT00822185|19386390|P3|STARTED|Overall Study||6
7877891|NCT00822185|19386391|P2|STARTED|Overall Study||6
7877892|NCT00822185|19386392|P1|STARTED|Overall Study||6
7877893|NCT00822172|19386459|P2|NOT COMPLETED|Overall Study||19
7877894|NCT00822172|19386460|P1|NOT COMPLETED|Overall Study||15
7877895|NCT00822172|19386459|P2|COMPLETED|Overall Study||64
7877896|NCT00822172|19386460|P1|COMPLETED|Overall Study||65
7877897|NCT00822172|19386459|P2|STARTED|Overall Study||83
7877898|NCT00822172|19386460|P1|STARTED|Overall Study||80
7877899|NCT00822120|19386480|P6|NOT COMPLETED|PET-directed Therapy||0
7877900|NCT00822120|19386481|P5|NOT COMPLETED|PET-directed Therapy||0
7877901|NCT00822120|19386482|P4|NOT COMPLETED|PET-directed Therapy||10
7877902|NCT00822120|19386483|P3|NOT COMPLETED|PET-directed Therapy||0
7877903|NCT00822120|19386484|P2|NOT COMPLETED|PET-directed Therapy||0
7877904|NCT00822120|19386485|P1|NOT COMPLETED|PET-directed Therapy||0
7877905|NCT00822120|19386480|P6|COMPLETED|PET-directed Therapy||1
7877906|NCT00822120|19386481|P5|COMPLETED|PET-directed Therapy||10
7877907|NCT00822120|19386482|P4|COMPLETED|PET-directed Therapy||45
7877908|NCT00822120|19386483|P3|COMPLETED|PET-directed Therapy||270
7877909|NCT00822120|19386484|P2|COMPLETED|PET-directed Therapy||0
7877910|NCT00822120|19386485|P1|COMPLETED|PET-directed Therapy||0
7877911|NCT00822120|19386480|P6|Eligibile and Evaluable Patients|PET-directed Therapy||1
7877912|NCT00822120|19386481|P5|Eligibile and Evaluable Patients|PET-directed Therapy||10
7877913|NCT00822120|19386482|P4|Eligibile and Evaluable Patients|PET-directed Therapy||55
7877914|NCT00822120|19386483|P3|Eligibile and Evaluable Patients|PET-directed Therapy||270
7877915|NCT00822120|19386484|P2|Eligibile and Evaluable Patients|PET-directed Therapy||0
7877916|NCT00822120|19386485|P1|Eligibile and Evaluable Patients|PET-directed Therapy||0
7877917|NCT00822120|19386480|P6|STARTED|PET-directed Therapy||1
7877918|NCT00822120|19386481|P5|STARTED|PET-directed Therapy||10
7877919|NCT00822120|19386482|P4|STARTED|PET-directed Therapy||55
7877920|NCT00822120|19386483|P3|STARTED|PET-directed Therapy||270
7877921|NCT00822120|19386484|P2|STARTED|PET-directed Therapy||0
7877922|NCT00822120|19386485|P1|STARTED|PET-directed Therapy||0
7877923|NCT00822120|19386480|P6|NOT COMPLETED|Initial Registration||0
7877924|NCT00822120|19386481|P5|NOT COMPLETED|Initial Registration||0
7877925|NCT00822120|19386482|P4|NOT COMPLETED|Initial Registration||0
7877926|NCT00822120|19386483|P3|NOT COMPLETED|Initial Registration||0
7877927|NCT00822120|19386484|P2|NOT COMPLETED|Initial Registration||1
7877928|NCT00822120|19386485|P1|NOT COMPLETED|Initial Registration||26
7877929|NCT00822120|19386480|P6|COMPLETED|Initial Registration||0
7877930|NCT00822120|19386481|P5|COMPLETED|Initial Registration||0
7877931|NCT00822120|19386482|P4|COMPLETED|Initial Registration||0
7877932|NCT00822120|19386483|P3|COMPLETED|Initial Registration||0
7877933|NCT00822120|19386484|P2|COMPLETED|Initial Registration||12
7877934|NCT00822120|19386485|P1|COMPLETED|Initial Registration||332
7877935|NCT00822120|19386480|P6|Eligible and Evaluable Patients|Initial Registration||0
7877936|NCT00822120|19386481|P5|Eligible and Evaluable Patients|Initial Registration||0
7877937|NCT00822120|19386482|P4|Eligible and Evaluable Patients|Initial Registration||0
7877938|NCT00822120|19386483|P3|Eligible and Evaluable Patients|Initial Registration||0
7877939|NCT00822120|19386484|P2|Eligible and Evaluable Patients|Initial Registration||12
7877940|NCT00822120|19386485|P1|Eligible and Evaluable Patients|Initial Registration||336
7877941|NCT00822120|19386480|P6|STARTED|Initial Registration||0
7877942|NCT00822120|19386481|P5|STARTED|Initial Registration||0
7877943|NCT00822120|19386482|P4|STARTED|Initial Registration||0
7877944|NCT00822120|19386483|P3|STARTED|Initial Registration||0
7877945|NCT00822120|19386484|P2|STARTED|Initial Registration||13
7877946|NCT00822120|19386485|P1|STARTED|Initial Registration||358
7877947|NCT00822107|19386508|P1|NOT COMPLETED|Overall Study||0
7877948|NCT00822107|19386508|P1|COMPLETED|Overall Study||5
7877949|NCT00822107|19386508|P1|STARTED|Overall Study||5
7877950|NCT00822094|19386514|P2|NOT COMPLETED|Overall Study||25
7877951|NCT00822094|19386515|P1|NOT COMPLETED|Overall Study||44
7877952|NCT00822094|19386514|P2|COMPLETED|Overall Study||20
7877953|NCT00822094|19386515|P1|COMPLETED|Overall Study||37
7877954|NCT00822094|19386514|P2|STARTED|Overall Study||45
7877955|NCT00822094|19386515|P1|STARTED|Overall Study||81
7877956|NCT00821964|19386531|P1|NOT COMPLETED|Overall Study||6
7877957|NCT00821964|19386531|P1|COMPLETED|Overall Study||9
7877958|NCT00821964|19386531|P1|Evaluable for Pathologic Response|Overall Study||7
7877959|NCT00821964|19386531|P1|Evaluable for Clinical Response|Overall Study||14
7877960|NCT00821964|19386531|P1|STARTED|Overall Study||15
7877961|NCT00821951|19386540|P1|NOT COMPLETED|Overall Study||5
7877962|NCT00821951|19386540|P1|COMPLETED|Overall Study||12
7877963|NCT00821951|19386540|P1|STARTED|Overall Study||17
7877964|NCT00821886|19386544|P1|NOT COMPLETED|Overall Study||9
7877965|NCT00821886|19386544|P1|COMPLETED|Overall Study||49
7877966|NCT00821886|19386544|P1|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58
7877967|NCT00821873|19386551|P1|NOT COMPLETED|Overall Study||4
7877968|NCT00821873|19386551|P1|COMPLETED|Overall Study||5
7877969|NCT00821873|19386551|P1|STARTED|Overall Study||9
7877970|NCT00821821|19386558|P3|NOT COMPLETED|Overall Study||0
7877971|NCT00821821|19386559|P2|NOT COMPLETED|Overall Study||0
7877972|NCT00821821|19386560|P1|NOT COMPLETED|Overall Study||0
7877973|NCT00821821|19386558|P3|COMPLETED|Overall Study||11
7877974|NCT00821821|19386559|P2|COMPLETED|Overall Study||13
7877975|NCT00821821|19386560|P1|COMPLETED|Overall Study||12
7877976|NCT00821821|19386558|P3|STARTED|Overall Study||11
7877977|NCT00821821|19386559|P2|STARTED|Overall Study||13
7877978|NCT00821821|19386560|P1|STARTED|Overall Study||12
7877979|NCT00821795|19386572|P2|NOT COMPLETED|Overall Study||4
7877980|NCT00821795|19386573|P1|NOT COMPLETED|Overall Study||6
7877981|NCT00821795|19386572|P2|COMPLETED|Overall Study||60
7877982|NCT00821795|19386573|P1|COMPLETED|Overall Study||44
7877983|NCT00821795|19386572|P2|STARTED|Overall Study||64
7877984|NCT00821795|19386573|P1|STARTED|Overall Study||50
7877985|NCT00821678|19386581|P2|NOT COMPLETED|Overall Study||14
7877986|NCT00821678|19386582|P1|NOT COMPLETED|Overall Study||21
7877987|NCT00821678|19386581|P2|COMPLETED|Overall Study||118
7877988|NCT00821678|19386582|P1|COMPLETED|Overall Study||112
7877989|NCT00821678|19386581|P2|STARTED|Overall Study||132
7877990|NCT00821678|19386582|P1|STARTED|Overall Study||133
7877991|NCT00821626|19386604|P2|NOT COMPLETED|Overall Study||0
7877992|NCT00821626|19386605|P1|NOT COMPLETED|Overall Study||0
7877993|NCT00821626|19386604|P2|COMPLETED|Overall Study||33
7877994|NCT00821626|19386605|P1|COMPLETED|Overall Study||60
7877995|NCT00821626|19386604|P2|STARTED|Overall Study||33
7877996|NCT00821626|19386605|P1|STARTED|Overall Study||60
7877997|NCT00821587|19386617|P2|NOT COMPLETED|Overall Study||1
7877998|NCT00821587|19386618|P1|NOT COMPLETED|Overall Study||0
7877999|NCT00821587|19386617|P2|COMPLETED|Overall Study||18
7878000|NCT00821587|19386618|P1|COMPLETED|Overall Study||20
7878001|NCT00821587|19386617|P2|STARTED|Overall Study||19
7878002|NCT00821587|19386618|P1|STARTED|Overall Study||20
7878003|NCT00821509|19386627|P3|NOT COMPLETED|Overall Study||34
7878004|NCT00821509|19386628|P2|NOT COMPLETED|Overall Study||11
7878005|NCT00821509|19386629|P1|NOT COMPLETED|Overall Study||12
7878006|NCT00821509|19386627|P3|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190
7878007|NCT00821509|19386628|P2|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191
7878008|NCT00821509|19386629|P1|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245
7878009|NCT00821509|19386627|P3|STARTED|Overall Study||224
7878010|NCT00821509|19386628|P2|STARTED|Overall Study||202
7878011|NCT00821509|19386629|P1|STARTED|Overall Study||257
7878012|NCT00821431|19386642|P2|NOT COMPLETED|Overall Study||5
7878013|NCT00821431|19386643|P1|NOT COMPLETED|Overall Study||15
7878014|NCT00821431|19386642|P2|COMPLETED|Overall Study||47
7878015|NCT00821431|19386643|P1|COMPLETED|Overall Study||23
7878016|NCT00821431|19386642|P2|STARTED|Overall Study||52
7878017|NCT00821431|19386643|P1|STARTED|Overall Study||38
7878018|NCT00821327|19386651|P1|NOT COMPLETED|Overall Study||35
7878019|NCT00821327|19386651|P1|COMPLETED|Overall Study||1
7878020|NCT00821327|19386651|P1|STARTED|Overall Study||36
7878021|NCT00821236|19386660|P1|NOT COMPLETED|Overall Study||3
7878022|NCT00821236|19386660|P1|COMPLETED|Overall Study||37
7878023|NCT00821236|19386660|P1|STARTED|Overall Study||40
7878024|NCT00821184|19386676|P2|NOT COMPLETED|Overall Study||0
7878025|NCT00821184|19386677|P1|NOT COMPLETED|Overall Study||0
7878026|NCT00821184|19386676|P2|COMPLETED|Overall Study||6
7878027|NCT00821184|19386677|P1|COMPLETED|Overall Study||6
7878028|NCT00821184|19386676|P2|STARTED|Overall Study||6
7878029|NCT00821184|19386677|P1|STARTED|Overall Study||6
7878030|NCT00821119|19386687|P2|NOT COMPLETED|Overall Study||0
7878031|NCT00821119|19386688|P1|NOT COMPLETED|Overall Study||0
7878032|NCT00821119|19386687|P2|COMPLETED|Overall Study||100
7878033|NCT00821119|19386688|P1|COMPLETED|Overall Study||100
7878034|NCT00821119|19386687|P2|STARTED|Overall Study||100
7878035|NCT00821119|19386688|P1|STARTED|Overall Study||100
7878036|NCT00821093|19386700|P2|NOT COMPLETED|Overall Study||40
7878037|NCT00821093|19386701|P1|NOT COMPLETED|Overall Study||49
7878038|NCT00821093|19386700|P2|COMPLETED|Overall Study||523
7878039|NCT00821093|19386701|P1|COMPLETED|Overall Study||511
7878040|NCT00821093|19386700|P2|Exposed to Drug|Overall Study||562
7878041|NCT00821093|19386701|P1|Exposed to Drug|Overall Study||559
7878042|NCT00821093|19386700|P2|STARTED|Overall Study||563
7878043|NCT00821093|19386701|P1|STARTED|Overall Study||560
7878044|NCT00821041|19386711|P2|NOT COMPLETED|Overall Study||0
7878045|NCT00821041|19386712|P1|NOT COMPLETED|Overall Study||0
7878046|NCT00821041|19386711|P2|COMPLETED|Overall Study||59
7878047|NCT00821041|19386712|P1|COMPLETED|Overall Study||59
7878048|NCT00821041|19386711|P2|STARTED|Overall Study||59
7878049|NCT00821041|19386712|P1|STARTED|Overall Study||59
7878050|NCT00821015|19386720|P1|NOT COMPLETED|Overall Study||12
7878051|NCT00821015|19386720|P1|COMPLETED|Overall Study||15
7878052|NCT00821015|19386720|P1|STARTED|Overall Study||27
7878053|NCT00820898|19386731|P1|NOT COMPLETED|Overall Study||1
7878054|NCT00820898|19386731|P1|COMPLETED|Overall Study||23
7878055|NCT00820898|19386731|P1|STARTED|Overall Study||24
7878056|NCT00820872|19386741|P1|NOT COMPLETED|Overall Study||0
7878057|NCT00820872|19386741|P1|COMPLETED|Overall Study||30
7878058|NCT00820872|19386741|P1|STARTED|Overall Study||30
7878059|NCT00820755|19386745|P3|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
7878060|NCT00820755|19386746|P2|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
7878061|NCT00820755|19386747|P1|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0
7878062|NCT00820755|19386745|P3|COMPLETED|Period 2: Maintenance Therapy Phase||109
7878063|NCT00820755|19386746|P2|COMPLETED|Period 2: Maintenance Therapy Phase||112
7878064|NCT00820755|19386747|P1|COMPLETED|Period 2: Maintenance Therapy Phase||0
7878065|NCT00820755|19386745|P3|STARTED|Period 2: Maintenance Therapy Phase||154
7878066|NCT00820755|19386746|P2|STARTED|Period 2: Maintenance Therapy Phase||157
7878067|NCT00820755|19386747|P1|STARTED|Period 2: Maintenance Therapy Phase||0
7878068|NCT00820755|19386745|P3|NOT COMPLETED|Period 1: Combination Therapy Phase||0
7878069|NCT00820755|19386746|P2|NOT COMPLETED|Period 1: Combination Therapy Phase||0
7878070|NCT00820755|19386747|P1|NOT COMPLETED|Period 1: Combination Therapy Phase||270
7878071|NCT00820755|19386745|P3|COMPLETED|Period 1: Combination Therapy Phase||0
7878072|NCT00820755|19386746|P2|COMPLETED|Period 1: Combination Therapy Phase||0
7878073|NCT00820755|19386747|P1|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313
7878074|NCT00820755|19386745|P3|STARTED|Period 1: Combination Therapy Phase||0
7878075|NCT00820755|19386746|P2|STARTED|Period 1: Combination Therapy Phase||0
7878076|NCT00820755|19386747|P1|STARTED|Period 1: Combination Therapy Phase||583
7878077|NCT00820664|19386771|P3|NOT COMPLETED|Overall Study||0
7878078|NCT00820664|19386772|P2|NOT COMPLETED|Overall Study||0
7878079|NCT00820664|19386773|P1|NOT COMPLETED|Overall Study||0
7878080|NCT00820664|19386771|P3|COMPLETED|Overall Study||9
7878081|NCT00820664|19386772|P2|COMPLETED|Overall Study||11
7878082|NCT00820664|19386773|P1|COMPLETED|Overall Study||9
7878083|NCT00820664|19386771|P3|STARTED|Overall Study||9
7878084|NCT00820664|19386772|P2|STARTED|Overall Study||11
7878085|NCT00820664|19386773|P1|STARTED|Overall Study||9
7878086|NCT00820612|19386783|P2|NOT COMPLETED|Overall Study||0
7878087|NCT00820612|19386784|P1|NOT COMPLETED|Overall Study||0
7878088|NCT00820612|19386783|P2|COMPLETED|Overall Study||295
7878089|NCT00820612|19386784|P1|COMPLETED|Overall Study||307
7878090|NCT00820612|19386783|P2|STARTED|Overall Study||295
7878091|NCT00820612|19386784|P1|STARTED|Overall Study||307
7878092|NCT00820599|19386790|P1|NOT COMPLETED|Overall Study||131
7878093|NCT00820599|19386790|P1|COMPLETED|Overall Study||80
7878094|NCT00820599|19386790|P1|STARTED|Overall Study||211
7878095|NCT00820573|19386799|P4|NOT COMPLETED|Overall Study||0
7878096|NCT00820573|19386800|P3|NOT COMPLETED|Overall Study||0
7878097|NCT00820573|19386801|P2|NOT COMPLETED|Overall Study||0
7878098|NCT00820573|19386802|P1|NOT COMPLETED|Overall Study||0
7878099|NCT00820573|19386799|P4|COMPLETED|Overall Study||4
7878100|NCT00820573|19386800|P3|COMPLETED|Overall Study||4
7878101|NCT00820573|19386801|P2|COMPLETED|Overall Study||4
7878102|NCT00820573|19386802|P1|COMPLETED|Overall Study||4
7878103|NCT00820573|19386799|P4|STARTED|Overall Study||4
7878104|NCT00820573|19386800|P3|STARTED|Overall Study||4
7878105|NCT00820573|19386801|P2|STARTED|Overall Study||4
7878106|NCT00820573|19386802|P1|STARTED|Overall Study||4
7878107|NCT00820534|19386826|P2|NOT COMPLETED|Overall Study||0
7878108|NCT00820534|19386827|P1|NOT COMPLETED|Overall Study||0
7878109|NCT00820534|19386826|P2|COMPLETED|Overall Study||62
7878110|NCT00820534|19386827|P1|COMPLETED|Overall Study||64
7878111|NCT00820534|19386826|P2|STARTED|Overall Study||62
7878112|NCT00820534|19386827|P1|STARTED|Overall Study||64
7878113|NCT00820443|19386835|P1|NOT COMPLETED|24 Month||43
7878114|NCT00820443|19386835|P1|COMPLETED|24 Month||202
7878115|NCT00820443|19386835|P1|STARTED|24 Month||245
7878116|NCT00820443|19386835|P1|NOT COMPLETED|12 Month||24
7878117|NCT00820443|19386835|P1|COMPLETED|12 Month||226
7878118|NCT00820443|19386835|P1|STARTED|12 Month||250
7878119|NCT00820443|19386835|P1|NOT COMPLETED|6 Month||20
7878120|NCT00820443|19386835|P1|COMPLETED|6 Month||233
7878121|NCT00820443|19386835|P1|STARTED|6 Month||253
7878122|NCT00820443|19386835|P1|NOT COMPLETED|3 Month||9
7878123|NCT00820443|19386835|P1|COMPLETED|3 Month||244
7878124|NCT00820443|19386835|P1|STARTED|3 Month||253
7878125|NCT00820443|19386835|P1|NOT COMPLETED|Immediately||5
7878126|NCT00820443|19386835|P1|COMPLETED|Immediately||248
7878127|NCT00820443|19386835|P1|STARTED|Immediately||253
7878128|NCT00820443|19386835|P1|NOT COMPLETED|Op||0
7878129|NCT00820443|19386835|P1|COMPLETED|Op||253
7878130|NCT00820443|19386835|P1|STARTED|Op||253
7878131|NCT00820443|19386835|P1|NOT COMPLETED|Pre-Op||0
7878132|NCT00820443|19386835|P1|COMPLETED|Pre-Op||253
7878133|NCT00820443|19386835|P1|STARTED|Pre-Op||253
7878134|NCT00820248|19386845|P2|NOT COMPLETED|Overall Study||1
7878135|NCT00820248|19386846|P1|NOT COMPLETED|Overall Study||4
7878136|NCT00820248|19386845|P2|COMPLETED|Overall Study||159
7878137|NCT00820248|19386846|P1|COMPLETED|Overall Study||156
7878138|NCT00820248|19386845|P2|Received Protocol Treatment|Overall Study||159
7878139|NCT00820248|19386846|P1|Received Protocol Treatment|Overall Study||156
7878140|NCT00820248|19386845|P2|STARTED|Overall Study||160
7878141|NCT00820248|19386846|P1|STARTED|Overall Study||160
7878142|NCT00820235|19386857|P3|NOT COMPLETED|Overall Study||17
7878143|NCT00820235|19386858|P2|NOT COMPLETED|Overall Study||21
7878144|NCT00820235|19386859|P1|NOT COMPLETED|Overall Study||15
7878145|NCT00820235|19386857|P3|COMPLETED|Overall Study||27
7878146|NCT00820235|19386858|P2|COMPLETED|Overall Study||28
7878147|NCT00820235|19386859|P1|COMPLETED|Overall Study||33
7878148|NCT00820235|19386857|P3|STARTED|Overall Study||44
7878149|NCT00820235|19386858|P2|STARTED|Overall Study||49
7878150|NCT00820235|19386859|P1|STARTED|Overall Study||48
7878151|NCT00820222|19386878|P2|NOT COMPLETED|Overall Study||190
7878152|NCT00820222|19386879|P1|NOT COMPLETED|Overall Study||176
7878153|NCT00820222|19386878|P2|COMPLETED|Overall Study||79
7878154|NCT00820222|19386879|P1|COMPLETED|Overall Study||95
7878155|NCT00820222|19386878|P2|STARTED|Overall Study||269
7878156|NCT00820222|19386879|P1|STARTED|Overall Study||271
7878157|NCT00820170|19386910|P5|NOT COMPLETED|Overall Study||4
7878158|NCT00820170|19386911|P4|NOT COMPLETED|Overall Study||0
7878159|NCT00820170|19386912|P3|NOT COMPLETED|Overall Study||0
7878160|NCT00820170|19386913|P2|NOT COMPLETED|Overall Study||0
7878161|NCT00820170|19386914|P1|NOT COMPLETED|Overall Study||0
7878162|NCT00820170|19386910|P5|COMPLETED|Overall Study||0
7878163|NCT00820170|19386911|P4|COMPLETED|Overall Study||40
7878164|NCT00820170|19386912|P3|COMPLETED|Overall Study||3
7878165|NCT00820170|19386913|P2|COMPLETED|Overall Study||5
7878166|NCT00820170|19386914|P1|COMPLETED|Overall Study||3
7878167|NCT00820170|19386910|P5|STARTED|Overall Study||4
7878168|NCT00820170|19386911|P4|STARTED|Overall Study||40
7878169|NCT00820170|19386912|P3|STARTED|Overall Study||3
7878170|NCT00820170|19386913|P2|STARTED|Overall Study||5
7878171|NCT00820170|19386914|P1|STARTED|Overall Study||3
7878172|NCT00820040|19386962|P1|NOT COMPLETED|Overall Study||3
7878173|NCT00820040|19386962|P1|COMPLETED|Overall Study||7
7878174|NCT00820040|19386962|P1|Full Analysis Set|Overall Study||8
7878175|NCT00820040|19386962|P1|Safety Evaluable Population|Overall Study||8
7878176|NCT00820040|19386962|P1|STARTED|Overall Study||10
7878177|NCT00820027|19386974|P4|NOT COMPLETED|Overall Study||13
7878178|NCT00820027|19386975|P3|NOT COMPLETED|Overall Study||21
7878179|NCT00820027|19386976|P2|NOT COMPLETED|Overall Study||14
7878180|NCT00820027|19386977|P1|NOT COMPLETED|Overall Study||26
7878181|NCT00820027|19386974|P4|COMPLETED|Overall Study||85
7878182|NCT00820027|19386975|P3|COMPLETED|Overall Study||203
7878183|NCT00820027|19386976|P2|COMPLETED|Overall Study||216
7878184|NCT00820027|19386977|P1|COMPLETED|Overall Study||198
7878185|NCT00820027|19386974|P4|STARTED|Overall Study||98
7878186|NCT00820027|19386975|P3|STARTED|Overall Study||224
7878187|NCT00820027|19386976|P2|STARTED|Overall Study||230
7878188|NCT00820027|19386977|P1|STARTED|Overall Study||224
7878189|NCT00819910|19387019|P4|NOT COMPLETED|Overall Study||1
7878190|NCT00819910|19387020|P3|NOT COMPLETED|Overall Study||3
7878191|NCT00819910|19387021|P2|NOT COMPLETED|Overall Study||1
7878192|NCT00819910|19387022|P1|NOT COMPLETED|Overall Study||2
7878193|NCT00819910|19387019|P4|COMPLETED|Overall Study||10
7878194|NCT00819910|19387020|P3|COMPLETED|Overall Study||7
7878195|NCT00819910|19387021|P2|COMPLETED|Overall Study||9
7878196|NCT00819910|19387022|P1|COMPLETED|Overall Study||8
7878197|NCT00819910|19387019|P4|STARTED|Overall Study||11
7878198|NCT00819910|19387020|P3|STARTED|Overall Study||10
7878199|NCT00819910|19387021|P2|STARTED|Overall Study||10
7878200|NCT00819910|19387022|P1|STARTED|Overall Study||10
7878201|NCT00819832|19387054|P6|NOT COMPLETED|Overall Study||0
7878202|NCT00819832|19387055|P5|NOT COMPLETED|Overall Study||0
7878203|NCT00819832|19387056|P4|NOT COMPLETED|Overall Study||0
7878204|NCT00819832|19387057|P3|NOT COMPLETED|Overall Study||0
7878205|NCT00819832|19387058|P2|NOT COMPLETED|Overall Study||0
7878206|NCT00819832|19387059|P1|NOT COMPLETED|Overall Study||3
7878207|NCT00819832|19387054|P6|COMPLETED|Overall Study||0
7878208|NCT00819832|19387055|P5|COMPLETED|Overall Study||0
7878209|NCT00819832|19387056|P4|COMPLETED|Overall Study||0
7878210|NCT00819832|19387057|P3|COMPLETED|Overall Study||0
7878211|NCT00819832|19387058|P2|COMPLETED|Overall Study||0
7878212|NCT00819832|19387059|P1|COMPLETED|Overall Study||0
7878213|NCT00819832|19387054|P6|STARTED|Overall Study||0
7878214|NCT00819832|19387055|P5|STARTED|Overall Study||0
7878215|NCT00819832|19387056|P4|STARTED|Overall Study||0
7878216|NCT00819832|19387057|P3|STARTED|Overall Study||0
7878217|NCT00819832|19387058|P2|STARTED|Overall Study||0
7878218|NCT00819832|19387059|P1|STARTED|Overall Study|No patient data analysis.|3
7878219|NCT00819793|19387073|P1|NOT COMPLETED|Overall Study||0
7878220|NCT00819793|19387073|P1|COMPLETED|Overall Study||32
7878221|NCT00819793|19387073|P1|STARTED|Overall Study||32
7878222|NCT00819780|19387080|P2|NOT COMPLETED|Overall Study||21
7878223|NCT00819780|19387081|P1|NOT COMPLETED|Overall Study||28
7878224|NCT00819780|19387080|P2|COMPLETED|Overall Study|Indicates participants who ended study treatment|122
7878225|NCT00819780|19387081|P1|COMPLETED|Overall Study|Indicates participants who ended study treatment|114
7878226|NCT00819780|19387080|P2|Received Study Treatment|Overall Study||139
7878227|NCT00819780|19387081|P1|Received Study Treatment|Overall Study||139
7878228|NCT00819780|19387080|P2|STARTED|Overall Study||143
7878229|NCT00819780|19387081|P1|STARTED|Overall Study||142
7878230|NCT00819767|19387115|P2|NOT COMPLETED|Overall Study||2
7878231|NCT00819767|19387116|P1|NOT COMPLETED|Overall Study||1
7878232|NCT00819767|19387115|P2|COMPLETED|Overall Study||33
7878233|NCT00819767|19387116|P1|COMPLETED|Overall Study||32
7878234|NCT00819767|19387115|P2|STARTED|Overall Study||35
7878235|NCT00819767|19387116|P1|STARTED|Overall Study||33
7878236|NCT00819741|19387128|P2|NOT COMPLETED|Overall Study||14
7878237|NCT00819741|19387129|P1|NOT COMPLETED|Overall Study||22
7878238|NCT00819741|19387128|P2|COMPLETED|Overall Study||201
7878239|NCT00819741|19387129|P1|COMPLETED|Overall Study||196
7878240|NCT00819741|19387128|P2|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214
7878241|NCT00819741|19387129|P1|Exposed to Drug|Overall Study||218
7878242|NCT00819741|19387128|P2|STARTED|Overall Study||215
7878243|NCT00819741|19387129|P1|STARTED|Overall Study||218
7878244|NCT00819637|19387166|P3|NOT COMPLETED|Overall Study||0
7878245|NCT00819637|19387167|P2|NOT COMPLETED|Overall Study||0
7878246|NCT00819637|19387168|P1|NOT COMPLETED|Overall Study||0
7878247|NCT00819637|19387166|P3|COMPLETED|Overall Study||0
7878248|NCT00819637|19387167|P2|COMPLETED|Overall Study||0
7878249|NCT00819637|19387168|P1|COMPLETED|Overall Study||2
7878250|NCT00819637|19387166|P3|STARTED|Overall Study||0
7878251|NCT00819637|19387167|P2|STARTED|Overall Study||0
7878252|NCT00819637|19387168|P1|STARTED|Overall Study||2
7878253|NCT00819585|19387183|P11|NOT COMPLETED|Extension Study||2
7878254|NCT00819585|19387184|P10|NOT COMPLETED|Extension Study||1
7878255|NCT00819585|19387185|P9|NOT COMPLETED|Extension Study||8
7878256|NCT00819585|19387186|P8|NOT COMPLETED|Extension Study||0
7878257|NCT00819585|19387187|P7|NOT COMPLETED|Extension Study||0
7878258|NCT00819585|19387188|P6|NOT COMPLETED|Extension Study||0
7878259|NCT00819585|19387189|P5|NOT COMPLETED|Extension Study||0
7878260|NCT00819585|19387190|P4|NOT COMPLETED|Extension Study||0
7878261|NCT00819585|19387191|P3|NOT COMPLETED|Extension Study||0
7878262|NCT00819585|19387192|P2|NOT COMPLETED|Extension Study||0
7878263|NCT00819585|19387193|P1|NOT COMPLETED|Extension Study||0
7878264|NCT00819585|19387183|P11|COMPLETED|Extension Study||58
7878265|NCT00819585|19387184|P10|COMPLETED|Extension Study||24
7878266|NCT00819585|19387185|P9|COMPLETED|Extension Study||173
7878267|NCT00819585|19387186|P8|COMPLETED|Extension Study||75
7878268|NCT00819585|19387187|P7|COMPLETED|Extension Study||0
7878269|NCT00819585|19387188|P6|COMPLETED|Extension Study||0
7878270|NCT00819585|19387189|P5|COMPLETED|Extension Study||0
7878271|NCT00819585|19387190|P4|COMPLETED|Extension Study||0
7878272|NCT00819585|19387191|P3|COMPLETED|Extension Study||0
7878273|NCT00819585|19387192|P2|COMPLETED|Extension Study||0
7878274|NCT00819585|19387193|P1|COMPLETED|Extension Study||0
7878275|NCT00819585|19387183|P11|STARTED|Extension Study||60
7878276|NCT00819585|19387184|P10|STARTED|Extension Study||25
7878277|NCT00819585|19387185|P9|STARTED|Extension Study||181
7878278|NCT00819585|19387186|P8|STARTED|Extension Study||75
7878279|NCT00819585|19387187|P7|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
7878280|NCT00819585|19387188|P6|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
7878281|NCT00819585|19387189|P5|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
7878282|NCT00819585|19387190|P4|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
7878283|NCT00819585|19387191|P3|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
7878284|NCT00819585|19387192|P2|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
7878285|NCT00819585|19387193|P1|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
7878286|NCT00819585|19387183|P11|NOT COMPLETED|Core Study||0
7878287|NCT00819585|19387184|P10|NOT COMPLETED|Core Study||0
7878288|NCT00819585|19387185|P9|NOT COMPLETED|Core Study||0
7878289|NCT00819585|19387186|P8|NOT COMPLETED|Core Study||0
7878290|NCT00819585|19387187|P7|NOT COMPLETED|Core Study||13
7878291|NCT00819585|19387188|P6|NOT COMPLETED|Core Study||2
7878292|NCT00819585|19387189|P5|NOT COMPLETED|Core Study||3
7878293|NCT00819585|19387190|P4|NOT COMPLETED|Core Study||5
7878294|NCT00819585|19387191|P3|NOT COMPLETED|Core Study||6
7878295|NCT00819585|19387192|P2|NOT COMPLETED|Core Study||6
7878296|NCT00819585|19387193|P1|NOT COMPLETED|Core Study||6
7878297|NCT00819585|19387183|P11|COMPLETED|Core Study||0
7878298|NCT00819585|19387184|P10|COMPLETED|Core Study||0
7878299|NCT00819585|19387185|P9|COMPLETED|Core Study||0
7878300|NCT00819585|19387186|P8|COMPLETED|Core Study||0
7878301|NCT00819585|19387187|P7|COMPLETED|Core Study||95
7878302|NCT00819585|19387188|P6|COMPLETED|Core Study||52
7878303|NCT00819585|19387189|P5|COMPLETED|Core Study||50
7878304|NCT00819585|19387190|P4|COMPLETED|Core Study||49
7878305|NCT00819585|19387191|P3|COMPLETED|Core Study||48
7878306|NCT00819585|19387192|P2|COMPLETED|Core Study||48
7878307|NCT00819585|19387193|P1|COMPLETED|Core Study||49
7878308|NCT00819585|19387183|P11|Received Study Medication|Core Study||0
7878309|NCT00819585|19387184|P10|Received Study Medication|Core Study||0
7878310|NCT00819585|19387185|P9|Received Study Medication|Core Study||0
7878311|NCT00819585|19387186|P8|Received Study Medication|Core Study||0
7878312|NCT00819585|19387187|P7|Received Study Medication|Core Study||108
7878313|NCT00819585|19387188|P6|Received Study Medication|Core Study|One participant in this treatment arm was HIV+ve and did not receive any study medication.|53
7878314|NCT00819585|19387189|P5|Received Study Medication|Core Study||53
7878315|NCT00819585|19387190|P4|Received Study Medication|Core Study||54
7878316|NCT00819585|19387191|P3|Received Study Medication|Core Study||54
7878317|NCT00819585|19387192|P2|Received Study Medication|Core Study||54
7878318|NCT00819585|19387193|P1|Received Study Medication|Core Study|Participants who received study medication are included in the safety population.|55
7878319|NCT00819585|19387183|P11|STARTED|Core Study|There were no participants in this arm during the core study.|0
7878320|NCT00819585|19387184|P10|STARTED|Core Study|There were no participants in this arm during the core study.|0
7878321|NCT00819585|19387185|P9|STARTED|Core Study|There were no participants in this arm during the core study.|0
7878322|NCT00819585|19387186|P8|STARTED|Core Study|There were no participants in this arm during the core study.|0
7878323|NCT00819585|19387187|P7|STARTED|Core Study||108
7878324|NCT00819585|19387188|P6|STARTED|Core Study||54
7878325|NCT00819585|19387189|P5|STARTED|Core Study||53
7878326|NCT00819585|19387190|P4|STARTED|Core Study||54
7878327|NCT00819585|19387191|P3|STARTED|Core Study||54
7878328|NCT00819585|19387192|P2|STARTED|Core Study||54
7878329|NCT00819585|19387193|P1|STARTED|Core Study|Participants who started the core study are included in the randomized and full analysis sets.|55
7878330|NCT00819507|19387264|P1|NOT COMPLETED|Overall Study||0
7878331|NCT00819507|19387264|P1|COMPLETED|Overall Study||25
7878332|NCT00819507|19387264|P1|STARTED|Overall Study||25
7878333|NCT00819403|19387271|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
7878334|NCT00819403|19387272|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
7878335|NCT00819403|19387271|P2|COMPLETED|Second Intervention (6 Weeks)||8
7878336|NCT00819403|19387272|P1|COMPLETED|Second Intervention (6 Weeks)||7
7878337|NCT00819403|19387271|P2|STARTED|Second Intervention (6 Weeks)||8
7878338|NCT00819403|19387272|P1|STARTED|Second Intervention (6 Weeks)||7
7878339|NCT00819403|19387271|P2|NOT COMPLETED|Washout (14 Days)||0
7878340|NCT00819403|19387272|P1|NOT COMPLETED|Washout (14 Days)||0
7878341|NCT00819403|19387271|P2|COMPLETED|Washout (14 Days)||8
7878342|NCT00819403|19387272|P1|COMPLETED|Washout (14 Days)||7
7878343|NCT00819403|19387271|P2|STARTED|Washout (14 Days)||8
7878344|NCT00819403|19387272|P1|STARTED|Washout (14 Days)||7
7878345|NCT00819403|19387271|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
7878346|NCT00819403|19387272|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
7878347|NCT00819403|19387271|P2|COMPLETED|First Intervention (6 Weeks)||8
7878348|NCT00819403|19387272|P1|COMPLETED|First Intervention (6 Weeks)||7
7878349|NCT00819403|19387271|P2|STARTED|First Intervention (6 Weeks)||8
7878350|NCT00819403|19387272|P1|STARTED|First Intervention (6 Weeks)||7
7878351|NCT00819390|19387284|P4|NOT COMPLETED|Overall Study||0
7878352|NCT00819390|19387285|P3|NOT COMPLETED|Overall Study||1
7878353|NCT00819390|19387286|P2|NOT COMPLETED|Overall Study||1
7878354|NCT00819390|19387287|P1|NOT COMPLETED|Overall Study||3
7878355|NCT00819390|19387284|P4|COMPLETED|Overall Study||19
7878356|NCT00819390|19387285|P3|COMPLETED|Overall Study||17
7878357|NCT00819390|19387286|P2|COMPLETED|Overall Study||16
7878358|NCT00819390|19387287|P1|COMPLETED|Overall Study||13
7878359|NCT00819390|19387284|P4|STARTED|Overall Study||19
7878360|NCT00819390|19387285|P3|STARTED|Overall Study||18
7878361|NCT00819390|19387286|P2|STARTED|Overall Study||17
7878362|NCT00819390|19387287|P1|STARTED|Overall Study||16
7878363|NCT00819286|19387399|P2|NOT COMPLETED|Overall Study||25
7878364|NCT00819286|19387400|P1|NOT COMPLETED|Overall Study||14
7878365|NCT00819286|19387399|P2|COMPLETED|Overall Study||45
7878366|NCT00819286|19387400|P1|COMPLETED|Overall Study||56
7878367|NCT00819286|19387399|P2|STARTED|Overall Study||70
7878368|NCT00819286|19387400|P1|STARTED|Overall Study||70
7878369|NCT00819260|19387408|P1|NOT COMPLETED|Overall Study||0
7878370|NCT00819260|19387408|P1|COMPLETED|Overall Study||31
7878371|NCT00819260|19387408|P1|STARTED|Overall Study||31
7878372|NCT00819247|19387423|P3|NOT COMPLETED|Overall Study||14
7878373|NCT00819247|19387424|P2|NOT COMPLETED|Overall Study||16
7878374|NCT00819247|19387425|P1|NOT COMPLETED|Overall Study||11
7878375|NCT00819247|19387423|P3|COMPLETED|Overall Study||26
7878376|NCT00819247|19387424|P2|COMPLETED|Overall Study||30
7878377|NCT00819247|19387425|P1|COMPLETED|Overall Study||32
7878378|NCT00819247|19387423|P3|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38
7878379|NCT00819247|19387424|P2|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44
7878380|NCT00819247|19387425|P1|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38
7878381|NCT00819247|19387423|P3|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39
7878382|NCT00819247|19387424|P2|Intent-to-treat Population|Overall Study||46
7878383|NCT00819247|19387425|P1|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42
7878384|NCT00819247|19387423|P3|Randomized|Overall Study||40
7878385|NCT00819247|19387424|P2|Randomized|Overall Study||46
7878386|NCT00819247|19387425|P1|Randomized|Overall Study||43
7878387|NCT00819247|19387423|P3|STARTED|Overall Study||40
7878388|NCT00819247|19387424|P2|STARTED|Overall Study||46
7878389|NCT00819247|19387425|P1|STARTED|Overall Study||43
7878390|NCT00819234|19387451|P10|NOT COMPLETED|Overall Study||7
7878391|NCT00819234|19387452|P9|NOT COMPLETED|Overall Study||6
7878392|NCT00819234|19387453|P8|NOT COMPLETED|Overall Study||9
7878393|NCT00819234|19387454|P7|NOT COMPLETED|Overall Study||5
7878394|NCT00819234|19387455|P6|NOT COMPLETED|Overall Study||7
7878395|NCT00819234|19387456|P5|NOT COMPLETED|Overall Study||1
7878396|NCT00819234|19387457|P4|NOT COMPLETED|Overall Study||6
7878397|NCT00819234|19387458|P3|NOT COMPLETED|Overall Study||8
7878398|NCT00819234|19387459|P2|NOT COMPLETED|Overall Study||15
7878399|NCT00819234|19387460|P1|NOT COMPLETED|Overall Study||10
7878400|NCT00819234|19387451|P10|COMPLETED|Overall Study||30
7878401|NCT00819234|19387452|P9|COMPLETED|Overall Study||31
7878402|NCT00819234|19387453|P8|COMPLETED|Overall Study||20
7878403|NCT00819234|19387454|P7|COMPLETED|Overall Study||8
7878404|NCT00819234|19387455|P6|COMPLETED|Overall Study||7
7878405|NCT00819234|19387456|P5|COMPLETED|Overall Study||12
7878406|NCT00819234|19387457|P4|COMPLETED|Overall Study||22
7878407|NCT00819234|19387458|P3|COMPLETED|Overall Study||28
7878408|NCT00819234|19387459|P2|COMPLETED|Overall Study||20
7878409|NCT00819234|19387460|P1|COMPLETED|Overall Study||21
7878410|NCT00819234|19387451|P10|STARTED|Overall Study||37
7878411|NCT00819234|19387452|P9|STARTED|Overall Study||37
7878412|NCT00819234|19387453|P8|STARTED|Overall Study||29
7878413|NCT00819234|19387454|P7|STARTED|Overall Study||13
7878414|NCT00819234|19387455|P6|STARTED|Overall Study||14
7878415|NCT00819234|19387456|P5|STARTED|Overall Study||13
7878416|NCT00819234|19387457|P4|STARTED|Overall Study||28
7878417|NCT00819234|19387458|P3|STARTED|Overall Study||36
7878418|NCT00819234|19387459|P2|STARTED|Overall Study||35
7878419|NCT00819234|19387460|P1|STARTED|Overall Study||31
7878420|NCT00819182|19387621|P3|NOT COMPLETED|Overall Study||1
7878421|NCT00819182|19387622|P2|NOT COMPLETED|Overall Study||8
7878422|NCT00819182|19387623|P1|NOT COMPLETED|Overall Study||13
7878423|NCT00819182|19387621|P3|COMPLETED|Overall Study||43
7878424|NCT00819182|19387622|P2|COMPLETED|Overall Study||78
7878425|NCT00819182|19387623|P1|COMPLETED|Overall Study||75
7878426|NCT00819182|19387621|P3|Week 16 Visit|Overall Study||43
7878427|NCT00819182|19387622|P2|Week 16 Visit|Overall Study||78
7878428|NCT00819182|19387623|P1|Week 16 Visit|Overall Study||75
7878429|NCT00819182|19387621|P3|STARTED|Overall Study|Consented participants allocated to this arm.|44
7878430|NCT00819182|19387622|P2|STARTED|Overall Study|Consented participants allocated to this arm.|86
7878431|NCT00819182|19387623|P1|STARTED|Overall Study|Consented participants allocated to this arm.|88
7878432|NCT00819156|19387659|P6|NOT COMPLETED|Overall Study||8
7878433|NCT00819156|19387660|P5|NOT COMPLETED|Overall Study||6
7878434|NCT00819156|19387661|P4|NOT COMPLETED|Overall Study||2
7878435|NCT00819156|19387662|P3|NOT COMPLETED|Overall Study||6
7878436|NCT00819156|19387663|P2|NOT COMPLETED|Overall Study||10
7878437|NCT00819156|19387664|P1|NOT COMPLETED|Overall Study||10
7878438|NCT00819156|19387659|P6|COMPLETED|Overall Study||23
7878439|NCT00819156|19387660|P5|COMPLETED|Overall Study||27
7878440|NCT00819156|19387661|P4|COMPLETED|Overall Study||28
7878441|NCT00819156|19387662|P3|COMPLETED|Overall Study||26
7878442|NCT00819156|19387663|P2|COMPLETED|Overall Study||23
7878443|NCT00819156|19387664|P1|COMPLETED|Overall Study||20
7878444|NCT00819156|19387659|P6|Randomised and Treated (ITT Population)|Overall Study||30
7878445|NCT00819156|19387660|P5|Randomised and Treated (ITT Population)|Overall Study||33
7878446|NCT00819156|19387661|P4|Randomised and Treated (ITT Population)|Overall Study||30
7878447|NCT00819156|19387662|P3|Randomised and Treated (ITT Population)|Overall Study||32
7878448|NCT00819156|19387663|P2|Randomised and Treated (ITT Population)|Overall Study||32
7878449|NCT00819156|19387664|P1|Randomised and Treated (ITT Population)|Overall Study||30
7878450|NCT00819156|19387659|P6|STARTED|Overall Study||31
7878451|NCT00819156|19387660|P5|STARTED|Overall Study||33
7878452|NCT00819156|19387661|P4|STARTED|Overall Study||30
7878453|NCT00819156|19387662|P3|STARTED|Overall Study||32
7878454|NCT00819156|19387663|P2|STARTED|Overall Study||33
7878455|NCT00819156|19387664|P1|STARTED|Overall Study||30
7878456|NCT00819091|19387754|P2|NOT COMPLETED|Overall Study||10
7878457|NCT00819091|19387755|P1|NOT COMPLETED|Overall Study||7
7878458|NCT00819091|19387754|P2|COMPLETED|Overall Study||151
7878459|NCT00819091|19387755|P1|COMPLETED|Overall Study||77
7878460|NCT00819091|19387754|P2|STARTED|Overall Study||161
7878461|NCT00819091|19387755|P1|STARTED|Overall Study||84
7878462|NCT00819052|19387781|P2|NOT COMPLETED|Overall Study||14
7878463|NCT00819052|19387782|P1|NOT COMPLETED|Overall Study||6
7878464|NCT00819052|19387781|P2|COMPLETED|Overall Study||281
7878465|NCT00819052|19387782|P1|COMPLETED|Overall Study||142
7878466|NCT00819052|19387781|P2|STARTED|Overall Study||295
7878467|NCT00819052|19387782|P1|STARTED|Overall Study||148
7878468|NCT00819039|19387897|P3|NOT COMPLETED|Overall Study||1
7878469|NCT00819039|19387898|P2|NOT COMPLETED|Overall Study||0
7878470|NCT00819039|19387899|P1|NOT COMPLETED|Overall Study||2
7878471|NCT00819039|19387897|P3|COMPLETED|Overall Study||24
7878472|NCT00819039|19387898|P2|COMPLETED|Overall Study||27
7878473|NCT00819039|19387899|P1|COMPLETED|Overall Study||44
7878474|NCT00819039|19387897|P3|STARTED|Overall Study||25
7878475|NCT00819039|19387898|P2|STARTED|Overall Study||27
7878476|NCT00819039|19387899|P1|STARTED|Overall Study||46
7878477|NCT00819013|19387929|P4|NOT COMPLETED|Overall Study||4
7878478|NCT00819013|19387930|P3|NOT COMPLETED|Overall Study||5
7878479|NCT00819013|19387931|P2|NOT COMPLETED|Overall Study||1
7878480|NCT00819013|19387932|P1|NOT COMPLETED|Overall Study||3
7878481|NCT00819013|19387929|P4|COMPLETED|Overall Study||17
7878482|NCT00819013|19387930|P3|COMPLETED|Overall Study||16
7878483|NCT00819013|19387931|P2|COMPLETED|Overall Study||22
7878484|NCT00819013|19387932|P1|COMPLETED|Overall Study||19
7878485|NCT00819013|19387929|P4|STARTED|Overall Study||21
7878486|NCT00819013|19387930|P3|STARTED|Overall Study||21
7878487|NCT00819013|19387931|P2|STARTED|Overall Study||23
7878488|NCT00819013|19387932|P1|STARTED|Overall Study||22
7878489|NCT00818961|19387982|P1|NOT COMPLETED|Overall Study||0
7878490|NCT00818961|19387982|P1|COMPLETED|Overall Study||36
7878491|NCT00818961|19387982|P1|STARTED|Overall Study||36
7878492|NCT00818883|19387998|P2|NOT COMPLETED|Overall Study||46
7878493|NCT00818883|19387999|P1|NOT COMPLETED|Overall Study||51
7878494|NCT00818883|19387998|P2|COMPLETED|Overall Study||260
7878495|NCT00818883|19387999|P1|COMPLETED|Overall Study||252
7878496|NCT00818883|19387998|P2|STARTED|Overall Study||306
7878497|NCT00818883|19387999|P1|STARTED|Overall Study||303
7878498|NCT00818805|19388033|P2|NOT COMPLETED|Second Intervention||0
7878499|NCT00818805|19388034|P1|NOT COMPLETED|Second Intervention||0
7878500|NCT00818805|19388033|P2|COMPLETED|Second Intervention||25
7878501|NCT00818805|19388034|P1|COMPLETED|Second Intervention||25
7878502|NCT00818805|19388033|P2|STARTED|Second Intervention||25
7878503|NCT00818805|19388034|P1|STARTED|Second Intervention||25
7878504|NCT00818805|19388033|P2|NOT COMPLETED|First Intervention||0
7878505|NCT00818805|19388034|P1|NOT COMPLETED|First Intervention||0
7878506|NCT00818805|19388033|P2|COMPLETED|First Intervention||25
7878507|NCT00818805|19388034|P1|COMPLETED|First Intervention||25
7878508|NCT00818805|19388033|P2|STARTED|First Intervention||25
7878509|NCT00818805|19388034|P1|STARTED|First Intervention||25
7878510|NCT00818779|19388046|P2|NOT COMPLETED|Overall Study||1
7878511|NCT00818779|19388047|P1|NOT COMPLETED|Overall Study||6
7878512|NCT00818779|19388046|P2|COMPLETED|Overall Study||15
7878513|NCT00818779|19388047|P1|COMPLETED|Overall Study||16
7878514|NCT00818779|19388046|P2|STARTED|Overall Study||16
7878515|NCT00818779|19388047|P1|STARTED|Overall Study||22
7878516|NCT00818766|19388063|P2|NOT COMPLETED|Overall Study||10
7878517|NCT00818766|19388064|P1|NOT COMPLETED|Overall Study||15
7878518|NCT00818766|19388063|P2|COMPLETED|Overall Study||116
7878519|NCT00818766|19388064|P1|COMPLETED|Overall Study||110
7878520|NCT00818766|19388063|P2|Intent-to-Treat Population|Overall Study|2 participants were randomized twice but only counted once (per first randomization).|124
7878521|NCT00818766|19388064|P1|Intent-to-Treat Population|Overall Study|1 participant was randomized twice but only counted once (per first randomization).|121
7878522|NCT00818766|19388063|P2|Received Allocated Intervention|Overall Study||126
7878523|NCT00818766|19388064|P1|Received Allocated Intervention|Overall Study|1 withdrew consent, 1 had active infection and 1 was given open-label antibiotic after surgery.|122
7878524|NCT00818766|19388063|P2|STARTED|Overall Study||126
7878525|NCT00818766|19388064|P1|STARTED|Overall Study||125
7878526|NCT00818753|19388093|P3|NOT COMPLETED|Overall Study||1
7878527|NCT00818753|19388094|P2|NOT COMPLETED|Overall Study||0
7878528|NCT00818753|19388095|P1|NOT COMPLETED|Overall Study||3
7878529|NCT00818753|19388093|P3|COMPLETED|Overall Study||9
7878530|NCT00818753|19388094|P2|COMPLETED|Overall Study||21
7878531|NCT00818753|19388095|P1|COMPLETED|Overall Study||19
7878532|NCT00818753|19388093|P3|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10
7878533|NCT00818753|19388094|P2|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21
7878534|NCT00818753|19388095|P1|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22
7878535|NCT00818662|19388119|P4|NOT COMPLETED|Overall Study||16
7878536|NCT00818662|19388120|P3|NOT COMPLETED|Overall Study||9
7878537|NCT00818662|19388121|P2|NOT COMPLETED|Overall Study||33
7878538|NCT00818662|19388122|P1|NOT COMPLETED|Overall Study||23
7878539|NCT00818662|19388119|P4|COMPLETED|Overall Study||47
7878540|NCT00818662|19388120|P3|COMPLETED|Overall Study||49
7878541|NCT00818662|19388121|P2|COMPLETED|Overall Study||102
7878542|NCT00818662|19388122|P1|COMPLETED|Overall Study||104
7878543|NCT00818662|19388119|P4|STARTED|Overall Study||63
7878544|NCT00818662|19388120|P3|STARTED|Overall Study||58
7878545|NCT00818662|19388121|P2|STARTED|Overall Study||135
7878546|NCT00818662|19388122|P1|STARTED|Overall Study||127
7878547|NCT00818649|19388208|P1|NOT COMPLETED|Overall Study||4
7878548|NCT00818649|19388208|P1|COMPLETED|Overall Study||12
7878549|NCT00818649|19388208|P1|STARTED|Overall Study||16
7878550|NCT00818623|19388222|P8|NOT COMPLETED|Overall Study||1
7878551|NCT00818623|19388223|P7|NOT COMPLETED|Overall Study||4
7878552|NCT00818623|19388224|P6|NOT COMPLETED|Overall Study||3
7878553|NCT00818623|19388225|P5|NOT COMPLETED|Overall Study||4
7878554|NCT00818623|19388226|P4|NOT COMPLETED|Overall Study||5
7878555|NCT00818623|19388227|P3|NOT COMPLETED|Overall Study||4
7878556|NCT00818623|19388228|P2|NOT COMPLETED|Overall Study||4
7878557|NCT00818623|19388229|P1|NOT COMPLETED|Overall Study||2
7878558|NCT00818623|19388222|P8|COMPLETED|Overall Study||26
7878559|NCT00818623|19388223|P7|COMPLETED|Overall Study||23
7878560|NCT00818623|19388224|P6|COMPLETED|Overall Study||21
7878561|NCT00818623|19388225|P5|COMPLETED|Overall Study||23
7878562|NCT00818623|19388226|P4|COMPLETED|Overall Study||19
7878563|NCT00818623|19388227|P3|COMPLETED|Overall Study||9
7878564|NCT00818623|19388228|P2|COMPLETED|Overall Study||8
7878565|NCT00818623|19388229|P1|COMPLETED|Overall Study||24
7878566|NCT00818623|19388222|P8|Intent-to-treat (ITT) Population|Overall Study||27
7878567|NCT00818623|19388223|P7|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
7878568|NCT00818623|19388224|P6|Intent-to-treat (ITT) Population|Overall Study||24
7878569|NCT00818623|19388225|P5|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
7878570|NCT00818623|19388226|P4|Intent-to-treat (ITT) Population|Overall Study||24
7878571|NCT00818623|19388227|P3|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12
7878572|NCT00818623|19388228|P2|Intent-to-treat (ITT) Population|Overall Study||12
7878573|NCT00818623|19388229|P1|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25
7878574|NCT00818623|19388222|P8|STARTED|Overall Study||27
7878575|NCT00818623|19388223|P7|STARTED|Overall Study||27
7878576|NCT00818623|19388224|P6|STARTED|Overall Study||24
7878577|NCT00818623|19388225|P5|STARTED|Overall Study||27
7878578|NCT00818623|19388226|P4|STARTED|Overall Study||24
7878579|NCT00818623|19388227|P3|STARTED|Overall Study||13
7878580|NCT00818623|19388228|P2|STARTED|Overall Study||12
7878581|NCT00818623|19388229|P1|STARTED|Overall Study||26
7878582|NCT00818519|19388305|P2|NOT COMPLETED|Overall Study||19
7878583|NCT00818519|19388306|P1|NOT COMPLETED|Overall Study||14
7878584|NCT00818519|19388305|P2|COMPLETED|Overall Study||71
7878585|NCT00818519|19388306|P1|COMPLETED|Overall Study||75
7878586|NCT00818519|19388305|P2|Participants Received Treatment|Overall Study|= Baseline|86
7878587|NCT00818519|19388306|P1|Participants Received Treatment|Overall Study|= Baseline|87
7878588|NCT00818519|19388305|P2|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90
7878589|NCT00818519|19388306|P1|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89
7878590|NCT00818454|19388336|P4|NOT COMPLETED|Treatment Period 3||1
7878591|NCT00818454|19388337|P3|NOT COMPLETED|Treatment Period 3||0
7878592|NCT00818454|19388338|P2|NOT COMPLETED|Treatment Period 3||0
7878593|NCT00818454|19388339|P1|NOT COMPLETED|Treatment Period 3||0
7878594|NCT00818454|19388336|P4|COMPLETED|Treatment Period 3||138
7878595|NCT00818454|19388337|P3|COMPLETED|Treatment Period 3||26
7878596|NCT00818454|19388338|P2|COMPLETED|Treatment Period 3||0
7878597|NCT00818454|19388339|P1|COMPLETED|Treatment Period 3||0
7878598|NCT00818454|19388336|P4|STARTED|Treatment Period 3||139
7878599|NCT00818454|19388337|P3|STARTED|Treatment Period 3||26
7878600|NCT00818454|19388338|P2|STARTED|Treatment Period 3||0
7878601|NCT00818454|19388339|P1|STARTED|Treatment Period 3||0
7878602|NCT00818454|19388336|P4|NOT COMPLETED|Treatment Period 2||0
7878603|NCT00818454|19388337|P3|NOT COMPLETED|Treatment Period 2||0
7878604|NCT00818454|19388338|P2|NOT COMPLETED|Treatment Period 2||1
7878605|NCT00818454|19388339|P1|NOT COMPLETED|Treatment Period 2||2
7878606|NCT00818454|19388336|P4|COMPLETED|Treatment Period 2||0
7878607|NCT00818454|19388337|P3|COMPLETED|Treatment Period 2||0
7878608|NCT00818454|19388338|P2|COMPLETED|Treatment Period 2||106
7878609|NCT00818454|19388339|P1|COMPLETED|Treatment Period 2||106
7878610|NCT00818454|19388336|P4|STARTED|Treatment Period 2||0
7878611|NCT00818454|19388337|P3|STARTED|Treatment Period 2||0
7878612|NCT00818454|19388338|P2|STARTED|Treatment Period 2||107
7878613|NCT00818454|19388339|P1|STARTED|Treatment Period 2||108
7878614|NCT00818454|19388336|P4|NOT COMPLETED|Washout Period of 1 Week||0
7878615|NCT00818454|19388337|P3|NOT COMPLETED|Washout Period of 1 Week||0
7878616|NCT00818454|19388338|P2|NOT COMPLETED|Washout Period of 1 Week||3
7878617|NCT00818454|19388339|P1|NOT COMPLETED|Washout Period of 1 Week||4
7878618|NCT00818454|19388336|P4|COMPLETED|Washout Period of 1 Week||0
7878619|NCT00818454|19388337|P3|COMPLETED|Washout Period of 1 Week||0
7878620|NCT00818454|19388338|P2|COMPLETED|Washout Period of 1 Week||107
7878621|NCT00818454|19388339|P1|COMPLETED|Washout Period of 1 Week||108
7878622|NCT00818454|19388336|P4|STARTED|Washout Period of 1 Week||0
7878623|NCT00818454|19388337|P3|STARTED|Washout Period of 1 Week||0
7878624|NCT00818454|19388338|P2|STARTED|Washout Period of 1 Week||110
7878625|NCT00818454|19388339|P1|STARTED|Washout Period of 1 Week||112
7878626|NCT00818454|19388336|P4|NOT COMPLETED|Treatment Period 1||0
7878627|NCT00818454|19388337|P3|NOT COMPLETED|Treatment Period 1||0
7878628|NCT00818454|19388338|P2|NOT COMPLETED|Treatment Period 1||1
7878629|NCT00818454|19388339|P1|NOT COMPLETED|Treatment Period 1||3
7878630|NCT00818454|19388336|P4|COMPLETED|Treatment Period 1||0
7878631|NCT00818454|19388337|P3|COMPLETED|Treatment Period 1||0
7878632|NCT00818454|19388338|P2|COMPLETED|Treatment Period 1||110
7878633|NCT00818454|19388339|P1|COMPLETED|Treatment Period 1||112
7878634|NCT00818454|19388336|P4|STARTED|Treatment Period 1||0
7878635|NCT00818454|19388337|P3|STARTED|Treatment Period 1||0
7878636|NCT00818454|19388338|P2|STARTED|Treatment Period 1||111
7878637|NCT00818454|19388339|P1|STARTED|Treatment Period 1||115
7878638|NCT00818441|19388367|P2|NOT COMPLETED|Overall Study||30
7878639|NCT00818441|19388368|P1|NOT COMPLETED|Overall Study||89
7878640|NCT00818441|19388367|P2|COMPLETED|Overall Study||0
7878641|NCT00818441|19388368|P1|COMPLETED|Overall Study||0
7878642|NCT00818441|19388367|P2|STARTED|Overall Study||30
7878643|NCT00818441|19388368|P1|STARTED|Overall Study||89
7878644|NCT00818389|19388390|P2|NOT COMPLETED|Overall Study||6
7878645|NCT00818389|19388391|P1|NOT COMPLETED|Overall Study||4
7878646|NCT00818389|19388390|P2|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38
7878647|NCT00818389|19388391|P1|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36
7878648|NCT00818389|19388390|P2|STARTED|Overall Study||44
7878649|NCT00818389|19388391|P1|STARTED|Overall Study||40
7878650|NCT00818337|19388401|P1|NOT COMPLETED|Overall Study||0
7878651|NCT00818337|19388401|P1|COMPLETED|Overall Study||36
7878652|NCT00818337|19388401|P1|STARTED|Overall Study||36
7878653|NCT00818324|19388406|P1|NOT COMPLETED|Overall Study||27
7878654|NCT00818324|19388406|P1|COMPLETED|Overall Study||127
7878655|NCT00818324|19388406|P1|STARTED|Overall Study||154
7878656|NCT00818272|19388411|P1|NOT COMPLETED|Overall Study||74
7878657|NCT00818272|19388411|P1|COMPLETED|Overall Study||74
7878658|NCT00818272|19388411|P1|STARTED|Overall Study||148
7878659|NCT00818259|19388426|P9|NOT COMPLETED|Part V||0
7878660|NCT00818259|19388427|P8|NOT COMPLETED|Part V||1
7878661|NCT00818259|19388428|P7|NOT COMPLETED|Part V||0
7878662|NCT00818259|19388429|P6|NOT COMPLETED|Part V||0
7878663|NCT00818259|19388430|P5|NOT COMPLETED|Part V||0
7878664|NCT00818259|19388431|P4|NOT COMPLETED|Part V||0
7878665|NCT00818259|19388432|P3|NOT COMPLETED|Part V||0
7878666|NCT00818259|19388433|P2|NOT COMPLETED|Part V||0
7878667|NCT00818259|19388434|P1|NOT COMPLETED|Part V||0
7878668|NCT00818259|19388426|P9|COMPLETED|Part V||6
7878669|NCT00818259|19388427|P8|COMPLETED|Part V||16
7878670|NCT00818259|19388428|P7|COMPLETED|Part V||0
7878671|NCT00818259|19388429|P6|COMPLETED|Part V||0
7878672|NCT00818259|19388430|P5|COMPLETED|Part V||0
7878673|NCT00818259|19388431|P4|COMPLETED|Part V||0
7878674|NCT00818259|19388432|P3|COMPLETED|Part V||0
7878675|NCT00818259|19388433|P2|COMPLETED|Part V||0
7878676|NCT00818259|19388434|P1|COMPLETED|Part V||0
7878677|NCT00818259|19388426|P9|STARTED|Part V|Newly enrolled participants|6
7878678|NCT00818259|19388427|P8|STARTED|Part V|Participants continuing from Part IV|17
7878679|NCT00818259|19388428|P7|STARTED|Part V||0
7878680|NCT00818259|19388429|P6|STARTED|Part V||0
7878681|NCT00818259|19388430|P5|STARTED|Part V||0
7878682|NCT00818259|19388431|P4|STARTED|Part V||0
7878683|NCT00818259|19388432|P3|STARTED|Part V||0
7878684|NCT00818259|19388433|P2|STARTED|Part V||0
7878685|NCT00818259|19388434|P1|STARTED|Part V||0
7878686|NCT00818259|19388426|P9|NOT COMPLETED|Part IV||0
7878687|NCT00818259|19388427|P8|NOT COMPLETED|Part IV||0
7878688|NCT00818259|19388428|P7|NOT COMPLETED|Part IV||0
7878689|NCT00818259|19388429|P6|NOT COMPLETED|Part IV||1
7878690|NCT00818259|19388430|P5|NOT COMPLETED|Part IV||0
7878691|NCT00818259|19388431|P4|NOT COMPLETED|Part IV||0
7878692|NCT00818259|19388432|P3|NOT COMPLETED|Part IV||0
7878693|NCT00818259|19388433|P2|NOT COMPLETED|Part IV||0
7878694|NCT00818259|19388434|P1|NOT COMPLETED|Part IV||0
7878695|NCT00818259|19388426|P9|COMPLETED|Part IV||0
7878696|NCT00818259|19388427|P8|COMPLETED|Part IV||0
7878697|NCT00818259|19388428|P7|COMPLETED|Part IV||5
7878698|NCT00818259|19388429|P6|COMPLETED|Part IV||14
7878699|NCT00818259|19388430|P5|COMPLETED|Part IV||0
7878700|NCT00818259|19388431|P4|COMPLETED|Part IV||0
7878701|NCT00818259|19388432|P3|COMPLETED|Part IV||0
7878702|NCT00818259|19388433|P2|COMPLETED|Part IV||0
7878703|NCT00818259|19388434|P1|COMPLETED|Part IV||0
7878704|NCT00818259|19388426|P9|STARTED|Part IV||0
7878705|NCT00818259|19388427|P8|STARTED|Part IV||0
7878706|NCT00818259|19388428|P7|STARTED|Part IV|Newly enrolled participants|5
7878707|NCT00818259|19388429|P6|STARTED|Part IV|Participants continuing from Part III|15
7878708|NCT00818259|19388430|P5|STARTED|Part IV||0
7878709|NCT00818259|19388431|P4|STARTED|Part IV||0
7878710|NCT00818259|19388432|P3|STARTED|Part IV||0
7878711|NCT00818259|19388433|P2|STARTED|Part IV||0
7878712|NCT00818259|19388434|P1|STARTED|Part IV||0
7878713|NCT00818259|19388426|P9|NOT COMPLETED|Part III||0
7878714|NCT00818259|19388427|P8|NOT COMPLETED|Part III||0
7878715|NCT00818259|19388428|P7|NOT COMPLETED|Part III||0
7878716|NCT00818259|19388429|P6|NOT COMPLETED|Part III||0
7878717|NCT00818259|19388430|P5|NOT COMPLETED|Part III||0
7878718|NCT00818259|19388431|P4|NOT COMPLETED|Part III||0
7878719|NCT00818259|19388432|P3|NOT COMPLETED|Part III||0
7878720|NCT00818259|19388433|P2|NOT COMPLETED|Part III||0
7878721|NCT00818259|19388434|P1|NOT COMPLETED|Part III||0
7878722|NCT00818259|19388426|P9|COMPLETED|Part III||0
7878723|NCT00818259|19388427|P8|COMPLETED|Part III||0
7878724|NCT00818259|19388428|P7|COMPLETED|Part III||0
7878725|NCT00818259|19388429|P6|COMPLETED|Part III||0
7878726|NCT00818259|19388430|P5|COMPLETED|Part III||19
7878727|NCT00818259|19388431|P4|COMPLETED|Part III||0
7878728|NCT00818259|19388432|P3|COMPLETED|Part III||0
7878729|NCT00818259|19388433|P2|COMPLETED|Part III||0
7878730|NCT00818259|19388434|P1|COMPLETED|Part III||0
7878731|NCT00818259|19388426|P9|STARTED|Part III||0
7878732|NCT00818259|19388427|P8|STARTED|Part III||0
7878733|NCT00818259|19388428|P7|STARTED|Part III||0
7878734|NCT00818259|19388429|P6|STARTED|Part III||0
7878735|NCT00818259|19388430|P5|STARTED|Part III|Newly enrolled participants|19
7878736|NCT00818259|19388431|P4|STARTED|Part III||0
7878737|NCT00818259|19388432|P3|STARTED|Part III||0
7878738|NCT00818259|19388433|P2|STARTED|Part III||0
7878739|NCT00818259|19388434|P1|STARTED|Part III||0
7878740|NCT00818259|19388426|P9|NOT COMPLETED|Part II||0
7878741|NCT00818259|19388427|P8|NOT COMPLETED|Part II||0
7878742|NCT00818259|19388428|P7|NOT COMPLETED|Part II||0
7878743|NCT00818259|19388429|P6|NOT COMPLETED|Part II||0
7878744|NCT00818259|19388430|P5|NOT COMPLETED|Part II||0
7878745|NCT00818259|19388431|P4|NOT COMPLETED|Part II||2
7878746|NCT00818259|19388432|P3|NOT COMPLETED|Part II||1
7878747|NCT00818259|19388433|P2|NOT COMPLETED|Part II||0
7878748|NCT00818259|19388434|P1|NOT COMPLETED|Part II||0
7878749|NCT00818259|19388426|P9|COMPLETED|Part II||0
7878750|NCT00818259|19388427|P8|COMPLETED|Part II||0
7878751|NCT00818259|19388428|P7|COMPLETED|Part II||0
7878752|NCT00818259|19388429|P6|COMPLETED|Part II||0
7878753|NCT00818259|19388430|P5|COMPLETED|Part II||0
7878754|NCT00818259|19388431|P4|COMPLETED|Part II||18
7878755|NCT00818259|19388432|P3|COMPLETED|Part II||18
7878756|NCT00818259|19388433|P2|COMPLETED|Part II||0
7878757|NCT00818259|19388434|P1|COMPLETED|Part II||0
7878758|NCT00818259|19388426|P9|Treated|Part II||0
7878759|NCT00818259|19388427|P8|Treated|Part II||0
7878760|NCT00818259|19388428|P7|Treated|Part II||0
7878761|NCT00818259|19388429|P6|Treated|Part II||0
7878762|NCT00818259|19388430|P5|Treated|Part II||0
7878763|NCT00818259|19388431|P4|Treated|Part II||19
7878764|NCT00818259|19388432|P3|Treated|Part II||19
7878765|NCT00818259|19388433|P2|Treated|Part II||0
7878766|NCT00818259|19388434|P1|Treated|Part II||0
7878767|NCT00818259|19388426|P9|STARTED|Part II||0
7878768|NCT00818259|19388427|P8|STARTED|Part II||0
7878769|NCT00818259|19388428|P7|STARTED|Part II||0
7878770|NCT00818259|19388429|P6|STARTED|Part II||0
7878771|NCT00818259|19388430|P5|STARTED|Part II||0
7878772|NCT00818259|19388431|P4|STARTED|Part II|Newly enrolled participants|20
7878773|NCT00818259|19388432|P3|STARTED|Part II|Newly enrolled participants|19
7878774|NCT00818259|19388433|P2|STARTED|Part II||0
7878775|NCT00818259|19388434|P1|STARTED|Part II||0
7878776|NCT00818259|19388426|P9|NOT COMPLETED|Part I||0
7878777|NCT00818259|19388427|P8|NOT COMPLETED|Part I||0
7878778|NCT00818259|19388428|P7|NOT COMPLETED|Part I||0
7878779|NCT00818259|19388429|P6|NOT COMPLETED|Part I||0
7878780|NCT00818259|19388430|P5|NOT COMPLETED|Part I||0
7878781|NCT00818259|19388431|P4|NOT COMPLETED|Part I||0
7878782|NCT00818259|19388432|P3|NOT COMPLETED|Part I||0
7878783|NCT00818259|19388433|P2|NOT COMPLETED|Part I||0
7878784|NCT00818259|19388434|P1|NOT COMPLETED|Part I||1
7878785|NCT00818259|19388426|P9|COMPLETED|Part I||0
7878786|NCT00818259|19388427|P8|COMPLETED|Part I||0
7878787|NCT00818259|19388428|P7|COMPLETED|Part I||0
7878788|NCT00818259|19388429|P6|COMPLETED|Part I||0
7878789|NCT00818259|19388430|P5|COMPLETED|Part I||0
7878790|NCT00818259|19388431|P4|COMPLETED|Part I||0
7878791|NCT00818259|19388432|P3|COMPLETED|Part I||0
7878792|NCT00818259|19388433|P2|COMPLETED|Part I||11
7878793|NCT00818259|19388434|P1|COMPLETED|Part I||11
7878794|NCT00818259|19388426|P9|STARTED|Part I||0
7878795|NCT00818259|19388427|P8|STARTED|Part I||0
7878796|NCT00818259|19388428|P7|STARTED|Part I||0
7878797|NCT00818259|19388429|P6|STARTED|Part I||0
7878798|NCT00818259|19388430|P5|STARTED|Part I||0
7878799|NCT00818259|19388431|P4|STARTED|Part I||0
7878800|NCT00818259|19388432|P3|STARTED|Part I||0
7878801|NCT00818259|19388433|P2|STARTED|Part I|Newly enrolled participants|11
7878802|NCT00818259|19388434|P1|STARTED|Part I|Newly enrolled participants|12
7878803|NCT00818259|19388426|P9|NOT COMPLETED|Randomization||0
7878804|NCT00818259|19388427|P8|NOT COMPLETED|Randomization||0
7878805|NCT00818259|19388428|P7|NOT COMPLETED|Randomization||0
7878806|NCT00818259|19388429|P6|NOT COMPLETED|Randomization||0
7878807|NCT00818259|19388430|P5|NOT COMPLETED|Randomization||0
7878808|NCT00818259|19388431|P4|NOT COMPLETED|Randomization||0
7878809|NCT00818259|19388432|P3|NOT COMPLETED|Randomization||0
7878810|NCT00818259|19388433|P2|NOT COMPLETED|Randomization||0
7878811|NCT00818259|19388434|P1|NOT COMPLETED|Randomization||0
7878812|NCT00818259|19388426|P9|COMPLETED|Randomization||6
7878813|NCT00818259|19388427|P8|COMPLETED|Randomization||0
7878814|NCT00818259|19388428|P7|COMPLETED|Randomization||5
7878815|NCT00818259|19388429|P6|COMPLETED|Randomization||0
7878816|NCT00818259|19388430|P5|COMPLETED|Randomization||19
7878817|NCT00818259|19388431|P4|COMPLETED|Randomization||20
7878818|NCT00818259|19388432|P3|COMPLETED|Randomization||19
7878819|NCT00818259|19388433|P2|COMPLETED|Randomization||11
7878820|NCT00818259|19388434|P1|COMPLETED|Randomization||12
7878821|NCT00818259|19388426|P9|STARTED|Randomization||6
7878822|NCT00818259|19388427|P8|STARTED|Randomization||0
7878823|NCT00818259|19388428|P7|STARTED|Randomization||5
7878824|NCT00818259|19388429|P6|STARTED|Randomization||0
7878825|NCT00818259|19388430|P5|STARTED|Randomization||19
7878826|NCT00818259|19388431|P4|STARTED|Randomization||20
7878827|NCT00818259|19388432|P3|STARTED|Randomization||19
7878828|NCT00818259|19388433|P2|STARTED|Randomization||11
7878829|NCT00818259|19388434|P1|STARTED|Randomization||12
7878830|NCT00818246|19388506|P1|NOT COMPLETED|Overall Study||5
7878831|NCT00818246|19388506|P1|COMPLETED|Overall Study|split-face study|35
7878832|NCT00818246|19388506|P1|STARTED|Overall Study||40
7878833|NCT00818207|19388515|P2|NOT COMPLETED|Overall Study||267
7878834|NCT00818207|19388516|P1|NOT COMPLETED|Overall Study||222
7878835|NCT00818207|19388515|P2|COMPLETED|Overall Study||417
7878836|NCT00818207|19388516|P1|COMPLETED|Overall Study||474
7878837|NCT00818207|19388515|P2|STARTED|Overall Study||684
7878838|NCT00818207|19388516|P1|STARTED|Overall Study||696
7878839|NCT00818168|19388530|P1|NOT COMPLETED|Overall Study||70
7878840|NCT00818168|19388530|P1|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250
7878841|NCT00818168|19388530|P1|STARTED|Overall Study||320
7878842|NCT00818116|19388538|P1|NOT COMPLETED|Overall Study||0
7878843|NCT00818116|19388538|P1|COMPLETED|Overall Study||34
7878844|NCT00818116|19388538|P1|STARTED|Overall Study||34
7878845|NCT00817999|19388544|P2|NOT COMPLETED|No Grapefruit Juice||0
7878846|NCT00817999|19388545|P1|NOT COMPLETED|No Grapefruit Juice||0
7878847|NCT00817999|19388544|P2|COMPLETED|No Grapefruit Juice||17
7878848|NCT00817999|19388545|P1|COMPLETED|No Grapefruit Juice||15
7878849|NCT00817999|19388544|P2|STARTED|No Grapefruit Juice||17
7878850|NCT00817999|19388545|P1|STARTED|No Grapefruit Juice||15
7878851|NCT00817999|19388544|P2|NOT COMPLETED|Grapefruit Juice||0
7878852|NCT00817999|19388545|P1|NOT COMPLETED|Grapefruit Juice||0
7878853|NCT00817999|19388544|P2|COMPLETED|Grapefruit Juice||17
7878854|NCT00817999|19388545|P1|COMPLETED|Grapefruit Juice||15
7878855|NCT00817999|19388544|P2|STARTED|Grapefruit Juice||17
7878856|NCT00817999|19388545|P1|STARTED|Grapefruit Juice||15
7878857|NCT00817843|19388553|P2|NOT COMPLETED|Second Period (6 Weeks)||1
7878858|NCT00817843|19388554|P1|NOT COMPLETED|Second Period (6 Weeks)||0
7878859|NCT00817843|19388553|P2|COMPLETED|Second Period (6 Weeks)||44
7878860|NCT00817843|19388554|P1|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41
7878861|NCT00817843|19388553|P2|STARTED|Second Period (6 Weeks)||45
7878862|NCT00817843|19388554|P1|STARTED|Second Period (6 Weeks)||41
7878863|NCT00817843|19388553|P2|NOT COMPLETED|Washout Period (6 Weeks)||1
7878864|NCT00817843|19388554|P1|NOT COMPLETED|Washout Period (6 Weeks)||1
7878865|NCT00817843|19388553|P2|COMPLETED|Washout Period (6 Weeks)||45
7878866|NCT00817843|19388554|P1|COMPLETED|Washout Period (6 Weeks)||41
7878867|NCT00817843|19388553|P2|STARTED|Washout Period (6 Weeks)||46
7878868|NCT00817843|19388554|P1|STARTED|Washout Period (6 Weeks)||42
7878869|NCT00817843|19388553|P2|NOT COMPLETED|First Period (6 Weeks)||4
7878870|NCT00817843|19388554|P1|NOT COMPLETED|First Period (6 Weeks)||8
7878871|NCT00817843|19388553|P2|COMPLETED|First Period (6 Weeks)||46
7878872|NCT00817843|19388554|P1|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42
7878873|NCT00817843|19388553|P2|STARTED|First Period (6 Weeks)||50
7878874|NCT00817843|19388554|P1|STARTED|First Period (6 Weeks)||50
7878875|NCT00817804|19388561|P2|NOT COMPLETED|Overall Study||0
7878876|NCT00817804|19388562|P1|NOT COMPLETED|Overall Study||0
7878877|NCT00817804|19388561|P2|COMPLETED|Overall Study||2
7878878|NCT00817804|19388562|P1|COMPLETED|Overall Study||1
7878879|NCT00817804|19388561|P2|STARTED|Overall Study||2
7878880|NCT00817804|19388562|P1|STARTED|Overall Study||1
7878881|NCT00817778|19388570|P2|NOT COMPLETED|Overall Study||3
7878882|NCT00817778|19388571|P1|NOT COMPLETED|Overall Study||3
7878883|NCT00817778|19388570|P2|COMPLETED|Overall Study||5
7878884|NCT00817778|19388571|P1|COMPLETED|Overall Study||16
7878885|NCT00817778|19388570|P2|STARTED|Overall Study||8
7878886|NCT00817778|19388571|P1|STARTED|Overall Study||19
7878887|NCT00817596|19388596|P1|NOT COMPLETED|Overall Study||48
7878888|NCT00817596|19388596|P1|COMPLETED|Overall Study||62
7878889|NCT00817596|19388596|P1|STARTED|Overall Study||110
7878890|NCT00817531|19388600|P1|NOT COMPLETED|Overall Study||2
7878891|NCT00817531|19388600|P1|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20
7878892|NCT00817531|19388600|P1|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22
7878893|NCT00817479|19388606|P2|NOT COMPLETED|Overall Study||1
7878894|NCT00817479|19388607|P1|NOT COMPLETED|Overall Study||1
7878895|NCT00817479|19388606|P2|COMPLETED|Overall Study||13
7878896|NCT00817479|19388607|P1|COMPLETED|Overall Study||5
7878897|NCT00817479|19388606|P2|STARTED|Overall Study||14
7878898|NCT00817479|19388607|P1|STARTED|Overall Study||6
7878899|NCT00817336|19388617|P2|NOT COMPLETED|Overall Study||1
7878900|NCT00817336|19388618|P1|NOT COMPLETED|Overall Study||1
7878901|NCT00817336|19388617|P2|COMPLETED|Overall Study||7
7878902|NCT00817336|19388618|P1|COMPLETED|Overall Study||7
7878903|NCT00817336|19388617|P2|STARTED|Overall Study||8
7878904|NCT00817336|19388618|P1|STARTED|Overall Study||8
7878905|NCT00817219|19388629|P1|NOT COMPLETED|Overall Study||0
7878906|NCT00817219|19388629|P1|COMPLETED|Overall Study||33
7878907|NCT00817219|19388629|P1|STARTED|Overall Study||33
7878908|NCT00817206|19388644|P2|NOT COMPLETED|Overall Study||9
7878909|NCT00817206|19388645|P1|NOT COMPLETED|Overall Study||21
7878910|NCT00817206|19388644|P2|COMPLETED|Overall Study||154
7878911|NCT00817206|19388645|P1|COMPLETED|Overall Study||142
7878912|NCT00817206|19388644|P2|STARTED|Overall Study||163
7878913|NCT00817206|19388645|P1|STARTED|Overall Study||163
7878914|NCT00817089|19388655|P4|NOT COMPLETED|Second Alcohol Challenge||0
7878915|NCT00817089|19388656|P3|NOT COMPLETED|Second Alcohol Challenge||0
7878916|NCT00817089|19388657|P2|NOT COMPLETED|Second Alcohol Challenge||1
7878917|NCT00817089|19388658|P1|NOT COMPLETED|Second Alcohol Challenge||0
7878918|NCT00817089|19388655|P4|COMPLETED|Second Alcohol Challenge||5
7878919|NCT00817089|19388656|P3|COMPLETED|Second Alcohol Challenge||4
7878920|NCT00817089|19388657|P2|COMPLETED|Second Alcohol Challenge||7
7878921|NCT00817089|19388658|P1|COMPLETED|Second Alcohol Challenge||6
7878922|NCT00817089|19388655|P4|STARTED|Second Alcohol Challenge||5
7878923|NCT00817089|19388656|P3|STARTED|Second Alcohol Challenge||4
7878924|NCT00817089|19388657|P2|STARTED|Second Alcohol Challenge||8
7878925|NCT00817089|19388658|P1|STARTED|Second Alcohol Challenge||6
7878926|NCT00817089|19388655|P4|NOT COMPLETED|First Alcohol Challenge||1
7878927|NCT00817089|19388656|P3|NOT COMPLETED|First Alcohol Challenge||0
7878928|NCT00817089|19388657|P2|NOT COMPLETED|First Alcohol Challenge||0
7878929|NCT00817089|19388658|P1|NOT COMPLETED|First Alcohol Challenge||0
7878930|NCT00817089|19388655|P4|COMPLETED|First Alcohol Challenge||5
7878931|NCT00817089|19388656|P3|COMPLETED|First Alcohol Challenge||4
7878932|NCT00817089|19388657|P2|COMPLETED|First Alcohol Challenge||8
7878933|NCT00817089|19388658|P1|COMPLETED|First Alcohol Challenge||6
7878934|NCT00817089|19388655|P4|STARTED|First Alcohol Challenge||6
7878935|NCT00817089|19388656|P3|STARTED|First Alcohol Challenge||4
7878936|NCT00817089|19388657|P2|STARTED|First Alcohol Challenge||8
7878937|NCT00817089|19388658|P1|STARTED|First Alcohol Challenge||6
7878938|NCT00817063|19388674|P2|NOT COMPLETED|Overall Study||170
7878939|NCT00817063|19388675|P1|NOT COMPLETED|Overall Study||137
7878940|NCT00817063|19388674|P2|COMPLETED|Overall Study||128
7878941|NCT00817063|19388675|P1|COMPLETED|Overall Study||161
7878942|NCT00817063|19388674|P2|STARTED|Overall Study||298
7878943|NCT00817063|19388675|P1|STARTED|Overall Study||298
7878944|NCT00816907|19388719|P2|NOT COMPLETED|Overall Study||17
7878945|NCT00816907|19388720|P1|NOT COMPLETED|Overall Study||13
7878946|NCT00816907|19388719|P2|COMPLETED|Overall Study||58
7878947|NCT00816907|19388720|P1|COMPLETED|Overall Study||58
7878948|NCT00816907|19388719|P2|STARTED|Overall Study||75
7878949|NCT00816907|19388720|P1|STARTED|Overall Study||71
7878950|NCT00816829|19388742|P2|NOT COMPLETED|Overall Study||0
7878951|NCT00816829|19388743|P1|NOT COMPLETED|Overall Study||0
7878952|NCT00816829|19388742|P2|COMPLETED|Overall Study||18
7878953|NCT00816829|19388743|P1|COMPLETED|Overall Study||16
7878954|NCT00816829|19388742|P2|STARTED|Overall Study||18
7878955|NCT00816829|19388743|P1|STARTED|Overall Study||16
7878956|NCT00816777|19388769|P2|NOT COMPLETED|Overall Study||0
7878957|NCT00816777|19388770|P1|NOT COMPLETED|Overall Study||0
7878958|NCT00816777|19388769|P2|COMPLETED|Overall Study||2
7878959|NCT00816777|19388770|P1|COMPLETED|Overall Study||2
7878960|NCT00816777|19388769|P2|STARTED|Overall Study||2
7878961|NCT00816777|19388770|P1|STARTED|Overall Study||2
7878962|NCT00816751|19388792|P2|NOT COMPLETED|Overall Study||0
7878963|NCT00816751|19388793|P1|NOT COMPLETED|Overall Study||0
7878964|NCT00816751|19388792|P2|COMPLETED|Overall Study||44
7878965|NCT00816751|19388793|P1|COMPLETED|Overall Study||45
7878966|NCT00816751|19388792|P2|STARTED|Overall Study||44
7878967|NCT00816751|19388793|P1|STARTED|Overall Study||45
7878968|NCT00816595|19388803|P2|NOT COMPLETED|Overall Study||0
7878969|NCT00816595|19388804|P1|NOT COMPLETED|Overall Study||2
7878970|NCT00816595|19388803|P2|COMPLETED|Overall Study||33
7878971|NCT00816595|19388804|P1|COMPLETED|Overall Study||33
7878972|NCT00816595|19388803|P2|STARTED|Overall Study||33
7878973|NCT00816595|19388804|P1|STARTED|Overall Study||35
7878974|NCT00816556|19388817|P3|NOT COMPLETED|Overall Study||3
7878975|NCT00816556|19388818|P2|NOT COMPLETED|Overall Study||2
7878976|NCT00816556|19388819|P1|NOT COMPLETED|Overall Study||2
7878977|NCT00816556|19388817|P3|COMPLETED|Overall Study||19
7878978|NCT00816556|19388818|P2|COMPLETED|Overall Study||19
7878979|NCT00816556|19388819|P1|COMPLETED|Overall Study||18
7878980|NCT00816556|19388817|P3|STARTED|Overall Study||22
7878981|NCT00816556|19388818|P2|STARTED|Overall Study||21
7878982|NCT00816556|19388819|P1|STARTED|Overall Study||20
7878983|NCT00816400|19388842|P9|NOT COMPLETED|Overall Study||6
7878984|NCT00816400|19388843|P8|NOT COMPLETED|Overall Study||5
7878985|NCT00816400|19388844|P7|NOT COMPLETED|Overall Study||2
7878986|NCT00816400|19388845|P6|NOT COMPLETED|Overall Study||3
7878987|NCT00816400|19388846|P5|NOT COMPLETED|Overall Study||2
7878988|NCT00816400|19388847|P4|NOT COMPLETED|Overall Study||3
7878989|NCT00816400|19388848|P3|NOT COMPLETED|Overall Study||5
7878990|NCT00816400|19388849|P2|NOT COMPLETED|Overall Study||3
7878991|NCT00816400|19388850|P1|NOT COMPLETED|Overall Study||2
7878992|NCT00816400|19388842|P9|COMPLETED|Overall Study||0
7878993|NCT00816400|19388843|P8|COMPLETED|Overall Study||1
7878994|NCT00816400|19388844|P7|COMPLETED|Overall Study||1
7878995|NCT00816400|19388845|P6|COMPLETED|Overall Study||0
7878996|NCT00816400|19388846|P5|COMPLETED|Overall Study||1
7878997|NCT00816400|19388847|P4|COMPLETED|Overall Study||0
7878998|NCT00816400|19388848|P3|COMPLETED|Overall Study||0
7878999|NCT00816400|19388849|P2|COMPLETED|Overall Study||0
7879000|NCT00816400|19388850|P1|COMPLETED|Overall Study||1
7879001|NCT00816400|19388842|P9|STARTED|Overall Study||6
7879002|NCT00816400|19388843|P8|STARTED|Overall Study||6
7879003|NCT00816400|19388844|P7|STARTED|Overall Study||3
7879004|NCT00816400|19388845|P6|STARTED|Overall Study||3
7879005|NCT00816400|19388846|P5|STARTED|Overall Study||3
7879006|NCT00816400|19388847|P4|STARTED|Overall Study||3
7879007|NCT00816400|19388848|P3|STARTED|Overall Study||5
7879008|NCT00816400|19388849|P2|STARTED|Overall Study||3
7879009|NCT00816400|19388850|P1|STARTED|Overall Study||3
7879010|NCT00816361|19389041|P9|NOT COMPLETED|Overall Study||10
7879011|NCT00816361|19389042|P8|NOT COMPLETED|Overall Study||9
7879012|NCT00816361|19389043|P7|NOT COMPLETED|Overall Study||3
7879013|NCT00816361|19389044|P6|NOT COMPLETED|Overall Study||3
7879014|NCT00816361|19389045|P5|NOT COMPLETED|Overall Study||2
7879015|NCT00816361|19389046|P4|NOT COMPLETED|Overall Study||3
7879016|NCT00816361|19389047|P3|NOT COMPLETED|Overall Study||3
7879017|NCT00816361|19389048|P2|NOT COMPLETED|Overall Study||3
7879018|NCT00816361|19389049|P1|NOT COMPLETED|Overall Study||4
7879019|NCT00816361|19389041|P9|COMPLETED|Overall Study||0
7879020|NCT00816361|19389042|P8|COMPLETED|Overall Study||1
7879021|NCT00816361|19389043|P7|COMPLETED|Overall Study||0
7879022|NCT00816361|19389044|P6|COMPLETED|Overall Study||0
7879023|NCT00816361|19389045|P5|COMPLETED|Overall Study||1
7879024|NCT00816361|19389046|P4|COMPLETED|Overall Study||0
7879025|NCT00816361|19389047|P3|COMPLETED|Overall Study||1
7879026|NCT00816361|19389048|P2|COMPLETED|Overall Study||0
7879027|NCT00816361|19389049|P1|COMPLETED|Overall Study||0
7879028|NCT00816361|19389041|P9|STARTED|Overall Study||10
7879029|NCT00816361|19389042|P8|STARTED|Overall Study||10
7879030|NCT00816361|19389043|P7|STARTED|Overall Study||3
7879031|NCT00816361|19389044|P6|STARTED|Overall Study||3
7879032|NCT00816361|19389045|P5|STARTED|Overall Study||3
7879033|NCT00816361|19389046|P4|STARTED|Overall Study||3
7879034|NCT00816361|19389047|P3|STARTED|Overall Study||4
7879035|NCT00816361|19389048|P2|STARTED|Overall Study||3
7879036|NCT00816361|19389049|P1|STARTED|Overall Study||4
7879037|NCT00816348|19389202|P1|NOT COMPLETED|Overall Study||0
7879038|NCT00816348|19389202|P1|COMPLETED|Overall Study||15
7879039|NCT00816348|19389202|P1|STARTED|Overall Study||15
7879040|NCT00816166|19389208|P2|NOT COMPLETED|Overall Study||12
7879041|NCT00816166|19389209|P1|NOT COMPLETED|Overall Study||10
7879042|NCT00816166|19389208|P2|COMPLETED|Overall Study||41
7879043|NCT00816166|19389209|P1|COMPLETED|Overall Study||49
7879044|NCT00816166|19389208|P2|ITT Population (Met Eligibility)|Overall Study||53
7879045|NCT00816166|19389209|P1|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58
7879046|NCT00816166|19389208|P2|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53
7879047|NCT00816166|19389209|P1|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59
7879048|NCT00816101|19389218|P3|NOT COMPLETED|Overall Study||0
7879049|NCT00816101|19389219|P2|NOT COMPLETED|Overall Study||0
7879050|NCT00816101|19389220|P1|NOT COMPLETED|Overall Study||0
7879051|NCT00816101|19389218|P3|COMPLETED|Overall Study||5
7879052|NCT00816101|19389219|P2|COMPLETED|Overall Study||8
7879053|NCT00816101|19389220|P1|COMPLETED|Overall Study||13
7879054|NCT00816101|19389218|P3|STARTED|Overall Study||5
7879055|NCT00816101|19389219|P2|STARTED|Overall Study||8
7879056|NCT00816101|19389220|P1|STARTED|Overall Study||13
7879057|NCT00816062|19389234|P1|NOT COMPLETED|Overall Study||127
7879058|NCT00816062|19389234|P1|COMPLETED|Overall Study||133
7879059|NCT00816062|19389234|P1|STARTED|Overall Study||260
7879060|NCT00816036|19389241|P2|NOT COMPLETED|Overall Study||108
7879061|NCT00816036|19389242|P1|NOT COMPLETED|Overall Study||176
7879062|NCT00816036|19389241|P2|COMPLETED|Overall Study||287
7879063|NCT00816036|19389242|P1|COMPLETED|Overall Study||327
7879064|NCT00816036|19389241|P2|STARTED|Overall Study||395
7879065|NCT00816036|19389242|P1|STARTED|Overall Study||503
7879066|NCT00816023|19389256|P4|NOT COMPLETED|Overall Study||12
7879067|NCT00816023|19389257|P3|NOT COMPLETED|Overall Study||9
7879068|NCT00816023|19389258|P2|NOT COMPLETED|Overall Study||6
7879069|NCT00816023|19389259|P1|NOT COMPLETED|Overall Study||9
7879070|NCT00816023|19389256|P4|COMPLETED|Overall Study||62
7879071|NCT00816023|19389257|P3|COMPLETED|Overall Study||60
7879072|NCT00816023|19389258|P2|COMPLETED|Overall Study||56
7879073|NCT00816023|19389259|P1|COMPLETED|Overall Study||62
7879074|NCT00816023|19389256|P4|Completed Therapy|Overall Study||63
7879075|NCT00816023|19389257|P3|Completed Therapy|Overall Study||61
7879076|NCT00816023|19389258|P2|Completed Therapy|Overall Study||59
7879077|NCT00816023|19389259|P1|Completed Therapy|Overall Study||65
7879078|NCT00816023|19389256|P4|STARTED|Overall Study||74
7879079|NCT00816023|19389257|P3|STARTED|Overall Study||69
7879080|NCT00816023|19389258|P2|STARTED|Overall Study||62
7879081|NCT00816023|19389259|P1|STARTED|Overall Study||71
7879082|NCT00815997|19389275|P2|NOT COMPLETED|Overall Study||0
7879083|NCT00815997|19389276|P1|NOT COMPLETED|Overall Study||0
7879084|NCT00815997|19389275|P2|COMPLETED|Overall Study||80
7879085|NCT00815997|19389276|P1|COMPLETED|Overall Study||80
7879086|NCT00815997|19389275|P2|STARTED|Overall Study||80
7879087|NCT00815997|19389276|P1|STARTED|Overall Study||80
7879088|NCT00815919|19389296|P1|NOT COMPLETED|Overall Study||4
7879089|NCT00815919|19389296|P1|COMPLETED|Overall Study||18
7879090|NCT00815919|19389296|P1|STARTED|Overall Study||22
7879091|NCT00815776|19389307|P3|NOT COMPLETED|Overall Study||6
7879092|NCT00815776|19389308|P2|NOT COMPLETED|Overall Study||8
7879093|NCT00815776|19389309|P1|NOT COMPLETED|Overall Study||8
7879094|NCT00815776|19389307|P3|COMPLETED|Overall Study||22
7879095|NCT00815776|19389308|P2|COMPLETED|Overall Study||56
7879096|NCT00815776|19389309|P1|COMPLETED|Overall Study||52
7879097|NCT00815776|19389307|P3|STARTED|Overall Study||28
7879098|NCT00815776|19389308|P2|STARTED|Overall Study||64
7879099|NCT00815776|19389309|P1|STARTED|Overall Study||60
7879100|NCT00815698|19389325|P2|NOT COMPLETED|Overall Study||0
7879101|NCT00815698|19389326|P1|NOT COMPLETED|Overall Study||0
7879102|NCT00815698|19389325|P2|COMPLETED|Overall Study||171
7879103|NCT00815698|19389326|P1|COMPLETED|Overall Study||163
7879104|NCT00815698|19389325|P2|STARTED|Overall Study||171
7879105|NCT00815698|19389326|P1|STARTED|Overall Study||163
7879106|NCT00815685|19389334|P1|NOT COMPLETED|Overall Study||22
7879107|NCT00815685|19389334|P1|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14
7879108|NCT00815685|19389334|P1|STARTED|Overall Study||36
7879109|NCT00815659|19389339|P1|NOT COMPLETED|Overall Study||23
7879110|NCT00815659|19389339|P1|COMPLETED|Overall Study||74
7879111|NCT00815659|19389339|P1|STARTED|Overall Study||97
7879112|NCT00815633|19389382|P1|NOT COMPLETED|Overall Study||1
7879113|NCT00815633|19389382|P1|COMPLETED|Overall Study||0
7879114|NCT00815633|19389382|P1|STARTED|Overall Study||1
7879115|NCT00815516|19389389|P2|NOT COMPLETED|Overall Study||1
7879116|NCT00815516|19389390|P1|NOT COMPLETED|Overall Study||4
7879117|NCT00815516|19389389|P2|COMPLETED|Overall Study||9
7879118|NCT00815516|19389390|P1|COMPLETED|Overall Study||16
7879119|NCT00815516|19389389|P2|STARTED|Overall Study||10
7879120|NCT00815516|19389390|P1|STARTED|Overall Study||20
7879121|NCT00815490|19389421|P2|NOT COMPLETED|Overall Study||0
7879122|NCT00815490|19389422|P1|NOT COMPLETED|Overall Study||0
7879123|NCT00815490|19389421|P2|COMPLETED|Overall Study||9
7879124|NCT00815490|19389422|P1|COMPLETED|Overall Study||9
7879125|NCT00815490|19389421|P2|STARTED|Overall Study||9
7879126|NCT00815490|19389422|P1|STARTED|Overall Study||9
7879127|NCT00815360|19389430|P2|NOT COMPLETED|Overall Study||0
7879128|NCT00815360|19389431|P1|NOT COMPLETED|Overall Study||0
7879129|NCT00815360|19389430|P2|COMPLETED|Overall Study||11
7879130|NCT00815360|19389431|P1|COMPLETED|Overall Study||11
7879131|NCT00815360|19389430|P2|STARTED|Overall Study||11
7879132|NCT00815360|19389431|P1|STARTED|Overall Study||11
7879133|NCT00815347|19389439|P1|NOT COMPLETED|Overall Study||4
7879134|NCT00815347|19389439|P1|COMPLETED|Overall Study||7
7879135|NCT00815347|19389439|P1|STARTED|Overall Study||11
7879136|NCT00815308|19389455|P1|NOT COMPLETED|Overall Study||10
7879137|NCT00815308|19389455|P1|COMPLETED|Overall Study||45
7879138|NCT00815308|19389455|P1|STARTED|Overall Study||55
7879139|NCT00815295|19389464|P3|NOT COMPLETED|Overall Study||3
7879140|NCT00815295|19389465|P2|NOT COMPLETED|Overall Study||1
7879141|NCT00815295|19389466|P1|NOT COMPLETED|Overall Study||0
7879142|NCT00815295|19389464|P3|COMPLETED|Overall Study||9
7879143|NCT00815295|19389465|P2|COMPLETED|Overall Study||7
7879144|NCT00815295|19389466|P1|COMPLETED|Overall Study||8
7879145|NCT00815295|19389464|P3|STARTED|Overall Study||12
7879146|NCT00815295|19389465|P2|STARTED|Overall Study||8
7879147|NCT00815295|19389466|P1|STARTED|Overall Study||8
7879148|NCT00815191|19389478|P2|NOT COMPLETED|Overall Study||1
7879149|NCT00815191|19389479|P1|NOT COMPLETED|Overall Study||1
7879150|NCT00815191|19389478|P2|COMPLETED|Overall Study||34
7879151|NCT00815191|19389479|P1|COMPLETED|Overall Study||37
7879152|NCT00815191|19389478|P2|STARTED|Overall Study||35
7879153|NCT00815191|19389479|P1|STARTED|Overall Study||38
7879154|NCT00815087|19389487|P2|NOT COMPLETED|Overall Study||0
7879155|NCT00815087|19389488|P1|NOT COMPLETED|Overall Study||0
7879156|NCT00815087|19389487|P2|COMPLETED|Overall Study||10
7879157|NCT00815087|19389488|P1|COMPLETED|Overall Study||10
7879158|NCT00815087|19389487|P2|STARTED|Overall Study||10
7879159|NCT00815087|19389488|P1|STARTED|Overall Study||10
7879160|NCT00815035|19389496|P3|NOT COMPLETED|Open Label Extension Phase||6
7879161|NCT00815035|19389497|P2|NOT COMPLETED|Open Label Extension Phase||0
7879162|NCT00815035|19389498|P1|NOT COMPLETED|Open Label Extension Phase||0
7879163|NCT00815035|19389496|P3|COMPLETED|Open Label Extension Phase||9
7879164|NCT00815035|19389497|P2|COMPLETED|Open Label Extension Phase||0
7879165|NCT00815035|19389498|P1|COMPLETED|Open Label Extension Phase||0
7879166|NCT00815035|19389496|P3|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|15
7879167|NCT00815035|19389497|P2|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
7879168|NCT00815035|19389498|P1|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
7879169|NCT00815035|19389496|P3|NOT COMPLETED|Blinded Phase||0
7879170|NCT00815035|19389497|P2|NOT COMPLETED|Blinded Phase||0
7879171|NCT00815035|19389498|P1|NOT COMPLETED|Blinded Phase||1
7879172|NCT00815035|19389496|P3|COMPLETED|Blinded Phase||0
7879173|NCT00815035|19389497|P2|COMPLETED|Blinded Phase||6
7879174|NCT00815035|19389498|P1|COMPLETED|Blinded Phase||9
7879175|NCT00815035|19389496|P3|STARTED|Blinded Phase||0
7879176|NCT00815035|19389497|P2|STARTED|Blinded Phase||6
7879177|NCT00815035|19389498|P1|STARTED|Blinded Phase||10
7879178|NCT00814983|19389516|P2|NOT COMPLETED|Overall Study||0
7879179|NCT00814983|19389517|P1|NOT COMPLETED|Overall Study||3
7879180|NCT00814983|19389516|P2|COMPLETED|Overall Study||0
7879181|NCT00814983|19389517|P1|COMPLETED|Overall Study||12
7879182|NCT00814983|19389516|P2|STARTED|Overall Study||0
7879183|NCT00814983|19389517|P1|STARTED|Overall Study||15
7879184|NCT00814970|19389527|P1|NOT COMPLETED|Overall Study||50
7879185|NCT00814970|19389527|P1|COMPLETED|Overall Study||146
7879186|NCT00814970|19389527|P1|STARTED|Overall Study||196
7879187|NCT00814892|19389548|P1|NOT COMPLETED|Overall Study||2
7879188|NCT00814892|19389548|P1|COMPLETED|Overall Study||0
7879189|NCT00814892|19389548|P1|STARTED|Overall Study||2
7879190|NCT00814879|19389560|P2|NOT COMPLETED|By Week 48||3
7879191|NCT00814879|19389561|P1|NOT COMPLETED|By Week 48||2
7879192|NCT00814879|19389560|P2|COMPLETED|By Week 48||26
7879193|NCT00814879|19389561|P1|COMPLETED|By Week 48||25
7879194|NCT00814879|19389560|P2|STARTED|By Week 48||29
7879195|NCT00814879|19389561|P1|STARTED|By Week 48||27
7879196|NCT00814879|19389560|P2|NOT COMPLETED|By Week 24||1
7879197|NCT00814879|19389561|P1|NOT COMPLETED|By Week 24||1
7879198|NCT00814879|19389560|P2|COMPLETED|By Week 24||29
7879199|NCT00814879|19389561|P1|COMPLETED|By Week 24||27
7879200|NCT00814879|19389560|P2|STARTED|By Week 24||30
7879201|NCT00814879|19389561|P1|STARTED|By Week 24||28
7879202|NCT00814801|19389580|P3|NOT COMPLETED|Overall Study||43
7879203|NCT00814801|19389581|P2|NOT COMPLETED|Overall Study||38
7879204|NCT00814801|19389582|P1|NOT COMPLETED|Overall Study||34
7879205|NCT00814801|19389580|P3|COMPLETED|Overall Study||151
7879206|NCT00814801|19389581|P2|COMPLETED|Overall Study||154
7879207|NCT00814801|19389582|P1|COMPLETED|Overall Study||160
7879208|NCT00814801|19389580|P3|STARTED|Overall Study||194
7879209|NCT00814801|19389581|P2|STARTED|Overall Study||192
7879210|NCT00814801|19389582|P1|STARTED|Overall Study||194
7879211|NCT00814788|19389602|P1|NOT COMPLETED|Overall Study||0
7879212|NCT00814788|19389602|P1|COMPLETED|Overall Study||24
7879213|NCT00814788|19389602|P1|STARTED|Overall Study||24
7879214|NCT00814775|19389610|P2|NOT COMPLETED|Overall Study||0
7879215|NCT00814775|19389611|P1|NOT COMPLETED|Overall Study||0
7879216|NCT00814775|19389610|P2|COMPLETED|Overall Study||20
7879217|NCT00814775|19389611|P1|COMPLETED|Overall Study||23
7879218|NCT00814775|19389610|P2|STARTED|Overall Study||20
7879219|NCT00814775|19389611|P1|STARTED|Overall Study||23
7879220|NCT00814710|19389621|P2|NOT COMPLETED|Overall Study||3
7879221|NCT00814710|19389622|P1|NOT COMPLETED|Overall Study||8
7879222|NCT00814710|19389621|P2|COMPLETED|Overall Study||117
7879223|NCT00814710|19389622|P1|COMPLETED|Overall Study||232
7879224|NCT00814710|19389621|P2|STARTED|Overall Study||120
7879225|NCT00814710|19389622|P1|STARTED|Overall Study||240
7879226|NCT00814697|19389660|P1|NOT COMPLETED|Overall Study||0
7879227|NCT00814697|19389660|P1|COMPLETED|Overall Study||12
7879228|NCT00814697|19389660|P1|STARTED|Overall Study||12
7879229|NCT00814671|19389667|P3|NOT COMPLETED|Overall Study||2
7879230|NCT00814671|19389668|P2|NOT COMPLETED|Overall Study||4
7879231|NCT00814671|19389669|P1|NOT COMPLETED|Overall Study||7
7879232|NCT00814671|19389667|P3|COMPLETED|Overall Study||49
7879233|NCT00814671|19389668|P2|COMPLETED|Overall Study||44
7879234|NCT00814671|19389669|P1|COMPLETED|Overall Study||47
7879235|NCT00814671|19389667|P3|STARTED|Overall Study||51
7879236|NCT00814671|19389668|P2|STARTED|Overall Study||48
7879237|NCT00814671|19389669|P1|STARTED|Overall Study||54
7879238|NCT00814658|19389690|P2|NOT COMPLETED|Overall Study||4
7879239|NCT00814658|19389691|P1|NOT COMPLETED|Overall Study||4
7879240|NCT00814658|19389690|P2|COMPLETED|Overall Study||8
7879241|NCT00814658|19389691|P1|COMPLETED|Overall Study||5
7879242|NCT00814658|19389690|P2|STARTED|Overall Study||12
7879243|NCT00814658|19389691|P1|STARTED|Overall Study||9
7879244|NCT00814632|19389757|P1|NOT COMPLETED|Overall Study||2
7879245|NCT00814632|19389757|P1|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7
7879246|NCT00814632|19389757|P1|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9
7879247|NCT00814580|19389763|P2|NOT COMPLETED|Overall Study||47
7879248|NCT00814580|19389764|P1|NOT COMPLETED|Overall Study||31
7879249|NCT00814580|19389763|P2|COMPLETED|Overall Study||141
7879250|NCT00814580|19389764|P1|COMPLETED|Overall Study||163
7879251|NCT00814580|19389763|P2|STARTED|Overall Study||188
7879252|NCT00814580|19389764|P1|STARTED|Overall Study||194
7879253|NCT00814502|19389894|P2|NOT COMPLETED|Overall Study||2
7879254|NCT00814502|19389895|P1|NOT COMPLETED|Overall Study||1
7879255|NCT00814502|19389894|P2|COMPLETED|Overall Study||7
7879256|NCT00814502|19389895|P1|COMPLETED|Overall Study||7
7879257|NCT00814502|19389894|P2|STARTED|Overall Study||9
7879258|NCT00814502|19389895|P1|STARTED|Overall Study||8
7879259|NCT00814489|19389908|P3|NOT COMPLETED|Overall Study||1
7879260|NCT00814489|19389909|P2|NOT COMPLETED|Overall Study||0
7879261|NCT00814489|19389910|P1|NOT COMPLETED|Overall Study||2
7879262|NCT00814489|19389908|P3|COMPLETED|Overall Study||7
7879263|NCT00814489|19389909|P2|COMPLETED|Overall Study||17
7879264|NCT00814489|19389910|P1|COMPLETED|Overall Study||13
7879265|NCT00814489|19389908|P3|STARTED|Overall Study||8
7879266|NCT00814489|19389909|P2|STARTED|Overall Study||17
7879267|NCT00814489|19389910|P1|STARTED|Overall Study||15
7879268|NCT00814463|19389942|P1|NOT COMPLETED|Overall Study||1
7879269|NCT00814463|19389942|P1|COMPLETED|Overall Study||0
7879270|NCT00814463|19389942|P1|STARTED|Overall Study||1
7879271|NCT00814346|19389955|P2|NOT COMPLETED|Open Phase (17 Months)||0
7879272|NCT00814346|19389956|P1|NOT COMPLETED|Open Phase (17 Months)||10
7879273|NCT00814346|19389955|P2|COMPLETED|Open Phase (17 Months)||0
7879274|NCT00814346|19389956|P1|COMPLETED|Open Phase (17 Months)||31
7879275|NCT00814346|19389955|P2|AD|Open Phase (17 Months)||0
7879276|NCT00814346|19389956|P1|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0
7879277|NCT00814346|19389955|P2|MC|Open Phase (17 Months)||0
7879278|NCT00814346|19389956|P1|MC|Open Phase (17 Months)||20
7879279|NCT00814346|19389955|P2|CNE|Open Phase (17 Months)||0
7879280|NCT00814346|19389956|P1|CNE|Open Phase (17 Months)||21
7879281|NCT00814346|19389955|P2|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0
7879282|NCT00814346|19389956|P1|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41
7879283|NCT00814346|19389955|P2|NOT COMPLETED|Double-blind Phase (4 Weeks)||3
7879284|NCT00814346|19389956|P1|NOT COMPLETED|Double-blind Phase (4 Weeks)||0
7879285|NCT00814346|19389955|P2|COMPLETED|Double-blind Phase (4 Weeks)||23
7879286|NCT00814346|19389956|P1|COMPLETED|Double-blind Phase (4 Weeks)||23
7879287|NCT00814346|19389955|P2|AD|Double-blind Phase (4 Weeks)||2
7879288|NCT00814346|19389956|P1|AD|Double-blind Phase (4 Weeks)||3
7879289|NCT00814346|19389955|P2|MC|Double-blind Phase (4 Weeks)||11
7879290|NCT00814346|19389956|P1|MC|Double-blind Phase (4 Weeks)||10
7879291|NCT00814346|19389955|P2|CNE|Double-blind Phase (4 Weeks)||13
7879292|NCT00814346|19389956|P1|CNE|Double-blind Phase (4 Weeks)||10
7879293|NCT00814346|19389955|P2|STARTED|Double-blind Phase (4 Weeks)||26
7879294|NCT00814346|19389956|P1|STARTED|Double-blind Phase (4 Weeks)||23
7879295|NCT00814333|19390022|P2|NOT COMPLETED|Treatment Period||0
7879296|NCT00814333|19390023|P1|NOT COMPLETED|Treatment Period||0
7879297|NCT00814333|19390022|P2|COMPLETED|Treatment Period||0
7879298|NCT00814333|19390023|P1|COMPLETED|Treatment Period||0
7879299|NCT00814333|19390022|P2|STARTED|Treatment Period||0
7879300|NCT00814333|19390023|P1|STARTED|Treatment Period||0
7879301|NCT00814333|19390022|P2|NOT COMPLETED|Enrollment||0
7879302|NCT00814333|19390023|P1|NOT COMPLETED|Enrollment||1
7879303|NCT00814333|19390022|P2|COMPLETED|Enrollment||0
7879304|NCT00814333|19390023|P1|COMPLETED|Enrollment||0
7879305|NCT00814333|19390022|P2|STARTED|Enrollment||0
7879306|NCT00814333|19390023|P1|STARTED|Enrollment||1
7879307|NCT00814320|19390031|P2|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10
7879308|NCT00814320|19390032|P1|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3
7879309|NCT00814320|19390031|P2|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60
7879310|NCT00814320|19390032|P1|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8
7879311|NCT00814320|19390031|P2|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70
7879312|NCT00814320|19390032|P1|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11
7879313|NCT00814320|19390031|P2|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0
7879314|NCT00814320|19390032|P1|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2
7879315|NCT00814320|19390031|P2|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70
7879316|NCT00814320|19390032|P1|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11
7879317|NCT00814320|19390031|P2|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70
7879318|NCT00814320|19390032|P1|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13
7879319|NCT00814320|19390031|P2|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1
7879320|NCT00814320|19390032|P1|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0
7879321|NCT00814320|19390031|P2|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70
7879322|NCT00814320|19390032|P1|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
7879323|NCT00814320|19390031|P2|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71
7879324|NCT00814320|19390032|P1|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
7879325|NCT00814320|19390031|P2|NOT COMPLETED|Epoch 1 (IV Treatment)||2
7879326|NCT00814320|19390032|P1|NOT COMPLETED|Epoch 1 (IV Treatment)||1
7879327|NCT00814320|19390031|P2|COMPLETED|Epoch 1 (IV Treatment)||71
7879328|NCT00814320|19390032|P1|COMPLETED|Epoch 1 (IV Treatment)||13
7879329|NCT00814320|19390031|P2|STARTED|Epoch 1 (IV Treatment)||73
7879330|NCT00814320|19390032|P1|STARTED|Epoch 1 (IV Treatment)||14
7879331|NCT00814307|19390164|P4|NOT COMPLETED|Overall Study||10
7879332|NCT00814307|19390165|P3|NOT COMPLETED|Overall Study||7
7879333|NCT00814307|19390166|P2|NOT COMPLETED|Overall Study||27
7879334|NCT00814307|19390167|P1|NOT COMPLETED|Overall Study||12
7879335|NCT00814307|19390164|P4|COMPLETED|Overall Study||51
7879336|NCT00814307|19390165|P3|COMPLETED|Overall Study||54
7879337|NCT00814307|19390166|P2|COMPLETED|Overall Study||218
7879338|NCT00814307|19390167|P1|COMPLETED|Overall Study||232
7879339|NCT00814307|19390164|P4|Treated|Overall Study||61
7879340|NCT00814307|19390165|P3|Treated|Overall Study||61
7879341|NCT00814307|19390166|P2|Treated|Overall Study||245
7879342|NCT00814307|19390167|P1|Treated|Overall Study||243
7879343|NCT00814307|19390164|P4|STARTED|Overall Study||61
7879344|NCT00814307|19390165|P3|STARTED|Overall Study||61
7879345|NCT00814307|19390166|P2|STARTED|Overall Study||245
7879346|NCT00814307|19390167|P1|STARTED|Overall Study||244
7879347|NCT00814255|19390332|P3|NOT COMPLETED|Overall Study||1
7879348|NCT00814255|19390333|P2|NOT COMPLETED|Overall Study||0
7879349|NCT00814255|19390334|P1|NOT COMPLETED|Overall Study||1
7879350|NCT00814255|19390332|P3|COMPLETED|Overall Study||7
7879351|NCT00814255|19390333|P2|COMPLETED|Overall Study||7
7879352|NCT00814255|19390334|P1|COMPLETED|Overall Study||7
7879353|NCT00814255|19390332|P3|STARTED|Overall Study||8
7879354|NCT00814255|19390333|P2|STARTED|Overall Study||7
7879355|NCT00814255|19390334|P1|STARTED|Overall Study||8
7879356|NCT00814177|19390356|P2|NOT COMPLETED|Overall Study||0
7879357|NCT00814177|19390357|P1|NOT COMPLETED|Overall Study||0
7879358|NCT00814177|19390356|P2|COMPLETED|Overall Study||80
7879359|NCT00814177|19390357|P1|COMPLETED|Overall Study||80
7879360|NCT00814177|19390356|P2|STARTED|Overall Study||80
7879361|NCT00814177|19390357|P1|STARTED|Overall Study||80
7879362|NCT00814164|19390363|P1|NOT COMPLETED|Overall Study||19
7879363|NCT00814164|19390363|P1|COMPLETED|Overall Study||2
7879364|NCT00814164|19390363|P1|STARTED|Overall Study||21
7879365|NCT00814138|19390376|P2|NOT COMPLETED|Overall Study||7
7879366|NCT00814138|19390377|P1|NOT COMPLETED|Overall Study||1
7879367|NCT00814138|19390376|P2|COMPLETED|Overall Study||18
7879368|NCT00814138|19390377|P1|COMPLETED|Overall Study||24
7879369|NCT00814138|19390376|P2|STARTED|Overall Study||25
7879370|NCT00814138|19390377|P1|STARTED|Overall Study||25
7879371|NCT00813995|19390397|P2|NOT COMPLETED|Overall Study||16
7879372|NCT00813995|19390398|P1|NOT COMPLETED|Overall Study||23
7879373|NCT00813995|19390397|P2|COMPLETED|Overall Study||182
7879374|NCT00813995|19390398|P1|COMPLETED|Overall Study||174
7879375|NCT00813995|19390397|P2|STARTED|Overall Study||198
7879376|NCT00813995|19390398|P1|STARTED|Overall Study||197
7879377|NCT00813982|19390412|P1|NOT COMPLETED|Overall Study||0
7879378|NCT00813982|19390412|P1|COMPLETED|Overall Study||59
7879379|NCT00813982|19390412|P1|STARTED|Overall Study||59
7879380|NCT00813943|19390421|P3|NOT COMPLETED|Overall Study||3
7879381|NCT00813943|19390422|P2|NOT COMPLETED|Overall Study||5
7879382|NCT00813943|19390423|P1|NOT COMPLETED|Overall Study||5
7879383|NCT00813943|19390421|P3|COMPLETED|Overall Study||86
7879384|NCT00813943|19390422|P2|COMPLETED|Overall Study||83
7879385|NCT00813943|19390423|P1|COMPLETED|Overall Study||83
7879386|NCT00813943|19390421|P3|STARTED|Overall Study||89
7879387|NCT00813943|19390422|P2|STARTED|Overall Study||88
7879388|NCT00813943|19390423|P1|STARTED|Overall Study||88
7879389|NCT00813917|19390453|P2|NOT COMPLETED|Overall Study||6
7879390|NCT00813917|19390454|P1|NOT COMPLETED|Overall Study||6
7879391|NCT00813917|19390453|P2|COMPLETED|Overall Study||32
7879392|NCT00813917|19390454|P1|COMPLETED|Overall Study||32
7879393|NCT00813917|19390453|P2|STARTED|Overall Study||38
7879394|NCT00813917|19390454|P1|STARTED|Overall Study||38
7879395|NCT00813904|19390460|P1|NOT COMPLETED|Overall Study||1
7879396|NCT00813904|19390460|P1|COMPLETED|Overall Study||30
7879397|NCT00813904|19390460|P1|STARTED|Overall Study||31
7879398|NCT00813865|19390466|P1|NOT COMPLETED|Overall Study||7
7879399|NCT00813865|19390466|P1|COMPLETED|Overall Study||1
7879400|NCT00813865|19390466|P1|Pharmacodynamic (PD) Population|Overall Study||8
7879401|NCT00813865|19390466|P1|Safety Population|Overall Study||8
7879402|NCT00813865|19390466|P1|STARTED|Overall Study||8
7879403|NCT00813813|19390474|P2|NOT COMPLETED|Overall Study||9
7879404|NCT00813813|19390475|P1|NOT COMPLETED|Overall Study||3
7879405|NCT00813813|19390474|P2|COMPLETED|Overall Study||16
7879406|NCT00813813|19390475|P1|COMPLETED|Overall Study||4
7879407|NCT00813813|19390474|P2|STARTED|Overall Study||25
7879408|NCT00813813|19390475|P1|STARTED|Overall Study||7
7879409|NCT00813800|19390491|P1|NOT COMPLETED|Overall Study||6
7879410|NCT00813800|19390491|P1|COMPLETED|Overall Study||5
7879411|NCT00813800|19390491|P1|STARTED|Overall Study||11
7879412|NCT00813761|19390499|P4|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5
7879413|NCT00813761|19390500|P3|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
7879414|NCT00813761|19390501|P2|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
7879415|NCT00813761|19390502|P1|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16
7879416|NCT00813761|19390499|P4|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100
7879417|NCT00813761|19390500|P3|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94
7879418|NCT00813761|19390501|P2|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91
7879419|NCT00813761|19390502|P1|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101
7879420|NCT00813761|19390499|P4|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105
7879421|NCT00813761|19390500|P3|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103
7879422|NCT00813761|19390501|P2|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100
7879423|NCT00813761|19390502|P1|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117
7879424|NCT00813761|19390499|P4|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2
7879425|NCT00813761|19390500|P3|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12
7879426|NCT00813761|19390501|P2|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3
7879427|NCT00813761|19390502|P1|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4
7879428|NCT00813761|19390499|P4|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105
7879429|NCT00813761|19390500|P3|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103
7879430|NCT00813761|19390501|P2|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100
7879431|NCT00813761|19390502|P1|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117
7879432|NCT00813761|19390499|P4|STARTED|Phase 1 (Baseline to 4 Weeks)||107
7879433|NCT00813761|19390500|P3|STARTED|Phase 1 (Baseline to 4 Weeks)||115
7879434|NCT00813761|19390501|P2|STARTED|Phase 1 (Baseline to 4 Weeks)||103
7879435|NCT00813761|19390502|P1|STARTED|Phase 1 (Baseline to 4 Weeks)||121
7879436|NCT00813748|19390552|P2|NOT COMPLETED|Skin Test Substudy||1
7879437|NCT00813748|19390553|P1|NOT COMPLETED|Skin Test Substudy||0
7879438|NCT00813748|19390552|P2|COMPLETED|Skin Test Substudy||7
7879439|NCT00813748|19390553|P1|COMPLETED|Skin Test Substudy||3
7879440|NCT00813748|19390552|P2|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8
7879441|NCT00813748|19390553|P1|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3
7879442|NCT00813748|19390552|P2|NOT COMPLETED|Main Observational Study||0
7879443|NCT00813748|19390553|P1|NOT COMPLETED|Main Observational Study||0
7879444|NCT00813748|19390552|P2|COMPLETED|Main Observational Study||88
7879445|NCT00813748|19390553|P1|COMPLETED|Main Observational Study||30
7879446|NCT00813748|19390552|P2|STARTED|Main Observational Study||88
7879447|NCT00813748|19390553|P1|STARTED|Main Observational Study||30
7879448|NCT00813709|19390582|P6|NOT COMPLETED|Open Label Period||11
7879449|NCT00813709|19390583|P5|NOT COMPLETED|Open Label Period||10
7879450|NCT00813709|19390584|P4|NOT COMPLETED|Open Label Period||20
7879451|NCT00813709|19390585|P3|NOT COMPLETED|Open Label Period||0
7879452|NCT00813709|19390586|P2|NOT COMPLETED|Open Label Period||0
7879453|NCT00813709|19390587|P1|NOT COMPLETED|Open Label Period||0
7879454|NCT00813709|19390582|P6|COMPLETED|Open Label Period||35
7879455|NCT00813709|19390583|P5|COMPLETED|Open Label Period||41
7879456|NCT00813709|19390584|P4|COMPLETED|Open Label Period||38
7879457|NCT00813709|19390585|P3|COMPLETED|Open Label Period||0
7879458|NCT00813709|19390586|P2|COMPLETED|Open Label Period||0
7879459|NCT00813709|19390587|P1|COMPLETED|Open Label Period||0
7879460|NCT00813709|19390582|P6|Treated|Open Label Period||45
7879461|NCT00813709|19390583|P5|Treated|Open Label Period||51
7879462|NCT00813709|19390584|P4|Treated|Open Label Period||57
7879463|NCT00813709|19390585|P3|Treated|Open Label Period||0
7879464|NCT00813709|19390586|P2|Treated|Open Label Period||0
7879465|NCT00813709|19390587|P1|Treated|Open Label Period||0
7879466|NCT00813709|19390582|P6|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46
7879467|NCT00813709|19390583|P5|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51
7879468|NCT00813709|19390584|P4|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58
7879469|NCT00813709|19390585|P3|STARTED|Open Label Period||0
7879470|NCT00813709|19390586|P2|STARTED|Open Label Period||0
7879471|NCT00813709|19390587|P1|STARTED|Open Label Period||0
7879472|NCT00813709|19390582|P6|NOT COMPLETED|Double Blind Period||0
7879473|NCT00813709|19390583|P5|NOT COMPLETED|Double Blind Period||0
7879474|NCT00813709|19390584|P4|NOT COMPLETED|Double Blind Period||0
7879475|NCT00813709|19390585|P3|NOT COMPLETED|Double Blind Period||31
7879476|NCT00813709|19390586|P2|NOT COMPLETED|Double Blind Period||41
7879477|NCT00813709|19390587|P1|NOT COMPLETED|Double Blind Period||31
7879478|NCT00813709|19390582|P6|COMPLETED|Double Blind Period||0
7879479|NCT00813709|19390583|P5|COMPLETED|Double Blind Period||0
7879480|NCT00813709|19390584|P4|COMPLETED|Double Blind Period||0
7879481|NCT00813709|19390585|P3|COMPLETED|Double Blind Period||68
7879482|NCT00813709|19390586|P2|COMPLETED|Double Blind Period||76
7879483|NCT00813709|19390587|P1|COMPLETED|Double Blind Period||53
7879484|NCT00813709|19390582|P6|Treated|Double Blind Period||0
7879485|NCT00813709|19390583|P5|Treated|Double Blind Period||0
7879486|NCT00813709|19390584|P4|Treated|Double Blind Period||0
7879487|NCT00813709|19390585|P3|Treated|Double Blind Period||98
7879488|NCT00813709|19390586|P2|Treated|Double Blind Period||114
7879489|NCT00813709|19390587|P1|Treated|Double Blind Period||83
7879490|NCT00813709|19390582|P6|STARTED|Double Blind Period||0
7879491|NCT00813709|19390583|P5|STARTED|Double Blind Period||0
7879492|NCT00813709|19390584|P4|STARTED|Double Blind Period||0
7879493|NCT00813709|19390585|P3|STARTED|Double Blind Period||99
7879494|NCT00813709|19390586|P2|STARTED|Double Blind Period||117
7879495|NCT00813709|19390587|P1|STARTED|Double Blind Period||84
7879496|NCT00813592|19390667|P1|NOT COMPLETED|Overall Study||2
7879497|NCT00813592|19390667|P1|COMPLETED|Overall Study||0
7879498|NCT00813592|19390667|P1|Response Assessment|Overall Study|One patient met the response assessment.|1
7879499|NCT00813592|19390667|P1|Treated|Overall Study|Two patients were treated.|2
7879500|NCT00813592|19390667|P1|STARTED|Overall Study||2
7879501|NCT00813488|19390676|P2|NOT COMPLETED|Open-label Extension||7
7879502|NCT00813488|19390677|P1|NOT COMPLETED|Open-label Extension||12
7879503|NCT00813488|19390676|P2|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59
7879504|NCT00813488|19390677|P1|COMPLETED|Open-label Extension|This group received FBT open--label|53
7879505|NCT00813488|19390676|P2|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66
7879506|NCT00813488|19390677|P1|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65
7879507|NCT00813488|19390676|P2|NOT COMPLETED|Double-blind Treatment Period 2||1
7879508|NCT00813488|19390677|P1|NOT COMPLETED|Double-blind Treatment Period 2||5
7879509|NCT00813488|19390676|P2|COMPLETED|Double-blind Treatment Period 2||65
7879510|NCT00813488|19390677|P1|COMPLETED|Double-blind Treatment Period 2||66
7879511|NCT00813488|19390676|P2|STARTED|Double-blind Treatment Period 2||66
7879512|NCT00813488|19390677|P1|STARTED|Double-blind Treatment Period 2||71
7879513|NCT00813488|19390676|P2|NOT COMPLETED|Double-blind Treatment Period 1||5
7879514|NCT00813488|19390677|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
7879515|NCT00813488|19390676|P2|COMPLETED|Double-blind Treatment Period 1||66
7879516|NCT00813488|19390677|P1|COMPLETED|Double-blind Treatment Period 1||71
7879517|NCT00813488|19390676|P2|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71
7879518|NCT00813488|19390677|P1|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72
7879519|NCT00813488|19390676|P2|NOT COMPLETED|Titration Period 2||10
7879520|NCT00813488|19390677|P1|NOT COMPLETED|Titration Period 2||16
7879521|NCT00813488|19390676|P2|COMPLETED|Titration Period 2||79
7879522|NCT00813488|19390677|P1|COMPLETED|Titration Period 2||64
7879523|NCT00813488|19390676|P2|STARTED|Titration Period 2||89
7879524|NCT00813488|19390677|P1|STARTED|Titration Period 2||80
7879525|NCT00813488|19390676|P2|NOT COMPLETED|Titration Period 1||17
7879526|NCT00813488|19390677|P1|NOT COMPLETED|Titration Period 1||27
7879527|NCT00813488|19390676|P2|COMPLETED|Titration Period 1||89
7879528|NCT00813488|19390677|P1|COMPLETED|Titration Period 1||80
7879529|NCT00813488|19390676|P2|STARTED|Titration Period 1||106
7879530|NCT00813488|19390677|P1|STARTED|Titration Period 1||107
7879531|NCT00813319|19390775|P2|NOT COMPLETED|Overall Study||0
7879532|NCT00813319|19390776|P1|NOT COMPLETED|Overall Study||0
7879533|NCT00813319|19390775|P2|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108
7879534|NCT00813319|19390776|P1|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108
7879535|NCT00813319|19390775|P2|STARTED|Overall Study||108
7879536|NCT00813319|19390776|P1|STARTED|Overall Study||108
7879537|NCT00813293|19390788|P2|NOT COMPLETED|Overall Study||1
7879538|NCT00813293|19390789|P1|NOT COMPLETED|Overall Study||1
7879539|NCT00813293|19390788|P2|COMPLETED|Overall Study||9
7879540|NCT00813293|19390789|P1|COMPLETED|Overall Study||9
7879541|NCT00813293|19390788|P2|Evaluable RFA|Overall Study||8
7879542|NCT00813293|19390789|P1|Evaluable RFA|Overall Study||7
7879543|NCT00813293|19390788|P2|Started Treatment|Overall Study||10
7879544|NCT00813293|19390789|P1|Started Treatment|Overall Study||9
7879545|NCT00813293|19390788|P2|STARTED|Overall Study||10
7879546|NCT00813293|19390789|P1|STARTED|Overall Study||10
7879547|NCT00813176|19390809|P2|NOT COMPLETED|Overall Study||0
7879548|NCT00813176|19390810|P1|NOT COMPLETED|Overall Study||0
7879549|NCT00813176|19390809|P2|COMPLETED|Overall Study||25
7879550|NCT00813176|19390810|P1|COMPLETED|Overall Study||25
7879551|NCT00813176|19390809|P2|STARTED|Overall Study||25
7879552|NCT00813176|19390810|P1|STARTED|Overall Study||25
7879553|NCT00813150|19390828|P2|NOT COMPLETED|Long Term Follow-up||31
7879554|NCT00813150|19390829|P1|NOT COMPLETED|Long Term Follow-up||24
7879555|NCT00813150|19390828|P2|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0
7879556|NCT00813150|19390829|P1|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2
7879557|NCT00813150|19390828|P2|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31
7879558|NCT00813150|19390829|P1|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26
7879559|NCT00813150|19390828|P2|NOT COMPLETED|Treatment Period||32
7879560|NCT00813150|19390829|P1|NOT COMPLETED|Treatment Period||32
7879561|NCT00813150|19390828|P2|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15
7879562|NCT00813150|19390829|P1|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14
7879563|NCT00813150|19390828|P2|Intent-to-treat Participants|Treatment Period||47
7879564|NCT00813150|19390829|P1|Intent-to-treat Participants|Treatment Period||43
7879565|NCT00813150|19390828|P2|STARTED|Treatment Period|Number of randomized and treated participants|47
7879566|NCT00813150|19390829|P1|STARTED|Treatment Period|Number of randomized and treated participants|46
7879567|NCT00813111|19390843|P2|NOT COMPLETED|Overall Study||0
7879568|NCT00813111|19390844|P1|NOT COMPLETED|Overall Study||2
7879569|NCT00813111|19390843|P2|COMPLETED|Overall Study||70
7879570|NCT00813111|19390844|P1|COMPLETED|Overall Study||64
7879571|NCT00813111|19390843|P2|STARTED|Overall Study||70
7879572|NCT00813111|19390844|P1|STARTED|Overall Study||66
7879573|NCT00813098|19390853|P3|NOT COMPLETED|Overall Study||2
7879574|NCT00813098|19390854|P2|NOT COMPLETED|Overall Study||8
7879575|NCT00813098|19390855|P1|NOT COMPLETED|Overall Study||3
7879576|NCT00813098|19390853|P3|COMPLETED|Overall Study||50
7879577|NCT00813098|19390854|P2|COMPLETED|Overall Study||46
7879578|NCT00813098|19390855|P1|COMPLETED|Overall Study||46
7879579|NCT00813098|19390853|P3|STARTED|Overall Study||52
7879580|NCT00813098|19390854|P2|STARTED|Overall Study||54
7879581|NCT00813098|19390855|P1|STARTED|Overall Study||49
7879582|NCT00812981|19390880|P2|NOT COMPLETED|Overall Study||1
7879583|NCT00812981|19390881|P1|NOT COMPLETED|Overall Study||0
7879584|NCT00812981|19390880|P2|COMPLETED|Overall Study||159
7879585|NCT00812981|19390881|P1|COMPLETED|Overall Study||160
7879586|NCT00812981|19390880|P2|STARTED|Overall Study||160
7879587|NCT00812981|19390881|P1|STARTED|Overall Study||160
7879588|NCT00812968|19390919|P1|NOT COMPLETED|Overall Study||11
7879589|NCT00812968|19390919|P1|COMPLETED|Overall Study||0
7879590|NCT00812968|19390919|P1|STARTED|Overall Study||11
7879591|NCT00812955|19390954|P4|NOT COMPLETED|Overall Study||8
7879592|NCT00812955|19390955|P3|NOT COMPLETED|Overall Study||6
7879593|NCT00812955|19390956|P2|NOT COMPLETED|Overall Study||7
7879594|NCT00812955|19390957|P1|NOT COMPLETED|Overall Study||10
7879595|NCT00812955|19390954|P4|COMPLETED|Overall Study||110
7879596|NCT00812955|19390955|P3|COMPLETED|Overall Study||113
7879597|NCT00812955|19390956|P2|COMPLETED|Overall Study||111
7879598|NCT00812955|19390957|P1|COMPLETED|Overall Study||109
7879599|NCT00812955|19390954|P4|STARTED|Overall Study||118
7879600|NCT00812955|19390955|P3|STARTED|Overall Study||119
7879601|NCT00812955|19390956|P2|STARTED|Overall Study||118
7879602|NCT00812955|19390957|P1|STARTED|Overall Study||119
7879603|NCT00812929|19390977|P10|NOT COMPLETED|Treatment Period 5||0
7879604|NCT00812929|19390978|P9|NOT COMPLETED|Treatment Period 5||0
7879605|NCT00812929|19390979|P8|NOT COMPLETED|Treatment Period 5||0
7879606|NCT00812929|19390980|P7|NOT COMPLETED|Treatment Period 5||0
7879607|NCT00812929|19390981|P6|NOT COMPLETED|Treatment Period 5||0
7879608|NCT00812929|19390982|P5|NOT COMPLETED|Treatment Period 5||0
7879609|NCT00812929|19390983|P4|NOT COMPLETED|Treatment Period 5||0
7879610|NCT00812929|19390984|P3|NOT COMPLETED|Treatment Period 5||0
7879611|NCT00812929|19390985|P2|NOT COMPLETED|Treatment Period 5||0
7879612|NCT00812929|19390986|P1|NOT COMPLETED|Treatment Period 5||0
7879613|NCT00812929|19390977|P10|COMPLETED|Treatment Period 5||4
7879614|NCT00812929|19390978|P9|COMPLETED|Treatment Period 5||4
7879615|NCT00812929|19390979|P8|COMPLETED|Treatment Period 5||5
7879616|NCT00812929|19390980|P7|COMPLETED|Treatment Period 5||5
7879617|NCT00812929|19390981|P6|COMPLETED|Treatment Period 5||4
7879618|NCT00812929|19390982|P5|COMPLETED|Treatment Period 5||5
7879619|NCT00812929|19390983|P4|COMPLETED|Treatment Period 5||4
7879620|NCT00812929|19390984|P3|COMPLETED|Treatment Period 5||4
7879621|NCT00812929|19390985|P2|COMPLETED|Treatment Period 5||4
7879622|NCT00812929|19390986|P1|COMPLETED|Treatment Period 5||5
7879623|NCT00812929|19390977|P10|STARTED|Treatment Period 5||4
7879624|NCT00812929|19390978|P9|STARTED|Treatment Period 5||4
7879625|NCT00812929|19390979|P8|STARTED|Treatment Period 5||5
7879626|NCT00812929|19390980|P7|STARTED|Treatment Period 5||5
7879627|NCT00812929|19390981|P6|STARTED|Treatment Period 5||4
7879628|NCT00812929|19390982|P5|STARTED|Treatment Period 5||5
7879629|NCT00812929|19390983|P4|STARTED|Treatment Period 5||4
7879630|NCT00812929|19390984|P3|STARTED|Treatment Period 5||4
7879631|NCT00812929|19390985|P2|STARTED|Treatment Period 5||4
7879632|NCT00812929|19390986|P1|STARTED|Treatment Period 5||5
7879633|NCT00812929|19390977|P10|NOT COMPLETED|Washout Period 4 (7 Days)||0
7879634|NCT00812929|19390978|P9|NOT COMPLETED|Washout Period 4 (7 Days)||0
7879635|NCT00812929|19390979|P8|NOT COMPLETED|Washout Period 4 (7 Days)||0
7879636|NCT00812929|19390980|P7|NOT COMPLETED|Washout Period 4 (7 Days)||0
7879637|NCT00812929|19390981|P6|NOT COMPLETED|Washout Period 4 (7 Days)||0
7879638|NCT00812929|19390982|P5|NOT COMPLETED|Washout Period 4 (7 Days)||0
7879639|NCT00812929|19390983|P4|NOT COMPLETED|Washout Period 4 (7 Days)||0
7879640|NCT00812929|19390984|P3|NOT COMPLETED|Washout Period 4 (7 Days)||0
7879641|NCT00812929|19390985|P2|NOT COMPLETED|Washout Period 4 (7 Days)||0
7879642|NCT00812929|19390986|P1|NOT COMPLETED|Washout Period 4 (7 Days)||0
7879643|NCT00812929|19390977|P10|COMPLETED|Washout Period 4 (7 Days)||4
7879644|NCT00812929|19390978|P9|COMPLETED|Washout Period 4 (7 Days)||4
7879645|NCT00812929|19390979|P8|COMPLETED|Washout Period 4 (7 Days)||5
7879646|NCT00812929|19390980|P7|COMPLETED|Washout Period 4 (7 Days)||5
7879647|NCT00812929|19390981|P6|COMPLETED|Washout Period 4 (7 Days)||4
7879648|NCT00812929|19390982|P5|COMPLETED|Washout Period 4 (7 Days)||5
7879649|NCT00812929|19390983|P4|COMPLETED|Washout Period 4 (7 Days)||4
7879650|NCT00812929|19390984|P3|COMPLETED|Washout Period 4 (7 Days)||4
7879651|NCT00812929|19390985|P2|COMPLETED|Washout Period 4 (7 Days)||4
7879652|NCT00812929|19390986|P1|COMPLETED|Washout Period 4 (7 Days)||5
7879653|NCT00812929|19390977|P10|STARTED|Washout Period 4 (7 Days)||4
7879654|NCT00812929|19390978|P9|STARTED|Washout Period 4 (7 Days)||4
7879655|NCT00812929|19390979|P8|STARTED|Washout Period 4 (7 Days)||5
7879656|NCT00812929|19390980|P7|STARTED|Washout Period 4 (7 Days)||5
7879657|NCT00812929|19390981|P6|STARTED|Washout Period 4 (7 Days)||4
7879658|NCT00812929|19390982|P5|STARTED|Washout Period 4 (7 Days)||5
7879659|NCT00812929|19390983|P4|STARTED|Washout Period 4 (7 Days)||4
7879660|NCT00812929|19390984|P3|STARTED|Washout Period 4 (7 Days)||4
7879661|NCT00812929|19390985|P2|STARTED|Washout Period 4 (7 Days)||4
7879662|NCT00812929|19390986|P1|STARTED|Washout Period 4 (7 Days)||5
7879663|NCT00812929|19390977|P10|NOT COMPLETED|Treatment Period 4||0
7879664|NCT00812929|19390978|P9|NOT COMPLETED|Treatment Period 4||0
7879665|NCT00812929|19390979|P8|NOT COMPLETED|Treatment Period 4||0
7879666|NCT00812929|19390980|P7|NOT COMPLETED|Treatment Period 4||0
7879667|NCT00812929|19390981|P6|NOT COMPLETED|Treatment Period 4||0
7879668|NCT00812929|19390982|P5|NOT COMPLETED|Treatment Period 4||0
7879669|NCT00812929|19390983|P4|NOT COMPLETED|Treatment Period 4||0
7879670|NCT00812929|19390984|P3|NOT COMPLETED|Treatment Period 4||0
7879671|NCT00812929|19390985|P2|NOT COMPLETED|Treatment Period 4||0
7879672|NCT00812929|19390986|P1|NOT COMPLETED|Treatment Period 4||0
7879673|NCT00812929|19390977|P10|COMPLETED|Treatment Period 4||4
7879674|NCT00812929|19390978|P9|COMPLETED|Treatment Period 4||4
7879675|NCT00812929|19390979|P8|COMPLETED|Treatment Period 4||5
7879676|NCT00812929|19390980|P7|COMPLETED|Treatment Period 4||5
7879677|NCT00812929|19390981|P6|COMPLETED|Treatment Period 4||4
7879678|NCT00812929|19390982|P5|COMPLETED|Treatment Period 4||5
7879679|NCT00812929|19390983|P4|COMPLETED|Treatment Period 4||4
7879680|NCT00812929|19390984|P3|COMPLETED|Treatment Period 4||4
7879681|NCT00812929|19390985|P2|COMPLETED|Treatment Period 4||4
7879682|NCT00812929|19390986|P1|COMPLETED|Treatment Period 4||5
7879683|NCT00812929|19390977|P10|STARTED|Treatment Period 4||4
7879684|NCT00812929|19390978|P9|STARTED|Treatment Period 4||4
7879685|NCT00812929|19390979|P8|STARTED|Treatment Period 4||5
7879686|NCT00812929|19390980|P7|STARTED|Treatment Period 4||5
7879687|NCT00812929|19390981|P6|STARTED|Treatment Period 4||4
7879688|NCT00812929|19390982|P5|STARTED|Treatment Period 4||5
7879689|NCT00812929|19390983|P4|STARTED|Treatment Period 4||4
7879690|NCT00812929|19390984|P3|STARTED|Treatment Period 4||4
7879691|NCT00812929|19390985|P2|STARTED|Treatment Period 4||4
7879692|NCT00812929|19390986|P1|STARTED|Treatment Period 4||5
7879693|NCT00812929|19390977|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
7879694|NCT00812929|19390978|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
7879695|NCT00812929|19390979|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
7879696|NCT00812929|19390980|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
7879697|NCT00812929|19390981|P6|NOT COMPLETED|Washout Period 3 (7 Days)||1
7879698|NCT00812929|19390982|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
7879699|NCT00812929|19390983|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
7879700|NCT00812929|19390984|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
7879701|NCT00812929|19390985|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
7879702|NCT00812929|19390986|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
7879703|NCT00812929|19390977|P10|COMPLETED|Washout Period 3 (7 Days)||4
7879704|NCT00812929|19390978|P9|COMPLETED|Washout Period 3 (7 Days)||4
7879705|NCT00812929|19390979|P8|COMPLETED|Washout Period 3 (7 Days)||5
7879706|NCT00812929|19390980|P7|COMPLETED|Washout Period 3 (7 Days)||5
7879707|NCT00812929|19390981|P6|COMPLETED|Washout Period 3 (7 Days)||4
7879708|NCT00812929|19390982|P5|COMPLETED|Washout Period 3 (7 Days)||5
7879709|NCT00812929|19390983|P4|COMPLETED|Washout Period 3 (7 Days)||4
7879710|NCT00812929|19390984|P3|COMPLETED|Washout Period 3 (7 Days)||4
7879711|NCT00812929|19390985|P2|COMPLETED|Washout Period 3 (7 Days)||4
7879712|NCT00812929|19390986|P1|COMPLETED|Washout Period 3 (7 Days)||5
7879713|NCT00812929|19390977|P10|STARTED|Washout Period 3 (7 Days)||4
7879714|NCT00812929|19390978|P9|STARTED|Washout Period 3 (7 Days)||4
7879715|NCT00812929|19390979|P8|STARTED|Washout Period 3 (7 Days)||5
7879716|NCT00812929|19390980|P7|STARTED|Washout Period 3 (7 Days)||5
7879717|NCT00812929|19390981|P6|STARTED|Washout Period 3 (7 Days)||5
7879718|NCT00812929|19390982|P5|STARTED|Washout Period 3 (7 Days)||5
7879719|NCT00812929|19390983|P4|STARTED|Washout Period 3 (7 Days)||4
7879720|NCT00812929|19390984|P3|STARTED|Washout Period 3 (7 Days)||4
7879721|NCT00812929|19390985|P2|STARTED|Washout Period 3 (7 Days)||4
7879722|NCT00812929|19390986|P1|STARTED|Washout Period 3 (7 Days)||5
7879723|NCT00812929|19390977|P10|NOT COMPLETED|Treatment Period 3||0
7879724|NCT00812929|19390978|P9|NOT COMPLETED|Treatment Period 3||0
7879725|NCT00812929|19390979|P8|NOT COMPLETED|Treatment Period 3||0
7879726|NCT00812929|19390980|P7|NOT COMPLETED|Treatment Period 3||0
7879727|NCT00812929|19390981|P6|NOT COMPLETED|Treatment Period 3||0
7879728|NCT00812929|19390982|P5|NOT COMPLETED|Treatment Period 3||0
7879729|NCT00812929|19390983|P4|NOT COMPLETED|Treatment Period 3||0
7879730|NCT00812929|19390984|P3|NOT COMPLETED|Treatment Period 3||0
7879731|NCT00812929|19390985|P2|NOT COMPLETED|Treatment Period 3||0
7879732|NCT00812929|19390986|P1|NOT COMPLETED|Treatment Period 3||0
7879733|NCT00812929|19390977|P10|COMPLETED|Treatment Period 3||4
7879734|NCT00812929|19390978|P9|COMPLETED|Treatment Period 3||4
7879735|NCT00812929|19390979|P8|COMPLETED|Treatment Period 3||5
7879736|NCT00812929|19390980|P7|COMPLETED|Treatment Period 3||5
7879737|NCT00812929|19390981|P6|COMPLETED|Treatment Period 3||5
7879738|NCT00812929|19390982|P5|COMPLETED|Treatment Period 3||5
7879739|NCT00812929|19390983|P4|COMPLETED|Treatment Period 3||4
7879740|NCT00812929|19390984|P3|COMPLETED|Treatment Period 3||4
7879741|NCT00812929|19390985|P2|COMPLETED|Treatment Period 3||4
7879742|NCT00812929|19390986|P1|COMPLETED|Treatment Period 3||5
7879743|NCT00812929|19390977|P10|STARTED|Treatment Period 3||4
7879744|NCT00812929|19390978|P9|STARTED|Treatment Period 3||4
7879745|NCT00812929|19390979|P8|STARTED|Treatment Period 3||5
7879746|NCT00812929|19390980|P7|STARTED|Treatment Period 3||5
7879747|NCT00812929|19390981|P6|STARTED|Treatment Period 3||5
7879748|NCT00812929|19390982|P5|STARTED|Treatment Period 3||5
7879749|NCT00812929|19390983|P4|STARTED|Treatment Period 3||4
7879750|NCT00812929|19390984|P3|STARTED|Treatment Period 3||4
7879751|NCT00812929|19390985|P2|STARTED|Treatment Period 3||4
7879752|NCT00812929|19390986|P1|STARTED|Treatment Period 3||5
7879753|NCT00812929|19390977|P10|NOT COMPLETED|Washout Period 2 (7 Days)||1
7879754|NCT00812929|19390978|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
7879755|NCT00812929|19390979|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
7879756|NCT00812929|19390980|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
7879757|NCT00812929|19390981|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
7879758|NCT00812929|19390982|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
7879759|NCT00812929|19390983|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
7879760|NCT00812929|19390984|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
7879761|NCT00812929|19390985|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
7879762|NCT00812929|19390986|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
7879763|NCT00812929|19390977|P10|COMPLETED|Washout Period 2 (7 Days)||4
7879764|NCT00812929|19390978|P9|COMPLETED|Washout Period 2 (7 Days)||4
7879765|NCT00812929|19390979|P8|COMPLETED|Washout Period 2 (7 Days)||5
7879766|NCT00812929|19390980|P7|COMPLETED|Washout Period 2 (7 Days)||5
7879767|NCT00812929|19390981|P6|COMPLETED|Washout Period 2 (7 Days)||5
7879768|NCT00812929|19390982|P5|COMPLETED|Washout Period 2 (7 Days)||5
7879769|NCT00812929|19390983|P4|COMPLETED|Washout Period 2 (7 Days)||4
7879770|NCT00812929|19390984|P3|COMPLETED|Washout Period 2 (7 Days)||4
7879771|NCT00812929|19390985|P2|COMPLETED|Washout Period 2 (7 Days)||4
7879772|NCT00812929|19390986|P1|COMPLETED|Washout Period 2 (7 Days)||5
7879773|NCT00812929|19390977|P10|STARTED|Washout Period 2 (7 Days)||5
7879774|NCT00812929|19390978|P9|STARTED|Washout Period 2 (7 Days)||4
7879775|NCT00812929|19390979|P8|STARTED|Washout Period 2 (7 Days)||5
7879776|NCT00812929|19390980|P7|STARTED|Washout Period 2 (7 Days)||5
7879777|NCT00812929|19390981|P6|STARTED|Washout Period 2 (7 Days)||5
7879778|NCT00812929|19390982|P5|STARTED|Washout Period 2 (7 Days)||5
7879779|NCT00812929|19390983|P4|STARTED|Washout Period 2 (7 Days)||4
7879780|NCT00812929|19390984|P3|STARTED|Washout Period 2 (7 Days)||4
7879781|NCT00812929|19390985|P2|STARTED|Washout Period 2 (7 Days)||4
7879782|NCT00812929|19390986|P1|STARTED|Washout Period 2 (7 Days)||5
7879783|NCT00812929|19390977|P10|NOT COMPLETED|Treatment Period 2||0
7879784|NCT00812929|19390978|P9|NOT COMPLETED|Treatment Period 2||0
7879785|NCT00812929|19390979|P8|NOT COMPLETED|Treatment Period 2||0
7879786|NCT00812929|19390980|P7|NOT COMPLETED|Treatment Period 2||0
7879787|NCT00812929|19390981|P6|NOT COMPLETED|Treatment Period 2||0
7879788|NCT00812929|19390982|P5|NOT COMPLETED|Treatment Period 2||0
7879789|NCT00812929|19390983|P4|NOT COMPLETED|Treatment Period 2||0
7879790|NCT00812929|19390984|P3|NOT COMPLETED|Treatment Period 2||0
7879791|NCT00812929|19390985|P2|NOT COMPLETED|Treatment Period 2||0
7879792|NCT00812929|19390986|P1|NOT COMPLETED|Treatment Period 2||0
7879793|NCT00812929|19390977|P10|COMPLETED|Treatment Period 2||5
7879794|NCT00812929|19390978|P9|COMPLETED|Treatment Period 2||4
7879795|NCT00812929|19390979|P8|COMPLETED|Treatment Period 2||5
7879796|NCT00812929|19390980|P7|COMPLETED|Treatment Period 2||5
7879797|NCT00812929|19390981|P6|COMPLETED|Treatment Period 2||5
7879798|NCT00812929|19390982|P5|COMPLETED|Treatment Period 2||5
7879799|NCT00812929|19390983|P4|COMPLETED|Treatment Period 2||4
7879800|NCT00812929|19390984|P3|COMPLETED|Treatment Period 2||4
7879801|NCT00812929|19390985|P2|COMPLETED|Treatment Period 2||4
7879802|NCT00812929|19390986|P1|COMPLETED|Treatment Period 2||5
7879803|NCT00812929|19390977|P10|STARTED|Treatment Period 2||5
7879804|NCT00812929|19390978|P9|STARTED|Treatment Period 2||4
7879805|NCT00812929|19390979|P8|STARTED|Treatment Period 2||5
7879806|NCT00812929|19390980|P7|STARTED|Treatment Period 2||5
7879807|NCT00812929|19390981|P6|STARTED|Treatment Period 2||5
7879808|NCT00812929|19390982|P5|STARTED|Treatment Period 2||5
7879809|NCT00812929|19390983|P4|STARTED|Treatment Period 2||4
7879810|NCT00812929|19390984|P3|STARTED|Treatment Period 2||4
7879811|NCT00812929|19390985|P2|STARTED|Treatment Period 2||4
7879812|NCT00812929|19390986|P1|STARTED|Treatment Period 2||5
7879813|NCT00812929|19390977|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
7879814|NCT00812929|19390978|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
7879815|NCT00812929|19390979|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
7879816|NCT00812929|19390980|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
7879817|NCT00812929|19390981|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
7879818|NCT00812929|19390982|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
7879819|NCT00812929|19390983|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
7879820|NCT00812929|19390984|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
7879821|NCT00812929|19390985|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
7879822|NCT00812929|19390986|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
7879823|NCT00812929|19390977|P10|COMPLETED|Washout Period 1 (7 Days)||5
7879824|NCT00812929|19390978|P9|COMPLETED|Washout Period 1 (7 Days)||4
7879825|NCT00812929|19390979|P8|COMPLETED|Washout Period 1 (7 Days)||5
7879826|NCT00812929|19390980|P7|COMPLETED|Washout Period 1 (7 Days)||5
7879827|NCT00812929|19390981|P6|COMPLETED|Washout Period 1 (7 Days)||5
7879828|NCT00812929|19390982|P5|COMPLETED|Washout Period 1 (7 Days)||5
7879829|NCT00812929|19390983|P4|COMPLETED|Washout Period 1 (7 Days)||4
7879830|NCT00812929|19390984|P3|COMPLETED|Washout Period 1 (7 Days)||4
7879831|NCT00812929|19390985|P2|COMPLETED|Washout Period 1 (7 Days)||4
7879832|NCT00812929|19390986|P1|COMPLETED|Washout Period 1 (7 Days)||5
7879833|NCT00812929|19390977|P10|STARTED|Washout Period 1 (7 Days)||5
7879834|NCT00812929|19390978|P9|STARTED|Washout Period 1 (7 Days)||4
7879835|NCT00812929|19390979|P8|STARTED|Washout Period 1 (7 Days)||5
7879836|NCT00812929|19390980|P7|STARTED|Washout Period 1 (7 Days)||5
7879837|NCT00812929|19390981|P6|STARTED|Washout Period 1 (7 Days)||5
7879838|NCT00812929|19390982|P5|STARTED|Washout Period 1 (7 Days)||5
7879839|NCT00812929|19390983|P4|STARTED|Washout Period 1 (7 Days)||4
7879840|NCT00812929|19390984|P3|STARTED|Washout Period 1 (7 Days)||5
7879841|NCT00812929|19390985|P2|STARTED|Washout Period 1 (7 Days)||4
7879842|NCT00812929|19390986|P1|STARTED|Washout Period 1 (7 Days)||5
7879843|NCT00812929|19390977|P10|NOT COMPLETED|Treatment Period 1||0
7879844|NCT00812929|19390978|P9|NOT COMPLETED|Treatment Period 1||0
7879845|NCT00812929|19390979|P8|NOT COMPLETED|Treatment Period 1||0
7879846|NCT00812929|19390980|P7|NOT COMPLETED|Treatment Period 1||0
7879847|NCT00812929|19390981|P6|NOT COMPLETED|Treatment Period 1||0
7879848|NCT00812929|19390982|P5|NOT COMPLETED|Treatment Period 1||0
7879849|NCT00812929|19390983|P4|NOT COMPLETED|Treatment Period 1||0
7879850|NCT00812929|19390984|P3|NOT COMPLETED|Treatment Period 1||0
7879851|NCT00812929|19390985|P2|NOT COMPLETED|Treatment Period 1||0
7879852|NCT00812929|19390986|P1|NOT COMPLETED|Treatment Period 1||0
7879853|NCT00812929|19390977|P10|COMPLETED|Treatment Period 1||5
7879854|NCT00812929|19390978|P9|COMPLETED|Treatment Period 1||4
7879855|NCT00812929|19390979|P8|COMPLETED|Treatment Period 1||5
7879856|NCT00812929|19390980|P7|COMPLETED|Treatment Period 1||5
7879857|NCT00812929|19390981|P6|COMPLETED|Treatment Period 1||5
7879858|NCT00812929|19390982|P5|COMPLETED|Treatment Period 1||5
7879859|NCT00812929|19390983|P4|COMPLETED|Treatment Period 1||4
7879860|NCT00812929|19390984|P3|COMPLETED|Treatment Period 1||5
7879861|NCT00812929|19390985|P2|COMPLETED|Treatment Period 1||4
7879862|NCT00812929|19390986|P1|COMPLETED|Treatment Period 1||5
7879863|NCT00812929|19390977|P10|STARTED|Treatment Period 1||5
7879864|NCT00812929|19390978|P9|STARTED|Treatment Period 1||4
7879865|NCT00812929|19390979|P8|STARTED|Treatment Period 1||5
7879866|NCT00812929|19390980|P7|STARTED|Treatment Period 1||5
7879867|NCT00812929|19390981|P6|STARTED|Treatment Period 1||5
7879868|NCT00812929|19390982|P5|STARTED|Treatment Period 1||5
7879869|NCT00812929|19390983|P4|STARTED|Treatment Period 1||4
7879870|NCT00812929|19390984|P3|STARTED|Treatment Period 1||5
7879871|NCT00812929|19390985|P2|STARTED|Treatment Period 1||4
7879872|NCT00812929|19390986|P1|STARTED|Treatment Period 1||5
7879873|NCT00812916|19391102|P1|NOT COMPLETED|Overall Study||3
7879874|NCT00812916|19391102|P1|COMPLETED|Overall Study||203
7879875|NCT00812916|19391102|P1|CFAE - Guided Ablation|Overall Study||203
7879876|NCT00812916|19391102|P1|Data Available|Overall Study||205
7879877|NCT00812916|19391102|P1|STARTED|Overall Study|206 enrolled (consented)|206
7879878|NCT00812877|19391113|P2|NOT COMPLETED|Overall Study||51
7879879|NCT00812877|19391114|P1|NOT COMPLETED|Overall Study||37
7879880|NCT00812877|19391113|P2|COMPLETED|Overall Study||130
7879881|NCT00812877|19391114|P1|COMPLETED|Overall Study||158
7879882|NCT00812877|19391113|P2|STARTED|Overall Study||181
7879883|NCT00812877|19391114|P1|STARTED|Overall Study||195
7879884|NCT00812838|19391124|P2|NOT COMPLETED|Optional Crossover of 16 Weeks||0
7879885|NCT00812838|19391125|P1|NOT COMPLETED|Optional Crossover of 16 Weeks||0
7879886|NCT00812838|19391124|P2|COMPLETED|Optional Crossover of 16 Weeks||4
7879887|NCT00812838|19391125|P1|COMPLETED|Optional Crossover of 16 Weeks||0
7879888|NCT00812838|19391124|P2|STARTED|Optional Crossover of 16 Weeks||4
7879889|NCT00812838|19391125|P1|STARTED|Optional Crossover of 16 Weeks||0
7879890|NCT00812838|19391124|P2|NOT COMPLETED|Treatment Period of 16 Weeks||0
7879891|NCT00812838|19391125|P1|NOT COMPLETED|Treatment Period of 16 Weeks||0
7879892|NCT00812838|19391124|P2|COMPLETED|Treatment Period of 16 Weeks||6
7879893|NCT00812838|19391125|P1|COMPLETED|Treatment Period of 16 Weeks||6
7879894|NCT00812838|19391124|P2|STARTED|Treatment Period of 16 Weeks||6
7879895|NCT00812838|19391125|P1|STARTED|Treatment Period of 16 Weeks||6
7879896|NCT00812812|19391141|P2|NOT COMPLETED|Overall Study||4
7879897|NCT00812812|19391142|P1|NOT COMPLETED|Overall Study||3
7879898|NCT00812812|19391141|P2|COMPLETED|Overall Study||25
7879899|NCT00812812|19391142|P1|COMPLETED|Overall Study||24
7879900|NCT00812812|19391141|P2|STARTED|Overall Study||29
7879901|NCT00812812|19391142|P1|STARTED|Overall Study||27
7879902|NCT00812708|19391155|P1|NOT COMPLETED|Overall Study||8
7879903|NCT00812708|19391155|P1|COMPLETED|Overall Study||64
7879904|NCT00812708|19391155|P1|Taken to Surgery for Device Implantation|Overall Study|2 patients could not be implanted because of intraoperative complications.|66
7879905|NCT00812708|19391155|P1|STARTED|Overall Study|6 patients withdrew from the study before being taken to the operating room.|72
7879906|NCT00812604|19391166|P2|NOT COMPLETED|Overall Study||5
7879907|NCT00812604|19391167|P1|NOT COMPLETED|Overall Study||5
7879908|NCT00812604|19391166|P2|COMPLETED|Overall Study||22
7879909|NCT00812604|19391167|P1|COMPLETED|Overall Study||23
7879910|NCT00812604|19391166|P2|STARTED|Overall Study||27
7879911|NCT00812604|19391167|P1|STARTED|Overall Study||28
7879912|NCT00812565|19391183|P8|NOT COMPLETED|Overall Study||1
7879913|NCT00812565|19391184|P7|NOT COMPLETED|Overall Study||0
7879914|NCT00812565|19391185|P6|NOT COMPLETED|Overall Study||1
7879915|NCT00812565|19391186|P5|NOT COMPLETED|Overall Study||1
7879916|NCT00812565|19391187|P4|NOT COMPLETED|Overall Study||2
7879917|NCT00812565|19391188|P3|NOT COMPLETED|Overall Study||0
7879918|NCT00812565|19391189|P2|NOT COMPLETED|Overall Study||1
7879919|NCT00812565|19391190|P1|NOT COMPLETED|Overall Study||3
7879920|NCT00812565|19391183|P8|COMPLETED|Overall Study||6
7879921|NCT00812565|19391184|P7|COMPLETED|Overall Study||8
7879922|NCT00812565|19391185|P6|COMPLETED|Overall Study||6
7879923|NCT00812565|19391186|P5|COMPLETED|Overall Study||6
7879924|NCT00812565|19391187|P4|COMPLETED|Overall Study||5
7879925|NCT00812565|19391188|P3|COMPLETED|Overall Study||7
7879926|NCT00812565|19391189|P2|COMPLETED|Overall Study||6
7879927|NCT00812565|19391190|P1|COMPLETED|Overall Study||5
7879928|NCT00812565|19391183|P8|STARTED|Overall Study||7
7879929|NCT00812565|19391184|P7|STARTED|Overall Study||8
7879930|NCT00812565|19391185|P6|STARTED|Overall Study||7
7879931|NCT00812565|19391186|P5|STARTED|Overall Study||7
7879932|NCT00812565|19391187|P4|STARTED|Overall Study||7
7879933|NCT00812565|19391188|P3|STARTED|Overall Study||7
7879934|NCT00812565|19391189|P2|STARTED|Overall Study||7
7879935|NCT00812565|19391190|P1|STARTED|Overall Study||8
7879936|NCT00812487|19391314|P2|NOT COMPLETED|Overall Study||3
7879937|NCT00812487|19391315|P1|NOT COMPLETED|Overall Study||6
7879938|NCT00812487|19391314|P2|COMPLETED|Overall Study||39
7879939|NCT00812487|19391315|P1|COMPLETED|Overall Study||26
7879940|NCT00812487|19391314|P2|STARTED|Overall Study||42
7879941|NCT00812487|19391315|P1|STARTED|Overall Study||32
7879942|NCT00812461|19391341|P2|NOT COMPLETED|All Treated Patients||147
7879943|NCT00812461|19391342|P1|NOT COMPLETED|All Treated Patients||132
7879944|NCT00812461|19391341|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194
7879945|NCT00812461|19391342|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205
7879946|NCT00812461|19391341|P2|STARTED|All Treated Patients||341
7879947|NCT00812461|19391342|P1|STARTED|All Treated Patients||337
7879948|NCT00812461|19391341|P2|NOT COMPLETED|All Randomised Patients||17
7879949|NCT00812461|19391342|P1|NOT COMPLETED|All Randomised Patients||23
7879950|NCT00812461|19391341|P2|COMPLETED|All Randomised Patients||341
7879951|NCT00812461|19391342|P1|COMPLETED|All Randomised Patients||337
7879952|NCT00812461|19391341|P2|STARTED|All Randomised Patients||358
7879953|NCT00812461|19391342|P1|STARTED|All Randomised Patients||360
7879954|NCT00812331|19391365|P5|NOT COMPLETED|Overall Study||0
7879955|NCT00812331|19391366|P4|NOT COMPLETED|Overall Study||0
7879956|NCT00812331|19391367|P3|NOT COMPLETED|Overall Study||0
7879957|NCT00812331|19391368|P2|NOT COMPLETED|Overall Study||0
7879958|NCT00812331|19391369|P1|NOT COMPLETED|Overall Study||1
7879959|NCT00812331|19391365|P5|COMPLETED|Overall Study||8
7879960|NCT00812331|19391366|P4|COMPLETED|Overall Study||7
7879961|NCT00812331|19391367|P3|COMPLETED|Overall Study||8
7879962|NCT00812331|19391368|P2|COMPLETED|Overall Study||8
7879963|NCT00812331|19391369|P1|COMPLETED|Overall Study||5
7879964|NCT00812331|19391365|P5|STARTED|Overall Study||8
7879965|NCT00812331|19391366|P4|STARTED|Overall Study||7
7879966|NCT00812331|19391367|P3|STARTED|Overall Study||8
7879967|NCT00812331|19391368|P2|STARTED|Overall Study||8
7879968|NCT00812331|19391369|P1|STARTED|Overall Study||6
7879969|NCT00812253|19391444|P2|NOT COMPLETED|Overall Study||3
7879970|NCT00812253|19391445|P1|NOT COMPLETED|Overall Study||6
7879971|NCT00812253|19391444|P2|COMPLETED|Overall Study||39
7879972|NCT00812253|19391445|P1|COMPLETED|Overall Study||26
7879973|NCT00812253|19391444|P2|STARTED|Overall Study||42
7879974|NCT00812253|19391445|P1|STARTED|Overall Study||32
7879975|NCT00812110|19391461|P1|NOT COMPLETED|Overall Study||0
7879976|NCT00812110|19391461|P1|COMPLETED|Overall Study||292
7879977|NCT00812110|19391461|P1|STARTED|Overall Study||292
7879978|NCT00812097|19391470|P4|NOT COMPLETED|Overall Study||35
7879979|NCT00812097|19391471|P3|NOT COMPLETED|Overall Study||57
7879980|NCT00812097|19391472|P2|NOT COMPLETED|Overall Study||89
7879981|NCT00812097|19391473|P1|NOT COMPLETED|Overall Study||245
7879982|NCT00812097|19391470|P4|COMPLETED|Overall Study||34
7879983|NCT00812097|19391471|P3|COMPLETED|Overall Study||67
7879984|NCT00812097|19391472|P2|COMPLETED|Overall Study||101
7879985|NCT00812097|19391473|P1|COMPLETED|Overall Study||327
7879986|NCT00812097|19391470|P4|STARTED|Overall Study||69
7879987|NCT00812097|19391471|P3|STARTED|Overall Study||124
7879988|NCT00812097|19391472|P2|STARTED|Overall Study||190
7879989|NCT00812097|19391473|P1|STARTED|Overall Study||572
7879990|NCT00812006|19391502|P3|NOT COMPLETED|Overall Study||6
7879991|NCT00812006|19391503|P2|NOT COMPLETED|Overall Study||3
7879992|NCT00812006|19391504|P1|NOT COMPLETED|Overall Study||6
7879993|NCT00812006|19391502|P3|COMPLETED|Overall Study||30
7879994|NCT00812006|19391503|P2|COMPLETED|Overall Study||33
7879995|NCT00812006|19391504|P1|COMPLETED|Overall Study||30
7879996|NCT00812006|19391502|P3|STARTED|Overall Study||36
7879997|NCT00812006|19391503|P2|STARTED|Overall Study||36
7879998|NCT00812006|19391504|P1|STARTED|Overall Study||36
7879999|NCT00811954|19391521|P3|NOT COMPLETED|Overall Study||101
7880000|NCT00811954|19391522|P2|NOT COMPLETED|Overall Study||72
7880001|NCT00811954|19391523|P1|NOT COMPLETED|Overall Study||89
7880002|NCT00811954|19391521|P3|COMPLETED|Overall Study||500
7880003|NCT00811954|19391522|P2|COMPLETED|Overall Study||531
7880004|NCT00811954|19391523|P1|COMPLETED|Overall Study||516
7880005|NCT00811954|19391521|P3|STARTED|Overall Study||601
7880006|NCT00811954|19391522|P2|STARTED|Overall Study||603
7880007|NCT00811954|19391523|P1|STARTED|Overall Study||605
7880008|NCT00811941|19391587|P2|NOT COMPLETED|All Treated Patients||191
7880009|NCT00811941|19391588|P1|NOT COMPLETED|All Treated Patients||52
7880010|NCT00811941|19391587|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310
7880011|NCT00811941|19391588|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112
7880012|NCT00811941|19391587|P2|STARTED|All Treated Patients||501
7880013|NCT00811941|19391588|P1|STARTED|All Treated Patients||164
7880014|NCT00811941|19391587|P2|NOT COMPLETED|All Randomised Patients||8
7880015|NCT00811941|19391588|P1|NOT COMPLETED|All Randomised Patients||2
7880016|NCT00811941|19391587|P2|COMPLETED|All Randomised Patients||501
7880017|NCT00811941|19391588|P1|COMPLETED|All Randomised Patients||164
7880018|NCT00811941|19391587|P2|STARTED|All Randomised Patients||509
7880019|NCT00811941|19391588|P1|STARTED|All Randomised Patients||166
7880020|NCT00811928|19391626|P2|NOT COMPLETED|Overall Study||33
7880021|NCT00811928|19391627|P1|NOT COMPLETED|Overall Study||39
7880022|NCT00811928|19391626|P2|COMPLETED|Overall Study||90
7880023|NCT00811928|19391627|P1|COMPLETED|Overall Study||90
7880024|NCT00811928|19391626|P2|STARTED|Overall Study||123
7880025|NCT00811928|19391627|P1|STARTED|Overall Study||129
7880026|NCT00811850|19391645|P1|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0
7880027|NCT00811850|19391645|P1|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15
7880028|NCT00811850|19391645|P1|STARTED|Treatment Period 3: Combigan® or Cosopt®||15
7880029|NCT00811850|19391645|P1|NOT COMPLETED|Treatment Period 2: Wash Out||0
7880030|NCT00811850|19391645|P1|COMPLETED|Treatment Period 2: Wash Out||15
7880031|NCT00811850|19391645|P1|STARTED|Treatment Period 2: Wash Out||15
7880032|NCT00811850|19391645|P1|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0
7880033|NCT00811850|19391645|P1|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15
7880034|NCT00811850|19391645|P1|STARTED|Treatment Period 1: Combigan® or Cosopt®||15
7880035|NCT00811798|19391665|P1|NOT COMPLETED|Overall Study||0
7880036|NCT00811798|19391665|P1|COMPLETED|Overall Study||92
7880037|NCT00811798|19391665|P1|STARTED|Overall Study||92
7880038|NCT00811733|19391671|P2|NOT COMPLETED|Overall Study||10
7880039|NCT00811733|19391672|P1|NOT COMPLETED|Overall Study||11
7880040|NCT00811733|19391671|P2|COMPLETED|Overall Study||12
7880041|NCT00811733|19391672|P1|COMPLETED|Overall Study||4
7880042|NCT00811733|19391671|P2|STARTED|Overall Study||22
7880043|NCT00811733|19391672|P1|STARTED|Overall Study||15
7880044|NCT00811720|19391720|P2|NOT COMPLETED|All Treated Patients||164
7880045|NCT00811720|19391721|P1|NOT COMPLETED|All Treated Patients||96
7880046|NCT00811720|19391720|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138
7880047|NCT00811720|19391721|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200
7880048|NCT00811720|19391720|P2|STARTED|All Treated Patients||302
7880049|NCT00811720|19391721|P1|STARTED|All Treated Patients||296
7880050|NCT00811720|19391720|P2|NOT COMPLETED|All Randomised Patients||4
7880051|NCT00811720|19391721|P1|NOT COMPLETED|All Randomised Patients||2
7880052|NCT00811720|19391720|P2|COMPLETED|All Randomised Patients||302
7880053|NCT00811720|19391721|P1|COMPLETED|All Randomised Patients||296
7880054|NCT00811720|19391720|P2|STARTED|All Randomised Patients||306
7880055|NCT00811720|19391721|P1|STARTED|All Randomised Patients||298
7880056|NCT00811655|19391739|P1|NOT COMPLETED|Overall Study||1
7880057|NCT00811655|19391739|P1|COMPLETED|Overall Study||5
7880058|NCT00811655|19391739|P1|STARTED|Overall Study||6
7880059|NCT00811642|19391751|P1|NOT COMPLETED|Overall Study||15
7880060|NCT00811642|19391751|P1|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47
7880061|NCT00811642|19391751|P1|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62
7880062|NCT00811590|19391761|P1|NOT COMPLETED|Overall Study||0
7880063|NCT00811590|19391761|P1|COMPLETED|Overall Study||3
7880064|NCT00811590|19391761|P1|STARTED|Overall Study||3
7880065|NCT00811577|19391767|P2|NOT COMPLETED|Overall Study||1
7880066|NCT00811577|19391768|P1|NOT COMPLETED|Overall Study||10
7880067|NCT00811577|19391767|P2|COMPLETED|Overall Study||23
7880068|NCT00811577|19391768|P1|COMPLETED|Overall Study||116
7880069|NCT00811577|19391767|P2|STARTED|Overall Study||24
7880070|NCT00811577|19391768|P1|STARTED|Overall Study||126
7880071|NCT00811564|19391819|P2|NOT COMPLETED|Overall Study||2
7880072|NCT00811564|19391820|P1|NOT COMPLETED|Overall Study||9
7880073|NCT00811564|19391819|P2|COMPLETED|Overall Study||73
7880074|NCT00811564|19391820|P1|COMPLETED|Overall Study||64
7880075|NCT00811564|19391819|P2|STARTED|Overall Study||75
7880076|NCT00811564|19391820|P1|STARTED|Overall Study||73
7880077|NCT00811473|19391828|P2|NOT COMPLETED|Overall Study||26
7880078|NCT00811473|19391829|P1|NOT COMPLETED|Overall Study||23
7880079|NCT00811473|19391828|P2|COMPLETED|Overall Study||74
7880080|NCT00811473|19391829|P1|COMPLETED|Overall Study||70
7880081|NCT00811473|19391828|P2|STARTED|Overall Study||100
7880082|NCT00811473|19391829|P1|STARTED|Overall Study||93
7880083|NCT00811434|19391845|P2|NOT COMPLETED|Second Intervention||0
7880084|NCT00811434|19391846|P1|NOT COMPLETED|Second Intervention||0
7880085|NCT00811434|19391845|P2|COMPLETED|Second Intervention||5
7880086|NCT00811434|19391846|P1|COMPLETED|Second Intervention||4
7880087|NCT00811434|19391845|P2|STARTED|Second Intervention||5
7880088|NCT00811434|19391846|P1|STARTED|Second Intervention||4
7880089|NCT00811434|19391845|P2|NOT COMPLETED|Washout (1 Month)||0
7880090|NCT00811434|19391846|P1|NOT COMPLETED|Washout (1 Month)||0
7880091|NCT00811434|19391845|P2|COMPLETED|Washout (1 Month)||5
7880092|NCT00811434|19391846|P1|COMPLETED|Washout (1 Month)||4
7880093|NCT00811434|19391845|P2|STARTED|Washout (1 Month)||5
7880094|NCT00811434|19391846|P1|STARTED|Washout (1 Month)||4
7880095|NCT00811434|19391845|P2|NOT COMPLETED|First Intervention||0
7880096|NCT00811434|19391846|P1|NOT COMPLETED|First Intervention||3
7880097|NCT00811434|19391845|P2|COMPLETED|First Intervention||5
7880098|NCT00811434|19391846|P1|COMPLETED|First Intervention||4
7880099|NCT00811434|19391845|P2|STARTED|First Intervention||5
7880100|NCT00811434|19391846|P1|STARTED|First Intervention||7
7880101|NCT00811395|19391860|P6|NOT COMPLETED|Extension Treatment||2
7880102|NCT00811395|19391861|P5|NOT COMPLETED|Extension Treatment||0
7880103|NCT00811395|19391862|P4|NOT COMPLETED|Extension Treatment||3
7880104|NCT00811395|19391863|P3|NOT COMPLETED|Extension Treatment||3
7880105|NCT00811395|19391864|P2|NOT COMPLETED|Extension Treatment||6
7880106|NCT00811395|19391865|P1|NOT COMPLETED|Extension Treatment||2
7880107|NCT00811395|19391860|P6|COMPLETED|Extension Treatment|completed 48-week treatment|27
7880108|NCT00811395|19391861|P5|COMPLETED|Extension Treatment|completed 48-week treatment|30
7880109|NCT00811395|19391862|P4|COMPLETED|Extension Treatment|completed 48-week treatment|34
7880110|NCT00811395|19391863|P3|COMPLETED|Extension Treatment|completed 48-week treatment|24
7880111|NCT00811395|19391864|P2|COMPLETED|Extension Treatment|completed 48-week treatment|22
7880112|NCT00811395|19391865|P1|COMPLETED|Extension Treatment|completed 48-week treatment|29
7880113|NCT00811395|19391860|P6|STARTED|Extension Treatment|continued initial treatment|29
7880114|NCT00811395|19391861|P5|STARTED|Extension Treatment|continued initial treatment|30
7880115|NCT00811395|19391862|P4|STARTED|Extension Treatment|continued initial treatment|37
7880116|NCT00811395|19391863|P3|STARTED|Extension Treatment|continued initial treatment|27
7880117|NCT00811395|19391864|P2|STARTED|Extension Treatment|continued initial treatment|28
7880118|NCT00811395|19391865|P1|STARTED|Extension Treatment|continued initial treatment|31
7880119|NCT00811395|19391860|P6|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6
7880120|NCT00811395|19391861|P5|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5
7880121|NCT00811395|19391862|P4|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
7880122|NCT00811395|19391863|P3|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
7880123|NCT00811395|19391864|P2|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4
7880124|NCT00811395|19391865|P1|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3
7880125|NCT00811395|19391860|P6|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35
7880126|NCT00811395|19391861|P5|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37
7880127|NCT00811395|19391862|P4|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38
7880128|NCT00811395|19391863|P3|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36
7880129|NCT00811395|19391864|P2|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33
7880130|NCT00811395|19391865|P1|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38
7880131|NCT00811395|19391860|P6|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
7880132|NCT00811395|19391861|P5|STARTED|Initial Treatment (PDY6045 or PDY6046)||42
7880133|NCT00811395|19391862|P4|STARTED|Initial Treatment (PDY6045 or PDY6046)||40
7880134|NCT00811395|19391863|P3|STARTED|Initial Treatment (PDY6045 or PDY6046)||38
7880135|NCT00811395|19391864|P2|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37
7880136|NCT00811395|19391865|P1|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
7880137|NCT00811382|19391929|P2|NOT COMPLETED|Overall Study||0
7880138|NCT00811382|19391930|P1|NOT COMPLETED|Overall Study||0
7880139|NCT00811382|19391929|P2|COMPLETED|Overall Study||75
7880140|NCT00811382|19391930|P1|COMPLETED|Overall Study||88
7880141|NCT00811382|19391929|P2|STARTED|Overall Study||75
7880142|NCT00811382|19391930|P1|STARTED|Overall Study||88
7880143|NCT00811317|19391942|P1|NOT COMPLETED|Overall Study||0
7880144|NCT00811317|19391942|P1|COMPLETED|Overall Study||11
7880145|NCT00811317|19391942|P1|STARTED|Overall Study||11
7880146|NCT00811252|19391971|P3|NOT COMPLETED|Overall Study||23
7880147|NCT00811252|19391972|P2|NOT COMPLETED|Overall Study||20
7880148|NCT00811252|19391973|P1|NOT COMPLETED|Overall Study||17
7880149|NCT00811252|19391971|P3|COMPLETED|Overall Study||128
7880150|NCT00811252|19391972|P2|COMPLETED|Overall Study||136
7880151|NCT00811252|19391973|P1|COMPLETED|Overall Study||128
7880152|NCT00811252|19391971|P3|STARTED|Overall Study||151
7880153|NCT00811252|19391972|P2|STARTED|Overall Study||156
7880154|NCT00811252|19391973|P1|STARTED|Overall Study||145
7880155|NCT00811187|19392019|P2|NOT COMPLETED|Overall Study||3
7880156|NCT00811187|19392020|P1|NOT COMPLETED|Overall Study||3
7880157|NCT00811187|19392019|P2|COMPLETED|Overall Study||37
7880158|NCT00811187|19392020|P1|COMPLETED|Overall Study||37
7880159|NCT00811187|19392019|P2|STARTED|Overall Study||40
7880160|NCT00811187|19392020|P1|STARTED|Overall Study||40
7880161|NCT00811174|19392026|P1|NOT COMPLETED|Overall Study||3
7880162|NCT00811174|19392026|P1|COMPLETED|Overall Study||2
7880163|NCT00811174|19392026|P1|STARTED|Overall Study||5
7880164|NCT00811135|19392037|P1|NOT COMPLETED|Overall Study||88
7880165|NCT00811135|19392037|P1|COMPLETED|Overall Study||0
7880166|NCT00811135|19392037|P1|STARTED|Overall Study||88
7880167|NCT00811070|19392055|P6|NOT COMPLETED|Overall Study||1
7880168|NCT00811070|19392056|P5|NOT COMPLETED|Overall Study||5
7880169|NCT00811070|19392057|P4|NOT COMPLETED|Overall Study||2
7880170|NCT00811070|19392058|P3|NOT COMPLETED|Overall Study||0
7880171|NCT00811070|19392059|P2|NOT COMPLETED|Overall Study||1
7880172|NCT00811070|19392060|P1|NOT COMPLETED|Overall Study||1
7880173|NCT00811070|19392055|P6|COMPLETED|Overall Study||10
7880174|NCT00811070|19392056|P5|COMPLETED|Overall Study||2
7880175|NCT00811070|19392057|P4|COMPLETED|Overall Study||26
7880176|NCT00811070|19392058|P3|COMPLETED|Overall Study||3
7880177|NCT00811070|19392059|P2|COMPLETED|Overall Study||6
7880178|NCT00811070|19392060|P1|COMPLETED|Overall Study||6
7880179|NCT00811070|19392055|P6|STARTED|Overall Study||11
7880180|NCT00811070|19392056|P5|STARTED|Overall Study||7
7880181|NCT00811070|19392057|P4|STARTED|Overall Study||28
7880182|NCT00811070|19392058|P3|STARTED|Overall Study||3
7880183|NCT00811070|19392059|P2|STARTED|Overall Study||7
7880184|NCT00811070|19392060|P1|STARTED|Overall Study||7
7880185|NCT00811057|19392120|P3|NOT COMPLETED|Overall Study||10
7880186|NCT00811057|19392121|P2|NOT COMPLETED|Overall Study||10
7880187|NCT00811057|19392122|P1|NOT COMPLETED|Overall Study||5
7880188|NCT00811057|19392120|P3|COMPLETED|Overall Study||87
7880189|NCT00811057|19392121|P2|COMPLETED|Overall Study||104
7880190|NCT00811057|19392122|P1|COMPLETED|Overall Study||85
7880191|NCT00811057|19392120|P3|STARTED|Overall Study||97
7880192|NCT00811057|19392121|P2|STARTED|Overall Study||114
7880193|NCT00811057|19392122|P1|STARTED|Overall Study||90
7880194|NCT00811018|19392133|P1|NOT COMPLETED|Overall Study||968
7880195|NCT00811018|19392133|P1|COMPLETED|Overall Study||224
7880196|NCT00811018|19392133|P1|STARTED|Overall Study||1192
7880197|NCT00810901|19392151|P2|NOT COMPLETED|Overall Study||58
7880198|NCT00810901|19392152|P1|NOT COMPLETED|Overall Study||88
7880199|NCT00810901|19392151|P2|COMPLETED|Overall Study||118
7880200|NCT00810901|19392152|P1|COMPLETED|Overall Study||165
7880201|NCT00810901|19392151|P2|6-month Follow-up|Overall Study||122
7880202|NCT00810901|19392152|P1|6-month Follow-up|Overall Study||181
7880203|NCT00810901|19392151|P2|1-month Follow up|Overall Study||146
7880204|NCT00810901|19392152|P1|1-month Follow up|Overall Study||242
7880205|NCT00810901|19392151|P2|STARTED|Overall Study||176
7880206|NCT00810901|19392152|P1|STARTED|Overall Study||253
7880207|NCT00810888|19392163|P3|NOT COMPLETED|Overall Study||0
7880208|NCT00810888|19392164|P2|NOT COMPLETED|Overall Study||0
7880209|NCT00810888|19392165|P1|NOT COMPLETED|Overall Study||0
7880210|NCT00810888|19392163|P3|COMPLETED|Overall Study||73
7880211|NCT00810888|19392164|P2|COMPLETED|Overall Study||9
7880212|NCT00810888|19392165|P1|COMPLETED|Overall Study||10
7880213|NCT00810888|19392163|P3|STARTED|Overall Study||73
7880214|NCT00810888|19392164|P2|STARTED|Overall Study||9
7880215|NCT00810888|19392165|P1|STARTED|Overall Study||10
7880216|NCT00810810|19392198|P4|NOT COMPLETED|Overall Study||13
7880217|NCT00810810|19392199|P3|NOT COMPLETED|Overall Study||11
7880218|NCT00810810|19392200|P2|NOT COMPLETED|Overall Study||11
7880219|NCT00810810|19392201|P1|NOT COMPLETED|Overall Study||0
7880220|NCT00810810|19392198|P4|COMPLETED|Overall Study||38
7880221|NCT00810810|19392199|P3|COMPLETED|Overall Study||45
7880222|NCT00810810|19392200|P2|COMPLETED|Overall Study||38
7880223|NCT00810810|19392201|P1|COMPLETED|Overall Study||124
7880224|NCT00810810|19392198|P4|STARTED|Overall Study||51
7880225|NCT00810810|19392199|P3|STARTED|Overall Study||56
7880226|NCT00810810|19392200|P2|STARTED|Overall Study||49
7880227|NCT00810810|19392201|P1|STARTED|Overall Study||124
7880228|NCT00810797|19392215|P1|NOT COMPLETED|Overall Study||0
7880229|NCT00810797|19392215|P1|COMPLETED|Overall Study||36
7880230|NCT00810797|19392215|P1|STARTED|Overall Study||36
7880231|NCT00810771|19392223|P3|NOT COMPLETED|Overall Study||0
7880232|NCT00810771|19392224|P2|NOT COMPLETED|Overall Study||0
7880233|NCT00810771|19392225|P1|NOT COMPLETED|Overall Study||0
7880234|NCT00810771|19392223|P3|COMPLETED|Overall Study||84
7880235|NCT00810771|19392224|P2|COMPLETED|Overall Study||234
7880236|NCT00810771|19392225|P1|COMPLETED|Overall Study||232
7880237|NCT00810771|19392223|P3|STARTED|Overall Study||84
7880238|NCT00810771|19392224|P2|STARTED|Overall Study||234
7880239|NCT00810771|19392225|P1|STARTED|Overall Study||232
7880240|NCT00810719|19392245|P1|NOT COMPLETED|Overall Study||0
7880241|NCT00810719|19392245|P1|COMPLETED|Overall Study||30
7880242|NCT00810719|19392245|P1|STARTED|Overall Study||30
7880243|NCT00810693|19392254|P3|NOT COMPLETED|Follow-up Period (FUP)||4
7880244|NCT00810693|19392255|P2|NOT COMPLETED|Follow-up Period (FUP)||3
7880245|NCT00810693|19392256|P1|NOT COMPLETED|Follow-up Period (FUP)||8
7880246|NCT00810693|19392254|P3|COMPLETED|Follow-up Period (FUP)||12
7880247|NCT00810693|19392255|P2|COMPLETED|Follow-up Period (FUP)||4
7880248|NCT00810693|19392256|P1|COMPLETED|Follow-up Period (FUP)||15
7880249|NCT00810693|19392254|P3|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16
7880250|NCT00810693|19392255|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7
7880251|NCT00810693|19392256|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23
7880252|NCT00810693|19392254|P3|NOT COMPLETED|Treatment Period||16
7880253|NCT00810693|19392255|P2|NOT COMPLETED|Treatment Period||7
7880254|NCT00810693|19392256|P1|NOT COMPLETED|Treatment Period||17
7880255|NCT00810693|19392254|P3|COMPLETED|Treatment Period||111
7880256|NCT00810693|19392255|P2|COMPLETED|Treatment Period||57
7880257|NCT00810693|19392256|P1|COMPLETED|Treatment Period||237
7880258|NCT00810693|19392254|P3|Participants Received Treatment|Treatment Period||126
7880259|NCT00810693|19392255|P2|Participants Received Treatment|Treatment Period||63
7880260|NCT00810693|19392256|P1|Participants Received Treatment|Treatment Period||254
7880261|NCT00810693|19392254|P3|STARTED|Treatment Period|1 randomized but not treated|127
7880262|NCT00810693|19392255|P2|STARTED|Treatment Period|1 randomized but not treated|64
7880263|NCT00810693|19392256|P1|STARTED|Treatment Period||254
7880264|NCT00810641|19392288|P3|NOT COMPLETED|Overall Study||2
7880265|NCT00810641|19392289|P2|NOT COMPLETED|Overall Study||1
7880266|NCT00810641|19392290|P1|NOT COMPLETED|Overall Study||0
7880267|NCT00810641|19392288|P3|COMPLETED|Overall Study||49
7880268|NCT00810641|19392289|P2|COMPLETED|Overall Study||53
7880269|NCT00810641|19392290|P1|COMPLETED|Overall Study||52
7880270|NCT00810641|19392288|P3|STARTED|Overall Study||51
7880271|NCT00810641|19392289|P2|STARTED|Overall Study||54
7880272|NCT00810641|19392290|P1|STARTED|Overall Study||52
7880273|NCT00810615|19392300|P2|NOT COMPLETED|Overall Study||1
7880274|NCT00810615|19392301|P1|NOT COMPLETED|Overall Study||1
7880275|NCT00810615|19392300|P2|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
7880276|NCT00810615|19392301|P1|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
7880277|NCT00810615|19392300|P2|STARTED|Overall Study||25
7880278|NCT00810615|19392301|P1|STARTED|Overall Study||25
7880279|NCT00810602|19392351|P2|NOT COMPLETED|Overall Study||3
7880280|NCT00810602|19392352|P1|NOT COMPLETED|Overall Study||8
7880281|NCT00810602|19392351|P2|COMPLETED|Overall Study||31
7880282|NCT00810602|19392352|P1|COMPLETED|Overall Study||19
7880283|NCT00810602|19392351|P2|STARTED|Overall Study||34
7880284|NCT00810602|19392352|P1|STARTED|Overall Study||27
7880285|NCT00810576|19392359|P1|NOT COMPLETED|Overall Study||0
7880286|NCT00810576|19392359|P1|COMPLETED|Overall Study||1
7880287|NCT00810576|19392359|P1|STARTED|Overall Study||1
7880288|NCT00810511|19392365|P2|NOT COMPLETED|Overall Study||4
7880289|NCT00810511|19392366|P1|NOT COMPLETED|Overall Study||10
7880290|NCT00810511|19392365|P2|COMPLETED|Overall Study||102
7880291|NCT00810511|19392366|P1|COMPLETED|Overall Study||97
7880292|NCT00810511|19392365|P2|STARTED|Overall Study||106
7880293|NCT00810511|19392366|P1|STARTED|Overall Study||107
7880294|NCT00810446|19392372|P1|NOT COMPLETED|Overall Study||0
7880295|NCT00810446|19392372|P1|COMPLETED|Overall Study||72
7880296|NCT00810446|19392372|P1|STARTED|Overall Study||72
7880297|NCT00810407|19392384|P1|NOT COMPLETED|Overall Study||6
7880298|NCT00810407|19392384|P1|COMPLETED|Overall Study||588
7880299|NCT00810407|19392384|P1|STARTED|Overall Study||594
7880300|NCT00810394|19392396|P1|NOT COMPLETED|Overall Study||3
7880301|NCT00810394|19392396|P1|COMPLETED|Overall Study||47
7880302|NCT00810394|19392396|P1|Cycle 3 400mg Twice Daily|Overall Study||5
7880303|NCT00810394|19392396|P1|Cycle 3 800 mg Twice Daily|Overall Study||4
7880304|NCT00810394|19392396|P1|Cycle 2 400mg Once Daily|Overall Study||22
7880305|NCT00810394|19392396|P1|Cycle 2 600mg Twice Daily|Overall Study||13
7880306|NCT00810394|19392396|P1|STARTED|Overall Study||50
7880307|NCT00810368|19392404|P2|NOT COMPLETED|Overall Study||2
7880308|NCT00810368|19392405|P1|NOT COMPLETED|Overall Study||6
7880309|NCT00810368|19392404|P2|COMPLETED|Overall Study||13
7880310|NCT00810368|19392405|P1|COMPLETED|Overall Study||12
7880311|NCT00810368|19392404|P2|STARTED|Overall Study||15
7880312|NCT00810368|19392405|P1|STARTED|Overall Study||18
7880313|NCT00810355|19392426|P3|NOT COMPLETED|Overall Study||11
7880314|NCT00810355|19392427|P2|NOT COMPLETED|Overall Study||17
7880315|NCT00810355|19392428|P1|NOT COMPLETED|Overall Study||14
7880316|NCT00810355|19392426|P3|COMPLETED|Overall Study||14
7880317|NCT00810355|19392427|P2|COMPLETED|Overall Study||8
7880318|NCT00810355|19392428|P1|COMPLETED|Overall Study||11
7880319|NCT00810355|19392426|P3|STARTED|Overall Study||25
7880320|NCT00810355|19392427|P2|STARTED|Overall Study||25
7880321|NCT00810355|19392428|P1|STARTED|Overall Study||25
7880322|NCT00810342|19392444|P2|NOT COMPLETED|12-month Followup||11
7880323|NCT00810342|19392445|P1|NOT COMPLETED|12-month Followup||12
7880324|NCT00810342|19392444|P2|COMPLETED|12-month Followup||136
7880325|NCT00810342|19392445|P1|COMPLETED|12-month Followup||113
7880326|NCT00810342|19392444|P2|STARTED|12-month Followup||147
7880327|NCT00810342|19392445|P1|STARTED|12-month Followup||125
7880328|NCT00810342|19392444|P2|NOT COMPLETED|6-month Follow-up||8
7880329|NCT00810342|19392445|P1|NOT COMPLETED|6-month Follow-up||24
7880330|NCT00810342|19392444|P2|COMPLETED|6-month Follow-up||147
7880331|NCT00810342|19392445|P1|COMPLETED|6-month Follow-up||125
7880332|NCT00810342|19392444|P2|STARTED|6-month Follow-up||155
7880333|NCT00810342|19392445|P1|STARTED|6-month Follow-up||149
7880334|NCT00810342|19392444|P2|NOT COMPLETED|Month 1 Follow-up||2
7880335|NCT00810342|19392445|P1|NOT COMPLETED|Month 1 Follow-up||5
7880336|NCT00810342|19392444|P2|COMPLETED|Month 1 Follow-up||155
7880337|NCT00810342|19392445|P1|COMPLETED|Month 1 Follow-up||149
7880338|NCT00810342|19392444|P2|STARTED|Month 1 Follow-up||157
7880339|NCT00810342|19392445|P1|STARTED|Month 1 Follow-up||154
7880340|NCT00810303|19392453|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0
7880341|NCT00810303|19392453|P1|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12
7880342|NCT00810303|19392453|P1|STARTED|Ezetimibe and Efavirenz - Day 21-30||12
7880343|NCT00810303|19392453|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0
7880344|NCT00810303|19392453|P1|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12
7880345|NCT00810303|19392453|P1|STARTED|Ezetimibe and Efavirenz - Day 16-20||12
7880346|NCT00810303|19392453|P1|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0
7880347|NCT00810303|19392453|P1|COMPLETED|Ezetimibe Alone - Day 6-15||12
7880348|NCT00810303|19392453|P1|STARTED|Ezetimibe Alone - Day 6-15||12
7880349|NCT00810303|19392453|P1|NOT COMPLETED|Efavirenz Alone - Day 1-5||0
7880350|NCT00810303|19392453|P1|COMPLETED|Efavirenz Alone - Day 1-5||12
7880351|NCT00810303|19392453|P1|STARTED|Efavirenz Alone - Day 1-5||12
7880352|NCT00810277|19392478|P1|NOT COMPLETED|Overall Study||1
7880353|NCT00810277|19392478|P1|COMPLETED|Overall Study||13
7880354|NCT00810277|19392478|P1|STARTED|Overall Study||14
7880355|NCT00810264|19392491|P1|NOT COMPLETED|Overall Study||1553
7880356|NCT00810264|19392491|P1|COMPLETED|Overall Study||946
7880357|NCT00810264|19392491|P1|STARTED|Overall Study||2499
7880358|NCT00810199|19392518|P2|NOT COMPLETED|Overall Study||82
7880359|NCT00810199|19392519|P1|NOT COMPLETED|Overall Study||59
7880360|NCT00810199|19392518|P2|COMPLETED|Overall Study|Completed=Completed Treatment|195
7880361|NCT00810199|19392519|P1|COMPLETED|Overall Study||220
7880362|NCT00810199|19392518|P2|Completed Week 104|Overall Study||201
7880363|NCT00810199|19392519|P1|Completed Week 104|Overall Study||222
7880364|NCT00810199|19392518|P2|Completed Week 52|Overall Study||229
7880365|NCT00810199|19392519|P1|Completed Week 52|Overall Study||243
7880366|NCT00810199|19392518|P2|Completed Week 24|Overall Study||250
7880367|NCT00810199|19392519|P1|Completed Week 24|Overall Study||259
7880368|NCT00810199|19392518|P2|Received Study Drug|Overall Study||276
7880369|NCT00810199|19392519|P1|Received Study Drug|Overall Study||277
7880370|NCT00810199|19392518|P2|STARTED|Overall Study||277
7880371|NCT00810199|19392519|P1|STARTED|Overall Study||279
7880372|NCT00810108|19392597|P2|NOT COMPLETED|Overall Study||0
7880373|NCT00810108|19392598|P1|NOT COMPLETED|Overall Study||1
7880374|NCT00810108|19392597|P2|COMPLETED|Overall Study||7
7880375|NCT00810108|19392598|P1|COMPLETED|Overall Study||5
7880376|NCT00810108|19392597|P2|STARTED|Overall Study||7
7880377|NCT00810108|19392598|P1|STARTED|Overall Study||6
7880378|NCT00810095|19392603|P1|NOT COMPLETED|Overall Study||0
7880379|NCT00810095|19392603|P1|COMPLETED|Overall Study||40
7880380|NCT00810095|19392603|P1|STARTED|Overall Study||40
7880381|NCT00810082|19392612|P2|NOT COMPLETED|Overall Study||4
7880382|NCT00810082|19392613|P1|NOT COMPLETED|Overall Study||0
7880383|NCT00810082|19392612|P2|COMPLETED|Overall Study||27
7880384|NCT00810082|19392613|P1|COMPLETED|Overall Study||34
7880385|NCT00810082|19392612|P2|STARTED|Overall Study||31
7880386|NCT00810082|19392613|P1|STARTED|Overall Study||34
7880387|NCT00810069|19392621|P3|NOT COMPLETED|Double-Blind Period II||72
7880388|NCT00810069|19392622|P2|NOT COMPLETED|Double-Blind Period II||56
7880389|NCT00810069|19392623|P1|NOT COMPLETED|Double-Blind Period II||0
7880390|NCT00810069|19392621|P3|COMPLETED|Double-Blind Period II||212
7880391|NCT00810069|19392622|P2|COMPLETED|Double-Blind Period II||226
7880392|NCT00810069|19392623|P1|COMPLETED|Double-Blind Period II||0
7880393|NCT00810069|19392621|P3|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284
7880394|NCT00810069|19392622|P2|STARTED|Double-Blind Period II||282
7880395|NCT00810069|19392623|P1|STARTED|Double-Blind Period II||0
7880396|NCT00810069|19392621|P3|NOT COMPLETED|Lead-in Period I||0
7880397|NCT00810069|19392622|P2|NOT COMPLETED|Lead-in Period I||0
7880398|NCT00810069|19392623|P1|NOT COMPLETED|Lead-in Period I||274
7880399|NCT00810069|19392621|P3|COMPLETED|Lead-in Period I||0
7880400|NCT00810069|19392622|P2|COMPLETED|Lead-in Period I||0
7880401|NCT00810069|19392623|P1|COMPLETED|Lead-in Period I||566
7880402|NCT00810069|19392621|P3|STARTED|Lead-in Period I||0
7880403|NCT00810069|19392622|P2|STARTED|Lead-in Period I||0
7880404|NCT00810069|19392623|P1|STARTED|Lead-in Period I||840
7880405|NCT00810043|19392668|P3|NOT COMPLETED|Overall Study||8
7880406|NCT00810043|19392669|P2|NOT COMPLETED|Overall Study||1
7880407|NCT00810043|19392670|P1|NOT COMPLETED|Overall Study||4
7880408|NCT00810043|19392668|P3|COMPLETED|Overall Study||0
7880409|NCT00810043|19392669|P2|COMPLETED|Overall Study||54
7880410|NCT00810043|19392670|P1|COMPLETED|Overall Study||53
7880411|NCT00810043|19392668|P3|STARTED|Overall Study||8
7880412|NCT00810043|19392669|P2|STARTED|Overall Study||55
7880413|NCT00810043|19392670|P1|STARTED|Overall Study||57
7880414|NCT00809965|19392692|P3|NOT COMPLETED|Overall Study||844
7880415|NCT00809965|19392693|P2|NOT COMPLETED|Overall Study||775
7880416|NCT00809965|19392694|P1|NOT COMPLETED|Overall Study||783
7880417|NCT00809965|19392692|P3|COMPLETED|Overall Study||4332
7880418|NCT00809965|19392693|P2|COMPLETED|Overall Study||4399
7880419|NCT00809965|19392694|P1|COMPLETED|Overall Study||4393
7880420|NCT00809965|19392692|P3|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115
7880421|NCT00809965|19392693|P2|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114
7880422|NCT00809965|19392694|P1|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113
7880423|NCT00809965|19392692|P3|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110
7880424|NCT00809965|19392693|P2|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115
7880425|NCT00809965|19392694|P1|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125
7880426|NCT00809965|19392692|P3|STARTED|Overall Study||5176
7880427|NCT00809965|19392693|P2|STARTED|Overall Study||5174
7880428|NCT00809965|19392694|P1|STARTED|Overall Study||5176
7880429|NCT00809926|19392716|P2|NOT COMPLETED|Overall Study||23
7880430|NCT00809926|19392717|P1|NOT COMPLETED|Overall Study||31
7880431|NCT00809926|19392716|P2|COMPLETED|Overall Study||196
7880432|NCT00809926|19392717|P1|COMPLETED|Overall Study||201
7880433|NCT00809926|19392716|P2|STARTED|Overall Study||219
7880434|NCT00809926|19392717|P1|STARTED|Overall Study||232
7880435|NCT00809848|19392746|P5|NOT COMPLETED|Overall Study||3
7880436|NCT00809848|19392747|P4|NOT COMPLETED|Overall Study||1
7880437|NCT00809848|19392748|P3|NOT COMPLETED|Overall Study||0
7880438|NCT00809848|19392749|P2|NOT COMPLETED|Overall Study||0
7880439|NCT00809848|19392750|P1|NOT COMPLETED|Overall Study||0
7880440|NCT00809848|19392746|P5|COMPLETED|Overall Study||34
7880441|NCT00809848|19392747|P4|COMPLETED|Overall Study||30
7880442|NCT00809848|19392748|P3|COMPLETED|Overall Study||34
7880443|NCT00809848|19392749|P2|COMPLETED|Overall Study||34
7880444|NCT00809848|19392750|P1|COMPLETED|Overall Study||36
7880445|NCT00809848|19392746|P5|STARTED|Overall Study||37
7880446|NCT00809848|19392747|P4|STARTED|Overall Study||31
7880447|NCT00809848|19392748|P3|STARTED|Overall Study||34
7880448|NCT00809848|19392749|P2|STARTED|Overall Study||34
7880449|NCT00809848|19392750|P1|STARTED|Overall Study||36
7880450|NCT00809835|19392771|P4|NOT COMPLETED|Overall Study||2
7880451|NCT00809835|19392772|P3|NOT COMPLETED|Overall Study||11
7880452|NCT00809835|19392773|P2|NOT COMPLETED|Overall Study||7
7880453|NCT00809835|19392774|P1|NOT COMPLETED|Overall Study||8
7880454|NCT00809835|19392771|P4|COMPLETED|Overall Study||25
7880455|NCT00809835|19392772|P3|COMPLETED|Overall Study||27
7880456|NCT00809835|19392773|P2|COMPLETED|Overall Study||20
7880457|NCT00809835|19392774|P1|COMPLETED|Overall Study||20
7880458|NCT00809835|19392771|P4|STARTED|Overall Study||27
7880459|NCT00809835|19392772|P3|STARTED|Overall Study||38
7880460|NCT00809835|19392773|P2|STARTED|Overall Study||27
7880461|NCT00809835|19392774|P1|STARTED|Overall Study||28
7880462|NCT00809809|19392794|P2|NOT COMPLETED|Overall Study||2
7880463|NCT00809809|19392795|P1|NOT COMPLETED|Overall Study||3
7880464|NCT00809809|19392794|P2|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77
7880465|NCT00809809|19392795|P1|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75
7880466|NCT00809809|19392794|P2|STARTED|Overall Study||79
7880467|NCT00809809|19392795|P1|STARTED|Overall Study||78
7880468|NCT00809757|19392804|P3|NOT COMPLETED|Overall Study||11
7880469|NCT00809757|19392805|P2|NOT COMPLETED|Overall Study||5
7880470|NCT00809757|19392806|P1|NOT COMPLETED|Overall Study||6
7880471|NCT00809757|19392804|P3|COMPLETED|Overall Study||53
7880472|NCT00809757|19392805|P2|COMPLETED|Overall Study||60
7880473|NCT00809757|19392806|P1|COMPLETED|Overall Study||62
7880474|NCT00809757|19392804|P3|STARTED|Overall Study||64
7880475|NCT00809757|19392805|P2|STARTED|Overall Study||65
7880476|NCT00809757|19392806|P1|STARTED|Overall Study||68
7880477|NCT00809614|19392891|P2|NOT COMPLETED|Overall Study||4
7880478|NCT00809614|19392892|P1|NOT COMPLETED|Overall Study||3
7880479|NCT00809614|19392891|P2|COMPLETED|Overall Study||10
7880480|NCT00809614|19392892|P1|COMPLETED|Overall Study||25
7880481|NCT00809614|19392891|P2|Pharmacodynamic (PD) Set|Overall Study||13
7880482|NCT00809614|19392892|P1|Pharmacodynamic (PD) Set|Overall Study||24
7880483|NCT00809614|19392891|P2|Pharmacokinetic Safety Set|Overall Study||14
7880484|NCT00809614|19392892|P1|Pharmacokinetic Safety Set|Overall Study||27
7880485|NCT00809614|19392891|P2|STARTED|Overall Study||14
7880486|NCT00809614|19392892|P1|STARTED|Overall Study||28
7880487|NCT00809523|19392922|P2|NOT COMPLETED|Overall Study||4
7880488|NCT00809523|19392923|P1|NOT COMPLETED|Overall Study||7
7880489|NCT00809523|19392922|P2|COMPLETED|Overall Study||48
7880490|NCT00809523|19392923|P1|COMPLETED|Overall Study||47
7880491|NCT00809523|19392922|P2|STARTED|Overall Study||52
7880492|NCT00809523|19392923|P1|STARTED|Overall Study||54
7880493|NCT00809471|19392936|P3|NOT COMPLETED|Overall Study||17
7880494|NCT00809471|19392937|P2|NOT COMPLETED|Overall Study||20
7880495|NCT00809471|19392938|P1|NOT COMPLETED|Overall Study||20
7880496|NCT00809471|19392936|P3|COMPLETED|Overall Study||114
7880497|NCT00809471|19392937|P2|COMPLETED|Overall Study||109
7880498|NCT00809471|19392938|P1|COMPLETED|Overall Study||110
7880499|NCT00809471|19392936|P3|STARTED|Overall Study||131
7880500|NCT00809471|19392937|P2|STARTED|Overall Study||129
7880501|NCT00809471|19392938|P1|STARTED|Overall Study||130
7880502|NCT00809458|19392954|P2|NOT COMPLETED|Overall Study||1
7880503|NCT00809458|19392955|P1|NOT COMPLETED|Overall Study||1
7880504|NCT00809458|19392954|P2|COMPLETED|Overall Study||5
7880505|NCT00809458|19392955|P1|COMPLETED|Overall Study||8
7880506|NCT00809458|19392954|P2|STARTED|Overall Study||6
7880507|NCT00809458|19392955|P1|STARTED|Overall Study||9
7880508|NCT00809445|19392968|P3|NOT COMPLETED|6 Month Follow-up||24
7880509|NCT00809445|19392969|P2|NOT COMPLETED|6 Month Follow-up||23
7880510|NCT00809445|19392970|P1|NOT COMPLETED|6 Month Follow-up||24
7880511|NCT00809445|19392968|P3|COMPLETED|6 Month Follow-up||395
7880512|NCT00809445|19392969|P2|COMPLETED|6 Month Follow-up||410
7880513|NCT00809445|19392970|P1|COMPLETED|6 Month Follow-up||405
7880514|NCT00809445|19392968|P3|STARTED|6 Month Follow-up||419
7880515|NCT00809445|19392969|P2|STARTED|6 Month Follow-up||433
7880516|NCT00809445|19392970|P1|STARTED|6 Month Follow-up||429
7880517|NCT00809445|19392968|P3|NOT COMPLETED|1 Month Follow-up||4
7880518|NCT00809445|19392969|P2|NOT COMPLETED|1 Month Follow-up||4
7880519|NCT00809445|19392970|P1|NOT COMPLETED|1 Month Follow-up||2
7880520|NCT00809445|19392968|P3|COMPLETED|1 Month Follow-up||415
7880521|NCT00809445|19392969|P2|COMPLETED|1 Month Follow-up||429
7880522|NCT00809445|19392970|P1|COMPLETED|1 Month Follow-up||427
7880523|NCT00809445|19392968|P3|STARTED|1 Month Follow-up||419
7880524|NCT00809445|19392969|P2|STARTED|1 Month Follow-up||433
7880525|NCT00809445|19392970|P1|STARTED|1 Month Follow-up||429
7880526|NCT00809341|19392989|P2|NOT COMPLETED|Overall Study||1
7880527|NCT00809341|19392990|P1|NOT COMPLETED|Overall Study||0
7880528|NCT00809341|19392989|P2|COMPLETED|Overall Study||4
7880529|NCT00809341|19392990|P1|COMPLETED|Overall Study||20
7880530|NCT00809341|19392989|P2|STARTED|Overall Study||5
7880531|NCT00809341|19392990|P1|STARTED|Overall Study||20
7880532|NCT00809328|19392998|P1|NOT COMPLETED|Overall Study||29
7880533|NCT00809328|19392998|P1|COMPLETED|Overall Study||73
7880534|NCT00809328|19392998|P1|STARTED|Overall Study||102
7880535|NCT00809276|19393006|P1|NOT COMPLETED|Overall Study||0
7880536|NCT00809276|19393006|P1|COMPLETED|Overall Study||92
7880537|NCT00809276|19393006|P1|STARTED|Overall Study||92
7880538|NCT00809185|19393010|P1|NOT COMPLETED|Overall Study||0
7880539|NCT00809185|19393010|P1|COMPLETED|Overall Study||7
7880540|NCT00809185|19393010|P1|STARTED|Overall Study||7
7880541|NCT00809159|19393020|P6|NOT COMPLETED|Part 1 and 2||3
7880542|NCT00809159|19393021|P5|NOT COMPLETED|Part 1 and 2||6
7880543|NCT00809159|19393022|P4|NOT COMPLETED|Part 1 and 2||5
7880544|NCT00809159|19393023|P3|NOT COMPLETED|Part 1 and 2||10
7880545|NCT00809159|19393024|P2|NOT COMPLETED|Part 1 and 2||0
7880546|NCT00809159|19393025|P1|NOT COMPLETED|Part 1 and 2||0
7880547|NCT00809159|19393020|P6|COMPLETED|Part 1 and 2||3
7880548|NCT00809159|19393021|P5|COMPLETED|Part 1 and 2||6
7880549|NCT00809159|19393022|P4|COMPLETED|Part 1 and 2||7
7880550|NCT00809159|19393023|P3|COMPLETED|Part 1 and 2||20
7880551|NCT00809159|19393024|P2|COMPLETED|Part 1 and 2||0
7880552|NCT00809159|19393025|P1|COMPLETED|Part 1 and 2||0
7880553|NCT00809159|19393020|P6|PD Analysis Set|Part 1 and 2||6
7880554|NCT00809159|19393021|P5|PD Analysis Set|Part 1 and 2||12
7880555|NCT00809159|19393022|P4|PD Analysis Set|Part 1 and 2||12
7880556|NCT00809159|19393023|P3|PD Analysis Set|Part 1 and 2||28
7880557|NCT00809159|19393024|P2|PD Analysis Set|Part 1 and 2||0
7880558|NCT00809159|19393025|P1|PD Analysis Set|Part 1 and 2||0
7880559|NCT00809159|19393020|P6|PK Analysis Set|Part 1 and 2||6
7880560|NCT00809159|19393021|P5|PK Analysis Set|Part 1 and 2||12
7880561|NCT00809159|19393022|P4|PK Analysis Set|Part 1 and 2||12
7880562|NCT00809159|19393023|P3|PK Analysis Set|Part 1 and 2||30
7880563|NCT00809159|19393024|P2|PK Analysis Set|Part 1 and 2||0
7880564|NCT00809159|19393025|P1|PK Analysis Set|Part 1 and 2||0
7880565|NCT00809159|19393020|P6|STARTED|Part 1 and 2||6
7880566|NCT00809159|19393021|P5|STARTED|Part 1 and 2||12
7880567|NCT00809159|19393022|P4|STARTED|Part 1 and 2||12
7880568|NCT00809159|19393023|P3|STARTED|Part 1 and 2||30
7880569|NCT00809159|19393024|P2|STARTED|Part 1 and 2||0
7880570|NCT00809159|19393025|P1|STARTED|Part 1 and 2||0
7880571|NCT00809159|19393020|P6|NOT COMPLETED|Part 1||0
7880572|NCT00809159|19393021|P5|NOT COMPLETED|Part 1||0
7880573|NCT00809159|19393022|P4|NOT COMPLETED|Part 1||0
7880574|NCT00809159|19393023|P3|NOT COMPLETED|Part 1||0
7880575|NCT00809159|19393024|P2|NOT COMPLETED|Part 1||3
7880576|NCT00809159|19393025|P1|NOT COMPLETED|Part 1||8
7880577|NCT00809159|19393020|P6|COMPLETED|Part 1||0
7880578|NCT00809159|19393021|P5|COMPLETED|Part 1||0
7880579|NCT00809159|19393022|P4|COMPLETED|Part 1||0
7880580|NCT00809159|19393023|P3|COMPLETED|Part 1||0
7880581|NCT00809159|19393024|P2|COMPLETED|Part 1||3
7880582|NCT00809159|19393025|P1|COMPLETED|Part 1||16
7880583|NCT00809159|19393020|P6|PD Analysis Set|Part 1||0
7880584|NCT00809159|19393021|P5|PD Analysis Set|Part 1||0
7880585|NCT00809159|19393022|P4|PD Analysis Set|Part 1||0
7880586|NCT00809159|19393023|P3|PD Analysis Set|Part 1||0
7880587|NCT00809159|19393024|P2|PD Analysis Set|Part 1||6
7880588|NCT00809159|19393025|P1|PD Analysis Set|Part 1||23
7880589|NCT00809159|19393020|P6|PK Analysis Set|Part 1||0
7880590|NCT00809159|19393021|P5|PK Analysis Set|Part 1||0
7880591|NCT00809159|19393022|P4|PK Analysis Set|Part 1||0
7880592|NCT00809159|19393023|P3|PK Analysis Set|Part 1||0
7880593|NCT00809159|19393024|P2|PK Analysis Set|Part 1||6
7880594|NCT00809159|19393025|P1|PK Analysis Set|Part 1||24
7880595|NCT00809159|19393020|P6|STARTED|Part 1||0
7880596|NCT00809159|19393021|P5|STARTED|Part 1||0
7880597|NCT00809159|19393022|P4|STARTED|Part 1||0
7880598|NCT00809159|19393023|P3|STARTED|Part 1||0
7880599|NCT00809159|19393024|P2|STARTED|Part 1||6
7880600|NCT00809159|19393025|P1|STARTED|Part 1||24
7880601|NCT00809146|19393091|P2|NOT COMPLETED|Overall Study||0
7880602|NCT00809146|19393092|P1|NOT COMPLETED|Overall Study||0
7880603|NCT00809146|19393091|P2|COMPLETED|Overall Study||445
7880604|NCT00809146|19393092|P1|COMPLETED|Overall Study||448
7880605|NCT00809146|19393091|P2|STARTED|Overall Study||445
7880606|NCT00809146|19393092|P1|STARTED|Overall Study||448
7880607|NCT00809133|19393130|P14|NOT COMPLETED|Overall Study||7
7880608|NCT00809133|19393131|P13|NOT COMPLETED|Overall Study||5
7880609|NCT00809133|19393132|P12|NOT COMPLETED|Overall Study||8
7880610|NCT00809133|19393133|P11|NOT COMPLETED|Overall Study||6
7880611|NCT00809133|19393134|P10|NOT COMPLETED|Overall Study||9
7880612|NCT00809133|19393135|P9|NOT COMPLETED|Overall Study||3
7880613|NCT00809133|19393136|P8|NOT COMPLETED|Overall Study||8
7880614|NCT00809133|19393137|P7|NOT COMPLETED|Overall Study||6
7880615|NCT00809133|19393138|P6|NOT COMPLETED|Overall Study||7
7880616|NCT00809133|19393139|P5|NOT COMPLETED|Overall Study||5
7880617|NCT00809133|19393140|P4|NOT COMPLETED|Overall Study||3
7880618|NCT00809133|19393141|P3|NOT COMPLETED|Overall Study||6
7880619|NCT00809133|19393142|P2|NOT COMPLETED|Overall Study||7
7880620|NCT00809133|19393143|P1|NOT COMPLETED|Overall Study||3
7880621|NCT00809133|19393130|P14|COMPLETED|Overall Study||0
7880622|NCT00809133|19393131|P13|COMPLETED|Overall Study||0
7880623|NCT00809133|19393132|P12|COMPLETED|Overall Study||0
7880624|NCT00809133|19393133|P11|COMPLETED|Overall Study||0
7880625|NCT00809133|19393134|P10|COMPLETED|Overall Study||0
7880626|NCT00809133|19393135|P9|COMPLETED|Overall Study||0
7880627|NCT00809133|19393136|P8|COMPLETED|Overall Study||0
7880628|NCT00809133|19393137|P7|COMPLETED|Overall Study||0
7880629|NCT00809133|19393138|P6|COMPLETED|Overall Study||0
7880630|NCT00809133|19393139|P5|COMPLETED|Overall Study||0
7880631|NCT00809133|19393140|P4|COMPLETED|Overall Study||0
7880632|NCT00809133|19393141|P3|COMPLETED|Overall Study||0
7880633|NCT00809133|19393142|P2|COMPLETED|Overall Study||0
7880634|NCT00809133|19393143|P1|COMPLETED|Overall Study||0
7880635|NCT00809133|19393130|P14|STARTED|Overall Study||7
7880636|NCT00809133|19393131|P13|STARTED|Overall Study||5
7880637|NCT00809133|19393132|P12|STARTED|Overall Study||8
7880638|NCT00809133|19393133|P11|STARTED|Overall Study||6
7880639|NCT00809133|19393134|P10|STARTED|Overall Study||9
7880640|NCT00809133|19393135|P9|STARTED|Overall Study||3
7880641|NCT00809133|19393136|P8|STARTED|Overall Study||8
7880642|NCT00809133|19393137|P7|STARTED|Overall Study||6
7880643|NCT00809133|19393138|P6|STARTED|Overall Study||7
7880644|NCT00809133|19393139|P5|STARTED|Overall Study||5
7880645|NCT00809133|19393140|P4|STARTED|Overall Study||3
7880646|NCT00809133|19393141|P3|STARTED|Overall Study||6
7880647|NCT00809133|19393142|P2|STARTED|Overall Study||7
7880648|NCT00809133|19393143|P1|STARTED|Overall Study||3
7880649|NCT00809094|19393297|P2|NOT COMPLETED|Overall Study||1
7880650|NCT00809094|19393298|P1|NOT COMPLETED|Overall Study||0
7880651|NCT00809094|19393297|P2|COMPLETED|Overall Study||33
7880652|NCT00809094|19393298|P1|COMPLETED|Overall Study||36
7880653|NCT00809094|19393297|P2|STARTED|Overall Study||34
7880654|NCT00809094|19393298|P1|STARTED|Overall Study||36
7880655|NCT00809055|19393318|P2|NOT COMPLETED|Overall Study||7
7880656|NCT00809055|19393319|P1|NOT COMPLETED|Overall Study||9
7880657|NCT00809055|19393318|P2|COMPLETED|Overall Study||30
7880658|NCT00809055|19393319|P1|COMPLETED|Overall Study||28
7880659|NCT00809055|19393318|P2|STARTED|Overall Study||37
7880660|NCT00809055|19393319|P1|STARTED|Overall Study||37
7880661|NCT00808899|19393343|P1|NOT COMPLETED|Overall Study||4
7880662|NCT00808899|19393343|P1|COMPLETED|Overall Study||0
7880663|NCT00808899|19393343|P1|STARTED|Overall Study||4
7880664|NCT00808834|19393347|P2|NOT COMPLETED|Period 2||0
7880665|NCT00808834|19393348|P1|NOT COMPLETED|Period 2||0
7880666|NCT00808834|19393347|P2|COMPLETED|Period 2||99
7880667|NCT00808834|19393348|P1|COMPLETED|Period 2||97
7880668|NCT00808834|19393347|P2|STARTED|Period 2||99
7880669|NCT00808834|19393348|P1|STARTED|Period 2||97
7880670|NCT00808834|19393347|P2|NOT COMPLETED|Period 1||0
7880671|NCT00808834|19393348|P1|NOT COMPLETED|Period 1||0
7880672|NCT00808834|19393347|P2|COMPLETED|Period 1||99
7880673|NCT00808834|19393348|P1|COMPLETED|Period 1||97
7880674|NCT00808834|19393347|P2|STARTED|Period 1||99
7880675|NCT00808834|19393348|P1|STARTED|Period 1||97
7880676|NCT00808808|19393357|P3|NOT COMPLETED|Overall Study||2557
7880677|NCT00808808|19393358|P2|NOT COMPLETED|Overall Study||2437
7880678|NCT00808808|19393359|P1|NOT COMPLETED|Overall Study||2817
7880679|NCT00808808|19393357|P3|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830
7880680|NCT00808808|19393358|P2|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320
7880681|NCT00808808|19393359|P1|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261
7880682|NCT00808808|19393357|P3|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132
7880683|NCT00808808|19393358|P2|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489
7880684|NCT00808808|19393359|P1|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392
7880685|NCT00808808|19393357|P3|STARTED|Overall Study|Started includes all employees at participating sites.|4387
7880686|NCT00808808|19393358|P2|STARTED|Overall Study|Started includes all employees at participating sites|3757
7880687|NCT00808808|19393359|P1|STARTED|Overall Study|Started includes all employees at participating sites.|4078
7880688|NCT00808769|19393385|P2|NOT COMPLETED|Second Intervention||0
7880689|NCT00808769|19393386|P1|NOT COMPLETED|Second Intervention||0
7880690|NCT00808769|19393385|P2|COMPLETED|Second Intervention||15
7880691|NCT00808769|19393386|P1|COMPLETED|Second Intervention||15
7880692|NCT00808769|19393385|P2|STARTED|Second Intervention||15
7880693|NCT00808769|19393386|P1|STARTED|Second Intervention||15
7880694|NCT00808769|19393385|P2|NOT COMPLETED|First Intervention||0
7880695|NCT00808769|19393386|P1|NOT COMPLETED|First Intervention||0
7880696|NCT00808769|19393385|P2|COMPLETED|First Intervention||15
7880697|NCT00808769|19393386|P1|COMPLETED|First Intervention||15
7880698|NCT00808769|19393385|P2|STARTED|First Intervention||15
7880699|NCT00808769|19393386|P1|STARTED|First Intervention||15
7880700|NCT00808665|19393394|P2|NOT COMPLETED|Overall Study||3
7880701|NCT00808665|19393395|P1|NOT COMPLETED|Overall Study||6
7880702|NCT00808665|19393394|P2|COMPLETED|Overall Study||29
7880703|NCT00808665|19393395|P1|COMPLETED|Overall Study||25
7880704|NCT00808665|19393394|P2|Completed Post Operative Doses|Overall Study||29
7880705|NCT00808665|19393395|P1|Completed Post Operative Doses|Overall Study||25
7880706|NCT00808665|19393394|P2|Completed Intra-operative Dose|Overall Study||32
7880707|NCT00808665|19393395|P1|Completed Intra-operative Dose|Overall Study||26
7880708|NCT00808665|19393394|P2|Medication Started|Overall Study||32
7880709|NCT00808665|19393395|P1|Medication Started|Overall Study||30
7880710|NCT00808665|19393394|P2|STARTED|Overall Study||32
7880711|NCT00808665|19393395|P1|STARTED|Overall Study||31
7880712|NCT00808639|19393401|P1|NOT COMPLETED|Overall Study||1
7880713|NCT00808639|19393401|P1|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38
7880714|NCT00808639|19393401|P1|STARTED|Overall Study||39
7880715|NCT00808509|19393409|P2|NOT COMPLETED|Observation Phase||0
7880716|NCT00808509|19393410|P1|NOT COMPLETED|Observation Phase||0
7880717|NCT00808509|19393409|P2|COMPLETED|Observation Phase||15
7880718|NCT00808509|19393410|P1|COMPLETED|Observation Phase||16
7880719|NCT00808509|19393409|P2|STARTED|Observation Phase|The observation phase was open to all participants|15
7880720|NCT00808509|19393410|P1|STARTED|Observation Phase|The observation phase was open to all participants|16
7880721|NCT00808509|19393409|P2|NOT COMPLETED|Randomized Phase||5
7880722|NCT00808509|19393410|P1|NOT COMPLETED|Randomized Phase||2
7880723|NCT00808509|19393409|P2|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11
7880724|NCT00808509|19393410|P1|COMPLETED|Randomized Phase||15
7880725|NCT00808509|19393409|P2|Received Rescue Therapy|Randomized Phase||9
7880726|NCT00808509|19393410|P1|Received Rescue Therapy|Randomized Phase||0
7880727|NCT00808509|19393409|P2|STARTED|Randomized Phase||16
7880728|NCT00808509|19393410|P1|STARTED|Randomized Phase||17
7880729|NCT00808483|19393508|P2|NOT COMPLETED|From 5 Months to 12 Months||0
7880730|NCT00808483|19393509|P1|NOT COMPLETED|From 5 Months to 12 Months||1
7880731|NCT00808483|19393508|P2|COMPLETED|From 5 Months to 12 Months||32
7880732|NCT00808483|19393509|P1|COMPLETED|From 5 Months to 12 Months||32
7880733|NCT00808483|19393508|P2|STARTED|From 5 Months to 12 Months||32
7880734|NCT00808483|19393509|P1|STARTED|From 5 Months to 12 Months||33
7880735|NCT00808483|19393508|P2|NOT COMPLETED|From 3 to 5 Months After Surgery||1
7880736|NCT00808483|19393509|P1|NOT COMPLETED|From 3 to 5 Months After Surgery||2
7880737|NCT00808483|19393508|P2|COMPLETED|From 3 to 5 Months After Surgery||32
7880738|NCT00808483|19393509|P1|COMPLETED|From 3 to 5 Months After Surgery||33
7880739|NCT00808483|19393508|P2|STARTED|From 3 to 5 Months After Surgery||33
7880740|NCT00808483|19393509|P1|STARTED|From 3 to 5 Months After Surgery||35
7880741|NCT00808470|19393531|P2|NOT COMPLETED|Overall Study||0
7880742|NCT00808470|19393532|P1|NOT COMPLETED|Overall Study||2
7880743|NCT00808470|19393531|P2|COMPLETED|Overall Study||35
7880744|NCT00808470|19393532|P1|COMPLETED|Overall Study||35
7880745|NCT00808470|19393531|P2|STARTED|Overall Study||35
7880746|NCT00808470|19393532|P1|STARTED|Overall Study||37
7880747|NCT00808444|19393546|P2|NOT COMPLETED|Overall Study||1
7880748|NCT00808444|19393547|P1|NOT COMPLETED|Overall Study||1
7880749|NCT00808444|19393546|P2|COMPLETED|Overall Study||232
7880750|NCT00808444|19393547|P1|COMPLETED|Overall Study||232
7880751|NCT00808444|19393546|P2|STARTED|Overall Study||233
7880752|NCT00808444|19393547|P1|STARTED|Overall Study||233
7880753|NCT00808405|19393587|P2|NOT COMPLETED|Overall Study||0
7880754|NCT00808405|19393588|P1|NOT COMPLETED|Overall Study||0
7880755|NCT00808405|19393587|P2|COMPLETED|Overall Study||27
7880756|NCT00808405|19393588|P1|COMPLETED|Overall Study||61
7880757|NCT00808405|19393587|P2|STARTED|Overall Study||27
7880758|NCT00808405|19393588|P1|STARTED|Overall Study||61
7880759|NCT00808340|19393596|P6|NOT COMPLETED|Third Intervention||0
7880760|NCT00808340|19393597|P5|NOT COMPLETED|Third Intervention||0
7880761|NCT00808340|19393598|P4|NOT COMPLETED|Third Intervention||0
7880762|NCT00808340|19393599|P3|NOT COMPLETED|Third Intervention||0
7880763|NCT00808340|19393600|P2|NOT COMPLETED|Third Intervention||0
7880764|NCT00808340|19393601|P1|NOT COMPLETED|Third Intervention||0
7880765|NCT00808340|19393596|P6|COMPLETED|Third Intervention||6
7880766|NCT00808340|19393597|P5|COMPLETED|Third Intervention||5
7880767|NCT00808340|19393598|P4|COMPLETED|Third Intervention||3
7880768|NCT00808340|19393599|P3|COMPLETED|Third Intervention||7
7880769|NCT00808340|19393600|P2|COMPLETED|Third Intervention||9
7880770|NCT00808340|19393601|P1|COMPLETED|Third Intervention||4
7880771|NCT00808340|19393596|P6|STARTED|Third Intervention||6
7880772|NCT00808340|19393597|P5|STARTED|Third Intervention||5
7880773|NCT00808340|19393598|P4|STARTED|Third Intervention||3
7880774|NCT00808340|19393599|P3|STARTED|Third Intervention||7
7880775|NCT00808340|19393600|P2|STARTED|Third Intervention||9
7880776|NCT00808340|19393601|P1|STARTED|Third Intervention||4
7880777|NCT00808340|19393596|P6|NOT COMPLETED|Second Intervention||0
7880778|NCT00808340|19393597|P5|NOT COMPLETED|Second Intervention||0
7880779|NCT00808340|19393598|P4|NOT COMPLETED|Second Intervention||0
7880780|NCT00808340|19393599|P3|NOT COMPLETED|Second Intervention||0
7880781|NCT00808340|19393600|P2|NOT COMPLETED|Second Intervention||0
7880782|NCT00808340|19393601|P1|NOT COMPLETED|Second Intervention||0
7880783|NCT00808340|19393596|P6|COMPLETED|Second Intervention||6
7880784|NCT00808340|19393597|P5|COMPLETED|Second Intervention||5
7880785|NCT00808340|19393598|P4|COMPLETED|Second Intervention||3
7880786|NCT00808340|19393599|P3|COMPLETED|Second Intervention||7
7880787|NCT00808340|19393600|P2|COMPLETED|Second Intervention||9
7880788|NCT00808340|19393601|P1|COMPLETED|Second Intervention||4
7880789|NCT00808340|19393596|P6|STARTED|Second Intervention||6
7880790|NCT00808340|19393597|P5|STARTED|Second Intervention||5
7880791|NCT00808340|19393598|P4|STARTED|Second Intervention||3
7880792|NCT00808340|19393599|P3|STARTED|Second Intervention||7
7880793|NCT00808340|19393600|P2|STARTED|Second Intervention||9
7880794|NCT00808340|19393601|P1|STARTED|Second Intervention||4
7880795|NCT00808340|19393596|P6|NOT COMPLETED|First Intervention||0
7880796|NCT00808340|19393597|P5|NOT COMPLETED|First Intervention||0
7880797|NCT00808340|19393598|P4|NOT COMPLETED|First Intervention||0
7880798|NCT00808340|19393599|P3|NOT COMPLETED|First Intervention||0
7880799|NCT00808340|19393600|P2|NOT COMPLETED|First Intervention||0
7880800|NCT00808340|19393601|P1|NOT COMPLETED|First Intervention||0
7880801|NCT00808340|19393596|P6|COMPLETED|First Intervention||6
7880802|NCT00808340|19393597|P5|COMPLETED|First Intervention||5
7880803|NCT00808340|19393598|P4|COMPLETED|First Intervention||3
7880804|NCT00808340|19393599|P3|COMPLETED|First Intervention||7
7880805|NCT00808340|19393600|P2|COMPLETED|First Intervention||9
7880806|NCT00808340|19393601|P1|COMPLETED|First Intervention||4
7880807|NCT00808340|19393596|P6|STARTED|First Intervention||6
7880808|NCT00808340|19393597|P5|STARTED|First Intervention||5
7880809|NCT00808340|19393598|P4|STARTED|First Intervention||3
7880810|NCT00808340|19393599|P3|STARTED|First Intervention||7
7880811|NCT00808340|19393600|P2|STARTED|First Intervention||9
7880812|NCT00808340|19393601|P1|STARTED|First Intervention||4
7880813|NCT00808249|19393622|P4|NOT COMPLETED|Overall Study||16
7880814|NCT00808249|19393623|P3|NOT COMPLETED|Overall Study||22
7880815|NCT00808249|19393624|P2|NOT COMPLETED|Overall Study||15
7880816|NCT00808249|19393625|P1|NOT COMPLETED|Overall Study||17
7880817|NCT00808249|19393622|P4|COMPLETED|Overall Study||90
7880818|NCT00808249|19393623|P3|COMPLETED|Overall Study||83
7880819|NCT00808249|19393624|P2|COMPLETED|Overall Study||91
7880820|NCT00808249|19393625|P1|COMPLETED|Overall Study||90
7880821|NCT00808249|19393622|P4|STARTED|Overall Study||106
7880822|NCT00808249|19393623|P3|STARTED|Overall Study||105
7880823|NCT00808249|19393624|P2|STARTED|Overall Study||106
7880824|NCT00808249|19393625|P1|STARTED|Overall Study||107
7880825|NCT00808236|19393653|P2|NOT COMPLETED|Overall Study||91
7880826|NCT00808236|19393654|P1|NOT COMPLETED|Overall Study||82
7880827|NCT00808236|19393653|P2|COMPLETED|Overall Study||13
7880828|NCT00808236|19393654|P1|COMPLETED|Overall Study||14
7880829|NCT00808236|19393653|P2|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42
7880830|NCT00808236|19393654|P1|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30
7880831|NCT00808236|19393653|P2|Achieved ROSC|Overall Study||43
7880832|NCT00808236|19393654|P1|Achieved ROSC|Overall Study||33
7880833|NCT00808236|19393653|P2|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99
7880834|NCT00808236|19393654|P1|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83
7880835|NCT00808236|19393653|P2|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101
7880836|NCT00808236|19393654|P1|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84
7880837|NCT00808236|19393653|P2|STARTED|Overall Study||104
7880838|NCT00808236|19393654|P1|STARTED|Overall Study||96
7880839|NCT00808210|19393684|P2|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||4
7880840|NCT00808210|19393685|P1|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||9
7880841|NCT00808210|19393684|P2|COMPLETED|Open Label Ocrelizumab Treatment Period||0
7880842|NCT00808210|19393685|P1|COMPLETED|Open Label Ocrelizumab Treatment Period||0
7880843|NCT00808210|19393684|P2|STARTED|Open Label Ocrelizumab Treatment Period||4
7880844|NCT00808210|19393685|P1|STARTED|Open Label Ocrelizumab Treatment Period||9
7880845|NCT00808210|19393684|P2|NOT COMPLETED|Double-Blind TX Period||3
7880846|NCT00808210|19393685|P1|NOT COMPLETED|Double-Blind TX Period||2
7880847|NCT00808210|19393684|P2|COMPLETED|Double-Blind TX Period||10
7880848|NCT00808210|19393685|P1|COMPLETED|Double-Blind TX Period||13
7880849|NCT00808210|19393684|P2|STARTED|Double-Blind TX Period||13
7880850|NCT00808210|19393685|P1|STARTED|Double-Blind TX Period||15
7880851|NCT00808210|19393684|P2|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9
7880852|NCT00808210|19393685|P1|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9
7880853|NCT00808210|19393684|P2|COMPLETED|Study Period + 48 Weeks of Follow-up||4
7880854|NCT00808210|19393685|P1|COMPLETED|Study Period + 48 Weeks of Follow-up||6
7880855|NCT00808210|19393684|P2|STARTED|Study Period + 48 Weeks of Follow-up||13
7880856|NCT00808210|19393685|P1|STARTED|Study Period + 48 Weeks of Follow-up||15
7880857|NCT00808132|19393710|P5|NOT COMPLETED|Overall Study||100
7880858|NCT00808132|19393711|P4|NOT COMPLETED|Overall Study||69
7880859|NCT00808132|19393712|P3|NOT COMPLETED|Overall Study||54
7880860|NCT00808132|19393713|P2|NOT COMPLETED|Overall Study||88
7880861|NCT00808132|19393714|P1|NOT COMPLETED|Overall Study||98
7880862|NCT00808132|19393710|P5|COMPLETED|Overall Study||383
7880863|NCT00808132|19393711|P4|COMPLETED|Overall Study||159
7880864|NCT00808132|19393712|P3|COMPLETED|Overall Study||185
7880865|NCT00808132|19393713|P2|COMPLETED|Overall Study||393
7880866|NCT00808132|19393714|P1|COMPLETED|Overall Study||357
7880867|NCT00808132|19393710|P5|Treated|Overall Study||474
7880868|NCT00808132|19393711|P4|Treated|Overall Study||220
7880869|NCT00808132|19393712|P3|Treated|Overall Study||230
7880870|NCT00808132|19393713|P2|Treated|Overall Study||474
7880871|NCT00808132|19393714|P1|Treated|Overall Study||445
7880872|NCT00808132|19393710|P5|STARTED|Overall Study||483
7880873|NCT00808132|19393711|P4|STARTED|Overall Study||228
7880874|NCT00808132|19393712|P3|STARTED|Overall Study||239
7880875|NCT00808132|19393713|P2|STARTED|Overall Study||481
7880876|NCT00808132|19393714|P1|STARTED|Overall Study||455
7880877|NCT00808080|19393786|P1|NOT COMPLETED|Overall Study||6
7880878|NCT00808080|19393786|P1|COMPLETED|Overall Study||0
7880879|NCT00808080|19393786|P1|STARTED|Overall Study||6
7880880|NCT00808067|19393793|P2|NOT COMPLETED|Overall Study||518
7880881|NCT00808067|19393794|P1|NOT COMPLETED|Overall Study||481
7880882|NCT00808067|19393793|P2|COMPLETED|Overall Study||2438
7880883|NCT00808067|19393794|P1|COMPLETED|Overall Study||2446
7880884|NCT00808067|19393793|P2|STARTED|Overall Study|Number of patients which are treated.|2956
7880885|NCT00808067|19393794|P1|STARTED|Overall Study|Number of patients which are treated.|2927
7880886|NCT00808028|19393830|P4|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23
7880887|NCT00808028|19393831|P3|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29
7880888|NCT00808028|19393832|P2|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0
7880889|NCT00808028|19393833|P1|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11
7880890|NCT00808028|19393830|P4|COMPLETED|Stage 2 (Followed up to 48 Months )||128
7880891|NCT00808028|19393831|P3|COMPLETED|Stage 2 (Followed up to 48 Months )||141
7880892|NCT00808028|19393832|P2|COMPLETED|Stage 2 (Followed up to 48 Months )||0
7880893|NCT00808028|19393833|P1|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69
7880894|NCT00808028|19393830|P4|STARTED|Stage 2 (Followed up to 48 Months )||151
7880895|NCT00808028|19393831|P3|STARTED|Stage 2 (Followed up to 48 Months )||170
7880896|NCT00808028|19393832|P2|STARTED|Stage 2 (Followed up to 48 Months )||0
7880897|NCT00808028|19393833|P1|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80
7880898|NCT00808028|19393830|P4|NOT COMPLETED|Stage 1 (6 Months)||15
7880899|NCT00808028|19393831|P3|NOT COMPLETED|Stage 1 (6 Months)||7
7880900|NCT00808028|19393832|P2|NOT COMPLETED|Stage 1 (6 Months)||1
7880901|NCT00808028|19393833|P1|NOT COMPLETED|Stage 1 (6 Months)||5
7880902|NCT00808028|19393830|P4|COMPLETED|Stage 1 (6 Months)||183
7880903|NCT00808028|19393831|P3|COMPLETED|Stage 1 (6 Months)||191
7880904|NCT00808028|19393832|P2|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21
7880905|NCT00808028|19393833|P1|COMPLETED|Stage 1 (6 Months)||116
7880906|NCT00808028|19393830|P4|STARTED|Stage 1 (6 Months)||198
7880907|NCT00808028|19393831|P3|STARTED|Stage 1 (6 Months)||198
7880908|NCT00808028|19393832|P2|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22
7880909|NCT00808028|19393833|P1|STARTED|Stage 1 (6 Months)||121
7880910|NCT00808015|19393869|P1|NOT COMPLETED|Overall Study||344
7880911|NCT00808015|19393869|P1|COMPLETED|Overall Study||1033
7880912|NCT00808015|19393869|P1|Treated|Overall Study||1373
7880913|NCT00808015|19393869|P1|STARTED|Overall Study||1377
7880914|NCT00807989|19393883|P2|NOT COMPLETED|Overall Study||2
7880915|NCT00807989|19393884|P1|NOT COMPLETED|Overall Study||3
7880916|NCT00807989|19393883|P2|COMPLETED|Overall Study||98
7880917|NCT00807989|19393884|P1|COMPLETED|Overall Study||104
7880918|NCT00807989|19393883|P2|STARTED|Overall Study||100
7880919|NCT00807989|19393884|P1|STARTED|Overall Study||107
7880920|NCT00807937|19393898|P4|NOT COMPLETED|Overall Study||15
7880921|NCT00807937|19393899|P3|NOT COMPLETED|Overall Study||14
7880922|NCT00807937|19393900|P2|NOT COMPLETED|Overall Study||25
7880923|NCT00807937|19393901|P1|NOT COMPLETED|Overall Study||27
7880924|NCT00807937|19393898|P4|COMPLETED|Overall Study||77
7880925|NCT00807937|19393899|P3|COMPLETED|Overall Study||78
7880926|NCT00807937|19393900|P2|COMPLETED|Overall Study||67
7880927|NCT00807937|19393901|P1|COMPLETED|Overall Study||66
7880928|NCT00807937|19393898|P4|STARTED|Overall Study||92
7880929|NCT00807937|19393899|P3|STARTED|Overall Study||92
7880930|NCT00807937|19393900|P2|STARTED|Overall Study||92
7880931|NCT00807937|19393901|P1|STARTED|Overall Study||93
7880932|NCT00807885|19393936|P9|NOT COMPLETED|Overall Study||0
7880933|NCT00807885|19393937|P8|NOT COMPLETED|Overall Study||0
7880934|NCT00807885|19393938|P7|NOT COMPLETED|Overall Study||0
7880935|NCT00807885|19393939|P6|NOT COMPLETED|Overall Study||1
7880936|NCT00807885|19393940|P5|NOT COMPLETED|Overall Study||0
7880937|NCT00807885|19393941|P4|NOT COMPLETED|Overall Study||0
7880938|NCT00807885|19393942|P3|NOT COMPLETED|Overall Study||0
7880939|NCT00807885|19393943|P2|NOT COMPLETED|Overall Study||0
7880940|NCT00807885|19393944|P1|NOT COMPLETED|Overall Study||0
7880941|NCT00807885|19393936|P9|COMPLETED|Overall Study||11
7880942|NCT00807885|19393937|P8|COMPLETED|Overall Study||11
7880943|NCT00807885|19393938|P7|COMPLETED|Overall Study||12
7880944|NCT00807885|19393939|P6|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11
7880945|NCT00807885|19393940|P5|COMPLETED|Overall Study||12
7880946|NCT00807885|19393941|P4|COMPLETED|Overall Study||10
7880947|NCT00807885|19393942|P3|COMPLETED|Overall Study||11
7880948|NCT00807885|19393943|P2|COMPLETED|Overall Study||11
7880949|NCT00807885|19393944|P1|COMPLETED|Overall Study||10
7880950|NCT00807885|19393936|P9|STARTED|Overall Study||11
7880951|NCT00807885|19393937|P8|STARTED|Overall Study||11
7880952|NCT00807885|19393938|P7|STARTED|Overall Study||12
7880953|NCT00807885|19393939|P6|STARTED|Overall Study||12
7880954|NCT00807885|19393940|P5|STARTED|Overall Study||12
7880955|NCT00807885|19393941|P4|STARTED|Overall Study||10
7880956|NCT00807885|19393942|P3|STARTED|Overall Study||11
7880957|NCT00807885|19393943|P2|STARTED|Overall Study||11
7880958|NCT00807885|19393944|P1|STARTED|Overall Study||10
7880959|NCT00807846|19393993|P2|NOT COMPLETED|Overall Study||4
7880960|NCT00807846|19393994|P1|NOT COMPLETED|Overall Study||12
7880961|NCT00807846|19393993|P2|COMPLETED|Overall Study||94
7880962|NCT00807846|19393994|P1|COMPLETED|Overall Study||88
7880963|NCT00807846|19393993|P2|STARTED|Overall Study||98
7880964|NCT00807846|19393994|P1|STARTED|Overall Study||100
7880965|NCT00807768|19394028|P2|NOT COMPLETED|Overall Study||0
7880966|NCT00807768|19394029|P1|NOT COMPLETED|Overall Study||0
7880967|NCT00807768|19394028|P2|COMPLETED|Overall Study||300
7880968|NCT00807768|19394029|P1|COMPLETED|Overall Study||301
7880969|NCT00807768|19394028|P2|STARTED|Overall Study||300
7880970|NCT00807768|19394029|P1|STARTED|Overall Study||301
7880971|NCT00807742|19394047|P2|NOT COMPLETED|Overall Study||54
7880972|NCT00807742|19394048|P1|NOT COMPLETED|Overall Study||46
7880973|NCT00807742|19394047|P2|COMPLETED|Overall Study||114
7880974|NCT00807742|19394048|P1|COMPLETED|Overall Study||126
7880975|NCT00807742|19394047|P2|STARTED|Overall Study||168
7880976|NCT00807742|19394048|P1|STARTED|Overall Study||172
7880977|NCT00807664|19394094|P2|NOT COMPLETED|Overall Study||19
7880978|NCT00807664|19394095|P1|NOT COMPLETED|Overall Study||11
7880979|NCT00807664|19394094|P2|COMPLETED|Overall Study||75
7880980|NCT00807664|19394095|P1|COMPLETED|Overall Study||77
7880981|NCT00807664|19394094|P2|STARTED|Overall Study||94
7880982|NCT00807664|19394095|P1|STARTED|Overall Study||88
7880983|NCT00807599|19394107|P3|NOT COMPLETED|Overall Study||17
7880984|NCT00807599|19394108|P2|NOT COMPLETED|Overall Study||0
7880985|NCT00807599|19394109|P1|NOT COMPLETED|Overall Study||0
7880986|NCT00807599|19394107|P3|COMPLETED|Overall Study||0
7880987|NCT00807599|19394108|P2|COMPLETED|Overall Study||24
7880988|NCT00807599|19394109|P1|COMPLETED|Overall Study||26
7880989|NCT00807599|19394107|P3|STARTED|Overall Study||17
7880990|NCT00807599|19394108|P2|STARTED|Overall Study||24
7880991|NCT00807599|19394109|P1|STARTED|Overall Study||26
7880992|NCT00807586|19394123|P2|NOT COMPLETED|Overall Study||1
7880993|NCT00807586|19394124|P1|NOT COMPLETED|Overall Study||6
7880994|NCT00807586|19394123|P2|COMPLETED|Overall Study||58
7880995|NCT00807586|19394124|P1|COMPLETED|Overall Study||54
7880996|NCT00807586|19394123|P2|STARTED|Overall Study||59
7880997|NCT00807586|19394124|P1|STARTED|Overall Study||60
7880998|NCT00807573|19394136|P1|NOT COMPLETED|Overall Study||2
7880999|NCT00807573|19394136|P1|COMPLETED|Overall Study||42
7881000|NCT00807573|19394136|P1|STARTED|Overall Study||44
7881001|NCT00807560|19394142|P2|NOT COMPLETED|Overall Study||0
7881002|NCT00807560|19394143|P1|NOT COMPLETED|Overall Study||0
7881003|NCT00807560|19394142|P2|COMPLETED|Overall Study||39
7881004|NCT00807560|19394143|P1|COMPLETED|Overall Study||38
7881005|NCT00807560|19394142|P2|STARTED|Overall Study||39
7881006|NCT00807560|19394143|P1|STARTED|Overall Study||38
7881007|NCT00807495|19394182|P5|NOT COMPLETED|Overall Study||5
7881008|NCT00807495|19394183|P4|NOT COMPLETED|Overall Study||1
7881009|NCT00807495|19394184|P3|NOT COMPLETED|Overall Study||4
7881010|NCT00807495|19394185|P2|NOT COMPLETED|Overall Study||6
7881011|NCT00807495|19394186|P1|NOT COMPLETED|Overall Study||8
7881012|NCT00807495|19394182|P5|COMPLETED|Overall Study||2
7881013|NCT00807495|19394183|P4|COMPLETED|Overall Study||0
7881014|NCT00807495|19394184|P3|COMPLETED|Overall Study||1
7881015|NCT00807495|19394185|P2|COMPLETED|Overall Study||7
7881016|NCT00807495|19394186|P1|COMPLETED|Overall Study|Completed = participants who completed the study treatment to PD or symptomatic deterioration.|14
7881017|NCT00807495|19394182|P5|STARTED|Overall Study|An ATL participant had late on-study biopsy and was in DLBL, reducing ATL participants from 8 to 7.|7
7881018|NCT00807495|19394183|P4|STARTED|Overall Study||1
7881019|NCT00807495|19394184|P3|STARTED|Overall Study||5
7881020|NCT00807495|19394185|P2|STARTED|Overall Study||13
7881021|NCT00807495|19394186|P1|STARTED|Overall Study||22
7881022|NCT00807456|19394228|P1|NOT COMPLETED|Overall Study||0
7881023|NCT00807456|19394228|P1|COMPLETED|Overall Study||65
7881024|NCT00807456|19394228|P1|STARTED|Overall Study||65
7881025|NCT00807365|19394232|P1|NOT COMPLETED|Overall Study||5
7881026|NCT00807365|19394232|P1|COMPLETED|Overall Study||0
7881027|NCT00807365|19394232|P1|STARTED|Overall Study||5
7881028|NCT00807248|19394240|P4|NOT COMPLETED|Overall Study||14
7881029|NCT00807248|19394241|P3|NOT COMPLETED|Overall Study||18
7881030|NCT00807248|19394242|P2|NOT COMPLETED|Overall Study||12
7881031|NCT00807248|19394243|P1|NOT COMPLETED|Overall Study||21
7881032|NCT00807248|19394240|P4|COMPLETED|Overall Study||126
7881033|NCT00807248|19394241|P3|COMPLETED|Overall Study||121
7881034|NCT00807248|19394242|P2|COMPLETED|Overall Study||128
7881035|NCT00807248|19394243|P1|COMPLETED|Overall Study||50
7881036|NCT00807248|19394240|P4|STARTED|Overall Study||140
7881037|NCT00807248|19394241|P3|STARTED|Overall Study||139
7881038|NCT00807248|19394242|P2|STARTED|Overall Study||140
7881039|NCT00807248|19394243|P1|STARTED|Overall Study||71
7881040|NCT00807235|19394287|P2|NOT COMPLETED|Overall Study||0
7881041|NCT00807235|19394288|P1|NOT COMPLETED|Overall Study||1
7881042|NCT00807235|19394287|P2|COMPLETED|Overall Study||6
7881043|NCT00807235|19394288|P1|COMPLETED|Overall Study||10
7881044|NCT00807235|19394287|P2|STARTED|Overall Study||6
7881045|NCT00807235|19394288|P1|STARTED|Overall Study||11
7881046|NCT00807209|19394321|P3|NOT COMPLETED|Overall Study||0
7881047|NCT00807209|19394322|P2|NOT COMPLETED|Overall Study||0
7881048|NCT00807209|19394323|P1|NOT COMPLETED|Overall Study||0
7881049|NCT00807209|19394321|P3|COMPLETED|Overall Study||1
7881050|NCT00807209|19394322|P2|COMPLETED|Overall Study||1
7881051|NCT00807209|19394323|P1|COMPLETED|Overall Study||1
7881052|NCT00807209|19394321|P3|STARTED|Overall Study||1
7881053|NCT00807209|19394322|P2|STARTED|Overall Study||1
7881054|NCT00807209|19394323|P1|STARTED|Overall Study||1
7881055|NCT00807092|19394333|P2|NOT COMPLETED|Overall Study||4
7881056|NCT00807092|19394334|P1|NOT COMPLETED|Overall Study||1
7881057|NCT00807092|19394333|P2|COMPLETED|Overall Study||69
7881058|NCT00807092|19394334|P1|COMPLETED|Overall Study||71
7881059|NCT00807092|19394333|P2|Exposed to Drug|Overall Study||73
7881060|NCT00807092|19394334|P1|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71
7881061|NCT00807092|19394333|P2|STARTED|Overall Study||73
7881062|NCT00807092|19394334|P1|STARTED|Overall Study||72
7881063|NCT00807040|19394364|P2|NOT COMPLETED|Overall Study||41
7881064|NCT00807040|19394365|P1|NOT COMPLETED|Overall Study||36
7881065|NCT00807040|19394364|P2|COMPLETED|Overall Study||84
7881066|NCT00807040|19394365|P1|COMPLETED|Overall Study||90
7881067|NCT00807040|19394364|P2|STARTED|Overall Study||125
7881068|NCT00807040|19394365|P1|STARTED|Overall Study||126
7881069|NCT00807014|19394375|P2|NOT COMPLETED|Overall Study||27
7881070|NCT00807014|19394376|P1|NOT COMPLETED|Overall Study||27
7881071|NCT00807014|19394375|P2|COMPLETED|Overall Study||58
7881072|NCT00807014|19394376|P1|COMPLETED|Overall Study||56
7881073|NCT00807014|19394375|P2|STARTED|Overall Study||85
7881074|NCT00807014|19394376|P1|STARTED|Overall Study||83
7881075|NCT00807001|19394407|P5|NOT COMPLETED|Overall Study||0
7881076|NCT00807001|19394408|P4|NOT COMPLETED|Overall Study||0
7881077|NCT00807001|19394409|P3|NOT COMPLETED|Overall Study||0
7881078|NCT00807001|19394410|P2|NOT COMPLETED|Overall Study||1
7881079|NCT00807001|19394411|P1|NOT COMPLETED|Overall Study||0
7881080|NCT00807001|19394407|P5|COMPLETED|Overall Study||9
7881081|NCT00807001|19394408|P4|COMPLETED|Overall Study||8
7881082|NCT00807001|19394409|P3|COMPLETED|Overall Study||8
7881083|NCT00807001|19394410|P2|COMPLETED|Overall Study||7
7881084|NCT00807001|19394411|P1|COMPLETED|Overall Study||8
7881085|NCT00807001|19394407|P5|STARTED|Overall Study||9
7881086|NCT00807001|19394408|P4|STARTED|Overall Study||8
7881087|NCT00807001|19394409|P3|STARTED|Overall Study||8
7881088|NCT00807001|19394410|P2|STARTED|Overall Study||8
7881089|NCT00807001|19394411|P1|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8
7881090|NCT00806988|19394430|P2|NOT COMPLETED|Overall Study||43
7881091|NCT00806988|19394431|P1|NOT COMPLETED|Overall Study||27
7881092|NCT00806988|19394430|P2|COMPLETED|Overall Study||108
7881093|NCT00806988|19394431|P1|COMPLETED|Overall Study||123
7881094|NCT00806988|19394430|P2|STARTED|Overall Study||151
7881095|NCT00806988|19394431|P1|STARTED|Overall Study||150
7881096|NCT00806819|19394441|P2|NOT COMPLETED|Overall Study||358
7881097|NCT00806819|19394442|P1|NOT COMPLETED|Overall Study||346
7881098|NCT00806819|19394441|P2|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2
7881099|NCT00806819|19394442|P1|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7
7881100|NCT00806819|19394441|P2|STARTED|Overall Study|randomised patients|360
7881101|NCT00806819|19394442|P1|STARTED|Overall Study|randomised patients|353
7881102|NCT00806676|19394477|P3|NOT COMPLETED|Overall Study||6
7881103|NCT00806676|19394478|P2|NOT COMPLETED|Overall Study||0
7881104|NCT00806676|19394479|P1|NOT COMPLETED|Overall Study||4
7881105|NCT00806676|19394477|P3|COMPLETED|Overall Study||23
7881106|NCT00806676|19394478|P2|COMPLETED|Overall Study||9
7881107|NCT00806676|19394479|P1|COMPLETED|Overall Study||25
7881108|NCT00806676|19394477|P3|STARTED|Overall Study||29
7881109|NCT00806676|19394478|P2|STARTED|Overall Study||9
7881110|NCT00806676|19394479|P1|STARTED|Overall Study||29
7881111|NCT00806624|19394511|P3|NOT COMPLETED|Overall Study||6
7881112|NCT00806624|19394512|P2|NOT COMPLETED|Overall Study||12
7881113|NCT00806624|19394513|P1|NOT COMPLETED|Overall Study||9
7881114|NCT00806624|19394511|P3|COMPLETED|Overall Study||69
7881115|NCT00806624|19394512|P2|COMPLETED|Overall Study||68
7881116|NCT00806624|19394513|P1|COMPLETED|Overall Study||70
7881117|NCT00806624|19394511|P3|STARTED|Overall Study||75
7881118|NCT00806624|19394512|P2|STARTED|Overall Study||80
7881119|NCT00806624|19394513|P1|STARTED|Overall Study||79
7881120|NCT00806598|19394521|P1|NOT COMPLETED|Overall Study||0
7881121|NCT00806598|19394521|P1|COMPLETED|Overall Study||48
7881122|NCT00806598|19394521|P1|STARTED|Overall Study||48
7881123|NCT00806585|19394530|P5|NOT COMPLETED|Overall Study||31
7881124|NCT00806585|19394531|P4|NOT COMPLETED|Overall Study||15
7881125|NCT00806585|19394532|P3|NOT COMPLETED|Overall Study||32
7881126|NCT00806585|19394533|P2|NOT COMPLETED|Overall Study||31
7881127|NCT00806585|19394534|P1|NOT COMPLETED|Overall Study||32
7881128|NCT00806585|19394530|P5|COMPLETED|Overall Study||106
7881129|NCT00806585|19394531|P4|COMPLETED|Overall Study||56
7881130|NCT00806585|19394532|P3|COMPLETED|Overall Study||109
7881131|NCT00806585|19394533|P2|COMPLETED|Overall Study||103
7881132|NCT00806585|19394534|P1|COMPLETED|Overall Study||105
7881133|NCT00806585|19394530|P5|STARTED|Overall Study||137
7881134|NCT00806585|19394531|P4|STARTED|Overall Study||71
7881135|NCT00806585|19394532|P3|STARTED|Overall Study||141
7881136|NCT00806585|19394533|P2|STARTED|Overall Study||134
7881137|NCT00806585|19394534|P1|STARTED|Overall Study||137
7881138|NCT00806546|19394566|P1|NOT COMPLETED|Overall Study||307
7881139|NCT00806546|19394566|P1|COMPLETED|Overall Study||207
7881140|NCT00806546|19394566|P1|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514
7881141|NCT00806494|19394570|P1|NOT COMPLETED|Overall Study||80
7881142|NCT00806494|19394570|P1|COMPLETED|Overall Study||251
7881143|NCT00806494|19394570|P1|STARTED|Overall Study||331
7881144|NCT00806442|19394594|P2|NOT COMPLETED|Overall Study||7
7881145|NCT00806442|19394595|P1|NOT COMPLETED|Overall Study||4
7881146|NCT00806442|19394594|P2|COMPLETED|Overall Study||14
7881147|NCT00806442|19394595|P1|COMPLETED|Overall Study||14
7881148|NCT00806442|19394594|P2|Second Intervention (3 Wks)|Overall Study||14
7881149|NCT00806442|19394595|P1|Second Intervention (3 Wks)|Overall Study||15
7881150|NCT00806442|19394594|P2|Washout (3 Wks)|Overall Study||14
7881151|NCT00806442|19394595|P1|Washout (3 Wks)|Overall Study||15
7881152|NCT00806442|19394594|P2|First Intervention (3 Wks)|Overall Study||21
7881153|NCT00806442|19394595|P1|First Intervention (3 Wks)|Overall Study||18
7881154|NCT00806442|19394594|P2|STARTED|Overall Study||21
7881155|NCT00806442|19394595|P1|STARTED|Overall Study||18
7881156|NCT00806416|19394617|P4|NOT COMPLETED|Period 2 - Part II||0
7881157|NCT00806416|19394618|P3|NOT COMPLETED|Period 2 - Part II||0
7881158|NCT00806416|19394619|P2|NOT COMPLETED|Period 2 - Part II||0
7881159|NCT00806416|19394620|P1|NOT COMPLETED|Period 2 - Part II||0
7881160|NCT00806416|19394617|P4|COMPLETED|Period 2 - Part II||14
7881161|NCT00806416|19394618|P3|COMPLETED|Period 2 - Part II||14
7881162|NCT00806416|19394619|P2|COMPLETED|Period 2 - Part II||0
7881163|NCT00806416|19394620|P1|COMPLETED|Period 2 - Part II||0
7881164|NCT00806416|19394617|P4|STARTED|Period 2 - Part II||14
7881165|NCT00806416|19394618|P3|STARTED|Period 2 - Part II||14
7881166|NCT00806416|19394619|P2|STARTED|Period 2 - Part II||0
7881167|NCT00806416|19394620|P1|STARTED|Period 2 - Part II||0
7881168|NCT00806416|19394617|P4|NOT COMPLETED|Period 1 - Part II||2
7881169|NCT00806416|19394618|P3|NOT COMPLETED|Period 1 - Part II||0
7881170|NCT00806416|19394619|P2|NOT COMPLETED|Period 1 - Part II||0
7881171|NCT00806416|19394620|P1|NOT COMPLETED|Period 1 - Part II||0
7881172|NCT00806416|19394617|P4|COMPLETED|Period 1 - Part II||14
7881173|NCT00806416|19394618|P3|COMPLETED|Period 1 - Part II||14
7881174|NCT00806416|19394619|P2|COMPLETED|Period 1 - Part II||0
7881175|NCT00806416|19394620|P1|COMPLETED|Period 1 - Part II||0
7881176|NCT00806416|19394617|P4|STARTED|Period 1 - Part II||16
7881177|NCT00806416|19394618|P3|STARTED|Period 1 - Part II||14
7881178|NCT00806416|19394619|P2|STARTED|Period 1 - Part II||0
7881179|NCT00806416|19394620|P1|STARTED|Period 1 - Part II||0
7881180|NCT00806416|19394617|P4|NOT COMPLETED|Period 2 - Part I||0
7881181|NCT00806416|19394618|P3|NOT COMPLETED|Period 2 - Part I||0
7881182|NCT00806416|19394619|P2|NOT COMPLETED|Period 2 - Part I||0
7881183|NCT00806416|19394620|P1|NOT COMPLETED|Period 2 - Part I||0
7881184|NCT00806416|19394617|P4|COMPLETED|Period 2 - Part I||0
7881185|NCT00806416|19394618|P3|COMPLETED|Period 2 - Part I||0
7881186|NCT00806416|19394619|P2|COMPLETED|Period 2 - Part I||103
7881187|NCT00806416|19394620|P1|COMPLETED|Period 2 - Part I||104
7881188|NCT00806416|19394617|P4|STARTED|Period 2 - Part I||0
7881189|NCT00806416|19394618|P3|STARTED|Period 2 - Part I||0
7881190|NCT00806416|19394619|P2|STARTED|Period 2 - Part I||103
7881191|NCT00806416|19394620|P1|STARTED|Period 2 - Part I||104
7881192|NCT00806416|19394617|P4|NOT COMPLETED|Period 1 - Part I||0
7881193|NCT00806416|19394618|P3|NOT COMPLETED|Period 1 - Part I||0
7881194|NCT00806416|19394619|P2|NOT COMPLETED|Period 1 - Part I||4
7881195|NCT00806416|19394620|P1|NOT COMPLETED|Period 1 - Part I||3
7881196|NCT00806416|19394617|P4|COMPLETED|Period 1 - Part I||0
7881197|NCT00806416|19394618|P3|COMPLETED|Period 1 - Part I||0
7881198|NCT00806416|19394619|P2|COMPLETED|Period 1 - Part I||103
7881199|NCT00806416|19394620|P1|COMPLETED|Period 1 - Part I||104
7881200|NCT00806416|19394617|P4|STARTED|Period 1 - Part I||0
7881201|NCT00806416|19394618|P3|STARTED|Period 1 - Part I||0
7881202|NCT00806416|19394619|P2|STARTED|Period 1 - Part I||107
7881203|NCT00806416|19394620|P1|STARTED|Period 1 - Part I||107
7881204|NCT00806403|19394633|P2|NOT COMPLETED|Overall Study||3
7881205|NCT00806403|19394634|P1|NOT COMPLETED|Overall Study||4
7881206|NCT00806403|19394633|P2|COMPLETED|Overall Study||98
7881207|NCT00806403|19394634|P1|COMPLETED|Overall Study||100
7881208|NCT00806403|19394633|P2|STARTED|Overall Study||101
7881209|NCT00806403|19394634|P1|STARTED|Overall Study||104
7881210|NCT00806390|19394648|P2|NOT COMPLETED|Overall Study||0
7881211|NCT00806390|19394649|P1|NOT COMPLETED|Overall Study||0
7881212|NCT00806390|19394648|P2|COMPLETED|Overall Study||8
7881213|NCT00806390|19394649|P1|COMPLETED|Overall Study||7
7881214|NCT00806390|19394648|P2|STARTED|Overall Study||8
7881215|NCT00806390|19394649|P1|STARTED|Overall Study||7
7881216|NCT00806351|19394657|P2|NOT COMPLETED|Overall Study||4
7881217|NCT00806351|19394658|P1|NOT COMPLETED|Overall Study||5
7881218|NCT00806351|19394657|P2|COMPLETED|Overall Study||2
7881219|NCT00806351|19394658|P1|COMPLETED|Overall Study||10
7881220|NCT00806351|19394657|P2|STARTED|Overall Study||6
7881221|NCT00806351|19394658|P1|STARTED|Overall Study||15
7881222|NCT00806286|19394692|P3|NOT COMPLETED|Overall Study||3
7881223|NCT00806286|19394693|P2|NOT COMPLETED|Overall Study||54
7881224|NCT00806286|19394694|P1|NOT COMPLETED|Overall Study||54
7881225|NCT00806286|19394692|P3|COMPLETED|Overall Study||0
7881226|NCT00806286|19394693|P2|COMPLETED|Overall Study||0
7881227|NCT00806286|19394694|P1|COMPLETED|Overall Study||0
7881228|NCT00806286|19394692|P3|STARTED|Overall Study||3
7881229|NCT00806286|19394693|P2|STARTED|Overall Study||54
7881230|NCT00806286|19394694|P1|STARTED|Overall Study||54
7881231|NCT00806260|19394716|P6|NOT COMPLETED|Period 3||0
7881232|NCT00806260|19394717|P5|NOT COMPLETED|Period 3||0
7881233|NCT00806260|19394718|P4|NOT COMPLETED|Period 3||0
7881234|NCT00806260|19394719|P3|NOT COMPLETED|Period 3||1
7881235|NCT00806260|19394720|P2|NOT COMPLETED|Period 3||1
7881236|NCT00806260|19394721|P1|NOT COMPLETED|Period 3||1
7881237|NCT00806260|19394716|P6|COMPLETED|Period 3||0
7881238|NCT00806260|19394717|P5|COMPLETED|Period 3||0
7881239|NCT00806260|19394718|P4|COMPLETED|Period 3||12
7881240|NCT00806260|19394719|P3|COMPLETED|Period 3||5
7881241|NCT00806260|19394720|P2|COMPLETED|Period 3||7
7881242|NCT00806260|19394721|P1|COMPLETED|Period 3||12
7881243|NCT00806260|19394716|P6|STARTED|Period 3||0
7881244|NCT00806260|19394717|P5|STARTED|Period 3||0
7881245|NCT00806260|19394718|P4|STARTED|Period 3||12
7881246|NCT00806260|19394719|P3|STARTED|Period 3||6
7881247|NCT00806260|19394720|P2|STARTED|Period 3||8
7881248|NCT00806260|19394721|P1|STARTED|Period 3||13
7881249|NCT00806260|19394716|P6|NOT COMPLETED|Period 2||0
7881250|NCT00806260|19394717|P5|NOT COMPLETED|Period 2||0
7881251|NCT00806260|19394718|P4|NOT COMPLETED|Period 2||2
7881252|NCT00806260|19394719|P3|NOT COMPLETED|Period 2||2
7881253|NCT00806260|19394720|P2|NOT COMPLETED|Period 2||0
7881254|NCT00806260|19394721|P1|NOT COMPLETED|Period 2||2
7881255|NCT00806260|19394716|P6|COMPLETED|Period 2||0
7881256|NCT00806260|19394717|P5|COMPLETED|Period 2||0
7881257|NCT00806260|19394718|P4|COMPLETED|Period 2||12
7881258|NCT00806260|19394719|P3|COMPLETED|Period 2||6
7881259|NCT00806260|19394720|P2|COMPLETED|Period 2||8
7881260|NCT00806260|19394721|P1|COMPLETED|Period 2||13
7881261|NCT00806260|19394716|P6|STARTED|Period 2||0
7881262|NCT00806260|19394717|P5|STARTED|Period 2||0
7881263|NCT00806260|19394718|P4|STARTED|Period 2||14
7881264|NCT00806260|19394719|P3|STARTED|Period 2||8
7881265|NCT00806260|19394720|P2|STARTED|Period 2||8
7881266|NCT00806260|19394721|P1|STARTED|Period 2||15
7881267|NCT00806260|19394716|P6|NOT COMPLETED|Period 1 (1 Day)||0
7881268|NCT00806260|19394717|P5|NOT COMPLETED|Period 1 (1 Day)||3
7881269|NCT00806260|19394718|P4|NOT COMPLETED|Period 1 (1 Day)||0
7881270|NCT00806260|19394719|P3|NOT COMPLETED|Period 1 (1 Day)||0
7881271|NCT00806260|19394720|P2|NOT COMPLETED|Period 1 (1 Day)||0
7881272|NCT00806260|19394721|P1|NOT COMPLETED|Period 1 (1 Day)||0
7881273|NCT00806260|19394716|P6|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17
7881274|NCT00806260|19394717|P5|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15
7881275|NCT00806260|19394718|P4|COMPLETED|Period 1 (1 Day)||14
7881276|NCT00806260|19394719|P3|COMPLETED|Period 1 (1 Day)||8
7881277|NCT00806260|19394720|P2|COMPLETED|Period 1 (1 Day)||8
7881278|NCT00806260|19394721|P1|COMPLETED|Period 1 (1 Day)||15
7881279|NCT00806260|19394716|P6|STARTED|Period 1 (1 Day)||17
7881280|NCT00806260|19394717|P5|STARTED|Period 1 (1 Day)||18
7881281|NCT00806260|19394718|P4|STARTED|Period 1 (1 Day)||14
7881282|NCT00806260|19394719|P3|STARTED|Period 1 (1 Day)||8
7881283|NCT00806260|19394720|P2|STARTED|Period 1 (1 Day)||8
7881284|NCT00806260|19394721|P1|STARTED|Period 1 (1 Day)||15
7881285|NCT00806234|19394736|P3|NOT COMPLETED|Overall Study||12
7881286|NCT00806234|19394737|P2|NOT COMPLETED|Overall Study||12
7881287|NCT00806234|19394738|P1|NOT COMPLETED|Overall Study||13
7881288|NCT00806234|19394736|P3|COMPLETED|Overall Study||37
7881289|NCT00806234|19394737|P2|COMPLETED|Overall Study||19
7881290|NCT00806234|19394738|P1|COMPLETED|Overall Study||34
7881291|NCT00806234|19394736|P3|STARTED|Overall Study||49
7881292|NCT00806234|19394737|P2|STARTED|Overall Study||31
7881293|NCT00806234|19394738|P1|STARTED|Overall Study||47
7881294|NCT00806221|19394755|P1|NOT COMPLETED|Overall Study||2
7881295|NCT00806221|19394755|P1|COMPLETED|Overall Study||20
7881296|NCT00806221|19394755|P1|STARTED|Overall Study||22
7881297|NCT00806195|19394766|P4|NOT COMPLETED|Overall Study||106
7881298|NCT00806195|19394767|P3|NOT COMPLETED|Overall Study||270
7881299|NCT00806195|19394768|P2|NOT COMPLETED|Overall Study||162
7881300|NCT00806195|19394769|P1|NOT COMPLETED|Overall Study||514
7881301|NCT00806195|19394766|P4|COMPLETED|Overall Study||383
7881302|NCT00806195|19394767|P3|COMPLETED|Overall Study||1139
7881303|NCT00806195|19394768|P2|COMPLETED|Overall Study||1321
7881304|NCT00806195|19394769|P1|COMPLETED|Overall Study||3849
7881305|NCT00806195|19394766|P4|STARTED|Overall Study||489
7881306|NCT00806195|19394767|P3|STARTED|Overall Study||1409
7881307|NCT00806195|19394768|P2|STARTED|Overall Study||1483
7881308|NCT00806195|19394769|P1|STARTED|Overall Study||4363
7881309|NCT00806078|19394783|P2|NOT COMPLETED|Second Intervention||0
7881310|NCT00806078|19394784|P1|NOT COMPLETED|Second Intervention||0
7881311|NCT00806078|19394783|P2|COMPLETED|Second Intervention||9
7881312|NCT00806078|19394784|P1|COMPLETED|Second Intervention||9
7881313|NCT00806078|19394783|P2|STARTED|Second Intervention||9
7881314|NCT00806078|19394784|P1|STARTED|Second Intervention||9
7881315|NCT00806078|19394783|P2|NOT COMPLETED|7 Day Washout Period||0
7881316|NCT00806078|19394784|P1|NOT COMPLETED|7 Day Washout Period||0
7881317|NCT00806078|19394783|P2|COMPLETED|7 Day Washout Period||9
7881318|NCT00806078|19394784|P1|COMPLETED|7 Day Washout Period||9
7881319|NCT00806078|19394783|P2|STARTED|7 Day Washout Period||9
7881320|NCT00806078|19394784|P1|STARTED|7 Day Washout Period||9
7881321|NCT00806078|19394783|P2|NOT COMPLETED|First Intervention||0
7881322|NCT00806078|19394784|P1|NOT COMPLETED|First Intervention||0
7881323|NCT00806078|19394783|P2|COMPLETED|First Intervention||9
7881324|NCT00806078|19394784|P1|COMPLETED|First Intervention||9
7881325|NCT00806078|19394783|P2|STARTED|First Intervention||9
7881326|NCT00806078|19394784|P1|STARTED|First Intervention||9
7881327|NCT00806026|19394800|P6|NOT COMPLETED|Overall Study||32
7881328|NCT00806026|19394801|P5|NOT COMPLETED|Overall Study||30
7881329|NCT00806026|19394802|P4|NOT COMPLETED|Overall Study||29
7881330|NCT00806026|19394803|P3|NOT COMPLETED|Overall Study||93
7881331|NCT00806026|19394804|P2|NOT COMPLETED|Overall Study||101
7881332|NCT00806026|19394805|P1|NOT COMPLETED|Overall Study||92
7881333|NCT00806026|19394800|P6|COMPLETED|Overall Study||29
7881334|NCT00806026|19394801|P5|COMPLETED|Overall Study||29
7881335|NCT00806026|19394802|P4|COMPLETED|Overall Study||32
7881336|NCT00806026|19394803|P3|COMPLETED|Overall Study||89
7881337|NCT00806026|19394804|P2|COMPLETED|Overall Study||82
7881338|NCT00806026|19394805|P1|COMPLETED|Overall Study||93
7881339|NCT00806026|19394800|P6|Treated|Overall Study||61
7881340|NCT00806026|19394801|P5|Treated|Overall Study||59
7881341|NCT00806026|19394802|P4|Treated|Overall Study||59
7881342|NCT00806026|19394803|P3|Treated|Overall Study||180
7881343|NCT00806026|19394804|P2|Treated|Overall Study||178
7881344|NCT00806026|19394805|P1|Treated|Overall Study||182
7881345|NCT00806026|19394800|P6|STARTED|Overall Study||61
7881346|NCT00806026|19394801|P5|STARTED|Overall Study||59
7881347|NCT00806026|19394802|P4|STARTED|Overall Study||61
7881348|NCT00806026|19394803|P3|STARTED|Overall Study||182
7881349|NCT00806026|19394804|P2|STARTED|Overall Study||183
7881350|NCT00806026|19394805|P1|STARTED|Overall Study||185
7881351|NCT00805961|19394900|P1|NOT COMPLETED|Maintenance Treatment||34
7881352|NCT00805961|19394900|P1|COMPLETED|Maintenance Treatment||23
7881353|NCT00805961|19394900|P1|STARTED|Maintenance Treatment||57
7881354|NCT00805961|19394900|P1|NOT COMPLETED|Treatment-Free Interval||7
7881355|NCT00805961|19394900|P1|COMPLETED|Treatment-Free Interval||57
7881356|NCT00805961|19394900|P1|STARTED|Treatment-Free Interval||64
7881357|NCT00805961|19394900|P1|NOT COMPLETED|Modality Therapy||4
7881358|NCT00805961|19394900|P1|COMPLETED|Modality Therapy||64
7881359|NCT00805961|19394900|P1|STARTED|Modality Therapy||68
7881360|NCT00805948|19394908|P2|NOT COMPLETED|Overall Study||96
7881361|NCT00805948|19394909|P1|NOT COMPLETED|Overall Study||68
7881362|NCT00805948|19394908|P2|COMPLETED|Overall Study||99
7881363|NCT00805948|19394909|P1|COMPLETED|Overall Study||86
7881364|NCT00805948|19394908|P2|STARTED|Overall Study||195
7881365|NCT00805948|19394909|P1|STARTED|Overall Study||154
7881366|NCT00805935|19394924|P4|NOT COMPLETED|Overall Study||11
7881367|NCT00805935|19394925|P3|NOT COMPLETED|Overall Study||15
7881368|NCT00805935|19394926|P2|NOT COMPLETED|Overall Study||19
7881369|NCT00805935|19394927|P1|NOT COMPLETED|Overall Study||13
7881370|NCT00805935|19394924|P4|COMPLETED|Overall Study||19
7881371|NCT00805935|19394925|P3|COMPLETED|Overall Study||13
7881372|NCT00805935|19394926|P2|COMPLETED|Overall Study||8
7881373|NCT00805935|19394927|P1|COMPLETED|Overall Study||12
7881374|NCT00805935|19394924|P4|STARTED|Overall Study||30
7881375|NCT00805935|19394925|P3|STARTED|Overall Study||28
7881376|NCT00805935|19394926|P2|STARTED|Overall Study||27
7881377|NCT00805935|19394927|P1|STARTED|Overall Study||25
7881378|NCT00805870|19394981|P2|NOT COMPLETED|Overall Study||0
7881379|NCT00805870|19394982|P1|NOT COMPLETED|Overall Study||0
7881380|NCT00805870|19394981|P2|COMPLETED|Overall Study||10
7881381|NCT00805870|19394982|P1|COMPLETED|Overall Study||10
7881382|NCT00805870|19394981|P2|STARTED|Overall Study||10
7881383|NCT00805870|19394982|P1|STARTED|Overall Study||10
7881384|NCT00805792|19394994|P1|NOT COMPLETED|Overall Study||5
7881385|NCT00805792|19394994|P1|COMPLETED|Overall Study||28
7881386|NCT00805792|19394994|P1|STARTED|Overall Study||33
7881387|NCT00805766|19395002|P1|NOT COMPLETED|Increased Dose Period||13
7881388|NCT00805766|19395002|P1|COMPLETED|Increased Dose Period||26
7881389|NCT00805766|19395002|P1|STARTED|Increased Dose Period||39
7881390|NCT00805766|19395002|P1|NOT COMPLETED|Screening Period||6
7881391|NCT00805766|19395002|P1|COMPLETED|Screening Period||39
7881392|NCT00805766|19395002|P1|STARTED|Screening Period||45
7881393|NCT00805740|19395016|P2|NOT COMPLETED|Overall Study||4
7881394|NCT00805740|19395017|P1|NOT COMPLETED|Overall Study||11
7881395|NCT00805740|19395016|P2|COMPLETED|Overall Study||9
7881396|NCT00805740|19395017|P1|COMPLETED|Overall Study||17
7881397|NCT00805740|19395016|P2|Treated|Overall Study||13
7881398|NCT00805740|19395017|P1|Treated|Overall Study||26
7881399|NCT00805740|19395016|P2|STARTED|Overall Study||13
7881400|NCT00805740|19395017|P1|STARTED|Overall Study||28
7881401|NCT00805675|19395042|P3|NOT COMPLETED|Overall Study||1
7881402|NCT00805675|19395043|P2|NOT COMPLETED|Overall Study||0
7881403|NCT00805675|19395044|P1|NOT COMPLETED|Overall Study||0
7881404|NCT00805675|19395042|P3|COMPLETED|Overall Study||15
7881405|NCT00805675|19395043|P2|COMPLETED|Overall Study||14
7881406|NCT00805675|19395044|P1|COMPLETED|Overall Study||16
7881407|NCT00805675|19395042|P3|STARTED|Overall Study||16
7881408|NCT00805675|19395043|P2|STARTED|Overall Study||14
7881409|NCT00805675|19395044|P1|STARTED|Overall Study||16
7881410|NCT00805545|19395078|P2|NOT COMPLETED|Overall Study||3
7881411|NCT00805545|19395079|P1|NOT COMPLETED|Overall Study||6
7881412|NCT00805545|19395078|P2|COMPLETED|Overall Study||197
7881413|NCT00805545|19395079|P1|COMPLETED|Overall Study||194
7881414|NCT00805545|19395078|P2|STARTED|Overall Study||200
7881415|NCT00805545|19395079|P1|STARTED|Overall Study||200
7881416|NCT00805532|19395087|P2|NOT COMPLETED|Overall Study||1
7881417|NCT00805532|19395088|P1|NOT COMPLETED|Overall Study||0
7881418|NCT00805532|19395087|P2|COMPLETED|Overall Study||38
7881419|NCT00805532|19395088|P1|COMPLETED|Overall Study|We did intent-to-treat analyses so 42 participants' data were analyzed.|42
7881420|NCT00805532|19395087|P2|STARTED|Overall Study||39
7881421|NCT00805532|19395088|P1|STARTED|Overall Study||42
7881422|NCT00805493|19395105|P3|NOT COMPLETED|Overall Study||1
7881423|NCT00805493|19395106|P2|NOT COMPLETED|Overall Study||0
7881424|NCT00805493|19395107|P1|NOT COMPLETED|Overall Study||2
7881425|NCT00805493|19395105|P3|COMPLETED|Overall Study||0
7881426|NCT00805493|19395106|P2|COMPLETED|Overall Study||2
7881427|NCT00805493|19395107|P1|COMPLETED|Overall Study||1
7881428|NCT00805493|19395105|P3|STARTED|Overall Study||1
7881429|NCT00805493|19395106|P2|STARTED|Overall Study||2
7881430|NCT00805493|19395107|P1|STARTED|Overall Study||3
7881431|NCT00805480|19395122|P4|NOT COMPLETED|Overall Study||5
7881432|NCT00805480|19395123|P3|NOT COMPLETED|Overall Study||12
7881433|NCT00805480|19395124|P2|NOT COMPLETED|Overall Study||7
7881434|NCT00805480|19395125|P1|NOT COMPLETED|Overall Study||14
7881435|NCT00805480|19395122|P4|COMPLETED|Overall Study||5
7881436|NCT00805480|19395123|P3|COMPLETED|Overall Study||19
7881437|NCT00805480|19395124|P2|COMPLETED|Overall Study||22
7881438|NCT00805480|19395125|P1|COMPLETED|Overall Study||16
7881439|NCT00805480|19395122|P4|Pharmacodynamic Analysis Set|Overall Study||10
7881440|NCT00805480|19395123|P3|Pharmacodynamic Analysis Set|Overall Study||29
7881441|NCT00805480|19395124|P2|Pharmacodynamic Analysis Set|Overall Study||25
7881442|NCT00805480|19395125|P1|Pharmacodynamic Analysis Set|Overall Study||30
7881443|NCT00805480|19395122|P4|STARTED|Overall Study||10
7881444|NCT00805480|19395123|P3|STARTED|Overall Study||31
7881445|NCT00805480|19395124|P2|STARTED|Overall Study||29
7881446|NCT00805480|19395125|P1|STARTED|Overall Study||30
7881447|NCT00805467|19395154|P4|NOT COMPLETED|Overall Study||237
7881448|NCT00805467|19395155|P3|NOT COMPLETED|Overall Study||103
7881449|NCT00805467|19395156|P2|NOT COMPLETED|Overall Study||34
7881450|NCT00805467|19395157|P1|NOT COMPLETED|Overall Study||0
7881451|NCT00805467|19395154|P4|COMPLETED|Overall Study|Ongoing when study terminated|144
7881452|NCT00805467|19395155|P3|COMPLETED|Overall Study|Ongoing when study terminated|80
7881453|NCT00805467|19395156|P2|COMPLETED|Overall Study|Ongoing when study terminated|25
7881454|NCT00805467|19395157|P1|COMPLETED|Overall Study|Ongoing when study terminated|1
7881455|NCT00805467|19395154|P4|Enrolled But Did Not Receive Treatment|Overall Study||0
7881456|NCT00805467|19395155|P3|Enrolled But Did Not Receive Treatment|Overall Study||0
7881457|NCT00805467|19395156|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
7881458|NCT00805467|19395157|P1|Enrolled But Did Not Receive Treatment|Overall Study||0
7881459|NCT00805467|19395154|P4|STARTED|Overall Study|Patients who received treatment|381
7881460|NCT00805467|19395155|P3|STARTED|Overall Study|Patients who received treatment|183
7881461|NCT00805467|19395156|P2|STARTED|Overall Study|Patients who received treatment|59
7881462|NCT00805467|19395157|P1|STARTED|Overall Study|Patients who received treatment|1
7881463|NCT00805441|19395177|P2|NOT COMPLETED|Overall Study||36
7881464|NCT00805441|19395178|P1|NOT COMPLETED|Overall Study||34
7881465|NCT00805441|19395177|P2|COMPLETED|Overall Study||60
7881466|NCT00805441|19395178|P1|COMPLETED|Overall Study||60
7881467|NCT00805441|19395177|P2|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|91
7881468|NCT00805441|19395178|P1|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|92
7881469|NCT00805441|19395177|P2|STARTED|Overall Study||96
7881470|NCT00805441|19395178|P1|STARTED|Overall Study||94
7881471|NCT00805389|19395213|P5|NOT COMPLETED|Overall Study||13
7881472|NCT00805389|19395214|P4|NOT COMPLETED|Overall Study||17
7881473|NCT00805389|19395215|P3|NOT COMPLETED|Overall Study||12
7881474|NCT00805389|19395216|P2|NOT COMPLETED|Overall Study||5
7881475|NCT00805389|19395217|P1|NOT COMPLETED|Overall Study||7
7881476|NCT00805389|19395213|P5|COMPLETED|Overall Study||129
7881477|NCT00805389|19395214|P4|COMPLETED|Overall Study||128
7881478|NCT00805389|19395215|P3|COMPLETED|Overall Study||129
7881479|NCT00805389|19395216|P2|COMPLETED|Overall Study||137
7881480|NCT00805389|19395217|P1|COMPLETED|Overall Study||136
7881481|NCT00805389|19395213|P5|STARTED|Overall Study||142
7881482|NCT00805389|19395214|P4|STARTED|Overall Study||145
7881483|NCT00805389|19395215|P3|STARTED|Overall Study||141
7881484|NCT00805389|19395216|P2|STARTED|Overall Study||142
7881485|NCT00805389|19395217|P1|STARTED|Overall Study||143
7881486|NCT00805285|19395464|P1|NOT COMPLETED|Overall Study||1
7881487|NCT00805285|19395464|P1|COMPLETED|Overall Study||0
7881488|NCT00805285|19395464|P1|STARTED|Overall Study||1
7881489|NCT00805207|19395481|P9|NOT COMPLETED|Overall Study||0
7881490|NCT00805207|19395482|P8|NOT COMPLETED|Overall Study||0
7881491|NCT00805207|19395483|P7|NOT COMPLETED|Overall Study||0
7881492|NCT00805207|19395484|P6|NOT COMPLETED|Overall Study||3
7881493|NCT00805207|19395485|P5|NOT COMPLETED|Overall Study||1
7881494|NCT00805207|19395486|P4|NOT COMPLETED|Overall Study||0
7881495|NCT00805207|19395487|P3|NOT COMPLETED|Overall Study||1
7881496|NCT00805207|19395488|P2|NOT COMPLETED|Overall Study||2
7881497|NCT00805207|19395489|P1|NOT COMPLETED|Overall Study||0
7881498|NCT00805207|19395481|P9|COMPLETED|Overall Study||6
7881499|NCT00805207|19395482|P8|COMPLETED|Overall Study||6
7881500|NCT00805207|19395483|P7|COMPLETED|Overall Study||6
7881501|NCT00805207|19395484|P6|COMPLETED|Overall Study||9
7881502|NCT00805207|19395485|P5|COMPLETED|Overall Study||2
7881503|NCT00805207|19395486|P4|COMPLETED|Overall Study||6
7881504|NCT00805207|19395487|P3|COMPLETED|Overall Study||11
7881505|NCT00805207|19395488|P2|COMPLETED|Overall Study||7
7881506|NCT00805207|19395489|P1|COMPLETED|Overall Study||1
7881507|NCT00805207|19395481|P9|STARTED|Overall Study||6
7881508|NCT00805207|19395482|P8|STARTED|Overall Study||6
7881509|NCT00805207|19395483|P7|STARTED|Overall Study||6
7881510|NCT00805207|19395484|P6|STARTED|Overall Study||12
7881511|NCT00805207|19395485|P5|STARTED|Overall Study||3
7881512|NCT00805207|19395486|P4|STARTED|Overall Study||6
7881513|NCT00805207|19395487|P3|STARTED|Overall Study||12
7881514|NCT00805207|19395488|P2|STARTED|Overall Study||9
7881515|NCT00805207|19395489|P1|STARTED|Overall Study||1
7881516|NCT00805194|19395547|P2|NOT COMPLETED|Overall Study||654
7881517|NCT00805194|19395548|P1|NOT COMPLETED|Overall Study||649
7881518|NCT00805194|19395547|P2|COMPLETED|Overall Study||5
7881519|NCT00805194|19395548|P1|COMPLETED|Overall Study||6
7881520|NCT00805194|19395547|P2|STARTED|Overall Study|randomised patients|659
7881521|NCT00805194|19395548|P1|STARTED|Overall Study|randomised patients|655
7881522|NCT00805142|19395582|P2|NOT COMPLETED|Maintenance Period||2
7881523|NCT00805142|19395583|P1|NOT COMPLETED|Maintenance Period||0
7881524|NCT00805142|19395582|P2|COMPLETED|Maintenance Period||30
7881525|NCT00805142|19395583|P1|COMPLETED|Maintenance Period||30
7881526|NCT00805142|19395582|P2|STARTED|Maintenance Period||32
7881527|NCT00805142|19395583|P1|STARTED|Maintenance Period||30
7881528|NCT00805142|19395582|P2|NOT COMPLETED|Titration Period||10
7881529|NCT00805142|19395583|P1|NOT COMPLETED|Titration Period||6
7881530|NCT00805142|19395582|P2|COMPLETED|Titration Period||32
7881531|NCT00805142|19395583|P1|COMPLETED|Titration Period||30
7881532|NCT00805142|19395582|P2|STARTED|Titration Period||42
7881533|NCT00805142|19395583|P1|STARTED|Titration Period||36
7881534|NCT00805038|19395609|P2|NOT COMPLETED|Overall Study||0
7881535|NCT00805038|19395610|P1|NOT COMPLETED|Overall Study||0
7881536|NCT00805038|19395609|P2|COMPLETED|Overall Study||92
7881537|NCT00805038|19395610|P1|COMPLETED|Overall Study||75
7881538|NCT00805038|19395609|P2|STARTED|Overall Study||92
7881539|NCT00805038|19395610|P1|STARTED|Overall Study||75
7881540|NCT00805025|19395616|P1|NOT COMPLETED|Overall Study||49
7881541|NCT00805025|19395616|P1|COMPLETED|Overall Study||82
7881542|NCT00805025|19395616|P1|Enrolled and Treated|Overall Study||89
7881543|NCT00805025|19395616|P1|STARTED|Overall Study||131
7881544|NCT00804999|19395626|P4|NOT COMPLETED|Overall Study||0
7881545|NCT00804999|19395627|P3|NOT COMPLETED|Overall Study||0
7881546|NCT00804999|19395628|P2|NOT COMPLETED|Overall Study||0
7881547|NCT00804999|19395629|P1|NOT COMPLETED|Overall Study||0
7881548|NCT00804999|19395626|P4|COMPLETED|Overall Study||10
7881549|NCT00804999|19395627|P3|COMPLETED|Overall Study||14
7881550|NCT00804999|19395628|P2|COMPLETED|Overall Study||12
7881551|NCT00804999|19395629|P1|COMPLETED|Overall Study||15
7881552|NCT00804999|19395626|P4|STARTED|Overall Study||10
7881553|NCT00804999|19395627|P3|STARTED|Overall Study||14
7881554|NCT00804999|19395628|P2|STARTED|Overall Study||12
7881555|NCT00804999|19395629|P1|STARTED|Overall Study||15
7881556|NCT00804986|19395645|P6|NOT COMPLETED|Overall Study||10
7881557|NCT00804986|19395646|P5|NOT COMPLETED|Overall Study||9
7881558|NCT00804986|19395647|P4|NOT COMPLETED|Overall Study||8
7881559|NCT00804986|19395648|P3|NOT COMPLETED|Overall Study||2
7881560|NCT00804986|19395649|P2|NOT COMPLETED|Overall Study||8
7881561|NCT00804986|19395650|P1|NOT COMPLETED|Overall Study||1
7881562|NCT00804986|19395645|P6|COMPLETED|Overall Study||31
7881563|NCT00804986|19395646|P5|COMPLETED|Overall Study||34
7881564|NCT00804986|19395647|P4|COMPLETED|Overall Study||34
7881565|NCT00804986|19395648|P3|COMPLETED|Overall Study||40
7881566|NCT00804986|19395649|P2|COMPLETED|Overall Study||35
7881567|NCT00804986|19395650|P1|COMPLETED|Overall Study||35
7881568|NCT00804986|19395645|P6|STARTED|Overall Study||41
7881569|NCT00804986|19395646|P5|STARTED|Overall Study||43
7881570|NCT00804986|19395647|P4|STARTED|Overall Study||42
7881571|NCT00804986|19395648|P3|STARTED|Overall Study||42
7881572|NCT00804986|19395649|P2|STARTED|Overall Study||43
7881573|NCT00804986|19395650|P1|STARTED|Overall Study||36
7881574|NCT00804973|19395745|P3|NOT COMPLETED|Overall Study||0
7881575|NCT00804973|19395746|P2|NOT COMPLETED|Overall Study||0
7881576|NCT00804973|19395747|P1|NOT COMPLETED|Overall Study||0
7881577|NCT00804973|19395745|P3|COMPLETED|Overall Study||40
7881578|NCT00804973|19395746|P2|COMPLETED|Overall Study||40
7881579|NCT00804973|19395747|P1|COMPLETED|Overall Study||40
7881580|NCT00804973|19395745|P3|Received at Least 1 Dose of Study Drug|Overall Study||40
7881581|NCT00804973|19395746|P2|Received at Least 1 Dose of Study Drug|Overall Study||40
7881582|NCT00804973|19395747|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
7881583|NCT00804973|19395745|P3|STARTED|Overall Study||40
7881584|NCT00804973|19395746|P2|STARTED|Overall Study||40
7881585|NCT00804973|19395747|P1|STARTED|Overall Study||40
7881586|NCT00804908|19395785|P3|NOT COMPLETED|Overall Study||114
7881587|NCT00804908|19395786|P2|NOT COMPLETED|Overall Study||116
7881588|NCT00804908|19395787|P1|NOT COMPLETED|Overall Study||115
7881589|NCT00804908|19395785|P3|COMPLETED|Overall Study||1
7881590|NCT00804908|19395786|P2|COMPLETED|Overall Study||0
7881591|NCT00804908|19395787|P1|COMPLETED|Overall Study||0
7881592|NCT00804908|19395785|P3|STARTED|Overall Study||115
7881593|NCT00804908|19395786|P2|STARTED|Overall Study||116
7881594|NCT00804908|19395787|P1|STARTED|Overall Study||115
7881595|NCT00804843|19395818|P2|NOT COMPLETED|Overall Study||7
7881596|NCT00804843|19395819|P1|NOT COMPLETED|Overall Study||10
7881597|NCT00804843|19395818|P2|COMPLETED|Overall Study||43
7881598|NCT00804843|19395819|P1|COMPLETED|Overall Study||40
7881599|NCT00804843|19395818|P2|STARTED|Overall Study||50
7881600|NCT00804843|19395819|P1|STARTED|Overall Study||50
7881601|NCT00804713|19395829|P1|NOT COMPLETED|Overall Study||0
7881602|NCT00804713|19395829|P1|COMPLETED|Overall Study||1978
7881603|NCT00804713|19395829|P1|STARTED|Overall Study||1978
7881604|NCT00804687|19395837|P6|NOT COMPLETED|Period 5: Treatment Period||0
7881605|NCT00804687|19395838|P5|NOT COMPLETED|Period 5: Treatment Period||1
7881606|NCT00804687|19395839|P4|NOT COMPLETED|Period 5: Treatment Period||0
7881607|NCT00804687|19395840|P3|NOT COMPLETED|Period 5: Treatment Period||1
7881608|NCT00804687|19395841|P2|NOT COMPLETED|Period 5: Treatment Period||0
7881609|NCT00804687|19395842|P1|NOT COMPLETED|Period 5: Treatment Period||1
7881610|NCT00804687|19395837|P6|COMPLETED|Period 5: Treatment Period||8
7881611|NCT00804687|19395838|P5|COMPLETED|Period 5: Treatment Period||8
7881612|NCT00804687|19395839|P4|COMPLETED|Period 5: Treatment Period||8
7881613|NCT00804687|19395840|P3|COMPLETED|Period 5: Treatment Period||8
7881614|NCT00804687|19395841|P2|COMPLETED|Period 5: Treatment Period||9
7881615|NCT00804687|19395842|P1|COMPLETED|Period 5: Treatment Period||8
7881616|NCT00804687|19395837|P6|STARTED|Period 5: Treatment Period||8
7881617|NCT00804687|19395838|P5|STARTED|Period 5: Treatment Period||9
7881618|NCT00804687|19395839|P4|STARTED|Period 5: Treatment Period||8
7881619|NCT00804687|19395840|P3|STARTED|Period 5: Treatment Period||9
7881620|NCT00804687|19395841|P2|STARTED|Period 5: Treatment Period||9
7881621|NCT00804687|19395842|P1|STARTED|Period 5: Treatment Period||9
7881622|NCT00804687|19395837|P6|NOT COMPLETED|Period 4: Washout Period||0
7881623|NCT00804687|19395838|P5|NOT COMPLETED|Period 4: Washout Period||0
7881624|NCT00804687|19395839|P4|NOT COMPLETED|Period 4: Washout Period||0
7881625|NCT00804687|19395840|P3|NOT COMPLETED|Period 4: Washout Period||0
7881626|NCT00804687|19395841|P2|NOT COMPLETED|Period 4: Washout Period||0
7881627|NCT00804687|19395842|P1|NOT COMPLETED|Period 4: Washout Period||0
7881628|NCT00804687|19395837|P6|COMPLETED|Period 4: Washout Period||8
7881629|NCT00804687|19395838|P5|COMPLETED|Period 4: Washout Period||9
7881630|NCT00804687|19395839|P4|COMPLETED|Period 4: Washout Period||8
7881631|NCT00804687|19395840|P3|COMPLETED|Period 4: Washout Period||9
7881632|NCT00804687|19395841|P2|COMPLETED|Period 4: Washout Period||9
7881633|NCT00804687|19395842|P1|COMPLETED|Period 4: Washout Period||9
7881634|NCT00804687|19395837|P6|STARTED|Period 4: Washout Period||8
7881635|NCT00804687|19395838|P5|STARTED|Period 4: Washout Period||9
7881636|NCT00804687|19395839|P4|STARTED|Period 4: Washout Period||8
7881637|NCT00804687|19395840|P3|STARTED|Period 4: Washout Period||9
7881638|NCT00804687|19395841|P2|STARTED|Period 4: Washout Period||9
7881639|NCT00804687|19395842|P1|STARTED|Period 4: Washout Period||9
7881640|NCT00804687|19395837|P6|NOT COMPLETED|Period 3: Treatment Period||0
7881641|NCT00804687|19395838|P5|NOT COMPLETED|Period 3: Treatment Period||0
7881642|NCT00804687|19395839|P4|NOT COMPLETED|Period 3: Treatment Period||1
7881643|NCT00804687|19395840|P3|NOT COMPLETED|Period 3: Treatment Period||0
7881644|NCT00804687|19395841|P2|NOT COMPLETED|Period 3: Treatment Period||0
7881645|NCT00804687|19395842|P1|NOT COMPLETED|Period 3: Treatment Period||0
7881646|NCT00804687|19395837|P6|COMPLETED|Period 3: Treatment Period||8
7881647|NCT00804687|19395838|P5|COMPLETED|Period 3: Treatment Period||9
7881648|NCT00804687|19395839|P4|COMPLETED|Period 3: Treatment Period||8
7881649|NCT00804687|19395840|P3|COMPLETED|Period 3: Treatment Period||9
7881650|NCT00804687|19395841|P2|COMPLETED|Period 3: Treatment Period||9
7881651|NCT00804687|19395842|P1|COMPLETED|Period 3: Treatment Period||9
7881652|NCT00804687|19395837|P6|STARTED|Period 3: Treatment Period||8
7881653|NCT00804687|19395838|P5|STARTED|Period 3: Treatment Period||9
7881654|NCT00804687|19395839|P4|STARTED|Period 3: Treatment Period||9
7881655|NCT00804687|19395840|P3|STARTED|Period 3: Treatment Period||9
7881656|NCT00804687|19395841|P2|STARTED|Period 3: Treatment Period||9
7881657|NCT00804687|19395842|P1|STARTED|Period 3: Treatment Period||9
7881658|NCT00804687|19395837|P6|NOT COMPLETED|Period 2: Washout Period||0
7881659|NCT00804687|19395838|P5|NOT COMPLETED|Period 2: Washout Period||0
7881660|NCT00804687|19395839|P4|NOT COMPLETED|Period 2: Washout Period||0
7881661|NCT00804687|19395840|P3|NOT COMPLETED|Period 2: Washout Period||0
7881662|NCT00804687|19395841|P2|NOT COMPLETED|Period 2: Washout Period||0
7881663|NCT00804687|19395842|P1|NOT COMPLETED|Period 2: Washout Period||0
7881664|NCT00804687|19395837|P6|COMPLETED|Period 2: Washout Period||8
7881665|NCT00804687|19395838|P5|COMPLETED|Period 2: Washout Period||9
7881666|NCT00804687|19395839|P4|COMPLETED|Period 2: Washout Period||9
7881667|NCT00804687|19395840|P3|COMPLETED|Period 2: Washout Period||9
7881668|NCT00804687|19395841|P2|COMPLETED|Period 2: Washout Period||9
7881669|NCT00804687|19395842|P1|COMPLETED|Period 2: Washout Period||9
7881670|NCT00804687|19395837|P6|STARTED|Period 2: Washout Period||8
7881671|NCT00804687|19395838|P5|STARTED|Period 2: Washout Period||9
7881672|NCT00804687|19395839|P4|STARTED|Period 2: Washout Period||9
7881673|NCT00804687|19395840|P3|STARTED|Period 2: Washout Period||9
7881674|NCT00804687|19395841|P2|STARTED|Period 2: Washout Period||9
7881675|NCT00804687|19395842|P1|STARTED|Period 2: Washout Period||9
7881676|NCT00804687|19395837|P6|NOT COMPLETED|Period 1: Treatment Period||0
7881677|NCT00804687|19395838|P5|NOT COMPLETED|Period 1: Treatment Period||0
7881678|NCT00804687|19395839|P4|NOT COMPLETED|Period 1: Treatment Period||0
7881679|NCT00804687|19395840|P3|NOT COMPLETED|Period 1: Treatment Period||0
7881680|NCT00804687|19395841|P2|NOT COMPLETED|Period 1: Treatment Period||0
7881681|NCT00804687|19395842|P1|NOT COMPLETED|Period 1: Treatment Period||0
7881682|NCT00804687|19395837|P6|COMPLETED|Period 1: Treatment Period||8
7881683|NCT00804687|19395838|P5|COMPLETED|Period 1: Treatment Period||9
7881684|NCT00804687|19395839|P4|COMPLETED|Period 1: Treatment Period||9
7881685|NCT00804687|19395840|P3|COMPLETED|Period 1: Treatment Period||9
7881686|NCT00804687|19395841|P2|COMPLETED|Period 1: Treatment Period||9
7881687|NCT00804687|19395842|P1|COMPLETED|Period 1: Treatment Period||9
7881688|NCT00804687|19395837|P6|STARTED|Period 1: Treatment Period||8
7881689|NCT00804687|19395838|P5|STARTED|Period 1: Treatment Period||9
7881690|NCT00804687|19395839|P4|STARTED|Period 1: Treatment Period||9
7881691|NCT00804687|19395840|P3|STARTED|Period 1: Treatment Period||9
7881692|NCT00804687|19395841|P2|STARTED|Period 1: Treatment Period||9
7881693|NCT00804687|19395842|P1|STARTED|Period 1: Treatment Period||9
7881694|NCT00804648|19395859|P6|NOT COMPLETED|Third Invervention||0
7881695|NCT00804648|19395860|P5|NOT COMPLETED|Third Invervention||0
7881696|NCT00804648|19395861|P4|NOT COMPLETED|Third Invervention||0
7881697|NCT00804648|19395862|P3|NOT COMPLETED|Third Invervention||0
7881698|NCT00804648|19395863|P2|NOT COMPLETED|Third Invervention||0
7881699|NCT00804648|19395864|P1|NOT COMPLETED|Third Invervention||0
7881700|NCT00804648|19395859|P6|COMPLETED|Third Invervention||8
7881701|NCT00804648|19395860|P5|COMPLETED|Third Invervention||4
7881702|NCT00804648|19395861|P4|COMPLETED|Third Invervention||4
7881703|NCT00804648|19395862|P3|COMPLETED|Third Invervention||6
7881704|NCT00804648|19395863|P2|COMPLETED|Third Invervention||5
7881705|NCT00804648|19395864|P1|COMPLETED|Third Invervention||3
7881706|NCT00804648|19395859|P6|STARTED|Third Invervention||8
7881707|NCT00804648|19395860|P5|STARTED|Third Invervention||4
7881708|NCT00804648|19395861|P4|STARTED|Third Invervention||4
7881709|NCT00804648|19395862|P3|STARTED|Third Invervention||6
7881710|NCT00804648|19395863|P2|STARTED|Third Invervention||5
7881711|NCT00804648|19395864|P1|STARTED|Third Invervention||3
7881712|NCT00804648|19395859|P6|NOT COMPLETED|Second Intervention||0
7881713|NCT00804648|19395860|P5|NOT COMPLETED|Second Intervention||0
7881714|NCT00804648|19395861|P4|NOT COMPLETED|Second Intervention||0
7881715|NCT00804648|19395862|P3|NOT COMPLETED|Second Intervention||0
7881716|NCT00804648|19395863|P2|NOT COMPLETED|Second Intervention||0
7881717|NCT00804648|19395864|P1|NOT COMPLETED|Second Intervention||0
7881718|NCT00804648|19395859|P6|COMPLETED|Second Intervention||8
7881719|NCT00804648|19395860|P5|COMPLETED|Second Intervention||4
7881720|NCT00804648|19395861|P4|COMPLETED|Second Intervention||4
7881721|NCT00804648|19395862|P3|COMPLETED|Second Intervention||6
7881722|NCT00804648|19395863|P2|COMPLETED|Second Intervention||5
7881723|NCT00804648|19395864|P1|COMPLETED|Second Intervention||3
7881724|NCT00804648|19395859|P6|STARTED|Second Intervention||8
7881725|NCT00804648|19395860|P5|STARTED|Second Intervention||4
7881726|NCT00804648|19395861|P4|STARTED|Second Intervention||4
7881727|NCT00804648|19395862|P3|STARTED|Second Intervention||6
7881728|NCT00804648|19395863|P2|STARTED|Second Intervention||5
7881729|NCT00804648|19395864|P1|STARTED|Second Intervention||3
7881730|NCT00804648|19395859|P6|NOT COMPLETED|First Intervention||0
7881731|NCT00804648|19395860|P5|NOT COMPLETED|First Intervention||0
7881732|NCT00804648|19395861|P4|NOT COMPLETED|First Intervention||0
7881733|NCT00804648|19395862|P3|NOT COMPLETED|First Intervention||0
7881734|NCT00804648|19395863|P2|NOT COMPLETED|First Intervention||0
7881735|NCT00804648|19395864|P1|NOT COMPLETED|First Intervention||0
7881736|NCT00804648|19395859|P6|COMPLETED|First Intervention||8
7881737|NCT00804648|19395860|P5|COMPLETED|First Intervention||4
7881738|NCT00804648|19395861|P4|COMPLETED|First Intervention||4
7881739|NCT00804648|19395862|P3|COMPLETED|First Intervention||6
7881740|NCT00804648|19395863|P2|COMPLETED|First Intervention||5
7881741|NCT00804648|19395864|P1|COMPLETED|First Intervention||3
7881742|NCT00804648|19395859|P6|STARTED|First Intervention||8
7881743|NCT00804648|19395860|P5|STARTED|First Intervention||4
7881744|NCT00804648|19395861|P4|STARTED|First Intervention||4
7881745|NCT00804648|19395862|P3|STARTED|First Intervention||6
7881746|NCT00804648|19395863|P2|STARTED|First Intervention||5
7881747|NCT00804648|19395864|P1|STARTED|First Intervention||3
7881748|NCT00804609|19395907|P2|NOT COMPLETED|Overall Study||1
7881749|NCT00804609|19395908|P1|NOT COMPLETED|Overall Study||0
7881750|NCT00804609|19395907|P2|COMPLETED|Overall Study||14
7881751|NCT00804609|19395908|P1|COMPLETED|Overall Study||15
7881752|NCT00804609|19395907|P2|STARTED|Overall Study||15
7881753|NCT00804609|19395908|P1|STARTED|Overall Study||15
7881754|NCT00804596|19395914|P1|NOT COMPLETED|Overall Study||0
7881755|NCT00804596|19395914|P1|COMPLETED|Overall Study||74
7881756|NCT00804596|19395914|P1|STARTED|Overall Study||74
7881757|NCT00804570|19395921|P2|NOT COMPLETED|Overall Study||94
7881758|NCT00804570|19395922|P1|NOT COMPLETED|Overall Study||72
7881759|NCT00804570|19395921|P2|COMPLETED|Overall Study||94
7881760|NCT00804570|19395922|P1|COMPLETED|Overall Study||115
7881761|NCT00804570|19395921|P2|STARTED|Overall Study||188
7881762|NCT00804570|19395922|P1|STARTED|Overall Study||187
7881763|NCT00804349|19395980|P2|NOT COMPLETED|Overall Study||0
7881764|NCT00804349|19395981|P1|NOT COMPLETED|Overall Study||0
7881765|NCT00804349|19395980|P2|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
7881766|NCT00804349|19395981|P1|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
7881767|NCT00804349|19395980|P2|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
7881768|NCT00804349|19395981|P1|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available.|0
7881769|NCT00804193|19395996|P3|NOT COMPLETED|Overall Study||32
7881770|NCT00804193|19395997|P2|NOT COMPLETED|Overall Study||44
7881771|NCT00804193|19395998|P1|NOT COMPLETED|Overall Study||39
7881772|NCT00804193|19395996|P3|COMPLETED|Overall Study||77
7881773|NCT00804193|19395997|P2|COMPLETED|Overall Study||180
7881774|NCT00804193|19395998|P1|COMPLETED|Overall Study||181
7881775|NCT00804193|19395996|P3|STARTED|Overall Study||109
7881776|NCT00804193|19395997|P2|STARTED|Overall Study||224
7881777|NCT00804193|19395998|P1|STARTED|Overall Study||220
7881778|NCT00804141|19396012|P1|NOT COMPLETED|Overall Study||563
7881779|NCT00804141|19396012|P1|COMPLETED|Overall Study||477
7881780|NCT00804141|19396012|P1|Received at Least 1 Dose of Study Drug|Overall Study||1034
7881781|NCT00804141|19396012|P1|STARTED|Overall Study||1040
7881782|NCT00803959|19396019|P2|NOT COMPLETED|Overall Study||51
7881783|NCT00803959|19396020|P1|NOT COMPLETED|Overall Study||56
7881784|NCT00803959|19396019|P2|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264
7881785|NCT00803959|19396020|P1|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259
7881786|NCT00803959|19396019|P2|ITT Analysis With Primary Outcome Data|Overall Study||272
7881787|NCT00803959|19396020|P1|ITT Analysis With Primary Outcome Data|Overall Study||266
7881788|NCT00803959|19396019|P2|STARTED|Overall Study||315
7881789|NCT00803959|19396020|P1|STARTED|Overall Study||315
7881790|NCT00803790|19396052|P4|NOT COMPLETED|Period 2||1
7881791|NCT00803790|19396053|P3|NOT COMPLETED|Period 2||1
7881792|NCT00803790|19396054|P2|NOT COMPLETED|Period 2||0
7881793|NCT00803790|19396055|P1|NOT COMPLETED|Period 2||2
7881794|NCT00803790|19396052|P4|COMPLETED|Period 2||30
7881795|NCT00803790|19396053|P3|COMPLETED|Period 2||30
7881796|NCT00803790|19396054|P2|COMPLETED|Period 2||114
7881797|NCT00803790|19396055|P1|COMPLETED|Period 2||114
7881798|NCT00803790|19396052|P4|STARTED|Period 2||31
7881799|NCT00803790|19396053|P3|STARTED|Period 2||31
7881800|NCT00803790|19396054|P2|STARTED|Period 2||114
7881801|NCT00803790|19396055|P1|STARTED|Period 2||116
7881802|NCT00803790|19396052|P4|NOT COMPLETED|Period 1||4
7881803|NCT00803790|19396053|P3|NOT COMPLETED|Period 1||1
7881804|NCT00803790|19396054|P2|NOT COMPLETED|Period 1||12
7881805|NCT00803790|19396055|P1|NOT COMPLETED|Period 1||9
7881806|NCT00803790|19396052|P4|COMPLETED|Period 1||31
7881807|NCT00803790|19396053|P3|COMPLETED|Period 1||31
7881808|NCT00803790|19396054|P2|COMPLETED|Period 1||114
7881809|NCT00803790|19396055|P1|COMPLETED|Period 1||116
7881810|NCT00803790|19396052|P4|STARTED|Period 1||35
7881811|NCT00803790|19396053|P3|STARTED|Period 1||32
7881812|NCT00803790|19396054|P2|STARTED|Period 1||126
7881813|NCT00803790|19396055|P1|STARTED|Period 1||125
7881814|NCT00803777|19396066|P1|NOT COMPLETED|Overall Study||0
7881815|NCT00803777|19396066|P1|COMPLETED|Overall Study||147
7881816|NCT00803777|19396066|P1|STARTED|Overall Study||147
7881817|NCT00803751|19396076|P2|NOT COMPLETED|Overall Study||0
7881818|NCT00803751|19396077|P1|NOT COMPLETED|Overall Study||0
7881819|NCT00803751|19396076|P2|COMPLETED|Overall Study||23
7881820|NCT00803751|19396077|P1|COMPLETED|Overall Study||26
7881821|NCT00803751|19396076|P2|STARTED|Overall Study||23
7881822|NCT00803751|19396077|P1|STARTED|Overall Study||26
7881823|NCT00803738|19396095|P2|NOT COMPLETED|Overall Study||110
7881824|NCT00803738|19396096|P1|NOT COMPLETED|Overall Study||94
7881825|NCT00803738|19396095|P2|COMPLETED|Overall Study||176
7881826|NCT00803738|19396096|P1|COMPLETED|Overall Study||192
7881827|NCT00803738|19396095|P2|STARTED|Overall Study||286
7881828|NCT00803738|19396096|P1|STARTED|Overall Study||286
7881829|NCT00803712|19396108|P2|NOT COMPLETED|Overall Study||27
7881830|NCT00803712|19396109|P1|NOT COMPLETED|Overall Study||36
7881831|NCT00803712|19396108|P2|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128
7881832|NCT00803712|19396109|P1|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118
7881833|NCT00803712|19396108|P2|Safety Analysis Set|Overall Study|Randomized to the control group|154
7881834|NCT00803712|19396109|P1|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155
7881835|NCT00803712|19396108|P2|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151
7881836|NCT00803712|19396109|P1|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153
7881837|NCT00803712|19396108|P2|STARTED|Overall Study|155 participants were randomized to the control group|155
7881838|NCT00803712|19396109|P1|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154
7881839|NCT00803686|19396177|P4|NOT COMPLETED|Part 2, Period 3||0
7881840|NCT00803686|19396178|P3|NOT COMPLETED|Part 2, Period 3||0
7881841|NCT00803686|19396179|P2|NOT COMPLETED|Part 2, Period 3||0
7881842|NCT00803686|19396180|P1|NOT COMPLETED|Part 2, Period 3||0
7881843|NCT00803686|19396177|P4|COMPLETED|Part 2, Period 3|All who started this period completed|4
7881844|NCT00803686|19396178|P3|COMPLETED|Part 2, Period 3|All who started this period completed|5
7881845|NCT00803686|19396179|P2|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0
7881846|NCT00803686|19396180|P1|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0
7881847|NCT00803686|19396177|P4|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4
7881848|NCT00803686|19396178|P3|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5
7881849|NCT00803686|19396179|P2|STARTED|Part 2, Period 3|No subjects were treated in this period.|0
7881850|NCT00803686|19396180|P1|STARTED|Part 2, Period 3|No subjects were treated in this period|0
7881851|NCT00803686|19396177|P4|NOT COMPLETED|Part 1, Period 2||0
7881852|NCT00803686|19396178|P3|NOT COMPLETED|Part 1, Period 2||0
7881853|NCT00803686|19396179|P2|NOT COMPLETED|Part 1, Period 2||0
7881854|NCT00803686|19396180|P1|NOT COMPLETED|Part 1, Period 2||0
7881855|NCT00803686|19396177|P4|COMPLETED|Part 1, Period 2|No subjects treated.|0
7881856|NCT00803686|19396178|P3|COMPLETED|Part 1, Period 2|No subjects treated.|0
7881857|NCT00803686|19396179|P2|COMPLETED|Part 1, Period 2||6
7881858|NCT00803686|19396180|P1|COMPLETED|Part 1, Period 2||6
7881859|NCT00803686|19396177|P4|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
7881860|NCT00803686|19396178|P3|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
7881861|NCT00803686|19396179|P2|STARTED|Part 1, Period 2||6
7881862|NCT00803686|19396180|P1|STARTED|Part 1, Period 2||6
7881863|NCT00803686|19396177|P4|NOT COMPLETED|Part 1, Period 1||0
7881864|NCT00803686|19396178|P3|NOT COMPLETED|Part 1, Period 1||0
7881865|NCT00803686|19396179|P2|NOT COMPLETED|Part 1, Period 1||0
7881866|NCT00803686|19396180|P1|NOT COMPLETED|Part 1, Period 1||0
7881867|NCT00803686|19396177|P4|COMPLETED|Part 1, Period 1||0
7881868|NCT00803686|19396178|P3|COMPLETED|Part 1, Period 1||0
7881869|NCT00803686|19396179|P2|COMPLETED|Part 1, Period 1||6
7881870|NCT00803686|19396180|P1|COMPLETED|Part 1, Period 1||6
7881871|NCT00803686|19396177|P4|STARTED|Part 1, Period 1||0
7881872|NCT00803686|19396178|P3|STARTED|Part 1, Period 1||0
7881873|NCT00803686|19396179|P2|STARTED|Part 1, Period 1||6
7881874|NCT00803686|19396180|P1|STARTED|Part 1, Period 1||6
7881875|NCT00803647|19396198|P1|NOT COMPLETED|Overall Study||0
7881876|NCT00803647|19396198|P1|COMPLETED|Overall Study||20
7881877|NCT00803647|19396198|P1|STARTED|Overall Study||20
7881878|NCT00803634|19396208|P2|NOT COMPLETED|Overall Study||5
7881879|NCT00803634|19396209|P1|NOT COMPLETED|Overall Study||6
7881880|NCT00803634|19396208|P2|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48
7881881|NCT00803634|19396209|P1|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45
7881973|NCT00803205|19396395|P1|STARTED|Overall Study||120
7881974|NCT00803179|19396438|P1|NOT COMPLETED|Overall Study||3
7881882|NCT00803634|19396208|P2|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41
7881883|NCT00803634|19396209|P1|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44
7881884|NCT00803634|19396208|P2|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53
7881885|NCT00803634|19396209|P1|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51
7881886|NCT00803595|19396238|P3|NOT COMPLETED|Overall Study||16
7881887|NCT00803595|19396239|P2|NOT COMPLETED|Overall Study||8
7881888|NCT00803595|19396240|P1|NOT COMPLETED|Overall Study||15
7881889|NCT00803595|19396238|P3|COMPLETED|Overall Study||322
7881890|NCT00803595|19396239|P2|COMPLETED|Overall Study||319
7881891|NCT00803595|19396240|P1|COMPLETED|Overall Study||322
7881892|NCT00803595|19396238|P3|STARTED|Overall Study||338
7881893|NCT00803595|19396239|P2|STARTED|Overall Study||327
7881894|NCT00803595|19396240|P1|STARTED|Overall Study||337
7881895|NCT00803569|19396251|P1|NOT COMPLETED|Overall Study||4
7881896|NCT00803569|19396251|P1|COMPLETED|Overall Study||9
7881897|NCT00803569|19396251|P1|STARTED|Overall Study||13
7881898|NCT00803543|19396261|P2|NOT COMPLETED|Overall Study||12
7881899|NCT00803543|19396262|P1|NOT COMPLETED|Overall Study||24
7881900|NCT00803543|19396261|P2|COMPLETED|Overall Study||22
7881901|NCT00803543|19396262|P1|COMPLETED|Overall Study||45
7881902|NCT00803543|19396261|P2|STARTED|Overall Study||34
7881903|NCT00803543|19396262|P1|STARTED|Overall Study||69
7881904|NCT00803517|19396276|P2|NOT COMPLETED|Overall Study||0
7881905|NCT00803517|19396277|P1|NOT COMPLETED|Overall Study||0
7881906|NCT00803517|19396276|P2|COMPLETED|Overall Study||12
7881907|NCT00803517|19396277|P1|COMPLETED|Overall Study||12
7881908|NCT00803517|19396276|P2|STARTED|Overall Study||12
7881909|NCT00803517|19396277|P1|STARTED|Overall Study||12
7881910|NCT00803452|19396285|P2|NOT COMPLETED|Overall Study||5
7881911|NCT00803452|19396286|P1|NOT COMPLETED|Overall Study||0
7881912|NCT00803452|19396285|P2|COMPLETED|Overall Study||17
7881913|NCT00803452|19396286|P1|COMPLETED|Overall Study||9
7881914|NCT00803452|19396285|P2|STARTED|Overall Study||22
7881915|NCT00803452|19396286|P1|STARTED|Overall Study||9
7881916|NCT00803413|19396296|P4|NOT COMPLETED|Overall Period||0
7881917|NCT00803413|19396297|P3|NOT COMPLETED|Overall Period||0
7881918|NCT00803413|19396298|P2|NOT COMPLETED|Overall Period||0
7881919|NCT00803413|19396299|P1|NOT COMPLETED|Overall Period||0
7881920|NCT00803413|19396296|P4|COMPLETED|Overall Period||30
7881921|NCT00803413|19396297|P3|COMPLETED|Overall Period||29
7881922|NCT00803413|19396298|P2|COMPLETED|Overall Period||32
7881923|NCT00803413|19396299|P1|COMPLETED|Overall Period||28
7881924|NCT00803413|19396296|P4|STARTED|Overall Period||30
7881925|NCT00803413|19396297|P3|STARTED|Overall Period||29
7881926|NCT00803413|19396298|P2|STARTED|Overall Period||32
7881927|NCT00803413|19396299|P1|STARTED|Overall Period||28
7881928|NCT00803400|19396311|P2|NOT COMPLETED|Overall Study||24
7881929|NCT00803400|19396312|P1|NOT COMPLETED|Overall Study||20
7881930|NCT00803400|19396311|P2|COMPLETED|Overall Study||51
7881931|NCT00803400|19396312|P1|COMPLETED|Overall Study||55
7881932|NCT00803400|19396311|P2|STARTED|Overall Study||75
7881933|NCT00803400|19396312|P1|STARTED|Overall Study||75
7881934|NCT00803361|19396324|P2|NOT COMPLETED|Overall Study||28
7881935|NCT00803361|19396325|P1|NOT COMPLETED|Overall Study||26
7881936|NCT00803361|19396324|P2|COMPLETED|Overall Study||74
7881937|NCT00803361|19396325|P1|COMPLETED|Overall Study||82
7881938|NCT00803361|19396324|P2|STARTED|Overall Study||102
7881939|NCT00803361|19396325|P1|STARTED|Overall Study||108
7881940|NCT00803283|19396345|P2|NOT COMPLETED|Overall Study||0
7881941|NCT00803283|19396346|P1|NOT COMPLETED|Overall Study||0
7881942|NCT00803283|19396345|P2|COMPLETED|Overall Study||1
7881943|NCT00803283|19396346|P1|COMPLETED|Overall Study||1
7881944|NCT00803283|19396345|P2|STARTED|Overall Study||1
7881945|NCT00803283|19396346|P1|STARTED|Overall Study||1
7881946|NCT00803270|19396372|P2|NOT COMPLETED|Overall Study||2
7881947|NCT00803270|19396373|P1|NOT COMPLETED|Overall Study||1
7881948|NCT00803270|19396372|P2|COMPLETED|Overall Study||12
7881949|NCT00803270|19396373|P1|COMPLETED|Overall Study||12
7881950|NCT00803270|19396372|P2|STARTED|Overall Study||14
7881951|NCT00803270|19396373|P1|STARTED|Overall Study||13
7881952|NCT00803244|19396383|P2|NOT COMPLETED|Overall Study||15
7881953|NCT00803244|19396384|P1|NOT COMPLETED|Overall Study||7
7881954|NCT00803244|19396383|P2|COMPLETED|Overall Study||178
7881955|NCT00803244|19396384|P1|COMPLETED|Overall Study||181
7881956|NCT00803244|19396383|P2|STARTED|Overall Study||193
7881957|NCT00803244|19396384|P1|STARTED|Overall Study||188
7881958|NCT00803205|19396394|P2|NOT COMPLETED|Overall Study||14
7881959|NCT00803205|19396395|P1|NOT COMPLETED|Overall Study||20
7881960|NCT00803205|19396394|P2|COMPLETED|Overall Study||104
7881961|NCT00803205|19396395|P1|COMPLETED|Overall Study||100
7881962|NCT00803205|19396394|P2|Per Protocol Population|Overall Study||103
7881963|NCT00803205|19396395|P1|Per Protocol Population|Overall Study||100
7881964|NCT00803205|19396394|P2|ITT Population|Overall Study||116
7881965|NCT00803205|19396395|P1|ITT Population|Overall Study||116
7881966|NCT00803205|19396394|P2|As-Treated Population*|Overall Study||118
7881967|NCT00803205|19396395|P1|As-Treated Population*|Overall Study||120
7881968|NCT00803205|19396394|P2|Completed Week 24|Overall Study||110
7881969|NCT00803205|19396395|P1|Completed Week 24|Overall Study||103
7881970|NCT00803205|19396394|P2|Completed Week 16|Overall Study||113
7881971|NCT00803205|19396395|P1|Completed Week 16|Overall Study||107
7881972|NCT00803205|19396394|P2|STARTED|Overall Study||118
7881975|NCT00803179|19396438|P1|COMPLETED|Overall Study||2
7881976|NCT00803179|19396438|P1|STARTED|Overall Study||5
7881977|NCT00803114|19396444|P2|NOT COMPLETED|Overall Study||0
7881978|NCT00803114|19396445|P1|NOT COMPLETED|Overall Study||0
7881979|NCT00803114|19396444|P2|COMPLETED|Overall Study||115
7881980|NCT00803114|19396445|P1|COMPLETED|Overall Study||113
7881981|NCT00803114|19396444|P2|STARTED|Overall Study||115
7881982|NCT00803114|19396445|P1|STARTED|Overall Study||113
7881983|NCT00803101|19396457|P2|NOT COMPLETED|Overall Study||22
7881984|NCT00803101|19396458|P1|NOT COMPLETED|Overall Study||18
7881985|NCT00803101|19396457|P2|COMPLETED|Overall Study||66
7881986|NCT00803101|19396458|P1|COMPLETED|Overall Study||70
7881987|NCT00803101|19396457|P2|STARTED|Overall Study||88
7881988|NCT00803101|19396458|P1|STARTED|Overall Study||88
7881989|NCT00803062|19396480|P4|NOT COMPLETED|Overall Study||0
7881990|NCT00803062|19396481|P3|NOT COMPLETED|Overall Study||0
7881991|NCT00803062|19396482|P2|NOT COMPLETED|Overall Study||0
7881992|NCT00803062|19396483|P1|NOT COMPLETED|Overall Study||0
7881993|NCT00803062|19396480|P4|COMPLETED|Overall Study||112
7881994|NCT00803062|19396481|P3|COMPLETED|Overall Study||111
7881995|NCT00803062|19396482|P2|COMPLETED|Overall Study||115
7881996|NCT00803062|19396483|P1|COMPLETED|Overall Study||114
7881997|NCT00803062|19396480|P4|STARTED|Overall Study||112
7881998|NCT00803062|19396481|P3|STARTED|Overall Study||111
7881999|NCT00803062|19396482|P2|STARTED|Overall Study||115
7882000|NCT00803062|19396483|P1|STARTED|Overall Study||114
7882001|NCT00803049|19396509|P4|NOT COMPLETED|Overall Study||102
7882002|NCT00803049|19396510|P3|NOT COMPLETED|Overall Study||44
7882003|NCT00803049|19396511|P2|NOT COMPLETED|Overall Study||118
7882004|NCT00803049|19396512|P1|NOT COMPLETED|Overall Study||61
7882005|NCT00803049|19396509|P4|COMPLETED|Overall Study||151
7882006|NCT00803049|19396510|P3|COMPLETED|Overall Study||64
7882007|NCT00803049|19396511|P2|COMPLETED|Overall Study||134
7882008|NCT00803049|19396512|P1|COMPLETED|Overall Study||68
7882009|NCT00803049|19396509|P4|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250
7882010|NCT00803049|19396510|P3|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107
7882011|NCT00803049|19396511|P2|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254
7882012|NCT00803049|19396512|P1|Safety Population|Overall Study||129
7882013|NCT00803049|19396509|P4|Treated|Overall Study||251
7882014|NCT00803049|19396510|P3|Treated|Overall Study||108
7882015|NCT00803049|19396511|P2|Treated|Overall Study||252
7882016|NCT00803049|19396512|P1|Treated|Overall Study||129
7882017|NCT00803049|19396509|P4|STARTED|Overall Study|Randomized in extension study|253
7882018|NCT00803049|19396510|P3|STARTED|Overall Study|Randomized in extension study|108
7882019|NCT00803049|19396511|P2|STARTED|Overall Study|Randomized in extension study|252
7882020|NCT00803049|19396512|P1|STARTED|Overall Study|Randomized in extension study|129
7882021|NCT00803023|19396546|P4|NOT COMPLETED|Overall Study||8
7882022|NCT00803023|19396547|P3|NOT COMPLETED|Overall Study||11
7882023|NCT00803023|19396548|P2|NOT COMPLETED|Overall Study||8
7882024|NCT00803023|19396549|P1|NOT COMPLETED|Overall Study||5
7882025|NCT00803023|19396546|P4|COMPLETED|Overall Study||25
7882026|NCT00803023|19396547|P3|COMPLETED|Overall Study||20
7882027|NCT00803023|19396548|P2|COMPLETED|Overall Study||25
7882028|NCT00803023|19396549|P1|COMPLETED|Overall Study||27
7882029|NCT00803023|19396546|P4|STARTED|Overall Study||33
7882030|NCT00803023|19396547|P3|STARTED|Overall Study||31
7882031|NCT00803023|19396548|P2|STARTED|Overall Study||33
7882032|NCT00803023|19396549|P1|STARTED|Overall Study||32
7882033|NCT00803010|19396561|P2|NOT COMPLETED|Overall Study||0
7882034|NCT00803010|19396562|P1|NOT COMPLETED|Overall Study||0
7882035|NCT00803010|19396561|P2|COMPLETED|Overall Study||37
7882036|NCT00803010|19396562|P1|COMPLETED|Overall Study||37
7882037|NCT00803010|19396561|P2|STARTED|Overall Study||37
7882038|NCT00803010|19396562|P1|STARTED|Overall Study||37
7882039|NCT00802997|19396574|P2|NOT COMPLETED|6 Month to 9 Months||0
7882040|NCT00802997|19396575|P1|NOT COMPLETED|6 Month to 9 Months||2
7882041|NCT00802997|19396574|P2|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
7882042|NCT00802997|19396575|P1|COMPLETED|6 Month to 9 Months||25
7882043|NCT00802997|19396574|P2|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
7882044|NCT00802997|19396575|P1|STARTED|6 Month to 9 Months||27
7882045|NCT00802997|19396574|P2|NOT COMPLETED|3 Months to 6 Months||0
7882046|NCT00802997|19396575|P1|NOT COMPLETED|3 Months to 6 Months||7
7882047|NCT00802997|19396574|P2|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
7882048|NCT00802997|19396575|P1|COMPLETED|3 Months to 6 Months||27
7882049|NCT00802997|19396574|P2|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
7882050|NCT00802997|19396575|P1|STARTED|3 Months to 6 Months||34
7882051|NCT00802997|19396574|P2|NOT COMPLETED|Baseline to 3 Months||0
7882052|NCT00802997|19396575|P1|NOT COMPLETED|Baseline to 3 Months||0
7882053|NCT00802997|19396574|P2|COMPLETED|Baseline to 3 Months||17
7882054|NCT00802997|19396575|P1|COMPLETED|Baseline to 3 Months||34
7882055|NCT00802997|19396574|P2|STARTED|Baseline to 3 Months||17
7882056|NCT00802997|19396575|P1|STARTED|Baseline to 3 Months||34
7882057|NCT00802945|19396587|P2|NOT COMPLETED|Overall Study||35
7882058|NCT00802945|19396588|P1|NOT COMPLETED|Overall Study||35
7882059|NCT00802945|19396587|P2|COMPLETED|Overall Study||0
7882060|NCT00802945|19396588|P1|COMPLETED|Overall Study||0
7882061|NCT00802945|19396587|P2|STARTED|Overall Study||35
7882062|NCT00802945|19396588|P1|STARTED|Overall Study||35
7882063|NCT00802919|19396606|P2|NOT COMPLETED|Overall Study||1
7882064|NCT00802919|19396607|P1|NOT COMPLETED|Overall Study||3
7882065|NCT00802919|19396606|P2|COMPLETED|Overall Study||45
7882066|NCT00802919|19396607|P1|COMPLETED|Overall Study||42
7882067|NCT00802919|19396606|P2|STARTED|Overall Study||46
7882068|NCT00802919|19396607|P1|STARTED|Overall Study||45
7882069|NCT00802893|19396619|P1|NOT COMPLETED|Overall Study||3
7882070|NCT00802893|19396619|P1|COMPLETED|Overall Study||0
7882071|NCT00802893|19396619|P1|STARTED|Overall Study||3
7882072|NCT00802880|19396624|P1|NOT COMPLETED|Overall Study||0
7882073|NCT00802880|19396624|P1|COMPLETED|Overall Study||80
7882074|NCT00802880|19396624|P1|STARTED|Overall Study||80
7882075|NCT00802867|19396643|P1|NOT COMPLETED|Overall Study||13
7882076|NCT00802867|19396643|P1|COMPLETED|Overall Study||976
7882077|NCT00802867|19396643|P1|STARTED|Overall Study||989
7882078|NCT00802854|19396651|P1|NOT COMPLETED|Overall Study||0
7882079|NCT00802854|19396651|P1|COMPLETED|Overall Study||244
7882080|NCT00802854|19396651|P1|STARTED|Overall Study||244
7882081|NCT00802841|19396666|P2|NOT COMPLETED|Overall Study||95
7882082|NCT00802841|19396667|P1|NOT COMPLETED|Overall Study||96
7882083|NCT00802841|19396666|P2|COMPLETED|Overall Study||0
7882084|NCT00802841|19396667|P1|COMPLETED|Overall Study||0
7882085|NCT00802841|19396666|P2|Cross-over Set|Overall Study||56
7882086|NCT00802841|19396667|P1|Cross-over Set|Overall Study||13
7882087|NCT00802841|19396666|P2|Safety Set|Overall Study||93
7882088|NCT00802841|19396667|P1|Safety Set|Overall Study||96
7882089|NCT00802841|19396666|P2|Full Analysis Set|Overall Study||95
7882090|NCT00802841|19396667|P1|Full Analysis Set|Overall Study||96
7882091|NCT00802841|19396666|P2|STARTED|Overall Study||95
7882092|NCT00802841|19396667|P1|STARTED|Overall Study||96
7882093|NCT00802737|19396692|P3|NOT COMPLETED|Overall Study||1
7882094|NCT00802737|19396693|P2|NOT COMPLETED|Overall Study||11
7882095|NCT00802737|19396694|P1|NOT COMPLETED|Overall Study||17
7882096|NCT00802737|19396692|P3|COMPLETED|Overall Study||0
7882097|NCT00802737|19396693|P2|COMPLETED|Overall Study||0
7882098|NCT00802737|19396694|P1|COMPLETED|Overall Study||0
7882099|NCT00802737|19396692|P3|STARTED|Overall Study||1
7882100|NCT00802737|19396693|P2|STARTED|Overall Study||11
7882101|NCT00802737|19396694|P1|STARTED|Overall Study||17
7882102|NCT00802685|19396742|P2|NOT COMPLETED|Overall Study||0
7882103|NCT00802685|19396743|P1|NOT COMPLETED|Overall Study||0
7882104|NCT00802685|19396742|P2|COMPLETED|Overall Study||51
7882105|NCT00802685|19396743|P1|COMPLETED|Overall Study||54
7882106|NCT00802685|19396742|P2|STARTED|Overall Study||51
7882107|NCT00802685|19396743|P1|STARTED|Overall Study||54
7882108|NCT00802672|19396754|P3|NOT COMPLETED|Overall Study||34
7882109|NCT00802672|19396755|P2|NOT COMPLETED|Overall Study||52
7882110|NCT00802672|19396756|P1|NOT COMPLETED|Overall Study||68
7882111|NCT00802672|19396754|P3|COMPLETED|Overall Study||77
7882112|NCT00802672|19396755|P2|COMPLETED|Overall Study||174
7882113|NCT00802672|19396756|P1|COMPLETED|Overall Study||156
7882114|NCT00802672|19396754|P3|STARTED|Overall Study||111
7882115|NCT00802672|19396755|P2|STARTED|Overall Study||226
7882116|NCT00802672|19396756|P1|STARTED|Overall Study||224
7882117|NCT00802659|19396774|P4|NOT COMPLETED|Overall Study||0
7882118|NCT00802659|19396775|P3|NOT COMPLETED|Overall Study||0
7882119|NCT00802659|19396776|P2|NOT COMPLETED|Overall Study||1
7882120|NCT00802659|19396777|P1|NOT COMPLETED|Overall Study||0
7882121|NCT00802659|19396774|P4|COMPLETED|Overall Study||0
7882122|NCT00802659|19396775|P3|COMPLETED|Overall Study||0
7882123|NCT00802659|19396776|P2|COMPLETED|Overall Study||1
7882124|NCT00802659|19396777|P1|COMPLETED|Overall Study||0
7882125|NCT00802659|19396774|P4|STARTED|Overall Study||0
7882126|NCT00802659|19396775|P3|STARTED|Overall Study||0
7882127|NCT00802659|19396776|P2|STARTED|Overall Study||2
7882128|NCT00802659|19396777|P1|STARTED|Overall Study||0
7882129|NCT00802633|19396805|P2|NOT COMPLETED|Overall Study||0
7882130|NCT00802633|19396806|P1|NOT COMPLETED|Overall Study||0
7882131|NCT00802633|19396805|P2|COMPLETED|Overall Study||40
7882132|NCT00802633|19396806|P1|COMPLETED|Overall Study||40
7882133|NCT00802633|19396805|P2|STARTED|Overall Study||40
7882134|NCT00802633|19396806|P1|STARTED|Overall Study||40
7882135|NCT00802529|19396816|P2|NOT COMPLETED|Overall Study||1
7882136|NCT00802529|19396817|P1|NOT COMPLETED|Overall Study||0
7882137|NCT00802529|19396816|P2|COMPLETED|Overall Study||29
7882138|NCT00802529|19396817|P1|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30
7882139|NCT00802529|19396816|P2|STARTED|Overall Study||30
7882140|NCT00802529|19396817|P1|STARTED|Overall Study||30
7882141|NCT00802503|19396829|P2|NOT COMPLETED|Overall Study||20
7882142|NCT00802503|19396830|P1|NOT COMPLETED|Overall Study||10
7882143|NCT00802503|19396829|P2|COMPLETED|Overall Study||133
7882144|NCT00802503|19396830|P1|COMPLETED|Overall Study||142
7882145|NCT00802503|19396829|P2|STARTED|Overall Study||153
7882146|NCT00802503|19396830|P1|STARTED|Overall Study||152
7882147|NCT00802464|19396856|P4|NOT COMPLETED|Month 8 - Month 14||0
7882148|NCT00802464|19396857|P3|NOT COMPLETED|Month 8 - Month 14||1
7882149|NCT00802464|19396858|P2|NOT COMPLETED|Month 8 - Month 14||2
7882150|NCT00802464|19396859|P1|NOT COMPLETED|Month 8 - Month 14||1
7882151|NCT00802464|19396856|P4|COMPLETED|Month 8 - Month 14||126
7882152|NCT00802464|19396857|P3|COMPLETED|Month 8 - Month 14||129
7882153|NCT00802464|19396858|P2|COMPLETED|Month 8 - Month 14||63
7882154|NCT00802464|19396859|P1|COMPLETED|Month 8 - Month 14||33
7882155|NCT00802464|19396856|P4|STARTED|Month 8 - Month 14||126
7882156|NCT00802464|19396857|P3|STARTED|Month 8 - Month 14||130
7882157|NCT00802464|19396858|P2|STARTED|Month 8 - Month 14||65
7882158|NCT00802464|19396859|P1|STARTED|Month 8 - Month 14||34
7882159|NCT00802464|19396856|P4|NOT COMPLETED|Month 0 - Month 8||9
7882160|NCT00802464|19396857|P3|NOT COMPLETED|Month 0 - Month 8||7
7882161|NCT00802464|19396858|P2|NOT COMPLETED|Month 0 - Month 8||3
7882162|NCT00802464|19396859|P1|NOT COMPLETED|Month 0 - Month 8||0
7882163|NCT00802464|19396856|P4|COMPLETED|Month 0 - Month 8||141
7882164|NCT00802464|19396857|P3|COMPLETED|Month 0 - Month 8||142
7882165|NCT00802464|19396858|P2|COMPLETED|Month 0 - Month 8||70
7882166|NCT00802464|19396859|P1|COMPLETED|Month 0 - Month 8||38
7882167|NCT00802464|19396856|P4|STARTED|Month 0 - Month 8||150
7882168|NCT00802464|19396857|P3|STARTED|Month 0 - Month 8||149
7882169|NCT00802464|19396858|P2|STARTED|Month 0 - Month 8||73
7882170|NCT00802464|19396859|P1|STARTED|Month 0 - Month 8||38
7882171|NCT00802438|19396945|P1|NOT COMPLETED|Overall Study||28
7882172|NCT00802438|19396945|P1|COMPLETED|Overall Study||10
7882173|NCT00802438|19396945|P1|STARTED|Overall Study||38
7882174|NCT00802412|19396952|P2|NOT COMPLETED|Overall Study||1
7882175|NCT00802412|19396953|P1|NOT COMPLETED|Overall Study||2
7882176|NCT00802412|19396952|P2|COMPLETED|Overall Study||66
7882177|NCT00802412|19396953|P1|COMPLETED|Overall Study||63
7882178|NCT00802412|19396952|P2|STARTED|Overall Study||67
7882179|NCT00802412|19396953|P1|STARTED|Overall Study||65
7882180|NCT00802360|19396965|P4|NOT COMPLETED|Overall Study||22
7882181|NCT00802360|19396966|P3|NOT COMPLETED|Overall Study||25
7882182|NCT00802360|19396967|P2|NOT COMPLETED|Overall Study||26
7882183|NCT00802360|19396968|P1|NOT COMPLETED|Overall Study||24
7882184|NCT00802360|19396965|P4|COMPLETED|Overall Study||17
7882185|NCT00802360|19396966|P3|COMPLETED|Overall Study||17
7882186|NCT00802360|19396967|P2|COMPLETED|Overall Study||16
7882187|NCT00802360|19396968|P1|COMPLETED|Overall Study||18
7882188|NCT00802360|19396965|P4|STARTED|Overall Study||39
7882189|NCT00802360|19396966|P3|STARTED|Overall Study||42
7882190|NCT00802360|19396967|P2|STARTED|Overall Study||42
7882191|NCT00802360|19396968|P1|STARTED|Overall Study||42
7882192|NCT00802204|19397010|P2|NOT COMPLETED|Overall Study||1
7882193|NCT00802204|19397011|P1|NOT COMPLETED|Overall Study||1
7882194|NCT00802204|19397010|P2|COMPLETED|Overall Study||18
7882195|NCT00802204|19397011|P1|COMPLETED|Overall Study||8
7882196|NCT00802204|19397010|P2|STARTED|Overall Study||19
7882197|NCT00802204|19397011|P1|STARTED|Overall Study||9
7882198|NCT00802178|19397035|P1|NOT COMPLETED|Overall Study||113
7882199|NCT00802178|19397035|P1|COMPLETED|Overall Study||2335
7882200|NCT00802178|19397035|P1|STARTED|Overall Study||2448
7882201|NCT00802113|19397044|P2|NOT COMPLETED|Overall Study||0
7882202|NCT00802113|19397045|P1|NOT COMPLETED|Overall Study||0
7882203|NCT00802113|19397044|P2|COMPLETED|Overall Study||17
7882204|NCT00802113|19397045|P1|COMPLETED|Overall Study||6
7882205|NCT00802113|19397044|P2|STARTED|Overall Study||17
7882206|NCT00802113|19397045|P1|STARTED|Overall Study||6
7882207|NCT00802100|19397066|P3|NOT COMPLETED|Overall Study||4
7882208|NCT00802100|19397067|P2|NOT COMPLETED|Overall Study||7
7882209|NCT00802100|19397068|P1|NOT COMPLETED|Overall Study||6
7882210|NCT00802100|19397066|P3|COMPLETED|Overall Study||2
7882211|NCT00802100|19397067|P2|COMPLETED|Overall Study||2
7882212|NCT00802100|19397068|P1|COMPLETED|Overall Study||0
7882213|NCT00802100|19397066|P3|STARTED|Overall Study||6
7882214|NCT00802100|19397067|P2|STARTED|Overall Study||9
7882215|NCT00802100|19397068|P1|STARTED|Overall Study||6
7882216|NCT00802074|19397083|P6|NOT COMPLETED|Overall Study||0
7882217|NCT00802074|19397084|P5|NOT COMPLETED|Overall Study||0
7882218|NCT00802074|19397085|P4|NOT COMPLETED|Overall Study||0
7882219|NCT00802074|19397086|P3|NOT COMPLETED|Overall Study||1
7882220|NCT00802074|19397087|P2|NOT COMPLETED|Overall Study||1
7882221|NCT00802074|19397088|P1|NOT COMPLETED|Overall Study||2
7882222|NCT00802074|19397083|P6|COMPLETED|Overall Study||7
7882223|NCT00802074|19397084|P5|COMPLETED|Overall Study||7
7882224|NCT00802074|19397085|P4|COMPLETED|Overall Study||7
7882225|NCT00802074|19397086|P3|COMPLETED|Overall Study||6
7882226|NCT00802074|19397087|P2|COMPLETED|Overall Study||7
7882227|NCT00802074|19397088|P1|COMPLETED|Overall Study||7
7882228|NCT00802074|19397083|P6|STARTED|Overall Study||7
7882229|NCT00802074|19397084|P5|STARTED|Overall Study||7
7882230|NCT00802074|19397085|P4|STARTED|Overall Study||7
7882231|NCT00802074|19397086|P3|STARTED|Overall Study||7
7882232|NCT00802074|19397087|P2|STARTED|Overall Study||8
7882233|NCT00802074|19397088|P1|STARTED|Overall Study||9
7882234|NCT00801983|19397122|P2|NOT COMPLETED|Period 2||1
7882235|NCT00801983|19397123|P1|NOT COMPLETED|Period 2||2
7882236|NCT00801983|19397122|P2|COMPLETED|Period 2||32
7882237|NCT00801983|19397123|P1|COMPLETED|Period 2||38
7882238|NCT00801983|19397122|P2|STARTED|Period 2||33
7882239|NCT00801983|19397123|P1|STARTED|Period 2||40
7882240|NCT00801983|19397122|P2|NOT COMPLETED|Period 1||8
7882241|NCT00801983|19397123|P1|NOT COMPLETED|Period 1||4
7882242|NCT00801983|19397122|P2|COMPLETED|Period 1||33
7882243|NCT00801983|19397123|P1|COMPLETED|Period 1||40
7882244|NCT00801983|19397122|P2|STARTED|Period 1||41
7882245|NCT00801983|19397123|P1|STARTED|Period 1||44
7882246|NCT00801931|19397129|P1|NOT COMPLETED|Overall Study||0
7882247|NCT00801931|19397129|P1|COMPLETED|Overall Study||1
7882248|NCT00801931|19397129|P1|STARTED|Overall Study||1
7882249|NCT00801892|19397138|P2|NOT COMPLETED|Sham Crossover Period||2
7882250|NCT00801892|19397139|P1|NOT COMPLETED|Sham Crossover Period||0
7882251|NCT00801892|19397138|P2|COMPLETED|Sham Crossover Period||5
7882252|NCT00801892|19397139|P1|COMPLETED|Sham Crossover Period||0
7882253|NCT00801892|19397138|P2|STARTED|Sham Crossover Period||7
7882254|NCT00801892|19397139|P1|STARTED|Sham Crossover Period||0
7882255|NCT00801892|19397138|P2|NOT COMPLETED|Main Study Period||1
7882256|NCT00801892|19397139|P1|NOT COMPLETED|Main Study Period||0
7882257|NCT00801892|19397138|P2|COMPLETED|Main Study Period||10
7882258|NCT00801892|19397139|P1|COMPLETED|Main Study Period||12
7882259|NCT00801892|19397138|P2|STARTED|Main Study Period||11
7882260|NCT00801892|19397139|P1|STARTED|Main Study Period||12
7882261|NCT00801827|19397155|P1|NOT COMPLETED|Overall Study||0
7882262|NCT00801827|19397155|P1|COMPLETED|Overall Study||5
7882263|NCT00801827|19397155|P1|STARTED|Overall Study|2 others consented but due to scheduling did not complete|5
7882264|NCT00801801|19397159|P1|NOT COMPLETED|Overall Study||0
7882265|NCT00801801|19397159|P1|COMPLETED|Overall Study||5
7882266|NCT00801801|19397159|P1|STARTED|Overall Study||5
7882267|NCT00801723|19397166|P2|NOT COMPLETED|Overall Study||35
7882268|NCT00801723|19397167|P1|NOT COMPLETED|Overall Study||36
7882269|NCT00801723|19397166|P2|COMPLETED|Overall Study||27
7882270|NCT00801723|19397167|P1|COMPLETED|Overall Study||25
7882271|NCT00801723|19397166|P2|STARTED|Overall Study||62
7882272|NCT00801723|19397167|P1|STARTED|Overall Study||61
7882273|NCT00801684|19397177|P1|NOT COMPLETED|Overall Study||0
7882274|NCT00801684|19397177|P1|COMPLETED|Overall Study||24
7882275|NCT00801684|19397177|P1|STARTED|Overall Study||24
7882276|NCT00801632|19397199|P1|NOT COMPLETED|Overall Study||1
7882277|NCT00801632|19397199|P1|COMPLETED|Overall Study||4
7882278|NCT00801632|19397199|P1|STARTED|Overall Study||5
7882279|NCT00801398|19397216|P6|NOT COMPLETED|Overall Study||3
7882280|NCT00801398|19397217|P5|NOT COMPLETED|Overall Study||7
7882281|NCT00801398|19397218|P4|NOT COMPLETED|Overall Study||6
7882282|NCT00801398|19397219|P3|NOT COMPLETED|Overall Study||7
7882283|NCT00801398|19397220|P2|NOT COMPLETED|Overall Study||9
7882284|NCT00801398|19397221|P1|NOT COMPLETED|Overall Study||6
7882285|NCT00801398|19397216|P6|COMPLETED|Overall Study||5
7882286|NCT00801398|19397217|P5|COMPLETED|Overall Study||1
7882287|NCT00801398|19397218|P4|COMPLETED|Overall Study||3
7882288|NCT00801398|19397219|P3|COMPLETED|Overall Study||4
7882289|NCT00801398|19397220|P2|COMPLETED|Overall Study||0
7882290|NCT00801398|19397221|P1|COMPLETED|Overall Study||7
7882291|NCT00801398|19397216|P6|STARTED|Overall Study||8
7882292|NCT00801398|19397217|P5|STARTED|Overall Study||8
7882293|NCT00801398|19397218|P4|STARTED|Overall Study||9
7882294|NCT00801398|19397219|P3|STARTED|Overall Study||11
7882295|NCT00801398|19397220|P2|STARTED|Overall Study||9
7882296|NCT00801398|19397221|P1|STARTED|Overall Study||13
7882297|NCT00801242|19397277|P1|NOT COMPLETED|Overall Study||52
7882298|NCT00801242|19397277|P1|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168
7882299|NCT00801242|19397277|P1|Started Cycle 3|Overall Study||2
7882300|NCT00801242|19397277|P1|Started Cycle 2|Overall Study||35
7882301|NCT00801242|19397277|P1|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191
7882302|NCT00801242|19397277|P1|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213
7882303|NCT00801242|19397277|P1|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216
7882304|NCT00801242|19397277|P1|STARTED|Overall Study|Randomized participants.|220
7882305|NCT00801229|19397290|P2|NOT COMPLETED|Received Study Drug/Placebo||4
7882306|NCT00801229|19397291|P1|NOT COMPLETED|Received Study Drug/Placebo||4
7882307|NCT00801229|19397290|P2|COMPLETED|Received Study Drug/Placebo||30
7882308|NCT00801229|19397291|P1|COMPLETED|Received Study Drug/Placebo||31
7882309|NCT00801229|19397290|P2|STARTED|Received Study Drug/Placebo||34
7882310|NCT00801229|19397291|P1|STARTED|Received Study Drug/Placebo||35
7882311|NCT00801229|19397290|P2|NOT COMPLETED|Signed Consent||3
7882312|NCT00801229|19397291|P1|NOT COMPLETED|Signed Consent||3
7882313|NCT00801229|19397290|P2|COMPLETED|Signed Consent||34
7882314|NCT00801229|19397291|P1|COMPLETED|Signed Consent||35
7882315|NCT00801229|19397290|P2|STARTED|Signed Consent||37
7882316|NCT00801229|19397291|P1|STARTED|Signed Consent||38
7882317|NCT00801138|19397301|P4|NOT COMPLETED|Overall Study||0
7882318|NCT00801138|19397302|P3|NOT COMPLETED|Overall Study||0
7882319|NCT00801138|19397303|P2|NOT COMPLETED|Overall Study||0
7882320|NCT00801138|19397304|P1|NOT COMPLETED|Overall Study||0
7882321|NCT00801138|19397301|P4|COMPLETED|Overall Study||54
7882322|NCT00801138|19397302|P3|COMPLETED|Overall Study||54
7882323|NCT00801138|19397303|P2|COMPLETED|Overall Study||56
7882324|NCT00801138|19397304|P1|COMPLETED|Overall Study||54
7882325|NCT00801138|19397301|P4|STARTED|Overall Study||54
7882326|NCT00801138|19397302|P3|STARTED|Overall Study||54
7882327|NCT00801138|19397303|P2|STARTED|Overall Study||56
7882328|NCT00801138|19397304|P1|STARTED|Overall Study||54
7882329|NCT00801099|19397326|P1|NOT COMPLETED|Overall Study||101
7882330|NCT00801099|19397326|P1|COMPLETED|Overall Study||175
7882331|NCT00801099|19397326|P1|STARTED|Overall Study||276
7882332|NCT00800982|19397332|P2|NOT COMPLETED|Overall Study||3
7882333|NCT00800982|19397333|P1|NOT COMPLETED|Overall Study||2
7882334|NCT00800982|19397332|P2|COMPLETED|Overall Study||12
7882335|NCT00800982|19397333|P1|COMPLETED|Overall Study||13
7882336|NCT00800982|19397332|P2|STARTED|Overall Study||15
7882337|NCT00800982|19397333|P1|STARTED|Overall Study||15
7882338|NCT00800865|19397341|P2|NOT COMPLETED|Overall Study||0
7882339|NCT00800865|19397342|P1|NOT COMPLETED|Overall Study||0
7882340|NCT00800865|19397341|P2|COMPLETED|Overall Study||16
7882341|NCT00800865|19397342|P1|COMPLETED|Overall Study||15
7882342|NCT00800865|19397341|P2|STARTED|Overall Study||16
7882343|NCT00800865|19397342|P1|STARTED|Overall Study||15
7882344|NCT00800839|19397350|P1|NOT COMPLETED|Overall Study||7
7882345|NCT00800839|19397350|P1|COMPLETED|Overall Study||49
7882346|NCT00800839|19397350|P1|STARTED|Overall Study||56
7882347|NCT00800735|19397359|P1|NOT COMPLETED|Overall Study||14
7882348|NCT00800735|19397359|P1|COMPLETED|Overall Study||16
7882349|NCT00800735|19397359|P1|STARTED|Overall Study||30
7882350|NCT00800683|19397365|P2|NOT COMPLETED|Overall Study||19
7882351|NCT00800683|19397366|P1|NOT COMPLETED|Overall Study||17
7882352|NCT00800683|19397365|P2|COMPLETED|Overall Study|Number who completed treatment|49
7882353|NCT00800683|19397366|P1|COMPLETED|Overall Study|Number who completed treatment|48
7882354|NCT00800683|19397365|P2|STARTED|Overall Study|Number who started treatment|68
7882355|NCT00800683|19397366|P1|STARTED|Overall Study|Number who started treatment|65
7882356|NCT00800540|19397412|P2|NOT COMPLETED|Period 2: 6 Weeks||1
7882357|NCT00800540|19397413|P1|NOT COMPLETED|Period 2: 6 Weeks||0
7882358|NCT00800540|19397412|P2|COMPLETED|Period 2: 6 Weeks||16
7882359|NCT00800540|19397413|P1|COMPLETED|Period 2: 6 Weeks||16
7882360|NCT00800540|19397412|P2|STARTED|Period 2: 6 Weeks||17
7882361|NCT00800540|19397413|P1|STARTED|Period 2: 6 Weeks||16
7882362|NCT00800540|19397412|P2|NOT COMPLETED|Washout: 4 Weeks||0
7882363|NCT00800540|19397413|P1|NOT COMPLETED|Washout: 4 Weeks||0
7882364|NCT00800540|19397412|P2|COMPLETED|Washout: 4 Weeks||17
7882365|NCT00800540|19397413|P1|COMPLETED|Washout: 4 Weeks||16
7882366|NCT00800540|19397412|P2|STARTED|Washout: 4 Weeks||17
7882367|NCT00800540|19397413|P1|STARTED|Washout: 4 Weeks||16
7882368|NCT00800540|19397412|P2|NOT COMPLETED|Period One: 6 Weeks||1
7882369|NCT00800540|19397413|P1|NOT COMPLETED|Period One: 6 Weeks||1
7882370|NCT00800540|19397412|P2|COMPLETED|Period One: 6 Weeks||17
7882371|NCT00800540|19397413|P1|COMPLETED|Period One: 6 Weeks||16
7882372|NCT00800540|19397412|P2|STARTED|Period One: 6 Weeks||18
7882373|NCT00800540|19397413|P1|STARTED|Period One: 6 Weeks||17
7882374|NCT00800436|19397448|P7|NOT COMPLETED|Overall Study||0
7882375|NCT00800436|19397449|P6|NOT COMPLETED|Overall Study||0
7882376|NCT00800436|19397450|P5|NOT COMPLETED|Overall Study||0
7882377|NCT00800436|19397451|P4|NOT COMPLETED|Overall Study||1
7882378|NCT00800436|19397452|P3|NOT COMPLETED|Overall Study||1
7882379|NCT00800436|19397453|P2|NOT COMPLETED|Overall Study||0
7882380|NCT00800436|19397454|P1|NOT COMPLETED|Overall Study||0
7882381|NCT00800436|19397448|P7|COMPLETED|Overall Study||20
7882382|NCT00800436|19397449|P6|COMPLETED|Overall Study||20
7882383|NCT00800436|19397450|P5|COMPLETED|Overall Study||6
7882384|NCT00800436|19397451|P4|COMPLETED|Overall Study||5
7882385|NCT00800436|19397452|P3|COMPLETED|Overall Study||5
7882386|NCT00800436|19397453|P2|COMPLETED|Overall Study||6
7882387|NCT00800436|19397454|P1|COMPLETED|Overall Study||6
7882388|NCT00800436|19397448|P7|STARTED|Overall Study||20
7882389|NCT00800436|19397449|P6|STARTED|Overall Study||20
7882390|NCT00800436|19397450|P5|STARTED|Overall Study||6
7882391|NCT00800436|19397451|P4|STARTED|Overall Study||6
7882392|NCT00800436|19397452|P3|STARTED|Overall Study||6
7882393|NCT00800436|19397453|P2|STARTED|Overall Study||6
7882394|NCT00800436|19397454|P1|STARTED|Overall Study||6
7882395|NCT00800384|19397500|P2|NOT COMPLETED|Overall Study||43
7882396|NCT00800384|19397501|P1|NOT COMPLETED|Overall Study||41
7882397|NCT00800384|19397500|P2|COMPLETED|Overall Study||1210
7882398|NCT00800384|19397501|P1|COMPLETED|Overall Study||1206
7882399|NCT00800384|19397500|P2|STARTED|Overall Study||1253
7882400|NCT00800384|19397501|P1|STARTED|Overall Study||1247
7882401|NCT00800345|19397509|P1|NOT COMPLETED|Overall Study||0
7882402|NCT00800345|19397509|P1|COMPLETED|Overall Study||33
7882403|NCT00800345|19397509|P1|STARTED|Overall Study||33
7882404|NCT00800254|19397516|P2|NOT COMPLETED|Overall Study||6
7882405|NCT00800254|19397517|P1|NOT COMPLETED|Overall Study||5
7882406|NCT00800254|19397516|P2|COMPLETED|Overall Study||25
7882407|NCT00800254|19397517|P1|COMPLETED|Overall Study||30
7882408|NCT00800254|19397516|P2|3.5 Weeks Post-operatively|Overall Study||31
7882409|NCT00800254|19397517|P1|3.5 Weeks Post-operatively|Overall Study||31
7882410|NCT00800254|19397516|P2|STARTED|Overall Study||31
7882411|NCT00800254|19397517|P1|STARTED|Overall Study||35
7882412|NCT00800202|19397539|P2|NOT COMPLETED|Overall Study||24
7882413|NCT00800202|19397540|P1|NOT COMPLETED|Overall Study||67
7882414|NCT00800202|19397539|P2|COMPLETED|Overall Study||0
7882415|NCT00800202|19397540|P1|COMPLETED|Overall Study||0
7882416|NCT00800202|19397539|P2|STARTED|Overall Study||24
7882417|NCT00800202|19397540|P1|STARTED|Overall Study||67
7882418|NCT00800176|19397564|P6|NOT COMPLETED|Overall Study||5
7882419|NCT00800176|19397565|P5|NOT COMPLETED|Overall Study||4
7882420|NCT00800176|19397566|P4|NOT COMPLETED|Overall Study||4
7882421|NCT00800176|19397567|P3|NOT COMPLETED|Overall Study||0
7882422|NCT00800176|19397568|P2|NOT COMPLETED|Overall Study||6
7882423|NCT00800176|19397569|P1|NOT COMPLETED|Overall Study||9
7882424|NCT00800176|19397564|P6|COMPLETED|Overall Study||62
7882425|NCT00800176|19397565|P5|COMPLETED|Overall Study||60
7882426|NCT00800176|19397566|P4|COMPLETED|Overall Study||62
7882427|NCT00800176|19397567|P3|COMPLETED|Overall Study||65
7882428|NCT00800176|19397568|P2|COMPLETED|Overall Study||60
7882429|NCT00800176|19397569|P1|COMPLETED|Overall Study||57
7882430|NCT00800176|19397564|P6|STARTED|Overall Study||67
7882431|NCT00800176|19397565|P5|STARTED|Overall Study||64
7882432|NCT00800176|19397566|P4|STARTED|Overall Study||66
7882433|NCT00800176|19397567|P3|STARTED|Overall Study||65
7882434|NCT00800176|19397568|P2|STARTED|Overall Study||66
7882435|NCT00800176|19397569|P1|STARTED|Overall Study||66
7882436|NCT00799903|19397645|P2|NOT COMPLETED|Overall Study||278
7882437|NCT00799903|19397646|P1|NOT COMPLETED|Overall Study||273
7882438|NCT00799903|19397645|P2|COMPLETED|Overall Study||7646
7882439|NCT00799903|19397646|P1|COMPLETED|Overall Study||7631
7882440|NCT00799903|19397645|P2|STARTED|Overall Study||7924
7882441|NCT00799903|19397646|P1|STARTED|Overall Study||7904
7882442|NCT00799825|19397666|P1|NOT COMPLETED|Overall Study||48
7882443|NCT00799825|19397666|P1|COMPLETED|Overall Study||296
7882444|NCT00799825|19397666|P1|STARTED|Overall Study||344
7882445|NCT00799773|19397674|P2|NOT COMPLETED|Overall Study||0
7882446|NCT00799773|19397675|P1|NOT COMPLETED|Overall Study||0
7882447|NCT00799773|19397674|P2|COMPLETED|Overall Study||1
7882448|NCT00799773|19397675|P1|COMPLETED|Overall Study||2
7882449|NCT00799773|19397674|P2|STARTED|Overall Study||1
7882450|NCT00799773|19397675|P1|STARTED|Overall Study||2
7882451|NCT00799708|19397706|P3|NOT COMPLETED|Overall Study||0
7882452|NCT00799708|19397707|P2|NOT COMPLETED|Overall Study||0
7882453|NCT00799708|19397708|P1|NOT COMPLETED|Overall Study||1
7882454|NCT00799708|19397706|P3|COMPLETED|Overall Study||11
7882455|NCT00799708|19397707|P2|COMPLETED|Overall Study||6
7882456|NCT00799708|19397708|P1|COMPLETED|Overall Study||9
7882457|NCT00799708|19397706|P3|STARTED|Overall Study||11
7882458|NCT00799708|19397707|P2|STARTED|Overall Study||6
7882459|NCT00799708|19397708|P1|STARTED|Overall Study||10
7882460|NCT00799643|19397720|P2|NOT COMPLETED|Overall Study||27
7882461|NCT00799643|19397721|P1|NOT COMPLETED|Overall Study||25
7882462|NCT00799643|19397720|P2|COMPLETED|Overall Study||119
7882463|NCT00799643|19397721|P1|COMPLETED|Overall Study||115
7882464|NCT00799643|19397720|P2|STARTED|Overall Study||146
7882465|NCT00799643|19397721|P1|STARTED|Overall Study||140
7882466|NCT00799617|19397731|P2|NOT COMPLETED|Anemia Trial||3
7882467|NCT00799617|19397732|P1|NOT COMPLETED|Anemia Trial||3
7882468|NCT00799617|19397731|P2|COMPLETED|Anemia Trial||32
7882469|NCT00799617|19397732|P1|COMPLETED|Anemia Trial||24
7882470|NCT00799617|19397731|P2|STARTED|Anemia Trial||35
7882471|NCT00799617|19397732|P1|STARTED|Anemia Trial||27
7882472|NCT00799617|19397731|P2|NOT COMPLETED|Cognitive Function Trial||1
7882473|NCT00799617|19397732|P1|NOT COMPLETED|Cognitive Function Trial||0
7882474|NCT00799617|19397731|P2|COMPLETED|Cognitive Function Trial||245
7882475|NCT00799617|19397732|P1|COMPLETED|Cognitive Function Trial||247
7882476|NCT00799617|19397731|P2|STARTED|Cognitive Function Trial||246
7882477|NCT00799617|19397732|P1|STARTED|Cognitive Function Trial||247
7882478|NCT00799617|19397731|P2|NOT COMPLETED|Bone Trial||16
7882479|NCT00799617|19397732|P1|NOT COMPLETED|Bone Trial||6
7882480|NCT00799617|19397731|P2|COMPLETED|Bone Trial||85
7882481|NCT00799617|19397732|P1|COMPLETED|Bone Trial||104
7882482|NCT00799617|19397731|P2|STARTED|Bone Trial||101
7882483|NCT00799617|19397732|P1|STARTED|Bone Trial||110
7882484|NCT00799617|19397731|P2|NOT COMPLETED|Cardiovascular Trial||17
7882485|NCT00799617|19397732|P1|NOT COMPLETED|Cardiovascular Trial||15
7882486|NCT00799617|19397731|P2|COMPLETED|Cardiovascular Trial||65
7882487|NCT00799617|19397732|P1|COMPLETED|Cardiovascular Trial||73
7882488|NCT00799617|19397731|P2|STARTED|Cardiovascular Trial||82
7882489|NCT00799617|19397732|P1|STARTED|Cardiovascular Trial||88
7882490|NCT00799617|19397731|P2|NOT COMPLETED|Vitality Trial||22
7882491|NCT00799617|19397732|P1|NOT COMPLETED|Vitality Trial||7
7882492|NCT00799617|19397731|P2|COMPLETED|Vitality Trial||216
7882493|NCT00799617|19397732|P1|COMPLETED|Vitality Trial||229
7882494|NCT00799617|19397731|P2|STARTED|Vitality Trial||238
7882495|NCT00799617|19397732|P1|STARTED|Vitality Trial||236
7882496|NCT00799617|19397731|P2|NOT COMPLETED|Physical Function Trial||11
7882497|NCT00799617|19397732|P1|NOT COMPLETED|Physical Function Trial||6
7882498|NCT00799617|19397731|P2|COMPLETED|Physical Function Trial||185
7882499|NCT00799617|19397732|P1|COMPLETED|Physical Function Trial||185
7882500|NCT00799617|19397731|P2|STARTED|Physical Function Trial||196
7882501|NCT00799617|19397732|P1|STARTED|Physical Function Trial||191
7882502|NCT00799617|19397731|P2|NOT COMPLETED|Sexual Funtion Trial||21
7882503|NCT00799617|19397732|P1|NOT COMPLETED|Sexual Funtion Trial||16
7882504|NCT00799617|19397731|P2|COMPLETED|Sexual Funtion Trial||215
7882505|NCT00799617|19397732|P1|COMPLETED|Sexual Funtion Trial||218
7882506|NCT00799617|19397731|P2|STARTED|Sexual Funtion Trial||236
7882507|NCT00799617|19397732|P1|STARTED|Sexual Funtion Trial||234
7882508|NCT00799617|19397731|P2|NOT COMPLETED|Main Testosterone Trial||21
7882509|NCT00799617|19397732|P1|NOT COMPLETED|Main Testosterone Trial||19
7882510|NCT00799617|19397731|P2|COMPLETED|Main Testosterone Trial||374
7882511|NCT00799617|19397732|P1|COMPLETED|Main Testosterone Trial|Participants qualified for 1 of the 3 main trials (sexual function, physical function, vitality).|376
7882512|NCT00799617|19397731|P2|STARTED|Main Testosterone Trial||395
7882513|NCT00799617|19397732|P1|STARTED|Main Testosterone Trial||395
7882514|NCT00799604|19397813|P3|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
7882515|NCT00799604|19397814|P2|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
7882516|NCT00799604|19397815|P1|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
7882517|NCT00799604|19397813|P3|COMPLETED|Bolus 2 (With Anesthesia)||3
7882518|NCT00799604|19397814|P2|COMPLETED|Bolus 2 (With Anesthesia)||12
7882519|NCT00799604|19397815|P1|COMPLETED|Bolus 2 (With Anesthesia)||6
7882520|NCT00799604|19397813|P3|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3
7882521|NCT00799604|19397814|P2|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12
7882522|NCT00799604|19397815|P1|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6
7882523|NCT00799604|19397813|P3|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
7882524|NCT00799604|19397814|P2|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
7882525|NCT00799604|19397815|P1|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
7882526|NCT00799604|19397813|P3|COMPLETED|Bolus 1 (Pre-anesthesia)||10
7882527|NCT00799604|19397814|P2|COMPLETED|Bolus 1 (Pre-anesthesia)||10
7882528|NCT00799604|19397815|P1|COMPLETED|Bolus 1 (Pre-anesthesia)||10
7882529|NCT00799604|19397813|P3|STARTED|Bolus 1 (Pre-anesthesia)||10
7882530|NCT00799604|19397814|P2|STARTED|Bolus 1 (Pre-anesthesia)||10
7882531|NCT00799604|19397815|P1|STARTED|Bolus 1 (Pre-anesthesia)||10
7882532|NCT00799591|19397839|P1|NOT COMPLETED|Overall Study||66
7882533|NCT00799591|19397839|P1|COMPLETED|Overall Study||90
7882534|NCT00799591|19397839|P1|STARTED|Overall Study||156
7882535|NCT00799578|19397850|P1|NOT COMPLETED|Overall Study||2
7882536|NCT00799578|19397850|P1|COMPLETED|Overall Study||11
7882537|NCT00799578|19397850|P1|STARTED|Overall Study||13
7882538|NCT00799487|19397857|P3|NOT COMPLETED|Double-Blind Assessment Period||2
7882539|NCT00799487|19397858|P2|NOT COMPLETED|Double-Blind Assessment Period||1
7882540|NCT00799487|19397859|P1|NOT COMPLETED|Double-Blind Assessment Period||0
7882541|NCT00799487|19397857|P3|COMPLETED|Double-Blind Assessment Period||32
7882542|NCT00799487|19397858|P2|COMPLETED|Double-Blind Assessment Period||33
7882543|NCT00799487|19397859|P1|COMPLETED|Double-Blind Assessment Period||0
7882544|NCT00799487|19397857|P3|STARTED|Double-Blind Assessment Period||34
7882545|NCT00799487|19397858|P2|STARTED|Double-Blind Assessment Period||34
7882546|NCT00799487|19397859|P1|STARTED|Double-Blind Assessment Period||0
7882547|NCT00799487|19397857|P3|NOT COMPLETED|Dose Adjustment Period||0
7882548|NCT00799487|19397858|P2|NOT COMPLETED|Dose Adjustment Period||0
7882549|NCT00799487|19397859|P1|NOT COMPLETED|Dose Adjustment Period||21
7882550|NCT00799487|19397857|P3|COMPLETED|Dose Adjustment Period||34
7882551|NCT00799487|19397858|P2|COMPLETED|Dose Adjustment Period||34
7882552|NCT00799487|19397859|P1|COMPLETED|Dose Adjustment Period||0
7882553|NCT00799487|19397857|P3|STARTED|Dose Adjustment Period||34
7882554|NCT00799487|19397858|P2|STARTED|Dose Adjustment Period||34
7882555|NCT00799487|19397859|P1|STARTED|Dose Adjustment Period||21
7882556|NCT00799474|19397939|P1|NOT COMPLETED|Overall Study||0
7882557|NCT00799474|19397939|P1|COMPLETED|Overall Study||609
7882558|NCT00799474|19397939|P1|STARTED|Overall Study||609
7882559|NCT00799435|19397947|P2|NOT COMPLETED|Overall Study||0
7882560|NCT00799435|19397948|P1|NOT COMPLETED|Overall Study||0
7882561|NCT00799435|19397947|P2|COMPLETED|Overall Study||1
7882562|NCT00799435|19397948|P1|COMPLETED|Overall Study||1
7882563|NCT00799435|19397947|P2|STARTED|Overall Study||1
7882564|NCT00799435|19397948|P1|STARTED|Overall Study||1
7882565|NCT00799422|19397956|P6|NOT COMPLETED|Third Week of Wear||0
7882566|NCT00799422|19397957|P5|NOT COMPLETED|Third Week of Wear||0
7882567|NCT00799422|19397958|P4|NOT COMPLETED|Third Week of Wear||0
7882568|NCT00799422|19397959|P3|NOT COMPLETED|Third Week of Wear||0
7882569|NCT00799422|19397960|P2|NOT COMPLETED|Third Week of Wear||0
7882570|NCT00799422|19397961|P1|NOT COMPLETED|Third Week of Wear||0
7882571|NCT00799422|19397956|P6|COMPLETED|Third Week of Wear||4
7882572|NCT00799422|19397957|P5|COMPLETED|Third Week of Wear||4
7882573|NCT00799422|19397958|P4|COMPLETED|Third Week of Wear||3
7882574|NCT00799422|19397959|P3|COMPLETED|Third Week of Wear||3
7882575|NCT00799422|19397960|P2|COMPLETED|Third Week of Wear||4
7882576|NCT00799422|19397961|P1|COMPLETED|Third Week of Wear||4
7882577|NCT00799422|19397956|P6|STARTED|Third Week of Wear||4
7882578|NCT00799422|19397957|P5|STARTED|Third Week of Wear||4
7882579|NCT00799422|19397958|P4|STARTED|Third Week of Wear||3
7882580|NCT00799422|19397959|P3|STARTED|Third Week of Wear||3
7882581|NCT00799422|19397960|P2|STARTED|Third Week of Wear||4
7882582|NCT00799422|19397961|P1|STARTED|Third Week of Wear||4
7882583|NCT00799422|19397956|P6|NOT COMPLETED|Second Week of Wear||0
7882584|NCT00799422|19397957|P5|NOT COMPLETED|Second Week of Wear||0
7882585|NCT00799422|19397958|P4|NOT COMPLETED|Second Week of Wear||0
7882586|NCT00799422|19397959|P3|NOT COMPLETED|Second Week of Wear||0
7882587|NCT00799422|19397960|P2|NOT COMPLETED|Second Week of Wear||0
7882588|NCT00799422|19397961|P1|NOT COMPLETED|Second Week of Wear||0
7882589|NCT00799422|19397956|P6|COMPLETED|Second Week of Wear||4
7882590|NCT00799422|19397957|P5|COMPLETED|Second Week of Wear||4
7882591|NCT00799422|19397958|P4|COMPLETED|Second Week of Wear||3
7882592|NCT00799422|19397959|P3|COMPLETED|Second Week of Wear||3
7882593|NCT00799422|19397960|P2|COMPLETED|Second Week of Wear||4
7882594|NCT00799422|19397961|P1|COMPLETED|Second Week of Wear||4
7882595|NCT00799422|19397956|P6|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4
7882596|NCT00799422|19397957|P5|STARTED|Second Week of Wear||4
7882597|NCT00799422|19397958|P4|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3
7882598|NCT00799422|19397959|P3|STARTED|Second Week of Wear||3
7882599|NCT00799422|19397960|P2|STARTED|Second Week of Wear||4
7882600|NCT00799422|19397961|P1|STARTED|Second Week of Wear||4
7882601|NCT00799422|19397956|P6|NOT COMPLETED|First Week of Wear||0
7882602|NCT00799422|19397957|P5|NOT COMPLETED|First Week of Wear||0
7882603|NCT00799422|19397958|P4|NOT COMPLETED|First Week of Wear||1
7882604|NCT00799422|19397959|P3|NOT COMPLETED|First Week of Wear||1
7882605|NCT00799422|19397960|P2|NOT COMPLETED|First Week of Wear||0
7882606|NCT00799422|19397961|P1|NOT COMPLETED|First Week of Wear||0
7882607|NCT00799422|19397956|P6|COMPLETED|First Week of Wear||5
7882608|NCT00799422|19397957|P5|COMPLETED|First Week of Wear||4
7882609|NCT00799422|19397958|P4|COMPLETED|First Week of Wear||4
7882610|NCT00799422|19397959|P3|COMPLETED|First Week of Wear||3
7882611|NCT00799422|19397960|P2|COMPLETED|First Week of Wear||4
7882612|NCT00799422|19397961|P1|COMPLETED|First Week of Wear||4
7882613|NCT00799422|19397956|P6|STARTED|First Week of Wear||5
7882614|NCT00799422|19397957|P5|STARTED|First Week of Wear||4
7882615|NCT00799422|19397958|P4|STARTED|First Week of Wear||5
7882616|NCT00799422|19397959|P3|STARTED|First Week of Wear||4
7882617|NCT00799422|19397960|P2|STARTED|First Week of Wear||4
7882618|NCT00799422|19397961|P1|STARTED|First Week of Wear||4
7882619|NCT00799409|19397978|P3|NOT COMPLETED|Overall Study||0
7882620|NCT00799409|19397979|P2|NOT COMPLETED|Overall Study||0
7882621|NCT00799409|19397980|P1|NOT COMPLETED|Overall Study||7
7882622|NCT00799409|19397978|P3|COMPLETED|Overall Study||35
7882623|NCT00799409|19397979|P2|COMPLETED|Overall Study||36
7882624|NCT00799409|19397980|P1|COMPLETED|Overall Study||0
7882625|NCT00799409|19397978|P3|STARTED|Overall Study||35
7882626|NCT00799409|19397979|P2|STARTED|Overall Study||36
7882627|NCT00799409|19397980|P1|STARTED|Overall Study||7
7882628|NCT00799396|19398060|P1|NOT COMPLETED|Clopidogrel Plus Aspirin||6
7882629|NCT00799396|19398060|P1|COMPLETED|Clopidogrel Plus Aspirin||663
7882630|NCT00799396|19398060|P1|STARTED|Clopidogrel Plus Aspirin||669
7882631|NCT00799396|19398060|P1|NOT COMPLETED|Clopidogrel Treatment||13
7882632|NCT00799396|19398060|P1|COMPLETED|Clopidogrel Treatment||669
7882633|NCT00799396|19398060|P1|STARTED|Clopidogrel Treatment||682
7882634|NCT00799383|19398067|P2|NOT COMPLETED|Overall Study||6
7882635|NCT00799383|19398068|P1|NOT COMPLETED|Overall Study||3
7882636|NCT00799383|19398067|P2|COMPLETED|Overall Study||18
7882637|NCT00799383|19398068|P1|COMPLETED|Overall Study||20
7882638|NCT00799383|19398067|P2|STARTED|Overall Study||24
7882639|NCT00799383|19398068|P1|STARTED|Overall Study||23
7882640|NCT00799292|19398090|P2|NOT COMPLETED|Overall Study||0
7882641|NCT00799292|19398091|P1|NOT COMPLETED|Overall Study||0
7882642|NCT00799292|19398090|P2|COMPLETED|Overall Study||29
7882643|NCT00799292|19398091|P1|COMPLETED|Overall Study||29
7882644|NCT00799292|19398090|P2|STARTED|Overall Study||29
7882645|NCT00799292|19398091|P1|STARTED|Overall Study||29
7882646|NCT00799266|19398097|P2|NOT COMPLETED|Overall Study||1
7882647|NCT00799266|19398098|P1|NOT COMPLETED|Overall Study||3
7882648|NCT00799266|19398097|P2|COMPLETED|Overall Study||15
7882649|NCT00799266|19398098|P1|COMPLETED|Overall Study||15
7882650|NCT00799266|19398097|P2|Safety Set|Overall Study||16
7882651|NCT00799266|19398098|P1|Safety Set|Overall Study||18
7882652|NCT00799266|19398097|P2|Modified Intention-to-treat (MITT)|Overall Study||16
7882653|NCT00799266|19398098|P1|Modified Intention-to-treat (MITT)|Overall Study||17
7882654|NCT00799266|19398097|P2|STARTED|Overall Study||16
7882655|NCT00799266|19398098|P1|STARTED|Overall Study||18
7882656|NCT00799227|19398129|P1|NOT COMPLETED|Overall Study||3
7882657|NCT00799227|19398129|P1|COMPLETED|Overall Study||53
7882658|NCT00799227|19398129|P1|STARTED|Overall Study||56
7882659|NCT00798967|19398138|P2|NOT COMPLETED|Overall Study||4
7882660|NCT00798967|19398139|P1|NOT COMPLETED|Overall Study||4
7882661|NCT00798967|19398138|P2|COMPLETED|Overall Study||39
7882662|NCT00798967|19398139|P1|COMPLETED|Overall Study||39
7882663|NCT00798967|19398138|P2|Discontinued During Dosing Period|Overall Study||4
7882664|NCT00798967|19398139|P1|Discontinued During Dosing Period|Overall Study||4
7882665|NCT00798967|19398138|P2|STARTED|Overall Study||43
7882666|NCT00798967|19398139|P1|STARTED|Overall Study||43
7882667|NCT00798889|19398147|P1|NOT COMPLETED|Overall Study||314
7882668|NCT00798889|19398147|P1|COMPLETED|Overall Study||0
7882669|NCT00798889|19398147|P1|Treated|Overall Study||311
7882670|NCT00798889|19398147|P1|STARTED|Overall Study||314
7882671|NCT00798759|19398153|P2|NOT COMPLETED|Overall Study||13
7882672|NCT00798759|19398154|P1|NOT COMPLETED|Overall Study||8
7882673|NCT00798759|19398153|P2|COMPLETED|Overall Study||106
7882674|NCT00798759|19398154|P1|COMPLETED|Overall Study||109
7882675|NCT00798759|19398153|P2|STARTED|Overall Study||119
7882676|NCT00798759|19398154|P1|STARTED|Overall Study||117
7882677|NCT00798720|19398162|P1|NOT COMPLETED|Overall Study||0
7882678|NCT00798720|19398162|P1|COMPLETED|Overall Study||18
7882679|NCT00798720|19398162|P1|STARTED|Overall Study||18
7882680|NCT00798707|19398172|P3|NOT COMPLETED|Overall Study||22
7882681|NCT00798707|19398173|P2|NOT COMPLETED|Overall Study||33
7882682|NCT00798707|19398174|P1|NOT COMPLETED|Overall Study||26
7882683|NCT00798707|19398172|P3|COMPLETED|Overall Study||215
7882684|NCT00798707|19398173|P2|COMPLETED|Overall Study||204
7882685|NCT00798707|19398174|P1|COMPLETED|Overall Study||209
7882686|NCT00798707|19398172|P3|Treated|Overall Study||236
7882687|NCT00798707|19398173|P2|Treated|Overall Study||232
7882688|NCT00798707|19398174|P1|Treated|Overall Study||231
7882689|NCT00798707|19398172|P3|STARTED|Overall Study||237
7882690|NCT00798707|19398173|P2|STARTED|Overall Study||237
7882691|NCT00798707|19398174|P1|STARTED|Overall Study||235
7882692|NCT00798694|19398226|P2|NOT COMPLETED|Overall Study||1
7882693|NCT00798694|19398227|P1|NOT COMPLETED|Overall Study||2
7882694|NCT00798694|19398226|P2|COMPLETED|Overall Study||27
7882695|NCT00798694|19398227|P1|COMPLETED|Overall Study||28
7882696|NCT00798694|19398226|P2|STARTED|Overall Study||28
7882697|NCT00798694|19398227|P1|STARTED|Overall Study||30
7882698|NCT00798655|19398251|P1|NOT COMPLETED|Overall Study||2
7882699|NCT00798655|19398251|P1|COMPLETED|Overall Study||44
7882700|NCT00798655|19398251|P1|STARTED|Overall Study||46
7882701|NCT00798603|19398256|P1|NOT COMPLETED|Overall Study||35
7882702|NCT00798603|19398256|P1|COMPLETED|Overall Study||27
7882703|NCT00798603|19398256|P1|STARTED|Overall Study||62
7882704|NCT00798590|19398278|P2|NOT COMPLETED|Overall Study||8
7882705|NCT00798590|19398279|P1|NOT COMPLETED|Overall Study||11
7882706|NCT00798590|19398278|P2|COMPLETED|Overall Study||0
7882707|NCT00798590|19398279|P1|COMPLETED|Overall Study||0
7882708|NCT00798590|19398278|P2|STARTED|Overall Study||8
7882709|NCT00798590|19398279|P1|STARTED|Overall Study||11
7882710|NCT00798577|19398289|P2|NOT COMPLETED|Overall Study||0
7882711|NCT00798577|19398290|P1|NOT COMPLETED|Overall Study||0
7882712|NCT00798577|19398289|P2|COMPLETED|Overall Study||7
7882713|NCT00798577|19398290|P1|COMPLETED|Overall Study||17
7882714|NCT00798577|19398289|P2|STARTED|Overall Study||7
7882715|NCT00798577|19398290|P1|STARTED|Overall Study||17
7882716|NCT00798486|19398304|P1|NOT COMPLETED|Overall Study||0
7882717|NCT00798486|19398304|P1|COMPLETED|Overall Study||110
7882718|NCT00798486|19398304|P1|STARTED|Overall Study||110
7882719|NCT00798434|19398313|P2|NOT COMPLETED|Open-Label||32
7882720|NCT00798434|19398314|P1|NOT COMPLETED|Open-Label||42
7882721|NCT00798434|19398313|P2|COMPLETED|Open-Label||282
7882722|NCT00798434|19398314|P1|COMPLETED|Open-Label||299
7882723|NCT00798434|19398313|P2|Received Treatment|Open-Label||313
7882724|NCT00798434|19398314|P1|Received Treatment|Open-Label||341
7882725|NCT00798434|19398313|P2|STARTED|Open-Label||314
7882726|NCT00798434|19398314|P1|STARTED|Open-Label||341
7882727|NCT00798434|19398313|P2|NOT COMPLETED|Double-Blind||84
7882728|NCT00798434|19398314|P1|NOT COMPLETED|Double-Blind||55
7882729|NCT00798434|19398313|P2|COMPLETED|Double-Blind||314
7882730|NCT00798434|19398314|P1|COMPLETED|Double-Blind||341
7882731|NCT00798434|19398313|P2|Received Treatment|Double-Blind||392
7882732|NCT00798434|19398314|P1|Received Treatment|Double-Blind||393
7882733|NCT00798434|19398313|P2|STARTED|Double-Blind||398
7882734|NCT00798434|19398314|P1|STARTED|Double-Blind||396
7882735|NCT00798369|19398400|P6|NOT COMPLETED|Overall Study||3
7882736|NCT00798369|19398401|P5|NOT COMPLETED|Overall Study||1
7882737|NCT00798369|19398402|P4|NOT COMPLETED|Overall Study||1
7882738|NCT00798369|19398403|P3|NOT COMPLETED|Overall Study||2
7882739|NCT00798369|19398404|P2|NOT COMPLETED|Overall Study||1
7882740|NCT00798369|19398405|P1|NOT COMPLETED|Overall Study||1
7882741|NCT00798369|19398400|P6|COMPLETED|Overall Study||54
7882742|NCT00798369|19398401|P5|COMPLETED|Overall Study||27
7882743|NCT00798369|19398402|P4|COMPLETED|Overall Study||28
7882744|NCT00798369|19398403|P3|COMPLETED|Overall Study||27
7882745|NCT00798369|19398404|P2|COMPLETED|Overall Study||28
7882746|NCT00798369|19398405|P1|COMPLETED|Overall Study||27
7882747|NCT00798369|19398400|P6|STARTED|Overall Study||57
7882748|NCT00798369|19398401|P5|STARTED|Overall Study||28
7882749|NCT00798369|19398402|P4|STARTED|Overall Study||29
7882750|NCT00798369|19398403|P3|STARTED|Overall Study||29
7882751|NCT00798369|19398404|P2|STARTED|Overall Study||29
7882752|NCT00798369|19398405|P1|STARTED|Overall Study||28
7882753|NCT00798317|19398452|P2|NOT COMPLETED|Overall Study||7
7882754|NCT00798317|19398453|P1|NOT COMPLETED|Overall Study||10
7882755|NCT00798317|19398452|P2|COMPLETED|Overall Study||74
7882756|NCT00798317|19398453|P1|COMPLETED|Overall Study||235
7882757|NCT00798317|19398452|P2|STARTED|Overall Study||81
7882758|NCT00798317|19398453|P1|STARTED|Overall Study||245
7882759|NCT00798304|19398464|P3|NOT COMPLETED|Overall Study||10
7882760|NCT00798304|19398465|P2|NOT COMPLETED|Overall Study||22
7882761|NCT00798304|19398466|P1|NOT COMPLETED|Overall Study||14
7882762|NCT00798304|19398464|P3|COMPLETED|Overall Study||0
7882763|NCT00798304|19398465|P2|COMPLETED|Overall Study||0
7882764|NCT00798304|19398466|P1|COMPLETED|Overall Study||0
7882765|NCT00798304|19398464|P3|STARTED|Overall Study||10
7882766|NCT00798304|19398465|P2|STARTED|Overall Study||22
7882767|NCT00798304|19398466|P1|STARTED|Overall Study||14
7882768|NCT00798174|19398492|P2|NOT COMPLETED|Overall Study||3
7882769|NCT00798174|19398493|P1|NOT COMPLETED|Overall Study||4
7882770|NCT00798174|19398492|P2|COMPLETED|Overall Study||13
7882771|NCT00798174|19398493|P1|COMPLETED|Overall Study||12
7882772|NCT00798174|19398492|P2|STARTED|Overall Study||16
7882773|NCT00798174|19398493|P1|STARTED|Overall Study||16
7882774|NCT00798161|19398504|P7|NOT COMPLETED|Overall Study||10
7882775|NCT00798161|19398505|P6|NOT COMPLETED|Overall Study||11
7882776|NCT00798161|19398506|P5|NOT COMPLETED|Overall Study||16
7882777|NCT00798161|19398507|P4|NOT COMPLETED|Overall Study||21
7882778|NCT00798161|19398508|P3|NOT COMPLETED|Overall Study||21
7882779|NCT00798161|19398509|P2|NOT COMPLETED|Overall Study||17
7882780|NCT00798161|19398510|P1|NOT COMPLETED|Overall Study||18
7882781|NCT00798161|19398504|P7|COMPLETED|Overall Study||56
7882782|NCT00798161|19398505|P6|COMPLETED|Overall Study||132
7882783|NCT00798161|19398506|P5|COMPLETED|Overall Study||127
7882784|NCT00798161|19398507|P4|COMPLETED|Overall Study||121
7882785|NCT00798161|19398508|P3|COMPLETED|Overall Study||126
7882786|NCT00798161|19398509|P2|COMPLETED|Overall Study||127
7882787|NCT00798161|19398510|P1|COMPLETED|Overall Study||54
7882788|NCT00798161|19398504|P7|STARTED|Overall Study||66
7882789|NCT00798161|19398505|P6|STARTED|Overall Study||143
7882790|NCT00798161|19398506|P5|STARTED|Overall Study||143
7882791|NCT00798161|19398507|P4|STARTED|Overall Study||142
7882792|NCT00798161|19398508|P3|STARTED|Overall Study||147
7882793|NCT00798161|19398509|P2|STARTED|Overall Study||144
7882794|NCT00798161|19398510|P1|STARTED|Overall Study||72
7882795|NCT00798135|19398617|P1|NOT COMPLETED|Overall Study||13
7882796|NCT00798135|19398617|P1|COMPLETED|Overall Study||0
7882797|NCT00798135|19398617|P1|STARTED|Overall Study||13
7882798|NCT00798096|19398623|P1|NOT COMPLETED|Overall Study||2
7882799|NCT00798096|19398623|P1|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16
7882891|NCT00797823|19398752|P3|COMPLETED|First Period (Initial Randomization)||0
7882800|NCT00798096|19398623|P1|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18
7882801|NCT00798018|19398634|P4|NOT COMPLETED|Overall Study||0
7882802|NCT00798018|19398635|P3|NOT COMPLETED|Overall Study||0
7882803|NCT00798018|19398636|P2|NOT COMPLETED|Overall Study||0
7882804|NCT00798018|19398637|P1|NOT COMPLETED|Overall Study||0
7882805|NCT00798018|19398634|P4|COMPLETED|Overall Study||25
7882806|NCT00798018|19398635|P3|COMPLETED|Overall Study||25
7882807|NCT00798018|19398636|P2|COMPLETED|Overall Study||25
7882808|NCT00798018|19398637|P1|COMPLETED|Overall Study||25
7882809|NCT00798018|19398634|P4|STARTED|Overall Study||25
7882810|NCT00798018|19398635|P3|STARTED|Overall Study||25
7882811|NCT00798018|19398636|P2|STARTED|Overall Study||25
7882812|NCT00798018|19398637|P1|STARTED|Overall Study||25
7882813|NCT00797966|19398651|P6|NOT COMPLETED|Phase A+||28
7882814|NCT00797966|19398652|P5|NOT COMPLETED|Phase A+||0
7882815|NCT00797966|19398653|P4|NOT COMPLETED|Phase A+||0
7882816|NCT00797966|19398654|P3|NOT COMPLETED|Phase A+||0
7882817|NCT00797966|19398655|P2|NOT COMPLETED|Phase A+||0
7882818|NCT00797966|19398656|P1|NOT COMPLETED|Phase A+||0
7882819|NCT00797966|19398651|P6|COMPLETED|Phase A+||207
7882820|NCT00797966|19398652|P5|COMPLETED|Phase A+||0
7882821|NCT00797966|19398653|P4|COMPLETED|Phase A+||0
7882822|NCT00797966|19398654|P3|COMPLETED|Phase A+||0
7882823|NCT00797966|19398655|P2|COMPLETED|Phase A+||0
7882824|NCT00797966|19398656|P1|COMPLETED|Phase A+||0
7882825|NCT00797966|19398651|P6|STARTED|Phase A+||235
7882826|NCT00797966|19398652|P5|STARTED|Phase A+||0
7882827|NCT00797966|19398653|P4|STARTED|Phase A+||0
7882828|NCT00797966|19398654|P3|STARTED|Phase A+||0
7882829|NCT00797966|19398655|P2|STARTED|Phase A+||0
7882830|NCT00797966|19398656|P1|STARTED|Phase A+||0
7882831|NCT00797966|19398651|P6|NOT COMPLETED|Phase B||0
7882832|NCT00797966|19398652|P5|NOT COMPLETED|Phase B||0
7882833|NCT00797966|19398653|P4|NOT COMPLETED|Phase B||16
7882834|NCT00797966|19398654|P3|NOT COMPLETED|Phase B||21
7882835|NCT00797966|19398655|P2|NOT COMPLETED|Phase B||18
7882836|NCT00797966|19398656|P1|NOT COMPLETED|Phase B||11
7882837|NCT00797966|19398651|P6|COMPLETED|Phase B||0
7882838|NCT00797966|19398652|P5|COMPLETED|Phase B||0
7882839|NCT00797966|19398653|P4|COMPLETED|Phase B||110
7882840|NCT00797966|19398654|P3|COMPLETED|Phase B||100
7882841|NCT00797966|19398655|P2|COMPLETED|Phase B||102
7882842|NCT00797966|19398656|P1|COMPLETED|Phase B||51
7882843|NCT00797966|19398651|P6|STARTED|Phase B||0
7882844|NCT00797966|19398652|P5|STARTED|Phase B||0
7882845|NCT00797966|19398653|P4|STARTED|Phase B|Randomized participants.|126
7882846|NCT00797966|19398654|P3|STARTED|Phase B|Randomized participants.|121
7882847|NCT00797966|19398655|P2|STARTED|Phase B|Randomized participants.|120
7882848|NCT00797966|19398656|P1|STARTED|Phase B|Randomized participants.|62
7882849|NCT00797966|19398651|P6|NOT COMPLETED|Phase A||0
7882850|NCT00797966|19398652|P5|NOT COMPLETED|Phase A||185
7882851|NCT00797966|19398653|P4|NOT COMPLETED|Phase A||0
7882852|NCT00797966|19398654|P3|NOT COMPLETED|Phase A||0
7882853|NCT00797966|19398655|P2|NOT COMPLETED|Phase A||0
7882854|NCT00797966|19398656|P1|NOT COMPLETED|Phase A||0
7882855|NCT00797966|19398651|P6|COMPLETED|Phase A||0
7882856|NCT00797966|19398652|P5|COMPLETED|Phase A||664
7882857|NCT00797966|19398653|P4|COMPLETED|Phase A||0
7882858|NCT00797966|19398654|P3|COMPLETED|Phase A||0
7882859|NCT00797966|19398655|P2|COMPLETED|Phase A||0
7882860|NCT00797966|19398656|P1|COMPLETED|Phase A||0
7882861|NCT00797966|19398651|P6|STARTED|Phase A||0
7882862|NCT00797966|19398652|P5|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849
7882863|NCT00797966|19398653|P4|STARTED|Phase A||0
7882864|NCT00797966|19398654|P3|STARTED|Phase A||0
7882865|NCT00797966|19398655|P2|STARTED|Phase A||0
7882866|NCT00797966|19398656|P1|STARTED|Phase A||0
7882867|NCT00797862|19398721|P3|NOT COMPLETED|Overall Study||86
7882868|NCT00797862|19398722|P2|NOT COMPLETED|Overall Study||68
7882869|NCT00797862|19398723|P1|NOT COMPLETED|Overall Study||124
7882870|NCT00797862|19398721|P3|COMPLETED|Overall Study||230
7882871|NCT00797862|19398722|P2|COMPLETED|Overall Study||250
7882872|NCT00797862|19398723|P1|COMPLETED|Overall Study||496
7882873|NCT00797862|19398721|P3|Entered Double-Blind Treatment (FAS)|Overall Study||315
7882874|NCT00797862|19398722|P2|Entered Double-Blind Treatment (FAS)|Overall Study||315
7882875|NCT00797862|19398723|P1|Entered Double-Blind Treatment (FAS)|Overall Study||617
7882876|NCT00797862|19398721|P3|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316
7882877|NCT00797862|19398722|P2|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318
7882878|NCT00797862|19398723|P1|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620
7882879|NCT00797823|19398752|P3|NOT COMPLETED|Second Period (Crossover)||0
7882880|NCT00797823|19398753|P2|NOT COMPLETED|Second Period (Crossover)||0
7882881|NCT00797823|19398754|P1|NOT COMPLETED|Second Period (Crossover)||0
7882882|NCT00797823|19398752|P3|COMPLETED|Second Period (Crossover)||0
7882883|NCT00797823|19398753|P2|COMPLETED|Second Period (Crossover)||4
7882884|NCT00797823|19398754|P1|COMPLETED|Second Period (Crossover)||3
7882885|NCT00797823|19398752|P3|STARTED|Second Period (Crossover)||0
7882886|NCT00797823|19398753|P2|STARTED|Second Period (Crossover)||4
7882887|NCT00797823|19398754|P1|STARTED|Second Period (Crossover)||3
7882888|NCT00797823|19398752|P3|NOT COMPLETED|First Period (Initial Randomization)||0
7882889|NCT00797823|19398753|P2|NOT COMPLETED|First Period (Initial Randomization)||0
7882890|NCT00797823|19398754|P1|NOT COMPLETED|First Period (Initial Randomization)||1
7882892|NCT00797823|19398753|P2|COMPLETED|First Period (Initial Randomization)||4
7882893|NCT00797823|19398754|P1|COMPLETED|First Period (Initial Randomization)||3
7882894|NCT00797823|19398752|P3|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0
7882895|NCT00797823|19398753|P2|STARTED|First Period (Initial Randomization)||4
7882896|NCT00797823|19398754|P1|STARTED|First Period (Initial Randomization)||4
7882897|NCT00797823|19398752|P3|NOT COMPLETED|Pilot Studies||0
7882898|NCT00797823|19398753|P2|NOT COMPLETED|Pilot Studies||0
7882899|NCT00797823|19398754|P1|NOT COMPLETED|Pilot Studies||0
7882900|NCT00797823|19398752|P3|COMPLETED|Pilot Studies||6
7882901|NCT00797823|19398753|P2|COMPLETED|Pilot Studies||0
7882902|NCT00797823|19398754|P1|COMPLETED|Pilot Studies||0
7882903|NCT00797823|19398752|P3|STARTED|Pilot Studies||6
7882904|NCT00797823|19398753|P2|STARTED|Pilot Studies|Not involved in pilot studies|0
7882905|NCT00797823|19398754|P1|STARTED|Pilot Studies|Not involved in pilot studies|0
7882906|NCT00797797|19398765|P2|NOT COMPLETED|Overall Study||43
7882907|NCT00797797|19398766|P1|NOT COMPLETED|Overall Study||55
7882908|NCT00797797|19398765|P2|COMPLETED|Overall Study||141
7882909|NCT00797797|19398766|P1|COMPLETED|Overall Study||123
7882910|NCT00797797|19398765|P2|STARTED|Overall Study||184
7882911|NCT00797797|19398766|P1|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178
7882912|NCT00797732|19398776|P3|NOT COMPLETED|Overall Study||154
7882913|NCT00797732|19398777|P2|NOT COMPLETED|Overall Study||3
7882914|NCT00797732|19398778|P1|NOT COMPLETED|Overall Study||5
7882915|NCT00797732|19398776|P3|COMPLETED|Overall Study||0
7882916|NCT00797732|19398777|P2|COMPLETED|Overall Study||18
7882917|NCT00797732|19398778|P1|COMPLETED|Overall Study||16
7882918|NCT00797732|19398776|P3|Evaluable at 12 Months|Overall Study||0
7882919|NCT00797732|19398777|P2|Evaluable at 12 Months|Overall Study||18
7882920|NCT00797732|19398778|P1|Evaluable at 12 Months|Overall Study||17
7882921|NCT00797732|19398776|P3|Evaluable at 20 Weeks|Overall Study||0
7882922|NCT00797732|19398777|P2|Evaluable at 20 Weeks|Overall Study||18
7882923|NCT00797732|19398778|P1|Evaluable at 20 Weeks|Overall Study||17
7882924|NCT00797732|19398776|P3|Evaluable at Baseline|Overall Study||0
7882925|NCT00797732|19398777|P2|Evaluable at Baseline|Overall Study||18
7882926|NCT00797732|19398778|P1|Evaluable at Baseline|Overall Study||18
7882927|NCT00797732|19398776|P3|STARTED|Overall Study||154
7882928|NCT00797732|19398777|P2|STARTED|Overall Study||21
7882929|NCT00797732|19398778|P1|STARTED|Overall Study||21
7882930|NCT00797667|19398793|P3|NOT COMPLETED|Overall Study||127
7882931|NCT00797667|19398794|P2|NOT COMPLETED|Overall Study||259
7882932|NCT00797667|19398795|P1|NOT COMPLETED|Overall Study||260
7882933|NCT00797667|19398793|P3|COMPLETED|Overall Study||4
7882934|NCT00797667|19398794|P2|COMPLETED|Overall Study||5
7882935|NCT00797667|19398795|P1|COMPLETED|Overall Study||5
7882936|NCT00797667|19398793|P3|Treated|Overall Study||130
7882937|NCT00797667|19398794|P2|Treated|Overall Study||263
7882938|NCT00797667|19398795|P1|Treated|Overall Study||263
7882939|NCT00797667|19398793|P3|STARTED|Overall Study||131
7882940|NCT00797667|19398794|P2|STARTED|Overall Study||264
7882941|NCT00797667|19398795|P1|STARTED|Overall Study||265
7882942|NCT00797563|19398821|P1|NOT COMPLETED|Overall Study||1
7882943|NCT00797563|19398821|P1|COMPLETED|Overall Study||101
7882944|NCT00797563|19398821|P1|STARTED|Overall Study|number of subjects|102
7882945|NCT00797511|19398827|P1|NOT COMPLETED|Overall Study||1
7882946|NCT00797511|19398827|P1|COMPLETED|Overall Study||131
7882947|NCT00797511|19398827|P1|STARTED|Overall Study||132
7882948|NCT00797459|19398835|P1|NOT COMPLETED|Overall Study||0
7882949|NCT00797459|19398835|P1|COMPLETED|Overall Study||60
7882950|NCT00797459|19398835|P1|STARTED|Overall Study||60
7882951|NCT00797316|19398845|P2|NOT COMPLETED|Overall Study||32
7882952|NCT00797316|19398846|P1|NOT COMPLETED|Overall Study||23
7882953|NCT00797316|19398845|P2|COMPLETED|Overall Study||233
7882954|NCT00797316|19398846|P1|COMPLETED|Overall Study||244
7882955|NCT00797316|19398845|P2|STARTED|Overall Study||265
7882956|NCT00797316|19398846|P1|STARTED|Overall Study||267
7882957|NCT00797277|19398862|P2|NOT COMPLETED|Overall Study||0
7882958|NCT00797277|19398863|P1|NOT COMPLETED|Overall Study||0
7882959|NCT00797277|19398862|P2|COMPLETED|Overall Study||30
7882960|NCT00797277|19398863|P1|COMPLETED|Overall Study||37
7882961|NCT00797277|19398862|P2|STARTED|Overall Study||30
7882962|NCT00797277|19398863|P1|STARTED|Overall Study||37
7882963|NCT00797225|19398875|P8|NOT COMPLETED|Weeks 13 to 24||0
7882964|NCT00797225|19398876|P7|NOT COMPLETED|Weeks 13 to 24||2
7882965|NCT00797225|19398877|P6|NOT COMPLETED|Weeks 13 to 24||0
7882966|NCT00797225|19398878|P5|NOT COMPLETED|Weeks 13 to 24||1
7882967|NCT00797225|19398879|P4|NOT COMPLETED|Weeks 13 to 24||0
7882968|NCT00797225|19398880|P3|NOT COMPLETED|Weeks 13 to 24||2
7882969|NCT00797225|19398881|P2|NOT COMPLETED|Weeks 13 to 24||4
7882970|NCT00797225|19398882|P1|NOT COMPLETED|Weeks 13 to 24||0
7882971|NCT00797225|19398875|P8|COMPLETED|Weeks 13 to 24||22
7882972|NCT00797225|19398876|P7|COMPLETED|Weeks 13 to 24||20
7882973|NCT00797225|19398877|P6|COMPLETED|Weeks 13 to 24||21
7882974|NCT00797225|19398878|P5|COMPLETED|Weeks 13 to 24||19
7882975|NCT00797225|19398879|P4|COMPLETED|Weeks 13 to 24||0
7882976|NCT00797225|19398880|P3|COMPLETED|Weeks 13 to 24||41
7882977|NCT00797225|19398881|P2|COMPLETED|Weeks 13 to 24||38
7882978|NCT00797225|19398882|P1|COMPLETED|Weeks 13 to 24||0
7882979|NCT00797225|19398875|P8|STARTED|Weeks 13 to 24||22
7882980|NCT00797225|19398876|P7|STARTED|Weeks 13 to 24||22
7882981|NCT00797225|19398877|P6|STARTED|Weeks 13 to 24||21
7882982|NCT00797225|19398878|P5|STARTED|Weeks 13 to 24||20
7882983|NCT00797225|19398879|P4|STARTED|Weeks 13 to 24||0
7882984|NCT00797225|19398880|P3|STARTED|Weeks 13 to 24||43
7882985|NCT00797225|19398881|P2|STARTED|Weeks 13 to 24||42
7882986|NCT00797225|19398882|P1|STARTED|Weeks 13 to 24||0
7882987|NCT00797225|19398875|P8|NOT COMPLETED|Weeks 1 to 12||0
7882988|NCT00797225|19398876|P7|NOT COMPLETED|Weeks 1 to 12||0
7882989|NCT00797225|19398877|P6|NOT COMPLETED|Weeks 1 to 12||0
7882990|NCT00797225|19398878|P5|NOT COMPLETED|Weeks 1 to 12||0
7882991|NCT00797225|19398879|P4|NOT COMPLETED|Weeks 1 to 12||0
7882992|NCT00797225|19398880|P3|NOT COMPLETED|Weeks 1 to 12||1
7882993|NCT00797225|19398881|P2|NOT COMPLETED|Weeks 1 to 12||1
7882994|NCT00797225|19398882|P1|NOT COMPLETED|Weeks 1 to 12||2
7882995|NCT00797225|19398875|P8|COMPLETED|Weeks 1 to 12||0
7882996|NCT00797225|19398876|P7|COMPLETED|Weeks 1 to 12||0
7882997|NCT00797225|19398877|P6|COMPLETED|Weeks 1 to 12||0
7882998|NCT00797225|19398878|P5|COMPLETED|Weeks 1 to 12||0
7882999|NCT00797225|19398879|P4|COMPLETED|Weeks 1 to 12||44
7883000|NCT00797225|19398880|P3|COMPLETED|Weeks 1 to 12||43
7883001|NCT00797225|19398881|P2|COMPLETED|Weeks 1 to 12||42
7883002|NCT00797225|19398882|P1|COMPLETED|Weeks 1 to 12||41
7883003|NCT00797225|19398875|P8|Received Study Drug|Weeks 1 to 12||0
7883004|NCT00797225|19398876|P7|Received Study Drug|Weeks 1 to 12||0
7883005|NCT00797225|19398877|P6|Received Study Drug|Weeks 1 to 12||0
7883006|NCT00797225|19398878|P5|Received Study Drug|Weeks 1 to 12||0
7883007|NCT00797225|19398879|P4|Received Study Drug|Weeks 1 to 12||44
7883008|NCT00797225|19398880|P3|Received Study Drug|Weeks 1 to 12||44
7883009|NCT00797225|19398881|P2|Received Study Drug|Weeks 1 to 12||43
7883010|NCT00797225|19398882|P1|Received Study Drug|Weeks 1 to 12||43
7883011|NCT00797225|19398875|P8|STARTED|Weeks 1 to 12||0
7883012|NCT00797225|19398876|P7|STARTED|Weeks 1 to 12||0
7883013|NCT00797225|19398877|P6|STARTED|Weeks 1 to 12||0
7883014|NCT00797225|19398878|P5|STARTED|Weeks 1 to 12||0
7883015|NCT00797225|19398879|P4|STARTED|Weeks 1 to 12||44
7883016|NCT00797225|19398880|P3|STARTED|Weeks 1 to 12||44
7883017|NCT00797225|19398881|P2|STARTED|Weeks 1 to 12||43
7883018|NCT00797225|19398882|P1|STARTED|Weeks 1 to 12||43
7883019|NCT00797212|19398990|P1|NOT COMPLETED|Overall Study||0
7883020|NCT00797212|19398990|P1|COMPLETED|Overall Study||50
7883021|NCT00797212|19398990|P1|STARTED|Overall Study||50
7883022|NCT00797108|19398999|P3|NOT COMPLETED|Overall Study||6
7883023|NCT00797108|19399000|P2|NOT COMPLETED|Overall Study||2
7883024|NCT00797108|19399001|P1|NOT COMPLETED|Overall Study||4
7883025|NCT00797108|19398999|P3|COMPLETED|Overall Study||6
7883026|NCT00797108|19399000|P2|COMPLETED|Overall Study||9
7883027|NCT00797108|19399001|P1|COMPLETED|Overall Study||8
7883028|NCT00797108|19398999|P3|Treated|Overall Study||12
7883029|NCT00797108|19399000|P2|Treated|Overall Study||11
7883030|NCT00797108|19399001|P1|Treated|Overall Study||10
7883031|NCT00797108|19398999|P3|STARTED|Overall Study||12
7883032|NCT00797108|19399000|P2|STARTED|Overall Study||11
7883033|NCT00797108|19399001|P1|STARTED|Overall Study||12
7883034|NCT00796991|19399036|P3|NOT COMPLETED|Overall Study||14
7883035|NCT00796991|19399037|P2|NOT COMPLETED|Overall Study||12
7883036|NCT00796991|19399038|P1|NOT COMPLETED|Overall Study||15
7883037|NCT00796991|19399036|P3|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6
7883038|NCT00796991|19399037|P2|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7
7883039|NCT00796991|19399038|P1|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5
7883040|NCT00796991|19399036|P3|STARTED|Overall Study||20
7883041|NCT00796991|19399037|P2|STARTED|Overall Study||19
7883042|NCT00796991|19399038|P1|STARTED|Overall Study||20
7883043|NCT00796978|19399136|P1|NOT COMPLETED|Overall Study||12
7883044|NCT00796978|19399136|P1|COMPLETED|Overall Study||44
7883045|NCT00796978|19399136|P1|STARTED|Overall Study||56
7883046|NCT00796926|19399155|P2|NOT COMPLETED|Overall Study||0
7883047|NCT00796926|19399156|P1|NOT COMPLETED|Overall Study||1
7883048|NCT00796926|19399155|P2|COMPLETED|Overall Study||15
7883049|NCT00796926|19399156|P1|COMPLETED|Overall Study||14
7883050|NCT00796926|19399155|P2|STARTED|Overall Study||15
7883051|NCT00796926|19399156|P1|STARTED|Overall Study||15
7883052|NCT00796861|19399162|P1|NOT COMPLETED|Overall Study||4
7883053|NCT00796861|19399162|P1|COMPLETED|Overall Study||0
7883054|NCT00796861|19399162|P1|STARTED|Overall Study||4
7883055|NCT00796822|19399168|P2|NOT COMPLETED|Overall Study||0
7883056|NCT00796822|19399169|P1|NOT COMPLETED|Overall Study||3
7883057|NCT00796822|19399168|P2|COMPLETED|Overall Study||13
7883058|NCT00796822|19399169|P1|COMPLETED|Overall Study||10
7883059|NCT00796822|19399168|P2|STARTED|Overall Study||13
7883060|NCT00796822|19399169|P1|STARTED|Overall Study||13
7883061|NCT00796757|19399177|P1|NOT COMPLETED|Overall Study||86
7883062|NCT00796757|19399177|P1|COMPLETED|Overall Study||60
7883063|NCT00796757|19399177|P1|STARTED|Overall Study||146
7883064|NCT00796744|19399192|P3|NOT COMPLETED|Overall Study||1
7883065|NCT00796744|19399193|P2|NOT COMPLETED|Overall Study||0
7883066|NCT00796744|19399194|P1|NOT COMPLETED|Overall Study||0
7883067|NCT00796744|19399192|P3|COMPLETED|Overall Study||27
7883068|NCT00796744|19399193|P2|COMPLETED|Overall Study||26
7883069|NCT00796744|19399194|P1|COMPLETED|Overall Study||24
7883070|NCT00796744|19399192|P3|STARTED|Overall Study||28
7883071|NCT00796744|19399193|P2|STARTED|Overall Study||26
7883072|NCT00796744|19399194|P1|STARTED|Overall Study||24
7883073|NCT00796718|19399211|P1|NOT COMPLETED|Overall Study||9
7883074|NCT00796718|19399211|P1|COMPLETED|Overall Study||53
7883075|NCT00796718|19399211|P1|STARTED|Overall Study||62
7883076|NCT00796705|19399222|P4|NOT COMPLETED|Overall Study||0
7883077|NCT00796705|19399223|P3|NOT COMPLETED|Overall Study||0
7883078|NCT00796705|19399224|P2|NOT COMPLETED|Overall Study||0
7883079|NCT00796705|19399225|P1|NOT COMPLETED|Overall Study||0
7883080|NCT00796705|19399222|P4|COMPLETED|Overall Study||2
7883081|NCT00796705|19399223|P3|COMPLETED|Overall Study||4
7883082|NCT00796705|19399224|P2|COMPLETED|Overall Study||4
7883083|NCT00796705|19399225|P1|COMPLETED|Overall Study||3
7883084|NCT00796705|19399222|P4|STARTED|Overall Study||2
7883085|NCT00796705|19399223|P3|STARTED|Overall Study||4
7883086|NCT00796705|19399224|P2|STARTED|Overall Study||4
7883087|NCT00796705|19399225|P1|STARTED|Overall Study||3
7883088|NCT00796666|19399263|P2|NOT COMPLETED|Overall Study||64
7883089|NCT00796666|19399264|P1|NOT COMPLETED|Overall Study||67
7883090|NCT00796666|19399263|P2|COMPLETED|Overall Study||0
7883091|NCT00796666|19399264|P1|COMPLETED|Overall Study||0
7883092|NCT00796666|19399263|P2|Randomized and Not Treated|Overall Study||0
7883093|NCT00796666|19399264|P1|Randomized and Not Treated|Overall Study||1
7883094|NCT00796666|19399263|P2|Treated|Overall Study||64
7883095|NCT00796666|19399264|P1|Treated|Overall Study||66
7883096|NCT00796666|19399263|P2|STARTED|Overall Study||64
7883097|NCT00796666|19399264|P1|STARTED|Overall Study||67
7883098|NCT00796653|19399298|P4|NOT COMPLETED|Overall Study||40
7883099|NCT00796653|19399299|P3|NOT COMPLETED|Overall Study||36
7883100|NCT00796653|19399300|P2|NOT COMPLETED|Overall Study||37
7883101|NCT00796653|19399301|P1|NOT COMPLETED|Overall Study||51
7883102|NCT00796653|19399298|P4|COMPLETED|Overall Study||193
7883103|NCT00796653|19399299|P3|COMPLETED|Overall Study||198
7883104|NCT00796653|19399300|P2|COMPLETED|Overall Study||195
7883105|NCT00796653|19399301|P1|COMPLETED|Overall Study||184
7883106|NCT00796653|19399298|P4|STARTED|Overall Study||233
7883107|NCT00796653|19399299|P3|STARTED|Overall Study||234
7883108|NCT00796653|19399300|P2|STARTED|Overall Study||232
7883109|NCT00796653|19399301|P1|STARTED|Overall Study||235
7883110|NCT00796627|19399569|P2|NOT COMPLETED|Overall Study||0
7883111|NCT00796627|19399570|P1|NOT COMPLETED|Overall Study||0
7883112|NCT00796627|19399569|P2|COMPLETED|Overall Study||31
7883113|NCT00796627|19399570|P1|COMPLETED|Overall Study||10
7883114|NCT00796627|19399569|P2|STARTED|Overall Study||31
7883115|NCT00796627|19399570|P1|STARTED|Overall Study||10
7883116|NCT00796614|19399586|P4|NOT COMPLETED|Overall Study||1
7883117|NCT00796614|19399587|P3|NOT COMPLETED|Overall Study||3
7883118|NCT00796614|19399588|P2|NOT COMPLETED|Overall Study||4
7883119|NCT00796614|19399589|P1|NOT COMPLETED|Overall Study||5
7883120|NCT00796614|19399586|P4|COMPLETED|Overall Study||40
7883121|NCT00796614|19399587|P3|COMPLETED|Overall Study||36
7883122|NCT00796614|19399588|P2|COMPLETED|Overall Study||36
7883123|NCT00796614|19399589|P1|COMPLETED|Overall Study||36
7883124|NCT00796614|19399586|P4|Not Treated|Overall Study||0
7883125|NCT00796614|19399587|P3|Not Treated|Overall Study||1
7883126|NCT00796614|19399588|P2|Not Treated|Overall Study||0
7883127|NCT00796614|19399589|P1|Not Treated|Overall Study||0
7883128|NCT00796614|19399586|P4|STARTED|Overall Study||41
7883129|NCT00796614|19399587|P3|STARTED|Overall Study||39
7883130|NCT00796614|19399588|P2|STARTED|Overall Study||40
7883131|NCT00796614|19399589|P1|STARTED|Overall Study||41
7883132|NCT00796562|19399631|P1|NOT COMPLETED|Overall Study||49
7883133|NCT00796562|19399631|P1|COMPLETED|Overall Study||47
7883134|NCT00796562|19399631|P1|STARTED|Overall Study||96
7883135|NCT00796549|19399640|P1|NOT COMPLETED|Overall Study||218
7883136|NCT00796549|19399640|P1|COMPLETED|Overall Study||0
7883137|NCT00796549|19399640|P1|Entered|Overall Study|entered and treated|69
7883138|NCT00796549|19399640|P1|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218
7883139|NCT00796523|19399657|P2|NOT COMPLETED|Overall Study||7
7883140|NCT00796523|19399658|P1|NOT COMPLETED|Overall Study||9
7883141|NCT00796523|19399657|P2|COMPLETED|Overall Study||17
7883142|NCT00796523|19399658|P1|COMPLETED|Overall Study||18
7883143|NCT00796523|19399657|P2|STARTED|Overall Study||24
7883144|NCT00796523|19399658|P1|STARTED|Overall Study||27
7883145|NCT00796510|19399668|P2|NOT COMPLETED|Overall Study||0
7883146|NCT00796510|19399669|P1|NOT COMPLETED|Overall Study||3
7883147|NCT00796510|19399668|P2|COMPLETED|Overall Study||0
7883148|NCT00796510|19399669|P1|COMPLETED|Overall Study||0
7883149|NCT00796510|19399668|P2|STARTED|Overall Study||0
7883150|NCT00796510|19399669|P1|STARTED|Overall Study||3
7883151|NCT00796445|19399681|P2|NOT COMPLETED|Overall Study||292
7883152|NCT00796445|19399682|P1|NOT COMPLETED|Overall Study||584
7883153|NCT00796445|19399681|P2|COMPLETED|Overall Study||158
7883154|NCT00796445|19399682|P1|COMPLETED|Overall Study||310
7883155|NCT00796445|19399681|P2|STARTED|Overall Study||450
7883156|NCT00796445|19399682|P1|STARTED|Overall Study||894
7883157|NCT00796419|19399734|P2|NOT COMPLETED|Overall Study||1
7883158|NCT00796419|19399735|P1|NOT COMPLETED|Overall Study||0
7883159|NCT00796419|19399734|P2|COMPLETED|Overall Study||13
7883160|NCT00796419|19399735|P1|COMPLETED|Overall Study||13
7883161|NCT00796419|19399734|P2|STARTED|Overall Study||14
7883162|NCT00796419|19399735|P1|STARTED|Overall Study||13
7883163|NCT00796367|19399748|P3|NOT COMPLETED|Overall Study||47
7883164|NCT00796367|19399749|P2|NOT COMPLETED|Overall Study||25
7883165|NCT00796367|19399750|P1|NOT COMPLETED|Overall Study||30
7883166|NCT00796367|19399748|P3|COMPLETED|Overall Study||248
7883167|NCT00796367|19399749|P2|COMPLETED|Overall Study||129
7883168|NCT00796367|19399750|P1|COMPLETED|Overall Study||197
7883169|NCT00796367|19399748|P3|STARTED|Overall Study||295
7883170|NCT00796367|19399749|P2|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154
7883171|NCT00796367|19399750|P1|STARTED|Overall Study||227
7883172|NCT00796328|19399761|P1|NOT COMPLETED|Overall Study||6
7883173|NCT00796328|19399761|P1|COMPLETED|Overall Study||40
7883174|NCT00796328|19399761|P1|STARTED|Overall Study||46
7883175|NCT00796315|19399765|P3|NOT COMPLETED|Overall Study||0
7883176|NCT00796315|19399766|P2|NOT COMPLETED|Overall Study||1
7883177|NCT00796315|19399767|P1|NOT COMPLETED|Overall Study||0
7883178|NCT00796315|19399765|P3|COMPLETED|Overall Study||15
7883179|NCT00796315|19399766|P2|COMPLETED|Overall Study||16
7883180|NCT00796315|19399767|P1|COMPLETED|Overall Study||9
7883181|NCT00796315|19399765|P3|STARTED|Overall Study||15
7883182|NCT00796315|19399766|P2|STARTED|Overall Study||17
7883183|NCT00796315|19399767|P1|STARTED|Overall Study||9
7883184|NCT00796302|19399780|P2|NOT COMPLETED|Overall Study||18
7883185|NCT00796302|19399781|P1|NOT COMPLETED|Overall Study||13
7883186|NCT00796302|19399780|P2|COMPLETED|Overall Study||66
7883187|NCT00796302|19399781|P1|COMPLETED|Overall Study||71
7883188|NCT00796302|19399780|P2|STARTED|Overall Study||84
7883189|NCT00796302|19399781|P1|STARTED|Overall Study||84
7883190|NCT00796224|19399795|P2|NOT COMPLETED|Overall Study||1
7883191|NCT00796224|19399796|P1|NOT COMPLETED|Overall Study||1
7883192|NCT00796224|19399795|P2|COMPLETED|Overall Study||18
7883193|NCT00796224|19399796|P1|COMPLETED|Overall Study||18
7883194|NCT00796224|19399795|P2|STARTED|Overall Study||19
7883195|NCT00796224|19399796|P1|STARTED|Overall Study||19
7883196|NCT00796120|19399816|P2|NOT COMPLETED|Overall Study||60
7883197|NCT00796120|19399817|P1|NOT COMPLETED|Overall Study||61
7883198|NCT00796120|19399816|P2|COMPLETED|Overall Study||0
7883199|NCT00796120|19399817|P1|COMPLETED|Overall Study||0
7883200|NCT00796120|19399816|P2|Treated|Overall Study||57
7883201|NCT00796120|19399817|P1|Treated|Overall Study||61
7883202|NCT00796120|19399816|P2|STARTED|Overall Study||60
7883203|NCT00796120|19399817|P1|STARTED|Overall Study||61
7883204|NCT00796107|19399831|P1|NOT COMPLETED|Overall Study||6
7883205|NCT00796107|19399831|P1|COMPLETED|Overall Study||0
7883206|NCT00796107|19399831|P1|STARTED|Overall Study||6
7883207|NCT00796003|19399840|P2|NOT COMPLETED|Overall Study||29
7883208|NCT00796003|19399841|P1|NOT COMPLETED|Overall Study||3
7883209|NCT00796003|19399840|P2|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7
7883210|NCT00796003|19399841|P1|COMPLETED|Overall Study||0
7883211|NCT00796003|19399840|P2|Treated|Overall Study|Number of participants treated|34
7883212|NCT00796003|19399841|P1|Treated|Overall Study|Number of participants treated|3
7883213|NCT00796003|19399840|P2|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36
7883214|NCT00796003|19399841|P1|STARTED|Overall Study|Number of participants enrolled|3
7883215|NCT00795951|19399862|P1|NOT COMPLETED|Overall Study||2
7883216|NCT00795951|19399862|P1|COMPLETED|Overall Study||100
7883217|NCT00795951|19399862|P1|STARTED|Overall Study||102
7883218|NCT00795886|19399955|P1|NOT COMPLETED|Overall Study||10
7883219|NCT00795886|19399955|P1|COMPLETED|Overall Study||53
7883220|NCT00795886|19399955|P1|STARTED|Overall Study||63
7883221|NCT00795821|19399963|P2|NOT COMPLETED|Taper Phase||0
7883222|NCT00795821|19399964|P1|NOT COMPLETED|Taper Phase||9
7883223|NCT00795821|19399963|P2|COMPLETED|Taper Phase|N=6 participants completed only Acute Taper Phase; N=0 participants entered Extension Taper Phase.|6
7883224|NCT00795821|19399964|P1|COMPLETED|Taper Phase|N=231 participants completed Taper Phases: N=3 from Acute Phase; N=228 from Extension Phase.|231
7883225|NCT00795821|19399963|P2|STARTED|Taper Phase|N=6 participants entered only Acute Taper Phase.|6
7883226|NCT00795821|19399964|P1|STARTED|Taper Phase|N=240 participants entered Taper Phases: N=4 from Acute Phase; N=236 from Extension Phase.|240
7883227|NCT00795821|19399963|P2|NOT COMPLETED|Long-term Extension Phase||92
7883228|NCT00795821|19399964|P1|NOT COMPLETED|Long-term Extension Phase||90
7883229|NCT00795821|19399963|P2|COMPLETED|Long-term Extension Phase||115
7883230|NCT00795821|19399964|P1|COMPLETED|Long-term Extension Phase||100
7883231|NCT00795821|19399963|P2|STARTED|Long-term Extension Phase|All placebo-treated participants received LY2216684 in the Long-term Extension Phase.|207
7883232|NCT00795821|19399964|P1|STARTED|Long-term Extension Phase||190
7883233|NCT00795821|19399963|P2|NOT COMPLETED|Acute Treatment Phase||31
7883234|NCT00795821|19399964|P1|NOT COMPLETED|Acute Treatment Phase||56
7883235|NCT00795821|19399963|P2|COMPLETED|Acute Treatment Phase|7 placebo-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|214
7883236|NCT00795821|19399964|P1|COMPLETED|Acute Treatment Phase|4 LY-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|194
7883237|NCT00795821|19399963|P2|STARTED|Acute Treatment Phase||245
7883238|NCT00795821|19399964|P1|STARTED|Acute Treatment Phase||250
7883239|NCT00795769|19400033|P1|NOT COMPLETED|Overall Study||0
7883240|NCT00795769|19400033|P1|COMPLETED|Overall Study||49
7883241|NCT00795769|19400033|P1|STARTED|Overall Study||49
7883242|NCT00795717|19400039|P2|NOT COMPLETED|Phase II||1
7883243|NCT00795717|19400040|P1|NOT COMPLETED|Phase II||0
7883244|NCT00795717|19400039|P2|COMPLETED|Phase II||18
7883245|NCT00795717|19400040|P1|COMPLETED|Phase II||18
7883246|NCT00795717|19400039|P2|STARTED|Phase II||19
7883247|NCT00795717|19400040|P1|STARTED|Phase II||18
7883248|NCT00795717|19400039|P2|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
7883249|NCT00795717|19400040|P1|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
7883250|NCT00795717|19400039|P2|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19
7883251|NCT00795717|19400040|P1|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18
7883252|NCT00795717|19400039|P2|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21
7883253|NCT00795717|19400040|P1|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20
7883254|NCT00795704|19400052|P2|NOT COMPLETED|Overall Study||3
7883255|NCT00795704|19400053|P1|NOT COMPLETED|Overall Study||4
7883256|NCT00795704|19400052|P2|COMPLETED|Overall Study||9
7883257|NCT00795704|19400053|P1|COMPLETED|Overall Study||8
7883258|NCT00795704|19400052|P2|STARTED|Overall Study||12
7883259|NCT00795704|19400053|P1|STARTED|Overall Study||12
7883260|NCT00795665|19400063|P1|NOT COMPLETED|Overall Study||0
7883261|NCT00795665|19400063|P1|COMPLETED|Overall Study||7
7883262|NCT00795665|19400063|P1|STARTED|Overall Study||7
7883263|NCT00795639|19400073|P2|NOT COMPLETED|Overall Study||26
7883264|NCT00795639|19400074|P1|NOT COMPLETED|Overall Study||21
7883265|NCT00795639|19400073|P2|COMPLETED|Overall Study||66
7883266|NCT00795639|19400074|P1|COMPLETED|Overall Study||70
7883267|NCT00795639|19400073|P2|Randomized and Not Treated|Overall Study||1
7883268|NCT00795639|19400074|P1|Randomized and Not Treated|Overall Study||0
7883269|NCT00795639|19400073|P2|STARTED|Overall Study||92
7883270|NCT00795639|19400074|P1|STARTED|Overall Study||91
7883271|NCT00795600|19400086|P2|NOT COMPLETED|Overall Study||4
7883272|NCT00795600|19400087|P1|NOT COMPLETED|Overall Study||4
7883273|NCT00795600|19400086|P2|COMPLETED|Overall Study||31
7883274|NCT00795600|19400087|P1|COMPLETED|Overall Study||21
7883275|NCT00795600|19400086|P2|Exposed to Drug|Overall Study||35
7883276|NCT00795600|19400087|P1|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24
7883277|NCT00795600|19400086|P2|STARTED|Overall Study||35
7883278|NCT00795600|19400087|P1|STARTED|Overall Study||25
7883279|NCT00795535|19400207|P1|NOT COMPLETED|Overall Study||20
7883280|NCT00795535|19400207|P1|COMPLETED|Overall Study||75
7883281|NCT00795535|19400207|P1|STARTED|Overall Study||95
7883282|NCT00795509|19400214|P1|NOT COMPLETED|Overall Study||31
7883283|NCT00795509|19400214|P1|COMPLETED|Overall Study||343
7883284|NCT00795509|19400214|P1|STARTED|Overall Study||374
7883285|NCT00795366|19400221|P2|NOT COMPLETED|Overall Study||0
7883286|NCT00795366|19400222|P1|NOT COMPLETED|Overall Study||0
7883287|NCT00795366|19400221|P2|COMPLETED|Overall Study||54
7883288|NCT00795366|19400222|P1|COMPLETED|Overall Study||42
7883289|NCT00795366|19400221|P2|STARTED|Overall Study||54
7883290|NCT00795366|19400222|P1|STARTED|Overall Study||42
7883291|NCT00795340|19400230|P2|NOT COMPLETED|Overall Study||0
7883292|NCT00795340|19400231|P1|NOT COMPLETED|Overall Study||7
7883293|NCT00795340|19400230|P2|COMPLETED|Overall Study||153
7883294|NCT00795340|19400231|P1|COMPLETED|Overall Study||146
7883295|NCT00795340|19400230|P2|STARTED|Overall Study||153
7883296|NCT00795340|19400231|P1|STARTED|Overall Study||153
7883297|NCT00795288|19400243|P2|NOT COMPLETED|Overall Study||0
7883298|NCT00795288|19400244|P1|NOT COMPLETED|Overall Study||0
7883299|NCT00795288|19400243|P2|COMPLETED|Overall Study||21
7883300|NCT00795288|19400244|P1|COMPLETED|Overall Study||21
7883301|NCT00795288|19400243|P2|STARTED|Overall Study||21
7883302|NCT00795288|19400244|P1|STARTED|Overall Study||21
7883303|NCT00795236|19400256|P2|NOT COMPLETED|Overall Study||0
7883304|NCT00795236|19400257|P1|NOT COMPLETED|Overall Study||0
7883305|NCT00795236|19400256|P2|COMPLETED|Overall Study||0
7883306|NCT00795236|19400257|P1|COMPLETED|Overall Study|Unable to consistently obtain saliva DLMO in subjects and thus couldn't measure circadian period|0
7883307|NCT00795236|19400256|P2|STARTED|Overall Study||0
7883308|NCT00795236|19400257|P1|STARTED|Overall Study||0
7883309|NCT00795210|19400270|P3|NOT COMPLETED|Overall Study||2
7883310|NCT00795210|19400271|P2|NOT COMPLETED|Overall Study||1
7883311|NCT00795210|19400272|P1|NOT COMPLETED|Overall Study||0
7883312|NCT00795210|19400270|P3|COMPLETED|Overall Study||3
7883313|NCT00795210|19400271|P2|COMPLETED|Overall Study||11
7883314|NCT00795210|19400272|P1|COMPLETED|Overall Study||8
7883315|NCT00795210|19400270|P3|STARTED|Overall Study||5
7883316|NCT00795210|19400271|P2|STARTED|Overall Study||12
7883317|NCT00795210|19400272|P1|STARTED|Overall Study||8
7883318|NCT00795184|19400283|P2|NOT COMPLETED|Overall Study||13
7883319|NCT00795184|19400284|P1|NOT COMPLETED|Overall Study||8
7883320|NCT00795184|19400283|P2|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44
7883321|NCT00795184|19400284|P1|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57
7883322|NCT00795184|19400283|P2|STARTED|Overall Study||57
7883323|NCT00795184|19400284|P1|STARTED|Overall Study||65
7883324|NCT00795145|19400295|P7|NOT COMPLETED|Cohort 2||0
7883325|NCT00795145|19400296|P6|NOT COMPLETED|Cohort 2||0
7883326|NCT00795145|19400297|P5|NOT COMPLETED|Cohort 2||0
7883327|NCT00795145|19400298|P4|NOT COMPLETED|Cohort 2||0
7883328|NCT00795145|19400299|P3|NOT COMPLETED|Cohort 2||0
7883329|NCT00795145|19400300|P2|NOT COMPLETED|Cohort 2||0
7883330|NCT00795145|19400301|P1|NOT COMPLETED|Cohort 2||0
7883331|NCT00795145|19400295|P7|COMPLETED|Cohort 2||10
7883332|NCT00795145|19400296|P6|COMPLETED|Cohort 2||10
7883333|NCT00795145|19400297|P5|COMPLETED|Cohort 2||10
7883334|NCT00795145|19400298|P4|COMPLETED|Cohort 2||10
7883335|NCT00795145|19400299|P3|COMPLETED|Cohort 2||0
7883336|NCT00795145|19400300|P2|COMPLETED|Cohort 2||0
7883337|NCT00795145|19400301|P1|COMPLETED|Cohort 2||0
7883338|NCT00795145|19400295|P7|STARTED|Cohort 2||10
7883339|NCT00795145|19400296|P6|STARTED|Cohort 2||10
7883340|NCT00795145|19400297|P5|STARTED|Cohort 2||10
7883341|NCT00795145|19400298|P4|STARTED|Cohort 2||10
7883342|NCT00795145|19400299|P3|STARTED|Cohort 2||0
7883343|NCT00795145|19400300|P2|STARTED|Cohort 2||0
7883344|NCT00795145|19400301|P1|STARTED|Cohort 2||0
7883345|NCT00795145|19400295|P7|NOT COMPLETED|Cohort 1||0
7883346|NCT00795145|19400296|P6|NOT COMPLETED|Cohort 1||0
7883347|NCT00795145|19400297|P5|NOT COMPLETED|Cohort 1||0
7883348|NCT00795145|19400298|P4|NOT COMPLETED|Cohort 1||0
7883349|NCT00795145|19400299|P3|NOT COMPLETED|Cohort 1||0
7883350|NCT00795145|19400300|P2|NOT COMPLETED|Cohort 1||0
7883351|NCT00795145|19400301|P1|NOT COMPLETED|Cohort 1||0
7883352|NCT00795145|19400295|P7|COMPLETED|Cohort 1||0
7883353|NCT00795145|19400296|P6|COMPLETED|Cohort 1||0
7883354|NCT00795145|19400297|P5|COMPLETED|Cohort 1||0
7883355|NCT00795145|19400298|P4|COMPLETED|Cohort 1||0
7883356|NCT00795145|19400299|P3|COMPLETED|Cohort 1||3
7883357|NCT00795145|19400300|P2|COMPLETED|Cohort 1||3
7883358|NCT00795145|19400301|P1|COMPLETED|Cohort 1||3
7883359|NCT00795145|19400295|P7|STARTED|Cohort 1||0
7883360|NCT00795145|19400296|P6|STARTED|Cohort 1||0
7883361|NCT00795145|19400297|P5|STARTED|Cohort 1||0
7883362|NCT00795145|19400298|P4|STARTED|Cohort 1||0
7883363|NCT00795145|19400299|P3|STARTED|Cohort 1||3
7883364|NCT00795145|19400300|P2|STARTED|Cohort 1||3
7883365|NCT00795145|19400301|P1|STARTED|Cohort 1||3
7883366|NCT00795132|19400345|P1|NOT COMPLETED|Overall Study||3
7883367|NCT00795132|19400345|P1|COMPLETED|Overall Study||44
7883368|NCT00795132|19400345|P1|STARTED|Overall Study||47
7883369|NCT00795002|19400359|P2|NOT COMPLETED|Overall Study||0
7883370|NCT00795002|19400360|P1|NOT COMPLETED|Overall Study||0
7883371|NCT00795002|19400359|P2|COMPLETED|Overall Study||37
7883372|NCT00795002|19400360|P1|COMPLETED|Overall Study||37
7883373|NCT00795002|19400359|P2|STARTED|Overall Study||37
7883374|NCT00795002|19400360|P1|STARTED|Overall Study||37
7883375|NCT00794963|19400372|P2|NOT COMPLETED|Overall Study||4
7883376|NCT00794963|19400373|P1|NOT COMPLETED|Overall Study||1
7883377|NCT00794963|19400372|P2|COMPLETED|Overall Study||0
7883378|NCT00794963|19400373|P1|COMPLETED|Overall Study||3
7883379|NCT00794963|19400372|P2|STARTED|Overall Study||4
7883380|NCT00794963|19400373|P1|STARTED|Overall Study||4
7883381|NCT00794950|19400379|P1|NOT COMPLETED|Beginning Sunitinib Treatment||12
7883382|NCT00794950|19400379|P1|COMPLETED|Beginning Sunitinib Treatment||24
7883383|NCT00794950|19400379|P1|STARTED|Beginning Sunitinib Treatment||36
7883384|NCT00794950|19400379|P1|NOT COMPLETED|BCG Induction||7
7883385|NCT00794950|19400379|P1|COMPLETED|BCG Induction||36
7883386|NCT00794950|19400379|P1|STARTED|BCG Induction||43
7883387|NCT00794924|19400388|P2|NOT COMPLETED|Overall Study||70
7883388|NCT00794924|19400389|P1|NOT COMPLETED|Overall Study||60
7883389|NCT00794924|19400388|P2|COMPLETED|Overall Study||101
7883390|NCT00794924|19400389|P1|COMPLETED|Overall Study||114
7883391|NCT00794924|19400388|P2|STARTED|Overall Study|14 patients refused to start the study|171
7883392|NCT00794924|19400389|P1|STARTED|Overall Study|14 patients refused to start the study|174
7883393|NCT00794820|19400393|P1|NOT COMPLETED|Overall Study||16
7883394|NCT00794820|19400393|P1|COMPLETED|Overall Study||50
7883395|NCT00794820|19400393|P1|STARTED|Overall Study||66
7883396|NCT00794677|19400401|P2|NOT COMPLETED|Second Intervention||0
7883397|NCT00794677|19400402|P1|NOT COMPLETED|Second Intervention||0
7883398|NCT00794677|19400401|P2|COMPLETED|Second Intervention||13
7883399|NCT00794677|19400402|P1|COMPLETED|Second Intervention||11
7883400|NCT00794677|19400401|P2|STARTED|Second Intervention||13
7883401|NCT00794677|19400402|P1|STARTED|Second Intervention||11
7883402|NCT00794677|19400401|P2|NOT COMPLETED|First Intervention||0
7883403|NCT00794677|19400402|P1|NOT COMPLETED|First Intervention||2
7883404|NCT00794677|19400401|P2|COMPLETED|First Intervention||13
7883405|NCT00794677|19400402|P1|COMPLETED|First Intervention||11
7883406|NCT00794677|19400401|P2|STARTED|First Intervention||13
7883407|NCT00794677|19400402|P1|STARTED|First Intervention||13
7883408|NCT00794664|19400424|P2|NOT COMPLETED|Follow-up Period||5
7883409|NCT00794664|19400425|P1|NOT COMPLETED|Follow-up Period||1
7883410|NCT00794664|19400424|P2|COMPLETED|Follow-up Period||28
7883411|NCT00794664|19400425|P1|COMPLETED|Follow-up Period||15
7883412|NCT00794664|19400424|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33
7883413|NCT00794664|19400425|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16
7883414|NCT00794664|19400424|P2|NOT COMPLETED|Treatment Period||12
7883415|NCT00794664|19400425|P1|NOT COMPLETED|Treatment Period||1
7883416|NCT00794664|19400424|P2|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27
7883417|NCT00794664|19400425|P1|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18
7883418|NCT00794664|19400424|P2|STARTED|Treatment Period||39
7883419|NCT00794664|19400425|P1|STARTED|Treatment Period||19
7883420|NCT00794573|19400471|P2|NOT COMPLETED|Overall Study||45
7883421|NCT00794573|19400472|P1|NOT COMPLETED|Overall Study||38
7883422|NCT00794573|19400471|P2|COMPLETED|Overall Study||106
7883423|NCT00794573|19400472|P1|COMPLETED|Overall Study||113
7883424|NCT00794573|19400471|P2|STARTED|Overall Study||151
7883425|NCT00794573|19400472|P1|STARTED|Overall Study||151
7883426|NCT00794560|19400504|P4|NOT COMPLETED|Overall Study||4
7883427|NCT00794560|19400505|P3|NOT COMPLETED|Overall Study||4
7883428|NCT00794560|19400506|P2|NOT COMPLETED|Overall Study||4
7883429|NCT00794560|19400507|P1|NOT COMPLETED|Overall Study||3
7883430|NCT00794560|19400504|P4|COMPLETED|Overall Study||34
7883431|NCT00794560|19400505|P3|COMPLETED|Overall Study||40
7883432|NCT00794560|19400506|P2|COMPLETED|Overall Study||32
7883433|NCT00794560|19400507|P1|COMPLETED|Overall Study||33
7883434|NCT00794560|19400504|P4|STARTED|Overall Study||38
7883435|NCT00794560|19400505|P3|STARTED|Overall Study||44
7883436|NCT00794560|19400506|P2|STARTED|Overall Study||36
7883437|NCT00794560|19400507|P1|STARTED|Overall Study||36
7883438|NCT00794547|19400521|P2|NOT COMPLETED|Overall Study||0
7883439|NCT00794547|19400522|P1|NOT COMPLETED|Overall Study||0
7883440|NCT00794547|19400521|P2|COMPLETED|Overall Study||16
7883441|NCT00794547|19400522|P1|COMPLETED|Overall Study||18
7883442|NCT00794547|19400521|P2|STARTED|Overall Study||16
7883443|NCT00794547|19400522|P1|STARTED|Overall Study||18
7883444|NCT00794508|19400530|P1|NOT COMPLETED|Overall Study||0
7883445|NCT00794508|19400530|P1|COMPLETED|Overall Study||10
7883446|NCT00794508|19400530|P1|STARTED|Overall Study||10
7883447|NCT00794469|19400536|P1|NOT COMPLETED|Overall Study||0
7883448|NCT00794469|19400536|P1|COMPLETED|Overall Study||21
7883449|NCT00794469|19400536|P1|STARTED|Overall Study||21
7883450|NCT00794417|19400545|P4|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||35
7883451|NCT00794417|19400546|P3|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
7883452|NCT00794417|19400547|P2|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
7883453|NCT00794417|19400548|P1|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
7883454|NCT00794417|19400545|P4|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||7
7883455|NCT00794417|19400546|P3|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
7883456|NCT00794417|19400547|P2|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
7883457|NCT00794417|19400548|P1|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
7883458|NCT00794417|19400545|P4|STARTED|Phase 2: Baseline (Day 421) to Day 972||42
7883459|NCT00794417|19400546|P3|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
7883460|NCT00794417|19400547|P2|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
7883461|NCT00794417|19400548|P1|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
7883462|NCT00794417|19400545|P4|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0
7883463|NCT00794417|19400546|P3|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
7883464|NCT00794417|19400547|P2|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
7883465|NCT00794417|19400548|P1|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
7883466|NCT00794417|19400545|P4|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0
7883467|NCT00794417|19400546|P3|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4
7883468|NCT00794417|19400547|P2|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4
7883469|NCT00794417|19400548|P1|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||1
7883470|NCT00794417|19400545|P4|STARTED|Phase 1: Baseline (Day 1) up to Day 751||0
7883471|NCT00794417|19400546|P3|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7
7883472|NCT00794417|19400547|P2|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7
7883473|NCT00794417|19400548|P1|STARTED|Phase 1: Baseline (Day 1) up to Day 751||4
7883474|NCT00794365|19400601|P1|NOT COMPLETED|Overall Study||79
7883475|NCT00794365|19400601|P1|COMPLETED|Overall Study||251
7883476|NCT00794365|19400601|P1|STARTED|Overall Study||330
7883477|NCT00794313|19400607|P3|NOT COMPLETED|Overall Study||0
7883478|NCT00794313|19400608|P2|NOT COMPLETED|Overall Study||0
7883479|NCT00794313|19400609|P1|NOT COMPLETED|Overall Study||0
7883480|NCT00794313|19400607|P3|COMPLETED|Overall Study||1
7883481|NCT00794313|19400608|P2|COMPLETED|Overall Study||1
7883482|NCT00794313|19400609|P1|COMPLETED|Overall Study||1
7883483|NCT00794313|19400607|P3|STARTED|Overall Study||1
7883484|NCT00794313|19400608|P2|STARTED|Overall Study||1
7883485|NCT00794313|19400609|P1|STARTED|Overall Study||1
7883486|NCT00794196|19400622|P2|NOT COMPLETED|Overall Study||23
7883487|NCT00794196|19400623|P1|NOT COMPLETED|Overall Study||5
7883488|NCT00794196|19400622|P2|COMPLETED|Overall Study||64
7883489|NCT00794196|19400623|P1|COMPLETED|Overall Study||87
7883490|NCT00794196|19400622|P2|STARTED|Overall Study||87
7883491|NCT00794196|19400623|P1|STARTED|Overall Study||92
7883492|NCT00794170|19400633|P2|NOT COMPLETED|Overall Study||3
7883493|NCT00794170|19400634|P1|NOT COMPLETED|Overall Study||7
7883494|NCT00794170|19400633|P2|COMPLETED|Overall Study||152
7883495|NCT00794170|19400634|P1|COMPLETED|Overall Study||150
7883496|NCT00794170|19400633|P2|STARTED|Overall Study||155
7883497|NCT00794170|19400634|P1|STARTED|Overall Study||157
7883498|NCT00794157|19400643|P3|NOT COMPLETED|Overall Study||19
7883499|NCT00794157|19400644|P2|NOT COMPLETED|Overall Study||10
7883500|NCT00794157|19400645|P1|NOT COMPLETED|Overall Study||10
7883501|NCT00794157|19400643|P3|COMPLETED|Overall Study||98
7883502|NCT00794157|19400644|P2|COMPLETED|Overall Study||106
7883503|NCT00794157|19400645|P1|COMPLETED|Overall Study||104
7883504|NCT00794157|19400643|P3|STARTED|Overall Study||117
7883505|NCT00794157|19400644|P2|STARTED|Overall Study||116
7883506|NCT00794157|19400645|P1|STARTED|Overall Study||114
7883507|NCT00794144|19400667|P2|NOT COMPLETED|Overall Study||3
7883508|NCT00794144|19400668|P1|NOT COMPLETED|Overall Study||3
7883509|NCT00794144|19400667|P2|COMPLETED|Overall Study||63
7883510|NCT00794144|19400668|P1|COMPLETED|Overall Study||63
7883511|NCT00794144|19400667|P2|STARTED|Overall Study||66
7883512|NCT00794144|19400668|P1|STARTED|Overall Study||66
7883513|NCT00794118|19400674|P1|NOT COMPLETED|Overall Study||27
7883514|NCT00794118|19400674|P1|COMPLETED|Overall Study||272
7883515|NCT00794118|19400674|P1|STARTED|Overall Study||299
7883516|NCT00794040|19400734|P2|NOT COMPLETED|Overall Study||5
7883517|NCT00794040|19400735|P1|NOT COMPLETED|Overall Study||3
7883518|NCT00794040|19400734|P2|COMPLETED|Overall Study||23
7883519|NCT00794040|19400735|P1|COMPLETED|Overall Study||22
7883520|NCT00794040|19400734|P2|STARTED|Overall Study||28
7883521|NCT00794040|19400735|P1|STARTED|Overall Study||25
7883522|NCT00793910|19400751|P2|NOT COMPLETED|Overall Study||7
7883523|NCT00793910|19400752|P1|NOT COMPLETED|Overall Study||5
7883524|NCT00793910|19400751|P2|COMPLETED|Overall Study||46
7883525|NCT00793910|19400752|P1|COMPLETED|Overall Study||48
7883526|NCT00793910|19400751|P2|STARTED|Overall Study||53
7883527|NCT00793910|19400752|P1|STARTED|Overall Study||53
7883528|NCT00793871|19400766|P1|NOT COMPLETED|Overall Study||60
7883529|NCT00793871|19400766|P1|COMPLETED|Overall Study||0
7883530|NCT00793871|19400766|P1|Received Treatment|Overall Study||59
7883531|NCT00793871|19400766|P1|STARTED|Overall Study||60
7883532|NCT00793819|19400780|P2|NOT COMPLETED|Overall Study||9
7883533|NCT00793819|19400781|P1|NOT COMPLETED|Overall Study||14
7883534|NCT00793819|19400780|P2|COMPLETED|Overall Study||89
7883535|NCT00793819|19400781|P1|COMPLETED|Overall Study||97
7883536|NCT00793819|19400780|P2|STARTED|Overall Study||98
7883537|NCT00793819|19400781|P1|STARTED|Overall Study||111
7883538|NCT00793793|19400799|P12|NOT COMPLETED|Overall Study||6
7883539|NCT00793793|19400800|P11|NOT COMPLETED|Overall Study||3
7883540|NCT00793793|19400801|P10|NOT COMPLETED|Overall Study||9
7883541|NCT00793793|19400802|P9|NOT COMPLETED|Overall Study||9
7883542|NCT00793793|19400803|P8|NOT COMPLETED|Overall Study||0
7883543|NCT00793793|19400804|P7|NOT COMPLETED|Overall Study||4
7883544|NCT00793793|19400805|P6|NOT COMPLETED|Overall Study||2
7883545|NCT00793793|19400806|P5|NOT COMPLETED|Overall Study||2
7883546|NCT00793793|19400807|P4|NOT COMPLETED|Overall Study||3
7883547|NCT00793793|19400808|P3|NOT COMPLETED|Overall Study||2
7883548|NCT00793793|19400809|P2|NOT COMPLETED|Overall Study||1
7883549|NCT00793793|19400810|P1|NOT COMPLETED|Overall Study||0
7883550|NCT00793793|19400799|P12|COMPLETED|Overall Study||1
7883551|NCT00793793|19400800|P11|COMPLETED|Overall Study||3
7883552|NCT00793793|19400801|P10|COMPLETED|Overall Study||6
7883553|NCT00793793|19400802|P9|COMPLETED|Overall Study||6
7883554|NCT00793793|19400803|P8|COMPLETED|Overall Study||6
7883555|NCT00793793|19400804|P7|COMPLETED|Overall Study||3
7883556|NCT00793793|19400805|P6|COMPLETED|Overall Study||4
7883557|NCT00793793|19400806|P5|COMPLETED|Overall Study||4
7883558|NCT00793793|19400807|P4|COMPLETED|Overall Study||4
7883559|NCT00793793|19400808|P3|COMPLETED|Overall Study||5
7883560|NCT00793793|19400809|P2|COMPLETED|Overall Study||5
7883561|NCT00793793|19400810|P1|COMPLETED|Overall Study||8
7883562|NCT00793793|19400799|P12|STARTED|Overall Study||7
7883563|NCT00793793|19400800|P11|STARTED|Overall Study||6
7883564|NCT00793793|19400801|P10|STARTED|Overall Study||15
7883565|NCT00793793|19400802|P9|STARTED|Overall Study||15
7883566|NCT00793793|19400803|P8|STARTED|Overall Study||6
7883567|NCT00793793|19400804|P7|STARTED|Overall Study||7
7883568|NCT00793793|19400805|P6|STARTED|Overall Study||6
7883569|NCT00793793|19400806|P5|STARTED|Overall Study||6
7883570|NCT00793793|19400807|P4|STARTED|Overall Study||7
7883571|NCT00793793|19400808|P3|STARTED|Overall Study||7
7883572|NCT00793793|19400809|P2|STARTED|Overall Study||6
7883573|NCT00793793|19400810|P1|STARTED|Overall Study||8
7883574|NCT00793780|19401185|P2|NOT COMPLETED|Overall Study||1
7883575|NCT00793780|19401186|P1|NOT COMPLETED|Overall Study||2
7883576|NCT00793780|19401185|P2|COMPLETED|Overall Study||11
7883577|NCT00793780|19401186|P1|COMPLETED|Overall Study||10
7883578|NCT00793780|19401185|P2|Collected Baseline Data|Overall Study||12
7883579|NCT00793780|19401186|P1|Collected Baseline Data|Overall Study||11
7883580|NCT00793780|19401185|P2|Randomization|Overall Study||12
7883581|NCT00793780|19401186|P1|Randomization|Overall Study||12
7883582|NCT00793780|19401185|P2|STARTED|Overall Study||12
7883583|NCT00793780|19401186|P1|STARTED|Overall Study||12
7883584|NCT00793650|19401204|P2|NOT COMPLETED|Overall Study||0
7883585|NCT00793650|19401205|P1|NOT COMPLETED|Overall Study||0
7883586|NCT00793650|19401204|P2|COMPLETED|Overall Study||20
7883587|NCT00793650|19401205|P1|COMPLETED|Overall Study||19
7883588|NCT00793650|19401204|P2|STARTED|Overall Study||20
7883589|NCT00793650|19401205|P1|STARTED|Overall Study||19
7883590|NCT00793624|19401217|P4|NOT COMPLETED|Overall Study||43
7883591|NCT00793624|19401218|P3|NOT COMPLETED|Overall Study||39
7883592|NCT00793624|19401219|P2|NOT COMPLETED|Overall Study||36
7883593|NCT00793624|19401220|P1|NOT COMPLETED|Overall Study||57
7883594|NCT00793624|19401217|P4|COMPLETED|Overall Study||184
7883595|NCT00793624|19401218|P3|COMPLETED|Overall Study||186
7883596|NCT00793624|19401219|P2|COMPLETED|Overall Study||191
7883597|NCT00793624|19401220|P1|COMPLETED|Overall Study||168
7883598|NCT00793624|19401217|P4|STARTED|Overall Study||227
7883599|NCT00793624|19401218|P3|STARTED|Overall Study||225
7883600|NCT00793624|19401219|P2|STARTED|Overall Study||227
7883601|NCT00793624|19401220|P1|STARTED|Overall Study||225
7883602|NCT00793611|19401488|P2|NOT COMPLETED|Overall Study||0
7883603|NCT00793611|19401489|P1|NOT COMPLETED|Overall Study||0
7883604|NCT00793611|19401488|P2|COMPLETED|Overall Study||10
7883605|NCT00793611|19401489|P1|COMPLETED|Overall Study||10
7883606|NCT00793611|19401488|P2|STARTED|Overall Study||10
7883607|NCT00793611|19401489|P1|STARTED|Overall Study||10
7883608|NCT00793585|19401501|P2|NOT COMPLETED|Overall Study||3
7883609|NCT00793585|19401502|P1|NOT COMPLETED|Overall Study||2
7883610|NCT00793585|19401501|P2|COMPLETED|Overall Study||18
7883611|NCT00793585|19401502|P1|COMPLETED|Overall Study||17
7883612|NCT00793585|19401501|P2|STARTED|Overall Study||21
7883613|NCT00793585|19401502|P1|STARTED|Overall Study||19
7883614|NCT00793572|19401510|P1|NOT COMPLETED|Overall Study||0
7883615|NCT00793572|19401510|P1|COMPLETED|Overall Study||32
7883616|NCT00793572|19401510|P1|STARTED|Overall Study||32
7883617|NCT00793546|19401521|P2|NOT COMPLETED|Overall Study||28
7883618|NCT00793546|19401522|P1|NOT COMPLETED|Overall Study||14
7883619|NCT00793546|19401521|P2|COMPLETED|Overall Study||0
7883620|NCT00793546|19401522|P1|COMPLETED|Overall Study||0
7883621|NCT00793546|19401521|P2|STARTED|Overall Study||28
7883622|NCT00793546|19401522|P1|STARTED|Overall Study||14
7883623|NCT00793520|19401552|P2|NOT COMPLETED|Placebo Crossover to Milnacipran||1
7883624|NCT00793520|19401553|P1|NOT COMPLETED|Placebo Crossover to Milnacipran||0
7883625|NCT00793520|19401552|P2|COMPLETED|Placebo Crossover to Milnacipran||0
7883626|NCT00793520|19401553|P1|COMPLETED|Placebo Crossover to Milnacipran||0
7883627|NCT00793520|19401552|P2|STARTED|Placebo Crossover to Milnacipran||1
7883628|NCT00793520|19401553|P1|STARTED|Placebo Crossover to Milnacipran||0
7883629|NCT00793520|19401552|P2|NOT COMPLETED|Milnacipran Crossover to Placebo||0
7883630|NCT00793520|19401553|P1|NOT COMPLETED|Milnacipran Crossover to Placebo||1
7883631|NCT00793520|19401552|P2|COMPLETED|Milnacipran Crossover to Placebo||0
7883632|NCT00793520|19401553|P1|COMPLETED|Milnacipran Crossover to Placebo||0
7883633|NCT00793520|19401552|P2|STARTED|Milnacipran Crossover to Placebo||0
7883634|NCT00793520|19401553|P1|STARTED|Milnacipran Crossover to Placebo||1
7883635|NCT00793455|19401563|P2|NOT COMPLETED|Overall Study||0
7883636|NCT00793455|19401564|P1|NOT COMPLETED|Overall Study||0
7883637|NCT00793455|19401563|P2|COMPLETED|Overall Study||314
7883638|NCT00793455|19401564|P1|COMPLETED|Overall Study||314
7883639|NCT00793455|19401563|P2|STARTED|Overall Study||314
7883640|NCT00793455|19401564|P1|STARTED|Overall Study||314
7883641|NCT00793403|19401572|P1|NOT COMPLETED|Overall Study||73
7883642|NCT00793403|19401572|P1|COMPLETED|Overall Study||220
7883643|NCT00793403|19401572|P1|STARTED|Overall Study||293
7883644|NCT00793325|19401619|P1|NOT COMPLETED|Overall Study||19
7883645|NCT00793325|19401619|P1|COMPLETED|Overall Study||890
7883646|NCT00793325|19401619|P1|STARTED|Overall Study||909
7883647|NCT00793182|19401645|P2|NOT COMPLETED|Overall Study||1
7883648|NCT00793182|19401646|P1|NOT COMPLETED|Overall Study||0
7883649|NCT00793182|19401645|P2|COMPLETED|Overall Study||3
7883650|NCT00793182|19401646|P1|COMPLETED|Overall Study||2
7883651|NCT00793182|19401645|P2|STARTED|Overall Study||4
7883652|NCT00793182|19401646|P1|STARTED|Overall Study||2
7883653|NCT00793169|19401652|P1|NOT COMPLETED|Overall Study||0
7883654|NCT00793169|19401652|P1|COMPLETED|Overall Study||19
7883655|NCT00793169|19401652|P1|STARTED|Overall Study||19
7883656|NCT00793104|19401656|P1|NOT COMPLETED|Overall Study||1
7883657|NCT00793104|19401656|P1|COMPLETED|Overall Study||9
7883658|NCT00793104|19401656|P1|STARTED|Overall Study||10
7883659|NCT00792948|19401664|P1|NOT COMPLETED|Overall Study||28
7883660|NCT00792948|19401664|P1|COMPLETED|Overall Study|Patients who completed induction/consolidation step|69
7883661|NCT00792948|19401664|P1|STARTED|Overall Study|Patients registered to induction/consolidation step|97
7883662|NCT00792935|19401675|P2|NOT COMPLETED|Overall Study||3
7883663|NCT00792935|19401676|P1|NOT COMPLETED|Overall Study||4
7883664|NCT00792935|19401675|P2|COMPLETED|Overall Study||68
7883665|NCT00792935|19401676|P1|COMPLETED|Overall Study||68
7883666|NCT00792935|19401675|P2|STARTED|Overall Study||71
7883667|NCT00792935|19401676|P1|STARTED|Overall Study||72
7883668|NCT00792922|19401688|P4|NOT COMPLETED|At 3 Years||0
7883669|NCT00792922|19401689|P3|NOT COMPLETED|At 3 Years||0
7883670|NCT00792922|19401690|P2|NOT COMPLETED|At 3 Years||0
7883671|NCT00792922|19401691|P1|NOT COMPLETED|At 3 Years||0
7883672|NCT00792922|19401688|P4|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
7883673|NCT00792922|19401689|P3|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
7883674|NCT00792922|19401690|P2|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
7883675|NCT00792922|19401691|P1|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
7883676|NCT00792922|19401688|P4|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
7883677|NCT00792922|19401689|P3|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
7883678|NCT00792922|19401690|P2|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
7883679|NCT00792922|19401691|P1|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
7883680|NCT00792922|19401688|P4|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
7883681|NCT00792922|19401689|P3|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
7883682|NCT00792922|19401690|P2|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
7883683|NCT00792922|19401691|P1|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
7883684|NCT00792922|19401688|P4|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
7883685|NCT00792922|19401689|P3|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
7883686|NCT00792922|19401690|P2|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
7883687|NCT00792922|19401691|P1|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
7883688|NCT00792922|19401688|P4|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
~the trial was conducted at community level and data reported per community basis"|0
7883689|NCT00792922|19401689|P3|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
~the trial was conducted at community level and data reported per community basis"|0
7883690|NCT00792922|19401690|P2|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
~the trial was conducted at community level and data reported per community basis"|0
7883691|NCT00792922|19401691|P1|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
~the trial was conducted at community level and data reported per community basis"|0
7883692|NCT00792922|19401688|P4|NOT COMPLETED|At Baseline||0
7883693|NCT00792922|19401689|P3|NOT COMPLETED|At Baseline||0
7883694|NCT00792922|19401690|P2|NOT COMPLETED|At Baseline||0
7883695|NCT00792922|19401691|P1|NOT COMPLETED|At Baseline||0
7883696|NCT00792922|19401688|P4|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
7883697|NCT00792922|19401689|P3|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
7883698|NCT00792922|19401690|P2|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
7883699|NCT00792922|19401691|P1|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
7883700|NCT00792922|19401688|P4|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
7883701|NCT00792922|19401689|P3|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
7883702|NCT00792922|19401690|P2|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
7883703|NCT00792922|19401691|P1|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
7883704|NCT00792922|19401688|P4|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
7883705|NCT00792922|19401689|P3|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
7883706|NCT00792922|19401690|P2|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
7883707|NCT00792922|19401691|P1|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
7883708|NCT00792922|19401688|P4|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
7883709|NCT00792922|19401689|P3|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
7883710|NCT00792922|19401690|P2|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
7883711|NCT00792922|19401691|P1|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
7883712|NCT00792922|19401688|P4|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
7883713|NCT00792922|19401689|P3|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
7883714|NCT00792922|19401690|P2|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
7883715|NCT00792922|19401691|P1|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
7883716|NCT00792909|19401708|P3|NOT COMPLETED|Overall Study||0
7883717|NCT00792909|19401709|P2|NOT COMPLETED|Overall Study||1
7883718|NCT00792909|19401710|P1|NOT COMPLETED|Overall Study||0
7883719|NCT00792909|19401708|P3|COMPLETED|Overall Study||62
7883720|NCT00792909|19401709|P2|COMPLETED|Overall Study||58
7883721|NCT00792909|19401710|P1|COMPLETED|Overall Study||51
7883722|NCT00792909|19401708|P3|STARTED|Overall Study||62
7883723|NCT00792909|19401709|P2|STARTED|Overall Study||59
7883724|NCT00792909|19401710|P1|STARTED|Overall Study||51
7883725|NCT00792805|19401766|P3|NOT COMPLETED|Overall Study||33
7883726|NCT00792805|19401767|P2|NOT COMPLETED|Overall Study||26
7883727|NCT00792805|19401768|P1|NOT COMPLETED|Overall Study||22
7883728|NCT00792805|19401766|P3|COMPLETED|Overall Study||154
7883729|NCT00792805|19401767|P2|COMPLETED|Overall Study||162
7883730|NCT00792805|19401768|P1|COMPLETED|Overall Study||166
7883731|NCT00792805|19401766|P3|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186
7883732|NCT00792805|19401767|P2|Exposed to Study Medication or Placebo|Overall Study||188
7883733|NCT00792805|19401768|P1|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187
7883734|NCT00792805|19401766|P3|STARTED|Overall Study||187
7883735|NCT00792805|19401767|P2|STARTED|Overall Study||188
7883736|NCT00792805|19401768|P1|STARTED|Overall Study||188
7883737|NCT00792701|19401778|P2|NOT COMPLETED|Overall Study||44
7883738|NCT00792701|19401779|P1|NOT COMPLETED|Overall Study||19
7883739|NCT00792701|19401778|P2|COMPLETED|Overall Study||22
7883740|NCT00792701|19401779|P1|COMPLETED|Overall Study||0
7883741|NCT00792701|19401778|P2|Eligible and Analyzable|Overall Study||44
7883742|NCT00792701|19401779|P1|Eligible and Analyzable|Overall Study||17
7883743|NCT00792701|19401778|P2|Eligible|Overall Study||63
7883744|NCT00792701|19401779|P1|Eligible|Overall Study||18
7883745|NCT00792701|19401778|P2|STARTED|Overall Study||66
7883746|NCT00792701|19401779|P1|STARTED|Overall Study||19
7883747|NCT00792688|19401793|P3|NOT COMPLETED|Overall Study||0
7883748|NCT00792688|19401794|P2|NOT COMPLETED|Overall Study||0
7883749|NCT00792688|19401795|P1|NOT COMPLETED|Overall Study||0
7883750|NCT00792688|19401793|P3|COMPLETED|Overall Study||9
7883751|NCT00792688|19401794|P2|COMPLETED|Overall Study||8
7883752|NCT00792688|19401795|P1|COMPLETED|Overall Study||9
7883753|NCT00792688|19401793|P3|STARTED|Overall Study||9
7883754|NCT00792688|19401794|P2|STARTED|Overall Study||8
7883755|NCT00792688|19401795|P1|STARTED|Overall Study||9
7883756|NCT00792636|19401809|P3|NOT COMPLETED|Overall Study||81
7883757|NCT00792636|19401810|P2|NOT COMPLETED|Overall Study||81
7883758|NCT00792636|19401811|P1|NOT COMPLETED|Overall Study||68
7883759|NCT00792636|19401809|P3|COMPLETED|Overall Study||55
7883760|NCT00792636|19401810|P2|COMPLETED|Overall Study||55
7883761|NCT00792636|19401811|P1|COMPLETED|Overall Study||67
7883762|NCT00792636|19401809|P3|STARTED|Overall Study||136
7883763|NCT00792636|19401810|P2|STARTED|Overall Study||136
7883764|NCT00792636|19401811|P1|STARTED|Overall Study||135
7883765|NCT00792623|19401848|P1|NOT COMPLETED|Overall Study||7
7883766|NCT00792623|19401848|P1|COMPLETED|Overall Study||22
7883767|NCT00792623|19401848|P1|STARTED|Overall Study||29
7883768|NCT00792610|19401861|P1|NOT COMPLETED|Overall Study||0
7883769|NCT00792610|19401861|P1|COMPLETED|Overall Study||127
7883770|NCT00792610|19401861|P1|Youths|Overall Study||127
7883771|NCT00792610|19401861|P1|STARTED|Overall Study||127
7883772|NCT00792571|19401865|P1|NOT COMPLETED|Overall Study||10
7883773|NCT00792571|19401865|P1|COMPLETED|Overall Study||8
7883774|NCT00792571|19401865|P1|STARTED|Overall Study||18
7883775|NCT00792428|19401876|P2|NOT COMPLETED|Overall Study||0
7883776|NCT00792428|19401877|P1|NOT COMPLETED|Overall Study||0
7883777|NCT00792428|19401876|P2|COMPLETED|Overall Study||10
7883778|NCT00792428|19401877|P1|COMPLETED|Overall Study||10
7883779|NCT00792428|19401876|P2|STARTED|Overall Study||10
7883780|NCT00792428|19401877|P1|STARTED|Overall Study||10
7883781|NCT00792298|19401885|P8|NOT COMPLETED|Treatment Period 2||2
7883782|NCT00792298|19401886|P7|NOT COMPLETED|Treatment Period 2||1
7883783|NCT00792298|19401887|P6|NOT COMPLETED|Treatment Period 2||0
7883784|NCT00792298|19401888|P5|NOT COMPLETED|Treatment Period 2||2
7883785|NCT00792298|19401889|P4|NOT COMPLETED|Treatment Period 2||2
7883786|NCT00792298|19401890|P3|NOT COMPLETED|Treatment Period 2||1
7883787|NCT00792298|19401891|P2|NOT COMPLETED|Treatment Period 2||1
7883788|NCT00792298|19401892|P1|NOT COMPLETED|Treatment Period 2||1
7883789|NCT00792298|19401885|P8|COMPLETED|Treatment Period 2||28
7883790|NCT00792298|19401886|P7|COMPLETED|Treatment Period 2||28
7883791|NCT00792298|19401887|P6|COMPLETED|Treatment Period 2||27
7883792|NCT00792298|19401888|P5|COMPLETED|Treatment Period 2||30
7883793|NCT00792298|19401889|P4|COMPLETED|Treatment Period 2||26
7883794|NCT00792298|19401890|P3|COMPLETED|Treatment Period 2||30
7883795|NCT00792298|19401891|P2|COMPLETED|Treatment Period 2||30
7883796|NCT00792298|19401892|P1|COMPLETED|Treatment Period 2||29
7883797|NCT00792298|19401885|P8|STARTED|Treatment Period 2||30
7883798|NCT00792298|19401886|P7|STARTED|Treatment Period 2||29
7883799|NCT00792298|19401887|P6|STARTED|Treatment Period 2||27
7883800|NCT00792298|19401888|P5|STARTED|Treatment Period 2||32
7883801|NCT00792298|19401889|P4|STARTED|Treatment Period 2||28
7883802|NCT00792298|19401890|P3|STARTED|Treatment Period 2||31
7883803|NCT00792298|19401891|P2|STARTED|Treatment Period 2||31
7883804|NCT00792298|19401892|P1|STARTED|Treatment Period 2||30
7883805|NCT00792298|19401885|P8|NOT COMPLETED|Washout||0
7883806|NCT00792298|19401886|P7|NOT COMPLETED|Washout||0
7883807|NCT00792298|19401887|P6|NOT COMPLETED|Washout||2
7883808|NCT00792298|19401888|P5|NOT COMPLETED|Washout||0
7883809|NCT00792298|19401889|P4|NOT COMPLETED|Washout||0
7883810|NCT00792298|19401890|P3|NOT COMPLETED|Washout||1
7883811|NCT00792298|19401891|P2|NOT COMPLETED|Washout||0
7883812|NCT00792298|19401892|P1|NOT COMPLETED|Washout||0
7883813|NCT00792298|19401885|P8|COMPLETED|Washout||30
7883814|NCT00792298|19401886|P7|COMPLETED|Washout||29
7883815|NCT00792298|19401887|P6|COMPLETED|Washout||27
7883816|NCT00792298|19401888|P5|COMPLETED|Washout||32
7883817|NCT00792298|19401889|P4|COMPLETED|Washout||28
7883818|NCT00792298|19401890|P3|COMPLETED|Washout||31
7883819|NCT00792298|19401891|P2|COMPLETED|Washout||31
7883820|NCT00792298|19401892|P1|COMPLETED|Washout||30
7883821|NCT00792298|19401885|P8|STARTED|Washout||30
7883822|NCT00792298|19401886|P7|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29
7883823|NCT00792298|19401887|P6|STARTED|Washout||29
7883824|NCT00792298|19401888|P5|STARTED|Washout||32
7883825|NCT00792298|19401889|P4|STARTED|Washout||28
7883826|NCT00792298|19401890|P3|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32
7883827|NCT00792298|19401891|P2|STARTED|Washout||31
7883828|NCT00792298|19401892|P1|STARTED|Washout||30
7883829|NCT00792298|19401885|P8|NOT COMPLETED|Treatment Period 1||1
7883830|NCT00792298|19401886|P7|NOT COMPLETED|Treatment Period 1||4
7883831|NCT00792298|19401887|P6|NOT COMPLETED|Treatment Period 1||3
7883832|NCT00792298|19401888|P5|NOT COMPLETED|Treatment Period 1||0
7883833|NCT00792298|19401889|P4|NOT COMPLETED|Treatment Period 1||4
7883834|NCT00792298|19401890|P3|NOT COMPLETED|Treatment Period 1||2
7883835|NCT00792298|19401891|P2|NOT COMPLETED|Treatment Period 1||1
7883836|NCT00792298|19401892|P1|NOT COMPLETED|Treatment Period 1||1
7883837|NCT00792298|19401885|P8|COMPLETED|Treatment Period 1||30
7883838|NCT00792298|19401886|P7|COMPLETED|Treatment Period 1||27
7883839|NCT00792298|19401887|P6|COMPLETED|Treatment Period 1||29
7883840|NCT00792298|19401888|P5|COMPLETED|Treatment Period 1||32
7883841|NCT00792298|19401889|P4|COMPLETED|Treatment Period 1||28
7883842|NCT00792298|19401890|P3|COMPLETED|Treatment Period 1||31
7883843|NCT00792298|19401891|P2|COMPLETED|Treatment Period 1||31
7883844|NCT00792298|19401892|P1|COMPLETED|Treatment Period 1||30
7883845|NCT00792298|19401885|P8|STARTED|Treatment Period 1||31
7883846|NCT00792298|19401886|P7|STARTED|Treatment Period 1||31
7883847|NCT00792298|19401887|P6|STARTED|Treatment Period 1||32
7883848|NCT00792298|19401888|P5|STARTED|Treatment Period 1||32
7883849|NCT00792298|19401889|P4|STARTED|Treatment Period 1||32
7883850|NCT00792298|19401890|P3|STARTED|Treatment Period 1||33
7883851|NCT00792298|19401891|P2|STARTED|Treatment Period 1||32
7883852|NCT00792298|19401892|P1|STARTED|Treatment Period 1||31
7883853|NCT00792259|19401922|P3|NOT COMPLETED|Overall Study||0
7883854|NCT00792259|19401923|P2|NOT COMPLETED|Overall Study||0
7883855|NCT00792259|19401924|P1|NOT COMPLETED|Overall Study||1
7883856|NCT00792259|19401922|P3|COMPLETED|Overall Study||13
7883857|NCT00792259|19401923|P2|COMPLETED|Overall Study||20
7883858|NCT00792259|19401924|P1|COMPLETED|Overall Study||14
7883859|NCT00792259|19401922|P3|STARTED|Overall Study||13
7883860|NCT00792259|19401923|P2|STARTED|Overall Study||20
7883861|NCT00792259|19401924|P1|STARTED|Overall Study||15
7883862|NCT00792142|19401932|P1|NOT COMPLETED|Overall Study||0
7883863|NCT00792142|19401932|P1|COMPLETED|Overall Study||45
7883864|NCT00792142|19401932|P1|STARTED|Overall Study||45
7883865|NCT00792116|19401941|P2|NOT COMPLETED|Overall Study||1
7883866|NCT00792116|19401942|P1|NOT COMPLETED|Overall Study||1
7883867|NCT00792116|19401941|P2|COMPLETED|Overall Study||54
7883868|NCT00792116|19401942|P1|COMPLETED|Overall Study||52
7883869|NCT00792116|19401941|P2|STARTED|Overall Study||55
7883870|NCT00792116|19401942|P1|STARTED|Overall Study||53
7883871|NCT00792103|19401952|P1|NOT COMPLETED|Overall Study||133
7883872|NCT00792103|19401952|P1|COMPLETED|Overall Study||65
7883873|NCT00792103|19401952|P1|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198
7883874|NCT00791999|19401964|P4|NOT COMPLETED|Overall Study||52
7883875|NCT00791999|19401965|P3|NOT COMPLETED|Overall Study||20
7883876|NCT00791999|19401966|P2|NOT COMPLETED|Overall Study||16
7883877|NCT00791999|19401967|P1|NOT COMPLETED|Overall Study||21
7883878|NCT00791999|19401964|P4|COMPLETED|Overall Study||25
7883879|NCT00791999|19401965|P3|COMPLETED|Overall Study||65
7883880|NCT00791999|19401966|P2|COMPLETED|Overall Study||66
7883881|NCT00791999|19401967|P1|COMPLETED|Overall Study||51
7883882|NCT00791999|19401964|P4|STARTED|Overall Study||77
7883883|NCT00791999|19401965|P3|STARTED|Overall Study||85
7883884|NCT00791999|19401966|P2|STARTED|Overall Study||82
7883885|NCT00791999|19401967|P1|STARTED|Overall Study||72
7883886|NCT00791973|19401983|P2|NOT COMPLETED|Second Intervention (1 Week)||0
7883887|NCT00791973|19401984|P1|NOT COMPLETED|Second Intervention (1 Week)||0
7883888|NCT00791973|19401983|P2|COMPLETED|Second Intervention (1 Week)||7
7883889|NCT00791973|19401984|P1|COMPLETED|Second Intervention (1 Week)||8
7883890|NCT00791973|19401983|P2|STARTED|Second Intervention (1 Week)||7
7883891|NCT00791973|19401984|P1|STARTED|Second Intervention (1 Week)||8
7883892|NCT00791973|19401983|P2|NOT COMPLETED|Washout (1 Week)||0
7883893|NCT00791973|19401984|P1|NOT COMPLETED|Washout (1 Week)||0
7883894|NCT00791973|19401983|P2|COMPLETED|Washout (1 Week)||7
7883895|NCT00791973|19401984|P1|COMPLETED|Washout (1 Week)||8
7883896|NCT00791973|19401983|P2|STARTED|Washout (1 Week)||7
7883897|NCT00791973|19401984|P1|STARTED|Washout (1 Week)||8
7883898|NCT00791973|19401983|P2|NOT COMPLETED|First Intervention (1 Week)||0
7883899|NCT00791973|19401984|P1|NOT COMPLETED|First Intervention (1 Week)||0
7883900|NCT00791973|19401983|P2|COMPLETED|First Intervention (1 Week)||7
7883901|NCT00791973|19401984|P1|COMPLETED|First Intervention (1 Week)||8
7883902|NCT00791973|19401983|P2|STARTED|First Intervention (1 Week)||7
7883903|NCT00791973|19401984|P1|STARTED|First Intervention (1 Week)||8
7883904|NCT00791934|19401992|P1|NOT COMPLETED|Overall Study||15
7883905|NCT00791934|19401992|P1|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48
7883906|NCT00791934|19401992|P1|STARTED|Overall Study||63
7883907|NCT00791921|19402002|P2|NOT COMPLETED|Overall Study||96
7883908|NCT00791921|19402003|P1|NOT COMPLETED|Overall Study||34
7883909|NCT00791921|19402002|P2|COMPLETED|Overall Study||18
7883910|NCT00791921|19402003|P1|COMPLETED|Overall Study||82
7883911|NCT00791921|19402002|P2|STARTED|Overall Study||114
7883912|NCT00791921|19402003|P1|STARTED|Overall Study||116
7883913|NCT00791908|19402011|P1|NOT COMPLETED|Overall Study||0
7883914|NCT00791908|19402011|P1|COMPLETED|Overall Study||15
7883915|NCT00791908|19402011|P1|STARTED|Overall Study||15
7883916|NCT00791843|19402019|P1|NOT COMPLETED|Overall Study||0
7883917|NCT00791843|19402019|P1|COMPLETED|Overall Study|Data unavailable for the study|0
7883918|NCT00791843|19402019|P1|STARTED|Overall Study|Data unavailable for the study|0
7883919|NCT00791817|19402025|P2|NOT COMPLETED|2: Single Dose||0
7883920|NCT00791817|19402026|P1|NOT COMPLETED|2: Single Dose||0
7883921|NCT00791817|19402025|P2|COMPLETED|2: Single Dose||5
7883922|NCT00791817|19402026|P1|COMPLETED|2: Single Dose||5
7883923|NCT00791817|19402025|P2|STARTED|2: Single Dose||5
7883924|NCT00791817|19402026|P1|STARTED|2: Single Dose||5
7883925|NCT00791817|19402025|P2|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
7883926|NCT00791817|19402026|P1|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
7883927|NCT00791817|19402025|P2|COMPLETED|1: Single Dose Followed by Week Washout||5
7883928|NCT00791817|19402026|P1|COMPLETED|1: Single Dose Followed by Week Washout||5
7883929|NCT00791817|19402025|P2|STARTED|1: Single Dose Followed by Week Washout||5
7883930|NCT00791817|19402026|P1|STARTED|1: Single Dose Followed by Week Washout||5
7883931|NCT00791778|19402034|P2|NOT COMPLETED|Follow-up||1
7883932|NCT00791778|19402035|P1|NOT COMPLETED|Follow-up||5
7883933|NCT00791778|19402034|P2|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90
7883934|NCT00791778|19402035|P1|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95
7883935|NCT00791778|19402034|P2|STARTED|Follow-up||91
7883936|NCT00791778|19402035|P1|STARTED|Follow-up||100
7883937|NCT00791778|19402034|P2|NOT COMPLETED|Double-blind Treatment||48
7883938|NCT00791778|19402035|P1|NOT COMPLETED|Double-blind Treatment||77
7883939|NCT00791778|19402034|P2|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75
7883940|NCT00791778|19402035|P1|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46
7883941|NCT00791778|19402034|P2|STARTED|Double-blind Treatment||123
7883942|NCT00791778|19402035|P1|STARTED|Double-blind Treatment||123
7883943|NCT00791765|19402089|P2|NOT COMPLETED|Weeks 13 to 24||8
7883944|NCT00791765|19402090|P1|NOT COMPLETED|Weeks 13 to 24||5
7883945|NCT00791765|19402089|P2|COMPLETED|Weeks 13 to 24||49
7883946|NCT00791765|19402090|P1|COMPLETED|Weeks 13 to 24||49
7883947|NCT00791765|19402089|P2|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57
7883948|NCT00791765|19402090|P1|STARTED|Weeks 13 to 24||54
7883949|NCT00791765|19402089|P2|NOT COMPLETED|Weeks 1 to 12||4
7883950|NCT00791765|19402090|P1|NOT COMPLETED|Weeks 1 to 12||8
7883951|NCT00791765|19402089|P2|COMPLETED|Weeks 1 to 12||58
7883952|NCT00791765|19402090|P1|COMPLETED|Weeks 1 to 12||54
7883953|NCT00791765|19402089|P2|Treated|Weeks 1 to 12||59
7883954|NCT00791765|19402090|P1|Treated|Weeks 1 to 12||62
7883955|NCT00791765|19402089|P2|STARTED|Weeks 1 to 12||62
7883956|NCT00791765|19402090|P1|STARTED|Weeks 1 to 12||62
7883957|NCT00791700|19402105|P4|NOT COMPLETED|Overall Study||30
7883958|NCT00791700|19402106|P3|NOT COMPLETED|Overall Study||6
7883959|NCT00791700|19402107|P2|NOT COMPLETED|Overall Study||11
7883960|NCT00791700|19402108|P1|NOT COMPLETED|Overall Study||6
7883961|NCT00791700|19402105|P4|COMPLETED|Overall Study||13
7883962|NCT00791700|19402106|P3|COMPLETED|Overall Study||7
7883963|NCT00791700|19402107|P2|COMPLETED|Overall Study||20
7883964|NCT00791700|19402108|P1|COMPLETED|Overall Study||10
7883965|NCT00791700|19402105|P4|STARTED|Overall Study||43
7883966|NCT00791700|19402106|P3|STARTED|Overall Study||13
7883967|NCT00791700|19402107|P2|STARTED|Overall Study||31
7883968|NCT00791700|19402108|P1|STARTED|Overall Study||16
7883969|NCT00791661|19402196|P3|NOT COMPLETED|Period 3||0
7883970|NCT00791661|19402197|P2|NOT COMPLETED|Period 3||0
7883971|NCT00791661|19402198|P1|NOT COMPLETED|Period 3||0
7883972|NCT00791661|19402196|P3|COMPLETED|Period 3||6
7883973|NCT00791661|19402197|P2|COMPLETED|Period 3||8
7883974|NCT00791661|19402198|P1|COMPLETED|Period 3||8
7883975|NCT00791661|19402196|P3|Received Matching Placebo to MK-1006|Period 3||1
7883976|NCT00791661|19402197|P2|Received Matching Placebo to MK-1006|Period 3||2
7883977|NCT00791661|19402198|P1|Received Matching Placebo to MK-1006|Period 3||2
7883978|NCT00791661|19402196|P3|Received MK-1006|Period 3||5
7883979|NCT00791661|19402197|P2|Received MK-1006|Period 3||6
7883980|NCT00791661|19402198|P1|Received MK-1006|Period 3||6
7883981|NCT00791661|19402196|P3|STARTED|Period 3||6
7883982|NCT00791661|19402197|P2|STARTED|Period 3||8
7883983|NCT00791661|19402198|P1|STARTED|Period 3||8
7883984|NCT00791661|19402196|P3|NOT COMPLETED|7 Day Wash-out||0
7883985|NCT00791661|19402197|P2|NOT COMPLETED|7 Day Wash-out||0
7883986|NCT00791661|19402198|P1|NOT COMPLETED|7 Day Wash-out||0
7883987|NCT00791661|19402196|P3|COMPLETED|7 Day Wash-out||6
7883988|NCT00791661|19402197|P2|COMPLETED|7 Day Wash-out||8
7883989|NCT00791661|19402198|P1|COMPLETED|7 Day Wash-out||8
7883990|NCT00791661|19402196|P3|STARTED|7 Day Wash-out||6
7883991|NCT00791661|19402197|P2|STARTED|7 Day Wash-out||8
7883992|NCT00791661|19402198|P1|STARTED|7 Day Wash-out||8
7883993|NCT00791661|19402196|P3|NOT COMPLETED|Period 2||0
7883994|NCT00791661|19402197|P2|NOT COMPLETED|Period 2||0
7883995|NCT00791661|19402198|P1|NOT COMPLETED|Period 2||0
7883996|NCT00791661|19402196|P3|COMPLETED|Period 2||6
7883997|NCT00791661|19402197|P2|COMPLETED|Period 2||8
7883998|NCT00791661|19402198|P1|COMPLETED|Period 2||8
7883999|NCT00791661|19402196|P3|Received Matching Placebo to MK-1006|Period 2||2
7884000|NCT00791661|19402197|P2|Received Matching Placebo to MK-1006|Period 2||2
7884001|NCT00791661|19402198|P1|Received Matching Placebo to MK-1006|Period 2||2
7884002|NCT00791661|19402196|P3|Received MK-1006|Period 2||4
7884003|NCT00791661|19402197|P2|Received MK-1006|Period 2||6
7884004|NCT00791661|19402198|P1|Received MK-1006|Period 2||6
7884005|NCT00791661|19402196|P3|STARTED|Period 2||6
7884006|NCT00791661|19402197|P2|STARTED|Period 2||8
7884007|NCT00791661|19402198|P1|STARTED|Period 2||8
7884008|NCT00791661|19402196|P3|NOT COMPLETED|7 Day Wash-out||2
7884009|NCT00791661|19402197|P2|NOT COMPLETED|7 Day Wash-out||0
7884010|NCT00791661|19402198|P1|NOT COMPLETED|7 Day Wash-out||0
7884011|NCT00791661|19402196|P3|COMPLETED|7 Day Wash-out||6
7884012|NCT00791661|19402197|P2|COMPLETED|7 Day Wash-out||8
7884013|NCT00791661|19402198|P1|COMPLETED|7 Day Wash-out||8
7884014|NCT00791661|19402196|P3|STARTED|7 Day Wash-out||8
7884015|NCT00791661|19402197|P2|STARTED|7 Day Wash-out||8
7884016|NCT00791661|19402198|P1|STARTED|7 Day Wash-out||8
7884017|NCT00791661|19402196|P3|NOT COMPLETED|Period 1||0
7884018|NCT00791661|19402197|P2|NOT COMPLETED|Period 1||0
7884019|NCT00791661|19402198|P1|NOT COMPLETED|Period 1||0
7884020|NCT00791661|19402196|P3|COMPLETED|Period 1||8
7884021|NCT00791661|19402197|P2|COMPLETED|Period 1||8
7884022|NCT00791661|19402198|P1|COMPLETED|Period 1||8
7884023|NCT00791661|19402196|P3|Received Matching Placebo to MK-1006|Period 1||2
7884024|NCT00791661|19402197|P2|Received Matching Placebo to MK-1006|Period 1||2
7884025|NCT00791661|19402198|P1|Received Matching Placebo to MK-1006|Period 1||2
7884026|NCT00791661|19402196|P3|Received MK-1006|Period 1||6
7884027|NCT00791661|19402197|P2|Received MK-1006|Period 1||6
7884028|NCT00791661|19402198|P1|Received MK-1006|Period 1||6
7884029|NCT00791661|19402196|P3|STARTED|Period 1||8
7884030|NCT00791661|19402197|P2|STARTED|Period 1||8
7884031|NCT00791661|19402198|P1|STARTED|Period 1||8
7884032|NCT00791648|19402291|P2|NOT COMPLETED|Overall Study||2
7884033|NCT00791648|19402292|P1|NOT COMPLETED|Overall Study||0
7884034|NCT00791648|19402291|P2|COMPLETED|Overall Study||307
7884035|NCT00791648|19402292|P1|COMPLETED|Overall Study||308
7884036|NCT00791648|19402291|P2|STARTED|Overall Study||309
7884037|NCT00791648|19402292|P1|STARTED|Overall Study||308
7884038|NCT00791557|19402328|P1|NOT COMPLETED|Overall Study||1
7884039|NCT00791557|19402328|P1|COMPLETED|Overall Study||1
7884040|NCT00791557|19402328|P1|STARTED|Overall Study||2
7884041|NCT00791518|19402332|P1|NOT COMPLETED|Overall Study||93
7884042|NCT00791518|19402332|P1|COMPLETED|Overall Study||991
7884043|NCT00791518|19402332|P1|STARTED|Overall Study||1084
7884044|NCT00791492|19402360|P2|NOT COMPLETED|Overall Study||3
7884045|NCT00791492|19402361|P1|NOT COMPLETED|Overall Study||6
7884046|NCT00791492|19402360|P2|COMPLETED|Overall Study||38
7884047|NCT00791492|19402361|P1|COMPLETED|Overall Study||39
7884048|NCT00791492|19402360|P2|TREATED|Overall Study||41
7884049|NCT00791492|19402361|P1|TREATED|Overall Study||44
7884050|NCT00791492|19402360|P2|STARTED|Overall Study||41
7884051|NCT00791492|19402361|P1|STARTED|Overall Study||45
7884052|NCT00791479|19402409|P6|NOT COMPLETED|Overall Study||3
7884053|NCT00791479|19402410|P5|NOT COMPLETED|Overall Study||3
7884054|NCT00791479|19402411|P4|NOT COMPLETED|Overall Study||4
7884055|NCT00791479|19402412|P3|NOT COMPLETED|Overall Study||0
7884056|NCT00791479|19402413|P2|NOT COMPLETED|Overall Study||3
7884057|NCT00791479|19402414|P1|NOT COMPLETED|Overall Study||2
7884058|NCT00791479|19402409|P6|COMPLETED|Overall Study||29
7884059|NCT00791479|19402410|P5|COMPLETED|Overall Study||0
7884060|NCT00791479|19402411|P4|COMPLETED|Overall Study||25
7884061|NCT00791479|19402412|P3|COMPLETED|Overall Study||34
7884062|NCT00791479|19402413|P2|COMPLETED|Overall Study||31
7884063|NCT00791479|19402414|P1|COMPLETED|Overall Study||33
7884064|NCT00791479|19402409|P6|Received at Least One Dose of Study Drug|Overall Study||32
7884065|NCT00791479|19402410|P5|Received at Least One Dose of Study Drug|Overall Study||3
7884066|NCT00791479|19402411|P4|Received at Least One Dose of Study Drug|Overall Study||29
7884067|NCT00791479|19402412|P3|Received at Least One Dose of Study Drug|Overall Study||34
7884068|NCT00791479|19402413|P2|Received at Least One Dose of Study Drug|Overall Study||34
7884069|NCT00791479|19402414|P1|Received at Least One Dose of Study Drug|Overall Study||35
7884070|NCT00791479|19402409|P6|STARTED|Overall Study||32
7884071|NCT00791479|19402410|P5|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3
7884072|NCT00791479|19402411|P4|STARTED|Overall Study||29
7884073|NCT00791479|19402412|P3|STARTED|Overall Study||34
7884074|NCT00791479|19402413|P2|STARTED|Overall Study||34
7884075|NCT00791479|19402414|P1|STARTED|Overall Study||35
7884076|NCT00791388|19402513|P5|NOT COMPLETED|Period 4 - 400 mg Dose Group||4
7884077|NCT00791388|19402514|P4|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
7884078|NCT00791388|19402515|P3|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
7884079|NCT00791388|19402516|P2|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
7884080|NCT00791388|19402517|P1|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
7884081|NCT00791388|19402513|P5|COMPLETED|Period 4 - 400 mg Dose Group||4
7884082|NCT00791388|19402514|P4|COMPLETED|Period 4 - 400 mg Dose Group||0
7884083|NCT00791388|19402515|P3|COMPLETED|Period 4 - 400 mg Dose Group||0
7884084|NCT00791388|19402516|P2|COMPLETED|Period 4 - 400 mg Dose Group||0
7884085|NCT00791388|19402517|P1|COMPLETED|Period 4 - 400 mg Dose Group||4
7884086|NCT00791388|19402513|P5|STARTED|Period 4 - 400 mg Dose Group||8
7884087|NCT00791388|19402514|P4|STARTED|Period 4 - 400 mg Dose Group||0
7884088|NCT00791388|19402515|P3|STARTED|Period 4 - 400 mg Dose Group||0
7884089|NCT00791388|19402516|P2|STARTED|Period 4 - 400 mg Dose Group||0
7884090|NCT00791388|19402517|P1|STARTED|Period 4 - 400 mg Dose Group||4
7884091|NCT00791388|19402513|P5|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
7884092|NCT00791388|19402514|P4|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
7884093|NCT00791388|19402515|P3|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
7884094|NCT00791388|19402516|P2|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
7884095|NCT00791388|19402517|P1|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
7884096|NCT00791388|19402513|P5|COMPLETED|Period 3 - 200 mg Dose Group||0
7884097|NCT00791388|19402514|P4|COMPLETED|Period 3 - 200 mg Dose Group||8
7884098|NCT00791388|19402515|P3|COMPLETED|Period 3 - 200 mg Dose Group||0
7884099|NCT00791388|19402516|P2|COMPLETED|Period 3 - 200 mg Dose Group||0
7884100|NCT00791388|19402517|P1|COMPLETED|Period 3 - 200 mg Dose Group||3
7884101|NCT00791388|19402513|P5|STARTED|Period 3 - 200 mg Dose Group||0
7884102|NCT00791388|19402514|P4|STARTED|Period 3 - 200 mg Dose Group||8
7884103|NCT00791388|19402515|P3|STARTED|Period 3 - 200 mg Dose Group||0
7884104|NCT00791388|19402516|P2|STARTED|Period 3 - 200 mg Dose Group||0
7884105|NCT00791388|19402517|P1|STARTED|Period 3 - 200 mg Dose Group||3
7884106|NCT00791388|19402513|P5|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
7884107|NCT00791388|19402514|P4|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
7884108|NCT00791388|19402515|P3|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
7884109|NCT00791388|19402516|P2|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
7884110|NCT00791388|19402517|P1|NOT COMPLETED|Period 2 - 100 mg Dose Group||1
7884111|NCT00791388|19402513|P5|COMPLETED|Period 2 - 100 mg Dose Group||0
7884112|NCT00791388|19402514|P4|COMPLETED|Period 2 - 100 mg Dose Group||0
7884113|NCT00791388|19402515|P3|COMPLETED|Period 2 - 100 mg Dose Group||8
7884114|NCT00791388|19402516|P2|COMPLETED|Period 2 - 100 mg Dose Group||0
7884115|NCT00791388|19402517|P1|COMPLETED|Period 2 - 100 mg Dose Group||2
7884116|NCT00791388|19402513|P5|STARTED|Period 2 - 100 mg Dose Group||0
7884117|NCT00791388|19402514|P4|STARTED|Period 2 - 100 mg Dose Group||0
7884118|NCT00791388|19402515|P3|STARTED|Period 2 - 100 mg Dose Group||8
7884119|NCT00791388|19402516|P2|STARTED|Period 2 - 100 mg Dose Group||0
7884120|NCT00791388|19402517|P1|STARTED|Period 2 - 100 mg Dose Group||3
7884121|NCT00791388|19402513|P5|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
7884122|NCT00791388|19402514|P4|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
7884123|NCT00791388|19402515|P3|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
7884124|NCT00791388|19402516|P2|NOT COMPLETED|Period 1 - 50 mg Dose Group||1
7884125|NCT00791388|19402517|P1|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
7884126|NCT00791388|19402513|P5|COMPLETED|Period 1 - 50 mg Dose Group||0
7884127|NCT00791388|19402514|P4|COMPLETED|Period 1 - 50 mg Dose Group||0
7884128|NCT00791388|19402515|P3|COMPLETED|Period 1 - 50 mg Dose Group||0
7884129|NCT00791388|19402516|P2|COMPLETED|Period 1 - 50 mg Dose Group||7
7884130|NCT00791388|19402517|P1|COMPLETED|Period 1 - 50 mg Dose Group||3
7884131|NCT00791388|19402513|P5|STARTED|Period 1 - 50 mg Dose Group||0
7884132|NCT00791388|19402514|P4|STARTED|Period 1 - 50 mg Dose Group||0
7884133|NCT00791388|19402515|P3|STARTED|Period 1 - 50 mg Dose Group||0
7884134|NCT00791388|19402516|P2|STARTED|Period 1 - 50 mg Dose Group||8
7884135|NCT00791388|19402517|P1|STARTED|Period 1 - 50 mg Dose Group||3
7884136|NCT00791336|19402544|P1|NOT COMPLETED|Overall Study||0
7884137|NCT00791336|19402544|P1|COMPLETED|Overall Study||1
7884138|NCT00791336|19402544|P1|STARTED|Overall Study||1
7884139|NCT00791323|19402552|P2|NOT COMPLETED|Overall Study||0
7884140|NCT00791323|19402553|P1|NOT COMPLETED|Overall Study||0
7884141|NCT00791323|19402552|P2|COMPLETED|Overall Study||3
7884142|NCT00791323|19402553|P1|COMPLETED|Overall Study||6
7884143|NCT00791323|19402552|P2|STARTED|Overall Study||3
7884144|NCT00791323|19402553|P1|STARTED|Overall Study||6
7884145|NCT00791258|19402559|P1|NOT COMPLETED|Overall Study||263
7884146|NCT00791258|19402559|P1|COMPLETED|Overall Study||736
7884147|NCT00791258|19402559|P1|STARTED|Overall Study||999
7884148|NCT00791219|19402624|P3|NOT COMPLETED|Overall Study||14
7884149|NCT00791219|19402625|P2|NOT COMPLETED|Overall Study||16
7884150|NCT00791219|19402626|P1|NOT COMPLETED|Overall Study||5
7884151|NCT00791219|19402624|P3|COMPLETED|Overall Study||61
7884152|NCT00791219|19402625|P2|COMPLETED|Overall Study||60
7884153|NCT00791219|19402626|P1|COMPLETED|Overall Study||19
7884154|NCT00791219|19402624|P3|STARTED|Overall Study||75
7884155|NCT00791219|19402625|P2|STARTED|Overall Study||76
7884156|NCT00791219|19402626|P1|STARTED|Overall Study||24
7884157|NCT00791128|19402652|P1|NOT COMPLETED|Overall Study||9
7884158|NCT00791128|19402652|P1|COMPLETED|Overall Study||13
7884159|NCT00791128|19402652|P1|STARTED|Overall Study||22
7884160|NCT00791102|19402657|P2|NOT COMPLETED|Period 2||0
7884161|NCT00791102|19402658|P1|NOT COMPLETED|Period 2||0
7884162|NCT00791102|19402657|P2|COMPLETED|Period 2||10
7884163|NCT00791102|19402658|P1|COMPLETED|Period 2||10
7884164|NCT00791102|19402657|P2|STARTED|Period 2||10
7884165|NCT00791102|19402658|P1|STARTED|Period 2||10
7884166|NCT00791102|19402657|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
7884167|NCT00791102|19402658|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
7884168|NCT00791102|19402657|P2|COMPLETED|Washout Period of 2 Weeks||10
7884169|NCT00791102|19402658|P1|COMPLETED|Washout Period of 2 Weeks||10
7884170|NCT00791102|19402657|P2|STARTED|Washout Period of 2 Weeks||10
7884171|NCT00791102|19402658|P1|STARTED|Washout Period of 2 Weeks||10
7884172|NCT00791102|19402657|P2|NOT COMPLETED|Period 1||0
7884173|NCT00791102|19402658|P1|NOT COMPLETED|Period 1||0
7884174|NCT00791102|19402657|P2|COMPLETED|Period 1||10
7884175|NCT00791102|19402658|P1|COMPLETED|Period 1||10
7884176|NCT00791102|19402657|P2|STARTED|Period 1||10
7884177|NCT00791102|19402658|P1|STARTED|Period 1||10
7884178|NCT00791089|19402676|P2|NOT COMPLETED|Overall Study||6
7884179|NCT00791089|19402677|P1|NOT COMPLETED|Overall Study||6
7884180|NCT00791089|19402676|P2|COMPLETED|Overall Study||0
7884181|NCT00791089|19402677|P1|COMPLETED|Overall Study||0
7884182|NCT00791089|19402676|P2|Six-month Data Collected|Overall Study||5
7884183|NCT00791089|19402677|P1|Six-month Data Collected|Overall Study||6
7884184|NCT00791089|19402676|P2|Began Actually Taking Fish Oil or Placeb|Overall Study||5
7884185|NCT00791089|19402677|P1|Began Actually Taking Fish Oil or Placeb|Overall Study||6
7884186|NCT00791089|19402676|P2|STARTED|Overall Study||6
7884187|NCT00791089|19402677|P1|STARTED|Overall Study||6
7884188|NCT00791076|19402683|P1|NOT COMPLETED|Overall Study||8
7884189|NCT00791076|19402683|P1|COMPLETED|Overall Study||0
7884190|NCT00791076|19402683|P1|STARTED|Overall Study||8
7884191|NCT00791037|19402691|P1|NOT COMPLETED|Overall Study||0
7884192|NCT00791037|19402691|P1|COMPLETED|Overall Study||23
7884193|NCT00791037|19402691|P1|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1
7884194|NCT00791037|19402691|P1|Primary Outcome|Overall Study||19
7884195|NCT00791037|19402691|P1|STARTED|Overall Study||23
7884196|NCT00790933|19402703|P5|NOT COMPLETED|Overall Study||276
7884197|NCT00790933|19402704|P4|NOT COMPLETED|Overall Study||14
7884198|NCT00790933|19402705|P3|NOT COMPLETED|Overall Study||269
7884199|NCT00790933|19402706|P2|NOT COMPLETED|Overall Study||480
7884200|NCT00790933|19402707|P1|NOT COMPLETED|Overall Study||438
7884201|NCT00790933|19402703|P5|COMPLETED|Overall Study||145
7884202|NCT00790933|19402704|P4|COMPLETED|Overall Study||23
7884203|NCT00790933|19402705|P3|COMPLETED|Overall Study||115
7884204|NCT00790933|19402706|P2|COMPLETED|Overall Study||246
7884205|NCT00790933|19402707|P1|COMPLETED|Overall Study||237
7884206|NCT00790933|19402703|P5|STARTED|Overall Study||421
7884207|NCT00790933|19402704|P4|STARTED|Overall Study||37
7884208|NCT00790933|19402705|P3|STARTED|Overall Study||384
7884209|NCT00790933|19402706|P2|STARTED|Overall Study||726
7884210|NCT00790933|19402707|P1|STARTED|Overall Study||675
7884211|NCT00790907|19403238|P3|NOT COMPLETED|Overall Study||339
7884212|NCT00790907|19403239|P2|NOT COMPLETED|Overall Study||340
7884213|NCT00790907|19403240|P1|NOT COMPLETED|Overall Study||455
7884214|NCT00790907|19403238|P3|COMPLETED|Overall Study||663
7884215|NCT00790907|19403239|P2|COMPLETED|Overall Study||684
7884216|NCT00790907|19403240|P1|COMPLETED|Overall Study||754
7884217|NCT00790907|19403238|P3|STARTED|Overall Study||1002
7884218|NCT00790907|19403239|P2|STARTED|Overall Study||1024
7884219|NCT00790907|19403240|P1|STARTED|Overall Study||1209
7884220|NCT00790868|19403263|P2|NOT COMPLETED|Overall Study||17
7884221|NCT00790868|19403264|P1|NOT COMPLETED|Overall Study||6
7884222|NCT00790868|19403263|P2|COMPLETED|Overall Study||75
7884223|NCT00790868|19403264|P1|COMPLETED|Overall Study||82
7884224|NCT00790868|19403263|P2|STARTED|Overall Study||92
7884225|NCT00790868|19403264|P1|STARTED|Overall Study||88
7884226|NCT00790855|19403278|P1|NOT COMPLETED|Overall Study||0
7884227|NCT00790855|19403278|P1|COMPLETED|Overall Study||25
7884228|NCT00790855|19403278|P1|STARTED|Overall Study||25
7884229|NCT00790842|19403286|P11|NOT COMPLETED|Expansion Cohort||0
7884230|NCT00790842|19403287|P10|NOT COMPLETED|Expansion Cohort||0
7884231|NCT00790842|19403288|P9|NOT COMPLETED|Expansion Cohort||0
7884232|NCT00790842|19403289|P8|NOT COMPLETED|Expansion Cohort||0
7884233|NCT00790842|19403290|P7|NOT COMPLETED|Expansion Cohort||1
7884234|NCT00790842|19403291|P6|NOT COMPLETED|Expansion Cohort||0
7884235|NCT00790842|19403292|P5|NOT COMPLETED|Expansion Cohort||0
7884236|NCT00790842|19403293|P4|NOT COMPLETED|Expansion Cohort||0
7884237|NCT00790842|19403294|P3|NOT COMPLETED|Expansion Cohort||7
7884238|NCT00790842|19403295|P2|NOT COMPLETED|Expansion Cohort||0
7884239|NCT00790842|19403296|P1|NOT COMPLETED|Expansion Cohort||0
7884240|NCT00790842|19403286|P11|COMPLETED|Expansion Cohort||0
7884241|NCT00790842|19403287|P10|COMPLETED|Expansion Cohort||0
7884242|NCT00790842|19403288|P9|COMPLETED|Expansion Cohort||0
7884243|NCT00790842|19403289|P8|COMPLETED|Expansion Cohort||0
7884244|NCT00790842|19403290|P7|COMPLETED|Expansion Cohort||1
7884245|NCT00790842|19403291|P6|COMPLETED|Expansion Cohort||0
7884246|NCT00790842|19403292|P5|COMPLETED|Expansion Cohort||0
7884247|NCT00790842|19403293|P4|COMPLETED|Expansion Cohort||0
7884248|NCT00790842|19403294|P3|COMPLETED|Expansion Cohort||7
7884249|NCT00790842|19403295|P2|COMPLETED|Expansion Cohort||0
7884250|NCT00790842|19403296|P1|COMPLETED|Expansion Cohort||0
7884251|NCT00790842|19403286|P11|Began Treatment|Expansion Cohort||0
7884252|NCT00790842|19403287|P10|Began Treatment|Expansion Cohort||0
7884253|NCT00790842|19403288|P9|Began Treatment|Expansion Cohort||0
7884254|NCT00790842|19403289|P8|Began Treatment|Expansion Cohort||0
7884255|NCT00790842|19403290|P7|Began Treatment|Expansion Cohort||2
7884256|NCT00790842|19403291|P6|Began Treatment|Expansion Cohort||0
7884257|NCT00790842|19403292|P5|Began Treatment|Expansion Cohort||0
7884258|NCT00790842|19403293|P4|Began Treatment|Expansion Cohort||0
7884259|NCT00790842|19403294|P3|Began Treatment|Expansion Cohort||14
7884260|NCT00790842|19403295|P2|Began Treatment|Expansion Cohort||0
7884261|NCT00790842|19403296|P1|Began Treatment|Expansion Cohort||0
7884262|NCT00790842|19403286|P11|STARTED|Expansion Cohort||0
7884263|NCT00790842|19403287|P10|STARTED|Expansion Cohort||0
7884264|NCT00790842|19403288|P9|STARTED|Expansion Cohort||0
7884265|NCT00790842|19403289|P8|STARTED|Expansion Cohort||0
7884266|NCT00790842|19403290|P7|STARTED|Expansion Cohort||2
7884267|NCT00790842|19403291|P6|STARTED|Expansion Cohort||0
7884268|NCT00790842|19403292|P5|STARTED|Expansion Cohort||0
7884269|NCT00790842|19403293|P4|STARTED|Expansion Cohort||0
7884270|NCT00790842|19403294|P3|STARTED|Expansion Cohort||14
7884271|NCT00790842|19403295|P2|STARTED|Expansion Cohort||0
7884272|NCT00790842|19403296|P1|STARTED|Expansion Cohort||0
7884273|NCT00790842|19403286|P11|NOT COMPLETED|Dose Level 4||2
7884274|NCT00790842|19403287|P10|NOT COMPLETED|Dose Level 4||0
7884275|NCT00790842|19403288|P9|NOT COMPLETED|Dose Level 4||0
7884276|NCT00790842|19403289|P8|NOT COMPLETED|Dose Level 4||0
7884277|NCT00790842|19403290|P7|NOT COMPLETED|Dose Level 4||2
7884278|NCT00790842|19403291|P6|NOT COMPLETED|Dose Level 4||0
7884279|NCT00790842|19403292|P5|NOT COMPLETED|Dose Level 4||0
7884280|NCT00790842|19403293|P4|NOT COMPLETED|Dose Level 4||0
7884281|NCT00790842|19403294|P3|NOT COMPLETED|Dose Level 4||0
7884282|NCT00790842|19403295|P2|NOT COMPLETED|Dose Level 4||0
7884283|NCT00790842|19403296|P1|NOT COMPLETED|Dose Level 4||0
7884284|NCT00790842|19403286|P11|COMPLETED|Dose Level 4||3
7884285|NCT00790842|19403287|P10|COMPLETED|Dose Level 4||0
7884286|NCT00790842|19403288|P9|COMPLETED|Dose Level 4||0
7884287|NCT00790842|19403289|P8|COMPLETED|Dose Level 4||0
7884288|NCT00790842|19403290|P7|COMPLETED|Dose Level 4||6
7884289|NCT00790842|19403291|P6|COMPLETED|Dose Level 4||0
7884290|NCT00790842|19403292|P5|COMPLETED|Dose Level 4||0
7884291|NCT00790842|19403293|P4|COMPLETED|Dose Level 4||0
7884292|NCT00790842|19403294|P3|COMPLETED|Dose Level 4||0
7884293|NCT00790842|19403295|P2|COMPLETED|Dose Level 4||0
7884294|NCT00790842|19403296|P1|COMPLETED|Dose Level 4||0
7884295|NCT00790842|19403286|P11|Began Treatment|Dose Level 4||5
7884296|NCT00790842|19403287|P10|Began Treatment|Dose Level 4||0
7884297|NCT00790842|19403288|P9|Began Treatment|Dose Level 4||0
7884298|NCT00790842|19403289|P8|Began Treatment|Dose Level 4||0
7884299|NCT00790842|19403290|P7|Began Treatment|Dose Level 4||8
7884300|NCT00790842|19403291|P6|Began Treatment|Dose Level 4||0
7884301|NCT00790842|19403292|P5|Began Treatment|Dose Level 4||0
7884302|NCT00790842|19403293|P4|Began Treatment|Dose Level 4||0
7884303|NCT00790842|19403294|P3|Began Treatment|Dose Level 4||0
7884304|NCT00790842|19403295|P2|Began Treatment|Dose Level 4||0
7884305|NCT00790842|19403296|P1|Began Treatment|Dose Level 4||0
7884306|NCT00790842|19403286|P11|STARTED|Dose Level 4||5
7884307|NCT00790842|19403287|P10|STARTED|Dose Level 4||0
7884308|NCT00790842|19403288|P9|STARTED|Dose Level 4||0
7884309|NCT00790842|19403289|P8|STARTED|Dose Level 4||0
7884310|NCT00790842|19403290|P7|STARTED|Dose Level 4||8
7884311|NCT00790842|19403291|P6|STARTED|Dose Level 4||0
7884312|NCT00790842|19403292|P5|STARTED|Dose Level 4||0
7884313|NCT00790842|19403293|P4|STARTED|Dose Level 4||0
7884314|NCT00790842|19403294|P3|STARTED|Dose Level 4||0
7884315|NCT00790842|19403295|P2|STARTED|Dose Level 4||0
7884316|NCT00790842|19403296|P1|STARTED|Dose Level 4||0
7884317|NCT00790842|19403286|P11|NOT COMPLETED|Dose Level 3||0
7884318|NCT00790842|19403287|P10|NOT COMPLETED|Dose Level 3||2
7884319|NCT00790842|19403288|P9|NOT COMPLETED|Dose Level 3||0
7884320|NCT00790842|19403289|P8|NOT COMPLETED|Dose Level 3||0
7884321|NCT00790842|19403290|P7|NOT COMPLETED|Dose Level 3||0
7884322|NCT00790842|19403291|P6|NOT COMPLETED|Dose Level 3||1
7884323|NCT00790842|19403292|P5|NOT COMPLETED|Dose Level 3||0
7884324|NCT00790842|19403293|P4|NOT COMPLETED|Dose Level 3||0
7884325|NCT00790842|19403294|P3|NOT COMPLETED|Dose Level 3||5
7884326|NCT00790842|19403295|P2|NOT COMPLETED|Dose Level 3||0
7884327|NCT00790842|19403296|P1|NOT COMPLETED|Dose Level 3||0
7884328|NCT00790842|19403286|P11|COMPLETED|Dose Level 3||0
7884329|NCT00790842|19403287|P10|COMPLETED|Dose Level 3||1
7884330|NCT00790842|19403288|P9|COMPLETED|Dose Level 3||0
7884331|NCT00790842|19403289|P8|COMPLETED|Dose Level 3||0
7884332|NCT00790842|19403290|P7|COMPLETED|Dose Level 3||0
7884333|NCT00790842|19403291|P6|COMPLETED|Dose Level 3||2
7884334|NCT00790842|19403292|P5|COMPLETED|Dose Level 3||0
7884335|NCT00790842|19403293|P4|COMPLETED|Dose Level 3||0
7884336|NCT00790842|19403294|P3|COMPLETED|Dose Level 3||2
7884337|NCT00790842|19403295|P2|COMPLETED|Dose Level 3||0
7884338|NCT00790842|19403296|P1|COMPLETED|Dose Level 3||0
7884339|NCT00790842|19403286|P11|Began Treatment|Dose Level 3||0
7884340|NCT00790842|19403287|P10|Began Treatment|Dose Level 3||3
7884341|NCT00790842|19403288|P9|Began Treatment|Dose Level 3||0
7884342|NCT00790842|19403289|P8|Began Treatment|Dose Level 3||0
7884343|NCT00790842|19403290|P7|Began Treatment|Dose Level 3||0
7884344|NCT00790842|19403291|P6|Began Treatment|Dose Level 3||3
7884345|NCT00790842|19403292|P5|Began Treatment|Dose Level 3||0
7884346|NCT00790842|19403293|P4|Began Treatment|Dose Level 3||0
7884347|NCT00790842|19403294|P3|Began Treatment|Dose Level 3||6
7884348|NCT00790842|19403295|P2|Began Treatment|Dose Level 3||0
7884349|NCT00790842|19403296|P1|Began Treatment|Dose Level 3||0
7884350|NCT00790842|19403286|P11|STARTED|Dose Level 3||0
7884351|NCT00790842|19403287|P10|STARTED|Dose Level 3||3
7884352|NCT00790842|19403288|P9|STARTED|Dose Level 3||0
7884353|NCT00790842|19403289|P8|STARTED|Dose Level 3||0
7884354|NCT00790842|19403290|P7|STARTED|Dose Level 3||0
7884355|NCT00790842|19403291|P6|STARTED|Dose Level 3||3
7884356|NCT00790842|19403292|P5|STARTED|Dose Level 3||0
7884357|NCT00790842|19403293|P4|STARTED|Dose Level 3||0
7884358|NCT00790842|19403294|P3|STARTED|Dose Level 3||7
7884359|NCT00790842|19403295|P2|STARTED|Dose Level 3||0
7884360|NCT00790842|19403296|P1|STARTED|Dose Level 3||0
7884361|NCT00790842|19403286|P11|NOT COMPLETED|Dose Level 2||0
7884362|NCT00790842|19403287|P10|NOT COMPLETED|Dose Level 2||0
7884363|NCT00790842|19403288|P9|NOT COMPLETED|Dose Level 2||2
7884364|NCT00790842|19403289|P8|NOT COMPLETED|Dose Level 2||0
7884365|NCT00790842|19403290|P7|NOT COMPLETED|Dose Level 2||0
7884366|NCT00790842|19403291|P6|NOT COMPLETED|Dose Level 2||0
7884367|NCT00790842|19403292|P5|NOT COMPLETED|Dose Level 2||1
7884368|NCT00790842|19403293|P4|NOT COMPLETED|Dose Level 2||0
7884369|NCT00790842|19403294|P3|NOT COMPLETED|Dose Level 2||0
7884370|NCT00790842|19403295|P2|NOT COMPLETED|Dose Level 2||3
7884371|NCT00790842|19403296|P1|NOT COMPLETED|Dose Level 2||0
7884372|NCT00790842|19403286|P11|COMPLETED|Dose Level 2||0
7884373|NCT00790842|19403287|P10|COMPLETED|Dose Level 2||0
7884374|NCT00790842|19403288|P9|COMPLETED|Dose Level 2||1
7884375|NCT00790842|19403289|P8|COMPLETED|Dose Level 2||0
7884376|NCT00790842|19403290|P7|COMPLETED|Dose Level 2||0
7884377|NCT00790842|19403291|P6|COMPLETED|Dose Level 2||0
7884378|NCT00790842|19403292|P5|COMPLETED|Dose Level 2||2
7884379|NCT00790842|19403293|P4|COMPLETED|Dose Level 2||0
7884380|NCT00790842|19403294|P3|COMPLETED|Dose Level 2||0
7884381|NCT00790842|19403295|P2|COMPLETED|Dose Level 2||0
7884382|NCT00790842|19403296|P1|COMPLETED|Dose Level 2||0
7884383|NCT00790842|19403286|P11|Began Treatment|Dose Level 2||0
7884384|NCT00790842|19403287|P10|Began Treatment|Dose Level 2||0
7884385|NCT00790842|19403288|P9|Began Treatment|Dose Level 2||3
7884386|NCT00790842|19403289|P8|Began Treatment|Dose Level 2||0
7884387|NCT00790842|19403290|P7|Began Treatment|Dose Level 2||0
7884388|NCT00790842|19403291|P6|Began Treatment|Dose Level 2||0
7884389|NCT00790842|19403292|P5|Began Treatment|Dose Level 2||3
7884390|NCT00790842|19403293|P4|Began Treatment|Dose Level 2||0
7884391|NCT00790842|19403294|P3|Began Treatment|Dose Level 2||0
7884392|NCT00790842|19403295|P2|Began Treatment|Dose Level 2||3
7884393|NCT00790842|19403296|P1|Began Treatment|Dose Level 2||0
7884394|NCT00790842|19403286|P11|STARTED|Dose Level 2||0
7884395|NCT00790842|19403287|P10|STARTED|Dose Level 2||0
7884396|NCT00790842|19403288|P9|STARTED|Dose Level 2||3
7884397|NCT00790842|19403289|P8|STARTED|Dose Level 2||0
7884398|NCT00790842|19403290|P7|STARTED|Dose Level 2||0
7884399|NCT00790842|19403291|P6|STARTED|Dose Level 2||0
7884400|NCT00790842|19403292|P5|STARTED|Dose Level 2||3
7884401|NCT00790842|19403293|P4|STARTED|Dose Level 2||0
7884402|NCT00790842|19403294|P3|STARTED|Dose Level 2||0
7884403|NCT00790842|19403295|P2|STARTED|Dose Level 2||3
7884404|NCT00790842|19403296|P1|STARTED|Dose Level 2||0
7884405|NCT00790842|19403286|P11|NOT COMPLETED|Dose Level 1||0
7884406|NCT00790842|19403287|P10|NOT COMPLETED|Dose Level 1||0
7884407|NCT00790842|19403288|P9|NOT COMPLETED|Dose Level 1||0
7884408|NCT00790842|19403289|P8|NOT COMPLETED|Dose Level 1||2
7884409|NCT00790842|19403290|P7|NOT COMPLETED|Dose Level 1||0
7884410|NCT00790842|19403291|P6|NOT COMPLETED|Dose Level 1||0
7884411|NCT00790842|19403292|P5|NOT COMPLETED|Dose Level 1||0
7884412|NCT00790842|19403293|P4|NOT COMPLETED|Dose Level 1||2
7884413|NCT00790842|19403294|P3|NOT COMPLETED|Dose Level 1||0
7884414|NCT00790842|19403295|P2|NOT COMPLETED|Dose Level 1||0
7884415|NCT00790842|19403296|P1|NOT COMPLETED|Dose Level 1||3
7884416|NCT00790842|19403286|P11|COMPLETED|Dose Level 1||0
7884417|NCT00790842|19403287|P10|COMPLETED|Dose Level 1||0
7884418|NCT00790842|19403288|P9|COMPLETED|Dose Level 1||0
7884419|NCT00790842|19403289|P8|COMPLETED|Dose Level 1||1
7884420|NCT00790842|19403290|P7|COMPLETED|Dose Level 1||0
7884421|NCT00790842|19403291|P6|COMPLETED|Dose Level 1||0
7884422|NCT00790842|19403292|P5|COMPLETED|Dose Level 1||0
7884423|NCT00790842|19403293|P4|COMPLETED|Dose Level 1||1
7884424|NCT00790842|19403294|P3|COMPLETED|Dose Level 1||0
7884425|NCT00790842|19403295|P2|COMPLETED|Dose Level 1||0
7884426|NCT00790842|19403296|P1|COMPLETED|Dose Level 1||3
7884427|NCT00790842|19403286|P11|Began Treatment|Dose Level 1||0
7884428|NCT00790842|19403287|P10|Began Treatment|Dose Level 1||0
7884429|NCT00790842|19403288|P9|Began Treatment|Dose Level 1||0
7884430|NCT00790842|19403289|P8|Began Treatment|Dose Level 1||3
7884431|NCT00790842|19403290|P7|Began Treatment|Dose Level 1||0
7884432|NCT00790842|19403291|P6|Began Treatment|Dose Level 1||0
7884433|NCT00790842|19403292|P5|Began Treatment|Dose Level 1||0
7884434|NCT00790842|19403293|P4|Began Treatment|Dose Level 1||3
7884435|NCT00790842|19403294|P3|Began Treatment|Dose Level 1||0
7884436|NCT00790842|19403295|P2|Began Treatment|Dose Level 1||0
7884437|NCT00790842|19403296|P1|Began Treatment|Dose Level 1||6
7884438|NCT00790842|19403286|P11|STARTED|Dose Level 1||0
7884439|NCT00790842|19403287|P10|STARTED|Dose Level 1||0
7884440|NCT00790842|19403288|P9|STARTED|Dose Level 1||0
7884441|NCT00790842|19403289|P8|STARTED|Dose Level 1||3
7884442|NCT00790842|19403290|P7|STARTED|Dose Level 1||0
7884443|NCT00790842|19403291|P6|STARTED|Dose Level 1||0
7884444|NCT00790842|19403292|P5|STARTED|Dose Level 1||0
7884445|NCT00790842|19403293|P4|STARTED|Dose Level 1||3
7884446|NCT00790842|19403294|P3|STARTED|Dose Level 1||0
7884447|NCT00790842|19403295|P2|STARTED|Dose Level 1||0
7884448|NCT00790842|19403296|P1|STARTED|Dose Level 1||6
7884449|NCT00790803|19403353|P1|NOT COMPLETED|Overall Study||0
7884450|NCT00790803|19403353|P1|COMPLETED|Overall Study||5
7884451|NCT00790803|19403353|P1|STARTED|Overall Study||5
7884452|NCT00790790|19403364|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
7884453|NCT00790790|19403365|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
7884454|NCT00790790|19403366|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
7884455|NCT00790790|19403364|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||26
7884456|NCT00790790|19403365|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||31
7884457|NCT00790790|19403366|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||37
7884458|NCT00790790|19403364|P3|STARTED|Study Period 3: 1-Week Washout Phase||27
7884459|NCT00790790|19403365|P2|STARTED|Study Period 3: 1-Week Washout Phase||32
7884460|NCT00790790|19403366|P1|STARTED|Study Period 3: 1-Week Washout Phase||37
7884461|NCT00790790|19403364|P3|NOT COMPLETED|Study Period 2: Therapy Phase||21
7884462|NCT00790790|19403365|P2|NOT COMPLETED|Study Period 2: Therapy Phase||18
7884463|NCT00790790|19403366|P1|NOT COMPLETED|Study Period 2: Therapy Phase||12
7884464|NCT00790790|19403364|P3|COMPLETED|Study Period 2: Therapy Phase||27
7884465|NCT00790790|19403365|P2|COMPLETED|Study Period 2: Therapy Phase||32
7884466|NCT00790790|19403366|P1|COMPLETED|Study Period 2: Therapy Phase||37
7884467|NCT00790790|19403364|P3|STARTED|Study Period 2: Therapy Phase||48
7884468|NCT00790790|19403365|P2|STARTED|Study Period 2: Therapy Phase||50
7884469|NCT00790790|19403366|P1|STARTED|Study Period 2: Therapy Phase||49
7884470|NCT00790751|19403443|P4|NOT COMPLETED|Overall Study||21
7884471|NCT00790751|19403444|P3|NOT COMPLETED|Overall Study||20
7884472|NCT00790751|19403445|P2|NOT COMPLETED|Overall Study||30
7884473|NCT00790751|19403446|P1|NOT COMPLETED|Overall Study||25
7884474|NCT00790751|19403443|P4|COMPLETED|Overall Study||141
7884475|NCT00790751|19403444|P3|COMPLETED|Overall Study||141
7884476|NCT00790751|19403445|P2|COMPLETED|Overall Study||131
7884477|NCT00790751|19403446|P1|COMPLETED|Overall Study||137
7884478|NCT00790751|19403443|P4|STARTED|Overall Study||162
7884479|NCT00790751|19403444|P3|STARTED|Overall Study||161
7884480|NCT00790751|19403445|P2|STARTED|Overall Study||161
7884481|NCT00790751|19403446|P1|STARTED|Overall Study||162
7884482|NCT00790738|19403466|P2|NOT COMPLETED|Overall Study||3
7884483|NCT00790738|19403467|P1|NOT COMPLETED|Overall Study||2
7884484|NCT00790738|19403466|P2|COMPLETED|Overall Study||3
7884485|NCT00790738|19403467|P1|COMPLETED|Overall Study||3
7884486|NCT00790738|19403466|P2|STARTED|Overall Study||6
7884487|NCT00790738|19403467|P1|STARTED|Overall Study||5
7884488|NCT00790699|19403479|P2|NOT COMPLETED|Overall Study||0
7884489|NCT00790699|19403480|P1|NOT COMPLETED|Overall Study||1
7884490|NCT00790699|19403479|P2|COMPLETED|Overall Study||14
7884491|NCT00790699|19403480|P1|COMPLETED|Overall Study||16
7884492|NCT00790699|19403479|P2|STARTED|Overall Study||14
7884493|NCT00790699|19403480|P1|STARTED|Overall Study||17
7884494|NCT00790673|19403492|P4|NOT COMPLETED|Overall Study||0
7884495|NCT00790673|19403493|P3|NOT COMPLETED|Overall Study||0
7884496|NCT00790673|19403494|P2|NOT COMPLETED|Overall Study||0
7884497|NCT00790673|19403495|P1|NOT COMPLETED|Overall Study||0
7884498|NCT00790673|19403492|P4|COMPLETED|Overall Study||8
7884499|NCT00790673|19403493|P3|COMPLETED|Overall Study||12
7884500|NCT00790673|19403494|P2|COMPLETED|Overall Study||6
7884501|NCT00790673|19403495|P1|COMPLETED|Overall Study||6
7884502|NCT00790673|19403492|P4|STARTED|Overall Study||8
7884503|NCT00790673|19403493|P3|STARTED|Overall Study||12
7884504|NCT00790673|19403494|P2|STARTED|Overall Study||6
7884505|NCT00790673|19403495|P1|STARTED|Overall Study||6
7884506|NCT00790647|19403505|P1|NOT COMPLETED|Overall Study||1
7884507|NCT00790647|19403505|P1|COMPLETED|Overall Study||9
7884508|NCT00790647|19403505|P1|STARTED|Overall Study||10
7884509|NCT00790582|19403514|P2|NOT COMPLETED|Overall Study||87
7884510|NCT00790582|19403515|P1|NOT COMPLETED|Overall Study||31
7884511|NCT00790582|19403514|P2|COMPLETED|Overall Study||162
7884512|NCT00790582|19403515|P1|COMPLETED|Overall Study||78
7884513|NCT00790582|19403514|P2|STARTED|Overall Study||249
7884514|NCT00790582|19403515|P1|STARTED|Overall Study||109
7884515|NCT00790569|19403526|P3|NOT COMPLETED|End of Study (12 Month Interview)||50
7884516|NCT00790569|19403527|P2|NOT COMPLETED|End of Study (12 Month Interview)||19
7884517|NCT00790569|19403528|P1|NOT COMPLETED|End of Study (12 Month Interview)||66
7884518|NCT00790569|19403526|P3|COMPLETED|End of Study (12 Month Interview)||83
7884519|NCT00790569|19403527|P2|COMPLETED|End of Study (12 Month Interview)||26
7884520|NCT00790569|19403528|P1|COMPLETED|End of Study (12 Month Interview)||71
7884521|NCT00790569|19403526|P3|STARTED|End of Study (12 Month Interview)||133
7884522|NCT00790569|19403527|P2|STARTED|End of Study (12 Month Interview)||45
7884523|NCT00790569|19403528|P1|STARTED|End of Study (12 Month Interview)||137
7884524|NCT00790569|19403526|P3|NOT COMPLETED|End of Treatment (6 Month Interview)||26
7884525|NCT00790569|19403527|P2|NOT COMPLETED|End of Treatment (6 Month Interview)||10
7884526|NCT00790569|19403528|P1|NOT COMPLETED|End of Treatment (6 Month Interview)||22
7884527|NCT00790569|19403526|P3|COMPLETED|End of Treatment (6 Month Interview)||107
7884528|NCT00790569|19403527|P2|COMPLETED|End of Treatment (6 Month Interview)||35
7884529|NCT00790569|19403528|P1|COMPLETED|End of Treatment (6 Month Interview)||115
7884530|NCT00790569|19403526|P3|STARTED|End of Treatment (6 Month Interview)||133
7884531|NCT00790569|19403527|P2|STARTED|End of Treatment (6 Month Interview)||45
7884532|NCT00790569|19403528|P1|STARTED|End of Treatment (6 Month Interview)||137
7884533|NCT00790556|19403569|P2|NOT COMPLETED|Treatment Period 2||0
7884534|NCT00790556|19403570|P1|NOT COMPLETED|Treatment Period 2||0
7884535|NCT00790556|19403569|P2|COMPLETED|Treatment Period 2||6
7884536|NCT00790556|19403570|P1|COMPLETED|Treatment Period 2||6
7884537|NCT00790556|19403569|P2|STARTED|Treatment Period 2||6
7884538|NCT00790556|19403570|P1|STARTED|Treatment Period 2||6
7884539|NCT00790556|19403569|P2|NOT COMPLETED|Washout After Period 1||0
7884540|NCT00790556|19403570|P1|NOT COMPLETED|Washout After Period 1||0
7884541|NCT00790556|19403569|P2|COMPLETED|Washout After Period 1||6
7884542|NCT00790556|19403570|P1|COMPLETED|Washout After Period 1||6
7884543|NCT00790556|19403569|P2|STARTED|Washout After Period 1||6
7884544|NCT00790556|19403570|P1|STARTED|Washout After Period 1||6
7884545|NCT00790556|19403569|P2|NOT COMPLETED|Treatment Period 1||0
7884546|NCT00790556|19403570|P1|NOT COMPLETED|Treatment Period 1||2
7884547|NCT00790556|19403569|P2|COMPLETED|Treatment Period 1||6
7884548|NCT00790556|19403570|P1|COMPLETED|Treatment Period 1||6
7884549|NCT00790556|19403569|P2|STARTED|Treatment Period 1||6
7884550|NCT00790556|19403570|P1|STARTED|Treatment Period 1||8
7884551|NCT00790452|19403582|P2|NOT COMPLETED|Overall Study||0
7884552|NCT00790452|19403583|P1|NOT COMPLETED|Overall Study||1
7884553|NCT00790452|19403582|P2|COMPLETED|Overall Study||0
7884554|NCT00790452|19403583|P1|COMPLETED|Overall Study||0
7884555|NCT00790452|19403582|P2|STARTED|Overall Study||0
7884556|NCT00790452|19403583|P1|STARTED|Overall Study||1
7884557|NCT00790400|19403591|P2|NOT COMPLETED|Everolimus Period (Core or Extension)||0
7884558|NCT00790400|19403592|P1|NOT COMPLETED|Everolimus Period (Core or Extension)||29
7884559|NCT00790400|19403591|P2|COMPLETED|Everolimus Period (Core or Extension)||0
7884560|NCT00790400|19403592|P1|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83
7884561|NCT00790400|19403591|P2|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0
7884562|NCT00790400|19403592|P1|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112
7884563|NCT00790400|19403591|P2|NOT COMPLETED|Double-blind Period (Core Phase)||13
7884564|NCT00790400|19403592|P1|NOT COMPLETED|Double-blind Period (Core Phase)||7
7884565|NCT00790400|19403591|P2|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26
7884566|NCT00790400|19403592|P1|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72
7884567|NCT00790400|19403591|P2|STARTED|Double-blind Period (Core Phase)||39
7884568|NCT00790400|19403592|P1|STARTED|Double-blind Period (Core Phase)||79
7884569|NCT00790335|19403621|P2|NOT COMPLETED|Overall Study||112
7884570|NCT00790335|19403622|P1|NOT COMPLETED|Overall Study||80
7884571|NCT00790335|19403621|P2|COMPLETED|Overall Study||243
7884572|NCT00790335|19403622|P1|COMPLETED|Overall Study||257
7884573|NCT00790335|19403621|P2|STARTED|Overall Study||355
7884574|NCT00790335|19403622|P1|STARTED|Overall Study||337
7884575|NCT00790296|19403682|P2|NOT COMPLETED|Overall Study||2
7884576|NCT00790296|19403683|P1|NOT COMPLETED|Overall Study||1
7884577|NCT00790296|19403682|P2|COMPLETED|Overall Study||4
7884578|NCT00790296|19403683|P1|COMPLETED|Overall Study||4
7884579|NCT00790296|19403682|P2|STARTED|Overall Study||6
7884580|NCT00790296|19403683|P1|STARTED|Overall Study||5
7884581|NCT00790270|19403692|P3|NOT COMPLETED|Overall Study||0
7884582|NCT00790270|19403693|P2|NOT COMPLETED|Overall Study||0
7884583|NCT00790270|19403694|P1|NOT COMPLETED|Overall Study||0
7884584|NCT00790270|19403692|P3|COMPLETED|Overall Study||20
7884585|NCT00790270|19403693|P2|COMPLETED|Overall Study||20
7884586|NCT00790270|19403694|P1|COMPLETED|Overall Study||21
7884587|NCT00790270|19403692|P3|STARTED|Overall Study||20
7884588|NCT00790270|19403693|P2|STARTED|Overall Study||20
7884589|NCT00790270|19403694|P1|STARTED|Overall Study||21
7884590|NCT00790218|19403705|P3|NOT COMPLETED|Overall Study||0
7884591|NCT00790218|19403706|P2|NOT COMPLETED|Overall Study||0
7884592|NCT00790218|19403707|P1|NOT COMPLETED|Overall Study||1
7884593|NCT00790218|19403705|P3|COMPLETED|Overall Study||7
7884594|NCT00790218|19403706|P2|COMPLETED|Overall Study||6
7884595|NCT00790218|19403707|P1|COMPLETED|Overall Study||5
7884596|NCT00790218|19403705|P3|STARTED|Overall Study||7
7884597|NCT00790218|19403706|P2|STARTED|Overall Study||6
7884598|NCT00790218|19403707|P1|STARTED|Overall Study||6
7884599|NCT00790205|19403717|P2|NOT COMPLETED|Overall Study||434
7884600|NCT00790205|19403718|P1|NOT COMPLETED|Overall Study||360
7884601|NCT00790205|19403717|P2|COMPLETED|Overall Study||6905
7884602|NCT00790205|19403718|P1|COMPLETED|Overall Study||6972
7884603|NCT00790205|19403717|P2|Treated|Overall Study||7274
7884604|NCT00790205|19403718|P1|Treated|Overall Study||7266
7884605|NCT00790205|19403717|P2|STARTED|Overall Study||7339
7884606|NCT00790205|19403718|P1|STARTED|Overall Study||7332
7884607|NCT00790192|19403762|P4|NOT COMPLETED|Overall Study||48
7884608|NCT00790192|19403763|P3|NOT COMPLETED|Overall Study||23
7884609|NCT00790192|19403764|P2|NOT COMPLETED|Overall Study||28
7884610|NCT00790192|19403765|P1|NOT COMPLETED|Overall Study||36
7884611|NCT00790192|19403762|P4|COMPLETED|Overall Study||74
7884612|NCT00790192|19403763|P3|COMPLETED|Overall Study||97
7884613|NCT00790192|19403764|P2|COMPLETED|Overall Study||93
7884614|NCT00790192|19403765|P1|COMPLETED|Overall Study||89
7884615|NCT00790192|19403762|P4|STARTED|Overall Study||122
7884616|NCT00790192|19403763|P3|STARTED|Overall Study||120
7884617|NCT00790192|19403764|P2|STARTED|Overall Study||121
7884618|NCT00790192|19403765|P1|STARTED|Overall Study||125
7884619|NCT00790088|19403779|P1|NOT COMPLETED|Overall Study||39
7884620|NCT00790088|19403779|P1|COMPLETED|Overall Study||235
7884621|NCT00790088|19403779|P1|Eligible for Data Analysis|Overall Study|Number of participants minus 11 protocol violation|263
7884622|NCT00790088|19403779|P1|STARTED|Overall Study||274
7884623|NCT00790062|19403792|P3|NOT COMPLETED|Overall Study||0
7884624|NCT00790062|19403793|P2|NOT COMPLETED|Overall Study||0
7884625|NCT00790062|19403794|P1|NOT COMPLETED|Overall Study||0
7884626|NCT00790062|19403792|P3|COMPLETED|Overall Study||658
7884627|NCT00790062|19403793|P2|COMPLETED|Overall Study||481
7884628|NCT00790062|19403794|P1|COMPLETED|Overall Study||659
7884629|NCT00790062|19403792|P3|STARTED|Overall Study||658
7884630|NCT00790062|19403793|P2|STARTED|Overall Study||481
7884631|NCT00790062|19403794|P1|STARTED|Overall Study||659
7884632|NCT00790036|19403825|P2|NOT COMPLETED|Overall Study||121
7884633|NCT00790036|19403826|P1|NOT COMPLETED|Overall Study||195
7884634|NCT00790036|19403825|P2|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|249
7884635|NCT00790036|19403826|P1|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|177
7884636|NCT00790036|19403825|P2|Untreated Participants|Overall Study|not treated due to administrative problems and subject withdrawal of consent.|6
7884637|NCT00790036|19403826|P1|Untreated Participants|Overall Study|not treated due to administrative problems, protocol deviation, and subject withdrawal of consent.|4
7884638|NCT00790036|19403825|P2|STARTED|Overall Study||370
7884639|NCT00790036|19403826|P1|STARTED|Overall Study||372
7884640|NCT00790023|19403840|P3|NOT COMPLETED|Overall Study||21
7884641|NCT00790023|19403841|P2|NOT COMPLETED|Overall Study||10
7884642|NCT00790023|19403842|P1|NOT COMPLETED|Overall Study||11
7884643|NCT00790023|19403840|P3|COMPLETED|Overall Study||214
7884644|NCT00790023|19403841|P2|COMPLETED|Overall Study||225
7884645|NCT00790023|19403842|P1|COMPLETED|Overall Study||226
7884646|NCT00790023|19403840|P3|STARTED|Overall Study||235
7884647|NCT00790023|19403841|P2|STARTED|Overall Study||235
7884648|NCT00790023|19403842|P1|STARTED|Overall Study||237
7884649|NCT00789997|19403932|P2|NOT COMPLETED|Overall Study||2
7884650|NCT00789997|19403933|P1|NOT COMPLETED|Overall Study||1
7884651|NCT00789997|19403932|P2|COMPLETED|Overall Study||38
7884652|NCT00789997|19403933|P1|COMPLETED|Overall Study||40
7884653|NCT00789997|19403932|P2|STARTED|Overall Study||40
7884654|NCT00789997|19403933|P1|STARTED|Overall Study||41
7884655|NCT00789958|19403941|P1|NOT COMPLETED|Overall Study||37
7884656|NCT00789958|19403941|P1|COMPLETED|Overall Study||68
7884657|NCT00789958|19403941|P1|Eligible and Analyzable|Overall Study||79
7884658|NCT00789958|19403941|P1|STARTED|Overall Study||105
7884659|NCT00789880|19403960|P6|NOT COMPLETED|Overall Study||0
7884660|NCT00789880|19403961|P5|NOT COMPLETED|Overall Study||3
7884661|NCT00789880|19403962|P4|NOT COMPLETED|Overall Study||1
7884662|NCT00789880|19403963|P3|NOT COMPLETED|Overall Study||0
7884663|NCT00789880|19403964|P2|NOT COMPLETED|Overall Study||1
7884664|NCT00789880|19403965|P1|NOT COMPLETED|Overall Study||1
7884665|NCT00789880|19403960|P6|COMPLETED|Overall Study||8
7884666|NCT00789880|19403961|P5|COMPLETED|Overall Study||15
7884667|NCT00789880|19403962|P4|COMPLETED|Overall Study||15
7884668|NCT00789880|19403963|P3|COMPLETED|Overall Study||8
7884669|NCT00789880|19403964|P2|COMPLETED|Overall Study||15
7884670|NCT00789880|19403965|P1|COMPLETED|Overall Study||15
7884671|NCT00789880|19403960|P6|STARTED|Overall Study||8
7884672|NCT00789880|19403961|P5|STARTED|Overall Study||18
7884673|NCT00789880|19403962|P4|STARTED|Overall Study||16
7884674|NCT00789880|19403963|P3|STARTED|Overall Study||8
7884675|NCT00789880|19403964|P2|STARTED|Overall Study||16
7884676|NCT00789880|19403965|P1|STARTED|Overall Study||16
7884677|NCT00789867|19403994|P3|NOT COMPLETED|Overall Study||0
7884678|NCT00789867|19403995|P2|NOT COMPLETED|Overall Study||0
7884679|NCT00789867|19403996|P1|NOT COMPLETED|Overall Study||0
7884680|NCT00789867|19403994|P3|COMPLETED|Overall Study||8
7884681|NCT00789867|19403995|P2|COMPLETED|Overall Study||10
7884682|NCT00789867|19403996|P1|COMPLETED|Overall Study||17
7884683|NCT00789867|19403994|P3|STARTED|Overall Study||8
7884684|NCT00789867|19403995|P2|STARTED|Overall Study||10
7884685|NCT00789867|19403996|P1|STARTED|Overall Study||17
7884686|NCT00789854|19404022|P3|NOT COMPLETED|Overall Study||47
7884687|NCT00789854|19404023|P2|NOT COMPLETED|Overall Study||35
7884688|NCT00789854|19404024|P1|NOT COMPLETED|Overall Study||49
7884689|NCT00789854|19404022|P3|COMPLETED|Overall Study||182
7884690|NCT00789854|19404023|P2|COMPLETED|Overall Study||196
7884691|NCT00789854|19404024|P1|COMPLETED|Overall Study||179
7884692|NCT00789854|19404022|P3|STARTED|Overall Study||229
7884693|NCT00789854|19404023|P2|STARTED|Overall Study||231
7884694|NCT00789854|19404024|P1|STARTED|Overall Study||228
7884695|NCT00789828|19404121|P2|NOT COMPLETED|Open-label Extension Period (4 Years)||0
7884696|NCT00789828|19404122|P1|NOT COMPLETED|Open-label Extension Period (4 Years)||29
7884697|NCT00789828|19404121|P2|COMPLETED|Open-label Extension Period (4 Years)||0
7884698|NCT00789828|19404122|P1|COMPLETED|Open-label Extension Period (4 Years)||82
7884699|NCT00789828|19404121|P2|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0
7884700|NCT00789828|19404122|P1|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111
7884701|NCT00789828|19404121|P2|NOT COMPLETED|Core Period (48 Weeks)||6
7884702|NCT00789828|19404122|P1|NOT COMPLETED|Core Period (48 Weeks)||0
7884703|NCT00789828|19404121|P2|COMPLETED|Core Period (48 Weeks)||33
7884704|NCT00789828|19404122|P1|COMPLETED|Core Period (48 Weeks)||78
7884705|NCT00789828|19404121|P2|STARTED|Core Period (48 Weeks)||39
7884706|NCT00789828|19404122|P1|STARTED|Core Period (48 Weeks)||78
7884707|NCT00789815|19404156|P2|NOT COMPLETED|Overall Study||1
7884708|NCT00789815|19404157|P1|NOT COMPLETED|Overall Study||7
7884709|NCT00789815|19404156|P2|COMPLETED|Overall Study||249
7884710|NCT00789815|19404157|P1|COMPLETED|Overall Study||243
7884711|NCT00789815|19404156|P2|STARTED|Overall Study||250
7884712|NCT00789815|19404157|P1|STARTED|Overall Study||250
7884713|NCT00789802|19404180|P3|NOT COMPLETED|Overall Study||6
7884714|NCT00789802|19404181|P2|NOT COMPLETED|Overall Study||7
7884715|NCT00789802|19404182|P1|NOT COMPLETED|Overall Study||10
7884716|NCT00789802|19404180|P3|COMPLETED|Overall Study||37
7884717|NCT00789802|19404181|P2|COMPLETED|Overall Study||35
7884718|NCT00789802|19404182|P1|COMPLETED|Overall Study||34
7884719|NCT00789802|19404180|P3|STARTED|Overall Study||43
7884720|NCT00789802|19404181|P2|STARTED|Overall Study||42
7884721|NCT00789802|19404182|P1|STARTED|Overall Study||44
7884722|NCT00789776|19404201|P2|NOT COMPLETED|Overall Study||1
7884723|NCT00789776|19404202|P1|NOT COMPLETED|Overall Study||0
7884724|NCT00789776|19404201|P2|COMPLETED|Overall Study||35
7884725|NCT00789776|19404202|P1|COMPLETED|Overall Study||5
7884726|NCT00789776|19404201|P2|STARTED|Overall Study||36
7884727|NCT00789776|19404202|P1|STARTED|Overall Study||5
7884728|NCT00789750|19404222|P2|NOT COMPLETED|Overall Study||60
7884729|NCT00789750|19404223|P1|NOT COMPLETED|Overall Study||59
7884730|NCT00789750|19404222|P2|COMPLETED|Overall Study||222
7884731|NCT00789750|19404223|P1|COMPLETED|Overall Study||221
7884732|NCT00789750|19404222|P2|Intent to Treat Set|Overall Study||276
7884733|NCT00789750|19404223|P1|Intent to Treat Set|Overall Study||271
7884734|NCT00789750|19404222|P2|Safety Set|Overall Study||277
7884735|NCT00789750|19404223|P1|Safety Set|Overall Study||274
7884736|NCT00789750|19404222|P2|Dropped During run-in Period|Overall Study||5
7884737|NCT00789750|19404223|P1|Dropped During run-in Period|Overall Study||6
7884738|NCT00789750|19404222|P2|STARTED|Overall Study||282
7884739|NCT00789750|19404223|P1|STARTED|Overall Study||280
7884740|NCT00789737|19404267|P2|NOT COMPLETED|Overall Study||55
7884741|NCT00789737|19404268|P1|NOT COMPLETED|Overall Study||48
7884742|NCT00789737|19404267|P2|COMPLETED|Overall Study||126
7884743|NCT00789737|19404268|P1|COMPLETED|Overall Study||128
7884744|NCT00789737|19404267|P2|STARTED|Overall Study||181
7884745|NCT00789737|19404268|P1|STARTED|Overall Study||176
7884746|NCT00789724|19404300|P2|NOT COMPLETED|Overall Study||0
7884747|NCT00789724|19404301|P1|NOT COMPLETED|Overall Study||0
7884748|NCT00789724|19404300|P2|COMPLETED|Overall Study||5
7884749|NCT00789724|19404301|P1|COMPLETED|Overall Study||5
7884750|NCT00789724|19404300|P2|STARTED|Overall Study||5
7884751|NCT00789724|19404301|P1|STARTED|Overall Study||5
7884752|NCT00789698|19404311|P4|NOT COMPLETED|Overall Study||52
7884753|NCT00789698|19404312|P3|NOT COMPLETED|Overall Study||27
7884754|NCT00789698|19404313|P2|NOT COMPLETED|Overall Study||33
7884755|NCT00789698|19404314|P1|NOT COMPLETED|Overall Study||40
7884756|NCT00789698|19404311|P4|COMPLETED|Overall Study||33
7884757|NCT00789698|19404312|P3|COMPLETED|Overall Study||29
7884758|NCT00789698|19404313|P2|COMPLETED|Overall Study||46
7884759|NCT00789698|19404314|P1|COMPLETED|Overall Study||32
7884760|NCT00789698|19404311|P4|STARTED|Overall Study||85
7884761|NCT00789698|19404312|P3|STARTED|Overall Study||56
7884762|NCT00789698|19404313|P2|STARTED|Overall Study||79
7884763|NCT00789698|19404314|P1|STARTED|Overall Study||72
7884764|NCT00789685|19404328|P1|NOT COMPLETED|Overall Study||12
7884765|NCT00789685|19404328|P1|COMPLETED|Overall Study|Completed the study to Day 28|25
7884766|NCT00789685|19404328|P1|STARTED|Overall Study||37
7884767|NCT00789672|19404336|P2|NOT COMPLETED|Overall Study||0
7884768|NCT00789672|19404337|P1|NOT COMPLETED|Overall Study||0
7884769|NCT00789672|19404336|P2|COMPLETED|Overall Study||17
7884770|NCT00789672|19404337|P1|COMPLETED|Overall Study||16
7884771|NCT00789672|19404336|P2|STARTED|Overall Study||17
7884772|NCT00789672|19404337|P1|STARTED|Overall Study||16
7884773|NCT00789581|19404369|P2|NOT COMPLETED|Adjuvant Therapy||57
7884774|NCT00789581|19404370|P1|NOT COMPLETED|Adjuvant Therapy||40
7884775|NCT00789581|19404369|P2|COMPLETED|Adjuvant Therapy||234
7884776|NCT00789581|19404370|P1|COMPLETED|Adjuvant Therapy||255
7884777|NCT00789581|19404369|P2|STARTED|Adjuvant Therapy||291
7884778|NCT00789581|19404370|P1|STARTED|Adjuvant Therapy||295
7884779|NCT00789581|19404369|P2|NOT COMPLETED|AC Therapy||17
7884780|NCT00789581|19404370|P1|NOT COMPLETED|AC Therapy||11
7884781|NCT00789581|19404369|P2|COMPLETED|AC Therapy||291
7884782|NCT00789581|19404370|P1|COMPLETED|AC Therapy||295
7884783|NCT00789581|19404369|P2|STARTED|AC Therapy||308
7884784|NCT00789581|19404370|P1|STARTED|AC Therapy||306
7884785|NCT00789555|19404381|P3|NOT COMPLETED|Overall Study||159
7884786|NCT00789555|19404382|P2|NOT COMPLETED|Overall Study||139
7884787|NCT00789555|19404383|P1|NOT COMPLETED|Overall Study||159
7884788|NCT00789555|19404381|P3|COMPLETED|Overall Study||263
7884789|NCT00789555|19404382|P2|COMPLETED|Overall Study||278
7884790|NCT00789555|19404383|P1|COMPLETED|Overall Study||262
7884791|NCT00789555|19404381|P3|STARTED|Overall Study||422
7884792|NCT00789555|19404382|P2|STARTED|Overall Study||417
7884793|NCT00789555|19404383|P1|STARTED|Overall Study||421
7884794|NCT00789529|19404408|P2|NOT COMPLETED|Overall Study||1
7884795|NCT00789529|19404409|P1|NOT COMPLETED|Overall Study||1
7884796|NCT00789529|19404408|P2|COMPLETED|Overall Study||15
7884797|NCT00789529|19404409|P1|COMPLETED|Overall Study||15
7884798|NCT00789529|19404408|P2|STARTED|Overall Study||16
7884799|NCT00789529|19404409|P1|STARTED|Overall Study||16
7884800|NCT00789477|19404422|P5|NOT COMPLETED|Overall Study||7
7884801|NCT00789477|19404423|P4|NOT COMPLETED|Overall Study||10
7884802|NCT00789477|19404424|P3|NOT COMPLETED|Overall Study||11
7884803|NCT00789477|19404425|P2|NOT COMPLETED|Overall Study||6
7884804|NCT00789477|19404426|P1|NOT COMPLETED|Overall Study||11
7884805|NCT00789477|19404422|P5|COMPLETED|Overall Study||38
7884806|NCT00789477|19404423|P4|COMPLETED|Overall Study||34
7884807|NCT00789477|19404424|P3|COMPLETED|Overall Study||33
7884808|NCT00789477|19404425|P2|COMPLETED|Overall Study||38
7884809|NCT00789477|19404426|P1|COMPLETED|Overall Study||33
7884810|NCT00789477|19404422|P5|Participants Received Treatment|Overall Study|SAF|45
7884811|NCT00789477|19404423|P4|Participants Received Treatment|Overall Study|SAF|42
7884812|NCT00789477|19404424|P3|Participants Received Treatment|Overall Study|SAF|44
7884813|NCT00789477|19404425|P2|Participants Received Treatment|Overall Study|SAF|44
7884814|NCT00789477|19404426|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44
7884815|NCT00789477|19404422|P5|STARTED|Overall Study|randomized|45
7884816|NCT00789477|19404423|P4|STARTED|Overall Study|randomized|44
7884817|NCT00789477|19404424|P3|STARTED|Overall Study|randomized|44
7884818|NCT00789477|19404425|P2|STARTED|Overall Study|randomized|44
7884819|NCT00789477|19404426|P1|STARTED|Overall Study|randomized|44
7884820|NCT00789438|19404461|P3|NOT COMPLETED|Overall Study||0
7884821|NCT00789438|19404462|P2|NOT COMPLETED|Overall Study||0
7884822|NCT00789438|19404463|P1|NOT COMPLETED|Overall Study||0
7884823|NCT00789438|19404461|P3|COMPLETED|Overall Study||28
7884824|NCT00789438|19404462|P2|COMPLETED|Overall Study||20
7884825|NCT00789438|19404463|P1|COMPLETED|Overall Study||21
7884826|NCT00789438|19404461|P3|STARTED|Overall Study||28
7884827|NCT00789438|19404462|P2|STARTED|Overall Study||20
7884828|NCT00789438|19404463|P1|STARTED|Overall Study||21
7884829|NCT00789373|19404471|P3|NOT COMPLETED|Maintenance||180
7884830|NCT00789373|19404472|P2|NOT COMPLETED|Maintenance||359
7884831|NCT00789373|19404473|P1|NOT COMPLETED|Maintenance||0
7884832|NCT00789373|19404471|P3|COMPLETED|Maintenance||0
7884833|NCT00789373|19404472|P2|COMPLETED|Maintenance||0
7884834|NCT00789373|19404473|P1|COMPLETED|Maintenance||0
7884835|NCT00789373|19404471|P3|STARTED|Maintenance||180
7884836|NCT00789373|19404472|P2|STARTED|Maintenance||359
7884837|NCT00789373|19404473|P1|STARTED|Maintenance||0
7884838|NCT00789373|19404471|P3|NOT COMPLETED|Induction||0
7884839|NCT00789373|19404472|P2|NOT COMPLETED|Induction||0
7884840|NCT00789373|19404473|P1|NOT COMPLETED|Induction||399
7884841|NCT00789373|19404471|P3|COMPLETED|Induction||0
7884842|NCT00789373|19404472|P2|COMPLETED|Induction||0
7884843|NCT00789373|19404473|P1|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540
7884844|NCT00789373|19404471|P3|STARTED|Induction||0
7884845|NCT00789373|19404472|P2|STARTED|Induction||0
7884846|NCT00789373|19404473|P1|STARTED|Induction||939
7884847|NCT00789360|19404500|P2|NOT COMPLETED|Overall Study||1
7884848|NCT00789360|19404501|P1|NOT COMPLETED|Overall Study||3
7884849|NCT00789360|19404500|P2|COMPLETED|Overall Study||14
7884850|NCT00789360|19404501|P1|COMPLETED|Overall Study||12
7884851|NCT00789360|19404500|P2|STARTED|Overall Study||15
7884852|NCT00789360|19404501|P1|STARTED|Overall Study||15
7884853|NCT00789321|19404511|P2|NOT COMPLETED|Overall Study||1
7884854|NCT00789321|19404512|P1|NOT COMPLETED|Overall Study||0
7884855|NCT00789321|19404511|P2|COMPLETED|Overall Study||22
7884856|NCT00789321|19404512|P1|COMPLETED|Overall Study||24
7884857|NCT00789321|19404511|P2|STARTED|Overall Study||23
7884858|NCT00789321|19404512|P1|STARTED|Overall Study||24
7884859|NCT00789256|19404522|P2|NOT COMPLETED|Overall Study||0
7884860|NCT00789256|19404523|P1|NOT COMPLETED|Overall Study||0
7884861|NCT00789256|19404522|P2|COMPLETED|Overall Study||12
7884862|NCT00789256|19404523|P1|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14
7884863|NCT00789256|19404522|P2|STARTED|Overall Study||12
7884864|NCT00789256|19404523|P1|STARTED|Overall Study||14
7884865|NCT00789191|19404534|P2|NOT COMPLETED|Overall Study||19
7884866|NCT00789191|19404535|P1|NOT COMPLETED|Overall Study||14
7884867|NCT00789191|19404534|P2|COMPLETED|Overall Study||92
7884868|NCT00789191|19404535|P1|COMPLETED|Overall Study||97
7884869|NCT00789191|19404534|P2|Exposed|Overall Study|1 non-compliance|110
7884870|NCT00789191|19404535|P1|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107
7884871|NCT00789191|19404534|P2|STARTED|Overall Study||111
7884872|NCT00789191|19404535|P1|STARTED|Overall Study||111
7884873|NCT00789113|19404563|P1|NOT COMPLETED|Overall Study||0
7884874|NCT00789113|19404563|P1|COMPLETED|Overall Study||12
7884875|NCT00789113|19404563|P1|STARTED|Overall Study||12
7884876|NCT00789074|19404570|P2|NOT COMPLETED|Overall Study||13
7884877|NCT00789074|19404571|P1|NOT COMPLETED|Overall Study||11
7884878|NCT00789074|19404570|P2|COMPLETED|Overall Study||35
7884879|NCT00789074|19404571|P1|COMPLETED|Overall Study||42
7884880|NCT00789074|19404570|P2|STARTED|Overall Study||48
7884881|NCT00789074|19404571|P1|STARTED|Overall Study||53
7884882|NCT00789035|19404592|P5|NOT COMPLETED|Overall Study||6
7884883|NCT00789035|19404593|P4|NOT COMPLETED|Overall Study||1
7884884|NCT00789035|19404594|P3|NOT COMPLETED|Overall Study||1
7884885|NCT00789035|19404595|P2|NOT COMPLETED|Overall Study||7
7884886|NCT00789035|19404596|P1|NOT COMPLETED|Overall Study||6
7884887|NCT00789035|19404592|P5|COMPLETED|Overall Study||74
7884888|NCT00789035|19404593|P4|COMPLETED|Overall Study||81
7884889|NCT00789035|19404594|P3|COMPLETED|Overall Study||80
7884890|NCT00789035|19404595|P2|COMPLETED|Overall Study||74
7884891|NCT00789035|19404596|P1|COMPLETED|Overall Study||76
7884892|NCT00789035|19404592|P5|STARTED|Overall Study||80
7884893|NCT00789035|19404593|P4|STARTED|Overall Study||82
7884894|NCT00789035|19404594|P3|STARTED|Overall Study||81
7884895|NCT00789035|19404595|P2|STARTED|Overall Study||81
7884896|NCT00789035|19404596|P1|STARTED|Overall Study||82
7884897|NCT00788957|19404655|P6|NOT COMPLETED|Part 3||11
7884898|NCT00788957|19404656|P5|NOT COMPLETED|Part 3||9
7884899|NCT00788957|19404657|P4|NOT COMPLETED|Part 3||0
7884900|NCT00788957|19404658|P3|NOT COMPLETED|Part 3||0
7884901|NCT00788957|19404659|P2|NOT COMPLETED|Part 3||0
7884902|NCT00788957|19404660|P1|NOT COMPLETED|Part 3||0
7884903|NCT00788957|19404655|P6|COMPLETED|Part 3|Completed the safety follow-up visit|1
7884904|NCT00788957|19404656|P5|COMPLETED|Part 3|Completed the safety follow-up visit|4
7884905|NCT00788957|19404657|P4|COMPLETED|Part 3||0
7884906|NCT00788957|19404658|P3|COMPLETED|Part 3||0
7884907|NCT00788957|19404659|P2|COMPLETED|Part 3||0
7884908|NCT00788957|19404660|P1|COMPLETED|Part 3||0
7884909|NCT00788957|19404655|P6|STARTED|Part 3||12
7884910|NCT00788957|19404656|P5|STARTED|Part 3||13
7884911|NCT00788957|19404657|P4|STARTED|Part 3||0
7884912|NCT00788957|19404658|P3|STARTED|Part 3||0
7884913|NCT00788957|19404659|P2|STARTED|Part 3||0
7884914|NCT00788957|19404660|P1|STARTED|Part 3||0
7884915|NCT00788957|19404655|P6|NOT COMPLETED|Part 2||0
7884916|NCT00788957|19404656|P5|NOT COMPLETED|Part 2||0
7884917|NCT00788957|19404657|P4|NOT COMPLETED|Part 2||41
7884918|NCT00788957|19404658|P3|NOT COMPLETED|Part 2||44
7884919|NCT00788957|19404659|P2|NOT COMPLETED|Part 2||42
7884920|NCT00788957|19404660|P1|NOT COMPLETED|Part 2||0
7884921|NCT00788957|19404655|P6|COMPLETED|Part 2||0
7884922|NCT00788957|19404656|P5|COMPLETED|Part 2||0
7884923|NCT00788957|19404657|P4|COMPLETED|Part 2|Completed the safety follow-up visit|5
7884924|NCT00788957|19404658|P3|COMPLETED|Part 2|Completed the safety follow-up visit|4
7884925|NCT00788957|19404659|P2|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6
7884926|NCT00788957|19404660|P1|COMPLETED|Part 2||0
7884927|NCT00788957|19404655|P6|STARTED|Part 2||0
7884928|NCT00788957|19404656|P5|STARTED|Part 2||0
7884929|NCT00788957|19404657|P4|STARTED|Part 2||46
7884930|NCT00788957|19404658|P3|STARTED|Part 2||48
7884931|NCT00788957|19404659|P2|STARTED|Part 2||48
7884932|NCT00788957|19404660|P1|STARTED|Part 2||0
7884933|NCT00788957|19404655|P6|NOT COMPLETED|Part 1||0
7884934|NCT00788957|19404656|P5|NOT COMPLETED|Part 1||0
7884935|NCT00788957|19404657|P4|NOT COMPLETED|Part 1||0
7884936|NCT00788957|19404658|P3|NOT COMPLETED|Part 1||0
7884937|NCT00788957|19404659|P2|NOT COMPLETED|Part 1||0
7884938|NCT00788957|19404660|P1|NOT COMPLETED|Part 1||9
7884939|NCT00788957|19404655|P6|COMPLETED|Part 1||0
7884940|NCT00788957|19404656|P5|COMPLETED|Part 1||0
7884941|NCT00788957|19404657|P4|COMPLETED|Part 1||0
7884942|NCT00788957|19404658|P3|COMPLETED|Part 1||0
7884943|NCT00788957|19404659|P2|COMPLETED|Part 1||0
7884944|NCT00788957|19404660|P1|COMPLETED|Part 1|Completed the safety follow-up visit|2
7884945|NCT00788957|19404655|P6|STARTED|Part 1||0
7884946|NCT00788957|19404656|P5|STARTED|Part 1||0
7884947|NCT00788957|19404657|P4|STARTED|Part 1||0
7884948|NCT00788957|19404658|P3|STARTED|Part 1||0
7884949|NCT00788957|19404659|P2|STARTED|Part 1||0
7884950|NCT00788957|19404660|P1|STARTED|Part 1||11
7884951|NCT00788892|19404716|P2|NOT COMPLETED|Overall Study||23
7884952|NCT00788892|19404717|P1|NOT COMPLETED|Overall Study||49
7884953|NCT00788892|19404716|P2|COMPLETED|Overall Study||18
7884954|NCT00788892|19404717|P1|COMPLETED|Overall Study||36
7884955|NCT00788892|19404716|P2|STARTED|Overall Study||41
7884956|NCT00788892|19404717|P1|STARTED|Overall Study||85
7884957|NCT00788827|19404733|P1|NOT COMPLETED|Overall Study||2
7884958|NCT00788827|19404733|P1|COMPLETED|Overall Study||5
7884959|NCT00788827|19404733|P1|STARTED|Overall Study||7
7884960|NCT00788775|19404747|P2|NOT COMPLETED|Overall Study||8
7884961|NCT00788775|19404748|P1|NOT COMPLETED|Overall Study||10
7884962|NCT00788775|19404747|P2|COMPLETED|Overall Study||1
7884963|NCT00788775|19404748|P1|COMPLETED|Overall Study||1
7884964|NCT00788775|19404747|P2|Treated|Overall Study||8
7884965|NCT00788775|19404748|P1|Treated|Overall Study||11
7884966|NCT00788775|19404747|P2|STARTED|Overall Study||9
7884967|NCT00788775|19404748|P1|STARTED|Overall Study||11
7884968|NCT00788710|19404763|P3|NOT COMPLETED|Overall Study||6
7884969|NCT00788710|19404764|P2|NOT COMPLETED|Overall Study||8
7884970|NCT00788710|19404765|P1|NOT COMPLETED|Overall Study||5
7884971|NCT00788710|19404763|P3|COMPLETED|Overall Study||138
7884972|NCT00788710|19404764|P2|COMPLETED|Overall Study||134
7884973|NCT00788710|19404765|P1|COMPLETED|Overall Study||139
7884974|NCT00788710|19404763|P3|STARTED|Overall Study||144
7884975|NCT00788710|19404764|P2|STARTED|Overall Study||142
7884976|NCT00788710|19404765|P1|STARTED|Overall Study||144
7884977|NCT00788697|19404779|P1|NOT COMPLETED|Overall Study||109
7884978|NCT00788697|19404779|P1|COMPLETED|Overall Study||240
7884979|NCT00788697|19404779|P1|STARTED|Overall Study||349
7884980|NCT00788593|19404826|P3|NOT COMPLETED|Second Intervention Period||1
7884981|NCT00788593|19404827|P2|NOT COMPLETED|Second Intervention Period||1
7884982|NCT00788593|19404828|P1|NOT COMPLETED|Second Intervention Period||0
7884983|NCT00788593|19404826|P3|COMPLETED|Second Intervention Period||36
7884984|NCT00788593|19404827|P2|COMPLETED|Second Intervention Period||37
7884985|NCT00788593|19404828|P1|COMPLETED|Second Intervention Period||0
7884986|NCT00788593|19404826|P3|STARTED|Second Intervention Period||37
7884987|NCT00788593|19404827|P2|STARTED|Second Intervention Period||38
7884988|NCT00788593|19404828|P1|STARTED|Second Intervention Period||0
7884989|NCT00788593|19404826|P3|NOT COMPLETED|First Intervention Period||0
7884990|NCT00788593|19404827|P2|NOT COMPLETED|First Intervention Period||1
7884991|NCT00788593|19404828|P1|NOT COMPLETED|First Intervention Period||0
7884992|NCT00788593|19404826|P3|COMPLETED|First Intervention Period||37
7884993|NCT00788593|19404827|P2|COMPLETED|First Intervention Period||38
7884994|NCT00788593|19404828|P1|COMPLETED|First Intervention Period||0
7884995|NCT00788593|19404826|P3|STARTED|First Intervention Period||37
7884996|NCT00788593|19404827|P2|STARTED|First Intervention Period||39
7884997|NCT00788593|19404828|P1|STARTED|First Intervention Period||0
7884998|NCT00788593|19404826|P3|NOT COMPLETED|Placebo Run-in Phase||0
7884999|NCT00788593|19404827|P2|NOT COMPLETED|Placebo Run-in Phase||0
7885000|NCT00788593|19404828|P1|NOT COMPLETED|Placebo Run-in Phase||6
7885001|NCT00788593|19404826|P3|COMPLETED|Placebo Run-in Phase||0
7885002|NCT00788593|19404827|P2|COMPLETED|Placebo Run-in Phase||0
7885003|NCT00788593|19404828|P1|COMPLETED|Placebo Run-in Phase||76
7885004|NCT00788593|19404826|P3|STARTED|Placebo Run-in Phase||0
7885005|NCT00788593|19404827|P2|STARTED|Placebo Run-in Phase||0
7885006|NCT00788593|19404828|P1|STARTED|Placebo Run-in Phase||82
7885007|NCT00788372|19404845|P1|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32
7885008|NCT00788372|19404845|P1|COMPLETED|Period 2 (Week 4 to Week 52)||79
7885009|NCT00788372|19404845|P1|STARTED|Period 2 (Week 4 to Week 52)||111
7885010|NCT00788372|19404845|P1|NOT COMPLETED|Period 1 (up to 4 Weeks)||31
7885011|NCT00788372|19404845|P1|COMPLETED|Period 1 (up to 4 Weeks)||111
7885012|NCT00788372|19404845|P1|STARTED|Period 1 (up to 4 Weeks)||142
7885013|NCT00788255|19404859|P1|NOT COMPLETED|Overall Study||0
7885014|NCT00788255|19404859|P1|COMPLETED|Overall Study||25
7885015|NCT00788255|19404859|P1|Oxytocin: 0 μU/mL|Overall Study||25
7885016|NCT00788255|19404859|P1|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25
7885017|NCT00788255|19404859|P1|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25
7885018|NCT00788255|19404859|P1|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25
7885019|NCT00788255|19404859|P1|STARTED|Overall Study||25
7885020|NCT00788151|19404874|P2|NOT COMPLETED|Overall Study||10
7885021|NCT00788151|19404875|P1|NOT COMPLETED|Overall Study||14
7885022|NCT00788151|19404874|P2|COMPLETED|Overall Study||90
7885023|NCT00788151|19404875|P1|COMPLETED|Overall Study||186
7885024|NCT00788151|19404874|P2|Received Vaccination 3|Overall Study||90
7885025|NCT00788151|19404875|P1|Received Vaccination 3|Overall Study||186
7885026|NCT00788151|19404874|P2|Received Vaccination 2|Overall Study||92
7885027|NCT00788151|19404875|P1|Received Vaccination 2|Overall Study||188
7885028|NCT00788151|19404874|P2|Received Vaccination 1|Overall Study||99
7885029|NCT00788151|19404875|P1|Received Vaccination 1|Overall Study||199
7885030|NCT00788151|19404874|P2|STARTED|Overall Study||100
7885031|NCT00788151|19404875|P1|STARTED|Overall Study||200
7885032|NCT00788073|19404919|P2|NOT COMPLETED|Placebo Then STX209||1
7885033|NCT00788073|19404920|P1|NOT COMPLETED|Placebo Then STX209||2
7885034|NCT00788073|19404919|P2|COMPLETED|Placebo Then STX209||29
7885035|NCT00788073|19404920|P1|COMPLETED|Placebo Then STX209||27
7885036|NCT00788073|19404919|P2|STARTED|Placebo Then STX209||30
7885037|NCT00788073|19404920|P1|STARTED|Placebo Then STX209||29
7885038|NCT00788073|19404919|P2|NOT COMPLETED|STX209 Then Placebo||3
7885039|NCT00788073|19404920|P1|NOT COMPLETED|STX209 Then Placebo||1
7885040|NCT00788073|19404919|P2|COMPLETED|STX209 Then Placebo||30
7885041|NCT00788073|19404920|P1|COMPLETED|STX209 Then Placebo||29
7885042|NCT00788073|19404919|P2|STARTED|STX209 Then Placebo||33
7885043|NCT00788073|19404920|P1|STARTED|STX209 Then Placebo||30
7885044|NCT00788008|19404930|P2|NOT COMPLETED|Overall Study||0
7885045|NCT00788008|19404931|P1|NOT COMPLETED|Overall Study||0
7885046|NCT00788008|19404930|P2|COMPLETED|Overall Study||101
7885047|NCT00788008|19404931|P1|COMPLETED|Overall Study||98
7885048|NCT00788008|19404930|P2|STARTED|Overall Study||101
7885049|NCT00788008|19404931|P1|STARTED|Overall Study||98
7885050|NCT00787943|19404937|P1|NOT COMPLETED|Overall Study||0
7885051|NCT00787943|19404937|P1|COMPLETED|Overall Study||10
7885052|NCT00787943|19404937|P1|STARTED|Overall Study||10
7885053|NCT00787930|19404945|P1|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3
7885054|NCT00787930|19404945|P1|COMPLETED|Continuation Treatment -- up to 12 Month||16
7885055|NCT00787930|19404945|P1|STARTED|Continuation Treatment -- up to 12 Month||19
7885056|NCT00787930|19404945|P1|NOT COMPLETED|Acute Treatment -- 3 Weeks||0
7885057|NCT00787930|19404945|P1|COMPLETED|Acute Treatment -- 3 Weeks||19
7885058|NCT00787930|19404945|P1|STARTED|Acute Treatment -- 3 Weeks||19
7885059|NCT00787917|19404960|P2|NOT COMPLETED|Open Label||0
7885060|NCT00787917|19404961|P1|NOT COMPLETED|Open Label||4
7885061|NCT00787917|19404960|P2|COMPLETED|Open Label||0
7885062|NCT00787917|19404961|P1|COMPLETED|Open Label||3
7885063|NCT00787917|19404960|P2|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0
7885064|NCT00787917|19404961|P1|STARTED|Open Label||7
7885065|NCT00787917|19404960|P2|NOT COMPLETED|Blinded Treatment||2
7885066|NCT00787917|19404961|P1|NOT COMPLETED|Blinded Treatment||5
7885067|NCT00787917|19404960|P2|COMPLETED|Blinded Treatment||3
7885068|NCT00787917|19404961|P1|COMPLETED|Blinded Treatment||4
7885069|NCT00787917|19404960|P2|STARTED|Blinded Treatment||5
7885070|NCT00787917|19404961|P1|STARTED|Blinded Treatment||9
7885071|NCT00787904|19404980|P2|NOT COMPLETED|Overall Study||0
7885072|NCT00787904|19404981|P1|NOT COMPLETED|Overall Study||0
7885073|NCT00787904|19404980|P2|COMPLETED|Overall Study||13
7885074|NCT00787904|19404981|P1|COMPLETED|Overall Study||6
7885075|NCT00787904|19404980|P2|STARTED|Overall Study||13
7885076|NCT00787904|19404981|P1|STARTED|Overall Study||6
7885077|NCT00787891|19404991|P2|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
7885078|NCT00787891|19404992|P1|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
7885079|NCT00787891|19404991|P2|COMPLETED|Maintenance Double-blind Phase (Part 2)||24
7885080|NCT00787891|19404992|P1|COMPLETED|Maintenance Double-blind Phase (Part 2)||26
7885081|NCT00787891|19404991|P2|STARTED|Maintenance Double-blind Phase (Part 2)||31
7885082|NCT00787891|19404992|P1|STARTED|Maintenance Double-blind Phase (Part 2)||33
7885083|NCT00787891|19404991|P2|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9
7885084|NCT00787891|19404992|P1|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10
7885085|NCT00787891|19404991|P2|COMPLETED|Short-term Double-blind Phase (Part 1)||53
7885086|NCT00787891|19404992|P1|COMPLETED|Short-term Double-blind Phase (Part 1)||55
7885087|NCT00787891|19404991|P2|STARTED|Short-term Double-blind Phase (Part 1)||62
7885088|NCT00787891|19404992|P1|STARTED|Short-term Double-blind Phase (Part 1)||65
7885089|NCT00787852|19405012|P2|NOT COMPLETED|Overall Study||0
7885090|NCT00787852|19405013|P1|NOT COMPLETED|Overall Study||1
7885091|NCT00787852|19405012|P2|COMPLETED|Overall Study||5
7885092|NCT00787852|19405013|P1|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5
7885093|NCT00787852|19405012|P2|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5
7885094|NCT00787852|19405013|P1|STARTED|Overall Study||6
7885095|NCT00787839|19405019|P1|NOT COMPLETED|Overall Study||404
7885096|NCT00787839|19405019|P1|COMPLETED|Overall Study||1535
7885097|NCT00787839|19405019|P1|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535
7885098|NCT00787839|19405019|P1|Completed GCT Screening|Overall Study||1876
7885099|NCT00787839|19405019|P1|Consented|Overall Study|consented|1939
7885100|NCT00787839|19405019|P1|STARTED|Overall Study||1939
7885101|NCT00787800|19405042|P2|NOT COMPLETED|Overall Study||7
7885102|NCT00787800|19405043|P1|NOT COMPLETED|Overall Study||3
7885103|NCT00787800|19405042|P2|COMPLETED|Overall Study||43
7885104|NCT00787800|19405043|P1|COMPLETED|Overall Study||47
7885105|NCT00787800|19405042|P2|STARTED|Overall Study||50
7885106|NCT00787800|19405043|P1|STARTED|Overall Study||50
7885107|NCT00787787|19405059|P1|NOT COMPLETED|Overall Study||7
7885108|NCT00787787|19405059|P1|COMPLETED|Overall Study||0
7885109|NCT00787787|19405059|P1|STARTED|Overall Study||7
7885110|NCT00787761|19405065|P1|NOT COMPLETED|Overall Study||0
7885111|NCT00787761|19405065|P1|COMPLETED|Overall Study||24
7885112|NCT00787761|19405065|P1|STARTED|Overall Study||24
7885113|NCT00787722|19405076|P1|NOT COMPLETED|Overall Study||1
7885114|NCT00787722|19405076|P1|COMPLETED|Overall Study||12
7885115|NCT00787722|19405076|P1|STARTED|Overall Study||13
7885116|NCT00787644|19405087|P2|NOT COMPLETED|Overall Study||2
7885117|NCT00787644|19405088|P1|NOT COMPLETED|Overall Study||2
7885118|NCT00787644|19405087|P2|COMPLETED|Overall Study||9
7885119|NCT00787644|19405088|P1|COMPLETED|Overall Study||10
7885120|NCT00787644|19405087|P2|STARTED|Overall Study||11
7885121|NCT00787644|19405088|P1|STARTED|Overall Study||12
7885122|NCT00787618|19405097|P3|NOT COMPLETED|Overall Study||0
7885123|NCT00787618|19405098|P2|NOT COMPLETED|Overall Study||0
7885124|NCT00787618|19405099|P1|NOT COMPLETED|Overall Study||0
7885125|NCT00787618|19405097|P3|COMPLETED|Overall Study||3
7885126|NCT00787618|19405098|P2|COMPLETED|Overall Study||0
7885127|NCT00787618|19405099|P1|COMPLETED|Overall Study||3
7885128|NCT00787618|19405097|P3|STARTED|Overall Study||3
7885129|NCT00787618|19405098|P2|STARTED|Overall Study||0
7885130|NCT00787618|19405099|P1|STARTED|Overall Study||3
7885131|NCT00787605|19405109|P2|NOT COMPLETED|Overall Study||56
7885132|NCT00787605|19405110|P1|NOT COMPLETED|Overall Study||46
7885133|NCT00787605|19405109|P2|COMPLETED|Overall Study||376
7885134|NCT00787605|19405110|P1|COMPLETED|Overall Study||382
7885135|NCT00787605|19405109|P2|STARTED|Overall Study||432
7885136|NCT00787605|19405110|P1|STARTED|Overall Study||428
7885137|NCT00787566|19405129|P3|NOT COMPLETED|Overall Study||0
7885138|NCT00787566|19405130|P2|NOT COMPLETED|Overall Study||1
7885139|NCT00787566|19405131|P1|NOT COMPLETED|Overall Study||0
7885140|NCT00787566|19405129|P3|COMPLETED|Overall Study||22
7885141|NCT00787566|19405130|P2|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24
7885142|NCT00787566|19405131|P1|COMPLETED|Overall Study||21
7885143|NCT00787566|19405129|P3|STARTED|Overall Study||22
7885144|NCT00787566|19405130|P2|STARTED|Overall Study||25
7885145|NCT00787566|19405131|P1|STARTED|Overall Study||21
7885146|NCT00787527|19405139|P1|NOT COMPLETED|Overall Study||3
7885147|NCT00787527|19405139|P1|COMPLETED|Overall Study||11
7885148|NCT00787527|19405139|P1|STARTED|Overall Study||14
7885149|NCT00787332|19405149|P2|NOT COMPLETED|Overall Study||0
7885150|NCT00787332|19405150|P1|NOT COMPLETED|Overall Study||0
7885151|NCT00787332|19405149|P2|COMPLETED|Overall Study||8
7885152|NCT00787332|19405150|P1|COMPLETED|Overall Study||8
7885153|NCT00787332|19405149|P2|STARTED|Overall Study||8
7885154|NCT00787332|19405150|P1|STARTED|Overall Study||8
7885155|NCT00787319|19405156|P1|NOT COMPLETED|Overall Study||63
7885156|NCT00787319|19405156|P1|COMPLETED|Overall Study||45
7885157|NCT00787319|19405156|P1|STARTED|Overall Study||108
7885158|NCT00787267|19405168|P1|NOT COMPLETED|Overall Study||12
7885159|NCT00787267|19405168|P1|COMPLETED|Overall Study|Received at least one dose of study drug|25
7885160|NCT00787267|19405168|P1|STARTED|Overall Study|Signed a consent form|37
7885161|NCT00787254|19405178|P2|NOT COMPLETED|Overall Study||82
7885162|NCT00787254|19405179|P1|NOT COMPLETED|Overall Study||76
7885163|NCT00787254|19405178|P2|COMPLETED|Overall Study||99
7885164|NCT00787254|19405179|P1|COMPLETED|Overall Study||109
7885165|NCT00787254|19405178|P2|STARTED|Overall Study||181
7885166|NCT00787254|19405179|P1|STARTED|Overall Study||185
7885167|NCT00787241|19405282|P3|NOT COMPLETED|Overall Study||0
7885168|NCT00787241|19405283|P2|NOT COMPLETED|Overall Study||0
7885169|NCT00787241|19405284|P1|NOT COMPLETED|Overall Study||0
7885170|NCT00787241|19405282|P3|COMPLETED|Overall Study||41
7885171|NCT00787241|19405283|P2|COMPLETED|Overall Study||143
7885172|NCT00787241|19405284|P1|COMPLETED|Overall Study||261
7885173|NCT00787241|19405282|P3|STARTED|Overall Study||41
7885174|NCT00787241|19405283|P2|STARTED|Overall Study||143
7885175|NCT00787241|19405284|P1|STARTED|Overall Study||261
7885176|NCT00787202|19405303|P5|NOT COMPLETED|Overall Study||4
7885177|NCT00787202|19405304|P4|NOT COMPLETED|Overall Study||2
7885178|NCT00787202|19405305|P3|NOT COMPLETED|Overall Study||7
7885179|NCT00787202|19405306|P2|NOT COMPLETED|Overall Study||11
7885180|NCT00787202|19405307|P1|NOT COMPLETED|Overall Study||14
7885181|NCT00787202|19405303|P5|COMPLETED|Overall Study||45
7885182|NCT00787202|19405304|P4|COMPLETED|Overall Study||31
7885183|NCT00787202|19405305|P3|COMPLETED|Overall Study||26
7885184|NCT00787202|19405306|P2|COMPLETED|Overall Study||20
7885185|NCT00787202|19405307|P1|COMPLETED|Overall Study||35
7885186|NCT00787202|19405303|P5|Treated|Overall Study||49
7885187|NCT00787202|19405304|P4|Treated|Overall Study||33
7885188|NCT00787202|19405305|P3|Treated|Overall Study||33
7885189|NCT00787202|19405306|P2|Treated|Overall Study||31
7885190|NCT00787202|19405307|P1|Treated|Overall Study||48
7885191|NCT00787202|19405303|P5|STARTED|Overall Study||49
7885192|NCT00787202|19405304|P4|STARTED|Overall Study||33
7885193|NCT00787202|19405305|P3|STARTED|Overall Study||33
7885194|NCT00787202|19405306|P2|STARTED|Overall Study||31
7885195|NCT00787202|19405307|P1|STARTED|Overall Study||49
7885196|NCT00787189|19405360|P2|NOT COMPLETED|Overall Study||2
7885197|NCT00787189|19405361|P1|NOT COMPLETED|Overall Study||2
7885198|NCT00787189|19405360|P2|COMPLETED|Overall Study|To study end point.|30
7885199|NCT00787189|19405361|P1|COMPLETED|Overall Study|To study end point.|30
7885200|NCT00787189|19405360|P2|STARTED|Overall Study||32
7885201|NCT00787189|19405361|P1|STARTED|Overall Study||32
7885202|NCT00787150|19405370|P3|NOT COMPLETED|Overall Study||5
7885203|NCT00787150|19405371|P2|NOT COMPLETED|Overall Study||7
7885204|NCT00787150|19405372|P1|NOT COMPLETED|Overall Study||9
7885205|NCT00787150|19405370|P3|COMPLETED|Overall Study||66
7885206|NCT00787150|19405371|P2|COMPLETED|Overall Study||65
7885207|NCT00787150|19405372|P1|COMPLETED|Overall Study||66
7885208|NCT00787150|19405370|P3|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71
7885209|NCT00787150|19405371|P2|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72
7885210|NCT00787150|19405372|P1|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75
7885211|NCT00787137|19405417|P3|NOT COMPLETED|Overall Study||1
7885212|NCT00787137|19405418|P2|NOT COMPLETED|Overall Study||0
7885213|NCT00787137|19405419|P1|NOT COMPLETED|Overall Study||0
7885214|NCT00787137|19405417|P3|COMPLETED|Overall Study||4
7885215|NCT00787137|19405418|P2|COMPLETED|Overall Study||6
7885216|NCT00787137|19405419|P1|COMPLETED|Overall Study||6
7885217|NCT00787137|19405417|P3|STARTED|Overall Study||5
7885218|NCT00787137|19405418|P2|STARTED|Overall Study||6
7885219|NCT00787137|19405419|P1|STARTED|Overall Study||6
7885220|NCT00787124|19405441|P2|NOT COMPLETED|Overall Study||0
7885221|NCT00787124|19405442|P1|NOT COMPLETED|Overall Study||0
7885222|NCT00787124|19405441|P2|COMPLETED|Overall Study||4
7885223|NCT00787124|19405442|P1|COMPLETED|Overall Study||4
7885224|NCT00787124|19405441|P2|STARTED|Overall Study||4
7885225|NCT00787124|19405442|P1|STARTED|Overall Study||4
7885226|NCT00787020|19405452|P2|NOT COMPLETED|Overall Study||0
7885227|NCT00787020|19405453|P1|NOT COMPLETED|Overall Study||0
7885228|NCT00787020|19405452|P2|COMPLETED|Overall Study||13
7885229|NCT00787020|19405453|P1|COMPLETED|Overall Study||24
7885230|NCT00787020|19405452|P2|STARTED|Overall Study||13
7885231|NCT00787020|19405453|P1|STARTED|Overall Study||24
7885232|NCT00786994|19405467|P4|NOT COMPLETED|Overall Study||6
7885233|NCT00786994|19405468|P3|NOT COMPLETED|Overall Study||2
7885234|NCT00786994|19405469|P2|NOT COMPLETED|Overall Study||15
7885235|NCT00786994|19405470|P1|NOT COMPLETED|Overall Study||10
7885236|NCT00786994|19405467|P4|COMPLETED|Overall Study||22
7885237|NCT00786994|19405468|P3|COMPLETED|Overall Study||24
7885238|NCT00786994|19405469|P2|COMPLETED|Overall Study||39
7885239|NCT00786994|19405470|P1|COMPLETED|Overall Study||47
7885240|NCT00786994|19405467|P4|ITT|Overall Study||28
7885241|NCT00786994|19405468|P3|ITT|Overall Study||25
7885242|NCT00786994|19405469|P2|ITT|Overall Study||51
7885243|NCT00786994|19405470|P1|ITT|Overall Study||53
7885244|NCT00786994|19405467|P4|STARTED|Overall Study||28
7885245|NCT00786994|19405468|P3|STARTED|Overall Study||26
7885246|NCT00786994|19405469|P2|STARTED|Overall Study||54
7885247|NCT00786994|19405470|P1|STARTED|Overall Study||57
7885248|NCT00786916|19405482|P3|NOT COMPLETED|Overall Study||0
7885249|NCT00786916|19405483|P2|NOT COMPLETED|Overall Study||0
7885250|NCT00786916|19405484|P1|NOT COMPLETED|Overall Study||0
7885251|NCT00786916|19405482|P3|COMPLETED|Overall Study||34
7885252|NCT00786916|19405483|P2|COMPLETED|Overall Study||36
7885253|NCT00786916|19405484|P1|COMPLETED|Overall Study||39
7885254|NCT00786916|19405482|P3|STARTED|Overall Study||34
7885255|NCT00786916|19405483|P2|STARTED|Overall Study||36
7885256|NCT00786916|19405484|P1|STARTED|Overall Study||39
7885257|NCT00786864|19405494|P2|NOT COMPLETED|Overall Study||1
7885258|NCT00786864|19405495|P1|NOT COMPLETED|Overall Study||1
7885259|NCT00786864|19405494|P2|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32
7885260|NCT00786864|19405495|P1|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38
7885261|NCT00786864|19405494|P2|STARTED|Overall Study||33
7885262|NCT00786864|19405495|P1|STARTED|Overall Study||39
7885263|NCT00786838|19405507|P1|NOT COMPLETED|Overall Study||49
7885264|NCT00786838|19405507|P1|COMPLETED|Overall Study||26
7885265|NCT00786838|19405507|P1|STARTED|Overall Study||75
7885266|NCT00786825|19405534|P2|NOT COMPLETED|Overall Study||0
7885267|NCT00786825|19405535|P1|NOT COMPLETED|Overall Study||0
7885268|NCT00786825|19405534|P2|COMPLETED|Overall Study||5
7885269|NCT00786825|19405535|P1|COMPLETED|Overall Study||5
7885270|NCT00786825|19405534|P2|STARTED|Overall Study||5
7885271|NCT00786825|19405535|P1|STARTED|Overall Study||5
7885272|NCT00786799|19405543|P2|NOT COMPLETED|Overall Study||1
7885273|NCT00786799|19405544|P1|NOT COMPLETED|Overall Study||1
7885274|NCT00786799|19405543|P2|COMPLETED|Overall Study||12
7885275|NCT00786799|19405544|P1|COMPLETED|Overall Study||13
7885276|NCT00786799|19405543|P2|STARTED|Overall Study||13
7885277|NCT00786799|19405544|P1|STARTED|Overall Study||14
7885278|NCT00786682|19405555|P1|NOT COMPLETED|Overall Study||0
7885279|NCT00786682|19405555|P1|COMPLETED|Overall Study||11
7885280|NCT00786682|19405555|P1|STARTED|Overall Study||11
7885281|NCT00786643|19405563|P2|NOT COMPLETED|Overall Study||0
7885282|NCT00786643|19405564|P1|NOT COMPLETED|Overall Study||0
7885283|NCT00786643|19405563|P2|COMPLETED|Overall Study||28
7885284|NCT00786643|19405564|P1|COMPLETED|Overall Study||20
7885285|NCT00786643|19405563|P2|STARTED|Overall Study||28
7885286|NCT00786643|19405564|P1|STARTED|Overall Study||20
7885287|NCT00786565|19405574|P1|NOT COMPLETED|Post Surgery||2
7885288|NCT00786565|19405574|P1|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67
7885289|NCT00786565|19405574|P1|STARTED|Post Surgery||69
7885290|NCT00786565|19405574|P1|NOT COMPLETED|Enrollment Prior to Surgery||6
7885291|NCT00786565|19405574|P1|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69
7885292|NCT00786565|19405574|P1|STARTED|Enrollment Prior to Surgery||75
7885293|NCT00786487|19405616|P4|NOT COMPLETED|Overall Study||0
7885294|NCT00786487|19405617|P3|NOT COMPLETED|Overall Study||0
7885295|NCT00786487|19405618|P2|NOT COMPLETED|Overall Study||0
7885296|NCT00786487|19405619|P1|NOT COMPLETED|Overall Study||0
7885297|NCT00786487|19405616|P4|COMPLETED|Overall Study||7
7885298|NCT00786487|19405617|P3|COMPLETED|Overall Study||9
7885299|NCT00786487|19405618|P2|COMPLETED|Overall Study||7
7885300|NCT00786487|19405619|P1|COMPLETED|Overall Study||10
7885301|NCT00786487|19405616|P4|STARTED|Overall Study||7
7885302|NCT00786487|19405617|P3|STARTED|Overall Study||9
7885303|NCT00786487|19405618|P2|STARTED|Overall Study||7
7885304|NCT00786487|19405619|P1|STARTED|Overall Study||10
7885305|NCT00786474|19405631|P2|NOT COMPLETED|Overall Study||43
7885306|NCT00786474|19405632|P1|NOT COMPLETED|Overall Study||37
7885307|NCT00786474|19405631|P2|COMPLETED|Overall Study||891
7885308|NCT00786474|19405632|P1|COMPLETED|Overall Study||913
7885309|NCT00786474|19405631|P2|STARTED|Overall Study||934
7885310|NCT00786474|19405632|P1|STARTED|Overall Study||950
7885311|NCT00786422|19405644|P1|NOT COMPLETED|Follow-up Period||3
7885312|NCT00786422|19405644|P1|COMPLETED|Follow-up Period||17
7885313|NCT00786422|19405644|P1|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20
7885314|NCT00786422|19405644|P1|NOT COMPLETED|Rivaroxaban Treatment||11
7885315|NCT00786422|19405644|P1|COMPLETED|Rivaroxaban Treatment||14
7885316|NCT00786422|19405644|P1|STARTED|Rivaroxaban Treatment||25
7885317|NCT00786409|19405660|P1|NOT COMPLETED|Overall Study||7
7885318|NCT00786409|19405660|P1|COMPLETED|Overall Study||20
7885319|NCT00786409|19405660|P1|STARTED|Overall Study||27
7885320|NCT00786188|19405677|P2|NOT COMPLETED|Overall Study||1
7885321|NCT00786188|19405678|P1|NOT COMPLETED|Overall Study||5
7885322|NCT00786188|19405677|P2|COMPLETED|Overall Study||51
7885323|NCT00786188|19405678|P1|COMPLETED|Overall Study||45
7885324|NCT00786188|19405677|P2|STARTED|Overall Study||52
7885325|NCT00786188|19405678|P1|STARTED|Overall Study||50
7885326|NCT00786032|19405704|P1|NOT COMPLETED|Overall Study||24
7885327|NCT00786032|19405704|P1|COMPLETED|Overall Study||3
7885328|NCT00786032|19405704|P1|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14
7885329|NCT00786032|19405704|P1|STARTED|Overall Study||27
7885330|NCT00786019|19405716|P2|NOT COMPLETED|Overall Study||10
7885331|NCT00786019|19405717|P1|NOT COMPLETED|Overall Study||5
7885332|NCT00786019|19405716|P2|COMPLETED|Overall Study||17
7885333|NCT00786019|19405717|P1|COMPLETED|Overall Study||15
7885334|NCT00786019|19405716|P2|STARTED|Overall Study||27
7885335|NCT00786019|19405717|P1|STARTED|Overall Study||20
7885336|NCT00785980|19405725|P1|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0
7885337|NCT00785980|19405725|P1|COMPLETED|Quinine Sulfate With Ciprofloxacin||21
7885338|NCT00785980|19405725|P1|STARTED|Quinine Sulfate With Ciprofloxacin||21
7885339|NCT00785980|19405725|P1|NOT COMPLETED|Ciprofloxacin Alone||0
7885340|NCT00785980|19405725|P1|COMPLETED|Ciprofloxacin Alone||21
7885341|NCT00785980|19405725|P1|STARTED|Ciprofloxacin Alone||21
7885342|NCT00785980|19405725|P1|NOT COMPLETED|7 Day Washout Period||3
7885343|NCT00785980|19405725|P1|COMPLETED|7 Day Washout Period||21
7885344|NCT00785980|19405725|P1|STARTED|7 Day Washout Period||24
7885345|NCT00785980|19405725|P1|NOT COMPLETED|Quinine Sulfate Alone||0
7885346|NCT00785980|19405725|P1|COMPLETED|Quinine Sulfate Alone||24
7885347|NCT00785980|19405725|P1|STARTED|Quinine Sulfate Alone||24
7885348|NCT00785928|19405743|P7|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||5
7885349|NCT00785928|19405744|P6|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
7885350|NCT00785928|19405745|P5|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
7885351|NCT00785928|19405746|P4|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
7885352|NCT00785928|19405747|P3|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
7885353|NCT00785928|19405748|P2|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||3
7885354|NCT00785928|19405749|P1|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||1
7885355|NCT00785928|19405743|P7|COMPLETED|Follow-up Phases (Weeks 24-72)||9
7885356|NCT00785928|19405744|P6|COMPLETED|Follow-up Phases (Weeks 24-72)||0
7885357|NCT00785928|19405745|P5|COMPLETED|Follow-up Phases (Weeks 24-72)||4
7885358|NCT00785928|19405746|P4|COMPLETED|Follow-up Phases (Weeks 24-72)||4
7885359|NCT00785928|19405747|P3|COMPLETED|Follow-up Phases (Weeks 24-72)||4
7885360|NCT00785928|19405748|P2|COMPLETED|Follow-up Phases (Weeks 24-72)||5
7885361|NCT00785928|19405749|P1|COMPLETED|Follow-up Phases (Weeks 24-72)||7
7885362|NCT00785928|19405743|P7|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|14
7885363|NCT00785928|19405744|P6|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|0
7885364|NCT00785928|19405745|P5|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
7885365|NCT00785928|19405746|P4|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|4
7885366|NCT00785928|19405747|P3|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
7885367|NCT00785928|19405748|P2|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
7885368|NCT00785928|19405749|P1|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
7885369|NCT00785928|19405743|P7|NOT COMPLETED|Treatment Phase||3
7885370|NCT00785928|19405744|P6|NOT COMPLETED|Treatment Phase||0
7885371|NCT00785928|19405745|P5|NOT COMPLETED|Treatment Phase||2
7885372|NCT00785928|19405746|P4|NOT COMPLETED|Treatment Phase||0
7885373|NCT00785928|19405747|P3|NOT COMPLETED|Treatment Phase||3
7885374|NCT00785928|19405748|P2|NOT COMPLETED|Treatment Phase||5
7885375|NCT00785928|19405749|P1|NOT COMPLETED|Treatment Phase||3
7885376|NCT00785928|19405743|P7|COMPLETED|Treatment Phase||23
7885377|NCT00785928|19405744|P6|COMPLETED|Treatment Phase||13
7885378|NCT00785928|19405745|P5|COMPLETED|Treatment Phase||16
7885379|NCT00785928|19405746|P4|COMPLETED|Treatment Phase||15
7885380|NCT00785928|19405747|P3|COMPLETED|Treatment Phase||17
7885381|NCT00785928|19405748|P2|COMPLETED|Treatment Phase||25
7885382|NCT00785928|19405749|P1|COMPLETED|Treatment Phase||33
7885383|NCT00785928|19405743|P7|STARTED|Treatment Phase||26
7885384|NCT00785928|19405744|P6|STARTED|Treatment Phase||13
7885385|NCT00785928|19405745|P5|STARTED|Treatment Phase||18
7885386|NCT00785928|19405746|P4|STARTED|Treatment Phase||15
7885387|NCT00785928|19405747|P3|STARTED|Treatment Phase||20
7885388|NCT00785928|19405748|P2|STARTED|Treatment Phase||30
7885389|NCT00785928|19405749|P1|STARTED|Treatment Phase||36
7885390|NCT00785798|19405889|P1|NOT COMPLETED|Overall Study||1
7885391|NCT00785798|19405889|P1|COMPLETED|Overall Study||16
7885392|NCT00785798|19405889|P1|STARTED|Overall Study||17
7885393|NCT00785785|19405896|P2|NOT COMPLETED|Optional Extension Phase||125
7885394|NCT00785785|19405897|P1|NOT COMPLETED|Optional Extension Phase||39
7885395|NCT00785785|19405896|P2|COMPLETED|Optional Extension Phase||0
7885396|NCT00785785|19405897|P1|COMPLETED|Optional Extension Phase||0
7885397|NCT00785785|19405896|P2|STARTED|Optional Extension Phase|crossover extension phase was optional|125
7885484|NCT00785512|19406132|P1|COMPLETED|Overall Study||99
7885398|NCT00785785|19405897|P1|STARTED|Optional Extension Phase|crossover extension phase was optional|39
7885399|NCT00785785|19405896|P2|NOT COMPLETED|Core Phase up to 36 Months||320
7885400|NCT00785785|19405897|P1|NOT COMPLETED|Core Phase up to 36 Months||324
7885401|NCT00785785|19405896|P2|COMPLETED|Core Phase up to 36 Months||0
7885402|NCT00785785|19405897|P1|COMPLETED|Core Phase up to 36 Months||0
7885403|NCT00785785|19405896|P2|STARTED|Core Phase up to 36 Months||320
7885404|NCT00785785|19405897|P1|STARTED|Core Phase up to 36 Months||324
7885405|NCT00785772|19405905|P1|NOT COMPLETED|Overall Study||0
7885406|NCT00785772|19405905|P1|COMPLETED|Overall Study||1
7885407|NCT00785772|19405905|P1|STARTED|Overall Study||1
7885408|NCT00785707|19405911|P1|NOT COMPLETED|Overall Study||7
7885409|NCT00785707|19405911|P1|COMPLETED|Overall Study||24
7885410|NCT00785707|19405911|P1|STARTED|Overall Study||31
7885411|NCT00785629|19405920|P4|NOT COMPLETED|Overall Study||16
7885412|NCT00785629|19405921|P3|NOT COMPLETED|Overall Study||10
7885413|NCT00785629|19405922|P2|NOT COMPLETED|Overall Study||5
7885414|NCT00785629|19405923|P1|NOT COMPLETED|Overall Study||8
7885415|NCT00785629|19405920|P4|COMPLETED|Overall Study|16 not completed|41
7885416|NCT00785629|19405921|P3|COMPLETED|Overall Study|10 not completed|18
7885417|NCT00785629|19405922|P2|COMPLETED|Overall Study|5 not completed|25
7885418|NCT00785629|19405923|P1|COMPLETED|Overall Study|8 not completed|22
7885419|NCT00785629|19405920|P4|STARTED|Overall Study||57
7885420|NCT00785629|19405921|P3|STARTED|Overall Study||28
7885421|NCT00785629|19405922|P2|STARTED|Overall Study||30
7885422|NCT00785629|19405923|P1|STARTED|Overall Study||30
7885423|NCT00785577|19405936|P5|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
7885424|NCT00785577|19405937|P4|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
7885425|NCT00785577|19405938|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
7885426|NCT00785577|19405939|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
7885427|NCT00785577|19405940|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
7885428|NCT00785577|19405936|P5|COMPLETED|Study Period 3: 1-Week Washout Phase||26
7885429|NCT00785577|19405937|P4|COMPLETED|Study Period 3: 1-Week Washout Phase||35
7885430|NCT00785577|19405938|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||25
7885431|NCT00785577|19405939|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||36
7885432|NCT00785577|19405940|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||78
7885433|NCT00785577|19405936|P5|STARTED|Study Period 3: 1-Week Washout Phase||27
7885434|NCT00785577|19405937|P4|STARTED|Study Period 3: 1-Week Washout Phase||36
7885435|NCT00785577|19405938|P3|STARTED|Study Period 3: 1-Week Washout Phase||25
7885436|NCT00785577|19405939|P2|STARTED|Study Period 3: 1-Week Washout Phase||36
7885437|NCT00785577|19405940|P1|STARTED|Study Period 3: 1-Week Washout Phase||78
7885438|NCT00785577|19405936|P5|NOT COMPLETED|Study Period 2: Therapy Phase||20
7885439|NCT00785577|19405937|P4|NOT COMPLETED|Study Period 2: Therapy Phase||13
7885440|NCT00785577|19405938|P3|NOT COMPLETED|Study Period 2: Therapy Phase||18
7885441|NCT00785577|19405939|P2|NOT COMPLETED|Study Period 2: Therapy Phase||9
7885442|NCT00785577|19405940|P1|NOT COMPLETED|Study Period 2: Therapy Phase||11
7885443|NCT00785577|19405936|P5|COMPLETED|Study Period 2: Therapy Phase||27
7885444|NCT00785577|19405937|P4|COMPLETED|Study Period 2: Therapy Phase||36
7885445|NCT00785577|19405938|P3|COMPLETED|Study Period 2: Therapy Phase||25
7885446|NCT00785577|19405939|P2|COMPLETED|Study Period 2: Therapy Phase||36
7885447|NCT00785577|19405940|P1|COMPLETED|Study Period 2: Therapy Phase||78
7885448|NCT00785577|19405936|P5|STARTED|Study Period 2: Therapy Phase||47
7885449|NCT00785577|19405937|P4|STARTED|Study Period 2: Therapy Phase||49
7885450|NCT00785577|19405938|P3|STARTED|Study Period 2: Therapy Phase||43
7885451|NCT00785577|19405939|P2|STARTED|Study Period 2: Therapy Phase||45
7885452|NCT00785577|19405940|P1|STARTED|Study Period 2: Therapy Phase||89
7885453|NCT00785538|19406080|P4|NOT COMPLETED|Treatment Period||1
7885454|NCT00785538|19406081|P3|NOT COMPLETED|Treatment Period||2
7885455|NCT00785538|19406082|P2|NOT COMPLETED|Treatment Period||2
7885456|NCT00785538|19406083|P1|NOT COMPLETED|Treatment Period||1
7885457|NCT00785538|19406080|P4|COMPLETED|Treatment Period||1
7885458|NCT00785538|19406081|P3|COMPLETED|Treatment Period||4
7885459|NCT00785538|19406082|P2|COMPLETED|Treatment Period||7
7885460|NCT00785538|19406083|P1|COMPLETED|Treatment Period||6
7885461|NCT00785538|19406080|P4|Received at Least 1 Dose of Study Drug|Treatment Period||2
7885462|NCT00785538|19406081|P3|Received at Least 1 Dose of Study Drug|Treatment Period||6
7885463|NCT00785538|19406082|P2|Received at Least 1 Dose of Study Drug|Treatment Period||9
7885464|NCT00785538|19406083|P1|Received at Least 1 Dose of Study Drug|Treatment Period||7
7885465|NCT00785538|19406080|P4|STARTED|Treatment Period||2
7885466|NCT00785538|19406081|P3|STARTED|Treatment Period||6
7885467|NCT00785538|19406082|P2|STARTED|Treatment Period||9
7885468|NCT00785538|19406083|P1|STARTED|Treatment Period||7
7885469|NCT00785538|19406080|P4|NOT COMPLETED|PK Period||0
7885470|NCT00785538|19406081|P3|NOT COMPLETED|PK Period||0
7885471|NCT00785538|19406082|P2|NOT COMPLETED|PK Period||0
7885472|NCT00785538|19406083|P1|NOT COMPLETED|PK Period||0
7885473|NCT00785538|19406080|P4|COMPLETED|PK Period||0
7885474|NCT00785538|19406081|P3|COMPLETED|PK Period||1
7885475|NCT00785538|19406082|P2|COMPLETED|PK Period||1
7885476|NCT00785538|19406083|P1|COMPLETED|PK Period||7
7885477|NCT00785538|19406080|P4|STARTED|PK Period||0
7885478|NCT00785538|19406081|P3|STARTED|PK Period||1
7885479|NCT00785538|19406082|P2|STARTED|PK Period||1
7885480|NCT00785538|19406083|P1|STARTED|PK Period||7
7885481|NCT00785512|19406131|P2|NOT COMPLETED|Overall Study||4
7885482|NCT00785512|19406132|P1|NOT COMPLETED|Overall Study||3
7885483|NCT00785512|19406131|P2|COMPLETED|Overall Study||101
7885485|NCT00785512|19406131|P2|STARTED|Overall Study||105
7885486|NCT00785512|19406132|P1|STARTED|Overall Study||102
7885487|NCT00785486|19406141|P1|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0
7885488|NCT00785486|19406141|P1|COMPLETED|Midazolam With Qualaquin at Steady State||23
7885489|NCT00785486|19406141|P1|STARTED|Midazolam With Qualaquin at Steady State||23
7885490|NCT00785486|19406141|P1|NOT COMPLETED|Qualaquin Alone at Steady State||0
7885491|NCT00785486|19406141|P1|COMPLETED|Qualaquin Alone at Steady State||23
7885492|NCT00785486|19406141|P1|STARTED|Qualaquin Alone at Steady State||23
7885493|NCT00785486|19406141|P1|NOT COMPLETED|3 Day Washout||0
7885494|NCT00785486|19406141|P1|COMPLETED|3 Day Washout||23
7885495|NCT00785486|19406141|P1|STARTED|3 Day Washout||23
7885496|NCT00785486|19406141|P1|NOT COMPLETED|Midazolam Alone||1
7885497|NCT00785486|19406141|P1|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23
7885498|NCT00785486|19406141|P1|STARTED|Midazolam Alone||24
7885499|NCT00785356|19406165|P1|NOT COMPLETED|Overall Study||8
7885500|NCT00785356|19406165|P1|COMPLETED|Overall Study||0
7885501|NCT00785356|19406165|P1|STARTED|Overall Study||8
7885502|NCT00785291|19406176|P3|NOT COMPLETED|Overall Study||106
7885503|NCT00785291|19406177|P2|NOT COMPLETED|Overall Study||149
7885504|NCT00785291|19406178|P1|NOT COMPLETED|Overall Study||136
7885505|NCT00785291|19406176|P3|COMPLETED|Overall Study||139
7885506|NCT00785291|19406177|P2|COMPLETED|Overall Study||122
7885507|NCT00785291|19406178|P1|COMPLETED|Overall Study||147
7885508|NCT00785291|19406176|P3|STARTED|Overall Study||245
7885509|NCT00785291|19406177|P2|STARTED|Overall Study||271
7885510|NCT00785291|19406178|P1|STARTED|Overall Study||283
7885511|NCT00785213|19406198|P1|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1
7885512|NCT00785213|19406198|P1|COMPLETED|Rosiglitazone With Quinine Sulfate||18
7885513|NCT00785213|19406198|P1|STARTED|Rosiglitazone With Quinine Sulfate||19
7885514|NCT00785213|19406198|P1|NOT COMPLETED|Quinine Sulfate Alone||4
7885515|NCT00785213|19406198|P1|COMPLETED|Quinine Sulfate Alone||19
7885516|NCT00785213|19406198|P1|STARTED|Quinine Sulfate Alone||23
7885517|NCT00785213|19406198|P1|NOT COMPLETED|2 Day Washout Period||0
7885518|NCT00785213|19406198|P1|COMPLETED|2 Day Washout Period||23
7885519|NCT00785213|19406198|P1|STARTED|2 Day Washout Period||23
7885520|NCT00785213|19406198|P1|NOT COMPLETED|Rosiglitazone Alone||0
7885521|NCT00785213|19406198|P1|COMPLETED|Rosiglitazone Alone||23
7885522|NCT00785213|19406198|P1|STARTED|Rosiglitazone Alone||23
7885523|NCT00785044|19406209|P1|NOT COMPLETED|Overall Study||496
7885524|NCT00785044|19406209|P1|COMPLETED|Overall Study|Data for 471 participants (MBG313) combined with data from MBG311 and MBG312 for efficacy analysis|468
7885525|NCT00785044|19406209|P1|Enrolled Participants|Overall Study|Out of 964 from MBG311 and MBG312 HF participants, 471 enrolled into the extension MBG313 study.|471
7885526|NCT00785044|19406209|P1|STARTED|Overall Study|Eligible to participate in MBG313|964
7885527|NCT00784979|19406214|P1|NOT COMPLETED|Overall Study||6
7885528|NCT00784979|19406214|P1|COMPLETED|Overall Study||20
7885529|NCT00784979|19406214|P1|STARTED|Overall Study||26
7885530|NCT00784927|19406218|P1|NOT COMPLETED|Overall Study||3
7885531|NCT00784927|19406218|P1|COMPLETED|Overall Study||33
7885532|NCT00784927|19406218|P1|STARTED|Overall Study||36
7885533|NCT00784875|19406230|P4|NOT COMPLETED|Period D||1
7885534|NCT00784875|19406231|P3|NOT COMPLETED|Period D||6
7885535|NCT00784875|19406232|P2|NOT COMPLETED|Period D||4
7885536|NCT00784875|19406233|P1|NOT COMPLETED|Period D||5
7885537|NCT00784875|19406230|P4|COMPLETED|Period D||87
7885538|NCT00784875|19406231|P3|COMPLETED|Period D||88
7885539|NCT00784875|19406232|P2|COMPLETED|Period D||85
7885540|NCT00784875|19406233|P1|COMPLETED|Period D||86
7885541|NCT00784875|19406230|P4|STARTED|Period D||88
7885542|NCT00784875|19406231|P3|STARTED|Period D||94
7885543|NCT00784875|19406232|P2|STARTED|Period D||89
7885544|NCT00784875|19406233|P1|STARTED|Period D||91
7885545|NCT00784875|19406230|P4|NOT COMPLETED|Period C||7
7885546|NCT00784875|19406231|P3|NOT COMPLETED|Period C||13
7885547|NCT00784875|19406232|P2|NOT COMPLETED|Period C||6
7885548|NCT00784875|19406233|P1|NOT COMPLETED|Period C||7
7885549|NCT00784875|19406230|P4|COMPLETED|Period C||91
7885550|NCT00784875|19406231|P3|COMPLETED|Period C||84
7885551|NCT00784875|19406232|P2|COMPLETED|Period C||91
7885552|NCT00784875|19406233|P1|COMPLETED|Period C||96
7885553|NCT00784875|19406230|P4|STARTED|Period C||98
7885554|NCT00784875|19406231|P3|STARTED|Period C||97
7885555|NCT00784875|19406232|P2|STARTED|Period C||97
7885556|NCT00784875|19406233|P1|STARTED|Period C||103
7885557|NCT00784875|19406230|P4|NOT COMPLETED|Period B - Efficacy Endpoint||19
7885558|NCT00784875|19406231|P3|NOT COMPLETED|Period B - Efficacy Endpoint||21
7885559|NCT00784875|19406232|P2|NOT COMPLETED|Period B - Efficacy Endpoint||12
7885560|NCT00784875|19406233|P1|NOT COMPLETED|Period B - Efficacy Endpoint||14
7885561|NCT00784875|19406230|P4|COMPLETED|Period B - Efficacy Endpoint||98
7885562|NCT00784875|19406231|P3|COMPLETED|Period B - Efficacy Endpoint||96
7885563|NCT00784875|19406232|P2|COMPLETED|Period B - Efficacy Endpoint||101
7885564|NCT00784875|19406233|P1|COMPLETED|Period B - Efficacy Endpoint||100
7885565|NCT00784875|19406230|P4|Cohort 2|Period B - Efficacy Endpoint||101
7885566|NCT00784875|19406231|P3|Cohort 2|Period B - Efficacy Endpoint||102
7885567|NCT00784875|19406232|P2|Cohort 2|Period B - Efficacy Endpoint||102
7885568|NCT00784875|19406233|P1|Cohort 2|Period B - Efficacy Endpoint||102
7885569|NCT00784875|19406230|P4|STARTED|Period B - Efficacy Endpoint||117
7885570|NCT00784875|19406231|P3|STARTED|Period B - Efficacy Endpoint||117
7885571|NCT00784875|19406232|P2|STARTED|Period B - Efficacy Endpoint||113
7885572|NCT00784875|19406233|P1|STARTED|Period B - Efficacy Endpoint||114
7885573|NCT00784875|19406230|P4|NOT COMPLETED|Period A - Baseline||182
7885574|NCT00784875|19406231|P3|NOT COMPLETED|Period A - Baseline||0
7885575|NCT00784875|19406232|P2|NOT COMPLETED|Period A - Baseline||0
7885576|NCT00784875|19406233|P1|NOT COMPLETED|Period A - Baseline||0
7885577|NCT00784875|19406230|P4|COMPLETED|Period A - Baseline||461
7885578|NCT00784875|19406231|P3|COMPLETED|Period A - Baseline||0
7885579|NCT00784875|19406232|P2|COMPLETED|Period A - Baseline||0
7885580|NCT00784875|19406233|P1|COMPLETED|Period A - Baseline||0
7885581|NCT00784875|19406230|P4|STARTED|Period A - Baseline||643
7885582|NCT00784875|19406231|P3|STARTED|Period A - Baseline||0
7885583|NCT00784875|19406232|P2|STARTED|Period A - Baseline||0
7885584|NCT00784875|19406233|P1|STARTED|Period A - Baseline||0
7885585|NCT00784849|19406347|P1|NOT COMPLETED|Overall Study||0
7885586|NCT00784849|19406347|P1|COMPLETED|Overall Study||62
7885587|NCT00784849|19406347|P1|STARTED|Overall Study||62
7885588|NCT00784836|19406353|P1|NOT COMPLETED|Overall Study||3
7885589|NCT00784836|19406353|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0
7885590|NCT00784836|19406353|P1|STARTED|Overall Study||3
7885591|NCT00784810|19406360|P2|NOT COMPLETED|Overall Study||49
7885592|NCT00784810|19406361|P1|NOT COMPLETED|Overall Study||63
7885593|NCT00784810|19406360|P2|COMPLETED|Overall Study||74
7885594|NCT00784810|19406361|P1|COMPLETED|Overall Study||61
7885595|NCT00784810|19406360|P2|STARTED|Overall Study||123
7885596|NCT00784810|19406361|P1|STARTED|Overall Study||124
7885597|NCT00784784|19406371|P2|NOT COMPLETED|Overall Study||2
7885598|NCT00784784|19406372|P1|NOT COMPLETED|Overall Study||2
7885599|NCT00784784|19406371|P2|COMPLETED|Overall Study||40
7885600|NCT00784784|19406372|P1|COMPLETED|Overall Study||20
7885601|NCT00784784|19406371|P2|STARTED|Overall Study||42
7885602|NCT00784784|19406372|P1|STARTED|Overall Study||22
7885603|NCT00784758|19406382|P2|NOT COMPLETED|Overall Study||0
7885604|NCT00784758|19406383|P1|NOT COMPLETED|Overall Study||4
7885605|NCT00784758|19406382|P2|COMPLETED|Overall Study||39
7885606|NCT00784758|19406383|P1|COMPLETED|Overall Study||38
7885607|NCT00784758|19406382|P2|Completed Treatment|Overall Study||39
7885608|NCT00784758|19406383|P1|Completed Treatment|Overall Study||40
7885609|NCT00784758|19406382|P2|Began Treatment|Overall Study||39
7885610|NCT00784758|19406383|P1|Began Treatment|Overall Study||41
7885611|NCT00784758|19406382|P2|STARTED|Overall Study||39
7885612|NCT00784758|19406383|P1|STARTED|Overall Study||42
7885613|NCT00784719|19406432|P7|NOT COMPLETED|Overall Study||5
7885614|NCT00784719|19406433|P6|NOT COMPLETED|Overall Study||3
7885615|NCT00784719|19406434|P5|NOT COMPLETED|Overall Study||6
7885616|NCT00784719|19406435|P4|NOT COMPLETED|Overall Study||0
7885617|NCT00784719|19406436|P3|NOT COMPLETED|Overall Study||1
7885618|NCT00784719|19406437|P2|NOT COMPLETED|Overall Study||3
7885619|NCT00784719|19406438|P1|NOT COMPLETED|Overall Study||3
7885620|NCT00784719|19406432|P7|COMPLETED|Overall Study||42
7885621|NCT00784719|19406433|P6|COMPLETED|Overall Study||41
7885622|NCT00784719|19406434|P5|COMPLETED|Overall Study||42
7885623|NCT00784719|19406435|P4|COMPLETED|Overall Study||48
7885624|NCT00784719|19406436|P3|COMPLETED|Overall Study||46
7885625|NCT00784719|19406437|P2|COMPLETED|Overall Study||43
7885626|NCT00784719|19406438|P1|COMPLETED|Overall Study||44
7885627|NCT00784719|19406432|P7|STARTED|Overall Study||47
7885628|NCT00784719|19406433|P6|STARTED|Overall Study||44
7885629|NCT00784719|19406434|P5|STARTED|Overall Study||48
7885630|NCT00784719|19406435|P4|STARTED|Overall Study||48
7885631|NCT00784719|19406436|P3|STARTED|Overall Study||47
7885632|NCT00784719|19406437|P2|STARTED|Overall Study||46
7885633|NCT00784719|19406438|P1|STARTED|Overall Study||47
7885634|NCT00784654|19406608|P3|NOT COMPLETED|Randomized Withdrawal Period||63
7885635|NCT00784654|19406609|P2|NOT COMPLETED|Randomized Withdrawal Period||18
7885636|NCT00784654|19406610|P1|NOT COMPLETED|Randomized Withdrawal Period||0
7885637|NCT00784654|19406608|P3|COMPLETED|Randomized Withdrawal Period||16
7885638|NCT00784654|19406609|P2|COMPLETED|Randomized Withdrawal Period||60
7885639|NCT00784654|19406610|P1|COMPLETED|Randomized Withdrawal Period||0
7885640|NCT00784654|19406608|P3|STARTED|Randomized Withdrawal Period||79
7885641|NCT00784654|19406609|P2|STARTED|Randomized Withdrawal Period||78
7885642|NCT00784654|19406610|P1|STARTED|Randomized Withdrawal Period||0
7885643|NCT00784654|19406608|P3|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
7885644|NCT00784654|19406609|P2|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
7885645|NCT00784654|19406610|P1|NOT COMPLETED|Open-Label Period (Non-Randomized)||111
7885646|NCT00784654|19406608|P3|COMPLETED|Open-Label Period (Non-Randomized)||0
7885647|NCT00784654|19406609|P2|COMPLETED|Open-Label Period (Non-Randomized)||0
7885648|NCT00784654|19406610|P1|COMPLETED|Open-Label Period (Non-Randomized)||165
7885649|NCT00784654|19406608|P3|STARTED|Open-Label Period (Non-Randomized)||0
7885650|NCT00784654|19406609|P2|STARTED|Open-Label Period (Non-Randomized)||0
7885651|NCT00784654|19406610|P1|STARTED|Open-Label Period (Non-Randomized)||276
7885652|NCT00784641|19406645|P3|NOT COMPLETED|Overall Study||2
7885653|NCT00784641|19406646|P2|NOT COMPLETED|Overall Study||3
7885654|NCT00784641|19406647|P1|NOT COMPLETED|Overall Study||6
7885655|NCT00784641|19406645|P3|COMPLETED|Overall Study||187
7885656|NCT00784641|19406646|P2|COMPLETED|Overall Study||186
7885657|NCT00784641|19406647|P1|COMPLETED|Overall Study||183
7885658|NCT00784641|19406645|P3|STARTED|Overall Study||189
7885659|NCT00784641|19406646|P2|STARTED|Overall Study||189
7885660|NCT00784641|19406647|P1|STARTED|Overall Study||189
7885661|NCT00784563|19406658|P3|NOT COMPLETED|Year 3||3
7885662|NCT00784563|19406659|P2|NOT COMPLETED|Year 3||0
7885663|NCT00784563|19406660|P1|NOT COMPLETED|Year 3||0
7885664|NCT00784563|19406658|P3|COMPLETED|Year 3||14
7885665|NCT00784563|19406659|P2|COMPLETED|Year 3||0
7885666|NCT00784563|19406660|P1|COMPLETED|Year 3||0
7885667|NCT00784563|19406658|P3|STARTED|Year 3||17
7885668|NCT00784563|19406659|P2|STARTED|Year 3||0
7885669|NCT00784563|19406660|P1|STARTED|Year 3||0
7885670|NCT00784563|19406658|P3|NOT COMPLETED|Years 1 & 2||0
7885671|NCT00784563|19406659|P2|NOT COMPLETED|Years 1 & 2||5
7885672|NCT00784563|19406660|P1|NOT COMPLETED|Years 1 & 2||3
7885673|NCT00784563|19406658|P3|COMPLETED|Years 1 & 2||0
7885674|NCT00784563|19406659|P2|COMPLETED|Years 1 & 2||17
7885675|NCT00784563|19406660|P1|COMPLETED|Years 1 & 2||18
7885676|NCT00784563|19406658|P3|STARTED|Years 1 & 2||0
7885677|NCT00784563|19406659|P2|STARTED|Years 1 & 2||22
7885678|NCT00784563|19406660|P1|STARTED|Years 1 & 2||21
7885679|NCT00784550|19406678|P2|NOT COMPLETED|Overall Study||42
7885680|NCT00784550|19406679|P1|NOT COMPLETED|Overall Study||36
7885681|NCT00784550|19406678|P2|COMPLETED|Overall Study||127
7885682|NCT00784550|19406679|P1|COMPLETED|Overall Study||137
7885683|NCT00784550|19406678|P2|STARTED|Overall Study||169
7885684|NCT00784550|19406679|P1|STARTED|Overall Study||173
7885685|NCT00784524|19406695|P1|NOT COMPLETED|Overall Study||0
7885686|NCT00784524|19406695|P1|COMPLETED|Overall Study||14
7885687|NCT00784524|19406695|P1|STARTED|Overall Study||14
7885688|NCT00784459|19406705|P2|NOT COMPLETED|Overall Study||2
7885689|NCT00784459|19406706|P1|NOT COMPLETED|Overall Study||0
7885690|NCT00784459|19406705|P2|COMPLETED|Overall Study||11
7885691|NCT00784459|19406706|P1|COMPLETED|Overall Study||11
7885692|NCT00784459|19406705|P2|STARTED|Overall Study||13
7885693|NCT00784459|19406706|P1|STARTED|Overall Study||11
7885694|NCT00784368|19406717|P3|NOT COMPLETED|Overall Study||11
7885695|NCT00784368|19406718|P2|NOT COMPLETED|Overall Study||11
7885696|NCT00784368|19406719|P1|NOT COMPLETED|Overall Study||8
7885697|NCT00784368|19406717|P3|COMPLETED|Overall Study||12
7885698|NCT00784368|19406718|P2|COMPLETED|Overall Study||5
7885699|NCT00784368|19406719|P1|COMPLETED|Overall Study||8
7885700|NCT00784368|19406717|P3|STARTED|Overall Study||23
7885701|NCT00784368|19406718|P2|STARTED|Overall Study||16
7885702|NCT00784368|19406719|P1|STARTED|Overall Study||16
7885703|NCT00784303|19406755|P2|NOT COMPLETED|Overall Study||0
7885704|NCT00784303|19406756|P1|NOT COMPLETED|Overall Study||0
7885705|NCT00784303|19406755|P2|COMPLETED|Overall Study||59
7885706|NCT00784303|19406756|P1|COMPLETED|Overall Study||58
7885707|NCT00784303|19406755|P2|STARTED|Overall Study||59
7885708|NCT00784303|19406756|P1|STARTED|Overall Study||58
7885709|NCT00784277|19406795|P7|NOT COMPLETED|ER Treatment||15
7885710|NCT00784277|19406796|P6|NOT COMPLETED|ER Treatment||24
7885711|NCT00784277|19406797|P5|NOT COMPLETED|ER Treatment||9
7885712|NCT00784277|19406798|P4|NOT COMPLETED|ER Treatment||0
7885713|NCT00784277|19406799|P3|NOT COMPLETED|ER Treatment||0
7885714|NCT00784277|19406800|P2|NOT COMPLETED|ER Treatment||0
7885715|NCT00784277|19406801|P1|NOT COMPLETED|ER Treatment||0
7885716|NCT00784277|19406795|P7|COMPLETED|ER Treatment||76
7885717|NCT00784277|19406796|P6|COMPLETED|ER Treatment||226
7885718|NCT00784277|19406797|P5|COMPLETED|ER Treatment||113
7885719|NCT00784277|19406798|P4|COMPLETED|ER Treatment||0
7885720|NCT00784277|19406799|P3|COMPLETED|ER Treatment||0
7885721|NCT00784277|19406800|P2|COMPLETED|ER Treatment||0
7885722|NCT00784277|19406801|P1|COMPLETED|ER Treatment||0
7885723|NCT00784277|19406795|P7|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91
7885724|NCT00784277|19406796|P6|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250
7885725|NCT00784277|19406797|P5|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122
7885726|NCT00784277|19406798|P4|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
7885727|NCT00784277|19406799|P3|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
7885728|NCT00784277|19406800|P2|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
7885729|NCT00784277|19406801|P1|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
7885730|NCT00784277|19406795|P7|NOT COMPLETED|IR Treatment||0
7885731|NCT00784277|19406796|P6|NOT COMPLETED|IR Treatment||0
7885732|NCT00784277|19406797|P5|NOT COMPLETED|IR Treatment||0
7885733|NCT00784277|19406798|P4|NOT COMPLETED|IR Treatment||43
7885734|NCT00784277|19406799|P3|NOT COMPLETED|IR Treatment||28
7885735|NCT00784277|19406800|P2|NOT COMPLETED|IR Treatment||17
7885736|NCT00784277|19406801|P1|NOT COMPLETED|IR Treatment||16
7885737|NCT00784277|19406795|P7|COMPLETED|IR Treatment||0
7885738|NCT00784277|19406796|P6|COMPLETED|IR Treatment||0
7885739|NCT00784277|19406797|P5|COMPLETED|IR Treatment||0
7885740|NCT00784277|19406798|P4|COMPLETED|IR Treatment||100
7885741|NCT00784277|19406799|P3|COMPLETED|IR Treatment||126
7885742|NCT00784277|19406800|P2|COMPLETED|IR Treatment||134
7885743|NCT00784277|19406801|P1|COMPLETED|IR Treatment||132
7885744|NCT00784277|19406795|P7|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
7885745|NCT00784277|19406796|P6|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
7885746|NCT00784277|19406797|P5|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
7885747|NCT00784277|19406798|P4|STARTED|IR Treatment||143
7885748|NCT00784277|19406799|P3|STARTED|IR Treatment||154
7885749|NCT00784277|19406800|P2|STARTED|IR Treatment||151
7885750|NCT00784277|19406801|P1|STARTED|IR Treatment||148
7885751|NCT00784238|19406818|P1|NOT COMPLETED|Overall Study||119
7885752|NCT00784238|19406818|P1|COMPLETED|Overall Study||170
7885753|NCT00784238|19406818|P1|STARTED|Overall Study||289
7885754|NCT00784225|19406863|P4|NOT COMPLETED|Overall Study||0
7885755|NCT00784225|19406864|P3|NOT COMPLETED|Overall Study||0
7885756|NCT00784225|19406865|P2|NOT COMPLETED|Overall Study||0
7885757|NCT00784225|19406866|P1|NOT COMPLETED|Overall Study||0
7885758|NCT00784225|19406863|P4|COMPLETED|Overall Study||3374
7885759|NCT00784225|19406864|P3|COMPLETED|Overall Study||3369
7885760|NCT00784225|19406865|P2|COMPLETED|Overall Study||3357
7885761|NCT00784225|19406866|P1|COMPLETED|Overall Study||3375
7885762|NCT00784225|19406863|P4|STARTED|Overall Study||3374
7885763|NCT00784225|19406864|P3|STARTED|Overall Study||3369
7885764|NCT00784225|19406865|P2|STARTED|Overall Study||3357
7885765|NCT00784225|19406866|P1|STARTED|Overall Study||3375
7885766|NCT00784147|19406890|P2|NOT COMPLETED|Overall Study||9
7885767|NCT00784147|19406891|P1|NOT COMPLETED|Overall Study||8
7885768|NCT00784147|19406890|P2|COMPLETED|Overall Study||45
7885769|NCT00784147|19406891|P1|COMPLETED|Overall Study||51
7885770|NCT00784147|19406890|P2|STARTED|Overall Study||54
7885771|NCT00784147|19406891|P1|STARTED|Overall Study||59
7885772|NCT00784134|19406911|P2|NOT COMPLETED|Overall Study||6
7885773|NCT00784134|19406912|P1|NOT COMPLETED|Overall Study||3
7885774|NCT00784134|19406911|P2|COMPLETED|Overall Study||245
7885775|NCT00784134|19406912|P1|COMPLETED|Overall Study||246
7885776|NCT00784134|19406911|P2|STARTED|Overall Study||251
7885777|NCT00784134|19406912|P1|STARTED|Overall Study||249
7885778|NCT00784095|19407011|P3|NOT COMPLETED|Overall Study||1
7885779|NCT00784095|19407012|P2|NOT COMPLETED|Overall Study||1
7885780|NCT00784095|19407013|P1|NOT COMPLETED|Overall Study||0
7885781|NCT00784095|19407011|P3|COMPLETED|Overall Study||11
7885782|NCT00784095|19407012|P2|COMPLETED|Overall Study||11
7885783|NCT00784095|19407013|P1|COMPLETED|Overall Study||12
7885784|NCT00784095|19407011|P3|STARTED|Overall Study||12
7885785|NCT00784095|19407012|P2|STARTED|Overall Study||12
7885786|NCT00784095|19407013|P1|STARTED|Overall Study||12
7885787|NCT00784043|19407035|P2|NOT COMPLETED|Overall Study||6
7885788|NCT00784043|19407036|P1|NOT COMPLETED|Overall Study||31
7885789|NCT00784043|19407035|P2|COMPLETED|Overall Study||0
7885790|NCT00784043|19407036|P1|COMPLETED|Overall Study||0
7885791|NCT00784043|19407035|P2|STARTED|Overall Study||6
7885792|NCT00784043|19407036|P1|STARTED|Overall Study||31
7885793|NCT00784030|19407048|P2|NOT COMPLETED|Overall Study||0
7885794|NCT00784030|19407049|P1|NOT COMPLETED|Overall Study||0
7885795|NCT00784030|19407048|P2|COMPLETED|Overall Study||10
7885796|NCT00784030|19407049|P1|COMPLETED|Overall Study||13
7885797|NCT00784030|19407048|P2|STARTED|Overall Study||10
7885798|NCT00784030|19407049|P1|STARTED|Overall Study||13
7885799|NCT00783965|19407057|P2|NOT COMPLETED|Second Intervention (24 Months)||9
7885800|NCT00783965|19407058|P1|NOT COMPLETED|Second Intervention (24 Months)||0
7885801|NCT00783965|19407057|P2|COMPLETED|Second Intervention (24 Months)||16
7885802|NCT00783965|19407058|P1|COMPLETED|Second Intervention (24 Months)||2
7885803|NCT00783965|19407057|P2|STARTED|Second Intervention (24 Months)||25
7885804|NCT00783965|19407058|P1|STARTED|Second Intervention (24 Months)||2
7885805|NCT00783965|19407057|P2|NOT COMPLETED|First Intervention (12 Months)||4
7885806|NCT00783965|19407058|P1|NOT COMPLETED|First Intervention (12 Months)||3
7885807|NCT00783965|19407057|P2|COMPLETED|First Intervention (12 Months)||25
7885808|NCT00783965|19407058|P1|COMPLETED|First Intervention (12 Months)||2
7885809|NCT00783965|19407057|P2|STARTED|First Intervention (12 Months)||29
7885810|NCT00783965|19407058|P1|STARTED|First Intervention (12 Months)||5
7885811|NCT00783952|19407066|P1|NOT COMPLETED|Overall Study||0
7885812|NCT00783952|19407066|P1|COMPLETED|Overall Study||8
7885813|NCT00783952|19407066|P1|STARTED|Overall Study||8
7885814|NCT00783835|19407071|P1|NOT COMPLETED|Overall Study||10
7885815|NCT00783835|19407071|P1|COMPLETED|Overall Study||50
7885816|NCT00783835|19407071|P1|STARTED|Overall Study||60
7885817|NCT00783796|19407083|P1|NOT COMPLETED|Overall Study||6
7885818|NCT00783796|19407083|P1|COMPLETED|Overall Study||144
7885819|NCT00783796|19407083|P1|STARTED|Overall Study||150
7885820|NCT00783718|19407188|P7|NOT COMPLETED|Maintenance Phase||195
7885821|NCT00783718|19407189|P6|NOT COMPLETED|Maintenance Phase||41
7885822|NCT00783718|19407190|P5|NOT COMPLETED|Maintenance Phase||45
7885823|NCT00783718|19407191|P4|NOT COMPLETED|Maintenance Phase||78
7885824|NCT00783718|19407192|P3|NOT COMPLETED|Maintenance Phase||0
7885825|NCT00783718|19407193|P2|NOT COMPLETED|Maintenance Phase||0
7885826|NCT00783718|19407194|P1|NOT COMPLETED|Maintenance Phase||105
7885827|NCT00783718|19407188|P7|COMPLETED|Maintenance Phase||135
7885828|NCT00783718|19407189|P6|COMPLETED|Maintenance Phase||84
7885829|NCT00783718|19407190|P5|COMPLETED|Maintenance Phase||77
7885830|NCT00783718|19407191|P4|COMPLETED|Maintenance Phase||48
7885831|NCT00783718|19407192|P3|COMPLETED|Maintenance Phase||0
7885832|NCT00783718|19407193|P2|COMPLETED|Maintenance Phase||0
7885833|NCT00783718|19407194|P1|COMPLETED|Maintenance Phase||30
7885834|NCT00783718|19407188|P7|STARTED|Maintenance Phase||330
7885835|NCT00783718|19407189|P6|STARTED|Maintenance Phase||125
7885836|NCT00783718|19407190|P5|STARTED|Maintenance Phase||122
7885837|NCT00783718|19407191|P4|STARTED|Maintenance Phase||126
7885838|NCT00783718|19407192|P3|STARTED|Maintenance Phase||0
7885839|NCT00783718|19407193|P2|STARTED|Maintenance Phase||0
7885840|NCT00783718|19407194|P1|STARTED|Maintenance Phase||135
7885841|NCT00783718|19407188|P7|NOT COMPLETED|Induction Phase||0
7885842|NCT00783718|19407189|P6|NOT COMPLETED|Induction Phase||0
7885843|NCT00783718|19407190|P5|NOT COMPLETED|Induction Phase||0
7885844|NCT00783718|19407191|P4|NOT COMPLETED|Induction Phase||0
7885845|NCT00783718|19407192|P3|NOT COMPLETED|Induction Phase||36
7885846|NCT00783718|19407193|P2|NOT COMPLETED|Induction Phase||7
7885847|NCT00783718|19407194|P1|NOT COMPLETED|Induction Phase||14
7885848|NCT00783718|19407188|P7|COMPLETED|Induction Phase||0
7885849|NCT00783718|19407189|P6|COMPLETED|Induction Phase||0
7885850|NCT00783718|19407190|P5|COMPLETED|Induction Phase||0
7885851|NCT00783718|19407191|P4|COMPLETED|Induction Phase||0
7885852|NCT00783718|19407192|P3|COMPLETED|Induction Phase||485
7885853|NCT00783718|19407193|P2|COMPLETED|Induction Phase||218
7885854|NCT00783718|19407194|P1|COMPLETED|Induction Phase||135
7885855|NCT00783718|19407188|P7|STARTED|Induction Phase||0
7885856|NCT00783718|19407189|P6|STARTED|Induction Phase||0
7885857|NCT00783718|19407190|P5|STARTED|Induction Phase||0
7885858|NCT00783718|19407191|P4|STARTED|Induction Phase||0
7885859|NCT00783718|19407192|P3|STARTED|Induction Phase||521
7885860|NCT00783718|19407193|P2|STARTED|Induction Phase||225
7885861|NCT00783718|19407194|P1|STARTED|Induction Phase||149
7885862|NCT00783705|19407222|P2|NOT COMPLETED|Overall Study||5
7885863|NCT00783705|19407223|P1|NOT COMPLETED|Overall Study||6
7885864|NCT00783705|19407222|P2|COMPLETED|Overall Study||36
7885865|NCT00783705|19407223|P1|COMPLETED|Overall Study||38
7885866|NCT00783705|19407222|P2|STARTED|Overall Study||41
7885867|NCT00783705|19407223|P1|STARTED|Overall Study||44
7885868|NCT00783692|19407270|P7|NOT COMPLETED|Maintenance Phase||249
7885869|NCT00783692|19407271|P6|NOT COMPLETED|Maintenance Phase||72
7885870|NCT00783692|19407272|P5|NOT COMPLETED|Maintenance Phase||81
7885871|NCT00783692|19407273|P4|NOT COMPLETED|Maintenance Phase||89
7885872|NCT00783692|19407274|P3|NOT COMPLETED|Maintenance Phase||0
7885873|NCT00783692|19407275|P2|NOT COMPLETED|Maintenance Phase||0
7885874|NCT00783692|19407276|P1|NOT COMPLETED|Maintenance Phase||95
7885875|NCT00783692|19407270|P7|COMPLETED|Maintenance Phase||163
7885876|NCT00783692|19407271|P6|COMPLETED|Maintenance Phase||82
7885877|NCT00783692|19407272|P5|COMPLETED|Maintenance Phase||73
7885878|NCT00783692|19407273|P4|COMPLETED|Maintenance Phase||64
7885879|NCT00783692|19407274|P3|COMPLETED|Maintenance Phase||0
7885880|NCT00783692|19407275|P2|COMPLETED|Maintenance Phase||0
7885881|NCT00783692|19407276|P1|COMPLETED|Maintenance Phase||42
7885882|NCT00783692|19407270|P7|STARTED|Maintenance Phase||412
7885883|NCT00783692|19407271|P6|STARTED|Maintenance Phase||154
7885884|NCT00783692|19407272|P5|STARTED|Maintenance Phase||154
7885885|NCT00783692|19407273|P4|STARTED|Maintenance Phase||153
7885886|NCT00783692|19407274|P3|STARTED|Maintenance Phase||0
7885887|NCT00783692|19407275|P2|STARTED|Maintenance Phase||0
7885888|NCT00783692|19407276|P1|STARTED|Maintenance Phase||137
7885889|NCT00783692|19407270|P7|NOT COMPLETED|Induction Phase||0
7885890|NCT00783692|19407271|P6|NOT COMPLETED|Induction Phase||0
7885891|NCT00783692|19407272|P5|NOT COMPLETED|Induction Phase||0
7885892|NCT00783692|19407273|P4|NOT COMPLETED|Induction Phase||0
7885893|NCT00783692|19407274|P3|NOT COMPLETED|Induction Phase||74
7885894|NCT00783692|19407275|P2|NOT COMPLETED|Induction Phase||21
7885895|NCT00783692|19407276|P1|NOT COMPLETED|Induction Phase||11
7885896|NCT00783692|19407270|P7|COMPLETED|Induction Phase||0
7885897|NCT00783692|19407271|P6|COMPLETED|Induction Phase||0
7885898|NCT00783692|19407272|P5|COMPLETED|Induction Phase||0
7885899|NCT00783692|19407273|P4|COMPLETED|Induction Phase||0
7885900|NCT00783692|19407274|P3|COMPLETED|Induction Phase||674
7885901|NCT00783692|19407275|P2|COMPLETED|Induction Phase||199
7885902|NCT00783692|19407276|P1|COMPLETED|Induction Phase||137
7885903|NCT00783692|19407270|P7|Treated|Induction Phase||0
7885904|NCT00783692|19407271|P6|Treated|Induction Phase||0
7885905|NCT00783692|19407272|P5|Treated|Induction Phase||0
7885906|NCT00783692|19407273|P4|Treated|Induction Phase||0
7885907|NCT00783692|19407274|P3|Treated|Induction Phase||747
7885908|NCT00783692|19407275|P2|Treated|Induction Phase||220
7885909|NCT00783692|19407276|P1|Treated|Induction Phase||148
7885910|NCT00783692|19407270|P7|STARTED|Induction Phase||0
7885911|NCT00783692|19407271|P6|STARTED|Induction Phase||0
7885912|NCT00783692|19407272|P5|STARTED|Induction Phase||0
7885913|NCT00783692|19407273|P4|STARTED|Induction Phase||0
7885914|NCT00783692|19407274|P3|STARTED|Induction Phase||748
7885915|NCT00783692|19407275|P2|STARTED|Induction Phase||220
7885916|NCT00783692|19407276|P1|STARTED|Induction Phase||148
7885917|NCT00783614|19407303|P4|NOT COMPLETED|Overall Study||0
7885918|NCT00783614|19407304|P3|NOT COMPLETED|Overall Study||0
7885919|NCT00783614|19407305|P2|NOT COMPLETED|Overall Study||0
7885920|NCT00783614|19407306|P1|NOT COMPLETED|Overall Study||0
7885921|NCT00783614|19407303|P4|COMPLETED|Overall Study||5
7885922|NCT00783614|19407304|P3|COMPLETED|Overall Study||5
7885923|NCT00783614|19407305|P2|COMPLETED|Overall Study||6
7885924|NCT00783614|19407306|P1|COMPLETED|Overall Study||6
7885925|NCT00783614|19407303|P4|STARTED|Overall Study||5
7885926|NCT00783614|19407304|P3|STARTED|Overall Study||5
7885927|NCT00783614|19407305|P2|STARTED|Overall Study||6
7885928|NCT00783614|19407306|P1|STARTED|Overall Study||6
7885929|NCT00783432|19407322|P2|NOT COMPLETED|Overall Study||78
7885930|NCT00783432|19407323|P1|NOT COMPLETED|Overall Study||85
7885931|NCT00783432|19407322|P2|COMPLETED|Overall Study||354
7885932|NCT00783432|19407323|P1|COMPLETED|Overall Study||345
7885933|NCT00783432|19407322|P2|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432
7885934|NCT00783432|19407323|P1|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430
7885935|NCT00783302|19407333|P1|NOT COMPLETED|Overall Study||35
7885936|NCT00783302|19407333|P1|COMPLETED|Overall Study||850
7885937|NCT00783302|19407333|P1|STARTED|Overall Study||885
7885938|NCT00783289|19407355|P4|NOT COMPLETED|Overall Study||0
7885939|NCT00783289|19407356|P3|NOT COMPLETED|Overall Study||0
7885940|NCT00783289|19407357|P2|NOT COMPLETED|Overall Study||1
7885941|NCT00783289|19407358|P1|NOT COMPLETED|Overall Study||0
7885942|NCT00783289|19407355|P4|COMPLETED|Overall Study||6
7885943|NCT00783289|19407356|P3|COMPLETED|Overall Study||6
7885944|NCT00783289|19407357|P2|COMPLETED|Overall Study||6
7885945|NCT00783289|19407358|P1|COMPLETED|Overall Study||6
7885946|NCT00783289|19407355|P4|STARTED|Overall Study||6
7885947|NCT00783289|19407356|P3|STARTED|Overall Study||6
7885948|NCT00783289|19407357|P2|STARTED|Overall Study||7
7885949|NCT00783289|19407358|P1|STARTED|Overall Study||6
7885950|NCT00783263|19407388|P4|NOT COMPLETED|Overall Study||3
7885951|NCT00783263|19407389|P3|NOT COMPLETED|Overall Study||3
7885952|NCT00783263|19407390|P2|NOT COMPLETED|Overall Study||2
7885953|NCT00783263|19407391|P1|NOT COMPLETED|Overall Study||4
7885954|NCT00783263|19407388|P4|COMPLETED|Overall Study||118
7885955|NCT00783263|19407389|P3|COMPLETED|Overall Study||119
7885956|NCT00783263|19407390|P2|COMPLETED|Overall Study||96
7885957|NCT00783263|19407391|P1|COMPLETED|Overall Study||95
7885958|NCT00783263|19407388|P4|STARTED|Overall Study||121
7885959|NCT00783263|19407389|P3|STARTED|Overall Study||122
7885960|NCT00783263|19407390|P2|STARTED|Overall Study||98
7885961|NCT00783263|19407391|P1|STARTED|Overall Study||99
7885962|NCT00783224|19407421|P4|NOT COMPLETED|Overall Study||2
7885963|NCT00783224|19407422|P3|NOT COMPLETED|Overall Study||1
7885964|NCT00783224|19407423|P2|NOT COMPLETED|Overall Study||0
7885965|NCT00783224|19407424|P1|NOT COMPLETED|Overall Study||0
7885966|NCT00783224|19407421|P4|COMPLETED|Overall Study||140
7885967|NCT00783224|19407422|P3|COMPLETED|Overall Study||142
7885968|NCT00783224|19407423|P2|COMPLETED|Overall Study||34
7885969|NCT00783224|19407424|P1|COMPLETED|Overall Study||32
7885970|NCT00783224|19407421|P4|STARTED|Overall Study||142
7885971|NCT00783224|19407422|P3|STARTED|Overall Study||143
7885972|NCT00783224|19407423|P2|STARTED|Overall Study||34
7885973|NCT00783224|19407424|P1|STARTED|Overall Study||32
7885974|NCT00783198|19407436|P3|NOT COMPLETED|Overall Study||42
7885975|NCT00783198|19407437|P2|NOT COMPLETED|Overall Study||43
7885976|NCT00783198|19407438|P1|NOT COMPLETED|Overall Study||57
7885977|NCT00783198|19407436|P3|COMPLETED|Overall Study||146
7885978|NCT00783198|19407437|P2|COMPLETED|Overall Study||144
7885979|NCT00783198|19407438|P1|COMPLETED|Overall Study||133
7885980|NCT00783198|19407436|P3|STARTED|Overall Study||188
7885981|NCT00783198|19407437|P2|STARTED|Overall Study||187
7885982|NCT00783198|19407438|P1|STARTED|Overall Study||190
7885983|NCT00783094|19407461|P3|NOT COMPLETED|Open-Label Extension Period||30
7885984|NCT00783094|19407462|P2|NOT COMPLETED|Open-Label Extension Period||19
7885985|NCT00783094|19407463|P1|NOT COMPLETED|Open-Label Extension Period||22
7885986|NCT00783094|19407461|P3|COMPLETED|Open-Label Extension Period||101
7885987|NCT00783094|19407462|P2|COMPLETED|Open-Label Extension Period||109
7885988|NCT00783094|19407463|P1|COMPLETED|Open-Label Extension Period||113
7885989|NCT00783094|19407461|P3|STARTED|Open-Label Extension Period||131
7885990|NCT00783094|19407462|P2|STARTED|Open-Label Extension Period||128
7885991|NCT00783094|19407463|P1|STARTED|Open-Label Extension Period||135
7885992|NCT00783094|19407461|P3|NOT COMPLETED|Randomized Double-Blind Treatment Period||9
7885993|NCT00783094|19407462|P2|NOT COMPLETED|Randomized Double-Blind Treatment Period||12
7885994|NCT00783094|19407463|P1|NOT COMPLETED|Randomized Double-Blind Treatment Period||7
7885995|NCT00783094|19407461|P3|COMPLETED|Randomized Double-Blind Treatment Period||131
7885996|NCT00783094|19407462|P2|COMPLETED|Randomized Double-Blind Treatment Period||128
7885997|NCT00783094|19407463|P1|COMPLETED|Randomized Double-Blind Treatment Period||135
7885998|NCT00783094|19407461|P3|STARTED|Randomized Double-Blind Treatment Period||140
7885999|NCT00783094|19407462|P2|STARTED|Randomized Double-Blind Treatment Period||140
7886000|NCT00783094|19407463|P1|STARTED|Randomized Double-Blind Treatment Period||142
7886001|NCT00782834|19407539|P1|NOT COMPLETED|Treatment Phase||1
7886002|NCT00782834|19407539|P1|COMPLETED|Treatment Phase||13
7886003|NCT00782834|19407539|P1|STARTED|Treatment Phase||14
7886004|NCT00782834|19407539|P1|NOT COMPLETED|Screened Patients||1
7886005|NCT00782834|19407539|P1|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14
7886006|NCT00782834|19407539|P1|STARTED|Screened Patients||15
7886007|NCT00782821|19407548|P4|NOT COMPLETED|Overall Study||2
7886008|NCT00782821|19407549|P3|NOT COMPLETED|Overall Study||1
7886009|NCT00782821|19407550|P2|NOT COMPLETED|Overall Study||0
7886010|NCT00782821|19407551|P1|NOT COMPLETED|Overall Study||0
7886011|NCT00782821|19407548|P4|COMPLETED|Overall Study||8
7886012|NCT00782821|19407549|P3|COMPLETED|Overall Study||9
7886013|NCT00782821|19407550|P2|COMPLETED|Overall Study||10
7886014|NCT00782821|19407551|P1|COMPLETED|Overall Study||10
7886015|NCT00782821|19407548|P4|STARTED|Overall Study||10
7886016|NCT00782821|19407549|P3|STARTED|Overall Study||10
7886017|NCT00782821|19407550|P2|STARTED|Overall Study||10
7886018|NCT00782821|19407551|P1|STARTED|Overall Study||10
7886019|NCT00782795|19407579|P2|NOT COMPLETED|Overall Study||2
7886020|NCT00782795|19407580|P1|NOT COMPLETED|Overall Study||1
7886021|NCT00782795|19407579|P2|COMPLETED|Overall Study||6
7886022|NCT00782795|19407580|P1|COMPLETED|Overall Study||16
7886023|NCT00782795|19407579|P2|24 Week Appointment|Overall Study||7
7886024|NCT00782795|19407580|P1|24 Week Appointment|Overall Study||16
7886025|NCT00782795|19407579|P2|6 Weeks (1st Apptment)|Overall Study||7
7886026|NCT00782795|19407580|P1|6 Weeks (1st Apptment)|Overall Study||16
7886027|NCT00782795|19407579|P2|STARTED|Overall Study||8
7886028|NCT00782795|19407580|P1|STARTED|Overall Study||17
7886029|NCT00782756|19407612|P1|NOT COMPLETED|Overall Study||0
7886030|NCT00782756|19407612|P1|COMPLETED|Overall Study||40
7886031|NCT00782756|19407612|P1|STARTED|Overall Study||40
7886032|NCT00782717|19407620|P2|NOT COMPLETED|Overall Study||28
7886033|NCT00782717|19407621|P1|NOT COMPLETED|Overall Study||15
7886034|NCT00782717|19407620|P2|COMPLETED|Overall Study||102
7886035|NCT00782717|19407621|P1|COMPLETED|Overall Study||118
7886036|NCT00782717|19407620|P2|STARTED|Overall Study||130
7886037|NCT00782717|19407621|P1|STARTED|Overall Study||133
7886038|NCT00782639|19407631|P2|NOT COMPLETED|Overall Study||0
7886039|NCT00782639|19407632|P1|NOT COMPLETED|Overall Study||0
7886040|NCT00782639|19407631|P2|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11
7886041|NCT00782639|19407632|P1|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12
7886042|NCT00782639|19407631|P2|STARTED|Overall Study||11
7886043|NCT00782639|19407632|P1|STARTED|Overall Study||12
7886044|NCT00782626|19407648|P1|NOT COMPLETED|Overall Study||7
7886045|NCT00782626|19407648|P1|COMPLETED|Overall Study||16
7886046|NCT00782626|19407648|P1|STARTED|Overall Study||23
7886047|NCT00782509|19407655|P3|NOT COMPLETED|Overall Study||36
7886048|NCT00782509|19407656|P2|NOT COMPLETED|Overall Study||24
7886049|NCT00782509|19407657|P1|NOT COMPLETED|Overall Study||41
7886050|NCT00782509|19407655|P3|COMPLETED|Overall Study||181
7886051|NCT00782509|19407656|P2|COMPLETED|Overall Study||185
7886052|NCT00782509|19407657|P1|COMPLETED|Overall Study||175
7886053|NCT00782509|19407655|P3|STARTED|Overall Study||217
7886054|NCT00782509|19407656|P2|STARTED|Overall Study||209
7886055|NCT00782509|19407657|P1|STARTED|Overall Study||216
7886056|NCT00782496|19407850|P2|NOT COMPLETED|Overall Study||15
7886057|NCT00782496|19407851|P1|NOT COMPLETED|Overall Study||14
7886058|NCT00782496|19407850|P2|COMPLETED|Overall Study||90
7886059|NCT00782496|19407851|P1|COMPLETED|Overall Study||92
7886060|NCT00782496|19407850|P2|STARTED|Overall Study||105
7886061|NCT00782496|19407851|P1|STARTED|Overall Study||106
7886062|NCT00782483|19407858|P1|NOT COMPLETED|Overall Study||6
7886063|NCT00782483|19407858|P1|COMPLETED|Overall Study||0
7886064|NCT00782483|19407858|P1|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6
7886065|NCT00782418|19407862|P7|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
7886066|NCT00782418|19407863|P6|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
7886067|NCT00782418|19407864|P5|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
7886068|NCT00782418|19407865|P4|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
7886069|NCT00782418|19407866|P3|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
7886070|NCT00782418|19407867|P2|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
7886071|NCT00782418|19407868|P1|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
7886072|NCT00782418|19407862|P7|COMPLETED|Period 2 Procedure/Treatment Groups||4
7886073|NCT00782418|19407863|P6|COMPLETED|Period 2 Procedure/Treatment Groups||4
7886074|NCT00782418|19407864|P5|COMPLETED|Period 2 Procedure/Treatment Groups||3
7886075|NCT00782418|19407865|P4|COMPLETED|Period 2 Procedure/Treatment Groups||1
7886076|NCT00782418|19407866|P3|COMPLETED|Period 2 Procedure/Treatment Groups||4
7886077|NCT00782418|19407867|P2|COMPLETED|Period 2 Procedure/Treatment Groups||4
7886078|NCT00782418|19407868|P1|COMPLETED|Period 2 Procedure/Treatment Groups||3
7886079|NCT00782418|19407862|P7|STARTED|Period 2 Procedure/Treatment Groups||4
7886080|NCT00782418|19407863|P6|STARTED|Period 2 Procedure/Treatment Groups||4
7886081|NCT00782418|19407864|P5|STARTED|Period 2 Procedure/Treatment Groups||3
7886082|NCT00782418|19407865|P4|STARTED|Period 2 Procedure/Treatment Groups||1
7886083|NCT00782418|19407866|P3|STARTED|Period 2 Procedure/Treatment Groups||4
7886084|NCT00782418|19407867|P2|STARTED|Period 2 Procedure/Treatment Groups||4
7886085|NCT00782418|19407868|P1|STARTED|Period 2 Procedure/Treatment Groups||3
7886086|NCT00782418|19407862|P7|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
7886087|NCT00782418|19407863|P6|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
7886088|NCT00782418|19407864|P5|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
7886089|NCT00782418|19407865|P4|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
7886090|NCT00782418|19407866|P3|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
7886091|NCT00782418|19407867|P2|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
7886092|NCT00782418|19407868|P1|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2
7886093|NCT00782418|19407862|P7|COMPLETED|Period 1 Procedure/Treatment Groups||4
7886094|NCT00782418|19407863|P6|COMPLETED|Period 1 Procedure/Treatment Groups||4
7886095|NCT00782418|19407864|P5|COMPLETED|Period 1 Procedure/Treatment Groups||4
7886096|NCT00782418|19407865|P4|COMPLETED|Period 1 Procedure/Treatment Groups||2
7886097|NCT00782418|19407866|P3|COMPLETED|Period 1 Procedure/Treatment Groups||4
7886098|NCT00782418|19407867|P2|COMPLETED|Period 1 Procedure/Treatment Groups||4
7886099|NCT00782418|19407868|P1|COMPLETED|Period 1 Procedure/Treatment Groups||1
7886100|NCT00782418|19407862|P7|STARTED|Period 1 Procedure/Treatment Groups||4
7886101|NCT00782418|19407863|P6|STARTED|Period 1 Procedure/Treatment Groups||5
7886102|NCT00782418|19407864|P5|STARTED|Period 1 Procedure/Treatment Groups||5
7886103|NCT00782418|19407865|P4|STARTED|Period 1 Procedure/Treatment Groups||2
7886104|NCT00782418|19407866|P3|STARTED|Period 1 Procedure/Treatment Groups||4
7886105|NCT00782418|19407867|P2|STARTED|Period 1 Procedure/Treatment Groups||4
7886106|NCT00782418|19407868|P1|STARTED|Period 1 Procedure/Treatment Groups||3
7886107|NCT00782379|19407888|P1|NOT COMPLETED|Overall Study||0
7886108|NCT00782379|19407888|P1|COMPLETED|Overall Study||20
7886109|NCT00782379|19407888|P1|STARTED|Overall Study||20
7886110|NCT00782340|19407905|P3|NOT COMPLETED|Randomized Double Blind||0
7886111|NCT00782340|19407906|P2|NOT COMPLETED|Randomized Double Blind||0
7886112|NCT00782340|19407907|P1|NOT COMPLETED|Randomized Double Blind||0
7886113|NCT00782340|19407905|P3|COMPLETED|Randomized Double Blind||80
7886114|NCT00782340|19407906|P2|COMPLETED|Randomized Double Blind||82
7886115|NCT00782340|19407907|P1|COMPLETED|Randomized Double Blind||0
7886116|NCT00782340|19407905|P3|STARTED|Randomized Double Blind||80
7886117|NCT00782340|19407906|P2|STARTED|Randomized Double Blind||82
7886118|NCT00782340|19407907|P1|STARTED|Randomized Double Blind||0
7886119|NCT00782340|19407905|P3|NOT COMPLETED|Open Label Titration||0
7886120|NCT00782340|19407906|P2|NOT COMPLETED|Open Label Titration||0
7886121|NCT00782340|19407907|P1|NOT COMPLETED|Open Label Titration||101
7886122|NCT00782340|19407905|P3|COMPLETED|Open Label Titration||0
7886123|NCT00782340|19407906|P2|COMPLETED|Open Label Titration||0
7886124|NCT00782340|19407907|P1|COMPLETED|Open Label Titration||162
7886125|NCT00782340|19407905|P3|STARTED|Open Label Titration||0
7886126|NCT00782340|19407906|P2|STARTED|Open Label Titration||0
7886127|NCT00782340|19407907|P1|STARTED|Open Label Titration||263
7886128|NCT00782288|19407933|P3|NOT COMPLETED|Overall Study||0
7886129|NCT00782288|19407934|P2|NOT COMPLETED|Overall Study||0
7886130|NCT00782288|19407935|P1|NOT COMPLETED|Overall Study||0
7886131|NCT00782288|19407933|P3|COMPLETED|Overall Study||8
7886132|NCT00782288|19407934|P2|COMPLETED|Overall Study||8
7886133|NCT00782288|19407935|P1|COMPLETED|Overall Study||8
7886134|NCT00782288|19407933|P3|STARTED|Overall Study||8
7886135|NCT00782288|19407934|P2|STARTED|Overall Study||8
7886136|NCT00782288|19407935|P1|STARTED|Overall Study||8
7886137|NCT00782275|19407977|P1|NOT COMPLETED|Overall Study||41
7886138|NCT00782275|19407977|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
7886139|NCT00782275|19407977|P1|Prior VEGFR Response Evaluable|Overall Study|One patient was unevaluable and therefore excluded from related subgroup analyses.|39
7886140|NCT00782275|19407977|P1|Treated|Overall Study||40
7886141|NCT00782275|19407977|P1|STARTED|Overall Study||41
7886142|NCT00782210|19407986|P3|NOT COMPLETED|Overall Study||35
7886143|NCT00782210|19407987|P2|NOT COMPLETED|Overall Study||35
7886144|NCT00782210|19407988|P1|NOT COMPLETED|Overall Study||50
7886145|NCT00782210|19407986|P3|COMPLETED|Overall Study||172
7886146|NCT00782210|19407987|P2|COMPLETED|Overall Study||173
7886147|NCT00782210|19407988|P1|COMPLETED|Overall Study||159
7886148|NCT00782210|19407986|P3|STARTED|Overall Study||207
7886149|NCT00782210|19407987|P2|STARTED|Overall Study||208
7886150|NCT00782210|19407988|P1|STARTED|Overall Study||209
7886151|NCT00782184|19408181|P2|NOT COMPLETED|Overall Study||5
7886152|NCT00782184|19408182|P1|NOT COMPLETED|Overall Study||4
7886153|NCT00782184|19408181|P2|COMPLETED|Overall Study||125
7886154|NCT00782184|19408182|P1|COMPLETED|Overall Study||116
7886155|NCT00782184|19408181|P2|STARTED|Overall Study||130
7886156|NCT00782184|19408182|P1|STARTED|Overall Study||120
7886157|NCT00782171|19408219|P2|NOT COMPLETED|Overall Study||19
7886158|NCT00782171|19408220|P1|NOT COMPLETED|Overall Study||22
7886159|NCT00782171|19408219|P2|COMPLETED|Overall Study||115
7886160|NCT00782171|19408220|P1|COMPLETED|Overall Study||124
7886161|NCT00782171|19408219|P2|Surgery (Baseline)|Overall Study||128
7886162|NCT00782171|19408220|P1|Surgery (Baseline)|Overall Study||138
7886163|NCT00782171|19408219|P2|1 Year|Overall Study||120
7886164|NCT00782171|19408220|P1|1 Year|Overall Study||131
7886165|NCT00782171|19408219|P2|20-23 Weeks|Overall Study||124
7886166|NCT00782171|19408220|P1|20-23 Weeks|Overall Study||135
7886167|NCT00782171|19408219|P2|STARTED|Overall Study||134
7886168|NCT00782171|19408220|P1|STARTED|Overall Study||146
7886169|NCT00782067|19408252|P1|NOT COMPLETED|Overall Study||116
7886170|NCT00782067|19408252|P1|COMPLETED|Overall Study||0
7886171|NCT00782067|19408252|P1|Primary Efficacy Population (PEP)|Overall Study||89
7886172|NCT00782067|19408252|P1|Safety Set (SS)|Overall Study||116
7886173|NCT00782067|19408252|P1|STARTED|Overall Study||116
7886174|NCT00781963|19408264|P2|NOT COMPLETED|Overall Study||2
7886175|NCT00781963|19408265|P1|NOT COMPLETED|Overall Study||17
7886176|NCT00781963|19408264|P2|COMPLETED|Overall Study||51
7886177|NCT00781963|19408265|P1|COMPLETED|Overall Study||89
7886178|NCT00781963|19408264|P2|STARTED|Overall Study||53
7886179|NCT00781963|19408265|P1|STARTED|Overall Study||106
7886180|NCT00781950|19408283|P2|NOT COMPLETED|Overall Study||13
7886181|NCT00781950|19408284|P1|NOT COMPLETED|Overall Study||11
7886182|NCT00781950|19408283|P2|COMPLETED|Overall Study||45
7886183|NCT00781950|19408284|P1|COMPLETED|Overall Study||41
7886184|NCT00781950|19408283|P2|STARTED|Overall Study||58
7886185|NCT00781950|19408284|P1|STARTED|Overall Study||52
7886186|NCT00781937|19408294|P2|NOT COMPLETED|Follow up Period (Week 56-68)||5
7886187|NCT00781937|19408295|P1|NOT COMPLETED|Follow up Period (Week 56-68)||6
7886188|NCT00781937|19408294|P2|COMPLETED|Follow up Period (Week 56-68)||141
7886189|NCT00781937|19408295|P1|COMPLETED|Follow up Period (Week 56-68)||153
7886190|NCT00781937|19408294|P2|STARTED|Follow up Period (Week 56-68)||146
7886191|NCT00781937|19408295|P1|STARTED|Follow up Period (Week 56-68)||159
7886192|NCT00781937|19408294|P2|NOT COMPLETED|Main Trial Period Through Week 56||64
7886193|NCT00781937|19408295|P1|NOT COMPLETED|Main Trial Period Through Week 56||53
7886194|NCT00781937|19408294|P2|COMPLETED|Main Trial Period Through Week 56||146
7886195|NCT00781937|19408295|P1|COMPLETED|Main Trial Period Through Week 56||159
7886196|NCT00781937|19408294|P2|STARTED|Main Trial Period Through Week 56||210
7886197|NCT00781937|19408295|P1|STARTED|Main Trial Period Through Week 56||212
7886198|NCT00781911|19408353|P2|NOT COMPLETED|Overall Study||8
7886199|NCT00781911|19408354|P1|NOT COMPLETED|Overall Study||6
7886200|NCT00781911|19408353|P2|COMPLETED|Overall Study||4
7886201|NCT00781911|19408354|P1|COMPLETED|Overall Study||25
7886202|NCT00781911|19408353|P2|Received at Least 1 Dose of Study Drug|Overall Study||12
7886203|NCT00781911|19408354|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
7886204|NCT00781911|19408353|P2|STARTED|Overall Study||12
7886205|NCT00781911|19408354|P1|STARTED|Overall Study||31
7886206|NCT00781898|19408382|P2|NOT COMPLETED|Overall Study||29
7886207|NCT00781898|19408383|P1|NOT COMPLETED|Overall Study||34
7886208|NCT00781898|19408382|P2|COMPLETED|Overall Study||126
7886209|NCT00781898|19408383|P1|COMPLETED|Overall Study||119
7886210|NCT00781898|19408382|P2|STARTED|Overall Study||155
7886211|NCT00781898|19408383|P1|STARTED|Overall Study||153
7886212|NCT00781885|19408389|P1|NOT COMPLETED|Overall Study||1
7886213|NCT00781885|19408389|P1|COMPLETED|Overall Study||18
7886214|NCT00781885|19408389|P1|Received at Least 1 Dose of Study Drug|Overall Study||19
7886215|NCT00781885|19408389|P1|STARTED|Overall Study||19
7886216|NCT00781859|19408406|P2|NOT COMPLETED|Overall Study||9
7886217|NCT00781859|19408407|P1|NOT COMPLETED|Overall Study||19
7886218|NCT00781859|19408406|P2|COMPLETED|Overall Study||98
7886219|NCT00781859|19408407|P1|COMPLETED|Overall Study||200
7886220|NCT00781859|19408406|P2|STARTED|Overall Study||107
7886221|NCT00781859|19408407|P1|STARTED|Overall Study||219
7886222|NCT00781768|19408417|P2|NOT COMPLETED|Overall Study||2
7886223|NCT00781768|19408418|P1|NOT COMPLETED|Overall Study||0
7886224|NCT00781768|19408417|P2|COMPLETED|Overall Study||90
7886225|NCT00781768|19408418|P1|COMPLETED|Overall Study||89
7886226|NCT00781768|19408417|P2|STARTED|Overall Study||92
7886227|NCT00781768|19408418|P1|STARTED|Overall Study||89
7886228|NCT00781599|19408426|P2|NOT COMPLETED|Overall Study||4
7886229|NCT00781599|19408427|P1|NOT COMPLETED|Overall Study||7
7886230|NCT00781599|19408426|P2|COMPLETED|Overall Study||32
7886231|NCT00781599|19408427|P1|COMPLETED|Overall Study||29
7886232|NCT00781599|19408426|P2|STARTED|Overall Study||36
7886233|NCT00781599|19408427|P1|STARTED|Overall Study||36
7886234|NCT00781508|19408441|P2|NOT COMPLETED|Overall Study||0
7886235|NCT00781508|19408442|P1|NOT COMPLETED|Overall Study||0
7886236|NCT00781508|19408441|P2|COMPLETED|Overall Study||5
7886237|NCT00781508|19408442|P1|COMPLETED|Overall Study||5
7886238|NCT00781508|19408441|P2|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
7886239|NCT00781508|19408442|P1|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
7886240|NCT00781456|19408452|P2|NOT COMPLETED|Overall Study||16
7886241|NCT00781456|19408453|P1|NOT COMPLETED|Overall Study||21
7886242|NCT00781456|19408452|P2|COMPLETED|Overall Study||35
7886243|NCT00781456|19408453|P1|COMPLETED|Overall Study||37
7886244|NCT00781456|19408452|P2|Received Study Drug|Overall Study||49
7886245|NCT00781456|19408453|P1|Received Study Drug|Overall Study||57
7886246|NCT00781456|19408452|P2|STARTED|Overall Study||51
7886247|NCT00781456|19408453|P1|STARTED|Overall Study||58
7886248|NCT00781391|19408476|P3|NOT COMPLETED|Overall Study||784
7886249|NCT00781391|19408477|P2|NOT COMPLETED|Overall Study||807
7886250|NCT00781391|19408478|P1|NOT COMPLETED|Overall Study||879
7886251|NCT00781391|19408476|P3|COMPLETED|Overall Study||6250
7886252|NCT00781391|19408477|P2|COMPLETED|Overall Study||6228
7886253|NCT00781391|19408478|P1|COMPLETED|Overall Study||6157
7886254|NCT00781391|19408476|P3|Per Protocol Analysis Set|Overall Study||6982
7886255|NCT00781391|19408477|P2|Per Protocol Analysis Set|Overall Study||6995
7886256|NCT00781391|19408478|P1|Per Protocol Analysis Set|Overall Study||6993
7886257|NCT00781391|19408476|P3|mITT Analysis Set (Received Drug)|Overall Study||7002
7886258|NCT00781391|19408477|P2|mITT Analysis Set (Received Drug)|Overall Study||7012
7886259|NCT00781391|19408478|P1|mITT Analysis Set (Received Drug)|Overall Study||7012
7886260|NCT00781391|19408476|P3|Safety Analysis Set (Received Drug)|Overall Study||7002
7886261|NCT00781391|19408477|P2|Safety Analysis Set (Received Drug)|Overall Study||7012
7886262|NCT00781391|19408478|P1|Safety Analysis Set (Received Drug)|Overall Study||7012
7886263|NCT00781391|19408476|P3|STARTED|Overall Study||7034
7886264|NCT00781391|19408477|P2|STARTED|Overall Study||7035
7886265|NCT00781391|19408478|P1|STARTED|Overall Study||7036
7886266|NCT00781365|19408512|P2|NOT COMPLETED|Overall Study||36
7886267|NCT00781365|19408513|P1|NOT COMPLETED|Overall Study||34
7886268|NCT00781365|19408512|P2|COMPLETED|Overall Study|completed both 6 and 12 month follow up|186
7886269|NCT00781365|19408513|P1|COMPLETED|Overall Study|completed both 6 and 12 month follow up|194
7886270|NCT00781365|19408512|P2|STARTED|Overall Study||222
7886271|NCT00781365|19408513|P1|STARTED|Overall Study||228
7886272|NCT00781326|19408523|P1|NOT COMPLETED|Phase 2||0
7886273|NCT00781326|19408523|P1|COMPLETED|Phase 2||0
7886274|NCT00781326|19408523|P1|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0
7886275|NCT00781326|19408523|P1|NOT COMPLETED|Phase I||4
7886276|NCT00781326|19408523|P1|COMPLETED|Phase I||2
7886277|NCT00781326|19408523|P1|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6
7886278|NCT00781274|19408527|P1|NOT COMPLETED|Overall Study||2
7886279|NCT00781274|19408527|P1|COMPLETED|Overall Study||30
7886280|NCT00781274|19408527|P1|STARTED|Overall Study||32
7886281|NCT00781079|19408533|P2|NOT COMPLETED|Overall Study||17
7886282|NCT00781079|19408534|P1|NOT COMPLETED|Overall Study||27
7886283|NCT00781079|19408533|P2|COMPLETED|Overall Study||116
7886284|NCT00781079|19408534|P1|COMPLETED|Overall Study||122
7886285|NCT00781079|19408533|P2|STARTED|Overall Study||133
7886286|NCT00781079|19408534|P1|STARTED|Overall Study||149
7886287|NCT00780975|19408550|P1|NOT COMPLETED|Overall Study||8
7886288|NCT00780975|19408550|P1|COMPLETED|Overall Study||0
7886289|NCT00780975|19408550|P1|STARTED|Overall Study||8
7886290|NCT00780962|19408561|P2|NOT COMPLETED|Overall Study||27
7886291|NCT00780962|19408562|P1|NOT COMPLETED|Overall Study||15
7886292|NCT00780962|19408561|P2|COMPLETED|Overall Study||172
7886293|NCT00780962|19408562|P1|COMPLETED|Overall Study||185
7886294|NCT00780962|19408561|P2|Second Blood Draw (Outcome Measurement)|Overall Study||172
7886295|NCT00780962|19408562|P1|Second Blood Draw (Outcome Measurement)|Overall Study||185
7886296|NCT00780962|19408561|P2|STARTED|Overall Study||199
7886297|NCT00780962|19408562|P1|STARTED|Overall Study||200
7886298|NCT00780910|19408568|P1|NOT COMPLETED|Overall Study||2
7886299|NCT00780910|19408568|P1|COMPLETED|Overall Study||107
7886300|NCT00780910|19408568|P1|STARTED|Overall Study||109
7886301|NCT00780741|19408574|P2|NOT COMPLETED|Overall Study||10
7886302|NCT00780741|19408575|P1|NOT COMPLETED|Overall Study||7
7886303|NCT00780741|19408574|P2|COMPLETED|Overall Study|18 months of age (±4 weeks)|71
7886304|NCT00780741|19408575|P1|COMPLETED|Overall Study|18 months of age (±4 weeks)|75
7886305|NCT00780741|19408574|P2|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67
7886306|NCT00780741|19408575|P1|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73
7886307|NCT00780741|19408574|P2|STARTED|Overall Study|randomized|81
7886308|NCT00780741|19408575|P1|STARTED|Overall Study|randomized|82
7886309|NCT00780715|19408591|P4|NOT COMPLETED|Overall Study||0
7886310|NCT00780715|19408592|P3|NOT COMPLETED|Overall Study||0
7886311|NCT00780715|19408593|P2|NOT COMPLETED|Overall Study||0
7886312|NCT00780715|19408594|P1|NOT COMPLETED|Overall Study||0
7886313|NCT00780715|19408591|P4|COMPLETED|Overall Study||11
7886314|NCT00780715|19408592|P3|COMPLETED|Overall Study||6
7886315|NCT00780715|19408593|P2|COMPLETED|Overall Study||6
7886316|NCT00780715|19408594|P1|COMPLETED|Overall Study||6
7886317|NCT00780715|19408591|P4|STARTED|Overall Study||11
7886318|NCT00780715|19408592|P3|STARTED|Overall Study||6
7886319|NCT00780715|19408593|P2|STARTED|Overall Study||6
7886320|NCT00780715|19408594|P1|STARTED|Overall Study||6
7886321|NCT00780676|19408609|P5|NOT COMPLETED|Overall Study||0
7886322|NCT00780676|19408610|P4|NOT COMPLETED|Overall Study||0
7886323|NCT00780676|19408611|P3|NOT COMPLETED|Overall Study||0
7886324|NCT00780676|19408612|P2|NOT COMPLETED|Overall Study||0
7886325|NCT00780676|19408613|P1|NOT COMPLETED|Overall Study||0
7886326|NCT00780676|19408609|P5|COMPLETED|Overall Study||0
7886327|NCT00780676|19408610|P4|COMPLETED|Overall Study||0
7886328|NCT00780676|19408611|P3|COMPLETED|Overall Study||13
7886329|NCT00780676|19408612|P2|COMPLETED|Overall Study||8
7886330|NCT00780676|19408613|P1|COMPLETED|Overall Study||9
7886331|NCT00780676|19408609|P5|STARTED|Overall Study||0
7886332|NCT00780676|19408610|P4|STARTED|Overall Study||0
7886333|NCT00780676|19408611|P3|STARTED|Overall Study||13
7886334|NCT00780676|19408612|P2|STARTED|Overall Study||8
7886335|NCT00780676|19408613|P1|STARTED|Overall Study||9
7886336|NCT00780572|19408621|P2|NOT COMPLETED|Overall Study||0
7886337|NCT00780572|19408622|P1|NOT COMPLETED|Overall Study||0
7886338|NCT00780572|19408621|P2|COMPLETED|Overall Study||298
7886339|NCT00780572|19408622|P1|COMPLETED|Overall Study||297
7886340|NCT00780572|19408621|P2|STARTED|Overall Study||298
7886341|NCT00780572|19408622|P1|STARTED|Overall Study||297
7886342|NCT00780559|19408630|P2|NOT COMPLETED|Overall Study||7
7886343|NCT00780559|19408631|P1|NOT COMPLETED|Overall Study||3
7886344|NCT00780559|19408630|P2|COMPLETED|Overall Study||33
7886345|NCT00780559|19408631|P1|COMPLETED|Overall Study||29
7886346|NCT00780559|19408630|P2|STARTED|Overall Study||40
7886347|NCT00780559|19408631|P1|STARTED|Overall Study||32
7886348|NCT00780494|19408645|P1|NOT COMPLETED|Overall Study||0
7886349|NCT00780494|19408645|P1|COMPLETED|Overall Study||35
7886350|NCT00780494|19408645|P1|STARTED|Overall Study||35
7886351|NCT00780481|19408654|P1|NOT COMPLETED|Overall Study||0
7886352|NCT00780481|19408654|P1|COMPLETED|Overall Study||13
7886353|NCT00780481|19408654|P1|STARTED|Overall Study||13
7886354|NCT00780455|19408663|P2|NOT COMPLETED|Overall Study||0
7886355|NCT00780455|19408664|P1|NOT COMPLETED|Overall Study||0
7886356|NCT00780455|19408663|P2|COMPLETED|Overall Study||2
7886357|NCT00780455|19408664|P1|COMPLETED|Overall Study||2
7886358|NCT00780455|19408663|P2|STARTED|Overall Study||2
7886359|NCT00780455|19408664|P1|STARTED|Overall Study||2
7886360|NCT00780442|19408690|P2|NOT COMPLETED|Overall Study||0
7886361|NCT00780442|19408691|P1|NOT COMPLETED|Overall Study||0
7886362|NCT00780442|19408690|P2|COMPLETED|Overall Study||15
7886363|NCT00780442|19408691|P1|COMPLETED|Overall Study||12
7886364|NCT00780442|19408690|P2|STARTED|Overall Study||15
7886365|NCT00780442|19408691|P1|STARTED|Overall Study||12
7886366|NCT00780416|19408699|P2|NOT COMPLETED|Overall Study||9
7886367|NCT00780416|19408700|P1|NOT COMPLETED|Overall Study||12
7886368|NCT00780416|19408699|P2|COMPLETED|Overall Study||54
7886369|NCT00780416|19408700|P1|COMPLETED|Overall Study||114
7886370|NCT00780416|19408699|P2|STARTED|Overall Study||63
7886371|NCT00780416|19408700|P1|STARTED|Overall Study||126
7886372|NCT00780403|19408706|P2|NOT COMPLETED|Second Intervention||0
7886373|NCT00780403|19408707|P1|NOT COMPLETED|Second Intervention||0
7886374|NCT00780403|19408706|P2|COMPLETED|Second Intervention||111
7886375|NCT00780403|19408707|P1|COMPLETED|Second Intervention||109
7886376|NCT00780403|19408706|P2|STARTED|Second Intervention||111
7886377|NCT00780403|19408707|P1|STARTED|Second Intervention||109
7886378|NCT00780403|19408706|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
7886379|NCT00780403|19408707|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
7886380|NCT00780403|19408706|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||111
7886381|NCT00780403|19408707|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
7886382|NCT00780403|19408706|P2|STARTED|Interval Between Doses (8-10 Minutes)||111
7886383|NCT00780403|19408707|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
7886384|NCT00780403|19408706|P2|NOT COMPLETED|First Intervention||0
7886385|NCT00780403|19408707|P1|NOT COMPLETED|First Intervention||0
7886386|NCT00780403|19408706|P2|COMPLETED|First Intervention||111
7886387|NCT00780403|19408707|P1|COMPLETED|First Intervention||109
7886388|NCT00780403|19408706|P2|STARTED|First Intervention||111
7886389|NCT00780403|19408707|P1|STARTED|First Intervention||109
7886390|NCT00780338|19408716|P2|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5
7886391|NCT00780338|19408717|P1|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13
7886392|NCT00780338|19408716|P2|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159
7886393|NCT00780338|19408717|P1|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156
7886394|NCT00780338|19408716|P2|STARTED|Mid to Post (1 Year; 2 Years in Total)||164
7886395|NCT00780338|19408717|P1|STARTED|Mid to Post (1 Year; 2 Years in Total)||169
7886396|NCT00780338|19408716|P2|NOT COMPLETED|Baseline to Mid (1 Year)||38
7886397|NCT00780338|19408717|P1|NOT COMPLETED|Baseline to Mid (1 Year)||5
7886398|NCT00780338|19408716|P2|COMPLETED|Baseline to Mid (1 Year)||164
7886399|NCT00780338|19408717|P1|COMPLETED|Baseline to Mid (1 Year)||169
7886400|NCT00780338|19408716|P2|STARTED|Baseline to Mid (1 Year)||202
7886401|NCT00780338|19408717|P1|STARTED|Baseline to Mid (1 Year)||174
7886402|NCT00780273|19408745|P1|NOT COMPLETED|Overall Study||2
7886403|NCT00780273|19408745|P1|COMPLETED|Overall Study||17
7886404|NCT00780273|19408745|P1|STARTED|Overall Study||19
7886405|NCT00780234|19408756|P2|NOT COMPLETED|Overall Study||8
7886406|NCT00780234|19408757|P1|NOT COMPLETED|Overall Study||8
7886407|NCT00780234|19408756|P2|COMPLETED|Overall Study||37
7886408|NCT00780234|19408757|P1|COMPLETED|Overall Study||39
7886409|NCT00780234|19408756|P2|STARTED|Overall Study||45
7886410|NCT00780234|19408757|P1|STARTED|Overall Study||47
7886411|NCT00780208|19408763|P1|NOT COMPLETED|Overall Study||6
7886412|NCT00780208|19408763|P1|COMPLETED|Overall Study||8
7886413|NCT00780208|19408763|P1|STARTED|Overall Study||14
7886414|NCT00780143|19408768|P1|NOT COMPLETED|Overall Study||3
7886415|NCT00780143|19408768|P1|COMPLETED|Overall Study||0
7886416|NCT00780143|19408768|P1|STARTED|Overall Study||3
7886417|NCT00780026|19408776|P2|NOT COMPLETED|Overall Study||0
7886418|NCT00780026|19408777|P1|NOT COMPLETED|Overall Study||0
7886419|NCT00780026|19408776|P2|COMPLETED|Overall Study||50
7886420|NCT00780026|19408777|P1|COMPLETED|Overall Study||50
7886421|NCT00780026|19408776|P2|STARTED|Overall Study||50
7886422|NCT00780026|19408777|P1|STARTED|Overall Study||50
7886423|NCT00779909|19408799|P4|NOT COMPLETED|Overall Study||1
7886424|NCT00779909|19408800|P3|NOT COMPLETED|Overall Study||0
7886425|NCT00779909|19408801|P2|NOT COMPLETED|Overall Study||1
7886426|NCT00779909|19408802|P1|NOT COMPLETED|Overall Study||1
7886427|NCT00779909|19408799|P4|COMPLETED|Overall Study||7
7886428|NCT00779909|19408800|P3|COMPLETED|Overall Study||8
7886429|NCT00779909|19408801|P2|COMPLETED|Overall Study||8
7886430|NCT00779909|19408802|P1|COMPLETED|Overall Study||9
7886431|NCT00779909|19408799|P4|STARTED|Overall Study||8
7886432|NCT00779909|19408800|P3|STARTED|Overall Study||8
7886433|NCT00779909|19408801|P2|STARTED|Overall Study||9
7886434|NCT00779909|19408802|P1|STARTED|Overall Study||10
7886435|NCT00779870|19408847|P3|NOT COMPLETED|Overall Study||0
7886436|NCT00779870|19408848|P2|NOT COMPLETED|Overall Study||0
7886437|NCT00779870|19408849|P1|NOT COMPLETED|Overall Study||0
7886438|NCT00779870|19408847|P3|COMPLETED|Overall Study||7
7886439|NCT00779870|19408848|P2|COMPLETED|Overall Study||6
7886440|NCT00779870|19408849|P1|COMPLETED|Overall Study||5
7886441|NCT00779870|19408847|P3|STARTED|Overall Study||7
7886442|NCT00779870|19408848|P2|STARTED|Overall Study||6
7886443|NCT00779870|19408849|P1|STARTED|Overall Study||5
7886444|NCT00779857|19408866|P1|NOT COMPLETED|Overall Study||6
7886445|NCT00779857|19408866|P1|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64
7886446|NCT00779857|19408866|P1|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65
7886447|NCT00779857|19408866|P1|30 Day Post Procedure|Overall Study|2 missed Visit|68
7886448|NCT00779857|19408866|P1|STARTED|Overall Study|70 patients treated|70
7886449|NCT00779779|19408871|P1|NOT COMPLETED|Overall Study||24
7886450|NCT00779779|19408871|P1|COMPLETED|Overall Study||498
7886451|NCT00779779|19408871|P1|STARTED|Overall Study||522
7886452|NCT00779766|19408880|P2|NOT COMPLETED|Month 72||189
7886453|NCT00779766|19408881|P1|NOT COMPLETED|Month 72||185
7886454|NCT00779766|19408880|P2|COMPLETED|Month 72||2158
7886455|NCT00779766|19408881|P1|COMPLETED|Month 72||2134
7886456|NCT00779766|19408880|P2|STARTED|Month 72||2347
7886457|NCT00779766|19408881|P1|STARTED|Month 72||2319
7886458|NCT00779766|19408880|P2|NOT COMPLETED|Month 48||168
7886459|NCT00779766|19408881|P1|NOT COMPLETED|Month 48||174
7886460|NCT00779766|19408880|P2|COMPLETED|Month 48||2559
7886461|NCT00779766|19408881|P1|COMPLETED|Month 48||2529
7886462|NCT00779766|19408880|P2|STARTED|Month 48||2727
7886463|NCT00779766|19408881|P1|STARTED|Month 48||2703
7886464|NCT00779766|19408880|P2|NOT COMPLETED|Month 24||332
7886465|NCT00779766|19408881|P1|NOT COMPLETED|Month 24||332
7886466|NCT00779766|19408880|P2|COMPLETED|Month 24||2693
7886467|NCT00779766|19408881|P1|COMPLETED|Month 24||2694
7886468|NCT00779766|19408880|P2|STARTED|Month 24||3025
7886469|NCT00779766|19408881|P1|STARTED|Month 24||3026
7886470|NCT00779701|19408965|P1|NOT COMPLETED|Overall Study||0
7886471|NCT00779701|19408965|P1|COMPLETED|Overall Study||27
7886472|NCT00779701|19408965|P1|STARTED|Overall Study||27
7886473|NCT00779675|19408969|P1|NOT COMPLETED|Extended Treatment Period||46
7886474|NCT00779675|19408969|P1|COMPLETED|Extended Treatment Period||147
7886567|NCT00779311|19409168|P4|NOT COMPLETED|Overall Study||0
7886475|NCT00779675|19408969|P1|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193
7886476|NCT00779675|19408969|P1|NOT COMPLETED|Treatment Period||332
7886477|NCT00779675|19408969|P1|COMPLETED|Treatment Period||328
7886478|NCT00779675|19408969|P1|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660
7886479|NCT00779584|19408997|P9|NOT COMPLETED|Overall Study||2
7886480|NCT00779584|19408998|P8|NOT COMPLETED|Overall Study||3
7886481|NCT00779584|19408999|P7|NOT COMPLETED|Overall Study||8
7886482|NCT00779584|19409000|P6|NOT COMPLETED|Overall Study||6
7886483|NCT00779584|19409001|P5|NOT COMPLETED|Overall Study||7
7886484|NCT00779584|19409002|P4|NOT COMPLETED|Overall Study||6
7886485|NCT00779584|19409003|P3|NOT COMPLETED|Overall Study||7
7886486|NCT00779584|19409004|P2|NOT COMPLETED|Overall Study||3
7886487|NCT00779584|19409005|P1|NOT COMPLETED|Overall Study||3
7886488|NCT00779584|19408997|P9|COMPLETED|Overall Study||0
7886489|NCT00779584|19408998|P8|COMPLETED|Overall Study||0
7886490|NCT00779584|19408999|P7|COMPLETED|Overall Study||0
7886491|NCT00779584|19409000|P6|COMPLETED|Overall Study||0
7886492|NCT00779584|19409001|P5|COMPLETED|Overall Study||0
7886493|NCT00779584|19409002|P4|COMPLETED|Overall Study||0
7886494|NCT00779584|19409003|P3|COMPLETED|Overall Study||0
7886495|NCT00779584|19409004|P2|COMPLETED|Overall Study||0
7886496|NCT00779584|19409005|P1|COMPLETED|Overall Study||0
7886497|NCT00779584|19408997|P9|Treated|Overall Study||2
7886498|NCT00779584|19408998|P8|Treated|Overall Study||3
7886499|NCT00779584|19408999|P7|Treated|Overall Study||8
7886500|NCT00779584|19409000|P6|Treated|Overall Study||4
7886501|NCT00779584|19409001|P5|Treated|Overall Study||7
7886502|NCT00779584|19409002|P4|Treated|Overall Study||6
7886503|NCT00779584|19409003|P3|Treated|Overall Study||7
7886504|NCT00779584|19409004|P2|Treated|Overall Study||3
7886505|NCT00779584|19409005|P1|Treated|Overall Study||3
7886506|NCT00779584|19408997|P9|STARTED|Overall Study||2
7886507|NCT00779584|19408998|P8|STARTED|Overall Study||3
7886508|NCT00779584|19408999|P7|STARTED|Overall Study||8
7886509|NCT00779584|19409000|P6|STARTED|Overall Study||6
7886510|NCT00779584|19409001|P5|STARTED|Overall Study||7
7886511|NCT00779584|19409002|P4|STARTED|Overall Study||6
7886512|NCT00779584|19409003|P3|STARTED|Overall Study||7
7886513|NCT00779584|19409004|P2|STARTED|Overall Study||3
7886514|NCT00779584|19409005|P1|STARTED|Overall Study||3
7886515|NCT00779558|19409081|P2|NOT COMPLETED|Overall Study||7
7886516|NCT00779558|19409082|P1|NOT COMPLETED|Overall Study||4
7886517|NCT00779558|19409081|P2|COMPLETED|Overall Study||37
7886518|NCT00779558|19409082|P1|COMPLETED|Overall Study||53
7886519|NCT00779558|19409081|P2|STARTED|Overall Study||44
7886520|NCT00779558|19409082|P1|STARTED|Overall Study||57
7886521|NCT00779506|19409096|P1|NOT COMPLETED|Overall Study||29
7886522|NCT00779506|19409096|P1|COMPLETED|Overall Study||67
7886523|NCT00779506|19409096|P1|Withdrawal Treatment|Overall Study||27
7886524|NCT00779506|19409096|P1|Treatment Complete|Overall Study||67
7886525|NCT00779506|19409096|P1|MITT|Overall Study||89
7886526|NCT00779506|19409096|P1|Assigned|Overall Study||94
7886527|NCT00779506|19409096|P1|Screen Failed|Overall Study||2
7886528|NCT00779506|19409096|P1|Enrolled|Overall Study||96
7886529|NCT00779506|19409096|P1|STARTED|Overall Study||96
7886530|NCT00779467|19409110|P4|NOT COMPLETED|Overall Study||19
7886531|NCT00779467|19409111|P3|NOT COMPLETED|Overall Study||10
7886532|NCT00779467|19409112|P2|NOT COMPLETED|Overall Study||5
7886533|NCT00779467|19409113|P1|NOT COMPLETED|Overall Study||15
7886534|NCT00779467|19409110|P4|COMPLETED|Overall Study||35
7886535|NCT00779467|19409111|P3|COMPLETED|Overall Study||38
7886536|NCT00779467|19409112|P2|COMPLETED|Overall Study||40
7886537|NCT00779467|19409113|P1|COMPLETED|Overall Study||38
7886538|NCT00779467|19409110|P4|STARTED|Overall Study||54
7886539|NCT00779467|19409111|P3|STARTED|Overall Study||48
7886540|NCT00779467|19409112|P2|STARTED|Overall Study||45
7886541|NCT00779467|19409113|P1|STARTED|Overall Study||53
7886542|NCT00779402|19409153|P2|NOT COMPLETED|Long-term Follow-up||6
7886543|NCT00779402|19409154|P1|NOT COMPLETED|Long-term Follow-up||21
7886544|NCT00779402|19409153|P2|COMPLETED|Long-term Follow-up||7
7886545|NCT00779402|19409154|P1|COMPLETED|Long-term Follow-up||20
7886546|NCT00779402|19409153|P2|STARTED|Long-term Follow-up||13
7886547|NCT00779402|19409154|P1|STARTED|Long-term Follow-up||41
7886548|NCT00779402|19409153|P2|NOT COMPLETED|Surveillance Phase||31
7886549|NCT00779402|19409154|P1|NOT COMPLETED|Surveillance Phase||43
7886550|NCT00779402|19409153|P2|COMPLETED|Surveillance Phase||13
7886551|NCT00779402|19409154|P1|COMPLETED|Surveillance Phase||41
7886552|NCT00779402|19409153|P2|STARTED|Surveillance Phase||44
7886553|NCT00779402|19409154|P1|STARTED|Surveillance Phase||84
7886554|NCT00779402|19409153|P2|NOT COMPLETED|Treatment Phase 1||15
7886555|NCT00779402|19409154|P1|NOT COMPLETED|Treatment Phase 1||33
7886556|NCT00779402|19409153|P2|COMPLETED|Treatment Phase 1||44
7886557|NCT00779402|19409154|P1|COMPLETED|Treatment Phase 1||84
7886558|NCT00779402|19409153|P2|Received Booster Infusion|Treatment Phase 1||30
7886559|NCT00779402|19409154|P1|Received Booster Infusion|Treatment Phase 1||50
7886560|NCT00779402|19409153|P2|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||59
7886561|NCT00779402|19409154|P1|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||113
7886562|NCT00779402|19409153|P2|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||59
7886563|NCT00779402|19409154|P1|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||116
7886564|NCT00779402|19409153|P2|STARTED|Treatment Phase 1||59
7886565|NCT00779402|19409154|P1|STARTED|Treatment Phase 1||117
7886566|NCT00779311|19409167|P5|NOT COMPLETED|Overall Study||0
7886568|NCT00779311|19409169|P3|NOT COMPLETED|Overall Study||0
7886569|NCT00779311|19409170|P2|NOT COMPLETED|Overall Study||0
7886570|NCT00779311|19409171|P1|NOT COMPLETED|Overall Study||0
7886571|NCT00779311|19409167|P5|COMPLETED|Overall Study||0
7886572|NCT00779311|19409168|P4|COMPLETED|Overall Study||0
7886573|NCT00779311|19409169|P3|COMPLETED|Overall Study||0
7886574|NCT00779311|19409170|P2|COMPLETED|Overall Study||0
7886575|NCT00779311|19409171|P1|COMPLETED|Overall Study||8
7886576|NCT00779311|19409167|P5|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
7886577|NCT00779311|19409168|P4|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
7886578|NCT00779311|19409169|P3|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
7886579|NCT00779311|19409170|P2|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
7886580|NCT00779311|19409171|P1|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6
7886581|NCT00779311|19409167|P5|STARTED|Overall Study||0
7886582|NCT00779311|19409168|P4|STARTED|Overall Study||0
7886583|NCT00779311|19409169|P3|STARTED|Overall Study||0
7886584|NCT00779311|19409170|P2|STARTED|Overall Study||0
7886585|NCT00779311|19409171|P1|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8
7886586|NCT00779285|19409193|P1|NOT COMPLETED|Overall Study||0
7886587|NCT00779285|19409193|P1|COMPLETED|Overall Study||1
7886588|NCT00779285|19409193|P1|STARTED|Overall Study||1
7886589|NCT00779259|19409197|P1|NOT COMPLETED|Theophylline With Quinine||0
7886590|NCT00779259|19409197|P1|COMPLETED|Theophylline With Quinine||22
7886591|NCT00779259|19409197|P1|STARTED|Theophylline With Quinine||22
7886592|NCT00779259|19409197|P1|NOT COMPLETED|Quinine Alone||2
7886593|NCT00779259|19409197|P1|COMPLETED|Quinine Alone||22
7886594|NCT00779259|19409197|P1|STARTED|Quinine Alone||24
7886595|NCT00779259|19409197|P1|NOT COMPLETED|4 Day Washout Period||0
7886596|NCT00779259|19409197|P1|COMPLETED|4 Day Washout Period||24
7886597|NCT00779259|19409197|P1|STARTED|4 Day Washout Period||24
7886598|NCT00779259|19409197|P1|NOT COMPLETED|Theophylline Alone||0
7886599|NCT00779259|19409197|P1|COMPLETED|Theophylline Alone||24
7886600|NCT00779259|19409197|P1|STARTED|Theophylline Alone||24
7886601|NCT00779246|19409218|P2|NOT COMPLETED|Overall Study||53
7886602|NCT00779246|19409219|P1|NOT COMPLETED|Overall Study||33
7886603|NCT00779246|19409218|P2|COMPLETED|Overall Study||715
7886604|NCT00779246|19409219|P1|COMPLETED|Overall Study||717
7886605|NCT00779246|19409218|P2|STARTED|Overall Study||768
7886606|NCT00779246|19409219|P1|STARTED|Overall Study||750
7886607|NCT00779155|19409231|P2|NOT COMPLETED|Overall Study||0
7886608|NCT00779155|19409232|P1|NOT COMPLETED|Overall Study||0
7886609|NCT00779155|19409231|P2|COMPLETED|Overall Study||6
7886610|NCT00779155|19409232|P1|COMPLETED|Overall Study||6
7886611|NCT00779155|19409231|P2|STARTED|Overall Study||6
7886612|NCT00779155|19409232|P1|STARTED|Overall Study||6
7886613|NCT00779142|19409238|P1|NOT COMPLETED|Overall Study||3
7886614|NCT00779142|19409238|P1|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2
7886615|NCT00779142|19409238|P1|STARTED|Overall Study|5 patients signed consent and were screened.|5
7886616|NCT00779116|19409244|P2|NOT COMPLETED|Second Intervention||0
7886617|NCT00779116|19409245|P1|NOT COMPLETED|Second Intervention||0
7886618|NCT00779116|19409244|P2|COMPLETED|Second Intervention||108
7886619|NCT00779116|19409245|P1|COMPLETED|Second Intervention||109
7886620|NCT00779116|19409244|P2|STARTED|Second Intervention||108
7886621|NCT00779116|19409245|P1|STARTED|Second Intervention||109
7886622|NCT00779116|19409244|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
7886623|NCT00779116|19409245|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
7886624|NCT00779116|19409244|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||108
7886625|NCT00779116|19409245|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
7886626|NCT00779116|19409244|P2|STARTED|Interval Between Doses (8-10 Minutes)||108
7886627|NCT00779116|19409245|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
7886628|NCT00779116|19409244|P2|NOT COMPLETED|First Intervention||0
7886629|NCT00779116|19409245|P1|NOT COMPLETED|First Intervention||0
7886630|NCT00779116|19409244|P2|COMPLETED|First Intervention||108
7886631|NCT00779116|19409245|P1|COMPLETED|First Intervention||109
7886632|NCT00779116|19409244|P2|STARTED|First Intervention||108
7886633|NCT00779116|19409245|P1|STARTED|First Intervention||109
7886634|NCT00779038|19409252|P1|NOT COMPLETED|Overall Study||13
7886635|NCT00779038|19409252|P1|COMPLETED|Overall Study||0
7886636|NCT00779038|19409252|P1|STARTED|Overall Study||13
7886637|NCT00779025|19409261|P1|NOT COMPLETED|Overall Study||1
7886638|NCT00779025|19409261|P1|COMPLETED|Overall Study||81
7886639|NCT00779025|19409261|P1|STARTED|Overall Study||82
7886640|NCT00778999|19409272|P2|NOT COMPLETED|Overall Study||34
7886641|NCT00778999|19409273|P1|NOT COMPLETED|Overall Study||28
7886642|NCT00778999|19409272|P2|COMPLETED|Overall Study||185
7886643|NCT00778999|19409273|P1|COMPLETED|Overall Study||195
7886644|NCT00778999|19409272|P2|STARTED|Overall Study||219
7886645|NCT00778999|19409273|P1|STARTED|Overall Study||223
7886646|NCT00778921|19409282|P3|NOT COMPLETED|Overall Study||28
7886647|NCT00778921|19409283|P2|NOT COMPLETED|Overall Study||19
7886648|NCT00778921|19409284|P1|NOT COMPLETED|Overall Study||18
7886649|NCT00778921|19409282|P3|COMPLETED|Overall Study||255
7886650|NCT00778921|19409283|P2|COMPLETED|Overall Study||266
7886651|NCT00778921|19409284|P1|COMPLETED|Overall Study||261
7886652|NCT00778921|19409282|P3|STARTED|Overall Study||283
7886653|NCT00778921|19409283|P2|STARTED|Overall Study||285
7886654|NCT00778921|19409284|P1|STARTED|Overall Study||279
7886655|NCT00778895|19409301|P3|NOT COMPLETED|ESFU Phase||2
7886656|NCT00778895|19409302|P2|NOT COMPLETED|ESFU Phase||12
7886657|NCT00778895|19409303|P1|NOT COMPLETED|ESFU Phase||11
7886658|NCT00778895|19409301|P3|COMPLETED|ESFU Phase||41
7886659|NCT00778895|19409302|P2|COMPLETED|ESFU Phase||155
7886660|NCT00778895|19409303|P1|COMPLETED|ESFU Phase||153
7886661|NCT00778895|19409301|P3|STARTED|ESFU Phase||43
7886662|NCT00778895|19409302|P2|STARTED|ESFU Phase||167
7886663|NCT00778895|19409303|P1|STARTED|ESFU Phase||164
7886664|NCT00778895|19409301|P3|NOT COMPLETED|Active Phase||0
7886665|NCT00778895|19409302|P2|NOT COMPLETED|Active Phase||6
7886666|NCT00778895|19409303|P1|NOT COMPLETED|Active Phase||7
7886667|NCT00778895|19409301|P3|COMPLETED|Active Phase||43
7886668|NCT00778895|19409302|P2|COMPLETED|Active Phase||161
7886669|NCT00778895|19409303|P1|COMPLETED|Active Phase||157
7886670|NCT00778895|19409301|P3|STARTED|Active Phase||43
7886671|NCT00778895|19409302|P2|STARTED|Active Phase||167
7886672|NCT00778895|19409303|P1|STARTED|Active Phase||164
7886673|NCT00778869|19409341|P1|NOT COMPLETED|Overall Study||0
7886674|NCT00778869|19409341|P1|COMPLETED|Overall Study||10
7886675|NCT00778869|19409341|P1|STARTED|Overall Study||10
7886676|NCT00778830|19409347|P2|NOT COMPLETED|Overall Study||1
7886677|NCT00778830|19409348|P1|NOT COMPLETED|Overall Study||0
7886678|NCT00778830|19409347|P2|COMPLETED|Overall Study||187
7886679|NCT00778830|19409348|P1|COMPLETED|Overall Study||101
7886680|NCT00778830|19409347|P2|STARTED|Overall Study||188
7886681|NCT00778830|19409348|P1|STARTED|Overall Study||101
7886682|NCT00778817|19409360|P1|NOT COMPLETED|Overall Study||4
7886683|NCT00778817|19409360|P1|COMPLETED|Overall Study||16
7886684|NCT00778817|19409360|P1|STARTED|Overall Study||20
7886685|NCT00778648|19409377|P2|NOT COMPLETED|Overall Study||5
7886686|NCT00778648|19409378|P1|NOT COMPLETED|Overall Study||9
7886687|NCT00778648|19409377|P2|COMPLETED|Overall Study||266
7886688|NCT00778648|19409378|P1|COMPLETED|Overall Study||263
7886689|NCT00778648|19409377|P2|STARTED|Overall Study||271
7886690|NCT00778648|19409378|P1|STARTED|Overall Study||272
7886691|NCT00778622|19409387|P3|NOT COMPLETED|Overall Study||15
7886692|NCT00778622|19409388|P2|NOT COMPLETED|Overall Study||15
7886693|NCT00778622|19409389|P1|NOT COMPLETED|Overall Study||16
7886694|NCT00778622|19409387|P3|COMPLETED|Overall Study||109
7886695|NCT00778622|19409388|P2|COMPLETED|Overall Study||107
7886696|NCT00778622|19409389|P1|COMPLETED|Overall Study||109
7886697|NCT00778622|19409387|P3|STARTED|Overall Study||124
7886698|NCT00778622|19409388|P2|STARTED|Overall Study||122
7886699|NCT00778622|19409389|P1|STARTED|Overall Study||125
7886700|NCT00778375|19409442|P1|NOT COMPLETED|Overall Study||3
7886701|NCT00778375|19409442|P1|COMPLETED|Overall Study||119
7886702|NCT00778375|19409442|P1|STARTED|Overall Study||122
7886703|NCT00778336|19409456|P4|NOT COMPLETED|3 Month Follow Up||0
7886704|NCT00778336|19409457|P3|NOT COMPLETED|3 Month Follow Up||5
7886705|NCT00778336|19409458|P2|NOT COMPLETED|3 Month Follow Up||23
7886706|NCT00778336|19409459|P1|NOT COMPLETED|3 Month Follow Up||23
7886707|NCT00778336|19409456|P4|COMPLETED|3 Month Follow Up||12
7886708|NCT00778336|19409457|P3|COMPLETED|3 Month Follow Up||65
7886709|NCT00778336|19409458|P2|COMPLETED|3 Month Follow Up||144
7886710|NCT00778336|19409459|P1|COMPLETED|3 Month Follow Up||169
7886711|NCT00778336|19409456|P4|STARTED|3 Month Follow Up||12
7886712|NCT00778336|19409457|P3|STARTED|3 Month Follow Up||70
7886713|NCT00778336|19409458|P2|STARTED|3 Month Follow Up||167
7886714|NCT00778336|19409459|P1|STARTED|3 Month Follow Up||192
7886715|NCT00778336|19409456|P4|NOT COMPLETED|Index Procedure-Discharge||0
7886716|NCT00778336|19409457|P3|NOT COMPLETED|Index Procedure-Discharge||2
7886717|NCT00778336|19409458|P2|NOT COMPLETED|Index Procedure-Discharge||3
7886718|NCT00778336|19409459|P1|NOT COMPLETED|Index Procedure-Discharge||6
7886719|NCT00778336|19409456|P4|COMPLETED|Index Procedure-Discharge||12
7886720|NCT00778336|19409457|P3|COMPLETED|Index Procedure-Discharge||70
7886721|NCT00778336|19409458|P2|COMPLETED|Index Procedure-Discharge||167
7886722|NCT00778336|19409459|P1|COMPLETED|Index Procedure-Discharge||192
7886723|NCT00778336|19409456|P4|STARTED|Index Procedure-Discharge||12
7886724|NCT00778336|19409457|P3|STARTED|Index Procedure-Discharge||72
7886725|NCT00778336|19409458|P2|STARTED|Index Procedure-Discharge||170
7886726|NCT00778336|19409459|P1|STARTED|Index Procedure-Discharge||198
7886727|NCT00778310|19409479|P2|NOT COMPLETED|Overall Study||0
7886728|NCT00778310|19409480|P1|NOT COMPLETED|Overall Study||0
7886729|NCT00778310|19409479|P2|COMPLETED|Overall Study||26
7886730|NCT00778310|19409480|P1|COMPLETED|Overall Study||17
7886731|NCT00778310|19409479|P2|Usable Data|Overall Study||21
7886732|NCT00778310|19409480|P1|Usable Data|Overall Study||14
7886733|NCT00778310|19409479|P2|STARTED|Overall Study||26
7886734|NCT00778310|19409480|P1|STARTED|Overall Study||17
7886735|NCT00778258|19409497|P9|NOT COMPLETED|Overall Study||4
7886736|NCT00778258|19409498|P8|NOT COMPLETED|Overall Study||15
7886737|NCT00778258|19409499|P7|NOT COMPLETED|Overall Study||15
7886738|NCT00778258|19409500|P6|NOT COMPLETED|Overall Study||10
7886739|NCT00778258|19409501|P5|NOT COMPLETED|Overall Study||0
7886740|NCT00778258|19409502|P4|NOT COMPLETED|Overall Study||3
7886741|NCT00778258|19409503|P3|NOT COMPLETED|Overall Study||10
7886742|NCT00778258|19409504|P2|NOT COMPLETED|Overall Study||2
7886743|NCT00778258|19409505|P1|NOT COMPLETED|Overall Study||7
7886744|NCT00778258|19409497|P9|COMPLETED|Overall Study||6
7886745|NCT00778258|19409498|P8|COMPLETED|Overall Study||26
7886746|NCT00778258|19409499|P7|COMPLETED|Overall Study||19
7886747|NCT00778258|19409500|P6|COMPLETED|Overall Study||13
7886748|NCT00778258|19409501|P5|COMPLETED|Overall Study||6
7886749|NCT00778258|19409502|P4|COMPLETED|Overall Study||12
7886750|NCT00778258|19409503|P3|COMPLETED|Overall Study||10
7886751|NCT00778258|19409504|P2|COMPLETED|Overall Study||3
7886752|NCT00778258|19409505|P1|COMPLETED|Overall Study||9
7886753|NCT00778258|19409497|P9|STARTED|Overall Study||10
7886754|NCT00778258|19409498|P8|STARTED|Overall Study||41
7886755|NCT00778258|19409499|P7|STARTED|Overall Study||34
7886756|NCT00778258|19409500|P6|STARTED|Overall Study||23
7886757|NCT00778258|19409501|P5|STARTED|Overall Study||6
7886758|NCT00778258|19409502|P4|STARTED|Overall Study||15
7886759|NCT00778258|19409503|P3|STARTED|Overall Study||20
7886760|NCT00778258|19409504|P2|STARTED|Overall Study||5
7886761|NCT00778258|19409505|P1|STARTED|Overall Study||16
7886762|NCT00778167|19409560|P3|NOT COMPLETED|Overall Study||0
7886763|NCT00778167|19409561|P2|NOT COMPLETED|Overall Study||0
7886764|NCT00778167|19409562|P1|NOT COMPLETED|Overall Study||0
7886765|NCT00778167|19409560|P3|COMPLETED|Overall Study||4
7886766|NCT00778167|19409561|P2|COMPLETED|Overall Study||8
7886767|NCT00778167|19409562|P1|COMPLETED|Overall Study||6
7886768|NCT00778167|19409560|P3|STARTED|Overall Study||4
7886769|NCT00778167|19409561|P2|STARTED|Overall Study||8
7886770|NCT00778167|19409562|P1|STARTED|Overall Study||6
7886771|NCT00778102|19409572|P2|NOT COMPLETED|Overall Study||22
7886772|NCT00778102|19409573|P1|NOT COMPLETED|Overall Study||21
7886773|NCT00778102|19409572|P2|COMPLETED|Overall Study||19
7886774|NCT00778102|19409573|P1|COMPLETED|Overall Study||18
7886775|NCT00778102|19409572|P2|STARTED|Overall Study||41
7886776|NCT00778102|19409573|P1|STARTED|Overall Study||39
7886777|NCT00777946|19409608|P3|NOT COMPLETED|Overall Study||16
7886778|NCT00777946|19409609|P2|NOT COMPLETED|Overall Study||6
7886779|NCT00777946|19409610|P1|NOT COMPLETED|Overall Study||21
7886780|NCT00777946|19409608|P3|COMPLETED|Overall Study||244
7886781|NCT00777946|19409609|P2|COMPLETED|Overall Study||271
7886782|NCT00777946|19409610|P1|COMPLETED|Overall Study||262
7886783|NCT00777946|19409608|P3|Safety & Full Analysis Sets|Overall Study||260
7886784|NCT00777946|19409609|P2|Safety & Full Analysis Sets|Overall Study||276
7886785|NCT00777946|19409610|P1|Safety & Full Analysis Sets|Overall Study||282
7886786|NCT00777946|19409608|P3|STARTED|Overall Study||260
7886787|NCT00777946|19409609|P2|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277
7886788|NCT00777946|19409610|P1|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283
7886789|NCT00777920|19409633|P1|NOT COMPLETED|Overall Study||50
7886790|NCT00777920|19409633|P1|COMPLETED|Overall Study||90
7886791|NCT00777920|19409633|P1|STARTED|Overall Study||140
7886792|NCT00777855|19409637|P2|NOT COMPLETED|Second Intervention||0
7886793|NCT00777855|19409638|P1|NOT COMPLETED|Second Intervention||0
7886794|NCT00777855|19409637|P2|COMPLETED|Second Intervention||5
7886795|NCT00777855|19409638|P1|COMPLETED|Second Intervention||5
7886796|NCT00777855|19409637|P2|STARTED|Second Intervention||5
7886797|NCT00777855|19409638|P1|STARTED|Second Intervention||5
7886798|NCT00777855|19409637|P2|NOT COMPLETED|Washout Period (>= 14 Days)||0
7886799|NCT00777855|19409638|P1|NOT COMPLETED|Washout Period (>= 14 Days)||0
7886800|NCT00777855|19409637|P2|COMPLETED|Washout Period (>= 14 Days)||5
7886801|NCT00777855|19409638|P1|COMPLETED|Washout Period (>= 14 Days)||5
7886802|NCT00777855|19409637|P2|STARTED|Washout Period (>= 14 Days)||5
7886803|NCT00777855|19409638|P1|STARTED|Washout Period (>= 14 Days)||5
7886804|NCT00777855|19409637|P2|NOT COMPLETED|First Intervention||0
7886805|NCT00777855|19409638|P1|NOT COMPLETED|First Intervention||0
7886806|NCT00777855|19409637|P2|COMPLETED|First Intervention||5
7886807|NCT00777855|19409638|P1|COMPLETED|First Intervention||5
7886808|NCT00777855|19409637|P2|STARTED|First Intervention||5
7886809|NCT00777855|19409638|P1|STARTED|First Intervention||5
7886810|NCT00777803|19409649|P2|NOT COMPLETED|Overall Study||7
7886811|NCT00777803|19409650|P1|NOT COMPLETED|Overall Study||15
7886812|NCT00777803|19409649|P2|COMPLETED|Overall Study||90
7886813|NCT00777803|19409650|P1|COMPLETED|Overall Study||269
7886814|NCT00777803|19409649|P2|STARTED|Overall Study||97
7886815|NCT00777803|19409650|P1|STARTED|Overall Study||284
7886816|NCT00777790|19409685|P3|NOT COMPLETED|Overall Study||0
7886817|NCT00777790|19409686|P2|NOT COMPLETED|Overall Study||0
7886818|NCT00777790|19409687|P1|NOT COMPLETED|Overall Study||0
7886819|NCT00777790|19409685|P3|COMPLETED|Overall Study||88
7886820|NCT00777790|19409686|P2|COMPLETED|Overall Study||77
7886821|NCT00777790|19409687|P1|COMPLETED|Overall Study||76
7886822|NCT00777790|19409685|P3|STARTED|Overall Study||88
7886823|NCT00777790|19409686|P2|STARTED|Overall Study||77
7886824|NCT00777790|19409687|P1|STARTED|Overall Study||76
7886825|NCT00777764|19409697|P2|NOT COMPLETED|Overall Study||1
7886826|NCT00777764|19409698|P1|NOT COMPLETED|Overall Study||0
7886827|NCT00777764|19409697|P2|COMPLETED|Overall Study||29
7886828|NCT00777764|19409698|P1|COMPLETED|Overall Study||30
7886829|NCT00777764|19409697|P2|STARTED|Overall Study||30
7886830|NCT00777764|19409698|P1|STARTED|Overall Study||30
7886831|NCT00777634|19409710|P2|NOT COMPLETED|Overall Study||1
7886832|NCT00777634|19409711|P1|NOT COMPLETED|Overall Study||5
7886833|NCT00777634|19409710|P2|COMPLETED|Overall Study||133
7886834|NCT00777634|19409711|P1|COMPLETED|Overall Study||129
7886835|NCT00777634|19409710|P2|STARTED|Overall Study||134
7886836|NCT00777634|19409711|P1|STARTED|Overall Study||134
7886837|NCT00777608|19409729|P2|NOT COMPLETED|Overall Study||6
7886838|NCT00777608|19409730|P1|NOT COMPLETED|Overall Study||4
7886839|NCT00777608|19409729|P2|COMPLETED|Overall Study||47
7886840|NCT00777608|19409730|P1|COMPLETED|Overall Study||49
7886841|NCT00777608|19409729|P2|STARTED|Overall Study||53
7886842|NCT00777608|19409730|P1|STARTED|Overall Study||53
7886843|NCT00777556|19409740|P1|NOT COMPLETED|Overall Study||66
7886844|NCT00777556|19409740|P1|COMPLETED|Overall Study|Completed all 3 follow-up visits|277
7886845|NCT00777556|19409740|P1|Used Product|Overall Study||297
7886846|NCT00777556|19409740|P1|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299
7886847|NCT00777556|19409740|P1|Dispensed Product|Overall Study||307
7886848|NCT00777556|19409740|P1|STARTED|Overall Study|Enrolled; signed informed consent|343
7886849|NCT00777491|19409749|P2|NOT COMPLETED|Overall Study||2
7886850|NCT00777491|19409750|P1|NOT COMPLETED|Overall Study||2
7886851|NCT00777491|19409749|P2|COMPLETED|Overall Study||33
7886852|NCT00777491|19409750|P1|COMPLETED|Overall Study||33
7886853|NCT00777491|19409749|P2|Has 3 Year AUASI Data|Overall Study||6
7886854|NCT00777491|19409750|P1|Has 3 Year AUASI Data|Overall Study||6
7886855|NCT00777491|19409749|P2|Has Adverse Event Data (Late)|Overall Study||31
7886856|NCT00777491|19409750|P1|Has Adverse Event Data (Late)|Overall Study||32
7886857|NCT00777491|19409749|P2|Has Adverse Event Data (Treatment)|Overall Study||33
7886858|NCT00777491|19409750|P1|Has Adverse Event Data (Treatment)|Overall Study||33
7886859|NCT00777491|19409749|P2|Started Adjuvant Therapy|Overall Study||31
7886860|NCT00777491|19409750|P1|Started Adjuvant Therapy|Overall Study||32
7886861|NCT00777491|19409749|P2|Started Consolidation Therapy|Overall Study||25
7886862|NCT00777491|19409750|P1|Started Consolidation Therapy|Overall Study||29
7886863|NCT00777491|19409749|P2|Started Induction Therapy|Overall Study||33
7886864|NCT00777491|19409750|P1|Started Induction Therapy|Overall Study||33
7886865|NCT00777491|19409749|P2|Has 3-year Efficacy Data|Overall Study||25
7886866|NCT00777491|19409750|P1|Has 3-year Efficacy Data|Overall Study||27
7886867|NCT00777491|19409749|P2|Eligible|Overall Study||33
7886868|NCT00777491|19409750|P1|Eligible|Overall Study||33
7886869|NCT00777491|19409749|P2|STARTED|Overall Study||35
7886870|NCT00777491|19409750|P1|STARTED|Overall Study||35
7886871|NCT00777335|19409770|P2|NOT COMPLETED|Overall Study||0
7886872|NCT00777335|19409771|P1|NOT COMPLETED|Overall Study||0
7886873|NCT00777335|19409770|P2|COMPLETED|Overall Study||2
7886874|NCT00777335|19409771|P1|COMPLETED|Overall Study||2
7886875|NCT00777335|19409770|P2|STARTED|Overall Study||2
7886876|NCT00777335|19409771|P1|STARTED|Overall Study||2
7886877|NCT00777296|19409783|P4|NOT COMPLETED|Overall Study||1
7886878|NCT00777296|19409784|P3|NOT COMPLETED|Overall Study||2
7886879|NCT00777296|19409785|P2|NOT COMPLETED|Overall Study||1
7886880|NCT00777296|19409786|P1|NOT COMPLETED|Overall Study||1
7886881|NCT00777296|19409783|P4|COMPLETED|Overall Study||10
7886882|NCT00777296|19409784|P3|COMPLETED|Overall Study||21
7886883|NCT00777296|19409785|P2|COMPLETED|Overall Study||10
7886884|NCT00777296|19409786|P1|COMPLETED|Overall Study||20
7886885|NCT00777296|19409783|P4|STARTED|Overall Study||11
7886886|NCT00777296|19409784|P3|STARTED|Overall Study||23
7886887|NCT00777296|19409785|P2|STARTED|Overall Study||11
7886888|NCT00777296|19409786|P1|STARTED|Overall Study||21
7886889|NCT00777257|19409828|P3|NOT COMPLETED|Overall Study||9
7886890|NCT00777257|19409829|P2|NOT COMPLETED|Overall Study||12
7886891|NCT00777257|19409830|P1|NOT COMPLETED|Overall Study||11
7886892|NCT00777257|19409828|P3|COMPLETED|Overall Study||442
7886893|NCT00777257|19409829|P2|COMPLETED|Overall Study||438
7886894|NCT00777257|19409830|P1|COMPLETED|Overall Study||433
7886895|NCT00777257|19409828|P3|STARTED|Overall Study||451
7886896|NCT00777257|19409829|P2|STARTED|Overall Study||450
7886897|NCT00777257|19409830|P1|STARTED|Overall Study||444
7886898|NCT00777205|19409849|P2|NOT COMPLETED|Overall Study||71
7886899|NCT00777205|19409850|P1|NOT COMPLETED|Overall Study||31
7886900|NCT00777205|19409849|P2|COMPLETED|Overall Study||129
7886901|NCT00777205|19409850|P1|COMPLETED|Overall Study||212
7886902|NCT00777205|19409849|P2|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56
7886903|NCT00777205|19409850|P1|Intervention Interruption|Overall Study||0
7886904|NCT00777205|19409849|P2|STARTED|Overall Study||200
7886905|NCT00777205|19409850|P1|STARTED|Overall Study||243
7886906|NCT00777179|19409866|P2|NOT COMPLETED|Overall Study||0
7886907|NCT00777179|19409867|P1|NOT COMPLETED|Overall Study||0
7886908|NCT00777179|19409866|P2|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42
7886909|NCT00777179|19409867|P1|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75
7886910|NCT00777179|19409866|P2|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42
7886911|NCT00777179|19409867|P1|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75
7886912|NCT00777153|19409884|P3|NOT COMPLETED|Overall Study||37
7886913|NCT00777153|19409885|P2|NOT COMPLETED|Overall Study||83
7886914|NCT00777153|19409886|P1|NOT COMPLETED|Overall Study||90
7886915|NCT00777153|19409884|P3|COMPLETED|Overall Study||28
7886916|NCT00777153|19409885|P2|COMPLETED|Overall Study||46
7886917|NCT00777153|19409886|P1|COMPLETED|Overall Study||41
7886918|NCT00777153|19409884|P3|STARTED|Overall Study||65
7886919|NCT00777153|19409885|P2|STARTED|Overall Study||129
7886920|NCT00777153|19409886|P1|STARTED|Overall Study||131
7886921|NCT00777101|19409911|P2|NOT COMPLETED|Overall Study||51
7886922|NCT00777101|19409912|P1|NOT COMPLETED|Overall Study||62
7886923|NCT00777101|19409911|P2|COMPLETED|Overall Study||65
7886924|NCT00777101|19409912|P1|COMPLETED|Overall Study||55
7886925|NCT00777101|19409911|P2|Treated|Overall Study||115
7886926|NCT00777101|19409912|P1|Treated|Overall Study||116
7886927|NCT00777101|19409911|P2|STARTED|Overall Study||116
7886928|NCT00777101|19409912|P1|STARTED|Overall Study||117
7886929|NCT00777088|19409930|P1|NOT COMPLETED|Overall Study||1
7886930|NCT00777088|19409930|P1|COMPLETED|Overall Study||107
7886931|NCT00777088|19409930|P1|STARTED|Overall Study||108
7886932|NCT00777062|19409944|P2|NOT COMPLETED|Overall Study||5
7886933|NCT00777062|19409945|P1|NOT COMPLETED|Overall Study||3
7886934|NCT00777062|19409944|P2|COMPLETED|Overall Study||36
7886935|NCT00777062|19409945|P1|COMPLETED|Overall Study||36
7886936|NCT00777062|19409944|P2|STARTED|Overall Study||41
7886937|NCT00777062|19409945|P1|STARTED|Overall Study||39
7886938|NCT00777049|19409955|P2|NOT COMPLETED|Overall Study||1
7886939|NCT00777049|19409956|P1|NOT COMPLETED|Overall Study||1
7886940|NCT00777049|19409955|P2|COMPLETED|Overall Study||20
7886941|NCT00777049|19409956|P1|COMPLETED|Overall Study||32
7886942|NCT00777049|19409955|P2|STARTED|Overall Study||21
7886943|NCT00777049|19409956|P1|STARTED|Overall Study||33
7886944|NCT00777036|19409965|P3|NOT COMPLETED|Follow-Up||4
7886945|NCT00777036|19409966|P2|NOT COMPLETED|Follow-Up||8
7886946|NCT00777036|19409967|P1|NOT COMPLETED|Follow-Up||5
7886947|NCT00777036|19409965|P3|COMPLETED|Follow-Up|Completed = Still in Follow-up|19
7886948|NCT00777036|19409966|P2|COMPLETED|Follow-Up|Completed = Still in Follow-up|5
7886949|NCT00777036|19409967|P1|COMPLETED|Follow-Up|Completed = Still in Follow-up|9
7886950|NCT00777036|19409965|P3|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|23
7886951|NCT00777036|19409966|P2|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|13
7886952|NCT00777036|19409967|P1|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|14
7886953|NCT00777036|19409965|P3|NOT COMPLETED|On Treatment||23
7886954|NCT00777036|19409966|P2|NOT COMPLETED|On Treatment||16
7886955|NCT00777036|19409967|P1|NOT COMPLETED|On Treatment||15
7886956|NCT00777036|19409965|P3|COMPLETED|On Treatment|Completed = Still on treatment|61
7886957|NCT00777036|19409966|P2|COMPLETED|On Treatment|Completed = Still on treatment|1
7886958|NCT00777036|19409967|P1|COMPLETED|On Treatment|Completed = Still on treatment|14
7886959|NCT00777036|19409965|P3|STARTED|On Treatment||84
7886960|NCT00777036|19409966|P2|STARTED|On Treatment||17
7886961|NCT00777036|19409967|P1|STARTED|On Treatment||29
7886962|NCT00777023|19410063|P3|NOT COMPLETED|Overall Study||37
7886963|NCT00777023|19410064|P2|NOT COMPLETED|Overall Study||41
7886964|NCT00777023|19410065|P1|NOT COMPLETED|Overall Study||35
7886965|NCT00777023|19410063|P3|COMPLETED|Overall Study||146
7886966|NCT00777023|19410064|P2|COMPLETED|Overall Study||149
7886967|NCT00777023|19410065|P1|COMPLETED|Overall Study||151
7886968|NCT00777023|19410063|P3|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183
7886969|NCT00777023|19410064|P2|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190
7886970|NCT00777023|19410065|P1|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186
7886971|NCT00776997|19410082|P1|NOT COMPLETED|Overall Study||2
7886972|NCT00776997|19410082|P1|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98
7886973|NCT00776997|19410082|P1|STARTED|Overall Study||100
7886974|NCT00776984|19410091|P2|NOT COMPLETED|Overall Study||21
7886975|NCT00776984|19410092|P1|NOT COMPLETED|Overall Study||31
7886976|NCT00776984|19410091|P2|COMPLETED|Overall Study||198
7886977|NCT00776984|19410092|P1|COMPLETED|Overall Study||203
7886978|NCT00776984|19410091|P2|STARTED|Overall Study||219
7886979|NCT00776984|19410092|P1|STARTED|Overall Study||234
7886980|NCT00776919|19410166|P4|NOT COMPLETED|Overall Study||39
7886981|NCT00776919|19410167|P3|NOT COMPLETED|Overall Study||32
7886982|NCT00776919|19410168|P2|NOT COMPLETED|Overall Study||33
7886983|NCT00776919|19410169|P1|NOT COMPLETED|Overall Study||27
7886984|NCT00776919|19410166|P4|COMPLETED|Overall Study||293
7886985|NCT00776919|19410167|P3|COMPLETED|Overall Study||296
7886986|NCT00776919|19410168|P2|COMPLETED|Overall Study||295
7886987|NCT00776919|19410169|P1|COMPLETED|Overall Study||300
7886988|NCT00776919|19410166|P4|STARTED|Overall Study||332
7886989|NCT00776919|19410167|P3|STARTED|Overall Study||328
7886990|NCT00776919|19410168|P2|STARTED|Overall Study||328
7886991|NCT00776919|19410169|P1|STARTED|Overall Study||327
7886992|NCT00776789|19410233|P2|NOT COMPLETED|Overall Study||3
7886993|NCT00776789|19410234|P1|NOT COMPLETED|Overall Study||3
7886994|NCT00776789|19410233|P2|COMPLETED|Overall Study||18
7886995|NCT00776789|19410234|P1|COMPLETED|Overall Study||17
7886996|NCT00776789|19410233|P2|STARTED|Overall Study||21
7886997|NCT00776789|19410234|P1|STARTED|Overall Study||20
7886998|NCT00776659|19410246|P1|NOT COMPLETED|Overall Study||26
7886999|NCT00776659|19410246|P1|COMPLETED|Overall Study||13
7887000|NCT00776659|19410246|P1|STARTED|Overall Study||39
7887001|NCT00776594|19410258|P2|NOT COMPLETED|Overall Study||2
7887002|NCT00776594|19410259|P1|NOT COMPLETED|Overall Study||4
7887003|NCT00776594|19410258|P2|COMPLETED|Overall Study||34
7887004|NCT00776594|19410259|P1|COMPLETED|Overall Study||62
7887005|NCT00776594|19410258|P2|STARTED|Overall Study||36
7887006|NCT00776594|19410259|P1|STARTED|Overall Study||66
7887007|NCT00776555|19410273|P2|NOT COMPLETED|Overall Study||0
7887008|NCT00776555|19410274|P1|NOT COMPLETED|Overall Study||3
7887009|NCT00776555|19410273|P2|COMPLETED|Overall Study||0
7887010|NCT00776555|19410274|P1|COMPLETED|Overall Study||0
7887011|NCT00776555|19410273|P2|STARTED|Overall Study||0
7887012|NCT00776555|19410274|P1|STARTED|Overall Study||3
7887013|NCT00776295|19410284|P1|NOT COMPLETED|Overall Study||0
7887014|NCT00776295|19410284|P1|COMPLETED|Overall Study||2
7887015|NCT00776295|19410284|P1|STARTED|Overall Study||2
7887016|NCT00776230|19410292|P3|NOT COMPLETED|Overall Study||5
7887017|NCT00776230|19410293|P2|NOT COMPLETED|Overall Study||3
7887018|NCT00776230|19410294|P1|NOT COMPLETED|Overall Study||3
7887019|NCT00776230|19410292|P3|COMPLETED|Overall Study||97
7887020|NCT00776230|19410293|P2|COMPLETED|Overall Study||100
7887021|NCT00776230|19410294|P1|COMPLETED|Overall Study||96
7887022|NCT00776230|19410292|P3|Enrolled and Vaccinated at Day 0|Overall Study||102
7887023|NCT00776230|19410293|P2|Enrolled and Vaccinated at Day 0|Overall Study||103
7887024|NCT00776230|19410294|P1|Enrolled and Vaccinated at Day 0|Overall Study||98
7887025|NCT00776230|19410292|P3|STARTED|Overall Study||102
7887026|NCT00776230|19410293|P2|STARTED|Overall Study||103
7887027|NCT00776230|19410294|P1|STARTED|Overall Study||99
7887028|NCT00776100|19410304|P2|NOT COMPLETED|Overall Study||0
7887029|NCT00776100|19410305|P1|NOT COMPLETED|Overall Study||1
7887030|NCT00776100|19410304|P2|COMPLETED|Overall Study||1
7887031|NCT00776100|19410305|P1|COMPLETED|Overall Study||0
7887032|NCT00776100|19410304|P2|STARTED|Overall Study||1
7887033|NCT00776100|19410305|P1|STARTED|Overall Study||1
7887034|NCT00776009|19410327|P6|NOT COMPLETED|Period 3: Third Intervention||0
7887035|NCT00776009|19410328|P5|NOT COMPLETED|Period 3: Third Intervention||0
7887036|NCT00776009|19410329|P4|NOT COMPLETED|Period 3: Third Intervention||0
7887037|NCT00776009|19410330|P3|NOT COMPLETED|Period 3: Third Intervention||0
7887038|NCT00776009|19410331|P2|NOT COMPLETED|Period 3: Third Intervention||0
7887039|NCT00776009|19410332|P1|NOT COMPLETED|Period 3: Third Intervention||1
7887040|NCT00776009|19410327|P6|COMPLETED|Period 3: Third Intervention||26
7887041|NCT00776009|19410328|P5|COMPLETED|Period 3: Third Intervention||26
7887042|NCT00776009|19410329|P4|COMPLETED|Period 3: Third Intervention||27
7887043|NCT00776009|19410330|P3|COMPLETED|Period 3: Third Intervention||27
7887044|NCT00776009|19410331|P2|COMPLETED|Period 3: Third Intervention||27
7887045|NCT00776009|19410332|P1|COMPLETED|Period 3: Third Intervention||24
7887046|NCT00776009|19410327|P6|STARTED|Period 3: Third Intervention||26
7887047|NCT00776009|19410328|P5|STARTED|Period 3: Third Intervention||26
7887048|NCT00776009|19410329|P4|STARTED|Period 3: Third Intervention||27
7887049|NCT00776009|19410330|P3|STARTED|Period 3: Third Intervention||27
7887050|NCT00776009|19410331|P2|STARTED|Period 3: Third Intervention||27
7887051|NCT00776009|19410332|P1|STARTED|Period 3: Third Intervention||25
7887052|NCT00776009|19410327|P6|NOT COMPLETED|Period 2: Second Intervention||1
7887053|NCT00776009|19410328|P5|NOT COMPLETED|Period 2: Second Intervention||0
7887054|NCT00776009|19410329|P4|NOT COMPLETED|Period 2: Second Intervention||0
7887055|NCT00776009|19410330|P3|NOT COMPLETED|Period 2: Second Intervention||1
7887056|NCT00776009|19410331|P2|NOT COMPLETED|Period 2: Second Intervention||0
7887057|NCT00776009|19410332|P1|NOT COMPLETED|Period 2: Second Intervention||1
7887058|NCT00776009|19410327|P6|COMPLETED|Period 2: Second Intervention||26
7887059|NCT00776009|19410328|P5|COMPLETED|Period 2: Second Intervention||26
7887060|NCT00776009|19410329|P4|COMPLETED|Period 2: Second Intervention||27
7887061|NCT00776009|19410330|P3|COMPLETED|Period 2: Second Intervention||27
7887062|NCT00776009|19410331|P2|COMPLETED|Period 2: Second Intervention||27
7887063|NCT00776009|19410332|P1|COMPLETED|Period 2: Second Intervention||25
7887064|NCT00776009|19410327|P6|STARTED|Period 2: Second Intervention||27
7887065|NCT00776009|19410328|P5|STARTED|Period 2: Second Intervention||26
7887066|NCT00776009|19410329|P4|STARTED|Period 2: Second Intervention||27
7887067|NCT00776009|19410330|P3|STARTED|Period 2: Second Intervention||28
7887068|NCT00776009|19410331|P2|STARTED|Period 2: Second Intervention||27
7887069|NCT00776009|19410332|P1|STARTED|Period 2: Second Intervention||26
7887070|NCT00776009|19410327|P6|NOT COMPLETED|Period 1: First Intervention||0
7887071|NCT00776009|19410328|P5|NOT COMPLETED|Period 1: First Intervention||2
7887072|NCT00776009|19410329|P4|NOT COMPLETED|Period 1: First Intervention||0
7887073|NCT00776009|19410330|P3|NOT COMPLETED|Period 1: First Intervention||1
7887074|NCT00776009|19410331|P2|NOT COMPLETED|Period 1: First Intervention||1
7887075|NCT00776009|19410332|P1|NOT COMPLETED|Period 1: First Intervention||0
7887076|NCT00776009|19410327|P6|COMPLETED|Period 1: First Intervention||27
7887077|NCT00776009|19410328|P5|COMPLETED|Period 1: First Intervention||26
7887078|NCT00776009|19410329|P4|COMPLETED|Period 1: First Intervention||27
7887079|NCT00776009|19410330|P3|COMPLETED|Period 1: First Intervention||28
7887080|NCT00776009|19410331|P2|COMPLETED|Period 1: First Intervention||27
7887081|NCT00776009|19410332|P1|COMPLETED|Period 1: First Intervention||26
7887082|NCT00776009|19410327|P6|STARTED|Period 1: First Intervention||27
7887083|NCT00776009|19410328|P5|STARTED|Period 1: First Intervention||28
7887084|NCT00776009|19410329|P4|STARTED|Period 1: First Intervention||27
7887085|NCT00776009|19410330|P3|STARTED|Period 1: First Intervention||29
7887086|NCT00776009|19410331|P2|STARTED|Period 1: First Intervention||28
7887087|NCT00776009|19410332|P1|STARTED|Period 1: First Intervention||26
7887088|NCT00775983|19410354|P2|NOT COMPLETED|Overall Study||2
7887089|NCT00775983|19410355|P1|NOT COMPLETED|Overall Study||1
7887090|NCT00775983|19410354|P2|COMPLETED|Overall Study||34
7887091|NCT00775983|19410355|P1|COMPLETED|Overall Study||35
7887092|NCT00775983|19410354|P2|STARTED|Overall Study||36
7887093|NCT00775983|19410355|P1|STARTED|Overall Study||36
7887094|NCT00775944|19410367|P4|NOT COMPLETED|Overall Study||16
7887095|NCT00775944|19410368|P3|NOT COMPLETED|Overall Study||16
7887096|NCT00775944|19410369|P2|NOT COMPLETED|Overall Study||9
7887097|NCT00775944|19410370|P1|NOT COMPLETED|Overall Study||15
7887098|NCT00775944|19410367|P4|COMPLETED|Overall Study|16 participants withdrew consent|632
7887099|NCT00775944|19410368|P3|COMPLETED|Overall Study|16 participants withdrew consent|632
7887100|NCT00775944|19410369|P2|COMPLETED|Overall Study|9 participants withdrew consent|638
7887101|NCT00775944|19410370|P1|COMPLETED|Overall Study|15 participants withdrew consent|633
7887102|NCT00775944|19410367|P4|STARTED|Overall Study||648
7887103|NCT00775944|19410368|P3|STARTED|Overall Study||648
7887104|NCT00775944|19410369|P2|STARTED|Overall Study||647
7887105|NCT00775944|19410370|P1|STARTED|Overall Study||648
7887106|NCT00775931|19410398|P2|NOT COMPLETED|Overall Study||0
7887107|NCT00775931|19410399|P1|NOT COMPLETED|Overall Study||0
7887108|NCT00775931|19410398|P2|COMPLETED|Overall Study||1
7887109|NCT00775931|19410399|P1|COMPLETED|Overall Study||6
7887110|NCT00775931|19410398|P2|STARTED|Overall Study||1
7887111|NCT00775931|19410399|P1|STARTED|Overall Study||6
7887112|NCT00775684|19410414|P3|NOT COMPLETED|Overall Study||3
7887113|NCT00775684|19410415|P2|NOT COMPLETED|Overall Study||1
7887114|NCT00775684|19410416|P1|NOT COMPLETED|Overall Study||3
7887115|NCT00775684|19410414|P3|COMPLETED|Overall Study||14
7887116|NCT00775684|19410415|P2|COMPLETED|Overall Study||12
7887117|NCT00775684|19410416|P1|COMPLETED|Overall Study||14
7887118|NCT00775684|19410414|P3|STARTED|Overall Study||17
7887119|NCT00775684|19410415|P2|STARTED|Overall Study||13
7887120|NCT00775684|19410416|P1|STARTED|Overall Study||17
7887121|NCT00775671|19410438|P2|NOT COMPLETED|Overall Study||0
7887122|NCT00775671|19410439|P1|NOT COMPLETED|Overall Study||0
7887123|NCT00775671|19410438|P2|COMPLETED|Overall Study||23
7887124|NCT00775671|19410439|P1|COMPLETED|Overall Study||23
7887125|NCT00775671|19410438|P2|STARTED|Overall Study||23
7887126|NCT00775671|19410439|P1|STARTED|Overall Study||23
7887127|NCT00775658|19410447|P2|NOT COMPLETED|Second Intervention||0
7887128|NCT00775658|19410448|P1|NOT COMPLETED|Second Intervention||0
7887129|NCT00775658|19410447|P2|COMPLETED|Second Intervention||11
7887130|NCT00775658|19410448|P1|COMPLETED|Second Intervention||10
7887131|NCT00775658|19410447|P2|STARTED|Second Intervention||11
7887132|NCT00775658|19410448|P1|STARTED|Second Intervention||10
7887133|NCT00775658|19410447|P2|NOT COMPLETED|First Intervention||0
7887134|NCT00775658|19410448|P1|NOT COMPLETED|First Intervention||0
7887135|NCT00775658|19410447|P2|COMPLETED|First Intervention||11
7887136|NCT00775658|19410448|P1|COMPLETED|First Intervention||10
7887137|NCT00775658|19410447|P2|STARTED|First Intervention||11
7887138|NCT00775658|19410448|P1|STARTED|First Intervention||10
7887139|NCT00775645|19410458|P2|NOT COMPLETED|Overall Study||20
7887140|NCT00775645|19410459|P1|NOT COMPLETED|Overall Study||17
7887141|NCT00775645|19410458|P2|COMPLETED|Overall Study||181
7887142|NCT00775645|19410459|P1|COMPLETED|Overall Study||191
7887143|NCT00775645|19410458|P2|STARTED|Overall Study||201
7887144|NCT00775645|19410459|P1|STARTED|Overall Study||208
7887145|NCT00775606|19410481|P2|NOT COMPLETED|Overall Study||0
7887146|NCT00775606|19410482|P1|NOT COMPLETED|Overall Study||3
7887147|NCT00775606|19410481|P2|COMPLETED|Overall Study||5
7887148|NCT00775606|19410482|P1|COMPLETED|Overall Study||5
7887149|NCT00775606|19410481|P2|STARTED|Overall Study||5
7887150|NCT00775606|19410482|P1|STARTED|Overall Study||8
7887151|NCT00775593|19410492|P1|NOT COMPLETED|Overall Study||7
7887152|NCT00775593|19410492|P1|COMPLETED|Overall Study||53
7887153|NCT00775593|19410492|P1|STARTED|Overall Study||60
7887154|NCT00775528|19410499|P1|NOT COMPLETED|Overall Study||1
7887155|NCT00775528|19410499|P1|COMPLETED|Overall Study||18
7887156|NCT00775528|19410499|P1|STARTED|Overall Study|Started means number of patients who consented|19
7887157|NCT00775463|19410508|P2|NOT COMPLETED|Overall Study||13
7887158|NCT00775463|19410509|P1|NOT COMPLETED|Overall Study||11
7887159|NCT00775463|19410508|P2|COMPLETED|Overall Study||59
7887160|NCT00775463|19410509|P1|COMPLETED|Overall Study||65
7887161|NCT00775463|19410508|P2|STARTED|Overall Study||72
7887162|NCT00775463|19410509|P1|STARTED|Overall Study||76
7887163|NCT00775450|19410546|P5|NOT COMPLETED|Overall Study||2
7887164|NCT00775450|19410547|P4|NOT COMPLETED|Overall Study||0
7887165|NCT00775450|19410548|P3|NOT COMPLETED|Overall Study||0
7887166|NCT00775450|19410549|P2|NOT COMPLETED|Overall Study||0
7887167|NCT00775450|19410550|P1|NOT COMPLETED|Overall Study||3
7887168|NCT00775450|19410546|P5|COMPLETED|Overall Study||199
7887169|NCT00775450|19410547|P4|COMPLETED|Overall Study||108
7887170|NCT00775450|19410548|P3|COMPLETED|Overall Study||105
7887171|NCT00775450|19410549|P2|COMPLETED|Overall Study||98
7887172|NCT00775450|19410550|P1|COMPLETED|Overall Study||292
7887173|NCT00775450|19410546|P5|STARTED|Overall Study||201
7887174|NCT00775450|19410547|P4|STARTED|Overall Study||108
7887175|NCT00775450|19410548|P3|STARTED|Overall Study||105
7887176|NCT00775450|19410549|P2|STARTED|Overall Study||98
7887177|NCT00775450|19410550|P1|STARTED|Overall Study||295
7887178|NCT00775437|19410577|P1|NOT COMPLETED|Overall Study||6
7887179|NCT00775437|19410577|P1|COMPLETED|Overall Study||26
7887180|NCT00775437|19410577|P1|STARTED|Overall Study||32
7887181|NCT00775411|19410627|P1|NOT COMPLETED|Overall Study||1
7887182|NCT00775411|19410627|P1|COMPLETED|Overall Study||43
7887183|NCT00775411|19410627|P1|STARTED|Overall Study||44
7887184|NCT00775346|19410633|P1|NOT COMPLETED|Overall Study||0
7887185|NCT00775346|19410633|P1|COMPLETED|Overall Study||92
7887186|NCT00775346|19410633|P1|STARTED|Overall Study||92
7887187|NCT00775229|19410639|P2|NOT COMPLETED|Overall Study||2
7887188|NCT00775229|19410640|P1|NOT COMPLETED|Overall Study||5
7887189|NCT00775229|19410639|P2|COMPLETED|Overall Study||24
7887190|NCT00775229|19410640|P1|COMPLETED|Overall Study||20
7887191|NCT00775229|19410639|P2|STARTED|Overall Study||26
7887192|NCT00775229|19410640|P1|STARTED|Overall Study||25
7887193|NCT00775203|19410652|P2|NOT COMPLETED|Overall Study||43
7887194|NCT00775203|19410653|P1|NOT COMPLETED|Overall Study||62
7887195|NCT00775203|19410652|P2|COMPLETED|Overall Study||163
7887196|NCT00775203|19410653|P1|COMPLETED|Overall Study||144
7887197|NCT00775203|19410652|P2|Received Study Medication|Overall Study||204
7887198|NCT00775203|19410653|P1|Received Study Medication|Overall Study||202
7887199|NCT00775203|19410652|P2|STARTED|Overall Study||206
7887200|NCT00775203|19410653|P1|STARTED|Overall Study||206
7887201|NCT00775190|19410687|P2|NOT COMPLETED|Overall Study||5
7887202|NCT00775190|19410688|P1|NOT COMPLETED|Overall Study||4
7887203|NCT00775190|19410687|P2|COMPLETED|Overall Study||0
7887204|NCT00775190|19410688|P1|COMPLETED|Overall Study||3
7887205|NCT00775190|19410687|P2|STARTED|Overall Study||5
7887206|NCT00775190|19410688|P1|STARTED|Overall Study||7
7887207|NCT00775138|19410714|P4|NOT COMPLETED|Overall Study||2
7887208|NCT00775138|19410715|P3|NOT COMPLETED|Overall Study||3
7887209|NCT00775138|19410716|P2|NOT COMPLETED|Overall Study||0
7887210|NCT00775138|19410717|P1|NOT COMPLETED|Overall Study||0
7887211|NCT00775138|19410714|P4|COMPLETED|Overall Study||8
7887212|NCT00775138|19410715|P3|COMPLETED|Overall Study||17
7887213|NCT00775138|19410716|P2|COMPLETED|Overall Study||10
7887214|NCT00775138|19410717|P1|COMPLETED|Overall Study||24
7887215|NCT00775138|19410714|P4|STARTED|Overall Study||10
7887216|NCT00775138|19410715|P3|STARTED|Overall Study||20
7887217|NCT00775138|19410716|P2|STARTED|Overall Study||10
7887218|NCT00775138|19410717|P1|STARTED|Overall Study||24
7887219|NCT00775021|19410763|P2|NOT COMPLETED|Second Intervention||1
7887220|NCT00775021|19410764|P1|NOT COMPLETED|Second Intervention||0
7887221|NCT00775021|19410763|P2|COMPLETED|Second Intervention||59
7887222|NCT00775021|19410764|P1|COMPLETED|Second Intervention||62
7887223|NCT00775021|19410763|P2|STARTED|Second Intervention||60
7887224|NCT00775021|19410764|P1|STARTED|Second Intervention||62
7887225|NCT00775021|19410763|P2|NOT COMPLETED|First Intervention||0
7887226|NCT00775021|19410764|P1|NOT COMPLETED|First Intervention||1
7887227|NCT00775021|19410763|P2|COMPLETED|First Intervention||60
7887228|NCT00775021|19410764|P1|COMPLETED|First Intervention||62
7887229|NCT00775021|19410763|P2|STARTED|First Intervention||60
7887230|NCT00775021|19410764|P1|STARTED|First Intervention||63
7887231|NCT00774995|19410782|P4|NOT COMPLETED|Overall Study||0
7887232|NCT00774995|19410783|P3|NOT COMPLETED|Overall Study||1
7887233|NCT00774995|19410784|P2|NOT COMPLETED|Overall Study||0
7887234|NCT00774995|19410785|P1|NOT COMPLETED|Overall Study||0
7887235|NCT00774995|19410782|P4|COMPLETED|Overall Study||16
7887236|NCT00774995|19410783|P3|COMPLETED|Overall Study||7
7887237|NCT00774995|19410784|P2|COMPLETED|Overall Study||16
7887238|NCT00774995|19410785|P1|COMPLETED|Overall Study||9
7887239|NCT00774995|19410782|P4|STARTED|Overall Study||16
7887240|NCT00774995|19410783|P3|STARTED|Overall Study||8
7887241|NCT00774995|19410784|P2|STARTED|Overall Study||16
7887242|NCT00774995|19410785|P1|STARTED|Overall Study||9
7887243|NCT00774930|19410825|P2|NOT COMPLETED|LTOLE Phase||17
7887244|NCT00774930|19410826|P1|NOT COMPLETED|LTOLE Phase||15
7887245|NCT00774930|19410825|P2|COMPLETED|LTOLE Phase||8
7887246|NCT00774930|19410826|P1|COMPLETED|LTOLE Phase||17
7887247|NCT00774930|19410825|P2|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25
7887248|NCT00774930|19410826|P1|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32
7887249|NCT00774930|19410825|P2|NOT COMPLETED|IOL Phase||9
7887250|NCT00774930|19410826|P1|NOT COMPLETED|IOL Phase||13
7887251|NCT00774930|19410825|P2|COMPLETED|IOL Phase||37
7887252|NCT00774930|19410826|P1|COMPLETED|IOL Phase||43
7887253|NCT00774930|19410825|P2|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46
7887254|NCT00774930|19410826|P1|STARTED|IOL Phase||56
7887255|NCT00774930|19410825|P2|NOT COMPLETED|DB Phase||22
7887256|NCT00774930|19410826|P1|NOT COMPLETED|DB Phase||14
7887257|NCT00774930|19410825|P2|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34
7887258|NCT00774930|19410826|P1|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45
7887259|NCT00774930|19410825|P2|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56
7887260|NCT00774930|19410826|P1|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59
7887261|NCT00774852|19410854|P2|NOT COMPLETED|Overall Study||41
7887262|NCT00774852|19410855|P1|NOT COMPLETED|Overall Study||45
7887263|NCT00774852|19410854|P2|COMPLETED|Overall Study||27
7887264|NCT00774852|19410855|P1|COMPLETED|Overall Study||24
7887265|NCT00774852|19410854|P2|STARTED|Overall Study||68
7887266|NCT00774852|19410855|P1|STARTED|Overall Study||69
7887267|NCT00774800|19410903|P1|NOT COMPLETED|Intervention 4||1
7887268|NCT00774800|19410903|P1|COMPLETED|Intervention 4||21
7887269|NCT00774800|19410903|P1|Received at Least One Dose of Study Drug|Intervention 4||21
7887270|NCT00774800|19410903|P1|STARTED|Intervention 4||22
7887271|NCT00774800|19410903|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
7887272|NCT00774800|19410903|P1|COMPLETED|Washout (3 to 10 Days)||22
7887273|NCT00774800|19410903|P1|STARTED|Washout (3 to 10 Days)||22
7887274|NCT00774800|19410903|P1|NOT COMPLETED|Intervention 3||0
7887275|NCT00774800|19410903|P1|COMPLETED|Intervention 3||22
7887276|NCT00774800|19410903|P1|Received at Least One Dose of Study Drug|Intervention 3||22
7887277|NCT00774800|19410903|P1|STARTED|Intervention 3||22
7887278|NCT00774800|19410903|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
7887279|NCT00774800|19410903|P1|COMPLETED|Washout (3 to 10 Days)||22
7887280|NCT00774800|19410903|P1|STARTED|Washout (3 to 10 Days)||22
7887281|NCT00774800|19410903|P1|NOT COMPLETED|Intervention 2||0
7887282|NCT00774800|19410903|P1|COMPLETED|Intervention 2||22
7887283|NCT00774800|19410903|P1|Received at Least One Dose of Study Drug|Intervention 2||22
7887284|NCT00774800|19410903|P1|STARTED|Intervention 2||22
7887285|NCT00774800|19410903|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
7887286|NCT00774800|19410903|P1|COMPLETED|Washout (3 to 10 Days)||22
7887287|NCT00774800|19410903|P1|STARTED|Washout (3 to 10 Days)||22
7887288|NCT00774800|19410903|P1|NOT COMPLETED|Intervention 1||0
7887289|NCT00774800|19410903|P1|COMPLETED|Intervention 1||22
7887290|NCT00774800|19410903|P1|Received at Least One Dose of Study Drug|Intervention 1||22
7887291|NCT00774800|19410903|P1|STARTED|Intervention 1||22
7887292|NCT00774787|19410925|P1|NOT COMPLETED|Overall Study||1
7887293|NCT00774787|19410925|P1|COMPLETED|Overall Study||26
7887294|NCT00774787|19410925|P1|STARTED|Overall Study||27
7887295|NCT00774748|19410932|P1|NOT COMPLETED|Overall Study||3
7887296|NCT00774748|19410932|P1|COMPLETED|Overall Study||18
7887297|NCT00774748|19410932|P1|STARTED|Overall Study||21
7887298|NCT00774579|19410942|P2|NOT COMPLETED|Overall Study||0
7887299|NCT00774579|19410943|P1|NOT COMPLETED|Overall Study||0
7887300|NCT00774579|19410942|P2|COMPLETED|Overall Study||9
7887301|NCT00774579|19410943|P1|COMPLETED|Overall Study||9
7887302|NCT00774579|19410942|P2|STARTED|Overall Study||9
7887303|NCT00774579|19410943|P1|STARTED|Overall Study||9
7887304|NCT00774397|19410958|P7|NOT COMPLETED|Overall Study||30
7887305|NCT00774397|19410959|P6|NOT COMPLETED|Overall Study||22
7887306|NCT00774397|19410960|P5|NOT COMPLETED|Overall Study||46
7887307|NCT00774397|19410961|P4|NOT COMPLETED|Overall Study||17
7887308|NCT00774397|19410962|P3|NOT COMPLETED|Overall Study||30
7887309|NCT00774397|19410963|P2|NOT COMPLETED|Overall Study||13
7887310|NCT00774397|19410964|P1|NOT COMPLETED|Overall Study||14
7887311|NCT00774397|19410958|P7|COMPLETED|Overall Study||41
7887312|NCT00774397|19410959|P6|COMPLETED|Overall Study||54
7887313|NCT00774397|19410960|P5|COMPLETED|Overall Study||97
7887314|NCT00774397|19410961|P4|COMPLETED|Overall Study||129
7887315|NCT00774397|19410962|P3|COMPLETED|Overall Study||113
7887316|NCT00774397|19410963|P2|COMPLETED|Overall Study||56
7887317|NCT00774397|19410964|P1|COMPLETED|Overall Study||57
7887318|NCT00774397|19410958|P7|STARTED|Overall Study||71
7887319|NCT00774397|19410959|P6|STARTED|Overall Study||76
7887320|NCT00774397|19410960|P5|STARTED|Overall Study||143
7887321|NCT00774397|19410961|P4|STARTED|Overall Study||146
7887322|NCT00774397|19410962|P3|STARTED|Overall Study||143
7887323|NCT00774397|19410963|P2|STARTED|Overall Study||69
7887324|NCT00774397|19410964|P1|STARTED|Overall Study||71
7887325|NCT00774306|19411200|P4|NOT COMPLETED|Overall Study||5
7887326|NCT00774306|19411201|P3|NOT COMPLETED|Overall Study||8
7887327|NCT00774306|19411202|P2|NOT COMPLETED|Overall Study||2
7887328|NCT00774306|19411203|P1|NOT COMPLETED|Overall Study||18
7887329|NCT00774306|19411200|P4|COMPLETED|Overall Study||2
7887330|NCT00774306|19411201|P3|COMPLETED|Overall Study||8
7887331|NCT00774306|19411202|P2|COMPLETED|Overall Study||3
7887332|NCT00774306|19411203|P1|COMPLETED|Overall Study||6
7887333|NCT00774306|19411200|P4|STARTED|Overall Study||7
7887334|NCT00774306|19411201|P3|STARTED|Overall Study||16
7887335|NCT00774306|19411202|P2|STARTED|Overall Study||5
7887336|NCT00774306|19411203|P1|STARTED|Overall Study||24
7887337|NCT00774267|19411217|P4|NOT COMPLETED|Overall Study||0
7887338|NCT00774267|19411218|P3|NOT COMPLETED|Overall Study||0
7887339|NCT00774267|19411219|P2|NOT COMPLETED|Overall Study||0
7887340|NCT00774267|19411220|P1|NOT COMPLETED|Overall Study||0
7887341|NCT00774267|19411217|P4|COMPLETED|Overall Study||135
7887342|NCT00774267|19411218|P3|COMPLETED|Overall Study||129
7887343|NCT00774267|19411219|P2|COMPLETED|Overall Study||111
7887344|NCT00774267|19411220|P1|COMPLETED|Overall Study||132
7887345|NCT00774267|19411217|P4|STARTED|Overall Study||135
7887346|NCT00774267|19411218|P3|STARTED|Overall Study||129
7887347|NCT00774267|19411219|P2|STARTED|Overall Study||111
7887348|NCT00774267|19411220|P1|STARTED|Overall Study||132
7887349|NCT00774202|19411232|P2|NOT COMPLETED|Overall Study||0
7887350|NCT00774202|19411233|P1|NOT COMPLETED|Overall Study||0
7887351|NCT00774202|19411232|P2|COMPLETED|Overall Study||8
7887352|NCT00774202|19411233|P1|COMPLETED|Overall Study||9
7887353|NCT00774202|19411232|P2|STARTED|Overall Study||8
7887354|NCT00774202|19411233|P1|STARTED|Overall Study||9
7887355|NCT00774163|19411245|P2|NOT COMPLETED|Overall Study||0
7887356|NCT00774163|19411246|P1|NOT COMPLETED|Overall Study||0
7887357|NCT00774163|19411245|P2|COMPLETED|Overall Study||15
7887358|NCT00774163|19411246|P1|COMPLETED|Overall Study||30
7887359|NCT00774163|19411245|P2|STARTED|Overall Study||15
7887360|NCT00774163|19411246|P1|STARTED|Overall Study||30
7887361|NCT00774046|19411284|P1|NOT COMPLETED|Autologous Transplant||0
7887362|NCT00774046|19411284|P1|COMPLETED|Autologous Transplant||4
7887363|NCT00774046|19411284|P1|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4
7887364|NCT00774046|19411284|P1|NOT COMPLETED|Stem Cell Mobilization||3
7887365|NCT00774046|19411284|P1|COMPLETED|Stem Cell Mobilization||7
7887366|NCT00774046|19411284|P1|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10
7887367|NCT00774046|19411284|P1|NOT COMPLETED|Induction Therapy||0
7887368|NCT00774046|19411284|P1|COMPLETED|Induction Therapy||32
7887369|NCT00774046|19411284|P1|STARTED|Induction Therapy||32
7887370|NCT00774046|19411284|P1|NOT COMPLETED|Enrollment||28
7887371|NCT00774046|19411284|P1|COMPLETED|Enrollment||32
7887372|NCT00774046|19411284|P1|STARTED|Enrollment||60
7887373|NCT00774046|19411284|P1|NOT COMPLETED|Screening||56
7887374|NCT00774046|19411284|P1|COMPLETED|Screening||60
7887375|NCT00774046|19411284|P1|STARTED|Screening||116
7887376|NCT00773968|19411294|P1|NOT COMPLETED|Overall Study||45
7887377|NCT00773968|19411294|P1|COMPLETED|Overall Study||95
7887378|NCT00773968|19411294|P1|Treated|Overall Study||111
7887379|NCT00773968|19411294|P1|STARTED|Overall Study||140
7887380|NCT00773955|19411303|P1|NOT COMPLETED|Overall Study||0
7887381|NCT00773955|19411303|P1|COMPLETED|Overall Study||15
7887382|NCT00773955|19411303|P1|STARTED|Overall Study||15
7887383|NCT00773786|19411310|P2|NOT COMPLETED|Second Intervention (1 Week)||0
7887384|NCT00773786|19411311|P1|NOT COMPLETED|Second Intervention (1 Week)||0
7887385|NCT00773786|19411310|P2|COMPLETED|Second Intervention (1 Week)||10
7887386|NCT00773786|19411311|P1|COMPLETED|Second Intervention (1 Week)||10
7887387|NCT00773786|19411310|P2|STARTED|Second Intervention (1 Week)||10
7887388|NCT00773786|19411311|P1|STARTED|Second Intervention (1 Week)||10
7887389|NCT00773786|19411310|P2|NOT COMPLETED|Washout (1 Week)||0
7887390|NCT00773786|19411311|P1|NOT COMPLETED|Washout (1 Week)||0
7887391|NCT00773786|19411310|P2|COMPLETED|Washout (1 Week)||10
7887392|NCT00773786|19411311|P1|COMPLETED|Washout (1 Week)||10
7887393|NCT00773786|19411310|P2|STARTED|Washout (1 Week)||10
7887394|NCT00773786|19411311|P1|STARTED|Washout (1 Week)||10
7887395|NCT00773786|19411310|P2|NOT COMPLETED|First Intervention (1 Week)||0
7887396|NCT00773786|19411311|P1|NOT COMPLETED|First Intervention (1 Week)||0
7887397|NCT00773786|19411310|P2|COMPLETED|First Intervention (1 Week)||10
7887398|NCT00773786|19411311|P1|COMPLETED|First Intervention (1 Week)||10
7887399|NCT00773786|19411310|P2|STARTED|First Intervention (1 Week)||10
7887400|NCT00773786|19411311|P1|STARTED|First Intervention (1 Week)||10
7887401|NCT00773734|19411325|P6|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
7887402|NCT00773734|19411326|P5|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
7887403|NCT00773734|19411327|P4|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
7887404|NCT00773734|19411328|P3|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
7887405|NCT00773734|19411329|P2|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
7887406|NCT00773734|19411330|P1|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
7887407|NCT00773734|19411325|P6|COMPLETED|LTE Period: Week 52 to 6 Years||0
7887408|NCT00773734|19411326|P5|COMPLETED|LTE Period: Week 52 to 6 Years||0
7887409|NCT00773734|19411327|P4|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5
7887410|NCT00773734|19411328|P3|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4
7887411|NCT00773734|19411329|P2|COMPLETED|LTE Period: Week 52 to 6 Years||0
7887412|NCT00773734|19411330|P1|COMPLETED|LTE Period: Week 52 to 6 Years||0
7887413|NCT00773734|19411325|P6|STARTED|LTE Period: Week 52 to 6 Years||0
7887414|NCT00773734|19411326|P5|STARTED|LTE Period: Week 52 to 6 Years||0
7887415|NCT00773734|19411327|P4|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17
7887416|NCT00773734|19411328|P3|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16
7887417|NCT00773734|19411329|P2|STARTED|LTE Period: Week 52 to 6 Years||0
7887418|NCT00773734|19411330|P1|STARTED|LTE Period: Week 52 to 6 Years||0
7887419|NCT00773734|19411325|P6|NOT COMPLETED|Extension: Active Treatment Week 24-52||8
7887420|NCT00773734|19411326|P5|NOT COMPLETED|Extension: Active Treatment Week 24-52||5
7887421|NCT00773734|19411327|P4|NOT COMPLETED|Extension: Active Treatment Week 24-52||10
7887422|NCT00773734|19411328|P3|NOT COMPLETED|Extension: Active Treatment Week 24-52||17
7887423|NCT00773734|19411329|P2|NOT COMPLETED|Extension: Active Treatment Week 24-52||13
7887424|NCT00773734|19411330|P1|NOT COMPLETED|Extension: Active Treatment Week 24-52||0
7887425|NCT00773734|19411325|P6|COMPLETED|Extension: Active Treatment Week 24-52||19
7887426|NCT00773734|19411326|P5|COMPLETED|Extension: Active Treatment Week 24-52||22
7887427|NCT00773734|19411327|P4|COMPLETED|Extension: Active Treatment Week 24-52||48
7887428|NCT00773734|19411328|P3|COMPLETED|Extension: Active Treatment Week 24-52||33
7887429|NCT00773734|19411329|P2|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34
7887430|NCT00773734|19411330|P1|COMPLETED|Extension: Active Treatment Week 24-52||0
7887431|NCT00773734|19411325|P6|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
7887432|NCT00773734|19411326|P5|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
7887433|NCT00773734|19411327|P4|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
7887434|NCT00773734|19411328|P3|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
7887435|NCT00773734|19411329|P2|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5
7887436|NCT00773734|19411330|P1|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0
7887437|NCT00773734|19411325|P6|STARTED|Extension: Active Treatment Week 24-52||27
7887438|NCT00773734|19411326|P5|STARTED|Extension: Active Treatment Week 24-52||27
7887439|NCT00773734|19411327|P4|STARTED|Extension: Active Treatment Week 24-52||58
7887440|NCT00773734|19411328|P3|STARTED|Extension: Active Treatment Week 24-52||50
7887441|NCT00773734|19411329|P2|STARTED|Extension: Active Treatment Week 24-52||47
7887442|NCT00773734|19411330|P1|STARTED|Extension: Active Treatment Week 24-52||0
7887443|NCT00773734|19411325|P6|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5
7887444|NCT00773734|19411326|P5|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1
7887445|NCT00773734|19411327|P4|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2
7887446|NCT00773734|19411328|P3|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7
7887447|NCT00773734|19411329|P2|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12
7887448|NCT00773734|19411330|P1|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0
7887449|NCT00773734|19411325|P6|COMPLETED|Core: Active Treatment Phase Week 16-24||31
7887450|NCT00773734|19411326|P5|COMPLETED|Core: Active Treatment Phase Week 16-24||33
7887451|NCT00773734|19411327|P4|COMPLETED|Core: Active Treatment Phase Week 16-24||65
7887452|NCT00773734|19411328|P3|COMPLETED|Core: Active Treatment Phase Week 16-24||59
7887453|NCT00773734|19411329|P2|COMPLETED|Core: Active Treatment Phase Week 16-24||65
7887454|NCT00773734|19411330|P1|COMPLETED|Core: Active Treatment Phase Week 16-24||0
7887455|NCT00773734|19411325|P6|STARTED|Core: Active Treatment Phase Week 16-24||36
7887456|NCT00773734|19411326|P5|STARTED|Core: Active Treatment Phase Week 16-24||34
7887457|NCT00773734|19411327|P4|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67
7887458|NCT00773734|19411328|P3|STARTED|Core: Active Treatment Phase Week 16-24||66
7887459|NCT00773734|19411329|P2|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77
7887460|NCT00773734|19411330|P1|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0
7887461|NCT00773734|19411325|P6|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
7887462|NCT00773734|19411326|P5|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
7887463|NCT00773734|19411327|P4|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18
7887464|NCT00773734|19411328|P3|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21
7887465|NCT00773734|19411329|P2|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10
7887466|NCT00773734|19411330|P1|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16
7887467|NCT00773734|19411325|P6|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
7887468|NCT00773734|19411326|P5|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
7887469|NCT00773734|19411327|P4|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70
7887470|NCT00773734|19411328|P3|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66
7887471|NCT00773734|19411329|P2|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79
7887472|NCT00773734|19411330|P1|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72
7887473|NCT00773734|19411325|P6|STARTED|Core: Placebo Controlled Phase Week 0-16||0
7887474|NCT00773734|19411326|P5|STARTED|Core: Placebo Controlled Phase Week 0-16||0
7887475|NCT00773734|19411327|P4|STARTED|Core: Placebo Controlled Phase Week 0-16||88
7887476|NCT00773734|19411328|P3|STARTED|Core: Placebo Controlled Phase Week 0-16||87
7887477|NCT00773734|19411329|P2|STARTED|Core: Placebo Controlled Phase Week 0-16||89
7887478|NCT00773734|19411330|P1|STARTED|Core: Placebo Controlled Phase Week 0-16||88
7887479|NCT00773604|19411892|P1|NOT COMPLETED|Overall Study||0
7887480|NCT00773604|19411892|P1|COMPLETED|Overall Study||9
7887481|NCT00773604|19411892|P1|STARTED|Overall Study||9
7887482|NCT00773513|19411898|P2|NOT COMPLETED|Overall Study||1109
7887483|NCT00773513|19411899|P1|NOT COMPLETED|Overall Study||1101
7887484|NCT00773513|19411898|P2|COMPLETED|Overall Study||303
7887485|NCT00773513|19411899|P1|COMPLETED|Overall Study||312
7887486|NCT00773513|19411898|P2|Received Study Treatment|Overall Study||1409
7887487|NCT00773513|19411899|P1|Received Study Treatment|Overall Study||1409
7887488|NCT00773513|19411898|P2|STARTED|Overall Study||1412
7887489|NCT00773513|19411899|P1|STARTED|Overall Study||1413
7887490|NCT00773474|19411919|P1|NOT COMPLETED|Overall Study||0
7887491|NCT00773474|19411919|P1|COMPLETED|Overall Study||29
7887492|NCT00773474|19411919|P1|STARTED|Overall Study||29
7887493|NCT00773461|19411928|P2|NOT COMPLETED|Overall Study||4
7887494|NCT00773461|19411929|P1|NOT COMPLETED|Overall Study||5
7887495|NCT00773461|19411928|P2|COMPLETED|Overall Study||135
7887496|NCT00773461|19411929|P1|COMPLETED|Overall Study||65
7887497|NCT00773461|19411928|P2|STARTED|Overall Study||139
7887498|NCT00773461|19411929|P1|STARTED|Overall Study||70
7887499|NCT00773422|19411970|P3|NOT COMPLETED|Overall Study||0
7887500|NCT00773422|19411971|P2|NOT COMPLETED|Overall Study||0
7887501|NCT00773422|19411972|P1|NOT COMPLETED|Overall Study||0
7887502|NCT00773422|19411970|P3|COMPLETED|Overall Study||10
7887503|NCT00773422|19411971|P2|COMPLETED|Overall Study||9
7887504|NCT00773422|19411972|P1|COMPLETED|Overall Study||11
7887505|NCT00773422|19411970|P3|STARTED|Overall Study||10
7887506|NCT00773422|19411971|P2|STARTED|Overall Study||9
7887507|NCT00773422|19411972|P1|STARTED|Overall Study||11
7887508|NCT00773383|19411983|P1|NOT COMPLETED|Overall Study||31
7887509|NCT00773383|19411983|P1|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4
7887510|NCT00773383|19411983|P1|Received Study Drug|Overall Study||34
7887511|NCT00773383|19411983|P1|STARTED|Overall Study||35
7887512|NCT00773370|19412005|P2|NOT COMPLETED|Overall Study||10
7887513|NCT00773370|19412006|P1|NOT COMPLETED|Overall Study||18
7887514|NCT00773370|19412005|P2|COMPLETED|Overall Study||23
7887515|NCT00773370|19412006|P1|COMPLETED|Overall Study||25
7887516|NCT00773370|19412005|P2|STARTED|Overall Study||33
7887517|NCT00773370|19412006|P1|STARTED|Overall Study||43
7887518|NCT00773279|19412018|P2|NOT COMPLETED|Period 2||6
7887519|NCT00773279|19412019|P1|NOT COMPLETED|Period 2||3
7887520|NCT00773279|19412018|P2|COMPLETED|Period 2||111
7887521|NCT00773279|19412019|P1|COMPLETED|Period 2||111
7887522|NCT00773279|19412018|P2|STARTED|Period 2||117
7887523|NCT00773279|19412019|P1|STARTED|Period 2||114
7887524|NCT00773279|19412018|P2|NOT COMPLETED|Period 1||4
7887525|NCT00773279|19412019|P1|NOT COMPLETED|Period 1||7
7887526|NCT00773279|19412018|P2|COMPLETED|Period 1||117
7887527|NCT00773279|19412019|P1|COMPLETED|Period 1||114
7887528|NCT00773279|19412018|P2|STARTED|Period 1||121
7887529|NCT00773279|19412019|P1|STARTED|Period 1||121
7887530|NCT00773253|19412040|P2|NOT COMPLETED|Second Intervention (Week 24-48)||0
7887531|NCT00773253|19412041|P1|NOT COMPLETED|Second Intervention (Week 24-48)||0
7887532|NCT00773253|19412040|P2|COMPLETED|Second Intervention (Week 24-48)||4
7887533|NCT00773253|19412041|P1|COMPLETED|Second Intervention (Week 24-48)||5
7887534|NCT00773253|19412040|P2|STARTED|Second Intervention (Week 24-48)||4
7887535|NCT00773253|19412041|P1|STARTED|Second Intervention (Week 24-48)||5
7887536|NCT00773253|19412040|P2|NOT COMPLETED|First Intervention (Week 0-24)||1
7887537|NCT00773253|19412041|P1|NOT COMPLETED|First Intervention (Week 0-24)||0
7887538|NCT00773253|19412040|P2|COMPLETED|First Intervention (Week 0-24)||4
7887539|NCT00773253|19412041|P1|COMPLETED|First Intervention (Week 0-24)||5
7887540|NCT00773253|19412040|P2|STARTED|First Intervention (Week 0-24)||5
7887541|NCT00773253|19412041|P1|STARTED|First Intervention (Week 0-24)||5
7887542|NCT00773175|19412051|P2|NOT COMPLETED|Overall Study||2
7887543|NCT00773175|19412052|P1|NOT COMPLETED|Overall Study||2
7887544|NCT00773175|19412051|P2|COMPLETED|Overall Study||73
7887545|NCT00773175|19412052|P1|COMPLETED|Overall Study||71
7887546|NCT00773175|19412051|P2|No Fluids Received|Overall Study||1
7887547|NCT00773175|19412052|P1|No Fluids Received|Overall Study||0
7887548|NCT00773175|19412051|P2|Initial Fluids Via Subcutaneous Rescue|Overall Study||15
7887549|NCT00773175|19412052|P1|Initial Fluids Via Subcutaneous Rescue|Overall Study||0
7887550|NCT00773175|19412051|P2|Initial Fluids Via Randomized Route|Overall Study||59
7887551|NCT00773175|19412052|P1|Initial Fluids Via Randomized Route|Overall Study||73
7887552|NCT00773175|19412051|P2|STARTED|Overall Study||75
7887553|NCT00773175|19412052|P1|STARTED|Overall Study||73
7887554|NCT00773136|19412144|P1|NOT COMPLETED|Overall Study||2
7887555|NCT00773136|19412144|P1|COMPLETED|Overall Study||19
7887556|NCT00773136|19412144|P1|STARTED|Overall Study||21
7887557|NCT00773097|19412149|P1|NOT COMPLETED|Overall Study||7
7887558|NCT00773097|19412149|P1|COMPLETED|Overall Study||39
7887559|NCT00773097|19412149|P1|STARTED|Overall Study||46
7887560|NCT00772967|19412155|P6|NOT COMPLETED|Crossover Treatment 3||0
7887561|NCT00772967|19412156|P5|NOT COMPLETED|Crossover Treatment 3||1
7887562|NCT00772967|19412157|P4|NOT COMPLETED|Crossover Treatment 3||0
7887563|NCT00772967|19412158|P3|NOT COMPLETED|Crossover Treatment 3||0
7887564|NCT00772967|19412159|P2|NOT COMPLETED|Crossover Treatment 3||0
7887565|NCT00772967|19412160|P1|NOT COMPLETED|Crossover Treatment 3||0
7887566|NCT00772967|19412155|P6|COMPLETED|Crossover Treatment 3||3
7887567|NCT00772967|19412156|P5|COMPLETED|Crossover Treatment 3||3
7887568|NCT00772967|19412157|P4|COMPLETED|Crossover Treatment 3||3
7887569|NCT00772967|19412158|P3|COMPLETED|Crossover Treatment 3||3
7887570|NCT00772967|19412159|P2|COMPLETED|Crossover Treatment 3||4
7887571|NCT00772967|19412160|P1|COMPLETED|Crossover Treatment 3||3
7887572|NCT00772967|19412155|P6|STARTED|Crossover Treatment 3||3
7887573|NCT00772967|19412156|P5|STARTED|Crossover Treatment 3||4
7887574|NCT00772967|19412157|P4|STARTED|Crossover Treatment 3||3
7887575|NCT00772967|19412158|P3|STARTED|Crossover Treatment 3||3
7887576|NCT00772967|19412159|P2|STARTED|Crossover Treatment 3||4
7887577|NCT00772967|19412160|P1|STARTED|Crossover Treatment 3||3
7887578|NCT00772967|19412155|P6|NOT COMPLETED|Break 2 (4-7 Days)||0
7887579|NCT00772967|19412156|P5|NOT COMPLETED|Break 2 (4-7 Days)||0
7887580|NCT00772967|19412157|P4|NOT COMPLETED|Break 2 (4-7 Days)||0
7887581|NCT00772967|19412158|P3|NOT COMPLETED|Break 2 (4-7 Days)||0
7887582|NCT00772967|19412159|P2|NOT COMPLETED|Break 2 (4-7 Days)||0
7887583|NCT00772967|19412160|P1|NOT COMPLETED|Break 2 (4-7 Days)||0
7887584|NCT00772967|19412155|P6|COMPLETED|Break 2 (4-7 Days)||3
7887585|NCT00772967|19412156|P5|COMPLETED|Break 2 (4-7 Days)||4
7887586|NCT00772967|19412157|P4|COMPLETED|Break 2 (4-7 Days)||3
7887587|NCT00772967|19412158|P3|COMPLETED|Break 2 (4-7 Days)||3
7887588|NCT00772967|19412159|P2|COMPLETED|Break 2 (4-7 Days)||4
7887589|NCT00772967|19412160|P1|COMPLETED|Break 2 (4-7 Days)||3
7887590|NCT00772967|19412155|P6|STARTED|Break 2 (4-7 Days)||3
7887591|NCT00772967|19412156|P5|STARTED|Break 2 (4-7 Days)||4
7887592|NCT00772967|19412157|P4|STARTED|Break 2 (4-7 Days)||3
7887593|NCT00772967|19412158|P3|STARTED|Break 2 (4-7 Days)||3
7887594|NCT00772967|19412159|P2|STARTED|Break 2 (4-7 Days)||4
7887595|NCT00772967|19412160|P1|STARTED|Break 2 (4-7 Days)||3
7887596|NCT00772967|19412155|P6|NOT COMPLETED|Crossover Treatment 2||0
7887597|NCT00772967|19412156|P5|NOT COMPLETED|Crossover Treatment 2||0
7887598|NCT00772967|19412157|P4|NOT COMPLETED|Crossover Treatment 2||0
7887599|NCT00772967|19412158|P3|NOT COMPLETED|Crossover Treatment 2||0
7887600|NCT00772967|19412159|P2|NOT COMPLETED|Crossover Treatment 2||0
7887601|NCT00772967|19412160|P1|NOT COMPLETED|Crossover Treatment 2||0
7887602|NCT00772967|19412155|P6|COMPLETED|Crossover Treatment 2||3
7887603|NCT00772967|19412156|P5|COMPLETED|Crossover Treatment 2||4
7887604|NCT00772967|19412157|P4|COMPLETED|Crossover Treatment 2||3
7887605|NCT00772967|19412158|P3|COMPLETED|Crossover Treatment 2||3
7887606|NCT00772967|19412159|P2|COMPLETED|Crossover Treatment 2||4
7887607|NCT00772967|19412160|P1|COMPLETED|Crossover Treatment 2||3
7887608|NCT00772967|19412155|P6|STARTED|Crossover Treatment 2||3
7887609|NCT00772967|19412156|P5|STARTED|Crossover Treatment 2||4
7887610|NCT00772967|19412157|P4|STARTED|Crossover Treatment 2||3
7887611|NCT00772967|19412158|P3|STARTED|Crossover Treatment 2||3
7887612|NCT00772967|19412159|P2|STARTED|Crossover Treatment 2||4
7887613|NCT00772967|19412160|P1|STARTED|Crossover Treatment 2||3
7887614|NCT00772967|19412155|P6|NOT COMPLETED|Break 1 (4-7 Days)||0
7887615|NCT00772967|19412156|P5|NOT COMPLETED|Break 1 (4-7 Days)||0
7887616|NCT00772967|19412157|P4|NOT COMPLETED|Break 1 (4-7 Days)||0
7887617|NCT00772967|19412158|P3|NOT COMPLETED|Break 1 (4-7 Days)||0
7887618|NCT00772967|19412159|P2|NOT COMPLETED|Break 1 (4-7 Days)||1
7887619|NCT00772967|19412160|P1|NOT COMPLETED|Break 1 (4-7 Days)||0
7887620|NCT00772967|19412155|P6|COMPLETED|Break 1 (4-7 Days)||3
7887621|NCT00772967|19412156|P5|COMPLETED|Break 1 (4-7 Days)||4
7887622|NCT00772967|19412157|P4|COMPLETED|Break 1 (4-7 Days)||3
7887623|NCT00772967|19412158|P3|COMPLETED|Break 1 (4-7 Days)||3
7887624|NCT00772967|19412159|P2|COMPLETED|Break 1 (4-7 Days)||4
7887625|NCT00772967|19412160|P1|COMPLETED|Break 1 (4-7 Days)||3
7887626|NCT00772967|19412155|P6|STARTED|Break 1 (4-7 Days)||3
7887627|NCT00772967|19412156|P5|STARTED|Break 1 (4-7 Days)||4
7887628|NCT00772967|19412157|P4|STARTED|Break 1 (4-7 Days)||3
7887629|NCT00772967|19412158|P3|STARTED|Break 1 (4-7 Days)||3
7887630|NCT00772967|19412159|P2|STARTED|Break 1 (4-7 Days)||5
7887631|NCT00772967|19412160|P1|STARTED|Break 1 (4-7 Days)||3
7887632|NCT00772967|19412155|P6|NOT COMPLETED|Crossover Treatment 1||0
7887633|NCT00772967|19412156|P5|NOT COMPLETED|Crossover Treatment 1||0
7887634|NCT00772967|19412157|P4|NOT COMPLETED|Crossover Treatment 1||1
7887635|NCT00772967|19412158|P3|NOT COMPLETED|Crossover Treatment 1||0
7887636|NCT00772967|19412159|P2|NOT COMPLETED|Crossover Treatment 1||0
7887637|NCT00772967|19412160|P1|NOT COMPLETED|Crossover Treatment 1||0
7887638|NCT00772967|19412155|P6|COMPLETED|Crossover Treatment 1||3
7887639|NCT00772967|19412156|P5|COMPLETED|Crossover Treatment 1||4
7887640|NCT00772967|19412157|P4|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3
7887641|NCT00772967|19412158|P3|COMPLETED|Crossover Treatment 1||3
7887642|NCT00772967|19412159|P2|COMPLETED|Crossover Treatment 1||5
7887643|NCT00772967|19412160|P1|COMPLETED|Crossover Treatment 1||3
7887644|NCT00772967|19412155|P6|STARTED|Crossover Treatment 1||3
7887645|NCT00772967|19412156|P5|STARTED|Crossover Treatment 1||4
7887646|NCT00772967|19412157|P4|STARTED|Crossover Treatment 1||4
7887647|NCT00772967|19412158|P3|STARTED|Crossover Treatment 1||3
7887648|NCT00772967|19412159|P2|STARTED|Crossover Treatment 1||5
7887649|NCT00772967|19412160|P1|STARTED|Crossover Treatment 1||3
7887650|NCT00772954|19412180|P3|NOT COMPLETED|Overall Study||1
7887651|NCT00772954|19412181|P2|NOT COMPLETED|Overall Study||0
7887652|NCT00772954|19412182|P1|NOT COMPLETED|Overall Study||0
7887653|NCT00772954|19412180|P3|COMPLETED|Overall Study||11
7887654|NCT00772954|19412181|P2|COMPLETED|Overall Study||12
7887655|NCT00772954|19412182|P1|COMPLETED|Overall Study||12
7887656|NCT00772954|19412180|P3|STARTED|Overall Study||12
7887657|NCT00772954|19412181|P2|STARTED|Overall Study||12
7887658|NCT00772954|19412182|P1|STARTED|Overall Study||12
7887659|NCT00772941|19412190|P1|NOT COMPLETED|Overall Study||682
7887660|NCT00772941|19412190|P1|COMPLETED|Overall Study||3257
7887661|NCT00772941|19412190|P1|STARTED|Overall Study||3939
7887662|NCT00772928|19412221|P2|NOT COMPLETED|Overall Study||41
7887663|NCT00772928|19412222|P1|NOT COMPLETED|Overall Study||44
7887664|NCT00772928|19412221|P2|COMPLETED|Overall Study||538
7887665|NCT00772928|19412222|P1|COMPLETED|Overall Study||543
7887666|NCT00772928|19412221|P2|STARTED|Overall Study||579
7887667|NCT00772928|19412222|P1|STARTED|Overall Study||587
7887668|NCT00772915|19412232|P1|NOT COMPLETED|Overall Study||15
7887669|NCT00772915|19412232|P1|COMPLETED|Overall Study||23
7887670|NCT00772915|19412232|P1|STARTED|Overall Study||38
7887671|NCT00772889|19412243|P3|NOT COMPLETED|Overall Study||16
7887672|NCT00772889|19412244|P2|NOT COMPLETED|Overall Study||18
7887673|NCT00772889|19412245|P1|NOT COMPLETED|Overall Study||22
7887674|NCT00772889|19412243|P3|COMPLETED|Overall Study||187
7887675|NCT00772889|19412244|P2|COMPLETED|Overall Study||375
7887676|NCT00772889|19412245|P1|COMPLETED|Overall Study||353
7887677|NCT00772889|19412243|P3|Completed at Day 21|Overall Study||203
7887678|NCT00772889|19412244|P2|Completed at Day 21|Overall Study||390
7887679|NCT00772889|19412245|P1|Completed at Day 21|Overall Study||374
7887680|NCT00772889|19412243|P3|STARTED|Overall Study||203
7887681|NCT00772889|19412244|P2|STARTED|Overall Study||393
7887682|NCT00772889|19412245|P1|STARTED|Overall Study||375
7887683|NCT00772772|19412298|P1|NOT COMPLETED|Overall Study||0
7887684|NCT00772772|19412298|P1|COMPLETED|Overall Study||12
7887685|NCT00772772|19412298|P1|STARTED|Overall Study||12
7887686|NCT00772707|19412303|P1|NOT COMPLETED|Overall Study||3
7887687|NCT00772707|19412303|P1|COMPLETED|Overall Study||111
7887688|NCT00772707|19412303|P1|STARTED|Overall Study||114
7887689|NCT00772668|19412308|P1|NOT COMPLETED|Overall Study||3
7887690|NCT00772668|19412308|P1|COMPLETED|Overall Study||0
7887691|NCT00772668|19412308|P1|STARTED|Overall Study||3
7887692|NCT00772629|19412317|P2|NOT COMPLETED|Overall Study||0
7887693|NCT00772629|19412318|P1|NOT COMPLETED|Overall Study||1
7887694|NCT00772629|19412317|P2|COMPLETED|Overall Study||1
7887695|NCT00772629|19412318|P1|COMPLETED|Overall Study||16
7887696|NCT00772629|19412317|P2|STARTED|Overall Study||1
7887697|NCT00772629|19412318|P1|STARTED|Overall Study||17
7887698|NCT00772603|19412327|P3|NOT COMPLETED|Overall Study||26
7887699|NCT00772603|19412328|P2|NOT COMPLETED|Overall Study||40
7887700|NCT00772603|19412329|P1|NOT COMPLETED|Overall Study||52
7887701|NCT00772603|19412327|P3|COMPLETED|Overall Study||95
7887702|NCT00772603|19412328|P2|COMPLETED|Overall Study||82
7887703|NCT00772603|19412329|P1|COMPLETED|Overall Study||71
7887704|NCT00772603|19412327|P3|STARTED|Overall Study||121
7887705|NCT00772603|19412328|P2|STARTED|Overall Study||122
7887706|NCT00772603|19412329|P1|STARTED|Overall Study||123
7887707|NCT00772590|19412353|P4|NOT COMPLETED|Overall Study||0
7887708|NCT00772590|19412354|P3|NOT COMPLETED|Overall Study||0
7887709|NCT00772590|19412355|P2|NOT COMPLETED|Overall Study||0
7887710|NCT00772590|19412356|P1|NOT COMPLETED|Overall Study||0
7887711|NCT00772590|19412353|P4|COMPLETED|Overall Study||17
7887712|NCT00772590|19412354|P3|COMPLETED|Overall Study||18
7887713|NCT00772590|19412355|P2|COMPLETED|Overall Study||19
7887714|NCT00772590|19412356|P1|COMPLETED|Overall Study||19
7887715|NCT00772590|19412353|P4|STARTED|Overall Study||17
7887716|NCT00772590|19412354|P3|STARTED|Overall Study||18
7887717|NCT00772590|19412355|P2|STARTED|Overall Study||19
7887718|NCT00772590|19412356|P1|STARTED|Overall Study||19
7887719|NCT00772577|19412368|P2|NOT COMPLETED|Overall Study||23
7887720|NCT00772577|19412369|P1|NOT COMPLETED|Overall Study||23
7887721|NCT00772577|19412368|P2|COMPLETED|Overall Study||170
7887722|NCT00772577|19412369|P1|COMPLETED|Overall Study||170
7887723|NCT00772577|19412368|P2|STARTED|Overall Study||193
7887724|NCT00772577|19412369|P1|STARTED|Overall Study||193
7887725|NCT00772538|19412385|P2|NOT COMPLETED|Overall Study||26
7887726|NCT00772538|19412386|P1|NOT COMPLETED|Overall Study||20
7887727|NCT00772538|19412385|P2|COMPLETED|Overall Study||211
7887728|NCT00772538|19412386|P1|COMPLETED|Overall Study||202
7887729|NCT00772538|19412385|P2|STARTED|Overall Study||237
7887730|NCT00772538|19412386|P1|STARTED|Overall Study||222
7887731|NCT00772447|19412458|P2|NOT COMPLETED|Overall Study||24
7887732|NCT00772447|19412459|P1|NOT COMPLETED|Overall Study||20
7887733|NCT00772447|19412458|P2|COMPLETED|Overall Study||110
7887734|NCT00772447|19412459|P1|COMPLETED|Overall Study||111
7887735|NCT00772447|19412458|P2|STARTED|Overall Study||134
7887736|NCT00772447|19412459|P1|STARTED|Overall Study||131
7887737|NCT00772382|19412487|P1|NOT COMPLETED|Overall Study||55
7887738|NCT00772382|19412487|P1|COMPLETED|Overall Study||61
7887739|NCT00772382|19412487|P1|STARTED|Overall Study||116
7887740|NCT00772369|19412492|P1|NOT COMPLETED|Overall Study||1
7887741|NCT00772369|19412492|P1|COMPLETED|Overall Study||3213
7887742|NCT00772369|19412492|P1|STARTED|Overall Study||3214
7887743|NCT00772304|19412497|P1|NOT COMPLETED|Overall Study||0
7887744|NCT00772304|19412497|P1|COMPLETED|Overall Study||102
7887745|NCT00772304|19412497|P1|STARTED|Overall Study||102
7887746|NCT00772148|19412503|P2|NOT COMPLETED|Maintenance Phase (Week 52)||5
7887747|NCT00772148|19412504|P1|NOT COMPLETED|Maintenance Phase (Week 52)||4
7887748|NCT00772148|19412503|P2|COMPLETED|Maintenance Phase (Week 52)||18
7887749|NCT00772148|19412504|P1|COMPLETED|Maintenance Phase (Week 52)||17
7887750|NCT00772148|19412503|P2|STARTED|Maintenance Phase (Week 52)||23
7887751|NCT00772148|19412504|P1|STARTED|Maintenance Phase (Week 52)||21
7887752|NCT00772148|19412503|P2|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6
7887753|NCT00772148|19412504|P1|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8
7887754|NCT00772148|19412503|P2|COMPLETED|Pharmacokinetic Phase (14 Days)||23
7887755|NCT00772148|19412504|P1|COMPLETED|Pharmacokinetic Phase (14 Days)||21
7887756|NCT00772148|19412503|P2|STARTED|Pharmacokinetic Phase (14 Days)||29
7887757|NCT00772148|19412504|P1|STARTED|Pharmacokinetic Phase (14 Days)||29
7887758|NCT00772109|19412524|P4|NOT COMPLETED|Overall Study||31
7887759|NCT00772109|19412525|P3|NOT COMPLETED|Overall Study||19
7887760|NCT00772109|19412526|P2|NOT COMPLETED|Overall Study||19
7887761|NCT00772109|19412527|P1|NOT COMPLETED|Overall Study||21
7887762|NCT00772109|19412524|P4|COMPLETED|Overall Study||1397
7887763|NCT00772109|19412525|P3|COMPLETED|Overall Study||936
7887764|NCT00772109|19412526|P2|COMPLETED|Overall Study||934
7887765|NCT00772109|19412527|P1|COMPLETED|Overall Study||935
7887766|NCT00772109|19412524|P4|STARTED|Overall Study||1428
7887767|NCT00772109|19412525|P3|STARTED|Overall Study||955
7887768|NCT00772109|19412526|P2|STARTED|Overall Study||953
7887769|NCT00772109|19412527|P1|STARTED|Overall Study||956
7887770|NCT00772070|19412551|P2|NOT COMPLETED|Overall Study||10
7887771|NCT00772070|19412552|P1|NOT COMPLETED|Overall Study||2
7887772|NCT00772070|19412551|P2|COMPLETED|Overall Study||61
7887773|NCT00772070|19412552|P1|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100
7887774|NCT00772070|19412551|P2|STARTED|Overall Study||71
7887775|NCT00772070|19412552|P1|STARTED|Overall Study||102
7887776|NCT00772031|19412564|P2|NOT COMPLETED|Overall Study||43
7887777|NCT00772031|19412565|P1|NOT COMPLETED|Overall Study||32
7887778|NCT00772031|19412564|P2|COMPLETED|Overall Study||52
7887779|NCT00772031|19412565|P1|COMPLETED|Overall Study||64
7887780|NCT00772031|19412564|P2|STARTED|Overall Study||95
7887781|NCT00772031|19412565|P1|STARTED|Overall Study||96
7887782|NCT00772005|19412591|P4|NOT COMPLETED|Overall Study||26
7887783|NCT00772005|19412592|P3|NOT COMPLETED|Overall Study||28
7887784|NCT00772005|19412593|P2|NOT COMPLETED|Overall Study||30
7887785|NCT00772005|19412594|P1|NOT COMPLETED|Overall Study||25
7887786|NCT00772005|19412591|P4|COMPLETED|Overall Study||46
7887787|NCT00772005|19412592|P3|COMPLETED|Overall Study||44
7887788|NCT00772005|19412593|P2|COMPLETED|Overall Study||40
7887789|NCT00772005|19412594|P1|COMPLETED|Overall Study||46
7887790|NCT00772005|19412591|P4|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72
7887791|NCT00772005|19412592|P3|STARTED|Overall Study|One patient withdrew before taking any study drug.|72
7887792|NCT00772005|19412593|P2|STARTED|Overall Study|One patient withdrew before taking any study drug.|70
7887793|NCT00772005|19412594|P1|STARTED|Overall Study||71
7887794|NCT00771953|19413282|P2|NOT COMPLETED|Overall Study||10
7887795|NCT00771953|19413283|P1|NOT COMPLETED|Overall Study||10
7887796|NCT00771953|19413282|P2|COMPLETED|Overall Study||26
7887797|NCT00771953|19413283|P1|COMPLETED|Overall Study||26
7887798|NCT00771953|19413282|P2|STARTED|Overall Study||36
7887799|NCT00771953|19413283|P1|STARTED|Overall Study||36
7887800|NCT00771927|19413293|P2|NOT COMPLETED|Overall Study||237
7887801|NCT00771927|19413294|P1|NOT COMPLETED|Overall Study||255
7887802|NCT00771927|19413293|P2|COMPLETED|Overall Study||256
7887803|NCT00771927|19413294|P1|COMPLETED|Overall Study||256
7887804|NCT00771927|19413293|P2|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493
7887805|NCT00771927|19413294|P1|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511
7887806|NCT00771914|19413306|P4|NOT COMPLETED|Overall Study||2
7887807|NCT00771914|19413307|P3|NOT COMPLETED|Overall Study||0
7887808|NCT00771914|19413308|P2|NOT COMPLETED|Overall Study||0
7887809|NCT00771914|19413309|P1|NOT COMPLETED|Overall Study||0
7887810|NCT00771914|19413306|P4|COMPLETED|Overall Study||6
7887811|NCT00771914|19413307|P3|COMPLETED|Overall Study||6
7887812|NCT00771914|19413308|P2|COMPLETED|Overall Study||6
7887813|NCT00771914|19413309|P1|COMPLETED|Overall Study||7
7887814|NCT00771914|19413306|P4|STARTED|Overall Study||8
7887815|NCT00771914|19413307|P3|STARTED|Overall Study||6
7887816|NCT00771914|19413308|P2|STARTED|Overall Study||6
7887817|NCT00771914|19413309|P1|STARTED|Overall Study||7
7887818|NCT00771901|19413322|P3|NOT COMPLETED|Overall Study||4
7887819|NCT00771901|19413323|P2|NOT COMPLETED|Overall Study||0
7887820|NCT00771901|19413324|P1|NOT COMPLETED|Overall Study||0
7887821|NCT00771901|19413322|P3|COMPLETED|Overall Study||6
7887822|NCT00771901|19413323|P2|COMPLETED|Overall Study||10
7887823|NCT00771901|19413324|P1|COMPLETED|Overall Study||10
7887824|NCT00771901|19413322|P3|STARTED|Overall Study||10
7887825|NCT00771901|19413323|P2|STARTED|Overall Study||10
7887826|NCT00771901|19413324|P1|STARTED|Overall Study||10
7887827|NCT00771875|19413341|P3|NOT COMPLETED|Overall Study||0
7887828|NCT00771875|19413342|P2|NOT COMPLETED|Overall Study||1
7887829|NCT00771875|19413343|P1|NOT COMPLETED|Overall Study||0
7887830|NCT00771875|19413341|P3|COMPLETED|Overall Study||10
7887831|NCT00771875|19413342|P2|COMPLETED|Overall Study||9
7887832|NCT00771875|19413343|P1|COMPLETED|Overall Study||10
7887833|NCT00771875|19413341|P3|STARTED|Overall Study||10
7887834|NCT00771875|19413342|P2|STARTED|Overall Study||10
7887835|NCT00771875|19413343|P1|STARTED|Overall Study||10
7887836|NCT00771849|19413371|P2|NOT COMPLETED|Overall Study||4
7887837|NCT00771849|19413372|P1|NOT COMPLETED|Overall Study||2
7887838|NCT00771849|19413371|P2|COMPLETED|Overall Study||47
7887839|NCT00771849|19413372|P1|COMPLETED|Overall Study||50
7887840|NCT00771849|19413371|P2|STARTED|Overall Study|One subject was not vaccinated|51
7887841|NCT00771849|19413372|P1|STARTED|Overall Study||52
7887842|NCT00771810|19413383|P3|NOT COMPLETED|Overall Study||7
7887843|NCT00771810|19413384|P2|NOT COMPLETED|Overall Study||5
7887844|NCT00771810|19413385|P1|NOT COMPLETED|Overall Study||5
7887845|NCT00771810|19413383|P3|COMPLETED|Overall Study||6
7887846|NCT00771810|19413384|P2|COMPLETED|Overall Study||6
7887847|NCT00771810|19413385|P1|COMPLETED|Overall Study||5
7887848|NCT00771810|19413383|P3|STARTED|Overall Study||13
7887849|NCT00771810|19413384|P2|STARTED|Overall Study||11
7887850|NCT00771810|19413385|P1|STARTED|Overall Study||10
7887851|NCT00771758|19413423|P3|NOT COMPLETED|Overall Study||2
7887852|NCT00771758|19413424|P2|NOT COMPLETED|Overall Study||12
7887853|NCT00771758|19413425|P1|NOT COMPLETED|Overall Study||8
7887854|NCT00771758|19413423|P3|COMPLETED|Overall Study||19
7887855|NCT00771758|19413424|P2|COMPLETED|Overall Study||31
7887856|NCT00771758|19413425|P1|COMPLETED|Overall Study||36
7887857|NCT00771758|19413423|P3|STARTED|Overall Study||21
7887858|NCT00771758|19413424|P2|STARTED|Overall Study||43
7887859|NCT00771758|19413425|P1|STARTED|Overall Study||44
7887860|NCT00771745|19413575|P2|NOT COMPLETED|Overall Study||0
7887861|NCT00771745|19413576|P1|NOT COMPLETED|Overall Study||0
7887862|NCT00771745|19413575|P2|COMPLETED|Overall Study||5
7887863|NCT00771745|19413576|P1|COMPLETED|Overall Study||6
7887864|NCT00771745|19413575|P2|STARTED|Overall Study||5
7887865|NCT00771745|19413576|P1|STARTED|Overall Study||6
7887866|NCT00771667|19413586|P10|NOT COMPLETED|Maintenance Phase||17
7887867|NCT00771667|19413587|P9|NOT COMPLETED|Maintenance Phase||22
7887868|NCT00771667|19413588|P8|NOT COMPLETED|Maintenance Phase||5
7887869|NCT00771667|19413589|P7|NOT COMPLETED|Maintenance Phase||10
7887870|NCT00771667|19413590|P6|NOT COMPLETED|Maintenance Phase||7
7887871|NCT00771667|19413591|P5|NOT COMPLETED|Maintenance Phase||2
7887872|NCT00771667|19413592|P4|NOT COMPLETED|Maintenance Phase||0
7887873|NCT00771667|19413593|P3|NOT COMPLETED|Maintenance Phase||0
7887874|NCT00771667|19413594|P2|NOT COMPLETED|Maintenance Phase||0
7887875|NCT00771667|19413595|P1|NOT COMPLETED|Maintenance Phase||0
7887876|NCT00771667|19413586|P10|COMPLETED|Maintenance Phase||92
7887877|NCT00771667|19413587|P9|COMPLETED|Maintenance Phase||88
7887878|NCT00771667|19413588|P8|COMPLETED|Maintenance Phase||67
7887879|NCT00771667|19413589|P7|COMPLETED|Maintenance Phase||63
7887880|NCT00771667|19413590|P6|COMPLETED|Maintenance Phase||78
7887881|NCT00771667|19413591|P5|COMPLETED|Maintenance Phase||26
7887882|NCT00771667|19413592|P4|COMPLETED|Maintenance Phase||0
7887883|NCT00771667|19413593|P3|COMPLETED|Maintenance Phase||0
7887884|NCT00771667|19413594|P2|COMPLETED|Maintenance Phase||0
7887885|NCT00771667|19413595|P1|COMPLETED|Maintenance Phase||0
7887886|NCT00771667|19413586|P10|STARTED|Maintenance Phase||109
7887887|NCT00771667|19413587|P9|STARTED|Maintenance Phase||110
7887888|NCT00771667|19413588|P8|STARTED|Maintenance Phase||72
7887889|NCT00771667|19413589|P7|STARTED|Maintenance Phase||73
7887890|NCT00771667|19413590|P6|STARTED|Maintenance Phase||85
7887891|NCT00771667|19413591|P5|STARTED|Maintenance Phase||28
7887892|NCT00771667|19413592|P4|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
7887893|NCT00771667|19413593|P3|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
7887894|NCT00771667|19413594|P2|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
7887895|NCT00771667|19413595|P1|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
7887896|NCT00771667|19413586|P10|NOT COMPLETED|Induction Phase||0
7887897|NCT00771667|19413587|P9|NOT COMPLETED|Induction Phase||0
7887898|NCT00771667|19413588|P8|NOT COMPLETED|Induction Phase||0
7887899|NCT00771667|19413589|P7|NOT COMPLETED|Induction Phase||0
7887900|NCT00771667|19413590|P6|NOT COMPLETED|Induction Phase||0
7887901|NCT00771667|19413591|P5|NOT COMPLETED|Induction Phase||0
7887902|NCT00771667|19413592|P4|NOT COMPLETED|Induction Phase||8
7887903|NCT00771667|19413593|P3|NOT COMPLETED|Induction Phase||12
7887904|NCT00771667|19413594|P2|NOT COMPLETED|Induction Phase||10
7887905|NCT00771667|19413595|P1|NOT COMPLETED|Induction Phase||19
7887906|NCT00771667|19413586|P10|COMPLETED|Induction Phase||0
7887907|NCT00771667|19413587|P9|COMPLETED|Induction Phase||0
7887908|NCT00771667|19413588|P8|COMPLETED|Induction Phase||0
7887909|NCT00771667|19413589|P7|COMPLETED|Induction Phase||0
7887910|NCT00771667|19413590|P6|COMPLETED|Induction Phase||0
7887911|NCT00771667|19413591|P5|COMPLETED|Induction Phase||0
7887912|NCT00771667|19413592|P4|COMPLETED|Induction Phase||123
7887913|NCT00771667|19413593|P3|COMPLETED|Induction Phase||120
7887914|NCT00771667|19413594|P2|COMPLETED|Induction Phase||121
7887915|NCT00771667|19413595|P1|COMPLETED|Induction Phase||113
7887916|NCT00771667|19413586|P10|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
7887917|NCT00771667|19413587|P9|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
7887918|NCT00771667|19413588|P8|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
7887919|NCT00771667|19413589|P7|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
7887920|NCT00771667|19413590|P6|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
7887921|NCT00771667|19413591|P5|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
7887922|NCT00771667|19413592|P4|STARTED|Induction Phase||131
7887923|NCT00771667|19413593|P3|STARTED|Induction Phase||132
7887924|NCT00771667|19413594|P2|STARTED|Induction Phase||131
7887925|NCT00771667|19413595|P1|STARTED|Induction Phase||132
7887926|NCT00771615|19413640|P9|NOT COMPLETED|Overall Study||0
7887927|NCT00771615|19413641|P8|NOT COMPLETED|Overall Study||1
7887928|NCT00771615|19413642|P7|NOT COMPLETED|Overall Study||1
7887929|NCT00771615|19413643|P6|NOT COMPLETED|Overall Study||1
7887930|NCT00771615|19413644|P5|NOT COMPLETED|Overall Study||0
7887931|NCT00771615|19413645|P4|NOT COMPLETED|Overall Study||1
7887932|NCT00771615|19413646|P3|NOT COMPLETED|Overall Study||1
7887933|NCT00771615|19413647|P2|NOT COMPLETED|Overall Study||2
7887934|NCT00771615|19413648|P1|NOT COMPLETED|Overall Study||1
7887935|NCT00771615|19413640|P9|COMPLETED|Overall Study|Up to Day 364|41
7887936|NCT00771615|19413641|P8|COMPLETED|Overall Study|Up to Day 364|58
7887937|NCT00771615|19413642|P7|COMPLETED|Overall Study|Up to Day 364|45
7887938|NCT00771615|19413643|P6|COMPLETED|Overall Study|Up to Day 364|60
7887939|NCT00771615|19413644|P5|COMPLETED|Overall Study|Up to Day 364|40
7887940|NCT00771615|19413645|P4|COMPLETED|Overall Study|Up to Day 364|59
7887941|NCT00771615|19413646|P3|COMPLETED|Overall Study|Up to Day 364|40
7887942|NCT00771615|19413647|P2|COMPLETED|Overall Study|Up to Day 364|70
7887943|NCT00771615|19413648|P1|COMPLETED|Overall Study|Up to Day 364|48
7887944|NCT00771615|19413640|P9|STARTED|Overall Study||41
7887945|NCT00771615|19413641|P8|STARTED|Overall Study||59
7887946|NCT00771615|19413642|P7|STARTED|Overall Study||46
7887947|NCT00771615|19413643|P6|STARTED|Overall Study||61
7887948|NCT00771615|19413644|P5|STARTED|Overall Study||40
7887949|NCT00771615|19413645|P4|STARTED|Overall Study||60
7887950|NCT00771615|19413646|P3|STARTED|Overall Study||41
7887951|NCT00771615|19413647|P2|STARTED|Overall Study||72
7887952|NCT00771615|19413648|P1|STARTED|Overall Study||49
7887953|NCT00771602|19413842|P3|NOT COMPLETED|Overall Study||0
7887954|NCT00771602|19413843|P2|NOT COMPLETED|Overall Study||0
7887955|NCT00771602|19413844|P1|NOT COMPLETED|Overall Study||0
7887956|NCT00771602|19413842|P3|COMPLETED|Overall Study||0
7887957|NCT00771602|19413843|P2|COMPLETED|Overall Study||0
7887958|NCT00771602|19413844|P1|COMPLETED|Overall Study||1
7887959|NCT00771602|19413842|P3|STARTED|Overall Study||0
7887960|NCT00771602|19413843|P2|STARTED|Overall Study||0
7887961|NCT00771602|19413844|P1|STARTED|Overall Study||1
7887962|NCT00771537|19413868|P16|NOT COMPLETED|Overall Study||0
7887963|NCT00771537|19413869|P15|NOT COMPLETED|Overall Study||0
7887964|NCT00771537|19413870|P14|NOT COMPLETED|Overall Study||0
7887965|NCT00771537|19413871|P13|NOT COMPLETED|Overall Study||0
7887966|NCT00771537|19413872|P12|NOT COMPLETED|Overall Study||0
7887967|NCT00771537|19413873|P11|NOT COMPLETED|Overall Study||0
7887968|NCT00771537|19413874|P10|NOT COMPLETED|Overall Study||0
7887969|NCT00771537|19413875|P9|NOT COMPLETED|Overall Study||0
7887970|NCT00771537|19413876|P8|NOT COMPLETED|Overall Study||0
7887971|NCT00771537|19413877|P7|NOT COMPLETED|Overall Study||0
7887972|NCT00771537|19413878|P6|NOT COMPLETED|Overall Study||0
7887973|NCT00771537|19413879|P5|NOT COMPLETED|Overall Study||0
7887974|NCT00771537|19413880|P4|NOT COMPLETED|Overall Study||0
7887975|NCT00771537|19413881|P3|NOT COMPLETED|Overall Study||0
7887976|NCT00771537|19413882|P2|NOT COMPLETED|Overall Study||0
7887977|NCT00771537|19413883|P1|NOT COMPLETED|Overall Study||0
7887978|NCT00771537|19413868|P16|COMPLETED|Overall Study||122
7887979|NCT00771537|19413869|P15|COMPLETED|Overall Study||124
7887980|NCT00771537|19413870|P14|COMPLETED|Overall Study||124
7887981|NCT00771537|19413871|P13|COMPLETED|Overall Study||128
7887982|NCT00771537|19413872|P12|COMPLETED|Overall Study||137
7887983|NCT00771537|19413873|P11|COMPLETED|Overall Study||133
7887984|NCT00771537|19413874|P10|COMPLETED|Overall Study||119
7887985|NCT00771537|19413875|P9|COMPLETED|Overall Study||115
7887986|NCT00771537|19413876|P8|COMPLETED|Overall Study||132
7887987|NCT00771537|19413877|P7|COMPLETED|Overall Study||128
7887988|NCT00771537|19413878|P6|COMPLETED|Overall Study||118
7887989|NCT00771537|19413879|P5|COMPLETED|Overall Study||127
7887990|NCT00771537|19413880|P4|COMPLETED|Overall Study||114
7887991|NCT00771537|19413881|P3|COMPLETED|Overall Study||151
7887992|NCT00771537|19413882|P2|COMPLETED|Overall Study||124
7887993|NCT00771537|19413883|P1|COMPLETED|Overall Study||135
7887994|NCT00771537|19413868|P16|STARTED|Overall Study||122
7887995|NCT00771537|19413869|P15|STARTED|Overall Study||124
7887996|NCT00771537|19413870|P14|STARTED|Overall Study||124
7887997|NCT00771537|19413871|P13|STARTED|Overall Study||128
7887998|NCT00771537|19413872|P12|STARTED|Overall Study||137
7887999|NCT00771537|19413873|P11|STARTED|Overall Study||133
7888000|NCT00771537|19413874|P10|STARTED|Overall Study||119
7888001|NCT00771537|19413875|P9|STARTED|Overall Study||115
7888002|NCT00771537|19413876|P8|STARTED|Overall Study||132
7888003|NCT00771537|19413877|P7|STARTED|Overall Study||128
7888004|NCT00771537|19413878|P6|STARTED|Overall Study||118
7888005|NCT00771537|19413879|P5|STARTED|Overall Study||127
7888006|NCT00771537|19413880|P4|STARTED|Overall Study||114
7888007|NCT00771537|19413881|P3|STARTED|Overall Study||151
7888008|NCT00771537|19413882|P2|STARTED|Overall Study||124
7888009|NCT00771537|19413883|P1|STARTED|Overall Study||135
7888010|NCT00771472|19413909|P2|NOT COMPLETED|Overall Study||4
7888011|NCT00771472|19413910|P1|NOT COMPLETED|Overall Study||6
7888012|NCT00771472|19413909|P2|COMPLETED|Overall Study||0
7888013|NCT00771472|19413910|P1|COMPLETED|Overall Study||0
7888014|NCT00771472|19413909|P2|STARTED|Overall Study||4
7888015|NCT00771472|19413910|P1|STARTED|Overall Study||6
7888016|NCT00771407|19413921|P2|NOT COMPLETED|Overall Study||25
7888017|NCT00771407|19413922|P1|NOT COMPLETED|Overall Study||20
7888018|NCT00771407|19413921|P2|COMPLETED|Overall Study||35
7888019|NCT00771407|19413922|P1|COMPLETED|Overall Study||40
7888020|NCT00771407|19413921|P2|STARTED|Overall Study||60
7888021|NCT00771407|19413922|P1|STARTED|Overall Study||60
7888022|NCT00771316|19413930|P2|NOT COMPLETED|Overall Study||1
7888023|NCT00771316|19413931|P1|NOT COMPLETED|Overall Study||2
7888024|NCT00771316|19413930|P2|COMPLETED|Overall Study||1
7888025|NCT00771316|19413931|P1|COMPLETED|Overall Study||2
7888026|NCT00771316|19413930|P2|STARTED|Overall Study||2
7888027|NCT00771316|19413931|P1|STARTED|Overall Study||4
7888028|NCT00771277|19413941|P1|NOT COMPLETED|Overall Study||0
7888029|NCT00771277|19413941|P1|COMPLETED|Overall Study||6
7888030|NCT00771277|19413941|P1|STARTED|Overall Study||6
7888031|NCT00771264|19413949|P2|NOT COMPLETED|Overall Study||5
7888032|NCT00771264|19413950|P1|NOT COMPLETED|Overall Study||7
7888033|NCT00771264|19413949|P2|COMPLETED|Overall Study||105
7888034|NCT00771264|19413950|P1|COMPLETED|Overall Study||103
7888035|NCT00771264|19413949|P2|STARTED|Overall Study||110
7888036|NCT00771264|19413950|P1|STARTED|Overall Study||110
7888037|NCT00771238|19413958|P2|NOT COMPLETED|Overall Study||0
7888038|NCT00771238|19413959|P1|NOT COMPLETED|Overall Study||0
7888039|NCT00771238|19413958|P2|COMPLETED|Overall Study||21
7888040|NCT00771238|19413959|P1|COMPLETED|Overall Study||31
7888041|NCT00771238|19413958|P2|STARTED|Overall Study||21
7888042|NCT00771238|19413959|P1|STARTED|Overall Study||31
7888043|NCT00771173|19413969|P2|NOT COMPLETED|Overall Study||17
7888044|NCT00771173|19413970|P1|NOT COMPLETED|Overall Study||22
7888045|NCT00771173|19413969|P2|COMPLETED|Overall Study||112
7888046|NCT00771173|19413970|P1|COMPLETED|Overall Study||107
7888047|NCT00771173|19413969|P2|STARTED|Overall Study||129
7888048|NCT00771173|19413970|P1|STARTED|Overall Study||129
7888049|NCT00771056|19413976|P1|NOT COMPLETED|Overall Study||5
7888050|NCT00771056|19413976|P1|COMPLETED|Overall Study||18
7888051|NCT00771056|19413976|P1|STARTED|Overall Study||23
7888052|NCT00770991|19413983|P2|NOT COMPLETED|Overall Study||5
7888053|NCT00770991|19413984|P1|NOT COMPLETED|Overall Study||5
7888054|NCT00770991|19413983|P2|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
7888055|NCT00770991|19413984|P1|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
7888056|NCT00770991|19413983|P2|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12
7888057|NCT00770991|19413984|P1|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12
7888058|NCT00770965|19414000|P4|NOT COMPLETED|Excluded Set||13
7888059|NCT00770965|19414001|P3|NOT COMPLETED|Excluded Set||14
7888060|NCT00770965|19414002|P2|NOT COMPLETED|Excluded Set||13
7888061|NCT00770965|19414003|P1|NOT COMPLETED|Excluded Set||15
7888062|NCT00770965|19414000|P4|COMPLETED|Excluded Set||2
7888063|NCT00770965|19414001|P3|COMPLETED|Excluded Set||2
7888064|NCT00770965|19414002|P2|COMPLETED|Excluded Set||3
7888065|NCT00770965|19414003|P1|COMPLETED|Excluded Set||3
7888066|NCT00770965|19414000|P4|STARTED|Excluded Set||15
7888067|NCT00770965|19414001|P3|STARTED|Excluded Set||16
7888068|NCT00770965|19414002|P2|STARTED|Excluded Set||16
7888069|NCT00770965|19414003|P1|STARTED|Excluded Set||18
7888070|NCT00770965|19414000|P4|NOT COMPLETED|Safety Set||1
7888071|NCT00770965|19414001|P3|NOT COMPLETED|Safety Set||1
7888072|NCT00770965|19414002|P2|NOT COMPLETED|Safety Set||0
7888073|NCT00770965|19414003|P1|NOT COMPLETED|Safety Set||0
7888074|NCT00770965|19414000|P4|COMPLETED|Safety Set||4
7888075|NCT00770965|19414001|P3|COMPLETED|Safety Set||3
7888076|NCT00770965|19414002|P2|COMPLETED|Safety Set||4
7888077|NCT00770965|19414003|P1|COMPLETED|Safety Set||2
7888078|NCT00770965|19414000|P4|STARTED|Safety Set||5
7888079|NCT00770965|19414001|P3|STARTED|Safety Set||4
7888080|NCT00770965|19414002|P2|STARTED|Safety Set||4
7888081|NCT00770965|19414003|P1|STARTED|Safety Set||2
7888082|NCT00770913|19414024|P3|NOT COMPLETED|Overall Study||13
7888083|NCT00770913|19414025|P2|NOT COMPLETED|Overall Study||8
7888084|NCT00770913|19414026|P1|NOT COMPLETED|Overall Study||11
7888085|NCT00770913|19414024|P3|COMPLETED|Overall Study||100
7888086|NCT00770913|19414025|P2|COMPLETED|Overall Study||103
7888087|NCT00770913|19414026|P1|COMPLETED|Overall Study||102
7888088|NCT00770913|19414024|P3|STARTED|Overall Study||113
7888089|NCT00770913|19414025|P2|STARTED|Overall Study||111
7888090|NCT00770913|19414026|P1|STARTED|Overall Study||113
7888091|NCT00770874|19414036|P2|NOT COMPLETED|Overall Study||0
7888092|NCT00770874|19414037|P1|NOT COMPLETED|Overall Study||0
7888093|NCT00770874|19414036|P2|COMPLETED|Overall Study||176
7888094|NCT00770874|19414037|P1|COMPLETED|Overall Study||188
7888095|NCT00770874|19414036|P2|STARTED|Overall Study||176
7888096|NCT00770874|19414037|P1|STARTED|Overall Study||188
7888097|NCT00770861|19414047|P2|NOT COMPLETED|Overall Study||16
7888098|NCT00770861|19414048|P1|NOT COMPLETED|Overall Study||10
7888099|NCT00770861|19414047|P2|COMPLETED|Overall Study||120
7888100|NCT00770861|19414048|P1|COMPLETED|Overall Study||131
7888101|NCT00770861|19414047|P2|STARTED|Overall Study||136
7888102|NCT00770861|19414048|P1|STARTED|Overall Study||141
7888103|NCT00770809|19414059|P3|NOT COMPLETED|Overall Study||23
7888104|NCT00770809|19414060|P2|NOT COMPLETED|Overall Study||10
7888105|NCT00770809|19414061|P1|NOT COMPLETED|Overall Study||17
7888106|NCT00770809|19414059|P3|COMPLETED|Overall Study||44
7888107|NCT00770809|19414060|P2|COMPLETED|Overall Study||110
7888108|NCT00770809|19414061|P1|COMPLETED|Overall Study||101
7888109|NCT00770809|19414059|P3|STARTED|Overall Study||67
7888110|NCT00770809|19414060|P2|STARTED|Overall Study||120
7888111|NCT00770809|19414061|P1|STARTED|Overall Study||118
7888112|NCT00770770|19414071|P2|NOT COMPLETED|Overall Study||1
7888113|NCT00770770|19414072|P1|NOT COMPLETED|Overall Study||10
7888114|NCT00770770|19414071|P2|COMPLETED|Overall Study||5
7888115|NCT00770770|19414072|P1|COMPLETED|Overall Study||4
7888116|NCT00770770|19414071|P2|STARTED|Overall Study||6
7888117|NCT00770770|19414072|P1|STARTED|Overall Study||14
7888118|NCT00770757|19414078|P1|NOT COMPLETED|Overall Study||0
7888119|NCT00770757|19414078|P1|COMPLETED|Overall Study||13
7888120|NCT00770757|19414078|P1|STARTED|Overall Study||13
7888121|NCT00770692|19414090|P4|NOT COMPLETED|Overall Study||11
7888122|NCT00770692|19414091|P3|NOT COMPLETED|Overall Study||14
7888123|NCT00770692|19414092|P2|NOT COMPLETED|Overall Study||9
7888124|NCT00770692|19414093|P1|NOT COMPLETED|Overall Study||12
7888125|NCT00770692|19414090|P4|COMPLETED|Overall Study||66
7888126|NCT00770692|19414091|P3|COMPLETED|Overall Study||70
7888127|NCT00770692|19414092|P2|COMPLETED|Overall Study||74
7888128|NCT00770692|19414093|P1|COMPLETED|Overall Study||69
7888129|NCT00770692|19414090|P4|STARTED|Overall Study||77
7888130|NCT00770692|19414091|P3|STARTED|Overall Study||84
7888131|NCT00770692|19414092|P2|STARTED|Overall Study||83
7888132|NCT00770692|19414093|P1|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81
7888133|NCT00770679|19414119|P1|NOT COMPLETED|Overall Study||6
7888134|NCT00770679|19414119|P1|COMPLETED|Overall Study||10
7888135|NCT00770679|19414119|P1|STARTED|Overall Study||16
7888136|NCT00770653|19414127|P2|NOT COMPLETED|Overall Study||29
7888137|NCT00770653|19414128|P1|NOT COMPLETED|Overall Study||32
7888138|NCT00770653|19414127|P2|COMPLETED|Overall Study||121
7888139|NCT00770653|19414128|P1|COMPLETED|Overall Study||123
7888140|NCT00770653|19414127|P2|STARTED|Overall Study||150
7888141|NCT00770653|19414128|P1|STARTED|Overall Study||155
7888142|NCT00770588|19414198|P2|NOT COMPLETED|Overall Study||95
7888143|NCT00770588|19414199|P1|NOT COMPLETED|Overall Study||81
7888144|NCT00770588|19414198|P2|COMPLETED|Overall Study||53
7888145|NCT00770588|19414199|P1|COMPLETED|Overall Study||67
7888146|NCT00770588|19414198|P2|STARTED|Overall Study||148
7888147|NCT00770588|19414199|P1|STARTED|Overall Study||148
7888148|NCT00770562|19414215|P2|NOT COMPLETED|Overall Study||1
7888149|NCT00770562|19414216|P1|NOT COMPLETED|Overall Study||1
7888150|NCT00770562|19414215|P2|COMPLETED|Overall Study||49
7888151|NCT00770562|19414216|P1|COMPLETED|Overall Study||52
7888152|NCT00770562|19414215|P2|STARTED|Overall Study||50
7888153|NCT00770562|19414216|P1|STARTED|Overall Study||53
7888154|NCT00770510|19414227|P1|NOT COMPLETED|Overall Study||5
7888155|NCT00770510|19414227|P1|COMPLETED|Overall Study||67
7888156|NCT00770510|19414227|P1|STARTED|Overall Study||72
7888157|NCT00770484|19414266|P2|NOT COMPLETED|Overall Study||0
7888158|NCT00770484|19414267|P1|NOT COMPLETED|Overall Study||1
7888159|NCT00770484|19414266|P2|COMPLETED|Overall Study||4
7888160|NCT00770484|19414267|P1|COMPLETED|Overall Study||7
7888161|NCT00770484|19414266|P2|STARTED|Overall Study||4
7888162|NCT00770484|19414267|P1|STARTED|Overall Study||8
7888163|NCT00770432|19414275|P2|NOT COMPLETED|Overall Study||7
7888164|NCT00770432|19414276|P1|NOT COMPLETED|Overall Study||4
7888165|NCT00770432|19414275|P2|COMPLETED|Overall Study||94
7888166|NCT00770432|19414276|P1|COMPLETED|Overall Study||98
7888167|NCT00770432|19414275|P2|STARTED|Overall Study||101
7888168|NCT00770432|19414276|P1|STARTED|Overall Study||102
7888169|NCT00770367|19414284|P2|NOT COMPLETED|Second Intervention||0
7888170|NCT00770367|19414285|P1|NOT COMPLETED|Second Intervention||2
7888171|NCT00770367|19414284|P2|COMPLETED|Second Intervention||15
7888172|NCT00770367|19414285|P1|COMPLETED|Second Intervention||16
7888173|NCT00770367|19414284|P2|STARTED|Second Intervention||15
7888174|NCT00770367|19414285|P1|STARTED|Second Intervention||18
7888175|NCT00770367|19414284|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
7888176|NCT00770367|19414285|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
7888177|NCT00770367|19414284|P2|COMPLETED|Washout Period of 4 Weeks||15
7888178|NCT00770367|19414285|P1|COMPLETED|Washout Period of 4 Weeks||18
7888179|NCT00770367|19414284|P2|STARTED|Washout Period of 4 Weeks||16
7888180|NCT00770367|19414285|P1|STARTED|Washout Period of 4 Weeks||18
7888181|NCT00770367|19414284|P2|NOT COMPLETED|First Intervention||2
7888182|NCT00770367|19414285|P1|NOT COMPLETED|First Intervention||0
7888183|NCT00770367|19414284|P2|COMPLETED|First Intervention||16
7888184|NCT00770367|19414285|P1|COMPLETED|First Intervention||18
7888185|NCT00770367|19414284|P2|STARTED|First Intervention||18
7888186|NCT00770367|19414285|P1|STARTED|First Intervention||18
7888187|NCT00770341|19414296|P3|NOT COMPLETED|Overall Study||3
7888188|NCT00770341|19414297|P2|NOT COMPLETED|Overall Study||5
7888189|NCT00770341|19414298|P1|NOT COMPLETED|Overall Study||12
7888190|NCT00770341|19414296|P3|COMPLETED|Overall Study||8
7888191|NCT00770341|19414297|P2|COMPLETED|Overall Study||17
7888192|NCT00770341|19414298|P1|COMPLETED|Overall Study||77
7888193|NCT00770341|19414296|P3|STARTED|Overall Study|Number randomized|11
7888194|NCT00770341|19414297|P2|STARTED|Overall Study|Number randomized|22
7888195|NCT00770341|19414298|P1|STARTED|Overall Study|Number randomized|89
7888196|NCT00770328|19414324|P2|NOT COMPLETED|Overall Study||4
7888197|NCT00770328|19414325|P1|NOT COMPLETED|Overall Study||13
7888198|NCT00770328|19414324|P2|COMPLETED|Overall Study||11
7888199|NCT00770328|19414325|P1|COMPLETED|Overall Study||9
7888200|NCT00770328|19414324|P2|STARTED|Overall Study||15
7888201|NCT00770328|19414325|P1|STARTED|Overall Study||22
7888202|NCT00770315|19414341|P4|NOT COMPLETED|Overall Study||38
7888203|NCT00770315|19414342|P3|NOT COMPLETED|Overall Study||57
7888204|NCT00770315|19414343|P2|NOT COMPLETED|Overall Study||43
7888205|NCT00770315|19414344|P1|NOT COMPLETED|Overall Study||40
7888206|NCT00770315|19414341|P4|COMPLETED|Overall Study||160
7888207|NCT00770315|19414342|P3|COMPLETED|Overall Study||137
7888208|NCT00770315|19414343|P2|COMPLETED|Overall Study||152
7888209|NCT00770315|19414344|P1|COMPLETED|Overall Study||157
7888210|NCT00770315|19414341|P4|STARTED|Overall Study||198
7888211|NCT00770315|19414342|P3|STARTED|Overall Study||194
7888212|NCT00770315|19414343|P2|STARTED|Overall Study||195
7888213|NCT00770315|19414344|P1|STARTED|Overall Study||197
7888214|NCT00770289|19414370|P1|NOT COMPLETED|Overall Study||6
7888215|NCT00770289|19414370|P1|COMPLETED|Overall Study||845
7888216|NCT00770289|19414370|P1|STARTED|Overall Study||851
7888217|NCT00770224|19414379|P2|NOT COMPLETED|Step 2: Maintenance||30
7888218|NCT00770224|19414380|P1|NOT COMPLETED|Step 2: Maintenance||0
7888219|NCT00770224|19414379|P2|COMPLETED|Step 2: Maintenance||41
7888220|NCT00770224|19414380|P1|COMPLETED|Step 2: Maintenance||0
7888221|NCT00770224|19414379|P2|Eligible and Evaluable|Step 2: Maintenance||69
7888222|NCT00770224|19414380|P1|Eligible and Evaluable|Step 2: Maintenance||0
7888223|NCT00770224|19414379|P2|STARTED|Step 2: Maintenance||71
7888224|NCT00770224|19414380|P1|STARTED|Step 2: Maintenance||0
7888225|NCT00770224|19414379|P2|NOT COMPLETED|Step 1: Induction||0
7888226|NCT00770224|19414380|P1|NOT COMPLETED|Step 1: Induction||14
7888227|NCT00770224|19414379|P2|COMPLETED|Step 1: Induction||0
7888228|NCT00770224|19414380|P1|COMPLETED|Step 1: Induction||73
7888229|NCT00770224|19414379|P2|Eligible and Evaluable|Step 1: Induction||0
7888230|NCT00770224|19414380|P1|Eligible and Evaluable|Step 1: Induction||84
7888231|NCT00770224|19414379|P2|STARTED|Step 1: Induction||0
7888232|NCT00770224|19414380|P1|STARTED|Step 1: Induction||87
7888233|NCT00770211|19414392|P2|NOT COMPLETED|Overall Study||2
7888234|NCT00770211|19414393|P1|NOT COMPLETED|Overall Study||1
7888235|NCT00770211|19414392|P2|COMPLETED|Overall Study||87
7888236|NCT00770211|19414393|P1|COMPLETED|Overall Study||181
7888237|NCT00770211|19414392|P2|STARTED|Overall Study||89
7888238|NCT00770211|19414393|P1|STARTED|Overall Study||182
7888239|NCT00770146|19414409|P2|NOT COMPLETED|Follow-up Period||20
7888240|NCT00770146|19414410|P1|NOT COMPLETED|Follow-up Period||11
7888241|NCT00770146|19414409|P2|COMPLETED|Follow-up Period||85
7888242|NCT00770146|19414410|P1|COMPLETED|Follow-up Period||42
7888243|NCT00770146|19414409|P2|STARTED|Follow-up Period||105
7888244|NCT00770146|19414410|P1|STARTED|Follow-up Period||53
7888245|NCT00770146|19414409|P2|NOT COMPLETED|Treatment Period||45
7888246|NCT00770146|19414410|P1|NOT COMPLETED|Treatment Period||9
7888247|NCT00770146|19414409|P2|COMPLETED|Treatment Period||60
7888248|NCT00770146|19414410|P1|COMPLETED|Treatment Period||44
7888249|NCT00770146|19414409|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101
7888250|NCT00770146|19414410|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50
7888251|NCT00770146|19414409|P2|Treated|Treatment Period||105
7888252|NCT00770146|19414410|P1|Treated|Treatment Period||52
7888253|NCT00770146|19414409|P2|STARTED|Treatment Period||105
7888254|NCT00770146|19414410|P1|STARTED|Treatment Period||53
7888255|NCT00770133|19414458|P4|NOT COMPLETED|Overall Study||3
7888256|NCT00770133|19414459|P3|NOT COMPLETED|Overall Study||3
7888257|NCT00770133|19414460|P2|NOT COMPLETED|Overall Study||1
7888258|NCT00770133|19414461|P1|NOT COMPLETED|Overall Study||3
7888259|NCT00770133|19414458|P4|COMPLETED|Overall Study||32
7888260|NCT00770133|19414459|P3|COMPLETED|Overall Study||32
7888261|NCT00770133|19414460|P2|COMPLETED|Overall Study||35
7888262|NCT00770133|19414461|P1|COMPLETED|Overall Study||32
7888263|NCT00770133|19414458|P4|STARTED|Overall Study||35
7888264|NCT00770133|19414459|P3|STARTED|Overall Study||35
7888265|NCT00770133|19414460|P2|STARTED|Overall Study||36
7888266|NCT00770133|19414461|P1|STARTED|Overall Study||35
7888267|NCT00770120|19414499|P1|NOT COMPLETED|Overall Study||61
7888268|NCT00770120|19414499|P1|COMPLETED|Overall Study||0
7888269|NCT00770120|19414499|P1|Not Analyzable|Overall Study||1
7888270|NCT00770120|19414499|P1|Eligible|Overall Study||60
7888271|NCT00770120|19414499|P1|STARTED|Overall Study||61
7888272|NCT00770029|19414508|P2|NOT COMPLETED|Overall Study||3
7888273|NCT00770029|19414509|P1|NOT COMPLETED|Overall Study||6
7888274|NCT00770029|19414508|P2|COMPLETED|Overall Study||89
7888275|NCT00770029|19414509|P1|COMPLETED|Overall Study||178
7888276|NCT00770029|19414508|P2|STARTED|Overall Study||92
7888277|NCT00770029|19414509|P1|STARTED|Overall Study||184
7888278|NCT00769886|19414527|P4|NOT COMPLETED|Overall Study||2
7888279|NCT00769886|19414528|P3|NOT COMPLETED|Overall Study||1
7888280|NCT00769886|19414529|P2|NOT COMPLETED|Overall Study||4
7888281|NCT00769886|19414530|P1|NOT COMPLETED|Overall Study||5
7888282|NCT00769886|19414527|P4|COMPLETED|Overall Study||35
7888283|NCT00769886|19414528|P3|COMPLETED|Overall Study||34
7888284|NCT00769886|19414529|P2|COMPLETED|Overall Study||32
7888285|NCT00769886|19414530|P1|COMPLETED|Overall Study||31
7888286|NCT00769886|19414527|P4|STARTED|Overall Study||37
7888287|NCT00769886|19414528|P3|STARTED|Overall Study||35
7888288|NCT00769886|19414529|P2|STARTED|Overall Study||36
7888289|NCT00769886|19414530|P1|STARTED|Overall Study||36
7888290|NCT00769860|19414570|P2|NOT COMPLETED|Overall Study||0
7888291|NCT00769860|19414571|P1|NOT COMPLETED|Overall Study||2
7888292|NCT00769860|19414570|P2|COMPLETED|Overall Study||8
7888293|NCT00769860|19414571|P1|COMPLETED|Overall Study||14
7888294|NCT00769860|19414570|P2|Month 8|Overall Study||8
7888295|NCT00769860|19414571|P1|Month 8|Overall Study||14
7888296|NCT00769860|19414570|P2|Month 4|Overall Study||8
7888297|NCT00769860|19414571|P1|Month 4|Overall Study||16
7888298|NCT00769860|19414570|P2|STARTED|Overall Study||8
7888299|NCT00769860|19414571|P1|STARTED|Overall Study||16
7888300|NCT00769808|19414597|P1|NOT COMPLETED|Overall Study||8
7888301|NCT00769808|19414597|P1|COMPLETED|Overall Study||64
7888302|NCT00769808|19414597|P1|STARTED|Overall Study||72
7888303|NCT00769704|19414609|P2|NOT COMPLETED|Overall Study||199
7888304|NCT00769704|19414610|P1|NOT COMPLETED|Overall Study||111
7888305|NCT00769704|19414609|P2|COMPLETED|Overall Study||97
7888306|NCT00769704|19414610|P1|COMPLETED|Overall Study||30
7888307|NCT00769704|19414609|P2|Received Treatment|Overall Study||292
7888308|NCT00769704|19414610|P1|Received Treatment|Overall Study||127
7888309|NCT00769704|19414609|P2|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295
7888310|NCT00769704|19414610|P1|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141
7888311|NCT00769704|19414609|P2|STARTED|Overall Study||296
7888312|NCT00769704|19414610|P1|STARTED|Overall Study||141
7888313|NCT00769652|19414630|P2|NOT COMPLETED|Overall Study||0
7888314|NCT00769652|19414631|P1|NOT COMPLETED|Overall Study||0
7888315|NCT00769652|19414630|P2|COMPLETED|Overall Study||1
7888316|NCT00769652|19414631|P1|COMPLETED|Overall Study||6
7888317|NCT00769652|19414630|P2|STARTED|Overall Study||1
7888318|NCT00769652|19414631|P1|STARTED|Overall Study||6
7888319|NCT00769600|19414643|P2|NOT COMPLETED|Overall Study||0
7888320|NCT00769600|19414644|P1|NOT COMPLETED|Overall Study||0
7888321|NCT00769600|19414643|P2|COMPLETED|Overall Study||8
7888322|NCT00769600|19414644|P1|COMPLETED|Overall Study||15
7888323|NCT00769600|19414643|P2|STARTED|Overall Study||8
7888324|NCT00769600|19414644|P1|STARTED|Overall Study||15
7888325|NCT00769561|19414660|P2|NOT COMPLETED|Overall Study||5
7888326|NCT00769561|19414661|P1|NOT COMPLETED|Overall Study||3
7888327|NCT00769561|19414660|P2|COMPLETED|Overall Study||24
7888328|NCT00769561|19414661|P1|COMPLETED|Overall Study||26
7888329|NCT00769561|19414660|P2|STARTED|Overall Study||29
7888330|NCT00769561|19414661|P1|STARTED|Overall Study||29
7888331|NCT00769483|19414687|P6|NOT COMPLETED|Overall Study||0
7888332|NCT00769483|19414688|P5|NOT COMPLETED|Overall Study||1
7888333|NCT00769483|19414689|P4|NOT COMPLETED|Overall Study||0
7888334|NCT00769483|19414690|P3|NOT COMPLETED|Overall Study||0
7888335|NCT00769483|19414691|P2|NOT COMPLETED|Overall Study||1
7888336|NCT00769483|19414692|P1|NOT COMPLETED|Overall Study||0
7888337|NCT00769483|19414687|P6|COMPLETED|Overall Study||9
7888338|NCT00769483|19414688|P5|COMPLETED|Overall Study||15
7888339|NCT00769483|19414689|P4|COMPLETED|Overall Study||15
7888340|NCT00769483|19414690|P3|COMPLETED|Overall Study||15
7888341|NCT00769483|19414691|P2|COMPLETED|Overall Study||12
7888342|NCT00769483|19414692|P1|COMPLETED|Overall Study||9
7888343|NCT00769483|19414687|P6|STARTED|Overall Study||9
7888344|NCT00769483|19414688|P5|STARTED|Overall Study||16
7888345|NCT00769483|19414689|P4|STARTED|Overall Study||15
7888346|NCT00769483|19414690|P3|STARTED|Overall Study||15
7888347|NCT00769483|19414691|P2|STARTED|Overall Study||13
7888348|NCT00769483|19414692|P1|STARTED|Overall Study||9
7888349|NCT00769392|19414730|P1|NOT COMPLETED|Overall Study||4
7888350|NCT00769392|19414730|P1|COMPLETED|Overall Study||24
7888351|NCT00769392|19414730|P1|STARTED|Overall Study||28
7888352|NCT00769314|19414737|P2|NOT COMPLETED|Overall Study||13
7888353|NCT00769314|19414738|P1|NOT COMPLETED|Overall Study||17
7888354|NCT00769314|19414737|P2|COMPLETED|Overall Study||384
7888355|NCT00769314|19414738|P1|COMPLETED|Overall Study||361
7888356|NCT00769314|19414737|P2|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397
7888450|NCT00768989|19414898|P2|NOT COMPLETED|On or After Week 36||27
7888357|NCT00769314|19414738|P1|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378
7888358|NCT00769184|19414764|P2|NOT COMPLETED|No Treatment (6 Weeks)||1
7888359|NCT00769184|19414765|P1|NOT COMPLETED|No Treatment (6 Weeks)||1
7888360|NCT00769184|19414764|P2|COMPLETED|No Treatment (6 Weeks)||6
7888361|NCT00769184|19414765|P1|COMPLETED|No Treatment (6 Weeks)||5
7888362|NCT00769184|19414764|P2|STARTED|No Treatment (6 Weeks)||7
7888363|NCT00769184|19414765|P1|STARTED|No Treatment (6 Weeks)||6
7888364|NCT00769184|19414764|P2|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
7888365|NCT00769184|19414765|P1|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
7888366|NCT00769184|19414764|P2|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7
7888367|NCT00769184|19414765|P1|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6
7888368|NCT00769184|19414764|P2|STARTED|+LCD / +Placebo Only (4 Weeks)||7
7888369|NCT00769184|19414765|P1|STARTED|+LCD / +Placebo Only (4 Weeks)||6
7888370|NCT00769184|19414764|P2|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
7888371|NCT00769184|19414765|P1|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
7888372|NCT00769184|19414764|P2|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
7888373|NCT00769184|19414765|P1|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6
7888374|NCT00769184|19414764|P2|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8
7888375|NCT00769184|19414765|P1|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
7888376|NCT00769132|19414773|P4|NOT COMPLETED|Period 4||0
7888377|NCT00769132|19414774|P3|NOT COMPLETED|Period 4||0
7888378|NCT00769132|19414775|P2|NOT COMPLETED|Period 4||1
7888379|NCT00769132|19414776|P1|NOT COMPLETED|Period 4||0
7888380|NCT00769132|19414773|P4|COMPLETED|Period 4||5
7888381|NCT00769132|19414774|P3|COMPLETED|Period 4||6
7888382|NCT00769132|19414775|P2|COMPLETED|Period 4||5
7888383|NCT00769132|19414776|P1|COMPLETED|Period 4||5
7888384|NCT00769132|19414773|P4|STARTED|Period 4||5
7888385|NCT00769132|19414774|P3|STARTED|Period 4||6
7888386|NCT00769132|19414775|P2|STARTED|Period 4||6
7888387|NCT00769132|19414776|P1|STARTED|Period 4||5
7888388|NCT00769132|19414773|P4|NOT COMPLETED|Period 3||0
7888389|NCT00769132|19414774|P3|NOT COMPLETED|Period 3||0
7888390|NCT00769132|19414775|P2|NOT COMPLETED|Period 3||0
7888391|NCT00769132|19414776|P1|NOT COMPLETED|Period 3||1
7888392|NCT00769132|19414773|P4|COMPLETED|Period 3||5
7888393|NCT00769132|19414774|P3|COMPLETED|Period 3||6
7888394|NCT00769132|19414775|P2|COMPLETED|Period 3||6
7888395|NCT00769132|19414776|P1|COMPLETED|Period 3||5
7888396|NCT00769132|19414773|P4|STARTED|Period 3||5
7888397|NCT00769132|19414774|P3|STARTED|Period 3||6
7888398|NCT00769132|19414775|P2|STARTED|Period 3||6
7888399|NCT00769132|19414776|P1|STARTED|Period 3||6
7888400|NCT00769132|19414773|P4|NOT COMPLETED|Period 2||1
7888401|NCT00769132|19414774|P3|NOT COMPLETED|Period 2||0
7888402|NCT00769132|19414775|P2|NOT COMPLETED|Period 2||0
7888403|NCT00769132|19414776|P1|NOT COMPLETED|Period 2||0
7888404|NCT00769132|19414773|P4|COMPLETED|Period 2||5
7888405|NCT00769132|19414774|P3|COMPLETED|Period 2||6
7888406|NCT00769132|19414775|P2|COMPLETED|Period 2||6
7888407|NCT00769132|19414776|P1|COMPLETED|Period 2||6
7888408|NCT00769132|19414773|P4|STARTED|Period 2||6
7888409|NCT00769132|19414774|P3|STARTED|Period 2||6
7888410|NCT00769132|19414775|P2|STARTED|Period 2||6
7888411|NCT00769132|19414776|P1|STARTED|Period 2||6
7888412|NCT00769132|19414773|P4|NOT COMPLETED|Period 1||1
7888413|NCT00769132|19414774|P3|NOT COMPLETED|Period 1||0
7888414|NCT00769132|19414775|P2|NOT COMPLETED|Period 1||0
7888415|NCT00769132|19414776|P1|NOT COMPLETED|Period 1||1
7888416|NCT00769132|19414773|P4|COMPLETED|Period 1||6
7888417|NCT00769132|19414774|P3|COMPLETED|Period 1||6
7888418|NCT00769132|19414775|P2|COMPLETED|Period 1||6
7888419|NCT00769132|19414776|P1|COMPLETED|Period 1||6
7888420|NCT00769132|19414773|P4|STARTED|Period 1||7
7888421|NCT00769132|19414774|P3|STARTED|Period 1||6
7888422|NCT00769132|19414775|P2|STARTED|Period 1||6
7888423|NCT00769132|19414776|P1|STARTED|Period 1||7
7888424|NCT00769119|19414792|P2|NOT COMPLETED|Overall Study||3
7888425|NCT00769119|19414793|P1|NOT COMPLETED|Overall Study||2
7888426|NCT00769119|19414792|P2|COMPLETED|Overall Study||13
7888427|NCT00769119|19414793|P1|COMPLETED|Overall Study||20
7888428|NCT00769119|19414792|P2|STARTED|Overall Study||16
7888429|NCT00769119|19414793|P1|STARTED|Overall Study||22
7888430|NCT00769067|19414839|P2|NOT COMPLETED|Overall Study||94
7888431|NCT00769067|19414840|P1|NOT COMPLETED|Overall Study||94
7888432|NCT00769067|19414839|P2|COMPLETED|Overall Study||0
7888433|NCT00769067|19414840|P1|COMPLETED|Overall Study||0
7888434|NCT00769067|19414839|P2|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93
7888435|NCT00769067|19414840|P1|Treated|Overall Study||94
7888436|NCT00769067|19414839|P2|STARTED|Overall Study||94
7888437|NCT00769067|19414840|P1|STARTED|Overall Study||94
7888438|NCT00769015|19414867|P2|NOT COMPLETED|Overall Study||16
7888439|NCT00769015|19414868|P1|NOT COMPLETED|Overall Study||9
7888440|NCT00769015|19414867|P2|COMPLETED|Overall Study||76
7888441|NCT00769015|19414868|P1|COMPLETED|Overall Study||87
7888442|NCT00769015|19414867|P2|STARTED|Overall Study||92
7888443|NCT00769015|19414868|P1|STARTED|Overall Study||96
7888444|NCT00769002|19414890|P2|NOT COMPLETED|Overall Study||9
7888445|NCT00769002|19414891|P1|NOT COMPLETED|Overall Study||9
7888446|NCT00769002|19414890|P2|COMPLETED|Overall Study||0
7888447|NCT00769002|19414891|P1|COMPLETED|Overall Study||0
7888448|NCT00769002|19414890|P2|STARTED|Overall Study||9
7888449|NCT00769002|19414891|P1|STARTED|Overall Study||9
7888451|NCT00768989|19414899|P1|NOT COMPLETED|On or After Week 36||51
7888452|NCT00768989|19414898|P2|COMPLETED|On or After Week 36||0
7888453|NCT00768989|19414899|P1|COMPLETED|On or After Week 36||0
7888454|NCT00768989|19414898|P2|STARTED|On or After Week 36||27
7888455|NCT00768989|19414899|P1|STARTED|On or After Week 36||51
7888456|NCT00768989|19414898|P2|NOT COMPLETED|Week 24 to Prior to Week 36||0
7888457|NCT00768989|19414899|P1|NOT COMPLETED|Week 24 to Prior to Week 36||8
7888458|NCT00768989|19414898|P2|COMPLETED|Week 24 to Prior to Week 36||27
7888459|NCT00768989|19414899|P1|COMPLETED|Week 24 to Prior to Week 36||51
7888460|NCT00768989|19414898|P2|STARTED|Week 24 to Prior to Week 36||27
7888461|NCT00768989|19414899|P1|STARTED|Week 24 to Prior to Week 36||59
7888462|NCT00768989|19414898|P2|NOT COMPLETED|Prior to Week 24||3
7888463|NCT00768989|19414899|P1|NOT COMPLETED|Prior to Week 24||4
7888464|NCT00768989|19414898|P2|COMPLETED|Prior to Week 24||27
7888465|NCT00768989|19414899|P1|COMPLETED|Prior to Week 24||59
7888466|NCT00768989|19414898|P2|STARTED|Prior to Week 24||30
7888467|NCT00768989|19414899|P1|STARTED|Prior to Week 24||63
7888468|NCT00768898|19414947|P1|NOT COMPLETED|Overall Study||2
7888469|NCT00768898|19414947|P1|COMPLETED|Overall Study||28
7888470|NCT00768898|19414947|P1|STARTED|Overall Study||30
7888471|NCT00768755|19414971|P4|NOT COMPLETED|Phase 2||57
7888472|NCT00768755|19414972|P3|NOT COMPLETED|Phase 2||58
7888473|NCT00768755|19414973|P2|NOT COMPLETED|Phase 2||55
7888474|NCT00768755|19414974|P1|NOT COMPLETED|Phase 2||0
7888475|NCT00768755|19414971|P4|COMPLETED|Phase 2||0
7888476|NCT00768755|19414972|P3|COMPLETED|Phase 2||0
7888477|NCT00768755|19414973|P2|COMPLETED|Phase 2||0
7888478|NCT00768755|19414974|P1|COMPLETED|Phase 2||0
7888479|NCT00768755|19414971|P4|Treated|Phase 2||55
7888480|NCT00768755|19414972|P3|Treated|Phase 2||58
7888481|NCT00768755|19414973|P2|Treated|Phase 2||55
7888482|NCT00768755|19414974|P1|Treated|Phase 2||0
7888483|NCT00768755|19414971|P4|STARTED|Phase 2||57
7888484|NCT00768755|19414972|P3|STARTED|Phase 2||58
7888485|NCT00768755|19414973|P2|STARTED|Phase 2||55
7888486|NCT00768755|19414974|P1|STARTED|Phase 2||0
7888487|NCT00768755|19414971|P4|NOT COMPLETED|Phase 1||0
7888488|NCT00768755|19414972|P3|NOT COMPLETED|Phase 1||0
7888489|NCT00768755|19414973|P2|NOT COMPLETED|Phase 1||0
7888490|NCT00768755|19414974|P1|NOT COMPLETED|Phase 1||10
7888491|NCT00768755|19414971|P4|COMPLETED|Phase 1||0
7888492|NCT00768755|19414972|P3|COMPLETED|Phase 1||0
7888493|NCT00768755|19414973|P2|COMPLETED|Phase 1||0
7888494|NCT00768755|19414974|P1|COMPLETED|Phase 1||0
7888495|NCT00768755|19414971|P4|STARTED|Phase 1||0
7888496|NCT00768755|19414972|P3|STARTED|Phase 1||0
7888497|NCT00768755|19414973|P2|STARTED|Phase 1||0
7888498|NCT00768755|19414974|P1|STARTED|Phase 1||10
7888499|NCT00768716|19415000|P2|NOT COMPLETED|Overall Study||0
7888500|NCT00768716|19415001|P1|NOT COMPLETED|Overall Study||0
7888501|NCT00768716|19415000|P2|COMPLETED|Overall Study||41
7888502|NCT00768716|19415001|P1|COMPLETED|Overall Study||54
7888503|NCT00768716|19415000|P2|STARTED|Overall Study||41
7888504|NCT00768716|19415001|P1|STARTED|Overall Study||54
7888505|NCT00768651|19415022|P1|NOT COMPLETED|Overall Study||1
7888506|NCT00768651|19415022|P1|COMPLETED|Overall Study||7
7888507|NCT00768651|19415022|P1|STARTED|Overall Study||8
7888508|NCT00768599|19415030|P3|NOT COMPLETED|Overall Study||12
7888509|NCT00768599|19415031|P2|NOT COMPLETED|Overall Study||16
7888510|NCT00768599|19415032|P1|NOT COMPLETED|Overall Study||11
7888511|NCT00768599|19415030|P3|COMPLETED|Overall Study||35
7888512|NCT00768599|19415031|P2|COMPLETED|Overall Study||27
7888513|NCT00768599|19415032|P1|COMPLETED|Overall Study||34
7888514|NCT00768599|19415030|P3|STARTED|Overall Study||47
7888515|NCT00768599|19415031|P2|STARTED|Overall Study||43
7888516|NCT00768599|19415032|P1|STARTED|Overall Study||45
7888517|NCT00768560|19415061|P6|NOT COMPLETED|Intervention Set 3||0
7888518|NCT00768560|19415062|P5|NOT COMPLETED|Intervention Set 3||0
7888519|NCT00768560|19415063|P4|NOT COMPLETED|Intervention Set 3||0
7888520|NCT00768560|19415064|P3|NOT COMPLETED|Intervention Set 3||0
7888521|NCT00768560|19415065|P2|NOT COMPLETED|Intervention Set 3||0
7888522|NCT00768560|19415066|P1|NOT COMPLETED|Intervention Set 3||0
7888523|NCT00768560|19415061|P6|COMPLETED|Intervention Set 3||6
7888524|NCT00768560|19415062|P5|COMPLETED|Intervention Set 3||6
7888525|NCT00768560|19415063|P4|COMPLETED|Intervention Set 3||6
7888526|NCT00768560|19415064|P3|COMPLETED|Intervention Set 3||6
7888527|NCT00768560|19415065|P2|COMPLETED|Intervention Set 3||5
7888528|NCT00768560|19415066|P1|COMPLETED|Intervention Set 3||5
7888529|NCT00768560|19415061|P6|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
7888530|NCT00768560|19415062|P5|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6
7888531|NCT00768560|19415063|P4|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6
7888532|NCT00768560|19415064|P3|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
7888533|NCT00768560|19415065|P2|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5
7888534|NCT00768560|19415066|P1|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5
7888535|NCT00768560|19415061|P6|NOT COMPLETED|Intervention Set 2||0
7888536|NCT00768560|19415062|P5|NOT COMPLETED|Intervention Set 2||0
7888537|NCT00768560|19415063|P4|NOT COMPLETED|Intervention Set 2||0
7888538|NCT00768560|19415064|P3|NOT COMPLETED|Intervention Set 2||0
7888539|NCT00768560|19415065|P2|NOT COMPLETED|Intervention Set 2||0
7888540|NCT00768560|19415066|P1|NOT COMPLETED|Intervention Set 2||0
7888541|NCT00768560|19415061|P6|COMPLETED|Intervention Set 2||6
7888542|NCT00768560|19415062|P5|COMPLETED|Intervention Set 2||6
7888543|NCT00768560|19415063|P4|COMPLETED|Intervention Set 2||6
7888544|NCT00768560|19415064|P3|COMPLETED|Intervention Set 2||6
7888545|NCT00768560|19415065|P2|COMPLETED|Intervention Set 2||5
7888546|NCT00768560|19415066|P1|COMPLETED|Intervention Set 2||5
7888547|NCT00768560|19415061|P6|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6
7888548|NCT00768560|19415062|P5|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
7888549|NCT00768560|19415063|P4|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
7888550|NCT00768560|19415064|P3|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6
7888551|NCT00768560|19415065|P2|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5
7888552|NCT00768560|19415066|P1|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5
7888553|NCT00768560|19415061|P6|NOT COMPLETED|Intervention Set 1||0
7888554|NCT00768560|19415062|P5|NOT COMPLETED|Intervention Set 1||0
7888555|NCT00768560|19415063|P4|NOT COMPLETED|Intervention Set 1||0
7888556|NCT00768560|19415064|P3|NOT COMPLETED|Intervention Set 1||0
7888557|NCT00768560|19415065|P2|NOT COMPLETED|Intervention Set 1||1
7888558|NCT00768560|19415066|P1|NOT COMPLETED|Intervention Set 1||0
7888559|NCT00768560|19415061|P6|COMPLETED|Intervention Set 1||6
7888560|NCT00768560|19415062|P5|COMPLETED|Intervention Set 1||6
7888561|NCT00768560|19415063|P4|COMPLETED|Intervention Set 1||6
7888562|NCT00768560|19415064|P3|COMPLETED|Intervention Set 1||6
7888563|NCT00768560|19415065|P2|COMPLETED|Intervention Set 1||5
7888564|NCT00768560|19415066|P1|COMPLETED|Intervention Set 1||5
7888565|NCT00768560|19415061|P6|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
7888566|NCT00768560|19415062|P5|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
7888567|NCT00768560|19415063|P4|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6
7888568|NCT00768560|19415064|P3|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6
7888569|NCT00768560|19415065|P2|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6
7888570|NCT00768560|19415066|P1|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5
7888571|NCT00768560|19415061|P6|STARTED|Intervention Set 1|3-period/treatment crossover|6
7888572|NCT00768560|19415062|P5|STARTED|Intervention Set 1|3-period/treatment crossover|6
7888573|NCT00768560|19415063|P4|STARTED|Intervention Set 1|3-period/treatment crossover|6
7888574|NCT00768560|19415064|P3|STARTED|Intervention Set 1|3-period/treatment crossover|6
7888575|NCT00768560|19415065|P2|STARTED|Intervention Set 1|3-period/treatment crossover|6
7888576|NCT00768560|19415066|P1|STARTED|Intervention Set 1|3-period/treatment crossover|5
7888577|NCT00768521|19415092|P2|NOT COMPLETED|Period 2||0
7888578|NCT00768521|19415093|P1|NOT COMPLETED|Period 2||0
7888579|NCT00768521|19415092|P2|COMPLETED|Period 2||11
7888580|NCT00768521|19415093|P1|COMPLETED|Period 2||9
7888581|NCT00768521|19415092|P2|STARTED|Period 2||11
7888582|NCT00768521|19415093|P1|STARTED|Period 2||9
7888583|NCT00768521|19415092|P2|NOT COMPLETED|Period 1||0
7888584|NCT00768521|19415093|P1|NOT COMPLETED|Period 1||0
7888585|NCT00768521|19415092|P2|COMPLETED|Period 1||11
7888586|NCT00768521|19415093|P1|COMPLETED|Period 1||9
7888587|NCT00768521|19415092|P2|STARTED|Period 1||11
7888588|NCT00768521|19415093|P1|STARTED|Period 1||9
7888589|NCT00768469|19415103|P2|NOT COMPLETED|Overall Study||7
7888590|NCT00768469|19415104|P1|NOT COMPLETED|Overall Study||3
7888591|NCT00768469|19415103|P2|COMPLETED|Overall Study||0
7888592|NCT00768469|19415104|P1|COMPLETED|Overall Study||0
7888593|NCT00768469|19415103|P2|STARTED|Overall Study||7
7888594|NCT00768469|19415104|P1|STARTED|Overall Study||3
7888595|NCT00768430|19415119|P2|NOT COMPLETED|7 Day Endpoint||3
7888596|NCT00768430|19415120|P1|NOT COMPLETED|7 Day Endpoint||2
7888597|NCT00768430|19415119|P2|COMPLETED|7 Day Endpoint||22
7888598|NCT00768430|19415120|P1|COMPLETED|7 Day Endpoint||45
7888599|NCT00768430|19415119|P2|STARTED|7 Day Endpoint||25
7888600|NCT00768430|19415120|P1|STARTED|7 Day Endpoint||47
7888601|NCT00768430|19415119|P2|NOT COMPLETED|24 Hour Endpoint||0
7888602|NCT00768430|19415120|P1|NOT COMPLETED|24 Hour Endpoint||1
7888603|NCT00768430|19415119|P2|COMPLETED|24 Hour Endpoint||25
7888604|NCT00768430|19415120|P1|COMPLETED|24 Hour Endpoint||47
7888605|NCT00768430|19415119|P2|STARTED|24 Hour Endpoint||25
7888606|NCT00768430|19415120|P1|STARTED|24 Hour Endpoint||48
7888607|NCT00768300|19415128|P2|NOT COMPLETED|Overall Study||163
7888608|NCT00768300|19415129|P1|NOT COMPLETED|Overall Study||329
7888609|NCT00768300|19415128|P2|COMPLETED|Overall Study||1
7888610|NCT00768300|19415129|P1|COMPLETED|Overall Study||1
7888611|NCT00768300|19415128|P2|Randomized and Treated|Overall Study||163
7888612|NCT00768300|19415129|P1|Randomized and Treated|Overall Study||329
7888613|NCT00768300|19415128|P2|STARTED|Overall Study||164
7888614|NCT00768300|19415129|P1|STARTED|Overall Study||330
7888615|NCT00768287|19415151|P6|NOT COMPLETED|Surgical Sub-study||0
7888616|NCT00768287|19415152|P5|NOT COMPLETED|Surgical Sub-study||0
7888617|NCT00768287|19415153|P4|NOT COMPLETED|Surgical Sub-study||0
7888618|NCT00768287|19415154|P3|NOT COMPLETED|Surgical Sub-study||0
7888619|NCT00768287|19415155|P2|NOT COMPLETED|Surgical Sub-study||0
7888620|NCT00768287|19415156|P1|NOT COMPLETED|Surgical Sub-study||0
7888621|NCT00768287|19415151|P6|COMPLETED|Surgical Sub-study||17
7888622|NCT00768287|19415152|P5|COMPLETED|Surgical Sub-study||0
7888623|NCT00768287|19415153|P4|COMPLETED|Surgical Sub-study||0
7888624|NCT00768287|19415154|P3|COMPLETED|Surgical Sub-study||0
7888625|NCT00768287|19415155|P2|COMPLETED|Surgical Sub-study||0
7888626|NCT00768287|19415156|P1|COMPLETED|Surgical Sub-study||0
7888627|NCT00768287|19415151|P6|STARTED|Surgical Sub-study|1 female subject was excluded from the efficacy analysis. She was included in the safety population.|17
7888628|NCT00768287|19415152|P5|STARTED|Surgical Sub-study||0
7888629|NCT00768287|19415153|P4|STARTED|Surgical Sub-study||0
7888630|NCT00768287|19415154|P3|STARTED|Surgical Sub-study||0
7888631|NCT00768287|19415155|P2|STARTED|Surgical Sub-study||0
7888632|NCT00768287|19415156|P1|STARTED|Surgical Sub-study||0
7888633|NCT00768287|19415151|P6|NOT COMPLETED|Treatment Study||0
7888634|NCT00768287|19415152|P5|NOT COMPLETED|Treatment Study||0
7888635|NCT00768287|19415153|P4|NOT COMPLETED|Treatment Study||0
7888636|NCT00768287|19415154|P3|NOT COMPLETED|Treatment Study||0
7888637|NCT00768287|19415155|P2|NOT COMPLETED|Treatment Study||0
7888638|NCT00768287|19415156|P1|NOT COMPLETED|Treatment Study||0
7888639|NCT00768287|19415151|P6|COMPLETED|Treatment Study||0
7888640|NCT00768287|19415152|P5|COMPLETED|Treatment Study||9
7888641|NCT00768287|19415153|P4|COMPLETED|Treatment Study||58
7888642|NCT00768287|19415154|P3|COMPLETED|Treatment Study||0
7888643|NCT00768287|19415155|P2|COMPLETED|Treatment Study||0
7888644|NCT00768287|19415156|P1|COMPLETED|Treatment Study||0
7888645|NCT00768287|19415151|P6|Treated|Treatment Study||0
7888646|NCT00768287|19415152|P5|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from Prophylaxis to On Demand.|12
7888647|NCT00768287|19415153|P4|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from On Demand to Prophylaxis.|61
7888648|NCT00768287|19415154|P3|Treated|Treatment Study||0
7888649|NCT00768287|19415155|P2|Treated|Treatment Study||0
7888650|NCT00768287|19415156|P1|Treated|Treatment Study||0
7888651|NCT00768287|19415151|P6|STARTED|Treatment Study||0
7888652|NCT00768287|19415152|P5|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|9
7888653|NCT00768287|19415153|P4|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|58
7888654|NCT00768287|19415154|P3|STARTED|Treatment Study||0
7888655|NCT00768287|19415155|P2|STARTED|Treatment Study||0
7888656|NCT00768287|19415156|P1|STARTED|Treatment Study||0
7888657|NCT00768287|19415151|P6|NOT COMPLETED|Repeat Pharmacokinetic Study||0
7888658|NCT00768287|19415152|P5|NOT COMPLETED|Repeat Pharmacokinetic Study||0
7888659|NCT00768287|19415153|P4|NOT COMPLETED|Repeat Pharmacokinetic Study||0
7888660|NCT00768287|19415154|P3|NOT COMPLETED|Repeat Pharmacokinetic Study||0
7888661|NCT00768287|19415155|P2|NOT COMPLETED|Repeat Pharmacokinetic Study||0
7888662|NCT00768287|19415156|P1|NOT COMPLETED|Repeat Pharmacokinetic Study||0
7888663|NCT00768287|19415151|P6|COMPLETED|Repeat Pharmacokinetic Study||0
7888664|NCT00768287|19415152|P5|COMPLETED|Repeat Pharmacokinetic Study||0
7888665|NCT00768287|19415153|P4|COMPLETED|Repeat Pharmacokinetic Study||0
7888666|NCT00768287|19415154|P3|COMPLETED|Repeat Pharmacokinetic Study||14
7888667|NCT00768287|19415155|P2|COMPLETED|Repeat Pharmacokinetic Study||0
7888668|NCT00768287|19415156|P1|COMPLETED|Repeat Pharmacokinetic Study||0
7888669|NCT00768287|19415151|P6|STARTED|Repeat Pharmacokinetic Study||0
7888670|NCT00768287|19415152|P5|STARTED|Repeat Pharmacokinetic Study||0
7888671|NCT00768287|19415153|P4|STARTED|Repeat Pharmacokinetic Study||0
7888672|NCT00768287|19415154|P3|STARTED|Repeat Pharmacokinetic Study|Eight subjects were part of the IB1001 first group; 6 were from the nonacog alfa first group.|14
7888673|NCT00768287|19415155|P2|STARTED|Repeat Pharmacokinetic Study||0
7888674|NCT00768287|19415156|P1|STARTED|Repeat Pharmacokinetic Study||0
7888675|NCT00768287|19415151|P6|NOT COMPLETED|Pharmacokinetic Study||0
7888676|NCT00768287|19415152|P5|NOT COMPLETED|Pharmacokinetic Study||0
7888677|NCT00768287|19415153|P4|NOT COMPLETED|Pharmacokinetic Study||0
7888678|NCT00768287|19415154|P3|NOT COMPLETED|Pharmacokinetic Study||0
7888679|NCT00768287|19415155|P2|NOT COMPLETED|Pharmacokinetic Study||0
7888680|NCT00768287|19415156|P1|NOT COMPLETED|Pharmacokinetic Study||0
7888681|NCT00768287|19415151|P6|COMPLETED|Pharmacokinetic Study||0
7888682|NCT00768287|19415152|P5|COMPLETED|Pharmacokinetic Study||0
7888683|NCT00768287|19415153|P4|COMPLETED|Pharmacokinetic Study||0
7888684|NCT00768287|19415154|P3|COMPLETED|Pharmacokinetic Study||0
7888685|NCT00768287|19415155|P2|COMPLETED|Pharmacokinetic Study||16
7888686|NCT00768287|19415156|P1|COMPLETED|Pharmacokinetic Study||16
7888687|NCT00768287|19415151|P6|STARTED|Pharmacokinetic Study||0
7888688|NCT00768287|19415152|P5|STARTED|Pharmacokinetic Study||0
7888689|NCT00768287|19415153|P4|STARTED|Pharmacokinetic Study||0
7888690|NCT00768287|19415154|P3|STARTED|Pharmacokinetic Study||0
7888691|NCT00768287|19415155|P2|STARTED|Pharmacokinetic Study||16
7888692|NCT00768287|19415156|P1|STARTED|Pharmacokinetic Study||16
7888693|NCT00768261|19415195|P4|NOT COMPLETED|Overall Study||0
7888694|NCT00768261|19415196|P3|NOT COMPLETED|Overall Study||25
7888695|NCT00768261|19415197|P2|NOT COMPLETED|Overall Study||0
7888696|NCT00768261|19415198|P1|NOT COMPLETED|Overall Study||0
7888697|NCT00768261|19415195|P4|COMPLETED|Overall Study||56
7888698|NCT00768261|19415196|P3|COMPLETED|Overall Study||14
7888699|NCT00768261|19415197|P2|COMPLETED|Overall Study||18
7888700|NCT00768261|19415198|P1|COMPLETED|Overall Study||14
7888701|NCT00768261|19415195|P4|STARTED|Overall Study||56
7888702|NCT00768261|19415196|P3|STARTED|Overall Study||39
7888703|NCT00768261|19415197|P2|STARTED|Overall Study||18
7888704|NCT00768261|19415198|P1|STARTED|Overall Study||14
7888705|NCT00768248|19415213|P2|NOT COMPLETED|Overall Study||1
7888706|NCT00768248|19415214|P1|NOT COMPLETED|Overall Study||1
7888707|NCT00768248|19415213|P2|COMPLETED|Overall Study||0
7888708|NCT00768248|19415214|P1|COMPLETED|Overall Study||0
7888709|NCT00768248|19415213|P2|STARTED|Overall Study||1
7888710|NCT00768248|19415214|P1|STARTED|Overall Study||1
7888711|NCT00768222|19415230|P2|NOT COMPLETED|Overall Study||4
7888712|NCT00768222|19415231|P1|NOT COMPLETED|Overall Study||4
7888713|NCT00768222|19415230|P2|COMPLETED|Overall Study||47
7888714|NCT00768222|19415231|P1|COMPLETED|Overall Study||46
7888715|NCT00768222|19415230|P2|STARTED|Overall Study||51
7888716|NCT00768222|19415231|P1|STARTED|Overall Study||50
7888717|NCT00768144|19415253|P1|NOT COMPLETED|Overall Study||36
7888718|NCT00768144|19415253|P1|COMPLETED|Overall Study||0
7888719|NCT00768144|19415253|P1|STARTED|Overall Study||36
7888720|NCT00768118|19415259|P1|NOT COMPLETED|Overall Study||0
7888721|NCT00768118|19415259|P1|COMPLETED|Overall Study||11
7888722|NCT00768118|19415259|P1|STARTED|Overall Study||11
7888723|NCT00768079|19415266|P3|NOT COMPLETED|Overall Study||4
7888724|NCT00768079|19415267|P2|NOT COMPLETED|Overall Study||1
7888725|NCT00768079|19415268|P1|NOT COMPLETED|Overall Study||2
7888726|NCT00768079|19415266|P3|COMPLETED|Overall Study||32
7888727|NCT00768079|19415267|P2|COMPLETED|Overall Study||35
7888728|NCT00768079|19415268|P1|COMPLETED|Overall Study||36
7888729|NCT00768079|19415266|P3|STARTED|Overall Study||36
7888730|NCT00768079|19415267|P2|STARTED|Overall Study||36
7888731|NCT00768079|19415268|P1|STARTED|Overall Study||38
7888732|NCT00768066|19415325|P3|NOT COMPLETED|Overall Study||0
7888733|NCT00768066|19415326|P2|NOT COMPLETED|Overall Study||3
7888734|NCT00768066|19415327|P1|NOT COMPLETED|Overall Study||3
7888735|NCT00768066|19415325|P3|COMPLETED|Overall Study||21
7888736|NCT00768066|19415326|P2|COMPLETED|Overall Study||19
7888737|NCT00768066|19415327|P1|COMPLETED|Overall Study||19
7888738|NCT00768066|19415325|P3|STARTED|Overall Study||21
7888739|NCT00768066|19415326|P2|STARTED|Overall Study||22
7888740|NCT00768066|19415327|P1|STARTED|Overall Study||22
7888741|NCT00768053|19415359|P1|NOT COMPLETED|Overall Study||11
7888742|NCT00768053|19415359|P1|COMPLETED|Overall Study||97
7888743|NCT00768053|19415359|P1|STARTED|Overall Study||108
7888744|NCT00768040|19415390|P2|NOT COMPLETED|Overall Study||3
7888745|NCT00768040|19415391|P1|NOT COMPLETED|Overall Study||4
7888746|NCT00768040|19415390|P2|COMPLETED|Overall Study||16
7888747|NCT00768040|19415391|P1|COMPLETED|Overall Study||16
7888748|NCT00768040|19415390|P2|STARTED|Overall Study||19
7888749|NCT00768040|19415391|P1|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20
7888750|NCT00767819|19415400|P3|NOT COMPLETED|Overall Study||0
7888751|NCT00767819|19415401|P2|NOT COMPLETED|Overall Study||19
7888752|NCT00767819|19415402|P1|NOT COMPLETED|Overall Study||25
7888753|NCT00767819|19415400|P3|COMPLETED|Overall Study||10
7888754|NCT00767819|19415401|P2|COMPLETED|Overall Study||5
7888755|NCT00767819|19415402|P1|COMPLETED|Overall Study||12
7888756|NCT00767819|19415400|P3|Safety Analysis Set (SAF)|Overall Study||10
7888757|NCT00767819|19415401|P2|Safety Analysis Set (SAF)|Overall Study||24
7888758|NCT00767819|19415402|P1|Safety Analysis Set (SAF)|Overall Study||37
7888759|NCT00767819|19415400|P3|Intent to Treat (ITT) Analysis Set|Overall Study||10
7888760|NCT00767819|19415401|P2|Intent to Treat (ITT) Analysis Set|Overall Study||24
7888761|NCT00767819|19415402|P1|Intent to Treat (ITT) Analysis Set|Overall Study||37
7888762|NCT00767819|19415400|P3|STARTED|Overall Study||10
7888763|NCT00767819|19415401|P2|STARTED|Overall Study||24
7888764|NCT00767819|19415402|P1|STARTED|Overall Study||37
7888765|NCT00767806|19415427|P2|NOT COMPLETED|Overall Study||47
7888766|NCT00767806|19415428|P1|NOT COMPLETED|Overall Study||51
7888767|NCT00767806|19415427|P2|COMPLETED|Overall Study||156
7888768|NCT00767806|19415428|P1|COMPLETED|Overall Study||147
7888769|NCT00767806|19415427|P2|STARTED|Overall Study||203
7888770|NCT00767806|19415428|P1|STARTED|Overall Study||198
7888771|NCT00767767|19415489|P5|NOT COMPLETED|Overall Study||0
7888772|NCT00767767|19415490|P4|NOT COMPLETED|Overall Study||0
7888773|NCT00767767|19415491|P3|NOT COMPLETED|Overall Study||0
7888774|NCT00767767|19415492|P2|NOT COMPLETED|Overall Study||0
7888775|NCT00767767|19415493|P1|NOT COMPLETED|Overall Study||0
7888776|NCT00767767|19415489|P5|COMPLETED|Overall Study||3
7888777|NCT00767767|19415490|P4|COMPLETED|Overall Study||3
7888778|NCT00767767|19415491|P3|COMPLETED|Overall Study||20
7888779|NCT00767767|19415492|P2|COMPLETED|Overall Study||20
7888780|NCT00767767|19415493|P1|COMPLETED|Overall Study||21
7888781|NCT00767767|19415489|P5|STARTED|Overall Study||3
7888782|NCT00767767|19415490|P4|STARTED|Overall Study||3
7888783|NCT00767767|19415491|P3|STARTED|Overall Study||20
7888784|NCT00767767|19415492|P2|STARTED|Overall Study||20
7888785|NCT00767767|19415493|P1|STARTED|Overall Study||21
7888786|NCT00767676|19415505|P1|NOT COMPLETED|Overall Study||54
7888787|NCT00767676|19415505|P1|COMPLETED|Overall Study||205
7888788|NCT00767676|19415505|P1|STARTED|Overall Study||259
7888789|NCT00767624|19415511|P2|NOT COMPLETED|Overall Study||17
7888790|NCT00767624|19415512|P1|NOT COMPLETED|Overall Study||24
7888791|NCT00767624|19415511|P2|COMPLETED|Overall Study||58
7888792|NCT00767624|19415512|P1|COMPLETED|Overall Study||51
7888793|NCT00767624|19415511|P2|STARTED|Overall Study||75
7888794|NCT00767624|19415512|P1|STARTED|Overall Study||75
7888795|NCT00767572|19415520|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
7888796|NCT00767572|19415520|P1|COMPLETED|Second Intervention (12 Weeks)||12
7888797|NCT00767572|19415520|P1|STARTED|Second Intervention (12 Weeks)||12
7888798|NCT00767572|19415520|P1|NOT COMPLETED|Washout (4 Weeks)||0
7888799|NCT00767572|19415520|P1|COMPLETED|Washout (4 Weeks)||12
7888800|NCT00767572|19415520|P1|STARTED|Washout (4 Weeks)||12
7888801|NCT00767572|19415520|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
7888802|NCT00767572|19415520|P1|COMPLETED|First Intervention (12 Weeks)||12
7888803|NCT00767572|19415520|P1|STARTED|First Intervention (12 Weeks)||12
7888804|NCT00767520|19415528|P2|NOT COMPLETED|Overall Study||17
7888805|NCT00767520|19415529|P1|NOT COMPLETED|Overall Study||11
7888806|NCT00767520|19415528|P2|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61
7888892|NCT00766753|19415735|P1|NOT COMPLETED|Overall Study||0
7888807|NCT00767520|19415529|P1|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68
7888808|NCT00767520|19415528|P2|STARTED|Overall Study||78
7888809|NCT00767520|19415529|P1|STARTED|Overall Study||79
7888810|NCT00767507|19415555|P4|NOT COMPLETED|Overall Study||3
7888811|NCT00767507|19415556|P3|NOT COMPLETED|Overall Study||0
7888812|NCT00767507|19415557|P2|NOT COMPLETED|Overall Study||0
7888813|NCT00767507|19415558|P1|NOT COMPLETED|Overall Study||0
7888814|NCT00767507|19415555|P4|COMPLETED|Overall Study||101
7888815|NCT00767507|19415556|P3|COMPLETED|Overall Study||106
7888816|NCT00767507|19415557|P2|COMPLETED|Overall Study||6
7888817|NCT00767507|19415558|P1|COMPLETED|Overall Study||5
7888818|NCT00767507|19415555|P4|STARTED|Overall Study||104
7888819|NCT00767507|19415556|P3|STARTED|Overall Study||106
7888820|NCT00767507|19415557|P2|STARTED|Overall Study||6
7888821|NCT00767507|19415558|P1|STARTED|Overall Study||5
7888822|NCT00767455|19415582|P1|NOT COMPLETED|Overall Study||19
7888823|NCT00767455|19415582|P1|COMPLETED|Overall Study||40
7888824|NCT00767455|19415582|P1|STARTED|Overall Study||59
7888825|NCT00767364|19415590|P2|NOT COMPLETED|Overall Study||0
7888826|NCT00767364|19415591|P1|NOT COMPLETED|Overall Study||0
7888827|NCT00767364|19415590|P2|COMPLETED|Overall Study||3
7888828|NCT00767364|19415591|P1|COMPLETED|Overall Study||5
7888829|NCT00767364|19415590|P2|STARTED|Overall Study||3
7888830|NCT00767364|19415591|P1|STARTED|Overall Study||5
7888831|NCT00767338|19415603|P4|NOT COMPLETED|Overall Study||0
7888832|NCT00767338|19415604|P3|NOT COMPLETED|Overall Study||0
7888833|NCT00767338|19415605|P2|NOT COMPLETED|Overall Study||2
7888834|NCT00767338|19415606|P1|NOT COMPLETED|Overall Study||1
7888835|NCT00767338|19415603|P4|COMPLETED|Overall Study||0
7888836|NCT00767338|19415604|P3|COMPLETED|Overall Study||0
7888837|NCT00767338|19415605|P2|COMPLETED|Overall Study||0
7888838|NCT00767338|19415606|P1|COMPLETED|Overall Study||0
7888839|NCT00767338|19415603|P4|STARTED|Overall Study||0
7888840|NCT00767338|19415604|P3|STARTED|Overall Study||0
7888841|NCT00767338|19415605|P2|STARTED|Overall Study||2
7888842|NCT00767338|19415606|P1|STARTED|Overall Study||1
7888843|NCT00767325|19415616|P1|NOT COMPLETED|Overall Study||15
7888844|NCT00767325|19415616|P1|COMPLETED|Overall Study||89
7888845|NCT00767325|19415616|P1|STARTED|Overall Study||104
7888846|NCT00767104|19415627|P2|NOT COMPLETED|Overall Study||2
7888847|NCT00767104|19415628|P1|NOT COMPLETED|Overall Study||1
7888848|NCT00767104|19415627|P2|COMPLETED|Overall Study||18
7888849|NCT00767104|19415628|P1|COMPLETED|Overall Study||19
7888850|NCT00767104|19415627|P2|STARTED|Overall Study||20
7888851|NCT00767104|19415628|P1|STARTED|Overall Study||20
7888852|NCT00767039|19415638|P2|NOT COMPLETED|Overall Study||2
7888853|NCT00767039|19415639|P1|NOT COMPLETED|Overall Study||5
7888854|NCT00767039|19415638|P2|COMPLETED|Overall Study||23
7888855|NCT00767039|19415639|P1|COMPLETED|Overall Study||22
7888856|NCT00767039|19415638|P2|STARTED|Overall Study||25
7888857|NCT00767039|19415639|P1|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27
7888858|NCT00767000|19415670|P5|NOT COMPLETED|Optional 104-week Extension||4
7888859|NCT00767000|19415671|P4|NOT COMPLETED|Optional 104-week Extension||2
7888860|NCT00767000|19415672|P3|NOT COMPLETED|Optional 104-week Extension||7
7888861|NCT00767000|19415673|P2|NOT COMPLETED|Optional 104-week Extension||3
7888862|NCT00767000|19415674|P1|NOT COMPLETED|Optional 104-week Extension||7
7888863|NCT00767000|19415670|P5|COMPLETED|Optional 104-week Extension||0
7888864|NCT00767000|19415671|P4|COMPLETED|Optional 104-week Extension||0
7888865|NCT00767000|19415672|P3|COMPLETED|Optional 104-week Extension||0
7888866|NCT00767000|19415673|P2|COMPLETED|Optional 104-week Extension||0
7888867|NCT00767000|19415674|P1|COMPLETED|Optional 104-week Extension||0
7888868|NCT00767000|19415670|P5|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4
7888869|NCT00767000|19415671|P4|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2
7888870|NCT00767000|19415672|P3|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
7888871|NCT00767000|19415673|P2|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3
7888872|NCT00767000|19415674|P1|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
7888873|NCT00767000|19415670|P5|NOT COMPLETED|54-week Study||224
7888874|NCT00767000|19415671|P4|NOT COMPLETED|54-week Study||225
7888875|NCT00767000|19415672|P3|NOT COMPLETED|54-week Study||109
7888876|NCT00767000|19415673|P2|NOT COMPLETED|54-week Study||113
7888877|NCT00767000|19415674|P1|NOT COMPLETED|54-week Study||108
7888878|NCT00767000|19415670|P5|COMPLETED|54-week Study||7
7888879|NCT00767000|19415671|P4|COMPLETED|54-week Study||4
7888880|NCT00767000|19415672|P3|COMPLETED|54-week Study||8
7888881|NCT00767000|19415673|P2|COMPLETED|54-week Study||4
7888882|NCT00767000|19415674|P1|COMPLETED|54-week Study||11
7888883|NCT00767000|19415670|P5|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231
7888884|NCT00767000|19415671|P4|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229
7888885|NCT00767000|19415672|P3|STARTED|54-week Study||117
7888886|NCT00767000|19415673|P2|STARTED|54-week Study||117
7888887|NCT00767000|19415674|P1|STARTED|54-week Study||119
7888888|NCT00766831|19415716|P1|NOT COMPLETED|Overall Study||115
7888889|NCT00766831|19415716|P1|COMPLETED|Overall Study||75
7888890|NCT00766831|19415716|P1|STARTED|Overall Study||190
7888891|NCT00766753|19415734|P2|NOT COMPLETED|Overall Study||0
7888893|NCT00766753|19415734|P2|COMPLETED|Overall Study||11
7888894|NCT00766753|19415735|P1|COMPLETED|Overall Study||11
7888895|NCT00766753|19415734|P2|Completed at Least Four Vaccines|Overall Study||9
7888896|NCT00766753|19415735|P1|Completed at Least Four Vaccines|Overall Study||10
7888897|NCT00766753|19415734|P2|Received at Least One Vaccine|Overall Study||11
7888898|NCT00766753|19415735|P1|Received at Least One Vaccine|Overall Study||11
7888899|NCT00766753|19415734|P2|STARTED|Overall Study||11
7888900|NCT00766753|19415735|P1|STARTED|Overall Study||11
7888901|NCT00766727|19415746|P1|NOT COMPLETED|Overall Study||3
7888902|NCT00766727|19415746|P1|COMPLETED|Overall Study||9
7888903|NCT00766727|19415746|P1|STARTED|Overall Study||12
7888904|NCT00766675|19415752|P1|NOT COMPLETED|Overall Study||40
7888905|NCT00766675|19415752|P1|COMPLETED|Overall Study||40
7888906|NCT00766675|19415752|P1|STARTED|Overall Study||80
7888907|NCT00766649|19415765|P1|NOT COMPLETED|Overall Study||10
7888908|NCT00766649|19415765|P1|COMPLETED|Overall Study||1
7888909|NCT00766649|19415765|P1|STARTED|Overall Study||11
7888910|NCT00766636|19415781|P2|NOT COMPLETED|Overall Study||2
7888911|NCT00766636|19415782|P1|NOT COMPLETED|Overall Study||3
7888912|NCT00766636|19415781|P2|COMPLETED|Overall Study||0
7888913|NCT00766636|19415782|P1|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0
7888914|NCT00766636|19415781|P2|STARTED|Overall Study||2
7888915|NCT00766636|19415782|P1|STARTED|Overall Study||3
7888916|NCT00766597|19415788|P1|NOT COMPLETED|Overall Study||9
7888917|NCT00766597|19415788|P1|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0
7888918|NCT00766597|19415788|P1|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0
7888919|NCT00766597|19415788|P1|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1
7888920|NCT00766597|19415788|P1|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5
7888921|NCT00766597|19415788|P1|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4
7888922|NCT00766597|19415788|P1|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9
7888923|NCT00766532|19415800|P1|NOT COMPLETED|Overall Study||2
7888924|NCT00766532|19415800|P1|COMPLETED|Overall Study||10
7888925|NCT00766532|19415800|P1|STARTED|Overall Study||12
7888926|NCT00766506|19415806|P2|NOT COMPLETED|Overall Study||2
7888927|NCT00766506|19415807|P1|NOT COMPLETED|Overall Study||5
7888928|NCT00766506|19415806|P2|COMPLETED|Overall Study||48
7888929|NCT00766506|19415807|P1|COMPLETED|Overall Study||53
7888930|NCT00766506|19415806|P2|STARTED|Overall Study||50
7888931|NCT00766506|19415807|P1|STARTED|Overall Study||58
7888932|NCT00766493|19415831|P1|NOT COMPLETED|30 Days Post-Procedure||12
7888933|NCT00766493|19415831|P1|COMPLETED|30 Days Post-Procedure||238
7888934|NCT00766493|19415831|P1|STARTED|30 Days Post-Procedure||250
7888935|NCT00766493|19415831|P1|NOT COMPLETED|Pre-Discharge||0
7888936|NCT00766493|19415831|P1|COMPLETED|Pre-Discharge||250
7888937|NCT00766493|19415831|P1|STARTED|Pre-Discharge||250
7888938|NCT00766467|19415841|P2|NOT COMPLETED|Overall Study||8
7888939|NCT00766467|19415842|P1|NOT COMPLETED|Overall Study||11
7888940|NCT00766467|19415841|P2|COMPLETED|Overall Study||31
7888941|NCT00766467|19415842|P1|COMPLETED|Overall Study||31
7888942|NCT00766467|19415841|P2|Initiated Treatment|Overall Study||38
7888943|NCT00766467|19415842|P1|Initiated Treatment|Overall Study||39
7888944|NCT00766467|19415841|P2|STARTED|Overall Study||39
7888945|NCT00766467|19415842|P1|STARTED|Overall Study||42
7888946|NCT00766415|19415854|P2|NOT COMPLETED|Overall Study||1
7888947|NCT00766415|19415855|P1|NOT COMPLETED|Overall Study||0
7888948|NCT00766415|19415854|P2|COMPLETED|Overall Study||26
7888949|NCT00766415|19415855|P1|COMPLETED|Overall Study||25
7888950|NCT00766415|19415854|P2|STARTED|Overall Study||27
7888951|NCT00766415|19415855|P1|STARTED|Overall Study||25
7888952|NCT00766376|19415903|P1|NOT COMPLETED|Overall Study||27
7888953|NCT00766376|19415903|P1|COMPLETED|Overall Study||124
7888954|NCT00766376|19415903|P1|STARTED|Overall Study||151
7888955|NCT00766363|19415912|P4|NOT COMPLETED|Overall Study||0
7888956|NCT00766363|19415913|P3|NOT COMPLETED|Overall Study||0
7888957|NCT00766363|19415914|P2|NOT COMPLETED|Overall Study||1
7888958|NCT00766363|19415915|P1|NOT COMPLETED|Overall Study||1
7888959|NCT00766363|19415912|P4|COMPLETED|Overall Study||12
7888960|NCT00766363|19415913|P3|COMPLETED|Overall Study||12
7888961|NCT00766363|19415914|P2|COMPLETED|Overall Study||12
7888962|NCT00766363|19415915|P1|COMPLETED|Overall Study||11
7888963|NCT00766363|19415912|P4|PK POPULATION|Overall Study||13
7888964|NCT00766363|19415913|P3|PK POPULATION|Overall Study||10
7888965|NCT00766363|19415914|P2|PK POPULATION|Overall Study||13
7888966|NCT00766363|19415915|P1|PK POPULATION|Overall Study||12
7888967|NCT00766363|19415912|P4|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13
7888968|NCT00766363|19415913|P3|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11
7888969|NCT00766363|19415914|P2|SAFETY POPULATION|Overall Study||13
7888970|NCT00766363|19415915|P1|SAFETY POPULATION|Overall Study||12
7888971|NCT00766363|19415912|P4|STARTED|Overall Study|Number randomized.|12
7888972|NCT00766363|19415913|P3|STARTED|Overall Study|Number randomized.|12
7888973|NCT00766363|19415914|P2|STARTED|Overall Study||13
7888974|NCT00766363|19415915|P1|STARTED|Overall Study||12
7888975|NCT00766116|19415952|P1|NOT COMPLETED|Overall Study||0
7888976|NCT00766116|19415952|P1|COMPLETED|Overall Study||50
7888977|NCT00766116|19415952|P1|STARTED|Overall Study||50
7888978|NCT00766090|19415961|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||1
7888979|NCT00766090|19415962|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7888980|NCT00766090|19415963|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7888981|NCT00766090|19415964|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7888982|NCT00766090|19415965|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7888983|NCT00766090|19415966|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7888984|NCT00766090|19415967|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||1
7888985|NCT00766090|19415968|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||1
7888986|NCT00766090|19415969|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||1
7888987|NCT00766090|19415970|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7888988|NCT00766090|19415971|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||1
7888989|NCT00766090|19415972|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
7888990|NCT00766090|19415961|P12|COMPLETED|Treatment Period 3 (28 Days)||6
7888991|NCT00766090|19415962|P11|COMPLETED|Treatment Period 3 (28 Days)||7
7888992|NCT00766090|19415963|P10|COMPLETED|Treatment Period 3 (28 Days)||8
7888993|NCT00766090|19415964|P9|COMPLETED|Treatment Period 3 (28 Days)||6
7888994|NCT00766090|19415965|P8|COMPLETED|Treatment Period 3 (28 Days)||8
7888995|NCT00766090|19415966|P7|COMPLETED|Treatment Period 3 (28 Days)||6
7888996|NCT00766090|19415967|P6|COMPLETED|Treatment Period 3 (28 Days)||22
7888997|NCT00766090|19415968|P5|COMPLETED|Treatment Period 3 (28 Days)||20
7888998|NCT00766090|19415969|P4|COMPLETED|Treatment Period 3 (28 Days)||24
7888999|NCT00766090|19415970|P3|COMPLETED|Treatment Period 3 (28 Days)||20
7889000|NCT00766090|19415971|P2|COMPLETED|Treatment Period 3 (28 Days)||26
7889001|NCT00766090|19415972|P1|COMPLETED|Treatment Period 3 (28 Days)||22
7889002|NCT00766090|19415961|P12|STARTED|Treatment Period 3 (28 Days)||7
7889003|NCT00766090|19415962|P11|STARTED|Treatment Period 3 (28 Days)||7
7889004|NCT00766090|19415963|P10|STARTED|Treatment Period 3 (28 Days)||8
7889005|NCT00766090|19415964|P9|STARTED|Treatment Period 3 (28 Days)||6
7889006|NCT00766090|19415965|P8|STARTED|Treatment Period 3 (28 Days)||8
7889007|NCT00766090|19415966|P7|STARTED|Treatment Period 3 (28 Days)||6
7889008|NCT00766090|19415967|P6|STARTED|Treatment Period 3 (28 Days)||23
7889009|NCT00766090|19415968|P5|STARTED|Treatment Period 3 (28 Days)||21
7889010|NCT00766090|19415969|P4|STARTED|Treatment Period 3 (28 Days)||25
7889011|NCT00766090|19415970|P3|STARTED|Treatment Period 3 (28 Days)||20
7889012|NCT00766090|19415971|P2|STARTED|Treatment Period 3 (28 Days)||27
7889013|NCT00766090|19415972|P1|STARTED|Treatment Period 3 (28 Days)||22
7889014|NCT00766090|19415961|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
7889015|NCT00766090|19415962|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
7889016|NCT00766090|19415963|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
7889017|NCT00766090|19415964|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
7889018|NCT00766090|19415965|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
7889019|NCT00766090|19415966|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
7889020|NCT00766090|19415967|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
7889021|NCT00766090|19415968|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
7889022|NCT00766090|19415969|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
7889023|NCT00766090|19415970|P3|NOT COMPLETED|Washout Period 2 (14 Days)||1
7889024|NCT00766090|19415971|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
7889025|NCT00766090|19415972|P1|NOT COMPLETED|Washout Period 2 (14 Days)||0
7889026|NCT00766090|19415961|P12|COMPLETED|Washout Period 2 (14 Days)||7
7889027|NCT00766090|19415962|P11|COMPLETED|Washout Period 2 (14 Days)||7
7889028|NCT00766090|19415963|P10|COMPLETED|Washout Period 2 (14 Days)||8
7889029|NCT00766090|19415964|P9|COMPLETED|Washout Period 2 (14 Days)||6
7889030|NCT00766090|19415965|P8|COMPLETED|Washout Period 2 (14 Days)||8
7889031|NCT00766090|19415966|P7|COMPLETED|Washout Period 2 (14 Days)||6
7889032|NCT00766090|19415967|P6|COMPLETED|Washout Period 2 (14 Days)||23
7889033|NCT00766090|19415968|P5|COMPLETED|Washout Period 2 (14 Days)||21
7889034|NCT00766090|19415969|P4|COMPLETED|Washout Period 2 (14 Days)||25
7889035|NCT00766090|19415970|P3|COMPLETED|Washout Period 2 (14 Days)||20
7889036|NCT00766090|19415971|P2|COMPLETED|Washout Period 2 (14 Days)||27
7889037|NCT00766090|19415972|P1|COMPLETED|Washout Period 2 (14 Days)||22
7889038|NCT00766090|19415961|P12|STARTED|Washout Period 2 (14 Days)||7
7889039|NCT00766090|19415962|P11|STARTED|Washout Period 2 (14 Days)||7
7889040|NCT00766090|19415963|P10|STARTED|Washout Period 2 (14 Days)||8
7889041|NCT00766090|19415964|P9|STARTED|Washout Period 2 (14 Days)||6
7889042|NCT00766090|19415965|P8|STARTED|Washout Period 2 (14 Days)||8
7889043|NCT00766090|19415966|P7|STARTED|Washout Period 2 (14 Days)||6
7889044|NCT00766090|19415967|P6|STARTED|Washout Period 2 (14 Days)||23
7889045|NCT00766090|19415968|P5|STARTED|Washout Period 2 (14 Days)||21
7889046|NCT00766090|19415969|P4|STARTED|Washout Period 2 (14 Days)||25
7889047|NCT00766090|19415970|P3|STARTED|Washout Period 2 (14 Days)||21
7889048|NCT00766090|19415971|P2|STARTED|Washout Period 2 (14 Days)||27
7889049|NCT00766090|19415972|P1|STARTED|Washout Period 2 (14 Days)||22
7889050|NCT00766090|19415961|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7889051|NCT00766090|19415962|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7889052|NCT00766090|19415963|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7889053|NCT00766090|19415964|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7889054|NCT00766090|19415965|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7889055|NCT00766090|19415966|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7889056|NCT00766090|19415967|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7889057|NCT00766090|19415968|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||2
7889058|NCT00766090|19415969|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7889059|NCT00766090|19415970|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
7889060|NCT00766090|19415971|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7889061|NCT00766090|19415972|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
7889062|NCT00766090|19415961|P12|COMPLETED|Treatment Period 2 (28 Days)||7
7889063|NCT00766090|19415962|P11|COMPLETED|Treatment Period 2 (28 Days)||7
7889064|NCT00766090|19415963|P10|COMPLETED|Treatment Period 2 (28 Days)||8
7889065|NCT00766090|19415964|P9|COMPLETED|Treatment Period 2 (28 Days)||6
7889066|NCT00766090|19415965|P8|COMPLETED|Treatment Period 2 (28 Days)||8
7889067|NCT00766090|19415966|P7|COMPLETED|Treatment Period 2 (28 Days)||6
7889068|NCT00766090|19415967|P6|COMPLETED|Treatment Period 2 (28 Days)||23
7889069|NCT00766090|19415968|P5|COMPLETED|Treatment Period 2 (28 Days)||21
7889070|NCT00766090|19415969|P4|COMPLETED|Treatment Period 2 (28 Days)||25
7889071|NCT00766090|19415970|P3|COMPLETED|Treatment Period 2 (28 Days)||21
7889072|NCT00766090|19415971|P2|COMPLETED|Treatment Period 2 (28 Days)||27
7889073|NCT00766090|19415972|P1|COMPLETED|Treatment Period 2 (28 Days)||22
7889074|NCT00766090|19415961|P12|STARTED|Treatment Period 2 (28 Days)||7
7889075|NCT00766090|19415962|P11|STARTED|Treatment Period 2 (28 Days)||7
7889076|NCT00766090|19415963|P10|STARTED|Treatment Period 2 (28 Days)||8
7889077|NCT00766090|19415964|P9|STARTED|Treatment Period 2 (28 Days)||6
7889078|NCT00766090|19415965|P8|STARTED|Treatment Period 2 (28 Days)||8
7889079|NCT00766090|19415966|P7|STARTED|Treatment Period 2 (28 Days)||6
7889080|NCT00766090|19415967|P6|STARTED|Treatment Period 2 (28 Days)||23
7889081|NCT00766090|19415968|P5|STARTED|Treatment Period 2 (28 Days)||23
7889082|NCT00766090|19415969|P4|STARTED|Treatment Period 2 (28 Days)||25
7889083|NCT00766090|19415970|P3|STARTED|Treatment Period 2 (28 Days)||22
7889084|NCT00766090|19415971|P2|STARTED|Treatment Period 2 (28 Days)||27
7889085|NCT00766090|19415972|P1|STARTED|Treatment Period 2 (28 Days)||22
7889086|NCT00766090|19415961|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
7889087|NCT00766090|19415962|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
7889088|NCT00766090|19415963|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
7889089|NCT00766090|19415964|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
7889090|NCT00766090|19415965|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
7889091|NCT00766090|19415966|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
7889092|NCT00766090|19415967|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
7889093|NCT00766090|19415968|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
7889094|NCT00766090|19415969|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
7889095|NCT00766090|19415970|P3|NOT COMPLETED|Washout Period 1 (14 Days)||1
7889096|NCT00766090|19415971|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
7889097|NCT00766090|19415972|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
7889098|NCT00766090|19415961|P12|COMPLETED|Washout Period 1 (14 Days)||7
7889099|NCT00766090|19415962|P11|COMPLETED|Washout Period 1 (14 Days)||7
7889100|NCT00766090|19415963|P10|COMPLETED|Washout Period 1 (14 Days)||8
7889101|NCT00766090|19415964|P9|COMPLETED|Washout Period 1 (14 Days)||6
7889102|NCT00766090|19415965|P8|COMPLETED|Washout Period 1 (14 Days)||8
7889103|NCT00766090|19415966|P7|COMPLETED|Washout Period 1 (14 Days)||6
7889104|NCT00766090|19415967|P6|COMPLETED|Washout Period 1 (14 Days)||23
7889105|NCT00766090|19415968|P5|COMPLETED|Washout Period 1 (14 Days)||23
7889106|NCT00766090|19415969|P4|COMPLETED|Washout Period 1 (14 Days)||25
7889107|NCT00766090|19415970|P3|COMPLETED|Washout Period 1 (14 Days)||22
7889108|NCT00766090|19415971|P2|COMPLETED|Washout Period 1 (14 Days)||27
7889109|NCT00766090|19415972|P1|COMPLETED|Washout Period 1 (14 Days)||22
7889110|NCT00766090|19415961|P12|STARTED|Washout Period 1 (14 Days)||7
7889111|NCT00766090|19415962|P11|STARTED|Washout Period 1 (14 Days)||7
7889112|NCT00766090|19415963|P10|STARTED|Washout Period 1 (14 Days)||8
7889113|NCT00766090|19415964|P9|STARTED|Washout Period 1 (14 Days)||6
7889114|NCT00766090|19415965|P8|STARTED|Washout Period 1 (14 Days)||8
7889115|NCT00766090|19415966|P7|STARTED|Washout Period 1 (14 Days)||6
7889116|NCT00766090|19415967|P6|STARTED|Washout Period 1 (14 Days)||23
7889117|NCT00766090|19415968|P5|STARTED|Washout Period 1 (14 Days)||23
7889118|NCT00766090|19415969|P4|STARTED|Washout Period 1 (14 Days)||25
7889119|NCT00766090|19415970|P3|STARTED|Washout Period 1 (14 Days)||23
7889120|NCT00766090|19415971|P2|STARTED|Washout Period 1 (14 Days)||27
7889121|NCT00766090|19415972|P1|STARTED|Washout Period 1 (14 Days)||22
7889122|NCT00766090|19415961|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7889123|NCT00766090|19415962|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7889124|NCT00766090|19415963|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7889125|NCT00766090|19415964|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||1
7889126|NCT00766090|19415965|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7889127|NCT00766090|19415966|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7889128|NCT00766090|19415967|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7889129|NCT00766090|19415968|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7889130|NCT00766090|19415969|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||1
7889131|NCT00766090|19415970|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7889132|NCT00766090|19415971|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
7889133|NCT00766090|19415972|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||3
7889134|NCT00766090|19415961|P12|COMPLETED|Treatment Period 1 (28 Days)||7
7889135|NCT00766090|19415962|P11|COMPLETED|Treatment Period 1 (28 Days)||7
7889136|NCT00766090|19415963|P10|COMPLETED|Treatment Period 1 (28 Days)||8
7889137|NCT00766090|19415964|P9|COMPLETED|Treatment Period 1 (28 Days)||6
7889138|NCT00766090|19415965|P8|COMPLETED|Treatment Period 1 (28 Days)||8
7889139|NCT00766090|19415966|P7|COMPLETED|Treatment Period 1 (28 Days)||6
7889140|NCT00766090|19415967|P6|COMPLETED|Treatment Period 1 (28 Days)||23
7889141|NCT00766090|19415968|P5|COMPLETED|Treatment Period 1 (28 Days)||23
7889142|NCT00766090|19415969|P4|COMPLETED|Treatment Period 1 (28 Days)||25
7889143|NCT00766090|19415970|P3|COMPLETED|Treatment Period 1 (28 Days)||23
7889144|NCT00766090|19415971|P2|COMPLETED|Treatment Period 1 (28 Days)||27
7889145|NCT00766090|19415972|P1|COMPLETED|Treatment Period 1 (28 Days)||22
7889146|NCT00766090|19415961|P12|STARTED|Treatment Period 1 (28 Days)||7
7889147|NCT00766090|19415962|P11|STARTED|Treatment Period 1 (28 Days)||7
7889148|NCT00766090|19415963|P10|STARTED|Treatment Period 1 (28 Days)||8
7889149|NCT00766090|19415964|P9|STARTED|Treatment Period 1 (28 Days)||7
7889150|NCT00766090|19415965|P8|STARTED|Treatment Period 1 (28 Days)||8
7889151|NCT00766090|19415966|P7|STARTED|Treatment Period 1 (28 Days)||6
7889152|NCT00766090|19415967|P6|STARTED|Treatment Period 1 (28 Days)||23
7889153|NCT00766090|19415968|P5|STARTED|Treatment Period 1 (28 Days)||23
7889154|NCT00766090|19415969|P4|STARTED|Treatment Period 1 (28 Days)||26
7889155|NCT00766090|19415970|P3|STARTED|Treatment Period 1 (28 Days)||23
7889156|NCT00766090|19415971|P2|STARTED|Treatment Period 1 (28 Days)||27
7889157|NCT00766090|19415972|P1|STARTED|Treatment Period 1 (28 Days)||25
7889158|NCT00766051|19416013|P2|NOT COMPLETED|Overall Study||0
7889159|NCT00766051|19416014|P1|NOT COMPLETED|Overall Study||2
7889160|NCT00766051|19416013|P2|COMPLETED|Overall Study||10
7889161|NCT00766051|19416014|P1|COMPLETED|Overall Study||10
7889162|NCT00766051|19416013|P2|STARTED|Overall Study||10
7889163|NCT00766051|19416014|P1|STARTED|Overall Study||12
7889164|NCT00766038|19416026|P2|NOT COMPLETED|Overall Study||14
7889165|NCT00766038|19416027|P1|NOT COMPLETED|Overall Study||15
7889166|NCT00766038|19416026|P2|COMPLETED|Overall Study||18
7889167|NCT00766038|19416027|P1|COMPLETED|Overall Study||16
7889168|NCT00766038|19416026|P2|STARTED|Overall Study||32
7889169|NCT00766038|19416027|P1|STARTED|Overall Study||31
7889170|NCT00765999|19416043|P1|NOT COMPLETED|Overall Study||784
7889171|NCT00765999|19416043|P1|COMPLETED|Overall Study||770
7889172|NCT00765999|19416043|P1|STARTED|Overall Study||1554
7889173|NCT00765947|19416049|P1|NOT COMPLETED|Overall Study||24
7889174|NCT00765947|19416049|P1|COMPLETED|Overall Study||232
7889175|NCT00765947|19416049|P1|STARTED|Overall Study||256
7889176|NCT00765895|19416060|P2|NOT COMPLETED|Overall Study||0
7889177|NCT00765895|19416061|P1|NOT COMPLETED|Overall Study||0
7889178|NCT00765895|19416060|P2|COMPLETED|Overall Study||65
7889179|NCT00765895|19416061|P1|COMPLETED|Overall Study||65
7889180|NCT00765895|19416060|P2|STARTED|Overall Study||65
7889181|NCT00765895|19416061|P1|STARTED|Overall Study||65
7889182|NCT00765882|19416070|P3|NOT COMPLETED|Overall Study||36
7889183|NCT00765882|19416071|P2|NOT COMPLETED|Overall Study||40
7889184|NCT00765882|19416072|P1|NOT COMPLETED|Overall Study||24
7889185|NCT00765882|19416070|P3|COMPLETED|Overall Study||169
7889186|NCT00765882|19416071|P2|COMPLETED|Overall Study||173
7889187|NCT00765882|19416072|P1|COMPLETED|Overall Study||191
7889188|NCT00765882|19416070|P3|STARTED|Overall Study||205
7889189|NCT00765882|19416071|P2|STARTED|Overall Study||213
7889190|NCT00765882|19416072|P1|STARTED|Overall Study||215
7889191|NCT00765856|19416101|P1|NOT COMPLETED|Maintenance Period||6
7889192|NCT00765856|19416101|P1|COMPLETED|Maintenance Period||18
7889193|NCT00765856|19416101|P1|STARTED|Maintenance Period||24
7889194|NCT00765856|19416101|P1|NOT COMPLETED|Titration Period||3
7889195|NCT00765856|19416101|P1|COMPLETED|Titration Period||24
7889196|NCT00765856|19416101|P1|STARTED|Titration Period||27
7889197|NCT00765843|19416118|P3|NOT COMPLETED|Overall Study||3
7889198|NCT00765843|19416119|P2|NOT COMPLETED|Overall Study||4
7889199|NCT00765843|19416120|P1|NOT COMPLETED|Overall Study||1
7889200|NCT00765843|19416118|P3|COMPLETED|Overall Study||23
7889201|NCT00765843|19416119|P2|COMPLETED|Overall Study||21
7889202|NCT00765843|19416120|P1|COMPLETED|Overall Study||25
7889203|NCT00765843|19416118|P3|STARTED|Overall Study||26
7889204|NCT00765843|19416119|P2|STARTED|Overall Study||25
7889205|NCT00765843|19416120|P1|STARTED|Overall Study||26
7889206|NCT00765817|19416130|P2|NOT COMPLETED|Overall Study||22
7889207|NCT00765817|19416131|P1|NOT COMPLETED|Overall Study||26
7889208|NCT00765817|19416130|P2|COMPLETED|Overall Study||101
7889209|NCT00765817|19416131|P1|COMPLETED|Overall Study||112
7889210|NCT00765817|19416130|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123
7889211|NCT00765817|19416131|P1|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138
7889212|NCT00765765|19416169|P1|NOT COMPLETED|Overall Study||0
7889213|NCT00765765|19416169|P1|COMPLETED|Overall Study||6
7889214|NCT00765765|19416169|P1|STARTED|Overall Study||6
7889215|NCT00765726|19416179|P1|NOT COMPLETED|Overall Study||9
7889216|NCT00765726|19416179|P1|COMPLETED|Overall Study||3
7889217|NCT00765726|19416179|P1|STARTED|Overall Study||12
7889218|NCT00765674|19416187|P4|NOT COMPLETED|Overall Study||25
7889219|NCT00765674|19416188|P3|NOT COMPLETED|Overall Study||17
7889220|NCT00765674|19416189|P2|NOT COMPLETED|Overall Study||22
7889221|NCT00765674|19416190|P1|NOT COMPLETED|Overall Study||21
7889222|NCT00765674|19416187|P4|COMPLETED|Overall Study||285
7889223|NCT00765674|19416188|P3|COMPLETED|Overall Study||279
7889224|NCT00765674|19416189|P2|COMPLETED|Overall Study||276
7889225|NCT00765674|19416190|P1|COMPLETED|Overall Study||266
7889226|NCT00765674|19416187|P4|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310
7889227|NCT00765674|19416188|P3|STARTED|Overall Study||296
7889228|NCT00765674|19416189|P2|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298
7889229|NCT00765674|19416190|P1|STARTED|Overall Study||287
7889230|NCT00765661|19416214|P2|NOT COMPLETED|Overall Study||0
7889231|NCT00765661|19416215|P1|NOT COMPLETED|Overall Study||0
7889232|NCT00765661|19416214|P2|COMPLETED|Overall Study||31
7889233|NCT00765661|19416215|P1|COMPLETED|Overall Study||32
7889234|NCT00765661|19416214|P2|STARTED|Overall Study||31
7889235|NCT00765661|19416215|P1|STARTED|Overall Study||32
7889236|NCT00765648|19416229|P2|NOT COMPLETED|Overall Study||2
7889237|NCT00765648|19416230|P1|NOT COMPLETED|Overall Study||1
7889238|NCT00765648|19416229|P2|COMPLETED|Overall Study||114
7889239|NCT00765648|19416230|P1|COMPLETED|Overall Study||109
7889240|NCT00765648|19416229|P2|STARTED|Overall Study||116
7889241|NCT00765648|19416230|P1|STARTED|Overall Study||110
7889242|NCT00765570|19416248|P2|NOT COMPLETED|Overall Study||0
7889243|NCT00765570|19416249|P1|NOT COMPLETED|Overall Study||2
7889244|NCT00765570|19416248|P2|COMPLETED|Overall Study||3
7889245|NCT00765570|19416249|P1|COMPLETED|Overall Study||7
7889246|NCT00765570|19416248|P2|STARTED|Overall Study||3
7889247|NCT00765570|19416249|P1|STARTED|Overall Study||9
7889248|NCT00765388|19416257|P2|NOT COMPLETED|Period 2||0
7889249|NCT00765388|19416258|P1|NOT COMPLETED|Period 2||0
7889250|NCT00765388|19416257|P2|COMPLETED|Period 2||6
7889251|NCT00765388|19416258|P1|COMPLETED|Period 2||15
7889252|NCT00765388|19416257|P2|STARTED|Period 2||6
7889253|NCT00765388|19416258|P1|STARTED|Period 2||15
7889254|NCT00765388|19416257|P2|NOT COMPLETED|Period 1||5
7889255|NCT00765388|19416258|P1|NOT COMPLETED|Period 1||1
7889256|NCT00765388|19416257|P2|COMPLETED|Period 1||6
7889257|NCT00765388|19416258|P1|COMPLETED|Period 1||15
7889258|NCT00765388|19416257|P2|STARTED|Period 1||11
7889259|NCT00765388|19416258|P1|STARTED|Period 1|A cross-over study|16
7889260|NCT00765375|19416286|P1|NOT COMPLETED|Overall Study||0
7889261|NCT00765375|19416286|P1|COMPLETED|Overall Study||5
7889262|NCT00765375|19416286|P1|STARTED|Overall Study||5
7889263|NCT00765362|19416292|P1|NOT COMPLETED|Overall Study||137
7889264|NCT00765362|19416292|P1|COMPLETED|Overall Study||282
7889265|NCT00765362|19416292|P1|STARTED|Overall Study||419
7889266|NCT00765336|19416300|P2|NOT COMPLETED|Overall Study||16
7889267|NCT00765336|19416301|P1|NOT COMPLETED|Overall Study||19
7889268|NCT00765336|19416300|P2|COMPLETED|Overall Study||73
7889269|NCT00765336|19416301|P1|COMPLETED|Overall Study||72
7889270|NCT00765336|19416300|P2|STARTED|Overall Study||89
7889271|NCT00765336|19416301|P1|STARTED|Overall Study||91
7889272|NCT00765245|19416309|P2|NOT COMPLETED|Overall Study||2
7889273|NCT00765245|19416310|P1|NOT COMPLETED|Overall Study||13
7889274|NCT00765245|19416309|P2|COMPLETED|Overall Study||20
7889275|NCT00765245|19416310|P1|COMPLETED|Overall Study||9
7889276|NCT00765245|19416309|P2|STARTED|Overall Study||22
7889277|NCT00765245|19416310|P1|STARTED|Overall Study||22
7889278|NCT00765232|19416322|P2|NOT COMPLETED|Overall Study||0
7889279|NCT00765232|19416323|P1|NOT COMPLETED|Overall Study||0
7889280|NCT00765232|19416322|P2|COMPLETED|Overall Study||54
7889281|NCT00765232|19416323|P1|COMPLETED|Overall Study||57
7889282|NCT00765232|19416322|P2|STARTED|Overall Study||54
7889283|NCT00765232|19416323|P1|STARTED|Overall Study||57
7889284|NCT00765206|19416331|P4|NOT COMPLETED|Second Intervention||0
7889285|NCT00765206|19416332|P3|NOT COMPLETED|Second Intervention||0
7889286|NCT00765206|19416333|P2|NOT COMPLETED|Second Intervention||0
7889287|NCT00765206|19416334|P1|NOT COMPLETED|Second Intervention||0
7889288|NCT00765206|19416331|P4|COMPLETED|Second Intervention||15
7889289|NCT00765206|19416332|P3|COMPLETED|Second Intervention||15
7889290|NCT00765206|19416333|P2|COMPLETED|Second Intervention||15
7889291|NCT00765206|19416334|P1|COMPLETED|Second Intervention||15
7889292|NCT00765206|19416331|P4|STARTED|Second Intervention||15
7889293|NCT00765206|19416332|P3|STARTED|Second Intervention||15
7889294|NCT00765206|19416333|P2|STARTED|Second Intervention||15
7889295|NCT00765206|19416334|P1|STARTED|Second Intervention||15
7889296|NCT00765206|19416331|P4|NOT COMPLETED|Washout Period of 14 Days||0
7889297|NCT00765206|19416332|P3|NOT COMPLETED|Washout Period of 14 Days||0
7889298|NCT00765206|19416333|P2|NOT COMPLETED|Washout Period of 14 Days||0
7889299|NCT00765206|19416334|P1|NOT COMPLETED|Washout Period of 14 Days||0
7889300|NCT00765206|19416331|P4|COMPLETED|Washout Period of 14 Days||15
7889301|NCT00765206|19416332|P3|COMPLETED|Washout Period of 14 Days||15
7889302|NCT00765206|19416333|P2|COMPLETED|Washout Period of 14 Days||15
7889303|NCT00765206|19416334|P1|COMPLETED|Washout Period of 14 Days||15
7889304|NCT00765206|19416331|P4|STARTED|Washout Period of 14 Days||15
7889305|NCT00765206|19416332|P3|STARTED|Washout Period of 14 Days||15
7889306|NCT00765206|19416333|P2|STARTED|Washout Period of 14 Days||15
7889307|NCT00765206|19416334|P1|STARTED|Washout Period of 14 Days||15
7889308|NCT00765206|19416331|P4|NOT COMPLETED|First Intervention||0
7889309|NCT00765206|19416332|P3|NOT COMPLETED|First Intervention||0
7889310|NCT00765206|19416333|P2|NOT COMPLETED|First Intervention||0
7889311|NCT00765206|19416334|P1|NOT COMPLETED|First Intervention||0
7889312|NCT00765206|19416331|P4|COMPLETED|First Intervention||15
7889313|NCT00765206|19416332|P3|COMPLETED|First Intervention||15
7889314|NCT00765206|19416333|P2|COMPLETED|First Intervention||15
7889315|NCT00765206|19416334|P1|COMPLETED|First Intervention||15
7889316|NCT00765206|19416331|P4|STARTED|First Intervention||15
7889317|NCT00765206|19416332|P3|STARTED|First Intervention||15
7889318|NCT00765206|19416333|P2|STARTED|First Intervention||15
7889319|NCT00765206|19416334|P1|STARTED|First Intervention||15
7889320|NCT00765193|19416340|P1|NOT COMPLETED|Full Body Examination||0
7889321|NCT00765193|19416340|P1|COMPLETED|Full Body Examination||14381
7889322|NCT00765193|19416340|P1|STARTED|Full Body Examination||14381
7889323|NCT00765193|19416340|P1|NOT COMPLETED|Problem Area Examination||0
7889324|NCT00765193|19416340|P1|COMPLETED|Problem Area Examination||14381
7889325|NCT00765193|19416340|P1|STARTED|Problem Area Examination||14381
7889326|NCT00765128|19416347|P2|NOT COMPLETED|Overall Study||0
7889327|NCT00765128|19416348|P1|NOT COMPLETED|Overall Study||0
7889328|NCT00765128|19416347|P2|COMPLETED|Overall Study||9
7889329|NCT00765128|19416348|P1|COMPLETED|Overall Study||8
7889330|NCT00765128|19416347|P2|STARTED|Overall Study||9
7889331|NCT00765128|19416348|P1|STARTED|Overall Study||8
7889332|NCT00765102|19416356|P1|NOT COMPLETED|Overall Study||31
7889333|NCT00765102|19416356|P1|COMPLETED|Overall Study|Completed 8 cycles of treatment|1
7889334|NCT00765102|19416356|P1|STARTED|Overall Study||32
7889335|NCT00765076|19416381|P3|NOT COMPLETED|Overall Study||1
7889336|NCT00765076|19416382|P2|NOT COMPLETED|Overall Study||0
7889337|NCT00765076|19416383|P1|NOT COMPLETED|Overall Study||1
7889338|NCT00765076|19416381|P3|COMPLETED|Overall Study||49
7889339|NCT00765076|19416382|P2|COMPLETED|Overall Study||73
7889340|NCT00765076|19416383|P1|COMPLETED|Overall Study||68
7889341|NCT00765076|19416381|P3|STARTED|Overall Study||50
7889342|NCT00765076|19416382|P2|STARTED|Overall Study||73
7889343|NCT00765076|19416383|P1|STARTED|Overall Study||69
7889344|NCT00765063|19416436|P1|NOT COMPLETED|Overall Study||32
7889345|NCT00765063|19416436|P1|COMPLETED|Overall Study||30
7889346|NCT00765063|19416436|P1|STARTED|Overall Study||62
7889347|NCT00765037|19416452|P1|NOT COMPLETED|Overall Study||6
7889348|NCT00765037|19416452|P1|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13
7889349|NCT00765037|19416452|P1|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19
7889350|NCT00764946|19416459|P3|NOT COMPLETED|Overall Study||4
7889351|NCT00764946|19416460|P2|NOT COMPLETED|Overall Study||17
7889352|NCT00764946|19416461|P1|NOT COMPLETED|Overall Study||13
7889353|NCT00764946|19416459|P3|COMPLETED|Overall Study||18
7889354|NCT00764946|19416460|P2|COMPLETED|Overall Study||72
7889355|NCT00764946|19416461|P1|COMPLETED|Overall Study||85
7889356|NCT00764946|19416459|P3|TREATED|Overall Study||21
7889357|NCT00764946|19416460|P2|TREATED|Overall Study||88
7889358|NCT00764946|19416461|P1|TREATED|Overall Study||97
7889359|NCT00764946|19416459|P3|STARTED|Overall Study||22
7889360|NCT00764946|19416460|P2|STARTED|Overall Study||89
7889361|NCT00764946|19416461|P1|STARTED|Overall Study||98
7889362|NCT00764881|19416489|P2|NOT COMPLETED|Overall Study||10
7889363|NCT00764881|19416490|P1|NOT COMPLETED|Overall Study||16
7889364|NCT00764881|19416489|P2|COMPLETED|Overall Study||99
7889365|NCT00764881|19416490|P1|COMPLETED|Overall Study||92
7889366|NCT00764881|19416489|P2|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107
7889367|NCT00764881|19416490|P1|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106
7889368|NCT00764881|19416489|P2|STARTED|Overall Study||109
7889369|NCT00764881|19416490|P1|STARTED|Overall Study||108
7889370|NCT00764868|19416714|P1|NOT COMPLETED|Overall Study||113
7889371|NCT00764868|19416714|P1|COMPLETED|Overall Study||156
7889372|NCT00764868|19416714|P1|STARTED|Overall Study||269
7889373|NCT00764790|19416723|P3|NOT COMPLETED|Overall Study||30
7889374|NCT00764790|19416724|P2|NOT COMPLETED|Overall Study||41
7889375|NCT00764790|19416725|P1|NOT COMPLETED|Overall Study||38
7889376|NCT00764790|19416723|P3|COMPLETED|Overall Study||1074
7889377|NCT00764790|19416724|P2|COMPLETED|Overall Study||1065
7889378|NCT00764790|19416725|P1|COMPLETED|Overall Study||1069
7889379|NCT00764790|19416723|P3|STARTED|Overall Study||1104
7889380|NCT00764790|19416724|P2|STARTED|Overall Study||1106
7889381|NCT00764790|19416725|P1|STARTED|Overall Study||1107
7889382|NCT00764751|19416759|P2|NOT COMPLETED|Overall Study||1
7889383|NCT00764751|19416760|P1|NOT COMPLETED|Overall Study||2
7889384|NCT00764751|19416759|P2|COMPLETED|Overall Study||11
7889385|NCT00764751|19416760|P1|COMPLETED|Overall Study||37
7889386|NCT00764751|19416759|P2|STARTED|Overall Study||12
7889387|NCT00764751|19416760|P1|STARTED|Overall Study||39
7889388|NCT00764738|19416798|P4|NOT COMPLETED|Overall Study||6
7889389|NCT00764738|19416799|P3|NOT COMPLETED|Overall Study||3
7889390|NCT00764738|19416800|P2|NOT COMPLETED|Overall Study||3
7889391|NCT00764738|19416801|P1|NOT COMPLETED|Overall Study||2
7889392|NCT00764738|19416798|P4|COMPLETED|Overall Study||18
7889393|NCT00764738|19416799|P3|COMPLETED|Overall Study||12
7889394|NCT00764738|19416800|P2|COMPLETED|Overall Study||25
7889395|NCT00764738|19416801|P1|COMPLETED|Overall Study||22
7889396|NCT00764738|19416798|P4|STARTED|Overall Study||24
7889397|NCT00764738|19416799|P3|STARTED|Overall Study||15
7889398|NCT00764738|19416800|P2|STARTED|Overall Study||28
7889399|NCT00764738|19416801|P1|STARTED|Overall Study||24
7889400|NCT00764699|19416823|P1|NOT COMPLETED|Overall Study||3
7889401|NCT00764699|19416823|P1|COMPLETED|Overall Study||0
7889402|NCT00764699|19416823|P1|STARTED|Overall Study||3
7889403|NCT00764673|19416827|P1|NOT COMPLETED|Overall Study||12
7889404|NCT00764673|19416827|P1|COMPLETED|Overall Study||59
7889405|NCT00764673|19416827|P1|STARTED|Overall Study||71
7889406|NCT00764660|19416837|P2|NOT COMPLETED|Overall Study||11
7889407|NCT00764660|19416838|P1|NOT COMPLETED|Overall Study||22
7889408|NCT00764660|19416837|P2|COMPLETED|Overall Study||55
7889409|NCT00764660|19416838|P1|COMPLETED|Overall Study||53
7889410|NCT00764660|19416837|P2|STARTED|Overall Study||66
7889411|NCT00764660|19416838|P1|STARTED|Overall Study||75
7889412|NCT00764517|19416872|P2|NOT COMPLETED|Overall Study||14
7889413|NCT00764517|19416873|P1|NOT COMPLETED|Overall Study||15
7889414|NCT00764517|19416872|P2|COMPLETED|Overall Study||4
7889415|NCT00764517|19416873|P1|COMPLETED|Overall Study||24
7889416|NCT00764517|19416872|P2|STARTED|Overall Study||18
7889417|NCT00764517|19416873|P1|STARTED|Overall Study||39
7889418|NCT00764504|19416894|P3|NOT COMPLETED|Overall Study||103
7889419|NCT00764504|19416895|P2|NOT COMPLETED|Overall Study||70
7889420|NCT00764504|19416896|P1|NOT COMPLETED|Overall Study||66
7889421|NCT00764504|19416894|P3|COMPLETED|Overall Study||131
7889422|NCT00764504|19416895|P2|COMPLETED|Overall Study||71
7889423|NCT00764504|19416896|P1|COMPLETED|Overall Study||75
7889424|NCT00764504|19416894|P3|STARTED|Overall Study||234
7889425|NCT00764504|19416895|P2|STARTED|Overall Study||141
7889426|NCT00764504|19416896|P1|STARTED|Overall Study||141
7889427|NCT00764478|19416925|P3|NOT COMPLETED|Overall Study||8
7889428|NCT00764478|19416926|P2|NOT COMPLETED|Overall Study||22
7889429|NCT00764478|19416927|P1|NOT COMPLETED|Overall Study||15
7889430|NCT00764478|19416925|P3|COMPLETED|Overall Study||118
7889431|NCT00764478|19416926|P2|COMPLETED|Overall Study||97
7889432|NCT00764478|19416927|P1|COMPLETED|Overall Study||107
7889433|NCT00764478|19416925|P3|STARTED|Overall Study||126
7889434|NCT00764478|19416926|P2|STARTED|Overall Study||119
7889435|NCT00764478|19416927|P1|STARTED|Overall Study||122
7889436|NCT00764465|19417007|P6|NOT COMPLETED|Overall Study||1
7889437|NCT00764465|19417008|P5|NOT COMPLETED|Overall Study||1
7889438|NCT00764465|19417009|P4|NOT COMPLETED|Overall Study||1
7889439|NCT00764465|19417010|P3|NOT COMPLETED|Overall Study||1
7889440|NCT00764465|19417011|P2|NOT COMPLETED|Overall Study||1
7889441|NCT00764465|19417012|P1|NOT COMPLETED|Overall Study||2
7889442|NCT00764465|19417007|P6|COMPLETED|Overall Study||7
7889443|NCT00764465|19417008|P5|COMPLETED|Overall Study||6
7889444|NCT00764465|19417009|P4|COMPLETED|Overall Study||6
7889445|NCT00764465|19417010|P3|COMPLETED|Overall Study||6
7889446|NCT00764465|19417011|P2|COMPLETED|Overall Study||6
7889447|NCT00764465|19417012|P1|COMPLETED|Overall Study||7
7889448|NCT00764465|19417007|P6|STARTED|Overall Study||8
7889449|NCT00764465|19417008|P5|STARTED|Overall Study||7
7889450|NCT00764465|19417009|P4|STARTED|Overall Study||7
7889451|NCT00764465|19417010|P3|STARTED|Overall Study||7
7889452|NCT00764465|19417011|P2|STARTED|Overall Study||7
7889453|NCT00764465|19417012|P1|STARTED|Overall Study||9
7889454|NCT00764361|19417040|P2|NOT COMPLETED|Overall Study||4
7889455|NCT00764361|19417041|P1|NOT COMPLETED|Overall Study||2
7889456|NCT00764361|19417040|P2|COMPLETED|Overall Study||3
7889457|NCT00764361|19417041|P1|COMPLETED|Overall Study||6
7889458|NCT00764361|19417040|P2|STARTED|Overall Study||7
7889459|NCT00764361|19417041|P1|STARTED|Overall Study||8
7889460|NCT00764322|19417049|P1|NOT COMPLETED|Overall Study||20
7889461|NCT00764322|19417049|P1|COMPLETED|Overall Study||480
7889462|NCT00764322|19417049|P1|STARTED|Overall Study||500
7889463|NCT00764309|19417066|P1|NOT COMPLETED|Overall Study||0
7889464|NCT00764309|19417066|P1|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31
7889465|NCT00764309|19417066|P1|STARTED|Overall Study|Number of participants treated.|31
7889466|NCT00763971|19417076|P3|NOT COMPLETED|Overall Study||69
7889467|NCT00763971|19417077|P2|NOT COMPLETED|Overall Study||38
7889468|NCT00763971|19417078|P1|NOT COMPLETED|Overall Study||33
7889469|NCT00763971|19417076|P3|COMPLETED|Overall Study||42
7889470|NCT00763971|19417077|P2|COMPLETED|Overall Study||74
7889471|NCT00763971|19417078|P1|COMPLETED|Overall Study||80
7889472|NCT00763971|19417076|P3|STARTED|Overall Study||111
7889473|NCT00763971|19417077|P2|STARTED|Overall Study||112
7889474|NCT00763971|19417078|P1|STARTED|Overall Study||113
7889475|NCT00763958|19417109|P2|NOT COMPLETED|Overall Study||11
7889476|NCT00763958|19417110|P1|NOT COMPLETED|Overall Study||14
7889477|NCT00763958|19417109|P2|COMPLETED|Overall Study||5
7889478|NCT00763958|19417110|P1|COMPLETED|Overall Study||14
7889479|NCT00763958|19417109|P2|STARTED|Overall Study||16
7889480|NCT00763958|19417110|P1|STARTED|Overall Study||28
7889481|NCT00763919|19417120|P1|NOT COMPLETED|Overall Study||13
7889482|NCT00763919|19417120|P1|COMPLETED|Overall Study||30
7889483|NCT00763919|19417120|P1|STARTED|Overall Study||43
7889484|NCT00763867|19417148|P2|NOT COMPLETED|Overall Study||12
7889485|NCT00763867|19417149|P1|NOT COMPLETED|Overall Study||5
7889486|NCT00763867|19417148|P2|COMPLETED|Overall Study||101
7889487|NCT00763867|19417149|P1|COMPLETED|Overall Study||98
7889488|NCT00763867|19417148|P2|STARTED|Overall Study||113
7889489|NCT00763867|19417149|P1|STARTED|Overall Study||103
7889490|NCT00763815|19417245|P2|NOT COMPLETED|Overall Study||84
7889491|NCT00763815|19417246|P1|NOT COMPLETED|Overall Study||52
7889492|NCT00763815|19417245|P2|COMPLETED|Overall Study||239
7889493|NCT00763815|19417246|P1|COMPLETED|Overall Study||109
7889494|NCT00763815|19417245|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||320
7889495|NCT00763815|19417246|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159
7889496|NCT00763815|19417245|P2|Treated/Safety Population|Overall Study||323
7889497|NCT00763815|19417246|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161
7889498|NCT00763815|19417245|P2|STARTED|Overall Study||323
7889499|NCT00763815|19417246|P1|STARTED|Overall Study|Randomized.|161
7889500|NCT00763750|19417270|P1|NOT COMPLETED|Overall Study||0
7889501|NCT00763750|19417270|P1|COMPLETED|Overall Study||25
7889502|NCT00763750|19417270|P1|STARTED|Overall Study||25
7889503|NCT00763698|19417274|P1|NOT COMPLETED|Overall Study||10
7889504|NCT00763698|19417274|P1|COMPLETED|Overall Study||76
7889505|NCT00763698|19417274|P1|STARTED|Overall Study||86
7889506|NCT00763490|19417280|P1|NOT COMPLETED|Overall Study||0
7889507|NCT00763490|19417280|P1|COMPLETED|Overall Study||20
7889508|NCT00763490|19417280|P1|STARTED|Overall Study||20
7889509|NCT00763451|19417291|P4|NOT COMPLETED|Overall Study||30
7889510|NCT00763451|19417292|P3|NOT COMPLETED|Overall Study||40
7889511|NCT00763451|19417293|P2|NOT COMPLETED|Overall Study||22
7889512|NCT00763451|19417294|P1|NOT COMPLETED|Overall Study||13
7889513|NCT00763451|19417291|P4|COMPLETED|Overall Study||131
7889514|NCT00763451|19417292|P3|COMPLETED|Overall Study||121
7889515|NCT00763451|19417293|P2|COMPLETED|Overall Study||60
7889516|NCT00763451|19417294|P1|COMPLETED|Overall Study||67
7889517|NCT00763451|19417291|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||160
7889518|NCT00763451|19417292|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||160
7889519|NCT00763451|19417293|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||80
7889520|NCT00763451|19417294|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79
7889521|NCT00763451|19417291|P4|Treated/Safety Population|Overall Study||161
7889522|NCT00763451|19417292|P3|Treated/Safety Population|Overall Study||161
7889523|NCT00763451|19417293|P2|Treated/Safety Population|Overall Study||81
7889524|NCT00763451|19417294|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79
7889525|NCT00763451|19417291|P4|STARTED|Overall Study||161
7889526|NCT00763451|19417292|P3|STARTED|Overall Study||161
7889527|NCT00763451|19417293|P2|STARTED|Overall Study||82
7889528|NCT00763451|19417294|P1|STARTED|Overall Study|Randomized.|80
7889529|NCT00763412|19417328|P2|NOT COMPLETED|Overall Study||4
7889530|NCT00763412|19417329|P1|NOT COMPLETED|Overall Study||4
7889531|NCT00763412|19417328|P2|COMPLETED|Overall Study||4
7889532|NCT00763412|19417329|P1|COMPLETED|Overall Study||4
7889533|NCT00763412|19417328|P2|STARTED|Overall Study||8
7889534|NCT00763412|19417329|P1|STARTED|Overall Study||8
7889535|NCT00763386|19417353|P2|NOT COMPLETED|Overall Study||40
7889536|NCT00763386|19417354|P1|NOT COMPLETED|Overall Study||48
7889537|NCT00763386|19417353|P2|COMPLETED|Overall Study||127
7889538|NCT00763386|19417354|P1|COMPLETED|Overall Study||116
7889539|NCT00763386|19417353|P2|STARTED|Overall Study||167
7889540|NCT00763386|19417354|P1|STARTED|Overall Study||164
7889541|NCT00763360|19417365|P3|NOT COMPLETED|Overall Study||0
7889542|NCT00763360|19417366|P2|NOT COMPLETED|Overall Study||2
7889543|NCT00763360|19417367|P1|NOT COMPLETED|Overall Study||0
7889544|NCT00763360|19417365|P3|COMPLETED|Overall Study||63
7889545|NCT00763360|19417366|P2|COMPLETED|Overall Study||58
7889546|NCT00763360|19417367|P1|COMPLETED|Overall Study||61
7889547|NCT00763360|19417365|P3|STARTED|Overall Study||63
7889548|NCT00763360|19417366|P2|STARTED|Overall Study||60
7889549|NCT00763360|19417367|P1|STARTED|Overall Study||61
7889550|NCT00763321|19417387|P3|NOT COMPLETED|Double-blind Period||29
7889551|NCT00763321|19417388|P2|NOT COMPLETED|Double-blind Period||21
7889552|NCT00763321|19417389|P1|NOT COMPLETED|Double-blind Period||0
7889553|NCT00763321|19417387|P3|COMPLETED|Double-blind Period||84
7889554|NCT00763321|19417388|P2|COMPLETED|Double-blind Period||88
7889555|NCT00763321|19417389|P1|COMPLETED|Double-blind Period||0
7889556|NCT00763321|19417387|P3|STARTED|Double-blind Period||113
7889557|NCT00763321|19417388|P2|STARTED|Double-blind Period||109
7889558|NCT00763321|19417389|P1|STARTED|Double-blind Period||0
7889559|NCT00763321|19417387|P3|NOT COMPLETED|Open-label Period||0
7889560|NCT00763321|19417388|P2|NOT COMPLETED|Open-label Period||0
7889561|NCT00763321|19417389|P1|NOT COMPLETED|Open-label Period||63
7889562|NCT00763321|19417387|P3|COMPLETED|Open-label Period||0
7889563|NCT00763321|19417388|P2|COMPLETED|Open-label Period||0
7889564|NCT00763321|19417389|P1|COMPLETED|Open-label Period||222
7889565|NCT00763321|19417387|P3|STARTED|Open-label Period||0
7889566|NCT00763321|19417388|P2|STARTED|Open-label Period||0
7889567|NCT00763321|19417389|P1|STARTED|Open-label Period||285
7889568|NCT00763282|19417400|P2|NOT COMPLETED|Overall Study||34
7889569|NCT00763282|19417401|P1|NOT COMPLETED|Overall Study||32
7889570|NCT00763282|19417400|P2|COMPLETED|Overall Study||38
7889571|NCT00763282|19417401|P1|COMPLETED|Overall Study||40
7889572|NCT00763282|19417400|P2|STARTED|Overall Study||72
7889573|NCT00763282|19417401|P1|STARTED|Overall Study||72
7889574|NCT00763269|19417417|P2|NOT COMPLETED|Overall Study||13
7889575|NCT00763269|19417418|P1|NOT COMPLETED|Overall Study||12
7889576|NCT00763269|19417417|P2|COMPLETED|Overall Study||299
7889577|NCT00763269|19417418|P1|COMPLETED|Overall Study||302
7889578|NCT00763269|19417417|P2|STARTED|Overall Study||312
7889579|NCT00763269|19417418|P1|STARTED|Overall Study||314
7889580|NCT00763256|19417432|P2|NOT COMPLETED|Overall Study||10
7889581|NCT00763256|19417433|P1|NOT COMPLETED|Overall Study||7
7889582|NCT00763256|19417432|P2|COMPLETED|Overall Study||8
7889583|NCT00763256|19417433|P1|COMPLETED|Overall Study||8
7889584|NCT00763256|19417432|P2|STARTED|Overall Study||18
7889585|NCT00763256|19417433|P1|STARTED|Overall Study||15
7889586|NCT00763243|19417447|P1|NOT COMPLETED|6-Month Follow-Up Period||0
7889587|NCT00763243|19417447|P1|COMPLETED|6-Month Follow-Up Period||9
7889588|NCT00763243|19417447|P1|STARTED|6-Month Follow-Up Period||9
7889589|NCT00763243|19417447|P1|NOT COMPLETED|1-Month Follow-Up Period||0
7889590|NCT00763243|19417447|P1|COMPLETED|1-Month Follow-Up Period||9
7889591|NCT00763243|19417447|P1|STARTED|1-Month Follow-Up Period||9
7889592|NCT00763243|19417447|P1|NOT COMPLETED|Training Period||0
7889593|NCT00763243|19417447|P1|COMPLETED|Training Period||9
7889594|NCT00763243|19417447|P1|STARTED|Training Period||9
7889595|NCT00763243|19417447|P1|NOT COMPLETED|Waiting Period||0
7889596|NCT00763243|19417447|P1|COMPLETED|Waiting Period||9
7889597|NCT00763243|19417447|P1|STARTED|Waiting Period||9
7889598|NCT00763139|19417469|P2|NOT COMPLETED|Overall Study||3
7889599|NCT00763139|19417470|P1|NOT COMPLETED|Overall Study||5
7889600|NCT00763139|19417469|P2|COMPLETED|Overall Study||14
7889601|NCT00763139|19417470|P1|COMPLETED|Overall Study||12
7889602|NCT00763139|19417469|P2|STARTED|Overall Study||17
7889603|NCT00763139|19417470|P1|STARTED|Overall Study||17
7889604|NCT00763061|19417492|P2|NOT COMPLETED|Overall Study||13
7889605|NCT00763061|19417493|P1|NOT COMPLETED|Overall Study||5
7889606|NCT00763061|19417492|P2|COMPLETED|Overall Study||44
7889607|NCT00763061|19417493|P1|COMPLETED|Overall Study||49
7889608|NCT00763061|19417492|P2|STARTED|Overall Study||57
7889609|NCT00763061|19417493|P1|STARTED|Overall Study||54
7889610|NCT00763048|19417507|P2|NOT COMPLETED|Overall Study||0
7889611|NCT00763048|19417508|P1|NOT COMPLETED|Overall Study||0
7889612|NCT00763048|19417507|P2|COMPLETED|Overall Study||18
7889613|NCT00763048|19417508|P1|COMPLETED|Overall Study||21
7889614|NCT00763048|19417507|P2|STARTED|Overall Study||18
7889615|NCT00763048|19417508|P1|STARTED|Overall Study||21
7889616|NCT00763035|19417532|P2|NOT COMPLETED|Second Intervention||0
7889617|NCT00763035|19417533|P1|NOT COMPLETED|Second Intervention||3
7889618|NCT00763035|19417532|P2|COMPLETED|Second Intervention||3
7889619|NCT00763035|19417533|P1|COMPLETED|Second Intervention||6
7889620|NCT00763035|19417532|P2|STARTED|Second Intervention||3
7889621|NCT00763035|19417533|P1|STARTED|Second Intervention||9
7889622|NCT00763035|19417532|P2|NOT COMPLETED|First Intervention||1
7889623|NCT00763035|19417533|P1|NOT COMPLETED|First Intervention||1
7889624|NCT00763035|19417532|P2|COMPLETED|First Intervention||3
7889625|NCT00763035|19417533|P1|COMPLETED|First Intervention||9
7889626|NCT00763035|19417532|P2|STARTED|First Intervention||4
7889627|NCT00763035|19417533|P1|STARTED|First Intervention||10
7889628|NCT00763009|19417551|P1|NOT COMPLETED|Overall Study||1
7889629|NCT00763009|19417551|P1|COMPLETED|Overall Study||7
7889630|NCT00763009|19417551|P1|STARTED|Overall Study||8
7889631|NCT00762996|19417556|P4|NOT COMPLETED|Period Two||0
7889632|NCT00762996|19417557|P3|NOT COMPLETED|Period Two||0
7889633|NCT00762996|19417558|P2|NOT COMPLETED|Period Two||0
7889634|NCT00762996|19417559|P1|NOT COMPLETED|Period Two||0
7889635|NCT00762996|19417556|P4|COMPLETED|Period Two||16
7889636|NCT00762996|19417557|P3|COMPLETED|Period Two||13
7889637|NCT00762996|19417558|P2|COMPLETED|Period Two||16
7889638|NCT00762996|19417559|P1|COMPLETED|Period Two||15
7889639|NCT00762996|19417556|P4|STARTED|Period Two||16
7889640|NCT00762996|19417557|P3|STARTED|Period Two||13
7889641|NCT00762996|19417558|P2|STARTED|Period Two||16
7889642|NCT00762996|19417559|P1|STARTED|Period Two||15
7889643|NCT00762996|19417556|P4|NOT COMPLETED|Period One||1
7889644|NCT00762996|19417557|P3|NOT COMPLETED|Period One||4
7889645|NCT00762996|19417558|P2|NOT COMPLETED|Period One||0
7889646|NCT00762996|19417559|P1|NOT COMPLETED|Period One||0
7889647|NCT00762996|19417556|P4|COMPLETED|Period One||16
7889648|NCT00762996|19417557|P3|COMPLETED|Period One||13
7889649|NCT00762996|19417558|P2|COMPLETED|Period One||16
7889650|NCT00762996|19417559|P1|COMPLETED|Period One||15
7889651|NCT00762996|19417556|P4|STARTED|Period One||17
7889652|NCT00762996|19417557|P3|STARTED|Period One||17
7889653|NCT00762996|19417558|P2|STARTED|Period One||16
7889654|NCT00762996|19417559|P1|STARTED|Period One||15
7889655|NCT00762970|19417572|P3|NOT COMPLETED|Overall Study||1
7889656|NCT00762970|19417573|P2|NOT COMPLETED|Overall Study||9
7889657|NCT00762970|19417574|P1|NOT COMPLETED|Overall Study||12
7889658|NCT00762970|19417572|P3|COMPLETED|Overall Study||46
7889659|NCT00762970|19417573|P2|COMPLETED|Overall Study||35
7889660|NCT00762970|19417574|P1|COMPLETED|Overall Study||34
7889661|NCT00762970|19417572|P3|STARTED|Overall Study||47
7889662|NCT00762970|19417573|P2|STARTED|Overall Study||44
7889663|NCT00762970|19417574|P1|STARTED|Overall Study||46
7889664|NCT00762931|19417585|P1|NOT COMPLETED|Overall Study||2
7889665|NCT00762931|19417585|P1|COMPLETED|Overall Study||23
7889666|NCT00762931|19417585|P1|STARTED|Overall Study||25
7889667|NCT00762892|19417592|P2|NOT COMPLETED|Overall Study||6
7889668|NCT00762892|19417593|P1|NOT COMPLETED|Overall Study||5
7889669|NCT00762892|19417592|P2|COMPLETED|Overall Study||8
7889670|NCT00762892|19417593|P1|COMPLETED|Overall Study||9
7889671|NCT00762892|19417592|P2|STARTED|Overall Study||14
7889672|NCT00762892|19417593|P1|STARTED|Overall Study||14
7889673|NCT00762853|19417609|P2|NOT COMPLETED|Second Treatment Period||0
7889674|NCT00762853|19417610|P1|NOT COMPLETED|Second Treatment Period||0
7889675|NCT00762853|19417609|P2|COMPLETED|Second Treatment Period||10
7889676|NCT00762853|19417610|P1|COMPLETED|Second Treatment Period||10
7889677|NCT00762853|19417609|P2|STARTED|Second Treatment Period||10
7889678|NCT00762853|19417610|P1|STARTED|Second Treatment Period||10
7889679|NCT00762853|19417609|P2|NOT COMPLETED|1 Week Washout After Treatment 1||0
7889680|NCT00762853|19417610|P1|NOT COMPLETED|1 Week Washout After Treatment 1||0
7889681|NCT00762853|19417609|P2|COMPLETED|1 Week Washout After Treatment 1||10
7889682|NCT00762853|19417610|P1|COMPLETED|1 Week Washout After Treatment 1||10
7889683|NCT00762853|19417609|P2|STARTED|1 Week Washout After Treatment 1||10
7889684|NCT00762853|19417610|P1|STARTED|1 Week Washout After Treatment 1||10
7889685|NCT00762853|19417609|P2|NOT COMPLETED|First Treatment Period||0
7889686|NCT00762853|19417610|P1|NOT COMPLETED|First Treatment Period||0
7889687|NCT00762853|19417609|P2|COMPLETED|First Treatment Period||10
7889688|NCT00762853|19417610|P1|COMPLETED|First Treatment Period||10
7889689|NCT00762853|19417609|P2|STARTED|First Treatment Period||10
7889690|NCT00762853|19417610|P1|STARTED|First Treatment Period||10
7889691|NCT00762788|19417622|P6|NOT COMPLETED|Overall Study||21
7889692|NCT00762788|19417623|P5|NOT COMPLETED|Overall Study||13
7889693|NCT00762788|19417624|P4|NOT COMPLETED|Overall Study||26
7889694|NCT00762788|19417625|P3|NOT COMPLETED|Overall Study||21
7889695|NCT00762788|19417626|P2|NOT COMPLETED|Overall Study||37
7889696|NCT00762788|19417627|P1|NOT COMPLETED|Overall Study||26
7889697|NCT00762788|19417622|P6|COMPLETED|Overall Study||31
7889698|NCT00762788|19417623|P5|COMPLETED|Overall Study||30
7889699|NCT00762788|19417624|P4|COMPLETED|Overall Study||38
7889700|NCT00762788|19417625|P3|COMPLETED|Overall Study||21
7889701|NCT00762788|19417626|P2|COMPLETED|Overall Study||21
7889702|NCT00762788|19417627|P1|COMPLETED|Overall Study||29
7889703|NCT00762788|19417622|P6|STARTED|Overall Study||52
7889704|NCT00762788|19417623|P5|STARTED|Overall Study||43
7889705|NCT00762788|19417624|P4|STARTED|Overall Study||64
7889706|NCT00762788|19417625|P3|STARTED|Overall Study||42
7889707|NCT00762788|19417626|P2|STARTED|Overall Study||58
7889708|NCT00762788|19417627|P1|STARTED|Overall Study||55
7889709|NCT00762762|19417649|P2|NOT COMPLETED|Overall Study||10
7889710|NCT00762762|19417650|P1|NOT COMPLETED|Overall Study||8
7889711|NCT00762762|19417649|P2|COMPLETED|Overall Study||20
7889712|NCT00762762|19417650|P1|COMPLETED|Overall Study||22
7889713|NCT00762762|19417649|P2|STARTED|Overall Study||30
7889714|NCT00762762|19417650|P1|STARTED|Overall Study||30
7889715|NCT00762723|19417667|P3|NOT COMPLETED|Overall Study||3
7889716|NCT00762723|19417668|P2|NOT COMPLETED|Overall Study||5
7889717|NCT00762723|19417669|P1|NOT COMPLETED|Overall Study||5
7889718|NCT00762723|19417667|P3|COMPLETED|Overall Study||0
7889719|NCT00762723|19417668|P2|COMPLETED|Overall Study||6
7889720|NCT00762723|19417669|P1|COMPLETED|Overall Study||0
7889721|NCT00762723|19417667|P3|STARTED|Overall Study||3
7889722|NCT00762723|19417668|P2|STARTED|Overall Study||11
7889723|NCT00762723|19417669|P1|STARTED|Overall Study||5
7889724|NCT00762710|19417679|P2|NOT COMPLETED|Overall Study||15
7889725|NCT00762710|19417680|P1|NOT COMPLETED|Overall Study||21
7889726|NCT00762710|19417679|P2|COMPLETED|Overall Study||29
7889727|NCT00762710|19417680|P1|COMPLETED|Overall Study||27
7889728|NCT00762710|19417679|P2|STARTED|Overall Study||44
7889729|NCT00762710|19417680|P1|STARTED|Overall Study||48
7889730|NCT00762645|19417688|P2|NOT COMPLETED|Overall Study||2
7889731|NCT00762645|19417689|P1|NOT COMPLETED|Overall Study||4
7889732|NCT00762645|19417688|P2|COMPLETED|Overall Study||12
7889733|NCT00762645|19417689|P1|COMPLETED|Overall Study||12
7889734|NCT00762645|19417688|P2|STARTED|Overall Study||14
7889735|NCT00762645|19417689|P1|STARTED|Overall Study||16
7889736|NCT00762619|19417699|P2|NOT COMPLETED|Overall Study||0
7889737|NCT00762619|19417700|P1|NOT COMPLETED|Overall Study||0
7889738|NCT00762619|19417699|P2|COMPLETED|Overall Study||50
7889739|NCT00762619|19417700|P1|COMPLETED|Overall Study||55
7889740|NCT00762619|19417699|P2|STARTED|Overall Study||50
7889741|NCT00762619|19417700|P1|STARTED|Overall Study||55
7889742|NCT00762606|19417842|P2|NOT COMPLETED|Overall Study||13
7889743|NCT00762606|19417843|P1|NOT COMPLETED|Overall Study||18
7889744|NCT00762606|19417842|P2|COMPLETED|Overall Study||38
7889745|NCT00762606|19417843|P1|COMPLETED|Overall Study||37
7889746|NCT00762606|19417842|P2|STARTED|Overall Study||51
7889747|NCT00762606|19417843|P1|STARTED|Overall Study||55
7889748|NCT00762528|19417853|P2|NOT COMPLETED|Overall Study||0
7889749|NCT00762528|19417854|P1|NOT COMPLETED|Overall Study||0
7889750|NCT00762528|19417853|P2|COMPLETED|Overall Study||25
7889751|NCT00762528|19417854|P1|COMPLETED|Overall Study||24
7889752|NCT00762528|19417853|P2|STARTED|Overall Study||25
7889753|NCT00762528|19417854|P1|STARTED|Overall Study||24
7889754|NCT00762515|19417876|P2|NOT COMPLETED|Overall Study||0
7889755|NCT00762515|19417877|P1|NOT COMPLETED|Overall Study||0
7889756|NCT00762515|19417876|P2|COMPLETED|Overall Study||22
7889757|NCT00762515|19417877|P1|COMPLETED|Overall Study||22
7889758|NCT00762515|19417876|P2|STARTED|Overall Study||22
7889759|NCT00762515|19417877|P1|STARTED|Overall Study||22
7889760|NCT00762502|19417888|P3|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
7889761|NCT00762502|19417889|P2|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1
7889762|NCT00762502|19417890|P1|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
7889763|NCT00762502|19417888|P3|COMPLETED|Month 3 to Month 6 (Period 2)||23
7889764|NCT00762502|19417889|P2|COMPLETED|Month 3 to Month 6 (Period 2)||4
7889765|NCT00762502|19417890|P1|COMPLETED|Month 3 to Month 6 (Period 2)||9
7889766|NCT00762502|19417888|P3|STARTED|Month 3 to Month 6 (Period 2)||23
7889767|NCT00762502|19417889|P2|STARTED|Month 3 to Month 6 (Period 2)||5
7889768|NCT00762502|19417890|P1|STARTED|Month 3 to Month 6 (Period 2)||9
7889769|NCT00762502|19417888|P3|NOT COMPLETED|Baseline to Month 3 (Period 1)||19
7889770|NCT00762502|19417889|P2|NOT COMPLETED|Baseline to Month 3 (Period 1)||6
7889771|NCT00762502|19417890|P1|NOT COMPLETED|Baseline to Month 3 (Period 1)||10
7889772|NCT00762502|19417888|P3|COMPLETED|Baseline to Month 3 (Period 1)||32
7889773|NCT00762502|19417889|P2|COMPLETED|Baseline to Month 3 (Period 1)||19
7889774|NCT00762502|19417890|P1|COMPLETED|Baseline to Month 3 (Period 1)||26
7889775|NCT00762502|19417888|P3|STARTED|Baseline to Month 3 (Period 1)||51
7889776|NCT00762502|19417889|P2|STARTED|Baseline to Month 3 (Period 1)||25
7889777|NCT00762502|19417890|P1|STARTED|Baseline to Month 3 (Period 1)||36
7889778|NCT00762476|19417904|P2|NOT COMPLETED|Overall Study||36
7889779|NCT00762476|19417905|P1|NOT COMPLETED|Overall Study||23
7889780|NCT00762476|19417904|P2|COMPLETED|Overall Study||169
7889781|NCT00762476|19417905|P1|COMPLETED|Overall Study||183
7889782|NCT00762476|19417904|P2|STARTED|Overall Study||205
7889783|NCT00762476|19417905|P1|STARTED|Overall Study||206
7889784|NCT00762463|19417917|P4|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2
7889785|NCT00762463|19417918|P3|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4
7889786|NCT00762463|19417919|P2|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1
7889787|NCT00762463|19417920|P1|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3
7889788|NCT00762463|19417917|P4|COMPLETED|Extension Phase (Week 6 to Week 12)||52
7889789|NCT00762463|19417918|P3|COMPLETED|Extension Phase (Week 6 to Week 12)||50
7889790|NCT00762463|19417919|P2|COMPLETED|Extension Phase (Week 6 to Week 12)||54
7889791|NCT00762463|19417920|P1|COMPLETED|Extension Phase (Week 6 to Week 12)||52
7889792|NCT00762463|19417917|P4|STARTED|Extension Phase (Week 6 to Week 12)||54
7889793|NCT00762463|19417918|P3|STARTED|Extension Phase (Week 6 to Week 12)||54
7889794|NCT00762463|19417919|P2|STARTED|Extension Phase (Week 6 to Week 12)||55
7889795|NCT00762463|19417920|P1|STARTED|Extension Phase (Week 6 to Week 12)||55
7889796|NCT00762463|19417917|P4|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
7889797|NCT00762463|19417918|P3|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
7889798|NCT00762463|19417919|P2|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1
7889799|NCT00762463|19417920|P1|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4
7889800|NCT00762463|19417917|P4|COMPLETED|Enrollment in Extension Phase (Week 6)||0
7889801|NCT00762463|19417918|P3|COMPLETED|Enrollment in Extension Phase (Week 6)||0
7889802|NCT00762463|19417919|P2|COMPLETED|Enrollment in Extension Phase (Week 6)||109
7889803|NCT00762463|19417920|P1|COMPLETED|Enrollment in Extension Phase (Week 6)||109
7889804|NCT00762463|19417917|P4|STARTED|Enrollment in Extension Phase (Week 6)||0
7889805|NCT00762463|19417918|P3|STARTED|Enrollment in Extension Phase (Week 6)||0
7889806|NCT00762463|19417919|P2|STARTED|Enrollment in Extension Phase (Week 6)||110
7889807|NCT00762463|19417920|P1|STARTED|Enrollment in Extension Phase (Week 6)||113
7889808|NCT00762463|19417917|P4|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
7889809|NCT00762463|19417918|P3|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
7889810|NCT00762463|19417919|P2|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10
7889811|NCT00762463|19417920|P1|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7
7889812|NCT00762463|19417917|P4|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
7889813|NCT00762463|19417918|P3|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
7889814|NCT00762463|19417919|P2|COMPLETED|Double-blind Phase (Baseline to Week 6)||110
7889815|NCT00762463|19417920|P1|COMPLETED|Double-blind Phase (Baseline to Week 6)||113
7889816|NCT00762463|19417917|P4|STARTED|Double-blind Phase (Baseline to Week 6)||0
7889817|NCT00762463|19417918|P3|STARTED|Double-blind Phase (Baseline to Week 6)||0
7889818|NCT00762463|19417919|P2|STARTED|Double-blind Phase (Baseline to Week 6)||120
7889819|NCT00762463|19417920|P1|STARTED|Double-blind Phase (Baseline to Week 6)||120
7889820|NCT00762450|19418005|P3|NOT COMPLETED|3rd Treatment Period||0
7889821|NCT00762450|19418006|P2|NOT COMPLETED|3rd Treatment Period||0
7889822|NCT00762450|19418007|P1|NOT COMPLETED|3rd Treatment Period||0
7889823|NCT00762450|19418005|P3|COMPLETED|3rd Treatment Period||2
7889824|NCT00762450|19418006|P2|COMPLETED|3rd Treatment Period||2
7889825|NCT00762450|19418007|P1|COMPLETED|3rd Treatment Period||2
7889826|NCT00762450|19418005|P3|STARTED|3rd Treatment Period||2
7889827|NCT00762450|19418006|P2|STARTED|3rd Treatment Period||2
7889828|NCT00762450|19418007|P1|STARTED|3rd Treatment Period||2
7889829|NCT00762450|19418005|P3|NOT COMPLETED|Washout After 2nd Treatment Period||0
7889830|NCT00762450|19418006|P2|NOT COMPLETED|Washout After 2nd Treatment Period||0
7889831|NCT00762450|19418007|P1|NOT COMPLETED|Washout After 2nd Treatment Period||0
7889832|NCT00762450|19418005|P3|COMPLETED|Washout After 2nd Treatment Period||2
7889833|NCT00762450|19418006|P2|COMPLETED|Washout After 2nd Treatment Period||2
7889834|NCT00762450|19418007|P1|COMPLETED|Washout After 2nd Treatment Period||2
7889835|NCT00762450|19418005|P3|STARTED|Washout After 2nd Treatment Period||2
7889836|NCT00762450|19418006|P2|STARTED|Washout After 2nd Treatment Period||2
7889837|NCT00762450|19418007|P1|STARTED|Washout After 2nd Treatment Period||2
7889838|NCT00762450|19418005|P3|NOT COMPLETED|2nd Treatment Period||0
7889839|NCT00762450|19418006|P2|NOT COMPLETED|2nd Treatment Period||0
7889840|NCT00762450|19418007|P1|NOT COMPLETED|2nd Treatment Period||0
7889841|NCT00762450|19418005|P3|COMPLETED|2nd Treatment Period||2
7889842|NCT00762450|19418006|P2|COMPLETED|2nd Treatment Period||2
7889843|NCT00762450|19418007|P1|COMPLETED|2nd Treatment Period||2
7889844|NCT00762450|19418005|P3|STARTED|2nd Treatment Period||2
7889845|NCT00762450|19418006|P2|STARTED|2nd Treatment Period||2
7889846|NCT00762450|19418007|P1|STARTED|2nd Treatment Period||2
7889847|NCT00762450|19418005|P3|NOT COMPLETED|Washout After 1st Treatment Period||0
7889848|NCT00762450|19418006|P2|NOT COMPLETED|Washout After 1st Treatment Period||0
7889849|NCT00762450|19418007|P1|NOT COMPLETED|Washout After 1st Treatment Period||0
7889850|NCT00762450|19418005|P3|COMPLETED|Washout After 1st Treatment Period||2
7889851|NCT00762450|19418006|P2|COMPLETED|Washout After 1st Treatment Period||2
7889852|NCT00762450|19418007|P1|COMPLETED|Washout After 1st Treatment Period||2
7889853|NCT00762450|19418005|P3|STARTED|Washout After 1st Treatment Period||2
7889854|NCT00762450|19418006|P2|STARTED|Washout After 1st Treatment Period||2
7889855|NCT00762450|19418007|P1|STARTED|Washout After 1st Treatment Period||2
7889856|NCT00762450|19418005|P3|NOT COMPLETED|1st Treatment Period||0
7889857|NCT00762450|19418006|P2|NOT COMPLETED|1st Treatment Period||0
7889858|NCT00762450|19418007|P1|NOT COMPLETED|1st Treatment Period||0
7889859|NCT00762450|19418005|P3|COMPLETED|1st Treatment Period||2
7889860|NCT00762450|19418006|P2|COMPLETED|1st Treatment Period||2
7889861|NCT00762450|19418007|P1|COMPLETED|1st Treatment Period||2
7889862|NCT00762450|19418005|P3|STARTED|1st Treatment Period||2
7889863|NCT00762450|19418006|P2|STARTED|1st Treatment Period||2
7889864|NCT00762450|19418007|P1|STARTED|1st Treatment Period||2
7889865|NCT00762424|19418017|P2|NOT COMPLETED|Overall Study||0
7889866|NCT00762424|19418018|P1|NOT COMPLETED|Overall Study||0
7889867|NCT00762424|19418017|P2|COMPLETED|Overall Study||25
7889868|NCT00762424|19418018|P1|COMPLETED|Overall Study||28
7889869|NCT00762424|19418017|P2|STARTED|Overall Study||25
7889870|NCT00762424|19418018|P1|STARTED|Overall Study||28
7889871|NCT00762411|19418026|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118
7889872|NCT00762411|19418027|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84
7889873|NCT00762411|19418026|P2|COMPLETED|Safety Follow Up (SFU)-Optional||312
7889874|NCT00762411|19418027|P1|COMPLETED|Safety Follow Up (SFU)-Optional||228
7889875|NCT00762411|19418026|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430
7889876|NCT00762411|19418027|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312
7889877|NCT00762411|19418026|P2|NOT COMPLETED|Delayed Start||26
7889878|NCT00762411|19418027|P1|NOT COMPLETED|Delayed Start||17
7889879|NCT00762411|19418026|P2|COMPLETED|Delayed Start||8
7889880|NCT00762411|19418027|P1|COMPLETED|Delayed Start||5
7889881|NCT00762411|19418026|P2|STARTED|Delayed Start||34
7889882|NCT00762411|19418027|P1|STARTED|Delayed Start||22
7889883|NCT00762411|19418026|P2|NOT COMPLETED|Initial Treatment||521
7889884|NCT00762411|19418027|P1|NOT COMPLETED|Initial Treatment||534
7889885|NCT00762411|19418026|P2|COMPLETED|Initial Treatment||34
7889886|NCT00762411|19418027|P1|COMPLETED|Initial Treatment||22
7889887|NCT00762411|19418026|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553
7889888|NCT00762411|19418027|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555
7889889|NCT00762411|19418026|P2|STARTED|Initial Treatment||555
7889890|NCT00762411|19418027|P1|STARTED|Initial Treatment||556
7889891|NCT00762385|19418091|P2|NOT COMPLETED|Second Intervention||3
7889892|NCT00762385|19418092|P1|NOT COMPLETED|Second Intervention||3
7889893|NCT00762385|19418091|P2|COMPLETED|Second Intervention||39
7889894|NCT00762385|19418092|P1|COMPLETED|Second Intervention||46
7889895|NCT00762385|19418091|P2|STARTED|Second Intervention||42
7889896|NCT00762385|19418092|P1|STARTED|Second Intervention||49
7889897|NCT00762385|19418091|P2|NOT COMPLETED|First Intervention||4
7889898|NCT00762385|19418092|P1|NOT COMPLETED|First Intervention||2
7889899|NCT00762385|19418091|P2|COMPLETED|First Intervention||42
7889900|NCT00762385|19418092|P1|COMPLETED|First Intervention||49
7889901|NCT00762385|19418091|P2|STARTED|First Intervention||46
7889902|NCT00762385|19418092|P1|STARTED|First Intervention||51
7889903|NCT00762372|19418105|P3|NOT COMPLETED|Overall Study||0
7889904|NCT00762372|19418106|P2|NOT COMPLETED|Overall Study||0
7889905|NCT00762372|19418107|P1|NOT COMPLETED|Overall Study||1
7889906|NCT00762372|19418105|P3|COMPLETED|Overall Study||50
7889907|NCT00762372|19418106|P2|COMPLETED|Overall Study||55
7889908|NCT00762372|19418107|P1|COMPLETED|Overall Study||110
7889909|NCT00762372|19418105|P3|STARTED|Overall Study|N=53 enrolled but 3 participant's discontinued before start of study drug administration.|50
7889910|NCT00762372|19418106|P2|STARTED|Overall Study|N=57 enrolled but 2 participant's discontinued before start of study drug administration.|55
7889911|NCT00762372|19418107|P1|STARTED|Overall Study|N=114 enrolled but 3 participant's discontinued before start of study drug administration.|111
7889912|NCT00762359|19418183|P2|NOT COMPLETED|Overall Study||57
7889913|NCT00762359|19418184|P1|NOT COMPLETED|Overall Study||59
7889914|NCT00762359|19418183|P2|COMPLETED|Overall Study||178
7889915|NCT00762359|19418184|P1|COMPLETED|Overall Study||167
7889916|NCT00762359|19418183|P2|STARTED|Overall Study||235
7889917|NCT00762359|19418184|P1|STARTED|Overall Study||226
7889918|NCT00762320|19418284|P1|NOT COMPLETED|Overall Study||0
7889919|NCT00762320|19418284|P1|COMPLETED|Overall Study||8
7889920|NCT00762320|19418284|P1|STARTED|Overall Study||8
7889921|NCT00762268|19418301|P2|NOT COMPLETED|Overall Study||3
7889922|NCT00762268|19418302|P1|NOT COMPLETED|Overall Study||3
7889923|NCT00762268|19418301|P2|COMPLETED|Overall Study||8
7889924|NCT00762268|19418302|P1|COMPLETED|Overall Study||9
7889925|NCT00762268|19418301|P2|STARTED|Overall Study||11
7889926|NCT00762268|19418302|P1|STARTED|Overall Study||12
7889927|NCT00762229|19418314|P2|NOT COMPLETED|Overall Study||2
7889928|NCT00762229|19418315|P1|NOT COMPLETED|Overall Study||1
7889929|NCT00762229|19418314|P2|COMPLETED|Overall Study||22
7889930|NCT00762229|19418315|P1|COMPLETED|Overall Study||14
7889931|NCT00762229|19418314|P2|STARTED|Overall Study||24
7889932|NCT00762229|19418315|P1|STARTED|Overall Study||15
7889933|NCT00762216|19418323|P1|NOT COMPLETED|Overall Study||0
7889934|NCT00762216|19418323|P1|COMPLETED|Overall Study||71
7889935|NCT00762216|19418323|P1|STARTED|Overall Study||71
7889936|NCT00762177|19418331|P3|NOT COMPLETED|3rd Treatment Period||0
7889937|NCT00762177|19418332|P2|NOT COMPLETED|3rd Treatment Period||0
7889938|NCT00762177|19418333|P1|NOT COMPLETED|3rd Treatment Period||0
7889939|NCT00762177|19418331|P3|COMPLETED|3rd Treatment Period||8
7889940|NCT00762177|19418332|P2|COMPLETED|3rd Treatment Period||8
7889941|NCT00762177|19418333|P1|COMPLETED|3rd Treatment Period||8
7889942|NCT00762177|19418331|P3|STARTED|3rd Treatment Period||8
7889943|NCT00762177|19418332|P2|STARTED|3rd Treatment Period||8
7889944|NCT00762177|19418333|P1|STARTED|3rd Treatment Period||8
7889945|NCT00762177|19418331|P3|NOT COMPLETED|Washout After 2nd Treatment||0
7889946|NCT00762177|19418332|P2|NOT COMPLETED|Washout After 2nd Treatment||0
7889947|NCT00762177|19418333|P1|NOT COMPLETED|Washout After 2nd Treatment||0
7889948|NCT00762177|19418331|P3|COMPLETED|Washout After 2nd Treatment||8
7889949|NCT00762177|19418332|P2|COMPLETED|Washout After 2nd Treatment||8
7889950|NCT00762177|19418333|P1|COMPLETED|Washout After 2nd Treatment||8
7889951|NCT00762177|19418331|P3|STARTED|Washout After 2nd Treatment||8
7889952|NCT00762177|19418332|P2|STARTED|Washout After 2nd Treatment||8
7889953|NCT00762177|19418333|P1|STARTED|Washout After 2nd Treatment||8
7889954|NCT00762177|19418331|P3|NOT COMPLETED|2nd Treatment Period||0
7889955|NCT00762177|19418332|P2|NOT COMPLETED|2nd Treatment Period||0
7889956|NCT00762177|19418333|P1|NOT COMPLETED|2nd Treatment Period||0
7889957|NCT00762177|19418331|P3|COMPLETED|2nd Treatment Period||8
7889958|NCT00762177|19418332|P2|COMPLETED|2nd Treatment Period||8
7889959|NCT00762177|19418333|P1|COMPLETED|2nd Treatment Period||8
7889960|NCT00762177|19418331|P3|STARTED|2nd Treatment Period||8
7889961|NCT00762177|19418332|P2|STARTED|2nd Treatment Period||8
7889962|NCT00762177|19418333|P1|STARTED|2nd Treatment Period||8
7889963|NCT00762177|19418331|P3|NOT COMPLETED|Washout After 1st Treatment||0
7889964|NCT00762177|19418332|P2|NOT COMPLETED|Washout After 1st Treatment||0
7889965|NCT00762177|19418333|P1|NOT COMPLETED|Washout After 1st Treatment||0
7889966|NCT00762177|19418331|P3|COMPLETED|Washout After 1st Treatment||8
7889967|NCT00762177|19418332|P2|COMPLETED|Washout After 1st Treatment||8
7889968|NCT00762177|19418333|P1|COMPLETED|Washout After 1st Treatment||8
7889969|NCT00762177|19418331|P3|STARTED|Washout After 1st Treatment||8
7889970|NCT00762177|19418332|P2|STARTED|Washout After 1st Treatment||8
7889971|NCT00762177|19418333|P1|STARTED|Washout After 1st Treatment||8
7889972|NCT00762177|19418331|P3|NOT COMPLETED|1st Treatment Period||0
7889973|NCT00762177|19418332|P2|NOT COMPLETED|1st Treatment Period||0
7889974|NCT00762177|19418333|P1|NOT COMPLETED|1st Treatment Period||0
7889975|NCT00762177|19418331|P3|COMPLETED|1st Treatment Period||8
7889976|NCT00762177|19418332|P2|COMPLETED|1st Treatment Period||8
7889977|NCT00762177|19418333|P1|COMPLETED|1st Treatment Period||8
7889978|NCT00762177|19418331|P3|STARTED|1st Treatment Period||8
7889979|NCT00762177|19418332|P2|STARTED|1st Treatment Period||8
7889980|NCT00762177|19418333|P1|STARTED|1st Treatment Period||8
7889981|NCT00762164|19418412|P2|NOT COMPLETED|Overall Study||2
7889982|NCT00762164|19418413|P1|NOT COMPLETED|Overall Study||3
7889983|NCT00762164|19418412|P2|COMPLETED|Overall Study||15
7889984|NCT00762164|19418413|P1|COMPLETED|Overall Study||14
7889985|NCT00762164|19418412|P2|STARTED|Overall Study||17
7889986|NCT00762164|19418413|P1|STARTED|Overall Study||17
7889987|NCT00762086|19418423|P2|NOT COMPLETED|Overall Study||4
7889988|NCT00762086|19418424|P1|NOT COMPLETED|Overall Study||6
7889989|NCT00762086|19418423|P2|COMPLETED|Overall Study||24
7889990|NCT00762086|19418424|P1|COMPLETED|Overall Study||33
7889991|NCT00762086|19418423|P2|STARTED|Overall Study||28
7889992|NCT00762086|19418424|P1|STARTED|Overall Study||39
7889993|NCT00762073|19418434|P4|NOT COMPLETED|Overall Study||3
7889994|NCT00762073|19418435|P3|NOT COMPLETED|Overall Study||2
7889995|NCT00762073|19418436|P2|NOT COMPLETED|Overall Study||4
7889996|NCT00762073|19418437|P1|NOT COMPLETED|Overall Study||4
7889997|NCT00762073|19418434|P4|COMPLETED|Overall Study||17
7889998|NCT00762073|19418435|P3|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18
7889999|NCT00762073|19418436|P2|COMPLETED|Overall Study||17
7890000|NCT00762073|19418437|P1|COMPLETED|Overall Study||17
7890001|NCT00762073|19418434|P4|STARTED|Overall Study||20
7890002|NCT00762073|19418435|P3|STARTED|Overall Study||20
7890003|NCT00762073|19418436|P2|STARTED|Overall Study||21
7890004|NCT00762073|19418437|P1|STARTED|Overall Study||21
7890005|NCT00762034|19418501|P2|NOT COMPLETED|Maintenance Period||298
7890006|NCT00762034|19418502|P1|NOT COMPLETED|Maintenance Period||294
7890007|NCT00762034|19418501|P2|COMPLETED|Maintenance Period||0
7890008|NCT00762034|19418502|P1|COMPLETED|Maintenance Period||0
7890009|NCT00762034|19418501|P2|Received at Least 1 Dose of Study Drug|Maintenance Period||298
7890010|NCT00762034|19418502|P1|Received at Least 1 Dose of Study Drug|Maintenance Period||294
7890011|NCT00762034|19418501|P2|STARTED|Maintenance Period||298
7890012|NCT00762034|19418502|P1|STARTED|Maintenance Period||294
7890013|NCT00762034|19418501|P2|NOT COMPLETED|Induction Period||169
7890014|NCT00762034|19418502|P1|NOT COMPLETED|Induction Period||178
7890015|NCT00762034|19418501|P2|COMPLETED|Induction Period||298
7890016|NCT00762034|19418502|P1|COMPLETED|Induction Period||294
7890017|NCT00762034|19418501|P2|Received at Least 1 Dose of Study Drug|Induction Period||443
7890018|NCT00762034|19418502|P1|Received at Least 1 Dose of Study Drug|Induction Period||442
7890019|NCT00762034|19418501|P2|STARTED|Induction Period||467
7890020|NCT00762034|19418502|P1|STARTED|Induction Period||472
7890021|NCT00762021|19418561|P2|NOT COMPLETED|Overall Study||8
7890022|NCT00762021|19418562|P1|NOT COMPLETED|Overall Study||8
7890023|NCT00762021|19418561|P2|COMPLETED|Overall Study||44
7890024|NCT00762021|19418562|P1|COMPLETED|Overall Study||44
7890025|NCT00762021|19418561|P2|STARTED|Overall Study||52
7890026|NCT00762021|19418562|P1|STARTED|Overall Study||52
7890027|NCT00761969|19418574|P2|NOT COMPLETED|Overall Study||140
7890028|NCT00761969|19418575|P1|NOT COMPLETED|Overall Study||200
7890029|NCT00761969|19418574|P2|COMPLETED|Overall Study||573
7890030|NCT00761969|19418575|P1|COMPLETED|Overall Study||542
7890031|NCT00761969|19418574|P2|STARTED|Overall Study||713
7890032|NCT00761969|19418575|P1|STARTED|Overall Study||742
7890033|NCT00761956|19418585|P2|NOT COMPLETED|Overall Study||54
7890034|NCT00761956|19418586|P1|NOT COMPLETED|Overall Study||35
7890035|NCT00761956|19418585|P2|COMPLETED|Overall Study||48
7890036|NCT00761956|19418586|P1|COMPLETED|Overall Study||52
7890037|NCT00761956|19418585|P2|STARTED|Overall Study||102
7890038|NCT00761956|19418586|P1|STARTED|Overall Study||87
7890039|NCT00761930|19418597|P3|NOT COMPLETED|Overall Study||0
7890040|NCT00761930|19418598|P2|NOT COMPLETED|Overall Study||0
7890041|NCT00761930|19418599|P1|NOT COMPLETED|Overall Study||0
7890042|NCT00761930|19418597|P3|COMPLETED|Overall Study||35
7890043|NCT00761930|19418598|P2|COMPLETED|Overall Study||34
7890044|NCT00761930|19418599|P1|COMPLETED|Overall Study||34
7890045|NCT00761930|19418597|P3|STARTED|Overall Study||35
7890046|NCT00761930|19418598|P2|STARTED|Overall Study||34
7890047|NCT00761930|19418599|P1|STARTED|Overall Study||34
7890048|NCT00761891|19418613|P1|NOT COMPLETED|Overall Study||10
7890049|NCT00761891|19418613|P1|COMPLETED|Overall Study||54
7890050|NCT00761891|19418613|P1|STARTED|Overall Study||64
7890051|NCT00761865|19418620|P2|NOT COMPLETED|Overall Study||7
7890052|NCT00761865|19418621|P1|NOT COMPLETED|Overall Study||8
7890053|NCT00761865|19418620|P2|COMPLETED|Overall Study||11
7890054|NCT00761865|19418621|P1|COMPLETED|Overall Study||8
7890055|NCT00761865|19418620|P2|STARTED|Overall Study||18
7890056|NCT00761865|19418621|P1|STARTED|Overall Study||16
7890057|NCT00761813|19418631|P2|NOT COMPLETED|Overall Study||14
7890058|NCT00761813|19418632|P1|NOT COMPLETED|Overall Study||15
7890059|NCT00761813|19418631|P2|COMPLETED|Overall Study||537
7890060|NCT00761813|19418632|P1|COMPLETED|Overall Study||542
7890061|NCT00761813|19418631|P2|STARTED|Overall Study||551
7890062|NCT00761813|19418632|P1|STARTED|Overall Study||557
7890063|NCT00761774|19418642|P1|NOT COMPLETED|Overall Study||79
7890064|NCT00761774|19418642|P1|COMPLETED|Overall Study||29
7890065|NCT00761774|19418642|P1|STARTED|Overall Study||108
7890066|NCT00761761|19418653|P2|NOT COMPLETED|Overall Study||1
7890067|NCT00761761|19418654|P1|NOT COMPLETED|Overall Study||6
7890068|NCT00761761|19418653|P2|COMPLETED|Overall Study||29
7890069|NCT00761761|19418654|P1|COMPLETED|Overall Study||24
7890070|NCT00761761|19418653|P2|STARTED|Overall Study||30
7890071|NCT00761761|19418654|P1|STARTED|Overall Study||30
7890072|NCT00761748|19418666|P2|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
7890073|NCT00761748|19418667|P1|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
7890074|NCT00761748|19418666|P2|COMPLETED|Second Intervention (21 +/- 3 Days)||7
7890075|NCT00761748|19418667|P1|COMPLETED|Second Intervention (21 +/- 3 Days)||17
7890076|NCT00761748|19418666|P2|STARTED|Second Intervention (21 +/- 3 Days)||7
7890077|NCT00761748|19418667|P1|STARTED|Second Intervention (21 +/- 3 Days)||17
7890078|NCT00761748|19418666|P2|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
7890079|NCT00761748|19418667|P1|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
7890080|NCT00761748|19418666|P2|COMPLETED|First Intervention (21 +/- 3 Days)||7
7890081|NCT00761748|19418667|P1|COMPLETED|First Intervention (21 +/- 3 Days)||17
7890082|NCT00761748|19418666|P2|STARTED|First Intervention (21 +/- 3 Days)||10
7890083|NCT00761748|19418667|P1|STARTED|First Intervention (21 +/- 3 Days)||20
7890084|NCT00761735|19418673|P1|NOT COMPLETED|Overall Study||14
7890085|NCT00761735|19418673|P1|COMPLETED|Overall Study||80
7890086|NCT00761735|19418673|P1|STARTED|Overall Study||94
7890087|NCT00761631|19418689|P6|NOT COMPLETED|Overall Study||5
7890088|NCT00761631|19418690|P5|NOT COMPLETED|Overall Study||22
7890089|NCT00761631|19418691|P4|NOT COMPLETED|Overall Study||3
7890090|NCT00761631|19418692|P3|NOT COMPLETED|Overall Study||16
7890091|NCT00761631|19418693|P2|NOT COMPLETED|Overall Study||7
7890092|NCT00761631|19418694|P1|NOT COMPLETED|Overall Study||15
7890093|NCT00761631|19418689|P6|COMPLETED|Overall Study||294
7890094|NCT00761631|19418690|P5|COMPLETED|Overall Study||277
7890095|NCT00761631|19418691|P4|COMPLETED|Overall Study||116
7890096|NCT00761631|19418692|P3|COMPLETED|Overall Study||160
7890097|NCT00761631|19418693|P2|COMPLETED|Overall Study||174
7890098|NCT00761631|19418694|P1|COMPLETED|Overall Study||111
7890099|NCT00761631|19418689|P6|Vaccinated Dose 2|Overall Study||0
7890100|NCT00761631|19418690|P5|Vaccinated Dose 2|Overall Study||0
7890101|NCT00761631|19418691|P4|Vaccinated Dose 2|Overall Study||0
7890102|NCT00761631|19418692|P3|Vaccinated Dose 2|Overall Study||165
7890103|NCT00761631|19418693|P2|Vaccinated Dose 2|Overall Study||0
7890104|NCT00761631|19418694|P1|Vaccinated Dose 2|Overall Study||112
7890105|NCT00761631|19418689|P6|Vaccinated Dose 1|Overall Study||298
7890106|NCT00761631|19418690|P5|Vaccinated Dose 1|Overall Study||294
7890107|NCT00761631|19418691|P4|Vaccinated Dose 1|Overall Study||118
7890108|NCT00761631|19418692|P3|Vaccinated Dose 1|Overall Study||175
7890109|NCT00761631|19418693|P2|Vaccinated Dose 1|Overall Study||179
7890110|NCT00761631|19418694|P1|Vaccinated Dose 1|Overall Study||124
7890111|NCT00761631|19418689|P6|STARTED|Overall Study||299
7890112|NCT00761631|19418690|P5|STARTED|Overall Study||299
7890113|NCT00761631|19418691|P4|STARTED|Overall Study||119
7890114|NCT00761631|19418692|P3|STARTED|Overall Study||176
7890115|NCT00761631|19418693|P2|STARTED|Overall Study||181
7890116|NCT00761631|19418694|P1|STARTED|Overall Study||126
7890117|NCT00761605|19418729|P1|NOT COMPLETED|Overall Study||141
7890118|NCT00761605|19418729|P1|COMPLETED|Overall Study||246
7890119|NCT00761605|19418729|P1|STARTED|Overall Study||387
7890120|NCT00761592|19418758|P2|NOT COMPLETED|Overall Study||1
7890121|NCT00761592|19418759|P1|NOT COMPLETED|Overall Study||1
7890122|NCT00761592|19418758|P2|COMPLETED|Overall Study||32
7890123|NCT00761592|19418759|P1|COMPLETED|Overall Study||31
7890124|NCT00761592|19418758|P2|STARTED|Overall Study||33
7890125|NCT00761592|19418759|P1|STARTED|Overall Study||32
7890126|NCT00761579|19418773|P1|NOT COMPLETED|Overall Study||92
7890127|NCT00761579|19418773|P1|COMPLETED|Overall Study||98
7890128|NCT00761579|19418773|P1|STARTED|Overall Study||190
7890129|NCT00761527|19418806|P1|NOT COMPLETED|Overall Study||22
7890130|NCT00761527|19418806|P1|COMPLETED|Overall Study||2958
7890131|NCT00761527|19418806|P1|Received One Dose of Study Medication|Overall Study||2978
7890132|NCT00761527|19418806|P1|STARTED|Overall Study||2980
7890133|NCT00761514|19418813|P1|NOT COMPLETED|Overall Study||7
7890134|NCT00761514|19418813|P1|COMPLETED|Overall Study||7
7890135|NCT00761514|19418813|P1|STARTED|Overall Study||14
7890136|NCT00761462|19418820|P2|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51
7890137|NCT00761462|19418821|P1|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154
7890138|NCT00761462|19418820|P2|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456
7890139|NCT00761462|19418821|P1|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333
7890140|NCT00761462|19418820|P2|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507
7890141|NCT00761462|19418821|P1|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485
7890142|NCT00761462|19418820|P2|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507
7890143|NCT00761462|19418821|P1|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487
7890144|NCT00761462|19418820|P2|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507
7890145|NCT00761462|19418821|P1|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487
7890146|NCT00761462|19418820|P2|NOT COMPLETED|Treatment||12
7890147|NCT00761462|19418821|P1|NOT COMPLETED|Treatment||23
7890148|NCT00761462|19418820|P2|COMPLETED|Treatment|Patients with confirmed intake of study drug|507
7890149|NCT00761462|19418821|P1|COMPLETED|Treatment|Patients with confirmed intake of study drug|487
7890150|NCT00761462|19418820|P2|STARTED|Treatment|Patients enrolled in study group|519
7890151|NCT00761462|19418821|P1|STARTED|Treatment|Patients enrolled in study group|510
7890152|NCT00761345|19418829|P1|NOT COMPLETED|Overall Study||3
7890153|NCT00761345|19418829|P1|COMPLETED|Overall Study||24
7890154|NCT00761345|19418829|P1|STARTED|Overall Study||27
7890155|NCT00761319|19418835|P2|NOT COMPLETED|Overall Study||34
7890156|NCT00761319|19418836|P1|NOT COMPLETED|Overall Study||48
7890157|NCT00761319|19418835|P2|COMPLETED|Overall Study||318
7890158|NCT00761319|19418836|P1|COMPLETED|Overall Study||305
7890159|NCT00761319|19418835|P2|STARTED|Overall Study||352
7890160|NCT00761319|19418836|P1|STARTED|Overall Study||353
7890161|NCT00761306|19418844|P1|NOT COMPLETED|Overall Study||20
7890162|NCT00761306|19418844|P1|COMPLETED|Overall Study||54
7890163|NCT00761306|19418844|P1|STARTED|Overall Study||74
7890164|NCT00761280|19418855|P2|NOT COMPLETED|First Dose to End of Study||11
7890165|NCT00761280|19418856|P1|NOT COMPLETED|First Dose to End of Study||12
7890166|NCT00761280|19418855|P2|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
7890167|NCT00761280|19418856|P1|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
7890168|NCT00761280|19418855|P2|STARTED|First Dose to End of Study||11
7890169|NCT00761280|19418856|P1|STARTED|First Dose to End of Study||12
7890170|NCT00761280|19418855|P2|NOT COMPLETED|Randomization to First Dose||2
7890171|NCT00761280|19418856|P1|NOT COMPLETED|Randomization to First Dose||2
7890172|NCT00761280|19418855|P2|COMPLETED|Randomization to First Dose||11
7890173|NCT00761280|19418856|P1|COMPLETED|Randomization to First Dose||12
7890174|NCT00761280|19418855|P2|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11
7890175|NCT00761280|19418856|P1|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12
7890176|NCT00761280|19418855|P2|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0
7890177|NCT00761280|19418856|P1|Catheter Surgery|Randomization to First Dose|Safety population|13
7890178|NCT00761280|19418855|P2|STARTED|Randomization to First Dose||13
7890179|NCT00761280|19418856|P1|STARTED|Randomization to First Dose||14
7890180|NCT00761267|19418887|P3|NOT COMPLETED|Overall Study||6
7890181|NCT00761267|19418888|P2|NOT COMPLETED|Overall Study||4
7890182|NCT00761267|19418889|P1|NOT COMPLETED|Overall Study||2
7890183|NCT00761267|19418887|P3|COMPLETED|Overall Study||24
7890184|NCT00761267|19418888|P2|COMPLETED|Overall Study||16
7890185|NCT00761267|19418889|P1|COMPLETED|Overall Study||18
7890186|NCT00761267|19418887|P3|Treated|Overall Study||30
7890187|NCT00761267|19418888|P2|Treated|Overall Study||19
7890188|NCT00761267|19418889|P1|Treated|Overall Study||19
7890189|NCT00761267|19418887|P3|STARTED|Overall Study||30
7890190|NCT00761267|19418888|P2|STARTED|Overall Study||20
7890191|NCT00761267|19418889|P1|STARTED|Overall Study||20
7890192|NCT00761215|19418940|P3|NOT COMPLETED|Overall Study||8
7890193|NCT00761215|19418941|P2|NOT COMPLETED|Overall Study||4
7890194|NCT00761215|19418942|P1|NOT COMPLETED|Overall Study||9
7890195|NCT00761215|19418940|P3|COMPLETED|Overall Study||56
7890196|NCT00761215|19418941|P2|COMPLETED|Overall Study||60
7890197|NCT00761215|19418942|P1|COMPLETED|Overall Study||55
7890198|NCT00761215|19418940|P3|STARTED|Overall Study||64
7890199|NCT00761215|19418941|P2|STARTED|Overall Study||64
7890200|NCT00761215|19418942|P1|STARTED|Overall Study||64
7890201|NCT00761202|19418967|P2|NOT COMPLETED|Overall Study||2
7890202|NCT00761202|19418968|P1|NOT COMPLETED|Overall Study||1
7890203|NCT00761202|19418967|P2|COMPLETED|Overall Study||26
7890204|NCT00761202|19418968|P1|COMPLETED|Overall Study||21
7890205|NCT00761202|19418967|P2|STARTED|Overall Study||28
7890206|NCT00761202|19418968|P1|STARTED|Overall Study||22
7890207|NCT00761189|19418984|P1|NOT COMPLETED|Overall Study||185
7890208|NCT00761189|19418984|P1|COMPLETED|Overall Study||306
7890209|NCT00761189|19418984|P1|STARTED|Overall Study||491
7890210|NCT00761176|19419001|P2|NOT COMPLETED|Overall Study||1
7890211|NCT00761176|19419002|P1|NOT COMPLETED|Overall Study||2
7890212|NCT00761176|19419001|P2|COMPLETED|Overall Study||3
7890213|NCT00761176|19419002|P1|COMPLETED|Overall Study||2
7890214|NCT00761176|19419001|P2|STARTED|Overall Study||4
7890215|NCT00761176|19419002|P1|STARTED|Overall Study||4
7890216|NCT00761150|19419011|P3|NOT COMPLETED|Double-blind Period||29
7890217|NCT00761150|19419012|P2|NOT COMPLETED|Double-blind Period||14
7890218|NCT00761150|19419013|P1|NOT COMPLETED|Double-blind Period||0
7890219|NCT00761150|19419011|P3|COMPLETED|Double-blind Period||89
7890220|NCT00761150|19419012|P2|COMPLETED|Double-blind Period||106
7890221|NCT00761150|19419013|P1|COMPLETED|Double-blind Period||0
7890222|NCT00761150|19419011|P3|STARTED|Double-blind Period||118
7890223|NCT00761150|19419012|P2|STARTED|Double-blind Period||120
7890224|NCT00761150|19419013|P1|STARTED|Double-blind Period||0
7890225|NCT00761150|19419011|P3|NOT COMPLETED|Open-label Period||0
7890226|NCT00761150|19419012|P2|NOT COMPLETED|Open-label Period||0
7890227|NCT00761150|19419013|P1|NOT COMPLETED|Open-label Period||70
7890228|NCT00761150|19419011|P3|COMPLETED|Open-label Period||0
7890229|NCT00761150|19419012|P2|COMPLETED|Open-label Period||0
7890230|NCT00761150|19419013|P1|COMPLETED|Open-label Period||238
7890231|NCT00761150|19419011|P3|STARTED|Open-label Period||0
7890232|NCT00761150|19419012|P2|STARTED|Open-label Period||0
7890233|NCT00761150|19419013|P1|STARTED|Open-label Period||308
7890234|NCT00761137|19419022|P1|NOT COMPLETED|Overall Study||0
7890235|NCT00761137|19419022|P1|COMPLETED|Overall Study||19
7890236|NCT00761137|19419022|P1|3 mg Tropicamide|Overall Study||19
7890237|NCT00761137|19419022|P1|1 mg Tropicamide|Overall Study||19
7890238|NCT00761137|19419022|P1|0.3 mg Tropicamide|Overall Study||19
7890239|NCT00761137|19419022|P1|Placebo|Overall Study||19
7890240|NCT00761137|19419022|P1|STARTED|Overall Study||19
7890241|NCT00761085|19419037|P4|NOT COMPLETED|Overall Study||4
7890242|NCT00761085|19419038|P3|NOT COMPLETED|Overall Study||0
7890243|NCT00761085|19419039|P2|NOT COMPLETED|Overall Study||6
7890244|NCT00761085|19419040|P1|NOT COMPLETED|Overall Study||0
7890245|NCT00761085|19419037|P4|COMPLETED|Overall Study||8
7890246|NCT00761085|19419038|P3|COMPLETED|Overall Study||11
7890247|NCT00761085|19419039|P2|COMPLETED|Overall Study||6
7890248|NCT00761085|19419040|P1|COMPLETED|Overall Study||12
7890249|NCT00761085|19419037|P4|STARTED|Overall Study||12
7890250|NCT00761085|19419038|P3|STARTED|Overall Study||11
7890251|NCT00761085|19419039|P2|STARTED|Overall Study||12
7890252|NCT00761085|19419040|P1|STARTED|Overall Study||12
7890253|NCT00761007|19419058|P4|NOT COMPLETED|Overall Study||7
7890254|NCT00761007|19419059|P3|NOT COMPLETED|Overall Study||18
7890255|NCT00761007|19419060|P2|NOT COMPLETED|Overall Study||11
7890256|NCT00761007|19419061|P1|NOT COMPLETED|Overall Study||13
7890257|NCT00761007|19419058|P4|COMPLETED|Overall Study||131
7890258|NCT00761007|19419059|P3|COMPLETED|Overall Study||121
7890259|NCT00761007|19419060|P2|COMPLETED|Overall Study||124
7890260|NCT00761007|19419061|P1|COMPLETED|Overall Study||129
7890261|NCT00761007|19419058|P4|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136
7890262|NCT00761007|19419059|P3|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135
7890263|NCT00761007|19419060|P2|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133
7890264|NCT00761007|19419061|P1|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140
7890265|NCT00761007|19419058|P4|Safety (>=1 Dose of Study Medication)|Overall Study||137
7890266|NCT00761007|19419059|P3|Safety (>=1 Dose of Study Medication)|Overall Study||139
7890267|NCT00761007|19419060|P2|Safety (>=1 Dose of Study Medication)|Overall Study||135
7890268|NCT00761007|19419061|P1|Safety (>=1 Dose of Study Medication)|Overall Study||140
7890269|NCT00761007|19419058|P4|STARTED|Overall Study||138
7890270|NCT00761007|19419059|P3|STARTED|Overall Study||139
7890271|NCT00761007|19419060|P2|STARTED|Overall Study||135
7890272|NCT00761007|19419061|P1|STARTED|Overall Study||142
7890273|NCT00760994|19419086|P3|NOT COMPLETED|Overall Study||3
7890274|NCT00760994|19419087|P2|NOT COMPLETED|Overall Study||4
7890275|NCT00760994|19419088|P1|NOT COMPLETED|Overall Study||4
7890276|NCT00760994|19419086|P3|COMPLETED|Overall Study||17
7890277|NCT00760994|19419087|P2|COMPLETED|Overall Study||27
7890278|NCT00760994|19419088|P1|COMPLETED|Overall Study||25
7890279|NCT00760994|19419086|P3|STARTED|Overall Study||20
7890280|NCT00760994|19419087|P2|STARTED|Overall Study||31
7890281|NCT00760994|19419088|P1|STARTED|Overall Study||29
7890282|NCT00760877|19419101|P2|NOT COMPLETED|Overall Study||26
7890283|NCT00760877|19419102|P1|NOT COMPLETED|Overall Study||45
7890284|NCT00760877|19419101|P2|COMPLETED|Overall Study||77
7890285|NCT00760877|19419102|P1|COMPLETED|Overall Study||59
7890286|NCT00760877|19419101|P2|Safety Set|Overall Study||103
7890287|NCT00760877|19419102|P1|Safety Set|Overall Study||101
7890288|NCT00760877|19419101|P2|Cross-over to Nilotinib|Overall Study||46
7890289|NCT00760877|19419102|P1|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0
7890290|NCT00760877|19419101|P2|STARTED|Overall Study||103
7890291|NCT00760877|19419102|P1|STARTED|Overall Study||104
7890292|NCT00760838|19419120|P2|NOT COMPLETED|Overall Study||2
7890293|NCT00760838|19419121|P1|NOT COMPLETED|Overall Study||5
7890294|NCT00760838|19419120|P2|COMPLETED|Overall Study||53
7890295|NCT00760838|19419121|P1|COMPLETED|Overall Study||49
7890296|NCT00760838|19419120|P2|STARTED|Overall Study||55
7890297|NCT00760838|19419121|P1|STARTED|Overall Study||54
7890298|NCT00760747|19419139|P2|NOT COMPLETED|Study Period III||3
7890299|NCT00760747|19419140|P1|NOT COMPLETED|Study Period III||3
7890300|NCT00760747|19419139|P2|COMPLETED|Study Period III||38
7890301|NCT00760747|19419140|P1|COMPLETED|Study Period III||41
7890302|NCT00760747|19419139|P2|STARTED|Study Period III||41
7890303|NCT00760747|19419140|P1|STARTED|Study Period III||44
7890304|NCT00760747|19419139|P2|NOT COMPLETED|Study Period II||14
7890305|NCT00760747|19419140|P1|NOT COMPLETED|Study Period II||13
7890306|NCT00760747|19419139|P2|COMPLETED|Study Period II||41
7890307|NCT00760747|19419140|P1|COMPLETED|Study Period II||44
7890308|NCT00760747|19419139|P2|Received at Least One Dose of Study Drug|Study Period II||54
7890309|NCT00760747|19419140|P1|Received at Least One Dose of Study Drug|Study Period II||57
7890310|NCT00760747|19419139|P2|STARTED|Study Period II||55
7890311|NCT00760747|19419140|P1|STARTED|Study Period II||57
7890312|NCT00760669|19419168|P1|NOT COMPLETED|Overall Study||30
7890313|NCT00760669|19419168|P1|COMPLETED|Overall Study||1031
7890314|NCT00760669|19419168|P1|STARTED|Overall Study||1061
7890315|NCT00760617|19419185|P3|NOT COMPLETED|Overall Study||5
7890316|NCT00760617|19419186|P2|NOT COMPLETED|Overall Study||2
7890317|NCT00760617|19419187|P1|NOT COMPLETED|Overall Study||5
7890318|NCT00760617|19419185|P3|COMPLETED|Overall Study||111
7890319|NCT00760617|19419186|P2|COMPLETED|Overall Study||142
7890320|NCT00760617|19419187|P1|COMPLETED|Overall Study||261
7890321|NCT00760617|19419185|P3|STARTED|Overall Study||116
7890322|NCT00760617|19419186|P2|STARTED|Overall Study||144
7890323|NCT00760617|19419187|P1|STARTED|Overall Study||266
7890324|NCT00760578|19419262|P4|NOT COMPLETED|Overall Study||4
7890325|NCT00760578|19419263|P3|NOT COMPLETED|Overall Study||5
7890326|NCT00760578|19419264|P2|NOT COMPLETED|Overall Study||2
7890327|NCT00760578|19419265|P1|NOT COMPLETED|Overall Study||3
7890328|NCT00760578|19419262|P4|COMPLETED|Overall Study||18
7890329|NCT00760578|19419263|P3|COMPLETED|Overall Study||16
7890330|NCT00760578|19419264|P2|COMPLETED|Overall Study||19
7890331|NCT00760578|19419265|P1|COMPLETED|Overall Study||19
7890332|NCT00760578|19419262|P4|Entered Drug Treatment Period|Overall Study||22
7890333|NCT00760578|19419263|P3|Entered Drug Treatment Period|Overall Study||19
7890334|NCT00760578|19419264|P2|Entered Drug Treatment Period|Overall Study||20
7890335|NCT00760578|19419265|P1|Entered Drug Treatment Period|Overall Study||21
7890336|NCT00760578|19419262|P4|STARTED|Overall Study||22
7890337|NCT00760578|19419263|P3|STARTED|Overall Study||21
7890338|NCT00760578|19419264|P2|STARTED|Overall Study||21
7890339|NCT00760578|19419265|P1|STARTED|Overall Study||22
7890340|NCT00760552|19419301|P2|NOT COMPLETED|Overall Study||10
7890341|NCT00760552|19419302|P1|NOT COMPLETED|Overall Study||13
7890342|NCT00760552|19419301|P2|COMPLETED|Overall Study||52
7890343|NCT00760552|19419302|P1|COMPLETED|Overall Study||48
7890344|NCT00760552|19419301|P2|STARTED|Overall Study||62
7890345|NCT00760552|19419302|P1|STARTED|Overall Study||61
7890346|NCT00760526|19419310|P2|NOT COMPLETED|Overall Study||4
7890347|NCT00760526|19419311|P1|NOT COMPLETED|Overall Study||5
7890348|NCT00760526|19419310|P2|COMPLETED|Overall Study||68
7890349|NCT00760526|19419311|P1|COMPLETED|Overall Study||69
7890350|NCT00760526|19419310|P2|STARTED|Overall Study||72
7890351|NCT00760526|19419311|P1|STARTED|Overall Study||74
7890352|NCT00760513|19419338|P2|NOT COMPLETED|Overall Study||7
7890353|NCT00760513|19419339|P1|NOT COMPLETED|Overall Study||5
7890354|NCT00760513|19419338|P2|COMPLETED|Overall Study||45
7890355|NCT00760513|19419339|P1|COMPLETED|Overall Study||46
7890356|NCT00760513|19419338|P2|STARTED|Overall Study||52
7890357|NCT00760513|19419339|P1|STARTED|Overall Study||51
7890358|NCT00760487|19419349|P1|NOT COMPLETED|Overall Study||3
7890359|NCT00760487|19419349|P1|COMPLETED|Overall Study||117
7890360|NCT00760487|19419349|P1|STARTED|Overall Study||120
7890361|NCT00760474|19419355|P2|NOT COMPLETED|Period 2 (P2)||1
7890362|NCT00760474|19419356|P1|NOT COMPLETED|Period 2 (P2)||1
7890363|NCT00760474|19419355|P2|COMPLETED|Period 2 (P2)||11
7890364|NCT00760474|19419356|P1|COMPLETED|Period 2 (P2)||11
7890365|NCT00760474|19419355|P2|STARTED|Period 2 (P2)||12
7890366|NCT00760474|19419356|P1|STARTED|Period 2 (P2)||12
7890367|NCT00760474|19419355|P2|NOT COMPLETED|Placebo Washout Period||1
7890368|NCT00760474|19419356|P1|NOT COMPLETED|Placebo Washout Period||0
7890369|NCT00760474|19419355|P2|COMPLETED|Placebo Washout Period||12
7890370|NCT00760474|19419356|P1|COMPLETED|Placebo Washout Period||12
7890371|NCT00760474|19419355|P2|STARTED|Placebo Washout Period||13
7890372|NCT00760474|19419356|P1|STARTED|Placebo Washout Period||12
7890373|NCT00760474|19419355|P2|NOT COMPLETED|Period 1 (P1)||1
7890374|NCT00760474|19419356|P1|NOT COMPLETED|Period 1 (P1)||1
7890375|NCT00760474|19419355|P2|COMPLETED|Period 1 (P1)||13
7890376|NCT00760474|19419356|P1|COMPLETED|Period 1 (P1)||12
7890377|NCT00760474|19419355|P2|Overall Number of Unique Participants|Period 1 (P1)||13
7890378|NCT00760474|19419356|P1|Overall Number of Unique Participants|Period 1 (P1)||12
7890379|NCT00760474|19419355|P2|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14
7890380|NCT00760474|19419356|P1|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13
7890381|NCT00760474|19419355|P2|STARTED|Period 1 (P1)||14
7890382|NCT00760474|19419356|P1|STARTED|Period 1 (P1)||13
7890383|NCT00760461|19419392|P1|NOT COMPLETED|Overall Study||44
7890384|NCT00760461|19419392|P1|COMPLETED|Overall Study||0
7890385|NCT00760461|19419392|P1|STARTED|Overall Study||44
7890386|NCT00760435|19419398|P2|NOT COMPLETED|Overall Study||5
7890387|NCT00760435|19419399|P1|NOT COMPLETED|Overall Study||4
7890388|NCT00760435|19419398|P2|COMPLETED|Overall Study||93
7890389|NCT00760435|19419399|P1|COMPLETED|Overall Study||94
7890390|NCT00760435|19419398|P2|STARTED|Overall Study||98
7890391|NCT00760435|19419399|P1|STARTED|Overall Study||98
7890392|NCT00760383|19419413|P2|NOT COMPLETED|Overall Study||7
7890393|NCT00760383|19419414|P1|NOT COMPLETED|Overall Study||5
7890394|NCT00760383|19419413|P2|COMPLETED|Overall Study||12
7890395|NCT00760383|19419414|P1|COMPLETED|Overall Study||16
7890396|NCT00760383|19419413|P2|STARTED|Overall Study||19
7890397|NCT00760383|19419414|P1|STARTED|Overall Study||21
7890398|NCT00760266|19419426|P2|NOT COMPLETED|Overall Study||18
7890399|NCT00760266|19419427|P1|NOT COMPLETED|Overall Study||24
7890400|NCT00760266|19419426|P2|COMPLETED|Overall Study||205
7890401|NCT00760266|19419427|P1|COMPLETED|Overall Study||204
7890402|NCT00760266|19419426|P2|STARTED|Overall Study||223
7890403|NCT00760266|19419427|P1|STARTED|Overall Study||228
7890404|NCT00760214|19419444|P3|NOT COMPLETED|Overall Study||41
7890405|NCT00760214|19419445|P2|NOT COMPLETED|Overall Study||30
7890406|NCT00760214|19419446|P1|NOT COMPLETED|Overall Study||30
7890407|NCT00760214|19419444|P3|COMPLETED|Overall Study||255
7890408|NCT00760214|19419445|P2|COMPLETED|Overall Study||264
7890409|NCT00760214|19419446|P1|COMPLETED|Overall Study||265
7890410|NCT00760214|19419444|P3|STARTED|Overall Study||296
7890411|NCT00760214|19419445|P2|STARTED|Overall Study||294
7890412|NCT00760214|19419446|P1|STARTED|Overall Study||295
7890413|NCT00760084|19419487|P1|NOT COMPLETED|Overall Study||10
7890414|NCT00760084|19419487|P1|COMPLETED|Overall Study||0
7890415|NCT00760084|19419487|P1|STARTED|Overall Study||10
7890416|NCT00760019|19419493|P4|NOT COMPLETED|Overall Study||0
7890417|NCT00760019|19419494|P3|NOT COMPLETED|Overall Study||0
7890418|NCT00760019|19419495|P2|NOT COMPLETED|Overall Study||0
7890419|NCT00760019|19419496|P1|NOT COMPLETED|Overall Study||0
7890420|NCT00760019|19419493|P4|COMPLETED|Overall Study||14
7890421|NCT00760019|19419494|P3|COMPLETED|Overall Study||14
7890422|NCT00760019|19419495|P2|COMPLETED|Overall Study||15
7890423|NCT00760019|19419496|P1|COMPLETED|Overall Study||15
7890424|NCT00760019|19419493|P4|STARTED|Overall Study||14
7890425|NCT00760019|19419494|P3|STARTED|Overall Study||14
7890426|NCT00760019|19419495|P2|STARTED|Overall Study||15
7890427|NCT00760019|19419496|P1|STARTED|Overall Study||15
7890428|NCT00760006|19419504|P2|NOT COMPLETED|Overall Study||0
7890429|NCT00760006|19419505|P1|NOT COMPLETED|Overall Study||0
7890430|NCT00760006|19419504|P2|COMPLETED|Overall Study||138
7890431|NCT00760006|19419505|P1|COMPLETED|Overall Study||86
7890432|NCT00760006|19419504|P2|STARTED|Overall Study||138
7890433|NCT00760006|19419505|P1|STARTED|Overall Study||86
7890434|NCT00759967|19419511|P2|NOT COMPLETED|Second Intervention||0
7890435|NCT00759967|19419512|P1|NOT COMPLETED|Second Intervention||2
7890436|NCT00759967|19419511|P2|COMPLETED|Second Intervention||9
7890437|NCT00759967|19419512|P1|COMPLETED|Second Intervention||8
7890438|NCT00759967|19419511|P2|STARTED|Second Intervention||9
7890439|NCT00759967|19419512|P1|STARTED|Second Intervention||10
7890440|NCT00759967|19419511|P2|NOT COMPLETED|First Intervention||0
7890441|NCT00759967|19419512|P1|NOT COMPLETED|First Intervention||0
7890442|NCT00759967|19419511|P2|COMPLETED|First Intervention||9
7890443|NCT00759967|19419512|P1|COMPLETED|First Intervention||10
7890444|NCT00759967|19419511|P2|STARTED|First Intervention||9
7890445|NCT00759967|19419512|P1|STARTED|First Intervention||10
7890446|NCT00759954|19419530|P2|NOT COMPLETED|Overall Study||2
7890447|NCT00759954|19419531|P1|NOT COMPLETED|Overall Study||2
7890448|NCT00759954|19419530|P2|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16
7890449|NCT00759954|19419531|P1|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16
7890450|NCT00759954|19419530|P2|STARTED|Overall Study|All assigned participants entered trial|18
7890451|NCT00759954|19419531|P1|STARTED|Overall Study|All assigned participants entered trial|18
7890452|NCT00759941|19419545|P2|NOT COMPLETED|Overall Study||1
7890453|NCT00759941|19419546|P1|NOT COMPLETED|Overall Study||3
7890454|NCT00759941|19419545|P2|COMPLETED|Overall Study||43
7890455|NCT00759941|19419546|P1|COMPLETED|Overall Study||39
7890456|NCT00759941|19419545|P2|STARTED|Overall Study||44
7890457|NCT00759941|19419546|P1|STARTED|Overall Study||42
7890458|NCT00759915|19419560|P2|NOT COMPLETED|Overall Study||1
7890459|NCT00759915|19419561|P1|NOT COMPLETED|Overall Study||1
7890460|NCT00759915|19419560|P2|COMPLETED|Overall Study||17
7890461|NCT00759915|19419561|P1|COMPLETED|Overall Study||17
7890462|NCT00759915|19419560|P2|STARTED|Overall Study||18
7890463|NCT00759915|19419561|P1|STARTED|Overall Study||18
7890464|NCT00759902|19419575|P2|NOT COMPLETED|Overall Study||1
7890465|NCT00759902|19419576|P1|NOT COMPLETED|Overall Study||0
7890466|NCT00759902|19419575|P2|COMPLETED|Overall Study||17
7890467|NCT00759902|19419576|P1|COMPLETED|Overall Study||18
7890468|NCT00759902|19419575|P2|STARTED|Overall Study||18
7890469|NCT00759902|19419576|P1|STARTED|Overall Study||18
7890470|NCT00759876|19419588|P1|NOT COMPLETED|Overall Study||36
7890471|NCT00759876|19419588|P1|COMPLETED|Overall Study||0
7890472|NCT00759876|19419588|P1|Ambulatory Evaluable Population|Overall Study||24
7890473|NCT00759876|19419588|P1|Evaluable Population|Overall Study||35
7890474|NCT00759876|19419588|P1|As-Treated Population|Overall Study||36
7890475|NCT00759876|19419588|P1|STARTED|Overall Study||36
7890476|NCT00759863|19419612|P2|NOT COMPLETED|Overall Study||18
7890477|NCT00759863|19419613|P1|NOT COMPLETED|Overall Study||20
7890478|NCT00759863|19419612|P2|COMPLETED|Overall Study||80
7890479|NCT00759863|19419613|P1|COMPLETED|Overall Study||124
7890480|NCT00759863|19419612|P2|STARTED|Overall Study||98
7890481|NCT00759863|19419613|P1|STARTED|Overall Study||144
7890482|NCT00759811|19419625|P2|NOT COMPLETED|Overall Study||1
7890483|NCT00759811|19419626|P1|NOT COMPLETED|Overall Study||2
7890484|NCT00759811|19419625|P2|COMPLETED|Overall Study||24
7890485|NCT00759811|19419626|P1|COMPLETED|Overall Study||23
7890486|NCT00759811|19419625|P2|STARTED|Overall Study||25
7890487|NCT00759811|19419626|P1|STARTED|Overall Study||25
7890488|NCT00759785|19419634|P2|NOT COMPLETED|Overall Study||5
7890489|NCT00759785|19419635|P1|NOT COMPLETED|Overall Study||12
7890490|NCT00759785|19419634|P2|COMPLETED|Overall Study||17
7890491|NCT00759785|19419635|P1|COMPLETED|Overall Study||14
7890492|NCT00759785|19419634|P2|Treated|Overall Study||20
7890493|NCT00759785|19419635|P1|Treated|Overall Study||25
7890494|NCT00759785|19419634|P2|STARTED|Overall Study||22
7890495|NCT00759785|19419635|P1|STARTED|Overall Study||26
7890496|NCT00759772|19419649|P2|NOT COMPLETED|Overall Study||0
7890497|NCT00759772|19419650|P1|NOT COMPLETED|Overall Study||0
7890498|NCT00759772|19419649|P2|COMPLETED|Overall Study||11
7890499|NCT00759772|19419650|P1|COMPLETED|Overall Study||12
7890500|NCT00759772|19419649|P2|STARTED|Overall Study||11
7890501|NCT00759772|19419650|P1|STARTED|Overall Study||12
7890502|NCT00759759|19419658|P2|NOT COMPLETED|Overall Study||1
7890503|NCT00759759|19419659|P1|NOT COMPLETED|Overall Study||4
7890504|NCT00759759|19419658|P2|COMPLETED|Overall Study||17
7890505|NCT00759759|19419659|P1|COMPLETED|Overall Study||14
7890506|NCT00759759|19419658|P2|STARTED|Overall Study||18
7890507|NCT00759759|19419659|P1|STARTED|Overall Study||18
7890508|NCT00759707|19419671|P1|NOT COMPLETED|Overall Study||0
7890509|NCT00759707|19419671|P1|COMPLETED|Overall Study||19
7890510|NCT00759707|19419671|P1|STARTED|Overall Study||19
7890511|NCT00759681|19419677|P2|NOT COMPLETED|Overall Study||10
7890512|NCT00759681|19419678|P1|NOT COMPLETED|Overall Study||10
7890513|NCT00759681|19419677|P2|COMPLETED|Overall Study||100
7890514|NCT00759681|19419678|P1|COMPLETED|Overall Study||97
7890515|NCT00759681|19419677|P2|STARTED|Overall Study||110
7890516|NCT00759681|19419678|P1|STARTED|Overall Study||107
7890517|NCT00759668|19419688|P2|NOT COMPLETED|Overall Study||3
7890518|NCT00759668|19419689|P1|NOT COMPLETED|Overall Study||1
7890519|NCT00759668|19419688|P2|COMPLETED|Overall Study||15
7890520|NCT00759668|19419689|P1|COMPLETED|Overall Study||16
7890521|NCT00759668|19419688|P2|STARTED|Overall Study||18
7890522|NCT00759668|19419689|P1|STARTED|Overall Study||17
7890523|NCT00759655|19419705|P1|NOT COMPLETED|Overall Study||1
7890524|NCT00759655|19419705|P1|COMPLETED|Overall Study||0
7890525|NCT00759655|19419705|P1|STARTED|Overall Study||1
7890526|NCT00759642|19419716|P1|NOT COMPLETED|Overall Study||0
7890527|NCT00759642|19419716|P1|COMPLETED|Overall Study||33
7890528|NCT00759642|19419716|P1|STARTED|Overall Study||33
7890529|NCT00759603|19419720|P1|NOT COMPLETED|Overall Study||0
7890530|NCT00759603|19419720|P1|COMPLETED|Overall Study||59
7890531|NCT00759603|19419720|P1|STARTED|Overall Study||59
7890532|NCT00759577|19419724|P1|NOT COMPLETED|Overall Study||0
7890533|NCT00759577|19419724|P1|COMPLETED|Overall Study||36
7890534|NCT00759577|19419724|P1|STARTED|Overall Study||36
7890535|NCT00759564|19419733|P5|NOT COMPLETED|Second Intervention Period (4 Days)||0
7890536|NCT00759564|19419734|P4|NOT COMPLETED|Second Intervention Period (4 Days)||0
7890537|NCT00759564|19419735|P3|NOT COMPLETED|Second Intervention Period (4 Days)||0
7890538|NCT00759564|19419736|P2|NOT COMPLETED|Second Intervention Period (4 Days)||0
7890539|NCT00759564|19419737|P1|NOT COMPLETED|Second Intervention Period (4 Days)||0
7890540|NCT00759564|19419733|P5|COMPLETED|Second Intervention Period (4 Days)||3
7890541|NCT00759564|19419734|P4|COMPLETED|Second Intervention Period (4 Days)||1
7890542|NCT00759564|19419735|P3|COMPLETED|Second Intervention Period (4 Days)||8
7890543|NCT00759564|19419736|P2|COMPLETED|Second Intervention Period (4 Days)||8
7890544|NCT00759564|19419737|P1|COMPLETED|Second Intervention Period (4 Days)||8
7890545|NCT00759564|19419733|P5|STARTED|Second Intervention Period (4 Days)||3
7890546|NCT00759564|19419734|P4|STARTED|Second Intervention Period (4 Days)||1
7890547|NCT00759564|19419735|P3|STARTED|Second Intervention Period (4 Days)||8
7890548|NCT00759564|19419736|P2|STARTED|Second Intervention Period (4 Days)||8
7890549|NCT00759564|19419737|P1|STARTED|Second Intervention Period (4 Days)||8
7890550|NCT00759564|19419733|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||1
7890551|NCT00759564|19419734|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7890552|NCT00759564|19419735|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7890553|NCT00759564|19419736|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7890554|NCT00759564|19419737|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
7890555|NCT00759564|19419733|P5|COMPLETED|Washout Period (at Least 14 Days)||3
7890556|NCT00759564|19419734|P4|COMPLETED|Washout Period (at Least 14 Days)||1
7890557|NCT00759564|19419735|P3|COMPLETED|Washout Period (at Least 14 Days)||8
7890558|NCT00759564|19419736|P2|COMPLETED|Washout Period (at Least 14 Days)||8
7890559|NCT00759564|19419737|P1|COMPLETED|Washout Period (at Least 14 Days)||8
7890560|NCT00759564|19419733|P5|STARTED|Washout Period (at Least 14 Days)||4
7890561|NCT00759564|19419734|P4|STARTED|Washout Period (at Least 14 Days)||1
7890562|NCT00759564|19419735|P3|STARTED|Washout Period (at Least 14 Days)||8
7890563|NCT00759564|19419736|P2|STARTED|Washout Period (at Least 14 Days)||8
7890564|NCT00759564|19419737|P1|STARTED|Washout Period (at Least 14 Days)||8
7890565|NCT00759564|19419733|P5|NOT COMPLETED|First Intervention Period (4 Days)||0
7890566|NCT00759564|19419734|P4|NOT COMPLETED|First Intervention Period (4 Days)||0
7890567|NCT00759564|19419735|P3|NOT COMPLETED|First Intervention Period (4 Days)||0
7890568|NCT00759564|19419736|P2|NOT COMPLETED|First Intervention Period (4 Days)||0
7890569|NCT00759564|19419737|P1|NOT COMPLETED|First Intervention Period (4 Days)||0
7890570|NCT00759564|19419733|P5|COMPLETED|First Intervention Period (4 Days)||4
7890571|NCT00759564|19419734|P4|COMPLETED|First Intervention Period (4 Days)||1
7890572|NCT00759564|19419735|P3|COMPLETED|First Intervention Period (4 Days)||8
7890573|NCT00759564|19419736|P2|COMPLETED|First Intervention Period (4 Days)||8
7890574|NCT00759564|19419737|P1|COMPLETED|First Intervention Period (4 Days)||8
7890575|NCT00759564|19419733|P5|STARTED|First Intervention Period (4 Days)||4
7890576|NCT00759564|19419734|P4|STARTED|First Intervention Period (4 Days)||1
7890577|NCT00759564|19419735|P3|STARTED|First Intervention Period (4 Days)||8
7890578|NCT00759564|19419736|P2|STARTED|First Intervention Period (4 Days)||8
7890579|NCT00759564|19419737|P1|STARTED|First Intervention Period (4 Days)||8
7890580|NCT00759525|19419877|P2|NOT COMPLETED|Second Intervention (14 Days)||0
7890581|NCT00759525|19419878|P1|NOT COMPLETED|Second Intervention (14 Days)||0
7890582|NCT00759525|19419877|P2|COMPLETED|Second Intervention (14 Days)||8
7890583|NCT00759525|19419878|P1|COMPLETED|Second Intervention (14 Days)||7
7890584|NCT00759525|19419877|P2|STARTED|Second Intervention (14 Days)||8
7890585|NCT00759525|19419878|P1|STARTED|Second Intervention (14 Days)||7
7890586|NCT00759525|19419877|P2|NOT COMPLETED|Washout (14 Days)||0
7890587|NCT00759525|19419878|P1|NOT COMPLETED|Washout (14 Days)||0
7890588|NCT00759525|19419877|P2|COMPLETED|Washout (14 Days)||8
7890589|NCT00759525|19419878|P1|COMPLETED|Washout (14 Days)||7
7890590|NCT00759525|19419877|P2|STARTED|Washout (14 Days)||8
7890591|NCT00759525|19419878|P1|STARTED|Washout (14 Days)||7
7890592|NCT00759525|19419877|P2|NOT COMPLETED|First Intervention (14 Days)||0
7890593|NCT00759525|19419878|P1|NOT COMPLETED|First Intervention (14 Days)||0
7890594|NCT00759525|19419877|P2|COMPLETED|First Intervention (14 Days)||8
7890595|NCT00759525|19419878|P1|COMPLETED|First Intervention (14 Days)||7
7890596|NCT00759525|19419877|P2|STARTED|First Intervention (14 Days)||8
7890597|NCT00759525|19419878|P1|STARTED|First Intervention (14 Days)||7
7890598|NCT00759473|19419889|P5|NOT COMPLETED|Overall Study||0
7890599|NCT00759473|19419890|P4|NOT COMPLETED|Overall Study||0
7890600|NCT00759473|19419891|P3|NOT COMPLETED|Overall Study||0
7890601|NCT00759473|19419892|P2|NOT COMPLETED|Overall Study||0
7890602|NCT00759473|19419893|P1|NOT COMPLETED|Overall Study||0
7890603|NCT00759473|19419889|P5|COMPLETED|Overall Study||24
7890604|NCT00759473|19419890|P4|COMPLETED|Overall Study||23
7890605|NCT00759473|19419891|P3|COMPLETED|Overall Study||12
7890606|NCT00759473|19419892|P2|COMPLETED|Overall Study||10
7890607|NCT00759473|19419893|P1|COMPLETED|Overall Study||10
7890608|NCT00759473|19419889|P5|STARTED|Overall Study||24
7890609|NCT00759473|19419890|P4|STARTED|Overall Study||23
7890610|NCT00759473|19419891|P3|STARTED|Overall Study||12
7890611|NCT00759473|19419892|P2|STARTED|Overall Study||10
7890612|NCT00759473|19419893|P1|STARTED|Overall Study||10
7890613|NCT00759408|19419905|P1|NOT COMPLETED|Overall Study||19
7890614|NCT00759408|19419905|P1|COMPLETED|Overall Study||19
7890615|NCT00759408|19419905|P1|STARTED|Overall Study||38
7890616|NCT00759395|19419914|P2|NOT COMPLETED|Overall Study||2
7890617|NCT00759395|19419915|P1|NOT COMPLETED|Overall Study||2
7890618|NCT00759395|19419914|P2|COMPLETED|Overall Study||7
7890619|NCT00759395|19419915|P1|COMPLETED|Overall Study||11
7890620|NCT00759395|19419914|P2|STARTED|Overall Study||9
7890621|NCT00759395|19419915|P1|STARTED|Overall Study||13
7890622|NCT00759356|19419931|P2|NOT COMPLETED|Overall Study||3
7890623|NCT00759356|19419932|P1|NOT COMPLETED|Overall Study||1
7890624|NCT00759356|19419931|P2|COMPLETED|Overall Study||15
7890625|NCT00759356|19419932|P1|COMPLETED|Overall Study||17
7890626|NCT00759356|19419931|P2|STARTED|Overall Study||18
7890627|NCT00759356|19419932|P1|STARTED|Overall Study||18
7890628|NCT00759330|19419948|P4|NOT COMPLETED|Overall Study||2
7890629|NCT00759330|19419949|P3|NOT COMPLETED|Overall Study||0
7890630|NCT00759330|19419950|P2|NOT COMPLETED|Overall Study||1
7890631|NCT00759330|19419951|P1|NOT COMPLETED|Overall Study||1
7890632|NCT00759330|19419948|P4|COMPLETED|Overall Study||41
7890633|NCT00759330|19419949|P3|COMPLETED|Overall Study||22
7890634|NCT00759330|19419950|P2|COMPLETED|Overall Study||41
7890635|NCT00759330|19419951|P1|COMPLETED|Overall Study||19
7890636|NCT00759330|19419948|P4|STARTED|Overall Study||43
7890637|NCT00759330|19419949|P3|STARTED|Overall Study||22
7890638|NCT00759330|19419950|P2|STARTED|Overall Study||42
7890639|NCT00759330|19419951|P1|STARTED|Overall Study||20
7890640|NCT00759187|19420000|P3|NOT COMPLETED|Overall Study||0
7890641|NCT00759187|19420001|P2|NOT COMPLETED|Overall Study||0
7890642|NCT00759187|19420002|P1|NOT COMPLETED|Overall Study||0
7890643|NCT00759187|19420000|P3|COMPLETED|Overall Study||9
7890644|NCT00759187|19420001|P2|COMPLETED|Overall Study||8
7890645|NCT00759187|19420002|P1|COMPLETED|Overall Study||8
7890646|NCT00759187|19420000|P3|STARTED|Overall Study||9
7890647|NCT00759187|19420001|P2|STARTED|Overall Study||8
7890648|NCT00759187|19420002|P1|STARTED|Overall Study||8
7890649|NCT00759174|19420012|P2|NOT COMPLETED|Overall Study||2
7890650|NCT00759174|19420013|P1|NOT COMPLETED|Overall Study||0
7890651|NCT00759174|19420012|P2|COMPLETED|Overall Study||595
7890652|NCT00759174|19420013|P1|COMPLETED|Overall Study||76
7890653|NCT00759174|19420012|P2|STARTED|Overall Study||597
7890654|NCT00759174|19420013|P1|STARTED|Overall Study||76
7890655|NCT00759161|19420022|P1|NOT COMPLETED|Overall Study||0
7890656|NCT00759161|19420022|P1|COMPLETED|Overall Study||35
7890657|NCT00759161|19420022|P1|STARTED|Overall Study||35
7890658|NCT00759148|19420037|P2|NOT COMPLETED|Overall Study||32
7890659|NCT00759148|19420038|P1|NOT COMPLETED|Overall Study||14
7890660|NCT00759148|19420037|P2|COMPLETED|Overall Study||554
7890661|NCT00759148|19420038|P1|COMPLETED|Overall Study||579
7890662|NCT00759148|19420037|P2|STARTED|Overall Study||586
7890663|NCT00759148|19420038|P1|STARTED|Overall Study||593
7890664|NCT00759109|19420048|P2|NOT COMPLETED|Overall Study||35
7890665|NCT00759109|19420049|P1|NOT COMPLETED|Overall Study||39
7890666|NCT00759109|19420048|P2|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41
7890667|NCT00759109|19420049|P1|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35
7890668|NCT00759109|19420048|P2|STARTED|Overall Study||76
7890669|NCT00759109|19420049|P1|STARTED|Overall Study||74
7890670|NCT00759096|19420065|P1|NOT COMPLETED|Overall Study||0
7890671|NCT00759096|19420065|P1|COMPLETED|Overall Study||30
7890672|NCT00759096|19420065|P1|STARTED|Overall Study||30
7890673|NCT00759031|19420071|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7890674|NCT00759031|19420072|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7890675|NCT00759031|19420071|P2|COMPLETED|Second Intervention (1 Day)||8
7890676|NCT00759031|19420072|P1|COMPLETED|Second Intervention (1 Day)||8
7890677|NCT00759031|19420071|P2|STARTED|Second Intervention (1 Day)||8
7890678|NCT00759031|19420072|P1|STARTED|Second Intervention (1 Day)||8
7890679|NCT00759031|19420071|P2|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
7890680|NCT00759031|19420072|P1|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
7890681|NCT00759031|19420071|P2|COMPLETED|Washout After 1st Intervention (1 Week)||8
7890682|NCT00759031|19420072|P1|COMPLETED|Washout After 1st Intervention (1 Week)||8
7890683|NCT00759031|19420071|P2|STARTED|Washout After 1st Intervention (1 Week)||8
7890684|NCT00759031|19420072|P1|STARTED|Washout After 1st Intervention (1 Week)||8
7890685|NCT00759031|19420071|P2|NOT COMPLETED|First Intervention (1 Day)||1
7890686|NCT00759031|19420072|P1|NOT COMPLETED|First Intervention (1 Day)||2
7890687|NCT00759031|19420071|P2|COMPLETED|First Intervention (1 Day)||8
7890688|NCT00759031|19420072|P1|COMPLETED|First Intervention (1 Day)||8
7890689|NCT00759031|19420071|P2|STARTED|First Intervention (1 Day)||9
7890690|NCT00759031|19420072|P1|STARTED|First Intervention (1 Day)||10
7890691|NCT00758862|19420078|P1|NOT COMPLETED|Overall Study||1
7890692|NCT00758862|19420078|P1|COMPLETED|Overall Study||19
7890693|NCT00758862|19420078|P1|STARTED|Overall Study||20
7890694|NCT00758836|19420098|P4|NOT COMPLETED|Overall Study||32
7890695|NCT00758836|19420099|P3|NOT COMPLETED|Overall Study||38
7890696|NCT00758836|19420100|P2|NOT COMPLETED|Overall Study||26
7890697|NCT00758836|19420101|P1|NOT COMPLETED|Overall Study||24
7890698|NCT00758836|19420098|P4|COMPLETED|Overall Study||138
7890699|NCT00758836|19420099|P3|COMPLETED|Overall Study||133
7890700|NCT00758836|19420100|P2|COMPLETED|Overall Study||145
7890701|NCT00758836|19420101|P1|COMPLETED|Overall Study||147
7890702|NCT00758836|19420098|P4|Treated|Overall Study||138
7890703|NCT00758836|19420099|P3|Treated|Overall Study||133
7890704|NCT00758836|19420100|P2|Treated|Overall Study||145
7890705|NCT00758836|19420101|P1|Treated|Overall Study||147
7890706|NCT00758836|19420098|P4|STARTED|Overall Study||170
7890707|NCT00758836|19420099|P3|STARTED|Overall Study||171
7890708|NCT00758836|19420100|P2|STARTED|Overall Study||171
7890709|NCT00758836|19420101|P1|STARTED|Overall Study||171
7890710|NCT00758784|19420123|P1|NOT COMPLETED|Overall Study||2
7890711|NCT00758784|19420123|P1|COMPLETED|Overall Study||36
7890712|NCT00758784|19420123|P1|STARTED|Overall Study||38
7890713|NCT00758771|19420131|P2|NOT COMPLETED|Overall Study||5
7890714|NCT00758771|19420132|P1|NOT COMPLETED|Overall Study||3
7890715|NCT00758771|19420131|P2|COMPLETED|Overall Study||15
7890716|NCT00758771|19420132|P1|COMPLETED|Overall Study||15
7890717|NCT00758771|19420131|P2|STARTED|Overall Study||20
7890718|NCT00758771|19420132|P1|STARTED|Overall Study||18
7890719|NCT00758758|19420146|P8|NOT COMPLETED|Overall Study||0
7890720|NCT00758758|19420147|P7|NOT COMPLETED|Overall Study||14
7890721|NCT00758758|19420148|P6|NOT COMPLETED|Overall Study||14
7890722|NCT00758758|19420149|P5|NOT COMPLETED|Overall Study||2
7890723|NCT00758758|19420150|P4|NOT COMPLETED|Overall Study||2
7890724|NCT00758758|19420151|P3|NOT COMPLETED|Overall Study||18
7890725|NCT00758758|19420152|P2|NOT COMPLETED|Overall Study||25
7890726|NCT00758758|19420153|P1|NOT COMPLETED|Overall Study||3
7890727|NCT00758758|19420146|P8|COMPLETED|Overall Study||0
7890728|NCT00758758|19420147|P7|COMPLETED|Overall Study||17
7890729|NCT00758758|19420148|P6|COMPLETED|Overall Study||36
7890730|NCT00758758|19420149|P5|COMPLETED|Overall Study||1
7890731|NCT00758758|19420150|P4|COMPLETED|Overall Study||4
7890732|NCT00758758|19420151|P3|COMPLETED|Overall Study||35
7890733|NCT00758758|19420152|P2|COMPLETED|Overall Study||49
7890734|NCT00758758|19420153|P1|COMPLETED|Overall Study||11
7890735|NCT00758758|19420146|P8|STARTED|Overall Study||0
7890736|NCT00758758|19420147|P7|STARTED|Overall Study||31
7890737|NCT00758758|19420148|P6|STARTED|Overall Study||50
7890738|NCT00758758|19420149|P5|STARTED|Overall Study||3
7890739|NCT00758758|19420150|P4|STARTED|Overall Study||6
7890740|NCT00758758|19420151|P3|STARTED|Overall Study||53
7890741|NCT00758758|19420152|P2|STARTED|Overall Study||74
7890742|NCT00758758|19420153|P1|STARTED|Overall Study||14
7890743|NCT00758745|19420181|P2|NOT COMPLETED|Overall Study||21
7890744|NCT00758745|19420182|P1|NOT COMPLETED|Overall Study||21
7890745|NCT00758745|19420181|P2|COMPLETED|Overall Study||60
7890746|NCT00758745|19420182|P1|COMPLETED|Overall Study||60
7890747|NCT00758745|19420181|P2|STARTED|Overall Study||81
7890748|NCT00758745|19420182|P1|STARTED|Overall Study||81
7890749|NCT00758706|19420190|P2|NOT COMPLETED|Overall Study||4
7890750|NCT00758706|19420191|P1|NOT COMPLETED|Overall Study||4
7890751|NCT00758706|19420190|P2|COMPLETED|Overall Study||25
7890752|NCT00758706|19420191|P1|COMPLETED|Overall Study||22
7890753|NCT00758706|19420190|P2|STARTED|Overall Study||29
7890754|NCT00758706|19420191|P1|STARTED|Overall Study||26
7890755|NCT00758680|19420227|P10|NOT COMPLETED|Overall Study||1
7890756|NCT00758680|19420228|P9|NOT COMPLETED|Overall Study||2
7890757|NCT00758680|19420229|P8|NOT COMPLETED|Overall Study||1
7890758|NCT00758680|19420230|P7|NOT COMPLETED|Overall Study||1
7890759|NCT00758680|19420231|P6|NOT COMPLETED|Overall Study||0
7890760|NCT00758680|19420232|P5|NOT COMPLETED|Overall Study||0
7890761|NCT00758680|19420233|P4|NOT COMPLETED|Overall Study||0
7890762|NCT00758680|19420234|P3|NOT COMPLETED|Overall Study||0
7890763|NCT00758680|19420235|P2|NOT COMPLETED|Overall Study||0
7890764|NCT00758680|19420236|P1|NOT COMPLETED|Overall Study||0
7890765|NCT00758680|19420227|P10|COMPLETED|Overall Study||28
7890766|NCT00758680|19420228|P9|COMPLETED|Overall Study||18
7890767|NCT00758680|19420229|P8|COMPLETED|Overall Study||19
7890768|NCT00758680|19420230|P7|COMPLETED|Overall Study||6
7890769|NCT00758680|19420231|P6|COMPLETED|Overall Study||6
7890770|NCT00758680|19420232|P5|COMPLETED|Overall Study||6
7890771|NCT00758680|19420233|P4|COMPLETED|Overall Study||6
7890772|NCT00758680|19420234|P3|COMPLETED|Overall Study||6
7890773|NCT00758680|19420235|P2|COMPLETED|Overall Study||6
7890774|NCT00758680|19420236|P1|COMPLETED|Overall Study||6
7890775|NCT00758680|19420227|P10|STARTED|Overall Study||29
7890776|NCT00758680|19420228|P9|STARTED|Overall Study||20
7890777|NCT00758680|19420229|P8|STARTED|Overall Study||20
7890778|NCT00758680|19420230|P7|STARTED|Overall Study||7
7890779|NCT00758680|19420231|P6|STARTED|Overall Study||6
7890780|NCT00758680|19420232|P5|STARTED|Overall Study||6
7890781|NCT00758680|19420233|P4|STARTED|Overall Study||6
7890782|NCT00758680|19420234|P3|STARTED|Overall Study||6
7890783|NCT00758680|19420235|P2|STARTED|Overall Study||6
7890784|NCT00758680|19420236|P1|STARTED|Overall Study||6
7890785|NCT00758667|19420278|P2|NOT COMPLETED|Overall Study||0
7890786|NCT00758667|19420279|P1|NOT COMPLETED|Overall Study||0
7890787|NCT00758667|19420278|P2|COMPLETED|Overall Study||11
7890788|NCT00758667|19420279|P1|COMPLETED|Overall Study||9
7890789|NCT00758667|19420278|P2|STARTED|Overall Study||11
7890790|NCT00758667|19420279|P1|STARTED|Overall Study||9
7890791|NCT00758602|19420289|P2|NOT COMPLETED|Overall Study||22
7890792|NCT00758602|19420290|P1|NOT COMPLETED|Overall Study||19
7890793|NCT00758602|19420289|P2|COMPLETED|Overall Study||84
7890794|NCT00758602|19420290|P1|COMPLETED|Overall Study||85
7890795|NCT00758602|19420289|P2|STARTED|Overall Study||106
7890796|NCT00758602|19420290|P1|STARTED|Overall Study||104
7890797|NCT00758589|19420316|P4|NOT COMPLETED|Overall Study||6
7890798|NCT00758589|19420317|P3|NOT COMPLETED|Overall Study||6
7890799|NCT00758589|19420318|P2|NOT COMPLETED|Overall Study||3
7890800|NCT00758589|19420319|P1|NOT COMPLETED|Overall Study||3
7890801|NCT00758589|19420316|P4|COMPLETED|Overall Study||85
7890802|NCT00758589|19420317|P3|COMPLETED|Overall Study||86
7890803|NCT00758589|19420318|P2|COMPLETED|Overall Study||87
7890804|NCT00758589|19420319|P1|COMPLETED|Overall Study||92
7890805|NCT00758589|19420316|P4|STARTED|Overall Study||91
7890806|NCT00758589|19420317|P3|STARTED|Overall Study||92
7890807|NCT00758589|19420318|P2|STARTED|Overall Study||90
7890808|NCT00758589|19420319|P1|STARTED|Overall Study||95
7890809|NCT00758576|19420385|P1|NOT COMPLETED|Overall Study||1
7890810|NCT00758576|19420385|P1|COMPLETED|Overall Study||63
7890811|NCT00758576|19420385|P1|STARTED|Overall Study||64
7890812|NCT00758563|19420393|P2|NOT COMPLETED|Overall Study||0
7890813|NCT00758563|19420394|P1|NOT COMPLETED|Overall Study||0
7890814|NCT00758563|19420393|P2|COMPLETED|Overall Study||8
7890815|NCT00758563|19420394|P1|COMPLETED|Overall Study||7
7890816|NCT00758563|19420393|P2|STARTED|Overall Study||8
7890817|NCT00758563|19420394|P1|STARTED|Overall Study||7
7890818|NCT00758550|19420400|P2|NOT COMPLETED|Overall Study||0
7890819|NCT00758550|19420401|P1|NOT COMPLETED|Overall Study||0
7890820|NCT00758550|19420400|P2|COMPLETED|Overall Study||30
7890821|NCT00758550|19420401|P1|COMPLETED|Overall Study||30
7890822|NCT00758550|19420400|P2|STARTED|Overall Study||30
7890823|NCT00758550|19420401|P1|STARTED|Overall Study||30
7890824|NCT00758498|19420412|P3|NOT COMPLETED|Overall Study||5
7890825|NCT00758498|19420413|P2|NOT COMPLETED|Overall Study||2
7890826|NCT00758498|19420414|P1|NOT COMPLETED|Overall Study||3
7890827|NCT00758498|19420412|P3|COMPLETED|Overall Study||137
7890828|NCT00758498|19420413|P2|COMPLETED|Overall Study||141
7890829|NCT00758498|19420414|P1|COMPLETED|Overall Study||139
7890830|NCT00758498|19420412|P3|STARTED|Overall Study||142
7890831|NCT00758498|19420413|P2|STARTED|Overall Study||143
7890832|NCT00758498|19420414|P1|STARTED|Overall Study||142
7890833|NCT00758485|19420499|P2|NOT COMPLETED|Overall Study||3
7890834|NCT00758485|19420500|P1|NOT COMPLETED|Overall Study||1
7890835|NCT00758485|19420499|P2|COMPLETED|Overall Study||67
7890836|NCT00758485|19420500|P1|COMPLETED|Overall Study||69
7890837|NCT00758485|19420499|P2|TREATED|Overall Study||68
7890838|NCT00758485|19420500|P1|TREATED|Overall Study||69
7890839|NCT00758485|19420499|P2|STARTED|Overall Study||70
7890840|NCT00758485|19420500|P1|STARTED|Overall Study||70
7890841|NCT00758459|19420512|P2|NOT COMPLETED|Overall Study||4
7890842|NCT00758459|19420513|P1|NOT COMPLETED|Overall Study||3
7890843|NCT00758459|19420512|P2|COMPLETED|Overall Study||35
7890844|NCT00758459|19420513|P1|COMPLETED|Overall Study||32
7890845|NCT00758459|19420512|P2|STARTED|Overall Study||39
7890846|NCT00758459|19420513|P1|STARTED|Overall Study||35
7890847|NCT00758420|19420547|P2|NOT COMPLETED|Overall Study||0
7890848|NCT00758420|19420548|P1|NOT COMPLETED|Overall Study||0
7890849|NCT00758420|19420547|P2|COMPLETED|Overall Study||38
7890850|NCT00758420|19420548|P1|COMPLETED|Overall Study||39
7890851|NCT00758420|19420547|P2|STARTED|Overall Study||38
7890852|NCT00758420|19420548|P1|STARTED|Overall Study||39
7890853|NCT00758394|19420558|P4|NOT COMPLETED|4th Intervention||0
7890854|NCT00758394|19420559|P3|NOT COMPLETED|4th Intervention||0
7890855|NCT00758394|19420560|P2|NOT COMPLETED|4th Intervention||0
7890856|NCT00758394|19420561|P1|NOT COMPLETED|4th Intervention||0
7890857|NCT00758394|19420558|P4|COMPLETED|4th Intervention||7
7890858|NCT00758394|19420559|P3|COMPLETED|4th Intervention||6
7890859|NCT00758394|19420560|P2|COMPLETED|4th Intervention||6
7890860|NCT00758394|19420561|P1|COMPLETED|4th Intervention||7
7890861|NCT00758394|19420558|P4|STARTED|4th Intervention||7
7890862|NCT00758394|19420559|P3|STARTED|4th Intervention||6
7890863|NCT00758394|19420560|P2|STARTED|4th Intervention||6
7890864|NCT00758394|19420561|P1|STARTED|4th Intervention||7
7890865|NCT00758394|19420558|P4|NOT COMPLETED|Washout After 3rd Intervention||0
7890866|NCT00758394|19420559|P3|NOT COMPLETED|Washout After 3rd Intervention||0
7890867|NCT00758394|19420560|P2|NOT COMPLETED|Washout After 3rd Intervention||0
7890868|NCT00758394|19420561|P1|NOT COMPLETED|Washout After 3rd Intervention||0
7890869|NCT00758394|19420558|P4|COMPLETED|Washout After 3rd Intervention||7
7890870|NCT00758394|19420559|P3|COMPLETED|Washout After 3rd Intervention||6
7890871|NCT00758394|19420560|P2|COMPLETED|Washout After 3rd Intervention||6
7890872|NCT00758394|19420561|P1|COMPLETED|Washout After 3rd Intervention||7
7890873|NCT00758394|19420558|P4|STARTED|Washout After 3rd Intervention||7
7890874|NCT00758394|19420559|P3|STARTED|Washout After 3rd Intervention||6
7890875|NCT00758394|19420560|P2|STARTED|Washout After 3rd Intervention||6
7890876|NCT00758394|19420561|P1|STARTED|Washout After 3rd Intervention||7
7890877|NCT00758394|19420558|P4|NOT COMPLETED|3rd Intervention||1
7890878|NCT00758394|19420559|P3|NOT COMPLETED|3rd Intervention||0
7890879|NCT00758394|19420560|P2|NOT COMPLETED|3rd Intervention||0
7890880|NCT00758394|19420561|P1|NOT COMPLETED|3rd Intervention||1
7890881|NCT00758394|19420558|P4|COMPLETED|3rd Intervention||7
7890882|NCT00758394|19420559|P3|COMPLETED|3rd Intervention||6
7890883|NCT00758394|19420560|P2|COMPLETED|3rd Intervention||6
7890884|NCT00758394|19420561|P1|COMPLETED|3rd Intervention||7
7890885|NCT00758394|19420558|P4|STARTED|3rd Intervention||8
7890886|NCT00758394|19420559|P3|STARTED|3rd Intervention||6
7890887|NCT00758394|19420560|P2|STARTED|3rd Intervention||6
7890888|NCT00758394|19420561|P1|STARTED|3rd Intervention||8
7890889|NCT00758394|19420558|P4|NOT COMPLETED|Washout After 2nd Intervention||0
7890890|NCT00758394|19420559|P3|NOT COMPLETED|Washout After 2nd Intervention||0
7890891|NCT00758394|19420560|P2|NOT COMPLETED|Washout After 2nd Intervention||0
7890892|NCT00758394|19420561|P1|NOT COMPLETED|Washout After 2nd Intervention||0
7890893|NCT00758394|19420558|P4|COMPLETED|Washout After 2nd Intervention||8
7890894|NCT00758394|19420559|P3|COMPLETED|Washout After 2nd Intervention||6
7890895|NCT00758394|19420560|P2|COMPLETED|Washout After 2nd Intervention||6
7890896|NCT00758394|19420561|P1|COMPLETED|Washout After 2nd Intervention||8
7890897|NCT00758394|19420558|P4|STARTED|Washout After 2nd Intervention||8
7890898|NCT00758394|19420559|P3|STARTED|Washout After 2nd Intervention||6
7890899|NCT00758394|19420560|P2|STARTED|Washout After 2nd Intervention||6
7890900|NCT00758394|19420561|P1|STARTED|Washout After 2nd Intervention||8
7890901|NCT00758394|19420558|P4|NOT COMPLETED|2nd Intervention Order||0
7890902|NCT00758394|19420559|P3|NOT COMPLETED|2nd Intervention Order||0
7890903|NCT00758394|19420560|P2|NOT COMPLETED|2nd Intervention Order||1
7890904|NCT00758394|19420561|P1|NOT COMPLETED|2nd Intervention Order||0
7890905|NCT00758394|19420558|P4|COMPLETED|2nd Intervention Order||8
7890906|NCT00758394|19420559|P3|COMPLETED|2nd Intervention Order||6
7890907|NCT00758394|19420560|P2|COMPLETED|2nd Intervention Order||6
7890908|NCT00758394|19420561|P1|COMPLETED|2nd Intervention Order||8
7890909|NCT00758394|19420558|P4|STARTED|2nd Intervention Order||8
7890910|NCT00758394|19420559|P3|STARTED|2nd Intervention Order||6
7890911|NCT00758394|19420560|P2|STARTED|2nd Intervention Order||7
7890912|NCT00758394|19420561|P1|STARTED|2nd Intervention Order||8
7890913|NCT00758394|19420558|P4|NOT COMPLETED|Washout After 1st Intervention||0
7890914|NCT00758394|19420559|P3|NOT COMPLETED|Washout After 1st Intervention||0
7890915|NCT00758394|19420560|P2|NOT COMPLETED|Washout After 1st Intervention||0
7890916|NCT00758394|19420561|P1|NOT COMPLETED|Washout After 1st Intervention||0
7890917|NCT00758394|19420558|P4|COMPLETED|Washout After 1st Intervention||8
7890918|NCT00758394|19420559|P3|COMPLETED|Washout After 1st Intervention||6
7890919|NCT00758394|19420560|P2|COMPLETED|Washout After 1st Intervention||7
7890920|NCT00758394|19420561|P1|COMPLETED|Washout After 1st Intervention||8
7890921|NCT00758394|19420558|P4|STARTED|Washout After 1st Intervention||8
7890922|NCT00758394|19420559|P3|STARTED|Washout After 1st Intervention||6
7890923|NCT00758394|19420560|P2|STARTED|Washout After 1st Intervention||7
7890924|NCT00758394|19420561|P1|STARTED|Washout After 1st Intervention||8
7890925|NCT00758394|19420558|P4|NOT COMPLETED|1st Intervention||0
7890926|NCT00758394|19420559|P3|NOT COMPLETED|1st Intervention||0
7890927|NCT00758394|19420560|P2|NOT COMPLETED|1st Intervention||0
7890928|NCT00758394|19420561|P1|NOT COMPLETED|1st Intervention||0
7890929|NCT00758394|19420558|P4|COMPLETED|1st Intervention||8
7890930|NCT00758394|19420559|P3|COMPLETED|1st Intervention||6
7890931|NCT00758394|19420560|P2|COMPLETED|1st Intervention||7
7890932|NCT00758394|19420561|P1|COMPLETED|1st Intervention||8
7890933|NCT00758394|19420558|P4|STARTED|1st Intervention||8
7890934|NCT00758394|19420559|P3|STARTED|1st Intervention||6
7890935|NCT00758394|19420560|P2|STARTED|1st Intervention||7
7890936|NCT00758394|19420561|P1|STARTED|1st Intervention||8
7890937|NCT00758342|19420573|P2|NOT COMPLETED|Overall Study||1
7890938|NCT00758342|19420574|P1|NOT COMPLETED|Overall Study||4
7890939|NCT00758342|19420573|P2|COMPLETED|Overall Study||17
7890940|NCT00758342|19420574|P1|COMPLETED|Overall Study||15
7890941|NCT00758342|19420573|P2|STARTED|Overall Study||18
7890942|NCT00758342|19420574|P1|STARTED|Overall Study||19
7890943|NCT00758290|19420582|P2|NOT COMPLETED|Overall Study||0
7890944|NCT00758290|19420583|P1|NOT COMPLETED|Overall Study||0
7890945|NCT00758290|19420582|P2|COMPLETED|Overall Study||12
7890946|NCT00758290|19420583|P1|COMPLETED|Overall Study||11
7890947|NCT00758290|19420582|P2|STARTED|Overall Study||12
7890948|NCT00758290|19420583|P1|STARTED|Overall Study||11
7890949|NCT00758264|19420590|P3|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
7890950|NCT00758264|19420591|P2|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
7890951|NCT00758264|19420592|P1|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
7890952|NCT00758264|19420590|P3|COMPLETED|Extended Safety Follow Up (ESFU) Phase||89
7890953|NCT00758264|19420591|P2|COMPLETED|Extended Safety Follow Up (ESFU) Phase||90
7890954|NCT00758264|19420592|P1|COMPLETED|Extended Safety Follow Up (ESFU) Phase||181
7890955|NCT00758264|19420590|P3|STARTED|Extended Safety Follow Up (ESFU) Phase||89
7890956|NCT00758264|19420591|P2|STARTED|Extended Safety Follow Up (ESFU) Phase||90
7890957|NCT00758264|19420592|P1|STARTED|Extended Safety Follow Up (ESFU) Phase||181
7890958|NCT00758264|19420590|P3|NOT COMPLETED|Active Phase||5
7890959|NCT00758264|19420591|P2|NOT COMPLETED|Active Phase||0
7890960|NCT00758264|19420592|P1|NOT COMPLETED|Active Phase||1
7890961|NCT00758264|19420590|P3|COMPLETED|Active Phase||85
7890962|NCT00758264|19420591|P2|COMPLETED|Active Phase||91
7890963|NCT00758264|19420592|P1|COMPLETED|Active Phase||181
7890964|NCT00758264|19420590|P3|STARTED|Active Phase||90
7890965|NCT00758264|19420591|P2|STARTED|Active Phase||91
7890966|NCT00758264|19420592|P1|STARTED|Active Phase||182
7890967|NCT00758160|19420651|P1|NOT COMPLETED|Overall Study||66
7890968|NCT00758160|19420651|P1|COMPLETED|Overall Study||230
7890969|NCT00758160|19420651|P1|STARTED|Overall Study||296
7890970|NCT00758069|19420672|P3|NOT COMPLETED|Overall Study||1
7890971|NCT00758069|19420673|P2|NOT COMPLETED|Overall Study||0
7890972|NCT00758069|19420674|P1|NOT COMPLETED|Overall Study||1
7890973|NCT00758069|19420672|P3|COMPLETED|Overall Study||27
7890974|NCT00758069|19420673|P2|COMPLETED|Overall Study||25
7890975|NCT00758069|19420674|P1|COMPLETED|Overall Study||26
7890976|NCT00758069|19420672|P3|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28
7890977|NCT00758069|19420673|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25
7890978|NCT00758069|19420674|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27
7890979|NCT00758043|19420689|P4|NOT COMPLETED|Overall Study||100
7890980|NCT00758043|19420690|P3|NOT COMPLETED|Overall Study||39
7890981|NCT00758043|19420691|P2|NOT COMPLETED|Overall Study||41
7890982|NCT00758043|19420692|P1|NOT COMPLETED|Overall Study||1
7890983|NCT00758043|19420689|P4|COMPLETED|Overall Study||0
7890984|NCT00758043|19420690|P3|COMPLETED|Overall Study||79
7890985|NCT00758043|19420691|P2|COMPLETED|Overall Study||119
7890986|NCT00758043|19420692|P1|COMPLETED|Overall Study||161
7890987|NCT00758043|19420689|P4|STARTED|Overall Study||100
7890988|NCT00758043|19420690|P3|STARTED|Overall Study||118
7890989|NCT00758043|19420691|P2|STARTED|Overall Study||160
7890990|NCT00758043|19420692|P1|STARTED|Overall Study||162
7890991|NCT00757848|19420720|P2|NOT COMPLETED|Overall Study||2
7890992|NCT00757848|19420721|P1|NOT COMPLETED|Overall Study||3
7890993|NCT00757848|19420720|P2|COMPLETED|Overall Study||27
7890994|NCT00757848|19420721|P1|COMPLETED|Overall Study||24
7890995|NCT00757848|19420720|P2|STARTED|Overall Study||29
7890996|NCT00757848|19420721|P1|STARTED|Overall Study||27
7890997|NCT00757822|19420767|P2|NOT COMPLETED|Overall Study||31
7890998|NCT00757822|19420768|P1|NOT COMPLETED|Overall Study||28
7890999|NCT00757822|19420767|P2|COMPLETED|Overall Study||57
7891000|NCT00757822|19420768|P1|COMPLETED|Overall Study||64
7891001|NCT00757822|19420767|P2|Data Lock, Unblinding Analysis|Overall Study||57
7891002|NCT00757822|19420768|P1|Data Lock, Unblinding Analysis|Overall Study||64
7891003|NCT00757822|19420767|P2|Withdrawn-protocol Deviation|Overall Study||8
7891004|NCT00757822|19420768|P1|Withdrawn-protocol Deviation|Overall Study||9
7891005|NCT00757822|19420767|P2|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9
7891006|NCT00757822|19420768|P1|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12
7891007|NCT00757822|19420767|P2|Data Entry, QC Assessment|Overall Study||74
7891008|NCT00757822|19420768|P1|Data Entry, QC Assessment|Overall Study||85
7891009|NCT00757822|19420767|P2|2-6 wk Post-op Assessment|Overall Study||74
7891010|NCT00757822|19420768|P1|2-6 wk Post-op Assessment|Overall Study||85
7891011|NCT00757822|19420767|P2|24-48 hr Telephone Assessment|Overall Study||74
7891012|NCT00757822|19420768|P1|24-48 hr Telephone Assessment|Overall Study||85
7891013|NCT00757822|19420767|P2|DOS: Post-operative Assessments|Overall Study||74
7891014|NCT00757822|19420768|P1|DOS: Post-operative Assessments|Overall Study||85
7891015|NCT00757822|19420767|P2|Received Study Intervention|Overall Study||74
7891016|NCT00757822|19420768|P1|Received Study Intervention|Overall Study||85
7891017|NCT00757822|19420767|P2|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11
7891018|NCT00757822|19420768|P1|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6
7891019|NCT00757822|19420767|P2|Withdrawal by Subject-no Intervention|Overall Study||3
7891020|NCT00757822|19420768|P1|Withdrawal by Subject-no Intervention|Overall Study||1
7891021|NCT00757822|19420767|P2|Day of Surgery (DOS) Assessment|Overall Study||88
7891022|NCT00757822|19420768|P1|Day of Surgery (DOS) Assessment|Overall Study||92
7891023|NCT00757822|19420767|P2|STARTED|Overall Study||88
7891024|NCT00757822|19420768|P1|STARTED|Overall Study||92
7891025|NCT00757783|19420790|P2|NOT COMPLETED|Overall Study||6
7891026|NCT00757783|19420791|P1|NOT COMPLETED|Overall Study||5
7891027|NCT00757783|19420790|P2|COMPLETED|Overall Study||25
7891028|NCT00757783|19420791|P1|COMPLETED|Overall Study||29
7891029|NCT00757783|19420790|P2|STARTED|Overall Study||31
7891030|NCT00757783|19420791|P1|STARTED|Overall Study||34
7891031|NCT00757705|19420827|P1|NOT COMPLETED|Overall Study||121
7891032|NCT00757705|19420827|P1|COMPLETED|Overall Study||178
7891033|NCT00757705|19420827|P1|STARTED|Overall Study||299
7891034|NCT00757666|19420841|P2|NOT COMPLETED|Overall Study||23
7891035|NCT00757666|19420842|P1|NOT COMPLETED|Overall Study||22
7891036|NCT00757666|19420841|P2|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|11
7891037|NCT00757666|19420842|P1|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|12
7891038|NCT00757666|19420841|P2|STARTED|Overall Study||34
7891039|NCT00757666|19420842|P1|STARTED|Overall Study||34
7891040|NCT00757627|19420856|P1|NOT COMPLETED|Overall Study||81
7891041|NCT00757627|19420856|P1|COMPLETED|Overall Study||419
7891042|NCT00757627|19420856|P1|STARTED|Overall Study||500
7891043|NCT00757601|19420869|P12|NOT COMPLETED|Period 5||0
7891044|NCT00757601|19420870|P11|NOT COMPLETED|Period 5||0
7891045|NCT00757601|19420871|P10|NOT COMPLETED|Period 5||0
7891046|NCT00757601|19420872|P9|NOT COMPLETED|Period 5||0
7891047|NCT00757601|19420873|P8|NOT COMPLETED|Period 5||0
7891048|NCT00757601|19420874|P7|NOT COMPLETED|Period 5||0
7891049|NCT00757601|19420875|P6|NOT COMPLETED|Period 5||0
7891050|NCT00757601|19420876|P5|NOT COMPLETED|Period 5||0
7891051|NCT00757601|19420877|P4|NOT COMPLETED|Period 5||0
7891052|NCT00757601|19420878|P3|NOT COMPLETED|Period 5||0
7891053|NCT00757601|19420879|P2|NOT COMPLETED|Period 5||0
7891054|NCT00757601|19420880|P1|NOT COMPLETED|Period 5||0
7891055|NCT00757601|19420869|P12|COMPLETED|Period 5||1
7891056|NCT00757601|19420870|P11|COMPLETED|Period 5||2
7891057|NCT00757601|19420871|P10|COMPLETED|Period 5||1
7891058|NCT00757601|19420872|P9|COMPLETED|Period 5||2
7891059|NCT00757601|19420873|P8|COMPLETED|Period 5||2
7891060|NCT00757601|19420874|P7|COMPLETED|Period 5||2
7891061|NCT00757601|19420875|P6|COMPLETED|Period 5||2
7891062|NCT00757601|19420876|P5|COMPLETED|Period 5||2
7891063|NCT00757601|19420877|P4|COMPLETED|Period 5||2
7891064|NCT00757601|19420878|P3|COMPLETED|Period 5||2
7891065|NCT00757601|19420879|P2|COMPLETED|Period 5||2
7891066|NCT00757601|19420880|P1|COMPLETED|Period 5||2
7891067|NCT00757601|19420869|P12|STARTED|Period 5||1
7891068|NCT00757601|19420870|P11|STARTED|Period 5||2
7891069|NCT00757601|19420871|P10|STARTED|Period 5||1
7891070|NCT00757601|19420872|P9|STARTED|Period 5||2
7891071|NCT00757601|19420873|P8|STARTED|Period 5||2
7891072|NCT00757601|19420874|P7|STARTED|Period 5||2
7891073|NCT00757601|19420875|P6|STARTED|Period 5||2
7891074|NCT00757601|19420876|P5|STARTED|Period 5||2
7891075|NCT00757601|19420877|P4|STARTED|Period 5||2
7891076|NCT00757601|19420878|P3|STARTED|Period 5||2
7891077|NCT00757601|19420879|P2|STARTED|Period 5||2
7891078|NCT00757601|19420880|P1|STARTED|Period 5||2
7891079|NCT00757601|19420869|P12|NOT COMPLETED|Period 4||1
7891080|NCT00757601|19420870|P11|NOT COMPLETED|Period 4||0
7891081|NCT00757601|19420871|P10|NOT COMPLETED|Period 4||1
7891082|NCT00757601|19420872|P9|NOT COMPLETED|Period 4||0
7891083|NCT00757601|19420873|P8|NOT COMPLETED|Period 4||0
7891084|NCT00757601|19420874|P7|NOT COMPLETED|Period 4||0
7891085|NCT00757601|19420875|P6|NOT COMPLETED|Period 4||0
7891086|NCT00757601|19420876|P5|NOT COMPLETED|Period 4||0
7891087|NCT00757601|19420877|P4|NOT COMPLETED|Period 4||0
7891088|NCT00757601|19420878|P3|NOT COMPLETED|Period 4||0
7891089|NCT00757601|19420879|P2|NOT COMPLETED|Period 4||0
7891090|NCT00757601|19420880|P1|NOT COMPLETED|Period 4||0
7891091|NCT00757601|19420869|P12|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1
7891092|NCT00757601|19420870|P11|COMPLETED|Period 4||2
7891093|NCT00757601|19420871|P10|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1
7891094|NCT00757601|19420872|P9|COMPLETED|Period 4||2
7891095|NCT00757601|19420873|P8|COMPLETED|Period 4||2
7891096|NCT00757601|19420874|P7|COMPLETED|Period 4||2
7891097|NCT00757601|19420875|P6|COMPLETED|Period 4||2
7891098|NCT00757601|19420876|P5|COMPLETED|Period 4||2
7891099|NCT00757601|19420877|P4|COMPLETED|Period 4||2
7891100|NCT00757601|19420878|P3|COMPLETED|Period 4||2
7891101|NCT00757601|19420879|P2|COMPLETED|Period 4||2
7891102|NCT00757601|19420880|P1|COMPLETED|Period 4||2
7891103|NCT00757601|19420869|P12|STARTED|Period 4||2
7891104|NCT00757601|19420870|P11|STARTED|Period 4||2
7891105|NCT00757601|19420871|P10|STARTED|Period 4||2
7891106|NCT00757601|19420872|P9|STARTED|Period 4||2
7891107|NCT00757601|19420873|P8|STARTED|Period 4||2
7891108|NCT00757601|19420874|P7|STARTED|Period 4||2
7891109|NCT00757601|19420875|P6|STARTED|Period 4||2
7891110|NCT00757601|19420876|P5|STARTED|Period 4||2
7891111|NCT00757601|19420877|P4|STARTED|Period 4||2
7891112|NCT00757601|19420878|P3|STARTED|Period 4||2
7891113|NCT00757601|19420879|P2|STARTED|Period 4||2
7891114|NCT00757601|19420880|P1|STARTED|Period 4||2
7891115|NCT00757601|19420869|P12|NOT COMPLETED|Period 3||0
7891116|NCT00757601|19420870|P11|NOT COMPLETED|Period 3||0
7891117|NCT00757601|19420871|P10|NOT COMPLETED|Period 3||0
7891118|NCT00757601|19420872|P9|NOT COMPLETED|Period 3||0
7891119|NCT00757601|19420873|P8|NOT COMPLETED|Period 3||0
7891120|NCT00757601|19420874|P7|NOT COMPLETED|Period 3||0
7891121|NCT00757601|19420875|P6|NOT COMPLETED|Period 3||0
7891122|NCT00757601|19420876|P5|NOT COMPLETED|Period 3||0
7891123|NCT00757601|19420877|P4|NOT COMPLETED|Period 3||0
7891124|NCT00757601|19420878|P3|NOT COMPLETED|Period 3||0
7891125|NCT00757601|19420879|P2|NOT COMPLETED|Period 3||0
7891126|NCT00757601|19420880|P1|NOT COMPLETED|Period 3||0
7891127|NCT00757601|19420869|P12|COMPLETED|Period 3||2
7891128|NCT00757601|19420870|P11|COMPLETED|Period 3||2
7891129|NCT00757601|19420871|P10|COMPLETED|Period 3||2
7891130|NCT00757601|19420872|P9|COMPLETED|Period 3||2
7891131|NCT00757601|19420873|P8|COMPLETED|Period 3||2
7891132|NCT00757601|19420874|P7|COMPLETED|Period 3||2
7891133|NCT00757601|19420875|P6|COMPLETED|Period 3||2
7891134|NCT00757601|19420876|P5|COMPLETED|Period 3||2
7891135|NCT00757601|19420877|P4|COMPLETED|Period 3||2
7891136|NCT00757601|19420878|P3|COMPLETED|Period 3||2
7891137|NCT00757601|19420879|P2|COMPLETED|Period 3||2
7891138|NCT00757601|19420880|P1|COMPLETED|Period 3||2
7891139|NCT00757601|19420869|P12|STARTED|Period 3||2
7891140|NCT00757601|19420870|P11|STARTED|Period 3||2
7891141|NCT00757601|19420871|P10|STARTED|Period 3||2
7891142|NCT00757601|19420872|P9|STARTED|Period 3||2
7891143|NCT00757601|19420873|P8|STARTED|Period 3||2
7891144|NCT00757601|19420874|P7|STARTED|Period 3||2
7891145|NCT00757601|19420875|P6|STARTED|Period 3||2
7891146|NCT00757601|19420876|P5|STARTED|Period 3||2
7891147|NCT00757601|19420877|P4|STARTED|Period 3||2
7891148|NCT00757601|19420878|P3|STARTED|Period 3||2
7891149|NCT00757601|19420879|P2|STARTED|Period 3||2
7891150|NCT00757601|19420880|P1|STARTED|Period 3||2
7891151|NCT00757601|19420869|P12|NOT COMPLETED|Period 2||1
7891152|NCT00757601|19420870|P11|NOT COMPLETED|Period 2||0
7891153|NCT00757601|19420871|P10|NOT COMPLETED|Period 2||0
7891154|NCT00757601|19420872|P9|NOT COMPLETED|Period 2||0
7891155|NCT00757601|19420873|P8|NOT COMPLETED|Period 2||0
7891156|NCT00757601|19420874|P7|NOT COMPLETED|Period 2||0
7891157|NCT00757601|19420875|P6|NOT COMPLETED|Period 2||0
7891158|NCT00757601|19420876|P5|NOT COMPLETED|Period 2||0
7891159|NCT00757601|19420877|P4|NOT COMPLETED|Period 2||0
7891160|NCT00757601|19420878|P3|NOT COMPLETED|Period 2||0
7891161|NCT00757601|19420879|P2|NOT COMPLETED|Period 2||0
7891162|NCT00757601|19420880|P1|NOT COMPLETED|Period 2||0
7891163|NCT00757601|19420869|P12|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2
7891164|NCT00757601|19420870|P11|COMPLETED|Period 2||2
7891165|NCT00757601|19420871|P10|COMPLETED|Period 2||2
7891166|NCT00757601|19420872|P9|COMPLETED|Period 2||2
7891167|NCT00757601|19420873|P8|COMPLETED|Period 2||2
7891168|NCT00757601|19420874|P7|COMPLETED|Period 2||2
7891169|NCT00757601|19420875|P6|COMPLETED|Period 2||2
7891170|NCT00757601|19420876|P5|COMPLETED|Period 2||2
7891171|NCT00757601|19420877|P4|COMPLETED|Period 2||2
7891172|NCT00757601|19420878|P3|COMPLETED|Period 2||2
7891173|NCT00757601|19420879|P2|COMPLETED|Period 2||2
7891174|NCT00757601|19420880|P1|COMPLETED|Period 2||2
7891175|NCT00757601|19420869|P12|STARTED|Period 2||3
7891176|NCT00757601|19420870|P11|STARTED|Period 2||2
7891177|NCT00757601|19420871|P10|STARTED|Period 2||2
7891178|NCT00757601|19420872|P9|STARTED|Period 2||2
7891179|NCT00757601|19420873|P8|STARTED|Period 2||2
7891180|NCT00757601|19420874|P7|STARTED|Period 2||2
7891181|NCT00757601|19420875|P6|STARTED|Period 2||2
7891182|NCT00757601|19420876|P5|STARTED|Period 2||2
7891183|NCT00757601|19420877|P4|STARTED|Period 2||2
7891184|NCT00757601|19420878|P3|STARTED|Period 2||2
7891185|NCT00757601|19420879|P2|STARTED|Period 2||2
7891186|NCT00757601|19420880|P1|STARTED|Period 2||2
7891187|NCT00757601|19420869|P12|NOT COMPLETED|Period 1||0
7891188|NCT00757601|19420870|P11|NOT COMPLETED|Period 1||0
7891189|NCT00757601|19420871|P10|NOT COMPLETED|Period 1||0
7891190|NCT00757601|19420872|P9|NOT COMPLETED|Period 1||0
7891191|NCT00757601|19420873|P8|NOT COMPLETED|Period 1||0
7891192|NCT00757601|19420874|P7|NOT COMPLETED|Period 1||0
7891193|NCT00757601|19420875|P6|NOT COMPLETED|Period 1||0
7891194|NCT00757601|19420876|P5|NOT COMPLETED|Period 1||0
7891195|NCT00757601|19420877|P4|NOT COMPLETED|Period 1||0
7891196|NCT00757601|19420878|P3|NOT COMPLETED|Period 1||0
7891197|NCT00757601|19420879|P2|NOT COMPLETED|Period 1||0
7891198|NCT00757601|19420880|P1|NOT COMPLETED|Period 1||0
7891199|NCT00757601|19420869|P12|COMPLETED|Period 1||3
7891200|NCT00757601|19420870|P11|COMPLETED|Period 1||2
7891201|NCT00757601|19420871|P10|COMPLETED|Period 1||2
7891202|NCT00757601|19420872|P9|COMPLETED|Period 1||2
7891203|NCT00757601|19420873|P8|COMPLETED|Period 1||2
7891204|NCT00757601|19420874|P7|COMPLETED|Period 1||2
7891205|NCT00757601|19420875|P6|COMPLETED|Period 1||2
7891206|NCT00757601|19420876|P5|COMPLETED|Period 1||2
7891207|NCT00757601|19420877|P4|COMPLETED|Period 1||2
7891208|NCT00757601|19420878|P3|COMPLETED|Period 1||2
7891209|NCT00757601|19420879|P2|COMPLETED|Period 1||2
7891210|NCT00757601|19420880|P1|COMPLETED|Period 1||2
7891211|NCT00757601|19420869|P12|STARTED|Period 1||3
7891212|NCT00757601|19420870|P11|STARTED|Period 1||2
7891213|NCT00757601|19420871|P10|STARTED|Period 1||2
7891214|NCT00757601|19420872|P9|STARTED|Period 1||2
7891215|NCT00757601|19420873|P8|STARTED|Period 1||2
7891216|NCT00757601|19420874|P7|STARTED|Period 1||2
7891217|NCT00757601|19420875|P6|STARTED|Period 1||2
7891218|NCT00757601|19420876|P5|STARTED|Period 1||2
7891219|NCT00757601|19420877|P4|STARTED|Period 1||2
7891220|NCT00757601|19420878|P3|STARTED|Period 1||2
7891221|NCT00757601|19420879|P2|STARTED|Period 1||2
7891222|NCT00757601|19420880|P1|STARTED|Period 1||2
7891223|NCT00757588|19420991|P2|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9
7891224|NCT00757588|19420992|P1|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22
7891225|NCT00757588|19420991|P2|COMPLETED|Period 2: Long-term (52-week) Phase||125
7891226|NCT00757588|19420992|P1|COMPLETED|Period 2: Long-term (52-week) Phase||246
7891227|NCT00757588|19420991|P2|STARTED|Period 2: Long-term (52-week) Phase||134
7891228|NCT00757588|19420992|P1|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268
7891229|NCT00757588|19420991|P2|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17
7891230|NCT00757588|19420992|P1|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36
7891231|NCT00757588|19420991|P2|COMPLETED|Period 1: Short-term (24-week) Phase||134
7891232|NCT00757588|19420992|P1|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268
7891233|NCT00757588|19420991|P2|STARTED|Period 1: Short-term (24-week) Phase||151
7891234|NCT00757588|19420992|P1|STARTED|Period 1: Short-term (24-week) Phase||304
7891235|NCT00757484|19421024|P1|NOT COMPLETED|Overall Study||0
7891236|NCT00757484|19421024|P1|COMPLETED|Overall Study||491
7891237|NCT00757484|19421024|P1|STARTED|Overall Study||491
7891238|NCT00757237|19421033|P2|NOT COMPLETED|Overall Study||25
7891239|NCT00757237|19421034|P1|NOT COMPLETED|Overall Study||13
7891240|NCT00757237|19421033|P2|COMPLETED|Overall Study||111
7891241|NCT00757237|19421034|P1|COMPLETED|Overall Study||124
7891242|NCT00757237|19421033|P2|Treated|Overall Study||132
7891243|NCT00757237|19421034|P1|Treated|Overall Study||136
7891244|NCT00757237|19421033|P2|STARTED|Overall Study||136
7891245|NCT00757237|19421034|P1|STARTED|Overall Study||137
7891246|NCT00757172|19421062|P1|NOT COMPLETED|Overall Study||11
7891247|NCT00757172|19421062|P1|COMPLETED|Overall Study|Participants underwent surgery.|54
7891248|NCT00757172|19421062|P1|STARTED|Overall Study||65
7891249|NCT00757003|19421070|P1|NOT COMPLETED|Overall Study||49
7891250|NCT00757003|19421070|P1|COMPLETED|Overall Study||51
7891251|NCT00757003|19421070|P1|STARTED|Overall Study||100
7891252|NCT00756977|19421078|P2|NOT COMPLETED|Overall Study||11
7891253|NCT00756977|19421079|P1|NOT COMPLETED|Overall Study||21
7891254|NCT00756977|19421078|P2|COMPLETED|Overall Study||187
7891255|NCT00756977|19421079|P1|COMPLETED|Overall Study||175
7891256|NCT00756977|19421078|P2|STARTED|Overall Study||198
7891257|NCT00756977|19421079|P1|STARTED|Overall Study||196
7891258|NCT00756964|19421107|P2|NOT COMPLETED|Overall Study||0
7891259|NCT00756964|19421108|P1|NOT COMPLETED|Overall Study||0
7891260|NCT00756964|19421107|P2|COMPLETED|Overall Study||13
7891261|NCT00756964|19421108|P1|COMPLETED|Overall Study||13
7891262|NCT00756964|19421107|P2|STARTED|Overall Study||13
7891263|NCT00756964|19421108|P1|STARTED|Overall Study||13
7891264|NCT00756938|19421117|P4|NOT COMPLETED|Optional Extension||37
7891265|NCT00756938|19421118|P3|NOT COMPLETED|Optional Extension||0
7891266|NCT00756938|19421119|P2|NOT COMPLETED|Optional Extension||0
7891267|NCT00756938|19421120|P1|NOT COMPLETED|Optional Extension||0
7891268|NCT00756938|19421117|P4|COMPLETED|Optional Extension||53
7891269|NCT00756938|19421118|P3|COMPLETED|Optional Extension||0
7891270|NCT00756938|19421119|P2|COMPLETED|Optional Extension||0
7891271|NCT00756938|19421120|P1|COMPLETED|Optional Extension||0
7891272|NCT00756938|19421117|P4|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90
7891273|NCT00756938|19421118|P3|STARTED|Optional Extension||0
7891274|NCT00756938|19421119|P2|STARTED|Optional Extension||0
7891275|NCT00756938|19421120|P1|STARTED|Optional Extension||0
7891276|NCT00756938|19421117|P4|NOT COMPLETED|12-week Base Study||0
7891277|NCT00756938|19421118|P3|NOT COMPLETED|12-week Base Study||2
7891278|NCT00756938|19421119|P2|NOT COMPLETED|12-week Base Study||0
7891279|NCT00756938|19421120|P1|NOT COMPLETED|12-week Base Study||2
7891280|NCT00756938|19421117|P4|COMPLETED|12-week Base Study||0
7891281|NCT00756938|19421118|P3|COMPLETED|12-week Base Study||32
7891282|NCT00756938|19421119|P2|COMPLETED|12-week Base Study||34
7891283|NCT00756938|19421120|P1|COMPLETED|12-week Base Study||31
7891284|NCT00756938|19421117|P4|STARTED|12-week Base Study||0
7891285|NCT00756938|19421118|P3|STARTED|12-week Base Study||34
7891286|NCT00756938|19421119|P2|STARTED|12-week Base Study||34
7891287|NCT00756938|19421120|P1|STARTED|12-week Base Study||33
7891288|NCT00756886|19421148|P2|NOT COMPLETED|Overall Study||7
7891289|NCT00756886|19421149|P1|NOT COMPLETED|Overall Study||11
7891290|NCT00756886|19421148|P2|COMPLETED|Overall Study||25
7891291|NCT00756886|19421149|P1|COMPLETED|Overall Study||30
7891292|NCT00756886|19421148|P2|STARTED|Overall Study||32
7891293|NCT00756886|19421149|P1|STARTED|Overall Study||41
7891294|NCT00756730|19421157|P2|NOT COMPLETED|Overall Study||2
7891295|NCT00756730|19421158|P1|NOT COMPLETED|Overall Study||0
7891296|NCT00756730|19421157|P2|COMPLETED|Overall Study||22
7891297|NCT00756730|19421158|P1|COMPLETED|Overall Study||25
7891298|NCT00756730|19421157|P2|STARTED|Overall Study||24
7891299|NCT00756730|19421158|P1|STARTED|Overall Study||25
7891300|NCT00756717|19421178|P1|NOT COMPLETED|Overall Study||2
7891301|NCT00756717|19421178|P1|COMPLETED|Overall Study||20
7891302|NCT00756717|19421178|P1|STARTED|Overall Study||22
7891303|NCT00756678|19421182|P1|NOT COMPLETED|Overall Study||1
7891304|NCT00756678|19421182|P1|COMPLETED|Overall Study||50
7891305|NCT00756678|19421182|P1|STARTED|Overall Study||51
7891306|NCT00756652|19421195|P2|NOT COMPLETED|Re-Op Phase||0
7891307|NCT00756652|19421196|P1|NOT COMPLETED|Re-Op Phase||2876
7891308|NCT00756652|19421195|P2|COMPLETED|Re-Op Phase||0
7891309|NCT00756652|19421196|P1|COMPLETED|Re-Op Phase||8225
7891310|NCT00756652|19421195|P2|STARTED|Re-Op Phase|NA - The Re-Op Phase was limited in scope to data collection for only MemoryGel participants.|0
7891311|NCT00756652|19421196|P1|STARTED|Re-Op Phase||11101
7891312|NCT00756652|19421195|P2|NOT COMPLETED|Original Phase||921
7891313|NCT00756652|19421196|P1|NOT COMPLETED|Original Phase||35389
7891314|NCT00756652|19421195|P2|COMPLETED|Original Phase||118
7891315|NCT00756652|19421196|P1|COMPLETED|Original Phase|At Year 7|6063
7891316|NCT00756652|19421195|P2|STARTED|Original Phase||1039
7891317|NCT00756652|19421196|P1|STARTED|Original Phase||41452
7891318|NCT00756613|19421204|P2|NOT COMPLETED|Overall Study||70
7891319|NCT00756613|19421205|P1|NOT COMPLETED|Overall Study||86
7891320|NCT00756613|19421204|P2|COMPLETED|Overall Study||462
7891321|NCT00756613|19421205|P1|COMPLETED|Overall Study||426
7891322|NCT00756613|19421204|P2|STARTED|Overall Study||532
7891323|NCT00756613|19421205|P1|STARTED|Overall Study||512
7891324|NCT00756600|19421220|P2|NOT COMPLETED|Overall Study||0
7891325|NCT00756600|19421221|P1|NOT COMPLETED|Overall Study||0
7891326|NCT00756600|19421220|P2|COMPLETED|Overall Study||356
7891327|NCT00756600|19421221|P1|COMPLETED|Overall Study||287
7891328|NCT00756600|19421220|P2|STARTED|Overall Study||356
7891329|NCT00756600|19421221|P1|STARTED|Overall Study||287
7891330|NCT00756574|19421307|P2|NOT COMPLETED|Overall Study||11
7891331|NCT00756574|19421308|P1|NOT COMPLETED|Overall Study||13
7891332|NCT00756574|19421307|P2|COMPLETED|Overall Study||210
7891333|NCT00756574|19421308|P1|COMPLETED|Overall Study||212
7891334|NCT00756574|19421307|P2|STARTED|Overall Study||221
7891335|NCT00756574|19421308|P1|STARTED|Overall Study||225
7891336|NCT00756561|19421318|P1|NOT COMPLETED|Overall Study||0
7891337|NCT00756561|19421318|P1|COMPLETED|Overall Study||10
7891338|NCT00756561|19421318|P1|STARTED|Overall Study||10
7891339|NCT00756548|19421325|P2|NOT COMPLETED|Overall Study||0
7891340|NCT00756548|19421326|P1|NOT COMPLETED|Overall Study||2
7891341|NCT00756548|19421325|P2|COMPLETED|Overall Study||185
7891342|NCT00756548|19421326|P1|COMPLETED|Overall Study||184
7891343|NCT00756548|19421325|P2|STARTED|Overall Study||185
7891344|NCT00756548|19421326|P1|STARTED|Overall Study||186
7891345|NCT00756496|19421352|P1|NOT COMPLETED|Overall Study||0
7891346|NCT00756496|19421352|P1|COMPLETED|Overall Study||442
7891347|NCT00756496|19421352|P1|STARTED|Overall Study||442
7891348|NCT00756470|19421357|P1|NOT COMPLETED|Overall Study||5
7891349|NCT00756470|19421357|P1|COMPLETED|Overall Study||10
7891350|NCT00756470|19421357|P1|STARTED|Overall Study||15
7891351|NCT00756457|19421364|P2|NOT COMPLETED|Overall Study||2
7891352|NCT00756457|19421365|P1|NOT COMPLETED|Overall Study||1
7891353|NCT00756457|19421364|P2|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17
7891354|NCT00756457|19421365|P1|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19
7891355|NCT00756457|19421364|P2|STARTED|Overall Study||19
7891356|NCT00756457|19421365|P1|STARTED|Overall Study||20
7891357|NCT00756444|19421395|P2|NOT COMPLETED|Overall Study||21
7891358|NCT00756444|19421396|P1|NOT COMPLETED|Overall Study||15
7891359|NCT00756444|19421395|P2|COMPLETED|Overall Study||13
7891360|NCT00756444|19421396|P1|COMPLETED|Overall Study||18
7891361|NCT00756444|19421395|P2|STARTED|Overall Study||34
7891362|NCT00756444|19421396|P1|STARTED|Overall Study||33
7891363|NCT00756314|19421407|P2|NOT COMPLETED|Overall Study||59
7891364|NCT00756314|19421408|P1|NOT COMPLETED|Overall Study||2
7891365|NCT00756314|19421407|P2|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64
7891366|NCT00756314|19421408|P1|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121
7891367|NCT00756314|19421407|P2|STARTED|Overall Study||123
7891368|NCT00756314|19421408|P1|STARTED|Overall Study||123
7891369|NCT00756275|19421424|P2|NOT COMPLETED|Overall Study||28
7891370|NCT00756275|19421425|P1|NOT COMPLETED|Overall Study||29
7891371|NCT00756275|19421424|P2|COMPLETED|Overall Study||49
7891372|NCT00756275|19421425|P1|COMPLETED|Overall Study||31
7891373|NCT00756275|19421424|P2|STARTED|Overall Study||77
7891374|NCT00756275|19421425|P1|STARTED|Overall Study||60
7891375|NCT00756236|19421452|P3|NOT COMPLETED|Overall Study||0
7891376|NCT00756236|19421453|P2|NOT COMPLETED|Overall Study||0
7891377|NCT00756236|19421454|P1|NOT COMPLETED|Overall Study||0
7891378|NCT00756236|19421452|P3|COMPLETED|Overall Study||20
7891379|NCT00756236|19421453|P2|COMPLETED|Overall Study||20
7891380|NCT00756236|19421454|P1|COMPLETED|Overall Study||20
7891381|NCT00756236|19421452|P3|STARTED|Overall Study||20
7891382|NCT00756236|19421453|P2|STARTED|Overall Study||20
7891383|NCT00756236|19421454|P1|STARTED|Overall Study||20
7891384|NCT00756106|19421462|P1|NOT COMPLETED|Overall Study||12
7891385|NCT00756106|19421462|P1|COMPLETED|Overall Study||3
7891386|NCT00756106|19421462|P1|STARTED|Overall Study||15
7891387|NCT00756093|19421474|P4|NOT COMPLETED|Fourth Intervention||0
7891388|NCT00756093|19421475|P3|NOT COMPLETED|Fourth Intervention||0
7891389|NCT00756093|19421476|P2|NOT COMPLETED|Fourth Intervention||0
7891390|NCT00756093|19421477|P1|NOT COMPLETED|Fourth Intervention||0
7891391|NCT00756093|19421474|P4|COMPLETED|Fourth Intervention||5
7891392|NCT00756093|19421475|P3|COMPLETED|Fourth Intervention||5
7891393|NCT00756093|19421476|P2|COMPLETED|Fourth Intervention||5
7891394|NCT00756093|19421477|P1|COMPLETED|Fourth Intervention||5
7891395|NCT00756093|19421474|P4|STARTED|Fourth Intervention||5
7891396|NCT00756093|19421475|P3|STARTED|Fourth Intervention||5
7891397|NCT00756093|19421476|P2|STARTED|Fourth Intervention||5
7891398|NCT00756093|19421477|P1|STARTED|Fourth Intervention||5
7891399|NCT00756093|19421474|P4|NOT COMPLETED|Third Intervention||0
7891400|NCT00756093|19421475|P3|NOT COMPLETED|Third Intervention||0
7891401|NCT00756093|19421476|P2|NOT COMPLETED|Third Intervention||0
7891402|NCT00756093|19421477|P1|NOT COMPLETED|Third Intervention||0
7891403|NCT00756093|19421474|P4|COMPLETED|Third Intervention||5
7891404|NCT00756093|19421475|P3|COMPLETED|Third Intervention||5
7891405|NCT00756093|19421476|P2|COMPLETED|Third Intervention||5
7891406|NCT00756093|19421477|P1|COMPLETED|Third Intervention||5
7891407|NCT00756093|19421474|P4|STARTED|Third Intervention||5
7891408|NCT00756093|19421475|P3|STARTED|Third Intervention||5
7891409|NCT00756093|19421476|P2|STARTED|Third Intervention||5
7891410|NCT00756093|19421477|P1|STARTED|Third Intervention||5
7891411|NCT00756093|19421474|P4|NOT COMPLETED|Second Intervention||0
7891412|NCT00756093|19421475|P3|NOT COMPLETED|Second Intervention||0
7891413|NCT00756093|19421476|P2|NOT COMPLETED|Second Intervention||0
7891414|NCT00756093|19421477|P1|NOT COMPLETED|Second Intervention||0
7891415|NCT00756093|19421474|P4|COMPLETED|Second Intervention||5
7891416|NCT00756093|19421475|P3|COMPLETED|Second Intervention||5
7891417|NCT00756093|19421476|P2|COMPLETED|Second Intervention||5
7891418|NCT00756093|19421477|P1|COMPLETED|Second Intervention||5
7891419|NCT00756093|19421474|P4|STARTED|Second Intervention||5
7891420|NCT00756093|19421475|P3|STARTED|Second Intervention||5
7891421|NCT00756093|19421476|P2|STARTED|Second Intervention||5
7891422|NCT00756093|19421477|P1|STARTED|Second Intervention||5
7891423|NCT00756093|19421474|P4|NOT COMPLETED|First Intervention||0
7891424|NCT00756093|19421475|P3|NOT COMPLETED|First Intervention||0
7891425|NCT00756093|19421476|P2|NOT COMPLETED|First Intervention||0
7891426|NCT00756093|19421477|P1|NOT COMPLETED|First Intervention||0
7891427|NCT00756093|19421474|P4|COMPLETED|First Intervention||5
7891428|NCT00756093|19421475|P3|COMPLETED|First Intervention||5
7891429|NCT00756093|19421476|P2|COMPLETED|First Intervention||5
7891430|NCT00756093|19421477|P1|COMPLETED|First Intervention||5
7891431|NCT00756093|19421474|P4|STARTED|First Intervention||5
7891432|NCT00756093|19421475|P3|STARTED|First Intervention||5
7891433|NCT00756093|19421476|P2|STARTED|First Intervention||5
7891434|NCT00756093|19421477|P1|STARTED|First Intervention||5
7891435|NCT00756002|19421489|P2|NOT COMPLETED|Placebo Run-out||0
7891436|NCT00756002|19421490|P1|NOT COMPLETED|Placebo Run-out||0
7891437|NCT00756002|19421489|P2|COMPLETED|Placebo Run-out||0
7891438|NCT00756002|19421490|P1|COMPLETED|Placebo Run-out||114
7891439|NCT00756002|19421489|P2|STARTED|Placebo Run-out||0
7891440|NCT00756002|19421490|P1|STARTED|Placebo Run-out||114
7891441|NCT00756002|19421489|P2|NOT COMPLETED|Double-Blind Treatment Period||15
7891442|NCT00756002|19421490|P1|NOT COMPLETED|Double-Blind Treatment Period||15
7891443|NCT00756002|19421489|P2|COMPLETED|Double-Blind Treatment Period||115
7891444|NCT00756002|19421490|P1|COMPLETED|Double-Blind Treatment Period||114
7891445|NCT00756002|19421489|P2|STARTED|Double-Blind Treatment Period||130
7891446|NCT00756002|19421490|P1|STARTED|Double-Blind Treatment Period||129
7891447|NCT00756002|19421489|P2|NOT COMPLETED|Placebo Run-in||0
7891448|NCT00756002|19421490|P1|NOT COMPLETED|Placebo Run-in||229
7891449|NCT00756002|19421489|P2|COMPLETED|Placebo Run-in||0
7891450|NCT00756002|19421490|P1|COMPLETED|Placebo Run-in||259
7891451|NCT00756002|19421489|P2|STARTED|Placebo Run-in||0
7891452|NCT00756002|19421490|P1|STARTED|Placebo Run-in||488
7891453|NCT00755937|19421584|P1|NOT COMPLETED|Observational Follow-up||148
7891454|NCT00755937|19421584|P1|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244
7891455|NCT00755937|19421584|P1|STARTED|Observational Follow-up||392
7891456|NCT00755937|19421584|P1|NOT COMPLETED|Recruitment||164
7891457|NCT00755937|19421584|P1|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392
7891458|NCT00755937|19421584|P1|STARTED|Recruitment|Subjects registered in the program|556
7891459|NCT00755911|19421596|P2|NOT COMPLETED|Overall Study||0
7891460|NCT00755911|19421597|P1|NOT COMPLETED|Overall Study||0
7891461|NCT00755911|19421596|P2|COMPLETED|Overall Study||12
7891462|NCT00755911|19421597|P1|COMPLETED|Overall Study||12
7891463|NCT00755911|19421596|P2|STARTED|Overall Study||12
7891464|NCT00755911|19421597|P1|STARTED|Overall Study||12
7891465|NCT00755846|19421611|P6|NOT COMPLETED|Overall Study||14
7891466|NCT00755846|19421612|P5|NOT COMPLETED|Overall Study||17
7891467|NCT00755846|19421613|P4|NOT COMPLETED|Overall Study||13
7891468|NCT00755846|19421614|P3|NOT COMPLETED|Overall Study||12
7891469|NCT00755846|19421615|P2|NOT COMPLETED|Overall Study||17
7891470|NCT00755846|19421616|P1|NOT COMPLETED|Overall Study||25
7891471|NCT00755846|19421611|P6|COMPLETED|Overall Study||31
7891472|NCT00755846|19421612|P5|COMPLETED|Overall Study||27
7891473|NCT00755846|19421613|P4|COMPLETED|Overall Study||32
7891474|NCT00755846|19421614|P3|COMPLETED|Overall Study||32
7891475|NCT00755846|19421615|P2|COMPLETED|Overall Study||27
7891476|NCT00755846|19421616|P1|COMPLETED|Overall Study||18
7891477|NCT00755846|19421611|P6|STARTED|Overall Study||45
7891478|NCT00755846|19421612|P5|STARTED|Overall Study||44
7891479|NCT00755846|19421613|P4|STARTED|Overall Study||45
7891480|NCT00755846|19421614|P3|STARTED|Overall Study||44
7891481|NCT00755846|19421615|P2|STARTED|Overall Study||44
7891482|NCT00755846|19421616|P1|STARTED|Overall Study||43
7891483|NCT00755807|19421716|P2|NOT COMPLETED|Open-label Extension Phase||16
7891484|NCT00755807|19421717|P1|NOT COMPLETED|Open-label Extension Phase||18
7891485|NCT00755807|19421716|P2|COMPLETED|Open-label Extension Phase||93
7891486|NCT00755807|19421717|P1|COMPLETED|Open-label Extension Phase||82
7891487|NCT00755807|19421716|P2|STARTED|Open-label Extension Phase||109
7891488|NCT00755807|19421717|P1|STARTED|Open-label Extension Phase||100
7891489|NCT00755807|19421716|P2|NOT COMPLETED|Acute Phase||12
7891490|NCT00755807|19421717|P1|NOT COMPLETED|Acute Phase||18
7891491|NCT00755807|19421716|P2|COMPLETED|Acute Phase||109
7891492|NCT00755807|19421717|P1|COMPLETED|Acute Phase||100
7891493|NCT00755807|19421716|P2|STARTED|Acute Phase||121
7891494|NCT00755807|19421717|P1|STARTED|Acute Phase||118
7891495|NCT00755755|19421781|P3|NOT COMPLETED|Overall Study||3
7891496|NCT00755755|19421782|P2|NOT COMPLETED|Overall Study||8
7891497|NCT00755755|19421783|P1|NOT COMPLETED|Overall Study||6
7891498|NCT00755755|19421781|P3|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45
7891499|NCT00755755|19421782|P2|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90
7891500|NCT00755755|19421783|P1|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89
7891501|NCT00755755|19421781|P3|STARTED|Overall Study|Safety population|48
7891502|NCT00755755|19421782|P2|STARTED|Overall Study|Safety population|98
7891503|NCT00755755|19421783|P1|STARTED|Overall Study|Safety population|95
7891504|NCT00755716|19421797|P3|NOT COMPLETED|Overall Study||3
7891505|NCT00755716|19421798|P2|NOT COMPLETED|Overall Study||8
7891506|NCT00755716|19421799|P1|NOT COMPLETED|Overall Study||8
7891507|NCT00755716|19421797|P3|COMPLETED|Overall Study||16
7891508|NCT00755716|19421798|P2|COMPLETED|Overall Study||11
7891509|NCT00755716|19421799|P1|COMPLETED|Overall Study||11
7891510|NCT00755716|19421797|P3|STARTED|Overall Study||19
7891511|NCT00755716|19421798|P2|STARTED|Overall Study||19
7891512|NCT00755716|19421799|P1|STARTED|Overall Study||19
7891513|NCT00755417|19421813|P3|NOT COMPLETED|Overall Study||42
7891514|NCT00755417|19421814|P2|NOT COMPLETED|Overall Study||55
7891515|NCT00755417|19421815|P1|NOT COMPLETED|Overall Study||62
7891516|NCT00755417|19421813|P3|COMPLETED|Overall Study||135
7891517|NCT00755417|19421814|P2|COMPLETED|Overall Study||126
7891518|NCT00755417|19421815|P1|COMPLETED|Overall Study||112
7891519|NCT00755417|19421813|P3|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177
7891520|NCT00755417|19421814|P2|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181
7891521|NCT00755417|19421815|P1|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174
7891522|NCT00755326|19421834|P2|NOT COMPLETED|Overall Study||3
7891523|NCT00755326|19421835|P1|NOT COMPLETED|Overall Study||2
7891524|NCT00755326|19421834|P2|COMPLETED|Overall Study||42
7891525|NCT00755326|19421835|P1|COMPLETED|Overall Study||45
7891526|NCT00755326|19421834|P2|STARTED|Overall Study||45
7891527|NCT00755326|19421835|P1|STARTED|Overall Study||47
7891528|NCT00755274|19421847|P2|NOT COMPLETED|Overall Study||0
7891529|NCT00755274|19421848|P1|NOT COMPLETED|Overall Study||0
7891530|NCT00755274|19421847|P2|COMPLETED|Overall Study||8
7891531|NCT00755274|19421848|P1|COMPLETED|Overall Study||24
7891532|NCT00755274|19421847|P2|STARTED|Overall Study||8
7891533|NCT00755274|19421848|P1|STARTED|Overall Study||24
7891534|NCT00755261|19421868|P1|NOT COMPLETED|Overall Study||2
7891535|NCT00755261|19421868|P1|COMPLETED|Overall Study||4
7891536|NCT00755261|19421868|P1|STARTED|Overall Study||6
7891537|NCT00755235|19421874|P2|NOT COMPLETED|Overall Study||9
7891538|NCT00755235|19421875|P1|NOT COMPLETED|Overall Study||2
7891539|NCT00755235|19421874|P2|COMPLETED|Overall Study||93
7891540|NCT00755235|19421875|P1|COMPLETED|Overall Study||104
7891541|NCT00755235|19421874|P2|STARTED|Overall Study||102
7891542|NCT00755235|19421875|P1|STARTED|Overall Study||106
7891543|NCT00755222|19421885|P2|NOT COMPLETED|Overall Study||2
7891544|NCT00755222|19421886|P1|NOT COMPLETED|Overall Study||8
7891545|NCT00755222|19421885|P2|COMPLETED|Overall Study||34
7891546|NCT00755222|19421886|P1|COMPLETED|Overall Study||103
7891547|NCT00755222|19421885|P2|STARTED|Overall Study||36
7891548|NCT00755222|19421886|P1|STARTED|Overall Study||111
7891549|NCT00755196|19421900|P1|NOT COMPLETED|Overall Study||2
7891550|NCT00755196|19421900|P1|COMPLETED|Overall Study||28
7891551|NCT00755196|19421900|P1|STARTED|Overall Study||30
7891552|NCT00755183|19421907|P2|NOT COMPLETED|Overall Study||6
7891553|NCT00755183|19421908|P1|NOT COMPLETED|Overall Study||7
7891554|NCT00755183|19421907|P2|COMPLETED|Overall Study||24
7891555|NCT00755183|19421908|P1|COMPLETED|Overall Study||23
7891556|NCT00755183|19421907|P2|STARTED|Overall Study||30
7891557|NCT00755183|19421908|P1|STARTED|Overall Study||30
7891558|NCT00755131|19421918|P2|NOT COMPLETED|Overall Study||0
7891559|NCT00755131|19421919|P1|NOT COMPLETED|Overall Study||0
7891560|NCT00755131|19421918|P2|COMPLETED|Overall Study||38
7891561|NCT00755131|19421919|P1|COMPLETED|Overall Study||37
7891562|NCT00755131|19421918|P2|STARTED|Overall Study||38
7891563|NCT00755131|19421919|P1|STARTED|Overall Study||37
7891564|NCT00755105|19421932|P3|NOT COMPLETED|Overall Study||4
7891565|NCT00755105|19421933|P2|NOT COMPLETED|Overall Study||11
7891566|NCT00755105|19421934|P1|NOT COMPLETED|Overall Study||9
7891567|NCT00755105|19421932|P3|COMPLETED|Overall Study||5
7891568|NCT00755105|19421933|P2|COMPLETED|Overall Study||19
7891569|NCT00755105|19421934|P1|COMPLETED|Overall Study||29
7891570|NCT00755105|19421932|P3|STARTED|Overall Study||9
7891571|NCT00755105|19421933|P2|STARTED|Overall Study||30
7891572|NCT00755105|19421934|P1|STARTED|Overall Study||38
7891573|NCT00755079|19421944|P2|NOT COMPLETED|Overall Study||6
7891574|NCT00755079|19421945|P1|NOT COMPLETED|Overall Study||1
7891575|NCT00755079|19421944|P2|COMPLETED|Overall Study||16
7891576|NCT00755079|19421945|P1|COMPLETED|Overall Study||17
7891577|NCT00755079|19421944|P2|STARTED|Overall Study||22
7891578|NCT00755079|19421945|P1|STARTED|Overall Study||18
7891579|NCT00755040|19421955|P2|NOT COMPLETED|Overall Study||34
7891580|NCT00755040|19421956|P1|NOT COMPLETED|Overall Study||43
7891581|NCT00755040|19421955|P2|COMPLETED|Overall Study||47
7891582|NCT00755040|19421956|P1|COMPLETED|Overall Study||40
7891583|NCT00755040|19421955|P2|STARTED|Overall Study||81
7891584|NCT00755040|19421956|P1|STARTED|Overall Study||83
7891585|NCT00754936|19421964|P1|NOT COMPLETED|Overall Study||12
7891586|NCT00754936|19421964|P1|COMPLETED|Overall Study||59
7891587|NCT00754936|19421964|P1|STARTED|Overall Study||71
7891588|NCT00754923|19421969|P1|NOT COMPLETED|Overall Study||0
7891589|NCT00754923|19421969|P1|COMPLETED|Overall Study||11
7891590|NCT00754923|19421969|P1|STARTED|Overall Study||11
7891591|NCT00754845|19421978|P2|NOT COMPLETED|Overall Study||0
7891592|NCT00754845|19421979|P1|NOT COMPLETED|Overall Study||0
7891593|NCT00754845|19421978|P2|COMPLETED|Overall Study||959
7891594|NCT00754845|19421979|P1|COMPLETED|Overall Study||959
7891595|NCT00754845|19421978|P2|STARTED|Overall Study||959
7891596|NCT00754845|19421979|P1|STARTED|Overall Study||959
7891597|NCT00754832|19421991|P2|NOT COMPLETED|Second 6 Weeks Intervention||2
7891598|NCT00754832|19421992|P1|NOT COMPLETED|Second 6 Weeks Intervention||0
7891599|NCT00754832|19421991|P2|COMPLETED|Second 6 Weeks Intervention||24
7891600|NCT00754832|19421992|P1|COMPLETED|Second 6 Weeks Intervention||17
7891601|NCT00754832|19421991|P2|STARTED|Second 6 Weeks Intervention||26
7891602|NCT00754832|19421992|P1|STARTED|Second 6 Weeks Intervention||17
7891603|NCT00754832|19421991|P2|NOT COMPLETED|2 Weeks Washout||2
7891604|NCT00754832|19421992|P1|NOT COMPLETED|2 Weeks Washout||1
7891605|NCT00754832|19421991|P2|COMPLETED|2 Weeks Washout||26
7891606|NCT00754832|19421992|P1|COMPLETED|2 Weeks Washout||17
7891607|NCT00754832|19421991|P2|STARTED|2 Weeks Washout||28
7891608|NCT00754832|19421992|P1|STARTED|2 Weeks Washout||18
7891609|NCT00754832|19421991|P2|NOT COMPLETED|First 6 Weeks Intervention||2
7891610|NCT00754832|19421992|P1|NOT COMPLETED|First 6 Weeks Intervention||8
7891611|NCT00754832|19421991|P2|COMPLETED|First 6 Weeks Intervention||28
7891612|NCT00754832|19421992|P1|COMPLETED|First 6 Weeks Intervention||18
7891613|NCT00754832|19421991|P2|STARTED|First 6 Weeks Intervention||30
7891614|NCT00754832|19421992|P1|STARTED|First 6 Weeks Intervention||26
7891615|NCT00754793|19422004|P2|NOT COMPLETED|Overall Study||1
7891616|NCT00754793|19422005|P1|NOT COMPLETED|Overall Study||0
7891617|NCT00754793|19422004|P2|COMPLETED|Overall Study||1
7891618|NCT00754793|19422005|P1|COMPLETED|Overall Study||1
7891619|NCT00754793|19422004|P2|STARTED|Overall Study||2
7891620|NCT00754793|19422005|P1|STARTED|Overall Study||1
7891621|NCT00754767|19422013|P2|NOT COMPLETED|Overall Study||0
7891622|NCT00754767|19422014|P1|NOT COMPLETED|Overall Study||0
7891623|NCT00754767|19422013|P2|COMPLETED|Overall Study||0
7891624|NCT00754767|19422014|P1|COMPLETED|Overall Study||2
7891625|NCT00754767|19422013|P2|STARTED|Overall Study||0
7891626|NCT00754767|19422014|P1|STARTED|Overall Study||2
7891627|NCT00754741|19422023|P3|NOT COMPLETED|Overall Study||54
7891628|NCT00754741|19422024|P2|NOT COMPLETED|Overall Study||69
7891629|NCT00754741|19422025|P1|NOT COMPLETED|Overall Study||57
7891630|NCT00754741|19422023|P3|COMPLETED|Overall Study||502
7891631|NCT00754741|19422024|P2|COMPLETED|Overall Study||500
7891632|NCT00754741|19422025|P1|COMPLETED|Overall Study||510
7891633|NCT00754741|19422023|P3|STARTED|Overall Study||556
7891634|NCT00754741|19422024|P2|STARTED|Overall Study||569
7891635|NCT00754741|19422025|P1|STARTED|Overall Study||567
7891636|NCT00754650|19422072|P1|NOT COMPLETED|Overall Study||2
7891637|NCT00754650|19422072|P1|COMPLETED|Overall Study||0
7891638|NCT00754650|19422072|P1|STARTED|Overall Study||2
7891639|NCT00754624|19422077|P1|NOT COMPLETED|Overall Study||69
7891640|NCT00754624|19422077|P1|COMPLETED|Overall Study||160
7891641|NCT00754624|19422077|P1|STARTED|Overall Study||229
7891642|NCT00754572|19422087|P1|NOT COMPLETED|Overall Study||71
7891643|NCT00754572|19422087|P1|COMPLETED|Overall Study||347
7891644|NCT00754572|19422087|P1|STARTED|Overall Study||418
7891645|NCT00754559|19422114|P1|NOT COMPLETED|Overall Study||47
7891646|NCT00754559|19422114|P1|COMPLETED|Overall Study||239
7891647|NCT00754559|19422114|P1|STARTED|Overall Study||286
7891648|NCT00754546|19422138|P1|NOT COMPLETED|Overall Study||0
7891649|NCT00754546|19422138|P1|COMPLETED|Overall Study||20
7891650|NCT00754546|19422138|P1|STARTED|Overall Study||20
7891651|NCT00754494|19422155|P3|NOT COMPLETED|Overall Study||1
7891652|NCT00754494|19422156|P2|NOT COMPLETED|Overall Study||0
7891653|NCT00754494|19422157|P1|NOT COMPLETED|Overall Study||2
7891654|NCT00754494|19422155|P3|COMPLETED|Overall Study||14
7891655|NCT00754494|19422156|P2|COMPLETED|Overall Study||15
7891656|NCT00754494|19422157|P1|COMPLETED|Overall Study||13
7891657|NCT00754494|19422155|P3|STARTED|Overall Study||15
7891658|NCT00754494|19422156|P2|STARTED|Overall Study||15
7891659|NCT00754494|19422157|P1|STARTED|Overall Study||15
7891660|NCT00754468|19422203|P2|NOT COMPLETED|Overall Study||0
7891661|NCT00754468|19422204|P1|NOT COMPLETED|Overall Study||0
7891662|NCT00754468|19422203|P2|COMPLETED|Overall Study||3
7891663|NCT00754468|19422204|P1|COMPLETED|Overall Study||4
7891664|NCT00754468|19422203|P2|STARTED|Overall Study||3
7891665|NCT00754468|19422204|P1|STARTED|Overall Study||4
7891666|NCT00754442|19422214|P2|NOT COMPLETED|Overall Study||3
7891667|NCT00754442|19422215|P1|NOT COMPLETED|Overall Study||5
7891668|NCT00754442|19422214|P2|COMPLETED|Overall Study||6
7891669|NCT00754442|19422215|P1|COMPLETED|Overall Study||6
7891670|NCT00754442|19422214|P2|STARTED|Overall Study|patients 9|9
7891671|NCT00754442|19422215|P1|STARTED|Overall Study|controls 11|11
7891672|NCT00754390|19422222|P1|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1
7891673|NCT00754390|19422222|P1|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10
7891674|NCT00754390|19422222|P1|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11
7891675|NCT00754390|19422222|P1|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1
7891676|NCT00754390|19422222|P1|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11
7891677|NCT00754390|19422222|P1|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12
7891678|NCT00754390|19422222|P1|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0
7891679|NCT00754390|19422222|P1|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12
7891680|NCT00754390|19422222|P1|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12
7891681|NCT00754390|19422222|P1|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5
7891682|NCT00754390|19422222|P1|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12
7891683|NCT00754390|19422222|P1|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17
7891684|NCT00754377|19422231|P2|NOT COMPLETED|Overall Study||0
7891685|NCT00754377|19422232|P1|NOT COMPLETED|Overall Study||0
7891686|NCT00754377|19422231|P2|COMPLETED|Overall Study||42
7891687|NCT00754377|19422232|P1|COMPLETED|Overall Study||50
7891688|NCT00754377|19422231|P2|STARTED|Overall Study||42
7891689|NCT00754377|19422232|P1|STARTED|Overall Study||50
7891690|NCT00754338|19422244|P4|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
7891691|NCT00754338|19422245|P3|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
7891692|NCT00754338|19422246|P2|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
7891693|NCT00754338|19422247|P1|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
7891694|NCT00754338|19422244|P4|COMPLETED|Second Intervention for Phase1&Phase2||18
7891695|NCT00754338|19422245|P3|COMPLETED|Second Intervention for Phase1&Phase2||16
7891696|NCT00754338|19422246|P2|COMPLETED|Second Intervention for Phase1&Phase2||17
7891697|NCT00754338|19422247|P1|COMPLETED|Second Intervention for Phase1&Phase2||17
7891698|NCT00754338|19422244|P4|STARTED|Second Intervention for Phase1&Phase2||19
7891699|NCT00754338|19422245|P3|STARTED|Second Intervention for Phase1&Phase2||16
7891700|NCT00754338|19422246|P2|STARTED|Second Intervention for Phase1&Phase2||18
7891701|NCT00754338|19422247|P1|STARTED|Second Intervention for Phase1&Phase2||17
7891702|NCT00754338|19422244|P4|NOT COMPLETED|First Intervention for Phase1&Phase2||0
7891703|NCT00754338|19422245|P3|NOT COMPLETED|First Intervention for Phase1&Phase2||3
7891704|NCT00754338|19422246|P2|NOT COMPLETED|First Intervention for Phase1&Phase2||3
7891705|NCT00754338|19422247|P1|NOT COMPLETED|First Intervention for Phase1&Phase2||0
7891706|NCT00754338|19422244|P4|COMPLETED|First Intervention for Phase1&Phase2||19
7891707|NCT00754338|19422245|P3|COMPLETED|First Intervention for Phase1&Phase2||16
7891708|NCT00754338|19422246|P2|COMPLETED|First Intervention for Phase1&Phase2||18
7891709|NCT00754338|19422247|P1|COMPLETED|First Intervention for Phase1&Phase2||17
7891710|NCT00754338|19422244|P4|STARTED|First Intervention for Phase1&Phase2||19
7891711|NCT00754338|19422245|P3|STARTED|First Intervention for Phase1&Phase2||19
7891712|NCT00754338|19422246|P2|STARTED|First Intervention for Phase1&Phase2||21
7891713|NCT00754338|19422247|P1|STARTED|First Intervention for Phase1&Phase2||17
7891714|NCT00754325|19422279|P2|NOT COMPLETED|Progression and Cross-over||21
7891715|NCT00754325|19422280|P1|NOT COMPLETED|Progression and Cross-over||0
7891716|NCT00754325|19422279|P2|COMPLETED|Progression and Cross-over||0
7891717|NCT00754325|19422280|P1|COMPLETED|Progression and Cross-over||0
7891718|NCT00754325|19422279|P2|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21
7891719|NCT00754325|19422280|P1|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0
7891720|NCT00754325|19422279|P2|NOT COMPLETED|Initial Treatment||49
7891721|NCT00754325|19422280|P1|NOT COMPLETED|Initial Treatment||50
7891722|NCT00754325|19422279|P2|COMPLETED|Initial Treatment||0
7891723|NCT00754325|19422280|P1|COMPLETED|Initial Treatment||0
7891724|NCT00754325|19422279|P2|STARTED|Initial Treatment||49
7891725|NCT00754325|19422280|P1|STARTED|Initial Treatment||50
7891726|NCT00754247|19422302|P3|NOT COMPLETED|Overall Study||5
7891727|NCT00754247|19422303|P2|NOT COMPLETED|Overall Study||5
7891728|NCT00754247|19422304|P1|NOT COMPLETED|Overall Study||5
7891729|NCT00754247|19422302|P3|COMPLETED|Overall Study||5
7891730|NCT00754247|19422303|P2|COMPLETED|Overall Study||5
7891731|NCT00754247|19422304|P1|COMPLETED|Overall Study||5
7891732|NCT00754247|19422302|P3|STARTED|Overall Study||10
7891733|NCT00754247|19422303|P2|STARTED|Overall Study||10
7891734|NCT00754247|19422304|P1|STARTED|Overall Study||10
7891735|NCT00754234|19422333|P1|NOT COMPLETED|Overall Study||3
7891736|NCT00754234|19422333|P1|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13
7891737|NCT00754234|19422333|P1|STARTED|Overall Study|7 Menus were consumed in randomized order|16
7891738|NCT00754208|19422337|P1|NOT COMPLETED|Overall Study||0
7891739|NCT00754208|19422337|P1|COMPLETED|Overall Study||7
7891740|NCT00754208|19422337|P1|STARTED|Overall Study||7
7891741|NCT00754156|19422346|P2|NOT COMPLETED|Overall Study||0
7891742|NCT00754156|19422347|P1|NOT COMPLETED|Overall Study||0
7891743|NCT00754156|19422346|P2|COMPLETED|Overall Study||6
7891744|NCT00754156|19422347|P1|COMPLETED|Overall Study||8
7891745|NCT00754156|19422346|P2|STARTED|Overall Study||6
7891746|NCT00754156|19422347|P1|STARTED|Overall Study||8
7891747|NCT00754130|19422371|P6|NOT COMPLETED|Period 2 (5 Days)||0
7891748|NCT00754130|19422372|P5|NOT COMPLETED|Period 2 (5 Days)||0
7891749|NCT00754130|19422373|P4|NOT COMPLETED|Period 2 (5 Days)||0
7891750|NCT00754130|19422374|P3|NOT COMPLETED|Period 2 (5 Days)||0
7891751|NCT00754130|19422375|P2|NOT COMPLETED|Period 2 (5 Days)||0
7891752|NCT00754130|19422376|P1|NOT COMPLETED|Period 2 (5 Days)||0
7891753|NCT00754130|19422371|P6|COMPLETED|Period 2 (5 Days)||4
7891754|NCT00754130|19422372|P5|COMPLETED|Period 2 (5 Days)||2
7891755|NCT00754130|19422373|P4|COMPLETED|Period 2 (5 Days)||2
7891756|NCT00754130|19422374|P3|COMPLETED|Period 2 (5 Days)||4
7891757|NCT00754130|19422375|P2|COMPLETED|Period 2 (5 Days)||2
7891758|NCT00754130|19422376|P1|COMPLETED|Period 2 (5 Days)||2
7891759|NCT00754130|19422371|P6|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4
7891760|NCT00754130|19422372|P5|STARTED|Period 2 (5 Days)||2
7891761|NCT00754130|19422373|P4|STARTED|Period 2 (5 Days)||2
7891762|NCT00754130|19422374|P3|STARTED|Period 2 (5 Days)||4
7891763|NCT00754130|19422375|P2|STARTED|Period 2 (5 Days)||2
7891764|NCT00754130|19422376|P1|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2
7891765|NCT00754130|19422371|P6|NOT COMPLETED|Washout Period (>=8 Days)||0
7891766|NCT00754130|19422372|P5|NOT COMPLETED|Washout Period (>=8 Days)||0
7891767|NCT00754130|19422373|P4|NOT COMPLETED|Washout Period (>=8 Days)||0
7891768|NCT00754130|19422374|P3|NOT COMPLETED|Washout Period (>=8 Days)||0
7891769|NCT00754130|19422375|P2|NOT COMPLETED|Washout Period (>=8 Days)||0
7891770|NCT00754130|19422376|P1|NOT COMPLETED|Washout Period (>=8 Days)||0
7891771|NCT00754130|19422371|P6|COMPLETED|Washout Period (>=8 Days)||4
7891772|NCT00754130|19422372|P5|COMPLETED|Washout Period (>=8 Days)||2
7891773|NCT00754130|19422373|P4|COMPLETED|Washout Period (>=8 Days)||2
7891774|NCT00754130|19422374|P3|COMPLETED|Washout Period (>=8 Days)||4
7891775|NCT00754130|19422375|P2|COMPLETED|Washout Period (>=8 Days)||2
7891776|NCT00754130|19422376|P1|COMPLETED|Washout Period (>=8 Days)||2
7891777|NCT00754130|19422371|P6|STARTED|Washout Period (>=8 Days)||4
7891778|NCT00754130|19422372|P5|STARTED|Washout Period (>=8 Days)||2
7891779|NCT00754130|19422373|P4|STARTED|Washout Period (>=8 Days)||2
7891780|NCT00754130|19422374|P3|STARTED|Washout Period (>=8 Days)||4
7891781|NCT00754130|19422375|P2|STARTED|Washout Period (>=8 Days)||2
7891782|NCT00754130|19422376|P1|STARTED|Washout Period (>=8 Days)||2
7891783|NCT00754130|19422371|P6|NOT COMPLETED|Period 1 (5 Days)||0
7891784|NCT00754130|19422372|P5|NOT COMPLETED|Period 1 (5 Days)||0
7891785|NCT00754130|19422373|P4|NOT COMPLETED|Period 1 (5 Days)||0
7891786|NCT00754130|19422374|P3|NOT COMPLETED|Period 1 (5 Days)||0
7891787|NCT00754130|19422375|P2|NOT COMPLETED|Period 1 (5 Days)||0
7891788|NCT00754130|19422376|P1|NOT COMPLETED|Period 1 (5 Days)||0
7891789|NCT00754130|19422371|P6|COMPLETED|Period 1 (5 Days)||4
7891790|NCT00754130|19422372|P5|COMPLETED|Period 1 (5 Days)||2
7891791|NCT00754130|19422373|P4|COMPLETED|Period 1 (5 Days)||2
7891792|NCT00754130|19422374|P3|COMPLETED|Period 1 (5 Days)||4
7891793|NCT00754130|19422375|P2|COMPLETED|Period 1 (5 Days)||2
7891794|NCT00754130|19422376|P1|COMPLETED|Period 1 (5 Days)||2
7891795|NCT00754130|19422371|P6|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4
7891796|NCT00754130|19422372|P5|STARTED|Period 1 (5 Days)||2
7891797|NCT00754130|19422373|P4|STARTED|Period 1 (5 Days)||2
7891798|NCT00754130|19422374|P3|STARTED|Period 1 (5 Days)||4
7891799|NCT00754130|19422375|P2|STARTED|Period 1 (5 Days)||2
7891800|NCT00754130|19422376|P1|STARTED|Period 1 (5 Days)||2
7891801|NCT00754065|19422419|P2|NOT COMPLETED|Overall Study||80
7891802|NCT00754065|19422420|P1|NOT COMPLETED|Overall Study||81
7891803|NCT00754065|19422419|P2|COMPLETED|Overall Study||126
7891804|NCT00754065|19422420|P1|COMPLETED|Overall Study||122
7891805|NCT00754065|19422419|P2|Cycle 6|Overall Study||153
7891806|NCT00754065|19422420|P1|Cycle 6|Overall Study||141
7891807|NCT00754065|19422419|P2|Participants Received Treatment|Overall Study||204
7891808|NCT00754065|19422420|P1|Participants Received Treatment|Overall Study||191
7891809|NCT00754065|19422419|P2|STARTED|Overall Study||206
7891810|NCT00754065|19422420|P1|STARTED|Overall Study||203
7891811|NCT00754052|19422660|P2|NOT COMPLETED|Overall Study||3
7891812|NCT00754052|19422661|P1|NOT COMPLETED|Overall Study||5
7891813|NCT00754052|19422660|P2|COMPLETED|Overall Study||0
7891814|NCT00754052|19422661|P1|COMPLETED|Overall Study||0
7891815|NCT00754052|19422660|P2|STARTED|Overall Study||3
7891816|NCT00754052|19422661|P1|STARTED|Overall Study||5
7891817|NCT00754013|19422675|P2|NOT COMPLETED|Overall Study||5
7891818|NCT00754013|19422676|P1|NOT COMPLETED|Overall Study||4
7891819|NCT00754013|19422675|P2|COMPLETED|Overall Study||0
7891820|NCT00754013|19422676|P1|COMPLETED|Overall Study||0
7891821|NCT00754013|19422675|P2|STARTED|Overall Study||5
7891822|NCT00754013|19422676|P1|STARTED|Overall Study||4
7891823|NCT00753948|19422687|P3|NOT COMPLETED|Overall Study||0
7891824|NCT00753948|19422688|P2|NOT COMPLETED|Overall Study||0
7891825|NCT00753948|19422689|P1|NOT COMPLETED|Overall Study||0
7891826|NCT00753948|19422687|P3|COMPLETED|Overall Study||7
7891827|NCT00753948|19422688|P2|COMPLETED|Overall Study||7
7891828|NCT00753948|19422689|P1|COMPLETED|Overall Study||9
7891829|NCT00753948|19422687|P3|STARTED|Overall Study||7
7891830|NCT00753948|19422688|P2|STARTED|Overall Study||7
7891831|NCT00753948|19422689|P1|STARTED|Overall Study||9
7891832|NCT00753935|19422702|P2|NOT COMPLETED|Overall Study||0
7891833|NCT00753935|19422703|P1|NOT COMPLETED|Overall Study||0
7891834|NCT00753935|19422702|P2|COMPLETED|Overall Study||47
7891835|NCT00753935|19422703|P1|COMPLETED|Overall Study||45
7891836|NCT00753935|19422702|P2|STARTED|Overall Study||47
7891837|NCT00753935|19422703|P1|STARTED|Overall Study||45
7891838|NCT00753922|19422713|P4|NOT COMPLETED|Overall Study||23
7891839|NCT00753922|19422714|P3|NOT COMPLETED|Overall Study||63
7891840|NCT00753922|19422715|P2|NOT COMPLETED|Overall Study||94
7891841|NCT00753922|19422716|P1|NOT COMPLETED|Overall Study||246
7891842|NCT00753922|19422713|P4|COMPLETED|Overall Study||37
7891843|NCT00753922|19422714|P3|COMPLETED|Overall Study||82
7891844|NCT00753922|19422715|P2|COMPLETED|Overall Study||157
7891845|NCT00753922|19422716|P1|COMPLETED|Overall Study||306
7891846|NCT00753922|19422713|P4|STARTED|Overall Study||60
7891847|NCT00753922|19422714|P3|STARTED|Overall Study||145
7891848|NCT00753922|19422715|P2|STARTED|Overall Study||251
7891849|NCT00753922|19422716|P1|STARTED|Overall Study||552
7891850|NCT00753896|19422746|P1|NOT COMPLETED|Overall Study||16
7891851|NCT00753896|19422746|P1|COMPLETED|Overall Study||118
7891852|NCT00753896|19422746|P1|STARTED|Overall Study||134
7891853|NCT00753766|19422762|P2|NOT COMPLETED|Overall Study||0
7891854|NCT00753766|19422763|P1|NOT COMPLETED|Overall Study||1
7891855|NCT00753766|19422762|P2|COMPLETED|Overall Study||0
7891856|NCT00753766|19422763|P1|COMPLETED|Overall Study||0
7891857|NCT00753766|19422762|P2|STARTED|Overall Study||0
7891858|NCT00753766|19422763|P1|STARTED|Overall Study||1
7891859|NCT00753714|19422785|P2|NOT COMPLETED|Overall Study||62
7891860|NCT00753714|19422786|P1|NOT COMPLETED|Overall Study||60
7891861|NCT00753714|19422785|P2|COMPLETED|Overall Study||1
7891862|NCT00753714|19422786|P1|COMPLETED|Overall Study||1
7891863|NCT00753714|19422785|P2|STARTED|Overall Study||63
7891864|NCT00753714|19422786|P1|STARTED|Overall Study||61
7891865|NCT00753688|19422802|P2|NOT COMPLETED|Overall Study||246
7891866|NCT00753688|19422803|P1|NOT COMPLETED|Overall Study||123
7891867|NCT00753688|19422802|P2|COMPLETED|Overall Study||0
7891868|NCT00753688|19422803|P1|COMPLETED|Overall Study||0
7891869|NCT00753688|19422802|P2|Ongoing - in Follow-up|Overall Study||31
7891870|NCT00753688|19422803|P1|Ongoing - in Follow-up|Overall Study||15
7891871|NCT00753688|19422802|P2|STARTED|Overall Study||246
7891872|NCT00753688|19422803|P1|STARTED|Overall Study||123
7891873|NCT00753675|19422832|P3|NOT COMPLETED|Overall Study||56
7891874|NCT00753675|19422833|P2|NOT COMPLETED|Overall Study||59
7891875|NCT00753675|19422834|P1|NOT COMPLETED|Overall Study||59
7891876|NCT00753675|19422832|P3|COMPLETED|Overall Study||0
7891877|NCT00753675|19422833|P2|COMPLETED|Overall Study||0
7891878|NCT00753675|19422834|P1|COMPLETED|Overall Study||0
7891879|NCT00753675|19422832|P3|STARTED|Overall Study||56
7891880|NCT00753675|19422833|P2|STARTED|Overall Study||59
7891881|NCT00753675|19422834|P1|STARTED|Overall Study||59
7891882|NCT00753649|19422856|P2|NOT COMPLETED|Overall Study||0
7891883|NCT00753649|19422857|P1|NOT COMPLETED|Overall Study||7
7891884|NCT00753649|19422856|P2|COMPLETED|Overall Study||112
7891885|NCT00753649|19422857|P1|COMPLETED|Overall Study||105
7891886|NCT00753649|19422856|P2|STARTED|Overall Study||112
7891887|NCT00753649|19422857|P1|STARTED|Overall Study||112
7891888|NCT00753636|19422877|P1|NOT COMPLETED|Overall Study||6
7891889|NCT00753636|19422877|P1|COMPLETED|Overall Study||25
7891890|NCT00753636|19422877|P1|STARTED|Overall Study||31
7891891|NCT00753623|19422889|P2|NOT COMPLETED|Phase II (14 Days)||1
7891892|NCT00753623|19422890|P1|NOT COMPLETED|Phase II (14 Days)||0
7891893|NCT00753623|19422889|P2|COMPLETED|Phase II (14 Days)||7
7891894|NCT00753623|19422890|P1|COMPLETED|Phase II (14 Days)||8
7891895|NCT00753623|19422889|P2|STARTED|Phase II (14 Days)||8
7891896|NCT00753623|19422890|P1|STARTED|Phase II (14 Days)||8
7891897|NCT00753623|19422889|P2|NOT COMPLETED|Washout (7 Days)||0
7891898|NCT00753623|19422890|P1|NOT COMPLETED|Washout (7 Days)||1
7891899|NCT00753623|19422889|P2|COMPLETED|Washout (7 Days)||8
7891900|NCT00753623|19422890|P1|COMPLETED|Washout (7 Days)||8
7891901|NCT00753623|19422889|P2|STARTED|Washout (7 Days)||8
7891902|NCT00753623|19422890|P1|STARTED|Washout (7 Days)||9
7891903|NCT00753623|19422889|P2|NOT COMPLETED|Phase I (14 Days)||4
7891904|NCT00753623|19422890|P1|NOT COMPLETED|Phase I (14 Days)||2
7891905|NCT00753623|19422889|P2|COMPLETED|Phase I (14 Days)||8
7891906|NCT00753623|19422890|P1|COMPLETED|Phase I (14 Days)||9
7891907|NCT00753623|19422889|P2|STARTED|Phase I (14 Days)||12
7891908|NCT00753623|19422890|P1|STARTED|Phase I (14 Days)||11
7891909|NCT00753545|19422898|P2|NOT COMPLETED|Overall Study||118
7891910|NCT00753545|19422899|P1|NOT COMPLETED|Overall Study||108
7891911|NCT00753545|19422898|P2|COMPLETED|Overall Study|Patients completing the Study|11
7891912|NCT00753545|19422899|P1|COMPLETED|Overall Study|Patients completing the Study|28
7891913|NCT00753545|19422898|P2|STARTED|Overall Study|Patients randomized|129
7891914|NCT00753545|19422899|P1|STARTED|Overall Study|Patients randomized|136
7891915|NCT00753519|19422937|P2|NOT COMPLETED|Overall Study||2
7891916|NCT00753519|19422938|P1|NOT COMPLETED|Overall Study||0
7891917|NCT00753519|19422937|P2|COMPLETED|Overall Study||13
7891918|NCT00753519|19422938|P1|COMPLETED|Overall Study||13
7891919|NCT00753519|19422937|P2|STARTED|Overall Study||15
7891920|NCT00753519|19422938|P1|STARTED|Overall Study||13
7891921|NCT00753506|19422960|P2|NOT COMPLETED|Overall Study||2
7891922|NCT00753506|19422961|P1|NOT COMPLETED|Overall Study||7
7891923|NCT00753506|19422960|P2|COMPLETED|Overall Study||31
7891924|NCT00753506|19422961|P1|COMPLETED|Overall Study||26
7891925|NCT00753506|19422960|P2|STARTED|Overall Study||33
7891926|NCT00753506|19422961|P1|STARTED|Overall Study||33
7891927|NCT00753454|19422967|P1|NOT COMPLETED|Overall Study||14
7891928|NCT00753454|19422967|P1|COMPLETED|Overall Study||154
7891929|NCT00753454|19422967|P1|STARTED|Overall Study||168
7891930|NCT00753415|19423001|P10|NOT COMPLETED|Part B||1
7891931|NCT00753415|19423002|P9|NOT COMPLETED|Part B||3
7891932|NCT00753415|19423003|P8|NOT COMPLETED|Part B||1
7891933|NCT00753415|19423004|P7|NOT COMPLETED|Part B||0
7891934|NCT00753415|19423005|P6|NOT COMPLETED|Part B||0
7891935|NCT00753415|19423006|P5|NOT COMPLETED|Part B||0
7891936|NCT00753415|19423007|P4|NOT COMPLETED|Part B||0
7891937|NCT00753415|19423008|P3|NOT COMPLETED|Part B||0
7891938|NCT00753415|19423009|P2|NOT COMPLETED|Part B||0
7891939|NCT00753415|19423010|P1|NOT COMPLETED|Part B||0
7891940|NCT00753415|19423001|P10|COMPLETED|Part B||8
7891941|NCT00753415|19423002|P9|COMPLETED|Part B||6
7891942|NCT00753415|19423003|P8|COMPLETED|Part B||6
7891943|NCT00753415|19423004|P7|COMPLETED|Part B||2
7891944|NCT00753415|19423005|P6|COMPLETED|Part B||1
7891945|NCT00753415|19423006|P5|COMPLETED|Part B||0
7891946|NCT00753415|19423007|P4|COMPLETED|Part B||0
7891947|NCT00753415|19423008|P3|COMPLETED|Part B||0
7891948|NCT00753415|19423009|P2|COMPLETED|Part B||0
7891949|NCT00753415|19423010|P1|COMPLETED|Part B||0
7891950|NCT00753415|19423001|P10|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9
7891951|NCT00753415|19423002|P9|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9
7891952|NCT00753415|19423003|P8|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7
7891953|NCT00753415|19423004|P7|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2
7891954|NCT00753415|19423005|P6|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1
7891955|NCT00753415|19423006|P5|STARTED|Part B||0
7891956|NCT00753415|19423007|P4|STARTED|Part B||0
7891957|NCT00753415|19423008|P3|STARTED|Part B||0
7891958|NCT00753415|19423009|P2|STARTED|Part B||0
7891959|NCT00753415|19423010|P1|STARTED|Part B||0
7891960|NCT00753415|19423001|P10|NOT COMPLETED|Part A||0
7891961|NCT00753415|19423002|P9|NOT COMPLETED|Part A||0
7891962|NCT00753415|19423003|P8|NOT COMPLETED|Part A||0
7891963|NCT00753415|19423004|P7|NOT COMPLETED|Part A||0
7891964|NCT00753415|19423005|P6|NOT COMPLETED|Part A||0
7891965|NCT00753415|19423006|P5|NOT COMPLETED|Part A||0
7891966|NCT00753415|19423007|P4|NOT COMPLETED|Part A||2
7891967|NCT00753415|19423008|P3|NOT COMPLETED|Part A||2
7891968|NCT00753415|19423009|P2|NOT COMPLETED|Part A||0
7891969|NCT00753415|19423010|P1|NOT COMPLETED|Part A||1
7891970|NCT00753415|19423001|P10|COMPLETED|Part A||0
7891971|NCT00753415|19423002|P9|COMPLETED|Part A||0
7891972|NCT00753415|19423003|P8|COMPLETED|Part A||0
7891973|NCT00753415|19423004|P7|COMPLETED|Part A||0
7891974|NCT00753415|19423005|P6|COMPLETED|Part A||0
7891975|NCT00753415|19423006|P5|COMPLETED|Part A||10
7891976|NCT00753415|19423007|P4|COMPLETED|Part A||9
7891977|NCT00753415|19423008|P3|COMPLETED|Part A||8
7891978|NCT00753415|19423009|P2|COMPLETED|Part A||3
7891979|NCT00753415|19423010|P1|COMPLETED|Part A||2
7891980|NCT00753415|19423001|P10|STARTED|Part A||0
7891981|NCT00753415|19423002|P9|STARTED|Part A||0
7891982|NCT00753415|19423003|P8|STARTED|Part A||0
7891983|NCT00753415|19423004|P7|STARTED|Part A||0
7891984|NCT00753415|19423005|P6|STARTED|Part A||0
7891985|NCT00753415|19423006|P5|STARTED|Part A||10
7891986|NCT00753415|19423007|P4|STARTED|Part A||11
7891987|NCT00753415|19423008|P3|STARTED|Part A||10
7891988|NCT00753415|19423009|P2|STARTED|Part A||3
7891989|NCT00753415|19423010|P1|STARTED|Part A||3
7891990|NCT00753363|19423054|P2|NOT COMPLETED|Overall Study||39
7891991|NCT00753363|19423055|P1|NOT COMPLETED|Overall Study||40
7891992|NCT00753363|19423054|P2|COMPLETED|Overall Study||21
7891993|NCT00753363|19423055|P1|COMPLETED|Overall Study||19
7891994|NCT00753363|19423054|P2|STARTED|Overall Study||60
7891995|NCT00753363|19423055|P1|STARTED|Overall Study||59
7891996|NCT00753337|19423065|P1|NOT COMPLETED|Overall Study||0
7891997|NCT00753337|19423065|P1|COMPLETED|Overall Study||123
7891998|NCT00753337|19423065|P1|STARTED|Overall Study||123
7891999|NCT00753298|19423081|P2|NOT COMPLETED|Overall Study||4
7892000|NCT00753298|19423082|P1|NOT COMPLETED|Overall Study||8
7892001|NCT00753298|19423081|P2|COMPLETED|Overall Study||94
7892002|NCT00753298|19423082|P1|COMPLETED|Overall Study||89
7892003|NCT00753298|19423081|P2|STARTED|Overall Study||98
7892004|NCT00753298|19423082|P1|STARTED|Overall Study||97
7892005|NCT00753272|19423100|P2|NOT COMPLETED|Overall Study||4907
7892006|NCT00753272|19423101|P1|NOT COMPLETED|Overall Study||4982
7892007|NCT00753272|19423100|P2|COMPLETED|Overall Study||16895
7892008|NCT00753272|19423101|P1|COMPLETED|Overall Study||16911
7892009|NCT00753272|19423100|P2|STARTED|Overall Study||21802
7892010|NCT00753272|19423101|P1|STARTED|Overall Study||21893
7892011|NCT00753220|19423163|P1|NOT COMPLETED|Overall Study||5
7892012|NCT00753220|19423163|P1|COMPLETED|Overall Study||2
7892013|NCT00753220|19423163|P1|STARTED|Overall Study||7
7892014|NCT00753142|19423170|P3|NOT COMPLETED|Overall Study||0
7892015|NCT00753142|19423171|P2|NOT COMPLETED|Overall Study||0
7892016|NCT00753142|19423172|P1|NOT COMPLETED|Overall Study||0
7892017|NCT00753142|19423170|P3|COMPLETED|Overall Study||13
7892018|NCT00753142|19423171|P2|COMPLETED|Overall Study||7
7892019|NCT00753142|19423172|P1|COMPLETED|Overall Study||8
7892020|NCT00753142|19423170|P3|STARTED|Overall Study||13
7892021|NCT00753142|19423171|P2|STARTED|Overall Study||7
7892022|NCT00753142|19423172|P1|STARTED|Overall Study||8
7892023|NCT00753012|19423185|P2|NOT COMPLETED|Overall Study||1
7892024|NCT00753012|19423186|P1|NOT COMPLETED|Overall Study||8
7892025|NCT00753012|19423185|P2|COMPLETED|Overall Study||8
7892026|NCT00753012|19423186|P1|COMPLETED|Overall Study||7
7892027|NCT00753012|19423185|P2|STARTED|Overall Study||9
7892028|NCT00753012|19423186|P1|STARTED|Overall Study||15
7892029|NCT00752986|19423199|P3|NOT COMPLETED|Overall Study||2
7892030|NCT00752986|19423200|P2|NOT COMPLETED|Overall Study||1
7892031|NCT00752986|19423201|P1|NOT COMPLETED|Overall Study||5
7892032|NCT00752986|19423199|P3|COMPLETED|Overall Study||9
7892033|NCT00752986|19423200|P2|COMPLETED|Overall Study||11
7892034|NCT00752986|19423201|P1|COMPLETED|Overall Study||11
7892035|NCT00752986|19423199|P3|STARTED|Overall Study||11
7892036|NCT00752986|19423200|P2|STARTED|Overall Study||12
7892037|NCT00752986|19423201|P1|STARTED|Overall Study||16
7892038|NCT00752973|19423218|P1|NOT COMPLETED|Overall Study||0
7892039|NCT00752973|19423218|P1|COMPLETED|Overall Study||12
7892040|NCT00752973|19423218|P1|STARTED|Overall Study||12
7892041|NCT00752908|19423230|P2|NOT COMPLETED|Overall Study||0
7892042|NCT00752908|19423231|P1|NOT COMPLETED|Overall Study||0
7892043|NCT00752908|19423230|P2|COMPLETED|Overall Study||13
7892044|NCT00752908|19423231|P1|COMPLETED|Overall Study||14
7892045|NCT00752908|19423230|P2|STARTED|Overall Study||13
7892046|NCT00752908|19423231|P1|STARTED|Overall Study||14
7892047|NCT00752895|19423241|P2|NOT COMPLETED|Overall Study||3
7892048|NCT00752895|19423242|P1|NOT COMPLETED|Overall Study||8
7892049|NCT00752895|19423241|P2|COMPLETED|Overall Study||143
7892050|NCT00752895|19423242|P1|COMPLETED|Overall Study||139
7892051|NCT00752895|19423241|P2|STARTED|Overall Study||146
7892052|NCT00752895|19423242|P1|STARTED|Overall Study||147
7892053|NCT00752856|19423252|P2|NOT COMPLETED|Overall Study||1
7892054|NCT00752856|19423253|P1|NOT COMPLETED|Overall Study||0
7892055|NCT00752856|19423252|P2|COMPLETED|Overall Study||24
7892056|NCT00752856|19423253|P1|COMPLETED|Overall Study||26
7892057|NCT00752856|19423252|P2|STARTED|Overall Study||25
7892058|NCT00752856|19423253|P1|STARTED|Overall Study||26
7892059|NCT00752791|19423265|P1|NOT COMPLETED|Overall Study||16
7892060|NCT00752791|19423265|P1|COMPLETED|Overall Study||43
7892061|NCT00752791|19423265|P1|STARTED|Overall Study||59
7892062|NCT00752726|19423277|P2|NOT COMPLETED|Overall Study||13
7892063|NCT00752726|19423278|P1|NOT COMPLETED|Overall Study||11
7892064|NCT00752726|19423277|P2|COMPLETED|Overall Study||53
7892065|NCT00752726|19423278|P1|COMPLETED|Overall Study||54
7892066|NCT00752726|19423277|P2|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61
7892067|NCT00752726|19423278|P1|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62
7892068|NCT00752726|19423277|P2|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64
7892069|NCT00752726|19423278|P1|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63
7892070|NCT00752726|19423277|P2|STARTED|Overall Study||66
7892071|NCT00752726|19423278|P1|STARTED|Overall Study||65
7892072|NCT00752622|19423303|P1|NOT COMPLETED|Interventional Phase||8
7892073|NCT00752622|19423303|P1|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0
7892074|NCT00752622|19423303|P1|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8
7892075|NCT00752622|19423303|P1|NOT COMPLETED|Observational Phase||43
7892076|NCT00752622|19423303|P1|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22
7892077|NCT00752622|19423303|P1|STARTED|Observational Phase||65
7892078|NCT00752622|19423303|P1|NOT COMPLETED|Induction Phase||35
7892079|NCT00752622|19423303|P1|COMPLETED|Induction Phase||65
7892080|NCT00752622|19423303|P1|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100
7892081|NCT00752609|19423316|P2|NOT COMPLETED|Overall Study||2
7892082|NCT00752609|19423317|P1|NOT COMPLETED|Overall Study||9
7892083|NCT00752609|19423316|P2|COMPLETED|Overall Study||47
7892084|NCT00752609|19423317|P1|COMPLETED|Overall Study||44
7892085|NCT00752609|19423316|P2|Full Analysis Set|Overall Study||49
7892086|NCT00752609|19423317|P1|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52
7892087|NCT00752609|19423316|P2|STARTED|Overall Study||49
7892088|NCT00752609|19423317|P1|STARTED|Overall Study||53
7892089|NCT00752557|19423339|P3|NOT COMPLETED|Overall Study||6
7892090|NCT00752557|19423340|P2|NOT COMPLETED|Overall Study||5
7892091|NCT00752557|19423341|P1|NOT COMPLETED|Overall Study||5
7892092|NCT00752557|19423339|P3|COMPLETED|Overall Study||11
7892093|NCT00752557|19423340|P2|COMPLETED|Overall Study||11
7892094|NCT00752557|19423341|P1|COMPLETED|Overall Study||12
7892095|NCT00752557|19423339|P3|STARTED|Overall Study||17
7892096|NCT00752557|19423340|P2|STARTED|Overall Study||16
7892097|NCT00752557|19423341|P1|STARTED|Overall Study||17
7892098|NCT00752232|19423373|P7|NOT COMPLETED|Overall Study||0
7892099|NCT00752232|19423374|P6|NOT COMPLETED|Overall Study||1
7892100|NCT00752232|19423375|P5|NOT COMPLETED|Overall Study||3
7892101|NCT00752232|19423376|P4|NOT COMPLETED|Overall Study||1
7892102|NCT00752232|19423377|P3|NOT COMPLETED|Overall Study||1
7892103|NCT00752232|19423378|P2|NOT COMPLETED|Overall Study||0
7892104|NCT00752232|19423379|P1|NOT COMPLETED|Overall Study||2
7892105|NCT00752232|19423373|P7|COMPLETED|Overall Study||4
7892106|NCT00752232|19423374|P6|COMPLETED|Overall Study||5
7892107|NCT00752232|19423375|P5|COMPLETED|Overall Study||3
7892108|NCT00752232|19423376|P4|COMPLETED|Overall Study||5
7892109|NCT00752232|19423377|P3|COMPLETED|Overall Study||5
7892110|NCT00752232|19423378|P2|COMPLETED|Overall Study||6
7892111|NCT00752232|19423379|P1|COMPLETED|Overall Study||4
7892112|NCT00752232|19423373|P7|STARTED|Overall Study||4
7892113|NCT00752232|19423374|P6|STARTED|Overall Study||6
7892114|NCT00752232|19423375|P5|STARTED|Overall Study||6
7892115|NCT00752232|19423376|P4|STARTED|Overall Study||6
7892116|NCT00752232|19423377|P3|STARTED|Overall Study||6
7892117|NCT00752232|19423378|P2|STARTED|Overall Study||6
7892118|NCT00752232|19423379|P1|STARTED|Overall Study||6
7892119|NCT00752219|19423453|P2|NOT COMPLETED|Overall Study||6
7892120|NCT00752219|19423454|P1|NOT COMPLETED|Overall Study||11
7892121|NCT00752219|19423453|P2|COMPLETED|Overall Study||96
7892122|NCT00752219|19423454|P1|COMPLETED|Overall Study||91
7892123|NCT00752219|19423453|P2|Treated|Overall Study||102
7892124|NCT00752219|19423454|P1|Treated|Overall Study||101
7892125|NCT00752219|19423453|P2|STARTED|Overall Study||102
7892126|NCT00752219|19423454|P1|STARTED|Overall Study||102
7892127|NCT00752206|19423480|P2|NOT COMPLETED|Overall Study||11
7892128|NCT00752206|19423481|P1|NOT COMPLETED|Overall Study||9
7892129|NCT00752206|19423480|P2|COMPLETED|Overall Study||8
7892130|NCT00752206|19423481|P1|COMPLETED|Overall Study||10
7892131|NCT00752206|19423480|P2|STARTED|Overall Study||19
7892132|NCT00752206|19423481|P1|STARTED|Overall Study||19
7892133|NCT00752128|19423499|P1|NOT COMPLETED|Overall Study||4
7892134|NCT00752128|19423499|P1|COMPLETED|Overall Study||2345
7892135|NCT00752128|19423499|P1|STARTED|Overall Study||2349
7892136|NCT00752102|19423506|P2|NOT COMPLETED|Overall Study||1
7892137|NCT00752102|19423507|P1|NOT COMPLETED|Overall Study||3
7892138|NCT00752102|19423506|P2|COMPLETED|Overall Study||21
7892139|NCT00752102|19423507|P1|COMPLETED|Overall Study||19
7892140|NCT00752102|19423506|P2|STARTED|Overall Study||22
7892141|NCT00752102|19423507|P1|STARTED|Overall Study||22
7892142|NCT00752089|19423513|P1|NOT COMPLETED|Overall Study||6
7892143|NCT00752089|19423513|P1|COMPLETED|Overall Study||14
7892144|NCT00752089|19423513|P1|Received Placebo|Overall Study||18
7892145|NCT00752089|19423513|P1|Received NaF|Overall Study||18
7892146|NCT00752089|19423513|P1|Received NaF/KNO3/ 0% Isopentane|Overall Study||17
7892147|NCT00752089|19423513|P1|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19
7892148|NCT00752089|19423513|P1|STARTED|Overall Study||20
7892149|NCT00751998|19423527|P1|NOT COMPLETED|Overall Study||20
7892150|NCT00751998|19423527|P1|COMPLETED|Overall Study||277
7892151|NCT00751998|19423527|P1|STARTED|Overall Study||297
7892152|NCT00751972|19423533|P2|NOT COMPLETED|Overall Study||0
7892153|NCT00751972|19423534|P1|NOT COMPLETED|Overall Study||0
7892154|NCT00751972|19423533|P2|COMPLETED|Overall Study||499
7892155|NCT00751972|19423534|P1|COMPLETED|Overall Study||140
7892156|NCT00751972|19423533|P2|STARTED|Overall Study||499
7892157|NCT00751972|19423534|P1|STARTED|Overall Study||140
7892158|NCT00751933|19423546|P4|NOT COMPLETED|Overall Study||1
7892159|NCT00751933|19423547|P3|NOT COMPLETED|Overall Study||1
7892160|NCT00751933|19423548|P2|NOT COMPLETED|Overall Study||1
7892161|NCT00751933|19423549|P1|NOT COMPLETED|Overall Study||0
7892162|NCT00751933|19423546|P4|COMPLETED|Overall Study||0
7892163|NCT00751933|19423547|P3|COMPLETED|Overall Study||0
7892164|NCT00751933|19423548|P2|COMPLETED|Overall Study||0
7892165|NCT00751933|19423549|P1|COMPLETED|Overall Study||0
7892166|NCT00751933|19423546|P4|STARTED|Overall Study||1
7892167|NCT00751933|19423547|P3|STARTED|Overall Study||1
7892168|NCT00751933|19423548|P2|STARTED|Overall Study||1
7892169|NCT00751933|19423549|P1|STARTED|Overall Study||0
7892170|NCT00751881|19423557|P3|NOT COMPLETED|Extension Study Period||66
7892171|NCT00751881|19423558|P2|NOT COMPLETED|Extension Study Period||71
7892172|NCT00751881|19423559|P1|NOT COMPLETED|Extension Study Period||65
7892173|NCT00751881|19423557|P3|COMPLETED|Extension Study Period||167
7892174|NCT00751881|19423558|P2|COMPLETED|Extension Study Period||194
7892175|NCT00751881|19423559|P1|COMPLETED|Extension Study Period||188
7892176|NCT00751881|19423557|P3|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233
7892177|NCT00751881|19423558|P2|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265
7892178|NCT00751881|19423559|P1|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253
7892179|NCT00751881|19423557|P3|NOT COMPLETED|Core Treatment Period||128
7892180|NCT00751881|19423558|P2|NOT COMPLETED|Core Treatment Period||135
7892181|NCT00751881|19423559|P1|NOT COMPLETED|Core Treatment Period||126
7892182|NCT00751881|19423557|P3|COMPLETED|Core Treatment Period||244
7892183|NCT00751881|19423558|P2|COMPLETED|Core Treatment Period||273
7892184|NCT00751881|19423559|P1|COMPLETED|Core Treatment Period||263
7892185|NCT00751881|19423557|P3|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370
7892186|NCT00751881|19423558|P2|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407
7892187|NCT00751881|19423559|P1|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388
7892188|NCT00751881|19423557|P3|STARTED|Core Treatment Period|Randomized|372
7892189|NCT00751881|19423558|P2|STARTED|Core Treatment Period|Randomized|408
7892190|NCT00751881|19423559|P1|STARTED|Core Treatment Period|Randomized|389
7892191|NCT00751790|19423606|P1|NOT COMPLETED|Overall Study||5
7892192|NCT00751790|19423606|P1|COMPLETED|Overall Study||115
7892193|NCT00751790|19423606|P1|STARTED|Overall Study||120
7892194|NCT00751777|19423612|P2|NOT COMPLETED|Overall Study||3
7892195|NCT00751777|19423613|P1|NOT COMPLETED|Overall Study||11
7892196|NCT00751777|19423612|P2|COMPLETED|Overall Study|Day 194: study completion for placebo group|36
7892197|NCT00751777|19423613|P1|COMPLETED|Overall Study|Day 380: study completion for LT group|70
7892198|NCT00751777|19423612|P2|STARTED|Overall Study||39
7892199|NCT00751777|19423613|P1|STARTED|Overall Study||81
7892200|NCT00751634|19423629|P1|NOT COMPLETED|Overall Study||0
7892201|NCT00751634|19423629|P1|COMPLETED|Overall Study||20
7892202|NCT00751634|19423629|P1|STARTED|Overall Study||20
7892203|NCT00751621|19423637|P1|NOT COMPLETED|Overall Study||4
7892204|NCT00751621|19423637|P1|COMPLETED|Overall Study||36
7892205|NCT00751621|19423637|P1|STARTED|Overall Study||40
7892206|NCT00751530|19423656|P2|NOT COMPLETED|Overall Study||0
7892207|NCT00751530|19423657|P1|NOT COMPLETED|Overall Study||0
7892208|NCT00751530|19423656|P2|COMPLETED|Overall Study||110
7892209|NCT00751530|19423657|P1|COMPLETED|Overall Study||332
7892210|NCT00751530|19423656|P2|STARTED|Overall Study||110
7892211|NCT00751530|19423657|P1|STARTED|Overall Study||332
7892212|NCT00751400|19423671|P1|NOT COMPLETED|Overall Study||10
7892213|NCT00751400|19423671|P1|COMPLETED|Overall Study||487
7892214|NCT00751400|19423671|P1|Subjects Provided Detailed Use Data|Overall Study||467
7892215|NCT00751400|19423671|P1|Subjects Consumed Drug|Overall Study||485
7892216|NCT00751400|19423671|P1|Subjects Provided Drug|Overall Study||497
7892217|NCT00751400|19423671|P1|STARTED|Overall Study||497
7892218|NCT00751348|19423686|P2|NOT COMPLETED|Overall Study||2
7892219|NCT00751348|19423687|P1|NOT COMPLETED|Overall Study||6
7892220|NCT00751348|19423686|P2|COMPLETED|Overall Study||159
7892221|NCT00751348|19423687|P1|COMPLETED|Overall Study||307
7892222|NCT00751348|19423686|P2|STARTED|Overall Study||161
7892223|NCT00751348|19423687|P1|STARTED|Overall Study||313
7892224|NCT00751335|19423711|P2|NOT COMPLETED|Overall Study||0
7892225|NCT00751335|19423712|P1|NOT COMPLETED|Overall Study||0
7892226|NCT00751335|19423711|P2|COMPLETED|Overall Study||0
7892227|NCT00751335|19423712|P1|COMPLETED|Overall Study||0
7892228|NCT00751335|19423711|P2|STARTED|Overall Study||0
7892229|NCT00751335|19423712|P1|STARTED|Overall Study||0
7892230|NCT00751296|19423720|P1|NOT COMPLETED|Overall Study||2
7892231|NCT00751296|19423720|P1|COMPLETED|Overall Study||25
7892232|NCT00751296|19423720|P1|STARTED|Overall Study|The start date of the study was 25 August 2006.|27
7892233|NCT00751179|19423727|P2|NOT COMPLETED|Overall Study||15
7892234|NCT00751179|19423728|P1|NOT COMPLETED|Overall Study||14
7892235|NCT00751179|19423727|P2|COMPLETED|Overall Study||70
7892236|NCT00751179|19423728|P1|COMPLETED|Overall Study||62
7892237|NCT00751179|19423727|P2|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85
7892238|NCT00751179|19423728|P1|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76
7892239|NCT00751140|19423748|P1|NOT COMPLETED|Overall Study||1
7892240|NCT00751140|19423748|P1|COMPLETED|Overall Study||19
7892241|NCT00751140|19423748|P1|STARTED|Overall Study||20
7892242|NCT00751114|19423758|P2|NOT COMPLETED|Overall Study||32
7892243|NCT00751114|19423759|P1|NOT COMPLETED|Overall Study||38
7892244|NCT00751114|19423758|P2|COMPLETED|Overall Study||233
7892245|NCT00751114|19423759|P1|COMPLETED|Overall Study||212
7892246|NCT00751114|19423758|P2|mITT Population|Overall Study||253
7892247|NCT00751114|19423759|P1|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227
7892248|NCT00751114|19423758|P2|TREATED = Safety Population|Overall Study||264
7892249|NCT00751114|19423759|P1|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237
7892250|NCT00751114|19423758|P2|STARTED|Overall Study||265
7892251|NCT00751114|19423759|P1|STARTED|Overall Study|randomized|250
7892252|NCT00751101|19423784|P2|NOT COMPLETED|Overall Study||5
7892253|NCT00751101|19423785|P1|NOT COMPLETED|Overall Study||2
7892254|NCT00751101|19423784|P2|COMPLETED|Overall Study||7
7892255|NCT00751101|19423785|P1|COMPLETED|Overall Study||10
7892256|NCT00751101|19423784|P2|Started Capecitabine|Overall Study||11
7892257|NCT00751101|19423785|P1|Started Capecitabine|Overall Study||11
7892258|NCT00751101|19423784|P2|STARTED|Overall Study||12
7892259|NCT00751101|19423785|P1|STARTED|Overall Study||12
7892260|NCT00751036|19423805|P2|NOT COMPLETED|Overall Study||46
7892261|NCT00751036|19423806|P1|NOT COMPLETED|Overall Study||48
7892262|NCT00751036|19423805|P2|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
7892263|NCT00751036|19423806|P1|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
7892264|NCT00751036|19423805|P2|STARTED|Overall Study|Started = Treated|46
7892265|NCT00751036|19423806|P1|STARTED|Overall Study|Started = Treated|48
7892266|NCT00751023|19423820|P2|NOT COMPLETED|Overall Study||7
7892267|NCT00751023|19423821|P1|NOT COMPLETED|Overall Study||11
7892268|NCT00751023|19423820|P2|COMPLETED|Overall Study||13
7892269|NCT00751023|19423821|P1|COMPLETED|Overall Study||9
7892270|NCT00751023|19423820|P2|STARTED|Overall Study||20
7892271|NCT00751023|19423821|P1|STARTED|Overall Study||20
7892272|NCT00750919|19423841|P1|NOT COMPLETED|Overall Study||58
7892273|NCT00750919|19423841|P1|COMPLETED|Overall Study||126
7892274|NCT00750919|19423841|P1|STARTED|Overall Study||184
7892275|NCT00750893|19423849|P1|NOT COMPLETED|Overall Study||542
7892276|NCT00750893|19423849|P1|COMPLETED|Overall Study||2569
7892277|NCT00750893|19423849|P1|STARTED|Overall Study||3111
7892278|NCT00750880|19423861|P1|NOT COMPLETED|Overall Study||215
7892279|NCT00750880|19423861|P1|COMPLETED|Overall Study||1466
7892280|NCT00750880|19423861|P1|STARTED|Overall Study||1681
7892281|NCT00750867|19423884|P1|NOT COMPLETED|Overall Study||2
7892282|NCT00750867|19423884|P1|COMPLETED|Overall Study||7
7892283|NCT00750867|19423884|P1|STARTED|Overall Study||9
7892284|NCT00750815|19423891|P2|NOT COMPLETED|Overall Study||0
7892285|NCT00750815|19423892|P1|NOT COMPLETED|Overall Study||0
7892286|NCT00750815|19423891|P2|COMPLETED|Overall Study||46
7892287|NCT00750815|19423892|P1|COMPLETED|Overall Study||12
7892288|NCT00750815|19423891|P2|STARTED|Overall Study||46
7892289|NCT00750815|19423892|P1|STARTED|Overall Study||12
7892290|NCT00750737|19423905|P2|NOT COMPLETED|Overall Study||3
7892291|NCT00750737|19423906|P1|NOT COMPLETED|Overall Study||3
7892292|NCT00750737|19423905|P2|COMPLETED|Overall Study||19
7892293|NCT00750737|19423906|P1|COMPLETED|Overall Study||21
7892294|NCT00750737|19423905|P2|STARTED|Overall Study||22
7892295|NCT00750737|19423906|P1|STARTED|Overall Study||24
7892296|NCT00750555|19423914|P1|NOT COMPLETED|Overall Study||0
7892297|NCT00750555|19423914|P1|COMPLETED|Overall Study||0
7892298|NCT00750555|19423914|P1|STARTED|Overall Study||0
7892299|NCT00750438|19423921|P2|NOT COMPLETED|Overall Study||4
7892300|NCT00750438|19423922|P1|NOT COMPLETED|Overall Study||7
7892301|NCT00750438|19423921|P2|COMPLETED|Overall Study||25
7892302|NCT00750438|19423922|P1|COMPLETED|Overall Study||24
7892303|NCT00750438|19423921|P2|STARTED|Overall Study||29
7892304|NCT00750438|19423922|P1|STARTED|Overall Study||31
7892305|NCT00750373|19423938|P2|NOT COMPLETED|Overall Study||0
7892306|NCT00750373|19423939|P1|NOT COMPLETED|Overall Study||0
7892307|NCT00750373|19423938|P2|COMPLETED|Overall Study||37
7892308|NCT00750373|19423939|P1|COMPLETED|Overall Study||39
7892309|NCT00750373|19423938|P2|STARTED|Overall Study||37
7892310|NCT00750373|19423939|P1|STARTED|Overall Study||39
7892311|NCT00750360|19423951|P6|NOT COMPLETED|Overall Study||0
7892312|NCT00750360|19423952|P5|NOT COMPLETED|Overall Study||0
7892313|NCT00750360|19423953|P4|NOT COMPLETED|Overall Study||0
7892314|NCT00750360|19423954|P3|NOT COMPLETED|Overall Study||0
7892315|NCT00750360|19423955|P2|NOT COMPLETED|Overall Study||0
7892316|NCT00750360|19423956|P1|NOT COMPLETED|Overall Study||0
7892317|NCT00750360|19423951|P6|COMPLETED|Overall Study||71
7892318|NCT00750360|19423952|P5|COMPLETED|Overall Study||46
7892319|NCT00750360|19423953|P4|COMPLETED|Overall Study||79
7892320|NCT00750360|19423954|P3|COMPLETED|Overall Study||384
7892321|NCT00750360|19423955|P2|COMPLETED|Overall Study||1
7892322|NCT00750360|19423956|P1|COMPLETED|Overall Study||294
7892323|NCT00750360|19423951|P6|STARTED|Overall Study||71
7892324|NCT00750360|19423952|P5|STARTED|Overall Study||46
7892325|NCT00750360|19423953|P4|STARTED|Overall Study||79
7892326|NCT00750360|19423954|P3|STARTED|Overall Study||384
7892327|NCT00750360|19423955|P2|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1
7892328|NCT00750360|19423956|P1|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294
7892329|NCT00750308|19423988|P12|NOT COMPLETED|Fourth Treatment||0
7892330|NCT00750308|19423989|P11|NOT COMPLETED|Fourth Treatment||0
7892331|NCT00750308|19423990|P10|NOT COMPLETED|Fourth Treatment||0
7892332|NCT00750308|19423991|P9|NOT COMPLETED|Fourth Treatment||0
7892333|NCT00750308|19423992|P8|NOT COMPLETED|Fourth Treatment||0
7892334|NCT00750308|19423993|P7|NOT COMPLETED|Fourth Treatment||0
7892335|NCT00750308|19423994|P6|NOT COMPLETED|Fourth Treatment||0
7892336|NCT00750308|19423995|P5|NOT COMPLETED|Fourth Treatment||0
7892337|NCT00750308|19423996|P4|NOT COMPLETED|Fourth Treatment||0
7892338|NCT00750308|19423997|P3|NOT COMPLETED|Fourth Treatment||0
7892339|NCT00750308|19423998|P2|NOT COMPLETED|Fourth Treatment||0
7892340|NCT00750308|19423999|P1|NOT COMPLETED|Fourth Treatment||0
7892341|NCT00750308|19423988|P12|COMPLETED|Fourth Treatment||1
7892342|NCT00750308|19423989|P11|COMPLETED|Fourth Treatment||1
7892343|NCT00750308|19423990|P10|COMPLETED|Fourth Treatment||2
7892344|NCT00750308|19423991|P9|COMPLETED|Fourth Treatment||1
7892345|NCT00750308|19423992|P8|COMPLETED|Fourth Treatment||2
7892346|NCT00750308|19423993|P7|COMPLETED|Fourth Treatment||2
7892347|NCT00750308|19423994|P6|COMPLETED|Fourth Treatment||2
7892348|NCT00750308|19423995|P5|COMPLETED|Fourth Treatment||1
7892349|NCT00750308|19423996|P4|COMPLETED|Fourth Treatment||1
7892350|NCT00750308|19423997|P3|COMPLETED|Fourth Treatment||2
7892351|NCT00750308|19423998|P2|COMPLETED|Fourth Treatment||1
7892352|NCT00750308|19423999|P1|COMPLETED|Fourth Treatment||2
7892353|NCT00750308|19423988|P12|STARTED|Fourth Treatment||1
7892354|NCT00750308|19423989|P11|STARTED|Fourth Treatment||1
7892355|NCT00750308|19423990|P10|STARTED|Fourth Treatment||2
7892356|NCT00750308|19423991|P9|STARTED|Fourth Treatment||1
7892357|NCT00750308|19423992|P8|STARTED|Fourth Treatment||2
7892358|NCT00750308|19423993|P7|STARTED|Fourth Treatment||2
7892359|NCT00750308|19423994|P6|STARTED|Fourth Treatment||2
7892360|NCT00750308|19423995|P5|STARTED|Fourth Treatment||1
7892361|NCT00750308|19423996|P4|STARTED|Fourth Treatment||1
7892362|NCT00750308|19423997|P3|STARTED|Fourth Treatment||2
7892363|NCT00750308|19423998|P2|STARTED|Fourth Treatment||1
7892364|NCT00750308|19423999|P1|STARTED|Fourth Treatment||2
7892365|NCT00750308|19423988|P12|NOT COMPLETED|Washout||0
7892366|NCT00750308|19423989|P11|NOT COMPLETED|Washout||0
7892367|NCT00750308|19423990|P10|NOT COMPLETED|Washout||0
7892368|NCT00750308|19423991|P9|NOT COMPLETED|Washout||0
7892369|NCT00750308|19423992|P8|NOT COMPLETED|Washout||0
7892370|NCT00750308|19423993|P7|NOT COMPLETED|Washout||0
7892371|NCT00750308|19423994|P6|NOT COMPLETED|Washout||0
7892372|NCT00750308|19423995|P5|NOT COMPLETED|Washout||0
7892373|NCT00750308|19423996|P4|NOT COMPLETED|Washout||0
7892374|NCT00750308|19423997|P3|NOT COMPLETED|Washout||0
7892375|NCT00750308|19423998|P2|NOT COMPLETED|Washout||0
7892376|NCT00750308|19423999|P1|NOT COMPLETED|Washout||0
7892377|NCT00750308|19423988|P12|COMPLETED|Washout||1
7892378|NCT00750308|19423989|P11|COMPLETED|Washout||1
7892379|NCT00750308|19423990|P10|COMPLETED|Washout||2
7892380|NCT00750308|19423991|P9|COMPLETED|Washout||1
7892381|NCT00750308|19423992|P8|COMPLETED|Washout||2
7892382|NCT00750308|19423993|P7|COMPLETED|Washout||2
7892383|NCT00750308|19423994|P6|COMPLETED|Washout||2
7892384|NCT00750308|19423995|P5|COMPLETED|Washout||1
7892385|NCT00750308|19423996|P4|COMPLETED|Washout||1
7892386|NCT00750308|19423997|P3|COMPLETED|Washout||2
7892387|NCT00750308|19423998|P2|COMPLETED|Washout||1
7892388|NCT00750308|19423999|P1|COMPLETED|Washout||2
7892389|NCT00750308|19423988|P12|STARTED|Washout||1
7892390|NCT00750308|19423989|P11|STARTED|Washout||1
7892391|NCT00750308|19423990|P10|STARTED|Washout||2
7892392|NCT00750308|19423991|P9|STARTED|Washout||1
7892393|NCT00750308|19423992|P8|STARTED|Washout||2
7892394|NCT00750308|19423993|P7|STARTED|Washout||2
7892395|NCT00750308|19423994|P6|STARTED|Washout||2
7892396|NCT00750308|19423995|P5|STARTED|Washout||1
7892397|NCT00750308|19423996|P4|STARTED|Washout||1
7892398|NCT00750308|19423997|P3|STARTED|Washout||2
7892399|NCT00750308|19423998|P2|STARTED|Washout||1
7892400|NCT00750308|19423999|P1|STARTED|Washout||2
7892401|NCT00750308|19423988|P12|NOT COMPLETED|Third Treatment||0
7892402|NCT00750308|19423989|P11|NOT COMPLETED|Third Treatment||0
7892403|NCT00750308|19423990|P10|NOT COMPLETED|Third Treatment||0
7892404|NCT00750308|19423991|P9|NOT COMPLETED|Third Treatment||0
7892405|NCT00750308|19423992|P8|NOT COMPLETED|Third Treatment||0
7892406|NCT00750308|19423993|P7|NOT COMPLETED|Third Treatment||0
7892407|NCT00750308|19423994|P6|NOT COMPLETED|Third Treatment||0
7892408|NCT00750308|19423995|P5|NOT COMPLETED|Third Treatment||0
7892409|NCT00750308|19423996|P4|NOT COMPLETED|Third Treatment||0
7892410|NCT00750308|19423997|P3|NOT COMPLETED|Third Treatment||0
7892411|NCT00750308|19423998|P2|NOT COMPLETED|Third Treatment||1
7892412|NCT00750308|19423999|P1|NOT COMPLETED|Third Treatment||0
7892413|NCT00750308|19423988|P12|COMPLETED|Third Treatment||1
7892414|NCT00750308|19423989|P11|COMPLETED|Third Treatment||1
7892415|NCT00750308|19423990|P10|COMPLETED|Third Treatment||2
7892416|NCT00750308|19423991|P9|COMPLETED|Third Treatment||1
7892417|NCT00750308|19423992|P8|COMPLETED|Third Treatment||2
7892418|NCT00750308|19423993|P7|COMPLETED|Third Treatment||2
7892419|NCT00750308|19423994|P6|COMPLETED|Third Treatment||2
7892420|NCT00750308|19423995|P5|COMPLETED|Third Treatment||1
7892421|NCT00750308|19423996|P4|COMPLETED|Third Treatment||1
7892422|NCT00750308|19423997|P3|COMPLETED|Third Treatment||2
7892423|NCT00750308|19423998|P2|COMPLETED|Third Treatment||1
7892424|NCT00750308|19423999|P1|COMPLETED|Third Treatment||2
7892425|NCT00750308|19423988|P12|STARTED|Third Treatment||1
7892426|NCT00750308|19423989|P11|STARTED|Third Treatment||1
7892427|NCT00750308|19423990|P10|STARTED|Third Treatment||2
7892428|NCT00750308|19423991|P9|STARTED|Third Treatment||1
7892429|NCT00750308|19423992|P8|STARTED|Third Treatment||2
7892430|NCT00750308|19423993|P7|STARTED|Third Treatment||2
7892431|NCT00750308|19423994|P6|STARTED|Third Treatment||2
7892432|NCT00750308|19423995|P5|STARTED|Third Treatment||1
7892433|NCT00750308|19423996|P4|STARTED|Third Treatment||1
7892434|NCT00750308|19423997|P3|STARTED|Third Treatment||2
7892435|NCT00750308|19423998|P2|STARTED|Third Treatment||2
7892436|NCT00750308|19423999|P1|STARTED|Third Treatment||2
7892437|NCT00750308|19423988|P12|NOT COMPLETED|Washout||0
7892438|NCT00750308|19423989|P11|NOT COMPLETED|Washout||0
7892439|NCT00750308|19423990|P10|NOT COMPLETED|Washout||0
7892440|NCT00750308|19423991|P9|NOT COMPLETED|Washout||0
7892441|NCT00750308|19423992|P8|NOT COMPLETED|Washout||0
7892442|NCT00750308|19423993|P7|NOT COMPLETED|Washout||0
7892443|NCT00750308|19423994|P6|NOT COMPLETED|Washout||0
7892444|NCT00750308|19423995|P5|NOT COMPLETED|Washout||0
7892445|NCT00750308|19423996|P4|NOT COMPLETED|Washout||0
7892446|NCT00750308|19423997|P3|NOT COMPLETED|Washout||0
7892447|NCT00750308|19423998|P2|NOT COMPLETED|Washout||0
7892448|NCT00750308|19423999|P1|NOT COMPLETED|Washout||0
7892449|NCT00750308|19423988|P12|COMPLETED|Washout||1
7892450|NCT00750308|19423989|P11|COMPLETED|Washout||1
7892451|NCT00750308|19423990|P10|COMPLETED|Washout||2
7892452|NCT00750308|19423991|P9|COMPLETED|Washout||1
7892453|NCT00750308|19423992|P8|COMPLETED|Washout||2
7892454|NCT00750308|19423993|P7|COMPLETED|Washout||2
7892455|NCT00750308|19423994|P6|COMPLETED|Washout||2
7892456|NCT00750308|19423995|P5|COMPLETED|Washout||1
7892457|NCT00750308|19423996|P4|COMPLETED|Washout||1
7892458|NCT00750308|19423997|P3|COMPLETED|Washout||2
7892459|NCT00750308|19423998|P2|COMPLETED|Washout||2
7892460|NCT00750308|19423999|P1|COMPLETED|Washout||2
7892461|NCT00750308|19423988|P12|STARTED|Washout||1
7892462|NCT00750308|19423989|P11|STARTED|Washout||1
7892463|NCT00750308|19423990|P10|STARTED|Washout||2
7892464|NCT00750308|19423991|P9|STARTED|Washout||1
7892465|NCT00750308|19423992|P8|STARTED|Washout||2
7892466|NCT00750308|19423993|P7|STARTED|Washout||2
7892467|NCT00750308|19423994|P6|STARTED|Washout||2
7892468|NCT00750308|19423995|P5|STARTED|Washout||1
7892469|NCT00750308|19423996|P4|STARTED|Washout||1
7892470|NCT00750308|19423997|P3|STARTED|Washout||2
7892471|NCT00750308|19423998|P2|STARTED|Washout||2
7892472|NCT00750308|19423999|P1|STARTED|Washout||2
7892473|NCT00750308|19423988|P12|NOT COMPLETED|Second Treatment||0
7892474|NCT00750308|19423989|P11|NOT COMPLETED|Second Treatment||0
7892475|NCT00750308|19423990|P10|NOT COMPLETED|Second Treatment||0
7892476|NCT00750308|19423991|P9|NOT COMPLETED|Second Treatment||1
7892477|NCT00750308|19423992|P8|NOT COMPLETED|Second Treatment||0
7892478|NCT00750308|19423993|P7|NOT COMPLETED|Second Treatment||0
7892479|NCT00750308|19423994|P6|NOT COMPLETED|Second Treatment||1
7892480|NCT00750308|19423995|P5|NOT COMPLETED|Second Treatment||1
7892481|NCT00750308|19423996|P4|NOT COMPLETED|Second Treatment||0
7892482|NCT00750308|19423997|P3|NOT COMPLETED|Second Treatment||0
7892483|NCT00750308|19423998|P2|NOT COMPLETED|Second Treatment||0
7892484|NCT00750308|19423999|P1|NOT COMPLETED|Second Treatment||0
7892485|NCT00750308|19423988|P12|COMPLETED|Second Treatment||1
7892486|NCT00750308|19423989|P11|COMPLETED|Second Treatment||1
7892487|NCT00750308|19423990|P10|COMPLETED|Second Treatment||2
7892488|NCT00750308|19423991|P9|COMPLETED|Second Treatment||1
7892489|NCT00750308|19423992|P8|COMPLETED|Second Treatment||2
7892490|NCT00750308|19423993|P7|COMPLETED|Second Treatment||2
7892491|NCT00750308|19423994|P6|COMPLETED|Second Treatment||2
7892492|NCT00750308|19423995|P5|COMPLETED|Second Treatment||1
7892493|NCT00750308|19423996|P4|COMPLETED|Second Treatment||1
7892494|NCT00750308|19423997|P3|COMPLETED|Second Treatment||2
7892495|NCT00750308|19423998|P2|COMPLETED|Second Treatment||2
7892496|NCT00750308|19423999|P1|COMPLETED|Second Treatment||2
7892497|NCT00750308|19423988|P12|STARTED|Second Treatment||1
7892498|NCT00750308|19423989|P11|STARTED|Second Treatment||1
7892499|NCT00750308|19423990|P10|STARTED|Second Treatment||2
7892500|NCT00750308|19423991|P9|STARTED|Second Treatment||2
7892501|NCT00750308|19423992|P8|STARTED|Second Treatment||2
7892502|NCT00750308|19423993|P7|STARTED|Second Treatment||2
7892503|NCT00750308|19423994|P6|STARTED|Second Treatment||3
7892504|NCT00750308|19423995|P5|STARTED|Second Treatment||2
7892505|NCT00750308|19423996|P4|STARTED|Second Treatment||1
7892506|NCT00750308|19423997|P3|STARTED|Second Treatment||2
7892507|NCT00750308|19423998|P2|STARTED|Second Treatment||2
7892508|NCT00750308|19423999|P1|STARTED|Second Treatment||2
7892509|NCT00750308|19423988|P12|NOT COMPLETED|Washout||0
7892510|NCT00750308|19423989|P11|NOT COMPLETED|Washout||0
7892511|NCT00750308|19423990|P10|NOT COMPLETED|Washout||0
7892512|NCT00750308|19423991|P9|NOT COMPLETED|Washout||0
7892513|NCT00750308|19423992|P8|NOT COMPLETED|Washout||0
7892514|NCT00750308|19423993|P7|NOT COMPLETED|Washout||0
7892515|NCT00750308|19423994|P6|NOT COMPLETED|Washout||0
7892516|NCT00750308|19423995|P5|NOT COMPLETED|Washout||0
7892517|NCT00750308|19423996|P4|NOT COMPLETED|Washout||0
7892518|NCT00750308|19423997|P3|NOT COMPLETED|Washout||0
7892519|NCT00750308|19423998|P2|NOT COMPLETED|Washout||0
7892520|NCT00750308|19423999|P1|NOT COMPLETED|Washout||0
7892521|NCT00750308|19423988|P12|COMPLETED|Washout||1
7892522|NCT00750308|19423989|P11|COMPLETED|Washout||1
7892523|NCT00750308|19423990|P10|COMPLETED|Washout||2
7892524|NCT00750308|19423991|P9|COMPLETED|Washout||2
7892525|NCT00750308|19423992|P8|COMPLETED|Washout||2
7892526|NCT00750308|19423993|P7|COMPLETED|Washout||2
7892527|NCT00750308|19423994|P6|COMPLETED|Washout||3
7892528|NCT00750308|19423995|P5|COMPLETED|Washout||2
7892529|NCT00750308|19423996|P4|COMPLETED|Washout||1
7892530|NCT00750308|19423997|P3|COMPLETED|Washout||2
7892531|NCT00750308|19423998|P2|COMPLETED|Washout||2
7892532|NCT00750308|19423999|P1|COMPLETED|Washout||2
7892533|NCT00750308|19423988|P12|STARTED|Washout||1
7892534|NCT00750308|19423989|P11|STARTED|Washout||1
7892535|NCT00750308|19423990|P10|STARTED|Washout||2
7892536|NCT00750308|19423991|P9|STARTED|Washout||2
7892537|NCT00750308|19423992|P8|STARTED|Washout||2
7892538|NCT00750308|19423993|P7|STARTED|Washout||2
7892539|NCT00750308|19423994|P6|STARTED|Washout||3
7892540|NCT00750308|19423995|P5|STARTED|Washout||2
7892541|NCT00750308|19423996|P4|STARTED|Washout||1
7892542|NCT00750308|19423997|P3|STARTED|Washout||2
7892543|NCT00750308|19423998|P2|STARTED|Washout||2
7892544|NCT00750308|19423999|P1|STARTED|Washout||2
7892545|NCT00750308|19423988|P12|NOT COMPLETED|First Treatment||1
7892546|NCT00750308|19423989|P11|NOT COMPLETED|First Treatment||1
7892547|NCT00750308|19423990|P10|NOT COMPLETED|First Treatment||0
7892548|NCT00750308|19423991|P9|NOT COMPLETED|First Treatment||0
7892549|NCT00750308|19423992|P8|NOT COMPLETED|First Treatment||1
7892550|NCT00750308|19423993|P7|NOT COMPLETED|First Treatment||0
7892551|NCT00750308|19423994|P6|NOT COMPLETED|First Treatment||0
7892552|NCT00750308|19423995|P5|NOT COMPLETED|First Treatment||0
7892553|NCT00750308|19423996|P4|NOT COMPLETED|First Treatment||1
7892554|NCT00750308|19423997|P3|NOT COMPLETED|First Treatment||0
7892555|NCT00750308|19423998|P2|NOT COMPLETED|First Treatment||1
7892556|NCT00750308|19423999|P1|NOT COMPLETED|First Treatment||0
7892557|NCT00750308|19423988|P12|COMPLETED|First Treatment||1
7892558|NCT00750308|19423989|P11|COMPLETED|First Treatment||1
7892559|NCT00750308|19423990|P10|COMPLETED|First Treatment||2
7892560|NCT00750308|19423991|P9|COMPLETED|First Treatment||2
7892561|NCT00750308|19423992|P8|COMPLETED|First Treatment||2
7892562|NCT00750308|19423993|P7|COMPLETED|First Treatment||2
7892563|NCT00750308|19423994|P6|COMPLETED|First Treatment||3
7892564|NCT00750308|19423995|P5|COMPLETED|First Treatment||2
7892565|NCT00750308|19423996|P4|COMPLETED|First Treatment||1
7892566|NCT00750308|19423997|P3|COMPLETED|First Treatment||2
7892567|NCT00750308|19423998|P2|COMPLETED|First Treatment||2
7892568|NCT00750308|19423999|P1|COMPLETED|First Treatment||2
7892569|NCT00750308|19423988|P12|STARTED|First Treatment||2
7892570|NCT00750308|19423989|P11|STARTED|First Treatment||2
7892571|NCT00750308|19423990|P10|STARTED|First Treatment||2
7892572|NCT00750308|19423991|P9|STARTED|First Treatment||2
7892573|NCT00750308|19423992|P8|STARTED|First Treatment||3
7892574|NCT00750308|19423993|P7|STARTED|First Treatment||2
7892575|NCT00750308|19423994|P6|STARTED|First Treatment||3
7892576|NCT00750308|19423995|P5|STARTED|First Treatment||2
7892577|NCT00750308|19423996|P4|STARTED|First Treatment||2
7892578|NCT00750308|19423997|P3|STARTED|First Treatment||2
7892579|NCT00750308|19423998|P2|STARTED|First Treatment||3
7892580|NCT00750308|19423999|P1|STARTED|First Treatment|One female withdrew due to muscle pain|2
7892581|NCT00750282|19424017|P4|NOT COMPLETED|Overall Study||1
7892582|NCT00750282|19424018|P3|NOT COMPLETED|Overall Study||1
7892583|NCT00750282|19424019|P2|NOT COMPLETED|Overall Study||1
7892584|NCT00750282|19424020|P1|NOT COMPLETED|Overall Study||0
7892585|NCT00750282|19424017|P4|COMPLETED|Overall Study||147
7892586|NCT00750282|19424018|P3|COMPLETED|Overall Study||125
7892587|NCT00750282|19424019|P2|COMPLETED|Overall Study||81
7892588|NCT00750282|19424020|P1|COMPLETED|Overall Study||69
7892589|NCT00750282|19424017|P4|STARTED|Overall Study||148
7892590|NCT00750282|19424018|P3|STARTED|Overall Study||126
7892591|NCT00750282|19424019|P2|STARTED|Overall Study||82
7892592|NCT00750282|19424020|P1|STARTED|Overall Study||69
7892593|NCT00750269|19424049|P5|NOT COMPLETED|Overall Study||10
7892594|NCT00750269|19424050|P4|NOT COMPLETED|Overall Study||5
7892595|NCT00750269|19424051|P3|NOT COMPLETED|Overall Study||4
7892596|NCT00750269|19424052|P2|NOT COMPLETED|Overall Study||1
7892597|NCT00750269|19424053|P1|NOT COMPLETED|Overall Study||0
7892598|NCT00750269|19424049|P5|COMPLETED|Overall Study||33
7892599|NCT00750269|19424050|P4|COMPLETED|Overall Study||38
7892600|NCT00750269|19424051|P3|COMPLETED|Overall Study||14
7892601|NCT00750269|19424052|P2|COMPLETED|Overall Study||7
7892602|NCT00750269|19424053|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|8
7892603|NCT00750269|19424049|P5|STARTED|Overall Study||43
7892604|NCT00750269|19424050|P4|STARTED|Overall Study||43
7892605|NCT00750269|19424051|P3|STARTED|Overall Study||18
7892606|NCT00750269|19424052|P2|STARTED|Overall Study||8
7892607|NCT00750269|19424053|P1|STARTED|Overall Study||8
7892608|NCT00750204|19424100|P2|NOT COMPLETED|Overall Study||1
7892609|NCT00750204|19424101|P1|NOT COMPLETED|Overall Study||1
7892610|NCT00750204|19424100|P2|COMPLETED|Overall Study||0
7892611|NCT00750204|19424101|P1|COMPLETED|Overall Study||0
7892612|NCT00750204|19424100|P2|STARTED|Overall Study||1
7892613|NCT00750204|19424101|P1|STARTED|Overall Study||1
7892614|NCT00750191|19424109|P2|NOT COMPLETED|Overall Study||10
7892615|NCT00750191|19424110|P1|NOT COMPLETED|Overall Study||5
7892616|NCT00750191|19424109|P2|COMPLETED|Overall Study||20
7892617|NCT00750191|19424110|P1|COMPLETED|Overall Study||22
7892618|NCT00750191|19424109|P2|STARTED|Overall Study||30
7892619|NCT00750191|19424110|P1|STARTED|Overall Study||27
7892620|NCT00750165|19424122|P1|NOT COMPLETED|Overall Study||11
7892621|NCT00750165|19424122|P1|COMPLETED|Overall Study||21
7892622|NCT00750165|19424122|P1|STARTED|Overall Study||32
7892623|NCT00750152|19424131|P2|NOT COMPLETED|Overall Study||27
7892624|NCT00750152|19424132|P1|NOT COMPLETED|Overall Study||22
7892625|NCT00750152|19424131|P2|COMPLETED|Overall Study||141
7892626|NCT00750152|19424132|P1|COMPLETED|Overall Study||144
7892627|NCT00750152|19424131|P2|STARTED|Overall Study||168
7892628|NCT00750152|19424132|P1|STARTED|Overall Study||166
7892629|NCT00750139|19424144|P4|NOT COMPLETED|Overall Study||46
7892630|NCT00750139|19424145|P3|NOT COMPLETED|Overall Study||101
7892631|NCT00750139|19424146|P2|NOT COMPLETED|Overall Study||59
7892632|NCT00750139|19424147|P1|NOT COMPLETED|Overall Study||89
7892633|NCT00750139|19424144|P4|COMPLETED|Overall Study||73
7892634|NCT00750139|19424145|P3|COMPLETED|Overall Study||135
7892635|NCT00750139|19424146|P2|COMPLETED|Overall Study||59
7892636|NCT00750139|19424147|P1|COMPLETED|Overall Study||145
7892637|NCT00750139|19424144|P4|STARTED|Overall Study||119
7892638|NCT00750139|19424145|P3|STARTED|Overall Study||236
7892639|NCT00750139|19424146|P2|STARTED|Overall Study||118
7892640|NCT00750139|19424147|P1|STARTED|Overall Study||234
7892641|NCT00750061|19424163|P2|NOT COMPLETED|Overall Study||2
7892642|NCT00750061|19424164|P1|NOT COMPLETED|Overall Study||2
7892643|NCT00750061|19424163|P2|COMPLETED|Overall Study||18
7892644|NCT00750061|19424164|P1|COMPLETED|Overall Study||18
7892645|NCT00750061|19424163|P2|STARTED|Overall Study||20
7892646|NCT00750061|19424164|P1|STARTED|Overall Study||20
7892647|NCT00749996|19424174|P2|NOT COMPLETED|Overall Study||13
7892648|NCT00749996|19424175|P1|NOT COMPLETED|Overall Study||18
7892649|NCT00749996|19424174|P2|COMPLETED|Overall Study||58
7892650|NCT00749996|19424175|P1|COMPLETED|Overall Study||57
7892651|NCT00749996|19424174|P2|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58
7892652|NCT00749996|19424175|P1|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57
7892653|NCT00749996|19424174|P2|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60
7892654|NCT00749996|19424175|P1|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68
7892655|NCT00749996|19424174|P2|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63
7892656|NCT00749996|19424175|P1|6 Months Follow-up|Overall Study|Visit not done (n=3)|71
7892657|NCT00749996|19424174|P2|3 Months Follow-up|Overall Study|Visit not done (n=1)|68
7892658|NCT00749996|19424175|P1|3 Months Follow-up|Overall Study|Visit not done (n=2)|72
7892659|NCT00749996|19424174|P2|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67
7892660|NCT00749996|19424175|P1|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72
7892661|NCT00749996|19424174|P2|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71
7892662|NCT00749996|19424175|P1|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75
7892663|NCT00749957|19424185|P2|NOT COMPLETED|Overall Study||0
7892664|NCT00749957|19424186|P1|NOT COMPLETED|Overall Study||0
7892665|NCT00749957|19424185|P2|COMPLETED|Overall Study||6
7892666|NCT00749957|19424186|P1|COMPLETED|Overall Study||6
7892667|NCT00749957|19424185|P2|STARTED|Overall Study||6
7892668|NCT00749957|19424186|P1|STARTED|Overall Study||6
7892669|NCT00749944|19424198|P2|NOT COMPLETED|Overall Study||1
7892670|NCT00749944|19424199|P1|NOT COMPLETED|Overall Study||5
7892671|NCT00749944|19424198|P2|COMPLETED|Overall Study||54
7892672|NCT00749944|19424199|P1|COMPLETED|Overall Study||50
7892673|NCT00749944|19424198|P2|STARTED|Overall Study||55
7892674|NCT00749944|19424199|P1|STARTED|Overall Study||55
7892675|NCT00749931|19424267|P3|NOT COMPLETED|Overall Study||0
7892676|NCT00749931|19424268|P2|NOT COMPLETED|Overall Study||0
7892677|NCT00749931|19424269|P1|NOT COMPLETED|Overall Study||0
7892678|NCT00749931|19424267|P3|COMPLETED|Overall Study||68
7892679|NCT00749931|19424268|P2|COMPLETED|Overall Study||298
7892680|NCT00749931|19424269|P1|COMPLETED|Overall Study||298
7892681|NCT00749931|19424267|P3|STARTED|Overall Study||68
7892682|NCT00749931|19424268|P2|STARTED|Overall Study||298
7892683|NCT00749931|19424269|P1|STARTED|Overall Study||298
7892684|NCT00749892|19424278|P1|NOT COMPLETED|Overall Study||3
7892685|NCT00749892|19424278|P1|COMPLETED|Overall Study||31
7892686|NCT00749892|19424278|P1|STARTED|Overall Study||34
7892687|NCT00749879|19424282|P1|NOT COMPLETED|Overall Study||0
7892688|NCT00749879|19424282|P1|COMPLETED|Overall Study||12
7892689|NCT00749879|19424282|P1|STARTED|Overall Study||12
7892690|NCT00749775|19424314|P1|NOT COMPLETED|Overall Study||107
7892691|NCT00749775|19424314|P1|COMPLETED|Overall Study||3210
7892692|NCT00749775|19424314|P1|STARTED|Overall Study||3317
7892693|NCT00749749|19424332|P2|NOT COMPLETED|Overall Study||0
7892694|NCT00749749|19424333|P1|NOT COMPLETED|Overall Study||0
7892695|NCT00749749|19424332|P2|COMPLETED|Overall Study||13
7892696|NCT00749749|19424333|P1|COMPLETED|Overall Study||14
7892697|NCT00749749|19424332|P2|STARTED|Overall Study||13
7892698|NCT00749749|19424333|P1|STARTED|Overall Study||14
7892699|NCT00749684|19424351|P1|NOT COMPLETED|Overall Study||82
7892700|NCT00749684|19424351|P1|COMPLETED|Overall Study||56
7892701|NCT00749684|19424351|P1|STARTED|Overall Study||138
7892702|NCT00749671|19424358|P2|NOT COMPLETED|Overall Study||0
7892703|NCT00749671|19424359|P1|NOT COMPLETED|Overall Study||0
7892704|NCT00749671|19424358|P2|COMPLETED|Overall Study||9
7892705|NCT00749671|19424359|P1|COMPLETED|Overall Study||11
7892706|NCT00749671|19424358|P2|STARTED|Overall Study||9
7892707|NCT00749671|19424359|P1|STARTED|Overall Study||11
7892708|NCT00749658|19424369|P2|NOT COMPLETED|Overall Study||0
7892709|NCT00749658|19424370|P1|NOT COMPLETED|Overall Study||0
7892710|NCT00749658|19424369|P2|COMPLETED|Overall Study||61
7892711|NCT00749658|19424370|P1|COMPLETED|Overall Study||60
7892712|NCT00749658|19424369|P2|STARTED|Overall Study||61
7892713|NCT00749658|19424370|P1|STARTED|Overall Study||60
7892714|NCT00749606|19424378|P2|NOT COMPLETED|Year 3 (Observation)||3
7892715|NCT00749606|19424379|P1|NOT COMPLETED|Year 3 (Observation)||0
7892716|NCT00749606|19424378|P2|COMPLETED|Year 3 (Observation)||69
7892717|NCT00749606|19424379|P1|COMPLETED|Year 3 (Observation)||63
7892718|NCT00749606|19424378|P2|STARTED|Year 3 (Observation)||72
7892719|NCT00749606|19424379|P1|STARTED|Year 3 (Observation)||63
7892720|NCT00749606|19424378|P2|NOT COMPLETED|Year 2||8
7892721|NCT00749606|19424379|P1|NOT COMPLETED|Year 2||11
7892722|NCT00749606|19424378|P2|COMPLETED|Year 2||72
7892723|NCT00749606|19424379|P1|COMPLETED|Year 2||63
7892724|NCT00749606|19424378|P2|STARTED|Year 2||80
7892725|NCT00749606|19424379|P1|STARTED|Year 2||74
7892726|NCT00749606|19424378|P2|NOT COMPLETED|Year 1||48
7892727|NCT00749606|19424379|P1|NOT COMPLETED|Year 1||55
7892728|NCT00749606|19424378|P2|COMPLETED|Year 1||80
7892729|NCT00749606|19424379|P1|COMPLETED|Year 1||74
7892730|NCT00749606|19424378|P2|STARTED|Year 1||128
7892731|NCT00749606|19424379|P1|STARTED|Year 1||129
7892732|NCT00749580|19424399|P2|NOT COMPLETED|Overall Study||9
7892733|NCT00749580|19424400|P1|NOT COMPLETED|Overall Study||4
7892734|NCT00749580|19424399|P2|COMPLETED|Overall Study||16
7892735|NCT00749580|19424400|P1|COMPLETED|Overall Study|December 2010|17
7892736|NCT00749580|19424399|P2|STARTED|Overall Study||25
7892737|NCT00749580|19424400|P1|STARTED|Overall Study|September 2008|21
7892738|NCT00749515|19424410|P2|NOT COMPLETED|Overall Study||0
7892739|NCT00749515|19424411|P1|NOT COMPLETED|Overall Study||0
7892740|NCT00749515|19424410|P2|COMPLETED|Overall Study||5
7892741|NCT00749515|19424411|P1|COMPLETED|Overall Study||10
7892742|NCT00749515|19424410|P2|STARTED|Overall Study||5
7892743|NCT00749515|19424411|P1|STARTED|Overall Study||10
7892744|NCT00749476|19424427|P1|NOT COMPLETED|Overall Study||0
7892745|NCT00749476|19424427|P1|COMPLETED|Overall Study||1
7892746|NCT00749476|19424427|P1|STARTED|Overall Study||1
7892747|NCT00749463|19424434|P3|NOT COMPLETED|Overall Study||1
7892748|NCT00749463|19424435|P2|NOT COMPLETED|Overall Study||4
7892749|NCT00749463|19424436|P1|NOT COMPLETED|Overall Study||1
7892750|NCT00749463|19424434|P3|COMPLETED|Overall Study||149
7892751|NCT00749463|19424435|P2|COMPLETED|Overall Study||60
7892752|NCT00749463|19424436|P1|COMPLETED|Overall Study||85
7892753|NCT00749463|19424434|P3|STARTED|Overall Study||150
7892754|NCT00749463|19424435|P2|STARTED|Overall Study||64
7892755|NCT00749463|19424436|P1|STARTED|Overall Study||86
7892756|NCT00749411|19424464|P2|NOT COMPLETED|Overall Study||5
7892757|NCT00749411|19424465|P1|NOT COMPLETED|Overall Study||1
7892758|NCT00749411|19424464|P2|COMPLETED|Overall Study||35
7892759|NCT00749411|19424465|P1|COMPLETED|Overall Study||20
7892760|NCT00749411|19424464|P2|STARTED|Overall Study||40
7892761|NCT00749411|19424465|P1|STARTED|Overall Study||21
7892762|NCT00749398|19424473|P1|NOT COMPLETED|Overall Study||53
7892763|NCT00749398|19424473|P1|COMPLETED|Overall Study||71
7892764|NCT00749398|19424473|P1|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124
7892765|NCT00749268|19424491|P2|NOT COMPLETED|Overall Study||36
7892766|NCT00749268|19424492|P1|NOT COMPLETED|Overall Study||34
7892767|NCT00749268|19424491|P2|COMPLETED|Overall Study||74
7892768|NCT00749268|19424492|P1|COMPLETED|Overall Study||72
7892769|NCT00749268|19424491|P2|STARTED|Overall Study||110
7892770|NCT00749268|19424492|P1|STARTED|Overall Study||106
7892771|NCT00749203|19424516|P2|NOT COMPLETED|Second Infusion at 2 Weeks||2
7892772|NCT00749203|19424517|P1|NOT COMPLETED|Second Infusion at 2 Weeks||0
7892773|NCT00749203|19424516|P2|COMPLETED|Second Infusion at 2 Weeks||13
7892774|NCT00749203|19424517|P1|COMPLETED|Second Infusion at 2 Weeks||16
7892775|NCT00749203|19424516|P2|STARTED|Second Infusion at 2 Weeks||15
7892776|NCT00749203|19424517|P1|STARTED|Second Infusion at 2 Weeks|N=6 completed the study at 2 wks due to CAPS scores < 50, precluding 2nd infusion.|16
7892777|NCT00749203|19424516|P2|NOT COMPLETED|no Infusion at Week 1||4
7892778|NCT00749203|19424517|P1|NOT COMPLETED|no Infusion at Week 1||0
7892779|NCT00749203|19424516|P2|COMPLETED|no Infusion at Week 1||15
7892780|NCT00749203|19424517|P1|COMPLETED|no Infusion at Week 1||22
7892781|NCT00749203|19424516|P2|STARTED|no Infusion at Week 1||19
7892782|NCT00749203|19424517|P1|STARTED|no Infusion at Week 1||22
7892783|NCT00749203|19424516|P2|NOT COMPLETED|First Infusion Day 1||0
7892784|NCT00749203|19424517|P1|NOT COMPLETED|First Infusion Day 1||0
7892785|NCT00749203|19424516|P2|COMPLETED|First Infusion Day 1||19
7892786|NCT00749203|19424517|P1|COMPLETED|First Infusion Day 1||22
7892787|NCT00749203|19424516|P2|STARTED|First Infusion Day 1||19
7892788|NCT00749203|19424517|P1|STARTED|First Infusion Day 1||22
7892789|NCT00749190|19424538|P7|NOT COMPLETED|Overall Study||1
7892790|NCT00749190|19424539|P6|NOT COMPLETED|Overall Study||5
7892791|NCT00749190|19424540|P5|NOT COMPLETED|Overall Study||0
7892792|NCT00749190|19424541|P4|NOT COMPLETED|Overall Study||5
7892793|NCT00749190|19424542|P3|NOT COMPLETED|Overall Study||1
7892794|NCT00749190|19424543|P2|NOT COMPLETED|Overall Study||5
7892795|NCT00749190|19424544|P1|NOT COMPLETED|Overall Study||5
7892796|NCT00749190|19424538|P7|COMPLETED|Overall Study||70
7892797|NCT00749190|19424539|P6|COMPLETED|Overall Study||65
7892798|NCT00749190|19424540|P5|COMPLETED|Overall Study||70
7892799|NCT00749190|19424541|P4|COMPLETED|Overall Study||66
7892800|NCT00749190|19424542|P3|COMPLETED|Overall Study||70
7892801|NCT00749190|19424543|P2|COMPLETED|Overall Study||66
7892802|NCT00749190|19424544|P1|COMPLETED|Overall Study||66
7892803|NCT00749190|19424538|P7|STARTED|Overall Study||71
7892804|NCT00749190|19424539|P6|STARTED|Overall Study||70
7892805|NCT00749190|19424540|P5|STARTED|Overall Study||70
7892806|NCT00749190|19424541|P4|STARTED|Overall Study||71
7892807|NCT00749190|19424542|P3|STARTED|Overall Study||71
7892808|NCT00749190|19424543|P2|STARTED|Overall Study||71
7892809|NCT00749190|19424544|P1|STARTED|Overall Study||71
7892810|NCT00749125|19424623|P2|NOT COMPLETED|Overall Study||18
7892811|NCT00749125|19424624|P1|NOT COMPLETED|Overall Study||11
7892812|NCT00749125|19424623|P2|COMPLETED|Overall Study||34
7892813|NCT00749125|19424624|P1|COMPLETED|Overall Study||36
7892814|NCT00749125|19424623|P2|STARTED|Overall Study||52
7892815|NCT00749125|19424624|P1|STARTED|Overall Study||47
7892816|NCT00749073|19424630|P1|NOT COMPLETED|Overall Study||0
7892817|NCT00749073|19424630|P1|COMPLETED|Overall Study||10
7892818|NCT00749073|19424630|P1|STARTED|Overall Study||10
7892819|NCT00748982|19424638|P2|NOT COMPLETED|Overall Study||0
7892820|NCT00748982|19424639|P1|NOT COMPLETED|Overall Study||0
7892821|NCT00748982|19424638|P2|COMPLETED|Overall Study||4
7892822|NCT00748982|19424639|P1|COMPLETED|Overall Study||12
7892823|NCT00748982|19424638|P2|STARTED|Overall Study||4
7892824|NCT00748982|19424639|P1|STARTED|Overall Study||12
7892825|NCT00748969|19424653|P2|NOT COMPLETED|Overall Study||1
7892826|NCT00748969|19424654|P1|NOT COMPLETED|Overall Study||1
7892827|NCT00748969|19424653|P2|COMPLETED|Overall Study||0
7892828|NCT00748969|19424654|P1|COMPLETED|Overall Study||0
7892829|NCT00748969|19424653|P2|STARTED|Overall Study|Subject withdrew from study due to randomization to no treatment|1
7892830|NCT00748969|19424654|P1|STARTED|Overall Study|Subject withdrew from study due to worsening sleep apnea|1
7892831|NCT00748956|19424665|P3|NOT COMPLETED|Overall Study||0
7892832|NCT00748956|19424666|P2|NOT COMPLETED|Overall Study||0
7892833|NCT00748956|19424667|P1|NOT COMPLETED|Overall Study||0
7892834|NCT00748956|19424665|P3|COMPLETED|Overall Study||5
7892835|NCT00748956|19424666|P2|COMPLETED|Overall Study||5
7892836|NCT00748956|19424667|P1|COMPLETED|Overall Study||0
7892837|NCT00748956|19424665|P3|STARTED|Overall Study||5
7892838|NCT00748956|19424666|P2|STARTED|Overall Study||5
7892839|NCT00748956|19424667|P1|STARTED|Overall Study||0
7892840|NCT00748865|19424690|P2|NOT COMPLETED|Overall Study||0
7892841|NCT00748865|19424691|P1|NOT COMPLETED|Overall Study||0
7892842|NCT00748865|19424690|P2|COMPLETED|Overall Study||10
7892843|NCT00748865|19424691|P1|COMPLETED|Overall Study||10
7892844|NCT00748865|19424690|P2|STARTED|Overall Study||10
7892845|NCT00748865|19424691|P1|STARTED|Overall Study||10
7892846|NCT00748826|19424697|P1|NOT COMPLETED|Overall Study||301
7892847|NCT00748826|19424697|P1|COMPLETED|Overall Study||207
7892848|NCT00748826|19424697|P1|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508
7892849|NCT00748709|19424704|P1|NOT COMPLETED|Overall Study||20
7892850|NCT00748709|19424704|P1|COMPLETED|Overall Study||0
7892851|NCT00748709|19424704|P1|STARTED|Overall Study|Treated|20
7892852|NCT00748657|19424716|P1|NOT COMPLETED|Overall Study||0
7892853|NCT00748657|19424716|P1|COMPLETED|Overall Study||36
7892854|NCT00748657|19424716|P1|STARTED|Overall Study||36
7892855|NCT00748579|19424730|P2|NOT COMPLETED|Overall Study||0
7892856|NCT00748579|19424731|P1|NOT COMPLETED|Overall Study||0
7892857|NCT00748579|19424730|P2|COMPLETED|Overall Study||0
7892858|NCT00748579|19424731|P1|COMPLETED|Overall Study||2
7892859|NCT00748579|19424730|P2|STARTED|Overall Study||0
7892860|NCT00748579|19424731|P1|STARTED|Overall Study||2
7892861|NCT00748566|19424747|P1|NOT COMPLETED|Overall Study||112
7892862|NCT00748566|19424747|P1|COMPLETED|Overall Study||60
7892863|NCT00748566|19424747|P1|STARTED|Overall Study||172
7892864|NCT00748553|19424777|P2|NOT COMPLETED|Overall Study||1
7892865|NCT00748553|19424778|P1|NOT COMPLETED|Overall Study||3
7892866|NCT00748553|19424777|P2|COMPLETED|Overall Study||13
7892867|NCT00748553|19424778|P1|COMPLETED|Overall Study||13
7892868|NCT00748553|19424777|P2|STARTED|Overall Study||14
7892869|NCT00748553|19424778|P1|STARTED|Overall Study||16
7892870|NCT00748540|19424785|P1|NOT COMPLETED|Overall Study||1
7892871|NCT00748540|19424785|P1|COMPLETED|Overall Study||49
7892872|NCT00748540|19424785|P1|STARTED|Overall Study||50
7892873|NCT00748410|19424794|P2|NOT COMPLETED|Overall Study||0
7892874|NCT00748410|19424795|P1|NOT COMPLETED|Overall Study||0
7892875|NCT00748410|19424794|P2|COMPLETED|Overall Study||2
7892876|NCT00748410|19424795|P1|COMPLETED|Overall Study||1
7892877|NCT00748410|19424794|P2|STARTED|Overall Study||2
7892878|NCT00748410|19424795|P1|STARTED|Overall Study||1
7892879|NCT00748241|19424811|P1|NOT COMPLETED|Overall Study||8
7892880|NCT00748241|19424811|P1|COMPLETED|Overall Study||11
7892881|NCT00748241|19424811|P1|STARTED|Overall Study||19
7892882|NCT00748215|19424821|P2|NOT COMPLETED|Overall Study||18
7892883|NCT00748215|19424822|P1|NOT COMPLETED|Overall Study||9
7892884|NCT00748215|19424821|P2|COMPLETED|Overall Study||32
7892885|NCT00748215|19424822|P1|COMPLETED|Overall Study||41
7892886|NCT00748215|19424821|P2|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||17
7892887|NCT00748215|19424822|P1|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||22
7892888|NCT00748215|19424821|P2|STARTED|Overall Study||50
7892889|NCT00748215|19424822|P1|STARTED|Overall Study||50
7892890|NCT00748189|19424830|P2|NOT COMPLETED|Overall Study||212
7892891|NCT00748189|19424831|P1|NOT COMPLETED|Overall Study||216
7892892|NCT00748189|19424830|P2|COMPLETED|Overall Study||9
7892893|NCT00748189|19424831|P1|COMPLETED|Overall Study||10
7892894|NCT00748189|19424830|P2|STARTED|Overall Study||221
7892895|NCT00748189|19424831|P1|STARTED|Overall Study||226
7892896|NCT00748098|19424886|P2|NOT COMPLETED|Second Taper Period||0
7892897|NCT00748098|19424887|P1|NOT COMPLETED|Second Taper Period||0
7892898|NCT00748098|19424886|P2|COMPLETED|Second Taper Period||61
7892899|NCT00748098|19424887|P1|COMPLETED|Second Taper Period||53
7892900|NCT00748098|19424886|P2|STARTED|Second Taper Period||61
7892901|NCT00748098|19424887|P1|STARTED|Second Taper Period||53
7892902|NCT00748098|19424886|P2|NOT COMPLETED|Second Treatment Intervention Period||3
7892903|NCT00748098|19424887|P1|NOT COMPLETED|Second Treatment Intervention Period||6
7892904|NCT00748098|19424886|P2|COMPLETED|Second Treatment Intervention Period||61
7892905|NCT00748098|19424887|P1|COMPLETED|Second Treatment Intervention Period||53
7892906|NCT00748098|19424886|P2|STARTED|Second Treatment Intervention Period||64
7892907|NCT00748098|19424887|P1|STARTED|Second Treatment Intervention Period||59
7892908|NCT00748098|19424886|P2|NOT COMPLETED|1-Week Washout Period||1
7892909|NCT00748098|19424887|P1|NOT COMPLETED|1-Week Washout Period||2
7892910|NCT00748098|19424886|P2|COMPLETED|1-Week Washout Period||64
7892911|NCT00748098|19424887|P1|COMPLETED|1-Week Washout Period||59
7892912|NCT00748098|19424886|P2|STARTED|1-Week Washout Period||65
7892913|NCT00748098|19424887|P1|STARTED|1-Week Washout Period||61
7892914|NCT00748098|19424886|P2|NOT COMPLETED|First Taper Period||1
7892915|NCT00748098|19424887|P1|NOT COMPLETED|First Taper Period||3
7892916|NCT00748098|19424886|P2|COMPLETED|First Taper Period||65
7892917|NCT00748098|19424887|P1|COMPLETED|First Taper Period||61
7892918|NCT00748098|19424886|P2|STARTED|First Taper Period||66
7892919|NCT00748098|19424887|P1|STARTED|First Taper Period||64
7892920|NCT00748098|19424886|P2|NOT COMPLETED|First Treatment Intervention Period||1
7892921|NCT00748098|19424887|P1|NOT COMPLETED|First Treatment Intervention Period||5
7892922|NCT00748098|19424886|P2|COMPLETED|First Treatment Intervention Period||66
7892923|NCT00748098|19424887|P1|COMPLETED|First Treatment Intervention Period||64
7892924|NCT00748098|19424886|P2|STARTED|First Treatment Intervention Period||67
7892925|NCT00748098|19424887|P1|STARTED|First Treatment Intervention Period||69
7892926|NCT00748085|19424947|P1|NOT COMPLETED|Overall Study||0
7892927|NCT00748085|19424947|P1|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5
7892928|NCT00748085|19424947|P1|STARTED|Overall Study||5
7892929|NCT00748072|19424954|P2|NOT COMPLETED|Overall Study||0
7892930|NCT00748072|19424955|P1|NOT COMPLETED|Overall Study||0
7892931|NCT00748072|19424954|P2|COMPLETED|Overall Study||80
7892932|NCT00748072|19424955|P1|COMPLETED|Overall Study||82
7892933|NCT00748072|19424954|P2|STARTED|Overall Study||80
7892934|NCT00748072|19424955|P1|STARTED|Overall Study||82
7892935|NCT00747916|19424961|P1|NOT COMPLETED|Overall Study||0
7892936|NCT00747916|19424961|P1|COMPLETED|Overall Study||3
7892937|NCT00747916|19424961|P1|STARTED|Overall Study||3
7892938|NCT00747812|19424968|P2|NOT COMPLETED|Overall Study||3
7892939|NCT00747812|19424969|P1|NOT COMPLETED|Overall Study||5
7892940|NCT00747812|19424968|P2|COMPLETED|Overall Study||0
7892941|NCT00747812|19424969|P1|COMPLETED|Overall Study||0
7892942|NCT00747812|19424968|P2|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3
7892943|NCT00747812|19424969|P1|STARTED|Overall Study||5
7892944|NCT00747747|19424980|P3|NOT COMPLETED|Overall Study||0
7892945|NCT00747747|19424981|P2|NOT COMPLETED|Overall Study||0
7892946|NCT00747747|19424982|P1|NOT COMPLETED|Overall Study||0
7892947|NCT00747747|19424980|P3|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21
7892948|NCT00747747|19424981|P2|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14
7892949|NCT00747747|19424982|P1|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14
7892950|NCT00747747|19424980|P3|STARTED|Overall Study||21
7892951|NCT00747747|19424981|P2|STARTED|Overall Study||14
7892952|NCT00747747|19424982|P1|STARTED|Overall Study||14
7892953|NCT00747643|19425007|P2|NOT COMPLETED|Overall Study||27
7892954|NCT00747643|19425008|P1|NOT COMPLETED|Overall Study||36
7892955|NCT00747643|19425007|P2|COMPLETED|Overall Study||54
7892956|NCT00747643|19425008|P1|COMPLETED|Overall Study||46
7892957|NCT00747643|19425007|P2|STARTED|Overall Study||81
7892958|NCT00747643|19425008|P1|STARTED|Overall Study||82
7892959|NCT00747617|19425022|P2|NOT COMPLETED|Overall Study||1
7892960|NCT00747617|19425023|P1|NOT COMPLETED|Overall Study||3
7892961|NCT00747617|19425022|P2|COMPLETED|Overall Study||11
7892962|NCT00747617|19425023|P1|COMPLETED|Overall Study||10
7892963|NCT00747617|19425022|P2|STARTED|Overall Study||12
7892964|NCT00747617|19425023|P1|STARTED|Overall Study||13
7892965|NCT00747565|19425033|P2|NOT COMPLETED|Overall Study||7
7892966|NCT00747565|19425034|P1|NOT COMPLETED|Overall Study||14
7892967|NCT00747565|19425033|P2|COMPLETED|Overall Study||116
7892968|NCT00747565|19425034|P1|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333
7892969|NCT00747565|19425033|P2|STARTED|Overall Study||123
7892970|NCT00747565|19425034|P1|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347
7892971|NCT00747552|19425042|P1|NOT COMPLETED|Overall Study||0
7892972|NCT00747552|19425042|P1|COMPLETED|Overall Study||30
7892973|NCT00747552|19425042|P1|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30
7892974|NCT00747474|19425047|P12|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892975|NCT00747474|19425048|P11|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892976|NCT00747474|19425049|P10|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892977|NCT00747474|19425050|P9|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892978|NCT00747474|19425051|P8|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892979|NCT00747474|19425052|P7|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892980|NCT00747474|19425053|P6|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892981|NCT00747474|19425054|P5|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892982|NCT00747474|19425055|P4|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892983|NCT00747474|19425056|P3|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892984|NCT00747474|19425057|P2|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892985|NCT00747474|19425058|P1|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892986|NCT00747474|19425047|P12|COMPLETED|Cohort 12 (60 mg/m^2) Period||6
7892987|NCT00747474|19425048|P11|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892988|NCT00747474|19425049|P10|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892989|NCT00747474|19425050|P9|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892990|NCT00747474|19425051|P8|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892991|NCT00747474|19425052|P7|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892992|NCT00747474|19425053|P6|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892993|NCT00747474|19425054|P5|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892994|NCT00747474|19425055|P4|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892995|NCT00747474|19425056|P3|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892996|NCT00747474|19425057|P2|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892997|NCT00747474|19425058|P1|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
7892998|NCT00747474|19425047|P12|STARTED|Cohort 12 (60 mg/m^2) Period||6
7892999|NCT00747474|19425048|P11|STARTED|Cohort 12 (60 mg/m^2) Period||0
7893000|NCT00747474|19425049|P10|STARTED|Cohort 12 (60 mg/m^2) Period||0
7893001|NCT00747474|19425050|P9|STARTED|Cohort 12 (60 mg/m^2) Period||0
7893002|NCT00747474|19425051|P8|STARTED|Cohort 12 (60 mg/m^2) Period||0
7893003|NCT00747474|19425052|P7|STARTED|Cohort 12 (60 mg/m^2) Period||0
7893004|NCT00747474|19425053|P6|STARTED|Cohort 12 (60 mg/m^2) Period||0
7893005|NCT00747474|19425054|P5|STARTED|Cohort 12 (60 mg/m^2) Period||0
7893006|NCT00747474|19425055|P4|STARTED|Cohort 12 (60 mg/m^2) Period||0
7893007|NCT00747474|19425056|P3|STARTED|Cohort 12 (60 mg/m^2) Period||0
7893008|NCT00747474|19425057|P2|STARTED|Cohort 12 (60 mg/m^2) Period||0
7893009|NCT00747474|19425058|P1|STARTED|Cohort 12 (60 mg/m^2) Period||0
7893010|NCT00747474|19425047|P12|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893011|NCT00747474|19425048|P11|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893012|NCT00747474|19425049|P10|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893013|NCT00747474|19425050|P9|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893014|NCT00747474|19425051|P8|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893015|NCT00747474|19425052|P7|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893016|NCT00747474|19425053|P6|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893017|NCT00747474|19425054|P5|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893018|NCT00747474|19425055|P4|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893019|NCT00747474|19425056|P3|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893020|NCT00747474|19425057|P2|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893021|NCT00747474|19425058|P1|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893022|NCT00747474|19425047|P12|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893023|NCT00747474|19425048|P11|COMPLETED|Cohort 11 (50 mg/m^2) Period||5
7893024|NCT00747474|19425049|P10|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893025|NCT00747474|19425050|P9|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893026|NCT00747474|19425051|P8|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893027|NCT00747474|19425052|P7|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893028|NCT00747474|19425053|P6|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893029|NCT00747474|19425054|P5|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893030|NCT00747474|19425055|P4|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893031|NCT00747474|19425056|P3|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893032|NCT00747474|19425057|P2|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893033|NCT00747474|19425058|P1|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
7893034|NCT00747474|19425047|P12|STARTED|Cohort 11 (50 mg/m^2) Period||0
7893035|NCT00747474|19425048|P11|STARTED|Cohort 11 (50 mg/m^2) Period||5
7893036|NCT00747474|19425049|P10|STARTED|Cohort 11 (50 mg/m^2) Period||0
7893037|NCT00747474|19425050|P9|STARTED|Cohort 11 (50 mg/m^2) Period||0
7893038|NCT00747474|19425051|P8|STARTED|Cohort 11 (50 mg/m^2) Period||0
7893039|NCT00747474|19425052|P7|STARTED|Cohort 11 (50 mg/m^2) Period||0
7893040|NCT00747474|19425053|P6|STARTED|Cohort 11 (50 mg/m^2) Period||0
7893041|NCT00747474|19425054|P5|STARTED|Cohort 11 (50 mg/m^2) Period||0
7893042|NCT00747474|19425055|P4|STARTED|Cohort 11 (50 mg/m^2) Period||0
7893043|NCT00747474|19425056|P3|STARTED|Cohort 11 (50 mg/m^2) Period||0
7893044|NCT00747474|19425057|P2|STARTED|Cohort 11 (50 mg/m^2) Period||0
7893045|NCT00747474|19425058|P1|STARTED|Cohort 11 (50 mg/m^2) Period||0
7893046|NCT00747474|19425047|P12|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893047|NCT00747474|19425048|P11|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893048|NCT00747474|19425049|P10|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893049|NCT00747474|19425050|P9|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893050|NCT00747474|19425051|P8|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893051|NCT00747474|19425052|P7|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893052|NCT00747474|19425053|P6|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893053|NCT00747474|19425054|P5|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893054|NCT00747474|19425055|P4|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893055|NCT00747474|19425056|P3|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893056|NCT00747474|19425057|P2|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893057|NCT00747474|19425058|P1|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893058|NCT00747474|19425047|P12|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893059|NCT00747474|19425048|P11|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893060|NCT00747474|19425049|P10|COMPLETED|Cohort 10 (40 mg/m^2) Period||7
7893061|NCT00747474|19425050|P9|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893062|NCT00747474|19425051|P8|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893063|NCT00747474|19425052|P7|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893064|NCT00747474|19425053|P6|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893065|NCT00747474|19425054|P5|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893066|NCT00747474|19425055|P4|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893067|NCT00747474|19425056|P3|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893068|NCT00747474|19425057|P2|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893069|NCT00747474|19425058|P1|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
7893070|NCT00747474|19425047|P12|STARTED|Cohort 10 (40 mg/m^2) Period||0
7893071|NCT00747474|19425048|P11|STARTED|Cohort 10 (40 mg/m^2) Period||0
7893072|NCT00747474|19425049|P10|STARTED|Cohort 10 (40 mg/m^2) Period||7
7893073|NCT00747474|19425050|P9|STARTED|Cohort 10 (40 mg/m^2) Period||0
7893074|NCT00747474|19425051|P8|STARTED|Cohort 10 (40 mg/m^2) Period||0
7893075|NCT00747474|19425052|P7|STARTED|Cohort 10 (40 mg/m^2) Period||0
7893076|NCT00747474|19425053|P6|STARTED|Cohort 10 (40 mg/m^2) Period||0
7893077|NCT00747474|19425054|P5|STARTED|Cohort 10 (40 mg/m^2) Period||0
7893078|NCT00747474|19425055|P4|STARTED|Cohort 10 (40 mg/m^2) Period||0
7893079|NCT00747474|19425056|P3|STARTED|Cohort 10 (40 mg/m^2) Period||0
7893080|NCT00747474|19425057|P2|STARTED|Cohort 10 (40 mg/m^2) Period||0
7893081|NCT00747474|19425058|P1|STARTED|Cohort 10 (40 mg/m^2) Period||0
7893082|NCT00747474|19425047|P12|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893083|NCT00747474|19425048|P11|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893084|NCT00747474|19425049|P10|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893085|NCT00747474|19425050|P9|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893086|NCT00747474|19425051|P8|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893087|NCT00747474|19425052|P7|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893088|NCT00747474|19425053|P6|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893089|NCT00747474|19425054|P5|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893090|NCT00747474|19425055|P4|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893091|NCT00747474|19425056|P3|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893092|NCT00747474|19425057|P2|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893093|NCT00747474|19425058|P1|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893094|NCT00747474|19425047|P12|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893095|NCT00747474|19425048|P11|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893096|NCT00747474|19425049|P10|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893097|NCT00747474|19425050|P9|COMPLETED|Cohort 9 (35 mg/m^2) Period||4
7893098|NCT00747474|19425051|P8|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893099|NCT00747474|19425052|P7|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893100|NCT00747474|19425053|P6|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893101|NCT00747474|19425054|P5|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893102|NCT00747474|19425055|P4|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893103|NCT00747474|19425056|P3|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893104|NCT00747474|19425057|P2|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893105|NCT00747474|19425058|P1|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
7893106|NCT00747474|19425047|P12|STARTED|Cohort 9 (35 mg/m^2) Period||0
7893107|NCT00747474|19425048|P11|STARTED|Cohort 9 (35 mg/m^2) Period||0
7893108|NCT00747474|19425049|P10|STARTED|Cohort 9 (35 mg/m^2) Period||0
7893109|NCT00747474|19425050|P9|STARTED|Cohort 9 (35 mg/m^2) Period||4
7893110|NCT00747474|19425051|P8|STARTED|Cohort 9 (35 mg/m^2) Period||0
7893111|NCT00747474|19425052|P7|STARTED|Cohort 9 (35 mg/m^2) Period||0
7893112|NCT00747474|19425053|P6|STARTED|Cohort 9 (35 mg/m^2) Period||0
7893113|NCT00747474|19425054|P5|STARTED|Cohort 9 (35 mg/m^2) Period||0
7893114|NCT00747474|19425055|P4|STARTED|Cohort 9 (35 mg/m^2) Period||0
7893115|NCT00747474|19425056|P3|STARTED|Cohort 9 (35 mg/m^2) Period||0
7893116|NCT00747474|19425057|P2|STARTED|Cohort 9 (35 mg/m^2) Period||0
7893117|NCT00747474|19425058|P1|STARTED|Cohort 9 (35 mg/m^2) Period||0
7893118|NCT00747474|19425047|P12|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893119|NCT00747474|19425048|P11|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893120|NCT00747474|19425049|P10|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893121|NCT00747474|19425050|P9|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893122|NCT00747474|19425051|P8|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1
7893123|NCT00747474|19425052|P7|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893124|NCT00747474|19425053|P6|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893125|NCT00747474|19425054|P5|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893126|NCT00747474|19425055|P4|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893127|NCT00747474|19425056|P3|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893128|NCT00747474|19425057|P2|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893129|NCT00747474|19425058|P1|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893130|NCT00747474|19425047|P12|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893131|NCT00747474|19425048|P11|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893132|NCT00747474|19425049|P10|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893133|NCT00747474|19425050|P9|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893134|NCT00747474|19425051|P8|COMPLETED|Cohort 8 (40 mg/m^2) Period||5
7893135|NCT00747474|19425052|P7|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893136|NCT00747474|19425053|P6|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893137|NCT00747474|19425054|P5|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893138|NCT00747474|19425055|P4|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893139|NCT00747474|19425056|P3|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893140|NCT00747474|19425057|P2|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893141|NCT00747474|19425058|P1|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
7893142|NCT00747474|19425047|P12|STARTED|Cohort 8 (40 mg/m^2) Period||0
7893143|NCT00747474|19425048|P11|STARTED|Cohort 8 (40 mg/m^2) Period||0
7893144|NCT00747474|19425049|P10|STARTED|Cohort 8 (40 mg/m^2) Period||0
7893145|NCT00747474|19425050|P9|STARTED|Cohort 8 (40 mg/m^2) Period||0
7893146|NCT00747474|19425051|P8|STARTED|Cohort 8 (40 mg/m^2) Period||6
7893147|NCT00747474|19425052|P7|STARTED|Cohort 8 (40 mg/m^2) Period||0
7893148|NCT00747474|19425053|P6|STARTED|Cohort 8 (40 mg/m^2) Period||0
7893149|NCT00747474|19425054|P5|STARTED|Cohort 8 (40 mg/m^2) Period||0
7893150|NCT00747474|19425055|P4|STARTED|Cohort 8 (40 mg/m^2) Period||0
7893151|NCT00747474|19425056|P3|STARTED|Cohort 8 (40 mg/m^2) Period||0
7893152|NCT00747474|19425057|P2|STARTED|Cohort 8 (40 mg/m^2) Period||0
7893153|NCT00747474|19425058|P1|STARTED|Cohort 8 (40 mg/m^2) Period||0
7893154|NCT00747474|19425047|P12|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893155|NCT00747474|19425048|P11|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893156|NCT00747474|19425049|P10|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893157|NCT00747474|19425050|P9|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893158|NCT00747474|19425051|P8|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893159|NCT00747474|19425052|P7|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893160|NCT00747474|19425053|P6|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893161|NCT00747474|19425054|P5|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893162|NCT00747474|19425055|P4|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893163|NCT00747474|19425056|P3|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893164|NCT00747474|19425057|P2|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893165|NCT00747474|19425058|P1|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893166|NCT00747474|19425047|P12|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893167|NCT00747474|19425048|P11|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893168|NCT00747474|19425049|P10|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893169|NCT00747474|19425050|P9|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893170|NCT00747474|19425051|P8|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893171|NCT00747474|19425052|P7|COMPLETED|Cohort 7 (30 mg/m^2) Period||4
7893172|NCT00747474|19425053|P6|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893173|NCT00747474|19425054|P5|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893174|NCT00747474|19425055|P4|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893175|NCT00747474|19425056|P3|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893176|NCT00747474|19425057|P2|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893177|NCT00747474|19425058|P1|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
7893178|NCT00747474|19425047|P12|STARTED|Cohort 7 (30 mg/m^2) Period||0
7893179|NCT00747474|19425048|P11|STARTED|Cohort 7 (30 mg/m^2) Period||0
7893180|NCT00747474|19425049|P10|STARTED|Cohort 7 (30 mg/m^2) Period||0
7893181|NCT00747474|19425050|P9|STARTED|Cohort 7 (30 mg/m^2) Period||0
7893182|NCT00747474|19425051|P8|STARTED|Cohort 7 (30 mg/m^2) Period||0
7893183|NCT00747474|19425052|P7|STARTED|Cohort 7 (30 mg/m^2) Period||4
7893184|NCT00747474|19425053|P6|STARTED|Cohort 7 (30 mg/m^2) Period||0
7893185|NCT00747474|19425054|P5|STARTED|Cohort 7 (30 mg/m^2) Period||0
7893186|NCT00747474|19425055|P4|STARTED|Cohort 7 (30 mg/m^2) Period||0
7893187|NCT00747474|19425056|P3|STARTED|Cohort 7 (30 mg/m^2) Period||0
7893188|NCT00747474|19425057|P2|STARTED|Cohort 7 (30 mg/m^2) Period||0
7893189|NCT00747474|19425058|P1|STARTED|Cohort 7 (30 mg/m^2) Period||0
7893190|NCT00747474|19425047|P12|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893191|NCT00747474|19425048|P11|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893192|NCT00747474|19425049|P10|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893193|NCT00747474|19425050|P9|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893194|NCT00747474|19425051|P8|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893195|NCT00747474|19425052|P7|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893196|NCT00747474|19425053|P6|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893197|NCT00747474|19425054|P5|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893198|NCT00747474|19425055|P4|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893199|NCT00747474|19425056|P3|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893200|NCT00747474|19425057|P2|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893201|NCT00747474|19425058|P1|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893202|NCT00747474|19425047|P12|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893203|NCT00747474|19425048|P11|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893204|NCT00747474|19425049|P10|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893205|NCT00747474|19425050|P9|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893206|NCT00747474|19425051|P8|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893207|NCT00747474|19425052|P7|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893208|NCT00747474|19425053|P6|COMPLETED|Cohort 6 (20 mg/m^2) Period||4
7893209|NCT00747474|19425054|P5|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893210|NCT00747474|19425055|P4|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893211|NCT00747474|19425056|P3|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893212|NCT00747474|19425057|P2|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893213|NCT00747474|19425058|P1|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
7893214|NCT00747474|19425047|P12|STARTED|Cohort 6 (20 mg/m^2) Period||0
7893215|NCT00747474|19425048|P11|STARTED|Cohort 6 (20 mg/m^2) Period||0
7893216|NCT00747474|19425049|P10|STARTED|Cohort 6 (20 mg/m^2) Period||0
7893217|NCT00747474|19425050|P9|STARTED|Cohort 6 (20 mg/m^2) Period||0
7893218|NCT00747474|19425051|P8|STARTED|Cohort 6 (20 mg/m^2) Period||0
7893219|NCT00747474|19425052|P7|STARTED|Cohort 6 (20 mg/m^2) Period||0
7893220|NCT00747474|19425053|P6|STARTED|Cohort 6 (20 mg/m^2) Period||4
7893221|NCT00747474|19425054|P5|STARTED|Cohort 6 (20 mg/m^2) Period||0
7893222|NCT00747474|19425055|P4|STARTED|Cohort 6 (20 mg/m^2) Period||0
7893223|NCT00747474|19425056|P3|STARTED|Cohort 6 (20 mg/m^2) Period||0
7893224|NCT00747474|19425057|P2|STARTED|Cohort 6 (20 mg/m^2) Period||0
7893225|NCT00747474|19425058|P1|STARTED|Cohort 6 (20 mg/m^2) Period||0
7893226|NCT00747474|19425047|P12|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893227|NCT00747474|19425048|P11|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893228|NCT00747474|19425049|P10|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893229|NCT00747474|19425050|P9|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893230|NCT00747474|19425051|P8|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893231|NCT00747474|19425052|P7|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893232|NCT00747474|19425053|P6|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893233|NCT00747474|19425054|P5|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893234|NCT00747474|19425055|P4|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893235|NCT00747474|19425056|P3|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893236|NCT00747474|19425057|P2|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893237|NCT00747474|19425058|P1|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893238|NCT00747474|19425047|P12|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893239|NCT00747474|19425048|P11|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893240|NCT00747474|19425049|P10|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893241|NCT00747474|19425050|P9|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893242|NCT00747474|19425051|P8|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893243|NCT00747474|19425052|P7|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893244|NCT00747474|19425053|P6|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893245|NCT00747474|19425054|P5|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4
7893246|NCT00747474|19425055|P4|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893247|NCT00747474|19425056|P3|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893248|NCT00747474|19425057|P2|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893249|NCT00747474|19425058|P1|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
7893250|NCT00747474|19425047|P12|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
7893251|NCT00747474|19425048|P11|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
7893252|NCT00747474|19425049|P10|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
7893253|NCT00747474|19425050|P9|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
7893254|NCT00747474|19425051|P8|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
7893255|NCT00747474|19425052|P7|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
7893256|NCT00747474|19425053|P6|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
7893257|NCT00747474|19425054|P5|STARTED|Cohort 5 (13.5 mg/m^2) Period||4
7893258|NCT00747474|19425055|P4|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
7893259|NCT00747474|19425056|P3|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
7893260|NCT00747474|19425057|P2|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
7893261|NCT00747474|19425058|P1|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
7893262|NCT00747474|19425047|P12|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893263|NCT00747474|19425048|P11|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893264|NCT00747474|19425049|P10|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893265|NCT00747474|19425050|P9|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893266|NCT00747474|19425051|P8|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893267|NCT00747474|19425052|P7|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893268|NCT00747474|19425053|P6|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893269|NCT00747474|19425054|P5|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893270|NCT00747474|19425055|P4|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893271|NCT00747474|19425056|P3|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893272|NCT00747474|19425057|P2|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893273|NCT00747474|19425058|P1|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893274|NCT00747474|19425047|P12|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893275|NCT00747474|19425048|P11|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893276|NCT00747474|19425049|P10|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893277|NCT00747474|19425050|P9|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893278|NCT00747474|19425051|P8|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893279|NCT00747474|19425052|P7|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893280|NCT00747474|19425053|P6|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893281|NCT00747474|19425054|P5|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893282|NCT00747474|19425055|P4|COMPLETED|Cohort 4 (9 mg/m^2) Period||4
7893283|NCT00747474|19425056|P3|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893284|NCT00747474|19425057|P2|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893285|NCT00747474|19425058|P1|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
7893286|NCT00747474|19425047|P12|STARTED|Cohort 4 (9 mg/m^2) Period||0
7893287|NCT00747474|19425048|P11|STARTED|Cohort 4 (9 mg/m^2) Period||0
7893288|NCT00747474|19425049|P10|STARTED|Cohort 4 (9 mg/m^2) Period||0
7893289|NCT00747474|19425050|P9|STARTED|Cohort 4 (9 mg/m^2) Period||0
7893290|NCT00747474|19425051|P8|STARTED|Cohort 4 (9 mg/m^2) Period||0
7893291|NCT00747474|19425052|P7|STARTED|Cohort 4 (9 mg/m^2) Period||0
7893292|NCT00747474|19425053|P6|STARTED|Cohort 4 (9 mg/m^2) Period||0
7893293|NCT00747474|19425054|P5|STARTED|Cohort 4 (9 mg/m^2) Period||0
7893294|NCT00747474|19425055|P4|STARTED|Cohort 4 (9 mg/m^2) Period||4
7893295|NCT00747474|19425056|P3|STARTED|Cohort 4 (9 mg/m^2) Period||0
7893296|NCT00747474|19425057|P2|STARTED|Cohort 4 (9 mg/m^2) Period||0
7893297|NCT00747474|19425058|P1|STARTED|Cohort 4 (9 mg/m^2) Period||0
7893298|NCT00747474|19425047|P12|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893299|NCT00747474|19425048|P11|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893300|NCT00747474|19425049|P10|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893301|NCT00747474|19425050|P9|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893302|NCT00747474|19425051|P8|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893303|NCT00747474|19425052|P7|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893304|NCT00747474|19425053|P6|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893305|NCT00747474|19425054|P5|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893306|NCT00747474|19425055|P4|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893307|NCT00747474|19425056|P3|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893308|NCT00747474|19425057|P2|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893309|NCT00747474|19425058|P1|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893310|NCT00747474|19425047|P12|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893311|NCT00747474|19425048|P11|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893312|NCT00747474|19425049|P10|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893313|NCT00747474|19425050|P9|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893314|NCT00747474|19425051|P8|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893315|NCT00747474|19425052|P7|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893316|NCT00747474|19425053|P6|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893317|NCT00747474|19425054|P5|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893318|NCT00747474|19425055|P4|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893319|NCT00747474|19425056|P3|COMPLETED|Cohort 3 (6 mg/m^2) Period||3
7893320|NCT00747474|19425057|P2|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893321|NCT00747474|19425058|P1|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
7893322|NCT00747474|19425047|P12|STARTED|Cohort 3 (6 mg/m^2) Period||0
7893323|NCT00747474|19425048|P11|STARTED|Cohort 3 (6 mg/m^2) Period||0
7893324|NCT00747474|19425049|P10|STARTED|Cohort 3 (6 mg/m^2) Period||0
7893325|NCT00747474|19425050|P9|STARTED|Cohort 3 (6 mg/m^2) Period||0
7893326|NCT00747474|19425051|P8|STARTED|Cohort 3 (6 mg/m^2) Period||0
7893327|NCT00747474|19425052|P7|STARTED|Cohort 3 (6 mg/m^2) Period||0
7893328|NCT00747474|19425053|P6|STARTED|Cohort 3 (6 mg/m^2) Period||0
7893329|NCT00747474|19425054|P5|STARTED|Cohort 3 (6 mg/m^2) Period||0
7893330|NCT00747474|19425055|P4|STARTED|Cohort 3 (6 mg/m^2) Period||0
7893331|NCT00747474|19425056|P3|STARTED|Cohort 3 (6 mg/m^2) Period||3
7893332|NCT00747474|19425057|P2|STARTED|Cohort 3 (6 mg/m^2) Period||0
7893333|NCT00747474|19425058|P1|STARTED|Cohort 3 (6 mg/m^2) Period||0
7893334|NCT00747474|19425047|P12|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893335|NCT00747474|19425048|P11|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893336|NCT00747474|19425049|P10|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893337|NCT00747474|19425050|P9|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893338|NCT00747474|19425051|P8|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893339|NCT00747474|19425052|P7|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893340|NCT00747474|19425053|P6|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893341|NCT00747474|19425054|P5|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893342|NCT00747474|19425055|P4|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893343|NCT00747474|19425056|P3|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893344|NCT00747474|19425057|P2|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893345|NCT00747474|19425058|P1|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893346|NCT00747474|19425047|P12|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893347|NCT00747474|19425048|P11|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893348|NCT00747474|19425049|P10|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893349|NCT00747474|19425050|P9|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893350|NCT00747474|19425051|P8|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893351|NCT00747474|19425052|P7|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893352|NCT00747474|19425053|P6|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893353|NCT00747474|19425054|P5|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893354|NCT00747474|19425055|P4|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893355|NCT00747474|19425056|P3|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893356|NCT00747474|19425057|P2|COMPLETED|Cohort 2 (3 mg/m^2) Period||4
7893357|NCT00747474|19425058|P1|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
7893358|NCT00747474|19425047|P12|STARTED|Cohort 2 (3 mg/m^2) Period||0
7893359|NCT00747474|19425048|P11|STARTED|Cohort 2 (3 mg/m^2) Period||0
7893360|NCT00747474|19425049|P10|STARTED|Cohort 2 (3 mg/m^2) Period||0
7893361|NCT00747474|19425050|P9|STARTED|Cohort 2 (3 mg/m^2) Period||0
7893362|NCT00747474|19425051|P8|STARTED|Cohort 2 (3 mg/m^2) Period||0
7893363|NCT00747474|19425052|P7|STARTED|Cohort 2 (3 mg/m^2) Period||0
7893364|NCT00747474|19425053|P6|STARTED|Cohort 2 (3 mg/m^2) Period||0
7893365|NCT00747474|19425054|P5|STARTED|Cohort 2 (3 mg/m^2) Period||0
7893366|NCT00747474|19425055|P4|STARTED|Cohort 2 (3 mg/m^2) Period||0
7893367|NCT00747474|19425056|P3|STARTED|Cohort 2 (3 mg/m^2) Period||0
7893368|NCT00747474|19425057|P2|STARTED|Cohort 2 (3 mg/m^2) Period||4
7893369|NCT00747474|19425058|P1|STARTED|Cohort 2 (3 mg/m^2) Period||0
7893370|NCT00747474|19425047|P12|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893371|NCT00747474|19425048|P11|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893372|NCT00747474|19425049|P10|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893373|NCT00747474|19425050|P9|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893374|NCT00747474|19425051|P8|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893375|NCT00747474|19425052|P7|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893376|NCT00747474|19425053|P6|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893377|NCT00747474|19425054|P5|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893378|NCT00747474|19425055|P4|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893379|NCT00747474|19425056|P3|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893380|NCT00747474|19425057|P2|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893381|NCT00747474|19425058|P1|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893382|NCT00747474|19425047|P12|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893383|NCT00747474|19425048|P11|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893384|NCT00747474|19425049|P10|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893385|NCT00747474|19425050|P9|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893386|NCT00747474|19425051|P8|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893387|NCT00747474|19425052|P7|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893388|NCT00747474|19425053|P6|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893389|NCT00747474|19425054|P5|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893390|NCT00747474|19425055|P4|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893391|NCT00747474|19425056|P3|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893392|NCT00747474|19425057|P2|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
7893393|NCT00747474|19425058|P1|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3
7893394|NCT00747474|19425047|P12|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
7893395|NCT00747474|19425048|P11|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
7893396|NCT00747474|19425049|P10|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
7893397|NCT00747474|19425050|P9|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
7893398|NCT00747474|19425051|P8|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
7893399|NCT00747474|19425052|P7|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
7893400|NCT00747474|19425053|P6|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
7893401|NCT00747474|19425054|P5|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
7893402|NCT00747474|19425055|P4|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
7893403|NCT00747474|19425056|P3|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
7893404|NCT00747474|19425057|P2|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
7893405|NCT00747474|19425058|P1|STARTED|Cohort 1 (1.5 mg/m^2) Period||3
7893406|NCT00747461|19425084|P1|NOT COMPLETED|Overall Study||5
7893407|NCT00747461|19425084|P1|COMPLETED|Overall Study||0
7893408|NCT00747461|19425084|P1|STARTED|Overall Study||5
7893409|NCT00747435|19425089|P1|NOT COMPLETED|Overall Study||6
7893410|NCT00747435|19425089|P1|COMPLETED|Overall Study||67
7893411|NCT00747435|19425089|P1|STARTED|Overall Study||73
7893412|NCT00747344|19425099|P4|NOT COMPLETED|After Controlled Period||1
7893413|NCT00747344|19425100|P3|NOT COMPLETED|After Controlled Period||0
7893414|NCT00747344|19425101|P2|NOT COMPLETED|After Controlled Period||0
7893415|NCT00747344|19425102|P1|NOT COMPLETED|After Controlled Period||0
7893416|NCT00747344|19425099|P4|COMPLETED|After Controlled Period||56
7893417|NCT00747344|19425100|P3|COMPLETED|After Controlled Period||55
7893418|NCT00747344|19425101|P2|COMPLETED|After Controlled Period||0
7893419|NCT00747344|19425102|P1|COMPLETED|After Controlled Period||0
7893420|NCT00747344|19425099|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57
7893421|NCT00747344|19425100|P3|STARTED|After Controlled Period||55
7893422|NCT00747344|19425101|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
7893423|NCT00747344|19425102|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
7893424|NCT00747344|19425099|P4|NOT COMPLETED|Controlled Period||0
7893425|NCT00747344|19425100|P3|NOT COMPLETED|Controlled Period||0
7893426|NCT00747344|19425101|P2|NOT COMPLETED|Controlled Period||4
7893427|NCT00747344|19425102|P1|NOT COMPLETED|Controlled Period||5
7893428|NCT00747344|19425099|P4|COMPLETED|Controlled Period||0
7893429|NCT00747344|19425100|P3|COMPLETED|Controlled Period||0
7893430|NCT00747344|19425101|P2|COMPLETED|Controlled Period||57
7893431|NCT00747344|19425102|P1|COMPLETED|Controlled Period||55
7893432|NCT00747344|19425099|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
7893433|NCT00747344|19425100|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
7893434|NCT00747344|19425101|P2|STARTED|Controlled Period||61
7893435|NCT00747344|19425102|P1|STARTED|Controlled Period||60
7893436|NCT00747227|19425116|P2|NOT COMPLETED|Overall Study||4
7893437|NCT00747227|19425117|P1|NOT COMPLETED|Overall Study||6
7893438|NCT00747227|19425116|P2|COMPLETED|Overall Study||120
7893439|NCT00747227|19425117|P1|COMPLETED|Overall Study||120
7893440|NCT00747227|19425116|P2|STARTED|Overall Study||124
7893441|NCT00747227|19425117|P1|STARTED|Overall Study||126
7893442|NCT00747214|19425131|P2|NOT COMPLETED|Overall Study||3
7893443|NCT00747214|19425132|P1|NOT COMPLETED|Overall Study||8
7893444|NCT00747214|19425131|P2|COMPLETED|Overall Study||29
7893445|NCT00747214|19425132|P1|COMPLETED|Overall Study||19
7893446|NCT00747214|19425131|P2|STARTED|Overall Study||32
7893447|NCT00747214|19425132|P1|STARTED|Overall Study||27
7893448|NCT00747149|19425146|P2|NOT COMPLETED|Overall Study||43
7893449|NCT00747149|19425147|P1|NOT COMPLETED|Overall Study||1
7893450|NCT00747149|19425146|P2|COMPLETED|Overall Study||401
7893451|NCT00747149|19425147|P1|COMPLETED|Overall Study||153
7893452|NCT00747149|19425146|P2|STARTED|Overall Study||444
7893453|NCT00747149|19425147|P1|STARTED|Overall Study||154
7893454|NCT00747006|19425162|P3|NOT COMPLETED|Overall Study||1
7893455|NCT00747006|19425163|P2|NOT COMPLETED|Overall Study||1
7893456|NCT00747006|19425164|P1|NOT COMPLETED|Overall Study||3
7893457|NCT00747006|19425162|P3|COMPLETED|Overall Study||2
7893458|NCT00747006|19425163|P2|COMPLETED|Overall Study||7
7893459|NCT00747006|19425164|P1|COMPLETED|Overall Study||4
7893460|NCT00747006|19425162|P3|STARTED|Overall Study||3
7893461|NCT00747006|19425163|P2|STARTED|Overall Study||8
7893462|NCT00747006|19425164|P1|STARTED|Overall Study||7
7893463|NCT00746954|19425230|P3|NOT COMPLETED|Overall Study||0
7893464|NCT00746954|19425231|P2|NOT COMPLETED|Overall Study||0
7893465|NCT00746954|19425232|P1|NOT COMPLETED|Overall Study||0
7893466|NCT00746954|19425230|P3|COMPLETED|Overall Study||2
7893467|NCT00746954|19425231|P2|COMPLETED|Overall Study||3
7893468|NCT00746954|19425232|P1|COMPLETED|Overall Study||3
7893469|NCT00746954|19425230|P3|STARTED|Overall Study||2
7893470|NCT00746954|19425231|P2|STARTED|Overall Study||3
7893471|NCT00746954|19425232|P1|STARTED|Overall Study||3
7893472|NCT00746941|19425242|P4|NOT COMPLETED|Overall Study||13
7893473|NCT00746941|19425243|P3|NOT COMPLETED|Overall Study||2
7893474|NCT00746941|19425244|P2|NOT COMPLETED|Overall Study||4
7893475|NCT00746941|19425245|P1|NOT COMPLETED|Overall Study||7
7893476|NCT00746941|19425242|P4|COMPLETED|Overall Study||7
7893477|NCT00746941|19425243|P3|COMPLETED|Overall Study||3
7893478|NCT00746941|19425244|P2|COMPLETED|Overall Study||1
7893479|NCT00746941|19425245|P1|COMPLETED|Overall Study||0
7893480|NCT00746941|19425242|P4|STARTED|Overall Study||20
7893481|NCT00746941|19425243|P3|STARTED|Overall Study||5
7893482|NCT00746941|19425244|P2|STARTED|Overall Study||5
7893483|NCT00746941|19425245|P1|STARTED|Overall Study||7
7893484|NCT00746889|19425273|P2|NOT COMPLETED|Overall Study||4
7893485|NCT00746889|19425274|P1|NOT COMPLETED|Overall Study||4
7893486|NCT00746889|19425273|P2|COMPLETED|Overall Study||35
7893487|NCT00746889|19425274|P1|COMPLETED|Overall Study||36
7893488|NCT00746889|19425273|P2|STARTED|Overall Study||39
7893489|NCT00746889|19425274|P1|STARTED|Overall Study||40
7893490|NCT00746863|19425284|P2|NOT COMPLETED|Overall Study||0
7893491|NCT00746863|19425285|P1|NOT COMPLETED|Overall Study||0
7893492|NCT00746863|19425284|P2|COMPLETED|Overall Study||21
7893493|NCT00746863|19425285|P1|COMPLETED|Overall Study||21
7893494|NCT00746863|19425284|P2|STARTED|Overall Study||21
7893495|NCT00746863|19425285|P1|STARTED|Overall Study||21
7893496|NCT00746798|19425303|P4|NOT COMPLETED|Overall Study||0
7893497|NCT00746798|19425304|P3|NOT COMPLETED|Overall Study||3
7893498|NCT00746798|19425305|P2|NOT COMPLETED|Overall Study||2
7893499|NCT00746798|19425306|P1|NOT COMPLETED|Overall Study||1
7893500|NCT00746798|19425303|P4|COMPLETED|Overall Study||120
7893501|NCT00746798|19425304|P3|COMPLETED|Overall Study||110
7893502|NCT00746798|19425305|P2|COMPLETED|Overall Study||122
7893503|NCT00746798|19425306|P1|COMPLETED|Overall Study||121
7893504|NCT00746798|19425303|P4|STARTED|Overall Study||120
7893505|NCT00746798|19425304|P3|STARTED|Overall Study||113
7893506|NCT00746798|19425305|P2|STARTED|Overall Study||124
7893507|NCT00746798|19425306|P1|STARTED|Overall Study||122
7893508|NCT00746785|19425331|P3|NOT COMPLETED|Overall Study||27
7893509|NCT00746785|19425332|P2|NOT COMPLETED|Overall Study||25
7893510|NCT00746785|19425333|P1|NOT COMPLETED|Overall Study||29
7893511|NCT00746785|19425331|P3|COMPLETED|Overall Study||13
7893512|NCT00746785|19425332|P2|COMPLETED|Overall Study||21
7893513|NCT00746785|19425333|P1|COMPLETED|Overall Study||14
7893514|NCT00746785|19425331|P3|STARTED|Overall Study||40
7893515|NCT00746785|19425332|P2|STARTED|Overall Study||46
7893516|NCT00746785|19425333|P1|STARTED|Overall Study||43
7893517|NCT00746733|19425341|P2|NOT COMPLETED|Fourth Intervention||0
7893518|NCT00746733|19425342|P1|NOT COMPLETED|Fourth Intervention||0
7893519|NCT00746733|19425341|P2|COMPLETED|Fourth Intervention||11
7893520|NCT00746733|19425342|P1|COMPLETED|Fourth Intervention||10
7893521|NCT00746733|19425341|P2|STARTED|Fourth Intervention||11
7893522|NCT00746733|19425342|P1|STARTED|Fourth Intervention||10
7893523|NCT00746733|19425341|P2|NOT COMPLETED|Third Intervention||1
7893524|NCT00746733|19425342|P1|NOT COMPLETED|Third Intervention||1
7893525|NCT00746733|19425341|P2|COMPLETED|Third Intervention||11
7893526|NCT00746733|19425342|P1|COMPLETED|Third Intervention||10
7893527|NCT00746733|19425341|P2|STARTED|Third Intervention||12
7893528|NCT00746733|19425342|P1|STARTED|Third Intervention||11
7893529|NCT00746733|19425341|P2|NOT COMPLETED|Second Intervention||0
7893530|NCT00746733|19425342|P1|NOT COMPLETED|Second Intervention||1
7893531|NCT00746733|19425341|P2|COMPLETED|Second Intervention||12
7893532|NCT00746733|19425342|P1|COMPLETED|Second Intervention||11
7893533|NCT00746733|19425341|P2|STARTED|Second Intervention||12
7893534|NCT00746733|19425342|P1|STARTED|Second Intervention||12
7893535|NCT00746733|19425341|P2|NOT COMPLETED|First Intervention||0
7893536|NCT00746733|19425342|P1|NOT COMPLETED|First Intervention||0
7893537|NCT00746733|19425341|P2|COMPLETED|First Intervention||12
7893538|NCT00746733|19425342|P1|COMPLETED|First Intervention||12
7893539|NCT00746733|19425341|P2|STARTED|First Intervention||12
7893540|NCT00746733|19425342|P1|STARTED|First Intervention||12
7893541|NCT00746694|19425402|P1|NOT COMPLETED|Overall Study||0
7893542|NCT00746694|19425402|P1|COMPLETED|Overall Study||154
7893543|NCT00746694|19425402|P1|STARTED|Overall Study||154
7893544|NCT00746668|19425407|P7|NOT COMPLETED|Overall Study||0
7893545|NCT00746668|19425408|P6|NOT COMPLETED|Overall Study||0
7893546|NCT00746668|19425409|P5|NOT COMPLETED|Overall Study||0
7893547|NCT00746668|19425410|P4|NOT COMPLETED|Overall Study||0
7893548|NCT00746668|19425411|P3|NOT COMPLETED|Overall Study||0
7893549|NCT00746668|19425412|P2|NOT COMPLETED|Overall Study||0
7893550|NCT00746668|19425413|P1|NOT COMPLETED|Overall Study||0
7893551|NCT00746668|19425407|P7|COMPLETED|Overall Study||5
7893552|NCT00746668|19425408|P6|COMPLETED|Overall Study||5
7893553|NCT00746668|19425409|P5|COMPLETED|Overall Study||5
7893554|NCT00746668|19425410|P4|COMPLETED|Overall Study||5
7893555|NCT00746668|19425411|P3|COMPLETED|Overall Study||5
7893556|NCT00746668|19425412|P2|COMPLETED|Overall Study||5
7893557|NCT00746668|19425413|P1|COMPLETED|Overall Study||6
7893558|NCT00746668|19425407|P7|STARTED|Overall Study||5
7893559|NCT00746668|19425408|P6|STARTED|Overall Study||5
7893560|NCT00746668|19425409|P5|STARTED|Overall Study||5
7893561|NCT00746668|19425410|P4|STARTED|Overall Study||5
7893562|NCT00746668|19425411|P3|STARTED|Overall Study||5
7893563|NCT00746668|19425412|P2|STARTED|Overall Study||5
7893564|NCT00746668|19425413|P1|STARTED|Overall Study||6
7893565|NCT00746590|19425426|P1|NOT COMPLETED|Overall Study||1
7893566|NCT00746590|19425426|P1|COMPLETED|Overall Study||0
7893567|NCT00746590|19425426|P1|STARTED|Overall Study||1
7893568|NCT00746564|19425430|P1|NOT COMPLETED|Overall Study||2
7893569|NCT00746564|19425430|P1|COMPLETED|Overall Study||73
7893570|NCT00746564|19425430|P1|STARTED|Overall Study||75
7893571|NCT00746551|19425445|P2|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
7893572|NCT00746551|19425446|P1|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
7893573|NCT00746551|19425445|P2|COMPLETED|At Delivery (GA of 39 Weeks)||25
7893574|NCT00746551|19425446|P1|COMPLETED|At Delivery (GA of 39 Weeks)||25
7893575|NCT00746551|19425445|P2|STARTED|At Delivery (GA of 39 Weeks)||40
7893576|NCT00746551|19425446|P1|STARTED|At Delivery (GA of 39 Weeks)||40
7893577|NCT00746551|19425445|P2|NOT COMPLETED|At Gestational Age of 36 Weeks||4
7893578|NCT00746551|19425446|P1|NOT COMPLETED|At Gestational Age of 36 Weeks||2
7893579|NCT00746551|19425445|P2|COMPLETED|At Gestational Age of 36 Weeks||36
7893580|NCT00746551|19425446|P1|COMPLETED|At Gestational Age of 36 Weeks||38
7893581|NCT00746551|19425445|P2|STARTED|At Gestational Age of 36 Weeks||40
7893582|NCT00746551|19425446|P1|STARTED|At Gestational Age of 36 Weeks||40
7893583|NCT00746512|19425458|P4|NOT COMPLETED|Overall Study||0
7893584|NCT00746512|19425459|P3|NOT COMPLETED|Overall Study||0
7893585|NCT00746512|19425460|P2|NOT COMPLETED|Overall Study||0
7893586|NCT00746512|19425461|P1|NOT COMPLETED|Overall Study||0
7893587|NCT00746512|19425458|P4|COMPLETED|Overall Study||9
7893588|NCT00746512|19425459|P3|COMPLETED|Overall Study||18
7893589|NCT00746512|19425460|P2|COMPLETED|Overall Study||10
7893590|NCT00746512|19425461|P1|COMPLETED|Overall Study||8
7893591|NCT00746512|19425458|P4|STARTED|Overall Study||9
7893592|NCT00746512|19425459|P3|STARTED|Overall Study||18
7893593|NCT00746512|19425460|P2|STARTED|Overall Study||10
7893594|NCT00746512|19425461|P1|STARTED|Overall Study||8
7893595|NCT00746421|19425477|P2|NOT COMPLETED|Overall Study||2
7893596|NCT00746421|19425478|P1|NOT COMPLETED|Overall Study||7
7893597|NCT00746421|19425477|P2|COMPLETED|Overall Study||9
7893598|NCT00746421|19425478|P1|COMPLETED|Overall Study||5
7893599|NCT00746421|19425477|P2|STARTED|Overall Study||11
7893600|NCT00746421|19425478|P1|STARTED|Overall Study||12
7893601|NCT00746395|19425488|P2|NOT COMPLETED|Overall Study||0
7893602|NCT00746395|19425489|P1|NOT COMPLETED|Overall Study||0
7893603|NCT00746395|19425488|P2|COMPLETED|Overall Study||20
7893604|NCT00746395|19425489|P1|COMPLETED|Overall Study||20
7893605|NCT00746395|19425488|P2|STARTED|Overall Study||20
7893606|NCT00746395|19425489|P1|STARTED|Overall Study||20
7893607|NCT00746356|19425497|P2|NOT COMPLETED|Overall Study||7
7893608|NCT00746356|19425498|P1|NOT COMPLETED|Overall Study||11
7893609|NCT00746356|19425497|P2|COMPLETED|Overall Study||40
7893610|NCT00746356|19425498|P1|COMPLETED|Overall Study||70
7893611|NCT00746356|19425497|P2|STARTED|Overall Study||47
7893612|NCT00746356|19425498|P1|STARTED|Overall Study||81
7893613|NCT00746330|19425510|P4|NOT COMPLETED|Period 4||0
7893614|NCT00746330|19425511|P3|NOT COMPLETED|Period 4||0
7893615|NCT00746330|19425512|P2|NOT COMPLETED|Period 4||0
7893616|NCT00746330|19425513|P1|NOT COMPLETED|Period 4||0
7893617|NCT00746330|19425510|P4|COMPLETED|Period 4||7
7893618|NCT00746330|19425511|P3|COMPLETED|Period 4||8
7893619|NCT00746330|19425512|P2|COMPLETED|Period 4||9
7893620|NCT00746330|19425513|P1|COMPLETED|Period 4||7
7893621|NCT00746330|19425510|P4|STARTED|Period 4||7
7893622|NCT00746330|19425511|P3|STARTED|Period 4||8
7893623|NCT00746330|19425512|P2|STARTED|Period 4||9
7893624|NCT00746330|19425513|P1|STARTED|Period 4||7
7893625|NCT00746330|19425510|P4|NOT COMPLETED|Period 3||0
7893626|NCT00746330|19425511|P3|NOT COMPLETED|Period 3||0
7893627|NCT00746330|19425512|P2|NOT COMPLETED|Period 3||0
7893628|NCT00746330|19425513|P1|NOT COMPLETED|Period 3||0
7893629|NCT00746330|19425510|P4|COMPLETED|Period 3||7
7893630|NCT00746330|19425511|P3|COMPLETED|Period 3||8
7893631|NCT00746330|19425512|P2|COMPLETED|Period 3||9
7893632|NCT00746330|19425513|P1|COMPLETED|Period 3||7
7893633|NCT00746330|19425510|P4|STARTED|Period 3||7
7893634|NCT00746330|19425511|P3|STARTED|Period 3||8
7893635|NCT00746330|19425512|P2|STARTED|Period 3||9
7893636|NCT00746330|19425513|P1|STARTED|Period 3||7
7893637|NCT00746330|19425510|P4|NOT COMPLETED|Period 2||0
7893638|NCT00746330|19425511|P3|NOT COMPLETED|Period 2||0
7893639|NCT00746330|19425512|P2|NOT COMPLETED|Period 2||0
7893640|NCT00746330|19425513|P1|NOT COMPLETED|Period 2||0
7893641|NCT00746330|19425510|P4|COMPLETED|Period 2||7
7893642|NCT00746330|19425511|P3|COMPLETED|Period 2||8
7893643|NCT00746330|19425512|P2|COMPLETED|Period 2||9
7893644|NCT00746330|19425513|P1|COMPLETED|Period 2||7
7893645|NCT00746330|19425510|P4|STARTED|Period 2||7
7893646|NCT00746330|19425511|P3|STARTED|Period 2||8
7893647|NCT00746330|19425512|P2|STARTED|Period 2||9
7893648|NCT00746330|19425513|P1|STARTED|Period 2||7
7893649|NCT00746330|19425510|P4|NOT COMPLETED|Period 1||0
7893650|NCT00746330|19425511|P3|NOT COMPLETED|Period 1||1
7893651|NCT00746330|19425512|P2|NOT COMPLETED|Period 1||0
7893652|NCT00746330|19425513|P1|NOT COMPLETED|Period 1||0
7893653|NCT00746330|19425510|P4|COMPLETED|Period 1||7
7893654|NCT00746330|19425511|P3|COMPLETED|Period 1||8
7893655|NCT00746330|19425512|P2|COMPLETED|Period 1||9
7893656|NCT00746330|19425513|P1|COMPLETED|Period 1||7
7893657|NCT00746330|19425510|P4|STARTED|Period 1||7
7893658|NCT00746330|19425511|P3|STARTED|Period 1||9
7893659|NCT00746330|19425512|P2|STARTED|Period 1||9
7893660|NCT00746330|19425513|P1|STARTED|Period 1||7
7893661|NCT00746252|19425543|P2|NOT COMPLETED|Overall Study||2
7893662|NCT00746252|19425544|P1|NOT COMPLETED|Overall Study||1
7893663|NCT00746252|19425543|P2|COMPLETED|Overall Study||0
7893664|NCT00746252|19425544|P1|COMPLETED|Overall Study||0
7893665|NCT00746252|19425543|P2|STARTED|Overall Study||2
7893666|NCT00746252|19425544|P1|STARTED|Overall Study||1
7893667|NCT00746239|19425550|P1|NOT COMPLETED|Overall Study||6
7893668|NCT00746239|19425550|P1|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5
7893669|NCT00746239|19425550|P1|STARTED|Overall Study||11
7893670|NCT00746187|19425557|P2|NOT COMPLETED|Overall Study||2
7893671|NCT00746187|19425558|P1|NOT COMPLETED|Overall Study||3
7893672|NCT00746187|19425557|P2|COMPLETED|Overall Study||16
7893673|NCT00746187|19425558|P1|COMPLETED|Overall Study||15
7893674|NCT00746187|19425557|P2|STARTED|Overall Study||18
7893675|NCT00746187|19425558|P1|STARTED|Overall Study||18
7893676|NCT00746122|19425566|P2|NOT COMPLETED|Overall Study||0
7893677|NCT00746122|19425567|P1|NOT COMPLETED|Overall Study||0
7893678|NCT00746122|19425566|P2|COMPLETED|Overall Study||316
7893679|NCT00746122|19425567|P1|COMPLETED|Overall Study||297
7893680|NCT00746122|19425566|P2|STARTED|Overall Study|After 600 recruitment target 13 more patients were randomised before sites could be closed down.|316
7893681|NCT00746122|19425567|P1|STARTED|Overall Study||297
7893682|NCT00746096|19425579|P2|NOT COMPLETED|Overall Study||3
7893683|NCT00746096|19425580|P1|NOT COMPLETED|Overall Study||10
7893684|NCT00746096|19425579|P2|COMPLETED|Overall Study||54
7893685|NCT00746096|19425580|P1|COMPLETED|Overall Study||48
7893686|NCT00746096|19425579|P2|STARTED|Overall Study||57
7893687|NCT00746096|19425580|P1|STARTED|Overall Study||58
7893688|NCT00746018|19425588|P1|NOT COMPLETED|Overall Study||0
7893689|NCT00746018|19425588|P1|COMPLETED|Overall Study||39
7893690|NCT00746018|19425588|P1|STARTED|Overall Study||39
7893691|NCT00745940|19425594|P2|NOT COMPLETED|Overall Study||10
7893692|NCT00745940|19425595|P1|NOT COMPLETED|Overall Study||19
7893693|NCT00745940|19425594|P2|COMPLETED|Overall Study||38
7893694|NCT00745940|19425595|P1|COMPLETED|Overall Study||38
7893695|NCT00745940|19425594|P2|STARTED|Overall Study||48
7893696|NCT00745940|19425595|P1|STARTED|Overall Study||57
7893697|NCT00745901|19425611|P2|NOT COMPLETED|Overall Study||21
7893698|NCT00745901|19425612|P1|NOT COMPLETED|Overall Study||24
7893699|NCT00745901|19425611|P2|COMPLETED|Overall Study||156
7893700|NCT00745901|19425612|P1|COMPLETED|Overall Study||154
7893701|NCT00745901|19425611|P2|STARTED|Overall Study|Number of Patients Randomized|177
7893702|NCT00745901|19425612|P1|STARTED|Overall Study|Number of Patients Randomized|178
7893703|NCT00745875|19425658|P2|NOT COMPLETED|Overall Study||4
7893704|NCT00745875|19425659|P1|NOT COMPLETED|Overall Study||4
7893705|NCT00745875|19425658|P2|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|26
7893706|NCT00745875|19425659|P1|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|32
7893707|NCT00745875|19425658|P2|STARTED|Overall Study|Started - Number of patients randomised|30
7893708|NCT00745875|19425659|P1|STARTED|Overall Study|Started - Number of patients randomised|36
7893709|NCT00745849|19425667|P2|NOT COMPLETED|Second Intervention||1
7893710|NCT00745849|19425668|P1|NOT COMPLETED|Second Intervention||2
7893711|NCT00745849|19425667|P2|COMPLETED|Second Intervention||19
7893712|NCT00745849|19425668|P1|COMPLETED|Second Intervention||18
7893713|NCT00745849|19425667|P2|STARTED|Second Intervention||20
7893714|NCT00745849|19425668|P1|STARTED|Second Intervention||20
7893715|NCT00745849|19425667|P2|NOT COMPLETED|Washout Period||0
7893716|NCT00745849|19425668|P1|NOT COMPLETED|Washout Period||0
7893717|NCT00745849|19425667|P2|COMPLETED|Washout Period||20
7893718|NCT00745849|19425668|P1|COMPLETED|Washout Period||20
7893719|NCT00745849|19425667|P2|STARTED|Washout Period||20
7893720|NCT00745849|19425668|P1|STARTED|Washout Period||20
7893721|NCT00745849|19425667|P2|NOT COMPLETED|First Intervention||2
7893722|NCT00745849|19425668|P1|NOT COMPLETED|First Intervention||1
7893723|NCT00745849|19425667|P2|COMPLETED|First Intervention||20
7893724|NCT00745849|19425668|P1|COMPLETED|First Intervention||20
7893725|NCT00745849|19425667|P2|STARTED|First Intervention||22
7893726|NCT00745849|19425668|P1|STARTED|First Intervention||21
7893727|NCT00745823|19425676|P2|NOT COMPLETED|Overall Study||386
7893728|NCT00745823|19425677|P1|NOT COMPLETED|Overall Study||385
7893729|NCT00745823|19425676|P2|COMPLETED|Overall Study||3
7893730|NCT00745823|19425677|P1|COMPLETED|Overall Study||1
7893731|NCT00745823|19425676|P2|TREATED Week 0 - 96|Overall Study||388
7893732|NCT00745823|19425677|P1|TREATED Week 0 - 96|Overall Study||382
7893733|NCT00745823|19425676|P2|STARTED|Overall Study||389
7893734|NCT00745823|19425677|P1|STARTED|Overall Study||386
7893735|NCT00745615|19425705|P6|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||108
7893736|NCT00745615|19425706|P5|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||91
7893737|NCT00745615|19425707|P4|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
7893738|NCT00745615|19425708|P3|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
7893739|NCT00745615|19425709|P2|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
7893740|NCT00745615|19425710|P1|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
7893741|NCT00745615|19425705|P6|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
7893742|NCT00745615|19425706|P5|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
7893743|NCT00745615|19425707|P4|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
7893744|NCT00745615|19425708|P3|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
7893745|NCT00745615|19425709|P2|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
7893746|NCT00745615|19425710|P1|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
7893747|NCT00745615|19425705|P6|STARTED|Open-Label (up to Approx 10.5 Years)||113
7893748|NCT00745615|19425706|P5|STARTED|Open-Label (up to Approx 10.5 Years)||96
7893749|NCT00745615|19425707|P4|STARTED|Open-Label (up to Approx 10.5 Years)||0
7893750|NCT00745615|19425708|P3|STARTED|Open-Label (up to Approx 10.5 Years)||0
7893751|NCT00745615|19425709|P2|STARTED|Open-Label (up to Approx 10.5 Years)||0
7893752|NCT00745615|19425710|P1|STARTED|Open-Label (up to Approx 10.5 Years)||0
7893753|NCT00745615|19425705|P6|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
7893754|NCT00745615|19425706|P5|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
7893755|NCT00745615|19425707|P4|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
7893756|NCT00745615|19425708|P3|NOT COMPLETED|Double-Blind Extension (36 Weeks)||1
7893757|NCT00745615|19425709|P2|NOT COMPLETED|Double-Blind Extension (36 Weeks)||7
7893758|NCT00745615|19425710|P1|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
7893759|NCT00745615|19425705|P6|COMPLETED|Double-Blind Extension (36 Weeks)||0
7893760|NCT00745615|19425706|P5|COMPLETED|Double-Blind Extension (36 Weeks)||0
7893761|NCT00745615|19425707|P4|COMPLETED|Double-Blind Extension (36 Weeks)||39
7893762|NCT00745615|19425708|P3|COMPLETED|Double-Blind Extension (36 Weeks)||38
7893763|NCT00745615|19425709|P2|COMPLETED|Double-Blind Extension (36 Weeks)||87
7893764|NCT00745615|19425710|P1|COMPLETED|Double-Blind Extension (36 Weeks)||75
7893765|NCT00745615|19425705|P6|STARTED|Double-Blind Extension (36 Weeks)||0
7893766|NCT00745615|19425706|P5|STARTED|Double-Blind Extension (36 Weeks)||0
7893767|NCT00745615|19425707|P4|STARTED|Double-Blind Extension (36 Weeks)||44
7893768|NCT00745615|19425708|P3|STARTED|Double-Blind Extension (36 Weeks)||39
7893769|NCT00745615|19425709|P2|STARTED|Double-Blind Extension (36 Weeks)||94
7893770|NCT00745615|19425710|P1|STARTED|Double-Blind Extension (36 Weeks)||80
7893771|NCT00745498|19425759|P3|NOT COMPLETED|Overall Study||8
7893772|NCT00745498|19425760|P2|NOT COMPLETED|Overall Study||6
7893773|NCT00745498|19425761|P1|NOT COMPLETED|Overall Study||5
7893774|NCT00745498|19425759|P3|COMPLETED|Overall Study||34
7893775|NCT00745498|19425760|P2|COMPLETED|Overall Study||37
7893776|NCT00745498|19425761|P1|COMPLETED|Overall Study||36
7893777|NCT00745498|19425759|P3|STARTED|Overall Study||42
7893778|NCT00745498|19425760|P2|STARTED|Overall Study||43
7893779|NCT00745498|19425761|P1|STARTED|Overall Study||41
7893780|NCT00745420|19425775|P1|NOT COMPLETED|Overall Study||1
7893781|NCT00745420|19425775|P1|COMPLETED|Overall Study||29
7893782|NCT00745420|19425775|P1|STARTED|Overall Study||30
7893783|NCT00745368|19425792|P1|NOT COMPLETED|Overall Study||3
7893784|NCT00745368|19425792|P1|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16
7893785|NCT00745368|19425792|P1|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19
7893786|NCT00745290|19425805|P2|NOT COMPLETED|Overall Study||0
7893787|NCT00745290|19425806|P1|NOT COMPLETED|Overall Study||0
7893788|NCT00745290|19425805|P2|COMPLETED|Overall Study||122
7893789|NCT00745290|19425806|P1|COMPLETED|Overall Study||123
7893790|NCT00745290|19425805|P2|STARTED|Overall Study||122
7893791|NCT00745290|19425806|P1|STARTED|Overall Study||123
7893792|NCT00745251|19425814|P2|NOT COMPLETED|Overall Study||3
7893793|NCT00745251|19425815|P1|NOT COMPLETED|Overall Study||2
7893794|NCT00745251|19425814|P2|COMPLETED|Overall Study||19
7893795|NCT00745251|19425815|P1|COMPLETED|Overall Study||21
7893796|NCT00745251|19425814|P2|STARTED|Overall Study||22
7893797|NCT00745251|19425815|P1|STARTED|Overall Study||23
7893798|NCT00745121|19425825|P2|NOT COMPLETED|Overall Study||2
7893799|NCT00745121|19425826|P1|NOT COMPLETED|Overall Study||9
7893800|NCT00745121|19425825|P2|COMPLETED|Overall Study||26
7893801|NCT00745121|19425826|P1|COMPLETED|Overall Study||11
7893802|NCT00745121|19425825|P2|STARTED|Overall Study||28
7893803|NCT00745121|19425826|P1|STARTED|Overall Study||20
7893804|NCT00745095|19425838|P6|NOT COMPLETED|Overall Study||123
7893805|NCT00745095|19425839|P5|NOT COMPLETED|Overall Study||122
7893806|NCT00745095|19425840|P4|NOT COMPLETED|Overall Study||3
7893807|NCT00745095|19425841|P3|NOT COMPLETED|Overall Study||3
7893808|NCT00745095|19425842|P2|NOT COMPLETED|Overall Study||2
7893809|NCT00745095|19425843|P1|NOT COMPLETED|Overall Study||1
7893810|NCT00745095|19425838|P6|COMPLETED|Overall Study||27
7893811|NCT00745095|19425839|P5|COMPLETED|Overall Study||28
7893812|NCT00745095|19425840|P4|COMPLETED|Overall Study||12
7893813|NCT00745095|19425841|P3|COMPLETED|Overall Study||12
7893814|NCT00745095|19425842|P2|COMPLETED|Overall Study||13
7893815|NCT00745095|19425843|P1|COMPLETED|Overall Study||14
7893816|NCT00745095|19425838|P6|STARTED|Overall Study||150
7893817|NCT00745095|19425839|P5|STARTED|Overall Study||150
7893818|NCT00745095|19425840|P4|STARTED|Overall Study||15
7893819|NCT00745095|19425841|P3|STARTED|Overall Study||15
7893820|NCT00745095|19425842|P2|STARTED|Overall Study||15
7893821|NCT00745095|19425843|P1|STARTED|Overall Study||15
7893822|NCT00745030|19425865|P2|NOT COMPLETED|Overall Study||0
7893823|NCT00745030|19425866|P1|NOT COMPLETED|Overall Study||0
7893824|NCT00745030|19425865|P2|COMPLETED|Overall Study||2
7893825|NCT00745030|19425866|P1|COMPLETED|Overall Study||1
7893826|NCT00745030|19425865|P2|STARTED|Overall Study||2
7893827|NCT00745030|19425866|P1|STARTED|Overall Study||1
7893828|NCT00744991|19425872|P1|NOT COMPLETED|Overall Study||25
7893829|NCT00744991|19425872|P1|COMPLETED|Overall Study||0
7893830|NCT00744991|19425872|P1|Received at Least 1 Dose|Overall Study||25
7893831|NCT00744991|19425872|P1|STARTED|Overall Study||25
7893832|NCT00744978|19425889|P2|NOT COMPLETED|Period 2||1
7893833|NCT00744978|19425890|P1|NOT COMPLETED|Period 2||0
7893834|NCT00744978|19425889|P2|COMPLETED|Period 2||28
7893835|NCT00744978|19425890|P1|COMPLETED|Period 2||26
7893836|NCT00744978|19425889|P2|STARTED|Period 2||29
7893837|NCT00744978|19425890|P1|STARTED|Period 2||26
7893838|NCT00744978|19425889|P2|NOT COMPLETED|Placebo Washout||0
7893839|NCT00744978|19425890|P1|NOT COMPLETED|Placebo Washout||0
7893840|NCT00744978|19425889|P2|COMPLETED|Placebo Washout||29
7893841|NCT00744978|19425890|P1|COMPLETED|Placebo Washout||26
7893842|NCT00744978|19425889|P2|STARTED|Placebo Washout||29
7893843|NCT00744978|19425890|P1|STARTED|Placebo Washout||26
7893844|NCT00744978|19425889|P2|NOT COMPLETED|Period 1||5
7893845|NCT00744978|19425890|P1|NOT COMPLETED|Period 1||6
7893846|NCT00744978|19425889|P2|COMPLETED|Period 1||29
7893847|NCT00744978|19425890|P1|COMPLETED|Period 1||26
7893848|NCT00744978|19425889|P2|Treated|Period 1||33
7893849|NCT00744978|19425890|P1|Treated|Period 1||31
7893850|NCT00744978|19425889|P2|STARTED|Period 1||34
7893851|NCT00744978|19425890|P1|STARTED|Period 1||32
7893852|NCT00744965|19425940|P2|NOT COMPLETED|Overall Study||9
7893853|NCT00744965|19425941|P1|NOT COMPLETED|Overall Study||11
7893854|NCT00744965|19425940|P2|COMPLETED|Overall Study||189
7893855|NCT00744965|19425941|P1|COMPLETED|Overall Study||186
7893856|NCT00744965|19425940|P2|STARTED|Overall Study||198
7893857|NCT00744965|19425941|P1|STARTED|Overall Study||197
7893858|NCT00744939|19425971|P1|NOT COMPLETED|Overall Study||91
7893859|NCT00744939|19425971|P1|COMPLETED|Overall Study||77
7893860|NCT00744939|19425971|P1|Treatment Received|Overall Study||141
7893861|NCT00744939|19425971|P1|STARTED|Overall Study||168
7893862|NCT00744874|19426007|P1|NOT COMPLETED|Overall Study||4
7893863|NCT00744874|19426007|P1|COMPLETED|Overall Study||51
7893864|NCT00744874|19426007|P1|STARTED|Overall Study||55
7893865|NCT00744848|19426025|P2|NOT COMPLETED|Overall Study||0
7893866|NCT00744848|19426026|P1|NOT COMPLETED|Overall Study||0
7893867|NCT00744848|19426025|P2|COMPLETED|Overall Study||101
7893868|NCT00744848|19426026|P1|COMPLETED|Overall Study||103
7893869|NCT00744848|19426025|P2|STARTED|Overall Study||101
7893870|NCT00744848|19426026|P1|STARTED|Overall Study||103
7893871|NCT00744796|19426032|P1|NOT COMPLETED|Post-Operative 6-9 Months||12
7893872|NCT00744796|19426032|P1|COMPLETED|Post-Operative 6-9 Months||9
7893873|NCT00744796|19426032|P1|STARTED|Post-Operative 6-9 Months||21
7893874|NCT00744796|19426032|P1|NOT COMPLETED|Post-Operative 3-6 Months||0
7893875|NCT00744796|19426032|P1|COMPLETED|Post-Operative 3-6 Months||21
7893876|NCT00744796|19426032|P1|STARTED|Post-Operative 3-6 Months||21
7893877|NCT00744796|19426032|P1|NOT COMPLETED|Post-Operative Day 1||0
7893878|NCT00744796|19426032|P1|COMPLETED|Post-Operative Day 1||21
7893879|NCT00744796|19426032|P1|STARTED|Post-Operative Day 1||21
7893880|NCT00744796|19426032|P1|NOT COMPLETED|Pre-operative||0
7893881|NCT00744796|19426032|P1|COMPLETED|Pre-operative||21
7893882|NCT00744796|19426032|P1|STARTED|Pre-operative||21
7893883|NCT00744757|19426038|P1|NOT COMPLETED|Overall Study||21
7893884|NCT00744757|19426038|P1|COMPLETED|Overall Study||16
7893885|NCT00744757|19426038|P1|STARTED|Overall Study||37
7893886|NCT00744692|19426051|P1|NOT COMPLETED|Overall Study||0
7893887|NCT00744692|19426051|P1|COMPLETED|Overall Study||22
7893888|NCT00744692|19426051|P1|STARTED|Overall Study||22
7893889|NCT00744653|19426063|P1|NOT COMPLETED|Overall Study||16
7893890|NCT00744653|19426063|P1|COMPLETED|Overall Study||1
7893891|NCT00744653|19426063|P1|STARTED|Overall Study||17
7893892|NCT00744627|19426071|P2|NOT COMPLETED|Overall Study||22
7893893|NCT00744627|19426072|P1|NOT COMPLETED|Overall Study||25
7893894|NCT00744627|19426071|P2|COMPLETED|Overall Study||128
7893895|NCT00744627|19426072|P1|COMPLETED|Overall Study||126
7893896|NCT00744627|19426071|P2|Treated|Overall Study||150
7893897|NCT00744627|19426072|P1|Treated|Overall Study||150
7893898|NCT00744627|19426071|P2|STARTED|Overall Study||150
7893899|NCT00744627|19426072|P1|STARTED|Overall Study||151
7893900|NCT00744523|19426128|P2|NOT COMPLETED|30 Days After the Procedure||5
7893901|NCT00744523|19426129|P1|NOT COMPLETED|30 Days After the Procedure||0
7893902|NCT00744523|19426128|P2|COMPLETED|30 Days After the Procedure||220
7893903|NCT00744523|19426129|P1|COMPLETED|30 Days After the Procedure||37
7893904|NCT00744523|19426128|P2|STARTED|30 Days After the Procedure||225
7893905|NCT00744523|19426129|P1|STARTED|30 Days After the Procedure||37
7893906|NCT00744523|19426128|P2|NOT COMPLETED|Procedure||0
7893907|NCT00744523|19426129|P1|NOT COMPLETED|Procedure||0
7893908|NCT00744523|19426128|P2|COMPLETED|Procedure||225
7893909|NCT00744523|19426129|P1|COMPLETED|Procedure||37
7893910|NCT00744523|19426128|P2|STARTED|Procedure||225
7893911|NCT00744523|19426129|P1|STARTED|Procedure||37
7893912|NCT00744497|19426149|P2|NOT COMPLETED|Overall Study||762
7893913|NCT00744497|19426150|P1|NOT COMPLETED|Overall Study||760
7893914|NCT00744497|19426149|P2|COMPLETED|Overall Study||0
7893915|NCT00744497|19426150|P1|COMPLETED|Overall Study||0
7893916|NCT00744497|19426149|P2|Received Treatment|Overall Study||761
7893917|NCT00744497|19426150|P1|Received Treatment|Overall Study||757
7893918|NCT00744497|19426149|P2|STARTED|Overall Study|Randomized|762
7893919|NCT00744497|19426150|P1|STARTED|Overall Study|Randomized|760
7893920|NCT00744380|19426186|P2|NOT COMPLETED|Overall Study||0
7893921|NCT00744380|19426187|P1|NOT COMPLETED|Overall Study||0
7893922|NCT00744380|19426186|P2|COMPLETED|Overall Study||11
7893923|NCT00744380|19426187|P1|COMPLETED|Overall Study||12
7893924|NCT00744380|19426186|P2|STARTED|Overall Study||11
7893925|NCT00744380|19426187|P1|STARTED|Overall Study||12
7893926|NCT00744328|19426210|P3|NOT COMPLETED|Overall Study||8
7893927|NCT00744328|19426211|P2|NOT COMPLETED|Overall Study||8
7893928|NCT00744328|19426212|P1|NOT COMPLETED|Overall Study||7
7893929|NCT00744328|19426210|P3|COMPLETED|Overall Study||21
7893930|NCT00744328|19426211|P2|COMPLETED|Overall Study||22
7893931|NCT00744328|19426212|P1|COMPLETED|Overall Study||19
7893932|NCT00744328|19426210|P3|STARTED|Overall Study||29
7893933|NCT00744328|19426211|P2|STARTED|Overall Study||30
7893934|NCT00744328|19426212|P1|STARTED|Overall Study||26
7893935|NCT00744263|19426225|P2|NOT COMPLETED|Overall Study||5320
7893936|NCT00744263|19426226|P1|NOT COMPLETED|Overall Study||5236
7893937|NCT00744263|19426225|P2|COMPLETED|Overall Study||36936
7893938|NCT00744263|19426226|P1|COMPLETED|Overall Study||37004
7893939|NCT00744263|19426225|P2|STARTED|Overall Study||42256
7893940|NCT00744263|19426226|P1|STARTED|Overall Study||42240
7893941|NCT00744237|19426249|P3|NOT COMPLETED|Overall Study||15
7893942|NCT00744237|19426250|P2|NOT COMPLETED|Overall Study||27
7893943|NCT00744237|19426251|P1|NOT COMPLETED|Overall Study||27
7893944|NCT00744237|19426249|P3|COMPLETED|Overall Study||59
7893945|NCT00744237|19426250|P2|COMPLETED|Overall Study||46
7893946|NCT00744237|19426251|P1|COMPLETED|Overall Study||56
7893947|NCT00744237|19426249|P3|STARTED|Overall Study||74
7893948|NCT00744237|19426250|P2|STARTED|Overall Study||73
7893949|NCT00744237|19426251|P1|STARTED|Overall Study||83
7893950|NCT00744211|19426265|P3|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
7893951|NCT00744211|19426266|P2|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
7893952|NCT00744211|19426267|P1|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
7893953|NCT00744211|19426265|P3|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
7893954|NCT00744211|19426266|P2|COMPLETED|24 Hours After Cardiopulmonary Bypass||9
7893955|NCT00744211|19426267|P1|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
7893956|NCT00744211|19426265|P3|STARTED|24 Hours After Cardiopulmonary Bypass||10
7893957|NCT00744211|19426266|P2|STARTED|24 Hours After Cardiopulmonary Bypass||9
7893958|NCT00744211|19426267|P1|STARTED|24 Hours After Cardiopulmonary Bypass||10
7893959|NCT00744211|19426265|P3|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
7893960|NCT00744211|19426266|P2|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
7893961|NCT00744211|19426267|P1|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
7893962|NCT00744211|19426265|P3|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
7893963|NCT00744211|19426266|P2|COMPLETED|12 Hours After Cardiopulmonary Bypass||9
7893964|NCT00744211|19426267|P1|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
7893965|NCT00744211|19426265|P3|STARTED|12 Hours After Cardiopulmonary Bypass||10
7893966|NCT00744211|19426266|P2|STARTED|12 Hours After Cardiopulmonary Bypass||9
7893967|NCT00744211|19426267|P1|STARTED|12 Hours After Cardiopulmonary Bypass||10
7893968|NCT00744211|19426265|P3|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
7893969|NCT00744211|19426266|P2|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
7893970|NCT00744211|19426267|P1|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
7893971|NCT00744211|19426265|P3|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
7893972|NCT00744211|19426266|P2|COMPLETED|6 Hours After Cardiopulmonary Bypass||9
7893973|NCT00744211|19426267|P1|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
7893974|NCT00744211|19426265|P3|STARTED|6 Hours After Cardiopulmonary Bypass||10
7893975|NCT00744211|19426266|P2|STARTED|6 Hours After Cardiopulmonary Bypass||9
7893976|NCT00744211|19426267|P1|STARTED|6 Hours After Cardiopulmonary Bypass||10
7893977|NCT00744211|19426265|P3|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
7893978|NCT00744211|19426266|P2|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
7893979|NCT00744211|19426267|P1|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
7893980|NCT00744211|19426265|P3|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
7893981|NCT00744211|19426266|P2|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||9
7893982|NCT00744211|19426267|P1|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
7893983|NCT00744211|19426265|P3|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
7893984|NCT00744211|19426266|P2|STARTED|0.5 Hours After Cardiopulmonary Bypass||9
7893985|NCT00744211|19426267|P1|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
7893986|NCT00744211|19426265|P3|NOT COMPLETED|Baseline||0
7893987|NCT00744211|19426266|P2|NOT COMPLETED|Baseline||0
7893988|NCT00744211|19426267|P1|NOT COMPLETED|Baseline||0
7893989|NCT00744211|19426265|P3|COMPLETED|Baseline||10
7893990|NCT00744211|19426266|P2|COMPLETED|Baseline||9
7893991|NCT00744211|19426267|P1|COMPLETED|Baseline||10
7893992|NCT00744211|19426265|P3|STARTED|Baseline||10
7893993|NCT00744211|19426266|P2|STARTED|Baseline||9
7893994|NCT00744211|19426267|P1|STARTED|Baseline||10
7893995|NCT00744055|19426285|P2|NOT COMPLETED|Overall Study||14
7893996|NCT00744055|19426286|P1|NOT COMPLETED|Overall Study||7
7893997|NCT00744055|19426285|P2|COMPLETED|Overall Study||32
7893998|NCT00744055|19426286|P1|COMPLETED|Overall Study||43
7893999|NCT00744055|19426285|P2|STARTED|Overall Study||46
7894000|NCT00744055|19426286|P1|STARTED|Overall Study||50
7894001|NCT00744042|19426294|P1|NOT COMPLETED|Overall Study||1
7894002|NCT00744042|19426294|P1|COMPLETED|Overall Study||10
7894003|NCT00744042|19426294|P1|STARTED|Overall Study||11
7894004|NCT00743730|19426310|P3|NOT COMPLETED|Overall Study||5
7894005|NCT00743730|19426311|P2|NOT COMPLETED|Overall Study||4
7894006|NCT00743730|19426312|P1|NOT COMPLETED|Overall Study||5
7894007|NCT00743730|19426310|P3|COMPLETED|Overall Study||28
7894008|NCT00743730|19426311|P2|COMPLETED|Overall Study||30
7894009|NCT00743730|19426312|P1|COMPLETED|Overall Study||22
7894010|NCT00743730|19426310|P3|STARTED|Overall Study||33
7894011|NCT00743730|19426311|P2|STARTED|Overall Study||34
7894012|NCT00743730|19426312|P1|STARTED|Overall Study||27
7894013|NCT00743717|19426328|P2|NOT COMPLETED|Overall Study||0
7894014|NCT00743717|19426329|P1|NOT COMPLETED|Overall Study||0
7894015|NCT00743717|19426328|P2|COMPLETED|Overall Study||2
7894016|NCT00743717|19426329|P1|COMPLETED|Overall Study||2
7894017|NCT00743717|19426328|P2|STARTED|Overall Study||2
7894018|NCT00743717|19426329|P1|STARTED|Overall Study||2
7894019|NCT00743652|19426340|P5|NOT COMPLETED|Overall Study||0
7894020|NCT00743652|19426341|P4|NOT COMPLETED|Overall Study||4
7894021|NCT00743652|19426342|P3|NOT COMPLETED|Overall Study||2
7894022|NCT00743652|19426343|P2|NOT COMPLETED|Overall Study||3
7894023|NCT00743652|19426344|P1|NOT COMPLETED|Overall Study||10
7894024|NCT00743652|19426340|P5|COMPLETED|Overall Study||79
7894025|NCT00743652|19426341|P4|COMPLETED|Overall Study||63
7894026|NCT00743652|19426342|P3|COMPLETED|Overall Study||23
7894027|NCT00743652|19426343|P2|COMPLETED|Overall Study||48
7894028|NCT00743652|19426344|P1|COMPLETED|Overall Study||141
7894029|NCT00743652|19426340|P5|Toddler Dose|Overall Study||0
7894030|NCT00743652|19426341|P4|Toddler Dose|Overall Study||0
7894031|NCT00743652|19426342|P3|Toddler Dose|Overall Study||16
7894032|NCT00743652|19426343|P2|Toddler Dose|Overall Study||23
7894033|NCT00743652|19426344|P1|Toddler Dose|Overall Study||15
7894034|NCT00743652|19426340|P5|Vaccinated Dose 3|Overall Study||0
7894035|NCT00743652|19426341|P4|Vaccinated Dose 3|Overall Study||0
7894036|NCT00743652|19426342|P3|Vaccinated Dose 3|Overall Study||0
7894037|NCT00743652|19426343|P2|Vaccinated Dose 3|Overall Study||0
7894038|NCT00743652|19426344|P1|Vaccinated Dose 3|Overall Study||74
7894039|NCT00743652|19426340|P5|Vaccinated Dose 2|Overall Study||0
7894040|NCT00743652|19426341|P4|Vaccinated Dose 2|Overall Study||49
7894041|NCT00743652|19426342|P3|Vaccinated Dose 2|Overall Study||0
7894042|NCT00743652|19426343|P2|Vaccinated Dose 2|Overall Study||41
7894043|NCT00743652|19426344|P1|Vaccinated Dose 2|Overall Study||112
7894044|NCT00743652|19426340|P5|Vaccinated Dose 1|Overall Study||79
7894045|NCT00743652|19426341|P4|Vaccinated Dose 1|Overall Study||66
7894046|NCT00743652|19426342|P3|Vaccinated Dose 1|Overall Study||25
7894047|NCT00743652|19426343|P2|Vaccinated Dose 1|Overall Study||51
7894048|NCT00743652|19426344|P1|Vaccinated Dose 1|Overall Study||151
7894049|NCT00743652|19426340|P5|STARTED|Overall Study||79
7894050|NCT00743652|19426341|P4|STARTED|Overall Study||67
7894051|NCT00743652|19426342|P3|STARTED|Overall Study||25
7894052|NCT00743652|19426343|P2|STARTED|Overall Study||51
7894053|NCT00743652|19426344|P1|STARTED|Overall Study||151
7894054|NCT00743574|19426419|P1|NOT COMPLETED|Overall Study||24
7894055|NCT00743574|19426419|P1|COMPLETED|Overall Study||12
7894056|NCT00743574|19426419|P1|Dropped Out After Initiating Trial|Overall Study||3
7894057|NCT00743574|19426419|P1|Further Exclusions|Overall Study||8
7894058|NCT00743574|19426419|P1|Dropped Out Before Eligibility Testing|Overall Study||13
7894059|NCT00743574|19426419|P1|STARTED|Overall Study||36
7894060|NCT00743509|19426428|P1|NOT COMPLETED|Overall Study||2
7894061|NCT00743509|19426428|P1|COMPLETED|Overall Study||47
7894062|NCT00743509|19426428|P1|STARTED|Overall Study||49
7894063|NCT00743483|19426433|P1|NOT COMPLETED|Treatment Period||1
7894064|NCT00743483|19426433|P1|COMPLETED|Treatment Period||13
7894065|NCT00743483|19426433|P1|STARTED|Treatment Period||14
7894066|NCT00743483|19426433|P1|NOT COMPLETED|Baseline Period||1
7894067|NCT00743483|19426433|P1|COMPLETED|Baseline Period||14
7894068|NCT00743483|19426433|P1|STARTED|Baseline Period||15
7894069|NCT00743444|19426437|P2|NOT COMPLETED|Second Intervention||0
7894070|NCT00743444|19426438|P1|NOT COMPLETED|Second Intervention||0
7894071|NCT00743444|19426437|P2|COMPLETED|Second Intervention||11
7894072|NCT00743444|19426438|P1|COMPLETED|Second Intervention||14
7894073|NCT00743444|19426437|P2|STARTED|Second Intervention||11
7894074|NCT00743444|19426438|P1|STARTED|Second Intervention||14
7894075|NCT00743444|19426437|P2|NOT COMPLETED|Washout Period||1
7894076|NCT00743444|19426438|P1|NOT COMPLETED|Washout Period||0
7894077|NCT00743444|19426437|P2|COMPLETED|Washout Period||11
7894078|NCT00743444|19426438|P1|COMPLETED|Washout Period||14
7894079|NCT00743444|19426437|P2|STARTED|Washout Period||12
7894080|NCT00743444|19426438|P1|STARTED|Washout Period||14
7894081|NCT00743444|19426437|P2|NOT COMPLETED|First Intervention||1
7894082|NCT00743444|19426438|P1|NOT COMPLETED|First Intervention||0
7894083|NCT00743444|19426437|P2|COMPLETED|First Intervention||12
7894084|NCT00743444|19426438|P1|COMPLETED|First Intervention||14
7894085|NCT00743444|19426437|P2|STARTED|First Intervention||13
7894086|NCT00743444|19426438|P1|STARTED|First Intervention||14
7894087|NCT00743431|19426447|P1|NOT COMPLETED|Overall Study||126
7894088|NCT00743431|19426447|P1|COMPLETED|Overall Study||98
7894089|NCT00743431|19426447|P1|STARTED|Overall Study||224
7894090|NCT00743366|19426451|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
7894091|NCT00743366|19426452|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
7894092|NCT00743366|19426451|P2|COMPLETED|Intervention 2 (8 Days)||7
7894093|NCT00743366|19426452|P1|COMPLETED|Intervention 2 (8 Days)||7
7894094|NCT00743366|19426451|P2|STARTED|Intervention 2 (8 Days)||7
7894095|NCT00743366|19426452|P1|STARTED|Intervention 2 (8 Days)||7
7894096|NCT00743366|19426451|P2|NOT COMPLETED|Intervention 1 (8 Days)||3
7894097|NCT00743366|19426452|P1|NOT COMPLETED|Intervention 1 (8 Days)||3
7894098|NCT00743366|19426451|P2|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
7894099|NCT00743366|19426452|P1|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
7894100|NCT00743366|19426451|P2|STARTED|Intervention 1 (8 Days)||10
7894101|NCT00743366|19426452|P1|STARTED|Intervention 1 (8 Days)||10
7894102|NCT00743340|19426458|P1|NOT COMPLETED|Overall Study||41
7894103|NCT00743340|19426458|P1|COMPLETED|Overall Study||9
7894104|NCT00743340|19426458|P1|STARTED|Overall Study||50
7894105|NCT00743288|19426462|P7|NOT COMPLETED|Overall Study||9
7894106|NCT00743288|19426463|P6|NOT COMPLETED|Overall Study||5
7894107|NCT00743288|19426464|P5|NOT COMPLETED|Overall Study||6
7894108|NCT00743288|19426465|P4|NOT COMPLETED|Overall Study||7
7894109|NCT00743288|19426466|P3|NOT COMPLETED|Overall Study||5
7894110|NCT00743288|19426467|P2|NOT COMPLETED|Overall Study||3
7894111|NCT00743288|19426468|P1|NOT COMPLETED|Overall Study||3
7894112|NCT00743288|19426462|P7|COMPLETED|Overall Study||0
7894113|NCT00743288|19426463|P6|COMPLETED|Overall Study||1
7894114|NCT00743288|19426464|P5|COMPLETED|Overall Study||0
7894115|NCT00743288|19426465|P4|COMPLETED|Overall Study||0
7894116|NCT00743288|19426466|P3|COMPLETED|Overall Study||1
7894117|NCT00743288|19426467|P2|COMPLETED|Overall Study||0
7894118|NCT00743288|19426468|P1|COMPLETED|Overall Study||0
7894119|NCT00743288|19426462|P7|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9
7894120|NCT00743288|19426463|P6|STARTED|Overall Study||6
7894121|NCT00743288|19426464|P5|STARTED|Overall Study||6
7894122|NCT00743288|19426465|P4|STARTED|Overall Study||7
7894123|NCT00743288|19426466|P3|STARTED|Overall Study||6
7894124|NCT00743288|19426467|P2|STARTED|Overall Study||3
7894125|NCT00743288|19426468|P1|STARTED|Overall Study||3
7894126|NCT00743275|19426482|P2|NOT COMPLETED|Overall Study||1
7894127|NCT00743275|19426483|P1|NOT COMPLETED|Overall Study||0
7894128|NCT00743275|19426482|P2|COMPLETED|Overall Study||60
7894129|NCT00743275|19426483|P1|COMPLETED|Overall Study||59
7894130|NCT00743275|19426482|P2|STARTED|Overall Study||61
7894131|NCT00743275|19426483|P1|STARTED|Overall Study||59
7894132|NCT00743262|19426495|P1|NOT COMPLETED|Overall Study||0
7894133|NCT00743262|19426495|P1|COMPLETED|Overall Study||15
7894134|NCT00743262|19426495|P1|STARTED|Overall Study||15
7894135|NCT00743249|19426503|P2|NOT COMPLETED|Overall Study||6
7894136|NCT00743249|19426504|P1|NOT COMPLETED|Overall Study||2
7894137|NCT00743249|19426503|P2|COMPLETED|Overall Study||24
7894138|NCT00743249|19426504|P1|COMPLETED|Overall Study||28
7894139|NCT00743249|19426503|P2|STARTED|Overall Study||30
7894140|NCT00743249|19426504|P1|STARTED|Overall Study||30
7894141|NCT00743197|19426514|P2|NOT COMPLETED|Overall Study||2
7894142|NCT00743197|19426515|P1|NOT COMPLETED|Overall Study||1
7894143|NCT00743197|19426514|P2|COMPLETED|Overall Study||0
7894144|NCT00743197|19426515|P1|COMPLETED|Overall Study||0
7894145|NCT00743197|19426514|P2|STARTED|Overall Study||2
7894146|NCT00743197|19426515|P1|STARTED|Overall Study||1
7894147|NCT00743145|19426521|P1|NOT COMPLETED|Overall Study||4
7894148|NCT00743145|19426521|P1|COMPLETED|Overall Study||19
7894149|NCT00743145|19426521|P1|STARTED|Overall Study||23
7894150|NCT00743119|19426535|P1|NOT COMPLETED|Overall Study||4
7894151|NCT00743119|19426535|P1|COMPLETED|Overall Study||30
7894152|NCT00743119|19426535|P1|STARTED|Overall Study||34
7894153|NCT00743106|19426549|P2|NOT COMPLETED|Overall Study||5
7894154|NCT00743106|19426550|P1|NOT COMPLETED|Overall Study||8
7894155|NCT00743106|19426549|P2|COMPLETED|Overall Study||43
7894156|NCT00743106|19426550|P1|COMPLETED|Overall Study||34
7894157|NCT00743106|19426549|P2|STARTED|Overall Study||48
7894158|NCT00743106|19426550|P1|STARTED|Overall Study||42
7894159|NCT00743093|19426560|P2|NOT COMPLETED|Extended Dosing Period||0
7894160|NCT00743093|19426561|P1|NOT COMPLETED|Extended Dosing Period||3
7894161|NCT00743093|19426560|P2|COMPLETED|Extended Dosing Period||1
7894162|NCT00743093|19426561|P1|COMPLETED|Extended Dosing Period||48
7894163|NCT00743093|19426560|P2|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1
7894164|NCT00743093|19426561|P1|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51
7894165|NCT00743093|19426560|P2|NOT COMPLETED|Base Study Period||5
7894166|NCT00743093|19426561|P1|NOT COMPLETED|Base Study Period||19
7894167|NCT00743093|19426560|P2|COMPLETED|Base Study Period||47
7894168|NCT00743093|19426561|P1|COMPLETED|Base Study Period||205
7894169|NCT00743093|19426560|P2|STARTED|Base Study Period||52
7894170|NCT00743093|19426561|P1|STARTED|Base Study Period||224
7894171|NCT00742963|19426569|P1|NOT COMPLETED|Overall Study||33
7894172|NCT00742963|19426569|P1|COMPLETED|Overall Study||68
7894173|NCT00742963|19426569|P1|Completed All Treatment Cycles|Overall Study||68
7894174|NCT00742963|19426569|P1|STARTED|Overall Study||101
7894175|NCT00742924|19426577|P4|NOT COMPLETED|Overall Study||6
7894176|NCT00742924|19426578|P3|NOT COMPLETED|Overall Study||4
7894177|NCT00742924|19426579|P2|NOT COMPLETED|Overall Study||2
7894178|NCT00742924|19426580|P1|NOT COMPLETED|Overall Study||5
7894179|NCT00742924|19426577|P4|COMPLETED|Overall Study||0
7894180|NCT00742924|19426578|P3|COMPLETED|Overall Study||2
7894181|NCT00742924|19426579|P2|COMPLETED|Overall Study||4
7894182|NCT00742924|19426580|P1|COMPLETED|Overall Study||1
7894183|NCT00742924|19426577|P4|STARTED|Overall Study||6
7894184|NCT00742924|19426578|P3|STARTED|Overall Study||6
7894185|NCT00742924|19426579|P2|STARTED|Overall Study||6
7894186|NCT00742924|19426580|P1|STARTED|Overall Study||6
7894187|NCT00742885|19426592|P2|NOT COMPLETED|Overall Study||0
7894188|NCT00742885|19426593|P1|NOT COMPLETED|Overall Study||1
7894189|NCT00742885|19426592|P2|COMPLETED|Overall Study|to Day 182|50
7894190|NCT00742885|19426593|P1|COMPLETED|Overall Study|to Day 182|49
7894191|NCT00742885|19426592|P2|STARTED|Overall Study||50
7894192|NCT00742885|19426593|P1|STARTED|Overall Study||50
7894193|NCT00742872|19426641|P2|NOT COMPLETED|Overall Study||8
7894194|NCT00742872|19426642|P1|NOT COMPLETED|Overall Study||12
7894195|NCT00742872|19426641|P2|COMPLETED|Overall Study||12
7894196|NCT00742872|19426642|P1|COMPLETED|Overall Study||9
7894197|NCT00742872|19426641|P2|STARTED|Overall Study||20
7894198|NCT00742872|19426642|P1|STARTED|Overall Study||21
7894199|NCT00742859|19426652|P4|NOT COMPLETED|Overall Study||8
7894200|NCT00742859|19426653|P3|NOT COMPLETED|Overall Study||11
7894201|NCT00742859|19426654|P2|NOT COMPLETED|Overall Study||12
7894202|NCT00742859|19426655|P1|NOT COMPLETED|Overall Study||11
7894203|NCT00742859|19426652|P4|COMPLETED|Overall Study||119
7894204|NCT00742859|19426653|P3|COMPLETED|Overall Study||116
7894205|NCT00742859|19426654|P2|COMPLETED|Overall Study||115
7894206|NCT00742859|19426655|P1|COMPLETED|Overall Study||116
7894207|NCT00742859|19426652|P4|STARTED|Overall Study||127
7894208|NCT00742859|19426653|P3|STARTED|Overall Study||127
7894209|NCT00742859|19426654|P2|STARTED|Overall Study||127
7894210|NCT00742859|19426655|P1|STARTED|Overall Study||127
7894211|NCT00742781|19426669|P1|NOT COMPLETED|Overall Study||3
7894212|NCT00742781|19426669|P1|COMPLETED|Overall Study||18
7894213|NCT00742781|19426669|P1|STARTED|Overall Study||21
7894214|NCT00742625|19426678|P1|NOT COMPLETED|Consolidation||21
7894215|NCT00742625|19426678|P1|COMPLETED|Consolidation||20
7894216|NCT00742625|19426678|P1|STARTED|Consolidation||41
7894217|NCT00742625|19426678|P1|NOT COMPLETED|Remission Induction||54
7894218|NCT00742625|19426678|P1|COMPLETED|Remission Induction||41
7894219|NCT00742625|19426678|P1|STARTED|Remission Induction||95
7894220|NCT00742573|19426689|P2|NOT COMPLETED|Overall Study||62
7894221|NCT00742573|19426690|P1|NOT COMPLETED|Overall Study||57
7894222|NCT00742573|19426689|P2|COMPLETED|Overall Study||25
7894223|NCT00742573|19426690|P1|COMPLETED|Overall Study||26
7894224|NCT00742573|19426689|P2|Week 52|Overall Study||25
7894225|NCT00742573|19426690|P1|Week 52|Overall Study||26
7894226|NCT00742573|19426689|P2|Week 24|Overall Study||37
7894227|NCT00742573|19426690|P1|Week 24|Overall Study||39
7894228|NCT00742573|19426689|P2|Week 12|Overall Study||51
7894229|NCT00742573|19426690|P1|Week 12|Overall Study||46
7894230|NCT00742573|19426689|P2|STARTED|Overall Study||87
7894231|NCT00742573|19426690|P1|STARTED|Overall Study||83
7894232|NCT00742560|19426703|P5|NOT COMPLETED|Overall Study||37
7894233|NCT00742560|19426704|P4|NOT COMPLETED|Overall Study||36
7894234|NCT00742560|19426705|P3|NOT COMPLETED|Overall Study||22
7894235|NCT00742560|19426706|P2|NOT COMPLETED|Overall Study||3
7894236|NCT00742560|19426707|P1|NOT COMPLETED|Overall Study||3
7894237|NCT00742560|19426703|P5|COMPLETED|Overall Study||0
7894238|NCT00742560|19426704|P4|COMPLETED|Overall Study||0
7894239|NCT00742560|19426705|P3|COMPLETED|Overall Study||0
7894240|NCT00742560|19426706|P2|COMPLETED|Overall Study||0
7894241|NCT00742560|19426707|P1|COMPLETED|Overall Study||0
7894242|NCT00742560|19426703|P5|STARTED|Overall Study||37
7894243|NCT00742560|19426704|P4|STARTED|Overall Study||36
7894244|NCT00742560|19426705|P3|STARTED|Overall Study||22
7894245|NCT00742560|19426706|P2|STARTED|Overall Study||3
7894246|NCT00742560|19426707|P1|STARTED|Overall Study||3
7894247|NCT00742508|19426781|P2|NOT COMPLETED|4-Week Exploratory Evaluation Period||1
7894248|NCT00742508|19426782|P1|NOT COMPLETED|4-Week Exploratory Evaluation Period||0
7894249|NCT00742508|19426781|P2|COMPLETED|4-Week Exploratory Evaluation Period||7
7894250|NCT00742508|19426782|P1|COMPLETED|4-Week Exploratory Evaluation Period||0
7894251|NCT00742508|19426781|P2|STARTED|4-Week Exploratory Evaluation Period||8
7894252|NCT00742508|19426782|P1|STARTED|4-Week Exploratory Evaluation Period||0
7894253|NCT00742508|19426781|P2|NOT COMPLETED|8-Week Primary Evaluation Period||11
7894254|NCT00742508|19426782|P1|NOT COMPLETED|8-Week Primary Evaluation Period||11
7894255|NCT00742508|19426781|P2|COMPLETED|8-Week Primary Evaluation Period||8
7894256|NCT00742508|19426782|P1|COMPLETED|8-Week Primary Evaluation Period||11
7894257|NCT00742508|19426781|P2|STARTED|8-Week Primary Evaluation Period||19
7894258|NCT00742508|19426782|P1|STARTED|8-Week Primary Evaluation Period||22
7894259|NCT00742469|19426846|P2|NOT COMPLETED|Overall Study||35
7894260|NCT00742469|19426847|P1|NOT COMPLETED|Overall Study||18
7894261|NCT00742469|19426846|P2|COMPLETED|Overall Study||69
7894262|NCT00742469|19426847|P1|COMPLETED|Overall Study||88
7894263|NCT00742469|19426846|P2|STARTED|Overall Study||104
7894264|NCT00742469|19426847|P1|STARTED|Overall Study||106
7894265|NCT00742417|19426855|P2|NOT COMPLETED|Maintenance II||0
7894266|NCT00742417|19426856|P1|NOT COMPLETED|Maintenance II||0
7894267|NCT00742417|19426855|P2|COMPLETED|Maintenance II||19
7894268|NCT00742417|19426856|P1|COMPLETED|Maintenance II||16
7894269|NCT00742417|19426855|P2|STARTED|Maintenance II||19
7894270|NCT00742417|19426856|P1|STARTED|Maintenance II||16
7894271|NCT00742417|19426855|P2|NOT COMPLETED|Maintenance I||0
7894272|NCT00742417|19426856|P1|NOT COMPLETED|Maintenance I||0
7894273|NCT00742417|19426855|P2|COMPLETED|Maintenance I||19
7894274|NCT00742417|19426856|P1|COMPLETED|Maintenance I||16
7894275|NCT00742417|19426855|P2|STARTED|Maintenance I||19
7894276|NCT00742417|19426856|P1|STARTED|Maintenance I||16
7894277|NCT00742417|19426855|P2|NOT COMPLETED|Intensive Period||1
7894278|NCT00742417|19426856|P1|NOT COMPLETED|Intensive Period||3
7894279|NCT00742417|19426855|P2|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19
7894280|NCT00742417|19426856|P1|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16
7894281|NCT00742417|19426855|P2|STARTED|Intensive Period||20
7894282|NCT00742417|19426856|P1|STARTED|Intensive Period||19
7894283|NCT00742417|19426855|P2|NOT COMPLETED|Randomized||1
7894284|NCT00742417|19426856|P1|NOT COMPLETED|Randomized||2
7894285|NCT00742417|19426855|P2|COMPLETED|Randomized||20
7894286|NCT00742417|19426856|P1|COMPLETED|Randomized||19
7894287|NCT00742417|19426855|P2|STARTED|Randomized||21
7894288|NCT00742417|19426856|P1|STARTED|Randomized||21
7894289|NCT00742391|19426880|P2|NOT COMPLETED|Overall Study||1
7894290|NCT00742391|19426881|P1|NOT COMPLETED|Overall Study||4
7894291|NCT00742391|19426880|P2|COMPLETED|Overall Study||128
7894292|NCT00742391|19426881|P1|COMPLETED|Overall Study||122
7894293|NCT00742391|19426880|P2|STARTED|Overall Study||129
7894294|NCT00742391|19426881|P1|STARTED|Overall Study||126
7894295|NCT00742326|19426891|P2|NOT COMPLETED|Overall Study||1
7894296|NCT00742326|19426892|P1|NOT COMPLETED|Overall Study||0
7894297|NCT00742326|19426891|P2|COMPLETED|Overall Study||6
7894298|NCT00742326|19426892|P1|COMPLETED|Overall Study||6
7894299|NCT00742326|19426891|P2|STARTED|Overall Study||7
7894300|NCT00742326|19426892|P1|STARTED|Overall Study||6
7894301|NCT00742313|19426902|P2|NOT COMPLETED|Overall Study||0
7894302|NCT00742313|19426903|P1|NOT COMPLETED|Overall Study||1
7894303|NCT00742313|19426902|P2|COMPLETED|Overall Study||19
7894304|NCT00742313|19426903|P1|COMPLETED|Overall Study||24
7894305|NCT00742313|19426902|P2|STARTED|Overall Study||19
7894306|NCT00742313|19426903|P1|STARTED|Overall Study||25
7894307|NCT00742274|19426911|P2|NOT COMPLETED|Overall Study||3
7894308|NCT00742274|19426912|P1|NOT COMPLETED|Overall Study||3
7894309|NCT00742274|19426911|P2|COMPLETED|Overall Study||28
7894310|NCT00742274|19426912|P1|COMPLETED|Overall Study||27
7894311|NCT00742274|19426911|P2|STARTED|Overall Study||31
7894312|NCT00742274|19426912|P1|STARTED|Overall Study||30
7894313|NCT00742235|19426920|P2|NOT COMPLETED|Overall Study||31
7894314|NCT00742235|19426921|P1|NOT COMPLETED|Overall Study||0
7894315|NCT00742235|19426920|P2|COMPLETED|Overall Study||36
7894316|NCT00742235|19426921|P1|COMPLETED|Overall Study||32
7894317|NCT00742235|19426920|P2|STARTED|Overall Study||67
7894318|NCT00742235|19426921|P1|STARTED|Overall Study||32
7894319|NCT00742209|19426934|P5|NOT COMPLETED|Overall Study||25
7894320|NCT00742209|19426935|P4|NOT COMPLETED|Overall Study||37
7894321|NCT00742209|19426936|P3|NOT COMPLETED|Overall Study||46
7894322|NCT00742209|19426937|P2|NOT COMPLETED|Overall Study||18
7894323|NCT00742209|19426938|P1|NOT COMPLETED|Overall Study||34
7894324|NCT00742209|19426934|P5|COMPLETED|Overall Study||37
7894325|NCT00742209|19426935|P4|COMPLETED|Overall Study||97
7894326|NCT00742209|19426936|P3|COMPLETED|Overall Study||88
7894327|NCT00742209|19426937|P2|COMPLETED|Overall Study||49
7894328|NCT00742209|19426938|P1|COMPLETED|Overall Study||95
7894329|NCT00742209|19426934|P5|STARTED|Overall Study||62
7894330|NCT00742209|19426935|P4|STARTED|Overall Study||134
7894331|NCT00742209|19426936|P3|STARTED|Overall Study||134
7894332|NCT00742209|19426937|P2|STARTED|Overall Study||67
7894333|NCT00742209|19426938|P1|STARTED|Overall Study||129
7894334|NCT00742183|19427041|P2|NOT COMPLETED|Overall Study||12
7894335|NCT00742183|19427042|P1|NOT COMPLETED|Overall Study||9
7894336|NCT00742183|19427041|P2|COMPLETED|Overall Study||39
7894337|NCT00742183|19427042|P1|COMPLETED|Overall Study||40
7894338|NCT00742183|19427041|P2|STARTED|Overall Study||51
7894339|NCT00742183|19427042|P1|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49
7894340|NCT00742170|19427050|P2|NOT COMPLETED|Overall Study||5
7894341|NCT00742170|19427051|P1|NOT COMPLETED|Overall Study||2
7894342|NCT00742170|19427050|P2|COMPLETED|Overall Study||24
7894343|NCT00742170|19427051|P1|COMPLETED|Overall Study||24
7894344|NCT00742170|19427050|P2|STARTED|Overall Study||29
7894345|NCT00742170|19427051|P1|STARTED|Overall Study||26
7894346|NCT00742079|19427061|P2|NOT COMPLETED|Overall Study||1
7894347|NCT00742079|19427062|P1|NOT COMPLETED|Overall Study||0
7894348|NCT00742079|19427061|P2|COMPLETED|Overall Study||9
7894349|NCT00742079|19427062|P1|COMPLETED|Overall Study||11
7894350|NCT00742079|19427061|P2|Week 2 (Received Dose 2)|Overall Study||9
7894351|NCT00742079|19427062|P1|Week 2 (Received Dose 2)|Overall Study||11
7894352|NCT00742079|19427061|P2|Baseline/Week 1 (Received Dose 1)|Overall Study||9
7894353|NCT00742079|19427062|P1|Baseline/Week 1 (Received Dose 1)|Overall Study||11
7894354|NCT00742079|19427061|P2|STARTED|Overall Study||10
7894355|NCT00742079|19427062|P1|STARTED|Overall Study||11
7894356|NCT00742053|19427076|P1|NOT COMPLETED|Overall Study||0
7894357|NCT00742053|19427076|P1|COMPLETED|Overall Study||7
7894358|NCT00742053|19427076|P1|STARTED|Overall Study||7
7894359|NCT00742001|19427083|P3|NOT COMPLETED|Overall Study||1
7894360|NCT00742001|19427084|P2|NOT COMPLETED|Overall Study||0
7894361|NCT00742001|19427085|P1|NOT COMPLETED|Overall Study||0
7894362|NCT00742001|19427083|P3|COMPLETED|Overall Study||3
7894363|NCT00742001|19427084|P2|COMPLETED|Overall Study||4
7894364|NCT00742001|19427085|P1|COMPLETED|Overall Study||4
7894365|NCT00742001|19427083|P3|STARTED|Overall Study||4
7894366|NCT00742001|19427084|P2|STARTED|Overall Study||4
7894367|NCT00742001|19427085|P1|STARTED|Overall Study||4
7894368|NCT00741988|19427101|P2|NOT COMPLETED|Overall Study||4
7894369|NCT00741988|19427102|P1|NOT COMPLETED|Overall Study||4
7894370|NCT00741988|19427101|P2|COMPLETED|Overall Study||36
7894371|NCT00741988|19427102|P1|COMPLETED|Overall Study||38
7894372|NCT00741988|19427101|P2|STARTED|Overall Study||40
7894373|NCT00741988|19427102|P1|STARTED|Overall Study||42
7894374|NCT00741936|19427114|P2|NOT COMPLETED|Overall Study||8
7894375|NCT00741936|19427115|P1|NOT COMPLETED|Overall Study||9
7894376|NCT00741936|19427114|P2|COMPLETED|Overall Study||52
7894377|NCT00741936|19427115|P1|COMPLETED|Overall Study||51
7894378|NCT00741936|19427114|P2|STARTED|Overall Study||60
7894379|NCT00741936|19427115|P1|STARTED|Overall Study||60
7894380|NCT00741858|19427143|P2|NOT COMPLETED|Overall Study||0
7894381|NCT00741858|19427144|P1|NOT COMPLETED|Overall Study||0
7894382|NCT00741858|19427143|P2|COMPLETED|Overall Study||18
7894383|NCT00741858|19427144|P1|COMPLETED|Overall Study||16
7894384|NCT00741858|19427143|P2|STARTED|Overall Study||18
7894385|NCT00741858|19427144|P1|STARTED|Overall Study||16
7894386|NCT00741819|19427150|P1|NOT COMPLETED|Overall Study||8
7894387|NCT00741819|19427150|P1|COMPLETED|Overall Study||65
7894388|NCT00741819|19427150|P1|STARTED|Overall Study||73
7894389|NCT00741611|19427164|P3|NOT COMPLETED|Overall Study||3
7894390|NCT00741611|19427165|P2|NOT COMPLETED|Overall Study||2
7894391|NCT00741611|19427166|P1|NOT COMPLETED|Overall Study||0
7894392|NCT00741611|19427164|P3|COMPLETED|Overall Study||26
7894393|NCT00741611|19427165|P2|COMPLETED|Overall Study||1
7894394|NCT00741611|19427166|P1|COMPLETED|Overall Study||4
7894395|NCT00741611|19427164|P3|STARTED|Overall Study||29
7894396|NCT00741611|19427165|P2|STARTED|Overall Study||3
7894397|NCT00741611|19427166|P1|STARTED|Overall Study||4
7894398|NCT00741598|19427185|P2|NOT COMPLETED|Overall Study||9
7894399|NCT00741598|19427186|P1|NOT COMPLETED|Overall Study||9
7894400|NCT00741598|19427185|P2|COMPLETED|Overall Study||30
7894401|NCT00741598|19427186|P1|COMPLETED|Overall Study||24
7894402|NCT00741598|19427185|P2|STARTED|Overall Study||39
7894403|NCT00741598|19427186|P1|STARTED|Overall Study||33
7894404|NCT00741468|19427200|P1|NOT COMPLETED|Overall Study||0
7894405|NCT00741468|19427200|P1|COMPLETED|Overall Study||18
7894406|NCT00741468|19427200|P1|STARTED|Overall Study||18
7894407|NCT00741455|19427208|P1|NOT COMPLETED|Overall Study||1
7894408|NCT00741455|19427208|P1|COMPLETED|Overall Study||17
7894409|NCT00741455|19427208|P1|STARTED|Overall Study||18
7894410|NCT00741390|19427217|P4|NOT COMPLETED|Visit 2||1
7894411|NCT00741390|19427218|P3|NOT COMPLETED|Visit 2||1
7894412|NCT00741390|19427219|P2|NOT COMPLETED|Visit 2||0
7894413|NCT00741390|19427220|P1|NOT COMPLETED|Visit 2||0
7894414|NCT00741390|19427217|P4|COMPLETED|Visit 2||60
7894415|NCT00741390|19427218|P3|COMPLETED|Visit 2||54
7894416|NCT00741390|19427219|P2|COMPLETED|Visit 2||61
7894417|NCT00741390|19427220|P1|COMPLETED|Visit 2||59
7894418|NCT00741390|19427217|P4|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61
7894419|NCT00741390|19427218|P3|STARTED|Visit 2||55
7894420|NCT00741390|19427219|P2|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61
7894421|NCT00741390|19427220|P1|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59
7894422|NCT00741390|19427217|P4|NOT COMPLETED|Visit 1||1
7894423|NCT00741390|19427218|P3|NOT COMPLETED|Visit 1||7
7894424|NCT00741390|19427219|P2|NOT COMPLETED|Visit 1||0
7894425|NCT00741390|19427220|P1|NOT COMPLETED|Visit 1||2
7894426|NCT00741390|19427217|P4|COMPLETED|Visit 1||62
7894427|NCT00741390|19427218|P3|COMPLETED|Visit 1||55
7894428|NCT00741390|19427219|P2|COMPLETED|Visit 1||63
7894429|NCT00741390|19427220|P1|COMPLETED|Visit 1||60
7894430|NCT00741390|19427217|P4|STARTED|Visit 1||63
7894431|NCT00741390|19427218|P3|STARTED|Visit 1||62
7894432|NCT00741390|19427219|P2|STARTED|Visit 1||63
7894433|NCT00741390|19427220|P1|STARTED|Visit 1||62
7894434|NCT00741338|19427241|P2|NOT COMPLETED|Overall Study||1
7894435|NCT00741338|19427242|P1|NOT COMPLETED|Overall Study||0
7894436|NCT00741338|19427241|P2|COMPLETED|Overall Study||2
7894437|NCT00741338|19427242|P1|COMPLETED|Overall Study||3
7894438|NCT00741338|19427241|P2|STARTED|Overall Study||3
7894439|NCT00741338|19427242|P1|STARTED|Overall Study||3
7894440|NCT00741286|19427252|P2|NOT COMPLETED|Overall Study||19
7894441|NCT00741286|19427253|P1|NOT COMPLETED|Overall Study||20
7894442|NCT00741286|19427252|P2|COMPLETED|Overall Study||81
7894443|NCT00741286|19427253|P1|COMPLETED|Overall Study||83
7894444|NCT00741286|19427252|P2|STARTED|Overall Study||100
7894445|NCT00741286|19427253|P1|STARTED|Overall Study||103
7894446|NCT00741273|19427263|P2|NOT COMPLETED|Overall Study||0
7894447|NCT00741273|19427264|P1|NOT COMPLETED|Overall Study||0
7894448|NCT00741273|19427263|P2|COMPLETED|Overall Study||8
7894449|NCT00741273|19427264|P1|COMPLETED|Overall Study||8
7894450|NCT00741273|19427263|P2|STARTED|Overall Study||8
7894451|NCT00741273|19427264|P1|STARTED|Overall Study||8
7894452|NCT00741260|19427287|P7|NOT COMPLETED|Overall Study||7
7894453|NCT00741260|19427288|P6|NOT COMPLETED|Overall Study||45
7894454|NCT00741260|19427289|P5|NOT COMPLETED|Overall Study||9
7894455|NCT00741260|19427290|P4|NOT COMPLETED|Overall Study||6
7894456|NCT00741260|19427291|P3|NOT COMPLETED|Overall Study||4
7894457|NCT00741260|19427292|P2|NOT COMPLETED|Overall Study||8
7894458|NCT00741260|19427293|P1|NOT COMPLETED|Overall Study||6
7894459|NCT00741260|19427287|P7|COMPLETED|Overall Study||0
7894460|NCT00741260|19427288|P6|COMPLETED|Overall Study||20
7894461|NCT00741260|19427289|P5|COMPLETED|Overall Study||0
7894462|NCT00741260|19427290|P4|COMPLETED|Overall Study||0
7894463|NCT00741260|19427291|P3|COMPLETED|Overall Study||0
7894464|NCT00741260|19427292|P2|COMPLETED|Overall Study||0
7894465|NCT00741260|19427293|P1|COMPLETED|Overall Study||0
7894466|NCT00741260|19427287|P7|STARTED|Overall Study||7
7894467|NCT00741260|19427288|P6|STARTED|Overall Study||65
7894468|NCT00741260|19427289|P5|STARTED|Overall Study||9
7894469|NCT00741260|19427290|P4|STARTED|Overall Study||6
7894470|NCT00741260|19427291|P3|STARTED|Overall Study||4
7894471|NCT00741260|19427292|P2|STARTED|Overall Study||8
7894472|NCT00741260|19427293|P1|STARTED|Overall Study||6
7894473|NCT00741156|19427320|P1|NOT COMPLETED|Overall Study||0
7894474|NCT00741156|19427320|P1|COMPLETED|Overall Study||12
7894475|NCT00741156|19427320|P1|STARTED|Overall Study||12
7894476|NCT00741104|19427335|P1|NOT COMPLETED|Overall Study||0
7894477|NCT00741104|19427335|P1|COMPLETED|Overall Study||363
7894478|NCT00741104|19427335|P1|STARTED|Overall Study||363
7894479|NCT00741091|19427342|P1|NOT COMPLETED|Overall Study||57
7894480|NCT00741091|19427342|P1|COMPLETED|Overall Study||1040
7894481|NCT00741091|19427342|P1|STARTED|Overall Study||1097
7894482|NCT00741039|19427352|P2|NOT COMPLETED|Overall Study||0
7894483|NCT00741039|19427353|P1|NOT COMPLETED|Overall Study||2
7894484|NCT00741039|19427352|P2|COMPLETED|Overall Study||25
7894485|NCT00741039|19427353|P1|COMPLETED|Overall Study||100
7894486|NCT00741039|19427352|P2|STARTED|Overall Study||25
7894487|NCT00741039|19427353|P1|STARTED|Overall Study||102
7894488|NCT00741026|19427359|P1|NOT COMPLETED|Overall Study||0
7894489|NCT00741026|19427359|P1|COMPLETED|Overall Study||15
7894490|NCT00741026|19427359|P1|STARTED|Overall Study||15
7894491|NCT00741013|19427390|P3|NOT COMPLETED|Overall Study||1
7894492|NCT00741013|19427391|P2|NOT COMPLETED|Overall Study||2
7894493|NCT00741013|19427392|P1|NOT COMPLETED|Overall Study||1
7894494|NCT00741013|19427390|P3|COMPLETED|Overall Study||6
7894495|NCT00741013|19427391|P2|COMPLETED|Overall Study||6
7894496|NCT00741013|19427392|P1|COMPLETED|Overall Study||6
7894497|NCT00741013|19427390|P3|STARTED|Overall Study||7
7894498|NCT00741013|19427391|P2|STARTED|Overall Study||8
7894499|NCT00741013|19427392|P1|STARTED|Overall Study||7
7894500|NCT00740870|19427403|P1|NOT COMPLETED|Overall Study||21
7894501|NCT00740870|19427403|P1|COMPLETED|Overall Study||150
7894502|NCT00740870|19427403|P1|STARTED|Overall Study||171
7894503|NCT00740857|19427418|P3|NOT COMPLETED|Overall Study||0
7894504|NCT00740857|19427419|P2|NOT COMPLETED|Overall Study||0
7894505|NCT00740857|19427420|P1|NOT COMPLETED|Overall Study||1
7894506|NCT00740857|19427418|P3|COMPLETED|Overall Study||90
7894507|NCT00740857|19427419|P2|COMPLETED|Overall Study||88
7894508|NCT00740857|19427420|P1|COMPLETED|Overall Study||32
7894509|NCT00740857|19427418|P3|STARTED|Overall Study||90
7894510|NCT00740857|19427419|P2|STARTED|Overall Study||88
7894511|NCT00740857|19427420|P1|STARTED|Overall Study||33
7894512|NCT00740831|19427452|P3|NOT COMPLETED|Overall Study||6
7894513|NCT00740831|19427453|P2|NOT COMPLETED|Overall Study||3
7894514|NCT00740831|19427454|P1|NOT COMPLETED|Overall Study||4
7894515|NCT00740831|19427452|P3|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95
7894516|NCT00740831|19427453|P2|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100
7894517|NCT00740831|19427454|P1|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93
7894518|NCT00740831|19427452|P3|STARTED|Overall Study|Safety population|101
7894519|NCT00740831|19427453|P2|STARTED|Overall Study|Safety population|103
7894520|NCT00740831|19427454|P1|STARTED|Overall Study|Safety population|97
7894521|NCT00740792|19427475|P4|NOT COMPLETED|Overall Study||10
7894522|NCT00740792|19427476|P3|NOT COMPLETED|Overall Study||9
7894523|NCT00740792|19427477|P2|NOT COMPLETED|Overall Study||8
7894524|NCT00740792|19427478|P1|NOT COMPLETED|Overall Study||10
7894525|NCT00740792|19427475|P4|COMPLETED|Overall Study||190
7894526|NCT00740792|19427476|P3|COMPLETED|Overall Study||180
7894527|NCT00740792|19427477|P2|COMPLETED|Overall Study||186
7894528|NCT00740792|19427478|P1|COMPLETED|Overall Study||183
7894529|NCT00740792|19427475|P4|STARTED|Overall Study||200
7894530|NCT00740792|19427476|P3|STARTED|Overall Study||189
7894531|NCT00740792|19427477|P2|STARTED|Overall Study||194
7894532|NCT00740792|19427478|P1|STARTED|Overall Study||193
7894533|NCT00740779|19427499|P3|NOT COMPLETED|Overall Study||13
7894534|NCT00740779|19427500|P2|NOT COMPLETED|Overall Study||14
7894535|NCT00740779|19427501|P1|NOT COMPLETED|Overall Study||9
7894536|NCT00740779|19427499|P3|COMPLETED|Overall Study||41
7894537|NCT00740779|19427500|P2|COMPLETED|Overall Study||31
7894538|NCT00740779|19427501|P1|COMPLETED|Overall Study||43
7894539|NCT00740779|19427499|P3|STARTED|Overall Study||54
7894540|NCT00740779|19427500|P2|STARTED|Overall Study||45
7894541|NCT00740779|19427501|P1|STARTED|Overall Study||52
7894542|NCT00740727|19427509|P1|NOT COMPLETED|Overall Study||0
7894543|NCT00740727|19427509|P1|COMPLETED|Overall Study||18
7894544|NCT00740727|19427509|P1|STARTED|Overall Study||18
7894545|NCT00740714|19427518|P3|NOT COMPLETED|Overall Study||29
7894546|NCT00740714|19427519|P2|NOT COMPLETED|Overall Study||19
7894547|NCT00740714|19427520|P1|NOT COMPLETED|Overall Study||17
7894548|NCT00740714|19427518|P3|COMPLETED|Overall Study||174
7894549|NCT00740714|19427519|P2|COMPLETED|Overall Study||182
7894550|NCT00740714|19427520|P1|COMPLETED|Overall Study||179
7894551|NCT00740714|19427518|P3|Active Patients at Study Termination|Overall Study||33
7894552|NCT00740714|19427519|P2|Active Patients at Study Termination|Overall Study||12
7894553|NCT00740714|19427520|P1|Active Patients at Study Termination|Overall Study||24
7894554|NCT00740714|19427518|P3|Reaching Endpoint Before May 6, 2011|Overall Study||94
7894555|NCT00740714|19427519|P2|Reaching Endpoint Before May 6, 2011|Overall Study||87
7894556|NCT00740714|19427520|P1|Reaching Endpoint Before May 6, 2011|Overall Study||86
7894557|NCT00740714|19427518|P3|STARTED|Overall Study|Randomized throughout the recruitment period|203
7894558|NCT00740714|19427519|P2|STARTED|Overall Study|Randomized throughout the recruitment period|201
7894559|NCT00740714|19427520|P1|STARTED|Overall Study|Randomized throughout the recruitment period|196
7894560|NCT00740636|19427596|P2|NOT COMPLETED|Overall Study||4
7894561|NCT00740636|19427597|P1|NOT COMPLETED|Overall Study||2
7894562|NCT00740636|19427596|P2|COMPLETED|Overall Study||63
7894563|NCT00740636|19427597|P1|COMPLETED|Overall Study||23
7894564|NCT00740636|19427596|P2|STARTED|Overall Study||67
7894565|NCT00740636|19427597|P1|STARTED|Overall Study||25
7894566|NCT00740597|19427603|P1|NOT COMPLETED|Overall Study||1
7894567|NCT00740597|19427603|P1|COMPLETED|Overall Study||0
7894568|NCT00740597|19427603|P1|STARTED|Overall Study||1
7894569|NCT00740584|19427607|P1|NOT COMPLETED|Overall Study||1
7894570|NCT00740584|19427607|P1|COMPLETED|Overall Study||11
7894571|NCT00740584|19427607|P1|STARTED|Overall Study||12
7894572|NCT00740480|19427612|P1|NOT COMPLETED|Overall Study||2
7894573|NCT00740480|19427612|P1|COMPLETED|Overall Study||23
7894574|NCT00740480|19427612|P1|STARTED|Overall Study||25
7894575|NCT00740376|19427618|P2|NOT COMPLETED|Overall Study||3
7894576|NCT00740376|19427619|P1|NOT COMPLETED|Overall Study||3
7894577|NCT00740376|19427618|P2|COMPLETED|Overall Study||12
7894578|NCT00740376|19427619|P1|COMPLETED|Overall Study||19
7894579|NCT00740376|19427618|P2|STARTED|Overall Study||15
7894580|NCT00740376|19427619|P1|STARTED|Overall Study||22
7894581|NCT00740220|19427637|P1|NOT COMPLETED|Overall Study||9
7894582|NCT00740220|19427637|P1|COMPLETED|Overall Study||88
7894583|NCT00740220|19427637|P1|STARTED|Overall Study||97
7894584|NCT00740207|19427643|P2|NOT COMPLETED|Overall Study||0
7894585|NCT00740207|19427644|P1|NOT COMPLETED|Overall Study||0
7894586|NCT00740207|19427643|P2|COMPLETED|Overall Study||16
7894587|NCT00740207|19427644|P1|COMPLETED|Overall Study||17
7894588|NCT00740207|19427643|P2|STARTED|Overall Study||16
7894589|NCT00740207|19427644|P1|STARTED|Overall Study||17
7894590|NCT00740181|19427656|P1|NOT COMPLETED|Overall Study||0
7894591|NCT00740181|19427656|P1|COMPLETED|Overall Study||9
7894592|NCT00740181|19427656|P1|STARTED|Overall Study||9
7894593|NCT00740051|19427662|P2|NOT COMPLETED|Overall Study||32
7894594|NCT00740051|19427663|P1|NOT COMPLETED|Overall Study||18
7894595|NCT00740051|19427662|P2|COMPLETED|Overall Study||119
7894596|NCT00740051|19427663|P1|COMPLETED|Overall Study||58
7894597|NCT00740051|19427662|P2|STARTED|Overall Study||151
7894598|NCT00740051|19427663|P1|STARTED|Overall Study||76
7894599|NCT00739999|19427685|P2|NOT COMPLETED|Overall Study||0
7894600|NCT00739999|19427686|P1|NOT COMPLETED|Overall Study||0
7894601|NCT00739999|19427685|P2|COMPLETED|Overall Study||24
7894602|NCT00739999|19427686|P1|COMPLETED|Overall Study||15
7894603|NCT00739999|19427685|P2|STARTED|Overall Study||24
7894604|NCT00739999|19427686|P1|STARTED|Overall Study||15
7894605|NCT00739973|19427766|P9|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14
7894606|NCT00739973|19427767|P8|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10
7894607|NCT00739973|19427768|P7|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13
7894608|NCT00739973|19427769|P6|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
7894609|NCT00739973|19427770|P5|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
7894610|NCT00739973|19427771|P4|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
7894611|NCT00739973|19427772|P3|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
7894612|NCT00739973|19427773|P2|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20
7894613|NCT00739973|19427774|P1|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30
7894614|NCT00739973|19427766|P9|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
7894615|NCT00739973|19427767|P8|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
7894616|NCT00739973|19427768|P7|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
7894617|NCT00739973|19427769|P6|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169
7894618|NCT00739973|19427770|P5|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162
7894619|NCT00739973|19427771|P4|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173
7894620|NCT00739973|19427772|P3|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184
7894621|NCT00739973|19427773|P2|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175
7894622|NCT00739973|19427774|P1|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
7894623|NCT00739973|19427766|P9|STARTED|Double-blind:Randomized Period (8 Weeks)||184
7894624|NCT00739973|19427767|P8|STARTED|Double-blind:Randomized Period (8 Weeks)||178
7894625|NCT00739973|19427768|P7|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183
7894626|NCT00739973|19427769|P6|STARTED|Double-blind:Randomized Period (8 Weeks)||181
7894627|NCT00739973|19427770|P5|STARTED|Double-blind:Randomized Period (8 Weeks)||181
7894628|NCT00739973|19427771|P4|STARTED|Double-blind:Randomized Period (8 Weeks)||185
7894629|NCT00739973|19427772|P3|STARTED|Double-blind:Randomized Period (8 Weeks)||203
7894630|NCT00739973|19427773|P2|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195
7894631|NCT00739973|19427774|P1|STARTED|Double-blind:Randomized Period (8 Weeks)||198
7894632|NCT00739973|19427766|P9|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
7894633|NCT00739973|19427767|P8|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
7894634|NCT00739973|19427768|P7|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
7894635|NCT00739973|19427769|P6|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
7894636|NCT00739973|19427770|P5|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
7894637|NCT00739973|19427771|P4|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
7894638|NCT00739973|19427772|P3|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
7894639|NCT00739973|19427773|P2|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
7894640|NCT00739973|19427774|P1|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009
7894641|NCT00739973|19427766|P9|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
7894642|NCT00739973|19427767|P8|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
7894643|NCT00739973|19427768|P7|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
7894644|NCT00739973|19427769|P6|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
7894645|NCT00739973|19427770|P5|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
7894646|NCT00739973|19427771|P4|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
7894647|NCT00739973|19427772|P3|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
7894648|NCT00739973|19427773|P2|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
7894649|NCT00739973|19427774|P1|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685
7894650|NCT00739973|19427766|P9|STARTED|Single-blind Period (2 to 4 Weeks)||0
7894651|NCT00739973|19427767|P8|STARTED|Single-blind Period (2 to 4 Weeks)||0
7894652|NCT00739973|19427768|P7|STARTED|Single-blind Period (2 to 4 Weeks)||0
7894653|NCT00739973|19427769|P6|STARTED|Single-blind Period (2 to 4 Weeks)||0
7894654|NCT00739973|19427770|P5|STARTED|Single-blind Period (2 to 4 Weeks)||0
7894655|NCT00739973|19427771|P4|STARTED|Single-blind Period (2 to 4 Weeks)||0
7894656|NCT00739973|19427772|P3|STARTED|Single-blind Period (2 to 4 Weeks)||0
7894657|NCT00739973|19427773|P2|STARTED|Single-blind Period (2 to 4 Weeks)||0
7894658|NCT00739973|19427774|P1|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694
7894659|NCT00739960|19427860|P1|NOT COMPLETED|Overall Study||0
7894660|NCT00739960|19427860|P1|COMPLETED|Overall Study||1
7894661|NCT00739960|19427860|P1|STARTED|Overall Study||1
7894662|NCT00739934|19427865|P1|NOT COMPLETED|Voriconazole Oral||3
7894663|NCT00739934|19427865|P1|COMPLETED|Voriconazole Oral||31
7894664|NCT00739934|19427865|P1|STARTED|Voriconazole Oral||34
7894665|NCT00739934|19427865|P1|NOT COMPLETED|Voriconazole IV||6
7894666|NCT00739934|19427865|P1|COMPLETED|Voriconazole IV||34
7894667|NCT00739934|19427865|P1|STARTED|Voriconazole IV||40
7894668|NCT00739908|19427887|P2|NOT COMPLETED|Overall Study||25
7894669|NCT00739908|19427888|P1|NOT COMPLETED|Overall Study||25
7894670|NCT00739908|19427887|P2|COMPLETED|Overall Study||118
7894671|NCT00739908|19427888|P1|COMPLETED|Overall Study||117
7894672|NCT00739908|19427887|P2|STARTED|Overall Study||143
7894673|NCT00739908|19427888|P1|STARTED|Overall Study||142
7894674|NCT00739882|19427908|P2|NOT COMPLETED|Open-label Period||5
7894675|NCT00739882|19427909|P1|NOT COMPLETED|Open-label Period||10
7894676|NCT00739882|19427908|P2|COMPLETED|Open-label Period||9
7894677|NCT00739882|19427909|P1|COMPLETED|Open-label Period||7
7894678|NCT00739882|19427908|P2|STARTED|Open-label Period||14
7894679|NCT00739882|19427909|P1|STARTED|Open-label Period||17
7894680|NCT00739882|19427908|P2|NOT COMPLETED|Double-blind Period||11
7894681|NCT00739882|19427909|P1|NOT COMPLETED|Double-blind Period||19
7894682|NCT00739882|19427908|P2|COMPLETED|Double-blind Period||14
7894683|NCT00739882|19427909|P1|COMPLETED|Double-blind Period||32
7894684|NCT00739882|19427908|P2|STARTED|Double-blind Period||25
7894685|NCT00739882|19427909|P1|STARTED|Double-blind Period||51
7894686|NCT00739765|19427930|P3|NOT COMPLETED|Overall Study||11
7894687|NCT00739765|19427931|P2|NOT COMPLETED|Overall Study||11
7894688|NCT00739765|19427932|P1|NOT COMPLETED|Overall Study||6
7894689|NCT00739765|19427930|P3|COMPLETED|Overall Study||21
7894690|NCT00739765|19427931|P2|COMPLETED|Overall Study||27
7894691|NCT00739765|19427932|P1|COMPLETED|Overall Study||34
7894692|NCT00739765|19427930|P3|STARTED|Overall Study||32
7894693|NCT00739765|19427931|P2|STARTED|Overall Study||38
7894694|NCT00739765|19427932|P1|STARTED|Overall Study||40
7894695|NCT00739752|19427949|P6|NOT COMPLETED|Overall Study||0
7894696|NCT00739752|19427950|P5|NOT COMPLETED|Overall Study||0
7894697|NCT00739752|19427951|P4|NOT COMPLETED|Overall Study||0
7894698|NCT00739752|19427952|P3|NOT COMPLETED|Overall Study||0
7894699|NCT00739752|19427953|P2|NOT COMPLETED|Overall Study||0
7894700|NCT00739752|19427954|P1|NOT COMPLETED|Overall Study||0
7894701|NCT00739752|19427949|P6|COMPLETED|Overall Study||293
7894702|NCT00739752|19427950|P5|COMPLETED|Overall Study||291
7894703|NCT00739752|19427951|P4|COMPLETED|Overall Study||288
7894704|NCT00739752|19427952|P3|COMPLETED|Overall Study||292
7894705|NCT00739752|19427953|P2|COMPLETED|Overall Study||284
7894706|NCT00739752|19427954|P1|COMPLETED|Overall Study||299
7894707|NCT00739752|19427949|P6|STARTED|Overall Study||293
7894708|NCT00739752|19427950|P5|STARTED|Overall Study||291
7894709|NCT00739752|19427951|P4|STARTED|Overall Study||288
7894710|NCT00739752|19427952|P3|STARTED|Overall Study||292
7894711|NCT00739752|19427953|P2|STARTED|Overall Study||284
7894712|NCT00739752|19427954|P1|STARTED|Overall Study||299
7894713|NCT00739674|19427970|P2|NOT COMPLETED|Overall Study||122
7894714|NCT00739674|19427971|P1|NOT COMPLETED|Overall Study||181
7894715|NCT00739674|19427970|P2|COMPLETED|Overall Study||335
7894716|NCT00739674|19427971|P1|COMPLETED|Overall Study||354
7894717|NCT00739674|19427970|P2|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400
7894718|NCT00739674|19427971|P1|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463
7894719|NCT00739674|19427970|P2|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9
7894720|NCT00739674|19427971|P1|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1
7894721|NCT00739674|19427970|P2|No Follow-up Data|Overall Study||18
7894722|NCT00739674|19427971|P1|No Follow-up Data|Overall Study||33
7894723|NCT00739674|19427970|P2|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13
7894724|NCT00739674|19427971|P1|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19
7894725|NCT00739674|19427970|P2|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17
7894726|NCT00739674|19427971|P1|Screening Failures|Overall Study||19
7894727|NCT00739674|19427970|P2|STARTED|Overall Study||457
7894728|NCT00739674|19427971|P1|STARTED|Overall Study||535
7894729|NCT00739661|19427999|P2|NOT COMPLETED|Overall Study||42
7894730|NCT00739661|19428000|P1|NOT COMPLETED|Overall Study||46
7894731|NCT00739661|19427999|P2|COMPLETED|Overall Study||10
7894732|NCT00739661|19428000|P1|COMPLETED|Overall Study||6
7894733|NCT00739661|19427999|P2|STARTED|Overall Study||52
7894734|NCT00739661|19428000|P1|STARTED|Overall Study||52
7894735|NCT00739648|19428012|P2|NOT COMPLETED|Overall Study||53
7894736|NCT00739648|19428013|P1|NOT COMPLETED|Overall Study||26
7894737|NCT00739648|19428012|P2|COMPLETED|Overall Study||161
7894738|NCT00739648|19428013|P1|COMPLETED|Overall Study||82
7894739|NCT00739648|19428012|P2|STARTED|Overall Study||214
7894740|NCT00739648|19428013|P1|STARTED|Overall Study||108
7894741|NCT00739596|19428027|P2|NOT COMPLETED|Overall Study||17
7894742|NCT00739596|19428028|P1|NOT COMPLETED|Overall Study||25
7894743|NCT00739596|19428027|P2|COMPLETED|Overall Study||149
7894744|NCT00739596|19428028|P1|COMPLETED|Overall Study||141
7894745|NCT00739596|19428027|P2|STARTED|Overall Study||166
7894746|NCT00739596|19428028|P1|STARTED|Overall Study||166
7894747|NCT00739583|19428044|P2|NOT COMPLETED|Overall Study||0
7894748|NCT00739583|19428045|P1|NOT COMPLETED|Overall Study||0
7894749|NCT00739583|19428044|P2|COMPLETED|Overall Study||10
7894750|NCT00739583|19428045|P1|COMPLETED|Overall Study||10
7894751|NCT00739583|19428044|P2|STARTED|Overall Study||10
7894752|NCT00739583|19428045|P1|STARTED|Overall Study||10
7894753|NCT00739336|19428057|P2|NOT COMPLETED|Overall Study||0
7894754|NCT00739336|19428058|P1|NOT COMPLETED|Overall Study||4
7894755|NCT00739336|19428057|P2|COMPLETED|Overall Study||24
7894756|NCT00739336|19428058|P1|COMPLETED|Overall Study||17
7894757|NCT00739336|19428057|P2|STARTED|Overall Study||24
7894758|NCT00739336|19428058|P1|STARTED|Overall Study||21
7894759|NCT00739310|19428070|P1|NOT COMPLETED|Overall Study||7
7894760|NCT00739310|19428070|P1|COMPLETED|Overall Study||22
7894761|NCT00739310|19428070|P1|STARTED|Overall Study||29
7894762|NCT00739297|19428075|P7|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
7894763|NCT00739297|19428076|P6|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
7894764|NCT00739297|19428077|P5|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
7894765|NCT00739297|19428078|P4|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
7894766|NCT00739297|19428079|P3|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
7894767|NCT00739297|19428080|P2|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
7894768|NCT00739297|19428081|P1|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
7894769|NCT00739297|19428075|P7|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65
7894770|NCT00739297|19428076|P6|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
7894771|NCT00739297|19428077|P5|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7
7894772|NCT00739297|19428078|P4|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15
7894773|NCT00739297|19428079|P3|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
7894774|NCT00739297|19428080|P2|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11
7894775|NCT00739297|19428081|P1|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16
7894776|NCT00739297|19428075|P7|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66
7894777|NCT00739297|19428076|P6|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9
7894778|NCT00739297|19428077|P5|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7
7894779|NCT00739297|19428078|P4|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15
7894780|NCT00739297|19428079|P3|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8
7894781|NCT00739297|19428080|P2|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11
7894782|NCT00739297|19428081|P1|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16
7894783|NCT00739297|19428075|P7|NOT COMPLETED|Third Washout Period of 4-7 Days||0
7894784|NCT00739297|19428076|P6|NOT COMPLETED|Third Washout Period of 4-7 Days||0
7894785|NCT00739297|19428077|P5|NOT COMPLETED|Third Washout Period of 4-7 Days||0
7894786|NCT00739297|19428078|P4|NOT COMPLETED|Third Washout Period of 4-7 Days||0
7894787|NCT00739297|19428079|P3|NOT COMPLETED|Third Washout Period of 4-7 Days||0
7894788|NCT00739297|19428080|P2|NOT COMPLETED|Third Washout Period of 4-7 Days||0
7894789|NCT00739297|19428081|P1|NOT COMPLETED|Third Washout Period of 4-7 Days||0
7894790|NCT00739297|19428075|P7|COMPLETED|Third Washout Period of 4-7 Days||66
7894791|NCT00739297|19428076|P6|COMPLETED|Third Washout Period of 4-7 Days||8
7894792|NCT00739297|19428077|P5|COMPLETED|Third Washout Period of 4-7 Days||6
7894793|NCT00739297|19428078|P4|COMPLETED|Third Washout Period of 4-7 Days||18
7894794|NCT00739297|19428079|P3|COMPLETED|Third Washout Period of 4-7 Days||6
7894795|NCT00739297|19428080|P2|COMPLETED|Third Washout Period of 4-7 Days||12
7894796|NCT00739297|19428081|P1|COMPLETED|Third Washout Period of 4-7 Days||16
7894797|NCT00739297|19428075|P7|STARTED|Third Washout Period of 4-7 Days||66
7894798|NCT00739297|19428076|P6|STARTED|Third Washout Period of 4-7 Days||8
7894799|NCT00739297|19428077|P5|STARTED|Third Washout Period of 4-7 Days||6
7894800|NCT00739297|19428078|P4|STARTED|Third Washout Period of 4-7 Days||18
7894801|NCT00739297|19428079|P3|STARTED|Third Washout Period of 4-7 Days||6
7894802|NCT00739297|19428080|P2|STARTED|Third Washout Period of 4-7 Days||12
7894803|NCT00739297|19428081|P1|STARTED|Third Washout Period of 4-7 Days||16
7894804|NCT00739297|19428075|P7|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
7894805|NCT00739297|19428076|P6|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
7894806|NCT00739297|19428077|P5|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
7894807|NCT00739297|19428078|P4|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
7894808|NCT00739297|19428079|P3|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
7894809|NCT00739297|19428080|P2|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
7894810|NCT00739297|19428081|P1|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
7894976|NCT00738543|19428247|P1|COMPLETED|Povidone Iodine||48
7894811|NCT00739297|19428075|P7|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66
7894812|NCT00739297|19428076|P6|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8
7894813|NCT00739297|19428077|P5|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
7894814|NCT00739297|19428078|P4|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18
7894815|NCT00739297|19428079|P3|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
7894816|NCT00739297|19428080|P2|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12
7894817|NCT00739297|19428081|P1|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16
7894818|NCT00739297|19428075|P7|STARTED|Third Intervention (Visit 7 to Visit 8)||66
7894819|NCT00739297|19428076|P6|STARTED|Third Intervention (Visit 7 to Visit 8)||8
7894820|NCT00739297|19428077|P5|STARTED|Third Intervention (Visit 7 to Visit 8)||6
7894821|NCT00739297|19428078|P4|STARTED|Third Intervention (Visit 7 to Visit 8)||18
7894822|NCT00739297|19428079|P3|STARTED|Third Intervention (Visit 7 to Visit 8)||6
7894823|NCT00739297|19428080|P2|STARTED|Third Intervention (Visit 7 to Visit 8)||12
7894824|NCT00739297|19428081|P1|STARTED|Third Intervention (Visit 7 to Visit 8)||16
7894825|NCT00739297|19428075|P7|NOT COMPLETED|Second Washout Period of 4-7 Days||0
7894826|NCT00739297|19428076|P6|NOT COMPLETED|Second Washout Period of 4-7 Days||0
7894827|NCT00739297|19428077|P5|NOT COMPLETED|Second Washout Period of 4-7 Days||0
7894828|NCT00739297|19428078|P4|NOT COMPLETED|Second Washout Period of 4-7 Days||0
7894829|NCT00739297|19428079|P3|NOT COMPLETED|Second Washout Period of 4-7 Days||0
7894830|NCT00739297|19428080|P2|NOT COMPLETED|Second Washout Period of 4-7 Days||0
7894831|NCT00739297|19428081|P1|NOT COMPLETED|Second Washout Period of 4-7 Days||0
7894832|NCT00739297|19428075|P7|COMPLETED|Second Washout Period of 4-7 Days||66
7894833|NCT00739297|19428076|P6|COMPLETED|Second Washout Period of 4-7 Days||10
7894834|NCT00739297|19428077|P5|COMPLETED|Second Washout Period of 4-7 Days||6
7894835|NCT00739297|19428078|P4|COMPLETED|Second Washout Period of 4-7 Days||14
7894836|NCT00739297|19428079|P3|COMPLETED|Second Washout Period of 4-7 Days||10
7894837|NCT00739297|19428080|P2|COMPLETED|Second Washout Period of 4-7 Days||8
7894838|NCT00739297|19428081|P1|COMPLETED|Second Washout Period of 4-7 Days||18
7894839|NCT00739297|19428075|P7|STARTED|Second Washout Period of 4-7 Days||66
7894840|NCT00739297|19428076|P6|STARTED|Second Washout Period of 4-7 Days||10
7894841|NCT00739297|19428077|P5|STARTED|Second Washout Period of 4-7 Days||6
7894842|NCT00739297|19428078|P4|STARTED|Second Washout Period of 4-7 Days||14
7894843|NCT00739297|19428079|P3|STARTED|Second Washout Period of 4-7 Days||10
7894844|NCT00739297|19428080|P2|STARTED|Second Washout Period of 4-7 Days||8
7894845|NCT00739297|19428081|P1|STARTED|Second Washout Period of 4-7 Days||18
7894846|NCT00739297|19428075|P7|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
7894847|NCT00739297|19428076|P6|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
7894848|NCT00739297|19428077|P5|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
7894849|NCT00739297|19428078|P4|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
7894850|NCT00739297|19428079|P3|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
7894851|NCT00739297|19428080|P2|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
7894852|NCT00739297|19428081|P1|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
7894853|NCT00739297|19428075|P7|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66
7894854|NCT00739297|19428076|P6|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
7894855|NCT00739297|19428077|P5|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6
7894856|NCT00739297|19428078|P4|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14
7894857|NCT00739297|19428079|P3|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
7894858|NCT00739297|19428080|P2|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8
7894859|NCT00739297|19428081|P1|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18
7894860|NCT00739297|19428075|P7|STARTED|Second Intervention (Visit 5 to Visit 6)||66
7894861|NCT00739297|19428076|P6|STARTED|Second Intervention (Visit 5 to Visit 6)||10
7894862|NCT00739297|19428077|P5|STARTED|Second Intervention (Visit 5 to Visit 6)||6
7894863|NCT00739297|19428078|P4|STARTED|Second Intervention (Visit 5 to Visit 6)||14
7894864|NCT00739297|19428079|P3|STARTED|Second Intervention (Visit 5 to Visit 6)||10
7894865|NCT00739297|19428080|P2|STARTED|Second Intervention (Visit 5 to Visit 6)||8
7894866|NCT00739297|19428081|P1|STARTED|Second Intervention (Visit 5 to Visit 6)||18
7894867|NCT00739297|19428075|P7|NOT COMPLETED|First Washout Period of 4-7 Days||2
7894868|NCT00739297|19428076|P6|NOT COMPLETED|First Washout Period of 4-7 Days||0
7894869|NCT00739297|19428077|P5|NOT COMPLETED|First Washout Period of 4-7 Days||0
7894870|NCT00739297|19428078|P4|NOT COMPLETED|First Washout Period of 4-7 Days||2
7894871|NCT00739297|19428079|P3|NOT COMPLETED|First Washout Period of 4-7 Days||0
7894872|NCT00739297|19428080|P2|NOT COMPLETED|First Washout Period of 4-7 Days||0
7894873|NCT00739297|19428081|P1|NOT COMPLETED|First Washout Period of 4-7 Days||0
7894874|NCT00739297|19428075|P7|COMPLETED|First Washout Period of 4-7 Days||66
7894875|NCT00739297|19428076|P6|COMPLETED|First Washout Period of 4-7 Days||9
7894876|NCT00739297|19428077|P5|COMPLETED|First Washout Period of 4-7 Days||6
7894877|NCT00739297|19428078|P4|COMPLETED|First Washout Period of 4-7 Days||17
7894878|NCT00739297|19428079|P3|COMPLETED|First Washout Period of 4-7 Days||6
7894879|NCT00739297|19428080|P2|COMPLETED|First Washout Period of 4-7 Days||11
7894880|NCT00739297|19428081|P1|COMPLETED|First Washout Period of 4-7 Days||17
7894881|NCT00739297|19428075|P7|STARTED|First Washout Period of 4-7 Days||68
7894882|NCT00739297|19428076|P6|STARTED|First Washout Period of 4-7 Days||9
7894883|NCT00739297|19428077|P5|STARTED|First Washout Period of 4-7 Days||6
7894884|NCT00739297|19428078|P4|STARTED|First Washout Period of 4-7 Days||19
7894885|NCT00739297|19428079|P3|STARTED|First Washout Period of 4-7 Days||6
7894886|NCT00739297|19428080|P2|STARTED|First Washout Period of 4-7 Days||11
7894887|NCT00739297|19428081|P1|STARTED|First Washout Period of 4-7 Days||17
7894888|NCT00739297|19428075|P7|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
7894889|NCT00739297|19428076|P6|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
7894890|NCT00739297|19428077|P5|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
7894891|NCT00739297|19428078|P4|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
7894892|NCT00739297|19428079|P3|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
7894893|NCT00739297|19428080|P2|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
7894894|NCT00739297|19428081|P1|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
7894895|NCT00739297|19428075|P7|COMPLETED|First Intervention (Visit 3 to Visit 4)||68
7894896|NCT00739297|19428076|P6|COMPLETED|First Intervention (Visit 3 to Visit 4)||9
7894897|NCT00739297|19428077|P5|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
7894898|NCT00739297|19428078|P4|COMPLETED|First Intervention (Visit 3 to Visit 4)||19
7894899|NCT00739297|19428079|P3|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
7894900|NCT00739297|19428080|P2|COMPLETED|First Intervention (Visit 3 to Visit 4)||11
7894901|NCT00739297|19428081|P1|COMPLETED|First Intervention (Visit 3 to Visit 4)||17
7894902|NCT00739297|19428075|P7|STARTED|First Intervention (Visit 3 to Visit 4)||68
7894903|NCT00739297|19428076|P6|STARTED|First Intervention (Visit 3 to Visit 4)||9
7894904|NCT00739297|19428077|P5|STARTED|First Intervention (Visit 3 to Visit 4)||6
7894905|NCT00739297|19428078|P4|STARTED|First Intervention (Visit 3 to Visit 4)||19
7894906|NCT00739297|19428079|P3|STARTED|First Intervention (Visit 3 to Visit 4)||6
7894907|NCT00739297|19428080|P2|STARTED|First Intervention (Visit 3 to Visit 4)||11
7894908|NCT00739297|19428081|P1|STARTED|First Intervention (Visit 3 to Visit 4)||17
7894909|NCT00739102|19428109|P1|NOT COMPLETED|Overall Study||15
7894910|NCT00739102|19428109|P1|COMPLETED|Overall Study|Completed 12-Month Follow-up|235
7894911|NCT00739102|19428109|P1|STARTED|Overall Study||250
7894912|NCT00739063|19428125|P1|NOT COMPLETED|Overall Study||8
7894913|NCT00739063|19428125|P1|COMPLETED|Overall Study||3
7894914|NCT00739063|19428125|P1|STARTED|Overall Study||11
7894915|NCT00739050|19428129|P2|NOT COMPLETED|Overall Study||0
7894916|NCT00739050|19428130|P1|NOT COMPLETED|Overall Study||1
7894917|NCT00739050|19428129|P2|COMPLETED|Overall Study||0
7894918|NCT00739050|19428130|P1|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3
7894919|NCT00739050|19428129|P2|STARTED|Overall Study||0
7894920|NCT00739050|19428130|P1|STARTED|Overall Study||4
7894921|NCT00739024|19428144|P2|NOT COMPLETED|Overall Study||0
7894922|NCT00739024|19428145|P1|NOT COMPLETED|Overall Study||0
7894923|NCT00739024|19428144|P2|COMPLETED|Overall Study||6
7894924|NCT00739024|19428145|P1|COMPLETED|Overall Study||7
7894925|NCT00739024|19428144|P2|STARTED|Overall Study||6
7894926|NCT00739024|19428145|P1|STARTED|Overall Study||7
7894927|NCT00738972|19428155|P4|NOT COMPLETED|Overall Study||1
7894928|NCT00738972|19428156|P3|NOT COMPLETED|Overall Study||0
7894929|NCT00738972|19428157|P2|NOT COMPLETED|Overall Study||0
7894930|NCT00738972|19428158|P1|NOT COMPLETED|Overall Study||0
7894931|NCT00738972|19428155|P4|COMPLETED|Overall Study||2
7894932|NCT00738972|19428156|P3|COMPLETED|Overall Study||3
7894933|NCT00738972|19428157|P2|COMPLETED|Overall Study||3
7894934|NCT00738972|19428158|P1|COMPLETED|Overall Study||3
7894935|NCT00738972|19428155|P4|STARTED|Overall Study||3
7894936|NCT00738972|19428156|P3|STARTED|Overall Study||3
7894937|NCT00738972|19428157|P2|STARTED|Overall Study||3
7894938|NCT00738972|19428158|P1|STARTED|Overall Study||3
7894939|NCT00738894|19428170|P2|NOT COMPLETED|Overall Study||33
7894940|NCT00738894|19428171|P1|NOT COMPLETED|Overall Study||39
7894941|NCT00738894|19428170|P2|COMPLETED|Overall Study||190
7894942|NCT00738894|19428171|P1|COMPLETED|Overall Study||402
7894943|NCT00738894|19428170|P2|STARTED|Overall Study||223
7894944|NCT00738894|19428171|P1|STARTED|Overall Study||441
7894945|NCT00738881|19428184|P2|NOT COMPLETED|Overall Study||2
7894946|NCT00738881|19428185|P1|NOT COMPLETED|Overall Study||0
7894947|NCT00738881|19428184|P2|COMPLETED|Overall Study||10
7894948|NCT00738881|19428185|P1|COMPLETED|Overall Study||11
7894949|NCT00738881|19428184|P2|STARTED|Overall Study||12
7894950|NCT00738881|19428185|P1|STARTED|Overall Study||11
7894951|NCT00738699|19428199|P2|NOT COMPLETED|Overall Study||140
7894952|NCT00738699|19428200|P1|NOT COMPLETED|Overall Study||275
7894953|NCT00738699|19428199|P2|COMPLETED|Overall Study||0
7894954|NCT00738699|19428200|P1|COMPLETED|Overall Study||0
7894955|NCT00738699|19428199|P2|Participants Treated|Overall Study||139
7894956|NCT00738699|19428200|P1|Participants Treated|Overall Study||273
7894957|NCT00738699|19428199|P2|Participants Not Treated|Overall Study||1
7894958|NCT00738699|19428200|P1|Participants Not Treated|Overall Study||2
7894959|NCT00738699|19428199|P2|STARTED|Overall Study||140
7894960|NCT00738699|19428200|P1|STARTED|Overall Study||275
7894961|NCT00738673|19428218|P2|NOT COMPLETED|Overall Study||11
7894962|NCT00738673|19428219|P1|NOT COMPLETED|Overall Study||24
7894963|NCT00738673|19428218|P2|COMPLETED|Overall Study||1
7894964|NCT00738673|19428219|P1|COMPLETED|Overall Study||1
7894965|NCT00738673|19428218|P2|Intent to Treat Population|Overall Study||12
7894966|NCT00738673|19428219|P1|Intent to Treat Population|Overall Study||24
7894967|NCT00738673|19428218|P2|STARTED|Overall Study||12
7894968|NCT00738673|19428219|P1|STARTED|Overall Study||25
7894969|NCT00738543|19428247|P1|NOT COMPLETED|Control||0
7894970|NCT00738543|19428247|P1|COMPLETED|Control||48
7894971|NCT00738543|19428247|P1|STARTED|Control||48
7894972|NCT00738543|19428247|P1|NOT COMPLETED|Sodium Hypochlorite||0
7894973|NCT00738543|19428247|P1|COMPLETED|Sodium Hypochlorite||48
7894974|NCT00738543|19428247|P1|STARTED|Sodium Hypochlorite||48
7894975|NCT00738543|19428247|P1|NOT COMPLETED|Povidone Iodine||0
7894977|NCT00738543|19428247|P1|STARTED|Povidone Iodine||48
7894978|NCT00738530|19428257|P2|NOT COMPLETED|Overall Study||238
7894979|NCT00738530|19428258|P1|NOT COMPLETED|Overall Study||234
7894980|NCT00738530|19428257|P2|COMPLETED|Overall Study||84
7894981|NCT00738530|19428258|P1|COMPLETED|Overall Study||93
7894982|NCT00738530|19428257|P2|Treated|Overall Study||316
7894983|NCT00738530|19428258|P1|Treated|Overall Study||325
7894984|NCT00738530|19428257|P2|STARTED|Overall Study||322
7894985|NCT00738530|19428258|P1|STARTED|Overall Study||327
7894986|NCT00738426|19428284|P2|NOT COMPLETED|Overall Study||3
7894987|NCT00738426|19428285|P1|NOT COMPLETED|Overall Study||2
7894988|NCT00738426|19428284|P2|COMPLETED|Overall Study||32
7894989|NCT00738426|19428285|P1|COMPLETED|Overall Study||35
7894990|NCT00738426|19428284|P2|STARTED|Overall Study||35
7894991|NCT00738426|19428285|P1|STARTED|Overall Study||37
7894992|NCT00738400|19428293|P2|NOT COMPLETED|Overall Study||7
7894993|NCT00738400|19428294|P1|NOT COMPLETED|Overall Study||4
7894994|NCT00738400|19428293|P2|COMPLETED|Overall Study||67
7894995|NCT00738400|19428294|P1|COMPLETED|Overall Study||72
7894996|NCT00738400|19428293|P2|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70
7894997|NCT00738400|19428294|P1|ITT (Intent To Treatment) Population|Overall Study||75
7894998|NCT00738400|19428293|P2|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72
7894999|NCT00738400|19428294|P1|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75
7895000|NCT00738400|19428293|P2|STARTED|Overall Study||74
7895001|NCT00738400|19428294|P1|STARTED|Overall Study||76
7895002|NCT00738374|19428315|P4|NOT COMPLETED|Maintenance Treatment/Observation Phase||12
7895003|NCT00738374|19428316|P3|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
7895004|NCT00738374|19428317|P2|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
7895005|NCT00738374|19428318|P1|NOT COMPLETED|Maintenance Treatment/Observation Phase||0
7895006|NCT00738374|19428315|P4|COMPLETED|Maintenance Treatment/Observation Phase||20
7895007|NCT00738374|19428316|P3|COMPLETED|Maintenance Treatment/Observation Phase||27
7895008|NCT00738374|19428317|P2|COMPLETED|Maintenance Treatment/Observation Phase||0
7895009|NCT00738374|19428318|P1|COMPLETED|Maintenance Treatment/Observation Phase||0
7895010|NCT00738374|19428315|P4|STARTED|Maintenance Treatment/Observation Phase||32
7895011|NCT00738374|19428316|P3|STARTED|Maintenance Treatment/Observation Phase||34
7895012|NCT00738374|19428317|P2|STARTED|Maintenance Treatment/Observation Phase||7
7895013|NCT00738374|19428318|P1|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0
7895014|NCT00738374|19428315|P4|NOT COMPLETED|Induction Treatment Phase||0
7895015|NCT00738374|19428316|P3|NOT COMPLETED|Induction Treatment Phase||0
7895016|NCT00738374|19428317|P2|NOT COMPLETED|Induction Treatment Phase||0
7895017|NCT00738374|19428318|P1|NOT COMPLETED|Induction Treatment Phase||24
7895018|NCT00738374|19428315|P4|COMPLETED|Induction Treatment Phase||0
7895019|NCT00738374|19428316|P3|COMPLETED|Induction Treatment Phase||0
7895020|NCT00738374|19428317|P2|COMPLETED|Induction Treatment Phase||0
7895021|NCT00738374|19428318|P1|COMPLETED|Induction Treatment Phase||73
7895022|NCT00738374|19428315|P4|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
7895023|NCT00738374|19428316|P3|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
7895024|NCT00738374|19428317|P2|STARTED|Induction Treatment Phase||0
7895025|NCT00738374|19428318|P1|STARTED|Induction Treatment Phase||97
7895026|NCT00738361|19428350|P1|NOT COMPLETED|Overall Study||0
7895027|NCT00738361|19428350|P1|COMPLETED|Overall Study||4
7895028|NCT00738361|19428350|P1|STARTED|Overall Study||4
7895029|NCT00738283|19428356|P1|NOT COMPLETED|Overall Study||4
7895030|NCT00738283|19428356|P1|COMPLETED|Overall Study||13
7895031|NCT00738283|19428356|P1|STARTED|Overall Study||17
7895032|NCT00738101|19428360|P1|NOT COMPLETED|Overall Study||7
7895033|NCT00738101|19428360|P1|COMPLETED|Overall Study|7 exclusions. 5 primary liver or unrelated disease, 1 died before Omegaven, 1 repeat enrollment|286
7895034|NCT00738101|19428360|P1|STARTED|Overall Study||293
7895035|NCT00738062|19428375|P3|NOT COMPLETED|Open-Label Extension||0
7895036|NCT00738062|19428376|P2|NOT COMPLETED|Open-Label Extension||0
7895037|NCT00738062|19428377|P1|NOT COMPLETED|Open-Label Extension||17
7895038|NCT00738062|19428375|P3|COMPLETED|Open-Label Extension||0
7895039|NCT00738062|19428376|P2|COMPLETED|Open-Label Extension||0
7895040|NCT00738062|19428377|P1|COMPLETED|Open-Label Extension||57
7895041|NCT00738062|19428375|P3|STARTED|Open-Label Extension||0
7895042|NCT00738062|19428376|P2|STARTED|Open-Label Extension||0
7895043|NCT00738062|19428377|P1|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74
7895044|NCT00738062|19428375|P3|NOT COMPLETED|2 Week Randomized Withdrawal||0
7895045|NCT00738062|19428376|P2|NOT COMPLETED|2 Week Randomized Withdrawal||0
7895046|NCT00738062|19428377|P1|NOT COMPLETED|2 Week Randomized Withdrawal||0
7895047|NCT00738062|19428375|P3|COMPLETED|2 Week Randomized Withdrawal||37
7895048|NCT00738062|19428376|P2|COMPLETED|2 Week Randomized Withdrawal||38
7895049|NCT00738062|19428377|P1|COMPLETED|2 Week Randomized Withdrawal||0
7895050|NCT00738062|19428375|P3|STARTED|2 Week Randomized Withdrawal||37
7895051|NCT00738062|19428376|P2|STARTED|2 Week Randomized Withdrawal||38
7895052|NCT00738062|19428377|P1|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0
7895053|NCT00738062|19428375|P3|NOT COMPLETED|Open Label Treatment||0
7895054|NCT00738062|19428376|P2|NOT COMPLETED|Open Label Treatment||0
7895055|NCT00738062|19428377|P1|NOT COMPLETED|Open Label Treatment||28
7895056|NCT00738062|19428375|P3|COMPLETED|Open Label Treatment||0
7895057|NCT00738062|19428376|P2|COMPLETED|Open Label Treatment||0
7895058|NCT00738062|19428377|P1|COMPLETED|Open Label Treatment||75
7895059|NCT00738062|19428375|P3|STARTED|Open Label Treatment||0
7895060|NCT00738062|19428376|P2|STARTED|Open Label Treatment||0
7895061|NCT00738062|19428377|P1|STARTED|Open Label Treatment||103
7895062|NCT00738049|19428404|P2|NOT COMPLETED|Washout||0
7895063|NCT00738049|19428405|P1|NOT COMPLETED|Washout||0
7895064|NCT00738049|19428404|P2|COMPLETED|Washout||7
7895065|NCT00738049|19428405|P1|COMPLETED|Washout||13
7895066|NCT00738049|19428404|P2|STARTED|Washout||7
7895067|NCT00738049|19428405|P1|STARTED|Washout||13
7895068|NCT00738049|19428404|P2|NOT COMPLETED|2nd Intervention(14 Days)||0
7895069|NCT00738049|19428405|P1|NOT COMPLETED|2nd Intervention(14 Days)||0
7895070|NCT00738049|19428404|P2|COMPLETED|2nd Intervention(14 Days)||7
7895071|NCT00738049|19428405|P1|COMPLETED|2nd Intervention(14 Days)||13
7895072|NCT00738049|19428404|P2|STARTED|2nd Intervention(14 Days)||7
7895073|NCT00738049|19428405|P1|STARTED|2nd Intervention(14 Days)||13
7895074|NCT00738049|19428404|P2|NOT COMPLETED|1st Intervention(14 Days)||0
7895075|NCT00738049|19428405|P1|NOT COMPLETED|1st Intervention(14 Days)||0
7895076|NCT00738049|19428404|P2|COMPLETED|1st Intervention(14 Days)||7
7895077|NCT00738049|19428405|P1|COMPLETED|1st Intervention(14 Days)||13
7895078|NCT00738049|19428404|P2|STARTED|1st Intervention(14 Days)||7
7895079|NCT00738049|19428405|P1|STARTED|1st Intervention(14 Days)||13
7895080|NCT00738023|19428419|P2|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
7895081|NCT00738023|19428420|P1|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
7895082|NCT00738023|19428419|P2|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
7895083|NCT00738023|19428420|P1|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19
7895084|NCT00738023|19428419|P2|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0
7895085|NCT00738023|19428420|P1|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19
7895086|NCT00738023|19428419|P2|NOT COMPLETED|Saline Infusion||0
7895087|NCT00738023|19428420|P1|NOT COMPLETED|Saline Infusion||0
7895088|NCT00738023|19428419|P2|COMPLETED|Saline Infusion||0
7895089|NCT00738023|19428420|P1|COMPLETED|Saline Infusion||19
7895090|NCT00738023|19428419|P2|STARTED|Saline Infusion||0
7895091|NCT00738023|19428420|P1|STARTED|Saline Infusion||19
7895092|NCT00738023|19428419|P2|NOT COMPLETED|Intralipid Infusion||0
7895093|NCT00738023|19428420|P1|NOT COMPLETED|Intralipid Infusion||0
7895094|NCT00738023|19428419|P2|COMPLETED|Intralipid Infusion||13
7895095|NCT00738023|19428420|P1|COMPLETED|Intralipid Infusion||19
7895096|NCT00738023|19428419|P2|STARTED|Intralipid Infusion||13
7895097|NCT00738023|19428420|P1|STARTED|Intralipid Infusion||19
7895098|NCT00737893|19428430|P2|NOT COMPLETED|Overall Study||0
7895099|NCT00737893|19428431|P1|NOT COMPLETED|Overall Study||0
7895100|NCT00737893|19428430|P2|COMPLETED|Overall Study||27
7895101|NCT00737893|19428431|P1|COMPLETED|Overall Study||29
7895102|NCT00737893|19428430|P2|STARTED|Overall Study||27
7895103|NCT00737893|19428431|P1|STARTED|Overall Study||29
7895104|NCT00737737|19428481|P2|NOT COMPLETED|Overall Study||0
7895105|NCT00737737|19428482|P1|NOT COMPLETED|Overall Study||0
7895106|NCT00737737|19428481|P2|COMPLETED|Overall Study||2
7895107|NCT00737737|19428482|P1|COMPLETED|Overall Study||2
7895108|NCT00737737|19428481|P2|STARTED|Overall Study||2
7895109|NCT00737737|19428482|P1|STARTED|Overall Study||2
7895110|NCT00737711|19428490|P1|NOT COMPLETED|Overall Study||31
7895111|NCT00737711|19428490|P1|COMPLETED|Overall Study||158
7895112|NCT00737711|19428490|P1|STARTED|Overall Study||189
7895113|NCT00737698|19428524|P3|NOT COMPLETED|Overall Study||4
7895114|NCT00737698|19428525|P2|NOT COMPLETED|Overall Study||5
7895115|NCT00737698|19428526|P1|NOT COMPLETED|Overall Study||6
7895116|NCT00737698|19428524|P3|COMPLETED|Overall Study||17
7895117|NCT00737698|19428525|P2|COMPLETED|Overall Study||37
7895118|NCT00737698|19428526|P1|COMPLETED|Overall Study||17
7895119|NCT00737698|19428524|P3|STARTED|Overall Study||21
7895120|NCT00737698|19428525|P2|STARTED|Overall Study||42
7895121|NCT00737698|19428526|P1|STARTED|Overall Study||23
7895122|NCT00737672|19428536|P2|NOT COMPLETED|Overall Study||83
7895123|NCT00737672|19428537|P1|NOT COMPLETED|Overall Study||80
7895124|NCT00737672|19428536|P2|COMPLETED|Overall Study||65
7895125|NCT00737672|19428537|P1|COMPLETED|Overall Study||65
7895126|NCT00737672|19428536|P2|Per Protocol Population|Overall Study||138
7895127|NCT00737672|19428537|P1|Per Protocol Population|Overall Study||131
7895128|NCT00737672|19428536|P2|Exclusions Due to Protocol Deviations|Overall Study||10
7895129|NCT00737672|19428537|P1|Exclusions Due to Protocol Deviations|Overall Study||14
7895130|NCT00737672|19428536|P2|STARTED|Overall Study||148
7895131|NCT00737672|19428537|P1|STARTED|Overall Study||145
7895132|NCT00737633|19428575|P2|NOT COMPLETED|Overall Study||57
7895133|NCT00737633|19428576|P1|NOT COMPLETED|Overall Study||44
7895134|NCT00737633|19428575|P2|COMPLETED|Overall Study||0
7895135|NCT00737633|19428576|P1|COMPLETED|Overall Study||0
7895136|NCT00737633|19428575|P2|STARTED|Overall Study||57
7895137|NCT00737633|19428576|P1|STARTED|Overall Study||44
7895138|NCT00737594|19428587|P3|NOT COMPLETED|Overall Study||0
7895139|NCT00737594|19428588|P2|NOT COMPLETED|Overall Study||0
7895140|NCT00737594|19428589|P1|NOT COMPLETED|Overall Study||0
7895141|NCT00737594|19428587|P3|COMPLETED|Overall Study||0
7895142|NCT00737594|19428588|P2|COMPLETED|Overall Study||0
7895143|NCT00737594|19428589|P1|COMPLETED|Overall Study||0
7895144|NCT00737594|19428587|P3|STARTED|Overall Study||0
7895145|NCT00737594|19428588|P2|STARTED|Overall Study||0
7895146|NCT00737594|19428589|P1|STARTED|Overall Study||0
7895147|NCT00737568|19428599|P2|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18
7895148|NCT00737568|19428600|P1|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26
7895149|NCT00737568|19428599|P2|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19
7895150|NCT00737568|19428600|P1|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12
7895151|NCT00737568|19428599|P2|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37
7895152|NCT00737568|19428600|P1|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38
7895153|NCT00737568|19428599|P2|NOT COMPLETED|Treatment Period Through Week 240||21
7895154|NCT00737568|19428600|P1|NOT COMPLETED|Treatment Period Through Week 240||20
7895155|NCT00737568|19428599|P2|COMPLETED|Treatment Period Through Week 240||118
7895156|NCT00737568|19428600|P1|COMPLETED|Treatment Period Through Week 240||121
7895157|NCT00737568|19428599|P2|STARTED|Treatment Period Through Week 240||139
7895158|NCT00737568|19428600|P1|STARTED|Treatment Period Through Week 240||141
7895159|NCT00737529|19428630|P1|NOT COMPLETED|Overall Study||133
7895160|NCT00737529|19428630|P1|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 30 March 2017|1
7895161|NCT00737529|19428630|P1|STARTED|Overall Study||134
7895162|NCT00737477|19428644|P1|NOT COMPLETED|Overall Study||34
7895163|NCT00737477|19428644|P1|COMPLETED|Overall Study||62
7895164|NCT00737477|19428644|P1|STARTED|Overall Study||96
7895165|NCT00737464|19428660|P1|NOT COMPLETED|Overall Study||18
7895166|NCT00737464|19428660|P1|COMPLETED|Overall Study||114
7895167|NCT00737464|19428660|P1|STARTED|Overall Study||132
7895168|NCT00737438|19428681|P1|NOT COMPLETED|Overall Study||3
7895169|NCT00737438|19428681|P1|COMPLETED|Overall Study||20
7895170|NCT00737438|19428681|P1|STARTED|Overall Study||23
7895171|NCT00737360|19428685|P1|NOT COMPLETED|Overall Study||0
7895172|NCT00737360|19428685|P1|COMPLETED|Overall Study||27
7895173|NCT00737360|19428685|P1|STARTED|Overall Study||27
7895174|NCT00737282|19428694|P1|NOT COMPLETED|Overall Study||175
7895175|NCT00737282|19428694|P1|COMPLETED|Overall Study||0
7895176|NCT00737282|19428694|P1|STARTED|Overall Study||175
7895177|NCT00737243|19428700|P1|NOT COMPLETED|Overall Study||95
7895178|NCT00737243|19428700|P1|COMPLETED|Overall Study||194
7895179|NCT00737243|19428700|P1|Empiric CUP Therapy|Overall Study||29
7895180|NCT00737243|19428700|P1|Site Specific Therapy Less Responsive|Overall Study||79
7895181|NCT00737243|19428700|P1|Site Specific Therapy More Responsive|Overall Study||115
7895182|NCT00737243|19428700|P1|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29
7895183|NCT00737243|19428700|P1|Treated|Overall Study||223
7895184|NCT00737243|19428700|P1|Insufficient Tissue for Assay, Withdrawn|Overall Study||37
7895185|NCT00737243|19428700|P1|Successful Assay Performed|Overall Study||252
7895186|NCT00737243|19428700|P1|STARTED|Overall Study||289
7895187|NCT00737204|19428708|P2|NOT COMPLETED|Overall Study||6
7895188|NCT00737204|19428709|P1|NOT COMPLETED|Overall Study||0
7895189|NCT00737204|19428708|P2|COMPLETED|Overall Study||28
7895190|NCT00737204|19428709|P1|COMPLETED|Overall Study||36
7895191|NCT00737204|19428708|P2|STARTED|Overall Study||34
7895192|NCT00737204|19428709|P1|STARTED|Overall Study||36
7895193|NCT00737178|19428723|P2|NOT COMPLETED|Overall Study||9
7895194|NCT00737178|19428724|P1|NOT COMPLETED|Overall Study||5
7895195|NCT00737178|19428723|P2|COMPLETED|Overall Study||76
7895196|NCT00737178|19428724|P1|COMPLETED|Overall Study||66
7895197|NCT00737178|19428723|P2|STARTED|Overall Study||85
7895198|NCT00737178|19428724|P1|STARTED|Overall Study||71
7895199|NCT00737100|19428737|P3|NOT COMPLETED|Overall Study||7
7895200|NCT00737100|19428738|P2|NOT COMPLETED|Overall Study||7
7895201|NCT00737100|19428739|P1|NOT COMPLETED|Overall Study||7
7895202|NCT00737100|19428737|P3|COMPLETED|Overall Study||169
7895203|NCT00737100|19428738|P2|COMPLETED|Overall Study||159
7895204|NCT00737100|19428739|P1|COMPLETED|Overall Study||161
7895205|NCT00737100|19428737|P3|STARTED|Overall Study||176
7895206|NCT00737100|19428738|P2|STARTED|Overall Study||166
7895207|NCT00737100|19428739|P1|STARTED|Overall Study||168
7895208|NCT00737061|19428783|P1|NOT COMPLETED|1 Year Wearing Period||17
7895209|NCT00737061|19428783|P1|COMPLETED|1 Year Wearing Period||553
7895210|NCT00737061|19428783|P1|STARTED|1 Year Wearing Period||570
7895211|NCT00737061|19428783|P1|NOT COMPLETED|Waiting Period||75
7895212|NCT00737061|19428783|P1|COMPLETED|Waiting Period||570
7895213|NCT00737061|19428783|P1|STARTED|Waiting Period||645
7895214|NCT00737048|19428800|P3|NOT COMPLETED|Overall Study||4
7895215|NCT00737048|19428801|P2|NOT COMPLETED|Overall Study||6
7895216|NCT00737048|19428802|P1|NOT COMPLETED|Overall Study||3
7895217|NCT00737048|19428800|P3|COMPLETED|Overall Study||126
7895218|NCT00737048|19428801|P2|COMPLETED|Overall Study||60
7895219|NCT00737048|19428802|P1|COMPLETED|Overall Study||129
7895220|NCT00737048|19428800|P3|STARTED|Overall Study||130
7895221|NCT00737048|19428801|P2|STARTED|Overall Study||66
7895222|NCT00737048|19428802|P1|STARTED|Overall Study||132
7895223|NCT00736996|19428846|P3|NOT COMPLETED|Overall Study||2
7895224|NCT00736996|19428847|P2|NOT COMPLETED|Overall Study||9
7895225|NCT00736996|19428848|P1|NOT COMPLETED|Overall Study||1
7895226|NCT00736996|19428846|P3|COMPLETED|Overall Study||25
7895227|NCT00736996|19428847|P2|COMPLETED|Overall Study||17
7895228|NCT00736996|19428848|P1|COMPLETED|Overall Study||24
7895229|NCT00736996|19428846|P3|STARTED|Overall Study||27
7895230|NCT00736996|19428847|P2|STARTED|Overall Study||26
7895231|NCT00736996|19428848|P1|STARTED|Overall Study||25
7895232|NCT00736957|19428862|P1|NOT COMPLETED|Overall Study||122
7895233|NCT00736957|19428862|P1|COMPLETED|Overall Study||97
7895234|NCT00736957|19428862|P1|Treated|Overall Study||190
7895235|NCT00736957|19428862|P1|STARTED|Overall Study||219
7895236|NCT00736944|19428872|P1|NOT COMPLETED|Definitive Treatment||1
7895237|NCT00736944|19428872|P1|COMPLETED|Definitive Treatment||28
7895238|NCT00736944|19428872|P1|STARTED|Definitive Treatment||29
7895239|NCT00736944|19428872|P1|NOT COMPLETED|Induction||1
7895240|NCT00736944|19428872|P1|COMPLETED|Induction||29
7895241|NCT00736944|19428872|P1|STARTED|Induction||30
7895242|NCT00736879|19428906|P4|NOT COMPLETED|Follow up Period - No Drug Treatment||0
7895243|NCT00736879|19428907|P3|NOT COMPLETED|Follow up Period - No Drug Treatment||0
7895244|NCT00736879|19428908|P2|NOT COMPLETED|Follow up Period - No Drug Treatment||3
7895245|NCT00736879|19428909|P1|NOT COMPLETED|Follow up Period - No Drug Treatment||1
7895246|NCT00736879|19428906|P4|COMPLETED|Follow up Period - No Drug Treatment||62
7895247|NCT00736879|19428907|P3|COMPLETED|Follow up Period - No Drug Treatment||66
7895248|NCT00736879|19428908|P2|COMPLETED|Follow up Period - No Drug Treatment||67
7895249|NCT00736879|19428909|P1|COMPLETED|Follow up Period - No Drug Treatment||65
7895250|NCT00736879|19428906|P4|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62
7895251|NCT00736879|19428907|P3|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
7895252|NCT00736879|19428908|P2|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70
7895253|NCT00736879|19428909|P1|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
7895254|NCT00736879|19428906|P4|NOT COMPLETED|Double Blind Treatment Period||5
7895255|NCT00736879|19428907|P3|NOT COMPLETED|Double Blind Treatment Period||7
7895256|NCT00736879|19428908|P2|NOT COMPLETED|Double Blind Treatment Period||4
7895257|NCT00736879|19428909|P1|NOT COMPLETED|Double Blind Treatment Period||3
7895258|NCT00736879|19428906|P4|COMPLETED|Double Blind Treatment Period||63
7895259|NCT00736879|19428907|P3|COMPLETED|Double Blind Treatment Period||67
7895260|NCT00736879|19428908|P2|COMPLETED|Double Blind Treatment Period||68
7895261|NCT00736879|19428909|P1|COMPLETED|Double Blind Treatment Period||65
7895262|NCT00736879|19428906|P4|STARTED|Double Blind Treatment Period||68
7895263|NCT00736879|19428907|P3|STARTED|Double Blind Treatment Period||74
7895264|NCT00736879|19428908|P2|STARTED|Double Blind Treatment Period||72
7895265|NCT00736879|19428909|P1|STARTED|Double Blind Treatment Period||68
7895266|NCT00736853|19428963|P3|NOT COMPLETED|Double-Blind Period||48
7895267|NCT00736853|19428964|P2|NOT COMPLETED|Double-Blind Period||24
7895268|NCT00736853|19428965|P1|NOT COMPLETED|Double-Blind Period||0
7895269|NCT00736853|19428963|P3|COMPLETED|Double-Blind Period||45
7895270|NCT00736853|19428964|P2|COMPLETED|Double-Blind Period||70
7895271|NCT00736853|19428965|P1|COMPLETED|Double-Blind Period||0
7895272|NCT00736853|19428963|P3|STARTED|Double-Blind Period||93
7895273|NCT00736853|19428964|P2|STARTED|Double-Blind Period||94
7895274|NCT00736853|19428965|P1|STARTED|Double-Blind Period||0
7895275|NCT00736853|19428963|P3|NOT COMPLETED|Open-Label Period||0
7895276|NCT00736853|19428964|P2|NOT COMPLETED|Open-Label Period||0
7895277|NCT00736853|19428965|P1|NOT COMPLETED|Open-Label Period||132
7895278|NCT00736853|19428963|P3|COMPLETED|Open-Label Period||0
7895279|NCT00736853|19428964|P2|COMPLETED|Open-Label Period||0
7895280|NCT00736853|19428965|P1|COMPLETED|Open-Label Period||187
7895281|NCT00736853|19428963|P3|Treated|Open-Label Period||0
7895282|NCT00736853|19428964|P2|Treated|Open-Label Period||0
7895283|NCT00736853|19428965|P1|Treated|Open-Label Period||277
7895284|NCT00736853|19428963|P3|STARTED|Open-Label Period||0
7895285|NCT00736853|19428964|P2|STARTED|Open-Label Period||0
7895286|NCT00736853|19428965|P1|STARTED|Open-Label Period||319
7895287|NCT00736840|19429005|P1|NOT COMPLETED|Overall Study||13
7895288|NCT00736840|19429005|P1|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401
7895289|NCT00736840|19429005|P1|STARTED|Overall Study||414
7895290|NCT00736723|19429012|P2|NOT COMPLETED|Overall Study||3
7895291|NCT00736723|19429013|P1|NOT COMPLETED|Overall Study||4
7895292|NCT00736723|19429012|P2|COMPLETED|Overall Study||18
7895293|NCT00736723|19429013|P1|COMPLETED|Overall Study||26
7895294|NCT00736723|19429012|P2|STARTED|Overall Study||21
7895295|NCT00736723|19429013|P1|STARTED|Overall Study||30
7895296|NCT00736645|19429023|P4|NOT COMPLETED|Overall Study||0
7895297|NCT00736645|19429024|P3|NOT COMPLETED|Overall Study||0
7895298|NCT00736645|19429025|P2|NOT COMPLETED|Overall Study||2
7895299|NCT00736645|19429026|P1|NOT COMPLETED|Overall Study||0
7895300|NCT00736645|19429023|P4|COMPLETED|Overall Study||13
7895301|NCT00736645|19429024|P3|COMPLETED|Overall Study||14
7895302|NCT00736645|19429025|P2|COMPLETED|Overall Study||13
7895303|NCT00736645|19429026|P1|COMPLETED|Overall Study||13
7895304|NCT00736645|19429023|P4|STARTED|Overall Study||13
7895305|NCT00736645|19429024|P3|STARTED|Overall Study||14
7895306|NCT00736645|19429025|P2|STARTED|Overall Study||15
7895307|NCT00736645|19429026|P1|STARTED|Overall Study||13
7895308|NCT00736632|19429043|P3|NOT COMPLETED|Overall Study||0
7895309|NCT00736632|19429044|P2|NOT COMPLETED|Overall Study||0
7895310|NCT00736632|19429045|P1|NOT COMPLETED|Overall Study||0
7895311|NCT00736632|19429043|P3|COMPLETED|Overall Study||31
7895312|NCT00736632|19429044|P2|COMPLETED|Overall Study||50
7895313|NCT00736632|19429045|P1|COMPLETED|Overall Study||44
7895314|NCT00736632|19429043|P3|STARTED|Overall Study||31
7895315|NCT00736632|19429044|P2|STARTED|Overall Study||50
7895316|NCT00736632|19429045|P1|STARTED|Overall Study||44
7895317|NCT00736580|19429069|P2|NOT COMPLETED|Overall Study||0
7895318|NCT00736580|19429070|P1|NOT COMPLETED|Overall Study||0
7895319|NCT00736580|19429069|P2|COMPLETED|Overall Study||123
7895320|NCT00736580|19429070|P1|COMPLETED|Overall Study||117
7895321|NCT00736580|19429069|P2|STARTED|Overall Study||123
7895322|NCT00736580|19429070|P1|STARTED|Overall Study||117
7895323|NCT00736502|19429076|P1|NOT COMPLETED|Overall Study||65
7895324|NCT00736502|19429076|P1|COMPLETED|Overall Study||213
7895325|NCT00736502|19429076|P1|STARTED|Overall Study|Entered and treated.|278
7895326|NCT00736489|19429082|P6|NOT COMPLETED|Period 6||0
7895327|NCT00736489|19429083|P5|NOT COMPLETED|Period 6||0
7895328|NCT00736489|19429084|P4|NOT COMPLETED|Period 6||0
7895329|NCT00736489|19429085|P3|NOT COMPLETED|Period 6||0
7895330|NCT00736489|19429086|P2|NOT COMPLETED|Period 6||0
7895331|NCT00736489|19429087|P1|NOT COMPLETED|Period 6||0
7895332|NCT00736489|19429082|P6|COMPLETED|Period 6||5
7895333|NCT00736489|19429083|P5|COMPLETED|Period 6||7
7895334|NCT00736489|19429084|P4|COMPLETED|Period 6||7
7895335|NCT00736489|19429085|P3|COMPLETED|Period 6||6
7895336|NCT00736489|19429086|P2|COMPLETED|Period 6||5
7895337|NCT00736489|19429087|P1|COMPLETED|Period 6||5
7895338|NCT00736489|19429082|P6|STARTED|Period 6||5
7895339|NCT00736489|19429083|P5|STARTED|Period 6||7
7895340|NCT00736489|19429084|P4|STARTED|Period 6||7
7895341|NCT00736489|19429085|P3|STARTED|Period 6||6
7895342|NCT00736489|19429086|P2|STARTED|Period 6||5
7895343|NCT00736489|19429087|P1|STARTED|Period 6||5
7895344|NCT00736489|19429082|P6|NOT COMPLETED|Period 5||0
7895345|NCT00736489|19429083|P5|NOT COMPLETED|Period 5||0
7895346|NCT00736489|19429084|P4|NOT COMPLETED|Period 5||0
7895347|NCT00736489|19429085|P3|NOT COMPLETED|Period 5||0
7895348|NCT00736489|19429086|P2|NOT COMPLETED|Period 5||0
7895349|NCT00736489|19429087|P1|NOT COMPLETED|Period 5||0
7895350|NCT00736489|19429082|P6|COMPLETED|Period 5||5
7895351|NCT00736489|19429083|P5|COMPLETED|Period 5||7
7895352|NCT00736489|19429084|P4|COMPLETED|Period 5||7
7895353|NCT00736489|19429085|P3|COMPLETED|Period 5||6
7895354|NCT00736489|19429086|P2|COMPLETED|Period 5||5
7895355|NCT00736489|19429087|P1|COMPLETED|Period 5||5
7895356|NCT00736489|19429082|P6|STARTED|Period 5||5
7895357|NCT00736489|19429083|P5|STARTED|Period 5||7
7895358|NCT00736489|19429084|P4|STARTED|Period 5||7
7895359|NCT00736489|19429085|P3|STARTED|Period 5||6
7895360|NCT00736489|19429086|P2|STARTED|Period 5||5
7895361|NCT00736489|19429087|P1|STARTED|Period 5||5
7895362|NCT00736489|19429082|P6|NOT COMPLETED|Period 4||0
7895363|NCT00736489|19429083|P5|NOT COMPLETED|Period 4||0
7895364|NCT00736489|19429084|P4|NOT COMPLETED|Period 4||0
7895365|NCT00736489|19429085|P3|NOT COMPLETED|Period 4||0
7895366|NCT00736489|19429086|P2|NOT COMPLETED|Period 4||0
7895367|NCT00736489|19429087|P1|NOT COMPLETED|Period 4||0
7895368|NCT00736489|19429082|P6|COMPLETED|Period 4||5
7895369|NCT00736489|19429083|P5|COMPLETED|Period 4||7
7895370|NCT00736489|19429084|P4|COMPLETED|Period 4||7
7895371|NCT00736489|19429085|P3|COMPLETED|Period 4||6
7895372|NCT00736489|19429086|P2|COMPLETED|Period 4||5
7895373|NCT00736489|19429087|P1|COMPLETED|Period 4||5
7895374|NCT00736489|19429082|P6|STARTED|Period 4||5
7895375|NCT00736489|19429083|P5|STARTED|Period 4||7
7895376|NCT00736489|19429084|P4|STARTED|Period 4||7
7895377|NCT00736489|19429085|P3|STARTED|Period 4||6
7895378|NCT00736489|19429086|P2|STARTED|Period 4||5
7895379|NCT00736489|19429087|P1|STARTED|Period 4||5
7895380|NCT00736489|19429082|P6|NOT COMPLETED|Period 3||0
7895381|NCT00736489|19429083|P5|NOT COMPLETED|Period 3||0
7895382|NCT00736489|19429084|P4|NOT COMPLETED|Period 3||0
7895383|NCT00736489|19429085|P3|NOT COMPLETED|Period 3||0
7895384|NCT00736489|19429086|P2|NOT COMPLETED|Period 3||0
7895385|NCT00736489|19429087|P1|NOT COMPLETED|Period 3||0
7895386|NCT00736489|19429082|P6|COMPLETED|Period 3||5
7895387|NCT00736489|19429083|P5|COMPLETED|Period 3||7
7895388|NCT00736489|19429084|P4|COMPLETED|Period 3||7
7895389|NCT00736489|19429085|P3|COMPLETED|Period 3||6
7895390|NCT00736489|19429086|P2|COMPLETED|Period 3||5
7895391|NCT00736489|19429087|P1|COMPLETED|Period 3||5
7895392|NCT00736489|19429082|P6|STARTED|Period 3||5
7895393|NCT00736489|19429083|P5|STARTED|Period 3||7
7895394|NCT00736489|19429084|P4|STARTED|Period 3||7
7895395|NCT00736489|19429085|P3|STARTED|Period 3||6
7895396|NCT00736489|19429086|P2|STARTED|Period 3||5
7895397|NCT00736489|19429087|P1|STARTED|Period 3||5
7895398|NCT00736489|19429082|P6|NOT COMPLETED|Period 2||0
7895399|NCT00736489|19429083|P5|NOT COMPLETED|Period 2||0
7895400|NCT00736489|19429084|P4|NOT COMPLETED|Period 2||0
7895401|NCT00736489|19429085|P3|NOT COMPLETED|Period 2||0
7895402|NCT00736489|19429086|P2|NOT COMPLETED|Period 2||0
7895403|NCT00736489|19429087|P1|NOT COMPLETED|Period 2||0
7895404|NCT00736489|19429082|P6|COMPLETED|Period 2||5
7895405|NCT00736489|19429083|P5|COMPLETED|Period 2||7
7895406|NCT00736489|19429084|P4|COMPLETED|Period 2||7
7895407|NCT00736489|19429085|P3|COMPLETED|Period 2||6
7895408|NCT00736489|19429086|P2|COMPLETED|Period 2||5
7895409|NCT00736489|19429087|P1|COMPLETED|Period 2||5
7895410|NCT00736489|19429082|P6|STARTED|Period 2||5
7895411|NCT00736489|19429083|P5|STARTED|Period 2||7
7895412|NCT00736489|19429084|P4|STARTED|Period 2||7
7895413|NCT00736489|19429085|P3|STARTED|Period 2||6
7895414|NCT00736489|19429086|P2|STARTED|Period 2||5
7895415|NCT00736489|19429087|P1|STARTED|Period 2||5
7895416|NCT00736489|19429082|P6|NOT COMPLETED|Period 1||1
7895417|NCT00736489|19429083|P5|NOT COMPLETED|Period 1||0
7895418|NCT00736489|19429084|P4|NOT COMPLETED|Period 1||0
7895419|NCT00736489|19429085|P3|NOT COMPLETED|Period 1||0
7895420|NCT00736489|19429086|P2|NOT COMPLETED|Period 1||0
7895421|NCT00736489|19429087|P1|NOT COMPLETED|Period 1||1
7895422|NCT00736489|19429082|P6|COMPLETED|Period 1||5
7895423|NCT00736489|19429083|P5|COMPLETED|Period 1||7
7895424|NCT00736489|19429084|P4|COMPLETED|Period 1||7
7895425|NCT00736489|19429085|P3|COMPLETED|Period 1||6
7895426|NCT00736489|19429086|P2|COMPLETED|Period 1||5
7895427|NCT00736489|19429087|P1|COMPLETED|Period 1||5
7895428|NCT00736489|19429082|P6|STARTED|Period 1||6
7895429|NCT00736489|19429083|P5|STARTED|Period 1||7
7895430|NCT00736489|19429084|P4|STARTED|Period 1||7
7895431|NCT00736489|19429085|P3|STARTED|Period 1||6
7895432|NCT00736489|19429086|P2|STARTED|Period 1||5
7895433|NCT00736489|19429087|P1|STARTED|Period 1|Cross-over study|6
7895434|NCT00736476|19429241|P2|NOT COMPLETED|Overall Study||0
7895435|NCT00736476|19429242|P1|NOT COMPLETED|Overall Study||1
7895436|NCT00736476|19429241|P2|COMPLETED|Overall Study||27
7895437|NCT00736476|19429242|P1|COMPLETED|Overall Study||35
7895438|NCT00736476|19429241|P2|STARTED|Overall Study||27
7895439|NCT00736476|19429242|P1|STARTED|Overall Study||36
7895440|NCT00736450|19429262|P1|NOT COMPLETED|Overall Study||25
7895441|NCT00736450|19429262|P1|COMPLETED|Overall Study||12
7895442|NCT00736450|19429262|P1|STARTED|Overall Study||37
7895443|NCT00736385|19429270|P2|NOT COMPLETED|Overall Study||3
7895444|NCT00736385|19429271|P1|NOT COMPLETED|Overall Study||2
7895445|NCT00736385|19429270|P2|COMPLETED|Overall Study||2
7895446|NCT00736385|19429271|P1|COMPLETED|Overall Study||2
7895447|NCT00736385|19429270|P2|STARTED|Overall Study||5
7895448|NCT00736385|19429271|P1|STARTED|Overall Study||4
7895449|NCT00736333|19429283|P1|NOT COMPLETED|Overall Study||111
7895450|NCT00736333|19429283|P1|COMPLETED|Overall Study||56
7895451|NCT00736333|19429283|P1|STARTED|Overall Study||167
7895452|NCT00736255|19429294|P2|NOT COMPLETED|Overall Study||1
7895453|NCT00736255|19429295|P1|NOT COMPLETED|Overall Study||3
7895454|NCT00736255|19429294|P2|COMPLETED|Overall Study||14
7895455|NCT00736255|19429295|P1|COMPLETED|Overall Study||14
7895456|NCT00736255|19429294|P2|STARTED|Overall Study||15
7895457|NCT00736255|19429295|P1|STARTED|Overall Study||17
7895458|NCT00736242|19429313|P1|NOT COMPLETED|Overall Study||125
7895459|NCT00736242|19429313|P1|COMPLETED|Overall Study||107
7895460|NCT00736242|19429313|P1|Participants in Safety Analysis Set|Overall Study||229
7895461|NCT00736242|19429313|P1|STARTED|Overall Study||232
7895462|NCT00736229|19429327|P3|NOT COMPLETED|Overall Study||0
7895463|NCT00736229|19429328|P2|NOT COMPLETED|Overall Study||0
7895464|NCT00736229|19429329|P1|NOT COMPLETED|Overall Study||0
7895465|NCT00736229|19429327|P3|COMPLETED|Overall Study||84
7895466|NCT00736229|19429328|P2|COMPLETED|Overall Study||71
7895467|NCT00736229|19429329|P1|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40
7895468|NCT00736229|19429327|P3|STARTED|Overall Study|Historic Control|84
7895469|NCT00736229|19429328|P2|STARTED|Overall Study|Historic control|71
7895470|NCT00736229|19429329|P1|STARTED|Overall Study|Actively Enrolled|40
7895471|NCT00736190|19429342|P1|NOT COMPLETED|Overall Study||3
7895472|NCT00736190|19429342|P1|COMPLETED|Overall Study||87
7895473|NCT00736190|19429342|P1|STARTED|Overall Study||90
7895474|NCT00736125|19429357|P2|NOT COMPLETED|Overall Study||2
7895475|NCT00736125|19429358|P1|NOT COMPLETED|Overall Study||1
7895476|NCT00736125|19429357|P2|COMPLETED|Overall Study||8
7895477|NCT00736125|19429358|P1|COMPLETED|Overall Study||9
7895478|NCT00736125|19429357|P2|STARTED|Overall Study||10
7895479|NCT00736125|19429358|P1|STARTED|Overall Study||10
7895480|NCT00736099|19429372|P2|NOT COMPLETED|Overall Study||58
7895481|NCT00736099|19429373|P1|NOT COMPLETED|Overall Study||183
7895482|NCT00736099|19429372|P2|COMPLETED|Overall Study|Number who completed treatment.|531
7895483|NCT00736099|19429373|P1|COMPLETED|Overall Study|Number who completed treatment.|1349
7895484|NCT00736099|19429372|P2|STARTED|Overall Study|Number who started treatment.|589
7895485|NCT00736099|19429373|P1|STARTED|Overall Study|Number who started treatment.|1532
7895486|NCT00736073|19429471|P2|NOT COMPLETED|Overall Study||0
7895487|NCT00736073|19429472|P1|NOT COMPLETED|Overall Study||0
7895488|NCT00736073|19429471|P2|COMPLETED|Overall Study||39
7895489|NCT00736073|19429472|P1|COMPLETED|Overall Study||34
7895490|NCT00736073|19429471|P2|STARTED|Overall Study||39
7895491|NCT00736073|19429472|P1|STARTED|Overall Study||34
7895492|NCT00736034|19429482|P1|NOT COMPLETED|Overall Study||2
7895493|NCT00736034|19429482|P1|COMPLETED|Overall Study||16
7895494|NCT00736034|19429482|P1|STARTED|Overall Study||18
7895495|NCT00735969|19429486|P1|NOT COMPLETED|Overall Study||0
7895496|NCT00735969|19429486|P1|COMPLETED|Overall Study||21
7895497|NCT00735969|19429486|P1|STARTED|Overall Study||21
7895498|NCT00735943|19429490|P1|NOT COMPLETED|Overall Study||2
7895499|NCT00735943|19429490|P1|COMPLETED|Overall Study||20
7895500|NCT00735943|19429490|P1|STARTED|Overall Study||22
7895501|NCT00735917|19429507|P1|NOT COMPLETED|Overall Study||0
7895502|NCT00735917|19429507|P1|COMPLETED|Overall Study||19
7895503|NCT00735917|19429507|P1|STARTED|Overall Study||19
7895504|NCT00735904|19429515|P1|NOT COMPLETED|Overall Study||38
7895505|NCT00735904|19429515|P1|COMPLETED|Overall Study||0
7895506|NCT00735904|19429515|P1|STARTED|Overall Study||38
7895507|NCT00735878|19429525|P3|NOT COMPLETED|Phase II- Determined Dose||0
7895508|NCT00735878|19429526|P2|NOT COMPLETED|Phase II- Determined Dose||0
7895509|NCT00735878|19429527|P1|NOT COMPLETED|Phase II- Determined Dose||0
7895510|NCT00735878|19429525|P3|COMPLETED|Phase II- Determined Dose||0
7895511|NCT00735878|19429526|P2|COMPLETED|Phase II- Determined Dose||7
7895512|NCT00735878|19429527|P1|COMPLETED|Phase II- Determined Dose|Seven subjects completed therapy within the Phase II portion of the trial.|0
7895513|NCT00735878|19429525|P3|STARTED|Phase II- Determined Dose||0
7895514|NCT00735878|19429526|P2|STARTED|Phase II- Determined Dose||7
7895515|NCT00735878|19429527|P1|STARTED|Phase II- Determined Dose||0
7895516|NCT00735878|19429525|P3|NOT COMPLETED|Phase I- Dose Determination||1
7895517|NCT00735878|19429526|P2|NOT COMPLETED|Phase I- Dose Determination||0
7895518|NCT00735878|19429527|P1|NOT COMPLETED|Phase I- Dose Determination||0
7895519|NCT00735878|19429525|P3|COMPLETED|Phase I- Dose Determination||4
7895520|NCT00735878|19429526|P2|COMPLETED|Phase I- Dose Determination||7
7895521|NCT00735878|19429527|P1|COMPLETED|Phase I- Dose Determination|12 subjects received at least one cycle of treatment and were evaluable per the protocol.|1
7895522|NCT00735878|19429525|P3|STARTED|Phase I- Dose Determination||5
7895523|NCT00735878|19429526|P2|STARTED|Phase I- Dose Determination||7
7895524|NCT00735878|19429527|P1|STARTED|Phase I- Dose Determination|13 subjects enrolled. One subject withdrew consent prior to receiving therapy & was replaced.|1
7895525|NCT00735839|19429540|P2|NOT COMPLETED|Overall Study||0
7895526|NCT00735839|19429541|P1|NOT COMPLETED|Overall Study||0
7895527|NCT00735839|19429540|P2|COMPLETED|Overall Study||10
7895528|NCT00735839|19429541|P1|COMPLETED|Overall Study||30
7895529|NCT00735839|19429540|P2|STARTED|Overall Study||10
7895530|NCT00735839|19429541|P1|STARTED|Overall Study||30
7895531|NCT00735826|19429549|P1|NOT COMPLETED|Overall Study||0
7895532|NCT00735826|19429549|P1|COMPLETED|Overall Study||10
7895533|NCT00735826|19429549|P1|STARTED|Overall Study||10
7895534|NCT00735787|19429557|P2|NOT COMPLETED|Period 2||1
7895535|NCT00735787|19429558|P1|NOT COMPLETED|Period 2||5
7895536|NCT00735787|19429557|P2|COMPLETED|Period 2||40
7895537|NCT00735787|19429558|P1|COMPLETED|Period 2||13
7895538|NCT00735787|19429557|P2|STARTED|Period 2||41
7895539|NCT00735787|19429558|P1|STARTED|Period 2||18
7895540|NCT00735787|19429557|P2|NOT COMPLETED|Period 1||8
7895541|NCT00735787|19429558|P1|NOT COMPLETED|Period 1||6
7895542|NCT00735787|19429557|P2|COMPLETED|Period 1||41
7895543|NCT00735787|19429558|P1|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17
7895544|NCT00735787|19429557|P2|STARTED|Period 1||49
7895545|NCT00735787|19429558|P1|STARTED|Period 1||23
7895546|NCT00735709|19429606|P4|NOT COMPLETED|Overall Study||18
7895547|NCT00735709|19429607|P3|NOT COMPLETED|Overall Study||11
7895548|NCT00735709|19429608|P2|NOT COMPLETED|Overall Study||13
7895549|NCT00735709|19429609|P1|NOT COMPLETED|Overall Study||13
7895550|NCT00735709|19429606|P4|COMPLETED|Overall Study||122
7895551|NCT00735709|19429607|P3|COMPLETED|Overall Study||129
7895552|NCT00735709|19429608|P2|COMPLETED|Overall Study||127
7895553|NCT00735709|19429609|P1|COMPLETED|Overall Study||127
7895554|NCT00735709|19429606|P4|Treated|Overall Study||139
7895555|NCT00735709|19429607|P3|Treated|Overall Study||140
7895556|NCT00735709|19429608|P2|Treated|Overall Study||140
7895557|NCT00735709|19429609|P1|Treated|Overall Study||140
7895558|NCT00735709|19429606|P4|STARTED|Overall Study||140
7895559|NCT00735709|19429607|P3|STARTED|Overall Study||140
7895560|NCT00735709|19429608|P2|STARTED|Overall Study||140
7895561|NCT00735709|19429609|P1|STARTED|Overall Study||140
7895562|NCT00735696|19429719|P1|NOT COMPLETED|Overall Study||2
7895563|NCT00735696|19429719|P1|COMPLETED|Overall Study||39
7895564|NCT00735696|19429719|P1|Received Any Quantity of Study Drug|Overall Study||40
7895565|NCT00735696|19429719|P1|STARTED|Overall Study||41
7895566|NCT00735670|19429733|P2|NOT COMPLETED|Overall Study||5
7895567|NCT00735670|19429734|P1|NOT COMPLETED|Overall Study||4
7895568|NCT00735670|19429733|P2|COMPLETED|Overall Study||6
7895569|NCT00735670|19429734|P1|COMPLETED|Overall Study||6
7895570|NCT00735670|19429733|P2|STARTED|Overall Study||11
7895571|NCT00735670|19429734|P1|STARTED|Overall Study||10
7895572|NCT00735644|19429747|P5|NOT COMPLETED|Overall Study||0
7895573|NCT00735644|19429748|P4|NOT COMPLETED|Overall Study||1
7895574|NCT00735644|19429749|P3|NOT COMPLETED|Overall Study||1
7895575|NCT00735644|19429750|P2|NOT COMPLETED|Overall Study||2
7895576|NCT00735644|19429751|P1|NOT COMPLETED|Overall Study||0
7895577|NCT00735644|19429747|P5|COMPLETED|Overall Study||102
7895578|NCT00735644|19429748|P4|COMPLETED|Overall Study||198
7895579|NCT00735644|19429749|P3|COMPLETED|Overall Study||295
7895580|NCT00735644|19429750|P2|COMPLETED|Overall Study||298
7895581|NCT00735644|19429751|P1|COMPLETED|Overall Study||303
7895582|NCT00735644|19429747|P5|STARTED|Overall Study||102
7895583|NCT00735644|19429748|P4|STARTED|Overall Study||199
7895584|NCT00735644|19429749|P3|STARTED|Overall Study||296
7895585|NCT00735644|19429750|P2|STARTED|Overall Study||300
7895586|NCT00735644|19429751|P1|STARTED|Overall Study||303
7895587|NCT00735618|19429788|P1|NOT COMPLETED|Overall Study||0
7895588|NCT00735618|19429788|P1|COMPLETED|Overall Study||19
7895589|NCT00735618|19429788|P1|STARTED|Overall Study||19
7895590|NCT00735553|19429795|P1|NOT COMPLETED|Overall Study||77
7895591|NCT00735553|19429795|P1|COMPLETED|Overall Study||0
7895592|NCT00735553|19429795|P1|STARTED|Overall Study||77
7895593|NCT00735475|19429805|P2|NOT COMPLETED|Overall Study||11
7895594|NCT00735475|19429806|P1|NOT COMPLETED|Overall Study||8
7895595|NCT00735475|19429805|P2|COMPLETED|Overall Study||626
7895596|NCT00735475|19429806|P1|COMPLETED|Overall Study||623
7895597|NCT00735475|19429805|P2|STARTED|Overall Study||637
7895598|NCT00735475|19429806|P1|STARTED|Overall Study||631
7895599|NCT00735462|19429827|P3|NOT COMPLETED|Overall Study||28
7895600|NCT00735462|19429828|P2|NOT COMPLETED|Overall Study||55
7895601|NCT00735462|19429829|P1|NOT COMPLETED|Overall Study||63
7895602|NCT00735462|19429827|P3|COMPLETED|Overall Study||77
7895603|NCT00735462|19429828|P2|COMPLETED|Overall Study||149
7895604|NCT00735462|19429829|P1|COMPLETED|Overall Study||139
7895605|NCT00735462|19429827|P3|STARTED|Overall Study||105
7895606|NCT00735462|19429828|P2|STARTED|Overall Study||204
7895607|NCT00735462|19429829|P1|STARTED|Overall Study||202
7895608|NCT00735449|19429842|P2|NOT COMPLETED|Overall Study||6
7895609|NCT00735449|19429843|P1|NOT COMPLETED|Overall Study||7
7895610|NCT00735449|19429842|P2|COMPLETED|Overall Study||96
7895611|NCT00735449|19429843|P1|COMPLETED|Overall Study||95
7895612|NCT00735449|19429842|P2|STARTED|Overall Study||102
7895613|NCT00735449|19429843|P1|STARTED|Overall Study||102
7895614|NCT00735436|19429857|P1|NOT COMPLETED|Overall Study||0
7895615|NCT00735436|19429857|P1|COMPLETED|Overall Study||18
7895616|NCT00735436|19429857|P1|STARTED|Overall Study||18
7895617|NCT00735397|19429866|P1|NOT COMPLETED|Overall Study||1183
7895618|NCT00735397|19429866|P1|COMPLETED|Overall Study||35
7895619|NCT00735397|19429866|P1|STARTED|Overall Study||1218
7895620|NCT00735371|19429880|P4|NOT COMPLETED|Overall Study||10
7895621|NCT00735371|19429881|P3|NOT COMPLETED|Overall Study||11
7895622|NCT00735371|19429882|P2|NOT COMPLETED|Overall Study||13
7895623|NCT00735371|19429883|P1|NOT COMPLETED|Overall Study||15
7895624|NCT00735371|19429880|P4|COMPLETED|Overall Study||69
7895625|NCT00735371|19429881|P3|COMPLETED|Overall Study||67
7895626|NCT00735371|19429882|P2|COMPLETED|Overall Study||66
7895627|NCT00735371|19429883|P1|COMPLETED|Overall Study||63
7895628|NCT00735371|19429880|P4|STARTED|Overall Study||79
7895629|NCT00735371|19429881|P3|STARTED|Overall Study||78
7895630|NCT00735371|19429882|P2|STARTED|Overall Study||79
7895631|NCT00735371|19429883|P1|STARTED|Overall Study||78
7895632|NCT00735306|19429901|P1|NOT COMPLETED|Overall Study||0
7895633|NCT00735306|19429901|P1|COMPLETED|Overall Study||12
7895634|NCT00735306|19429901|P1|STARTED|Overall Study||12
7895635|NCT00735254|19429911|P4|NOT COMPLETED|Overall Study||0
7895636|NCT00735254|19429912|P3|NOT COMPLETED|Overall Study||1
7895637|NCT00735254|19429913|P2|NOT COMPLETED|Overall Study||1
7895638|NCT00735254|19429914|P1|NOT COMPLETED|Overall Study||1
7895639|NCT00735254|19429911|P4|COMPLETED|Overall Study||0
7895640|NCT00735254|19429912|P3|COMPLETED|Overall Study||0
7895641|NCT00735254|19429913|P2|COMPLETED|Overall Study||0
7895642|NCT00735254|19429914|P1|COMPLETED|Overall Study||0
7895643|NCT00735254|19429911|P4|STARTED|Overall Study||0
7895644|NCT00735254|19429912|P3|STARTED|Overall Study||1
7895645|NCT00735254|19429913|P2|STARTED|Overall Study||1
7895646|NCT00735254|19429914|P1|STARTED|Overall Study||1
7895647|NCT00735072|19429926|P2|NOT COMPLETED|Overall Study||1
7895648|NCT00735072|19429927|P1|NOT COMPLETED|Overall Study||1
7895649|NCT00735072|19429926|P2|COMPLETED|Overall Study||21
7895650|NCT00735072|19429927|P1|COMPLETED|Overall Study||22
7895651|NCT00735072|19429926|P2|STARTED|Overall Study||22
7895652|NCT00735072|19429927|P1|STARTED|Overall Study||23
7895653|NCT00735007|19429941|P1|NOT COMPLETED|Overall Study||5
7895654|NCT00735007|19429941|P1|COMPLETED|Overall Study||101
7895655|NCT00735007|19429941|P1|STARTED|Overall Study||106
7895656|NCT00734994|19429966|P1|NOT COMPLETED|Overall Study||1
7895657|NCT00734994|19429966|P1|COMPLETED|Overall Study||14
7895658|NCT00734994|19429966|P1|STARTED|Overall Study||15
7895659|NCT00734968|19429973|P2|NOT COMPLETED|Overall Study||1
7895660|NCT00734968|19429974|P1|NOT COMPLETED|Overall Study||1
7895661|NCT00734968|19429973|P2|COMPLETED|Overall Study||75
7895662|NCT00734968|19429974|P1|COMPLETED|Overall Study||76
7895663|NCT00734968|19429973|P2|STARTED|Overall Study||76
7895664|NCT00734968|19429974|P1|STARTED|Overall Study||77
7895665|NCT00734929|19429986|P2|NOT COMPLETED|Overall Study||5
7895666|NCT00734929|19429987|P1|NOT COMPLETED|Overall Study||6
7895667|NCT00734929|19429986|P2|COMPLETED|Overall Study||53
7895668|NCT00734929|19429987|P1|COMPLETED|Overall Study||51
7895669|NCT00734929|19429986|P2|STARTED|Overall Study||58
7895670|NCT00734929|19429987|P1|STARTED|Overall Study||57
7895671|NCT00734903|19430017|P2|NOT COMPLETED|Overall Study||1
7895672|NCT00734903|19430018|P1|NOT COMPLETED|Overall Study||3
7895673|NCT00734903|19430017|P2|COMPLETED|Overall Study||32
7895674|NCT00734903|19430018|P1|COMPLETED|Overall Study||30
7895675|NCT00734903|19430017|P2|Completed 3-month Followup|Overall Study||15
7895676|NCT00734903|19430018|P1|Completed 3-month Followup|Overall Study||14
7895677|NCT00734903|19430017|P2|Completed End of Treatment Assessment|Overall Study||23
7895678|NCT00734903|19430018|P1|Completed End of Treatment Assessment|Overall Study||21
7895679|NCT00734903|19430017|P2|STARTED|Overall Study||33
7895680|NCT00734903|19430018|P1|STARTED|Overall Study||33
7895681|NCT00734851|19430044|P1|NOT COMPLETED|Overall Study||21
7895682|NCT00734851|19430044|P1|COMPLETED|Overall Study||13
7895683|NCT00734851|19430044|P1|STARTED|Overall Study||34
7895684|NCT00734799|19430056|P2|NOT COMPLETED|Overall Study||4
7895685|NCT00734799|19430057|P1|NOT COMPLETED|Overall Study||0
7895686|NCT00734799|19430056|P2|COMPLETED|Overall Study||9
7895687|NCT00734799|19430057|P1|COMPLETED|Overall Study||9
7895688|NCT00734799|19430056|P2|STARTED|Overall Study||13
7895689|NCT00734799|19430057|P1|STARTED|Overall Study||9
7895690|NCT00734747|19430065|P1|NOT COMPLETED|6 Month Follow-up||3
7895691|NCT00734747|19430065|P1|COMPLETED|6 Month Follow-up||66
7895692|NCT00734747|19430065|P1|STARTED|6 Month Follow-up||69
7895693|NCT00734747|19430065|P1|NOT COMPLETED|SRS Procedure||3
7895694|NCT00734747|19430065|P1|COMPLETED|SRS Procedure||69
7895695|NCT00734747|19430065|P1|STARTED|SRS Procedure||72
7895696|NCT00734734|19430072|P1|NOT COMPLETED|Overall Study||0
7895697|NCT00734734|19430072|P1|COMPLETED|Overall Study||64
7895698|NCT00734734|19430072|P1|STARTED|Overall Study||64
7895699|NCT00734656|19430079|P4|NOT COMPLETED|Lab Session 4||1
7895700|NCT00734656|19430080|P3|NOT COMPLETED|Lab Session 4||0
7895701|NCT00734656|19430081|P2|NOT COMPLETED|Lab Session 4||0
7895702|NCT00734656|19430082|P1|NOT COMPLETED|Lab Session 4||0
7895703|NCT00734656|19430079|P4|COMPLETED|Lab Session 4||19
7895704|NCT00734656|19430080|P3|COMPLETED|Lab Session 4||16
7895705|NCT00734656|19430081|P2|COMPLETED|Lab Session 4||18
7895706|NCT00734656|19430082|P1|COMPLETED|Lab Session 4||20
7895707|NCT00734656|19430079|P4|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
7895708|NCT00734656|19430080|P3|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16
7895709|NCT00734656|19430081|P2|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18
7895710|NCT00734656|19430082|P1|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
7895711|NCT00734656|19430079|P4|NOT COMPLETED|Washout 3||1
7895712|NCT00734656|19430080|P3|NOT COMPLETED|Washout 3||0
7895713|NCT00734656|19430081|P2|NOT COMPLETED|Washout 3||0
7895714|NCT00734656|19430082|P1|NOT COMPLETED|Washout 3||1
7895715|NCT00734656|19430079|P4|COMPLETED|Washout 3||18
7895716|NCT00734656|19430080|P3|COMPLETED|Washout 3||20
7895717|NCT00734656|19430081|P2|COMPLETED|Washout 3||19
7895718|NCT00734656|19430082|P1|COMPLETED|Washout 3||17
7895719|NCT00734656|19430079|P4|STARTED|Washout 3||19
7895720|NCT00734656|19430080|P3|STARTED|Washout 3||20
7895721|NCT00734656|19430081|P2|STARTED|Washout 3||19
7895722|NCT00734656|19430082|P1|STARTED|Washout 3||18
7895723|NCT00734656|19430079|P4|NOT COMPLETED|Lab Session 3||0
7895724|NCT00734656|19430080|P3|NOT COMPLETED|Lab Session 3||0
7895725|NCT00734656|19430081|P2|NOT COMPLETED|Lab Session 3||0
7895726|NCT00734656|19430082|P1|NOT COMPLETED|Lab Session 3||0
7895727|NCT00734656|19430079|P4|COMPLETED|Lab Session 3||19
7895728|NCT00734656|19430080|P3|COMPLETED|Lab Session 3||20
7895729|NCT00734656|19430081|P2|COMPLETED|Lab Session 3||19
7895730|NCT00734656|19430082|P1|COMPLETED|Lab Session 3||18
7895731|NCT00734656|19430079|P4|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
7895732|NCT00734656|19430080|P3|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20
7895733|NCT00734656|19430081|P2|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
7895734|NCT00734656|19430082|P1|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18
7895735|NCT00734656|19430079|P4|NOT COMPLETED|Washout 2||0
7895736|NCT00734656|19430080|P3|NOT COMPLETED|Washout 2||1
7895737|NCT00734656|19430081|P2|NOT COMPLETED|Washout 2||1
7895738|NCT00734656|19430082|P1|NOT COMPLETED|Washout 2||1
7895739|NCT00734656|19430079|P4|COMPLETED|Washout 2||19
7895740|NCT00734656|19430080|P3|COMPLETED|Washout 2||20
7895741|NCT00734656|19430081|P2|COMPLETED|Washout 2||20
7895742|NCT00734656|19430082|P1|COMPLETED|Washout 2||17
7895743|NCT00734656|19430079|P4|STARTED|Washout 2||19
7895744|NCT00734656|19430080|P3|STARTED|Washout 2||21
7895745|NCT00734656|19430081|P2|STARTED|Washout 2||21
7895746|NCT00734656|19430082|P1|STARTED|Washout 2||18
7895747|NCT00734656|19430079|P4|NOT COMPLETED|Lab Session 2||1
7895748|NCT00734656|19430080|P3|NOT COMPLETED|Lab Session 2||0
7895749|NCT00734656|19430081|P2|NOT COMPLETED|Lab Session 2||0
7895750|NCT00734656|19430082|P1|NOT COMPLETED|Lab Session 2||1
7895751|NCT00734656|19430079|P4|COMPLETED|Lab Session 2||19
7895752|NCT00734656|19430080|P3|COMPLETED|Lab Session 2||21
7895753|NCT00734656|19430081|P2|COMPLETED|Lab Session 2||21
7895754|NCT00734656|19430082|P1|COMPLETED|Lab Session 2||18
7895755|NCT00734656|19430079|P4|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20
7895756|NCT00734656|19430080|P3|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
7895757|NCT00734656|19430081|P2|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
7895758|NCT00734656|19430082|P1|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19
7895759|NCT00734656|19430079|P4|NOT COMPLETED|Washout 1||3
7895760|NCT00734656|19430080|P3|NOT COMPLETED|Washout 1||2
7895761|NCT00734656|19430081|P2|NOT COMPLETED|Washout 1||5
7895762|NCT00734656|19430082|P1|NOT COMPLETED|Washout 1||1
7895763|NCT00734656|19430079|P4|COMPLETED|Washout 1||18
7895764|NCT00734656|19430080|P3|COMPLETED|Washout 1||24
7895765|NCT00734656|19430081|P2|COMPLETED|Washout 1||18
7895766|NCT00734656|19430082|P1|COMPLETED|Washout 1||21
7895767|NCT00734656|19430079|P4|STARTED|Washout 1||21
7895768|NCT00734656|19430080|P3|STARTED|Washout 1||26
7895769|NCT00734656|19430081|P2|STARTED|Washout 1||23
7895770|NCT00734656|19430082|P1|STARTED|Washout 1||22
7895771|NCT00734656|19430079|P4|NOT COMPLETED|Lab Session 1||0
7895772|NCT00734656|19430080|P3|NOT COMPLETED|Lab Session 1||0
7895773|NCT00734656|19430081|P2|NOT COMPLETED|Lab Session 1||0
7895774|NCT00734656|19430082|P1|NOT COMPLETED|Lab Session 1||2
7895775|NCT00734656|19430079|P4|COMPLETED|Lab Session 1||21
7895776|NCT00734656|19430080|P3|COMPLETED|Lab Session 1||26
7895777|NCT00734656|19430081|P2|COMPLETED|Lab Session 1||23
7895778|NCT00734656|19430082|P1|COMPLETED|Lab Session 1||22
7895779|NCT00734656|19430079|P4|STARTED|Lab Session 1||21
7895780|NCT00734656|19430080|P3|STARTED|Lab Session 1||26
7895781|NCT00734656|19430081|P2|STARTED|Lab Session 1||23
7895782|NCT00734656|19430082|P1|STARTED|Lab Session 1||24
7895783|NCT00734630|19430106|P2|NOT COMPLETED|Overall Study||33
7895784|NCT00734630|19430107|P1|NOT COMPLETED|Overall Study||29
7895785|NCT00734630|19430106|P2|COMPLETED|Overall Study||200
7895786|NCT00734630|19430107|P1|COMPLETED|Overall Study||229
7895787|NCT00734630|19430106|P2|STARTED|Overall Study||233
7895788|NCT00734630|19430107|P1|STARTED|Overall Study||258
7895789|NCT00734617|19430117|P2|NOT COMPLETED|Overall Study||102
7895790|NCT00734617|19430118|P1|NOT COMPLETED|Overall Study||107
7895791|NCT00734617|19430117|P2|COMPLETED|Overall Study||128
7895792|NCT00734617|19430118|P1|COMPLETED|Overall Study||142
7895793|NCT00734617|19430117|P2|STARTED|Overall Study||230
7895794|NCT00734617|19430118|P1|STARTED|Overall Study||249
7895795|NCT00734604|19430130|P6|NOT COMPLETED|Overall Study||6
7895796|NCT00734604|19430131|P5|NOT COMPLETED|Overall Study||8
7895797|NCT00734604|19430132|P4|NOT COMPLETED|Overall Study||9
7895798|NCT00734604|19430133|P3|NOT COMPLETED|Overall Study||6
7895799|NCT00734604|19430134|P2|NOT COMPLETED|Overall Study||12
7895800|NCT00734604|19430135|P1|NOT COMPLETED|Overall Study||3
7895801|NCT00734604|19430130|P6|COMPLETED|Overall Study||58
7895802|NCT00734604|19430131|P5|COMPLETED|Overall Study||55
7895803|NCT00734604|19430132|P4|COMPLETED|Overall Study||54
7895804|NCT00734604|19430133|P3|COMPLETED|Overall Study||57
7895805|NCT00734604|19430134|P2|COMPLETED|Overall Study||51
7895806|NCT00734604|19430135|P1|COMPLETED|Overall Study||59
7895807|NCT00734604|19430130|P6|STARTED|Overall Study||64
7895808|NCT00734604|19430131|P5|STARTED|Overall Study||63
7895809|NCT00734604|19430132|P4|STARTED|Overall Study||63
7895810|NCT00734604|19430133|P3|STARTED|Overall Study||63
7895811|NCT00734604|19430134|P2|STARTED|Overall Study||63
7895812|NCT00734604|19430135|P1|STARTED|Overall Study||62
7895813|NCT00734591|19430185|P2|NOT COMPLETED|Prospective Period||44
7895814|NCT00734591|19430186|P1|NOT COMPLETED|Prospective Period||51
7895815|NCT00734591|19430185|P2|COMPLETED|Prospective Period||1229
7895816|NCT00734591|19430186|P1|COMPLETED|Prospective Period||1307
7895817|NCT00734591|19430185|P2|STARTED|Prospective Period||1273
7895818|NCT00734591|19430186|P1|STARTED|Prospective Period||1358
7895819|NCT00734591|19430185|P2|NOT COMPLETED|Screening for Prospective Period||2291
7895820|NCT00734591|19430186|P1|NOT COMPLETED|Screening for Prospective Period||2517
7895821|NCT00734591|19430185|P2|COMPLETED|Screening for Prospective Period||1273
7895822|NCT00734591|19430186|P1|COMPLETED|Screening for Prospective Period||1358
7895823|NCT00734591|19430185|P2|STARTED|Screening for Prospective Period||3564
7895824|NCT00734591|19430186|P1|STARTED|Screening for Prospective Period||3875
7895825|NCT00734591|19430185|P2|NOT COMPLETED|Retrospective Period||0
7895826|NCT00734591|19430186|P1|NOT COMPLETED|Retrospective Period||0
7895827|NCT00734591|19430185|P2|COMPLETED|Retrospective Period||3564
7895828|NCT00734591|19430186|P1|COMPLETED|Retrospective Period||3875
7895829|NCT00734591|19430185|P2|STARTED|Retrospective Period||3564
7895830|NCT00734591|19430186|P1|STARTED|Retrospective Period||3875
7895831|NCT00734578|19430201|P3|NOT COMPLETED|Overall Study||25
7895832|NCT00734578|19430202|P2|NOT COMPLETED|Overall Study||25
7895833|NCT00734578|19430203|P1|NOT COMPLETED|Overall Study||33
7895834|NCT00734578|19430201|P3|COMPLETED|Overall Study||129
7895835|NCT00734578|19430202|P2|COMPLETED|Overall Study||128
7895836|NCT00734578|19430203|P1|COMPLETED|Overall Study||121
7895837|NCT00734578|19430201|P3|STARTED|Overall Study||154
7895838|NCT00734578|19430202|P2|STARTED|Overall Study||153
7895839|NCT00734578|19430203|P1|STARTED|Overall Study||154
7895840|NCT00734539|19430237|P2|NOT COMPLETED|Long Term Follow up||31
7895841|NCT00734539|19430238|P1|NOT COMPLETED|Long Term Follow up||34
7895842|NCT00734539|19430237|P2|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107
7895843|NCT00734539|19430238|P1|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118
7895844|NCT00734539|19430237|P2|STARTED|Long Term Follow up||138
7895845|NCT00734539|19430238|P1|STARTED|Long Term Follow up||152
7895846|NCT00734539|19430237|P2|NOT COMPLETED|Main Study||35
7895847|NCT00734539|19430238|P1|NOT COMPLETED|Main Study||37
7895848|NCT00734539|19430237|P2|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138
7895849|NCT00734539|19430238|P1|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152
7895850|NCT00734539|19430237|P2|STARTED|Main Study||173
7895851|NCT00734539|19430238|P1|STARTED|Main Study||189
7895852|NCT00734500|19430266|P1|NOT COMPLETED|Overall Study||1
7895853|NCT00734500|19430266|P1|COMPLETED|Overall Study||14
7895854|NCT00734500|19430266|P1|STARTED|Overall Study||15
7895855|NCT00734474|19430280|P9|NOT COMPLETED|Overall Study||82
7895856|NCT00734474|19430281|P8|NOT COMPLETED|Overall Study||129
7895857|NCT00734474|19430282|P7|NOT COMPLETED|Overall Study||24
7895858|NCT00734474|19430283|P6|NOT COMPLETED|Overall Study||25
7895859|NCT00734474|19430284|P5|NOT COMPLETED|Overall Study||118
7895860|NCT00734474|19430285|P4|NOT COMPLETED|Overall Study||10
7895861|NCT00734474|19430286|P3|NOT COMPLETED|Overall Study||112
7895862|NCT00734474|19430287|P2|NOT COMPLETED|Overall Study||30
7895863|NCT00734474|19430288|P1|NOT COMPLETED|Overall Study||15
7895864|NCT00734474|19430280|P9|COMPLETED|Overall Study||95
7895865|NCT00734474|19430281|P8|COMPLETED|Overall Study||186
7895866|NCT00734474|19430282|P7|COMPLETED|Overall Study||0
7895867|NCT00734474|19430283|P6|COMPLETED|Overall Study||0
7895868|NCT00734474|19430284|P5|COMPLETED|Overall Study||184
7895869|NCT00734474|19430285|P4|COMPLETED|Overall Study||0
7895870|NCT00734474|19430286|P3|COMPLETED|Overall Study||192
7895871|NCT00734474|19430287|P2|COMPLETED|Overall Study||0
7895872|NCT00734474|19430288|P1|COMPLETED|Overall Study||0
7895873|NCT00734474|19430280|P9|Completed 52-Week Visit|Overall Study||112
7895874|NCT00734474|19430281|P8|Completed 52-Week Visit|Overall Study||238
7895875|NCT00734474|19430282|P7|Completed 52-Week Visit|Overall Study||0
7895876|NCT00734474|19430283|P6|Completed 52-Week Visit|Overall Study||0
7895877|NCT00734474|19430284|P5|Completed 52-Week Visit|Overall Study||243
7895878|NCT00734474|19430285|P4|Completed 52-Week Visit|Overall Study||0
7895879|NCT00734474|19430286|P3|Completed 52-Week Visit|Overall Study||238
7895880|NCT00734474|19430287|P2|Completed 52-Week Visit|Overall Study||0
7895881|NCT00734474|19430288|P1|Completed 52-Week Visit|Overall Study||0
7895882|NCT00734474|19430280|P9|Completed 26-Week Visit|Overall Study||124
7895883|NCT00734474|19430281|P8|Completed 26-Week Visit|Overall Study||270
7895884|NCT00734474|19430282|P7|Completed 26-Week Visit|Overall Study||2
7895885|NCT00734474|19430283|P6|Completed 26-Week Visit|Overall Study||2
7895886|NCT00734474|19430284|P5|Completed 26-Week Visit|Overall Study||268
7895887|NCT00734474|19430285|P4|Completed 26-Week Visit|Overall Study||2
7895888|NCT00734474|19430286|P3|Completed 26-Week Visit|Overall Study||258
7895889|NCT00734474|19430287|P2|Completed 26-Week Visit|Overall Study||0
7895890|NCT00734474|19430288|P1|Completed 26-Week Visit|Overall Study||0
7895891|NCT00734474|19430280|P9|Entered Study After Dose Decision Point|Overall Study||139
7895892|NCT00734474|19430281|P8|Entered Study After Dose Decision Point|Overall Study||273
7895893|NCT00734474|19430282|P7|Entered Study After Dose Decision Point|Overall Study||0
7895894|NCT00734474|19430283|P6|Entered Study After Dose Decision Point|Overall Study||0
7895895|NCT00734474|19430284|P5|Entered Study After Dose Decision Point|Overall Study||281
7895896|NCT00734474|19430285|P4|Entered Study After Dose Decision Point|Overall Study||0
7895897|NCT00734474|19430286|P3|Entered Study After Dose Decision Point|Overall Study||279
7895898|NCT00734474|19430287|P2|Entered Study After Dose Decision Point|Overall Study||0
7895899|NCT00734474|19430288|P1|Entered Study After Dose Decision Point|Overall Study||0
7895900|NCT00734474|19430280|P9|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34
7895901|NCT00734474|19430281|P8|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42
7895902|NCT00734474|19430282|P7|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23
7895903|NCT00734474|19430283|P6|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21
7895904|NCT00734474|19430284|P5|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21
7895905|NCT00734474|19430285|P4|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
7895906|NCT00734474|19430286|P3|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24
7895907|NCT00734474|19430287|P2|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25
7895908|NCT00734474|19430288|P1|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
7895909|NCT00734474|19430280|P9|Entered Study Before Dose Decision Point|Overall Study||38
7895910|NCT00734474|19430281|P8|Entered Study Before Dose Decision Point|Overall Study||42
7895911|NCT00734474|19430282|P7|Entered Study Before Dose Decision Point|Overall Study||24
7895912|NCT00734474|19430283|P6|Entered Study Before Dose Decision Point|Overall Study||25
7895913|NCT00734474|19430284|P5|Entered Study Before Dose Decision Point|Overall Study||21
7895914|NCT00734474|19430285|P4|Entered Study Before Dose Decision Point|Overall Study||10
7895915|NCT00734474|19430286|P3|Entered Study Before Dose Decision Point|Overall Study||25
7895916|NCT00734474|19430287|P2|Entered Study Before Dose Decision Point|Overall Study||30
7895917|NCT00734474|19430288|P1|Entered Study Before Dose Decision Point|Overall Study||15
7895918|NCT00734474|19430280|P9|Received at Least 1 Dose of Study Drug|Overall Study||177
7895919|NCT00734474|19430281|P8|Received at Least 1 Dose of Study Drug|Overall Study||315
7895920|NCT00734474|19430282|P7|Received at Least 1 Dose of Study Drug|Overall Study||24
7895921|NCT00734474|19430283|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
7895922|NCT00734474|19430284|P5|Received at Least 1 Dose of Study Drug|Overall Study||302
7895923|NCT00734474|19430285|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
7895924|NCT00734474|19430286|P3|Received at Least 1 Dose of Study Drug|Overall Study||304
7895925|NCT00734474|19430287|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
7895926|NCT00734474|19430288|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
7895927|NCT00734474|19430280|P9|STARTED|Overall Study||177
7895928|NCT00734474|19430281|P8|STARTED|Overall Study||315
7895929|NCT00734474|19430282|P7|STARTED|Overall Study||24
7895930|NCT00734474|19430283|P6|STARTED|Overall Study||25
7895931|NCT00734474|19430284|P5|STARTED|Overall Study||302
7895932|NCT00734474|19430285|P4|STARTED|Overall Study||10
7895933|NCT00734474|19430286|P3|STARTED|Overall Study||304
7895934|NCT00734474|19430287|P2|STARTED|Overall Study||30
7895935|NCT00734474|19430288|P1|STARTED|Overall Study||15
7895936|NCT00734409|19430457|P2|NOT COMPLETED|Overall Study||0
7895937|NCT00734409|19430458|P1|NOT COMPLETED|Overall Study||0
7895938|NCT00734409|19430457|P2|COMPLETED|Overall Study||145
7895939|NCT00734409|19430458|P1|COMPLETED|Overall Study||155
7895940|NCT00734409|19430457|P2|STARTED|Overall Study||145
7895941|NCT00734409|19430458|P1|STARTED|Overall Study||155
7895942|NCT00734344|19430470|P2|NOT COMPLETED|Overall Study||0
7895943|NCT00734344|19430471|P1|NOT COMPLETED|Overall Study||0
7895944|NCT00734344|19430470|P2|COMPLETED|Overall Study||9
7895945|NCT00734344|19430471|P1|COMPLETED|Overall Study||9
7895946|NCT00734344|19430470|P2|STARTED|Overall Study||9
7895947|NCT00734344|19430471|P1|STARTED|Overall Study||9
7895948|NCT00734305|19430541|P7|NOT COMPLETED|Overall Study||0
7895949|NCT00734305|19430542|P6|NOT COMPLETED|Overall Study||0
7895950|NCT00734305|19430543|P5|NOT COMPLETED|Overall Study||0
7895951|NCT00734305|19430544|P4|NOT COMPLETED|Overall Study||0
7895952|NCT00734305|19430545|P3|NOT COMPLETED|Overall Study||0
7895953|NCT00734305|19430546|P2|NOT COMPLETED|Overall Study||0
7895954|NCT00734305|19430547|P1|NOT COMPLETED|Overall Study||1
7895955|NCT00734305|19430541|P7|COMPLETED|Overall Study||18
7895956|NCT00734305|19430542|P6|COMPLETED|Overall Study||4
7895957|NCT00734305|19430543|P5|COMPLETED|Overall Study||5
7895958|NCT00734305|19430544|P4|COMPLETED|Overall Study||3
7895959|NCT00734305|19430545|P3|COMPLETED|Overall Study||4
7895960|NCT00734305|19430546|P2|COMPLETED|Overall Study||3
7895961|NCT00734305|19430547|P1|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6
7895962|NCT00734305|19430541|P7|STARTED|Overall Study||18
7895963|NCT00734305|19430542|P6|STARTED|Overall Study||4
7895964|NCT00734305|19430543|P5|STARTED|Overall Study||5
7895965|NCT00734305|19430544|P4|STARTED|Overall Study||3
7895966|NCT00734305|19430545|P3|STARTED|Overall Study||4
7895967|NCT00734305|19430546|P2|STARTED|Overall Study||3
7895968|NCT00734305|19430547|P1|STARTED|Overall Study||7
7895969|NCT00734214|19430578|P2|NOT COMPLETED|Overall Study||4
7895970|NCT00734214|19430579|P1|NOT COMPLETED|Overall Study||4
7895971|NCT00734214|19430578|P2|COMPLETED|Overall Study||126
7895972|NCT00734214|19430579|P1|COMPLETED|Overall Study||124
7895973|NCT00734214|19430578|P2|STARTED|Overall Study||130
7895974|NCT00734214|19430579|P1|STARTED|Overall Study||128
7895975|NCT00734162|19430589|P4|NOT COMPLETED|Open-Label Phase||3
7895976|NCT00734162|19430590|P3|NOT COMPLETED|Open-Label Phase||1
7895977|NCT00734162|19430591|P2|NOT COMPLETED|Open-Label Phase||2
7895978|NCT00734162|19430592|P1|NOT COMPLETED|Open-Label Phase||3
7895979|NCT00734162|19430589|P4|COMPLETED|Open-Label Phase||36
7895980|NCT00734162|19430590|P3|COMPLETED|Open-Label Phase||12
7895981|NCT00734162|19430591|P2|COMPLETED|Open-Label Phase||39
7895982|NCT00734162|19430592|P1|COMPLETED|Open-Label Phase||7
7895983|NCT00734162|19430589|P4|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39
7895984|NCT00734162|19430590|P3|STARTED|Open-Label Phase||13
7895985|NCT00734162|19430591|P2|STARTED|Open-Label Phase||41
7895986|NCT00734162|19430592|P1|STARTED|Open-Label Phase||10
7895987|NCT00734162|19430589|P4|NOT COMPLETED|Randomized Phase (Through Week 72)||4
7895988|NCT00734162|19430590|P3|NOT COMPLETED|Randomized Phase (Through Week 72)||0
7895989|NCT00734162|19430591|P2|NOT COMPLETED|Randomized Phase (Through Week 72)||1
7895990|NCT00734162|19430592|P1|NOT COMPLETED|Randomized Phase (Through Week 72)||0
7895991|NCT00734162|19430589|P4|COMPLETED|Randomized Phase (Through Week 72)||37
7895992|NCT00734162|19430590|P3|COMPLETED|Randomized Phase (Through Week 72)||13
7895993|NCT00734162|19430591|P2|COMPLETED|Randomized Phase (Through Week 72)||41
7895994|NCT00734162|19430592|P1|COMPLETED|Randomized Phase (Through Week 72)||10
7895995|NCT00734162|19430589|P4|STARTED|Randomized Phase (Through Week 72)||41
7895996|NCT00734162|19430590|P3|STARTED|Randomized Phase (Through Week 72)||13
7895997|NCT00734162|19430591|P2|STARTED|Randomized Phase (Through Week 72)||42
7895998|NCT00734162|19430592|P1|STARTED|Randomized Phase (Through Week 72)||10
7895999|NCT00734149|19430816|P1|NOT COMPLETED|Overall Study||1
7896000|NCT00734149|19430816|P1|COMPLETED|Overall Study||44
7896001|NCT00734149|19430816|P1|STARTED|Overall Study||45
7896002|NCT00734097|19430823|P1|NOT COMPLETED|Open Label||16
7896003|NCT00734097|19430823|P1|COMPLETED|Open Label|16 patients discontinued after randomization|301
7896004|NCT00734097|19430823|P1|Per Protocol|Open Label||301
7896005|NCT00734097|19430823|P1|Full Analysis|Open Label||311
7896006|NCT00734097|19430823|P1|Safety Analysis|Open Label||317
7896007|NCT00734097|19430823|P1|STARTED|Open Label|Full analysis performed in 311|317
7896008|NCT00734097|19430823|P1|NOT COMPLETED|Screening||20
7896009|NCT00734097|19430823|P1|COMPLETED|Screening|20 participants were screening failure.|317
7896010|NCT00734097|19430823|P1|STARTED|Screening||337
7896011|NCT00734071|19430840|P2|NOT COMPLETED|Overall Study||27
7896012|NCT00734071|19430841|P1|NOT COMPLETED|Overall Study||38
7896013|NCT00734071|19430840|P2|COMPLETED|Overall Study||125
7896014|NCT00734071|19430841|P1|COMPLETED|Overall Study||114
7896015|NCT00734071|19430840|P2|Treated|Overall Study||148
7896016|NCT00734071|19430841|P1|Treated|Overall Study||151
7896017|NCT00734071|19430840|P2|STARTED|Overall Study||152
7896018|NCT00734071|19430841|P1|STARTED|Overall Study||152
7896019|NCT00734032|19430899|P4|NOT COMPLETED|Overall Study||0
7896020|NCT00734032|19430900|P3|NOT COMPLETED|Overall Study||0
7896021|NCT00734032|19430901|P2|NOT COMPLETED|Overall Study||1
7896022|NCT00734032|19430902|P1|NOT COMPLETED|Overall Study||0
7896023|NCT00734032|19430899|P4|COMPLETED|Overall Study||26
7896024|NCT00734032|19430900|P3|COMPLETED|Overall Study||28
7896025|NCT00734032|19430901|P2|COMPLETED|Overall Study||27
7896026|NCT00734032|19430902|P1|COMPLETED|Overall Study||25
7896027|NCT00734032|19430899|P4|STARTED|Overall Study||26
7896028|NCT00734032|19430900|P3|STARTED|Overall Study||28
7896029|NCT00734032|19430901|P2|STARTED|Overall Study||28
7896030|NCT00734032|19430902|P1|STARTED|Overall Study||25
7896031|NCT00733993|19430922|P2|NOT COMPLETED|Overall Study||0
7896032|NCT00733993|19430923|P1|NOT COMPLETED|Overall Study||0
7896033|NCT00733993|19430922|P2|COMPLETED|Overall Study||10
7896034|NCT00733993|19430923|P1|COMPLETED|Overall Study||13
7896035|NCT00733993|19430922|P2|STARTED|Overall Study||10
7896036|NCT00733993|19430923|P1|STARTED|Overall Study||13
7896037|NCT00733980|19430958|P2|NOT COMPLETED|Overall Study||21
7896038|NCT00733980|19430959|P1|NOT COMPLETED|Overall Study||22
7896039|NCT00733980|19430958|P2|COMPLETED|Overall Study||55
7896040|NCT00733980|19430959|P1|COMPLETED|Overall Study||52
7896041|NCT00733980|19430958|P2|STARTED|Overall Study||76
7896042|NCT00733980|19430959|P1|STARTED|Overall Study||74
7896043|NCT00733954|19431003|P2|NOT COMPLETED|Overall Study||2
7896044|NCT00733954|19431004|P1|NOT COMPLETED|Overall Study||8
7896045|NCT00733954|19431003|P2|COMPLETED|Overall Study||123
7896046|NCT00733954|19431004|P1|COMPLETED|Overall Study||116
7896047|NCT00733954|19431003|P2|STARTED|Overall Study||125
7896048|NCT00733954|19431004|P1|STARTED|Overall Study||124
7896049|NCT00733824|19431051|P5|NOT COMPLETED|Phase II||0
7896050|NCT00733824|19431052|P4|NOT COMPLETED|Phase II||0
7896051|NCT00733824|19431053|P3|NOT COMPLETED|Phase II||0
7896052|NCT00733824|19431054|P2|NOT COMPLETED|Phase II||0
7896053|NCT00733824|19431055|P1|NOT COMPLETED|Phase II||0
7896054|NCT00733824|19431051|P5|COMPLETED|Phase II||36
7896055|NCT00733824|19431052|P4|COMPLETED|Phase II||0
7896056|NCT00733824|19431053|P3|COMPLETED|Phase II||0
7896057|NCT00733824|19431054|P2|COMPLETED|Phase II||0
7896058|NCT00733824|19431055|P1|COMPLETED|Phase II||0
7896059|NCT00733824|19431051|P5|STARTED|Phase II||36
7896060|NCT00733824|19431052|P4|STARTED|Phase II||0
7896061|NCT00733824|19431053|P3|STARTED|Phase II||0
7896062|NCT00733824|19431054|P2|STARTED|Phase II||0
7896063|NCT00733824|19431055|P1|STARTED|Phase II||0
7896064|NCT00733824|19431051|P5|NOT COMPLETED|Phase I||0
7896065|NCT00733824|19431052|P4|NOT COMPLETED|Phase I||0
7896066|NCT00733824|19431053|P3|NOT COMPLETED|Phase I||0
7896067|NCT00733824|19431054|P2|NOT COMPLETED|Phase I||0
7896068|NCT00733824|19431055|P1|NOT COMPLETED|Phase I||1
7896069|NCT00733824|19431051|P5|COMPLETED|Phase I||0
7896070|NCT00733824|19431052|P4|COMPLETED|Phase I||6
7896071|NCT00733824|19431053|P3|COMPLETED|Phase I||6
7896072|NCT00733824|19431054|P2|COMPLETED|Phase I||3
7896073|NCT00733824|19431055|P1|COMPLETED|Phase I||9
7896074|NCT00733824|19431051|P5|STARTED|Phase I||0
7896075|NCT00733824|19431052|P4|STARTED|Phase I||6
7896076|NCT00733824|19431053|P3|STARTED|Phase I||6
7896077|NCT00733824|19431054|P2|STARTED|Phase I||3
7896078|NCT00733824|19431055|P1|STARTED|Phase I||10
7896079|NCT00733746|19431074|P1|NOT COMPLETED|Overall Study||5
7896080|NCT00733746|19431074|P1|COMPLETED|Overall Study||114
7896081|NCT00733746|19431074|P1|STARTED|Overall Study||119
7896082|NCT00733512|19431082|P1|NOT COMPLETED|Overall Study||0
7896083|NCT00733512|19431082|P1|COMPLETED|Overall Study||146
7896084|NCT00733512|19431082|P1|STARTED|Overall Study||146
7896085|NCT00733499|19431089|P2|NOT COMPLETED|10 Year Followup||19
7896086|NCT00733499|19431090|P1|NOT COMPLETED|10 Year Followup||20
7896087|NCT00733499|19431089|P2|COMPLETED|10 Year Followup||13
7896088|NCT00733499|19431090|P1|COMPLETED|10 Year Followup||26
7896089|NCT00733499|19431089|P2|STARTED|10 Year Followup||32
7896090|NCT00733499|19431090|P1|STARTED|10 Year Followup||46
7896091|NCT00733499|19431089|P2|NOT COMPLETED|5 Year Followup||25
7896092|NCT00733499|19431090|P1|NOT COMPLETED|5 Year Followup||21
7896093|NCT00733499|19431089|P2|COMPLETED|5 Year Followup||53
7896094|NCT00733499|19431090|P1|COMPLETED|5 Year Followup||70
7896095|NCT00733499|19431089|P2|STARTED|5 Year Followup||78
7896096|NCT00733499|19431090|P1|STARTED|5 Year Followup||91
7896097|NCT00733499|19431089|P2|NOT COMPLETED|24 Months Follow-up||1
7896098|NCT00733499|19431090|P1|NOT COMPLETED|24 Months Follow-up||0
7896099|NCT00733499|19431089|P2|COMPLETED|24 Months Follow-up||95
7896100|NCT00733499|19431090|P1|COMPLETED|24 Months Follow-up||99
7896101|NCT00733499|19431089|P2|STARTED|24 Months Follow-up||96
7896102|NCT00733499|19431090|P1|STARTED|24 Months Follow-up||99
7896103|NCT00733499|19431089|P2|NOT COMPLETED|12 Months Follow-up||1
7896104|NCT00733499|19431090|P1|NOT COMPLETED|12 Months Follow-up||2
7896105|NCT00733499|19431089|P2|COMPLETED|12 Months Follow-up||96
7896106|NCT00733499|19431090|P1|COMPLETED|12 Months Follow-up||99
7896107|NCT00733499|19431089|P2|STARTED|12 Months Follow-up||97
7896108|NCT00733499|19431090|P1|STARTED|12 Months Follow-up||101
7896109|NCT00733499|19431089|P2|NOT COMPLETED|6 Months Follow-up||3
7896110|NCT00733499|19431090|P1|NOT COMPLETED|6 Months Follow-up||0
7896111|NCT00733499|19431089|P2|COMPLETED|6 Months Follow-up||97
7896112|NCT00733499|19431090|P1|COMPLETED|6 Months Follow-up||101
7896113|NCT00733499|19431089|P2|STARTED|6 Months Follow-up||100
7896114|NCT00733499|19431090|P1|STARTED|6 Months Follow-up||101
7896115|NCT00733499|19431089|P2|NOT COMPLETED|3 Months Follow-up||2
7896116|NCT00733499|19431090|P1|NOT COMPLETED|3 Months Follow-up||1
7896117|NCT00733499|19431089|P2|COMPLETED|3 Months Follow-up||100
7896118|NCT00733499|19431090|P1|COMPLETED|3 Months Follow-up||101
7896119|NCT00733499|19431089|P2|STARTED|3 Months Follow-up||102
7896120|NCT00733499|19431090|P1|STARTED|3 Months Follow-up||102
7896121|NCT00733499|19431089|P2|NOT COMPLETED|Pre-operative||1
7896122|NCT00733499|19431090|P1|NOT COMPLETED|Pre-operative||0
7896123|NCT00733499|19431089|P2|COMPLETED|Pre-operative||102
7896124|NCT00733499|19431090|P1|COMPLETED|Pre-operative||102
7896125|NCT00733499|19431089|P2|STARTED|Pre-operative|A death occurred prior to surgery which left a total of 102 participants|103
7896126|NCT00733499|19431090|P1|STARTED|Pre-operative||102
7896127|NCT00733421|19431150|P2|NOT COMPLETED|Overall Study||1
7896128|NCT00733421|19431151|P1|NOT COMPLETED|Overall Study||1
7896129|NCT00733421|19431150|P2|COMPLETED|Overall Study|All but one randomised patient|49
7896130|NCT00733421|19431151|P1|COMPLETED|Overall Study|All but one randomsied patient|49
7896131|NCT00733421|19431150|P2|STARTED|Overall Study|November 2008|50
7896132|NCT00733421|19431151|P1|STARTED|Overall Study|November 2008|50
7896133|NCT00733408|19431173|P1|NOT COMPLETED|Overall Study||4
7896134|NCT00733408|19431173|P1|COMPLETED|Overall Study||55
7896135|NCT00733408|19431173|P1|STARTED|Overall Study||59
7896136|NCT00733369|19431185|P2|NOT COMPLETED|Overall Study||9
7896137|NCT00733369|19431186|P1|NOT COMPLETED|Overall Study||10
7896138|NCT00733369|19431185|P2|COMPLETED|Overall Study||47
7896139|NCT00733369|19431186|P1|COMPLETED|Overall Study||40
7896140|NCT00733369|19431185|P2|STARTED|Overall Study||56
7896141|NCT00733369|19431186|P1|STARTED|Overall Study||50
7896142|NCT00733356|19431302|P1|NOT COMPLETED|Modified Lab School, Reading Evaluation||0
7896143|NCT00733356|19431302|P1|COMPLETED|Modified Lab School, Reading Evaluation||26
7896144|NCT00733356|19431302|P1|STARTED|Modified Lab School, Reading Evaluation||26
7896145|NCT00733356|19431302|P1|NOT COMPLETED|Vyvanse Dose Titration||2
7896146|NCT00733356|19431302|P1|COMPLETED|Vyvanse Dose Titration||26
7896147|NCT00733356|19431302|P1|STARTED|Vyvanse Dose Titration||28
7896148|NCT00733343|19431308|P2|NOT COMPLETED|Overall Study||81
7896149|NCT00733343|19431309|P1|NOT COMPLETED|Overall Study||83
7896150|NCT00733343|19431308|P2|COMPLETED|Overall Study||578
7896151|NCT00733343|19431309|P1|COMPLETED|Overall Study||583
7896152|NCT00733343|19431308|P2|STARTED|Overall Study||659
7896153|NCT00733343|19431309|P1|STARTED|Overall Study||666
7896154|NCT00733330|19431399|P2|NOT COMPLETED|Overall Study||4
7896155|NCT00733330|19431400|P1|NOT COMPLETED|Overall Study||2
7896156|NCT00733330|19431399|P2|COMPLETED|Overall Study||48
7896157|NCT00733330|19431400|P1|COMPLETED|Overall Study||30
7896158|NCT00733330|19431399|P2|STARTED|Overall Study||52
7896159|NCT00733330|19431400|P1|STARTED|Overall Study||32
7896160|NCT00733304|19431485|P3|NOT COMPLETED|Overall Study||5
7896161|NCT00733304|19431486|P2|NOT COMPLETED|Overall Study||3
7896162|NCT00733304|19431487|P1|NOT COMPLETED|Overall Study||7
7896163|NCT00733304|19431485|P3|COMPLETED|Overall Study||3
7896164|NCT00733304|19431486|P2|COMPLETED|Overall Study||12
7896165|NCT00733304|19431487|P1|COMPLETED|Overall Study||12
7896166|NCT00733304|19431485|P3|STARTED|Overall Study||8
7896167|NCT00733304|19431486|P2|STARTED|Overall Study||15
7896168|NCT00733304|19431487|P1|STARTED|Overall Study||19
7896169|NCT00733291|19431569|P4|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
7896170|NCT00733291|19431570|P3|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
7896171|NCT00733291|19431571|P2|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
7896172|NCT00733291|19431572|P1|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
7896173|NCT00733291|19431569|P4|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
7896174|NCT00733291|19431570|P3|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
7896175|NCT00733291|19431571|P2|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
7896176|NCT00733291|19431572|P1|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12
7896177|NCT00733291|19431569|P4|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
7896178|NCT00733291|19431570|P3|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
7896179|NCT00733291|19431571|P2|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
7896180|NCT00733291|19431572|P1|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12
7896181|NCT00733291|19431569|P4|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
7896182|NCT00733291|19431570|P3|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
7896183|NCT00733291|19431571|P2|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
7896184|NCT00733291|19431572|P1|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1
7896185|NCT00733291|19431569|P4|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
7896186|NCT00733291|19431570|P3|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
7896187|NCT00733291|19431571|P2|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
7896188|NCT00733291|19431572|P1|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12
7896189|NCT00733291|19431569|P4|STARTED|Washout Period, 3 Days (+/-1 Day)||17
7896190|NCT00733291|19431570|P3|STARTED|Washout Period, 3 Days (+/-1 Day)||17
7896191|NCT00733291|19431571|P2|STARTED|Washout Period, 3 Days (+/-1 Day)||17
7896192|NCT00733291|19431572|P1|STARTED|Washout Period, 3 Days (+/-1 Day)||13
7896193|NCT00733291|19431569|P4|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
7896194|NCT00733291|19431570|P3|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
7896195|NCT00733291|19431571|P2|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
7896196|NCT00733291|19431572|P1|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
7896197|NCT00733291|19431569|P4|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
7896198|NCT00733291|19431570|P3|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
7896199|NCT00733291|19431571|P2|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
7896200|NCT00733291|19431572|P1|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13
7896201|NCT00733291|19431569|P4|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
7896202|NCT00733291|19431570|P3|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
7896203|NCT00733291|19431571|P2|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
7896204|NCT00733291|19431572|P1|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13
7896205|NCT00733278|19431594|P1|NOT COMPLETED|Overall Study||0
7896206|NCT00733278|19431594|P1|COMPLETED|Overall Study||7
7896207|NCT00733278|19431594|P1|STARTED|Overall Study||7
7896208|NCT00733226|19431601|P2|NOT COMPLETED|Overall Study||0
7896209|NCT00733226|19431602|P1|NOT COMPLETED|Overall Study||5
7896210|NCT00733226|19431601|P2|COMPLETED|Overall Study||40
7896211|NCT00733226|19431602|P1|COMPLETED|Overall Study||35
7896212|NCT00733226|19431601|P2|STARTED|Overall Study||40
7896213|NCT00733226|19431602|P1|STARTED|Overall Study||40
7896214|NCT00733135|19431618|P1|NOT COMPLETED|Overall Study||2
7896215|NCT00733135|19431618|P1|COMPLETED|Overall Study||131
7896216|NCT00733135|19431618|P1|STARTED|Overall Study||133
7896217|NCT00733096|19431630|P3|NOT COMPLETED|Overall Study||0
7896218|NCT00733096|19431631|P2|NOT COMPLETED|Overall Study||0
7896219|NCT00733096|19431632|P1|NOT COMPLETED|Overall Study||0
7896220|NCT00733096|19431630|P3|COMPLETED|Overall Study||30
7896221|NCT00733096|19431631|P2|COMPLETED|Overall Study||26
7896222|NCT00733096|19431632|P1|COMPLETED|Overall Study||28
7896223|NCT00733096|19431630|P3|STARTED|Overall Study||30
7896224|NCT00733096|19431631|P2|STARTED|Overall Study||26
7896225|NCT00733096|19431632|P1|STARTED|Overall Study||28
7896226|NCT00733005|19431651|P2|NOT COMPLETED|Overall Study||3
7896227|NCT00733005|19431652|P1|NOT COMPLETED|Overall Study||2
7896228|NCT00733005|19431651|P2|COMPLETED|Overall Study||159
7896229|NCT00733005|19431652|P1|COMPLETED|Overall Study||160
7896230|NCT00733005|19431651|P2|STARTED|Overall Study||162
7896231|NCT00733005|19431652|P1|STARTED|Overall Study||162
7896232|NCT00732992|19431662|P2|NOT COMPLETED|Overall Study||6
7896233|NCT00732992|19431663|P1|NOT COMPLETED|Overall Study||6
7896234|NCT00732992|19431662|P2|COMPLETED|Overall Study||0
7896235|NCT00732992|19431663|P1|COMPLETED|Overall Study||0
7896236|NCT00732992|19431662|P2|STARTED|Overall Study||6
7896237|NCT00732992|19431663|P1|STARTED|Overall Study||6
7896238|NCT00732940|19431682|P2|NOT COMPLETED|Overall Study||3
7896239|NCT00732940|19431683|P1|NOT COMPLETED|Overall Study||2
7896240|NCT00732940|19431682|P2|COMPLETED|Overall Study||25
7896241|NCT00732940|19431683|P1|COMPLETED|Overall Study||26
7896242|NCT00732940|19431682|P2|STARTED|Overall Study||28
7896243|NCT00732940|19431683|P1|STARTED|Overall Study||28
7896244|NCT00732901|19431753|P2|NOT COMPLETED|Overall Study||0
7896245|NCT00732901|19431754|P1|NOT COMPLETED|Overall Study||0
7896246|NCT00732901|19431753|P2|COMPLETED|Overall Study||12
7896247|NCT00732901|19431754|P1|COMPLETED|Overall Study||11
7896248|NCT00732901|19431753|P2|STARTED|Overall Study||12
7896249|NCT00732901|19431754|P1|STARTED|Overall Study||11
7896250|NCT00732875|19431764|P1|NOT COMPLETED|Overall Study||35
7896251|NCT00732875|19431764|P1|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57
7896252|NCT00732875|19431764|P1|STARTED|Overall Study||92
7896253|NCT00732758|19431772|P2|NOT COMPLETED|Overall Study||16
7896254|NCT00732758|19431773|P1|NOT COMPLETED|Overall Study||8
7896255|NCT00732758|19431772|P2|COMPLETED|Overall Study||63
7896256|NCT00732758|19431773|P1|COMPLETED|Overall Study||70
7896257|NCT00732758|19431772|P2|STARTED|Overall Study||79
7896258|NCT00732758|19431773|P1|STARTED|Overall Study||78
7896259|NCT00732680|19431785|P1|NOT COMPLETED|Overall Study||0
7896260|NCT00732680|19431785|P1|COMPLETED|Overall Study||9
7896261|NCT00732680|19431785|P1|STARTED|Overall Study||9
7896262|NCT00732654|19431792|P3|NOT COMPLETED|Overall Study||0
7896263|NCT00732654|19431793|P2|NOT COMPLETED|Overall Study||1
7896264|NCT00732654|19431794|P1|NOT COMPLETED|Overall Study||0
7896265|NCT00732654|19431792|P3|COMPLETED|Overall Study||10
7896266|NCT00732654|19431793|P2|COMPLETED|Overall Study||9
7896267|NCT00732654|19431794|P1|COMPLETED|Overall Study||10
7896268|NCT00732654|19431792|P3|STARTED|Overall Study||10
7896269|NCT00732654|19431793|P2|STARTED|Overall Study||10
7896270|NCT00732654|19431794|P1|STARTED|Overall Study||10
7896271|NCT00732641|19431813|P2|NOT COMPLETED|Overall Study||112
7896272|NCT00732641|19431814|P1|NOT COMPLETED|Overall Study||106
7896273|NCT00732641|19431813|P2|COMPLETED|Overall Study||9
7896274|NCT00732641|19431814|P1|COMPLETED|Overall Study||17
7896275|NCT00732641|19431813|P2|STARTED|Overall Study||121
7896276|NCT00732641|19431814|P1|STARTED|Overall Study||123
7896277|NCT00732615|19431834|P2|NOT COMPLETED|Overall Study||5
7896278|NCT00732615|19431835|P1|NOT COMPLETED|Overall Study||7
7896279|NCT00732615|19431834|P2|COMPLETED|Overall Study||79
7896280|NCT00732615|19431835|P1|COMPLETED|Overall Study||33
7896281|NCT00732615|19431834|P2|STARTED|Overall Study||84
7896282|NCT00732615|19431835|P1|STARTED|Overall Study||40
7896283|NCT00732498|19431847|P1|NOT COMPLETED|Overall Study||6
7896284|NCT00732498|19431847|P1|COMPLETED|Overall Study||22
7896285|NCT00732498|19431847|P1|STARTED|Overall Study||28
7896286|NCT00732472|19431858|P4|NOT COMPLETED|Overall Study||3
7896287|NCT00732472|19431859|P3|NOT COMPLETED|Overall Study||1
7896288|NCT00732472|19431860|P2|NOT COMPLETED|Overall Study||3
7896289|NCT00732472|19431861|P1|NOT COMPLETED|Overall Study||0
7896290|NCT00732472|19431858|P4|COMPLETED|Overall Study||6
7896291|NCT00732472|19431859|P3|COMPLETED|Overall Study||9
7896292|NCT00732472|19431860|P2|COMPLETED|Overall Study||7
7896293|NCT00732472|19431861|P1|COMPLETED|Overall Study||9
7896294|NCT00732472|19431858|P4|STARTED|Overall Study||9
7896295|NCT00732472|19431859|P3|STARTED|Overall Study||10
7896296|NCT00732472|19431860|P2|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10
7896297|NCT00732472|19431861|P1|STARTED|Overall Study||9
7896298|NCT00732381|19431961|P2|NOT COMPLETED|Overall Study||1
7896299|NCT00732381|19431962|P1|NOT COMPLETED|Overall Study||2
7896300|NCT00732381|19431961|P2|COMPLETED|Overall Study||174
7896301|NCT00732381|19431962|P1|COMPLETED|Overall Study||174
7896302|NCT00732381|19431961|P2|STARTED|Overall Study||175
7896303|NCT00732381|19431962|P1|STARTED|Overall Study||176
7896304|NCT00732303|19431970|P1|NOT COMPLETED|Overall Study||2
7896305|NCT00732303|19431970|P1|COMPLETED|Overall Study||6
7896306|NCT00732303|19431970|P1|STARTED|Overall Study||8
7896307|NCT00732251|19431976|P1|NOT COMPLETED|Overall Study||7
7896308|NCT00732251|19431976|P1|COMPLETED|Overall Study||1
7896309|NCT00732251|19431976|P1|STARTED|Overall Study||8
7896310|NCT00732238|19431984|P2|NOT COMPLETED|Overall Study||1
7896311|NCT00732238|19431985|P1|NOT COMPLETED|Overall Study||5
7896312|NCT00732238|19431984|P2|COMPLETED|Overall Study||27
7896313|NCT00732238|19431985|P1|COMPLETED|Overall Study||28
7896314|NCT00732238|19431984|P2|STARTED|Overall Study||28
7896315|NCT00732238|19431985|P1|STARTED|Overall Study||33
7896316|NCT00732225|19431998|P5|NOT COMPLETED|Overall Study||6
7896317|NCT00732225|19431999|P4|NOT COMPLETED|Overall Study||4
7896318|NCT00732225|19432000|P3|NOT COMPLETED|Overall Study||3
7896319|NCT00732225|19432001|P2|NOT COMPLETED|Overall Study||8
7896320|NCT00732225|19432002|P1|NOT COMPLETED|Overall Study||11
7896321|NCT00732225|19431998|P5|COMPLETED|Overall Study|48 eyes of 48 patients|48
7896322|NCT00732225|19431999|P4|COMPLETED|Overall Study|29 eyes of 29 patients|29
7896323|NCT00732225|19432000|P3|COMPLETED|Overall Study|23 eyes of 23 patients|23
7896324|NCT00732225|19432001|P2|COMPLETED|Overall Study|33 eyes of 32 patients|32
7896325|NCT00732225|19432002|P1|COMPLETED|Overall Study|64 eyes of 60 patients|60
7896326|NCT00732225|19431998|P5|STARTED|Overall Study|55 eyes of 54 patients|54
7896327|NCT00732225|19431999|P4|STARTED|Overall Study|33 eyes of 33 patients|33
7896328|NCT00732225|19432000|P3|STARTED|Overall Study|26 eyes of 26 patients|26
7896329|NCT00732225|19432001|P2|STARTED|Overall Study|41 eyes of 40 patients|40
7896330|NCT00732225|19432002|P1|STARTED|Overall Study|76 eyes of 71 patients|71
7896331|NCT00732212|19432053|P2|NOT COMPLETED|Overall Study||0
7896332|NCT00732212|19432054|P1|NOT COMPLETED|Overall Study||0
7896333|NCT00732212|19432053|P2|COMPLETED|Overall Study||123
7896334|NCT00732212|19432054|P1|COMPLETED|Overall Study||112
7896335|NCT00732212|19432053|P2|Temporarily Suspended|Overall Study||50
7896336|NCT00732212|19432054|P1|Temporarily Suspended|Overall Study|Study was suspended for a 9 month period by the VA DMC because of slow enrollment, then restarted.|50
7896337|NCT00732212|19432053|P2|STARTED|Overall Study||123
7896338|NCT00732212|19432054|P1|STARTED|Overall Study||112
7896339|NCT00732199|19432086|P2|NOT COMPLETED|Overall Study||26
7896340|NCT00732199|19432087|P1|NOT COMPLETED|Overall Study||34
7896341|NCT00732199|19432086|P2|COMPLETED|Overall Study||16
7896342|NCT00732199|19432087|P1|COMPLETED|Overall Study||16
7896343|NCT00732199|19432086|P2|STARTED|Overall Study||42
7896344|NCT00732199|19432087|P1|STARTED|Overall Study||50
7896345|NCT00732160|19432102|P4|NOT COMPLETED|Overall Study||2
7896346|NCT00732160|19432103|P3|NOT COMPLETED|Overall Study||3
7896347|NCT00732160|19432104|P2|NOT COMPLETED|Overall Study||4
7896348|NCT00732160|19432105|P1|NOT COMPLETED|Overall Study||5
7896349|NCT00732160|19432102|P4|COMPLETED|Overall Study||3
7896350|NCT00732160|19432103|P3|COMPLETED|Overall Study||3
7896351|NCT00732160|19432104|P2|COMPLETED|Overall Study||1
7896352|NCT00732160|19432105|P1|COMPLETED|Overall Study||2
7896353|NCT00732160|19432102|P4|LS Aldosterone|Overall Study||5
7896354|NCT00732160|19432103|P3|LS Aldosterone|Overall Study||6
7896355|NCT00732160|19432104|P2|LS Aldosterone|Overall Study||1
7896356|NCT00732160|19432105|P1|LS Aldosterone|Overall Study||2
7896357|NCT00732160|19432102|P4|LS Vehicle|Overall Study||5
7896358|NCT00732160|19432103|P3|LS Vehicle|Overall Study||6
7896359|NCT00732160|19432104|P2|LS Vehicle|Overall Study||1
7896360|NCT00732160|19432105|P1|LS Vehicle|Overall Study||2
7896361|NCT00732160|19432102|P4|HS Aldosterone|Overall Study||3
7896362|NCT00732160|19432103|P3|HS Aldosterone|Overall Study||3
7896363|NCT00732160|19432104|P2|HS Aldosterone|Overall Study||5
7896364|NCT00732160|19432105|P1|HS Aldosterone|Overall Study||7
7896365|NCT00732160|19432102|P4|HS Vehicle|Overall Study||3
7896366|NCT00732160|19432103|P3|HS Vehicle|Overall Study||3
7896367|NCT00732160|19432104|P2|HS Vehicle|Overall Study||5
7896368|NCT00732160|19432105|P1|HS Vehicle|Overall Study||7
7896369|NCT00732160|19432102|P4|STARTED|Overall Study||5
7896370|NCT00732160|19432103|P3|STARTED|Overall Study||6
7896371|NCT00732160|19432104|P2|STARTED|Overall Study||5
7896372|NCT00732160|19432105|P1|STARTED|Overall Study||7
7896373|NCT00732069|19432119|P6|NOT COMPLETED|Third Study Drug||0
7896374|NCT00732069|19432120|P5|NOT COMPLETED|Third Study Drug||0
7896375|NCT00732069|19432121|P4|NOT COMPLETED|Third Study Drug||0
7896376|NCT00732069|19432122|P3|NOT COMPLETED|Third Study Drug||0
7896377|NCT00732069|19432123|P2|NOT COMPLETED|Third Study Drug||0
7896378|NCT00732069|19432124|P1|NOT COMPLETED|Third Study Drug||0
7896379|NCT00732069|19432119|P6|COMPLETED|Third Study Drug||2
7896380|NCT00732069|19432120|P5|COMPLETED|Third Study Drug||3
7896381|NCT00732069|19432121|P4|COMPLETED|Third Study Drug||2
7896382|NCT00732069|19432122|P3|COMPLETED|Third Study Drug||3
7896383|NCT00732069|19432123|P2|COMPLETED|Third Study Drug||3
7896384|NCT00732069|19432124|P1|COMPLETED|Third Study Drug||2
7896385|NCT00732069|19432119|P6|STARTED|Third Study Drug||2
7896386|NCT00732069|19432120|P5|STARTED|Third Study Drug||3
7896387|NCT00732069|19432121|P4|STARTED|Third Study Drug||2
7896388|NCT00732069|19432122|P3|STARTED|Third Study Drug||3
7896389|NCT00732069|19432123|P2|STARTED|Third Study Drug||3
7896390|NCT00732069|19432124|P1|STARTED|Third Study Drug||2
7896391|NCT00732069|19432119|P6|NOT COMPLETED|Washout After Second Study Drug||0
7896392|NCT00732069|19432120|P5|NOT COMPLETED|Washout After Second Study Drug||0
7896393|NCT00732069|19432121|P4|NOT COMPLETED|Washout After Second Study Drug||0
7896394|NCT00732069|19432122|P3|NOT COMPLETED|Washout After Second Study Drug||0
7896395|NCT00732069|19432123|P2|NOT COMPLETED|Washout After Second Study Drug||0
7896396|NCT00732069|19432124|P1|NOT COMPLETED|Washout After Second Study Drug||0
7896397|NCT00732069|19432119|P6|COMPLETED|Washout After Second Study Drug||2
7896398|NCT00732069|19432120|P5|COMPLETED|Washout After Second Study Drug||3
7896399|NCT00732069|19432121|P4|COMPLETED|Washout After Second Study Drug||2
7896400|NCT00732069|19432122|P3|COMPLETED|Washout After Second Study Drug||3
7896401|NCT00732069|19432123|P2|COMPLETED|Washout After Second Study Drug||3
7896402|NCT00732069|19432124|P1|COMPLETED|Washout After Second Study Drug||2
7896403|NCT00732069|19432119|P6|STARTED|Washout After Second Study Drug||2
7896404|NCT00732069|19432120|P5|STARTED|Washout After Second Study Drug||3
7896405|NCT00732069|19432121|P4|STARTED|Washout After Second Study Drug||2
7896406|NCT00732069|19432122|P3|STARTED|Washout After Second Study Drug||3
7896407|NCT00732069|19432123|P2|STARTED|Washout After Second Study Drug||3
7896408|NCT00732069|19432124|P1|STARTED|Washout After Second Study Drug||2
7896409|NCT00732069|19432119|P6|NOT COMPLETED|Second Study Drug||0
7896410|NCT00732069|19432120|P5|NOT COMPLETED|Second Study Drug||0
7896411|NCT00732069|19432121|P4|NOT COMPLETED|Second Study Drug||0
7896412|NCT00732069|19432122|P3|NOT COMPLETED|Second Study Drug||0
7896413|NCT00732069|19432123|P2|NOT COMPLETED|Second Study Drug||0
7896414|NCT00732069|19432124|P1|NOT COMPLETED|Second Study Drug||0
7896415|NCT00732069|19432119|P6|COMPLETED|Second Study Drug||2
7896416|NCT00732069|19432120|P5|COMPLETED|Second Study Drug||3
7896417|NCT00732069|19432121|P4|COMPLETED|Second Study Drug||2
7896418|NCT00732069|19432122|P3|COMPLETED|Second Study Drug||3
7896419|NCT00732069|19432123|P2|COMPLETED|Second Study Drug||3
7896420|NCT00732069|19432124|P1|COMPLETED|Second Study Drug||2
7896421|NCT00732069|19432119|P6|STARTED|Second Study Drug||2
7896422|NCT00732069|19432120|P5|STARTED|Second Study Drug||3
7896423|NCT00732069|19432121|P4|STARTED|Second Study Drug||2
7896424|NCT00732069|19432122|P3|STARTED|Second Study Drug||3
7896425|NCT00732069|19432123|P2|STARTED|Second Study Drug||3
7896426|NCT00732069|19432124|P1|STARTED|Second Study Drug||2
7896427|NCT00732069|19432119|P6|NOT COMPLETED|Washout After First Study Drug||0
7896428|NCT00732069|19432120|P5|NOT COMPLETED|Washout After First Study Drug||0
7896429|NCT00732069|19432121|P4|NOT COMPLETED|Washout After First Study Drug||0
7896430|NCT00732069|19432122|P3|NOT COMPLETED|Washout After First Study Drug||0
7896431|NCT00732069|19432123|P2|NOT COMPLETED|Washout After First Study Drug||0
7896432|NCT00732069|19432124|P1|NOT COMPLETED|Washout After First Study Drug||1
7896433|NCT00732069|19432119|P6|COMPLETED|Washout After First Study Drug||2
7896434|NCT00732069|19432120|P5|COMPLETED|Washout After First Study Drug||3
7896435|NCT00732069|19432121|P4|COMPLETED|Washout After First Study Drug||2
7896436|NCT00732069|19432122|P3|COMPLETED|Washout After First Study Drug||3
7896437|NCT00732069|19432123|P2|COMPLETED|Washout After First Study Drug||3
7896438|NCT00732069|19432124|P1|COMPLETED|Washout After First Study Drug||2
7896439|NCT00732069|19432119|P6|STARTED|Washout After First Study Drug||2
7896440|NCT00732069|19432120|P5|STARTED|Washout After First Study Drug||3
7896441|NCT00732069|19432121|P4|STARTED|Washout After First Study Drug||2
7896442|NCT00732069|19432122|P3|STARTED|Washout After First Study Drug||3
7896443|NCT00732069|19432123|P2|STARTED|Washout After First Study Drug||3
7896444|NCT00732069|19432124|P1|STARTED|Washout After First Study Drug||3
7896445|NCT00732069|19432119|P6|NOT COMPLETED|First Study Drug||0
7896446|NCT00732069|19432120|P5|NOT COMPLETED|First Study Drug||0
7896447|NCT00732069|19432121|P4|NOT COMPLETED|First Study Drug||0
7896448|NCT00732069|19432122|P3|NOT COMPLETED|First Study Drug||0
7896449|NCT00732069|19432123|P2|NOT COMPLETED|First Study Drug||0
7896450|NCT00732069|19432124|P1|NOT COMPLETED|First Study Drug||0
7896451|NCT00732069|19432119|P6|COMPLETED|First Study Drug||2
7896452|NCT00732069|19432120|P5|COMPLETED|First Study Drug||3
7896453|NCT00732069|19432121|P4|COMPLETED|First Study Drug||2
7896454|NCT00732069|19432122|P3|COMPLETED|First Study Drug||3
7896455|NCT00732069|19432123|P2|COMPLETED|First Study Drug||3
7896456|NCT00732069|19432124|P1|COMPLETED|First Study Drug||3
7896457|NCT00732069|19432119|P6|STARTED|First Study Drug||2
7896458|NCT00732069|19432120|P5|STARTED|First Study Drug||3
7896459|NCT00732069|19432121|P4|STARTED|First Study Drug||2
7896460|NCT00732069|19432122|P3|STARTED|First Study Drug||3
7896461|NCT00732069|19432123|P2|STARTED|First Study Drug||3
7896462|NCT00732069|19432124|P1|STARTED|First Study Drug||3
7896463|NCT00732030|19432135|P1|NOT COMPLETED|Overall Study||2
7896464|NCT00732030|19432135|P1|COMPLETED|Overall Study||24
7896465|NCT00732030|19432135|P1|STARTED|Overall Study||26
7896466|NCT00731939|19432142|P1|NOT COMPLETED|Overall Study||34
7896467|NCT00731939|19432142|P1|COMPLETED|Overall Study||90
7896468|NCT00731939|19432142|P1|STARTED|Overall Study||124
7896469|NCT00731874|19432192|P2|NOT COMPLETED|Overall Study||0
7896470|NCT00731874|19432193|P1|NOT COMPLETED|Overall Study||0
7896471|NCT00731874|19432192|P2|COMPLETED|Overall Study||13
7896472|NCT00731874|19432193|P1|COMPLETED|Overall Study||10
7896473|NCT00731874|19432192|P2|STARTED|Overall Study||13
7896474|NCT00731874|19432193|P1|STARTED|Overall Study||10
7896475|NCT00731822|19432219|P2|NOT COMPLETED|Overall Study||1
7896476|NCT00731822|19432220|P1|NOT COMPLETED|Overall Study||4
7896477|NCT00731822|19432219|P2|COMPLETED|Overall Study||39
7896478|NCT00731822|19432220|P1|COMPLETED|Overall Study||16
7896479|NCT00731822|19432219|P2|STARTED|Overall Study||40
7896480|NCT00731822|19432220|P1|STARTED|Overall Study||20
7896481|NCT00731783|19432234|P2|NOT COMPLETED|12 Month Follow-Up Visit||7
7896482|NCT00731783|19432235|P1|NOT COMPLETED|12 Month Follow-Up Visit||6
7896483|NCT00731783|19432234|P2|COMPLETED|12 Month Follow-Up Visit||58
7896484|NCT00731783|19432235|P1|COMPLETED|12 Month Follow-Up Visit||68
7896485|NCT00731783|19432234|P2|STARTED|12 Month Follow-Up Visit||65
7896486|NCT00731783|19432235|P1|STARTED|12 Month Follow-Up Visit||74
7896487|NCT00731783|19432234|P2|NOT COMPLETED|Six Month Follow-Up Visit||3
7896488|NCT00731783|19432235|P1|NOT COMPLETED|Six Month Follow-Up Visit||6
7896489|NCT00731783|19432234|P2|COMPLETED|Six Month Follow-Up Visit||64
7896490|NCT00731783|19432235|P1|COMPLETED|Six Month Follow-Up Visit||71
7896491|NCT00731783|19432234|P2|STARTED|Six Month Follow-Up Visit||67
7896492|NCT00731783|19432235|P1|STARTED|Six Month Follow-Up Visit||77
7896493|NCT00731783|19432234|P2|NOT COMPLETED|Three Month Follow-Up Visit||16
7896494|NCT00731783|19432235|P1|NOT COMPLETED|Three Month Follow-Up Visit||7
7896495|NCT00731783|19432234|P2|COMPLETED|Three Month Follow-Up Visit||57
7896496|NCT00731783|19432235|P1|COMPLETED|Three Month Follow-Up Visit||72
7896497|NCT00731783|19432234|P2|STARTED|Three Month Follow-Up Visit||73
7896498|NCT00731783|19432235|P1|STARTED|Three Month Follow-Up Visit||79
7896499|NCT00731783|19432234|P2|NOT COMPLETED|One Month Follow-Up Visit||22
7896500|NCT00731783|19432235|P1|NOT COMPLETED|One Month Follow-Up Visit||14
7896501|NCT00731783|19432234|P2|COMPLETED|One Month Follow-Up Visit||69
7896502|NCT00731783|19432235|P1|COMPLETED|One Month Follow-Up Visit||78
7896503|NCT00731783|19432234|P2|STARTED|One Month Follow-Up Visit||91
7896504|NCT00731783|19432235|P1|STARTED|One Month Follow-Up Visit||92
7896505|NCT00731770|19432257|P2|NOT COMPLETED|Overall Study||0
7896506|NCT00731770|19432258|P1|NOT COMPLETED|Overall Study||0
7896507|NCT00731770|19432257|P2|COMPLETED|Overall Study||5
7896508|NCT00731770|19432258|P1|COMPLETED|Overall Study||5
7896509|NCT00731770|19432257|P2|STARTED|Overall Study||5
7896510|NCT00731770|19432258|P1|STARTED|Overall Study||5
7896511|NCT00731731|19432269|P3|NOT COMPLETED|Overall Study||3
7896512|NCT00731731|19432270|P2|NOT COMPLETED|Overall Study||0
7896513|NCT00731731|19432271|P1|NOT COMPLETED|Overall Study||0
7896514|NCT00731731|19432269|P3|COMPLETED|Overall Study||107
7896515|NCT00731731|19432270|P2|COMPLETED|Overall Study||3
7896516|NCT00731731|19432271|P1|COMPLETED|Overall Study||12
7896517|NCT00731731|19432269|P3|STARTED|Overall Study||110
7896518|NCT00731731|19432270|P2|STARTED|Overall Study||3
7896519|NCT00731731|19432271|P1|STARTED|Overall Study||12
7896520|NCT00731692|19432289|P3|NOT COMPLETED|Extension Phase||301
7896521|NCT00731692|19432290|P2|NOT COMPLETED|Extension Phase||196
7896522|NCT00731692|19432291|P1|NOT COMPLETED|Extension Phase||74
7896523|NCT00731692|19432289|P3|COMPLETED|Extension Phase||0
7896524|NCT00731692|19432290|P2|COMPLETED|Extension Phase||0
7896525|NCT00731692|19432291|P1|COMPLETED|Extension Phase||0
7896526|NCT00731692|19432289|P3|STARTED|Extension Phase||301
7896527|NCT00731692|19432290|P2|STARTED|Extension Phase||196
7896528|NCT00731692|19432291|P1|STARTED|Extension Phase||74
7896529|NCT00731692|19432289|P3|NOT COMPLETED|Core Study (36 Months)||170
7896530|NCT00731692|19432290|P2|NOT COMPLETED|Core Study (36 Months)||116
7896531|NCT00731692|19432291|P1|NOT COMPLETED|Core Study (36 Months)||68
7896532|NCT00731692|19432289|P3|COMPLETED|Core Study (36 Months)||317
7896533|NCT00731692|19432290|P2|COMPLETED|Core Study (36 Months)||220
7896534|NCT00731692|19432291|P1|COMPLETED|Core Study (36 Months)||79
7896535|NCT00731692|19432289|P3|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
7896536|NCT00731692|19432290|P2|Post Protocol Amendment 5 Switch|Core Study (36 Months)|post protocol amendment 121 patients switch to 0.5 mg dose from 125mg dose|121
7896537|NCT00731692|19432291|P1|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
7896538|NCT00731692|19432289|P3|Pharmacokinetic Analysis Set|Core Study (36 Months)||0
7896539|NCT00731692|19432290|P2|Pharmacokinetic Analysis Set|Core Study (36 Months)||249
7896540|NCT00731692|19432291|P1|Pharmacokinetic Analysis Set|Core Study (36 Months)||102
7896541|NCT00731692|19432289|P3|Full Analysis Set (FAS)|Core Study (36 Months)||487
7896542|NCT00731692|19432290|P2|Full Analysis Set (FAS)|Core Study (36 Months)||336
7896543|NCT00731692|19432291|P1|Full Analysis Set (FAS)|Core Study (36 Months)||0
7896544|NCT00731692|19432289|P3|Safety Set (SAF)|Core Study (36 Months)||487
7896545|NCT00731692|19432290|P2|Safety Set (SAF)|Core Study (36 Months)||336
7896546|NCT00731692|19432291|P1|Safety Set (SAF)|Core Study (36 Months)||0
7896547|NCT00731692|19432289|P3|STARTED|Core Study (36 Months)||487
7896548|NCT00731692|19432290|P2|STARTED|Core Study (36 Months)||336
7896549|NCT00731692|19432291|P1|STARTED|Core Study (36 Months)||147
7896550|NCT00731679|19432337|P2|NOT COMPLETED|Overall Study||26
7896551|NCT00731679|19432338|P1|NOT COMPLETED|Overall Study||22
7896552|NCT00731679|19432337|P2|COMPLETED|Overall Study||283
7896553|NCT00731679|19432338|P1|COMPLETED|Overall Study||292
7896554|NCT00731679|19432337|P2|STARTED|Overall Study||309
7896555|NCT00731679|19432338|P1|STARTED|Overall Study||314
7896556|NCT00731666|19432346|P1|NOT COMPLETED|Overall Study||12
7896557|NCT00731666|19432346|P1|COMPLETED|Overall Study||28
7896558|NCT00731666|19432346|P1|STARTED|Overall Study||40
7896559|NCT00731653|19432352|P1|NOT COMPLETED|Overall Study||9
7896560|NCT00731653|19432352|P1|COMPLETED|Overall Study||72
7896561|NCT00731653|19432352|P1|STARTED|Overall Study||81
7896562|NCT00731640|19432358|P2|NOT COMPLETED|Overall Study||0
7896563|NCT00731640|19432359|P1|NOT COMPLETED|Overall Study||0
7896564|NCT00731640|19432358|P2|COMPLETED|Overall Study||32
7896565|NCT00731640|19432359|P1|COMPLETED|Overall Study||20
7896566|NCT00731640|19432358|P2|STARTED|Overall Study||32
7896567|NCT00731640|19432359|P1|STARTED|Overall Study||20
7896568|NCT00731614|19432373|P2|NOT COMPLETED|Overall Study||13
7896569|NCT00731614|19432374|P1|NOT COMPLETED|Overall Study||7
7896570|NCT00731614|19432373|P2|COMPLETED|Overall Study||18
7896571|NCT00731614|19432374|P1|COMPLETED|Overall Study||16
7896572|NCT00731614|19432373|P2|12 Weeks Posttreatment|Overall Study||23
7896573|NCT00731614|19432374|P1|12 Weeks Posttreatment|Overall Study||18
7896574|NCT00731614|19432373|P2|End of Treatment|Overall Study||24
7896575|NCT00731614|19432374|P1|End of Treatment|Overall Study||16
7896576|NCT00731614|19432373|P2|STARTED|Overall Study||31
7896577|NCT00731614|19432374|P1|STARTED|Overall Study||23
7896578|NCT00731549|19432382|P1|NOT COMPLETED|Overall Study||223
7896579|NCT00731549|19432382|P1|COMPLETED|Overall Study||858
7896580|NCT00731549|19432382|P1|STARTED|Overall Study||1081
7896581|NCT00731484|19432395|P1|NOT COMPLETED|Overall Study||0
7896582|NCT00731484|19432395|P1|COMPLETED|Overall Study||233
7896583|NCT00731484|19432395|P1|STARTED|Overall Study||233
7896584|NCT00731341|19432399|P1|NOT COMPLETED|Overall Study||0
7896585|NCT00731341|19432399|P1|COMPLETED|Overall Study||3
7896586|NCT00731341|19432399|P1|STARTED|Overall Study||3
7896587|NCT00731211|19432408|P1|NOT COMPLETED|Overall Study||0
7896588|NCT00731211|19432408|P1|COMPLETED|Overall Study||55
7896589|NCT00731211|19432408|P1|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55
7896590|NCT00731198|19432415|P2|NOT COMPLETED|Overall Study||6
7896591|NCT00731198|19432416|P1|NOT COMPLETED|Overall Study||6
7896592|NCT00731198|19432415|P2|COMPLETED|Overall Study||319
7896593|NCT00731198|19432416|P1|COMPLETED|Overall Study||319
7896594|NCT00731198|19432415|P2|STARTED|Overall Study||325
7896595|NCT00731198|19432416|P1|STARTED|Overall Study||325
7896596|NCT00731133|19432422|P1|NOT COMPLETED|Overall Study||10
7896597|NCT00731133|19432422|P1|COMPLETED|Overall Study||5
7896598|NCT00731133|19432422|P1|STARTED|Overall Study||15
7896599|NCT00731120|19432430|P3|NOT COMPLETED|Overall Study||36
7896600|NCT00731120|19432431|P2|NOT COMPLETED|Overall Study||43
7896601|NCT00731120|19432432|P1|NOT COMPLETED|Overall Study||42
7896602|NCT00731120|19432430|P3|COMPLETED|Overall Study||116
7896603|NCT00731120|19432431|P2|COMPLETED|Overall Study||109
7896604|NCT00731120|19432432|P1|COMPLETED|Overall Study||111
7896605|NCT00731120|19432430|P3|Treated|Overall Study||152
7896606|NCT00731120|19432431|P2|Treated|Overall Study||151
7896607|NCT00731120|19432432|P1|Treated|Overall Study||153
7896608|NCT00731120|19432430|P3|STARTED|Overall Study||152
7896609|NCT00731120|19432431|P2|STARTED|Overall Study||152
7896610|NCT00731120|19432432|P1|STARTED|Overall Study||153
7896611|NCT00731094|19432469|P2|NOT COMPLETED|Overall Study||11
7896612|NCT00731094|19432470|P1|NOT COMPLETED|Overall Study||18
7896613|NCT00731094|19432469|P2|COMPLETED|Overall Study||105
7896614|NCT00731094|19432470|P1|COMPLETED|Overall Study||98
7896615|NCT00731094|19432469|P2|Month 6|Overall Study||107
7896616|NCT00731094|19432470|P1|Month 6|Overall Study||101
7896617|NCT00731094|19432469|P2|STARTED|Overall Study||116
7896618|NCT00731094|19432470|P1|STARTED|Overall Study||116
7896619|NCT00731055|19432540|P1|NOT COMPLETED|Overall Study||0
7896620|NCT00731055|19432540|P1|COMPLETED|Overall Study||16
7896621|NCT00731055|19432540|P1|Received Varenicline 2.0 mg|Overall Study||16
7896622|NCT00731055|19432540|P1|Received Varenicline 1.0 mg|Overall Study||16
7896623|NCT00731055|19432540|P1|Received Varenicline 0.5 mg|Overall Study||16
7896624|NCT00731055|19432540|P1|Received Placebo|Overall Study||16
7896625|NCT00731055|19432540|P1|STARTED|Overall Study|This is a within-subjects study design.|16
7896626|NCT00731042|19432549|P2|NOT COMPLETED|Second Intervention||2
7896627|NCT00731042|19432550|P1|NOT COMPLETED|Second Intervention||0
7896628|NCT00731042|19432549|P2|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15
7896629|NCT00731042|19432550|P1|COMPLETED|Second Intervention||16
7896630|NCT00731042|19432549|P2|STARTED|Second Intervention||17
7896631|NCT00731042|19432550|P1|STARTED|Second Intervention||16
7896632|NCT00731042|19432549|P2|NOT COMPLETED|Wash-out||0
7896633|NCT00731042|19432550|P1|NOT COMPLETED|Wash-out||0
7896634|NCT00731042|19432549|P2|COMPLETED|Wash-out||17
7896635|NCT00731042|19432550|P1|COMPLETED|Wash-out||16
7896636|NCT00731042|19432549|P2|STARTED|Wash-out||17
7896637|NCT00731042|19432550|P1|STARTED|Wash-out||16
7896638|NCT00731042|19432549|P2|NOT COMPLETED|First Intervention||0
7896639|NCT00731042|19432550|P1|NOT COMPLETED|First Intervention||0
7896640|NCT00731042|19432549|P2|COMPLETED|First Intervention||17
7896641|NCT00731042|19432550|P1|COMPLETED|First Intervention||16
7896642|NCT00731042|19432549|P2|STARTED|First Intervention||17
7896643|NCT00731042|19432550|P1|STARTED|First Intervention||16
7896644|NCT00730964|19432556|P1|NOT COMPLETED|Overall Study||0
7896645|NCT00730964|19432556|P1|COMPLETED|Overall Study||1039
7896646|NCT00730964|19432556|P1|STARTED|Overall Study||1039
7896647|NCT00730925|19432561|P1|NOT COMPLETED|Overall Study||41
7896648|NCT00730925|19432561|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date|0
7896649|NCT00730925|19432561|P1|STARTED|Overall Study||41
7896650|NCT00730912|19432571|P3|NOT COMPLETED|Overall Study||1
7896651|NCT00730912|19432572|P2|NOT COMPLETED|Overall Study||0
7896652|NCT00730912|19432573|P1|NOT COMPLETED|Overall Study||0
7896653|NCT00730912|19432571|P3|COMPLETED|Overall Study||103
7896654|NCT00730912|19432572|P2|COMPLETED|Overall Study||104
7896655|NCT00730912|19432573|P1|COMPLETED|Overall Study||53
7896656|NCT00730912|19432571|P3|STARTED|Overall Study||104
7896657|NCT00730912|19432572|P2|STARTED|Overall Study||104
7896658|NCT00730912|19432573|P1|STARTED|Overall Study||53
7896659|NCT00730886|19432586|P2|NOT COMPLETED|Overall Study||0
7896660|NCT00730886|19432587|P1|NOT COMPLETED|Overall Study||2
7896661|NCT00730886|19432586|P2|COMPLETED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
7896662|NCT00730886|19432587|P1|COMPLETED|Overall Study||0
7896663|NCT00730886|19432586|P2|STARTED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
7896664|NCT00730886|19432587|P1|STARTED|Overall Study||2
7896665|NCT00730847|19432611|P1|NOT COMPLETED|Overall Study||131
7896666|NCT00730847|19432611|P1|COMPLETED|Overall Study||465
7896667|NCT00730847|19432611|P1|STARTED|Overall Study||596
7896668|NCT00730756|19432620|P2|NOT COMPLETED|Overall Study||5
7896669|NCT00730756|19432621|P1|NOT COMPLETED|Overall Study||4
7896670|NCT00730756|19432620|P2|COMPLETED|Overall Study||48
7896671|NCT00730756|19432621|P1|COMPLETED|Overall Study||45
7896672|NCT00730756|19432620|P2|STARTED|Overall Study||53
7896673|NCT00730756|19432621|P1|STARTED|Overall Study||49
7896674|NCT00730730|19432643|P1|NOT COMPLETED|Overall Study||0
7896675|NCT00730730|19432643|P1|COMPLETED|Overall Study||50
7896676|NCT00730730|19432643|P1|STARTED|Overall Study||50
7896677|NCT00730691|19432655|P5|NOT COMPLETED|Overall Study||50
7896678|NCT00730691|19432656|P4|NOT COMPLETED|Overall Study||45
7896679|NCT00730691|19432657|P3|NOT COMPLETED|Overall Study||39
7896680|NCT00730691|19432658|P2|NOT COMPLETED|Overall Study||36
7896681|NCT00730691|19432659|P1|NOT COMPLETED|Overall Study||36
7896682|NCT00730691|19432655|P5|COMPLETED|Overall Study||106
7896683|NCT00730691|19432656|P4|COMPLETED|Overall Study||111
7896684|NCT00730691|19432657|P3|COMPLETED|Overall Study||117
7896685|NCT00730691|19432658|P2|COMPLETED|Overall Study||120
7896686|NCT00730691|19432659|P1|COMPLETED|Overall Study||121
7896687|NCT00730691|19432655|P5|STARTED|Overall Study||156
7896688|NCT00730691|19432656|P4|STARTED|Overall Study||156
7896689|NCT00730691|19432657|P3|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156
7896690|NCT00730691|19432658|P2|STARTED|Overall Study||156
7896691|NCT00730691|19432659|P1|STARTED|Overall Study||157
7896692|NCT00730639|19432751|P5|NOT COMPLETED|Overall Study||131
7896693|NCT00730639|19432752|P4|NOT COMPLETED|Overall Study||54
7896694|NCT00730639|19432753|P3|NOT COMPLETED|Overall Study||86
7896695|NCT00730639|19432754|P2|NOT COMPLETED|Overall Study||18
7896696|NCT00730639|19432755|P1|NOT COMPLETED|Overall Study||17
7896697|NCT00730639|19432751|P5|COMPLETED|Overall Study||0
7896698|NCT00730639|19432752|P4|COMPLETED|Overall Study||0
7896699|NCT00730639|19432753|P3|COMPLETED|Overall Study||0
7896700|NCT00730639|19432754|P2|COMPLETED|Overall Study||0
7896701|NCT00730639|19432755|P1|COMPLETED|Overall Study||0
7896702|NCT00730639|19432751|P5|STARTED|Overall Study||131
7896703|NCT00730639|19432752|P4|STARTED|Overall Study||54
7896704|NCT00730639|19432753|P3|STARTED|Overall Study||86
7896705|NCT00730639|19432754|P2|STARTED|Overall Study||18
7896706|NCT00730639|19432755|P1|STARTED|Overall Study||17
7896707|NCT00730522|19432821|P2|NOT COMPLETED|Overall Study||0
7896708|NCT00730522|19432822|P1|NOT COMPLETED|Overall Study||0
7896709|NCT00730522|19432821|P2|COMPLETED|Overall Study||27
7896710|NCT00730522|19432822|P1|COMPLETED|Overall Study||28
7896711|NCT00730522|19432821|P2|STARTED|Overall Study||27
7896712|NCT00730522|19432822|P1|STARTED|Overall Study||28
7896713|NCT00730483|19432830|P1|NOT COMPLETED|Overall Study||7
7896714|NCT00730483|19432830|P1|COMPLETED|Overall Study||6
7896715|NCT00730483|19432830|P1|6 Months After First DEB-TACE|Overall Study||10
7896716|NCT00730483|19432830|P1|1 Month After First DEB-TACE|Overall Study||13
7896717|NCT00730483|19432830|P1|STARTED|Overall Study||13
7896718|NCT00730405|19432843|P5|NOT COMPLETED|Overall Study-follow-up Phase||22
7896719|NCT00730405|19432844|P4|NOT COMPLETED|Overall Study-follow-up Phase||17
7896720|NCT00730405|19432845|P3|NOT COMPLETED|Overall Study-follow-up Phase||23
7896721|NCT00730405|19432846|P2|NOT COMPLETED|Overall Study-follow-up Phase||21
7896722|NCT00730405|19432847|P1|NOT COMPLETED|Overall Study-follow-up Phase||21
7896723|NCT00730405|19432843|P5|COMPLETED|Overall Study-follow-up Phase||93
7896724|NCT00730405|19432844|P4|COMPLETED|Overall Study-follow-up Phase||100
7896725|NCT00730405|19432845|P3|COMPLETED|Overall Study-follow-up Phase||94
7896726|NCT00730405|19432846|P2|COMPLETED|Overall Study-follow-up Phase||96
7896727|NCT00730405|19432847|P1|COMPLETED|Overall Study-follow-up Phase||95
7896728|NCT00730405|19432843|P5|STARTED|Overall Study-follow-up Phase||115
7896729|NCT00730405|19432844|P4|STARTED|Overall Study-follow-up Phase||117
7896730|NCT00730405|19432845|P3|STARTED|Overall Study-follow-up Phase||117
7896731|NCT00730405|19432846|P2|STARTED|Overall Study-follow-up Phase||117
7896732|NCT00730405|19432847|P1|STARTED|Overall Study-follow-up Phase||116
7896733|NCT00730405|19432843|P5|NOT COMPLETED|Overall Study-Treatment Phase||20
7896734|NCT00730405|19432844|P4|NOT COMPLETED|Overall Study-Treatment Phase||19
7896735|NCT00730405|19432845|P3|NOT COMPLETED|Overall Study-Treatment Phase||21
7896736|NCT00730405|19432846|P2|NOT COMPLETED|Overall Study-Treatment Phase||21
7896737|NCT00730405|19432847|P1|NOT COMPLETED|Overall Study-Treatment Phase||19
7896738|NCT00730405|19432843|P5|COMPLETED|Overall Study-Treatment Phase||95
7896739|NCT00730405|19432844|P4|COMPLETED|Overall Study-Treatment Phase||98
7896740|NCT00730405|19432845|P3|COMPLETED|Overall Study-Treatment Phase||96
7896741|NCT00730405|19432846|P2|COMPLETED|Overall Study-Treatment Phase||96
7896742|NCT00730405|19432847|P1|COMPLETED|Overall Study-Treatment Phase||97
7896743|NCT00730405|19432843|P5|STARTED|Overall Study-Treatment Phase||115
7896744|NCT00730405|19432844|P4|STARTED|Overall Study-Treatment Phase||117
7896745|NCT00730405|19432845|P3|STARTED|Overall Study-Treatment Phase||117
7896746|NCT00730405|19432846|P2|STARTED|Overall Study-Treatment Phase||117
7896747|NCT00730405|19432847|P1|STARTED|Overall Study-Treatment Phase||116
7896748|NCT00730353|19432884|P1|NOT COMPLETED|Overall Study||0
7896749|NCT00730353|19432884|P1|COMPLETED|Overall Study||28
7896750|NCT00730353|19432884|P1|STARTED|Overall Study||28
7896751|NCT00730327|19432894|P2|NOT COMPLETED|Overall Study||37
7896752|NCT00730327|19432895|P1|NOT COMPLETED|Overall Study||27
7896753|NCT00730327|19432894|P2|COMPLETED|Overall Study||93
7896754|NCT00730327|19432895|P1|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98
7896755|NCT00730327|19432894|P2|Completed Week 26|Overall Study||99
7896756|NCT00730327|19432895|P1|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125
7896757|NCT00730327|19432894|P2|STARTED|Overall Study||130
7896758|NCT00730327|19432895|P1|STARTED|Overall Study|Started is defined as subjects that began treatment.|125
7896759|NCT00730275|19432920|P4|NOT COMPLETED|Overall Study||1
7896760|NCT00730275|19432921|P3|NOT COMPLETED|Overall Study||0
7896761|NCT00730275|19432922|P2|NOT COMPLETED|Overall Study||0
7896762|NCT00730275|19432923|P1|NOT COMPLETED|Overall Study||0
7896763|NCT00730275|19432920|P4|COMPLETED|Overall Study||8
7896764|NCT00730275|19432921|P3|COMPLETED|Overall Study||8
7896765|NCT00730275|19432922|P2|COMPLETED|Overall Study||9
7896766|NCT00730275|19432923|P1|COMPLETED|Overall Study||9
7896767|NCT00730275|19432920|P4|STARTED|Overall Study||9
7896768|NCT00730275|19432921|P3|STARTED|Overall Study||8
7896769|NCT00730275|19432922|P2|STARTED|Overall Study||9
7896770|NCT00730275|19432923|P1|STARTED|Overall Study||9
7896771|NCT00730236|19432949|P1|NOT COMPLETED|Overall Study||6
7896772|NCT00730236|19432949|P1|COMPLETED|Overall Study||23
7896773|NCT00730236|19432949|P1|STARTED|Overall Study||29
7896774|NCT00730171|19432964|P1|NOT COMPLETED|Overall Study||771
7896775|NCT00730171|19432964|P1|COMPLETED|Overall Study||954
7896776|NCT00730171|19432964|P1|IBS-C Safety Population|Overall Study||1119
7896777|NCT00730171|19432964|P1|CC Safety Population|Overall Study||607
7896778|NCT00730171|19432964|P1|STARTED|Overall Study||1725
7896779|NCT00730158|19432974|P2|NOT COMPLETED|Overall Study||1
7896780|NCT00730158|19432975|P1|NOT COMPLETED|Overall Study||1
7896781|NCT00730158|19432974|P2|COMPLETED|Overall Study||15
7896782|NCT00730158|19432975|P1|COMPLETED|Overall Study||16
7896783|NCT00730158|19432974|P2|STARTED|Overall Study||16
7896784|NCT00730158|19432975|P1|STARTED|Overall Study||17
7896785|NCT00730132|19433013|P1|NOT COMPLETED|Overall Study||155
7896786|NCT00730132|19433013|P1|COMPLETED|Overall Study||557
7896787|NCT00730132|19433013|P1|STARTED|Overall Study||712
7896788|NCT00730041|19433031|P2|NOT COMPLETED|Overall Study||2
7896789|NCT00730041|19433032|P1|NOT COMPLETED|Overall Study||0
7896790|NCT00730041|19433031|P2|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23
7896791|NCT00730041|19433032|P1|COMPLETED|Overall Study||26
7896792|NCT00730041|19433031|P2|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25
7896793|NCT00730041|19433032|P1|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26
7896794|NCT00730028|19433055|P5|NOT COMPLETED|Overall Study||82
7896795|NCT00730028|19433056|P4|NOT COMPLETED|Overall Study||56
7896796|NCT00730028|19433057|P3|NOT COMPLETED|Overall Study||45
7896797|NCT00730028|19433058|P2|NOT COMPLETED|Overall Study||66
7896798|NCT00730028|19433059|P1|NOT COMPLETED|Overall Study||60
7896799|NCT00730028|19433055|P5|COMPLETED|Overall Study||175
7896800|NCT00730028|19433056|P4|COMPLETED|Overall Study||207
7896801|NCT00730028|19433057|P3|COMPLETED|Overall Study||221
7896802|NCT00730028|19433058|P2|COMPLETED|Overall Study||194
7896803|NCT00730028|19433059|P1|COMPLETED|Overall Study||204
7896804|NCT00730028|19433055|P5|STARTED|Overall Study||257
7896805|NCT00730028|19433056|P4|STARTED|Overall Study||263
7896806|NCT00730028|19433057|P3|STARTED|Overall Study||266
7896807|NCT00730028|19433058|P2|STARTED|Overall Study||260
7896808|NCT00730028|19433059|P1|STARTED|Overall Study||264
7896809|NCT00730015|19433109|P3|NOT COMPLETED|Overall Study||32
7896810|NCT00730015|19433110|P2|NOT COMPLETED|Overall Study||40
7896811|NCT00730015|19433111|P1|NOT COMPLETED|Overall Study||31
7896812|NCT00730015|19433109|P3|COMPLETED|Overall Study||177
7896813|NCT00730015|19433110|P2|COMPLETED|Overall Study||177
7896814|NCT00730015|19433111|P1|COMPLETED|Overall Study||186
7896815|NCT00730015|19433109|P3|STARTED|Overall Study||209
7896816|NCT00730015|19433110|P2|STARTED|Overall Study||217
7896817|NCT00730015|19433111|P1|STARTED|Overall Study||217
7896818|NCT00729937|19433151|P6|NOT COMPLETED|Overall Study||37
7896819|NCT00729937|19433152|P5|NOT COMPLETED|Overall Study||28
7896820|NCT00729937|19433153|P4|NOT COMPLETED|Overall Study||34
7896821|NCT00729937|19433154|P3|NOT COMPLETED|Overall Study||29
7896822|NCT00729937|19433155|P2|NOT COMPLETED|Overall Study||88
7896823|NCT00729937|19433156|P1|NOT COMPLETED|Overall Study||74
7896824|NCT00729937|19433151|P6|COMPLETED|Overall Study||214
7896825|NCT00729937|19433152|P5|COMPLETED|Overall Study||221
7896826|NCT00729937|19433153|P4|COMPLETED|Overall Study||215
7896827|NCT00729937|19433154|P3|COMPLETED|Overall Study||222
7896828|NCT00729937|19433155|P2|COMPLETED|Overall Study||548
7896829|NCT00729937|19433156|P1|COMPLETED|Overall Study||555
7896830|NCT00729937|19433151|P6|STARTED|Overall Study||251
7896831|NCT00729937|19433152|P5|STARTED|Overall Study||249
7896832|NCT00729937|19433153|P4|STARTED|Overall Study||249
7896833|NCT00729937|19433154|P3|STARTED|Overall Study||251
7896834|NCT00729937|19433155|P2|STARTED|Overall Study||636
7896835|NCT00729937|19433156|P1|STARTED|Overall Study||629
7896836|NCT00729924|19433350|P1|NOT COMPLETED|Overall Study||0
7896837|NCT00729924|19433350|P1|COMPLETED|Overall Study||40
7896838|NCT00729924|19433350|P1|STARTED|Overall Study||40
7896839|NCT00729859|19433360|P3|NOT COMPLETED|Overall Study||0
7896840|NCT00729859|19433361|P2|NOT COMPLETED|Overall Study||2
7896841|NCT00729859|19433362|P1|NOT COMPLETED|Overall Study||0
7896842|NCT00729859|19433360|P3|COMPLETED|Overall Study||8
7896843|NCT00729859|19433361|P2|COMPLETED|Overall Study||6
7896844|NCT00729859|19433362|P1|COMPLETED|Overall Study||8
7896845|NCT00729859|19433360|P3|STARTED|Overall Study||8
7896846|NCT00729859|19433361|P2|STARTED|Overall Study||8
7896847|NCT00729859|19433362|P1|STARTED|Overall Study||8
7896848|NCT00729846|19433399|P2|NOT COMPLETED|Overall Study||0
7896849|NCT00729846|19433400|P1|NOT COMPLETED|Overall Study||0
7896850|NCT00729846|19433399|P2|COMPLETED|Overall Study||11
7896851|NCT00729846|19433400|P1|COMPLETED|Overall Study||11
7896852|NCT00729846|19433399|P2|STARTED|Overall Study||11
7896853|NCT00729846|19433400|P1|STARTED|Overall Study||11
7896854|NCT00729833|19433406|P4|NOT COMPLETED|Overall Study||6
7896855|NCT00729833|19433407|P3|NOT COMPLETED|Overall Study||12
7896856|NCT00729833|19433408|P2|NOT COMPLETED|Overall Study||7
7896857|NCT00729833|19433409|P1|NOT COMPLETED|Overall Study||20
7896858|NCT00729833|19433406|P4|COMPLETED|Overall Study||0
7896859|NCT00729833|19433407|P3|COMPLETED|Overall Study||0
7896860|NCT00729833|19433408|P2|COMPLETED|Overall Study||0
7896861|NCT00729833|19433409|P1|COMPLETED|Overall Study||0
7896862|NCT00729833|19433406|P4|STARTED|Overall Study||6
7896863|NCT00729833|19433407|P3|STARTED|Overall Study||12
7896864|NCT00729833|19433408|P2|STARTED|Overall Study||7
7896865|NCT00729833|19433409|P1|STARTED|Overall Study||20
7896866|NCT00729807|19433448|P1|NOT COMPLETED|Overall Study||0
7896867|NCT00729807|19433448|P1|COMPLETED|Overall Study||6
7896868|NCT00729807|19433448|P1|STARTED|Overall Study||6
7896869|NCT00729781|19433458|P1|NOT COMPLETED|Long-term Follow-up Study||0
7896870|NCT00729781|19433458|P1|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42
7896871|NCT00729781|19433458|P1|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42
7896872|NCT00729781|19433458|P1|NOT COMPLETED|Original Study||0
7896873|NCT00729781|19433458|P1|COMPLETED|Original Study||45
7896874|NCT00729781|19433458|P1|STARTED|Original Study||45
7896875|NCT00729690|19433467|P3|NOT COMPLETED|Overall Study||2
7896876|NCT00729690|19433468|P2|NOT COMPLETED|Overall Study||2
7896877|NCT00729690|19433469|P1|NOT COMPLETED|Overall Study||0
7896878|NCT00729690|19433467|P3|COMPLETED|Overall Study||14
7896879|NCT00729690|19433468|P2|COMPLETED|Overall Study||14
7896880|NCT00729690|19433469|P1|COMPLETED|Overall Study||16
7896881|NCT00729690|19433467|P3|STARTED|Overall Study||16
7896882|NCT00729690|19433468|P2|STARTED|Overall Study||16
7896883|NCT00729690|19433469|P1|STARTED|Overall Study||16
7896884|NCT00729677|19433486|P1|NOT COMPLETED|Overall Study||0
7896885|NCT00729677|19433486|P1|COMPLETED|Overall Study||64
7896886|NCT00729677|19433486|P1|STARTED|Overall Study||64
7896887|NCT00729651|19433499|P2|NOT COMPLETED|Overall Study||18
7896888|NCT00729651|19433500|P1|NOT COMPLETED|Overall Study||19
7896889|NCT00729651|19433499|P2|COMPLETED|Overall Study||152
7896890|NCT00729651|19433500|P1|COMPLETED|Overall Study||154
7896891|NCT00729651|19433499|P2|STARTED|Overall Study||170
7896892|NCT00729651|19433500|P1|STARTED|Overall Study||173
7896893|NCT00729612|19433512|P1|NOT COMPLETED|Overall Study||10
7896894|NCT00729612|19433512|P1|COMPLETED|Overall Study||53
7896895|NCT00729612|19433512|P1|Died After Cycle 2 Before Response Eval|Overall Study||1
7896896|NCT00729612|19433512|P1|Received Cycle 2|Overall Study||54
7896897|NCT00729612|19433512|P1|Did Not Receive Cycle 2|Overall Study||7
7896898|NCT00729612|19433512|P1|Received Cycle 1|Overall Study||62
7896899|NCT00729612|19433512|P1|Died Before Cycle 1|Overall Study||1
7896900|NCT00729612|19433512|P1|STARTED|Overall Study||63
7896901|NCT00729586|19433521|P2|NOT COMPLETED|Overall Study||1
7896902|NCT00729586|19433522|P1|NOT COMPLETED|Overall Study||1
7896903|NCT00729586|19433521|P2|COMPLETED|Overall Study|Eligible and treated patients|21
7896904|NCT00729586|19433522|P1|COMPLETED|Overall Study|Eligible and treated patients|50
7896905|NCT00729586|19433521|P2|STARTED|Overall Study||22
7896906|NCT00729586|19433522|P1|STARTED|Overall Study||51
7896907|NCT00729560|19433535|P1|NOT COMPLETED|Overall Study||3
7896908|NCT00729560|19433535|P1|COMPLETED|Overall Study||5
7896909|NCT00729560|19433535|P1|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8
7896910|NCT00729521|19433542|P3|NOT COMPLETED|Overall Study||0
7896911|NCT00729521|19433543|P2|NOT COMPLETED|Overall Study||0
7896912|NCT00729521|19433544|P1|NOT COMPLETED|Overall Study||0
7896913|NCT00729521|19433542|P3|COMPLETED|Overall Study|Average annual population over 65 years old.|7701
7896914|NCT00729521|19433543|P2|COMPLETED|Overall Study|Average annual population over 65 years old.|14842
7896915|NCT00729521|19433544|P1|COMPLETED|Overall Study|Average annual population over 65 years old.|12494
7896916|NCT00729521|19433542|P3|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701
7896917|NCT00729521|19433543|P2|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842
7896918|NCT00729521|19433544|P1|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494
7896919|NCT00729482|19433552|P1|NOT COMPLETED|Overall Study||0
7896920|NCT00729482|19433552|P1|COMPLETED|Overall Study||54
7896921|NCT00729482|19433552|P1|STARTED|Overall Study||54
7896922|NCT00729469|19433561|P2|NOT COMPLETED|Overall Study||47
7896923|NCT00729469|19433562|P1|NOT COMPLETED|Overall Study||53
7896924|NCT00729469|19433561|P2|COMPLETED|Overall Study||416
7896925|NCT00729469|19433562|P1|COMPLETED|Overall Study||403
7896926|NCT00729469|19433561|P2|STARTED|Overall Study||463
7896927|NCT00729469|19433562|P1|STARTED|Overall Study||456
7896928|NCT00729430|19433600|P2|NOT COMPLETED|Overall Study||50
7896929|NCT00729430|19433601|P1|NOT COMPLETED|Overall Study||47
7896930|NCT00729430|19433600|P2|COMPLETED|Overall Study||128
7896931|NCT00729430|19433601|P1|COMPLETED|Overall Study||133
7896932|NCT00729430|19433600|P2|STARTED|Overall Study||178
7896933|NCT00729430|19433601|P1|STARTED|Overall Study||180
7896934|NCT00729378|19433615|P2|NOT COMPLETED|36-months||6
7896935|NCT00729378|19433616|P1|NOT COMPLETED|36-months||15
7896936|NCT00729378|19433615|P2|COMPLETED|36-months||95
7896937|NCT00729378|19433616|P1|COMPLETED|36-months||105
7896938|NCT00729378|19433615|P2|STARTED|36-months||101
7896939|NCT00729378|19433616|P1|STARTED|36-months||120
7896940|NCT00729378|19433615|P2|NOT COMPLETED|24-months||51
7896941|NCT00729378|19433616|P1|NOT COMPLETED|24-months||72
7896942|NCT00729378|19433615|P2|COMPLETED|24-months||101
7896943|NCT00729378|19433616|P1|COMPLETED|24-months||120
7896944|NCT00729378|19433615|P2|STARTED|24-months||152
7896945|NCT00729378|19433616|P1|STARTED|24-months||192
7896946|NCT00729378|19433615|P2|NOT COMPLETED|12-months||65
7896947|NCT00729378|19433616|P1|NOT COMPLETED|12-months||100
7896948|NCT00729378|19433615|P2|COMPLETED|12-months||152
7896949|NCT00729378|19433616|P1|COMPLETED|12-months||192
7896950|NCT00729378|19433615|P2|STARTED|12-months||217
7896951|NCT00729378|19433616|P1|STARTED|12-months||292
7896952|NCT00729378|19433615|P2|NOT COMPLETED|Baseline||92
7896953|NCT00729378|19433616|P1|NOT COMPLETED|Baseline||138
7896954|NCT00729378|19433615|P2|COMPLETED|Baseline||217
7896955|NCT00729378|19433616|P1|COMPLETED|Baseline||292
7896956|NCT00729378|19433615|P2|STARTED|Baseline||309
7896957|NCT00729378|19433616|P1|STARTED|Baseline||430
7896958|NCT00729365|19433815|P3|NOT COMPLETED|Overall Study||7
7896959|NCT00729365|19433816|P2|NOT COMPLETED|Overall Study||6
7896960|NCT00729365|19433817|P1|NOT COMPLETED|Overall Study||33
7896961|NCT00729365|19433815|P3|COMPLETED|Overall Study|Study terminated|0
7896962|NCT00729365|19433816|P2|COMPLETED|Overall Study|Study Terminated|0
7896963|NCT00729365|19433817|P1|COMPLETED|Overall Study|Study terminated|0
7896964|NCT00729365|19433815|P3|STARTED|Overall Study||7
7896965|NCT00729365|19433816|P2|STARTED|Overall Study||6
7896966|NCT00729365|19433817|P1|STARTED|Overall Study||33
7896967|NCT00729326|19433830|P2|NOT COMPLETED|Overall Study||9
7896968|NCT00729326|19433831|P1|NOT COMPLETED|Overall Study||10
7896969|NCT00729326|19433830|P2|COMPLETED|Overall Study||33
7896970|NCT00729326|19433831|P1|COMPLETED|Overall Study||31
7896971|NCT00729326|19433830|P2|STARTED|Overall Study||42
7896972|NCT00729326|19433831|P1|STARTED|Overall Study||41
7896973|NCT00729248|19433873|P1|NOT COMPLETED|Overall Study||2
7896974|NCT00729248|19433873|P1|COMPLETED|Overall Study||10
7896975|NCT00729248|19433873|P1|STARTED|Overall Study||12
7896976|NCT00729183|19433880|P2|NOT COMPLETED|Overall Study||15
7896977|NCT00729183|19433881|P1|NOT COMPLETED|Overall Study||25
7896978|NCT00729183|19433880|P2|COMPLETED|Overall Study|Completed 24 month visit|90
7896979|NCT00729183|19433881|P1|COMPLETED|Overall Study|Completed 24 month visit|84
7896980|NCT00729183|19433880|P2|STARTED|Overall Study||105
7896981|NCT00729183|19433881|P1|STARTED|Overall Study||109
7896982|NCT00729157|19433913|P1|NOT COMPLETED|Overall Study||1
7896983|NCT00729157|19433913|P1|COMPLETED|Overall Study||40
7896984|NCT00729157|19433913|P1|STARTED|Overall Study||41
7896985|NCT00729053|19433925|P4|NOT COMPLETED|Overall Study||0
7896986|NCT00729053|19433926|P3|NOT COMPLETED|Overall Study||0
7896987|NCT00729053|19433927|P2|NOT COMPLETED|Overall Study||0
7896988|NCT00729053|19433928|P1|NOT COMPLETED|Overall Study||0
7896989|NCT00729053|19433925|P4|COMPLETED|Overall Study||23
7896990|NCT00729053|19433926|P3|COMPLETED|Overall Study||23
7896991|NCT00729053|19433927|P2|COMPLETED|Overall Study||23
7896992|NCT00729053|19433928|P1|COMPLETED|Overall Study||23
7896993|NCT00729053|19433925|P4|STARTED|Overall Study||23
7896994|NCT00729053|19433926|P3|STARTED|Overall Study||23
7896995|NCT00729053|19433927|P2|STARTED|Overall Study||23
7896996|NCT00729053|19433928|P1|STARTED|Overall Study||23
7896997|NCT00728988|19433956|P2|NOT COMPLETED|Overall Study||88
7896998|NCT00728988|19433957|P1|NOT COMPLETED|Overall Study||93
7896999|NCT00728988|19433956|P2|COMPLETED|Overall Study||164
7897000|NCT00728988|19433957|P1|COMPLETED|Overall Study||154
7897001|NCT00728988|19433956|P2|Full Analysis Set|Overall Study||172
7897002|NCT00728988|19433957|P1|Full Analysis Set|Overall Study||163
7897003|NCT00728988|19433956|P2|Treated|Overall Study||250
7897004|NCT00728988|19433957|P1|Treated|Overall Study||245
7897005|NCT00728988|19433956|P2|STARTED|Overall Study||252
7897006|NCT00728988|19433957|P1|STARTED|Overall Study||247
7897007|NCT00728962|19433975|P1|NOT COMPLETED|Two Year Post Placement Follow-up||3
7897008|NCT00728962|19433975|P1|COMPLETED|Two Year Post Placement Follow-up||59
7897009|NCT00728962|19433975|P1|STARTED|Two Year Post Placement Follow-up||62
7897010|NCT00728962|19433975|P1|NOT COMPLETED|One Year Post Placement Follow-up||0
7897011|NCT00728962|19433975|P1|COMPLETED|One Year Post Placement Follow-up||62
7897012|NCT00728962|19433975|P1|STARTED|One Year Post Placement Follow-up||62
7897013|NCT00728962|19433975|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
7897014|NCT00728962|19433975|P1|COMPLETED|Permanent Prosthesis Placement||62
7897015|NCT00728962|19433975|P1|STARTED|Permanent Prosthesis Placement||65
7897016|NCT00728962|19433975|P1|NOT COMPLETED|Implant Placement Surgery||10
7897017|NCT00728962|19433975|P1|COMPLETED|Implant Placement Surgery||65
7897018|NCT00728962|19433975|P1|STARTED|Implant Placement Surgery||75
7897019|NCT00728949|19433981|P2|NOT COMPLETED|Overall Study||4
7897020|NCT00728949|19433982|P1|NOT COMPLETED|Overall Study||11
7897021|NCT00728949|19433981|P2|COMPLETED|Overall Study||27
7897022|NCT00728949|19433982|P1|COMPLETED|Overall Study||51
7897023|NCT00728949|19433981|P2|STARTED|Overall Study||31
7897024|NCT00728949|19433982|P1|STARTED|Overall Study||62
7897025|NCT00728936|19434007|P7|NOT COMPLETED|Overall Study||0
7897026|NCT00728936|19434008|P6|NOT COMPLETED|Overall Study||1
7897027|NCT00728936|19434009|P5|NOT COMPLETED|Overall Study||0
7897028|NCT00728936|19434010|P4|NOT COMPLETED|Overall Study||0
7897029|NCT00728936|19434011|P3|NOT COMPLETED|Overall Study||0
7897030|NCT00728936|19434012|P2|NOT COMPLETED|Overall Study||0
7897031|NCT00728936|19434013|P1|NOT COMPLETED|Overall Study||0
7897032|NCT00728936|19434007|P7|COMPLETED|Overall Study||7
7897033|NCT00728936|19434008|P6|COMPLETED|Overall Study||7
7897034|NCT00728936|19434009|P5|COMPLETED|Overall Study||8
7897035|NCT00728936|19434010|P4|COMPLETED|Overall Study||8
7897036|NCT00728936|19434011|P3|COMPLETED|Overall Study||9
7897037|NCT00728936|19434012|P2|COMPLETED|Overall Study||8
7897038|NCT00728936|19434013|P1|COMPLETED|Overall Study||10
7897039|NCT00728936|19434007|P7|STARTED|Overall Study||7
7897040|NCT00728936|19434008|P6|STARTED|Overall Study||8
7897041|NCT00728936|19434009|P5|STARTED|Overall Study||8
7897042|NCT00728936|19434010|P4|STARTED|Overall Study||8
7897043|NCT00728936|19434011|P3|STARTED|Overall Study||9
7897044|NCT00728936|19434012|P2|STARTED|Overall Study||8
7897045|NCT00728936|19434013|P1|STARTED|Overall Study||10
7897046|NCT00728923|19434029|P1|NOT COMPLETED|Overall Study||0
7897047|NCT00728923|19434029|P1|COMPLETED|Overall Study||9
7897048|NCT00728923|19434029|P1|STARTED|Overall Study||9
7897049|NCT00728910|19434034|P1|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0
7897050|NCT00728910|19434034|P1|COMPLETED|Atorvastatin+ABT335+ER Niacin||22
7897051|NCT00728910|19434034|P1|STARTED|Atorvastatin+ABT335+ER Niacin||22
7897052|NCT00728910|19434034|P1|NOT COMPLETED|Atorvastatin+ABT335||0
7897053|NCT00728910|19434034|P1|COMPLETED|Atorvastatin+ABT335||22
7897054|NCT00728910|19434034|P1|STARTED|Atorvastatin+ABT335||22
7897055|NCT00728910|19434034|P1|NOT COMPLETED|Atorvastatin||3
7897056|NCT00728910|19434034|P1|COMPLETED|Atorvastatin||22
7897057|NCT00728910|19434034|P1|STARTED|Atorvastatin||25
7897058|NCT00728884|19434046|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
7897059|NCT00728884|19434046|P1|COMPLETED|Two Year Post Placement Follow-up||145
7897060|NCT00728884|19434046|P1|STARTED|Two Year Post Placement Follow-up||145
7897061|NCT00728884|19434046|P1|NOT COMPLETED|One Year Post Placement Follow-up||4
7897062|NCT00728884|19434046|P1|COMPLETED|One Year Post Placement Follow-up||145
7897063|NCT00728884|19434046|P1|STARTED|One Year Post Placement Follow-up||149
7897064|NCT00728884|19434046|P1|NOT COMPLETED|Permanent Prosthesis Placement||13
7897065|NCT00728884|19434046|P1|COMPLETED|Permanent Prosthesis Placement||149
7897066|NCT00728884|19434046|P1|STARTED|Permanent Prosthesis Placement||162
7897067|NCT00728884|19434046|P1|NOT COMPLETED|Implant Placement Surgery||0
7897068|NCT00728884|19434046|P1|COMPLETED|Implant Placement Surgery||162
7897069|NCT00728884|19434046|P1|STARTED|Implant Placement Surgery||162
7897070|NCT00728845|19434052|P2|NOT COMPLETED|Overall Study||0
7897071|NCT00728845|19434053|P1|NOT COMPLETED|Overall Study||0
7897072|NCT00728845|19434052|P2|COMPLETED|Overall Study||0
7897073|NCT00728845|19434053|P1|COMPLETED|Overall Study||8
7897074|NCT00728845|19434052|P2|STARTED|Overall Study||0
7897075|NCT00728845|19434053|P1|STARTED|Overall Study||8
7897076|NCT00728819|19434069|P2|NOT COMPLETED|Overall Study||29
7897077|NCT00728819|19434070|P1|NOT COMPLETED|Overall Study||36
7897078|NCT00728819|19434069|P2|COMPLETED|Overall Study||139
7897079|NCT00728819|19434070|P1|COMPLETED|Overall Study||135
7897080|NCT00728819|19434069|P2|STARTED|Overall Study||168
7897081|NCT00728819|19434070|P1|STARTED|Overall Study||171
7897082|NCT00728754|19434082|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
7897083|NCT00728754|19434083|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
7897084|NCT00728754|19434082|P2|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28
7897085|NCT00728754|19434083|P1|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24
7897086|NCT00728754|19434082|P2|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28
7897087|NCT00728754|19434083|P1|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24
7897088|NCT00728754|19434082|P2|NOT COMPLETED|One Year Post Placement Follow-up||0
7897089|NCT00728754|19434083|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
7897090|NCT00728754|19434082|P2|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28
7897091|NCT00728754|19434083|P1|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24
7897092|NCT00728754|19434082|P2|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28
7897093|NCT00728754|19434083|P1|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25
7897094|NCT00728754|19434082|P2|NOT COMPLETED|Permanent Prosthesis Placement||4
7897095|NCT00728754|19434083|P1|NOT COMPLETED|Permanent Prosthesis Placement||4
7897096|NCT00728754|19434082|P2|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28
7897097|NCT00728754|19434083|P1|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25
7897098|NCT00728754|19434082|P2|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32
7897099|NCT00728754|19434083|P1|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29
7897100|NCT00728754|19434082|P2|NOT COMPLETED|Implant Placement Surgery||0
7897101|NCT00728754|19434083|P1|NOT COMPLETED|Implant Placement Surgery||0
7897102|NCT00728754|19434082|P2|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32
7897103|NCT00728754|19434083|P1|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29
7897104|NCT00728754|19434082|P2|STARTED|Implant Placement Surgery|Individual control implant units is 78|32
7897105|NCT00728754|19434083|P1|STARTED|Implant Placement Surgery|Individual test implant units is 75|29
7897106|NCT00728728|19434091|P2|NOT COMPLETED|Overall Study||12
7897107|NCT00728728|19434092|P1|NOT COMPLETED|Overall Study||4
7897108|NCT00728728|19434091|P2|COMPLETED|Overall Study||34
7897109|NCT00728728|19434092|P1|COMPLETED|Overall Study||38
7897110|NCT00728728|19434091|P2|STARTED|Overall Study||46
7897111|NCT00728728|19434092|P1|STARTED|Overall Study||42
7897112|NCT00728689|19434112|P2|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
7897113|NCT00728689|19434113|P1|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
7897114|NCT00728689|19434112|P2|COMPLETED|Second Intervention (Days 11 - 13)||6
7897115|NCT00728689|19434113|P1|COMPLETED|Second Intervention (Days 11 - 13)||5
7897116|NCT00728689|19434112|P2|STARTED|Second Intervention (Days 11 - 13)||6
7897117|NCT00728689|19434113|P1|STARTED|Second Intervention (Days 11 - 13)||5
7897118|NCT00728689|19434112|P2|NOT COMPLETED|Washout Period (Days 4 - 10)||0
7897119|NCT00728689|19434113|P1|NOT COMPLETED|Washout Period (Days 4 - 10)||1
7897120|NCT00728689|19434112|P2|COMPLETED|Washout Period (Days 4 - 10)||6
7897121|NCT00728689|19434113|P1|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5
7897122|NCT00728689|19434112|P2|STARTED|Washout Period (Days 4 - 10)||6
7897123|NCT00728689|19434113|P1|STARTED|Washout Period (Days 4 - 10)||6
7897124|NCT00728689|19434112|P2|NOT COMPLETED|First Intervention (Days 1 - 3)||0
7897125|NCT00728689|19434113|P1|NOT COMPLETED|First Intervention (Days 1 - 3)||0
7897126|NCT00728689|19434112|P2|COMPLETED|First Intervention (Days 1 - 3)||6
7897127|NCT00728689|19434113|P1|COMPLETED|First Intervention (Days 1 - 3)||6
7897128|NCT00728689|19434112|P2|STARTED|First Intervention (Days 1 - 3)||6
7897129|NCT00728689|19434113|P1|STARTED|First Intervention (Days 1 - 3)||6
7897130|NCT00728507|19434131|P2|NOT COMPLETED|Overall Study||8
7897131|NCT00728507|19434132|P1|NOT COMPLETED|Overall Study||2
7897132|NCT00728507|19434131|P2|COMPLETED|Overall Study||51
7897133|NCT00728507|19434132|P1|COMPLETED|Overall Study||60
7897134|NCT00728507|19434131|P2|STARTED|Overall Study||59
7897135|NCT00728507|19434132|P1|STARTED|Overall Study||62
7897136|NCT00728494|19434142|P2|NOT COMPLETED|Overall Study||7
7897137|NCT00728494|19434143|P1|NOT COMPLETED|Overall Study||9
7897138|NCT00728494|19434142|P2|COMPLETED|Overall Study||32
7897139|NCT00728494|19434143|P1|COMPLETED|Overall Study||51
7897140|NCT00728494|19434142|P2|STARTED|Overall Study||39
7897141|NCT00728494|19434143|P1|STARTED|Overall Study||60
7897142|NCT00728481|19434161|P2|NOT COMPLETED|Overall Study||4
7897143|NCT00728481|19434162|P1|NOT COMPLETED|Overall Study||1
7897144|NCT00728481|19434161|P2|COMPLETED|Overall Study||28
7897145|NCT00728481|19434162|P1|COMPLETED|Overall Study||18
7897146|NCT00728481|19434161|P2|STARTED|Overall Study||32
7897147|NCT00728481|19434162|P1|STARTED|Overall Study||19
7897148|NCT00728468|19434178|P1|NOT COMPLETED|Overall Study||16
7897149|NCT00728468|19434178|P1|COMPLETED|Overall Study||0
7897150|NCT00728468|19434178|P1|Treated|Overall Study||15
7897151|NCT00728468|19434178|P1|STARTED|Overall Study||16
7897152|NCT00728416|19434202|P2|NOT COMPLETED|Overall Study||2
7897153|NCT00728416|19434203|P1|NOT COMPLETED|Overall Study||2
7897154|NCT00728416|19434202|P2|COMPLETED|Overall Study||163
7897155|NCT00728416|19434203|P1|COMPLETED|Overall Study||166
7897156|NCT00728416|19434202|P2|STARTED|Overall Study||165
7897157|NCT00728416|19434203|P1|STARTED|Overall Study||168
7897158|NCT00728260|19434211|P1|NOT COMPLETED|Overall Study||0
7897159|NCT00728260|19434211|P1|COMPLETED|Overall Study||1421
7897160|NCT00728260|19434211|P1|STARTED|Overall Study||1421
7897161|NCT00728182|19434219|P2|NOT COMPLETED|Overall Study||3
7897162|NCT00728182|19434220|P1|NOT COMPLETED|Overall Study||3
7897163|NCT00728182|19434219|P2|COMPLETED|Overall Study||90
7897164|NCT00728182|19434220|P1|COMPLETED|Overall Study||89
7897165|NCT00728182|19434219|P2|STARTED|Overall Study||93
7897166|NCT00728182|19434220|P1|STARTED|Overall Study||92
7897167|NCT00728130|19434248|P1|NOT COMPLETED|Overall Study||3
7897168|NCT00728130|19434248|P1|COMPLETED|Overall Study||19
7897169|NCT00728130|19434248|P1|STARTED|Overall Study||22
7897170|NCT00727961|19434253|P1|NOT COMPLETED|Overall Study||37
7897171|NCT00727961|19434253|P1|COMPLETED|Overall Study||21
7897172|NCT00727961|19434253|P1|STARTED|Overall Study||58
7897173|NCT00727909|19434263|P4|NOT COMPLETED|Overall Study||5
7897174|NCT00727909|19434264|P3|NOT COMPLETED|Overall Study||9
7897175|NCT00727909|19434265|P2|NOT COMPLETED|Overall Study||11
7897176|NCT00727909|19434266|P1|NOT COMPLETED|Overall Study||5
7897177|NCT00727909|19434263|P4|COMPLETED|Overall Study||70
7897178|NCT00727909|19434264|P3|COMPLETED|Overall Study||58
7897179|NCT00727909|19434265|P2|COMPLETED|Overall Study||61
7897180|NCT00727909|19434266|P1|COMPLETED|Overall Study||60
7897181|NCT00727909|19434263|P4|STARTED|Overall Study||75
7897182|NCT00727909|19434264|P3|STARTED|Overall Study||67
7897183|NCT00727909|19434265|P2|STARTED|Overall Study||72
7897184|NCT00727909|19434266|P1|STARTED|Overall Study||65
7897185|NCT00727857|19434273|P3|NOT COMPLETED|Overall Study||68
7897186|NCT00727857|19434274|P2|NOT COMPLETED|Overall Study||64
7897187|NCT00727857|19434275|P1|NOT COMPLETED|Overall Study||44
7897188|NCT00727857|19434273|P3|COMPLETED|Overall Study||142
7897189|NCT00727857|19434274|P2|COMPLETED|Overall Study||125
7897190|NCT00727857|19434275|P1|COMPLETED|Overall Study||157
7897191|NCT00727857|19434273|P3|STARTED|Overall Study||210
7897192|NCT00727857|19434274|P2|STARTED|Overall Study||189
7897193|NCT00727857|19434275|P1|STARTED|Overall Study||201
7897194|NCT00727844|19434363|P4|NOT COMPLETED|Second Randomization||0
7897195|NCT00727844|19434364|P3|NOT COMPLETED|Second Randomization||0
7897196|NCT00727844|19434365|P2|NOT COMPLETED|Second Randomization||0
7897197|NCT00727844|19434366|P1|NOT COMPLETED|Second Randomization||0
7897198|NCT00727844|19434363|P4|COMPLETED|Second Randomization||16
7897199|NCT00727844|19434364|P3|COMPLETED|Second Randomization||17
7897200|NCT00727844|19434365|P2|COMPLETED|Second Randomization||0
7897201|NCT00727844|19434366|P1|COMPLETED|Second Randomization||0
7897202|NCT00727844|19434363|P4|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16
7897203|NCT00727844|19434364|P3|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17
7897204|NCT00727844|19434365|P2|STARTED|Second Randomization||0
7897205|NCT00727844|19434366|P1|STARTED|Second Randomization||0
7897206|NCT00727844|19434363|P4|NOT COMPLETED|Initial Randomization||0
7897207|NCT00727844|19434364|P3|NOT COMPLETED|Initial Randomization||0
7897208|NCT00727844|19434365|P2|NOT COMPLETED|Initial Randomization||0
7897209|NCT00727844|19434366|P1|NOT COMPLETED|Initial Randomization||2
7897210|NCT00727844|19434363|P4|COMPLETED|Initial Randomization||0
7897211|NCT00727844|19434364|P3|COMPLETED|Initial Randomization||0
7897212|NCT00727844|19434365|P2|COMPLETED|Initial Randomization||20
7897213|NCT00727844|19434366|P1|COMPLETED|Initial Randomization||19
7897214|NCT00727844|19434363|P4|Included in MITT Analysis|Initial Randomization||0
7897215|NCT00727844|19434364|P3|Included in MITT Analysis|Initial Randomization||0
7897216|NCT00727844|19434365|P2|Included in MITT Analysis|Initial Randomization||20
7897217|NCT00727844|19434366|P1|Included in MITT Analysis|Initial Randomization||19
7897218|NCT00727844|19434363|P4|STARTED|Initial Randomization||0
7897219|NCT00727844|19434364|P3|STARTED|Initial Randomization||0
7897220|NCT00727844|19434365|P2|STARTED|Initial Randomization||20
7897221|NCT00727844|19434366|P1|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21
7897222|NCT00727740|19434373|P2|NOT COMPLETED|Overall Study||0
7897223|NCT00727740|19434374|P1|NOT COMPLETED|Overall Study||0
7897224|NCT00727740|19434373|P2|COMPLETED|Overall Study||61
7897225|NCT00727740|19434374|P1|COMPLETED|Overall Study||56
7897226|NCT00727740|19434373|P2|STARTED|Overall Study||61
7897227|NCT00727740|19434374|P1|STARTED|Overall Study||56
7897228|NCT00727714|19434380|P1|NOT COMPLETED|Overall Study||2
7897229|NCT00727714|19434380|P1|COMPLETED|Overall Study||93
7897230|NCT00727714|19434380|P1|STARTED|Overall Study||95
7897231|NCT00727649|19434390|P2|NOT COMPLETED|Second Intervention (4-weeks)||3
7897232|NCT00727649|19434391|P1|NOT COMPLETED|Second Intervention (4-weeks)||1
7897233|NCT00727649|19434390|P2|COMPLETED|Second Intervention (4-weeks)||34
7897234|NCT00727649|19434391|P1|COMPLETED|Second Intervention (4-weeks)||29
7897235|NCT00727649|19434390|P2|STARTED|Second Intervention (4-weeks)||37
7897236|NCT00727649|19434391|P1|STARTED|Second Intervention (4-weeks)||30
7897237|NCT00727649|19434390|P2|NOT COMPLETED|Wash-out (2-weeks)||3
7897238|NCT00727649|19434391|P1|NOT COMPLETED|Wash-out (2-weeks)||4
7897239|NCT00727649|19434390|P2|COMPLETED|Wash-out (2-weeks)||37
7897240|NCT00727649|19434391|P1|COMPLETED|Wash-out (2-weeks)||30
7897241|NCT00727649|19434390|P2|STARTED|Wash-out (2-weeks)||40
7897242|NCT00727649|19434391|P1|STARTED|Wash-out (2-weeks)||34
7897243|NCT00727649|19434390|P2|NOT COMPLETED|First Intervention (4-weeks)||3
7897244|NCT00727649|19434391|P1|NOT COMPLETED|First Intervention (4-weeks)||3
7897245|NCT00727649|19434390|P2|COMPLETED|First Intervention (4-weeks)||40
7897246|NCT00727649|19434391|P1|COMPLETED|First Intervention (4-weeks)||34
7897247|NCT00727649|19434390|P2|STARTED|First Intervention (4-weeks)||43
7897248|NCT00727649|19434391|P1|STARTED|First Intervention (4-weeks)||37
7897249|NCT00727636|19434405|P2|NOT COMPLETED|Overall Study||0
7897250|NCT00727636|19434406|P1|NOT COMPLETED|Overall Study||4
7897251|NCT00727636|19434405|P2|COMPLETED|Overall Study||15
7897252|NCT00727636|19434406|P1|COMPLETED|Overall Study||33
7897253|NCT00727636|19434405|P2|STARTED|Overall Study||15
7897254|NCT00727636|19434406|P1|STARTED|Overall Study||37
7897255|NCT00727597|19434420|P2|NOT COMPLETED|Overall Study||0
7897256|NCT00727597|19434421|P1|NOT COMPLETED|Overall Study||0
7897257|NCT00727597|19434420|P2|COMPLETED|Overall Study||50
7897258|NCT00727597|19434421|P1|COMPLETED|Overall Study||51
7897259|NCT00727597|19434420|P2|STARTED|Overall Study||50
7897260|NCT00727597|19434421|P1|STARTED|Overall Study||51
7897261|NCT00727571|19434433|P4|NOT COMPLETED|Overall Study||6
7897262|NCT00727571|19434434|P3|NOT COMPLETED|Overall Study||30
7897263|NCT00727571|19434435|P2|NOT COMPLETED|Overall Study||55
7897264|NCT00727571|19434436|P1|NOT COMPLETED|Overall Study||1
7897265|NCT00727571|19434433|P4|COMPLETED|Overall Study||163
7897266|NCT00727571|19434434|P3|COMPLETED|Overall Study||135
7897267|NCT00727571|19434435|P2|COMPLETED|Overall Study||173
7897268|NCT00727571|19434436|P1|COMPLETED|Overall Study||231
7897269|NCT00727571|19434433|P4|STARTED|Overall Study||169
7897270|NCT00727571|19434434|P3|STARTED|Overall Study||165
7897271|NCT00727571|19434435|P2|STARTED|Overall Study||228
7897272|NCT00727571|19434436|P1|STARTED|Overall Study||232
7897273|NCT00727558|19434463|P2|NOT COMPLETED|Overall Study||3
7897274|NCT00727558|19434464|P1|NOT COMPLETED|Overall Study||2
7897275|NCT00727558|19434463|P2|COMPLETED|Overall Study||118
7897276|NCT00727558|19434464|P1|COMPLETED|Overall Study||125
7897277|NCT00727558|19434463|P2|STARTED|Overall Study||121
7897278|NCT00727558|19434464|P1|STARTED|Overall Study||127
7897279|NCT00727532|19434482|P1|NOT COMPLETED|Overall Study||2
7897280|NCT00727532|19434482|P1|COMPLETED|Overall Study||7
7897281|NCT00727532|19434482|P1|STARTED|Overall Study||9
7897282|NCT00727506|19434494|P6|NOT COMPLETED|Overall Study||39
7897283|NCT00727506|19434495|P5|NOT COMPLETED|Overall Study||41
7897284|NCT00727506|19434496|P4|NOT COMPLETED|Overall Study||39
7897285|NCT00727506|19434497|P3|NOT COMPLETED|Overall Study||18
7897286|NCT00727506|19434498|P2|NOT COMPLETED|Overall Study||8
7897287|NCT00727506|19434499|P1|NOT COMPLETED|Overall Study||6
7897288|NCT00727506|19434494|P6|COMPLETED|Overall Study||0
7897289|NCT00727506|19434495|P5|COMPLETED|Overall Study||0
7897290|NCT00727506|19434496|P4|COMPLETED|Overall Study||0
7897291|NCT00727506|19434497|P3|COMPLETED|Overall Study||0
7897292|NCT00727506|19434498|P2|COMPLETED|Overall Study||0
7897293|NCT00727506|19434499|P1|COMPLETED|Overall Study||0
7897294|NCT00727506|19434494|P6|STARTED|Overall Study|Randomized|39
7897295|NCT00727506|19434495|P5|STARTED|Overall Study|Randomized|41
7897296|NCT00727506|19434496|P4|STARTED|Overall Study|Randomized|39
7897297|NCT00727506|19434497|P3|STARTED|Overall Study|Entered|18
7897298|NCT00727506|19434498|P2|STARTED|Overall Study|Entered|8
7897299|NCT00727506|19434499|P1|STARTED|Overall Study|Entered|6
7897300|NCT00727441|19434595|P3|NOT COMPLETED|Overall Study||25
7897301|NCT00727441|19434596|P2|NOT COMPLETED|Overall Study||22
7897302|NCT00727441|19434597|P1|NOT COMPLETED|Overall Study||18
7897303|NCT00727441|19434595|P3|COMPLETED|Overall Study||5
7897304|NCT00727441|19434596|P2|COMPLETED|Overall Study||6
7897305|NCT00727441|19434597|P1|COMPLETED|Overall Study||11
7897306|NCT00727441|19434595|P3|STARTED|Overall Study||30
7897307|NCT00727441|19434596|P2|STARTED|Overall Study||28
7897308|NCT00727441|19434597|P1|STARTED|Overall Study||29
7897309|NCT00727415|19434617|P1|NOT COMPLETED|Phase II||0
7897310|NCT00727415|19434617|P1|COMPLETED|Phase II||33
7897311|NCT00727415|19434617|P1|STARTED|Phase II||33
7897312|NCT00727415|19434617|P1|NOT COMPLETED|Phase I||2
7897313|NCT00727415|19434617|P1|COMPLETED|Phase I||7
7897314|NCT00727415|19434617|P1|STARTED|Phase I||9
7897315|NCT00727402|19434626|P1|NOT COMPLETED|Overall Study||116
7897316|NCT00727402|19434626|P1|COMPLETED|Overall Study||89
7897317|NCT00727402|19434626|P1|STARTED|Overall Study||205
7897318|NCT00727337|19434634|P4|NOT COMPLETED|Overall Study||9
7897319|NCT00727337|19434635|P3|NOT COMPLETED|Overall Study||10
7897320|NCT00727337|19434636|P2|NOT COMPLETED|Overall Study||10
7897321|NCT00727337|19434637|P1|NOT COMPLETED|Overall Study||7
7897322|NCT00727337|19434634|P4|COMPLETED|Overall Study||64
7897323|NCT00727337|19434635|P3|COMPLETED|Overall Study||63
7897324|NCT00727337|19434636|P2|COMPLETED|Overall Study||55
7897325|NCT00727337|19434637|P1|COMPLETED|Overall Study||61
7897326|NCT00727337|19434634|P4|STARTED|Overall Study||73
7897327|NCT00727337|19434635|P3|STARTED|Overall Study||73
7897328|NCT00727337|19434636|P2|STARTED|Overall Study||65
7897329|NCT00727337|19434637|P1|STARTED|Overall Study||68
7897330|NCT00727311|19434655|P1|NOT COMPLETED|Overall Study||1107
7897331|NCT00727311|19434655|P1|COMPLETED|Overall Study||1195
7897332|NCT00727311|19434655|P1|STARTED|Overall Study||2302
7897333|NCT00727298|19434662|P1|NOT COMPLETED|Overall Study||1257
7897334|NCT00727298|19434662|P1|COMPLETED|Overall Study||3228
7897335|NCT00727298|19434662|P1|STARTED|Overall Study||4485
7897336|NCT00727272|19434668|P3|NOT COMPLETED|Period III||0
7897337|NCT00727272|19434669|P2|NOT COMPLETED|Period III||0
7897338|NCT00727272|19434670|P1|NOT COMPLETED|Period III||0
7897339|NCT00727272|19434668|P3|COMPLETED|Period III||7
7897340|NCT00727272|19434669|P2|COMPLETED|Period III||9
7897341|NCT00727272|19434670|P1|COMPLETED|Period III||9
7897342|NCT00727272|19434668|P3|STARTED|Period III||7
7897343|NCT00727272|19434669|P2|STARTED|Period III||9
7897344|NCT00727272|19434670|P1|STARTED|Period III||9
7897345|NCT00727272|19434668|P3|NOT COMPLETED|Washout Period B||1
7897346|NCT00727272|19434669|P2|NOT COMPLETED|Washout Period B||0
7897347|NCT00727272|19434670|P1|NOT COMPLETED|Washout Period B||0
7897348|NCT00727272|19434668|P3|COMPLETED|Washout Period B|personal reasons|7
7897349|NCT00727272|19434669|P2|COMPLETED|Washout Period B||9
7897350|NCT00727272|19434670|P1|COMPLETED|Washout Period B||9
7897351|NCT00727272|19434668|P3|STARTED|Washout Period B||8
7897352|NCT00727272|19434669|P2|STARTED|Washout Period B||9
7897353|NCT00727272|19434670|P1|STARTED|Washout Period B||9
7897354|NCT00727272|19434668|P3|NOT COMPLETED|Period II||0
7897355|NCT00727272|19434669|P2|NOT COMPLETED|Period II||0
7897356|NCT00727272|19434670|P1|NOT COMPLETED|Period II||0
7897357|NCT00727272|19434668|P3|COMPLETED|Period II||8
7897358|NCT00727272|19434669|P2|COMPLETED|Period II||9
7897359|NCT00727272|19434670|P1|COMPLETED|Period II||9
7897360|NCT00727272|19434668|P3|STARTED|Period II||8
7897361|NCT00727272|19434669|P2|STARTED|Period II||9
7897362|NCT00727272|19434670|P1|STARTED|Period II||9
7897363|NCT00727272|19434668|P3|NOT COMPLETED|Washout Period A||1
7897364|NCT00727272|19434669|P2|NOT COMPLETED|Washout Period A||0
7897365|NCT00727272|19434670|P1|NOT COMPLETED|Washout Period A||0
7897366|NCT00727272|19434668|P3|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8
7897367|NCT00727272|19434669|P2|COMPLETED|Washout Period A||9
7897368|NCT00727272|19434670|P1|COMPLETED|Washout Period A||9
7897369|NCT00727272|19434668|P3|STARTED|Washout Period A||9
7897370|NCT00727272|19434669|P2|STARTED|Washout Period A||9
7897371|NCT00727272|19434670|P1|STARTED|Washout Period A||9
7897372|NCT00727272|19434668|P3|NOT COMPLETED|Period I||0
7897373|NCT00727272|19434669|P2|NOT COMPLETED|Period I||0
7897374|NCT00727272|19434670|P1|NOT COMPLETED|Period I||0
7897375|NCT00727272|19434668|P3|COMPLETED|Period I||9
7897376|NCT00727272|19434669|P2|COMPLETED|Period I||9
7897377|NCT00727272|19434670|P1|COMPLETED|Period I||9
7897378|NCT00727272|19434668|P3|STARTED|Period I||9
7897379|NCT00727272|19434669|P2|STARTED|Period I||9
7897380|NCT00727272|19434670|P1|STARTED|Period I||9
7897381|NCT00727259|19434687|P1|NOT COMPLETED|Overall Study||1055
7897382|NCT00727259|19434687|P1|COMPLETED|Overall Study||940
7897383|NCT00727259|19434687|P1|STARTED|Overall Study||1995
7897384|NCT00727246|19434696|P4|NOT COMPLETED|Overall Study||2
7897385|NCT00727246|19434697|P3|NOT COMPLETED|Overall Study||1
7897386|NCT00727246|19434698|P2|NOT COMPLETED|Overall Study||1
7897387|NCT00727246|19434699|P1|NOT COMPLETED|Overall Study||0
7897388|NCT00727246|19434696|P4|COMPLETED|Overall Study||3
7897389|NCT00727246|19434697|P3|COMPLETED|Overall Study||7
7897390|NCT00727246|19434698|P2|COMPLETED|Overall Study||2
7897391|NCT00727246|19434699|P1|COMPLETED|Overall Study||3
7897392|NCT00727246|19434696|P4|STARTED|Overall Study||5
7897393|NCT00727246|19434697|P3|STARTED|Overall Study||8
7897394|NCT00727246|19434698|P2|STARTED|Overall Study||3
7897395|NCT00727246|19434699|P1|STARTED|Overall Study||3
7897396|NCT00727220|19434715|P2|NOT COMPLETED|Overall Study||4
7897397|NCT00727220|19434716|P1|NOT COMPLETED|Overall Study||1
7897398|NCT00727220|19434715|P2|COMPLETED|Overall Study||17
7897399|NCT00727220|19434716|P1|COMPLETED|Overall Study||20
7897400|NCT00727220|19434715|P2|STARTED|Overall Study||21
7897401|NCT00727220|19434716|P1|STARTED|Overall Study||21
7897402|NCT00727194|19434722|P3|NOT COMPLETED|Treatment Period 2||0
7897403|NCT00727194|19434723|P2|NOT COMPLETED|Treatment Period 2||1
7897404|NCT00727194|19434724|P1|NOT COMPLETED|Treatment Period 2||0
7897405|NCT00727194|19434722|P3|COMPLETED|Treatment Period 2||0
7897406|NCT00727194|19434723|P2|COMPLETED|Treatment Period 2||5
7897407|NCT00727194|19434724|P1|COMPLETED|Treatment Period 2||6
7897408|NCT00727194|19434722|P3|STARTED|Treatment Period 2||0
7897409|NCT00727194|19434723|P2|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
7897410|NCT00727194|19434724|P1|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
7897411|NCT00727194|19434722|P3|NOT COMPLETED|Washout Period||0
7897412|NCT00727194|19434723|P2|NOT COMPLETED|Washout Period||0
7897413|NCT00727194|19434724|P1|NOT COMPLETED|Washout Period||0
7897414|NCT00727194|19434722|P3|COMPLETED|Washout Period||0
7897415|NCT00727194|19434723|P2|COMPLETED|Washout Period||7
7897416|NCT00727194|19434724|P1|COMPLETED|Washout Period||7
7897417|NCT00727194|19434722|P3|STARTED|Washout Period||0
7897418|NCT00727194|19434723|P2|STARTED|Washout Period||7
7897419|NCT00727194|19434724|P1|STARTED|Washout Period||7
7897420|NCT00727194|19434722|P3|NOT COMPLETED|Treatment Period 1||0
7897421|NCT00727194|19434723|P2|NOT COMPLETED|Treatment Period 1||0
7897422|NCT00727194|19434724|P1|NOT COMPLETED|Treatment Period 1||0
7897423|NCT00727194|19434722|P3|COMPLETED|Treatment Period 1||0
7897424|NCT00727194|19434723|P2|COMPLETED|Treatment Period 1||7
7897425|NCT00727194|19434724|P1|COMPLETED|Treatment Period 1||7
7897426|NCT00727194|19434722|P3|STARTED|Treatment Period 1||0
7897427|NCT00727194|19434723|P2|STARTED|Treatment Period 1||7
7897428|NCT00727194|19434724|P1|STARTED|Treatment Period 1||7
7897429|NCT00727194|19434722|P3|NOT COMPLETED|Screening Period||16
7897430|NCT00727194|19434723|P2|NOT COMPLETED|Screening Period||0
7897431|NCT00727194|19434724|P1|NOT COMPLETED|Screening Period||0
7897432|NCT00727194|19434722|P3|COMPLETED|Screening Period||0
7897433|NCT00727194|19434723|P2|COMPLETED|Screening Period||7
7897434|NCT00727194|19434724|P1|COMPLETED|Screening Period||7
7897435|NCT00727194|19434722|P3|STARTED|Screening Period||16
7897436|NCT00727194|19434723|P2|STARTED|Screening Period||7
7897437|NCT00727194|19434724|P1|STARTED|Screening Period||7
7897438|NCT00727090|19434760|P2|NOT COMPLETED|Overall Study||0
7897439|NCT00727090|19434761|P1|NOT COMPLETED|Overall Study||0
7897440|NCT00727090|19434760|P2|COMPLETED|Overall Study||3
7897441|NCT00727090|19434761|P1|COMPLETED|Overall Study||3
7897442|NCT00727090|19434760|P2|STARTED|Overall Study||3
7897443|NCT00727090|19434761|P1|STARTED|Overall Study||3
7897444|NCT00727064|19434779|P2|NOT COMPLETED|Overall Study||0
7897445|NCT00727064|19434780|P1|NOT COMPLETED|Overall Study||0
7897446|NCT00727064|19434779|P2|COMPLETED|Overall Study||7
7897447|NCT00727064|19434780|P1|COMPLETED|Overall Study||7
7897448|NCT00727064|19434779|P2|STARTED|Overall Study||7
7897449|NCT00727064|19434780|P1|STARTED|Overall Study||7
7897450|NCT00727025|19434796|P1|NOT COMPLETED|Overall Study||23
7897451|NCT00727025|19434796|P1|COMPLETED|Overall Study||51
7897452|NCT00727025|19434796|P1|STARTED|Overall Study||74
7897453|NCT00726999|19434808|P2|NOT COMPLETED|Overall Study||1
7897454|NCT00726999|19434809|P1|NOT COMPLETED|Overall Study||3
7897455|NCT00726999|19434808|P2|COMPLETED|Overall Study||30
7897456|NCT00726999|19434809|P1|COMPLETED|Overall Study||29
7897457|NCT00726999|19434808|P2|STARTED|Overall Study||31
7897458|NCT00726999|19434809|P1|STARTED|Overall Study||32
7897459|NCT00726986|19434821|P1|NOT COMPLETED|Maintenance Phase||3
7897460|NCT00726986|19434821|P1|COMPLETED|Maintenance Phase||0
7897461|NCT00726986|19434821|P1|STARTED|Maintenance Phase||3
7897462|NCT00726986|19434821|P1|NOT COMPLETED|Induction Phase||15
7897463|NCT00726986|19434821|P1|COMPLETED|Induction Phase||3
7897464|NCT00726986|19434821|P1|Maintance|Induction Phase||3
7897465|NCT00726986|19434821|P1|STARTED|Induction Phase||18
7897466|NCT00726895|19434828|P2|NOT COMPLETED|Second Intervention||0
7897467|NCT00726895|19434829|P1|NOT COMPLETED|Second Intervention||0
7897468|NCT00726895|19434828|P2|COMPLETED|Second Intervention||11
7897469|NCT00726895|19434829|P1|COMPLETED|Second Intervention||12
7897470|NCT00726895|19434828|P2|STARTED|Second Intervention||11
7897471|NCT00726895|19434829|P1|STARTED|Second Intervention||12
7897472|NCT00726895|19434828|P2|NOT COMPLETED|Washout Period of 7 Days||1
7897473|NCT00726895|19434829|P1|NOT COMPLETED|Washout Period of 7 Days||0
7897474|NCT00726895|19434828|P2|COMPLETED|Washout Period of 7 Days||11
7897475|NCT00726895|19434829|P1|COMPLETED|Washout Period of 7 Days||12
7897476|NCT00726895|19434828|P2|STARTED|Washout Period of 7 Days||12
7897477|NCT00726895|19434829|P1|STARTED|Washout Period of 7 Days||12
7897478|NCT00726895|19434828|P2|NOT COMPLETED|First Intervention||0
7897479|NCT00726895|19434829|P1|NOT COMPLETED|First Intervention||0
7897480|NCT00726895|19434828|P2|COMPLETED|First Intervention||12
7897481|NCT00726895|19434829|P1|COMPLETED|First Intervention||12
7897482|NCT00726895|19434828|P2|STARTED|First Intervention||12
7897483|NCT00726895|19434829|P1|STARTED|First Intervention||12
7897484|NCT00726882|19434842|P1|NOT COMPLETED|Overall Study||22
7897485|NCT00726882|19434842|P1|COMPLETED|Overall Study||13
7897486|NCT00726882|19434842|P1|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6
7897487|NCT00726882|19434842|P1|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22
7897488|NCT00726882|19434842|P1|STARTED|Overall Study||35
7897489|NCT00726830|19434850|P2|NOT COMPLETED|Overall Study||0
7897490|NCT00726830|19434851|P1|NOT COMPLETED|Overall Study||0
7897491|NCT00726830|19434850|P2|COMPLETED|Overall Study||0
7897492|NCT00726830|19434851|P1|COMPLETED|Overall Study||1
7897493|NCT00726830|19434850|P2|STARTED|Overall Study||0
7897494|NCT00726830|19434851|P1|STARTED|Overall Study||1
7897495|NCT00726752|19434857|P1|NOT COMPLETED|Overall Study||6
7897496|NCT00726752|19434857|P1|COMPLETED|Overall Study||0
7897497|NCT00726752|19434857|P1|STARTED|Overall Study||6
7897498|NCT00726739|19434873|P2|NOT COMPLETED|Overall Study||0
7897499|NCT00726739|19434874|P1|NOT COMPLETED|Overall Study||1
7897500|NCT00726739|19434873|P2|COMPLETED|Overall Study||10
7897501|NCT00726739|19434874|P1|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10
7897502|NCT00726739|19434873|P2|STARTED|Overall Study||10
7897503|NCT00726739|19434874|P1|STARTED|Overall Study||11
7897504|NCT00726713|19434890|P2|NOT COMPLETED|Overall Study||7
7897505|NCT00726713|19434891|P1|NOT COMPLETED|Overall Study||7
7897506|NCT00726713|19434890|P2|COMPLETED|Overall Study||101
7897507|NCT00726713|19434891|P1|COMPLETED|Overall Study||99
7897508|NCT00726713|19434890|P2|STARTED|Overall Study||108
7897509|NCT00726713|19434891|P1|STARTED|Overall Study||106
7897510|NCT00726661|19434919|P2|NOT COMPLETED|Overall Study||418
7897511|NCT00726661|19434920|P1|NOT COMPLETED|Overall Study||814
7897512|NCT00726661|19434919|P2|COMPLETED|Overall Study||17
7897513|NCT00726661|19434920|P1|COMPLETED|Overall Study||18
7897514|NCT00726661|19434919|P2|STARTED|Overall Study||435
7897515|NCT00726661|19434920|P1|STARTED|Overall Study||832
7897516|NCT00726622|19434937|P2|NOT COMPLETED|Overall Study||3
7897517|NCT00726622|19434938|P1|NOT COMPLETED|Overall Study||18
7897518|NCT00726622|19434937|P2|COMPLETED|Overall Study||240
7897519|NCT00726622|19434938|P1|COMPLETED|Overall Study||225
7897520|NCT00726622|19434937|P2|STARTED|Overall Study||243
7897521|NCT00726622|19434938|P1|STARTED|Overall Study||243
7897522|NCT00726609|19434956|P1|NOT COMPLETED|Overall Study||98
7897523|NCT00726609|19434956|P1|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116
7897524|NCT00726609|19434956|P1|STARTED|Overall Study||214
7897525|NCT00726557|19434960|P1|NOT COMPLETED|Overall Study||128
7897526|NCT00726557|19434960|P1|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118
7897527|NCT00726557|19434960|P1|STARTED|Overall Study||246
7897528|NCT00726453|19434967|P2|NOT COMPLETED|38 mm Length Group||3
7897529|NCT00726453|19434968|P1|NOT COMPLETED|38 mm Length Group||0
7897530|NCT00726453|19434967|P2|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111
7897531|NCT00726453|19434968|P1|COMPLETED|38 mm Length Group||0
7897532|NCT00726453|19434967|P2|STARTED|38 mm Length Group||114
7897533|NCT00726453|19434968|P1|STARTED|38 mm Length Group||0
7897534|NCT00726453|19434967|P2|NOT COMPLETED|Primary Enrollment Group||0
7897535|NCT00726453|19434968|P1|NOT COMPLETED|Primary Enrollment Group||31
7897536|NCT00726453|19434967|P2|COMPLETED|Primary Enrollment Group||0
7897537|NCT00726453|19434968|P1|COMPLETED|Primary Enrollment Group||1371
7897538|NCT00726453|19434967|P2|STARTED|Primary Enrollment Group||0
7897539|NCT00726453|19434968|P1|STARTED|Primary Enrollment Group||1402
7897540|NCT00726414|19434978|P2|NOT COMPLETED|Second Intervention||0
7897541|NCT00726414|19434979|P1|NOT COMPLETED|Second Intervention||0
7897542|NCT00726414|19434978|P2|COMPLETED|Second Intervention||11
7897543|NCT00726414|19434979|P1|COMPLETED|Second Intervention||11
7897544|NCT00726414|19434978|P2|STARTED|Second Intervention||11
7897545|NCT00726414|19434979|P1|STARTED|Second Intervention||11
7897546|NCT00726414|19434978|P2|NOT COMPLETED|Washout Period of 7 Days||0
7897547|NCT00726414|19434979|P1|NOT COMPLETED|Washout Period of 7 Days||0
7897548|NCT00726414|19434978|P2|COMPLETED|Washout Period of 7 Days||11
7897549|NCT00726414|19434979|P1|COMPLETED|Washout Period of 7 Days||11
7897550|NCT00726414|19434978|P2|STARTED|Washout Period of 7 Days||11
7897551|NCT00726414|19434979|P1|STARTED|Washout Period of 7 Days||11
7897552|NCT00726414|19434978|P2|NOT COMPLETED|First Intervention||0
7897553|NCT00726414|19434979|P1|NOT COMPLETED|First Intervention||0
7897554|NCT00726414|19434978|P2|COMPLETED|First Intervention||11
7897555|NCT00726414|19434979|P1|COMPLETED|First Intervention||11
7897556|NCT00726414|19434978|P2|STARTED|First Intervention||11
7897557|NCT00726414|19434979|P1|STARTED|First Intervention||11
7897558|NCT00726375|19434989|P1|NOT COMPLETED|Overall Study||0
7897559|NCT00726375|19434989|P1|COMPLETED|Overall Study||34
7897560|NCT00726375|19434989|P1|STARTED|Overall Study||34
7897561|NCT00726323|19434996|P2|NOT COMPLETED|Overall Study||31
7897562|NCT00726323|19434997|P1|NOT COMPLETED|Overall Study||37
7897563|NCT00726323|19434996|P2|COMPLETED|Overall Study||6
7897564|NCT00726323|19434997|P1|COMPLETED|Overall Study||0
7897565|NCT00726323|19434996|P2|STARTED|Overall Study||37
7897566|NCT00726323|19434997|P1|STARTED|Overall Study||37
7897567|NCT00726232|19435027|P8|NOT COMPLETED|Expansion Phase||38
7897568|NCT00726232|19435028|P7|NOT COMPLETED|Expansion Phase||24
7897569|NCT00726232|19435029|P6|NOT COMPLETED|Expansion Phase||0
7897570|NCT00726232|19435030|P5|NOT COMPLETED|Expansion Phase||0
7897571|NCT00726232|19435031|P4|NOT COMPLETED|Expansion Phase||0
7897572|NCT00726232|19435032|P3|NOT COMPLETED|Expansion Phase||0
7897573|NCT00726232|19435033|P2|NOT COMPLETED|Expansion Phase||0
7897574|NCT00726232|19435034|P1|NOT COMPLETED|Expansion Phase||0
7897575|NCT00726232|19435027|P8|COMPLETED|Expansion Phase||1
7897576|NCT00726232|19435028|P7|COMPLETED|Expansion Phase||10
7897577|NCT00726232|19435029|P6|COMPLETED|Expansion Phase||0
7897578|NCT00726232|19435030|P5|COMPLETED|Expansion Phase||0
7897579|NCT00726232|19435031|P4|COMPLETED|Expansion Phase||0
7897580|NCT00726232|19435032|P3|COMPLETED|Expansion Phase||0
7897581|NCT00726232|19435033|P2|COMPLETED|Expansion Phase||0
7897582|NCT00726232|19435034|P1|COMPLETED|Expansion Phase||0
7897583|NCT00726232|19435027|P8|ITT Participants|Expansion Phase||39
7897584|NCT00726232|19435028|P7|ITT Participants|Expansion Phase||34
7897585|NCT00726232|19435029|P6|ITT Participants|Expansion Phase||0
7897586|NCT00726232|19435030|P5|ITT Participants|Expansion Phase||0
7897587|NCT00726232|19435031|P4|ITT Participants|Expansion Phase||0
7897588|NCT00726232|19435032|P3|ITT Participants|Expansion Phase||0
7897589|NCT00726232|19435033|P2|ITT Participants|Expansion Phase||0
7897590|NCT00726232|19435034|P1|ITT Participants|Expansion Phase||0
7897591|NCT00726232|19435027|P8|Safety Evaluable Participants|Expansion Phase||39
7897592|NCT00726232|19435028|P7|Safety Evaluable Participants|Expansion Phase||34
7897593|NCT00726232|19435029|P6|Safety Evaluable Participants|Expansion Phase||0
7897594|NCT00726232|19435030|P5|Safety Evaluable Participants|Expansion Phase||0
7897595|NCT00726232|19435031|P4|Safety Evaluable Participants|Expansion Phase||0
7897596|NCT00726232|19435032|P3|Safety Evaluable Participants|Expansion Phase||0
7897597|NCT00726232|19435033|P2|Safety Evaluable Participants|Expansion Phase||0
7897598|NCT00726232|19435034|P1|Safety Evaluable Participants|Expansion Phase||0
7897599|NCT00726232|19435027|P8|STARTED|Expansion Phase||39
7897600|NCT00726232|19435028|P7|STARTED|Expansion Phase||34
7897601|NCT00726232|19435029|P6|STARTED|Expansion Phase||0
7897602|NCT00726232|19435030|P5|STARTED|Expansion Phase||0
7897603|NCT00726232|19435031|P4|STARTED|Expansion Phase||0
7897604|NCT00726232|19435032|P3|STARTED|Expansion Phase||0
7897605|NCT00726232|19435033|P2|STARTED|Expansion Phase||0
7897606|NCT00726232|19435034|P1|STARTED|Expansion Phase||0
7897607|NCT00726232|19435027|P8|NOT COMPLETED|Initial Phase (Dose-finding)||0
7897608|NCT00726232|19435028|P7|NOT COMPLETED|Initial Phase (Dose-finding)||0
7897609|NCT00726232|19435029|P6|NOT COMPLETED|Initial Phase (Dose-finding)||9
7897610|NCT00726232|19435030|P5|NOT COMPLETED|Initial Phase (Dose-finding)||21
7897611|NCT00726232|19435031|P4|NOT COMPLETED|Initial Phase (Dose-finding)||8
7897612|NCT00726232|19435032|P3|NOT COMPLETED|Initial Phase (Dose-finding)||5
7897613|NCT00726232|19435033|P2|NOT COMPLETED|Initial Phase (Dose-finding)||6
7897614|NCT00726232|19435034|P1|NOT COMPLETED|Initial Phase (Dose-finding)||13
7897615|NCT00726232|19435027|P8|COMPLETED|Initial Phase (Dose-finding)||0
7897616|NCT00726232|19435028|P7|COMPLETED|Initial Phase (Dose-finding)||0
7897617|NCT00726232|19435029|P6|COMPLETED|Initial Phase (Dose-finding)||0
7897618|NCT00726232|19435030|P5|COMPLETED|Initial Phase (Dose-finding)||1
7897619|NCT00726232|19435031|P4|COMPLETED|Initial Phase (Dose-finding)||0
7897620|NCT00726232|19435032|P3|COMPLETED|Initial Phase (Dose-finding)||2
7897621|NCT00726232|19435033|P2|COMPLETED|Initial Phase (Dose-finding)||2
7897622|NCT00726232|19435034|P1|COMPLETED|Initial Phase (Dose-finding)||6
7897623|NCT00726232|19435027|P8|ITT Participants|Initial Phase (Dose-finding)||0
7897624|NCT00726232|19435028|P7|ITT Participants|Initial Phase (Dose-finding)||0
7897625|NCT00726232|19435029|P6|ITT Participants|Initial Phase (Dose-finding)||9
7897626|NCT00726232|19435030|P5|ITT Participants|Initial Phase (Dose-finding)||22
7897627|NCT00726232|19435031|P4|ITT Participants|Initial Phase (Dose-finding)||8
7897628|NCT00726232|19435032|P3|ITT Participants|Initial Phase (Dose-finding)||7
7897629|NCT00726232|19435033|P2|ITT Participants|Initial Phase (Dose-finding)||8
7897630|NCT00726232|19435034|P1|ITT Participants|Initial Phase (Dose-finding)||19
7897631|NCT00726232|19435027|P8|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
7897632|NCT00726232|19435028|P7|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
7897633|NCT00726232|19435029|P6|Safety Evaluable Participants|Initial Phase (Dose-finding)||9
7897634|NCT00726232|19435030|P5|Safety Evaluable Participants|Initial Phase (Dose-finding)||22
7897635|NCT00726232|19435031|P4|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
7897636|NCT00726232|19435032|P3|Safety Evaluable Participants|Initial Phase (Dose-finding)||7
7897637|NCT00726232|19435033|P2|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
7897638|NCT00726232|19435034|P1|Safety Evaluable Participants|Initial Phase (Dose-finding)||19
7897639|NCT00726232|19435027|P8|STARTED|Initial Phase (Dose-finding)||0
7897640|NCT00726232|19435028|P7|STARTED|Initial Phase (Dose-finding)||0
7897641|NCT00726232|19435029|P6|STARTED|Initial Phase (Dose-finding)||9
7897642|NCT00726232|19435030|P5|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22
7897643|NCT00726232|19435031|P4|STARTED|Initial Phase (Dose-finding)||8
7897644|NCT00726232|19435032|P3|STARTED|Initial Phase (Dose-finding)||7
7897645|NCT00726232|19435033|P2|STARTED|Initial Phase (Dose-finding)||8
7897646|NCT00726232|19435034|P1|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19
7897647|NCT00726180|19435080|P1|NOT COMPLETED|Overall Study||0
7897648|NCT00726180|19435080|P1|COMPLETED|Overall Study||1
7897649|NCT00726180|19435080|P1|STARTED|Overall Study||1
7897650|NCT00726063|19435086|P2|NOT COMPLETED|Overall Study||7
7897651|NCT00726063|19435087|P1|NOT COMPLETED|Overall Study||9
7897652|NCT00726063|19435086|P2|COMPLETED|Overall Study|Number of implants = 239|112
7897653|NCT00726063|19435087|P1|COMPLETED|Overall Study|Number of implants =230|113
7897654|NCT00726063|19435086|P2|STARTED|Overall Study|Number of implants= 246|119
7897655|NCT00726063|19435087|P1|STARTED|Overall Study|Number of implants= 239|122
7897656|NCT00726037|19435093|P1|NOT COMPLETED|Overall Study||0
7897657|NCT00726037|19435093|P1|COMPLETED|Overall Study||7
7897658|NCT00726037|19435093|P1|STARTED|Overall Study||7
7897659|NCT00725985|19435101|P12|NOT COMPLETED|LTFU (No Cladribine Treatment)||14
7897660|NCT00725985|19435102|P11|NOT COMPLETED|LTFU (No Cladribine Treatment)||36
7897661|NCT00725985|19435103|P10|NOT COMPLETED|LTFU (No Cladribine Treatment)||34
7897662|NCT00725985|19435104|P9|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
7897663|NCT00725985|19435105|P8|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
7897664|NCT00725985|19435106|P7|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
7897665|NCT00725985|19435107|P6|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
7897666|NCT00725985|19435108|P5|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
7897667|NCT00725985|19435109|P4|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
7897668|NCT00725985|19435110|P3|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
7897669|NCT00725985|19435111|P2|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
7897670|NCT00725985|19435112|P1|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
7897671|NCT00725985|19435101|P12|COMPLETED|LTFU (No Cladribine Treatment)||0
7897672|NCT00725985|19435102|P11|COMPLETED|LTFU (No Cladribine Treatment)||0
7897673|NCT00725985|19435103|P10|COMPLETED|LTFU (No Cladribine Treatment)||0
7897674|NCT00725985|19435104|P9|COMPLETED|LTFU (No Cladribine Treatment)||0
7897675|NCT00725985|19435105|P8|COMPLETED|LTFU (No Cladribine Treatment)||0
7897676|NCT00725985|19435106|P7|COMPLETED|LTFU (No Cladribine Treatment)||0
7897677|NCT00725985|19435107|P6|COMPLETED|LTFU (No Cladribine Treatment)||0
7897678|NCT00725985|19435108|P5|COMPLETED|LTFU (No Cladribine Treatment)||0
7897679|NCT00725985|19435109|P4|COMPLETED|LTFU (No Cladribine Treatment)||0
7897680|NCT00725985|19435110|P3|COMPLETED|LTFU (No Cladribine Treatment)||0
7897681|NCT00725985|19435111|P2|COMPLETED|LTFU (No Cladribine Treatment)||0
7897682|NCT00725985|19435112|P1|COMPLETED|LTFU (No Cladribine Treatment)||0
7897683|NCT00725985|19435101|P12|STARTED|LTFU (No Cladribine Treatment)||14
7897684|NCT00725985|19435102|P11|STARTED|LTFU (No Cladribine Treatment)||36
7897685|NCT00725985|19435103|P10|STARTED|LTFU (No Cladribine Treatment)||34
7897686|NCT00725985|19435104|P9|STARTED|LTFU (No Cladribine Treatment)||0
7897687|NCT00725985|19435105|P8|STARTED|LTFU (No Cladribine Treatment)||0
7897688|NCT00725985|19435106|P7|STARTED|LTFU (No Cladribine Treatment)||0
7897689|NCT00725985|19435107|P6|STARTED|LTFU (No Cladribine Treatment)||0
7897690|NCT00725985|19435108|P5|STARTED|LTFU (No Cladribine Treatment)||0
7897691|NCT00725985|19435109|P4|STARTED|LTFU (No Cladribine Treatment)||0
7897692|NCT00725985|19435110|P3|STARTED|LTFU (No Cladribine Treatment)||0
7897693|NCT00725985|19435111|P2|STARTED|LTFU (No Cladribine Treatment)||0
7897694|NCT00725985|19435112|P1|STARTED|LTFU (No Cladribine Treatment)||0
7897695|NCT00725985|19435101|P12|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
7897696|NCT00725985|19435102|P11|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
7897697|NCT00725985|19435103|P10|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
7897698|NCT00725985|19435104|P9|NOT COMPLETED|LTFU (With Cladribine Treatment)||17
7897699|NCT00725985|19435105|P8|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
7897700|NCT00725985|19435106|P7|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
7897701|NCT00725985|19435107|P6|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
7897702|NCT00725985|19435108|P5|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
7897703|NCT00725985|19435109|P4|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
7897704|NCT00725985|19435110|P3|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
7897705|NCT00725985|19435111|P2|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
7897706|NCT00725985|19435112|P1|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
7897707|NCT00725985|19435101|P12|COMPLETED|LTFU (With Cladribine Treatment)||0
7897708|NCT00725985|19435102|P11|COMPLETED|LTFU (With Cladribine Treatment)||0
7897709|NCT00725985|19435103|P10|COMPLETED|LTFU (With Cladribine Treatment)||0
7897710|NCT00725985|19435104|P9|COMPLETED|LTFU (With Cladribine Treatment)||0
7897711|NCT00725985|19435105|P8|COMPLETED|LTFU (With Cladribine Treatment)||0
7897712|NCT00725985|19435106|P7|COMPLETED|LTFU (With Cladribine Treatment)||0
7897713|NCT00725985|19435107|P6|COMPLETED|LTFU (With Cladribine Treatment)||0
7897714|NCT00725985|19435108|P5|COMPLETED|LTFU (With Cladribine Treatment)||0
7897715|NCT00725985|19435109|P4|COMPLETED|LTFU (With Cladribine Treatment)||0
7897716|NCT00725985|19435110|P3|COMPLETED|LTFU (With Cladribine Treatment)||0
7897717|NCT00725985|19435111|P2|COMPLETED|LTFU (With Cladribine Treatment)||0
7897718|NCT00725985|19435112|P1|COMPLETED|LTFU (With Cladribine Treatment)||0
7897719|NCT00725985|19435101|P12|STARTED|LTFU (With Cladribine Treatment)||0
7897720|NCT00725985|19435102|P11|STARTED|LTFU (With Cladribine Treatment)||0
7897721|NCT00725985|19435103|P10|STARTED|LTFU (With Cladribine Treatment)||0
7897722|NCT00725985|19435104|P9|STARTED|LTFU (With Cladribine Treatment)||17
7897723|NCT00725985|19435105|P8|STARTED|LTFU (With Cladribine Treatment)||9
7897724|NCT00725985|19435106|P7|STARTED|LTFU (With Cladribine Treatment)||9
7897725|NCT00725985|19435107|P6|STARTED|LTFU (With Cladribine Treatment)||0
7897726|NCT00725985|19435108|P5|STARTED|LTFU (With Cladribine Treatment)||0
7897727|NCT00725985|19435109|P4|STARTED|LTFU (With Cladribine Treatment)||0
7897728|NCT00725985|19435110|P3|STARTED|LTFU (With Cladribine Treatment)||0
7897729|NCT00725985|19435111|P2|STARTED|LTFU (With Cladribine Treatment)||0
7897730|NCT00725985|19435112|P1|STARTED|LTFU (With Cladribine Treatment)||0
7897731|NCT00725985|19435101|P12|NOT COMPLETED|OLMP||0
7897732|NCT00725985|19435102|P11|NOT COMPLETED|OLMP||0
7897733|NCT00725985|19435103|P10|NOT COMPLETED|OLMP||0
7897734|NCT00725985|19435104|P9|NOT COMPLETED|OLMP||0
7897735|NCT00725985|19435105|P8|NOT COMPLETED|OLMP||0
7897736|NCT00725985|19435106|P7|NOT COMPLETED|OLMP||0
7897737|NCT00725985|19435107|P6|NOT COMPLETED|OLMP||53
7897738|NCT00725985|19435108|P5|NOT COMPLETED|OLMP||23
7897739|NCT00725985|19435109|P4|NOT COMPLETED|OLMP||18
7897740|NCT00725985|19435110|P3|NOT COMPLETED|OLMP||0
7897741|NCT00725985|19435111|P2|NOT COMPLETED|OLMP||0
7897742|NCT00725985|19435112|P1|NOT COMPLETED|OLMP||0
7897743|NCT00725985|19435101|P12|COMPLETED|OLMP||0
7897744|NCT00725985|19435102|P11|COMPLETED|OLMP||0
7897745|NCT00725985|19435103|P10|COMPLETED|OLMP||0
7897746|NCT00725985|19435104|P9|COMPLETED|OLMP||0
7897747|NCT00725985|19435105|P8|COMPLETED|OLMP||0
7897748|NCT00725985|19435106|P7|COMPLETED|OLMP||0
7897749|NCT00725985|19435107|P6|COMPLETED|OLMP||7
7897750|NCT00725985|19435108|P5|COMPLETED|OLMP||2
7897751|NCT00725985|19435109|P4|COMPLETED|OLMP||6
7897752|NCT00725985|19435110|P3|COMPLETED|OLMP||0
7897753|NCT00725985|19435111|P2|COMPLETED|OLMP||0
7897754|NCT00725985|19435112|P1|COMPLETED|OLMP||0
7897755|NCT00725985|19435101|P12|STARTED|OLMP||0
7897756|NCT00725985|19435102|P11|STARTED|OLMP||0
7897757|NCT00725985|19435103|P10|STARTED|OLMP||0
7897758|NCT00725985|19435104|P9|STARTED|OLMP||0
7897759|NCT00725985|19435105|P8|STARTED|OLMP||0
7897760|NCT00725985|19435106|P7|STARTED|OLMP||0
7897761|NCT00725985|19435107|P6|STARTED|OLMP||60
7897762|NCT00725985|19435108|P5|STARTED|OLMP||25
7897763|NCT00725985|19435109|P4|STARTED|OLMP||24
7897764|NCT00725985|19435110|P3|STARTED|OLMP||0
7897765|NCT00725985|19435111|P2|STARTED|OLMP||0
7897766|NCT00725985|19435112|P1|STARTED|OLMP||0
7897767|NCT00725985|19435101|P12|NOT COMPLETED|ITP (Up to 96 Weeks)||0
7897768|NCT00725985|19435102|P11|NOT COMPLETED|ITP (Up to 96 Weeks)||0
7897769|NCT00725985|19435103|P10|NOT COMPLETED|ITP (Up to 96 Weeks)||0
7897770|NCT00725985|19435104|P9|NOT COMPLETED|ITP (Up to 96 Weeks)||0
7897771|NCT00725985|19435105|P8|NOT COMPLETED|ITP (Up to 96 Weeks)||0
7897772|NCT00725985|19435106|P7|NOT COMPLETED|ITP (Up to 96 Weeks)||0
7897773|NCT00725985|19435107|P6|NOT COMPLETED|ITP (Up to 96 Weeks)||0
7897774|NCT00725985|19435108|P5|NOT COMPLETED|ITP (Up to 96 Weeks)||0
7897775|NCT00725985|19435109|P4|NOT COMPLETED|ITP (Up to 96 Weeks)||0
7897776|NCT00725985|19435110|P3|NOT COMPLETED|ITP (Up to 96 Weeks)||102
7897777|NCT00725985|19435111|P2|NOT COMPLETED|ITP (Up to 96 Weeks)||75
7897778|NCT00725985|19435112|P1|NOT COMPLETED|ITP (Up to 96 Weeks)||101
7897779|NCT00725985|19435101|P12|COMPLETED|ITP (Up to 96 Weeks)||0
7897780|NCT00725985|19435102|P11|COMPLETED|ITP (Up to 96 Weeks)||0
7897781|NCT00725985|19435103|P10|COMPLETED|ITP (Up to 96 Weeks)||0
7897782|NCT00725985|19435104|P9|COMPLETED|ITP (Up to 96 Weeks)||0
7897783|NCT00725985|19435105|P8|COMPLETED|ITP (Up to 96 Weeks)||0
7897784|NCT00725985|19435106|P7|COMPLETED|ITP (Up to 96 Weeks)||0
7897785|NCT00725985|19435107|P6|COMPLETED|ITP (Up to 96 Weeks)||0
7897786|NCT00725985|19435108|P5|COMPLETED|ITP (Up to 96 Weeks)||0
7897787|NCT00725985|19435109|P4|COMPLETED|ITP (Up to 96 Weeks)||0
7897788|NCT00725985|19435110|P3|COMPLETED|ITP (Up to 96 Weeks)||104
7897789|NCT00725985|19435111|P2|COMPLETED|ITP (Up to 96 Weeks)||131
7897790|NCT00725985|19435112|P1|COMPLETED|ITP (Up to 96 Weeks)||104
7897791|NCT00725985|19435101|P12|Treated|ITP (Up to 96 Weeks)||0
7897792|NCT00725985|19435102|P11|Treated|ITP (Up to 96 Weeks)||0
7897793|NCT00725985|19435103|P10|Treated|ITP (Up to 96 Weeks)||0
7897794|NCT00725985|19435104|P9|Treated|ITP (Up to 96 Weeks)||0
7897795|NCT00725985|19435105|P8|Treated|ITP (Up to 96 Weeks)||0
7897796|NCT00725985|19435106|P7|Treated|ITP (Up to 96 Weeks)||0
7897797|NCT00725985|19435107|P6|Treated|ITP (Up to 96 Weeks)||0
7897798|NCT00725985|19435108|P5|Treated|ITP (Up to 96 Weeks)||0
7897799|NCT00725985|19435109|P4|Treated|ITP (Up to 96 Weeks)||0
7897800|NCT00725985|19435110|P3|Treated|ITP (Up to 96 Weeks)||206
7897801|NCT00725985|19435111|P2|Treated|ITP (Up to 96 Weeks)||206
7897802|NCT00725985|19435112|P1|Treated|ITP (Up to 96 Weeks)||204
7897803|NCT00725985|19435101|P12|STARTED|ITP (Up to 96 Weeks)||0
7897804|NCT00725985|19435102|P11|STARTED|ITP (Up to 96 Weeks)||0
7897805|NCT00725985|19435103|P10|STARTED|ITP (Up to 96 Weeks)||0
7897806|NCT00725985|19435104|P9|STARTED|ITP (Up to 96 Weeks)||0
7897807|NCT00725985|19435105|P8|STARTED|ITP (Up to 96 Weeks)||0
7897808|NCT00725985|19435106|P7|STARTED|ITP (Up to 96 Weeks)||0
7897809|NCT00725985|19435107|P6|STARTED|ITP (Up to 96 Weeks)||0
7897810|NCT00725985|19435108|P5|STARTED|ITP (Up to 96 Weeks)||0
7897811|NCT00725985|19435109|P4|STARTED|ITP (Up to 96 Weeks)||0
7897812|NCT00725985|19435110|P3|STARTED|ITP (Up to 96 Weeks)||206
7897813|NCT00725985|19435111|P2|STARTED|ITP (Up to 96 Weeks)||206
7897814|NCT00725985|19435112|P1|STARTED|ITP (Up to 96 Weeks)||205
7897815|NCT00725959|19435140|P2|NOT COMPLETED|Overall Study||197
7897816|NCT00725959|19435141|P1|NOT COMPLETED|Overall Study||289
7897817|NCT00725959|19435140|P2|COMPLETED|Overall Study||439
7897818|NCT00725959|19435141|P1|COMPLETED|Overall Study||653
7897819|NCT00725959|19435140|P2|STARTED|Overall Study||636
7897820|NCT00725959|19435141|P1|STARTED|Overall Study||942
7897821|NCT00725920|19435149|P2|NOT COMPLETED|Overall Study||6
7897822|NCT00725920|19435150|P1|NOT COMPLETED|Overall Study||3
7897823|NCT00725920|19435149|P2|COMPLETED|Overall Study||12
7897824|NCT00725920|19435150|P1|COMPLETED|Overall Study||14
7897825|NCT00725920|19435149|P2|STARTED|Overall Study||18
7897826|NCT00725920|19435150|P1|STARTED|Overall Study||17
7897827|NCT00725842|19435156|P1|NOT COMPLETED|Overall Study||40
7897828|NCT00725842|19435156|P1|COMPLETED|Overall Study||57
7897829|NCT00725842|19435156|P1|Participants Eligible for Analysis|Overall Study||90
7897830|NCT00725842|19435156|P1|STARTED|Overall Study||97
7897831|NCT00725764|19435163|P1|NOT COMPLETED|Overall Study||14
7897832|NCT00725764|19435163|P1|COMPLETED|Overall Study||0
7897833|NCT00725764|19435163|P1|STARTED|Overall Study||14
7897834|NCT00725751|19435183|P2|NOT COMPLETED|Overall Study||108
7897835|NCT00725751|19435184|P1|NOT COMPLETED|Overall Study||34
7897836|NCT00725751|19435183|P2|COMPLETED|Overall Study||150
7897837|NCT00725751|19435184|P1|COMPLETED|Overall Study||56
7897838|NCT00725751|19435183|P2|STARTED|Overall Study||258
7897839|NCT00725751|19435184|P1|STARTED|Overall Study||90
7897840|NCT00725725|19435196|P3|NOT COMPLETED|Overall Study||5
7897841|NCT00725725|19435197|P2|NOT COMPLETED|Overall Study||4
7897842|NCT00725725|19435198|P1|NOT COMPLETED|Overall Study||4
7897843|NCT00725725|19435196|P3|COMPLETED|Overall Study||12
7897844|NCT00725725|19435197|P2|COMPLETED|Overall Study||11
7897845|NCT00725725|19435198|P1|COMPLETED|Overall Study||10
7897846|NCT00725725|19435196|P3|Treated|Overall Study||14
7897847|NCT00725725|19435197|P2|Treated|Overall Study||15
7897848|NCT00725725|19435198|P1|Treated|Overall Study||11
7897849|NCT00725725|19435196|P3|STARTED|Overall Study||17
7897850|NCT00725725|19435197|P2|STARTED|Overall Study||15
7897851|NCT00725725|19435198|P1|STARTED|Overall Study||14
7897852|NCT00725712|19435241|P2|NOT COMPLETED|Overall Study||26
7897853|NCT00725712|19435242|P1|NOT COMPLETED|Overall Study||48
7897854|NCT00725712|19435241|P2|COMPLETED|Overall Study||0
7897855|NCT00725712|19435242|P1|COMPLETED|Overall Study||0
7897856|NCT00725712|19435241|P2|STARTED|Overall Study||26
7897857|NCT00725712|19435242|P1|STARTED|Overall Study||48
7897858|NCT00725621|19435278|P1|NOT COMPLETED|Overall Study||271
7897859|NCT00725621|19435278|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245
7897860|NCT00725621|19435278|P1|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516
7897861|NCT00725608|19435301|P1|NOT COMPLETED|Overall Study||167
7897862|NCT00725608|19435301|P1|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140
7897863|NCT00725608|19435301|P1|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307
7897864|NCT00725543|19435307|P1|NOT COMPLETED|Overall Study||153
7897865|NCT00725543|19435307|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205
7897866|NCT00725543|19435307|P1|STARTED|Overall Study||358
7897867|NCT00725530|19435316|P2|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
7897868|NCT00725530|19435317|P1|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
7897869|NCT00725530|19435316|P2|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
7897870|NCT00725530|19435317|P1|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
7897871|NCT00725530|19435316|P2|STARTED|Second Intervention, 7 Days (+0/-1)||27
7897872|NCT00725530|19435317|P1|STARTED|Second Intervention, 7 Days (+0/-1)||27
7897873|NCT00725530|19435316|P2|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
7897874|NCT00725530|19435317|P1|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
7897875|NCT00725530|19435316|P2|COMPLETED|First Intervention, 7 Days (+0/-1)||27
7897876|NCT00725530|19435317|P1|COMPLETED|First Intervention, 7 Days (+0/-1)||27
7897877|NCT00725530|19435316|P2|STARTED|First Intervention, 7 Days (+0/-1)||27
7897878|NCT00725530|19435317|P1|STARTED|First Intervention, 7 Days (+0/-1)||27
7897879|NCT00725504|19435323|P1|NOT COMPLETED|Overall Study||0
7897880|NCT00725504|19435323|P1|COMPLETED|Overall Study||71
7897881|NCT00725504|19435323|P1|STARTED|Overall Study||71
7897882|NCT00725491|19435332|P2|NOT COMPLETED|Overall Study||18
7897883|NCT00725491|19435333|P1|NOT COMPLETED|Overall Study||9
7897884|NCT00725491|19435332|P2|COMPLETED|Overall Study||102
7897885|NCT00725491|19435333|P1|COMPLETED|Overall Study||104
7897886|NCT00725491|19435332|P2|STARTED|Overall Study|Intent-to-Treat Group|120
7897887|NCT00725491|19435333|P1|STARTED|Overall Study|Intent-to-Treat Group|113
7897888|NCT00725452|19435339|P1|NOT COMPLETED|Overall Study||11
7897889|NCT00725452|19435339|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15
7897890|NCT00725452|19435339|P1|STARTED|Overall Study||26
7897891|NCT00725361|19435348|P1|NOT COMPLETED|Overall Study||4
7897892|NCT00725361|19435348|P1|COMPLETED|Overall Study||16
7897893|NCT00725361|19435348|P1|STARTED|Overall Study||20
7897894|NCT00725322|19435358|P2|NOT COMPLETED|Second Injection Visit||0
7897895|NCT00725322|19435359|P1|NOT COMPLETED|Second Injection Visit||0
7897896|NCT00725322|19435358|P2|COMPLETED|Second Injection Visit||14
7897897|NCT00725322|19435359|P1|COMPLETED|Second Injection Visit||13
7897898|NCT00725322|19435358|P2|STARTED|Second Injection Visit||14
7897899|NCT00725322|19435359|P1|STARTED|Second Injection Visit||13
7897900|NCT00725322|19435358|P2|NOT COMPLETED|Washout (28 Days)||1
7897901|NCT00725322|19435359|P1|NOT COMPLETED|Washout (28 Days)||2
7897902|NCT00725322|19435358|P2|COMPLETED|Washout (28 Days)||14
7897903|NCT00725322|19435359|P1|COMPLETED|Washout (28 Days)||13
7897904|NCT00725322|19435358|P2|STARTED|Washout (28 Days)||15
7897905|NCT00725322|19435359|P1|STARTED|Washout (28 Days)||15
7897906|NCT00725322|19435358|P2|NOT COMPLETED|First Injection Visit||0
7897907|NCT00725322|19435359|P1|NOT COMPLETED|First Injection Visit||0
7897908|NCT00725322|19435358|P2|COMPLETED|First Injection Visit||15
7897909|NCT00725322|19435359|P1|COMPLETED|First Injection Visit||15
7897910|NCT00725322|19435358|P2|STARTED|First Injection Visit||15
7897911|NCT00725322|19435359|P1|STARTED|First Injection Visit||15
7897912|NCT00725296|19435367|P1|NOT COMPLETED|Overall Study||62
7897913|NCT00725296|19435367|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101
7897914|NCT00725296|19435367|P1|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163
7897915|NCT00725283|19435376|P1|NOT COMPLETED|Overall Study||24
7897916|NCT00725283|19435376|P1|COMPLETED|Overall Study||10
7897917|NCT00725283|19435376|P1|STARTED|Overall Study||34
7897918|NCT00725270|19435388|P2|NOT COMPLETED|Overall Study||0
7897919|NCT00725270|19435389|P1|NOT COMPLETED|Overall Study||0
7897920|NCT00725270|19435388|P2|COMPLETED|Overall Study||7
7897921|NCT00725270|19435389|P1|COMPLETED|Overall Study||5
7897922|NCT00725270|19435388|P2|STARTED|Overall Study||7
7897923|NCT00725270|19435389|P1|STARTED|Overall Study||5
7897924|NCT00725205|19435397|P1|NOT COMPLETED|Overall Study||87
7897925|NCT00725205|19435397|P1|COMPLETED|Overall Study||207
7897926|NCT00725205|19435397|P1|STARTED|Overall Study||294
7897927|NCT00725153|19435403|P2|NOT COMPLETED|Period Two, 10 Hours of Wear||0
7897928|NCT00725153|19435404|P1|NOT COMPLETED|Period Two, 10 Hours of Wear||0
7897929|NCT00725153|19435403|P2|COMPLETED|Period Two, 10 Hours of Wear||28
7897930|NCT00725153|19435404|P1|COMPLETED|Period Two, 10 Hours of Wear||27
7897931|NCT00725153|19435403|P2|STARTED|Period Two, 10 Hours of Wear||28
7897932|NCT00725153|19435404|P1|STARTED|Period Two, 10 Hours of Wear||27
7897933|NCT00725153|19435403|P2|NOT COMPLETED|Period One, 10 Hours of Wear||0
7897934|NCT00725153|19435404|P1|NOT COMPLETED|Period One, 10 Hours of Wear||0
7897935|NCT00725153|19435403|P2|COMPLETED|Period One, 10 Hours of Wear||28
7897936|NCT00725153|19435404|P1|COMPLETED|Period One, 10 Hours of Wear||27
7897937|NCT00725153|19435403|P2|STARTED|Period One, 10 Hours of Wear||28
7897938|NCT00725153|19435404|P1|STARTED|Period One, 10 Hours of Wear||27
7897939|NCT00725101|19435410|P1|NOT COMPLETED|Overall Study||495
7897940|NCT00725101|19435410|P1|COMPLETED|Overall Study||1205
7897941|NCT00725101|19435410|P1|STARTED|Overall Study||1700
7897942|NCT00725075|19435433|P3|NOT COMPLETED|Overall Study||9
7897943|NCT00725075|19435434|P2|NOT COMPLETED|Overall Study||8
7897944|NCT00725075|19435435|P1|NOT COMPLETED|Overall Study||11
7897945|NCT00725075|19435433|P3|COMPLETED|Overall Study||61
7897946|NCT00725075|19435434|P2|COMPLETED|Overall Study||65
7897947|NCT00725075|19435435|P1|COMPLETED|Overall Study||61
7897948|NCT00725075|19435433|P3|Treated|Overall Study||70
7897949|NCT00725075|19435434|P2|Treated|Overall Study||73
7897950|NCT00725075|19435435|P1|Treated|Overall Study||71
7897951|NCT00725075|19435433|P3|STARTED|Overall Study||70
7897952|NCT00725075|19435434|P2|STARTED|Overall Study||73
7897953|NCT00725075|19435435|P1|STARTED|Overall Study||72
7897954|NCT00725049|19435481|P2|NOT COMPLETED|Overall Study||0
7897955|NCT00725049|19435482|P1|NOT COMPLETED|Overall Study||0
7897956|NCT00725049|19435481|P2|COMPLETED|Overall Study||20
7897957|NCT00725049|19435482|P1|COMPLETED|Overall Study||17
7897958|NCT00725049|19435481|P2|STARTED|Overall Study||20
7897959|NCT00725049|19435482|P1|STARTED|Overall Study||17
7897960|NCT00725010|19435488|P1|NOT COMPLETED|Overall Study||25
7897961|NCT00725010|19435488|P1|COMPLETED|Overall Study||25
7897962|NCT00725010|19435488|P1|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50
7897963|NCT00724984|19435502|P6|NOT COMPLETED|Overall Study||5
7897964|NCT00724984|19435503|P5|NOT COMPLETED|Overall Study||4
7897965|NCT00724984|19435504|P4|NOT COMPLETED|Overall Study||2
7897966|NCT00724984|19435505|P3|NOT COMPLETED|Overall Study||0
7897967|NCT00724984|19435506|P2|NOT COMPLETED|Overall Study||1
7897968|NCT00724984|19435507|P1|NOT COMPLETED|Overall Study||1
7897969|NCT00724984|19435502|P6|COMPLETED|Overall Study||9
7897970|NCT00724984|19435503|P5|COMPLETED|Overall Study||12
7897971|NCT00724984|19435504|P4|COMPLETED|Overall Study||7
7897972|NCT00724984|19435505|P3|COMPLETED|Overall Study||3
7897973|NCT00724984|19435506|P2|COMPLETED|Overall Study||7
7897974|NCT00724984|19435507|P1|COMPLETED|Overall Study||4
7897975|NCT00724984|19435502|P6|STARTED|Overall Study||14
7897976|NCT00724984|19435503|P5|STARTED|Overall Study||16
7897977|NCT00724984|19435504|P4|STARTED|Overall Study||9
7897978|NCT00724984|19435505|P3|STARTED|Overall Study||3
7897979|NCT00724984|19435506|P2|STARTED|Overall Study||8
7897980|NCT00724984|19435507|P1|STARTED|Overall Study||5
7897981|NCT00724971|19435521|P1|NOT COMPLETED|Overall Study||6
7897982|NCT00724971|19435521|P1|COMPLETED|Overall Study||4
7897983|NCT00724971|19435521|P1|STARTED|Overall Study||10
7897984|NCT00724958|19435536|P1|NOT COMPLETED|Overall Study||182
7897985|NCT00724958|19435536|P1|COMPLETED|Overall Study||166
7897986|NCT00724958|19435536|P1|STARTED|Overall Study||348
7897987|NCT00724945|19435545|P2|NOT COMPLETED|Period 2||0
7897988|NCT00724945|19435546|P1|NOT COMPLETED|Period 2||4
7897989|NCT00724945|19435545|P2|COMPLETED|Period 2||54
7897990|NCT00724945|19435546|P1|COMPLETED|Period 2||51
7897991|NCT00724945|19435545|P2|STARTED|Period 2||54
7897992|NCT00724945|19435546|P1|STARTED|Period 2||55
7897993|NCT00724945|19435545|P2|NOT COMPLETED|Period 1||1
7897994|NCT00724945|19435546|P1|NOT COMPLETED|Period 1||3
7897995|NCT00724945|19435545|P2|COMPLETED|Period 1||54
7897996|NCT00724945|19435546|P1|COMPLETED|Period 1||55
7897997|NCT00724945|19435545|P2|STARTED|Period 1||55
7897998|NCT00724945|19435546|P1|STARTED|Period 1||58
7897999|NCT00724932|19435558|P2|NOT COMPLETED|Overall Study||3
7898000|NCT00724932|19435559|P1|NOT COMPLETED|Overall Study||5
7898001|NCT00724932|19435558|P2|COMPLETED|Overall Study||67
7898002|NCT00724932|19435559|P1|COMPLETED|Overall Study||65
7898003|NCT00724932|19435558|P2|STARTED|Overall Study||70
7898004|NCT00724932|19435559|P1|STARTED|Overall Study||70
7898005|NCT00724893|19435630|P2|NOT COMPLETED|Overall Study||458
7898006|NCT00724893|19435631|P1|NOT COMPLETED|Overall Study||364
7898007|NCT00724893|19435630|P2|COMPLETED|Overall Study||670
7898008|NCT00724893|19435631|P1|COMPLETED|Overall Study||938
7898009|NCT00724893|19435630|P2|STARTED|Overall Study||1128
7898010|NCT00724893|19435631|P1|STARTED|Overall Study||1302
7898011|NCT00724867|19435699|P1|NOT COMPLETED|Overall Study||128
7898012|NCT00724867|19435699|P1|COMPLETED|Overall Study||140
7898013|NCT00724867|19435699|P1|STARTED|Overall Study||268
7898014|NCT00724854|19435739|P2|NOT COMPLETED|Overall Study||31
7898015|NCT00724854|19435740|P1|NOT COMPLETED|Overall Study||403
7898016|NCT00724854|19435739|P2|COMPLETED|Overall Study||41
7898017|NCT00724854|19435740|P1|COMPLETED|Overall Study||607
7898018|NCT00724854|19435739|P2|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72
7898019|NCT00724854|19435740|P1|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010
7898020|NCT00724815|19435757|P2|NOT COMPLETED|Overall Study||39
7898021|NCT00724815|19435758|P1|NOT COMPLETED|Overall Study||43
7898022|NCT00724815|19435757|P2|COMPLETED|Overall Study||226
7898023|NCT00724815|19435758|P1|COMPLETED|Overall Study||222
7898024|NCT00724815|19435757|P2|STARTED|Overall Study|subjects randomized|265
7898025|NCT00724815|19435758|P1|STARTED|Overall Study|subjects randomized|265
7898026|NCT00724750|19435772|P2|NOT COMPLETED|Overall Study||0
7898027|NCT00724750|19435773|P1|NOT COMPLETED|Overall Study||0
7898028|NCT00724750|19435772|P2|COMPLETED|Overall Study||42
7898029|NCT00724750|19435773|P1|COMPLETED|Overall Study||45
7898030|NCT00724750|19435772|P2|STARTED|Overall Study||42
7898031|NCT00724750|19435773|P1|STARTED|Overall Study||45
7898032|NCT00724711|19435791|P2|NOT COMPLETED|Overall Study||17
7898033|NCT00724711|19435792|P1|NOT COMPLETED|Overall Study||17
7898034|NCT00724711|19435791|P2|COMPLETED|Overall Study||139
7898035|NCT00724711|19435792|P1|COMPLETED|Overall Study||138
7898036|NCT00724711|19435791|P2|STARTED|Overall Study||156
7898037|NCT00724711|19435792|P1|STARTED|Overall Study||155
7898038|NCT00724698|19435824|P1|NOT COMPLETED|Overall Study||90
7898039|NCT00724698|19435824|P1|COMPLETED|Overall Study||2921
7898040|NCT00724698|19435824|P1|STARTED|Overall Study||3011
7898041|NCT00724594|19435831|P4|NOT COMPLETED|Overall Study||1
7898042|NCT00724594|19435832|P3|NOT COMPLETED|Overall Study||0
7898043|NCT00724594|19435833|P2|NOT COMPLETED|Overall Study||0
7898044|NCT00724594|19435834|P1|NOT COMPLETED|Overall Study||0
7898045|NCT00724594|19435831|P4|COMPLETED|Overall Study||10
7898046|NCT00724594|19435832|P3|COMPLETED|Overall Study||11
7898047|NCT00724594|19435833|P2|COMPLETED|Overall Study||12
7898048|NCT00724594|19435834|P1|COMPLETED|Overall Study||12
7898049|NCT00724594|19435831|P4|STARTED|Overall Study||11
7898050|NCT00724594|19435832|P3|STARTED|Overall Study||11
7898051|NCT00724594|19435833|P2|STARTED|Overall Study||12
7898052|NCT00724594|19435834|P1|STARTED|Overall Study||12
7898053|NCT00724568|19435869|P2|NOT COMPLETED|Overall Study||0
7898054|NCT00724568|19435870|P1|NOT COMPLETED|Overall Study||0
7898055|NCT00724568|19435869|P2|COMPLETED|Overall Study||32
7898056|NCT00724568|19435870|P1|COMPLETED|Overall Study||42
7898057|NCT00724568|19435869|P2|STARTED|Overall Study||32
7898058|NCT00724568|19435870|P1|STARTED|Overall Study||42
7898059|NCT00724503|19435877|P2|NOT COMPLETED|Overall Study||220
7898060|NCT00724503|19435878|P1|NOT COMPLETED|Overall Study||210
7898061|NCT00724503|19435877|P2|COMPLETED|Overall Study||43
7898062|NCT00724503|19435878|P1|COMPLETED|Overall Study||57
7898063|NCT00724503|19435877|P2|STARTED|Overall Study||263
7898064|NCT00724503|19435878|P1|STARTED|Overall Study||267
7898065|NCT00724477|19435886|P1|NOT COMPLETED|Overall Study||0
7898066|NCT00724477|19435886|P1|COMPLETED|Overall Study||1663
7898067|NCT00724477|19435886|P1|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663
7898068|NCT00724464|19435890|P1|NOT COMPLETED|Overall Study||23
7898069|NCT00724464|19435890|P1|COMPLETED|Overall Study||309
7898070|NCT00724464|19435890|P1|STARTED|Overall Study||332
7898071|NCT00724451|19435902|P1|NOT COMPLETED|Overall Study||802
7898072|NCT00724451|19435902|P1|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326
7898073|NCT00724451|19435902|P1|Received Antiviral Treatment|Overall Study||500
7898074|NCT00724451|19435902|P1|STARTED|Overall Study||1128
7898075|NCT00724373|19435908|P1|NOT COMPLETED|Overall Study||171
7898076|NCT00724373|19435908|P1|COMPLETED|Overall Study||271
7898077|NCT00724373|19435908|P1|STARTED|Overall Study||442
7898078|NCT00724347|19435912|P1|NOT COMPLETED|Overall Study||2
7898079|NCT00724347|19435912|P1|COMPLETED|Overall Study||16
7898080|NCT00724347|19435912|P1|Baseline Testing|Overall Study||18
7898081|NCT00724347|19435912|P1|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18
7898082|NCT00724308|19435918|P2|NOT COMPLETED|Overall Study||97
7898083|NCT00724308|19435919|P1|NOT COMPLETED|Overall Study||80
7898084|NCT00724308|19435918|P2|COMPLETED|Overall Study||210
7898085|NCT00724308|19435919|P1|COMPLETED|Overall Study||190
7898086|NCT00724308|19435918|P2|STARTED|Overall Study||307
7898087|NCT00724308|19435919|P1|STARTED|Overall Study||270
7898088|NCT00724282|19435933|P1|NOT COMPLETED|Overall Study||4
7898089|NCT00724282|19435933|P1|COMPLETED|Overall Study||16
7898090|NCT00724282|19435933|P1|STARTED|Overall Study||20
7898091|NCT00724243|19435937|P1|NOT COMPLETED|Overall Study||15
7898092|NCT00724243|19435937|P1|COMPLETED|Overall Study||18
7898093|NCT00724243|19435937|P1|STARTED|Overall Study||33
7898094|NCT00724152|19435947|P3|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
7898095|NCT00724152|19435948|P2|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2
7898096|NCT00724152|19435949|P1|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
7898097|NCT00724152|19435947|P3|COMPLETED|Three-arm Study Period (+Standard Care)||1
7898098|NCT00724152|19435948|P2|COMPLETED|Three-arm Study Period (+Standard Care)||0
7898099|NCT00724152|19435949|P1|COMPLETED|Three-arm Study Period (+Standard Care)||3
7898100|NCT00724152|19435947|P3|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2
7898101|NCT00724152|19435948|P2|STARTED|Three-arm Study Period (+Standard Care)||2
7898102|NCT00724152|19435949|P1|STARTED|Three-arm Study Period (+Standard Care)||4
7898103|NCT00724152|19435947|P3|NOT COMPLETED|Two-arm Study Period||0
7898104|NCT00724152|19435948|P2|NOT COMPLETED|Two-arm Study Period||2
7898105|NCT00724152|19435949|P1|NOT COMPLETED|Two-arm Study Period||3
7898106|NCT00724152|19435947|P3|COMPLETED|Two-arm Study Period||0
7898107|NCT00724152|19435948|P2|COMPLETED|Two-arm Study Period||9
7898108|NCT00724152|19435949|P1|COMPLETED|Two-arm Study Period||11
7898109|NCT00724152|19435947|P3|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0
7898110|NCT00724152|19435948|P2|STARTED|Two-arm Study Period||11
7898111|NCT00724152|19435949|P1|STARTED|Two-arm Study Period||14
7898112|NCT00724126|19435966|P2|NOT COMPLETED|Overall Study||15
7898113|NCT00724126|19435967|P1|NOT COMPLETED|Overall Study||19
7898114|NCT00724126|19435966|P2|COMPLETED|Overall Study||301
7898115|NCT00724126|19435967|P1|COMPLETED|Overall Study||302
7898116|NCT00724126|19435966|P2|STARTED|Overall Study||316
7898117|NCT00724126|19435967|P1|STARTED|Overall Study||321
7898118|NCT00724061|19435975|P1|NOT COMPLETED|Maintenance Therapy||0
7898119|NCT00724061|19435975|P1|COMPLETED|Maintenance Therapy||2
7898120|NCT00724061|19435975|P1|STARTED|Maintenance Therapy||2
7898121|NCT00724061|19435975|P1|NOT COMPLETED|Dose Escalation Phase||5
7898122|NCT00724061|19435975|P1|COMPLETED|Dose Escalation Phase||2
7898123|NCT00724061|19435975|P1|STARTED|Dose Escalation Phase||7
7898124|NCT00724009|19435982|P1|NOT COMPLETED|Overall Study||0
7898125|NCT00724009|19435982|P1|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29
7898126|NCT00724009|19435982|P1|STARTED|Overall Study||29
7898127|NCT00723957|19435995|P2|NOT COMPLETED|Overall Study||53
7898128|NCT00723957|19435996|P1|NOT COMPLETED|Overall Study||51
7898129|NCT00723957|19435995|P2|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46
7898130|NCT00723957|19435996|P1|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47
7898131|NCT00723957|19435995|P2|STARTED|Overall Study|Randomized|99
7898132|NCT00723957|19435996|P1|STARTED|Overall Study|Randomized|98
7898133|NCT00723944|19436020|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
7898134|NCT00723944|19436021|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
7898135|NCT00723944|19436020|P2|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37
7898136|NCT00723944|19436021|P1|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48
7898137|NCT00723944|19436020|P2|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37
7898138|NCT00723944|19436021|P1|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48
7898139|NCT00723944|19436020|P2|NOT COMPLETED|One Year Post Placement Follow-up||4
7898140|NCT00723944|19436021|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
7898141|NCT00723944|19436020|P2|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37
7898142|NCT00723944|19436021|P1|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48
7898143|NCT00723944|19436020|P2|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41
7898144|NCT00723944|19436021|P1|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49
7898145|NCT00723944|19436020|P2|NOT COMPLETED|Permanent Prosthesis Placement||9
7898146|NCT00723944|19436021|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
7898147|NCT00723944|19436020|P2|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41
7898148|NCT00723944|19436021|P1|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49
7898149|NCT00723944|19436020|P2|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50
7898150|NCT00723944|19436021|P1|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52
7898151|NCT00723944|19436020|P2|NOT COMPLETED|Implant Placement Surgery||0
7898152|NCT00723944|19436021|P1|NOT COMPLETED|Implant Placement Surgery||0
7898153|NCT00723944|19436020|P2|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50
7898154|NCT00723944|19436021|P1|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52
7898155|NCT00723944|19436020|P2|STARTED|Implant Placement Surgery|number of individual implant units is 138|50
7898156|NCT00723944|19436021|P1|STARTED|Implant Placement Surgery|number of individual implant units is 148|52
7898157|NCT00723931|19436027|P1|NOT COMPLETED|Overall Study||0
7898158|NCT00723931|19436027|P1|COMPLETED|Overall Study||1267
7898159|NCT00723931|19436027|P1|STARTED|Overall Study||1267
7898160|NCT00723892|19436034|P2|NOT COMPLETED|Overall Study||87
7898161|NCT00723892|19436035|P1|NOT COMPLETED|Overall Study||107
7898162|NCT00723892|19436034|P2|COMPLETED|Overall Study||168
7898163|NCT00723892|19436035|P1|COMPLETED|Overall Study||206
7898164|NCT00723892|19436034|P2|STARTED|Overall Study||255
7898165|NCT00723892|19436035|P1|STARTED|Overall Study||313
7898166|NCT00723840|19436042|P1|NOT COMPLETED|Overall Study||82
7898167|NCT00723840|19436042|P1|COMPLETED|Overall Study||163
7898168|NCT00723840|19436042|P1|STARTED|Overall Study||245
7898169|NCT00723827|19436053|P1|NOT COMPLETED|Overall Study||0
7898170|NCT00723827|19436053|P1|COMPLETED|Overall Study||682
7898171|NCT00723827|19436053|P1|STARTED|Overall Study||682
7898172|NCT00723801|19436063|P2|NOT COMPLETED|Overall Study||3
7898173|NCT00723801|19436064|P1|NOT COMPLETED|Overall Study||3
7898174|NCT00723801|19436063|P2|COMPLETED|Overall Study||17
7898175|NCT00723801|19436064|P1|COMPLETED|Overall Study||17
7898176|NCT00723801|19436063|P2|STARTED|Overall Study||20
7898177|NCT00723801|19436064|P1|STARTED|Overall Study||20
7898178|NCT00723788|19436072|P1|NOT COMPLETED|Overall Study||0
7898179|NCT00723788|19436072|P1|COMPLETED|Overall Study||21
7898180|NCT00723788|19436072|P1|STARTED|Overall Study||21
7898181|NCT00723749|19436078|P1|NOT COMPLETED|Overall Study||163
7898182|NCT00723749|19436078|P1|COMPLETED|Overall Study||182
7898183|NCT00723749|19436078|P1|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345
7898184|NCT00723736|19436085|P1|NOT COMPLETED|Overall Study||1
7898185|NCT00723736|19436085|P1|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99
7898186|NCT00723736|19436085|P1|STARTED|Overall Study||100
7898187|NCT00723710|19436089|P1|NOT COMPLETED|Overall Study||174
7898188|NCT00723710|19436089|P1|COMPLETED|Overall Study||120
7898189|NCT00723710|19436089|P1|STARTED|Overall Study||294
7898190|NCT00723697|19436093|P1|NOT COMPLETED|Overall Study||18
7898191|NCT00723697|19436093|P1|COMPLETED|Overall Study||1289
7898192|NCT00723697|19436093|P1|STARTED|Overall Study||1307
7898193|NCT00723645|19436101|P1|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0
7898194|NCT00723645|19436101|P1|COMPLETED|Visit 3 (Week 72 Post-treatment)||187
7898195|NCT00723645|19436101|P1|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187
7898196|NCT00723645|19436101|P1|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0
7898197|NCT00723645|19436101|P1|COMPLETED|Visit 2 (Week 24 Post-treatment)||248
7898198|NCT00723645|19436101|P1|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248
7898199|NCT00723645|19436101|P1|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0
7898200|NCT00723645|19436101|P1|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258
7898201|NCT00723645|19436101|P1|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258
7898202|NCT00723632|19436106|P1|NOT COMPLETED|Overall Study||203
7898203|NCT00723632|19436106|P1|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698
7898204|NCT00723632|19436106|P1|STARTED|Overall Study||901
7898205|NCT00723606|19436114|P2|NOT COMPLETED|Overall Study||7
7898206|NCT00723606|19436115|P1|NOT COMPLETED|Overall Study||4
7898207|NCT00723606|19436114|P2|COMPLETED|Overall Study||180
7898208|NCT00723606|19436115|P1|COMPLETED|Overall Study||185
7898209|NCT00723606|19436114|P2|STARTED|Overall Study||187
7898210|NCT00723606|19436115|P1|STARTED|Overall Study||189
7898211|NCT00723580|19436131|P1|NOT COMPLETED|Overall Study||0
7898212|NCT00723580|19436131|P1|COMPLETED|Overall Study|Completion of repeated Measurements|1
7898213|NCT00723580|19436131|P1|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1
7898214|NCT00723580|19436131|P1|STARTED|Overall Study|Study was extended with continued repeated measurements.|1
7898215|NCT00723554|19436135|P1|NOT COMPLETED|Overall Study||29
7898216|NCT00723554|19436135|P1|COMPLETED|Overall Study||34
7898217|NCT00723554|19436135|P1|STARTED|Overall Study||63
7898218|NCT00723528|19436185|P7|NOT COMPLETED|Period 2: After Controlled Period||4
7898219|NCT00723528|19436186|P6|NOT COMPLETED|Period 2: After Controlled Period||6
7898220|NCT00723528|19436187|P5|NOT COMPLETED|Period 2: After Controlled Period||2
7898221|NCT00723528|19436188|P4|NOT COMPLETED|Period 2: After Controlled Period||1
7898222|NCT00723528|19436189|P3|NOT COMPLETED|Period 2: After Controlled Period||0
7898223|NCT00723528|19436190|P2|NOT COMPLETED|Period 2: After Controlled Period||0
7898224|NCT00723528|19436191|P1|NOT COMPLETED|Period 2: After Controlled Period||0
7898225|NCT00723528|19436185|P7|COMPLETED|Period 2: After Controlled Period||54
7898226|NCT00723528|19436186|P6|COMPLETED|Period 2: After Controlled Period||58
7898227|NCT00723528|19436187|P5|COMPLETED|Period 2: After Controlled Period||11
7898228|NCT00723528|19436188|P4|COMPLETED|Period 2: After Controlled Period||14
7898229|NCT00723528|19436189|P3|COMPLETED|Period 2: After Controlled Period||0
7898230|NCT00723528|19436190|P2|COMPLETED|Period 2: After Controlled Period||0
7898231|NCT00723528|19436191|P1|COMPLETED|Period 2: After Controlled Period||0
7898232|NCT00723528|19436185|P7|STARTED|Period 2: After Controlled Period||58
7898233|NCT00723528|19436186|P6|STARTED|Period 2: After Controlled Period||64
7898234|NCT00723528|19436187|P5|STARTED|Period 2: After Controlled Period||13
7898235|NCT00723528|19436188|P4|STARTED|Period 2: After Controlled Period||15
7898236|NCT00723528|19436189|P3|STARTED|Period 2: After Controlled Period||0
7898237|NCT00723528|19436190|P2|STARTED|Period 2: After Controlled Period||0
7898238|NCT00723528|19436191|P1|STARTED|Period 2: After Controlled Period||0
7898239|NCT00723528|19436185|P7|NOT COMPLETED|Period 1: Controlled Period (CP)||0
7898240|NCT00723528|19436186|P6|NOT COMPLETED|Period 1: Controlled Period (CP)||0
7898241|NCT00723528|19436187|P5|NOT COMPLETED|Period 1: Controlled Period (CP)||0
7898242|NCT00723528|19436188|P4|NOT COMPLETED|Period 1: Controlled Period (CP)||0
7898243|NCT00723528|19436189|P3|NOT COMPLETED|Period 1: Controlled Period (CP)||4
7898244|NCT00723528|19436190|P2|NOT COMPLETED|Period 1: Controlled Period (CP)||0
7898245|NCT00723528|19436191|P1|NOT COMPLETED|Period 1: Controlled Period (CP)||4
7898246|NCT00723528|19436185|P7|COMPLETED|Period 1: Controlled Period (CP)||0
7898247|NCT00723528|19436186|P6|COMPLETED|Period 1: Controlled Period (CP)||0
7898248|NCT00723528|19436187|P5|COMPLETED|Period 1: Controlled Period (CP)||0
7898249|NCT00723528|19436188|P4|COMPLETED|Period 1: Controlled Period (CP)||0
7898250|NCT00723528|19436189|P3|COMPLETED|Period 1: Controlled Period (CP)||58
7898251|NCT00723528|19436190|P2|COMPLETED|Period 1: Controlled Period (CP)||64
7898252|NCT00723528|19436191|P1|COMPLETED|Period 1: Controlled Period (CP)||28
7898253|NCT00723528|19436185|P7|STARTED|Period 1: Controlled Period (CP)||0
7898254|NCT00723528|19436186|P6|STARTED|Period 1: Controlled Period (CP)||0
7898255|NCT00723528|19436187|P5|STARTED|Period 1: Controlled Period (CP)||0
7898256|NCT00723528|19436188|P4|STARTED|Period 1: Controlled Period (CP)||0
7898257|NCT00723528|19436189|P3|STARTED|Period 1: Controlled Period (CP)||62
7898258|NCT00723528|19436190|P2|STARTED|Period 1: Controlled Period (CP)||64
7898259|NCT00723528|19436191|P1|STARTED|Period 1: Controlled Period (CP)||32
7898260|NCT00723489|19436253|P4|NOT COMPLETED|Overall Study||3
7898261|NCT00723489|19436254|P3|NOT COMPLETED|Overall Study||0
7898262|NCT00723489|19436255|P2|NOT COMPLETED|Overall Study||4
7898263|NCT00723489|19436256|P1|NOT COMPLETED|Overall Study||1
7898264|NCT00723489|19436253|P4|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
7898265|NCT00723489|19436254|P3|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19
7898266|NCT00723489|19436255|P2|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15
7898267|NCT00723489|19436256|P1|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
7898268|NCT00723489|19436253|P4|STARTED|Overall Study||23
7898269|NCT00723489|19436254|P3|STARTED|Overall Study||19
7898270|NCT00723489|19436255|P2|STARTED|Overall Study||19
7898271|NCT00723489|19436256|P1|STARTED|Overall Study||21
7898272|NCT00723450|19436284|P3|NOT COMPLETED|Randomized Phase||67
7898273|NCT00723450|19436285|P2|NOT COMPLETED|Randomized Phase||65
7898274|NCT00723450|19436286|P1|NOT COMPLETED|Randomized Phase||0
7898275|NCT00723450|19436284|P3|COMPLETED|Randomized Phase||20
7898276|NCT00723450|19436285|P2|COMPLETED|Randomized Phase||21
7898277|NCT00723450|19436286|P1|COMPLETED|Randomized Phase||0
7898278|NCT00723450|19436284|P3|STARTED|Randomized Phase||87
7898279|NCT00723450|19436285|P2|STARTED|Randomized Phase||86
7898280|NCT00723450|19436286|P1|STARTED|Randomized Phase||0
7898281|NCT00723450|19436284|P3|NOT COMPLETED|Open-Label Phase||0
7898282|NCT00723450|19436285|P2|NOT COMPLETED|Open-Label Phase||0
7898283|NCT00723450|19436286|P1|NOT COMPLETED|Open-Label Phase||125
7898284|NCT00723450|19436284|P3|COMPLETED|Open-Label Phase||0
7898285|NCT00723450|19436285|P2|COMPLETED|Open-Label Phase||0
7898286|NCT00723450|19436286|P1|COMPLETED|Open-Label Phase||173
7898287|NCT00723450|19436284|P3|STARTED|Open-Label Phase||0
7898288|NCT00723450|19436285|P2|STARTED|Open-Label Phase||0
7898289|NCT00723450|19436286|P1|STARTED|Open-Label Phase||298
7898290|NCT00723398|19436332|P5|NOT COMPLETED|Overall Study||9
7898291|NCT00723398|19436333|P4|NOT COMPLETED|Overall Study||5
7898292|NCT00723398|19436334|P3|NOT COMPLETED|Overall Study||17
7898293|NCT00723398|19436335|P2|NOT COMPLETED|Overall Study||15
7898294|NCT00723398|19436336|P1|NOT COMPLETED|Overall Study||6
7898295|NCT00723398|19436332|P5|COMPLETED|Overall Study||44
7898296|NCT00723398|19436333|P4|COMPLETED|Overall Study||49
7898297|NCT00723398|19436334|P3|COMPLETED|Overall Study||36
7898298|NCT00723398|19436335|P2|COMPLETED|Overall Study||38
7898299|NCT00723398|19436336|P1|COMPLETED|Overall Study||47
7898300|NCT00723398|19436332|P5|STARTED|Overall Study||53
7898301|NCT00723398|19436333|P4|STARTED|Overall Study||54
7898302|NCT00723398|19436334|P3|STARTED|Overall Study||53
7898303|NCT00723398|19436335|P2|STARTED|Overall Study||53
7898304|NCT00723398|19436336|P1|STARTED|Overall Study||53
7898305|NCT00723294|19436398|P1|NOT COMPLETED|Overall Study||13
7898306|NCT00723294|19436398|P1|COMPLETED|Overall Study||86
7898307|NCT00723294|19436398|P1|STARTED|Overall Study||99
7898308|NCT00723255|19436403|P1|NOT COMPLETED|Overall Study||4
7898309|NCT00723255|19436403|P1|COMPLETED|Overall Study|Eligible and treated patients|49
7898310|NCT00723255|19436403|P1|STARTED|Overall Study||53
7898311|NCT00723229|19436430|P2|NOT COMPLETED|Second Intervention||0
7898312|NCT00723229|19436431|P1|NOT COMPLETED|Second Intervention||0
7898313|NCT00723229|19436430|P2|COMPLETED|Second Intervention||20
7898314|NCT00723229|19436431|P1|COMPLETED|Second Intervention||18
7898315|NCT00723229|19436430|P2|STARTED|Second Intervention||20
7898316|NCT00723229|19436431|P1|STARTED|Second Intervention||18
7898317|NCT00723229|19436430|P2|NOT COMPLETED|First Intervention||3
7898318|NCT00723229|19436431|P1|NOT COMPLETED|First Intervention||7
7898319|NCT00723229|19436430|P2|COMPLETED|First Intervention||20
7898320|NCT00723229|19436431|P1|COMPLETED|First Intervention||18
7898321|NCT00723229|19436430|P2|STARTED|First Intervention||23
7898322|NCT00723229|19436431|P1|STARTED|First Intervention||25
7898323|NCT00723203|19436443|P1|NOT COMPLETED|Overall Study||3
7898324|NCT00723203|19436443|P1|COMPLETED|Overall Study||13
7898325|NCT00723203|19436443|P1|STARTED|Overall Study||16
7898326|NCT00723190|19436447|P1|NOT COMPLETED|Overall Study||142
7898327|NCT00723190|19436447|P1|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161
7898328|NCT00723190|19436447|P1|SAFETY POPULATION|Overall Study||301
7898329|NCT00723190|19436447|P1|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303
7898330|NCT00723177|19436465|P3|NOT COMPLETED|Overall Study||5
7898331|NCT00723177|19436466|P2|NOT COMPLETED|Overall Study||4
7898332|NCT00723177|19436467|P1|NOT COMPLETED|Overall Study||5
7898333|NCT00723177|19436465|P3|COMPLETED|Overall Study||10
7898334|NCT00723177|19436466|P2|COMPLETED|Overall Study||10
7898335|NCT00723177|19436467|P1|COMPLETED|Overall Study||10
7898336|NCT00723177|19436465|P3|STARTED|Overall Study||15
7898337|NCT00723177|19436466|P2|STARTED|Overall Study||14
7898338|NCT00723177|19436467|P1|STARTED|Overall Study||15
7898339|NCT00723125|19436480|P2|NOT COMPLETED|Overall Study||6
7898340|NCT00723125|19436481|P1|NOT COMPLETED|Overall Study||18
7898341|NCT00723125|19436480|P2|COMPLETED|Overall Study||21
7898342|NCT00723125|19436481|P1|COMPLETED|Overall Study||15
7898343|NCT00723125|19436480|P2|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27
7898344|NCT00723125|19436481|P1|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33
7898345|NCT00723099|19436491|P1|NOT COMPLETED|Overall Study||1
7898346|NCT00723099|19436491|P1|COMPLETED|Overall Study||72
7898347|NCT00723099|19436491|P1|STARTED|Overall Study||73
7898348|NCT00723073|19436505|P2|NOT COMPLETED|Overall Study||0
7898349|NCT00723073|19436506|P1|NOT COMPLETED|Overall Study||0
7898350|NCT00723073|19436505|P2|COMPLETED|Overall Study||174
7898351|NCT00723073|19436506|P1|COMPLETED|Overall Study||149
7898352|NCT00723073|19436505|P2|STARTED|Overall Study||174
7898353|NCT00723073|19436506|P1|STARTED|Overall Study||149
7898354|NCT00723021|19436530|P5|NOT COMPLETED|Intervention Period 5||0
7898355|NCT00723021|19436531|P4|NOT COMPLETED|Intervention Period 5||0
7898356|NCT00723021|19436532|P3|NOT COMPLETED|Intervention Period 5||0
7898357|NCT00723021|19436533|P2|NOT COMPLETED|Intervention Period 5||0
7898358|NCT00723021|19436534|P1|NOT COMPLETED|Intervention Period 5||0
7898359|NCT00723021|19436530|P5|COMPLETED|Intervention Period 5||2
7898360|NCT00723021|19436531|P4|COMPLETED|Intervention Period 5||3
7898361|NCT00723021|19436532|P3|COMPLETED|Intervention Period 5||3
7898362|NCT00723021|19436533|P2|COMPLETED|Intervention Period 5||3
7898363|NCT00723021|19436534|P1|COMPLETED|Intervention Period 5||3
7898364|NCT00723021|19436530|P5|STARTED|Intervention Period 5||2
7898365|NCT00723021|19436531|P4|STARTED|Intervention Period 5||3
7898366|NCT00723021|19436532|P3|STARTED|Intervention Period 5||3
7898367|NCT00723021|19436533|P2|STARTED|Intervention Period 5||3
7898368|NCT00723021|19436534|P1|STARTED|Intervention Period 5||3
7898369|NCT00723021|19436530|P5|NOT COMPLETED|Intervention Period 4||1
7898370|NCT00723021|19436531|P4|NOT COMPLETED|Intervention Period 4||0
7898371|NCT00723021|19436532|P3|NOT COMPLETED|Intervention Period 4||0
7898372|NCT00723021|19436533|P2|NOT COMPLETED|Intervention Period 4||0
7898373|NCT00723021|19436534|P1|NOT COMPLETED|Intervention Period 4||0
7898374|NCT00723021|19436530|P5|COMPLETED|Intervention Period 4||2
7898375|NCT00723021|19436531|P4|COMPLETED|Intervention Period 4||3
7898376|NCT00723021|19436532|P3|COMPLETED|Intervention Period 4||3
7898377|NCT00723021|19436533|P2|COMPLETED|Intervention Period 4||3
7898378|NCT00723021|19436534|P1|COMPLETED|Intervention Period 4||3
7898379|NCT00723021|19436530|P5|STARTED|Intervention Period 4||3
7898380|NCT00723021|19436531|P4|STARTED|Intervention Period 4||3
7898381|NCT00723021|19436532|P3|STARTED|Intervention Period 4||3
7898382|NCT00723021|19436533|P2|STARTED|Intervention Period 4||3
7898383|NCT00723021|19436534|P1|STARTED|Intervention Period 4||3
7898384|NCT00723021|19436530|P5|NOT COMPLETED|Intervention Period 3||0
7898385|NCT00723021|19436531|P4|NOT COMPLETED|Intervention Period 3||0
7898386|NCT00723021|19436532|P3|NOT COMPLETED|Intervention Period 3||0
7898387|NCT00723021|19436533|P2|NOT COMPLETED|Intervention Period 3||0
7898388|NCT00723021|19436534|P1|NOT COMPLETED|Intervention Period 3||0
7898389|NCT00723021|19436530|P5|COMPLETED|Intervention Period 3||3
7898390|NCT00723021|19436531|P4|COMPLETED|Intervention Period 3||3
7898391|NCT00723021|19436532|P3|COMPLETED|Intervention Period 3||3
7898392|NCT00723021|19436533|P2|COMPLETED|Intervention Period 3||3
7898393|NCT00723021|19436534|P1|COMPLETED|Intervention Period 3||3
7898394|NCT00723021|19436530|P5|STARTED|Intervention Period 3||3
7898395|NCT00723021|19436531|P4|STARTED|Intervention Period 3||3
7898396|NCT00723021|19436532|P3|STARTED|Intervention Period 3||3
7898397|NCT00723021|19436533|P2|STARTED|Intervention Period 3||3
7898398|NCT00723021|19436534|P1|STARTED|Intervention Period 3||3
7898399|NCT00723021|19436530|P5|NOT COMPLETED|Intervention Period 2||0
7898400|NCT00723021|19436531|P4|NOT COMPLETED|Intervention Period 2||0
7898401|NCT00723021|19436532|P3|NOT COMPLETED|Intervention Period 2||0
7898402|NCT00723021|19436533|P2|NOT COMPLETED|Intervention Period 2||0
7898403|NCT00723021|19436534|P1|NOT COMPLETED|Intervention Period 2||0
7898404|NCT00723021|19436530|P5|COMPLETED|Intervention Period 2||3
7898405|NCT00723021|19436531|P4|COMPLETED|Intervention Period 2||3
7898406|NCT00723021|19436532|P3|COMPLETED|Intervention Period 2||3
7898407|NCT00723021|19436533|P2|COMPLETED|Intervention Period 2||3
7898408|NCT00723021|19436534|P1|COMPLETED|Intervention Period 2||3
7898409|NCT00723021|19436530|P5|STARTED|Intervention Period 2||3
7898410|NCT00723021|19436531|P4|STARTED|Intervention Period 2||3
7898411|NCT00723021|19436532|P3|STARTED|Intervention Period 2||3
7898412|NCT00723021|19436533|P2|STARTED|Intervention Period 2||3
7898413|NCT00723021|19436534|P1|STARTED|Intervention Period 2||3
7898414|NCT00723021|19436530|P5|NOT COMPLETED|Intervention Period 1||0
7898415|NCT00723021|19436531|P4|NOT COMPLETED|Intervention Period 1||0
7898416|NCT00723021|19436532|P3|NOT COMPLETED|Intervention Period 1||0
7898417|NCT00723021|19436533|P2|NOT COMPLETED|Intervention Period 1||0
7898418|NCT00723021|19436534|P1|NOT COMPLETED|Intervention Period 1||0
7898419|NCT00723021|19436530|P5|COMPLETED|Intervention Period 1||3
7898420|NCT00723021|19436531|P4|COMPLETED|Intervention Period 1||3
7898421|NCT00723021|19436532|P3|COMPLETED|Intervention Period 1||3
7898422|NCT00723021|19436533|P2|COMPLETED|Intervention Period 1||3
7898423|NCT00723021|19436534|P1|COMPLETED|Intervention Period 1||3
7898424|NCT00723021|19436530|P5|STARTED|Intervention Period 1||3
7898425|NCT00723021|19436531|P4|STARTED|Intervention Period 1||3
7898426|NCT00723021|19436532|P3|STARTED|Intervention Period 1||3
7898427|NCT00723021|19436533|P2|STARTED|Intervention Period 1||3
7898428|NCT00723021|19436534|P1|STARTED|Intervention Period 1||3
7898429|NCT00723008|19436588|P2|NOT COMPLETED|4-Week Unblinded Treatment||1
7898430|NCT00723008|19436589|P1|NOT COMPLETED|4-Week Unblinded Treatment||1
7898431|NCT00723008|19436588|P2|COMPLETED|4-Week Unblinded Treatment||3
7898432|NCT00723008|19436589|P1|COMPLETED|4-Week Unblinded Treatment||4
7898433|NCT00723008|19436588|P2|STARTED|4-Week Unblinded Treatment||4
7898434|NCT00723008|19436589|P1|STARTED|4-Week Unblinded Treatment||5
7898435|NCT00723008|19436588|P2|NOT COMPLETED|4-Week Double Blinded||5
7898436|NCT00723008|19436589|P1|NOT COMPLETED|4-Week Double Blinded||5
7898437|NCT00723008|19436588|P2|COMPLETED|4-Week Double Blinded||4
7898438|NCT00723008|19436589|P1|COMPLETED|4-Week Double Blinded||5
7898439|NCT00723008|19436588|P2|STARTED|4-Week Double Blinded||9
7898440|NCT00723008|19436589|P1|STARTED|4-Week Double Blinded||10
7898441|NCT00723008|19436588|P2|NOT COMPLETED|Enrollment||0
7898442|NCT00723008|19436589|P1|NOT COMPLETED|Enrollment||1
7898443|NCT00723008|19436588|P2|COMPLETED|Enrollment||9
7898444|NCT00723008|19436589|P1|COMPLETED|Enrollment||10
7898445|NCT00723008|19436588|P2|STARTED|Enrollment||9
7898446|NCT00723008|19436589|P1|STARTED|Enrollment||11
7898447|NCT00722865|19436611|P1|NOT COMPLETED|Overall Study||2
7898448|NCT00722865|19436611|P1|COMPLETED|Overall Study||23
7898449|NCT00722865|19436611|P1|STARTED|Overall Study||25
7898450|NCT00722800|19436621|P2|NOT COMPLETED|Overall Study||0
7898451|NCT00722800|19436622|P1|NOT COMPLETED|Overall Study||2
7898452|NCT00722800|19436621|P2|COMPLETED|Overall Study||2
7898453|NCT00722800|19436622|P1|COMPLETED|Overall Study||0
7898454|NCT00722800|19436621|P2|STARTED|Overall Study||2
7898455|NCT00722800|19436622|P1|STARTED|Overall Study||2
7898456|NCT00722761|19436634|P2|NOT COMPLETED|Overall Study||6
7898457|NCT00722761|19436635|P1|NOT COMPLETED|Overall Study||6
7898458|NCT00722761|19436634|P2|COMPLETED|Overall Study||8
7898459|NCT00722761|19436635|P1|COMPLETED|Overall Study||10
7898460|NCT00722761|19436634|P2|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10
7898461|NCT00722761|19436635|P1|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15
7898462|NCT00722761|19436634|P2|STARTED|Overall Study||14
7898463|NCT00722761|19436635|P1|STARTED|Overall Study||16
7898464|NCT00722722|19436646|P3|NOT COMPLETED|Overall Study||0
7898465|NCT00722722|19436647|P2|NOT COMPLETED|Overall Study||0
7898466|NCT00722722|19436648|P1|NOT COMPLETED|Overall Study||0
7898467|NCT00722722|19436646|P3|COMPLETED|Overall Study||10
7898468|NCT00722722|19436647|P2|COMPLETED|Overall Study||5
7898469|NCT00722722|19436648|P1|COMPLETED|Overall Study||3
7898470|NCT00722722|19436646|P3|STARTED|Overall Study||10
7898471|NCT00722722|19436647|P2|STARTED|Overall Study||5
7898472|NCT00722722|19436648|P1|STARTED|Overall Study||3
7898473|NCT00722566|19436658|P2|NOT COMPLETED|Overall Study||35
7898474|NCT00722566|19436659|P1|NOT COMPLETED|Overall Study||67
7898475|NCT00722566|19436658|P2|COMPLETED|Overall Study|Completed 8 cycles|39
7898476|NCT00722566|19436659|P1|COMPLETED|Overall Study|Completed 8 cycles|81
7898477|NCT00722566|19436658|P2|STARTED|Overall Study||74
7898478|NCT00722566|19436659|P1|STARTED|Overall Study|One patient randomized and not dosed|148
7898479|NCT00722553|19436667|P1|NOT COMPLETED|Overall Study||0
7898480|NCT00722553|19436667|P1|COMPLETED|Overall Study||30
7898481|NCT00722553|19436667|P1|STARTED|Overall Study||30
7898482|NCT00722436|19436677|P2|NOT COMPLETED|Overall Study||0
7898483|NCT00722436|19436678|P1|NOT COMPLETED|Overall Study||0
7898484|NCT00722436|19436677|P2|COMPLETED|Overall Study||11
7898485|NCT00722436|19436678|P1|COMPLETED|Overall Study||9
7898486|NCT00722436|19436677|P2|STARTED|Overall Study||11
7898487|NCT00722436|19436678|P1|STARTED|Overall Study||9
7898488|NCT00722423|19436692|P2|NOT COMPLETED|Overall Study||1
7898489|NCT00722423|19436693|P1|NOT COMPLETED|Overall Study||0
7898490|NCT00722423|19436692|P2|COMPLETED|Overall Study||181
7898491|NCT00722423|19436693|P1|COMPLETED|Overall Study||182
7898492|NCT00722423|19436692|P2|STARTED|Overall Study||182
7898493|NCT00722423|19436693|P1|STARTED|Overall Study||182
7898494|NCT00722371|19436708|P7|NOT COMPLETED|Overall Study||51
7898495|NCT00722371|19436709|P6|NOT COMPLETED|Overall Study||53
7898496|NCT00722371|19436710|P5|NOT COMPLETED|Overall Study||48
7898497|NCT00722371|19436711|P4|NOT COMPLETED|Overall Study||63
7898498|NCT00722371|19436712|P3|NOT COMPLETED|Overall Study||65
7898499|NCT00722371|19436713|P2|NOT COMPLETED|Overall Study||72
7898500|NCT00722371|19436714|P1|NOT COMPLETED|Overall Study||56
7898501|NCT00722371|19436708|P7|COMPLETED|Overall Study||179
7898502|NCT00722371|19436709|P6|COMPLETED|Overall Study||178
7898503|NCT00722371|19436710|P5|COMPLETED|Overall Study||182
7898504|NCT00722371|19436711|P4|COMPLETED|Overall Study||167
7898505|NCT00722371|19436712|P3|COMPLETED|Overall Study||168
7898506|NCT00722371|19436713|P2|COMPLETED|Overall Study||158
7898507|NCT00722371|19436714|P1|COMPLETED|Overall Study||175
7898508|NCT00722371|19436708|P7|STARTED|Overall Study||230
7898509|NCT00722371|19436709|P6|STARTED|Overall Study||231
7898510|NCT00722371|19436710|P5|STARTED|Overall Study||230
7898511|NCT00722371|19436711|P4|STARTED|Overall Study||230
7898512|NCT00722371|19436712|P3|STARTED|Overall Study||233
7898513|NCT00722371|19436713|P2|STARTED|Overall Study||230
7898514|NCT00722371|19436714|P1|STARTED|Overall Study||231
7898515|NCT00722137|19436767|P2|NOT COMPLETED|Overall Study||48
7898516|NCT00722137|19436768|P1|NOT COMPLETED|Overall Study||45
7898517|NCT00722137|19436767|P2|COMPLETED|Overall Study||195
7898518|NCT00722137|19436768|P1|COMPLETED|Overall Study||199
7898519|NCT00722137|19436767|P2|STARTED|Overall Study||243
7898520|NCT00722137|19436768|P1|STARTED|Overall Study||244
7898521|NCT00722124|19436797|P3|NOT COMPLETED|Overall Study||20
7898522|NCT00722124|19436798|P2|NOT COMPLETED|Overall Study||14
7898523|NCT00722124|19436799|P1|NOT COMPLETED|Overall Study||17
7898524|NCT00722124|19436797|P3|COMPLETED|Overall Study||20
7898525|NCT00722124|19436798|P2|COMPLETED|Overall Study||26
7898526|NCT00722124|19436799|P1|COMPLETED|Overall Study||23
7898527|NCT00722124|19436797|P3|STARTED|Overall Study||40
7898528|NCT00722124|19436798|P2|STARTED|Overall Study||40
7898529|NCT00722124|19436799|P1|STARTED|Overall Study||40
7898530|NCT00722111|19436809|P2|NOT COMPLETED|Overall Study||0
7898531|NCT00722111|19436810|P1|NOT COMPLETED|Overall Study||0
7898532|NCT00722111|19436809|P2|COMPLETED|Overall Study||72
7898533|NCT00722111|19436810|P1|COMPLETED|Overall Study||11
7898534|NCT00722111|19436809|P2|STARTED|Overall Study||72
7898535|NCT00722111|19436810|P1|STARTED|Overall Study||11
7898536|NCT00722072|19436817|P1|NOT COMPLETED|Overall Study||3
7898537|NCT00722072|19436817|P1|COMPLETED|Overall Study||9
7898538|NCT00722072|19436817|P1|STARTED|Overall Study||12
7898539|NCT00722020|19436827|P2|NOT COMPLETED|Overall Study||0
7898540|NCT00722020|19436828|P1|NOT COMPLETED|Overall Study||0
7898541|NCT00722020|19436827|P2|COMPLETED|Overall Study||24
7898542|NCT00722020|19436828|P1|COMPLETED|Overall Study||19
7898543|NCT00722020|19436827|P2|STARTED|Overall Study||24
7898544|NCT00722020|19436828|P1|STARTED|Overall Study||19
7898545|NCT00722007|19436836|P1|NOT COMPLETED|Overall Study||30
7898546|NCT00722007|19436836|P1|COMPLETED|Overall Study||117
7898547|NCT00722007|19436836|P1|STARTED|Overall Study||147
7898548|NCT00721968|19436846|P2|NOT COMPLETED|Overall Study||0
7898549|NCT00721968|19436847|P1|NOT COMPLETED|Overall Study||2
7898550|NCT00721968|19436846|P2|COMPLETED|Overall Study||17
7898551|NCT00721968|19436847|P1|COMPLETED|Overall Study||25
7898552|NCT00721968|19436846|P2|STARTED|Overall Study||17
7898553|NCT00721968|19436847|P1|STARTED|Overall Study||27
7898554|NCT00721955|19436858|P3|NOT COMPLETED|Overall Study||2
7898555|NCT00721955|19436859|P2|NOT COMPLETED|Overall Study||0
7898556|NCT00721955|19436860|P1|NOT COMPLETED|Overall Study||0
7898557|NCT00721955|19436858|P3|COMPLETED|Overall Study||103
7898558|NCT00721955|19436859|P2|COMPLETED|Overall Study||104
7898559|NCT00721955|19436860|P1|COMPLETED|Overall Study||105
7898560|NCT00721955|19436858|P3|STARTED|Overall Study||105
7898561|NCT00721955|19436859|P2|STARTED|Overall Study||104
7898562|NCT00721955|19436860|P1|STARTED|Overall Study||105
7898563|NCT00721799|19436874|P1|NOT COMPLETED|Overall Study||8
7898564|NCT00721799|19436874|P1|COMPLETED|Overall Study||25
7898565|NCT00721799|19436874|P1|Received FLT PET Scan #2|Overall Study||25
7898566|NCT00721799|19436874|P1|Recieved FLT PET Scan 1|Overall Study||26
7898567|NCT00721799|19436874|P1|STARTED|Overall Study||33
7898568|NCT00721734|19436914|P5|NOT COMPLETED|Overall Study||6
7898569|NCT00721734|19436915|P4|NOT COMPLETED|Overall Study||6
7898570|NCT00721734|19436916|P3|NOT COMPLETED|Overall Study||8
7898571|NCT00721734|19436917|P2|NOT COMPLETED|Overall Study||12
7898572|NCT00721734|19436918|P1|NOT COMPLETED|Overall Study||8
7898573|NCT00721734|19436914|P5|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
7898574|NCT00721734|19436915|P4|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
7898575|NCT00721734|19436916|P3|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
7898576|NCT00721734|19436917|P2|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0
7898577|NCT00721734|19436918|P1|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4
7898578|NCT00721734|19436914|P5|STARTED|Overall Study||8
7898579|NCT00721734|19436915|P4|STARTED|Overall Study||8
7898580|NCT00721734|19436916|P3|STARTED|Overall Study||10
7898581|NCT00721734|19436917|P2|STARTED|Overall Study||12
7898582|NCT00721734|19436918|P1|STARTED|Overall Study||12
7898583|NCT00721630|19437030|P1|NOT COMPLETED|Overall Study||1
7898584|NCT00721630|19437030|P1|COMPLETED|Overall Study||23
7898585|NCT00721630|19437030|P1|STARTED|Overall Study||24
7898586|NCT00721617|19437035|P1|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0
7898587|NCT00721617|19437035|P1|COMPLETED|8 Hours Into Intralipid/Dextrose||12
7898588|NCT00721617|19437035|P1|STARTED|8 Hours Into Intralipid/Dextrose||12
7898589|NCT00721617|19437035|P1|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0
7898590|NCT00721617|19437035|P1|COMPLETED|4 Hours Into Intralipid/Dextrose||12
7898591|NCT00721617|19437035|P1|STARTED|4 Hours Into Intralipid/Dextrose||12
7898592|NCT00721617|19437035|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0
7898593|NCT00721617|19437035|P1|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12
7898594|NCT00721617|19437035|P1|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12
7898595|NCT00721617|19437035|P1|NOT COMPLETED|8 Hours Into Dextrose Infusion||0
7898596|NCT00721617|19437035|P1|COMPLETED|8 Hours Into Dextrose Infusion||12
7898597|NCT00721617|19437035|P1|STARTED|8 Hours Into Dextrose Infusion||12
7898598|NCT00721617|19437035|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
7898599|NCT00721617|19437035|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
7898600|NCT00721617|19437035|P1|STARTED|4 Hours Into Dextrose Infusion||12
7898601|NCT00721617|19437035|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
7898602|NCT00721617|19437035|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
7898603|NCT00721617|19437035|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
7898604|NCT00721617|19437035|P1|NOT COMPLETED|8 Hours Into Intralipid Infusion||0
7898605|NCT00721617|19437035|P1|COMPLETED|8 Hours Into Intralipid Infusion||12
7898606|NCT00721617|19437035|P1|STARTED|8 Hours Into Intralipid Infusion||12
7898607|NCT00721617|19437035|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
7898608|NCT00721617|19437035|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
7898609|NCT00721617|19437035|P1|STARTED|4 Hours Into Intralipid Infusion||12
7898610|NCT00721617|19437035|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
7898611|NCT00721617|19437035|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
7898612|NCT00721617|19437035|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
7898613|NCT00721617|19437035|P1|NOT COMPLETED|8 Hours Into Saline Infusion||0
7898614|NCT00721617|19437035|P1|COMPLETED|8 Hours Into Saline Infusion||12
7898615|NCT00721617|19437035|P1|STARTED|8 Hours Into Saline Infusion||12
7898616|NCT00721617|19437035|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
7898617|NCT00721617|19437035|P1|COMPLETED|4 Hours Into Saline Infusion||12
7898618|NCT00721617|19437035|P1|STARTED|4 Hours Into Saline Infusion||12
7898619|NCT00721617|19437035|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
7898620|NCT00721617|19437035|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
7898621|NCT00721617|19437035|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
7898622|NCT00721578|19437059|P2|NOT COMPLETED|Overall Study||2
7898623|NCT00721578|19437060|P1|NOT COMPLETED|Overall Study||2
7898624|NCT00721578|19437059|P2|COMPLETED|Overall Study||9
7898625|NCT00721578|19437060|P1|COMPLETED|Overall Study||10
7898626|NCT00721578|19437059|P2|STARTED|Overall Study||11
7898627|NCT00721578|19437060|P1|STARTED|Overall Study||12
7898628|NCT00721539|19437072|P1|NOT COMPLETED|Overall Study||0
7898629|NCT00721539|19437072|P1|COMPLETED|Overall Study||9
7898630|NCT00721539|19437072|P1|STARTED|Overall Study||9
7898631|NCT00721513|19437079|P1|NOT COMPLETED|Overall Study||0
7898632|NCT00721513|19437079|P1|COMPLETED|Overall Study||20
7898633|NCT00721513|19437079|P1|STARTED|Overall Study||20
7898634|NCT00721500|19437091|P4|NOT COMPLETED|Period Three||0
7898635|NCT00721500|19437092|P3|NOT COMPLETED|Period Three||0
7898636|NCT00721500|19437093|P2|NOT COMPLETED|Period Three||0
7898637|NCT00721500|19437094|P1|NOT COMPLETED|Period Three||0
7898638|NCT00721500|19437091|P4|COMPLETED|Period Three||6
7898639|NCT00721500|19437092|P3|COMPLETED|Period Three||6
7898640|NCT00721500|19437093|P2|COMPLETED|Period Three||7
7898641|NCT00721500|19437094|P1|COMPLETED|Period Three||6
7898642|NCT00721500|19437091|P4|STARTED|Period Three||6
7898643|NCT00721500|19437092|P3|STARTED|Period Three||6
7898644|NCT00721500|19437093|P2|STARTED|Period Three||7
7898645|NCT00721500|19437094|P1|STARTED|Period Three||6
7898646|NCT00721500|19437091|P4|NOT COMPLETED|Period Two||0
7898647|NCT00721500|19437092|P3|NOT COMPLETED|Period Two||0
7898648|NCT00721500|19437093|P2|NOT COMPLETED|Period Two||0
7898649|NCT00721500|19437094|P1|NOT COMPLETED|Period Two||0
7898650|NCT00721500|19437091|P4|COMPLETED|Period Two||6
7898651|NCT00721500|19437092|P3|COMPLETED|Period Two||6
7898652|NCT00721500|19437093|P2|COMPLETED|Period Two||7
7898653|NCT00721500|19437094|P1|COMPLETED|Period Two||6
7898654|NCT00721500|19437091|P4|STARTED|Period Two||6
7898655|NCT00721500|19437092|P3|STARTED|Period Two||6
7898656|NCT00721500|19437093|P2|STARTED|Period Two||7
7898657|NCT00721500|19437094|P1|STARTED|Period Two||6
7898658|NCT00721500|19437091|P4|NOT COMPLETED|Period One||0
7898659|NCT00721500|19437092|P3|NOT COMPLETED|Period One||0
7898660|NCT00721500|19437093|P2|NOT COMPLETED|Period One||0
7898661|NCT00721500|19437094|P1|NOT COMPLETED|Period One||0
7898662|NCT00721500|19437091|P4|COMPLETED|Period One||6
7898663|NCT00721500|19437092|P3|COMPLETED|Period One||6
7898664|NCT00721500|19437093|P2|COMPLETED|Period One||7
7898665|NCT00721500|19437094|P1|COMPLETED|Period One||6
7898666|NCT00721500|19437091|P4|STARTED|Period One||6
7898667|NCT00721500|19437092|P3|STARTED|Period One||6
7898668|NCT00721500|19437093|P2|STARTED|Period One||7
7898669|NCT00721500|19437094|P1|STARTED|Period One||6
7898670|NCT00721409|19437115|P3|NOT COMPLETED|Overall Study||79
7898671|NCT00721409|19437116|P2|NOT COMPLETED|Overall Study||82
7898672|NCT00721409|19437117|P1|NOT COMPLETED|Overall Study||12
7898673|NCT00721409|19437115|P3|COMPLETED|Overall Study||2
7898674|NCT00721409|19437116|P2|COMPLETED|Overall Study||2
7898675|NCT00721409|19437117|P1|COMPLETED|Overall Study||0
7898676|NCT00721409|19437115|P3|Treated|Overall Study||77
7898677|NCT00721409|19437116|P2|Treated|Overall Study||83
7898678|NCT00721409|19437117|P1|Treated|Overall Study||12
7898679|NCT00721409|19437115|P3|STARTED|Overall Study||81
7898680|NCT00721409|19437116|P2|STARTED|Overall Study||84
7898681|NCT00721409|19437117|P1|STARTED|Overall Study||12
7898682|NCT00721396|19437244|P4|NOT COMPLETED|Overall Study||10
7898683|NCT00721396|19437245|P3|NOT COMPLETED|Overall Study||10
7898684|NCT00721396|19437246|P2|NOT COMPLETED|Overall Study||36
7898685|NCT00721396|19437247|P1|NOT COMPLETED|Overall Study||30
7898686|NCT00721396|19437244|P4|COMPLETED|Overall Study||302
7898687|NCT00721396|19437245|P3|COMPLETED|Overall Study||308
7898688|NCT00721396|19437246|P2|COMPLETED|Overall Study||592
7898689|NCT00721396|19437247|P1|COMPLETED|Overall Study||597
7898690|NCT00721396|19437244|P4|STARTED|Overall Study||312
7898691|NCT00721396|19437245|P3|STARTED|Overall Study||318
7898692|NCT00721396|19437246|P2|STARTED|Overall Study||628
7898693|NCT00721396|19437247|P1|STARTED|Overall Study||627
7898694|NCT00721357|19437285|P2|NOT COMPLETED|Overall Study||0
7898695|NCT00721357|19437286|P1|NOT COMPLETED|Overall Study||0
7898696|NCT00721357|19437285|P2|COMPLETED|Overall Study||15
7898697|NCT00721357|19437286|P1|COMPLETED|Overall Study||15
7898698|NCT00721357|19437285|P2|STARTED|Overall Study||15
7898699|NCT00721357|19437286|P1|STARTED|Overall Study||15
7898700|NCT00721279|19437298|P2|NOT COMPLETED|Overall Study||24
7898701|NCT00721279|19437299|P1|NOT COMPLETED|Overall Study||36
7898702|NCT00721279|19437298|P2|COMPLETED|Overall Study||73
7898703|NCT00721279|19437299|P1|COMPLETED|Overall Study||416
7898704|NCT00721279|19437298|P2|STARTED|Overall Study||97
7898705|NCT00721279|19437299|P1|STARTED|Overall Study||452
7898706|NCT00721253|19437313|P3|NOT COMPLETED|Overall Study||0
7898707|NCT00721253|19437314|P2|NOT COMPLETED|Overall Study||0
7898708|NCT00721253|19437315|P1|NOT COMPLETED|Overall Study||0
7898709|NCT00721253|19437313|P3|COMPLETED|Overall Study||0
7898710|NCT00721253|19437314|P2|COMPLETED|Overall Study||22
7898711|NCT00721253|19437315|P1|COMPLETED|Overall Study||20
7898712|NCT00721253|19437313|P3|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0
7898713|NCT00721253|19437314|P2|STARTED|Overall Study||22
7898714|NCT00721253|19437315|P1|STARTED|Overall Study||20
7898715|NCT00721227|19437327|P2|NOT COMPLETED|Overall Study||0
7898716|NCT00721227|19437328|P1|NOT COMPLETED|Overall Study||4
7898717|NCT00721227|19437327|P2|COMPLETED|Overall Study||6
7898718|NCT00721227|19437328|P1|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5
7898719|NCT00721227|19437327|P2|STARTED|Overall Study||6
7898720|NCT00721227|19437328|P1|STARTED|Overall Study||9
7898721|NCT00721214|19437338|P1|NOT COMPLETED|Overall Study||4
7898722|NCT00721214|19437338|P1|COMPLETED|Overall Study||12
7898723|NCT00721214|19437338|P1|STARTED|Overall Study||16
7898724|NCT00721188|19437349|P1|NOT COMPLETED|Overall Study||0
7898725|NCT00721188|19437349|P1|COMPLETED|Overall Study||11
7898726|NCT00721188|19437349|P1|STARTED|Overall Study||11
7898727|NCT00721175|19437366|P2|NOT COMPLETED|Overall Study||0
7898728|NCT00721175|19437367|P1|NOT COMPLETED|Overall Study||0
7898729|NCT00721175|19437366|P2|COMPLETED|Overall Study||54
7898730|NCT00721175|19437367|P1|COMPLETED|Overall Study||54
7898731|NCT00721175|19437366|P2|STARTED|Overall Study||54
7898732|NCT00721175|19437367|P1|STARTED|Overall Study||54
7898733|NCT00721162|19437379|P1|NOT COMPLETED|Overall Study||0
7898734|NCT00721162|19437379|P1|COMPLETED|Overall Study||60
7898735|NCT00721162|19437379|P1|Received Any Amount of Study Drug|Overall Study||60
7898736|NCT00721162|19437379|P1|STARTED|Overall Study||60
7898737|NCT00721149|19437388|P1|NOT COMPLETED|Overall Study||1
7898738|NCT00721149|19437388|P1|COMPLETED|Overall Study||9
7898739|NCT00721149|19437388|P1|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10
7898740|NCT00721136|19437401|P4|NOT COMPLETED|Overall Study||0
7898741|NCT00721136|19437402|P3|NOT COMPLETED|Overall Study||0
7898742|NCT00721136|19437403|P2|NOT COMPLETED|Overall Study||0
7898743|NCT00721136|19437404|P1|NOT COMPLETED|Overall Study||0
7898744|NCT00721136|19437401|P4|COMPLETED|Overall Study||8
7898745|NCT00721136|19437402|P3|COMPLETED|Overall Study||8
7898746|NCT00721136|19437403|P2|COMPLETED|Overall Study||42
7898747|NCT00721136|19437404|P1|COMPLETED|Overall Study||42
7898748|NCT00721136|19437401|P4|STARTED|Overall Study||8
7898749|NCT00721136|19437402|P3|STARTED|Overall Study||8
7898750|NCT00721136|19437403|P2|STARTED|Overall Study||42
7898751|NCT00721136|19437404|P1|STARTED|Overall Study||42
7898752|NCT00721123|19437422|P1|NOT COMPLETED|Overall Study||183
7898753|NCT00721123|19437422|P1|COMPLETED|Overall Study||355
7898754|NCT00721123|19437422|P1|STARTED|Overall Study||538
7898755|NCT00721110|19437500|P4|NOT COMPLETED|Overall Study||0
7898756|NCT00721110|19437501|P3|NOT COMPLETED|Overall Study||1
7898757|NCT00721110|19437502|P2|NOT COMPLETED|Overall Study||0
7898758|NCT00721110|19437503|P1|NOT COMPLETED|Overall Study||1
7898759|NCT00721110|19437500|P4|COMPLETED|Overall Study||16
7898760|NCT00721110|19437501|P3|COMPLETED|Overall Study||15
7898761|NCT00721110|19437502|P2|COMPLETED|Overall Study||16
7898762|NCT00721110|19437503|P1|COMPLETED|Overall Study||15
7898763|NCT00721110|19437500|P4|STARTED|Overall Study||16
7898764|NCT00721110|19437501|P3|STARTED|Overall Study||16
7898765|NCT00721110|19437502|P2|STARTED|Overall Study||16
7898766|NCT00721110|19437503|P1|STARTED|Overall Study||16
7898767|NCT00720941|19437531|P2|NOT COMPLETED|Overall Study||415
7898768|NCT00720941|19437532|P1|NOT COMPLETED|Overall Study||413
7898769|NCT00720941|19437531|P2|COMPLETED|Overall Study||138
7898770|NCT00720941|19437532|P1|COMPLETED|Overall Study||144
7898771|NCT00720941|19437531|P2|Ongoing|Overall Study||23
7898772|NCT00720941|19437532|P1|Ongoing|Overall Study||34
7898773|NCT00720941|19437531|P2|STARTED|Overall Study||553
7898774|NCT00720941|19437532|P1|STARTED|Overall Study||557
7898775|NCT00720876|19437572|P1|NOT COMPLETED|Overall Study||2
7898776|NCT00720876|19437572|P1|COMPLETED|Overall Study||28
7898777|NCT00720876|19437572|P1|STARTED|Overall Study||30
7898778|NCT00720798|19437578|P1|NOT COMPLETED|Overall Study||756
7898779|NCT00720798|19437578|P1|COMPLETED|Overall Study||1311
7898780|NCT00720798|19437578|P1|STARTED|Overall Study||2067
7898781|NCT00720759|19437601|P4|NOT COMPLETED|Overall Study||0
7898782|NCT00720759|19437602|P3|NOT COMPLETED|Overall Study||1
7898783|NCT00720759|19437603|P2|NOT COMPLETED|Overall Study||1
7898784|NCT00720759|19437604|P1|NOT COMPLETED|Overall Study||0
7898785|NCT00720759|19437601|P4|COMPLETED|Overall Study||6
7898786|NCT00720759|19437602|P3|COMPLETED|Overall Study||5
7898787|NCT00720759|19437603|P2|COMPLETED|Overall Study||5
7898788|NCT00720759|19437604|P1|COMPLETED|Overall Study||6
7898789|NCT00720759|19437601|P4|STARTED|Overall Study||6
7898790|NCT00720759|19437602|P3|STARTED|Overall Study||6
7898791|NCT00720759|19437603|P2|STARTED|Overall Study||6
7898792|NCT00720759|19437604|P1|STARTED|Overall Study||6
7898793|NCT00720629|19437614|P1|NOT COMPLETED|Overall Study||0
7898794|NCT00720629|19437614|P1|COMPLETED|Overall Study||8
7898795|NCT00720629|19437614|P1|STARTED|Overall Study||8
7898796|NCT00720499|19437624|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3
7898797|NCT00720499|19437625|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2
7898798|NCT00720499|19437624|P2|COMPLETED|Treatment Period 2 (4 Weeks)||67
7898799|NCT00720499|19437625|P1|COMPLETED|Treatment Period 2 (4 Weeks)||64
7898800|NCT00720499|19437624|P2|STARTED|Treatment Period 2 (4 Weeks)||70
7898801|NCT00720499|19437625|P1|STARTED|Treatment Period 2 (4 Weeks)||66
7898802|NCT00720499|19437624|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
7898803|NCT00720499|19437625|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
7898804|NCT00720499|19437624|P2|COMPLETED|Washout Period (2 Weeks)||70
7898805|NCT00720499|19437625|P1|COMPLETED|Washout Period (2 Weeks)||66
7898806|NCT00720499|19437624|P2|STARTED|Washout Period (2 Weeks)||70
7898807|NCT00720499|19437625|P1|STARTED|Washout Period (2 Weeks)||66
7898808|NCT00720499|19437624|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2
7898809|NCT00720499|19437625|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3
7898810|NCT00720499|19437624|P2|COMPLETED|Treatment Period 1 (4 Weeks)||70
7898811|NCT00720499|19437625|P1|COMPLETED|Treatment Period 1 (4 Weeks)||66
7898812|NCT00720499|19437624|P2|STARTED|Treatment Period 1 (4 Weeks)||72
7898813|NCT00720499|19437625|P1|STARTED|Treatment Period 1 (4 Weeks)||69
7898814|NCT00720473|19437689|P2|NOT COMPLETED|Overall Study||8
7898815|NCT00720473|19437690|P1|NOT COMPLETED|Overall Study||30
7898816|NCT00720473|19437689|P2|COMPLETED|Overall Study||16
7898817|NCT00720473|19437690|P1|COMPLETED|Overall Study||15
7898818|NCT00720473|19437689|P2|STARTED|Overall Study||24
7898819|NCT00720473|19437690|P1|STARTED|Overall Study||45
7898820|NCT00720434|19437718|P4|NOT COMPLETED|Open-Label Period (Week 5-72)||4
7898821|NCT00720434|19437719|P3|NOT COMPLETED|Open-Label Period (Week 5-72)||4
7898822|NCT00720434|19437720|P2|NOT COMPLETED|Open-Label Period (Week 5-72)||3
7898823|NCT00720434|19437721|P1|NOT COMPLETED|Open-Label Period (Week 5-72)||6
7898824|NCT00720434|19437718|P4|COMPLETED|Open-Label Period (Week 5-72)||4
7898825|NCT00720434|19437719|P3|COMPLETED|Open-Label Period (Week 5-72)||4
7898826|NCT00720434|19437720|P2|COMPLETED|Open-Label Period (Week 5-72)||5
7898827|NCT00720434|19437721|P1|COMPLETED|Open-Label Period (Week 5-72)||4
7898828|NCT00720434|19437718|P4|STARTED|Open-Label Period (Week 5-72)||8
7898829|NCT00720434|19437719|P3|STARTED|Open-Label Period (Week 5-72)||8
7898830|NCT00720434|19437720|P2|STARTED|Open-Label Period (Week 5-72)||8
7898831|NCT00720434|19437721|P1|STARTED|Open-Label Period (Week 5-72)||10
7898832|NCT00720434|19437718|P4|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
7898833|NCT00720434|19437719|P3|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
7898834|NCT00720434|19437720|P2|NOT COMPLETED|Double-Blind Period (Week 1-4)||1
7898835|NCT00720434|19437721|P1|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
7898836|NCT00720434|19437718|P4|COMPLETED|Double-Blind Period (Week 1-4)||8
7898837|NCT00720434|19437719|P3|COMPLETED|Double-Blind Period (Week 1-4)||8
7898838|NCT00720434|19437720|P2|COMPLETED|Double-Blind Period (Week 1-4)||8
7898839|NCT00720434|19437721|P1|COMPLETED|Double-Blind Period (Week 1-4)||10
7898840|NCT00720434|19437718|P4|STARTED|Double-Blind Period (Week 1-4)||8
7898841|NCT00720434|19437719|P3|STARTED|Double-Blind Period (Week 1-4)||8
7898842|NCT00720434|19437720|P2|STARTED|Double-Blind Period (Week 1-4)||9
7898843|NCT00720434|19437721|P1|STARTED|Double-Blind Period (Week 1-4)||10
7898844|NCT00720382|19437745|P2|NOT COMPLETED|Overall Study||59
7898845|NCT00720382|19437746|P1|NOT COMPLETED|Overall Study||176
7898846|NCT00720382|19437745|P2|COMPLETED|Overall Study||178
7898847|NCT00720382|19437746|P1|COMPLETED|Overall Study||290
7898848|NCT00720382|19437745|P2|STARTED|Overall Study||237
7898849|NCT00720382|19437746|P1|STARTED|Overall Study||466
7898850|NCT00720369|19437756|P2|NOT COMPLETED|Overall Study||0
7898851|NCT00720369|19437757|P1|NOT COMPLETED|Overall Study||1
7898852|NCT00720369|19437756|P2|COMPLETED|Overall Study||8
7898853|NCT00720369|19437757|P1|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10
7898854|NCT00720369|19437756|P2|STARTED|Overall Study||8
7898855|NCT00720369|19437757|P1|STARTED|Overall Study||11
7898856|NCT00720356|19437765|P1|NOT COMPLETED|Follow up Until Death||5
7898857|NCT00720356|19437765|P1|COMPLETED|Follow up Until Death||43
7898858|NCT00720356|19437765|P1|STARTED|Follow up Until Death|All patients that are treated on study go into the follow up period|48
7898859|NCT00720356|19437765|P1|NOT COMPLETED|Went on to be Treated Cycle 3||2
7898860|NCT00720356|19437765|P1|COMPLETED|Went on to be Treated Cycle 3||44
7898861|NCT00720356|19437765|P1|STARTED|Went on to be Treated Cycle 3||46
7898862|NCT00720356|19437765|P1|NOT COMPLETED|Reached 1st Response/2 Cycles||2
7898863|NCT00720356|19437765|P1|COMPLETED|Reached 1st Response/2 Cycles||46
7898864|NCT00720356|19437765|P1|STARTED|Reached 1st Response/2 Cycles||48
7898865|NCT00720356|19437765|P1|NOT COMPLETED|Registration to Study||67
7898866|NCT00720356|19437765|P1|COMPLETED|Registration to Study||48
7898867|NCT00720356|19437765|P1|Completed Registration Step 2|Registration to Study||48
7898868|NCT00720356|19437765|P1|Completed Registration Step 1|Registration to Study||115
7898869|NCT00720356|19437765|P1|STARTED|Registration to Study||115
7898870|NCT00720343|19437779|P1|NOT COMPLETED|Overall Study||6
7898871|NCT00720343|19437779|P1|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48
7898872|NCT00720343|19437779|P1|STARTED|Overall Study||54
7898873|NCT00720330|19437788|P3|NOT COMPLETED|Overall Study||0
7898874|NCT00720330|19437789|P2|NOT COMPLETED|Overall Study||0
7898875|NCT00720330|19437790|P1|NOT COMPLETED|Overall Study||0
7898876|NCT00720330|19437788|P3|COMPLETED|Overall Study||3
7898877|NCT00720330|19437789|P2|COMPLETED|Overall Study||4
7898878|NCT00720330|19437790|P1|COMPLETED|Overall Study||5
7898879|NCT00720330|19437788|P3|STARTED|Overall Study||3
7898880|NCT00720330|19437789|P2|STARTED|Overall Study||4
7898881|NCT00720330|19437790|P1|STARTED|Overall Study||5
7898882|NCT00720278|19437813|P3|NOT COMPLETED|Overall Study||6
7898883|NCT00720278|19437814|P2|NOT COMPLETED|Overall Study||4
7898884|NCT00720278|19437815|P1|NOT COMPLETED|Overall Study||7
7898885|NCT00720278|19437813|P3|COMPLETED|Overall Study||172
7898886|NCT00720278|19437814|P2|COMPLETED|Overall Study||166
7898887|NCT00720278|19437815|P1|COMPLETED|Overall Study||171
7898888|NCT00720278|19437813|P3|STARTED|Overall Study|1 subject was randomized in error|178
7898889|NCT00720278|19437814|P2|STARTED|Overall Study|1 subject was randomized in error|170
7898890|NCT00720278|19437815|P1|STARTED|Overall Study|1 subject was randomized in error|178
7898891|NCT00720226|19437837|P2|NOT COMPLETED|Overall Study||4
7898892|NCT00720226|19437838|P1|NOT COMPLETED|Overall Study||7
7898893|NCT00720226|19437837|P2|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|48
7898894|NCT00720226|19437838|P1|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|47
7898895|NCT00720226|19437837|P2|STARTED|Overall Study||52
7898896|NCT00720226|19437838|P1|STARTED|Overall Study||54
7898897|NCT00720213|19437846|P3|NOT COMPLETED|Treatment Period||0
7898898|NCT00720213|19437847|P2|NOT COMPLETED|Treatment Period||0
7898899|NCT00720213|19437848|P1|NOT COMPLETED|Treatment Period||0
7898900|NCT00720213|19437846|P3|COMPLETED|Treatment Period||17
7898901|NCT00720213|19437847|P2|COMPLETED|Treatment Period||20
7898902|NCT00720213|19437848|P1|COMPLETED|Treatment Period||0
7898903|NCT00720213|19437846|P3|STARTED|Treatment Period||17
7898904|NCT00720213|19437847|P2|STARTED|Treatment Period||20
7898905|NCT00720213|19437848|P1|STARTED|Treatment Period||0
7898906|NCT00720213|19437846|P3|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
7898907|NCT00720213|19437847|P2|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
7898908|NCT00720213|19437848|P1|NOT COMPLETED|Screening Phase With Diagnostic PSG||7
7898909|NCT00720213|19437846|P3|COMPLETED|Screening Phase With Diagnostic PSG||0
7898910|NCT00720213|19437847|P2|COMPLETED|Screening Phase With Diagnostic PSG||0
7898911|NCT00720213|19437848|P1|COMPLETED|Screening Phase With Diagnostic PSG||37
7898912|NCT00720213|19437846|P3|STARTED|Screening Phase With Diagnostic PSG||0
7898913|NCT00720213|19437847|P2|STARTED|Screening Phase With Diagnostic PSG||0
7898914|NCT00720213|19437848|P1|STARTED|Screening Phase With Diagnostic PSG||44
7898915|NCT00720122|19437886|P1|NOT COMPLETED|Overall Study||9
7898916|NCT00720122|19437886|P1|COMPLETED|Overall Study||19
7898917|NCT00720122|19437886|P1|STARTED|Overall Study||28
7898918|NCT00720109|19437890|P3|NOT COMPLETED|Risk Stratification Period||8
7898919|NCT00720109|19437891|P2|NOT COMPLETED|Risk Stratification Period||15
7898920|NCT00720109|19437892|P1|NOT COMPLETED|Risk Stratification Period||0
7898921|NCT00720109|19437890|P3|COMPLETED|Risk Stratification Period||1
7898922|NCT00720109|19437891|P2|COMPLETED|Risk Stratification Period||33
7898923|NCT00720109|19437892|P1|COMPLETED|Risk Stratification Period||0
7898924|NCT00720109|19437890|P3|STARTED|Risk Stratification Period||9
7898925|NCT00720109|19437891|P2|STARTED|Risk Stratification Period||48
7898926|NCT00720109|19437892|P1|STARTED|Risk Stratification Period||0
7898927|NCT00720109|19437890|P3|NOT COMPLETED|Induction Period||0
7898928|NCT00720109|19437891|P2|NOT COMPLETED|Induction Period||0
7898929|NCT00720109|19437892|P1|NOT COMPLETED|Induction Period||6
7898930|NCT00720109|19437890|P3|COMPLETED|Induction Period||0
7898931|NCT00720109|19437891|P2|COMPLETED|Induction Period||0
7898932|NCT00720109|19437892|P1|COMPLETED|Induction Period||57
7898933|NCT00720109|19437890|P3|STARTED|Induction Period||0
7898934|NCT00720109|19437891|P2|STARTED|Induction Period||0
7898935|NCT00720109|19437892|P1|STARTED|Induction Period||63
7898936|NCT00720096|19437912|P2|NOT COMPLETED|Overall Study||2
7898937|NCT00720096|19437913|P1|NOT COMPLETED|Overall Study||0
7898938|NCT00720096|19437912|P2|COMPLETED|Overall Study||0
7898939|NCT00720096|19437913|P1|COMPLETED|Overall Study||2
7898940|NCT00720096|19437912|P2|STARTED|Overall Study||2
7898941|NCT00720096|19437913|P1|STARTED|Overall Study||2
7898942|NCT00720083|19437925|P2|NOT COMPLETED|Overall Study||2
7898943|NCT00720083|19437926|P1|NOT COMPLETED|Overall Study||1
7898944|NCT00720083|19437925|P2|COMPLETED|Overall Study||13
7898945|NCT00720083|19437926|P1|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16
7898946|NCT00720083|19437925|P2|STARTED|Overall Study||15
7898947|NCT00720083|19437926|P1|STARTED|Overall Study||17
7898948|NCT00720057|19437934|P2|NOT COMPLETED|Overall Study||3
7898949|NCT00720057|19437935|P1|NOT COMPLETED|Overall Study||1
7898950|NCT00720057|19437934|P2|COMPLETED|Overall Study||156
7898951|NCT00720057|19437935|P1|COMPLETED|Overall Study||152
7898952|NCT00720057|19437934|P2|STARTED|Overall Study||159
7898953|NCT00720057|19437935|P1|STARTED|Overall Study||153
7898954|NCT00719953|19437951|P1|NOT COMPLETED|Overall Study||4
7898955|NCT00719953|19437951|P1|COMPLETED|Overall Study||26
7898956|NCT00719953|19437951|P1|STARTED|Overall Study||30
7898957|NCT00719914|19437957|P2|NOT COMPLETED|Overall Study||0
7898958|NCT00719914|19437958|P1|NOT COMPLETED|Overall Study||0
7898959|NCT00719914|19437957|P2|COMPLETED|Overall Study||7
7898960|NCT00719914|19437958|P1|COMPLETED|Overall Study||10
7898961|NCT00719914|19437957|P2|STARTED|Overall Study||7
7898962|NCT00719914|19437958|P1|STARTED|Overall Study||10
7898963|NCT00719901|19437964|P1|NOT COMPLETED|Overall Study||11
7898964|NCT00719901|19437964|P1|COMPLETED|Overall Study||0
7898965|NCT00719901|19437964|P1|STARTED|Overall Study||11
7898966|NCT00719862|19437976|P2|NOT COMPLETED|Overall Study||6
7898967|NCT00719862|19437977|P1|NOT COMPLETED|Overall Study||8
7898968|NCT00719862|19437976|P2|COMPLETED|Overall Study||233
7898969|NCT00719862|19437977|P1|COMPLETED|Overall Study||234
7898970|NCT00719862|19437976|P2|STARTED|Overall Study|1 subject was randomized in error|239
7898971|NCT00719862|19437977|P1|STARTED|Overall Study||242
7898972|NCT00719849|19437995|P2|NOT COMPLETED|Overall Study||1
7898973|NCT00719849|19437996|P1|NOT COMPLETED|Overall Study||0
7898974|NCT00719849|19437995|P2|COMPLETED|Overall Study||8
7898975|NCT00719849|19437996|P1|COMPLETED|Overall Study||4
7898976|NCT00719849|19437995|P2|STARTED|Overall Study||9
7898977|NCT00719849|19437996|P1|STARTED|Overall Study||4
7898978|NCT00719810|19438035|P3|NOT COMPLETED|Overall Study||8
7898979|NCT00719810|19438036|P2|NOT COMPLETED|Overall Study||4
7898980|NCT00719810|19438037|P1|NOT COMPLETED|Overall Study||3
7898981|NCT00719810|19438035|P3|COMPLETED|Overall Study||42
7898982|NCT00719810|19438036|P2|COMPLETED|Overall Study||47
7898983|NCT00719810|19438037|P1|COMPLETED|Overall Study||46
7898984|NCT00719810|19438035|P3|STARTED|Overall Study||50
7898985|NCT00719810|19438036|P2|STARTED|Overall Study||51
7898986|NCT00719810|19438037|P1|STARTED|Overall Study||49
7898987|NCT00719732|19438048|P1|NOT COMPLETED|Overall Study||22
7898988|NCT00719732|19438048|P1|COMPLETED|Overall Study||196
7898989|NCT00719732|19438048|P1|STARTED|Overall Study||218
7898990|NCT00719706|19438054|P2|NOT COMPLETED|Overall Study||6
7898991|NCT00719706|19438055|P1|NOT COMPLETED|Overall Study||9
7898992|NCT00719706|19438054|P2|COMPLETED|Overall Study||14
7898993|NCT00719706|19438055|P1|COMPLETED|Overall Study||11
7898994|NCT00719706|19438054|P2|STARTED|Overall Study||20
7898995|NCT00719706|19438055|P1|STARTED|Overall Study||20
7898996|NCT00719680|19438069|P1|NOT COMPLETED|Overall Study||5
7898997|NCT00719680|19438069|P1|COMPLETED|Overall Study||16
7898998|NCT00719680|19438069|P1|STARTED|Overall Study||21
7898999|NCT00719615|19438092|P3|NOT COMPLETED|Overall Study||0
7899000|NCT00719615|19438093|P2|NOT COMPLETED|Overall Study||0
7899001|NCT00719615|19438094|P1|NOT COMPLETED|Overall Study||0
7899002|NCT00719615|19438092|P3|COMPLETED|Overall Study||24
7899003|NCT00719615|19438093|P2|COMPLETED|Overall Study||45
7899004|NCT00719615|19438094|P1|COMPLETED|Overall Study||42
7899005|NCT00719615|19438092|P3|STARTED|Overall Study||24
7899006|NCT00719615|19438093|P2|STARTED|Overall Study||45
7899007|NCT00719615|19438094|P1|STARTED|Overall Study||42
7899008|NCT00719576|19438104|P2|NOT COMPLETED|Overall Study||5
7899009|NCT00719576|19438105|P1|NOT COMPLETED|Overall Study||2
7899010|NCT00719576|19438104|P2|COMPLETED|Overall Study||67
7899011|NCT00719576|19438105|P1|COMPLETED|Overall Study||70
7899012|NCT00719576|19438104|P2|STARTED|Overall Study||72
7899013|NCT00719576|19438105|P1|STARTED|Overall Study||72
7899014|NCT00719563|19438125|P2|NOT COMPLETED|Overall Study||42
7899015|NCT00719563|19438126|P1|NOT COMPLETED|Overall Study||38
7899016|NCT00719563|19438125|P2|COMPLETED|Overall Study||128
7899017|NCT00719563|19438126|P1|COMPLETED|Overall Study||133
7899018|NCT00719563|19438125|P2|STARTED|Overall Study||170
7899019|NCT00719563|19438126|P1|STARTED|Overall Study||171
7899020|NCT00719537|19438158|P2|NOT COMPLETED|Overall Study||1
7899021|NCT00719537|19438159|P1|NOT COMPLETED|Overall Study||1
7899022|NCT00719537|19438158|P2|COMPLETED|Overall Study||0
7899023|NCT00719537|19438159|P1|COMPLETED|Overall Study||1
7899024|NCT00719537|19438158|P2|STARTED|Overall Study||1
7899025|NCT00719537|19438159|P1|STARTED|Overall Study||2
7899026|NCT00719472|19438165|P1|NOT COMPLETED|Received Cycle 2 Treatment||68
7899027|NCT00719472|19438165|P1|COMPLETED|Received Cycle 2 Treatment||304
7899028|NCT00719472|19438165|P1|STARTED|Received Cycle 2 Treatment||372
7899029|NCT00719472|19438165|P1|NOT COMPLETED|Received Cycle 1 Treatment||53
7899030|NCT00719472|19438165|P1|COMPLETED|Received Cycle 1 Treatment||372
7899031|NCT00719472|19438165|P1|STARTED|Received Cycle 1 Treatment||425
7899032|NCT00719472|19438165|P1|NOT COMPLETED|Enrolled in Study||26
7899033|NCT00719472|19438165|P1|COMPLETED|Enrolled in Study||425
7899034|NCT00719472|19438165|P1|STARTED|Enrolled in Study||451
7899035|NCT00719355|19438176|P2|NOT COMPLETED|Overall Study||13
7899036|NCT00719355|19438177|P1|NOT COMPLETED|Overall Study||18
7899037|NCT00719355|19438176|P2|COMPLETED|Overall Study||39
7899038|NCT00719355|19438177|P1|COMPLETED|Overall Study||33
7899039|NCT00719355|19438176|P2|Completed 32 Weeks|Overall Study||39
7899040|NCT00719355|19438177|P1|Completed 32 Weeks|Overall Study||33
7899041|NCT00719355|19438176|P2|Completed 24 Weeks|Overall Study||43
7899042|NCT00719355|19438177|P1|Completed 24 Weeks|Overall Study||34
7899043|NCT00719355|19438176|P2|Completed 12 Weeks|Overall Study||46
7899044|NCT00719355|19438177|P1|Completed 12 Weeks|Overall Study||43
7899045|NCT00719355|19438176|P2|Completed 6 Weeks|Overall Study||48
7899046|NCT00719355|19438177|P1|Completed 6 Weeks|Overall Study||49
7899047|NCT00719355|19438176|P2|STARTED|Overall Study||52
7899048|NCT00719355|19438177|P1|STARTED|Overall Study||51
7899049|NCT00719329|19438188|P3|NOT COMPLETED|Overall Study||1
7899050|NCT00719329|19438189|P2|NOT COMPLETED|Overall Study||2
7899051|NCT00719329|19438190|P1|NOT COMPLETED|Overall Study||0
7899052|NCT00719329|19438188|P3|COMPLETED|Overall Study||646
7899053|NCT00719329|19438189|P2|COMPLETED|Overall Study||569
7899054|NCT00719329|19438190|P1|COMPLETED|Overall Study||705
7899055|NCT00719329|19438188|P3|Day 7 Swab|Overall Study||561
7899056|NCT00719329|19438189|P2|Day 7 Swab|Overall Study||467
7899057|NCT00719329|19438190|P1|Day 7 Swab|Overall Study||593
7899058|NCT00719329|19438188|P3|Day 3 Swab|Overall Study||578
7899059|NCT00719329|19438189|P2|Day 3 Swab|Overall Study||501
7899060|NCT00719329|19438190|P1|Day 3 Swab|Overall Study||614
7899061|NCT00719329|19438188|P3|Day 1 Swab|Overall Study||646
7899062|NCT00719329|19438189|P2|Day 1 Swab|Overall Study||569
7899063|NCT00719329|19438190|P1|Day 1 Swab|Overall Study||705
7899064|NCT00719329|19438188|P3|STARTED|Overall Study||647
7899065|NCT00719329|19438189|P2|STARTED|Overall Study||571
7899066|NCT00719329|19438190|P1|STARTED|Overall Study||705
7899067|NCT00719264|19438206|P2|NOT COMPLETED|Overall Study||183
7899068|NCT00719264|19438207|P1|NOT COMPLETED|Overall Study||182
7899069|NCT00719264|19438206|P2|COMPLETED|Overall Study||0
7899070|NCT00719264|19438207|P1|COMPLETED|Overall Study||0
7899071|NCT00719264|19438206|P2|Safety Set|Overall Study||181
7899072|NCT00719264|19438207|P1|Safety Set|Overall Study||180
7899073|NCT00719264|19438206|P2|Full Analysis Set|Overall Study||183
7899074|NCT00719264|19438207|P1|Full Analysis Set|Overall Study||182
7899075|NCT00719264|19438206|P2|STARTED|Overall Study||183
7899076|NCT00719264|19438207|P1|STARTED|Overall Study||182
7899077|NCT00719212|19438226|P1|NOT COMPLETED|Overall Study||44
7899078|NCT00719212|19438226|P1|COMPLETED|Overall Study||17
7899079|NCT00719212|19438226|P1|STARTED|Overall Study||61
7899080|NCT00719186|19438238|P2|NOT COMPLETED|Overall Study||0
7899081|NCT00719186|19438239|P1|NOT COMPLETED|Overall Study||0
7899082|NCT00719186|19438238|P2|COMPLETED|Overall Study||374
7899083|NCT00719186|19438239|P1|COMPLETED|Overall Study||376
7899084|NCT00719186|19438238|P2|STARTED|Overall Study||374
7899085|NCT00719186|19438239|P1|STARTED|Overall Study||376
7899086|NCT00719160|19438253|P2|NOT COMPLETED|Overall Study||0
7899087|NCT00719160|19438254|P1|NOT COMPLETED|Overall Study||0
7899088|NCT00719160|19438253|P2|COMPLETED|Overall Study||6
7899089|NCT00719160|19438254|P1|COMPLETED|Overall Study||6
7899090|NCT00719160|19438253|P2|STARTED|Overall Study||6
7899091|NCT00719160|19438254|P1|STARTED|Overall Study||6
7899092|NCT00719134|19438261|P1|NOT COMPLETED|Overall Study||10
7899093|NCT00719134|19438261|P1|COMPLETED|Overall Study||66
7899094|NCT00719134|19438261|P1|STARTED|Overall Study||76
7899095|NCT00719043|19438274|P7|NOT COMPLETED|Overall Study||28
7899096|NCT00719043|19438275|P6|NOT COMPLETED|Overall Study||34
7899097|NCT00719043|19438276|P5|NOT COMPLETED|Overall Study||27
7899098|NCT00719043|19438277|P4|NOT COMPLETED|Overall Study||23
7899099|NCT00719043|19438278|P3|NOT COMPLETED|Overall Study||20
7899100|NCT00719043|19438279|P2|NOT COMPLETED|Overall Study||25
7899101|NCT00719043|19438280|P1|NOT COMPLETED|Overall Study||32
7899102|NCT00719043|19438274|P7|COMPLETED|Overall Study|Up to Day 909|92
7899103|NCT00719043|19438275|P6|COMPLETED|Overall Study|Up to Day 909|86
7899104|NCT00719043|19438276|P5|COMPLETED|Overall Study|Up to Day 909|95
7899105|NCT00719043|19438277|P4|COMPLETED|Overall Study|Up to Day 909|96
7899106|NCT00719043|19438278|P3|COMPLETED|Overall Study|Up to Day 909|99
7899107|NCT00719043|19438279|P2|COMPLETED|Overall Study|Up to Day 909|96
7899108|NCT00719043|19438280|P1|COMPLETED|Overall Study|Up to Day 909|88
7899109|NCT00719043|19438274|P7|STARTED|Overall Study||120
7899110|NCT00719043|19438275|P6|STARTED|Overall Study||120
7899111|NCT00719043|19438276|P5|STARTED|Overall Study||122
7899112|NCT00719043|19438277|P4|STARTED|Overall Study||119
7899113|NCT00719043|19438278|P3|STARTED|Overall Study||119
7899114|NCT00719043|19438279|P2|STARTED|Overall Study||121
7899115|NCT00719043|19438280|P1|STARTED|Overall Study||120
7899116|NCT00718887|19438404|P2|NOT COMPLETED|Overall Study||9
7899117|NCT00718887|19438405|P1|NOT COMPLETED|Overall Study||5
7899118|NCT00718887|19438404|P2|COMPLETED|Overall Study||68
7899119|NCT00718887|19438405|P1|COMPLETED|Overall Study|Continued in study after 48 weeks|84
7899120|NCT00718887|19438404|P2|STARTED|Overall Study|Participants who received treatment.|77
7899121|NCT00718887|19438405|P1|STARTED|Overall Study|Participants who received treatment.|89
7899122|NCT00718861|19438429|P2|NOT COMPLETED|Overall Study||18
7899123|NCT00718861|19438430|P1|NOT COMPLETED|Overall Study||21
7899124|NCT00718861|19438429|P2|COMPLETED|Overall Study||77
7899125|NCT00718861|19438430|P1|COMPLETED|Overall Study||74
7899126|NCT00718861|19438429|P2|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69
7899127|NCT00718861|19438430|P1|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67
7899128|NCT00718861|19438429|P2|Safety Set|Overall Study||95
7899129|NCT00718861|19438430|P1|Safety Set|Overall Study|3 patients randomized but never received study drug|92
7899130|NCT00718861|19438429|P2|STARTED|Overall Study||95
7899131|NCT00718861|19438430|P1|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95
7899132|NCT00718809|19438458|P2|NOT COMPLETED|Overall Study||9
7899133|NCT00718809|19438459|P1|NOT COMPLETED|Overall Study||12
7899134|NCT00718809|19438458|P2|COMPLETED|Overall Study||0
7899135|NCT00718809|19438459|P1|COMPLETED|Overall Study||0
7899136|NCT00718809|19438458|P2|STARTED|Overall Study||9
7899137|NCT00718809|19438459|P1|STARTED|Overall Study||12
7899138|NCT00718770|19438473|P1|NOT COMPLETED|Overall Study||8
7899139|NCT00718770|19438473|P1|COMPLETED|Overall Study||2
7899140|NCT00718770|19438473|P1|STARTED|Overall Study||10
7899141|NCT00718718|19438484|P10|NOT COMPLETED|Week 12 to End of Study||0
7899142|NCT00718718|19438485|P9|NOT COMPLETED|Week 12 to End of Study||1
7899143|NCT00718718|19438486|P8|NOT COMPLETED|Week 12 to End of Study||1
7899144|NCT00718718|19438487|P7|NOT COMPLETED|Week 12 to End of Study||2
7899145|NCT00718718|19438488|P6|NOT COMPLETED|Week 12 to End of Study||3
7899146|NCT00718718|19438489|P5|NOT COMPLETED|Week 12 to End of Study||0
7899147|NCT00718718|19438490|P4|NOT COMPLETED|Week 12 to End of Study||1
7899148|NCT00718718|19438491|P3|NOT COMPLETED|Week 12 to End of Study||0
7899149|NCT00718718|19438492|P2|NOT COMPLETED|Week 12 to End of Study||1
7899150|NCT00718718|19438493|P1|NOT COMPLETED|Week 12 to End of Study||0
7899151|NCT00718718|19438484|P10|COMPLETED|Week 12 to End of Study||31
7899152|NCT00718718|19438485|P9|COMPLETED|Week 12 to End of Study||27
7899153|NCT00718718|19438486|P8|COMPLETED|Week 12 to End of Study||27
7899154|NCT00718718|19438487|P7|COMPLETED|Week 12 to End of Study||27
7899155|NCT00718718|19438488|P6|COMPLETED|Week 12 to End of Study||24
7899156|NCT00718718|19438489|P5|COMPLETED|Week 12 to End of Study||0
7899157|NCT00718718|19438490|P4|COMPLETED|Week 12 to End of Study||15
7899158|NCT00718718|19438491|P3|COMPLETED|Week 12 to End of Study||0
7899159|NCT00718718|19438492|P2|COMPLETED|Week 12 to End of Study||17
7899160|NCT00718718|19438493|P1|COMPLETED|Week 12 to End of Study||0
7899161|NCT00718718|19438484|P10|Treated|Week 12 to End of Study||31
7899162|NCT00718718|19438485|P9|Treated|Week 12 to End of Study||28
7899163|NCT00718718|19438486|P8|Treated|Week 12 to End of Study||28
7899164|NCT00718718|19438487|P7|Treated|Week 12 to End of Study||29
7899165|NCT00718718|19438488|P6|Treated|Week 12 to End of Study||26
7899166|NCT00718718|19438489|P5|Treated|Week 12 to End of Study||0
7899167|NCT00718718|19438490|P4|Treated|Week 12 to End of Study||16
7899168|NCT00718718|19438491|P3|Treated|Week 12 to End of Study||0
7899169|NCT00718718|19438492|P2|Treated|Week 12 to End of Study||18
7899170|NCT00718718|19438493|P1|Treated|Week 12 to End of Study||0
7899171|NCT00718718|19438484|P10|STARTED|Week 12 to End of Study||31
7899172|NCT00718718|19438485|P9|STARTED|Week 12 to End of Study||28
7899173|NCT00718718|19438486|P8|STARTED|Week 12 to End of Study||28
7899174|NCT00718718|19438487|P7|STARTED|Week 12 to End of Study||29
7899175|NCT00718718|19438488|P6|STARTED|Week 12 to End of Study||27
7899176|NCT00718718|19438489|P5|STARTED|Week 12 to End of Study||0
7899177|NCT00718718|19438490|P4|STARTED|Week 12 to End of Study||16
7899178|NCT00718718|19438491|P3|STARTED|Week 12 to End of Study||0
7899179|NCT00718718|19438492|P2|STARTED|Week 12 to End of Study||18
7899180|NCT00718718|19438493|P1|STARTED|Week 12 to End of Study||0
7899181|NCT00718718|19438484|P10|NOT COMPLETED|Prior to Week 12||0
7899182|NCT00718718|19438485|P9|NOT COMPLETED|Prior to Week 12||2
7899183|NCT00718718|19438486|P8|NOT COMPLETED|Prior to Week 12||2
7899184|NCT00718718|19438487|P7|NOT COMPLETED|Prior to Week 12||1
7899185|NCT00718718|19438488|P6|NOT COMPLETED|Prior to Week 12||0
7899186|NCT00718718|19438489|P5|NOT COMPLETED|Prior to Week 12||3
7899187|NCT00718718|19438490|P4|NOT COMPLETED|Prior to Week 12||0
7899188|NCT00718718|19438491|P3|NOT COMPLETED|Prior to Week 12||1
7899189|NCT00718718|19438492|P2|NOT COMPLETED|Prior to Week 12||0
7899190|NCT00718718|19438493|P1|NOT COMPLETED|Prior to Week 12||1
7899191|NCT00718718|19438484|P10|COMPLETED|Prior to Week 12||31
7899192|NCT00718718|19438485|P9|COMPLETED|Prior to Week 12||28
7899193|NCT00718718|19438486|P8|COMPLETED|Prior to Week 12||28
7899194|NCT00718718|19438487|P7|COMPLETED|Prior to Week 12||29
7899195|NCT00718718|19438488|P6|COMPLETED|Prior to Week 12||0
7899196|NCT00718718|19438489|P5|COMPLETED|Prior to Week 12||27
7899197|NCT00718718|19438490|P4|COMPLETED|Prior to Week 12||0
7899198|NCT00718718|19438491|P3|COMPLETED|Prior to Week 12||16
7899199|NCT00718718|19438492|P2|COMPLETED|Prior to Week 12||0
7899200|NCT00718718|19438493|P1|COMPLETED|Prior to Week 12||18
7899201|NCT00718718|19438484|P10|STARTED|Prior to Week 12||31
7899202|NCT00718718|19438485|P9|STARTED|Prior to Week 12||30
7899203|NCT00718718|19438486|P8|STARTED|Prior to Week 12||30
7899204|NCT00718718|19438487|P7|STARTED|Prior to Week 12||30
7899205|NCT00718718|19438488|P6|STARTED|Prior to Week 12||0
7899206|NCT00718718|19438489|P5|STARTED|Prior to Week 12||30
7899207|NCT00718718|19438490|P4|STARTED|Prior to Week 12||0
7899208|NCT00718718|19438491|P3|STARTED|Prior to Week 12||17
7899209|NCT00718718|19438492|P2|STARTED|Prior to Week 12||0
7899210|NCT00718718|19438493|P1|STARTED|Prior to Week 12||19
7899211|NCT00718666|19438536|P3|NOT COMPLETED|Booster Phase Year 5||6
7899212|NCT00718666|19438537|P2|NOT COMPLETED|Booster Phase Year 5||0
7899213|NCT00718666|19438538|P1|NOT COMPLETED|Booster Phase Year 5||2
7899214|NCT00718666|19438536|P3|COMPLETED|Booster Phase Year 5||94
7899215|NCT00718666|19438537|P2|COMPLETED|Booster Phase Year 5||46
7899216|NCT00718666|19438538|P1|COMPLETED|Booster Phase Year 5||36
7899217|NCT00718666|19438536|P3|STARTED|Booster Phase Year 5||100
7899218|NCT00718666|19438537|P2|STARTED|Booster Phase Year 5||46
7899219|NCT00718666|19438538|P1|STARTED|Booster Phase Year 5||38
7899220|NCT00718666|19438536|P3|NOT COMPLETED|Persistence Phase Year 5||0
7899221|NCT00718666|19438537|P2|NOT COMPLETED|Persistence Phase Year 5||0
7899222|NCT00718666|19438538|P1|NOT COMPLETED|Persistence Phase Year 5||0
7899223|NCT00718666|19438536|P3|COMPLETED|Persistence Phase Year 5|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
7899224|NCT00718666|19438537|P2|COMPLETED|Persistence Phase Year 5||82
7899225|NCT00718666|19438538|P1|COMPLETED|Persistence Phase Year 5||70
7899226|NCT00718666|19438536|P3|STARTED|Persistence Phase Year 5||0
7899227|NCT00718666|19438537|P2|STARTED|Persistence Phase Year 5||82
7899228|NCT00718666|19438538|P1|STARTED|Persistence Phase Year 5||70
7899229|NCT00718666|19438536|P3|NOT COMPLETED|Persistence Phase Year 3||0
7899230|NCT00718666|19438537|P2|NOT COMPLETED|Persistence Phase Year 3||0
7899231|NCT00718666|19438538|P1|NOT COMPLETED|Persistence Phase Year 3||0
7899232|NCT00718666|19438536|P3|COMPLETED|Persistence Phase Year 3|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
7899233|NCT00718666|19438537|P2|COMPLETED|Persistence Phase Year 3||104
7899234|NCT00718666|19438538|P1|COMPLETED|Persistence Phase Year 3||98
7899235|NCT00718666|19438536|P3|STARTED|Persistence Phase Year 3||0
7899236|NCT00718666|19438537|P2|STARTED|Persistence Phase Year 3||104
7899237|NCT00718666|19438538|P1|STARTED|Persistence Phase Year 3||98
7899238|NCT00718666|19438536|P3|NOT COMPLETED|Persistence Phase Year 1||0
7899239|NCT00718666|19438537|P2|NOT COMPLETED|Persistence Phase Year 1||0
7899240|NCT00718666|19438538|P1|NOT COMPLETED|Persistence Phase Year 1||0
7899241|NCT00718666|19438536|P3|COMPLETED|Persistence Phase Year 1|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
7899242|NCT00718666|19438537|P2|COMPLETED|Persistence Phase Year 1||130
7899243|NCT00718666|19438538|P1|COMPLETED|Persistence Phase Year 1||118
7899244|NCT00718666|19438536|P3|STARTED|Persistence Phase Year 1||0
7899245|NCT00718666|19438537|P2|STARTED|Persistence Phase Year 1||130
7899246|NCT00718666|19438538|P1|STARTED|Persistence Phase Year 1||118
7899247|NCT00718640|19438622|P1|NOT COMPLETED|Overall Study||7
7899248|NCT00718640|19438622|P1|COMPLETED|Overall Study||3
7899249|NCT00718640|19438622|P1|STARTED|Overall Study||10
7899250|NCT00718549|19438634|P3|NOT COMPLETED|Maintenance/ Observation Phase||30
7899251|NCT00718549|19438635|P2|NOT COMPLETED|Maintenance/ Observation Phase||28
7899252|NCT00718549|19438636|P1|NOT COMPLETED|Maintenance/ Observation Phase||0
7899253|NCT00718549|19438634|P3|COMPLETED|Maintenance/ Observation Phase||3
7899254|NCT00718549|19438635|P2|COMPLETED|Maintenance/ Observation Phase||5
7899255|NCT00718549|19438636|P1|COMPLETED|Maintenance/ Observation Phase||0
7899256|NCT00718549|19438634|P3|STARTED|Maintenance/ Observation Phase||33
7899257|NCT00718549|19438635|P2|STARTED|Maintenance/ Observation Phase||33
7899258|NCT00718549|19438636|P1|STARTED|Maintenance/ Observation Phase||0
7899259|NCT00718549|19438634|P3|NOT COMPLETED|Induction Phase||0
7899260|NCT00718549|19438635|P2|NOT COMPLETED|Induction Phase||0
7899261|NCT00718549|19438636|P1|NOT COMPLETED|Induction Phase||62
7899262|NCT00718549|19438634|P3|COMPLETED|Induction Phase||0
7899263|NCT00718549|19438635|P2|COMPLETED|Induction Phase||0
7899264|NCT00718549|19438636|P1|COMPLETED|Induction Phase||66
7899265|NCT00718549|19438634|P3|STARTED|Induction Phase||0
7899266|NCT00718549|19438635|P2|STARTED|Induction Phase||0
7899267|NCT00718549|19438636|P1|STARTED|Induction Phase||128
7899268|NCT00718523|19438661|P2|NOT COMPLETED|Overall Study||24
7899269|NCT00718523|19438662|P1|NOT COMPLETED|Overall Study||18
7899270|NCT00718523|19438661|P2|COMPLETED|Overall Study||62
7899271|NCT00718523|19438662|P1|COMPLETED|Overall Study||66
7899272|NCT00718523|19438661|P2|STARTED|Overall Study||86
7899273|NCT00718523|19438662|P1|STARTED|Overall Study||84
7899274|NCT00718510|19438674|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
7899275|NCT00718510|19438675|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
7899276|NCT00718510|19438674|P2|COMPLETED|Second Intervention (3 Weeks)||7
7899277|NCT00718510|19438675|P1|COMPLETED|Second Intervention (3 Weeks)||6
7899278|NCT00718510|19438674|P2|STARTED|Second Intervention (3 Weeks)||7
7899279|NCT00718510|19438675|P1|STARTED|Second Intervention (3 Weeks)||7
7899280|NCT00718510|19438674|P2|NOT COMPLETED|Washout (5 Days)||0
7899281|NCT00718510|19438675|P1|NOT COMPLETED|Washout (5 Days)||0
7899282|NCT00718510|19438674|P2|COMPLETED|Washout (5 Days)||7
7899283|NCT00718510|19438675|P1|COMPLETED|Washout (5 Days)||7
7899284|NCT00718510|19438674|P2|STARTED|Washout (5 Days)||7
7899285|NCT00718510|19438675|P1|STARTED|Washout (5 Days)||7
7899286|NCT00718510|19438674|P2|NOT COMPLETED|First Intervention (3 Weeks)||1
7899287|NCT00718510|19438675|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
7899288|NCT00718510|19438674|P2|COMPLETED|First Intervention (3 Weeks)||7
7899289|NCT00718510|19438675|P1|COMPLETED|First Intervention (3 Weeks)||7
7899290|NCT00718510|19438674|P2|Received Intervention|First Intervention (3 Weeks)||7
7899291|NCT00718510|19438675|P1|Received Intervention|First Intervention (3 Weeks)||7
7899292|NCT00718510|19438674|P2|STARTED|First Intervention (3 Weeks)||8
7899293|NCT00718510|19438675|P1|STARTED|First Intervention (3 Weeks)||7
7899294|NCT00718419|19438687|P2|NOT COMPLETED|Overall Study||39
7899295|NCT00718419|19438688|P1|NOT COMPLETED|Overall Study||13
7899296|NCT00718419|19438687|P2|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|3
7899297|NCT00718419|19438688|P1|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|1
7899298|NCT00718419|19438687|P2|Received at Least One Dose of Study Drug|Overall Study||42
7899299|NCT00718419|19438688|P1|Received at Least One Dose of Study Drug|Overall Study||14
7899300|NCT00718419|19438687|P2|STARTED|Overall Study||42
7899301|NCT00718419|19438688|P1|STARTED|Overall Study||14
7899302|NCT00718328|19438704|P2|NOT COMPLETED|Overall Study||0
7899303|NCT00718328|19438705|P1|NOT COMPLETED|Overall Study||1
7899304|NCT00718328|19438704|P2|COMPLETED|Overall Study|Terminated due to poor enrollment|0
7899305|NCT00718328|19438705|P1|COMPLETED|Overall Study|Prematurely terminated due to poor enrollment|0
7899306|NCT00718328|19438704|P2|STARTED|Overall Study||0
7899307|NCT00718328|19438705|P1|STARTED|Overall Study||1
7899308|NCT00718315|19438714|P3|NOT COMPLETED|Overall Study||21
7899309|NCT00718315|19438715|P2|NOT COMPLETED|Overall Study||22
7899310|NCT00718315|19438716|P1|NOT COMPLETED|Overall Study||19
7899311|NCT00718315|19438714|P3|COMPLETED|Overall Study||46
7899312|NCT00718315|19438715|P2|COMPLETED|Overall Study||45
7899313|NCT00718315|19438716|P1|COMPLETED|Overall Study||48
7899314|NCT00718315|19438714|P3|STARTED|Overall Study||67
7899315|NCT00718315|19438715|P2|STARTED|Overall Study||67
7899316|NCT00718315|19438716|P1|STARTED|Overall Study||67
7899317|NCT00718302|19438750|P2|NOT COMPLETED|Overall Study||0
7899318|NCT00718302|19438751|P1|NOT COMPLETED|Overall Study||0
7899319|NCT00718302|19438750|P2|COMPLETED|Overall Study||114
7899320|NCT00718302|19438751|P1|COMPLETED|Overall Study||119
7899321|NCT00718302|19438750|P2|STARTED|Overall Study||114
7899322|NCT00718302|19438751|P1|STARTED|Overall Study||119
7899323|NCT00718237|19438767|P2|NOT COMPLETED|Overall Study||15
7899324|NCT00718237|19438768|P1|NOT COMPLETED|Overall Study||13
7899325|NCT00718237|19438767|P2|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366
7899326|NCT00718237|19438768|P1|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368
7899327|NCT00718237|19438767|P2|Vaccinated at Visit 3|Overall Study||369
7899328|NCT00718237|19438768|P1|Vaccinated at Visit 3|Overall Study||371
7899329|NCT00718237|19438767|P2|Vaccinated at Visit 2|Overall Study||374
7899330|NCT00718237|19438768|P1|Vaccinated at Visit 2|Overall Study||373
7899331|NCT00718237|19438767|P2|Vaccinated at Visit 1|Overall Study||381
7899332|NCT00718237|19438768|P1|Vaccinated at Visit 1|Overall Study||380
7899333|NCT00718237|19438767|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
7899334|NCT00718237|19438768|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
7899335|NCT00718159|19438785|P7|NOT COMPLETED|Overall Study||1
7899336|NCT00718159|19438786|P6|NOT COMPLETED|Overall Study||1
7899337|NCT00718159|19438787|P5|NOT COMPLETED|Overall Study||8
7899338|NCT00718159|19438788|P4|NOT COMPLETED|Overall Study||4
7899339|NCT00718159|19438789|P3|NOT COMPLETED|Overall Study||3
7899340|NCT00718159|19438790|P2|NOT COMPLETED|Overall Study||3
7899341|NCT00718159|19438791|P1|NOT COMPLETED|Overall Study||3
7899342|NCT00718159|19438785|P7|COMPLETED|Overall Study||0
7899343|NCT00718159|19438786|P6|COMPLETED|Overall Study||0
7899344|NCT00718159|19438787|P5|COMPLETED|Overall Study||0
7899345|NCT00718159|19438788|P4|COMPLETED|Overall Study||0
7899346|NCT00718159|19438789|P3|COMPLETED|Overall Study||0
7899347|NCT00718159|19438790|P2|COMPLETED|Overall Study||0
7899348|NCT00718159|19438791|P1|COMPLETED|Overall Study||0
7899349|NCT00718159|19438785|P7|Received at Least 1 Dose of Study Drug|Overall Study||1
7899350|NCT00718159|19438786|P6|Received at Least 1 Dose of Study Drug|Overall Study||1
7899351|NCT00718159|19438787|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
7899352|NCT00718159|19438788|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
7899353|NCT00718159|19438789|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
7899354|NCT00718159|19438790|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
7899355|NCT00718159|19438791|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
7899356|NCT00718159|19438785|P7|STARTED|Overall Study||1
7899357|NCT00718159|19438786|P6|STARTED|Overall Study||1
7899358|NCT00718159|19438787|P5|STARTED|Overall Study||8
7899359|NCT00718159|19438788|P4|STARTED|Overall Study||4
7899360|NCT00718159|19438789|P3|STARTED|Overall Study||3
7899361|NCT00718159|19438790|P2|STARTED|Overall Study||3
7899362|NCT00718159|19438791|P1|STARTED|Overall Study||3
7899363|NCT00718120|19438817|P2|NOT COMPLETED|Overall Study||0
7899364|NCT00718120|19438818|P1|NOT COMPLETED|Overall Study||0
7899365|NCT00718120|19438817|P2|COMPLETED|Overall Study||55
7899366|NCT00718120|19438818|P1|COMPLETED|Overall Study||55
7899367|NCT00718120|19438817|P2|STARTED|Overall Study||55
7899368|NCT00718120|19438818|P1|STARTED|Overall Study||55
7899369|NCT00718094|19438838|P2|NOT COMPLETED|Overall Study||0
7899370|NCT00718094|19438839|P1|NOT COMPLETED|Overall Study||0
7899371|NCT00718094|19438838|P2|COMPLETED|Overall Study||5
7899372|NCT00718094|19438839|P1|COMPLETED|Overall Study||15
7899373|NCT00718094|19438838|P2|STARTED|Overall Study||5
7899374|NCT00718094|19438839|P1|STARTED|Overall Study||15
7899375|NCT00718081|19438848|P3|NOT COMPLETED|Overall Study||21
7899376|NCT00718081|19438849|P2|NOT COMPLETED|Overall Study||4
7899377|NCT00718081|19438850|P1|NOT COMPLETED|Overall Study||7
7899378|NCT00718081|19438848|P3|COMPLETED|Overall Study||9
7899379|NCT00718081|19438849|P2|COMPLETED|Overall Study||25
7899380|NCT00718081|19438850|P1|COMPLETED|Overall Study||22
7899381|NCT00718081|19438848|P3|STARTED|Overall Study||30
7899382|NCT00718081|19438849|P2|STARTED|Overall Study||29
7899383|NCT00718081|19438850|P1|STARTED|Overall Study||29
7899384|NCT00718042|19438867|P6|NOT COMPLETED|Donor Follow-up||0
7899385|NCT00718042|19438868|P5|NOT COMPLETED|Donor Follow-up||19
7899386|NCT00718042|19438869|P4|NOT COMPLETED|Donor Follow-up||0
7899387|NCT00718042|19438870|P3|NOT COMPLETED|Donor Follow-up||0
7899388|NCT00718042|19438871|P2|NOT COMPLETED|Donor Follow-up||0
7899389|NCT00718042|19438872|P1|NOT COMPLETED|Donor Follow-up||13
7899390|NCT00718042|19438867|P6|COMPLETED|Donor Follow-up||0
7899391|NCT00718042|19438868|P5|COMPLETED|Donor Follow-up||24
7899392|NCT00718042|19438869|P4|COMPLETED|Donor Follow-up||0
7899393|NCT00718042|19438870|P3|COMPLETED|Donor Follow-up||0
7899394|NCT00718042|19438871|P2|COMPLETED|Donor Follow-up||0
7899395|NCT00718042|19438872|P1|COMPLETED|Donor Follow-up||23
7899396|NCT00718042|19438867|P6|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
7899397|NCT00718042|19438868|P5|STARTED|Donor Follow-up||43
7899398|NCT00718042|19438869|P4|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
7899399|NCT00718042|19438870|P3|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
7899400|NCT00718042|19438871|P2|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
7899401|NCT00718042|19438872|P1|STARTED|Donor Follow-up||36
7899402|NCT00718042|19438867|P6|NOT COMPLETED|ESA Chagas Testing||0
7899403|NCT00718042|19438868|P5|NOT COMPLETED|ESA Chagas Testing||0
7899404|NCT00718042|19438869|P4|NOT COMPLETED|ESA Chagas Testing||0
7899405|NCT00718042|19438870|P3|NOT COMPLETED|ESA Chagas Testing||0
7899406|NCT00718042|19438871|P2|NOT COMPLETED|ESA Chagas Testing||0
7899407|NCT00718042|19438872|P1|NOT COMPLETED|ESA Chagas Testing||0
7899408|NCT00718042|19438867|P6|COMPLETED|ESA Chagas Testing||330
7899409|NCT00718042|19438868|P5|COMPLETED|ESA Chagas Testing||43
7899410|NCT00718042|19438869|P4|COMPLETED|ESA Chagas Testing||110
7899411|NCT00718042|19438870|P3|COMPLETED|ESA Chagas Testing||524
7899412|NCT00718042|19438871|P2|COMPLETED|ESA Chagas Testing||287
7899413|NCT00718042|19438872|P1|COMPLETED|ESA Chagas Testing||36
7899414|NCT00718042|19438867|P6|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330
7899415|NCT00718042|19438868|P5|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43
7899416|NCT00718042|19438869|P4|STARTED|ESA Chagas Testing||110
7899417|NCT00718042|19438870|P3|STARTED|ESA Chagas Testing||524
7899418|NCT00718042|19438871|P2|STARTED|ESA Chagas Testing||287
7899419|NCT00718042|19438872|P1|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36
7899420|NCT00718042|19438867|P6|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
7899421|NCT00718042|19438868|P5|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38
7899422|NCT00718042|19438869|P4|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
7899423|NCT00718042|19438870|P3|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1
7899424|NCT00718042|19438871|P2|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2
7899425|NCT00718042|19438872|P1|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64
7899426|NCT00718042|19438867|P6|COMPLETED|ABBOTT PRISM Chagas Testing||0
7899427|NCT00718042|19438868|P5|COMPLETED|ABBOTT PRISM Chagas Testing||25511
7899428|NCT00718042|19438869|P4|COMPLETED|ABBOTT PRISM Chagas Testing||110
7899429|NCT00718042|19438870|P3|COMPLETED|ABBOTT PRISM Chagas Testing||524
7899430|NCT00718042|19438871|P2|COMPLETED|ABBOTT PRISM Chagas Testing||287
7899431|NCT00718042|19438872|P1|COMPLETED|ABBOTT PRISM Chagas Testing||16249
7899432|NCT00718042|19438867|P6|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0
7899433|NCT00718042|19438868|P5|STARTED|ABBOTT PRISM Chagas Testing||25549
7899434|NCT00718042|19438869|P4|STARTED|ABBOTT PRISM Chagas Testing||110
7899435|NCT00718042|19438870|P3|STARTED|ABBOTT PRISM Chagas Testing||525
7899436|NCT00718042|19438871|P2|STARTED|ABBOTT PRISM Chagas Testing||289
7899437|NCT00718042|19438872|P1|STARTED|ABBOTT PRISM Chagas Testing||16313
7899438|NCT00717977|19438884|P1|NOT COMPLETED|Overall Study||0
7899439|NCT00717977|19438884|P1|COMPLETED|Overall Study||74
7899440|NCT00717977|19438884|P1|STARTED|Overall Study||74
7899441|NCT00717912|19438912|P6|NOT COMPLETED|Overall Study||0
7899442|NCT00717912|19438913|P5|NOT COMPLETED|Overall Study||0
7899443|NCT00717912|19438914|P4|NOT COMPLETED|Overall Study||0
7899444|NCT00717912|19438915|P3|NOT COMPLETED|Overall Study||0
7899445|NCT00717912|19438916|P2|NOT COMPLETED|Overall Study||0
7899446|NCT00717912|19438917|P1|NOT COMPLETED|Overall Study||0
7899447|NCT00717912|19438912|P6|COMPLETED|Overall Study||1
7899448|NCT00717912|19438913|P5|COMPLETED|Overall Study||1
7899449|NCT00717912|19438914|P4|COMPLETED|Overall Study||1
7899450|NCT00717912|19438915|P3|COMPLETED|Overall Study||1
7899451|NCT00717912|19438916|P2|COMPLETED|Overall Study||1
7899452|NCT00717912|19438917|P1|COMPLETED|Overall Study||1
7899453|NCT00717912|19438912|P6|STARTED|Overall Study||1
7899454|NCT00717912|19438913|P5|STARTED|Overall Study||1
7899455|NCT00717912|19438914|P4|STARTED|Overall Study||1
7899456|NCT00717912|19438915|P3|STARTED|Overall Study||1
7899457|NCT00717912|19438916|P2|STARTED|Overall Study||1
7899458|NCT00717912|19438917|P1|STARTED|Overall Study||1
7899459|NCT00717886|19438928|P1|NOT COMPLETED|Overall Study||4
7899460|NCT00717886|19438928|P1|COMPLETED|Overall Study||9
7899461|NCT00717886|19438928|P1|STARTED|Overall Study||13
7899462|NCT00717873|19438934|P2|NOT COMPLETED|Overall Study||0
7899463|NCT00717873|19438935|P1|NOT COMPLETED|Overall Study||0
7899464|NCT00717873|19438934|P2|COMPLETED|Overall Study||59
7899465|NCT00717873|19438935|P1|COMPLETED|Overall Study||46
7899466|NCT00717873|19438934|P2|STARTED|Overall Study||59
7899467|NCT00717873|19438935|P1|STARTED|Overall Study||46
7899468|NCT00717860|19438943|P2|NOT COMPLETED|Overall Study||28
7899469|NCT00717860|19438944|P1|NOT COMPLETED|Overall Study||27
7899470|NCT00717860|19438943|P2|COMPLETED|Overall Study||32
7899471|NCT00717860|19438944|P1|COMPLETED|Overall Study||34
7899472|NCT00717860|19438943|P2|STARTED|Overall Study||60
7899473|NCT00717860|19438944|P1|STARTED|Overall Study||61
7899474|NCT00717756|19438954|P1|NOT COMPLETED|Overall Study||1
7899475|NCT00717756|19438954|P1|COMPLETED|Overall Study||40
7899476|NCT00717756|19438954|P1|STARTED|Overall Study||41
7899477|NCT00717626|19438958|P1|NOT COMPLETED|Overall Study||0
7899478|NCT00717626|19438958|P1|COMPLETED|Overall Study||14
7899479|NCT00717626|19438958|P1|STARTED|Overall Study||14
7899480|NCT00717574|19438970|P2|NOT COMPLETED|Overall Study||2
7899481|NCT00717574|19438971|P1|NOT COMPLETED|Overall Study||2
7899482|NCT00717574|19438970|P2|COMPLETED|Overall Study||14
7899483|NCT00717574|19438971|P1|COMPLETED|Overall Study||14
7899484|NCT00717574|19438970|P2|STARTED|Overall Study||16
7899485|NCT00717574|19438971|P1|STARTED|Overall Study||16
7899486|NCT00717522|19438977|P1|NOT COMPLETED|Overall Study||7
7899487|NCT00717522|19438977|P1|COMPLETED|Overall Study||0
7899488|NCT00717522|19438977|P1|STARTED|Overall Study||7
7899489|NCT00717418|19438986|P4|NOT COMPLETED|1-Year Follow-Up||4
7899490|NCT00717418|19438987|P3|NOT COMPLETED|1-Year Follow-Up||434
7899491|NCT00717418|19438988|P2|NOT COMPLETED|1-Year Follow-Up||51
7899492|NCT00717418|19438989|P1|NOT COMPLETED|1-Year Follow-Up||147
7899493|NCT00717418|19438986|P4|COMPLETED|1-Year Follow-Up||0
7899494|NCT00717418|19438987|P3|COMPLETED|1-Year Follow-Up||74
7899495|NCT00717418|19438988|P2|COMPLETED|1-Year Follow-Up||23
7899496|NCT00717418|19438989|P1|COMPLETED|1-Year Follow-Up||33
7899497|NCT00717418|19438986|P4|STARTED|1-Year Follow-Up||4
7899498|NCT00717418|19438987|P3|STARTED|1-Year Follow-Up||508
7899499|NCT00717418|19438988|P2|STARTED|1-Year Follow-Up||74
7899500|NCT00717418|19438989|P1|STARTED|1-Year Follow-Up||180
7899501|NCT00717418|19438986|P4|NOT COMPLETED|Baseline||15
7899502|NCT00717418|19438987|P3|NOT COMPLETED|Baseline||0
7899503|NCT00717418|19438988|P2|NOT COMPLETED|Baseline||0
7899504|NCT00717418|19438989|P1|NOT COMPLETED|Baseline||0
7899505|NCT00717418|19438986|P4|COMPLETED|Baseline||4
7899506|NCT00717418|19438987|P3|COMPLETED|Baseline||508
7899507|NCT00717418|19438988|P2|COMPLETED|Baseline||74
7899508|NCT00717418|19438989|P1|COMPLETED|Baseline||180
7899509|NCT00717418|19438986|P4|STARTED|Baseline||19
7899510|NCT00717418|19438987|P3|STARTED|Baseline||508
7899511|NCT00717418|19438988|P2|STARTED|Baseline||74
7899512|NCT00717418|19438989|P1|STARTED|Baseline||180
7899513|NCT00717405|19438994|P1|NOT COMPLETED|Overall Study||0
7899514|NCT00717405|19438994|P1|COMPLETED|Overall Study||52
7899515|NCT00717405|19438994|P1|STARTED|Overall Study||52
7899516|NCT00717366|19439013|P2|NOT COMPLETED|Extension Period (52 Weeks)||16
7899517|NCT00717366|19439014|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
7899518|NCT00717366|19439013|P2|COMPLETED|Extension Period (52 Weeks)||12
7899519|NCT00717366|19439014|P1|COMPLETED|Extension Period (52 Weeks)||5
7899520|NCT00717366|19439013|P2|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||28
7899521|NCT00717366|19439014|P1|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||8
7899522|NCT00717366|19439013|P2|STARTED|Extension Period (52 Weeks)||28
7899523|NCT00717366|19439014|P1|STARTED|Extension Period (52 Weeks)||9
7899524|NCT00717366|19439013|P2|NOT COMPLETED|Core Study Period (20 Weeks)||13
7899525|NCT00717366|19439014|P1|NOT COMPLETED|Core Study Period (20 Weeks)||4
7899526|NCT00717366|19439013|P2|COMPLETED|Core Study Period (20 Weeks)||35
7899527|NCT00717366|19439014|P1|COMPLETED|Core Study Period (20 Weeks)||12
7899528|NCT00717366|19439013|P2|STARTED|Core Study Period (20 Weeks)||48
7899529|NCT00717366|19439014|P1|STARTED|Core Study Period (20 Weeks)||16
7899530|NCT00717314|19439038|P2|NOT COMPLETED|Overall Study||10
7899531|NCT00717314|19439039|P1|NOT COMPLETED|Overall Study||6
7899532|NCT00717314|19439038|P2|COMPLETED|Overall Study||34
7899533|NCT00717314|19439039|P1|COMPLETED|Overall Study||37
7899534|NCT00717314|19439038|P2|STARTED|Overall Study||44
7899535|NCT00717314|19439039|P1|STARTED|Overall Study||43
7899536|NCT00717288|19439060|P3|NOT COMPLETED|Overall Study||0
7899537|NCT00717288|19439061|P2|NOT COMPLETED|Overall Study||0
7899538|NCT00717288|19439062|P1|NOT COMPLETED|Overall Study||0
7899539|NCT00717288|19439060|P3|COMPLETED|Overall Study||25
7899540|NCT00717288|19439061|P2|COMPLETED|Overall Study||29
7899541|NCT00717288|19439062|P1|COMPLETED|Overall Study||28
7899542|NCT00717288|19439060|P3|STARTED|Overall Study||25
7899543|NCT00717288|19439061|P2|STARTED|Overall Study||29
7899544|NCT00717288|19439062|P1|STARTED|Overall Study||28
7899545|NCT00717275|19439076|P1|NOT COMPLETED|Overall Study||3
7899546|NCT00717275|19439076|P1|COMPLETED|Overall Study||0
7899547|NCT00717275|19439076|P1|STARTED|Overall Study||3
7899548|NCT00717249|19439082|P2|NOT COMPLETED|Overall Study||15
7899549|NCT00717249|19439083|P1|NOT COMPLETED|Overall Study||22
7899550|NCT00717249|19439082|P2|COMPLETED|Overall Study||150
7899551|NCT00717249|19439083|P1|COMPLETED|Overall Study||304
7899552|NCT00717249|19439082|P2|STARTED|Overall Study||165
7899553|NCT00717249|19439083|P1|STARTED|Overall Study||326
7899554|NCT00717236|19439097|P2|NOT COMPLETED|Open-Label Period||21
7899555|NCT00717236|19439098|P1|NOT COMPLETED|Open-Label Period||125
7899556|NCT00717236|19439097|P2|COMPLETED|Open-Label Period||163
7899557|NCT00717236|19439098|P1|COMPLETED|Open-Label Period||646
7899558|NCT00717236|19439097|P2|STARTED|Open-Label Period||184
7899559|NCT00717236|19439098|P1|STARTED|Open-Label Period||771
7899560|NCT00717236|19439097|P2|NOT COMPLETED|Double-Blind Period||28
7899561|NCT00717236|19439098|P1|NOT COMPLETED|Double-Blind Period||80
7899562|NCT00717236|19439097|P2|COMPLETED|Double-Blind Period||184
7899563|NCT00717236|19439098|P1|COMPLETED|Double-Blind Period||771
7899564|NCT00717236|19439097|P2|STARTED|Double-Blind Period||212
7899565|NCT00717236|19439098|P1|STARTED|Double-Blind Period||851
7899566|NCT00717197|19439167|P1|NOT COMPLETED|Overall Study||7
7899567|NCT00717197|19439167|P1|COMPLETED|Overall Study||23
7899568|NCT00717197|19439167|P1|STARTED|Overall Study||30
7899569|NCT00717093|19439173|P2|NOT COMPLETED|Overall Study||48
7899570|NCT00717093|19439174|P1|NOT COMPLETED|Overall Study||44
7899571|NCT00717093|19439173|P2|COMPLETED|Overall Study||170
7899572|NCT00717093|19439174|P1|COMPLETED|Overall Study||170
7899573|NCT00717093|19439173|P2|Received Treatment|Overall Study||218
7899574|NCT00717093|19439174|P1|Received Treatment|Overall Study||213
7899575|NCT00717093|19439173|P2|STARTED|Overall Study||218
7899576|NCT00717093|19439174|P1|STARTED|Overall Study||214
7899577|NCT00717067|19439191|P5|NOT COMPLETED|Part 2: End Stage Renal Disease||0
7899578|NCT00717067|19439192|P4|NOT COMPLETED|Part 2: End Stage Renal Disease||0
7899579|NCT00717067|19439193|P3|NOT COMPLETED|Part 2: End Stage Renal Disease||0
7899580|NCT00717067|19439194|P2|NOT COMPLETED|Part 2: End Stage Renal Disease||0
7899581|NCT00717067|19439195|P1|NOT COMPLETED|Part 2: End Stage Renal Disease||0
7899582|NCT00717067|19439191|P5|COMPLETED|Part 2: End Stage Renal Disease||6
7899583|NCT00717067|19439192|P4|COMPLETED|Part 2: End Stage Renal Disease||0
7899584|NCT00717067|19439193|P3|COMPLETED|Part 2: End Stage Renal Disease||0
7899585|NCT00717067|19439194|P2|COMPLETED|Part 2: End Stage Renal Disease||0
7899586|NCT00717067|19439195|P1|COMPLETED|Part 2: End Stage Renal Disease||0
7899587|NCT00717067|19439191|P5|STARTED|Part 2: End Stage Renal Disease||6
7899588|NCT00717067|19439192|P4|STARTED|Part 2: End Stage Renal Disease||0
7899589|NCT00717067|19439193|P3|STARTED|Part 2: End Stage Renal Disease||0
7899590|NCT00717067|19439194|P2|STARTED|Part 2: End Stage Renal Disease||0
7899591|NCT00717067|19439195|P1|STARTED|Part 2: End Stage Renal Disease||0
7899592|NCT00717067|19439191|P5|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
7899593|NCT00717067|19439192|P4|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
7899594|NCT00717067|19439193|P3|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
7899595|NCT00717067|19439194|P2|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
7899596|NCT00717067|19439195|P1|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
7899597|NCT00717067|19439191|P5|COMPLETED|Part 1b: Severe Renal Impairment||0
7899598|NCT00717067|19439192|P4|COMPLETED|Part 1b: Severe Renal Impairment||6
7899599|NCT00717067|19439193|P3|COMPLETED|Part 1b: Severe Renal Impairment||0
7899600|NCT00717067|19439194|P2|COMPLETED|Part 1b: Severe Renal Impairment||0
7899601|NCT00717067|19439195|P1|COMPLETED|Part 1b: Severe Renal Impairment||0
7899602|NCT00717067|19439191|P5|STARTED|Part 1b: Severe Renal Impairment||0
7899603|NCT00717067|19439192|P4|STARTED|Part 1b: Severe Renal Impairment||6
7899604|NCT00717067|19439193|P3|STARTED|Part 1b: Severe Renal Impairment||0
7899605|NCT00717067|19439194|P2|STARTED|Part 1b: Severe Renal Impairment||0
7899606|NCT00717067|19439195|P1|STARTED|Part 1b: Severe Renal Impairment||0
7899607|NCT00717067|19439191|P5|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
7899608|NCT00717067|19439192|P4|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
7899609|NCT00717067|19439193|P3|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1
7899610|NCT00717067|19439194|P2|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
7899611|NCT00717067|19439195|P1|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
7899612|NCT00717067|19439191|P5|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
7899613|NCT00717067|19439192|P4|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
7899614|NCT00717067|19439193|P3|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5
7899615|NCT00717067|19439194|P2|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
7899616|NCT00717067|19439195|P1|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
7899617|NCT00717067|19439191|P5|STARTED|Part 1a: Normal/Mild/Moderate Group||0
7899618|NCT00717067|19439192|P4|STARTED|Part 1a: Normal/Mild/Moderate Group||0
7899619|NCT00717067|19439193|P3|STARTED|Part 1a: Normal/Mild/Moderate Group||6
7899620|NCT00717067|19439194|P2|STARTED|Part 1a: Normal/Mild/Moderate Group||6
7899621|NCT00717067|19439195|P1|STARTED|Part 1a: Normal/Mild/Moderate Group||6
7899622|NCT00717054|19439279|P2|NOT COMPLETED|Overall Study||0
7899623|NCT00717054|19439280|P1|NOT COMPLETED|Overall Study||0
7899624|NCT00717054|19439279|P2|COMPLETED|Overall Study||57
7899625|NCT00717054|19439280|P1|COMPLETED|Overall Study||58
7899626|NCT00717054|19439279|P2|STARTED|Overall Study||57
7899627|NCT00717054|19439280|P1|STARTED|Overall Study||58
7899628|NCT00717041|19439292|P1|NOT COMPLETED|Overall Study||0
7899629|NCT00717041|19439292|P1|COMPLETED|Overall Study||1206
7899630|NCT00717041|19439292|P1|STARTED|Overall Study||1206
7899631|NCT00716976|19439302|P2|NOT COMPLETED|Overall Study||9
7899632|NCT00716976|19439303|P1|NOT COMPLETED|Overall Study||20
7899633|NCT00716976|19439302|P2|COMPLETED|Overall Study||57
7899634|NCT00716976|19439303|P1|COMPLETED|Overall Study||45
7899635|NCT00716976|19439302|P2|STARTED|Overall Study||66
7899636|NCT00716976|19439303|P1|STARTED|Overall Study||65
7899637|NCT00716963|19439325|P6|NOT COMPLETED|Overall Study||0
7899638|NCT00716963|19439326|P5|NOT COMPLETED|Overall Study||0
7899639|NCT00716963|19439327|P4|NOT COMPLETED|Overall Study||0
7899640|NCT00716963|19439328|P3|NOT COMPLETED|Overall Study||0
7899641|NCT00716963|19439329|P2|NOT COMPLETED|Overall Study||0
7899642|NCT00716963|19439330|P1|NOT COMPLETED|Overall Study||1
7899643|NCT00716963|19439325|P6|COMPLETED|Overall Study||1
7899644|NCT00716963|19439326|P5|COMPLETED|Overall Study||1
7899645|NCT00716963|19439327|P4|COMPLETED|Overall Study||1
7899646|NCT00716963|19439328|P3|COMPLETED|Overall Study||1
7899647|NCT00716963|19439329|P2|COMPLETED|Overall Study||1
7899648|NCT00716963|19439330|P1|COMPLETED|Overall Study||1
7899649|NCT00716963|19439325|P6|STARTED|Overall Study||1
7899650|NCT00716963|19439326|P5|STARTED|Overall Study||1
7899651|NCT00716963|19439327|P4|STARTED|Overall Study||1
7899652|NCT00716963|19439328|P3|STARTED|Overall Study||1
7899653|NCT00716963|19439329|P2|STARTED|Overall Study||1
7899654|NCT00716963|19439330|P1|STARTED|Overall Study||2
7899655|NCT00716859|19439343|P2|NOT COMPLETED|Overall Study||5
7899656|NCT00716859|19439344|P1|NOT COMPLETED|Overall Study||9
7899657|NCT00716859|19439343|P2|COMPLETED|Overall Study||64
7899658|NCT00716859|19439344|P1|COMPLETED|Overall Study||61
7899659|NCT00716859|19439343|P2|Received Treatment|Overall Study||68
7899660|NCT00716859|19439344|P1|Received Treatment|Overall Study||69
7899661|NCT00716859|19439343|P2|STARTED|Overall Study||69
7899662|NCT00716859|19439344|P1|STARTED|Overall Study||70
7899663|NCT00716820|19439368|P1|NOT COMPLETED|Overall Study||0
7899664|NCT00716820|19439368|P1|COMPLETED|Overall Study||472
7899665|NCT00716820|19439368|P1|STARTED|Overall Study||472
7899666|NCT00716807|19439403|P4|NOT COMPLETED|Overall Study||0
7899667|NCT00716807|19439404|P3|NOT COMPLETED|Overall Study||0
7899668|NCT00716807|19439405|P2|NOT COMPLETED|Overall Study||0
7899669|NCT00716807|19439406|P1|NOT COMPLETED|Overall Study||0
7899670|NCT00716807|19439403|P4|COMPLETED|Overall Study||15
7899671|NCT00716807|19439404|P3|COMPLETED|Overall Study||18
7899672|NCT00716807|19439405|P2|COMPLETED|Overall Study||5
7899673|NCT00716807|19439406|P1|COMPLETED|Overall Study||8
7899674|NCT00716807|19439403|P4|STARTED|Overall Study||15
7899675|NCT00716807|19439404|P3|STARTED|Overall Study||18
7899676|NCT00716807|19439405|P2|STARTED|Overall Study||5
7899677|NCT00716807|19439406|P1|STARTED|Overall Study||8
7899678|NCT00716742|19439419|P3|NOT COMPLETED|3 Year Follow-up||21
7899679|NCT00716742|19439420|P2|NOT COMPLETED|3 Year Follow-up||32
7899680|NCT00716742|19439421|P1|NOT COMPLETED|3 Year Follow-up||30
7899681|NCT00716742|19439419|P3|COMPLETED|3 Year Follow-up||29
7899682|NCT00716742|19439420|P2|COMPLETED|3 Year Follow-up||35
7899683|NCT00716742|19439421|P1|COMPLETED|3 Year Follow-up||26
7899684|NCT00716742|19439419|P3|STARTED|3 Year Follow-up||50
7899685|NCT00716742|19439420|P2|STARTED|3 Year Follow-up||67
7899686|NCT00716742|19439421|P1|STARTED|3 Year Follow-up||56
7899687|NCT00716742|19439419|P3|NOT COMPLETED|2 Year Follow-up||102
7899688|NCT00716742|19439420|P2|NOT COMPLETED|2 Year Follow-up||96
7899689|NCT00716742|19439421|P1|NOT COMPLETED|2 Year Follow-up||104
7899690|NCT00716742|19439419|P3|COMPLETED|2 Year Follow-up||50
7899691|NCT00716742|19439420|P2|COMPLETED|2 Year Follow-up||67
7899692|NCT00716742|19439421|P1|COMPLETED|2 Year Follow-up||56
7899693|NCT00716742|19439419|P3|STARTED|2 Year Follow-up||152
7899694|NCT00716742|19439420|P2|STARTED|2 Year Follow-up||163
7899695|NCT00716742|19439421|P1|STARTED|2 Year Follow-up||160
7899696|NCT00716742|19439419|P3|NOT COMPLETED|1 Year Follow-up||200
7899697|NCT00716742|19439420|P2|NOT COMPLETED|1 Year Follow-up||193
7899698|NCT00716742|19439421|P1|NOT COMPLETED|1 Year Follow-up||187
7899699|NCT00716742|19439419|P3|COMPLETED|1 Year Follow-up||152
7899700|NCT00716742|19439420|P2|COMPLETED|1 Year Follow-up||163
7899701|NCT00716742|19439421|P1|COMPLETED|1 Year Follow-up||160
7899702|NCT00716742|19439419|P3|STARTED|1 Year Follow-up||352
7899703|NCT00716742|19439420|P2|STARTED|1 Year Follow-up||356
7899704|NCT00716742|19439421|P1|STARTED|1 Year Follow-up||347
7899705|NCT00716742|19439419|P3|NOT COMPLETED|Baseline||13
7899706|NCT00716742|19439420|P2|NOT COMPLETED|Baseline||14
7899707|NCT00716742|19439421|P1|NOT COMPLETED|Baseline||17
7899708|NCT00716742|19439419|P3|COMPLETED|Baseline||352
7899709|NCT00716742|19439420|P2|COMPLETED|Baseline||356
7899710|NCT00716742|19439421|P1|COMPLETED|Baseline||347
7899711|NCT00716742|19439419|P3|STARTED|Baseline||365
7899712|NCT00716742|19439420|P2|STARTED|Baseline||370
7899713|NCT00716742|19439421|P1|STARTED|Baseline||364
7899714|NCT00716625|19439429|P1|NOT COMPLETED|Overall Study||1
7899715|NCT00716625|19439429|P1|COMPLETED|Overall Study||1673
7899716|NCT00716625|19439429|P1|STARTED|Overall Study||1674
7899717|NCT00716482|19439454|P1|NOT COMPLETED|Overall Study||119
7899718|NCT00716482|19439454|P1|COMPLETED|Overall Study||1562
7899719|NCT00716482|19439454|P1|STARTED|Overall Study||1681
7899720|NCT00716456|19439467|P3|NOT COMPLETED|Overall Study||0
7899721|NCT00716456|19439468|P2|NOT COMPLETED|Overall Study||2
7899722|NCT00716456|19439469|P1|NOT COMPLETED|Overall Study||0
7899723|NCT00716456|19439467|P3|COMPLETED|Overall Study||13
7899724|NCT00716456|19439468|P2|COMPLETED|Overall Study||3
7899725|NCT00716456|19439469|P1|COMPLETED|Overall Study||3
7899726|NCT00716456|19439467|P3|STARTED|Overall Study||13
7899727|NCT00716456|19439468|P2|STARTED|Overall Study||5
7899728|NCT00716456|19439469|P1|STARTED|Overall Study||3
7899729|NCT00716443|19439477|P1|NOT COMPLETED|Overall Study||0
7899730|NCT00716443|19439477|P1|COMPLETED|Overall Study||51
7899731|NCT00716443|19439477|P1|STARTED|Overall Study||51
7899732|NCT00716417|19439520|P10|NOT COMPLETED|Overall Study||3
7899733|NCT00716417|19439521|P9|NOT COMPLETED|Overall Study||5
7899734|NCT00716417|19439522|P8|NOT COMPLETED|Overall Study||3
7899735|NCT00716417|19439523|P7|NOT COMPLETED|Overall Study||7
7899736|NCT00716417|19439524|P6|NOT COMPLETED|Overall Study||3
7899737|NCT00716417|19439525|P5|NOT COMPLETED|Overall Study||1
7899738|NCT00716417|19439526|P4|NOT COMPLETED|Overall Study||11
7899739|NCT00716417|19439527|P3|NOT COMPLETED|Overall Study||5
7899740|NCT00716417|19439528|P2|NOT COMPLETED|Overall Study||6
7899741|NCT00716417|19439529|P1|NOT COMPLETED|Overall Study||3
7899742|NCT00716417|19439520|P10|COMPLETED|Overall Study||0
7899743|NCT00716417|19439521|P9|COMPLETED|Overall Study||0
7899744|NCT00716417|19439522|P8|COMPLETED|Overall Study||0
7899745|NCT00716417|19439523|P7|COMPLETED|Overall Study||0
7899746|NCT00716417|19439524|P6|COMPLETED|Overall Study||0
7899747|NCT00716417|19439525|P5|COMPLETED|Overall Study||0
7899748|NCT00716417|19439526|P4|COMPLETED|Overall Study||0
7899749|NCT00716417|19439527|P3|COMPLETED|Overall Study||0
7899750|NCT00716417|19439528|P2|COMPLETED|Overall Study||0
7899751|NCT00716417|19439529|P1|COMPLETED|Overall Study||0
7899752|NCT00716417|19439520|P10|STARTED|Overall Study||3
7899753|NCT00716417|19439521|P9|STARTED|Overall Study||5
7899754|NCT00716417|19439522|P8|STARTED|Overall Study||3
7899755|NCT00716417|19439523|P7|STARTED|Overall Study||7
7899756|NCT00716417|19439524|P6|STARTED|Overall Study||3
7899757|NCT00716417|19439525|P5|STARTED|Overall Study||1
7899758|NCT00716417|19439526|P4|STARTED|Overall Study||11
7899759|NCT00716417|19439527|P3|STARTED|Overall Study||5
7899760|NCT00716417|19439528|P2|STARTED|Overall Study||6
7899761|NCT00716417|19439529|P1|STARTED|Overall Study||3
7899762|NCT00716274|19439576|P6|NOT COMPLETED|Study Period III (16-Weeks)||0
7899763|NCT00716274|19439577|P5|NOT COMPLETED|Study Period III (16-Weeks)||3
7899764|NCT00716274|19439578|P4|NOT COMPLETED|Study Period III (16-Weeks)||1
7899765|NCT00716274|19439579|P3|NOT COMPLETED|Study Period III (16-Weeks)||2
7899766|NCT00716274|19439580|P2|NOT COMPLETED|Study Period III (16-Weeks)||0
7899767|NCT00716274|19439581|P1|NOT COMPLETED|Study Period III (16-Weeks)||0
7899768|NCT00716274|19439576|P6|COMPLETED|Study Period III (16-Weeks)||19
7899769|NCT00716274|19439577|P5|COMPLETED|Study Period III (16-Weeks)||32
7899770|NCT00716274|19439578|P4|COMPLETED|Study Period III (16-Weeks)||17
7899771|NCT00716274|19439579|P3|COMPLETED|Study Period III (16-Weeks)||16
7899772|NCT00716274|19439580|P2|COMPLETED|Study Period III (16-Weeks)||0
7899773|NCT00716274|19439581|P1|COMPLETED|Study Period III (16-Weeks)||0
7899854|NCT00715910|19439808|P4|NOT COMPLETED|Year 5||0
7899774|NCT00716274|19439576|P6|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|19
7899775|NCT00716274|19439577|P5|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|35
7899776|NCT00716274|19439578|P4|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
7899777|NCT00716274|19439579|P3|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
7899778|NCT00716274|19439580|P2|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
7899779|NCT00716274|19439581|P1|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
7899780|NCT00716274|19439576|P6|NOT COMPLETED|Study Period II (16-Weeks)||2
7899781|NCT00716274|19439577|P5|NOT COMPLETED|Study Period II (16-Weeks)||0
7899782|NCT00716274|19439578|P4|NOT COMPLETED|Study Period II (16-Weeks)||0
7899783|NCT00716274|19439579|P3|NOT COMPLETED|Study Period II (16-Weeks)||0
7899784|NCT00716274|19439580|P2|NOT COMPLETED|Study Period II (16-Weeks)||9
7899785|NCT00716274|19439581|P1|NOT COMPLETED|Study Period II (16-Weeks)||9
7899786|NCT00716274|19439576|P6|COMPLETED|Study Period II (16-Weeks)||19
7899787|NCT00716274|19439577|P5|COMPLETED|Study Period II (16-Weeks)||0
7899788|NCT00716274|19439578|P4|COMPLETED|Study Period II (16-Weeks)||0
7899789|NCT00716274|19439579|P3|COMPLETED|Study Period II (16-Weeks)||0
7899790|NCT00716274|19439580|P2|COMPLETED|Study Period II (16-Weeks)||35
7899791|NCT00716274|19439581|P1|COMPLETED|Study Period II (16-Weeks)||36
7899792|NCT00716274|19439576|P6|STARTED|Study Period II (16-Weeks)||21
7899793|NCT00716274|19439577|P5|STARTED|Study Period II (16-Weeks)||0
7899794|NCT00716274|19439578|P4|STARTED|Study Period II (16-Weeks)||0
7899795|NCT00716274|19439579|P3|STARTED|Study Period II (16-Weeks)||0
7899796|NCT00716274|19439580|P2|STARTED|Study Period II (16-Weeks)||44
7899797|NCT00716274|19439581|P1|STARTED|Study Period II (16-Weeks)||45
7899798|NCT00716144|19439715|P4|NOT COMPLETED|Overall Study||12
7899799|NCT00716144|19439716|P3|NOT COMPLETED|Overall Study||12
7899800|NCT00716144|19439717|P2|NOT COMPLETED|Overall Study||7
7899801|NCT00716144|19439718|P1|NOT COMPLETED|Overall Study||9
7899802|NCT00716144|19439715|P4|COMPLETED|Overall Study||33
7899803|NCT00716144|19439716|P3|COMPLETED|Overall Study||33
7899804|NCT00716144|19439717|P2|COMPLETED|Overall Study||38
7899805|NCT00716144|19439718|P1|COMPLETED|Overall Study||32
7899806|NCT00716144|19439715|P4|STARTED|Overall Study||45
7899807|NCT00716144|19439716|P3|STARTED|Overall Study||45
7899808|NCT00716144|19439717|P2|STARTED|Overall Study||45
7899809|NCT00716144|19439718|P1|STARTED|Overall Study||41
7899810|NCT00716092|19439743|P3|NOT COMPLETED|Overall Study||0
7899811|NCT00716092|19439744|P2|NOT COMPLETED|Overall Study||1
7899812|NCT00716092|19439745|P1|NOT COMPLETED|Overall Study||2
7899813|NCT00716092|19439743|P3|COMPLETED|Overall Study||41
7899814|NCT00716092|19439744|P2|COMPLETED|Overall Study||39
7899815|NCT00716092|19439745|P1|COMPLETED|Overall Study||38
7899816|NCT00716092|19439743|P3|STARTED|Overall Study||41
7899817|NCT00716092|19439744|P2|STARTED|Overall Study||40
7899818|NCT00716092|19439745|P1|STARTED|Overall Study||40
7899819|NCT00716079|19439776|P2|NOT COMPLETED|Overall Study||15
7899820|NCT00716079|19439777|P1|NOT COMPLETED|Overall Study||9
7899821|NCT00716079|19439776|P2|COMPLETED|Overall Study||1421
7899822|NCT00716079|19439777|P1|COMPLETED|Overall Study||1394
7899823|NCT00716079|19439776|P2|STARTED|Overall Study||1436
7899824|NCT00716079|19439777|P1|STARTED|Overall Study||1403
7899825|NCT00715962|19439787|P2|NOT COMPLETED|Overall Study||2
7899826|NCT00715962|19439788|P1|NOT COMPLETED|Overall Study||6
7899827|NCT00715962|19439787|P2|COMPLETED|Overall Study||48
7899828|NCT00715962|19439788|P1|COMPLETED|Overall Study||44
7899829|NCT00715962|19439787|P2|STARTED|Overall Study||50
7899830|NCT00715962|19439788|P1|STARTED|Overall Study||50
7899831|NCT00715949|19439798|P1|NOT COMPLETED|Overall Study||4
7899832|NCT00715949|19439798|P1|COMPLETED|Overall Study|116 patients completed first test|116
7899833|NCT00715949|19439798|P1|STARTED|Overall Study|4 dropped because could not finish first test|120
7899834|NCT00715910|19439806|P6|NOT COMPLETED|Booster and ESFU Phase||13
7899835|NCT00715910|19439807|P5|NOT COMPLETED|Booster and ESFU Phase||2
7899836|NCT00715910|19439808|P4|NOT COMPLETED|Booster and ESFU Phase||11
7899837|NCT00715910|19439809|P3|NOT COMPLETED|Booster and ESFU Phase||0
7899838|NCT00715910|19439810|P2|NOT COMPLETED|Booster and ESFU Phase||0
7899839|NCT00715910|19439811|P1|NOT COMPLETED|Booster and ESFU Phase||0
7899840|NCT00715910|19439806|P6|COMPLETED|Booster and ESFU Phase||88
7899841|NCT00715910|19439807|P5|COMPLETED|Booster and ESFU Phase||36
7899842|NCT00715910|19439808|P4|COMPLETED|Booster and ESFU Phase||172
7899843|NCT00715910|19439809|P3|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
7899844|NCT00715910|19439810|P2|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
7899845|NCT00715910|19439811|P1|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
7899846|NCT00715910|19439806|P6|STARTED|Booster and ESFU Phase||101
7899847|NCT00715910|19439807|P5|STARTED|Booster and ESFU Phase||38
7899848|NCT00715910|19439808|P4|STARTED|Booster and ESFU Phase||183
7899849|NCT00715910|19439809|P3|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
7899850|NCT00715910|19439810|P2|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
7899851|NCT00715910|19439811|P1|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
7899852|NCT00715910|19439806|P6|NOT COMPLETED|Year 5||0
7899853|NCT00715910|19439807|P5|NOT COMPLETED|Year 5||0
7899855|NCT00715910|19439809|P3|NOT COMPLETED|Year 5||0
7899856|NCT00715910|19439810|P2|NOT COMPLETED|Year 5||0
7899857|NCT00715910|19439811|P1|NOT COMPLETED|Year 5||0
7899858|NCT00715910|19439806|P6|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
7899859|NCT00715910|19439807|P5|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
7899860|NCT00715910|19439808|P4|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
7899861|NCT00715910|19439809|P3|COMPLETED|Year 5||38
7899862|NCT00715910|19439810|P2|COMPLETED|Year 5||56
7899863|NCT00715910|19439811|P1|COMPLETED|Year 5||218
7899864|NCT00715910|19439806|P6|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
7899865|NCT00715910|19439807|P5|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
7899866|NCT00715910|19439808|P4|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
7899867|NCT00715910|19439809|P3|STARTED|Year 5||38
7899868|NCT00715910|19439810|P2|STARTED|Year 5||56
7899869|NCT00715910|19439811|P1|STARTED|Year 5||218
7899870|NCT00715910|19439806|P6|NOT COMPLETED|Year 3||0
7899871|NCT00715910|19439807|P5|NOT COMPLETED|Year 3||0
7899872|NCT00715910|19439808|P4|NOT COMPLETED|Year 3||0
7899873|NCT00715910|19439809|P3|NOT COMPLETED|Year 3||0
7899874|NCT00715910|19439810|P2|NOT COMPLETED|Year 3||0
7899875|NCT00715910|19439811|P1|NOT COMPLETED|Year 3||0
7899876|NCT00715910|19439806|P6|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
7899877|NCT00715910|19439807|P5|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
7899878|NCT00715910|19439808|P4|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
7899879|NCT00715910|19439809|P3|COMPLETED|Year 3||56
7899880|NCT00715910|19439810|P2|COMPLETED|Year 3||86
7899881|NCT00715910|19439811|P1|COMPLETED|Year 3||345
7899882|NCT00715910|19439806|P6|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
7899883|NCT00715910|19439807|P5|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
7899884|NCT00715910|19439808|P4|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
7899885|NCT00715910|19439809|P3|STARTED|Year 3||56
7899886|NCT00715910|19439810|P2|STARTED|Year 3||86
7899887|NCT00715910|19439811|P1|STARTED|Year 3||345
7899888|NCT00715910|19439806|P6|NOT COMPLETED|Year 1||0
7899889|NCT00715910|19439807|P5|NOT COMPLETED|Year 1||0
7899890|NCT00715910|19439808|P4|NOT COMPLETED|Year 1||0
7899891|NCT00715910|19439809|P3|NOT COMPLETED|Year 1||0
7899892|NCT00715910|19439810|P2|NOT COMPLETED|Year 1||0
7899893|NCT00715910|19439811|P1|NOT COMPLETED|Year 1||0
7899894|NCT00715910|19439806|P6|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
7899895|NCT00715910|19439807|P5|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
7899896|NCT00715910|19439808|P4|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
7899897|NCT00715910|19439809|P3|COMPLETED|Year 1||68
7899898|NCT00715910|19439810|P2|COMPLETED|Year 1||147
7899899|NCT00715910|19439811|P1|COMPLETED|Year 1||433
7899900|NCT00715910|19439806|P6|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
7899901|NCT00715910|19439807|P5|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
7899902|NCT00715910|19439808|P4|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
7899903|NCT00715910|19439809|P3|STARTED|Year 1||68
7899904|NCT00715910|19439810|P2|STARTED|Year 1||147
7899905|NCT00715910|19439811|P1|STARTED|Year 1||433
7899906|NCT00715884|19439887|P2|NOT COMPLETED|Overall Study||1
7899907|NCT00715884|19439888|P1|NOT COMPLETED|Overall Study||8
7899908|NCT00715884|19439887|P2|COMPLETED|Overall Study||225
7899909|NCT00715884|19439888|P1|COMPLETED|Overall Study||444
7899910|NCT00715884|19439887|P2|STARTED|Overall Study||226
7899911|NCT00715884|19439888|P1|STARTED|Overall Study||452
7899912|NCT00715793|19439930|P2|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||2
7899913|NCT00715793|19439931|P1|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
7899914|NCT00715793|19439930|P2|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||27
7899915|NCT00715793|19439931|P1|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
7899916|NCT00715793|19439930|P2|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||29
7899917|NCT00715793|19439931|P1|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
7899918|NCT00715793|19439930|P2|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||0
7899919|NCT00715793|19439931|P1|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||1
7899920|NCT00715793|19439930|P2|COMPLETED|Phase 1 RP2D DAC + TMZ||6
7899921|NCT00715793|19439931|P1|COMPLETED|Phase 1 RP2D DAC + TMZ||3
7899922|NCT00715793|19439930|P2|STARTED|Phase 1 RP2D DAC + TMZ||6
7899923|NCT00715793|19439931|P1|STARTED|Phase 1 RP2D DAC + TMZ||4
7899924|NCT00715754|19439943|P1|NOT COMPLETED|Overall Study||0
7899925|NCT00715754|19439943|P1|COMPLETED|Overall Study||47
7899926|NCT00715754|19439943|P1|STARTED|Overall Study||47
7899927|NCT00715741|19439953|P4|NOT COMPLETED|Overall Study||0
7899928|NCT00715741|19439954|P3|NOT COMPLETED|Overall Study||0
7899929|NCT00715741|19439955|P2|NOT COMPLETED|Overall Study||0
7899930|NCT00715741|19439956|P1|NOT COMPLETED|Overall Study||0
7899931|NCT00715741|19439953|P4|COMPLETED|Overall Study||25
7899932|NCT00715741|19439954|P3|COMPLETED|Overall Study||25
7899933|NCT00715741|19439955|P2|COMPLETED|Overall Study||25
7899934|NCT00715741|19439956|P1|COMPLETED|Overall Study||25
7899935|NCT00715741|19439953|P4|STARTED|Overall Study||25
7899936|NCT00715741|19439954|P3|STARTED|Overall Study||25
7899937|NCT00715741|19439955|P2|STARTED|Overall Study||25
7899938|NCT00715741|19439956|P1|STARTED|Overall Study||25
7899939|NCT00715728|19439980|P2|NOT COMPLETED|Overall Study||0
7899940|NCT00715728|19439981|P1|NOT COMPLETED|Overall Study||0
7899941|NCT00715728|19439980|P2|COMPLETED|Overall Study||14
7899942|NCT00715728|19439981|P1|COMPLETED|Overall Study||14
7899943|NCT00715728|19439980|P2|STARTED|Overall Study||14
7899944|NCT00715728|19439981|P1|STARTED|Overall Study||14
7899945|NCT00715676|19439992|P3|NOT COMPLETED|Overall Study||32
7899946|NCT00715676|19439993|P2|NOT COMPLETED|Overall Study||11
7899947|NCT00715676|19439994|P1|NOT COMPLETED|Overall Study||6
7899948|NCT00715676|19439992|P3|COMPLETED|Overall Study||21
7899949|NCT00715676|19439993|P2|COMPLETED|Overall Study||43
7899950|NCT00715676|19439994|P1|COMPLETED|Overall Study||43
7899951|NCT00715676|19439992|P3|STARTED|Overall Study||53
7899952|NCT00715676|19439993|P2|STARTED|Overall Study||54
7899953|NCT00715676|19439994|P1|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49
7899954|NCT00715650|19440022|P2|NOT COMPLETED|Follow-up||5
7899955|NCT00715650|19440023|P1|NOT COMPLETED|Follow-up||13
7899956|NCT00715650|19440022|P2|COMPLETED|Follow-up||37
7899957|NCT00715650|19440023|P1|COMPLETED|Follow-up||29
7899958|NCT00715650|19440022|P2|Completed Month 6 Follow-up|Follow-up||37
7899959|NCT00715650|19440023|P1|Completed Month 6 Follow-up|Follow-up||29
7899960|NCT00715650|19440022|P2|Completed Month 3 Follow-up|Follow-up||40
7899961|NCT00715650|19440023|P1|Completed Month 3 Follow-up|Follow-up||35
7899962|NCT00715650|19440022|P2|Completed Month 1 Follow-up|Follow-up||38
7899963|NCT00715650|19440023|P1|Completed Month 1 Follow-up|Follow-up||40
7899964|NCT00715650|19440022|P2|STARTED|Follow-up||42
7899965|NCT00715650|19440023|P1|STARTED|Follow-up||42
7899966|NCT00715650|19440022|P2|NOT COMPLETED|Intervention||3
7899967|NCT00715650|19440023|P1|NOT COMPLETED|Intervention||5
7899968|NCT00715650|19440022|P2|COMPLETED|Intervention||42
7899969|NCT00715650|19440023|P1|COMPLETED|Intervention||42
7899970|NCT00715650|19440022|P2|Attended ≥ 3 Sessions|Intervention||17
7899971|NCT00715650|19440023|P1|Attended ≥ 3 Sessions|Intervention||23
7899972|NCT00715650|19440022|P2|Attended ≥ 2 Sessions|Intervention||33
7899973|NCT00715650|19440023|P1|Attended ≥ 2 Sessions|Intervention||36
7899974|NCT00715650|19440022|P2|Received Any Session|Intervention||38
7899975|NCT00715650|19440023|P1|Received Any Session|Intervention||39
7899976|NCT00715650|19440022|P2|STARTED|Intervention||45
7899977|NCT00715650|19440023|P1|STARTED|Intervention||47
7899978|NCT00715624|19440037|P2|NOT COMPLETED|Overall Study||116
7899979|NCT00715624|19440038|P1|NOT COMPLETED|Overall Study||52
7899980|NCT00715624|19440037|P2|COMPLETED|Overall Study||213
7899981|NCT00715624|19440038|P1|COMPLETED|Overall Study||115
7899982|NCT00715624|19440037|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||327
7899983|NCT00715624|19440038|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166
7899984|NCT00715624|19440037|P2|Treated/Safety Population|Overall Study||328
7899985|NCT00715624|19440038|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167
7899986|NCT00715624|19440037|P2|STARTED|Overall Study||329
7899987|NCT00715624|19440038|P1|STARTED|Overall Study|Randomized|167
7899988|NCT00715559|19440066|P1|NOT COMPLETED|Overall Study||1
7899989|NCT00715559|19440066|P1|COMPLETED|Overall Study||2
7899990|NCT00715559|19440066|P1|STARTED|Overall Study||3
7899991|NCT00715520|19440076|P3|NOT COMPLETED|Overall Study||2
7899992|NCT00715520|19440077|P2|NOT COMPLETED|Overall Study||1
7899993|NCT00715520|19440078|P1|NOT COMPLETED|Overall Study||10
7899994|NCT00715520|19440076|P3|COMPLETED|Overall Study||1
7899995|NCT00715520|19440077|P2|COMPLETED|Overall Study||9
7899996|NCT00715520|19440078|P1|COMPLETED|Overall Study||10
7899997|NCT00715520|19440076|P3|STARTED|Overall Study||3
7899998|NCT00715520|19440077|P2|STARTED|Overall Study||10
7899999|NCT00715520|19440078|P1|STARTED|Overall Study||20
7900000|NCT00715429|19440093|P2|NOT COMPLETED|Overall Study||1
7900001|NCT00715429|19440094|P1|NOT COMPLETED|Overall Study||0
7900002|NCT00715429|19440093|P2|COMPLETED|Overall Study||6
7900003|NCT00715429|19440094|P1|COMPLETED|Overall Study||7
7900004|NCT00715429|19440093|P2|STARTED|Overall Study||7
7900005|NCT00715429|19440094|P1|STARTED|Overall Study||7
7900006|NCT00715403|19440109|P7|NOT COMPLETED|Overall Study||1
7900007|NCT00715403|19440110|P6|NOT COMPLETED|Overall Study||19
7900008|NCT00715403|19440111|P5|NOT COMPLETED|Overall Study||6
7900009|NCT00715403|19440112|P4|NOT COMPLETED|Overall Study||9
7900010|NCT00715403|19440113|P3|NOT COMPLETED|Overall Study||4
7900011|NCT00715403|19440114|P2|NOT COMPLETED|Overall Study||1
7900012|NCT00715403|19440115|P1|NOT COMPLETED|Overall Study||1
7900013|NCT00715403|19440109|P7|COMPLETED|Overall Study||0
7900014|NCT00715403|19440110|P6|COMPLETED|Overall Study||0
7900015|NCT00715403|19440111|P5|COMPLETED|Overall Study||0
7900016|NCT00715403|19440112|P4|COMPLETED|Overall Study||0
7900017|NCT00715403|19440113|P3|COMPLETED|Overall Study||0
7900018|NCT00715403|19440114|P2|COMPLETED|Overall Study||0
7900019|NCT00715403|19440115|P1|COMPLETED|Overall Study||0
7900020|NCT00715403|19440109|P7|STARTED|Overall Study||1
7900021|NCT00715403|19440110|P6|STARTED|Overall Study||19
7900022|NCT00715403|19440111|P5|STARTED|Overall Study||6
7900023|NCT00715403|19440112|P4|STARTED|Overall Study||9
7900024|NCT00715403|19440113|P3|STARTED|Overall Study||4
7900025|NCT00715403|19440114|P2|STARTED|Overall Study||1
7900026|NCT00715403|19440115|P1|STARTED|Overall Study||1
7900027|NCT00715390|19440250|P1|NOT COMPLETED|Overall Study||0
7900028|NCT00715390|19440250|P1|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234
7900029|NCT00715390|19440250|P1|Eligible|Overall Study||234
7900030|NCT00715390|19440250|P1|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234
7900031|NCT00715299|19440254|P1|NOT COMPLETED|Overall Study||6
7900032|NCT00715299|19440254|P1|COMPLETED|Overall Study||30
7900033|NCT00715299|19440254|P1|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36
7900034|NCT00715208|19440260|P2|NOT COMPLETED|Overall Study||9
7900035|NCT00715208|19440261|P1|NOT COMPLETED|Overall Study||1
7900036|NCT00715208|19440260|P2|COMPLETED|Overall Study||39
7900037|NCT00715208|19440261|P1|COMPLETED|Overall Study||6
7900038|NCT00715208|19440260|P2|STARTED|Overall Study||48
7900039|NCT00715208|19440261|P1|STARTED|Overall Study||7
7900040|NCT00715117|19440277|P2|NOT COMPLETED|Overall Study||1
7900041|NCT00715117|19440278|P1|NOT COMPLETED|Overall Study||0
7900042|NCT00715117|19440277|P2|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5
7900043|NCT00715117|19440278|P1|COMPLETED|Overall Study||6
7900044|NCT00715117|19440277|P2|Completion fo 8 Week Study|Overall Study||6
7900045|NCT00715117|19440278|P1|Completion fo 8 Week Study|Overall Study||6
7900046|NCT00715117|19440277|P2|STARTED|Overall Study||6
7900047|NCT00715117|19440278|P1|STARTED|Overall Study||6
7900048|NCT00715104|19440292|P3|NOT COMPLETED|Overall Study||0
7900049|NCT00715104|19440293|P2|NOT COMPLETED|Overall Study||0
7900050|NCT00715104|19440294|P1|NOT COMPLETED|Overall Study||0
7900051|NCT00715104|19440292|P3|COMPLETED|Overall Study||8
7900052|NCT00715104|19440293|P2|COMPLETED|Overall Study||16
7900053|NCT00715104|19440294|P1|COMPLETED|Overall Study||18
7900054|NCT00715104|19440292|P3|STARTED|Overall Study||8
7900055|NCT00715104|19440293|P2|STARTED|Overall Study||16
7900056|NCT00715104|19440294|P1|STARTED|Overall Study||18
7900057|NCT00715078|19440346|P3|NOT COMPLETED|Overall Study||38
7900058|NCT00715078|19440347|P2|NOT COMPLETED|Overall Study||36
7900059|NCT00715078|19440348|P1|NOT COMPLETED|Overall Study||30
7900060|NCT00715078|19440346|P3|COMPLETED|Overall Study||3
7900061|NCT00715078|19440347|P2|COMPLETED|Overall Study||4
7900062|NCT00715078|19440348|P1|COMPLETED|Overall Study||11
7900063|NCT00715078|19440346|P3|Received ≥ 1 Leukapheresis|Overall Study||40
7900064|NCT00715078|19440347|P2|Received ≥ 1 Leukapheresis|Overall Study||40
7900065|NCT00715078|19440348|P1|Received ≥ 1 Leukapheresis|Overall Study||40
7900066|NCT00715078|19440346|P3|Received ≥ 1 Study Infusion|Overall Study||39
7900067|NCT00715078|19440347|P2|Received ≥ 1 Study Infusion|Overall Study||40
7900068|NCT00715078|19440348|P1|Received ≥ 1 Study Infusion|Overall Study||40
7900069|NCT00715078|19440346|P3|STARTED|Overall Study||41
7900070|NCT00715078|19440347|P2|STARTED|Overall Study||40
7900071|NCT00715078|19440348|P1|STARTED|Overall Study||41
7900072|NCT00715026|19440356|P1|NOT COMPLETED|Overall Study||10
7900073|NCT00715026|19440356|P1|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21
7900074|NCT00715026|19440356|P1|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25
7900075|NCT00715026|19440356|P1|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31
7900076|NCT00714948|19440361|P1|NOT COMPLETED|Overall Study||2
7900077|NCT00714948|19440361|P1|COMPLETED|Overall Study||0
7900078|NCT00714948|19440361|P1|STARTED|Overall Study||2
7900079|NCT00714870|19440367|P2|NOT COMPLETED|Overall Study||5
7900080|NCT00714870|19440368|P1|NOT COMPLETED|Overall Study||27
7900081|NCT00714870|19440367|P2|COMPLETED|Overall Study||22
7900082|NCT00714870|19440368|P1|COMPLETED|Overall Study||22
7900083|NCT00714870|19440367|P2|STARTED|Overall Study||27
7900084|NCT00714870|19440368|P1|STARTED|Overall Study||49
7900085|NCT00714792|19440376|P2|NOT COMPLETED|Overall Study||0
7900086|NCT00714792|19440377|P1|NOT COMPLETED|Overall Study||0
7900087|NCT00714792|19440376|P2|COMPLETED|Overall Study||8
7900088|NCT00714792|19440377|P1|COMPLETED|Overall Study||10
7900089|NCT00714792|19440376|P2|STARTED|Overall Study||8
7900090|NCT00714792|19440377|P1|STARTED|Overall Study||10
7900091|NCT00714753|19440383|P1|NOT COMPLETED|Overall Study||0
7900092|NCT00714753|19440383|P1|COMPLETED|Overall Study||5
7900093|NCT00714753|19440383|P1|External Beam Radiotherapy (EBRT)|Overall Study||1
7900094|NCT00714753|19440383|P1|HDR Brachytherapy|Overall Study||5
7900095|NCT00714753|19440383|P1|STARTED|Overall Study||5
7900096|NCT00714714|19440392|P1|NOT COMPLETED|Overall Study||1
7900097|NCT00714714|19440392|P1|COMPLETED|Overall Study||24
7900098|NCT00714714|19440392|P1|STARTED|Overall Study||25
7900099|NCT00714688|19440401|P3|NOT COMPLETED|Overall Study||37
7900100|NCT00714688|19440402|P2|NOT COMPLETED|Overall Study||35
7900101|NCT00714688|19440403|P1|NOT COMPLETED|Overall Study||29
7900102|NCT00714688|19440401|P3|COMPLETED|Overall Study||55
7900103|NCT00714688|19440402|P2|COMPLETED|Overall Study||55
7900104|NCT00714688|19440403|P1|COMPLETED|Overall Study||68
7900105|NCT00714688|19440401|P3|STARTED|Overall Study||92
7900106|NCT00714688|19440402|P2|STARTED|Overall Study||90
7900107|NCT00714688|19440403|P1|STARTED|Overall Study||97
7900108|NCT00714571|19440426|P6|NOT COMPLETED|Stage 2||0
7900109|NCT00714571|19440427|P5|NOT COMPLETED|Stage 2||0
7900110|NCT00714571|19440428|P4|NOT COMPLETED|Stage 2||0
7900111|NCT00714571|19440429|P3|NOT COMPLETED|Stage 2||0
7900112|NCT00714571|19440430|P2|NOT COMPLETED|Stage 2||0
7900113|NCT00714571|19440431|P1|NOT COMPLETED|Stage 2||0
7900114|NCT00714571|19440426|P6|COMPLETED|Stage 2||15
7900115|NCT00714571|19440427|P5|COMPLETED|Stage 2||15
7900116|NCT00714571|19440428|P4|COMPLETED|Stage 2||0
7900117|NCT00714571|19440429|P3|COMPLETED|Stage 2||0
7900118|NCT00714571|19440430|P2|COMPLETED|Stage 2||0
7900119|NCT00714571|19440431|P1|COMPLETED|Stage 2||0
7900120|NCT00714571|19440426|P6|STARTED|Stage 2||15
7900121|NCT00714571|19440427|P5|STARTED|Stage 2||15
7900122|NCT00714571|19440428|P4|STARTED|Stage 2||0
7900123|NCT00714571|19440429|P3|STARTED|Stage 2||0
7900124|NCT00714571|19440430|P2|STARTED|Stage 2||0
7900125|NCT00714571|19440431|P1|STARTED|Stage 2||0
7900126|NCT00714571|19440426|P6|NOT COMPLETED|Stage 1||0
7900127|NCT00714571|19440427|P5|NOT COMPLETED|Stage 1||0
7900128|NCT00714571|19440428|P4|NOT COMPLETED|Stage 1||0
7900129|NCT00714571|19440429|P3|NOT COMPLETED|Stage 1||1
7900130|NCT00714571|19440430|P2|NOT COMPLETED|Stage 1||0
7900131|NCT00714571|19440431|P1|NOT COMPLETED|Stage 1||0
7900132|NCT00714571|19440426|P6|COMPLETED|Stage 1||0
7900133|NCT00714571|19440427|P5|COMPLETED|Stage 1||0
7900134|NCT00714571|19440428|P4|COMPLETED|Stage 1||14
7900135|NCT00714571|19440429|P3|COMPLETED|Stage 1||10
7900136|NCT00714571|19440430|P2|COMPLETED|Stage 1||15
7900137|NCT00714571|19440431|P1|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12
7900138|NCT00714571|19440426|P6|STARTED|Stage 1||0
7900139|NCT00714571|19440427|P5|STARTED|Stage 1||0
7900140|NCT00714571|19440428|P4|STARTED|Stage 1||14
7900141|NCT00714571|19440429|P3|STARTED|Stage 1||11
7900142|NCT00714571|19440430|P2|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15
7900143|NCT00714571|19440431|P1|STARTED|Stage 1||12
7900144|NCT00714493|19440445|P1|NOT COMPLETED|Overall Study||49
7900145|NCT00714493|19440445|P1|COMPLETED|Overall Study||154
7900146|NCT00714493|19440445|P1|STARTED|Overall Study||203
7900147|NCT00714415|19440457|P2|NOT COMPLETED|Overall Study||0
7900148|NCT00714415|19440458|P1|NOT COMPLETED|Overall Study||2
7900149|NCT00714415|19440457|P2|COMPLETED|Overall Study||55
7900150|NCT00714415|19440458|P1|COMPLETED|Overall Study||23
7900151|NCT00714415|19440457|P2|STARTED|Overall Study||55
7900152|NCT00714415|19440458|P1|STARTED|Overall Study||25
7900153|NCT00714389|19440490|P1|NOT COMPLETED|Overall Study||0
7900154|NCT00714389|19440490|P1|COMPLETED|Overall Study||12
7900155|NCT00714389|19440490|P1|STARTED|Overall Study||12
7900156|NCT00714311|19440497|P2|NOT COMPLETED|Overall Study||22
7900157|NCT00714311|19440498|P1|NOT COMPLETED|Overall Study||13
7900158|NCT00714311|19440497|P2|COMPLETED|Overall Study||30
7900159|NCT00714311|19440498|P1|COMPLETED|Overall Study||39
7900160|NCT00714311|19440497|P2|STARTED|Overall Study||52
7900161|NCT00714311|19440498|P1|STARTED|Overall Study||52
7900162|NCT00714285|19440508|P4|NOT COMPLETED|Overall Study||1
7900163|NCT00714285|19440509|P3|NOT COMPLETED|Overall Study||0
7900164|NCT00714285|19440510|P2|NOT COMPLETED|Overall Study||3
7900165|NCT00714285|19440511|P1|NOT COMPLETED|Overall Study||0
7900166|NCT00714285|19440508|P4|COMPLETED|Overall Study|Completed upto Day 180|104
7900167|NCT00714285|19440509|P3|COMPLETED|Overall Study|Completed upto Day 180|105
7900168|NCT00714285|19440510|P2|COMPLETED|Overall Study|Completed upto Day 180|102
7900169|NCT00714285|19440511|P1|COMPLETED|Overall Study|Completed upto Day 180|105
7900170|NCT00714285|19440508|P4|STARTED|Overall Study||105
7900171|NCT00714285|19440509|P3|STARTED|Overall Study||105
7900172|NCT00714285|19440510|P2|STARTED|Overall Study||105
7900173|NCT00714285|19440511|P1|STARTED|Overall Study||105
7900174|NCT00714272|19440563|P2|NOT COMPLETED|Overall Study||0
7900175|NCT00714272|19440564|P1|NOT COMPLETED|Overall Study||0
7900176|NCT00714272|19440563|P2|COMPLETED|Overall Study||2
7900177|NCT00714272|19440564|P1|COMPLETED|Overall Study||2
7900178|NCT00714272|19440563|P2|STARTED|Overall Study||2
7900179|NCT00714272|19440564|P1|STARTED|Overall Study||2
7900180|NCT00714259|19440572|P1|NOT COMPLETED|Overall Study||2
7900181|NCT00714259|19440572|P1|COMPLETED|Overall Study||3
7900182|NCT00714259|19440572|P1|STARTED|Overall Study||5
7900183|NCT00714233|19440586|P4|NOT COMPLETED|Overall Study||4
7900184|NCT00714233|19440587|P3|NOT COMPLETED|Overall Study||1
7900185|NCT00714233|19440588|P2|NOT COMPLETED|Overall Study||1
7900186|NCT00714233|19440589|P1|NOT COMPLETED|Overall Study||4
7900187|NCT00714233|19440586|P4|COMPLETED|Overall Study||6
7900188|NCT00714233|19440587|P3|COMPLETED|Overall Study||10
7900189|NCT00714233|19440588|P2|COMPLETED|Overall Study||10
7900190|NCT00714233|19440589|P1|COMPLETED|Overall Study||6
7900191|NCT00714233|19440586|P4|STARTED|Overall Study||10
7900192|NCT00714233|19440587|P3|STARTED|Overall Study||11
7900193|NCT00714233|19440588|P2|STARTED|Overall Study||11
7900194|NCT00714233|19440589|P1|STARTED|Overall Study||10
7900195|NCT00714168|19440618|P2|NOT COMPLETED|Overall Study||59
7900196|NCT00714168|19440619|P1|NOT COMPLETED|Overall Study||44
7900197|NCT00714168|19440618|P2|COMPLETED|Overall Study||139
7900198|NCT00714168|19440619|P1|COMPLETED|Overall Study||121
7900199|NCT00714168|19440618|P2|STARTED|Overall Study||198
7900200|NCT00714168|19440619|P1|STARTED|Overall Study||165
7900201|NCT00714051|19440635|P2|NOT COMPLETED|Overall Study||1
7900202|NCT00714051|19440636|P1|NOT COMPLETED|Overall Study||1
7900203|NCT00714051|19440635|P2|COMPLETED|Overall Study||27
7900204|NCT00714051|19440636|P1|COMPLETED|Overall Study||26
7900205|NCT00714051|19440635|P2|STARTED|Overall Study||28
7900206|NCT00714051|19440636|P1|STARTED|Overall Study||27
7900207|NCT00713830|19440644|P2|NOT COMPLETED|Overall Study||177
7900208|NCT00713830|19440645|P1|NOT COMPLETED|Overall Study||82
7900209|NCT00713830|19440644|P2|COMPLETED|Overall Study||396
7900210|NCT00713830|19440645|P1|COMPLETED|Overall Study||204
7900211|NCT00713830|19440644|P2|Subgroup for Standardized Meal Test|Overall Study||313
7900212|NCT00713830|19440645|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155
7900213|NCT00713830|19440644|P2|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574
7900214|NCT00713830|19440645|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285
7900215|NCT00713830|19440644|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||570
7900216|NCT00713830|19440645|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286
7900217|NCT00713830|19440644|P2|STARTED|Overall Study||573
7900218|NCT00713830|19440645|P1|STARTED|Overall Study|Randomized.|286
7900219|NCT00713817|19440683|P2|NOT COMPLETED|Overall Study||0
7900220|NCT00713817|19440684|P1|NOT COMPLETED|Overall Study||0
7900221|NCT00713817|19440683|P2|COMPLETED|Overall Study||9
7900222|NCT00713817|19440684|P1|COMPLETED|Overall Study||10
7900223|NCT00713817|19440683|P2|STARTED|Overall Study||9
7900224|NCT00713817|19440684|P1|STARTED|Overall Study||10
7900225|NCT00713700|19440702|P1|NOT COMPLETED|Overall Study||4
7900226|NCT00713700|19440702|P1|COMPLETED|Overall Study||188
7900227|NCT00713700|19440702|P1|STARTED|Overall Study||192
7900228|NCT00713661|19440711|P4|NOT COMPLETED|Overall Study||0
7900229|NCT00713661|19440712|P3|NOT COMPLETED|Overall Study||0
7900230|NCT00713661|19440713|P2|NOT COMPLETED|Overall Study||0
7900231|NCT00713661|19440714|P1|NOT COMPLETED|Overall Study||0
7900232|NCT00713661|19440711|P4|COMPLETED|Overall Study||5
7900233|NCT00713661|19440712|P3|COMPLETED|Overall Study||4
7900234|NCT00713661|19440713|P2|COMPLETED|Overall Study||9
7900235|NCT00713661|19440714|P1|COMPLETED|Overall Study||7
7900236|NCT00713661|19440711|P4|STARTED|Overall Study||5
7900237|NCT00713661|19440712|P3|STARTED|Overall Study||4
7900238|NCT00713661|19440713|P2|STARTED|Overall Study||9
7900239|NCT00713661|19440714|P1|STARTED|Overall Study||7
7900240|NCT00713648|19440728|P1|NOT COMPLETED|Overall Study||8
7900241|NCT00713648|19440728|P1|COMPLETED|Overall Study||33
7900242|NCT00713648|19440728|P1|STARTED|Overall Study||41
7900243|NCT00713609|19440741|P6|NOT COMPLETED|Overall Study||8
7900244|NCT00713609|19440742|P5|NOT COMPLETED|Overall Study||19
7900245|NCT00713609|19440743|P4|NOT COMPLETED|Overall Study||9
7900246|NCT00713609|19440744|P3|NOT COMPLETED|Overall Study||15
7900247|NCT00713609|19440745|P2|NOT COMPLETED|Overall Study||15
7900248|NCT00713609|19440746|P1|NOT COMPLETED|Overall Study||21
7900249|NCT00713609|19440741|P6|COMPLETED|Overall Study||47
7900250|NCT00713609|19440742|P5|COMPLETED|Overall Study||87
7900251|NCT00713609|19440743|P4|COMPLETED|Overall Study||99
7900252|NCT00713609|19440744|P3|COMPLETED|Overall Study||92
7900253|NCT00713609|19440745|P2|COMPLETED|Overall Study||90
7900254|NCT00713609|19440746|P1|COMPLETED|Overall Study||85
7900255|NCT00713609|19440741|P6|STARTED|Overall Study||55
7900256|NCT00713609|19440742|P5|STARTED|Overall Study||106
7900257|NCT00713609|19440743|P4|STARTED|Overall Study||108
7900258|NCT00713609|19440744|P3|STARTED|Overall Study||107
7900259|NCT00713609|19440745|P2|STARTED|Overall Study||105
7900260|NCT00713609|19440746|P1|STARTED|Overall Study||106
7900261|NCT00713596|19440781|P3|NOT COMPLETED|Overall Study||2
7900262|NCT00713596|19440782|P2|NOT COMPLETED|Overall Study||3
7900263|NCT00713596|19440783|P1|NOT COMPLETED|Overall Study||2
7900264|NCT00713596|19440781|P3|COMPLETED|Overall Study||6
7900265|NCT00713596|19440782|P2|COMPLETED|Overall Study||5
7900266|NCT00713596|19440783|P1|COMPLETED|Overall Study||7
7900267|NCT00713596|19440781|P3|STARTED|Overall Study||8
7900268|NCT00713596|19440782|P2|STARTED|Overall Study||8
7900269|NCT00713596|19440783|P1|STARTED|Overall Study||9
7900270|NCT00713583|19440796|P2|NOT COMPLETED|Overall Study||0
7900271|NCT00713583|19440797|P1|NOT COMPLETED|Overall Study||0
7900272|NCT00713583|19440796|P2|COMPLETED|Overall Study||40
7900273|NCT00713583|19440797|P1|COMPLETED|Overall Study||45
7900274|NCT00713583|19440796|P2|STARTED|Overall Study||40
7900275|NCT00713583|19440797|P1|STARTED|Overall Study||45
7900276|NCT00713544|19440809|P6|NOT COMPLETED|Overall Study||9
7900277|NCT00713544|19440810|P5|NOT COMPLETED|Overall Study||8
7900278|NCT00713544|19440811|P4|NOT COMPLETED|Overall Study||10
7900279|NCT00713544|19440812|P3|NOT COMPLETED|Overall Study||11
7900280|NCT00713544|19440813|P2|NOT COMPLETED|Overall Study||6
7900281|NCT00713544|19440814|P1|NOT COMPLETED|Overall Study||7
7900282|NCT00713544|19440809|P6|COMPLETED|Overall Study||67
7900283|NCT00713544|19440810|P5|COMPLETED|Overall Study||57
7900284|NCT00713544|19440811|P4|COMPLETED|Overall Study||66
7900285|NCT00713544|19440812|P3|COMPLETED|Overall Study||41
7900286|NCT00713544|19440813|P2|COMPLETED|Overall Study||46
7900287|NCT00713544|19440814|P1|COMPLETED|Overall Study||45
7900288|NCT00713544|19440809|P6|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76
7900289|NCT00713544|19440810|P5|STARTED|Overall Study||65
7900290|NCT00713544|19440811|P4|STARTED|Overall Study||76
7900291|NCT00713544|19440812|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52
7900292|NCT00713544|19440813|P2|STARTED|Overall Study||52
7900293|NCT00713544|19440814|P1|STARTED|Overall Study||52
7900294|NCT00713479|19440852|P2|NOT COMPLETED|Next Medication Condition||0
7900295|NCT00713479|19440853|P1|NOT COMPLETED|Next Medication Condition||0
7900296|NCT00713479|19440852|P2|COMPLETED|Next Medication Condition||6
7900297|NCT00713479|19440853|P1|COMPLETED|Next Medication Condition||2
7900298|NCT00713479|19440852|P2|STARTED|Next Medication Condition||6
7900299|NCT00713479|19440853|P1|STARTED|Next Medication Condition||2
7900300|NCT00713479|19440852|P2|NOT COMPLETED|Washout||0
7900301|NCT00713479|19440853|P1|NOT COMPLETED|Washout||0
7900302|NCT00713479|19440852|P2|COMPLETED|Washout||6
7900303|NCT00713479|19440853|P1|COMPLETED|Washout||2
7900304|NCT00713479|19440852|P2|STARTED|Washout||6
7900305|NCT00713479|19440853|P1|STARTED|Washout||2
7900306|NCT00713479|19440852|P2|NOT COMPLETED|First Medication Condition||0
7900307|NCT00713479|19440853|P1|NOT COMPLETED|First Medication Condition||4
7900308|NCT00713479|19440852|P2|COMPLETED|First Medication Condition||6
7900309|NCT00713479|19440853|P1|COMPLETED|First Medication Condition||2
7900310|NCT00713479|19440852|P2|STARTED|First Medication Condition||6
7900311|NCT00713479|19440853|P1|STARTED|First Medication Condition||6
7900312|NCT00713349|19440865|P1|NOT COMPLETED|Overall Study||1
7900313|NCT00713349|19440865|P1|COMPLETED|Overall Study||24
7900314|NCT00713349|19440865|P1|STARTED|Overall Study||25
7900315|NCT00713323|19440871|P1|NOT COMPLETED|Overall Study||146
7900316|NCT00713323|19440871|P1|COMPLETED|Overall Study||234
7900317|NCT00713323|19440871|P1|STARTED|Overall Study||380
7900318|NCT00713310|19440884|P2|NOT COMPLETED|Overall Study||6
7900319|NCT00713310|19440885|P1|NOT COMPLETED|Overall Study||5
7900320|NCT00713310|19440884|P2|COMPLETED|Overall Study||36
7900321|NCT00713310|19440885|P1|COMPLETED|Overall Study||36
7900322|NCT00713310|19440884|P2|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41
7900323|NCT00713310|19440885|P1|mITT Population|Overall Study||41
7900324|NCT00713310|19440884|P2|STARTED|Overall Study||42
7900325|NCT00713310|19440885|P1|STARTED|Overall Study||41
7900326|NCT00713284|19440893|P1|NOT COMPLETED|Overall Study||16
7900327|NCT00713284|19440893|P1|COMPLETED|Overall Study||13
7900328|NCT00713284|19440893|P1|STARTED|Overall Study|29 participants were screened but only 13 eligible for conversion and continue in the study.|29
7900329|NCT00713258|19440899|P2|NOT COMPLETED|Overall Study||6
7900330|NCT00713258|19440900|P1|NOT COMPLETED|Overall Study||5
7900331|NCT00713258|19440899|P2|COMPLETED|Overall Study||28
7900332|NCT00713258|19440900|P1|COMPLETED|Overall Study||36
7900333|NCT00713258|19440899|P2|STARTED|Overall Study||34
7900334|NCT00713258|19440900|P1|STARTED|Overall Study||41
7900335|NCT00713219|19440908|P1|NOT COMPLETED|Overall Study||2
7900336|NCT00713219|19440908|P1|COMPLETED|Overall Study||12
7900337|NCT00713219|19440908|P1|STARTED|Overall Study||14
7900338|NCT00713206|19440914|P2|NOT COMPLETED|Overall Study||3
7900339|NCT00713206|19440915|P1|NOT COMPLETED|Overall Study||7
7900340|NCT00713206|19440914|P2|COMPLETED|Overall Study||27
7900341|NCT00713206|19440915|P1|COMPLETED|Overall Study||55
7900342|NCT00713206|19440914|P2|STARTED|Overall Study||30
7900343|NCT00713206|19440915|P1|STARTED|Overall Study||62
7900344|NCT00712985|19440921|P1|NOT COMPLETED|Overall Study||5
7900345|NCT00712985|19440921|P1|COMPLETED|Overall Study||13
7900346|NCT00712985|19440921|P1|STARTED|Overall Study||18
7900347|NCT00712959|19440927|P2|NOT COMPLETED|Overall Study||3
7900348|NCT00712959|19440928|P1|NOT COMPLETED|Overall Study||19
7900349|NCT00712959|19440927|P2|COMPLETED|Overall Study||404
7900350|NCT00712959|19440928|P1|COMPLETED|Overall Study||342
7900351|NCT00712959|19440927|P2|STARTED|Overall Study||407
7900352|NCT00712959|19440928|P1|STARTED|Overall Study||361
7900353|NCT00712933|19440946|P1|NOT COMPLETED|Overall Study||367
7900354|NCT00712933|19440946|P1|COMPLETED|Overall Study||368
7900355|NCT00712933|19440946|P1|STARTED|Overall Study||735
7900356|NCT00712920|19440976|P3|NOT COMPLETED|Overall Study||12
7900357|NCT00712920|19440977|P2|NOT COMPLETED|Overall Study||17
7900358|NCT00712920|19440978|P1|NOT COMPLETED|Overall Study||17
7900359|NCT00712920|19440976|P3|COMPLETED|Overall Study||180
7900360|NCT00712920|19440977|P2|COMPLETED|Overall Study||180
7900361|NCT00712920|19440978|P1|COMPLETED|Overall Study||175
7900362|NCT00712920|19440976|P3|STARTED|Overall Study||192
7900363|NCT00712920|19440977|P2|STARTED|Overall Study|3 subjects were randomized in error|197
7900364|NCT00712920|19440978|P1|STARTED|Overall Study||192
7900365|NCT00712725|19441006|P8|NOT COMPLETED|Overall Study||11
7900366|NCT00712725|19441007|P7|NOT COMPLETED|Overall Study||22
7900367|NCT00712725|19441008|P6|NOT COMPLETED|Overall Study||16
7900368|NCT00712725|19441009|P5|NOT COMPLETED|Overall Study||19
7900369|NCT00712725|19441010|P4|NOT COMPLETED|Overall Study||17
7900370|NCT00712725|19441011|P3|NOT COMPLETED|Overall Study||10
7900371|NCT00712725|19441012|P2|NOT COMPLETED|Overall Study||6
7900372|NCT00712725|19441013|P1|NOT COMPLETED|Overall Study||29
7900373|NCT00712725|19441006|P8|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63
7900374|NCT00712725|19441007|P7|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61
7900375|NCT00712725|19441008|P6|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68
7900376|NCT00712725|19441009|P5|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
7900377|NCT00712725|19441010|P4|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
7900378|NCT00712725|19441011|P3|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47
7900379|NCT00712725|19441012|P2|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33
7900380|NCT00712725|19441013|P1|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140
7900381|NCT00712725|19441006|P8|STARTED|Overall Study||74
7900382|NCT00712725|19441007|P7|STARTED|Overall Study||83
7900383|NCT00712725|19441008|P6|STARTED|Overall Study||84
7900384|NCT00712725|19441009|P5|STARTED|Overall Study||86
7900385|NCT00712725|19441010|P4|STARTED|Overall Study||84
7900386|NCT00712725|19441011|P3|STARTED|Overall Study||57
7900387|NCT00712725|19441012|P2|STARTED|Overall Study||39
7900388|NCT00712725|19441013|P1|STARTED|Overall Study||169
7900389|NCT00712673|19441074|P4|NOT COMPLETED|Overall Study||70
7900390|NCT00712673|19441075|P3|NOT COMPLETED|Overall Study||57
7900391|NCT00712673|19441076|P2|NOT COMPLETED|Overall Study||21
7900392|NCT00712673|19441077|P1|NOT COMPLETED|Overall Study||21
7900393|NCT00712673|19441074|P4|COMPLETED|Overall Study||185
7900394|NCT00712673|19441075|P3|COMPLETED|Overall Study||198
7900395|NCT00712673|19441076|P2|COMPLETED|Overall Study||64
7900396|NCT00712673|19441077|P1|COMPLETED|Overall Study||64
7900397|NCT00712673|19441074|P4|Subgroup for Standardized Meal Test|Overall Study||0
7900398|NCT00712673|19441075|P3|Subgroup for Standardized Meal Test|Overall Study||255
7900399|NCT00712673|19441076|P2|Subgroup for Standardized Meal Test|Overall Study||0
7900400|NCT00712673|19441077|P1|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85
7900401|NCT00712673|19441074|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||255
7900402|NCT00712673|19441075|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||255
7900403|NCT00712673|19441076|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||85
7900404|NCT00712673|19441077|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85
7900405|NCT00712673|19441074|P4|Safety Population|Overall Study||255
7900406|NCT00712673|19441075|P3|Safety Population|Overall Study||255
7900407|NCT00712673|19441076|P2|Safety Population|Overall Study||85
7900408|NCT00712673|19441077|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85
7900409|NCT00712673|19441074|P4|STARTED|Overall Study||255
7900410|NCT00712673|19441075|P3|STARTED|Overall Study||255
7900411|NCT00712673|19441076|P2|STARTED|Overall Study||85
7900412|NCT00712673|19441077|P1|STARTED|Overall Study|Randomized.|85
7900413|NCT00712543|19441141|P2|NOT COMPLETED|Day 8-14||2
7900414|NCT00712543|19441142|P1|NOT COMPLETED|Day 8-14||0
7900415|NCT00712543|19441141|P2|COMPLETED|Day 8-14||25
7900416|NCT00712543|19441142|P1|COMPLETED|Day 8-14||23
7900417|NCT00712543|19441141|P2|STARTED|Day 8-14||27
7900418|NCT00712543|19441142|P1|STARTED|Day 8-14||23
7900419|NCT00712543|19441141|P2|NOT COMPLETED|Day 1-7||0
7900420|NCT00712543|19441142|P1|NOT COMPLETED|Day 1-7||0
7900421|NCT00712543|19441141|P2|COMPLETED|Day 1-7||27
7900422|NCT00712543|19441142|P1|COMPLETED|Day 1-7||23
7900423|NCT00712543|19441141|P2|STARTED|Day 1-7||27
7900424|NCT00712543|19441142|P1|STARTED|Day 1-7||23
7900425|NCT00712530|19441151|P3|NOT COMPLETED|Overall Study||0
7900426|NCT00712530|19441152|P2|NOT COMPLETED|Overall Study||0
7900427|NCT00712530|19441153|P1|NOT COMPLETED|Overall Study||0
7900428|NCT00712530|19441151|P3|COMPLETED|Overall Study||3
7900429|NCT00712530|19441152|P2|COMPLETED|Overall Study||3
7900430|NCT00712530|19441153|P1|COMPLETED|Overall Study||3
7900431|NCT00712530|19441151|P3|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3
7900432|NCT00712530|19441152|P2|STARTED|Overall Study||3
7900433|NCT00712530|19441153|P1|STARTED|Overall Study||3
7900434|NCT00712348|19441176|P1|NOT COMPLETED|Overall Study||1
7900435|NCT00712348|19441176|P1|COMPLETED|Overall Study||30
7900436|NCT00712348|19441176|P1|STARTED|Overall Study||31
7900437|NCT00712335|19441188|P5|NOT COMPLETED|Overall Study||0
7900438|NCT00712335|19441189|P4|NOT COMPLETED|Overall Study||5
7900439|NCT00712335|19441190|P3|NOT COMPLETED|Overall Study||5
7900440|NCT00712335|19441191|P2|NOT COMPLETED|Overall Study||17
7900441|NCT00712335|19441192|P1|NOT COMPLETED|Overall Study||3
7900442|NCT00712335|19441188|P5|COMPLETED|Overall Study||30
7900443|NCT00712335|19441189|P4|COMPLETED|Overall Study||19
7900444|NCT00712335|19441190|P3|COMPLETED|Overall Study||6
7900445|NCT00712335|19441191|P2|COMPLETED|Overall Study||15
7900446|NCT00712335|19441192|P1|COMPLETED|Overall Study||5
7900447|NCT00712335|19441188|P5|STARTED|Overall Study||30
7900448|NCT00712335|19441189|P4|STARTED|Overall Study||24
7900449|NCT00712335|19441190|P3|STARTED|Overall Study||11
7900450|NCT00712335|19441191|P2|STARTED|Overall Study||32
7900451|NCT00712335|19441192|P1|STARTED|Overall Study||8
7900452|NCT00712296|19441239|P5|NOT COMPLETED|Phase II (28 Weeks)||12
7900453|NCT00712296|19441240|P4|NOT COMPLETED|Phase II (28 Weeks)||15
7900454|NCT00712296|19441241|P3|NOT COMPLETED|Phase II (28 Weeks)||13
7900455|NCT00712296|19441242|P2|NOT COMPLETED|Phase II (28 Weeks)||0
7900456|NCT00712296|19441243|P1|NOT COMPLETED|Phase II (28 Weeks)||0
7900457|NCT00712296|19441239|P5|COMPLETED|Phase II (28 Weeks)||3
7900458|NCT00712296|19441240|P4|COMPLETED|Phase II (28 Weeks)||1
7900459|NCT00712296|19441241|P3|COMPLETED|Phase II (28 Weeks)|ASHMI/Placebo was discontinued on 9/29/10.20 participants were re-randomized into the Phase II.|2
7900460|NCT00712296|19441242|P2|COMPLETED|Phase II (28 Weeks)||0
7900461|NCT00712296|19441243|P1|COMPLETED|Phase II (28 Weeks)||0
7900462|NCT00712296|19441239|P5|STARTED|Phase II (28 Weeks)||15
7900463|NCT00712296|19441240|P4|STARTED|Phase II (28 Weeks)||16
7900464|NCT00712296|19441241|P3|STARTED|Phase II (28 Weeks)||15
7900465|NCT00712296|19441242|P2|STARTED|Phase II (28 Weeks)||0
7900466|NCT00712296|19441243|P1|STARTED|Phase II (28 Weeks)||0
7900467|NCT00712296|19441239|P5|NOT COMPLETED|Phase I ( 1 Week)||0
7900468|NCT00712296|19441240|P4|NOT COMPLETED|Phase I ( 1 Week)||0
7900469|NCT00712296|19441241|P3|NOT COMPLETED|Phase I ( 1 Week)||0
7900470|NCT00712296|19441242|P2|NOT COMPLETED|Phase I ( 1 Week)||0
7900471|NCT00712296|19441243|P1|NOT COMPLETED|Phase I ( 1 Week)||0
7900472|NCT00712296|19441239|P5|COMPLETED|Phase I ( 1 Week)||0
7900473|NCT00712296|19441240|P4|COMPLETED|Phase I ( 1 Week)||0
7900474|NCT00712296|19441241|P3|COMPLETED|Phase I ( 1 Week)||0
7900475|NCT00712296|19441242|P2|COMPLETED|Phase I ( 1 Week)||8
7900476|NCT00712296|19441243|P1|COMPLETED|Phase I ( 1 Week)||12
7900477|NCT00712296|19441239|P5|STARTED|Phase I ( 1 Week)||0
7900478|NCT00712296|19441240|P4|STARTED|Phase I ( 1 Week)||0
7900479|NCT00712296|19441241|P3|STARTED|Phase I ( 1 Week)||0
7900480|NCT00712296|19441242|P2|STARTED|Phase I ( 1 Week)||8
7900481|NCT00712296|19441243|P1|STARTED|Phase I ( 1 Week)||12
7900482|NCT00712270|19441322|P1|NOT COMPLETED|Overall Study||14
7900483|NCT00712270|19441322|P1|COMPLETED|Overall Study||7
7900484|NCT00712270|19441322|P1|STARTED|Overall Study||21
7900485|NCT00712244|19441335|P4|NOT COMPLETED|Overall Study||1
7900486|NCT00712244|19441336|P3|NOT COMPLETED|Overall Study||2
7900487|NCT00712244|19441337|P2|NOT COMPLETED|Overall Study||1
7900488|NCT00712244|19441338|P1|NOT COMPLETED|Overall Study||4
7900489|NCT00712244|19441335|P4|COMPLETED|Overall Study||26
7900490|NCT00712244|19441336|P3|COMPLETED|Overall Study||25
7900491|NCT00712244|19441337|P2|COMPLETED|Overall Study||28
7900492|NCT00712244|19441338|P1|COMPLETED|Overall Study||25
7900493|NCT00712244|19441335|P4|STARTED|Overall Study||27
7900494|NCT00712244|19441336|P3|STARTED|Overall Study||27
7900495|NCT00712244|19441337|P2|STARTED|Overall Study||29
7900496|NCT00712244|19441338|P1|STARTED|Overall Study||29
7900497|NCT00712179|19441380|P1|NOT COMPLETED|Overall Study||12
7900498|NCT00712179|19441380|P1|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37
7900499|NCT00712179|19441380|P1|STARTED|Overall Study||49
7900500|NCT00712166|19441386|P2|NOT COMPLETED|Overall Study||1
7900501|NCT00712166|19441387|P1|NOT COMPLETED|Overall Study||0
7900502|NCT00712166|19441386|P2|COMPLETED|Overall Study||75
7900503|NCT00712166|19441387|P1|COMPLETED|Overall Study||81
7900504|NCT00712166|19441386|P2|STARTED|Overall Study||76
7900505|NCT00712166|19441387|P1|STARTED|Overall Study||81
7900506|NCT00712075|19441414|P3|NOT COMPLETED|Overall Study||11
7900507|NCT00712075|19441415|P2|NOT COMPLETED|Overall Study||4
7900508|NCT00712075|19441416|P1|NOT COMPLETED|Overall Study||5
7900509|NCT00712075|19441414|P3|COMPLETED|Overall Study||14
7900510|NCT00712075|19441415|P2|COMPLETED|Overall Study||26
7900511|NCT00712075|19441416|P1|COMPLETED|Overall Study||17
7900512|NCT00712075|19441414|P3|STARTED|Overall Study||25
7900513|NCT00712075|19441415|P2|STARTED|Overall Study||30
7900514|NCT00712075|19441416|P1|STARTED|Overall Study||22
7900515|NCT00712010|19441430|P1|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0
7900516|NCT00712010|19441430|P1|COMPLETED|7th and Last Protein Testing (1 Day)||23
7900517|NCT00712010|19441430|P1|STARTED|7th and Last Protein Testing (1 Day)||23
7900518|NCT00712010|19441430|P1|NOT COMPLETED|Washout (7 Days)||0
7900519|NCT00712010|19441430|P1|COMPLETED|Washout (7 Days)||23
7900520|NCT00712010|19441430|P1|STARTED|Washout (7 Days)||23
7900521|NCT00712010|19441430|P1|NOT COMPLETED|6th Protein Testing (1 Day)||0
7900522|NCT00712010|19441430|P1|COMPLETED|6th Protein Testing (1 Day)||23
7900523|NCT00712010|19441430|P1|STARTED|6th Protein Testing (1 Day)||23
7900524|NCT00712010|19441430|P1|NOT COMPLETED|Washout (7 Days)||0
7900525|NCT00712010|19441430|P1|COMPLETED|Washout (7 Days)||23
7900526|NCT00712010|19441430|P1|STARTED|Washout (7 Days)||23
7900527|NCT00712010|19441430|P1|NOT COMPLETED|5th Protein Testing (1 Day)||0
7900528|NCT00712010|19441430|P1|COMPLETED|5th Protein Testing (1 Day)||23
7900529|NCT00712010|19441430|P1|STARTED|5th Protein Testing (1 Day)||23
7900530|NCT00712010|19441430|P1|NOT COMPLETED|Washout (7 Days)||1
7900531|NCT00712010|19441430|P1|COMPLETED|Washout (7 Days)||23
7900532|NCT00712010|19441430|P1|STARTED|Washout (7 Days)||24
7900533|NCT00712010|19441430|P1|NOT COMPLETED|4th Protein Testing (1 Day)||0
7900534|NCT00712010|19441430|P1|COMPLETED|4th Protein Testing (1 Day)||24
7900535|NCT00712010|19441430|P1|STARTED|4th Protein Testing (1 Day)||24
7900536|NCT00712010|19441430|P1|NOT COMPLETED|Washout (7 Days)||0
7900537|NCT00712010|19441430|P1|COMPLETED|Washout (7 Days)||24
7900538|NCT00712010|19441430|P1|STARTED|Washout (7 Days)||24
7900539|NCT00712010|19441430|P1|NOT COMPLETED|3rd Protein Testing (1 Day)||0
7900540|NCT00712010|19441430|P1|COMPLETED|3rd Protein Testing (1 Day)||24
7900541|NCT00712010|19441430|P1|STARTED|3rd Protein Testing (1 Day)||24
7900542|NCT00712010|19441430|P1|NOT COMPLETED|Washout (7 Days)||0
7900543|NCT00712010|19441430|P1|COMPLETED|Washout (7 Days)||24
7900544|NCT00712010|19441430|P1|STARTED|Washout (7 Days)||24
7900545|NCT00712010|19441430|P1|NOT COMPLETED|2nd Protein Testing (1 Day)||0
7900546|NCT00712010|19441430|P1|COMPLETED|2nd Protein Testing (1 Day)||24
7900547|NCT00712010|19441430|P1|STARTED|2nd Protein Testing (1 Day)||24
7900548|NCT00712010|19441430|P1|NOT COMPLETED|Washout (7 Days)||0
7900549|NCT00712010|19441430|P1|COMPLETED|Washout (7 Days)||24
7900550|NCT00712010|19441430|P1|STARTED|Washout (7 Days)||24
7900551|NCT00712010|19441430|P1|NOT COMPLETED|1st Protein Testing (1 Day)||0
7900552|NCT00712010|19441430|P1|COMPLETED|1st Protein Testing (1 Day)||24
7900553|NCT00712010|19441430|P1|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24
7900554|NCT00711997|19441455|P2|NOT COMPLETED|Overall Study||0
7900555|NCT00711997|19441456|P1|NOT COMPLETED|Overall Study||0
7900556|NCT00711997|19441455|P2|COMPLETED|Overall Study||6
7900557|NCT00711997|19441456|P1|COMPLETED|Overall Study||3
7900558|NCT00711997|19441455|P2|STARTED|Overall Study||6
7900559|NCT00711997|19441456|P1|STARTED|Overall Study||3
7900560|NCT00711971|19441469|P3|NOT COMPLETED|Overall Study||1
7900561|NCT00711971|19441470|P2|NOT COMPLETED|Overall Study||4
7900562|NCT00711971|19441471|P1|NOT COMPLETED|Overall Study||3
7900563|NCT00711971|19441469|P3|COMPLETED|Overall Study||41
7900564|NCT00711971|19441470|P2|COMPLETED|Overall Study||38
7900565|NCT00711971|19441471|P1|COMPLETED|Overall Study||39
7900566|NCT00711971|19441469|P3|STARTED|Overall Study||42
7900567|NCT00711971|19441470|P2|STARTED|Overall Study||42
7900568|NCT00711971|19441471|P1|STARTED|Overall Study||42
7900569|NCT00711958|19441505|P2|NOT COMPLETED|Overall Study||23
7900570|NCT00711958|19441506|P1|NOT COMPLETED|Overall Study||33
7900571|NCT00711958|19441505|P2|COMPLETED|Overall Study||17
7900572|NCT00711958|19441506|P1|COMPLETED|Overall Study||41
7900573|NCT00711958|19441505|P2|STARTED|Overall Study||40
7900574|NCT00711958|19441506|P1|STARTED|Overall Study||74
7900575|NCT00711880|19441514|P2|NOT COMPLETED|Overall Study||7
7900576|NCT00711880|19441515|P1|NOT COMPLETED|Overall Study||13
7900577|NCT00711880|19441514|P2|COMPLETED|Overall Study||55
7900578|NCT00711880|19441515|P1|COMPLETED|Overall Study||50
7900579|NCT00711880|19441514|P2|STARTED|Overall Study||62
7900580|NCT00711880|19441515|P1|STARTED|Overall Study||63
7900581|NCT00711867|19441553|P2|NOT COMPLETED|Overall Study||4
7900582|NCT00711867|19441554|P1|NOT COMPLETED|Overall Study||5
7900583|NCT00711867|19441553|P2|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21
7900584|NCT00711867|19441554|P1|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25
7900585|NCT00711867|19441553|P2|STARTED|Overall Study||25
7900586|NCT00711867|19441554|P1|STARTED|Overall Study||30
7900587|NCT00711828|19441560|P1|NOT COMPLETED|Overall Study||0
7900588|NCT00711828|19441560|P1|COMPLETED|Overall Study||21
7900589|NCT00711828|19441560|P1|STARTED|Overall Study||21
7900590|NCT00711802|19441577|P8|NOT COMPLETED|Overall Study||2
7900591|NCT00711802|19441578|P7|NOT COMPLETED|Overall Study||5
7900592|NCT00711802|19441579|P6|NOT COMPLETED|Overall Study||8
7900593|NCT00711802|19441580|P5|NOT COMPLETED|Overall Study||14
7900594|NCT00711802|19441581|P4|NOT COMPLETED|Overall Study||3
7900595|NCT00711802|19441582|P3|NOT COMPLETED|Overall Study||6
7900596|NCT00711802|19441583|P2|NOT COMPLETED|Overall Study||6
7900597|NCT00711802|19441584|P1|NOT COMPLETED|Overall Study||2
7900598|NCT00711802|19441577|P8|COMPLETED|Overall Study||13
7900599|NCT00711802|19441578|P7|COMPLETED|Overall Study||25
7900600|NCT00711802|19441579|P6|COMPLETED|Overall Study||34
7900601|NCT00711802|19441580|P5|COMPLETED|Overall Study||69
7900602|NCT00711802|19441581|P4|COMPLETED|Overall Study||35
7900603|NCT00711802|19441582|P3|COMPLETED|Overall Study||69
7900604|NCT00711802|19441583|P2|COMPLETED|Overall Study||32
7900605|NCT00711802|19441584|P1|COMPLETED|Overall Study||73
7900606|NCT00711802|19441577|P8|Received at Least 1 Dose of Study Drug|Overall Study||15
7900607|NCT00711802|19441578|P7|Received at Least 1 Dose of Study Drug|Overall Study||30
7900608|NCT00711802|19441579|P6|Received at Least 1 Dose of Study Drug|Overall Study||42
7900609|NCT00711802|19441580|P5|Received at Least 1 Dose of Study Drug|Overall Study||81
7900610|NCT00711802|19441581|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
7900611|NCT00711802|19441582|P3|Received at Least 1 Dose of Study Drug|Overall Study||73
7900612|NCT00711802|19441583|P2|Received at Least 1 Dose of Study Drug|Overall Study||37
7900613|NCT00711802|19441584|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
7900614|NCT00711802|19441577|P8|STARTED|Overall Study||15
7900615|NCT00711802|19441578|P7|STARTED|Overall Study||30
7900616|NCT00711802|19441579|P6|STARTED|Overall Study||42
7900617|NCT00711802|19441580|P5|STARTED|Overall Study||83
7900618|NCT00711802|19441581|P4|STARTED|Overall Study||38
7900619|NCT00711802|19441582|P3|STARTED|Overall Study||75
7900620|NCT00711802|19441583|P2|STARTED|Overall Study||38
7900621|NCT00711802|19441584|P1|STARTED|Overall Study||75
7900622|NCT00711711|19441616|P2|NOT COMPLETED|Overall Study||6
7900623|NCT00711711|19441617|P1|NOT COMPLETED|Overall Study||1
7900624|NCT00711711|19441616|P2|COMPLETED|Overall Study||24
7900625|NCT00711711|19441617|P1|COMPLETED|Overall Study||29
7900626|NCT00711711|19441616|P2|Seventh Postsurgical Day|Overall Study||27
7900627|NCT00711711|19441617|P1|Seventh Postsurgical Day|Overall Study||29
7900628|NCT00711711|19441616|P2|Second Postsurgical Day|Overall Study||30
7900629|NCT00711711|19441617|P1|Second Postsurgical Day|Overall Study||30
7900630|NCT00711711|19441616|P2|STARTED|Overall Study||30
7900631|NCT00711711|19441617|P1|STARTED|Overall Study||30
7900632|NCT00711646|19441627|P2|NOT COMPLETED|Overall Study||3
7900633|NCT00711646|19441628|P1|NOT COMPLETED|Overall Study||12
7900634|NCT00711646|19441627|P2|COMPLETED|Overall Study||62
7900635|NCT00711646|19441628|P1|COMPLETED|Overall Study||112
7900636|NCT00711646|19441627|P2|STARTED|Overall Study||65
7900637|NCT00711646|19441628|P1|STARTED|Overall Study||124
7900638|NCT00711594|19441650|P4|NOT COMPLETED|Overall Study||62
7900639|NCT00711594|19441651|P3|NOT COMPLETED|Overall Study||6
7900640|NCT00711594|19441652|P2|NOT COMPLETED|Overall Study||3
7900641|NCT00711594|19441653|P1|NOT COMPLETED|Overall Study||3
7900642|NCT00711594|19441650|P4|COMPLETED|Overall Study||0
7900643|NCT00711594|19441651|P3|COMPLETED|Overall Study||0
7900644|NCT00711594|19441652|P2|COMPLETED|Overall Study||0
7900645|NCT00711594|19441653|P1|COMPLETED|Overall Study||0
7900646|NCT00711594|19441650|P4|STARTED|Overall Study||62
7900647|NCT00711594|19441651|P3|STARTED|Overall Study||6
7900648|NCT00711594|19441652|P2|STARTED|Overall Study||3
7900649|NCT00711594|19441653|P1|STARTED|Overall Study||3
7900650|NCT00711555|19441690|P1|NOT COMPLETED|Overall Study||3
7900651|NCT00711555|19441690|P1|COMPLETED|Overall Study||19
7900652|NCT00711555|19441690|P1|STARTED|Overall Study||22
7900653|NCT00711529|19441699|P2|NOT COMPLETED|Overall Study||6
7900654|NCT00711529|19441700|P1|NOT COMPLETED|Overall Study||4
7900655|NCT00711529|19441699|P2|COMPLETED|Overall Study||8
7900656|NCT00711529|19441700|P1|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9
7900657|NCT00711529|19441699|P2|STARTED|Overall Study||14
7900658|NCT00711529|19441700|P1|STARTED|Overall Study||13
7900659|NCT00711516|19441724|P2|NOT COMPLETED|Overall Study||3
7900660|NCT00711516|19441725|P1|NOT COMPLETED|Overall Study||1
7900661|NCT00711516|19441724|P2|COMPLETED|Overall Study||16
7900662|NCT00711516|19441725|P1|COMPLETED|Overall Study||20
7900663|NCT00711516|19441724|P2|STARTED|Overall Study||19
7900664|NCT00711516|19441725|P1|STARTED|Overall Study||21
7900665|NCT00711490|19441819|P1|NOT COMPLETED|Overall Study||0
7900666|NCT00711490|19441819|P1|COMPLETED|Overall Study||5
7900667|NCT00711490|19441819|P1|STARTED|Overall Study||5
7900668|NCT00711477|19441832|P2|NOT COMPLETED|Overall Study||3
7900669|NCT00711477|19441833|P1|NOT COMPLETED|Overall Study||3
7900670|NCT00711477|19441832|P2|COMPLETED|Overall Study||20
7900671|NCT00711477|19441833|P1|COMPLETED|Overall Study||20
7900672|NCT00711477|19441832|P2|STARTED|Overall Study||23
7900673|NCT00711477|19441833|P1|STARTED|Overall Study||23
7900674|NCT00711464|19441861|P1|NOT COMPLETED|Overall Study||0
7900675|NCT00711464|19441861|P1|COMPLETED|Overall Study||29
7900676|NCT00711464|19441861|P1|STARTED|Overall Study||29
7900677|NCT00711425|19441879|P1|NOT COMPLETED|Overall Study||4
7900678|NCT00711425|19441879|P1|COMPLETED|Overall Study||41
7900679|NCT00711425|19441879|P1|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45
7900680|NCT00711412|19441885|P1|NOT COMPLETED|Survival Follow up Until Death||12
7900681|NCT00711412|19441885|P1|COMPLETED|Survival Follow up Until Death||26
7900682|NCT00711412|19441885|P1|STARTED|Survival Follow up Until Death|All patients that received treatment went into follow up period.|38
7900683|NCT00711412|19441885|P1|NOT COMPLETED|Evaluation for Response and Surgery||6
7900684|NCT00711412|19441885|P1|COMPLETED|Evaluation for Response and Surgery||28
7900685|NCT00711412|19441885|P1|STARTED|Evaluation for Response and Surgery|1 patient only completed 2 cycles of therapy was evaluated and eligible for surgical resection.|34
7900686|NCT00711412|19441885|P1|NOT COMPLETED|Combination Treatment||1
7900687|NCT00711412|19441885|P1|COMPLETED|Combination Treatment||33
7900688|NCT00711412|19441885|P1|STARTED|Combination Treatment||34
7900689|NCT00711412|19441885|P1|NOT COMPLETED|Evaluated for Combination Treatment||6
7900690|NCT00711412|19441885|P1|COMPLETED|Evaluated for Combination Treatment||34
7900691|NCT00711412|19441885|P1|STARTED|Evaluated for Combination Treatment||40
7900692|NCT00711412|19441885|P1|NOT COMPLETED|Induction Treatment||4
7900693|NCT00711412|19441885|P1|COMPLETED|Induction Treatment||40
7900694|NCT00711412|19441885|P1|Started Induction Treatment|Induction Treatment||43
7900695|NCT00711412|19441885|P1|Registered to Study|Induction Treatment||44
7900696|NCT00711412|19441885|P1|STARTED|Induction Treatment||44
7900697|NCT00711347|19441899|P2|NOT COMPLETED|Overall Study||0
7900698|NCT00711347|19441900|P1|NOT COMPLETED|Overall Study||0
7900699|NCT00711347|19441899|P2|COMPLETED|Overall Study||14
7900700|NCT00711347|19441900|P1|COMPLETED|Overall Study||14
7900701|NCT00711347|19441899|P2|STARTED|Overall Study||14
7900702|NCT00711347|19441900|P1|STARTED|Overall Study||14
7900703|NCT00711269|19441920|P4|NOT COMPLETED|Overall Study||14
7900704|NCT00711269|19441921|P3|NOT COMPLETED|Overall Study||50
7900705|NCT00711269|19441922|P2|NOT COMPLETED|Overall Study||48
7900706|NCT00711269|19441923|P1|NOT COMPLETED|Overall Study||44
7900707|NCT00711269|19441920|P4|COMPLETED|Overall Study||51
7900708|NCT00711269|19441921|P3|COMPLETED|Overall Study||83
7900709|NCT00711269|19441922|P2|COMPLETED|Overall Study||83
7900710|NCT00711269|19441923|P1|COMPLETED|Overall Study||87
7900711|NCT00711269|19441920|P4|STARTED|Overall Study||65
7900712|NCT00711269|19441921|P3|STARTED|Overall Study||133
7900713|NCT00711269|19441922|P2|STARTED|Overall Study||131
7900714|NCT00711269|19441923|P1|STARTED|Overall Study||131
7900715|NCT00711243|19441963|P6|NOT COMPLETED|Follow up Every 3 Months Until Death||2
7900716|NCT00711243|19441964|P5|NOT COMPLETED|Follow up Every 3 Months Until Death||0
7900717|NCT00711243|19441965|P4|NOT COMPLETED|Follow up Every 3 Months Until Death||0
7900718|NCT00711243|19441966|P3|NOT COMPLETED|Follow up Every 3 Months Until Death||0
7900719|NCT00711243|19441967|P2|NOT COMPLETED|Follow up Every 3 Months Until Death||0
7900720|NCT00711243|19441968|P1|NOT COMPLETED|Follow up Every 3 Months Until Death||0
7900721|NCT00711243|19441963|P6|COMPLETED|Follow up Every 3 Months Until Death||37
7900722|NCT00711243|19441964|P5|COMPLETED|Follow up Every 3 Months Until Death||3
7900723|NCT00711243|19441965|P4|COMPLETED|Follow up Every 3 Months Until Death||3
7900724|NCT00711243|19441966|P3|COMPLETED|Follow up Every 3 Months Until Death||3
7900725|NCT00711243|19441967|P2|COMPLETED|Follow up Every 3 Months Until Death||3
7900726|NCT00711243|19441968|P1|COMPLETED|Follow up Every 3 Months Until Death||3
7900727|NCT00711243|19441963|P6|STARTED|Follow up Every 3 Months Until Death|4 patients died whilst on study and 1 patient did not get treated on study|39
7900728|NCT00711243|19441964|P5|STARTED|Follow up Every 3 Months Until Death||3
7900729|NCT00711243|19441965|P4|STARTED|Follow up Every 3 Months Until Death||3
7900730|NCT00711243|19441966|P3|STARTED|Follow up Every 3 Months Until Death||3
7900731|NCT00711243|19441967|P2|STARTED|Follow up Every 3 Months Until Death||3
7900732|NCT00711243|19441968|P1|STARTED|Follow up Every 3 Months Until Death||3
7900733|NCT00711243|19441963|P6|NOT COMPLETED|Treated Cycle 5 After First Response||4
7900734|NCT00711243|19441964|P5|NOT COMPLETED|Treated Cycle 5 After First Response||1
7900735|NCT00711243|19441965|P4|NOT COMPLETED|Treated Cycle 5 After First Response||0
7900736|NCT00711243|19441966|P3|NOT COMPLETED|Treated Cycle 5 After First Response||0
7900737|NCT00711243|19441967|P2|NOT COMPLETED|Treated Cycle 5 After First Response||2
7900738|NCT00711243|19441968|P1|NOT COMPLETED|Treated Cycle 5 After First Response||1
7900739|NCT00711243|19441963|P6|COMPLETED|Treated Cycle 5 After First Response||37
7900740|NCT00711243|19441964|P5|COMPLETED|Treated Cycle 5 After First Response||2
7900741|NCT00711243|19441965|P4|COMPLETED|Treated Cycle 5 After First Response||2
7900742|NCT00711243|19441966|P3|COMPLETED|Treated Cycle 5 After First Response||3
7900743|NCT00711243|19441967|P2|COMPLETED|Treated Cycle 5 After First Response||1
7900744|NCT00711243|19441968|P1|COMPLETED|Treated Cycle 5 After First Response||2
7900745|NCT00711243|19441963|P6|STARTED|Treated Cycle 5 After First Response||41
7900746|NCT00711243|19441964|P5|STARTED|Treated Cycle 5 After First Response||3
7900747|NCT00711243|19441965|P4|STARTED|Treated Cycle 5 After First Response||2
7900748|NCT00711243|19441966|P3|STARTED|Treated Cycle 5 After First Response||3
7900749|NCT00711243|19441967|P2|STARTED|Treated Cycle 5 After First Response||3
7900750|NCT00711243|19441968|P1|STARTED|Treated Cycle 5 After First Response||3
7900751|NCT00711243|19441963|P6|NOT COMPLETED|Reached First Response/4 Cycles||2
7900752|NCT00711243|19441964|P5|NOT COMPLETED|Reached First Response/4 Cycles||0
7900753|NCT00711243|19441965|P4|NOT COMPLETED|Reached First Response/4 Cycles||1
7900754|NCT00711243|19441966|P3|NOT COMPLETED|Reached First Response/4 Cycles||0
7900755|NCT00711243|19441967|P2|NOT COMPLETED|Reached First Response/4 Cycles||0
7900756|NCT00711243|19441968|P1|NOT COMPLETED|Reached First Response/4 Cycles||0
7900757|NCT00711243|19441963|P6|COMPLETED|Reached First Response/4 Cycles||41
7900758|NCT00711243|19441964|P5|COMPLETED|Reached First Response/4 Cycles||3
7900759|NCT00711243|19441965|P4|COMPLETED|Reached First Response/4 Cycles||2
7900760|NCT00711243|19441966|P3|COMPLETED|Reached First Response/4 Cycles||3
7900761|NCT00711243|19441967|P2|COMPLETED|Reached First Response/4 Cycles||3
7900762|NCT00711243|19441968|P1|COMPLETED|Reached First Response/4 Cycles||3
7900763|NCT00711243|19441963|P6|STARTED|Reached First Response/4 Cycles||43
7900764|NCT00711243|19441964|P5|STARTED|Reached First Response/4 Cycles||3
7900765|NCT00711243|19441965|P4|STARTED|Reached First Response/4 Cycles||3
7900766|NCT00711243|19441966|P3|STARTED|Reached First Response/4 Cycles||3
7900767|NCT00711243|19441967|P2|STARTED|Reached First Response/4 Cycles||3
7900768|NCT00711243|19441968|P1|STARTED|Reached First Response/4 Cycles||3
7900769|NCT00711243|19441963|P6|NOT COMPLETED|Registed and Started Treatment||1
7900770|NCT00711243|19441964|P5|NOT COMPLETED|Registed and Started Treatment||0
7900771|NCT00711243|19441965|P4|NOT COMPLETED|Registed and Started Treatment||0
7900772|NCT00711243|19441966|P3|NOT COMPLETED|Registed and Started Treatment||0
7900773|NCT00711243|19441967|P2|NOT COMPLETED|Registed and Started Treatment||0
7900774|NCT00711243|19441968|P1|NOT COMPLETED|Registed and Started Treatment||0
7900775|NCT00711243|19441963|P6|COMPLETED|Registed and Started Treatment||43
7900776|NCT00711243|19441964|P5|COMPLETED|Registed and Started Treatment||3
7900777|NCT00711243|19441965|P4|COMPLETED|Registed and Started Treatment||3
7900778|NCT00711243|19441966|P3|COMPLETED|Registed and Started Treatment||3
7900779|NCT00711243|19441967|P2|COMPLETED|Registed and Started Treatment||3
7900780|NCT00711243|19441968|P1|COMPLETED|Registed and Started Treatment||3
7900781|NCT00711243|19441963|P6|Started Treatment|Registed and Started Treatment||43
7900782|NCT00711243|19441964|P5|Started Treatment|Registed and Started Treatment||3
7900783|NCT00711243|19441965|P4|Started Treatment|Registed and Started Treatment||3
7900784|NCT00711243|19441966|P3|Started Treatment|Registed and Started Treatment||3
7900785|NCT00711243|19441967|P2|Started Treatment|Registed and Started Treatment||3
7900786|NCT00711243|19441968|P1|Started Treatment|Registed and Started Treatment||3
7900787|NCT00711243|19441963|P6|Registered to Study|Registed and Started Treatment||44
7900788|NCT00711243|19441964|P5|Registered to Study|Registed and Started Treatment||3
7900789|NCT00711243|19441965|P4|Registered to Study|Registed and Started Treatment||3
7900790|NCT00711243|19441966|P3|Registered to Study|Registed and Started Treatment||3
7900791|NCT00711243|19441967|P2|Registered to Study|Registed and Started Treatment||3
7900792|NCT00711243|19441968|P1|Registered to Study|Registed and Started Treatment||3
7900793|NCT00711243|19441963|P6|STARTED|Registed and Started Treatment||44
7900794|NCT00711243|19441964|P5|STARTED|Registed and Started Treatment||3
7900795|NCT00711243|19441965|P4|STARTED|Registed and Started Treatment||3
7900796|NCT00711243|19441966|P3|STARTED|Registed and Started Treatment||3
7900797|NCT00711243|19441967|P2|STARTED|Registed and Started Treatment||3
7900798|NCT00711243|19441968|P1|STARTED|Registed and Started Treatment||3
7900799|NCT00711191|19441991|P3|NOT COMPLETED|Overall Study||12
7900800|NCT00711191|19441992|P2|NOT COMPLETED|Overall Study||5
7900801|NCT00711191|19441993|P1|NOT COMPLETED|Overall Study||3
7900802|NCT00711191|19441991|P3|COMPLETED|Overall Study||1
7900803|NCT00711191|19441992|P2|COMPLETED|Overall Study||1
7900804|NCT00711191|19441993|P1|COMPLETED|Overall Study||0
7900805|NCT00711191|19441991|P3|STARTED|Overall Study||13
7900806|NCT00711191|19441992|P2|STARTED|Overall Study||6
7900807|NCT00711191|19441993|P1|STARTED|Overall Study||3
7900808|NCT00711113|19442030|P1|NOT COMPLETED|Overall Study||11
7900809|NCT00711113|19442030|P1|COMPLETED|Overall Study||36
7900810|NCT00711113|19442030|P1|STARTED|Overall Study||47
7900811|NCT00711100|19442036|P1|NOT COMPLETED|Overall Study||13
7900812|NCT00711100|19442036|P1|COMPLETED|Overall Study||91
7900813|NCT00711100|19442036|P1|STARTED|Overall Study||104
7900814|NCT00711087|19442054|P2|NOT COMPLETED|Overall Study||0
7900815|NCT00711087|19442055|P1|NOT COMPLETED|Overall Study||1
7900816|NCT00711087|19442054|P2|COMPLETED|Overall Study||0
7900817|NCT00711087|19442055|P1|COMPLETED|Overall Study||0
7900818|NCT00711087|19442054|P2|STARTED|Overall Study||0
7900819|NCT00711087|19442055|P1|STARTED|Overall Study||1
7900820|NCT00711022|19442061|P1|NOT COMPLETED|Overall Study||11
7900821|NCT00711022|19442061|P1|COMPLETED|Overall Study||40
7900822|NCT00711022|19442061|P1|STARTED|Overall Study||51
7900823|NCT00711009|19442067|P2|NOT COMPLETED|Overall Study||19
7900824|NCT00711009|19442068|P1|NOT COMPLETED|Overall Study||15
7900825|NCT00711009|19442067|P2|COMPLETED|Overall Study||82
7900826|NCT00711009|19442068|P1|COMPLETED|Overall Study||90
7900827|NCT00711009|19442067|P2|STARTED|Overall Study||101
7900828|NCT00711009|19442068|P1|STARTED|Overall Study||105
7900829|NCT00710996|19442239|P3|NOT COMPLETED|Overall Study||0
7900830|NCT00710996|19442240|P2|NOT COMPLETED|Overall Study||4
7900831|NCT00710996|19442241|P1|NOT COMPLETED|Overall Study||1
7900832|NCT00710996|19442239|P3|COMPLETED|Overall Study||21
7900833|NCT00710996|19442240|P2|COMPLETED|Overall Study||16
7900834|NCT00710996|19442241|P1|COMPLETED|Overall Study||16
7900835|NCT00710996|19442239|P3|STARTED|Overall Study||21
7900836|NCT00710996|19442240|P2|STARTED|Overall Study||20
7900837|NCT00710996|19442241|P1|STARTED|Overall Study||17
7900838|NCT00710970|19442249|P1|NOT COMPLETED|Overall Study||10
7900839|NCT00710970|19442249|P1|COMPLETED|Overall Study||18
7900840|NCT00710970|19442249|P1|STARTED|Overall Study||28
7900841|NCT00710944|19442256|P3|NOT COMPLETED|Overall Study||2
7900842|NCT00710944|19442257|P2|NOT COMPLETED|Overall Study||9
7900843|NCT00710944|19442258|P1|NOT COMPLETED|Overall Study||10
7900844|NCT00710944|19442256|P3|COMPLETED|Overall Study||17
7900845|NCT00710944|19442257|P2|COMPLETED|Overall Study||49
7900846|NCT00710944|19442258|P1|COMPLETED|Overall Study||45
7900847|NCT00710944|19442256|P3|STARTED|Overall Study||19
7900848|NCT00710944|19442257|P2|STARTED|Overall Study||58
7900849|NCT00710944|19442258|P1|STARTED|Overall Study||55
7900850|NCT00710931|19442266|P1|NOT COMPLETED|Overall Study||5
7900851|NCT00710931|19442266|P1|COMPLETED|Overall Study||29
7900852|NCT00710931|19442266|P1|STARTED|Overall Study||34
7900853|NCT00710905|19442270|P1|NOT COMPLETED|Overall Study||16
7900854|NCT00710905|19442270|P1|COMPLETED|Overall Study||34
7900855|NCT00710905|19442270|P1|STARTED|Overall Study||50
7900856|NCT00710879|19442276|P2|NOT COMPLETED|Overall Study||4
7900857|NCT00710879|19442277|P1|NOT COMPLETED|Overall Study||2
7900858|NCT00710879|19442276|P2|COMPLETED|Overall Study||113
7900859|NCT00710879|19442277|P1|COMPLETED|Overall Study||58
7900860|NCT00710879|19442276|P2|STARTED|Overall Study||117
7900861|NCT00710879|19442277|P1|STARTED|Overall Study||60
7900862|NCT00710866|19442289|P2|NOT COMPLETED|Overall Study||6
7900863|NCT00710866|19442290|P1|NOT COMPLETED|Overall Study||9
7900864|NCT00710866|19442289|P2|COMPLETED|Overall Study||128
7900865|NCT00710866|19442290|P1|COMPLETED|Overall Study||124
7900866|NCT00710866|19442289|P2|STARTED|Overall Study||134
7900867|NCT00710866|19442290|P1|STARTED|Overall Study||133
7900868|NCT00710840|19442312|P2|NOT COMPLETED|Overall Study||3
7900869|NCT00710840|19442313|P1|NOT COMPLETED|Overall Study||0
7900870|NCT00710840|19442312|P2|COMPLETED|Overall Study||19
7900871|NCT00710840|19442313|P1|COMPLETED|Overall Study||22
7900872|NCT00710840|19442312|P2|STARTED|Overall Study||22
7900873|NCT00710840|19442313|P1|STARTED|Overall Study||22
7900874|NCT00710814|19442327|P2|NOT COMPLETED|Overall Study||3
7900875|NCT00710814|19442328|P1|NOT COMPLETED|Overall Study||1
7900876|NCT00710814|19442327|P2|COMPLETED|Overall Study||13
7900877|NCT00710814|19442328|P1|COMPLETED|Overall Study||14
7900878|NCT00710814|19442327|P2|STARTED|Overall Study||16
7900879|NCT00710814|19442328|P1|STARTED|Overall Study||15
7900880|NCT00710762|19442336|P2|NOT COMPLETED|Overall Study||40
7900881|NCT00710762|19442337|P1|NOT COMPLETED|Overall Study||39
7900882|NCT00710762|19442336|P2|COMPLETED|Overall Study||0
7900883|NCT00710762|19442337|P1|COMPLETED|Overall Study||5
7900884|NCT00710762|19442336|P2|STARTED|Overall Study||40
7900885|NCT00710762|19442337|P1|STARTED|Overall Study||44
7900886|NCT00710749|19442353|P2|NOT COMPLETED|Second Intervention||0
7900887|NCT00710749|19442354|P1|NOT COMPLETED|Second Intervention||0
7900888|NCT00710749|19442353|P2|COMPLETED|Second Intervention||30
7900889|NCT00710749|19442354|P1|COMPLETED|Second Intervention||29
7900890|NCT00710749|19442353|P2|STARTED|Second Intervention||30
7900891|NCT00710749|19442354|P1|STARTED|Second Intervention||29
7900892|NCT00710749|19442353|P2|NOT COMPLETED|First Intervention||0
7900893|NCT00710749|19442354|P1|NOT COMPLETED|First Intervention||1
7900894|NCT00710749|19442353|P2|COMPLETED|First Intervention||30
7900895|NCT00710749|19442354|P1|COMPLETED|First Intervention||29
7900896|NCT00710749|19442353|P2|STARTED|First Intervention||30
7900897|NCT00710749|19442354|P1|STARTED|First Intervention||30
7900898|NCT00710749|19442353|P2|NOT COMPLETED|Clinic Baseline Recording||0
7900899|NCT00710749|19442354|P1|NOT COMPLETED|Clinic Baseline Recording||0
7900900|NCT00710749|19442353|P2|COMPLETED|Clinic Baseline Recording||30
7900901|NCT00710749|19442354|P1|COMPLETED|Clinic Baseline Recording||30
7900902|NCT00710749|19442353|P2|STARTED|Clinic Baseline Recording||30
7900903|NCT00710749|19442354|P1|STARTED|Clinic Baseline Recording||30
7900904|NCT00710684|19442365|P3|NOT COMPLETED|Overall Study||64
7900905|NCT00710684|19442366|P2|NOT COMPLETED|Overall Study||74
7900906|NCT00710684|19442367|P1|NOT COMPLETED|Overall Study||74
7900907|NCT00710684|19442365|P3|COMPLETED|Overall Study||172
7900908|NCT00710684|19442366|P2|COMPLETED|Overall Study||147
7900909|NCT00710684|19442367|P1|COMPLETED|Overall Study||151
7900910|NCT00710684|19442365|P3|STARTED|Overall Study||236
7900911|NCT00710684|19442366|P2|STARTED|Overall Study||221
7900912|NCT00710684|19442367|P1|STARTED|Overall Study||225
7900913|NCT00710606|19442424|P2|NOT COMPLETED|Overall Study||2
7900914|NCT00710606|19442425|P1|NOT COMPLETED|Overall Study||0
7900915|NCT00710606|19442424|P2|COMPLETED|Overall Study||18
7900916|NCT00710606|19442425|P1|COMPLETED|Overall Study||20
7900917|NCT00710606|19442424|P2|STARTED|Overall Study||20
7900918|NCT00710606|19442425|P1|STARTED|Overall Study||20
7900919|NCT00710593|19442437|P2|NOT COMPLETED|Overall Study||5
7900920|NCT00710593|19442438|P1|NOT COMPLETED|Overall Study||15
7900921|NCT00710593|19442437|P2|COMPLETED|Overall Study|25 completed study and vaccine. 2 did not receive all vaccine, but completed all study visits.|25
7900922|NCT00710593|19442438|P1|COMPLETED|Overall Study|54 completed study and vaccine. 6 did not receive all vaccine, but completed all study visits.|54
7900923|NCT00710593|19442437|P2|STARTED|Overall Study||30
7900924|NCT00710593|19442438|P1|STARTED|Overall Study||69
7900925|NCT00710554|19442481|P2|NOT COMPLETED|Overall Study||24
7900926|NCT00710554|19442482|P1|NOT COMPLETED|Overall Study||49
7900927|NCT00710554|19442481|P2|COMPLETED|Overall Study||94
7900928|NCT00710554|19442482|P1|COMPLETED|Overall Study||79
7900929|NCT00710554|19442481|P2|STARTED|Overall Study||118
7900930|NCT00710554|19442482|P1|STARTED|Overall Study||128
7900931|NCT00710424|19442510|P2|NOT COMPLETED|Overall Study||23
7900932|NCT00710424|19442511|P1|NOT COMPLETED|Overall Study||44
7900933|NCT00710424|19442510|P2|COMPLETED|Overall Study||125
7900934|NCT00710424|19442511|P1|COMPLETED|Overall Study||105
7900935|NCT00710424|19442510|P2|STARTED|Overall Study||148
7900936|NCT00710424|19442511|P1|STARTED|Overall Study||149
7900937|NCT00710385|19442535|P1|NOT COMPLETED|Overall Study||5
7900938|NCT00710385|19442535|P1|COMPLETED|Overall Study||12
7900939|NCT00710385|19442535|P1|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17
7900940|NCT00710203|19442552|P1|NOT COMPLETED|Overall Study||0
7900941|NCT00710203|19442552|P1|COMPLETED|Overall Study||10
7900942|NCT00710203|19442552|P1|STARTED|Overall Study||10
7900943|NCT00710034|19442580|P2|NOT COMPLETED|Completed 12 Weeks of Treatment||11
7900944|NCT00710034|19442581|P1|NOT COMPLETED|Completed 12 Weeks of Treatment||13
7900945|NCT00710034|19442580|P2|COMPLETED|Completed 12 Weeks of Treatment||138
7900946|NCT00710034|19442581|P1|COMPLETED|Completed 12 Weeks of Treatment||141
7900947|NCT00710034|19442580|P2|STARTED|Completed 12 Weeks of Treatment||149
7900948|NCT00710034|19442581|P1|STARTED|Completed 12 Weeks of Treatment||154
7900949|NCT00710034|19442580|P2|NOT COMPLETED|Completed 6 Weeks of Treatment||47
7900950|NCT00710034|19442581|P1|NOT COMPLETED|Completed 6 Weeks of Treatment||41
7900951|NCT00710034|19442580|P2|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=149|149
7900952|NCT00710034|19442581|P1|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=154|154
7900953|NCT00710034|19442580|P2|STARTED|Completed 6 Weeks of Treatment||196
7900954|NCT00710034|19442581|P1|STARTED|Completed 6 Weeks of Treatment||195
7900955|NCT00710021|19442598|P3|NOT COMPLETED|Overall Study||1
7900956|NCT00710021|19442599|P2|NOT COMPLETED|Overall Study||3
7900957|NCT00710021|19442600|P1|NOT COMPLETED|Overall Study||1
7900958|NCT00710021|19442598|P3|COMPLETED|Overall Study||18
7900959|NCT00710021|19442599|P2|COMPLETED|Overall Study||16
7900960|NCT00710021|19442600|P1|COMPLETED|Overall Study||18
7900961|NCT00710021|19442598|P3|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18
7900962|NCT00710021|19442599|P2|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17
7900963|NCT00710021|19442600|P1|Modified Intent-to-Treat (mITT)|Overall Study||19
7900964|NCT00710021|19442598|P3|STARTED|Overall Study||19
7900965|NCT00710021|19442599|P2|STARTED|Overall Study||19
7900966|NCT00710021|19442600|P1|STARTED|Overall Study||19
7900967|NCT00709995|19442715|P2|NOT COMPLETED|Overall Study||5
7900968|NCT00709995|19442716|P1|NOT COMPLETED|Overall Study||5
7900969|NCT00709995|19442715|P2|COMPLETED|Overall Study||1
7900970|NCT00709995|19442716|P1|COMPLETED|Overall Study||6
7900971|NCT00709995|19442715|P2|Progressive Disease|Overall Study||1
7900972|NCT00709995|19442716|P1|Progressive Disease|Overall Study||6
7900973|NCT00709995|19442715|P2|STARTED|Overall Study||6
7900974|NCT00709995|19442716|P1|STARTED|Overall Study||11
7900975|NCT00709956|19442734|P2|NOT COMPLETED|Overall Study||4
7900976|NCT00709956|19442735|P1|NOT COMPLETED|Overall Study||3
7900977|NCT00709956|19442734|P2|COMPLETED|Overall Study||33
7900978|NCT00709956|19442735|P1|COMPLETED|Overall Study||30
7900979|NCT00709956|19442734|P2|Double-blind Crossover-period|Overall Study|Days 2 and 3|33
7900980|NCT00709956|19442735|P1|Double-blind Crossover-period|Overall Study|Days 2 and 3|31
7900981|NCT00709956|19442734|P2|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37
7900982|NCT00709956|19442735|P1|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33
7900983|NCT00709891|19442743|P1|NOT COMPLETED|Longitudinal Follow-up Phase||4982
7900984|NCT00709891|19442743|P1|COMPLETED|Longitudinal Follow-up Phase||5020
7900985|NCT00709891|19442743|P1|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002
7900986|NCT00709891|19442743|P1|NOT COMPLETED|Baseline, Cross-sectional Phase||1450
7900987|NCT00709891|19442743|P1|COMPLETED|Baseline, Cross-sectional Phase||45758
7900988|NCT00709891|19442743|P1|STARTED|Baseline, Cross-sectional Phase||47208
7900989|NCT00709878|19442752|P4|NOT COMPLETED|Overall Study||0
7900990|NCT00709878|19442753|P3|NOT COMPLETED|Overall Study||0
7900991|NCT00709878|19442754|P2|NOT COMPLETED|Overall Study||0
7900992|NCT00709878|19442755|P1|NOT COMPLETED|Overall Study||0
7900993|NCT00709878|19442752|P4|COMPLETED|Overall Study||8
7900994|NCT00709878|19442753|P3|COMPLETED|Overall Study||8
7900995|NCT00709878|19442754|P2|COMPLETED|Overall Study||8
7900996|NCT00709878|19442755|P1|COMPLETED|Overall Study||8
7900997|NCT00709878|19442752|P4|STARTED|Overall Study||8
7900998|NCT00709878|19442753|P3|STARTED|Overall Study||8
7900999|NCT00709878|19442754|P2|STARTED|Overall Study||8
7901000|NCT00709878|19442755|P1|STARTED|Overall Study||8
7901001|NCT00709852|19442765|P2|NOT COMPLETED|Period 2||2
7901002|NCT00709852|19442766|P1|NOT COMPLETED|Period 2||9
7901003|NCT00709852|19442765|P2|COMPLETED|Period 2||169
7901004|NCT00709852|19442766|P1|COMPLETED|Period 2||211
7901005|NCT00709852|19442765|P2|STARTED|Period 2||171
7901006|NCT00709852|19442766|P1|STARTED|Period 2||220
7901007|NCT00709852|19442765|P2|NOT COMPLETED|Period 1||3
7901008|NCT00709852|19442766|P1|NOT COMPLETED|Period 1||8
7901009|NCT00709852|19442765|P2|COMPLETED|Period 1||171
7901010|NCT00709852|19442766|P1|COMPLETED|Period 1||220
7901011|NCT00709852|19442765|P2|STARTED|Period 1||174
7901012|NCT00709852|19442766|P1|STARTED|Period 1||228
7901013|NCT00709826|19442921|P2|NOT COMPLETED|Overall Study||1
7901014|NCT00709826|19442922|P1|NOT COMPLETED|Overall Study||2
7901015|NCT00709826|19442921|P2|COMPLETED|Overall Study||38
7901016|NCT00709826|19442922|P1|COMPLETED|Overall Study||68
7901017|NCT00709826|19442921|P2|STARTED|Overall Study||39
7901018|NCT00709826|19442922|P1|STARTED|Overall Study||70
7901019|NCT00709761|19442930|P1|NOT COMPLETED|Overall Study||27
7901020|NCT00709761|19442930|P1|COMPLETED|Overall Study||33
7901021|NCT00709761|19442930|P1|STARTED|Overall Study||60
7901022|NCT00709735|19442941|P2|NOT COMPLETED|Overall Study||2
7901023|NCT00709735|19442942|P1|NOT COMPLETED|Overall Study||3
7901024|NCT00709735|19442941|P2|COMPLETED|Overall Study||10
7901025|NCT00709735|19442942|P1|COMPLETED|Overall Study||8
7901026|NCT00709735|19442941|P2|STARTED|Overall Study||12
7901027|NCT00709735|19442942|P1|STARTED|Overall Study||11
7901028|NCT00709722|19442950|P1|NOT COMPLETED|Overall Study||1
7901029|NCT00709722|19442950|P1|COMPLETED|Overall Study||20
7901030|NCT00709722|19442950|P1|STARTED|Overall Study||21
7901031|NCT00709696|19442958|P2|NOT COMPLETED|Overall Study||0
7901032|NCT00709696|19442959|P1|NOT COMPLETED|Overall Study||0
7901033|NCT00709696|19442958|P2|COMPLETED|Overall Study||3
7901034|NCT00709696|19442959|P1|COMPLETED|Overall Study||4
7901035|NCT00709696|19442958|P2|STARTED|Overall Study||3
7901036|NCT00709696|19442959|P1|STARTED|Overall Study||4
7901037|NCT00709618|19442965|P1|NOT COMPLETED|Overall Study||30
7901038|NCT00709618|19442965|P1|COMPLETED|Overall Study||14
7901039|NCT00709618|19442965|P1|STARTED|Overall Study||44
7901040|NCT00709592|19442977|P2|NOT COMPLETED|Overall Study||1
7901041|NCT00709592|19442978|P1|NOT COMPLETED|Overall Study||0
7901042|NCT00709592|19442977|P2|COMPLETED|Overall Study||22
7901043|NCT00709592|19442978|P1|COMPLETED|Overall Study||19
7901044|NCT00709592|19442977|P2|STARTED|Overall Study||23
7901045|NCT00709592|19442978|P1|STARTED|Overall Study||19
7901046|NCT00709319|19443000|P1|NOT COMPLETED|Overall Study||6
7901047|NCT00709319|19443000|P1|COMPLETED|Overall Study||81
7901048|NCT00709319|19443000|P1|STARTED|Overall Study||87
7901049|NCT00709306|19443012|P4|NOT COMPLETED|Overall Study||10
7901050|NCT00709306|19443013|P3|NOT COMPLETED|Overall Study||10
7901051|NCT00709306|19443014|P2|NOT COMPLETED|Overall Study||14
7901052|NCT00709306|19443015|P1|NOT COMPLETED|Overall Study||9
7901053|NCT00709306|19443012|P4|COMPLETED|Overall Study||37
7901054|NCT00709306|19443013|P3|COMPLETED|Overall Study||48
7901055|NCT00709306|19443014|P2|COMPLETED|Overall Study||30
7901056|NCT00709306|19443015|P1|COMPLETED|Overall Study||39
7901057|NCT00709306|19443012|P4|STARTED|Overall Study||47
7901058|NCT00709306|19443013|P3|STARTED|Overall Study||58
7901059|NCT00709306|19443014|P2|STARTED|Overall Study||44
7901060|NCT00709306|19443015|P1|STARTED|Overall Study||48
7901061|NCT00709228|19443029|P1|NOT COMPLETED|Overall Study||332
7901062|NCT00709228|19443029|P1|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164
7901063|NCT00709228|19443029|P1|STARTED|Overall Study||496
7901064|NCT00709202|19443035|P2|NOT COMPLETED|Overall Study||6
7901065|NCT00709202|19443036|P1|NOT COMPLETED|Overall Study||6
7901066|NCT00709202|19443035|P2|COMPLETED|Overall Study||15
7901067|NCT00709202|19443036|P1|COMPLETED|Overall Study||13
7901068|NCT00709202|19443035|P2|STARTED|Overall Study||21
7901069|NCT00709202|19443036|P1|STARTED|Overall Study||19
7901070|NCT00709124|19443064|P2|NOT COMPLETED|Overall Study||1
7901071|NCT00709124|19443065|P1|NOT COMPLETED|Overall Study||4
7901072|NCT00709124|19443064|P2|COMPLETED|Overall Study||17
7901073|NCT00709124|19443065|P1|COMPLETED|Overall Study||12
7901074|NCT00709124|19443064|P2|STARTED|Overall Study||18
7901075|NCT00709124|19443065|P1|STARTED|Overall Study||16
7901076|NCT00709111|19443099|P1|NOT COMPLETED|Overall Study||2
7901077|NCT00709111|19443099|P1|COMPLETED|Overall Study||32
7901078|NCT00709111|19443099|P1|Week 22/24|Overall Study||33
7901079|NCT00709111|19443099|P1|STARTED|Overall Study||34
7901080|NCT00709098|19443140|P3|NOT COMPLETED|Open-label Period||14
7901081|NCT00709098|19443141|P2|NOT COMPLETED|Open-label Period||0
7901082|NCT00709098|19443142|P1|NOT COMPLETED|Open-label Period||0
7901083|NCT00709098|19443140|P3|COMPLETED|Open-label Period||18
7901084|NCT00709098|19443141|P2|COMPLETED|Open-label Period||0
7901085|NCT00709098|19443142|P1|COMPLETED|Open-label Period||0
7901086|NCT00709098|19443140|P3|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32
7901087|NCT00709098|19443141|P2|STARTED|Open-label Period||0
7901088|NCT00709098|19443142|P1|STARTED|Open-label Period||0
7901089|NCT00709098|19443140|P3|NOT COMPLETED|Double-blind Period||0
7901090|NCT00709098|19443141|P2|NOT COMPLETED|Double-blind Period||8
7901091|NCT00709098|19443142|P1|NOT COMPLETED|Double-blind Period||6
7901092|NCT00709098|19443140|P3|COMPLETED|Double-blind Period||0
7901093|NCT00709098|19443141|P2|COMPLETED|Double-blind Period||16
7901094|NCT00709098|19443142|P1|COMPLETED|Double-blind Period||19
7901095|NCT00709098|19443140|P3|STARTED|Double-blind Period||0
7901096|NCT00709098|19443141|P2|STARTED|Double-blind Period||24
7901097|NCT00709098|19443142|P1|STARTED|Double-blind Period||25
7901098|NCT00709059|19443161|P1|NOT COMPLETED|Overall Study||94
7901099|NCT00709059|19443161|P1|COMPLETED|Overall Study||444
7901100|NCT00709059|19443161|P1|STARTED|Overall Study||538
7901101|NCT00708942|19443170|P5|NOT COMPLETED|Overall Study||1
7901102|NCT00708942|19443171|P4|NOT COMPLETED|Overall Study||0
7901103|NCT00708942|19443172|P3|NOT COMPLETED|Overall Study||2
7901104|NCT00708942|19443173|P2|NOT COMPLETED|Overall Study||1
7901105|NCT00708942|19443174|P1|NOT COMPLETED|Overall Study||7
7901106|NCT00708942|19443170|P5|COMPLETED|Overall Study||2
7901107|NCT00708942|19443171|P4|COMPLETED|Overall Study||10
7901108|NCT00708942|19443172|P3|COMPLETED|Overall Study||9
7901109|NCT00708942|19443173|P2|COMPLETED|Overall Study||11
7901110|NCT00708942|19443174|P1|COMPLETED|Overall Study||40
7901111|NCT00708942|19443170|P5|STARTED|Overall Study||3
7901112|NCT00708942|19443171|P4|STARTED|Overall Study||10
7901113|NCT00708942|19443172|P3|STARTED|Overall Study||11
7901114|NCT00708942|19443173|P2|STARTED|Overall Study||12
7901115|NCT00708942|19443174|P1|STARTED|Overall Study||47
7901116|NCT00708877|19443196|P1|NOT COMPLETED|Overall Study||0
7901117|NCT00708877|19443196|P1|COMPLETED|Overall Study||5
7901118|NCT00708877|19443196|P1|STARTED|Overall Study||5
7901119|NCT00708851|19443200|P1|NOT COMPLETED|Overall Study||0
7901120|NCT00708851|19443200|P1|COMPLETED|Overall Study||12
7901121|NCT00708851|19443200|P1|STARTED|Overall Study||12
7901122|NCT00708734|19443208|P1|NOT COMPLETED|Overall Study||7
7901123|NCT00708734|19443208|P1|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3
7901124|NCT00708734|19443208|P1|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10
7901125|NCT00708721|19443212|P4|NOT COMPLETED|Overall Study||0
7901126|NCT00708721|19443213|P3|NOT COMPLETED|Overall Study||0
7901127|NCT00708721|19443214|P2|NOT COMPLETED|Overall Study||0
7901128|NCT00708721|19443215|P1|NOT COMPLETED|Overall Study||0
7901129|NCT00708721|19443212|P4|COMPLETED|Overall Study||2
7901130|NCT00708721|19443213|P3|COMPLETED|Overall Study||3
7901131|NCT00708721|19443214|P2|COMPLETED|Overall Study||4
7901132|NCT00708721|19443215|P1|COMPLETED|Overall Study||2
7901133|NCT00708721|19443212|P4|STARTED|Overall Study||2
7901134|NCT00708721|19443213|P3|STARTED|Overall Study||3
7901135|NCT00708721|19443214|P2|STARTED|Overall Study||4
7901136|NCT00708721|19443215|P1|STARTED|Overall Study||2
7901137|NCT00708708|19443228|P1|NOT COMPLETED|Overall Study||742
7901138|NCT00708708|19443228|P1|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213
7901139|NCT00708708|19443228|P1|STARTED|Overall Study||955
7901140|NCT00708682|19443276|P1|NOT COMPLETED|Toddler Dose||8
7901141|NCT00708682|19443276|P1|COMPLETED|Toddler Dose||183
7901142|NCT00708682|19443276|P1|STARTED|Toddler Dose||191
7901143|NCT00708682|19443276|P1|NOT COMPLETED|After Infant Series||1
7901144|NCT00708682|19443276|P1|COMPLETED|After Infant Series||191
7901145|NCT00708682|19443276|P1|STARTED|After Infant Series||192
7901146|NCT00708682|19443276|P1|NOT COMPLETED|Infant Series||33
7901147|NCT00708682|19443276|P1|COMPLETED|Infant Series||192
7901148|NCT00708682|19443276|P1|Vaccinated Dose 3|Infant Series||194
7901149|NCT00708682|19443276|P1|Vaccinated Dose 2|Infant Series||214
7901150|NCT00708682|19443276|P1|Vaccinated Dose 1|Infant Series||223
7901151|NCT00708682|19443276|P1|STARTED|Infant Series||225
7901152|NCT00708643|19443297|P2|NOT COMPLETED|Overall Study||1
7901153|NCT00708643|19443298|P1|NOT COMPLETED|Overall Study||0
7901154|NCT00708643|19443297|P2|COMPLETED|Overall Study||39
7901155|NCT00708643|19443298|P1|COMPLETED|Overall Study||40
7901156|NCT00708643|19443297|P2|STARTED|Overall Study||40
7901157|NCT00708643|19443298|P1|STARTED|Overall Study||40
7901158|NCT00708552|19443318|P4|NOT COMPLETED|Overall Study||21
7901159|NCT00708552|19443319|P3|NOT COMPLETED|Overall Study||15
7901160|NCT00708552|19443320|P2|NOT COMPLETED|Overall Study||18
7901161|NCT00708552|19443321|P1|NOT COMPLETED|Overall Study||27
7901162|NCT00708552|19443318|P4|COMPLETED|Overall Study||130
7901163|NCT00708552|19443319|P3|COMPLETED|Overall Study||118
7901164|NCT00708552|19443320|P2|COMPLETED|Overall Study||127
7901165|NCT00708552|19443321|P1|COMPLETED|Overall Study||118
7901166|NCT00708552|19443318|P4|STARTED|Overall Study||151
7901167|NCT00708552|19443319|P3|STARTED|Overall Study||133
7901168|NCT00708552|19443320|P2|STARTED|Overall Study||145
7901169|NCT00708552|19443321|P1|STARTED|Overall Study||145
7901170|NCT00708526|19443471|P2|NOT COMPLETED|Return of Cognitive Function||0
7901171|NCT00708526|19443472|P1|NOT COMPLETED|Return of Cognitive Function||0
7901172|NCT00708526|19443471|P2|COMPLETED|Return of Cognitive Function||11
7901173|NCT00708526|19443472|P1|COMPLETED|Return of Cognitive Function||11
7901174|NCT00708526|19443471|P2|STARTED|Return of Cognitive Function||11
7901175|NCT00708526|19443472|P1|STARTED|Return of Cognitive Function||11
7901176|NCT00708526|19443471|P2|NOT COMPLETED|Wake up After Anesthesia||0
7901177|NCT00708526|19443472|P1|NOT COMPLETED|Wake up After Anesthesia||0
7901178|NCT00708526|19443471|P2|COMPLETED|Wake up After Anesthesia||11
7901179|NCT00708526|19443472|P1|COMPLETED|Wake up After Anesthesia||11
7901180|NCT00708526|19443471|P2|STARTED|Wake up After Anesthesia||11
7901181|NCT00708526|19443472|P1|STARTED|Wake up After Anesthesia||11
7901182|NCT00708500|19443483|P3|NOT COMPLETED|FOLLOWUP||15
7901183|NCT00708500|19443484|P2|NOT COMPLETED|FOLLOWUP||15
7901184|NCT00708500|19443485|P1|NOT COMPLETED|FOLLOWUP||40
7901185|NCT00708500|19443483|P3|COMPLETED|FOLLOWUP||143
7901186|NCT00708500|19443484|P2|COMPLETED|FOLLOWUP||136
7901187|NCT00708500|19443485|P1|COMPLETED|FOLLOWUP||37
7901188|NCT00708500|19443483|P3|STARTED|FOLLOWUP||158
7901189|NCT00708500|19443484|P2|STARTED|FOLLOWUP||151
7901190|NCT00708500|19443485|P1|STARTED|FOLLOWUP||77
7901191|NCT00708500|19443483|P3|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
7901192|NCT00708500|19443484|P2|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52
7901193|NCT00708500|19443485|P1|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
7901194|NCT00708500|19443483|P3|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105
7901195|NCT00708500|19443484|P2|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104
7901196|NCT00708500|19443485|P1|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23
7901197|NCT00708500|19443483|P3|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160
7901198|NCT00708500|19443484|P2|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156
7901199|NCT00708500|19443485|P1|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78
7901200|NCT00708500|19443483|P3|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
7901201|NCT00708500|19443484|P2|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6
7901202|NCT00708500|19443485|P1|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
7901203|NCT00708500|19443483|P3|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160
7901204|NCT00708500|19443484|P2|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156
7901205|NCT00708500|19443485|P1|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78
7901206|NCT00708500|19443483|P3|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161
7901207|NCT00708500|19443484|P2|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
7901208|NCT00708500|19443485|P1|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
7901209|NCT00708500|19443483|P3|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
7901210|NCT00708500|19443484|P2|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
7901211|NCT00708500|19443485|P1|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
7901212|NCT00708461|19443504|P2|NOT COMPLETED|Overall Study||200
7901213|NCT00708461|19443505|P1|NOT COMPLETED|Overall Study||141
7901214|NCT00708461|19443504|P2|COMPLETED|Overall Study||795
7901215|NCT00708461|19443505|P1|COMPLETED|Overall Study||611
7901216|NCT00708461|19443504|P2|STARTED|Overall Study||995
7901217|NCT00708461|19443505|P1|STARTED|Overall Study||752
7901218|NCT00708435|19443513|P2|NOT COMPLETED|Overall Study||17
7901219|NCT00708435|19443514|P1|NOT COMPLETED|Overall Study||25
7901220|NCT00708435|19443513|P2|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92
7901221|NCT00708435|19443514|P1|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82
7901222|NCT00708435|19443513|P2|STARTED|Overall Study||109
7901223|NCT00708435|19443514|P1|STARTED|Overall Study||107
7901224|NCT00708422|19443541|P2|NOT COMPLETED|Overall Study||1
7901225|NCT00708422|19443542|P1|NOT COMPLETED|Overall Study||4
7901226|NCT00708422|19443541|P2|COMPLETED|Overall Study||114
7901227|NCT00708422|19443542|P1|COMPLETED|Overall Study||112
7901228|NCT00708422|19443541|P2|STARTED|Overall Study||115
7901229|NCT00708422|19443542|P1|STARTED|Overall Study||116
7901230|NCT00708305|19443550|P4|NOT COMPLETED|Period 4||0
7901231|NCT00708305|19443551|P3|NOT COMPLETED|Period 4||0
7901232|NCT00708305|19443552|P2|NOT COMPLETED|Period 4||0
7901233|NCT00708305|19443553|P1|NOT COMPLETED|Period 4||0
7901234|NCT00708305|19443550|P4|COMPLETED|Period 4||14
7901235|NCT00708305|19443551|P3|COMPLETED|Period 4||14
7901236|NCT00708305|19443552|P2|COMPLETED|Period 4||14
7901237|NCT00708305|19443553|P1|COMPLETED|Period 4||12
7901238|NCT00708305|19443550|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
7901239|NCT00708305|19443551|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
7901240|NCT00708305|19443552|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
7901241|NCT00708305|19443553|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
7901242|NCT00708305|19443550|P4|NOT COMPLETED|Period 3||0
7901243|NCT00708305|19443551|P3|NOT COMPLETED|Period 3||0
7901244|NCT00708305|19443552|P2|NOT COMPLETED|Period 3||2
7901245|NCT00708305|19443553|P1|NOT COMPLETED|Period 3||1
7901246|NCT00708305|19443550|P4|COMPLETED|Period 3||14
7901247|NCT00708305|19443551|P3|COMPLETED|Period 3||14
7901248|NCT00708305|19443552|P2|COMPLETED|Period 3||12
7901249|NCT00708305|19443553|P1|COMPLETED|Period 3||14
7901250|NCT00708305|19443550|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
7901251|NCT00708305|19443551|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
7901252|NCT00708305|19443552|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
7901253|NCT00708305|19443553|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15
7901254|NCT00708305|19443550|P4|NOT COMPLETED|Period 2||1
7901255|NCT00708305|19443551|P3|NOT COMPLETED|Period 2||0
7901256|NCT00708305|19443552|P2|NOT COMPLETED|Period 2||2
7901257|NCT00708305|19443553|P1|NOT COMPLETED|Period 2||1
7901258|NCT00708305|19443550|P4|COMPLETED|Period 2||14
7901259|NCT00708305|19443551|P3|COMPLETED|Period 2||16
7901260|NCT00708305|19443552|P2|COMPLETED|Period 2||13
7901261|NCT00708305|19443553|P1|COMPLETED|Period 2||14
7901262|NCT00708305|19443550|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
7901263|NCT00708305|19443551|P3|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16
7901264|NCT00708305|19443552|P2|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
7901265|NCT00708305|19443553|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
7901266|NCT00708305|19443550|P4|NOT COMPLETED|Period 1||2
7901267|NCT00708305|19443551|P3|NOT COMPLETED|Period 1||1
7901268|NCT00708305|19443552|P2|NOT COMPLETED|Period 1||0
7901269|NCT00708305|19443553|P1|NOT COMPLETED|Period 1||1
7901270|NCT00708305|19443550|P4|COMPLETED|Period 1||14
7901271|NCT00708305|19443551|P3|COMPLETED|Period 1||16
7901272|NCT00708305|19443552|P2|COMPLETED|Period 1||16
7901273|NCT00708305|19443553|P1|COMPLETED|Period 1||15
7901274|NCT00708305|19443550|P4|STARTED|Period 1||16
7901275|NCT00708305|19443551|P3|STARTED|Period 1||17
7901276|NCT00708305|19443552|P2|STARTED|Period 1||16
7901277|NCT00708305|19443553|P1|STARTED|Period 1||16
7901278|NCT00708227|19443589|P4|NOT COMPLETED|Overall Study||3
7901279|NCT00708227|19443590|P3|NOT COMPLETED|Overall Study||1
7901280|NCT00708227|19443591|P2|NOT COMPLETED|Overall Study||5
7901281|NCT00708227|19443592|P1|NOT COMPLETED|Overall Study||1
7901282|NCT00708227|19443589|P4|COMPLETED|Overall Study||22
7901283|NCT00708227|19443590|P3|COMPLETED|Overall Study||17
7901284|NCT00708227|19443591|P2|COMPLETED|Overall Study||21
7901285|NCT00708227|19443592|P1|COMPLETED|Overall Study||18
7901286|NCT00708227|19443589|P4|STARTED|Overall Study||25
7901287|NCT00708227|19443590|P3|STARTED|Overall Study||18
7901288|NCT00708227|19443591|P2|STARTED|Overall Study||26
7901289|NCT00708227|19443592|P1|STARTED|Overall Study||19
7901290|NCT00708214|19443625|P3|NOT COMPLETED|Overall Study||8
7901291|NCT00708214|19443626|P2|NOT COMPLETED|Overall Study||13
7901292|NCT00708214|19443627|P1|NOT COMPLETED|Overall Study||7
7901293|NCT00708214|19443625|P3|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
7901294|NCT00708214|19443626|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
7901295|NCT00708214|19443627|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
7901296|NCT00708214|19443625|P3|STARTED|Overall Study||8
7901297|NCT00708214|19443626|P2|STARTED|Overall Study||13
7901298|NCT00708214|19443627|P1|STARTED|Overall Study||7
7901299|NCT00708201|19443670|P2|NOT COMPLETED|Overall Study||6
7901300|NCT00708201|19443671|P1|NOT COMPLETED|Overall Study||7
7901301|NCT00708201|19443670|P2|COMPLETED|Overall Study||137
7901302|NCT00708201|19443671|P1|COMPLETED|Overall Study||130
7901303|NCT00708201|19443670|P2|Received at Least 1 Dose of Study Drug|Overall Study||137
7901304|NCT00708201|19443671|P1|Received at Least 1 Dose of Study Drug|Overall Study||130
7901305|NCT00708201|19443670|P2|STARTED|Overall Study||143
7901306|NCT00708201|19443671|P1|STARTED|Overall Study||137
7901307|NCT00708175|19443695|P2|NOT COMPLETED|Overall Study||21
7901308|NCT00708175|19443696|P1|NOT COMPLETED|Overall Study||18
7901309|NCT00708175|19443695|P2|COMPLETED|Overall Study||57
7901310|NCT00708175|19443696|P1|COMPLETED|Overall Study||60
7901311|NCT00708175|19443695|P2|STARTED|Overall Study||78
7901312|NCT00708175|19443696|P1|STARTED|Overall Study||78
7901313|NCT00708162|19443712|P2|NOT COMPLETED|Open-Label Phase||30
7901314|NCT00708162|19443713|P1|NOT COMPLETED|Open-Label Phase||44
7901315|NCT00708162|19443712|P2|COMPLETED|Open-Label Phase||121
7901316|NCT00708162|19443713|P1|COMPLETED|Open-Label Phase||152
7901317|NCT00708162|19443712|P2|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151
7901318|NCT00708162|19443713|P1|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196
7901319|NCT00708162|19443712|P2|NOT COMPLETED|Randomized Phase||154
7901320|NCT00708162|19443713|P1|NOT COMPLETED|Randomized Phase||156
7901321|NCT00708162|19443712|P2|COMPLETED|Randomized Phase||209
7901322|NCT00708162|19443713|P1|COMPLETED|Randomized Phase||205
7901323|NCT00708162|19443712|P2|Randomized and Treated|Randomized Phase||358
7901324|NCT00708162|19443713|P1|Randomized and Treated|Randomized Phase||354
7901325|NCT00708162|19443712|P2|STARTED|Randomized Phase||363
7901326|NCT00708162|19443713|P1|STARTED|Randomized Phase||361
7901327|NCT00708123|19443754|P5|NOT COMPLETED|Period 5||0
7901328|NCT00708123|19443755|P4|NOT COMPLETED|Period 5||0
7901329|NCT00708123|19443756|P3|NOT COMPLETED|Period 5||0
7901330|NCT00708123|19443757|P2|NOT COMPLETED|Period 5||0
7901331|NCT00708123|19443758|P1|NOT COMPLETED|Period 5||0
7901332|NCT00708123|19443754|P5|COMPLETED|Period 5||10
7901333|NCT00708123|19443755|P4|COMPLETED|Period 5||11
7901334|NCT00708123|19443756|P3|COMPLETED|Period 5||11
7901335|NCT00708123|19443757|P2|COMPLETED|Period 5||10
7901336|NCT00708123|19443758|P1|COMPLETED|Period 5||10
7901337|NCT00708123|19443754|P5|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
7901338|NCT00708123|19443755|P4|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
7901339|NCT00708123|19443756|P3|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
7901340|NCT00708123|19443757|P2|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
7901341|NCT00708123|19443758|P1|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
7901342|NCT00708123|19443754|P5|NOT COMPLETED|Period 4||0
7901343|NCT00708123|19443755|P4|NOT COMPLETED|Period 4||0
7901344|NCT00708123|19443756|P3|NOT COMPLETED|Period 4||0
7901345|NCT00708123|19443757|P2|NOT COMPLETED|Period 4||1
7901346|NCT00708123|19443758|P1|NOT COMPLETED|Period 4||0
7901347|NCT00708123|19443754|P5|COMPLETED|Period 4||11
7901348|NCT00708123|19443755|P4|COMPLETED|Period 4||10
7901349|NCT00708123|19443756|P3|COMPLETED|Period 4||10
7901350|NCT00708123|19443757|P2|COMPLETED|Period 4||11
7901351|NCT00708123|19443758|P1|COMPLETED|Period 4||10
7901352|NCT00708123|19443754|P5|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11
7901353|NCT00708123|19443755|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
7901354|NCT00708123|19443756|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
7901355|NCT00708123|19443757|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
7901356|NCT00708123|19443758|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
7901357|NCT00708123|19443754|P5|NOT COMPLETED|Period 3||0
7901358|NCT00708123|19443755|P4|NOT COMPLETED|Period 3||1
7901359|NCT00708123|19443756|P3|NOT COMPLETED|Period 3||1
7901360|NCT00708123|19443757|P2|NOT COMPLETED|Period 3||0
7901361|NCT00708123|19443758|P1|NOT COMPLETED|Period 3||0
7901362|NCT00708123|19443754|P5|COMPLETED|Period 3||10
7901363|NCT00708123|19443755|P4|COMPLETED|Period 3||11
7901364|NCT00708123|19443756|P3|COMPLETED|Period 3||10
7901365|NCT00708123|19443757|P2|COMPLETED|Period 3||10
7901366|NCT00708123|19443758|P1|COMPLETED|Period 3||12
7901367|NCT00708123|19443754|P5|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
7901368|NCT00708123|19443755|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
7901369|NCT00708123|19443756|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11
7901370|NCT00708123|19443757|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
7901371|NCT00708123|19443758|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
7901372|NCT00708123|19443754|P5|NOT COMPLETED|Period 2||0
7901373|NCT00708123|19443755|P4|NOT COMPLETED|Period 2||1
7901374|NCT00708123|19443756|P3|NOT COMPLETED|Period 2||0
7901375|NCT00708123|19443757|P2|NOT COMPLETED|Period 2||0
7901376|NCT00708123|19443758|P1|NOT COMPLETED|Period 2||1
7901377|NCT00708123|19443754|P5|COMPLETED|Period 2||11
7901378|NCT00708123|19443755|P4|COMPLETED|Period 2||10
7901379|NCT00708123|19443756|P3|COMPLETED|Period 2||12
7901380|NCT00708123|19443757|P2|COMPLETED|Period 2||12
7901381|NCT00708123|19443758|P1|COMPLETED|Period 2||10
7901382|NCT00708123|19443754|P5|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
7901383|NCT00708123|19443755|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
7901384|NCT00708123|19443756|P3|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
7901385|NCT00708123|19443757|P2|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
7901386|NCT00708123|19443758|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
7901387|NCT00708123|19443754|P5|NOT COMPLETED|Period 1||0
7901388|NCT00708123|19443755|P4|NOT COMPLETED|Period 1||1
7901389|NCT00708123|19443756|P3|NOT COMPLETED|Period 1||1
7901390|NCT00708123|19443757|P2|NOT COMPLETED|Period 1||1
7901391|NCT00708123|19443758|P1|NOT COMPLETED|Period 1||0
7901392|NCT00708123|19443754|P5|COMPLETED|Period 1||12
7901393|NCT00708123|19443755|P4|COMPLETED|Period 1||11
7901394|NCT00708123|19443756|P3|COMPLETED|Period 1||11
7901395|NCT00708123|19443757|P2|COMPLETED|Period 1||11
7901396|NCT00708123|19443758|P1|COMPLETED|Period 1||12
7901397|NCT00708123|19443754|P5|STARTED|Period 1||12
7901398|NCT00708123|19443755|P4|STARTED|Period 1||12
7901399|NCT00708123|19443756|P3|STARTED|Period 1||12
7901400|NCT00708123|19443757|P2|STARTED|Period 1||12
7901401|NCT00708123|19443758|P1|STARTED|Period 1||12
7901402|NCT00708110|19443782|P4|NOT COMPLETED|Overall Study||0
7901403|NCT00708110|19443783|P3|NOT COMPLETED|Overall Study||0
7901404|NCT00708110|19443784|P2|NOT COMPLETED|Overall Study||0
7901405|NCT00708110|19443785|P1|NOT COMPLETED|Overall Study||0
7901406|NCT00708110|19443782|P4|COMPLETED|Overall Study||10
7901407|NCT00708110|19443783|P3|COMPLETED|Overall Study||9
7901408|NCT00708110|19443784|P2|COMPLETED|Overall Study||9
7901409|NCT00708110|19443785|P1|COMPLETED|Overall Study||7
7901410|NCT00708110|19443782|P4|STARTED|Overall Study||10
7901411|NCT00708110|19443783|P3|STARTED|Overall Study||9
7901412|NCT00708110|19443784|P2|STARTED|Overall Study||9
7901413|NCT00708110|19443785|P1|STARTED|Overall Study||7
7901414|NCT00708097|19443891|P5|NOT COMPLETED|Period 5||0
7901415|NCT00708097|19443892|P4|NOT COMPLETED|Period 5||0
7901416|NCT00708097|19443893|P3|NOT COMPLETED|Period 5||0
7901417|NCT00708097|19443894|P2|NOT COMPLETED|Period 5||0
7901418|NCT00708097|19443895|P1|NOT COMPLETED|Period 5||0
7901419|NCT00708097|19443891|P5|COMPLETED|Period 5||12
7901420|NCT00708097|19443892|P4|COMPLETED|Period 5||10
7901421|NCT00708097|19443893|P3|COMPLETED|Period 5||11
7901422|NCT00708097|19443894|P2|COMPLETED|Period 5||9
7901423|NCT00708097|19443895|P1|COMPLETED|Period 5||8
7901424|NCT00708097|19443891|P5|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12
7901425|NCT00708097|19443892|P4|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10
7901426|NCT00708097|19443893|P3|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11
7901427|NCT00708097|19443894|P2|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9
7901428|NCT00708097|19443895|P1|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8
7901429|NCT00708097|19443891|P5|NOT COMPLETED|Period 4||0
7901430|NCT00708097|19443892|P4|NOT COMPLETED|Period 4||0
7901431|NCT00708097|19443893|P3|NOT COMPLETED|Period 4||0
7901432|NCT00708097|19443894|P2|NOT COMPLETED|Period 4||0
7901433|NCT00708097|19443895|P1|NOT COMPLETED|Period 4||0
7901434|NCT00708097|19443891|P5|COMPLETED|Period 4||8
7901435|NCT00708097|19443892|P4|COMPLETED|Period 4||11
7901436|NCT00708097|19443893|P3|COMPLETED|Period 4||10
7901437|NCT00708097|19443894|P2|COMPLETED|Period 4||9
7901438|NCT00708097|19443895|P1|COMPLETED|Period 4||12
7901439|NCT00708097|19443891|P5|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8
7901440|NCT00708097|19443892|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11
7901441|NCT00708097|19443893|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10
7901442|NCT00708097|19443894|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9
7901443|NCT00708097|19443895|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12
7901444|NCT00708097|19443891|P5|NOT COMPLETED|Period 3||0
7901445|NCT00708097|19443892|P4|NOT COMPLETED|Period 3||0
7901446|NCT00708097|19443893|P3|NOT COMPLETED|Period 3||0
7901447|NCT00708097|19443894|P2|NOT COMPLETED|Period 3||0
7901448|NCT00708097|19443895|P1|NOT COMPLETED|Period 3||0
7901449|NCT00708097|19443891|P5|COMPLETED|Period 3||10
7901450|NCT00708097|19443892|P4|COMPLETED|Period 3||10
7901451|NCT00708097|19443893|P3|COMPLETED|Period 3||10
7901452|NCT00708097|19443894|P2|COMPLETED|Period 3||11
7901453|NCT00708097|19443895|P1|COMPLETED|Period 3||9
7901454|NCT00708097|19443891|P5|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
7901455|NCT00708097|19443892|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
7901456|NCT00708097|19443893|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
7901457|NCT00708097|19443894|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11
7901458|NCT00708097|19443895|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9
7901459|NCT00708097|19443891|P5|NOT COMPLETED|Period 2||0
7901460|NCT00708097|19443892|P4|NOT COMPLETED|Period 2||1
7901461|NCT00708097|19443893|P3|NOT COMPLETED|Period 2||1
7901462|NCT00708097|19443894|P2|NOT COMPLETED|Period 2||1
7901463|NCT00708097|19443895|P1|NOT COMPLETED|Period 2||0
7901464|NCT00708097|19443891|P5|COMPLETED|Period 2||10
7901465|NCT00708097|19443892|P4|COMPLETED|Period 2||10
7901466|NCT00708097|19443893|P3|COMPLETED|Period 2||9
7901467|NCT00708097|19443894|P2|COMPLETED|Period 2||11
7901468|NCT00708097|19443895|P1|COMPLETED|Period 2||10
7901469|NCT00708097|19443891|P5|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
7901470|NCT00708097|19443892|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11
7901471|NCT00708097|19443893|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
7901472|NCT00708097|19443894|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12
7901473|NCT00708097|19443895|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
7901474|NCT00708097|19443891|P5|NOT COMPLETED|Period 1||1
7901475|NCT00708097|19443892|P4|NOT COMPLETED|Period 1||2
7901476|NCT00708097|19443893|P3|NOT COMPLETED|Period 1||0
7901477|NCT00708097|19443894|P2|NOT COMPLETED|Period 1||1
7901478|NCT00708097|19443895|P1|NOT COMPLETED|Period 1||0
7901479|NCT00708097|19443891|P5|COMPLETED|Period 1||10
7901480|NCT00708097|19443892|P4|COMPLETED|Period 1||9
7901481|NCT00708097|19443893|P3|COMPLETED|Period 1||12
7901482|NCT00708097|19443894|P2|COMPLETED|Period 1||11
7901483|NCT00708097|19443895|P1|COMPLETED|Period 1||11
7901484|NCT00708097|19443891|P5|STARTED|Period 1||11
7901485|NCT00708097|19443892|P4|STARTED|Period 1||11
7901486|NCT00708097|19443893|P3|STARTED|Period 1||12
7901487|NCT00708097|19443894|P2|STARTED|Period 1||12
7901488|NCT00708097|19443895|P1|STARTED|Period 1||11
7901489|NCT00708071|19443925|P1|NOT COMPLETED|Overall Study||0
7901490|NCT00708071|19443925|P1|COMPLETED|Overall Study||45
7901491|NCT00708071|19443925|P1|STARTED|Overall Study|Randomized and treated|45
7901492|NCT00708032|19444005|P2|NOT COMPLETED|Overall Study||16
7901493|NCT00708032|19444006|P1|NOT COMPLETED|Overall Study||10
7901494|NCT00708032|19444005|P2|COMPLETED|Overall Study||22
7901495|NCT00708032|19444006|P1|COMPLETED|Overall Study||26
7901496|NCT00708032|19444005|P2|STARTED|Overall Study||38
7901497|NCT00708032|19444006|P1|STARTED|Overall Study||36
7901498|NCT00708019|19444022|P2|NOT COMPLETED|Overall Study||15
7901499|NCT00708019|19444023|P1|NOT COMPLETED|Overall Study||15
7901500|NCT00708019|19444022|P2|COMPLETED|Overall Study||78
7901501|NCT00708019|19444023|P1|COMPLETED|Overall Study||77
7901502|NCT00708019|19444022|P2|STARTED|Overall Study||93
7901503|NCT00708019|19444023|P1|STARTED|Overall Study||92
7901504|NCT00707993|19444033|P2|NOT COMPLETED|Overall Study||94
7901505|NCT00707993|19444034|P1|NOT COMPLETED|Overall Study||89
7901506|NCT00707993|19444033|P2|COMPLETED|Overall Study||125
7901507|NCT00707993|19444034|P1|COMPLETED|Overall Study||133
7901508|NCT00707993|19444033|P2|STARTED|Overall Study||219
7901509|NCT00707993|19444034|P1|STARTED|Overall Study||222
7901510|NCT00707980|19444076|P1|NOT COMPLETED|Overall Study||310
7901511|NCT00707980|19444076|P1|COMPLETED|Overall Study||526
7901512|NCT00707980|19444076|P1|Received Treatment|Overall Study||834
7901513|NCT00707980|19444076|P1|STARTED|Overall Study||836
7901514|NCT00707967|19444094|P3|NOT COMPLETED|Overall Study||0
7901515|NCT00707967|19444095|P2|NOT COMPLETED|Overall Study||0
7901516|NCT00707967|19444096|P1|NOT COMPLETED|Overall Study||0
7901517|NCT00707967|19444094|P3|COMPLETED|Overall Study||7
7901518|NCT00707967|19444095|P2|COMPLETED|Overall Study||8
7901519|NCT00707967|19444096|P1|COMPLETED|Overall Study||22
7901520|NCT00707967|19444094|P3|STARTED|Overall Study||7
7901521|NCT00707967|19444095|P2|STARTED|Overall Study||8
7901522|NCT00707967|19444096|P1|STARTED|Overall Study||22
7901523|NCT00707954|19444160|P5|NOT COMPLETED|Overall Study||1
7901524|NCT00707954|19444161|P4|NOT COMPLETED|Overall Study||0
7901525|NCT00707954|19444162|P3|NOT COMPLETED|Overall Study||0
7901526|NCT00707954|19444163|P2|NOT COMPLETED|Overall Study||0
7901527|NCT00707954|19444164|P1|NOT COMPLETED|Overall Study||0
7901528|NCT00707954|19444160|P5|COMPLETED|Overall Study||9
7901529|NCT00707954|19444161|P4|COMPLETED|Overall Study||13
7901530|NCT00707954|19444162|P3|COMPLETED|Overall Study||14
7901531|NCT00707954|19444163|P2|COMPLETED|Overall Study||12
7901532|NCT00707954|19444164|P1|COMPLETED|Overall Study||12
7901533|NCT00707954|19444160|P5|STARTED|Overall Study||10
7901534|NCT00707954|19444161|P4|STARTED|Overall Study||13
7901535|NCT00707954|19444162|P3|STARTED|Overall Study||14
7901536|NCT00707954|19444163|P2|STARTED|Overall Study||12
7901537|NCT00707954|19444164|P1|STARTED|Overall Study||12
7901538|NCT00707915|19444176|P1|NOT COMPLETED|Overall Study||0
7901539|NCT00707915|19444176|P1|COMPLETED|Overall Study||30
7901540|NCT00707915|19444176|P1|Effects of Discontinuing Benzodiazepine|Overall Study||30
7901541|NCT00707915|19444176|P1|STARTED|Overall Study||30
7901542|NCT00707863|19444187|P2|NOT COMPLETED|Overall Study||3
7901543|NCT00707863|19444188|P1|NOT COMPLETED|Overall Study||0
7901544|NCT00707863|19444187|P2|COMPLETED|Overall Study||8
7901545|NCT00707863|19444188|P1|COMPLETED|Overall Study||6
7901546|NCT00707863|19444187|P2|STARTED|Overall Study||11
7901547|NCT00707863|19444188|P1|STARTED|Overall Study||6
7901548|NCT00707759|19444196|P2|NOT COMPLETED|Overall Study||2
7901549|NCT00707759|19444197|P1|NOT COMPLETED|Overall Study||2
7901550|NCT00707759|19444196|P2|COMPLETED|Overall Study||12
7901551|NCT00707759|19444197|P1|COMPLETED|Overall Study||12
7901552|NCT00707759|19444196|P2|STARTED|Overall Study||14
7901553|NCT00707759|19444197|P1|STARTED|Overall Study||14
7901554|NCT00707746|19444205|P2|NOT COMPLETED|Follow-up Period||0
7901555|NCT00707746|19444206|P1|NOT COMPLETED|Follow-up Period||0
7901556|NCT00707746|19444205|P2|COMPLETED|Follow-up Period||21
7901557|NCT00707746|19444206|P1|COMPLETED|Follow-up Period||12
7901558|NCT00707746|19444205|P2|STARTED|Follow-up Period||21
7901559|NCT00707746|19444206|P1|STARTED|Follow-up Period||12
7901560|NCT00707746|19444205|P2|NOT COMPLETED|Treatment Period||5
7901561|NCT00707746|19444206|P1|NOT COMPLETED|Treatment Period||2
7901562|NCT00707746|19444205|P2|COMPLETED|Treatment Period||17
7901563|NCT00707746|19444206|P1|COMPLETED|Treatment Period||10
7901564|NCT00707746|19444205|P2|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21
7901565|NCT00707746|19444206|P1|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12
7901566|NCT00707746|19444205|P2|STARTED|Treatment Period||22
7901567|NCT00707746|19444206|P1|STARTED|Treatment Period||12
7901568|NCT00707655|19444254|P2|NOT COMPLETED|Overall Study||2
7901569|NCT00707655|19444255|P1|NOT COMPLETED|Overall Study||0
7901570|NCT00707655|19444254|P2|COMPLETED|Overall Study||3
7901571|NCT00707655|19444255|P1|COMPLETED|Overall Study||3
7901572|NCT00707655|19444254|P2|STARTED|Overall Study||5
7901573|NCT00707655|19444255|P1|STARTED|Overall Study||3
7901574|NCT00707577|19444267|P2|NOT COMPLETED|Overall Study||38
7901575|NCT00707577|19444268|P1|NOT COMPLETED|Overall Study||54
7901576|NCT00707577|19444267|P2|COMPLETED|Overall Study||118
7901577|NCT00707577|19444268|P1|COMPLETED|Overall Study||120
7901578|NCT00707577|19444267|P2|STARTED|Overall Study||156
7901579|NCT00707577|19444268|P1|STARTED|Overall Study||174
7901580|NCT00707486|19444274|P1|NOT COMPLETED|Overall Study||1
7901581|NCT00707486|19444274|P1|COMPLETED|Overall Study||71
7901582|NCT00707486|19444274|P1|STARTED|Overall Study||72
7901583|NCT00707447|19444285|P2|NOT COMPLETED|Overall Study||8
7901584|NCT00707447|19444286|P1|NOT COMPLETED|Overall Study||8
7901585|NCT00707447|19444285|P2|COMPLETED|Overall Study||85
7901586|NCT00707447|19444286|P1|COMPLETED|Overall Study||81
7901587|NCT00707447|19444285|P2|STARTED|Overall Study||93
7901588|NCT00707447|19444286|P1|STARTED|Overall Study||89
7901589|NCT00707434|19444310|P1|NOT COMPLETED|Overall Study||1
7901590|NCT00707434|19444310|P1|COMPLETED|Overall Study||5
7901591|NCT00707434|19444310|P1|STARTED|Overall Study||6
7901592|NCT00707343|19444314|P1|NOT COMPLETED|Overall Study||0
7901593|NCT00707343|19444314|P1|COMPLETED|Overall Study||15
7901594|NCT00707343|19444314|P1|STARTED|Overall Study||15
7901595|NCT00707239|19444321|P3|NOT COMPLETED|Overall Study||14
7901596|NCT00707239|19444322|P2|NOT COMPLETED|Overall Study||11
7901597|NCT00707239|19444323|P1|NOT COMPLETED|Overall Study||19
7901598|NCT00707239|19444321|P3|COMPLETED|Overall Study||21
7901599|NCT00707239|19444322|P2|COMPLETED|Overall Study||25
7901600|NCT00707239|19444323|P1|COMPLETED|Overall Study||18
7901601|NCT00707239|19444321|P3|Treated|Overall Study||34
7901602|NCT00707239|19444322|P2|Treated|Overall Study||35
7901603|NCT00707239|19444323|P1|Treated|Overall Study||36
7901604|NCT00707239|19444321|P3|STARTED|Overall Study||35
7901605|NCT00707239|19444322|P2|STARTED|Overall Study||36
7901606|NCT00707239|19444323|P1|STARTED|Overall Study||37
7901607|NCT00707174|19444371|P2|NOT COMPLETED|Overall Study||7
7901608|NCT00707174|19444372|P1|NOT COMPLETED|Overall Study||5
7901609|NCT00707174|19444371|P2|COMPLETED|Overall Study||37
7901610|NCT00707174|19444372|P1|COMPLETED|Overall Study||41
7901611|NCT00707174|19444371|P2|STARTED|Overall Study||44
7901612|NCT00707174|19444372|P1|STARTED|Overall Study||46
7901613|NCT00707161|19444378|P1|NOT COMPLETED|Overall Study||6
7901614|NCT00707161|19444378|P1|COMPLETED|Overall Study||0
7901615|NCT00707161|19444378|P1|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6
7901616|NCT00707057|19444384|P2|NOT COMPLETED|Overall Study||4
7901617|NCT00707057|19444385|P1|NOT COMPLETED|Overall Study||8
7901618|NCT00707057|19444384|P2|COMPLETED|Overall Study||83
7901619|NCT00707057|19444385|P1|COMPLETED|Overall Study||161
7901620|NCT00707057|19444384|P2|STARTED|Overall Study||87
7901621|NCT00707057|19444385|P1|STARTED|Overall Study||169
7901622|NCT00707031|19444419|P2|NOT COMPLETED|Overall Study||99
7901623|NCT00707031|19444420|P1|NOT COMPLETED|Overall Study||104
7901624|NCT00707031|19444419|P2|COMPLETED|Overall Study||220
7901625|NCT00707031|19444420|P1|COMPLETED|Overall Study||216
7901626|NCT00707031|19444419|P2|Modified Intent-to-Treat Population|Overall Study||315
7901627|NCT00707031|19444420|P1|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315
7901628|NCT00707031|19444419|P2|Treated/Safety Population|Overall Study||316
7901629|NCT00707031|19444420|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318
7901630|NCT00707031|19444419|P2|STARTED|Overall Study||319
7901631|NCT00707031|19444420|P1|STARTED|Overall Study|Randomized|320
7901632|NCT00706992|19444449|P7|NOT COMPLETED|Overall Study||3
7901633|NCT00706992|19444450|P6|NOT COMPLETED|Overall Study||2
7901634|NCT00706992|19444451|P5|NOT COMPLETED|Overall Study||4
7901635|NCT00706992|19444452|P4|NOT COMPLETED|Overall Study||2
7901636|NCT00706992|19444453|P3|NOT COMPLETED|Overall Study||6
7901637|NCT00706992|19444454|P2|NOT COMPLETED|Overall Study||5
7901638|NCT00706992|19444455|P1|NOT COMPLETED|Overall Study||5
7901639|NCT00706992|19444449|P7|COMPLETED|Overall Study||3
7901640|NCT00706992|19444450|P6|COMPLETED|Overall Study||3
7901641|NCT00706992|19444451|P5|COMPLETED|Overall Study||2
7901642|NCT00706992|19444452|P4|COMPLETED|Overall Study||6
7901643|NCT00706992|19444453|P3|COMPLETED|Overall Study||3
7901644|NCT00706992|19444454|P2|COMPLETED|Overall Study||3
7901645|NCT00706992|19444455|P1|COMPLETED|Overall Study||3
7901646|NCT00706992|19444449|P7|STARTED|Overall Study||6
7901647|NCT00706992|19444450|P6|STARTED|Overall Study||5
7901648|NCT00706992|19444451|P5|STARTED|Overall Study||6
7901649|NCT00706992|19444452|P4|STARTED|Overall Study||8
7901650|NCT00706992|19444453|P3|STARTED|Overall Study||9
7901651|NCT00706992|19444454|P2|STARTED|Overall Study||8
7901652|NCT00706992|19444455|P1|STARTED|Overall Study||8
7901653|NCT00706979|19444474|P2|NOT COMPLETED|Overall Study||0
7901654|NCT00706979|19444475|P1|NOT COMPLETED|Overall Study||0
7901655|NCT00706979|19444474|P2|COMPLETED|Overall Study||423
7901656|NCT00706979|19444475|P1|COMPLETED|Overall Study||426
7901657|NCT00706979|19444474|P2|STARTED|Overall Study||423
7901658|NCT00706979|19444475|P1|STARTED|Overall Study||426
7901659|NCT00706966|19444487|P1|NOT COMPLETED|Overall Study||1
7901660|NCT00706966|19444487|P1|COMPLETED|Overall Study||9
7901661|NCT00706966|19444487|P1|STARTED|Overall Study||10
7901662|NCT00706914|19444523|P3|NOT COMPLETED|Overall Study||1
7901663|NCT00706914|19444524|P2|NOT COMPLETED|Overall Study||4
7901664|NCT00706914|19444525|P1|NOT COMPLETED|Overall Study||6
7901665|NCT00706914|19444523|P3|COMPLETED|Overall Study||30
7901666|NCT00706914|19444524|P2|COMPLETED|Overall Study||58
7901667|NCT00706914|19444525|P1|COMPLETED|Overall Study||57
7901668|NCT00706914|19444523|P3|STARTED|Overall Study||31
7901669|NCT00706914|19444524|P2|STARTED|Overall Study||62
7901670|NCT00706914|19444525|P1|STARTED|Overall Study||63
7901671|NCT00706901|19444548|P3|NOT COMPLETED|Overall Study||8
7901672|NCT00706901|19444549|P2|NOT COMPLETED|Overall Study||5
7901673|NCT00706901|19444550|P1|NOT COMPLETED|Overall Study||8
7901674|NCT00706901|19444548|P3|COMPLETED|Overall Study||51
7901675|NCT00706901|19444549|P2|COMPLETED|Overall Study||57
7901676|NCT00706901|19444550|P1|COMPLETED|Overall Study||51
7901677|NCT00706901|19444548|P3|STARTED|Overall Study||59
7901678|NCT00706901|19444549|P2|STARTED|Overall Study||62
7901679|NCT00706901|19444550|P1|STARTED|Overall Study||59
7901680|NCT00706849|19444575|P2|NOT COMPLETED|Follow-up Period||3
7901681|NCT00706849|19444576|P1|NOT COMPLETED|Follow-up Period||0
7901682|NCT00706849|19444575|P2|COMPLETED|Follow-up Period||25
7901683|NCT00706849|19444576|P1|COMPLETED|Follow-up Period||3
7901684|NCT00706849|19444575|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28
7901685|NCT00706849|19444576|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3
7901686|NCT00706849|19444575|P2|NOT COMPLETED|Treatment Period||10
7901687|NCT00706849|19444576|P1|NOT COMPLETED|Treatment Period||0
7901688|NCT00706849|19444575|P2|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73
7901689|NCT00706849|19444576|P1|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41
7901690|NCT00706849|19444575|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82
7901691|NCT00706849|19444576|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41
7901692|NCT00706849|19444575|P2|STARTED|Treatment Period||83
7901693|NCT00706849|19444576|P1|STARTED|Treatment Period||41
7901694|NCT00706836|19444620|P1|NOT COMPLETED|Overall Study||0
7901695|NCT00706836|19444620|P1|COMPLETED|Overall Study||16
7901696|NCT00706836|19444620|P1|STARTED|Overall Study||16
7901697|NCT00706823|19444630|P2|NOT COMPLETED|Overall Study||0
7901698|NCT00706823|19444631|P1|NOT COMPLETED|Overall Study||0
7901699|NCT00706823|19444630|P2|COMPLETED|Overall Study||25
7901700|NCT00706823|19444631|P1|COMPLETED|Overall Study||25
7901701|NCT00706823|19444630|P2|STARTED|Overall Study||25
7901702|NCT00706823|19444631|P1|STARTED|Overall Study||25
7901703|NCT00706810|19444647|P1|NOT COMPLETED|Overall Study||1
7901704|NCT00706810|19444647|P1|COMPLETED|Overall Study||7
7901705|NCT00706810|19444647|P1|STARTED|Overall Study||8
7901706|NCT00706797|19444654|P2|NOT COMPLETED|Overall Study||71
7901707|NCT00706797|19444655|P1|NOT COMPLETED|Overall Study||69
7901708|NCT00706797|19444654|P2|COMPLETED|Overall Study||0
7901709|NCT00706797|19444655|P1|COMPLETED|Overall Study||1
7901710|NCT00706797|19444654|P2|Safety Population|Overall Study||71
7901711|NCT00706797|19444655|P1|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63
7901712|NCT00706797|19444654|P2|STARTED|Overall Study||71
7901713|NCT00706797|19444655|P1|STARTED|Overall Study||70
7901714|NCT00706784|19444697|P2|NOT COMPLETED|Overall Study||0
7901715|NCT00706784|19444698|P1|NOT COMPLETED|Overall Study||0
7901716|NCT00706784|19444697|P2|COMPLETED|Overall Study||3
7901717|NCT00706784|19444698|P1|COMPLETED|Overall Study||3
7901718|NCT00706784|19444697|P2|STARTED|Overall Study||3
7901719|NCT00706784|19444698|P1|STARTED|Overall Study||3
7901720|NCT00706719|19444707|P3|NOT COMPLETED|Overall Study||4
7901721|NCT00706719|19444708|P2|NOT COMPLETED|Overall Study||1
7901722|NCT00706719|19444709|P1|NOT COMPLETED|Overall Study||0
7901723|NCT00706719|19444707|P3|COMPLETED|Overall Study||1
7901724|NCT00706719|19444708|P2|COMPLETED|Overall Study||6
7901725|NCT00706719|19444709|P1|COMPLETED|Overall Study||5
7901726|NCT00706719|19444707|P3|STARTED|Overall Study||5
7901727|NCT00706719|19444708|P2|STARTED|Overall Study||7
7901728|NCT00706719|19444709|P1|STARTED|Overall Study||5
7901729|NCT00706706|19444724|P1|NOT COMPLETED|Overall Study||105
7901730|NCT00706706|19444724|P1|COMPLETED|Overall Study||0
7901731|NCT00706706|19444724|P1|STARTED|Overall Study||105
7901732|NCT00706654|19444734|P4|NOT COMPLETED|Depot Maintenance Phase||70
7901733|NCT00706654|19444735|P3|NOT COMPLETED|Depot Maintenance Phase||88
7901734|NCT00706654|19444736|P2|NOT COMPLETED|Depot Maintenance Phase||69
7901735|NCT00706654|19444737|P1|NOT COMPLETED|Depot Maintenance Phase||0
7901736|NCT00706654|19444734|P4|COMPLETED|Depot Maintenance Phase||61
7901737|NCT00706654|19444735|P3|COMPLETED|Depot Maintenance Phase||178
7901738|NCT00706654|19444736|P2|COMPLETED|Depot Maintenance Phase||196
7901739|NCT00706654|19444737|P1|COMPLETED|Depot Maintenance Phase||0
7901740|NCT00706654|19444734|P4|STARTED|Depot Maintenance Phase||131
7901741|NCT00706654|19444735|P3|STARTED|Depot Maintenance Phase||266
7901742|NCT00706654|19444736|P2|STARTED|Depot Maintenance Phase||265
7901743|NCT00706654|19444737|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0
7901744|NCT00706654|19444734|P4|NOT COMPLETED|Oral Stabilization Phase||0
7901745|NCT00706654|19444735|P3|NOT COMPLETED|Oral Stabilization Phase||0
7901746|NCT00706654|19444736|P2|NOT COMPLETED|Oral Stabilization Phase||0
7901747|NCT00706654|19444737|P1|NOT COMPLETED|Oral Stabilization Phase||180
7901748|NCT00706654|19444734|P4|COMPLETED|Oral Stabilization Phase||0
7901749|NCT00706654|19444735|P3|COMPLETED|Oral Stabilization Phase||0
7901750|NCT00706654|19444736|P2|COMPLETED|Oral Stabilization Phase||0
7901751|NCT00706654|19444737|P1|COMPLETED|Oral Stabilization Phase||662
7901752|NCT00706654|19444734|P4|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
7901753|NCT00706654|19444735|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
7901754|NCT00706654|19444736|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
7901755|NCT00706654|19444737|P1|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842
7901756|NCT00706654|19444734|P4|NOT COMPLETED|Conversion Phase||0
7901757|NCT00706654|19444735|P3|NOT COMPLETED|Conversion Phase||0
7901758|NCT00706654|19444736|P2|NOT COMPLETED|Conversion Phase||0
7901759|NCT00706654|19444737|P1|NOT COMPLETED|Conversion Phase||95
7901760|NCT00706654|19444734|P4|COMPLETED|Conversion Phase||0
7901761|NCT00706654|19444735|P3|COMPLETED|Conversion Phase||0
7901762|NCT00706654|19444736|P2|COMPLETED|Conversion Phase||0
7901763|NCT00706654|19444737|P1|COMPLETED|Conversion Phase||614
7901764|NCT00706654|19444734|P4|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
7901765|NCT00706654|19444735|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
7901766|NCT00706654|19444736|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
7901767|NCT00706654|19444737|P1|STARTED|Conversion Phase||709
7901768|NCT00706641|19444756|P1|NOT COMPLETED|Radical Cystectomy||1
7901769|NCT00706641|19444756|P1|COMPLETED|Radical Cystectomy||22
7901770|NCT00706641|19444756|P1|STARTED|Radical Cystectomy||23
7901771|NCT00706641|19444756|P1|NOT COMPLETED|Dasatinib Administration||2
7901772|NCT00706641|19444756|P1|COMPLETED|Dasatinib Administration||23
7901773|NCT00706641|19444756|P1|Toxicity Evaluation|Dasatinib Administration||24
7901774|NCT00706641|19444756|P1|STARTED|Dasatinib Administration||25
7901775|NCT00706628|19444770|P4|NOT COMPLETED|Overall Study||3
7901776|NCT00706628|19444771|P3|NOT COMPLETED|Overall Study||16
7901777|NCT00706628|19444772|P2|NOT COMPLETED|Overall Study||21
7901778|NCT00706628|19444773|P1|NOT COMPLETED|Overall Study||47
7901779|NCT00706628|19444770|P4|COMPLETED|Overall Study||0
7901780|NCT00706628|19444771|P3|COMPLETED|Overall Study||0
7901781|NCT00706628|19444772|P2|COMPLETED|Overall Study||0
7901782|NCT00706628|19444773|P1|COMPLETED|Overall Study||0
7901783|NCT00706628|19444770|P4|STARTED|Overall Study||3
7901784|NCT00706628|19444771|P3|STARTED|Overall Study||16
7901785|NCT00706628|19444772|P2|STARTED|Overall Study||21
7901786|NCT00706628|19444773|P1|STARTED|Overall Study||47
7901787|NCT00706589|19444823|P2|NOT COMPLETED|Overall Study||4
7901788|NCT00706589|19444824|P1|NOT COMPLETED|Overall Study||3
7901789|NCT00706589|19444823|P2|COMPLETED|Overall Study||25
7901790|NCT00706589|19444824|P1|COMPLETED|Overall Study||29
7901791|NCT00706589|19444823|P2|STARTED|Overall Study||29
7901792|NCT00706589|19444824|P1|STARTED|Overall Study||32
7901793|NCT00706563|19444832|P2|NOT COMPLETED|Overall Study||0
7901794|NCT00706563|19444833|P1|NOT COMPLETED|Overall Study||0
7901795|NCT00706563|19444832|P2|COMPLETED|Overall Study||59
7901796|NCT00706563|19444833|P1|COMPLETED|Overall Study||61
7901797|NCT00706563|19444832|P2|STARTED|Overall Study||59
7901798|NCT00706563|19444833|P1|STARTED|Overall Study||61
7901799|NCT00706550|19444857|P2|NOT COMPLETED|Overall Study||28
7901800|NCT00706550|19444858|P1|NOT COMPLETED|Overall Study||7
7901801|NCT00706550|19444857|P2|COMPLETED|Overall Study||36
7901802|NCT00706550|19444858|P1|COMPLETED|Overall Study||36
7901803|NCT00706550|19444857|P2|STARTED|Overall Study||64
7901804|NCT00706550|19444858|P1|STARTED|Overall Study||43
7901805|NCT00706511|19444878|P4|NOT COMPLETED|Overall Study||0
7901806|NCT00706511|19444879|P3|NOT COMPLETED|Overall Study||0
7901807|NCT00706511|19444880|P2|NOT COMPLETED|Overall Study||0
7901808|NCT00706511|19444881|P1|NOT COMPLETED|Overall Study||1
7901809|NCT00706511|19444878|P4|COMPLETED|Overall Study||10
7901810|NCT00706511|19444879|P3|COMPLETED|Overall Study||3
7901811|NCT00706511|19444880|P2|COMPLETED|Overall Study||4
7901812|NCT00706511|19444881|P1|COMPLETED|Overall Study||9
7901813|NCT00706511|19444878|P4|STARTED|Overall Study||10
7901814|NCT00706511|19444879|P3|STARTED|Overall Study||3
7901815|NCT00706511|19444880|P2|STARTED|Overall Study||4
7901816|NCT00706511|19444881|P1|STARTED|Overall Study||10
7901817|NCT00706485|19444913|P1|NOT COMPLETED|Overall Study||0
7901818|NCT00706485|19444913|P1|COMPLETED|Overall Study||5
7901819|NCT00706485|19444913|P1|STARTED|Overall Study||5
7901820|NCT00706446|19444925|P6|NOT COMPLETED|Overall Study||38
7901821|NCT00706446|19444926|P5|NOT COMPLETED|Overall Study||44
7901822|NCT00706446|19444927|P4|NOT COMPLETED|Overall Study||22
7901823|NCT00706446|19444928|P3|NOT COMPLETED|Overall Study||37
7901824|NCT00706446|19444929|P2|NOT COMPLETED|Overall Study||49
7901825|NCT00706446|19444930|P1|NOT COMPLETED|Overall Study||26
7901826|NCT00706446|19444925|P6|COMPLETED|Overall Study||7
7901827|NCT00706446|19444926|P5|COMPLETED|Overall Study||10
7901828|NCT00706446|19444927|P4|COMPLETED|Overall Study||4
7901829|NCT00706446|19444928|P3|COMPLETED|Overall Study||7
7901830|NCT00706446|19444929|P2|COMPLETED|Overall Study||8
7901831|NCT00706446|19444930|P1|COMPLETED|Overall Study||3
7901832|NCT00706446|19444925|P6|STARTED|Overall Study||45
7901833|NCT00706446|19444926|P5|STARTED|Overall Study||54
7901834|NCT00706446|19444927|P4|STARTED|Overall Study||26
7901835|NCT00706446|19444928|P3|STARTED|Overall Study||44
7901836|NCT00706446|19444929|P2|STARTED|Overall Study||57
7901837|NCT00706446|19444930|P1|STARTED|Overall Study||29
7901838|NCT00706433|19444972|P4|NOT COMPLETED|Overall Study||2
7901839|NCT00706433|19444973|P3|NOT COMPLETED|Overall Study||10
7901840|NCT00706433|19444974|P2|NOT COMPLETED|Overall Study||3
7901841|NCT00706433|19444975|P1|NOT COMPLETED|Overall Study||5
7901842|NCT00706433|19444972|P4|COMPLETED|Overall Study||64
7901843|NCT00706433|19444973|P3|COMPLETED|Overall Study||57
7901844|NCT00706433|19444974|P2|COMPLETED|Overall Study||62
7901845|NCT00706433|19444975|P1|COMPLETED|Overall Study||63
7901846|NCT00706433|19444972|P4|STARTED|Overall Study||66
7901847|NCT00706433|19444973|P3|STARTED|Overall Study||67
7901848|NCT00706433|19444974|P2|STARTED|Overall Study||65
7901849|NCT00706433|19444975|P1|STARTED|Overall Study||68
7901850|NCT00706407|19445291|P1|NOT COMPLETED|Overall Study||9
7901851|NCT00706407|19445291|P1|COMPLETED|Overall Study||33
7901852|NCT00706407|19445291|P1|STARTED|Overall Study||42
7901853|NCT00706381|19445302|P4|NOT COMPLETED|Overall Study||0
7901854|NCT00706381|19445303|P3|NOT COMPLETED|Overall Study||1
7901855|NCT00706381|19445304|P2|NOT COMPLETED|Overall Study||1
7901856|NCT00706381|19445305|P1|NOT COMPLETED|Overall Study||0
7901857|NCT00706381|19445302|P4|COMPLETED|Overall Study||9
7901858|NCT00706381|19445303|P3|COMPLETED|Overall Study||5
7901859|NCT00706381|19445304|P2|COMPLETED|Overall Study||5
7901860|NCT00706381|19445305|P1|COMPLETED|Overall Study||10
7901861|NCT00706381|19445302|P4|Intervention 5 (1 Day)|Overall Study||9
7901862|NCT00706381|19445303|P3|Intervention 5 (1 Day)|Overall Study||5
7901863|NCT00706381|19445304|P2|Intervention 5 (1 Day)|Overall Study||5
7901864|NCT00706381|19445305|P1|Intervention 5 (1 Day)|Overall Study||10
7901865|NCT00706381|19445302|P4|Intervention 4 (1 Day)|Overall Study||9
7901866|NCT00706381|19445303|P3|Intervention 4 (1 Day)|Overall Study||6
7901867|NCT00706381|19445304|P2|Intervention 4 (1 Day)|Overall Study||5
7901868|NCT00706381|19445305|P1|Intervention 4 (1 Day)|Overall Study||10
7901869|NCT00706381|19445302|P4|Intervention 3 (1 Day)|Overall Study||9
7901870|NCT00706381|19445303|P3|Intervention 3 (1 Day)|Overall Study||6
7901871|NCT00706381|19445304|P2|Intervention 3 (1 Day)|Overall Study||6
7901872|NCT00706381|19445305|P1|Intervention 3 (1 Day)|Overall Study||10
7901873|NCT00706381|19445302|P4|Intervention 2 (1 Day)|Overall Study||9
7901874|NCT00706381|19445303|P3|Intervention 2 (1 Day)|Overall Study||6
7901875|NCT00706381|19445304|P2|Intervention 2 (1 Day)|Overall Study||6
7901876|NCT00706381|19445305|P1|Intervention 2 (1 Day)|Overall Study||10
7901877|NCT00706381|19445302|P4|Intervention 1 (1 Day)|Overall Study||9
7901878|NCT00706381|19445303|P3|Intervention 1 (1 Day)|Overall Study||6
7901879|NCT00706381|19445304|P2|Intervention 1 (1 Day)|Overall Study||6
7901880|NCT00706381|19445305|P1|Intervention 1 (1 Day)|Overall Study||10
7901881|NCT00706381|19445302|P4|STARTED|Overall Study||9
7901882|NCT00706381|19445303|P3|STARTED|Overall Study||6
7901883|NCT00706381|19445304|P2|STARTED|Overall Study||6
7901884|NCT00706381|19445305|P1|STARTED|Overall Study||10
7901885|NCT00706355|19445326|P4|NOT COMPLETED|Period 4: PF-04217903 150 mg||4
7901886|NCT00706355|19445327|P3|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
7901887|NCT00706355|19445328|P2|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
7901888|NCT00706355|19445329|P1|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
7901889|NCT00706355|19445326|P4|COMPLETED|Period 4: PF-04217903 150 mg||0
7901890|NCT00706355|19445327|P3|COMPLETED|Period 4: PF-04217903 150 mg||0
7901891|NCT00706355|19445328|P2|COMPLETED|Period 4: PF-04217903 150 mg||0
7901892|NCT00706355|19445329|P1|COMPLETED|Period 4: PF-04217903 150 mg||0
7901893|NCT00706355|19445326|P4|STARTED|Period 4: PF-04217903 150 mg||4
7901894|NCT00706355|19445327|P3|STARTED|Period 4: PF-04217903 150 mg||0
7901895|NCT00706355|19445328|P2|STARTED|Period 4: PF-04217903 150 mg||0
7901896|NCT00706355|19445329|P1|STARTED|Period 4: PF-04217903 150 mg||0
7901897|NCT00706355|19445326|P4|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
7901898|NCT00706355|19445327|P3|NOT COMPLETED|Period 3: PF-04217903 200 mg||2
7901899|NCT00706355|19445328|P2|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
7901900|NCT00706355|19445329|P1|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
7901901|NCT00706355|19445326|P4|COMPLETED|Period 3: PF-04217903 200 mg||0
7901902|NCT00706355|19445327|P3|COMPLETED|Period 3: PF-04217903 200 mg||0
7901903|NCT00706355|19445328|P2|COMPLETED|Period 3: PF-04217903 200 mg||0
7901904|NCT00706355|19445329|P1|COMPLETED|Period 3: PF-04217903 200 mg||0
7901905|NCT00706355|19445326|P4|STARTED|Period 3: PF-04217903 200 mg||0
7901906|NCT00706355|19445327|P3|STARTED|Period 3: PF-04217903 200 mg||2
7901907|NCT00706355|19445328|P2|STARTED|Period 3: PF-04217903 200 mg||0
7901908|NCT00706355|19445329|P1|STARTED|Period 3: PF-04217903 200 mg||0
7901909|NCT00706355|19445326|P4|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
7901910|NCT00706355|19445327|P3|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
7901911|NCT00706355|19445328|P2|NOT COMPLETED|Period 2: PF-04217903 100 mg||7
7901912|NCT00706355|19445329|P1|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
7901913|NCT00706355|19445326|P4|COMPLETED|Period 2: PF-04217903 100 mg||0
7901914|NCT00706355|19445327|P3|COMPLETED|Period 2: PF-04217903 100 mg||0
7901915|NCT00706355|19445328|P2|COMPLETED|Period 2: PF-04217903 100 mg||0
7901916|NCT00706355|19445329|P1|COMPLETED|Period 2: PF-04217903 100 mg||0
7901917|NCT00706355|19445326|P4|STARTED|Period 2: PF-04217903 100 mg||0
7901918|NCT00706355|19445327|P3|STARTED|Period 2: PF-04217903 100 mg||0
7901919|NCT00706355|19445328|P2|STARTED|Period 2: PF-04217903 100 mg||7
7901920|NCT00706355|19445329|P1|STARTED|Period 2: PF-04217903 100 mg||0
7901921|NCT00706355|19445326|P4|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
7901922|NCT00706355|19445327|P3|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
7901923|NCT00706355|19445328|P2|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
7901924|NCT00706355|19445329|P1|NOT COMPLETED|Period 1: PF-04217903 50 mg||3
7901925|NCT00706355|19445326|P4|COMPLETED|Period 1: PF-04217903 50 mg||0
7901926|NCT00706355|19445327|P3|COMPLETED|Period 1: PF-04217903 50 mg||0
7901927|NCT00706355|19445328|P2|COMPLETED|Period 1: PF-04217903 50 mg||0
7901928|NCT00706355|19445329|P1|COMPLETED|Period 1: PF-04217903 50 mg||0
7901929|NCT00706355|19445326|P4|STARTED|Period 1: PF-04217903 50 mg||0
7901930|NCT00706355|19445327|P3|STARTED|Period 1: PF-04217903 50 mg||0
7901931|NCT00706355|19445328|P2|STARTED|Period 1: PF-04217903 50 mg||0
7901932|NCT00706355|19445329|P1|STARTED|Period 1: PF-04217903 50 mg||3
7901933|NCT00706342|19445381|P1|NOT COMPLETED|Overall Study||18
7901934|NCT00706342|19445381|P1|COMPLETED|Overall Study||0
7901935|NCT00706342|19445381|P1|STARTED|Overall Study||18
7901936|NCT00706329|19445390|P1|NOT COMPLETED|Overall Study||0
7901937|NCT00706329|19445390|P1|COMPLETED|Overall Study||25
7901938|NCT00706329|19445390|P1|STARTED|Overall Study||25
7901939|NCT00706238|19445394|P1|NOT COMPLETED|Overall Study||5
7901940|NCT00706238|19445394|P1|COMPLETED|Overall Study||0
7901941|NCT00706238|19445394|P1|STARTED|Overall Study||5
7901942|NCT00706134|19445411|P4|NOT COMPLETED|Overall Study||11
7901943|NCT00706134|19445412|P3|NOT COMPLETED|Overall Study||6
7901944|NCT00706134|19445413|P2|NOT COMPLETED|Overall Study||19
7901945|NCT00706134|19445414|P1|NOT COMPLETED|Overall Study||20
7901946|NCT00706134|19445411|P4|COMPLETED|Overall Study||175
7901947|NCT00706134|19445412|P3|COMPLETED|Overall Study||183
7901948|NCT00706134|19445413|P2|COMPLETED|Overall Study||173
7901949|NCT00706134|19445414|P1|COMPLETED|Overall Study||169
7901950|NCT00706134|19445411|P4|Entered Double-blind Period|Overall Study||186
7901951|NCT00706134|19445412|P3|Entered Double-blind Period|Overall Study||189
7901952|NCT00706134|19445413|P2|Entered Double-blind Period|Overall Study||192
7901953|NCT00706134|19445414|P1|Entered Double-blind Period|Overall Study||187
7901954|NCT00706134|19445411|P4|STARTED|Overall Study||186
7901955|NCT00706134|19445412|P3|STARTED|Overall Study||189
7901956|NCT00706134|19445413|P2|STARTED|Overall Study||192
7901957|NCT00706134|19445414|P1|STARTED|Overall Study||189
7901958|NCT00706121|19445448|P4|NOT COMPLETED|Overall Study||352
7901959|NCT00706121|19445449|P3|NOT COMPLETED|Overall Study||404
7901960|NCT00706121|19445450|P2|NOT COMPLETED|Overall Study||396
7901961|NCT00706121|19445451|P1|NOT COMPLETED|Overall Study||396
7901962|NCT00706121|19445448|P4|COMPLETED|Overall Study||1577
7901963|NCT00706121|19445449|P3|COMPLETED|Overall Study||1626
7901964|NCT00706121|19445450|P2|COMPLETED|Overall Study||1700
7901965|NCT00706121|19445451|P1|COMPLETED|Overall Study||1643
7901966|NCT00706121|19445448|P4|STARTED|Overall Study||1929
7901967|NCT00706121|19445449|P3|STARTED|Overall Study||2030
7901968|NCT00706121|19445450|P2|STARTED|Overall Study||2096
7901969|NCT00706121|19445451|P1|STARTED|Overall Study||2039
7901970|NCT00706095|19445480|P3|NOT COMPLETED|Overall Study||5
7901971|NCT00706095|19445481|P2|NOT COMPLETED|Overall Study||7
7901972|NCT00706095|19445482|P1|NOT COMPLETED|Overall Study||6
7901973|NCT00706095|19445480|P3|COMPLETED|Overall Study||0
7901974|NCT00706095|19445481|P2|COMPLETED|Overall Study||0
7901975|NCT00706095|19445482|P1|COMPLETED|Overall Study||0
7901976|NCT00706095|19445480|P3|STARTED|Overall Study||5
7901977|NCT00706095|19445481|P2|STARTED|Overall Study||7
7901978|NCT00706095|19445482|P1|STARTED|Overall Study||6
7901979|NCT00706030|19445500|P4|NOT COMPLETED|Overall Study||16
7901980|NCT00706030|19445501|P3|NOT COMPLETED|Overall Study||60
7901981|NCT00706030|19445502|P2|NOT COMPLETED|Overall Study||6
7901982|NCT00706030|19445503|P1|NOT COMPLETED|Overall Study||6
7901983|NCT00706030|19445500|P4|COMPLETED|Overall Study||0
7901984|NCT00706030|19445501|P3|COMPLETED|Overall Study||4
7901985|NCT00706030|19445502|P2|COMPLETED|Overall Study||0
7901986|NCT00706030|19445503|P1|COMPLETED|Overall Study||0
7901987|NCT00706030|19445500|P4|Treated|Overall Study||15
7901988|NCT00706030|19445501|P3|Treated|Overall Study||64
7901989|NCT00706030|19445502|P2|Treated|Overall Study||6
7901990|NCT00706030|19445503|P1|Treated|Overall Study||6
7901991|NCT00706030|19445500|P4|STARTED|Overall Study||16
7901992|NCT00706030|19445501|P3|STARTED|Overall Study||64
7901993|NCT00706030|19445502|P2|STARTED|Overall Study||6
7901994|NCT00706030|19445503|P1|STARTED|Overall Study||6
7901995|NCT00706004|19445518|P1|NOT COMPLETED|Overall Study||2
7901996|NCT00706004|19445518|P1|COMPLETED|Overall Study||7
7901997|NCT00706004|19445518|P1|STARTED|Overall Study||9
7901998|NCT00705939|19445546|P3|NOT COMPLETED|Overall Study||4
7901999|NCT00705939|19445547|P2|NOT COMPLETED|Overall Study||2
7902000|NCT00705939|19445548|P1|NOT COMPLETED|Overall Study||0
7902001|NCT00705939|19445546|P3|COMPLETED|Overall Study||14
7902002|NCT00705939|19445547|P2|COMPLETED|Overall Study||12
7902003|NCT00705939|19445548|P1|COMPLETED|Overall Study||12
7902004|NCT00705939|19445546|P3|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18
7902005|NCT00705939|19445547|P2|STARTED|Overall Study||14
7902006|NCT00705939|19445548|P1|STARTED|Overall Study||12
7902007|NCT00705874|19445578|P7|NOT COMPLETED|Overall Study||0
7902008|NCT00705874|19445579|P6|NOT COMPLETED|Overall Study||4
7902009|NCT00705874|19445580|P5|NOT COMPLETED|Overall Study||12
7902010|NCT00705874|19445581|P4|NOT COMPLETED|Overall Study||1
7902011|NCT00705874|19445582|P3|NOT COMPLETED|Overall Study||2
7902012|NCT00705874|19445583|P2|NOT COMPLETED|Overall Study||1
7902013|NCT00705874|19445584|P1|NOT COMPLETED|Overall Study||2
7902014|NCT00705874|19445578|P7|COMPLETED|Overall Study||3
7902015|NCT00705874|19445579|P6|COMPLETED|Overall Study||28
7902016|NCT00705874|19445580|P5|COMPLETED|Overall Study||36
7902017|NCT00705874|19445581|P4|COMPLETED|Overall Study||33
7902018|NCT00705874|19445582|P3|COMPLETED|Overall Study||32
7902019|NCT00705874|19445583|P2|COMPLETED|Overall Study||8
7902020|NCT00705874|19445584|P1|COMPLETED|Overall Study||10
7902021|NCT00705874|19445578|P7|STARTED|Overall Study||3
7902022|NCT00705874|19445579|P6|STARTED|Overall Study||32
7902023|NCT00705874|19445580|P5|STARTED|Overall Study||48
7902024|NCT00705874|19445581|P4|STARTED|Overall Study||34
7902025|NCT00705874|19445582|P3|STARTED|Overall Study||34
7902026|NCT00705874|19445583|P2|STARTED|Overall Study||9
7902027|NCT00705874|19445584|P1|STARTED|Overall Study||12
7902028|NCT00705783|19445602|P3|NOT COMPLETED|Depot Maintenance Phase||131
7902029|NCT00705783|19445603|P2|NOT COMPLETED|Depot Maintenance Phase||246
7902030|NCT00705783|19445604|P1|NOT COMPLETED|Depot Maintenance Phase||0
7902031|NCT00705783|19445602|P3|COMPLETED|Depot Maintenance Phase||3
7902032|NCT00705783|19445603|P2|COMPLETED|Depot Maintenance Phase||23
7902033|NCT00705783|19445604|P1|COMPLETED|Depot Maintenance Phase||0
7902034|NCT00705783|19445602|P3|STARTED|Depot Maintenance Phase||134
7902035|NCT00705783|19445603|P2|STARTED|Depot Maintenance Phase||269
7902036|NCT00705783|19445604|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0
7902037|NCT00705783|19445602|P3|NOT COMPLETED|Depot Stabilization Phase||0
7902038|NCT00705783|19445603|P2|NOT COMPLETED|Depot Stabilization Phase||0
7902039|NCT00705783|19445604|P1|NOT COMPLETED|Depot Stabilization Phase||173
7902040|NCT00705783|19445602|P3|COMPLETED|Depot Stabilization Phase||0
7902041|NCT00705783|19445603|P2|COMPLETED|Depot Stabilization Phase||0
7902042|NCT00705783|19445604|P1|COMPLETED|Depot Stabilization Phase||403
7902043|NCT00705783|19445602|P3|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
7902044|NCT00705783|19445603|P2|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
7902045|NCT00705783|19445604|P1|STARTED|Depot Stabilization Phase||576
7902046|NCT00705783|19445602|P3|NOT COMPLETED|Oral Stabilization Phase||0
7902047|NCT00705783|19445603|P2|NOT COMPLETED|Oral Stabilization Phase||0
7902048|NCT00705783|19445604|P1|NOT COMPLETED|Oral Stabilization Phase||134
7902049|NCT00705783|19445602|P3|COMPLETED|Oral Stabilization Phase||0
7902050|NCT00705783|19445603|P2|COMPLETED|Oral Stabilization Phase||0
7902051|NCT00705783|19445604|P1|COMPLETED|Oral Stabilization Phase||576
7902052|NCT00705783|19445602|P3|Received Study Medication|Oral Stabilization Phase||0
7902053|NCT00705783|19445603|P2|Received Study Medication|Oral Stabilization Phase||0
7902054|NCT00705783|19445604|P1|Received Study Medication|Oral Stabilization Phase||709
7902055|NCT00705783|19445602|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
7902056|NCT00705783|19445603|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
7902057|NCT00705783|19445604|P1|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710
7902058|NCT00705783|19445602|P3|NOT COMPLETED|Conversion Phase||0
7902059|NCT00705783|19445603|P2|NOT COMPLETED|Conversion Phase||0
7902060|NCT00705783|19445604|P1|NOT COMPLETED|Conversion Phase||133
7902061|NCT00705783|19445602|P3|COMPLETED|Conversion Phase||0
7902062|NCT00705783|19445603|P2|COMPLETED|Conversion Phase||0
7902063|NCT00705783|19445604|P1|COMPLETED|Conversion Phase||500
7902064|NCT00705783|19445602|P3|Received Study Medication|Conversion Phase||0
7902065|NCT00705783|19445603|P2|Received Study Medication|Conversion Phase||0
7902066|NCT00705783|19445604|P1|Received Study Medication|Conversion Phase||632
7902067|NCT00705783|19445602|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
7902068|NCT00705783|19445603|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
7902069|NCT00705783|19445604|P1|STARTED|Conversion Phase||633
7902070|NCT00705757|19445634|P3|NOT COMPLETED|Overall Study||11
7902071|NCT00705757|19445635|P2|NOT COMPLETED|Overall Study||8
7902072|NCT00705757|19445636|P1|NOT COMPLETED|Overall Study||13
7902073|NCT00705757|19445634|P3|COMPLETED|Overall Study||17
7902074|NCT00705757|19445635|P2|COMPLETED|Overall Study||21
7902075|NCT00705757|19445636|P1|COMPLETED|Overall Study||19
7902076|NCT00705757|19445634|P3|STARTED|Overall Study||28
7902077|NCT00705757|19445635|P2|STARTED|Overall Study||29
7902078|NCT00705757|19445636|P1|STARTED|Overall Study||32
7902079|NCT00705718|19445646|P2|NOT COMPLETED|Overall Study||22
7902080|NCT00705718|19445647|P1|NOT COMPLETED|Overall Study||7
7902081|NCT00705718|19445646|P2|COMPLETED|Overall Study||128
7902082|NCT00705718|19445647|P1|COMPLETED|Overall Study||37
7902083|NCT00705718|19445646|P2|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128
7902084|NCT00705718|19445647|P1|12 Month Follow up|Overall Study|2 Deaths|37
7902085|NCT00705718|19445646|P2|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143
7902086|NCT00705718|19445647|P1|6 Month Follow up|Overall Study|3 Deaths|40
7902087|NCT00705718|19445646|P2|1 Month Follow up|Overall Study|1 Subject Missed Visit|149
7902088|NCT00705718|19445647|P1|1 Month Follow up|Overall Study|1 Death|43
7902089|NCT00705718|19445646|P2|STARTED|Overall Study||150
7902090|NCT00705718|19445647|P1|STARTED|Overall Study||44
7902091|NCT00705679|19445668|P5|NOT COMPLETED|Overall Study||69
7902092|NCT00705679|19445669|P4|NOT COMPLETED|Overall Study||80
7902093|NCT00705679|19445670|P3|NOT COMPLETED|Overall Study||115
7902094|NCT00705679|19445671|P2|NOT COMPLETED|Overall Study||139
7902095|NCT00705679|19445672|P1|NOT COMPLETED|Overall Study||65
7902096|NCT00705679|19445668|P5|COMPLETED|Overall Study||934
7902097|NCT00705679|19445669|P4|COMPLETED|Overall Study||927
7902098|NCT00705679|19445670|P3|COMPLETED|Overall Study||894
7902099|NCT00705679|19445671|P2|COMPLETED|Overall Study||864
7902100|NCT00705679|19445672|P1|COMPLETED|Overall Study||942
7902101|NCT00705679|19445668|P5|STARTED|Overall Study||1003
7902102|NCT00705679|19445669|P4|STARTED|Overall Study||1007
7902103|NCT00705679|19445670|P3|STARTED|Overall Study||1009
7902104|NCT00705679|19445671|P2|STARTED|Overall Study||1003
7902105|NCT00705679|19445672|P1|STARTED|Overall Study||1007
7902106|NCT00705666|19445707|P1|NOT COMPLETED|Overall Study||339
7902107|NCT00705666|19445707|P1|COMPLETED|Overall Study||450
7902108|NCT00705666|19445707|P1|STARTED|Overall Study||789
7902109|NCT00705653|19445711|P1|NOT COMPLETED|Overall Study||0
7902110|NCT00705653|19445711|P1|COMPLETED|Overall Study||46
7902111|NCT00705653|19445711|P1|STARTED|Overall Study||46
7902112|NCT00705614|19445718|P2|NOT COMPLETED|Switch to Remicade||49
7902113|NCT00705614|19445719|P1|NOT COMPLETED|Switch to Remicade||0
7902114|NCT00705614|19445718|P2|COMPLETED|Switch to Remicade||249
7902115|NCT00705614|19445719|P1|COMPLETED|Switch to Remicade||0
7902116|NCT00705614|19445718|P2|STARTED|Switch to Remicade||298
7902117|NCT00705614|19445719|P1|STARTED|Switch to Remicade||0
7902118|NCT00705614|19445718|P2|NOT COMPLETED|Initial Intervention||321
7902119|NCT00705614|19445719|P1|NOT COMPLETED|Initial Intervention||518
7902120|NCT00705614|19445718|P2|COMPLETED|Initial Intervention||800
7902121|NCT00705614|19445719|P1|COMPLETED|Initial Intervention||1023
7902122|NCT00705614|19445718|P2|STARTED|Initial Intervention||1121
7902123|NCT00705614|19445719|P1|STARTED|Initial Intervention||1541
7902124|NCT00705575|19445768|P2|NOT COMPLETED|Overall Study||46
7902125|NCT00705575|19445769|P1|NOT COMPLETED|Overall Study||23
7902126|NCT00705575|19445768|P2|COMPLETED|Overall Study||293
7902127|NCT00705575|19445769|P1|COMPLETED|Overall Study||326
7902128|NCT00705575|19445768|P2|STARTED|Overall Study||339
7902129|NCT00705575|19445769|P1|STARTED|Overall Study||349
7902130|NCT00705536|19445783|P4|NOT COMPLETED|Completed Study||0
7902131|NCT00705536|19445784|P3|NOT COMPLETED|Completed Study||0
7902132|NCT00705536|19445785|P2|NOT COMPLETED|Completed Study||0
7902133|NCT00705536|19445786|P1|NOT COMPLETED|Completed Study||0
7902134|NCT00705536|19445783|P4|COMPLETED|Completed Study||6
7902135|NCT00705536|19445784|P3|COMPLETED|Completed Study||7
7902136|NCT00705536|19445785|P2|COMPLETED|Completed Study||6
7902137|NCT00705536|19445786|P1|COMPLETED|Completed Study||6
7902138|NCT00705536|19445783|P4|STARTED|Completed Study||6
7902139|NCT00705536|19445784|P3|STARTED|Completed Study||7
7902140|NCT00705536|19445785|P2|STARTED|Completed Study||6
7902141|NCT00705536|19445786|P1|STARTED|Completed Study||6
7902142|NCT00705536|19445783|P4|NOT COMPLETED|Start Period 2||0
7902143|NCT00705536|19445784|P3|NOT COMPLETED|Start Period 2||0
7902144|NCT00705536|19445785|P2|NOT COMPLETED|Start Period 2||0
7902145|NCT00705536|19445786|P1|NOT COMPLETED|Start Period 2||0
7902146|NCT00705536|19445783|P4|COMPLETED|Start Period 2||6
7902147|NCT00705536|19445784|P3|COMPLETED|Start Period 2||7
7902148|NCT00705536|19445785|P2|COMPLETED|Start Period 2||6
7902149|NCT00705536|19445786|P1|COMPLETED|Start Period 2||6
7902150|NCT00705536|19445783|P4|STARTED|Start Period 2||6
7902151|NCT00705536|19445784|P3|STARTED|Start Period 2||7
7902152|NCT00705536|19445785|P2|STARTED|Start Period 2||6
7902153|NCT00705536|19445786|P1|STARTED|Start Period 2||6
7902154|NCT00705536|19445783|P4|NOT COMPLETED|Washout Period of at Least 6 Days||0
7902155|NCT00705536|19445784|P3|NOT COMPLETED|Washout Period of at Least 6 Days||0
7902156|NCT00705536|19445785|P2|NOT COMPLETED|Washout Period of at Least 6 Days||0
7902157|NCT00705536|19445786|P1|NOT COMPLETED|Washout Period of at Least 6 Days||0
7902158|NCT00705536|19445783|P4|COMPLETED|Washout Period of at Least 6 Days||6
7902159|NCT00705536|19445784|P3|COMPLETED|Washout Period of at Least 6 Days||7
7902160|NCT00705536|19445785|P2|COMPLETED|Washout Period of at Least 6 Days||6
7902161|NCT00705536|19445786|P1|COMPLETED|Washout Period of at Least 6 Days||6
7902162|NCT00705536|19445783|P4|STARTED|Washout Period of at Least 6 Days||6
7902163|NCT00705536|19445784|P3|STARTED|Washout Period of at Least 6 Days||7
7902164|NCT00705536|19445785|P2|STARTED|Washout Period of at Least 6 Days||6
7902165|NCT00705536|19445786|P1|STARTED|Washout Period of at Least 6 Days||6
7902166|NCT00705536|19445783|P4|NOT COMPLETED|Start Period 1||1
7902167|NCT00705536|19445784|P3|NOT COMPLETED|Start Period 1||0
7902168|NCT00705536|19445785|P2|NOT COMPLETED|Start Period 1||0
7902169|NCT00705536|19445786|P1|NOT COMPLETED|Start Period 1||0
7902170|NCT00705536|19445783|P4|COMPLETED|Start Period 1||6
7902171|NCT00705536|19445784|P3|COMPLETED|Start Period 1||7
7902172|NCT00705536|19445785|P2|COMPLETED|Start Period 1||6
7902173|NCT00705536|19445786|P1|COMPLETED|Start Period 1||6
7902174|NCT00705536|19445783|P4|Received at Least 1 Dose of Study Drug|Start Period 1||7
7902175|NCT00705536|19445784|P3|Received at Least 1 Dose of Study Drug|Start Period 1||7
7902176|NCT00705536|19445785|P2|Received at Least 1 Dose of Study Drug|Start Period 1||6
7902177|NCT00705536|19445786|P1|Received at Least 1 Dose of Study Drug|Start Period 1||6
7902178|NCT00705536|19445783|P4|STARTED|Start Period 1||7
7902179|NCT00705536|19445784|P3|STARTED|Start Period 1||7
7902180|NCT00705536|19445785|P2|STARTED|Start Period 1||6
7902181|NCT00705536|19445786|P1|STARTED|Start Period 1||6
7902182|NCT00705523|19445847|P2|NOT COMPLETED|Overall Study||3
7902183|NCT00705523|19445848|P1|NOT COMPLETED|Overall Study||2
7902184|NCT00705523|19445847|P2|COMPLETED|Overall Study||18
7902185|NCT00705523|19445848|P1|COMPLETED|Overall Study||17
7902186|NCT00705523|19445847|P2|STARTED|Overall Study||21
7902187|NCT00705523|19445848|P1|STARTED|Overall Study||19
7902188|NCT00705484|19445858|P2|NOT COMPLETED|Overall Study||408
7902189|NCT00705484|19445859|P1|NOT COMPLETED|Overall Study||382
7902190|NCT00705484|19445858|P2|COMPLETED|Overall Study||772
7902191|NCT00705484|19445859|P1|COMPLETED|Overall Study||677
7902192|NCT00705484|19445858|P2|Follow-up Period|Overall Study|Switched From Standard Therapy to Remicade|296
7902193|NCT00705484|19445859|P1|Follow-up Period|Overall Study||1059
7902194|NCT00705484|19445858|P2|STARTED|Overall Study|Number Enrolled|1180
7902195|NCT00705484|19445859|P1|STARTED|Overall Study|Number Enrolled|1059
7902196|NCT00705432|19445873|P6|NOT COMPLETED|Follow-up Period (Upto Week 72)||7
7902197|NCT00705432|19445874|P5|NOT COMPLETED|Follow-up Period (Upto Week 72)||6
7902198|NCT00705432|19445875|P4|NOT COMPLETED|Follow-up Period (Upto Week 72)||14
7902199|NCT00705432|19445876|P3|NOT COMPLETED|Follow-up Period (Upto Week 72)||25
7902200|NCT00705432|19445877|P2|NOT COMPLETED|Follow-up Period (Upto Week 72)||43
7902201|NCT00705432|19445878|P1|NOT COMPLETED|Follow-up Period (Upto Week 72)||71
7902202|NCT00705432|19445873|P6|COMPLETED|Follow-up Period (Upto Week 72)||46
7902203|NCT00705432|19445874|P5|COMPLETED|Follow-up Period (Upto Week 72)||38
7902204|NCT00705432|19445875|P4|COMPLETED|Follow-up Period (Upto Week 72)||28
7902205|NCT00705432|19445876|P3|COMPLETED|Follow-up Period (Upto Week 72)||266
7902206|NCT00705432|19445877|P2|COMPLETED|Follow-up Period (Upto Week 72)||252
7902207|NCT00705432|19445878|P1|COMPLETED|Follow-up Period (Upto Week 72)||207
7902208|NCT00705432|19445873|P6|STARTED|Follow-up Period (Upto Week 72)||53
7902209|NCT00705432|19445874|P5|STARTED|Follow-up Period (Upto Week 72)||44
7902210|NCT00705432|19445875|P4|STARTED|Follow-up Period (Upto Week 72)||42
7902211|NCT00705432|19445876|P3|STARTED|Follow-up Period (Upto Week 72)||291
7902212|NCT00705432|19445877|P2|STARTED|Follow-up Period (Upto Week 72)||295
7902213|NCT00705432|19445878|P1|STARTED|Follow-up Period (Upto Week 72)||278
7902214|NCT00705432|19445873|P6|NOT COMPLETED|Treatment Period||30
7902215|NCT00705432|19445874|P5|NOT COMPLETED|Treatment Period||28
7902216|NCT00705432|19445875|P4|NOT COMPLETED|Treatment Period||41
7902217|NCT00705432|19445876|P3|NOT COMPLETED|Treatment Period||121
7902218|NCT00705432|19445877|P2|NOT COMPLETED|Treatment Period||111
7902219|NCT00705432|19445878|P1|NOT COMPLETED|Treatment Period||163
7902220|NCT00705432|19445873|P6|COMPLETED|Treatment Period||25
7902221|NCT00705432|19445874|P5|COMPLETED|Treatment Period||24
7902222|NCT00705432|19445875|P4|COMPLETED|Treatment Period||11
7902223|NCT00705432|19445876|P3|COMPLETED|Treatment Period||190
7902224|NCT00705432|19445877|P2|COMPLETED|Treatment Period||205
7902225|NCT00705432|19445878|P1|COMPLETED|Treatment Period||148
7902226|NCT00705432|19445873|P6|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55
7902227|NCT00705432|19445874|P5|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
7902228|NCT00705432|19445875|P4|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
7902229|NCT00705432|19445876|P3|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299
7902230|NCT00705432|19445877|P2|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303
7902231|NCT00705432|19445878|P1|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297
7902232|NCT00705432|19445873|P6|STARTED|Treatment Period||55
7902233|NCT00705432|19445874|P5|STARTED|Treatment Period||52
7902234|NCT00705432|19445875|P4|STARTED|Treatment Period||52
7902235|NCT00705432|19445876|P3|STARTED|Treatment Period||311
7902236|NCT00705432|19445877|P2|STARTED|Treatment Period||316
7902237|NCT00705432|19445878|P1|STARTED|Treatment Period||311
7902238|NCT00705406|19445915|P2|NOT COMPLETED|Overall Study||5
7902239|NCT00705406|19445916|P1|NOT COMPLETED|Overall Study||4
7902240|NCT00705406|19445915|P2|COMPLETED|Overall Study||197
7902241|NCT00705406|19445916|P1|COMPLETED|Overall Study||199
7902242|NCT00705406|19445915|P2|STARTED|Overall Study||202
7902243|NCT00705406|19445916|P1|STARTED|Overall Study||203
7902244|NCT00705367|19445940|P2|NOT COMPLETED|Long-term Extension Period||0
7902245|NCT00705367|19445941|P1|NOT COMPLETED|Long-term Extension Period||9
7902246|NCT00705367|19445940|P2|COMPLETED|Long-term Extension Period||0
7902247|NCT00705367|19445941|P1|COMPLETED|Long-term Extension Period||0
7902248|NCT00705367|19445940|P2|STARTED|Long-term Extension Period||0
7902249|NCT00705367|19445941|P1|STARTED|Long-term Extension Period||9
7902250|NCT00705367|19445940|P2|NOT COMPLETED|Short-term Period||0
7902251|NCT00705367|19445941|P1|NOT COMPLETED|Short-term Period||0
7902252|NCT00705367|19445940|P2|COMPLETED|Short-term Period||3
7902253|NCT00705367|19445941|P1|COMPLETED|Short-term Period||6
7902254|NCT00705367|19445940|P2|STARTED|Short-term Period||3
7902255|NCT00705367|19445941|P1|STARTED|Short-term Period||6
7902256|NCT00705341|19445968|P4|NOT COMPLETED|Phase 2: Trial||4
7902257|NCT00705341|19445969|P3|NOT COMPLETED|Phase 2: Trial||7
7902258|NCT00705341|19445970|P2|NOT COMPLETED|Phase 2: Trial||0
7902259|NCT00705341|19445971|P1|NOT COMPLETED|Phase 2: Trial||0
7902260|NCT00705341|19445968|P4|COMPLETED|Phase 2: Trial||28
7902261|NCT00705341|19445969|P3|COMPLETED|Phase 2: Trial||23
7902262|NCT00705341|19445970|P2|COMPLETED|Phase 2: Trial||0
7902263|NCT00705341|19445971|P1|COMPLETED|Phase 2: Trial||0
7902264|NCT00705341|19445968|P4|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32
7902265|NCT00705341|19445969|P3|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30
7902266|NCT00705341|19445970|P2|STARTED|Phase 2: Trial||0
7902267|NCT00705341|19445971|P1|STARTED|Phase 2: Trial||0
7902268|NCT00705341|19445968|P4|NOT COMPLETED|Phase 1:Control Challenge||0
7902269|NCT00705341|19445969|P3|NOT COMPLETED|Phase 1:Control Challenge||0
7902270|NCT00705341|19445970|P2|NOT COMPLETED|Phase 1:Control Challenge||0
7902271|NCT00705341|19445971|P1|NOT COMPLETED|Phase 1:Control Challenge||0
7902272|NCT00705341|19445968|P4|COMPLETED|Phase 1:Control Challenge||0
7902273|NCT00705341|19445969|P3|COMPLETED|Phase 1:Control Challenge||0
7902274|NCT00705341|19445970|P2|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93
7902275|NCT00705341|19445971|P1|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126
7902276|NCT00705341|19445968|P4|STARTED|Phase 1:Control Challenge||0
7902277|NCT00705341|19445969|P3|STARTED|Phase 1:Control Challenge||0
7902278|NCT00705341|19445970|P2|STARTED|Phase 1:Control Challenge||93
7902279|NCT00705341|19445971|P1|STARTED|Phase 1:Control Challenge||126
7902280|NCT00705289|19445979|P1|NOT COMPLETED|Overall Study||131
7902281|NCT00705289|19445979|P1|COMPLETED|Overall Study||597
7902282|NCT00705289|19445979|P1|STARTED|Overall Study||728
7902283|NCT00705263|19446003|P1|NOT COMPLETED|Overall Study||2
7902284|NCT00705263|19446003|P1|COMPLETED|Overall Study||108
7902285|NCT00705263|19446003|P1|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110
7902286|NCT00705250|19446007|P1|NOT COMPLETED|Overall Study||2
7902287|NCT00705250|19446007|P1|COMPLETED|Overall Study||34
7902288|NCT00705250|19446007|P1|STARTED|Overall Study||36
7902289|NCT00705224|19446011|P1|NOT COMPLETED|Overall Study||11
7902290|NCT00705224|19446011|P1|COMPLETED|Overall Study||239
7902291|NCT00705224|19446011|P1|STARTED|Overall Study||250
7902292|NCT00705159|19446027|P4|NOT COMPLETED|Overall Study||4
7902293|NCT00705159|19446028|P3|NOT COMPLETED|Overall Study||5
7902294|NCT00705159|19446029|P2|NOT COMPLETED|Overall Study||2
7902295|NCT00705159|19446030|P1|NOT COMPLETED|Overall Study||0
7902296|NCT00705159|19446027|P4|COMPLETED|Overall Study||30
7902297|NCT00705159|19446028|P3|COMPLETED|Overall Study||29
7902298|NCT00705159|19446029|P2|COMPLETED|Overall Study||33
7902299|NCT00705159|19446030|P1|COMPLETED|Overall Study||34
7902300|NCT00705159|19446027|P4|STARTED|Overall Study||34
7902301|NCT00705159|19446028|P3|STARTED|Overall Study||34
7902302|NCT00705159|19446029|P2|STARTED|Overall Study||35
7902303|NCT00705159|19446030|P1|STARTED|Overall Study||34
7902304|NCT00705146|19446050|P2|NOT COMPLETED|Overall Study||1
7902305|NCT00705146|19446051|P1|NOT COMPLETED|Overall Study||1
7902306|NCT00705146|19446050|P2|COMPLETED|Overall Study||23
7902307|NCT00705146|19446051|P1|COMPLETED|Overall Study||31
7902308|NCT00705146|19446050|P2|STARTED|Overall Study||24
7902309|NCT00705146|19446051|P1|STARTED|Overall Study||32
7902310|NCT00705133|19446059|P1|NOT COMPLETED|Overall Study||0
7902311|NCT00705133|19446059|P1|COMPLETED|Overall Study||15
7902312|NCT00705133|19446059|P1|STARTED|Overall Study||15
7902313|NCT00705107|19446066|P1|NOT COMPLETED|Overall Study||49
7902314|NCT00705107|19446066|P1|COMPLETED|Overall Study||218
7902315|NCT00705107|19446066|P1|STARTED|Overall Study||267
7902316|NCT00705081|19446073|P2|NOT COMPLETED|Overall Study||0
7902317|NCT00705081|19446074|P1|NOT COMPLETED|Overall Study||0
7902318|NCT00705081|19446073|P2|COMPLETED|Overall Study||198
7902319|NCT00705081|19446074|P1|COMPLETED|Overall Study||255
7902320|NCT00705081|19446073|P2|STARTED|Overall Study||198
7902321|NCT00705081|19446074|P1|STARTED|Overall Study||255
7902322|NCT00705016|19446087|P3|NOT COMPLETED|Overall Study||58
7902323|NCT00705016|19446088|P2|NOT COMPLETED|Overall Study||58
7902324|NCT00705016|19446089|P1|NOT COMPLETED|Overall Study||60
7902325|NCT00705016|19446087|P3|COMPLETED|Overall Study||4
7902326|NCT00705016|19446088|P2|COMPLETED|Overall Study||2
7902327|NCT00705016|19446089|P1|COMPLETED|Overall Study||2
7902328|NCT00705016|19446087|P3|STARTED|Overall Study||62
7902329|NCT00705016|19446088|P2|STARTED|Overall Study||60
7902330|NCT00705016|19446089|P1|STARTED|Overall Study||62
7902331|NCT00705003|19446118|P3|NOT COMPLETED|Treated||3
7902332|NCT00705003|19446119|P2|NOT COMPLETED|Treated||6
7902333|NCT00705003|19446120|P1|NOT COMPLETED|Treated||13
7902334|NCT00705003|19446118|P3|COMPLETED|Treated||30
7902335|NCT00705003|19446119|P2|COMPLETED|Treated||28
7902336|NCT00705003|19446120|P1|COMPLETED|Treated||54
7902337|NCT00705003|19446118|P3|STARTED|Treated||33
7902338|NCT00705003|19446119|P2|STARTED|Treated||34
7902339|NCT00705003|19446120|P1|STARTED|Treated||67
7902340|NCT00705003|19446118|P3|NOT COMPLETED|Enrolled||1
7902341|NCT00705003|19446119|P2|NOT COMPLETED|Enrolled||3
7902342|NCT00705003|19446120|P1|NOT COMPLETED|Enrolled||4
7902343|NCT00705003|19446118|P3|COMPLETED|Enrolled||33
7902344|NCT00705003|19446119|P2|COMPLETED|Enrolled||34
7902345|NCT00705003|19446120|P1|COMPLETED|Enrolled||67
7902346|NCT00705003|19446118|P3|STARTED|Enrolled||34
7902347|NCT00705003|19446119|P2|STARTED|Enrolled||37
7902348|NCT00705003|19446120|P1|STARTED|Enrolled||71
7902349|NCT00704964|19446140|P1|NOT COMPLETED|Overall Study||328
7902350|NCT00704964|19446140|P1|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418
7902351|NCT00704964|19446140|P1|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746
7902352|NCT00704938|19446147|P2|NOT COMPLETED|Overall Study||0
7902353|NCT00704938|19446148|P1|NOT COMPLETED|Overall Study||0
7902354|NCT00704938|19446147|P2|COMPLETED|Overall Study||1
7902355|NCT00704938|19446148|P1|COMPLETED|Overall Study||2
7902356|NCT00704938|19446147|P2|STARTED|Overall Study||1
7902357|NCT00704938|19446148|P1|STARTED|Overall Study||2
7902358|NCT00704912|19446159|P3|NOT COMPLETED|Overall Study||7
7902359|NCT00704912|19446160|P2|NOT COMPLETED|Overall Study||4
7902360|NCT00704912|19446161|P1|NOT COMPLETED|Overall Study||6
7902361|NCT00704912|19446159|P3|COMPLETED|Overall Study||43
7902362|NCT00704912|19446160|P2|COMPLETED|Overall Study||45
7902363|NCT00704912|19446161|P1|COMPLETED|Overall Study||44
7902364|NCT00704912|19446159|P3|STARTED|Overall Study||50
7902365|NCT00704912|19446160|P2|STARTED|Overall Study||49
7902366|NCT00704912|19446161|P1|STARTED|Overall Study||50
7902367|NCT00704847|19446180|P2|NOT COMPLETED|Overall Study||170
7902368|NCT00704847|19446181|P1|NOT COMPLETED|Overall Study||221
7902369|NCT00704847|19446180|P2|COMPLETED|Overall Study||339
7902370|NCT00704847|19446181|P1|COMPLETED|Overall Study||300
7902371|NCT00704847|19446180|P2|STARTED|Overall Study||509
7902372|NCT00704847|19446181|P1|STARTED|Overall Study||521
7902373|NCT00704808|19446201|P1|NOT COMPLETED|Overall Study||131
7902374|NCT00704808|19446201|P1|COMPLETED|Overall Study||49
7902375|NCT00704808|19446201|P1|STARTED|Overall Study||180
7902376|NCT00704769|19446205|P1|NOT COMPLETED|Overall Study||0
7902377|NCT00704769|19446205|P1|COMPLETED|Overall Study||591
7902378|NCT00704769|19446205|P1|STARTED|Overall Study||591
7902379|NCT00704730|19446212|P2|NOT COMPLETED|Overall Study||96
7902380|NCT00704730|19446213|P1|NOT COMPLETED|Overall Study||121
7902381|NCT00704730|19446212|P2|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15
7902382|NCT00704730|19446213|P1|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|98
7902383|NCT00704730|19446212|P2|STARTED|Overall Study|Randomized|111
7902384|NCT00704730|19446213|P1|STARTED|Overall Study|Randomized|219
7902385|NCT00704717|19446229|P1|NOT COMPLETED|Overall Study||0
7902386|NCT00704717|19446229|P1|COMPLETED|Overall Study||185
7902387|NCT00704717|19446229|P1|STARTED|Overall Study||185
7902388|NCT00704535|19446233|P1|NOT COMPLETED|Overall Study||146
7902389|NCT00704535|19446233|P1|COMPLETED|Overall Study||3959
7902390|NCT00704535|19446233|P1|STARTED|Overall Study||4105
7902391|NCT00704522|19446246|P2|NOT COMPLETED|Overall Study||45
7902392|NCT00704522|19446247|P1|NOT COMPLETED|Overall Study||183
7902393|NCT00704522|19446246|P2|COMPLETED|Overall Study||75
7902394|NCT00704522|19446247|P1|COMPLETED|Overall Study||298
7902395|NCT00704522|19446246|P2|STARTED|Overall Study||120
7902396|NCT00704522|19446247|P1|STARTED|Overall Study||481
7902397|NCT00704496|19446256|P2|NOT COMPLETED|Overall Study||0
7902398|NCT00704496|19446257|P1|NOT COMPLETED|Overall Study||0
7902399|NCT00704496|19446256|P2|COMPLETED|Overall Study||0
7902400|NCT00704496|19446257|P1|COMPLETED|Overall Study||0
7902401|NCT00704496|19446256|P2|STARTED|Overall Study||0
7902402|NCT00704496|19446257|P1|STARTED|Overall Study||0
7902403|NCT00704418|19446267|P2|NOT COMPLETED|Overall Study||6
7902404|NCT00704418|19446268|P1|NOT COMPLETED|Overall Study||5
7902405|NCT00704418|19446267|P2|COMPLETED|Overall Study||72
7902406|NCT00704418|19446268|P1|COMPLETED|Overall Study||73
7902407|NCT00704418|19446267|P2|STARTED|Overall Study||78
7902408|NCT00704418|19446268|P1|STARTED|Overall Study||78
7902409|NCT00704405|19446281|P5|NOT COMPLETED|Overall Study (C Population)||0
7902410|NCT00704405|19446282|P4|NOT COMPLETED|Overall Study (C Population)||1
7902411|NCT00704405|19446283|P3|NOT COMPLETED|Overall Study (C Population)||1
7902412|NCT00704405|19446284|P2|NOT COMPLETED|Overall Study (C Population)||3
7902413|NCT00704405|19446285|P1|NOT COMPLETED|Overall Study (C Population)||1
7902414|NCT00704405|19446281|P5|COMPLETED|Overall Study (C Population)||14
7902415|NCT00704405|19446282|P4|COMPLETED|Overall Study (C Population)||14
7902416|NCT00704405|19446283|P3|COMPLETED|Overall Study (C Population)||14
7902417|NCT00704405|19446284|P2|COMPLETED|Overall Study (C Population)||11
7902418|NCT00704405|19446285|P1|COMPLETED|Overall Study (C Population)||15
7902419|NCT00704405|19446281|P5|STARTED|Overall Study (C Population)||14
7902420|NCT00704405|19446282|P4|STARTED|Overall Study (C Population)||15
7902421|NCT00704405|19446283|P3|STARTED|Overall Study (C Population)||15
7902422|NCT00704405|19446284|P2|STARTED|Overall Study (C Population)||14
7902423|NCT00704405|19446285|P1|STARTED|Overall Study (C Population)||16
7902424|NCT00704405|19446281|P5|NOT COMPLETED|Overall Study (NC Population)||5
7902425|NCT00704405|19446282|P4|NOT COMPLETED|Overall Study (NC Population)||4
7902426|NCT00704405|19446283|P3|NOT COMPLETED|Overall Study (NC Population)||3
7902427|NCT00704405|19446284|P2|NOT COMPLETED|Overall Study (NC Population)||4
7902428|NCT00704405|19446285|P1|NOT COMPLETED|Overall Study (NC Population)||5
7902429|NCT00704405|19446281|P5|COMPLETED|Overall Study (NC Population)||37
7902430|NCT00704405|19446282|P4|COMPLETED|Overall Study (NC Population)||38
7902431|NCT00704405|19446283|P3|COMPLETED|Overall Study (NC Population)||38
7902432|NCT00704405|19446284|P2|COMPLETED|Overall Study (NC Population)||40
7902433|NCT00704405|19446285|P1|COMPLETED|Overall Study (NC Population)||37
7902434|NCT00704405|19446281|P5|STARTED|Overall Study (NC Population)||42
7902435|NCT00704405|19446282|P4|STARTED|Overall Study (NC Population)||42
7902436|NCT00704405|19446283|P3|STARTED|Overall Study (NC Population)||41
7902437|NCT00704405|19446284|P2|STARTED|Overall Study (NC Population)||44
7902438|NCT00704405|19446285|P1|STARTED|Overall Study (NC Population)||42
7902439|NCT00704379|19446315|P2|NOT COMPLETED|Overall Study||7
7902440|NCT00704379|19446316|P1|NOT COMPLETED|Overall Study||7
7902441|NCT00704379|19446315|P2|COMPLETED|Overall Study||41
7902442|NCT00704379|19446316|P1|COMPLETED|Overall Study||39
7902443|NCT00704379|19446315|P2|STARTED|Overall Study||48
7902444|NCT00704379|19446316|P1|STARTED|Overall Study||46
7902445|NCT00704353|19446334|P2|NOT COMPLETED|Overall Study||114
7902446|NCT00704353|19446335|P1|NOT COMPLETED|Overall Study||98
7902447|NCT00704353|19446334|P2|COMPLETED|Overall Study||255
7902448|NCT00704353|19446335|P1|COMPLETED|Overall Study||268
7902449|NCT00704353|19446334|P2|STARTED|Overall Study||369
7902450|NCT00704353|19446335|P1|STARTED|Overall Study||366
7902451|NCT00704340|19446343|P2|NOT COMPLETED|Overall Study||2
7902452|NCT00704340|19446344|P1|NOT COMPLETED|Overall Study||2
7902453|NCT00704340|19446343|P2|COMPLETED|Overall Study||115
7902454|NCT00704340|19446344|P1|COMPLETED|Overall Study||118
7902455|NCT00704340|19446343|P2|STARTED|Overall Study||117
7902456|NCT00704340|19446344|P1|STARTED|Overall Study||120
7902457|NCT00704262|19446354|P1|NOT COMPLETED|Overall Study||2
7902458|NCT00704262|19446354|P1|COMPLETED|Overall Study||31
7902459|NCT00704262|19446354|P1|STARTED|Overall Study||33
7902460|NCT00704184|19446375|P5|NOT COMPLETED|Open-Label Treatment||3
7902461|NCT00704184|19446376|P4|NOT COMPLETED|Open-Label Treatment||5
7902462|NCT00704184|19446377|P3|NOT COMPLETED|Open-Label Treatment||4
7902463|NCT00704184|19446378|P2|NOT COMPLETED|Open-Label Treatment||2
7902464|NCT00704184|19446379|P1|NOT COMPLETED|Open-Label Treatment||1
7902465|NCT00704184|19446375|P5|COMPLETED|Open-Label Treatment||16
7902466|NCT00704184|19446376|P4|COMPLETED|Open-Label Treatment||13
7902467|NCT00704184|19446377|P3|COMPLETED|Open-Label Treatment||16
7902468|NCT00704184|19446378|P2|COMPLETED|Open-Label Treatment||16
7902469|NCT00704184|19446379|P1|COMPLETED|Open-Label Treatment||18
7902470|NCT00704184|19446375|P5|STARTED|Open-Label Treatment||19
7902471|NCT00704184|19446376|P4|STARTED|Open-Label Treatment||18
7902472|NCT00704184|19446377|P3|STARTED|Open-Label Treatment||20
7902473|NCT00704184|19446378|P2|STARTED|Open-Label Treatment||18
7902474|NCT00704184|19446379|P1|STARTED|Open-Label Treatment||19
7902475|NCT00704184|19446375|P5|NOT COMPLETED|Double-Blind Treatment||0
7902476|NCT00704184|19446376|P4|NOT COMPLETED|Double-Blind Treatment||0
7902477|NCT00704184|19446377|P3|NOT COMPLETED|Double-Blind Treatment||0
7902478|NCT00704184|19446378|P2|NOT COMPLETED|Double-Blind Treatment||0
7902479|NCT00704184|19446379|P1|NOT COMPLETED|Double-Blind Treatment||1
7902480|NCT00704184|19446375|P5|COMPLETED|Double-Blind Treatment||19
7902481|NCT00704184|19446376|P4|COMPLETED|Double-Blind Treatment||18
7902482|NCT00704184|19446377|P3|COMPLETED|Double-Blind Treatment||20
7902483|NCT00704184|19446378|P2|COMPLETED|Double-Blind Treatment||18
7902484|NCT00704184|19446379|P1|COMPLETED|Double-Blind Treatment||19
7902485|NCT00704184|19446375|P5|Treated|Double-Blind Treatment||19
7902486|NCT00704184|19446376|P4|Treated|Double-Blind Treatment||18
7902487|NCT00704184|19446377|P3|Treated|Double-Blind Treatment||20
7902488|NCT00704184|19446378|P2|Treated|Double-Blind Treatment||18
7902489|NCT00704184|19446379|P1|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19
7902490|NCT00704184|19446375|P5|STARTED|Double-Blind Treatment||19
7902491|NCT00704184|19446376|P4|STARTED|Double-Blind Treatment||18
7902492|NCT00704184|19446377|P3|STARTED|Double-Blind Treatment||20
7902493|NCT00704184|19446378|P2|STARTED|Double-Blind Treatment||18
7902494|NCT00704184|19446379|P1|STARTED|Double-Blind Treatment||20
7902495|NCT00704171|19446418|P2|NOT COMPLETED|Overall Study||0
7902496|NCT00704171|19446419|P1|NOT COMPLETED|Overall Study||1
7902497|NCT00704171|19446418|P2|COMPLETED|Overall Study|All control subjects completed the study.|59
7902498|NCT00704171|19446419|P1|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61
7902499|NCT00704171|19446418|P2|STARTED|Overall Study||59
7902500|NCT00704171|19446419|P1|STARTED|Overall Study||62
7902501|NCT00704132|19446437|P2|NOT COMPLETED|Overall Study||2
7902502|NCT00704132|19446438|P1|NOT COMPLETED|Overall Study||1
7902503|NCT00704132|19446437|P2|COMPLETED|Overall Study||22
7902504|NCT00704132|19446438|P1|COMPLETED|Overall Study||25
7902505|NCT00704132|19446437|P2|STARTED|Overall Study||24
7902506|NCT00704132|19446438|P1|STARTED|Overall Study||26
7902507|NCT00704028|19446446|P2|NOT COMPLETED|Overall Study||21
7902508|NCT00704028|19446447|P1|NOT COMPLETED|Overall Study||12
7902509|NCT00704028|19446446|P2|COMPLETED|Overall Study||57
7902510|NCT00704028|19446447|P1|COMPLETED|Overall Study||70
7902511|NCT00704028|19446446|P2|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78
7902512|NCT00704028|19446447|P1|STARTED|Overall Study||82
7902513|NCT00703976|19446455|P2|NOT COMPLETED|Overall Study||0
7902514|NCT00703976|19446456|P1|NOT COMPLETED|Overall Study||0
7902515|NCT00703976|19446455|P2|COMPLETED|Overall Study||41
7902516|NCT00703976|19446456|P1|COMPLETED|Overall Study||37
7902517|NCT00703976|19446455|P2|STARTED|Overall Study||41
7902518|NCT00703976|19446456|P1|STARTED|Overall Study||37
7902519|NCT00703963|19446466|P2|NOT COMPLETED|Overall Study||14
7902520|NCT00703963|19446467|P1|NOT COMPLETED|Overall Study||7
7902521|NCT00703963|19446466|P2|COMPLETED|Overall Study||86
7902522|NCT00703963|19446467|P1|COMPLETED|Overall Study||93
7902523|NCT00703963|19446466|P2|STARTED|Overall Study||100
7902524|NCT00703963|19446467|P1|STARTED|Overall Study||100
7902525|NCT00703937|19446479|P2|NOT COMPLETED|Overall Study||93
7902526|NCT00703937|19446480|P1|NOT COMPLETED|Overall Study||65
7902527|NCT00703937|19446479|P2|COMPLETED|Overall Study||267
7902528|NCT00703937|19446480|P1|COMPLETED|Overall Study||278
7902529|NCT00703937|19446479|P2|STARTED|Overall Study||360
7902530|NCT00703937|19446480|P1|STARTED|Overall Study||343
7902531|NCT00703924|19446488|P2|NOT COMPLETED|Overall Study||1
7902532|NCT00703924|19446489|P1|NOT COMPLETED|Overall Study||1
7902533|NCT00703924|19446488|P2|COMPLETED|Overall Study||41
7902534|NCT00703924|19446489|P1|COMPLETED|Overall Study||49
7902535|NCT00703924|19446488|P2|STARTED|Overall Study||42
7902536|NCT00703924|19446489|P1|STARTED|Overall Study||50
7902537|NCT00703911|19446505|P1|NOT COMPLETED|Overall Study||10
7902538|NCT00703911|19446505|P1|COMPLETED|Overall Study||92
7902539|NCT00703911|19446505|P1|STARTED|Overall Study||102
7902540|NCT00703885|19446533|P1|NOT COMPLETED|Overall Study||0
7902541|NCT00703885|19446533|P1|COMPLETED|Overall Study||16
7902542|NCT00703885|19446533|P1|STARTED|Overall Study||16
7902543|NCT00703846|19446538|P1|NOT COMPLETED|Overall Study||137
7902544|NCT00703846|19446538|P1|COMPLETED|Overall Study||363
7902545|NCT00703846|19446538|P1|STARTED|Overall Study||500
7902546|NCT00703820|19446554|P2|NOT COMPLETED|Overall Study||34
7902547|NCT00703820|19446555|P1|NOT COMPLETED|Overall Study||35
7902548|NCT00703820|19446554|P2|COMPLETED|Overall Study||95
7902549|NCT00703820|19446555|P1|COMPLETED|Overall Study||98
7902550|NCT00703820|19446554|P2|STARTED|Overall Study||129
7902551|NCT00703820|19446555|P1|STARTED|Overall Study||133
7902552|NCT00703781|19446564|P2|NOT COMPLETED|Overall Study||2
7902553|NCT00703781|19446565|P1|NOT COMPLETED|Overall Study||2
7902554|NCT00703781|19446564|P2|COMPLETED|Overall Study||61
7902555|NCT00703781|19446565|P1|COMPLETED|Overall Study||61
7902556|NCT00703781|19446564|P2|STARTED|Overall Study||63
7902557|NCT00703781|19446565|P1|STARTED|Overall Study||63
7902558|NCT00703729|19446575|P2|NOT COMPLETED|Overall Study||3
7902559|NCT00703729|19446576|P1|NOT COMPLETED|Overall Study||0
7902560|NCT00703729|19446575|P2|COMPLETED|Overall Study||21
7902561|NCT00703729|19446576|P1|COMPLETED|Overall Study||25
7902562|NCT00703729|19446575|P2|STARTED|Overall Study||24
7902563|NCT00703729|19446576|P1|STARTED|Overall Study||25
7902564|NCT00703677|19446610|P1|NOT COMPLETED|Overall Study||3
7902565|NCT00703677|19446610|P1|COMPLETED|Overall Study||14
7902566|NCT00703677|19446610|P1|STARTED|Overall Study||17
7902567|NCT00703664|19446626|P3|NOT COMPLETED|Overall Study||0
7902568|NCT00703664|19446627|P2|NOT COMPLETED|Overall Study||0
7902569|NCT00703664|19446628|P1|NOT COMPLETED|Overall Study||0
7902570|NCT00703664|19446626|P3|COMPLETED|Overall Study||39
7902571|NCT00703664|19446627|P2|COMPLETED|Overall Study||4
7902572|NCT00703664|19446628|P1|COMPLETED|Overall Study||22
7902573|NCT00703664|19446626|P3|STARTED|Overall Study||39
7902574|NCT00703664|19446627|P2|STARTED|Overall Study||4
7902575|NCT00703664|19446628|P1|STARTED|Overall Study||22
7902576|NCT00703534|19446650|P2|NOT COMPLETED|Overall Study||25
7902577|NCT00703534|19446651|P1|NOT COMPLETED|Overall Study||30
7902578|NCT00703534|19446650|P2|COMPLETED|Overall Study||218
7902579|NCT00703534|19446651|P1|COMPLETED|Overall Study||205
7902580|NCT00703534|19446650|P2|STARTED|Overall Study||243
7902581|NCT00703534|19446651|P1|STARTED|Overall Study||235
7902582|NCT00703508|19446657|P1|NOT COMPLETED|Overall Study||0
7902583|NCT00703508|19446657|P1|COMPLETED|Overall Study||26
7902584|NCT00703508|19446657|P1|STARTED|Overall Study||26
7902585|NCT00703391|19446671|P2|NOT COMPLETED|Overall Study||0
7902586|NCT00703391|19446672|P1|NOT COMPLETED|Overall Study||0
7902587|NCT00703391|19446671|P2|COMPLETED|Overall Study||6
7902588|NCT00703391|19446672|P1|COMPLETED|Overall Study||12
7902589|NCT00703391|19446671|P2|STARTED|Overall Study||6
7902590|NCT00703391|19446672|P1|STARTED|Overall Study||12
7902591|NCT00703339|19446716|P1|NOT COMPLETED|Overall Study||0
7902592|NCT00703339|19446716|P1|COMPLETED|Overall Study||1
7902593|NCT00703339|19446716|P1|STARTED|Overall Study||1
7902594|NCT00703326|19446723|P2|NOT COMPLETED|Overall Study||225
7902595|NCT00703326|19446724|P1|NOT COMPLETED|Overall Study||447
7902596|NCT00703326|19446723|P2|COMPLETED|Overall Study||160
7902597|NCT00703326|19446724|P1|COMPLETED|Overall Study||312
7902598|NCT00703326|19446723|P2|Received at Least 1 Dose of Study Drug|Overall Study||382
7902599|NCT00703326|19446724|P1|Received at Least 1 Dose of Study Drug|Overall Study||752
7902600|NCT00703326|19446723|P2|STARTED|Overall Study||385
7902601|NCT00703326|19446724|P1|STARTED|Overall Study||759
7902602|NCT00703261|19446746|P2|NOT COMPLETED|Overall Study||6
7902603|NCT00703261|19446747|P1|NOT COMPLETED|Overall Study||6
7902604|NCT00703261|19446746|P2|COMPLETED|Overall Study||35
7902605|NCT00703261|19446747|P1|COMPLETED|Overall Study||36
7902606|NCT00703261|19446746|P2|STARTED|Overall Study||41
7902607|NCT00703261|19446747|P1|STARTED|Overall Study||42
7902608|NCT00703157|19446756|P2|NOT COMPLETED|Overall Study||2
7902609|NCT00703157|19446757|P1|NOT COMPLETED|Overall Study||4
7902610|NCT00703157|19446756|P2|COMPLETED|Overall Study||24
7902611|NCT00703157|19446757|P1|COMPLETED|Overall Study||22
7902612|NCT00703157|19446756|P2|24 Months FU|Overall Study||24
7902613|NCT00703157|19446757|P1|24 Months FU|Overall Study||22
7902614|NCT00703157|19446756|P2|6 Months FU|Overall Study||25
7902615|NCT00703157|19446757|P1|6 Months FU|Overall Study||25
7902616|NCT00703157|19446756|P2|STARTED|Overall Study||26
7902617|NCT00703157|19446757|P1|STARTED|Overall Study||26
7902618|NCT00703118|19446791|P3|NOT COMPLETED|Overall Study||22
7902619|NCT00703118|19446792|P2|NOT COMPLETED|Overall Study||16
7902620|NCT00703118|19446793|P1|NOT COMPLETED|Overall Study||21
7902621|NCT00703118|19446791|P3|COMPLETED|Overall Study||110
7902622|NCT00703118|19446792|P2|COMPLETED|Overall Study||248
7902623|NCT00703118|19446793|P1|COMPLETED|Overall Study||245
7902624|NCT00703118|19446791|P3|STARTED|Overall Study||132
7902625|NCT00703118|19446792|P2|STARTED|Overall Study||264
7902626|NCT00703118|19446793|P1|STARTED|Overall Study||266
7902627|NCT00703092|19446824|P1|NOT COMPLETED|Overall Study||2
7902628|NCT00703092|19446824|P1|COMPLETED|Overall Study||0
7902629|NCT00703092|19446824|P1|STARTED|Overall Study||2
7902630|NCT00703053|19446838|P9|NOT COMPLETED|Overall Study||1
7902631|NCT00703053|19446839|P8|NOT COMPLETED|Overall Study||6
7902632|NCT00703053|19446840|P7|NOT COMPLETED|Overall Study||7
7902633|NCT00703053|19446841|P6|NOT COMPLETED|Overall Study||6
7902634|NCT00703053|19446842|P5|NOT COMPLETED|Overall Study||1
7902635|NCT00703053|19446843|P4|NOT COMPLETED|Overall Study||3
7902636|NCT00703053|19446844|P3|NOT COMPLETED|Overall Study||3
7902637|NCT00703053|19446845|P2|NOT COMPLETED|Overall Study||2
7902638|NCT00703053|19446846|P1|NOT COMPLETED|Overall Study||1
7902639|NCT00703053|19446838|P9|COMPLETED|Overall Study||102
7902640|NCT00703053|19446839|P8|COMPLETED|Overall Study||91
7902641|NCT00703053|19446840|P7|COMPLETED|Overall Study||45
7902642|NCT00703053|19446841|P6|COMPLETED|Overall Study||43
7902643|NCT00703053|19446842|P5|COMPLETED|Overall Study||50
7902644|NCT00703053|19446843|P4|COMPLETED|Overall Study||46
7902645|NCT00703053|19446844|P3|COMPLETED|Overall Study||48
7902646|NCT00703053|19446845|P2|COMPLETED|Overall Study||24
7902647|NCT00703053|19446846|P1|COMPLETED|Overall Study||26
7902648|NCT00703053|19446838|P9|STARTED|Overall Study||103
7902649|NCT00703053|19446839|P8|STARTED|Overall Study||97
7902650|NCT00703053|19446840|P7|STARTED|Overall Study||52
7902651|NCT00703053|19446841|P6|STARTED|Overall Study||49
7902652|NCT00703053|19446842|P5|STARTED|Overall Study||51
7902653|NCT00703053|19446843|P4|STARTED|Overall Study||49
7902654|NCT00703053|19446844|P3|STARTED|Overall Study||51
7902655|NCT00703053|19446845|P2|STARTED|Overall Study||26
7902656|NCT00703053|19446846|P1|STARTED|Overall Study||27
7902657|NCT00703014|19447032|P4|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42
7902658|NCT00703014|19447033|P3|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47
7902659|NCT00703014|19447034|P2|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
7902660|NCT00703014|19447035|P1|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
7902661|NCT00703014|19447032|P4|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284
7902662|NCT00703014|19447033|P3|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305
7902663|NCT00703014|19447034|P2|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
7902664|NCT00703014|19447035|P1|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
7902665|NCT00703014|19447032|P4|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315
7902666|NCT00703014|19447033|P3|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344
7902667|NCT00703014|19447034|P2|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
7902668|NCT00703014|19447035|P1|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
7902669|NCT00703014|19447032|P4|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326
7902670|NCT00703014|19447033|P3|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352
7902671|NCT00703014|19447034|P2|STARTED|Fetuses/Infants Follow Up Trial P05712||0
7902672|NCT00703014|19447035|P1|STARTED|Fetuses/Infants Follow Up Trial P05712||0
7902673|NCT00703014|19447032|P4|NOT COMPLETED|Mothers Follow Up Trial P05712||0
7902674|NCT00703014|19447033|P3|NOT COMPLETED|Mothers Follow Up Trial P05712||0
7902675|NCT00703014|19447034|P2|NOT COMPLETED|Mothers Follow Up Trial P05712||32
7902676|NCT00703014|19447035|P1|NOT COMPLETED|Mothers Follow Up Trial P05712||33
7902677|NCT00703014|19447032|P4|COMPLETED|Mothers Follow Up Trial P05712||0
7902678|NCT00703014|19447033|P3|COMPLETED|Mothers Follow Up Trial P05712||0
7902679|NCT00703014|19447034|P2|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235
7902680|NCT00703014|19447035|P1|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241
7902681|NCT00703014|19447032|P4|STARTED|Mothers Follow Up Trial P05712||0
7902682|NCT00703014|19447033|P3|STARTED|Mothers Follow Up Trial P05712||0
7902683|NCT00703014|19447034|P2|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267
7902684|NCT00703014|19447035|P1|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274
7902685|NCT00703014|19447032|P4|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
7902686|NCT00703014|19447033|P3|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
7902687|NCT00703014|19447034|P2|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466
7902688|NCT00703014|19447035|P1|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462
7902689|NCT00703014|19447032|P4|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
7902690|NCT00703014|19447033|P3|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
7902691|NCT00703014|19447034|P2|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286
7902692|NCT00703014|19447035|P1|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295
7902693|NCT00703014|19447032|P4|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
7902694|NCT00703014|19447033|P3|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
7902695|NCT00703014|19447034|P2|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704
7902696|NCT00703014|19447035|P1|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672
7902697|NCT00703014|19447032|P4|Treated|Mothers Base Trial P05787 (NCT00696800)||0
7902698|NCT00703014|19447033|P3|Treated|Mothers Base Trial P05787 (NCT00696800)||0
7902699|NCT00703014|19447034|P2|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750
7902700|NCT00703014|19447035|P1|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756
7902701|NCT00703014|19447032|P4|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
7902702|NCT00703014|19447033|P3|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
7902703|NCT00703014|19447034|P2|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752
7902704|NCT00703014|19447035|P1|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757
7902705|NCT00702962|19447055|P2|NOT COMPLETED|Overall Study||1
7902706|NCT00702962|19447056|P1|NOT COMPLETED|Overall Study||1
7902707|NCT00702962|19447055|P2|COMPLETED|Overall Study|Two completed all required cycles. One experienced progressive disease after 2 cycles|2
7902708|NCT00702962|19447056|P1|COMPLETED|Overall Study|The one participant off treatment after 2 doses due to concurrent health disorder.|0
7902709|NCT00702962|19447055|P2|STARTED|Overall Study|Three treated. Milestone not met as Phase I closed prematurely as NCI research established the MTD.|3
7902710|NCT00702962|19447056|P1|STARTED|Overall Study|One initiated treatment. Milestones not achieved due to premature closing due to low accrual.|1
7902711|NCT00702949|19447067|P3|NOT COMPLETED|Overall Study||8
7902712|NCT00702949|19447068|P2|NOT COMPLETED|Overall Study||9
7902713|NCT00702949|19447069|P1|NOT COMPLETED|Overall Study||5
7902714|NCT00702949|19447067|P3|COMPLETED|Overall Study||54
7902715|NCT00702949|19447068|P2|COMPLETED|Overall Study||57
7902716|NCT00702949|19447069|P1|COMPLETED|Overall Study||58
7902717|NCT00702949|19447067|P3|Evaluable for Primary Endpoint|Overall Study||51
7902718|NCT00702949|19447068|P2|Evaluable for Primary Endpoint|Overall Study||56
7902719|NCT00702949|19447069|P1|Evaluable for Primary Endpoint|Overall Study||56
7902720|NCT00702949|19447067|P3|STARTED|Overall Study||62
7902721|NCT00702949|19447068|P2|STARTED|Overall Study||66
7902722|NCT00702949|19447069|P1|STARTED|Overall Study||63
7902723|NCT00702923|19447094|P1|NOT COMPLETED|Overall Study||1
7902724|NCT00702923|19447094|P1|COMPLETED|Overall Study||11
7902725|NCT00702923|19447094|P1|STARTED|Overall Study||12
7902726|NCT00702884|19447103|P1|NOT COMPLETED|Overall Study||0
7902727|NCT00702884|19447103|P1|COMPLETED|Overall Study||25
7902728|NCT00702884|19447103|P1|STARTED|Overall Study||25
7902729|NCT00702845|19447117|P2|NOT COMPLETED|Overall Study||8
7902730|NCT00702845|19447118|P1|NOT COMPLETED|Overall Study||22
7902731|NCT00702845|19447117|P2|COMPLETED|Overall Study||121
7902732|NCT00702845|19447118|P1|COMPLETED|Overall Study||246
7902733|NCT00702845|19447117|P2|Randomized|Overall Study||128
7902734|NCT00702845|19447118|P1|Randomized|Overall Study||268
7902735|NCT00702845|19447117|P2|STARTED|Overall Study|Includes one treated participant who was not randomized|129
7902736|NCT00702845|19447118|P1|STARTED|Overall Study||268
7902737|NCT00702780|19447158|P2|NOT COMPLETED|Overall Study||8
7902738|NCT00702780|19447159|P1|NOT COMPLETED|Overall Study||9
7902739|NCT00702780|19447158|P2|COMPLETED|Overall Study||29
7902740|NCT00702780|19447159|P1|COMPLETED|Overall Study||28
7902741|NCT00702780|19447158|P2|STARTED|Overall Study||37
7902742|NCT00702780|19447159|P1|STARTED|Overall Study||37
7902743|NCT00702754|19447167|P1|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24
7902744|NCT00702754|19447167|P1|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329
7902745|NCT00702754|19447167|P1|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353
7902746|NCT00702754|19447167|P1|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24
7902747|NCT00702754|19447167|P1|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353
7902748|NCT00702754|19447167|P1|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377
7902749|NCT00702754|19447167|P1|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19
7902750|NCT00702754|19447167|P1|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377
7902751|NCT00702754|19447167|P1|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396
7902752|NCT00702754|19447167|P1|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32
7902753|NCT00702754|19447167|P1|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396
7902754|NCT00702754|19447167|P1|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428
7902755|NCT00702754|19447167|P1|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22
7902756|NCT00702754|19447167|P1|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428
7902757|NCT00702754|19447167|P1|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450
7902758|NCT00702754|19447167|P1|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25
7902759|NCT00702754|19447167|P1|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450
7902760|NCT00702754|19447167|P1|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475
7902761|NCT00702754|19447167|P1|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20
7902762|NCT00702754|19447167|P1|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475
7902763|NCT00702754|19447167|P1|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495
7902764|NCT00702754|19447167|P1|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7
7902765|NCT00702754|19447167|P1|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495
7902766|NCT00702754|19447167|P1|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502
7902767|NCT00702715|19447180|P2|NOT COMPLETED|Overall Study||0
7902768|NCT00702715|19447181|P1|NOT COMPLETED|Overall Study||1
7902769|NCT00702715|19447180|P2|COMPLETED|Overall Study||33
7902770|NCT00702715|19447181|P1|COMPLETED|Overall Study||34
7902771|NCT00702715|19447180|P2|STARTED|Overall Study|One subject was enrolled but did not start study|33
7902772|NCT00702715|19447181|P1|STARTED|Overall Study||35
7902773|NCT00702702|19447194|P1|NOT COMPLETED|Overall Study||56
7902774|NCT00702702|19447194|P1|COMPLETED|Overall Study||0
7902775|NCT00702702|19447194|P1|STARTED|Overall Study||56
7902776|NCT00702689|19447202|P1|NOT COMPLETED|Overall Study||6
7902777|NCT00702689|19447202|P1|COMPLETED|Overall Study||14
7902778|NCT00702689|19447202|P1|STARTED|Overall Study||20
7902779|NCT00702650|19447213|P1|NOT COMPLETED|Overall Study||20
7902780|NCT00702650|19447213|P1|COMPLETED|Overall Study||135
7902781|NCT00702650|19447213|P1|STARTED|Overall Study||155
7902782|NCT00702624|19447233|P4|NOT COMPLETED|Fetuses/Infant Follow-up||0
7902783|NCT00702624|19447234|P3|NOT COMPLETED|Fetuses/Infant Follow-up||10
7902784|NCT00702624|19447235|P2|NOT COMPLETED|Fetuses/Infant Follow-up||0
7902785|NCT00702624|19447236|P1|NOT COMPLETED|Fetuses/Infant Follow-up||0
7902786|NCT00702624|19447233|P4|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55
7902787|NCT00702624|19447234|P3|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78
7902788|NCT00702624|19447235|P2|COMPLETED|Fetuses/Infant Follow-up||0
7902789|NCT00702624|19447236|P1|COMPLETED|Fetuses/Infant Follow-up||0
7902790|NCT00702624|19447233|P4|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55
7902791|NCT00702624|19447234|P3|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80
7902792|NCT00702624|19447235|P2|Live Born Infants|Fetuses/Infant Follow-up||0
7902793|NCT00702624|19447236|P1|Live Born Infants|Fetuses/Infant Follow-up||0
7902794|NCT00702624|19447233|P4|STARTED|Fetuses/Infant Follow-up||55
7902795|NCT00702624|19447234|P3|STARTED|Fetuses/Infant Follow-up||88
7902796|NCT00702624|19447235|P2|STARTED|Fetuses/Infant Follow-up||0
7902797|NCT00702624|19447236|P1|STARTED|Fetuses/Infant Follow-up||0
7902798|NCT00702624|19447233|P4|NOT COMPLETED|Expectant Mother Follow-up||0
7902799|NCT00702624|19447234|P3|NOT COMPLETED|Expectant Mother Follow-up||0
7902800|NCT00702624|19447235|P2|NOT COMPLETED|Expectant Mother Follow-up||0
7902801|NCT00702624|19447236|P1|NOT COMPLETED|Expectant Mother Follow-up||7
7902802|NCT00702624|19447233|P4|COMPLETED|Expectant Mother Follow-up||0
7902803|NCT00702624|19447234|P3|COMPLETED|Expectant Mother Follow-up||0
7902804|NCT00702624|19447235|P2|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45
7902805|NCT00702624|19447236|P1|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61
7902806|NCT00702624|19447233|P4|STARTED|Expectant Mother Follow-up||0
7902807|NCT00702624|19447234|P3|STARTED|Expectant Mother Follow-up||0
7902808|NCT00702624|19447235|P2|STARTED|Expectant Mother Follow-up||45
7902809|NCT00702624|19447236|P1|STARTED|Expectant Mother Follow-up||68
7902810|NCT00702624|19447233|P4|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
7902811|NCT00702624|19447234|P3|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
7902812|NCT00702624|19447235|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
7902813|NCT00702624|19447236|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
7902814|NCT00702624|19447233|P4|COMPLETED|Base Study P05690 (NCT00702845)||0
7902815|NCT00702624|19447234|P3|COMPLETED|Base Study P05690 (NCT00702845)||0
7902816|NCT00702624|19447235|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
7902817|NCT00702624|19447236|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
7902818|NCT00702624|19447233|P4|STARTED|Base Study P05690 (NCT00702845)||0
7902819|NCT00702624|19447234|P3|STARTED|Base Study P05690 (NCT00702845)||0
7902820|NCT00702624|19447235|P2|STARTED|Base Study P05690 (NCT00702845)||128
7902821|NCT00702624|19447236|P1|STARTED|Base Study P05690 (NCT00702845)||268
7902822|NCT00702546|19447254|P2|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1
7902823|NCT00702546|19447255|P1|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5
7902824|NCT00702546|19447254|P2|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24
7902825|NCT00702546|19447255|P1|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72
7902826|NCT00702546|19447254|P2|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25
7902827|NCT00702546|19447255|P1|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77
7902828|NCT00702546|19447254|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
7902829|NCT00702546|19447255|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
7902830|NCT00702546|19447254|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
7902831|NCT00702546|19447255|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
7902832|NCT00702546|19447254|P2|STARTED|Base Study P05690 (NCT00702845)||128
7902833|NCT00702546|19447255|P1|STARTED|Base Study P05690 (NCT00702845)||268
7902834|NCT00702520|19447275|P4|NOT COMPLETED|Follow-up Study P05783||0
7902835|NCT00702520|19447276|P3|NOT COMPLETED|Follow-up Study P05783||0
7902836|NCT00702520|19447277|P2|NOT COMPLETED|Follow-up Study P05783||0
7902837|NCT00702520|19447278|P1|NOT COMPLETED|Follow-up Study P05783||0
7902838|NCT00702520|19447275|P4|COMPLETED|Follow-up Study P05783||11
7902839|NCT00702520|19447276|P3|COMPLETED|Follow-up Study P05783||8
7902840|NCT00702520|19447277|P2|COMPLETED|Follow-up Study P05783||8
7902841|NCT00702520|19447278|P1|COMPLETED|Follow-up Study P05783||7
7902842|NCT00702520|19447275|P4|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11
7902843|NCT00702520|19447276|P3|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8
7902844|NCT00702520|19447277|P2|STARTED|Follow-up Study P05783||8
7902845|NCT00702520|19447278|P1|STARTED|Follow-up Study P05783||7
7902846|NCT00702520|19447275|P4|NOT COMPLETED|Base Study P05788 - Follow-Up||0
7902847|NCT00702520|19447276|P3|NOT COMPLETED|Base Study P05788 - Follow-Up||0
7902848|NCT00702520|19447277|P2|NOT COMPLETED|Base Study P05788 - Follow-Up||10
7902849|NCT00702520|19447278|P1|NOT COMPLETED|Base Study P05788 - Follow-Up||15
7902850|NCT00702520|19447275|P4|COMPLETED|Base Study P05788 - Follow-Up||0
7902851|NCT00702520|19447276|P3|COMPLETED|Base Study P05788 - Follow-Up||0
7902852|NCT00702520|19447277|P2|COMPLETED|Base Study P05788 - Follow-Up||8
7902853|NCT00702520|19447278|P1|COMPLETED|Base Study P05788 - Follow-Up||7
7902854|NCT00702520|19447275|P4|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
7902855|NCT00702520|19447276|P3|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
7902856|NCT00702520|19447277|P2|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8
7902857|NCT00702520|19447278|P1|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7
7902858|NCT00702520|19447275|P4|STARTED|Base Study P05788 - Follow-Up||0
7902859|NCT00702520|19447276|P3|STARTED|Base Study P05788 - Follow-Up||0
7902860|NCT00702520|19447277|P2|STARTED|Base Study P05788 - Follow-Up||18
7902861|NCT00702520|19447278|P1|STARTED|Base Study P05788 - Follow-Up||22
7902862|NCT00702520|19447275|P4|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
7902863|NCT00702520|19447276|P3|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
7902864|NCT00702520|19447277|P2|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6
7902865|NCT00702520|19447278|P1|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3
7902866|NCT00702520|19447275|P4|COMPLETED|Base Study P05788 - Embryo Transfer||0
7902867|NCT00702520|19447276|P3|COMPLETED|Base Study P05788 - Embryo Transfer||0
7902868|NCT00702520|19447277|P2|COMPLETED|Base Study P05788 - Embryo Transfer||18
7902869|NCT00702520|19447278|P1|COMPLETED|Base Study P05788 - Embryo Transfer||22
7902870|NCT00702520|19447275|P4|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
7902871|NCT00702520|19447276|P3|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
7902872|NCT00702520|19447277|P2|Embryo Transfer|Base Study P05788 - Embryo Transfer||18
7902873|NCT00702520|19447278|P1|Embryo Transfer|Base Study P05788 - Embryo Transfer||22
7902874|NCT00702520|19447275|P4|STARTED|Base Study P05788 - Embryo Transfer||0
7902875|NCT00702520|19447276|P3|STARTED|Base Study P05788 - Embryo Transfer||0
7902876|NCT00702520|19447277|P2|STARTED|Base Study P05788 - Embryo Transfer||24
7902877|NCT00702520|19447278|P1|STARTED|Base Study P05788 - Embryo Transfer||25
7902878|NCT00702520|19447275|P4|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
7902879|NCT00702520|19447276|P3|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
7902880|NCT00702520|19447277|P2|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1
7902881|NCT00702520|19447278|P1|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
7902882|NCT00702520|19447275|P4|COMPLETED|Base Study P05788 - Assigned Treatment||0
7902883|NCT00702520|19447276|P3|COMPLETED|Base Study P05788 - Assigned Treatment||0
7902884|NCT00702520|19447277|P2|COMPLETED|Base Study P05788 - Assigned Treatment||24
7902885|NCT00702520|19447278|P1|COMPLETED|Base Study P05788 - Assigned Treatment||25
7902886|NCT00702520|19447275|P4|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
7902887|NCT00702520|19447276|P3|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
7902888|NCT00702520|19447277|P2|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24
7902889|NCT00702520|19447278|P1|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25
7902890|NCT00702520|19447275|P4|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
7902891|NCT00702520|19447276|P3|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
7902892|NCT00702520|19447277|P2|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24
7902893|NCT00702520|19447278|P1|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25
7902894|NCT00702520|19447275|P4|STARTED|Base Study P05788 - Assigned Treatment||0
7902895|NCT00702520|19447276|P3|STARTED|Base Study P05788 - Assigned Treatment||0
7902896|NCT00702520|19447277|P2|STARTED|Base Study P05788 - Assigned Treatment||25
7902897|NCT00702520|19447278|P1|STARTED|Base Study P05788 - Assigned Treatment||25
7902898|NCT00702507|19447294|P1|NOT COMPLETED|Follow-up Phase||27
7902899|NCT00702507|19447294|P1|COMPLETED|Follow-up Phase||132
7902900|NCT00702507|19447294|P1|STARTED|Follow-up Phase||159
7902901|NCT00702507|19447294|P1|NOT COMPLETED|Initial Treatment Phase||41
7902902|NCT00702507|19447294|P1|COMPLETED|Initial Treatment Phase||159
7902903|NCT00702507|19447294|P1|STARTED|Initial Treatment Phase||200
7902904|NCT00702468|19447308|P2|NOT COMPLETED|Overall Study||16
7902905|NCT00702468|19447309|P1|NOT COMPLETED|Overall Study||3
7902906|NCT00702468|19447308|P2|COMPLETED|Overall Study||2
7902907|NCT00702468|19447309|P1|COMPLETED|Overall Study||15
7902908|NCT00702468|19447308|P2|STARTED|Overall Study||18
7902909|NCT00702468|19447309|P1|STARTED|Overall Study||18
7902910|NCT00702403|19447331|P1|NOT COMPLETED|From Engraftment to Study Completion||27
7902911|NCT00702403|19447331|P1|COMPLETED|From Engraftment to Study Completion||13
7902912|NCT00702403|19447331|P1|Patient Drop-outs|From Engraftment to Study Completion||27
7902913|NCT00702403|19447331|P1|STARTED|From Engraftment to Study Completion||40
7902914|NCT00702403|19447331|P1|NOT COMPLETED|From Consent to Engraftment||17
7902915|NCT00702403|19447331|P1|COMPLETED|From Consent to Engraftment|40 of 57 originally consented subjects remained eligible at engraftment (= the 2nd ITT population)|40
7902916|NCT00702403|19447331|P1|Ineligible for Study Drug|From Consent to Engraftment||17
7902917|NCT00702403|19447331|P1|STARTED|From Consent to Engraftment|"57 agreed to participate and completed informed consent (= the 1st intention to treat population)"|57
7902918|NCT00702377|19447341|P2|NOT COMPLETED|Overall Study||3
7902919|NCT00702377|19447342|P1|NOT COMPLETED|Overall Study||1
7902920|NCT00702377|19447341|P2|COMPLETED|Overall Study||53
7902921|NCT00702377|19447342|P1|COMPLETED|Overall Study||52
7902922|NCT00702377|19447341|P2|STARTED|Overall Study||56
7902923|NCT00702377|19447342|P1|STARTED|Overall Study||53
7902924|NCT00702364|19447354|P2|NOT COMPLETED|Overall Study||4
7902925|NCT00702364|19447355|P1|NOT COMPLETED|Overall Study||2
7902926|NCT00702364|19447354|P2|COMPLETED|Overall Study||25
7902927|NCT00702364|19447355|P1|COMPLETED|Overall Study||24
7902928|NCT00702364|19447354|P2|STARTED|Overall Study||29
7902929|NCT00702364|19447355|P1|STARTED|Overall Study||26
7902930|NCT00702338|19447367|P3|NOT COMPLETED|Follow-up Study: Infant FU||2
7902931|NCT00702338|19447368|P2|NOT COMPLETED|Follow-up Study: Infant FU||0
7902932|NCT00702338|19447369|P1|NOT COMPLETED|Follow-up Study: Infant FU||0
7902933|NCT00702338|19447367|P3|COMPLETED|Follow-up Study: Infant FU||0
7902934|NCT00702338|19447368|P2|COMPLETED|Follow-up Study: Infant FU||0
7902935|NCT00702338|19447369|P1|COMPLETED|Follow-up Study: Infant FU||0
7902936|NCT00702338|19447367|P3|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2
7902937|NCT00702338|19447368|P2|STARTED|Follow-up Study: Infant FU||0
7902938|NCT00702338|19447369|P1|STARTED|Follow-up Study: Infant FU||0
7902939|NCT00702338|19447367|P3|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
7902940|NCT00702338|19447368|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1
7902941|NCT00702338|19447369|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
7902942|NCT00702338|19447367|P3|COMPLETED|Follow-up Study: Expectant Mothers FU||0
7902943|NCT00702338|19447368|P2|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0
7902944|NCT00702338|19447369|P1|COMPLETED|Follow-up Study: Expectant Mothers FU||0
7902945|NCT00702338|19447367|P3|STARTED|Follow-up Study: Expectant Mothers FU||0
7902946|NCT00702338|19447368|P2|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1
7902947|NCT00702338|19447369|P1|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0
7902948|NCT00702338|19447367|P3|NOT COMPLETED|Base Study (NCT00697255)||0
7902949|NCT00702338|19447368|P2|NOT COMPLETED|Base Study (NCT00697255)||2
7902950|NCT00702338|19447369|P1|NOT COMPLETED|Base Study (NCT00697255)||3
7902951|NCT00702338|19447367|P3|COMPLETED|Base Study (NCT00697255)||0
7902952|NCT00702338|19447368|P2|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1
7902953|NCT00702338|19447369|P1|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2
7902954|NCT00702338|19447367|P3|STARTED|Base Study (NCT00697255)||0
7902955|NCT00702338|19447368|P2|STARTED|Base Study (NCT00697255)||3
7902956|NCT00702338|19447369|P1|STARTED|Base Study (NCT00697255)||5
7902957|NCT00702325|19447385|P2|NOT COMPLETED|Overall Study||53
7902958|NCT00702325|19447386|P1|NOT COMPLETED|Overall Study||38
7902959|NCT00702325|19447385|P2|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102
7902960|NCT00702325|19447386|P1|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118
7902961|NCT00702325|19447385|P2|STARTED|Overall Study|Randomized|155
7902962|NCT00702325|19447386|P1|STARTED|Overall Study|Randomized|156
7902963|NCT00702299|19447438|P1|NOT COMPLETED|Overall Study||0
7902964|NCT00702299|19447438|P1|COMPLETED|Overall Study||15
7902965|NCT00702299|19447438|P1|STARTED|Overall Study||15
7902966|NCT00702273|19447451|P2|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29
7902967|NCT00702273|19447452|P1|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20
7902968|NCT00702273|19447451|P2|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147
7902969|NCT00702273|19447452|P1|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148
7902970|NCT00702273|19447451|P2|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176
7902971|NCT00702273|19447452|P1|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168
7902972|NCT00702273|19447451|P2|NOT COMPLETED|Base Study P05787 (NCT00696800)||48
7902973|NCT00702273|19447452|P1|NOT COMPLETED|Base Study P05787 (NCT00696800)||85
7902974|NCT00702273|19447451|P2|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704
7902975|NCT00702273|19447452|P1|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672
7902976|NCT00702273|19447451|P2|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750
7902977|NCT00702273|19447452|P1|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756
7902978|NCT00702273|19447451|P2|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752
7902979|NCT00702273|19447452|P1|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757
7902980|NCT00702234|19447470|P2|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27
7902981|NCT00702234|19447471|P1|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0
7902982|NCT00702234|19447470|P2|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288
7902983|NCT00702234|19447471|P1|COMPLETED|Follow-up Study: Fetuses/Infants||0
7902984|NCT00702234|19447470|P2|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304
7902985|NCT00702234|19447471|P1|Live Born Infants|Follow-up Study: Fetuses/Infants||0
7902986|NCT00702234|19447470|P2|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315
7902987|NCT00702234|19447471|P1|STARTED|Follow-up Study: Fetuses/Infants||0
7902988|NCT00702234|19447470|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers||0
7902989|NCT00702234|19447471|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers||22
7902990|NCT00702234|19447470|P2|COMPLETED|Follow-up Study: Expectant Mothers||0
7902991|NCT00702234|19447471|P1|COMPLETED|Follow-up Study: Expectant Mothers||246
7902992|NCT00702234|19447470|P2|STARTED|Follow-up Study: Expectant Mothers||0
7902993|NCT00702234|19447471|P1|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268
7902994|NCT00702234|19447470|P2|NOT COMPLETED|Base Study (NCT00696878)||0
7902995|NCT00702234|19447471|P1|NOT COMPLETED|Base Study (NCT00696878)||504
7902996|NCT00702234|19447470|P2|COMPLETED|Base Study (NCT00696878)||0
7902997|NCT00702234|19447471|P1|COMPLETED|Base Study (NCT00696878)||178
7902998|NCT00702234|19447470|P2|STARTED|Base Study (NCT00696878)||0
7902999|NCT00702234|19447471|P1|STARTED|Base Study (NCT00696878)||682
7903000|NCT00702221|19447482|P2|NOT COMPLETED|Overall Study||3
7903001|NCT00702221|19447483|P1|NOT COMPLETED|Overall Study||4
7903002|NCT00702221|19447482|P2|COMPLETED|Overall Study||7
7903003|NCT00702221|19447483|P1|COMPLETED|Overall Study||6
7903004|NCT00702221|19447482|P2|STARTED|Overall Study||10
7903005|NCT00702221|19447483|P1|STARTED|Overall Study||10
7903006|NCT00702208|19447489|P1|NOT COMPLETED|Overall Study||31
7903007|NCT00702208|19447489|P1|COMPLETED|Overall Study||167
7903008|NCT00702208|19447489|P1|STARTED|Overall Study||198
7903009|NCT00702143|19447498|P3|NOT COMPLETED|Overall Study||1
7903010|NCT00702143|19447499|P2|NOT COMPLETED|Overall Study||0
7903011|NCT00702143|19447500|P1|NOT COMPLETED|Overall Study||0
7903012|NCT00702143|19447498|P3|COMPLETED|Overall Study||78
7903013|NCT00702143|19447499|P2|COMPLETED|Overall Study||60
7903014|NCT00702143|19447500|P1|COMPLETED|Overall Study||45
7903015|NCT00702143|19447498|P3|STARTED|Overall Study||79
7903016|NCT00702143|19447499|P2|STARTED|Overall Study||60
7903017|NCT00702143|19447500|P1|STARTED|Overall Study||45
7903018|NCT00701935|19447514|P2|NOT COMPLETED|Overall Study||11
7903019|NCT00701935|19447515|P1|NOT COMPLETED|Overall Study||16
7903020|NCT00701935|19447514|P2|COMPLETED|Overall Study||26
7903021|NCT00701935|19447515|P1|COMPLETED|Overall Study||27
7903022|NCT00701935|19447514|P2|STARTED|Overall Study||37
7903023|NCT00701935|19447515|P1|STARTED|Overall Study||43
7903024|NCT00701805|19447549|P4|NOT COMPLETED|Overall Study||4
7903025|NCT00701805|19447550|P3|NOT COMPLETED|Overall Study||7
7903026|NCT00701805|19447551|P2|NOT COMPLETED|Overall Study||4
7903027|NCT00701805|19447552|P1|NOT COMPLETED|Overall Study||3
7903028|NCT00701805|19447549|P4|COMPLETED|Overall Study||22
7903029|NCT00701805|19447550|P3|COMPLETED|Overall Study||16
7903030|NCT00701805|19447551|P2|COMPLETED|Overall Study||25
7903031|NCT00701805|19447552|P1|COMPLETED|Overall Study||23
7903032|NCT00701805|19447549|P4|STARTED|Overall Study||26
7903033|NCT00701805|19447550|P3|STARTED|Overall Study||23
7903034|NCT00701805|19447551|P2|STARTED|Overall Study||29
7903035|NCT00701805|19447552|P1|STARTED|Overall Study||26
7903036|NCT00701779|19447602|P1|NOT COMPLETED|Overall Study||9
7903037|NCT00701779|19447602|P1|COMPLETED|Overall Study||54
7903038|NCT00701779|19447602|P1|12 Month|Overall Study||54
7903039|NCT00701779|19447602|P1|9 Month|Overall Study||56
7903040|NCT00701779|19447602|P1|6 Month|Overall Study||58
7903041|NCT00701779|19447602|P1|3 Month|Overall Study||60
7903042|NCT00701779|19447602|P1|STARTED|Overall Study||63
7903043|NCT00701727|19447614|P2|NOT COMPLETED|Second Treatment Period||0
7903044|NCT00701727|19447615|P1|NOT COMPLETED|Second Treatment Period||2
7903045|NCT00701727|19447614|P2|COMPLETED|Second Treatment Period||13
7903046|NCT00701727|19447615|P1|COMPLETED|Second Treatment Period||13
7903047|NCT00701727|19447614|P2|STARTED|Second Treatment Period||13
7903048|NCT00701727|19447615|P1|STARTED|Second Treatment Period||15
7903049|NCT00701727|19447614|P2|NOT COMPLETED|First Treatment Period||2
7903050|NCT00701727|19447615|P1|NOT COMPLETED|First Treatment Period||1
7903051|NCT00701727|19447614|P2|COMPLETED|First Treatment Period||13
7903052|NCT00701727|19447615|P1|COMPLETED|First Treatment Period||15
7903053|NCT00701727|19447614|P2|STARTED|First Treatment Period||15
7903054|NCT00701727|19447615|P1|STARTED|First Treatment Period||16
7903055|NCT00701714|19447635|P2|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
7903056|NCT00701714|19447636|P1|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
7903057|NCT00701714|19447635|P2|COMPLETED|Safety Follow-up Period (6 Months)||112
7903058|NCT00701714|19447636|P1|COMPLETED|Safety Follow-up Period (6 Months)||144
7903059|NCT00701714|19447635|P2|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|119
7903060|NCT00701714|19447636|P1|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|151
7903061|NCT00701714|19447635|P2|NOT COMPLETED|Treatment Period (up to 1 Year)||134
7903062|NCT00701714|19447636|P1|NOT COMPLETED|Treatment Period (up to 1 Year)||137
7903063|NCT00701714|19447635|P2|COMPLETED|Treatment Period (up to 1 Year)||29
7903064|NCT00701714|19447636|P1|COMPLETED|Treatment Period (up to 1 Year)||37
7903065|NCT00701714|19447635|P2|STARTED|Treatment Period (up to 1 Year)||163
7903066|NCT00701714|19447636|P1|STARTED|Treatment Period (up to 1 Year)||174
7903067|NCT00701701|19447650|P2|NOT COMPLETED|Overall Study||2
7903068|NCT00701701|19447651|P1|NOT COMPLETED|Overall Study||0
7903069|NCT00701701|19447650|P2|COMPLETED|Overall Study||1
7903070|NCT00701701|19447651|P1|COMPLETED|Overall Study||1
7903071|NCT00701701|19447650|P2|STARTED|Overall Study||3
7903072|NCT00701701|19447651|P1|STARTED|Overall Study||1
7903073|NCT00701675|19447676|P3|NOT COMPLETED|Overall Study||7
7903074|NCT00701675|19447677|P2|NOT COMPLETED|Overall Study||8
7903075|NCT00701675|19447678|P1|NOT COMPLETED|Overall Study||4
7903076|NCT00701675|19447676|P3|COMPLETED|Overall Study||7
7903077|NCT00701675|19447677|P2|COMPLETED|Overall Study||6
7903078|NCT00701675|19447678|P1|COMPLETED|Overall Study||10
7903079|NCT00701675|19447676|P3|STARTED|Overall Study||14
7903080|NCT00701675|19447677|P2|STARTED|Overall Study||14
7903081|NCT00701675|19447678|P1|STARTED|Overall Study||14
7903082|NCT00701662|19447686|P1|NOT COMPLETED|Overall Study||1
7903083|NCT00701662|19447686|P1|COMPLETED|Overall Study||7
7903084|NCT00701662|19447686|P1|STARTED|Overall Study||8
7903085|NCT00701636|19447705|P2|NOT COMPLETED|Overall Study||0
7903086|NCT00701636|19447706|P1|NOT COMPLETED|Overall Study||0
7903087|NCT00701636|19447705|P2|COMPLETED|Overall Study||15
7903088|NCT00701636|19447706|P1|COMPLETED|Overall Study||15
7903089|NCT00701636|19447705|P2|STARTED|Overall Study||15
7903090|NCT00701636|19447706|P1|STARTED|Overall Study||15
7903091|NCT00701558|19447711|P1|NOT COMPLETED|Overall Study||15
7903092|NCT00701558|19447711|P1|COMPLETED|Overall Study||4
7903093|NCT00701558|19447711|P1|STARTED|Overall Study||19
7903094|NCT00701441|19447719|P2|NOT COMPLETED|Overall Study||4
7903095|NCT00701441|19447720|P1|NOT COMPLETED|Overall Study||0
7903096|NCT00701441|19447719|P2|COMPLETED|Overall Study||12
7903097|NCT00701441|19447720|P1|COMPLETED|Overall Study||9
7903098|NCT00701441|19447719|P2|STARTED|Overall Study||16
7903099|NCT00701441|19447720|P1|STARTED|Overall Study||9
7903100|NCT00701415|19447732|P2|NOT COMPLETED|Overall Study||1
7903101|NCT00701415|19447733|P1|NOT COMPLETED|Overall Study||1
7903102|NCT00701415|19447732|P2|COMPLETED|Overall Study||14
7903103|NCT00701415|19447733|P1|COMPLETED|Overall Study||15
7903104|NCT00701415|19447732|P2|STARTED|Overall Study||15
7903105|NCT00701415|19447733|P1|STARTED|Overall Study||16
7903106|NCT00701389|19447743|P4|NOT COMPLETED|Period 4||0
7903107|NCT00701389|19447744|P3|NOT COMPLETED|Period 4||0
7903108|NCT00701389|19447745|P2|NOT COMPLETED|Period 4||0
7903109|NCT00701389|19447746|P1|NOT COMPLETED|Period 4||0
7903110|NCT00701389|19447743|P4|COMPLETED|Period 4||6
7903111|NCT00701389|19447744|P3|COMPLETED|Period 4||6
7903112|NCT00701389|19447745|P2|COMPLETED|Period 4||6
7903113|NCT00701389|19447746|P1|COMPLETED|Period 4||6
7903114|NCT00701389|19447743|P4|STARTED|Period 4||6
7903115|NCT00701389|19447744|P3|STARTED|Period 4||6
7903116|NCT00701389|19447745|P2|STARTED|Period 4||6
7903117|NCT00701389|19447746|P1|STARTED|Period 4||6
7903118|NCT00701389|19447743|P4|NOT COMPLETED|Period 3||0
7903119|NCT00701389|19447744|P3|NOT COMPLETED|Period 3||0
7903120|NCT00701389|19447745|P2|NOT COMPLETED|Period 3||0
7903121|NCT00701389|19447746|P1|NOT COMPLETED|Period 3||0
7903122|NCT00701389|19447743|P4|COMPLETED|Period 3||6
7903123|NCT00701389|19447744|P3|COMPLETED|Period 3||6
7903124|NCT00701389|19447745|P2|COMPLETED|Period 3||6
7903125|NCT00701389|19447746|P1|COMPLETED|Period 3||6
7903126|NCT00701389|19447743|P4|STARTED|Period 3||6
7903127|NCT00701389|19447744|P3|STARTED|Period 3||6
7903128|NCT00701389|19447745|P2|STARTED|Period 3||6
7903129|NCT00701389|19447746|P1|STARTED|Period 3||6
7903130|NCT00701389|19447743|P4|NOT COMPLETED|Period 2||0
7903131|NCT00701389|19447744|P3|NOT COMPLETED|Period 2||0
7903132|NCT00701389|19447745|P2|NOT COMPLETED|Period 2||0
7903133|NCT00701389|19447746|P1|NOT COMPLETED|Period 2||0
7903134|NCT00701389|19447743|P4|COMPLETED|Period 2||6
7903135|NCT00701389|19447744|P3|COMPLETED|Period 2||6
7903136|NCT00701389|19447745|P2|COMPLETED|Period 2||6
7903137|NCT00701389|19447746|P1|COMPLETED|Period 2||6
7903138|NCT00701389|19447743|P4|STARTED|Period 2||6
7903139|NCT00701389|19447744|P3|STARTED|Period 2||6
7903140|NCT00701389|19447745|P2|STARTED|Period 2||6
7903141|NCT00701389|19447746|P1|STARTED|Period 2||6
7903142|NCT00701389|19447743|P4|NOT COMPLETED|Period 1||0
7903143|NCT00701389|19447744|P3|NOT COMPLETED|Period 1||0
7903144|NCT00701389|19447745|P2|NOT COMPLETED|Period 1||0
7903145|NCT00701389|19447746|P1|NOT COMPLETED|Period 1||0
7903146|NCT00701389|19447743|P4|COMPLETED|Period 1||6
7903147|NCT00701389|19447744|P3|COMPLETED|Period 1||6
7903148|NCT00701389|19447745|P2|COMPLETED|Period 1||6
7903149|NCT00701389|19447746|P1|COMPLETED|Period 1||6
7903150|NCT00701389|19447743|P4|STARTED|Period 1||6
7903151|NCT00701389|19447744|P3|STARTED|Period 1||6
7903152|NCT00701389|19447745|P2|STARTED|Period 1||6
7903153|NCT00701389|19447746|P1|STARTED|Period 1||6
7903154|NCT00701376|19447764|P1|NOT COMPLETED|Overall Study||1
7903155|NCT00701376|19447764|P1|COMPLETED|Overall Study||105
7903156|NCT00701376|19447764|P1|STARTED|Overall Study||106
7903157|NCT00701363|19447792|P4|NOT COMPLETED|Treatment Phase 2||0
7903158|NCT00701363|19447793|P3|NOT COMPLETED|Treatment Phase 2||2
7903159|NCT00701363|19447794|P2|NOT COMPLETED|Treatment Phase 2||0
7903160|NCT00701363|19447795|P1|NOT COMPLETED|Treatment Phase 2||0
7903161|NCT00701363|19447792|P4|COMPLETED|Treatment Phase 2||26
7903162|NCT00701363|19447793|P3|COMPLETED|Treatment Phase 2||68
7903163|NCT00701363|19447794|P2|COMPLETED|Treatment Phase 2||13
7903164|NCT00701363|19447795|P1|COMPLETED|Treatment Phase 2||0
7903165|NCT00701363|19447792|P4|STARTED|Treatment Phase 2||26
7903166|NCT00701363|19447793|P3|STARTED|Treatment Phase 2||70
7903167|NCT00701363|19447794|P2|STARTED|Treatment Phase 2||13
7903168|NCT00701363|19447795|P1|STARTED|Treatment Phase 2||0
7903169|NCT00701363|19447792|P4|NOT COMPLETED|Treatment Phase 1||0
7903170|NCT00701363|19447793|P3|NOT COMPLETED|Treatment Phase 1||0
7903171|NCT00701363|19447794|P2|NOT COMPLETED|Treatment Phase 1||0
7903172|NCT00701363|19447795|P1|NOT COMPLETED|Treatment Phase 1||15
7903173|NCT00701363|19447792|P4|COMPLETED|Treatment Phase 1||0
7903174|NCT00701363|19447793|P3|COMPLETED|Treatment Phase 1||0
7903175|NCT00701363|19447794|P2|COMPLETED|Treatment Phase 1||0
7903176|NCT00701363|19447795|P1|COMPLETED|Treatment Phase 1||109
7903177|NCT00701363|19447792|P4|STARTED|Treatment Phase 1||0
7903178|NCT00701363|19447793|P3|STARTED|Treatment Phase 1||0
7903179|NCT00701363|19447794|P2|STARTED|Treatment Phase 1||0
7903180|NCT00701363|19447795|P1|STARTED|Treatment Phase 1||124
7903181|NCT00701363|19447792|P4|NOT COMPLETED|Screening (Pre-assignment) Phase||0
7903182|NCT00701363|19447793|P3|NOT COMPLETED|Screening (Pre-assignment) Phase||0
7903183|NCT00701363|19447794|P2|NOT COMPLETED|Screening (Pre-assignment) Phase||0
7903184|NCT00701363|19447795|P1|NOT COMPLETED|Screening (Pre-assignment) Phase||4
7903185|NCT00701363|19447792|P4|COMPLETED|Screening (Pre-assignment) Phase||0
7903186|NCT00701363|19447793|P3|COMPLETED|Screening (Pre-assignment) Phase||0
7903187|NCT00701363|19447794|P2|COMPLETED|Screening (Pre-assignment) Phase||0
7903188|NCT00701363|19447795|P1|COMPLETED|Screening (Pre-assignment) Phase||124
7903189|NCT00701363|19447792|P4|STARTED|Screening (Pre-assignment) Phase||0
7903190|NCT00701363|19447793|P3|STARTED|Screening (Pre-assignment) Phase||0
7903191|NCT00701363|19447794|P2|STARTED|Screening (Pre-assignment) Phase||0
7903192|NCT00701363|19447795|P1|STARTED|Screening (Pre-assignment) Phase||128
7903193|NCT00701311|19447835|P1|NOT COMPLETED|Overall Study||8
7903194|NCT00701311|19447835|P1|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9
7903195|NCT00701311|19447835|P1|STARTED|Overall Study||17
7903196|NCT00701129|19447839|P1|NOT COMPLETED|Overall Study||2
7903197|NCT00701129|19447839|P1|COMPLETED|Overall Study||2
7903198|NCT00701129|19447839|P1|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4
7903199|NCT00701129|19447839|P1|STARTED|Overall Study||4
7903200|NCT00701103|19447861|P11|NOT COMPLETED|Overall Study||11
7903201|NCT00701103|19447862|P10|NOT COMPLETED|Overall Study||11
7903202|NCT00701103|19447863|P9|NOT COMPLETED|Overall Study||9
7903203|NCT00701103|19447864|P8|NOT COMPLETED|Overall Study||7
7903204|NCT00701103|19447865|P7|NOT COMPLETED|Overall Study||8
7903205|NCT00701103|19447866|P6|NOT COMPLETED|Overall Study||6
7903206|NCT00701103|19447867|P5|NOT COMPLETED|Overall Study||6
7903207|NCT00701103|19447868|P4|NOT COMPLETED|Overall Study||6
7903208|NCT00701103|19447869|P3|NOT COMPLETED|Overall Study||8
7903209|NCT00701103|19447870|P2|NOT COMPLETED|Overall Study||3
7903210|NCT00701103|19447871|P1|NOT COMPLETED|Overall Study||5
7903211|NCT00701103|19447861|P11|COMPLETED|Overall Study||0
7903212|NCT00701103|19447862|P10|COMPLETED|Overall Study||0
7903213|NCT00701103|19447863|P9|COMPLETED|Overall Study||0
7903214|NCT00701103|19447864|P8|COMPLETED|Overall Study||0
7903215|NCT00701103|19447865|P7|COMPLETED|Overall Study||0
7903216|NCT00701103|19447866|P6|COMPLETED|Overall Study||0
7903217|NCT00701103|19447867|P5|COMPLETED|Overall Study||0
7903218|NCT00701103|19447868|P4|COMPLETED|Overall Study||0
7903219|NCT00701103|19447869|P3|COMPLETED|Overall Study||0
7903220|NCT00701103|19447870|P2|COMPLETED|Overall Study||0
7903221|NCT00701103|19447871|P1|COMPLETED|Overall Study||0
7903222|NCT00701103|19447861|P11|STARTED|Overall Study||11
7903223|NCT00701103|19447862|P10|STARTED|Overall Study||11
7903224|NCT00701103|19447863|P9|STARTED|Overall Study||9
7903225|NCT00701103|19447864|P8|STARTED|Overall Study||7
7903226|NCT00701103|19447865|P7|STARTED|Overall Study||8
7903227|NCT00701103|19447866|P6|STARTED|Overall Study||6
7903228|NCT00701103|19447867|P5|STARTED|Overall Study||6
7903229|NCT00701103|19447868|P4|STARTED|Overall Study||6
7903230|NCT00701103|19447869|P3|STARTED|Overall Study||8
7903231|NCT00701103|19447870|P2|STARTED|Overall Study||3
7903232|NCT00701103|19447871|P1|STARTED|Overall Study||5
7903233|NCT00701090|19447977|P2|NOT COMPLETED|Overall Study||51
7903234|NCT00701090|19447978|P1|NOT COMPLETED|Overall Study||48
7903235|NCT00701090|19447977|P2|COMPLETED|Overall Study||468
7903236|NCT00701090|19447978|P1|COMPLETED|Overall Study||468
7903237|NCT00701090|19447977|P2|STARTED|Overall Study||519
7903238|NCT00701090|19447978|P1|STARTED|Overall Study||516
7903239|NCT00701064|19447996|P2|NOT COMPLETED|Overall Study||4
7903240|NCT00701064|19447997|P1|NOT COMPLETED|Overall Study||4
7903241|NCT00701064|19447996|P2|COMPLETED|Overall Study||32
7903242|NCT00701064|19447997|P1|COMPLETED|Overall Study||31
7903243|NCT00701064|19447996|P2|STARTED|Overall Study||36
7903244|NCT00701064|19447997|P1|STARTED|Overall Study||35
7903245|NCT00701051|19448009|P3|NOT COMPLETED|Detraining Intervention (Optional)||0
7903246|NCT00701051|19448010|P2|NOT COMPLETED|Detraining Intervention (Optional)||0
7903247|NCT00701051|19448011|P1|NOT COMPLETED|Detraining Intervention (Optional)||0
7903248|NCT00701051|19448009|P3|COMPLETED|Detraining Intervention (Optional)||6
7903249|NCT00701051|19448010|P2|COMPLETED|Detraining Intervention (Optional)||6
7903250|NCT00701051|19448011|P1|COMPLETED|Detraining Intervention (Optional)||0
7903251|NCT00701051|19448009|P3|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
7903252|NCT00701051|19448010|P2|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
7903253|NCT00701051|19448011|P1|STARTED|Detraining Intervention (Optional)||0
7903254|NCT00701051|19448009|P3|NOT COMPLETED|Exercise Intervention||3
7903255|NCT00701051|19448010|P2|NOT COMPLETED|Exercise Intervention||5
7903256|NCT00701051|19448011|P1|NOT COMPLETED|Exercise Intervention||0
7903257|NCT00701051|19448009|P3|COMPLETED|Exercise Intervention||9
7903258|NCT00701051|19448010|P2|COMPLETED|Exercise Intervention||14
7903259|NCT00701051|19448011|P1|COMPLETED|Exercise Intervention||0
7903260|NCT00701051|19448009|P3|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12
7903261|NCT00701051|19448010|P2|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19
7903262|NCT00701051|19448011|P1|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0
7903263|NCT00701051|19448009|P3|NOT COMPLETED|Screening||0
7903264|NCT00701051|19448010|P2|NOT COMPLETED|Screening||0
7903265|NCT00701051|19448011|P1|NOT COMPLETED|Screening||59
7903266|NCT00701051|19448009|P3|COMPLETED|Screening||0
7903267|NCT00701051|19448010|P2|COMPLETED|Screening||0
7903268|NCT00701051|19448011|P1|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31
7903269|NCT00701051|19448009|P3|STARTED|Screening||0
7903270|NCT00701051|19448010|P2|STARTED|Screening||0
7903271|NCT00701051|19448011|P1|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90
7903272|NCT00701038|19448029|P2|NOT COMPLETED|Overall Study||4
7903273|NCT00701038|19448030|P1|NOT COMPLETED|Overall Study||4
7903274|NCT00701038|19448029|P2|COMPLETED|Overall Study||23
7903275|NCT00701038|19448030|P1|COMPLETED|Overall Study||23
7903276|NCT00701038|19448029|P2|STARTED|Overall Study||27
7903277|NCT00701038|19448030|P1|STARTED|Overall Study||27
7903278|NCT00700999|19448038|P2|NOT COMPLETED|Overall Study||9
7903279|NCT00700999|19448039|P1|NOT COMPLETED|Overall Study||15
7903280|NCT00700999|19448038|P2|COMPLETED|Overall Study||20
7903281|NCT00700999|19448039|P1|COMPLETED|Overall Study||21
7903282|NCT00700999|19448038|P2|Second MRI Scan|Overall Study||18
7903283|NCT00700999|19448039|P1|Second MRI Scan|Overall Study||19
7903284|NCT00700999|19448038|P2|First MRI Scan|Overall Study||22
7903285|NCT00700999|19448039|P1|First MRI Scan|Overall Study||29
7903286|NCT00700999|19448038|P2|STARTED|Overall Study||29
7903287|NCT00700999|19448039|P1|STARTED|Overall Study||36
7903288|NCT00700973|19448047|P2|NOT COMPLETED|Overall Study||7
7903289|NCT00700973|19448048|P1|NOT COMPLETED|Overall Study||8
7903290|NCT00700973|19448047|P2|COMPLETED|Overall Study||63
7903291|NCT00700973|19448048|P1|COMPLETED|Overall Study||63
7903292|NCT00700973|19448047|P2|STARTED|Overall Study||70
7903293|NCT00700973|19448048|P1|STARTED|Overall Study||71
7903294|NCT00700882|19448054|P1|NOT COMPLETED|Overall Study||59
7903295|NCT00700882|19448054|P1|COMPLETED|Overall Study||22
7903296|NCT00700882|19448054|P1|Eligible, Treated and KIT+ Patients|Overall Study||22
7903297|NCT00700882|19448054|P1|Eligible and Treated Patients|Overall Study||73
7903298|NCT00700882|19448054|P1|Received Protocol Therapy|Overall Study||75
7903299|NCT00700882|19448054|P1|STARTED|Overall Study||81
7903300|NCT00700817|19448063|P5|NOT COMPLETED|Week 52-78 (Extension Period 2)||5
7903301|NCT00700817|19448064|P4|NOT COMPLETED|Week 52-78 (Extension Period 2)||8
7903302|NCT00700817|19448065|P3|NOT COMPLETED|Week 52-78 (Extension Period 2)||0
7903303|NCT00700817|19448066|P2|NOT COMPLETED|Week 52-78 (Extension Period 2)||15
7903304|NCT00700817|19448067|P1|NOT COMPLETED|Week 52-78 (Extension Period 2)||10
7903305|NCT00700817|19448063|P5|COMPLETED|Week 52-78 (Extension Period 2)||63
7903306|NCT00700817|19448064|P4|COMPLETED|Week 52-78 (Extension Period 2)||59
7903307|NCT00700817|19448065|P3|COMPLETED|Week 52-78 (Extension Period 2)||0
7903308|NCT00700817|19448066|P2|COMPLETED|Week 52-78 (Extension Period 2)||135
7903309|NCT00700817|19448067|P1|COMPLETED|Week 52-78 (Extension Period 2)||124
7903310|NCT00700817|19448063|P5|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68
7903311|NCT00700817|19448064|P4|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67
7903312|NCT00700817|19448065|P3|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0
7903313|NCT00700817|19448066|P2|STARTED|Week 52-78 (Extension Period 2)||150
7903314|NCT00700817|19448067|P1|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134
7903315|NCT00700817|19448063|P5|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
7903316|NCT00700817|19448064|P4|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
7903317|NCT00700817|19448065|P3|NOT COMPLETED|Week 26-52 (Extension Period 1)||15
7903318|NCT00700817|19448066|P2|NOT COMPLETED|Week 26-52 (Extension Period 1)||26
7903319|NCT00700817|19448067|P1|NOT COMPLETED|Week 26-52 (Extension Period 1)||20
7903320|NCT00700817|19448063|P5|COMPLETED|Week 26-52 (Extension Period 1)||0
7903321|NCT00700817|19448064|P4|COMPLETED|Week 26-52 (Extension Period 1)||0
7903322|NCT00700817|19448065|P3|COMPLETED|Week 26-52 (Extension Period 1)||151
7903323|NCT00700817|19448066|P2|COMPLETED|Week 26-52 (Extension Period 1)||150
7903324|NCT00700817|19448067|P1|COMPLETED|Week 26-52 (Extension Period 1)||135
7903325|NCT00700817|19448063|P5|STARTED|Week 26-52 (Extension Period 1)||0
7903326|NCT00700817|19448064|P4|STARTED|Week 26-52 (Extension Period 1)||0
7903327|NCT00700817|19448065|P3|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166
7903328|NCT00700817|19448066|P2|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176
7903329|NCT00700817|19448067|P1|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155
7903330|NCT00700817|19448063|P5|NOT COMPLETED|Week 0-26 (Main Period)||0
7903331|NCT00700817|19448064|P4|NOT COMPLETED|Week 0-26 (Main Period)||0
7903332|NCT00700817|19448065|P3|NOT COMPLETED|Week 0-26 (Main Period)||25
7903333|NCT00700817|19448066|P2|NOT COMPLETED|Week 0-26 (Main Period)||30
7903334|NCT00700817|19448067|P1|NOT COMPLETED|Week 0-26 (Main Period)||56
7903335|NCT00700817|19448063|P5|COMPLETED|Week 0-26 (Main Period)||0
7903336|NCT00700817|19448064|P4|COMPLETED|Week 0-26 (Main Period)||0
7903337|NCT00700817|19448065|P3|COMPLETED|Week 0-26 (Main Period)||194
7903338|NCT00700817|19448066|P2|COMPLETED|Week 0-26 (Main Period)||191
7903339|NCT00700817|19448067|P1|COMPLETED|Week 0-26 (Main Period)||169
7903340|NCT00700817|19448063|P5|Exposed|Week 0-26 (Main Period)||0
7903341|NCT00700817|19448064|P4|Exposed|Week 0-26 (Main Period)||0
7903342|NCT00700817|19448065|P3|Exposed|Week 0-26 (Main Period)||219
7903343|NCT00700817|19448066|P2|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218
7903344|NCT00700817|19448067|P1|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221
7903345|NCT00700817|19448063|P5|STARTED|Week 0-26 (Main Period)||0
7903346|NCT00700817|19448064|P4|STARTED|Week 0-26 (Main Period)||0
7903347|NCT00700817|19448065|P3|STARTED|Week 0-26 (Main Period)|Randomised|219
7903348|NCT00700817|19448066|P2|STARTED|Week 0-26 (Main Period)|Randomised|221
7903349|NCT00700817|19448067|P1|STARTED|Week 0-26 (Main Period)|Randomised|225
7903350|NCT00700804|19448449|P2|NOT COMPLETED|Overall Study||4
7903351|NCT00700804|19448450|P1|NOT COMPLETED|Overall Study||3
7903352|NCT00700804|19448449|P2|COMPLETED|Overall Study||13
7903353|NCT00700804|19448450|P1|COMPLETED|Overall Study||14
7903354|NCT00700804|19448449|P2|STARTED|Overall Study||17
7903355|NCT00700804|19448450|P1|STARTED|Overall Study||17
7903356|NCT00700752|19448458|P2|NOT COMPLETED|Second Intervention||0
7903357|NCT00700752|19448459|P1|NOT COMPLETED|Second Intervention||0
7903358|NCT00700752|19448458|P2|COMPLETED|Second Intervention||18
7903359|NCT00700752|19448459|P1|COMPLETED|Second Intervention||20
7903360|NCT00700752|19448458|P2|STARTED|Second Intervention||18
7903361|NCT00700752|19448459|P1|STARTED|Second Intervention||20
7903362|NCT00700752|19448458|P2|NOT COMPLETED|First Intervention||2
7903363|NCT00700752|19448459|P1|NOT COMPLETED|First Intervention||0
7903364|NCT00700752|19448458|P2|COMPLETED|First Intervention||18
7903365|NCT00700752|19448459|P1|COMPLETED|First Intervention||20
7903366|NCT00700752|19448458|P2|STARTED|First Intervention||20
7903367|NCT00700752|19448459|P1|STARTED|First Intervention||20
7903368|NCT00700739|19448467|P2|NOT COMPLETED|Overall Study||4
7903369|NCT00700739|19448468|P1|NOT COMPLETED|Overall Study||4
7903370|NCT00700739|19448467|P2|COMPLETED|Overall Study||12
7903371|NCT00700739|19448468|P1|COMPLETED|Overall Study||18
7903372|NCT00700739|19448467|P2|STARTED|Overall Study||16
7903373|NCT00700739|19448468|P1|STARTED|Overall Study||22
7903374|NCT00700713|19448507|P3|NOT COMPLETED|Overall Study||2
7903375|NCT00700713|19448508|P2|NOT COMPLETED|Overall Study||0
7903376|NCT00700713|19448509|P1|NOT COMPLETED|Overall Study||1
7903377|NCT00700713|19448507|P3|COMPLETED|Overall Study||65
7903378|NCT00700713|19448508|P2|COMPLETED|Overall Study||66
7903379|NCT00700713|19448509|P1|COMPLETED|Overall Study||47
7903380|NCT00700713|19448507|P3|STARTED|Overall Study||67
7903381|NCT00700713|19448508|P2|STARTED|Overall Study||66
7903382|NCT00700713|19448509|P1|STARTED|Overall Study||48
7903383|NCT00700635|19448526|P3|NOT COMPLETED|Overall Study||1
7903384|NCT00700635|19448527|P2|NOT COMPLETED|Overall Study||8
7903385|NCT00700635|19448528|P1|NOT COMPLETED|Overall Study||11
7903386|NCT00700635|19448526|P3|COMPLETED|Overall Study||110
7903387|NCT00700635|19448527|P2|COMPLETED|Overall Study||103
7903388|NCT00700635|19448528|P1|COMPLETED|Overall Study||100
7903389|NCT00700635|19448526|P3|STARTED|Overall Study||111
7903390|NCT00700635|19448527|P2|STARTED|Overall Study||111
7903391|NCT00700635|19448528|P1|STARTED|Overall Study||111
7903392|NCT00700622|19448550|P2|NOT COMPLETED|Overall Study||5
7903393|NCT00700622|19448551|P1|NOT COMPLETED|Overall Study||13
7903394|NCT00700622|19448550|P2|COMPLETED|Overall Study||60
7903395|NCT00700622|19448551|P1|COMPLETED|Overall Study||52
7903396|NCT00700622|19448550|P2|STARTED|Overall Study||65
7903397|NCT00700622|19448551|P1|STARTED|Overall Study||65
7903398|NCT00700570|19448559|P2|NOT COMPLETED|Overall Study||26
7903399|NCT00700570|19448560|P1|NOT COMPLETED|Overall Study||11
7903400|NCT00700570|19448559|P2|COMPLETED|Overall Study||0
7903401|NCT00700570|19448560|P1|COMPLETED|Overall Study||8
7903402|NCT00700570|19448559|P2|STARTED|Overall Study||26
7903403|NCT00700570|19448560|P1|STARTED|Overall Study||19
7903404|NCT00700440|19448572|P1|NOT COMPLETED|Overall Study||0
7903405|NCT00700440|19448572|P1|COMPLETED|Overall Study||100
7903406|NCT00700440|19448572|P1|STARTED|Overall Study||100
7903407|NCT00700427|19448576|P5|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84
7903408|NCT00700427|19448577|P4|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
7903409|NCT00700427|19448578|P3|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
7903410|NCT00700427|19448579|P2|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
7903411|NCT00700427|19448580|P1|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
7903412|NCT00700427|19448576|P5|COMPLETED|Study Period 4 (Open-Label Extension)||96
7903413|NCT00700427|19448577|P4|COMPLETED|Study Period 4 (Open-Label Extension)||0
7903414|NCT00700427|19448578|P3|COMPLETED|Study Period 4 (Open-Label Extension)||0
7903415|NCT00700427|19448579|P2|COMPLETED|Study Period 4 (Open-Label Extension)||0
7903416|NCT00700427|19448580|P1|COMPLETED|Study Period 4 (Open-Label Extension)||0
7903417|NCT00700427|19448576|P5|STARTED|Study Period 4 (Open-Label Extension)||180
7903418|NCT00700427|19448577|P4|STARTED|Study Period 4 (Open-Label Extension)||0
7903419|NCT00700427|19448578|P3|STARTED|Study Period 4 (Open-Label Extension)||0
7903420|NCT00700427|19448579|P2|STARTED|Study Period 4 (Open-Label Extension)||0
7903421|NCT00700427|19448580|P1|STARTED|Study Period 4 (Open-Label Extension)||0
7903422|NCT00700427|19448576|P5|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
7903423|NCT00700427|19448577|P4|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93
7903424|NCT00700427|19448578|P3|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82
7903425|NCT00700427|19448579|P2|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
7903426|NCT00700427|19448580|P1|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
7903427|NCT00700427|19448576|P5|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
7903428|NCT00700427|19448577|P4|COMPLETED|Study Period 3B (Randomized Withdrawal)||165
7903429|NCT00700427|19448578|P3|COMPLETED|Study Period 3B (Randomized Withdrawal)||184
7903430|NCT00700427|19448579|P2|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
7903431|NCT00700427|19448580|P1|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
7903432|NCT00700427|19448576|P5|STARTED|Study Period 3B (Randomized Withdrawal)||0
7903433|NCT00700427|19448577|P4|STARTED|Study Period 3B (Randomized Withdrawal)||258
7903434|NCT00700427|19448578|P3|STARTED|Study Period 3B (Randomized Withdrawal)||266
7903435|NCT00700427|19448579|P2|STARTED|Study Period 3B (Randomized Withdrawal)||0
7903436|NCT00700427|19448580|P1|STARTED|Study Period 3B (Randomized Withdrawal)||0
7903437|NCT00700427|19448576|P5|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
7903438|NCT00700427|19448577|P4|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
7903439|NCT00700427|19448578|P3|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
7903440|NCT00700427|19448579|P2|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481
7903441|NCT00700427|19448580|P1|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
7903442|NCT00700427|19448576|P5|COMPLETED|Study Period 3A (Blinded Maintenance)||0
7903443|NCT00700427|19448577|P4|COMPLETED|Study Period 3A (Blinded Maintenance)||0
7903444|NCT00700427|19448578|P3|COMPLETED|Study Period 3A (Blinded Maintenance)||0
7903445|NCT00700427|19448579|P2|COMPLETED|Study Period 3A (Blinded Maintenance)||524
7903446|NCT00700427|19448580|P1|COMPLETED|Study Period 3A (Blinded Maintenance)||0
7903447|NCT00700427|19448576|P5|STARTED|Study Period 3A (Blinded Maintenance)||0
7903448|NCT00700427|19448577|P4|STARTED|Study Period 3A (Blinded Maintenance)||0
7903449|NCT00700427|19448578|P3|STARTED|Study Period 3A (Blinded Maintenance)||0
7903450|NCT00700427|19448579|P2|STARTED|Study Period 3A (Blinded Maintenance)||1005
7903451|NCT00700427|19448580|P1|STARTED|Study Period 3A (Blinded Maintenance)||0
7903452|NCT00700427|19448576|P5|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
7903453|NCT00700427|19448577|P4|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
7903454|NCT00700427|19448578|P3|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
7903455|NCT00700427|19448579|P2|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
7903456|NCT00700427|19448580|P1|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011
7903457|NCT00700427|19448576|P5|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
7903458|NCT00700427|19448577|P4|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
7903459|NCT00700427|19448578|P3|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
7903460|NCT00700427|19448579|P2|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
7903461|NCT00700427|19448580|P1|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006
7903462|NCT00700427|19448576|P5|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
7903463|NCT00700427|19448577|P4|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
7903464|NCT00700427|19448578|P3|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
7903465|NCT00700427|19448579|P2|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
7903466|NCT00700427|19448580|P1|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011
7903467|NCT00700427|19448576|P5|STARTED|Study Period 2 (Open-Label Acute Trx)||0
7903468|NCT00700427|19448577|P4|STARTED|Study Period 2 (Open-Label Acute Trx)||0
7903469|NCT00700427|19448578|P3|STARTED|Study Period 2 (Open-Label Acute Trx)||0
7903470|NCT00700427|19448579|P2|STARTED|Study Period 2 (Open-Label Acute Trx)||0
7903471|NCT00700427|19448580|P1|STARTED|Study Period 2 (Open-Label Acute Trx)||2017
7903472|NCT00700401|19448602|P1|NOT COMPLETED|Overall Study||94
7903473|NCT00700401|19448602|P1|COMPLETED|Overall Study||168
7903474|NCT00700401|19448602|P1|STARTED|Overall Study||262
7903475|NCT00700375|19448615|P2|NOT COMPLETED|Overall Study||0
7903476|NCT00700375|19448616|P1|NOT COMPLETED|Overall Study||0
7903477|NCT00700375|19448615|P2|COMPLETED|Overall Study||29
7903478|NCT00700375|19448616|P1|COMPLETED|Overall Study||30
7903479|NCT00700375|19448615|P2|2 Days After Creatinine Mesurement|Overall Study||29
7903480|NCT00700375|19448616|P1|2 Days After Creatinine Mesurement|Overall Study||30
7903481|NCT00700375|19448615|P2|STARTED|Overall Study||29
7903482|NCT00700375|19448616|P1|STARTED|Overall Study||30
7903483|NCT00700310|19448626|P4|NOT COMPLETED|Overall Study||26
7903484|NCT00700310|19448627|P3|NOT COMPLETED|Overall Study||16
7903485|NCT00700310|19448628|P2|NOT COMPLETED|Overall Study||26
7903486|NCT00700310|19448629|P1|NOT COMPLETED|Overall Study||21
7903487|NCT00700310|19448626|P4|COMPLETED|Overall Study||145
7903488|NCT00700310|19448627|P3|COMPLETED|Overall Study||158
7903489|NCT00700310|19448628|P2|COMPLETED|Overall Study||154
7903490|NCT00700310|19448629|P1|COMPLETED|Overall Study||166
7903491|NCT00700310|19448626|P4|STARTED|Overall Study||171
7903492|NCT00700310|19448627|P3|STARTED|Overall Study||174
7903493|NCT00700310|19448628|P2|STARTED|Overall Study||180
7903494|NCT00700310|19448629|P1|STARTED|Overall Study||187
7903495|NCT00700271|19448649|P2|NOT COMPLETED|Overall Study||12
7903496|NCT00700271|19448650|P1|NOT COMPLETED|Overall Study||14
7903497|NCT00700271|19448649|P2|COMPLETED|Overall Study||256
7903498|NCT00700271|19448650|P1|COMPLETED|Overall Study||264
7903499|NCT00700271|19448649|P2|STARTED|Overall Study||268
7903500|NCT00700271|19448650|P1|STARTED|Overall Study||278
7903501|NCT00700180|19448678|P2|NOT COMPLETED|Overall Study||149
7903502|NCT00700180|19448679|P1|NOT COMPLETED|Overall Study||154
7903503|NCT00700180|19448678|P2|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
7903504|NCT00700180|19448679|P1|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
7903505|NCT00700180|19448678|P2|STARTED|Overall Study||149
7903506|NCT00700180|19448679|P1|STARTED|Overall Study||154
7903507|NCT00700141|19448701|P1|NOT COMPLETED|Overall Study||0
7903508|NCT00700141|19448701|P1|COMPLETED|Overall Study||482
7903509|NCT00700141|19448701|P1|STARTED|Overall Study||482
7903510|NCT00700115|19448708|P2|NOT COMPLETED|Overall Study||1
7903511|NCT00700115|19448709|P1|NOT COMPLETED|Overall Study||1
7903512|NCT00700115|19448708|P2|COMPLETED|Overall Study||19
7903513|NCT00700115|19448709|P1|COMPLETED|Overall Study||39
7903514|NCT00700115|19448708|P2|STARTED|Overall Study||20
7903515|NCT00700115|19448709|P1|STARTED|Overall Study||40
7903516|NCT00700102|19448719|P2|NOT COMPLETED|Overall Study||395
7903517|NCT00700102|19448720|P1|NOT COMPLETED|Overall Study||402
7903518|NCT00700102|19448719|P2|COMPLETED|Overall Study||14
7903519|NCT00700102|19448720|P1|COMPLETED|Overall Study||9
7903520|NCT00700102|19448719|P2|Received at Least One Dose|Overall Study||403
7903521|NCT00700102|19448720|P1|Received at Least One Dose|Overall Study||407
7903522|NCT00700102|19448719|P2|Intention to Treat|Overall Study||409
7903523|NCT00700102|19448720|P1|Intention to Treat|Overall Study||410
7903524|NCT00700102|19448719|P2|STARTED|Overall Study||409
7903525|NCT00700102|19448720|P1|STARTED|Overall Study||411
7903526|NCT00700063|19448744|P8|NOT COMPLETED|Overall Study||0
7903527|NCT00700063|19448745|P7|NOT COMPLETED|Overall Study||0
7903528|NCT00700063|19448746|P6|NOT COMPLETED|Overall Study||0
7903529|NCT00700063|19448747|P5|NOT COMPLETED|Overall Study||2
7903530|NCT00700063|19448748|P4|NOT COMPLETED|Overall Study||2
7903531|NCT00700063|19448749|P3|NOT COMPLETED|Overall Study||0
7903532|NCT00700063|19448750|P2|NOT COMPLETED|Overall Study||0
7903533|NCT00700063|19448751|P1|NOT COMPLETED|Overall Study||1
7903534|NCT00700063|19448744|P8|COMPLETED|Overall Study||33
7903535|NCT00700063|19448745|P7|COMPLETED|Overall Study||32
7903536|NCT00700063|19448746|P6|COMPLETED|Overall Study||34
7903537|NCT00700063|19448747|P5|COMPLETED|Overall Study||31
7903538|NCT00700063|19448748|P4|COMPLETED|Overall Study||31
7903539|NCT00700063|19448749|P3|COMPLETED|Overall Study||33
7903540|NCT00700063|19448750|P2|COMPLETED|Overall Study||34
7903541|NCT00700063|19448751|P1|COMPLETED|Overall Study||32
7903542|NCT00700063|19448744|P8|STARTED|Overall Study||33
7903543|NCT00700063|19448745|P7|STARTED|Overall Study||32
7903544|NCT00700063|19448746|P6|STARTED|Overall Study||34
7903545|NCT00700063|19448747|P5|STARTED|Overall Study||33
7903546|NCT00700063|19448748|P4|STARTED|Overall Study||33
7903547|NCT00700063|19448749|P3|STARTED|Overall Study||33
7903548|NCT00700063|19448750|P2|STARTED|Overall Study||34
7903549|NCT00700063|19448751|P1|STARTED|Overall Study||33
7903550|NCT00700011|19448859|P2|NOT COMPLETED|Overall Study||1
7903551|NCT00700011|19448860|P1|NOT COMPLETED|Overall Study||0
7903552|NCT00700011|19448859|P2|COMPLETED|Overall Study||1
7903553|NCT00700011|19448860|P1|COMPLETED|Overall Study||8
7903554|NCT00700011|19448859|P2|STARTED|Overall Study||2
7903555|NCT00700011|19448860|P1|STARTED|Overall Study||8
7903556|NCT00699998|19448876|P4|NOT COMPLETED|Overall Study||82
7903557|NCT00699998|19448877|P3|NOT COMPLETED|Overall Study||206
7903558|NCT00699998|19448878|P2|NOT COMPLETED|Overall Study||86
7903559|NCT00699998|19448879|P1|NOT COMPLETED|Overall Study||199
7903560|NCT00699998|19448876|P4|COMPLETED|Overall Study||958
7903561|NCT00699998|19448877|P3|COMPLETED|Overall Study||3417
7903562|NCT00699998|19448878|P2|COMPLETED|Overall Study||957
7903563|NCT00699998|19448879|P1|COMPLETED|Overall Study||3421
7903564|NCT00699998|19448876|P4|Received at Least 1 Dose of Study Drug|Overall Study||1027
7903565|NCT00699998|19448877|P3|Received at Least 1 Dose of Study Drug|Overall Study||3590
7903566|NCT00699998|19448878|P2|Received at Least 1 Dose of Study Drug|Overall Study||1033
7903567|NCT00699998|19448879|P1|Received at Least 1 Dose of Study Drug|Overall Study||3590
7903568|NCT00699998|19448876|P4|STARTED|Overall Study||1040
7903569|NCT00699998|19448877|P3|STARTED|Overall Study||3623
7903570|NCT00699998|19448878|P2|STARTED|Overall Study||1043
7903571|NCT00699998|19448879|P1|STARTED|Overall Study||3620
7903572|NCT00699972|19448924|P3|NOT COMPLETED|Overall Study||35
7903573|NCT00699972|19448925|P2|NOT COMPLETED|Overall Study||19
7903574|NCT00699972|19448926|P1|NOT COMPLETED|Overall Study||16
7903575|NCT00699972|19448924|P3|COMPLETED|Overall Study||100
7903576|NCT00699972|19448925|P2|COMPLETED|Overall Study||114
7903577|NCT00699972|19448926|P1|COMPLETED|Overall Study||106
7903578|NCT00699972|19448924|P3|STARTED|Overall Study||135
7903579|NCT00699972|19448925|P2|STARTED|Overall Study||133
7903580|NCT00699972|19448926|P1|STARTED|Overall Study||122
7903581|NCT00699907|19448943|P3|NOT COMPLETED|Overall Study||8
7903582|NCT00699907|19448944|P2|NOT COMPLETED|Overall Study||10
7903583|NCT00699907|19448945|P1|NOT COMPLETED|Overall Study||2
7903584|NCT00699907|19448943|P3|COMPLETED|Overall Study||48
7903585|NCT00699907|19448944|P2|COMPLETED|Overall Study||47
7903586|NCT00699907|19448945|P1|COMPLETED|Overall Study||12
7903587|NCT00699907|19448943|P3|STARTED|Overall Study||56
7903588|NCT00699907|19448944|P2|STARTED|Overall Study||57
7903589|NCT00699907|19448945|P1|STARTED|Overall Study||14
7903590|NCT00699842|19448980|P3|NOT COMPLETED|Overall Study||0
7903591|NCT00699842|19448981|P2|NOT COMPLETED|Overall Study||1
7903592|NCT00699842|19448982|P1|NOT COMPLETED|Overall Study||0
7903593|NCT00699842|19448980|P3|COMPLETED|Overall Study||0
7903594|NCT00699842|19448981|P2|COMPLETED|Overall Study||4
7903595|NCT00699842|19448982|P1|COMPLETED|Overall Study||3
7903596|NCT00699842|19448980|P3|STARTED|Overall Study||0
7903597|NCT00699842|19448981|P2|STARTED|Overall Study||5
7903598|NCT00699842|19448982|P1|STARTED|Overall Study||3
7903599|NCT00699816|19448995|P2|NOT COMPLETED|Overall Study||3
7903600|NCT00699816|19448996|P1|NOT COMPLETED|Overall Study||1
7903601|NCT00699816|19448995|P2|COMPLETED|Overall Study||112
7903602|NCT00699816|19448996|P1|COMPLETED|Overall Study||114
7903603|NCT00699816|19448995|P2|STARTED|Overall Study||115
7903604|NCT00699816|19448996|P1|STARTED|Overall Study||115
7903605|NCT00699803|19449014|P2|NOT COMPLETED|Overall Study||6
7903606|NCT00699803|19449015|P1|NOT COMPLETED|Overall Study||2
7903607|NCT00699803|19449014|P2|COMPLETED|Overall Study||26
7903608|NCT00699803|19449015|P1|COMPLETED|Overall Study||30
7903609|NCT00699803|19449014|P2|STARTED|Overall Study||32
7903610|NCT00699803|19449015|P1|STARTED|Overall Study||32
7903611|NCT00699751|19449023|P2|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9
7903612|NCT00699751|19449024|P1|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0
7903613|NCT00699751|19449023|P2|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17
7903614|NCT00699751|19449024|P1|COMPLETED|Period 2:Switched From Placebo to Xofigo||0
7903615|NCT00699751|19449023|P2|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
7903616|NCT00699751|19449024|P1|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
7903617|NCT00699751|19449023|P2|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15
7903618|NCT00699751|19449024|P1|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
7903619|NCT00699751|19449023|P2|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24
7903620|NCT00699751|19449024|P1|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0
7903621|NCT00699751|19449023|P2|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26
7903622|NCT00699751|19449024|P1|STARTED|Period 2:Switched From Placebo to Xofigo||0
7903623|NCT00699751|19449023|P2|NOT COMPLETED|Period 1: Without/Before Drug Switch||162
7903624|NCT00699751|19449024|P1|NOT COMPLETED|Period 1: Without/Before Drug Switch||225
7903625|NCT00699751|19449023|P2|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145
7903626|NCT00699751|19449024|P1|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389
7903627|NCT00699751|19449023|P2|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12
7903628|NCT00699751|19449024|P1|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49
7903629|NCT00699751|19449023|P2|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168
7903630|NCT00699751|19449024|P1|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407
7903631|NCT00699751|19449023|P2|Participants Received Treatment|Period 1: Without/Before Drug Switch||301
7903632|NCT00699751|19449024|P1|Participants Received Treatment|Period 1: Without/Before Drug Switch||600
7903633|NCT00699751|19449023|P2|STARTED|Period 1: Without/Before Drug Switch||307
7903634|NCT00699751|19449024|P1|STARTED|Period 1: Without/Before Drug Switch||614
7903635|NCT00699699|19449109|P1|NOT COMPLETED|Overall Study||57
7903636|NCT00699699|19449109|P1|COMPLETED|Overall Study||1223
7903637|NCT00699699|19449109|P1|STARTED|Overall Study||1280
7903638|NCT00699660|19449118|P2|NOT COMPLETED|Overall Study||8
7903639|NCT00699660|19449119|P1|NOT COMPLETED|Overall Study||14
7903640|NCT00699660|19449118|P2|COMPLETED|Overall Study||208
7903641|NCT00699660|19449119|P1|COMPLETED|Overall Study||176
7903642|NCT00699660|19449118|P2|STARTED|Overall Study||216
7903643|NCT00699660|19449119|P1|STARTED|Overall Study||190
7903644|NCT00699608|19449131|P6|NOT COMPLETED|Third Intervention||0
7903645|NCT00699608|19449132|P5|NOT COMPLETED|Third Intervention||0
7903646|NCT00699608|19449133|P4|NOT COMPLETED|Third Intervention||0
7903647|NCT00699608|19449134|P3|NOT COMPLETED|Third Intervention||0
7903648|NCT00699608|19449135|P2|NOT COMPLETED|Third Intervention||0
7903649|NCT00699608|19449136|P1|NOT COMPLETED|Third Intervention||0
7903650|NCT00699608|19449131|P6|COMPLETED|Third Intervention||15
7903651|NCT00699608|19449132|P5|COMPLETED|Third Intervention||14
7903652|NCT00699608|19449133|P4|COMPLETED|Third Intervention||14
7903653|NCT00699608|19449134|P3|COMPLETED|Third Intervention||13
7903654|NCT00699608|19449135|P2|COMPLETED|Third Intervention||15
7903655|NCT00699608|19449136|P1|COMPLETED|Third Intervention||16
7903656|NCT00699608|19449131|P6|STARTED|Third Intervention||15
7903657|NCT00699608|19449132|P5|STARTED|Third Intervention||14
7903658|NCT00699608|19449133|P4|STARTED|Third Intervention||14
7903659|NCT00699608|19449134|P3|STARTED|Third Intervention||13
7903660|NCT00699608|19449135|P2|STARTED|Third Intervention||15
7903661|NCT00699608|19449136|P1|STARTED|Third Intervention||16
7903662|NCT00699608|19449131|P6|NOT COMPLETED|Second 4-14 Day Washout Period||0
7903663|NCT00699608|19449132|P5|NOT COMPLETED|Second 4-14 Day Washout Period||0
7903664|NCT00699608|19449133|P4|NOT COMPLETED|Second 4-14 Day Washout Period||0
7903665|NCT00699608|19449134|P3|NOT COMPLETED|Second 4-14 Day Washout Period||0
7903666|NCT00699608|19449135|P2|NOT COMPLETED|Second 4-14 Day Washout Period||0
7903667|NCT00699608|19449136|P1|NOT COMPLETED|Second 4-14 Day Washout Period||0
7903668|NCT00699608|19449131|P6|COMPLETED|Second 4-14 Day Washout Period||15
7903669|NCT00699608|19449132|P5|COMPLETED|Second 4-14 Day Washout Period||14
7903670|NCT00699608|19449133|P4|COMPLETED|Second 4-14 Day Washout Period||14
7903671|NCT00699608|19449134|P3|COMPLETED|Second 4-14 Day Washout Period||13
7903672|NCT00699608|19449135|P2|COMPLETED|Second 4-14 Day Washout Period||15
7903673|NCT00699608|19449136|P1|COMPLETED|Second 4-14 Day Washout Period||16
7903674|NCT00699608|19449131|P6|STARTED|Second 4-14 Day Washout Period||15
7903675|NCT00699608|19449132|P5|STARTED|Second 4-14 Day Washout Period||14
7903676|NCT00699608|19449133|P4|STARTED|Second 4-14 Day Washout Period||14
7903677|NCT00699608|19449134|P3|STARTED|Second 4-14 Day Washout Period||13
7903678|NCT00699608|19449135|P2|STARTED|Second 4-14 Day Washout Period||15
7903679|NCT00699608|19449136|P1|STARTED|Second 4-14 Day Washout Period||16
7903680|NCT00699608|19449131|P6|NOT COMPLETED|Second Intervention||0
7903681|NCT00699608|19449132|P5|NOT COMPLETED|Second Intervention||0
7903682|NCT00699608|19449133|P4|NOT COMPLETED|Second Intervention||1
7903683|NCT00699608|19449134|P3|NOT COMPLETED|Second Intervention||1
7903684|NCT00699608|19449135|P2|NOT COMPLETED|Second Intervention||0
7903685|NCT00699608|19449136|P1|NOT COMPLETED|Second Intervention||0
7903686|NCT00699608|19449131|P6|COMPLETED|Second Intervention||15
7903687|NCT00699608|19449132|P5|COMPLETED|Second Intervention||14
7903688|NCT00699608|19449133|P4|COMPLETED|Second Intervention||14
7903689|NCT00699608|19449134|P3|COMPLETED|Second Intervention||13
7903690|NCT00699608|19449135|P2|COMPLETED|Second Intervention||15
7903691|NCT00699608|19449136|P1|COMPLETED|Second Intervention||16
7903692|NCT00699608|19449131|P6|STARTED|Second Intervention||15
7903693|NCT00699608|19449132|P5|STARTED|Second Intervention||14
7903694|NCT00699608|19449133|P4|STARTED|Second Intervention||15
7903695|NCT00699608|19449134|P3|STARTED|Second Intervention||14
7903696|NCT00699608|19449135|P2|STARTED|Second Intervention||15
7903697|NCT00699608|19449136|P1|STARTED|Second Intervention||16
7903698|NCT00699608|19449131|P6|NOT COMPLETED|First 4-14 Day Washout Period||0
7903699|NCT00699608|19449132|P5|NOT COMPLETED|First 4-14 Day Washout Period||0
7903700|NCT00699608|19449133|P4|NOT COMPLETED|First 4-14 Day Washout Period||0
7903701|NCT00699608|19449134|P3|NOT COMPLETED|First 4-14 Day Washout Period||0
7903702|NCT00699608|19449135|P2|NOT COMPLETED|First 4-14 Day Washout Period||0
7903703|NCT00699608|19449136|P1|NOT COMPLETED|First 4-14 Day Washout Period||0
7903704|NCT00699608|19449131|P6|COMPLETED|First 4-14 Day Washout Period||15
7903705|NCT00699608|19449132|P5|COMPLETED|First 4-14 Day Washout Period||14
7903706|NCT00699608|19449133|P4|COMPLETED|First 4-14 Day Washout Period||15
7903707|NCT00699608|19449134|P3|COMPLETED|First 4-14 Day Washout Period||14
7903708|NCT00699608|19449135|P2|COMPLETED|First 4-14 Day Washout Period||15
7903709|NCT00699608|19449136|P1|COMPLETED|First 4-14 Day Washout Period||16
7903710|NCT00699608|19449131|P6|STARTED|First 4-14 Day Washout Period||15
7903711|NCT00699608|19449132|P5|STARTED|First 4-14 Day Washout Period||14
7903712|NCT00699608|19449133|P4|STARTED|First 4-14 Day Washout Period||15
7903713|NCT00699608|19449134|P3|STARTED|First 4-14 Day Washout Period||14
7903714|NCT00699608|19449135|P2|STARTED|First 4-14 Day Washout Period||15
7903715|NCT00699608|19449136|P1|STARTED|First 4-14 Day Washout Period||16
7903716|NCT00699608|19449131|P6|NOT COMPLETED|First Intervention||0
7903717|NCT00699608|19449132|P5|NOT COMPLETED|First Intervention||1
7903718|NCT00699608|19449133|P4|NOT COMPLETED|First Intervention||0
7903719|NCT00699608|19449134|P3|NOT COMPLETED|First Intervention||1
7903720|NCT00699608|19449135|P2|NOT COMPLETED|First Intervention||0
7903721|NCT00699608|19449136|P1|NOT COMPLETED|First Intervention||0
7903722|NCT00699608|19449131|P6|COMPLETED|First Intervention||15
7903723|NCT00699608|19449132|P5|COMPLETED|First Intervention||14
7903724|NCT00699608|19449133|P4|COMPLETED|First Intervention||15
7903725|NCT00699608|19449134|P3|COMPLETED|First Intervention||14
7903726|NCT00699608|19449135|P2|COMPLETED|First Intervention||15
7903727|NCT00699608|19449136|P1|COMPLETED|First Intervention||16
7903728|NCT00699608|19449131|P6|STARTED|First Intervention||15
7903729|NCT00699608|19449132|P5|STARTED|First Intervention||15
7903730|NCT00699608|19449133|P4|STARTED|First Intervention||15
7903731|NCT00699608|19449134|P3|STARTED|First Intervention||15
7903732|NCT00699608|19449135|P2|STARTED|First Intervention||15
7903733|NCT00699608|19449136|P1|STARTED|First Intervention||16
7903734|NCT00699582|19449189|P3|NOT COMPLETED|Overall Study||28
7903735|NCT00699582|19449190|P2|NOT COMPLETED|Overall Study||22
7903736|NCT00699582|19449191|P1|NOT COMPLETED|Overall Study||18
7903737|NCT00699582|19449189|P3|COMPLETED|Overall Study||93
7903738|NCT00699582|19449190|P2|COMPLETED|Overall Study||108
7903739|NCT00699582|19449191|P1|COMPLETED|Overall Study||120
7903740|NCT00699582|19449189|P3|STARTED|Overall Study||121
7903741|NCT00699582|19449190|P2|STARTED|Overall Study||130
7903742|NCT00699582|19449191|P1|STARTED|Overall Study||138
7903743|NCT00699556|19449205|P2|NOT COMPLETED|Second Intervention (1 Day)||0
7903744|NCT00699556|19449206|P1|NOT COMPLETED|Second Intervention (1 Day)||0
7903745|NCT00699556|19449205|P2|COMPLETED|Second Intervention (1 Day)||11
7903746|NCT00699556|19449206|P1|COMPLETED|Second Intervention (1 Day)||11
7903747|NCT00699556|19449205|P2|STARTED|Second Intervention (1 Day)||11
7903748|NCT00699556|19449206|P1|STARTED|Second Intervention (1 Day)||11
7903749|NCT00699556|19449205|P2|NOT COMPLETED|First Intervention (1 Day)||0
7903750|NCT00699556|19449206|P1|NOT COMPLETED|First Intervention (1 Day)||0
7903751|NCT00699556|19449205|P2|COMPLETED|First Intervention (1 Day)||11
7903752|NCT00699556|19449206|P1|COMPLETED|First Intervention (1 Day)||11
7903753|NCT00699556|19449205|P2|STARTED|First Intervention (1 Day)||11
7903754|NCT00699556|19449206|P1|STARTED|First Intervention (1 Day)||11
7903755|NCT00699491|19449220|P6|NOT COMPLETED|Overall Study||0
7903756|NCT00699491|19449221|P5|NOT COMPLETED|Overall Study||0
7903757|NCT00699491|19449222|P4|NOT COMPLETED|Overall Study||0
7903758|NCT00699491|19449223|P3|NOT COMPLETED|Overall Study||0
7903759|NCT00699491|19449224|P2|NOT COMPLETED|Overall Study||0
7903760|NCT00699491|19449225|P1|NOT COMPLETED|Overall Study||0
7903761|NCT00699491|19449220|P6|COMPLETED|Overall Study||22
7903762|NCT00699491|19449221|P5|COMPLETED|Overall Study||8
7903763|NCT00699491|19449222|P4|COMPLETED|Overall Study||6
7903764|NCT00699491|19449223|P3|COMPLETED|Overall Study||7
7903765|NCT00699491|19449224|P2|COMPLETED|Overall Study||2
7903766|NCT00699491|19449225|P1|COMPLETED|Overall Study||3
7903767|NCT00699491|19449220|P6|STARTED|Overall Study||22
7903768|NCT00699491|19449221|P5|STARTED|Overall Study||8
7903769|NCT00699491|19449222|P4|STARTED|Overall Study||6
7903770|NCT00699491|19449223|P3|STARTED|Overall Study||7
7903771|NCT00699491|19449224|P2|STARTED|Overall Study||2
7903772|NCT00699491|19449225|P1|STARTED|Overall Study||3
7903773|NCT00699413|19449246|P2|NOT COMPLETED|Overall Study||4
7903774|NCT00699413|19449247|P1|NOT COMPLETED|Overall Study||4
7903775|NCT00699413|19449246|P2|COMPLETED|Overall Study||0
7903776|NCT00699413|19449247|P1|COMPLETED|Overall Study||0
7903777|NCT00699413|19449246|P2|STARTED|Overall Study||4
7903778|NCT00699413|19449247|P1|STARTED|Overall Study||4
7903779|NCT00699400|19449262|P6|NOT COMPLETED|Overall Study||11
7903780|NCT00699400|19449263|P5|NOT COMPLETED|Overall Study||0
7903781|NCT00699400|19449264|P4|NOT COMPLETED|Overall Study||0
7903782|NCT00699400|19449265|P3|NOT COMPLETED|Overall Study||0
7903783|NCT00699400|19449266|P2|NOT COMPLETED|Overall Study||0
7903784|NCT00699400|19449267|P1|NOT COMPLETED|Overall Study||0
7903785|NCT00699400|19449262|P6|COMPLETED|Overall Study||0
7903786|NCT00699400|19449263|P5|COMPLETED|Overall Study||4
7903787|NCT00699400|19449264|P4|COMPLETED|Overall Study||6
7903788|NCT00699400|19449265|P3|COMPLETED|Overall Study||138
7903789|NCT00699400|19449266|P2|COMPLETED|Overall Study||3
7903790|NCT00699400|19449267|P1|COMPLETED|Overall Study||42
7903791|NCT00699400|19449262|P6|STARTED|Overall Study||11
7903792|NCT00699400|19449263|P5|STARTED|Overall Study||4
7903793|NCT00699400|19449264|P4|STARTED|Overall Study||6
7903794|NCT00699400|19449265|P3|STARTED|Overall Study||138
7903795|NCT00699400|19449266|P2|STARTED|Overall Study||3
7903796|NCT00699400|19449267|P1|STARTED|Overall Study||42
7903797|NCT00699374|19449301|P2|NOT COMPLETED|Overall Study||544
7903798|NCT00699374|19449302|P1|NOT COMPLETED|Overall Study||530
7903799|NCT00699374|19449301|P2|COMPLETED|Overall Study||0
7903800|NCT00699374|19449302|P1|COMPLETED|Overall Study||0
7903801|NCT00699374|19449301|P2|Treated|Overall Study||542
7903802|NCT00699374|19449302|P1|Treated|Overall Study||526
7903803|NCT00699374|19449301|P2|STARTED|Overall Study||544
7903804|NCT00699374|19449302|P1|STARTED|Overall Study||530
7903805|NCT00699348|19449314|P1|NOT COMPLETED|Overall Study||90
7903806|NCT00699348|19449314|P1|COMPLETED|Overall Study||261
7903807|NCT00699348|19449314|P1|STARTED|Overall Study||351
7903808|NCT00699335|19449323|P1|NOT COMPLETED|Overall Study||228
7903809|NCT00699335|19449323|P1|COMPLETED|Overall Study||5080
7903810|NCT00699335|19449323|P1|STARTED|Overall Study||5308
7903811|NCT00699283|19449356|P2|NOT COMPLETED|Overall Study||8
7903812|NCT00699283|19449357|P1|NOT COMPLETED|Overall Study||33
7903813|NCT00699283|19449356|P2|COMPLETED|Overall Study||7
7903814|NCT00699283|19449357|P1|COMPLETED|Overall Study||14
7903815|NCT00699283|19449356|P2|STARTED|Overall Study||15
7903816|NCT00699283|19449357|P1|STARTED|Overall Study||47
7903817|NCT00699218|19449362|P1|NOT COMPLETED|Overall Study||0
7903818|NCT00699218|19449362|P1|COMPLETED|Overall Study||15
7903819|NCT00699218|19449362|P1|STARTED|Overall Study||15
7903820|NCT00699192|19449370|P3|NOT COMPLETED|Overall Study||11
7903821|NCT00699192|19449371|P2|NOT COMPLETED|Overall Study||12
7903822|NCT00699192|19449372|P1|NOT COMPLETED|Overall Study||16
7903823|NCT00699192|19449370|P3|COMPLETED|Overall Study||261
7903824|NCT00699192|19449371|P2|COMPLETED|Overall Study||260
7903825|NCT00699192|19449372|P1|COMPLETED|Overall Study||259
7903826|NCT00699192|19449370|P3|STARTED|Overall Study||272
7903827|NCT00699192|19449371|P2|STARTED|Overall Study||272
7903828|NCT00699192|19449372|P1|STARTED|Overall Study||275
7903829|NCT00699153|19449394|P2|NOT COMPLETED|Overall Study||2
7903830|NCT00699153|19449395|P1|NOT COMPLETED|Overall Study||3
7903831|NCT00699153|19449394|P2|COMPLETED|Overall Study||200
7903832|NCT00699153|19449395|P1|COMPLETED|Overall Study||200
7903833|NCT00699153|19449394|P2|STARTED|Overall Study|Intent to treat population|202
7903834|NCT00699153|19449395|P1|STARTED|Overall Study|Intent to treat population|203
7903835|NCT00699140|19449407|P1|NOT COMPLETED|Overall Study||0
7903836|NCT00699140|19449407|P1|COMPLETED|Overall Study||18
7903837|NCT00699140|19449407|P1|STARTED|Overall Study||18
7903838|NCT00699010|19449421|P2|NOT COMPLETED|Overall Study||0
7903839|NCT00699010|19449422|P1|NOT COMPLETED|Overall Study||0
7903840|NCT00699010|19449421|P2|COMPLETED|Overall Study||15
7903841|NCT00699010|19449422|P1|COMPLETED|Overall Study||15
7903842|NCT00699010|19449421|P2|STARTED|Overall Study||15
7903843|NCT00699010|19449422|P1|STARTED|Overall Study||15
7903844|NCT00698997|19449430|P2|NOT COMPLETED|Overall Study||27
7903845|NCT00698997|19449431|P1|NOT COMPLETED|Overall Study||10
7903846|NCT00698997|19449430|P2|COMPLETED|Overall Study|36 - final assessment completed|36
7903847|NCT00698997|19449431|P1|COMPLETED|Overall Study|45 - final participant assessment completed|45
7903848|NCT00698997|19449430|P2|STARTED|Overall Study|1 enrollment|63
7903849|NCT00698997|19449431|P1|STARTED|Overall Study|1 enrollment|55
7903850|NCT00698932|19449445|P2|NOT COMPLETED|Overall Study||36
7903851|NCT00698932|19449446|P1|NOT COMPLETED|Overall Study||22
7903852|NCT00698932|19449445|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248
7903853|NCT00698932|19449446|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262
7903854|NCT00698932|19449445|P2|STARTED|Overall Study|Randomized and treated|284
7903855|NCT00698932|19449446|P1|STARTED|Overall Study|Randomized and treated|284
7903856|NCT00698867|19449462|P1|NOT COMPLETED|Overall Study||91
7903857|NCT00698867|19449462|P1|COMPLETED|Overall Study||27
7903858|NCT00698867|19449462|P1|Subjects With 4 Year Data|Overall Study||34
7903859|NCT00698867|19449462|P1|Subjects With 3 Year Data|Overall Study||35
7903860|NCT00698867|19449462|P1|Subjects With 2 Year Data|Overall Study||55
7903861|NCT00698867|19449462|P1|Subjects With 1 Year Data|Overall Study||68
7903862|NCT00698867|19449462|P1|STARTED|Overall Study||118
7903863|NCT00698841|19449472|P1|NOT COMPLETED|Overall Study||18
7903864|NCT00698841|19449472|P1|COMPLETED|Overall Study||33
7903865|NCT00698841|19449472|P1|STARTED|Overall Study||51
7903866|NCT00698815|19449486|P3|NOT COMPLETED|Overall Study||10
7903867|NCT00698815|19449487|P2|NOT COMPLETED|Overall Study||14
7903868|NCT00698815|19449488|P1|NOT COMPLETED|Overall Study||10
7903869|NCT00698815|19449486|P3|COMPLETED|Overall Study||31
7903870|NCT00698815|19449487|P2|COMPLETED|Overall Study||33
7903871|NCT00698815|19449488|P1|COMPLETED|Overall Study||32
7903872|NCT00698815|19449486|P3|STARTED|Overall Study||41
7903873|NCT00698815|19449487|P2|STARTED|Overall Study||47
7903874|NCT00698815|19449488|P1|STARTED|Overall Study||42
7903875|NCT00698685|19449505|P1|NOT COMPLETED|Overall Study||2
7903876|NCT00698685|19449505|P1|COMPLETED|Overall Study||12
7903877|NCT00698685|19449505|P1|STARTED|Overall Study||14
7903878|NCT00698646|19449513|P3|NOT COMPLETED|Overall Study||29
7903879|NCT00698646|19449514|P2|NOT COMPLETED|Overall Study||31
7903880|NCT00698646|19449515|P1|NOT COMPLETED|Overall Study||36
7903881|NCT00698646|19449513|P3|COMPLETED|Overall Study||99
7903882|NCT00698646|19449514|P2|COMPLETED|Overall Study||97
7903883|NCT00698646|19449515|P1|COMPLETED|Overall Study||92
7903884|NCT00698646|19449513|P3|STARTED|Overall Study||128
7903885|NCT00698646|19449514|P2|STARTED|Overall Study||128
7903886|NCT00698646|19449515|P1|STARTED|Overall Study||128
7903887|NCT00698581|19449540|P2|NOT COMPLETED|Overall Study||12
7903888|NCT00698581|19449541|P1|NOT COMPLETED|Overall Study||45
7903889|NCT00698581|19449540|P2|COMPLETED|Overall Study||8
7903890|NCT00698581|19449541|P1|COMPLETED|Overall Study||23
7903891|NCT00698581|19449540|P2|STARTED|Overall Study||20
7903892|NCT00698581|19449541|P1|STARTED|Overall Study||68
7903893|NCT00698516|19449552|P1|NOT COMPLETED|Overall Study||5
7903894|NCT00698516|19449552|P1|COMPLETED|Overall Study||45
7903895|NCT00698516|19449552|P1|STARTED|Overall Study||50
7903896|NCT00698451|19449570|P1|NOT COMPLETED|Overall Study||39
7903897|NCT00698451|19449570|P1|COMPLETED|Overall Study||15
7903898|NCT00698451|19449570|P1|STARTED|Overall Study||54
7903899|NCT00698204|19449577|P2|NOT COMPLETED|Overall Study||0
7903900|NCT00698204|19449578|P1|NOT COMPLETED|Overall Study||1
7903901|NCT00698204|19449577|P2|COMPLETED|Overall Study||20
7903902|NCT00698204|19449578|P1|COMPLETED|Overall Study||19
7903903|NCT00698204|19449577|P2|STARTED|Overall Study||20
7903904|NCT00698204|19449578|P1|STARTED|Overall Study||20
7903905|NCT00698139|19449589|P3|NOT COMPLETED|Overall Study||0
7903906|NCT00698139|19449590|P2|NOT COMPLETED|Overall Study||0
7903907|NCT00698139|19449591|P1|NOT COMPLETED|Overall Study||0
7903908|NCT00698139|19449589|P3|COMPLETED|Overall Study||1
7903909|NCT00698139|19449590|P2|COMPLETED|Overall Study||1
7903910|NCT00698139|19449591|P1|COMPLETED|Overall Study||1
7903911|NCT00698139|19449589|P3|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0
7903912|NCT00698139|19449590|P2|2nd Visit|Overall Study||1
7903913|NCT00698139|19449591|P1|2nd Visit|Overall Study||1
7903914|NCT00698139|19449589|P3|STARTED|Overall Study||1
7903915|NCT00698139|19449590|P2|STARTED|Overall Study||1
7903916|NCT00698139|19449591|P1|STARTED|Overall Study||1
7903917|NCT00698035|19449607|P2|NOT COMPLETED|Overall Study||2
7903918|NCT00698035|19449608|P1|NOT COMPLETED|Overall Study||4
7903919|NCT00698035|19449607|P2|COMPLETED|Overall Study||34
7903920|NCT00698035|19449608|P1|COMPLETED|Overall Study||35
7903921|NCT00698035|19449607|P2|STARTED|Overall Study||36
7903922|NCT00698035|19449608|P1|STARTED|Overall Study||39
7903923|NCT00698022|19449628|P3|NOT COMPLETED|Overall Study||2
7903924|NCT00698022|19449629|P2|NOT COMPLETED|Overall Study||10
7903925|NCT00698022|19449630|P1|NOT COMPLETED|Overall Study||16
7903926|NCT00698022|19449628|P3|COMPLETED|Overall Study||14
7903927|NCT00698022|19449629|P2|COMPLETED|Overall Study||20
7903928|NCT00698022|19449630|P1|COMPLETED|Overall Study||14
7903929|NCT00698022|19449628|P3|STARTED|Overall Study||16
7903930|NCT00698022|19449629|P2|STARTED|Overall Study||30
7903931|NCT00698022|19449630|P1|STARTED|Overall Study||30
7903932|NCT00698009|19449638|P1|NOT COMPLETED|Overall Study||1
7903933|NCT00698009|19449638|P1|COMPLETED|Overall Study||0
7903934|NCT00698009|19449638|P1|STARTED|Overall Study||1
7903935|NCT00697827|19449644|P2|NOT COMPLETED|Overall Study||1
7903936|NCT00697827|19449645|P1|NOT COMPLETED|Overall Study||2
7903937|NCT00697827|19449644|P2|COMPLETED|Overall Study||15
7903938|NCT00697827|19449645|P1|COMPLETED|Overall Study||26
7903939|NCT00697827|19449644|P2|STARTED|Overall Study||16
7903940|NCT00697827|19449645|P1|STARTED|Overall Study||28
7903941|NCT00697801|19449656|P3|NOT COMPLETED|Overall Study||24
7903942|NCT00697801|19449657|P2|NOT COMPLETED|Overall Study||12
7903943|NCT00697801|19449658|P1|NOT COMPLETED|Overall Study||12
7903944|NCT00697801|19449656|P3|COMPLETED|Overall Study||45
7903945|NCT00697801|19449657|P2|COMPLETED|Overall Study||58
7903946|NCT00697801|19449658|P1|COMPLETED|Overall Study||57
7903947|NCT00697801|19449656|P3|STARTED|Overall Study||69
7903948|NCT00697801|19449657|P2|STARTED|Overall Study||70
7903949|NCT00697801|19449658|P1|STARTED|Overall Study||69
7903950|NCT00697788|19449672|P8|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903951|NCT00697788|19449673|P7|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903952|NCT00697788|19449674|P6|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903953|NCT00697788|19449675|P5|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903954|NCT00697788|19449676|P4|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903955|NCT00697788|19449677|P3|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903956|NCT00697788|19449678|P2|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903957|NCT00697788|19449679|P1|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903958|NCT00697788|19449672|P8|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
7903959|NCT00697788|19449673|P7|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903960|NCT00697788|19449674|P6|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903961|NCT00697788|19449675|P5|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903962|NCT00697788|19449676|P4|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903963|NCT00697788|19449677|P3|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903964|NCT00697788|19449678|P2|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903965|NCT00697788|19449679|P1|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903966|NCT00697788|19449672|P8|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
7903967|NCT00697788|19449673|P7|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903968|NCT00697788|19449674|P6|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903969|NCT00697788|19449675|P5|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903970|NCT00697788|19449676|P4|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903971|NCT00697788|19449677|P3|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903972|NCT00697788|19449678|P2|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903973|NCT00697788|19449679|P1|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
7903974|NCT00697788|19449672|P8|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903975|NCT00697788|19449673|P7|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903976|NCT00697788|19449674|P6|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903977|NCT00697788|19449675|P5|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903978|NCT00697788|19449676|P4|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903979|NCT00697788|19449677|P3|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903980|NCT00697788|19449678|P2|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903981|NCT00697788|19449679|P1|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903982|NCT00697788|19449672|P8|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903983|NCT00697788|19449673|P7|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
7903984|NCT00697788|19449674|P6|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903985|NCT00697788|19449675|P5|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903986|NCT00697788|19449676|P4|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903987|NCT00697788|19449677|P3|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903988|NCT00697788|19449678|P2|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903989|NCT00697788|19449679|P1|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903990|NCT00697788|19449672|P8|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903991|NCT00697788|19449673|P7|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
7903992|NCT00697788|19449674|P6|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903993|NCT00697788|19449675|P5|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903994|NCT00697788|19449676|P4|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903995|NCT00697788|19449677|P3|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903996|NCT00697788|19449678|P2|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903997|NCT00697788|19449679|P1|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
7903998|NCT00697788|19449672|P8|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7903999|NCT00697788|19449673|P7|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7904000|NCT00697788|19449674|P6|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7904001|NCT00697788|19449675|P5|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7904002|NCT00697788|19449676|P4|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7904003|NCT00697788|19449677|P3|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7904004|NCT00697788|19449678|P2|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7904005|NCT00697788|19449679|P1|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7904006|NCT00697788|19449672|P8|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7904007|NCT00697788|19449673|P7|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7904008|NCT00697788|19449674|P6|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
7904009|NCT00697788|19449675|P5|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7904010|NCT00697788|19449676|P4|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7904011|NCT00697788|19449677|P3|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7904012|NCT00697788|19449678|P2|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7904013|NCT00697788|19449679|P1|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7904014|NCT00697788|19449672|P8|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7904015|NCT00697788|19449673|P7|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7904016|NCT00697788|19449674|P6|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
7904017|NCT00697788|19449675|P5|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7904018|NCT00697788|19449676|P4|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7904019|NCT00697788|19449677|P3|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7904020|NCT00697788|19449678|P2|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7904021|NCT00697788|19449679|P1|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
7904022|NCT00697788|19449672|P8|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
7904023|NCT00697788|19449673|P7|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
7904024|NCT00697788|19449674|P6|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
7904025|NCT00697788|19449675|P5|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||1
7904026|NCT00697788|19449676|P4|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
7904027|NCT00697788|19449677|P3|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
7904028|NCT00697788|19449678|P2|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
7904029|NCT00697788|19449679|P1|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
7904030|NCT00697788|19449672|P8|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
7904031|NCT00697788|19449673|P7|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
7904032|NCT00697788|19449674|P6|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
7904033|NCT00697788|19449675|P5|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||2
7904034|NCT00697788|19449676|P4|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
7904035|NCT00697788|19449677|P3|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
7904036|NCT00697788|19449678|P2|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
7904037|NCT00697788|19449679|P1|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
7904038|NCT00697788|19449672|P8|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
7904039|NCT00697788|19449673|P7|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
7904040|NCT00697788|19449674|P6|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
7904041|NCT00697788|19449675|P5|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||3
7904042|NCT00697788|19449676|P4|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
7904043|NCT00697788|19449677|P3|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
7904044|NCT00697788|19449678|P2|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
7904045|NCT00697788|19449679|P1|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
7904046|NCT00697788|19449672|P8|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904047|NCT00697788|19449673|P7|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904048|NCT00697788|19449674|P6|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904049|NCT00697788|19449675|P5|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904050|NCT00697788|19449676|P4|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904051|NCT00697788|19449677|P3|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904052|NCT00697788|19449678|P2|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904053|NCT00697788|19449679|P1|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904054|NCT00697788|19449672|P8|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904055|NCT00697788|19449673|P7|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904056|NCT00697788|19449674|P6|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904057|NCT00697788|19449675|P5|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904058|NCT00697788|19449676|P4|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
7904059|NCT00697788|19449677|P3|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904060|NCT00697788|19449678|P2|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904061|NCT00697788|19449679|P1|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904062|NCT00697788|19449672|P8|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904063|NCT00697788|19449673|P7|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904064|NCT00697788|19449674|P6|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904065|NCT00697788|19449675|P5|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904066|NCT00697788|19449676|P4|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
7904067|NCT00697788|19449677|P3|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904068|NCT00697788|19449678|P2|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904069|NCT00697788|19449679|P1|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
7904070|NCT00697788|19449672|P8|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904071|NCT00697788|19449673|P7|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904072|NCT00697788|19449674|P6|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904073|NCT00697788|19449675|P5|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904074|NCT00697788|19449676|P4|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904075|NCT00697788|19449677|P3|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904076|NCT00697788|19449678|P2|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904077|NCT00697788|19449679|P1|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904078|NCT00697788|19449672|P8|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904079|NCT00697788|19449673|P7|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904080|NCT00697788|19449674|P6|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904081|NCT00697788|19449675|P5|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904082|NCT00697788|19449676|P4|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904083|NCT00697788|19449677|P3|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3
7904084|NCT00697788|19449678|P2|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904085|NCT00697788|19449679|P1|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904086|NCT00697788|19449672|P8|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904087|NCT00697788|19449673|P7|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904088|NCT00697788|19449674|P6|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904089|NCT00697788|19449675|P5|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904090|NCT00697788|19449676|P4|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904091|NCT00697788|19449677|P3|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion|2 participants did not begin this infusion due to hypotension (MAP<50)|3
7904092|NCT00697788|19449678|P2|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904093|NCT00697788|19449679|P1|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
7904094|NCT00697788|19449672|P8|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
7904095|NCT00697788|19449673|P7|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
7904096|NCT00697788|19449674|P6|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
7904097|NCT00697788|19449675|P5|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
7904098|NCT00697788|19449676|P4|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
7904099|NCT00697788|19449677|P3|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
7904100|NCT00697788|19449678|P2|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||2
7904101|NCT00697788|19449679|P1|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
7904102|NCT00697788|19449672|P8|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
7904103|NCT00697788|19449673|P7|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
7904104|NCT00697788|19449674|P6|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
7904105|NCT00697788|19449675|P5|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
7904106|NCT00697788|19449676|P4|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
7904107|NCT00697788|19449677|P3|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
7904108|NCT00697788|19449678|P2|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||5
7904109|NCT00697788|19449679|P1|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
7904110|NCT00697788|19449672|P8|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
7904111|NCT00697788|19449673|P7|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
7904112|NCT00697788|19449674|P6|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
7904113|NCT00697788|19449675|P5|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
7904114|NCT00697788|19449676|P4|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
7904115|NCT00697788|19449677|P3|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
7904116|NCT00697788|19449678|P2|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion|1 participant did not begin infusion due to hypotension (MAP<50)|7
7904117|NCT00697788|19449679|P1|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
7904118|NCT00697788|19449672|P8|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
7904119|NCT00697788|19449673|P7|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
7904120|NCT00697788|19449674|P6|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
7904121|NCT00697788|19449675|P5|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
7904122|NCT00697788|19449676|P4|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
7904123|NCT00697788|19449677|P3|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
7904124|NCT00697788|19449678|P2|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
7904125|NCT00697788|19449679|P1|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
7904126|NCT00697788|19449672|P8|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
7904127|NCT00697788|19449673|P7|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
7904128|NCT00697788|19449674|P6|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
7904129|NCT00697788|19449675|P5|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
7904130|NCT00697788|19449676|P4|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
7904131|NCT00697788|19449677|P3|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
7904132|NCT00697788|19449678|P2|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
7904133|NCT00697788|19449679|P1|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||8
7904134|NCT00697788|19449672|P8|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
7904135|NCT00697788|19449673|P7|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
7904136|NCT00697788|19449674|P6|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
7904137|NCT00697788|19449675|P5|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
7904138|NCT00697788|19449676|P4|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
7904139|NCT00697788|19449677|P3|STARTED|Dexmedetomidine Bolus 1 mcg/kg|2 participants did not begin the ascending (1.0 mcg/kg/hr) due to MAP<50|0
7904140|NCT00697788|19449678|P2|STARTED|Dexmedetomidine Bolus 1 mcg/kg|One participant did not begin infusion due to hypotension (mean pressure <50)|0
7904141|NCT00697788|19449679|P1|STARTED|Dexmedetomidine Bolus 1 mcg/kg||8
7904142|NCT00697697|19449723|P2|NOT COMPLETED|Overall Study||54
7904143|NCT00697697|19449724|P1|NOT COMPLETED|Overall Study||49
7904144|NCT00697697|19449723|P2|COMPLETED|Overall Study||44
7904145|NCT00697697|19449724|P1|COMPLETED|Overall Study||45
7904146|NCT00697697|19449723|P2|STARTED|Overall Study||98
7904147|NCT00697697|19449724|P1|STARTED|Overall Study||94
7904148|NCT00697619|19449734|P2|NOT COMPLETED|Overall Study||8
7904149|NCT00697619|19449735|P1|NOT COMPLETED|Overall Study||6
7904150|NCT00697619|19449734|P2|COMPLETED|Overall Study||22
7904151|NCT00697619|19449735|P1|COMPLETED|Overall Study||24
7904152|NCT00697619|19449734|P2|STARTED|Overall Study||30
7904153|NCT00697619|19449735|P1|STARTED|Overall Study||30
7904154|NCT00697593|19449741|P1|NOT COMPLETED|Overall Study||19
7904155|NCT00697593|19449741|P1|COMPLETED|Overall Study||51
7904156|NCT00697593|19449741|P1|STARTED|Overall Study||70
7904157|NCT00697541|19449774|P2|NOT COMPLETED|Overall Study||1
7904158|NCT00697541|19449775|P1|NOT COMPLETED|Overall Study||2
7904159|NCT00697541|19449774|P2|COMPLETED|Overall Study||9
7904160|NCT00697541|19449775|P1|COMPLETED|Overall Study||8
7904161|NCT00697541|19449774|P2|STARTED|Overall Study||10
7904162|NCT00697541|19449775|P1|STARTED|Overall Study||10
7904163|NCT00697515|19449785|P2|NOT COMPLETED|Second Intervention (Crossover Period)||1
7904164|NCT00697515|19449786|P1|NOT COMPLETED|Second Intervention (Crossover Period)||1
7904165|NCT00697515|19449785|P2|COMPLETED|Second Intervention (Crossover Period)||51
7904166|NCT00697515|19449786|P1|COMPLETED|Second Intervention (Crossover Period)||52
7904167|NCT00697515|19449785|P2|STARTED|Second Intervention (Crossover Period)||52
7904168|NCT00697515|19449786|P1|STARTED|Second Intervention (Crossover Period)||53
7904169|NCT00697515|19449785|P2|NOT COMPLETED|First Intervention (Crossover Period)||12
7904170|NCT00697515|19449786|P1|NOT COMPLETED|First Intervention (Crossover Period)||10
7904171|NCT00697515|19449785|P2|COMPLETED|First Intervention (Crossover Period)||52
7904172|NCT00697515|19449786|P1|COMPLETED|First Intervention (Crossover Period)||53
7904173|NCT00697515|19449785|P2|STARTED|First Intervention (Crossover Period)||64
7904174|NCT00697515|19449786|P1|STARTED|First Intervention (Crossover Period)||63
7904175|NCT00697515|19449785|P2|NOT COMPLETED|Dose Optimization Period||0
7904176|NCT00697515|19449786|P1|NOT COMPLETED|Dose Optimization Period||15
7904177|NCT00697515|19449785|P2|COMPLETED|Dose Optimization Period||0
7904178|NCT00697515|19449786|P1|COMPLETED|Dose Optimization Period||127
7904179|NCT00697515|19449785|P2|STARTED|Dose Optimization Period||0
7904180|NCT00697515|19449786|P1|STARTED|Dose Optimization Period||142
7904181|NCT00697463|19449814|P1|NOT COMPLETED|Overall Study||1
7904182|NCT00697463|19449814|P1|COMPLETED|Overall Study||21
7904183|NCT00697463|19449814|P1|STARTED|Overall Study||22
7904184|NCT00697346|19449821|P3|NOT COMPLETED|Overall Study||1
7904185|NCT00697346|19449822|P2|NOT COMPLETED|Overall Study||26
7904186|NCT00697346|19449823|P1|NOT COMPLETED|Overall Study||28
7904187|NCT00697346|19449821|P3|COMPLETED|Overall Study|1 participant was ongoing as of primary completion date 27 Dec 2011 and has now completed.|1
7904188|NCT00697346|19449822|P2|COMPLETED|Overall Study|2 participants were ongoing as of primary completion date 27 Dec 2011 and have now completed.|2
7904189|NCT00697346|19449823|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
7904190|NCT00697346|19449821|P3|STARTED|Overall Study||2
7904191|NCT00697346|19449822|P2|STARTED|Overall Study||28
7904192|NCT00697346|19449823|P1|STARTED|Overall Study||28
7904193|NCT00697255|19449931|P2|NOT COMPLETED|Stage 1b||2
7904194|NCT00697255|19449932|P1|NOT COMPLETED|Stage 1b||0
7904195|NCT00697255|19449931|P2|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1
7904196|NCT00697255|19449932|P1|COMPLETED|Stage 1b||0
7904197|NCT00697255|19449931|P2|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3
7904198|NCT00697255|19449932|P1|STARTED|Stage 1b||0
7904199|NCT00697255|19449931|P2|NOT COMPLETED|Stage 1a||0
7904200|NCT00697255|19449932|P1|NOT COMPLETED|Stage 1a||3
7904201|NCT00697255|19449931|P2|COMPLETED|Stage 1a||0
7904202|NCT00697255|19449932|P1|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2
7904203|NCT00697255|19449931|P2|STARTED|Stage 1a||0
7904204|NCT00697255|19449932|P1|STARTED|Stage 1a||5
7904205|NCT00697203|19449952|P4|NOT COMPLETED|Overall Study||7
7904206|NCT00697203|19449953|P3|NOT COMPLETED|Overall Study||8
7904207|NCT00697203|19449954|P2|NOT COMPLETED|Overall Study||6
7904208|NCT00697203|19449955|P1|NOT COMPLETED|Overall Study||9
7904209|NCT00697203|19449952|P4|COMPLETED|Overall Study||67
7904210|NCT00697203|19449953|P3|COMPLETED|Overall Study||66
7904211|NCT00697203|19449954|P2|COMPLETED|Overall Study||62
7904212|NCT00697203|19449955|P1|COMPLETED|Overall Study||67
7904213|NCT00697203|19449952|P4|STARTED|Overall Study||74
7904214|NCT00697203|19449953|P3|STARTED|Overall Study||74
7904215|NCT00697203|19449954|P2|STARTED|Overall Study||68
7904216|NCT00697203|19449955|P1|STARTED|Overall Study||76
7904217|NCT00697190|19449985|P2|NOT COMPLETED|Second Intervention||0
7904218|NCT00697190|19449986|P1|NOT COMPLETED|Second Intervention||0
7904219|NCT00697190|19449985|P2|COMPLETED|Second Intervention||20
7904220|NCT00697190|19449986|P1|COMPLETED|Second Intervention||18
7904221|NCT00697190|19449985|P2|STARTED|Second Intervention||20
7904222|NCT00697190|19449986|P1|STARTED|Second Intervention|one subject moved away between the first period and second period.|18
7904223|NCT00697190|19449985|P2|NOT COMPLETED|First Intervention||0
7904224|NCT00697190|19449986|P1|NOT COMPLETED|First Intervention||0
7904225|NCT00697190|19449985|P2|COMPLETED|First Intervention||20
7904226|NCT00697190|19449986|P1|COMPLETED|First Intervention||19
7904227|NCT00697190|19449985|P2|STARTED|First Intervention||20
7904228|NCT00697190|19449986|P1|STARTED|First Intervention||19
7904229|NCT00697112|19450020|P1|NOT COMPLETED|Overall Study||10
7904230|NCT00697112|19450020|P1|COMPLETED|Overall Study||43
7904231|NCT00697112|19450020|P1|Met the Inclusion Criteria|Overall Study||52
7904232|NCT00697112|19450020|P1|STARTED|Overall Study||53
7904233|NCT00697073|19450044|P1|NOT COMPLETED|Overall Study||9
7904234|NCT00697073|19450044|P1|COMPLETED|Overall Study||59
7904235|NCT00697073|19450044|P1|STARTED|Overall Study||68
7904236|NCT00696878|19450048|P1|NOT COMPLETED|Overall Study||504
7904237|NCT00696878|19450048|P1|COMPLETED|Overall Study||178
7904238|NCT00696878|19450048|P1|STARTED|Overall Study||682
7904239|NCT00696800|19450122|P2|NOT COMPLETED|Overall Study||48
7904240|NCT00696800|19450123|P1|NOT COMPLETED|Overall Study||85
7904241|NCT00696800|19450122|P2|COMPLETED|Overall Study|Participants who had embryos transferred|704
7904242|NCT00696800|19450123|P1|COMPLETED|Overall Study|Participants who had embryos transferred|672
7904243|NCT00696800|19450122|P2|Treated (ITT)|Overall Study|The ITT group|750
7904244|NCT00696800|19450123|P1|Treated (ITT)|Overall Study|The ITT group|756
7904245|NCT00696800|19450122|P2|STARTED|Overall Study||752
7904246|NCT00696800|19450123|P1|STARTED|Overall Study||757
7904247|NCT00696787|19450176|P3|NOT COMPLETED|Overall Study||26
7904248|NCT00696787|19450177|P2|NOT COMPLETED|Overall Study||20
7904249|NCT00696787|19450178|P1|NOT COMPLETED|Overall Study||15
7904250|NCT00696787|19450176|P3|COMPLETED|Overall Study||17
7904251|NCT00696787|19450177|P2|COMPLETED|Overall Study||22
7904252|NCT00696787|19450178|P1|COMPLETED|Overall Study||25
7904253|NCT00696787|19450176|P3|STARTED|Overall Study||43
7904254|NCT00696787|19450177|P2|STARTED|Overall Study||42
7904255|NCT00696787|19450178|P1|STARTED|Overall Study||40
7904256|NCT00696774|19450192|P3|NOT COMPLETED|Period III||0
7904257|NCT00696774|19450193|P2|NOT COMPLETED|Period III||7
7904258|NCT00696774|19450194|P1|NOT COMPLETED|Period III||7
7904259|NCT00696774|19450192|P3|COMPLETED|Period III||0
7904260|NCT00696774|19450193|P2|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81
7904261|NCT00696774|19450194|P1|COMPLETED|Period III||106
7904262|NCT00696774|19450192|P3|STARTED|Period III||0
7904263|NCT00696774|19450193|P2|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88
7904264|NCT00696774|19450194|P1|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113
7904265|NCT00696774|19450192|P3|NOT COMPLETED|Period II||36
7904266|NCT00696774|19450193|P2|NOT COMPLETED|Period II||0
7904267|NCT00696774|19450194|P1|NOT COMPLETED|Period II||0
7904268|NCT00696774|19450192|P3|COMPLETED|Period II||0
7904269|NCT00696774|19450193|P2|COMPLETED|Period II||91
7904270|NCT00696774|19450194|P1|COMPLETED|Period II||115
7904271|NCT00696774|19450192|P3|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36
7904272|NCT00696774|19450193|P2|STARTED|Period II||91
7904273|NCT00696774|19450194|P1|STARTED|Period II||115
7904274|NCT00696761|19450232|P4|NOT COMPLETED|Overall Study||10
7904275|NCT00696761|19450233|P3|NOT COMPLETED|Overall Study||11
7904276|NCT00696761|19450234|P2|NOT COMPLETED|Overall Study||26
7904277|NCT00696761|19450235|P1|NOT COMPLETED|Overall Study||20
7904278|NCT00696761|19450232|P4|COMPLETED|Overall Study||44
7904279|NCT00696761|19450233|P3|COMPLETED|Overall Study||30
7904280|NCT00696761|19450234|P2|COMPLETED|Overall Study||50
7904281|NCT00696761|19450235|P1|COMPLETED|Overall Study||41
7904282|NCT00696761|19450232|P4|STARTED|Overall Study||54
7904283|NCT00696761|19450233|P3|STARTED|Overall Study||41
7904284|NCT00696761|19450234|P2|STARTED|Overall Study||76
7904285|NCT00696761|19450235|P1|STARTED|Overall Study||61
7904286|NCT00696709|19450254|P5|NOT COMPLETED|Overall Study||3
7904287|NCT00696709|19450255|P4|NOT COMPLETED|Overall Study||5
7904288|NCT00696709|19450256|P3|NOT COMPLETED|Overall Study||1
7904289|NCT00696709|19450257|P2|NOT COMPLETED|Overall Study||3
7904290|NCT00696709|19450258|P1|NOT COMPLETED|Overall Study||3
7904291|NCT00696709|19450254|P5|COMPLETED|Overall Study||62
7904292|NCT00696709|19450255|P4|COMPLETED|Overall Study||59
7904293|NCT00696709|19450256|P3|COMPLETED|Overall Study||32
7904294|NCT00696709|19450257|P2|COMPLETED|Overall Study||60
7904295|NCT00696709|19450258|P1|COMPLETED|Overall Study||62
7904296|NCT00696709|19450254|P5|Vaccination 4 (~Day 90)|Overall Study||63
7904297|NCT00696709|19450255|P4|Vaccination 4 (~Day 90)|Overall Study||59
7904298|NCT00696709|19450256|P3|Vaccination 4 (~Day 90)|Overall Study||32
7904299|NCT00696709|19450257|P2|Vaccination 4 (~Day 90)|Overall Study||60
7904300|NCT00696709|19450258|P1|Vaccination 4 (~Day 90)|Overall Study||62
7904301|NCT00696709|19450254|P5|Vaccination 3 (~Day 60)|Overall Study||63
7904302|NCT00696709|19450255|P4|Vaccination 3 (~Day 60)|Overall Study||59
7904303|NCT00696709|19450256|P3|Vaccination 3 (~Day 60)|Overall Study||32
7904304|NCT00696709|19450257|P2|Vaccination 3 (~Day 60)|Overall Study||60
7904305|NCT00696709|19450258|P1|Vaccination 3 (~Day 60)|Overall Study||64
7904306|NCT00696709|19450254|P5|Vaccination 2 (~Day 30)|Overall Study||64
7904307|NCT00696709|19450255|P4|Vaccination 2 (~Day 30)|Overall Study||61
7904308|NCT00696709|19450256|P3|Vaccination 2 (~Day 30)|Overall Study||32
7904309|NCT00696709|19450257|P2|Vaccination 2 (~Day 30)|Overall Study||60
7904310|NCT00696709|19450258|P1|Vaccination 2 (~Day 30)|Overall Study||64
7904311|NCT00696709|19450254|P5|Vaccination 1 (Day 1)|Overall Study||65
7904312|NCT00696709|19450255|P4|Vaccination 1 (Day 1)|Overall Study||64
7904313|NCT00696709|19450256|P3|Vaccination 1 (Day 1)|Overall Study||32
7904314|NCT00696709|19450257|P2|Vaccination 1 (Day 1)|Overall Study||63
7904315|NCT00696709|19450258|P1|Vaccination 1 (Day 1)|Overall Study||65
7904316|NCT00696709|19450254|P5|STARTED|Overall Study||65
7904317|NCT00696709|19450255|P4|STARTED|Overall Study||64
7904318|NCT00696709|19450256|P3|STARTED|Overall Study||33
7904319|NCT00696709|19450257|P2|STARTED|Overall Study||63
7904320|NCT00696709|19450258|P1|STARTED|Overall Study||65
7904321|NCT00696696|19450294|P1|NOT COMPLETED|Overall Study||18
7904322|NCT00696696|19450294|P1|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26
7904323|NCT00696696|19450294|P1|STARTED|Overall Study||44
7904324|NCT00696657|19450309|P9|NOT COMPLETED|Overall Study||9
7904325|NCT00696657|19450310|P8|NOT COMPLETED|Overall Study||3
7904326|NCT00696657|19450311|P7|NOT COMPLETED|Overall Study||15
7904327|NCT00696657|19450312|P6|NOT COMPLETED|Overall Study||12
7904328|NCT00696657|19450313|P5|NOT COMPLETED|Overall Study||10
7904329|NCT00696657|19450314|P4|NOT COMPLETED|Overall Study||11
7904330|NCT00696657|19450315|P3|NOT COMPLETED|Overall Study||8
7904331|NCT00696657|19450316|P2|NOT COMPLETED|Overall Study||5
7904332|NCT00696657|19450317|P1|NOT COMPLETED|Overall Study||1
7904333|NCT00696657|19450309|P9|COMPLETED|Overall Study||41
7904334|NCT00696657|19450310|P8|COMPLETED|Overall Study||42
7904335|NCT00696657|19450311|P7|COMPLETED|Overall Study||30
7904336|NCT00696657|19450312|P6|COMPLETED|Overall Study||33
7904337|NCT00696657|19450313|P5|COMPLETED|Overall Study||34
7904338|NCT00696657|19450314|P4|COMPLETED|Overall Study||38
7904339|NCT00696657|19450315|P3|COMPLETED|Overall Study||36
7904340|NCT00696657|19450316|P2|COMPLETED|Overall Study||42
7904341|NCT00696657|19450317|P1|COMPLETED|Overall Study||45
7904342|NCT00696657|19450309|P9|EXPOSED|Overall Study||50
7904343|NCT00696657|19450310|P8|EXPOSED|Overall Study||45
7904344|NCT00696657|19450311|P7|EXPOSED|Overall Study||45
7904345|NCT00696657|19450312|P6|EXPOSED|Overall Study||43
7904346|NCT00696657|19450313|P5|EXPOSED|Overall Study||44
7904347|NCT00696657|19450314|P4|EXPOSED|Overall Study||48
7904348|NCT00696657|19450315|P3|EXPOSED|Overall Study||43
7904349|NCT00696657|19450316|P2|EXPOSED|Overall Study||47
7904350|NCT00696657|19450317|P1|EXPOSED|Overall Study||46
7904351|NCT00696657|19450309|P9|STARTED|Overall Study||50
7904352|NCT00696657|19450310|P8|STARTED|Overall Study||45
7904353|NCT00696657|19450311|P7|STARTED|Overall Study||45
7904354|NCT00696657|19450312|P6|STARTED|Overall Study||45
7904355|NCT00696657|19450313|P5|STARTED|Overall Study||44
7904356|NCT00696657|19450314|P4|STARTED|Overall Study||49
7904357|NCT00696657|19450315|P3|STARTED|Overall Study||44
7904358|NCT00696657|19450316|P2|STARTED|Overall Study||47
7904359|NCT00696657|19450317|P1|STARTED|Overall Study||46
7904360|NCT00696618|19450644|P3|NOT COMPLETED|Overall Study||0
7904361|NCT00696618|19450645|P2|NOT COMPLETED|Overall Study||0
7904362|NCT00696618|19450646|P1|NOT COMPLETED|Overall Study||0
7904363|NCT00696618|19450644|P3|COMPLETED|Overall Study||3
7904364|NCT00696618|19450645|P2|COMPLETED|Overall Study||3
7904365|NCT00696618|19450646|P1|COMPLETED|Overall Study||3
7904366|NCT00696618|19450644|P3|STARTED|Overall Study||3
7904367|NCT00696618|19450645|P2|STARTED|Overall Study||3
7904368|NCT00696618|19450646|P1|STARTED|Overall Study||3
7904369|NCT00696488|19450660|P1|NOT COMPLETED|Overall Study||0
7904370|NCT00696488|19450660|P1|COMPLETED|Overall Study||20
7904371|NCT00696488|19450660|P1|STARTED|Overall Study||20
7904372|NCT00696449|19450668|P4|NOT COMPLETED|Overall Study||3
7904373|NCT00696449|19450669|P3|NOT COMPLETED|Overall Study||1
7904374|NCT00696449|19450670|P2|NOT COMPLETED|Overall Study||6
7904375|NCT00696449|19450671|P1|NOT COMPLETED|Overall Study||3
7904376|NCT00696449|19450668|P4|COMPLETED|Overall Study||13
7904377|NCT00696449|19450669|P3|COMPLETED|Overall Study||14
7904378|NCT00696449|19450670|P2|COMPLETED|Overall Study||9
7904379|NCT00696449|19450671|P1|COMPLETED|Overall Study||12
7904380|NCT00696449|19450668|P4|STARTED|Overall Study||16
7904381|NCT00696449|19450669|P3|STARTED|Overall Study||15
7904382|NCT00696449|19450670|P2|STARTED|Overall Study||15
7904383|NCT00696449|19450671|P1|STARTED|Overall Study||15
7904384|NCT00696436|19450686|P5|NOT COMPLETED|Overall Study||13
7904385|NCT00696436|19450687|P4|NOT COMPLETED|Overall Study||22
7904386|NCT00696436|19450688|P3|NOT COMPLETED|Overall Study||28
7904387|NCT00696436|19450689|P2|NOT COMPLETED|Overall Study||30
7904388|NCT00696436|19450690|P1|NOT COMPLETED|Overall Study||23
7904389|NCT00696436|19450686|P5|COMPLETED|Overall Study||141
7904390|NCT00696436|19450687|P4|COMPLETED|Overall Study||268
7904391|NCT00696436|19450688|P3|COMPLETED|Overall Study||254
7904392|NCT00696436|19450689|P2|COMPLETED|Overall Study||255
7904393|NCT00696436|19450690|P1|COMPLETED|Overall Study||257
7904394|NCT00696436|19450686|P5|STARTED|Overall Study|Randomized participants only.|154
7904395|NCT00696436|19450687|P4|STARTED|Overall Study|Randomized participants only.|290
7904396|NCT00696436|19450688|P3|STARTED|Overall Study|Randomized participants only.|282
7904397|NCT00696436|19450689|P2|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285
7904398|NCT00696436|19450690|P1|STARTED|Overall Study|Randomized participants only.|280
7904399|NCT00696423|19450774|P2|NOT COMPLETED|Overall Study||5
7904400|NCT00696423|19450775|P1|NOT COMPLETED|Overall Study||0
7904401|NCT00696423|19450774|P2|COMPLETED|Overall Study||218
7904402|NCT00696423|19450775|P1|COMPLETED|Overall Study||244
7904403|NCT00696423|19450774|P2|STARTED|Overall Study||223
7904404|NCT00696423|19450775|P1|STARTED|Overall Study||244
7904405|NCT00696410|19450807|P2|NOT COMPLETED|Overall Study||0
7904406|NCT00696410|19450808|P1|NOT COMPLETED|Overall Study||13
7904407|NCT00696410|19450807|P2|COMPLETED|Overall Study||10
7904408|NCT00696410|19450808|P1|COMPLETED|Overall Study||25
7904409|NCT00696410|19450807|P2|STARTED|Overall Study||10
7904410|NCT00696410|19450808|P1|STARTED|Overall Study||38
7904411|NCT00696384|19450822|P3|NOT COMPLETED|Double Blind Phase||6
7904412|NCT00696384|19450823|P2|NOT COMPLETED|Double Blind Phase||11
7904413|NCT00696384|19450824|P1|NOT COMPLETED|Double Blind Phase||0
7904414|NCT00696384|19450822|P3|COMPLETED|Double Blind Phase||145
7904415|NCT00696384|19450823|P2|COMPLETED|Double Blind Phase||137
7904416|NCT00696384|19450824|P1|COMPLETED|Double Blind Phase||0
7904417|NCT00696384|19450822|P3|STARTED|Double Blind Phase||151
7904418|NCT00696384|19450823|P2|STARTED|Double Blind Phase||148
7904419|NCT00696384|19450824|P1|STARTED|Double Blind Phase||0
7904420|NCT00696384|19450822|P3|NOT COMPLETED|Open Label Phase||0
7904421|NCT00696384|19450823|P2|NOT COMPLETED|Open Label Phase||0
7904422|NCT00696384|19450824|P1|NOT COMPLETED|Open Label Phase||119
7904423|NCT00696384|19450822|P3|COMPLETED|Open Label Phase||0
7904424|NCT00696384|19450823|P2|COMPLETED|Open Label Phase||0
7904425|NCT00696384|19450824|P1|COMPLETED|Open Label Phase||299
7904426|NCT00696384|19450822|P3|STARTED|Open Label Phase||0
7904427|NCT00696384|19450823|P2|STARTED|Open Label Phase||0
7904428|NCT00696384|19450824|P1|STARTED|Open Label Phase||418
7904429|NCT00696293|19450838|P1|NOT COMPLETED|Overall Study||2
7904430|NCT00696293|19450838|P1|COMPLETED|Overall Study||28
7904431|NCT00696293|19450838|P1|STARTED|Overall Study||30
7904432|NCT00696241|19450848|P5|NOT COMPLETED|Overall Study||12
7904433|NCT00696241|19450849|P4|NOT COMPLETED|Overall Study||14
7904434|NCT00696241|19450850|P3|NOT COMPLETED|Overall Study||24
7904435|NCT00696241|19450851|P2|NOT COMPLETED|Overall Study||22
7904436|NCT00696241|19450852|P1|NOT COMPLETED|Overall Study||24
7904437|NCT00696241|19450848|P5|COMPLETED|Overall Study||130
7904438|NCT00696241|19450849|P4|COMPLETED|Overall Study||268
7904439|NCT00696241|19450850|P3|COMPLETED|Overall Study||261
7904440|NCT00696241|19450851|P2|COMPLETED|Overall Study||261
7904441|NCT00696241|19450852|P1|COMPLETED|Overall Study||259
7904442|NCT00696241|19450848|P5|STARTED|Overall Study||142
7904443|NCT00696241|19450849|P4|STARTED|Overall Study||282
7904444|NCT00696241|19450850|P3|STARTED|Overall Study||285
7904445|NCT00696241|19450851|P2|STARTED|Overall Study||283
7904446|NCT00696241|19450852|P1|STARTED|Overall Study||283
7904447|NCT00696137|19450934|P1|NOT COMPLETED|Overall Study||2
7904448|NCT00696137|19450934|P1|COMPLETED|Overall Study||3
7904449|NCT00696137|19450934|P1|STARTED|Overall Study||5
7904450|NCT00696072|19450940|P2|NOT COMPLETED|Overall Study||63
7904451|NCT00696072|19450941|P1|NOT COMPLETED|Overall Study||57
7904452|NCT00696072|19450940|P2|COMPLETED|Overall Study||0
7904453|NCT00696072|19450941|P1|COMPLETED|Overall Study||0
7904454|NCT00696072|19450940|P2|STARTED|Overall Study||63
7904455|NCT00696072|19450941|P1|STARTED|Overall Study||57
7904456|NCT00696020|19450962|P4|NOT COMPLETED|Overall Study||4
7904457|NCT00696020|19450963|P3|NOT COMPLETED|Overall Study||3
7904458|NCT00696020|19450964|P2|NOT COMPLETED|Overall Study||2
7904459|NCT00696020|19450965|P1|NOT COMPLETED|Overall Study||4
7904460|NCT00696020|19450962|P4|COMPLETED|Overall Study||84
7904461|NCT00696020|19450963|P3|COMPLETED|Overall Study||90
7904462|NCT00696020|19450964|P2|COMPLETED|Overall Study||87
7904463|NCT00696020|19450965|P1|COMPLETED|Overall Study||86
7904464|NCT00696020|19450962|P4|STARTED|Overall Study||88
7904465|NCT00696020|19450963|P3|STARTED|Overall Study||93
7904466|NCT00696020|19450964|P2|STARTED|Overall Study||89
7904467|NCT00696020|19450965|P1|STARTED|Overall Study||90
7904468|NCT00695955|19451073|P1|NOT COMPLETED|Cohort 2||104
7904469|NCT00695955|19451073|P1|COMPLETED|Cohort 2||203
7904470|NCT00695955|19451073|P1|STARTED|Cohort 2||307
7904471|NCT00695955|19451073|P1|NOT COMPLETED|Cohort 1||102
7904472|NCT00695955|19451073|P1|COMPLETED|Cohort 1||260
7904473|NCT00695955|19451073|P1|STARTED|Cohort 1||362
7904474|NCT00695903|19451085|P2|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1
7904475|NCT00695903|19451086|P1|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2
7904476|NCT00695903|19451085|P2|COMPLETED|Had Test of Cure (TOC) Assessment||3
7904477|NCT00695903|19451086|P1|COMPLETED|Had Test of Cure (TOC) Assessment||5
7904478|NCT00695903|19451085|P2|STARTED|Had Test of Cure (TOC) Assessment||4
7904479|NCT00695903|19451086|P1|STARTED|Had Test of Cure (TOC) Assessment||7
7904480|NCT00695903|19451085|P2|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15
7904481|NCT00695903|19451086|P1|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12
7904482|NCT00695903|19451085|P2|COMPLETED|Had End of Therapy (EOT) Assessment||4
7904483|NCT00695903|19451086|P1|COMPLETED|Had End of Therapy (EOT) Assessment||7
7904484|NCT00695903|19451085|P2|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6
7904485|NCT00695903|19451086|P1|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9
7904486|NCT00695903|19451085|P2|STARTED|Had End of Therapy (EOT) Assessment||19
7904487|NCT00695903|19451086|P1|STARTED|Had End of Therapy (EOT) Assessment||19
7904488|NCT00695864|19451098|P1|NOT COMPLETED|Ondansetron||5
7904489|NCT00695864|19451098|P1|COMPLETED|Ondansetron||9
7904490|NCT00695864|19451098|P1|STARTED|Ondansetron||14
7904491|NCT00695864|19451098|P1|NOT COMPLETED|Placebo||5
7904492|NCT00695864|19451098|P1|COMPLETED|Placebo||9
7904493|NCT00695864|19451098|P1|STARTED|Placebo||14
7904494|NCT00695669|19451108|P4|NOT COMPLETED|Overall Study||4
7904495|NCT00695669|19451109|P3|NOT COMPLETED|Overall Study||3
7904496|NCT00695669|19451110|P2|NOT COMPLETED|Overall Study||4
7904497|NCT00695669|19451111|P1|NOT COMPLETED|Overall Study||4
7904498|NCT00695669|19451108|P4|COMPLETED|Overall Study||74
7904499|NCT00695669|19451109|P3|COMPLETED|Overall Study||75
7904500|NCT00695669|19451110|P2|COMPLETED|Overall Study||74
7904501|NCT00695669|19451111|P1|COMPLETED|Overall Study||74
7904502|NCT00695669|19451108|P4|STARTED|Overall Study||78
7904503|NCT00695669|19451109|P3|STARTED|Overall Study||78
7904504|NCT00695669|19451110|P2|STARTED|Overall Study||78
7904505|NCT00695669|19451111|P1|STARTED|Overall Study||78
7904506|NCT00695578|19451187|P2|NOT COMPLETED|Overall Study||0
7904507|NCT00695578|19451188|P1|NOT COMPLETED|Overall Study||0
7904508|NCT00695578|19451187|P2|COMPLETED|Overall Study||10
7904509|NCT00695578|19451188|P1|COMPLETED|Overall Study||10
7904510|NCT00695578|19451187|P2|STARTED|Overall Study||10
7904511|NCT00695578|19451188|P1|STARTED|Overall Study||10
7904512|NCT00695565|19451196|P2|NOT COMPLETED|Overall Study||9
7904513|NCT00695565|19451197|P1|NOT COMPLETED|Overall Study||13
7904514|NCT00695565|19451196|P2|COMPLETED|Overall Study||81
7904515|NCT00695565|19451197|P1|COMPLETED|Overall Study||77
7904516|NCT00695565|19451196|P2|STARTED|Overall Study||90
7904517|NCT00695565|19451197|P1|STARTED|Overall Study||90
7904518|NCT00695500|19451231|P2|NOT COMPLETED|Overall Study||5
7904519|NCT00695500|19451232|P1|NOT COMPLETED|Overall Study||3
7904520|NCT00695500|19451231|P2|COMPLETED|Overall Study||17
7904521|NCT00695500|19451232|P1|COMPLETED|Overall Study||21
7904522|NCT00695500|19451231|P2|STARTED|Overall Study||22
7904523|NCT00695500|19451232|P1|STARTED|Overall Study||24
7904524|NCT00695435|19451242|P3|NOT COMPLETED|Overall Study||0
7904525|NCT00695435|19451243|P2|NOT COMPLETED|Overall Study||0
7904526|NCT00695435|19451244|P1|NOT COMPLETED|Overall Study||0
7904527|NCT00695435|19451242|P3|COMPLETED|Overall Study||7
7904528|NCT00695435|19451243|P2|COMPLETED|Overall Study||7
7904529|NCT00695435|19451244|P1|COMPLETED|Overall Study||7
7904530|NCT00695435|19451242|P3|STARTED|Overall Study||7
7904531|NCT00695435|19451243|P2|STARTED|Overall Study||7
7904532|NCT00695435|19451244|P1|STARTED|Overall Study||7
7904533|NCT00695409|19451255|P1|NOT COMPLETED|Overall Study||0
7904534|NCT00695409|19451255|P1|COMPLETED|Overall Study||122
7904535|NCT00695409|19451255|P1|STARTED|Overall Study||122
7904536|NCT00695396|19451270|P3|NOT COMPLETED|Overall Study||8
7904537|NCT00695396|19451271|P2|NOT COMPLETED|Overall Study||8
7904538|NCT00695396|19451272|P1|NOT COMPLETED|Overall Study||7
7904539|NCT00695396|19451270|P3|COMPLETED|Overall Study||1
7904540|NCT00695396|19451271|P2|COMPLETED|Overall Study||0
7904541|NCT00695396|19451272|P1|COMPLETED|Overall Study||1
7904542|NCT00695396|19451270|P3|STARTED|Overall Study||9
7904543|NCT00695396|19451271|P2|STARTED|Overall Study||8
7904544|NCT00695396|19451272|P1|STARTED|Overall Study||8
7904545|NCT00695318|19451288|P2|NOT COMPLETED|Overall Study||1
7904546|NCT00695318|19451289|P1|NOT COMPLETED|Overall Study||5
7904547|NCT00695318|19451288|P2|COMPLETED|Overall Study||6
7904548|NCT00695318|19451289|P1|COMPLETED|Overall Study||5
7904549|NCT00695318|19451288|P2|STARTED|Overall Study||7
7904550|NCT00695318|19451289|P1|STARTED|Overall Study||10
7904551|NCT00695292|19451300|P1|NOT COMPLETED|Overall Study||0
7904552|NCT00695292|19451300|P1|COMPLETED|Overall Study||37
7904553|NCT00695292|19451300|P1|STARTED|Overall Study||37
7904554|NCT00695188|19451307|P2|NOT COMPLETED|Overall Study||0
7904555|NCT00695188|19451308|P1|NOT COMPLETED|Overall Study||0
7904556|NCT00695188|19451307|P2|COMPLETED|Overall Study||9
7904557|NCT00695188|19451308|P1|COMPLETED|Overall Study||10
7904558|NCT00695188|19451307|P2|STARTED|Overall Study||9
7904559|NCT00695188|19451308|P1|STARTED|Overall Study||10
7904560|NCT00695136|19451314|P1|NOT COMPLETED|Overall Study||2
7904561|NCT00695136|19451314|P1|COMPLETED|Overall Study||5
7904562|NCT00695136|19451314|P1|STARTED|Overall Study|7|7
7904563|NCT00695097|19451320|P2|NOT COMPLETED|Overall Study||0
7904564|NCT00695097|19451321|P1|NOT COMPLETED|Overall Study||1
7904565|NCT00695097|19451320|P2|COMPLETED|Overall Study||5
7904566|NCT00695097|19451321|P1|COMPLETED|Overall Study||9
7904567|NCT00695097|19451320|P2|STARTED|Overall Study||5
7904568|NCT00695097|19451321|P1|STARTED|Overall Study||10
7904569|NCT00695019|19451330|P3|NOT COMPLETED|Overall Study||10
7904570|NCT00695019|19451331|P2|NOT COMPLETED|Overall Study||14
7904571|NCT00695019|19451332|P1|NOT COMPLETED|Overall Study||13
7904572|NCT00695019|19451330|P3|COMPLETED|Overall Study||47
7904573|NCT00695019|19451331|P2|COMPLETED|Overall Study||39
7904574|NCT00695019|19451332|P1|COMPLETED|Overall Study||46
7904575|NCT00695019|19451330|P3|STARTED|Overall Study||57
7904576|NCT00695019|19451331|P2|STARTED|Overall Study||53
7904577|NCT00695019|19451332|P1|STARTED|Overall Study||59
7904578|NCT00694707|19451366|P5|NOT COMPLETED|Overall Study||40
7904579|NCT00694707|19451367|P4|NOT COMPLETED|Overall Study||50
7904580|NCT00694707|19451368|P3|NOT COMPLETED|Overall Study||51
7904581|NCT00694707|19451369|P2|NOT COMPLETED|Overall Study||55
7904582|NCT00694707|19451370|P1|NOT COMPLETED|Overall Study||72
7904583|NCT00694707|19451366|P5|COMPLETED|Overall Study||101
7904584|NCT00694707|19451367|P4|COMPLETED|Overall Study||98
7904585|NCT00694707|19451368|P3|COMPLETED|Overall Study||96
7904586|NCT00694707|19451369|P2|COMPLETED|Overall Study||90
7904587|NCT00694707|19451370|P1|COMPLETED|Overall Study||79
7904588|NCT00694707|19451366|P5|STARTED|Overall Study||141
7904589|NCT00694707|19451367|P4|STARTED|Overall Study||148
7904590|NCT00694707|19451368|P3|STARTED|Overall Study||147
7904591|NCT00694707|19451369|P2|STARTED|Overall Study||145
7904592|NCT00694707|19451370|P1|STARTED|Overall Study||151
7904593|NCT00694603|19451387|P1|NOT COMPLETED|Overall Study||0
7904594|NCT00694603|19451387|P1|COMPLETED|Overall Study||18
7904595|NCT00694603|19451387|P1|STARTED|Overall Study||18
7904596|NCT00694564|19451392|P1|NOT COMPLETED|Overall Study||2
7904597|NCT00694564|19451392|P1|COMPLETED|Overall Study||6
7904598|NCT00694564|19451392|P1|STARTED|Overall Study||8
7904599|NCT00694551|19451399|P3|NOT COMPLETED|Overall Study||1
7904600|NCT00694551|19451400|P2|NOT COMPLETED|Overall Study||0
7904601|NCT00694551|19451401|P1|NOT COMPLETED|Overall Study||1
7904602|NCT00694551|19451399|P3|COMPLETED|Overall Study||8
7904603|NCT00694551|19451400|P2|COMPLETED|Overall Study||10
7904604|NCT00694551|19451401|P1|COMPLETED|Overall Study||9
7904605|NCT00694551|19451399|P3|STARTED|Overall Study||9
7904606|NCT00694551|19451400|P2|STARTED|Overall Study||10
7904607|NCT00694551|19451401|P1|STARTED|Overall Study||10
7904608|NCT00694473|19451415|P1|NOT COMPLETED|Overall Study||7
7904609|NCT00694473|19451415|P1|COMPLETED|Overall Study|Dec 2010|69
7904610|NCT00694473|19451415|P1|STARTED|Overall Study|Aug 2008|76
7904611|NCT00694369|19451430|P5|NOT COMPLETED|Overall Study||6
7904612|NCT00694369|19451431|P4|NOT COMPLETED|Overall Study||3
7904613|NCT00694369|19451432|P3|NOT COMPLETED|Overall Study||2
7904614|NCT00694369|19451433|P2|NOT COMPLETED|Overall Study||3
7904615|NCT00694369|19451434|P1|NOT COMPLETED|Overall Study||1
7904616|NCT00694369|19451430|P5|COMPLETED|Overall Study||56
7904617|NCT00694369|19451431|P4|COMPLETED|Overall Study||189
7904618|NCT00694369|19451432|P3|COMPLETED|Overall Study||95
7904619|NCT00694369|19451433|P2|COMPLETED|Overall Study||188
7904620|NCT00694369|19451434|P1|COMPLETED|Overall Study||45
7904621|NCT00694369|19451430|P5|STARTED|Overall Study||62
7904622|NCT00694369|19451431|P4|STARTED|Overall Study||192
7904623|NCT00694369|19451432|P3|STARTED|Overall Study||97
7904624|NCT00694369|19451433|P2|STARTED|Overall Study||191
7904625|NCT00694369|19451434|P1|STARTED|Overall Study||46
7904626|NCT00694356|19451454|P3|NOT COMPLETED|Overall Study||6
7904627|NCT00694356|19451455|P2|NOT COMPLETED|Overall Study||6
7904628|NCT00694356|19451456|P1|NOT COMPLETED|Overall Study||3
7904629|NCT00694356|19451454|P3|COMPLETED|Overall Study||0
7904630|NCT00694356|19451455|P2|COMPLETED|Overall Study||0
7904631|NCT00694356|19451456|P1|COMPLETED|Overall Study||0
7904632|NCT00694356|19451454|P3|STARTED|Overall Study||6
7904633|NCT00694356|19451455|P2|STARTED|Overall Study||6
7904634|NCT00694356|19451456|P1|STARTED|Overall Study||3
7904635|NCT00694304|19451491|P1|NOT COMPLETED|Overall Study||207
7904636|NCT00694304|19451491|P1|COMPLETED|Overall Study||328
7904637|NCT00694304|19451491|P1|STARTED|Overall Study||535
7904638|NCT00694161|19451504|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3
7904639|NCT00694161|19451504|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||32
7904640|NCT00694161|19451504|P1|STARTED|Part 2 (After Week 6 up to Month 12)||35
7904641|NCT00694161|19451504|P1|NOT COMPLETED|Part 1 (up to Week 6)||0
7904642|NCT00694161|19451504|P1|COMPLETED|Part 1 (up to Week 6)||35
7904643|NCT00694161|19451504|P1|STARTED|Part 1 (up to Week 6)||35
7904644|NCT00694122|19451543|P2|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
7904645|NCT00694122|19451544|P1|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
7904646|NCT00694122|19451543|P2|COMPLETED|Second Intervention (3-4 Weeks)||5
7904647|NCT00694122|19451544|P1|COMPLETED|Second Intervention (3-4 Weeks)||10
7904648|NCT00694122|19451543|P2|STARTED|Second Intervention (3-4 Weeks)||5
7904649|NCT00694122|19451544|P1|STARTED|Second Intervention (3-4 Weeks)||10
7904650|NCT00694122|19451543|P2|NOT COMPLETED|Washout (1 Day)||0
7904651|NCT00694122|19451544|P1|NOT COMPLETED|Washout (1 Day)||0
7904652|NCT00694122|19451543|P2|COMPLETED|Washout (1 Day)||5
7904653|NCT00694122|19451544|P1|COMPLETED|Washout (1 Day)||10
7904654|NCT00694122|19451543|P2|STARTED|Washout (1 Day)||5
7904655|NCT00694122|19451544|P1|STARTED|Washout (1 Day)||10
7904656|NCT00694122|19451543|P2|NOT COMPLETED|First Intervention (3-4 Weeks)||2
7904657|NCT00694122|19451544|P1|NOT COMPLETED|First Intervention (3-4 Weeks)||10
7904658|NCT00694122|19451543|P2|COMPLETED|First Intervention (3-4 Weeks)||5
7904659|NCT00694122|19451544|P1|COMPLETED|First Intervention (3-4 Weeks)||10
7904660|NCT00694122|19451543|P2|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7
7904661|NCT00694122|19451544|P1|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20
7904662|NCT00694109|19451560|P1|NOT COMPLETED|Overall Study||117
7904663|NCT00694109|19451560|P1|COMPLETED|Overall Study||25
7904664|NCT00694109|19451560|P1|Completed Consented Length of Treatment|Overall Study||60
7904665|NCT00694109|19451560|P1|Consented 2 Years Additional Treatment|Overall Study||42
7904666|NCT00694109|19451560|P1|Treated|Overall Study||141
7904667|NCT00694109|19451560|P1|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142
7904668|NCT00694096|19451584|P1|NOT COMPLETED|Overall Study||5
7904669|NCT00694096|19451584|P1|COMPLETED|Overall Study||20
7904670|NCT00694096|19451584|P1|STARTED|Overall Study||25
7904671|NCT00694070|19451590|P1|NOT COMPLETED|Overall Study||0
7904672|NCT00694070|19451590|P1|COMPLETED|Overall Study||51
7904673|NCT00694070|19451590|P1|STARTED|Overall Study||51
7904674|NCT00694018|19451598|P2|NOT COMPLETED|Overall Study||9
7904675|NCT00694018|19451599|P1|NOT COMPLETED|Overall Study||13
7904676|NCT00694018|19451598|P2|COMPLETED|Overall Study||102
7904677|NCT00694018|19451599|P1|COMPLETED|Overall Study||105
7904678|NCT00694018|19451598|P2|6 Months|Overall Study||101
7904679|NCT00694018|19451599|P1|6 Months|Overall Study||106
7904680|NCT00694018|19451598|P2|STARTED|Overall Study||111
7904681|NCT00694018|19451599|P1|STARTED|Overall Study||118
7904682|NCT00693992|19451607|P2|NOT COMPLETED|Overall Study||0
7904683|NCT00693992|19451608|P1|NOT COMPLETED|Overall Study||0
7904684|NCT00693992|19451607|P2|COMPLETED|Overall Study||104
7904685|NCT00693992|19451608|P1|COMPLETED|Overall Study||106
7904686|NCT00693992|19451607|P2|STARTED|Overall Study||104
7904687|NCT00693992|19451608|P1|STARTED|Overall Study||106
7904688|NCT00693784|19451624|P1|NOT COMPLETED|Overall Study||4
7904689|NCT00693784|19451624|P1|COMPLETED|Overall Study||11
7904690|NCT00693784|19451624|P1|104-week Extended Follow-up|Overall Study||11
7904691|NCT00693784|19451624|P1|52-week Extended Follow-up|Overall Study||13
7904692|NCT00693784|19451624|P1|26-Week Primary Endpoint|Overall Study||15
7904693|NCT00693784|19451624|P1|STARTED|Overall Study||15
7904694|NCT00693719|19451630|P1|NOT COMPLETED|Overall Study||0
7904695|NCT00693719|19451630|P1|COMPLETED|Overall Study||31
7904696|NCT00693719|19451630|P1|STARTED|Overall Study||31
7904697|NCT00693706|19451637|P2|NOT COMPLETED|Overall Study||1
7904698|NCT00693706|19451638|P1|NOT COMPLETED|Overall Study||0
7904699|NCT00693706|19451637|P2|COMPLETED|Overall Study||98
7904700|NCT00693706|19451638|P1|COMPLETED|Overall Study||101
7904701|NCT00693706|19451637|P2|STARTED|Overall Study||99
7904702|NCT00693706|19451638|P1|STARTED|Overall Study||101
7904703|NCT00693693|19451665|P3|NOT COMPLETED|Overall Study||2
7904704|NCT00693693|19451666|P2|NOT COMPLETED|Overall Study||1
7904705|NCT00693693|19451667|P1|NOT COMPLETED|Overall Study||1
7904706|NCT00693693|19451665|P3|COMPLETED|Overall Study||7
7904707|NCT00693693|19451666|P2|COMPLETED|Overall Study||8
7904708|NCT00693693|19451667|P1|COMPLETED|Overall Study||6
7904709|NCT00693693|19451665|P3|STARTED|Overall Study||9
7904710|NCT00693693|19451666|P2|STARTED|Overall Study||9
7904711|NCT00693693|19451667|P1|STARTED|Overall Study||7
7904712|NCT00693654|19451677|P2|NOT COMPLETED|Overall Study||0
7904713|NCT00693654|19451678|P1|NOT COMPLETED|Overall Study||0
7904714|NCT00693654|19451677|P2|COMPLETED|Overall Study||14
7904715|NCT00693654|19451678|P1|COMPLETED|Overall Study||14
7904716|NCT00693654|19451677|P2|STARTED|Overall Study||14
7904717|NCT00693654|19451678|P1|STARTED|Overall Study||14
7904718|NCT00693628|19451688|P2|NOT COMPLETED|Overall Study||0
7904719|NCT00693628|19451689|P1|NOT COMPLETED|Overall Study||0
7904720|NCT00693628|19451688|P2|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment.|0
7904721|NCT00693628|19451689|P1|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment|0
7904722|NCT00693628|19451688|P2|STARTED|Overall Study|No data is available indicating to which group patients were assigned .|0
7904723|NCT00693628|19451689|P1|STARTED|Overall Study|No data is available indicating to which group patients were assigned.|0
7904724|NCT00693498|19451697|P2|NOT COMPLETED|Overall Study||0
7904725|NCT00693498|19451698|P1|NOT COMPLETED|Overall Study||0
7904726|NCT00693498|19451697|P2|COMPLETED|Overall Study||81
7904727|NCT00693498|19451698|P1|COMPLETED|Overall Study||81
7904728|NCT00693498|19451697|P2|STARTED|Overall Study||81
7904729|NCT00693498|19451698|P1|STARTED|Overall Study||81
7904730|NCT00693485|19451709|P3|NOT COMPLETED|Overall Study||0
7904731|NCT00693485|19451710|P2|NOT COMPLETED|Overall Study||2
7904732|NCT00693485|19451711|P1|NOT COMPLETED|Overall Study||0
7904733|NCT00693485|19451709|P3|COMPLETED|Overall Study||24
7904734|NCT00693485|19451710|P2|COMPLETED|Overall Study||19
7904735|NCT00693485|19451711|P1|COMPLETED|Overall Study||25
7904736|NCT00693485|19451709|P3|STARTED|Overall Study||24
7904737|NCT00693485|19451710|P2|STARTED|Overall Study||21
7904738|NCT00693485|19451711|P1|STARTED|Overall Study||25
7904739|NCT00693472|19451726|P4|NOT COMPLETED|Part 2||2
7904740|NCT00693472|19451727|P3|NOT COMPLETED|Part 2||2
7904741|NCT00693472|19451728|P2|NOT COMPLETED|Part 2||0
7904742|NCT00693472|19451729|P1|NOT COMPLETED|Part 2||0
7904743|NCT00693472|19451726|P4|COMPLETED|Part 2||4
7904744|NCT00693472|19451727|P3|COMPLETED|Part 2||6
7904745|NCT00693472|19451728|P2|COMPLETED|Part 2||0
7904746|NCT00693472|19451729|P1|COMPLETED|Part 2||0
7904747|NCT00693472|19451726|P4|STARTED|Part 2||6
7904748|NCT00693472|19451727|P3|STARTED|Part 2||8
7904749|NCT00693472|19451728|P2|STARTED|Part 2||0
7904750|NCT00693472|19451729|P1|STARTED|Part 2||0
7904751|NCT00693472|19451726|P4|NOT COMPLETED|Part 1||0
7904752|NCT00693472|19451727|P3|NOT COMPLETED|Part 1||0
7904753|NCT00693472|19451728|P2|NOT COMPLETED|Part 1||4
7904754|NCT00693472|19451729|P1|NOT COMPLETED|Part 1||6
7904755|NCT00693472|19451726|P4|COMPLETED|Part 1||0
7904756|NCT00693472|19451727|P3|COMPLETED|Part 1||0
7904757|NCT00693472|19451728|P2|COMPLETED|Part 1||9
7904758|NCT00693472|19451729|P1|COMPLETED|Part 1||13
7904759|NCT00693472|19451726|P4|STARTED|Part 1||0
7904760|NCT00693472|19451727|P3|STARTED|Part 1||0
7904761|NCT00693472|19451728|P2|STARTED|Part 1||13
7904762|NCT00693472|19451729|P1|STARTED|Part 1||19
7904763|NCT00693420|19451749|P2|NOT COMPLETED|Overall Study||15
7904764|NCT00693420|19451750|P1|NOT COMPLETED|Overall Study||6
7904765|NCT00693420|19451749|P2|COMPLETED|Overall Study||126
7904766|NCT00693420|19451750|P1|COMPLETED|Overall Study||131
7904767|NCT00693420|19451749|P2|STARTED|Overall Study||141
7904768|NCT00693420|19451750|P1|STARTED|Overall Study||137
7904769|NCT00693303|19451774|P1|NOT COMPLETED|Overall Study||0
7904770|NCT00693303|19451774|P1|COMPLETED|Overall Study||21
7904771|NCT00693303|19451774|P1|STARTED|Overall Study||21
7904772|NCT00693238|19451780|P2|NOT COMPLETED|Overall Study||0
7904773|NCT00693238|19451781|P1|NOT COMPLETED|Overall Study||0
7904774|NCT00693238|19451780|P2|COMPLETED|Overall Study||106
7904775|NCT00693238|19451781|P1|COMPLETED|Overall Study||122
7904776|NCT00693238|19451780|P2|STARTED|Overall Study||106
7904777|NCT00693238|19451781|P1|STARTED|Overall Study||122
7904778|NCT00693225|19451789|P2|NOT COMPLETED|Overall Study||5
7904779|NCT00693225|19451790|P1|NOT COMPLETED|Overall Study||2
7904780|NCT00693225|19451789|P2|COMPLETED|Overall Study||43
7904781|NCT00693225|19451790|P1|COMPLETED|Overall Study||41
7904782|NCT00693225|19451789|P2|STARTED|Overall Study||48
7904783|NCT00693225|19451790|P1|STARTED|Overall Study||43
7904784|NCT00693160|19451802|P2|NOT COMPLETED|Overall Study||0
7904785|NCT00693160|19451803|P1|NOT COMPLETED|Overall Study||0
7904786|NCT00693160|19451802|P2|COMPLETED|Overall Study||16
7904787|NCT00693160|19451803|P1|COMPLETED|Overall Study||14
7904788|NCT00693160|19451802|P2|STARTED|Overall Study||16
7904789|NCT00693160|19451803|P1|STARTED|Overall Study||14
7904790|NCT00693017|19451813|P2|NOT COMPLETED|Overall Study||2
7904791|NCT00693017|19451814|P1|NOT COMPLETED|Overall Study||2
7904792|NCT00693017|19451813|P2|COMPLETED|Overall Study||0
7904793|NCT00693017|19451814|P1|COMPLETED|Overall Study||0
7904794|NCT00693017|19451813|P2|STARTED|Overall Study||2
7904795|NCT00693017|19451814|P1|STARTED|Overall Study||2
7904796|NCT00692978|19451824|P2|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0
7904797|NCT00692978|19451825|P1|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0
7904798|NCT00692978|19451824|P2|COMPLETED|FP 6 Microns Size With MDI Inhaler||15
7904799|NCT00692978|19451825|P1|COMPLETED|FP 6 Microns Size With MDI Inhaler||15
7904800|NCT00692978|19451824|P2|STARTED|FP 6 Microns Size With MDI Inhaler||15
7904801|NCT00692978|19451825|P1|STARTED|FP 6 Microns Size With MDI Inhaler||15
7904802|NCT00692978|19451824|P2|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0
7904803|NCT00692978|19451825|P1|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0
7904804|NCT00692978|19451824|P2|COMPLETED|FP 3 Microns Size With MDI Inhaler||15
7904805|NCT00692978|19451825|P1|COMPLETED|FP 3 Microns Size With MDI Inhaler||15
7904806|NCT00692978|19451824|P2|STARTED|FP 3 Microns Size With MDI Inhaler||15
7904807|NCT00692978|19451825|P1|STARTED|FP 3 Microns Size With MDI Inhaler||15
7904808|NCT00692978|19451824|P2|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0
7904809|NCT00692978|19451825|P1|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0
7904810|NCT00692978|19451824|P2|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15
7904811|NCT00692978|19451825|P1|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15
7904812|NCT00692978|19451824|P2|STARTED|FP1.5 Microns Size With MDI Inhaler||15
7904813|NCT00692978|19451825|P1|STARTED|FP1.5 Microns Size With MDI Inhaler||15
7904814|NCT00692978|19451824|P2|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0
7904815|NCT00692978|19451825|P1|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0
7904816|NCT00692978|19451824|P2|COMPLETED|FP From Active 250 ug MDI Inhaler||15
7904817|NCT00692978|19451825|P1|COMPLETED|FP From Active 250 ug MDI Inhaler||15
7904818|NCT00692978|19451824|P2|STARTED|FP From Active 250 ug MDI Inhaler||15
7904819|NCT00692978|19451825|P1|STARTED|FP From Active 250 ug MDI Inhaler||15
7904820|NCT00692913|19451845|P2|NOT COMPLETED|Overall Study||30
7904821|NCT00692913|19451846|P1|NOT COMPLETED|Overall Study||29
7904822|NCT00692913|19451845|P2|COMPLETED|Overall Study||228
7904823|NCT00692913|19451846|P1|COMPLETED|Overall Study||228
7904824|NCT00692913|19451845|P2|STARTED|Overall Study||258
7904825|NCT00692913|19451846|P1|STARTED|Overall Study||257
7904826|NCT00692770|19451868|P2|NOT COMPLETED|Overall Study||558
7904827|NCT00692770|19451869|P1|NOT COMPLETED|Overall Study||556
7904828|NCT00692770|19451868|P2|COMPLETED|Overall Study||0
7904829|NCT00692770|19451869|P1|COMPLETED|Overall Study||0
7904830|NCT00692770|19451868|P2|Participants Received Treatment|Overall Study||554
7904831|NCT00692770|19451869|P1|Participants Received Treatment|Overall Study||553
7904832|NCT00692770|19451868|P2|STARTED|Overall Study||558
7904833|NCT00692770|19451869|P1|STARTED|Overall Study||556
7904834|NCT00692692|19451893|P2|NOT COMPLETED|Overall Study||0
7904835|NCT00692692|19451894|P1|NOT COMPLETED|Overall Study||0
7904836|NCT00692692|19451893|P2|COMPLETED|Overall Study||16
7904837|NCT00692692|19451894|P1|COMPLETED|Overall Study||20
7904838|NCT00692692|19451893|P2|STARTED|Overall Study||16
7904839|NCT00692692|19451894|P1|STARTED|Overall Study||20
7904840|NCT00692419|19451904|P2|NOT COMPLETED|Overall Study||18
7904841|NCT00692419|19451905|P1|NOT COMPLETED|Overall Study||16
7904842|NCT00692419|19451904|P2|COMPLETED|Overall Study||102
7904843|NCT00692419|19451905|P1|COMPLETED|Overall Study||84
7904844|NCT00692419|19451904|P2|STARTED|Overall Study||120
7904845|NCT00692419|19451905|P1|STARTED|Overall Study||100
7904846|NCT00692406|19451915|P1|NOT COMPLETED|Overall Study||57
7904847|NCT00692406|19451915|P1|COMPLETED|Overall Study|This group quit smoking before their second scan.|23
7904848|NCT00692406|19451915|P1|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80
7904849|NCT00692341|19451929|P3|NOT COMPLETED|Overall Study||0
7904850|NCT00692341|19451930|P2|NOT COMPLETED|Overall Study||0
7904851|NCT00692341|19451931|P1|NOT COMPLETED|Overall Study||0
7904852|NCT00692341|19451929|P3|COMPLETED|Overall Study||8
7904853|NCT00692341|19451930|P2|COMPLETED|Overall Study||8
7904854|NCT00692341|19451931|P1|COMPLETED|Overall Study||8
7904855|NCT00692341|19451929|P3|STARTED|Overall Study||8
7904856|NCT00692341|19451930|P2|STARTED|Overall Study||8
7904857|NCT00692341|19451931|P1|STARTED|Overall Study||8
7904858|NCT00692276|19451977|P2|NOT COMPLETED|Completed 24 Months||14
7904859|NCT00692276|19451978|P1|NOT COMPLETED|Completed 24 Months||7
7904860|NCT00692276|19451977|P2|COMPLETED|Completed 24 Months||187
7904861|NCT00692276|19451978|P1|COMPLETED|Completed 24 Months||183
7904862|NCT00692276|19451977|P2|STARTED|Completed 24 Months||201
7904863|NCT00692276|19451978|P1|STARTED|Completed 24 Months||190
7904864|NCT00692276|19451977|P2|NOT COMPLETED|Randomized Population||0
7904865|NCT00692276|19451978|P1|NOT COMPLETED|Randomized Population||0
7904866|NCT00692276|19451977|P2|COMPLETED|Randomized Population||201
7904867|NCT00692276|19451978|P1|COMPLETED|Randomized Population||190
7904868|NCT00692276|19451977|P2|STARTED|Randomized Population||201
7904869|NCT00692276|19451978|P1|STARTED|Randomized Population||190
7904870|NCT00692237|19451986|P2|NOT COMPLETED|Overall Study||4
7904871|NCT00692237|19451987|P1|NOT COMPLETED|Overall Study||1
7904872|NCT00692237|19451986|P2|COMPLETED|Overall Study||25
7904873|NCT00692237|19451987|P1|COMPLETED|Overall Study||29
7904874|NCT00692237|19451986|P2|STARTED|Overall Study||29
7904875|NCT00692237|19451987|P1|STARTED|Overall Study||30
7904876|NCT00692211|19451997|P2|NOT COMPLETED|Overall Study||0
7904877|NCT00692211|19451998|P1|NOT COMPLETED|Overall Study||0
7904878|NCT00692211|19451997|P2|COMPLETED|Overall Study||202
7904879|NCT00692211|19451998|P1|COMPLETED|Overall Study||202
7904880|NCT00692211|19451997|P2|STARTED|Overall Study||202
7904881|NCT00692211|19451998|P1|STARTED|Overall Study||202
7904882|NCT00692198|19452006|P2|NOT COMPLETED|Overall Study||0
7904883|NCT00692198|19452007|P1|NOT COMPLETED|Overall Study||0
7904884|NCT00692198|19452006|P2|COMPLETED|Overall Study||370
7904885|NCT00692198|19452007|P1|COMPLETED|Overall Study||368
7904886|NCT00692198|19452006|P2|STARTED|Overall Study||370
7904887|NCT00692198|19452007|P1|STARTED|Overall Study||368
7904888|NCT00692185|19452042|P2|NOT COMPLETED|Overall Study||3
7904889|NCT00692185|19452043|P1|NOT COMPLETED|Overall Study||3
7904890|NCT00692185|19452042|P2|COMPLETED|Overall Study||9
7904891|NCT00692185|19452043|P1|COMPLETED|Overall Study||8
7904892|NCT00692185|19452042|P2|STARTED|Overall Study||12
7904893|NCT00692185|19452043|P1|STARTED|Overall Study||11
7904894|NCT00692094|19452055|P4|NOT COMPLETED|Overall Study||0
7904895|NCT00692094|19452056|P3|NOT COMPLETED|Overall Study||0
7904896|NCT00692094|19452057|P2|NOT COMPLETED|Overall Study||0
7904897|NCT00692094|19452058|P1|NOT COMPLETED|Overall Study||0
7904898|NCT00692094|19452055|P4|COMPLETED|Overall Study||0
7904899|NCT00692094|19452056|P3|COMPLETED|Overall Study||0
7904900|NCT00692094|19452057|P2|COMPLETED|Overall Study||0
7904901|NCT00692094|19452058|P1|COMPLETED|Overall Study||0
7904902|NCT00692094|19452055|P4|STARTED|Overall Study||0
7904903|NCT00692094|19452056|P3|STARTED|Overall Study||0
7904904|NCT00692094|19452057|P2|STARTED|Overall Study||0
7904905|NCT00692094|19452058|P1|STARTED|Overall Study||0
7904906|NCT00692003|19452074|P2|NOT COMPLETED|Overall Study||1
7904907|NCT00692003|19452075|P1|NOT COMPLETED|Overall Study||5
7904908|NCT00692003|19452074|P2|COMPLETED|Overall Study||0
7904909|NCT00692003|19452075|P1|COMPLETED|Overall Study||0
7904910|NCT00692003|19452074|P2|STARTED|Overall Study||1
7904911|NCT00692003|19452075|P1|STARTED|Overall Study||5
7904912|NCT00691938|19452090|P7|NOT COMPLETED|Overall Study||0
7904913|NCT00691938|19452091|P6|NOT COMPLETED|Overall Study||0
7904914|NCT00691938|19452092|P5|NOT COMPLETED|Overall Study||0
7904915|NCT00691938|19452093|P4|NOT COMPLETED|Overall Study||0
7904916|NCT00691938|19452094|P3|NOT COMPLETED|Overall Study||0
7904917|NCT00691938|19452095|P2|NOT COMPLETED|Overall Study||0
7904918|NCT00691938|19452096|P1|NOT COMPLETED|Overall Study||1
7904919|NCT00691938|19452090|P7|COMPLETED|Overall Study||14
7904920|NCT00691938|19452091|P6|COMPLETED|Overall Study||6
7904921|NCT00691938|19452092|P5|COMPLETED|Overall Study||10
7904922|NCT00691938|19452093|P4|COMPLETED|Overall Study||8
7904923|NCT00691938|19452094|P3|COMPLETED|Overall Study||6
7904924|NCT00691938|19452095|P2|COMPLETED|Overall Study||3
7904925|NCT00691938|19452096|P1|COMPLETED|Overall Study||4
7904926|NCT00691938|19452090|P7|STARTED|Overall Study||14
7904927|NCT00691938|19452091|P6|STARTED|Overall Study||6
7904928|NCT00691938|19452092|P5|STARTED|Overall Study||10
7904929|NCT00691938|19452093|P4|STARTED|Overall Study||8
7904930|NCT00691938|19452094|P3|STARTED|Overall Study||6
7904931|NCT00691938|19452095|P2|STARTED|Overall Study||3
7904932|NCT00691938|19452096|P1|STARTED|Overall Study||5
7904933|NCT00691808|19452120|P3|NOT COMPLETED|Overall Study||0
7904934|NCT00691808|19452121|P2|NOT COMPLETED|Overall Study||1
7904935|NCT00691808|19452122|P1|NOT COMPLETED|Overall Study||0
7904936|NCT00691808|19452120|P3|COMPLETED|Overall Study||32
7904937|NCT00691808|19452121|P2|COMPLETED|Overall Study||35
7904938|NCT00691808|19452122|P1|COMPLETED|Overall Study||35
7904939|NCT00691808|19452120|P3|STARTED|Overall Study||32
7904940|NCT00691808|19452121|P2|STARTED|Overall Study||36
7904941|NCT00691808|19452122|P1|STARTED|Overall Study||35
7904942|NCT00691704|19452163|P1|NOT COMPLETED|Two Years of Maintenance Therapy||13
7904943|NCT00691704|19452163|P1|COMPLETED|Two Years of Maintenance Therapy||3
7904944|NCT00691704|19452163|P1|STARTED|Two Years of Maintenance Therapy||16
7904945|NCT00691704|19452163|P1|NOT COMPLETED|Induction Therapy||2
7904946|NCT00691704|19452163|P1|COMPLETED|Induction Therapy||16
7904947|NCT00691704|19452163|P1|STARTED|Induction Therapy||18
7904948|NCT00691665|19452173|P2|NOT COMPLETED|Overall Study||0
7904949|NCT00691665|19452174|P1|NOT COMPLETED|Overall Study||0
7904950|NCT00691665|19452173|P2|COMPLETED|Overall Study||65
7904951|NCT00691665|19452174|P1|COMPLETED|Overall Study||65
7904952|NCT00691665|19452173|P2|STARTED|Overall Study||65
7904953|NCT00691665|19452174|P1|STARTED|Overall Study||65
7904954|NCT00691652|19452186|P1|NOT COMPLETED|Overall Study||1
7904955|NCT00691652|19452186|P1|COMPLETED|Overall Study||1
7904956|NCT00691652|19452186|P1|STARTED|Overall Study||2
7904957|NCT00691600|19452198|P2|NOT COMPLETED|Overall Study||0
7904958|NCT00691600|19452199|P1|NOT COMPLETED|Overall Study||0
7904959|NCT00691600|19452198|P2|COMPLETED|Overall Study||11
7904960|NCT00691600|19452199|P1|COMPLETED|Overall Study||12
7904961|NCT00691600|19452198|P2|STARTED|Overall Study||11
7904962|NCT00691600|19452199|P1|STARTED|Overall Study||12
7904963|NCT00691574|19452211|P2|NOT COMPLETED|Overall Study||0
7904964|NCT00691574|19452212|P1|NOT COMPLETED|Overall Study||0
7904965|NCT00691574|19452211|P2|COMPLETED|Overall Study||0
7904966|NCT00691574|19452212|P1|COMPLETED|Overall Study||0
7904967|NCT00691574|19452211|P2|STARTED|Overall Study||0
7904968|NCT00691574|19452212|P1|STARTED|Overall Study||0
7904969|NCT00691483|19452224|P2|NOT COMPLETED|Overall Study||25
7904970|NCT00691483|19452225|P1|NOT COMPLETED|Overall Study||68
7904971|NCT00691483|19452224|P2|COMPLETED|Overall Study||141
7904972|NCT00691483|19452225|P1|COMPLETED|Overall Study|Completed refers to completion of the study.|425
7904973|NCT00691483|19452224|P2|Received Treatment|Overall Study||165
7904974|NCT00691483|19452225|P1|Received Treatment|Overall Study||486
7904975|NCT00691483|19452224|P2|STARTED|Overall Study||166
7904976|NCT00691483|19452225|P1|STARTED|Overall Study||493
7904977|NCT00691444|19452244|P3|NOT COMPLETED|Overall Study||0
7904978|NCT00691444|19452245|P2|NOT COMPLETED|Overall Study||0
7904979|NCT00691444|19452246|P1|NOT COMPLETED|Overall Study||0
7904980|NCT00691444|19452244|P3|COMPLETED|Overall Study||0
7904981|NCT00691444|19452245|P2|COMPLETED|Overall Study||0
7904982|NCT00691444|19452246|P1|COMPLETED|Overall Study||0
7904983|NCT00691444|19452244|P3|STARTED|Overall Study||0
7904984|NCT00691444|19452245|P2|STARTED|Overall Study||0
7904985|NCT00691444|19452246|P1|STARTED|Overall Study||0
7904986|NCT00691327|19452259|P2|NOT COMPLETED|Overall Study||2508
7904987|NCT00691327|19452260|P1|NOT COMPLETED|Overall Study||2841
7904988|NCT00691327|19452259|P2|COMPLETED|Overall Study||36766
7904989|NCT00691327|19452260|P1|COMPLETED|Overall Study||42214
7904990|NCT00691327|19452259|P2|STARTED|Overall Study||39274
7904991|NCT00691327|19452260|P1|STARTED|Overall Study||45055
7904992|NCT00691301|19452268|P1|NOT COMPLETED|Overall Study||54
7904993|NCT00691301|19452268|P1|COMPLETED|Overall Study||1
7904994|NCT00691301|19452268|P1|STARTED|Overall Study||55
7904995|NCT00691210|19452288|P8|NOT COMPLETED|Overall Study||0
7904996|NCT00691210|19452289|P7|NOT COMPLETED|Overall Study||0
7904997|NCT00691210|19452290|P6|NOT COMPLETED|Overall Study||1
7904998|NCT00691210|19452291|P5|NOT COMPLETED|Overall Study||0
7904999|NCT00691210|19452292|P4|NOT COMPLETED|Overall Study||3
7905000|NCT00691210|19452293|P3|NOT COMPLETED|Overall Study||0
7905001|NCT00691210|19452294|P2|NOT COMPLETED|Overall Study||0
7905002|NCT00691210|19452295|P1|NOT COMPLETED|Overall Study||0
7905003|NCT00691210|19452288|P8|COMPLETED|Overall Study||0
7905004|NCT00691210|19452289|P7|COMPLETED|Overall Study||6
7905005|NCT00691210|19452290|P6|COMPLETED|Overall Study||6
7905006|NCT00691210|19452291|P5|COMPLETED|Overall Study||5
7905007|NCT00691210|19452292|P4|COMPLETED|Overall Study||6
7905008|NCT00691210|19452293|P3|COMPLETED|Overall Study||3
7905009|NCT00691210|19452294|P2|COMPLETED|Overall Study||5
7905010|NCT00691210|19452295|P1|COMPLETED|Overall Study||3
7905011|NCT00691210|19452288|P8|STARTED|Overall Study||0
7905012|NCT00691210|19452289|P7|STARTED|Overall Study||6
7905013|NCT00691210|19452290|P6|STARTED|Overall Study||7
7905014|NCT00691210|19452291|P5|STARTED|Overall Study||5
7905015|NCT00691210|19452292|P4|STARTED|Overall Study||9
7905016|NCT00691210|19452293|P3|STARTED|Overall Study||3
7905017|NCT00691210|19452294|P2|STARTED|Overall Study||5
7905018|NCT00691210|19452295|P1|STARTED|Overall Study||3
7905019|NCT00691197|19452315|P2|NOT COMPLETED|Overall Study||5
7905020|NCT00691197|19452316|P1|NOT COMPLETED|Overall Study||11
7905021|NCT00691197|19452315|P2|COMPLETED|Overall Study||75
7905022|NCT00691197|19452316|P1|COMPLETED|Overall Study||155
7905023|NCT00691197|19452315|P2|STARTED|Overall Study||80
7905024|NCT00691197|19452316|P1|STARTED|Overall Study||166
7905025|NCT00691132|19452330|P2|NOT COMPLETED|Overall Study||13
7905026|NCT00691132|19452331|P1|NOT COMPLETED|Overall Study||12
7905027|NCT00691132|19452330|P2|COMPLETED|Overall Study|45 completed, but 4 excluded b/c urinary measures indicated they did not smoke study cigarettes.|41
7905028|NCT00691132|19452331|P1|COMPLETED|Overall Study||41
7905029|NCT00691132|19452330|P2|STARTED|Overall Study|107 total randomized. Approximately 1/2 per arm.|54
7905030|NCT00691132|19452331|P1|STARTED|Overall Study||53
7905031|NCT00691093|19452350|P1|NOT COMPLETED|Overall Study||7
7905032|NCT00691093|19452350|P1|COMPLETED|Overall Study||816
7905033|NCT00691093|19452350|P1|STARTED|Overall Study||823
7905034|NCT00691054|19452384|P1|NOT COMPLETED|Overall Study||1
7905035|NCT00691054|19452384|P1|COMPLETED|Overall Study||19
7905036|NCT00691054|19452384|P1|STARTED|Overall Study||20
7905037|NCT00691028|19452396|P4|NOT COMPLETED|Double-blind Period||0
7905038|NCT00691028|19452397|P3|NOT COMPLETED|Double-blind Period||9
7905039|NCT00691028|19452398|P2|NOT COMPLETED|Double-blind Period||13
7905040|NCT00691028|19452399|P1|NOT COMPLETED|Double-blind Period||13
7905041|NCT00691028|19452396|P4|COMPLETED|Double-blind Period||0
7905042|NCT00691028|19452397|P3|COMPLETED|Double-blind Period||95
7905043|NCT00691028|19452398|P2|COMPLETED|Double-blind Period||91
7905044|NCT00691028|19452399|P1|COMPLETED|Double-blind Period||86
7905045|NCT00691028|19452396|P4|STARTED|Double-blind Period||0
7905046|NCT00691028|19452397|P3|STARTED|Double-blind Period||104
7905047|NCT00691028|19452398|P2|STARTED|Double-blind Period||104
7905048|NCT00691028|19452399|P1|STARTED|Double-blind Period||99
7905049|NCT00691028|19452396|P4|NOT COMPLETED|Open-label Period||20
7905050|NCT00691028|19452397|P3|NOT COMPLETED|Open-label Period||0
7905051|NCT00691028|19452398|P2|NOT COMPLETED|Open-label Period||0
7905052|NCT00691028|19452399|P1|NOT COMPLETED|Open-label Period||0
7905053|NCT00691028|19452396|P4|COMPLETED|Open-label Period||307
7905054|NCT00691028|19452397|P3|COMPLETED|Open-label Period||0
7905055|NCT00691028|19452398|P2|COMPLETED|Open-label Period||0
7905056|NCT00691028|19452399|P1|COMPLETED|Open-label Period||0
7905057|NCT00691028|19452396|P4|STARTED|Open-label Period||327
7905058|NCT00691028|19452397|P3|STARTED|Open-label Period||0
7905059|NCT00691028|19452398|P2|STARTED|Open-label Period||0
7905060|NCT00691028|19452399|P1|STARTED|Open-label Period||0
7905061|NCT00691015|19452432|P1|NOT COMPLETED|Overall Study||1
7905062|NCT00691015|19452432|P1|COMPLETED|Overall Study||47
7905063|NCT00691015|19452432|P1|STARTED|Overall Study||48
7905064|NCT00690924|19452443|P1|NOT COMPLETED|Overall Study||0
7905065|NCT00690924|19452443|P1|COMPLETED|Overall Study||16
7905066|NCT00690924|19452443|P1|STARTED|Overall Study||16
7905067|NCT00690898|19452447|P1|NOT COMPLETED|TREATMENT||26
7905068|NCT00690898|19452447|P1|COMPLETED|TREATMENT||64
7905069|NCT00690898|19452447|P1|STARTED|TREATMENT|Total number of patients treated.|90
7905070|NCT00690898|19452447|P1|NOT COMPLETED|SCREENING||18
7905071|NCT00690898|19452447|P1|COMPLETED|SCREENING|Number of patients included in the study.|90
7905072|NCT00690898|19452447|P1|STARTED|SCREENING|Total of patients screened for the study.|108
7905073|NCT00690833|19452461|P1|NOT COMPLETED|Overall Study||2
7905074|NCT00690833|19452461|P1|COMPLETED|Overall Study||39
7905075|NCT00690833|19452461|P1|STARTED|Overall Study||41
7905076|NCT00690820|19452467|P2|NOT COMPLETED|Period 2||0
7905077|NCT00690820|19452468|P1|NOT COMPLETED|Period 2||0
7905078|NCT00690820|19452467|P2|COMPLETED|Period 2||8
7905079|NCT00690820|19452468|P1|COMPLETED|Period 2||8
7905080|NCT00690820|19452467|P2|STARTED|Period 2||8
7905081|NCT00690820|19452468|P1|STARTED|Period 2||8
7905082|NCT00690820|19452467|P2|NOT COMPLETED|Period 1||1
7905083|NCT00690820|19452468|P1|NOT COMPLETED|Period 1||0
7905084|NCT00690820|19452467|P2|COMPLETED|Period 1||8
7905085|NCT00690820|19452468|P1|COMPLETED|Period 1||8
7905086|NCT00690820|19452467|P2|STARTED|Period 1||9
7905087|NCT00690820|19452468|P1|STARTED|Period 1||8
7905088|NCT00690794|19452490|P2|NOT COMPLETED|Overall Study||35
7905089|NCT00690794|19452491|P1|NOT COMPLETED|Overall Study||21
7905090|NCT00690794|19452490|P2|COMPLETED|Overall Study||328
7905091|NCT00690794|19452491|P1|COMPLETED|Overall Study||342
7905092|NCT00690794|19452490|P2|STARTED|Overall Study||363
7905093|NCT00690794|19452491|P1|STARTED|Overall Study||363
7905094|NCT00690755|19452506|P7|NOT COMPLETED|Overall Study||0
7905095|NCT00690755|19452507|P6|NOT COMPLETED|Overall Study||4
7905096|NCT00690755|19452508|P5|NOT COMPLETED|Overall Study||0
7905097|NCT00690755|19452509|P4|NOT COMPLETED|Overall Study||5
7905098|NCT00690755|19452510|P3|NOT COMPLETED|Overall Study||46
7905099|NCT00690755|19452511|P2|NOT COMPLETED|Overall Study||0
7905100|NCT00690755|19452512|P1|NOT COMPLETED|Overall Study||2
7905101|NCT00690755|19452506|P7|COMPLETED|Overall Study||0
7905102|NCT00690755|19452507|P6|COMPLETED|Overall Study||6
7905103|NCT00690755|19452508|P5|COMPLETED|Overall Study||0
7905104|NCT00690755|19452509|P4|COMPLETED|Overall Study||15
7905105|NCT00690755|19452510|P3|COMPLETED|Overall Study||51
7905106|NCT00690755|19452511|P2|COMPLETED|Overall Study||0
7905107|NCT00690755|19452512|P1|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28
7905108|NCT00690755|19452506|P7|STARTED|Overall Study||0
7905109|NCT00690755|19452507|P6|STARTED|Overall Study||10
7905110|NCT00690755|19452508|P5|STARTED|Overall Study||0
7905111|NCT00690755|19452509|P4|STARTED|Overall Study||20
7905112|NCT00690755|19452510|P3|STARTED|Overall Study||97
7905113|NCT00690755|19452511|P2|STARTED|Overall Study||0
7905114|NCT00690755|19452512|P1|STARTED|Overall Study||30
7905115|NCT00690612|19452528|P1|NOT COMPLETED|Overall Study||3
7905116|NCT00690612|19452528|P1|COMPLETED|Overall Study||32
7905117|NCT00690612|19452528|P1|STARTED|Overall Study||35
7905118|NCT00690573|19452533|P1|NOT COMPLETED|Overall Study||9
7905119|NCT00690573|19452533|P1|COMPLETED|Overall Study||16
7905120|NCT00690573|19452533|P1|STARTED|Overall Study||25
7905121|NCT00690495|19452543|P2|NOT COMPLETED|Overall Study||0
7905122|NCT00690495|19452544|P1|NOT COMPLETED|Overall Study||0
7905123|NCT00690495|19452543|P2|COMPLETED|Overall Study||50
7905124|NCT00690495|19452544|P1|COMPLETED|Overall Study||50
7905125|NCT00690495|19452543|P2|Primary Endpoint|Overall Study||50
7905126|NCT00690495|19452544|P1|Primary Endpoint|Overall Study||50
7905127|NCT00690495|19452543|P2|STARTED|Overall Study||50
7905128|NCT00690495|19452544|P1|STARTED|Overall Study||50
7905129|NCT00690482|19452552|P2|NOT COMPLETED|Overall Study||3
7905130|NCT00690482|19452553|P1|NOT COMPLETED|Overall Study||4
7905131|NCT00690482|19452552|P2|COMPLETED|Overall Study||54
7905132|NCT00690482|19452553|P1|COMPLETED|Overall Study||57
7905133|NCT00690482|19452552|P2|STARTED|Overall Study||57
7905134|NCT00690482|19452553|P1|STARTED|Overall Study||61
7905135|NCT00690443|19452587|P2|NOT COMPLETED|Overall Study||2
7905136|NCT00690443|19452588|P1|NOT COMPLETED|Overall Study||1
7905137|NCT00690443|19452587|P2|COMPLETED|Overall Study||19
7905138|NCT00690443|19452588|P1|COMPLETED|Overall Study||22
7905139|NCT00690443|19452587|P2|STARTED|Overall Study||21
7905140|NCT00690443|19452588|P1|STARTED|Overall Study||23
7905141|NCT00690430|19452598|P3|NOT COMPLETED|Extension Phase||13
7905142|NCT00690430|19452599|P2|NOT COMPLETED|Extension Phase||5
7905143|NCT00690430|19452600|P1|NOT COMPLETED|Extension Phase||18
7905144|NCT00690430|19452598|P3|COMPLETED|Extension Phase||2
7905145|NCT00690430|19452599|P2|COMPLETED|Extension Phase||1
7905146|NCT00690430|19452600|P1|COMPLETED|Extension Phase||2
7905147|NCT00690430|19452598|P3|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15
7905148|NCT00690430|19452599|P2|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6
7905149|NCT00690430|19452600|P1|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20
7905150|NCT00690430|19452598|P3|NOT COMPLETED|Core Phase||0
7905151|NCT00690430|19452599|P2|NOT COMPLETED|Core Phase||23
7905152|NCT00690430|19452600|P1|NOT COMPLETED|Core Phase||18
7905153|NCT00690430|19452598|P3|COMPLETED|Core Phase||0
7905154|NCT00690430|19452599|P2|COMPLETED|Core Phase||34
7905155|NCT00690430|19452600|P1|COMPLETED|Core Phase||35
7905156|NCT00690430|19452598|P3|STARTED|Core Phase|This arm belongs to Extension Phase.|0
7905157|NCT00690430|19452599|P2|STARTED|Core Phase||57
7905158|NCT00690430|19452600|P1|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53
7905159|NCT00690378|19452629|P2|NOT COMPLETED|Overall Study||14
7905160|NCT00690378|19452630|P1|NOT COMPLETED|Overall Study||20
7905161|NCT00690378|19452629|P2|COMPLETED|Overall Study|Up to LFU visit|54
7905162|NCT00690378|19452630|P1|COMPLETED|Overall Study|Up to Late follow up (LFU) visit|49
7905163|NCT00690378|19452629|P2|Treated|Overall Study||67
7905164|NCT00690378|19452630|P1|Treated|Overall Study||68
7905165|NCT00690378|19452629|P2|STARTED|Overall Study|Randomized|68
7905166|NCT00690378|19452630|P1|STARTED|Overall Study|Randomized|69
7905167|NCT00690339|19452678|P4|NOT COMPLETED|Overall Study||25
7905168|NCT00690339|19452679|P3|NOT COMPLETED|Overall Study||57
7905169|NCT00690339|19452680|P2|NOT COMPLETED|Overall Study||81
7905170|NCT00690339|19452681|P1|NOT COMPLETED|Overall Study||117
7905171|NCT00690339|19452678|P4|COMPLETED|Overall Study||43
7905172|NCT00690339|19452679|P3|COMPLETED|Overall Study||99
7905173|NCT00690339|19452680|P2|COMPLETED|Overall Study||144
7905174|NCT00690339|19452681|P1|COMPLETED|Overall Study||375
7905175|NCT00690339|19452678|P4|STARTED|Overall Study||68
7905176|NCT00690339|19452679|P3|STARTED|Overall Study||156
7905177|NCT00690339|19452680|P2|STARTED|Overall Study||225
7905178|NCT00690339|19452681|P1|STARTED|Overall Study||492
7905179|NCT00690274|19452697|P2|NOT COMPLETED|Overall Study||8
7905180|NCT00690274|19452698|P1|NOT COMPLETED|Overall Study||6
7905181|NCT00690274|19452697|P2|COMPLETED|Overall Study||15
7905182|NCT00690274|19452698|P1|COMPLETED|Overall Study||23
7905183|NCT00690274|19452697|P2|STARTED|Overall Study||23
7905184|NCT00690274|19452698|P1|STARTED|Overall Study||29
7905185|NCT00690235|19452708|P2|NOT COMPLETED|Overall Study||4
7905186|NCT00690235|19452709|P1|NOT COMPLETED|Overall Study||5
7905187|NCT00690235|19452708|P2|COMPLETED|Overall Study||12
7905188|NCT00690235|19452709|P1|COMPLETED|Overall Study||12
7905189|NCT00690235|19452708|P2|STARTED|Overall Study||16
7905190|NCT00690235|19452709|P1|STARTED|Overall Study||17
7905191|NCT00690040|19452717|P2|NOT COMPLETED|Overall Study||0
7905192|NCT00690040|19452718|P1|NOT COMPLETED|Overall Study||0
7905193|NCT00690040|19452717|P2|COMPLETED|Overall Study||148
7905194|NCT00690040|19452718|P1|COMPLETED|Overall Study||145
7905195|NCT00690040|19452717|P2|STARTED|Overall Study||148
7905196|NCT00690040|19452718|P1|STARTED|Overall Study||145
7905197|NCT00689936|19452727|P3|NOT COMPLETED|Long-Term Follow Up Phase||144
7905198|NCT00689936|19452728|P2|NOT COMPLETED|Long-Term Follow Up Phase||188
7905199|NCT00689936|19452729|P1|NOT COMPLETED|Long-Term Follow Up Phase||127
7905200|NCT00689936|19452727|P3|COMPLETED|Long-Term Follow Up Phase||315
7905201|NCT00689936|19452728|P2|COMPLETED|Long-Term Follow Up Phase||275
7905202|NCT00689936|19452729|P1|COMPLETED|Long-Term Follow Up Phase||255
7905203|NCT00689936|19452727|P3|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|459
7905204|NCT00689936|19452728|P2|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|463
7905205|NCT00689936|19452729|P1|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|382
7905206|NCT00689936|19452727|P3|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
7905207|NCT00689936|19452728|P2|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
7905208|NCT00689936|19452729|P1|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
7905209|NCT00689936|19452727|P3|COMPLETED|Progression Free Survival-PFS-Follow-Up||273
7905210|NCT00689936|19452728|P2|COMPLETED|Progression Free Survival-PFS-Follow-Up||300
7905211|NCT00689936|19452729|P1|COMPLETED|Progression Free Survival-PFS-Follow-Up||87
7905212|NCT00689936|19452727|P3|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 12 cycles MPT and did not experience progressive disease.|273
7905213|NCT00689936|19452728|P2|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 18 cycles (Rd18) and did not experience progressive disease.|300
7905214|NCT00689936|19452729|P1|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who discontinued treatment for reasons other than progressive disease.|87
7905215|NCT00689936|19452727|P3|NOT COMPLETED|Active Treatment Phase||547
7905216|NCT00689936|19452728|P2|NOT COMPLETED|Active Treatment Phase||541
7905217|NCT00689936|19452729|P1|NOT COMPLETED|Active Treatment Phase||535
7905218|NCT00689936|19452727|P3|COMPLETED|Active Treatment Phase||0
7905219|NCT00689936|19452728|P2|COMPLETED|Active Treatment Phase||0
7905220|NCT00689936|19452729|P1|COMPLETED|Active Treatment Phase||0
7905221|NCT00689936|19452727|P3|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|6
7905222|NCT00689936|19452728|P2|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|1
7905223|NCT00689936|19452729|P1|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|3
7905224|NCT00689936|19452727|P3|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|541
7905225|NCT00689936|19452728|P2|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|540
7905226|NCT00689936|19452729|P1|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|532
7905227|NCT00689936|19452727|P3|STARTED|Active Treatment Phase||547
7905228|NCT00689936|19452728|P2|STARTED|Active Treatment Phase||541
7905229|NCT00689936|19452729|P1|STARTED|Active Treatment Phase||535
7905230|NCT00689884|19452869|P1|NOT COMPLETED|Overall Study||0
7905231|NCT00689884|19452869|P1|COMPLETED|Overall Study||7
7905232|NCT00689884|19452869|P1|STARTED|Overall Study||7
7905233|NCT00689871|19452878|P4|NOT COMPLETED|Overall Study||7
7905234|NCT00689871|19452879|P3|NOT COMPLETED|Overall Study||73
7905235|NCT00689871|19452880|P2|NOT COMPLETED|Overall Study||52
7905236|NCT00689871|19452881|P1|NOT COMPLETED|Overall Study||175
7905237|NCT00689871|19452878|P4|COMPLETED|Overall Study|4 Patients discontinued|8
7905238|NCT00689871|19452879|P3|COMPLETED|Overall Study|28 Patients discontinued|74
7905239|NCT00689871|19452880|P2|COMPLETED|Overall Study|35 Patients discontinued|46
7905240|NCT00689871|19452881|P1|COMPLETED|Overall Study|35 Patients discontinued|280
7905241|NCT00689871|19452878|P4|STARTED|Overall Study|25 Implants|15
7905242|NCT00689871|19452879|P3|STARTED|Overall Study|288 Implants|147
7905243|NCT00689871|19452880|P2|STARTED|Overall Study|127 Implants|98
7905244|NCT00689871|19452881|P1|STARTED|Overall Study|908 Implants|455
7905245|NCT00689819|19452897|P2|NOT COMPLETED|Overall Study||15
7905246|NCT00689819|19452898|P1|NOT COMPLETED|Overall Study||20
7905247|NCT00689819|19452897|P2|COMPLETED|Overall Study||43
7905248|NCT00689819|19452898|P1|COMPLETED|Overall Study||45
7905249|NCT00689819|19452897|P2|STARTED|Overall Study||58
7905250|NCT00689819|19452898|P1|STARTED|Overall Study||65
7905251|NCT00689793|19452908|P2|NOT COMPLETED|Overall Study||5
7905252|NCT00689793|19452909|P1|NOT COMPLETED|Overall Study||4
7905253|NCT00689793|19452908|P2|COMPLETED|Overall Study||71
7905254|NCT00689793|19452909|P1|COMPLETED|Overall Study||74
7905255|NCT00689793|19452908|P2|STARTED|Overall Study||76
7905256|NCT00689793|19452909|P1|STARTED|Overall Study||78
7905257|NCT00689728|19452928|P3|NOT COMPLETED|Optional Follow-Up||6
7905258|NCT00689728|19452929|P2|NOT COMPLETED|Optional Follow-Up||6
7905259|NCT00689728|19452930|P1|NOT COMPLETED|Optional Follow-Up||3
7905260|NCT00689728|19452928|P3|COMPLETED|Optional Follow-Up||4
7905261|NCT00689728|19452929|P2|COMPLETED|Optional Follow-Up||5
7905262|NCT00689728|19452930|P1|COMPLETED|Optional Follow-Up||6
7905263|NCT00689728|19452928|P3|STARTED|Optional Follow-Up|19 participants who completed the rescue period did not enter the optional follow-up period.|10
7905264|NCT00689728|19452929|P2|STARTED|Optional Follow-Up|13 participants who completed the rescue period did not enter the optional follow-up period.|11
7905265|NCT00689728|19452930|P1|STARTED|Optional Follow-Up|21 participants who completed the rescue period did not enter the optional follow-up period.|9
7905266|NCT00689728|19452928|P3|NOT COMPLETED|Rescue||1
7905267|NCT00689728|19452929|P2|NOT COMPLETED|Rescue||2
7905268|NCT00689728|19452930|P1|NOT COMPLETED|Rescue||1
7905269|NCT00689728|19452928|P3|COMPLETED|Rescue||29
7905270|NCT00689728|19452929|P2|COMPLETED|Rescue||24
7905271|NCT00689728|19452930|P1|COMPLETED|Rescue||30
7905272|NCT00689728|19452928|P3|STARTED|Rescue||30
7905273|NCT00689728|19452929|P2|STARTED|Rescue||26
7905274|NCT00689728|19452930|P1|STARTED|Rescue||31
7905275|NCT00689728|19452928|P3|NOT COMPLETED|Double-Blind Treatment||5
7905276|NCT00689728|19452929|P2|NOT COMPLETED|Double-Blind Treatment||4
7905277|NCT00689728|19452930|P1|NOT COMPLETED|Double-Blind Treatment||4
7905278|NCT00689728|19452928|P3|COMPLETED|Double-Blind Treatment||30
7905279|NCT00689728|19452929|P2|COMPLETED|Double-Blind Treatment||26
7905280|NCT00689728|19452930|P1|COMPLETED|Double-Blind Treatment||31
7905281|NCT00689728|19452928|P3|STARTED|Double-Blind Treatment||35
7905282|NCT00689728|19452929|P2|STARTED|Double-Blind Treatment||30
7905283|NCT00689728|19452930|P1|STARTED|Double-Blind Treatment||35
7905284|NCT00689611|19453013|P2|NOT COMPLETED|Overall Study||46
7905285|NCT00689611|19453014|P1|NOT COMPLETED|Overall Study||41
7905286|NCT00689611|19453013|P2|COMPLETED|Overall Study||146
7905287|NCT00689611|19453014|P1|COMPLETED|Overall Study||159
7905288|NCT00689611|19453013|P2|STARTED|Overall Study||192
7905289|NCT00689611|19453014|P1|STARTED|Overall Study||200
7905290|NCT00689481|19453024|P2|NOT COMPLETED|Overall Study||14
7905291|NCT00689481|19453025|P1|NOT COMPLETED|Overall Study||24
7905292|NCT00689481|19453024|P2|COMPLETED|Overall Study||95
7905293|NCT00689481|19453025|P1|COMPLETED|Overall Study||190
7905294|NCT00689481|19453024|P2|STARTED|Overall Study||109
7905295|NCT00689481|19453025|P1|STARTED|Overall Study||214
7905296|NCT00689390|19453043|P2|NOT COMPLETED|Overall Study||10
7905297|NCT00689390|19453044|P1|NOT COMPLETED|Overall Study||426
7905298|NCT00689390|19453043|P2|COMPLETED|Overall Study||37
7905299|NCT00689390|19453044|P1|COMPLETED|Overall Study||1481
7905300|NCT00689390|19453043|P2|STARTED|Overall Study||47
7905301|NCT00689390|19453044|P1|STARTED|Overall Study||1907
7905302|NCT00689351|19453062|P2|NOT COMPLETED|Toddler Dose||0
7905303|NCT00689351|19453063|P1|NOT COMPLETED|Toddler Dose||0
7905304|NCT00689351|19453062|P2|COMPLETED|Toddler Dose||88
7905305|NCT00689351|19453063|P1|COMPLETED|Toddler Dose||84
7905306|NCT00689351|19453062|P2|STARTED|Toddler Dose||88
7905307|NCT00689351|19453063|P1|STARTED|Toddler Dose||84
7905308|NCT00689351|19453062|P2|NOT COMPLETED|After Infant Series||0
7905309|NCT00689351|19453063|P1|NOT COMPLETED|After Infant Series||1
7905310|NCT00689351|19453062|P2|COMPLETED|After Infant Series||88
7905311|NCT00689351|19453063|P1|COMPLETED|After Infant Series||84
7905312|NCT00689351|19453062|P2|STARTED|After Infant Series||88
7905313|NCT00689351|19453063|P1|STARTED|After Infant Series||85
7905314|NCT00689351|19453062|P2|NOT COMPLETED|Infant Series of Dosing||1
7905315|NCT00689351|19453063|P1|NOT COMPLETED|Infant Series of Dosing||6
7905316|NCT00689351|19453062|P2|COMPLETED|Infant Series of Dosing||88
7905317|NCT00689351|19453063|P1|COMPLETED|Infant Series of Dosing||85
7905318|NCT00689351|19453062|P2|Vaccinated Dose 3|Infant Series of Dosing||88
7905319|NCT00689351|19453063|P1|Vaccinated Dose 3|Infant Series of Dosing||85
7905320|NCT00689351|19453062|P2|Vaccinated Dose 2|Infant Series of Dosing||88
7905321|NCT00689351|19453063|P1|Vaccinated Dose 2|Infant Series of Dosing||86
7905322|NCT00689351|19453062|P2|Vaccinated Dose 1|Infant Series of Dosing||89
7905323|NCT00689351|19453063|P1|Vaccinated Dose 1|Infant Series of Dosing||88
7905324|NCT00689351|19453062|P2|STARTED|Infant Series of Dosing||89
7905325|NCT00689351|19453063|P1|STARTED|Infant Series of Dosing||91
7905326|NCT00689338|19453095|P1|NOT COMPLETED|Overall Study||143
7905327|NCT00689338|19453095|P1|COMPLETED|Overall Study||73
7905328|NCT00689338|19453095|P1|STARTED|Overall Study||216
7905329|NCT00689299|19453108|P3|NOT COMPLETED|Overall Study||5
7905330|NCT00689299|19453109|P2|NOT COMPLETED|Overall Study||3
7905331|NCT00689299|19453110|P1|NOT COMPLETED|Overall Study||7
7905332|NCT00689299|19453108|P3|COMPLETED|Overall Study||49
7905333|NCT00689299|19453109|P2|COMPLETED|Overall Study||54
7905334|NCT00689299|19453110|P1|COMPLETED|Overall Study||51
7905335|NCT00689299|19453108|P3|STARTED|Overall Study||54
7905336|NCT00689299|19453109|P2|STARTED|Overall Study||57
7905337|NCT00689299|19453110|P1|STARTED|Overall Study||58
7905338|NCT00689260|19453120|P2|NOT COMPLETED|Overall Study||0
7905339|NCT00689260|19453121|P1|NOT COMPLETED|Overall Study||2
7905340|NCT00689260|19453120|P2|COMPLETED|Overall Study||21
7905341|NCT00689260|19453121|P1|COMPLETED|Overall Study||19
7905342|NCT00689260|19453120|P2|STARTED|Overall Study||21
7905343|NCT00689260|19453121|P1|STARTED|Overall Study||21
7905344|NCT00689221|19453139|P2|NOT COMPLETED|Overall Study||36
7905345|NCT00689221|19453140|P1|NOT COMPLETED|Overall Study||39
7905346|NCT00689221|19453139|P2|COMPLETED|Overall Study||237
7905347|NCT00689221|19453140|P1|COMPLETED|Overall Study||233
7905348|NCT00689221|19453139|P2|STARTED|Overall Study||273
7905349|NCT00689221|19453140|P1|STARTED|Overall Study||272
7905350|NCT00689117|19453169|P4|NOT COMPLETED|Overall Study||31
7905351|NCT00689117|19453170|P3|NOT COMPLETED|Overall Study||59
7905352|NCT00689117|19453171|P2|NOT COMPLETED|Overall Study||51
7905353|NCT00689117|19453172|P1|NOT COMPLETED|Overall Study||62
7905354|NCT00689117|19453169|P4|COMPLETED|Overall Study||211
7905355|NCT00689117|19453170|P3|COMPLETED|Overall Study||405
7905356|NCT00689117|19453171|P2|COMPLETED|Overall Study||416
7905357|NCT00689117|19453172|P1|COMPLETED|Overall Study||414
7905358|NCT00689117|19453169|P4|STARTED|Overall Study||242
7905359|NCT00689117|19453170|P3|STARTED|Overall Study||464
7905360|NCT00689117|19453171|P2|STARTED|Overall Study||467
7905361|NCT00689117|19453172|P1|STARTED|Overall Study||476
7905362|NCT00689104|19453202|P4|NOT COMPLETED|Overall Study||50
7905363|NCT00689104|19453203|P3|NOT COMPLETED|Overall Study||45
7905364|NCT00689104|19453204|P2|NOT COMPLETED|Overall Study||57
7905365|NCT00689104|19453205|P1|NOT COMPLETED|Overall Study||44
7905366|NCT00689104|19453202|P4|COMPLETED|Overall Study||445
7905367|NCT00689104|19453203|P3|COMPLETED|Overall Study||453
7905368|NCT00689104|19453204|P2|COMPLETED|Overall Study||440
7905369|NCT00689104|19453205|P1|COMPLETED|Overall Study||453
7905370|NCT00689104|19453202|P4|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300
7905371|NCT00689104|19453203|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281
7905372|NCT00689104|19453204|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293
7905373|NCT00689104|19453205|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291
7905374|NCT00689104|19453202|P4|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475
7905375|NCT00689104|19453203|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478
7905376|NCT00689104|19453204|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473
7905377|NCT00689104|19453205|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480
7905378|NCT00689104|19453202|P4|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495
7905379|NCT00689104|19453203|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496
7905380|NCT00689104|19453204|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493
7905381|NCT00689104|19453205|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494
7905382|NCT00689104|19453202|P4|STARTED|Overall Study||495
7905383|NCT00689104|19453203|P3|STARTED|Overall Study||498
7905384|NCT00689104|19453204|P2|STARTED|Overall Study||497
7905385|NCT00689104|19453205|P1|STARTED|Overall Study||497
7905386|NCT00689091|19453337|P2|NOT COMPLETED|Overall Study||1394
7905387|NCT00689091|19453338|P1|NOT COMPLETED|Overall Study||1371
7905388|NCT00689091|19453337|P2|COMPLETED|Overall Study||9376
7905389|NCT00689091|19453338|P1|COMPLETED|Overall Study||9460
7905390|NCT00689091|19453337|P2|STARTED|Overall Study||10770
7905391|NCT00689091|19453338|P1|STARTED|Overall Study||10831
7905392|NCT00689078|19453360|P4|NOT COMPLETED|Overall Study||1
7905393|NCT00689078|19453361|P3|NOT COMPLETED|Overall Study||1
7905394|NCT00689078|19453362|P2|NOT COMPLETED|Overall Study||2
7905395|NCT00689078|19453363|P1|NOT COMPLETED|Overall Study||0
7905396|NCT00689078|19453360|P4|COMPLETED|Overall Study||8
7905397|NCT00689078|19453361|P3|COMPLETED|Overall Study||8
7905398|NCT00689078|19453362|P2|COMPLETED|Overall Study||7
7905399|NCT00689078|19453363|P1|COMPLETED|Overall Study||9
7905400|NCT00689078|19453360|P4|Intent to Treat|Overall Study||8
7905401|NCT00689078|19453361|P3|Intent to Treat|Overall Study||8
7905402|NCT00689078|19453362|P2|Intent to Treat|Overall Study||7
7905403|NCT00689078|19453363|P1|Intent to Treat|Overall Study||9
7905404|NCT00689078|19453360|P4|STARTED|Overall Study||9
7905405|NCT00689078|19453361|P3|STARTED|Overall Study||9
7905406|NCT00689078|19453362|P2|STARTED|Overall Study||9
7905407|NCT00689078|19453363|P1|STARTED|Overall Study||9
7905408|NCT00689052|19453411|P2|NOT COMPLETED|Overall Study||30
7905409|NCT00689052|19453412|P1|NOT COMPLETED|Overall Study||31
7905410|NCT00689052|19453411|P2|COMPLETED|Overall Study||0
7905411|NCT00689052|19453412|P1|COMPLETED|Overall Study||0
7905412|NCT00689052|19453411|P2|STARTED|Overall Study||30
7905413|NCT00689052|19453412|P1|STARTED|Overall Study||31
7905414|NCT00689026|19453444|P2|NOT COMPLETED|Overall Study||6
7905415|NCT00689026|19453445|P1|NOT COMPLETED|Overall Study||13
7905416|NCT00689026|19453444|P2|COMPLETED|Overall Study||24
7905417|NCT00689026|19453445|P1|COMPLETED|Overall Study||17
7905418|NCT00689026|19453444|P2|STARTED|Overall Study||30
7905419|NCT00689026|19453445|P1|STARTED|Overall Study||30
7905420|NCT00688935|19453451|P1|NOT COMPLETED|Overall Study||0
7905421|NCT00688935|19453451|P1|COMPLETED|Overall Study||0
7905422|NCT00688935|19453451|P1|STARTED|Overall Study||0
7905423|NCT00688870|19453458|P2|NOT COMPLETED|Toddler Dose||0
7905424|NCT00688870|19453459|P1|NOT COMPLETED|Toddler Dose||0
7905425|NCT00688870|19453458|P2|COMPLETED|Toddler Dose||84
7905426|NCT00688870|19453459|P1|COMPLETED|Toddler Dose||80
7905427|NCT00688870|19453458|P2|STARTED|Toddler Dose||84
7905428|NCT00688870|19453459|P1|STARTED|Toddler Dose||80
7905429|NCT00688870|19453458|P2|NOT COMPLETED|After Infant Series||0
7905430|NCT00688870|19453459|P1|NOT COMPLETED|After Infant Series||0
7905431|NCT00688870|19453458|P2|COMPLETED|After Infant Series||84
7905432|NCT00688870|19453459|P1|COMPLETED|After Infant Series||80
7905433|NCT00688870|19453458|P2|STARTED|After Infant Series||84
7905434|NCT00688870|19453459|P1|STARTED|After Infant Series||80
7905435|NCT00688870|19453458|P2|NOT COMPLETED|Infant Series||0
7905436|NCT00688870|19453459|P1|NOT COMPLETED|Infant Series||4
7905437|NCT00688870|19453458|P2|COMPLETED|Infant Series||84
7905438|NCT00688870|19453459|P1|COMPLETED|Infant Series||80
7905439|NCT00688870|19453458|P2|Vaccinated Dose 3|Infant Series||84
7905440|NCT00688870|19453459|P1|Vaccinated Dose 3|Infant Series||80
7905441|NCT00688870|19453458|P2|Vaccinated Dose 2|Infant Series||84
7905442|NCT00688870|19453459|P1|Vaccinated Dose 2|Infant Series||80
7905443|NCT00688870|19453458|P2|Vaccinated Dose 1|Infant Series||84
7905444|NCT00688870|19453459|P1|Vaccinated Dose 1|Infant Series||83
7905445|NCT00688870|19453458|P2|STARTED|Infant Series||84
7905446|NCT00688870|19453459|P1|STARTED|Infant Series||84
7905447|NCT00688844|19453491|P1|NOT COMPLETED|Overall Study||10
7905448|NCT00688844|19453491|P1|COMPLETED|Overall Study||48
7905449|NCT00688844|19453491|P1|STARTED|Overall Study||58
7905450|NCT00688753|19453501|P1|NOT COMPLETED|Overall Study||92
7905451|NCT00688753|19453501|P1|COMPLETED|Overall Study||0
7905452|NCT00688753|19453501|P1|STARTED|Overall Study||92
7905453|NCT00688740|19453512|P2|NOT COMPLETED|Overall Study||35
7905454|NCT00688740|19453513|P1|NOT COMPLETED|Overall Study||66
7905455|NCT00688740|19453512|P2|COMPLETED|Overall Study||711
7905456|NCT00688740|19453513|P1|COMPLETED|Overall Study||679
7905457|NCT00688740|19453512|P2|STARTED|Overall Study||746
7905458|NCT00688740|19453513|P1|STARTED|Overall Study||745
7905459|NCT00688701|19453526|P4|NOT COMPLETED|Overall Study||11
7905460|NCT00688701|19453527|P3|NOT COMPLETED|Overall Study||10
7905461|NCT00688701|19453528|P2|NOT COMPLETED|Overall Study||5
7905462|NCT00688701|19453529|P1|NOT COMPLETED|Overall Study||4
7905463|NCT00688701|19453526|P4|COMPLETED|Overall Study||108
7905464|NCT00688701|19453527|P3|COMPLETED|Overall Study||110
7905465|NCT00688701|19453528|P2|COMPLETED|Overall Study||56
7905466|NCT00688701|19453529|P1|COMPLETED|Overall Study||57
7905467|NCT00688701|19453526|P4|Subgroup for Standardized Meal Test|Overall Study||65
7905468|NCT00688701|19453527|P3|Subgroup for Standardized Meal Test|Overall Study||60
7905469|NCT00688701|19453528|P2|Subgroup for Standardized Meal Test|Overall Study||35
7905470|NCT00688701|19453529|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27
7905471|NCT00688701|19453526|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||118
7905472|NCT00688701|19453527|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||120
7905473|NCT00688701|19453528|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||60
7905474|NCT00688701|19453529|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61
7905475|NCT00688701|19453526|P4|Treated/Safety Population|Overall Study||119
7905476|NCT00688701|19453527|P3|Treated/Safety Population|Overall Study||120
7905477|NCT00688701|19453528|P2|Treated/Safety Population|Overall Study||61
7905478|NCT00688701|19453529|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61
7905479|NCT00688701|19453526|P4|STARTED|Overall Study||119
7905480|NCT00688701|19453527|P3|STARTED|Overall Study||120
7905481|NCT00688701|19453528|P2|STARTED|Overall Study||61
7905482|NCT00688701|19453529|P1|STARTED|Overall Study|Randomized|61
7905483|NCT00688688|19453570|P3|NOT COMPLETED|Overall Study||192
7905484|NCT00688688|19453571|P2|NOT COMPLETED|Overall Study||179
7905485|NCT00688688|19453572|P1|NOT COMPLETED|Overall Study||186
7905486|NCT00688688|19453570|P3|COMPLETED|Overall Study||621
7905487|NCT00688688|19453571|P2|COMPLETED|Overall Study||645
7905488|NCT00688688|19453572|P1|COMPLETED|Overall Study||629
7905489|NCT00688688|19453570|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488
7905490|NCT00688688|19453571|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483
7905491|NCT00688688|19453572|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479
7905492|NCT00688688|19453570|P3|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791
7905493|NCT00688688|19453571|P2|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802
7905494|NCT00688688|19453572|P1|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789
7905495|NCT00688688|19453570|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
7905496|NCT00688688|19453571|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820
7905497|NCT00688688|19453572|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
7905498|NCT00688688|19453570|P3|STARTED|Overall Study||813
7905499|NCT00688688|19453571|P2|STARTED|Overall Study||824
7905500|NCT00688688|19453572|P1|STARTED|Overall Study||815
7905501|NCT00688662|19453663|P2|NOT COMPLETED|Overall Study||18
7905502|NCT00688662|19453664|P1|NOT COMPLETED|Overall Study||23
7905503|NCT00688662|19453663|P2|COMPLETED|Overall Study||55
7905504|NCT00688662|19453664|P1|COMPLETED|Overall Study||118
7905505|NCT00688662|19453663|P2|STARTED|Overall Study||73
7905506|NCT00688662|19453664|P1|STARTED|Overall Study||141
7905507|NCT00688636|19453674|P2|NOT COMPLETED|Overall Study||1
7905508|NCT00688636|19453675|P1|NOT COMPLETED|Overall Study||2
7905509|NCT00688636|19453674|P2|COMPLETED|Overall Study||12
7905510|NCT00688636|19453675|P1|COMPLETED|Overall Study||9
7905511|NCT00688636|19453674|P2|STARTED|Overall Study||13
7905512|NCT00688636|19453675|P1|STARTED|Overall Study||11
7905513|NCT00688623|19453689|P1|NOT COMPLETED|Overall Study||55
7905514|NCT00688623|19453689|P1|COMPLETED|Overall Study||18
7905515|NCT00688623|19453689|P1|Per Protocol (PP)|Overall Study|no major protocol deviation and 50% of planned dose of 8 weeks or d/c due to disease progression|60
7905516|NCT00688623|19453689|P1|Safety Analysis Set|Overall Study|received at least one dose of study drug and had at least one post-baseline safety assessment|73
7905517|NCT00688623|19453689|P1|STARTED|Overall Study|Intent to treat (ITT)|73
7905518|NCT00688597|19453703|P3|NOT COMPLETED|Overall Study||0
7905519|NCT00688597|19453704|P2|NOT COMPLETED|Overall Study||0
7905520|NCT00688597|19453705|P1|NOT COMPLETED|Overall Study||3
7905521|NCT00688597|19453703|P3|COMPLETED|Overall Study||0
7905522|NCT00688597|19453704|P2|COMPLETED|Overall Study||0
7905523|NCT00688597|19453705|P1|COMPLETED|Overall Study||0
7905524|NCT00688597|19453703|P3|Received at Least 1 Dose of Study Drug|Overall Study||0
7905525|NCT00688597|19453704|P2|Received at Least 1 Dose of Study Drug|Overall Study||0
7905526|NCT00688597|19453705|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
7905527|NCT00688597|19453703|P3|STARTED|Overall Study||0
7905528|NCT00688597|19453704|P2|STARTED|Overall Study||0
7905529|NCT00688597|19453705|P1|STARTED|Overall Study||3
7905530|NCT00688545|19453718|P2|NOT COMPLETED|Overall Study||15
7905531|NCT00688545|19453719|P1|NOT COMPLETED|Overall Study||5
7905532|NCT00688545|19453718|P2|COMPLETED|Overall Study||204
7905533|NCT00688545|19453719|P1|COMPLETED|Overall Study||50
7905534|NCT00688545|19453718|P2|Switched Treatment at Least Once|Overall Study||13
7905535|NCT00688545|19453719|P1|Switched Treatment at Least Once|Overall Study||6
7905536|NCT00688545|19453718|P2|STARTED|Overall Study||219
7905537|NCT00688545|19453719|P1|STARTED|Overall Study||55
7905538|NCT00688519|19453729|P2|NOT COMPLETED|Overall Study||15
7905539|NCT00688519|19453730|P1|NOT COMPLETED|Overall Study||19
7905540|NCT00688519|19453729|P2|COMPLETED|Overall Study||98
7905541|NCT00688519|19453730|P1|COMPLETED|Overall Study||204
7905542|NCT00688519|19453729|P2|STARTED|Overall Study||113
7905543|NCT00688519|19453730|P1|STARTED|Overall Study||223
7905544|NCT00688467|19453748|P2|NOT COMPLETED|Treatment Period 2||2
7905545|NCT00688467|19453749|P1|NOT COMPLETED|Treatment Period 2||0
7905546|NCT00688467|19453748|P2|COMPLETED|Treatment Period 2||6
7905547|NCT00688467|19453749|P1|COMPLETED|Treatment Period 2||7
7905548|NCT00688467|19453748|P2|STARTED|Treatment Period 2||8
7905549|NCT00688467|19453749|P1|STARTED|Treatment Period 2||7
7905550|NCT00688467|19453748|P2|NOT COMPLETED|Treatment Period 1||2
7905551|NCT00688467|19453749|P1|NOT COMPLETED|Treatment Period 1||2
7905552|NCT00688467|19453748|P2|COMPLETED|Treatment Period 1||8
7905553|NCT00688467|19453749|P1|COMPLETED|Treatment Period 1||7
7905554|NCT00688467|19453748|P2|STARTED|Treatment Period 1||10
7905555|NCT00688467|19453749|P1|STARTED|Treatment Period 1||9
7905556|NCT00688376|19453781|P2|NOT COMPLETED|Blinded Extension Phase||5
7905557|NCT00688376|19453782|P1|NOT COMPLETED|Blinded Extension Phase||5
7905558|NCT00688376|19453781|P2|COMPLETED|Blinded Extension Phase||20
7905559|NCT00688376|19453782|P1|COMPLETED|Blinded Extension Phase||29
7905560|NCT00688376|19453781|P2|STARTED|Blinded Extension Phase||25
7905561|NCT00688376|19453782|P1|STARTED|Blinded Extension Phase||34
7905562|NCT00688376|19453781|P2|NOT COMPLETED|Double-Blind Phase||7
7905563|NCT00688376|19453782|P1|NOT COMPLETED|Double-Blind Phase||6
7905564|NCT00688376|19453781|P2|COMPLETED|Double-Blind Phase||25
7905565|NCT00688376|19453782|P1|COMPLETED|Double-Blind Phase||34
7905566|NCT00688376|19453781|P2|Safety Population|Double-Blind Phase||31
7905567|NCT00688376|19453782|P1|Safety Population|Double-Blind Phase||40
7905568|NCT00688376|19453781|P2|STARTED|Double-Blind Phase||32
7905569|NCT00688376|19453782|P1|STARTED|Double-Blind Phase||40
7905570|NCT00688324|19453796|P1|NOT COMPLETED|Overall Study||8
7905571|NCT00688324|19453796|P1|COMPLETED|Overall Study||28
7905572|NCT00688324|19453796|P1|STARTED|Overall Study||36
7905573|NCT00688259|19453841|P2|NOT COMPLETED|Overall Study||8
7905574|NCT00688259|19453842|P1|NOT COMPLETED|Overall Study||7
7905575|NCT00688259|19453841|P2|COMPLETED|Overall Study||36
7905576|NCT00688259|19453842|P1|COMPLETED|Overall Study||37
7905577|NCT00688259|19453841|P2|End to Active Treatment,|Overall Study||37
7905578|NCT00688259|19453842|P1|End to Active Treatment,|Overall Study||37
7905579|NCT00688259|19453841|P2|STARTED|Overall Study||44
7905580|NCT00688259|19453842|P1|STARTED|Overall Study||44
7905581|NCT00688155|19453862|P4|NOT COMPLETED|Overall Study||1
7905582|NCT00688155|19453863|P3|NOT COMPLETED|Overall Study||1
7905583|NCT00688155|19453864|P2|NOT COMPLETED|Overall Study||2
7905584|NCT00688155|19453865|P1|NOT COMPLETED|Overall Study||2
7905585|NCT00688155|19453862|P4|COMPLETED|Overall Study||17
7905586|NCT00688155|19453863|P3|COMPLETED|Overall Study||18
7905587|NCT00688155|19453864|P2|COMPLETED|Overall Study||16
7905588|NCT00688155|19453865|P1|COMPLETED|Overall Study||16
7905589|NCT00688155|19453862|P4|STARTED|Overall Study||18
7905590|NCT00688155|19453863|P3|STARTED|Overall Study||19
7905591|NCT00688155|19453864|P2|STARTED|Overall Study||18
7905592|NCT00688155|19453865|P1|STARTED|Overall Study||18
7905593|NCT00688103|19453885|P2|NOT COMPLETED|Overall Study||13
7905594|NCT00688103|19453886|P1|NOT COMPLETED|Overall Study||30
7905595|NCT00688103|19453885|P2|COMPLETED|Overall Study||64
7905596|NCT00688103|19453886|P1|COMPLETED|Overall Study||44
7905597|NCT00688103|19453885|P2|Actually Treated|Overall Study||76
7905598|NCT00688103|19453886|P1|Actually Treated|Overall Study||71
7905599|NCT00688103|19453885|P2|STARTED|Overall Study||77
7905600|NCT00688103|19453886|P1|STARTED|Overall Study||74
7905601|NCT00688064|19453898|P2|NOT COMPLETED|Overall Study||26
7905602|NCT00688064|19453899|P1|NOT COMPLETED|Overall Study||21
7905603|NCT00688064|19453898|P2|COMPLETED|Overall Study||201
7905604|NCT00688064|19453899|P1|COMPLETED|Overall Study||211
7905605|NCT00688064|19453898|P2|STARTED|Overall Study||227
7905606|NCT00688064|19453899|P1|STARTED|Overall Study||232
7905607|NCT00687973|19453915|P2|NOT COMPLETED|Overall Study||38
7905608|NCT00687973|19453916|P1|NOT COMPLETED|Overall Study||24
7905609|NCT00687973|19453915|P2|COMPLETED|Overall Study||162
7905610|NCT00687973|19453916|P1|COMPLETED|Overall Study||169
7905611|NCT00687973|19453915|P2|STARTED|Overall Study||200
7905612|NCT00687973|19453916|P1|STARTED|Overall Study||193
7905613|NCT00687908|19453945|P2|NOT COMPLETED|Overall Study||42
7905614|NCT00687908|19453946|P1|NOT COMPLETED|Overall Study||18
7905615|NCT00687908|19453945|P2|COMPLETED|Overall Study||78
7905616|NCT00687908|19453946|P1|COMPLETED|Overall Study||105
7905617|NCT00687908|19453945|P2|STARTED|Overall Study||120
7905618|NCT00687908|19453946|P1|STARTED|Overall Study||123
7905619|NCT00687856|19453960|P1|NOT COMPLETED|Overall Study||0
7905620|NCT00687856|19453960|P1|COMPLETED|Overall Study||211
7905621|NCT00687856|19453960|P1|STARTED|Overall Study||211
7905622|NCT00687830|19453966|P2|NOT COMPLETED|Overall Study||0
7905623|NCT00687830|19453967|P1|NOT COMPLETED|Overall Study||0
7905624|NCT00687830|19453966|P2|COMPLETED|Overall Study||68
7905625|NCT00687830|19453967|P1|COMPLETED|Overall Study||68
7905626|NCT00687830|19453966|P2|STARTED|Overall Study||68
7905627|NCT00687830|19453967|P1|STARTED|Overall Study||68
7905628|NCT00687804|19453978|P3|NOT COMPLETED|Open-Label Extension Study||11
7905629|NCT00687804|19453979|P2|NOT COMPLETED|Open-Label Extension Study||11
7905630|NCT00687804|19453980|P1|NOT COMPLETED|Open-Label Extension Study||10
7905631|NCT00687804|19453978|P3|COMPLETED|Open-Label Extension Study||63
7905632|NCT00687804|19453979|P2|COMPLETED|Open-Label Extension Study||72
7905633|NCT00687804|19453980|P1|COMPLETED|Open-Label Extension Study||73
7905634|NCT00687804|19453978|P3|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15
7905635|NCT00687804|19453979|P2|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21
7905636|NCT00687804|19453980|P1|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16
7905637|NCT00687804|19453978|P3|STARTED|Open-Label Extension Study||74
7905638|NCT00687804|19453979|P2|STARTED|Open-Label Extension Study||83
7905639|NCT00687804|19453980|P1|STARTED|Open-Label Extension Study||83
7905640|NCT00687804|19453978|P3|NOT COMPLETED|Core Study||13
7905641|NCT00687804|19453979|P2|NOT COMPLETED|Core Study||15
7905642|NCT00687804|19453980|P1|NOT COMPLETED|Core Study||14
7905643|NCT00687804|19453978|P3|COMPLETED|Core Study||98
7905644|NCT00687804|19453979|P2|COMPLETED|Core Study||103
7905645|NCT00687804|19453980|P1|COMPLETED|Core Study||102
7905646|NCT00687804|19453978|P3|STARTED|Core Study||111
7905647|NCT00687804|19453979|P2|STARTED|Core Study||118
7905648|NCT00687804|19453980|P1|STARTED|Core Study||116
7905649|NCT00687739|19454027|P4|NOT COMPLETED|Overall Study||2
7905650|NCT00687739|19454028|P3|NOT COMPLETED|Overall Study||2
7905651|NCT00687739|19454029|P2|NOT COMPLETED|Overall Study||3
7905652|NCT00687739|19454030|P1|NOT COMPLETED|Overall Study||2
7905653|NCT00687739|19454027|P4|COMPLETED|Overall Study||12
7905654|NCT00687739|19454028|P3|COMPLETED|Overall Study||23
7905655|NCT00687739|19454029|P2|COMPLETED|Overall Study||12
7905656|NCT00687739|19454030|P1|COMPLETED|Overall Study||23
7905657|NCT00687739|19454027|P4|STARTED|Overall Study||14
7905658|NCT00687739|19454028|P3|STARTED|Overall Study||25
7905659|NCT00687739|19454029|P2|STARTED|Overall Study||15
7905660|NCT00687739|19454030|P1|STARTED|Overall Study||25
7905661|NCT00687713|19454056|P2|NOT COMPLETED|Overall Study||40
7905662|NCT00687713|19454057|P1|NOT COMPLETED|Overall Study||32
7905663|NCT00687713|19454056|P2|COMPLETED|Overall Study||64
7905664|NCT00687713|19454057|P1|COMPLETED|Overall Study||68
7905665|NCT00687713|19454056|P2|STARTED|Overall Study||104
7905666|NCT00687713|19454057|P1|STARTED|Overall Study||100
7905667|NCT00687674|19454065|P1|NOT COMPLETED|Overall Study||2
7905668|NCT00687674|19454065|P1|COMPLETED|Overall Study||11
7905669|NCT00687674|19454065|P1|STARTED|Overall Study||13
7905670|NCT00687609|19454072|P1|NOT COMPLETED|Overall Study||3
7905671|NCT00687609|19454072|P1|COMPLETED|Overall Study||4
7905672|NCT00687609|19454072|P1|STARTED|Overall Study||7
7905673|NCT00687544|19454086|P1|NOT COMPLETED|Overall Study||11
7905674|NCT00687544|19454086|P1|COMPLETED|Overall Study||0
7905675|NCT00687544|19454086|P1|STARTED|Overall Study||11
7905676|NCT00687531|19454095|P1|NOT COMPLETED|Overall Study||135
7905677|NCT00687531|19454095|P1|COMPLETED|Overall Study||250
7905678|NCT00687531|19454095|P1|RECEIVED TREATMENT|Overall Study||281
7905679|NCT00687531|19454095|P1|STARTED|Overall Study|Completed screening procedures|385
7905680|NCT00687453|19454111|P2|NOT COMPLETED|Overall Study||6
7905681|NCT00687453|19454112|P1|NOT COMPLETED|Overall Study||3
7905682|NCT00687453|19454111|P2|COMPLETED|Overall Study||7
7905683|NCT00687453|19454112|P1|COMPLETED|Overall Study||8
7905684|NCT00687453|19454111|P2|STARTED|Overall Study||13
7905685|NCT00687453|19454112|P1|STARTED|Overall Study||11
7905686|NCT00687440|19454118|P1|NOT COMPLETED|Overall Study||12
7905687|NCT00687440|19454118|P1|COMPLETED|Overall Study||15
7905688|NCT00687440|19454118|P1|STARTED|Overall Study|Number of screened participants|27
7905689|NCT00687401|19454122|P1|NOT COMPLETED|Overall Study||30
7905690|NCT00687401|19454122|P1|COMPLETED|Overall Study||129
7905691|NCT00687401|19454122|P1|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159
7905692|NCT00687362|19454127|P1|NOT COMPLETED|Overall Study||3
7905693|NCT00687362|19454127|P1|COMPLETED|Overall Study|Completed protocol at Week 24|19
7905694|NCT00687362|19454127|P1|STARTED|Overall Study||22
7905695|NCT00687323|19454131|P1|NOT COMPLETED|Overall Study||180
7905696|NCT00687323|19454131|P1|COMPLETED|Overall Study|Number of participants alive at one year|15
7905697|NCT00687323|19454131|P1|Received Treatment|Overall Study||47
7905698|NCT00687323|19454131|P1|STARTED|Overall Study|Number of screened participants|195
7905699|NCT00687297|19454147|P2|NOT COMPLETED|Maintenance||1
7905700|NCT00687297|19454148|P1|NOT COMPLETED|Maintenance||3
7905701|NCT00687297|19454147|P2|COMPLETED|Maintenance||25
7905702|NCT00687297|19454148|P1|COMPLETED|Maintenance||29
7905703|NCT00687297|19454147|P2|STARTED|Maintenance||26
7905704|NCT00687297|19454148|P1|STARTED|Maintenance||32
7905705|NCT00687297|19454147|P2|NOT COMPLETED|Induction||55
7905706|NCT00687297|19454148|P1|NOT COMPLETED|Induction||45
7905707|NCT00687297|19454147|P2|COMPLETED|Induction||26
7905708|NCT00687297|19454148|P1|COMPLETED|Induction||32
7905709|NCT00687297|19454147|P2|STARTED|Induction||81
7905710|NCT00687297|19454148|P1|STARTED|Induction||77
7905711|NCT00687297|19454147|P2|NOT COMPLETED|Randomization||1
7905712|NCT00687297|19454148|P1|NOT COMPLETED|Randomization||3
7905713|NCT00687297|19454147|P2|COMPLETED|Randomization||81
7905714|NCT00687297|19454148|P1|COMPLETED|Randomization||77
7905715|NCT00687297|19454147|P2|STARTED|Randomization||82
7905716|NCT00687297|19454148|P1|STARTED|Randomization||80
7905717|NCT00687271|19454162|P4|NOT COMPLETED|Overall Study||0
7905718|NCT00687271|19454163|P3|NOT COMPLETED|Overall Study||5
7905719|NCT00687271|19454164|P2|NOT COMPLETED|Overall Study||6
7905720|NCT00687271|19454165|P1|NOT COMPLETED|Overall Study||3
7905721|NCT00687271|19454162|P4|COMPLETED|Overall Study||48
7905722|NCT00687271|19454163|P3|COMPLETED|Overall Study||91
7905723|NCT00687271|19454164|P2|COMPLETED|Overall Study||90
7905724|NCT00687271|19454165|P1|COMPLETED|Overall Study||91
7905725|NCT00687271|19454162|P4|Treated|Overall Study||48
7905726|NCT00687271|19454163|P3|Treated|Overall Study||96
7905727|NCT00687271|19454164|P2|Treated|Overall Study||95
7905728|NCT00687271|19454165|P1|Treated|Overall Study||94
7905729|NCT00687271|19454162|P4|STARTED|Overall Study||48
7905730|NCT00687271|19454163|P3|STARTED|Overall Study||96
7905731|NCT00687271|19454164|P2|STARTED|Overall Study||96
7905732|NCT00687271|19454165|P1|STARTED|Overall Study||94
7905733|NCT00687219|19454203|P1|NOT COMPLETED|Overall Study||51
7905734|NCT00687219|19454203|P1|COMPLETED|Overall Study||51
7905735|NCT00687219|19454203|P1|STARTED|Overall Study||102
7905736|NCT00687193|19454215|P6|NOT COMPLETED|Overall Study||4
7905737|NCT00687193|19454216|P5|NOT COMPLETED|Overall Study||2
7905738|NCT00687193|19454217|P4|NOT COMPLETED|Overall Study||4
7905739|NCT00687193|19454218|P3|NOT COMPLETED|Overall Study||2
7905740|NCT00687193|19454219|P2|NOT COMPLETED|Overall Study||4
7905741|NCT00687193|19454220|P1|NOT COMPLETED|Overall Study||2
7905742|NCT00687193|19454215|P6|COMPLETED|Overall Study||48
7905743|NCT00687193|19454216|P5|COMPLETED|Overall Study||52
7905744|NCT00687193|19454217|P4|COMPLETED|Overall Study||49
7905745|NCT00687193|19454218|P3|COMPLETED|Overall Study||50
7905746|NCT00687193|19454219|P2|COMPLETED|Overall Study||49
7905747|NCT00687193|19454220|P1|COMPLETED|Overall Study||51
7905748|NCT00687193|19454215|P6|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52
7905749|NCT00687193|19454216|P5|STARTED|Overall Study||54
7905750|NCT00687193|19454217|P4|STARTED|Overall Study||53
7905751|NCT00687193|19454218|P3|STARTED|Overall Study||52
7905752|NCT00687193|19454219|P2|STARTED|Overall Study||53
7905753|NCT00687193|19454220|P1|STARTED|Overall Study||53
7905754|NCT00687167|19454384|P2|NOT COMPLETED|Second Intervention||0
7905755|NCT00687167|19454385|P1|NOT COMPLETED|Second Intervention||0
7905756|NCT00687167|19454384|P2|COMPLETED|Second Intervention||17
7905757|NCT00687167|19454385|P1|COMPLETED|Second Intervention||17
7905758|NCT00687167|19454384|P2|STARTED|Second Intervention||17
7905759|NCT00687167|19454385|P1|STARTED|Second Intervention||17
7905760|NCT00687167|19454384|P2|NOT COMPLETED|Washout Period of 28 Days||0
7905761|NCT00687167|19454385|P1|NOT COMPLETED|Washout Period of 28 Days||0
7905762|NCT00687167|19454384|P2|COMPLETED|Washout Period of 28 Days||17
7905763|NCT00687167|19454385|P1|COMPLETED|Washout Period of 28 Days||17
7905764|NCT00687167|19454384|P2|STARTED|Washout Period of 28 Days||17
7905765|NCT00687167|19454385|P1|STARTED|Washout Period of 28 Days||17
7905766|NCT00687167|19454384|P2|NOT COMPLETED|First Intervention||0
7905767|NCT00687167|19454385|P1|NOT COMPLETED|First Intervention||0
7905768|NCT00687167|19454384|P2|COMPLETED|First Intervention||17
7905769|NCT00687167|19454385|P1|COMPLETED|First Intervention||17
7905770|NCT00687167|19454384|P2|STARTED|First Intervention||17
7905771|NCT00687167|19454385|P1|STARTED|First Intervention||17
7905772|NCT00687102|19454395|P2|NOT COMPLETED|Overall Study||0
7905773|NCT00687102|19454396|P1|NOT COMPLETED|Overall Study||0
7905774|NCT00687102|19454395|P2|COMPLETED|Overall Study||765
7905775|NCT00687102|19454396|P1|COMPLETED|Overall Study||733
7905776|NCT00687102|19454395|P2|STARTED|Overall Study||765
7905777|NCT00687102|19454396|P1|STARTED|Overall Study||733
7905778|NCT00687076|19454418|P2|NOT COMPLETED|Overall Study||30
7905779|NCT00687076|19454419|P1|NOT COMPLETED|Overall Study||32
7905780|NCT00687076|19454418|P2|COMPLETED|Overall Study||21
7905781|NCT00687076|19454419|P1|COMPLETED|Overall Study||19
7905782|NCT00687076|19454418|P2|STARTED|Overall Study||51
7905783|NCT00687076|19454419|P1|STARTED|Overall Study||51
7905784|NCT00686998|19454430|P3|NOT COMPLETED|Overall Study||4
7905785|NCT00686998|19454431|P2|NOT COMPLETED|Overall Study||8
7905786|NCT00686998|19454432|P1|NOT COMPLETED|Overall Study||13
7905787|NCT00686998|19454430|P3|COMPLETED|Overall Study||18
7905788|NCT00686998|19454431|P2|COMPLETED|Overall Study||33
7905789|NCT00686998|19454432|P1|COMPLETED|Overall Study||30
7905790|NCT00686998|19454430|P3|Completed Scheduled Treatment|Overall Study||18
7905791|NCT00686998|19454431|P2|Completed Scheduled Treatment|Overall Study||33
7905792|NCT00686998|19454432|P1|Completed Scheduled Treatment|Overall Study||30
7905793|NCT00686998|19454430|P3|Eligible for Efficacy Analysis|Overall Study||21
7905794|NCT00686998|19454431|P2|Eligible for Efficacy Analysis|Overall Study||39
7905795|NCT00686998|19454432|P1|Eligible for Efficacy Analysis|Overall Study||42
7905796|NCT00686998|19454430|P3|Received Treatment|Overall Study||22
7905797|NCT00686998|19454431|P2|Received Treatment|Overall Study||41
7905798|NCT00686998|19454432|P1|Received Treatment|Overall Study||43
7905799|NCT00686998|19454430|P3|Randomized|Overall Study||22
7905800|NCT00686998|19454431|P2|Randomized|Overall Study||41
7905801|NCT00686998|19454432|P1|Randomized|Overall Study||43
7905802|NCT00686998|19454430|P3|STARTED|Overall Study|Randomized & received study medication|22
7905803|NCT00686998|19454431|P2|STARTED|Overall Study|Randomized & received study medication|41
7905804|NCT00686998|19454432|P1|STARTED|Overall Study|Randomized & received study medication|43
7905805|NCT00686972|19454440|P1|NOT COMPLETED|Overall Study||51
7905806|NCT00686972|19454440|P1|COMPLETED|Overall Study||0
7905807|NCT00686972|19454440|P1|STARTED|Overall Study||51
7905808|NCT00686959|19454446|P2|NOT COMPLETED|Overall Study||117
7905809|NCT00686959|19454447|P1|NOT COMPLETED|Overall Study||124
7905810|NCT00686959|19454446|P2|COMPLETED|Overall Study|Study completion includes death due to any cause.|180
7905811|NCT00686959|19454447|P1|COMPLETED|Overall Study|Study completion includes death due to any cause|177
7905812|NCT00686959|19454446|P2|Entered Consolidation Phase|Overall Study||202
7905813|NCT00686959|19454447|P1|Entered Consolidation Phase|Overall Study||229
7905814|NCT00686959|19454446|P2|Received at Least One Dose of Study Drug|Overall Study||272
7905815|NCT00686959|19454447|P1|Received at Least One Dose of Study Drug|Overall Study||283
7905816|NCT00686959|19454446|P2|STARTED|Overall Study||297
7905817|NCT00686959|19454447|P1|STARTED|Overall Study||301
7905818|NCT00686920|19454467|P2|NOT COMPLETED|Overall Study||36
7905819|NCT00686920|19454468|P1|NOT COMPLETED|Overall Study||132
7905820|NCT00686920|19454467|P2|COMPLETED|Overall Study||34
7905821|NCT00686920|19454468|P1|COMPLETED|Overall Study||120
7905822|NCT00686920|19454467|P2|Received At Least 1 Dose Of Study Drug|Overall Study||70
7905823|NCT00686920|19454468|P1|Received At Least 1 Dose Of Study Drug|Overall Study||252
7905824|NCT00686920|19454467|P2|STARTED|Overall Study||70
7905825|NCT00686920|19454468|P1|STARTED|Overall Study||252
7905826|NCT00686894|19454480|P1|NOT COMPLETED|Overall Study||6
7905827|NCT00686894|19454480|P1|COMPLETED|Overall Study||1
7905828|NCT00686894|19454480|P1|STARTED|Overall Study||7
7905829|NCT00686881|19454486|P2|NOT COMPLETED|Overall Study||81
7905830|NCT00686881|19454487|P1|NOT COMPLETED|Overall Study||82
7905831|NCT00686881|19454486|P2|COMPLETED|Overall Study||53
7905832|NCT00686881|19454487|P1|COMPLETED|Overall Study||45
7905833|NCT00686881|19454486|P2|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134
7905834|NCT00686881|19454487|P1|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127
7905835|NCT00686855|19454499|P2|NOT COMPLETED|Overall Study||1
7905836|NCT00686855|19454500|P1|NOT COMPLETED|Overall Study||1
7905837|NCT00686855|19454499|P2|COMPLETED|Overall Study||17
7905838|NCT00686855|19454500|P1|COMPLETED|Overall Study||27
7905839|NCT00686855|19454499|P2|STARTED|Overall Study||18
7905840|NCT00686855|19454500|P1|STARTED|Overall Study||28
7905841|NCT00686842|19454506|P1|NOT COMPLETED|Overall Study||0
7905842|NCT00686842|19454506|P1|COMPLETED|Overall Study||17
7905843|NCT00686842|19454506|P1|STARTED|Overall Study||17
7905844|NCT00686829|19454510|P1|NOT COMPLETED|Overall Study||79
7905845|NCT00686829|19454510|P1|COMPLETED|Overall Study||0
7905846|NCT00686829|19454510|P1|STARTED|Overall Study||79
7905847|NCT00686803|19454527|P3|NOT COMPLETED|Overall Study||0
7905848|NCT00686803|19454528|P2|NOT COMPLETED|Overall Study||0
7905849|NCT00686803|19454529|P1|NOT COMPLETED|Overall Study||0
7905850|NCT00686803|19454527|P3|COMPLETED|Overall Study||3
7905851|NCT00686803|19454528|P2|COMPLETED|Overall Study||12
7905852|NCT00686803|19454529|P1|COMPLETED|Overall Study||6
7905853|NCT00686803|19454527|P3|STARTED|Overall Study||3
7905854|NCT00686803|19454528|P2|STARTED|Overall Study||12
7905855|NCT00686803|19454529|P1|STARTED|Overall Study||6
7905856|NCT00686790|19454540|P1|NOT COMPLETED|Overall Study||16
7905857|NCT00686790|19454540|P1|COMPLETED|Overall Study||32
7905858|NCT00686790|19454540|P1|STARTED|Overall Study||48
7905859|NCT00686777|19454548|P1|NOT COMPLETED|Overall Study||10
7905860|NCT00686777|19454548|P1|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65
7905861|NCT00686777|19454548|P1|Completed 24 Weeks of Follow-up|Overall Study||70
7905862|NCT00686777|19454548|P1|Included in Follow-up (All Treated)|Overall Study||75
7905863|NCT00686777|19454548|P1|Completed 48 Weeks of Treatment|Overall Study||65
7905864|NCT00686777|19454548|P1|Completed 24 Weeks of Treatment|Overall Study||69
7905865|NCT00686777|19454548|P1|STARTED|Overall Study||75
7905866|NCT00686725|19454556|P2|NOT COMPLETED|Overall Study||42
7905867|NCT00686725|19454557|P1|NOT COMPLETED|Overall Study||46
7905868|NCT00686725|19454556|P2|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10
7905869|NCT00686725|19454557|P1|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1
7905870|NCT00686725|19454556|P2|STARTED|Overall Study||52
7905871|NCT00686725|19454557|P1|STARTED|Overall Study||47
7905872|NCT00686712|19454582|P3|NOT COMPLETED|Overall Study||13
7905873|NCT00686712|19454583|P2|NOT COMPLETED|Overall Study||11
7905874|NCT00686712|19454584|P1|NOT COMPLETED|Overall Study||10
7905875|NCT00686712|19454582|P3|COMPLETED|Overall Study||17
7905876|NCT00686712|19454583|P2|COMPLETED|Overall Study||14
7905877|NCT00686712|19454584|P1|COMPLETED|Overall Study||20
7905878|NCT00686712|19454582|P3|STARTED|Overall Study||30
7905879|NCT00686712|19454583|P2|STARTED|Overall Study||25
7905880|NCT00686712|19454584|P1|STARTED|Overall Study||30
7905881|NCT00686699|19454612|P2|NOT COMPLETED|Treatment Period 2||0
7905882|NCT00686699|19454613|P1|NOT COMPLETED|Treatment Period 2||0
7905883|NCT00686699|19454612|P2|COMPLETED|Treatment Period 2||5
7905884|NCT00686699|19454613|P1|COMPLETED|Treatment Period 2||4
7905885|NCT00686699|19454612|P2|STARTED|Treatment Period 2||5
7905886|NCT00686699|19454613|P1|STARTED|Treatment Period 2||4
7905887|NCT00686699|19454612|P2|NOT COMPLETED|Treatment Period 1||2
7905888|NCT00686699|19454613|P1|NOT COMPLETED|Treatment Period 1||0
7905889|NCT00686699|19454612|P2|COMPLETED|Treatment Period 1||5
7905890|NCT00686699|19454613|P1|COMPLETED|Treatment Period 1||4
7905891|NCT00686699|19454612|P2|STARTED|Treatment Period 1||7
7905892|NCT00686699|19454613|P1|STARTED|Treatment Period 1||4
7905893|NCT00686686|19454637|P1|NOT COMPLETED|Overall Study||6
7905894|NCT00686686|19454637|P1|COMPLETED|Overall Study||17
7905895|NCT00686686|19454637|P1|STARTED|Overall Study||23
7905896|NCT00686647|19454645|P1|NOT COMPLETED|Overall Study||2
7905897|NCT00686647|19454645|P1|COMPLETED|Overall Study||91
7905898|NCT00686647|19454645|P1|STARTED|Overall Study||93
7905899|NCT00686634|19454651|P1|NOT COMPLETED|Overall Study||6
7905900|NCT00686634|19454651|P1|COMPLETED|Overall Study||102
7905901|NCT00686634|19454651|P1|STARTED|Overall Study||108
7905902|NCT00686595|19454658|P1|NOT COMPLETED|Overall Study||7
7905903|NCT00686595|19454658|P1|COMPLETED|Overall Study||31
7905904|NCT00686595|19454658|P1|STARTED|Overall Study||38
7905905|NCT00686582|19454686|P3|NOT COMPLETED|Overall Study||0
7905906|NCT00686582|19454687|P2|NOT COMPLETED|Overall Study||14
7905907|NCT00686582|19454688|P1|NOT COMPLETED|Overall Study||18
7905908|NCT00686582|19454686|P3|COMPLETED|Overall Study||121
7905909|NCT00686582|19454687|P2|COMPLETED|Overall Study||77
7905910|NCT00686582|19454688|P1|COMPLETED|Overall Study||74
7905911|NCT00686582|19454686|P3|Booster Vaccination|Overall Study||0
7905912|NCT00686582|19454687|P2|Booster Vaccination|Overall Study||77
7905913|NCT00686582|19454688|P1|Booster Vaccination|Overall Study||75
7905914|NCT00686582|19454686|P3|STARTED|Overall Study||121
7905915|NCT00686582|19454687|P2|STARTED|Overall Study||91
7905916|NCT00686582|19454688|P1|STARTED|Overall Study||92
7905917|NCT00686543|19454718|P4|NOT COMPLETED|Overall Study||3
7905918|NCT00686543|19454719|P3|NOT COMPLETED|Overall Study||5
7905919|NCT00686543|19454720|P2|NOT COMPLETED|Overall Study||1
7905920|NCT00686543|19454721|P1|NOT COMPLETED|Overall Study||14
7905921|NCT00686543|19454718|P4|COMPLETED|Overall Study||17
7905922|NCT00686543|19454719|P3|COMPLETED|Overall Study||15
7905923|NCT00686543|19454720|P2|COMPLETED|Overall Study||20
7905924|NCT00686543|19454721|P1|COMPLETED|Overall Study||0
7905925|NCT00686543|19454718|P4|STARTED|Overall Study||20
7905926|NCT00686543|19454719|P3|STARTED|Overall Study||20
7905927|NCT00686543|19454720|P2|STARTED|Overall Study||21
7905928|NCT00686543|19454721|P1|STARTED|Overall Study||14
7905929|NCT00686517|19454742|P3|NOT COMPLETED|Follow-up||10
7905930|NCT00686517|19454743|P2|NOT COMPLETED|Follow-up||10
7905931|NCT00686517|19454744|P1|NOT COMPLETED|Follow-up||8
7905932|NCT00686517|19454742|P3|COMPLETED|Follow-up||29
7905933|NCT00686517|19454743|P2|COMPLETED|Follow-up||28
7905934|NCT00686517|19454744|P1|COMPLETED|Follow-up||29
7905935|NCT00686517|19454742|P3|STARTED|Follow-up||39
7905936|NCT00686517|19454743|P2|STARTED|Follow-up||38
7905937|NCT00686517|19454744|P1|STARTED|Follow-up||37
7905938|NCT00686517|19454742|P3|NOT COMPLETED|Treatment||1
7905939|NCT00686517|19454743|P2|NOT COMPLETED|Treatment||3
7905940|NCT00686517|19454744|P1|NOT COMPLETED|Treatment||6
7905941|NCT00686517|19454742|P3|COMPLETED|Treatment||42
7905942|NCT00686517|19454743|P2|COMPLETED|Treatment||40
7905943|NCT00686517|19454744|P1|COMPLETED|Treatment||38
7905944|NCT00686517|19454742|P3|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
7905945|NCT00686517|19454743|P2|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
7905946|NCT00686517|19454744|P1|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44
7905947|NCT00686517|19454742|P3|STARTED|Treatment||43
7905948|NCT00686517|19454743|P2|STARTED|Treatment||43
7905949|NCT00686517|19454744|P1|STARTED|Treatment||44
7905950|NCT00686374|19454767|P1|NOT COMPLETED|Overall Study||61
7905951|NCT00686374|19454767|P1|COMPLETED|Overall Study||39
7905952|NCT00686374|19454767|P1|STARTED|Overall Study||100
7905953|NCT00686335|19454778|P1|NOT COMPLETED|Treatment Period||0
7905954|NCT00686335|19454778|P1|COMPLETED|Treatment Period||7
7905955|NCT00686335|19454778|P1|STARTED|Treatment Period||7
7905956|NCT00686335|19454778|P1|NOT COMPLETED|Run-in Period||5
7905957|NCT00686335|19454778|P1|COMPLETED|Run-in Period||7
7905958|NCT00686335|19454778|P1|STARTED|Run-in Period||12
7905959|NCT00686257|19454786|P2|NOT COMPLETED|Overall Study||0
7905960|NCT00686257|19454787|P1|NOT COMPLETED|Overall Study||0
7905961|NCT00686257|19454786|P2|COMPLETED|Overall Study||31
7905962|NCT00686257|19454787|P1|COMPLETED|Overall Study||29
7905963|NCT00686257|19454786|P2|STARTED|Overall Study||31
7905964|NCT00686257|19454787|P1|STARTED|Overall Study||29
7905965|NCT00686231|19454807|P4|NOT COMPLETED|Combination Test - Visit 2||0
7905966|NCT00686231|19454808|P3|NOT COMPLETED|Combination Test - Visit 2||0
7905967|NCT00686231|19454809|P2|NOT COMPLETED|Combination Test - Visit 2||0
7905968|NCT00686231|19454810|P1|NOT COMPLETED|Combination Test - Visit 2||0
7905969|NCT00686231|19454807|P4|COMPLETED|Combination Test - Visit 2||9
7905970|NCT00686231|19454808|P3|COMPLETED|Combination Test - Visit 2||10
7905971|NCT00686231|19454809|P2|COMPLETED|Combination Test - Visit 2||0
7905972|NCT00686231|19454810|P1|COMPLETED|Combination Test - Visit 2||0
7905973|NCT00686231|19454807|P4|STARTED|Combination Test - Visit 2||9
7905974|NCT00686231|19454808|P3|STARTED|Combination Test - Visit 2||10
7905975|NCT00686231|19454809|P2|STARTED|Combination Test - Visit 2||0
7905976|NCT00686231|19454810|P1|STARTED|Combination Test - Visit 2||0
7905977|NCT00686231|19454807|P4|NOT COMPLETED|Dose Test - Visit 1||0
7905978|NCT00686231|19454808|P3|NOT COMPLETED|Dose Test - Visit 1||0
7905979|NCT00686231|19454809|P2|NOT COMPLETED|Dose Test - Visit 1||0
7905980|NCT00686231|19454810|P1|NOT COMPLETED|Dose Test - Visit 1||0
7905981|NCT00686231|19454807|P4|COMPLETED|Dose Test - Visit 1||0
7905982|NCT00686231|19454808|P3|COMPLETED|Dose Test - Visit 1||0
7905983|NCT00686231|19454809|P2|COMPLETED|Dose Test - Visit 1||7
7905984|NCT00686231|19454810|P1|COMPLETED|Dose Test - Visit 1||12
7905985|NCT00686231|19454807|P4|STARTED|Dose Test - Visit 1||0
7905986|NCT00686231|19454808|P3|STARTED|Dose Test - Visit 1||0
7905987|NCT00686231|19454809|P2|STARTED|Dose Test - Visit 1||7
7905988|NCT00686231|19454810|P1|STARTED|Dose Test - Visit 1||12
7905989|NCT00686205|19454822|P2|NOT COMPLETED|Overall Study||981
7905990|NCT00686205|19454823|P1|NOT COMPLETED|Overall Study||6007
7905991|NCT00686205|19454822|P2|COMPLETED|Overall Study||1524
7905992|NCT00686205|19454823|P1|COMPLETED|Overall Study||15599
7905993|NCT00686205|19454822|P2|STARTED|Overall Study||2505
7905994|NCT00686205|19454823|P1|STARTED|Overall Study||21606
7905995|NCT00686166|19454829|P1|NOT COMPLETED|Overall Study||20
7905996|NCT00686166|19454829|P1|COMPLETED|Overall Study||63
7905997|NCT00686166|19454829|P1|Eligible and Began Protocol Therapy|Overall Study||74
7905998|NCT00686166|19454829|P1|Eligible|Overall Study||78
7905999|NCT00686166|19454829|P1|STARTED|Overall Study||83
7906000|NCT00686127|19454841|P2|NOT COMPLETED|Overall Study||6
7906001|NCT00686127|19454842|P1|NOT COMPLETED|Overall Study||14
7906002|NCT00686127|19454841|P2|COMPLETED|Overall Study||1
7906003|NCT00686127|19454842|P1|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0
7906004|NCT00686127|19454841|P2|STARTED|Overall Study||7
7906005|NCT00686127|19454842|P1|STARTED|Overall Study||14
7906006|NCT00686075|19454858|P10|NOT COMPLETED|Overall Study||10
7906007|NCT00686075|19454859|P9|NOT COMPLETED|Overall Study||6
7906008|NCT00686075|19454860|P8|NOT COMPLETED|Overall Study||2
7906009|NCT00686075|19454861|P7|NOT COMPLETED|Overall Study||0
7906010|NCT00686075|19454862|P6|NOT COMPLETED|Overall Study||3
7906011|NCT00686075|19454863|P5|NOT COMPLETED|Overall Study||4
7906012|NCT00686075|19454864|P4|NOT COMPLETED|Overall Study||9
7906013|NCT00686075|19454865|P3|NOT COMPLETED|Overall Study||6
7906014|NCT00686075|19454866|P2|NOT COMPLETED|Overall Study||10
7906015|NCT00686075|19454867|P1|NOT COMPLETED|Overall Study||8
7906016|NCT00686075|19454858|P10|COMPLETED|Overall Study||69
7906017|NCT00686075|19454859|P9|COMPLETED|Overall Study||75
7906018|NCT00686075|19454860|P8|COMPLETED|Overall Study||76
7906019|NCT00686075|19454861|P7|COMPLETED|Overall Study||82
7906020|NCT00686075|19454862|P6|COMPLETED|Overall Study||37
7906021|NCT00686075|19454863|P5|COMPLETED|Overall Study||36
7906022|NCT00686075|19454864|P4|COMPLETED|Overall Study||71
7906023|NCT00686075|19454865|P3|COMPLETED|Overall Study||74
7906024|NCT00686075|19454866|P2|COMPLETED|Overall Study||71
7906025|NCT00686075|19454867|P1|COMPLETED|Overall Study||71
7906026|NCT00686075|19454858|P10|Treated|Overall Study||78
7906027|NCT00686075|19454859|P9|Treated|Overall Study||80
7906028|NCT00686075|19454860|P8|Treated|Overall Study||77
7906029|NCT00686075|19454861|P7|Treated|Overall Study||82
7906030|NCT00686075|19454862|P6|Treated|Overall Study||40
7906031|NCT00686075|19454863|P5|Treated|Overall Study||40
7906032|NCT00686075|19454864|P4|Treated|Overall Study||80
7906033|NCT00686075|19454865|P3|Treated|Overall Study||80
7906034|NCT00686075|19454866|P2|Treated|Overall Study||79
7906035|NCT00686075|19454867|P1|Treated|Overall Study||78
7906036|NCT00686075|19454858|P10|STARTED|Overall Study||79
7906037|NCT00686075|19454859|P9|STARTED|Overall Study||81
7906038|NCT00686075|19454860|P8|STARTED|Overall Study||78
7906039|NCT00686075|19454861|P7|STARTED|Overall Study||82
7906040|NCT00686075|19454862|P6|STARTED|Overall Study||40
7906041|NCT00686075|19454863|P5|STARTED|Overall Study||40
7906042|NCT00686075|19454864|P4|STARTED|Overall Study||80
7906043|NCT00686075|19454865|P3|STARTED|Overall Study||80
7906044|NCT00686075|19454866|P2|STARTED|Overall Study||81
7906045|NCT00686075|19454867|P1|STARTED|Overall Study||79
7906046|NCT00686036|19455061|P2|NOT COMPLETED|Overall Study||6
7906047|NCT00686036|19455062|P1|NOT COMPLETED|Overall Study||9
7906048|NCT00686036|19455061|P2|COMPLETED|Overall Study||2
7906049|NCT00686036|19455062|P1|COMPLETED|Overall Study||0
7906050|NCT00686036|19455061|P2|STARTED|Overall Study||8
7906051|NCT00686036|19455062|P1|STARTED|Overall Study||9
7906052|NCT00685945|19455074|P1|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0
7906053|NCT00685945|19455074|P1|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12
7906054|NCT00685945|19455074|P1|STARTED|Sildenafil + L-NMMA + Bradykinin||12
7906055|NCT00685945|19455074|P1|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0
7906056|NCT00685945|19455074|P1|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11
7906057|NCT00685945|19455074|P1|STARTED|Isosorbide + L-NMMA + Bradykinin||11
7906058|NCT00685945|19455074|P1|NOT COMPLETED|L-NMMA + Bradykinin||1
7906059|NCT00685945|19455074|P1|COMPLETED|L-NMMA + Bradykinin||23
7906060|NCT00685945|19455074|P1|STARTED|L-NMMA + Bradykinin||24
7906061|NCT00685945|19455074|P1|NOT COMPLETED|Control (Bradykinin Infusion)||0
7906062|NCT00685945|19455074|P1|COMPLETED|Control (Bradykinin Infusion)||24
7906063|NCT00685945|19455074|P1|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24
7906064|NCT00685932|19455091|P2|NOT COMPLETED|Overall Study||20
7906065|NCT00685932|19455092|P1|NOT COMPLETED|Overall Study||21
7906066|NCT00685932|19455091|P2|COMPLETED|Overall Study||58
7906067|NCT00685932|19455092|P1|COMPLETED|Overall Study||55
7906068|NCT00685932|19455091|P2|STARTED|Overall Study||78
7906069|NCT00685932|19455092|P1|STARTED|Overall Study||76
7906070|NCT00685880|19455102|P2|NOT COMPLETED|Overall Study||0
7906071|NCT00685880|19455103|P1|NOT COMPLETED|Overall Study||0
7906072|NCT00685880|19455102|P2|COMPLETED|Overall Study||2
7906073|NCT00685880|19455103|P1|COMPLETED|Overall Study||0
7906074|NCT00685880|19455102|P2|STARTED|Overall Study||2
7906075|NCT00685880|19455103|P1|STARTED|Overall Study||0
7906076|NCT00685802|19455109|P2|NOT COMPLETED|Second Intervention||0
7906077|NCT00685802|19455110|P1|NOT COMPLETED|Second Intervention||0
7906078|NCT00685802|19455109|P2|COMPLETED|Second Intervention||15
7906079|NCT00685802|19455110|P1|COMPLETED|Second Intervention||14
7906080|NCT00685802|19455109|P2|STARTED|Second Intervention||15
7906081|NCT00685802|19455110|P1|STARTED|Second Intervention||14
7906082|NCT00685802|19455109|P2|NOT COMPLETED|Washout Period of 7 Days||1
7906083|NCT00685802|19455110|P1|NOT COMPLETED|Washout Period of 7 Days||2
7906084|NCT00685802|19455109|P2|COMPLETED|Washout Period of 7 Days||15
7906085|NCT00685802|19455110|P1|COMPLETED|Washout Period of 7 Days||14
7906086|NCT00685802|19455109|P2|STARTED|Washout Period of 7 Days||16
7906087|NCT00685802|19455110|P1|STARTED|Washout Period of 7 Days||16
7906088|NCT00685802|19455109|P2|NOT COMPLETED|First Intervention||0
7906089|NCT00685802|19455110|P1|NOT COMPLETED|First Intervention||0
7906090|NCT00685802|19455109|P2|COMPLETED|First Intervention||16
7906091|NCT00685802|19455110|P1|COMPLETED|First Intervention||16
7906092|NCT00685802|19455109|P2|STARTED|First Intervention||16
7906093|NCT00685802|19455110|P1|STARTED|First Intervention||16
7906094|NCT00685763|19455120|P1|NOT COMPLETED|Overall Study||2
7906095|NCT00685763|19455120|P1|COMPLETED|Overall Study||11
7906096|NCT00685763|19455120|P1|STARTED|Overall Study||13
7906097|NCT00685750|19455131|P7|NOT COMPLETED|Overall Study||1
7906098|NCT00685750|19455132|P6|NOT COMPLETED|Overall Study||0
7906099|NCT00685750|19455133|P5|NOT COMPLETED|Overall Study||0
7906100|NCT00685750|19455134|P4|NOT COMPLETED|Overall Study||0
7906101|NCT00685750|19455135|P3|NOT COMPLETED|Overall Study||2
7906102|NCT00685750|19455136|P2|NOT COMPLETED|Overall Study||0
7906103|NCT00685750|19455137|P1|NOT COMPLETED|Overall Study||0
7906104|NCT00685750|19455131|P7|COMPLETED|Overall Study||9
7906105|NCT00685750|19455132|P6|COMPLETED|Overall Study||20
7906106|NCT00685750|19455133|P5|COMPLETED|Overall Study||15
7906107|NCT00685750|19455134|P4|COMPLETED|Overall Study||2
7906108|NCT00685750|19455135|P3|COMPLETED|Overall Study||19
7906109|NCT00685750|19455136|P2|COMPLETED|Overall Study||3
7906110|NCT00685750|19455137|P1|COMPLETED|Overall Study||17
7906111|NCT00685750|19455131|P7|STARTED|Overall Study||10
7906112|NCT00685750|19455132|P6|STARTED|Overall Study||20
7906113|NCT00685750|19455133|P5|STARTED|Overall Study||15
7906114|NCT00685750|19455134|P4|STARTED|Overall Study||2
7906115|NCT00685750|19455135|P3|STARTED|Overall Study||21
7906116|NCT00685750|19455136|P2|STARTED|Overall Study||3
7906117|NCT00685750|19455137|P1|STARTED|Overall Study||17
7906118|NCT00685698|19455165|P1|NOT COMPLETED|Overall Study||13
7906119|NCT00685698|19455165|P1|COMPLETED|Overall Study||25
7906120|NCT00685698|19455165|P1|STARTED|Overall Study||38
7906121|NCT00685685|19455200|P2|NOT COMPLETED|Second Intervention||0
7906122|NCT00685685|19455201|P1|NOT COMPLETED|Second Intervention||0
7906123|NCT00685685|19455200|P2|COMPLETED|Second Intervention||26
7906124|NCT00685685|19455201|P1|COMPLETED|Second Intervention||25
7906125|NCT00685685|19455200|P2|STARTED|Second Intervention||26
7906126|NCT00685685|19455201|P1|STARTED|Second Intervention||25
7906127|NCT00685685|19455200|P2|NOT COMPLETED|Washout Period of 7 Days||1
7906128|NCT00685685|19455201|P1|NOT COMPLETED|Washout Period of 7 Days||2
7906129|NCT00685685|19455200|P2|COMPLETED|Washout Period of 7 Days||26
7906130|NCT00685685|19455201|P1|COMPLETED|Washout Period of 7 Days||25
7906131|NCT00685685|19455200|P2|STARTED|Washout Period of 7 Days||27
7906132|NCT00685685|19455201|P1|STARTED|Washout Period of 7 Days||27
7906133|NCT00685685|19455200|P2|NOT COMPLETED|First Intervention||0
7906134|NCT00685685|19455201|P1|NOT COMPLETED|First Intervention||0
7906135|NCT00685685|19455200|P2|COMPLETED|First Intervention||27
7906136|NCT00685685|19455201|P1|COMPLETED|First Intervention||27
7906137|NCT00685685|19455200|P2|STARTED|First Intervention||27
7906138|NCT00685685|19455201|P1|STARTED|First Intervention||27
7906139|NCT00685659|19455214|P3|NOT COMPLETED|Overall Study||15
7906140|NCT00685659|19455215|P2|NOT COMPLETED|Overall Study||25
7906141|NCT00685659|19455216|P1|NOT COMPLETED|Overall Study||31
7906142|NCT00685659|19455214|P3|COMPLETED|Overall Study||92
7906143|NCT00685659|19455215|P2|COMPLETED|Overall Study||81
7906144|NCT00685659|19455216|P1|COMPLETED|Overall Study||77
7906145|NCT00685659|19455214|P3|STARTED|Overall Study||107
7906146|NCT00685659|19455215|P2|STARTED|Overall Study||106
7906147|NCT00685659|19455216|P1|STARTED|Overall Study||108
7906148|NCT00685516|19455314|P3|NOT COMPLETED|Overall Study||7
7906149|NCT00685516|19455315|P2|NOT COMPLETED|Overall Study||5
7906150|NCT00685516|19455316|P1|NOT COMPLETED|Overall Study||8
7906151|NCT00685516|19455314|P3|COMPLETED|Overall Study||26
7906152|NCT00685516|19455315|P2|COMPLETED|Overall Study||33
7906153|NCT00685516|19455316|P1|COMPLETED|Overall Study||34
7906154|NCT00685516|19455314|P3|STARTED|Overall Study||33
7906155|NCT00685516|19455315|P2|STARTED|Overall Study||38
7906156|NCT00685516|19455316|P1|STARTED|Overall Study||42
7906157|NCT00685477|19455333|P6|NOT COMPLETED|Overall Study||0
7906158|NCT00685477|19455334|P5|NOT COMPLETED|Overall Study||0
7906159|NCT00685477|19455335|P4|NOT COMPLETED|Overall Study||0
7906160|NCT00685477|19455336|P3|NOT COMPLETED|Overall Study||0
7906161|NCT00685477|19455337|P2|NOT COMPLETED|Overall Study||0
7906162|NCT00685477|19455338|P1|NOT COMPLETED|Overall Study||0
7906163|NCT00685477|19455333|P6|COMPLETED|Overall Study||10
7906164|NCT00685477|19455334|P5|COMPLETED|Overall Study||10
7906165|NCT00685477|19455335|P4|COMPLETED|Overall Study||10
7906166|NCT00685477|19455336|P3|COMPLETED|Overall Study||10
7906167|NCT00685477|19455337|P2|COMPLETED|Overall Study||10
7906168|NCT00685477|19455338|P1|COMPLETED|Overall Study||10
7906169|NCT00685477|19455333|P6|STARTED|Overall Study||10
7906170|NCT00685477|19455334|P5|STARTED|Overall Study||10
7906171|NCT00685477|19455335|P4|STARTED|Overall Study||10
7906172|NCT00685477|19455336|P3|STARTED|Overall Study||10
7906173|NCT00685477|19455337|P2|STARTED|Overall Study||10
7906174|NCT00685477|19455338|P1|STARTED|Overall Study||10
7906175|NCT00685399|19455354|P8|NOT COMPLETED|Extension||0
7906176|NCT00685399|19455355|P7|NOT COMPLETED|Extension||0
7906177|NCT00685399|19455356|P6|NOT COMPLETED|Extension||0
7906178|NCT00685399|19455357|P5|NOT COMPLETED|Extension||0
7906179|NCT00685399|19455358|P4|NOT COMPLETED|Extension||7
7906180|NCT00685399|19455359|P3|NOT COMPLETED|Extension||0
7906181|NCT00685399|19455360|P2|NOT COMPLETED|Extension||0
7906182|NCT00685399|19455361|P1|NOT COMPLETED|Extension||0
7906183|NCT00685399|19455354|P8|COMPLETED|Extension||0
7906184|NCT00685399|19455355|P7|COMPLETED|Extension||0
7906185|NCT00685399|19455356|P6|COMPLETED|Extension||0
7906186|NCT00685399|19455357|P5|COMPLETED|Extension||0
7906187|NCT00685399|19455358|P4|COMPLETED|Extension||21
7906188|NCT00685399|19455359|P3|COMPLETED|Extension||0
7906189|NCT00685399|19455360|P2|COMPLETED|Extension||0
7906190|NCT00685399|19455361|P1|COMPLETED|Extension||0
7906191|NCT00685399|19455354|P8|STARTED|Extension||0
7906192|NCT00685399|19455355|P7|STARTED|Extension||0
7906193|NCT00685399|19455356|P6|STARTED|Extension||0
7906194|NCT00685399|19455357|P5|STARTED|Extension||0
7906195|NCT00685399|19455358|P4|STARTED|Extension||28
7906196|NCT00685399|19455359|P3|STARTED|Extension||0
7906197|NCT00685399|19455360|P2|STARTED|Extension||0
7906198|NCT00685399|19455361|P1|STARTED|Extension||0
7906199|NCT00685399|19455354|P8|NOT COMPLETED|Treatment Period 2||2
7906200|NCT00685399|19455355|P7|NOT COMPLETED|Treatment Period 2||0
7906201|NCT00685399|19455356|P6|NOT COMPLETED|Treatment Period 2||2
7906202|NCT00685399|19455357|P5|NOT COMPLETED|Treatment Period 2||0
7906203|NCT00685399|19455358|P4|NOT COMPLETED|Treatment Period 2||0
7906204|NCT00685399|19455359|P3|NOT COMPLETED|Treatment Period 2||3
7906205|NCT00685399|19455360|P2|NOT COMPLETED|Treatment Period 2||12
7906206|NCT00685399|19455361|P1|NOT COMPLETED|Treatment Period 2||0
7906207|NCT00685399|19455354|P8|COMPLETED|Treatment Period 2||10
7906208|NCT00685399|19455355|P7|COMPLETED|Treatment Period 2||13
7906209|NCT00685399|19455356|P6|COMPLETED|Treatment Period 2||10
7906210|NCT00685399|19455357|P5|COMPLETED|Treatment Period 2||4
7906211|NCT00685399|19455358|P4|COMPLETED|Treatment Period 2|in extension period only|0
7906212|NCT00685399|19455359|P3|COMPLETED|Treatment Period 2||2
7906213|NCT00685399|19455360|P2|COMPLETED|Treatment Period 2||2
7906214|NCT00685399|19455361|P1|COMPLETED|Treatment Period 2||0
7906215|NCT00685399|19455354|P8|STARTED|Treatment Period 2||12
7906216|NCT00685399|19455355|P7|STARTED|Treatment Period 2||13
7906217|NCT00685399|19455356|P6|STARTED|Treatment Period 2||12
7906218|NCT00685399|19455357|P5|STARTED|Treatment Period 2||4
7906219|NCT00685399|19455358|P4|STARTED|Treatment Period 2|in extension period only|0
7906220|NCT00685399|19455359|P3|STARTED|Treatment Period 2||5
7906221|NCT00685399|19455360|P2|STARTED|Treatment Period 2||14
7906222|NCT00685399|19455361|P1|STARTED|Treatment Period 2||0
7906223|NCT00685399|19455354|P8|NOT COMPLETED|Treatment Period 1||0
7906224|NCT00685399|19455355|P7|NOT COMPLETED|Treatment Period 1||0
7906225|NCT00685399|19455356|P6|NOT COMPLETED|Treatment Period 1||0
7906226|NCT00685399|19455357|P5|NOT COMPLETED|Treatment Period 1||0
7906227|NCT00685399|19455358|P4|NOT COMPLETED|Treatment Period 1||0
7906228|NCT00685399|19455359|P3|NOT COMPLETED|Treatment Period 1||0
7906229|NCT00685399|19455360|P2|NOT COMPLETED|Treatment Period 1||0
7906230|NCT00685399|19455361|P1|NOT COMPLETED|Treatment Period 1||6
7906231|NCT00685399|19455354|P8|COMPLETED|Treatment Period 1||0
7906232|NCT00685399|19455355|P7|COMPLETED|Treatment Period 1||0
7906233|NCT00685399|19455356|P6|COMPLETED|Treatment Period 1||0
7906234|NCT00685399|19455357|P5|COMPLETED|Treatment Period 1||0
7906235|NCT00685399|19455358|P4|COMPLETED|Treatment Period 1||0
7906236|NCT00685399|19455359|P3|COMPLETED|Treatment Period 1||0
7906237|NCT00685399|19455360|P2|COMPLETED|Treatment Period 1||0
7906238|NCT00685399|19455361|P1|COMPLETED|Treatment Period 1||10
7906239|NCT00685399|19455354|P8|STARTED|Treatment Period 1||0
7906240|NCT00685399|19455355|P7|STARTED|Treatment Period 1||0
7906241|NCT00685399|19455356|P6|STARTED|Treatment Period 1||0
7906242|NCT00685399|19455357|P5|STARTED|Treatment Period 1||0
7906243|NCT00685399|19455358|P4|STARTED|Treatment Period 1||0
7906244|NCT00685399|19455359|P3|STARTED|Treatment Period 1||0
7906245|NCT00685399|19455360|P2|STARTED|Treatment Period 1||0
7906246|NCT00685399|19455361|P1|STARTED|Treatment Period 1||16
7906247|NCT00685373|19455394|P1|NOT COMPLETED|Overall Study||15
7906248|NCT00685373|19455394|P1|COMPLETED|Overall Study||151
7906249|NCT00685373|19455394|P1|STARTED|Overall Study||166
7906250|NCT00685334|19455403|P2|NOT COMPLETED|Overall Study||7
7906251|NCT00685334|19455404|P1|NOT COMPLETED|Overall Study||10
7906252|NCT00685334|19455403|P2|COMPLETED|Overall Study||3
7906253|NCT00685334|19455404|P1|COMPLETED|Overall Study||2
7906254|NCT00685334|19455403|P2|STARTED|Overall Study||10
7906255|NCT00685334|19455404|P1|STARTED|Overall Study||12
7906256|NCT00685295|19455414|P2|NOT COMPLETED|Overall Study||0
7906257|NCT00685295|19455415|P1|NOT COMPLETED|Overall Study||0
7906258|NCT00685295|19455414|P2|COMPLETED|Overall Study||30
7906259|NCT00685295|19455415|P1|COMPLETED|Overall Study||30
7906260|NCT00685295|19455414|P2|STARTED|Overall Study||30
7906261|NCT00685295|19455415|P1|STARTED|Overall Study||30
7906262|NCT00685178|19455429|P4|NOT COMPLETED|Overall Study||14
7906263|NCT00685178|19455430|P3|NOT COMPLETED|Overall Study||12
7906264|NCT00685178|19455431|P2|NOT COMPLETED|Overall Study||19
7906265|NCT00685178|19455432|P1|NOT COMPLETED|Overall Study||13
7906266|NCT00685178|19455429|P4|COMPLETED|Overall Study||33
7906267|NCT00685178|19455430|P3|COMPLETED|Overall Study||27
7906268|NCT00685178|19455431|P2|COMPLETED|Overall Study||26
7906269|NCT00685178|19455432|P1|COMPLETED|Overall Study||27
7906270|NCT00685178|19455429|P4|STARTED|Overall Study||47
7906271|NCT00685178|19455430|P3|STARTED|Overall Study||39
7906272|NCT00685178|19455431|P2|STARTED|Overall Study||45
7906273|NCT00685178|19455432|P1|STARTED|Overall Study||40
7906274|NCT00685165|19455446|P2|NOT COMPLETED|Second Intervention||0
7906275|NCT00685165|19455447|P1|NOT COMPLETED|Second Intervention||0
7906276|NCT00685165|19455446|P2|COMPLETED|Second Intervention||11
7906277|NCT00685165|19455447|P1|COMPLETED|Second Intervention||10
7906278|NCT00685165|19455446|P2|STARTED|Second Intervention||11
7906279|NCT00685165|19455447|P1|STARTED|Second Intervention||10
7906280|NCT00685165|19455446|P2|NOT COMPLETED|Washout Period of 14 Days||0
7906281|NCT00685165|19455447|P1|NOT COMPLETED|Washout Period of 14 Days||1
7906282|NCT00685165|19455446|P2|COMPLETED|Washout Period of 14 Days||11
7906283|NCT00685165|19455447|P1|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10
7906284|NCT00685165|19455446|P2|STARTED|Washout Period of 14 Days||11
7906285|NCT00685165|19455447|P1|STARTED|Washout Period of 14 Days||11
7906286|NCT00685165|19455446|P2|NOT COMPLETED|First Intervention||0
7906287|NCT00685165|19455447|P1|NOT COMPLETED|First Intervention||0
7906288|NCT00685165|19455446|P2|COMPLETED|First Intervention||11
7906289|NCT00685165|19455447|P1|COMPLETED|First Intervention||11
7906290|NCT00685165|19455446|P2|STARTED|First Intervention||11
7906291|NCT00685165|19455447|P1|STARTED|First Intervention||11
7906292|NCT00685139|19455457|P2|NOT COMPLETED|Second Intervention||0
7906293|NCT00685139|19455458|P1|NOT COMPLETED|Second Intervention||0
7906294|NCT00685139|19455457|P2|COMPLETED|Second Intervention||17
7906295|NCT00685139|19455458|P1|COMPLETED|Second Intervention||17
7906296|NCT00685139|19455457|P2|STARTED|Second Intervention||17
7906297|NCT00685139|19455458|P1|STARTED|Second Intervention||17
7906298|NCT00685139|19455457|P2|NOT COMPLETED|Washout Period of 28 Days||0
7906299|NCT00685139|19455458|P1|NOT COMPLETED|Washout Period of 28 Days||0
7906300|NCT00685139|19455457|P2|COMPLETED|Washout Period of 28 Days||17
7906301|NCT00685139|19455458|P1|COMPLETED|Washout Period of 28 Days||17
7906302|NCT00685139|19455457|P2|STARTED|Washout Period of 28 Days||17
7906303|NCT00685139|19455458|P1|STARTED|Washout Period of 28 Days||17
7906304|NCT00685139|19455457|P2|NOT COMPLETED|First Intervention||0
7906305|NCT00685139|19455458|P1|NOT COMPLETED|First Intervention||0
7906306|NCT00685139|19455457|P2|COMPLETED|First Intervention||17
7906307|NCT00685139|19455458|P1|COMPLETED|First Intervention||17
7906308|NCT00685139|19455457|P2|STARTED|First Intervention||17
7906309|NCT00685139|19455458|P1|STARTED|First Intervention||17
7906310|NCT00685035|19455466|P2|NOT COMPLETED|Period 3: 2nd Intervention||0
7906311|NCT00685035|19455467|P1|NOT COMPLETED|Period 3: 2nd Intervention||0
7906312|NCT00685035|19455466|P2|COMPLETED|Period 3: 2nd Intervention||8
7906313|NCT00685035|19455467|P1|COMPLETED|Period 3: 2nd Intervention||8
7906314|NCT00685035|19455466|P2|STARTED|Period 3: 2nd Intervention||8
7906315|NCT00685035|19455467|P1|STARTED|Period 3: 2nd Intervention||8
7906316|NCT00685035|19455466|P2|NOT COMPLETED|Period 2: 2-day Washout||0
7906317|NCT00685035|19455467|P1|NOT COMPLETED|Period 2: 2-day Washout||0
7906318|NCT00685035|19455466|P2|COMPLETED|Period 2: 2-day Washout||8
7906319|NCT00685035|19455467|P1|COMPLETED|Period 2: 2-day Washout||8
7906320|NCT00685035|19455466|P2|STARTED|Period 2: 2-day Washout||8
7906321|NCT00685035|19455467|P1|STARTED|Period 2: 2-day Washout||8
7906322|NCT00685035|19455466|P2|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0
7906323|NCT00685035|19455467|P1|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1
7906324|NCT00685035|19455466|P2|COMPLETED|Period 1: First Intervention: 30 Minutes||8
7906325|NCT00685035|19455467|P1|COMPLETED|Period 1: First Intervention: 30 Minutes||8
7906326|NCT00685035|19455466|P2|STARTED|Period 1: First Intervention: 30 Minutes||8
7906327|NCT00685035|19455467|P1|STARTED|Period 1: First Intervention: 30 Minutes||9
7906328|NCT00684996|19455491|P1|NOT COMPLETED|Overall Study||5
7906329|NCT00684996|19455491|P1|COMPLETED|Overall Study||0
7906330|NCT00684996|19455491|P1|Eligible|Overall Study||5
7906331|NCT00684996|19455491|P1|STARTED|Overall Study||5
7906332|NCT00684983|19455506|P2|NOT COMPLETED|Overall Study||0
7906333|NCT00684983|19455507|P1|NOT COMPLETED|Overall Study||0
7906334|NCT00684983|19455506|P2|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45
7906335|NCT00684983|19455507|P1|COMPLETED|Overall Study||19
7906336|NCT00684983|19455506|P2|STARTED|Overall Study||45
7906337|NCT00684983|19455507|P1|STARTED|Overall Study||19
7906338|NCT00684814|19455523|P2|NOT COMPLETED|Second Intervention||0
7906339|NCT00684814|19455524|P1|NOT COMPLETED|Second Intervention||1
7906340|NCT00684814|19455523|P2|COMPLETED|Second Intervention||15
7906341|NCT00684814|19455524|P1|COMPLETED|Second Intervention||16
7906342|NCT00684814|19455523|P2|STARTED|Second Intervention||15
7906343|NCT00684814|19455524|P1|STARTED|Second Intervention||17
7906344|NCT00684814|19455523|P2|NOT COMPLETED|Washout Period of 7 Days||4
7906345|NCT00684814|19455524|P1|NOT COMPLETED|Washout Period of 7 Days||2
7906346|NCT00684814|19455523|P2|COMPLETED|Washout Period of 7 Days||15
7906347|NCT00684814|19455524|P1|COMPLETED|Washout Period of 7 Days||17
7906348|NCT00684814|19455523|P2|STARTED|Washout Period of 7 Days||19
7906349|NCT00684814|19455524|P1|STARTED|Washout Period of 7 Days||19
7906350|NCT00684814|19455523|P2|NOT COMPLETED|First Intervention||0
7906351|NCT00684814|19455524|P1|NOT COMPLETED|First Intervention||0
7906352|NCT00684814|19455523|P2|COMPLETED|First Intervention||19
7906353|NCT00684814|19455524|P1|COMPLETED|First Intervention||19
7906354|NCT00684814|19455523|P2|STARTED|First Intervention||19
7906355|NCT00684814|19455524|P1|STARTED|First Intervention||19
7906356|NCT00684788|19455536|P2|NOT COMPLETED|Overall Study||0
7906357|NCT00684788|19455537|P1|NOT COMPLETED|Overall Study||0
7906358|NCT00684788|19455536|P2|COMPLETED|Overall Study||18
7906359|NCT00684788|19455537|P1|COMPLETED|Overall Study||17
7906360|NCT00684788|19455536|P2|STARTED|Overall Study||18
7906361|NCT00684788|19455537|P1|STARTED|Overall Study||17
7906362|NCT00684775|19455557|P2|NOT COMPLETED|Overall Study||0
7906363|NCT00684775|19455558|P1|NOT COMPLETED|Overall Study||0
7906364|NCT00684775|19455557|P2|COMPLETED|Overall Study||19
7906365|NCT00684775|19455558|P1|COMPLETED|Overall Study||19
7906366|NCT00684775|19455557|P2|STARTED|Overall Study||19
7906367|NCT00684775|19455558|P1|STARTED|Overall Study||19
7906368|NCT00684762|19455576|P2|NOT COMPLETED|Second Intervention||0
7906369|NCT00684762|19455577|P1|NOT COMPLETED|Second Intervention||0
7906370|NCT00684762|19455576|P2|COMPLETED|Second Intervention||14
7906371|NCT00684762|19455577|P1|COMPLETED|Second Intervention||14
7906372|NCT00684762|19455576|P2|STARTED|Second Intervention||14
7906373|NCT00684762|19455577|P1|STARTED|Second Intervention||14
7906374|NCT00684762|19455576|P2|NOT COMPLETED|Washout Period of 7 Days||2
7906375|NCT00684762|19455577|P1|NOT COMPLETED|Washout Period of 7 Days||2
7906376|NCT00684762|19455576|P2|COMPLETED|Washout Period of 7 Days||14
7906377|NCT00684762|19455577|P1|COMPLETED|Washout Period of 7 Days||14
7906378|NCT00684762|19455576|P2|STARTED|Washout Period of 7 Days||16
7906379|NCT00684762|19455577|P1|STARTED|Washout Period of 7 Days||16
7906380|NCT00684762|19455576|P2|NOT COMPLETED|First Intervention||0
7906381|NCT00684762|19455577|P1|NOT COMPLETED|First Intervention||0
7906382|NCT00684762|19455576|P2|COMPLETED|First Intervention||16
7906383|NCT00684762|19455577|P1|COMPLETED|First Intervention||16
7906384|NCT00684762|19455576|P2|STARTED|First Intervention||16
7906385|NCT00684762|19455577|P1|STARTED|First Intervention||16
7906386|NCT00684749|19455587|P1|NOT COMPLETED|Overall Study||0
7906387|NCT00684749|19455587|P1|COMPLETED|Overall Study||142
7906388|NCT00684749|19455587|P1|STARTED|Overall Study||142
7906389|NCT00684723|19455591|P2|NOT COMPLETED|Second Intervention||0
7906390|NCT00684723|19455592|P1|NOT COMPLETED|Second Intervention||0
7906391|NCT00684723|19455591|P2|COMPLETED|Second Intervention||27
7906392|NCT00684723|19455592|P1|COMPLETED|Second Intervention||27
7906393|NCT00684723|19455591|P2|STARTED|Second Intervention||27
7906394|NCT00684723|19455592|P1|STARTED|Second Intervention||27
7906395|NCT00684723|19455591|P2|NOT COMPLETED|Washout Period of 7 Days||0
7906396|NCT00684723|19455592|P1|NOT COMPLETED|Washout Period of 7 Days||0
7906397|NCT00684723|19455591|P2|COMPLETED|Washout Period of 7 Days||27
7906398|NCT00684723|19455592|P1|COMPLETED|Washout Period of 7 Days||27
7906399|NCT00684723|19455591|P2|STARTED|Washout Period of 7 Days||27
7906400|NCT00684723|19455592|P1|STARTED|Washout Period of 7 Days||27
7906401|NCT00684723|19455591|P2|NOT COMPLETED|First Intervention||0
7906402|NCT00684723|19455592|P1|NOT COMPLETED|First Intervention||0
7906403|NCT00684723|19455591|P2|COMPLETED|First Intervention||27
7906404|NCT00684723|19455592|P1|COMPLETED|First Intervention||27
7906405|NCT00684723|19455591|P2|STARTED|First Intervention||27
7906406|NCT00684723|19455592|P1|STARTED|First Intervention||27
7906407|NCT00684671|19455605|P3|NOT COMPLETED|Overall Study||0
7906408|NCT00684671|19455606|P2|NOT COMPLETED|Overall Study||0
7906409|NCT00684671|19455607|P1|NOT COMPLETED|Overall Study||3
7906410|NCT00684671|19455605|P3|COMPLETED|Overall Study||164
7906411|NCT00684671|19455606|P2|COMPLETED|Overall Study||170
7906412|NCT00684671|19455607|P1|COMPLETED|Overall Study||169
7906413|NCT00684671|19455605|P3|STARTED|Overall Study||164
7906414|NCT00684671|19455606|P2|STARTED|Overall Study||170
7906415|NCT00684671|19455607|P1|STARTED|Overall Study||172
7906416|NCT00684645|19455636|P1|NOT COMPLETED|Overall Study||114
7906417|NCT00684645|19455636|P1|COMPLETED|Overall Study||72
7906418|NCT00684645|19455636|P1|STARTED|Overall Study||186
7906419|NCT00684593|19455656|P2|NOT COMPLETED|Overall Study||2
7906420|NCT00684593|19455657|P1|NOT COMPLETED|Overall Study||0
7906421|NCT00684593|19455656|P2|COMPLETED|Overall Study||8
7906422|NCT00684593|19455657|P1|COMPLETED|Overall Study||21
7906423|NCT00684593|19455656|P2|STARTED|Overall Study||10
7906424|NCT00684593|19455657|P1|STARTED|Overall Study||21
7906425|NCT00684567|19455669|P1|NOT COMPLETED|Monotherapy Period||14
7906426|NCT00684567|19455669|P1|COMPLETED|Monotherapy Period||9
7906427|NCT00684567|19455669|P1|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23
7906428|NCT00684567|19455669|P1|NOT COMPLETED|Concomitant Radiotherapy Period||2
7906429|NCT00684567|19455669|P1|COMPLETED|Concomitant Radiotherapy Period||28
7906430|NCT00684567|19455669|P1|STARTED|Concomitant Radiotherapy Period||30
7906431|NCT00684554|19455679|P2|NOT COMPLETED|Overall Study||0
7906432|NCT00684554|19455680|P1|NOT COMPLETED|Overall Study||0
7906433|NCT00684554|19455679|P2|COMPLETED|Overall Study||10
7906434|NCT00684554|19455680|P1|COMPLETED|Overall Study||10
7906435|NCT00684554|19455679|P2|STARTED|Overall Study||10
7906436|NCT00684554|19455680|P1|STARTED|Overall Study||10
7906437|NCT00684541|19455690|P2|NOT COMPLETED|Overall Study||3
7906438|NCT00684541|19455691|P1|NOT COMPLETED|Overall Study||3
7906439|NCT00684541|19455690|P2|COMPLETED|Overall Study||23
7906440|NCT00684541|19455691|P1|COMPLETED|Overall Study||20
7906441|NCT00684541|19455690|P2|STARTED|Overall Study||26
7906442|NCT00684541|19455691|P1|STARTED|Overall Study||23
7906443|NCT00684515|19455702|P3|NOT COMPLETED|Overall Study||1
7906444|NCT00684515|19455703|P2|NOT COMPLETED|Overall Study||3
7906445|NCT00684515|19455704|P1|NOT COMPLETED|Overall Study||4
7906446|NCT00684515|19455702|P3|COMPLETED|Overall Study||27
7906447|NCT00684515|19455703|P2|COMPLETED|Overall Study||26
7906448|NCT00684515|19455704|P1|COMPLETED|Overall Study||29
7906449|NCT00684515|19455702|P3|STARTED|Overall Study||28
7906450|NCT00684515|19455703|P2|STARTED|Overall Study||29
7906451|NCT00684515|19455704|P1|STARTED|Overall Study||33
7906452|NCT00684424|19455727|P1|NOT COMPLETED|Overall Study||5
7906453|NCT00684424|19455727|P1|COMPLETED|Overall Study||194
7906454|NCT00684424|19455727|P1|STARTED|Overall Study||199
7906455|NCT00684411|19455742|P1|NOT COMPLETED|Overall Study||12
7906456|NCT00684411|19455742|P1|COMPLETED|Overall Study||0
7906457|NCT00684411|19455742|P1|Disease Evaluable|Overall Study||11
7906458|NCT00684411|19455742|P1|STARTED|Overall Study||12
7906459|NCT00684320|19455750|P2|NOT COMPLETED|Overall Study||0
7906460|NCT00684320|19455751|P1|NOT COMPLETED|Overall Study||4
7906461|NCT00684320|19455750|P2|COMPLETED|Overall Study||22
7906462|NCT00684320|19455751|P1|COMPLETED|Overall Study||22
7906463|NCT00684320|19455750|P2|STARTED|Overall Study||22
7906464|NCT00684320|19455751|P1|STARTED|Overall Study||26
7906465|NCT00684307|19455764|P5|NOT COMPLETED|Overall Study||25
7906466|NCT00684307|19455765|P4|NOT COMPLETED|Overall Study||32
7906467|NCT00684307|19455766|P3|NOT COMPLETED|Overall Study||28
7906468|NCT00684307|19455767|P2|NOT COMPLETED|Overall Study||22
7906469|NCT00684307|19455768|P1|NOT COMPLETED|Overall Study||24
7906470|NCT00684307|19455764|P5|COMPLETED|Overall Study||293
7906471|NCT00684307|19455765|P4|COMPLETED|Overall Study||128
7906472|NCT00684307|19455766|P3|COMPLETED|Overall Study||128
7906473|NCT00684307|19455767|P2|COMPLETED|Overall Study||129
7906474|NCT00684307|19455768|P1|COMPLETED|Overall Study||140
7906475|NCT00684307|19455764|P5|On Treatment Period Completed|Overall Study||293
7906476|NCT00684307|19455765|P4|On Treatment Period Completed|Overall Study||128
7906477|NCT00684307|19455766|P3|On Treatment Period Completed|Overall Study||128
7906478|NCT00684307|19455767|P2|On Treatment Period Completed|Overall Study||129
7906479|NCT00684307|19455768|P1|On Treatment Period Completed|Overall Study|Patients who completed treatment|140
7906480|NCT00684307|19455764|P5|On Treatment Period Started|Overall Study||318
7906481|NCT00684307|19455765|P4|On Treatment Period Started|Overall Study||160
7906482|NCT00684307|19455766|P3|On Treatment Period Started|Overall Study||156
7906483|NCT00684307|19455767|P2|On Treatment Period Started|Overall Study||151
7906484|NCT00684307|19455768|P1|On Treatment Period Started|Overall Study||164
7906485|NCT00684307|19455764|P5|STARTED|Overall Study||318
7906486|NCT00684307|19455765|P4|STARTED|Overall Study||160
7906487|NCT00684307|19455766|P3|STARTED|Overall Study||156
7906488|NCT00684307|19455767|P2|STARTED|Overall Study||151
7906489|NCT00684307|19455768|P1|STARTED|Overall Study|Patients who received treatment|164
7906490|NCT00684255|19455835|P1|NOT COMPLETED|Overall Study||0
7906491|NCT00684255|19455835|P1|COMPLETED|Overall Study||1
7906492|NCT00684255|19455835|P1|STARTED|Overall Study||1
7906493|NCT00684242|19455840|P1|NOT COMPLETED|Overall Study||0
7906494|NCT00684242|19455840|P1|COMPLETED|Overall Study||3
7906495|NCT00684242|19455840|P1|STARTED|Overall Study||3
7906496|NCT00684203|19455850|P6|NOT COMPLETED|Overall Study||0
7906497|NCT00684203|19455851|P5|NOT COMPLETED|Overall Study||0
7906498|NCT00684203|19455852|P4|NOT COMPLETED|Overall Study||0
7906499|NCT00684203|19455853|P3|NOT COMPLETED|Overall Study||9
7906500|NCT00684203|19455854|P2|NOT COMPLETED|Overall Study||8
7906501|NCT00684203|19455855|P1|NOT COMPLETED|Overall Study||9
7906502|NCT00684203|19455850|P6|COMPLETED|Overall Study||2
7906503|NCT00684203|19455851|P5|COMPLETED|Overall Study||17
7906504|NCT00684203|19455852|P4|COMPLETED|Overall Study||6
7906505|NCT00684203|19455853|P3|COMPLETED|Overall Study||12
7906506|NCT00684203|19455854|P2|COMPLETED|Overall Study||23
7906507|NCT00684203|19455855|P1|COMPLETED|Overall Study||31
7906508|NCT00684203|19455850|P6|STARTED|Overall Study||2
7906509|NCT00684203|19455851|P5|STARTED|Overall Study||17
7906510|NCT00684203|19455852|P4|STARTED|Overall Study||6
7906511|NCT00684203|19455853|P3|STARTED|Overall Study||21
7906512|NCT00684203|19455854|P2|STARTED|Overall Study||31
7906513|NCT00684203|19455855|P1|STARTED|Overall Study||40
7906514|NCT00684177|19455916|P2|NOT COMPLETED|Overall Study||23
7906515|NCT00684177|19455917|P1|NOT COMPLETED|Overall Study||21
7906516|NCT00684177|19455916|P2|COMPLETED|Overall Study||141
7906517|NCT00684177|19455917|P1|COMPLETED|Overall Study||322
7906518|NCT00684177|19455916|P2|STARTED|Overall Study||164
7906519|NCT00684177|19455917|P1|STARTED|Overall Study||343
7906520|NCT00684138|19455935|P2|NOT COMPLETED|Overall Study||8
7906521|NCT00684138|19455936|P1|NOT COMPLETED|Overall Study||3
7906522|NCT00684138|19455935|P2|COMPLETED|Overall Study||131
7906523|NCT00684138|19455936|P1|COMPLETED|Overall Study||138
7906524|NCT00684138|19455935|P2|STARTED|Overall Study||139
7906525|NCT00684138|19455936|P1|STARTED|Overall Study||141
7906526|NCT00684073|19455952|P1|NOT COMPLETED|Treatment (Days 1 Through 5)||1
7906527|NCT00684073|19455952|P1|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52
7906528|NCT00684073|19455952|P1|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53
7906529|NCT00684073|19455952|P1|NOT COMPLETED|Selection||7
7906530|NCT00684073|19455952|P1|COMPLETED|Selection|number of subjects who had a Day 1 visit|53
7906531|NCT00684073|19455952|P1|STARTED|Selection||60
7906532|NCT00684060|19455962|P2|NOT COMPLETED|Overall Study||3
7906533|NCT00684060|19455963|P1|NOT COMPLETED|Overall Study||3
7906534|NCT00684060|19455962|P2|COMPLETED|Overall Study||26
7906535|NCT00684060|19455963|P1|COMPLETED|Overall Study||55
7906536|NCT00684060|19455962|P2|STARTED|Overall Study||29
7906537|NCT00684060|19455963|P1|STARTED|Overall Study||58
7906538|NCT00684047|19455986|P3|NOT COMPLETED|Overall Study||5
7906539|NCT00684047|19455987|P2|NOT COMPLETED|Overall Study||16
7906540|NCT00684047|19455988|P1|NOT COMPLETED|Overall Study||13
7906541|NCT00684047|19455986|P3|COMPLETED|Overall Study||52
7906542|NCT00684047|19455987|P2|COMPLETED|Overall Study||94
7906543|NCT00684047|19455988|P1|COMPLETED|Overall Study||59
7906544|NCT00684047|19455986|P3|STARTED|Overall Study||57
7906545|NCT00684047|19455987|P2|STARTED|Overall Study||110
7906546|NCT00684047|19455988|P1|STARTED|Overall Study||72
7906547|NCT00684021|19456002|P4|NOT COMPLETED|Overall Study||2
7906548|NCT00684021|19456003|P3|NOT COMPLETED|Overall Study||2
7906549|NCT00684021|19456004|P2|NOT COMPLETED|Overall Study||2
7906550|NCT00684021|19456005|P1|NOT COMPLETED|Overall Study||2
7906551|NCT00684021|19456002|P4|COMPLETED|Overall Study||15
7906552|NCT00684021|19456003|P3|COMPLETED|Overall Study||34
7906553|NCT00684021|19456004|P2|COMPLETED|Overall Study||22
7906554|NCT00684021|19456005|P1|COMPLETED|Overall Study||41
7906555|NCT00684021|19456002|P4|STARTED|Overall Study||17
7906556|NCT00684021|19456003|P3|STARTED|Overall Study||36
7906557|NCT00684021|19456004|P2|STARTED|Overall Study||24
7906558|NCT00684021|19456005|P1|STARTED|Overall Study||43
7906559|NCT00683930|19456046|P3|NOT COMPLETED|Overall Study||9
7906560|NCT00683930|19456047|P2|NOT COMPLETED|Overall Study||3
7906561|NCT00683930|19456048|P1|NOT COMPLETED|Overall Study||7
7906562|NCT00683930|19456046|P3|COMPLETED|Overall Study||28
7906563|NCT00683930|19456047|P2|COMPLETED|Overall Study||18
7906564|NCT00683930|19456048|P1|COMPLETED|Overall Study||29
7906565|NCT00683930|19456046|P3|STARTED|Overall Study||37
7906566|NCT00683930|19456047|P2|STARTED|Overall Study|One subject not included: no study drug dispensed.|21
7906567|NCT00683930|19456048|P1|STARTED|Overall Study|One subject not included: no study drug dispensed.|36
7906568|NCT00683917|19456066|P1|NOT COMPLETED|Overall Study||10
7906569|NCT00683917|19456066|P1|COMPLETED|Overall Study||0
7906570|NCT00683917|19456066|P1|STARTED|Overall Study||10
7906571|NCT00683904|19456076|P2|NOT COMPLETED|Dose Level 2||2
7906572|NCT00683904|19456077|P1|NOT COMPLETED|Dose Level 2||0
7906573|NCT00683904|19456076|P2|COMPLETED|Dose Level 2||4
7906574|NCT00683904|19456077|P1|COMPLETED|Dose Level 2||0
7906575|NCT00683904|19456076|P2|STARTED|Dose Level 2||6
7906576|NCT00683904|19456077|P1|STARTED|Dose Level 2||0
7906577|NCT00683904|19456076|P2|NOT COMPLETED|Dose Level 1||0
7906578|NCT00683904|19456077|P1|NOT COMPLETED|Dose Level 1||3
7906579|NCT00683904|19456076|P2|COMPLETED|Dose Level 1||0
7906580|NCT00683904|19456077|P1|COMPLETED|Dose Level 1||3
7906581|NCT00683904|19456076|P2|STARTED|Dose Level 1||0
7906582|NCT00683904|19456077|P1|STARTED|Dose Level 1||6
7906583|NCT00683878|19456113|P3|NOT COMPLETED|Overall Study||14
7906584|NCT00683878|19456114|P2|NOT COMPLETED|Overall Study||16
7906585|NCT00683878|19456115|P1|NOT COMPLETED|Overall Study||23
7906586|NCT00683878|19456113|P3|COMPLETED|Overall Study||126
7906587|NCT00683878|19456114|P2|COMPLETED|Overall Study||125
7906588|NCT00683878|19456115|P1|COMPLETED|Overall Study||116
7906589|NCT00683878|19456113|P3|STARTED|Overall Study||140
7906590|NCT00683878|19456114|P2|STARTED|Overall Study||141
7906591|NCT00683878|19456115|P1|STARTED|Overall Study||139
7906592|NCT00683852|19456143|P3|NOT COMPLETED|30-Day Phase 2 Period||9
7906593|NCT00683852|19456144|P2|NOT COMPLETED|30-Day Phase 2 Period||5
7906594|NCT00683852|19456145|P1|NOT COMPLETED|30-Day Phase 2 Period||6
7906595|NCT00683852|19456143|P3|COMPLETED|30-Day Phase 2 Period||75
7906596|NCT00683852|19456144|P2|COMPLETED|30-Day Phase 2 Period||78
7906597|NCT00683852|19456145|P1|COMPLETED|30-Day Phase 2 Period||48
7906598|NCT00683852|19456143|P3|STARTED|30-Day Phase 2 Period||84
7906599|NCT00683852|19456144|P2|STARTED|30-Day Phase 2 Period||83
7906600|NCT00683852|19456145|P1|STARTED|30-Day Phase 2 Period||54
7906601|NCT00683852|19456143|P3|NOT COMPLETED|30-Day Phase 1 Period||1
7906602|NCT00683852|19456144|P2|NOT COMPLETED|30-Day Phase 1 Period||1
7906603|NCT00683852|19456145|P1|NOT COMPLETED|30-Day Phase 1 Period||2
7906604|NCT00683852|19456143|P3|COMPLETED|30-Day Phase 1 Period||84
7906605|NCT00683852|19456144|P2|COMPLETED|30-Day Phase 1 Period||83
7906606|NCT00683852|19456145|P1|COMPLETED|30-Day Phase 1 Period||54
7906607|NCT00683852|19456143|P3|STARTED|30-Day Phase 1 Period||85
7906608|NCT00683852|19456144|P2|STARTED|30-Day Phase 1 Period||84
7906609|NCT00683852|19456145|P1|STARTED|30-Day Phase 1 Period||56
7906610|NCT00683826|19456179|P1|NOT COMPLETED|Overall Study||1
7906611|NCT00683826|19456179|P1|COMPLETED|Overall Study||7
7906612|NCT00683826|19456179|P1|4g Leucine|Overall Study||7
7906613|NCT00683826|19456179|P1|8g Leucine|Overall Study||8
7906614|NCT00683826|19456179|P1|0g Leucine|Overall Study||8
7906615|NCT00683826|19456179|P1|STARTED|Overall Study||8
7906616|NCT00683800|19456189|P2|NOT COMPLETED|Overall Study||366
7906617|NCT00683800|19456190|P1|NOT COMPLETED|Overall Study||432
7906618|NCT00683800|19456189|P2|COMPLETED|Overall Study||719
7906619|NCT00683800|19456190|P1|COMPLETED|Overall Study||669
7906620|NCT00683800|19456189|P2|Treated|Overall Study||1052
7906621|NCT00683800|19456190|P1|Treated|Overall Study||1066
7906622|NCT00683800|19456189|P2|STARTED|Overall Study||1085
7906623|NCT00683800|19456190|P1|STARTED|Overall Study||1101
7906624|NCT00683787|19456257|P3|NOT COMPLETED|Overall Study||2
7906625|NCT00683787|19456258|P2|NOT COMPLETED|Overall Study||3
7906626|NCT00683787|19456259|P1|NOT COMPLETED|Overall Study||3
7906627|NCT00683787|19456257|P3|COMPLETED|Overall Study||0
7906628|NCT00683787|19456258|P2|COMPLETED|Overall Study||0
7906629|NCT00683787|19456259|P1|COMPLETED|Overall Study||0
7906630|NCT00683787|19456257|P3|STARTED|Overall Study||2
7906631|NCT00683787|19456258|P2|STARTED|Overall Study||3
7906632|NCT00683787|19456259|P1|STARTED|Overall Study||3
7906633|NCT00683774|19456278|P2|NOT COMPLETED|Overall Study||1
7906634|NCT00683774|19456279|P1|NOT COMPLETED|Overall Study||3
7906635|NCT00683774|19456278|P2|COMPLETED|Overall Study||9
7906636|NCT00683774|19456279|P1|COMPLETED|Overall Study||8
7906637|NCT00683774|19456278|P2|STARTED|Overall Study||10
7906638|NCT00683774|19456279|P1|STARTED|Overall Study||11
7906639|NCT00683696|19456289|P2|NOT COMPLETED|Overall Study||405
7906640|NCT00683696|19456290|P1|NOT COMPLETED|Overall Study||404
7906641|NCT00683696|19456289|P2|COMPLETED|Overall Study||0
7906642|NCT00683696|19456290|P1|COMPLETED|Overall Study||0
7906643|NCT00683696|19456289|P2|STARTED|Overall Study||405
7906644|NCT00683696|19456290|P1|STARTED|Overall Study||404
7906645|NCT00683657|19456309|P2|NOT COMPLETED|Overall Study||1
7906646|NCT00683657|19456310|P1|NOT COMPLETED|Overall Study||1
7906647|NCT00683657|19456309|P2|COMPLETED|Overall Study||46
7906648|NCT00683657|19456310|P1|COMPLETED|Overall Study||45
7906649|NCT00683657|19456309|P2|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47
7906650|NCT00683657|19456310|P1|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46
7906651|NCT00683657|19456309|P2|STARTED|Overall Study||47
7906652|NCT00683657|19456310|P1|STARTED|Overall Study||46
7906653|NCT00683644|19456326|P2|NOT COMPLETED|Overall Study||14
7906654|NCT00683644|19456327|P1|NOT COMPLETED|Overall Study||13
7906655|NCT00683644|19456326|P2|COMPLETED|Overall Study||44
7906656|NCT00683644|19456327|P1|COMPLETED|Overall Study||45
7906657|NCT00683644|19456326|P2|STARTED|Overall Study||58
7906658|NCT00683644|19456327|P1|STARTED|Overall Study||58
7906659|NCT00683618|19456340|P3|NOT COMPLETED|Extension Treatment Period||0
7906660|NCT00683618|19456341|P2|NOT COMPLETED|Extension Treatment Period||0
7906661|NCT00683618|19456342|P1|NOT COMPLETED|Extension Treatment Period||3
7906662|NCT00683618|19456340|P3|COMPLETED|Extension Treatment Period||0
7906663|NCT00683618|19456341|P2|COMPLETED|Extension Treatment Period||23
7906664|NCT00683618|19456342|P1|COMPLETED|Extension Treatment Period||33
7906665|NCT00683618|19456340|P3|STARTED|Extension Treatment Period||0
7906666|NCT00683618|19456341|P2|STARTED|Extension Treatment Period||23
7906667|NCT00683618|19456342|P1|STARTED|Extension Treatment Period||36
7906668|NCT00683618|19456340|P3|NOT COMPLETED|Randomised Treatment Period||6
7906669|NCT00683618|19456341|P2|NOT COMPLETED|Randomised Treatment Period||2
7906670|NCT00683618|19456342|P1|NOT COMPLETED|Randomised Treatment Period||6
7906671|NCT00683618|19456340|P3|COMPLETED|Randomised Treatment Period||140
7906672|NCT00683618|19456341|P2|COMPLETED|Randomised Treatment Period||143
7906673|NCT00683618|19456342|P1|COMPLETED|Randomised Treatment Period||139
7906674|NCT00683618|19456340|P3|STARTED|Randomised Treatment Period||146
7906675|NCT00683618|19456341|P2|STARTED|Randomised Treatment Period||145
7906676|NCT00683618|19456342|P1|STARTED|Randomised Treatment Period||145
7906677|NCT00683592|19456392|P2|NOT COMPLETED|Overall Study||46
7906678|NCT00683592|19456393|P1|NOT COMPLETED|Overall Study||47
7906679|NCT00683592|19456392|P2|COMPLETED|Overall Study||195
7906680|NCT00683592|19456393|P1|COMPLETED|Overall Study||193
7906681|NCT00683592|19456392|P2|Safety Population|Overall Study||233
7906682|NCT00683592|19456393|P1|Safety Population|Overall Study||235
7906683|NCT00683592|19456392|P2|Intent to Treat Population|Overall Study||232
7906684|NCT00683592|19456393|P1|Intent to Treat Population|Overall Study||231
7906685|NCT00683592|19456392|P2|STARTED|Overall Study||241
7906686|NCT00683592|19456393|P1|STARTED|Overall Study||240
7906687|NCT00683475|19456411|P2|NOT COMPLETED|Overall Study||3
7906688|NCT00683475|19456412|P1|NOT COMPLETED|Overall Study||4
7906689|NCT00683475|19456411|P2|COMPLETED|Overall Study||66
7906690|NCT00683475|19456412|P1|COMPLETED|Overall Study||65
7906691|NCT00683475|19456411|P2|Received Any Quantity of Study Drug|Overall Study||66
7906692|NCT00683475|19456412|P1|Received Any Quantity of Study Drug|Overall Study||66
7906693|NCT00683475|19456411|P2|STARTED|Overall Study||69
7906694|NCT00683475|19456412|P1|STARTED|Overall Study||69
7906695|NCT00683449|19456447|P5|NOT COMPLETED|Overall Study||0
7906696|NCT00683449|19456448|P4|NOT COMPLETED|Overall Study||0
7906697|NCT00683449|19456449|P3|NOT COMPLETED|Overall Study||0
7906698|NCT00683449|19456450|P2|NOT COMPLETED|Overall Study||1
7906699|NCT00683449|19456451|P1|NOT COMPLETED|Overall Study||0
7906700|NCT00683449|19456447|P5|COMPLETED|Overall Study||2
7906701|NCT00683449|19456448|P4|COMPLETED|Overall Study||6
7906702|NCT00683449|19456449|P3|COMPLETED|Overall Study||3
7906703|NCT00683449|19456450|P2|COMPLETED|Overall Study||12
7906704|NCT00683449|19456451|P1|COMPLETED|Overall Study||5
7906705|NCT00683449|19456447|P5|STARTED|Overall Study||2
7906706|NCT00683449|19456448|P4|STARTED|Overall Study||6
7906707|NCT00683449|19456449|P3|STARTED|Overall Study||3
7906708|NCT00683449|19456450|P2|STARTED|Overall Study||13
7906709|NCT00683449|19456451|P1|STARTED|Overall Study||5
7906710|NCT00683410|19456473|P1|NOT COMPLETED|Overall Study||0
7906711|NCT00683410|19456473|P1|COMPLETED|Overall Study||3366
7906712|NCT00683410|19456473|P1|Vaccinated Dose 4|Overall Study||175
7906713|NCT00683410|19456473|P1|Vaccinated Dose 3|Overall Study||817
7906714|NCT00683410|19456473|P1|Vaccinated Dose 2|Overall Study||1623
7906715|NCT00683410|19456473|P1|Vaccinated Dose 1|Overall Study||3240
7906716|NCT00683410|19456473|P1|STARTED|Overall Study||3366
7906717|NCT00683384|19456477|P1|NOT COMPLETED|Overall Study||2
7906718|NCT00683384|19456477|P1|COMPLETED|Overall Study||91
7906719|NCT00683384|19456477|P1|STARTED|Overall Study||93
7906720|NCT00683332|19456481|P1|NOT COMPLETED|Overall Study||0
7906721|NCT00683332|19456481|P1|COMPLETED|Overall Study||621
7906722|NCT00683332|19456481|P1|STARTED|Overall Study||621
7906723|NCT00683293|19456487|P2|NOT COMPLETED|Overall Study||3
7906724|NCT00683293|19456488|P1|NOT COMPLETED|Overall Study||2
7906725|NCT00683293|19456487|P2|COMPLETED|Overall Study||47
7906726|NCT00683293|19456488|P1|COMPLETED|Overall Study||48
7906727|NCT00683293|19456487|P2|STARTED|Overall Study||50
7906728|NCT00683293|19456488|P1|STARTED|Overall Study||50
7906729|NCT00683163|19456498|P2|NOT COMPLETED|Overall Study||0
7906730|NCT00683163|19456499|P1|NOT COMPLETED|Overall Study||0
7906731|NCT00683163|19456498|P2|COMPLETED|Overall Study||22
7906732|NCT00683163|19456499|P1|COMPLETED|Overall Study||22
7906733|NCT00683163|19456498|P2|STARTED|Overall Study||22
7906734|NCT00683163|19456499|P1|STARTED|Overall Study||22
7906735|NCT00683085|19456507|P1|NOT COMPLETED|Overall Study||0
7906736|NCT00683085|19456507|P1|COMPLETED|Overall Study||2
7906737|NCT00683085|19456507|P1|STARTED|Overall Study||2
7906738|NCT00683046|19456512|P1|NOT COMPLETED|Overall Study||0
7906739|NCT00683046|19456512|P1|COMPLETED|Overall Study||204
7906740|NCT00683046|19456512|P1|STARTED|Overall Study||204
7906741|NCT00683020|19456519|P2|NOT COMPLETED|Overall Study||55
7906742|NCT00683020|19456520|P1|NOT COMPLETED|Overall Study||55
7906743|NCT00683020|19456519|P2|COMPLETED|Overall Study||125
7906744|NCT00683020|19456520|P1|COMPLETED|Overall Study||127
7906745|NCT00683020|19456519|P2|STARTED|Overall Study||180
7906746|NCT00683020|19456520|P1|STARTED|Overall Study||182
7906747|NCT00682929|19456551|P3|NOT COMPLETED|Overall Study||2
7906748|NCT00682929|19456552|P2|NOT COMPLETED|Overall Study||5
7906749|NCT00682929|19456553|P1|NOT COMPLETED|Overall Study||6
7906750|NCT00682929|19456551|P3|COMPLETED|Overall Study||12
7906751|NCT00682929|19456552|P2|COMPLETED|Overall Study||9
7906752|NCT00682929|19456553|P1|COMPLETED|Overall Study||7
7906753|NCT00682929|19456551|P3|STARTED|Overall Study||14
7906754|NCT00682929|19456552|P2|STARTED|Overall Study||14
7906755|NCT00682929|19456553|P1|STARTED|Overall Study||13
7906756|NCT00682890|19456722|P2|NOT COMPLETED|Overall Study||2
7906757|NCT00682890|19456723|P1|NOT COMPLETED|Overall Study||2
7906758|NCT00682890|19456722|P2|COMPLETED|Overall Study||9
7906759|NCT00682890|19456723|P1|COMPLETED|Overall Study||10
7906760|NCT00682890|19456722|P2|STARTED|Overall Study||11
7906761|NCT00682890|19456723|P1|STARTED|Overall Study||12
7906762|NCT00682851|19456733|P2|NOT COMPLETED|Overall Study||0
7906763|NCT00682851|19456734|P1|NOT COMPLETED|Overall Study||0
7906764|NCT00682851|19456733|P2|COMPLETED|Overall Study||268
7906765|NCT00682851|19456734|P1|COMPLETED|Overall Study||251
7906766|NCT00682851|19456733|P2|STARTED|Overall Study||268
7906767|NCT00682851|19456734|P1|STARTED|Overall Study||251
7906768|NCT00682838|19456750|P4|NOT COMPLETED|Overall Study||0
7906769|NCT00682838|19456751|P3|NOT COMPLETED|Overall Study||0
7906770|NCT00682838|19456752|P2|NOT COMPLETED|Overall Study||0
7906771|NCT00682838|19456753|P1|NOT COMPLETED|Overall Study||0
7906772|NCT00682838|19456750|P4|COMPLETED|Overall Study||73
7906773|NCT00682838|19456751|P3|COMPLETED|Overall Study||75
7906774|NCT00682838|19456752|P2|COMPLETED|Overall Study||67
7906775|NCT00682838|19456753|P1|COMPLETED|Overall Study||65
7906776|NCT00682838|19456750|P4|STARTED|Overall Study||73
7906777|NCT00682838|19456751|P3|STARTED|Overall Study||75
7906778|NCT00682838|19456752|P2|STARTED|Overall Study||67
7906779|NCT00682838|19456753|P1|STARTED|Overall Study||65
7906780|NCT00682786|19456765|P2|NOT COMPLETED|Overall Study||3
7906781|NCT00682786|19456766|P1|NOT COMPLETED|Overall Study||2
7906782|NCT00682786|19456765|P2|COMPLETED|Overall Study||34
7906783|NCT00682786|19456766|P1|COMPLETED|Overall Study||96
7906784|NCT00682786|19456765|P2|STARTED|Overall Study||37
7906785|NCT00682786|19456766|P1|STARTED|Overall Study||98
7906786|NCT00682734|19456803|P3|NOT COMPLETED|48 Hour Follow-up||11
7906787|NCT00682734|19456804|P2|NOT COMPLETED|48 Hour Follow-up||6
7906788|NCT00682734|19456805|P1|NOT COMPLETED|48 Hour Follow-up||6
7906789|NCT00682734|19456803|P3|COMPLETED|48 Hour Follow-up||106
7906790|NCT00682734|19456804|P2|COMPLETED|48 Hour Follow-up||111
7906791|NCT00682734|19456805|P1|COMPLETED|48 Hour Follow-up||107
7906792|NCT00682734|19456803|P3|STARTED|48 Hour Follow-up||117
7906793|NCT00682734|19456804|P2|STARTED|48 Hour Follow-up||117
7906794|NCT00682734|19456805|P1|STARTED|48 Hour Follow-up||113
7906795|NCT00682734|19456803|P3|NOT COMPLETED|Emergency Department Portion||1
7906796|NCT00682734|19456804|P2|NOT COMPLETED|Emergency Department Portion||1
7906797|NCT00682734|19456805|P1|NOT COMPLETED|Emergency Department Portion||0
7906798|NCT00682734|19456803|P3|COMPLETED|Emergency Department Portion||117
7906799|NCT00682734|19456804|P2|COMPLETED|Emergency Department Portion||117
7906800|NCT00682734|19456805|P1|COMPLETED|Emergency Department Portion||113
7906801|NCT00682734|19456803|P3|STARTED|Emergency Department Portion||118
7906802|NCT00682734|19456804|P2|STARTED|Emergency Department Portion||118
7906803|NCT00682734|19456805|P1|STARTED|Emergency Department Portion||113
7906804|NCT00682643|19456815|P2|NOT COMPLETED|Overall Study||169
7906805|NCT00682643|19456816|P1|NOT COMPLETED|Overall Study||78
7906806|NCT00682643|19456815|P2|COMPLETED|Overall Study||199
7906807|NCT00682643|19456816|P1|COMPLETED|Overall Study||104
7906808|NCT00682643|19456815|P2|STARTED|Overall Study||368
7906809|NCT00682643|19456816|P1|STARTED|Overall Study||182
7906810|NCT00682617|19456850|P2|NOT COMPLETED|Overall Study||7
7906811|NCT00682617|19456851|P1|NOT COMPLETED|Overall Study||3
7906812|NCT00682617|19456850|P2|COMPLETED|Overall Study||21
7906813|NCT00682617|19456851|P1|COMPLETED|Overall Study||10
7906814|NCT00682617|19456850|P2|STARTED|Overall Study||28
7906815|NCT00682617|19456851|P1|STARTED|Overall Study||13
7906816|NCT00682565|19456864|P3|NOT COMPLETED|Overall Study||0
7906817|NCT00682565|19456865|P2|NOT COMPLETED|Overall Study||3
7906818|NCT00682565|19456866|P1|NOT COMPLETED|Overall Study||1
7906819|NCT00682565|19456864|P3|COMPLETED|Overall Study||29
7906820|NCT00682565|19456865|P2|COMPLETED|Overall Study||32
7906821|NCT00682565|19456866|P1|COMPLETED|Overall Study||30
7906822|NCT00682565|19456864|P3|STARTED|Overall Study||29
7906823|NCT00682565|19456865|P2|STARTED|Overall Study||35
7906824|NCT00682565|19456866|P1|STARTED|Overall Study||31
7906825|NCT00682539|19456890|P3|NOT COMPLETED|Ranibizumab vs Triamcinolone||8
7906826|NCT00682539|19456891|P2|NOT COMPLETED|Ranibizumab vs Triamcinolone||3
7906827|NCT00682539|19456892|P1|NOT COMPLETED|Ranibizumab vs Triamcinolone||0
7906828|NCT00682539|19456890|P3|COMPLETED|Ranibizumab vs Triamcinolone||10
7906829|NCT00682539|19456891|P2|COMPLETED|Ranibizumab vs Triamcinolone||15
7906830|NCT00682539|19456892|P1|COMPLETED|Ranibizumab vs Triamcinolone||0
7906831|NCT00682539|19456890|P3|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18
7906832|NCT00682539|19456891|P2|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18
7906833|NCT00682539|19456892|P1|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0
7906834|NCT00682539|19456890|P3|NOT COMPLETED|Bevacizumab vs Triamcinolone||0
7906835|NCT00682539|19456891|P2|NOT COMPLETED|Bevacizumab vs Triamcinolone||1
7906836|NCT00682539|19456892|P1|NOT COMPLETED|Bevacizumab vs Triamcinolone||3
7906837|NCT00682539|19456890|P3|COMPLETED|Bevacizumab vs Triamcinolone||0
7906838|NCT00682539|19456891|P2|COMPLETED|Bevacizumab vs Triamcinolone||15
7906839|NCT00682539|19456892|P1|COMPLETED|Bevacizumab vs Triamcinolone||15
7906840|NCT00682539|19456890|P3|STARTED|Bevacizumab vs Triamcinolone||0
7906841|NCT00682539|19456891|P2|STARTED|Bevacizumab vs Triamcinolone||16
7906842|NCT00682539|19456892|P1|STARTED|Bevacizumab vs Triamcinolone||18
7906843|NCT00682461|19456905|P2|NOT COMPLETED|Overall Study||31
7906844|NCT00682461|19456906|P1|NOT COMPLETED|Overall Study||25
7906845|NCT00682461|19456905|P2|COMPLETED|Overall Study||69
7906846|NCT00682461|19456906|P1|COMPLETED|Overall Study||75
7906847|NCT00682461|19456905|P2|STARTED|Overall Study||100
7906848|NCT00682461|19456906|P1|STARTED|Overall Study||100
7906849|NCT00682435|19456920|P1|NOT COMPLETED|Overall Study||7
7906850|NCT00682435|19456920|P1|COMPLETED|Overall Study||223
7906851|NCT00682435|19456920|P1|Sufficient Data to Carry Out Analysis|Overall Study||223
7906852|NCT00682435|19456920|P1|Ensured Enrolled Only Once|Overall Study||228
7906853|NCT00682435|19456920|P1|STARTED|Overall Study||230
7906854|NCT00682357|19456930|P3|NOT COMPLETED|Overall Study||0
7906855|NCT00682357|19456931|P2|NOT COMPLETED|Overall Study||0
7906856|NCT00682357|19456932|P1|NOT COMPLETED|Overall Study||0
7906857|NCT00682357|19456930|P3|COMPLETED|Overall Study||5
7906858|NCT00682357|19456931|P2|COMPLETED|Overall Study||10
7906859|NCT00682357|19456932|P1|COMPLETED|Overall Study||10
7906860|NCT00682357|19456930|P3|STARTED|Overall Study||5
7906861|NCT00682357|19456931|P2|STARTED|Overall Study||10
7906862|NCT00682357|19456932|P1|STARTED|Overall Study||10
7906863|NCT00681889|19456949|P1|NOT COMPLETED|Overall Study||0
7906864|NCT00681889|19456949|P1|COMPLETED|Overall Study||9
7906865|NCT00681889|19456949|P1|STARTED|Overall Study||9
7906866|NCT00681863|19456953|P1|NOT COMPLETED|Overall Study||23
7906867|NCT00681863|19456953|P1|COMPLETED|Overall Study||22
7906868|NCT00681863|19456953|P1|STARTED|Overall Study||45
7906869|NCT00681824|19457001|P3|NOT COMPLETED|Overall Study||1
7906870|NCT00681824|19457002|P2|NOT COMPLETED|Overall Study||1
7906871|NCT00681824|19457003|P1|NOT COMPLETED|Overall Study||1
7906872|NCT00681824|19457001|P3|COMPLETED|Overall Study||33
7906873|NCT00681824|19457002|P2|COMPLETED|Overall Study||12
7906874|NCT00681824|19457003|P1|COMPLETED|Overall Study||27
7906875|NCT00681824|19457001|P3|STARTED|Overall Study||34
7906876|NCT00681824|19457002|P2|STARTED|Overall Study||13
7906877|NCT00681824|19457003|P1|STARTED|Overall Study||28
7906878|NCT00681811|19457021|P2|NOT COMPLETED|Overall Study||4
7906879|NCT00681811|19457022|P1|NOT COMPLETED|Overall Study||3
7906880|NCT00681811|19457021|P2|COMPLETED|Overall Study||1
7906881|NCT00681811|19457022|P1|COMPLETED|Overall Study||3
7906882|NCT00681811|19457021|P2|STARTED|Overall Study||5
7906883|NCT00681811|19457022|P1|STARTED|Overall Study||6
7906884|NCT00681668|19457050|P1|NOT COMPLETED|Overall Study||2
7906885|NCT00681668|19457050|P1|COMPLETED|Overall Study||3
7906886|NCT00681668|19457050|P1|STARTED|Overall Study||5
7906887|NCT00681629|19457059|P2|NOT COMPLETED|Overall Study||2
7906888|NCT00681629|19457060|P1|NOT COMPLETED|Overall Study||5
7906889|NCT00681629|19457059|P2|COMPLETED|Overall Study||0
7906890|NCT00681629|19457060|P1|COMPLETED|Overall Study||0
7906891|NCT00681629|19457059|P2|STARTED|Overall Study|It was planned to recruit 100 patient|2
7906892|NCT00681629|19457060|P1|STARTED|Overall Study|It was planned to recruit 100 patient|5
7906893|NCT00681590|19457106|P2|NOT COMPLETED|Overall Study||12
7906894|NCT00681590|19457107|P1|NOT COMPLETED|Overall Study||2
7906895|NCT00681590|19457106|P2|COMPLETED|Overall Study||59
7906896|NCT00681590|19457107|P1|COMPLETED|Overall Study||32
7906897|NCT00681590|19457106|P2|STARTED|Overall Study||71
7906898|NCT00681590|19457107|P1|STARTED|Overall Study||34
7906899|NCT00681564|19457117|P2|NOT COMPLETED|Overall Study||8
7906900|NCT00681564|19457118|P1|NOT COMPLETED|Overall Study||6
7906901|NCT00681564|19457117|P2|COMPLETED|Overall Study||47
7906902|NCT00681564|19457118|P1|COMPLETED|Overall Study||41
7906903|NCT00681564|19457117|P2|STARTED|Overall Study||55
7906904|NCT00681564|19457118|P1|STARTED|Overall Study||47
7906905|NCT00681538|19457148|P2|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2
7906906|NCT00681538|19457149|P1|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15
7906907|NCT00681538|19457148|P2|COMPLETED|Phase B- Responders;12 Week Double-blind||115
7906908|NCT00681538|19457149|P1|COMPLETED|Phase B- Responders;12 Week Double-blind||109
7906909|NCT00681538|19457148|P2|STARTED|Phase B- Responders;12 Week Double-blind||117
7906910|NCT00681538|19457149|P1|STARTED|Phase B- Responders;12 Week Double-blind||124
7906911|NCT00681538|19457148|P2|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0
7906912|NCT00681538|19457149|P1|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34
7906913|NCT00681538|19457148|P2|COMPLETED|Phase A- 4 Weeks Single Blind||0
7906914|NCT00681538|19457149|P1|COMPLETED|Phase A- 4 Weeks Single Blind||538
7906915|NCT00681538|19457148|P2|STARTED|Phase A- 4 Weeks Single Blind||0
7906916|NCT00681538|19457149|P1|STARTED|Phase A- 4 Weeks Single Blind||572
7906917|NCT00681473|19457179|P1|NOT COMPLETED|Overall Study||0
7906918|NCT00681473|19457179|P1|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20
7906919|NCT00681473|19457179|P1|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20
7906920|NCT00681291|19457187|P2|NOT COMPLETED|Overall Study||27
7906921|NCT00681291|19457188|P1|NOT COMPLETED|Overall Study||13
7906922|NCT00681291|19457187|P2|COMPLETED|Overall Study||57
7906923|NCT00681291|19457188|P1|COMPLETED|Overall Study||75
7906924|NCT00681291|19457187|P2|STARTED|Overall Study||84
7906925|NCT00681291|19457188|P1|STARTED|Overall Study||88
7906926|NCT00681265|19457200|P1|NOT COMPLETED|Overall Study||0
7906927|NCT00681265|19457200|P1|COMPLETED|Overall Study||16
7906928|NCT00681265|19457200|P1|STARTED|Overall Study||16
7906929|NCT00681187|19457210|P2|NOT COMPLETED|Overall Study||2
7906930|NCT00681187|19457211|P1|NOT COMPLETED|Overall Study||1
7906931|NCT00681187|19457210|P2|COMPLETED|Overall Study||13
7906932|NCT00681187|19457211|P1|COMPLETED|Overall Study||10
7906933|NCT00681187|19457210|P2|STARTED|Overall Study||15
7906934|NCT00681187|19457211|P1|STARTED|Overall Study||11
7906935|NCT00681109|19457246|P3|NOT COMPLETED|Overall Study||0
7906936|NCT00681109|19457247|P2|NOT COMPLETED|Overall Study||6
7906937|NCT00681109|19457248|P1|NOT COMPLETED|Overall Study||2
7906938|NCT00681109|19457246|P3|COMPLETED|Overall Study||15
7906939|NCT00681109|19457247|P2|COMPLETED|Overall Study||24
7906940|NCT00681109|19457248|P1|COMPLETED|Overall Study||28
7906941|NCT00681109|19457246|P3|STARTED|Overall Study||15
7906942|NCT00681109|19457247|P2|STARTED|Overall Study||30
7906943|NCT00681109|19457248|P1|STARTED|Overall Study||30
7906944|NCT00681083|19457265|P2|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
7906945|NCT00681083|19457266|P1|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
7906946|NCT00681083|19457265|P2|COMPLETED|Night 2 (Crossover of Night 1)||10
7906947|NCT00681083|19457266|P1|COMPLETED|Night 2 (Crossover of Night 1)||10
7906948|NCT00681083|19457265|P2|STARTED|Night 2 (Crossover of Night 1)||10
7906949|NCT00681083|19457266|P1|STARTED|Night 2 (Crossover of Night 1)||10
7906950|NCT00681083|19457265|P2|NOT COMPLETED|Night 1||3
7906951|NCT00681083|19457266|P1|NOT COMPLETED|Night 1||3
7906952|NCT00681083|19457265|P2|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
7906953|NCT00681083|19457266|P1|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
7906954|NCT00681083|19457265|P2|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
7906955|NCT00681083|19457266|P1|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
7906956|NCT00681044|19457274|P1|NOT COMPLETED|Overall Study||0
7906957|NCT00681044|19457274|P1|COMPLETED|Overall Study||4
7906958|NCT00681044|19457274|P1|STARTED|Overall Study||4
7906959|NCT00681031|19457282|P1|NOT COMPLETED|Overall Study||0
7906960|NCT00681031|19457282|P1|COMPLETED|Overall Study||96
7906961|NCT00681031|19457282|P1|STARTED|Overall Study||96
7906962|NCT00680992|19457289|P3|NOT COMPLETED|Overall Study||12
7906963|NCT00680992|19457290|P2|NOT COMPLETED|Overall Study||252
7906964|NCT00680992|19457291|P1|NOT COMPLETED|Overall Study||268
7906965|NCT00680992|19457289|P3|COMPLETED|Overall Study||0
7906966|NCT00680992|19457290|P2|COMPLETED|Overall Study||0
7906967|NCT00680992|19457291|P1|COMPLETED|Overall Study||0
7906968|NCT00680992|19457289|P3|Efficacy Analysis Set|Overall Study||11
7906969|NCT00680992|19457290|P2|Efficacy Analysis Set|Overall Study||242
7906970|NCT00680992|19457291|P1|Efficacy Analysis Set|Overall Study||260
7906971|NCT00680992|19457289|P3|Safety Analysis Set|Overall Study||12
7906972|NCT00680992|19457290|P2|Safety Analysis Set|Overall Study||249
7906973|NCT00680992|19457291|P1|Safety Analysis Set|Overall Study||265
7906974|NCT00680992|19457289|P3|STARTED|Overall Study||12
7906975|NCT00680992|19457290|P2|STARTED|Overall Study||252
7906976|NCT00680992|19457291|P1|STARTED|Overall Study||268
7906977|NCT00680953|19457307|P3|NOT COMPLETED|Overall Study||47
7906978|NCT00680953|19457308|P2|NOT COMPLETED|Overall Study||95
7906979|NCT00680953|19457309|P1|NOT COMPLETED|Overall Study||86
7906980|NCT00680953|19457307|P3|COMPLETED|Overall Study||204
7906981|NCT00680953|19457308|P2|COMPLETED|Overall Study||416
7906982|NCT00680953|19457309|P1|COMPLETED|Overall Study||414
7906983|NCT00680953|19457307|P3|STARTED|Overall Study||251
7906984|NCT00680953|19457308|P2|STARTED|Overall Study||511
7906985|NCT00680953|19457309|P1|STARTED|Overall Study||500
7906986|NCT00680914|19457325|P2|NOT COMPLETED|Overall Study||4
7906987|NCT00680914|19457326|P1|NOT COMPLETED|Overall Study||10
7906988|NCT00680914|19457325|P2|COMPLETED|Overall Study||125
7906989|NCT00680914|19457326|P1|COMPLETED|Overall Study||364
7906990|NCT00680914|19457325|P2|STARTED|Overall Study||129
7906991|NCT00680914|19457326|P1|STARTED|Overall Study||374
7906992|NCT00680901|19457360|P2|NOT COMPLETED|Overall Study||76
7906993|NCT00680901|19457361|P1|NOT COMPLETED|Overall Study||73
7906994|NCT00680901|19457360|P2|COMPLETED|Overall Study||197
7906995|NCT00680901|19457361|P1|COMPLETED|Overall Study||199
7906996|NCT00680901|19457360|P2|Ongoing: In Follow Up|Overall Study||41
7906997|NCT00680901|19457361|P1|Ongoing: In Follow Up|Overall Study||45
7906998|NCT00680901|19457360|P2|Ongoing: On Study Treatment|Overall Study||13
7906999|NCT00680901|19457361|P1|Ongoing: On Study Treatment|Overall Study||16
7907000|NCT00680901|19457360|P2|STARTED|Overall Study||273
7907001|NCT00680901|19457361|P1|STARTED|Overall Study||272
7907002|NCT00680862|19457393|P1|NOT COMPLETED|Overall Study||0
7907003|NCT00680862|19457393|P1|COMPLETED|Overall Study||25
7907004|NCT00680862|19457393|P1|STARTED|Overall Study||25
7907005|NCT00680836|19457399|P2|NOT COMPLETED|Overall Study||2
7907006|NCT00680836|19457400|P1|NOT COMPLETED|Overall Study||8
7907007|NCT00680836|19457399|P2|COMPLETED|Overall Study||25
7907008|NCT00680836|19457400|P1|COMPLETED|Overall Study||19
7907009|NCT00680836|19457399|P2|STARTED|Overall Study||27
7907010|NCT00680836|19457400|P1|STARTED|Overall Study||27
7907011|NCT00680823|19457419|P3|NOT COMPLETED|Overall Study||0
7907012|NCT00680823|19457420|P2|NOT COMPLETED|Overall Study||0
7907013|NCT00680823|19457421|P1|NOT COMPLETED|Overall Study||0
7907014|NCT00680823|19457419|P3|COMPLETED|Overall Study||50
7907015|NCT00680823|19457420|P2|COMPLETED|Overall Study||50
7907016|NCT00680823|19457421|P1|COMPLETED|Overall Study||50
7907017|NCT00680823|19457419|P3|STARTED|Overall Study||50
7907018|NCT00680823|19457420|P2|STARTED|Overall Study||50
7907019|NCT00680823|19457421|P1|STARTED|Overall Study||50
7907020|NCT00680797|19457439|P4|NOT COMPLETED|Overall Study||0
7907021|NCT00680797|19457440|P3|NOT COMPLETED|Overall Study||0
7907022|NCT00680797|19457441|P2|NOT COMPLETED|Overall Study||0
7907023|NCT00680797|19457442|P1|NOT COMPLETED|Overall Study||0
7907024|NCT00680797|19457439|P4|COMPLETED|Overall Study||8
7907025|NCT00680797|19457440|P3|COMPLETED|Overall Study||8
7907026|NCT00680797|19457441|P2|COMPLETED|Overall Study||8
7907027|NCT00680797|19457442|P1|COMPLETED|Overall Study||9
7907028|NCT00680797|19457439|P4|STARTED|Overall Study||8
7907029|NCT00680797|19457440|P3|STARTED|Overall Study||8
7907030|NCT00680797|19457441|P2|STARTED|Overall Study||8
7907031|NCT00680797|19457442|P1|STARTED|Overall Study||9
7907032|NCT00680771|19457454|P2|NOT COMPLETED|Overall Study||2
7907033|NCT00680771|19457455|P1|NOT COMPLETED|Overall Study||6
7907034|NCT00680771|19457454|P2|COMPLETED|Overall Study||11
7907035|NCT00680771|19457455|P1|COMPLETED|Overall Study||9
7907036|NCT00680771|19457454|P2|STARTED|Overall Study||13
7907037|NCT00680771|19457455|P1|STARTED|Overall Study||15
7907038|NCT00680745|19457465|P4|NOT COMPLETED|Overall Study||13
7907039|NCT00680745|19457466|P3|NOT COMPLETED|Overall Study||10
7907040|NCT00680745|19457467|P2|NOT COMPLETED|Overall Study||13
7907041|NCT00680745|19457468|P1|NOT COMPLETED|Overall Study||14
7907042|NCT00680745|19457465|P4|COMPLETED|Overall Study||133
7907043|NCT00680745|19457466|P3|COMPLETED|Overall Study||141
7907044|NCT00680745|19457467|P2|COMPLETED|Overall Study||132
7907045|NCT00680745|19457468|P1|COMPLETED|Overall Study||140
7907046|NCT00680745|19457465|P4|STARTED|Overall Study|Safety Analysis Set|146
7907047|NCT00680745|19457466|P3|STARTED|Overall Study|Safety Analysis Set|151
7907048|NCT00680745|19457467|P2|STARTED|Overall Study|Safety Analysis Set|145
7907049|NCT00680745|19457468|P1|STARTED|Overall Study|Safety Analysis Set|154
7907050|NCT00680706|19457500|P2|NOT COMPLETED|Overall Study||5
7907051|NCT00680706|19457501|P1|NOT COMPLETED|Overall Study||7
7907052|NCT00680706|19457500|P2|COMPLETED|Overall Study||55
7907053|NCT00680706|19457501|P1|COMPLETED|Overall Study||63
7907054|NCT00680706|19457500|P2|STARTED|Overall Study||60
7907055|NCT00680706|19457501|P1|STARTED|Overall Study||70
7907056|NCT00680628|19457511|P2|NOT COMPLETED|Overall Study||0
7907057|NCT00680628|19457512|P1|NOT COMPLETED|Overall Study||0
7907058|NCT00680628|19457511|P2|COMPLETED|Overall Study||40
7907059|NCT00680628|19457512|P1|COMPLETED|Overall Study||43
7907060|NCT00680628|19457511|P2|STARTED|Overall Study||40
7907061|NCT00680628|19457512|P1|STARTED|Overall Study||43
7907062|NCT00680524|19457522|P1|NOT COMPLETED|Overall Study||3
7907063|NCT00680524|19457522|P1|COMPLETED|Overall Study||17
7907064|NCT00680524|19457522|P1|STARTED|Overall Study||20
7907065|NCT00680459|19457528|P2|NOT COMPLETED|Overall Study||0
7907066|NCT00680459|19457529|P1|NOT COMPLETED|Overall Study||0
7907067|NCT00680459|19457528|P2|COMPLETED|Overall Study||6
7907068|NCT00680459|19457529|P1|COMPLETED|Overall Study||7
7907069|NCT00680459|19457528|P2|STARTED|Overall Study||6
7907070|NCT00680459|19457529|P1|STARTED|Overall Study||7
7907071|NCT00680407|19457542|P3|NOT COMPLETED|Overall Study||3
7907072|NCT00680407|19457543|P2|NOT COMPLETED|Overall Study||5
7907073|NCT00680407|19457544|P1|NOT COMPLETED|Overall Study||8
7907074|NCT00680407|19457542|P3|COMPLETED|Overall Study||22
7907075|NCT00680407|19457543|P2|COMPLETED|Overall Study||22
7907076|NCT00680407|19457544|P1|COMPLETED|Overall Study||18
7907077|NCT00680407|19457542|P3|STARTED|Overall Study||25
7907078|NCT00680407|19457543|P2|STARTED|Overall Study||27
7907079|NCT00680407|19457544|P1|STARTED|Overall Study||26
7907080|NCT00680368|19457558|P1|NOT COMPLETED|Overall Study||15
7907081|NCT00680368|19457558|P1|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97
7907082|NCT00680368|19457558|P1|STARTED|Overall Study||112
7907083|NCT00680316|19457566|P2|NOT COMPLETED|Overall Study||0
7907084|NCT00680316|19457567|P1|NOT COMPLETED|Overall Study||0
7907085|NCT00680316|19457566|P2|COMPLETED|Overall Study||2
7907086|NCT00680316|19457567|P1|COMPLETED|Overall Study||1
7907087|NCT00680316|19457566|P2|STARTED|Overall Study||2
7907088|NCT00680316|19457567|P1|STARTED|Overall Study||1
7907089|NCT00680225|19457579|P1|NOT COMPLETED|Overall Study||2
7907090|NCT00680225|19457579|P1|COMPLETED|Overall Study||8
7907091|NCT00680225|19457579|P1|STARTED|Overall Study||10
7907092|NCT00680186|19457586|P2|NOT COMPLETED|Overall Study||116
7907093|NCT00680186|19457587|P1|NOT COMPLETED|Overall Study||125
7907094|NCT00680186|19457586|P2|COMPLETED|Overall Study|Completed planned observation time.|1172
7907095|NCT00680186|19457587|P1|COMPLETED|Overall Study|Completed planned observation time.|1155
7907096|NCT00680186|19457586|P2|STARTED|Overall Study|Started treatment.|1288
7907097|NCT00680186|19457587|P1|STARTED|Overall Study|Started treatment.|1280
7907098|NCT00680121|19457613|P2|NOT COMPLETED|Overall Study||23
7907099|NCT00680121|19457614|P1|NOT COMPLETED|Overall Study||27
7907100|NCT00680121|19457613|P2|COMPLETED|Overall Study||37
7907101|NCT00680121|19457614|P1|COMPLETED|Overall Study||33
7907102|NCT00680121|19457613|P2|STARTED|Overall Study||60
7907103|NCT00680121|19457614|P1|STARTED|Overall Study||60
7907104|NCT00680056|19457628|P2|NOT COMPLETED|Second Intervention||1
7907105|NCT00680056|19457629|P1|NOT COMPLETED|Second Intervention||3
7907106|NCT00680056|19457628|P2|COMPLETED|Second Intervention||14
7907107|NCT00680056|19457629|P1|COMPLETED|Second Intervention||12
7907108|NCT00680056|19457628|P2|STARTED|Second Intervention||15
7907109|NCT00680056|19457629|P1|STARTED|Second Intervention||15
7907110|NCT00680056|19457628|P2|NOT COMPLETED|Washout Period of One Week||0
7907111|NCT00680056|19457629|P1|NOT COMPLETED|Washout Period of One Week||0
7907112|NCT00680056|19457628|P2|COMPLETED|Washout Period of One Week||15
7907113|NCT00680056|19457629|P1|COMPLETED|Washout Period of One Week||15
7907114|NCT00680056|19457628|P2|STARTED|Washout Period of One Week||15
7907115|NCT00680056|19457629|P1|STARTED|Washout Period of One Week||15
7907116|NCT00680056|19457628|P2|NOT COMPLETED|First Intervention||2
7907117|NCT00680056|19457629|P1|NOT COMPLETED|First Intervention||1
7907118|NCT00680056|19457628|P2|COMPLETED|First Intervention||15
7907119|NCT00680056|19457629|P1|COMPLETED|First Intervention||15
7907120|NCT00680056|19457628|P2|STARTED|First Intervention||17
7907121|NCT00680056|19457629|P1|STARTED|First Intervention||16
7907122|NCT00680043|19457640|P3|NOT COMPLETED|Overall Study||4
7907123|NCT00680043|19457641|P2|NOT COMPLETED|Overall Study||1
7907124|NCT00680043|19457642|P1|NOT COMPLETED|Overall Study||2
7907125|NCT00680043|19457640|P3|COMPLETED|Overall Study||34
7907126|NCT00680043|19457641|P2|COMPLETED|Overall Study||36
7907127|NCT00680043|19457642|P1|COMPLETED|Overall Study||37
7907128|NCT00680043|19457640|P3|STARTED|Overall Study||38
7907129|NCT00680043|19457641|P2|STARTED|Overall Study||37
7907130|NCT00680043|19457642|P1|STARTED|Overall Study||39
7907131|NCT00680017|19457658|P2|NOT COMPLETED|Overall Study||12
7907132|NCT00680017|19457659|P1|NOT COMPLETED|Overall Study||17
7907133|NCT00680017|19457658|P2|COMPLETED|Overall Study||128
7907134|NCT00680017|19457659|P1|COMPLETED|Overall Study||123
7907135|NCT00680017|19457658|P2|STARTED|Overall Study||140
7907136|NCT00680017|19457659|P1|STARTED|Overall Study||140
7907137|NCT00679952|19457669|P2|NOT COMPLETED|Overall Study||0
7907138|NCT00679952|19457670|P1|NOT COMPLETED|Overall Study||0
7907139|NCT00679952|19457669|P2|COMPLETED|Overall Study||82
7907140|NCT00679952|19457670|P1|COMPLETED|Overall Study||86
7907141|NCT00679952|19457669|P2|STARTED|Overall Study||82
7907142|NCT00679952|19457670|P1|STARTED|Overall Study||86
7907143|NCT00679939|19457678|P2|NOT COMPLETED|24-Week Open-Label (OL) Period||4
7907144|NCT00679939|19457679|P1|NOT COMPLETED|24-Week Open-Label (OL) Period||7
7907145|NCT00679939|19457678|P2|COMPLETED|24-Week Open-Label (OL) Period||80
7907146|NCT00679939|19457679|P1|COMPLETED|24-Week Open-Label (OL) Period||69
7907147|NCT00679939|19457678|P2|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84
7907148|NCT00679939|19457679|P1|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76
7907149|NCT00679939|19457678|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||27
7907150|NCT00679939|19457679|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||37
7907151|NCT00679939|19457678|P2|COMPLETED|52-Week Double-Blind (DB) Period||85
7907152|NCT00679939|19457679|P1|COMPLETED|52-Week Double-Blind (DB) Period||77
7907153|NCT00679939|19457678|P2|STARTED|52-Week Double-Blind (DB) Period||112
7907154|NCT00679939|19457679|P1|STARTED|52-Week Double-Blind (DB) Period||114
7907155|NCT00679926|19457828|P1|NOT COMPLETED|Overall Study||13
7907156|NCT00679926|19457828|P1|COMPLETED|Overall Study||2
7907157|NCT00679926|19457828|P1|STARTED|Overall Study||15
7907158|NCT00679913|19457845|P2|NOT COMPLETED|Overall Study||13
7907159|NCT00679913|19457846|P1|NOT COMPLETED|Overall Study||18
7907160|NCT00679913|19457845|P2|COMPLETED|Overall Study||86
7907161|NCT00679913|19457846|P1|COMPLETED|Overall Study||83
7907162|NCT00679913|19457845|P2|STARTED|Overall Study||99
7907163|NCT00679913|19457846|P1|STARTED|Overall Study||101
7907164|NCT00679783|19457861|P7|NOT COMPLETED|Overall Study||1
7907165|NCT00679783|19457862|P6|NOT COMPLETED|Overall Study||0
7907166|NCT00679783|19457863|P5|NOT COMPLETED|Overall Study||1
7907167|NCT00679783|19457864|P4|NOT COMPLETED|Overall Study||20
7907168|NCT00679783|19457865|P3|NOT COMPLETED|Overall Study||1
7907169|NCT00679783|19457866|P2|NOT COMPLETED|Overall Study||3
7907170|NCT00679783|19457867|P1|NOT COMPLETED|Overall Study||2
7907171|NCT00679783|19457861|P7|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15
7907172|NCT00679783|19457862|P6|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5
7907173|NCT00679783|19457863|P5|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4
7907174|NCT00679783|19457864|P4|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25
7907175|NCT00679783|19457865|P3|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
7907176|NCT00679783|19457866|P2|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10
7907177|NCT00679783|19457867|P1|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
7907178|NCT00679783|19457861|P7|STARTED|Overall Study|Gave Informed consent and passed screening|16
7907179|NCT00679783|19457862|P6|STARTED|Overall Study|Gave Informed consent and passed screening|5
7907180|NCT00679783|19457863|P5|STARTED|Overall Study|Gave Informed consent and passed screening|5
7907181|NCT00679783|19457864|P4|STARTED|Overall Study|Gave Informed consent and passed screening|45
7907182|NCT00679783|19457865|P3|STARTED|Overall Study|Gave Informed consent and passed screening|3
7907183|NCT00679783|19457866|P2|STARTED|Overall Study|Gave Informed consent and passed screening|13
7907184|NCT00679783|19457867|P1|STARTED|Overall Study|Gave Informed consent and passed screening|4
7907185|NCT00679627|19457920|P2|NOT COMPLETED|Overall Study||685
7907186|NCT00679627|19457921|P1|NOT COMPLETED|Overall Study||699
7907187|NCT00679627|19457920|P2|COMPLETED|Overall Study||339
7907188|NCT00679627|19457921|P1|COMPLETED|Overall Study||322
7907189|NCT00679627|19457920|P2|STARTED|Overall Study||1024
7907190|NCT00679627|19457921|P1|STARTED|Overall Study||1021
7907191|NCT00679549|19457945|P2|NOT COMPLETED|Overall Study||9
7907192|NCT00679549|19457946|P1|NOT COMPLETED|Overall Study||6
7907193|NCT00679549|19457945|P2|COMPLETED|Overall Study|4 dropouts in the control arm; 5 missing echocardiograms in the control arm|66
7907194|NCT00679549|19457946|P1|COMPLETED|Overall Study||69
7907195|NCT00679549|19457945|P2|STARTED|Overall Study||75
7907196|NCT00679549|19457946|P1|STARTED|Overall Study||75
7907197|NCT00679432|19457956|P4|NOT COMPLETED|Overall Study||32
7907198|NCT00679432|19457957|P3|NOT COMPLETED|Overall Study||53
7907199|NCT00679432|19457958|P2|NOT COMPLETED|Overall Study||38
7907200|NCT00679432|19457959|P1|NOT COMPLETED|Overall Study||37
7907201|NCT00679432|19457956|P4|COMPLETED|Overall Study||95
7907202|NCT00679432|19457957|P3|COMPLETED|Overall Study||76
7907203|NCT00679432|19457958|P2|COMPLETED|Overall Study||89
7907204|NCT00679432|19457959|P1|COMPLETED|Overall Study||89
7907205|NCT00679432|19457956|P4|STARTED|Overall Study||127
7907206|NCT00679432|19457957|P3|STARTED|Overall Study||129
7907207|NCT00679432|19457958|P2|STARTED|Overall Study||127
7907208|NCT00679432|19457959|P1|STARTED|Overall Study||126
7907209|NCT00679380|19457981|P4|NOT COMPLETED|Overall Study||28
7907210|NCT00679380|19457982|P3|NOT COMPLETED|Overall Study||35
7907211|NCT00679380|19457983|P2|NOT COMPLETED|Overall Study||33
7907212|NCT00679380|19457984|P1|NOT COMPLETED|Overall Study||42
7907213|NCT00679380|19457981|P4|COMPLETED|Overall Study||61
7907214|NCT00679380|19457982|P3|COMPLETED|Overall Study||68
7907215|NCT00679380|19457983|P2|COMPLETED|Overall Study||76
7907216|NCT00679380|19457984|P1|COMPLETED|Overall Study||67
7907217|NCT00679380|19457981|P4|STARTED|Overall Study||89
7907218|NCT00679380|19457982|P3|STARTED|Overall Study||103
7907219|NCT00679380|19457983|P2|STARTED|Overall Study||109
7907220|NCT00679380|19457984|P1|STARTED|Overall Study||109
7907221|NCT00679367|19458002|P1|NOT COMPLETED|Overall Study||12
7907222|NCT00679367|19458002|P1|COMPLETED|Overall Study||4
7907223|NCT00679367|19458002|P1|STARTED|Overall Study||16
7907224|NCT00679354|19458008|P1|NOT COMPLETED|Overall Study||30
7907225|NCT00679354|19458008|P1|COMPLETED|Overall Study||0
7907226|NCT00679354|19458008|P1|STARTED|Overall Study||30
7907227|NCT00679341|19458026|P2|NOT COMPLETED|Overall Study||51
7907228|NCT00679341|19458027|P1|NOT COMPLETED|Overall Study||53
7907229|NCT00679341|19458026|P2|COMPLETED|Overall Study||19
7907230|NCT00679341|19458027|P1|COMPLETED|Overall Study||14
7907231|NCT00679341|19458026|P2|STARTED|Overall Study||70
7907232|NCT00679341|19458027|P1|STARTED|Overall Study||67
7907233|NCT00679302|19458047|P2|NOT COMPLETED|Overall Study||4
7907234|NCT00679302|19458048|P1|NOT COMPLETED|Overall Study||8
7907235|NCT00679302|19458047|P2|COMPLETED|Overall Study||73
7907236|NCT00679302|19458048|P1|COMPLETED|Overall Study||76
7907237|NCT00679302|19458047|P2|STARTED|Overall Study||77
7907238|NCT00679302|19458048|P1|STARTED|Overall Study||84
7907239|NCT00679289|19458059|P3|NOT COMPLETED|Overall Study||23
7907240|NCT00679289|19458060|P2|NOT COMPLETED|Overall Study||6
7907241|NCT00679289|19458061|P1|NOT COMPLETED|Overall Study||5
7907242|NCT00679289|19458059|P3|COMPLETED|Overall Study||1
7907243|NCT00679289|19458060|P2|COMPLETED|Overall Study||0
7907244|NCT00679289|19458061|P1|COMPLETED|Overall Study||1
7907245|NCT00679289|19458059|P3|STARTED|Overall Study||24
7907246|NCT00679289|19458060|P2|STARTED|Overall Study||6
7907247|NCT00679289|19458061|P1|STARTED|Overall Study||6
7907248|NCT00679263|19458083|P3|NOT COMPLETED|Visit 2/Dose 1||0
7907249|NCT00679263|19458084|P2|NOT COMPLETED|Visit 2/Dose 1||1
7907250|NCT00679263|19458085|P1|NOT COMPLETED|Visit 2/Dose 1||2
7907251|NCT00679263|19458083|P3|COMPLETED|Visit 2/Dose 1||11
7907252|NCT00679263|19458084|P2|COMPLETED|Visit 2/Dose 1||5
7907253|NCT00679263|19458085|P1|COMPLETED|Visit 2/Dose 1||9
7907254|NCT00679263|19458083|P3|STARTED|Visit 2/Dose 1||11
7907255|NCT00679263|19458084|P2|STARTED|Visit 2/Dose 1||6
7907256|NCT00679263|19458085|P1|STARTED|Visit 2/Dose 1||11
7907257|NCT00679263|19458083|P3|NOT COMPLETED|Visit 3/Dose 2||0
7907258|NCT00679263|19458084|P2|NOT COMPLETED|Visit 3/Dose 2||5
7907259|NCT00679263|19458085|P1|NOT COMPLETED|Visit 3/Dose 2||1
7907260|NCT00679263|19458083|P3|COMPLETED|Visit 3/Dose 2||11
7907261|NCT00679263|19458084|P2|COMPLETED|Visit 3/Dose 2||6
7907262|NCT00679263|19458085|P1|COMPLETED|Visit 3/Dose 2||9
7907263|NCT00679263|19458083|P3|STARTED|Visit 3/Dose 2||11
7907264|NCT00679263|19458084|P2|STARTED|Visit 3/Dose 2||11
7907265|NCT00679263|19458085|P1|STARTED|Visit 3/Dose 2||10
7907266|NCT00679211|19458096|P1|NOT COMPLETED|Overall Study||110
7907267|NCT00679211|19458096|P1|COMPLETED|Overall Study||0
7907268|NCT00679211|19458096|P1|STARTED|Overall Study||110
7907269|NCT00679172|19458113|P5|NOT COMPLETED|Overall Study||0
7907270|NCT00679172|19458114|P4|NOT COMPLETED|Overall Study||1
7907271|NCT00679172|19458115|P3|NOT COMPLETED|Overall Study||1
7907272|NCT00679172|19458116|P2|NOT COMPLETED|Overall Study||1
7907273|NCT00679172|19458117|P1|NOT COMPLETED|Overall Study||1
7907274|NCT00679172|19458113|P5|COMPLETED|Overall Study||37
7907275|NCT00679172|19458114|P4|COMPLETED|Overall Study||38
7907276|NCT00679172|19458115|P3|COMPLETED|Overall Study||35
7907277|NCT00679172|19458116|P2|COMPLETED|Overall Study||37
7907278|NCT00679172|19458117|P1|COMPLETED|Overall Study||36
7907279|NCT00679172|19458113|P5|STARTED|Overall Study||37
7907280|NCT00679172|19458114|P4|STARTED|Overall Study||39
7907281|NCT00679172|19458115|P3|STARTED|Overall Study||36
7907282|NCT00679172|19458116|P2|STARTED|Overall Study||38
7907283|NCT00679172|19458117|P1|STARTED|Overall Study||37
7907284|NCT00679081|19458180|P1|NOT COMPLETED|Overall Study||1
7907285|NCT00679081|19458180|P1|COMPLETED|Overall Study||14
7907286|NCT00679081|19458180|P1|STARTED|Overall Study|Study design was within-subject control.|15
7907287|NCT00679055|19458190|P2|NOT COMPLETED|Overall Study||5
7907288|NCT00679055|19458191|P1|NOT COMPLETED|Overall Study||2
7907289|NCT00679055|19458190|P2|COMPLETED|Overall Study||1
7907290|NCT00679055|19458191|P1|COMPLETED|Overall Study||6
7907291|NCT00679055|19458190|P2|STARTED|Overall Study||6
7907292|NCT00679055|19458191|P1|STARTED|Overall Study||8
7907293|NCT00679029|19458201|P1|NOT COMPLETED|Overall Study||5
7907294|NCT00679029|19458201|P1|COMPLETED|Overall Study||10
7907295|NCT00679029|19458201|P1|STARTED|Overall Study||15
7907296|NCT00678899|19458208|P1|NOT COMPLETED|Overall Study||1
7907297|NCT00678899|19458208|P1|COMPLETED|Overall Study||49
7907298|NCT00678899|19458208|P1|STARTED|Overall Study||50
7907299|NCT00678886|19458217|P4|NOT COMPLETED|Overall Study||9
7907300|NCT00678886|19458218|P3|NOT COMPLETED|Overall Study||9
7907301|NCT00678886|19458219|P2|NOT COMPLETED|Overall Study||0
7907302|NCT00678886|19458220|P1|NOT COMPLETED|Overall Study||0
7907303|NCT00678886|19458217|P4|COMPLETED|Overall Study||153
7907304|NCT00678886|19458218|P3|COMPLETED|Overall Study||72
7907305|NCT00678886|19458219|P2|COMPLETED|Overall Study||19
7907306|NCT00678886|19458220|P1|COMPLETED|Overall Study||10
7907307|NCT00678886|19458217|P4|STARTED|Overall Study||162
7907308|NCT00678886|19458218|P3|STARTED|Overall Study||81
7907309|NCT00678886|19458219|P2|STARTED|Overall Study||19
7907310|NCT00678886|19458220|P1|STARTED|Overall Study||10
7907311|NCT00678834|19458267|P3|NOT COMPLETED|Overall Study||9
7907312|NCT00678834|19458268|P2|NOT COMPLETED|Overall Study||0
7907313|NCT00678834|19458269|P1|NOT COMPLETED|Overall Study||16
7907314|NCT00678834|19458267|P3|COMPLETED|Overall Study||16
7907315|NCT00678834|19458268|P2|COMPLETED|Overall Study||15
7907316|NCT00678834|19458269|P1|COMPLETED|Overall Study||24
7907317|NCT00678834|19458267|P3|STARTED|Overall Study||25
7907318|NCT00678834|19458268|P2|STARTED|Overall Study||15
7907319|NCT00678834|19458269|P1|STARTED|Overall Study||40
7907320|NCT00678795|19458289|P2|NOT COMPLETED|Overall Study||6
7907321|NCT00678795|19458290|P1|NOT COMPLETED|Overall Study||11
7907322|NCT00678795|19458289|P2|COMPLETED|Overall Study||62
7907323|NCT00678795|19458290|P1|COMPLETED|Overall Study||56
7907324|NCT00678795|19458289|P2|STARTED|Overall Study||68
7907325|NCT00678795|19458290|P1|STARTED|Overall Study||67
7907326|NCT00678691|19458312|P2|NOT COMPLETED|Overall Study||4
7907327|NCT00678691|19458313|P1|NOT COMPLETED|Overall Study||6
7907328|NCT00678691|19458312|P2|COMPLETED|Overall Study||24
7907329|NCT00678691|19458313|P1|COMPLETED|Overall Study||21
7907330|NCT00678691|19458312|P2|STARTED|Overall Study||28
7907331|NCT00678691|19458313|P1|STARTED|Overall Study||27
7907332|NCT00678652|19458323|P4|NOT COMPLETED|Overall Study||0
7907333|NCT00678652|19458324|P3|NOT COMPLETED|Overall Study||1
7907334|NCT00678652|19458325|P2|NOT COMPLETED|Overall Study||0
7907335|NCT00678652|19458326|P1|NOT COMPLETED|Overall Study||3
7907336|NCT00678652|19458323|P4|COMPLETED|Overall Study||9
7907337|NCT00678652|19458324|P3|COMPLETED|Overall Study||8
7907338|NCT00678652|19458325|P2|COMPLETED|Overall Study||9
7907339|NCT00678652|19458326|P1|COMPLETED|Overall Study||6
7907340|NCT00678652|19458323|P4|STARTED|Overall Study||9
7907341|NCT00678652|19458324|P3|STARTED|Overall Study||9
7907342|NCT00678652|19458325|P2|STARTED|Overall Study||9
7907343|NCT00678652|19458326|P1|STARTED|Overall Study||9
7907344|NCT00678639|19458350|P2|NOT COMPLETED|Overall Study||0
7907345|NCT00678639|19458351|P1|NOT COMPLETED|Overall Study||2
7907346|NCT00678639|19458350|P2|COMPLETED|Overall Study||57
7907347|NCT00678639|19458351|P1|COMPLETED|Overall Study||51
7907348|NCT00678639|19458350|P2|Hospital Discharge|Overall Study||57
7907349|NCT00678639|19458351|P1|Hospital Discharge|Overall Study||53
7907350|NCT00678639|19458350|P2|STARTED|Overall Study||57
7907351|NCT00678639|19458351|P1|STARTED|Overall Study||53
7907352|NCT00678587|19458366|P2|NOT COMPLETED|Overall Study||18
7907353|NCT00678587|19458367|P1|NOT COMPLETED|Overall Study||20
7907354|NCT00678587|19458366|P2|COMPLETED|Overall Study||127
7907355|NCT00678587|19458367|P1|COMPLETED|Overall Study||127
7907356|NCT00678587|19458366|P2|STARTED|Overall Study||145
7907357|NCT00678587|19458367|P1|STARTED|Overall Study||147
7907358|NCT00678574|19458401|P2|NOT COMPLETED|Overall Study||0
7907359|NCT00678574|19458402|P1|NOT COMPLETED|Overall Study||0
7907360|NCT00678574|19458401|P2|COMPLETED|Overall Study||27
7907361|NCT00678574|19458402|P1|COMPLETED|Overall Study||18
7907362|NCT00678574|19458401|P2|STARTED|Overall Study||27
7907363|NCT00678574|19458402|P1|STARTED|Overall Study||18
7907364|NCT00678561|19458416|P8|NOT COMPLETED|Overall Study||1
7907365|NCT00678561|19458417|P7|NOT COMPLETED|Overall Study||0
7907366|NCT00678561|19458418|P6|NOT COMPLETED|Overall Study||1
7907367|NCT00678561|19458419|P5|NOT COMPLETED|Overall Study||2
7907368|NCT00678561|19458420|P4|NOT COMPLETED|Overall Study||0
7907369|NCT00678561|19458421|P3|NOT COMPLETED|Overall Study||1
7907370|NCT00678561|19458422|P2|NOT COMPLETED|Overall Study||1
7907371|NCT00678561|19458423|P1|NOT COMPLETED|Overall Study||0
7907372|NCT00678561|19458416|P8|COMPLETED|Overall Study||7
7907373|NCT00678561|19458417|P7|COMPLETED|Overall Study||15
7907374|NCT00678561|19458418|P6|COMPLETED|Overall Study||16
7907375|NCT00678561|19458419|P5|COMPLETED|Overall Study||15
7907376|NCT00678561|19458420|P4|COMPLETED|Overall Study||4
7907377|NCT00678561|19458421|P3|COMPLETED|Overall Study||7
7907378|NCT00678561|19458422|P2|COMPLETED|Overall Study||5
7907379|NCT00678561|19458423|P1|COMPLETED|Overall Study||6
7907380|NCT00678561|19458416|P8|STARTED|Overall Study||8
7907381|NCT00678561|19458417|P7|STARTED|Overall Study||15
7907382|NCT00678561|19458418|P6|STARTED|Overall Study||17
7907383|NCT00678561|19458419|P5|STARTED|Overall Study||17
7907384|NCT00678561|19458420|P4|STARTED|Overall Study||4
7907385|NCT00678561|19458421|P3|STARTED|Overall Study||8
7907386|NCT00678561|19458422|P2|STARTED|Overall Study||6
7907387|NCT00678561|19458423|P1|STARTED|Overall Study||6
7907388|NCT00678535|19458478|P2|NOT COMPLETED|Overall Study||98
7907389|NCT00678535|19458479|P1|NOT COMPLETED|Overall Study||93
7907390|NCT00678535|19458478|P2|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351
7907391|NCT00678535|19458479|P1|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362
7907392|NCT00678535|19458478|P2|STARTED|Overall Study|ITT population|449
7907393|NCT00678535|19458479|P1|STARTED|Overall Study|ITT population|455
7907394|NCT00678470|19458495|P1|NOT COMPLETED|Overall Study||4
7907395|NCT00678470|19458495|P1|COMPLETED|Overall Study||14
7907396|NCT00678470|19458495|P1|STARTED|Overall Study||18
7907397|NCT00678444|19458501|P2|NOT COMPLETED|Overall Study||0
7907398|NCT00678444|19458502|P1|NOT COMPLETED|Overall Study||0
7907399|NCT00678444|19458501|P2|COMPLETED|Overall Study||99
7907400|NCT00678444|19458502|P1|COMPLETED|Overall Study||100
7907401|NCT00678444|19458501|P2|STARTED|Overall Study||99
7907402|NCT00678444|19458502|P1|STARTED|Overall Study||100
7907403|NCT00678418|19458512|P2|NOT COMPLETED|Part B (Open Label)||0
7907404|NCT00678418|19458513|P1|NOT COMPLETED|Part B (Open Label)||43
7907405|NCT00678418|19458512|P2|COMPLETED|Part B (Open Label)||0
7907406|NCT00678418|19458513|P1|COMPLETED|Part B (Open Label)||71
7907407|NCT00678418|19458512|P2|STARTED|Part B (Open Label)||0
7907408|NCT00678418|19458513|P1|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114
7907409|NCT00678418|19458512|P2|NOT COMPLETED|Part A (Double Blind)||77
7907410|NCT00678418|19458513|P1|NOT COMPLETED|Part A (Double Blind)||59
7907411|NCT00678418|19458512|P2|COMPLETED|Part A (Double Blind)||47
7907412|NCT00678418|19458513|P1|COMPLETED|Part A (Double Blind)||67
7907413|NCT00678418|19458512|P2|STARTED|Part A (Double Blind)||124
7907414|NCT00678418|19458513|P1|STARTED|Part A (Double Blind)||126
7907415|NCT00678392|19458529|P2|NOT COMPLETED|Overall Study||362
7907416|NCT00678392|19458530|P1|NOT COMPLETED|Overall Study||361
7907417|NCT00678392|19458529|P2|COMPLETED|Overall Study||0
7907418|NCT00678392|19458530|P1|COMPLETED|Overall Study||0
7907419|NCT00678392|19458529|P2|Treated|Overall Study||355
7907420|NCT00678392|19458530|P1|Treated|Overall Study||359
7907421|NCT00678392|19458529|P2|STARTED|Overall Study||362
7907422|NCT00678392|19458530|P1|STARTED|Overall Study||361
7907423|NCT00678379|19458565|P3|NOT COMPLETED|Overall Study||4
7907424|NCT00678379|19458566|P2|NOT COMPLETED|Overall Study||3
7907425|NCT00678379|19458567|P1|NOT COMPLETED|Overall Study||6
7907426|NCT00678379|19458565|P3|COMPLETED|Overall Study||36
7907427|NCT00678379|19458566|P2|COMPLETED|Overall Study||37
7907428|NCT00678379|19458567|P1|COMPLETED|Overall Study||34
7907429|NCT00678379|19458565|P3|STARTED|Overall Study||40
7907430|NCT00678379|19458566|P2|STARTED|Overall Study||40
7907431|NCT00678379|19458567|P1|STARTED|Overall Study||40
7907432|NCT00678301|19458595|P2|NOT COMPLETED|Overall Study||2
7907433|NCT00678301|19458596|P1|NOT COMPLETED|Overall Study||8
7907434|NCT00678301|19458595|P2|COMPLETED|Overall Study||116
7907435|NCT00678301|19458596|P1|COMPLETED|Overall Study||231
7907436|NCT00678301|19458595|P2|STARTED|Overall Study||118
7907437|NCT00678301|19458596|P1|STARTED|Overall Study||239
7907438|NCT00678288|19458654|P2|NOT COMPLETED|Overall Study||6
7907439|NCT00678288|19458655|P1|NOT COMPLETED|Overall Study||10
7907440|NCT00678288|19458654|P2|COMPLETED|Overall Study||0
7907441|NCT00678288|19458655|P1|COMPLETED|Overall Study||0
7907442|NCT00678288|19458654|P2|STARTED|Overall Study||6
7907443|NCT00678288|19458655|P1|STARTED|Overall Study||10
7907444|NCT00678249|19458672|P3|NOT COMPLETED|Overall Study||0
7907445|NCT00678249|19458673|P2|NOT COMPLETED|Overall Study||0
7907446|NCT00678249|19458674|P1|NOT COMPLETED|Overall Study||0
7907447|NCT00678249|19458672|P3|COMPLETED|Overall Study||37
7907448|NCT00678249|19458673|P2|COMPLETED|Overall Study||93
7907449|NCT00678249|19458674|P1|COMPLETED|Overall Study||97
7907450|NCT00678249|19458672|P3|STARTED|Overall Study||37
7907451|NCT00678249|19458673|P2|STARTED|Overall Study||93
7907452|NCT00678249|19458674|P1|STARTED|Overall Study||97
7907453|NCT00678210|19458710|P4|NOT COMPLETED|Overall Study||20
7907454|NCT00678210|19458711|P3|NOT COMPLETED|Overall Study||6
7907455|NCT00678210|19458712|P2|NOT COMPLETED|Overall Study||11
7907456|NCT00678210|19458713|P1|NOT COMPLETED|Overall Study||11
7907457|NCT00678210|19458710|P4|COMPLETED|Overall Study||30
7907458|NCT00678210|19458711|P3|COMPLETED|Overall Study||43
7907459|NCT00678210|19458712|P2|COMPLETED|Overall Study||38
7907460|NCT00678210|19458713|P1|COMPLETED|Overall Study||38
7907461|NCT00678210|19458710|P4|STARTED|Overall Study||50
7907462|NCT00678210|19458711|P3|STARTED|Overall Study||49
7907463|NCT00678210|19458712|P2|STARTED|Overall Study||49
7907464|NCT00678210|19458713|P1|STARTED|Overall Study||49
7907465|NCT00678080|19458749|P2|NOT COMPLETED|Overall Study||1
7907466|NCT00678080|19458750|P1|NOT COMPLETED|Overall Study||3
7907467|NCT00678080|19458749|P2|COMPLETED|Overall Study||13
7907468|NCT00678080|19458750|P1|COMPLETED|Overall Study||8
7907469|NCT00678080|19458749|P2|STARTED|Overall Study||14
7907470|NCT00678080|19458750|P1|STARTED|Overall Study||11
7907471|NCT00678041|19458776|P2|NOT COMPLETED|Overall Study||5
7907472|NCT00678041|19458777|P1|NOT COMPLETED|Overall Study||5
7907473|NCT00678041|19458776|P2|COMPLETED|Overall Study||0
7907474|NCT00678041|19458777|P1|COMPLETED|Overall Study||0
7907475|NCT00678041|19458776|P2|STARTED|Overall Study||5
7907476|NCT00678041|19458777|P1|STARTED|Overall Study||5
7907477|NCT00678015|19458789|P1|NOT COMPLETED|Overall Study||0
7907478|NCT00678015|19458789|P1|COMPLETED|Overall Study||12
7907479|NCT00678015|19458789|P1|STARTED|Overall Study||12
7907480|NCT00677924|19458798|P2|NOT COMPLETED|Overall Study||0
7907481|NCT00677924|19458799|P1|NOT COMPLETED|Overall Study||0
7907482|NCT00677924|19458798|P2|COMPLETED|Overall Study||6
7907483|NCT00677924|19458799|P1|COMPLETED|Overall Study||3
7907484|NCT00677924|19458798|P2|STARTED|Overall Study||6
7907485|NCT00677924|19458799|P1|STARTED|Overall Study||3
7907486|NCT00677898|19458809|P2|NOT COMPLETED|Overall Study||18
7907487|NCT00677898|19458810|P1|NOT COMPLETED|Overall Study||20
7907488|NCT00677898|19458809|P2|COMPLETED|Overall Study||102
7907489|NCT00677898|19458810|P1|COMPLETED|Overall Study||99
7907490|NCT00677898|19458809|P2|STARTED|Overall Study||120
7907491|NCT00677898|19458810|P1|STARTED|Overall Study||119
7907492|NCT00677833|19458830|P4|NOT COMPLETED|Overall Study||3
7907493|NCT00677833|19458831|P3|NOT COMPLETED|Overall Study||2
7907494|NCT00677833|19458832|P2|NOT COMPLETED|Overall Study||0
7907495|NCT00677833|19458833|P1|NOT COMPLETED|Overall Study||4
7907496|NCT00677833|19458830|P4|COMPLETED|Overall Study||128
7907497|NCT00677833|19458831|P3|COMPLETED|Overall Study||122
7907498|NCT00677833|19458832|P2|COMPLETED|Overall Study||51
7907499|NCT00677833|19458833|P1|COMPLETED|Overall Study||51
7907500|NCT00677833|19458830|P4|STARTED|Overall Study||131
7907501|NCT00677833|19458831|P3|STARTED|Overall Study||124
7907502|NCT00677833|19458832|P2|STARTED|Overall Study||51
7907503|NCT00677833|19458833|P1|STARTED|Overall Study||55
7907504|NCT00677820|19458883|P2|NOT COMPLETED|Overall Study||0
7907505|NCT00677820|19458884|P1|NOT COMPLETED|Overall Study||1
7907506|NCT00677820|19458883|P2|COMPLETED|Overall Study||60
7907507|NCT00677820|19458884|P1|COMPLETED|Overall Study||239
7907508|NCT00677820|19458883|P2|STARTED|Overall Study||60
7907509|NCT00677820|19458884|P1|STARTED|Overall Study||240
7907510|NCT00677807|19458905|P3|NOT COMPLETED|Overall Study||20
7907511|NCT00677807|19458906|P2|NOT COMPLETED|Overall Study||11
7907512|NCT00677807|19458907|P1|NOT COMPLETED|Overall Study||18
7907513|NCT00677807|19458905|P3|COMPLETED|Overall Study||105
7907514|NCT00677807|19458906|P2|COMPLETED|Overall Study||135
7907515|NCT00677807|19458907|P1|COMPLETED|Overall Study||126
7907516|NCT00677807|19458905|P3|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124
7907517|NCT00677807|19458906|P2|Safety/ITT: Received Study Drug|Overall Study||146
7907518|NCT00677807|19458907|P1|Safety/ITT: Received Study Drug|Overall Study||144
7907519|NCT00677807|19458905|P3|STARTED|Overall Study||125
7907520|NCT00677807|19458906|P2|STARTED|Overall Study||146
7907521|NCT00677807|19458907|P1|STARTED|Overall Study||144
7907522|NCT00677690|19458938|P2|NOT COMPLETED|Overall Study||0
7907523|NCT00677690|19458939|P1|NOT COMPLETED|Overall Study||0
7907524|NCT00677690|19458938|P2|COMPLETED|Overall Study||41
7907525|NCT00677690|19458939|P1|COMPLETED|Overall Study||42
7907526|NCT00677690|19458938|P2|STARTED|Overall Study||41
7907527|NCT00677690|19458939|P1|STARTED|Overall Study||42
7907528|NCT00677534|19458953|P1|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0
7907529|NCT00677534|19458953|P1|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7
7907530|NCT00677534|19458953|P1|STARTED|After Paricalcitol Restart (Weeks 13-14)||7
7907531|NCT00677534|19458953|P1|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0
7907532|NCT00677534|19458953|P1|COMPLETED|Cholecalciferol (Weeks 5-12)||7
7907533|NCT00677534|19458953|P1|STARTED|Cholecalciferol (Weeks 5-12)||7
7907534|NCT00677534|19458953|P1|NOT COMPLETED|Washout (Weeks 1-4)||3
7907535|NCT00677534|19458953|P1|COMPLETED|Washout (Weeks 1-4)||7
7907536|NCT00677534|19458953|P1|STARTED|Washout (Weeks 1-4)||10
7907537|NCT00677365|19458961|P4|NOT COMPLETED|Overall Study||3
7907538|NCT00677365|19458962|P3|NOT COMPLETED|Overall Study||2
7907539|NCT00677365|19458963|P2|NOT COMPLETED|Overall Study||1
7907540|NCT00677365|19458964|P1|NOT COMPLETED|Overall Study||2
7907541|NCT00677365|19458961|P4|COMPLETED|Overall Study||36
7907542|NCT00677365|19458962|P3|COMPLETED|Overall Study||35
7907543|NCT00677365|19458963|P2|COMPLETED|Overall Study||37
7907544|NCT00677365|19458964|P1|COMPLETED|Overall Study||35
7907545|NCT00677365|19458961|P4|STARTED|Overall Study||39
7907546|NCT00677365|19458962|P3|STARTED|Overall Study||37
7907547|NCT00677365|19458963|P2|STARTED|Overall Study||38
7907548|NCT00677365|19458964|P1|STARTED|Overall Study||37
7907549|NCT00677352|19458996|P2|NOT COMPLETED|Tapering Phase||10
7907550|NCT00677352|19458997|P1|NOT COMPLETED|Tapering Phase||6
7907551|NCT00677352|19458996|P2|COMPLETED|Tapering Phase||112
7907552|NCT00677352|19458997|P1|COMPLETED|Tapering Phase||126
7907553|NCT00677352|19458996|P2|STARTED|Tapering Phase||122
7907554|NCT00677352|19458997|P1|STARTED|Tapering Phase||132
7907555|NCT00677352|19458996|P2|NOT COMPLETED|Treatment Phase||42
7907556|NCT00677352|19458997|P1|NOT COMPLETED|Treatment Phase||25
7907557|NCT00677352|19458996|P2|COMPLETED|Treatment Phase||122
7907558|NCT00677352|19458997|P1|COMPLETED|Treatment Phase||132
7907559|NCT00677352|19458996|P2|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164
7907560|NCT00677352|19458997|P1|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157
7907561|NCT00677235|19459017|P2|NOT COMPLETED|Overall Study||38
7907562|NCT00677235|19459018|P1|NOT COMPLETED|Overall Study||41
7907563|NCT00677235|19459017|P2|COMPLETED|Overall Study||94
7907564|NCT00677235|19459018|P1|COMPLETED|Overall Study||97
7907565|NCT00677235|19459017|P2|STARTED|Overall Study||132
7907566|NCT00677235|19459018|P1|STARTED|Overall Study||138
7907567|NCT00677092|19459058|P1|NOT COMPLETED|Overall Study||6
7907568|NCT00677092|19459058|P1|COMPLETED|Overall Study||6
7907569|NCT00677092|19459058|P1|Received Study Treatment|Overall Study||11
7907570|NCT00677092|19459058|P1|STARTED|Overall Study||12
7907571|NCT00677040|19459067|P1|NOT COMPLETED|Overall Study||0
7907572|NCT00677040|19459067|P1|COMPLETED|Overall Study||20
7907573|NCT00677040|19459067|P1|STARTED|Overall Study||20
7907574|NCT00677014|19459075|P3|NOT COMPLETED|Overall Study||49
7907575|NCT00677014|19459076|P2|NOT COMPLETED|Overall Study||41
7907576|NCT00677014|19459077|P1|NOT COMPLETED|Overall Study||44
7907577|NCT00677014|19459075|P3|COMPLETED|Overall Study||283
7907578|NCT00677014|19459076|P2|COMPLETED|Overall Study||282
7907579|NCT00677014|19459077|P1|COMPLETED|Overall Study||281
7907580|NCT00677014|19459075|P3|STARTED|Overall Study||332
7907581|NCT00677014|19459076|P2|STARTED|Overall Study||323
7907582|NCT00677014|19459077|P1|STARTED|Overall Study||325
7907583|NCT00676897|19459087|P2|NOT COMPLETED|Overall Study||0
7907584|NCT00676897|19459088|P1|NOT COMPLETED|Overall Study||0
7907585|NCT00676897|19459087|P2|COMPLETED|Overall Study||10
7907586|NCT00676897|19459088|P1|COMPLETED|Overall Study||8
7907587|NCT00676897|19459087|P2|STARTED|Overall Study||10
7907588|NCT00676897|19459088|P1|STARTED|Overall Study||8
7907589|NCT00676806|19459098|P2|NOT COMPLETED|Overall Study||0
7907590|NCT00676806|19459099|P1|NOT COMPLETED|Overall Study||0
7907591|NCT00676806|19459098|P2|COMPLETED|Overall Study||3
7907592|NCT00676806|19459099|P1|COMPLETED|Overall Study||3
7907593|NCT00676806|19459098|P2|STARTED|Overall Study||3
7907594|NCT00676806|19459099|P1|STARTED|Overall Study||3
7907595|NCT00676793|19459115|P1|NOT COMPLETED|Overall Study||13
7907596|NCT00676793|19459115|P1|COMPLETED|Overall Study||19
7907597|NCT00676793|19459115|P1|STARTED|Overall Study||32
7907598|NCT00676780|19459120|P1|NOT COMPLETED|Overall Study||7
7907599|NCT00676780|19459120|P1|COMPLETED|Overall Study||26
7907600|NCT00676780|19459120|P1|STARTED|Overall Study||33
7907601|NCT00676715|19459130|P4|NOT COMPLETED|Overall Study||40
7907602|NCT00676715|19459131|P3|NOT COMPLETED|Overall Study||41
7907603|NCT00676715|19459132|P2|NOT COMPLETED|Overall Study||47
7907604|NCT00676715|19459133|P1|NOT COMPLETED|Overall Study||40
7907605|NCT00676715|19459130|P4|COMPLETED|Overall Study||14
7907606|NCT00676715|19459131|P3|COMPLETED|Overall Study||14
7907607|NCT00676715|19459132|P2|COMPLETED|Overall Study||8
7907608|NCT00676715|19459133|P1|COMPLETED|Overall Study||14
7907609|NCT00676715|19459130|P4|STARTED|Overall Study||54
7907610|NCT00676715|19459131|P3|STARTED|Overall Study||55
7907611|NCT00676715|19459132|P2|STARTED|Overall Study||55
7907612|NCT00676715|19459133|P1|STARTED|Overall Study||54
7907613|NCT00676689|19459163|P1|NOT COMPLETED|Overall Study||61
7907614|NCT00676689|19459163|P1|COMPLETED|Overall Study||20
7907615|NCT00676689|19459163|P1|1 Year Follow-up|Overall Study||64
7907616|NCT00676689|19459163|P1|30 Day Follow-up|Overall Study||78
7907617|NCT00676689|19459163|P1|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79
7907618|NCT00676689|19459163|P1|STARTED|Overall Study||81
7907619|NCT00676676|19459169|P1|NOT COMPLETED|Overall Study||0
7907620|NCT00676676|19459169|P1|COMPLETED|Overall Study||9
7907621|NCT00676676|19459169|P1|STARTED|Overall Study||9
7907622|NCT00676663|19459175|P2|NOT COMPLETED|Overall Study||38
7907623|NCT00676663|19459176|P1|NOT COMPLETED|Overall Study||45
7907624|NCT00676663|19459175|P2|COMPLETED|Overall Study||26
7907625|NCT00676663|19459176|P1|COMPLETED|Overall Study||21
7907626|NCT00676663|19459175|P2|STARTED|Overall Study||64
7907627|NCT00676663|19459176|P1|STARTED|Overall Study||66
7907628|NCT00676650|19459192|P2|NOT COMPLETED|Overall Study||289
7907629|NCT00676650|19459193|P1|NOT COMPLETED|Overall Study||584
7907630|NCT00676650|19459192|P2|COMPLETED|Overall Study||0
7907631|NCT00676650|19459193|P1|COMPLETED|Overall Study||0
7907632|NCT00676650|19459192|P2|Treated|Overall Study||285
7907633|NCT00676650|19459193|P1|Treated|Overall Study||581
7907634|NCT00676650|19459192|P2|STARTED|Overall Study||289
7907635|NCT00676650|19459193|P1|STARTED|Overall Study||584
7907636|NCT00676585|19459213|P2|NOT COMPLETED|Overall Study||0
7907637|NCT00676585|19459214|P1|NOT COMPLETED|Overall Study||0
7907638|NCT00676585|19459213|P2|COMPLETED|Overall Study||25
7907639|NCT00676585|19459214|P1|COMPLETED|Overall Study||25
7907640|NCT00676585|19459213|P2|STARTED|Overall Study||25
7907641|NCT00676585|19459214|P1|STARTED|Overall Study||25
7907642|NCT00676572|19459226|P2|NOT COMPLETED|Overall Study||0
7907643|NCT00676572|19459227|P1|NOT COMPLETED|Overall Study||0
7907644|NCT00676572|19459226|P2|COMPLETED|Overall Study||6
7907645|NCT00676572|19459227|P1|COMPLETED|Overall Study||6
7907646|NCT00676572|19459226|P2|STARTED|Overall Study||6
7907647|NCT00676572|19459227|P1|STARTED|Overall Study||6
7907648|NCT00676520|19459235|P1|NOT COMPLETED|Overall Study||731
7907649|NCT00676520|19459235|P1|COMPLETED|Overall Study||7309
7907650|NCT00676520|19459235|P1|STARTED|Overall Study||8040
7907651|NCT00676494|19459292|P1|NOT COMPLETED|Overall Study||14
7907652|NCT00676494|19459292|P1|COMPLETED|Overall Study||158
7907653|NCT00676494|19459292|P1|STARTED|Overall Study||172
7907654|NCT00676455|19459298|P1|NOT COMPLETED|Overall Study||0
7907655|NCT00676455|19459298|P1|COMPLETED|Overall Study||14
7907656|NCT00676455|19459298|P1|STARTED|Overall Study||14
7907657|NCT00676403|19459309|P6|NOT COMPLETED|Overall Study||5
7907658|NCT00676403|19459310|P5|NOT COMPLETED|Overall Study||1
7907659|NCT00676403|19459311|P4|NOT COMPLETED|Overall Study||5
7907660|NCT00676403|19459312|P3|NOT COMPLETED|Overall Study||1
7907661|NCT00676403|19459313|P2|NOT COMPLETED|Overall Study||2
7907662|NCT00676403|19459314|P1|NOT COMPLETED|Overall Study||2
7907663|NCT00676403|19459309|P6|COMPLETED|Overall Study||18
7907664|NCT00676403|19459310|P5|COMPLETED|Overall Study||23
7907665|NCT00676403|19459311|P4|COMPLETED|Overall Study||17
7907666|NCT00676403|19459312|P3|COMPLETED|Overall Study||22
7907667|NCT00676403|19459313|P2|COMPLETED|Overall Study||20
7907668|NCT00676403|19459314|P1|COMPLETED|Overall Study||21
7907669|NCT00676403|19459309|P6|STARTED|Overall Study||23
7907670|NCT00676403|19459310|P5|STARTED|Overall Study||24
7907671|NCT00676403|19459311|P4|STARTED|Overall Study||22
7907672|NCT00676403|19459312|P3|STARTED|Overall Study||23
7907673|NCT00676403|19459313|P2|STARTED|Overall Study||22
7907674|NCT00676403|19459314|P1|STARTED|Overall Study||23
7907675|NCT00676364|19459444|P2|NOT COMPLETED|Overall Study||0
7907676|NCT00676364|19459445|P1|NOT COMPLETED|Overall Study||0
7907677|NCT00676364|19459444|P2|COMPLETED|Overall Study||57
7907678|NCT00676364|19459445|P1|COMPLETED|Overall Study||57
7907679|NCT00676364|19459444|P2|STARTED|Overall Study||57
7907680|NCT00676364|19459445|P1|STARTED|Overall Study||57
7907681|NCT00676338|19459457|P4|NOT COMPLETED|Overall Study||23
7907682|NCT00676338|19459458|P3|NOT COMPLETED|Overall Study||30
7907683|NCT00676338|19459459|P2|NOT COMPLETED|Overall Study||33
7907684|NCT00676338|19459460|P1|NOT COMPLETED|Overall Study||38
7907685|NCT00676338|19459457|P4|COMPLETED|Overall Study||140
7907686|NCT00676338|19459458|P3|COMPLETED|Overall Study||133
7907687|NCT00676338|19459459|P2|COMPLETED|Overall Study||213
7907688|NCT00676338|19459460|P1|COMPLETED|Overall Study||210
7907689|NCT00676338|19459457|P4|STARTED|Overall Study||163
7907690|NCT00676338|19459458|P3|STARTED|Overall Study||163
7907691|NCT00676338|19459459|P2|STARTED|Overall Study||246
7907692|NCT00676338|19459460|P1|STARTED|Overall Study||248
7907693|NCT00676208|19459512|P2|NOT COMPLETED|Overall Study||6
7907694|NCT00676208|19459513|P1|NOT COMPLETED|Overall Study||2
7907695|NCT00676208|19459512|P2|COMPLETED|Overall Study||13
7907696|NCT00676208|19459513|P1|COMPLETED|Overall Study||12
7907697|NCT00676208|19459512|P2|STARTED|Overall Study||19
7907698|NCT00676208|19459513|P1|STARTED|Overall Study||14
7907699|NCT00676195|19459521|P1|NOT COMPLETED|Overall Study||3
7907700|NCT00676195|19459521|P1|COMPLETED|Overall Study||21
7907701|NCT00676195|19459521|P1|STARTED|Overall Study||24
7907702|NCT00676182|19459531|P1|NOT COMPLETED|Overall Study||0
7907703|NCT00676182|19459531|P1|COMPLETED|Overall Study||75
7907704|NCT00676182|19459531|P1|STARTED|Overall Study||75
7907705|NCT00676143|19459546|P2|NOT COMPLETED|Overall Study||260
7907706|NCT00676143|19459547|P1|NOT COMPLETED|Overall Study||156
7907707|NCT00676143|19459546|P2|COMPLETED|Overall Study||398
7907708|NCT00676143|19459547|P1|COMPLETED|Overall Study||285
7907709|NCT00676143|19459546|P2|Treated|Overall Study||654
7907710|NCT00676143|19459547|P1|Treated|Overall Study||439
7907711|NCT00676143|19459546|P2|STARTED|Overall Study||658
7907712|NCT00676143|19459547|P1|STARTED|Overall Study||441
7907713|NCT00676130|19459587|P2|NOT COMPLETED|Overall Study||4
7907714|NCT00676130|19459588|P1|NOT COMPLETED|Overall Study||3
7907715|NCT00676130|19459587|P2|COMPLETED|Overall Study||73
7907716|NCT00676130|19459588|P1|COMPLETED|Overall Study||73
7907717|NCT00676130|19459587|P2|STARTED|Overall Study||77
7907718|NCT00676130|19459588|P1|STARTED|Overall Study||76
7907719|NCT00676091|19459598|P2|NOT COMPLETED|Toddler Dose||0
7907720|NCT00676091|19459599|P1|NOT COMPLETED|Toddler Dose||3
7907721|NCT00676091|19459598|P2|COMPLETED|Toddler Dose||156
7907722|NCT00676091|19459599|P1|COMPLETED|Toddler Dose||153
7907723|NCT00676091|19459598|P2|STARTED|Toddler Dose||156
7907724|NCT00676091|19459599|P1|STARTED|Toddler Dose||156
7907725|NCT00676091|19459598|P2|NOT COMPLETED|After Infant Series||3
7907726|NCT00676091|19459599|P1|NOT COMPLETED|After Infant Series||1
7907727|NCT00676091|19459598|P2|COMPLETED|After Infant Series||156
7907728|NCT00676091|19459599|P1|COMPLETED|After Infant Series||156
7907729|NCT00676091|19459598|P2|STARTED|After Infant Series||159
7907730|NCT00676091|19459599|P1|STARTED|After Infant Series||157
7907731|NCT00676091|19459598|P2|NOT COMPLETED|Infant Series||18
7907732|NCT00676091|19459599|P1|NOT COMPLETED|Infant Series||20
7907733|NCT00676091|19459598|P2|COMPLETED|Infant Series||159
7907734|NCT00676091|19459599|P1|COMPLETED|Infant Series||157
7907735|NCT00676091|19459598|P2|Vaccinated Dose 3|Infant Series||161
7907736|NCT00676091|19459599|P1|Vaccinated Dose 3|Infant Series||158
7907737|NCT00676091|19459598|P2|Vaccinated Dose 2|Infant Series||162
7907738|NCT00676091|19459599|P1|Vaccinated Dose 2|Infant Series||159
7907739|NCT00676091|19459598|P2|Vaccinated Dose 1|Infant Series||162
7907740|NCT00676091|19459599|P1|Vaccinated Dose 1|Infant Series||163
7907741|NCT00676091|19459598|P2|STARTED|Infant Series||177
7907742|NCT00676091|19459599|P1|STARTED|Infant Series||177
7907743|NCT00676065|19459634|P3|NOT COMPLETED|Overall Study||0
7907744|NCT00676065|19459635|P2|NOT COMPLETED|Overall Study||0
7907745|NCT00676065|19459636|P1|NOT COMPLETED|Overall Study||0
7907746|NCT00676065|19459634|P3|COMPLETED|Overall Study||26341
7907747|NCT00676065|19459635|P2|COMPLETED|Overall Study||15428
7907748|NCT00676065|19459636|P1|COMPLETED|Overall Study||16534
7907749|NCT00676065|19459634|P3|STARTED|Overall Study||26341
7907750|NCT00676065|19459635|P2|STARTED|Overall Study||15428
7907751|NCT00676065|19459636|P1|STARTED|Overall Study||16534
7907752|NCT00676052|19459656|P6|NOT COMPLETED|Overall Study||6
7907753|NCT00676052|19459657|P5|NOT COMPLETED|Overall Study||6
7907754|NCT00676052|19459658|P4|NOT COMPLETED|Overall Study||5
7907755|NCT00676052|19459659|P3|NOT COMPLETED|Overall Study||6
7907756|NCT00676052|19459660|P2|NOT COMPLETED|Overall Study||7
7907757|NCT00676052|19459661|P1|NOT COMPLETED|Overall Study||9
7907758|NCT00676052|19459656|P6|COMPLETED|Overall Study||91
7907759|NCT00676052|19459657|P5|COMPLETED|Overall Study||89
7907760|NCT00676052|19459658|P4|COMPLETED|Overall Study||92
7907761|NCT00676052|19459659|P3|COMPLETED|Overall Study||90
7907762|NCT00676052|19459660|P2|COMPLETED|Overall Study||88
7907763|NCT00676052|19459661|P1|COMPLETED|Overall Study||87
7907764|NCT00676052|19459656|P6|STARTED|Overall Study||97
7907765|NCT00676052|19459657|P5|STARTED|Overall Study||95
7907766|NCT00676052|19459658|P4|STARTED|Overall Study||97
7907767|NCT00676052|19459659|P3|STARTED|Overall Study||96
7907768|NCT00676052|19459660|P2|STARTED|Overall Study||95
7907769|NCT00676052|19459661|P1|STARTED|Overall Study||96
7907770|NCT00676026|19459693|P1|NOT COMPLETED|Overall Study||0
7907771|NCT00676026|19459693|P1|COMPLETED|Overall Study||8
7907772|NCT00676026|19459693|P1|STARTED|Overall Study||8
7907773|NCT00676013|19459697|P1|NOT COMPLETED|Overall Study||1
7907774|NCT00676013|19459697|P1|COMPLETED|Overall Study||157
7907775|NCT00676013|19459697|P1|STARTED|Overall Study||158
7907776|NCT00675987|19459706|P2|NOT COMPLETED|Overall Study||0
7907777|NCT00675987|19459707|P1|NOT COMPLETED|Overall Study||0
7907778|NCT00675987|19459706|P2|COMPLETED|Overall Study||27
7907779|NCT00675987|19459707|P1|COMPLETED|Overall Study||26
7907780|NCT00675987|19459706|P2|STARTED|Overall Study||27
7907781|NCT00675987|19459707|P1|STARTED|Overall Study||26
7907782|NCT00675948|19459731|P2|NOT COMPLETED|Overall Study||3
7907783|NCT00675948|19459732|P1|NOT COMPLETED|Overall Study||39
7907784|NCT00675948|19459731|P2|COMPLETED|Overall Study||1
7907785|NCT00675948|19459732|P1|COMPLETED|Overall Study||0
7907786|NCT00675948|19459731|P2|STARTED|Overall Study||4
7907787|NCT00675948|19459732|P1|STARTED|Overall Study||39
7907788|NCT00675922|19459742|P1|NOT COMPLETED|Overall Study||0
7907789|NCT00675922|19459742|P1|COMPLETED|Overall Study||98
7907790|NCT00675922|19459742|P1|STARTED|Overall Study||98
7907791|NCT00675909|19459750|P3|NOT COMPLETED|Overall Study||0
7907792|NCT00675909|19459751|P2|NOT COMPLETED|Overall Study||0
7907793|NCT00675909|19459752|P1|NOT COMPLETED|Overall Study||0
7907794|NCT00675909|19459750|P3|COMPLETED|Overall Study||60
7907795|NCT00675909|19459751|P2|COMPLETED|Overall Study||60
7907796|NCT00675909|19459752|P1|COMPLETED|Overall Study||60
7907797|NCT00675909|19459750|P3|STARTED|Overall Study||60
7907798|NCT00675909|19459751|P2|STARTED|Overall Study||60
7907799|NCT00675909|19459752|P1|STARTED|Overall Study||60
7907800|NCT00675792|19459774|P2|NOT COMPLETED|Overall Study||0
7907801|NCT00675792|19459775|P1|NOT COMPLETED|Overall Study||0
7907802|NCT00675792|19459774|P2|COMPLETED|Overall Study||49
7907803|NCT00675792|19459775|P1|COMPLETED|Overall Study||51
7907804|NCT00675792|19459774|P2|STARTED|Overall Study||49
7907805|NCT00675792|19459775|P1|STARTED|Overall Study||51
7907806|NCT00675766|19459795|P4|NOT COMPLETED|Overall Study||26
7907807|NCT00675766|19459796|P3|NOT COMPLETED|Overall Study||21
7907808|NCT00675766|19459797|P2|NOT COMPLETED|Overall Study||5
7907809|NCT00675766|19459798|P1|NOT COMPLETED|Overall Study||6
7907810|NCT00675766|19459795|P4|COMPLETED|Overall Study||11
7907811|NCT00675766|19459796|P3|COMPLETED|Overall Study||29
7907812|NCT00675766|19459797|P2|COMPLETED|Overall Study||25
7907813|NCT00675766|19459798|P1|COMPLETED|Overall Study||100
7907814|NCT00675766|19459795|P4|Year 3|Overall Study||11
7907815|NCT00675766|19459796|P3|Year 3|Overall Study||29
7907816|NCT00675766|19459797|P2|Year 3|Overall Study||25
7907817|NCT00675766|19459798|P1|Year 3|Overall Study||100
7907818|NCT00675766|19459795|P4|Year 2|Overall Study||20
7907819|NCT00675766|19459796|P3|Year 2|Overall Study||34
7907820|NCT00675766|19459797|P2|Year 2|Overall Study||28
7907821|NCT00675766|19459798|P1|Year 2|Overall Study||105
7907822|NCT00675766|19459795|P4|STARTED|Overall Study||37
7907823|NCT00675766|19459796|P3|STARTED|Overall Study||50
7907824|NCT00675766|19459797|P2|STARTED|Overall Study||30
7907825|NCT00675766|19459798|P1|STARTED|Overall Study||106
7907826|NCT00675597|19459808|P1|NOT COMPLETED|Overall Study||3
7907827|NCT00675597|19459808|P1|COMPLETED|Overall Study||23
7907828|NCT00675597|19459808|P1|STARTED|Overall Study||26
7907829|NCT00675584|19459814|P2|NOT COMPLETED|Overall Study||26
7907830|NCT00675584|19459815|P1|NOT COMPLETED|Overall Study||39
7907831|NCT00675584|19459814|P2|COMPLETED|Overall Study||113
7907832|NCT00675584|19459815|P1|COMPLETED|Overall Study||100
7907833|NCT00675584|19459814|P2|STARTED|Overall Study||139
7907834|NCT00675584|19459815|P1|STARTED|Overall Study||139
7907835|NCT00675558|19459844|P3|NOT COMPLETED|Second Operation||0
7907836|NCT00675558|19459845|P2|NOT COMPLETED|Second Operation||0
7907837|NCT00675558|19459846|P1|NOT COMPLETED|Second Operation||0
7907838|NCT00675558|19459844|P3|COMPLETED|Second Operation||10
7907839|NCT00675558|19459845|P2|COMPLETED|Second Operation||0
7907840|NCT00675558|19459846|P1|COMPLETED|Second Operation||0
7907841|NCT00675558|19459844|P3|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10
7907842|NCT00675558|19459845|P2|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0
7907843|NCT00675558|19459846|P1|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0
7907844|NCT00675558|19459844|P3|NOT COMPLETED|Surgery||0
7907845|NCT00675558|19459845|P2|NOT COMPLETED|Surgery||0
7907846|NCT00675558|19459846|P1|NOT COMPLETED|Surgery||0
7907847|NCT00675558|19459844|P3|COMPLETED|Surgery||30
7907848|NCT00675558|19459845|P2|COMPLETED|Surgery||10
7907849|NCT00675558|19459846|P1|COMPLETED|Surgery||10
7907850|NCT00675558|19459844|P3|STARTED|Surgery||30
7907851|NCT00675558|19459845|P2|STARTED|Surgery||10
7907852|NCT00675558|19459846|P1|STARTED|Surgery||10
7907853|NCT00675506|19459862|P2|NOT COMPLETED|Overall Study||12
7907854|NCT00675506|19459863|P1|NOT COMPLETED|Overall Study||12
7907855|NCT00675506|19459862|P2|COMPLETED|Overall Study||17
7907856|NCT00675506|19459863|P1|COMPLETED|Overall Study||19
7907857|NCT00675506|19459862|P2|Received Intervention|Overall Study||29
7907858|NCT00675506|19459863|P1|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29
7907859|NCT00675506|19459862|P2|STARTED|Overall Study||29
7907860|NCT00675506|19459863|P1|STARTED|Overall Study||31
7907861|NCT00675441|19459879|P1|NOT COMPLETED|Overall Study||3
7907862|NCT00675441|19459879|P1|COMPLETED|Overall Study||2
7907863|NCT00675441|19459879|P1|STARTED|Overall Study||5
7907864|NCT00675428|19459885|P2|NOT COMPLETED|Overall Study||3
7907865|NCT00675428|19459886|P1|NOT COMPLETED|Overall Study||3
7907866|NCT00675428|19459885|P2|COMPLETED|Overall Study||0
7907867|NCT00675428|19459886|P1|COMPLETED|Overall Study||0
7907868|NCT00675428|19459885|P2|STARTED|Overall Study||3
7907869|NCT00675428|19459886|P1|STARTED|Overall Study||3
7907870|NCT00675415|19459906|P2|NOT COMPLETED|Overall Study||8
7907871|NCT00675415|19459907|P1|NOT COMPLETED|Overall Study||8
7907872|NCT00675415|19459906|P2|COMPLETED|Overall Study||123
7907873|NCT00675415|19459907|P1|COMPLETED|Overall Study||124
7907874|NCT00675415|19459906|P2|STARTED|Overall Study||131
7907875|NCT00675415|19459907|P1|STARTED|Overall Study||132
7907876|NCT00675259|19459919|P1|NOT COMPLETED|Overall Study||14
7907877|NCT00675259|19459919|P1|COMPLETED|Overall Study||19
7907878|NCT00675259|19459919|P1|STARTED|Overall Study||33
7907879|NCT00675103|19459928|P1|NOT COMPLETED|Overall Study||3
7907880|NCT00675103|19459928|P1|COMPLETED|Overall Study||4
7907881|NCT00675103|19459928|P1|STARTED|Overall Study||7
7907882|NCT00674986|19459935|P2|NOT COMPLETED|Overall Study||81
7907883|NCT00674986|19459936|P1|NOT COMPLETED|Overall Study||43
7907884|NCT00674986|19459935|P2|COMPLETED|Overall Study||188
7907885|NCT00674986|19459936|P1|COMPLETED|Overall Study||187
7907886|NCT00674986|19459935|P2|Intent to Treat Population|Overall Study||256
7907887|NCT00674986|19459936|P1|Intent to Treat Population|Overall Study||227
7907888|NCT00674986|19459935|P2|STARTED|Overall Study||269
7907889|NCT00674986|19459936|P1|STARTED|Overall Study||230
7907890|NCT00674973|19459957|P2|NOT COMPLETED|Overall Study||102
7907891|NCT00674973|19459958|P1|NOT COMPLETED|Overall Study||100
7907892|NCT00674973|19459957|P2|COMPLETED|Overall Study|Completed double-blind treatment.|2
7907893|NCT00674973|19459958|P1|COMPLETED|Overall Study|Completed double-blind treatment.|3
7907894|NCT00674973|19459957|P2|Switch to Open-Label Erlotinib|Overall Study||0
7907895|NCT00674973|19459958|P1|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57
7907896|NCT00674973|19459957|P2|STARTED|Overall Study||104
7907897|NCT00674973|19459958|P1|STARTED|Overall Study||103
7907898|NCT00674817|19459972|P1|NOT COMPLETED|Period 6||0
7907899|NCT00674817|19459972|P1|COMPLETED|Period 6||38
7907900|NCT00674817|19459972|P1|STARTED|Period 6||38
7907901|NCT00674817|19459972|P1|NOT COMPLETED|Period 5||0
7907902|NCT00674817|19459972|P1|COMPLETED|Period 5||38
7907903|NCT00674817|19459972|P1|STARTED|Period 5||38
7907904|NCT00674817|19459972|P1|NOT COMPLETED|Period 4||1
7907905|NCT00674817|19459972|P1|COMPLETED|Period 4||38
7907906|NCT00674817|19459972|P1|STARTED|Period 4||39
7907907|NCT00674817|19459972|P1|NOT COMPLETED|Period 3||2
7907908|NCT00674817|19459972|P1|COMPLETED|Period 3||39
7907909|NCT00674817|19459972|P1|STARTED|Period 3||41
7907910|NCT00674817|19459972|P1|NOT COMPLETED|Period 2||0
7907911|NCT00674817|19459972|P1|COMPLETED|Period 2||41
7907912|NCT00674817|19459972|P1|STARTED|Period 2||41
7907913|NCT00674817|19459972|P1|NOT COMPLETED|Period 1||3
7907914|NCT00674817|19459972|P1|COMPLETED|Period 1||41
7907915|NCT00674817|19459972|P1|STARTED|Period 1||44
7907916|NCT00674765|19460120|P2|NOT COMPLETED|Overall Study||29
7907917|NCT00674765|19460121|P1|NOT COMPLETED|Overall Study||36
7907918|NCT00674765|19460120|P2|COMPLETED|Overall Study||46
7907919|NCT00674765|19460121|P1|COMPLETED|Overall Study||45
7907920|NCT00674765|19460120|P2|STARTED|Overall Study||75
7907921|NCT00674765|19460121|P1|STARTED|Overall Study||81
7907922|NCT00674739|19460130|P3|NOT COMPLETED|Overall Study||32
7907923|NCT00674739|19460131|P2|NOT COMPLETED|Overall Study||59
7907924|NCT00674739|19460132|P1|NOT COMPLETED|Overall Study||57
7907925|NCT00674739|19460130|P3|COMPLETED|Overall Study||65
7907926|NCT00674739|19460131|P2|COMPLETED|Overall Study||136
7907927|NCT00674739|19460132|P1|COMPLETED|Overall Study||121
7907928|NCT00674739|19460130|P3|STARTED|Overall Study||97
7907929|NCT00674739|19460131|P2|STARTED|Overall Study||195
7907930|NCT00674739|19460132|P1|STARTED|Overall Study||178
7907931|NCT00674700|19460149|P3|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
7907932|NCT00674700|19460150|P2|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
7907933|NCT00674700|19460151|P1|NOT COMPLETED|Year 2 Follow-up Without Treatment||6
7907934|NCT00674700|19460149|P3|COMPLETED|Year 2 Follow-up Without Treatment||141
7907935|NCT00674700|19460150|P2|COMPLETED|Year 2 Follow-up Without Treatment||123
7907936|NCT00674700|19460151|P1|COMPLETED|Year 2 Follow-up Without Treatment||133
7907937|NCT00674700|19460149|P3|STARTED|Year 2 Follow-up Without Treatment||153
7907938|NCT00674700|19460150|P2|STARTED|Year 2 Follow-up Without Treatment||135
7907939|NCT00674700|19460151|P1|STARTED|Year 2 Follow-up Without Treatment||139
7907940|NCT00674700|19460149|P3|NOT COMPLETED|Year 1||17
7907941|NCT00674700|19460150|P2|NOT COMPLETED|Year 1||34
7907942|NCT00674700|19460151|P1|NOT COMPLETED|Year 1||31
7907943|NCT00674700|19460149|P3|COMPLETED|Year 1||153
7907944|NCT00674700|19460150|P2|COMPLETED|Year 1||135
7907945|NCT00674700|19460151|P1|COMPLETED|Year 1||139
7907946|NCT00674700|19460149|P3|STARTED|Year 1||170
7907947|NCT00674700|19460150|P2|STARTED|Year 1||169
7907948|NCT00674700|19460151|P1|STARTED|Year 1||170
7907949|NCT00674661|19460164|P2|NOT COMPLETED|Overall Study||15
7907950|NCT00674661|19460165|P1|NOT COMPLETED|Overall Study||11
7907951|NCT00674661|19460164|P2|COMPLETED|Overall Study||48
7907952|NCT00674661|19460165|P1|COMPLETED|Overall Study||56
7907953|NCT00674661|19460164|P2|STARTED|Overall Study||63
7907954|NCT00674661|19460165|P1|STARTED|Overall Study||67
7907955|NCT00674622|19460174|P3|NOT COMPLETED|Overall Study||0
7907956|NCT00674622|19460175|P2|NOT COMPLETED|Overall Study||4
7907957|NCT00674622|19460176|P1|NOT COMPLETED|Overall Study||1
7907958|NCT00674622|19460174|P3|COMPLETED|Overall Study||22
7907959|NCT00674622|19460175|P2|COMPLETED|Overall Study||18
7907960|NCT00674622|19460176|P1|COMPLETED|Overall Study||21
7907961|NCT00674622|19460174|P3|STARTED|Overall Study||22
7907962|NCT00674622|19460175|P2|STARTED|Overall Study||22
7907963|NCT00674622|19460176|P1|STARTED|Overall Study||22
7907964|NCT00674609|19460199|P3|NOT COMPLETED|Overall Study||8
7907965|NCT00674609|19460200|P2|NOT COMPLETED|Overall Study||13
7907966|NCT00674609|19460201|P1|NOT COMPLETED|Overall Study||12
7907967|NCT00674609|19460199|P3|COMPLETED|Overall Study||51
7907968|NCT00674609|19460200|P2|COMPLETED|Overall Study||45
7907969|NCT00674609|19460201|P1|COMPLETED|Overall Study||48
7907970|NCT00674609|19460199|P3|STARTED|Overall Study||59
7907971|NCT00674609|19460200|P2|STARTED|Overall Study||58
7907972|NCT00674609|19460201|P1|STARTED|Overall Study||60
7907973|NCT00674583|19460235|P2|NOT COMPLETED|Overall Study||0
7907974|NCT00674583|19460236|P1|NOT COMPLETED|Overall Study||0
7907975|NCT00674583|19460235|P2|COMPLETED|Overall Study||103
7907976|NCT00674583|19460236|P1|COMPLETED|Overall Study||311
7907977|NCT00674583|19460235|P2|STARTED|Overall Study||103
7907978|NCT00674583|19460236|P1|STARTED|Overall Study||311
7907979|NCT00674570|19460263|P3|NOT COMPLETED|Overall Study||0
7907980|NCT00674570|19460264|P2|NOT COMPLETED|Overall Study||2
7907981|NCT00674570|19460265|P1|NOT COMPLETED|Overall Study||0
7907982|NCT00674570|19460263|P3|COMPLETED|Overall Study||35
7907983|NCT00674570|19460264|P2|COMPLETED|Overall Study||32
7907984|NCT00674570|19460265|P1|COMPLETED|Overall Study||37
7907985|NCT00674570|19460263|P3|STARTED|Overall Study||35
7907986|NCT00674570|19460264|P2|STARTED|Overall Study||34
7907987|NCT00674570|19460265|P1|STARTED|Overall Study||37
7907988|NCT00674492|19460273|P1|NOT COMPLETED|Overall Study||0
7907989|NCT00674492|19460273|P1|COMPLETED|Overall Study||21
7907990|NCT00674492|19460273|P1|STARTED|Overall Study||21
7907991|NCT00674479|19460277|P1|NOT COMPLETED|Overall Study||0
7907992|NCT00674479|19460277|P1|COMPLETED|Overall Study||51
7907993|NCT00674479|19460277|P1|STARTED|Overall Study||51
7907994|NCT00674466|19460286|P3|NOT COMPLETED|Overall Study||9
7907995|NCT00674466|19460287|P2|NOT COMPLETED|Overall Study||8
7907996|NCT00674466|19460288|P1|NOT COMPLETED|Overall Study||7
7907997|NCT00674466|19460286|P3|COMPLETED|Overall Study||21
7907998|NCT00674466|19460287|P2|COMPLETED|Overall Study||22
7907999|NCT00674466|19460288|P1|COMPLETED|Overall Study||23
7908000|NCT00674466|19460286|P3|STARTED|Overall Study||30
7908001|NCT00674466|19460287|P2|STARTED|Overall Study||30
7908002|NCT00674466|19460288|P1|STARTED|Overall Study||30
7908003|NCT00674362|19460304|P2|NOT COMPLETED|Open Label||0
7908004|NCT00674362|19460305|P1|NOT COMPLETED|Open Label||2
7908005|NCT00674362|19460304|P2|COMPLETED|Open Label||7
7908006|NCT00674362|19460305|P1|COMPLETED|Open Label||18
7908007|NCT00674362|19460304|P2|STARTED|Open Label||7
7908008|NCT00674362|19460305|P1|STARTED|Open Label||20
7908009|NCT00674362|19460304|P2|NOT COMPLETED|Double Blind||18
7908010|NCT00674362|19460305|P1|NOT COMPLETED|Double Blind||12
7908011|NCT00674362|19460304|P2|COMPLETED|Double Blind||80
7908012|NCT00674362|19460305|P1|COMPLETED|Double Blind||84
7908013|NCT00674362|19460304|P2|STARTED|Double Blind||98
7908014|NCT00674362|19460305|P1|STARTED|Double Blind||96
7908015|NCT00674323|19460373|P3|NOT COMPLETED|Overall Study||0
7908016|NCT00674323|19460374|P2|NOT COMPLETED|Overall Study||1
7908017|NCT00674323|19460375|P1|NOT COMPLETED|Overall Study||1
7908018|NCT00674323|19460373|P3|COMPLETED|Overall Study||21
7908019|NCT00674323|19460374|P2|COMPLETED|Overall Study||20
7908020|NCT00674323|19460375|P1|COMPLETED|Overall Study||18
7908021|NCT00674323|19460373|P3|STARTED|Overall Study||21
7908022|NCT00674323|19460374|P2|STARTED|Overall Study||21
7908023|NCT00674323|19460375|P1|STARTED|Overall Study||19
7908024|NCT00674297|19460392|P4|NOT COMPLETED|Overall Study||3
7908025|NCT00674297|19460393|P3|NOT COMPLETED|Overall Study||4
7908026|NCT00674297|19460394|P2|NOT COMPLETED|Overall Study||0
7908027|NCT00674297|19460395|P1|NOT COMPLETED|Overall Study||10
7908028|NCT00674297|19460392|P4|COMPLETED|Overall Study||4
7908029|NCT00674297|19460393|P3|COMPLETED|Overall Study||5
7908030|NCT00674297|19460394|P2|COMPLETED|Overall Study||7
7908031|NCT00674297|19460395|P1|COMPLETED|Overall Study||8
7908032|NCT00674297|19460392|P4|STARTED|Overall Study||7
7908033|NCT00674297|19460393|P3|STARTED|Overall Study||9
7908034|NCT00674297|19460394|P2|STARTED|Overall Study||7
7908035|NCT00674297|19460395|P1|STARTED|Overall Study||18
7908036|NCT00674219|19460412|P2|NOT COMPLETED|Overall Study||0
7908037|NCT00674219|19460413|P1|NOT COMPLETED|Overall Study||0
7908038|NCT00674219|19460412|P2|COMPLETED|Overall Study||7
7908039|NCT00674219|19460413|P1|COMPLETED|Overall Study||10
7908040|NCT00674219|19460412|P2|STARTED|Overall Study||7
7908041|NCT00674219|19460413|P1|STARTED|Overall Study||10
7908042|NCT00674206|19460419|P1|NOT COMPLETED|Overall Study||0
7908043|NCT00674206|19460419|P1|COMPLETED|Overall Study||6
7908044|NCT00674206|19460419|P1|STARTED|Overall Study||6
7908045|NCT00674154|19460426|P2|NOT COMPLETED|Overall Study||3
7908046|NCT00674154|19460427|P1|NOT COMPLETED|Overall Study||3
7908047|NCT00674154|19460426|P2|COMPLETED|Overall Study||20
7908048|NCT00674154|19460427|P1|COMPLETED|Overall Study||20
7908049|NCT00674154|19460426|P2|STARTED|Overall Study||23
7908050|NCT00674154|19460427|P1|STARTED|Overall Study||23
7908051|NCT00674128|19460435|P2|NOT COMPLETED|Overall Study||23
7908052|NCT00674128|19460436|P1|NOT COMPLETED|Overall Study||25
7908053|NCT00674128|19460435|P2|COMPLETED|Overall Study||21
7908054|NCT00674128|19460436|P1|COMPLETED|Overall Study||25
7908055|NCT00674128|19460435|P2|STARTED|Overall Study||44
7908056|NCT00674128|19460436|P1|STARTED|Overall Study||50
7908057|NCT00674115|19460442|P4|NOT COMPLETED|Third Intervention||0
7908058|NCT00674115|19460443|P3|NOT COMPLETED|Third Intervention||0
7908059|NCT00674115|19460444|P2|NOT COMPLETED|Third Intervention||0
7908060|NCT00674115|19460445|P1|NOT COMPLETED|Third Intervention||0
7908061|NCT00674115|19460442|P4|COMPLETED|Third Intervention||0
7908062|NCT00674115|19460443|P3|COMPLETED|Third Intervention||0
7908063|NCT00674115|19460444|P2|COMPLETED|Third Intervention||16
7908064|NCT00674115|19460445|P1|COMPLETED|Third Intervention||14
7908065|NCT00674115|19460442|P4|STARTED|Third Intervention||0
7908066|NCT00674115|19460443|P3|STARTED|Third Intervention||0
7908067|NCT00674115|19460444|P2|STARTED|Third Intervention||16
7908068|NCT00674115|19460445|P1|STARTED|Third Intervention||14
7908069|NCT00674115|19460442|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
7908070|NCT00674115|19460443|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
7908071|NCT00674115|19460444|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
7908072|NCT00674115|19460445|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
7908073|NCT00674115|19460442|P4|COMPLETED|Washout Period of 2 Weeks||0
7908074|NCT00674115|19460443|P3|COMPLETED|Washout Period of 2 Weeks||0
7908075|NCT00674115|19460444|P2|COMPLETED|Washout Period of 2 Weeks||16
7908076|NCT00674115|19460445|P1|COMPLETED|Washout Period of 2 Weeks||14
7908077|NCT00674115|19460442|P4|STARTED|Washout Period of 2 Weeks||0
7908078|NCT00674115|19460443|P3|STARTED|Washout Period of 2 Weeks||0
7908079|NCT00674115|19460444|P2|STARTED|Washout Period of 2 Weeks||16
7908080|NCT00674115|19460445|P1|STARTED|Washout Period of 2 Weeks||14
7908081|NCT00674115|19460442|P4|NOT COMPLETED|Second Intervention||0
7908082|NCT00674115|19460443|P3|NOT COMPLETED|Second Intervention||0
7908083|NCT00674115|19460444|P2|NOT COMPLETED|Second Intervention||0
7908084|NCT00674115|19460445|P1|NOT COMPLETED|Second Intervention||0
7908085|NCT00674115|19460442|P4|COMPLETED|Second Intervention||16
7908086|NCT00674115|19460443|P3|COMPLETED|Second Intervention||14
7908087|NCT00674115|19460444|P2|COMPLETED|Second Intervention||16
7908088|NCT00674115|19460445|P1|COMPLETED|Second Intervention||14
7908089|NCT00674115|19460442|P4|STARTED|Second Intervention||16
7908090|NCT00674115|19460443|P3|STARTED|Second Intervention||14
7908091|NCT00674115|19460444|P2|STARTED|Second Intervention||16
7908092|NCT00674115|19460445|P1|STARTED|Second Intervention||14
7908093|NCT00674115|19460442|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
7908094|NCT00674115|19460443|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
7908095|NCT00674115|19460444|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
7908096|NCT00674115|19460445|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
7908097|NCT00674115|19460442|P4|COMPLETED|Washout Period of 2 Weeks||16
7908098|NCT00674115|19460443|P3|COMPLETED|Washout Period of 2 Weeks||14
7908099|NCT00674115|19460444|P2|COMPLETED|Washout Period of 2 Weeks||16
7908100|NCT00674115|19460445|P1|COMPLETED|Washout Period of 2 Weeks||14
7908101|NCT00674115|19460442|P4|STARTED|Washout Period of 2 Weeks||16
7908102|NCT00674115|19460443|P3|STARTED|Washout Period of 2 Weeks||14
7908103|NCT00674115|19460444|P2|STARTED|Washout Period of 2 Weeks||16
7908104|NCT00674115|19460445|P1|STARTED|Washout Period of 2 Weeks||14
7908105|NCT00674115|19460442|P4|NOT COMPLETED|First Intervention||0
7908106|NCT00674115|19460443|P3|NOT COMPLETED|First Intervention||0
7908107|NCT00674115|19460444|P2|NOT COMPLETED|First Intervention||0
7908108|NCT00674115|19460445|P1|NOT COMPLETED|First Intervention||0
7908109|NCT00674115|19460442|P4|COMPLETED|First Intervention||16
7908110|NCT00674115|19460443|P3|COMPLETED|First Intervention||14
7908111|NCT00674115|19460444|P2|COMPLETED|First Intervention||16
7908112|NCT00674115|19460445|P1|COMPLETED|First Intervention||14
7908113|NCT00674115|19460442|P4|STARTED|First Intervention||16
7908114|NCT00674115|19460443|P3|STARTED|First Intervention||14
7908115|NCT00674115|19460444|P2|STARTED|First Intervention||16
7908116|NCT00674115|19460445|P1|STARTED|First Intervention||14
7908117|NCT00673959|19460454|P2|NOT COMPLETED|Overall Study||0
7908118|NCT00673959|19460455|P1|NOT COMPLETED|Overall Study||0
7908119|NCT00673959|19460454|P2|COMPLETED|Overall Study||10
7908120|NCT00673959|19460455|P1|COMPLETED|Overall Study||10
7908121|NCT00673959|19460454|P2|STARTED|Overall Study||10
7908122|NCT00673959|19460455|P1|STARTED|Overall Study||10
7908123|NCT00673933|19460461|P1|NOT COMPLETED|Overall Study||3
7908124|NCT00673933|19460461|P1|COMPLETED|Overall Study||17
7908125|NCT00673933|19460461|P1|STARTED|Overall Study||20
7908126|NCT00673920|19460485|P8|NOT COMPLETED|Week 24 to Week 48||0
7908127|NCT00673920|19460486|P7|NOT COMPLETED|Week 24 to Week 48||1
7908128|NCT00673920|19460487|P6|NOT COMPLETED|Week 24 to Week 48||3
7908129|NCT00673920|19460488|P5|NOT COMPLETED|Week 24 to Week 48||0
7908130|NCT00673920|19460489|P4|NOT COMPLETED|Week 24 to Week 48||1
7908131|NCT00673920|19460490|P3|NOT COMPLETED|Week 24 to Week 48||0
7908132|NCT00673920|19460491|P2|NOT COMPLETED|Week 24 to Week 48||0
7908133|NCT00673920|19460492|P1|NOT COMPLETED|Week 24 to Week 48||0
7908134|NCT00673920|19460485|P8|COMPLETED|Week 24 to Week 48||28
7908135|NCT00673920|19460486|P7|COMPLETED|Week 24 to Week 48||28
7908136|NCT00673920|19460487|P6|COMPLETED|Week 24 to Week 48||106
7908137|NCT00673920|19460488|P5|COMPLETED|Week 24 to Week 48||61
7908138|NCT00673920|19460489|P4|COMPLETED|Week 24 to Week 48||60
7908139|NCT00673920|19460490|P3|COMPLETED|Week 24 to Week 48||0
7908140|NCT00673920|19460491|P2|COMPLETED|Week 24 to Week 48||0
7908141|NCT00673920|19460492|P1|COMPLETED|Week 24 to Week 48||0
7908142|NCT00673920|19460485|P8|STARTED|Week 24 to Week 48||28
7908143|NCT00673920|19460486|P7|STARTED|Week 24 to Week 48||29
7908144|NCT00673920|19460487|P6|STARTED|Week 24 to Week 48||109
7908145|NCT00673920|19460488|P5|STARTED|Week 24 to Week 48||61
7908146|NCT00673920|19460489|P4|STARTED|Week 24 to Week 48||61
7908147|NCT00673920|19460490|P3|STARTED|Week 24 to Week 48||0
7908148|NCT00673920|19460491|P2|STARTED|Week 24 to Week 48||0
7908149|NCT00673920|19460492|P1|STARTED|Week 24 to Week 48||0
7908150|NCT00673920|19460485|P8|NOT COMPLETED|Baseline up to Week 48||0
7908151|NCT00673920|19460486|P7|NOT COMPLETED|Baseline up to Week 48||0
7908152|NCT00673920|19460487|P6|NOT COMPLETED|Baseline up to Week 48||0
7908153|NCT00673920|19460488|P5|NOT COMPLETED|Baseline up to Week 48||0
7908154|NCT00673920|19460489|P4|NOT COMPLETED|Baseline up to Week 48||0
7908155|NCT00673920|19460490|P3|NOT COMPLETED|Baseline up to Week 48||7
7908156|NCT00673920|19460491|P2|NOT COMPLETED|Baseline up to Week 48||3
7908157|NCT00673920|19460492|P1|NOT COMPLETED|Baseline up to Week 48||4
7908158|NCT00673920|19460485|P8|COMPLETED|Baseline up to Week 48||0
7908159|NCT00673920|19460486|P7|COMPLETED|Baseline up to Week 48||0
7908160|NCT00673920|19460487|P6|COMPLETED|Baseline up to Week 48||0
7908161|NCT00673920|19460488|P5|COMPLETED|Baseline up to Week 48||0
7908162|NCT00673920|19460489|P4|COMPLETED|Baseline up to Week 48||0
7908163|NCT00673920|19460490|P3|COMPLETED|Baseline up to Week 48||126
7908164|NCT00673920|19460491|P2|COMPLETED|Baseline up to Week 48||114
7908165|NCT00673920|19460492|P1|COMPLETED|Baseline up to Week 48||60
7908166|NCT00673920|19460485|P8|STARTED|Baseline up to Week 48||0
7908167|NCT00673920|19460486|P7|STARTED|Baseline up to Week 48||0
7908168|NCT00673920|19460487|P6|STARTED|Baseline up to Week 48||0
7908169|NCT00673920|19460488|P5|STARTED|Baseline up to Week 48||0
7908170|NCT00673920|19460489|P4|STARTED|Baseline up to Week 48||0
7908171|NCT00673920|19460490|P3|STARTED|Baseline up to Week 48||133
7908172|NCT00673920|19460491|P2|STARTED|Baseline up to Week 48||117
7908173|NCT00673920|19460492|P1|STARTED|Baseline up to Week 48||64
7908174|NCT00673894|19460638|P2|NOT COMPLETED|Second Intervention 4 Weeks||0
7908175|NCT00673894|19460639|P1|NOT COMPLETED|Second Intervention 4 Weeks||0
7908176|NCT00673894|19460638|P2|COMPLETED|Second Intervention 4 Weeks||7
7908177|NCT00673894|19460639|P1|COMPLETED|Second Intervention 4 Weeks||6
7908178|NCT00673894|19460638|P2|STARTED|Second Intervention 4 Weeks||7
7908179|NCT00673894|19460639|P1|STARTED|Second Intervention 4 Weeks||6
7908180|NCT00673894|19460638|P2|NOT COMPLETED|Washout 4-6 Weeks||0
7908181|NCT00673894|19460639|P1|NOT COMPLETED|Washout 4-6 Weeks||0
7908182|NCT00673894|19460638|P2|COMPLETED|Washout 4-6 Weeks||7
7908183|NCT00673894|19460639|P1|COMPLETED|Washout 4-6 Weeks||6
7908184|NCT00673894|19460638|P2|STARTED|Washout 4-6 Weeks||7
7908185|NCT00673894|19460639|P1|STARTED|Washout 4-6 Weeks||6
7908186|NCT00673894|19460638|P2|NOT COMPLETED|First Intervention 4 Weeks||0
7908187|NCT00673894|19460639|P1|NOT COMPLETED|First Intervention 4 Weeks||2
7908188|NCT00673894|19460638|P2|COMPLETED|First Intervention 4 Weeks||7
7908189|NCT00673894|19460639|P1|COMPLETED|First Intervention 4 Weeks||6
7908190|NCT00673894|19460638|P2|STARTED|First Intervention 4 Weeks||7
7908191|NCT00673894|19460639|P1|STARTED|First Intervention 4 Weeks||8
7908192|NCT00673881|19460647|P1|NOT COMPLETED|Overall Study||1
7908193|NCT00673881|19460647|P1|COMPLETED|Overall Study||24
7908194|NCT00673881|19460647|P1|STARTED|Overall Study||25
7908195|NCT00673855|19460654|P2|NOT COMPLETED|Second Intervention||0
7908196|NCT00673855|19460655|P1|NOT COMPLETED|Second Intervention||0
7908197|NCT00673855|19460654|P2|COMPLETED|Second Intervention||10
7908198|NCT00673855|19460655|P1|COMPLETED|Second Intervention||10
7908199|NCT00673855|19460654|P2|STARTED|Second Intervention||10
7908200|NCT00673855|19460655|P1|STARTED|Second Intervention||10
7908201|NCT00673855|19460654|P2|NOT COMPLETED|First Intervention||0
7908202|NCT00673855|19460655|P1|NOT COMPLETED|First Intervention||0
7908203|NCT00673855|19460654|P2|COMPLETED|First Intervention||10
7908204|NCT00673855|19460655|P1|COMPLETED|First Intervention||10
7908205|NCT00673855|19460654|P2|STARTED|First Intervention||10
7908206|NCT00673855|19460655|P1|STARTED|First Intervention||10
7908207|NCT00673816|19460661|P1|NOT COMPLETED|Overall Study||2
7908208|NCT00673816|19460661|P1|COMPLETED|Overall Study||0
7908209|NCT00673816|19460661|P1|STARTED|Overall Study||2
7908210|NCT00673790|19460671|P3|NOT COMPLETED|Overall Study||12
7908211|NCT00673790|19460672|P2|NOT COMPLETED|Overall Study||38
7908212|NCT00673790|19460673|P1|NOT COMPLETED|Overall Study||45
7908213|NCT00673790|19460671|P3|COMPLETED|Overall Study||90
7908214|NCT00673790|19460672|P2|COMPLETED|Overall Study||174
7908215|NCT00673790|19460673|P1|COMPLETED|Overall Study||178
7908216|NCT00673790|19460671|P3|STARTED|Overall Study||102
7908217|NCT00673790|19460672|P2|STARTED|Overall Study||212
7908218|NCT00673790|19460673|P1|STARTED|Overall Study||223
7908219|NCT00673764|19460683|P2|NOT COMPLETED|Overall Study||0
7908220|NCT00673764|19460684|P1|NOT COMPLETED|Overall Study||0
7908221|NCT00673764|19460683|P2|COMPLETED|Overall Study||24
7908222|NCT00673764|19460684|P1|COMPLETED|Overall Study||24
7908223|NCT00673764|19460683|P2|STARTED|Overall Study||24
7908224|NCT00673764|19460684|P1|STARTED|Overall Study||24
7908225|NCT00673738|19460692|P1|NOT COMPLETED|Overall Study||0
7908226|NCT00673738|19460692|P1|COMPLETED|Overall Study||27
7908227|NCT00673738|19460692|P1|STARTED|Overall Study||27
7908228|NCT00673712|19460700|P2|NOT COMPLETED|Overall Study||0
7908229|NCT00673712|19460701|P1|NOT COMPLETED|Overall Study||0
7908230|NCT00673712|19460700|P2|COMPLETED|Overall Study||326
7908231|NCT00673712|19460701|P1|COMPLETED|Overall Study||321
7908232|NCT00673712|19460700|P2|STARTED|Overall Study||326
7908233|NCT00673712|19460701|P1|STARTED|Overall Study||321
7908234|NCT00673673|19460711|P1|NOT COMPLETED|Overall Study||36
7908235|NCT00673673|19460711|P1|COMPLETED|Overall Study||3
7908236|NCT00673673|19460711|P1|STARTED|Overall Study||39
7908237|NCT00673660|19460717|P1|NOT COMPLETED|Overall Study||107
7908238|NCT00673660|19460717|P1|COMPLETED|Overall Study||268
7908239|NCT00673660|19460717|P1|STARTED|Overall Study||375
7908240|NCT00673595|19460730|P2|NOT COMPLETED|Overall Study||0
7908241|NCT00673595|19460731|P1|NOT COMPLETED|Overall Study||0
7908242|NCT00673595|19460730|P2|COMPLETED|Overall Study||11
7908243|NCT00673595|19460731|P1|COMPLETED|Overall Study||8
7908244|NCT00673595|19460730|P2|STARTED|Overall Study||11
7908245|NCT00673595|19460731|P1|STARTED|Overall Study||8
7908246|NCT00673465|19460739|P12|NOT COMPLETED|Part 2 (India)||0
7908247|NCT00673465|19460740|P11|NOT COMPLETED|Part 2 (India)||0
7908248|NCT00673465|19460741|P10|NOT COMPLETED|Part 2 (India)||0
7908249|NCT00673465|19460742|P9|NOT COMPLETED|Part 2 (India)||0
7908250|NCT00673465|19460743|P8|NOT COMPLETED|Part 2 (India)||0
7908251|NCT00673465|19460744|P7|NOT COMPLETED|Part 2 (India)||0
7908252|NCT00673465|19460745|P6|NOT COMPLETED|Part 2 (India)||0
7908253|NCT00673465|19460746|P5|NOT COMPLETED|Part 2 (India)||0
7908254|NCT00673465|19460747|P4|NOT COMPLETED|Part 2 (India)||0
7908255|NCT00673465|19460748|P3|NOT COMPLETED|Part 2 (India)||0
7908256|NCT00673465|19460749|P2|NOT COMPLETED|Part 2 (India)||0
7908257|NCT00673465|19460750|P1|NOT COMPLETED|Part 2 (India)||0
7908258|NCT00673465|19460739|P12|COMPLETED|Part 2 (India)||0
7908259|NCT00673465|19460740|P11|COMPLETED|Part 2 (India)||0
7908260|NCT00673465|19460741|P10|COMPLETED|Part 2 (India)||0
7908261|NCT00673465|19460742|P9|COMPLETED|Part 2 (India)||0
7908262|NCT00673465|19460743|P8|COMPLETED|Part 2 (India)||0
7908263|NCT00673465|19460744|P7|COMPLETED|Part 2 (India)||0
7908264|NCT00673465|19460745|P6|COMPLETED|Part 2 (India)||0
7908265|NCT00673465|19460746|P5|COMPLETED|Part 2 (India)||0
7908266|NCT00673465|19460747|P4|COMPLETED|Part 2 (India)||0
7908267|NCT00673465|19460748|P3|COMPLETED|Part 2 (India)||0
7908268|NCT00673465|19460749|P2|COMPLETED|Part 2 (India)||0
7908269|NCT00673465|19460750|P1|COMPLETED|Part 2 (India)||0
7908270|NCT00673465|19460739|P12|STARTED|Part 2 (India)||0
7908271|NCT00673465|19460740|P11|STARTED|Part 2 (India)||0
7908272|NCT00673465|19460741|P10|STARTED|Part 2 (India)||0
7908273|NCT00673465|19460742|P9|STARTED|Part 2 (India)||0
7908274|NCT00673465|19460743|P8|STARTED|Part 2 (India)||0
7908275|NCT00673465|19460744|P7|STARTED|Part 2 (India)||0
7908276|NCT00673465|19460745|P6|STARTED|Part 2 (India)||0
7908277|NCT00673465|19460746|P5|STARTED|Part 2 (India)||0
7908278|NCT00673465|19460747|P4|STARTED|Part 2 (India)||0
7908279|NCT00673465|19460748|P3|STARTED|Part 2 (India)||0
7908280|NCT00673465|19460749|P2|STARTED|Part 2 (India)||0
7908281|NCT00673465|19460750|P1|STARTED|Part 2 (India)||0
7908282|NCT00673465|19460739|P12|NOT COMPLETED|Part 1/Period 3 (United States)||0
7908283|NCT00673465|19460740|P11|NOT COMPLETED|Part 1/Period 3 (United States)||0
7908284|NCT00673465|19460741|P10|NOT COMPLETED|Part 1/Period 3 (United States)||0
7908285|NCT00673465|19460742|P9|NOT COMPLETED|Part 1/Period 3 (United States)||0
7908286|NCT00673465|19460743|P8|NOT COMPLETED|Part 1/Period 3 (United States)||0
7908287|NCT00673465|19460744|P7|NOT COMPLETED|Part 1/Period 3 (United States)||0
7908288|NCT00673465|19460745|P6|NOT COMPLETED|Part 1/Period 3 (United States)||0
7908289|NCT00673465|19460746|P5|NOT COMPLETED|Part 1/Period 3 (United States)||0
7908290|NCT00673465|19460747|P4|NOT COMPLETED|Part 1/Period 3 (United States)||0
7908291|NCT00673465|19460748|P3|NOT COMPLETED|Part 1/Period 3 (United States)||0
7908292|NCT00673465|19460749|P2|NOT COMPLETED|Part 1/Period 3 (United States)||0
7908293|NCT00673465|19460750|P1|NOT COMPLETED|Part 1/Period 3 (United States)||0
7908294|NCT00673465|19460739|P12|COMPLETED|Part 1/Period 3 (United States)||0
7908295|NCT00673465|19460740|P11|COMPLETED|Part 1/Period 3 (United States)||0
7908296|NCT00673465|19460741|P10|COMPLETED|Part 1/Period 3 (United States)||0
7908297|NCT00673465|19460742|P9|COMPLETED|Part 1/Period 3 (United States)||0
7908298|NCT00673465|19460743|P8|COMPLETED|Part 1/Period 3 (United States)||0
7908299|NCT00673465|19460744|P7|COMPLETED|Part 1/Period 3 (United States)||0
7908300|NCT00673465|19460745|P6|COMPLETED|Part 1/Period 3 (United States)||1
7908301|NCT00673465|19460746|P5|COMPLETED|Part 1/Period 3 (United States)||1
7908302|NCT00673465|19460747|P4|COMPLETED|Part 1/Period 3 (United States)||3
7908303|NCT00673465|19460748|P3|COMPLETED|Part 1/Period 3 (United States)||3
7908304|NCT00673465|19460749|P2|COMPLETED|Part 1/Period 3 (United States)||3
7908305|NCT00673465|19460750|P1|COMPLETED|Part 1/Period 3 (United States)||3
7908306|NCT00673465|19460739|P12|STARTED|Part 1/Period 3 (United States)||0
7908307|NCT00673465|19460740|P11|STARTED|Part 1/Period 3 (United States)||0
7908308|NCT00673465|19460741|P10|STARTED|Part 1/Period 3 (United States)||0
7908309|NCT00673465|19460742|P9|STARTED|Part 1/Period 3 (United States)||0
7908310|NCT00673465|19460743|P8|STARTED|Part 1/Period 3 (United States)||0
7908311|NCT00673465|19460744|P7|STARTED|Part 1/Period 3 (United States)||0
7908312|NCT00673465|19460745|P6|STARTED|Part 1/Period 3 (United States)||1
7908313|NCT00673465|19460746|P5|STARTED|Part 1/Period 3 (United States)||1
7908314|NCT00673465|19460747|P4|STARTED|Part 1/Period 3 (United States)||3
7908315|NCT00673465|19460748|P3|STARTED|Part 1/Period 3 (United States)||3
7908316|NCT00673465|19460749|P2|STARTED|Part 1/Period 3 (United States)||3
7908317|NCT00673465|19460750|P1|STARTED|Part 1/Period 3 (United States)||3
7908318|NCT00673465|19460739|P12|NOT COMPLETED|Part 1/Period 2 (United States)||0
7908319|NCT00673465|19460740|P11|NOT COMPLETED|Part 1/Period 2 (United States)||0
7908320|NCT00673465|19460741|P10|NOT COMPLETED|Part 1/Period 2 (United States)||0
7908321|NCT00673465|19460742|P9|NOT COMPLETED|Part 1/Period 2 (United States)||0
7908322|NCT00673465|19460743|P8|NOT COMPLETED|Part 1/Period 2 (United States)||0
7908323|NCT00673465|19460744|P7|NOT COMPLETED|Part 1/Period 2 (United States)||0
7908324|NCT00673465|19460745|P6|NOT COMPLETED|Part 1/Period 2 (United States)||0
7908325|NCT00673465|19460746|P5|NOT COMPLETED|Part 1/Period 2 (United States)||1
7908326|NCT00673465|19460747|P4|NOT COMPLETED|Part 1/Period 2 (United States)||0
7908327|NCT00673465|19460748|P3|NOT COMPLETED|Part 1/Period 2 (United States)||0
7908328|NCT00673465|19460749|P2|NOT COMPLETED|Part 1/Period 2 (United States)||0
7908329|NCT00673465|19460750|P1|NOT COMPLETED|Part 1/Period 2 (United States)||0
7908330|NCT00673465|19460739|P12|COMPLETED|Part 1/Period 2 (United States)||0
7908331|NCT00673465|19460740|P11|COMPLETED|Part 1/Period 2 (United States)||0
7908332|NCT00673465|19460741|P10|COMPLETED|Part 1/Period 2 (United States)||0
7908333|NCT00673465|19460742|P9|COMPLETED|Part 1/Period 2 (United States)||0
7908334|NCT00673465|19460743|P8|COMPLETED|Part 1/Period 2 (United States)||0
7908335|NCT00673465|19460744|P7|COMPLETED|Part 1/Period 2 (United States)||0
7908336|NCT00673465|19460745|P6|COMPLETED|Part 1/Period 2 (United States)||1
7908337|NCT00673465|19460746|P5|COMPLETED|Part 1/Period 2 (United States)||1
7908338|NCT00673465|19460747|P4|COMPLETED|Part 1/Period 2 (United States)||3
7908339|NCT00673465|19460748|P3|COMPLETED|Part 1/Period 2 (United States)||3
7908340|NCT00673465|19460749|P2|COMPLETED|Part 1/Period 2 (United States)||3
7908341|NCT00673465|19460750|P1|COMPLETED|Part 1/Period 2 (United States)||3
7908342|NCT00673465|19460739|P12|STARTED|Part 1/Period 2 (United States)||0
7908343|NCT00673465|19460740|P11|STARTED|Part 1/Period 2 (United States)||0
7908344|NCT00673465|19460741|P10|STARTED|Part 1/Period 2 (United States)||0
7908345|NCT00673465|19460742|P9|STARTED|Part 1/Period 2 (United States)||0
7908346|NCT00673465|19460743|P8|STARTED|Part 1/Period 2 (United States)||0
7908347|NCT00673465|19460744|P7|STARTED|Part 1/Period 2 (United States)||0
7908348|NCT00673465|19460745|P6|STARTED|Part 1/Period 2 (United States)||1
7908349|NCT00673465|19460746|P5|STARTED|Part 1/Period 2 (United States)||2
7908350|NCT00673465|19460747|P4|STARTED|Part 1/Period 2 (United States)||3
7908351|NCT00673465|19460748|P3|STARTED|Part 1/Period 2 (United States)||3
7908352|NCT00673465|19460749|P2|STARTED|Part 1/Period 2 (United States)||3
7908353|NCT00673465|19460750|P1|STARTED|Part 1/Period 2 (United States)||3
7908354|NCT00673465|19460739|P12|NOT COMPLETED|Part 1/Period 1 (United States)||0
7908355|NCT00673465|19460740|P11|NOT COMPLETED|Part 1/Period 1 (United States)||0
7908356|NCT00673465|19460741|P10|NOT COMPLETED|Part 1/Period 1 (United States)||0
7908357|NCT00673465|19460742|P9|NOT COMPLETED|Part 1/Period 1 (United States)||0
7908358|NCT00673465|19460743|P8|NOT COMPLETED|Part 1/Period 1 (United States)||0
7908359|NCT00673465|19460744|P7|NOT COMPLETED|Part 1/Period 1 (United States)||0
7908360|NCT00673465|19460745|P6|NOT COMPLETED|Part 1/Period 1 (United States)||1
7908361|NCT00673465|19460746|P5|NOT COMPLETED|Part 1/Period 1 (United States)||1
7908362|NCT00673465|19460747|P4|NOT COMPLETED|Part 1/Period 1 (United States)||0
7908363|NCT00673465|19460748|P3|NOT COMPLETED|Part 1/Period 1 (United States)||0
7908364|NCT00673465|19460749|P2|NOT COMPLETED|Part 1/Period 1 (United States)||0
7908365|NCT00673465|19460750|P1|NOT COMPLETED|Part 1/Period 1 (United States)||0
7908366|NCT00673465|19460739|P12|COMPLETED|Part 1/Period 1 (United States)||0
7908367|NCT00673465|19460740|P11|COMPLETED|Part 1/Period 1 (United States)||0
7908368|NCT00673465|19460741|P10|COMPLETED|Part 1/Period 1 (United States)||0
7908369|NCT00673465|19460742|P9|COMPLETED|Part 1/Period 1 (United States)||0
7908370|NCT00673465|19460743|P8|COMPLETED|Part 1/Period 1 (United States)||0
7908371|NCT00673465|19460744|P7|COMPLETED|Part 1/Period 1 (United States)||0
7908372|NCT00673465|19460745|P6|COMPLETED|Part 1/Period 1 (United States)||1
7908373|NCT00673465|19460746|P5|COMPLETED|Part 1/Period 1 (United States)||2
7908374|NCT00673465|19460747|P4|COMPLETED|Part 1/Period 1 (United States)||3
7908375|NCT00673465|19460748|P3|COMPLETED|Part 1/Period 1 (United States)||3
7908376|NCT00673465|19460749|P2|COMPLETED|Part 1/Period 1 (United States)||3
7908377|NCT00673465|19460750|P1|COMPLETED|Part 1/Period 1 (United States)||3
7908378|NCT00673465|19460739|P12|STARTED|Part 1/Period 1 (United States)||0
7908379|NCT00673465|19460740|P11|STARTED|Part 1/Period 1 (United States)||0
7908380|NCT00673465|19460741|P10|STARTED|Part 1/Period 1 (United States)||0
7908381|NCT00673465|19460742|P9|STARTED|Part 1/Period 1 (United States)||0
7908382|NCT00673465|19460743|P8|STARTED|Part 1/Period 1 (United States)||0
7908383|NCT00673465|19460744|P7|STARTED|Part 1/Period 1 (United States)||0
7908384|NCT00673465|19460745|P6|STARTED|Part 1/Period 1 (United States)||2
7908385|NCT00673465|19460746|P5|STARTED|Part 1/Period 1 (United States)||3
7908386|NCT00673465|19460747|P4|STARTED|Part 1/Period 1 (United States)||3
7908387|NCT00673465|19460748|P3|STARTED|Part 1/Period 1 (United States)||3
7908388|NCT00673465|19460749|P2|STARTED|Part 1/Period 1 (United States)||3
7908389|NCT00673465|19460750|P1|STARTED|Part 1/Period 1 (United States)||3
7908390|NCT00673452|19460799|P2|NOT COMPLETED|Continuation Double-Blind Phase||34
7908391|NCT00673452|19460800|P1|NOT COMPLETED|Continuation Double-Blind Phase||25
7908392|NCT00673452|19460799|P2|COMPLETED|Continuation Double-Blind Phase||153
7908393|NCT00673452|19460800|P1|COMPLETED|Continuation Double-Blind Phase||151
7908394|NCT00673452|19460799|P2|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187
7908395|NCT00673452|19460800|P1|STARTED|Continuation Double-Blind Phase||176
7908396|NCT00673452|19460799|P2|NOT COMPLETED|Acute Double-Blind Phase||80
7908397|NCT00673452|19460800|P1|NOT COMPLETED|Acute Double-Blind Phase||87
7908398|NCT00673452|19460799|P2|COMPLETED|Acute Double-Blind Phase||187
7908399|NCT00673452|19460800|P1|COMPLETED|Acute Double-Blind Phase||176
7908400|NCT00673452|19460799|P2|STARTED|Acute Double-Blind Phase||267
7908401|NCT00673452|19460800|P1|STARTED|Acute Double-Blind Phase||263
7908402|NCT00673439|19460834|P1|NOT COMPLETED|Overall Study||0
7908403|NCT00673439|19460834|P1|COMPLETED|Overall Study||3
7908404|NCT00673439|19460834|P1|STARTED|Overall Study||3
7908405|NCT00673400|19460839|P1|NOT COMPLETED|Overall Study||0
7908406|NCT00673400|19460839|P1|COMPLETED|Overall Study||52
7908407|NCT00673400|19460839|P1|STARTED|Overall Study||52
7908408|NCT00673387|19460864|P8|NOT COMPLETED|Overall Study||35
7908409|NCT00673387|19460865|P7|NOT COMPLETED|Overall Study||30
7908410|NCT00673387|19460866|P6|NOT COMPLETED|Overall Study||34
7908411|NCT00673387|19460867|P5|NOT COMPLETED|Overall Study||30
7908412|NCT00673387|19460868|P4|NOT COMPLETED|Overall Study||26
7908413|NCT00673387|19460869|P3|NOT COMPLETED|Overall Study||31
7908414|NCT00673387|19460870|P2|NOT COMPLETED|Overall Study||23
7908415|NCT00673387|19460871|P1|NOT COMPLETED|Overall Study||29
7908416|NCT00673387|19460864|P8|COMPLETED|Overall Study||40
7908417|NCT00673387|19460865|P7|COMPLETED|Overall Study||48
7908418|NCT00673387|19460866|P6|COMPLETED|Overall Study||44
7908419|NCT00673387|19460867|P5|COMPLETED|Overall Study||48
7908420|NCT00673387|19460868|P4|COMPLETED|Overall Study||49
7908421|NCT00673387|19460869|P3|COMPLETED|Overall Study||41
7908422|NCT00673387|19460870|P2|COMPLETED|Overall Study||54
7908423|NCT00673387|19460871|P1|COMPLETED|Overall Study||46
7908424|NCT00673387|19460864|P8|STARTED|Overall Study||75
7908425|NCT00673387|19460865|P7|STARTED|Overall Study||78
7908426|NCT00673387|19460866|P6|STARTED|Overall Study||78
7908427|NCT00673387|19460867|P5|STARTED|Overall Study||78
7908428|NCT00673387|19460868|P4|STARTED|Overall Study||75
7908429|NCT00673387|19460869|P3|STARTED|Overall Study||72
7908430|NCT00673387|19460870|P2|STARTED|Overall Study||77
7908431|NCT00673387|19460871|P1|STARTED|Overall Study||75
7908432|NCT00673361|19461087|P1|NOT COMPLETED|Overall Study||2
7908433|NCT00673361|19461087|P1|COMPLETED|Overall Study||7
7908434|NCT00673361|19461087|P1|STARTED|Overall Study||9
7908435|NCT00673309|19461101|P10|NOT COMPLETED|Overall Study||0
7908436|NCT00673309|19461102|P9|NOT COMPLETED|Overall Study||0
7908437|NCT00673309|19461103|P8|NOT COMPLETED|Overall Study||0
7908438|NCT00673309|19461104|P7|NOT COMPLETED|Overall Study||0
7908439|NCT00673309|19461105|P6|NOT COMPLETED|Overall Study||0
7908440|NCT00673309|19461106|P5|NOT COMPLETED|Overall Study||0
7908441|NCT00673309|19461107|P4|NOT COMPLETED|Overall Study||0
7908442|NCT00673309|19461108|P3|NOT COMPLETED|Overall Study||0
7908443|NCT00673309|19461109|P2|NOT COMPLETED|Overall Study||0
7908444|NCT00673309|19461110|P1|NOT COMPLETED|Overall Study||0
7908445|NCT00673309|19461101|P10|COMPLETED|Overall Study||30
7908446|NCT00673309|19461102|P9|COMPLETED|Overall Study||17
7908447|NCT00673309|19461103|P8|COMPLETED|Overall Study||13
7908448|NCT00673309|19461104|P7|COMPLETED|Overall Study||14
7908449|NCT00673309|19461105|P6|COMPLETED|Overall Study||35
7908450|NCT00673309|19461106|P5|COMPLETED|Overall Study||18
7908451|NCT00673309|19461107|P4|COMPLETED|Overall Study||25
7908452|NCT00673309|19461108|P3|COMPLETED|Overall Study||14
7908453|NCT00673309|19461109|P2|COMPLETED|Overall Study||14
7908454|NCT00673309|19461110|P1|COMPLETED|Overall Study||64
7908455|NCT00673309|19461101|P10|STARTED|Overall Study||30
7908456|NCT00673309|19461102|P9|STARTED|Overall Study||17
7908457|NCT00673309|19461103|P8|STARTED|Overall Study||13
7908458|NCT00673309|19461104|P7|STARTED|Overall Study||14
7908459|NCT00673309|19461105|P6|STARTED|Overall Study||35
7908460|NCT00673309|19461106|P5|STARTED|Overall Study||18
7908461|NCT00673309|19461107|P4|STARTED|Overall Study||25
7908462|NCT00673309|19461108|P3|STARTED|Overall Study||14
7908463|NCT00673309|19461109|P2|STARTED|Overall Study||14
7908464|NCT00673309|19461110|P1|STARTED|Overall Study||64
7908465|NCT00673257|19461123|P1|NOT COMPLETED|Overall Study||5
7908466|NCT00673257|19461123|P1|COMPLETED|Overall Study||102
7908467|NCT00673257|19461123|P1|STARTED|Overall Study||107
7908468|NCT00673244|19461130|P2|NOT COMPLETED|Overall Study||0
7908469|NCT00673244|19461131|P1|NOT COMPLETED|Overall Study||0
7908470|NCT00673244|19461130|P2|COMPLETED|Overall Study||25
7908471|NCT00673244|19461131|P1|COMPLETED|Overall Study||52
7908472|NCT00673244|19461130|P2|STARTED|Overall Study||25
7908473|NCT00673244|19461131|P1|STARTED|Overall Study||52
7908474|NCT00673231|19461141|P4|NOT COMPLETED|Overall Study||18
7908475|NCT00673231|19461142|P3|NOT COMPLETED|Overall Study||26
7908476|NCT00673231|19461143|P2|NOT COMPLETED|Overall Study||22
7908477|NCT00673231|19461144|P1|NOT COMPLETED|Overall Study||29
7908478|NCT00673231|19461141|P4|COMPLETED|Overall Study||178
7908479|NCT00673231|19461142|P3|COMPLETED|Overall Study||186
7908480|NCT00673231|19461143|P2|COMPLETED|Overall Study||180
7908481|NCT00673231|19461144|P1|COMPLETED|Overall Study||168
7908482|NCT00673231|19461141|P4|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196
7908483|NCT00673231|19461142|P3|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212
7908484|NCT00673231|19461143|P2|STARTED|Overall Study|All 202 were included in the full analysis set|202
7908485|NCT00673231|19461144|P1|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197
7908486|NCT00673179|19461176|P2|NOT COMPLETED|Overall Study||0
7908487|NCT00673179|19461177|P1|NOT COMPLETED|Overall Study||3
7908488|NCT00673179|19461176|P2|COMPLETED|Overall Study||0
7908489|NCT00673179|19461177|P1|COMPLETED|Overall Study||4
7908490|NCT00673179|19461176|P2|STARTED|Overall Study||0
7908491|NCT00673179|19461177|P1|STARTED|Overall Study||7
7908492|NCT00673153|19461183|P1|NOT COMPLETED|Overall Study||1
7908493|NCT00673153|19461183|P1|COMPLETED|Overall Study||30
7908494|NCT00673153|19461183|P1|STARTED|Overall Study||31
7908495|NCT00673127|19461191|P1|NOT COMPLETED|Overall Study||0
7908496|NCT00673127|19461191|P1|COMPLETED|Overall Study||57
7908497|NCT00673127|19461191|P1|STARTED|Overall Study||57
7908498|NCT00673114|19461196|P1|NOT COMPLETED|Overall Study||0
7908499|NCT00673114|19461196|P1|COMPLETED|Overall Study||3
7908500|NCT00673114|19461196|P1|STARTED|Overall Study||3
7908501|NCT00673075|19461209|P2|NOT COMPLETED|Overall Study||7
7908502|NCT00673075|19461210|P1|NOT COMPLETED|Overall Study||9
7908503|NCT00673075|19461209|P2|COMPLETED|Overall Study||11
7908504|NCT00673075|19461210|P1|COMPLETED|Overall Study||12
7908505|NCT00673075|19461209|P2|STARTED|Overall Study||18
7908506|NCT00673075|19461210|P1|STARTED|Overall Study||21
7908507|NCT00673049|19461226|P4|NOT COMPLETED|After Progression on Erlotinib||83
7908508|NCT00673049|19461227|P3|NOT COMPLETED|After Progression on Erlotinib||0
7908509|NCT00673049|19461228|P2|NOT COMPLETED|After Progression on Erlotinib||0
7908510|NCT00673049|19461229|P1|NOT COMPLETED|After Progression on Erlotinib||0
7908511|NCT00673049|19461226|P4|COMPLETED|After Progression on Erlotinib||0
7908512|NCT00673049|19461227|P3|COMPLETED|After Progression on Erlotinib||0
7908513|NCT00673049|19461228|P2|COMPLETED|After Progression on Erlotinib||0
7908514|NCT00673049|19461229|P1|COMPLETED|After Progression on Erlotinib||0
7908515|NCT00673049|19461226|P4|STARTED|After Progression on Erlotinib||83
7908516|NCT00673049|19461227|P3|STARTED|After Progression on Erlotinib||0
7908517|NCT00673049|19461228|P2|STARTED|After Progression on Erlotinib||0
7908518|NCT00673049|19461229|P1|STARTED|After Progression on Erlotinib||0
7908519|NCT00673049|19461226|P4|NOT COMPLETED|Before Progression on Erlotinib||0
7908520|NCT00673049|19461227|P3|NOT COMPLETED|Before Progression on Erlotinib||1
7908521|NCT00673049|19461228|P2|NOT COMPLETED|Before Progression on Erlotinib||290
7908522|NCT00673049|19461229|P1|NOT COMPLETED|Before Progression on Erlotinib||292
7908523|NCT00673049|19461226|P4|COMPLETED|Before Progression on Erlotinib||0
7908524|NCT00673049|19461227|P3|COMPLETED|Before Progression on Erlotinib||0
7908525|NCT00673049|19461228|P2|COMPLETED|Before Progression on Erlotinib||0
7908526|NCT00673049|19461229|P1|COMPLETED|Before Progression on Erlotinib||0
7908527|NCT00673049|19461226|P4|Treated|Before Progression on Erlotinib||0
7908528|NCT00673049|19461227|P3|Treated|Before Progression on Erlotinib||1
7908529|NCT00673049|19461228|P2|Treated|Before Progression on Erlotinib||289
7908530|NCT00673049|19461229|P1|Treated|Before Progression on Erlotinib||289
7908531|NCT00673049|19461226|P4|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0
7908532|NCT00673049|19461227|P3|STARTED|Before Progression on Erlotinib||1
7908533|NCT00673049|19461228|P2|STARTED|Before Progression on Erlotinib||290
7908534|NCT00673049|19461229|P1|STARTED|Before Progression on Erlotinib||292
7908535|NCT00672984|19461253|P3|NOT COMPLETED|Third Intervention||1
7908536|NCT00672984|19461254|P2|NOT COMPLETED|Third Intervention||0
7908537|NCT00672984|19461255|P1|NOT COMPLETED|Third Intervention||1
7908538|NCT00672984|19461253|P3|COMPLETED|Third Intervention||23
7908539|NCT00672984|19461254|P2|COMPLETED|Third Intervention||17
7908540|NCT00672984|19461255|P1|COMPLETED|Third Intervention||21
7908541|NCT00672984|19461253|P3|STARTED|Third Intervention||24
7908542|NCT00672984|19461254|P2|STARTED|Third Intervention||17
7908543|NCT00672984|19461255|P1|STARTED|Third Intervention||22
7908544|NCT00672984|19461253|P3|NOT COMPLETED|Second Intervention||1
7908545|NCT00672984|19461254|P2|NOT COMPLETED|Second Intervention||6
7908546|NCT00672984|19461255|P1|NOT COMPLETED|Second Intervention||0
7908547|NCT00672984|19461253|P3|COMPLETED|Second Intervention||24
7908548|NCT00672984|19461254|P2|COMPLETED|Second Intervention||17
7908549|NCT00672984|19461255|P1|COMPLETED|Second Intervention||22
7908550|NCT00672984|19461253|P3|STARTED|Second Intervention||25
7908551|NCT00672984|19461254|P2|STARTED|Second Intervention||23
7908552|NCT00672984|19461255|P1|STARTED|Second Intervention||22
7908553|NCT00672984|19461253|P3|NOT COMPLETED|First Intervention||2
7908554|NCT00672984|19461254|P2|NOT COMPLETED|First Intervention||2
7908555|NCT00672984|19461255|P1|NOT COMPLETED|First Intervention||9
7908556|NCT00672984|19461253|P3|COMPLETED|First Intervention||25
7908557|NCT00672984|19461254|P2|COMPLETED|First Intervention||23
7908558|NCT00672984|19461255|P1|COMPLETED|First Intervention||22
7908559|NCT00672984|19461253|P3|STARTED|First Intervention||27
7908560|NCT00672984|19461254|P2|STARTED|First Intervention||25
7908561|NCT00672984|19461255|P1|STARTED|First Intervention||31
7908562|NCT00672958|19461306|P2|NOT COMPLETED|Overall Study||56
7908563|NCT00672958|19461307|P1|NOT COMPLETED|Overall Study||64
7908564|NCT00672958|19461306|P2|COMPLETED|Overall Study||244
7908565|NCT00672958|19461307|P1|COMPLETED|Overall Study||236
7908566|NCT00672958|19461306|P2|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292
7908567|NCT00672958|19461307|P1|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286
7908568|NCT00672958|19461306|P2|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299
7908569|NCT00672958|19461307|P1|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298
7908570|NCT00672958|19461306|P2|STARTED|Overall Study||300
7908571|NCT00672958|19461307|P1|STARTED|Overall Study||300
7908572|NCT00672932|19461339|P2|NOT COMPLETED|Overall Study||0
7908573|NCT00672932|19461340|P1|NOT COMPLETED|Overall Study||0
7908574|NCT00672932|19461339|P2|COMPLETED|Overall Study||9
7908575|NCT00672932|19461340|P1|COMPLETED|Overall Study||9
7908576|NCT00672932|19461339|P2|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6
7908577|NCT00672932|19461340|P1|Rolled Over to Raltegravir|Overall Study||0
7908578|NCT00672932|19461339|P2|Provided Analyzable Blood and CSF Sample|Overall Study||9
7908671|NCT00672438|19461565|P1|STARTED|Infusion 1||119
7908579|NCT00672932|19461340|P1|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8
7908580|NCT00672932|19461339|P2|Completed Initial 12-week Assignment|Overall Study||9
7908581|NCT00672932|19461340|P1|Completed Initial 12-week Assignment|Overall Study||9
7908582|NCT00672932|19461339|P2|STARTED|Overall Study||9
7908583|NCT00672932|19461340|P1|STARTED|Overall Study||9
7908584|NCT00672854|19461350|P2|NOT COMPLETED|Overall Study||0
7908585|NCT00672854|19461351|P1|NOT COMPLETED|Overall Study||0
7908586|NCT00672854|19461350|P2|COMPLETED|Overall Study||51
7908587|NCT00672854|19461351|P1|COMPLETED|Overall Study||49
7908588|NCT00672854|19461350|P2|STARTED|Overall Study||51
7908589|NCT00672854|19461351|P1|STARTED|Overall Study||49
7908590|NCT00672841|19461373|P2|NOT COMPLETED|Overall Study||15
7908591|NCT00672841|19461374|P1|NOT COMPLETED|Overall Study||1
7908592|NCT00672841|19461373|P2|COMPLETED|Overall Study||32
7908593|NCT00672841|19461374|P1|COMPLETED|Overall Study||16
7908594|NCT00672841|19461373|P2|STARTED|Overall Study||47
7908595|NCT00672841|19461374|P1|STARTED|Overall Study||17
7908596|NCT00672737|19461386|P1|NOT COMPLETED|Overall Study||8
7908597|NCT00672737|19461386|P1|COMPLETED|Overall Study||48
7908598|NCT00672737|19461386|P1|STARTED|Overall Study||56
7908599|NCT00672646|19461396|P3|NOT COMPLETED|Overall Study||3
7908600|NCT00672646|19461397|P2|NOT COMPLETED|Overall Study||1
7908601|NCT00672646|19461398|P1|NOT COMPLETED|Overall Study||0
7908602|NCT00672646|19461396|P3|COMPLETED|Overall Study||37
7908603|NCT00672646|19461397|P2|COMPLETED|Overall Study||22
7908604|NCT00672646|19461398|P1|COMPLETED|Overall Study||40
7908605|NCT00672646|19461396|P3|STARTED|Overall Study||40
7908606|NCT00672646|19461397|P2|STARTED|Overall Study||23
7908607|NCT00672646|19461398|P1|STARTED|Overall Study||40
7908608|NCT00672633|19461423|P2|NOT COMPLETED|Overall Study||1
7908609|NCT00672633|19461424|P1|NOT COMPLETED|Overall Study||0
7908610|NCT00672633|19461423|P2|COMPLETED|Overall Study||12
7908611|NCT00672633|19461424|P1|COMPLETED|Overall Study||12
7908612|NCT00672633|19461423|P2|STARTED|Overall Study||13
7908613|NCT00672633|19461424|P1|STARTED|Overall Study||12
7908614|NCT00672620|19461438|P4|NOT COMPLETED|Overall Study||42
7908615|NCT00672620|19461439|P3|NOT COMPLETED|Overall Study||31
7908616|NCT00672620|19461440|P2|NOT COMPLETED|Overall Study||54
7908617|NCT00672620|19461441|P1|NOT COMPLETED|Overall Study||33
7908618|NCT00672620|19461438|P4|COMPLETED|Overall Study||110
7908619|NCT00672620|19461439|P3|COMPLETED|Overall Study||122
7908620|NCT00672620|19461440|P2|COMPLETED|Overall Study||99
7908621|NCT00672620|19461441|P1|COMPLETED|Overall Study||120
7908622|NCT00672620|19461438|P4|Treated|Overall Study||150
7908623|NCT00672620|19461439|P3|Treated|Overall Study||153
7908624|NCT00672620|19461440|P2|Treated|Overall Study||149
7908625|NCT00672620|19461441|P1|Treated|Overall Study||151
7908626|NCT00672620|19461438|P4|STARTED|Overall Study||152
7908627|NCT00672620|19461439|P3|STARTED|Overall Study||153
7908628|NCT00672620|19461440|P2|STARTED|Overall Study||153
7908629|NCT00672620|19461441|P1|STARTED|Overall Study||153
7908630|NCT00672594|19461495|P1|NOT COMPLETED|Overall Study||3
7908631|NCT00672594|19461495|P1|COMPLETED|Overall Study||27
7908632|NCT00672594|19461495|P1|STARTED|Overall Study||30
7908633|NCT00672555|19461506|P1|NOT COMPLETED|Overall Study||6
7908634|NCT00672555|19461506|P1|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64
7908635|NCT00672555|19461506|P1|STARTED|Overall Study||70
7908636|NCT00672490|19461517|P2|NOT COMPLETED|Overall Study||32
7908637|NCT00672490|19461518|P1|NOT COMPLETED|Overall Study||24
7908638|NCT00672490|19461517|P2|COMPLETED|Overall Study||157
7908639|NCT00672490|19461518|P1|COMPLETED|Overall Study||163
7908640|NCT00672490|19461517|P2|STARTED|Overall Study||189
7908641|NCT00672490|19461518|P1|STARTED|Overall Study||187
7908642|NCT00672477|19461542|P2|NOT COMPLETED|Overall Study||26
7908643|NCT00672477|19461543|P1|NOT COMPLETED|Overall Study||27
7908644|NCT00672477|19461542|P2|COMPLETED|Overall Study||88
7908645|NCT00672477|19461543|P1|COMPLETED|Overall Study|One subject had missing data as reason for study termination - not counted as early termination.|89
7908646|NCT00672477|19461542|P2|STARTED|Overall Study|117 subjects were randomized to this group, but only 114 subjects received study drug.|114
7908647|NCT00672477|19461543|P1|STARTED|Overall Study|120 subjects were randomized to this group, but only 116 subjects received study drug.|116
7908648|NCT00672451|19461553|P2|NOT COMPLETED|Overall Study||0
7908649|NCT00672451|19461554|P1|NOT COMPLETED|Overall Study||0
7908650|NCT00672451|19461553|P2|COMPLETED|Overall Study||2
7908651|NCT00672451|19461554|P1|COMPLETED|Overall Study||1
7908652|NCT00672451|19461553|P2|STARTED|Overall Study||2
7908653|NCT00672451|19461554|P1|STARTED|Overall Study||1
7908654|NCT00672438|19461564|P2|NOT COMPLETED|Infusion 2||0
7908655|NCT00672438|19461565|P1|NOT COMPLETED|Infusion 2||0
7908656|NCT00672438|19461564|P2|COMPLETED|Infusion 2||118
7908657|NCT00672438|19461565|P1|COMPLETED|Infusion 2||119
7908658|NCT00672438|19461564|P2|STARTED|Infusion 2||118
7908659|NCT00672438|19461565|P1|STARTED|Infusion 2||119
7908660|NCT00672438|19461564|P2|NOT COMPLETED|Washout||0
7908661|NCT00672438|19461565|P1|NOT COMPLETED|Washout||0
7908662|NCT00672438|19461564|P2|COMPLETED|Washout||118
7908663|NCT00672438|19461565|P1|COMPLETED|Washout||119
7908664|NCT00672438|19461564|P2|STARTED|Washout||118
7908665|NCT00672438|19461565|P1|STARTED|Washout||119
7908666|NCT00672438|19461564|P2|NOT COMPLETED|Infusion 1||0
7908667|NCT00672438|19461565|P1|NOT COMPLETED|Infusion 1||0
7908668|NCT00672438|19461564|P2|COMPLETED|Infusion 1||118
7908669|NCT00672438|19461565|P1|COMPLETED|Infusion 1||119
7908670|NCT00672438|19461564|P2|STARTED|Infusion 1||118
7908672|NCT00672256|19461596|P1|NOT COMPLETED|Overall Study||44
7908673|NCT00672256|19461596|P1|COMPLETED|Overall Study||18
7908674|NCT00672256|19461596|P1|STARTED|Overall Study|January 2007|62
7908675|NCT00672243|19461603|P1|NOT COMPLETED|Overall Study||0
7908676|NCT00672243|19461603|P1|COMPLETED|Overall Study||32
7908677|NCT00672243|19461603|P1|STARTED|Overall Study||32
7908678|NCT00672204|19461611|P1|NOT COMPLETED|Overall Study||20
7908679|NCT00672204|19461611|P1|COMPLETED|Overall Study||3
7908680|NCT00672204|19461611|P1|STARTED|Overall Study||23
7908681|NCT00672178|19461615|P1|NOT COMPLETED|Overall Study||0
7908682|NCT00672178|19461615|P1|COMPLETED|Overall Study||1
7908683|NCT00672178|19461615|P1|STARTED|Overall Study||1
7908684|NCT00672139|19461621|P2|NOT COMPLETED|Overall Study||45
7908685|NCT00672139|19461622|P1|NOT COMPLETED|Overall Study||30
7908686|NCT00672139|19461621|P2|COMPLETED|Overall Study||47
7908687|NCT00672139|19461622|P1|COMPLETED|Overall Study||27
7908688|NCT00672139|19461621|P2|STARTED|Overall Study|Four of 96 enrolled subjects did not receive study drug.|92
7908689|NCT00672139|19461622|P1|STARTED|Overall Study|Three of 60 enrolled subjects did not receive study drug.|57
7908690|NCT00672100|19461631|P3|NOT COMPLETED|Overall Study||0
7908691|NCT00672100|19461632|P2|NOT COMPLETED|Overall Study||0
7908692|NCT00672100|19461633|P1|NOT COMPLETED|Overall Study||0
7908693|NCT00672100|19461631|P3|COMPLETED|Overall Study||12
7908694|NCT00672100|19461632|P2|COMPLETED|Overall Study||12
7908695|NCT00672100|19461633|P1|COMPLETED|Overall Study||12
7908696|NCT00672100|19461631|P3|PACU (Within 8 Hours)|Overall Study||12
7908697|NCT00672100|19461632|P2|PACU (Within 8 Hours)|Overall Study||12
7908698|NCT00672100|19461633|P1|PACU (Within 8 Hours)|Overall Study||12
7908699|NCT00672100|19461631|P3|STARTED|Overall Study||12
7908700|NCT00672100|19461632|P2|STARTED|Overall Study||12
7908701|NCT00672100|19461633|P1|STARTED|Overall Study||12
7908702|NCT00671970|19461650|P2|NOT COMPLETED|Overall Study||0
7908703|NCT00671970|19461651|P1|NOT COMPLETED|Overall Study||0
7908704|NCT00671970|19461650|P2|COMPLETED|Overall Study||25
7908705|NCT00671970|19461651|P1|COMPLETED|Overall Study||32
7908706|NCT00671970|19461650|P2|STARTED|Overall Study||25
7908707|NCT00671970|19461651|P1|STARTED|Overall Study||32
7908708|NCT00671931|19461679|P5|NOT COMPLETED|Overall Study||1
7908709|NCT00671931|19461680|P4|NOT COMPLETED|Overall Study||2
7908710|NCT00671931|19461681|P3|NOT COMPLETED|Overall Study||0
7908711|NCT00671931|19461682|P2|NOT COMPLETED|Overall Study||0
7908712|NCT00671931|19461683|P1|NOT COMPLETED|Overall Study||1
7908713|NCT00671931|19461679|P5|COMPLETED|Overall Study|Low heart rate requiring treatment|7
7908714|NCT00671931|19461680|P4|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8
7908715|NCT00671931|19461681|P3|COMPLETED|Overall Study|all completed|9
7908716|NCT00671931|19461682|P2|COMPLETED|Overall Study|All completed|8
7908717|NCT00671931|19461683|P1|COMPLETED|Overall Study|Nueromonitoring equipment falure|8
7908718|NCT00671931|19461679|P5|STARTED|Overall Study||8
7908719|NCT00671931|19461680|P4|STARTED|Overall Study||10
7908720|NCT00671931|19461681|P3|STARTED|Overall Study||9
7908721|NCT00671931|19461682|P2|STARTED|Overall Study||8
7908722|NCT00671931|19461683|P1|STARTED|Overall Study||9
7908723|NCT00671918|19461695|P1|NOT COMPLETED|Overall Study||17
7908724|NCT00671918|19461695|P1|COMPLETED|Overall Study||169
7908725|NCT00671918|19461695|P1|STARTED|Overall Study||186
7908726|NCT00671879|19461703|P3|NOT COMPLETED|Overall Study||6
7908727|NCT00671879|19461704|P2|NOT COMPLETED|Overall Study||4
7908728|NCT00671879|19461705|P1|NOT COMPLETED|Overall Study||0
7908729|NCT00671879|19461703|P3|COMPLETED|Overall Study||274
7908730|NCT00671879|19461704|P2|COMPLETED|Overall Study||275
7908731|NCT00671879|19461705|P1|COMPLETED|Overall Study||281
7908732|NCT00671879|19461703|P3|STARTED|Overall Study||280
7908733|NCT00671879|19461704|P2|STARTED|Overall Study||279
7908734|NCT00671879|19461705|P1|STARTED|Overall Study||281
7908735|NCT00671853|19461718|P2|NOT COMPLETED|Overall Study||27
7908736|NCT00671853|19461719|P1|NOT COMPLETED|Overall Study||20
7908737|NCT00671853|19461718|P2|COMPLETED|Overall Study||18
7908738|NCT00671853|19461719|P1|COMPLETED|Overall Study||26
7908739|NCT00671853|19461718|P2|STARTED|Overall Study||45
7908740|NCT00671853|19461719|P1|STARTED|Overall Study||46
7908741|NCT00671788|19461735|P1|NOT COMPLETED|Overall Study||14
7908742|NCT00671788|19461735|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21
7908743|NCT00671788|19461735|P1|STARTED|Overall Study||35
7908744|NCT00671749|19461742|P1|NOT COMPLETED|Overall Study||8
7908745|NCT00671749|19461742|P1|COMPLETED|Overall Study||92
7908746|NCT00671749|19461742|P1|STARTED|Overall Study||100
7908747|NCT00671723|19461755|P3|NOT COMPLETED|Overall Study||0
7908748|NCT00671723|19461756|P2|NOT COMPLETED|Overall Study||0
7908749|NCT00671723|19461757|P1|NOT COMPLETED|Overall Study||0
7908750|NCT00671723|19461755|P3|COMPLETED|Overall Study||11
7908751|NCT00671723|19461756|P2|COMPLETED|Overall Study||11
7908752|NCT00671723|19461757|P1|COMPLETED|Overall Study||11
7908753|NCT00671723|19461755|P3|STARTED|Overall Study||11
7908754|NCT00671723|19461756|P2|STARTED|Overall Study||11
7908755|NCT00671723|19461757|P1|STARTED|Overall Study||11
7908756|NCT00671671|19461770|P2|NOT COMPLETED|Overall Study||0
7908757|NCT00671671|19461771|P1|NOT COMPLETED|Overall Study||0
7908758|NCT00671671|19461770|P2|COMPLETED|Overall Study||10
7908759|NCT00671671|19461771|P1|COMPLETED|Overall Study||10
7908760|NCT00671671|19461770|P2|STARTED|Overall Study||10
7908761|NCT00671671|19461771|P1|STARTED|Overall Study||10
7908762|NCT00671658|19461797|P1|NOT COMPLETED|Overall Study||5
7908763|NCT00671658|19461797|P1|COMPLETED|Overall Study||215
7908764|NCT00671658|19461797|P1|STARTED|Overall Study||220
7908765|NCT00671606|19461801|P1|NOT COMPLETED|Overall Study||0
7908766|NCT00671606|19461801|P1|COMPLETED|Overall Study||5
7908767|NCT00671606|19461801|P1|STARTED|Overall Study||5
7908768|NCT00671554|19461805|P1|NOT COMPLETED|Overall Study||3
7908769|NCT00671554|19461805|P1|COMPLETED|Overall Study||0
7908770|NCT00671554|19461805|P1|STARTED|Overall Study||3
7908771|NCT00671528|19461813|P3|NOT COMPLETED|Overall Study||0
7908772|NCT00671528|19461814|P2|NOT COMPLETED|Overall Study||0
7908773|NCT00671528|19461815|P1|NOT COMPLETED|Overall Study||0
7908774|NCT00671528|19461813|P3|COMPLETED|Overall Study||1
7908775|NCT00671528|19461814|P2|COMPLETED|Overall Study||1
7908776|NCT00671528|19461815|P1|COMPLETED|Overall Study||1
7908777|NCT00671528|19461813|P3|STARTED|Overall Study||1
7908778|NCT00671528|19461814|P2|STARTED|Overall Study||1
7908779|NCT00671528|19461815|P1|STARTED|Overall Study||1
7908780|NCT00671515|19461826|P1|NOT COMPLETED|Phase 2||4
7908781|NCT00671515|19461826|P1|COMPLETED|Phase 2||9
7908782|NCT00671515|19461826|P1|STARTED|Phase 2||13
7908783|NCT00671515|19461826|P1|NOT COMPLETED|Phase 1||3
7908784|NCT00671515|19461826|P1|COMPLETED|Phase 1||20
7908785|NCT00671515|19461826|P1|STARTED|Phase 1||23
7908786|NCT00671502|19461834|P3|NOT COMPLETED|Overall Study||27
7908787|NCT00671502|19461835|P2|NOT COMPLETED|Overall Study||39
7908788|NCT00671502|19461836|P1|NOT COMPLETED|Overall Study||39
7908789|NCT00671502|19461834|P3|COMPLETED|Overall Study||252
7908790|NCT00671502|19461835|P2|COMPLETED|Overall Study||241
7908791|NCT00671502|19461836|P1|COMPLETED|Overall Study||242
7908792|NCT00671502|19461834|P3|STARTED|Overall Study||279
7908793|NCT00671502|19461835|P2|STARTED|Overall Study||280
7908794|NCT00671502|19461836|P1|STARTED|Overall Study||281
7908795|NCT00671437|19461844|P1|NOT COMPLETED|Overall Study||15
7908796|NCT00671437|19461844|P1|COMPLETED|Overall Study||27
7908797|NCT00671437|19461844|P1|STARTED|Overall Study||42
7908798|NCT00671177|19461865|P2|NOT COMPLETED|Overall Study||1
7908799|NCT00671177|19461866|P1|NOT COMPLETED|Overall Study||2
7908800|NCT00671177|19461865|P2|COMPLETED|Overall Study||114
7908801|NCT00671177|19461866|P1|COMPLETED|Overall Study||112
7908802|NCT00671177|19461865|P2|STARTED|Overall Study||115
7908803|NCT00671177|19461866|P1|STARTED|Overall Study||114
7908804|NCT00671060|19461878|P2|NOT COMPLETED|Overall Study||1
7908805|NCT00671060|19461879|P1|NOT COMPLETED|Overall Study||1
7908806|NCT00671060|19461878|P2|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75
7908807|NCT00671060|19461879|P1|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76
7908808|NCT00671060|19461878|P2|STARTED|Overall Study||76
7908809|NCT00671060|19461879|P1|STARTED|Overall Study||77
7908810|NCT00671034|19461888|P3|NOT COMPLETED|Overall Study||24
7908811|NCT00671034|19461889|P2|NOT COMPLETED|Overall Study||20
7908812|NCT00671034|19461890|P1|NOT COMPLETED|Overall Study||39
7908813|NCT00671034|19461888|P3|COMPLETED|Overall Study||31
7908814|NCT00671034|19461889|P2|COMPLETED|Overall Study||22
7908815|NCT00671034|19461890|P1|COMPLETED|Overall Study||30
7908816|NCT00671034|19461888|P3|STARTED|Overall Study||55
7908817|NCT00671034|19461889|P2|STARTED|Overall Study||42
7908818|NCT00671034|19461890|P1|STARTED|Overall Study||69
7908819|NCT00670982|19461927|P2|NOT COMPLETED|Overall Study||0
7908820|NCT00670982|19461928|P1|NOT COMPLETED|Overall Study||0
7908821|NCT00670982|19461927|P2|COMPLETED|Overall Study||7
7908822|NCT00670982|19461928|P1|COMPLETED|Overall Study||22
7908823|NCT00670982|19461927|P2|STARTED|Overall Study||7
7908824|NCT00670982|19461928|P1|STARTED|Overall Study||22
7908825|NCT00670956|19461937|P1|NOT COMPLETED|Overall Study||0
7908826|NCT00670956|19461937|P1|COMPLETED|Overall Study||1
7908827|NCT00670956|19461937|P1|STARTED|Overall Study||1
7908828|NCT00670930|19461945|P2|NOT COMPLETED|Overall Study||1
7908829|NCT00670930|19461946|P1|NOT COMPLETED|Overall Study||1
7908830|NCT00670930|19461945|P2|COMPLETED|Overall Study||12
7908831|NCT00670930|19461946|P1|COMPLETED|Overall Study||22
7908832|NCT00670930|19461945|P2|Intent to Treat (ITT) Population|Overall Study||12
7908833|NCT00670930|19461946|P1|Intent to Treat (ITT) Population|Overall Study||23
7908834|NCT00670930|19461945|P2|STARTED|Overall Study||13
7908835|NCT00670930|19461946|P1|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23
7908836|NCT00670800|19461962|P2|NOT COMPLETED|Overall Study||2
7908837|NCT00670800|19461963|P1|NOT COMPLETED|Overall Study||0
7908838|NCT00670800|19461962|P2|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5
7908839|NCT00670800|19461963|P1|COMPLETED|Overall Study||7
7908840|NCT00670800|19461962|P2|STARTED|Overall Study||7
7908841|NCT00670800|19461963|P1|STARTED|Overall Study||7
7908842|NCT00670774|19461979|P1|NOT COMPLETED|Overall Study||0
7908843|NCT00670774|19461979|P1|COMPLETED|Overall Study||26
7908844|NCT00670774|19461979|P1|STARTED|Overall Study||26
7908845|NCT00670748|19461994|P4|NOT COMPLETED|Overall Study||1
7908846|NCT00670748|19461995|P3|NOT COMPLETED|Overall Study||2
7908847|NCT00670748|19461996|P2|NOT COMPLETED|Overall Study||2
7908848|NCT00670748|19461997|P1|NOT COMPLETED|Overall Study||3
7908849|NCT00670748|19461994|P4|COMPLETED|Overall Study||4
7908850|NCT00670748|19461995|P3|COMPLETED|Overall Study||5
7908851|NCT00670748|19461996|P2|COMPLETED|Overall Study||14
7908852|NCT00670748|19461997|P1|COMPLETED|Overall Study||14
7908853|NCT00670748|19461994|P4|STARTED|Overall Study||5
7908854|NCT00670748|19461995|P3|STARTED|Overall Study||7
7908855|NCT00670748|19461996|P2|STARTED|Overall Study||16
7908856|NCT00670748|19461997|P1|STARTED|Overall Study||17
7908857|NCT00670709|19462017|P2|NOT COMPLETED|Overall Study||0
7908858|NCT00670709|19462018|P1|NOT COMPLETED|Overall Study||0
7908859|NCT00670709|19462017|P2|COMPLETED|Overall Study||15
7908860|NCT00670709|19462018|P1|COMPLETED|Overall Study||27
7908861|NCT00670709|19462017|P2|STARTED|Overall Study||15
7908862|NCT00670709|19462018|P1|STARTED|Overall Study||27
7908863|NCT00670631|19462026|P1|NOT COMPLETED|Overall Study||0
7908864|NCT00670631|19462026|P1|COMPLETED|Overall Study||0
7908865|NCT00670631|19462026|P1|STARTED|Overall Study||0
7908866|NCT00670540|19462032|P1|NOT COMPLETED|Overall Study||3325
7908867|NCT00670540|19462032|P1|COMPLETED|Overall Study|total recruited for the follow up|4931
7908868|NCT00670540|19462032|P1|STARTED|Overall Study||8256
7908869|NCT00670488|19462052|P10|NOT COMPLETED|Overall Study||2
7908870|NCT00670488|19462053|P9|NOT COMPLETED|Overall Study||3
7908871|NCT00670488|19462054|P8|NOT COMPLETED|Overall Study||3
7908872|NCT00670488|19462055|P7|NOT COMPLETED|Overall Study||17
7908873|NCT00670488|19462056|P6|NOT COMPLETED|Overall Study||5
7908874|NCT00670488|19462057|P5|NOT COMPLETED|Overall Study||3
7908875|NCT00670488|19462058|P4|NOT COMPLETED|Overall Study||7
7908876|NCT00670488|19462059|P3|NOT COMPLETED|Overall Study||3
7908877|NCT00670488|19462060|P2|NOT COMPLETED|Overall Study||58
7908878|NCT00670488|19462061|P1|NOT COMPLETED|Overall Study||3
7908879|NCT00670488|19462052|P10|COMPLETED|Overall Study||0
7908880|NCT00670488|19462053|P9|COMPLETED|Overall Study||0
7908881|NCT00670488|19462054|P8|COMPLETED|Overall Study||0
7908882|NCT00670488|19462055|P7|COMPLETED|Overall Study||0
7908883|NCT00670488|19462056|P6|COMPLETED|Overall Study||0
7908884|NCT00670488|19462057|P5|COMPLETED|Overall Study||0
7908885|NCT00670488|19462058|P4|COMPLETED|Overall Study||0
7908886|NCT00670488|19462059|P3|COMPLETED|Overall Study||0
7908887|NCT00670488|19462060|P2|COMPLETED|Overall Study||0
7908888|NCT00670488|19462061|P1|COMPLETED|Overall Study||0
7908889|NCT00670488|19462052|P10|STARTED|Overall Study||2
7908890|NCT00670488|19462053|P9|STARTED|Overall Study||3
7908891|NCT00670488|19462054|P8|STARTED|Overall Study||3
7908892|NCT00670488|19462055|P7|STARTED|Overall Study||17
7908893|NCT00670488|19462056|P6|STARTED|Overall Study||5
7908894|NCT00670488|19462057|P5|STARTED|Overall Study||3
7908895|NCT00670488|19462058|P4|STARTED|Overall Study||7
7908896|NCT00670488|19462059|P3|STARTED|Overall Study||3
7908897|NCT00670488|19462060|P2|STARTED|Overall Study||58
7908898|NCT00670488|19462061|P1|STARTED|Overall Study||3
7908899|NCT00670462|19462215|P2|NOT COMPLETED|Overall Study||31
7908900|NCT00670462|19462216|P1|NOT COMPLETED|Overall Study||30
7908901|NCT00670462|19462215|P2|COMPLETED|Overall Study||76
7908902|NCT00670462|19462216|P1|COMPLETED|Overall Study||76
7908903|NCT00670462|19462215|P2|STARTED|Overall Study||107
7908904|NCT00670462|19462216|P1|STARTED|Overall Study||106
7908905|NCT00670449|19462248|P4|NOT COMPLETED|Overall Study||8
7908906|NCT00670449|19462249|P3|NOT COMPLETED|Overall Study||9
7908907|NCT00670449|19462250|P2|NOT COMPLETED|Overall Study||10
7908908|NCT00670449|19462251|P1|NOT COMPLETED|Overall Study||9
7908909|NCT00670449|19462248|P4|COMPLETED|Overall Study||15
7908910|NCT00670449|19462249|P3|COMPLETED|Overall Study||18
7908911|NCT00670449|19462250|P2|COMPLETED|Overall Study||36
7908912|NCT00670449|19462251|P1|COMPLETED|Overall Study||38
7908913|NCT00670449|19462248|P4|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17
7908914|NCT00670449|19462249|P3|Switched to 0.5mg (Open Label)|Overall Study||23
7908915|NCT00670449|19462250|P2|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41
7908916|NCT00670449|19462251|P1|Switched to 0.5mg (Open Label)|Overall Study||45
7908917|NCT00670449|19462248|P4|STARTED|Overall Study||23
7908918|NCT00670449|19462249|P3|STARTED|Overall Study||27
7908919|NCT00670449|19462250|P2|STARTED|Overall Study||46
7908920|NCT00670449|19462251|P1|STARTED|Overall Study||47
7908921|NCT00670306|19462275|P1|NOT COMPLETED|Overall Study||55
7908922|NCT00670306|19462275|P1|COMPLETED|Overall Study||473
7908923|NCT00670306|19462275|P1|STARTED|Overall Study||528
7908924|NCT00670267|19462279|P1|NOT COMPLETED|Overall Study||1
7908925|NCT00670267|19462279|P1|COMPLETED|Overall Study||9
7908926|NCT00670267|19462279|P1|STARTED|Overall Study||10
7908927|NCT00670241|19462290|P3|NOT COMPLETED|Overall Study||27
7908928|NCT00670241|19462291|P2|NOT COMPLETED|Overall Study||21
7908929|NCT00670241|19462292|P1|NOT COMPLETED|Overall Study||12
7908930|NCT00670241|19462290|P3|COMPLETED|Overall Study||64
7908931|NCT00670241|19462291|P2|COMPLETED|Overall Study||163
7908932|NCT00670241|19462292|P1|COMPLETED|Overall Study||171
7908933|NCT00670241|19462290|P3|STARTED|Overall Study||91
7908934|NCT00670241|19462291|P2|STARTED|Overall Study||184
7908935|NCT00670241|19462292|P1|STARTED|Overall Study||183
7908936|NCT00670228|19462314|P2|NOT COMPLETED|Overall Study||3
7908937|NCT00670228|19462315|P1|NOT COMPLETED|Overall Study||5
7908938|NCT00670228|19462314|P2|COMPLETED|Overall Study||12
7908939|NCT00670228|19462315|P1|COMPLETED|Overall Study||13
7908940|NCT00670228|19462314|P2|STARTED|Overall Study||15
7908941|NCT00670228|19462315|P1|STARTED|Overall Study||18
7908942|NCT00670202|19462329|P2|NOT COMPLETED|Overall Study||0
7908943|NCT00670202|19462330|P1|NOT COMPLETED|Overall Study||0
7908944|NCT00670202|19462329|P2|COMPLETED|Overall Study||0
7908945|NCT00670202|19462330|P1|COMPLETED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
7908946|NCT00670202|19462329|P2|STARTED|Overall Study||0
7908947|NCT00670202|19462330|P1|STARTED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
7908948|NCT00670111|19462339|P3|NOT COMPLETED|Six Months to Twelve Months||0
7908949|NCT00670111|19462340|P2|NOT COMPLETED|Six Months to Twelve Months||0
7908950|NCT00670111|19462341|P1|NOT COMPLETED|Six Months to Twelve Months||0
7908951|NCT00670111|19462339|P3|COMPLETED|Six Months to Twelve Months||0
7908952|NCT00670111|19462340|P2|COMPLETED|Six Months to Twelve Months||8
7908953|NCT00670111|19462341|P1|COMPLETED|Six Months to Twelve Months||4
7908954|NCT00670111|19462339|P3|STARTED|Six Months to Twelve Months||0
7908955|NCT00670111|19462340|P2|STARTED|Six Months to Twelve Months||8
7908956|NCT00670111|19462341|P1|STARTED|Six Months to Twelve Months||4
7908957|NCT00670111|19462339|P3|NOT COMPLETED|One Month to Six Months||0
7908958|NCT00670111|19462340|P2|NOT COMPLETED|One Month to Six Months||0
7908959|NCT00670111|19462341|P1|NOT COMPLETED|One Month to Six Months||0
7908960|NCT00670111|19462339|P3|COMPLETED|One Month to Six Months||0
7908961|NCT00670111|19462340|P2|COMPLETED|One Month to Six Months|8 patients in this group completed the 1 month visit; 4 had data eligible for endpoint analysis.|8
7908962|NCT00670111|19462341|P1|COMPLETED|One Month to Six Months|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
7908963|NCT00670111|19462339|P3|STARTED|One Month to Six Months||0
7908964|NCT00670111|19462340|P2|STARTED|One Month to Six Months||8
7908965|NCT00670111|19462341|P1|STARTED|One Month to Six Months||4
7908966|NCT00670111|19462339|P3|NOT COMPLETED|One Month Period B||0
7908967|NCT00670111|19462340|P2|NOT COMPLETED|One Month Period B||0
7908968|NCT00670111|19462341|P1|NOT COMPLETED|One Month Period B||0
7908969|NCT00670111|19462339|P3|COMPLETED|One Month Period B||0
7908970|NCT00670111|19462340|P2|COMPLETED|One Month Period B|8 patients in this group completed the 1 month visit; 6 had data eligible for endpoint analysis.|8
7908971|NCT00670111|19462341|P1|COMPLETED|One Month Period B|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
7908972|NCT00670111|19462339|P3|STARTED|One Month Period B||0
7908973|NCT00670111|19462340|P2|STARTED|One Month Period B||8
7908974|NCT00670111|19462341|P1|STARTED|One Month Period B||4
7908975|NCT00670111|19462339|P3|NOT COMPLETED|One Month Period A||0
7908976|NCT00670111|19462340|P2|NOT COMPLETED|One Month Period A||0
7908977|NCT00670111|19462341|P1|NOT COMPLETED|One Month Period A||0
7908978|NCT00670111|19462339|P3|COMPLETED|One Month Period A||0
7908979|NCT00670111|19462340|P2|COMPLETED|One Month Period A||8
7908980|NCT00670111|19462341|P1|COMPLETED|One Month Period A||4
7908981|NCT00670111|19462339|P3|STARTED|One Month Period A||0
7908982|NCT00670111|19462340|P2|STARTED|One Month Period A||8
7908983|NCT00670111|19462341|P1|STARTED|One Month Period A||4
7908984|NCT00670111|19462339|P3|NOT COMPLETED|Enrollment to One Month||19
7908985|NCT00670111|19462340|P2|NOT COMPLETED|Enrollment to One Month||0
7908986|NCT00670111|19462341|P1|NOT COMPLETED|Enrollment to One Month||1
7908987|NCT00670111|19462339|P3|COMPLETED|Enrollment to One Month||0
7908988|NCT00670111|19462340|P2|COMPLETED|Enrollment to One Month||8
7908989|NCT00670111|19462341|P1|COMPLETED|Enrollment to One Month||4
7908990|NCT00670111|19462339|P3|STARTED|Enrollment to One Month||19
7908991|NCT00670111|19462340|P2|STARTED|Enrollment to One Month||8
7908992|NCT00670111|19462341|P1|STARTED|Enrollment to One Month||5
7908993|NCT00670046|19462351|P2|NOT COMPLETED|Overall Study||2
7908994|NCT00670046|19462352|P1|NOT COMPLETED|Overall Study||1
7908995|NCT00670046|19462351|P2|COMPLETED|Overall Study||6
7908996|NCT00670046|19462352|P1|COMPLETED|Overall Study||6
7908997|NCT00670046|19462351|P2|STARTED|Overall Study||8
7908998|NCT00670046|19462352|P1|STARTED|Overall Study||7
7908999|NCT00670007|19462366|P1|NOT COMPLETED|Overall Study||9
7909000|NCT00670007|19462366|P1|COMPLETED|Overall Study||131
7909001|NCT00670007|19462366|P1|STARTED|Overall Study||140
7909002|NCT00669955|19462393|P2|NOT COMPLETED|Overall Study||27
7909003|NCT00669955|19462394|P1|NOT COMPLETED|Overall Study||14
7909004|NCT00669955|19462393|P2|COMPLETED|Overall Study||195
7909005|NCT00669955|19462394|P1|COMPLETED|Overall Study||204
7909006|NCT00669955|19462393|P2|STARTED|Overall Study||222
7909007|NCT00669955|19462394|P1|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218
7909008|NCT00669942|19462424|P12|NOT COMPLETED|Healthy Volunteers||0
7909009|NCT00669942|19462425|P11|NOT COMPLETED|Healthy Volunteers||1
7909010|NCT00669942|19462426|P10|NOT COMPLETED|Healthy Volunteers||0
7909011|NCT00669942|19462427|P9|NOT COMPLETED|Healthy Volunteers||0
7909012|NCT00669942|19462428|P8|NOT COMPLETED|Healthy Volunteers||0
7909013|NCT00669942|19462429|P7|NOT COMPLETED|Healthy Volunteers||0
7909014|NCT00669942|19462430|P6|NOT COMPLETED|Healthy Volunteers||0
7909015|NCT00669942|19462431|P5|NOT COMPLETED|Healthy Volunteers||0
7909016|NCT00669942|19462432|P4|NOT COMPLETED|Healthy Volunteers||0
7909017|NCT00669942|19462433|P3|NOT COMPLETED|Healthy Volunteers||0
7909018|NCT00669942|19462434|P2|NOT COMPLETED|Healthy Volunteers||0
7909019|NCT00669942|19462435|P1|NOT COMPLETED|Healthy Volunteers||0
7909020|NCT00669942|19462424|P12|COMPLETED|Healthy Volunteers||2
7909021|NCT00669942|19462425|P11|COMPLETED|Healthy Volunteers||2
7909022|NCT00669942|19462426|P10|COMPLETED|Healthy Volunteers||3
7909023|NCT00669942|19462427|P9|COMPLETED|Healthy Volunteers||0
7909024|NCT00669942|19462428|P8|COMPLETED|Healthy Volunteers||0
7909025|NCT00669942|19462429|P7|COMPLETED|Healthy Volunteers||0
7909026|NCT00669942|19462430|P6|COMPLETED|Healthy Volunteers||0
7909027|NCT00669942|19462431|P5|COMPLETED|Healthy Volunteers||0
7909028|NCT00669942|19462432|P4|COMPLETED|Healthy Volunteers||0
7909029|NCT00669942|19462433|P3|COMPLETED|Healthy Volunteers||0
7909030|NCT00669942|19462434|P2|COMPLETED|Healthy Volunteers||0
7909031|NCT00669942|19462435|P1|COMPLETED|Healthy Volunteers||0
7909032|NCT00669942|19462424|P12|STARTED|Healthy Volunteers||2
7909033|NCT00669942|19462425|P11|STARTED|Healthy Volunteers||3
7909034|NCT00669942|19462426|P10|STARTED|Healthy Volunteers||3
7909035|NCT00669942|19462427|P9|STARTED|Healthy Volunteers||0
7909036|NCT00669942|19462428|P8|STARTED|Healthy Volunteers||0
7909037|NCT00669942|19462429|P7|STARTED|Healthy Volunteers||0
7909038|NCT00669942|19462430|P6|STARTED|Healthy Volunteers||0
7909039|NCT00669942|19462431|P5|STARTED|Healthy Volunteers||0
7909040|NCT00669942|19462432|P4|STARTED|Healthy Volunteers||0
7909041|NCT00669942|19462433|P3|STARTED|Healthy Volunteers||0
7909042|NCT00669942|19462434|P2|STARTED|Healthy Volunteers||0
7909043|NCT00669942|19462435|P1|STARTED|Healthy Volunteers||0
7909044|NCT00669942|19462424|P12|NOT COMPLETED|Parts 2 and 3||0
7909045|NCT00669942|19462425|P11|NOT COMPLETED|Parts 2 and 3||0
7909046|NCT00669942|19462426|P10|NOT COMPLETED|Parts 2 and 3||0
7909047|NCT00669942|19462427|P9|NOT COMPLETED|Parts 2 and 3||3
7909048|NCT00669942|19462428|P8|NOT COMPLETED|Parts 2 and 3||2
7909049|NCT00669942|19462429|P7|NOT COMPLETED|Parts 2 and 3||0
7909050|NCT00669942|19462430|P6|NOT COMPLETED|Parts 2 and 3||2
7909051|NCT00669942|19462431|P5|NOT COMPLETED|Parts 2 and 3||0
7909052|NCT00669942|19462432|P4|NOT COMPLETED|Parts 2 and 3||0
7909053|NCT00669942|19462433|P3|NOT COMPLETED|Parts 2 and 3||0
7909054|NCT00669942|19462434|P2|NOT COMPLETED|Parts 2 and 3||0
7909055|NCT00669942|19462435|P1|NOT COMPLETED|Parts 2 and 3||0
7909056|NCT00669942|19462424|P12|COMPLETED|Parts 2 and 3||0
7909057|NCT00669942|19462425|P11|COMPLETED|Parts 2 and 3||0
7909058|NCT00669942|19462426|P10|COMPLETED|Parts 2 and 3||0
7909059|NCT00669942|19462427|P9|COMPLETED|Parts 2 and 3||23
7909060|NCT00669942|19462428|P8|COMPLETED|Parts 2 and 3||24
7909061|NCT00669942|19462429|P7|COMPLETED|Parts 2 and 3||6
7909062|NCT00669942|19462430|P6|COMPLETED|Parts 2 and 3||4
7909063|NCT00669942|19462431|P5|COMPLETED|Parts 2 and 3||0
7909064|NCT00669942|19462432|P4|COMPLETED|Parts 2 and 3||0
7909065|NCT00669942|19462433|P3|COMPLETED|Parts 2 and 3||0
7909066|NCT00669942|19462434|P2|COMPLETED|Parts 2 and 3||0
7909067|NCT00669942|19462435|P1|COMPLETED|Parts 2 and 3||0
7909068|NCT00669942|19462424|P12|STARTED|Parts 2 and 3||0
7909069|NCT00669942|19462425|P11|STARTED|Parts 2 and 3||0
7909070|NCT00669942|19462426|P10|STARTED|Parts 2 and 3||0
7909071|NCT00669942|19462427|P9|STARTED|Parts 2 and 3||26
7909072|NCT00669942|19462428|P8|STARTED|Parts 2 and 3||26
7909073|NCT00669942|19462429|P7|STARTED|Parts 2 and 3||6
7909074|NCT00669942|19462430|P6|STARTED|Parts 2 and 3||6
7909075|NCT00669942|19462431|P5|STARTED|Parts 2 and 3||0
7909076|NCT00669942|19462432|P4|STARTED|Parts 2 and 3||0
7909077|NCT00669942|19462433|P3|STARTED|Parts 2 and 3||0
7909078|NCT00669942|19462434|P2|STARTED|Parts 2 and 3||0
7909079|NCT00669942|19462435|P1|STARTED|Parts 2 and 3||0
7909080|NCT00669942|19462424|P12|NOT COMPLETED|Part 1||0
7909081|NCT00669942|19462425|P11|NOT COMPLETED|Part 1||0
7909082|NCT00669942|19462426|P10|NOT COMPLETED|Part 1||0
7909083|NCT00669942|19462427|P9|NOT COMPLETED|Part 1||0
7909084|NCT00669942|19462428|P8|NOT COMPLETED|Part 1||0
7909085|NCT00669942|19462429|P7|NOT COMPLETED|Part 1||0
7909086|NCT00669942|19462430|P6|NOT COMPLETED|Part 1||0
7909087|NCT00669942|19462431|P5|NOT COMPLETED|Part 1||0
7909088|NCT00669942|19462432|P4|NOT COMPLETED|Part 1||0
7909089|NCT00669942|19462433|P3|NOT COMPLETED|Part 1||0
7909090|NCT00669942|19462434|P2|NOT COMPLETED|Part 1||0
7909091|NCT00669942|19462435|P1|NOT COMPLETED|Part 1||0
7909092|NCT00669942|19462424|P12|COMPLETED|Part 1||0
7909093|NCT00669942|19462425|P11|COMPLETED|Part 1||0
7909094|NCT00669942|19462426|P10|COMPLETED|Part 1||0
7909095|NCT00669942|19462427|P9|COMPLETED|Part 1||0
7909096|NCT00669942|19462428|P8|COMPLETED|Part 1||0
7909097|NCT00669942|19462429|P7|COMPLETED|Part 1||0
7909098|NCT00669942|19462430|P6|COMPLETED|Part 1||0
7909099|NCT00669942|19462431|P5|COMPLETED|Part 1||8
7909100|NCT00669942|19462432|P4|COMPLETED|Part 1||6
7909101|NCT00669942|19462433|P3|COMPLETED|Part 1||6
7909102|NCT00669942|19462434|P2|COMPLETED|Part 1||6
7909103|NCT00669942|19462435|P1|COMPLETED|Part 1||6
7909104|NCT00669942|19462424|P12|STARTED|Part 1||0
7909105|NCT00669942|19462425|P11|STARTED|Part 1||0
7909106|NCT00669942|19462426|P10|STARTED|Part 1||0
7909107|NCT00669942|19462427|P9|STARTED|Part 1||0
7909108|NCT00669942|19462428|P8|STARTED|Part 1||0
7909109|NCT00669942|19462429|P7|STARTED|Part 1||0
7909110|NCT00669942|19462430|P6|STARTED|Part 1||0
7909111|NCT00669942|19462431|P5|STARTED|Part 1||8
7909112|NCT00669942|19462432|P4|STARTED|Part 1||6
7909113|NCT00669942|19462433|P3|STARTED|Part 1||6
7909114|NCT00669942|19462434|P2|STARTED|Part 1||6
7909115|NCT00669942|19462435|P1|STARTED|Part 1||6
7909116|NCT00669916|19462499|P2|NOT COMPLETED|Overall Study||0
7909117|NCT00669916|19462500|P1|NOT COMPLETED|Overall Study||0
7909118|NCT00669916|19462499|P2|COMPLETED|Overall Study||18
7909119|NCT00669916|19462500|P1|COMPLETED|Overall Study||18
7909120|NCT00669916|19462499|P2|STARTED|Overall Study||18
7909121|NCT00669916|19462500|P1|STARTED|Overall Study||18
7909122|NCT00669903|19462518|P4|NOT COMPLETED|Overall Study||4
7909123|NCT00669903|19462519|P3|NOT COMPLETED|Overall Study||5
7909124|NCT00669903|19462520|P2|NOT COMPLETED|Overall Study||5
7909125|NCT00669903|19462521|P1|NOT COMPLETED|Overall Study||1
7909126|NCT00669903|19462518|P4|COMPLETED|Overall Study||18
7909127|NCT00669903|19462519|P3|COMPLETED|Overall Study||13
7909128|NCT00669903|19462520|P2|COMPLETED|Overall Study||32
7909129|NCT00669903|19462521|P1|COMPLETED|Overall Study||22
7909130|NCT00669903|19462518|P4|Completed Treatment Period|Overall Study||19
7909131|NCT00669903|19462519|P3|Completed Treatment Period|Overall Study||13
7909132|NCT00669903|19462520|P2|Completed Treatment Period|Overall Study||33
7909133|NCT00669903|19462521|P1|Completed Treatment Period|Overall Study||23
7909134|NCT00669903|19462518|P4|STARTED|Overall Study||22
7909135|NCT00669903|19462519|P3|STARTED|Overall Study||18
7909136|NCT00669903|19462520|P2|STARTED|Overall Study||37
7909137|NCT00669903|19462521|P1|STARTED|Overall Study||23
7909138|NCT00669877|19462551|P1|NOT COMPLETED|Overall Study||4
7909139|NCT00669877|19462551|P1|COMPLETED|Overall Study||52
7909140|NCT00669877|19462551|P1|STARTED|Overall Study||56
7909141|NCT00669864|19462556|P1|NOT COMPLETED|Overall Study||9
7909142|NCT00669864|19462556|P1|COMPLETED|Overall Study||284
7909143|NCT00669864|19462556|P1|STARTED|Overall Study||293
7909144|NCT00669682|19462565|P1|NOT COMPLETED|Overall Study||0
7909145|NCT00669682|19462565|P1|COMPLETED|Overall Study||9
7909146|NCT00669682|19462565|P1|STARTED|Overall Study||9
7909147|NCT00669669|19462570|P1|NOT COMPLETED|Overall Study||1
7909148|NCT00669669|19462570|P1|COMPLETED|Overall Study||11
7909149|NCT00669669|19462570|P1|STARTED|Overall Study||12
7909150|NCT00669617|19462575|P5|NOT COMPLETED|Period 5||0
7909151|NCT00669617|19462576|P4|NOT COMPLETED|Period 5||0
7909152|NCT00669617|19462577|P3|NOT COMPLETED|Period 5||0
7909153|NCT00669617|19462578|P2|NOT COMPLETED|Period 5||0
7909154|NCT00669617|19462579|P1|NOT COMPLETED|Period 5||0
7909155|NCT00669617|19462575|P5|COMPLETED|Period 5||17
7909156|NCT00669617|19462576|P4|COMPLETED|Period 5||18
7909157|NCT00669617|19462577|P3|COMPLETED|Period 5||17
7909158|NCT00669617|19462578|P2|COMPLETED|Period 5||17
7909159|NCT00669617|19462579|P1|COMPLETED|Period 5||17
7909160|NCT00669617|19462575|P5|STARTED|Period 5||17
7909161|NCT00669617|19462576|P4|STARTED|Period 5||18
7909162|NCT00669617|19462577|P3|STARTED|Period 5||17
7909163|NCT00669617|19462578|P2|STARTED|Period 5||17
7909164|NCT00669617|19462579|P1|STARTED|Period 5||17
7909165|NCT00669617|19462575|P5|NOT COMPLETED|Period 4||0
7909166|NCT00669617|19462576|P4|NOT COMPLETED|Period 4||0
7909167|NCT00669617|19462577|P3|NOT COMPLETED|Period 4||0
7909168|NCT00669617|19462578|P2|NOT COMPLETED|Period 4||0
7909169|NCT00669617|19462579|P1|NOT COMPLETED|Period 4||0
7909170|NCT00669617|19462575|P5|COMPLETED|Period 4||17
7909171|NCT00669617|19462576|P4|COMPLETED|Period 4||18
7909172|NCT00669617|19462577|P3|COMPLETED|Period 4||17
7909173|NCT00669617|19462578|P2|COMPLETED|Period 4||17
7909174|NCT00669617|19462579|P1|COMPLETED|Period 4||17
7909175|NCT00669617|19462575|P5|STARTED|Period 4||17
7909176|NCT00669617|19462576|P4|STARTED|Period 4||18
7909177|NCT00669617|19462577|P3|STARTED|Period 4||17
7909178|NCT00669617|19462578|P2|STARTED|Period 4||17
7909179|NCT00669617|19462579|P1|STARTED|Period 4||17
7909180|NCT00669617|19462575|P5|NOT COMPLETED|Period 3||0
7909181|NCT00669617|19462576|P4|NOT COMPLETED|Period 3||0
7909182|NCT00669617|19462577|P3|NOT COMPLETED|Period 3||0
7909183|NCT00669617|19462578|P2|NOT COMPLETED|Period 3||0
7909184|NCT00669617|19462579|P1|NOT COMPLETED|Period 3||1
7909185|NCT00669617|19462575|P5|COMPLETED|Period 3||17
7909186|NCT00669617|19462576|P4|COMPLETED|Period 3||18
7909187|NCT00669617|19462577|P3|COMPLETED|Period 3||17
7909188|NCT00669617|19462578|P2|COMPLETED|Period 3||17
7909189|NCT00669617|19462579|P1|COMPLETED|Period 3||17
7909190|NCT00669617|19462575|P5|STARTED|Period 3||17
7909191|NCT00669617|19462576|P4|STARTED|Period 3||18
7909192|NCT00669617|19462577|P3|STARTED|Period 3||17
7909193|NCT00669617|19462578|P2|STARTED|Period 3||17
7909194|NCT00669617|19462579|P1|STARTED|Period 3||18
7909195|NCT00669617|19462575|P5|NOT COMPLETED|Period 2||0
7909196|NCT00669617|19462576|P4|NOT COMPLETED|Period 2||0
7909197|NCT00669617|19462577|P3|NOT COMPLETED|Period 2||0
7909198|NCT00669617|19462578|P2|NOT COMPLETED|Period 2||0
7909199|NCT00669617|19462579|P1|NOT COMPLETED|Period 2||0
7909200|NCT00669617|19462575|P5|COMPLETED|Period 2||17
7909201|NCT00669617|19462576|P4|COMPLETED|Period 2||18
7909202|NCT00669617|19462577|P3|COMPLETED|Period 2||17
7909203|NCT00669617|19462578|P2|COMPLETED|Period 2||17
7909204|NCT00669617|19462579|P1|COMPLETED|Period 2||18
7909205|NCT00669617|19462575|P5|STARTED|Period 2||17
7909206|NCT00669617|19462576|P4|STARTED|Period 2||18
7909207|NCT00669617|19462577|P3|STARTED|Period 2||17
7909208|NCT00669617|19462578|P2|STARTED|Period 2||17
7909209|NCT00669617|19462579|P1|STARTED|Period 2||18
7909210|NCT00669617|19462575|P5|NOT COMPLETED|Period 1||1
7909211|NCT00669617|19462576|P4|NOT COMPLETED|Period 1||0
7909212|NCT00669617|19462577|P3|NOT COMPLETED|Period 1||1
7909213|NCT00669617|19462578|P2|NOT COMPLETED|Period 1||0
7909214|NCT00669617|19462579|P1|NOT COMPLETED|Period 1||0
7909215|NCT00669617|19462575|P5|COMPLETED|Period 1||17
7909216|NCT00669617|19462576|P4|COMPLETED|Period 1||18
7909217|NCT00669617|19462577|P3|COMPLETED|Period 1||17
7909218|NCT00669617|19462578|P2|COMPLETED|Period 1||17
7909219|NCT00669617|19462579|P1|COMPLETED|Period 1||18
7909220|NCT00669617|19462575|P5|STARTED|Period 1||18
7909221|NCT00669617|19462576|P4|STARTED|Period 1||18
7909222|NCT00669617|19462577|P3|STARTED|Period 1||18
7909223|NCT00669617|19462578|P2|STARTED|Period 1||17
7909224|NCT00669617|19462579|P1|STARTED|Period 1||18
7909225|NCT00669578|19462593|P2|NOT COMPLETED|Overall Study||0
7909226|NCT00669578|19462594|P1|NOT COMPLETED|Overall Study||0
7909227|NCT00669578|19462593|P2|COMPLETED|Overall Study||65
7909228|NCT00669578|19462594|P1|COMPLETED|Overall Study||12
7909229|NCT00669578|19462593|P2|STARTED|Overall Study||65
7909230|NCT00669578|19462594|P1|STARTED|Overall Study||12
7909231|NCT00669552|19462607|P1|NOT COMPLETED|Overall Study||0
7909232|NCT00669552|19462607|P1|COMPLETED|Overall Study||11
7909233|NCT00669552|19462607|P1|STARTED|Overall Study||11
7909234|NCT00669539|19462613|P2|NOT COMPLETED|Overall Study||9
7909235|NCT00669539|19462614|P1|NOT COMPLETED|Overall Study||8
7909236|NCT00669539|19462613|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43
7909237|NCT00669539|19462614|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86
7909238|NCT00669539|19462613|P2|STARTED|Overall Study||52
7909239|NCT00669539|19462614|P1|STARTED|Overall Study||94
7909240|NCT00669461|19462620|P1|NOT COMPLETED|Overall Study||0
7909241|NCT00669461|19462620|P1|COMPLETED|Overall Study||1
7909242|NCT00669461|19462620|P1|STARTED|Overall Study||1
7909243|NCT00669396|19462627|P2|NOT COMPLETED|Overall Study||12
7909244|NCT00669396|19462628|P1|NOT COMPLETED|Overall Study||10
7909245|NCT00669396|19462627|P2|COMPLETED|Overall Study||22
7909246|NCT00669396|19462628|P1|COMPLETED|Overall Study||13
7909247|NCT00669396|19462627|P2|STARTED|Overall Study||34
7909248|NCT00669396|19462628|P1|STARTED|Overall Study||23
7909249|NCT00669383|19462642|P2|NOT COMPLETED|Overall Study||0
7909250|NCT00669383|19462643|P1|NOT COMPLETED|Overall Study||0
7909251|NCT00669383|19462642|P2|COMPLETED|Overall Study||41
7909252|NCT00669383|19462643|P1|COMPLETED|Overall Study||44
7909253|NCT00669383|19462642|P2|STARTED|Overall Study||41
7909254|NCT00669383|19462643|P1|STARTED|Overall Study||44
7909255|NCT00669331|19462655|P2|NOT COMPLETED|Blinded Treatment Period||39
7909256|NCT00669331|19462656|P1|NOT COMPLETED|Blinded Treatment Period||42
7909257|NCT00669331|19462655|P2|COMPLETED|Blinded Treatment Period||189
7909258|NCT00669331|19462656|P1|COMPLETED|Blinded Treatment Period||191
7909259|NCT00669331|19462655|P2|STARTED|Blinded Treatment Period||228
7909260|NCT00669331|19462656|P1|STARTED|Blinded Treatment Period||233
7909261|NCT00669331|19462655|P2|NOT COMPLETED|Randomisation to First Dose||13
7909262|NCT00669331|19462656|P1|NOT COMPLETED|Randomisation to First Dose||11
7909263|NCT00669331|19462655|P2|COMPLETED|Randomisation to First Dose||228
7909264|NCT00669331|19462656|P1|COMPLETED|Randomisation to First Dose||233
7909265|NCT00669331|19462655|P2|STARTED|Randomisation to First Dose||241
7909266|NCT00669331|19462656|P1|STARTED|Randomisation to First Dose||244
7909267|NCT00669318|19462698|P1|NOT COMPLETED|Overall Study||2
7909268|NCT00669318|19462698|P1|COMPLETED|Overall Study||39
7909269|NCT00669318|19462698|P1|STARTED|Overall Study||41
7909270|NCT00669279|19462708|P2|NOT COMPLETED|Overall Study||0
7909271|NCT00669279|19462709|P1|NOT COMPLETED|Overall Study||0
7909272|NCT00669279|19462708|P2|COMPLETED|Overall Study||19
7909273|NCT00669279|19462709|P1|COMPLETED|Overall Study||22
7909274|NCT00669279|19462708|P2|STARTED|Overall Study||19
7909275|NCT00669279|19462709|P1|STARTED|Overall Study||22
7909276|NCT00669240|19462715|P1|NOT COMPLETED|Overall Study||165
7909277|NCT00669240|19462715|P1|COMPLETED|Overall Study||402
7909278|NCT00669240|19462715|P1|Received Treatment|Overall Study||551
7909279|NCT00669240|19462715|P1|Assigned to Treatment|Overall Study||566
7909280|NCT00669240|19462715|P1|STARTED|Overall Study||567
7909281|NCT00669214|19462731|P2|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9
7909282|NCT00669214|19462732|P1|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4
7909283|NCT00669214|19462731|P2|COMPLETED|Open-Label Treatment Period (Week 24)||46
7909284|NCT00669214|19462732|P1|COMPLETED|Open-Label Treatment Period (Week 24)||18
7909285|NCT00669214|19462731|P2|STARTED|Open-Label Treatment Period (Week 24)||55
7909286|NCT00669214|19462732|P1|STARTED|Open-Label Treatment Period (Week 24)||22
7909287|NCT00669214|19462731|P2|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7
7909288|NCT00669214|19462732|P1|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5
7909289|NCT00669214|19462731|P2|COMPLETED|Double-Blind Treatment Period (Week 12)||55
7909290|NCT00669214|19462732|P1|COMPLETED|Double-Blind Treatment Period (Week 12)||22
7909291|NCT00669214|19462731|P2|STARTED|Double-Blind Treatment Period (Week 12)||62
7909292|NCT00669214|19462732|P1|STARTED|Double-Blind Treatment Period (Week 12)||27
7909293|NCT00669162|19462764|P1|NOT COMPLETED|Overall Study||1
7909294|NCT00669162|19462764|P1|COMPLETED|Overall Study||26
7909295|NCT00669162|19462764|P1|STARTED|Overall Study||27
7909296|NCT00669110|19462770|P2|NOT COMPLETED|Overall Study||13
7909297|NCT00669110|19462771|P1|NOT COMPLETED|Overall Study||8
7909298|NCT00669110|19462770|P2|COMPLETED|Overall Study||7
7909299|NCT00669110|19462771|P1|COMPLETED|Overall Study||12
7909300|NCT00669110|19462770|P2|STARTED|Overall Study||20
7909301|NCT00669110|19462771|P1|STARTED|Overall Study||20
7909302|NCT00669071|19462807|P1|NOT COMPLETED|Overall Study||4
7909303|NCT00669071|19462807|P1|COMPLETED|Overall Study||52
7909304|NCT00669071|19462807|P1|STARTED|Overall Study||56
7909305|NCT00669032|19462828|P2|NOT COMPLETED|Overall Study||59
7909306|NCT00669032|19462829|P1|NOT COMPLETED|Overall Study||44
7909307|NCT00669032|19462828|P2|COMPLETED|Overall Study||94
7909308|NCT00669032|19462829|P1|COMPLETED|Overall Study||109
7909309|NCT00669032|19462828|P2|STARTED|Overall Study||153
7909310|NCT00669032|19462829|P1|STARTED|Overall Study||153
7909311|NCT00669019|19462857|P1|NOT COMPLETED|Overall Study||0
7909312|NCT00669019|19462857|P1|COMPLETED|Overall Study||23
7909313|NCT00669019|19462857|P1|STARTED|Overall Study||23
7909314|NCT00668902|19462865|P3|NOT COMPLETED|Overall Study||0
7909315|NCT00668902|19462866|P2|NOT COMPLETED|Overall Study||0
7909316|NCT00668902|19462867|P1|NOT COMPLETED|Overall Study||0
7909317|NCT00668902|19462865|P3|COMPLETED|Overall Study||5
7909318|NCT00668902|19462866|P2|COMPLETED|Overall Study||10
7909319|NCT00668902|19462867|P1|COMPLETED|Overall Study||10
7909320|NCT00668902|19462865|P3|STARTED|Overall Study||5
7909321|NCT00668902|19462866|P2|STARTED|Overall Study||10
7909322|NCT00668902|19462867|P1|STARTED|Overall Study||10
7909323|NCT00668863|19462875|P1|NOT COMPLETED|Overall Study||71
7909324|NCT00668863|19462875|P1|COMPLETED|Overall Study||0
7909325|NCT00668863|19462875|P1|STARTED|Overall Study||71
7909326|NCT00668811|19462894|P1|NOT COMPLETED|Overall Study||0
7909327|NCT00668811|19462894|P1|COMPLETED|Overall Study||23
7909328|NCT00668811|19462894|P1|STARTED|Overall Study||23
7909329|NCT00668785|19462899|P1|NOT COMPLETED|Overall Study||0
7909330|NCT00668785|19462899|P1|COMPLETED|Overall Study||6
7909331|NCT00668785|19462899|P1|STARTED|Overall Study||6
7909332|NCT00668746|19462907|P2|NOT COMPLETED|Overall Study||1
7909333|NCT00668746|19462908|P1|NOT COMPLETED|Overall Study||2
7909334|NCT00668746|19462907|P2|COMPLETED|Overall Study||11
7909335|NCT00668746|19462908|P1|COMPLETED|Overall Study||21
7909336|NCT00668746|19462907|P2|STARTED|Overall Study||12
7909337|NCT00668746|19462908|P1|STARTED|Overall Study||23
7909338|NCT00668733|19462928|P2|NOT COMPLETED|Overall Study||7
7909339|NCT00668733|19462929|P1|NOT COMPLETED|Overall Study||2
7909340|NCT00668733|19462928|P2|COMPLETED|Overall Study||83
7909341|NCT00668733|19462929|P1|COMPLETED|Overall Study||87
7909342|NCT00668733|19462928|P2|STARTED|Overall Study||90
7909343|NCT00668733|19462929|P1|STARTED|Overall Study||89
7909344|NCT00668564|19462935|P1|NOT COMPLETED|Overall Study||0
7909345|NCT00668564|19462935|P1|COMPLETED|Overall Study||18
7909346|NCT00668564|19462935|P1|STARTED|Overall Study||18
7909347|NCT00668525|19462943|P3|NOT COMPLETED|Overall Study||53
7909348|NCT00668525|19462944|P2|NOT COMPLETED|Overall Study||93
7909349|NCT00668525|19462945|P1|NOT COMPLETED|Overall Study||77
7909350|NCT00668525|19462943|P3|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167
7909351|NCT00668525|19462944|P2|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239
7909352|NCT00668525|19462945|P1|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248
7909353|NCT00668525|19462943|P3|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220
7909354|NCT00668525|19462944|P2|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332
7909355|NCT00668525|19462945|P1|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325
7909356|NCT00668434|19462958|P2|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11
7909357|NCT00668434|19462959|P1|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22
7909358|NCT00668434|19462958|P2|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77
7909359|NCT00668434|19462959|P1|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157
7909360|NCT00668434|19462958|P2|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88
7909361|NCT00668434|19462959|P1|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179
7909362|NCT00668434|19462958|P2|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0
7909363|NCT00668434|19462959|P1|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2
7909364|NCT00668434|19462958|P2|COMPLETED|Primary Outcome Time Point (3 Weeks)||88
7909365|NCT00668434|19462959|P1|COMPLETED|Primary Outcome Time Point (3 Weeks)||179
7909366|NCT00668434|19462958|P2|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88
7909367|NCT00668434|19462959|P1|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181
7909368|NCT00668395|19462974|P3|NOT COMPLETED|Overall Study||1
7909369|NCT00668395|19462975|P2|NOT COMPLETED|Overall Study||6
7909370|NCT00668395|19462976|P1|NOT COMPLETED|Overall Study||6
7909371|NCT00668395|19462974|P3|COMPLETED|Overall Study||5
7909372|NCT00668395|19462975|P2|COMPLETED|Overall Study||16
7909373|NCT00668395|19462976|P1|COMPLETED|Overall Study||39
7909374|NCT00668395|19462974|P3|STARTED|Overall Study||6
7909375|NCT00668395|19462975|P2|STARTED|Overall Study||22
7909376|NCT00668395|19462976|P1|STARTED|Overall Study||45
7909377|NCT00668382|19462984|P1|NOT COMPLETED|Overall Study||0
7909378|NCT00668382|19462984|P1|COMPLETED|Overall Study||11
7909379|NCT00668382|19462984|P1|STARTED|Overall Study|beginning of trial|11
7909380|NCT00668317|19462988|P1|NOT COMPLETED|Overall Study||2
7909381|NCT00668317|19462988|P1|COMPLETED|Overall Study||3
7909382|NCT00668317|19462988|P1|STARTED|Overall Study||5
7909383|NCT00668265|19462994|P2|NOT COMPLETED|Overall Study||5
7909384|NCT00668265|19462995|P1|NOT COMPLETED|Overall Study||9
7909385|NCT00668265|19462994|P2|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
7909386|NCT00668265|19462995|P1|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
7909387|NCT00668265|19462994|P2|STARTED|Overall Study||5
7909388|NCT00668265|19462995|P1|STARTED|Overall Study||9
7909389|NCT00668200|19463003|P1|NOT COMPLETED|Overall Study||3
7909390|NCT00668200|19463003|P1|COMPLETED|Overall Study||77
7909391|NCT00668200|19463003|P1|Intent to Treat (ITT)|Overall Study||80
7909392|NCT00668200|19463003|P1|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81
7909393|NCT00668200|19463003|P1|STARTED|Overall Study||80
7909394|NCT00668148|19463009|P1|NOT COMPLETED|Overall Study||10
7909395|NCT00668148|19463009|P1|COMPLETED|Overall Study||103
7909396|NCT00668148|19463009|P1|Received at Least 1 Dose of Study Drug|Overall Study||111
7909397|NCT00668148|19463009|P1|STARTED|Overall Study||113
7909398|NCT00667992|19463048|P2|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
7909399|NCT00667992|19463049|P1|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
7909400|NCT00667992|19463048|P2|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35
7909401|NCT00667992|19463049|P1|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33
7909402|NCT00667992|19463048|P2|STARTED|Forth Intervention 400 Mcg Twice Daily||35
7909403|NCT00667992|19463049|P1|STARTED|Forth Intervention 400 Mcg Twice Daily||33
7909404|NCT00667992|19463048|P2|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
7909405|NCT00667992|19463049|P1|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
7909406|NCT00667992|19463048|P2|COMPLETED|Third Intervention 100 Mcg Twice Daily||35
7909407|NCT00667992|19463049|P1|COMPLETED|Third Intervention 100 Mcg Twice Daily||33
7909408|NCT00667992|19463048|P2|STARTED|Third Intervention 100 Mcg Twice Daily||36
7909409|NCT00667992|19463049|P1|STARTED|Third Intervention 100 Mcg Twice Daily||34
7909410|NCT00667992|19463048|P2|NOT COMPLETED|Wash-out||5
7909411|NCT00667992|19463049|P1|NOT COMPLETED|Wash-out||7
7909412|NCT00667992|19463048|P2|COMPLETED|Wash-out||36
7909413|NCT00667992|19463049|P1|COMPLETED|Wash-out||34
7909414|NCT00667992|19463048|P2|STARTED|Wash-out||41
7909415|NCT00667992|19463049|P1|STARTED|Wash-out||41
7909416|NCT00667992|19463048|P2|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4
7909417|NCT00667992|19463049|P1|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3
7909418|NCT00667992|19463048|P2|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
7909419|NCT00667992|19463049|P1|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
7909420|NCT00667992|19463048|P2|STARTED|Second Intervention 400 Mcg Twice Daily||45
7909421|NCT00667992|19463049|P1|STARTED|Second Intervention 400 Mcg Twice Daily||44
7909422|NCT00667992|19463048|P2|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
7909423|NCT00667992|19463049|P1|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
7909424|NCT00667992|19463048|P2|COMPLETED|First Intervention 100 Mcg Twice Daily||45
7909425|NCT00667992|19463049|P1|COMPLETED|First Intervention 100 Mcg Twice Daily||44
7909426|NCT00667992|19463048|P2|STARTED|First Intervention 100 Mcg Twice Daily||50
7909427|NCT00667992|19463049|P1|STARTED|First Intervention 100 Mcg Twice Daily||49
7909428|NCT00667875|19463106|P3|NOT COMPLETED|Overall Study||13
7909429|NCT00667875|19463107|P2|NOT COMPLETED|Overall Study||11
7909430|NCT00667875|19463108|P1|NOT COMPLETED|Overall Study||10
7909431|NCT00667875|19463106|P3|COMPLETED|Overall Study||8
7909432|NCT00667875|19463107|P2|COMPLETED|Overall Study||10
7909433|NCT00667875|19463108|P1|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13
7909434|NCT00667875|19463106|P3|Subjects Included in Analysisd|Overall Study||19
7909435|NCT00667875|19463107|P2|Subjects Included in Analysisd|Overall Study||21
7909436|NCT00667875|19463108|P1|Subjects Included in Analysisd|Overall Study||20
7909437|NCT00667875|19463106|P3|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21
7909438|NCT00667875|19463107|P2|STARTED|Overall Study||21
7909439|NCT00667875|19463108|P1|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23
7909440|NCT00667849|19463127|P2|NOT COMPLETED|Overall Study||121
7909441|NCT00667849|19463128|P1|NOT COMPLETED|Overall Study||108
7909442|NCT00667849|19463127|P2|COMPLETED|Overall Study||130
7909443|NCT00667849|19463128|P1|COMPLETED|Overall Study||142
7909444|NCT00667849|19463127|P2|STARTED|Overall Study||251
7909445|NCT00667849|19463128|P1|STARTED|Overall Study||250
7909446|NCT00667810|19463142|P4|NOT COMPLETED|Overall Study||2
7909447|NCT00667810|19463143|P3|NOT COMPLETED|Overall Study||222
7909448|NCT00667810|19463144|P2|NOT COMPLETED|Overall Study||170
7909449|NCT00667810|19463145|P1|NOT COMPLETED|Overall Study||167
7909450|NCT00667810|19463142|P4|COMPLETED|Overall Study||9
7909451|NCT00667810|19463143|P3|COMPLETED|Overall Study||124
7909452|NCT00667810|19463144|P2|COMPLETED|Overall Study||94
7909453|NCT00667810|19463145|P1|COMPLETED|Overall Study||102
7909454|NCT00667810|19463142|P4|Treated|Overall Study||11
7909455|NCT00667810|19463143|P3|Treated|Overall Study||344
7909456|NCT00667810|19463144|P2|Treated|Overall Study||263
7909457|NCT00667810|19463145|P1|Treated|Overall Study||267
7909458|NCT00667810|19463142|P4|STARTED|Overall Study||11
7909459|NCT00667810|19463143|P3|STARTED|Overall Study||346
7909460|NCT00667810|19463144|P2|STARTED|Overall Study||264
7909461|NCT00667810|19463145|P1|STARTED|Overall Study||269
7909462|NCT00667745|19463204|P2|NOT COMPLETED|Overall Study||21
7909463|NCT00667745|19463205|P1|NOT COMPLETED|Overall Study||25
7909464|NCT00667745|19463204|P2|COMPLETED|Overall Study||121
7909465|NCT00667745|19463205|P1|COMPLETED|Overall Study||116
7909466|NCT00667745|19463204|P2|STARTED|Overall Study||142
7909467|NCT00667745|19463205|P1|STARTED|Overall Study||141
7909468|NCT00667732|19463221|P3|NOT COMPLETED|Extension (26 Weeks)||0
7909469|NCT00667732|19463222|P2|NOT COMPLETED|Extension (26 Weeks)||0
7909470|NCT00667732|19463223|P1|NOT COMPLETED|Extension (26 Weeks)||0
7909471|NCT00667732|19463221|P3|COMPLETED|Extension (26 Weeks)||17
7909472|NCT00667732|19463222|P2|COMPLETED|Extension (26 Weeks)||14
7909473|NCT00667732|19463223|P1|COMPLETED|Extension (26 Weeks)||0
7909474|NCT00667732|19463221|P3|STARTED|Extension (26 Weeks)||17
7909475|NCT00667732|19463222|P2|STARTED|Extension (26 Weeks)||14
7909476|NCT00667732|19463223|P1|STARTED|Extension (26 Weeks)||0
7909477|NCT00667732|19463221|P3|NOT COMPLETED|Randomization (24 Weeks)||0
7909478|NCT00667732|19463222|P2|NOT COMPLETED|Randomization (24 Weeks)||1
7909479|NCT00667732|19463223|P1|NOT COMPLETED|Randomization (24 Weeks)||0
7909480|NCT00667732|19463221|P3|COMPLETED|Randomization (24 Weeks)||17
7909481|NCT00667732|19463222|P2|COMPLETED|Randomization (24 Weeks)||16
7909482|NCT00667732|19463223|P1|COMPLETED|Randomization (24 Weeks)||0
7909483|NCT00667732|19463221|P3|Participants Enrolled in Substudy|Randomization (24 Weeks)||9
7909484|NCT00667732|19463222|P2|Participants Enrolled in Substudy|Randomization (24 Weeks)||11
7909485|NCT00667732|19463223|P1|Participants Enrolled in Substudy|Randomization (24 Weeks)||0
7909486|NCT00667732|19463221|P3|STARTED|Randomization (24 Weeks)||17
7909487|NCT00667732|19463222|P2|STARTED|Randomization (24 Weeks)||17
7909488|NCT00667732|19463223|P1|STARTED|Randomization (24 Weeks)||0
7909489|NCT00667732|19463221|P3|NOT COMPLETED|Run -In (8 Weeks)||0
7909490|NCT00667732|19463222|P2|NOT COMPLETED|Run -In (8 Weeks)||0
7909491|NCT00667732|19463223|P1|NOT COMPLETED|Run -In (8 Weeks)||7
7909492|NCT00667732|19463221|P3|COMPLETED|Run -In (8 Weeks)||0
7909493|NCT00667732|19463222|P2|COMPLETED|Run -In (8 Weeks)||0
7909494|NCT00667732|19463223|P1|COMPLETED|Run -In (8 Weeks)||34
7909495|NCT00667732|19463221|P3|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
7909496|NCT00667732|19463222|P2|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
7909497|NCT00667732|19463223|P1|Participants Enrolled in Substudy|Run -In (8 Weeks)||20
7909498|NCT00667732|19463221|P3|STARTED|Run -In (8 Weeks)||0
7909499|NCT00667732|19463222|P2|STARTED|Run -In (8 Weeks)||0
7909500|NCT00667732|19463223|P1|STARTED|Run -In (8 Weeks)||41
7909501|NCT00667693|19463236|P2|NOT COMPLETED|Overall Study||2
7909502|NCT00667693|19463237|P1|NOT COMPLETED|Overall Study||0
7909503|NCT00667693|19463236|P2|COMPLETED|Overall Study||50
7909504|NCT00667693|19463237|P1|COMPLETED|Overall Study||49
7909505|NCT00667693|19463236|P2|STARTED|Overall Study||52
7909506|NCT00667693|19463237|P1|STARTED|Overall Study||49
7909507|NCT00667615|19463251|P1|NOT COMPLETED|Overall Study||0
7909508|NCT00667615|19463251|P1|COMPLETED|Overall Study||30
7909509|NCT00667615|19463251|P1|STARTED|Overall Study||30
7909510|NCT00667602|19463259|P3|NOT COMPLETED|Overall Study||18
7909511|NCT00667602|19463260|P2|NOT COMPLETED|Overall Study||15
7909512|NCT00667602|19463261|P1|NOT COMPLETED|Overall Study||8
7909513|NCT00667602|19463259|P3|COMPLETED|Overall Study||197
7909514|NCT00667602|19463260|P2|COMPLETED|Overall Study||213
7909515|NCT00667602|19463261|P1|COMPLETED|Overall Study||211
7909516|NCT00667602|19463259|P3|STARTED|Overall Study||215
7909517|NCT00667602|19463260|P2|STARTED|Overall Study||228
7909518|NCT00667602|19463261|P1|STARTED|Overall Study||219
7909519|NCT00667589|19463311|P4|NOT COMPLETED|Overall Study||1
7909520|NCT00667589|19463312|P3|NOT COMPLETED|Overall Study||3
7909521|NCT00667589|19463313|P2|NOT COMPLETED|Overall Study||0
7909522|NCT00667589|19463314|P1|NOT COMPLETED|Overall Study||1
7909523|NCT00667589|19463311|P4|COMPLETED|Overall Study||1
7909524|NCT00667589|19463312|P3|COMPLETED|Overall Study||0
7909525|NCT00667589|19463313|P2|COMPLETED|Overall Study||0
7909526|NCT00667589|19463314|P1|COMPLETED|Overall Study||0
7909527|NCT00667589|19463311|P4|STARTED|Overall Study||2
7909528|NCT00667589|19463312|P3|STARTED|Overall Study||3
7909529|NCT00667589|19463313|P2|STARTED|Overall Study||0
7909530|NCT00667589|19463314|P1|STARTED|Overall Study||1
7909531|NCT00667576|19463329|P5|NOT COMPLETED|Overall Study||1
7909532|NCT00667576|19463330|P4|NOT COMPLETED|Overall Study||4
7909533|NCT00667576|19463331|P3|NOT COMPLETED|Overall Study||2
7909534|NCT00667576|19463332|P2|NOT COMPLETED|Overall Study||1
7909535|NCT00667576|19463333|P1|NOT COMPLETED|Overall Study||2
7909536|NCT00667576|19463329|P5|COMPLETED|Overall Study||29
7909537|NCT00667576|19463330|P4|COMPLETED|Overall Study||27
7909538|NCT00667576|19463331|P3|COMPLETED|Overall Study||29
7909539|NCT00667576|19463332|P2|COMPLETED|Overall Study||30
7909540|NCT00667576|19463333|P1|COMPLETED|Overall Study||28
7909541|NCT00667576|19463329|P5|STARTED|Overall Study||30
7909542|NCT00667576|19463330|P4|STARTED|Overall Study||31
7909543|NCT00667576|19463331|P3|STARTED|Overall Study||31
7909544|NCT00667576|19463332|P2|STARTED|Overall Study||31
7909545|NCT00667576|19463333|P1|STARTED|Overall Study||30
7909546|NCT00667563|19463380|P1|NOT COMPLETED|Overall Study||24
7909547|NCT00667563|19463380|P1|COMPLETED|Overall Study||126
7909548|NCT00667563|19463380|P1|STARTED|Overall Study||150
7909549|NCT00667511|19463390|P1|NOT COMPLETED|Intervention 2: Home NHD||4
7909550|NCT00667511|19463390|P1|COMPLETED|Intervention 2: Home NHD||39
7909551|NCT00667511|19463390|P1|STARTED|Intervention 2: Home NHD||43
7909552|NCT00667511|19463390|P1|NOT COMPLETED|Training/Transition Period||8
7909553|NCT00667511|19463390|P1|COMPLETED|Training/Transition Period||43
7909554|NCT00667511|19463390|P1|STARTED|Training/Transition Period||51
7909555|NCT00667511|19463390|P1|NOT COMPLETED|Intervention 1: Home DHD||7
7909556|NCT00667511|19463390|P1|COMPLETED|Intervention 1: Home DHD||51
7909557|NCT00667511|19463390|P1|STARTED|Intervention 1: Home DHD||58
7909558|NCT00667459|19463400|P2|NOT COMPLETED|Overall Study||45
7909559|NCT00667459|19463401|P1|NOT COMPLETED|Overall Study||8
7909560|NCT00667459|19463400|P2|COMPLETED|Overall Study||220
7909561|NCT00667459|19463401|P1|COMPLETED|Overall Study||272
7909562|NCT00667459|19463400|P2|STARTED|Overall Study||265
7909563|NCT00667459|19463401|P1|STARTED|Overall Study||280
7909564|NCT00667446|19463443|P2|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1
7909565|NCT00667446|19463444|P1|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0
7909566|NCT00667446|19463443|P2|COMPLETED|Safety Follow-up Period (12 Weeks)||25
7909567|NCT00667446|19463444|P1|COMPLETED|Safety Follow-up Period (12 Weeks)||28
7909568|NCT00667446|19463443|P2|STARTED|Safety Follow-up Period (12 Weeks)||26
7909569|NCT00667446|19463444|P1|STARTED|Safety Follow-up Period (12 Weeks)||28
7909570|NCT00667446|19463443|P2|NOT COMPLETED|Treatment Period (36 Months)||25
7909571|NCT00667446|19463444|P1|NOT COMPLETED|Treatment Period (36 Months)||23
7909572|NCT00667446|19463443|P2|COMPLETED|Treatment Period (36 Months)||13
7909573|NCT00667446|19463444|P1|COMPLETED|Treatment Period (36 Months)||11
7909574|NCT00667446|19463443|P2|STARTED|Treatment Period (36 Months)||38
7909575|NCT00667446|19463444|P1|STARTED|Treatment Period (36 Months)||34
7909576|NCT00667420|19463466|P1|NOT COMPLETED|Overall Study||10
7909577|NCT00667420|19463466|P1|COMPLETED|Overall Study||7
7909578|NCT00667420|19463466|P1|Completion of Surgery/Re-staging|Overall Study||11
7909579|NCT00667420|19463466|P1|Completion of Pre-operative EOX-P|Overall Study||15
7909580|NCT00667420|19463466|P1|STARTED|Overall Study||17
7909581|NCT00667394|19463476|P2|NOT COMPLETED|Overall Study||0
7909582|NCT00667394|19463477|P1|NOT COMPLETED|Overall Study||4
7909583|NCT00667394|19463476|P2|COMPLETED|Overall Study||1
7909584|NCT00667394|19463477|P1|COMPLETED|Overall Study||37
7909585|NCT00667394|19463476|P2|STARTED|Overall Study||1
7909586|NCT00667394|19463477|P1|STARTED|Overall Study||41
7909587|NCT00667381|19463487|P2|NOT COMPLETED|Overall Study||0
7909588|NCT00667381|19463488|P1|NOT COMPLETED|Overall Study||0
7909589|NCT00667381|19463487|P2|COMPLETED|Overall Study||503
7909590|NCT00667381|19463488|P1|COMPLETED|Overall Study||501
7909591|NCT00667381|19463487|P2|STARTED|Overall Study||503
7909592|NCT00667381|19463488|P1|STARTED|Overall Study||501
7909593|NCT00667368|19463504|P2|NOT COMPLETED|Overall Study||172
7909594|NCT00667368|19463505|P1|NOT COMPLETED|Overall Study||200
7909595|NCT00667368|19463504|P2|COMPLETED|Overall Study||511
7909596|NCT00667368|19463505|P1|COMPLETED|Overall Study||482
7909597|NCT00667368|19463504|P2|STARTED|Overall Study||683
7909598|NCT00667368|19463505|P1|STARTED|Overall Study||682
7909599|NCT00667355|19463513|P1|NOT COMPLETED|Overall Study||11
7909600|NCT00667355|19463513|P1|COMPLETED|Overall Study||30
7909601|NCT00667355|19463513|P1|STARTED|Overall Study||41
7909602|NCT00667342|19463538|P3|NOT COMPLETED|Overall Study||9
7909603|NCT00667342|19463539|P2|NOT COMPLETED|Overall Study||0
7909604|NCT00667342|19463540|P1|NOT COMPLETED|Overall Study||14
7909605|NCT00667342|19463538|P3|COMPLETED|Overall Study||3
7909606|NCT00667342|19463539|P2|COMPLETED|Overall Study||0
7909607|NCT00667342|19463540|P1|COMPLETED|Overall Study||17
7909608|NCT00667342|19463538|P3|STARTED|Overall Study||12
7909609|NCT00667342|19463539|P2|STARTED|Overall Study||0
7909610|NCT00667342|19463540|P1|STARTED|Overall Study||31
7909611|NCT00667277|19463578|P1|NOT COMPLETED|Overall Study||2
7909612|NCT00667277|19463578|P1|COMPLETED|Overall Study||11
7909613|NCT00667277|19463578|P1|STARTED|Overall Study||13
7909614|NCT00667251|19463585|P2|NOT COMPLETED|Overall Study||95
7909615|NCT00667251|19463586|P1|NOT COMPLETED|Overall Study||70
7909616|NCT00667251|19463585|P2|COMPLETED|Overall Study||231
7909617|NCT00667251|19463586|P1|COMPLETED|Overall Study||256
7909618|NCT00667251|19463585|P2|Not Started|Overall Study||1
7909619|NCT00667251|19463586|P1|Not Started|Overall Study||4
7909620|NCT00667251|19463585|P2|Monotherapy|Overall Study||232
7909621|NCT00667251|19463586|P1|Monotherapy|Overall Study||225
7909622|NCT00667251|19463585|P2|Combination Rx|Overall Study||325
7909623|NCT00667251|19463586|P1|Combination Rx|Overall Study||322
7909624|NCT00667251|19463585|P2|STARTED|Overall Study||326
7909625|NCT00667251|19463586|P1|STARTED|Overall Study||326
7909626|NCT00667225|19463612|P2|NOT COMPLETED|Overall Study||1
7909627|NCT00667225|19463613|P1|NOT COMPLETED|Overall Study||1
7909628|NCT00667225|19463612|P2|COMPLETED|Overall Study||12
7909629|NCT00667225|19463613|P1|COMPLETED|Overall Study||15
7909630|NCT00667225|19463612|P2|STARTED|Overall Study||13
7909631|NCT00667225|19463613|P1|STARTED|Overall Study||16
7909632|NCT00667186|19463623|P2|NOT COMPLETED|Overall Study||0
7909633|NCT00667186|19463624|P1|NOT COMPLETED|Overall Study||0
7909634|NCT00667186|19463623|P2|COMPLETED|Overall Study||4880
7909635|NCT00667186|19463624|P1|COMPLETED|Overall Study||4692
7909636|NCT00667186|19463623|P2|STARTED|Overall Study||4880
7909637|NCT00667186|19463624|P1|STARTED|Overall Study||4692
7909638|NCT00667095|19463634|P2|NOT COMPLETED|Overall Study||1
7909639|NCT00667095|19463635|P1|NOT COMPLETED|Overall Study||0
7909640|NCT00667095|19463634|P2|COMPLETED|Overall Study||9
7909641|NCT00667095|19463635|P1|COMPLETED|Overall Study||11
7909642|NCT00667095|19463634|P2|STARTED|Overall Study||10
7909643|NCT00667095|19463635|P1|STARTED|Overall Study||11
7909644|NCT00667017|19463651|P1|NOT COMPLETED|Overall Study||1
7909645|NCT00667017|19463651|P1|COMPLETED|Overall Study||0
7909646|NCT00667017|19463651|P1|STARTED|Overall Study||1
7909647|NCT00667004|19463657|P2|NOT COMPLETED|Overall Study||3
7909648|NCT00667004|19463658|P1|NOT COMPLETED|Overall Study||2
7909649|NCT00667004|19463657|P2|COMPLETED|Overall Study||85
7909650|NCT00667004|19463658|P1|COMPLETED|Overall Study||93
7909651|NCT00667004|19463657|P2|STARTED|Overall Study||88
7909652|NCT00667004|19463658|P1|STARTED|Overall Study||95
7909653|NCT00666978|19463666|P2|NOT COMPLETED|Overall Study||83
7909654|NCT00666978|19463667|P1|NOT COMPLETED|Overall Study||78
7909655|NCT00666978|19463666|P2|COMPLETED|Overall Study||187
7909656|NCT00666978|19463667|P1|COMPLETED|Overall Study||192
7909657|NCT00666978|19463666|P2|STARTED|Overall Study||270
7909658|NCT00666978|19463667|P1|STARTED|Overall Study||270
7909659|NCT00666965|19463680|P4|NOT COMPLETED|Overall Study||15
7909660|NCT00666965|19463681|P3|NOT COMPLETED|Overall Study||2
7909661|NCT00666965|19463682|P2|NOT COMPLETED|Overall Study||4
7909662|NCT00666965|19463683|P1|NOT COMPLETED|Overall Study||3
7909663|NCT00666965|19463680|P4|COMPLETED|Overall Study||42
7909664|NCT00666965|19463681|P3|COMPLETED|Overall Study||56
7909665|NCT00666965|19463682|P2|COMPLETED|Overall Study||53
7909666|NCT00666965|19463683|P1|COMPLETED|Overall Study||55
7909667|NCT00666965|19463680|P4|STARTED|Overall Study||57
7909668|NCT00666965|19463681|P3|STARTED|Overall Study||58
7909669|NCT00666965|19463682|P2|STARTED|Overall Study||57
7909670|NCT00666965|19463683|P1|STARTED|Overall Study||58
7909671|NCT00666926|19463713|P16|NOT COMPLETED|Overall Study||8
7909672|NCT00666926|19463714|P15|NOT COMPLETED|Overall Study||7
7909673|NCT00666926|19463715|P14|NOT COMPLETED|Overall Study||4
7909674|NCT00666926|19463716|P13|NOT COMPLETED|Overall Study||3
7909675|NCT00666926|19463717|P12|NOT COMPLETED|Overall Study||33
7909676|NCT00666926|19463718|P11|NOT COMPLETED|Overall Study||6
7909677|NCT00666926|19463719|P10|NOT COMPLETED|Overall Study||10
7909678|NCT00666926|19463720|P9|NOT COMPLETED|Overall Study||3
7909679|NCT00666926|19463721|P8|NOT COMPLETED|Overall Study||1
7909680|NCT00666926|19463722|P7|NOT COMPLETED|Overall Study||4
7909681|NCT00666926|19463723|P6|NOT COMPLETED|Overall Study||4
7909682|NCT00666926|19463724|P5|NOT COMPLETED|Overall Study||3
7909683|NCT00666926|19463725|P4|NOT COMPLETED|Overall Study||4
7909684|NCT00666926|19463726|P3|NOT COMPLETED|Overall Study||3
7909685|NCT00666926|19463727|P2|NOT COMPLETED|Overall Study||4
7909686|NCT00666926|19463728|P1|NOT COMPLETED|Overall Study||2
7909687|NCT00666926|19463713|P16|COMPLETED|Overall Study||0
7909688|NCT00666926|19463714|P15|COMPLETED|Overall Study||0
7909689|NCT00666926|19463715|P14|COMPLETED|Overall Study||0
7909690|NCT00666926|19463716|P13|COMPLETED|Overall Study||0
7909691|NCT00666926|19463717|P12|COMPLETED|Overall Study||0
7909692|NCT00666926|19463718|P11|COMPLETED|Overall Study||0
7909693|NCT00666926|19463719|P10|COMPLETED|Overall Study||0
7909694|NCT00666926|19463720|P9|COMPLETED|Overall Study||0
7909695|NCT00666926|19463721|P8|COMPLETED|Overall Study||0
7909696|NCT00666926|19463722|P7|COMPLETED|Overall Study||0
7909697|NCT00666926|19463723|P6|COMPLETED|Overall Study||0
7909698|NCT00666926|19463724|P5|COMPLETED|Overall Study||0
7909699|NCT00666926|19463725|P4|COMPLETED|Overall Study||0
7909700|NCT00666926|19463726|P3|COMPLETED|Overall Study||0
7909701|NCT00666926|19463727|P2|COMPLETED|Overall Study||0
7909702|NCT00666926|19463728|P1|COMPLETED|Overall Study||0
7909703|NCT00666926|19463713|P16|STARTED|Overall Study||8
7909704|NCT00666926|19463714|P15|STARTED|Overall Study||7
7909705|NCT00666926|19463715|P14|STARTED|Overall Study||4
7909706|NCT00666926|19463716|P13|STARTED|Overall Study||3
7909707|NCT00666926|19463717|P12|STARTED|Overall Study||33
7909708|NCT00666926|19463718|P11|STARTED|Overall Study||6
7909709|NCT00666926|19463719|P10|STARTED|Overall Study||10
7909710|NCT00666926|19463720|P9|STARTED|Overall Study||3
7909711|NCT00666926|19463721|P8|STARTED|Overall Study||1
7909712|NCT00666926|19463722|P7|STARTED|Overall Study||4
7909713|NCT00666926|19463723|P6|STARTED|Overall Study||4
7909714|NCT00666926|19463724|P5|STARTED|Overall Study||3
7909715|NCT00666926|19463725|P4|STARTED|Overall Study||4
7909716|NCT00666926|19463726|P3|STARTED|Overall Study||3
7909717|NCT00666926|19463727|P2|STARTED|Overall Study||4
7909718|NCT00666926|19463728|P1|STARTED|Overall Study||2
7909719|NCT00666848|19464022|P3|NOT COMPLETED|Overall Study||0
7909720|NCT00666848|19464023|P2|NOT COMPLETED|Overall Study||0
7909721|NCT00666848|19464024|P1|NOT COMPLETED|Overall Study||0
7909722|NCT00666848|19464022|P3|COMPLETED|Overall Study|finished Aim 3|7
7909723|NCT00666848|19464023|P2|COMPLETED|Overall Study|finished Aim 1|9
7909724|NCT00666848|19464024|P1|COMPLETED|Overall Study|finished Aim 2|8
7909725|NCT00666848|19464022|P3|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7
7909726|NCT00666848|19464023|P2|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9
7909727|NCT00666848|19464024|P1|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8
7909728|NCT00666835|19464037|P2|NOT COMPLETED|Overall Study||22
7909729|NCT00666835|19464038|P1|NOT COMPLETED|Overall Study||53
7909730|NCT00666835|19464037|P2|COMPLETED|Overall Study||142
7909731|NCT00666835|19464038|P1|COMPLETED|Overall Study||261
7909732|NCT00666835|19464037|P2|STARTED|Overall Study||164
7909733|NCT00666835|19464038|P1|STARTED|Overall Study||314
7909734|NCT00666757|19464048|P2|NOT COMPLETED|Overall Study||97
7909735|NCT00666757|19464049|P1|NOT COMPLETED|Overall Study||100
7909736|NCT00666757|19464048|P2|COMPLETED|Overall Study||281
7909737|NCT00666757|19464049|P1|COMPLETED|Overall Study||272
7909738|NCT00666757|19464048|P2|STARTED|Overall Study||378
7909739|NCT00666757|19464049|P1|STARTED|Overall Study||372
7909740|NCT00666718|19464108|P2|NOT COMPLETED|Overall Study||18
7909741|NCT00666718|19464109|P1|NOT COMPLETED|Overall Study||12
7909742|NCT00666718|19464108|P2|COMPLETED|Overall Study||169
7909743|NCT00666718|19464109|P1|COMPLETED|Overall Study||175
7909744|NCT00666718|19464108|P2|STARTED|Overall Study||187
7909745|NCT00666718|19464109|P1|STARTED|Overall Study||187
7909746|NCT00666705|19464135|P1|NOT COMPLETED|Overall Study||1
7909747|NCT00666705|19464135|P1|COMPLETED|Overall Study||17
7909748|NCT00666705|19464135|P1|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17
7909749|NCT00666705|19464135|P1|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18
7909750|NCT00666705|19464135|P1|Washout (Days 4 - 5)|Overall Study||18
7909751|NCT00666705|19464135|P1|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18
7909752|NCT00666705|19464135|P1|STARTED|Overall Study||18
7909753|NCT00666679|19464154|P2|NOT COMPLETED|Second Intervention||1
7909754|NCT00666679|19464155|P1|NOT COMPLETED|Second Intervention||1
7909755|NCT00666679|19464154|P2|COMPLETED|Second Intervention||64
7909756|NCT00666679|19464155|P1|COMPLETED|Second Intervention||61
7909757|NCT00666679|19464154|P2|STARTED|Second Intervention||65
7909758|NCT00666679|19464155|P1|STARTED|Second Intervention||62
7909759|NCT00666679|19464154|P2|NOT COMPLETED|Washout Period of 1 Week||2
7909760|NCT00666679|19464155|P1|NOT COMPLETED|Washout Period of 1 Week||0
7909761|NCT00666679|19464154|P2|COMPLETED|Washout Period of 1 Week||65
7909762|NCT00666679|19464155|P1|COMPLETED|Washout Period of 1 Week||62
7909763|NCT00666679|19464154|P2|STARTED|Washout Period of 1 Week||67
7909764|NCT00666679|19464155|P1|STARTED|Washout Period of 1 Week||62
7909765|NCT00666679|19464154|P2|NOT COMPLETED|First Intervention||1
7909766|NCT00666679|19464155|P1|NOT COMPLETED|First Intervention||4
7909767|NCT00666679|19464154|P2|COMPLETED|First Intervention||67
7909768|NCT00666679|19464155|P1|COMPLETED|First Intervention||62
7909769|NCT00666679|19464154|P2|STARTED|First Intervention||68
7909770|NCT00666679|19464155|P1|STARTED|First Intervention||66
7909771|NCT00666666|19464175|P1|NOT COMPLETED|Overall Study||0
7909772|NCT00666666|19464175|P1|COMPLETED|Overall Study||55
7909773|NCT00666666|19464175|P1|STARTED|Overall Study||55
7909774|NCT00666588|19464185|P4|NOT COMPLETED|Overall Study||2
7909775|NCT00666588|19464186|P3|NOT COMPLETED|Overall Study||0
7909776|NCT00666588|19464187|P2|NOT COMPLETED|Overall Study||0
7909777|NCT00666588|19464188|P1|NOT COMPLETED|Overall Study||4
7909778|NCT00666588|19464185|P4|COMPLETED|Overall Study||20
7909779|NCT00666588|19464186|P3|COMPLETED|Overall Study||6
7909780|NCT00666588|19464187|P2|COMPLETED|Overall Study||6
7909781|NCT00666588|19464188|P1|COMPLETED|Overall Study||14
7909782|NCT00666588|19464185|P4|STARTED|Overall Study||22
7909783|NCT00666588|19464186|P3|STARTED|Overall Study||6
7909784|NCT00666588|19464187|P2|STARTED|Overall Study||6
7909785|NCT00666588|19464188|P1|STARTED|Overall Study||18
7909786|NCT00666562|19464221|P3|NOT COMPLETED|Overall Study||0
7909787|NCT00666562|19464222|P2|NOT COMPLETED|Overall Study||2
7909788|NCT00666562|19464223|P1|NOT COMPLETED|Overall Study||0
7909789|NCT00666562|19464221|P3|COMPLETED|Overall Study||10
7909790|NCT00666562|19464222|P2|COMPLETED|Overall Study||8
7909791|NCT00666562|19464223|P1|COMPLETED|Overall Study||11
7909792|NCT00666562|19464221|P3|STARTED|Overall Study||10
7909793|NCT00666562|19464222|P2|STARTED|Overall Study||10
7909794|NCT00666562|19464223|P1|STARTED|Overall Study||11
7909795|NCT00666536|19464270|P2|NOT COMPLETED|Overall Study||37
7909796|NCT00666536|19464271|P1|NOT COMPLETED|Overall Study||33
7909797|NCT00666536|19464270|P2|COMPLETED|Overall Study||322
7909798|NCT00666536|19464271|P1|COMPLETED|Overall Study||336
7909799|NCT00666536|19464270|P2|STARTED|Overall Study||359
7909800|NCT00666536|19464271|P1|STARTED|Overall Study||369
7909801|NCT00666458|19464289|P2|NOT COMPLETED|Overall Study||24
7909802|NCT00666458|19464290|P1|NOT COMPLETED|Overall Study||38
7909803|NCT00666458|19464289|P2|COMPLETED|Overall Study|Completed 18 weeks of treatment|374
7909804|NCT00666458|19464290|P1|COMPLETED|Overall Study|Completed 18 weeks of treatment|365
7909805|NCT00666458|19464289|P2|STARTED|Overall Study|Randomized and treated|398
7909806|NCT00666458|19464290|P1|STARTED|Overall Study|Randomized and treated|403
7909807|NCT00666406|19464302|P2|NOT COMPLETED|Second PK Infusion||0
7909808|NCT00666406|19464303|P1|NOT COMPLETED|Second PK Infusion||0
7909809|NCT00666406|19464302|P2|COMPLETED|Second PK Infusion||3
7909810|NCT00666406|19464303|P1|COMPLETED|Second PK Infusion||6
7909811|NCT00666406|19464302|P2|STARTED|Second PK Infusion||3
7909812|NCT00666406|19464303|P1|STARTED|Second PK Infusion||6
7909813|NCT00666406|19464302|P2|NOT COMPLETED|First PK Infusion||0
7909814|NCT00666406|19464303|P1|NOT COMPLETED|First PK Infusion||0
7909815|NCT00666406|19464302|P2|COMPLETED|First PK Infusion||3
7909816|NCT00666406|19464303|P1|COMPLETED|First PK Infusion||6
7909817|NCT00666406|19464302|P2|STARTED|First PK Infusion||3
7909818|NCT00666406|19464303|P1|STARTED|First PK Infusion||6
7909819|NCT00666328|19464378|P1|NOT COMPLETED|Overall Study||5
7909820|NCT00666328|19464378|P1|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30
7909821|NCT00666328|19464378|P1|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33
7909822|NCT00666328|19464378|P1|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35
7909823|NCT00666276|19464391|P1|NOT COMPLETED|Overall Study||34
7909824|NCT00666276|19464391|P1|COMPLETED|Overall Study||970
7909825|NCT00666276|19464391|P1|STARTED|Overall Study||1004
7909826|NCT00666263|19464415|P2|NOT COMPLETED|End of Study Visit||0
7909827|NCT00666263|19464416|P1|NOT COMPLETED|End of Study Visit||0
7909828|NCT00666263|19464415|P2|COMPLETED|End of Study Visit||22
7909829|NCT00666263|19464416|P1|COMPLETED|End of Study Visit||22
7909830|NCT00666263|19464415|P2|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
7909831|NCT00666263|19464416|P1|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
7909832|NCT00666263|19464415|P2|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1
7909833|NCT00666263|19464416|P1|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0
7909834|NCT00666263|19464415|P2|COMPLETED|Study Part 5 (Stabilization Phase 3)||20
7909835|NCT00666263|19464416|P1|COMPLETED|Study Part 5 (Stabilization Phase 3)||21
7909836|NCT00666263|19464415|P2|STARTED|Study Part 5 (Stabilization Phase 3)||21
7909837|NCT00666263|19464416|P1|STARTED|Study Part 5 (Stabilization Phase 3)||21
7909838|NCT00666263|19464415|P2|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0
7909839|NCT00666263|19464416|P1|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1
7909840|NCT00666263|19464415|P2|COMPLETED|Study Part 4 (Cross-over Period 2)||21
7909841|NCT00666263|19464416|P1|COMPLETED|Study Part 4 (Cross-over Period 2)||21
7909842|NCT00666263|19464415|P2|STARTED|Study Part 4 (Cross-over Period 2)||21
7909843|NCT00666263|19464416|P1|STARTED|Study Part 4 (Cross-over Period 2)||22
7909844|NCT00666263|19464415|P2|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
7909845|NCT00666263|19464416|P1|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
7909846|NCT00666263|19464415|P2|COMPLETED|Study Part 3 (Stabilization Phase 2)||21
7909847|NCT00666263|19464416|P1|COMPLETED|Study Part 3 (Stabilization Phase 2)||22
7909848|NCT00666263|19464415|P2|STARTED|Study Part 3 (Stabilization Phase 2)||21
7909849|NCT00666263|19464416|P1|STARTED|Study Part 3 (Stabilization Phase 2)||22
7909850|NCT00666263|19464415|P2|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
7909851|NCT00666263|19464416|P1|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
7909852|NCT00666263|19464415|P2|COMPLETED|Study Part 2 (Cross-over Period 1)||21
7909853|NCT00666263|19464416|P1|COMPLETED|Study Part 2 (Cross-over Period 1)||22
7909854|NCT00666263|19464415|P2|STARTED|Study Part 2 (Cross-over Period 1)||21
7909855|NCT00666263|19464416|P1|STARTED|Study Part 2 (Cross-over Period 1)||22
7909856|NCT00666263|19464415|P2|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1
7909857|NCT00666263|19464416|P1|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0
7909858|NCT00666263|19464415|P2|COMPLETED|Study Part 1 (Stabilization Phase 1)||21
7909859|NCT00666263|19464416|P1|COMPLETED|Study Part 1 (Stabilization Phase 1)||22
7909860|NCT00666263|19464415|P2|STARTED|Study Part 1 (Stabilization Phase 1)||22
7909861|NCT00666263|19464416|P1|STARTED|Study Part 1 (Stabilization Phase 1)||22
7909862|NCT00666224|19464560|P2|NOT COMPLETED|Open-Label||85
7909863|NCT00666224|19464561|P1|NOT COMPLETED|Open-Label||35
7909864|NCT00666224|19464560|P2|COMPLETED|Open-Label||126
7909865|NCT00666224|19464561|P1|COMPLETED|Open-Label||163
7909866|NCT00666224|19464560|P2|STARTED|Open-Label||211
7909867|NCT00666224|19464561|P1|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198
7909868|NCT00666224|19464560|P2|NOT COMPLETED|Double-Blind||27
7909869|NCT00666224|19464561|P1|NOT COMPLETED|Double-Blind||45
7909870|NCT00666224|19464560|P2|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211
7909871|NCT00666224|19464561|P1|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198
7909872|NCT00666224|19464560|P2|STARTED|Double-Blind||238
7909873|NCT00666224|19464561|P1|STARTED|Double-Blind||243
7909874|NCT00666211|19464580|P2|NOT COMPLETED|Overall Study||38
7909875|NCT00666211|19464581|P1|NOT COMPLETED|Overall Study||20
7909876|NCT00666211|19464580|P2|COMPLETED|Overall Study||18
7909877|NCT00666211|19464581|P1|COMPLETED|Overall Study||22
7909878|NCT00666211|19464580|P2|STARTED|Overall Study||56
7909879|NCT00666211|19464581|P1|STARTED|Overall Study||42
7909880|NCT00666198|19464599|P1|NOT COMPLETED|Overall Study||33
7909881|NCT00666198|19464599|P1|COMPLETED|Overall Study||3304
7909882|NCT00666198|19464599|P1|STARTED|Overall Study||3337
7909883|NCT00666029|19464614|P2|NOT COMPLETED|Overall Study||0
7909884|NCT00666029|19464615|P1|NOT COMPLETED|Overall Study||1
7909885|NCT00666029|19464614|P2|COMPLETED|Overall Study||20
7909886|NCT00666029|19464615|P1|COMPLETED|Overall Study||19
7909887|NCT00666029|19464614|P2|STARTED|Overall Study||20
7909888|NCT00666029|19464615|P1|STARTED|Overall Study||20
7909889|NCT00665925|19464627|P4|NOT COMPLETED|Overall Study||21
7909890|NCT00665925|19464628|P3|NOT COMPLETED|Overall Study||26
7909891|NCT00665925|19464629|P2|NOT COMPLETED|Overall Study||17
7909892|NCT00665925|19464630|P1|NOT COMPLETED|Overall Study||15
7909893|NCT00665925|19464627|P4|COMPLETED|Overall Study|Participants completed the study|131
7909894|NCT00665925|19464628|P3|COMPLETED|Overall Study|Participants completed the study|126
7909895|NCT00665925|19464629|P2|COMPLETED|Overall Study|Participants completed the study|59
7909896|NCT00665925|19464630|P1|COMPLETED|Overall Study|Participants completed the study|62
7909897|NCT00665925|19464627|P4|STARTED|Overall Study|Participants randomized|152
7909898|NCT00665925|19464628|P3|STARTED|Overall Study|Participants randomized|152
7909899|NCT00665925|19464629|P2|STARTED|Overall Study|Participants randomized|76
7909900|NCT00665925|19464630|P1|STARTED|Overall Study|Participants randomized|77
7909901|NCT00665847|19465041|P1|NOT COMPLETED|Overall Study||25
7909902|NCT00665847|19465041|P1|COMPLETED|Overall Study||76
7909903|NCT00665847|19465041|P1|STARTED|Overall Study||101
7909904|NCT00665704|19465053|P1|NOT COMPLETED|Overall Study||0
7909905|NCT00665704|19465053|P1|COMPLETED|Overall Study||9
7909906|NCT00665704|19465053|P1|STARTED|Overall Study||9
7909907|NCT00665652|19465058|P1|NOT COMPLETED|Overall Study||6
7909908|NCT00665652|19465058|P1|COMPLETED|Overall Study||2
7909909|NCT00665652|19465058|P1|STARTED|Overall Study||8
7909910|NCT00665626|19465064|P2|NOT COMPLETED|Overall Study||22
7909911|NCT00665626|19465065|P1|NOT COMPLETED|Overall Study||10
7909912|NCT00665626|19465064|P2|COMPLETED|Overall Study|Participants completed the study|124
7909913|NCT00665626|19465065|P1|COMPLETED|Overall Study|Participants completed the study|63
7909914|NCT00665626|19465064|P2|STARTED|Overall Study|Participants randomized|146
7909915|NCT00665626|19465065|P1|STARTED|Overall Study|Participants randomized|73
7909916|NCT00665561|19465133|P2|NOT COMPLETED|Overall Study||534
7909917|NCT00665561|19465134|P1|NOT COMPLETED|Overall Study||502
7909918|NCT00665561|19465133|P2|COMPLETED|Overall Study||596
7909919|NCT00665561|19465134|P1|COMPLETED|Overall Study||814
7909920|NCT00665561|19465133|P2|STARTED|Overall Study||1130
7909921|NCT00665561|19465134|P1|STARTED|Overall Study||1316
7909922|NCT00665470|19465170|P2|NOT COMPLETED|Overall Study||0
7909923|NCT00665470|19465171|P1|NOT COMPLETED|Overall Study||0
7909924|NCT00665470|19465170|P2|COMPLETED|Overall Study||0
7909925|NCT00665470|19465171|P1|COMPLETED|Overall Study||10
7909926|NCT00665470|19465170|P2|STARTED|Overall Study||0
7909927|NCT00665470|19465171|P1|STARTED|Overall Study||10
7909928|NCT00665457|19465179|P1|NOT COMPLETED|Overall Study||0
7909929|NCT00665457|19465179|P1|COMPLETED|Overall Study||3
7909930|NCT00665457|19465179|P1|STARTED|Overall Study||3
7909931|NCT00665444|19465184|P1|NOT COMPLETED|Overall Study||2
7909932|NCT00665444|19465184|P1|COMPLETED|Overall Study||1
7909933|NCT00665444|19465184|P1|STARTED|Overall Study||3
7909934|NCT00665431|19465196|P3|NOT COMPLETED|Overall Study||24
7909935|NCT00665431|19465197|P2|NOT COMPLETED|Overall Study||57
7909936|NCT00665431|19465198|P1|NOT COMPLETED|Overall Study||40
7909937|NCT00665431|19465196|P3|COMPLETED|Overall Study||98
7909938|NCT00665431|19465197|P2|COMPLETED|Overall Study||188
7909939|NCT00665431|19465198|P1|COMPLETED|Overall Study||203
7909940|NCT00665431|19465196|P3|STARTED|Overall Study|Safety population|122
7909941|NCT00665431|19465197|P2|STARTED|Overall Study|Safety population|245
7909942|NCT00665431|19465198|P1|STARTED|Overall Study|Safety population|243
7909943|NCT00665366|19465241|P2|NOT COMPLETED|Overall Study||59
7909944|NCT00665366|19465242|P1|NOT COMPLETED|Overall Study||58
7909945|NCT00665366|19465241|P2|COMPLETED|Overall Study||122
7909946|NCT00665366|19465242|P1|COMPLETED|Overall Study||131
7909947|NCT00665366|19465241|P2|STARTED|Overall Study|Participants randomized|181
7909948|NCT00665366|19465242|P1|STARTED|Overall Study|Participants randomized|189
7909949|NCT00665353|19465270|P1|NOT COMPLETED|Study Step 2||14
7909950|NCT00665353|19465270|P1|COMPLETED|Study Step 2||2
7909951|NCT00665353|19465270|P1|STARTED|Study Step 2||16
7909952|NCT00665353|19465270|P1|NOT COMPLETED|Study Step 1||3
7909953|NCT00665353|19465270|P1|COMPLETED|Study Step 1||16
7909954|NCT00665353|19465270|P1|STARTED|Study Step 1||19
7909955|NCT00665132|19465280|P1|NOT COMPLETED|Overall Study||0
7909956|NCT00665132|19465280|P1|COMPLETED|Overall Study||10
7909957|NCT00665132|19465280|P1|STARTED|Overall Study||10
7909958|NCT00665002|19465287|P1|NOT COMPLETED|Overall Study||12
7909959|NCT00665002|19465287|P1|COMPLETED|Overall Study||4
7909960|NCT00665002|19465287|P1|STARTED|Overall Study||16
7909961|NCT00664859|19465295|P3|NOT COMPLETED|Overall Study||21
7909962|NCT00664859|19465296|P2|NOT COMPLETED|Overall Study||10
7909963|NCT00664859|19465297|P1|NOT COMPLETED|Overall Study||17
7909964|NCT00664859|19465295|P3|COMPLETED|Overall Study||23
7909965|NCT00664859|19465296|P2|COMPLETED|Overall Study||35
7909966|NCT00664859|19465297|P1|COMPLETED|Overall Study||34
7909967|NCT00664859|19465295|P3|STARTED|Overall Study||44
7909968|NCT00664859|19465296|P2|STARTED|Overall Study||45
7909969|NCT00664859|19465297|P1|STARTED|Overall Study||51
7909970|NCT00664755|19465310|P2|NOT COMPLETED|Overall Study||0
7909971|NCT00664755|19465311|P1|NOT COMPLETED|Overall Study||0
7909972|NCT00664755|19465310|P2|COMPLETED|Overall Study||73
7909973|NCT00664755|19465311|P1|COMPLETED|Overall Study||67
7909974|NCT00664755|19465310|P2|STARTED|Overall Study||73
7909975|NCT00664755|19465311|P1|STARTED|Overall Study||67
7909976|NCT00664742|19465317|P1|NOT COMPLETED|Overall Study||126
7909977|NCT00664742|19465317|P1|COMPLETED|Overall Study||481
7909978|NCT00664742|19465317|P1|STARTED|Overall Study||607
7909979|NCT00664560|19465325|P3|NOT COMPLETED|Overall Study||19
7909980|NCT00664560|19465326|P2|NOT COMPLETED|Overall Study||35
7909981|NCT00664560|19465327|P1|NOT COMPLETED|Overall Study||39
7909982|NCT00664560|19465325|P3|COMPLETED|Overall Study||105
7909983|NCT00664560|19465326|P2|COMPLETED|Overall Study||208
7909984|NCT00664560|19465327|P1|COMPLETED|Overall Study||208
7909985|NCT00664560|19465325|P3|STARTED|Overall Study|Safety Population|124
7909986|NCT00664560|19465326|P2|STARTED|Overall Study|Safety Population|243
7909987|NCT00664560|19465327|P1|STARTED|Overall Study|Safety Population|247
7909988|NCT00664534|19465370|P2|NOT COMPLETED|Overall Study||33
7909989|NCT00664534|19465371|P1|NOT COMPLETED|Overall Study||41
7909990|NCT00664534|19465370|P2|COMPLETED|Overall Study||138
7909991|NCT00664534|19465371|P1|COMPLETED|Overall Study||132
7909992|NCT00664534|19465370|P2|STARTED|Overall Study||171
7909993|NCT00664534|19465371|P1|STARTED|Overall Study||173
7909994|NCT00664521|19465399|P2|NOT COMPLETED|Overall Study||1
7909995|NCT00664521|19465400|P1|NOT COMPLETED|Overall Study||6
7909996|NCT00664521|19465399|P2|COMPLETED|Overall Study||8
7909997|NCT00664521|19465400|P1|COMPLETED|Overall Study||12
7909998|NCT00664521|19465399|P2|STARTED|Overall Study||9
7909999|NCT00664521|19465400|P1|STARTED|Overall Study||18
7910000|NCT00664430|19465420|P1|NOT COMPLETED|Overall Study||13
7910001|NCT00664430|19465420|P1|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0
7910002|NCT00664430|19465420|P1|STARTED|Overall Study||13
7910003|NCT00664326|19465426|P1|NOT COMPLETED|Overall Study||48
7910004|NCT00664326|19465426|P1|COMPLETED|Overall Study|transitioned to rollover study|1
7910005|NCT00664326|19465426|P1|STARTED|Overall Study||49
7910006|NCT00664209|19465445|P1|NOT COMPLETED|Study Treatment Period||6
7910007|NCT00664209|19465445|P1|COMPLETED|Study Treatment Period||0
7910008|NCT00664209|19465445|P1|STARTED|Study Treatment Period||6
7910009|NCT00664209|19465445|P1|NOT COMPLETED|Motor Fluctuations Screen||7
7910010|NCT00664209|19465445|P1|COMPLETED|Motor Fluctuations Screen||6
7910011|NCT00664209|19465445|P1|STARTED|Motor Fluctuations Screen||13
7910012|NCT00664105|19465453|P1|NOT COMPLETED|Overall Study||24
7910013|NCT00664105|19465453|P1|COMPLETED|Overall Study||39
7910014|NCT00664105|19465453|P1|STARTED|Overall Study||63
7910015|NCT00664066|19465460|P1|NOT COMPLETED|Overall Study||3
7910016|NCT00664066|19465460|P1|COMPLETED|Overall Study||0
7910017|NCT00664066|19465460|P1|STARTED|Overall Study||3
7910018|NCT00663962|19465466|P2|NOT COMPLETED|Overall Study||0
7910019|NCT00663962|19465467|P1|NOT COMPLETED|Overall Study||1
7910020|NCT00663962|19465466|P2|COMPLETED|Overall Study||8
7910021|NCT00663962|19465467|P1|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6
7910022|NCT00663962|19465466|P2|STARTED|Overall Study||8
7910023|NCT00663962|19465467|P1|STARTED|Overall Study||7
7910024|NCT00663923|19465473|P1|NOT COMPLETED|Overall Study||2
7910025|NCT00663923|19465473|P1|COMPLETED|Overall Study||48
7910026|NCT00663923|19465473|P1|STARTED|Overall Study||50
7910027|NCT00663858|19465490|P3|NOT COMPLETED|Overall Study||20
7910028|NCT00663858|19465491|P2|NOT COMPLETED|Overall Study||10
7910029|NCT00663858|19465492|P1|NOT COMPLETED|Overall Study||34
7910030|NCT00663858|19465490|P3|COMPLETED|Overall Study||82
7910031|NCT00663858|19465491|P2|COMPLETED|Overall Study||96
7910032|NCT00663858|19465492|P1|COMPLETED|Overall Study||178
7910033|NCT00663858|19465490|P3|STARTED|Overall Study||102
7910034|NCT00663858|19465491|P2|STARTED|Overall Study||106
7910035|NCT00663858|19465492|P1|STARTED|Overall Study||212
7910036|NCT00663819|19465502|P2|NOT COMPLETED|Overall Study||0
7910037|NCT00663819|19465503|P1|NOT COMPLETED|Overall Study||0
7910038|NCT00663819|19465502|P2|COMPLETED|Overall Study||135
7910039|NCT00663819|19465503|P1|COMPLETED|Overall Study||123
7910040|NCT00663819|19465502|P2|STARTED|Overall Study||135
7910041|NCT00663819|19465503|P1|STARTED|Overall Study||123
7910042|NCT00663793|19465517|P2|NOT COMPLETED|Overall Study||0
7910043|NCT00663793|19465518|P1|NOT COMPLETED|Overall Study||0
7910044|NCT00663793|19465517|P2|COMPLETED|Overall Study||8
7910045|NCT00663793|19465518|P1|COMPLETED|Overall Study||8
7910046|NCT00663793|19465517|P2|STARTED|Overall Study||8
7910047|NCT00663793|19465518|P1|STARTED|Overall Study||8
7910048|NCT00663702|19465530|P2|NOT COMPLETED|Overall Study||10
7910049|NCT00663702|19465531|P1|NOT COMPLETED|Overall Study||18
7910050|NCT00663702|19465530|P2|COMPLETED|Overall Study||61
7910051|NCT00663702|19465531|P1|COMPLETED|Overall Study||34
7910052|NCT00663702|19465530|P2|STARTED|Overall Study||71
7910053|NCT00663702|19465531|P1|STARTED|Overall Study||52
7910054|NCT00663403|19465554|P1|NOT COMPLETED|Overall Study||0
7910055|NCT00663403|19465554|P1|COMPLETED|Overall Study||8
7910056|NCT00663403|19465554|P1|STARTED|Overall Study||8
7910057|NCT00663260|19465567|P3|NOT COMPLETED|Overall Study||16
7910058|NCT00663260|19465568|P2|NOT COMPLETED|Overall Study||11
7910059|NCT00663260|19465569|P1|NOT COMPLETED|Overall Study||21
7910060|NCT00663260|19465567|P3|COMPLETED|Overall Study||69
7910061|NCT00663260|19465568|P2|COMPLETED|Overall Study||72
7910062|NCT00663260|19465569|P1|COMPLETED|Overall Study||63
7910063|NCT00663260|19465567|P3|STARTED|Overall Study||85
7910064|NCT00663260|19465568|P2|STARTED|Overall Study||83
7910065|NCT00663260|19465569|P1|STARTED|Overall Study||84
7910066|NCT00663234|19465583|P1|NOT COMPLETED|Overall Study||1
7910067|NCT00663234|19465583|P1|COMPLETED|Overall Study||27
7910068|NCT00663234|19465583|P1|Dose Increased to 20 mg at Week 8|Overall Study||10
7910069|NCT00663234|19465583|P1|STARTED|Overall Study||28
7910070|NCT00663208|19465616|P7|NOT COMPLETED|Follow-up Period||1
7910071|NCT00663208|19465617|P6|NOT COMPLETED|Follow-up Period||0
7910072|NCT00663208|19465618|P5|NOT COMPLETED|Follow-up Period||0
7910073|NCT00663208|19465619|P4|NOT COMPLETED|Follow-up Period||2
7910074|NCT00663208|19465620|P3|NOT COMPLETED|Follow-up Period||3
7910075|NCT00663208|19465621|P2|NOT COMPLETED|Follow-up Period||0
7910076|NCT00663208|19465622|P1|NOT COMPLETED|Follow-up Period||3
7910077|NCT00663208|19465616|P7|COMPLETED|Follow-up Period||5
7910078|NCT00663208|19465617|P6|COMPLETED|Follow-up Period||4
7910079|NCT00663208|19465618|P5|COMPLETED|Follow-up Period||4
7910080|NCT00663208|19465619|P4|COMPLETED|Follow-up Period||2
7910081|NCT00663208|19465620|P3|COMPLETED|Follow-up Period||1
7910082|NCT00663208|19465621|P2|COMPLETED|Follow-up Period||3
7910083|NCT00663208|19465622|P1|COMPLETED|Follow-up Period||1
7910084|NCT00663208|19465616|P7|STARTED|Follow-up Period||6
7910085|NCT00663208|19465617|P6|STARTED|Follow-up Period||4
7910086|NCT00663208|19465618|P5|STARTED|Follow-up Period||4
7910087|NCT00663208|19465619|P4|STARTED|Follow-up Period||4
7910088|NCT00663208|19465620|P3|STARTED|Follow-up Period||4
7910089|NCT00663208|19465621|P2|STARTED|Follow-up Period||3
7910090|NCT00663208|19465622|P1|STARTED|Follow-up Period||4
7910091|NCT00663208|19465616|P7|NOT COMPLETED|Treatment Period||0
7910092|NCT00663208|19465617|P6|NOT COMPLETED|Treatment Period||0
7910093|NCT00663208|19465618|P5|NOT COMPLETED|Treatment Period||0
7910094|NCT00663208|19465619|P4|NOT COMPLETED|Treatment Period||0
7910095|NCT00663208|19465620|P3|NOT COMPLETED|Treatment Period||0
7910096|NCT00663208|19465621|P2|NOT COMPLETED|Treatment Period||1
7910097|NCT00663208|19465622|P1|NOT COMPLETED|Treatment Period||0
7910098|NCT00663208|19465616|P7|COMPLETED|Treatment Period||6
7910099|NCT00663208|19465617|P6|COMPLETED|Treatment Period||4
7910100|NCT00663208|19465618|P5|COMPLETED|Treatment Period||4
7910101|NCT00663208|19465619|P4|COMPLETED|Treatment Period||4
7910102|NCT00663208|19465620|P3|COMPLETED|Treatment Period||4
7910103|NCT00663208|19465621|P2|COMPLETED|Treatment Period||3
7910104|NCT00663208|19465622|P1|COMPLETED|Treatment Period||4
7910105|NCT00663208|19465616|P7|STARTED|Treatment Period||6
7910106|NCT00663208|19465617|P6|STARTED|Treatment Period||4
7910107|NCT00663208|19465618|P5|STARTED|Treatment Period||4
7910108|NCT00663208|19465619|P4|STARTED|Treatment Period||4
7910109|NCT00663208|19465620|P3|STARTED|Treatment Period||4
7910110|NCT00663208|19465621|P2|STARTED|Treatment Period||4
7910111|NCT00663208|19465622|P1|STARTED|Treatment Period||4
7910112|NCT00663169|19465774|P2|NOT COMPLETED|Overall Study||0
7910113|NCT00663169|19465775|P1|NOT COMPLETED|Overall Study||0
7910114|NCT00663169|19465774|P2|COMPLETED|Overall Study||3
7910115|NCT00663169|19465775|P1|COMPLETED|Overall Study||3
7910116|NCT00663169|19465774|P2|STARTED|Overall Study||3
7910117|NCT00663169|19465775|P1|STARTED|Overall Study||3
7910118|NCT00663117|19465800|P2|NOT COMPLETED|Overall Study||0
7910119|NCT00663117|19465801|P1|NOT COMPLETED|Overall Study||1
7910120|NCT00663117|19465800|P2|COMPLETED|Overall Study||20
7910121|NCT00663117|19465801|P1|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19
7910122|NCT00663117|19465800|P2|STARTED|Overall Study||20
7910123|NCT00663117|19465801|P1|STARTED|Overall Study||20
7910124|NCT00663052|19465815|P2|NOT COMPLETED|Overall Study||10
7910125|NCT00663052|19465816|P1|NOT COMPLETED|Overall Study||12
7910126|NCT00663052|19465815|P2|COMPLETED|Overall Study||127
7910127|NCT00663052|19465816|P1|COMPLETED|Overall Study||124
7910128|NCT00663052|19465815|P2|STARTED|Overall Study||137
7910129|NCT00663052|19465816|P1|STARTED|Overall Study||136
7910130|NCT00663039|19465896|P2|NOT COMPLETED|Overall Study||4
7910131|NCT00663039|19465897|P1|NOT COMPLETED|Overall Study||4
7910132|NCT00663039|19465896|P2|COMPLETED|Overall Study||9
7910133|NCT00663039|19465897|P1|COMPLETED|Overall Study||10
7910134|NCT00663039|19465896|P2|STARTED|Overall Study||13
7910135|NCT00663039|19465897|P1|STARTED|Overall Study||14
7910136|NCT00663026|19465922|P3|NOT COMPLETED|Overall Study||4
7910137|NCT00663026|19465923|P2|NOT COMPLETED|Overall Study||6
7910138|NCT00663026|19465924|P1|NOT COMPLETED|Overall Study||2
7910139|NCT00663026|19465922|P3|COMPLETED|Overall Study||27
7910140|NCT00663026|19465923|P2|COMPLETED|Overall Study||23
7910141|NCT00663026|19465924|P1|COMPLETED|Overall Study||17
7910142|NCT00663026|19465922|P3|STARTED|Overall Study||31
7910143|NCT00663026|19465923|P2|STARTED|Overall Study||29
7910144|NCT00663026|19465924|P1|STARTED|Overall Study||19
7910145|NCT00662909|19465947|P3|NOT COMPLETED|Overall Study||53
7910146|NCT00662909|19465948|P2|NOT COMPLETED|Overall Study||59
7910147|NCT00662909|19465949|P1|NOT COMPLETED|Overall Study||69
7910148|NCT00662909|19465947|P3|COMPLETED|Overall Study||380
7910149|NCT00662909|19465948|P2|COMPLETED|Overall Study||383
7910150|NCT00662909|19465949|P1|COMPLETED|Overall Study||385
7910151|NCT00662909|19465947|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296
7910152|NCT00662909|19465948|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312
7910153|NCT00662909|19465949|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325
7910154|NCT00662909|19465947|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412
7910155|NCT00662909|19465948|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425
7910156|NCT00662909|19465949|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433
7910157|NCT00662909|19465947|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
7910158|NCT00662909|19465948|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442
7910159|NCT00662909|19465949|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453
7910160|NCT00662909|19465947|P3|STARTED|Overall Study||433
7910161|NCT00662909|19465948|P2|STARTED|Overall Study||442
7910162|NCT00662909|19465949|P1|STARTED|Overall Study||454
7910163|NCT00662857|19466047|P2|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
7910164|NCT00662857|19466048|P1|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
7910165|NCT00662857|19466047|P2|COMPLETED|Lispro Dosing Period (1 Day)||14
7910166|NCT00662857|19466048|P1|COMPLETED|Lispro Dosing Period (1 Day)||12
7910167|NCT00662857|19466047|P2|STARTED|Lispro Dosing Period (1 Day)||14
7910168|NCT00662857|19466048|P1|STARTED|Lispro Dosing Period (1 Day)||12
7910169|NCT00662857|19466047|P2|NOT COMPLETED|Washout 2 (3 - 14 Days)||0
7910170|NCT00662857|19466048|P1|NOT COMPLETED|Washout 2 (3 - 14 Days)||1
7910171|NCT00662857|19466047|P2|COMPLETED|Washout 2 (3 - 14 Days)||14
7910172|NCT00662857|19466048|P1|COMPLETED|Washout 2 (3 - 14 Days)||12
7910173|NCT00662857|19466047|P2|STARTED|Washout 2 (3 - 14 Days)||14
7910174|NCT00662857|19466048|P1|STARTED|Washout 2 (3 - 14 Days)||13
7910175|NCT00662857|19466047|P2|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
7910176|NCT00662857|19466048|P1|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
7910177|NCT00662857|19466047|P2|COMPLETED|TI Dosing Period 2 (1 Day)||14
7910178|NCT00662857|19466048|P1|COMPLETED|TI Dosing Period 2 (1 Day)||13
7910179|NCT00662857|19466047|P2|STARTED|TI Dosing Period 2 (1 Day)||14
7910180|NCT00662857|19466048|P1|STARTED|TI Dosing Period 2 (1 Day)||13
7910181|NCT00662857|19466047|P2|NOT COMPLETED|Washout 1 (3 - 14 Days)||2
7910182|NCT00662857|19466048|P1|NOT COMPLETED|Washout 1 (3 - 14 Days)||0
7910183|NCT00662857|19466047|P2|COMPLETED|Washout 1 (3 - 14 Days)||14
7910184|NCT00662857|19466048|P1|COMPLETED|Washout 1 (3 - 14 Days)||13
7910185|NCT00662857|19466047|P2|STARTED|Washout 1 (3 - 14 Days)||16
7910186|NCT00662857|19466048|P1|STARTED|Washout 1 (3 - 14 Days)||13
7910187|NCT00662857|19466047|P2|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
7910188|NCT00662857|19466048|P1|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
7910189|NCT00662857|19466047|P2|COMPLETED|TI Dosing Period 1 (1 Day)||16
7910190|NCT00662857|19466048|P1|COMPLETED|TI Dosing Period 1 (1 Day)||13
7910191|NCT00662857|19466047|P2|STARTED|TI Dosing Period 1 (1 Day)||16
7910192|NCT00662857|19466048|P1|STARTED|TI Dosing Period 1 (1 Day)||13
7910193|NCT00662831|19466063|P2|NOT COMPLETED|Overall Study||59
7910194|NCT00662831|19466064|P1|NOT COMPLETED|Overall Study||106
7910195|NCT00662831|19466063|P2|COMPLETED|Overall Study||33
7910196|NCT00662831|19466064|P1|COMPLETED|Overall Study||78
7910197|NCT00662831|19466063|P2|STARTED|Overall Study||92
7910198|NCT00662831|19466064|P1|STARTED|Overall Study||184
7910199|NCT00662818|19466104|P2|NOT COMPLETED|Period 2 (6 Weeks)||12
7910200|NCT00662818|19466105|P1|NOT COMPLETED|Period 2 (6 Weeks)||13
7910201|NCT00662818|19466104|P2|COMPLETED|Period 2 (6 Weeks)||41
7910202|NCT00662818|19466105|P1|COMPLETED|Period 2 (6 Weeks)||38
7910203|NCT00662818|19466104|P2|STARTED|Period 2 (6 Weeks)||53
7910204|NCT00662818|19466105|P1|STARTED|Period 2 (6 Weeks)||51
7910205|NCT00662818|19466104|P2|NOT COMPLETED|Wash-Out (14 Days)||5
7910206|NCT00662818|19466105|P1|NOT COMPLETED|Wash-Out (14 Days)||5
7910207|NCT00662818|19466104|P2|COMPLETED|Wash-Out (14 Days)||53
7910208|NCT00662818|19466105|P1|COMPLETED|Wash-Out (14 Days)||51
7910209|NCT00662818|19466104|P2|STARTED|Wash-Out (14 Days)||58
7910210|NCT00662818|19466105|P1|STARTED|Wash-Out (14 Days)||56
7910211|NCT00662818|19466104|P2|NOT COMPLETED|Period 1 (6 Weeks)||23
7910212|NCT00662818|19466105|P1|NOT COMPLETED|Period 1 (6 Weeks)||28
7910213|NCT00662818|19466104|P2|COMPLETED|Period 1 (6 Weeks)||58
7910214|NCT00662818|19466105|P1|COMPLETED|Period 1 (6 Weeks)||56
7910215|NCT00662818|19466104|P2|Treated|Period 1 (6 Weeks)||58
7910216|NCT00662818|19466105|P1|Treated|Period 1 (6 Weeks)||56
7910217|NCT00662818|19466104|P2|STARTED|Period 1 (6 Weeks)||81
7910218|NCT00662818|19466105|P1|STARTED|Period 1 (6 Weeks)||84
7910219|NCT00662675|19466129|P2|NOT COMPLETED|Overall Study||0
7910220|NCT00662675|19466130|P1|NOT COMPLETED|Overall Study||0
7910221|NCT00662675|19466129|P2|COMPLETED|Overall Study||20
7910222|NCT00662675|19466130|P1|COMPLETED|Overall Study||20
7910223|NCT00662675|19466129|P2|STARTED|Overall Study||20
7910224|NCT00662675|19466130|P1|STARTED|Overall Study||20
7910225|NCT00662649|19466144|P5|NOT COMPLETED|Extension Study (Month 24 to 60)||29
7910226|NCT00662649|19466145|P4|NOT COMPLETED|Extension Study (Month 24 to 60)||33
7910227|NCT00662649|19466146|P3|NOT COMPLETED|Extension Study (Month 24 to 60)||0
7910228|NCT00662649|19466147|P2|NOT COMPLETED|Extension Study (Month 24 to 60)||41
7910229|NCT00662649|19466148|P1|NOT COMPLETED|Extension Study (Month 24 to 60)||44
7910230|NCT00662649|19466144|P5|COMPLETED|Extension Study (Month 24 to 60)||126
7910231|NCT00662649|19466145|P4|COMPLETED|Extension Study (Month 24 to 60)||112
7910232|NCT00662649|19466146|P3|COMPLETED|Extension Study (Month 24 to 60)||0
7910233|NCT00662649|19466147|P2|COMPLETED|Extension Study (Month 24 to 60)||290
7910234|NCT00662649|19466148|P1|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245
7910235|NCT00662649|19466144|P5|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13
7910236|NCT00662649|19466145|P4|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11
7910237|NCT00662649|19466146|P3|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0
7910238|NCT00662649|19466147|P2|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32
7910239|NCT00662649|19466148|P1|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31
7910240|NCT00662649|19466144|P5|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67
7910241|NCT00662649|19466145|P4|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58
7910242|NCT00662649|19466146|P3|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0
7910243|NCT00662649|19466147|P2|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152
7910244|NCT00662649|19466148|P1|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125
7910245|NCT00662649|19466144|P5|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136
7910246|NCT00662649|19466145|P4|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120
7910247|NCT00662649|19466146|P3|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0
7910248|NCT00662649|19466147|P2|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301
7910249|NCT00662649|19466148|P1|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254
7910250|NCT00662649|19466144|P5|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145
7910251|NCT00662649|19466145|P4|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130
7910252|NCT00662649|19466146|P3|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0
7910253|NCT00662649|19466147|P2|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311
7910254|NCT00662649|19466148|P1|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270
7910255|NCT00662649|19466144|P5|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152
7910256|NCT00662649|19466145|P4|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136
7910257|NCT00662649|19466146|P3|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0
7910258|NCT00662649|19466147|P2|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324
7910259|NCT00662649|19466148|P1|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276
7910260|NCT00662649|19466144|P5|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155
7910261|NCT00662649|19466145|P4|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145
7910262|NCT00662649|19466146|P3|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0
7910263|NCT00662649|19466147|P2|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331
7910264|NCT00662649|19466148|P1|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289
7910265|NCT00662649|19466144|P5|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154
7910266|NCT00662649|19466145|P4|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145
7910267|NCT00662649|19466146|P3|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0
7910268|NCT00662649|19466147|P2|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330
7910269|NCT00662649|19466148|P1|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287
7910270|NCT00662649|19466144|P5|STARTED|Extension Study (Month 24 to 60)||155
7910271|NCT00662649|19466145|P4|STARTED|Extension Study (Month 24 to 60)||145
7910272|NCT00662649|19466146|P3|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0
7910273|NCT00662649|19466147|P2|STARTED|Extension Study (Month 24 to 60)||331
7910274|NCT00662649|19466148|P1|STARTED|Extension Study (Month 24 to 60)||289
7910275|NCT00662649|19466144|P5|NOT COMPLETED|Core Study (24 Months)||0
7910276|NCT00662649|19466145|P4|NOT COMPLETED|Core Study (24 Months)||0
7910277|NCT00662649|19466146|P3|NOT COMPLETED|Core Study (24 Months)||86
7910278|NCT00662649|19466147|P2|NOT COMPLETED|Core Study (24 Months)||56
7910279|NCT00662649|19466148|P1|NOT COMPLETED|Core Study (24 Months)||97
7910280|NCT00662649|19466144|P5|COMPLETED|Core Study (24 Months)||0
7910281|NCT00662649|19466145|P4|COMPLETED|Core Study (24 Months)||0
7910282|NCT00662649|19466146|P3|COMPLETED|Core Study (24 Months)||332
7910283|NCT00662649|19466147|P2|COMPLETED|Core Study (24 Months)||369
7910284|NCT00662649|19466148|P1|COMPLETED|Core Study (24 Months)||332
7910285|NCT00662649|19466144|P5|Intent to Treat (ITT)|Core Study (24 Months)||0
7910286|NCT00662649|19466145|P4|Intent to Treat (ITT)|Core Study (24 Months)||0
7910287|NCT00662649|19466146|P3|Intent to Treat (ITT)|Core Study (24 Months)||418
7910288|NCT00662649|19466147|P2|Intent to Treat (ITT)|Core Study (24 Months)||425
7910289|NCT00662649|19466148|P1|Intent to Treat (ITT)|Core Study (24 Months)||429
7910290|NCT00662649|19466144|P5|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
7910291|NCT00662649|19466145|P4|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
7910292|NCT00662649|19466146|P3|STARTED|Core Study (24 Months)||418
7910293|NCT00662649|19466147|P2|STARTED|Core Study (24 Months)||425
7910294|NCT00662649|19466148|P1|STARTED|Core Study (24 Months)||429
7910295|NCT00662558|19466188|P2|NOT COMPLETED|Overall Study||110
7910296|NCT00662558|19466189|P1|NOT COMPLETED|Overall Study||56
7910297|NCT00662558|19466188|P2|COMPLETED|Overall Study||294
7910298|NCT00662558|19466189|P1|COMPLETED|Overall Study||342
7910299|NCT00662558|19466188|P2|Received Treatment|Overall Study||396
7910300|NCT00662558|19466189|P1|Received Treatment|Overall Study||396
7910301|NCT00662558|19466188|P2|STARTED|Overall Study||404
7910302|NCT00662558|19466189|P1|STARTED|Overall Study||398
7910303|NCT00662545|19466223|P2|NOT COMPLETED|Overall Study||0
7910304|NCT00662545|19466224|P1|NOT COMPLETED|Overall Study||0
7910305|NCT00662545|19466223|P2|COMPLETED|Overall Study||5
7910306|NCT00662545|19466224|P1|COMPLETED|Overall Study||5
7910307|NCT00662545|19466223|P2|STARTED|Overall Study||5
7910308|NCT00662545|19466224|P1|STARTED|Overall Study||5
7910309|NCT00662532|19466240|P2|NOT COMPLETED|Overall Study||2
7910310|NCT00662532|19466241|P1|NOT COMPLETED|Overall Study||0
7910311|NCT00662532|19466240|P2|COMPLETED|Overall Study||20
7910312|NCT00662532|19466241|P1|COMPLETED|Overall Study||22
7910313|NCT00662532|19466240|P2|STARTED|Overall Study||22
7910314|NCT00662532|19466241|P1|STARTED|Overall Study||22
7910315|NCT00662389|19466251|P1|NOT COMPLETED|Overall Study||0
7910316|NCT00662389|19466251|P1|COMPLETED|Overall Study||4
7910317|NCT00662389|19466251|P1|STARTED|Overall Study||4
7910318|NCT00662363|19466256|P2|NOT COMPLETED|Overall Study||10
7910319|NCT00662363|19466257|P1|NOT COMPLETED|Overall Study||11
7910320|NCT00662363|19466256|P2|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22
7910321|NCT00662363|19466257|P1|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21
7910322|NCT00662363|19466256|P2|STARTED|Overall Study||32
7910323|NCT00662363|19466257|P1|STARTED|Overall Study||32
7910324|NCT00662311|19466268|P3|NOT COMPLETED|Overall Study||0
7910325|NCT00662311|19466269|P2|NOT COMPLETED|Overall Study||0
7910326|NCT00662311|19466270|P1|NOT COMPLETED|Overall Study||1
7910327|NCT00662311|19466268|P3|COMPLETED|Overall Study||0
7910328|NCT00662311|19466269|P2|COMPLETED|Overall Study||0
7910329|NCT00662311|19466270|P1|COMPLETED|Overall Study||4
7910330|NCT00662311|19466268|P3|STARTED|Overall Study||0
7910331|NCT00662311|19466269|P2|STARTED|Overall Study||0
7910332|NCT00662311|19466270|P1|STARTED|Overall Study||5
7910333|NCT00662298|19466293|P1|NOT COMPLETED|Overall Study||0
7910334|NCT00662298|19466293|P1|COMPLETED|Overall Study||5
7910335|NCT00662298|19466293|P1|STARTED|Overall Study||5
7910336|NCT00662259|19466305|P2|NOT COMPLETED|Overall Study||0
7910337|NCT00662259|19466306|P1|NOT COMPLETED|Overall Study||2
7910338|NCT00662259|19466305|P2|COMPLETED|Overall Study||11
7910339|NCT00662259|19466306|P1|COMPLETED|Overall Study||19
7910340|NCT00662259|19466305|P2|STARTED|Overall Study||11
7910341|NCT00662259|19466306|P1|STARTED|Overall Study||21
7910342|NCT00662207|19466320|P1|NOT COMPLETED|Overall Study||0
7910343|NCT00662207|19466320|P1|COMPLETED|Overall Study||3
7910344|NCT00662207|19466320|P1|STARTED|Overall Study||3
7910345|NCT00662155|19466331|P4|NOT COMPLETED|Overall Study||4
7910346|NCT00662155|19466332|P3|NOT COMPLETED|Overall Study||7
7910347|NCT00662155|19466333|P2|NOT COMPLETED|Overall Study||5
7910348|NCT00662155|19466334|P1|NOT COMPLETED|Overall Study||3
7910349|NCT00662155|19466331|P4|COMPLETED|Overall Study||14
7910350|NCT00662155|19466332|P3|COMPLETED|Overall Study||13
7910351|NCT00662155|19466333|P2|COMPLETED|Overall Study||15
7910352|NCT00662155|19466334|P1|COMPLETED|Overall Study||13
7910353|NCT00662155|19466331|P4|STARTED|Overall Study||18
7910354|NCT00662155|19466332|P3|STARTED|Overall Study||20
7910355|NCT00662155|19466333|P2|STARTED|Overall Study||20
7910356|NCT00662155|19466334|P1|STARTED|Overall Study||16
7910357|NCT00662129|19466348|P1|NOT COMPLETED|Overall Study||3
7910358|NCT00662129|19466348|P1|COMPLETED|Overall Study||47
7910359|NCT00662129|19466348|P1|STARTED|Overall Study||50
7910360|NCT00662038|19466358|P1|NOT COMPLETED|Overall Study||631
7910361|NCT00662038|19466358|P1|COMPLETED|Overall Study||427
7910362|NCT00662038|19466358|P1|STARTED|Overall Study||1058
7910363|NCT00662025|19466362|P1|NOT COMPLETED|Overall Study||63
7910364|NCT00662025|19466362|P1|COMPLETED|Overall Study||0
7910365|NCT00662025|19466362|P1|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63
7910366|NCT00662012|19466382|P1|NOT COMPLETED|Overall Study||87
7910367|NCT00662012|19466382|P1|COMPLETED|Overall Study||327
7910368|NCT00662012|19466382|P1|STARTED|Overall Study||414
7910369|NCT00661999|19466390|P3|NOT COMPLETED|Overall Study||57
7910370|NCT00661999|19466391|P2|NOT COMPLETED|Overall Study||50
7910371|NCT00661999|19466392|P1|NOT COMPLETED|Overall Study||59
7910372|NCT00661999|19466390|P3|COMPLETED|Overall Study||106
7910373|NCT00661999|19466391|P2|COMPLETED|Overall Study||113
7910374|NCT00661999|19466392|P1|COMPLETED|Overall Study||105
7910375|NCT00661999|19466390|P3|STARTED|Overall Study||163
7910376|NCT00661999|19466391|P2|STARTED|Overall Study||163
7910377|NCT00661999|19466392|P1|STARTED|Overall Study||164
7910378|NCT00661960|19466448|P3|NOT COMPLETED|Overall Study||1
7910379|NCT00661960|19466449|P2|NOT COMPLETED|Overall Study||3
7910380|NCT00661960|19466450|P1|NOT COMPLETED|Overall Study||0
7910381|NCT00661960|19466448|P3|COMPLETED|Overall Study||9
7910382|NCT00661960|19466449|P2|COMPLETED|Overall Study||7
7910383|NCT00661960|19466450|P1|COMPLETED|Overall Study||5
7910384|NCT00661960|19466448|P3|STARTED|Overall Study||10
7910385|NCT00661960|19466449|P2|STARTED|Overall Study||10
7910386|NCT00661960|19466450|P1|STARTED|Overall Study||5
7910387|NCT00661895|19466460|P2|NOT COMPLETED|Overall Study||0
7910388|NCT00661895|19466461|P1|NOT COMPLETED|Overall Study||0
7910389|NCT00661895|19466460|P2|COMPLETED|Overall Study||50
7910390|NCT00661895|19466461|P1|COMPLETED|Overall Study||49
7910391|NCT00661895|19466460|P2|STARTED|Overall Study||50
7910392|NCT00661895|19466461|P1|STARTED|Overall Study||49
7910393|NCT00661830|19466469|P2|NOT COMPLETED|Overall Study||42
7910394|NCT00661830|19466470|P1|NOT COMPLETED|Overall Study||40
7910395|NCT00661830|19466469|P2|COMPLETED|Overall Study||6
7910396|NCT00661830|19466470|P1|COMPLETED|Overall Study||9
7910397|NCT00661830|19466469|P2|STARTED|Overall Study||48
7910398|NCT00661830|19466470|P1|STARTED|Overall Study||49
7910399|NCT00661778|19466482|P1|NOT COMPLETED|Overall Study||50
7910400|NCT00661778|19466482|P1|COMPLETED|Overall Study||0
7910401|NCT00661778|19466482|P1|STARTED|Overall Study||50
7910402|NCT00661726|19466489|P1|NOT COMPLETED|Overall Study||1
7910403|NCT00661726|19466489|P1|COMPLETED|Overall Study||5
7910404|NCT00661726|19466489|P1|STARTED|Overall Study||6
7910405|NCT00661713|19466512|P8|NOT COMPLETED|Overall Study||11
7910406|NCT00661713|19466513|P7|NOT COMPLETED|Overall Study||64
7910407|NCT00661713|19466514|P6|NOT COMPLETED|Overall Study||37
7910408|NCT00661713|19466515|P5|NOT COMPLETED|Overall Study||20
7910409|NCT00661713|19466516|P4|NOT COMPLETED|Overall Study||28
7910410|NCT00661713|19466517|P3|NOT COMPLETED|Overall Study||17
7910411|NCT00661713|19466518|P2|NOT COMPLETED|Overall Study||39
7910412|NCT00661713|19466519|P1|NOT COMPLETED|Overall Study||16
7910413|NCT00661713|19466512|P8|COMPLETED|Overall Study||117
7910414|NCT00661713|19466513|P7|COMPLETED|Overall Study||309
7910415|NCT00661713|19466514|P6|COMPLETED|Overall Study||216
7910416|NCT00661713|19466515|P5|COMPLETED|Overall Study||107
7910417|NCT00661713|19466516|P4|COMPLETED|Overall Study||219
7910418|NCT00661713|19466517|P3|COMPLETED|Overall Study||111
7910419|NCT00661713|19466518|P2|COMPLETED|Overall Study||208
7910420|NCT00661713|19466519|P1|COMPLETED|Overall Study||112
7910421|NCT00661713|19466512|P8|STARTED|Overall Study||128
7910422|NCT00661713|19466513|P7|STARTED|Overall Study||373
7910423|NCT00661713|19466514|P6|STARTED|Overall Study||253
7910424|NCT00661713|19466515|P5|STARTED|Overall Study||127
7910425|NCT00661713|19466516|P4|STARTED|Overall Study||247
7910426|NCT00661713|19466517|P3|STARTED|Overall Study||128
7910427|NCT00661713|19466518|P2|STARTED|Overall Study||247
7910428|NCT00661713|19466519|P1|STARTED|Overall Study||128
7910429|NCT00661687|19466611|P1|NOT COMPLETED|Overall Study||15
7910430|NCT00661687|19466611|P1|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189
7910431|NCT00661687|19466611|P1|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204
7910432|NCT00661674|19466621|P6|NOT COMPLETED|Overall Study||0
7910433|NCT00661674|19466622|P5|NOT COMPLETED|Overall Study||0
7910434|NCT00661674|19466623|P4|NOT COMPLETED|Overall Study||0
7910435|NCT00661674|19466624|P3|NOT COMPLETED|Overall Study||0
7910436|NCT00661674|19466625|P2|NOT COMPLETED|Overall Study||0
7910437|NCT00661674|19466626|P1|NOT COMPLETED|Overall Study||0
7910438|NCT00661674|19466621|P6|COMPLETED|Overall Study|Participant 9 completed sequence 6|1
7910439|NCT00661674|19466622|P5|COMPLETED|Overall Study|Participants 6 & 8 completed sequence 5|2
7910440|NCT00661674|19466623|P4|COMPLETED|Overall Study|Participant 5 completed sequence 4|1
7910441|NCT00661674|19466624|P3|COMPLETED|Overall Study|Participants 4 & 7 completed sequence 3|2
7910442|NCT00661674|19466625|P2|COMPLETED|Overall Study|Participants 2 & 3 completed sequence 2|2
7910443|NCT00661674|19466626|P1|COMPLETED|Overall Study|Participants 1 & 10 completed sequence 1|2
7910444|NCT00661674|19466621|P6|STARTED|Overall Study|Participant 9 was assigned to sequence 6|1
7910445|NCT00661674|19466622|P5|STARTED|Overall Study|Participants 6 & 8 were assigned to sequence 5|2
7910446|NCT00661674|19466623|P4|STARTED|Overall Study|Participant 5 was assigned to sequence 4|1
7910447|NCT00661674|19466624|P3|STARTED|Overall Study|Participants 4 & 7 were assigned to sequence 3|2
7910448|NCT00661674|19466625|P2|STARTED|Overall Study|Participants 2 & 3 were assigned to sequence 2|2
7910449|NCT00661674|19466626|P1|STARTED|Overall Study|Participants 1 & 10 were assigned to sequence 1|2
7910450|NCT00661661|19466639|P2|NOT COMPLETED|Overall Study||39
7910451|NCT00661661|19466640|P1|NOT COMPLETED|Overall Study||140
7910452|NCT00661661|19466639|P2|COMPLETED|Overall Study||66
7910453|NCT00661661|19466640|P1|COMPLETED|Overall Study||242
7910454|NCT00661661|19466639|P2|STARTED|Overall Study||105
7910455|NCT00661661|19466640|P1|STARTED|Overall Study||382
7910456|NCT00661622|19466716|P2|NOT COMPLETED|Overall Study||0
7910457|NCT00661622|19466717|P1|NOT COMPLETED|Overall Study||1
7910458|NCT00661622|19466716|P2|COMPLETED|Overall Study||27
7910459|NCT00661622|19466717|P1|COMPLETED|Overall Study||25
7910460|NCT00661622|19466716|P2|STARTED|Overall Study||27
7910461|NCT00661622|19466717|P1|STARTED|Overall Study||26
7910462|NCT00661609|19466731|P1|NOT COMPLETED|Overall Study||41
7910463|NCT00661609|19466731|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
7910464|NCT00661609|19466731|P1|STARTED|Overall Study|All dosed patients|41
7910465|NCT00661583|19466741|P3|NOT COMPLETED|Overall Study||0
7910466|NCT00661583|19466742|P2|NOT COMPLETED|Overall Study||0
7910467|NCT00661583|19466743|P1|NOT COMPLETED|Overall Study||0
7910468|NCT00661583|19466741|P3|COMPLETED|Overall Study||10
7910469|NCT00661583|19466742|P2|COMPLETED|Overall Study||10
7910470|NCT00661583|19466743|P1|COMPLETED|Overall Study||10
7910471|NCT00661583|19466741|P3|STARTED|Overall Study||10
7910472|NCT00661583|19466742|P2|STARTED|Overall Study||10
7910473|NCT00661583|19466743|P1|STARTED|Overall Study||10
7910474|NCT00661570|19466760|P1|NOT COMPLETED|Overall Study||0
7910475|NCT00661570|19466760|P1|COMPLETED|Overall Study||26
7910476|NCT00661570|19466760|P1|STARTED|Overall Study||26
7910477|NCT00661557|19466769|P2|NOT COMPLETED|Overall Study||0
7910478|NCT00661557|19466770|P1|NOT COMPLETED|Overall Study||9
7910479|NCT00661557|19466769|P2|COMPLETED|Overall Study||79
7910480|NCT00661557|19466770|P1|COMPLETED|Overall Study||183
7910481|NCT00661557|19466769|P2|STARTED|Overall Study||79
7910482|NCT00661557|19466770|P1|STARTED|Overall Study||192
7910483|NCT00661544|19466794|P1|NOT COMPLETED|Overall Study||0
7910484|NCT00661544|19466794|P1|COMPLETED|Overall Study||48
7910485|NCT00661544|19466794|P1|STARTED|Overall Study||48
7910486|NCT00661531|19466798|P1|NOT COMPLETED|Overall Study||3
7910487|NCT00661531|19466798|P1|COMPLETED|Overall Study||8
7910488|NCT00661531|19466798|P1|STARTED|Overall Study||11
7910489|NCT00661505|19466803|P1|NOT COMPLETED|Overall Study||30
7910490|NCT00661505|19466803|P1|COMPLETED|Overall Study||102
7910491|NCT00661505|19466803|P1|STARTED|Overall Study||132
7910492|NCT00661492|19466831|P2|NOT COMPLETED|Overall Study||29
7910493|NCT00661492|19466832|P1|NOT COMPLETED|Overall Study||68
7910494|NCT00661492|19466831|P2|COMPLETED|Overall Study||11
7910495|NCT00661492|19466832|P1|COMPLETED|Overall Study||7
7910496|NCT00661492|19466831|P2|STARTED|Overall Study||40
7910497|NCT00661492|19466832|P1|STARTED|Overall Study||75
7910498|NCT00661479|19466856|P4|NOT COMPLETED|Overall Study||0
7910499|NCT00661479|19466857|P3|NOT COMPLETED|Overall Study||0
7910500|NCT00661479|19466858|P2|NOT COMPLETED|Overall Study||0
7910501|NCT00661479|19466859|P1|NOT COMPLETED|Overall Study||0
7910502|NCT00661479|19466856|P4|COMPLETED|Overall Study||3
7910503|NCT00661479|19466857|P3|COMPLETED|Overall Study||3
7910504|NCT00661479|19466858|P2|COMPLETED|Overall Study||3
7910505|NCT00661479|19466859|P1|COMPLETED|Overall Study||12
7910506|NCT00661479|19466856|P4|STARTED|Overall Study||3
7910507|NCT00661479|19466857|P3|STARTED|Overall Study||3
7910508|NCT00661479|19466858|P2|STARTED|Overall Study||3
7910509|NCT00661479|19466859|P1|STARTED|Overall Study||12
7910510|NCT00661466|19466874|P2|NOT COMPLETED|Overall Study||0
7910511|NCT00661466|19466875|P1|NOT COMPLETED|Overall Study||0
7910512|NCT00661466|19466874|P2|COMPLETED|Overall Study|Participants|3
7910513|NCT00661466|19466875|P1|COMPLETED|Overall Study|Participants|4
7910514|NCT00661466|19466874|P2|STARTED|Overall Study|Participants|3
7910515|NCT00661466|19466875|P1|STARTED|Overall Study|Participants|4
7910516|NCT00661453|19466901|P1|NOT COMPLETED|Overall Study||13
7910517|NCT00661453|19466901|P1|COMPLETED|Overall Study||25
7910518|NCT00661453|19466901|P1|STARTED|Overall Study||38
7910519|NCT00661427|19466907|P2|NOT COMPLETED|Overall Study||7
7910520|NCT00661427|19466908|P1|NOT COMPLETED|Overall Study||5
7910521|NCT00661427|19466907|P2|COMPLETED|Overall Study||19
7910522|NCT00661427|19466908|P1|COMPLETED|Overall Study||30
7910523|NCT00661427|19466907|P2|STARTED|Overall Study||26
7910524|NCT00661427|19466908|P1|STARTED|Overall Study||35
7910525|NCT00661388|19466916|P1|NOT COMPLETED|Overall Study||24
7910526|NCT00661388|19466916|P1|COMPLETED|Overall Study||51
7910527|NCT00661388|19466916|P1|STARTED|Overall Study||75
7910528|NCT00661362|19466939|P2|NOT COMPLETED|Overall Study||40
7910529|NCT00661362|19466940|P1|NOT COMPLETED|Overall Study||29
7910530|NCT00661362|19466939|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247
7910531|NCT00661362|19466940|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254
7910532|NCT00661362|19466939|P2|STARTED|Overall Study|Randomized and treated|287
7910533|NCT00661362|19466940|P1|STARTED|Overall Study|Randomized and treated|283
7910534|NCT00661271|19466958|P2|NOT COMPLETED|Overall Study||25
7910535|NCT00661271|19466959|P1|NOT COMPLETED|Overall Study||28
7910536|NCT00661271|19466958|P2|COMPLETED|Overall Study||20
7910537|NCT00661271|19466959|P1|COMPLETED|Overall Study||20
7910538|NCT00661271|19466958|P2|STARTED|Overall Study||45
7910539|NCT00661271|19466959|P1|STARTED|Overall Study||48
7910540|NCT00661258|19466969|P2|NOT COMPLETED|Overall Study||1
7910541|NCT00661258|19466970|P1|NOT COMPLETED|Overall Study||3
7910542|NCT00661258|19466969|P2|COMPLETED|Overall Study||33
7910543|NCT00661258|19466970|P1|COMPLETED|Overall Study||31
7910544|NCT00661258|19466969|P2|STARTED|Overall Study||34
7910545|NCT00661258|19466970|P1|STARTED|Overall Study||34
7910546|NCT00661193|19466980|P2|NOT COMPLETED|Overall Study||26
7910547|NCT00661193|19466981|P1|NOT COMPLETED|Overall Study||33
7910548|NCT00661193|19466980|P2|COMPLETED|Overall Study||0
7910549|NCT00661193|19466981|P1|COMPLETED|Overall Study||0
7910550|NCT00661193|19466980|P2|STARTED|Overall Study||26
7910551|NCT00661193|19466981|P1|STARTED|Overall Study||33
7910552|NCT00661141|19466992|P6|NOT COMPLETED|Overall Study||0
7910553|NCT00661141|19466993|P5|NOT COMPLETED|Overall Study||0
7910554|NCT00661141|19466994|P4|NOT COMPLETED|Overall Study||0
7910555|NCT00661141|19466995|P3|NOT COMPLETED|Overall Study||0
7910556|NCT00661141|19466996|P2|NOT COMPLETED|Overall Study||0
7910557|NCT00661141|19466997|P1|NOT COMPLETED|Overall Study||0
7910558|NCT00661141|19466992|P6|COMPLETED|Overall Study||4
7910559|NCT00661141|19466993|P5|COMPLETED|Overall Study||4
7910560|NCT00661141|19466994|P4|COMPLETED|Overall Study||4
7910561|NCT00661141|19466995|P3|COMPLETED|Overall Study||4
7910562|NCT00661141|19466996|P2|COMPLETED|Overall Study||8
7910563|NCT00661141|19466997|P1|COMPLETED|Overall Study||8
7910564|NCT00661141|19466992|P6|Administered 30 Minutes After Ethanol|Overall Study||0
7910565|NCT00661141|19466993|P5|Administered 30 Minutes After Ethanol|Overall Study||0
7910566|NCT00661141|19466994|P4|Administered 30 Minutes After Ethanol|Overall Study||2
7910567|NCT00661141|19466995|P3|Administered 30 Minutes After Ethanol|Overall Study||2
7910568|NCT00661141|19466996|P2|Administered 30 Minutes After Ethanol|Overall Study||2
7910569|NCT00661141|19466997|P1|Administered 30 Minutes After Ethanol|Overall Study||2
7910570|NCT00661141|19466992|P6|Administered 30 Minutes Prior to Ethanol|Overall Study||4
7910571|NCT00661141|19466993|P5|Administered 30 Minutes Prior to Ethanol|Overall Study||4
7910572|NCT00661141|19466994|P4|Administered 30 Minutes Prior to Ethanol|Overall Study||2
7910573|NCT00661141|19466995|P3|Administered 30 Minutes Prior to Ethanol|Overall Study||2
7910574|NCT00661141|19466996|P2|Administered 30 Minutes Prior to Ethanol|Overall Study||6
7910575|NCT00661141|19466997|P1|Administered 30 Minutes Prior to Ethanol|Overall Study||6
7910576|NCT00661141|19466992|P6|STARTED|Overall Study||4
7910577|NCT00661141|19466993|P5|STARTED|Overall Study||4
7910578|NCT00661141|19466994|P4|STARTED|Overall Study||4
7910579|NCT00661141|19466995|P3|STARTED|Overall Study||4
7910580|NCT00661141|19466996|P2|STARTED|Overall Study||8
7910581|NCT00661141|19466997|P1|STARTED|Overall Study||8
7910582|NCT00661089|19467206|P2|NOT COMPLETED|Overall Study||2
7910583|NCT00661089|19467207|P1|NOT COMPLETED|Overall Study||0
7910584|NCT00661089|19467206|P2|COMPLETED|Overall Study||9
7910585|NCT00661089|19467207|P1|COMPLETED|Overall Study||10
7910586|NCT00661089|19467206|P2|STARTED|Overall Study||11
7910587|NCT00661089|19467207|P1|STARTED|Overall Study||10
7910588|NCT00661037|19467217|P2|NOT COMPLETED|Overall Study||257
7910589|NCT00661037|19467218|P1|NOT COMPLETED|Overall Study||154
7910590|NCT00661037|19467217|P2|COMPLETED|Overall Study||1027
7910591|NCT00661037|19467218|P1|COMPLETED|Overall Study||682
7910592|NCT00661037|19467217|P2|Deaths|Overall Study||188
7910593|NCT00661037|19467218|P1|Deaths|Overall Study||108
7910594|NCT00661037|19467217|P2|Witdrawn|Overall Study||68
7910595|NCT00661037|19467218|P1|Witdrawn|Overall Study||47
7910596|NCT00661037|19467217|P2|STARTED|Overall Study||1284
7910597|NCT00661037|19467218|P1|STARTED|Overall Study||836
7910598|NCT00660985|19467230|P2|NOT COMPLETED|Overall Study||0
7910599|NCT00660985|19467231|P1|NOT COMPLETED|Overall Study||1
7910600|NCT00660985|19467230|P2|COMPLETED|Overall Study||25
7910601|NCT00660985|19467231|P1|COMPLETED|Overall Study||25
7910602|NCT00660985|19467230|P2|STARTED|Overall Study||25
7910603|NCT00660985|19467231|P1|STARTED|Overall Study||26
7910604|NCT00660907|19467255|P2|NOT COMPLETED|Overall Study||94
7910605|NCT00660907|19467256|P1|NOT COMPLETED|Overall Study||84
7910606|NCT00660907|19467255|P2|COMPLETED|Overall Study||314
7910607|NCT00660907|19467256|P1|COMPLETED|Overall Study||322
7910608|NCT00660907|19467255|P2|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408
7910609|NCT00660907|19467256|P1|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406
7910610|NCT00660829|19467270|P2|NOT COMPLETED|Overall Study||19
7910611|NCT00660829|19467271|P1|NOT COMPLETED|Overall Study||18
7910612|NCT00660829|19467270|P2|COMPLETED|Overall Study||249
7910613|NCT00660829|19467271|P1|COMPLETED|Overall Study||250
7910614|NCT00660829|19467270|P2|STARTED|Overall Study|2 subjects were randomized in error|268
7910615|NCT00660829|19467271|P1|STARTED|Overall Study|2 subjects were randomized in error|268
7910616|NCT00660816|19467289|P2|NOT COMPLETED|Overall Study||19
7910617|NCT00660816|19467290|P1|NOT COMPLETED|Overall Study||20
7910618|NCT00660816|19467289|P2|COMPLETED|Overall Study||3
7910619|NCT00660816|19467290|P1|COMPLETED|Overall Study||4
7910620|NCT00660816|19467289|P2|STARTED|Overall Study||22
7910621|NCT00660816|19467290|P1|STARTED|Overall Study||24
7910622|NCT00660790|19467302|P1|NOT COMPLETED|3 Months to 2 Years||17
7910623|NCT00660790|19467302|P1|COMPLETED|3 Months to 2 Years||77
7910624|NCT00660790|19467302|P1|STARTED|3 Months to 2 Years||94
7910625|NCT00660790|19467302|P1|NOT COMPLETED|Baseline to 3 Months||3
7910626|NCT00660790|19467302|P1|COMPLETED|Baseline to 3 Months||94
7910627|NCT00660790|19467302|P1|STARTED|Baseline to 3 Months||97
7910628|NCT00660699|19467306|P1|NOT COMPLETED|Overall Study||2
7910629|NCT00660699|19467306|P1|COMPLETED|Overall Study||48
7910630|NCT00660699|19467306|P1|STARTED|Overall Study||50
7910631|NCT00660660|19467322|P2|NOT COMPLETED|Overall Study||9
7910632|NCT00660660|19467323|P1|NOT COMPLETED|Overall Study||5
7910633|NCT00660660|19467322|P2|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124
7910634|NCT00660660|19467323|P1|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138
7910635|NCT00660660|19467322|P2|Met Criteria for MITT Population|Overall Study||125
7910636|NCT00660660|19467323|P1|Met Criteria for MITT Population|Overall Study||137
7910637|NCT00660660|19467322|P2|STARTED|Overall Study|Randomized|133
7910638|NCT00660660|19467323|P1|STARTED|Overall Study|Randomized|143
7910639|NCT00660595|19467423|P2|NOT COMPLETED|Overall Study||9
7910640|NCT00660595|19467424|P1|NOT COMPLETED|Overall Study||18
7910641|NCT00660595|19467423|P2|COMPLETED|Overall Study|One of the two was lost to follow-up|1
7910642|NCT00660595|19467424|P1|COMPLETED|Overall Study||1
7910643|NCT00660595|19467423|P2|STARTED|Overall Study||10
7910644|NCT00660595|19467424|P1|STARTED|Overall Study||19
7910645|NCT00660543|19467436|P1|NOT COMPLETED|Overall Study||0
7910646|NCT00660543|19467436|P1|COMPLETED|Overall Study||14
7910647|NCT00660543|19467436|P1|STARTED|Overall Study||14
7910648|NCT00660530|19467445|P1|NOT COMPLETED|Overall Study||0
7910649|NCT00660530|19467445|P1|COMPLETED|Overall Study||11
7910650|NCT00660530|19467445|P1|STARTED|Overall Study||11
7910651|NCT00660517|19467455|P4|NOT COMPLETED|Overall Study||7
7910652|NCT00660517|19467456|P3|NOT COMPLETED|Overall Study||7
7910653|NCT00660517|19467457|P2|NOT COMPLETED|Overall Study||8
7910654|NCT00660517|19467458|P1|NOT COMPLETED|Overall Study||8
7910655|NCT00660517|19467455|P4|COMPLETED|Overall Study||144
7910656|NCT00660517|19467456|P3|COMPLETED|Overall Study||144
7910657|NCT00660517|19467457|P2|COMPLETED|Overall Study||144
7910658|NCT00660517|19467458|P1|COMPLETED|Overall Study||145
7910659|NCT00660517|19467455|P4|STARTED|Overall Study||151
7910660|NCT00660517|19467456|P3|STARTED|Overall Study||151
7910661|NCT00660517|19467457|P2|STARTED|Overall Study||152
7910662|NCT00660517|19467458|P1|STARTED|Overall Study||153
7910663|NCT00660504|19467478|P2|NOT COMPLETED|Overall Study||1
7910664|NCT00660504|19467479|P1|NOT COMPLETED|Overall Study||0
7910665|NCT00660504|19467478|P2|COMPLETED|Overall Study||150
7910666|NCT00660504|19467479|P1|COMPLETED|Overall Study||149
7910667|NCT00660504|19467478|P2|STARTED|Overall Study||151
7910668|NCT00660504|19467479|P1|STARTED|Overall Study||149
7910669|NCT00660400|19467491|P1|NOT COMPLETED|Overall Study||4
7910670|NCT00660400|19467491|P1|COMPLETED|Overall Study||21
7910671|NCT00660400|19467491|P1|STARTED|Overall Study||25
7910672|NCT00660387|19467500|P2|NOT COMPLETED|Overall Study||3
7910673|NCT00660387|19467501|P1|NOT COMPLETED|Overall Study||2
7910674|NCT00660387|19467500|P2|COMPLETED|Overall Study||31
7910675|NCT00660387|19467501|P1|COMPLETED|Overall Study||35
7910676|NCT00660387|19467500|P2|STARTED|Overall Study||34
7910677|NCT00660387|19467501|P1|STARTED|Overall Study||37
7910678|NCT00660348|19467555|P2|NOT COMPLETED|Overall Study||0
7910679|NCT00660348|19467556|P1|NOT COMPLETED|Overall Study||1
7910680|NCT00660348|19467555|P2|COMPLETED|Overall Study||0
7910681|NCT00660348|19467556|P1|COMPLETED|Overall Study||0
7910682|NCT00660348|19467555|P2|STARTED|Overall Study||0
7910683|NCT00660348|19467556|P1|STARTED|Overall Study||1
7910684|NCT00660309|19467564|P2|NOT COMPLETED|Overall Study||3
7910685|NCT00660309|19467565|P1|NOT COMPLETED|Overall Study||2
7910686|NCT00660309|19467564|P2|COMPLETED|Overall Study||19
7910687|NCT00660309|19467565|P1|COMPLETED|Overall Study||21
7910688|NCT00660309|19467564|P2|Pharmacodynamic Analysis Set|Overall Study||20
7910689|NCT00660309|19467565|P1|Pharmacodynamic Analysis Set|Overall Study||22
7910690|NCT00660309|19467564|P2|Treated With Aliskiren or Irbesartan|Overall Study||21
7910691|NCT00660309|19467565|P1|Treated With Aliskiren or Irbesartan|Overall Study||22
7910692|NCT00660309|19467564|P2|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22
7910693|NCT00660309|19467565|P1|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23
7910694|NCT00660192|19467606|P2|NOT COMPLETED|Overall Study||3
7910695|NCT00660192|19467607|P1|NOT COMPLETED|Overall Study||2
7910696|NCT00660192|19467606|P2|COMPLETED|Overall Study||10
7910697|NCT00660192|19467607|P1|COMPLETED|Overall Study||10
7910698|NCT00660192|19467606|P2|STARTED|Overall Study||13
7910699|NCT00660192|19467607|P1|STARTED|Overall Study||12
7910700|NCT00660179|19467618|P3|NOT COMPLETED|Overall Study||41
7910701|NCT00660179|19467619|P2|NOT COMPLETED|Overall Study||58
7910702|NCT00660179|19467620|P1|NOT COMPLETED|Overall Study||56
7910703|NCT00660179|19467618|P3|COMPLETED|Overall Study||201
7910704|NCT00660179|19467619|P2|COMPLETED|Overall Study||192
7910705|NCT00660179|19467620|P1|COMPLETED|Overall Study||194
7910706|NCT00660179|19467618|P3|STARTED|Overall Study||242
7910707|NCT00660179|19467619|P2|STARTED|Overall Study||250
7910708|NCT00660179|19467620|P1|STARTED|Overall Study||250
7910709|NCT00660075|19467654|P2|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
7910710|NCT00660075|19467655|P1|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
7910711|NCT00660075|19467654|P2|COMPLETED|Second Intervention (Week 11 to Week 16||18
7910712|NCT00660075|19467655|P1|COMPLETED|Second Intervention (Week 11 to Week 16||18
7910713|NCT00660075|19467654|P2|STARTED|Second Intervention (Week 11 to Week 16||18
7910714|NCT00660075|19467655|P1|STARTED|Second Intervention (Week 11 to Week 16||18
7910715|NCT00660075|19467654|P2|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
7910716|NCT00660075|19467655|P1|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
7910717|NCT00660075|19467654|P2|COMPLETED|Washout Period (Week 7 to Week 10)||18
7910718|NCT00660075|19467655|P1|COMPLETED|Washout Period (Week 7 to Week 10)||18
7910719|NCT00660075|19467654|P2|STARTED|Washout Period (Week 7 to Week 10)||18
7910720|NCT00660075|19467655|P1|STARTED|Washout Period (Week 7 to Week 10)||18
7910721|NCT00660075|19467654|P2|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
7910722|NCT00660075|19467655|P1|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
7910723|NCT00660075|19467654|P2|COMPLETED|First Intervention (Week 1 to Week 6)||18
7910724|NCT00660075|19467655|P1|COMPLETED|First Intervention (Week 1 to Week 6)||18
7910725|NCT00660075|19467654|P2|STARTED|First Intervention (Week 1 to Week 6)||18
7910726|NCT00660075|19467655|P1|STARTED|First Intervention (Week 1 to Week 6)||18
7910727|NCT00660049|19467661|P1|NOT COMPLETED|Overall Study||6
7910728|NCT00660049|19467661|P1|COMPLETED|Overall Study||6
7910729|NCT00660049|19467661|P1|STARTED|Overall Study||12
7910730|NCT00660023|19467665|P1|NOT COMPLETED|Overall Study||29
7910731|NCT00660023|19467665|P1|COMPLETED|Overall Study||95
7910732|NCT00660023|19467665|P1|Treated|Overall Study||114
7910733|NCT00660023|19467665|P1|STARTED|Overall Study||124
7910734|NCT00660010|19467676|P1|NOT COMPLETED|Overall Study||9
7910735|NCT00660010|19467676|P1|COMPLETED|Overall Study||46
7910736|NCT00660010|19467676|P1|STARTED|Overall Study||55
7910737|NCT00659984|19467690|P1|NOT COMPLETED|Overall Study||1
7910738|NCT00659984|19467690|P1|COMPLETED|Overall Study||14
7910739|NCT00659984|19467690|P1|STARTED|Overall Study||15
7910740|NCT00659945|19467703|P2|NOT COMPLETED|Overall Study||0
7910741|NCT00659945|19467704|P1|NOT COMPLETED|Overall Study||0
7910742|NCT00659945|19467703|P2|COMPLETED|Overall Study||75
7910743|NCT00659945|19467704|P1|COMPLETED|Overall Study||75
7910744|NCT00659945|19467703|P2|STARTED|Overall Study||75
7910745|NCT00659945|19467704|P1|STARTED|Overall Study||75
7910746|NCT00659880|19467710|P1|NOT COMPLETED|Overall Study||5
7910747|NCT00659880|19467710|P1|COMPLETED|Overall Study|60 months|4
7910748|NCT00659880|19467710|P1|24 Months|Overall Study||6
7910749|NCT00659880|19467710|P1|12 Months|Overall Study||7
7910750|NCT00659880|19467710|P1|6 Months|Overall Study||9
7910751|NCT00659880|19467710|P1|6 Weeks|Overall Study||9
7910752|NCT00659880|19467710|P1|STARTED|Overall Study||9
7910753|NCT00659828|19467715|P1|NOT COMPLETED|Overall Study||0
7910754|NCT00659828|19467715|P1|COMPLETED|Overall Study||1
7910755|NCT00659828|19467715|P1|STARTED|Overall Study||1
7910756|NCT00659815|19467723|P2|NOT COMPLETED|Overall Study||4
7910757|NCT00659815|19467724|P1|NOT COMPLETED|Overall Study||4
7910758|NCT00659815|19467723|P2|COMPLETED|Overall Study||147
7910759|NCT00659815|19467724|P1|COMPLETED|Overall Study||153
7910760|NCT00659815|19467723|P2|STARTED|Overall Study||151
7910761|NCT00659815|19467724|P1|STARTED|Overall Study||157
7910762|NCT00659802|19467737|P3|NOT COMPLETED|Overall Study||11
7910763|NCT00659802|19467738|P2|NOT COMPLETED|Overall Study||18
7910764|NCT00659802|19467739|P1|NOT COMPLETED|Overall Study||15
7910765|NCT00659802|19467737|P3|COMPLETED|Overall Study||64
7910766|NCT00659802|19467738|P2|COMPLETED|Overall Study||57
7910767|NCT00659802|19467739|P1|COMPLETED|Overall Study||59
7910768|NCT00659802|19467737|P3|STARTED|Overall Study||75
7910769|NCT00659802|19467738|P2|STARTED|Overall Study|One patient was incorrectly randomized and was excluded from the efficacy analyses.|75
7910770|NCT00659802|19467739|P1|STARTED|Overall Study||74
7910771|NCT00659789|19467755|P2|NOT COMPLETED|Overall Study||7
7910772|NCT00659789|19467756|P1|NOT COMPLETED|Overall Study||7
7910773|NCT00659789|19467755|P2|COMPLETED|Overall Study||36
7910774|NCT00659789|19467756|P1|COMPLETED|Overall Study||86
7910775|NCT00659789|19467755|P2|STARTED|Overall Study||43
7910776|NCT00659789|19467756|P1|STARTED|Overall Study||93
7910777|NCT00659737|19467774|P2|NOT COMPLETED|Overall Study||0
7910778|NCT00659737|19467775|P1|NOT COMPLETED|Overall Study||0
7910779|NCT00659737|19467774|P2|COMPLETED|Overall Study||58
7910780|NCT00659737|19467775|P1|COMPLETED|Overall Study||57
7910781|NCT00659737|19467774|P2|STARTED|Overall Study||58
7910782|NCT00659737|19467775|P1|STARTED|Overall Study||57
7910783|NCT00659724|19467781|P1|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0
7910784|NCT00659724|19467781|P1|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33
7910785|NCT00659724|19467781|P1|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33
7910786|NCT00659724|19467781|P1|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0
7910787|NCT00659724|19467781|P1|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33
7910788|NCT00659724|19467781|P1|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33
7910789|NCT00659633|19467799|P1|NOT COMPLETED|Overall Study||0
7910790|NCT00659633|19467799|P1|COMPLETED|Overall Study||10
7910791|NCT00659633|19467799|P1|STARTED|Overall Study||10
7910792|NCT00659607|19467803|P1|NOT COMPLETED|Overall Study||316
7910793|NCT00659607|19467803|P1|COMPLETED|Overall Study||3616
7910794|NCT00659607|19467803|P1|STARTED|Overall Study||3932
7910795|NCT00659581|19467821|P1|NOT COMPLETED|Overall Study||8582
7910796|NCT00659581|19467821|P1|COMPLETED|Overall Study||12412
7910797|NCT00659581|19467821|P1|STARTED|Overall Study||20994
7910798|NCT00659529|19467833|P1|NOT COMPLETED|Overall Study||16
7910799|NCT00659529|19467833|P1|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20
7910800|NCT00659529|19467833|P1|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27
7910801|NCT00659529|19467833|P1|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36
7910802|NCT00659490|19467840|P3|NOT COMPLETED|Overall Study||1
7910803|NCT00659490|19467841|P2|NOT COMPLETED|Overall Study||0
7910804|NCT00659490|19467842|P1|NOT COMPLETED|Overall Study||2
7910805|NCT00659490|19467840|P3|COMPLETED|Overall Study||30
7910806|NCT00659490|19467841|P2|COMPLETED|Overall Study||59
7910807|NCT00659490|19467842|P1|COMPLETED|Overall Study||59
7910808|NCT00659490|19467840|P3|STARTED|Overall Study||31
7910809|NCT00659490|19467841|P2|STARTED|Overall Study||59
7910810|NCT00659490|19467842|P1|STARTED|Overall Study||61
7910811|NCT00659438|19467915|P2|NOT COMPLETED|Overall Study||8
7910812|NCT00659438|19467916|P1|NOT COMPLETED|Overall Study||14
7910813|NCT00659438|19467915|P2|COMPLETED|Overall Study||40
7910814|NCT00659438|19467916|P1|COMPLETED|Overall Study||33
7910815|NCT00659438|19467915|P2|Safety Analysis Set|Overall Study||47
7910816|NCT00659438|19467916|P1|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48
7910817|NCT00659438|19467915|P2|Secondary Analysis Set|Overall Study||48
7910818|NCT00659438|19467916|P1|Secondary Analysis Set|Overall Study||47
7910819|NCT00659438|19467915|P2|Assessable Set : Primary Analysis|Overall Study||45
7910820|NCT00659438|19467916|P1|Assessable Set : Primary Analysis|Overall Study||44
7910821|NCT00659438|19467915|P2|STARTED|Overall Study||48
7910822|NCT00659438|19467916|P1|STARTED|Overall Study||47
7910823|NCT00659425|19467948|P10|NOT COMPLETED|Overall Study||13
7910824|NCT00659425|19467949|P9|NOT COMPLETED|Overall Study||6
7910825|NCT00659425|19467950|P8|NOT COMPLETED|Overall Study||11
7910826|NCT00659425|19467951|P7|NOT COMPLETED|Overall Study||8
7910827|NCT00659425|19467952|P6|NOT COMPLETED|Overall Study||4
7910828|NCT00659425|19467953|P5|NOT COMPLETED|Overall Study||4
7910829|NCT00659425|19467954|P4|NOT COMPLETED|Overall Study||4
7910830|NCT00659425|19467955|P3|NOT COMPLETED|Overall Study||1
7910831|NCT00659425|19467956|P2|NOT COMPLETED|Overall Study||1
7910832|NCT00659425|19467957|P1|NOT COMPLETED|Overall Study||1
7910833|NCT00659425|19467948|P10|COMPLETED|Overall Study||1
7910834|NCT00659425|19467949|P9|COMPLETED|Overall Study||0
7910835|NCT00659425|19467950|P8|COMPLETED|Overall Study||0
7910836|NCT00659425|19467951|P7|COMPLETED|Overall Study||0
7910837|NCT00659425|19467952|P6|COMPLETED|Overall Study||1
7910838|NCT00659425|19467953|P5|COMPLETED|Overall Study||0
7910839|NCT00659425|19467954|P4|COMPLETED|Overall Study||0
7910840|NCT00659425|19467955|P3|COMPLETED|Overall Study||0
7910841|NCT00659425|19467956|P2|COMPLETED|Overall Study||0
7910842|NCT00659425|19467957|P1|COMPLETED|Overall Study||0
7910843|NCT00659425|19467948|P10|STARTED|Overall Study||14
7910844|NCT00659425|19467949|P9|STARTED|Overall Study||6
7910845|NCT00659425|19467950|P8|STARTED|Overall Study||11
7910846|NCT00659425|19467951|P7|STARTED|Overall Study||8
7910847|NCT00659425|19467952|P6|STARTED|Overall Study||5
7910848|NCT00659425|19467953|P5|STARTED|Overall Study||4
7910849|NCT00659425|19467954|P4|STARTED|Overall Study||4
7910850|NCT00659425|19467955|P3|STARTED|Overall Study||1
7910851|NCT00659425|19467956|P2|STARTED|Overall Study||1
7910852|NCT00659425|19467957|P1|STARTED|Overall Study||1
7910853|NCT00659373|19468188|P2|NOT COMPLETED|Overall Study||7
7910854|NCT00659373|19468189|P1|NOT COMPLETED|Overall Study||5
7910855|NCT00659373|19468188|P2|COMPLETED|Overall Study||54
7910856|NCT00659373|19468189|P1|COMPLETED|Overall Study||20
7910857|NCT00659373|19468188|P2|STARTED|Overall Study||61
7910858|NCT00659373|19468189|P1|STARTED|Overall Study||25
7910859|NCT00659360|19468195|P1|NOT COMPLETED|Overall Study||0
7910860|NCT00659360|19468195|P1|COMPLETED|Overall Study||17
7910861|NCT00659360|19468195|P1|STARTED|Overall Study||17
7910862|NCT00659334|19468211|P7|NOT COMPLETED|Overall Study||1
7910863|NCT00659334|19468212|P6|NOT COMPLETED|Overall Study||0
7910864|NCT00659334|19468213|P5|NOT COMPLETED|Overall Study||0
7910865|NCT00659334|19468214|P4|NOT COMPLETED|Overall Study||0
7910866|NCT00659334|19468215|P3|NOT COMPLETED|Overall Study||0
7910867|NCT00659334|19468216|P2|NOT COMPLETED|Overall Study||5
7910868|NCT00659334|19468217|P1|NOT COMPLETED|Overall Study||8
7910869|NCT00659334|19468211|P7|COMPLETED|Overall Study|1 screen failure|20
7910870|NCT00659334|19468212|P6|COMPLETED|Overall Study||0
7910871|NCT00659334|19468213|P5|COMPLETED|Overall Study||1
7910872|NCT00659334|19468214|P4|COMPLETED|Overall Study||2
7910873|NCT00659334|19468215|P3|COMPLETED|Overall Study||5
7910874|NCT00659334|19468216|P2|COMPLETED|Overall Study|5 Screen failures|36
7910875|NCT00659334|19468217|P1|COMPLETED|Overall Study|8 Screen failures|38
7910876|NCT00659334|19468211|P7|STARTED|Overall Study||21
7910877|NCT00659334|19468212|P6|STARTED|Overall Study||0
7910878|NCT00659334|19468213|P5|STARTED|Overall Study||1
7910879|NCT00659334|19468214|P4|STARTED|Overall Study||2
7910880|NCT00659334|19468215|P3|STARTED|Overall Study||5
7910881|NCT00659334|19468216|P2|STARTED|Overall Study||41
7910882|NCT00659334|19468217|P1|STARTED|Overall Study||46
7910883|NCT00659295|19468235|P2|NOT COMPLETED|Overall Study||5603
7910884|NCT00659295|19468236|P1|NOT COMPLETED|Overall Study||2708
7910885|NCT00659295|19468235|P2|COMPLETED|Overall Study||32038
7910886|NCT00659295|19468236|P1|COMPLETED|Overall Study||10821
7910887|NCT00659295|19468235|P2|STARTED|Overall Study||37641
7910888|NCT00659295|19468236|P1|STARTED|Overall Study||13529
7910889|NCT00659269|19468244|P2|NOT COMPLETED|Overall Study||1
7910890|NCT00659269|19468245|P1|NOT COMPLETED|Overall Study||1
7910891|NCT00659269|19468244|P2|COMPLETED|Overall Study||161
7910892|NCT00659269|19468245|P1|COMPLETED|Overall Study||156
7910893|NCT00659269|19468244|P2|Group 3 (Taxanes)|Overall Study||97
7910894|NCT00659269|19468245|P1|Group 3 (Taxanes)|Overall Study||92
7910895|NCT00659269|19468244|P2|Group 2 (Vinca Alkaloids)|Overall Study||12
7910896|NCT00659269|19468245|P1|Group 2 (Vinca Alkaloids)|Overall Study||12
7910897|NCT00659269|19468244|P2|Group 1 (Heavy Metals)|Overall Study||52
7910898|NCT00659269|19468245|P1|Group 1 (Heavy Metals)|Overall Study||52
7910899|NCT00659269|19468244|P2|STARTED|Overall Study||162
7910900|NCT00659269|19468245|P1|STARTED|Overall Study||157
7910901|NCT00659230|19468275|P2|NOT COMPLETED|Overall Study||12
7910902|NCT00659230|19468276|P1|NOT COMPLETED|Overall Study||9
7910903|NCT00659230|19468275|P2|COMPLETED|Overall Study||37
7910904|NCT00659230|19468276|P1|COMPLETED|Overall Study||42
7910905|NCT00659230|19468275|P2|STARTED|Overall Study|3 did not return post-randomization, 4 lost source documents, thus 7 excluded from results analysis|49
7910906|NCT00659230|19468276|P1|STARTED|Overall Study|2 did not return post-randomization, 5 lost source documents, thus 7 excluded from results analysis|51
7910907|NCT00659165|19468290|P2|NOT COMPLETED|Overall Study||0
7910908|NCT00659165|19468291|P1|NOT COMPLETED|Overall Study||0
7910909|NCT00659165|19468290|P2|COMPLETED|Overall Study||5
7910910|NCT00659165|19468291|P1|COMPLETED|Overall Study||5
7910911|NCT00659165|19468290|P2|STARTED|Overall Study||5
7910912|NCT00659165|19468291|P1|STARTED|Overall Study||5
7910913|NCT00659061|19468299|P2|NOT COMPLETED|Overall Study||15
7910914|NCT00659061|19468300|P1|NOT COMPLETED|Overall Study||21
7910915|NCT00659061|19468299|P2|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
7910916|NCT00659061|19468300|P1|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
7910917|NCT00659061|19468299|P2|STARTED|Overall Study||302
7910918|NCT00659061|19468300|P1|STARTED|Overall Study||308
7910919|NCT00658996|19468318|P2|NOT COMPLETED|Second Intervention||1
7910920|NCT00658996|19468319|P1|NOT COMPLETED|Second Intervention||1
7910921|NCT00658996|19468318|P2|COMPLETED|Second Intervention||104
7910922|NCT00658996|19468319|P1|COMPLETED|Second Intervention||105
7910923|NCT00658996|19468318|P2|STARTED|Second Intervention||105
7910924|NCT00658996|19468319|P1|STARTED|Second Intervention||106
7910925|NCT00658996|19468318|P2|NOT COMPLETED|Crossover Period||1
7910926|NCT00658996|19468319|P1|NOT COMPLETED|Crossover Period||2
7910927|NCT00658996|19468318|P2|COMPLETED|Crossover Period||105
7910928|NCT00658996|19468319|P1|COMPLETED|Crossover Period||106
7910929|NCT00658996|19468318|P2|STARTED|Crossover Period||106
7910930|NCT00658996|19468319|P1|STARTED|Crossover Period||108
7910931|NCT00658996|19468318|P2|NOT COMPLETED|First Intervention||1
7910932|NCT00658996|19468319|P1|NOT COMPLETED|First Intervention||1
7910933|NCT00658996|19468318|P2|COMPLETED|First Intervention||106
7910934|NCT00658996|19468319|P1|COMPLETED|First Intervention||108
7910935|NCT00658996|19468318|P2|STARTED|First Intervention||107
7910936|NCT00658996|19468319|P1|STARTED|First Intervention||109
7910937|NCT00658879|19468329|P1|NOT COMPLETED|Overall Study||1
7910938|NCT00658879|19468329|P1|COMPLETED|Overall Study||250
7910939|NCT00658879|19468329|P1|STARTED|Overall Study||251
7910940|NCT00658814|19468346|P2|NOT COMPLETED|Maintenance Therapy||1
7910941|NCT00658814|19468347|P1|NOT COMPLETED|Maintenance Therapy||3
7910942|NCT00658814|19468346|P2|COMPLETED|Maintenance Therapy||7
7910943|NCT00658814|19468347|P1|COMPLETED|Maintenance Therapy||17
7910944|NCT00658814|19468346|P2|Eligible|Maintenance Therapy||8
7910945|NCT00658814|19468347|P1|Eligible|Maintenance Therapy||19
7910946|NCT00658814|19468346|P2|STARTED|Maintenance Therapy||8
7910947|NCT00658814|19468347|P1|STARTED|Maintenance Therapy||20
7910948|NCT00658814|19468346|P2|NOT COMPLETED|Consolidation Therapy||3
7910949|NCT00658814|19468347|P1|NOT COMPLETED|Consolidation Therapy||2
7910950|NCT00658814|19468346|P2|COMPLETED|Consolidation Therapy||10
7910951|NCT00658814|19468347|P1|COMPLETED|Consolidation Therapy||22
7910952|NCT00658814|19468346|P2|Eligible|Consolidation Therapy||11
7910953|NCT00658814|19468347|P1|Eligible|Consolidation Therapy||22
7910954|NCT00658814|19468346|P2|STARTED|Consolidation Therapy||13
7910955|NCT00658814|19468347|P1|STARTED|Consolidation Therapy||24
7910956|NCT00658814|19468346|P2|NOT COMPLETED|Remission Induction Chemotherapy||18
7910957|NCT00658814|19468347|P1|NOT COMPLETED|Remission Induction Chemotherapy||8
7910958|NCT00658814|19468346|P2|COMPLETED|Remission Induction Chemotherapy||41
7910959|NCT00658814|19468347|P1|COMPLETED|Remission Induction Chemotherapy||75
7910960|NCT00658814|19468346|P2|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54
7910961|NCT00658814|19468347|P1|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79
7910962|NCT00658814|19468346|P2|Eligible|Remission Induction Chemotherapy||57
7910963|NCT00658814|19468347|P1|Eligible|Remission Induction Chemotherapy||82
7910964|NCT00658814|19468346|P2|STARTED|Remission Induction Chemotherapy||59
7910965|NCT00658814|19468347|P1|STARTED|Remission Induction Chemotherapy||83
7910966|NCT00658788|19468361|P1|NOT COMPLETED|Overall Study||74
7910967|NCT00658788|19468361|P1|COMPLETED|Overall Study||231
7910968|NCT00658788|19468361|P1|STARTED|Overall Study||305
7910969|NCT00658775|19468416|P2|NOT COMPLETED|Overall Study||43
7910970|NCT00658775|19468417|P1|NOT COMPLETED|Overall Study||42
7910971|NCT00658775|19468416|P2|COMPLETED|Overall Study||485
7910972|NCT00658775|19468417|P1|COMPLETED|Overall Study||495
7910973|NCT00658775|19468416|P2|STARTED|Overall Study|Treated|528
7910974|NCT00658775|19468417|P1|STARTED|Overall Study|Treated|537
7910975|NCT00658736|19468429|P2|NOT COMPLETED|Overall Study||2
7910976|NCT00658736|19468430|P1|NOT COMPLETED|Overall Study||6
7910977|NCT00658736|19468429|P2|COMPLETED|Overall Study||19
7910978|NCT00658736|19468430|P1|COMPLETED|Overall Study||13
7910979|NCT00658736|19468429|P2|STARTED|Overall Study||21
7910980|NCT00658736|19468430|P1|STARTED|Overall Study||19
7910981|NCT00658723|19468440|P3|NOT COMPLETED|Overall Study||7
7910982|NCT00658723|19468441|P2|NOT COMPLETED|Overall Study||4
7910983|NCT00658723|19468442|P1|NOT COMPLETED|Overall Study||4
7910984|NCT00658723|19468440|P3|COMPLETED|Overall Study||44
7910985|NCT00658723|19468441|P2|COMPLETED|Overall Study||26
7910986|NCT00658723|19468442|P1|COMPLETED|Overall Study||56
7910987|NCT00658723|19468440|P3|STARTED|Overall Study||51
7910988|NCT00658723|19468441|P2|STARTED|Overall Study||30
7910989|NCT00658723|19468442|P1|STARTED|Overall Study||60
7910990|NCT00658697|19468469|P1|NOT COMPLETED|Overall Study||0
7910991|NCT00658697|19468469|P1|COMPLETED|Overall Study||41
7910992|NCT00658697|19468469|P1|STARTED|Overall Study||41
7910993|NCT00658684|19468480|P4|NOT COMPLETED|Overall Study||1
7910994|NCT00658684|19468481|P3|NOT COMPLETED|Overall Study||3
7910995|NCT00658684|19468482|P2|NOT COMPLETED|Overall Study||15
7910996|NCT00658684|19468483|P1|NOT COMPLETED|Overall Study||19
7910997|NCT00658684|19468480|P4|COMPLETED|Overall Study||27
7910998|NCT00658684|19468481|P3|COMPLETED|Overall Study||22
7910999|NCT00658684|19468482|P2|COMPLETED|Overall Study||84
7911000|NCT00658684|19468483|P1|COMPLETED|Overall Study||133
7911001|NCT00658684|19468480|P4|STARTED|Overall Study||28
7911002|NCT00658684|19468481|P3|STARTED|Overall Study||25
7911003|NCT00658684|19468482|P2|STARTED|Overall Study||99
7911004|NCT00658684|19468483|P1|STARTED|Overall Study||152
7911005|NCT00658658|19468538|P5|NOT COMPLETED|Overall Study||5
7911006|NCT00658658|19468539|P4|NOT COMPLETED|Overall Study||2
7911007|NCT00658658|19468540|P3|NOT COMPLETED|Overall Study||0
7911008|NCT00658658|19468541|P2|NOT COMPLETED|Overall Study||2
7911009|NCT00658658|19468542|P1|NOT COMPLETED|Overall Study||5
7911010|NCT00658658|19468538|P5|COMPLETED|Overall Study||3
7911011|NCT00658658|19468539|P4|COMPLETED|Overall Study||4
7911012|NCT00658658|19468540|P3|COMPLETED|Overall Study||4
7911013|NCT00658658|19468541|P2|COMPLETED|Overall Study||5
7911014|NCT00658658|19468542|P1|COMPLETED|Overall Study||1
7911015|NCT00658658|19468538|P5|STARTED|Overall Study||8
7911016|NCT00658658|19468539|P4|STARTED|Overall Study||6
7911017|NCT00658658|19468540|P3|STARTED|Overall Study||4
7911018|NCT00658658|19468541|P2|STARTED|Overall Study||7
7911019|NCT00658658|19468542|P1|STARTED|Overall Study||6
7911020|NCT00658632|19468601|P2|NOT COMPLETED|Overall Study||65
7911021|NCT00658632|19468602|P1|NOT COMPLETED|Overall Study||64
7911022|NCT00658632|19468601|P2|COMPLETED|Overall Study||633
7911023|NCT00658632|19468602|P1|COMPLETED|Overall Study||618
7911024|NCT00658632|19468601|P2|STARTED|Overall Study|Treated|698
7911025|NCT00658632|19468602|P1|STARTED|Overall Study|Treated|682
7911026|NCT00658619|19468617|P5|NOT COMPLETED|Overall Study||2
7911027|NCT00658619|19468618|P4|NOT COMPLETED|Overall Study||12
7911028|NCT00658619|19468619|P3|NOT COMPLETED|Overall Study||10
7911029|NCT00658619|19468620|P2|NOT COMPLETED|Overall Study||1
7911030|NCT00658619|19468621|P1|NOT COMPLETED|Overall Study||0
7911031|NCT00658619|19468617|P5|COMPLETED|Overall Study||21
7911032|NCT00658619|19468618|P4|COMPLETED|Overall Study||37
7911033|NCT00658619|19468619|P3|COMPLETED|Overall Study||31
7911034|NCT00658619|19468620|P2|COMPLETED|Overall Study||2
7911035|NCT00658619|19468621|P1|COMPLETED|Overall Study||3
7911036|NCT00658619|19468617|P5|STARTED|Overall Study||23
7911037|NCT00658619|19468618|P4|STARTED|Overall Study||49
7911038|NCT00658619|19468619|P3|STARTED|Overall Study||41
7911039|NCT00658619|19468620|P2|STARTED|Overall Study||3
7911040|NCT00658619|19468621|P1|STARTED|Overall Study||3
7911041|NCT00658606|19468643|P2|NOT COMPLETED|Overall Study||23
7911042|NCT00658606|19468644|P1|NOT COMPLETED|Overall Study||16
7911043|NCT00658606|19468643|P2|COMPLETED|Overall Study|Represents patients who completed follow-up|26
7911044|NCT00658606|19468644|P1|COMPLETED|Overall Study|Represents patients who completed follow-up|33
7911045|NCT00658606|19468643|P2|Completed Treatment|Overall Study||44
7911046|NCT00658606|19468644|P1|Completed Treatment|Overall Study||42
7911047|NCT00658606|19468643|P2|STARTED|Overall Study||49
7911048|NCT00658606|19468644|P1|STARTED|Overall Study||49
7911049|NCT00658567|19468673|P3|NOT COMPLETED|Overall Study||6
7911050|NCT00658567|19468674|P2|NOT COMPLETED|Overall Study||4
7911051|NCT00658567|19468675|P1|NOT COMPLETED|Overall Study||8
7911052|NCT00658567|19468673|P3|COMPLETED|Overall Study||35
7911053|NCT00658567|19468674|P2|COMPLETED|Overall Study||38
7911054|NCT00658567|19468675|P1|COMPLETED|Overall Study||32
7911055|NCT00658567|19468673|P3|STARTED|Overall Study||41
7911056|NCT00658567|19468674|P2|STARTED|Overall Study||42
7911057|NCT00658567|19468675|P1|STARTED|Overall Study||40
7911058|NCT00658541|19468686|P2|NOT COMPLETED|Second Intervention||0
7911059|NCT00658541|19468687|P1|NOT COMPLETED|Second Intervention||0
7911060|NCT00658541|19468686|P2|COMPLETED|Second Intervention||17
7911061|NCT00658541|19468687|P1|COMPLETED|Second Intervention||18
7911062|NCT00658541|19468686|P2|STARTED|Second Intervention||17
7911063|NCT00658541|19468687|P1|STARTED|Second Intervention||18
7911064|NCT00658541|19468686|P2|NOT COMPLETED|Washout Period of 7 Days||2
7911065|NCT00658541|19468687|P1|NOT COMPLETED|Washout Period of 7 Days||1
7911066|NCT00658541|19468686|P2|COMPLETED|Washout Period of 7 Days||17
7911067|NCT00658541|19468687|P1|COMPLETED|Washout Period of 7 Days||18
7911068|NCT00658541|19468686|P2|STARTED|Washout Period of 7 Days||19
7911069|NCT00658541|19468687|P1|STARTED|Washout Period of 7 Days||19
7911070|NCT00658541|19468686|P2|NOT COMPLETED|First Intervention||0
7911071|NCT00658541|19468687|P1|NOT COMPLETED|First Intervention||0
7911072|NCT00658541|19468686|P2|COMPLETED|First Intervention||19
7911073|NCT00658541|19468687|P1|COMPLETED|First Intervention||19
7911074|NCT00658541|19468686|P2|STARTED|First Intervention||19
7911075|NCT00658541|19468687|P1|STARTED|First Intervention||19
7911076|NCT00658528|19468699|P2|NOT COMPLETED|Overall Study||45
7911077|NCT00658528|19468700|P1|NOT COMPLETED|Overall Study||40
7911078|NCT00658528|19468699|P2|COMPLETED|Overall Study||479
7911079|NCT00658528|19468700|P1|COMPLETED|Overall Study||491
7911080|NCT00658528|19468699|P2|STARTED|Overall Study|Treated|524
7911081|NCT00658528|19468700|P1|STARTED|Overall Study|Treated|531
7911082|NCT00658515|19468712|P2|NOT COMPLETED|Overall Study||265
7911083|NCT00658515|19468713|P1|NOT COMPLETED|Overall Study||312
7911084|NCT00658515|19468712|P2|COMPLETED|Overall Study||7668
7911085|NCT00658515|19468713|P1|COMPLETED|Overall Study||7626
7911086|NCT00658515|19468712|P2|STARTED|Overall Study||7933
7911087|NCT00658515|19468713|P1|STARTED|Overall Study||7938
7911088|NCT00658411|19468725|P1|NOT COMPLETED|Overall Study||0
7911089|NCT00658411|19468725|P1|COMPLETED|Overall Study||5
7911090|NCT00658411|19468725|P1|STARTED|Overall Study||5
7911091|NCT00658385|19468733|P1|NOT COMPLETED|Overall Study||0
7911092|NCT00658385|19468733|P1|COMPLETED|Overall Study||5
7911093|NCT00658385|19468733|P1|STARTED|Overall Study||5
7911094|NCT00658359|19468740|P3|NOT COMPLETED|Overall Study||46
7911095|NCT00658359|19468741|P2|NOT COMPLETED|Overall Study||45
7911096|NCT00658359|19468742|P1|NOT COMPLETED|Overall Study||28
7911097|NCT00658359|19468740|P3|COMPLETED|Overall Study||8
7911098|NCT00658359|19468741|P2|COMPLETED|Overall Study||15
7911099|NCT00658359|19468742|P1|COMPLETED|Overall Study||36
7911100|NCT00658359|19468740|P3|STARTED|Overall Study||54
7911101|NCT00658359|19468741|P2|STARTED|Overall Study||60
7911102|NCT00658359|19468742|P1|STARTED|Overall Study||64
7911103|NCT00658333|19468830|P2|NOT COMPLETED|Overall Study||1
7911104|NCT00658333|19468831|P1|NOT COMPLETED|Overall Study||2
7911105|NCT00658333|19468830|P2|COMPLETED|Overall Study||14
7911106|NCT00658333|19468831|P1|COMPLETED|Overall Study||13
7911107|NCT00658333|19468830|P2|STARTED|Overall Study||15
7911108|NCT00658333|19468831|P1|STARTED|Overall Study||15
7911109|NCT00658320|19468841|P2|NOT COMPLETED|Extension Study: After Month 24||0
7911110|NCT00658320|19468842|P1|NOT COMPLETED|Extension Study: After Month 24||2
7911111|NCT00658320|19468841|P2|COMPLETED|Extension Study: After Month 24||0
7911112|NCT00658320|19468842|P1|COMPLETED|Extension Study: After Month 24||42
7911113|NCT00658320|19468841|P2|STARTED|Extension Study: After Month 24||0
7911114|NCT00658320|19468842|P1|STARTED|Extension Study: After Month 24||44
7911115|NCT00658320|19468841|P2|NOT COMPLETED|Extension Study: Month 12 to Month 24||7
7911116|NCT00658320|19468842|P1|NOT COMPLETED|Extension Study: Month 12 to Month 24||6
7911117|NCT00658320|19468841|P2|COMPLETED|Extension Study: Month 12 to Month 24||50
7911118|NCT00658320|19468842|P1|COMPLETED|Extension Study: Month 12 to Month 24||47
7911119|NCT00658320|19468841|P2|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
7911120|NCT00658320|19468842|P1|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
7911121|NCT00658320|19468841|P2|STARTED|Extension Study: Month 12 to Month 24||57
7911122|NCT00658320|19468842|P1|STARTED|Extension Study: Month 12 to Month 24||53
7911123|NCT00658320|19468841|P2|NOT COMPLETED|Core Study: 12 Months||3
7911124|NCT00658320|19468842|P1|NOT COMPLETED|Core Study: 12 Months||5
7911125|NCT00658320|19468841|P2|COMPLETED|Core Study: 12 Months||58
7911126|NCT00658320|19468842|P1|COMPLETED|Core Study: 12 Months||56
7911127|NCT00658320|19468841|P2|STARTED|Core Study: 12 Months||61
7911128|NCT00658320|19468842|P1|STARTED|Core Study: 12 Months||61
7911129|NCT00658138|19468865|P1|NOT COMPLETED|Overall Study||21
7911130|NCT00658138|19468865|P1|COMPLETED|Overall Study||40
7911131|NCT00658138|19468865|P1|STARTED|Overall Study||61
7911132|NCT00658112|19468870|P1|NOT COMPLETED|Overall Study||9
7911133|NCT00658112|19468870|P1|COMPLETED|Overall Study||11
7911134|NCT00658112|19468870|P1|STARTED|Overall Study||20
7911135|NCT00658021|19468877|P3|NOT COMPLETED|Long-term Safety Follow-up Period||0
7911136|NCT00658021|19468878|P2|NOT COMPLETED|Long-term Safety Follow-up Period||3
7911137|NCT00658021|19468879|P1|NOT COMPLETED|Long-term Safety Follow-up Period||0
7911138|NCT00658021|19468877|P3|COMPLETED|Long-term Safety Follow-up Period||7
7911139|NCT00658021|19468878|P2|COMPLETED|Long-term Safety Follow-up Period||2
7911140|NCT00658021|19468879|P1|COMPLETED|Long-term Safety Follow-up Period||7
7911141|NCT00658021|19468877|P3|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7
7911142|NCT00658021|19468878|P2|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|5
7911143|NCT00658021|19468879|P1|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7
7911144|NCT00658021|19468877|P3|NOT COMPLETED|28-Week Treatment Period||17
7911145|NCT00658021|19468878|P2|NOT COMPLETED|28-Week Treatment Period||13
7911146|NCT00658021|19468879|P1|NOT COMPLETED|28-Week Treatment Period||11
7911147|NCT00658021|19468877|P3|COMPLETED|28-Week Treatment Period||25
7911148|NCT00658021|19468878|P2|COMPLETED|28-Week Treatment Period||25
7911149|NCT00658021|19468879|P1|COMPLETED|28-Week Treatment Period||31
7911150|NCT00658021|19468877|P3|Received Treatment|28-Week Treatment Period||42
7911151|NCT00658021|19468878|P2|Received Treatment|28-Week Treatment Period||38
7911152|NCT00658021|19468879|P1|Received Treatment|28-Week Treatment Period||40
7911153|NCT00658021|19468877|P3|STARTED|28-Week Treatment Period||42
7911154|NCT00658021|19468878|P2|STARTED|28-Week Treatment Period||38
7911155|NCT00658021|19468879|P1|STARTED|28-Week Treatment Period||42
7911156|NCT00657917|19468903|P1|NOT COMPLETED|Overall Study||0
7911157|NCT00657917|19468903|P1|COMPLETED|Overall Study||1
7911158|NCT00657917|19468903|P1|STARTED|Overall Study||1
7911159|NCT00657709|19468914|P5|NOT COMPLETED|Overall Study||33
7911160|NCT00657709|19468915|P4|NOT COMPLETED|Overall Study||14
7911161|NCT00657709|19468916|P3|NOT COMPLETED|Overall Study||28
7911162|NCT00657709|19468917|P2|NOT COMPLETED|Overall Study||33
7911163|NCT00657709|19468918|P1|NOT COMPLETED|Overall Study||23
7911164|NCT00657709|19468914|P5|COMPLETED|Overall Study||457
7911165|NCT00657709|19468915|P4|COMPLETED|Overall Study||645
7911166|NCT00657709|19468916|P3|COMPLETED|Overall Study||792
7911167|NCT00657709|19468917|P2|COMPLETED|Overall Study||795
7911168|NCT00657709|19468918|P1|COMPLETED|Overall Study||810
7911169|NCT00657709|19468914|P5|STARTED|Overall Study||490
7911170|NCT00657709|19468915|P4|STARTED|Overall Study||659
7911171|NCT00657709|19468916|P3|STARTED|Overall Study||820
7911172|NCT00657709|19468917|P2|STARTED|Overall Study||828
7911173|NCT00657709|19468918|P1|STARTED|Overall Study||833
7911174|NCT00657657|19468959|P1|NOT COMPLETED|Overall Study||0
7911175|NCT00657657|19468959|P1|COMPLETED|Overall Study||29
7911176|NCT00657657|19468959|P1|STARTED|Overall Study||29
7911177|NCT00657618|19468967|P1|NOT COMPLETED|Overall Study||43
7911178|NCT00657618|19468967|P1|COMPLETED|Overall Study||34
7911179|NCT00657618|19468967|P1|STARTED|Overall Study||77
7911180|NCT00657605|19468972|P1|NOT COMPLETED|Overall Study||0
7911181|NCT00657605|19468972|P1|COMPLETED|Overall Study||3
7911182|NCT00657605|19468972|P1|STARTED|Overall Study||3
7911183|NCT00657553|19468979|P2|NOT COMPLETED|Overall Study||5
7911184|NCT00657553|19468980|P1|NOT COMPLETED|Overall Study||5
7911185|NCT00657553|19468979|P2|COMPLETED|Overall Study||0
7911186|NCT00657553|19468980|P1|COMPLETED|Overall Study||0
7911187|NCT00657553|19468979|P2|STARTED|Overall Study||5
7911188|NCT00657553|19468980|P1|STARTED|Overall Study||5
7911189|NCT00657540|19468988|P2|NOT COMPLETED|Overall Study||4
7911190|NCT00657540|19468989|P1|NOT COMPLETED|Overall Study||1
7911191|NCT00657540|19468988|P2|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|27
7911192|NCT00657540|19468989|P1|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|28
7911193|NCT00657540|19468988|P2|STARTED|Overall Study||31
7911194|NCT00657540|19468989|P1|STARTED|Overall Study||29
7911195|NCT00657371|19469003|P1|NOT COMPLETED|Overall Study||39
7911196|NCT00657371|19469003|P1|COMPLETED|Overall Study||249
7911197|NCT00657371|19469003|P1|STARTED|Overall Study||288
7911198|NCT00657358|19469008|P1|NOT COMPLETED|Overall Study||6
7911199|NCT00657358|19469008|P1|COMPLETED|Overall Study||16
7911200|NCT00657358|19469008|P1|STARTED|Overall Study||22
7911201|NCT00657280|19469016|P1|NOT COMPLETED|Overall Study||0
7911202|NCT00657280|19469016|P1|COMPLETED|Overall Study||16
7911203|NCT00657280|19469016|P1|STARTED|Overall Study||16
7911204|NCT00657267|19469020|P1|NOT COMPLETED|Overall Study||54
7911205|NCT00657267|19469020|P1|COMPLETED|Overall Study||4
7911206|NCT00657267|19469020|P1|STARTED|Overall Study||58
7911207|NCT00657150|19469030|P2|NOT COMPLETED|Treatment||97
7911208|NCT00657150|19469031|P1|NOT COMPLETED|Treatment||107
7911209|NCT00657150|19469030|P2|COMPLETED|Treatment||906
7911210|NCT00657150|19469031|P1|COMPLETED|Treatment||903
7911211|NCT00657150|19469030|P2|STARTED|Treatment||1003
7911212|NCT00657150|19469031|P1|STARTED|Treatment||1010
7911213|NCT00657150|19469030|P2|NOT COMPLETED|Overall Study||93
7911214|NCT00657150|19469031|P1|NOT COMPLETED|Overall Study||115
7911215|NCT00657150|19469030|P2|COMPLETED|Overall Study||910
7911216|NCT00657150|19469031|P1|COMPLETED|Overall Study||895
7911217|NCT00657150|19469030|P2|STARTED|Overall Study||1003
7911218|NCT00657150|19469031|P1|STARTED|Overall Study||1010
7911219|NCT00657046|19469062|P3|NOT COMPLETED|Overall Study||2
7911220|NCT00657046|19469063|P2|NOT COMPLETED|Overall Study||3
7911221|NCT00657046|19469064|P1|NOT COMPLETED|Overall Study||4
7911222|NCT00657046|19469062|P3|COMPLETED|Overall Study||21
7911223|NCT00657046|19469063|P2|COMPLETED|Overall Study||29
7911224|NCT00657046|19469064|P1|COMPLETED|Overall Study||26
7911225|NCT00657046|19469062|P3|Had Visits up to Visit 18|Overall Study||23
7911226|NCT00657046|19469063|P2|Had Visits up to Visit 18|Overall Study||30
7911227|NCT00657046|19469064|P1|Had Visits up to Visit 18|Overall Study||28
7911228|NCT00657046|19469062|P3|Had at Least 1 Post Baseline Visit|Overall Study||23
7911229|NCT00657046|19469063|P2|Had at Least 1 Post Baseline Visit|Overall Study||31
7911230|NCT00657046|19469064|P1|Had at Least 1 Post Baseline Visit|Overall Study||30
7911231|NCT00657046|19469062|P3|STARTED|Overall Study||23
7911232|NCT00657046|19469063|P2|STARTED|Overall Study||32
7911233|NCT00657046|19469064|P1|STARTED|Overall Study||30
7911234|NCT00657020|19469096|P2|NOT COMPLETED|PERIOD 2||0
7911235|NCT00657020|19469097|P1|NOT COMPLETED|PERIOD 2||0
7911236|NCT00657020|19469096|P2|COMPLETED|PERIOD 2||11
7911237|NCT00657020|19469097|P1|COMPLETED|PERIOD 2||11
7911238|NCT00657020|19469096|P2|STARTED|PERIOD 2||11
7911239|NCT00657020|19469097|P1|STARTED|PERIOD 2||11
7911240|NCT00657020|19469096|P2|NOT COMPLETED|PERIOD 1||1
7911241|NCT00657020|19469097|P1|NOT COMPLETED|PERIOD 1||0
7911242|NCT00657020|19469096|P2|COMPLETED|PERIOD 1||11
7911243|NCT00657020|19469097|P1|COMPLETED|PERIOD 1||11
7911244|NCT00657020|19469096|P2|STARTED|PERIOD 1||12
7911245|NCT00657020|19469097|P1|STARTED|PERIOD 1||11
7911246|NCT00656968|19469127|P2|NOT COMPLETED|Overall Study||0
7911247|NCT00656968|19469128|P1|NOT COMPLETED|Overall Study||0
7911248|NCT00656968|19469127|P2|COMPLETED|Overall Study||117
7911249|NCT00656968|19469128|P1|COMPLETED|Overall Study||115
7911250|NCT00656968|19469127|P2|STARTED|Overall Study||117
7911251|NCT00656968|19469128|P1|STARTED|Overall Study||115
7911252|NCT00656916|19469138|P2|NOT COMPLETED|Overall Study||0
7911253|NCT00656916|19469139|P1|NOT COMPLETED|Overall Study||0
7911254|NCT00656916|19469138|P2|COMPLETED|Overall Study||0
7911255|NCT00656916|19469139|P1|COMPLETED|Overall Study||1
7911256|NCT00656916|19469138|P2|STARTED|Overall Study||0
7911257|NCT00656916|19469139|P1|STARTED|Overall Study||1
7911258|NCT00656851|19469147|P2|NOT COMPLETED|Overall Study||4
7911259|NCT00656851|19469148|P1|NOT COMPLETED|Overall Study||0
7911260|NCT00656851|19469147|P2|COMPLETED|Overall Study||8
7911261|NCT00656851|19469148|P1|COMPLETED|Overall Study||12
7911262|NCT00656851|19469147|P2|STARTED|Overall Study||12
7911263|NCT00656851|19469148|P1|STARTED|Overall Study||12
7911264|NCT00656799|19469170|P1|NOT COMPLETED|Overall Study||2
7911265|NCT00656799|19469170|P1|COMPLETED|Overall Study||4
7911266|NCT00656799|19469170|P1|STARTED|Overall Study||6
7911267|NCT00656669|19469192|P1|NOT COMPLETED|AC (Cycles 6-9)||2
7911268|NCT00656669|19469192|P1|COMPLETED|AC (Cycles 6-9)||15
7911269|NCT00656669|19469192|P1|STARTED|AC (Cycles 6-9)||17
7911270|NCT00656669|19469192|P1|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6
7911271|NCT00656669|19469192|P1|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17
7911272|NCT00656669|19469192|P1|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23
7911273|NCT00656669|19469192|P1|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0
7911274|NCT00656669|19469192|P1|COMPLETED|Single Agent Sunitinib (Cycle 1)||23
7911275|NCT00656669|19469192|P1|STARTED|Single Agent Sunitinib (Cycle 1)||23
7911276|NCT00656656|19469201|P1|NOT COMPLETED|Overall Study||0
7911277|NCT00656656|19469201|P1|COMPLETED|Overall Study||23
7911278|NCT00656656|19469201|P1|STARTED|Overall Study||23
7911279|NCT00656630|19469209|P3|NOT COMPLETED|Overall Study||2
7911280|NCT00656630|19469210|P2|NOT COMPLETED|Overall Study||2
7911281|NCT00656630|19469211|P1|NOT COMPLETED|Overall Study||2
7911282|NCT00656630|19469209|P3|COMPLETED|Overall Study||17
7911283|NCT00656630|19469210|P2|COMPLETED|Overall Study||25
7911284|NCT00656630|19469211|P1|COMPLETED|Overall Study||20
7911285|NCT00656630|19469209|P3|STARTED|Overall Study||19
7911286|NCT00656630|19469210|P2|STARTED|Overall Study||27
7911287|NCT00656630|19469211|P1|STARTED|Overall Study||22
7911288|NCT00656617|19469231|P1|NOT COMPLETED|Overall Study||7
7911289|NCT00656617|19469231|P1|COMPLETED|Overall Study||99
7911290|NCT00656617|19469231|P1|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103
7911291|NCT00656617|19469231|P1|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3
7911292|NCT00656617|19469231|P1|STARTED|Overall Study||106
7911293|NCT00656513|19469240|P3|NOT COMPLETED|Overall Study||22
7911294|NCT00656513|19469241|P2|NOT COMPLETED|Overall Study||30
7911295|NCT00656513|19469242|P1|NOT COMPLETED|Overall Study||4
7911296|NCT00656513|19469240|P3|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|53
7911297|NCT00656513|19469241|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|43
7911298|NCT00656513|19469242|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
7911299|NCT00656513|19469240|P3|STARTED|Overall Study||75
7911300|NCT00656513|19469241|P2|STARTED|Overall Study||73
7911301|NCT00656513|19469242|P1|STARTED|Overall Study||48
7911302|NCT00656487|19469264|P3|NOT COMPLETED|Overall Study||0
7911303|NCT00656487|19469265|P2|NOT COMPLETED|Overall Study||4
7911304|NCT00656487|19469266|P1|NOT COMPLETED|Overall Study||2
7911305|NCT00656487|19469264|P3|COMPLETED|Overall Study||20
7911306|NCT00656487|19469265|P2|COMPLETED|Overall Study||19
7911307|NCT00656487|19469266|P1|COMPLETED|Overall Study||21
7911308|NCT00656487|19469264|P3|STARTED|Overall Study||20
7911309|NCT00656487|19469265|P2|STARTED|Overall Study||23
7911310|NCT00656487|19469266|P1|STARTED|Overall Study||23
7911311|NCT00656474|19469289|P1|NOT COMPLETED|Overall Study||1
7911312|NCT00656474|19469289|P1|COMPLETED|Overall Study||11
7911313|NCT00656474|19469289|P1|STARTED|Overall Study||12
7911314|NCT00656448|19469298|P2|NOT COMPLETED|Overall Study||0
7911315|NCT00656448|19469299|P1|NOT COMPLETED|Overall Study||0
7911316|NCT00656448|19469298|P2|COMPLETED|Overall Study||25
7911317|NCT00656448|19469299|P1|COMPLETED|Overall Study||25
7911318|NCT00656448|19469298|P2|STARTED|Overall Study||25
7911319|NCT00656448|19469299|P1|STARTED|Overall Study||25
7911320|NCT00656370|19469307|P1|NOT COMPLETED|Overall Study||10
7911321|NCT00656370|19469307|P1|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1 (received both NS and LR).|15
7911322|NCT00656370|19469307|P1|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25
7911323|NCT00656305|19469323|P2|NOT COMPLETED|Overall Study||7
7911324|NCT00656305|19469324|P1|NOT COMPLETED|Overall Study||22
7911325|NCT00656305|19469323|P2|COMPLETED|Overall Study||21
7911326|NCT00656305|19469324|P1|COMPLETED|Overall Study||65
7911327|NCT00656305|19469323|P2|STARTED|Overall Study||28
7911328|NCT00656305|19469324|P1|STARTED|Overall Study||87
7911329|NCT00656292|19469336|P2|NOT COMPLETED|Overall Study||5
7911330|NCT00656292|19469337|P1|NOT COMPLETED|Overall Study||3
7911331|NCT00656292|19469336|P2|COMPLETED|Overall Study||24
7911332|NCT00656292|19469337|P1|COMPLETED|Overall Study||29
7911333|NCT00656292|19469336|P2|STARTED|Overall Study||29
7911334|NCT00656292|19469337|P1|STARTED|Overall Study||32
7911335|NCT00656201|19469355|P2|NOT COMPLETED|Overall Study||32
7911336|NCT00656201|19469356|P1|NOT COMPLETED|Overall Study||29
7911337|NCT00656201|19469355|P2|COMPLETED|Overall Study||201
7911338|NCT00656201|19469356|P1|COMPLETED|Overall Study||206
7911339|NCT00656201|19469355|P2|STARTED|Overall Study||233
7911340|NCT00656201|19469356|P1|STARTED|Overall Study||235
7911341|NCT00656175|19469364|P2|NOT COMPLETED|Overall Study||1
7911342|NCT00656175|19469365|P1|NOT COMPLETED|Overall Study||1
7911343|NCT00656175|19469364|P2|COMPLETED|Overall Study||20
7911344|NCT00656175|19469365|P1|COMPLETED|Overall Study||17
7911345|NCT00656175|19469364|P2|STARTED|Overall Study||21
7911346|NCT00656175|19469365|P1|STARTED|Overall Study||18
7911347|NCT00656136|19469373|P2|NOT COMPLETED|Overall Study||390
7911348|NCT00656136|19469374|P1|NOT COMPLETED|Overall Study||195
7911349|NCT00656136|19469373|P2|COMPLETED|Overall Study||0
7911350|NCT00656136|19469374|P1|COMPLETED|Overall Study||0
7911351|NCT00656136|19469373|P2|STARTED|Overall Study|Randomised patients.|390
7911352|NCT00656136|19469374|P1|STARTED|Overall Study|Randomised patients.|195
7911353|NCT00656084|19469384|P1|NOT COMPLETED|Overall Study||7
7911354|NCT00656084|19469384|P1|COMPLETED|Overall Study||9
7911355|NCT00656084|19469384|P1|STARTED|Overall Study||16
7911356|NCT00656058|19469391|P1|NOT COMPLETED|Overall Study||6
7911357|NCT00656058|19469391|P1|COMPLETED|Overall Study||19
7911358|NCT00656058|19469391|P1|STARTED|Overall Study||25
7911359|NCT00656019|19469404|P4|NOT COMPLETED|Overall Study||0
7911360|NCT00656019|19469405|P3|NOT COMPLETED|Overall Study||0
7911361|NCT00656019|19469406|P2|NOT COMPLETED|Overall Study||1
7911362|NCT00656019|19469407|P1|NOT COMPLETED|Overall Study||14
7911363|NCT00656019|19469404|P4|COMPLETED|Overall Study||4
7911364|NCT00656019|19469405|P3|COMPLETED|Overall Study||11
7911365|NCT00656019|19469406|P2|COMPLETED|Overall Study||18
7911366|NCT00656019|19469407|P1|COMPLETED|Overall Study||15
7911367|NCT00656019|19469404|P4|STARTED|Overall Study||4
7911368|NCT00656019|19469405|P3|STARTED|Overall Study||11
7911369|NCT00656019|19469406|P2|STARTED|Overall Study||19
7911370|NCT00656019|19469407|P1|STARTED|Overall Study||29
7911371|NCT00655980|19469420|P3|NOT COMPLETED|Overall Study||5
7911372|NCT00655980|19469421|P2|NOT COMPLETED|Overall Study||31
7911373|NCT00655980|19469422|P1|NOT COMPLETED|Overall Study||26
7911374|NCT00655980|19469420|P3|COMPLETED|Overall Study||125
7911375|NCT00655980|19469421|P2|COMPLETED|Overall Study||250
7911376|NCT00655980|19469422|P1|COMPLETED|Overall Study||250
7911377|NCT00655980|19469420|P3|STARTED|Overall Study||130
7911378|NCT00655980|19469421|P2|STARTED|Overall Study||281
7911379|NCT00655980|19469422|P1|STARTED|Overall Study||276
7911380|NCT00655928|19469435|P2|NOT COMPLETED|Overall Study||2
7911381|NCT00655928|19469436|P1|NOT COMPLETED|Overall Study||3
7911382|NCT00655928|19469435|P2|COMPLETED|Overall Study||24
7911383|NCT00655928|19469436|P1|COMPLETED|Overall Study||23
7911384|NCT00655928|19469435|P2|STARTED|Overall Study||26
7911385|NCT00655928|19469436|P1|STARTED|Overall Study||26
7911386|NCT00655889|19469442|P1|NOT COMPLETED|Overall Study||2
7911387|NCT00655889|19469442|P1|COMPLETED|Overall Study||11
7911388|NCT00655889|19469442|P1|STARTED|Overall Study||13
7911389|NCT00655876|19469449|P2|NOT COMPLETED|Overall Study||7
7911390|NCT00655876|19469450|P1|NOT COMPLETED|Overall Study||9
7911391|NCT00655876|19469449|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|169
7911392|NCT00655876|19469450|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|159
7911393|NCT00655876|19469449|P2|STARTED|Overall Study||176
7911394|NCT00655876|19469450|P1|STARTED|Overall Study||168
7911395|NCT00655863|19469469|P3|NOT COMPLETED|Overall Study||1
7911396|NCT00655863|19469470|P2|NOT COMPLETED|Overall Study||0
7911397|NCT00655863|19469471|P1|NOT COMPLETED|Overall Study||0
7911398|NCT00655863|19469469|P3|COMPLETED|Overall Study||21
7911399|NCT00655863|19469470|P2|COMPLETED|Overall Study||25
7911400|NCT00655863|19469471|P1|COMPLETED|Overall Study||24
7911401|NCT00655863|19469469|P3|STARTED|Overall Study||22
7911402|NCT00655863|19469470|P2|STARTED|Overall Study||25
7911403|NCT00655863|19469471|P1|STARTED|Overall Study||24
7911404|NCT00655850|19469530|P1|NOT COMPLETED|Overall Study||3
7911405|NCT00655850|19469530|P1|COMPLETED|Overall Study||36
7911406|NCT00655850|19469530|P1|STARTED|Overall Study||39
7911407|NCT00655824|19469537|P1|NOT COMPLETED|Overall Study||84
7911408|NCT00655824|19469537|P1|COMPLETED|Overall Study||8
7911409|NCT00655824|19469537|P1|STARTED|Overall Study||92
7911410|NCT00655811|19469571|P1|NOT COMPLETED|Overall Study||0
7911411|NCT00655811|19469571|P1|COMPLETED|Overall Study||40
7911412|NCT00655811|19469571|P1|STARTED|Overall Study||40
7911413|NCT00655746|19469585|P1|NOT COMPLETED|Overall Study||1
7911414|NCT00655746|19469585|P1|COMPLETED|Overall Study||13
7911415|NCT00655746|19469585|P1|STARTED|Overall Study||14
7911416|NCT00655733|19469604|P2|NOT COMPLETED|Overall Study||8
7911417|NCT00655733|19469605|P1|NOT COMPLETED|Overall Study||7
7911418|NCT00655733|19469604|P2|COMPLETED|Overall Study||42
7911419|NCT00655733|19469605|P1|COMPLETED|Overall Study||44
7911420|NCT00655733|19469604|P2|STARTED|Overall Study||50
7911421|NCT00655733|19469605|P1|STARTED|Overall Study||51
7911422|NCT00655707|19469633|P1|NOT COMPLETED|Overall Study||0
7911423|NCT00655707|19469633|P1|COMPLETED|Overall Study||5
7911424|NCT00655707|19469633|P1|STARTED|Overall Study||5
7911425|NCT00655668|19469638|P1|NOT COMPLETED|Overall Study||54
7911426|NCT00655668|19469638|P1|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0
7911427|NCT00655668|19469638|P1|STARTED|Overall Study|Planned enrollment: 80 participants|54
7911428|NCT00655642|19469650|P4|NOT COMPLETED|Overall Study||2
7911429|NCT00655642|19469651|P3|NOT COMPLETED|Overall Study||2
7911430|NCT00655642|19469652|P2|NOT COMPLETED|Overall Study||3
7911431|NCT00655642|19469653|P1|NOT COMPLETED|Overall Study||1
7911432|NCT00655642|19469650|P4|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39
7911433|NCT00655642|19469651|P3|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43
7911434|NCT00655642|19469652|P2|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40
7911435|NCT00655642|19469653|P1|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41
7911436|NCT00655642|19469650|P4|STARTED|Overall Study||41
7911437|NCT00655642|19469651|P3|STARTED|Overall Study||45
7911438|NCT00655642|19469652|P2|STARTED|Overall Study||43
7911439|NCT00655642|19469653|P1|STARTED|Overall Study||42
7911440|NCT00655629|19469665|P2|NOT COMPLETED|Overall Study||23
7911441|NCT00655629|19469666|P1|NOT COMPLETED|Overall Study||21
7911442|NCT00655629|19469665|P2|COMPLETED|Overall Study||144
7911443|NCT00655629|19469666|P1|COMPLETED|Overall Study||151
7911444|NCT00655629|19469665|P2|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166
7911445|NCT00655629|19469666|P1|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171
7911446|NCT00655629|19469665|P2|STARTED|Overall Study||167
7911447|NCT00655629|19469666|P1|STARTED|Overall Study||172
7911448|NCT00655564|19469702|P1|NOT COMPLETED|Overall Study||3
7911449|NCT00655564|19469702|P1|COMPLETED|Overall Study||12
7911450|NCT00655564|19469702|P1|STARTED|Overall Study||15
7911451|NCT00655551|19469710|P3|NOT COMPLETED|Period 4 (up to 7 Days)||0
7911452|NCT00655551|19469711|P2|NOT COMPLETED|Period 4 (up to 7 Days)||2
7911453|NCT00655551|19469712|P1|NOT COMPLETED|Period 4 (up to 7 Days)||0
7911454|NCT00655551|19469710|P3|COMPLETED|Period 4 (up to 7 Days)||0
7911455|NCT00655551|19469711|P2|COMPLETED|Period 4 (up to 7 Days)||23
7911456|NCT00655551|19469712|P1|COMPLETED|Period 4 (up to 7 Days)||0
7911457|NCT00655551|19469710|P3|STARTED|Period 4 (up to 7 Days)||0
7911458|NCT00655551|19469711|P2|STARTED|Period 4 (up to 7 Days)||25
7911459|NCT00655551|19469712|P1|STARTED|Period 4 (up to 7 Days)||0
7911460|NCT00655551|19469710|P3|NOT COMPLETED|Period 3 (up to 7 Days)||4
7911461|NCT00655551|19469711|P2|NOT COMPLETED|Period 3 (up to 7 Days)||0
7911462|NCT00655551|19469712|P1|NOT COMPLETED|Period 3 (up to 7 Days)||0
7911463|NCT00655551|19469710|P3|COMPLETED|Period 3 (up to 7 Days)||21
7911464|NCT00655551|19469711|P2|COMPLETED|Period 3 (up to 7 Days)||0
7911465|NCT00655551|19469712|P1|COMPLETED|Period 3 (up to 7 Days)||0
7911466|NCT00655551|19469710|P3|STARTED|Period 3 (up to 7 Days)||25
7911467|NCT00655551|19469711|P2|STARTED|Period 3 (up to 7 Days)||0
7911468|NCT00655551|19469712|P1|STARTED|Period 3 (up to 7 Days)||0
7911469|NCT00655551|19469710|P3|NOT COMPLETED|Period 2 (up to 7 Days)||0
7911470|NCT00655551|19469711|P2|NOT COMPLETED|Period 2 (up to 7 Days)||1
7911471|NCT00655551|19469712|P1|NOT COMPLETED|Period 2 (up to 7 Days)||0
7911472|NCT00655551|19469710|P3|COMPLETED|Period 2 (up to 7 Days)||0
7911473|NCT00655551|19469711|P2|COMPLETED|Period 2 (up to 7 Days)||24
7911474|NCT00655551|19469712|P1|COMPLETED|Period 2 (up to 7 Days)||0
7911475|NCT00655551|19469710|P3|STARTED|Period 2 (up to 7 Days)||0
7911476|NCT00655551|19469711|P2|STARTED|Period 2 (up to 7 Days)||25
7911477|NCT00655551|19469712|P1|STARTED|Period 2 (up to 7 Days)||0
7911478|NCT00655551|19469710|P3|NOT COMPLETED|Period 1 (up to 7 Days)||0
7911479|NCT00655551|19469711|P2|NOT COMPLETED|Period 1 (up to 7 Days)||0
7911480|NCT00655551|19469712|P1|NOT COMPLETED|Period 1 (up to 7 Days)||0
7911481|NCT00655551|19469710|P3|COMPLETED|Period 1 (up to 7 Days)||0
7911482|NCT00655551|19469711|P2|COMPLETED|Period 1 (up to 7 Days)||0
7911483|NCT00655551|19469712|P1|COMPLETED|Period 1 (up to 7 Days)||25
7911484|NCT00655551|19469710|P3|STARTED|Period 1 (up to 7 Days)||0
7911485|NCT00655551|19469711|P2|STARTED|Period 1 (up to 7 Days)||0
7911486|NCT00655551|19469712|P1|STARTED|Period 1 (up to 7 Days)||25
7911487|NCT00655551|19469710|P3|NOT COMPLETED|All Periods Combined||4
7911488|NCT00655551|19469711|P2|NOT COMPLETED|All Periods Combined||3
7911489|NCT00655551|19469712|P1|NOT COMPLETED|All Periods Combined||0
7911490|NCT00655551|19469710|P3|COMPLETED|All Periods Combined||21
7911491|NCT00655551|19469711|P2|COMPLETED|All Periods Combined||47
7911492|NCT00655551|19469712|P1|COMPLETED|All Periods Combined||25
7911493|NCT00655551|19469710|P3|STARTED|All Periods Combined||25
7911494|NCT00655551|19469711|P2|STARTED|All Periods Combined||50
7911495|NCT00655551|19469712|P1|STARTED|All Periods Combined||25
7911496|NCT00655538|19469728|P2|NOT COMPLETED|Overall Study||27
7911497|NCT00655538|19469729|P1|NOT COMPLETED|Overall Study||24
7911498|NCT00655538|19469728|P2|COMPLETED|Overall Study||211
7911499|NCT00655538|19469729|P1|COMPLETED|Overall Study||214
7911500|NCT00655538|19469728|P2|STARTED|Overall Study||238
7911501|NCT00655538|19469729|P1|STARTED|Overall Study||238
7911502|NCT00655486|19469749|P1|NOT COMPLETED|Overall Study||28
7911503|NCT00655486|19469749|P1|COMPLETED|Overall Study||69
7911504|NCT00655486|19469749|P1|STARTED|Overall Study||97
7911505|NCT00655473|19469756|P2|NOT COMPLETED|Overall Study||15
7911506|NCT00655473|19469757|P1|NOT COMPLETED|Overall Study||11
7911507|NCT00655473|19469756|P2|COMPLETED|Overall Study||51
7911508|NCT00655473|19469757|P1|COMPLETED|Overall Study||53
7911509|NCT00655473|19469756|P2|STARTED|Overall Study||66
7911510|NCT00655473|19469757|P1|STARTED|Overall Study||64
7911511|NCT00655356|19469777|P2|NOT COMPLETED|Overall Study||10
7911512|NCT00655356|19469778|P1|NOT COMPLETED|Overall Study||17
7911513|NCT00655356|19469777|P2|COMPLETED|Overall Study||98
7911514|NCT00655356|19469778|P1|COMPLETED|Overall Study||93
7911515|NCT00655356|19469777|P2|STARTED|Overall Study||108
7911516|NCT00655356|19469778|P1|STARTED|Overall Study||110
7911517|NCT00655083|19469792|P2|NOT COMPLETED|Overall Study||0
7911518|NCT00655083|19469793|P1|NOT COMPLETED|Overall Study||0
7911519|NCT00655083|19469792|P2|COMPLETED|Overall Study||8
7911520|NCT00655083|19469793|P1|COMPLETED|Overall Study||12
7911521|NCT00655083|19469792|P2|STARTED|Overall Study||8
7911522|NCT00655083|19469793|P1|STARTED|Overall Study||12
7911523|NCT00655057|19469808|P3|NOT COMPLETED|Overall Study||0
7911524|NCT00655057|19469809|P2|NOT COMPLETED|Overall Study||0
7911525|NCT00655057|19469810|P1|NOT COMPLETED|Overall Study||0
7911526|NCT00655057|19469808|P3|COMPLETED|Overall Study||0
7911527|NCT00655057|19469809|P2|COMPLETED|Overall Study||0
7911528|NCT00655057|19469810|P1|COMPLETED|Overall Study||0
7911529|NCT00655057|19469808|P3|STARTED|Overall Study||0
7911530|NCT00655057|19469809|P2|STARTED|Overall Study||0
7911531|NCT00655057|19469810|P1|STARTED|Overall Study||0
7911532|NCT00654992|19469820|P2|NOT COMPLETED|Overall Study||0
7911533|NCT00654992|19469821|P1|NOT COMPLETED|Overall Study||0
7911534|NCT00654992|19469820|P2|COMPLETED|Overall Study||35
7911535|NCT00654992|19469821|P1|COMPLETED|Overall Study||36
7911536|NCT00654992|19469820|P2|STARTED|Overall Study||35
7911537|NCT00654992|19469821|P1|STARTED|Overall Study||36
7911538|NCT00654953|19469830|P3|NOT COMPLETED|Overall Study||22
7911539|NCT00654953|19469831|P2|NOT COMPLETED|Overall Study||28
7911540|NCT00654953|19469832|P1|NOT COMPLETED|Overall Study||30
7911541|NCT00654953|19469830|P3|COMPLETED|Overall Study||8
7911542|NCT00654953|19469831|P2|COMPLETED|Overall Study||8
7911543|NCT00654953|19469832|P1|COMPLETED|Overall Study||6
7911544|NCT00654953|19469830|P3|STARTED|Overall Study||30
7911545|NCT00654953|19469831|P2|STARTED|Overall Study||36
7911546|NCT00654953|19469832|P1|STARTED|Overall Study||36
7911547|NCT00654940|19469842|P2|NOT COMPLETED|Period 2||0
7911548|NCT00654940|19469843|P1|NOT COMPLETED|Period 2||0
7911549|NCT00654940|19469842|P2|COMPLETED|Period 2||11
7911550|NCT00654940|19469843|P1|COMPLETED|Period 2||12
7911551|NCT00654940|19469842|P2|STARTED|Period 2||11
7911552|NCT00654940|19469843|P1|STARTED|Period 2||12
7911553|NCT00654940|19469842|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
7911554|NCT00654940|19469843|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
7911555|NCT00654940|19469842|P2|COMPLETED|Washout Period of 2 Weeks||11
7911556|NCT00654940|19469843|P1|COMPLETED|Washout Period of 2 Weeks||12
7911557|NCT00654940|19469842|P2|STARTED|Washout Period of 2 Weeks||11
7911558|NCT00654940|19469843|P1|STARTED|Washout Period of 2 Weeks||12
7911559|NCT00654940|19469842|P2|NOT COMPLETED|Period 1||1
7911560|NCT00654940|19469843|P1|NOT COMPLETED|Period 1||1
7911561|NCT00654940|19469842|P2|COMPLETED|Period 1||11
7911562|NCT00654940|19469843|P1|COMPLETED|Period 1||12
7911563|NCT00654940|19469842|P2|Received Study Treatment|Period 1||12
7911564|NCT00654940|19469843|P1|Received Study Treatment|Period 1||12
7911565|NCT00654940|19469842|P2|STARTED|Period 1|Assigned to study treatment.|12
7911566|NCT00654940|19469843|P1|STARTED|Period 1|Assigned to study treatment.|13
7911567|NCT00654927|19469855|P1|NOT COMPLETED|Overall Study||107
7911568|NCT00654927|19469855|P1|COMPLETED|Overall Study||70
7911569|NCT00654927|19469855|P1|STARTED|Overall Study||177
7911570|NCT00654901|19469867|P4|NOT COMPLETED|Overall Study||0
7911571|NCT00654901|19469868|P3|NOT COMPLETED|Overall Study||2
7911572|NCT00654901|19469869|P2|NOT COMPLETED|Overall Study||0
7911573|NCT00654901|19469870|P1|NOT COMPLETED|Overall Study||4
7911574|NCT00654901|19469867|P4|COMPLETED|Overall Study||113
7911575|NCT00654901|19469868|P3|COMPLETED|Overall Study||250
7911576|NCT00654901|19469869|P2|COMPLETED|Overall Study||262
7911577|NCT00654901|19469870|P1|COMPLETED|Overall Study||250
7911578|NCT00654901|19469867|P4|STARTED|Overall Study||113
7911579|NCT00654901|19469868|P3|STARTED|Overall Study||252
7911580|NCT00654901|19469869|P2|STARTED|Overall Study||262
7911581|NCT00654901|19469870|P1|STARTED|Overall Study||254
7911582|NCT00654875|19469890|P2|NOT COMPLETED|Overall Study||17
7911583|NCT00654875|19469891|P1|NOT COMPLETED|Overall Study||17
7911584|NCT00654875|19469890|P2|COMPLETED|Overall Study||147
7911585|NCT00654875|19469891|P1|COMPLETED|Overall Study||147
7911586|NCT00654875|19469890|P2|STARTED|Overall Study||164
7911587|NCT00654875|19469891|P1|STARTED|Overall Study||164
7911588|NCT00654836|19469909|P1|NOT COMPLETED|Overall Study||0
7911589|NCT00654836|19469909|P1|COMPLETED|Overall Study||32
7911590|NCT00654836|19469909|P1|STARTED|Overall Study||32
7911591|NCT00654784|19469917|P2|NOT COMPLETED|Overall Study||0
7911592|NCT00654784|19469918|P1|NOT COMPLETED|Overall Study||0
7911593|NCT00654784|19469917|P2|COMPLETED|Overall Study||8
7911594|NCT00654784|19469918|P1|COMPLETED|Overall Study||13
7911595|NCT00654784|19469917|P2|STARTED|Overall Study||8
7911596|NCT00654784|19469918|P1|STARTED|Overall Study||13
7911597|NCT00654745|19469924|P1|NOT COMPLETED|Overall Study||43
7911598|NCT00654745|19469924|P1|COMPLETED|Overall Study||164
7911599|NCT00654745|19469924|P1|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207
7911600|NCT00654732|19469964|P2|NOT COMPLETED|Overall Study||6
7911601|NCT00654732|19469965|P1|NOT COMPLETED|Overall Study||4
7911602|NCT00654732|19469964|P2|COMPLETED|Overall Study||26
7911603|NCT00654732|19469965|P1|COMPLETED|Overall Study||22
7911604|NCT00654732|19469964|P2|STARTED|Overall Study||32
7911605|NCT00654732|19469965|P1|STARTED|Overall Study||26
7911606|NCT00654654|19469971|P1|NOT COMPLETED|Overall Study||7
7911607|NCT00654654|19469971|P1|COMPLETED|Overall Study||43
7911608|NCT00654654|19469971|P1|STARTED|Overall Study||50
7911609|NCT00654641|19469978|P2|NOT COMPLETED|Overall Study||3
7911610|NCT00654641|19469979|P1|NOT COMPLETED|Overall Study||2
7911611|NCT00654641|19469978|P2|COMPLETED|Overall Study||23
7911612|NCT00654641|19469979|P1|COMPLETED|Overall Study||26
7911613|NCT00654641|19469978|P2|STARTED|Overall Study||26
7911614|NCT00654641|19469979|P1|STARTED|Overall Study||28
7911615|NCT00654628|19469985|P1|NOT COMPLETED|6 -Week Extension Period (Single Site)||5
7911616|NCT00654628|19469985|P1|COMPLETED|6 -Week Extension Period (Single Site)||55
7911617|NCT00654628|19469985|P1|STARTED|6 -Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60
7911618|NCT00654628|19469985|P1|NOT COMPLETED|6-week Active Treatment Period||21
7911619|NCT00654628|19469985|P1|COMPLETED|6-week Active Treatment Period||152
7911620|NCT00654628|19469985|P1|STARTED|6-week Active Treatment Period||173
7911621|NCT00654615|19470002|P2|NOT COMPLETED|Overall Study||7
7911622|NCT00654615|19470003|P1|NOT COMPLETED|Overall Study||8
7911623|NCT00654615|19470002|P2|COMPLETED|Overall Study||23
7911624|NCT00654615|19470003|P1|COMPLETED|Overall Study||22
7911625|NCT00654615|19470002|P2|STARTED|Overall Study||30
7911626|NCT00654615|19470003|P1|STARTED|Overall Study||30
7911627|NCT00654511|19470015|P4|NOT COMPLETED|Overall Study||0
7911628|NCT00654511|19470016|P3|NOT COMPLETED|Overall Study||0
7911629|NCT00654511|19470017|P2|NOT COMPLETED|Overall Study||0
7911630|NCT00654511|19470018|P1|NOT COMPLETED|Overall Study||0
7911631|NCT00654511|19470015|P4|COMPLETED|Overall Study||25
7911632|NCT00654511|19470016|P3|COMPLETED|Overall Study||25
7911633|NCT00654511|19470017|P2|COMPLETED|Overall Study||25
7911634|NCT00654511|19470018|P1|COMPLETED|Overall Study||26
7911635|NCT00654511|19470015|P4|STARTED|Overall Study||25
7911636|NCT00654511|19470016|P3|STARTED|Overall Study||25
7911637|NCT00654511|19470017|P2|STARTED|Overall Study||25
7911638|NCT00654511|19470018|P1|STARTED|Overall Study||26
7911639|NCT00654498|19470034|P2|NOT COMPLETED|Overall Study||12
7911640|NCT00654498|19470035|P1|NOT COMPLETED|Overall Study||14
7911641|NCT00654498|19470034|P2|COMPLETED|Overall Study||91
7911642|NCT00654498|19470035|P1|COMPLETED|Overall Study||189
7911643|NCT00654498|19470034|P2|STARTED|Overall Study||103
7911644|NCT00654498|19470035|P1|STARTED|Overall Study||203
7911645|NCT00654420|19470067|P4|NOT COMPLETED|Phase II||38
7911646|NCT00654420|19470068|P3|NOT COMPLETED|Phase II||37
7911647|NCT00654420|19470069|P2|NOT COMPLETED|Phase II||0
7911648|NCT00654420|19470070|P1|NOT COMPLETED|Phase II||0
7911649|NCT00654420|19470067|P4|COMPLETED|Phase II||0
7911650|NCT00654420|19470068|P3|COMPLETED|Phase II||0
7911651|NCT00654420|19470069|P2|COMPLETED|Phase II||0
7911652|NCT00654420|19470070|P1|COMPLETED|Phase II||0
7911653|NCT00654420|19470067|P4|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38
7911654|NCT00654420|19470068|P3|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37
7911655|NCT00654420|19470069|P2|STARTED|Phase II||0
7911656|NCT00654420|19470070|P1|STARTED|Phase II||0
7911657|NCT00654420|19470067|P4|NOT COMPLETED|Phase I (Dose Escalation)||0
7911658|NCT00654420|19470068|P3|NOT COMPLETED|Phase I (Dose Escalation)||0
7911659|NCT00654420|19470069|P2|NOT COMPLETED|Phase I (Dose Escalation)||16
7911660|NCT00654420|19470070|P1|NOT COMPLETED|Phase I (Dose Escalation)||4
7911661|NCT00654420|19470067|P4|COMPLETED|Phase I (Dose Escalation)||0
7911662|NCT00654420|19470068|P3|COMPLETED|Phase I (Dose Escalation)||0
7911663|NCT00654420|19470069|P2|COMPLETED|Phase I (Dose Escalation)||0
7911664|NCT00654420|19470070|P1|COMPLETED|Phase I (Dose Escalation)||0
7911665|NCT00654420|19470067|P4|STARTED|Phase I (Dose Escalation)||0
7911666|NCT00654420|19470068|P3|STARTED|Phase I (Dose Escalation)||0
7911667|NCT00654420|19470069|P2|STARTED|Phase I (Dose Escalation)||16
7911668|NCT00654420|19470070|P1|STARTED|Phase I (Dose Escalation)||4
7911669|NCT00654381|19470096|P6|NOT COMPLETED|Extension Stage||3
7911670|NCT00654381|19470097|P5|NOT COMPLETED|Extension Stage||3
7911671|NCT00654381|19470098|P4|NOT COMPLETED|Extension Stage||9
7911672|NCT00654381|19470099|P3|NOT COMPLETED|Extension Stage||11
7911673|NCT00654381|19470100|P2|NOT COMPLETED|Extension Stage||2
7911674|NCT00654381|19470101|P1|NOT COMPLETED|Extension Stage||1
7911675|NCT00654381|19470096|P6|COMPLETED|Extension Stage||73
7911676|NCT00654381|19470097|P5|COMPLETED|Extension Stage||68
7911677|NCT00654381|19470098|P4|COMPLETED|Extension Stage||142
7911678|NCT00654381|19470099|P3|COMPLETED|Extension Stage||142
7911679|NCT00654381|19470100|P2|COMPLETED|Extension Stage||36
7911680|NCT00654381|19470101|P1|COMPLETED|Extension Stage||33
7911681|NCT00654381|19470096|P6|STARTED|Extension Stage||76
7911682|NCT00654381|19470097|P5|STARTED|Extension Stage||71
7911683|NCT00654381|19470098|P4|STARTED|Extension Stage||151
7911684|NCT00654381|19470099|P3|STARTED|Extension Stage||153
7911685|NCT00654381|19470100|P2|STARTED|Extension Stage||38
7911686|NCT00654381|19470101|P1|STARTED|Extension Stage||34
7911687|NCT00654381|19470096|P6|NOT COMPLETED|2nd Stage||3
7911688|NCT00654381|19470097|P5|NOT COMPLETED|2nd Stage||8
7911689|NCT00654381|19470098|P4|NOT COMPLETED|2nd Stage||4
7911690|NCT00654381|19470099|P3|NOT COMPLETED|2nd Stage||3
7911691|NCT00654381|19470100|P2|NOT COMPLETED|2nd Stage||0
7911692|NCT00654381|19470101|P1|NOT COMPLETED|2nd Stage||2
7911693|NCT00654381|19470096|P6|COMPLETED|2nd Stage||76
7911694|NCT00654381|19470097|P5|COMPLETED|2nd Stage||71
7911695|NCT00654381|19470098|P4|COMPLETED|2nd Stage||151
7911696|NCT00654381|19470099|P3|COMPLETED|2nd Stage||153
7911697|NCT00654381|19470100|P2|COMPLETED|2nd Stage||38
7911698|NCT00654381|19470101|P1|COMPLETED|2nd Stage||34
7911699|NCT00654381|19470096|P6|STARTED|2nd Stage||79
7911700|NCT00654381|19470097|P5|STARTED|2nd Stage||79
7911701|NCT00654381|19470098|P4|STARTED|2nd Stage||155
7911702|NCT00654381|19470099|P3|STARTED|2nd Stage||156
7911703|NCT00654381|19470100|P2|STARTED|2nd Stage||38
7911704|NCT00654381|19470101|P1|STARTED|2nd Stage||36
7911705|NCT00654381|19470096|P6|NOT COMPLETED|1st Stage||2
7911706|NCT00654381|19470097|P5|NOT COMPLETED|1st Stage||2
7911707|NCT00654381|19470098|P4|NOT COMPLETED|1st Stage||5
7911708|NCT00654381|19470099|P3|NOT COMPLETED|1st Stage||3
7911709|NCT00654381|19470100|P2|NOT COMPLETED|1st Stage||3
7911710|NCT00654381|19470101|P1|NOT COMPLETED|1st Stage||3
7911711|NCT00654381|19470096|P6|COMPLETED|1st Stage||79
7911712|NCT00654381|19470097|P5|COMPLETED|1st Stage||79
7911713|NCT00654381|19470098|P4|COMPLETED|1st Stage||155
7911714|NCT00654381|19470099|P3|COMPLETED|1st Stage||156
7911715|NCT00654381|19470100|P2|COMPLETED|1st Stage||38
7911716|NCT00654381|19470101|P1|COMPLETED|1st Stage||36
7911717|NCT00654381|19470096|P6|STARTED|1st Stage||81
7911718|NCT00654381|19470097|P5|STARTED|1st Stage||81
7911719|NCT00654381|19470098|P4|STARTED|1st Stage||160
7911720|NCT00654381|19470099|P3|STARTED|1st Stage||159
7911721|NCT00654381|19470100|P2|STARTED|1st Stage||41
7911722|NCT00654381|19470101|P1|STARTED|1st Stage||39
7911723|NCT00654368|19470138|P3|NOT COMPLETED|Overall Study||32
7911724|NCT00654368|19470139|P2|NOT COMPLETED|Overall Study||48
7911725|NCT00654368|19470140|P1|NOT COMPLETED|Overall Study||53
7911726|NCT00654368|19470138|P3|COMPLETED|Overall Study||75
7911727|NCT00654368|19470139|P2|COMPLETED|Overall Study||50
7911728|NCT00654368|19470140|P1|COMPLETED|Overall Study||0
7911729|NCT00654368|19470138|P3|STARTED|Overall Study||107
7911730|NCT00654368|19470139|P2|STARTED|Overall Study||98
7911731|NCT00654368|19470140|P1|STARTED|Overall Study||53
7911732|NCT00654355|19470173|P2|NOT COMPLETED|Overall Study||2
7911733|NCT00654355|19470174|P1|NOT COMPLETED|Overall Study||2
7911734|NCT00654355|19470173|P2|COMPLETED|Overall Study||13
7911735|NCT00654355|19470174|P1|COMPLETED|Overall Study||13
7911736|NCT00654355|19470173|P2|STARTED|Overall Study||15
7911737|NCT00654355|19470174|P1|STARTED|Overall Study||15
7911738|NCT00654329|19470188|P4|NOT COMPLETED|Overall Study||0
7911739|NCT00654329|19470189|P3|NOT COMPLETED|Overall Study||0
7911740|NCT00654329|19470190|P2|NOT COMPLETED|Overall Study||0
7911741|NCT00654329|19470191|P1|NOT COMPLETED|Overall Study||0
7911742|NCT00654329|19470188|P4|COMPLETED|Overall Study||27
7911743|NCT00654329|19470189|P3|COMPLETED|Overall Study||23
7911744|NCT00654329|19470190|P2|COMPLETED|Overall Study||28
7911745|NCT00654329|19470191|P1|COMPLETED|Overall Study||23
7911746|NCT00654329|19470188|P4|STARTED|Overall Study||27
7911747|NCT00654329|19470189|P3|STARTED|Overall Study||23
7911748|NCT00654329|19470190|P2|STARTED|Overall Study||28
7911749|NCT00654329|19470191|P1|STARTED|Overall Study||23
7911750|NCT00654238|19470205|P1|NOT COMPLETED|Overall Study||4
7911751|NCT00654238|19470205|P1|COMPLETED|Overall Study||55
7911752|NCT00654238|19470205|P1|STARTED|Overall Study||59
7911753|NCT00654186|19470210|P1|NOT COMPLETED|Overall Study||5
7911754|NCT00654186|19470210|P1|COMPLETED|Overall Study||27
7911755|NCT00654186|19470210|P1|STARTED|Overall Study||32
7911756|NCT00654147|19470218|P2|NOT COMPLETED|Overall Study||4
7911757|NCT00654147|19470219|P1|NOT COMPLETED|Overall Study||2
7911758|NCT00654147|19470218|P2|COMPLETED|Overall Study||19
7911759|NCT00654147|19470219|P1|COMPLETED|Overall Study||19
7911760|NCT00654147|19470218|P2|STARTED|Overall Study||23
7911761|NCT00654147|19470219|P1|STARTED|Overall Study||21
7911762|NCT00654095|19470235|P1|NOT COMPLETED|Overall Study||32
7911763|NCT00654095|19470235|P1|COMPLETED|Overall Study||114
7911764|NCT00654095|19470235|P1|STARTED|Overall Study||146
7911765|NCT00654069|19470242|P3|NOT COMPLETED|Overall Study||18
7911766|NCT00654069|19470243|P2|NOT COMPLETED|Overall Study||11
7911767|NCT00654069|19470244|P1|NOT COMPLETED|Overall Study||17
7911768|NCT00654069|19470242|P3|COMPLETED|Overall Study||116
7911769|NCT00654069|19470243|P2|COMPLETED|Overall Study||124
7911770|NCT00654069|19470244|P1|COMPLETED|Overall Study||119
7911771|NCT00654069|19470242|P3|STARTED|Overall Study||134
7911772|NCT00654069|19470243|P2|STARTED|Overall Study||135
7911773|NCT00654069|19470244|P1|STARTED|Overall Study||136
7911774|NCT00654030|19470252|P1|NOT COMPLETED|Overall Study||1
7911775|NCT00654030|19470252|P1|COMPLETED|Overall Study||11
7911776|NCT00654030|19470252|P1|STARTED|Overall Study||12
7911777|NCT00654004|19470258|P2|NOT COMPLETED|Overall Study||0
7911778|NCT00654004|19470259|P1|NOT COMPLETED|Overall Study||1
7911779|NCT00654004|19470258|P2|COMPLETED|Overall Study||12
7911780|NCT00654004|19470259|P1|COMPLETED|Overall Study||13
7911781|NCT00654004|19470258|P2|STARTED|Overall Study||12
7911782|NCT00654004|19470259|P1|STARTED|Overall Study||14
7911783|NCT00653991|19470275|P2|NOT COMPLETED|6 Month Follow-up||141
7911784|NCT00653991|19470276|P1|NOT COMPLETED|6 Month Follow-up||133
7911785|NCT00653991|19470275|P2|COMPLETED|6 Month Follow-up||350
7911786|NCT00653991|19470276|P1|COMPLETED|6 Month Follow-up||311
7911787|NCT00653991|19470275|P2|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|491
7911788|NCT00653991|19470276|P1|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|444
7911789|NCT00653991|19470275|P2|NOT COMPLETED|3 Month Follow-up||157
7911790|NCT00653991|19470276|P1|NOT COMPLETED|3 Month Follow-up||150
7911791|NCT00653991|19470275|P2|COMPLETED|3 Month Follow-up||334
7911792|NCT00653991|19470276|P1|COMPLETED|3 Month Follow-up||294
7911793|NCT00653991|19470275|P2|STARTED|3 Month Follow-up||491
7911794|NCT00653991|19470276|P1|STARTED|3 Month Follow-up||444
7911795|NCT00653939|19470288|P2|NOT COMPLETED|Overall Study||15
7911796|NCT00653939|19470289|P1|NOT COMPLETED|Overall Study||12
7911797|NCT00653939|19470288|P2|COMPLETED|Overall Study||17
7911798|NCT00653939|19470289|P1|COMPLETED|Overall Study||19
7911799|NCT00653939|19470288|P2|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32
7911800|NCT00653939|19470289|P1|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31
7911801|NCT00653861|19470305|P1|NOT COMPLETED|Overall Study||0
7911802|NCT00653861|19470305|P1|COMPLETED|Overall Study||72
7911803|NCT00653861|19470305|P1|STARTED|Overall Study||72
7911804|NCT00653523|19470314|P1|NOT COMPLETED|Overall Study||19
7911805|NCT00653523|19470314|P1|COMPLETED|Overall Study||132
7911806|NCT00653523|19470314|P1|STARTED|Overall Study||151
7911807|NCT00653432|19470320|P2|NOT COMPLETED|Overall Study||16
7911808|NCT00653432|19470321|P1|NOT COMPLETED|Overall Study||22
7911809|NCT00653432|19470320|P2|COMPLETED|Overall Study||169
7911810|NCT00653432|19470321|P1|COMPLETED|Overall Study||162
7911811|NCT00653432|19470320|P2|Intend-to-treat ITT|Overall Study|1 of 185 excluded from ITT group for not having at least 1 post-injection visit. ITT=184 subjects|184
7911812|NCT00653432|19470321|P1|Intend-to-treat ITT|Overall Study|3 of 184 excluded from ITT group for not having at least 1 post-injection visit. ITT=181 subjects|181
7911813|NCT00653432|19470320|P2|STARTED|Overall Study||185
7911814|NCT00653432|19470321|P1|STARTED|Overall Study||184
7911815|NCT00653328|19470345|P1|NOT COMPLETED|Overall Study||15
7911816|NCT00653328|19470345|P1|COMPLETED|Overall Study||0
7911817|NCT00653328|19470345|P1|STARTED|Overall Study||15
7911818|NCT00653263|19470352|P1|NOT COMPLETED|Overall Study||2
7911819|NCT00653263|19470352|P1|COMPLETED|Overall Study||6
7911820|NCT00653263|19470352|P1|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8
7911821|NCT00653224|19470360|P2|NOT COMPLETED|Overall Study||7
7911822|NCT00653224|19470361|P1|NOT COMPLETED|Overall Study||7
7911823|NCT00653224|19470360|P2|COMPLETED|Overall Study||280
7911824|NCT00653224|19470361|P1|COMPLETED|Overall Study||286
7911825|NCT00653224|19470360|P2|STARTED|Overall Study||287
7911826|NCT00653224|19470361|P1|STARTED|Overall Study||293
7911827|NCT00653159|19470547|P2|NOT COMPLETED|Overall Study||3
7911828|NCT00653159|19470548|P1|NOT COMPLETED|Overall Study||5
7911829|NCT00653159|19470547|P2|COMPLETED|Overall Study||9
7911830|NCT00653159|19470548|P1|COMPLETED|Overall Study||6
7911831|NCT00653159|19470547|P2|STARTED|Overall Study||12
7911832|NCT00653159|19470548|P1|STARTED|Overall Study||11
7911833|NCT00653133|19470564|P2|NOT COMPLETED|Overall Study||0
7911834|NCT00653133|19470565|P1|NOT COMPLETED|Overall Study||0
7911835|NCT00653133|19470564|P2|COMPLETED|Overall Study||497
7911836|NCT00653133|19470565|P1|COMPLETED|Overall Study||1324
7911837|NCT00653133|19470564|P2|STARTED|Overall Study||497
7911838|NCT00653133|19470565|P1|STARTED|Overall Study||1324
7911839|NCT00653068|19470575|P1|NOT COMPLETED|Overall Study||50
7911840|NCT00653068|19470575|P1|COMPLETED|Overall Study||20
7911841|NCT00653068|19470575|P1|STARTED|Overall Study||70
7911842|NCT00652951|19470589|P3|NOT COMPLETED|Booster Phase||0
7911843|NCT00652951|19470590|P2|NOT COMPLETED|Booster Phase||1
7911844|NCT00652951|19470591|P1|NOT COMPLETED|Booster Phase||1
7911845|NCT00652951|19470589|P3|COMPLETED|Booster Phase||258
7911846|NCT00652951|19470590|P2|COMPLETED|Booster Phase||258
7911847|NCT00652951|19470591|P1|COMPLETED|Booster Phase||256
7911848|NCT00652951|19470589|P3|STARTED|Booster Phase||258
7911849|NCT00652951|19470590|P2|STARTED|Booster Phase||259
7911850|NCT00652951|19470591|P1|STARTED|Booster Phase||257
7911851|NCT00652951|19470589|P3|NOT COMPLETED|Primary Phase||0
7911852|NCT00652951|19470590|P2|NOT COMPLETED|Primary Phase||0
7911853|NCT00652951|19470591|P1|NOT COMPLETED|Primary Phase||0
7911854|NCT00652951|19470589|P3|COMPLETED|Primary Phase||260
7911855|NCT00652951|19470590|P2|COMPLETED|Primary Phase||260
7911856|NCT00652951|19470591|P1|COMPLETED|Primary Phase||260
7911857|NCT00652951|19470589|P3|STARTED|Primary Phase||260
7911858|NCT00652951|19470590|P2|STARTED|Primary Phase||260
7911859|NCT00652951|19470591|P1|STARTED|Primary Phase||260
7911860|NCT00652938|19470728|P3|NOT COMPLETED|Overall Study||5
7911861|NCT00652938|19470729|P2|NOT COMPLETED|Overall Study||7
7911862|NCT00652938|19470730|P1|NOT COMPLETED|Overall Study||1
7911863|NCT00652938|19470728|P3|COMPLETED|Overall Study||242
7911864|NCT00652938|19470729|P2|COMPLETED|Overall Study||240
7911865|NCT00652938|19470730|P1|COMPLETED|Overall Study||246
7911866|NCT00652938|19470728|P3|STARTED|Overall Study||247
7911867|NCT00652938|19470729|P2|STARTED|Overall Study||247
7911868|NCT00652938|19470730|P1|STARTED|Overall Study||247
7911869|NCT00652899|19470795|P1|NOT COMPLETED|Overall Study||2
7911870|NCT00652899|19470795|P1|COMPLETED|Overall Study||12
7911871|NCT00652899|19470795|P1|STARTED|Overall Study||14
7911872|NCT00652834|19470805|P1|NOT COMPLETED|Overall Study||5
7911873|NCT00652834|19470805|P1|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18
7911874|NCT00652834|19470805|P1|STARTED|Overall Study||23
7911875|NCT00652743|19470812|P3|NOT COMPLETED|Months 42-48||0
7911876|NCT00652743|19470813|P2|NOT COMPLETED|Months 42-48||0
7911877|NCT00652743|19470814|P1|NOT COMPLETED|Months 42-48||0
7911878|NCT00652743|19470812|P3|COMPLETED|Months 42-48||367
7911879|NCT00652743|19470813|P2|COMPLETED|Months 42-48||170
7911880|NCT00652743|19470814|P1|COMPLETED|Months 42-48||196
7911881|NCT00652743|19470812|P3|STARTED|Months 42-48||367
7911882|NCT00652743|19470813|P2|STARTED|Months 42-48||170
7911883|NCT00652743|19470814|P1|STARTED|Months 42-48||196
7911884|NCT00652743|19470812|P3|NOT COMPLETED|Months 36-42||9
7911885|NCT00652743|19470813|P2|NOT COMPLETED|Months 36-42||5
7911886|NCT00652743|19470814|P1|NOT COMPLETED|Months 36-42||6
7911887|NCT00652743|19470812|P3|COMPLETED|Months 36-42||381
7911888|NCT00652743|19470813|P2|COMPLETED|Months 36-42||180
7911889|NCT00652743|19470814|P1|COMPLETED|Months 36-42||210
7911890|NCT00652743|19470812|P3|STARTED|Months 36-42||390
7911891|NCT00652743|19470813|P2|STARTED|Months 36-42||185
7911892|NCT00652743|19470814|P1|STARTED|Months 36-42||216
7911893|NCT00652743|19470812|P3|NOT COMPLETED|Months 24-30||11
7911894|NCT00652743|19470813|P2|NOT COMPLETED|Months 24-30||1
7911895|NCT00652743|19470814|P1|NOT COMPLETED|Months 24-30||5
7911896|NCT00652743|19470812|P3|COMPLETED|Months 24-30||422
7911897|NCT00652743|19470813|P2|COMPLETED|Months 24-30||185
7911898|NCT00652743|19470814|P1|COMPLETED|Months 24-30||207
7911899|NCT00652743|19470812|P3|STARTED|Months 24-30||433
7911900|NCT00652743|19470813|P2|STARTED|Months 24-30||186
7911901|NCT00652743|19470814|P1|STARTED|Months 24-30||212
7911902|NCT00652743|19470812|P3|NOT COMPLETED|Months 12-18||7
7911903|NCT00652743|19470813|P2|NOT COMPLETED|Months 12-18||2
7911904|NCT00652743|19470814|P1|NOT COMPLETED|Months 12-18||1
7911905|NCT00652743|19470812|P3|COMPLETED|Months 12-18||430
7911906|NCT00652743|19470813|P2|COMPLETED|Months 12-18||186
7911907|NCT00652743|19470814|P1|COMPLETED|Months 12-18||218
7911908|NCT00652743|19470812|P3|STARTED|Months 12-18||437
7911909|NCT00652743|19470813|P2|STARTED|Months 12-18||188
7911910|NCT00652743|19470814|P1|STARTED|Months 12-18||219
7911911|NCT00652626|19470896|P7|NOT COMPLETED|Extension Phase||3
7911912|NCT00652626|19470897|P6|NOT COMPLETED|Extension Phase||12
7911913|NCT00652626|19470898|P5|NOT COMPLETED|Extension Phase||0
7911914|NCT00652626|19470899|P4|NOT COMPLETED|Extension Phase||0
7911915|NCT00652626|19470900|P3|NOT COMPLETED|Extension Phase||0
7911916|NCT00652626|19470901|P2|NOT COMPLETED|Extension Phase||0
7911917|NCT00652626|19470902|P1|NOT COMPLETED|Extension Phase||0
7911918|NCT00652626|19470896|P7|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1
7911919|NCT00652626|19470897|P6|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2
7911920|NCT00652626|19470898|P5|COMPLETED|Extension Phase||0
7911921|NCT00652626|19470899|P4|COMPLETED|Extension Phase||0
7911922|NCT00652626|19470900|P3|COMPLETED|Extension Phase||0
7911923|NCT00652626|19470901|P2|COMPLETED|Extension Phase||0
7911924|NCT00652626|19470902|P1|COMPLETED|Extension Phase||0
7911925|NCT00652626|19470896|P7|STARTED|Extension Phase||4
7911926|NCT00652626|19470897|P6|STARTED|Extension Phase||14
7911927|NCT00652626|19470898|P5|STARTED|Extension Phase||0
7911928|NCT00652626|19470899|P4|STARTED|Extension Phase||0
7911929|NCT00652626|19470900|P3|STARTED|Extension Phase||0
7911930|NCT00652626|19470901|P2|STARTED|Extension Phase||0
7911931|NCT00652626|19470902|P1|STARTED|Extension Phase||0
7911932|NCT00652626|19470896|P7|NOT COMPLETED|Initial Treatment Phase||0
7911933|NCT00652626|19470897|P6|NOT COMPLETED|Initial Treatment Phase||0
7911934|NCT00652626|19470898|P5|NOT COMPLETED|Initial Treatment Phase||3
7911935|NCT00652626|19470899|P4|NOT COMPLETED|Initial Treatment Phase||1
7911936|NCT00652626|19470900|P3|NOT COMPLETED|Initial Treatment Phase||1
7911937|NCT00652626|19470901|P2|NOT COMPLETED|Initial Treatment Phase||0
7911938|NCT00652626|19470902|P1|NOT COMPLETED|Initial Treatment Phase||0
7911939|NCT00652626|19470896|P7|COMPLETED|Initial Treatment Phase||0
7911940|NCT00652626|19470897|P6|COMPLETED|Initial Treatment Phase||0
7911941|NCT00652626|19470898|P5|COMPLETED|Initial Treatment Phase||5
7911942|NCT00652626|19470899|P4|COMPLETED|Initial Treatment Phase||5
7911943|NCT00652626|19470900|P3|COMPLETED|Initial Treatment Phase||6
7911944|NCT00652626|19470901|P2|COMPLETED|Initial Treatment Phase||5
7911945|NCT00652626|19470902|P1|COMPLETED|Initial Treatment Phase||5
7911946|NCT00652626|19470896|P7|Received Study Drug|Initial Treatment Phase||0
7911947|NCT00652626|19470897|P6|Received Study Drug|Initial Treatment Phase||0
7911948|NCT00652626|19470898|P5|Received Study Drug|Initial Treatment Phase||6
7911949|NCT00652626|19470899|P4|Received Study Drug|Initial Treatment Phase||5
7911950|NCT00652626|19470900|P3|Received Study Drug|Initial Treatment Phase||6
7911951|NCT00652626|19470901|P2|Received Study Drug|Initial Treatment Phase||5
7911952|NCT00652626|19470902|P1|Received Study Drug|Initial Treatment Phase||5
7911953|NCT00652626|19470896|P7|STARTED|Initial Treatment Phase||0
7911954|NCT00652626|19470897|P6|STARTED|Initial Treatment Phase||0
7911955|NCT00652626|19470898|P5|STARTED|Initial Treatment Phase||8
7911956|NCT00652626|19470899|P4|STARTED|Initial Treatment Phase||6
7911957|NCT00652626|19470900|P3|STARTED|Initial Treatment Phase||7
7911958|NCT00652626|19470901|P2|STARTED|Initial Treatment Phase||5
7911959|NCT00652626|19470902|P1|STARTED|Initial Treatment Phase||5
7911960|NCT00652366|19470971|P5|NOT COMPLETED|Overall Study||36
7911961|NCT00652366|19470972|P4|NOT COMPLETED|Overall Study||179
7911962|NCT00652366|19470973|P3|NOT COMPLETED|Overall Study||71
7911963|NCT00652366|19470974|P2|NOT COMPLETED|Overall Study||75
7911964|NCT00652366|19470975|P1|NOT COMPLETED|Overall Study||106
7911965|NCT00652366|19470971|P5|COMPLETED|Overall Study||0
7911966|NCT00652366|19470972|P4|COMPLETED|Overall Study||0
7911967|NCT00652366|19470973|P3|COMPLETED|Overall Study||0
7911968|NCT00652366|19470974|P2|COMPLETED|Overall Study||0
7911969|NCT00652366|19470975|P1|COMPLETED|Overall Study||0
7911970|NCT00652366|19470971|P5|STARTED|Overall Study||36
7911971|NCT00652366|19470972|P4|STARTED|Overall Study||179
7911972|NCT00652366|19470973|P3|STARTED|Overall Study||71
7911973|NCT00652366|19470974|P2|STARTED|Overall Study||75
7911974|NCT00652366|19470975|P1|STARTED|Overall Study||106
7911975|NCT00652340|19471010|P2|NOT COMPLETED|Overall Study||3
7911976|NCT00652340|19471011|P1|NOT COMPLETED|Overall Study||4
7911977|NCT00652340|19471010|P2|COMPLETED|Overall Study|3 patients remained on study at database lock.|39
7911978|NCT00652340|19471011|P1|COMPLETED|Overall Study|4 patients remained on study at database lock.|74
7911979|NCT00652340|19471010|P2|STARTED|Overall Study||42
7911980|NCT00652340|19471011|P1|STARTED|Overall Study||78
7911981|NCT00652327|19471021|P2|NOT COMPLETED|Overall Study||5
7911982|NCT00652327|19471022|P1|NOT COMPLETED|Overall Study||0
7911983|NCT00652327|19471021|P2|COMPLETED|Overall Study||36
7911984|NCT00652327|19471022|P1|COMPLETED|Overall Study||42
7911985|NCT00652327|19471021|P2|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41
7911986|NCT00652327|19471022|P1|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42
7911987|NCT00652314|19471030|P2|NOT COMPLETED|Overall Study||9
7911988|NCT00652314|19471031|P1|NOT COMPLETED|Overall Study||9
7911989|NCT00652314|19471030|P2|COMPLETED|Overall Study||26
7911990|NCT00652314|19471031|P1|COMPLETED|Overall Study||53
7911991|NCT00652314|19471030|P2|STARTED|Overall Study||35
7911992|NCT00652314|19471031|P1|STARTED|Overall Study||62
7911993|NCT00652145|19471047|P2|NOT COMPLETED|Overall Study||0
7911994|NCT00652145|19471048|P1|NOT COMPLETED|Overall Study||0
7911995|NCT00652145|19471047|P2|COMPLETED|Overall Study||26
7911996|NCT00652145|19471048|P1|COMPLETED|Overall Study||26
7911997|NCT00652145|19471047|P2|STARTED|Overall Study||26
7911998|NCT00652145|19471048|P1|STARTED|Overall Study||26
7911999|NCT00652093|19471064|P6|NOT COMPLETED|Overall Study||0
7912000|NCT00652093|19471065|P5|NOT COMPLETED|Overall Study||2
7912001|NCT00652093|19471066|P4|NOT COMPLETED|Overall Study||0
7912002|NCT00652093|19471067|P3|NOT COMPLETED|Overall Study||1
7912003|NCT00652093|19471068|P2|NOT COMPLETED|Overall Study||0
7912004|NCT00652093|19471069|P1|NOT COMPLETED|Overall Study||0
7912005|NCT00652093|19471064|P6|COMPLETED|Overall Study||4
7912006|NCT00652093|19471065|P5|COMPLETED|Overall Study||2
7912007|NCT00652093|19471066|P4|COMPLETED|Overall Study||4
7912008|NCT00652093|19471067|P3|COMPLETED|Overall Study||3
7912009|NCT00652093|19471068|P2|COMPLETED|Overall Study||4
7912010|NCT00652093|19471069|P1|COMPLETED|Overall Study||4
7912011|NCT00652093|19471064|P6|STARTED|Overall Study||4
7912012|NCT00652093|19471065|P5|STARTED|Overall Study||4
7912013|NCT00652093|19471066|P4|STARTED|Overall Study||4
7912014|NCT00652093|19471067|P3|STARTED|Overall Study||4
7912015|NCT00652093|19471068|P2|STARTED|Overall Study||4
7912016|NCT00652093|19471069|P1|STARTED|Overall Study||4
7912017|NCT00652080|19471149|P1|NOT COMPLETED|Overall Study||4
7912018|NCT00652080|19471149|P1|COMPLETED|Overall Study||31
7912019|NCT00652080|19471149|P1|STARTED|Overall Study||35
7912020|NCT00652028|19471159|P4|NOT COMPLETED|Overall Study||0
7912021|NCT00652028|19471160|P3|NOT COMPLETED|Overall Study||1
7912022|NCT00652028|19471161|P2|NOT COMPLETED|Overall Study||1
7912023|NCT00652028|19471162|P1|NOT COMPLETED|Overall Study||1
7912024|NCT00652028|19471159|P4|COMPLETED|Overall Study||14
7912025|NCT00652028|19471160|P3|COMPLETED|Overall Study||14
7912026|NCT00652028|19471161|P2|COMPLETED|Overall Study||13
7912027|NCT00652028|19471162|P1|COMPLETED|Overall Study||15
7912028|NCT00652028|19471159|P4|STARTED|Overall Study||14
7912029|NCT00652028|19471160|P3|STARTED|Overall Study||15
7912030|NCT00652028|19471161|P2|STARTED|Overall Study||14
7912031|NCT00652028|19471162|P1|STARTED|Overall Study||16
7912032|NCT00651937|19471206|P2|NOT COMPLETED|Overall Study||1
7912033|NCT00651937|19471207|P1|NOT COMPLETED|Overall Study||4
7912034|NCT00651937|19471206|P2|COMPLETED|Overall Study||40
7912035|NCT00651937|19471207|P1|COMPLETED|Overall Study||35
7912036|NCT00651937|19471206|P2|STARTED|Overall Study||41
7912037|NCT00651937|19471207|P1|STARTED|Overall Study||39
7912038|NCT00651924|19471217|P2|NOT COMPLETED|Overall Study||7
7912039|NCT00651924|19471218|P1|NOT COMPLETED|Overall Study||0
7912040|NCT00651924|19471217|P2|COMPLETED|Overall Study||2
7912041|NCT00651924|19471218|P1|COMPLETED|Overall Study||18
7912042|NCT00651924|19471217|P2|STARTED|Overall Study||9
7912043|NCT00651924|19471218|P1|STARTED|Overall Study||18
7912044|NCT00651820|19471224|P1|NOT COMPLETED|Overall Study||2
7912045|NCT00651820|19471224|P1|COMPLETED|Overall Study||26
7912046|NCT00651820|19471224|P1|STARTED|Overall Study||28
7912047|NCT00651794|19471234|P3|NOT COMPLETED|Overall Study||21
7912048|NCT00651794|19471235|P2|NOT COMPLETED|Overall Study||22
7912049|NCT00651794|19471236|P1|NOT COMPLETED|Overall Study||21
7912050|NCT00651794|19471234|P3|COMPLETED|Overall Study||10
7912051|NCT00651794|19471235|P2|COMPLETED|Overall Study||9
7912052|NCT00651794|19471236|P1|COMPLETED|Overall Study||15
7912053|NCT00651794|19471234|P3|STARTED|Overall Study||31
7912054|NCT00651794|19471235|P2|STARTED|Overall Study||31
7912055|NCT00651794|19471236|P1|STARTED|Overall Study||36
7912056|NCT00651755|19471256|P2|NOT COMPLETED|Cycle 2 (Second 21 Days)||1
7912057|NCT00651755|19471257|P1|NOT COMPLETED|Cycle 2 (Second 21 Days)||0
7912058|NCT00651755|19471256|P2|COMPLETED|Cycle 2 (Second 21 Days)||8
7912059|NCT00651755|19471257|P1|COMPLETED|Cycle 2 (Second 21 Days)||10
7912060|NCT00651755|19471256|P2|STARTED|Cycle 2 (Second 21 Days)||9
7912061|NCT00651755|19471257|P1|STARTED|Cycle 2 (Second 21 Days)||10
7912062|NCT00651755|19471256|P2|NOT COMPLETED|Cycle 1 (First 21 Days)||0
7912063|NCT00651755|19471257|P1|NOT COMPLETED|Cycle 1 (First 21 Days)||1
7912064|NCT00651755|19471256|P2|COMPLETED|Cycle 1 (First 21 Days)||9
7912065|NCT00651755|19471257|P1|COMPLETED|Cycle 1 (First 21 Days)||10
7912066|NCT00651755|19471256|P2|STARTED|Cycle 1 (First 21 Days)||9
7912067|NCT00651755|19471257|P1|STARTED|Cycle 1 (First 21 Days)||11
7912068|NCT00651664|19471283|P10|NOT COMPLETED|Overall Study||7
7912069|NCT00651664|19471284|P9|NOT COMPLETED|Overall Study||7
7912070|NCT00651664|19471285|P8|NOT COMPLETED|Overall Study||7
7912071|NCT00651664|19471286|P7|NOT COMPLETED|Overall Study||6
7912072|NCT00651664|19471287|P6|NOT COMPLETED|Overall Study||3
7912073|NCT00651664|19471288|P5|NOT COMPLETED|Overall Study||6
7912074|NCT00651664|19471289|P4|NOT COMPLETED|Overall Study||14
7912075|NCT00651664|19471290|P3|NOT COMPLETED|Overall Study||3
7912076|NCT00651664|19471291|P2|NOT COMPLETED|Overall Study||3
7912077|NCT00651664|19471292|P1|NOT COMPLETED|Overall Study||3
7912078|NCT00651664|19471283|P10|COMPLETED|Overall Study||0
7912079|NCT00651664|19471284|P9|COMPLETED|Overall Study||0
7912080|NCT00651664|19471285|P8|COMPLETED|Overall Study||0
7912081|NCT00651664|19471286|P7|COMPLETED|Overall Study||0
7912082|NCT00651664|19471287|P6|COMPLETED|Overall Study||0
7912083|NCT00651664|19471288|P5|COMPLETED|Overall Study||0
7912084|NCT00651664|19471289|P4|COMPLETED|Overall Study||0
7912085|NCT00651664|19471290|P3|COMPLETED|Overall Study||0
7912086|NCT00651664|19471291|P2|COMPLETED|Overall Study||0
7912087|NCT00651664|19471292|P1|COMPLETED|Overall Study||0
7912088|NCT00651664|19471283|P10|STARTED|Overall Study||7
7912089|NCT00651664|19471284|P9|STARTED|Overall Study||7
7912090|NCT00651664|19471285|P8|STARTED|Overall Study||7
7912091|NCT00651664|19471286|P7|STARTED|Overall Study||6
7912092|NCT00651664|19471287|P6|STARTED|Overall Study||3
7912093|NCT00651664|19471288|P5|STARTED|Overall Study||6
7912094|NCT00651664|19471289|P4|STARTED|Overall Study||14
7912095|NCT00651664|19471290|P3|STARTED|Overall Study||3
7912096|NCT00651664|19471291|P2|STARTED|Overall Study||3
7912097|NCT00651664|19471292|P1|STARTED|Overall Study||3
7912098|NCT00651625|19471418|P2|NOT COMPLETED|Overall Study||0
7912099|NCT00651625|19471419|P1|NOT COMPLETED|Overall Study||0
7912100|NCT00651625|19471418|P2|COMPLETED|Overall Study||218
7912101|NCT00651625|19471419|P1|COMPLETED|Overall Study||219
7912102|NCT00651625|19471418|P2|STARTED|Overall Study||218
7912103|NCT00651625|19471419|P1|STARTED|Overall Study||219
7912104|NCT00651573|19471433|P2|NOT COMPLETED|Overall Study||3
7912105|NCT00651573|19471434|P1|NOT COMPLETED|Overall Study||2
7912106|NCT00651573|19471433|P2|COMPLETED|Overall Study||354
7912107|NCT00651573|19471434|P1|COMPLETED|Overall Study||363
7912108|NCT00651573|19471433|P2|STARTED|Overall Study||357
7912109|NCT00651573|19471434|P1|STARTED|Overall Study||365
7912110|NCT00651482|19471450|P1|NOT COMPLETED|Overall Study||0
7912111|NCT00651482|19471450|P1|COMPLETED|Overall Study||10
7912112|NCT00651482|19471450|P1|STARTED|Overall Study||10
7912113|NCT00651313|19471464|P2|NOT COMPLETED|Overall Study||6
7912114|NCT00651313|19471465|P1|NOT COMPLETED|Overall Study||6
7912115|NCT00651313|19471464|P2|COMPLETED|Overall Study||37
7912116|NCT00651313|19471465|P1|COMPLETED|Overall Study||35
7912117|NCT00651313|19471464|P2|STARTED|Overall Study||43
7912118|NCT00651313|19471465|P1|STARTED|Overall Study||41
7912119|NCT00651261|19471473|P2|NOT COMPLETED|Overall Study||306
7912120|NCT00651261|19471474|P1|NOT COMPLETED|Overall Study||291
7912121|NCT00651261|19471473|P2|COMPLETED|Overall Study||51
7912122|NCT00651261|19471474|P1|COMPLETED|Overall Study||69
7912123|NCT00651261|19471473|P2|STARTED|Overall Study||357
7912124|NCT00651261|19471474|P1|STARTED|Overall Study||360
7912125|NCT00651183|19471490|P2|NOT COMPLETED|Overall Study||10
7912126|NCT00651183|19471491|P1|NOT COMPLETED|Overall Study||20
7912127|NCT00651183|19471490|P2|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87
7912128|NCT00651183|19471491|P1|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169
7912129|NCT00651183|19471490|P2|STARTED|Overall Study||97
7912130|NCT00651183|19471491|P1|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189
7912131|NCT00651157|19471503|P1|NOT COMPLETED|Overall Study||2
7912132|NCT00651157|19471503|P1|COMPLETED|Overall Study||21
7912133|NCT00651157|19471503|P1|STARTED|Overall Study||23
7912134|NCT00651118|19471513|P4|NOT COMPLETED|Overall Study||7
7912135|NCT00651118|19471514|P3|NOT COMPLETED|Overall Study||11
7912136|NCT00651118|19471515|P2|NOT COMPLETED|Overall Study||7
7912137|NCT00651118|19471516|P1|NOT COMPLETED|Overall Study||9
7912138|NCT00651118|19471513|P4|COMPLETED|Overall Study||203
7912139|NCT00651118|19471514|P3|COMPLETED|Overall Study||197
7912140|NCT00651118|19471515|P2|COMPLETED|Overall Study||200
7912141|NCT00651118|19471516|P1|COMPLETED|Overall Study||198
7912142|NCT00651118|19471513|P4|STARTED|Overall Study||210
7912143|NCT00651118|19471514|P3|STARTED|Overall Study||208
7912144|NCT00651118|19471515|P2|STARTED|Overall Study||207
7912145|NCT00651118|19471516|P1|STARTED|Overall Study||207
7912146|NCT00651040|19471536|P2|NOT COMPLETED|Overall Study||1
7912147|NCT00651040|19471537|P1|NOT COMPLETED|Overall Study||3
7912148|NCT00651040|19471536|P2|COMPLETED|Overall Study||14
7912149|NCT00651040|19471537|P1|COMPLETED|Overall Study||13
7912150|NCT00651040|19471536|P2|STARTED|Overall Study||15
7912151|NCT00651040|19471537|P1|STARTED|Overall Study||16
7912152|NCT00650936|19471543|P1|NOT COMPLETED|Overall Study||70
7912153|NCT00650936|19471543|P1|COMPLETED|Overall Study||930
7912154|NCT00650936|19471543|P1|STARTED|Overall Study||1000
7912155|NCT00650858|19471552|P3|NOT COMPLETED|Overall Study||0
7912156|NCT00650858|19471553|P2|NOT COMPLETED|Overall Study||0
7912157|NCT00650858|19471554|P1|NOT COMPLETED|Overall Study||0
7912158|NCT00650858|19471552|P3|COMPLETED|Overall Study||36
7912159|NCT00650858|19471553|P2|COMPLETED|Overall Study||8
7912160|NCT00650858|19471554|P1|COMPLETED|Overall Study||8
7912161|NCT00650858|19471552|P3|STARTED|Overall Study||36
7912162|NCT00650858|19471553|P2|STARTED|Overall Study||8
7912163|NCT00650858|19471554|P1|STARTED|Overall Study||8
7912164|NCT00650845|19471585|P2|NOT COMPLETED|Overall Study||13
7912165|NCT00650845|19471586|P1|NOT COMPLETED|Overall Study||5
7912166|NCT00650845|19471585|P2|COMPLETED|Overall Study||44
7912167|NCT00650845|19471586|P1|COMPLETED|Overall Study||70
7912168|NCT00650845|19471585|P2|STARTED|Overall Study||57
7912169|NCT00650845|19471586|P1|STARTED|Overall Study||75
7912170|NCT00650806|19471606|P4|NOT COMPLETED|Overall Study||26
7912171|NCT00650806|19471607|P3|NOT COMPLETED|Overall Study||29
7912172|NCT00650806|19471608|P2|NOT COMPLETED|Overall Study||21
7912173|NCT00650806|19471609|P1|NOT COMPLETED|Overall Study||18
7912174|NCT00650806|19471606|P4|COMPLETED|Overall Study||70
7912175|NCT00650806|19471607|P3|COMPLETED|Overall Study||64
7912176|NCT00650806|19471608|P2|COMPLETED|Overall Study||77
7912177|NCT00650806|19471609|P1|COMPLETED|Overall Study||71
7912178|NCT00650806|19471606|P4|STARTED|Overall Study||96
7912179|NCT00650806|19471607|P3|STARTED|Overall Study||93
7912180|NCT00650806|19471608|P2|STARTED|Overall Study||98
7912181|NCT00650806|19471609|P1|STARTED|Overall Study||89
7912182|NCT00650767|19471651|P4|NOT COMPLETED|Overall Study||11
7912183|NCT00650767|19471652|P3|NOT COMPLETED|Overall Study||14
7912184|NCT00650767|19471653|P2|NOT COMPLETED|Overall Study||9
7912185|NCT00650767|19471654|P1|NOT COMPLETED|Overall Study||5
7912186|NCT00650767|19471651|P4|COMPLETED|Overall Study||39
7912187|NCT00650767|19471652|P3|COMPLETED|Overall Study||36
7912188|NCT00650767|19471653|P2|COMPLETED|Overall Study||41
7912189|NCT00650767|19471654|P1|COMPLETED|Overall Study||46
7912190|NCT00650767|19471651|P4|STARTED|Overall Study||50
7912191|NCT00650767|19471652|P3|STARTED|Overall Study||50
7912192|NCT00650767|19471653|P2|STARTED|Overall Study||50
7912193|NCT00650767|19471654|P1|STARTED|Overall Study||51
7912194|NCT00650585|19472158|P2|NOT COMPLETED|Overall Study||1477
7912195|NCT00650585|19472159|P1|NOT COMPLETED|Overall Study||1797
7912196|NCT00650585|19472158|P2|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513
7912197|NCT00650585|19472159|P1|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551
7912198|NCT00650585|19472158|P2|STARTED|Overall Study||3990
7912199|NCT00650585|19472159|P1|STARTED|Overall Study||4348
7912200|NCT00650546|19472179|P1|NOT COMPLETED|Overall Study||0
7912201|NCT00650546|19472179|P1|COMPLETED|Overall Study||8
7912202|NCT00650546|19472179|P1|STARTED|Overall Study||8
7912203|NCT00650260|19472186|P2|NOT COMPLETED|Overall Study||0
7912204|NCT00650260|19472187|P1|NOT COMPLETED|Overall Study||0
7912205|NCT00650260|19472186|P2|COMPLETED|Overall Study||21
7912206|NCT00650260|19472187|P1|COMPLETED|Overall Study||21
7912207|NCT00650260|19472186|P2|STARTED|Overall Study||21
7912208|NCT00650260|19472187|P1|STARTED|Overall Study||21
7912209|NCT00650104|19472203|P1|NOT COMPLETED|Overall Study||41
7912210|NCT00650104|19472203|P1|COMPLETED|Overall Study||42
7912211|NCT00650104|19472203|P1|STARTED|Overall Study||83
7912212|NCT00650091|19472218|P3|NOT COMPLETED|Amended Study Design||0
7912213|NCT00650091|19472219|P2|NOT COMPLETED|Amended Study Design||20
7912214|NCT00650091|19472220|P1|NOT COMPLETED|Amended Study Design||23
7912215|NCT00650091|19472218|P3|COMPLETED|Amended Study Design||0
7912216|NCT00650091|19472219|P2|COMPLETED|Amended Study Design||111
7912217|NCT00650091|19472220|P1|COMPLETED|Amended Study Design||110
7912218|NCT00650091|19472218|P3|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0
7912219|NCT00650091|19472219|P2|STARTED|Amended Study Design||131
7912220|NCT00650091|19472220|P1|STARTED|Amended Study Design||133
7912221|NCT00650091|19472218|P3|NOT COMPLETED|Initial Study Design - Interim Analysis||0
7912222|NCT00650091|19472219|P2|NOT COMPLETED|Initial Study Design - Interim Analysis||0
7912223|NCT00650091|19472220|P1|NOT COMPLETED|Initial Study Design - Interim Analysis||0
7912224|NCT00650091|19472218|P3|COMPLETED|Initial Study Design - Interim Analysis||77
7912225|NCT00650091|19472219|P2|COMPLETED|Initial Study Design - Interim Analysis||78
7912226|NCT00650091|19472220|P1|COMPLETED|Initial Study Design - Interim Analysis||81
7912227|NCT00650091|19472218|P3|STARTED|Initial Study Design - Interim Analysis||77
7912228|NCT00650091|19472219|P2|STARTED|Initial Study Design - Interim Analysis||78
7912229|NCT00650091|19472220|P1|STARTED|Initial Study Design - Interim Analysis||81
7912230|NCT00650078|19472240|P2|NOT COMPLETED|Overall Study||13
7912231|NCT00650078|19472241|P1|NOT COMPLETED|Overall Study||14
7912232|NCT00650078|19472240|P2|COMPLETED|Overall Study||106
7912233|NCT00650078|19472241|P1|COMPLETED|Overall Study||217
7912234|NCT00650078|19472240|P2|STARTED|Overall Study||119
7912235|NCT00650078|19472241|P1|STARTED|Overall Study||231
7912236|NCT00649961|19472249|P1|NOT COMPLETED|Overall Study||0
7912237|NCT00649961|19472249|P1|COMPLETED|Overall Study||18
7912238|NCT00649961|19472249|P1|STARTED|Overall Study||18
7912239|NCT00649792|19472253|P1|NOT COMPLETED|Overall Study||68
7912240|NCT00649792|19472253|P1|COMPLETED|Overall Study||146
7912241|NCT00649792|19472253|P1|STARTED|Overall Study||214
7912242|NCT00649428|19472263|P2|NOT COMPLETED|Overall Study||15
7912243|NCT00649428|19472264|P1|NOT COMPLETED|Overall Study||20
7912244|NCT00649428|19472263|P2|COMPLETED|Overall Study||88
7912245|NCT00649428|19472264|P1|COMPLETED|Overall Study||80
7912246|NCT00649428|19472263|P2|STARTED|Overall Study||103
7912247|NCT00649428|19472264|P1|STARTED|Overall Study||100
7912248|NCT00649389|19472280|P4|NOT COMPLETED|Overall Study||111
7912249|NCT00649389|19472281|P3|NOT COMPLETED|Overall Study||88
7912250|NCT00649389|19472282|P2|NOT COMPLETED|Overall Study||106
7912251|NCT00649389|19472283|P1|NOT COMPLETED|Overall Study||71
7912252|NCT00649389|19472280|P4|COMPLETED|Overall Study||516
7912253|NCT00649389|19472281|P3|COMPLETED|Overall Study||512
7912254|NCT00649389|19472282|P2|COMPLETED|Overall Study||531
7912255|NCT00649389|19472283|P1|COMPLETED|Overall Study||557
7912256|NCT00649389|19472280|P4|STARTED|Overall Study||627
7912257|NCT00649389|19472281|P3|STARTED|Overall Study||600
7912258|NCT00649389|19472282|P2|STARTED|Overall Study||637
7912259|NCT00649389|19472283|P1|STARTED|Overall Study||628
7912260|NCT00649220|19472305|P1|NOT COMPLETED|Overall Study||3
7912261|NCT00649220|19472305|P1|COMPLETED|Overall Study||16
7912262|NCT00649220|19472305|P1|STARTED|Overall Study||19
7912263|NCT00648908|19472316|P1|NOT COMPLETED|Overall Study||115
7912264|NCT00648908|19472316|P1|COMPLETED|Overall Study||154
7912265|NCT00648908|19472316|P1|STARTED|Overall Study||269
7912266|NCT00648895|19472326|P2|NOT COMPLETED|Overall Study||1
7912267|NCT00648895|19472327|P1|NOT COMPLETED|Overall Study||0
7912268|NCT00648895|19472326|P2|COMPLETED|Overall Study||5
7912269|NCT00648895|19472327|P1|COMPLETED|Overall Study||6
7912270|NCT00648895|19472326|P2|STARTED|Overall Study||6
7912271|NCT00648895|19472327|P1|STARTED|Overall Study||6
7912272|NCT00648739|19472333|P7|NOT COMPLETED|Overall Study||1
7912273|NCT00648739|19472334|P6|NOT COMPLETED|Overall Study||5
7912274|NCT00648739|19472335|P5|NOT COMPLETED|Overall Study||2
7912275|NCT00648739|19472336|P4|NOT COMPLETED|Overall Study||2
7912276|NCT00648739|19472337|P3|NOT COMPLETED|Overall Study||3
7912277|NCT00648739|19472338|P2|NOT COMPLETED|Overall Study||2
7912278|NCT00648739|19472339|P1|NOT COMPLETED|Overall Study||2
7912279|NCT00648739|19472333|P7|COMPLETED|Overall Study||0
7912280|NCT00648739|19472334|P6|COMPLETED|Overall Study||2
7912281|NCT00648739|19472335|P5|COMPLETED|Overall Study||1
7912282|NCT00648739|19472336|P4|COMPLETED|Overall Study||1
7912283|NCT00648739|19472337|P3|COMPLETED|Overall Study||0
7912284|NCT00648739|19472338|P2|COMPLETED|Overall Study||3
7912285|NCT00648739|19472339|P1|COMPLETED|Overall Study||2
7912286|NCT00648739|19472333|P7|Received at Least 1 Dose of Study Drug|Overall Study||1
7912287|NCT00648739|19472334|P6|Received at Least 1 Dose of Study Drug|Overall Study||7
7912288|NCT00648739|19472335|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
7912289|NCT00648739|19472336|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
7912290|NCT00648739|19472337|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
7912291|NCT00648739|19472338|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
7912292|NCT00648739|19472339|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
7912293|NCT00648739|19472333|P7|STARTED|Overall Study||1
7912294|NCT00648739|19472334|P6|STARTED|Overall Study||7
7912295|NCT00648739|19472335|P5|STARTED|Overall Study||3
7912296|NCT00648739|19472336|P4|STARTED|Overall Study||3
7912297|NCT00648739|19472337|P3|STARTED|Overall Study||3
7912298|NCT00648739|19472338|P2|STARTED|Overall Study||5
7912299|NCT00648739|19472339|P1|STARTED|Overall Study||4
7912300|NCT00648648|19472405|P28|NOT COMPLETED|Overall Study||12
7912301|NCT00648648|19472406|P27|NOT COMPLETED|Overall Study||26
7912302|NCT00648648|19472407|P26|NOT COMPLETED|Overall Study||4
7912303|NCT00648648|19472408|P25|NOT COMPLETED|Overall Study||4
7912304|NCT00648648|19472409|P24|NOT COMPLETED|Overall Study||4
7912305|NCT00648648|19472410|P23|NOT COMPLETED|Overall Study||14
7912306|NCT00648648|19472411|P22|NOT COMPLETED|Overall Study||10
7912307|NCT00648648|19472412|P21|NOT COMPLETED|Overall Study||6
7912308|NCT00648648|19472413|P20|NOT COMPLETED|Overall Study||7
7912309|NCT00648648|19472414|P19|NOT COMPLETED|Overall Study||5
7912310|NCT00648648|19472415|P18|NOT COMPLETED|Overall Study||6
7912311|NCT00648648|19472416|P17|NOT COMPLETED|Overall Study||14
7912312|NCT00648648|19472417|P16|NOT COMPLETED|Overall Study||11
7912313|NCT00648648|19472418|P15|NOT COMPLETED|Overall Study||4
7912314|NCT00648648|19472419|P14|NOT COMPLETED|Overall Study||5
7912315|NCT00648648|19472420|P13|NOT COMPLETED|Overall Study||6
7912316|NCT00648648|19472421|P12|NOT COMPLETED|Overall Study||13
7912317|NCT00648648|19472422|P11|NOT COMPLETED|Overall Study||6
7912318|NCT00648648|19472423|P10|NOT COMPLETED|Overall Study||10
7912319|NCT00648648|19472424|P9|NOT COMPLETED|Overall Study||3
7912320|NCT00648648|19472425|P8|NOT COMPLETED|Overall Study||1
7912321|NCT00648648|19472426|P7|NOT COMPLETED|Overall Study||10
7912322|NCT00648648|19472427|P6|NOT COMPLETED|Overall Study||1
7912323|NCT00648648|19472428|P5|NOT COMPLETED|Overall Study||9
7912324|NCT00648648|19472429|P4|NOT COMPLETED|Overall Study||4
7912325|NCT00648648|19472430|P3|NOT COMPLETED|Overall Study||0
7912326|NCT00648648|19472431|P2|NOT COMPLETED|Overall Study||0
7912327|NCT00648648|19472432|P1|NOT COMPLETED|Overall Study||0
7912328|NCT00648648|19472405|P28|COMPLETED|Overall Study||0
7912329|NCT00648648|19472406|P27|COMPLETED|Overall Study||0
7912330|NCT00648648|19472407|P26|COMPLETED|Overall Study||0
7912331|NCT00648648|19472408|P25|COMPLETED|Overall Study||0
7912332|NCT00648648|19472409|P24|COMPLETED|Overall Study||0
7912333|NCT00648648|19472410|P23|COMPLETED|Overall Study||0
7912334|NCT00648648|19472411|P22|COMPLETED|Overall Study||0
7912335|NCT00648648|19472412|P21|COMPLETED|Overall Study||0
7912336|NCT00648648|19472413|P20|COMPLETED|Overall Study||0
7912337|NCT00648648|19472414|P19|COMPLETED|Overall Study||0
7912338|NCT00648648|19472415|P18|COMPLETED|Overall Study||0
7912339|NCT00648648|19472416|P17|COMPLETED|Overall Study||2
7912340|NCT00648648|19472417|P16|COMPLETED|Overall Study||0
7912341|NCT00648648|19472418|P15|COMPLETED|Overall Study||0
7912342|NCT00648648|19472419|P14|COMPLETED|Overall Study||0
7912343|NCT00648648|19472420|P13|COMPLETED|Overall Study||0
7912344|NCT00648648|19472421|P12|COMPLETED|Overall Study||0
7912345|NCT00648648|19472422|P11|COMPLETED|Overall Study||0
7912346|NCT00648648|19472423|P10|COMPLETED|Overall Study||0
7912347|NCT00648648|19472424|P9|COMPLETED|Overall Study||0
7912348|NCT00648648|19472425|P8|COMPLETED|Overall Study||0
7912349|NCT00648648|19472426|P7|COMPLETED|Overall Study||0
7912350|NCT00648648|19472427|P6|COMPLETED|Overall Study||0
7912351|NCT00648648|19472428|P5|COMPLETED|Overall Study||0
7912352|NCT00648648|19472429|P4|COMPLETED|Overall Study||0
7912353|NCT00648648|19472430|P3|COMPLETED|Overall Study||3
7912354|NCT00648648|19472431|P2|COMPLETED|Overall Study||3
7912355|NCT00648648|19472432|P1|COMPLETED|Overall Study||3
7912356|NCT00648648|19472405|P28|Treated|Overall Study||12
7912357|NCT00648648|19472406|P27|Treated|Overall Study||26
7912358|NCT00648648|19472407|P26|Treated|Overall Study||4
7912359|NCT00648648|19472408|P25|Treated|Overall Study||4
7912360|NCT00648648|19472409|P24|Treated|Overall Study||4
7912361|NCT00648648|19472410|P23|Treated|Overall Study||14
7912362|NCT00648648|19472411|P22|Treated|Overall Study||10
7912363|NCT00648648|19472412|P21|Treated|Overall Study||6
7912364|NCT00648648|19472413|P20|Treated|Overall Study||7
7912365|NCT00648648|19472414|P19|Treated|Overall Study||4
7912366|NCT00648648|19472415|P18|Treated|Overall Study||6
7912367|NCT00648648|19472416|P17|Treated|Overall Study||16
7912368|NCT00648648|19472417|P16|Treated|Overall Study||11
7912369|NCT00648648|19472418|P15|Treated|Overall Study||4
7912370|NCT00648648|19472419|P14|Treated|Overall Study||5
7912371|NCT00648648|19472420|P13|Treated|Overall Study||6
7912372|NCT00648648|19472421|P12|Treated|Overall Study||13
7912373|NCT00648648|19472422|P11|Treated|Overall Study||6
7912374|NCT00648648|19472423|P10|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
7912375|NCT00648648|19472424|P9|Treated|Overall Study|Does not include one Part 1 participant who was treated in this arm.|3
7912376|NCT00648648|19472425|P8|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
7912377|NCT00648648|19472426|P7|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
7912378|NCT00648648|19472427|P6|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
7912379|NCT00648648|19472428|P5|Treated|Overall Study||8
7912380|NCT00648648|19472429|P4|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|4
7912381|NCT00648648|19472430|P3|Treated|Overall Study||3
7912382|NCT00648648|19472431|P2|Treated|Overall Study||3
7912383|NCT00648648|19472432|P1|Treated|Overall Study||3
7912384|NCT00648648|19472405|P28|STARTED|Overall Study||12
7912385|NCT00648648|19472406|P27|STARTED|Overall Study||26
7912386|NCT00648648|19472407|P26|STARTED|Overall Study||4
7912387|NCT00648648|19472408|P25|STARTED|Overall Study||4
7912388|NCT00648648|19472409|P24|STARTED|Overall Study||4
7912389|NCT00648648|19472410|P23|STARTED|Overall Study||14
7912390|NCT00648648|19472411|P22|STARTED|Overall Study||10
7912391|NCT00648648|19472412|P21|STARTED|Overall Study||6
7912392|NCT00648648|19472413|P20|STARTED|Overall Study||7
7912393|NCT00648648|19472414|P19|STARTED|Overall Study||5
7912394|NCT00648648|19472415|P18|STARTED|Overall Study||6
7912395|NCT00648648|19472416|P17|STARTED|Overall Study||16
7912396|NCT00648648|19472417|P16|STARTED|Overall Study||11
7912397|NCT00648648|19472418|P15|STARTED|Overall Study||4
7912398|NCT00648648|19472419|P14|STARTED|Overall Study||5
7912399|NCT00648648|19472420|P13|STARTED|Overall Study||6
7912400|NCT00648648|19472421|P12|STARTED|Overall Study||13
7912401|NCT00648648|19472422|P11|STARTED|Overall Study||6
7912402|NCT00648648|19472423|P10|STARTED|Overall Study||10
7912403|NCT00648648|19472424|P9|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|3
7912404|NCT00648648|19472425|P8|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
7912405|NCT00648648|19472426|P7|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|10
7912406|NCT00648648|19472427|P6|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
7912407|NCT00648648|19472428|P5|STARTED|Overall Study||9
7912408|NCT00648648|19472429|P4|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|4
7912409|NCT00648648|19472430|P3|STARTED|Overall Study||3
7912410|NCT00648648|19472431|P2|STARTED|Overall Study||3
7912411|NCT00648648|19472432|P1|STARTED|Overall Study||3
7912412|NCT00648375|19472660|P2|NOT COMPLETED|Overall Study||0
7912413|NCT00648375|19472661|P1|NOT COMPLETED|Overall Study||0
7912414|NCT00648375|19472660|P2|COMPLETED|Overall Study||2
7912415|NCT00648375|19472661|P1|COMPLETED|Overall Study||1
7912416|NCT00648375|19472660|P2|STARTED|Overall Study||2
7912417|NCT00648375|19472661|P1|STARTED|Overall Study||1
7912418|NCT00648167|19472673|P1|NOT COMPLETED|Overall Study||7
7912419|NCT00648167|19472673|P1|COMPLETED|Overall Study||48
7912420|NCT00648167|19472673|P1|Start Dose 6 g/Day|Overall Study||21
7912421|NCT00648167|19472673|P1|Start Dose 4.5 g/Day|Overall Study||34
7912422|NCT00648167|19472673|P1|STARTED|Overall Study||55
7912423|NCT00648115|19472680|P3|NOT COMPLETED|Overall Study||0
7912424|NCT00648115|19472681|P2|NOT COMPLETED|Overall Study||0
7912425|NCT00648115|19472682|P1|NOT COMPLETED|Overall Study||0
7912426|NCT00648115|19472680|P3|COMPLETED|Overall Study||27
7912427|NCT00648115|19472681|P2|COMPLETED|Overall Study||42
7912428|NCT00648115|19472682|P1|COMPLETED|Overall Study||42
7912429|NCT00648115|19472680|P3|STARTED|Overall Study||27
7912430|NCT00648115|19472681|P2|STARTED|Overall Study||42
7912431|NCT00648115|19472682|P1|STARTED|Overall Study||42
7912432|NCT00648037|19472693|P1|NOT COMPLETED|Overall Study||16
7912433|NCT00648037|19472693|P1|COMPLETED|Overall Study||10
7912434|NCT00648037|19472693|P1|STARTED|Overall Study||26
7912435|NCT00647998|19472699|P2|NOT COMPLETED|Overall Study||0
7912436|NCT00647998|19472700|P1|NOT COMPLETED|Overall Study||0
7912437|NCT00647998|19472699|P2|COMPLETED|Overall Study||9
7912438|NCT00647998|19472700|P1|COMPLETED|Overall Study||9
7912439|NCT00647998|19472699|P2|STARTED|Overall Study||9
7912440|NCT00647998|19472700|P1|STARTED|Overall Study||9
7912441|NCT00647699|19472712|P2|NOT COMPLETED|Overall Study||12
7912442|NCT00647699|19472713|P1|NOT COMPLETED|Overall Study||8
7912443|NCT00647699|19472712|P2|COMPLETED|Overall Study||62
7912444|NCT00647699|19472713|P1|COMPLETED|Overall Study||65
7912445|NCT00647699|19472712|P2|STARTED|Overall Study||74
7912446|NCT00647699|19472713|P1|STARTED|Overall Study||73
7912447|NCT00647556|19472721|P2|NOT COMPLETED|Overall Study||2
7912448|NCT00647556|19472722|P1|NOT COMPLETED|Overall Study||3
7912449|NCT00647556|19472721|P2|COMPLETED|Overall Study||13
7912450|NCT00647556|19472722|P1|COMPLETED|Overall Study||12
7912451|NCT00647556|19472721|P2|STARTED|Overall Study||15
7912452|NCT00647556|19472722|P1|STARTED|Overall Study||15
7912453|NCT00647426|19472736|P1|NOT COMPLETED|Overall Study||2
7912454|NCT00647426|19472736|P1|COMPLETED|Overall Study||5
7912455|NCT00647426|19472736|P1|STARTED|Overall Study||7
7912456|NCT00647400|19472745|P2|NOT COMPLETED|Overall Study||13
7912457|NCT00647400|19472746|P1|NOT COMPLETED|Overall Study||22
7912458|NCT00647400|19472745|P2|COMPLETED|Overall Study||45
7912459|NCT00647400|19472746|P1|COMPLETED|Overall Study||67
7912460|NCT00647400|19472745|P2|STARTED|Overall Study||58
7912461|NCT00647400|19472746|P1|STARTED|Overall Study||89
7912462|NCT00647348|19472758|P2|NOT COMPLETED|Overall Study||6
7912463|NCT00647348|19472759|P1|NOT COMPLETED|Overall Study||3
7912464|NCT00647348|19472758|P2|COMPLETED|Overall Study||64
7912465|NCT00647348|19472759|P1|COMPLETED|Overall Study||67
7912466|NCT00647348|19472758|P2|STARTED|Overall Study||70
7912467|NCT00647348|19472759|P1|STARTED|Overall Study||70
7912468|NCT00647270|19472784|P3|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7
7912469|NCT00647270|19472785|P2|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9
7912470|NCT00647270|19472786|P1|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3
7912471|NCT00647270|19472784|P3|COMPLETED|Period 2, Placebo Switched to Adalimumab||175
7912472|NCT00647270|19472785|P2|COMPLETED|Period 2, Placebo Switched to Adalimumab||137
7912473|NCT00647270|19472786|P1|COMPLETED|Period 2, Placebo Switched to Adalimumab||45
7912474|NCT00647270|19472784|P3|STARTED|Period 2, Placebo Switched to Adalimumab||182
7912475|NCT00647270|19472785|P2|STARTED|Period 2, Placebo Switched to Adalimumab||146
7912476|NCT00647270|19472786|P1|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48
7912477|NCT00647270|19472784|P3|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23
7912478|NCT00647270|19472785|P2|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13
7912479|NCT00647270|19472786|P1|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8
7912480|NCT00647270|19472784|P3|COMPLETED|Period 1, Placebo-control (12 Weeks)||182
7912481|NCT00647270|19472785|P2|COMPLETED|Period 1, Placebo-control (12 Weeks)||146
7912482|NCT00647270|19472786|P1|COMPLETED|Period 1, Placebo-control (12 Weeks)||48
7912483|NCT00647270|19472784|P3|STARTED|Period 1, Placebo-control (12 Weeks)||205
7912484|NCT00647270|19472785|P2|STARTED|Period 1, Placebo-control (12 Weeks)||159
7912485|NCT00647270|19472786|P1|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56
7912486|NCT00646958|19472812|P3|NOT COMPLETED|Overall Study||9
7912487|NCT00646958|19472813|P2|NOT COMPLETED|Overall Study||9
7912488|NCT00646958|19472814|P1|NOT COMPLETED|Overall Study||11
7912489|NCT00646958|19472812|P3|COMPLETED|Overall Study||40
7912490|NCT00646958|19472813|P2|COMPLETED|Overall Study||41
7912491|NCT00646958|19472814|P1|COMPLETED|Overall Study||40
7912492|NCT00646958|19472812|P3|STARTED|Overall Study|No. Participants Randomized|49
7912493|NCT00646958|19472813|P2|STARTED|Overall Study|No. Participants Randomized|50
7912494|NCT00646958|19472814|P1|STARTED|Overall Study|Number (No.) Participants Randomized|51
7912495|NCT00646906|19472829|P7|NOT COMPLETED|Crossover Period 2||1
7912496|NCT00646906|19472830|P6|NOT COMPLETED|Crossover Period 2||0
7912497|NCT00646906|19472831|P5|NOT COMPLETED|Crossover Period 2||0
7912498|NCT00646906|19472832|P4|NOT COMPLETED|Crossover Period 2||1
7912499|NCT00646906|19472833|P3|NOT COMPLETED|Crossover Period 2||2
7912500|NCT00646906|19472834|P2|NOT COMPLETED|Crossover Period 2||1
7912501|NCT00646906|19472835|P1|NOT COMPLETED|Crossover Period 2||0
7912502|NCT00646906|19472829|P7|COMPLETED|Crossover Period 2||4
7912503|NCT00646906|19472830|P6|COMPLETED|Crossover Period 2||4
7912504|NCT00646906|19472831|P5|COMPLETED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
7912505|NCT00646906|19472832|P4|COMPLETED|Crossover Period 2||8
7912506|NCT00646906|19472833|P3|COMPLETED|Crossover Period 2||8
7912507|NCT00646906|19472834|P2|COMPLETED|Crossover Period 2||8
7912508|NCT00646906|19472835|P1|COMPLETED|Crossover Period 2||8
7912509|NCT00646906|19472829|P7|STARTED|Crossover Period 2||5
7912510|NCT00646906|19472830|P6|STARTED|Crossover Period 2||4
7912511|NCT00646906|19472831|P5|STARTED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
7912512|NCT00646906|19472832|P4|STARTED|Crossover Period 2||9
7912513|NCT00646906|19472833|P3|STARTED|Crossover Period 2||10
7912514|NCT00646906|19472834|P2|STARTED|Crossover Period 2||9
7912515|NCT00646906|19472835|P1|STARTED|Crossover Period 2||8
7912516|NCT00646906|19472829|P7|NOT COMPLETED|Washout (>/= 14 Days)||0
7912517|NCT00646906|19472830|P6|NOT COMPLETED|Washout (>/= 14 Days)||0
7912518|NCT00646906|19472831|P5|NOT COMPLETED|Washout (>/= 14 Days)||0
7912519|NCT00646906|19472832|P4|NOT COMPLETED|Washout (>/= 14 Days)||0
7912520|NCT00646906|19472833|P3|NOT COMPLETED|Washout (>/= 14 Days)||0
7912521|NCT00646906|19472834|P2|NOT COMPLETED|Washout (>/= 14 Days)||0
7912522|NCT00646906|19472835|P1|NOT COMPLETED|Washout (>/= 14 Days)||0
7912523|NCT00646906|19472829|P7|COMPLETED|Washout (>/= 14 Days)||5
7912524|NCT00646906|19472830|P6|COMPLETED|Washout (>/= 14 Days)||4
7912525|NCT00646906|19472831|P5|COMPLETED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
7912526|NCT00646906|19472832|P4|COMPLETED|Washout (>/= 14 Days)||9
7912527|NCT00646906|19472833|P3|COMPLETED|Washout (>/= 14 Days)||10
7912528|NCT00646906|19472834|P2|COMPLETED|Washout (>/= 14 Days)||9
7912529|NCT00646906|19472835|P1|COMPLETED|Washout (>/= 14 Days)||8
7912530|NCT00646906|19472829|P7|STARTED|Washout (>/= 14 Days)||5
7912531|NCT00646906|19472830|P6|STARTED|Washout (>/= 14 Days)||4
7912532|NCT00646906|19472831|P5|STARTED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
7912533|NCT00646906|19472832|P4|STARTED|Washout (>/= 14 Days)||9
7912534|NCT00646906|19472833|P3|STARTED|Washout (>/= 14 Days)||10
7912535|NCT00646906|19472834|P2|STARTED|Washout (>/= 14 Days)||9
7912536|NCT00646906|19472835|P1|STARTED|Washout (>/= 14 Days)||8
7912537|NCT00646906|19472829|P7|NOT COMPLETED|Crossover Period 1||0
7912538|NCT00646906|19472830|P6|NOT COMPLETED|Crossover Period 1||1
7912539|NCT00646906|19472831|P5|NOT COMPLETED|Crossover Period 1||0
7912540|NCT00646906|19472832|P4|NOT COMPLETED|Crossover Period 1||0
7912541|NCT00646906|19472833|P3|NOT COMPLETED|Crossover Period 1||0
7912542|NCT00646906|19472834|P2|NOT COMPLETED|Crossover Period 1||0
7912543|NCT00646906|19472835|P1|NOT COMPLETED|Crossover Period 1||1
7912544|NCT00646906|19472829|P7|COMPLETED|Crossover Period 1||5
7912545|NCT00646906|19472830|P6|COMPLETED|Crossover Period 1||4
7912546|NCT00646906|19472831|P5|COMPLETED|Crossover Period 1|Phase 1b had only one treatment period and no crossover. Phase 1b ended here.|8
7912547|NCT00646906|19472832|P4|COMPLETED|Crossover Period 1||9
7912548|NCT00646906|19472833|P3|COMPLETED|Crossover Period 1||10
7912549|NCT00646906|19472834|P2|COMPLETED|Crossover Period 1||9
7912550|NCT00646906|19472835|P1|COMPLETED|Crossover Period 1||8
7912551|NCT00646906|19472829|P7|STARTED|Crossover Period 1||5
7912552|NCT00646906|19472830|P6|STARTED|Crossover Period 1||5
7912553|NCT00646906|19472831|P5|STARTED|Crossover Period 1||8
7912554|NCT00646906|19472832|P4|STARTED|Crossover Period 1||9
7912555|NCT00646906|19472833|P3|STARTED|Crossover Period 1||10
7912556|NCT00646906|19472834|P2|STARTED|Crossover Period 1||9
7912557|NCT00646906|19472835|P1|STARTED|Crossover Period 1||9
7912558|NCT00646776|19472854|P2|NOT COMPLETED|Overall Study||13
7912559|NCT00646776|19472855|P1|NOT COMPLETED|Overall Study||1
7912560|NCT00646776|19472854|P2|COMPLETED|Overall Study||5
7912561|NCT00646776|19472855|P1|COMPLETED|Overall Study||14
7912562|NCT00646776|19472854|P2|STARTED|Overall Study|Treated on Day 1|18
7912563|NCT00646776|19472855|P1|STARTED|Overall Study|Treated on Day 1|15
7912564|NCT00646763|19472904|P2|NOT COMPLETED|Overall Study||0
7912565|NCT00646763|19472905|P1|NOT COMPLETED|Overall Study||0
7912566|NCT00646763|19472904|P2|COMPLETED|Overall Study||17
7912567|NCT00646763|19472905|P1|COMPLETED|Overall Study||18
7912568|NCT00646763|19472904|P2|STARTED|Overall Study||17
7912569|NCT00646763|19472905|P1|STARTED|Overall Study||18
7912570|NCT00646646|19472919|P4|NOT COMPLETED|Overall Study||0
7912571|NCT00646646|19472920|P3|NOT COMPLETED|Overall Study||0
7912572|NCT00646646|19472921|P2|NOT COMPLETED|Overall Study||0
7912573|NCT00646646|19472922|P1|NOT COMPLETED|Overall Study||0
7912574|NCT00646646|19472919|P4|COMPLETED|Overall Study||20
7912575|NCT00646646|19472920|P3|COMPLETED|Overall Study||15
7912576|NCT00646646|19472921|P2|COMPLETED|Overall Study||15
7912577|NCT00646646|19472922|P1|COMPLETED|Overall Study||15
7912578|NCT00646646|19472919|P4|STARTED|Overall Study||20
7912579|NCT00646646|19472920|P3|STARTED|Overall Study||15
7912580|NCT00646646|19472921|P2|STARTED|Overall Study||15
7912581|NCT00646646|19472922|P1|STARTED|Overall Study||15
7912582|NCT00646581|19472934|P2|NOT COMPLETED|Overall Study||0
7912583|NCT00646581|19472935|P1|NOT COMPLETED|Overall Study||0
7912584|NCT00646581|19472934|P2|COMPLETED|Overall Study||15
7912585|NCT00646581|19472935|P1|COMPLETED|Overall Study||15
7912586|NCT00646581|19472934|P2|STARTED|Overall Study||15
7912587|NCT00646581|19472935|P1|STARTED|Overall Study||15
7912588|NCT00646399|19472953|P2|NOT COMPLETED|Overall Study||74
7912589|NCT00646399|19472954|P1|NOT COMPLETED|Overall Study||83
7912590|NCT00646399|19472953|P2|COMPLETED|Overall Study||713
7912591|NCT00646399|19472954|P1|COMPLETED|Overall Study||709
7912592|NCT00646399|19472953|P2|STARTED|Overall Study||787
7912593|NCT00646399|19472954|P1|STARTED|Overall Study||792
7912594|NCT00646282|19472962|P2|NOT COMPLETED|Overall Study||4
7912595|NCT00646282|19472963|P1|NOT COMPLETED|Overall Study||4
7912596|NCT00646282|19472962|P2|COMPLETED|Overall Study||0
7912597|NCT00646282|19472963|P1|COMPLETED|Overall Study||0
7912598|NCT00646282|19472962|P2|STARTED|Overall Study||4
7912599|NCT00646282|19472963|P1|STARTED|Overall Study||4
7912600|NCT00646113|19472969|P1|NOT COMPLETED|Overall Study||8
7912601|NCT00646113|19472969|P1|COMPLETED|Overall Study||61
7912602|NCT00646113|19472969|P1|STARTED|Overall Study|3 of the 72 enrolled participants were excluded before surgery.|69
7912603|NCT00646048|19472973|P1|NOT COMPLETED|Overall Study||16
7912604|NCT00646048|19472973|P1|COMPLETED|Overall Study||27
7912605|NCT00646048|19472973|P1|STARTED|Overall Study||43
7912606|NCT00645970|19472981|P2|NOT COMPLETED|Overall Study||186
7912607|NCT00645970|19472982|P1|NOT COMPLETED|Overall Study||109
7912608|NCT00645970|19472981|P2|COMPLETED|Overall Study||32
7912609|NCT00645970|19472982|P1|COMPLETED|Overall Study||32
7912610|NCT00645970|19472981|P2|1 Year|Overall Study||42
7912611|NCT00645970|19472982|P1|1 Year|Overall Study||37
7912612|NCT00645970|19472981|P2|6 Months|Overall Study||97
7912613|NCT00645970|19472982|P1|6 Months|Overall Study||58
7912614|NCT00645970|19472981|P2|STARTED|Overall Study||218
7912615|NCT00645970|19472982|P1|STARTED|Overall Study||141
7912616|NCT00645944|19472990|P2|NOT COMPLETED|Received Medication||3
7912617|NCT00645944|19472991|P1|NOT COMPLETED|Received Medication||6
7912618|NCT00645944|19472990|P2|COMPLETED|Received Medication||14
7912619|NCT00645944|19472991|P1|COMPLETED|Received Medication||13
7912620|NCT00645944|19472990|P2|STARTED|Received Medication||17
7912621|NCT00645944|19472991|P1|STARTED|Received Medication||19
7912622|NCT00645944|19472990|P2|NOT COMPLETED|Randomized||2
7912623|NCT00645944|19472991|P1|NOT COMPLETED|Randomized||1
7912624|NCT00645944|19472990|P2|COMPLETED|Randomized||17
7912625|NCT00645944|19472991|P1|COMPLETED|Randomized||19
7912626|NCT00645944|19472990|P2|STARTED|Randomized||19
7912627|NCT00645944|19472991|P1|STARTED|Randomized||20
7912628|NCT00645853|19472999|P2|NOT COMPLETED|Overall Study||57
7912629|NCT00645853|19473000|P1|NOT COMPLETED|Overall Study||92
7912630|NCT00645853|19472999|P2|COMPLETED|Overall Study||178
7912631|NCT00645853|19473000|P1|COMPLETED|Overall Study||196
7912632|NCT00645853|19472999|P2|AZ Study Closure in Hungary|Overall Study||40
7912633|NCT00645853|19473000|P1|AZ Study Closure in Hungary|Overall Study||60
7912634|NCT00645853|19472999|P2|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178
7912635|NCT00645853|19473000|P1|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196
7912636|NCT00645853|19472999|P2|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188
7912637|NCT00645853|19473000|P1|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209
7912638|NCT00645853|19472999|P2|STARTED|Overall Study||235
7912639|NCT00645853|19473000|P1|STARTED|Overall Study||288
7912640|NCT00645840|19473018|P1|NOT COMPLETED|Overall Study||3
7912641|NCT00645840|19473018|P1|COMPLETED|Overall Study||12
7912642|NCT00645840|19473018|P1|STARTED|Overall Study||15
7912643|NCT00645827|19473025|P2|NOT COMPLETED|Overall Study||0
7912644|NCT00645827|19473026|P1|NOT COMPLETED|Overall Study||0
7912645|NCT00645827|19473025|P2|COMPLETED|Overall Study||17
7912646|NCT00645827|19473026|P1|COMPLETED|Overall Study||14
7912647|NCT00645827|19473025|P2|STARTED|Overall Study||17
7912648|NCT00645827|19473026|P1|STARTED|Overall Study||14
7912649|NCT00645788|19473036|P4|NOT COMPLETED|Overall Study||14
7912650|NCT00645788|19473037|P3|NOT COMPLETED|Overall Study||18
7912651|NCT00645788|19473038|P2|NOT COMPLETED|Overall Study||27
7912652|NCT00645788|19473039|P1|NOT COMPLETED|Overall Study||20
7912653|NCT00645788|19473036|P4|COMPLETED|Overall Study||21
7912654|NCT00645788|19473037|P3|COMPLETED|Overall Study||47
7912655|NCT00645788|19473038|P2|COMPLETED|Overall Study||67
7912656|NCT00645788|19473039|P1|COMPLETED|Overall Study||74
7912657|NCT00645788|19473036|P4|Participants Receive Treatment|Overall Study||35
7912658|NCT00645788|19473037|P3|Participants Receive Treatment|Overall Study||65
7912659|NCT00645788|19473038|P2|Participants Receive Treatment|Overall Study||93
7912660|NCT00645788|19473039|P1|Participants Receive Treatment|Overall Study||93
7912661|NCT00645788|19473036|P4|STARTED|Overall Study||35
7912662|NCT00645788|19473037|P3|STARTED|Overall Study||65
7912663|NCT00645788|19473038|P2|STARTED|Overall Study||94
7912664|NCT00645788|19473039|P1|STARTED|Overall Study||94
7912665|NCT00645762|19473089|P1|NOT COMPLETED|Overall Study||4
7912666|NCT00645762|19473089|P1|COMPLETED|Overall Study||67
7912667|NCT00645762|19473089|P1|STARTED|Overall Study||71
7912668|NCT00645710|19473098|P3|NOT COMPLETED|Overall Study||0
7912669|NCT00645710|19473099|P2|NOT COMPLETED|Overall Study||0
7912670|NCT00645710|19473100|P1|NOT COMPLETED|Overall Study||0
7912671|NCT00645710|19473098|P3|COMPLETED|Overall Study||10
7912672|NCT00645710|19473099|P2|COMPLETED|Overall Study||3
7912673|NCT00645710|19473100|P1|COMPLETED|Overall Study||3
7912674|NCT00645710|19473098|P3|STARTED|Overall Study||10
7912675|NCT00645710|19473099|P2|STARTED|Overall Study||3
7912676|NCT00645710|19473100|P1|STARTED|Overall Study||3
7912677|NCT00645671|19473117|P2|NOT COMPLETED|Overall Study||6
7912678|NCT00645671|19473118|P1|NOT COMPLETED|Overall Study||1
7912679|NCT00645671|19473117|P2|COMPLETED|Overall Study||193
7912680|NCT00645671|19473118|P1|COMPLETED|Overall Study||200
7912681|NCT00645671|19473117|P2|STARTED|Overall Study||199
7912682|NCT00645671|19473118|P1|STARTED|Overall Study||201
7912683|NCT00645593|19473132|P2|NOT COMPLETED|Overall Study||0
7912684|NCT00645593|19473133|P1|NOT COMPLETED|Overall Study||1
7912685|NCT00645593|19473132|P2|COMPLETED|Overall Study||60
7912686|NCT00645593|19473133|P1|COMPLETED|Overall Study||28
7912687|NCT00645593|19473132|P2|STARTED|Overall Study||60
7912688|NCT00645593|19473133|P1|STARTED|Overall Study||29
7912689|NCT00645567|19473145|P1|NOT COMPLETED|Overall Study||1
7912690|NCT00645567|19473145|P1|COMPLETED|Overall Study|One individual provided consent & was dropped due to an unrelated injury to his hand at his home.|4
7912691|NCT00645567|19473145|P1|STARTED|Overall Study||5
7912692|NCT00645528|19473153|P1|NOT COMPLETED|Overall Study||7
7912693|NCT00645528|19473153|P1|COMPLETED|Overall Study||32
7912694|NCT00645528|19473153|P1|STARTED|Overall Study||39
7912695|NCT00645450|19473164|P2|NOT COMPLETED|Overall Study||0
7912696|NCT00645450|19473165|P1|NOT COMPLETED|Overall Study||0
7912697|NCT00645450|19473164|P2|COMPLETED|Overall Study||4
7912698|NCT00645450|19473165|P1|COMPLETED|Overall Study||5
7912699|NCT00645450|19473164|P2|STARTED|Overall Study||4
7912700|NCT00645450|19473165|P1|STARTED|Overall Study||5
7912701|NCT00645411|19473175|P4|NOT COMPLETED|Overall Study||103
7912702|NCT00645411|19473176|P3|NOT COMPLETED|Overall Study||151
7912703|NCT00645411|19473177|P2|NOT COMPLETED|Overall Study||6
7912704|NCT00645411|19473178|P1|NOT COMPLETED|Overall Study||13
7912705|NCT00645411|19473175|P4|COMPLETED|Overall Study||919
7912706|NCT00645411|19473176|P3|COMPLETED|Overall Study||1457
7912707|NCT00645411|19473177|P2|COMPLETED|Overall Study||312
7912708|NCT00645411|19473178|P1|COMPLETED|Overall Study||643
7912709|NCT00645411|19473175|P4|STARTED|Overall Study||1022
7912710|NCT00645411|19473176|P3|STARTED|Overall Study||1608
7912711|NCT00645411|19473177|P2|STARTED|Overall Study||318
7912712|NCT00645411|19473178|P1|STARTED|Overall Study||656
7912713|NCT00645359|19473210|P1|NOT COMPLETED|Overall Study||0
7912714|NCT00645359|19473210|P1|COMPLETED|Overall Study||9
7912715|NCT00645359|19473210|P1|STARTED|Overall Study||9
7912716|NCT00645333|19473215|P1|NOT COMPLETED|Overall Study||0
7912717|NCT00645333|19473215|P1|COMPLETED|Overall Study||30
7912718|NCT00645333|19473215|P1|STARTED|Overall Study||30
7912719|NCT00645164|19473220|P1|NOT COMPLETED|Overall Study||7
7912720|NCT00645164|19473220|P1|COMPLETED|Overall Study||52
7912721|NCT00645164|19473220|P1|STARTED|Overall Study||59
7912722|NCT00645099|19473226|P2|NOT COMPLETED|Overall Study||42
7912723|NCT00645099|19473227|P1|NOT COMPLETED|Overall Study||71
7912724|NCT00645099|19473226|P2|COMPLETED|Overall Study||178
7912725|NCT00645099|19473227|P1|COMPLETED|Overall Study||168
7912726|NCT00645099|19473226|P2|STARTED|Overall Study||220
7912727|NCT00645099|19473227|P1|STARTED|Overall Study||239
7912728|NCT00645047|19473271|P2|NOT COMPLETED|Overall Study||39
7912729|NCT00645047|19473272|P1|NOT COMPLETED|Overall Study||43
7912730|NCT00645047|19473271|P2|COMPLETED|Overall Study||65
7912731|NCT00645047|19473272|P1|COMPLETED|Overall Study|6 month follow up|60
7912732|NCT00645047|19473271|P2|Post|Overall Study||80
7912733|NCT00645047|19473272|P1|Post|Overall Study||74
7912734|NCT00645047|19473271|P2|STARTED|Overall Study||104
7912735|NCT00645047|19473272|P1|STARTED|Overall Study||103
7912736|NCT00644995|19473296|P2|NOT COMPLETED|Overall Study||4
7912737|NCT00644995|19473297|P1|NOT COMPLETED|Overall Study||2
7912738|NCT00644995|19473296|P2|COMPLETED|Overall Study||23
7912739|NCT00644995|19473297|P1|COMPLETED|Overall Study|Completed 6 month assessment|23
7912740|NCT00644995|19473296|P2|Completed 4 Month Assessment|Overall Study||24
7912741|NCT00644995|19473297|P1|Completed 4 Month Assessment|Overall Study||23
7912742|NCT00644995|19473296|P2|STARTED|Overall Study||27
7912743|NCT00644995|19473297|P1|STARTED|Overall Study||25
7912744|NCT00644969|19473317|P2|NOT COMPLETED|Post Treatment Phase||3
7912745|NCT00644969|19473318|P1|NOT COMPLETED|Post Treatment Phase||10
7912746|NCT00644969|19473317|P2|COMPLETED|Post Treatment Phase||37
7912747|NCT00644969|19473318|P1|COMPLETED|Post Treatment Phase||61
7912748|NCT00644969|19473317|P2|STARTED|Post Treatment Phase||40
7912749|NCT00644969|19473318|P1|STARTED|Post Treatment Phase||71
7912750|NCT00644969|19473317|P2|NOT COMPLETED|Treatment Phase||3
7912751|NCT00644969|19473318|P1|NOT COMPLETED|Treatment Phase||14
7912752|NCT00644969|19473317|P2|COMPLETED|Treatment Phase||40
7912753|NCT00644969|19473318|P1|COMPLETED|Treatment Phase||71
7912754|NCT00644969|19473317|P2|STARTED|Treatment Phase||43
7912755|NCT00644969|19473318|P1|STARTED|Treatment Phase||85
7912756|NCT00644917|19473364|P1|NOT COMPLETED|Overall Study||2
7912757|NCT00644917|19473364|P1|COMPLETED|Overall Study||36
7912758|NCT00644917|19473364|P1|STARTED|Overall Study||38
7912759|NCT00644787|19473372|P3|NOT COMPLETED|Period 2: Double Blind Phase||7
7912760|NCT00644787|19473373|P2|NOT COMPLETED|Period 2: Double Blind Phase||9
7912761|NCT00644787|19473374|P1|NOT COMPLETED|Period 2: Double Blind Phase||0
7912762|NCT00644787|19473372|P3|COMPLETED|Period 2: Double Blind Phase||55
7912763|NCT00644787|19473373|P2|COMPLETED|Period 2: Double Blind Phase||49
7912764|NCT00644787|19473374|P1|COMPLETED|Period 2: Double Blind Phase||0
7912765|NCT00644787|19473372|P3|STARTED|Period 2: Double Blind Phase||62
7912766|NCT00644787|19473373|P2|STARTED|Period 2: Double Blind Phase||58
7912767|NCT00644787|19473374|P1|STARTED|Period 2: Double Blind Phase||0
7912768|NCT00644787|19473372|P3|NOT COMPLETED|Period 1: Titration Phase||0
7912769|NCT00644787|19473373|P2|NOT COMPLETED|Period 1: Titration Phase||0
7912770|NCT00644787|19473374|P1|NOT COMPLETED|Period 1: Titration Phase||27
7912771|NCT00644787|19473372|P3|COMPLETED|Period 1: Titration Phase||0
7912772|NCT00644787|19473373|P2|COMPLETED|Period 1: Titration Phase||0
7912773|NCT00644787|19473374|P1|COMPLETED|Period 1: Titration Phase||129
7912774|NCT00644787|19473372|P3|STARTED|Period 1: Titration Phase||0
7912775|NCT00644787|19473373|P2|STARTED|Period 1: Titration Phase||0
7912776|NCT00644787|19473374|P1|STARTED|Period 1: Titration Phase||156
7912777|NCT00644657|19473402|P1|NOT COMPLETED|Overall Study||0
7912778|NCT00644657|19473402|P1|COMPLETED|Overall Study||27
7912779|NCT00644657|19473402|P1|STARTED|Overall Study||27
7912780|NCT00644592|19473409|P2|NOT COMPLETED|Overall Study||0
7912781|NCT00644592|19473410|P1|NOT COMPLETED|Overall Study||0
7912782|NCT00644592|19473409|P2|COMPLETED|Overall Study||6
7912783|NCT00644592|19473410|P1|COMPLETED|Overall Study||5
7912784|NCT00644592|19473409|P2|STARTED|Overall Study||6
7912785|NCT00644592|19473410|P1|STARTED|Overall Study||5
7912786|NCT00644423|19473418|P2|NOT COMPLETED|Overall Study||1
7912787|NCT00644423|19473419|P1|NOT COMPLETED|Overall Study||1
7912788|NCT00644423|19473418|P2|COMPLETED|Overall Study||4
7912789|NCT00644423|19473419|P1|COMPLETED|Overall Study||5
7912790|NCT00644423|19473418|P2|STARTED|Overall Study||5
7912791|NCT00644423|19473419|P1|STARTED|Overall Study||6
7912792|NCT00644358|19473437|P1|NOT COMPLETED|Overall Study||362
7912793|NCT00644358|19473437|P1|COMPLETED|Overall Study||254
7912794|NCT00644358|19473437|P1|STARTED|Overall Study||616
7912795|NCT00644332|19473444|P1|NOT COMPLETED|Overall Study||21
7912796|NCT00644332|19473444|P1|COMPLETED|Overall Study||150
7912797|NCT00644332|19473444|P1|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171
7912798|NCT00644280|19473459|P2|NOT COMPLETED|Overall Study||0
7912799|NCT00644280|19473460|P1|NOT COMPLETED|Overall Study||0
7912800|NCT00644280|19473459|P2|COMPLETED|Overall Study||5
7912801|NCT00644280|19473460|P1|COMPLETED|Overall Study||6
7912802|NCT00644280|19473459|P2|STARTED|Overall Study||5
7912803|NCT00644280|19473460|P1|STARTED|Overall Study||6
7912804|NCT00644228|19473470|P2|NOT COMPLETED|Maintenance||135
7912805|NCT00644228|19473471|P1|NOT COMPLETED|Maintenance||143
7912806|NCT00644228|19473470|P2|COMPLETED|Maintenance||0
7912807|NCT00644228|19473471|P1|COMPLETED|Maintenance||0
7912808|NCT00644228|19473470|P2|STARTED|Maintenance|2 patients who completed induction did not continue on to maintenance due to other (2).|135
7912809|NCT00644228|19473471|P1|STARTED|Maintenance|3 patients who completed induction did not continue on to maintenance due to refusal (1), other (2).|143
7912810|NCT00644228|19473470|P2|NOT COMPLETED|Induction Therapy||105
7912811|NCT00644228|19473471|P1|NOT COMPLETED|Induction Therapy||83
7912812|NCT00644228|19473470|P2|COMPLETED|Induction Therapy||137
7912813|NCT00644228|19473471|P1|COMPLETED|Induction Therapy||146
7912814|NCT00644228|19473470|P2|STARTED|Induction Therapy||242
7912815|NCT00644228|19473471|P1|STARTED|Induction Therapy||229
7912816|NCT00644228|19473470|P2|NOT COMPLETED|Randomization & Eligibility||22
7912817|NCT00644228|19473471|P1|NOT COMPLETED|Randomization & Eligibility||32
7912818|NCT00644228|19473470|P2|COMPLETED|Randomization & Eligibility||242
7912819|NCT00644228|19473471|P1|COMPLETED|Randomization & Eligibility||229
7912820|NCT00644228|19473470|P2|Eligible and Analyzable|Randomization & Eligibility||242
7912821|NCT00644228|19473471|P1|Eligible and Analyzable|Randomization & Eligibility||229
7912822|NCT00644228|19473470|P2|STARTED|Randomization & Eligibility||264
7912823|NCT00644228|19473471|P1|STARTED|Randomization & Eligibility||261
7912824|NCT00644189|19473481|P4|NOT COMPLETED|Phase II||0
7912825|NCT00644189|19473482|P3|NOT COMPLETED|Phase II||0
7912826|NCT00644189|19473483|P2|NOT COMPLETED|Phase II||0
7912827|NCT00644189|19473484|P1|NOT COMPLETED|Phase II||0
7912828|NCT00644189|19473481|P4|COMPLETED|Phase II||50
7912829|NCT00644189|19473482|P3|COMPLETED|Phase II||0
7912830|NCT00644189|19473483|P2|COMPLETED|Phase II||0
7912831|NCT00644189|19473484|P1|COMPLETED|Phase II||0
7912832|NCT00644189|19473481|P4|Completed All 6 Cycles of Treatment|Phase II||19
7912833|NCT00644189|19473482|P3|Completed All 6 Cycles of Treatment|Phase II||0
7912834|NCT00644189|19473483|P2|Completed All 6 Cycles of Treatment|Phase II||0
7912835|NCT00644189|19473484|P1|Completed All 6 Cycles of Treatment|Phase II||0
7912836|NCT00644189|19473481|P4|STARTED|Phase II|Additional participants were added to the phase I sample at the phase II 3mg dose level|50
7912837|NCT00644189|19473482|P3|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
7912838|NCT00644189|19473483|P2|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
7912839|NCT00644189|19473484|P1|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
7912840|NCT00644189|19473481|P4|NOT COMPLETED|Phase I||0
7912841|NCT00644189|19473482|P3|NOT COMPLETED|Phase I||0
7912842|NCT00644189|19473483|P2|NOT COMPLETED|Phase I||0
7912843|NCT00644189|19473484|P1|NOT COMPLETED|Phase I||0
7912844|NCT00644189|19473481|P4|COMPLETED|Phase I||18
7912845|NCT00644189|19473482|P3|COMPLETED|Phase I||6
7912846|NCT00644189|19473483|P2|COMPLETED|Phase I||3
7912847|NCT00644189|19473484|P1|COMPLETED|Phase I||3
7912848|NCT00644189|19473481|P4|STARTED|Phase I||18
7912849|NCT00644189|19473482|P3|STARTED|Phase I||6
7912850|NCT00644189|19473483|P2|STARTED|Phase I||3
7912851|NCT00644189|19473484|P1|STARTED|Phase I||3
7912852|NCT00644059|19473500|P3|NOT COMPLETED|Overall Study||65
7912853|NCT00644059|19473501|P2|NOT COMPLETED|Overall Study||123
7912854|NCT00644059|19473502|P1|NOT COMPLETED|Overall Study||124
7912855|NCT00644059|19473500|P3|COMPLETED|Overall Study||969
7912856|NCT00644059|19473501|P2|COMPLETED|Overall Study||1726
7912857|NCT00644059|19473502|P1|COMPLETED|Overall Study||1895
7912858|NCT00644059|19473500|P3|STARTED|Overall Study||1034
7912859|NCT00644059|19473501|P2|STARTED|Overall Study||1849
7912860|NCT00644059|19473502|P1|STARTED|Overall Study||2019
7912861|NCT00643916|19473592|P6|NOT COMPLETED|Overall Study||1
7912862|NCT00643916|19473593|P5|NOT COMPLETED|Overall Study||2
7912863|NCT00643916|19473594|P4|NOT COMPLETED|Overall Study||2
7912864|NCT00643916|19473595|P3|NOT COMPLETED|Overall Study||6
7912865|NCT00643916|19473596|P2|NOT COMPLETED|Overall Study||6
7912866|NCT00643916|19473597|P1|NOT COMPLETED|Overall Study||4
7912867|NCT00643916|19473592|P6|COMPLETED|Overall Study||66
7912868|NCT00643916|19473593|P5|COMPLETED|Overall Study||57
7912869|NCT00643916|19473594|P4|COMPLETED|Overall Study||60
7912870|NCT00643916|19473595|P3|COMPLETED|Overall Study||62
7912871|NCT00643916|19473596|P2|COMPLETED|Overall Study||61
7912872|NCT00643916|19473597|P1|COMPLETED|Overall Study||51
7912873|NCT00643916|19473592|P6|STARTED|Overall Study||67
7912874|NCT00643916|19473593|P5|STARTED|Overall Study||59
7912875|NCT00643916|19473594|P4|STARTED|Overall Study||62
7912876|NCT00643916|19473595|P3|STARTED|Overall Study||68
7912877|NCT00643916|19473596|P2|STARTED|Overall Study||67
7912878|NCT00643916|19473597|P1|STARTED|Overall Study||55
7912879|NCT00643864|19473617|P1|NOT COMPLETED|Post-test Assessment||0
7912880|NCT00643864|19473617|P1|COMPLETED|Post-test Assessment||3
7912881|NCT00643864|19473617|P1|STARTED|Post-test Assessment||3
7912882|NCT00643864|19473617|P1|NOT COMPLETED|Pre-test Assessment||0
7912883|NCT00643864|19473617|P1|COMPLETED|Pre-test Assessment||3
7912884|NCT00643864|19473617|P1|STARTED|Pre-test Assessment||3
7912885|NCT00643851|19473626|P3|NOT COMPLETED|Overall Study||30
7912886|NCT00643851|19473627|P2|NOT COMPLETED|Overall Study||33
7912887|NCT00643851|19473628|P1|NOT COMPLETED|Overall Study||17
7912888|NCT00643851|19473626|P3|COMPLETED|Overall Study||171
7912889|NCT00643851|19473627|P2|COMPLETED|Overall Study||170
7912890|NCT00643851|19473628|P1|COMPLETED|Overall Study||177
7912891|NCT00643851|19473626|P3|STARTED|Overall Study||201
7912892|NCT00643851|19473627|P2|STARTED|Overall Study||203
7912893|NCT00643851|19473628|P1|STARTED|Overall Study||194
7912894|NCT00643760|19473656|P5|NOT COMPLETED|Overall Study||19
7912895|NCT00643760|19473657|P4|NOT COMPLETED|Overall Study||38
7912896|NCT00643760|19473658|P3|NOT COMPLETED|Overall Study||19
7912897|NCT00643760|19473659|P2|NOT COMPLETED|Overall Study||15
7912898|NCT00643760|19473660|P1|NOT COMPLETED|Overall Study||30
7912899|NCT00643760|19473656|P5|COMPLETED|Overall Study||47
7912900|NCT00643760|19473657|P4|COMPLETED|Overall Study||79
7912901|NCT00643760|19473658|P3|COMPLETED|Overall Study||37
7912902|NCT00643760|19473659|P2|COMPLETED|Overall Study||47
7912903|NCT00643760|19473660|P1|COMPLETED|Overall Study||90
7912904|NCT00643760|19473656|P5|ITT Population|Overall Study||66
7912905|NCT00643760|19473657|P4|ITT Population|Overall Study||116
7912906|NCT00643760|19473658|P3|ITT Population|Overall Study||56
7912907|NCT00643760|19473659|P2|ITT Population|Overall Study||62
7912908|NCT00643760|19473660|P1|ITT Population|Overall Study||120
7912909|NCT00643760|19473656|P5|Safety Population/Treated With Drug|Overall Study||66
7912910|NCT00643760|19473657|P4|Safety Population/Treated With Drug|Overall Study||116
7912911|NCT00643760|19473658|P3|Safety Population/Treated With Drug|Overall Study||56
7912912|NCT00643760|19473659|P2|Safety Population/Treated With Drug|Overall Study||62
7912913|NCT00643760|19473660|P1|Safety Population/Treated With Drug|Overall Study||120
7912914|NCT00643760|19473656|P5|STARTED|Overall Study||66
7912915|NCT00643760|19473657|P4|STARTED|Overall Study||117
7912916|NCT00643760|19473658|P3|STARTED|Overall Study||56
7912917|NCT00643760|19473659|P2|STARTED|Overall Study||62
7912918|NCT00643760|19473660|P1|STARTED|Overall Study||120
7912919|NCT00643682|19473764|P2|NOT COMPLETED|Overall Study||509
7912920|NCT00643682|19473765|P1|NOT COMPLETED|Overall Study||522
7912921|NCT00643682|19473764|P2|COMPLETED|Overall Study||492
7912922|NCT00643682|19473765|P1|COMPLETED|Overall Study||477
7912923|NCT00643682|19473764|P2|STARTED|Overall Study||1001
7912924|NCT00643682|19473765|P1|STARTED|Overall Study||999
7912925|NCT00643604|19473777|P1|NOT COMPLETED|Overall Study||1
7912926|NCT00643604|19473777|P1|COMPLETED|Overall Study||6
7912927|NCT00643604|19473777|P1|STARTED|Overall Study||7
7912928|NCT00643578|19473794|P2|NOT COMPLETED|Overall Study||0
7912929|NCT00643578|19473795|P1|NOT COMPLETED|Overall Study||2
7912930|NCT00643578|19473794|P2|COMPLETED|Overall Study||6
7912931|NCT00643578|19473795|P1|COMPLETED|Overall Study||4
7912932|NCT00643578|19473794|P2|STARTED|Overall Study||6
7912933|NCT00643578|19473795|P1|STARTED|Overall Study||6
7912934|NCT00643565|19473805|P2|NOT COMPLETED|Overall Study||67
7912935|NCT00643565|19473806|P1|NOT COMPLETED|Overall Study||73
7912936|NCT00643565|19473805|P2|COMPLETED|Overall Study||7
7912937|NCT00643565|19473806|P1|COMPLETED|Overall Study||7
7912938|NCT00643565|19473805|P2|STARTED|Overall Study||74
7912939|NCT00643565|19473806|P1|STARTED|Overall Study||80
7912940|NCT00643487|19473828|P1|NOT COMPLETED|Overall Study||3
7912941|NCT00643487|19473828|P1|COMPLETED|Overall Study||5
7912942|NCT00643487|19473828|P1|STARTED|Overall Study||8
7912943|NCT00643448|19473835|P3|NOT COMPLETED|Overall Study||6
7912944|NCT00643448|19473836|P2|NOT COMPLETED|Overall Study||5
7912945|NCT00643448|19473837|P1|NOT COMPLETED|Overall Study||4
7912946|NCT00643448|19473835|P3|COMPLETED|Overall Study||16
7912947|NCT00643448|19473836|P2|COMPLETED|Overall Study||17
7912948|NCT00643448|19473837|P1|COMPLETED|Overall Study||17
7912949|NCT00643448|19473835|P3|STARTED|Overall Study||22
7912950|NCT00643448|19473836|P2|STARTED|Overall Study||22
7912951|NCT00643448|19473837|P1|STARTED|Overall Study||21
7912952|NCT00643279|19473854|P2|NOT COMPLETED|Overall Study||13
7912953|NCT00643279|19473855|P1|NOT COMPLETED|Overall Study||16
7912954|NCT00643279|19473854|P2|COMPLETED|Overall Study||127
7912955|NCT00643279|19473855|P1|COMPLETED|Overall Study||118
7912956|NCT00643279|19473854|P2|STARTED|Overall Study||140
7912957|NCT00643279|19473855|P1|STARTED|Overall Study||134
7912958|NCT00643201|19473877|P2|NOT COMPLETED|Completed Study Follow Up||79
7912959|NCT00643201|19473878|P1|NOT COMPLETED|Completed Study Follow Up||70
7912960|NCT00643201|19473877|P2|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560
7912961|NCT00643201|19473878|P1|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547
7912962|NCT00643201|19473877|P2|STARTED|Completed Study Follow Up||2639
7912963|NCT00643201|19473878|P1|STARTED|Completed Study Follow Up||2617
7912964|NCT00643201|19473877|P2|NOT COMPLETED|Randomized, Completed 6 Months of Study||413
7912965|NCT00643201|19473878|P1|NOT COMPLETED|Randomized, Completed 6 Months of Study||377
7912966|NCT00643201|19473877|P2|COMPLETED|Randomized, Completed 6 Months of Study||2291
7912967|NCT00643201|19473878|P1|COMPLETED|Randomized, Completed 6 Months of Study||2314
7912968|NCT00643201|19473877|P2|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704
7912969|NCT00643201|19473878|P1|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691
7912970|NCT00643162|19473926|P2|NOT COMPLETED|Overall Study||1
7912971|NCT00643162|19473927|P1|NOT COMPLETED|Overall Study||1
7912972|NCT00643162|19473926|P2|COMPLETED|Overall Study||4
7912973|NCT00643162|19473927|P1|COMPLETED|Overall Study||6
7912974|NCT00643162|19473926|P2|STARTED|Overall Study||5
7912975|NCT00643162|19473927|P1|STARTED|Overall Study||7
7912976|NCT00643123|19473939|P2|NOT COMPLETED|Overall Study||1
7912977|NCT00643123|19473940|P1|NOT COMPLETED|Overall Study||5
7912978|NCT00643123|19473939|P2|COMPLETED|Overall Study||11
7912979|NCT00643123|19473940|P1|COMPLETED|Overall Study||10
7912980|NCT00643123|19473939|P2|STARTED|Overall Study||12
7912981|NCT00643123|19473940|P1|STARTED|Overall Study||15
7912982|NCT00643097|19473951|P3|NOT COMPLETED|Overall Study||0
7912983|NCT00643097|19473952|P2|NOT COMPLETED|Overall Study||0
7912984|NCT00643097|19473953|P1|NOT COMPLETED|Overall Study||0
7912985|NCT00643097|19473951|P3|COMPLETED|Overall Study||10
7912986|NCT00643097|19473952|P2|COMPLETED|Overall Study||12
7912987|NCT00643097|19473953|P1|COMPLETED|Overall Study||18
7912988|NCT00643097|19473951|P3|STARTED|Overall Study||10
7912989|NCT00643097|19473952|P2|STARTED|Overall Study||12
7912990|NCT00643097|19473953|P1|STARTED|Overall Study||18
7912991|NCT00643006|19473972|P2|NOT COMPLETED|Overall Study||4
7912992|NCT00643006|19473973|P1|NOT COMPLETED|Overall Study||5
7912993|NCT00643006|19473972|P2|COMPLETED|Overall Study||29
7912994|NCT00643006|19473973|P1|COMPLETED|Overall Study||29
7912995|NCT00643006|19473972|P2|STARTED|Overall Study||33
7912996|NCT00643006|19473973|P1|STARTED|Overall Study||34
7912997|NCT00642993|19473983|P2|NOT COMPLETED|Overall Study||16
7912998|NCT00642993|19473984|P1|NOT COMPLETED|Overall Study||106
7912999|NCT00642993|19473983|P2|COMPLETED|Overall Study||118
7913000|NCT00642993|19473984|P1|COMPLETED|Overall Study||161
7913001|NCT00642993|19473983|P2|STARTED|Overall Study||134
7913002|NCT00642993|19473984|P1|STARTED|Overall Study||267
7913003|NCT00642954|19474003|P5|NOT COMPLETED|Overall Study||16
7913004|NCT00642954|19474004|P4|NOT COMPLETED|Overall Study||3
7913005|NCT00642954|19474005|P3|NOT COMPLETED|Overall Study||3
7913006|NCT00642954|19474006|P2|NOT COMPLETED|Overall Study||4
7913007|NCT00642954|19474007|P1|NOT COMPLETED|Overall Study||4
7913008|NCT00642954|19474003|P5|COMPLETED|Overall Study||1
7913009|NCT00642954|19474004|P4|COMPLETED|Overall Study||0
7913010|NCT00642954|19474005|P3|COMPLETED|Overall Study||0
7913011|NCT00642954|19474006|P2|COMPLETED|Overall Study||0
7913012|NCT00642954|19474007|P1|COMPLETED|Overall Study||0
7913013|NCT00642954|19474003|P5|STARTED|Overall Study||17
7913014|NCT00642954|19474004|P4|STARTED|Overall Study||3
7913015|NCT00642954|19474005|P3|STARTED|Overall Study||3
7913016|NCT00642954|19474006|P2|STARTED|Overall Study||4
7913017|NCT00642954|19474007|P1|STARTED|Overall Study||4
7913018|NCT00642902|19474033|P4|NOT COMPLETED|Overall Study||40
7913019|NCT00642902|19474034|P3|NOT COMPLETED|Overall Study||43
7913020|NCT00642902|19474035|P2|NOT COMPLETED|Overall Study||42
7913021|NCT00642902|19474036|P1|NOT COMPLETED|Overall Study||40
7913022|NCT00642902|19474033|P4|COMPLETED|Overall Study||25
7913023|NCT00642902|19474034|P3|COMPLETED|Overall Study||21
7913024|NCT00642902|19474035|P2|COMPLETED|Overall Study||21
7913025|NCT00642902|19474036|P1|COMPLETED|Overall Study||23
7913026|NCT00642902|19474033|P4|Treated|Overall Study||65
7913027|NCT00642902|19474034|P3|Treated|Overall Study||63
7913028|NCT00642902|19474035|P2|Treated|Overall Study||63
7913029|NCT00642902|19474036|P1|Treated|Overall Study||63
7913030|NCT00642902|19474033|P4|STARTED|Overall Study||65
7913031|NCT00642902|19474034|P3|STARTED|Overall Study||64
7913032|NCT00642902|19474035|P2|STARTED|Overall Study||63
7913033|NCT00642902|19474036|P1|STARTED|Overall Study||63
7913034|NCT00642850|19474058|P1|NOT COMPLETED|Overall Study||33
7913035|NCT00642850|19474058|P1|COMPLETED|Overall Study||155
7913036|NCT00642850|19474058|P1|STARTED|Overall Study||188
7913037|NCT00642811|19474074|P6|NOT COMPLETED|Overall Study||1
7913038|NCT00642811|19474075|P5|NOT COMPLETED|Overall Study||1
7913039|NCT00642811|19474076|P4|NOT COMPLETED|Overall Study||1
7913040|NCT00642811|19474077|P3|NOT COMPLETED|Overall Study||0
7913041|NCT00642811|19474078|P2|NOT COMPLETED|Overall Study||4
7913042|NCT00642811|19474079|P1|NOT COMPLETED|Overall Study||3
7913043|NCT00642811|19474074|P6|COMPLETED|Overall Study||13
7913044|NCT00642811|19474075|P5|COMPLETED|Overall Study||13
7913045|NCT00642811|19474076|P4|COMPLETED|Overall Study||15
7913046|NCT00642811|19474077|P3|COMPLETED|Overall Study||13
7913047|NCT00642811|19474078|P2|COMPLETED|Overall Study||17
7913048|NCT00642811|19474079|P1|COMPLETED|Overall Study||17
7913049|NCT00642811|19474074|P6|STARTED|Overall Study||14
7913050|NCT00642811|19474075|P5|STARTED|Overall Study||14
7913051|NCT00642811|19474076|P4|STARTED|Overall Study||16
7913052|NCT00642811|19474077|P3|STARTED|Overall Study||13
7913053|NCT00642811|19474078|P2|STARTED|Overall Study||21
7913054|NCT00642811|19474079|P1|STARTED|Overall Study||20
7913055|NCT00642772|19474101|P1|NOT COMPLETED|Overall Study||10
7913056|NCT00642772|19474101|P1|COMPLETED|Overall Study||14
7913057|NCT00642772|19474101|P1|STARTED|Overall Study||24
7913058|NCT00642759|19474105|P1|NOT COMPLETED|Overall Study||1
7913059|NCT00642759|19474105|P1|COMPLETED|Overall Study||35
7913060|NCT00642759|19474105|P1|STARTED|Overall Study||36
7913061|NCT00642746|19474114|P2|NOT COMPLETED|Overall Study||0
7913062|NCT00642746|19474115|P1|NOT COMPLETED|Overall Study||1
7913063|NCT00642746|19474114|P2|COMPLETED|Overall Study||1
7913064|NCT00642746|19474115|P1|COMPLETED|Overall Study||9
7913065|NCT00642746|19474114|P2|STARTED|Overall Study||1
7913066|NCT00642746|19474115|P1|STARTED|Overall Study||10
7913067|NCT00642707|19474129|P4|NOT COMPLETED|Overall Study||2
7913068|NCT00642707|19474130|P3|NOT COMPLETED|Overall Study||0
7913069|NCT00642707|19474131|P2|NOT COMPLETED|Overall Study||0
7913070|NCT00642707|19474132|P1|NOT COMPLETED|Overall Study||1
7913071|NCT00642707|19474129|P4|COMPLETED|Overall Study||8
7913072|NCT00642707|19474130|P3|COMPLETED|Overall Study||12
7913073|NCT00642707|19474131|P2|COMPLETED|Overall Study||11
7913074|NCT00642707|19474132|P1|COMPLETED|Overall Study||10
7913075|NCT00642707|19474129|P4|STARTED|Overall Study||10
7913076|NCT00642707|19474130|P3|STARTED|Overall Study||12
7913077|NCT00642707|19474131|P2|STARTED|Overall Study||11
7913078|NCT00642707|19474132|P1|STARTED|Overall Study||11
7913079|NCT00642694|19474144|P2|NOT COMPLETED|Overall Study||4
7913080|NCT00642694|19474145|P1|NOT COMPLETED|Overall Study||6
7913081|NCT00642694|19474144|P2|COMPLETED|Overall Study||11
7913082|NCT00642694|19474145|P1|COMPLETED|Overall Study||8
7913083|NCT00642694|19474144|P2|STARTED|Overall Study||15
7913084|NCT00642694|19474145|P1|STARTED|Overall Study||14
7913085|NCT00642668|19474167|P1|NOT COMPLETED|Overall Study||14
7913086|NCT00642668|19474167|P1|COMPLETED|Overall Study||21
7913087|NCT00642668|19474167|P1|STARTED|Overall Study||35
7913088|NCT00642642|19474175|P1|NOT COMPLETED|Treatment & Follow Up||17
7913089|NCT00642642|19474175|P1|COMPLETED|Treatment & Follow Up||92
7913090|NCT00642642|19474175|P1|STARTED|Treatment & Follow Up||109
7913091|NCT00642642|19474175|P1|NOT COMPLETED|Biopsy & Product Manufacture||13
7913092|NCT00642642|19474175|P1|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109
7913093|NCT00642642|19474175|P1|STARTED|Biopsy & Product Manufacture||122
7913094|NCT00642616|19474192|P4|NOT COMPLETED|Overall Study||7
7913095|NCT00642616|19474193|P3|NOT COMPLETED|Overall Study||9
7913096|NCT00642616|19474194|P2|NOT COMPLETED|Overall Study||7
7913097|NCT00642616|19474195|P1|NOT COMPLETED|Overall Study||9
7913098|NCT00642616|19474192|P4|COMPLETED|Overall Study||1
7913099|NCT00642616|19474193|P3|COMPLETED|Overall Study||0
7913100|NCT00642616|19474194|P2|COMPLETED|Overall Study||1
7913101|NCT00642616|19474195|P1|COMPLETED|Overall Study||0
7913102|NCT00642616|19474192|P4|STARTED|Overall Study||8
7913103|NCT00642616|19474193|P3|STARTED|Overall Study||9
7913104|NCT00642616|19474194|P2|STARTED|Overall Study||8
7913105|NCT00642616|19474195|P1|STARTED|Overall Study||9
7913106|NCT00642603|19474219|P2|NOT COMPLETED|Overall Study||18
7913107|NCT00642603|19474220|P1|NOT COMPLETED|Overall Study||21
7913108|NCT00642603|19474219|P2|COMPLETED|Overall Study||2
7913109|NCT00642603|19474220|P1|COMPLETED|Overall Study||0
7913110|NCT00642603|19474219|P2|Safety Population|Overall Study||20
7913111|NCT00642603|19474220|P1|Safety Population|Overall Study||19
7913112|NCT00642603|19474219|P2|STARTED|Overall Study||20
7913113|NCT00642603|19474220|P1|STARTED|Overall Study||21
7913114|NCT00642473|19474228|P2|NOT COMPLETED|Overall Study||11
7913115|NCT00642473|19474229|P1|NOT COMPLETED|Overall Study||4
7913116|NCT00642473|19474228|P2|COMPLETED|Overall Study||5
7913117|NCT00642473|19474229|P1|COMPLETED|Overall Study||14
7913118|NCT00642473|19474228|P2|STARTED|Overall Study||16
7913119|NCT00642473|19474229|P1|STARTED|Overall Study||18
7913120|NCT00642460|19474243|P6|NOT COMPLETED|Part III: Open-Label Up to Week 260||21
7913121|NCT00642460|19474244|P5|NOT COMPLETED|Part III: Open-Label Up to Week 260||25
7913122|NCT00642460|19474245|P4|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
7913123|NCT00642460|19474246|P3|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
7913124|NCT00642460|19474247|P2|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
7913125|NCT00642460|19474248|P1|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
7913126|NCT00642460|19474243|P6|COMPLETED|Part III: Open-Label Up to Week 260||38
7913127|NCT00642460|19474244|P5|COMPLETED|Part III: Open-Label Up to Week 260||28
7913128|NCT00642460|19474245|P4|COMPLETED|Part III: Open-Label Up to Week 260||0
7913129|NCT00642460|19474246|P3|COMPLETED|Part III: Open-Label Up to Week 260||0
7913130|NCT00642460|19474247|P2|COMPLETED|Part III: Open-Label Up to Week 260||0
7913131|NCT00642460|19474248|P1|COMPLETED|Part III: Open-Label Up to Week 260||0
7913132|NCT00642460|19474243|P6|STARTED|Part III: Open-Label Up to Week 260||59
7913133|NCT00642460|19474244|P5|STARTED|Part III: Open-Label Up to Week 260||53
7913134|NCT00642460|19474245|P4|STARTED|Part III: Open-Label Up to Week 260||0
7913135|NCT00642460|19474246|P3|STARTED|Part III: Open-Label Up to Week 260||0
7913136|NCT00642460|19474247|P2|STARTED|Part III: Open-Label Up to Week 260||0
7913137|NCT00642460|19474248|P1|STARTED|Part III: Open-Label Up to Week 260||0
7913138|NCT00642460|19474243|P6|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
7913139|NCT00642460|19474244|P5|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
7913140|NCT00642460|19474245|P4|NOT COMPLETED|Part II: Open-Label Up to Week 92||3
7913141|NCT00642460|19474246|P3|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
7913142|NCT00642460|19474247|P2|NOT COMPLETED|Part II: Open-Label Up to Week 92||8
7913143|NCT00642460|19474248|P1|NOT COMPLETED|Part II: Open-Label Up to Week 92||9
7913144|NCT00642460|19474243|P6|COMPLETED|Part II: Open-Label Up to Week 92||0
7913145|NCT00642460|19474244|P5|COMPLETED|Part II: Open-Label Up to Week 92||0
7913146|NCT00642460|19474245|P4|COMPLETED|Part II: Open-Label Up to Week 92||17
7913147|NCT00642460|19474246|P3|COMPLETED|Part II: Open-Label Up to Week 92||0
7913148|NCT00642460|19474247|P2|COMPLETED|Part II: Open-Label Up to Week 92||32
7913149|NCT00642460|19474248|P1|COMPLETED|Part II: Open-Label Up to Week 92||43
7913150|NCT00642460|19474243|P6|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
7913151|NCT00642460|19474244|P5|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
7913152|NCT00642460|19474245|P4|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20
7913153|NCT00642460|19474246|P3|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
7913154|NCT00642460|19474247|P2|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40
7913155|NCT00642460|19474248|P1|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52
7913156|NCT00642460|19474243|P6|STARTED|Part II: Open-Label Up to Week 92||0
7913157|NCT00642460|19474244|P5|STARTED|Part II: Open-Label Up to Week 92||0
7913158|NCT00642460|19474245|P4|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20
7913159|NCT00642460|19474246|P3|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0
7913160|NCT00642460|19474247|P2|STARTED|Part II: Open-Label Up to Week 92||40
7913161|NCT00642460|19474248|P1|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52
7913162|NCT00642460|19474243|P6|NOT COMPLETED|Part I: 12 Week Double-Blind||0
7913163|NCT00642460|19474244|P5|NOT COMPLETED|Part I: 12 Week Double-Blind||0
7913164|NCT00642460|19474245|P4|NOT COMPLETED|Part I: 12 Week Double-Blind||0
7913165|NCT00642460|19474246|P3|NOT COMPLETED|Part I: 12 Week Double-Blind||1
7913166|NCT00642460|19474247|P2|NOT COMPLETED|Part I: 12 Week Double-Blind||1
7913167|NCT00642460|19474248|P1|NOT COMPLETED|Part I: 12 Week Double-Blind||1
7913168|NCT00642460|19474243|P6|COMPLETED|Part I: 12 Week Double-Blind||0
7913169|NCT00642460|19474244|P5|COMPLETED|Part I: 12 Week Double-Blind||0
7913170|NCT00642460|19474245|P4|COMPLETED|Part I: 12 Week Double-Blind||0
7913171|NCT00642460|19474246|P3|COMPLETED|Part I: 12 Week Double-Blind||36
7913172|NCT00642460|19474247|P2|COMPLETED|Part I: 12 Week Double-Blind||37
7913173|NCT00642460|19474248|P1|COMPLETED|Part I: 12 Week Double-Blind||36
7913174|NCT00642460|19474243|P6|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
7913175|NCT00642460|19474244|P5|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
7913176|NCT00642460|19474245|P4|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
7913177|NCT00642460|19474246|P3|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
7913178|NCT00642460|19474247|P2|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38
7913179|NCT00642460|19474248|P1|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
7913180|NCT00642460|19474243|P6|STARTED|Part I: 12 Week Double-Blind||0
7913181|NCT00642460|19474244|P5|STARTED|Part I: 12 Week Double-Blind||0
7913182|NCT00642460|19474245|P4|STARTED|Part I: 12 Week Double-Blind||0
7913183|NCT00642460|19474246|P3|STARTED|Part I: 12 Week Double-Blind||37
7913184|NCT00642460|19474247|P2|STARTED|Part I: 12 Week Double-Blind||38
7913185|NCT00642460|19474248|P1|STARTED|Part I: 12 Week Double-Blind||37
7913186|NCT00642382|19474314|P2|NOT COMPLETED|Overall Study||0
7913187|NCT00642382|19474315|P1|NOT COMPLETED|Overall Study||0
7913188|NCT00642382|19474314|P2|COMPLETED|Overall Study||0
7913189|NCT00642382|19474315|P1|COMPLETED|Overall Study||0
7913190|NCT00642382|19474314|P2|STARTED|Overall Study||0
7913191|NCT00642382|19474315|P1|STARTED|Overall Study||0
7913192|NCT00642369|19474323|P2|NOT COMPLETED|Overall Study||6
7913193|NCT00642369|19474324|P1|NOT COMPLETED|Overall Study||5
7913194|NCT00642369|19474323|P2|COMPLETED|Overall Study||24
7913195|NCT00642369|19474324|P1|COMPLETED|Overall Study||25
7913196|NCT00642369|19474323|P2|STARTED|Overall Study||30
7913197|NCT00642369|19474324|P1|STARTED|Overall Study||30
7913198|NCT00642356|19474334|P2|NOT COMPLETED|Overall Study||3
7913199|NCT00642356|19474335|P1|NOT COMPLETED|Overall Study||2
7913200|NCT00642356|19474334|P2|COMPLETED|Overall Study||4
7913201|NCT00642356|19474335|P1|COMPLETED|Overall Study||5
7913202|NCT00642356|19474334|P2|STARTED|Overall Study||7
7913203|NCT00642356|19474335|P1|STARTED|Overall Study||7
7913204|NCT00642304|19474343|P1|NOT COMPLETED|Overall Study||6
7913205|NCT00642304|19474343|P1|COMPLETED|Overall Study||14
7913206|NCT00642304|19474343|P1|STARTED|Overall Study||20
7913207|NCT00642278|19474359|P7|NOT COMPLETED|Overall Study||5
7913208|NCT00642278|19474360|P6|NOT COMPLETED|Overall Study||7
7913209|NCT00642278|19474361|P5|NOT COMPLETED|Overall Study||8
7913210|NCT00642278|19474362|P4|NOT COMPLETED|Overall Study||9
7913211|NCT00642278|19474363|P3|NOT COMPLETED|Overall Study||5
7913212|NCT00642278|19474364|P2|NOT COMPLETED|Overall Study||5
7913213|NCT00642278|19474365|P1|NOT COMPLETED|Overall Study||10
7913214|NCT00642278|19474359|P7|COMPLETED|Overall Study||60
7913215|NCT00642278|19474360|P6|COMPLETED|Overall Study||57
7913216|NCT00642278|19474361|P5|COMPLETED|Overall Study||56
7913217|NCT00642278|19474362|P4|COMPLETED|Overall Study||56
7913218|NCT00642278|19474363|P3|COMPLETED|Overall Study||59
7913219|NCT00642278|19474364|P2|COMPLETED|Overall Study||59
7913220|NCT00642278|19474365|P1|COMPLETED|Overall Study||55
7913221|NCT00642278|19474359|P7|STARTED|Overall Study||65
7913222|NCT00642278|19474360|P6|STARTED|Overall Study||64
7913223|NCT00642278|19474361|P5|STARTED|Overall Study||64
7913224|NCT00642278|19474362|P4|STARTED|Overall Study||65
7913225|NCT00642278|19474363|P3|STARTED|Overall Study||64
7913226|NCT00642278|19474364|P2|STARTED|Overall Study||64
7913227|NCT00642278|19474365|P1|STARTED|Overall Study||65
7913228|NCT00642174|19474418|P2|NOT COMPLETED|Period 2 - Crossover Drug||0
7913229|NCT00642174|19474419|P1|NOT COMPLETED|Period 2 - Crossover Drug||0
7913230|NCT00642174|19474418|P2|COMPLETED|Period 2 - Crossover Drug||16
7913231|NCT00642174|19474419|P1|COMPLETED|Period 2 - Crossover Drug||18
7913232|NCT00642174|19474418|P2|STARTED|Period 2 - Crossover Drug||16
7913233|NCT00642174|19474419|P1|STARTED|Period 2 - Crossover Drug||18
7913234|NCT00642174|19474418|P2|NOT COMPLETED|Period 1 - Initial Drug||1
7913235|NCT00642174|19474419|P1|NOT COMPLETED|Period 1 - Initial Drug||0
7913236|NCT00642174|19474418|P2|COMPLETED|Period 1 - Initial Drug||16
7913237|NCT00642174|19474419|P1|COMPLETED|Period 1 - Initial Drug||18
7913238|NCT00642174|19474418|P2|STARTED|Period 1 - Initial Drug||17
7913239|NCT00642174|19474419|P1|STARTED|Period 1 - Initial Drug||18
7913240|NCT00642018|19474435|P2|NOT COMPLETED|Overall Study||79
7913241|NCT00642018|19474436|P1|NOT COMPLETED|Overall Study||28
7913242|NCT00642018|19474435|P2|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|23
7913243|NCT00642018|19474436|P1|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|24
7913244|NCT00642018|19474435|P2|Received at Least One Dose of Study Drug|Overall Study||98
7913245|NCT00642018|19474436|P1|Received at Least One Dose of Study Drug|Overall Study||51
7913246|NCT00642018|19474435|P2|STARTED|Overall Study||102
7913247|NCT00642018|19474436|P1|STARTED|Overall Study||52
7913248|NCT00641862|19474466|P2|NOT COMPLETED|Overall Study||38
7913249|NCT00641862|19474467|P1|NOT COMPLETED|Overall Study||44
7913250|NCT00641862|19474466|P2|COMPLETED|Overall Study||145
7913251|NCT00641862|19474467|P1|COMPLETED|Overall Study||139
7913252|NCT00641862|19474466|P2|STARTED|Overall Study||183
7913253|NCT00641862|19474467|P1|STARTED|Overall Study||183
7913254|NCT00641797|19474485|P2|NOT COMPLETED|Overall Study||0
7913255|NCT00641797|19474486|P1|NOT COMPLETED|Overall Study||0
7913256|NCT00641797|19474485|P2|COMPLETED|Overall Study||15
7913257|NCT00641797|19474486|P1|COMPLETED|Overall Study||11
7913258|NCT00641797|19474485|P2|STARTED|Overall Study||15
7913259|NCT00641797|19474486|P1|STARTED|Overall Study||11
7913260|NCT00641745|19474494|P2|NOT COMPLETED|Overall Study||113
7913261|NCT00641745|19474495|P1|NOT COMPLETED|Overall Study||280
7913262|NCT00641745|19474494|P2|COMPLETED|Overall Study||89
7913263|NCT00641745|19474495|P1|COMPLETED|Overall Study||147
7913264|NCT00641745|19474494|P2|STARTED|Overall Study||202
7913265|NCT00641745|19474495|P1|STARTED|Overall Study||427
7913266|NCT00641719|19474503|P2|NOT COMPLETED|Overall Study||37
7913267|NCT00641719|19474504|P1|NOT COMPLETED|Overall Study||30
7913268|NCT00641719|19474503|P2|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92
7913269|NCT00641719|19474504|P1|COMPLETED|Overall Study||99
7913270|NCT00641719|19474503|P2|STARTED|Overall Study||129
7913271|NCT00641719|19474504|P1|STARTED|Overall Study||129
7913272|NCT00641706|19474528|P2|NOT COMPLETED|Overall Study||3
7913273|NCT00641706|19474529|P1|NOT COMPLETED|Overall Study||9
7913274|NCT00641706|19474528|P2|COMPLETED|Overall Study||4
7913275|NCT00641706|19474529|P1|COMPLETED|Overall Study||28
7913276|NCT00641706|19474528|P2|STARTED|Overall Study||7
7913277|NCT00641706|19474529|P1|STARTED|Overall Study||37
7913278|NCT00641667|19474541|P1|NOT COMPLETED|Overall Study||6
7913279|NCT00641667|19474541|P1|COMPLETED|Overall Study||60
7913280|NCT00641667|19474541|P1|STARTED|Overall Study||66
7913281|NCT00641641|19474551|P1|NOT COMPLETED|Overall Study||0
7913282|NCT00641641|19474551|P1|COMPLETED|Overall Study||16
7913283|NCT00641641|19474551|P1|STARTED|Overall Study||16
7913284|NCT00641563|19474555|P2|NOT COMPLETED|Infusion 2||0
7913285|NCT00641563|19474556|P1|NOT COMPLETED|Infusion 2||0
7913286|NCT00641563|19474555|P2|COMPLETED|Infusion 2||5
7913287|NCT00641563|19474556|P1|COMPLETED|Infusion 2||5
7913288|NCT00641563|19474555|P2|STARTED|Infusion 2||5
7913289|NCT00641563|19474556|P1|STARTED|Infusion 2||5
7913290|NCT00641563|19474555|P2|NOT COMPLETED|Infusion 1||0
7913291|NCT00641563|19474556|P1|NOT COMPLETED|Infusion 1||0
7913292|NCT00641563|19474555|P2|COMPLETED|Infusion 1||5
7913293|NCT00641563|19474556|P1|COMPLETED|Infusion 1||5
7913294|NCT00641563|19474555|P2|STARTED|Infusion 1||5
7913295|NCT00641563|19474556|P1|STARTED|Infusion 1||5
7913296|NCT00641537|19474569|P8|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
7913297|NCT00641537|19474570|P7|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
7913298|NCT00641537|19474571|P6|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
7913299|NCT00641537|19474572|P5|NOT COMPLETED|24-Week Supplemental Follow-up Period||5
7913300|NCT00641537|19474573|P4|NOT COMPLETED|24-Week Supplemental Follow-up Period||4
7913301|NCT00641537|19474574|P3|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
7913302|NCT00641537|19474575|P2|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
7913303|NCT00641537|19474576|P1|NOT COMPLETED|24-Week Supplemental Follow-up Period||0
7913304|NCT00641537|19474569|P8|COMPLETED|24-Week Supplemental Follow-up Period||10
7913305|NCT00641537|19474570|P7|COMPLETED|24-Week Supplemental Follow-up Period||8
7913306|NCT00641537|19474571|P6|COMPLETED|24-Week Supplemental Follow-up Period||14
7913307|NCT00641537|19474572|P5|COMPLETED|24-Week Supplemental Follow-up Period||193
7913308|NCT00641537|19474573|P4|COMPLETED|24-Week Supplemental Follow-up Period||147
7913309|NCT00641537|19474574|P3|COMPLETED|24-Week Supplemental Follow-up Period||140
7913310|NCT00641537|19474575|P2|COMPLETED|24-Week Supplemental Follow-up Period||66
7913311|NCT00641537|19474576|P1|COMPLETED|24-Week Supplemental Follow-up Period||75
7913312|NCT00641537|19474569|P8|STARTED|24-Week Supplemental Follow-up Period||11
7913313|NCT00641537|19474570|P7|STARTED|24-Week Supplemental Follow-up Period||9
7913314|NCT00641537|19474571|P6|STARTED|24-Week Supplemental Follow-up Period||15
7913315|NCT00641537|19474572|P5|STARTED|24-Week Supplemental Follow-up Period||198
7913316|NCT00641537|19474573|P4|STARTED|24-Week Supplemental Follow-up Period||151
7913317|NCT00641537|19474574|P3|STARTED|24-Week Supplemental Follow-up Period||143
7913318|NCT00641537|19474575|P2|STARTED|24-Week Supplemental Follow-up Period||69
7913319|NCT00641537|19474576|P1|STARTED|24-Week Supplemental Follow-up Period||75
7913320|NCT00641537|19474569|P8|NOT COMPLETED|96-week Period||6
7913321|NCT00641537|19474570|P7|NOT COMPLETED|96-week Period||5
7913322|NCT00641537|19474571|P6|NOT COMPLETED|96-week Period||7
7913323|NCT00641537|19474572|P5|NOT COMPLETED|96-week Period||17
7913324|NCT00641537|19474573|P4|NOT COMPLETED|96-week Period||12
7913325|NCT00641537|19474574|P3|NOT COMPLETED|96-week Period||20
7913326|NCT00641537|19474575|P2|NOT COMPLETED|96-week Period||10
7913327|NCT00641537|19474576|P1|NOT COMPLETED|96-week Period||9
7913328|NCT00641537|19474569|P8|COMPLETED|96-week Period||16
7913329|NCT00641537|19474570|P7|COMPLETED|96-week Period||12
7913330|NCT00641537|19474571|P6|COMPLETED|96-week Period||15
7913331|NCT00641537|19474572|P5|COMPLETED|96-week Period||227
7913332|NCT00641537|19474573|P4|COMPLETED|96-week Period||174
7913333|NCT00641537|19474574|P3|COMPLETED|96-week Period||166
7913334|NCT00641537|19474575|P2|COMPLETED|96-week Period||82
7913335|NCT00641537|19474576|P1|COMPLETED|96-week Period||89
7913336|NCT00641537|19474569|P8|STARTED|96-week Period||22
7913337|NCT00641537|19474570|P7|STARTED|96-week Period||17
7913338|NCT00641537|19474571|P6|STARTED|96-week Period||22
7913339|NCT00641537|19474572|P5|STARTED|96-week Period||244
7913340|NCT00641537|19474573|P4|STARTED|96-week Period||186
7913341|NCT00641537|19474574|P3|STARTED|96-week Period||186
7913342|NCT00641537|19474575|P2|STARTED|96-week Period||92
7913343|NCT00641537|19474576|P1|STARTED|96-week Period||98
7913344|NCT00641147|19474664|P2|NOT COMPLETED|Completed 16 Months.||0
7913345|NCT00641147|19474665|P1|NOT COMPLETED|Completed 16 Months.||2
7913346|NCT00641147|19474664|P2|COMPLETED|Completed 16 Months.||19
7913347|NCT00641147|19474665|P1|COMPLETED|Completed 16 Months.||13
7913348|NCT00641147|19474664|P2|STARTED|Completed 16 Months.||19
7913349|NCT00641147|19474665|P1|STARTED|Completed 16 Months.||15
7913350|NCT00641147|19474664|P2|NOT COMPLETED|Completed 12 Months.||2
7913351|NCT00641147|19474665|P1|NOT COMPLETED|Completed 12 Months.||1
7913352|NCT00641147|19474664|P2|COMPLETED|Completed 12 Months.||19
7913353|NCT00641147|19474665|P1|COMPLETED|Completed 12 Months.||15
7913354|NCT00641147|19474664|P2|STARTED|Completed 12 Months.||21
7913355|NCT00641147|19474665|P1|STARTED|Completed 12 Months.||16
7913356|NCT00641147|19474664|P2|NOT COMPLETED|Completed 8 Months.||2
7913357|NCT00641147|19474665|P1|NOT COMPLETED|Completed 8 Months.||3
7913358|NCT00641147|19474664|P2|COMPLETED|Completed 8 Months.||21
7913359|NCT00641147|19474665|P1|COMPLETED|Completed 8 Months.||16
7913360|NCT00641147|19474664|P2|STARTED|Completed 8 Months.||23
7913361|NCT00641147|19474665|P1|STARTED|Completed 8 Months.||19
7913362|NCT00641147|19474664|P2|NOT COMPLETED|Completed 4 Months.||0
7913363|NCT00641147|19474665|P1|NOT COMPLETED|Completed 4 Months.||2
7913364|NCT00641147|19474664|P2|COMPLETED|Completed 4 Months.||23
7913365|NCT00641147|19474665|P1|COMPLETED|Completed 4 Months.||19
7913366|NCT00641147|19474664|P2|STARTED|Completed 4 Months.||23
7913367|NCT00641147|19474665|P1|STARTED|Completed 4 Months.||21
7913368|NCT00641108|19474709|P2|NOT COMPLETED|Overall Study||0
7913369|NCT00641108|19474710|P1|NOT COMPLETED|Overall Study||0
7913370|NCT00641108|19474709|P2|COMPLETED|Overall Study||0
7913371|NCT00641108|19474710|P1|COMPLETED|Overall Study||0
7913372|NCT00641108|19474709|P2|STARTED|Overall Study||0
7913373|NCT00641108|19474710|P1|STARTED|Overall Study||0
7913374|NCT00641056|19474718|P2|NOT COMPLETED|Overall Study||25
7913375|NCT00641056|19474719|P1|NOT COMPLETED|Overall Study||29
7913376|NCT00641056|19474718|P2|COMPLETED|Overall Study||209
7913377|NCT00641056|19474719|P1|COMPLETED|Overall Study||204
7913378|NCT00641056|19474718|P2|Intent to Treat (ITT)|Overall Study||223
7913379|NCT00641056|19474719|P1|Intent to Treat (ITT)|Overall Study||233
7913380|NCT00641056|19474718|P2|STARTED|Overall Study||234
7913381|NCT00641056|19474719|P1|STARTED|Overall Study||233
7913382|NCT00641043|19474747|P2|NOT COMPLETED|Overall Study||15
7913383|NCT00641043|19474748|P1|NOT COMPLETED|Overall Study||19
7913384|NCT00641043|19474747|P2|COMPLETED|Overall Study|number who completed treatment|244
7913385|NCT00641043|19474748|P1|COMPLETED|Overall Study|number who completed treatment|111
7913386|NCT00641043|19474747|P2|STARTED|Overall Study|number who started treatment|259
7913387|NCT00641043|19474748|P1|STARTED|Overall Study|number who started treatment|130
7913388|NCT00640978|19474778|P1|NOT COMPLETED|Overall Study||0
7913389|NCT00640978|19474778|P1|COMPLETED|Overall Study||15
7913390|NCT00640978|19474778|P1|STARTED|Overall Study||15
7913391|NCT00640926|19474785|P3|NOT COMPLETED|Overall Study||8
7913392|NCT00640926|19474786|P2|NOT COMPLETED|Overall Study||6
7913393|NCT00640926|19474787|P1|NOT COMPLETED|Overall Study||8
7913394|NCT00640926|19474785|P3|COMPLETED|Overall Study||45
7913395|NCT00640926|19474786|P2|COMPLETED|Overall Study||46
7913396|NCT00640926|19474787|P1|COMPLETED|Overall Study||45
7913397|NCT00640926|19474785|P3|STARTED|Overall Study||53
7913398|NCT00640926|19474786|P2|STARTED|Overall Study||52
7913399|NCT00640926|19474787|P1|STARTED|Overall Study||53
7913400|NCT00640835|19474800|P2|NOT COMPLETED|Overall Study||57
7913401|NCT00640835|19474801|P1|NOT COMPLETED|Overall Study||76
7913402|NCT00640835|19474800|P2|COMPLETED|Overall Study||131
7913403|NCT00640835|19474801|P1|COMPLETED|Overall Study||118
7913404|NCT00640835|19474800|P2|STARTED|Overall Study||188
7913405|NCT00640835|19474801|P1|STARTED|Overall Study||194
7913406|NCT00640822|19474812|P3|NOT COMPLETED|Overall Study||25
7913407|NCT00640822|19474813|P2|NOT COMPLETED|Overall Study||59
7913408|NCT00640822|19474814|P1|NOT COMPLETED|Overall Study||43
7913409|NCT00640822|19474812|P3|COMPLETED|Overall Study||77
7913410|NCT00640822|19474813|P2|COMPLETED|Overall Study||258
7913411|NCT00640822|19474814|P1|COMPLETED|Overall Study||279
7913412|NCT00640822|19474812|P3|STARTED|Overall Study||102
7913413|NCT00640822|19474813|P2|STARTED|Overall Study||317
7913414|NCT00640822|19474814|P1|STARTED|Overall Study||322
7913415|NCT00640653|19474827|P5|NOT COMPLETED|Overall Study||5
7913416|NCT00640653|19474828|P4|NOT COMPLETED|Overall Study||2
7913417|NCT00640653|19474829|P3|NOT COMPLETED|Overall Study||0
7913418|NCT00640653|19474830|P2|NOT COMPLETED|Overall Study||3
7913419|NCT00640653|19474831|P1|NOT COMPLETED|Overall Study||3
7913420|NCT00640653|19474827|P5|COMPLETED|Overall Study||129
7913421|NCT00640653|19474828|P4|COMPLETED|Overall Study||132
7913422|NCT00640653|19474829|P3|COMPLETED|Overall Study||129
7913423|NCT00640653|19474830|P2|COMPLETED|Overall Study||131
7913424|NCT00640653|19474831|P1|COMPLETED|Overall Study||128
7913425|NCT00640653|19474827|P5|Followed-up at 24 mo|Overall Study||112
7913426|NCT00640653|19474828|P4|Followed-up at 24 mo|Overall Study||112
7913427|NCT00640653|19474829|P3|Followed-up at 24 mo|Overall Study||105
7913428|NCT00640653|19474830|P2|Followed-up at 24 mo|Overall Study||116
7913429|NCT00640653|19474831|P1|Followed-up at 24 mo|Overall Study||114
7913430|NCT00640653|19474827|P5|Followed-up at 18 mo|Overall Study||117
7913431|NCT00640653|19474828|P4|Followed-up at 18 mo|Overall Study||117
7913432|NCT00640653|19474829|P3|Followed-up at 18 mo|Overall Study||113
7913433|NCT00640653|19474830|P2|Followed-up at 18 mo|Overall Study||112
7913434|NCT00640653|19474831|P1|Followed-up at 18 mo|Overall Study||118
7913435|NCT00640653|19474827|P5|Followed-up at 12 mo|Overall Study||116
7913436|NCT00640653|19474828|P4|Followed-up at 12 mo|Overall Study||122
7913437|NCT00640653|19474829|P3|Followed-up at 12 mo|Overall Study||115
7913438|NCT00640653|19474830|P2|Followed-up at 12 mo|Overall Study||121
7913439|NCT00640653|19474831|P1|Followed-up at 12 mo|Overall Study||124
7913440|NCT00640653|19474827|P5|Followed-up at 6 mo|Overall Study||125
7913441|NCT00640653|19474828|P4|Followed-up at 6 mo|Overall Study||130
7913442|NCT00640653|19474829|P3|Followed-up at 6 mo|Overall Study||124
7913443|NCT00640653|19474830|P2|Followed-up at 6 mo|Overall Study||130
7913444|NCT00640653|19474831|P1|Followed-up at 6 mo|Overall Study||127
7913445|NCT00640653|19474827|P5|Followed-up at 3 mo|Overall Study||126
7913446|NCT00640653|19474828|P4|Followed-up at 3 mo|Overall Study||129
7913447|NCT00640653|19474829|P3|Followed-up at 3 mo|Overall Study||125
7913448|NCT00640653|19474830|P2|Followed-up at 3 mo|Overall Study||127
7913449|NCT00640653|19474831|P1|Followed-up at 3 mo|Overall Study||126
7913450|NCT00640653|19474827|P5|STARTED|Overall Study||134
7913451|NCT00640653|19474828|P4|STARTED|Overall Study||134
7913452|NCT00640653|19474829|P3|STARTED|Overall Study||129
7913453|NCT00640653|19474830|P2|STARTED|Overall Study||134
7913454|NCT00640653|19474831|P1|STARTED|Overall Study||131
7913455|NCT00640614|19474865|P2|NOT COMPLETED|Overall Study||0
7913456|NCT00640614|19474866|P1|NOT COMPLETED|Overall Study||1
7913457|NCT00640614|19474865|P2|COMPLETED|Overall Study||110
7913458|NCT00640614|19474866|P1|COMPLETED|Overall Study||124
7913459|NCT00640614|19474865|P2|STARTED|Overall Study||110
7913460|NCT00640614|19474866|P1|STARTED|Overall Study||125
7913461|NCT00640601|19474908|P1|NOT COMPLETED|Overall Study||112
7913462|NCT00640601|19474908|P1|COMPLETED|Overall Study||183
7913463|NCT00640601|19474908|P1|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295
7913464|NCT00640562|19474924|P2|NOT COMPLETED|Overall Study||26
7913465|NCT00640562|19474925|P1|NOT COMPLETED|Overall Study||18
7913466|NCT00640562|19474924|P2|COMPLETED|Overall Study||81
7913467|NCT00640562|19474925|P1|COMPLETED|Overall Study||91
7913468|NCT00640562|19474924|P2|STARTED|Overall Study||107
7913469|NCT00640562|19474925|P1|STARTED|Overall Study||109
7913470|NCT00640510|19474953|P2|NOT COMPLETED|Overall Study||2
7913471|NCT00640510|19474954|P1|NOT COMPLETED|Overall Study||1
7913472|NCT00640510|19474953|P2|COMPLETED|Overall Study||15
7913473|NCT00640510|19474954|P1|COMPLETED|Overall Study||16
7913474|NCT00640510|19474953|P2|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17
7913475|NCT00640510|19474954|P1|STARTED|Overall Study||17
7913476|NCT00640393|19474966|P3|NOT COMPLETED|Part 2||3
7913477|NCT00640393|19474967|P2|NOT COMPLETED|Part 2||10
7913478|NCT00640393|19474968|P1|NOT COMPLETED|Part 2||0
7913479|NCT00640393|19474966|P3|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35
7913480|NCT00640393|19474967|P2|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27
7913481|NCT00640393|19474968|P1|COMPLETED|Part 2||0
7913482|NCT00640393|19474966|P3|STARTED|Part 2||38
7913483|NCT00640393|19474967|P2|STARTED|Part 2||37
7913484|NCT00640393|19474968|P1|STARTED|Part 2||0
7913485|NCT00640393|19474966|P3|NOT COMPLETED|Randomization||0
7913486|NCT00640393|19474967|P2|NOT COMPLETED|Randomization||0
7913487|NCT00640393|19474968|P1|NOT COMPLETED|Randomization||19
7913488|NCT00640393|19474966|P3|COMPLETED|Randomization||0
7913489|NCT00640393|19474967|P2|COMPLETED|Randomization||0
7913490|NCT00640393|19474968|P1|COMPLETED|Randomization||75
7913491|NCT00640393|19474966|P3|STARTED|Randomization||0
7913492|NCT00640393|19474967|P2|STARTED|Randomization||0
7913493|NCT00640393|19474968|P1|STARTED|Randomization||94
7913494|NCT00640393|19474966|P3|NOT COMPLETED|Part 1||0
7913495|NCT00640393|19474967|P2|NOT COMPLETED|Part 1||0
7913496|NCT00640393|19474968|P1|NOT COMPLETED|Part 1||5
7913497|NCT00640393|19474966|P3|COMPLETED|Part 1||0
7913498|NCT00640393|19474967|P2|COMPLETED|Part 1||0
7913499|NCT00640393|19474968|P1|COMPLETED|Part 1||94
7913500|NCT00640393|19474966|P3|STARTED|Part 1||0
7913501|NCT00640393|19474967|P2|STARTED|Part 1||0
7913502|NCT00640393|19474968|P1|STARTED|Part 1||99
7913503|NCT00640341|19475033|P3|NOT COMPLETED|Overall Study||7
7913504|NCT00640341|19475034|P2|NOT COMPLETED|Overall Study||5
7913505|NCT00640341|19475035|P1|NOT COMPLETED|Overall Study||21
7913506|NCT00640341|19475033|P3|COMPLETED|Overall Study||163
7913507|NCT00640341|19475034|P2|COMPLETED|Overall Study||165
7913508|NCT00640341|19475035|P1|COMPLETED|Overall Study||149
7913509|NCT00640341|19475033|P3|Eligible Participants at Baseline|Overall Study||168
7913510|NCT00640341|19475034|P2|Eligible Participants at Baseline|Overall Study||167
7913511|NCT00640341|19475035|P1|Eligible Participants at Baseline|Overall Study||165
7913512|NCT00640341|19475033|P3|STARTED|Overall Study||170
7913513|NCT00640341|19475034|P2|STARTED|Overall Study||170
7913514|NCT00640341|19475035|P1|STARTED|Overall Study|All Starting participants were dispensed lenses|170
7913515|NCT00640328|19475055|P6|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
7913516|NCT00640328|19475056|P5|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
7913517|NCT00640328|19475057|P4|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
7913518|NCT00640328|19475058|P3|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
7913519|NCT00640328|19475059|P2|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
7913520|NCT00640328|19475060|P1|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
7913521|NCT00640328|19475055|P6|COMPLETED|IFUP (Week 48 to Individual Termination)||4
7913522|NCT00640328|19475056|P5|COMPLETED|IFUP (Week 48 to Individual Termination)||4
7913523|NCT00640328|19475057|P4|COMPLETED|IFUP (Week 48 to Individual Termination)||3
7913524|NCT00640328|19475058|P3|COMPLETED|IFUP (Week 48 to Individual Termination)||6
7913525|NCT00640328|19475059|P2|COMPLETED|IFUP (Week 48 to Individual Termination)||10
7913526|NCT00640328|19475060|P1|COMPLETED|IFUP (Week 48 to Individual Termination)||8
7913527|NCT00640328|19475055|P6|STARTED|IFUP (Week 48 to Individual Termination)||4
7913528|NCT00640328|19475056|P5|STARTED|IFUP (Week 48 to Individual Termination)||4
7913529|NCT00640328|19475057|P4|STARTED|IFUP (Week 48 to Individual Termination)||4
7913530|NCT00640328|19475058|P3|STARTED|IFUP (Week 48 to Individual Termination)||7
7913531|NCT00640328|19475059|P2|STARTED|IFUP (Week 48 to Individual Termination)||11
7913532|NCT00640328|19475060|P1|STARTED|IFUP (Week 48 to Individual Termination)||8
7913533|NCT00640328|19475055|P6|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
7913534|NCT00640328|19475056|P5|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1
7913535|NCT00640328|19475057|P4|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
7913536|NCT00640328|19475058|P3|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
7913537|NCT00640328|19475059|P2|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
7913538|NCT00640328|19475060|P1|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
7913539|NCT00640328|19475055|P6|COMPLETED|Second Treatment Period (Weeks 24-48)||4
7913540|NCT00640328|19475056|P5|COMPLETED|Second Treatment Period (Weeks 24-48)||3
7913541|NCT00640328|19475057|P4|COMPLETED|Second Treatment Period (Weeks 24-48)||4
7913542|NCT00640328|19475058|P3|COMPLETED|Second Treatment Period (Weeks 24-48)||7
7913543|NCT00640328|19475059|P2|COMPLETED|Second Treatment Period (Weeks 24-48)||10
7913544|NCT00640328|19475060|P1|COMPLETED|Second Treatment Period (Weeks 24-48)||8
7913545|NCT00640328|19475055|P6|STARTED|Second Treatment Period (Weeks 24-48)||4
7913546|NCT00640328|19475056|P5|STARTED|Second Treatment Period (Weeks 24-48)||4
7913547|NCT00640328|19475057|P4|STARTED|Second Treatment Period (Weeks 24-48)||4
7913548|NCT00640328|19475058|P3|STARTED|Second Treatment Period (Weeks 24-48)||7
7913549|NCT00640328|19475059|P2|STARTED|Second Treatment Period (Weeks 24-48)||10
7913550|NCT00640328|19475060|P1|STARTED|Second Treatment Period (Weeks 24-48)||8
7913551|NCT00640328|19475055|P6|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
7913552|NCT00640328|19475056|P5|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
7913553|NCT00640328|19475057|P4|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
7913554|NCT00640328|19475058|P3|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
7913555|NCT00640328|19475059|P2|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1
7913556|NCT00640328|19475060|P1|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
7913557|NCT00640328|19475055|P6|COMPLETED|First Treatment Period (Weeks 0-24)||4
7913558|NCT00640328|19475056|P5|COMPLETED|First Treatment Period (Weeks 0-24)||4
7913559|NCT00640328|19475057|P4|COMPLETED|First Treatment Period (Weeks 0-24)||4
7913560|NCT00640328|19475058|P3|COMPLETED|First Treatment Period (Weeks 0-24)||7
7913561|NCT00640328|19475059|P2|COMPLETED|First Treatment Period (Weeks 0-24)||10
7913562|NCT00640328|19475060|P1|COMPLETED|First Treatment Period (Weeks 0-24)||8
7913563|NCT00640328|19475055|P6|STARTED|First Treatment Period (Weeks 0-24)||4
7913564|NCT00640328|19475056|P5|STARTED|First Treatment Period (Weeks 0-24)||4
7913565|NCT00640328|19475057|P4|STARTED|First Treatment Period (Weeks 0-24)||4
7913566|NCT00640328|19475058|P3|STARTED|First Treatment Period (Weeks 0-24)||7
7913567|NCT00640328|19475059|P2|STARTED|First Treatment Period (Weeks 0-24)||11
7913568|NCT00640328|19475060|P1|STARTED|First Treatment Period (Weeks 0-24)||8
7913569|NCT00640315|19475226|P2|NOT COMPLETED|Overall Study||1
7913570|NCT00640315|19475227|P1|NOT COMPLETED|Overall Study||0
7913571|NCT00640315|19475226|P2|COMPLETED|Overall Study||12
7913572|NCT00640315|19475227|P1|COMPLETED|Overall Study||10
7913573|NCT00640315|19475226|P2|Participants Received Treatment|Overall Study||13
7913574|NCT00640315|19475227|P1|Participants Received Treatment|Overall Study||10
7913575|NCT00640315|19475226|P2|STARTED|Overall Study||13
7913576|NCT00640315|19475227|P1|STARTED|Overall Study||10
7913577|NCT00640289|19475353|P1|NOT COMPLETED|Overall Study||13
7913578|NCT00640289|19475353|P1|COMPLETED|Overall Study||59
7913579|NCT00640289|19475353|P1|STARTED|Overall Study||72
7913580|NCT00640250|19475358|P1|NOT COMPLETED|Overall Study||0
7913581|NCT00640250|19475358|P1|COMPLETED|Overall Study||48
7913582|NCT00640250|19475358|P1|STARTED|Overall Study||48
7913583|NCT00640224|19475465|P4|NOT COMPLETED|Overall Study||0
7913584|NCT00640224|19475466|P3|NOT COMPLETED|Overall Study||0
7913585|NCT00640224|19475467|P2|NOT COMPLETED|Overall Study||3
7913586|NCT00640224|19475468|P1|NOT COMPLETED|Overall Study||6
7913587|NCT00640224|19475465|P4|COMPLETED|Overall Study||0
7913588|NCT00640224|19475466|P3|COMPLETED|Overall Study||0
7913589|NCT00640224|19475467|P2|COMPLETED|Overall Study||20
7913590|NCT00640224|19475468|P1|COMPLETED|Overall Study||17
7913591|NCT00640224|19475465|P4|STARTED|Overall Study||0
7913592|NCT00640224|19475466|P3|STARTED|Overall Study||0
7913593|NCT00640224|19475467|P2|STARTED|Overall Study||23
7913594|NCT00640224|19475468|P1|STARTED|Overall Study||23
7913595|NCT00640146|19475568|P2|NOT COMPLETED|Overall Study||6
7913596|NCT00640146|19475569|P1|NOT COMPLETED|Overall Study||4
7913597|NCT00640146|19475568|P2|COMPLETED|Overall Study||12
7913598|NCT00640146|19475569|P1|COMPLETED|Overall Study||15
7913599|NCT00640146|19475568|P2|Received at Least 1 Dose of Study Drug|Overall Study||15
7913600|NCT00640146|19475569|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
7913601|NCT00640146|19475568|P2|STARTED|Overall Study||18
7913602|NCT00640146|19475569|P1|STARTED|Overall Study||19
7913603|NCT00640133|19475581|P2|NOT COMPLETED|Open Label Phase (Month 4-12)||0
7913604|NCT00640133|19475582|P1|NOT COMPLETED|Open Label Phase (Month 4-12)||3
7913605|NCT00640133|19475581|P2|COMPLETED|Open Label Phase (Month 4-12)||0
7913606|NCT00640133|19475582|P1|COMPLETED|Open Label Phase (Month 4-12)||24
7913607|NCT00640133|19475581|P2|STARTED|Open Label Phase (Month 4-12)||0
7913608|NCT00640133|19475582|P1|STARTED|Open Label Phase (Month 4-12)||27
7913609|NCT00640133|19475581|P2|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
7913610|NCT00640133|19475582|P1|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
7913611|NCT00640133|19475581|P2|COMPLETED|Randomization Phase (Baseline-Month 3)||12
7913612|NCT00640133|19475582|P1|COMPLETED|Randomization Phase (Baseline-Month 3)||15
7913613|NCT00640133|19475581|P2|STARTED|Randomization Phase (Baseline-Month 3)||12
7913614|NCT00640133|19475582|P1|STARTED|Randomization Phase (Baseline-Month 3)||15
7913615|NCT00640042|19475602|P1|NOT COMPLETED|Treatment||926
7913616|NCT00640042|19475602|P1|COMPLETED|Treatment||561
7913617|NCT00640042|19475602|P1|STARTED|Treatment||1487
7913618|NCT00640042|19475602|P1|NOT COMPLETED|Enrollment||83
7913619|NCT00640042|19475602|P1|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487
7913620|NCT00640042|19475602|P1|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570
7913621|NCT00640016|19475618|P4|NOT COMPLETED|Overall Study||3
7913622|NCT00640016|19475619|P3|NOT COMPLETED|Overall Study||3
7913623|NCT00640016|19475620|P2|NOT COMPLETED|Overall Study||2
7913624|NCT00640016|19475621|P1|NOT COMPLETED|Overall Study||2
7913625|NCT00640016|19475618|P4|COMPLETED|Overall Study||1
7913626|NCT00640016|19475619|P3|COMPLETED|Overall Study||1
7913627|NCT00640016|19475620|P2|COMPLETED|Overall Study||1
7913628|NCT00640016|19475621|P1|COMPLETED|Overall Study||1
7913629|NCT00640016|19475618|P4|Treated|Overall Study||4
7913630|NCT00640016|19475619|P3|Treated|Overall Study||4
7913631|NCT00640016|19475620|P2|Treated|Overall Study||2
7913632|NCT00640016|19475621|P1|Treated|Overall Study||3
7913633|NCT00640016|19475618|P4|STARTED|Overall Study||4
7913634|NCT00640016|19475619|P3|STARTED|Overall Study||4
7913635|NCT00640016|19475620|P2|STARTED|Overall Study||3
7913636|NCT00640016|19475621|P1|STARTED|Overall Study||3
7913637|NCT00639860|19475665|P1|NOT COMPLETED|Overall Study||0
7913638|NCT00639860|19475665|P1|COMPLETED|Overall Study||10
7913639|NCT00639860|19475665|P1|STARTED|Overall Study||10
7913640|NCT00639769|19475673|P1|NOT COMPLETED|Overall Study||40
7913641|NCT00639769|19475673|P1|COMPLETED|Overall Study||0
7913642|NCT00639769|19475673|P1|STARTED|Overall Study||40
7913643|NCT00639717|19475678|P1|NOT COMPLETED|Overall Study||0
7913644|NCT00639717|19475678|P1|COMPLETED|Overall Study||48
7913645|NCT00639717|19475678|P1|STARTED|Overall Study||48
7913646|NCT00639678|19475690|P4|NOT COMPLETED|Overall Study||0
7913647|NCT00639678|19475691|P3|NOT COMPLETED|Overall Study||11
7913648|NCT00639678|19475692|P2|NOT COMPLETED|Overall Study||1
7913649|NCT00639678|19475693|P1|NOT COMPLETED|Overall Study||4
7913650|NCT00639678|19475690|P4|COMPLETED|Overall Study||23
7913651|NCT00639678|19475691|P3|COMPLETED|Overall Study||206
7913652|NCT00639678|19475692|P2|COMPLETED|Overall Study||5
7913653|NCT00639678|19475693|P1|COMPLETED|Overall Study||70
7913654|NCT00639678|19475690|P4|STARTED|Overall Study||23
7913655|NCT00639678|19475691|P3|STARTED|Overall Study||217
7913656|NCT00639678|19475692|P2|STARTED|Overall Study||6
7913657|NCT00639678|19475693|P1|STARTED|Overall Study||74
7913658|NCT00639626|19475753|P1|NOT COMPLETED|Overall Study||0
7913659|NCT00639626|19475753|P1|COMPLETED|Overall Study||0
7913660|NCT00639626|19475753|P1|STARTED|Overall Study||0
7913661|NCT00639509|19475758|P1|NOT COMPLETED|Overall Study||1
7913662|NCT00639509|19475758|P1|COMPLETED|Overall Study||23
7913663|NCT00639509|19475758|P1|STARTED|Overall Study||24
7913664|NCT00639457|19475766|P2|NOT COMPLETED|Overall Study||3
7913665|NCT00639457|19475767|P1|NOT COMPLETED|Overall Study||2
7913666|NCT00639457|19475766|P2|COMPLETED|Overall Study||19
7913667|NCT00639457|19475767|P1|COMPLETED|Overall Study||20
7913668|NCT00639457|19475766|P2|STARTED|Overall Study||22
7913669|NCT00639457|19475767|P1|STARTED|Overall Study||22
7913670|NCT00639418|19475805|P4|NOT COMPLETED|Overall Study||0
7913671|NCT00639418|19475806|P3|NOT COMPLETED|Overall Study||0
7913672|NCT00639418|19475807|P2|NOT COMPLETED|Overall Study||0
7913673|NCT00639418|19475808|P1|NOT COMPLETED|Overall Study||0
7913674|NCT00639418|19475805|P4|COMPLETED|Overall Study||46930
7913675|NCT00639418|19475806|P3|COMPLETED|Overall Study||36496
7913676|NCT00639418|19475807|P2|COMPLETED|Overall Study||35967
7913677|NCT00639418|19475808|P1|COMPLETED|Overall Study||28101
7913678|NCT00639418|19475805|P4|STARTED|Overall Study||46930
7913679|NCT00639418|19475806|P3|STARTED|Overall Study||36496
7913680|NCT00639418|19475807|P2|STARTED|Overall Study||35967
7913681|NCT00639418|19475808|P1|STARTED|Overall Study||28101
7913682|NCT00639379|19475826|P2|NOT COMPLETED|Period 2 - 2 Weeks||0
7913683|NCT00639379|19475827|P1|NOT COMPLETED|Period 2 - 2 Weeks||0
7913684|NCT00639379|19475826|P2|COMPLETED|Period 2 - 2 Weeks||45
7913685|NCT00639379|19475827|P1|COMPLETED|Period 2 - 2 Weeks||39
7913686|NCT00639379|19475826|P2|STARTED|Period 2 - 2 Weeks||45
7913687|NCT00639379|19475827|P1|STARTED|Period 2 - 2 Weeks||39
7913688|NCT00639379|19475826|P2|NOT COMPLETED|Period 1 - 2 Weeks||0
7913689|NCT00639379|19475827|P1|NOT COMPLETED|Period 1 - 2 Weeks||5
7913690|NCT00639379|19475826|P2|COMPLETED|Period 1 - 2 Weeks||45
7913691|NCT00639379|19475827|P1|COMPLETED|Period 1 - 2 Weeks||39
7913692|NCT00639379|19475826|P2|STARTED|Period 1 - 2 Weeks||45
7913693|NCT00639379|19475827|P1|STARTED|Period 1 - 2 Weeks||44
7913694|NCT00639223|19475843|P2|NOT COMPLETED|Overall Study||2
7913695|NCT00639223|19475844|P1|NOT COMPLETED|Overall Study||0
7913696|NCT00639223|19475843|P2|COMPLETED|Overall Study||19
7913697|NCT00639223|19475844|P1|COMPLETED|Overall Study||22
7913698|NCT00639223|19475843|P2|STARTED|Overall Study||21
7913699|NCT00639223|19475844|P1|STARTED|Overall Study||22
7913700|NCT00639158|19475854|P2|NOT COMPLETED|Overall Study||30
7913701|NCT00639158|19475855|P1|NOT COMPLETED|Overall Study||26
7913702|NCT00639158|19475854|P2|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240
7913703|NCT00639158|19475855|P1|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246
7913704|NCT00639158|19475854|P2|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270
7913705|NCT00639158|19475855|P1|STARTED|Overall Study|All randomized subjects were treated.|272
7913706|NCT00639093|19475877|P2|NOT COMPLETED|Overall Study||0
7913707|NCT00639093|19475878|P1|NOT COMPLETED|Overall Study||0
7913708|NCT00639093|19475877|P2|COMPLETED|Overall Study|46|46
7913709|NCT00639093|19475878|P1|COMPLETED|Overall Study|45|45
7913710|NCT00639093|19475877|P2|STARTED|Overall Study|46|46
7913711|NCT00639093|19475878|P1|STARTED|Overall Study|45|45
7913712|NCT00639002|19475884|P1|NOT COMPLETED|Overall Study||13
7913713|NCT00639002|19475884|P1|COMPLETED|Overall Study||0
7913714|NCT00639002|19475884|P1|Received Ruxolitinib + Dexamethasone|Overall Study||7
7913715|NCT00639002|19475884|P1|Received Ruxolitinib|Overall Study||13
7913716|NCT00639002|19475884|P1|STARTED|Overall Study||13
7913717|NCT00638989|19475893|P3|NOT COMPLETED|Overall Study||1
7913718|NCT00638989|19475894|P2|NOT COMPLETED|Overall Study||0
7913719|NCT00638989|19475895|P1|NOT COMPLETED|Overall Study||0
7913720|NCT00638989|19475893|P3|COMPLETED|Overall Study||9
7913721|NCT00638989|19475894|P2|COMPLETED|Overall Study||10
7913722|NCT00638989|19475895|P1|COMPLETED|Overall Study||10
7913723|NCT00638989|19475893|P3|STARTED|Overall Study||10
7913724|NCT00638989|19475894|P2|STARTED|Overall Study||10
7913725|NCT00638989|19475895|P1|STARTED|Overall Study||10
7913726|NCT00638963|19475935|P2|NOT COMPLETED|Overall Study||0
7913727|NCT00638963|19475936|P1|NOT COMPLETED|Overall Study||1
7913728|NCT00638963|19475935|P2|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3
7913729|NCT00638963|19475936|P1|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2
7913730|NCT00638963|19475935|P2|STARTED|Overall Study|Received randomized treatment assignment|3
7913731|NCT00638963|19475936|P1|STARTED|Overall Study|Received randomized treatment assignment|3
7913732|NCT00638937|19475955|P1|NOT COMPLETED|Overall Study||0
7913733|NCT00638937|19475955|P1|COMPLETED|Overall Study||37
7913734|NCT00638937|19475955|P1|STARTED|Overall Study||37
7913735|NCT00638924|19475966|P1|NOT COMPLETED|Overall Study||0
7913736|NCT00638924|19475966|P1|COMPLETED|Overall Study||40
7913737|NCT00638924|19475966|P1|2 Months|Overall Study||40
7913738|NCT00638924|19475966|P1|STARTED|Overall Study||40
7913739|NCT00638885|19475971|P1|NOT COMPLETED|Overall Study||0
7913740|NCT00638885|19475971|P1|COMPLETED|Overall Study||142
7913741|NCT00638885|19475971|P1|STARTED|Overall Study||142
7913742|NCT00638846|19475977|P2|NOT COMPLETED|Overall Study||6
7913743|NCT00638846|19475978|P1|NOT COMPLETED|Overall Study||4
7913744|NCT00638846|19475977|P2|COMPLETED|Overall Study||133
7913745|NCT00638846|19475978|P1|COMPLETED|Overall Study||133
7913746|NCT00638846|19475977|P2|STARTED|Overall Study||139
7913747|NCT00638846|19475978|P1|STARTED|Overall Study||137
7913748|NCT00638820|19475994|P1|NOT COMPLETED|Overall Study||0
7913749|NCT00638820|19475994|P1|COMPLETED|Overall Study||3
7913750|NCT00638820|19475994|P1|STARTED|Overall Study||3
7913751|NCT00638716|19476004|P3|NOT COMPLETED|Overall Study||12
7913752|NCT00638716|19476005|P2|NOT COMPLETED|Overall Study||15
7913753|NCT00638716|19476006|P1|NOT COMPLETED|Overall Study||7
7913754|NCT00638716|19476004|P3|COMPLETED|Overall Study||46
7913755|NCT00638716|19476005|P2|COMPLETED|Overall Study||37
7913756|NCT00638716|19476006|P1|COMPLETED|Overall Study||43
7913757|NCT00638716|19476004|P3|STARTED|Overall Study||58
7913758|NCT00638716|19476005|P2|STARTED|Overall Study||52
7913759|NCT00638716|19476006|P1|STARTED|Overall Study||50
7913760|NCT00638690|19476022|P2|NOT COMPLETED|Overall Study||342
7913761|NCT00638690|19476023|P1|NOT COMPLETED|Overall Study||681
7913762|NCT00638690|19476022|P2|COMPLETED|Overall Study||56
7913763|NCT00638690|19476023|P1|COMPLETED|Overall Study||116
7913764|NCT00638690|19476022|P2|STARTED|Overall Study||398
7913765|NCT00638690|19476023|P1|STARTED|Overall Study||797
7913766|NCT00638651|19476036|P1|NOT COMPLETED|Overall Study||0
7913767|NCT00638651|19476036|P1|COMPLETED|Overall Study||3
7913768|NCT00638651|19476036|P1|STARTED|Overall Study||3
7913769|NCT00638508|19476043|P2|NOT COMPLETED|Overall Study||2
7913770|NCT00638508|19476044|P1|NOT COMPLETED|Overall Study||5
7913771|NCT00638508|19476043|P2|COMPLETED|Overall Study||30
7913772|NCT00638508|19476044|P1|COMPLETED|Overall Study||30
7913773|NCT00638508|19476043|P2|STARTED|Overall Study||32
7913774|NCT00638508|19476044|P1|STARTED|Overall Study||35
7913775|NCT00638456|19476090|P2|NOT COMPLETED|Overall Study||2
7913776|NCT00638456|19476091|P1|NOT COMPLETED|Overall Study||6
7913777|NCT00638456|19476090|P2|COMPLETED|Overall Study||9
7913778|NCT00638456|19476091|P1|COMPLETED|Overall Study||15
7913779|NCT00638456|19476090|P2|STARTED|Overall Study||11
7913780|NCT00638456|19476091|P1|STARTED|Overall Study||21
7913781|NCT00638443|19476101|P2|NOT COMPLETED|Second Intervention||0
7913782|NCT00638443|19476102|P1|NOT COMPLETED|Second Intervention||0
7913783|NCT00638443|19476101|P2|COMPLETED|Second Intervention||14
7913784|NCT00638443|19476102|P1|COMPLETED|Second Intervention||12
7913785|NCT00638443|19476101|P2|STARTED|Second Intervention||14
7913786|NCT00638443|19476102|P1|STARTED|Second Intervention||12
7913787|NCT00638443|19476101|P2|NOT COMPLETED|Washout||0
7913788|NCT00638443|19476102|P1|NOT COMPLETED|Washout||0
7913789|NCT00638443|19476101|P2|COMPLETED|Washout||14
7913790|NCT00638443|19476102|P1|COMPLETED|Washout||12
7913791|NCT00638443|19476101|P2|STARTED|Washout||14
7913792|NCT00638443|19476102|P1|STARTED|Washout||12
7913793|NCT00638443|19476101|P2|NOT COMPLETED|First Intervention||1
7913794|NCT00638443|19476102|P1|NOT COMPLETED|First Intervention||2
7913795|NCT00638443|19476101|P2|COMPLETED|First Intervention||14
7913796|NCT00638443|19476102|P1|COMPLETED|First Intervention||12
7913797|NCT00638443|19476101|P2|STARTED|First Intervention||15
7913798|NCT00638443|19476102|P1|STARTED|First Intervention||14
7913799|NCT00638404|19476132|P2|NOT COMPLETED|Overall Study||0
7913800|NCT00638404|19476133|P1|NOT COMPLETED|Overall Study||8
7913801|NCT00638404|19476132|P2|COMPLETED|Overall Study||100
7913802|NCT00638404|19476133|P1|COMPLETED|Overall Study||192
7913803|NCT00638404|19476132|P2|STARTED|Overall Study||100
7913804|NCT00638404|19476133|P1|STARTED|Overall Study||200
7913805|NCT00638378|19476145|P1|NOT COMPLETED|Overall Study||22
7913806|NCT00638378|19476145|P1|COMPLETED|Overall Study||0
7913807|NCT00638378|19476145|P1|STARTED|Overall Study||22
7913808|NCT00638365|19476155|P3|NOT COMPLETED|Overall Study||0
7913809|NCT00638365|19476156|P2|NOT COMPLETED|Overall Study||0
7913810|NCT00638365|19476157|P1|NOT COMPLETED|Overall Study||0
7913811|NCT00638365|19476155|P3|COMPLETED|Overall Study||8
7913812|NCT00638365|19476156|P2|COMPLETED|Overall Study||10
7913813|NCT00638365|19476157|P1|COMPLETED|Overall Study||9
7913814|NCT00638365|19476155|P3|STARTED|Overall Study||8
7913815|NCT00638365|19476156|P2|STARTED|Overall Study||10
7913816|NCT00638365|19476157|P1|STARTED|Overall Study||9
7913817|NCT00638274|19476167|P2|NOT COMPLETED|Overall Study||5
7913818|NCT00638274|19476168|P1|NOT COMPLETED|Overall Study||6
7913819|NCT00638274|19476167|P2|COMPLETED|Overall Study||172
7913820|NCT00638274|19476168|P1|COMPLETED|Overall Study||173
7913821|NCT00638274|19476167|P2|STARTED|Overall Study||177
7913822|NCT00638274|19476168|P1|STARTED|Overall Study||179
7913823|NCT00638235|19476185|P9|NOT COMPLETED|Overall Study||18
7913824|NCT00638235|19476186|P8|NOT COMPLETED|Overall Study||1
7913825|NCT00638235|19476187|P7|NOT COMPLETED|Overall Study||0
7913826|NCT00638235|19476188|P6|NOT COMPLETED|Overall Study||26
7913827|NCT00638235|19476189|P5|NOT COMPLETED|Overall Study||13
7913828|NCT00638235|19476190|P4|NOT COMPLETED|Overall Study||10
7913829|NCT00638235|19476191|P3|NOT COMPLETED|Overall Study||18
7913830|NCT00638235|19476192|P2|NOT COMPLETED|Overall Study||3
7913831|NCT00638235|19476193|P1|NOT COMPLETED|Overall Study||31
7913832|NCT00638235|19476185|P9|COMPLETED|Overall Study||124
7913833|NCT00638235|19476186|P8|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34
7913834|NCT00638235|19476187|P7|COMPLETED|Overall Study||23
7913835|NCT00638235|19476188|P6|COMPLETED|Overall Study||113
7913836|NCT00638235|19476189|P5|COMPLETED|Overall Study||42
7913837|NCT00638235|19476190|P4|COMPLETED|Overall Study||46
7913838|NCT00638235|19476191|P3|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63
7913839|NCT00638235|19476192|P2|COMPLETED|Overall Study||23
7913840|NCT00638235|19476193|P1|COMPLETED|Overall Study||110
7913841|NCT00638235|19476185|P9|STARTED|Overall Study||142
7913842|NCT00638235|19476186|P8|STARTED|Overall Study||35
7913843|NCT00638235|19476187|P7|STARTED|Overall Study||23
7913844|NCT00638235|19476188|P6|STARTED|Overall Study||139
7913845|NCT00638235|19476189|P5|STARTED|Overall Study||55
7913846|NCT00638235|19476190|P4|STARTED|Overall Study||56
7913847|NCT00638235|19476191|P3|STARTED|Overall Study||81
7913848|NCT00638235|19476192|P2|STARTED|Overall Study||26
7913849|NCT00638235|19476193|P1|STARTED|Overall Study||141
7913850|NCT00638222|19476594|P3|NOT COMPLETED|Overall Study||0
7913851|NCT00638222|19476595|P2|NOT COMPLETED|Overall Study||0
7913852|NCT00638222|19476596|P1|NOT COMPLETED|Overall Study||0
7913853|NCT00638222|19476594|P3|COMPLETED|Overall Study||6
7913854|NCT00638222|19476595|P2|COMPLETED|Overall Study||0
7913855|NCT00638222|19476596|P1|COMPLETED|Overall Study||0
7913856|NCT00638222|19476594|P3|STARTED|Overall Study||6
7913857|NCT00638222|19476595|P2|STARTED|Overall Study||0
7913858|NCT00638222|19476596|P1|STARTED|Overall Study||0
7913859|NCT00638183|19476603|P1|NOT COMPLETED|Overall Study||119
7913860|NCT00638183|19476603|P1|COMPLETED|Overall Study||266
7913861|NCT00638183|19476603|P1|STARTED|Overall Study||385
7913862|NCT00638157|19476612|P2|NOT COMPLETED|Overall Study||4
7913863|NCT00638157|19476613|P1|NOT COMPLETED|Overall Study||7
7913864|NCT00638157|19476612|P2|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8
7913865|NCT00638157|19476613|P1|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5
7913866|NCT00638157|19476612|P2|Treated|Overall Study||12
7913867|NCT00638157|19476613|P1|Treated|Overall Study||10
7913868|NCT00638157|19476612|P2|STARTED|Overall Study||12
7913869|NCT00638157|19476613|P1|STARTED|Overall Study||12
7913870|NCT00638027|19476623|P2|NOT COMPLETED|Overall Study||2
7913871|NCT00638027|19476624|P1|NOT COMPLETED|Overall Study||0
7913872|NCT00638027|19476623|P2|COMPLETED|Overall Study|all 10 included in analyses|8
7913873|NCT00638027|19476624|P1|COMPLETED|Overall Study||11
7913874|NCT00638027|19476623|P2|STARTED|Overall Study||10
7913875|NCT00638027|19476624|P1|STARTED|Overall Study||11
7913876|NCT00638014|19476636|P2|NOT COMPLETED|Overall Study||0
7913877|NCT00638014|19476637|P1|NOT COMPLETED|Overall Study||0
7913878|NCT00638014|19476636|P2|COMPLETED|Overall Study||28
7913879|NCT00638014|19476637|P1|COMPLETED|Overall Study||23
7913880|NCT00638014|19476636|P2|STARTED|Overall Study||28
7913881|NCT00638014|19476637|P1|STARTED|Overall Study||23
7913882|NCT00637923|19476647|P2|NOT COMPLETED|Overall Study||19
7913883|NCT00637923|19476648|P1|NOT COMPLETED|Overall Study||30
7913884|NCT00637923|19476647|P2|COMPLETED|Overall Study||18
7913885|NCT00637923|19476648|P1|COMPLETED|Overall Study||45
7913886|NCT00637923|19476647|P2|STARTED|Overall Study||37
7913887|NCT00637923|19476648|P1|STARTED|Overall Study||75
7913888|NCT00637806|19476671|P4|NOT COMPLETED|Extension Phase||1
7913889|NCT00637806|19476672|P3|NOT COMPLETED|Extension Phase||0
7913890|NCT00637806|19476673|P2|NOT COMPLETED|Extension Phase||0
7913891|NCT00637806|19476674|P1|NOT COMPLETED|Extension Phase||0
7913892|NCT00637806|19476671|P4|COMPLETED|Extension Phase||0
7913893|NCT00637806|19476672|P3|COMPLETED|Extension Phase||0
7913894|NCT00637806|19476673|P2|COMPLETED|Extension Phase||0
7913895|NCT00637806|19476674|P1|COMPLETED|Extension Phase||0
7913896|NCT00637806|19476671|P4|STARTED|Extension Phase||1
7913897|NCT00637806|19476672|P3|STARTED|Extension Phase||0
7913898|NCT00637806|19476673|P2|STARTED|Extension Phase||0
7913899|NCT00637806|19476674|P1|STARTED|Extension Phase||0
7913900|NCT00637806|19476671|P4|NOT COMPLETED|Double-blind Phase||0
7913901|NCT00637806|19476672|P3|NOT COMPLETED|Double-blind Phase||1
7913902|NCT00637806|19476673|P2|NOT COMPLETED|Double-blind Phase||0
7913903|NCT00637806|19476674|P1|NOT COMPLETED|Double-blind Phase||2
7913904|NCT00637806|19476671|P4|COMPLETED|Double-blind Phase||0
7913905|NCT00637806|19476672|P3|COMPLETED|Double-blind Phase||1
7913906|NCT00637806|19476673|P2|COMPLETED|Double-blind Phase||0
7913907|NCT00637806|19476674|P1|COMPLETED|Double-blind Phase||0
7913908|NCT00637806|19476671|P4|STARTED|Double-blind Phase||0
7913909|NCT00637806|19476672|P3|STARTED|Double-blind Phase||2
7913910|NCT00637806|19476673|P2|STARTED|Double-blind Phase||0
7913911|NCT00637806|19476674|P1|STARTED|Double-blind Phase||2
7913912|NCT00637780|19476692|P1|NOT COMPLETED|Overall Study||0
7913913|NCT00637780|19476692|P1|COMPLETED|Overall Study||2
7913914|NCT00637780|19476692|P1|STARTED|Overall Study||2
7913915|NCT00637728|19476709|P3|NOT COMPLETED|Extension Phase||0
7913916|NCT00637728|19476710|P2|NOT COMPLETED|Extension Phase||0
7913917|NCT00637728|19476711|P1|NOT COMPLETED|Extension Phase||0
7913918|NCT00637728|19476709|P3|COMPLETED|Extension Phase||0
7913919|NCT00637728|19476710|P2|COMPLETED|Extension Phase||0
7913920|NCT00637728|19476711|P1|COMPLETED|Extension Phase||0
7913921|NCT00637728|19476709|P3|STARTED|Extension Phase||0
7913922|NCT00637728|19476710|P2|STARTED|Extension Phase||0
7913923|NCT00637728|19476711|P1|STARTED|Extension Phase||0
7913924|NCT00637728|19476709|P3|NOT COMPLETED|Double-blind Phase||0
7913925|NCT00637728|19476710|P2|NOT COMPLETED|Double-blind Phase||1
7913926|NCT00637728|19476711|P1|NOT COMPLETED|Double-blind Phase||4
7913927|NCT00637728|19476709|P3|COMPLETED|Double-blind Phase||0
7913928|NCT00637728|19476710|P2|COMPLETED|Double-blind Phase||0
7913929|NCT00637728|19476711|P1|COMPLETED|Double-blind Phase||0
7913930|NCT00637728|19476709|P3|STARTED|Double-blind Phase||0
7913931|NCT00637728|19476710|P2|STARTED|Double-blind Phase||1
7913932|NCT00637728|19476711|P1|STARTED|Double-blind Phase||4
7913933|NCT00637572|19476726|P2|NOT COMPLETED|Overall Study||7
7913934|NCT00637572|19476727|P1|NOT COMPLETED|Overall Study||3
7913935|NCT00637572|19476726|P2|COMPLETED|Overall Study||24
7913936|NCT00637572|19476727|P1|COMPLETED|Overall Study||29
7913937|NCT00637572|19476726|P2|STARTED|Overall Study||31
7913938|NCT00637572|19476727|P1|STARTED|Overall Study||32
7913939|NCT00637494|19476755|P2|NOT COMPLETED|Overall Study||43
7913940|NCT00637494|19476756|P1|NOT COMPLETED|Overall Study||32
7913941|NCT00637494|19476755|P2|COMPLETED|Overall Study||108
7913942|NCT00637494|19476756|P1|COMPLETED|Overall Study||109
7913943|NCT00637494|19476755|P2|STARTED|Overall Study||151
7913944|NCT00637494|19476756|P1|STARTED|Overall Study||141
7913945|NCT00637416|19476766|P2|NOT COMPLETED|Overall Study||2
7913946|NCT00637416|19476767|P1|NOT COMPLETED|Overall Study||1
7913947|NCT00637416|19476766|P2|COMPLETED|Overall Study||3
7913948|NCT00637416|19476767|P1|COMPLETED|Overall Study||3
7913949|NCT00637416|19476766|P2|STARTED|Overall Study||5
7913950|NCT00637416|19476767|P1|STARTED|Overall Study||4
7913951|NCT00637377|19476777|P4|NOT COMPLETED|Overall Study||29
7913952|NCT00637377|19476778|P3|NOT COMPLETED|Overall Study||37
7913953|NCT00637377|19476779|P2|NOT COMPLETED|Overall Study||32
7913954|NCT00637377|19476780|P1|NOT COMPLETED|Overall Study||27
7913955|NCT00637377|19476777|P4|COMPLETED|Overall Study||284
7913956|NCT00637377|19476778|P3|COMPLETED|Overall Study||274
7913957|NCT00637377|19476779|P2|COMPLETED|Overall Study||281
7913958|NCT00637377|19476780|P1|COMPLETED|Overall Study||276
7913959|NCT00637377|19476777|P4|Participants Treated (FAS)|Overall Study||306
7913960|NCT00637377|19476778|P3|Participants Treated (FAS)|Overall Study||296
7913961|NCT00637377|19476779|P2|Participants Treated (FAS)|Overall Study||309
7913962|NCT00637377|19476780|P1|Participants Treated (FAS)|Overall Study||291
7913963|NCT00637377|19476777|P4|Participants Received Treatment|Overall Study|safety population|307
7913964|NCT00637377|19476778|P3|Participants Received Treatment|Overall Study|safety population|297
7913965|NCT00637377|19476779|P2|Participants Received Treatment|Overall Study|safety population|309
7913966|NCT00637377|19476780|P1|Participants Received Treatment|Overall Study|safety population|291
7913967|NCT00637377|19476777|P4|STARTED|Overall Study||313
7913968|NCT00637377|19476778|P3|STARTED|Overall Study||311
7913969|NCT00637377|19476779|P2|STARTED|Overall Study||313
7913970|NCT00637377|19476780|P1|STARTED|Overall Study||303
7913971|NCT00637312|19476808|P2|NOT COMPLETED|Overall Study||17
7913972|NCT00637312|19476809|P1|NOT COMPLETED|Overall Study||42
7913973|NCT00637312|19476808|P2|COMPLETED|Overall Study||19
7913974|NCT00637312|19476809|P1|COMPLETED|Overall Study||30
7913975|NCT00637312|19476808|P2|STARTED|Overall Study||36
7913976|NCT00637312|19476809|P1|STARTED|Overall Study||72
7913977|NCT00637299|19476817|P2|NOT COMPLETED|Overall Study||0
7913978|NCT00637299|19476818|P1|NOT COMPLETED|Overall Study||0
7913979|NCT00637299|19476817|P2|COMPLETED|Overall Study||10
7913980|NCT00637299|19476818|P1|COMPLETED|Overall Study||10
7913981|NCT00637299|19476817|P2|STARTED|Overall Study||10
7913982|NCT00637299|19476818|P1|STARTED|Overall Study||10
7913983|NCT00637273|19476829|P3|NOT COMPLETED|Overall Study||41
7913984|NCT00637273|19476830|P2|NOT COMPLETED|Overall Study||28
7913985|NCT00637273|19476831|P1|NOT COMPLETED|Overall Study||43
7913986|NCT00637273|19476829|P3|COMPLETED|Overall Study||131
7913987|NCT00637273|19476830|P2|COMPLETED|Overall Study||144
7913988|NCT00637273|19476831|P1|COMPLETED|Overall Study||127
7913989|NCT00637273|19476829|P3|Intent to Treat (ITT)|Overall Study||165
7913990|NCT00637273|19476830|P2|Intent to Treat (ITT)|Overall Study||166
7913991|NCT00637273|19476831|P1|Intent to Treat (ITT)|Overall Study||160
7913992|NCT00637273|19476829|P3|STARTED|Overall Study||172
7913993|NCT00637273|19476830|P2|STARTED|Overall Study||172
7913994|NCT00637273|19476831|P1|STARTED|Overall Study||170
7913995|NCT00637247|19476874|P2|NOT COMPLETED|Overall Study||0
7913996|NCT00637247|19476875|P1|NOT COMPLETED|Overall Study||0
7913997|NCT00637247|19476874|P2|COMPLETED|Overall Study||70
7913998|NCT00637247|19476875|P1|COMPLETED|Overall Study||72
7913999|NCT00637247|19476874|P2|STARTED|Overall Study||70
7914000|NCT00637247|19476875|P1|STARTED|Overall Study||72
7914001|NCT00637195|19476889|P2|NOT COMPLETED|Overall Study||1
7914002|NCT00637195|19476890|P1|NOT COMPLETED|Overall Study||3
7914003|NCT00637195|19476889|P2|COMPLETED|Overall Study||75
7914004|NCT00637195|19476890|P1|COMPLETED|Overall Study||73
7914005|NCT00637195|19476889|P2|STARTED|Overall Study||76
7914006|NCT00637195|19476890|P1|STARTED|Overall Study||76
7914007|NCT00637156|19476926|P2|NOT COMPLETED|Overall Study||24
7914008|NCT00637156|19476927|P1|NOT COMPLETED|Overall Study||10
7914009|NCT00637156|19476926|P2|COMPLETED|Overall Study||164
7914010|NCT00637156|19476927|P1|COMPLETED|Overall Study||199
7914011|NCT00637156|19476926|P2|STARTED|Overall Study||188
7914012|NCT00637156|19476927|P1|STARTED|Overall Study||209
7914013|NCT00637000|19476969|P2|NOT COMPLETED|Overall Study||3
7914014|NCT00637000|19476970|P1|NOT COMPLETED|Overall Study||4
7914015|NCT00637000|19476969|P2|COMPLETED|Overall Study||15
7914016|NCT00637000|19476970|P1|COMPLETED|Overall Study||16
7914017|NCT00637000|19476969|P2|Evaluable|Overall Study||16
7914018|NCT00637000|19476970|P1|Evaluable|Overall Study||18
7914019|NCT00637000|19476969|P2|STARTED|Overall Study|Randomized and treated|18
7914020|NCT00637000|19476970|P1|STARTED|Overall Study|Randomized and treated|20
7914021|NCT00636987|19477010|P1|NOT COMPLETED|Overall Study||189
7914022|NCT00636987|19477010|P1|COMPLETED|Overall Study||108
7914023|NCT00636987|19477010|P1|STARTED|Overall Study||297
7914024|NCT00636961|19477020|P2|NOT COMPLETED|Period 2||0
7914025|NCT00636961|19477021|P1|NOT COMPLETED|Period 2||1
7914026|NCT00636961|19477020|P2|COMPLETED|Period 2||12
7914027|NCT00636961|19477021|P1|COMPLETED|Period 2||12
7914028|NCT00636961|19477020|P2|STARTED|Period 2||12
7914029|NCT00636961|19477021|P1|STARTED|Period 2||13
7914030|NCT00636961|19477020|P2|NOT COMPLETED|Period 1||1
7914031|NCT00636961|19477021|P1|NOT COMPLETED|Period 1||1
7914032|NCT00636961|19477020|P2|COMPLETED|Period 1||12
7914033|NCT00636961|19477021|P1|COMPLETED|Period 1||13
7914034|NCT00636961|19477020|P2|STARTED|Period 1||13
7914035|NCT00636961|19477021|P1|STARTED|Period 1||14
7914036|NCT00636818|19477035|P1|NOT COMPLETED|Overall Study||11
7914037|NCT00636818|19477035|P1|COMPLETED|Overall Study||34
7914038|NCT00636818|19477035|P1|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44
7914039|NCT00636818|19477035|P1|STARTED|Overall Study||45
7914040|NCT00636805|19477050|P1|NOT COMPLETED|Overall Study||0
7914041|NCT00636805|19477050|P1|COMPLETED|Overall Study||63
7914042|NCT00636805|19477050|P1|STARTED|Overall Study||63
7914043|NCT00636792|19477060|P1|NOT COMPLETED|Overall Study||33
7914044|NCT00636792|19477060|P1|COMPLETED|Overall Study||40
7914045|NCT00636792|19477060|P1|STARTED|Overall Study||73
7914046|NCT00636701|19477067|P2|NOT COMPLETED|Overall Study||0
7914047|NCT00636701|19477068|P1|NOT COMPLETED|Overall Study||0
7914048|NCT00636701|19477067|P2|COMPLETED|Overall Study||2
7914049|NCT00636701|19477068|P1|COMPLETED|Overall Study||2
7914050|NCT00636701|19477067|P2|STARTED|Overall Study||2
7914051|NCT00636701|19477068|P1|STARTED|Overall Study||2
7914052|NCT00636675|19477076|P2|NOT COMPLETED|Overall Study||41
7914053|NCT00636675|19477077|P1|NOT COMPLETED|Overall Study||140
7914054|NCT00636675|19477076|P2|COMPLETED|Overall Study||734
7914055|NCT00636675|19477077|P1|COMPLETED|Overall Study||811
7914056|NCT00636675|19477076|P2|STARTED|Overall Study||775
7914057|NCT00636675|19477077|P1|STARTED|Overall Study||951
7914058|NCT00636649|19477089|P2|NOT COMPLETED|Overall Study||0
7914059|NCT00636649|19477090|P1|NOT COMPLETED|Overall Study||0
7914060|NCT00636649|19477089|P2|COMPLETED|Overall Study||20
7914061|NCT00636649|19477090|P1|COMPLETED|Overall Study||20
7914062|NCT00636649|19477089|P2|STARTED|Overall Study||20
7914063|NCT00636649|19477090|P1|STARTED|Overall Study||20
7914064|NCT00636636|19477120|P2|NOT COMPLETED|Overall Study||39
7914065|NCT00636636|19477121|P1|NOT COMPLETED|Overall Study||36
7914066|NCT00636636|19477120|P2|COMPLETED|Overall Study||192
7914067|NCT00636636|19477121|P1|COMPLETED|Overall Study||185
7914068|NCT00636636|19477120|P2|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
7914069|NCT00636636|19477121|P1|379|Overall Study||186
7914070|NCT00636636|19477120|P2|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
7914071|NCT00636636|19477121|P1|Safety & Efficacy of Gabapentin ER|Overall Study||186
7914072|NCT00636636|19477120|P2|STARTED|Overall Study||231
7914073|NCT00636636|19477121|P1|STARTED|Overall Study||221
7914074|NCT00636610|19477137|P2|NOT COMPLETED|Overall Study||83
7914075|NCT00636610|19477138|P1|NOT COMPLETED|Overall Study||92
7914076|NCT00636610|19477137|P2|COMPLETED|Overall Study||18
7914077|NCT00636610|19477138|P1|COMPLETED|Overall Study||6
7914078|NCT00636610|19477137|P2|STARTED|Overall Study||101
7914079|NCT00636610|19477138|P1|STARTED|Overall Study||98
7914080|NCT00636506|19477148|P1|NOT COMPLETED|Overall Study||16
7914081|NCT00636506|19477148|P1|COMPLETED|Overall Study||60
7914082|NCT00636506|19477148|P1|STARTED|Overall Study||76
7914083|NCT00636441|19477195|P7|NOT COMPLETED|Overall Study||18
7914084|NCT00636441|19477196|P6|NOT COMPLETED|Overall Study||1
7914085|NCT00636441|19477197|P5|NOT COMPLETED|Overall Study||0
7914086|NCT00636441|19477198|P4|NOT COMPLETED|Overall Study||0
7914087|NCT00636441|19477199|P3|NOT COMPLETED|Overall Study||1
7914088|NCT00636441|19477200|P2|NOT COMPLETED|Overall Study||1
7914089|NCT00636441|19477201|P1|NOT COMPLETED|Overall Study||0
7914090|NCT00636441|19477195|P7|COMPLETED|Overall Study||0
7914091|NCT00636441|19477196|P6|COMPLETED|Overall Study||6
7914092|NCT00636441|19477197|P5|COMPLETED|Overall Study||6
7914093|NCT00636441|19477198|P4|COMPLETED|Overall Study||6
7914094|NCT00636441|19477199|P3|COMPLETED|Overall Study||5
7914095|NCT00636441|19477200|P2|COMPLETED|Overall Study||6
7914096|NCT00636441|19477201|P1|COMPLETED|Overall Study||6
7914097|NCT00636441|19477195|P7|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1
7914098|NCT00636441|19477196|P6|Assigned Treatment|Overall Study||7
7914099|NCT00636441|19477197|P5|Assigned Treatment|Overall Study||6
7914100|NCT00636441|19477198|P4|Assigned Treatment|Overall Study||6
7914101|NCT00636441|19477199|P3|Assigned Treatment|Overall Study||6
7914102|NCT00636441|19477200|P2|Assigned Treatment|Overall Study||7
7914103|NCT00636441|19477201|P1|Assigned Treatment|Overall Study||6
7914104|NCT00636441|19477195|P7|STARTED|Overall Study||18
7914105|NCT00636441|19477196|P6|STARTED|Overall Study||7
7914106|NCT00636441|19477197|P5|STARTED|Overall Study||6
7914107|NCT00636441|19477198|P4|STARTED|Overall Study||6
7914108|NCT00636441|19477199|P3|STARTED|Overall Study||6
7914109|NCT00636441|19477200|P2|STARTED|Overall Study||7
7914110|NCT00636441|19477201|P1|STARTED|Overall Study||6
7914111|NCT00636389|19477230|P2|NOT COMPLETED|Period 2 - 1 Week||0
7914112|NCT00636389|19477231|P1|NOT COMPLETED|Period 2 - 1 Week||0
7914113|NCT00636389|19477230|P2|COMPLETED|Period 2 - 1 Week||5
7914114|NCT00636389|19477231|P1|COMPLETED|Period 2 - 1 Week||7
7914115|NCT00636389|19477230|P2|STARTED|Period 2 - 1 Week||5
7914116|NCT00636389|19477231|P1|STARTED|Period 2 - 1 Week||7
7914117|NCT00636389|19477230|P2|NOT COMPLETED|Period 1 - 1 Week||0
7914118|NCT00636389|19477231|P1|NOT COMPLETED|Period 1 - 1 Week||0
7914119|NCT00636389|19477230|P2|COMPLETED|Period 1 - 1 Week||5
7914120|NCT00636389|19477231|P1|COMPLETED|Period 1 - 1 Week||7
7914121|NCT00636389|19477230|P2|STARTED|Period 1 - 1 Week||5
7914122|NCT00636389|19477231|P1|STARTED|Period 1 - 1 Week||7
7914123|NCT00636363|19477244|P3|NOT COMPLETED|Overall Study||18
7914124|NCT00636363|19477245|P2|NOT COMPLETED|Overall Study||20
7914125|NCT00636363|19477246|P1|NOT COMPLETED|Overall Study||13
7914126|NCT00636363|19477244|P3|COMPLETED|Overall Study||163
7914127|NCT00636363|19477245|P2|COMPLETED|Overall Study||156
7914128|NCT00636363|19477246|P1|COMPLETED|Overall Study||165
7914129|NCT00636363|19477244|P3|STARTED|Overall Study||181
7914130|NCT00636363|19477245|P2|STARTED|Overall Study||176
7914131|NCT00636363|19477246|P1|STARTED|Overall Study||178
7914132|NCT00636220|19477260|P1|NOT COMPLETED|Overall Study||0
7914133|NCT00636220|19477260|P1|COMPLETED|Overall Study||101
7914134|NCT00636220|19477260|P1|STARTED|Overall Study||101
7914135|NCT00636207|19477267|P7|NOT COMPLETED|Overall Study||0
7914136|NCT00636207|19477268|P6|NOT COMPLETED|Overall Study||0
7914137|NCT00636207|19477269|P5|NOT COMPLETED|Overall Study||1
7914138|NCT00636207|19477270|P4|NOT COMPLETED|Overall Study||0
7914139|NCT00636207|19477271|P3|NOT COMPLETED|Overall Study||0
7914140|NCT00636207|19477272|P2|NOT COMPLETED|Overall Study||1
7914141|NCT00636207|19477273|P1|NOT COMPLETED|Overall Study||1
7914142|NCT00636207|19477267|P7|COMPLETED|Overall Study||3
7914143|NCT00636207|19477268|P6|COMPLETED|Overall Study||1
7914144|NCT00636207|19477269|P5|COMPLETED|Overall Study||8
7914145|NCT00636207|19477270|P4|COMPLETED|Overall Study||6
7914146|NCT00636207|19477271|P3|COMPLETED|Overall Study||18
7914147|NCT00636207|19477272|P2|COMPLETED|Overall Study||7
7914148|NCT00636207|19477273|P1|COMPLETED|Overall Study||0
7914149|NCT00636207|19477267|P7|STARTED|Overall Study||3
7914150|NCT00636207|19477268|P6|STARTED|Overall Study||1
7914151|NCT00636207|19477269|P5|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9
7914152|NCT00636207|19477270|P4|STARTED|Overall Study||6
7914153|NCT00636207|19477271|P3|STARTED|Overall Study||18
7914154|NCT00636207|19477272|P2|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8
7914155|NCT00636207|19477273|P1|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1
7914156|NCT00636194|19477337|P2|NOT COMPLETED|Overall Study||0
7914157|NCT00636194|19477338|P1|NOT COMPLETED|Overall Study||3
7914158|NCT00636194|19477337|P2|COMPLETED|Overall Study||175
7914159|NCT00636194|19477338|P1|COMPLETED|Overall Study||172
7914160|NCT00636194|19477337|P2|STARTED|Overall Study||175
7914161|NCT00636194|19477338|P1|STARTED|Overall Study||175
7914162|NCT00636181|19477351|P3|NOT COMPLETED|Overall Study||10
7914163|NCT00636181|19477352|P2|NOT COMPLETED|Overall Study||6
7914164|NCT00636181|19477353|P1|NOT COMPLETED|Overall Study||8
7914165|NCT00636181|19477351|P3|COMPLETED|Overall Study||47
7914166|NCT00636181|19477352|P2|COMPLETED|Overall Study||47
7914167|NCT00636181|19477353|P1|COMPLETED|Overall Study||46
7914168|NCT00636181|19477351|P3|STARTED|Overall Study||57
7914169|NCT00636181|19477352|P2|STARTED|Overall Study||53
7914170|NCT00636181|19477353|P1|STARTED|Overall Study||54
7914171|NCT00636168|19477381|P2|NOT COMPLETED|Long Term Follow-Up||14
7914172|NCT00636168|19477382|P1|NOT COMPLETED|Long Term Follow-Up||11
7914173|NCT00636168|19477381|P2|COMPLETED|Long Term Follow-Up||129
7914174|NCT00636168|19477382|P1|COMPLETED|Long Term Follow-Up||130
7914175|NCT00636168|19477381|P2|STARTED|Long Term Follow-Up||143
7914176|NCT00636168|19477382|P1|STARTED|Long Term Follow-Up||141
7914177|NCT00636168|19477381|P2|NOT COMPLETED|Treated With Study Drug||331
7914178|NCT00636168|19477382|P1|NOT COMPLETED|Treated With Study Drug||408
7914179|NCT00636168|19477381|P2|COMPLETED|Treated With Study Drug||143
7914180|NCT00636168|19477382|P1|COMPLETED|Treated With Study Drug||63
7914181|NCT00636168|19477381|P2|STARTED|Treated With Study Drug||474
7914182|NCT00636168|19477382|P1|STARTED|Treated With Study Drug||471
7914183|NCT00636168|19477381|P2|NOT COMPLETED|Randomized to Study Drug||2
7914184|NCT00636168|19477382|P1|NOT COMPLETED|Randomized to Study Drug||4
7914185|NCT00636168|19477381|P2|COMPLETED|Randomized to Study Drug||474
7914186|NCT00636168|19477382|P1|COMPLETED|Randomized to Study Drug||471
7914187|NCT00636168|19477381|P2|STARTED|Randomized to Study Drug||476
7914188|NCT00636168|19477382|P1|STARTED|Randomized to Study Drug||475
7914189|NCT00636155|19477410|P1|NOT COMPLETED|Overall Study||18
7914190|NCT00636155|19477410|P1|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2
7914191|NCT00636155|19477410|P1|STARTED|Overall Study||20
7914192|NCT00636077|19477416|P4|NOT COMPLETED|Week 4||0
7914193|NCT00636077|19477417|P3|NOT COMPLETED|Week 4||0
7914194|NCT00636077|19477418|P2|NOT COMPLETED|Week 4||0
7914195|NCT00636077|19477419|P1|NOT COMPLETED|Week 4||0
7914196|NCT00636077|19477416|P4|COMPLETED|Week 4||3
7914197|NCT00636077|19477417|P3|COMPLETED|Week 4||3
7914198|NCT00636077|19477418|P2|COMPLETED|Week 4||3
7914199|NCT00636077|19477419|P1|COMPLETED|Week 4||3
7914200|NCT00636077|19477416|P4|STARTED|Week 4||3
7914201|NCT00636077|19477417|P3|STARTED|Week 4||3
7914202|NCT00636077|19477418|P2|STARTED|Week 4||3
7914203|NCT00636077|19477419|P1|STARTED|Week 4||3
7914204|NCT00636077|19477416|P4|NOT COMPLETED|Week 3||0
7914205|NCT00636077|19477417|P3|NOT COMPLETED|Week 3||0
7914206|NCT00636077|19477418|P2|NOT COMPLETED|Week 3||0
7914207|NCT00636077|19477419|P1|NOT COMPLETED|Week 3||0
7914208|NCT00636077|19477416|P4|COMPLETED|Week 3||3
7914209|NCT00636077|19477417|P3|COMPLETED|Week 3||3
7914210|NCT00636077|19477418|P2|COMPLETED|Week 3||3
7914211|NCT00636077|19477419|P1|COMPLETED|Week 3||3
7914212|NCT00636077|19477416|P4|STARTED|Week 3||3
7914213|NCT00636077|19477417|P3|STARTED|Week 3||3
7914214|NCT00636077|19477418|P2|STARTED|Week 3||3
7914215|NCT00636077|19477419|P1|STARTED|Week 3||3
7914216|NCT00636077|19477416|P4|NOT COMPLETED|Week 2||0
7914217|NCT00636077|19477417|P3|NOT COMPLETED|Week 2||0
7914218|NCT00636077|19477418|P2|NOT COMPLETED|Week 2||0
7914219|NCT00636077|19477419|P1|NOT COMPLETED|Week 2||0
7914220|NCT00636077|19477416|P4|COMPLETED|Week 2||3
7914221|NCT00636077|19477417|P3|COMPLETED|Week 2||3
7914222|NCT00636077|19477418|P2|COMPLETED|Week 2||3
7914223|NCT00636077|19477419|P1|COMPLETED|Week 2||3
7914224|NCT00636077|19477416|P4|STARTED|Week 2||3
7914225|NCT00636077|19477417|P3|STARTED|Week 2||3
7914226|NCT00636077|19477418|P2|STARTED|Week 2||3
7914227|NCT00636077|19477419|P1|STARTED|Week 2||3
7914228|NCT00636077|19477416|P4|NOT COMPLETED|Week 1||0
7914229|NCT00636077|19477417|P3|NOT COMPLETED|Week 1||0
7914230|NCT00636077|19477418|P2|NOT COMPLETED|Week 1||0
7914231|NCT00636077|19477419|P1|NOT COMPLETED|Week 1||0
7914232|NCT00636077|19477416|P4|COMPLETED|Week 1||3
7914233|NCT00636077|19477417|P3|COMPLETED|Week 1||3
7914234|NCT00636077|19477418|P2|COMPLETED|Week 1||3
7914235|NCT00636077|19477419|P1|COMPLETED|Week 1||3
7914236|NCT00636077|19477416|P4|STARTED|Week 1||3
7914237|NCT00636077|19477417|P3|STARTED|Week 1||3
7914238|NCT00636077|19477418|P2|STARTED|Week 1||3
7914239|NCT00636077|19477419|P1|STARTED|Week 1||3
7914240|NCT00635999|19477452|P3|NOT COMPLETED|Overall Study||1
7914241|NCT00635999|19477453|P2|NOT COMPLETED|Overall Study||2
7914242|NCT00635999|19477454|P1|NOT COMPLETED|Overall Study||4
7914243|NCT00635999|19477452|P3|COMPLETED|Overall Study||23
7914244|NCT00635999|19477453|P2|COMPLETED|Overall Study||23
7914245|NCT00635999|19477454|P1|COMPLETED|Overall Study||23
7914246|NCT00635999|19477452|P3|STARTED|Overall Study||24
7914247|NCT00635999|19477453|P2|STARTED|Overall Study||25
7914248|NCT00635999|19477454|P1|STARTED|Overall Study||27
7914249|NCT00635882|19477471|P6|NOT COMPLETED|Overall Study||0
7914250|NCT00635882|19477472|P5|NOT COMPLETED|Overall Study||0
7914251|NCT00635882|19477473|P4|NOT COMPLETED|Overall Study||0
7914252|NCT00635882|19477474|P3|NOT COMPLETED|Overall Study||0
7914253|NCT00635882|19477475|P2|NOT COMPLETED|Overall Study||0
7914254|NCT00635882|19477476|P1|NOT COMPLETED|Overall Study||1
7914255|NCT00635882|19477471|P6|COMPLETED|Overall Study||13
7914256|NCT00635882|19477472|P5|COMPLETED|Overall Study||16
7914257|NCT00635882|19477473|P4|COMPLETED|Overall Study||15
7914258|NCT00635882|19477474|P3|COMPLETED|Overall Study||12
7914259|NCT00635882|19477475|P2|COMPLETED|Overall Study||17
7914260|NCT00635882|19477476|P1|COMPLETED|Overall Study||19
7914261|NCT00635882|19477471|P6|STARTED|Overall Study||13
7914262|NCT00635882|19477472|P5|STARTED|Overall Study||16
7914263|NCT00635882|19477473|P4|STARTED|Overall Study||15
7914264|NCT00635882|19477474|P3|STARTED|Overall Study||12
7914265|NCT00635882|19477475|P2|STARTED|Overall Study||17
7914266|NCT00635882|19477476|P1|STARTED|Overall Study||20
7914267|NCT00635830|19477540|P2|NOT COMPLETED|Overall Study||0
7914268|NCT00635830|19477541|P1|NOT COMPLETED|Overall Study||0
7914269|NCT00635830|19477540|P2|COMPLETED|Overall Study||20
7914270|NCT00635830|19477541|P1|COMPLETED|Overall Study||20
7914271|NCT00635830|19477540|P2|STARTED|Overall Study||20
7914272|NCT00635830|19477541|P1|STARTED|Overall Study||20
7914273|NCT00635817|19477551|P4|NOT COMPLETED|Overall Study||0
7914274|NCT00635817|19477552|P3|NOT COMPLETED|Overall Study||2
7914275|NCT00635817|19477553|P2|NOT COMPLETED|Overall Study||2
7914276|NCT00635817|19477554|P1|NOT COMPLETED|Overall Study||6
7914277|NCT00635817|19477551|P4|COMPLETED|Overall Study||21
7914278|NCT00635817|19477552|P3|COMPLETED|Overall Study||19
7914279|NCT00635817|19477553|P2|COMPLETED|Overall Study||19
7914280|NCT00635817|19477554|P1|COMPLETED|Overall Study||15
7914281|NCT00635817|19477551|P4|STARTED|Overall Study||21
7914282|NCT00635817|19477552|P3|STARTED|Overall Study||21
7914283|NCT00635817|19477553|P2|STARTED|Overall Study||21
7914284|NCT00635817|19477554|P1|STARTED|Overall Study||21
7914285|NCT00635804|19477606|P8|NOT COMPLETED|Overall Study||0
7914286|NCT00635804|19477607|P7|NOT COMPLETED|Overall Study||0
7914287|NCT00635804|19477608|P6|NOT COMPLETED|Overall Study||1
7914288|NCT00635804|19477609|P5|NOT COMPLETED|Overall Study||0
7914289|NCT00635804|19477610|P4|NOT COMPLETED|Overall Study||0
7914290|NCT00635804|19477611|P3|NOT COMPLETED|Overall Study||0
7914291|NCT00635804|19477612|P2|NOT COMPLETED|Overall Study||0
7914292|NCT00635804|19477613|P1|NOT COMPLETED|Overall Study||1
7914293|NCT00635804|19477606|P8|COMPLETED|Overall Study||14
7914294|NCT00635804|19477607|P7|COMPLETED|Overall Study||3
7914295|NCT00635804|19477608|P6|COMPLETED|Overall Study||11
7914296|NCT00635804|19477609|P5|COMPLETED|Overall Study||6
7914297|NCT00635804|19477610|P4|COMPLETED|Overall Study||6
7914298|NCT00635804|19477611|P3|COMPLETED|Overall Study||6
7914299|NCT00635804|19477612|P2|COMPLETED|Overall Study||6
7914300|NCT00635804|19477613|P1|COMPLETED|Overall Study||6
7914301|NCT00635804|19477606|P8|STARTED|Overall Study||14
7914302|NCT00635804|19477607|P7|STARTED|Overall Study||3
7914303|NCT00635804|19477608|P6|STARTED|Overall Study||12
7914304|NCT00635804|19477609|P5|STARTED|Overall Study||6
7914305|NCT00635804|19477610|P4|STARTED|Overall Study||6
7914306|NCT00635804|19477611|P3|STARTED|Overall Study||6
7914307|NCT00635804|19477612|P2|STARTED|Overall Study||6
7914308|NCT00635804|19477613|P1|STARTED|Overall Study||7
7914309|NCT00635778|19477717|P7|NOT COMPLETED|Overall Study||6
7914310|NCT00635778|19477718|P6|NOT COMPLETED|Overall Study||21
7914311|NCT00635778|19477719|P5|NOT COMPLETED|Overall Study||8
7914312|NCT00635778|19477720|P4|NOT COMPLETED|Overall Study||8
7914313|NCT00635778|19477721|P3|NOT COMPLETED|Overall Study||3
7914314|NCT00635778|19477722|P2|NOT COMPLETED|Overall Study||3
7914315|NCT00635778|19477723|P1|NOT COMPLETED|Overall Study||1
7914316|NCT00635778|19477717|P7|COMPLETED|Overall Study||0
7914317|NCT00635778|19477718|P6|COMPLETED|Overall Study||0
7914318|NCT00635778|19477719|P5|COMPLETED|Overall Study||0
7914319|NCT00635778|19477720|P4|COMPLETED|Overall Study||0
7914320|NCT00635778|19477721|P3|COMPLETED|Overall Study||0
7914321|NCT00635778|19477722|P2|COMPLETED|Overall Study||0
7914322|NCT00635778|19477723|P1|COMPLETED|Overall Study||0
7914323|NCT00635778|19477717|P7|STARTED|Overall Study||6
7914324|NCT00635778|19477718|P6|STARTED|Overall Study||21
7914325|NCT00635778|19477719|P5|STARTED|Overall Study||8
7914326|NCT00635778|19477720|P4|STARTED|Overall Study||8
7914327|NCT00635778|19477721|P3|STARTED|Overall Study||3
7914328|NCT00635778|19477722|P2|STARTED|Overall Study||3
7914329|NCT00635778|19477723|P1|STARTED|Overall Study||1
7914330|NCT00635739|19477776|P2|NOT COMPLETED|Overall Study||2
7914331|NCT00635739|19477777|P1|NOT COMPLETED|Overall Study||3
7914332|NCT00635739|19477776|P2|COMPLETED|Overall Study||36
7914333|NCT00635739|19477777|P1|COMPLETED|Overall Study||39
7914334|NCT00635739|19477776|P2|STARTED|Overall Study||38
7914335|NCT00635739|19477777|P1|STARTED|Overall Study||42
7914336|NCT00635700|19477787|P2|NOT COMPLETED|Overall Study||14
7914337|NCT00635700|19477788|P1|NOT COMPLETED|Overall Study||15
7914338|NCT00635700|19477787|P2|COMPLETED|Overall Study||13
7914339|NCT00635700|19477788|P1|COMPLETED|Overall Study||9
7914340|NCT00635700|19477787|P2|STARTED|Overall Study||27
7914341|NCT00635700|19477788|P1|STARTED|Overall Study||24
7914342|NCT00635661|19477794|P1|NOT COMPLETED|Overall Study||4
7914343|NCT00635661|19477794|P1|COMPLETED|Overall Study||30
7914344|NCT00635661|19477794|P1|STARTED|Overall Study||34
7914345|NCT00635648|19477798|P1|NOT COMPLETED|Overall Study||37
7914346|NCT00635648|19477798|P1|COMPLETED|Overall Study||26
7914347|NCT00635648|19477798|P1|STARTED|Overall Study||63
7914348|NCT00635609|19477807|P2|NOT COMPLETED|Overall Study||3
7914349|NCT00635609|19477808|P1|NOT COMPLETED|Overall Study||7
7914350|NCT00635609|19477807|P2|COMPLETED|Overall Study||42
7914351|NCT00635609|19477808|P1|COMPLETED|Overall Study||41
7914352|NCT00635609|19477807|P2|STARTED|Overall Study||45
7914353|NCT00635609|19477808|P1|STARTED|Overall Study||48
7914354|NCT00635570|19477820|P2|NOT COMPLETED|Overall Study||11
7914355|NCT00635570|19477821|P1|NOT COMPLETED|Overall Study||15
7914356|NCT00635570|19477820|P2|COMPLETED|Overall Study||126
7914357|NCT00635570|19477821|P1|COMPLETED|Overall Study||121
7914358|NCT00635570|19477820|P2|STARTED|Overall Study||137
7914359|NCT00635570|19477821|P1|STARTED|Overall Study||136
7914360|NCT00635492|19477835|P2|NOT COMPLETED|Overall Study||282
7914361|NCT00635492|19477836|P1|NOT COMPLETED|Overall Study||279
7914362|NCT00635492|19477835|P2|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992
7914363|NCT00635492|19477836|P1|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835
7914364|NCT00635492|19477835|P2|STARTED|Overall Study|This population consists of the analysis population.|1274
7914365|NCT00635492|19477836|P1|STARTED|Overall Study|This population consists of the analysis population.|1114
7914366|NCT00635479|19477882|P2|NOT COMPLETED|Overall Study||18
7914367|NCT00635479|19477883|P1|NOT COMPLETED|Overall Study||6
7914368|NCT00635479|19477882|P2|COMPLETED|Overall Study||42
7914369|NCT00635479|19477883|P1|COMPLETED|Overall Study||49
7914370|NCT00635479|19477882|P2|STARTED|Overall Study||60
7914371|NCT00635479|19477883|P1|STARTED|Overall Study||55
7914372|NCT00635453|19477891|P2|NOT COMPLETED|Overall Study||174
7914373|NCT00635453|19477892|P1|NOT COMPLETED|Overall Study||154
7914374|NCT00635453|19477891|P2|COMPLETED|Overall Study||181
7914375|NCT00635453|19477892|P1|COMPLETED|Overall Study||206
7914376|NCT00635453|19477891|P2|3 Years Assessment|Overall Study||204
7914377|NCT00635453|19477892|P1|3 Years Assessment|Overall Study||246
7914378|NCT00635453|19477891|P2|12 Months Assessment|Overall Study||260
7914379|NCT00635453|19477892|P1|12 Months Assessment|Overall Study||285
7914380|NCT00635453|19477891|P2|6 Months Assessment|Overall Study||311
7914381|NCT00635453|19477892|P1|6 Months Assessment|Overall Study||322
7914382|NCT00635453|19477891|P2|STARTED|Overall Study||355
7914383|NCT00635453|19477892|P1|STARTED|Overall Study||360
7914384|NCT00635427|19477909|P5|NOT COMPLETED|Overall Study||8
7914385|NCT00635427|19477910|P4|NOT COMPLETED|Overall Study||9
7914386|NCT00635427|19477911|P3|NOT COMPLETED|Overall Study||11
7914387|NCT00635427|19477912|P2|NOT COMPLETED|Overall Study||6
7914388|NCT00635427|19477913|P1|NOT COMPLETED|Overall Study||12
7914389|NCT00635427|19477909|P5|COMPLETED|Overall Study||30
7914390|NCT00635427|19477910|P4|COMPLETED|Overall Study||7
7914391|NCT00635427|19477911|P3|COMPLETED|Overall Study||5
7914392|NCT00635427|19477912|P2|COMPLETED|Overall Study||6
7914393|NCT00635427|19477913|P1|COMPLETED|Overall Study||1
7914394|NCT00635427|19477909|P5|STARTED|Overall Study||38
7914395|NCT00635427|19477910|P4|STARTED|Overall Study||16
7914396|NCT00635427|19477911|P3|STARTED|Overall Study||16
7914397|NCT00635427|19477912|P2|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12
7914398|NCT00635427|19477913|P1|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13
7914399|NCT00635362|19477935|P2|NOT COMPLETED|Overall Study||8
7914400|NCT00635362|19477936|P1|NOT COMPLETED|Overall Study||13
7914401|NCT00635362|19477935|P2|COMPLETED|Overall Study||12
7914402|NCT00635362|19477936|P1|COMPLETED|Overall Study||9
7914403|NCT00635362|19477935|P2|STARTED|Overall Study||20
7914404|NCT00635362|19477936|P1|STARTED|Overall Study||22
7914405|NCT00635349|19477952|P2|NOT COMPLETED|Overall Study||48
7914406|NCT00635349|19477953|P1|NOT COMPLETED|Overall Study||44
7914407|NCT00635349|19477952|P2|COMPLETED|Overall Study||19
7914408|NCT00635349|19477953|P1|COMPLETED|Overall Study||29
7914409|NCT00635349|19477952|P2|STARTED|Overall Study||67
7914410|NCT00635349|19477953|P1|STARTED|Overall Study||73
7914411|NCT00635232|19477976|P5|NOT COMPLETED|Overall Study||8
7914412|NCT00635232|19477977|P4|NOT COMPLETED|Overall Study||10
7914413|NCT00635232|19477978|P3|NOT COMPLETED|Overall Study||3
7914414|NCT00635232|19477979|P2|NOT COMPLETED|Overall Study||20
7914415|NCT00635232|19477980|P1|NOT COMPLETED|Overall Study||14
7914416|NCT00635232|19477976|P5|COMPLETED|Overall Study||20
7914417|NCT00635232|19477977|P4|COMPLETED|Overall Study||48
7914418|NCT00635232|19477978|P3|COMPLETED|Overall Study||55
7914419|NCT00635232|19477979|P2|COMPLETED|Overall Study||39
7914420|NCT00635232|19477980|P1|COMPLETED|Overall Study||44
7914421|NCT00635232|19477976|P5|STARTED|Overall Study||28
7914422|NCT00635232|19477977|P4|STARTED|Overall Study||58
7914423|NCT00635232|19477978|P3|STARTED|Overall Study||58
7914424|NCT00635232|19477979|P2|STARTED|Overall Study||59
7914425|NCT00635232|19477980|P1|STARTED|Overall Study||58
7914426|NCT00635219|19478007|P5|NOT COMPLETED|Overall Study||42
7914427|NCT00635219|19478008|P4|NOT COMPLETED|Overall Study||34
7914428|NCT00635219|19478009|P3|NOT COMPLETED|Overall Study||35
7914429|NCT00635219|19478010|P2|NOT COMPLETED|Overall Study||25
7914430|NCT00635219|19478011|P1|NOT COMPLETED|Overall Study||25
7914431|NCT00635219|19478007|P5|COMPLETED|Overall Study||113
7914432|NCT00635219|19478008|P4|COMPLETED|Overall Study||117
7914433|NCT00635219|19478009|P3|COMPLETED|Overall Study||122
7914434|NCT00635219|19478010|P2|COMPLETED|Overall Study||130
7914435|NCT00635219|19478011|P1|COMPLETED|Overall Study||123
7914436|NCT00635219|19478007|P5|STARTED|Overall Study||155
7914437|NCT00635219|19478008|P4|STARTED|Overall Study||151
7914438|NCT00635219|19478009|P3|STARTED|Overall Study||157
7914439|NCT00635219|19478010|P2|STARTED|Overall Study||155
7914440|NCT00635219|19478011|P1|STARTED|Overall Study||148
7914441|NCT00635167|19478068|P1|NOT COMPLETED|Overall Study||0
7914442|NCT00635167|19478068|P1|COMPLETED|Overall Study||1
7914443|NCT00635167|19478068|P1|STARTED|Overall Study||1
7914444|NCT00635154|19478074|P1|NOT COMPLETED|Overall Study||33
7914445|NCT00635154|19478074|P1|COMPLETED|Overall Study||21
7914446|NCT00635154|19478074|P1|STARTED|Overall Study||54
7914447|NCT00635128|19478086|P2|NOT COMPLETED|Overall Study||0
7914448|NCT00635128|19478087|P1|NOT COMPLETED|Overall Study||0
7914449|NCT00635128|19478086|P2|COMPLETED|Overall Study||64
7914450|NCT00635128|19478087|P1|COMPLETED|Overall Study||351
7914451|NCT00635128|19478086|P2|STARTED|Overall Study||64
7914452|NCT00635128|19478087|P1|STARTED|Overall Study||351
7914453|NCT00635102|19478117|P2|NOT COMPLETED|Overall Study||8
7914454|NCT00635102|19478118|P1|NOT COMPLETED|Overall Study||7
7914455|NCT00635102|19478117|P2|COMPLETED|Overall Study||22
7914456|NCT00635102|19478118|P1|COMPLETED|Overall Study||20
7914457|NCT00635102|19478117|P2|STARTED|Overall Study||30
7914458|NCT00635102|19478118|P1|STARTED|Overall Study||27
7914459|NCT00635089|19478212|P1|NOT COMPLETED|Overall Study||78
7914460|NCT00635089|19478212|P1|COMPLETED|Overall Study|Participants who had not withdrawn at the time of study termination.|112
7914461|NCT00635089|19478212|P1|Completed >/= 16 Weeks of Study|Overall Study||181
7914462|NCT00635089|19478212|P1|STARTED|Overall Study||190
7914463|NCT00635050|19478239|P1|NOT COMPLETED|Overall Study||1
7914464|NCT00635050|19478239|P1|COMPLETED|Overall Study|Followup through 10 years planned.|31
7914465|NCT00635050|19478239|P1|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32
7914466|NCT00635024|19478246|P1|NOT COMPLETED|Overall Study||1
7914467|NCT00635024|19478246|P1|COMPLETED|Overall Study||0
7914468|NCT00635024|19478246|P1|STARTED|Overall Study||1
7914469|NCT00634972|19478256|P2|NOT COMPLETED|Overall Study||0
7914470|NCT00634972|19478257|P1|NOT COMPLETED|Overall Study||0
7914471|NCT00634972|19478256|P2|COMPLETED|Overall Study||43
7914472|NCT00634972|19478257|P1|COMPLETED|Overall Study||40
7914473|NCT00634972|19478256|P2|STARTED|Overall Study||43
7914474|NCT00634972|19478257|P1|STARTED|Overall Study||40
7914475|NCT00634933|19478266|P5|NOT COMPLETED|Part B: Week 24 to Week 52||10
7914476|NCT00634933|19478267|P4|NOT COMPLETED|Part B: Week 24 to Week 52||6
7914477|NCT00634933|19478268|P3|NOT COMPLETED|Part B: Week 24 to Week 52||22
7914478|NCT00634933|19478269|P2|NOT COMPLETED|Part B: Week 24 to Week 52||14
7914479|NCT00634933|19478270|P1|NOT COMPLETED|Part B: Week 24 to Week 52||0
7914480|NCT00634933|19478266|P5|COMPLETED|Part B: Week 24 to Week 52||22
7914481|NCT00634933|19478267|P4|COMPLETED|Part B: Week 24 to Week 52||25
7914482|NCT00634933|19478268|P3|COMPLETED|Part B: Week 24 to Week 52||33
7914483|NCT00634933|19478269|P2|COMPLETED|Part B: Week 24 to Week 52||42
7914484|NCT00634933|19478270|P1|COMPLETED|Part B: Week 24 to Week 52||0
7914485|NCT00634933|19478266|P5|STARTED|Part B: Week 24 to Week 52||32
7914486|NCT00634933|19478267|P4|STARTED|Part B: Week 24 to Week 52||31
7914487|NCT00634933|19478268|P3|STARTED|Part B: Week 24 to Week 52||55
7914488|NCT00634933|19478269|P2|STARTED|Part B: Week 24 to Week 52||56
7914489|NCT00634933|19478270|P1|STARTED|Part B: Week 24 to Week 52||0
7914490|NCT00634933|19478266|P5|NOT COMPLETED|Between Part A and Part B||0
7914491|NCT00634933|19478267|P4|NOT COMPLETED|Between Part A and Part B||0
7914492|NCT00634933|19478268|P3|NOT COMPLETED|Between Part A and Part B||0
7914493|NCT00634933|19478269|P2|NOT COMPLETED|Between Part A and Part B||1
7914494|NCT00634933|19478270|P1|NOT COMPLETED|Between Part A and Part B||0
7914495|NCT00634933|19478266|P5|COMPLETED|Between Part A and Part B||32
7914496|NCT00634933|19478267|P4|COMPLETED|Between Part A and Part B||31
7914497|NCT00634933|19478268|P3|COMPLETED|Between Part A and Part B||55
7914498|NCT00634933|19478269|P2|COMPLETED|Between Part A and Part B||56
7914499|NCT00634933|19478270|P1|COMPLETED|Between Part A and Part B||0
7914500|NCT00634933|19478266|P5|STARTED|Between Part A and Part B||32
7914501|NCT00634933|19478267|P4|STARTED|Between Part A and Part B||31
7914502|NCT00634933|19478268|P3|STARTED|Between Part A and Part B||55
7914503|NCT00634933|19478269|P2|STARTED|Between Part A and Part B||57
7914504|NCT00634933|19478270|P1|STARTED|Between Part A and Part B||0
7914505|NCT00634933|19478266|P5|NOT COMPLETED|Part A: Baseline to Week 24||0
7914506|NCT00634933|19478267|P4|NOT COMPLETED|Part A: Baseline to Week 24||0
7914507|NCT00634933|19478268|P3|NOT COMPLETED|Part A: Baseline to Week 24||18
7914508|NCT00634933|19478269|P2|NOT COMPLETED|Part A: Baseline to Week 24||18
7914509|NCT00634933|19478270|P1|NOT COMPLETED|Part A: Baseline to Week 24||11
7914510|NCT00634933|19478266|P5|COMPLETED|Part A: Baseline to Week 24||0
7914511|NCT00634933|19478267|P4|COMPLETED|Part A: Baseline to Week 24||0
7914512|NCT00634933|19478268|P3|COMPLETED|Part A: Baseline to Week 24||55
7914513|NCT00634933|19478269|P2|COMPLETED|Part A: Baseline to Week 24||57
7914514|NCT00634933|19478270|P1|COMPLETED|Part A: Baseline to Week 24||63
7914515|NCT00634933|19478266|P5|STARTED|Part A: Baseline to Week 24||0
7914516|NCT00634933|19478267|P4|STARTED|Part A: Baseline to Week 24||0
7914517|NCT00634933|19478268|P3|STARTED|Part A: Baseline to Week 24||73
7914518|NCT00634933|19478269|P2|STARTED|Part A: Baseline to Week 24||75
7914519|NCT00634933|19478270|P1|STARTED|Part A: Baseline to Week 24||74
7914520|NCT00634920|19478339|P3|NOT COMPLETED|Period 2 - Post-Randomization||0
7914521|NCT00634920|19478340|P2|NOT COMPLETED|Period 2 - Post-Randomization||32
7914522|NCT00634920|19478341|P1|NOT COMPLETED|Period 2 - Post-Randomization||61
7914523|NCT00634920|19478339|P3|COMPLETED|Period 2 - Post-Randomization||0
7914524|NCT00634920|19478340|P2|COMPLETED|Period 2 - Post-Randomization||68
7914525|NCT00634920|19478341|P1|COMPLETED|Period 2 - Post-Randomization||43
7914526|NCT00634920|19478339|P3|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0
7914527|NCT00634920|19478340|P2|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90
7914528|NCT00634920|19478341|P1|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92
7914612|NCT00634621|19478473|P1|STARTED|Overall Study||283
7914529|NCT00634920|19478339|P3|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0
7914530|NCT00634920|19478340|P2|STARTED|Period 2 - Post-Randomization||100
7914531|NCT00634920|19478341|P1|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104
7914532|NCT00634920|19478339|P3|NOT COMPLETED|Period 1 - Pre-Randomization||137
7914533|NCT00634920|19478340|P2|NOT COMPLETED|Period 1 - Pre-Randomization||0
7914534|NCT00634920|19478341|P1|NOT COMPLETED|Period 1 - Pre-Randomization||0
7914535|NCT00634920|19478339|P3|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204
7914536|NCT00634920|19478340|P2|COMPLETED|Period 1 - Pre-Randomization||0
7914537|NCT00634920|19478341|P1|COMPLETED|Period 1 - Pre-Randomization||0
7914538|NCT00634920|19478339|P3|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341
7914539|NCT00634920|19478340|P2|STARTED|Period 1 - Pre-Randomization||0
7914540|NCT00634920|19478341|P1|STARTED|Period 1 - Pre-Randomization||0
7914541|NCT00634907|19478385|P2|NOT COMPLETED|Overall Study||17
7914542|NCT00634907|19478386|P1|NOT COMPLETED|Overall Study||17
7914543|NCT00634907|19478385|P2|COMPLETED|Overall Study||115
7914544|NCT00634907|19478386|P1|COMPLETED|Overall Study||114
7914545|NCT00634907|19478385|P2|STARTED|Overall Study||132
7914546|NCT00634907|19478386|P1|STARTED|Overall Study||131
7914547|NCT00634842|19478410|P2|NOT COMPLETED|Overall Study||18
7914548|NCT00634842|19478411|P1|NOT COMPLETED|Overall Study||15
7914549|NCT00634842|19478410|P2|COMPLETED|Overall Study||104
7914550|NCT00634842|19478411|P1|COMPLETED|Overall Study||107
7914551|NCT00634842|19478410|P2|STARTED|Overall Study||122
7914552|NCT00634842|19478411|P1|STARTED|Overall Study||122
7914553|NCT00634803|19478426|P3|NOT COMPLETED|Overall Study||7
7914554|NCT00634803|19478427|P2|NOT COMPLETED|Overall Study||7
7914555|NCT00634803|19478428|P1|NOT COMPLETED|Overall Study||6
7914556|NCT00634803|19478426|P3|COMPLETED|Overall Study||23
7914557|NCT00634803|19478427|P2|COMPLETED|Overall Study||23
7914558|NCT00634803|19478428|P1|COMPLETED|Overall Study||24
7914559|NCT00634803|19478426|P3|Month 3|Overall Study||26
7914560|NCT00634803|19478427|P2|Month 3|Overall Study||23
7914561|NCT00634803|19478428|P1|Month 3|Overall Study||25
7914562|NCT00634803|19478426|P3|Month 2|Overall Study||28
7914563|NCT00634803|19478427|P2|Month 2|Overall Study||26
7914564|NCT00634803|19478428|P1|Month 2|Overall Study||26
7914565|NCT00634803|19478426|P3|Month 1|Overall Study||29
7914566|NCT00634803|19478427|P2|Month 1|Overall Study||29
7914567|NCT00634803|19478428|P1|Month 1|Overall Study||29
7914568|NCT00634803|19478426|P3|STARTED|Overall Study||30
7914569|NCT00634803|19478427|P2|STARTED|Overall Study||30
7914570|NCT00634803|19478428|P1|STARTED|Overall Study||30
7914571|NCT00634751|19478446|P4|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
7914572|NCT00634751|19478447|P3|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
7914573|NCT00634751|19478448|P2|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
7914574|NCT00634751|19478449|P1|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
7914575|NCT00634751|19478446|P4|COMPLETED|Pancreatic and Bilial Tract Cancer||7
7914576|NCT00634751|19478447|P3|COMPLETED|Pancreatic and Bilial Tract Cancer||23
7914577|NCT00634751|19478448|P2|COMPLETED|Pancreatic and Bilial Tract Cancer||0
7914578|NCT00634751|19478449|P1|COMPLETED|Pancreatic and Bilial Tract Cancer||0
7914579|NCT00634751|19478446|P4|STARTED|Pancreatic and Bilial Tract Cancer||8
7914580|NCT00634751|19478447|P3|STARTED|Pancreatic and Bilial Tract Cancer||24
7914581|NCT00634751|19478448|P2|STARTED|Pancreatic and Bilial Tract Cancer||0
7914582|NCT00634751|19478449|P1|STARTED|Pancreatic and Bilial Tract Cancer||0
7914583|NCT00634751|19478446|P4|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
7914584|NCT00634751|19478447|P3|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
7914585|NCT00634751|19478448|P2|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||1
7914586|NCT00634751|19478449|P1|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
7914587|NCT00634751|19478446|P4|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
7914588|NCT00634751|19478447|P3|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
7914589|NCT00634751|19478448|P2|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||6
7914590|NCT00634751|19478449|P1|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
7914591|NCT00634751|19478446|P4|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
7914592|NCT00634751|19478447|P3|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
7914593|NCT00634751|19478448|P2|STARTED|Phase I: 400mg Sorafenib BID+2DOC||7
7914594|NCT00634751|19478449|P1|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
7914595|NCT00634751|19478446|P4|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
7914596|NCT00634751|19478447|P3|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
7914597|NCT00634751|19478448|P2|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
7914598|NCT00634751|19478449|P1|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||1
7914599|NCT00634751|19478446|P4|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
7914600|NCT00634751|19478447|P3|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
7914601|NCT00634751|19478448|P2|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
7914602|NCT00634751|19478449|P1|COMPLETED|Phase I: 200mg Sorafenib+2DOC||8
7914603|NCT00634751|19478446|P4|STARTED|Phase I: 200mg Sorafenib+2DOC||0
7914604|NCT00634751|19478447|P3|STARTED|Phase I: 200mg Sorafenib+2DOC||0
7914605|NCT00634751|19478448|P2|STARTED|Phase I: 200mg Sorafenib+2DOC||0
7914606|NCT00634751|19478449|P1|STARTED|Phase I: 200mg Sorafenib+2DOC||9
7914607|NCT00634647|19478467|P1|NOT COMPLETED|Overall Study||7
7914608|NCT00634647|19478467|P1|COMPLETED|Overall Study||17
7914609|NCT00634647|19478467|P1|STARTED|Overall Study||24
7914610|NCT00634621|19478473|P1|NOT COMPLETED|Overall Study||0
7914611|NCT00634621|19478473|P1|COMPLETED|Overall Study||283
7914613|NCT00634582|19478481|P1|NOT COMPLETED|Overall Study||0
7914614|NCT00634582|19478481|P1|COMPLETED|Overall Study||2
7914615|NCT00634582|19478481|P1|STARTED|Overall Study||2
7914616|NCT00634569|19478487|P2|NOT COMPLETED|Overall Study||5
7914617|NCT00634569|19478488|P1|NOT COMPLETED|Overall Study||0
7914618|NCT00634569|19478487|P2|COMPLETED|Overall Study||5
7914619|NCT00634569|19478488|P1|COMPLETED|Overall Study||14
7914620|NCT00634569|19478487|P2|STARTED|Overall Study||10
7914621|NCT00634569|19478488|P1|STARTED|Overall Study||14
7914622|NCT00634543|19478502|P2|NOT COMPLETED|Overall Study||21
7914623|NCT00634543|19478503|P1|NOT COMPLETED|Overall Study||19
7914624|NCT00634543|19478502|P2|COMPLETED|Overall Study||63
7914625|NCT00634543|19478503|P1|COMPLETED|Overall Study||59
7914626|NCT00634543|19478502|P2|Treated|Overall Study||80
7914627|NCT00634543|19478503|P1|Treated|Overall Study||76
7914628|NCT00634543|19478502|P2|STARTED|Overall Study||84
7914629|NCT00634543|19478503|P1|STARTED|Overall Study||78
7914630|NCT00634504|19478521|P2|NOT COMPLETED|Overall Study||0
7914631|NCT00634504|19478522|P1|NOT COMPLETED|Overall Study||1
7914632|NCT00634504|19478521|P2|COMPLETED|Overall Study||9
7914633|NCT00634504|19478522|P1|COMPLETED|Overall Study||10
7914634|NCT00634504|19478521|P2|STARTED|Overall Study||9
7914635|NCT00634504|19478522|P1|STARTED|Overall Study||11
7914636|NCT00634322|19478531|P3|NOT COMPLETED|Overall Study||0
7914637|NCT00634322|19478532|P2|NOT COMPLETED|Overall Study||0
7914638|NCT00634322|19478533|P1|NOT COMPLETED|Overall Study||0
7914639|NCT00634322|19478531|P3|COMPLETED|Overall Study||5
7914640|NCT00634322|19478532|P2|COMPLETED|Overall Study||1
7914641|NCT00634322|19478533|P1|COMPLETED|Overall Study||1
7914642|NCT00634322|19478531|P3|STARTED|Overall Study||5
7914643|NCT00634322|19478532|P2|STARTED|Overall Study||1
7914644|NCT00634322|19478533|P1|STARTED|Overall Study||1
7914645|NCT00634283|19478541|P1|NOT COMPLETED|Overall Study||0
7914646|NCT00634283|19478541|P1|COMPLETED|Overall Study||6
7914647|NCT00634283|19478541|P1|STARTED|Overall Study||6
7914648|NCT00634270|19478551|P2|NOT COMPLETED|Overall Study||1
7914649|NCT00634270|19478552|P1|NOT COMPLETED|Overall Study||3
7914650|NCT00634270|19478551|P2|COMPLETED|Overall Study||12
7914651|NCT00634270|19478552|P1|COMPLETED|Overall Study||46
7914652|NCT00634270|19478551|P2|STARTED|Overall Study||13
7914653|NCT00634270|19478552|P1|STARTED|Overall Study|February 12, 2008|49
7914654|NCT00634244|19478581|P3|NOT COMPLETED|Overall Study||0
7914655|NCT00634244|19478582|P2|NOT COMPLETED|Overall Study||13
7914656|NCT00634244|19478583|P1|NOT COMPLETED|Overall Study||1
7914657|NCT00634244|19478581|P3|COMPLETED|Overall Study||20
7914658|NCT00634244|19478582|P2|COMPLETED|Overall Study||24
7914659|NCT00634244|19478583|P1|COMPLETED|Overall Study||34
7914660|NCT00634244|19478581|P3|Eligible and Treated|Overall Study||20
7914661|NCT00634244|19478582|P2|Eligible and Treated|Overall Study||36
7914662|NCT00634244|19478583|P1|Eligible and Treated|Overall Study||35
7914663|NCT00634244|19478581|P3|STARTED|Overall Study||20
7914664|NCT00634244|19478582|P2|STARTED|Overall Study||37
7914665|NCT00634244|19478583|P1|STARTED|Overall Study||35
7914666|NCT00634179|19478594|P1|NOT COMPLETED|Phase II: Maintenance||1
7914667|NCT00634179|19478594|P1|COMPLETED|Phase II: Maintenance||29
7914668|NCT00634179|19478594|P1|STARTED|Phase II: Maintenance||30
7914669|NCT00634179|19478594|P1|NOT COMPLETED|Phase I: Induction||0
7914670|NCT00634179|19478594|P1|COMPLETED|Phase I: Induction||19
7914671|NCT00634179|19478594|P1|STARTED|Phase I: Induction||19
7914672|NCT00634166|19478603|P2|NOT COMPLETED|Overall Study||60
7914673|NCT00634166|19478604|P1|NOT COMPLETED|Overall Study||60
7914674|NCT00634166|19478603|P2|COMPLETED|Overall Study||78
7914675|NCT00634166|19478604|P1|COMPLETED|Overall Study||22
7914676|NCT00634166|19478603|P2|STARTED|Overall Study||138
7914677|NCT00634166|19478604|P1|STARTED|Overall Study||82
7914678|NCT00634114|19478613|P3|NOT COMPLETED|Overall Study||39
7914679|NCT00634114|19478614|P2|NOT COMPLETED|Overall Study||35
7914680|NCT00634114|19478615|P1|NOT COMPLETED|Overall Study||28
7914681|NCT00634114|19478613|P3|COMPLETED|Overall Study|Completed|148
7914682|NCT00634114|19478614|P2|COMPLETED|Overall Study|Completed|154
7914683|NCT00634114|19478615|P1|COMPLETED|Overall Study|Completed|160
7914684|NCT00634114|19478613|P3|STARTED|Overall Study|Randomised|187
7914685|NCT00634114|19478614|P2|STARTED|Overall Study|Randomised|189
7914686|NCT00634114|19478615|P1|STARTED|Overall Study|Randomised|188
7914687|NCT00634101|19478631|P2|NOT COMPLETED|Overall Study||3
7914688|NCT00634101|19478632|P1|NOT COMPLETED|Overall Study||5
7914689|NCT00634101|19478631|P2|COMPLETED|Overall Study||56
7914690|NCT00634101|19478632|P1|COMPLETED|Overall Study||61
7914691|NCT00634101|19478631|P2|STARTED|Overall Study||59
7914692|NCT00634101|19478632|P1|STARTED|Overall Study||66
7914693|NCT00634088|19478666|P4|NOT COMPLETED|Time Period 4: Triplet Combination||0
7914694|NCT00634088|19478667|P3|NOT COMPLETED|Time Period 4: Triplet Combination||0
7914695|NCT00634088|19478668|P2|NOT COMPLETED|Time Period 4: Triplet Combination||0
7914696|NCT00634088|19478669|P1|NOT COMPLETED|Time Period 4: Triplet Combination||0
7914697|NCT00634088|19478666|P4|COMPLETED|Time Period 4: Triplet Combination||0
7914698|NCT00634088|19478667|P3|COMPLETED|Time Period 4: Triplet Combination||0
7914699|NCT00634088|19478668|P2|COMPLETED|Time Period 4: Triplet Combination||0
7914700|NCT00634088|19478669|P1|COMPLETED|Time Period 4: Triplet Combination||0
7914701|NCT00634088|19478666|P4|STARTED|Time Period 4: Triplet Combination||0
7914702|NCT00634088|19478667|P3|STARTED|Time Period 4: Triplet Combination||0
7914703|NCT00634088|19478668|P2|STARTED|Time Period 4: Triplet Combination||0
7914704|NCT00634088|19478669|P1|STARTED|Time Period 4: Triplet Combination||0
7914705|NCT00634088|19478666|P4|NOT COMPLETED|Time Period 3: Dose Level 3||0
7914706|NCT00634088|19478667|P3|NOT COMPLETED|Time Period 3: Dose Level 3||1
7914707|NCT00634088|19478668|P2|NOT COMPLETED|Time Period 3: Dose Level 3||0
7914708|NCT00634088|19478669|P1|NOT COMPLETED|Time Period 3: Dose Level 3||0
7914709|NCT00634088|19478666|P4|COMPLETED|Time Period 3: Dose Level 3||0
7914710|NCT00634088|19478667|P3|COMPLETED|Time Period 3: Dose Level 3||0
7914711|NCT00634088|19478668|P2|COMPLETED|Time Period 3: Dose Level 3||0
7914712|NCT00634088|19478669|P1|COMPLETED|Time Period 3: Dose Level 3||0
7914713|NCT00634088|19478666|P4|STARTED|Time Period 3: Dose Level 3||0
7914714|NCT00634088|19478667|P3|STARTED|Time Period 3: Dose Level 3||1
7914715|NCT00634088|19478668|P2|STARTED|Time Period 3: Dose Level 3||0
7914716|NCT00634088|19478669|P1|STARTED|Time Period 3: Dose Level 3||0
7914717|NCT00634088|19478666|P4|NOT COMPLETED|Time Period 2: Dose Level 2||0
7914718|NCT00634088|19478667|P3|NOT COMPLETED|Time Period 2: Dose Level 2||0
7914719|NCT00634088|19478668|P2|NOT COMPLETED|Time Period 2: Dose Level 2||3
7914720|NCT00634088|19478669|P1|NOT COMPLETED|Time Period 2: Dose Level 2||0
7914721|NCT00634088|19478666|P4|COMPLETED|Time Period 2: Dose Level 2||0
7914722|NCT00634088|19478667|P3|COMPLETED|Time Period 2: Dose Level 2||0
7914723|NCT00634088|19478668|P2|COMPLETED|Time Period 2: Dose Level 2||0
7914724|NCT00634088|19478669|P1|COMPLETED|Time Period 2: Dose Level 2||0
7914725|NCT00634088|19478666|P4|STARTED|Time Period 2: Dose Level 2||0
7914726|NCT00634088|19478667|P3|STARTED|Time Period 2: Dose Level 2||0
7914727|NCT00634088|19478668|P2|STARTED|Time Period 2: Dose Level 2||3
7914728|NCT00634088|19478669|P1|STARTED|Time Period 2: Dose Level 2||0
7914729|NCT00634088|19478666|P4|NOT COMPLETED|Time Period 1: Dose Level 1||0
7914730|NCT00634088|19478667|P3|NOT COMPLETED|Time Period 1: Dose Level 1||0
7914731|NCT00634088|19478668|P2|NOT COMPLETED|Time Period 1: Dose Level 1||0
7914732|NCT00634088|19478669|P1|NOT COMPLETED|Time Period 1: Dose Level 1||6
7914733|NCT00634088|19478666|P4|COMPLETED|Time Period 1: Dose Level 1||0
7914734|NCT00634088|19478667|P3|COMPLETED|Time Period 1: Dose Level 1||0
7914735|NCT00634088|19478668|P2|COMPLETED|Time Period 1: Dose Level 1||0
7914736|NCT00634088|19478669|P1|COMPLETED|Time Period 1: Dose Level 1||0
7914737|NCT00634088|19478666|P4|STARTED|Time Period 1: Dose Level 1||0
7914738|NCT00634088|19478667|P3|STARTED|Time Period 1: Dose Level 1||0
7914739|NCT00634088|19478668|P2|STARTED|Time Period 1: Dose Level 1||0
7914740|NCT00634088|19478669|P1|STARTED|Time Period 1: Dose Level 1||6
7914741|NCT00634049|19478720|P1|NOT COMPLETED|Overall Study||3
7914742|NCT00634049|19478720|P1|COMPLETED|Overall Study||146
7914743|NCT00634049|19478720|P1|STARTED|Overall Study||149
7914744|NCT00634036|19478799|P2|NOT COMPLETED|Overall Study||2
7914745|NCT00634036|19478800|P1|NOT COMPLETED|Overall Study||2
7914746|NCT00634036|19478799|P2|COMPLETED|Overall Study||9
7914747|NCT00634036|19478800|P1|COMPLETED|Overall Study||10
7914748|NCT00634036|19478799|P2|STARTED|Overall Study||11
7914749|NCT00634036|19478800|P1|STARTED|Overall Study||12
7914750|NCT00634010|19478814|P2|NOT COMPLETED|Overall Study||14
7914751|NCT00634010|19478815|P1|NOT COMPLETED|Overall Study||10
7914752|NCT00634010|19478814|P2|COMPLETED|Overall Study||4
7914753|NCT00634010|19478815|P1|COMPLETED|Overall Study||8
7914754|NCT00634010|19478814|P2|STARTED|Overall Study||18
7914755|NCT00634010|19478815|P1|STARTED|Overall Study||18
7914756|NCT00633984|19478823|P2|NOT COMPLETED|Overall Study||13
7914757|NCT00633984|19478824|P1|NOT COMPLETED|Overall Study||9
7914758|NCT00633984|19478823|P2|COMPLETED|Overall Study||69
7914759|NCT00633984|19478824|P1|COMPLETED|Overall Study||78
7914760|NCT00633984|19478823|P2|STARTED|Overall Study||82
7914761|NCT00633984|19478824|P1|STARTED|Overall Study||87
7914762|NCT00633945|19478832|P1|NOT COMPLETED|Overall Study||2
7914763|NCT00633945|19478832|P1|COMPLETED|Overall Study||3
7914764|NCT00633945|19478832|P1|STARTED|Overall Study||5
7914765|NCT00633932|19478848|P3|NOT COMPLETED|Overall Study||11
7914766|NCT00633932|19478849|P2|NOT COMPLETED|Overall Study||14
7914767|NCT00633932|19478850|P1|NOT COMPLETED|Overall Study||12
7914768|NCT00633932|19478848|P3|COMPLETED|Overall Study||180
7914769|NCT00633932|19478849|P2|COMPLETED|Overall Study||176
7914770|NCT00633932|19478850|P1|COMPLETED|Overall Study||179
7914771|NCT00633932|19478848|P3|STARTED|Overall Study|Randomised|191
7914772|NCT00633932|19478849|P2|STARTED|Overall Study|Randomised|190
7914773|NCT00633932|19478850|P1|STARTED|Overall Study|Randomised|191
7914774|NCT00633919|19478863|P2|NOT COMPLETED|Overall Study||22
7914775|NCT00633919|19478864|P1|NOT COMPLETED|Overall Study||27
7914776|NCT00633919|19478863|P2|COMPLETED|Overall Study||39
7914777|NCT00633919|19478864|P1|COMPLETED|Overall Study||36
7914778|NCT00633919|19478863|P2|STARTED|Overall Study||61
7914779|NCT00633919|19478864|P1|STARTED|Overall Study||63
7914780|NCT00633893|19478881|P3|NOT COMPLETED|Overall Study||188
7914781|NCT00633893|19478882|P2|NOT COMPLETED|Overall Study||129
7914782|NCT00633893|19478883|P1|NOT COMPLETED|Overall Study||114
7914783|NCT00633893|19478881|P3|COMPLETED|Overall Study||641
7914784|NCT00633893|19478882|P2|COMPLETED|Overall Study||684
7914785|NCT00633893|19478883|P1|COMPLETED|Overall Study||726
7914786|NCT00633893|19478881|P3|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829
7914787|NCT00633893|19478882|P2|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813
7914788|NCT00633893|19478883|P1|STARTED|Overall Study||840
7914789|NCT00633880|19478957|P3|NOT COMPLETED|Randomized Double Blind||0
7914790|NCT00633880|19478958|P2|NOT COMPLETED|Randomized Double Blind||0
7914791|NCT00633880|19478959|P1|NOT COMPLETED|Randomized Double Blind||0
7914792|NCT00633880|19478957|P3|COMPLETED|Randomized Double Blind||51
7914793|NCT00633880|19478958|P2|COMPLETED|Randomized Double Blind||50
7914794|NCT00633880|19478959|P1|COMPLETED|Randomized Double Blind||0
7914795|NCT00633880|19478957|P3|STARTED|Randomized Double Blind||51
7914796|NCT00633880|19478958|P2|STARTED|Randomized Double Blind||50
7914797|NCT00633880|19478959|P1|STARTED|Randomized Double Blind||0
7914798|NCT00633880|19478957|P3|NOT COMPLETED|Open Label Titration||0
7914799|NCT00633880|19478958|P2|NOT COMPLETED|Open Label Titration||0
7914800|NCT00633880|19478959|P1|NOT COMPLETED|Open Label Titration||80
7914801|NCT00633880|19478957|P3|COMPLETED|Open Label Titration||0
7914802|NCT00633880|19478958|P2|COMPLETED|Open Label Titration||0
7914803|NCT00633880|19478959|P1|COMPLETED|Open Label Titration||101
7914804|NCT00633880|19478957|P3|STARTED|Open Label Titration||0
7914805|NCT00633880|19478958|P2|STARTED|Open Label Titration||0
7914806|NCT00633880|19478959|P1|STARTED|Open Label Titration||181
7914807|NCT00633867|19478988|P2|NOT COMPLETED|Overall Study||0
7914808|NCT00633867|19478989|P1|NOT COMPLETED|Overall Study||0
7914809|NCT00633867|19478988|P2|COMPLETED|Overall Study||60
7914810|NCT00633867|19478989|P1|COMPLETED|Overall Study||60
7914811|NCT00633867|19478988|P2|STARTED|Overall Study||60
7914812|NCT00633867|19478989|P1|STARTED|Overall Study||60
7914813|NCT00633750|19478995|P1|NOT COMPLETED|Overall Study||5
7914814|NCT00633750|19478995|P1|COMPLETED|Overall Study||42
7914815|NCT00633750|19478995|P1|STARTED|Overall Study||47
7914816|NCT00633594|19479004|P3|NOT COMPLETED|Overall Study||10
7914817|NCT00633594|19479005|P2|NOT COMPLETED|Overall Study||5
7914818|NCT00633594|19479006|P1|NOT COMPLETED|Overall Study||0
7914819|NCT00633594|19479004|P3|COMPLETED|Overall Study||16
7914820|NCT00633594|19479005|P2|COMPLETED|Overall Study||3
7914821|NCT00633594|19479006|P1|COMPLETED|Overall Study||5
7914822|NCT00633594|19479004|P3|STARTED|Overall Study||26
7914823|NCT00633594|19479005|P2|STARTED|Overall Study||8
7914824|NCT00633594|19479006|P1|STARTED|Overall Study||5
7914825|NCT00633477|19479035|P2|NOT COMPLETED|Overall Study||0
7914826|NCT00633477|19479036|P1|NOT COMPLETED|Overall Study||2
7914827|NCT00633477|19479035|P2|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11
7914828|NCT00633477|19479036|P1|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5
7914829|NCT00633477|19479035|P2|Completed Study Through Day 28|Overall Study||8
7914830|NCT00633477|19479036|P1|Completed Study Through Day 28|Overall Study||4
7914831|NCT00633477|19479035|P2|Prematurely Discontinued Study Drug|Overall Study||0
7914832|NCT00633477|19479036|P1|Prematurely Discontinued Study Drug|Overall Study||1
7914833|NCT00633477|19479035|P2|Randomized But Not Treated|Overall Study||0
7914834|NCT00633477|19479036|P1|Randomized But Not Treated|Overall Study||1
7914835|NCT00633477|19479035|P2|STARTED|Overall Study||11
7914836|NCT00633477|19479036|P1|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7
7914837|NCT00633464|19479052|P2|NOT COMPLETED|Overall Study||2
7914838|NCT00633464|19479053|P1|NOT COMPLETED|Overall Study||0
7914839|NCT00633464|19479052|P2|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37
7914840|NCT00633464|19479053|P1|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40
7914841|NCT00633464|19479052|P2|Treated|Overall Study||37
7914842|NCT00633464|19479053|P1|Treated|Overall Study||40
7914843|NCT00633464|19479052|P2|STARTED|Overall Study||39
7914844|NCT00633464|19479053|P1|STARTED|Overall Study||40
7914845|NCT00633399|19479075|P2|NOT COMPLETED|Overall Study||15
7914846|NCT00633399|19479076|P1|NOT COMPLETED|Overall Study||22
7914847|NCT00633399|19479075|P2|COMPLETED|Overall Study||53
7914848|NCT00633399|19479076|P1|COMPLETED|Overall Study||49
7914849|NCT00633399|19479075|P2|STARTED|Overall Study||68
7914850|NCT00633399|19479076|P1|STARTED|Overall Study||71
7914851|NCT00633360|19479088|P2|NOT COMPLETED|Overall Study||3
7914852|NCT00633360|19479089|P1|NOT COMPLETED|Overall Study||4
7914853|NCT00633360|19479088|P2|COMPLETED|Overall Study||13
7914854|NCT00633360|19479089|P1|COMPLETED|Overall Study||12
7914855|NCT00633360|19479088|P2|STARTED|Overall Study||16
7914856|NCT00633360|19479089|P1|STARTED|Overall Study||16
7914857|NCT00633256|19479099|P2|NOT COMPLETED|Overall Study||3
7914858|NCT00633256|19479100|P1|NOT COMPLETED|Overall Study||4
7914859|NCT00633256|19479099|P2|COMPLETED|Overall Study||10
7914860|NCT00633256|19479100|P1|COMPLETED|Overall Study||8
7914861|NCT00633256|19479099|P2|STARTED|Overall Study||13
7914862|NCT00633256|19479100|P1|STARTED|Overall Study||12
7914863|NCT00633243|19479112|P2|NOT COMPLETED|Overall Study||7
7914864|NCT00633243|19479113|P1|NOT COMPLETED|Overall Study||1
7914865|NCT00633243|19479112|P2|COMPLETED|Overall Study||2
7914866|NCT00633243|19479113|P1|COMPLETED|Overall Study||11
7914867|NCT00633243|19479112|P2|STARTED|Overall Study||9
7914868|NCT00633243|19479113|P1|STARTED|Overall Study||12
7914869|NCT00633217|19479121|P2|NOT COMPLETED|Overall Study||23
7914870|NCT00633217|19479122|P1|NOT COMPLETED|Overall Study||15
7914871|NCT00633217|19479121|P2|COMPLETED|Overall Study||103
7914872|NCT00633217|19479122|P1|COMPLETED|Overall Study||106
7914873|NCT00633217|19479121|P2|STARTED|Overall Study||126
7914874|NCT00633217|19479122|P1|STARTED|Overall Study||121
7914875|NCT00633152|19479134|P2|NOT COMPLETED|Overall Study||6
7914876|NCT00633152|19479135|P1|NOT COMPLETED|Overall Study||14
7914877|NCT00633152|19479134|P2|COMPLETED|Overall Study||41
7914878|NCT00633152|19479135|P1|COMPLETED|Overall Study||89
7914879|NCT00633152|19479134|P2|Clinically Evaluable Population|Overall Study||39
7914880|NCT00633152|19479135|P1|Clinically Evaluable Population|Overall Study||86
7914881|NCT00633152|19479134|P2|MITT and Safety Population|Overall Study||45
7914882|NCT00633152|19479135|P1|MITT and Safety Population|Overall Study||98
7914883|NCT00633152|19479134|P2|STARTED|Overall Study||47
7914884|NCT00633152|19479135|P1|STARTED|Overall Study||103
7914885|NCT00633139|19479146|P3|NOT COMPLETED|Overall Study||1
7914886|NCT00633139|19479147|P2|NOT COMPLETED|Overall Study||1
7914887|NCT00633139|19479148|P1|NOT COMPLETED|Overall Study||0
7914888|NCT00633139|19479146|P3|COMPLETED|Overall Study||3
7914889|NCT00633139|19479147|P2|COMPLETED|Overall Study||4
7914890|NCT00633139|19479148|P1|COMPLETED|Overall Study||4
7914891|NCT00633139|19479146|P3|STARTED|Overall Study||4
7914892|NCT00633139|19479147|P2|STARTED|Overall Study||5
7914893|NCT00633139|19479148|P1|STARTED|Overall Study||4
7914894|NCT00633126|19479162|P1|NOT COMPLETED|Overall Study||1
7914895|NCT00633126|19479162|P1|COMPLETED|Overall Study||8
7914896|NCT00633126|19479162|P1|STARTED|Overall Study||9
7914897|NCT00633087|19479167|P1|NOT COMPLETED|Overall Study||0
7914898|NCT00633087|19479167|P1|COMPLETED|Overall Study||12
7914899|NCT00633087|19479167|P1|STARTED|Overall Study||12
7914900|NCT00633074|19479176|P2|NOT COMPLETED|Overall Study||0
7914901|NCT00633074|19479177|P1|NOT COMPLETED|Overall Study||1
7914902|NCT00633074|19479176|P2|COMPLETED|Overall Study||360
7914903|NCT00633074|19479177|P1|COMPLETED|Overall Study||359
7914904|NCT00633074|19479176|P2|STARTED|Overall Study||360
7914905|NCT00633074|19479177|P1|STARTED|Overall Study||360
7914906|NCT00633061|19479207|P2|NOT COMPLETED|Overall Study||0
7914907|NCT00633061|19479208|P1|NOT COMPLETED|Overall Study||86
7914908|NCT00633061|19479207|P2|COMPLETED|Overall Study||0
7914909|NCT00633061|19479208|P1|COMPLETED|Overall Study||50
7914910|NCT00633061|19479207|P2|Had Prior Thrombosis Identified|Overall Study||0
7914911|NCT00633061|19479208|P1|Had Prior Thrombosis Identified|Overall Study||25
7914912|NCT00633061|19479207|P2|Met Criteria for Imaging|Overall Study||0
7914913|NCT00633061|19479208|P1|Met Criteria for Imaging|Overall Study||25
7914914|NCT00633061|19479207|P2|STARTED|Overall Study||0
7914915|NCT00633061|19479208|P1|STARTED|Overall Study|Study was on hold for 2 months for continuing review|136
7914916|NCT00633022|19479219|P3|NOT COMPLETED|Overall Study||5
7914917|NCT00633022|19479220|P2|NOT COMPLETED|Overall Study||1
7914918|NCT00633022|19479221|P1|NOT COMPLETED|Overall Study||1
7914919|NCT00633022|19479219|P3|COMPLETED|Overall Study||27
7914920|NCT00633022|19479220|P2|COMPLETED|Overall Study||32
7914921|NCT00633022|19479221|P1|COMPLETED|Overall Study||33
7914922|NCT00633022|19479219|P3|STARTED|Overall Study||32
7914923|NCT00633022|19479220|P2|STARTED|Overall Study||33
7914924|NCT00633022|19479221|P1|STARTED|Overall Study||34
7914925|NCT00633009|19479259|P3|NOT COMPLETED|Overall Study||1
7914926|NCT00633009|19479260|P2|NOT COMPLETED|Overall Study||4
7914927|NCT00633009|19479261|P1|NOT COMPLETED|Overall Study||4
7914928|NCT00633009|19479259|P3|COMPLETED|Overall Study||10
7914929|NCT00633009|19479260|P2|COMPLETED|Overall Study||23
7914930|NCT00633009|19479261|P1|COMPLETED|Overall Study||8
7914931|NCT00633009|19479259|P3|STARTED|Overall Study||11
7914932|NCT00633009|19479260|P2|STARTED|Overall Study||27
7914933|NCT00633009|19479261|P1|STARTED|Overall Study||12
7914934|NCT00632970|19479274|P2|NOT COMPLETED|Overall Study||0
7914935|NCT00632970|19479275|P1|NOT COMPLETED|Overall Study||0
7914936|NCT00632970|19479274|P2|COMPLETED|Overall Study||3
7914937|NCT00632970|19479275|P1|COMPLETED|Overall Study||3
7914938|NCT00632970|19479274|P2|STARTED|Overall Study||3
7914939|NCT00632970|19479275|P1|STARTED|Overall Study||3
7914940|NCT00632931|19479283|P3|NOT COMPLETED|Part 2||24
7914941|NCT00632931|19479284|P2|NOT COMPLETED|Part 2||0
7914942|NCT00632931|19479285|P1|NOT COMPLETED|Part 2||0
7914943|NCT00632931|19479283|P3|COMPLETED|Part 2||0
7914944|NCT00632931|19479284|P2|COMPLETED|Part 2||0
7914945|NCT00632931|19479285|P1|COMPLETED|Part 2||0
7914946|NCT00632931|19479283|P3|STARTED|Part 2||24
7914947|NCT00632931|19479284|P2|STARTED|Part 2||0
7914948|NCT00632931|19479285|P1|STARTED|Part 2||0
7914949|NCT00632931|19479283|P3|NOT COMPLETED|Post-Part 1 Washout||0
7914950|NCT00632931|19479284|P2|NOT COMPLETED|Post-Part 1 Washout||0
7914951|NCT00632931|19479285|P1|NOT COMPLETED|Post-Part 1 Washout||0
7914952|NCT00632931|19479283|P3|COMPLETED|Post-Part 1 Washout||0
7914953|NCT00632931|19479284|P2|COMPLETED|Post-Part 1 Washout||12
7914954|NCT00632931|19479285|P1|COMPLETED|Post-Part 1 Washout||12
7914955|NCT00632931|19479283|P3|STARTED|Post-Part 1 Washout||0
7914956|NCT00632931|19479284|P2|STARTED|Post-Part 1 Washout||12
7914957|NCT00632931|19479285|P1|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12
7914958|NCT00632931|19479283|P3|NOT COMPLETED|Part 1, Period 2||0
7914959|NCT00632931|19479284|P2|NOT COMPLETED|Part 1, Period 2||0
7914960|NCT00632931|19479285|P1|NOT COMPLETED|Part 1, Period 2||0
7914961|NCT00632931|19479283|P3|COMPLETED|Part 1, Period 2||0
7914962|NCT00632931|19479284|P2|COMPLETED|Part 1, Period 2||12
7914963|NCT00632931|19479285|P1|COMPLETED|Part 1, Period 2||11
7914964|NCT00632931|19479283|P3|STARTED|Part 1, Period 2||0
7914965|NCT00632931|19479284|P2|STARTED|Part 1, Period 2||12
7914966|NCT00632931|19479285|P1|STARTED|Part 1, Period 2||11
7914967|NCT00632931|19479283|P3|NOT COMPLETED|Part 1, Washout||0
7914968|NCT00632931|19479284|P2|NOT COMPLETED|Part 1, Washout||0
7914969|NCT00632931|19479285|P1|NOT COMPLETED|Part 1, Washout||0
7914970|NCT00632931|19479283|P3|COMPLETED|Part 1, Washout||0
7914971|NCT00632931|19479284|P2|COMPLETED|Part 1, Washout||12
7914972|NCT00632931|19479285|P1|COMPLETED|Part 1, Washout||11
7914973|NCT00632931|19479283|P3|STARTED|Part 1, Washout||0
7914974|NCT00632931|19479284|P2|STARTED|Part 1, Washout||12
7914975|NCT00632931|19479285|P1|STARTED|Part 1, Washout||11
7914976|NCT00632931|19479283|P3|NOT COMPLETED|Part 1, Period 1||0
7914977|NCT00632931|19479284|P2|NOT COMPLETED|Part 1, Period 1||0
7914978|NCT00632931|19479285|P1|NOT COMPLETED|Part 1, Period 1||2
7914979|NCT00632931|19479283|P3|COMPLETED|Part 1, Period 1||0
7914980|NCT00632931|19479284|P2|COMPLETED|Part 1, Period 1||12
7914981|NCT00632931|19479285|P1|COMPLETED|Part 1, Period 1||11
7914982|NCT00632931|19479283|P3|STARTED|Part 1, Period 1||0
7914983|NCT00632931|19479284|P2|STARTED|Part 1, Period 1||12
7914984|NCT00632931|19479285|P1|STARTED|Part 1, Period 1||13
7914985|NCT00632827|19479304|P1|NOT COMPLETED|Overall Study||10
7914986|NCT00632827|19479304|P1|COMPLETED|Overall Study||11
7914987|NCT00632827|19479304|P1|Evaluated Post Stem Cell Transplant|Overall Study||16
7914988|NCT00632827|19479304|P1|Received M-CHOP|Overall Study||18
7914989|NCT00632827|19479304|P1|Received GVD|Overall Study||21
7914990|NCT00632827|19479304|P1|STARTED|Overall Study||21
7914991|NCT00632814|19479314|P3|NOT COMPLETED|Overall Study||0
7914992|NCT00632814|19479315|P2|NOT COMPLETED|Overall Study||0
7914993|NCT00632814|19479316|P1|NOT COMPLETED|Overall Study||0
7914994|NCT00632814|19479314|P3|COMPLETED|Overall Study||8
7914995|NCT00632814|19479315|P2|COMPLETED|Overall Study||13
7914996|NCT00632814|19479316|P1|COMPLETED|Overall Study||11
7914997|NCT00632814|19479314|P3|STARTED|Overall Study||8
7914998|NCT00632814|19479315|P2|STARTED|Overall Study||13
7914999|NCT00632814|19479316|P1|STARTED|Overall Study||11
7915000|NCT00632749|19479362|P14|NOT COMPLETED|Overall Study||6
7915001|NCT00632749|19479363|P13|NOT COMPLETED|Overall Study||3
7915002|NCT00632749|19479364|P12|NOT COMPLETED|Overall Study||4
7915003|NCT00632749|19479365|P11|NOT COMPLETED|Overall Study||7
7915004|NCT00632749|19479366|P10|NOT COMPLETED|Overall Study||3
7915005|NCT00632749|19479367|P9|NOT COMPLETED|Overall Study||5
7915006|NCT00632749|19479368|P8|NOT COMPLETED|Overall Study||4
7915007|NCT00632749|19479369|P7|NOT COMPLETED|Overall Study||5
7915008|NCT00632749|19479370|P6|NOT COMPLETED|Overall Study||8
7915009|NCT00632749|19479371|P5|NOT COMPLETED|Overall Study||7
7915010|NCT00632749|19479372|P4|NOT COMPLETED|Overall Study||4
7915011|NCT00632749|19479373|P3|NOT COMPLETED|Overall Study||3
7915012|NCT00632749|19479374|P2|NOT COMPLETED|Overall Study||5
7915013|NCT00632749|19479375|P1|NOT COMPLETED|Overall Study||4
7915014|NCT00632749|19479362|P14|COMPLETED|Overall Study||0
7915015|NCT00632749|19479363|P13|COMPLETED|Overall Study||0
7915016|NCT00632749|19479364|P12|COMPLETED|Overall Study||0
7915017|NCT00632749|19479365|P11|COMPLETED|Overall Study||0
7915018|NCT00632749|19479366|P10|COMPLETED|Overall Study||0
7915019|NCT00632749|19479367|P9|COMPLETED|Overall Study||0
7915020|NCT00632749|19479368|P8|COMPLETED|Overall Study||0
7915021|NCT00632749|19479369|P7|COMPLETED|Overall Study||0
7915022|NCT00632749|19479370|P6|COMPLETED|Overall Study||0
7915023|NCT00632749|19479371|P5|COMPLETED|Overall Study||0
7915024|NCT00632749|19479372|P4|COMPLETED|Overall Study||0
7915025|NCT00632749|19479373|P3|COMPLETED|Overall Study||0
7915026|NCT00632749|19479374|P2|COMPLETED|Overall Study||0
7915027|NCT00632749|19479375|P1|COMPLETED|Overall Study||0
7915028|NCT00632749|19479362|P14|Not Treated|Overall Study||0
7915029|NCT00632749|19479363|P13|Not Treated|Overall Study||0
7915030|NCT00632749|19479364|P12|Not Treated|Overall Study||0
7915031|NCT00632749|19479365|P11|Not Treated|Overall Study||0
7915032|NCT00632749|19479366|P10|Not Treated|Overall Study||0
7915033|NCT00632749|19479367|P9|Not Treated|Overall Study||0
7915034|NCT00632749|19479368|P8|Not Treated|Overall Study||0
7915035|NCT00632749|19479369|P7|Not Treated|Overall Study||1
7915036|NCT00632749|19479370|P6|Not Treated|Overall Study||1
7915037|NCT00632749|19479371|P5|Not Treated|Overall Study||0
7915038|NCT00632749|19479372|P4|Not Treated|Overall Study||0
7915039|NCT00632749|19479373|P3|Not Treated|Overall Study||0
7915040|NCT00632749|19479374|P2|Not Treated|Overall Study||2
7915041|NCT00632749|19479375|P1|Not Treated|Overall Study||0
7915042|NCT00632749|19479362|P14|Treated|Overall Study||6
7915043|NCT00632749|19479363|P13|Treated|Overall Study||3
7915044|NCT00632749|19479364|P12|Treated|Overall Study||4
7915045|NCT00632749|19479365|P11|Treated|Overall Study||7
7915046|NCT00632749|19479366|P10|Treated|Overall Study||3
7915047|NCT00632749|19479367|P9|Treated|Overall Study||5
7915048|NCT00632749|19479368|P8|Treated|Overall Study||4
7915049|NCT00632749|19479369|P7|Treated|Overall Study||4
7915050|NCT00632749|19479370|P6|Treated|Overall Study||7
7915051|NCT00632749|19479371|P5|Treated|Overall Study||7
7915052|NCT00632749|19479372|P4|Treated|Overall Study||4
7915053|NCT00632749|19479373|P3|Treated|Overall Study||3
7915054|NCT00632749|19479374|P2|Treated|Overall Study||3
7915055|NCT00632749|19479375|P1|Treated|Overall Study||4
7915056|NCT00632749|19479362|P14|STARTED|Overall Study||6
7915057|NCT00632749|19479363|P13|STARTED|Overall Study||3
7915058|NCT00632749|19479364|P12|STARTED|Overall Study||4
7915059|NCT00632749|19479365|P11|STARTED|Overall Study||7
7915060|NCT00632749|19479366|P10|STARTED|Overall Study||3
7915061|NCT00632749|19479367|P9|STARTED|Overall Study||5
7915062|NCT00632749|19479368|P8|STARTED|Overall Study||4
7915063|NCT00632749|19479369|P7|STARTED|Overall Study||5
7915064|NCT00632749|19479370|P6|STARTED|Overall Study||8
7915065|NCT00632749|19479371|P5|STARTED|Overall Study||7
7915066|NCT00632749|19479372|P4|STARTED|Overall Study||4
7915067|NCT00632749|19479373|P3|STARTED|Overall Study||3
7915068|NCT00632749|19479374|P2|STARTED|Overall Study||5
7915069|NCT00632749|19479375|P1|STARTED|Overall Study||4
7915070|NCT00632736|19479669|P1|NOT COMPLETED|Overall Study||268
7915071|NCT00632736|19479669|P1|COMPLETED|Overall Study||151
7915072|NCT00632736|19479669|P1|STARTED|Overall Study||419
7915073|NCT00632632|19479676|P2|NOT COMPLETED|Overall Study||3
7915074|NCT00632632|19479677|P1|NOT COMPLETED|Overall Study||0
7915075|NCT00632632|19479676|P2|COMPLETED|Overall Study||9
7915076|NCT00632632|19479677|P1|COMPLETED|Overall Study||13
7915077|NCT00632632|19479676|P2|STARTED|Overall Study||12
7915078|NCT00632632|19479677|P1|STARTED|Overall Study||13
7915079|NCT00632619|19479689|P2|NOT COMPLETED|Overall Study||4
7915080|NCT00632619|19479690|P1|NOT COMPLETED|Overall Study||8
7915081|NCT00632619|19479689|P2|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10
~nd cohort completed follow up 7/18/11"|31
7915082|NCT00632619|19479690|P1|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10
~nd cohort completed follow up 7/18/11"|25
7915083|NCT00632619|19479689|P2|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35
7915084|NCT00632619|19479690|P1|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33
7915085|NCT00632541|19479704|P1|NOT COMPLETED|Overall Study||7
7915086|NCT00632541|19479704|P1|COMPLETED|Overall Study||11
7915087|NCT00632541|19479704|P1|STARTED|Overall Study|18 subjects were accrued to the study|18
7915088|NCT00632502|19479713|P2|NOT COMPLETED|Overall Study||1
7915089|NCT00632502|19479714|P1|NOT COMPLETED|Overall Study||3
7915090|NCT00632502|19479713|P2|COMPLETED|Overall Study||11
7915091|NCT00632502|19479714|P1|COMPLETED|Overall Study||22
7915092|NCT00632502|19479713|P2|Completed Treatment|Overall Study||9
7915093|NCT00632502|19479714|P1|Completed Treatment|Overall Study||19
7915094|NCT00632502|19479713|P2|Treated|Overall Study||12
7915095|NCT00632502|19479714|P1|Treated|Overall Study||22
7915096|NCT00632502|19479713|P2|STARTED|Overall Study||12
7915097|NCT00632502|19479714|P1|STARTED|Overall Study||25
7915098|NCT00632489|19479742|P3|NOT COMPLETED|Overall Study||0
7915099|NCT00632489|19479743|P2|NOT COMPLETED|Overall Study||5
7915100|NCT00632489|19479744|P1|NOT COMPLETED|Overall Study||15
7915101|NCT00632489|19479742|P3|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
7915102|NCT00632489|19479743|P2|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
7915103|NCT00632489|19479744|P1|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
7915104|NCT00632489|19479742|P3|STARTED|Overall Study||0
7915105|NCT00632489|19479743|P2|STARTED|Overall Study||5
7915106|NCT00632489|19479744|P1|STARTED|Overall Study||15
7915107|NCT00632463|19479758|P3|NOT COMPLETED|Overall Study||0
7915108|NCT00632463|19479759|P2|NOT COMPLETED|Overall Study||1
7915109|NCT00632463|19479760|P1|NOT COMPLETED|Overall Study||0
7915110|NCT00632463|19479758|P3|COMPLETED|Overall Study||7
7915111|NCT00632463|19479759|P2|COMPLETED|Overall Study||6
7915112|NCT00632463|19479760|P1|COMPLETED|Overall Study||7
7915113|NCT00632463|19479758|P3|STARTED|Overall Study||7
7915114|NCT00632463|19479759|P2|STARTED|Overall Study||7
7915115|NCT00632463|19479760|P1|STARTED|Overall Study||7
7915116|NCT00632424|19479777|P1|NOT COMPLETED|Overall Study||18
7915117|NCT00632424|19479777|P1|COMPLETED|Overall Study||0
7915118|NCT00632424|19479777|P1|STARTED|Overall Study||18
7915119|NCT00632411|19479801|P2|NOT COMPLETED|Overall Study||176
7915120|NCT00632411|19479802|P1|NOT COMPLETED|Overall Study||160
7915121|NCT00632411|19479801|P2|COMPLETED|Overall Study||473
7915122|NCT00632411|19479802|P1|COMPLETED|Overall Study||489
7915123|NCT00632411|19479801|P2|STARTED|Overall Study||649
7915124|NCT00632411|19479802|P1|STARTED|Overall Study||649
7915125|NCT00632359|19479808|P1|NOT COMPLETED|Overall Study||2
7915126|NCT00632359|19479808|P1|COMPLETED|Overall Study||31
7915127|NCT00632359|19479808|P1|STARTED|Overall Study||33
7915128|NCT00632281|19479814|P1|NOT COMPLETED|Overall Study||0
7915129|NCT00632281|19479814|P1|COMPLETED|Overall Study||38
7915130|NCT00632281|19479814|P1|STARTED|Overall Study||38
7915131|NCT00632229|19479821|P2|NOT COMPLETED|Overall Study||6
7915132|NCT00632229|19479822|P1|NOT COMPLETED|Overall Study||6
7915133|NCT00632229|19479821|P2|COMPLETED|Overall Study||11
7915134|NCT00632229|19479822|P1|COMPLETED|Overall Study||11
7915135|NCT00632229|19479821|P2|STARTED|Overall Study||17
7915136|NCT00632229|19479822|P1|STARTED|Overall Study||17
7915137|NCT00632203|19479832|P2|NOT COMPLETED|Overall Study||0
7915138|NCT00632203|19479833|P1|NOT COMPLETED|Overall Study||1
7915139|NCT00632203|19479832|P2|COMPLETED|Overall Study||27
7915140|NCT00632203|19479833|P1|COMPLETED|Overall Study||25
7915141|NCT00632203|19479832|P2|STARTED|Overall Study||27
7915142|NCT00632203|19479833|P1|STARTED|Overall Study||26
7915143|NCT00632125|19479851|P1|NOT COMPLETED|Overall Study||302
7915144|NCT00632125|19479851|P1|COMPLETED|Overall Study||1393
7915145|NCT00632125|19479851|P1|STARTED|Overall Study|1,698 patients were enrolled but 3 patients did not receive any study medication.|1695
7915146|NCT00632099|19479857|P2|NOT COMPLETED|Overall Study||3
7915147|NCT00632099|19479858|P1|NOT COMPLETED|Overall Study||3
7915148|NCT00632099|19479857|P2|COMPLETED|Overall Study||8
7915149|NCT00632099|19479858|P1|COMPLETED|Overall Study||7
7915150|NCT00632099|19479857|P2|STARTED|Overall Study||11
7915151|NCT00632099|19479858|P1|STARTED|Overall Study||10
7915152|NCT00632021|19479866|P2|NOT COMPLETED|Overall Study||7
7915153|NCT00632021|19479867|P1|NOT COMPLETED|Overall Study||4
7915154|NCT00632021|19479866|P2|COMPLETED|Overall Study||423
7915155|NCT00632021|19479867|P1|COMPLETED|Overall Study||428
7915156|NCT00632021|19479866|P2|STARTED|Overall Study||430
7915157|NCT00632021|19479867|P1|STARTED|Overall Study||432
7915158|NCT00631969|19479877|P2|NOT COMPLETED|Overall Study||21
7915159|NCT00631969|19479878|P1|NOT COMPLETED|Overall Study||15
7915160|NCT00631969|19479877|P2|COMPLETED|Overall Study||155
7915161|NCT00631969|19479878|P1|COMPLETED|Overall Study||171
7915162|NCT00631969|19479877|P2|Received Treatment|Overall Study|safety population|174
7915163|NCT00631969|19479878|P1|Received Treatment|Overall Study|safety population|184
7915164|NCT00631969|19479877|P2|STARTED|Overall Study||176
7915165|NCT00631969|19479878|P1|STARTED|Overall Study||186
7915166|NCT00631917|19479924|P2|NOT COMPLETED|Overall Study||108
7915167|NCT00631917|19479925|P1|NOT COMPLETED|Overall Study||88
7915168|NCT00631917|19479924|P2|COMPLETED|Overall Study||291
7915169|NCT00631917|19479925|P1|COMPLETED|Overall Study||287
7915170|NCT00631917|19479924|P2|STARTED|Overall Study||399
7915171|NCT00631917|19479925|P1|STARTED|Overall Study||375
7915172|NCT00631748|19479941|P2|NOT COMPLETED|Overall Study||22
7915173|NCT00631748|19479942|P1|NOT COMPLETED|Overall Study||18
7915174|NCT00631748|19479941|P2|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9
7915175|NCT00631748|19479942|P1|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11
7915176|NCT00631748|19479941|P2|STARTED|Overall Study||31
7915177|NCT00631748|19479942|P1|STARTED|Overall Study||29
7915178|NCT00631696|19479952|P2|NOT COMPLETED|Overall Study||40
7915179|NCT00631696|19479953|P1|NOT COMPLETED|Overall Study||37
7915180|NCT00631696|19479952|P2|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70
7915181|NCT00631696|19479953|P1|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75
7915182|NCT00631696|19479952|P2|Ongoing at Database Release 18Oct2011|Overall Study||0
7915183|NCT00631696|19479953|P1|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2
7915184|NCT00631696|19479952|P2|Received Study Treatment (Tx)|Overall Study||109
7915185|NCT00631696|19479953|P1|Received Study Treatment (Tx)|Overall Study||111
7915186|NCT00631696|19479952|P2|STARTED|Overall Study||110
7915187|NCT00631696|19479953|P1|STARTED|Overall Study||112
7915188|NCT00631670|19479979|P2|NOT COMPLETED|Overall Study||0
7915189|NCT00631670|19479980|P1|NOT COMPLETED|Overall Study||0
7915190|NCT00631670|19479979|P2|COMPLETED|Overall Study||0
7915191|NCT00631670|19479980|P1|COMPLETED|Overall Study||21
7915192|NCT00631670|19479979|P2|STARTED|Overall Study||0
7915193|NCT00631670|19479980|P1|STARTED|Overall Study||21
7915194|NCT00631657|19479996|P3|NOT COMPLETED|7-Day Discontinuation Period||1
7915195|NCT00631657|19479997|P2|NOT COMPLETED|7-Day Discontinuation Period||1
7915196|NCT00631657|19479998|P1|NOT COMPLETED|7-Day Discontinuation Period||2
7915197|NCT00631657|19479996|P3|COMPLETED|7-Day Discontinuation Period||65
7915198|NCT00631657|19479997|P2|COMPLETED|7-Day Discontinuation Period||136
7915199|NCT00631657|19479998|P1|COMPLETED|7-Day Discontinuation Period||65
7915200|NCT00631657|19479996|P3|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65
7915201|NCT00631657|19479997|P2|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136
7915202|NCT00631657|19479998|P1|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66
7915203|NCT00631657|19479996|P3|STARTED|7-Day Discontinuation Period||66
7915204|NCT00631657|19479997|P2|STARTED|7-Day Discontinuation Period||137
7915205|NCT00631657|19479998|P1|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67
7915206|NCT00631657|19479996|P3|NOT COMPLETED|6-Month Treatment Period||50
7915207|NCT00631657|19479997|P2|NOT COMPLETED|6-Month Treatment Period||0
7915208|NCT00631657|19479998|P1|NOT COMPLETED|6-Month Treatment Period||141
7915209|NCT00631657|19479996|P3|COMPLETED|6-Month Treatment Period||66
7915210|NCT00631657|19479997|P2|COMPLETED|6-Month Treatment Period||0
7915211|NCT00631657|19479998|P1|COMPLETED|6-Month Treatment Period||203
7915212|NCT00631657|19479996|P3|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115
7915213|NCT00631657|19479997|P2|Treated|6-Month Treatment Period||0
7915214|NCT00631657|19479998|P1|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342
7915215|NCT00631657|19479996|P3|STARTED|6-Month Treatment Period||116
7915216|NCT00631657|19479997|P2|STARTED|6-Month Treatment Period||0
7915217|NCT00631657|19479998|P1|STARTED|6-Month Treatment Period||344
7915218|NCT00631566|19480028|P3|NOT COMPLETED|Overall Study||0
7915219|NCT00631566|19480029|P2|NOT COMPLETED|Overall Study||4
7915220|NCT00631566|19480030|P1|NOT COMPLETED|Overall Study||2
7915221|NCT00631566|19480028|P3|COMPLETED|Overall Study||501
7915222|NCT00631566|19480029|P2|COMPLETED|Overall Study||24
7915223|NCT00631566|19480030|P1|COMPLETED|Overall Study||19
7915224|NCT00631566|19480028|P3|STARTED|Overall Study||501
7915225|NCT00631566|19480029|P2|STARTED|Overall Study||28
7915226|NCT00631566|19480030|P1|STARTED|Overall Study||21
7915227|NCT00631540|19480047|P1|NOT COMPLETED|Overall Study||14
7915228|NCT00631540|19480047|P1|COMPLETED|Overall Study||86
7915229|NCT00631540|19480047|P1|STARTED|Overall Study||100
7915230|NCT00631488|19480059|P3|NOT COMPLETED|Overall Study||2
7915231|NCT00631488|19480060|P2|NOT COMPLETED|Overall Study||2
7915232|NCT00631488|19480061|P1|NOT COMPLETED|Overall Study||4
7915233|NCT00631488|19480059|P3|COMPLETED|Overall Study||47
7915234|NCT00631488|19480060|P2|COMPLETED|Overall Study||47
7915235|NCT00631488|19480061|P1|COMPLETED|Overall Study||44
7915236|NCT00631488|19480059|P3|Completed Post-Treatment Period|Overall Study||47
7915237|NCT00631488|19480060|P2|Completed Post-Treatment Period|Overall Study||47
7915238|NCT00631488|19480061|P1|Completed Post-Treatment Period|Overall Study||44
7915239|NCT00631488|19480059|P3|STARTED|Overall Study||49
7915240|NCT00631488|19480060|P2|STARTED|Overall Study||49
7915241|NCT00631488|19480061|P1|STARTED|Overall Study||48
7915242|NCT00631475|19480081|P1|NOT COMPLETED|Overall Study||45
7915243|NCT00631475|19480081|P1|COMPLETED|Overall Study||83
7915244|NCT00631475|19480081|P1|STARTED|Overall Study||128
7915245|NCT00631449|19480091|P2|NOT COMPLETED|Overall Study||0
7915246|NCT00631449|19480092|P1|NOT COMPLETED|Overall Study||0
7915247|NCT00631449|19480091|P2|COMPLETED|Overall Study||15
7915248|NCT00631449|19480092|P1|COMPLETED|Overall Study||15
7915249|NCT00631449|19480091|P2|STARTED|Overall Study||15
7915250|NCT00631449|19480092|P1|STARTED|Overall Study||15
7915251|NCT00631410|19480102|P2|NOT COMPLETED|Overall Study||6
7915252|NCT00631410|19480103|P1|NOT COMPLETED|Overall Study||6
7915253|NCT00631410|19480102|P2|COMPLETED|Overall Study||0
7915254|NCT00631410|19480103|P1|COMPLETED|Overall Study||0
7915255|NCT00631410|19480102|P2|STARTED|Overall Study||6
7915256|NCT00631410|19480103|P1|STARTED|Overall Study||6
7915257|NCT00631371|19480122|P2|NOT COMPLETED|Overall Study||391
7915258|NCT00631371|19480123|P1|NOT COMPLETED|Overall Study||400
7915259|NCT00631371|19480122|P2|COMPLETED|Overall Study||0
7915260|NCT00631371|19480123|P1|COMPLETED|Overall Study||0
7915261|NCT00631371|19480122|P2|Treated|Overall Study||391
7915262|NCT00631371|19480123|P1|Treated|Overall Study||393
7915263|NCT00631371|19480122|P2|STARTED|Overall Study||391
7915264|NCT00631371|19480123|P1|STARTED|Overall Study||400
7915265|NCT00631358|19480137|P2|NOT COMPLETED|Overall Study||2
7915266|NCT00631358|19480138|P1|NOT COMPLETED|Overall Study||6
7915267|NCT00631358|19480137|P2|COMPLETED|Overall Study||45
7915268|NCT00631358|19480138|P1|COMPLETED|Overall Study||44
7915269|NCT00631358|19480137|P2|STARTED|Overall Study||47
7915270|NCT00631358|19480138|P1|STARTED|Overall Study||50
7915271|NCT00631319|19480154|P2|NOT COMPLETED|Double-blind Phase||35
7915272|NCT00631319|19480155|P1|NOT COMPLETED|Double-blind Phase||40
7915273|NCT00631319|19480154|P2|COMPLETED|Double-blind Phase||65
7915274|NCT00631319|19480155|P1|COMPLETED|Double-blind Phase||60
7915275|NCT00631319|19480154|P2|STARTED|Double-blind Phase||100
7915276|NCT00631319|19480155|P1|STARTED|Double-blind Phase||100
7915277|NCT00631319|19480154|P2|NOT COMPLETED|Conversion and Titration Phase||0
7915278|NCT00631319|19480155|P1|NOT COMPLETED|Conversion and Titration Phase||143
7915279|NCT00631319|19480154|P2|COMPLETED|Conversion and Titration Phase||0
7915280|NCT00631319|19480155|P1|COMPLETED|Conversion and Titration Phase||200
7915281|NCT00631319|19480154|P2|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
7915282|NCT00631319|19480155|P1|STARTED|Conversion and Titration Phase||343
7915283|NCT00631189|19480166|P4|NOT COMPLETED|Treatment Phase||7
7915284|NCT00631189|19480167|P3|NOT COMPLETED|Treatment Phase||11
7915285|NCT00631189|19480168|P2|NOT COMPLETED|Treatment Phase||7
7915286|NCT00631189|19480169|P1|NOT COMPLETED|Treatment Phase||0
7915287|NCT00631189|19480166|P4|COMPLETED|Treatment Phase||103
7915288|NCT00631189|19480167|P3|COMPLETED|Treatment Phase||92
7915289|NCT00631189|19480168|P2|COMPLETED|Treatment Phase||97
7915290|NCT00631189|19480169|P1|COMPLETED|Treatment Phase||0
7915291|NCT00631189|19480166|P4|STARTED|Treatment Phase||110
7915292|NCT00631189|19480167|P3|STARTED|Treatment Phase||103
7915293|NCT00631189|19480168|P2|STARTED|Treatment Phase||104
7915294|NCT00631189|19480169|P1|STARTED|Treatment Phase||0
7915295|NCT00631189|19480166|P4|NOT COMPLETED|Initial Phase||0
7915296|NCT00631189|19480167|P3|NOT COMPLETED|Initial Phase||0
7915297|NCT00631189|19480168|P2|NOT COMPLETED|Initial Phase||0
7915298|NCT00631189|19480169|P1|NOT COMPLETED|Initial Phase||351
7915299|NCT00631189|19480166|P4|COMPLETED|Initial Phase||0
7915300|NCT00631189|19480167|P3|COMPLETED|Initial Phase||0
7915301|NCT00631189|19480168|P2|COMPLETED|Initial Phase||0
7915302|NCT00631189|19480169|P1|COMPLETED|Initial Phase||317
7915303|NCT00631189|19480166|P4|STARTED|Initial Phase||0
7915304|NCT00631189|19480167|P3|STARTED|Initial Phase||0
7915305|NCT00631189|19480168|P2|STARTED|Initial Phase||0
7915306|NCT00631189|19480169|P1|STARTED|Initial Phase||668
7915307|NCT00631137|19480213|P2|NOT COMPLETED|Overall Study||0
7915308|NCT00631137|19480214|P1|NOT COMPLETED|Overall Study||1
7915309|NCT00631137|19480213|P2|COMPLETED|Overall Study||0
7915310|NCT00631137|19480214|P1|COMPLETED|Overall Study||0
7915311|NCT00631137|19480213|P2|STARTED|Overall Study||0
7915312|NCT00631137|19480214|P1|STARTED|Overall Study||1
7915313|NCT00631020|19480232|P1|NOT COMPLETED|Overall Study||8
7915314|NCT00631020|19480232|P1|COMPLETED|Overall Study||26
7915315|NCT00631020|19480232|P1|STARTED|Overall Study||34
7915316|NCT00631007|19480247|P6|NOT COMPLETED|Overall Study||15
7915317|NCT00631007|19480248|P5|NOT COMPLETED|Overall Study||12
7915318|NCT00631007|19480249|P4|NOT COMPLETED|Overall Study||9
7915319|NCT00631007|19480250|P3|NOT COMPLETED|Overall Study||10
7915320|NCT00631007|19480251|P2|NOT COMPLETED|Overall Study||11
7915321|NCT00631007|19480252|P1|NOT COMPLETED|Overall Study||11
7915322|NCT00631007|19480247|P6|COMPLETED|Overall Study||46
7915323|NCT00631007|19480248|P5|COMPLETED|Overall Study||48
7915324|NCT00631007|19480249|P4|COMPLETED|Overall Study||53
7915325|NCT00631007|19480250|P3|COMPLETED|Overall Study||53
7915326|NCT00631007|19480251|P2|COMPLETED|Overall Study||50
7915327|NCT00631007|19480252|P1|COMPLETED|Overall Study||49
7915328|NCT00631007|19480247|P6|STARTED|Overall Study||61
7915329|NCT00631007|19480248|P5|STARTED|Overall Study||60
7915330|NCT00631007|19480249|P4|STARTED|Overall Study||62
7915331|NCT00631007|19480250|P3|STARTED|Overall Study||63
7915332|NCT00631007|19480251|P2|STARTED|Overall Study||61
7915333|NCT00631007|19480252|P1|STARTED|Overall Study||60
7915334|NCT00630994|19480272|P1|NOT COMPLETED|Overall Study||4
7915335|NCT00630994|19480272|P1|COMPLETED|Overall Study||0
7915336|NCT00630994|19480272|P1|STARTED|Overall Study||4
7915337|NCT00630955|19480283|P3|NOT COMPLETED|Overall Study||12
7915338|NCT00630955|19480284|P2|NOT COMPLETED|Overall Study||6
7915339|NCT00630955|19480285|P1|NOT COMPLETED|Overall Study||3
7915340|NCT00630955|19480283|P3|COMPLETED|Overall Study||28
7915341|NCT00630955|19480284|P2|COMPLETED|Overall Study||31
7915342|NCT00630955|19480285|P1|COMPLETED|Overall Study||31
7915343|NCT00630955|19480283|P3|STARTED|Overall Study||40
7915344|NCT00630955|19480284|P2|STARTED|Overall Study||37
7915345|NCT00630955|19480285|P1|STARTED|Overall Study||34
7915346|NCT00630916|19480302|P1|NOT COMPLETED|Overall Study||210
7915347|NCT00630916|19480302|P1|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546
7915348|NCT00630916|19480302|P1|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699
7915349|NCT00630916|19480302|P1|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756
7915350|NCT00630877|19480312|P3|NOT COMPLETED|Overall Study||10
7915351|NCT00630877|19480313|P2|NOT COMPLETED|Overall Study||15
7915352|NCT00630877|19480314|P1|NOT COMPLETED|Overall Study||19
7915353|NCT00630877|19480312|P3|COMPLETED|Overall Study||80
7915354|NCT00630877|19480313|P2|COMPLETED|Overall Study||75
7915355|NCT00630877|19480314|P1|COMPLETED|Overall Study||72
7915356|NCT00630877|19480312|P3|STARTED|Overall Study||90
7915357|NCT00630877|19480313|P2|STARTED|Overall Study||90
7915358|NCT00630877|19480314|P1|STARTED|Overall Study|For all arms, started means treated.|91
7915359|NCT00630864|19480332|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2
7915360|NCT00630864|19480332|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||18
7915361|NCT00630864|19480332|P1|STARTED|Part 2 (After Week 6 up to Month 12)||20
7915362|NCT00630864|19480332|P1|NOT COMPLETED|Part 1 (up to Week 6)||1
7915363|NCT00630864|19480332|P1|COMPLETED|Part 1 (up to Week 6)||20
7915364|NCT00630864|19480332|P1|STARTED|Part 1 (up to Week 6)||21
7915365|NCT00630838|19480371|P2|NOT COMPLETED|Overall Study||2
7915366|NCT00630838|19480372|P1|NOT COMPLETED|Overall Study||0
7915367|NCT00630838|19480371|P2|COMPLETED|Overall Study||28
7915368|NCT00630838|19480372|P1|COMPLETED|Overall Study||32
7915369|NCT00630838|19480371|P2|STARTED|Overall Study||30
7915370|NCT00630838|19480372|P1|STARTED|Overall Study||32
7915371|NCT00630825|19480384|P4|NOT COMPLETED|Overall Study||6
7915372|NCT00630825|19480385|P3|NOT COMPLETED|Overall Study||8
7915373|NCT00630825|19480386|P2|NOT COMPLETED|Overall Study||7
7915374|NCT00630825|19480387|P1|NOT COMPLETED|Overall Study||9
7915375|NCT00630825|19480384|P4|COMPLETED|Overall Study||60
7915376|NCT00630825|19480385|P3|COMPLETED|Overall Study||58
7915377|NCT00630825|19480386|P2|COMPLETED|Overall Study||58
7915378|NCT00630825|19480387|P1|COMPLETED|Overall Study||56
7915379|NCT00630825|19480384|P4|Received at Least One Dose of Study Drug|Overall Study||66
7915380|NCT00630825|19480385|P3|Received at Least One Dose of Study Drug|Overall Study||66
7915381|NCT00630825|19480386|P2|Received at Least One Dose of Study Drug|Overall Study||65
7915382|NCT00630825|19480387|P1|Received at Least One Dose of Study Drug|Overall Study||65
7915383|NCT00630825|19480384|P4|STARTED|Overall Study||66
7915384|NCT00630825|19480385|P3|STARTED|Overall Study||66
7915385|NCT00630825|19480386|P2|STARTED|Overall Study||65
7915386|NCT00630825|19480387|P1|STARTED|Overall Study||65
7915387|NCT00630812|19480458|P2|NOT COMPLETED|Double Blind Treatment Period||14
7915388|NCT00630812|19480459|P1|NOT COMPLETED|Double Blind Treatment Period||31
7915389|NCT00630812|19480458|P2|COMPLETED|Double Blind Treatment Period||107
7915390|NCT00630812|19480459|P1|COMPLETED|Double Blind Treatment Period||153
7915391|NCT00630812|19480458|P2|STARTED|Double Blind Treatment Period||121
7915392|NCT00630812|19480459|P1|STARTED|Double Blind Treatment Period||184
7915393|NCT00630812|19480458|P2|NOT COMPLETED|Randomisation to First Dose||5
7915394|NCT00630812|19480459|P1|NOT COMPLETED|Randomisation to First Dose||8
7915395|NCT00630812|19480458|P2|COMPLETED|Randomisation to First Dose||121
7915396|NCT00630812|19480459|P1|COMPLETED|Randomisation to First Dose||184
7915397|NCT00630812|19480458|P2|STARTED|Randomisation to First Dose||126
7915398|NCT00630812|19480459|P1|STARTED|Randomisation to First Dose||192
7915399|NCT00630786|19480484|P3|NOT COMPLETED|Overall Study||2
7915400|NCT00630786|19480485|P2|NOT COMPLETED|Overall Study||2
7915401|NCT00630786|19480486|P1|NOT COMPLETED|Overall Study||1
7915402|NCT00630786|19480484|P3|COMPLETED|Overall Study|Completed study defined as participant death|7
7915403|NCT00630786|19480485|P2|COMPLETED|Overall Study|Completed study defined as participant death|23
7915404|NCT00630786|19480486|P1|COMPLETED|Overall Study|Completed study defined as participant death|18
7915405|NCT00630786|19480484|P3|Received Study Medication|Overall Study||8
7915406|NCT00630786|19480485|P2|Received Study Medication|Overall Study||25
7915407|NCT00630786|19480486|P1|Received Study Medication|Overall Study||19
7915408|NCT00630786|19480484|P3|STARTED|Overall Study|All patients were enrolled in Part 2.|9
7915409|NCT00630786|19480485|P2|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25
7915410|NCT00630786|19480486|P1|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19
7915411|NCT00630747|19480505|P1|NOT COMPLETED|Overall Study||9
7915412|NCT00630747|19480505|P1|COMPLETED|Overall Study||85
7915413|NCT00630747|19480505|P1|Participants Treated in Phase I of Study|Overall Study||94
7915414|NCT00630747|19480505|P1|STARTED|Overall Study||94
7915415|NCT00630734|19480517|P3|NOT COMPLETED|Overall Study||1
7915416|NCT00630734|19480518|P2|NOT COMPLETED|Overall Study||1
7915417|NCT00630734|19480519|P1|NOT COMPLETED|Overall Study||2
7915418|NCT00630734|19480517|P3|COMPLETED|Overall Study||7
7915419|NCT00630734|19480518|P2|COMPLETED|Overall Study||12
7915420|NCT00630734|19480519|P1|COMPLETED|Overall Study||9
7915421|NCT00630734|19480517|P3|STARTED|Overall Study||8
7915422|NCT00630734|19480518|P2|STARTED|Overall Study||13
7915423|NCT00630734|19480519|P1|STARTED|Overall Study||11
7915424|NCT00630539|19480558|P4|NOT COMPLETED|Overall Study||3
7915425|NCT00630539|19480559|P3|NOT COMPLETED|Overall Study||1
7915426|NCT00630539|19480560|P2|NOT COMPLETED|Overall Study||4
7915427|NCT00630539|19480561|P1|NOT COMPLETED|Overall Study||1
7915428|NCT00630539|19480558|P4|COMPLETED|Overall Study||27
7915429|NCT00630539|19480559|P3|COMPLETED|Overall Study||28
7915430|NCT00630539|19480560|P2|COMPLETED|Overall Study||29
7915431|NCT00630539|19480561|P1|COMPLETED|Overall Study||33
7915432|NCT00630539|19480558|P4|STARTED|Overall Study||30
7915433|NCT00630539|19480559|P3|STARTED|Overall Study||29
7915434|NCT00630539|19480560|P2|STARTED|Overall Study||33
7915435|NCT00630539|19480561|P1|STARTED|Overall Study||34
7915436|NCT00630487|19480617|P2|NOT COMPLETED|Overall Study||0
7915437|NCT00630487|19480618|P1|NOT COMPLETED|Overall Study||0
7915438|NCT00630487|19480617|P2|COMPLETED|Overall Study||0
7915439|NCT00630487|19480618|P1|COMPLETED|Overall Study||0
7915440|NCT00630487|19480617|P2|STARTED|Overall Study||0
7915441|NCT00630487|19480618|P1|STARTED|Overall Study||0
7915442|NCT00630409|19480652|P1|NOT COMPLETED|Overall Study||1
7915443|NCT00630409|19480652|P1|COMPLETED|Overall Study||4
7915444|NCT00630409|19480652|P1|STARTED|Overall Study||5
7915445|NCT00630396|19480657|P1|NOT COMPLETED|Overall Study||7
7915446|NCT00630396|19480657|P1|COMPLETED|Overall Study||53
7915447|NCT00630396|19480657|P1|STARTED|Overall Study||60
7915448|NCT00630344|19480663|P1|NOT COMPLETED|Overall Study||36
7915449|NCT00630344|19480663|P1|COMPLETED|Overall Study||0
7915450|NCT00630344|19480663|P1|STARTED|Overall Study||36
7915451|NCT00630331|19480675|P3|NOT COMPLETED|Overall Study||188
7915452|NCT00630331|19480676|P2|NOT COMPLETED|Overall Study||166
7915453|NCT00630331|19480677|P1|NOT COMPLETED|Overall Study||206
7915454|NCT00630331|19480675|P3|COMPLETED|Overall Study||3712
7915455|NCT00630331|19480676|P2|COMPLETED|Overall Study||3510
7915456|NCT00630331|19480677|P1|COMPLETED|Overall Study||3622
7915457|NCT00630331|19480675|P3|STARTED|Overall Study||3900
7915458|NCT00630331|19480676|P2|STARTED|Overall Study||3676
7915459|NCT00630331|19480677|P1|STARTED|Overall Study||3828
7915460|NCT00630305|19480718|P1|NOT COMPLETED|Overall Study||2
7915461|NCT00630305|19480718|P1|COMPLETED|Overall Study||35
7915462|NCT00630305|19480718|P1|STARTED|Overall Study||37
7915463|NCT00630292|19480740|P1|NOT COMPLETED|Overall Study||1
7915464|NCT00630292|19480740|P1|COMPLETED|Overall Study||5
7915465|NCT00630292|19480740|P1|STARTED|Overall Study||6
7915466|NCT00630058|19480746|P2|NOT COMPLETED|Overall Study||4
7915467|NCT00630058|19480747|P1|NOT COMPLETED|Overall Study||4
7915468|NCT00630058|19480746|P2|COMPLETED|Overall Study||6
7915469|NCT00630058|19480747|P1|COMPLETED|Overall Study||6
7915470|NCT00630058|19480746|P2|STARTED|Overall Study||10
7915471|NCT00630058|19480747|P1|STARTED|Overall Study||10
7915472|NCT00629850|19480765|P2|NOT COMPLETED|Overall Study||0
7915473|NCT00629850|19480766|P1|NOT COMPLETED|Overall Study||0
7915474|NCT00629850|19480765|P2|COMPLETED|Overall Study||0
7915475|NCT00629850|19480766|P1|COMPLETED|Overall Study||1
7915476|NCT00629850|19480765|P2|STARTED|Overall Study||0
7915477|NCT00629850|19480766|P1|STARTED|Overall Study||1
7915478|NCT00629772|19480778|P2|NOT COMPLETED|Second Intervention Week 14 - Week 26||2
7915479|NCT00629772|19480779|P1|NOT COMPLETED|Second Intervention Week 14 - Week 26||1
7915480|NCT00629772|19480778|P2|COMPLETED|Second Intervention Week 14 - Week 26||10
7915481|NCT00629772|19480779|P1|COMPLETED|Second Intervention Week 14 - Week 26||11
7915482|NCT00629772|19480778|P2|STARTED|Second Intervention Week 14 - Week 26||12
7915483|NCT00629772|19480779|P1|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12
7915484|NCT00629772|19480778|P2|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
7915485|NCT00629772|19480779|P1|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
7915486|NCT00629772|19480778|P2|COMPLETED|First Intervention - Day 0 - Week 14||12
7915487|NCT00629772|19480779|P1|COMPLETED|First Intervention - Day 0 - Week 14||12
7915488|NCT00629772|19480778|P2|STARTED|First Intervention - Day 0 - Week 14||12
7915489|NCT00629772|19480779|P1|STARTED|First Intervention - Day 0 - Week 14||12
7915490|NCT00629707|19480799|P2|NOT COMPLETED|Overall Study||2
7915491|NCT00629707|19480800|P1|NOT COMPLETED|Overall Study||0
7915492|NCT00629707|19480799|P2|COMPLETED|Overall Study||8
7915493|NCT00629707|19480800|P1|COMPLETED|Overall Study||10
7915494|NCT00629707|19480799|P2|STARTED|Overall Study||10
7915495|NCT00629707|19480800|P1|STARTED|Overall Study||10
7915496|NCT00629525|19480806|P1|NOT COMPLETED|Overall Study||3
7915497|NCT00629525|19480806|P1|COMPLETED|Overall Study||32
7915498|NCT00629525|19480806|P1|STARTED|Overall Study||35
7915499|NCT00629499|19480814|P1|NOT COMPLETED|Overall Study||0
7915500|NCT00629499|19480814|P1|COMPLETED|Overall Study||63
7915501|NCT00629499|19480814|P1|STARTED|Overall Study||63
7915502|NCT00629265|19480820|P2|NOT COMPLETED|Overall Study||20
7915503|NCT00629265|19480821|P1|NOT COMPLETED|Overall Study||32
7915504|NCT00629265|19480820|P2|COMPLETED|Overall Study||34
7915505|NCT00629265|19480821|P1|COMPLETED|Overall Study||84
7915506|NCT00629265|19480820|P2|STARTED|Overall Study||54
7915507|NCT00629265|19480821|P1|STARTED|Overall Study||116
7915508|NCT00629239|19480831|P2|NOT COMPLETED|Overall Study||4
7915509|NCT00629239|19480832|P1|NOT COMPLETED|Overall Study||8
7915510|NCT00629239|19480831|P2|COMPLETED|Overall Study||28
7915511|NCT00629239|19480832|P1|COMPLETED|Overall Study||26
7915512|NCT00629239|19480831|P2|STARTED|Overall Study||32
7915513|NCT00629239|19480832|P1|STARTED|Overall Study||34
7915514|NCT00629122|19480866|P2|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
7915515|NCT00629122|19480867|P1|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
7915516|NCT00629122|19480866|P2|COMPLETED|Third Period: Day 6-8 (Oral)||3
7915517|NCT00629122|19480867|P1|COMPLETED|Third Period: Day 6-8 (Oral)||2
7915518|NCT00629122|19480866|P2|STARTED|Third Period: Day 6-8 (Oral)||3
7915519|NCT00629122|19480867|P1|STARTED|Third Period: Day 6-8 (Oral)||2
7915520|NCT00629122|19480866|P2|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
7915521|NCT00629122|19480867|P1|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
7915522|NCT00629122|19480866|P2|COMPLETED|Second Period: Day 3-5 (Washout)||3
7915523|NCT00629122|19480867|P1|COMPLETED|Second Period: Day 3-5 (Washout)||2
7915524|NCT00629122|19480866|P2|STARTED|Second Period: Day 3-5 (Washout)||3
7915525|NCT00629122|19480867|P1|STARTED|Second Period: Day 3-5 (Washout)||2
7915526|NCT00629122|19480866|P2|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
7915527|NCT00629122|19480867|P1|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
7915528|NCT00629122|19480866|P2|COMPLETED|First Period: Day 1- 3 (Sublingual)||3
7915529|NCT00629122|19480867|P1|COMPLETED|First Period: Day 1- 3 (Sublingual)||2
7915530|NCT00629122|19480866|P2|STARTED|First Period: Day 1- 3 (Sublingual)||3
7915531|NCT00629122|19480867|P1|STARTED|First Period: Day 1- 3 (Sublingual)||2
7915532|NCT00629083|19480885|P2|NOT COMPLETED|Overall Study||14
7915533|NCT00629083|19480886|P1|NOT COMPLETED|Overall Study||28
7915534|NCT00629083|19480885|P2|COMPLETED|Overall Study||103
7915535|NCT00629083|19480886|P1|COMPLETED|Overall Study||200
7915536|NCT00629083|19480885|P2|STARTED|Overall Study||117
7915537|NCT00629083|19480886|P1|STARTED|Overall Study||228
7915538|NCT00629018|19480906|P2|NOT COMPLETED|Overall Study||0
7915539|NCT00629018|19480907|P1|NOT COMPLETED|Overall Study||0
7915540|NCT00629018|19480906|P2|COMPLETED|Overall Study||55
7915541|NCT00629018|19480907|P1|COMPLETED|Overall Study||55
7915542|NCT00629018|19480906|P2|STARTED|Overall Study||55
7915543|NCT00629018|19480907|P1|STARTED|Overall Study||55
7915544|NCT00628927|19480917|P2|NOT COMPLETED|Overall Study||0
7915545|NCT00628927|19480918|P1|NOT COMPLETED|Overall Study||8
7915546|NCT00628927|19480917|P2|COMPLETED|Overall Study||30
7915547|NCT00628927|19480918|P1|COMPLETED|Overall Study||175
7915548|NCT00628927|19480917|P2|STARTED|Overall Study||30
7915549|NCT00628927|19480918|P1|STARTED|Overall Study||183
7915550|NCT00628901|19480931|P2|NOT COMPLETED|Overall Study||1
7915551|NCT00628901|19480932|P1|NOT COMPLETED|Overall Study||3
7915552|NCT00628901|19480931|P2|COMPLETED|Overall Study||29
7915553|NCT00628901|19480932|P1|COMPLETED|Overall Study||27
7915554|NCT00628901|19480931|P2|STARTED|Overall Study||30
7915555|NCT00628901|19480932|P1|STARTED|Overall Study||30
7915556|NCT00628862|19480963|P3|NOT COMPLETED|Overall Study||22
7915557|NCT00628862|19480964|P2|NOT COMPLETED|Overall Study||17
7915558|NCT00628862|19480965|P1|NOT COMPLETED|Overall Study||11
7915559|NCT00628862|19480963|P3|COMPLETED|Overall Study|randomised patients|186
7915560|NCT00628862|19480964|P2|COMPLETED|Overall Study|randomised patients|182
7915561|NCT00628862|19480965|P1|COMPLETED|Overall Study|randomised patients|195
7915562|NCT00628862|19480963|P3|STARTED|Overall Study|randomised patients|208
7915563|NCT00628862|19480964|P2|STARTED|Overall Study|randomised patients|199
7915564|NCT00628862|19480965|P1|STARTED|Overall Study|randomised patients|206
7915565|NCT00628758|19481011|P2|NOT COMPLETED|Overall Study||42
7915566|NCT00628758|19481012|P1|NOT COMPLETED|Overall Study||44
7915567|NCT00628758|19481011|P2|COMPLETED|Overall Study||179
7915568|NCT00628758|19481012|P1|COMPLETED|Overall Study||165
7915569|NCT00628758|19481011|P2|STARTED|Overall Study||221
7915570|NCT00628758|19481012|P1|STARTED|Overall Study||209
7915571|NCT00628628|19481026|P2|NOT COMPLETED|Overall Study||0
7915572|NCT00628628|19481027|P1|NOT COMPLETED|Overall Study||0
7915573|NCT00628628|19481026|P2|COMPLETED|Overall Study||40
7915574|NCT00628628|19481027|P1|COMPLETED|Overall Study||40
7915575|NCT00628628|19481026|P2|STARTED|Overall Study||40
7915576|NCT00628628|19481027|P1|STARTED|Overall Study||40
7915577|NCT00628589|19481036|P3|NOT COMPLETED|Overall Study||3
7915578|NCT00628589|19481037|P2|NOT COMPLETED|Overall Study||2
7915579|NCT00628589|19481038|P1|NOT COMPLETED|Overall Study||1
7915580|NCT00628589|19481036|P3|COMPLETED|Overall Study||110
7915581|NCT00628589|19481037|P2|COMPLETED|Overall Study||114
7915582|NCT00628589|19481038|P1|COMPLETED|Overall Study||114
7915583|NCT00628589|19481036|P3|STARTED|Overall Study||113
7915584|NCT00628589|19481037|P2|STARTED|Overall Study||116
7915585|NCT00628589|19481038|P1|STARTED|Overall Study||115
7915586|NCT00628498|19481052|P1|NOT COMPLETED|Overall Study||52
7915587|NCT00628498|19481052|P1|COMPLETED|Overall Study||1154
7915588|NCT00628498|19481052|P1|STARTED|Overall Study||1206
7915589|NCT00628446|19481056|P1|NOT COMPLETED|Overall Study||7
7915590|NCT00628446|19481056|P1|COMPLETED|Overall Study||38
7915591|NCT00628446|19481056|P1|STARTED|Overall Study||45
7915592|NCT00628407|19481061|P1|NOT COMPLETED|Overall Study||0
7915593|NCT00628407|19481061|P1|COMPLETED|Overall Study||13
7915594|NCT00628407|19481061|P1|STARTED|Overall Study||13
7915595|NCT00628394|19481069|P4|NOT COMPLETED|Overall Study||3
7915596|NCT00628394|19481070|P3|NOT COMPLETED|Overall Study||2
7915597|NCT00628394|19481071|P2|NOT COMPLETED|Overall Study||4
7915598|NCT00628394|19481072|P1|NOT COMPLETED|Overall Study||4
7915599|NCT00628394|19481069|P4|COMPLETED|Overall Study||10
7915600|NCT00628394|19481070|P3|COMPLETED|Overall Study||11
7915601|NCT00628394|19481071|P2|COMPLETED|Overall Study||9
7915602|NCT00628394|19481072|P1|COMPLETED|Overall Study||10
7915603|NCT00628394|19481069|P4|STARTED|Overall Study||13
7915604|NCT00628394|19481070|P3|STARTED|Overall Study||13
7915605|NCT00628394|19481071|P2|STARTED|Overall Study||13
7915606|NCT00628394|19481072|P1|STARTED|Overall Study||14
7915607|NCT00628355|19481088|P2|NOT COMPLETED|Overall Study||1
7915608|NCT00628355|19481089|P1|NOT COMPLETED|Overall Study||1
7915609|NCT00628355|19481088|P2|COMPLETED|Overall Study||14
7915610|NCT00628355|19481089|P1|COMPLETED|Overall Study||14
7915611|NCT00628355|19481088|P2|STARTED|Overall Study||15
7915612|NCT00628355|19481089|P1|STARTED|Overall Study||15
7915613|NCT00628251|19481100|P3|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||25
7915614|NCT00628251|19481101|P2|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||20
7915615|NCT00628251|19481102|P1|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||22
7915616|NCT00628251|19481100|P3|COMPLETED|Ongoing Initial Study Treatment at DCO|Patients ongoing initial study treatment (Liposomal doxorubicin)|7
7915617|NCT00628251|19481101|P2|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|12
7915618|NCT00628251|19481102|P1|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|10
7915619|NCT00628251|19481100|P3|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||9
7915620|NCT00628251|19481101|P2|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
7915621|NCT00628251|19481102|P1|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
7915622|NCT00628251|19481100|P3|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||5
7915623|NCT00628251|19481101|P2|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
7915624|NCT00628251|19481102|P1|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
7915625|NCT00628251|19481100|P3|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO|Crossover dosage was 400 mg bd Olaparib|14
7915626|NCT00628251|19481101|P2|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
7915627|NCT00628251|19481102|P1|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
7915628|NCT00628251|19481100|P3|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||25
7915629|NCT00628251|19481101|P2|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||20
7915630|NCT00628251|19481102|P1|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||22
7915631|NCT00628251|19481100|P3|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received Liposomal doxorubicin 50 mg/m2|32
7915632|NCT00628251|19481101|P2|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
7915633|NCT00628251|19481102|P1|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
7915634|NCT00628251|19481100|P3|NOT COMPLETED|Randomised Part||1
7915635|NCT00628251|19481101|P2|NOT COMPLETED|Randomised Part||0
7915636|NCT00628251|19481102|P1|NOT COMPLETED|Randomised Part||0
7915637|NCT00628251|19481100|P3|COMPLETED|Randomised Part|1 of 33 patients did not receive Liposomal Doxorubicin. Patient voluntarily discontinued|32
7915638|NCT00628251|19481101|P2|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
7915639|NCT00628251|19481102|P1|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
7915640|NCT00628251|19481100|P3|STARTED|Randomised Part|Patients randomised|33
7915641|NCT00628251|19481101|P2|STARTED|Randomised Part|Patients randomised|32
7915642|NCT00628251|19481102|P1|STARTED|Randomised Part|Patients randomised|32
7915643|NCT00628212|19481148|P4|NOT COMPLETED|Overall Study||5
7915644|NCT00628212|19481149|P3|NOT COMPLETED|Overall Study||3
7915645|NCT00628212|19481150|P2|NOT COMPLETED|Overall Study||1
7915646|NCT00628212|19481151|P1|NOT COMPLETED|Overall Study||3
7915647|NCT00628212|19481148|P4|COMPLETED|Overall Study||76
7915648|NCT00628212|19481149|P3|COMPLETED|Overall Study||76
7915649|NCT00628212|19481150|P2|COMPLETED|Overall Study||83
7915650|NCT00628212|19481151|P1|COMPLETED|Overall Study||77
7915651|NCT00628212|19481148|P4|STARTED|Overall Study||81
7915652|NCT00628212|19481149|P3|STARTED|Overall Study||79
7915653|NCT00628212|19481150|P2|STARTED|Overall Study||84
7915654|NCT00628212|19481151|P1|STARTED|Overall Study||80
7915655|NCT00628147|19481175|P2|NOT COMPLETED|Overall Study||1
7915656|NCT00628147|19481176|P1|NOT COMPLETED|Overall Study||7
7915657|NCT00628147|19481175|P2|COMPLETED|Overall Study||141
7915658|NCT00628147|19481176|P1|COMPLETED|Overall Study||135
7915659|NCT00628147|19481175|P2|STARTED|Overall Study||142
7915660|NCT00628147|19481176|P1|STARTED|Overall Study||142
7915661|NCT00628134|19481188|P2|NOT COMPLETED|Overall Study||0
7915662|NCT00628134|19481189|P1|NOT COMPLETED|Overall Study||0
7915663|NCT00628134|19481188|P2|COMPLETED|Overall Study||4
7915664|NCT00628134|19481189|P1|COMPLETED|Overall Study||4
7915665|NCT00628134|19481188|P2|STARTED|Overall Study||4
7915666|NCT00628134|19481189|P1|STARTED|Overall Study||4
7915667|NCT00628108|19481199|P2|NOT COMPLETED|Overall Study||3
7915668|NCT00628108|19481200|P1|NOT COMPLETED|Overall Study||1
7915669|NCT00628108|19481199|P2|COMPLETED|Overall Study||43
7915670|NCT00628108|19481200|P1|COMPLETED|Overall Study||22
7915671|NCT00628108|19481199|P2|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45
7915672|NCT00628108|19481200|P1|Safety Population|Overall Study||24
7915673|NCT00628108|19481199|P2|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46
7915674|NCT00628108|19481200|P1|STARTED|Overall Study||23
7915675|NCT00628030|19481232|P2|NOT COMPLETED|Post to 6 Month Follow-up||30
7915676|NCT00628030|19481233|P1|NOT COMPLETED|Post to 6 Month Follow-up||32
7915677|NCT00628030|19481232|P2|COMPLETED|Post to 6 Month Follow-up||33
7915678|NCT00628030|19481233|P1|COMPLETED|Post to 6 Month Follow-up||27
7915679|NCT00628030|19481232|P2|STARTED|Post to 6 Month Follow-up||63
7915680|NCT00628030|19481233|P1|STARTED|Post to 6 Month Follow-up||59
7915681|NCT00628030|19481232|P2|NOT COMPLETED|Baseline to Post-Assessment||29
7915682|NCT00628030|19481233|P1|NOT COMPLETED|Baseline to Post-Assessment||33
7915683|NCT00628030|19481232|P2|COMPLETED|Baseline to Post-Assessment||63
7915684|NCT00628030|19481233|P1|COMPLETED|Baseline to Post-Assessment||59
7915685|NCT00628030|19481232|P2|STARTED|Baseline to Post-Assessment||92
7915686|NCT00628030|19481233|P1|STARTED|Baseline to Post-Assessment||92
7915687|NCT00627978|19481249|P2|NOT COMPLETED|Overall Study||0
7915688|NCT00627978|19481250|P1|NOT COMPLETED|Overall Study||0
7915689|NCT00627978|19481249|P2|COMPLETED|Overall Study||5
7915690|NCT00627978|19481250|P1|COMPLETED|Overall Study||10
7915691|NCT00627978|19481249|P2|STARTED|Overall Study||5
7915692|NCT00627978|19481250|P1|STARTED|Overall Study||10
7915693|NCT00627926|19481259|P3|NOT COMPLETED|Overall Study||95
7915694|NCT00627926|19481260|P2|NOT COMPLETED|Overall Study||104
7915695|NCT00627926|19481261|P1|NOT COMPLETED|Overall Study||159
7915696|NCT00627926|19481259|P3|COMPLETED|Overall Study||268
7915697|NCT00627926|19481260|P2|COMPLETED|Overall Study||260
7915698|NCT00627926|19481261|P1|COMPLETED|Overall Study||202
7915699|NCT00627926|19481259|P3|STARTED|Overall Study||363
7915700|NCT00627926|19481260|P2|STARTED|Overall Study||364
7915701|NCT00627926|19481261|P1|STARTED|Overall Study||361
7915702|NCT00627861|19481305|P1|NOT COMPLETED|Overall Study||0
7915703|NCT00627861|19481305|P1|COMPLETED|Overall Study||1
7915704|NCT00627861|19481305|P1|STARTED|Overall Study||1
7915705|NCT00627705|19481313|P2|NOT COMPLETED|Overall Study||6
7915706|NCT00627705|19481314|P1|NOT COMPLETED|Overall Study||2
7915707|NCT00627705|19481313|P2|COMPLETED|Overall Study||12
7915708|NCT00627705|19481314|P1|COMPLETED|Overall Study||13
7915709|NCT00627705|19481313|P2|STARTED|Overall Study||18
7915710|NCT00627705|19481314|P1|STARTED|Overall Study||15
7915711|NCT00627679|19481334|P4|NOT COMPLETED|Overall Study||0
7915712|NCT00627679|19481335|P3|NOT COMPLETED|Overall Study||0
7915713|NCT00627679|19481336|P2|NOT COMPLETED|Overall Study||0
7915714|NCT00627679|19481337|P1|NOT COMPLETED|Overall Study||0
7915715|NCT00627679|19481334|P4|COMPLETED|Overall Study||4
7915716|NCT00627679|19481335|P3|COMPLETED|Overall Study||4
7915717|NCT00627679|19481336|P2|COMPLETED|Overall Study||4
7915718|NCT00627679|19481337|P1|COMPLETED|Overall Study||4
7915719|NCT00627679|19481334|P4|STARTED|Overall Study||4
7915720|NCT00627679|19481335|P3|STARTED|Overall Study||4
7915721|NCT00627679|19481336|P2|STARTED|Overall Study||4
7915722|NCT00627679|19481337|P1|STARTED|Overall Study||4
7915723|NCT00627523|19481365|P2|NOT COMPLETED|Overall Study||2
7915724|NCT00627523|19481366|P1|NOT COMPLETED|Overall Study||2
7915725|NCT00627523|19481365|P2|COMPLETED|Overall Study||20
7915726|NCT00627523|19481366|P1|COMPLETED|Overall Study||19
7915727|NCT00627523|19481365|P2|STARTED|Overall Study||22
7915728|NCT00627523|19481366|P1|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21
7915729|NCT00627497|19481394|P4|NOT COMPLETED|Overall Study||0
7915730|NCT00627497|19481395|P3|NOT COMPLETED|Overall Study||0
7915731|NCT00627497|19481396|P2|NOT COMPLETED|Overall Study||1
7915732|NCT00627497|19481397|P1|NOT COMPLETED|Overall Study||1
7915733|NCT00627497|19481394|P4|COMPLETED|Overall Study||2
7915734|NCT00627497|19481395|P3|COMPLETED|Overall Study||4
7915735|NCT00627497|19481396|P2|COMPLETED|Overall Study||11
7915736|NCT00627497|19481397|P1|COMPLETED|Overall Study||13
7915737|NCT00627497|19481394|P4|STARTED|Overall Study||2
7915738|NCT00627497|19481395|P3|STARTED|Overall Study||4
7915739|NCT00627497|19481396|P2|STARTED|Overall Study||12
7915740|NCT00627497|19481397|P1|STARTED|Overall Study||14
7915741|NCT00627458|19481458|P3|NOT COMPLETED|Overall Study||6
7915742|NCT00627458|19481459|P2|NOT COMPLETED|Overall Study||7
7915743|NCT00627458|19481460|P1|NOT COMPLETED|Overall Study||4
7915744|NCT00627458|19481458|P3|COMPLETED|Overall Study||133
7915745|NCT00627458|19481459|P2|COMPLETED|Overall Study||130
7915746|NCT00627458|19481460|P1|COMPLETED|Overall Study||123
7915747|NCT00627458|19481458|P3|STARTED|Overall Study||139
7915748|NCT00627458|19481459|P2|STARTED|Overall Study||137
7915749|NCT00627458|19481460|P1|STARTED|Overall Study||127
7915750|NCT00627445|19481535|P2|NOT COMPLETED|Overall Study||12
7915751|NCT00627445|19481536|P1|NOT COMPLETED|Overall Study||9
7915752|NCT00627445|19481535|P2|COMPLETED|Overall Study||210
7915753|NCT00627445|19481536|P1|COMPLETED|Overall Study||210
7915754|NCT00627445|19481535|P2|Exposed to Study Drug|Overall Study||222
7915755|NCT00627445|19481536|P1|Exposed to Study Drug|Overall Study||219
7915756|NCT00627445|19481535|P2|STARTED|Overall Study||222
7915757|NCT00627445|19481536|P1|STARTED|Overall Study||219
7915758|NCT00627406|19481560|P4|NOT COMPLETED|Overall Study||0
7915759|NCT00627406|19481561|P3|NOT COMPLETED|Overall Study||0
7915760|NCT00627406|19481562|P2|NOT COMPLETED|Overall Study||0
7915761|NCT00627406|19481563|P1|NOT COMPLETED|Overall Study||0
7915762|NCT00627406|19481560|P4|COMPLETED|Overall Study||141
7915763|NCT00627406|19481561|P3|COMPLETED|Overall Study||125
7915764|NCT00627406|19481562|P2|COMPLETED|Overall Study||58
7915765|NCT00627406|19481563|P1|COMPLETED|Overall Study||60
7915766|NCT00627406|19481560|P4|STARTED|Overall Study||141
7915767|NCT00627406|19481561|P3|STARTED|Overall Study||125
7915768|NCT00627406|19481562|P2|STARTED|Overall Study||58
7915769|NCT00627406|19481563|P1|STARTED|Overall Study||60
7915770|NCT00627393|19481579|P2|NOT COMPLETED|Per-Protocol Analysis||13
7915771|NCT00627393|19481580|P1|NOT COMPLETED|Per-Protocol Analysis||10
7915772|NCT00627393|19481579|P2|COMPLETED|Per-Protocol Analysis||35
7915773|NCT00627393|19481580|P1|COMPLETED|Per-Protocol Analysis||39
7915774|NCT00627393|19481579|P2|STARTED|Per-Protocol Analysis||48
7915775|NCT00627393|19481580|P1|STARTED|Per-Protocol Analysis||49
7915776|NCT00627393|19481579|P2|NOT COMPLETED|Intention-To-Treat Analysis||8
7915777|NCT00627393|19481580|P1|NOT COMPLETED|Intention-To-Treat Analysis||9
7915778|NCT00627393|19481579|P2|COMPLETED|Intention-To-Treat Analysis||48
7915779|NCT00627393|19481580|P1|COMPLETED|Intention-To-Treat Analysis||49
7915780|NCT00627393|19481579|P2|STARTED|Intention-To-Treat Analysis||56
7915781|NCT00627393|19481580|P1|STARTED|Intention-To-Treat Analysis||58
7915782|NCT00627367|19481601|P2|NOT COMPLETED|Overall Study||0
7915783|NCT00627367|19481602|P1|NOT COMPLETED|Overall Study||0
7915784|NCT00627367|19481601|P2|COMPLETED|Overall Study||112
7915785|NCT00627367|19481602|P1|COMPLETED|Overall Study||112
7915786|NCT00627367|19481601|P2|STARTED|Overall Study||112
7915787|NCT00627367|19481602|P1|STARTED|Overall Study||112
7915788|NCT00627094|19481616|P2|NOT COMPLETED|Overall Study||15
7915789|NCT00627094|19481617|P1|NOT COMPLETED|Overall Study||12
7915790|NCT00627094|19481616|P2|COMPLETED|Overall Study||45
7915791|NCT00627094|19481617|P1|COMPLETED|Overall Study||48
7915792|NCT00627094|19481616|P2|STARTED|Overall Study||60
7915793|NCT00627094|19481617|P1|STARTED|Overall Study||60
7915794|NCT00627042|19481629|P1|NOT COMPLETED|Overall Study||2
7915795|NCT00627042|19481629|P1|COMPLETED|Overall Study||40
7915796|NCT00627042|19481629|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
7915797|NCT00627042|19481629|P1|STARTED|Overall Study||42
7915798|NCT00627016|19481641|P2|NOT COMPLETED|Overall Study||6
7915799|NCT00627016|19481642|P1|NOT COMPLETED|Overall Study||6
7915800|NCT00627016|19481641|P2|COMPLETED|Overall Study||146
7915801|NCT00627016|19481642|P1|COMPLETED|Overall Study||147
7915802|NCT00627016|19481641|P2|STARTED|Overall Study||152
7915803|NCT00627016|19481642|P1|STARTED|Overall Study||153
7915804|NCT00626925|19481654|P2|NOT COMPLETED|Overall Study||9
7915805|NCT00626925|19481655|P1|NOT COMPLETED|Overall Study||12
7915806|NCT00626925|19481654|P2|COMPLETED|Overall Study||62
7915807|NCT00626925|19481655|P1|COMPLETED|Overall Study||55
7915808|NCT00626925|19481654|P2|STARTED|Overall Study||71
7915809|NCT00626925|19481655|P1|STARTED|Overall Study||67
7915810|NCT00626912|19481689|P2|NOT COMPLETED|Overall Study||10
7915811|NCT00626912|19481690|P1|NOT COMPLETED|Overall Study||2
7915812|NCT00626912|19481689|P2|COMPLETED|Overall Study||215
7915813|NCT00626912|19481690|P1|COMPLETED|Overall Study||220
7915814|NCT00626912|19481689|P2|STARTED|Overall Study||225
7915815|NCT00626912|19481690|P1|STARTED|Overall Study||222
7915816|NCT00626821|19481702|P1|NOT COMPLETED|Overall Study||221
7915817|NCT00626821|19481702|P1|COMPLETED|Overall Study||2796
7915818|NCT00626821|19481702|P1|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672
7915819|NCT00626821|19481702|P1|STARTED|Overall Study||3017
7915820|NCT00626808|19481710|P4|NOT COMPLETED|Overall Study||0
7915821|NCT00626808|19481711|P3|NOT COMPLETED|Overall Study||0
7915822|NCT00626808|19481712|P2|NOT COMPLETED|Overall Study||0
7915823|NCT00626808|19481713|P1|NOT COMPLETED|Overall Study||0
7915824|NCT00626808|19481710|P4|COMPLETED|Overall Study||2906
7915825|NCT00626808|19481711|P3|COMPLETED|Overall Study||30011
7915826|NCT00626808|19481712|P2|COMPLETED|Overall Study||34316
7915827|NCT00626808|19481713|P1|COMPLETED|Overall Study||254464
7915828|NCT00626808|19481710|P4|STARTED|Overall Study||2906
7915829|NCT00626808|19481711|P3|STARTED|Overall Study||30011
7915830|NCT00626808|19481712|P2|STARTED|Overall Study||34316
7915831|NCT00626808|19481713|P1|STARTED|Overall Study||254464
7915832|NCT00626795|19481782|P3|NOT COMPLETED|Blinded Treatment||9
7915833|NCT00626795|19481783|P2|NOT COMPLETED|Blinded Treatment||5
7915834|NCT00626795|19481784|P1|NOT COMPLETED|Blinded Treatment||10
7915835|NCT00626795|19481782|P3|COMPLETED|Blinded Treatment||196
7915836|NCT00626795|19481783|P2|COMPLETED|Blinded Treatment||200
7915837|NCT00626795|19481784|P1|COMPLETED|Blinded Treatment||194
7915838|NCT00626795|19481782|P3|STARTED|Blinded Treatment||205
7915839|NCT00626795|19481783|P2|STARTED|Blinded Treatment||205
7915840|NCT00626795|19481784|P1|STARTED|Blinded Treatment||204
7915841|NCT00626795|19481782|P3|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
7915842|NCT00626795|19481783|P2|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||1
7915843|NCT00626795|19481784|P1|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
7915844|NCT00626795|19481782|P3|COMPLETED|Open-label TD1414 Cream TID Treatment||0
7915845|NCT00626795|19481783|P2|COMPLETED|Open-label TD1414 Cream TID Treatment||64
7915846|NCT00626795|19481784|P1|COMPLETED|Open-label TD1414 Cream TID Treatment||0
7915847|NCT00626795|19481782|P3|STARTED|Open-label TD1414 Cream TID Treatment||0
7915848|NCT00626795|19481783|P2|STARTED|Open-label TD1414 Cream TID Treatment||65
7915849|NCT00626795|19481784|P1|STARTED|Open-label TD1414 Cream TID Treatment||0
7915850|NCT00626782|19481813|P2|NOT COMPLETED|Overall Study||0
7915851|NCT00626782|19481814|P1|NOT COMPLETED|Overall Study||0
7915852|NCT00626782|19481813|P2|COMPLETED|Overall Study||12
7915853|NCT00626782|19481814|P1|COMPLETED|Overall Study||12
7915854|NCT00626782|19481813|P2|STARTED|Overall Study||12
7915855|NCT00626782|19481814|P1|STARTED|Overall Study||12
7915856|NCT00626743|19481824|P2|NOT COMPLETED|Treatment Period 2||0
7915857|NCT00626743|19481825|P1|NOT COMPLETED|Treatment Period 2||0
7915858|NCT00626743|19481824|P2|COMPLETED|Treatment Period 2||6
7915859|NCT00626743|19481825|P1|COMPLETED|Treatment Period 2||6
7915860|NCT00626743|19481824|P2|STARTED|Treatment Period 2||6
7915861|NCT00626743|19481825|P1|STARTED|Treatment Period 2||6
7915862|NCT00626743|19481824|P2|NOT COMPLETED|Wash-out Period of 6 Days||0
7915863|NCT00626743|19481825|P1|NOT COMPLETED|Wash-out Period of 6 Days||0
7915864|NCT00626743|19481824|P2|COMPLETED|Wash-out Period of 6 Days||6
7915865|NCT00626743|19481825|P1|COMPLETED|Wash-out Period of 6 Days||6
7915866|NCT00626743|19481824|P2|STARTED|Wash-out Period of 6 Days||6
7915867|NCT00626743|19481825|P1|STARTED|Wash-out Period of 6 Days||6
7915868|NCT00626743|19481824|P2|NOT COMPLETED|Treatment Period 1||1
7915869|NCT00626743|19481825|P1|NOT COMPLETED|Treatment Period 1||0
7915870|NCT00626743|19481824|P2|COMPLETED|Treatment Period 1||6
7915871|NCT00626743|19481825|P1|COMPLETED|Treatment Period 1||6
7915872|NCT00626743|19481824|P2|STARTED|Treatment Period 1||7
7915873|NCT00626743|19481825|P1|STARTED|Treatment Period 1||6
7915874|NCT00626639|19481835|P2|NOT COMPLETED|Overall Study||2
7915875|NCT00626639|19481836|P1|NOT COMPLETED|Overall Study||2
7915876|NCT00626639|19481835|P2|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1
7915877|NCT00626639|19481836|P1|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0
7915878|NCT00626639|19481835|P2|STARTED|Overall Study||3
7915879|NCT00626639|19481836|P1|STARTED|Overall Study||2
7915880|NCT00626626|19481856|P2|NOT COMPLETED|Overall Study||0
7915881|NCT00626626|19481857|P1|NOT COMPLETED|Overall Study||0
7915882|NCT00626626|19481856|P2|COMPLETED|Overall Study||3
7915883|NCT00626626|19481857|P1|COMPLETED|Overall Study||5
7915884|NCT00626626|19481856|P2|STARTED|Overall Study||3
7915885|NCT00626626|19481857|P1|STARTED|Overall Study||5
7915886|NCT00626574|19481869|P2|NOT COMPLETED|Overall Study||0
7915887|NCT00626574|19481870|P1|NOT COMPLETED|Overall Study||0
7915888|NCT00626574|19481869|P2|COMPLETED|Overall Study||1
7915889|NCT00626574|19481870|P1|COMPLETED|Overall Study||2
7915890|NCT00626574|19481869|P2|STARTED|Overall Study||1
7915891|NCT00626574|19481870|P1|STARTED|Overall Study||2
7915892|NCT00626561|19481882|P1|NOT COMPLETED|Overall Study||4
7915893|NCT00626561|19481882|P1|COMPLETED|Overall Study||0
7915894|NCT00626561|19481882|P1|STARTED|Overall Study||4
7915895|NCT00626548|19481888|P2|NOT COMPLETED|Overall Study||716
7915896|NCT00626548|19481889|P1|NOT COMPLETED|Overall Study||705
7915897|NCT00626548|19481888|P2|COMPLETED|Overall Study||0
7915898|NCT00626548|19481889|P1|COMPLETED|Overall Study||0
7915899|NCT00626548|19481888|P2|Patients Received Treatment|Overall Study||712
7915900|NCT00626548|19481889|P1|Patients Received Treatment|Overall Study||703
7915901|NCT00626548|19481888|P2|STARTED|Overall Study||716
7915902|NCT00626548|19481889|P1|STARTED|Overall Study||705
7915903|NCT00626522|19481903|P6|NOT COMPLETED|Overall Study||2
7915904|NCT00626522|19481904|P5|NOT COMPLETED|Overall Study||7
7915905|NCT00626522|19481905|P4|NOT COMPLETED|Overall Study||2
7915906|NCT00626522|19481906|P3|NOT COMPLETED|Overall Study||8
7915907|NCT00626522|19481907|P2|NOT COMPLETED|Overall Study||7
7915908|NCT00626522|19481908|P1|NOT COMPLETED|Overall Study||6
7915909|NCT00626522|19481903|P6|COMPLETED|Overall Study||57
7915910|NCT00626522|19481904|P5|COMPLETED|Overall Study||58
7915911|NCT00626522|19481905|P4|COMPLETED|Overall Study||74
7915912|NCT00626522|19481906|P3|COMPLETED|Overall Study||117
7915913|NCT00626522|19481907|P2|COMPLETED|Overall Study||113
7915914|NCT00626522|19481908|P1|COMPLETED|Overall Study||115
7915915|NCT00626522|19481903|P6|STARTED|Overall Study||59
7915916|NCT00626522|19481904|P5|STARTED|Overall Study||65
7915917|NCT00626522|19481905|P4|STARTED|Overall Study||76
7915918|NCT00626522|19481906|P3|STARTED|Overall Study||125
7915919|NCT00626522|19481907|P2|STARTED|Overall Study||120
7915920|NCT00626522|19481908|P1|STARTED|Overall Study||121
7915921|NCT00626444|19481946|P1|NOT COMPLETED|Overall Study||0
7915922|NCT00626444|19481946|P1|COMPLETED|Overall Study||2
7915923|NCT00626444|19481946|P1|STARTED|Overall Study||2
7915924|NCT00626431|19481953|P2|NOT COMPLETED|Overall Study||45
7915925|NCT00626431|19481954|P1|NOT COMPLETED|Overall Study||17
7915926|NCT00626431|19481953|P2|COMPLETED|Overall Study||114
7915927|NCT00626431|19481954|P1|COMPLETED|Overall Study||134
7915928|NCT00626431|19481953|P2|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159
7915929|NCT00626431|19481954|P1|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151
7915930|NCT00626405|19481971|P2|NOT COMPLETED|Overall Study||1
7915931|NCT00626405|19481972|P1|NOT COMPLETED|Overall Study||1
7915932|NCT00626405|19481971|P2|COMPLETED|Overall Study||51
7915933|NCT00626405|19481972|P1|COMPLETED|Overall Study||42
7915934|NCT00626405|19481971|P2|STARTED|Overall Study||52
7915935|NCT00626405|19481972|P1|STARTED|Overall Study||43
7915936|NCT00626392|19481988|P6|NOT COMPLETED|Coadministration Period||6
7915937|NCT00626392|19481989|P5|NOT COMPLETED|Coadministration Period||5
7915938|NCT00626392|19481990|P4|NOT COMPLETED|Coadministration Period||7
7915939|NCT00626392|19481991|P3|NOT COMPLETED|Coadministration Period||10
7915940|NCT00626392|19481992|P2|NOT COMPLETED|Coadministration Period||5
7915941|NCT00626392|19481993|P1|NOT COMPLETED|Coadministration Period||4
7915942|NCT00626392|19481988|P6|COMPLETED|Coadministration Period||38
7915943|NCT00626392|19481989|P5|COMPLETED|Coadministration Period||36
7915944|NCT00626392|19481990|P4|COMPLETED|Coadministration Period||36
7915945|NCT00626392|19481991|P3|COMPLETED|Coadministration Period||31
7915946|NCT00626392|19481992|P2|COMPLETED|Coadministration Period||38
7915947|NCT00626392|19481993|P1|COMPLETED|Coadministration Period||40
7915948|NCT00626392|19481988|P6|STARTED|Coadministration Period||44
7915949|NCT00626392|19481989|P5|STARTED|Coadministration Period||41
7915950|NCT00626392|19481990|P4|STARTED|Coadministration Period||43
7915951|NCT00626392|19481991|P3|STARTED|Coadministration Period||41
7915952|NCT00626392|19481992|P2|STARTED|Coadministration Period||43
7915953|NCT00626392|19481993|P1|STARTED|Coadministration Period||44
7915954|NCT00626392|19481988|P6|NOT COMPLETED|Run-in Period||1
7915955|NCT00626392|19481989|P5|NOT COMPLETED|Run-in Period||4
7915956|NCT00626392|19481990|P4|NOT COMPLETED|Run-in Period||1
7915957|NCT00626392|19481991|P3|NOT COMPLETED|Run-in Period||3
7915958|NCT00626392|19481992|P2|NOT COMPLETED|Run-in Period||1
7915959|NCT00626392|19481993|P1|NOT COMPLETED|Run-in Period||1
7915960|NCT00626392|19481988|P6|COMPLETED|Run-in Period||44
7915961|NCT00626392|19481989|P5|COMPLETED|Run-in Period||41
7915962|NCT00626392|19481990|P4|COMPLETED|Run-in Period||43
7915963|NCT00626392|19481991|P3|COMPLETED|Run-in Period||41
7915964|NCT00626392|19481992|P2|COMPLETED|Run-in Period||43
7915965|NCT00626392|19481993|P1|COMPLETED|Run-in Period||44
7915966|NCT00626392|19481988|P6|STARTED|Run-in Period||45
7915967|NCT00626392|19481989|P5|STARTED|Run-in Period||45
7915968|NCT00626392|19481990|P4|STARTED|Run-in Period||44
7915969|NCT00626392|19481991|P3|STARTED|Run-in Period||44
7915970|NCT00626392|19481992|P2|STARTED|Run-in Period||44
7915971|NCT00626392|19481993|P1|STARTED|Run-in Period||45
7915972|NCT00626366|19482007|P2|NOT COMPLETED|Overall Study||0
7915973|NCT00626366|19482008|P1|NOT COMPLETED|Overall Study||0
7915974|NCT00626366|19482007|P2|COMPLETED|Overall Study||9
7915975|NCT00626366|19482008|P1|COMPLETED|Overall Study||9
7915976|NCT00626366|19482007|P2|STARTED|Overall Study||9
7915977|NCT00626366|19482008|P1|STARTED|Overall Study||9
7915978|NCT00626340|19482014|P1|NOT COMPLETED|Overall Study||0
7915979|NCT00626340|19482014|P1|COMPLETED|Overall Study||18
7915980|NCT00626340|19482014|P1|STARTED|Overall Study||18
7915981|NCT00626327|19482021|P3|NOT COMPLETED|Overall Study||88
7915982|NCT00626327|19482022|P2|NOT COMPLETED|Overall Study||59
7915983|NCT00626327|19482023|P1|NOT COMPLETED|Overall Study||78
7915984|NCT00626327|19482021|P3|COMPLETED|Overall Study||422
7915985|NCT00626327|19482022|P2|COMPLETED|Overall Study||557
7915986|NCT00626327|19482023|P1|COMPLETED|Overall Study||426
7915987|NCT00626327|19482021|P3|STARTED|Overall Study||510
7915988|NCT00626327|19482022|P2|STARTED|Overall Study||616
7915989|NCT00626327|19482023|P1|STARTED|Overall Study||504
7915990|NCT00626275|19482049|P8|NOT COMPLETED|Part B||1
7915991|NCT00626275|19482050|P7|NOT COMPLETED|Part B||1
7915992|NCT00626275|19482051|P6|NOT COMPLETED|Part B||0
7915993|NCT00626275|19482052|P5|NOT COMPLETED|Part B||0
7915994|NCT00626275|19482053|P4|NOT COMPLETED|Part B||0
7915995|NCT00626275|19482054|P3|NOT COMPLETED|Part B||0
7915996|NCT00626275|19482055|P2|NOT COMPLETED|Part B||0
7915997|NCT00626275|19482056|P1|NOT COMPLETED|Part B||0
7915998|NCT00626275|19482049|P8|COMPLETED|Part B||23
7915999|NCT00626275|19482050|P7|COMPLETED|Part B||19
7916000|NCT00626275|19482051|P6|COMPLETED|Part B||0
7916001|NCT00626275|19482052|P5|COMPLETED|Part B||0
7916002|NCT00626275|19482053|P4|COMPLETED|Part B||0
7916003|NCT00626275|19482054|P3|COMPLETED|Part B||0
7916004|NCT00626275|19482055|P2|COMPLETED|Part B||0
7916005|NCT00626275|19482056|P1|COMPLETED|Part B||0
7916006|NCT00626275|19482049|P8|STARTED|Part B||24
7916007|NCT00626275|19482050|P7|STARTED|Part B||20
7916008|NCT00626275|19482051|P6|STARTED|Part B||0
7916009|NCT00626275|19482052|P5|STARTED|Part B||0
7916010|NCT00626275|19482053|P4|STARTED|Part B||0
7916011|NCT00626275|19482054|P3|STARTED|Part B||0
7916012|NCT00626275|19482055|P2|STARTED|Part B||0
7916013|NCT00626275|19482056|P1|STARTED|Part B||0
7916014|NCT00626275|19482049|P8|NOT COMPLETED|Re-randomization Period for Part B||0
7916015|NCT00626275|19482050|P7|NOT COMPLETED|Re-randomization Period for Part B||0
7916016|NCT00626275|19482051|P6|NOT COMPLETED|Re-randomization Period for Part B||0
7916017|NCT00626275|19482052|P5|NOT COMPLETED|Re-randomization Period for Part B||0
7916018|NCT00626275|19482053|P4|NOT COMPLETED|Re-randomization Period for Part B||0
7916019|NCT00626275|19482054|P3|NOT COMPLETED|Re-randomization Period for Part B||0
7916020|NCT00626275|19482055|P2|NOT COMPLETED|Re-randomization Period for Part B||0
7916021|NCT00626275|19482056|P1|NOT COMPLETED|Re-randomization Period for Part B||0
7916022|NCT00626275|19482049|P8|COMPLETED|Re-randomization Period for Part B||24
7916023|NCT00626275|19482050|P7|COMPLETED|Re-randomization Period for Part B||20
7916024|NCT00626275|19482051|P6|COMPLETED|Re-randomization Period for Part B||0
7916025|NCT00626275|19482052|P5|COMPLETED|Re-randomization Period for Part B||0
7916026|NCT00626275|19482053|P4|COMPLETED|Re-randomization Period for Part B||0
7916027|NCT00626275|19482054|P3|COMPLETED|Re-randomization Period for Part B||0
7916028|NCT00626275|19482055|P2|COMPLETED|Re-randomization Period for Part B||0
7916029|NCT00626275|19482056|P1|COMPLETED|Re-randomization Period for Part B||0
7916030|NCT00626275|19482049|P8|STARTED|Re-randomization Period for Part B||24
7916031|NCT00626275|19482050|P7|STARTED|Re-randomization Period for Part B||20
7916032|NCT00626275|19482051|P6|STARTED|Re-randomization Period for Part B||0
7916033|NCT00626275|19482052|P5|STARTED|Re-randomization Period for Part B||0
7916034|NCT00626275|19482053|P4|STARTED|Re-randomization Period for Part B||0
7916035|NCT00626275|19482054|P3|STARTED|Re-randomization Period for Part B||0
7916036|NCT00626275|19482055|P2|STARTED|Re-randomization Period for Part B||0
7916037|NCT00626275|19482056|P1|STARTED|Re-randomization Period for Part B||0
7916038|NCT00626275|19482049|P8|NOT COMPLETED|Part A - Treatment Period 3||0
7916039|NCT00626275|19482050|P7|NOT COMPLETED|Part A - Treatment Period 3||0
7916040|NCT00626275|19482051|P6|NOT COMPLETED|Part A - Treatment Period 3||0
7916041|NCT00626275|19482052|P5|NOT COMPLETED|Part A - Treatment Period 3||0
7916042|NCT00626275|19482053|P4|NOT COMPLETED|Part A - Treatment Period 3||0
7916043|NCT00626275|19482054|P3|NOT COMPLETED|Part A - Treatment Period 3||0
7916044|NCT00626275|19482055|P2|NOT COMPLETED|Part A - Treatment Period 3||0
7916045|NCT00626275|19482056|P1|NOT COMPLETED|Part A - Treatment Period 3||0
7916046|NCT00626275|19482049|P8|COMPLETED|Part A - Treatment Period 3||0
7916047|NCT00626275|19482050|P7|COMPLETED|Part A - Treatment Period 3||0
7916048|NCT00626275|19482051|P6|COMPLETED|Part A - Treatment Period 3||8
7916049|NCT00626275|19482052|P5|COMPLETED|Part A - Treatment Period 3||9
7916050|NCT00626275|19482053|P4|COMPLETED|Part A - Treatment Period 3||8
7916051|NCT00626275|19482054|P3|COMPLETED|Part A - Treatment Period 3||6
7916052|NCT00626275|19482055|P2|COMPLETED|Part A - Treatment Period 3||7
7916053|NCT00626275|19482056|P1|COMPLETED|Part A - Treatment Period 3||6
7916054|NCT00626275|19482049|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
7916055|NCT00626275|19482050|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
7916056|NCT00626275|19482051|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
7916057|NCT00626275|19482052|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9
7916058|NCT00626275|19482053|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
7916059|NCT00626275|19482054|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
7916060|NCT00626275|19482055|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7
7916061|NCT00626275|19482056|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
7916062|NCT00626275|19482049|P8|STARTED|Part A - Treatment Period 3||0
7916063|NCT00626275|19482050|P7|STARTED|Part A - Treatment Period 3||0
7916064|NCT00626275|19482051|P6|STARTED|Part A - Treatment Period 3||8
7916065|NCT00626275|19482052|P5|STARTED|Part A - Treatment Period 3||9
7916066|NCT00626275|19482053|P4|STARTED|Part A - Treatment Period 3||8
7916067|NCT00626275|19482054|P3|STARTED|Part A - Treatment Period 3||6
7916068|NCT00626275|19482055|P2|STARTED|Part A - Treatment Period 3||7
7916069|NCT00626275|19482056|P1|STARTED|Part A - Treatment Period 3||6
7916070|NCT00626275|19482049|P8|NOT COMPLETED|Part A - Washout Period 2||0
7916071|NCT00626275|19482050|P7|NOT COMPLETED|Part A - Washout Period 2||0
7916072|NCT00626275|19482051|P6|NOT COMPLETED|Part A - Washout Period 2||0
7916073|NCT00626275|19482052|P5|NOT COMPLETED|Part A - Washout Period 2||0
7916074|NCT00626275|19482053|P4|NOT COMPLETED|Part A - Washout Period 2||0
7916075|NCT00626275|19482054|P3|NOT COMPLETED|Part A - Washout Period 2||0
7916076|NCT00626275|19482055|P2|NOT COMPLETED|Part A - Washout Period 2||0
7916077|NCT00626275|19482056|P1|NOT COMPLETED|Part A - Washout Period 2||0
7916078|NCT00626275|19482049|P8|COMPLETED|Part A - Washout Period 2||0
7916079|NCT00626275|19482050|P7|COMPLETED|Part A - Washout Period 2||0
7916080|NCT00626275|19482051|P6|COMPLETED|Part A - Washout Period 2||8
7916081|NCT00626275|19482052|P5|COMPLETED|Part A - Washout Period 2||9
7916082|NCT00626275|19482053|P4|COMPLETED|Part A - Washout Period 2||8
7916083|NCT00626275|19482054|P3|COMPLETED|Part A - Washout Period 2||6
7916084|NCT00626275|19482055|P2|COMPLETED|Part A - Washout Period 2||7
7916085|NCT00626275|19482056|P1|COMPLETED|Part A - Washout Period 2||6
7916086|NCT00626275|19482049|P8|STARTED|Part A - Washout Period 2||0
7916087|NCT00626275|19482050|P7|STARTED|Part A - Washout Period 2||0
7916088|NCT00626275|19482051|P6|STARTED|Part A - Washout Period 2||8
7916089|NCT00626275|19482052|P5|STARTED|Part A - Washout Period 2||9
7916090|NCT00626275|19482053|P4|STARTED|Part A - Washout Period 2||8
7916091|NCT00626275|19482054|P3|STARTED|Part A - Washout Period 2||6
7916092|NCT00626275|19482055|P2|STARTED|Part A - Washout Period 2||7
7916093|NCT00626275|19482056|P1|STARTED|Part A - Washout Period 2||6
7916094|NCT00626275|19482049|P8|NOT COMPLETED|Part A - Treatment Period 2||0
7916095|NCT00626275|19482050|P7|NOT COMPLETED|Part A - Treatment Period 2||0
7916096|NCT00626275|19482051|P6|NOT COMPLETED|Part A - Treatment Period 2||0
7916097|NCT00626275|19482052|P5|NOT COMPLETED|Part A - Treatment Period 2||0
7916098|NCT00626275|19482053|P4|NOT COMPLETED|Part A - Treatment Period 2||0
7916099|NCT00626275|19482054|P3|NOT COMPLETED|Part A - Treatment Period 2||0
7916100|NCT00626275|19482055|P2|NOT COMPLETED|Part A - Treatment Period 2||0
7916101|NCT00626275|19482056|P1|NOT COMPLETED|Part A - Treatment Period 2||0
7916102|NCT00626275|19482049|P8|COMPLETED|Part A - Treatment Period 2||0
7916103|NCT00626275|19482050|P7|COMPLETED|Part A - Treatment Period 2||0
7916104|NCT00626275|19482051|P6|COMPLETED|Part A - Treatment Period 2||8
7916105|NCT00626275|19482052|P5|COMPLETED|Part A - Treatment Period 2||9
7916106|NCT00626275|19482053|P4|COMPLETED|Part A - Treatment Period 2||8
7916107|NCT00626275|19482054|P3|COMPLETED|Part A - Treatment Period 2||6
7916108|NCT00626275|19482055|P2|COMPLETED|Part A - Treatment Period 2||7
7916109|NCT00626275|19482056|P1|COMPLETED|Part A - Treatment Period 2||6
7916110|NCT00626275|19482049|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
7916111|NCT00626275|19482050|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
7916112|NCT00626275|19482051|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
7916113|NCT00626275|19482052|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9
7916114|NCT00626275|19482053|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
7916115|NCT00626275|19482054|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
7916116|NCT00626275|19482055|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7
7916117|NCT00626275|19482056|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
7916118|NCT00626275|19482049|P8|STARTED|Part A - Treatment Period 2||0
7916119|NCT00626275|19482050|P7|STARTED|Part A - Treatment Period 2||0
7916120|NCT00626275|19482051|P6|STARTED|Part A - Treatment Period 2||8
7916121|NCT00626275|19482052|P5|STARTED|Part A - Treatment Period 2||9
7916122|NCT00626275|19482053|P4|STARTED|Part A - Treatment Period 2||8
7916123|NCT00626275|19482054|P3|STARTED|Part A - Treatment Period 2||6
7916124|NCT00626275|19482055|P2|STARTED|Part A - Treatment Period 2||7
7916125|NCT00626275|19482056|P1|STARTED|Part A - Treatment Period 2||6
7916126|NCT00626275|19482049|P8|NOT COMPLETED|Part A - Washout Period 1||0
7916127|NCT00626275|19482050|P7|NOT COMPLETED|Part A - Washout Period 1||0
7916128|NCT00626275|19482051|P6|NOT COMPLETED|Part A - Washout Period 1||0
7916129|NCT00626275|19482052|P5|NOT COMPLETED|Part A - Washout Period 1||0
7916130|NCT00626275|19482053|P4|NOT COMPLETED|Part A - Washout Period 1||0
7916131|NCT00626275|19482054|P3|NOT COMPLETED|Part A - Washout Period 1||0
7916132|NCT00626275|19482055|P2|NOT COMPLETED|Part A - Washout Period 1||0
7916133|NCT00626275|19482056|P1|NOT COMPLETED|Part A - Washout Period 1||0
7916134|NCT00626275|19482049|P8|COMPLETED|Part A - Washout Period 1||0
7916135|NCT00626275|19482050|P7|COMPLETED|Part A - Washout Period 1||0
7916136|NCT00626275|19482051|P6|COMPLETED|Part A - Washout Period 1||8
7916137|NCT00626275|19482052|P5|COMPLETED|Part A - Washout Period 1||9
7916138|NCT00626275|19482053|P4|COMPLETED|Part A - Washout Period 1||8
7916139|NCT00626275|19482054|P3|COMPLETED|Part A - Washout Period 1||6
7916140|NCT00626275|19482055|P2|COMPLETED|Part A - Washout Period 1||7
7916141|NCT00626275|19482056|P1|COMPLETED|Part A - Washout Period 1||6
7916142|NCT00626275|19482049|P8|STARTED|Part A - Washout Period 1||0
7916143|NCT00626275|19482050|P7|STARTED|Part A - Washout Period 1||0
7916144|NCT00626275|19482051|P6|STARTED|Part A - Washout Period 1||8
7916145|NCT00626275|19482052|P5|STARTED|Part A - Washout Period 1||9
7916146|NCT00626275|19482053|P4|STARTED|Part A - Washout Period 1||8
7916147|NCT00626275|19482054|P3|STARTED|Part A - Washout Period 1||6
7916148|NCT00626275|19482055|P2|STARTED|Part A - Washout Period 1||7
7916149|NCT00626275|19482056|P1|STARTED|Part A - Washout Period 1||6
7916150|NCT00626275|19482049|P8|NOT COMPLETED|Part A - Treatment Period 1||0
7916151|NCT00626275|19482050|P7|NOT COMPLETED|Part A - Treatment Period 1||0
7916152|NCT00626275|19482051|P6|NOT COMPLETED|Part A - Treatment Period 1||0
7916153|NCT00626275|19482052|P5|NOT COMPLETED|Part A - Treatment Period 1||0
7916154|NCT00626275|19482053|P4|NOT COMPLETED|Part A - Treatment Period 1||0
7916155|NCT00626275|19482054|P3|NOT COMPLETED|Part A - Treatment Period 1||1
7916156|NCT00626275|19482055|P2|NOT COMPLETED|Part A - Treatment Period 1||0
7916157|NCT00626275|19482056|P1|NOT COMPLETED|Part A - Treatment Period 1||1
7916158|NCT00626275|19482049|P8|COMPLETED|Part A - Treatment Period 1||0
7916159|NCT00626275|19482050|P7|COMPLETED|Part A - Treatment Period 1||0
7916160|NCT00626275|19482051|P6|COMPLETED|Part A - Treatment Period 1||8
7916161|NCT00626275|19482052|P5|COMPLETED|Part A - Treatment Period 1||9
7916162|NCT00626275|19482053|P4|COMPLETED|Part A - Treatment Period 1||8
7916163|NCT00626275|19482054|P3|COMPLETED|Part A - Treatment Period 1||6
7916164|NCT00626275|19482055|P2|COMPLETED|Part A - Treatment Period 1||7
7916165|NCT00626275|19482056|P1|COMPLETED|Part A - Treatment Period 1||6
7916166|NCT00626275|19482049|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
7916167|NCT00626275|19482050|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
7916168|NCT00626275|19482051|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
7916169|NCT00626275|19482052|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9
7916170|NCT00626275|19482053|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
7916171|NCT00626275|19482054|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
7916172|NCT00626275|19482055|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
7916173|NCT00626275|19482056|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
7916174|NCT00626275|19482049|P8|STARTED|Part A - Treatment Period 1||0
7916175|NCT00626275|19482050|P7|STARTED|Part A - Treatment Period 1||0
7916176|NCT00626275|19482051|P6|STARTED|Part A - Treatment Period 1||8
7916177|NCT00626275|19482052|P5|STARTED|Part A - Treatment Period 1||9
7916178|NCT00626275|19482053|P4|STARTED|Part A - Treatment Period 1||8
7916179|NCT00626275|19482054|P3|STARTED|Part A - Treatment Period 1||7
7916180|NCT00626275|19482055|P2|STARTED|Part A - Treatment Period 1||7
7916181|NCT00626275|19482056|P1|STARTED|Part A - Treatment Period 1||7
7916182|NCT00626210|19482096|P1|NOT COMPLETED|Overall Study||0
7916183|NCT00626210|19482096|P1|COMPLETED|Overall Study||2
7916184|NCT00626210|19482096|P1|STARTED|Overall Study||2
7916185|NCT00626197|19482103|P3|NOT COMPLETED|Overall Study||77
7916186|NCT00626197|19482104|P2|NOT COMPLETED|Overall Study||54
7916187|NCT00626197|19482105|P1|NOT COMPLETED|Overall Study||44
7916188|NCT00626197|19482103|P3|COMPLETED|Overall Study||49
7916189|NCT00626197|19482104|P2|COMPLETED|Overall Study||74
7916190|NCT00626197|19482105|P1|COMPLETED|Overall Study||83
7916191|NCT00626197|19482103|P3|STARTED|Overall Study||126
7916192|NCT00626197|19482104|P2|STARTED|Overall Study||128
7916193|NCT00626197|19482105|P1|STARTED|Overall Study||127
7916194|NCT00626093|19482182|P1|NOT COMPLETED|Overall Study||23
7916195|NCT00626093|19482182|P1|COMPLETED|Overall Study||54
7916196|NCT00626093|19482182|P1|STARTED|Overall Study||77
7916197|NCT00626028|19482189|P2|NOT COMPLETED|Overall Study||9
7916198|NCT00626028|19482190|P1|NOT COMPLETED|Overall Study||6
7916199|NCT00626028|19482189|P2|COMPLETED|Overall Study||59
7916200|NCT00626028|19482190|P1|COMPLETED|Overall Study||62
7916201|NCT00626028|19482189|P2|STARTED|Overall Study||68
7916202|NCT00626028|19482190|P1|STARTED|Overall Study||68
7916203|NCT00625989|19482204|P2|NOT COMPLETED|Overall Study||0
7916204|NCT00625989|19482205|P1|NOT COMPLETED|Overall Study||0
7916205|NCT00625989|19482204|P2|COMPLETED|Overall Study||6
7916206|NCT00625989|19482205|P1|COMPLETED|Overall Study||6
7916207|NCT00625989|19482204|P2|STARTED|Overall Study||6
7916208|NCT00625989|19482205|P1|STARTED|Overall Study||6
7916209|NCT00625872|19482214|P2|NOT COMPLETED|Overall Study||6
7916210|NCT00625872|19482215|P1|NOT COMPLETED|Overall Study||4
7916211|NCT00625872|19482214|P2|COMPLETED|Overall Study||5
7916212|NCT00625872|19482215|P1|COMPLETED|Overall Study||8
7916213|NCT00625872|19482214|P2|Treated|Overall Study||10
7916214|NCT00625872|19482215|P1|Treated|Overall Study||12
7916215|NCT00625872|19482214|P2|STARTED|Overall Study||11
7916216|NCT00625872|19482215|P1|STARTED|Overall Study||12
7916217|NCT00625846|19482329|P4|NOT COMPLETED|Overall Study||2
7916218|NCT00625846|19482330|P3|NOT COMPLETED|Overall Study||1
7916219|NCT00625846|19482331|P2|NOT COMPLETED|Overall Study||0
7916220|NCT00625846|19482332|P1|NOT COMPLETED|Overall Study||2
7916221|NCT00625846|19482329|P4|COMPLETED|Overall Study||60
7916222|NCT00625846|19482330|P3|COMPLETED|Overall Study||15
7916223|NCT00625846|19482331|P2|COMPLETED|Overall Study||35
7916224|NCT00625846|19482332|P1|COMPLETED|Overall Study||37
7916225|NCT00625846|19482329|P4|STARTED|Overall Study||62
7916226|NCT00625846|19482330|P3|STARTED|Overall Study||16
7916227|NCT00625846|19482331|P2|STARTED|Overall Study||35
7916228|NCT00625846|19482332|P1|STARTED|Overall Study||39
7916229|NCT00625820|19482358|P1|NOT COMPLETED|Overall Study||1
7916230|NCT00625820|19482358|P1|COMPLETED|Overall Study||16
7916231|NCT00625820|19482358|P1|STARTED|Overall Study||17
7916232|NCT00625807|19482366|P2|NOT COMPLETED|Overall Study||8
7916233|NCT00625807|19482367|P1|NOT COMPLETED|Overall Study||2
7916234|NCT00625807|19482366|P2|COMPLETED|Overall Study||20
7916235|NCT00625807|19482367|P1|COMPLETED|Overall Study||20
7916236|NCT00625807|19482366|P2|STARTED|Overall Study||28
7916237|NCT00625807|19482367|P1|STARTED|Overall Study||22
7916238|NCT00625742|19482383|P1|NOT COMPLETED|Overall Study||12
7916239|NCT00625742|19482383|P1|COMPLETED|Overall Study||3
7916240|NCT00625742|19482383|P1|STARTED|Overall Study||15
7916241|NCT00625729|19482388|P1|NOT COMPLETED|Overall Study||0
7916242|NCT00625729|19482388|P1|COMPLETED|Overall Study||6
7916243|NCT00625729|19482388|P1|STARTED|Overall Study||6
7916244|NCT00625703|19482397|P1|NOT COMPLETED|Overall Study||0
7916245|NCT00625703|19482397|P1|COMPLETED|Overall Study||0
7916246|NCT00625703|19482397|P1|STARTED|Overall Study||0
7916247|NCT00625586|19482402|P1|NOT COMPLETED|Overall Study||1
7916248|NCT00625586|19482402|P1|COMPLETED|Overall Study||1
7916249|NCT00625586|19482402|P1|STARTED|Overall Study||2
7916250|NCT00625443|19482415|P3|NOT COMPLETED|Overall Study||5
7916251|NCT00625443|19482416|P2|NOT COMPLETED|Overall Study||11
7916252|NCT00625443|19482417|P1|NOT COMPLETED|Overall Study||2
7916253|NCT00625443|19482415|P3|COMPLETED|Overall Study||10
7916254|NCT00625443|19482416|P2|COMPLETED|Overall Study||15
7916255|NCT00625443|19482417|P1|COMPLETED|Overall Study||10
7916256|NCT00625443|19482415|P3|STARTED|Overall Study||15
7916257|NCT00625443|19482416|P2|STARTED|Overall Study||26
7916258|NCT00625443|19482417|P1|STARTED|Overall Study||12
7916259|NCT00625404|19482447|P2|NOT COMPLETED|Overall Study||173
7916260|NCT00625404|19482448|P1|NOT COMPLETED|Overall Study||207
7916261|NCT00625404|19482447|P2|COMPLETED|Overall Study||885
7916262|NCT00625404|19482448|P1|COMPLETED|Overall Study||855
7916263|NCT00625404|19482447|P2|STARTED|Overall Study||1058
7916264|NCT00625404|19482448|P1|STARTED|Overall Study||1062
7916265|NCT00625391|19482480|P4|NOT COMPLETED|Overall Study||1
7916266|NCT00625391|19482481|P3|NOT COMPLETED|Overall Study||5
7916267|NCT00625391|19482482|P2|NOT COMPLETED|Overall Study||8
7916268|NCT00625391|19482483|P1|NOT COMPLETED|Overall Study||7
7916269|NCT00625391|19482480|P4|COMPLETED|Overall Study||37
7916270|NCT00625391|19482481|P3|COMPLETED|Overall Study||37
7916271|NCT00625391|19482482|P2|COMPLETED|Overall Study||39
7916272|NCT00625391|19482483|P1|COMPLETED|Overall Study||37
7916273|NCT00625391|19482480|P4|STARTED|Overall Study||38
7916274|NCT00625391|19482481|P3|STARTED|Overall Study||42
7916275|NCT00625391|19482482|P2|STARTED|Overall Study||47
7916276|NCT00625391|19482483|P1|STARTED|Overall Study||44
7916277|NCT00625365|19482497|P1|NOT COMPLETED|Overall Study||7
7916278|NCT00625365|19482497|P1|COMPLETED|Overall Study|Participants who were analyzed for safety|1053
7916279|NCT00625365|19482497|P1|STARTED|Overall Study||1060
7916280|NCT00625183|19482503|P1|NOT COMPLETED|Overall Study||1
7916281|NCT00625183|19482503|P1|COMPLETED|Overall Study||4
7916282|NCT00625183|19482503|P1|STARTED|Overall Study||5
7916283|NCT00625131|19482514|P3|NOT COMPLETED|Overall Study||5
7916284|NCT00625131|19482515|P2|NOT COMPLETED|Overall Study||2
7916285|NCT00625131|19482516|P1|NOT COMPLETED|Overall Study||4
7916286|NCT00625131|19482514|P3|COMPLETED|Overall Study||0
7916287|NCT00625131|19482515|P2|COMPLETED|Overall Study||42
7916288|NCT00625131|19482516|P1|COMPLETED|Overall Study||34
7916289|NCT00625131|19482514|P3|STARTED|Overall Study|These participants were not included in any analyses.|5
7916290|NCT00625131|19482515|P2|STARTED|Overall Study||44
7916291|NCT00625131|19482516|P1|STARTED|Overall Study||38
7916292|NCT00624923|19482528|P2|NOT COMPLETED|Overall Study||23
7916293|NCT00624923|19482529|P1|NOT COMPLETED|Overall Study||38
7916294|NCT00624923|19482528|P2|COMPLETED|Overall Study||101
7916295|NCT00624923|19482529|P1|COMPLETED|Overall Study||89
7916296|NCT00624923|19482528|P2|STARTED|Overall Study||124
7916297|NCT00624923|19482529|P1|STARTED|Overall Study||127
7916298|NCT00624832|19482545|P4|NOT COMPLETED|Overall Study||1
7916299|NCT00624832|19482546|P3|NOT COMPLETED|Overall Study||0
7916300|NCT00624832|19482547|P2|NOT COMPLETED|Overall Study||1
7916301|NCT00624832|19482548|P1|NOT COMPLETED|Overall Study||2
7916302|NCT00624832|19482545|P4|COMPLETED|Overall Study||15
7916303|NCT00624832|19482546|P3|COMPLETED|Overall Study||10
7916304|NCT00624832|19482547|P2|COMPLETED|Overall Study||15
7916305|NCT00624832|19482548|P1|COMPLETED|Overall Study||16
7916306|NCT00624832|19482545|P4|STARTED|Overall Study||16
7916307|NCT00624832|19482546|P3|STARTED|Overall Study||10
7916308|NCT00624832|19482547|P2|STARTED|Overall Study||16
7916309|NCT00624832|19482548|P1|STARTED|Overall Study||18
7916310|NCT00624819|19482564|P4|NOT COMPLETED|Follow-up Period: Year 4||0
7916311|NCT00624819|19482565|P3|NOT COMPLETED|Follow-up Period: Year 4||1
7916312|NCT00624819|19482566|P2|NOT COMPLETED|Follow-up Period: Year 4||1
7916313|NCT00624819|19482567|P1|NOT COMPLETED|Follow-up Period: Year 4||1
7916314|NCT00624819|19482564|P4|COMPLETED|Follow-up Period: Year 4||100
7916315|NCT00624819|19482565|P3|COMPLETED|Follow-up Period: Year 4||64
7916316|NCT00624819|19482566|P2|COMPLETED|Follow-up Period: Year 4||19
7916317|NCT00624819|19482567|P1|COMPLETED|Follow-up Period: Year 4||263
7916318|NCT00624819|19482564|P4|STARTED|Follow-up Period: Year 4||100
7916319|NCT00624819|19482565|P3|STARTED|Follow-up Period: Year 4||65
7916320|NCT00624819|19482566|P2|STARTED|Follow-up Period: Year 4||20
7916321|NCT00624819|19482567|P1|STARTED|Follow-up Period: Year 4||264
7916322|NCT00624819|19482564|P4|NOT COMPLETED|Follow-up Period: Year 2||0
7916323|NCT00624819|19482565|P3|NOT COMPLETED|Follow-up Period: Year 2||0
7916324|NCT00624819|19482566|P2|NOT COMPLETED|Follow-up Period: Year 2||0
7916325|NCT00624819|19482567|P1|NOT COMPLETED|Follow-up Period: Year 2||0
7916326|NCT00624819|19482564|P4|COMPLETED|Follow-up Period: Year 2||0
7916327|NCT00624819|19482565|P3|COMPLETED|Follow-up Period: Year 2||96
7916328|NCT00624819|19482566|P2|COMPLETED|Follow-up Period: Year 2||31
7916329|NCT00624819|19482567|P1|COMPLETED|Follow-up Period: Year 2||370
7916330|NCT00624819|19482564|P4|STARTED|Follow-up Period: Year 2||0
7916331|NCT00624819|19482565|P3|STARTED|Follow-up Period: Year 2||96
7916332|NCT00624819|19482566|P2|STARTED|Follow-up Period: Year 2||31
7916333|NCT00624819|19482567|P1|STARTED|Follow-up Period: Year 2||370
7916334|NCT00624819|19482564|P4|NOT COMPLETED|Follow-up Period: Year 1||0
7916335|NCT00624819|19482565|P3|NOT COMPLETED|Follow-up Period: Year 1||0
7916336|NCT00624819|19482566|P2|NOT COMPLETED|Follow-up Period: Year 1||0
7916337|NCT00624819|19482567|P1|NOT COMPLETED|Follow-up Period: Year 1||0
7916338|NCT00624819|19482564|P4|COMPLETED|Follow-up Period: Year 1||0
7916339|NCT00624819|19482565|P3|COMPLETED|Follow-up Period: Year 1||102
7916340|NCT00624819|19482566|P2|COMPLETED|Follow-up Period: Year 1||31
7916341|NCT00624819|19482567|P1|COMPLETED|Follow-up Period: Year 1||391
7916342|NCT00624819|19482564|P4|STARTED|Follow-up Period: Year 1||0
7916343|NCT00624819|19482565|P3|STARTED|Follow-up Period: Year 1||102
7916344|NCT00624819|19482566|P2|STARTED|Follow-up Period: Year 1||31
7916345|NCT00624819|19482567|P1|STARTED|Follow-up Period: Year 1||391
7916346|NCT00624806|19482727|P2|NOT COMPLETED|Overall Study||0
7916347|NCT00624806|19482728|P1|NOT COMPLETED|Overall Study||0
7916348|NCT00624806|19482727|P2|COMPLETED|Overall Study||8
7916349|NCT00624806|19482728|P1|COMPLETED|Overall Study||10
7916350|NCT00624806|19482727|P2|STARTED|Overall Study||8
7916351|NCT00624806|19482728|P1|STARTED|Overall Study||10
7916352|NCT00624780|19482744|P6|NOT COMPLETED|Follow-up (Week 26)||0
7916353|NCT00624780|19482745|P5|NOT COMPLETED|Follow-up (Week 26)||2
7916354|NCT00624780|19482746|P4|NOT COMPLETED|Follow-up (Week 26)||0
7916355|NCT00624780|19482747|P3|NOT COMPLETED|Follow-up (Week 26)||2
7916356|NCT00624780|19482748|P2|NOT COMPLETED|Follow-up (Week 26)||1
7916357|NCT00624780|19482749|P1|NOT COMPLETED|Follow-up (Week 26)||2
7916358|NCT00624780|19482744|P6|COMPLETED|Follow-up (Week 26)||29
7916359|NCT00624780|19482745|P5|COMPLETED|Follow-up (Week 26)||93
7916360|NCT00624780|19482746|P4|COMPLETED|Follow-up (Week 26)||26
7916361|NCT00624780|19482747|P3|COMPLETED|Follow-up (Week 26)||89
7916362|NCT00624780|19482748|P2|COMPLETED|Follow-up (Week 26)||27
7916363|NCT00624780|19482749|P1|COMPLETED|Follow-up (Week 26)||102
7916364|NCT00624780|19482744|P6|STARTED|Follow-up (Week 26)||29
7916365|NCT00624780|19482745|P5|STARTED|Follow-up (Week 26)||95
7916366|NCT00624780|19482746|P4|STARTED|Follow-up (Week 26)||26
7916367|NCT00624780|19482747|P3|STARTED|Follow-up (Week 26)||91
7916368|NCT00624780|19482748|P2|STARTED|Follow-up (Week 26)||28
7916369|NCT00624780|19482749|P1|STARTED|Follow-up (Week 26)||104
7916370|NCT00624780|19482744|P6|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
7916371|NCT00624780|19482745|P5|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
7916372|NCT00624780|19482746|P4|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
7916373|NCT00624780|19482747|P3|NOT COMPLETED|Treatment Discontinuation (Week 25)||3
7916374|NCT00624780|19482748|P2|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
7916375|NCT00624780|19482749|P1|NOT COMPLETED|Treatment Discontinuation (Week 25)||2
7916376|NCT00624780|19482744|P6|COMPLETED|Treatment Discontinuation (Week 25)||29
7916377|NCT00624780|19482745|P5|COMPLETED|Treatment Discontinuation (Week 25)||95
7916378|NCT00624780|19482746|P4|COMPLETED|Treatment Discontinuation (Week 25)||26
7916379|NCT00624780|19482747|P3|COMPLETED|Treatment Discontinuation (Week 25)||91
7916380|NCT00624780|19482748|P2|COMPLETED|Treatment Discontinuation (Week 25)||28
7916381|NCT00624780|19482749|P1|COMPLETED|Treatment Discontinuation (Week 25)||104
7916382|NCT00624780|19482744|P6|STARTED|Treatment Discontinuation (Week 25)||30
7916383|NCT00624780|19482745|P5|STARTED|Treatment Discontinuation (Week 25)||95
7916384|NCT00624780|19482746|P4|STARTED|Treatment Discontinuation (Week 25)||27
7916385|NCT00624780|19482747|P3|STARTED|Treatment Discontinuation (Week 25)||94
7916386|NCT00624780|19482748|P2|STARTED|Treatment Discontinuation (Week 25)||28
7916387|NCT00624780|19482749|P1|STARTED|Treatment Discontinuation (Week 25)||106
7916388|NCT00624780|19482744|P6|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9
7916389|NCT00624780|19482745|P5|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19
7916390|NCT00624780|19482746|P4|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
7916391|NCT00624780|19482747|P3|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18
7916392|NCT00624780|19482748|P2|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
7916393|NCT00624780|19482749|P1|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15
7916394|NCT00624780|19482744|P6|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30
7916395|NCT00624780|19482745|P5|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95
7916396|NCT00624780|19482746|P4|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27
7916397|NCT00624780|19482747|P3|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94
7916398|NCT00624780|19482748|P2|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28
7916399|NCT00624780|19482749|P1|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106
7916400|NCT00624780|19482744|P6|STARTED|Fixed Dosing (Week 13 to Week 24)||39
7916401|NCT00624780|19482745|P5|STARTED|Fixed Dosing (Week 13 to Week 24)||114
7916402|NCT00624780|19482746|P4|STARTED|Fixed Dosing (Week 13 to Week 24)||38
7916403|NCT00624780|19482747|P3|STARTED|Fixed Dosing (Week 13 to Week 24)||112
7916404|NCT00624780|19482748|P2|STARTED|Fixed Dosing (Week 13 to Week 24)||39
7916405|NCT00624780|19482749|P1|STARTED|Fixed Dosing (Week 13 to Week 24)||121
7916406|NCT00624780|19482744|P6|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11
7916407|NCT00624780|19482745|P5|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39
7916408|NCT00624780|19482746|P4|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14
7916409|NCT00624780|19482747|P3|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42
7916410|NCT00624780|19482748|P2|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13
7916411|NCT00624780|19482749|P1|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33
7916412|NCT00624780|19482744|P6|COMPLETED|Treatment Optimization (Up to Week 12)||39
7916413|NCT00624780|19482745|P5|COMPLETED|Treatment Optimization (Up to Week 12)||114
7916414|NCT00624780|19482746|P4|COMPLETED|Treatment Optimization (Up to Week 12)||38
7916415|NCT00624780|19482747|P3|COMPLETED|Treatment Optimization (Up to Week 12)||112
7916416|NCT00624780|19482748|P2|COMPLETED|Treatment Optimization (Up to Week 12)||39
7916417|NCT00624780|19482749|P1|COMPLETED|Treatment Optimization (Up to Week 12)||121
7916418|NCT00624780|19482744|P6|STARTED|Treatment Optimization (Up to Week 12)||50
7916419|NCT00624780|19482745|P5|STARTED|Treatment Optimization (Up to Week 12)||153
7916420|NCT00624780|19482746|P4|STARTED|Treatment Optimization (Up to Week 12)||52
7916421|NCT00624780|19482747|P3|STARTED|Treatment Optimization (Up to Week 12)||154
7916422|NCT00624780|19482748|P2|STARTED|Treatment Optimization (Up to Week 12)||52
7916423|NCT00624780|19482749|P1|STARTED|Treatment Optimization (Up to Week 12)||154
7916424|NCT00624650|19482933|P2|NOT COMPLETED|Overall Study||1
7916425|NCT00624650|19482934|P1|NOT COMPLETED|Overall Study||1
7916426|NCT00624650|19482933|P2|COMPLETED|Overall Study||15
7916427|NCT00624650|19482934|P1|COMPLETED|Overall Study||16
7916428|NCT00624650|19482933|P2|STARTED|Overall Study||16
7916429|NCT00624650|19482934|P1|STARTED|Overall Study||17
7916430|NCT00624585|19482940|P1|NOT COMPLETED|Overall Study||12
7916431|NCT00624585|19482940|P1|COMPLETED|Overall Study||6
7916432|NCT00624585|19482940|P1|STARTED|Overall Study||18
7916433|NCT00624559|19482951|P4|NOT COMPLETED|Overall Study||0
7916434|NCT00624559|19482952|P3|NOT COMPLETED|Overall Study||0
7916435|NCT00624559|19482953|P2|NOT COMPLETED|Overall Study||0
7916436|NCT00624559|19482954|P1|NOT COMPLETED|Overall Study||0
7916437|NCT00624559|19482951|P4|COMPLETED|Overall Study||3
7916438|NCT00624559|19482952|P3|COMPLETED|Overall Study||3
7916439|NCT00624559|19482953|P2|COMPLETED|Overall Study||3
7916440|NCT00624559|19482954|P1|COMPLETED|Overall Study||3
7916441|NCT00624559|19482951|P4|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
7916442|NCT00624559|19482952|P3|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
7916443|NCT00624559|19482953|P2|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
7916444|NCT00624559|19482954|P1|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
7916445|NCT00624520|19482970|P2|NOT COMPLETED|Overall Study||8
7916446|NCT00624520|19482971|P1|NOT COMPLETED|Overall Study||12
7916447|NCT00624520|19482970|P2|COMPLETED|Overall Study||39
7916448|NCT00624520|19482971|P1|COMPLETED|Overall Study||44
7916449|NCT00624520|19482970|P2|STARTED|Overall Study||47
7916450|NCT00624520|19482971|P1|STARTED|Overall Study||56
7916451|NCT00624468|19482998|P4|NOT COMPLETED|Safety Follow-up (SFU) Period||3
7916452|NCT00624468|19482999|P3|NOT COMPLETED|Safety Follow-up (SFU) Period||2
7916453|NCT00624468|19483000|P2|NOT COMPLETED|Safety Follow-up (SFU) Period||0
7916454|NCT00624468|19483001|P1|NOT COMPLETED|Safety Follow-up (SFU) Period||0
7916455|NCT00624468|19482998|P4|COMPLETED|Safety Follow-up (SFU) Period||11
7916456|NCT00624468|19482999|P3|COMPLETED|Safety Follow-up (SFU) Period||11
7916457|NCT00624468|19483000|P2|COMPLETED|Safety Follow-up (SFU) Period||0
7916458|NCT00624468|19483001|P1|COMPLETED|Safety Follow-up (SFU) Period||0
7916459|NCT00624468|19482998|P4|STARTED|Safety Follow-up (SFU) Period||14
7916460|NCT00624468|19482999|P3|STARTED|Safety Follow-up (SFU) Period||13
7916461|NCT00624468|19483000|P2|STARTED|Safety Follow-up (SFU) Period||0
7916462|NCT00624468|19483001|P1|STARTED|Safety Follow-up (SFU) Period||0
7916463|NCT00624468|19482998|P4|NOT COMPLETED|Double-blind Period||0
7916464|NCT00624468|19482999|P3|NOT COMPLETED|Double-blind Period||0
7916465|NCT00624468|19483000|P2|NOT COMPLETED|Double-blind Period||13
7916466|NCT00624468|19483001|P1|NOT COMPLETED|Double-blind Period||14
7916467|NCT00624468|19482998|P4|COMPLETED|Double-blind Period||0
7916468|NCT00624468|19482999|P3|COMPLETED|Double-blind Period||0
7916469|NCT00624468|19483000|P2|COMPLETED|Double-blind Period||4
7916470|NCT00624468|19483001|P1|COMPLETED|Double-blind Period||3
7916471|NCT00624468|19482998|P4|STARTED|Double-blind Period||0
7916472|NCT00624468|19482999|P3|STARTED|Double-blind Period||0
7916473|NCT00624468|19483000|P2|STARTED|Double-blind Period||17
7916474|NCT00624468|19483001|P1|STARTED|Double-blind Period||17
7916475|NCT00624442|19483032|P5|NOT COMPLETED|Overall Study||2
7916476|NCT00624442|19483033|P4|NOT COMPLETED|Overall Study||0
7916477|NCT00624442|19483034|P3|NOT COMPLETED|Overall Study||2
7916478|NCT00624442|19483035|P2|NOT COMPLETED|Overall Study||1
7916479|NCT00624442|19483036|P1|NOT COMPLETED|Overall Study||0
7916480|NCT00624442|19483032|P5|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
7916481|NCT00624442|19483033|P4|COMPLETED|Overall Study||8
7916482|NCT00624442|19483034|P3|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
7916483|NCT00624442|19483035|P2|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8
7916484|NCT00624442|19483036|P1|COMPLETED|Overall Study||8
7916485|NCT00624442|19483032|P5|STARTED|Overall Study||10
7916486|NCT00624442|19483033|P4|STARTED|Overall Study||8
7916487|NCT00624442|19483034|P3|STARTED|Overall Study||10
7916488|NCT00624442|19483035|P2|STARTED|Overall Study||9
7916489|NCT00624442|19483036|P1|STARTED|Overall Study||8
7916490|NCT00624416|19483062|P1|NOT COMPLETED|Overall Study||0
7916491|NCT00624416|19483062|P1|COMPLETED|Overall Study||10
7916492|NCT00624416|19483062|P1|STARTED|Overall Study||10
7916493|NCT00624377|19483068|P1|NOT COMPLETED|Overall Study||644
7916494|NCT00624377|19483068|P1|COMPLETED|Overall Study||1387
7916495|NCT00624377|19483068|P1|STARTED|Overall Study||2031
7916496|NCT00624338|19483082|P3|NOT COMPLETED|Overall Study||46
7916497|NCT00624338|19483083|P2|NOT COMPLETED|Overall Study||83
7916498|NCT00624338|19483084|P1|NOT COMPLETED|Overall Study||47
7916499|NCT00624338|19483082|P3|COMPLETED|Overall Study||111
7916500|NCT00624338|19483083|P2|COMPLETED|Overall Study||62
7916501|NCT00624338|19483084|P1|COMPLETED|Overall Study||112
7916502|NCT00624338|19483082|P3|Treated|Overall Study||154
7916503|NCT00624338|19483083|P2|Treated|Overall Study||144
7916504|NCT00624338|19483084|P1|Treated|Overall Study||157
7916505|NCT00624338|19483082|P3|STARTED|Overall Study||157
7916506|NCT00624338|19483083|P2|STARTED|Overall Study||145
7916507|NCT00624338|19483084|P1|STARTED|Overall Study||159
7916508|NCT00624286|19483106|P2|NOT COMPLETED|Overall Study||27
7916509|NCT00624286|19483107|P1|NOT COMPLETED|Overall Study||25
7916510|NCT00624286|19483106|P2|COMPLETED|Overall Study||178
7916511|NCT00624286|19483107|P1|COMPLETED|Overall Study||186
7916512|NCT00624286|19483106|P2|STARTED|Overall Study||205
7916513|NCT00624286|19483107|P1|STARTED|Overall Study||211
7916514|NCT00624234|19483121|P6|NOT COMPLETED|Overall Study||0
7916515|NCT00624234|19483122|P5|NOT COMPLETED|Overall Study||0
7916516|NCT00624234|19483123|P4|NOT COMPLETED|Overall Study||0
7916517|NCT00624234|19483124|P3|NOT COMPLETED|Overall Study||0
7916518|NCT00624234|19483125|P2|NOT COMPLETED|Overall Study||0
7916519|NCT00624234|19483126|P1|NOT COMPLETED|Overall Study||0
7916520|NCT00624234|19483121|P6|COMPLETED|Overall Study||14
7916521|NCT00624234|19483122|P5|COMPLETED|Overall Study||18
7916522|NCT00624234|19483123|P4|COMPLETED|Overall Study||14
7916523|NCT00624234|19483124|P3|COMPLETED|Overall Study||26
7916524|NCT00624234|19483125|P2|COMPLETED|Overall Study||9
7916525|NCT00624234|19483126|P1|COMPLETED|Overall Study||8
7916526|NCT00624234|19483121|P6|STARTED|Overall Study||14
7916527|NCT00624234|19483122|P5|STARTED|Overall Study||18
7916528|NCT00624234|19483123|P4|STARTED|Overall Study||14
7916529|NCT00624234|19483124|P3|STARTED|Overall Study||26
7916530|NCT00624234|19483125|P2|STARTED|Overall Study||9
7916531|NCT00624234|19483126|P1|STARTED|Overall Study||8
7916532|NCT00624221|19483142|P2|NOT COMPLETED|Overall Study||0
7916533|NCT00624221|19483143|P1|NOT COMPLETED|Overall Study||0
7916534|NCT00624221|19483142|P2|COMPLETED|Overall Study||20
7916535|NCT00624221|19483143|P1|COMPLETED|Overall Study||20
7916536|NCT00624221|19483142|P2|STARTED|Overall Study||20
7916537|NCT00624221|19483143|P1|STARTED|Overall Study||20
7916538|NCT00624195|19483151|P2|NOT COMPLETED|Overall Study||7
7916539|NCT00624195|19483152|P1|NOT COMPLETED|Overall Study||3
7916540|NCT00624195|19483151|P2|COMPLETED|Overall Study||23
7916541|NCT00624195|19483152|P1|COMPLETED|Overall Study||26
7916542|NCT00624195|19483151|P2|STARTED|Overall Study||30
7916543|NCT00624195|19483152|P1|STARTED|Overall Study||29
7916544|NCT00624065|19483160|P2|NOT COMPLETED|Overall Study||24
7916545|NCT00624065|19483161|P1|NOT COMPLETED|Overall Study||19
7916546|NCT00624065|19483160|P2|COMPLETED|Overall Study||192
7916547|NCT00624065|19483161|P1|COMPLETED|Overall Study||197
7916548|NCT00624065|19483160|P2|STARTED|Overall Study||216
7916549|NCT00624065|19483161|P1|STARTED|Overall Study||216
7916550|NCT00624052|19483173|P4|NOT COMPLETED|Overall Study||4
7916551|NCT00624052|19483174|P3|NOT COMPLETED|Overall Study||3
7916552|NCT00624052|19483175|P2|NOT COMPLETED|Overall Study||14
7916553|NCT00624052|19483176|P1|NOT COMPLETED|Overall Study||15
7916554|NCT00624052|19483173|P4|COMPLETED|Overall Study||88
7916555|NCT00624052|19483174|P3|COMPLETED|Overall Study||88
7916556|NCT00624052|19483175|P2|COMPLETED|Overall Study||422
7916557|NCT00624052|19483176|P1|COMPLETED|Overall Study||204
7916558|NCT00624052|19483173|P4|STARTED|Overall Study||92
7916559|NCT00624052|19483174|P3|STARTED|Overall Study||91
7916560|NCT00624052|19483175|P2|STARTED|Overall Study||436
7916561|NCT00624052|19483176|P1|STARTED|Overall Study||219
7916562|NCT00624013|19483227|P2|NOT COMPLETED|Overall Study||6
7916563|NCT00624013|19483228|P1|NOT COMPLETED|Overall Study||8
7916564|NCT00624013|19483227|P2|COMPLETED|Overall Study||39
7916565|NCT00624013|19483228|P1|COMPLETED|Overall Study||36
7916566|NCT00624013|19483227|P2|STARTED|Overall Study||45
7916567|NCT00624013|19483228|P1|STARTED|Overall Study||44
7916568|NCT00623974|19483240|P4|NOT COMPLETED|Overall Study||0
7916569|NCT00623974|19483241|P3|NOT COMPLETED|Overall Study||0
7916570|NCT00623974|19483242|P2|NOT COMPLETED|Overall Study||0
7916571|NCT00623974|19483243|P1|NOT COMPLETED|Overall Study||0
7916572|NCT00623974|19483240|P4|COMPLETED|Overall Study||0
7916573|NCT00623974|19483241|P3|COMPLETED|Overall Study||0
7916574|NCT00623974|19483242|P2|COMPLETED|Overall Study||0
7916575|NCT00623974|19483243|P1|COMPLETED|Overall Study||0
7916576|NCT00623974|19483240|P4|STARTED|Overall Study||0
7916577|NCT00623974|19483241|P3|STARTED|Overall Study||0
7916578|NCT00623974|19483242|P2|STARTED|Overall Study||0
7916579|NCT00623974|19483243|P1|STARTED|Overall Study||0
7916580|NCT00623935|19483253|P1|NOT COMPLETED|Overall Study||2
7916581|NCT00623935|19483253|P1|COMPLETED|Overall Study||54
7916582|NCT00623935|19483253|P1|STARTED|Overall Study||56
7916583|NCT00623831|19483260|P2|NOT COMPLETED|Overall Study||1
7916584|NCT00623831|19483261|P1|NOT COMPLETED|Overall Study||1
7916585|NCT00623831|19483260|P2|COMPLETED|Overall Study||3
7916586|NCT00623831|19483261|P1|COMPLETED|Overall Study||12
7916587|NCT00623831|19483260|P2|STARTED|Overall Study||4
7916588|NCT00623831|19483261|P1|STARTED|Overall Study||13
7916589|NCT00623805|19483273|P2|NOT COMPLETED|Overall Study||22
7916590|NCT00623805|19483274|P1|NOT COMPLETED|Overall Study||20
7916591|NCT00623805|19483273|P2|COMPLETED|Overall Study||39
7916592|NCT00623805|19483274|P1|COMPLETED|Overall Study||42
7916593|NCT00623805|19483273|P2|STARTED|Overall Study||61
7916594|NCT00623805|19483274|P1|STARTED|Overall Study||62
7916595|NCT00623779|19483291|P3|NOT COMPLETED|Overall Study||1
7916596|NCT00623779|19483292|P2|NOT COMPLETED|Overall Study||3
7916597|NCT00623779|19483293|P1|NOT COMPLETED|Overall Study||3
7916598|NCT00623779|19483291|P3|COMPLETED|Overall Study||44
7916599|NCT00623779|19483292|P2|COMPLETED|Overall Study||39
7916600|NCT00623779|19483293|P1|COMPLETED|Overall Study||38
7916601|NCT00623779|19483291|P3|STARTED|Overall Study||45
7916602|NCT00623779|19483292|P2|STARTED|Overall Study||42
7916603|NCT00623779|19483293|P1|STARTED|Overall Study||41
7916604|NCT00623766|19483342|P2|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2
7916605|NCT00623766|19483343|P1|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10
7916606|NCT00623766|19483342|P2|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0
7916607|NCT00623766|19483343|P1|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1
7916608|NCT00623766|19483342|P2|STARTED|Maintenance Phase (Week 24 to Year 2)||2
7916609|NCT00623766|19483343|P1|STARTED|Maintenance Phase (Week 24 to Year 2)||11
7916610|NCT00623766|19483342|P2|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16
7916611|NCT00623766|19483343|P1|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36
7916612|NCT00623766|19483342|P2|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5
7916613|NCT00623766|19483343|P1|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15
7916614|NCT00623766|19483342|P2|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21
7916615|NCT00623766|19483343|P1|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51
7916616|NCT00623727|19483367|P2|NOT COMPLETED|Open Label Extension Period||0
7916617|NCT00623727|19483368|P1|NOT COMPLETED|Open Label Extension Period||0
7916618|NCT00623727|19483367|P2|COMPLETED|Open Label Extension Period||0
7916619|NCT00623727|19483368|P1|COMPLETED|Open Label Extension Period||20
7916620|NCT00623727|19483367|P2|STARTED|Open Label Extension Period||0
7916621|NCT00623727|19483368|P1|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20
7916622|NCT00623727|19483367|P2|NOT COMPLETED|Open Label Follow-up||8
7916623|NCT00623727|19483368|P1|NOT COMPLETED|Open Label Follow-up||0
7916624|NCT00623727|19483367|P2|COMPLETED|Open Label Follow-up||18
7916625|NCT00623727|19483368|P1|COMPLETED|Open Label Follow-up||0
7916626|NCT00623727|19483367|P2|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26
7916627|NCT00623727|19483368|P1|STARTED|Open Label Follow-up||0
7916628|NCT00623727|19483367|P2|NOT COMPLETED|Double Blind (DB)||32
7916629|NCT00623727|19483368|P1|NOT COMPLETED|Double Blind (DB)||36
7916630|NCT00623727|19483367|P2|COMPLETED|Double Blind (DB)||41
7916631|NCT00623727|19483368|P1|COMPLETED|Double Blind (DB)||34
7916632|NCT00623727|19483367|P2|Participants Received Treatment|Double Blind (DB)||72
7916633|NCT00623727|19483368|P1|Participants Received Treatment|Double Blind (DB)||67
7916634|NCT00623727|19483367|P2|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73
7916635|NCT00623727|19483368|P1|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70
7916636|NCT00623714|19483388|P2|NOT COMPLETED|Period 2||0
7916637|NCT00623714|19483389|P1|NOT COMPLETED|Period 2||0
7916638|NCT00623714|19483388|P2|COMPLETED|Period 2||7
7916639|NCT00623714|19483389|P1|COMPLETED|Period 2||6
7916640|NCT00623714|19483388|P2|STARTED|Period 2||7
7916641|NCT00623714|19483389|P1|STARTED|Period 2||6
7916642|NCT00623714|19483388|P2|NOT COMPLETED|Period 1||0
7916643|NCT00623714|19483389|P1|NOT COMPLETED|Period 1||0
7916644|NCT00623714|19483388|P2|COMPLETED|Period 1||7
7916645|NCT00623714|19483389|P1|COMPLETED|Period 1||6
7916646|NCT00623714|19483388|P2|STARTED|Period 1||7
7916647|NCT00623714|19483389|P1|STARTED|Period 1||6
7916648|NCT00623636|19483399|P2|NOT COMPLETED|Open Label||412
7916649|NCT00623636|19483400|P1|NOT COMPLETED|Open Label||0
7916650|NCT00623636|19483399|P2|COMPLETED|Open Label||263
7916651|NCT00623636|19483400|P1|COMPLETED|Open Label||0
7916652|NCT00623636|19483399|P2|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675
7916653|NCT00623636|19483400|P1|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0
7916654|NCT00623636|19483399|P2|NOT COMPLETED|Double Blind||28
7916655|NCT00623636|19483400|P1|NOT COMPLETED|Double Blind||33
7916656|NCT00623636|19483399|P2|COMPLETED|Double Blind||422
7916657|NCT00623636|19483400|P1|COMPLETED|Double Blind||419
7916658|NCT00623636|19483399|P2|STARTED|Double Blind||450
7916659|NCT00623636|19483400|P1|STARTED|Double Blind||452
7916660|NCT00623623|19483423|P2|NOT COMPLETED|Overall Study||1
7916661|NCT00623623|19483424|P1|NOT COMPLETED|Overall Study||1
7916662|NCT00623623|19483423|P2|COMPLETED|Overall Study||948
7916663|NCT00623623|19483424|P1|COMPLETED|Overall Study||949
7916664|NCT00623623|19483423|P2|STARTED|Overall Study||949
7916665|NCT00623623|19483424|P1|STARTED|Overall Study||950
7916666|NCT00623597|19483480|P2|NOT COMPLETED|Overall Study||0
7916667|NCT00623597|19483481|P1|NOT COMPLETED|Overall Study||1
7916668|NCT00623597|19483480|P2|COMPLETED|Overall Study||13
7916669|NCT00623597|19483481|P1|COMPLETED|Overall Study||4
7916670|NCT00623597|19483480|P2|STARTED|Overall Study||13
7916671|NCT00623597|19483481|P1|STARTED|Overall Study||5
7916672|NCT00623545|19483544|P1|NOT COMPLETED|Overall Study||10
7916673|NCT00623545|19483544|P1|COMPLETED|Overall Study||18
7916674|NCT00623545|19483544|P1|STARTED|Overall Study||28
7916675|NCT00623506|19483551|P2|NOT COMPLETED|Overall Study||4
7916676|NCT00623506|19483552|P1|NOT COMPLETED|Overall Study||4
7916677|NCT00623506|19483551|P2|COMPLETED|Overall Study||11
7916678|NCT00623506|19483552|P1|COMPLETED|Overall Study||11
7916679|NCT00623506|19483551|P2|Week 4|Overall Study||11
7916680|NCT00623506|19483552|P1|Week 4|Overall Study||11
7916681|NCT00623506|19483551|P2|STARTED|Overall Study||15
7916682|NCT00623506|19483552|P1|STARTED|Overall Study||15
7916683|NCT00623480|19483564|P2|NOT COMPLETED|Overall Study||7
7916684|NCT00623480|19483565|P1|NOT COMPLETED|Overall Study||7
7916685|NCT00623480|19483564|P2|COMPLETED|Overall Study||35
7916686|NCT00623480|19483565|P1|COMPLETED|Overall Study||35
7916687|NCT00623480|19483564|P2|STARTED|Overall Study||42
7916688|NCT00623480|19483565|P1|STARTED|Overall Study||42
7916689|NCT00623467|19483577|P1|NOT COMPLETED|Overall Study||7
7916690|NCT00623467|19483577|P1|COMPLETED|Overall Study||336
7916691|NCT00623467|19483577|P1|STARTED|Overall Study||343
7916692|NCT00623441|19483641|P1|NOT COMPLETED|Overall Study||0
7916693|NCT00623441|19483641|P1|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314
7916694|NCT00623441|19483641|P1|STARTED|Overall Study||8314
7916695|NCT00623428|19483647|P2|NOT COMPLETED|Follow-up Period||15
7916696|NCT00623428|19483648|P1|NOT COMPLETED|Follow-up Period||29
7916697|NCT00623428|19483647|P2|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78
7916698|NCT00623428|19483648|P1|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66
7916699|NCT00623428|19483647|P2|STARTED|Follow-up Period||93
7916700|NCT00623428|19483648|P1|STARTED|Follow-up Period||95
7916701|NCT00623428|19483647|P2|NOT COMPLETED|Treatment Period||27
7916702|NCT00623428|19483648|P1|NOT COMPLETED|Treatment Period||0
7916703|NCT00623428|19483647|P2|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66
7916704|NCT00623428|19483648|P1|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95
7916705|NCT00623428|19483647|P2|STARTED|Treatment Period||93
7916706|NCT00623428|19483648|P1|STARTED|Treatment Period||95
7916707|NCT00623233|19483666|P1|NOT COMPLETED|Overall Study||24
7916708|NCT00623233|19483666|P1|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28
7916709|NCT00623233|19483666|P1|STARTED|Overall Study||52
7916710|NCT00623194|19483673|P1|NOT COMPLETED|Overall Study||5
7916711|NCT00623194|19483673|P1|COMPLETED|Overall Study||141
7916712|NCT00623194|19483673|P1|STARTED|Overall Study||146
7916713|NCT00623181|19483695|P2|NOT COMPLETED|Overall Study||0
7916714|NCT00623181|19483696|P1|NOT COMPLETED|Overall Study||0
7916715|NCT00623181|19483695|P2|COMPLETED|Overall Study||54
7916716|NCT00623181|19483696|P1|COMPLETED|Overall Study||56
7916717|NCT00623181|19483695|P2|STARTED|Overall Study||54
7916718|NCT00623181|19483696|P1|STARTED|Overall Study||56
7916719|NCT00623103|19483710|P2|NOT COMPLETED|Overall Study||113
7916720|NCT00623103|19483711|P1|NOT COMPLETED|Overall Study||111
7916721|NCT00623103|19483710|P2|COMPLETED|Overall Study||175
7916722|NCT00623103|19483711|P1|COMPLETED|Overall Study||184
7916723|NCT00623103|19483710|P2|Safety Set: Received Study Drug|Overall Study||288
7916724|NCT00623103|19483711|P1|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294
7916725|NCT00623103|19483710|P2|STARTED|Overall Study||288
7916726|NCT00623103|19483711|P1|STARTED|Overall Study||295
7916727|NCT00623012|19483731|P1|NOT COMPLETED|Overall Study||0
7916728|NCT00623012|19483731|P1|COMPLETED|Overall Study||2
7916729|NCT00623012|19483731|P1|STARTED|Overall Study||2
7916730|NCT00622908|19483739|P2|NOT COMPLETED|Overall Study||10
7916731|NCT00622908|19483740|P1|NOT COMPLETED|Overall Study||3
7916732|NCT00622908|19483739|P2|COMPLETED|Overall Study||122
7916733|NCT00622908|19483740|P1|COMPLETED|Overall Study||134
7916734|NCT00622908|19483739|P2|STARTED|Overall Study|Intent to treat population|132
7916735|NCT00622908|19483740|P1|STARTED|Overall Study|Intent to treat population|137
7916736|NCT00622895|19483752|P1|NOT COMPLETED|Overall Study||0
7916737|NCT00622895|19483752|P1|COMPLETED|Overall Study||3
7916738|NCT00622895|19483752|P1|STARTED|Overall Study||3
7916739|NCT00622869|19483770|P3|NOT COMPLETED|Overall Study||39
7916740|NCT00622869|19483771|P2|NOT COMPLETED|Overall Study||57
7916741|NCT00622869|19483772|P1|NOT COMPLETED|Overall Study||43
7916742|NCT00622869|19483770|P3|COMPLETED|Overall Study||204
7916743|NCT00622869|19483771|P2|COMPLETED|Overall Study||174
7916744|NCT00622869|19483772|P1|COMPLETED|Overall Study||202
7916745|NCT00622869|19483770|P3|STARTED|Overall Study||243
7916746|NCT00622869|19483771|P2|STARTED|Overall Study||231
7916747|NCT00622869|19483772|P1|STARTED|Overall Study||245
7916748|NCT00622739|19483791|P2|NOT COMPLETED|Overall Study||6
7916749|NCT00622739|19483792|P1|NOT COMPLETED|Overall Study||2
7916750|NCT00622739|19483791|P2|COMPLETED|Overall Study||9
7916751|NCT00622739|19483792|P1|COMPLETED|Overall Study||11
7916752|NCT00622739|19483791|P2|STARTED|Overall Study||15
7916753|NCT00622739|19483792|P1|STARTED|Overall Study||13
7916754|NCT00622726|19483810|P2|NOT COMPLETED|August, 2010 to April, 2013||5
7916755|NCT00622726|19483811|P1|NOT COMPLETED|August, 2010 to April, 2013||1
7916756|NCT00622726|19483810|P2|COMPLETED|August, 2010 to April, 2013||68
7916757|NCT00622726|19483811|P1|COMPLETED|August, 2010 to April, 2013||69
7916758|NCT00622726|19483810|P2|STARTED|August, 2010 to April, 2013||73
7916759|NCT00622726|19483811|P1|STARTED|August, 2010 to April, 2013||70
7916760|NCT00622726|19483810|P2|NOT COMPLETED|March, 2008 to August, 2010||2
7916761|NCT00622726|19483811|P1|NOT COMPLETED|March, 2008 to August, 2010||5
7916762|NCT00622726|19483810|P2|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73
7916763|NCT00622726|19483811|P1|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70
7916764|NCT00622726|19483810|P2|STARTED|March, 2008 to August, 2010||75
7916765|NCT00622726|19483811|P1|STARTED|March, 2008 to August, 2010||75
7916766|NCT00622713|19483821|P1|NOT COMPLETED|Overall Study||59
7916767|NCT00622713|19483821|P1|COMPLETED|Overall Study||169
7916768|NCT00622713|19483821|P1|Intent to Treat (ITT) Population|Overall Study||218
7916769|NCT00622713|19483821|P1|Exposed to Study Drug|Overall Study||226
7916770|NCT00622713|19483821|P1|STARTED|Overall Study||228
7916771|NCT00622700|19483832|P7|NOT COMPLETED|Extension Treatment Period||30
7916772|NCT00622700|19483833|P6|NOT COMPLETED|Extension Treatment Period||17
7916773|NCT00622700|19483834|P5|NOT COMPLETED|Extension Treatment Period||39
7916774|NCT00622700|19483835|P4|NOT COMPLETED|Extension Treatment Period||21
7916775|NCT00622700|19483836|P3|NOT COMPLETED|Extension Treatment Period||0
7916776|NCT00622700|19483837|P2|NOT COMPLETED|Extension Treatment Period||0
7916777|NCT00622700|19483838|P1|NOT COMPLETED|Extension Treatment Period||0
7916778|NCT00622700|19483832|P7|COMPLETED|Extension Treatment Period||120
7916779|NCT00622700|19483833|P6|COMPLETED|Extension Treatment Period||50
7916780|NCT00622700|19483834|P5|COMPLETED|Extension Treatment Period||103
7916781|NCT00622700|19483835|P4|COMPLETED|Extension Treatment Period||43
7916782|NCT00622700|19483836|P3|COMPLETED|Extension Treatment Period||0
7916783|NCT00622700|19483837|P2|COMPLETED|Extension Treatment Period||0
7916784|NCT00622700|19483838|P1|COMPLETED|Extension Treatment Period||0
7916785|NCT00622700|19483832|P7|STARTED|Extension Treatment Period|13 participants completed core treatment period but did not enter in extension treatment period.|150
7916786|NCT00622700|19483833|P6|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|67
7916787|NCT00622700|19483834|P5|STARTED|Extension Treatment Period|8 participants completed core treatment period but did not enter in extension treatment period.|142
7916788|NCT00622700|19483835|P4|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|64
7916789|NCT00622700|19483836|P3|STARTED|Extension Treatment Period||0
7916790|NCT00622700|19483837|P2|STARTED|Extension Treatment Period||0
7916791|NCT00622700|19483838|P1|STARTED|Extension Treatment Period|Participants were re-randomized in a 1:1 ratio to either teriflunomide 7 mg or 14 mg treatment arm.|0
7916792|NCT00622700|19483832|P7|NOT COMPLETED|Core Treatment Period||0
7916793|NCT00622700|19483833|P6|NOT COMPLETED|Core Treatment Period||0
7916794|NCT00622700|19483834|P5|NOT COMPLETED|Core Treatment Period||0
7916795|NCT00622700|19483835|P4|NOT COMPLETED|Core Treatment Period||0
7916796|NCT00622700|19483836|P3|NOT COMPLETED|Core Treatment Period||53
7916797|NCT00622700|19483837|P2|NOT COMPLETED|Core Treatment Period||55
7916798|NCT00622700|19483838|P1|NOT COMPLETED|Core Treatment Period||56
7916799|NCT00622700|19483832|P7|COMPLETED|Core Treatment Period||0
7916800|NCT00622700|19483833|P6|COMPLETED|Core Treatment Period||0
7916801|NCT00622700|19483834|P5|COMPLETED|Core Treatment Period||0
7916802|NCT00622700|19483835|P4|COMPLETED|Core Treatment Period||0
7916803|NCT00622700|19483836|P3|COMPLETED|Core Treatment Period||163
7916804|NCT00622700|19483837|P2|COMPLETED|Core Treatment Period||150
7916805|NCT00622700|19483838|P1|COMPLETED|Core Treatment Period||141
7916806|NCT00622700|19483832|P7|Treated|Core Treatment Period||0
7916807|NCT00622700|19483833|P6|Treated|Core Treatment Period||0
7916808|NCT00622700|19483834|P5|Treated|Core Treatment Period||0
7916809|NCT00622700|19483835|P4|Treated|Core Treatment Period||0
7916810|NCT00622700|19483836|P3|Treated|Core Treatment Period||214
7916811|NCT00622700|19483837|P2|Treated|Core Treatment Period||203
7916812|NCT00622700|19483838|P1|Treated|Core Treatment Period||197
7916813|NCT00622700|19483832|P7|STARTED|Core Treatment Period||0
7916814|NCT00622700|19483833|P6|STARTED|Core Treatment Period||0
7916815|NCT00622700|19483834|P5|STARTED|Core Treatment Period||0
7916816|NCT00622700|19483835|P4|STARTED|Core Treatment Period||0
7916817|NCT00622700|19483836|P3|STARTED|Core Treatment Period||216
7916818|NCT00622700|19483837|P2|STARTED|Core Treatment Period||205
7916819|NCT00622700|19483838|P1|STARTED|Core Treatment Period||197
7916820|NCT00622635|19483897|P6|NOT COMPLETED|Treatment Period 3||0
7916821|NCT00622635|19483898|P5|NOT COMPLETED|Treatment Period 3||0
7916822|NCT00622635|19483899|P4|NOT COMPLETED|Treatment Period 3||3
7916823|NCT00622635|19483900|P3|NOT COMPLETED|Treatment Period 3||0
7916824|NCT00622635|19483901|P2|NOT COMPLETED|Treatment Period 3||0
7916825|NCT00622635|19483902|P1|NOT COMPLETED|Treatment Period 3||0
7916826|NCT00622635|19483897|P6|COMPLETED|Treatment Period 3||10
7916827|NCT00622635|19483898|P5|COMPLETED|Treatment Period 3||9
7916828|NCT00622635|19483899|P4|COMPLETED|Treatment Period 3||10
7916829|NCT00622635|19483900|P3|COMPLETED|Treatment Period 3||10
7916830|NCT00622635|19483901|P2|COMPLETED|Treatment Period 3||10
7916831|NCT00622635|19483902|P1|COMPLETED|Treatment Period 3||12
7916832|NCT00622635|19483897|P6|STARTED|Treatment Period 3||10
7916833|NCT00622635|19483898|P5|STARTED|Treatment Period 3||9
7916834|NCT00622635|19483899|P4|STARTED|Treatment Period 3||13
7916835|NCT00622635|19483900|P3|STARTED|Treatment Period 3||10
7916836|NCT00622635|19483901|P2|STARTED|Treatment Period 3||10
7916837|NCT00622635|19483902|P1|STARTED|Treatment Period 3||12
7916838|NCT00622635|19483897|P6|NOT COMPLETED|Treatment Period 2||0
7916839|NCT00622635|19483898|P5|NOT COMPLETED|Treatment Period 2||0
7916840|NCT00622635|19483899|P4|NOT COMPLETED|Treatment Period 2||0
7916841|NCT00622635|19483900|P3|NOT COMPLETED|Treatment Period 2||0
7916842|NCT00622635|19483901|P2|NOT COMPLETED|Treatment Period 2||0
7916843|NCT00622635|19483902|P1|NOT COMPLETED|Treatment Period 2||1
7916844|NCT00622635|19483897|P6|COMPLETED|Treatment Period 2||10
7916845|NCT00622635|19483898|P5|COMPLETED|Treatment Period 2||9
7916846|NCT00622635|19483899|P4|COMPLETED|Treatment Period 2||13
7916847|NCT00622635|19483900|P3|COMPLETED|Treatment Period 2||10
7916848|NCT00622635|19483901|P2|COMPLETED|Treatment Period 2||10
7916849|NCT00622635|19483902|P1|COMPLETED|Treatment Period 2||12
7916850|NCT00622635|19483897|P6|STARTED|Treatment Period 2||10
7916851|NCT00622635|19483898|P5|STARTED|Treatment Period 2||9
7916852|NCT00622635|19483899|P4|STARTED|Treatment Period 2||13
7916853|NCT00622635|19483900|P3|STARTED|Treatment Period 2||10
7916854|NCT00622635|19483901|P2|STARTED|Treatment Period 2||10
7916855|NCT00622635|19483902|P1|STARTED|Treatment Period 2||13
7916856|NCT00622635|19483897|P6|NOT COMPLETED|Treatment Period 1||0
7916857|NCT00622635|19483898|P5|NOT COMPLETED|Treatment Period 1||1
7916858|NCT00622635|19483899|P4|NOT COMPLETED|Treatment Period 1||0
7916859|NCT00622635|19483900|P3|NOT COMPLETED|Treatment Period 1||1
7916860|NCT00622635|19483901|P2|NOT COMPLETED|Treatment Period 1||1
7916861|NCT00622635|19483902|P1|NOT COMPLETED|Treatment Period 1||0
7916862|NCT00622635|19483897|P6|COMPLETED|Treatment Period 1||10
7916863|NCT00622635|19483898|P5|COMPLETED|Treatment Period 1||9
7916864|NCT00622635|19483899|P4|COMPLETED|Treatment Period 1||13
7916865|NCT00622635|19483900|P3|COMPLETED|Treatment Period 1||10
7916866|NCT00622635|19483901|P2|COMPLETED|Treatment Period 1||10
7916867|NCT00622635|19483902|P1|COMPLETED|Treatment Period 1||13
7916868|NCT00622635|19483897|P6|STARTED|Treatment Period 1||10
7916869|NCT00622635|19483898|P5|STARTED|Treatment Period 1||10
7916870|NCT00622635|19483899|P4|STARTED|Treatment Period 1||13
7916871|NCT00622635|19483900|P3|STARTED|Treatment Period 1||11
7916872|NCT00622635|19483901|P2|STARTED|Treatment Period 1||11
7916873|NCT00622635|19483902|P1|STARTED|Treatment Period 1||13
7916874|NCT00622544|19483967|P1|NOT COMPLETED|Overall Study||9
7916875|NCT00622544|19483967|P1|COMPLETED|Overall Study|35|35
7916876|NCT00622544|19483967|P1|STARTED|Overall Study||44
7916877|NCT00622518|19483974|P2|NOT COMPLETED|Overall Study||0
7916878|NCT00622518|19483975|P1|NOT COMPLETED|Overall Study||0
7916879|NCT00622518|19483974|P2|COMPLETED|Overall Study||60
7916880|NCT00622518|19483975|P1|COMPLETED|Overall Study||59
7916881|NCT00622518|19483974|P2|STARTED|Overall Study||60
7916882|NCT00622518|19483975|P1|STARTED|Overall Study||59
7916883|NCT00622466|19483983|P1|NOT COMPLETED|Overall Study||4
7916884|NCT00622466|19483983|P1|COMPLETED|Overall Study||16
7916885|NCT00622466|19483983|P1|STARTED|Overall Study||20
7916886|NCT00622440|19483996|P2|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1
7916887|NCT00622440|19483997|P1|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0
7916888|NCT00622440|19483996|P2|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27
7916889|NCT00622440|19483997|P1|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28
7916890|NCT00622440|19483996|P2|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
7916891|NCT00622440|19483997|P1|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
7916892|NCT00622440|19483996|P2|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6
7916893|NCT00622440|19483997|P1|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3
7916894|NCT00622440|19483996|P2|COMPLETED|Week 12 - Week 48 (Treatment)||28
7916895|NCT00622440|19483997|P1|COMPLETED|Week 12 - Week 48 (Treatment)||28
7916896|NCT00622440|19483996|P2|STARTED|Week 12 - Week 48 (Treatment)||34
7916897|NCT00622440|19483997|P1|STARTED|Week 12 - Week 48 (Treatment)||31
7916898|NCT00622440|19483996|P2|NOT COMPLETED|Baseline - Week 12 (Treatment)||1
7916899|NCT00622440|19483997|P1|NOT COMPLETED|Baseline - Week 12 (Treatment)||4
7916900|NCT00622440|19483996|P2|COMPLETED|Baseline - Week 12 (Treatment)||34
7916901|NCT00622440|19483997|P1|COMPLETED|Baseline - Week 12 (Treatment)||31
7916902|NCT00622440|19483996|P2|STARTED|Baseline - Week 12 (Treatment)||35
7916903|NCT00622440|19483997|P1|STARTED|Baseline - Week 12 (Treatment)||35
7916904|NCT00622427|19484011|P2|NOT COMPLETED|Overall Study||0
7916905|NCT00622427|19484012|P1|NOT COMPLETED|Overall Study||0
7916906|NCT00622427|19484011|P2|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16
7916907|NCT00622427|19484012|P1|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16
7916908|NCT00622427|19484011|P2|STARTED|Overall Study||16
7916909|NCT00622427|19484012|P1|STARTED|Overall Study||16
7916910|NCT00622401|19484023|P3|NOT COMPLETED|Overall Study||0
7916911|NCT00622401|19484024|P2|NOT COMPLETED|Overall Study||2
7916912|NCT00622401|19484025|P1|NOT COMPLETED|Overall Study||3
7916913|NCT00622401|19484023|P3|COMPLETED|Overall Study||0
7916914|NCT00622401|19484024|P2|COMPLETED|Overall Study||0
7916915|NCT00622401|19484025|P1|COMPLETED|Overall Study||3
7916916|NCT00622401|19484023|P3|STARTED|Overall Study|Never Opened|0
7916917|NCT00622401|19484024|P2|STARTED|Overall Study||2
7916918|NCT00622401|19484025|P1|STARTED|Overall Study||6
7916919|NCT00622388|19484032|P1|NOT COMPLETED|Overall Study||72
7916920|NCT00622388|19484032|P1|COMPLETED|Overall Study||9
7916921|NCT00622388|19484032|P1|STARTED|Overall Study||81
7916922|NCT00622336|19484050|P1|NOT COMPLETED|Extension Phase||21
7916923|NCT00622336|19484050|P1|COMPLETED|Extension Phase||0
7916924|NCT00622336|19484050|P1|STARTED|Extension Phase||21
7916925|NCT00622336|19484050|P1|NOT COMPLETED|Treatment Phase||309
7916926|NCT00622336|19484050|P1|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21
7916927|NCT00622336|19484050|P1|Safety Population|Treatment Phase||330
7916928|NCT00622336|19484050|P1|STARTED|Treatment Phase||330
7916929|NCT00622284|19484061|P2|NOT COMPLETED|Overall Study||171
7916930|NCT00622284|19484062|P1|NOT COMPLETED|Overall Study||189
7916931|NCT00622284|19484061|P2|COMPLETED|Overall Study|Number who completed treatment.|604
7916932|NCT00622284|19484062|P1|COMPLETED|Overall Study|Number who completed treatment.|587
7916933|NCT00622284|19484061|P2|STARTED|Overall Study|Number who started treatment.|775
7916934|NCT00622284|19484062|P1|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776
7916935|NCT00622180|19484124|P2|NOT COMPLETED|Overall Study||2
7916936|NCT00622180|19484125|P1|NOT COMPLETED|Overall Study||1
7916937|NCT00622180|19484124|P2|COMPLETED|Overall Study||5
7916938|NCT00622180|19484125|P1|COMPLETED|Overall Study||5
7916939|NCT00622180|19484124|P2|STARTED|Overall Study||7
7916940|NCT00622180|19484125|P1|STARTED|Overall Study||6
7916941|NCT00622167|19484131|P1|NOT COMPLETED|Overall Study||20
7916942|NCT00622167|19484131|P1|COMPLETED|Overall Study||4
7916943|NCT00622167|19484131|P1|STARTED|Overall Study||24
7916944|NCT00621985|19484135|P1|NOT COMPLETED|Dexamethasone Admission||1
7916945|NCT00621985|19484135|P1|COMPLETED|Dexamethasone Admission||4
7916946|NCT00621985|19484135|P1|STARTED|Dexamethasone Admission||5
7916947|NCT00621985|19484135|P1|NOT COMPLETED|Hydrocortisone Admission||0
7916948|NCT00621985|19484135|P1|COMPLETED|Hydrocortisone Admission||5
7916949|NCT00621985|19484135|P1|STARTED|Hydrocortisone Admission||5
7916950|NCT00621959|19484143|P2|NOT COMPLETED|Overall Study||9
7916951|NCT00621959|19484144|P1|NOT COMPLETED|Overall Study||7
7916952|NCT00621959|19484143|P2|COMPLETED|Overall Study||292
7916953|NCT00621959|19484144|P1|COMPLETED|Overall Study||288
7916954|NCT00621959|19484143|P2|STARTED|Overall Study||301
7916955|NCT00621959|19484144|P1|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295
7916956|NCT00621946|19484154|P2|NOT COMPLETED|Overall Study||1
7916957|NCT00621946|19484155|P1|NOT COMPLETED|Overall Study||0
7916958|NCT00621946|19484154|P2|COMPLETED|Overall Study||12
7916959|NCT00621946|19484155|P1|COMPLETED|Overall Study||13
7916960|NCT00621946|19484154|P2|STARTED|Overall Study||13
7916961|NCT00621946|19484155|P1|STARTED|Overall Study||13
7916962|NCT00621933|19484171|P1|NOT COMPLETED|Overall Study||0
7916963|NCT00621933|19484171|P1|COMPLETED|Overall Study||399
7916964|NCT00621933|19484171|P1|STARTED|Overall Study||399
7916965|NCT00621855|19484183|P5|NOT COMPLETED|Overall Study||55
7916966|NCT00621855|19484184|P4|NOT COMPLETED|Overall Study||67
7916967|NCT00621855|19484185|P3|NOT COMPLETED|Overall Study||81
7916968|NCT00621855|19484186|P2|NOT COMPLETED|Overall Study||61
7916969|NCT00621855|19484187|P1|NOT COMPLETED|Overall Study||76
7916970|NCT00621855|19484183|P5|COMPLETED|Overall Study|Completed means completed treatment|318
7916971|NCT00621855|19484184|P4|COMPLETED|Overall Study|Completed means completed treatment|284
7916972|NCT00621855|19484185|P3|COMPLETED|Overall Study|Completed means completed treatment|330
7916973|NCT00621855|19484186|P2|COMPLETED|Overall Study|Completed means completed treatment|310
7916974|NCT00621855|19484187|P1|COMPLETED|Overall Study|Completed means completed treatment|296
7916975|NCT00621855|19484183|P5|STARTED|Overall Study|Started means randomised to treatment|373
7916976|NCT00621855|19484184|P4|STARTED|Overall Study|Started means randomised to treatment|351
7916977|NCT00621855|19484185|P3|STARTED|Overall Study|Started means randomised to treatment|411
7916978|NCT00621855|19484186|P2|STARTED|Overall Study|Started means randomised to treatment|371
7916979|NCT00621855|19484187|P1|STARTED|Overall Study|Started means randomised to treatment|372
7916980|NCT00621842|19484229|P1|NOT COMPLETED|Overall Study||19
7916981|NCT00621842|19484229|P1|COMPLETED|Overall Study||38
7916982|NCT00621842|19484229|P1|STARTED|Overall Study||57
7916983|NCT00621777|19484246|P2|NOT COMPLETED|Randomized Phase||19
7916984|NCT00621777|19484247|P1|NOT COMPLETED|Randomized Phase||7
7916985|NCT00621777|19484246|P2|COMPLETED|Randomized Phase||28
7916986|NCT00621777|19484247|P1|COMPLETED|Randomized Phase||33
7916987|NCT00621777|19484246|P2|STARTED|Randomized Phase||47
7916988|NCT00621777|19484247|P1|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40
7916989|NCT00621777|19484246|P2|NOT COMPLETED|Open Phase||0
7916990|NCT00621777|19484247|P1|NOT COMPLETED|Open Phase||116
7916991|NCT00621777|19484246|P2|COMPLETED|Open Phase||0
7916992|NCT00621777|19484247|P1|COMPLETED|Open Phase||87
7916993|NCT00621777|19484246|P2|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0
7916994|NCT00621777|19484247|P1|STARTED|Open Phase||203
7916995|NCT00621764|19484262|P4|NOT COMPLETED|Overall Study||1
7916996|NCT00621764|19484263|P3|NOT COMPLETED|Overall Study||0
7916997|NCT00621764|19484264|P2|NOT COMPLETED|Overall Study||0
7916998|NCT00621764|19484265|P1|NOT COMPLETED|Overall Study||0
7916999|NCT00621764|19484262|P4|COMPLETED|Overall Study||98
7917000|NCT00621764|19484263|P3|COMPLETED|Overall Study||101
7917001|NCT00621764|19484264|P2|COMPLETED|Overall Study||50
7917002|NCT00621764|19484265|P1|COMPLETED|Overall Study||50
7917003|NCT00621764|19484262|P4|STARTED|Overall Study||99
7917004|NCT00621764|19484263|P3|STARTED|Overall Study||101
7917005|NCT00621764|19484264|P2|STARTED|Overall Study||50
7917006|NCT00621764|19484265|P1|STARTED|Overall Study||50
7917007|NCT00621686|19484297|P2|NOT COMPLETED|Overall Study||0
7917008|NCT00621686|19484298|P1|NOT COMPLETED|Overall Study||0
7917009|NCT00621686|19484297|P2|COMPLETED|Overall Study||35
7917010|NCT00621686|19484298|P1|COMPLETED|Overall Study||19
7917011|NCT00621686|19484297|P2|STARTED|Overall Study||35
7917012|NCT00621686|19484298|P1|STARTED|Overall Study||19
7917013|NCT00621621|19484311|P2|NOT COMPLETED|Overall Study||0
7917014|NCT00621621|19484312|P1|NOT COMPLETED|Overall Study||30
7917015|NCT00621621|19484311|P2|COMPLETED|Overall Study||705
7917016|NCT00621621|19484312|P1|COMPLETED|Overall Study|Treated with the experimental catheter|75
7917017|NCT00621621|19484311|P2|STARTED|Overall Study||705
7917018|NCT00621621|19484312|P1|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105
7917019|NCT00621582|19484320|P1|NOT COMPLETED|Overall Study||106
7917020|NCT00621582|19484320|P1|COMPLETED|Overall Study||4812
7917021|NCT00621582|19484320|P1|STARTED|Overall Study||4918
7917022|NCT00621543|19484327|P1|NOT COMPLETED|Overall Study||23
7917023|NCT00621543|19484327|P1|COMPLETED|Overall Study||97
7917024|NCT00621543|19484327|P1|STARTED|Overall Study||120
7917025|NCT00621530|19484334|P2|NOT COMPLETED|Overall Study||3
7917026|NCT00621530|19484335|P1|NOT COMPLETED|Overall Study||2
7917027|NCT00621530|19484334|P2|COMPLETED|Overall Study||29
7917028|NCT00621530|19484335|P1|COMPLETED|Overall Study||28
7917029|NCT00621530|19484334|P2|STARTED|Overall Study||32
7917030|NCT00621530|19484335|P1|STARTED|Overall Study||30
7917031|NCT00621517|19484351|P2|NOT COMPLETED|Overall Study||7
7917032|NCT00621517|19484352|P1|NOT COMPLETED|Overall Study||7
7917033|NCT00621517|19484351|P2|COMPLETED|Overall Study||24
7917034|NCT00621517|19484352|P1|COMPLETED|Overall Study||22
7917035|NCT00621517|19484351|P2|STARTED|Overall Study||31
7917036|NCT00621517|19484352|P1|STARTED|Overall Study||29
7917037|NCT00621504|19484364|P2|NOT COMPLETED|Overall Study||25
7917038|NCT00621504|19484365|P1|NOT COMPLETED|Overall Study||26
7917039|NCT00621504|19484364|P2|COMPLETED|Overall Study||282
7917040|NCT00621504|19484365|P1|COMPLETED|Overall Study||273
7917041|NCT00621504|19484364|P2|STARTED|Overall Study||307
7917042|NCT00621504|19484365|P1|STARTED|Overall Study||299
7917043|NCT00621348|19484374|P3|NOT COMPLETED|Overall Study||0
7917044|NCT00621348|19484375|P2|NOT COMPLETED|Overall Study||0
7917045|NCT00621348|19484376|P1|NOT COMPLETED|Overall Study||0
7917046|NCT00621348|19484374|P3|COMPLETED|Overall Study||56
7917047|NCT00621348|19484375|P2|COMPLETED|Overall Study||53
7917048|NCT00621348|19484376|P1|COMPLETED|Overall Study||58
7917049|NCT00621348|19484374|P3|STARTED|Overall Study||56
7917050|NCT00621348|19484375|P2|STARTED|Overall Study||53
7917051|NCT00621348|19484376|P1|STARTED|Overall Study||58
7917052|NCT00621322|19484399|P6|NOT COMPLETED|Overall Study||4
7917053|NCT00621322|19484400|P5|NOT COMPLETED|Overall Study||1
7917054|NCT00621322|19484401|P4|NOT COMPLETED|Overall Study||3
7917055|NCT00621322|19484402|P3|NOT COMPLETED|Overall Study||2
7917056|NCT00621322|19484403|P2|NOT COMPLETED|Overall Study||0
7917057|NCT00621322|19484404|P1|NOT COMPLETED|Overall Study||1
7917058|NCT00621322|19484399|P6|COMPLETED|Overall Study||36
7917059|NCT00621322|19484400|P5|COMPLETED|Overall Study||39
7917060|NCT00621322|19484401|P4|COMPLETED|Overall Study||37
7917061|NCT00621322|19484402|P3|COMPLETED|Overall Study||38
7917062|NCT00621322|19484403|P2|COMPLETED|Overall Study||10
7917063|NCT00621322|19484404|P1|COMPLETED|Overall Study||9
7917064|NCT00621322|19484399|P6|STARTED|Overall Study||40
7917065|NCT00621322|19484400|P5|STARTED|Overall Study||40
7917066|NCT00621322|19484401|P4|STARTED|Overall Study||40
7917067|NCT00621322|19484402|P3|STARTED|Overall Study||40
7917068|NCT00621322|19484403|P2|STARTED|Overall Study||10
7917069|NCT00621322|19484404|P1|STARTED|Overall Study||10
7917070|NCT00621309|19484484|P6|NOT COMPLETED|Overall Study||1
7917071|NCT00621309|19484485|P5|NOT COMPLETED|Overall Study||1
7917072|NCT00621309|19484486|P4|NOT COMPLETED|Overall Study||1
7917073|NCT00621309|19484487|P3|NOT COMPLETED|Overall Study||1
7917074|NCT00621309|19484488|P2|NOT COMPLETED|Overall Study||0
7917075|NCT00621309|19484489|P1|NOT COMPLETED|Overall Study||2
7917076|NCT00621309|19484484|P6|COMPLETED|Overall Study||3
7917077|NCT00621309|19484485|P5|COMPLETED|Overall Study||3
7917078|NCT00621309|19484486|P4|COMPLETED|Overall Study||5
7917079|NCT00621309|19484487|P3|COMPLETED|Overall Study||4
7917080|NCT00621309|19484488|P2|COMPLETED|Overall Study||4
7917081|NCT00621309|19484489|P1|COMPLETED|Overall Study||4
7917082|NCT00621309|19484484|P6|STARTED|Overall Study||4
7917083|NCT00621309|19484485|P5|STARTED|Overall Study||4
7917084|NCT00621309|19484486|P4|STARTED|Overall Study||6
7917085|NCT00621309|19484487|P3|STARTED|Overall Study||5
7917086|NCT00621309|19484488|P2|STARTED|Overall Study||4
7917087|NCT00621309|19484489|P1|STARTED|Overall Study||6
7917088|NCT00621296|19484495|P1|NOT COMPLETED|Overall Study||14
7917089|NCT00621296|19484495|P1|COMPLETED|Overall Study||1
7917090|NCT00621296|19484495|P1|STARTED|Overall Study||15
7917091|NCT00621257|19484504|P5|NOT COMPLETED|Overall Study||9
7917092|NCT00621257|19484505|P4|NOT COMPLETED|Overall Study||6
7917093|NCT00621257|19484506|P3|NOT COMPLETED|Overall Study||3
7917094|NCT00621257|19484507|P2|NOT COMPLETED|Overall Study||3
7917095|NCT00621257|19484508|P1|NOT COMPLETED|Overall Study||4
7917096|NCT00621257|19484504|P5|COMPLETED|Overall Study||22
7917097|NCT00621257|19484505|P4|COMPLETED|Overall Study||26
7917098|NCT00621257|19484506|P3|COMPLETED|Overall Study||20
7917099|NCT00621257|19484507|P2|COMPLETED|Overall Study||21
7917100|NCT00621257|19484508|P1|COMPLETED|Overall Study||20
7917101|NCT00621257|19484504|P5|STARTED|Overall Study||31
7917102|NCT00621257|19484505|P4|STARTED|Overall Study||32
7917103|NCT00621257|19484506|P3|STARTED|Overall Study||23
7917104|NCT00621257|19484507|P2|STARTED|Overall Study||24
7917105|NCT00621257|19484508|P1|STARTED|Overall Study||24
7917106|NCT00621244|19484524|P4|NOT COMPLETED|Overall Study||23
7917107|NCT00621244|19484525|P3|NOT COMPLETED|Overall Study||33
7917108|NCT00621244|19484526|P2|NOT COMPLETED|Overall Study||34
7917109|NCT00621244|19484527|P1|NOT COMPLETED|Overall Study||86
7917110|NCT00621244|19484524|P4|COMPLETED|Overall Study||0
7917111|NCT00621244|19484525|P3|COMPLETED|Overall Study||0
7917112|NCT00621244|19484526|P2|COMPLETED|Overall Study||0
7917113|NCT00621244|19484527|P1|COMPLETED|Overall Study||0
7917114|NCT00621244|19484524|P4|STARTED|Overall Study||23
7917115|NCT00621244|19484525|P3|STARTED|Overall Study||33
7917116|NCT00621244|19484526|P2|STARTED|Overall Study||34
7917117|NCT00621244|19484527|P1|STARTED|Overall Study||86
7917118|NCT00621192|19484631|P4|NOT COMPLETED|Overall Study||3
7917119|NCT00621192|19484632|P3|NOT COMPLETED|Overall Study||5
7917120|NCT00621192|19484633|P2|NOT COMPLETED|Overall Study||9
7917121|NCT00621192|19484634|P1|NOT COMPLETED|Overall Study||4
7917122|NCT00621192|19484631|P4|COMPLETED|Overall Study||24
7917123|NCT00621192|19484632|P3|COMPLETED|Overall Study||26
7917124|NCT00621192|19484633|P2|COMPLETED|Overall Study||94
7917125|NCT00621192|19484634|P1|COMPLETED|Overall Study||35
7917126|NCT00621192|19484631|P4|Efficacy Population|Overall Study||27
7917127|NCT00621192|19484632|P3|Efficacy Population|Overall Study||28
7917128|NCT00621192|19484633|P2|Efficacy Population|Overall Study||101
7917129|NCT00621192|19484634|P1|Efficacy Population|Overall Study||39
7917130|NCT00621192|19484631|P4|Safety Population|Overall Study||27
7917131|NCT00621192|19484632|P3|Safety Population|Overall Study||31
7917132|NCT00621192|19484633|P2|Safety Population|Overall Study||103
7917133|NCT00621192|19484634|P1|Safety Population|Overall Study||39
7917134|NCT00621192|19484631|P4|STARTED|Overall Study||27
7917135|NCT00621192|19484632|P3|STARTED|Overall Study||31
7917136|NCT00621192|19484633|P2|STARTED|Overall Study||103
7917137|NCT00621192|19484634|P1|STARTED|Overall Study||39
7917138|NCT00621179|19484660|P4|NOT COMPLETED|Overall Study||1
7917139|NCT00621179|19484661|P3|NOT COMPLETED|Overall Study||1
7917140|NCT00621179|19484662|P2|NOT COMPLETED|Overall Study||0
7917141|NCT00621179|19484663|P1|NOT COMPLETED|Overall Study||0
7917142|NCT00621179|19484660|P4|COMPLETED|Overall Study||9
7917143|NCT00621179|19484661|P3|COMPLETED|Overall Study||6
7917144|NCT00621179|19484662|P2|COMPLETED|Overall Study||8
7917145|NCT00621179|19484663|P1|COMPLETED|Overall Study||12
7917146|NCT00621179|19484660|P4|STARTED|Overall Study||10
7917147|NCT00621179|19484661|P3|STARTED|Overall Study||7
7917148|NCT00621179|19484662|P2|STARTED|Overall Study||8
7917149|NCT00621179|19484663|P1|STARTED|Overall Study||12
7917150|NCT00621153|19484675|P2|NOT COMPLETED|Overall Study||15
7917151|NCT00621153|19484676|P1|NOT COMPLETED|Overall Study||20
7917152|NCT00621153|19484675|P2|COMPLETED|Overall Study|completed|101
7917153|NCT00621153|19484676|P1|COMPLETED|Overall Study|completed|97
7917154|NCT00621153|19484675|P2|Discontinued|Overall Study||15
7917155|NCT00621153|19484676|P1|Discontinued|Overall Study||20
7917156|NCT00621153|19484675|P2|STARTED|Overall Study|randomised|116
7917157|NCT00621153|19484676|P1|STARTED|Overall Study|randomised|117
7917158|NCT00621140|19484684|P2|NOT COMPLETED|Overall Study||18
7917159|NCT00621140|19484685|P1|NOT COMPLETED|Overall Study||15
7917160|NCT00621140|19484684|P2|COMPLETED|Overall Study|number who completed treatment|318
7917161|NCT00621140|19484685|P1|COMPLETED|Overall Study|number who completed treatment|152
7917162|NCT00621140|19484684|P2|STARTED|Overall Study|number who started treatment|336
7917163|NCT00621140|19484685|P1|STARTED|Overall Study|number who started treatment|167
7917164|NCT00621049|19484719|P2|NOT COMPLETED|Maintenance Treatment||0
7917165|NCT00621049|19484720|P1|NOT COMPLETED|Maintenance Treatment||15
7917166|NCT00621049|19484719|P2|COMPLETED|Maintenance Treatment||0
7917167|NCT00621049|19484720|P1|COMPLETED|Maintenance Treatment||34
7917168|NCT00621049|19484719|P2|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0
7917169|NCT00621049|19484720|P1|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49
7917170|NCT00621049|19484719|P2|NOT COMPLETED|Adjuvant Treatment||10
7917171|NCT00621049|19484720|P1|NOT COMPLETED|Adjuvant Treatment||3
7917172|NCT00621049|19484719|P2|COMPLETED|Adjuvant Treatment||47
7917173|NCT00621049|19484720|P1|COMPLETED|Adjuvant Treatment||52
7917174|NCT00621049|19484719|P2|STARTED|Adjuvant Treatment||57
7917175|NCT00621049|19484720|P1|STARTED|Adjuvant Treatment||55
7917176|NCT00621023|19484732|P1|NOT COMPLETED|Overall Study||6
7917177|NCT00621023|19484732|P1|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0
7917178|NCT00621023|19484732|P1|STARTED|Overall Study||6
7917179|NCT00620945|19484738|P1|NOT COMPLETED|Overall Study||0
7917180|NCT00620945|19484738|P1|COMPLETED|Overall Study||87
7917181|NCT00620945|19484738|P1|STARTED|Overall Study|Total number in the study|87
7917182|NCT00620854|19484749|P6|NOT COMPLETED|Period 3||0
7917183|NCT00620854|19484750|P5|NOT COMPLETED|Period 3||0
7917184|NCT00620854|19484751|P4|NOT COMPLETED|Period 3||0
7917185|NCT00620854|19484752|P3|NOT COMPLETED|Period 3||0
7917186|NCT00620854|19484753|P2|NOT COMPLETED|Period 3||0
7917187|NCT00620854|19484754|P1|NOT COMPLETED|Period 3||0
7917188|NCT00620854|19484749|P6|COMPLETED|Period 3||4
7917189|NCT00620854|19484750|P5|COMPLETED|Period 3||4
7917190|NCT00620854|19484751|P4|COMPLETED|Period 3||3
7917191|NCT00620854|19484752|P3|COMPLETED|Period 3||3
7917192|NCT00620854|19484753|P2|COMPLETED|Period 3||4
7917193|NCT00620854|19484754|P1|COMPLETED|Period 3||4
7917194|NCT00620854|19484749|P6|STARTED|Period 3||4
7917195|NCT00620854|19484750|P5|STARTED|Period 3||4
7917196|NCT00620854|19484751|P4|STARTED|Period 3||3
7917197|NCT00620854|19484752|P3|STARTED|Period 3||3
7917198|NCT00620854|19484753|P2|STARTED|Period 3||4
7917199|NCT00620854|19484754|P1|STARTED|Period 3||4
7917200|NCT00620854|19484749|P6|NOT COMPLETED|Washout 2||0
7917201|NCT00620854|19484750|P5|NOT COMPLETED|Washout 2||0
7917202|NCT00620854|19484751|P4|NOT COMPLETED|Washout 2||0
7917203|NCT00620854|19484752|P3|NOT COMPLETED|Washout 2||0
7917204|NCT00620854|19484753|P2|NOT COMPLETED|Washout 2||0
7917205|NCT00620854|19484754|P1|NOT COMPLETED|Washout 2||0
7917206|NCT00620854|19484749|P6|COMPLETED|Washout 2||4
7917207|NCT00620854|19484750|P5|COMPLETED|Washout 2||4
7917208|NCT00620854|19484751|P4|COMPLETED|Washout 2||3
7917209|NCT00620854|19484752|P3|COMPLETED|Washout 2||3
7917210|NCT00620854|19484753|P2|COMPLETED|Washout 2||4
7917211|NCT00620854|19484754|P1|COMPLETED|Washout 2||4
7917212|NCT00620854|19484749|P6|STARTED|Washout 2||4
7917213|NCT00620854|19484750|P5|STARTED|Washout 2||4
7917214|NCT00620854|19484751|P4|STARTED|Washout 2||3
7917215|NCT00620854|19484752|P3|STARTED|Washout 2||3
7917216|NCT00620854|19484753|P2|STARTED|Washout 2||4
7917217|NCT00620854|19484754|P1|STARTED|Washout 2||4
7917218|NCT00620854|19484749|P6|NOT COMPLETED|Period 2||0
7917219|NCT00620854|19484750|P5|NOT COMPLETED|Period 2||0
7917220|NCT00620854|19484751|P4|NOT COMPLETED|Period 2||0
7917221|NCT00620854|19484752|P3|NOT COMPLETED|Period 2||0
7917222|NCT00620854|19484753|P2|NOT COMPLETED|Period 2||0
7917223|NCT00620854|19484754|P1|NOT COMPLETED|Period 2||0
7917224|NCT00620854|19484749|P6|COMPLETED|Period 2||4
7917225|NCT00620854|19484750|P5|COMPLETED|Period 2||4
7917226|NCT00620854|19484751|P4|COMPLETED|Period 2||3
7917227|NCT00620854|19484752|P3|COMPLETED|Period 2||3
7917228|NCT00620854|19484753|P2|COMPLETED|Period 2||4
7917229|NCT00620854|19484754|P1|COMPLETED|Period 2||4
7917230|NCT00620854|19484749|P6|STARTED|Period 2||4
7917231|NCT00620854|19484750|P5|STARTED|Period 2||4
7917232|NCT00620854|19484751|P4|STARTED|Period 2||3
7917233|NCT00620854|19484752|P3|STARTED|Period 2||3
7917234|NCT00620854|19484753|P2|STARTED|Period 2||4
7917235|NCT00620854|19484754|P1|STARTED|Period 2||4
7917236|NCT00620854|19484749|P6|NOT COMPLETED|Washout 1||0
7917237|NCT00620854|19484750|P5|NOT COMPLETED|Washout 1||0
7917238|NCT00620854|19484751|P4|NOT COMPLETED|Washout 1||1
7917239|NCT00620854|19484752|P3|NOT COMPLETED|Washout 1||1
7917240|NCT00620854|19484753|P2|NOT COMPLETED|Washout 1||0
7917241|NCT00620854|19484754|P1|NOT COMPLETED|Washout 1||0
7917242|NCT00620854|19484749|P6|COMPLETED|Washout 1||4
7917243|NCT00620854|19484750|P5|COMPLETED|Washout 1||4
7917244|NCT00620854|19484751|P4|COMPLETED|Washout 1||3
7917245|NCT00620854|19484752|P3|COMPLETED|Washout 1||3
7917246|NCT00620854|19484753|P2|COMPLETED|Washout 1||4
7917247|NCT00620854|19484754|P1|COMPLETED|Washout 1||4
7917248|NCT00620854|19484749|P6|STARTED|Washout 1||4
7917249|NCT00620854|19484750|P5|STARTED|Washout 1||4
7917250|NCT00620854|19484751|P4|STARTED|Washout 1||4
7917251|NCT00620854|19484752|P3|STARTED|Washout 1||4
7917252|NCT00620854|19484753|P2|STARTED|Washout 1||4
7917253|NCT00620854|19484754|P1|STARTED|Washout 1||4
7917254|NCT00620854|19484749|P6|NOT COMPLETED|Period 1||0
7917255|NCT00620854|19484750|P5|NOT COMPLETED|Period 1||0
7917256|NCT00620854|19484751|P4|NOT COMPLETED|Period 1||0
7917257|NCT00620854|19484752|P3|NOT COMPLETED|Period 1||0
7917258|NCT00620854|19484753|P2|NOT COMPLETED|Period 1||0
7917259|NCT00620854|19484754|P1|NOT COMPLETED|Period 1||0
7917260|NCT00620854|19484749|P6|COMPLETED|Period 1||4
7917261|NCT00620854|19484750|P5|COMPLETED|Period 1||4
7917262|NCT00620854|19484751|P4|COMPLETED|Period 1||4
7917263|NCT00620854|19484752|P3|COMPLETED|Period 1||4
7917264|NCT00620854|19484753|P2|COMPLETED|Period 1||4
7917265|NCT00620854|19484754|P1|COMPLETED|Period 1||4
7917266|NCT00620854|19484749|P6|STARTED|Period 1||4
7917267|NCT00620854|19484750|P5|STARTED|Period 1||4
7917268|NCT00620854|19484751|P4|STARTED|Period 1||4
7917269|NCT00620854|19484752|P3|STARTED|Period 1||4
7917270|NCT00620854|19484753|P2|STARTED|Period 1||4
7917271|NCT00620854|19484754|P1|STARTED|Period 1||4
7917272|NCT00620828|19484767|P2|NOT COMPLETED|Overall Study||0
7917273|NCT00620828|19484768|P1|NOT COMPLETED|Overall Study||0
7917274|NCT00620828|19484767|P2|COMPLETED|Overall Study||35
7917275|NCT00620828|19484768|P1|COMPLETED|Overall Study||32
7917276|NCT00620828|19484767|P2|Number of Subjects Enrolled = 67|Overall Study||35
7917277|NCT00620828|19484768|P1|Number of Subjects Enrolled = 67|Overall Study||32
7917278|NCT00620828|19484767|P2|STARTED|Overall Study||35
7917279|NCT00620828|19484768|P1|STARTED|Overall Study||32
7917280|NCT00620815|19484785|P3|NOT COMPLETED|Overall Study||7
7917281|NCT00620815|19484786|P2|NOT COMPLETED|Overall Study||11
7917282|NCT00620815|19484787|P1|NOT COMPLETED|Overall Study||4
7917283|NCT00620815|19484785|P3|COMPLETED|Overall Study||192
7917284|NCT00620815|19484786|P2|COMPLETED|Overall Study||192
7917285|NCT00620815|19484787|P1|COMPLETED|Overall Study||195
7917286|NCT00620815|19484785|P3|STARTED|Overall Study||199
7917287|NCT00620815|19484786|P2|STARTED|Overall Study||203
7917288|NCT00620815|19484787|P1|STARTED|Overall Study||199
7917289|NCT00620776|19484827|P2|NOT COMPLETED|Overall Study||16
7917290|NCT00620776|19484828|P1|NOT COMPLETED|Overall Study||12
7917291|NCT00620776|19484827|P2|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24
7917292|NCT00620776|19484828|P1|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17
7917293|NCT00620776|19484827|P2|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35
7917294|NCT00620776|19484828|P1|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26
7917295|NCT00620776|19484827|P2|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40
7917296|NCT00620776|19484828|P1|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29
7917297|NCT00620763|19484856|P2|NOT COMPLETED|Period: Second Intervention||0
7917298|NCT00620763|19484857|P1|NOT COMPLETED|Period: Second Intervention||1
7917299|NCT00620763|19484856|P2|COMPLETED|Period: Second Intervention||7
7917300|NCT00620763|19484857|P1|COMPLETED|Period: Second Intervention||9
7917301|NCT00620763|19484856|P2|STARTED|Period: Second Intervention||7
7917302|NCT00620763|19484857|P1|STARTED|Period: Second Intervention||10
7917303|NCT00620763|19484856|P2|NOT COMPLETED|Period: Washout Period of 1 Week||0
7917304|NCT00620763|19484857|P1|NOT COMPLETED|Period: Washout Period of 1 Week||0
7917305|NCT00620763|19484856|P2|COMPLETED|Period: Washout Period of 1 Week||7
7917306|NCT00620763|19484857|P1|COMPLETED|Period: Washout Period of 1 Week||10
7917307|NCT00620763|19484856|P2|STARTED|Period: Washout Period of 1 Week||7
7917308|NCT00620763|19484857|P1|STARTED|Period: Washout Period of 1 Week||10
7917309|NCT00620763|19484856|P2|NOT COMPLETED|Period: First Intervention||5
7917310|NCT00620763|19484857|P1|NOT COMPLETED|Period: First Intervention||0
7917311|NCT00620763|19484856|P2|COMPLETED|Period: First Intervention||7
7917312|NCT00620763|19484857|P1|COMPLETED|Period: First Intervention||10
7917313|NCT00620763|19484856|P2|STARTED|Period: First Intervention||12
7917314|NCT00620763|19484857|P1|STARTED|Period: First Intervention||10
7917315|NCT00620750|19484863|P1|NOT COMPLETED|Overall Study||25
7917316|NCT00620750|19484863|P1|COMPLETED|Overall Study||40
7917317|NCT00620750|19484863|P1|STARTED|Overall Study||65
7917318|NCT00620711|19484867|P1|NOT COMPLETED|Overall Study||0
7917319|NCT00620711|19484867|P1|COMPLETED|Overall Study||4
7917320|NCT00620711|19484867|P1|STARTED|Overall Study||4
7917321|NCT00620698|19484872|P1|NOT COMPLETED|Overall Study||29
7917322|NCT00620698|19484872|P1|COMPLETED|Overall Study||60
7917323|NCT00620698|19484872|P1|STARTED|Overall Study||89
7917324|NCT00620659|19484878|P6|NOT COMPLETED|Treatment Period 3||0
7917325|NCT00620659|19484879|P5|NOT COMPLETED|Treatment Period 3||0
7917326|NCT00620659|19484880|P4|NOT COMPLETED|Treatment Period 3||1
7917327|NCT00620659|19484881|P3|NOT COMPLETED|Treatment Period 3||0
7917328|NCT00620659|19484882|P2|NOT COMPLETED|Treatment Period 3||2
7917329|NCT00620659|19484883|P1|NOT COMPLETED|Treatment Period 3||0
7917330|NCT00620659|19484878|P6|COMPLETED|Treatment Period 3||20
7917331|NCT00620659|19484879|P5|COMPLETED|Treatment Period 3||15
7917332|NCT00620659|19484880|P4|COMPLETED|Treatment Period 3||17
7917333|NCT00620659|19484881|P3|COMPLETED|Treatment Period 3||19
7917334|NCT00620659|19484882|P2|COMPLETED|Treatment Period 3||16
7917335|NCT00620659|19484883|P1|COMPLETED|Treatment Period 3||16
7917336|NCT00620659|19484878|P6|STARTED|Treatment Period 3||20
7917337|NCT00620659|19484879|P5|STARTED|Treatment Period 3||15
7917338|NCT00620659|19484880|P4|STARTED|Treatment Period 3||18
7917339|NCT00620659|19484881|P3|STARTED|Treatment Period 3||19
7917340|NCT00620659|19484882|P2|STARTED|Treatment Period 3||18
7917341|NCT00620659|19484883|P1|STARTED|Treatment Period 3||16
7917342|NCT00620659|19484878|P6|NOT COMPLETED|Placebo Washout Period 2||0
7917343|NCT00620659|19484879|P5|NOT COMPLETED|Placebo Washout Period 2||0
7917344|NCT00620659|19484880|P4|NOT COMPLETED|Placebo Washout Period 2||0
7917345|NCT00620659|19484881|P3|NOT COMPLETED|Placebo Washout Period 2||0
7917346|NCT00620659|19484882|P2|NOT COMPLETED|Placebo Washout Period 2||0
7917347|NCT00620659|19484883|P1|NOT COMPLETED|Placebo Washout Period 2||2
7917348|NCT00620659|19484878|P6|COMPLETED|Placebo Washout Period 2||20
7917349|NCT00620659|19484879|P5|COMPLETED|Placebo Washout Period 2||15
7917350|NCT00620659|19484880|P4|COMPLETED|Placebo Washout Period 2||18
7917351|NCT00620659|19484881|P3|COMPLETED|Placebo Washout Period 2||19
7917352|NCT00620659|19484882|P2|COMPLETED|Placebo Washout Period 2||18
7917353|NCT00620659|19484883|P1|COMPLETED|Placebo Washout Period 2||16
7917354|NCT00620659|19484878|P6|STARTED|Placebo Washout Period 2||20
7917355|NCT00620659|19484879|P5|STARTED|Placebo Washout Period 2||15
7917356|NCT00620659|19484880|P4|STARTED|Placebo Washout Period 2||18
7917357|NCT00620659|19484881|P3|STARTED|Placebo Washout Period 2||19
7917358|NCT00620659|19484882|P2|STARTED|Placebo Washout Period 2||18
7917359|NCT00620659|19484883|P1|STARTED|Placebo Washout Period 2||18
7917360|NCT00620659|19484878|P6|NOT COMPLETED|Treatment Period 2||0
7917361|NCT00620659|19484879|P5|NOT COMPLETED|Treatment Period 2||5
7917362|NCT00620659|19484880|P4|NOT COMPLETED|Treatment Period 2||0
7917363|NCT00620659|19484881|P3|NOT COMPLETED|Treatment Period 2||1
7917364|NCT00620659|19484882|P2|NOT COMPLETED|Treatment Period 2||3
7917365|NCT00620659|19484883|P1|NOT COMPLETED|Treatment Period 2||0
7917366|NCT00620659|19484878|P6|COMPLETED|Treatment Period 2||20
7917367|NCT00620659|19484879|P5|COMPLETED|Treatment Period 2||15
7917368|NCT00620659|19484880|P4|COMPLETED|Treatment Period 2||18
7917369|NCT00620659|19484881|P3|COMPLETED|Treatment Period 2||19
7917370|NCT00620659|19484882|P2|COMPLETED|Treatment Period 2||18
7917371|NCT00620659|19484883|P1|COMPLETED|Treatment Period 2||18
7917372|NCT00620659|19484878|P6|STARTED|Treatment Period 2||20
7917373|NCT00620659|19484879|P5|STARTED|Treatment Period 2||20
7917374|NCT00620659|19484880|P4|STARTED|Treatment Period 2||18
7917375|NCT00620659|19484881|P3|STARTED|Treatment Period 2||20
7917376|NCT00620659|19484882|P2|STARTED|Treatment Period 2||21
7917377|NCT00620659|19484883|P1|STARTED|Treatment Period 2||18
7917378|NCT00620659|19484878|P6|NOT COMPLETED|Placebo Washout Period 1||0
7917379|NCT00620659|19484879|P5|NOT COMPLETED|Placebo Washout Period 1||0
7917380|NCT00620659|19484880|P4|NOT COMPLETED|Placebo Washout Period 1||1
7917381|NCT00620659|19484881|P3|NOT COMPLETED|Placebo Washout Period 1||0
7917382|NCT00620659|19484882|P2|NOT COMPLETED|Placebo Washout Period 1||0
7917383|NCT00620659|19484883|P1|NOT COMPLETED|Placebo Washout Period 1||0
7917384|NCT00620659|19484878|P6|COMPLETED|Placebo Washout Period 1||20
7917385|NCT00620659|19484879|P5|COMPLETED|Placebo Washout Period 1||20
7917386|NCT00620659|19484880|P4|COMPLETED|Placebo Washout Period 1||18
7917387|NCT00620659|19484881|P3|COMPLETED|Placebo Washout Period 1||20
7917388|NCT00620659|19484882|P2|COMPLETED|Placebo Washout Period 1||21
7917389|NCT00620659|19484883|P1|COMPLETED|Placebo Washout Period 1||18
7917390|NCT00620659|19484878|P6|STARTED|Placebo Washout Period 1||20
7917391|NCT00620659|19484879|P5|STARTED|Placebo Washout Period 1||20
7917392|NCT00620659|19484880|P4|STARTED|Placebo Washout Period 1||19
7917393|NCT00620659|19484881|P3|STARTED|Placebo Washout Period 1||20
7917394|NCT00620659|19484882|P2|STARTED|Placebo Washout Period 1||21
7917395|NCT00620659|19484883|P1|STARTED|Placebo Washout Period 1||18
7917396|NCT00620659|19484878|P6|NOT COMPLETED|Treatment Period 1||0
7917397|NCT00620659|19484879|P5|NOT COMPLETED|Treatment Period 1||1
7917398|NCT00620659|19484880|P4|NOT COMPLETED|Treatment Period 1||3
7917399|NCT00620659|19484881|P3|NOT COMPLETED|Treatment Period 1||1
7917400|NCT00620659|19484882|P2|NOT COMPLETED|Treatment Period 1||0
7917401|NCT00620659|19484883|P1|NOT COMPLETED|Treatment Period 1||3
7917402|NCT00620659|19484878|P6|COMPLETED|Treatment Period 1||20
7917403|NCT00620659|19484879|P5|COMPLETED|Treatment Period 1||20
7917404|NCT00620659|19484880|P4|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18
7917405|NCT00620659|19484881|P3|COMPLETED|Treatment Period 1||20
7917406|NCT00620659|19484882|P2|COMPLETED|Treatment Period 1||21
7917407|NCT00620659|19484883|P1|COMPLETED|Treatment Period 1||18
7917408|NCT00620659|19484878|P6|STARTED|Treatment Period 1||20
7917409|NCT00620659|19484879|P5|STARTED|Treatment Period 1||21
7917410|NCT00620659|19484880|P4|STARTED|Treatment Period 1||21
7917411|NCT00620659|19484881|P3|STARTED|Treatment Period 1||21
7917412|NCT00620659|19484882|P2|STARTED|Treatment Period 1||21
7917413|NCT00620659|19484883|P1|STARTED|Treatment Period 1||21
7917414|NCT00620555|19484901|P1|NOT COMPLETED|Overall Study||21
7917415|NCT00620555|19484901|P1|COMPLETED|Overall Study||44
7917416|NCT00620555|19484901|P1|STARTED|Overall Study||65
7917417|NCT00620542|19484910|P4|NOT COMPLETED|Part B (2 Year Core Study)||144
7917418|NCT00620542|19484911|P3|NOT COMPLETED|Part B (2 Year Core Study)||148
7917419|NCT00620542|19484912|P2|NOT COMPLETED|Part B (2 Year Core Study)||0
7917420|NCT00620542|19484913|P1|NOT COMPLETED|Part B (2 Year Core Study)||0
7917421|NCT00620542|19484910|P4|COMPLETED|Part B (2 Year Core Study)||547
7917422|NCT00620542|19484911|P3|COMPLETED|Part B (2 Year Core Study)||546
7917423|NCT00620542|19484912|P2|COMPLETED|Part B (2 Year Core Study)||0
7917424|NCT00620542|19484913|P1|COMPLETED|Part B (2 Year Core Study)||0
7917425|NCT00620542|19484910|P4|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519
7917426|NCT00620542|19484911|P3|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520
7917427|NCT00620542|19484912|P2|Intent-to-treat Population|Part B (2 Year Core Study)||0
7917428|NCT00620542|19484913|P1|Intent-to-treat Population|Part B (2 Year Core Study)||0
7917429|NCT00620542|19484910|P4|Received Treatment|Part B (2 Year Core Study)||689
7917430|NCT00620542|19484911|P3|Received Treatment|Part B (2 Year Core Study)||691
7917431|NCT00620542|19484912|P2|Received Treatment|Part B (2 Year Core Study)||0
7917432|NCT00620542|19484913|P1|Received Treatment|Part B (2 Year Core Study)||0
7917433|NCT00620542|19484910|P4|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691
7917434|NCT00620542|19484911|P3|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694
7917435|NCT00620542|19484912|P2|STARTED|Part B (2 Year Core Study)||0
7917436|NCT00620542|19484913|P1|STARTED|Part B (2 Year Core Study)||0
7917437|NCT00620542|19484910|P4|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
7917438|NCT00620542|19484911|P3|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
7917439|NCT00620542|19484912|P2|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476
7917440|NCT00620542|19484913|P1|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472
7917441|NCT00620542|19484910|P4|COMPLETED|Part A (Run-in - 2 Weeks)||0
7917442|NCT00620542|19484911|P3|COMPLETED|Part A (Run-in - 2 Weeks)||0
7917443|NCT00620542|19484912|P2|COMPLETED|Part A (Run-in - 2 Weeks)||690
7917444|NCT00620542|19484913|P1|COMPLETED|Part A (Run-in - 2 Weeks)||695
7917445|NCT00620542|19484910|P4|Received Treatment|Part A (Run-in - 2 Weeks)||0
7917446|NCT00620542|19484911|P3|Received Treatment|Part A (Run-in - 2 Weeks)||0
7917447|NCT00620542|19484912|P2|Received Treatment|Part A (Run-in - 2 Weeks)||795
7917448|NCT00620542|19484913|P1|Received Treatment|Part A (Run-in - 2 Weeks)||783
7917449|NCT00620542|19484910|P4|STARTED|Part A (Run-in - 2 Weeks)||0
7917450|NCT00620542|19484911|P3|STARTED|Part A (Run-in - 2 Weeks)||0
7917451|NCT00620542|19484912|P2|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166
7917452|NCT00620542|19484913|P1|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167
7917453|NCT00620503|19484951|P6|NOT COMPLETED|Follow-up (up to 14 Days)||0
7917454|NCT00620503|19484952|P5|NOT COMPLETED|Follow-up (up to 14 Days)||0
7917455|NCT00620503|19484953|P4|NOT COMPLETED|Follow-up (up to 14 Days)||0
7917456|NCT00620503|19484954|P3|NOT COMPLETED|Follow-up (up to 14 Days)||0
7917457|NCT00620503|19484955|P2|NOT COMPLETED|Follow-up (up to 14 Days)||0
7917458|NCT00620503|19484956|P1|NOT COMPLETED|Follow-up (up to 14 Days)||0
7917459|NCT00620503|19484951|P6|COMPLETED|Follow-up (up to 14 Days)||2
7917460|NCT00620503|19484952|P5|COMPLETED|Follow-up (up to 14 Days)||2
7917461|NCT00620503|19484953|P4|COMPLETED|Follow-up (up to 14 Days)||2
7917462|NCT00620503|19484954|P3|COMPLETED|Follow-up (up to 14 Days)||2
7917463|NCT00620503|19484955|P2|COMPLETED|Follow-up (up to 14 Days)||2
7917464|NCT00620503|19484956|P1|COMPLETED|Follow-up (up to 14 Days)||2
7917465|NCT00620503|19484951|P6|STARTED|Follow-up (up to 14 Days)||2
7917466|NCT00620503|19484952|P5|STARTED|Follow-up (up to 14 Days)||2
7917467|NCT00620503|19484953|P4|STARTED|Follow-up (up to 14 Days)||2
7917468|NCT00620503|19484954|P3|STARTED|Follow-up (up to 14 Days)||2
7917469|NCT00620503|19484955|P2|STARTED|Follow-up (up to 14 Days)||2
7917470|NCT00620503|19484956|P1|STARTED|Follow-up (up to 14 Days)||2
7917471|NCT00620503|19484951|P6|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
7917472|NCT00620503|19484952|P5|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
7917473|NCT00620503|19484953|P4|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
7917474|NCT00620503|19484954|P3|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
7917475|NCT00620503|19484955|P2|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
7917476|NCT00620503|19484956|P1|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
7917477|NCT00620503|19484951|P6|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
7917478|NCT00620503|19484952|P5|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
7917479|NCT00620503|19484953|P4|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
7917480|NCT00620503|19484954|P3|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
7917481|NCT00620503|19484955|P2|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
7917482|NCT00620503|19484956|P1|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
7917483|NCT00620503|19484951|P6|STARTED|Treatment Period 3 (TP3) (7 Days)||2
7917484|NCT00620503|19484952|P5|STARTED|Treatment Period 3 (TP3) (7 Days)||2
7917485|NCT00620503|19484953|P4|STARTED|Treatment Period 3 (TP3) (7 Days)||2
7917486|NCT00620503|19484954|P3|STARTED|Treatment Period 3 (TP3) (7 Days)||2
7917487|NCT00620503|19484955|P2|STARTED|Treatment Period 3 (TP3) (7 Days)||2
7917488|NCT00620503|19484956|P1|STARTED|Treatment Period 3 (TP3) (7 Days)||2
7917489|NCT00620503|19484951|P6|NOT COMPLETED|Washout (at Least 1 Day)||0
7917490|NCT00620503|19484952|P5|NOT COMPLETED|Washout (at Least 1 Day)||0
7917491|NCT00620503|19484953|P4|NOT COMPLETED|Washout (at Least 1 Day)||0
7917492|NCT00620503|19484954|P3|NOT COMPLETED|Washout (at Least 1 Day)||0
7917493|NCT00620503|19484955|P2|NOT COMPLETED|Washout (at Least 1 Day)||0
7917494|NCT00620503|19484956|P1|NOT COMPLETED|Washout (at Least 1 Day)||0
7917495|NCT00620503|19484951|P6|COMPLETED|Washout (at Least 1 Day)||2
7917496|NCT00620503|19484952|P5|COMPLETED|Washout (at Least 1 Day)||2
7917497|NCT00620503|19484953|P4|COMPLETED|Washout (at Least 1 Day)||2
7917498|NCT00620503|19484954|P3|COMPLETED|Washout (at Least 1 Day)||2
7917499|NCT00620503|19484955|P2|COMPLETED|Washout (at Least 1 Day)||2
7917500|NCT00620503|19484956|P1|COMPLETED|Washout (at Least 1 Day)||2
7917501|NCT00620503|19484951|P6|STARTED|Washout (at Least 1 Day)||2
7917502|NCT00620503|19484952|P5|STARTED|Washout (at Least 1 Day)||2
7917503|NCT00620503|19484953|P4|STARTED|Washout (at Least 1 Day)||2
7917504|NCT00620503|19484954|P3|STARTED|Washout (at Least 1 Day)||2
7917505|NCT00620503|19484955|P2|STARTED|Washout (at Least 1 Day)||2
7917506|NCT00620503|19484956|P1|STARTED|Washout (at Least 1 Day)||2
7917507|NCT00620503|19484951|P6|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
7917508|NCT00620503|19484952|P5|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
7917509|NCT00620503|19484953|P4|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
7917510|NCT00620503|19484954|P3|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
7917511|NCT00620503|19484955|P2|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
7917512|NCT00620503|19484956|P1|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
7917513|NCT00620503|19484951|P6|COMPLETED|Treatment Period 2 (TP2) (7days)||2
7917514|NCT00620503|19484952|P5|COMPLETED|Treatment Period 2 (TP2) (7days)||2
7917515|NCT00620503|19484953|P4|COMPLETED|Treatment Period 2 (TP2) (7days)||2
7917516|NCT00620503|19484954|P3|COMPLETED|Treatment Period 2 (TP2) (7days)||2
7917517|NCT00620503|19484955|P2|COMPLETED|Treatment Period 2 (TP2) (7days)||2
7917518|NCT00620503|19484956|P1|COMPLETED|Treatment Period 2 (TP2) (7days)||2
7917519|NCT00620503|19484951|P6|STARTED|Treatment Period 2 (TP2) (7days)||2
7917520|NCT00620503|19484952|P5|STARTED|Treatment Period 2 (TP2) (7days)||2
7917521|NCT00620503|19484953|P4|STARTED|Treatment Period 2 (TP2) (7days)||2
7917522|NCT00620503|19484954|P3|STARTED|Treatment Period 2 (TP2) (7days)||2
7917523|NCT00620503|19484955|P2|STARTED|Treatment Period 2 (TP2) (7days)||2
7917524|NCT00620503|19484956|P1|STARTED|Treatment Period 2 (TP2) (7days)||2
7917525|NCT00620503|19484951|P6|NOT COMPLETED|Washout (at Least 1 Day)||0
7917526|NCT00620503|19484952|P5|NOT COMPLETED|Washout (at Least 1 Day)||0
7917527|NCT00620503|19484953|P4|NOT COMPLETED|Washout (at Least 1 Day)||0
7917528|NCT00620503|19484954|P3|NOT COMPLETED|Washout (at Least 1 Day)||0
7917529|NCT00620503|19484955|P2|NOT COMPLETED|Washout (at Least 1 Day)||0
7917530|NCT00620503|19484956|P1|NOT COMPLETED|Washout (at Least 1 Day)||0
7917531|NCT00620503|19484951|P6|COMPLETED|Washout (at Least 1 Day)||2
7917532|NCT00620503|19484952|P5|COMPLETED|Washout (at Least 1 Day)||2
7917533|NCT00620503|19484953|P4|COMPLETED|Washout (at Least 1 Day)||2
7917534|NCT00620503|19484954|P3|COMPLETED|Washout (at Least 1 Day)||2
7917535|NCT00620503|19484955|P2|COMPLETED|Washout (at Least 1 Day)||2
7917536|NCT00620503|19484956|P1|COMPLETED|Washout (at Least 1 Day)||2
7917537|NCT00620503|19484951|P6|STARTED|Washout (at Least 1 Day)||2
7917538|NCT00620503|19484952|P5|STARTED|Washout (at Least 1 Day)||2
7917539|NCT00620503|19484953|P4|STARTED|Washout (at Least 1 Day)||2
7917540|NCT00620503|19484954|P3|STARTED|Washout (at Least 1 Day)||2
7917541|NCT00620503|19484955|P2|STARTED|Washout (at Least 1 Day)||2
7917542|NCT00620503|19484956|P1|STARTED|Washout (at Least 1 Day)||2
7917543|NCT00620503|19484951|P6|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
7917544|NCT00620503|19484952|P5|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
7917545|NCT00620503|19484953|P4|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
7917546|NCT00620503|19484954|P3|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
7917547|NCT00620503|19484955|P2|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
7917548|NCT00620503|19484956|P1|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
7917549|NCT00620503|19484951|P6|COMPLETED|Treatment Period 1 (TP1) (7days)||2
7917550|NCT00620503|19484952|P5|COMPLETED|Treatment Period 1 (TP1) (7days)||2
7917551|NCT00620503|19484953|P4|COMPLETED|Treatment Period 1 (TP1) (7days)||2
7917552|NCT00620503|19484954|P3|COMPLETED|Treatment Period 1 (TP1) (7days)||2
7917553|NCT00620503|19484955|P2|COMPLETED|Treatment Period 1 (TP1) (7days)||2
7917554|NCT00620503|19484956|P1|COMPLETED|Treatment Period 1 (TP1) (7days)||2
7917555|NCT00620503|19484951|P6|STARTED|Treatment Period 1 (TP1) (7days)||2
7917556|NCT00620503|19484952|P5|STARTED|Treatment Period 1 (TP1) (7days)||2
7917557|NCT00620503|19484953|P4|STARTED|Treatment Period 1 (TP1) (7days)||2
7917558|NCT00620503|19484954|P3|STARTED|Treatment Period 1 (TP1) (7days)||2
7917559|NCT00620503|19484955|P2|STARTED|Treatment Period 1 (TP1) (7days)||2
7917560|NCT00620503|19484956|P1|STARTED|Treatment Period 1 (TP1) (7days)||2
7917561|NCT00620503|19484951|P6|NOT COMPLETED|Screening (up to 21 Days)||0
7917562|NCT00620503|19484952|P5|NOT COMPLETED|Screening (up to 21 Days)||0
7917563|NCT00620503|19484953|P4|NOT COMPLETED|Screening (up to 21 Days)||0
7917564|NCT00620503|19484954|P3|NOT COMPLETED|Screening (up to 21 Days)||0
7917565|NCT00620503|19484955|P2|NOT COMPLETED|Screening (up to 21 Days)||0
7917566|NCT00620503|19484956|P1|NOT COMPLETED|Screening (up to 21 Days)||0
7917567|NCT00620503|19484951|P6|COMPLETED|Screening (up to 21 Days)||2
7917568|NCT00620503|19484952|P5|COMPLETED|Screening (up to 21 Days)||2
7917569|NCT00620503|19484953|P4|COMPLETED|Screening (up to 21 Days)||2
7917570|NCT00620503|19484954|P3|COMPLETED|Screening (up to 21 Days)||2
7917571|NCT00620503|19484955|P2|COMPLETED|Screening (up to 21 Days)||2
7917572|NCT00620503|19484956|P1|COMPLETED|Screening (up to 21 Days)||2
7917573|NCT00620503|19484951|P6|STARTED|Screening (up to 21 Days)||2
7917574|NCT00620503|19484952|P5|STARTED|Screening (up to 21 Days)||2
7917575|NCT00620503|19484953|P4|STARTED|Screening (up to 21 Days)||2
7917576|NCT00620503|19484954|P3|STARTED|Screening (up to 21 Days)||2
7917577|NCT00620503|19484955|P2|STARTED|Screening (up to 21 Days)||2
7917578|NCT00620503|19484956|P1|STARTED|Screening (up to 21 Days)||2
7917579|NCT00620464|19484978|P2|NOT COMPLETED|Overall Study||24
7917580|NCT00620464|19484979|P1|NOT COMPLETED|Overall Study||20
7917581|NCT00620464|19484978|P2|COMPLETED|Overall Study||32
7917582|NCT00620464|19484979|P1|COMPLETED|Overall Study||32
7917583|NCT00620464|19484978|P2|STARTED|Overall Study||56
7917584|NCT00620464|19484979|P1|STARTED|Overall Study||52
7917585|NCT00620425|19484987|P1|NOT COMPLETED|Overall Study||0
7917586|NCT00620425|19484987|P1|COMPLETED|Overall Study||18
7917587|NCT00620425|19484987|P1|STARTED|Overall Study||18
7917588|NCT00620373|19484998|P1|NOT COMPLETED|Overall Study||33
7917589|NCT00620373|19484998|P1|COMPLETED|Overall Study||936
7917590|NCT00620373|19484998|P1|STARTED|Overall Study||969
7917591|NCT00620321|19485016|P2|NOT COMPLETED|Overall Study||16
7917592|NCT00620321|19485017|P1|NOT COMPLETED|Overall Study||8
7917593|NCT00620321|19485016|P2|COMPLETED|Overall Study||0
7917594|NCT00620321|19485017|P1|COMPLETED|Overall Study||0
7917595|NCT00620321|19485016|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
7917596|NCT00620321|19485017|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
7917597|NCT00620321|19485016|P2|STARTED|Overall Study||16
7917598|NCT00620321|19485017|P1|STARTED|Overall Study||8
7917599|NCT00620282|19485036|P3|NOT COMPLETED|Overall Study||1
7917600|NCT00620282|19485037|P2|NOT COMPLETED|Overall Study||2
7917601|NCT00620282|19485038|P1|NOT COMPLETED|Overall Study||0
7917602|NCT00620282|19485036|P3|COMPLETED|Overall Study||16
7917603|NCT00620282|19485037|P2|COMPLETED|Overall Study||14
7917604|NCT00620282|19485038|P1|COMPLETED|Overall Study||16
7917605|NCT00620282|19485036|P3|STARTED|Overall Study||17
7917606|NCT00620282|19485037|P2|STARTED|Overall Study||16
7917607|NCT00620282|19485038|P1|STARTED|Overall Study||16
7917608|NCT00620191|19485087|P2|NOT COMPLETED|Overall Study||8
7917609|NCT00620191|19485088|P1|NOT COMPLETED|Overall Study||7
7917610|NCT00620191|19485087|P2|COMPLETED|Overall Study|12 month follow-up|32
7917611|NCT00620191|19485088|P1|COMPLETED|Overall Study|12 month follow-up|33
7917612|NCT00620191|19485087|P2|9 Month Follow-up|Overall Study||34
7917613|NCT00620191|19485088|P1|9 Month Follow-up|Overall Study||37
7917614|NCT00620191|19485087|P2|6 Month Follow-up|Overall Study||36
7917615|NCT00620191|19485088|P1|6 Month Follow-up|Overall Study||38
7917616|NCT00620191|19485087|P2|3 Month Follow-up|Overall Study||39
7917617|NCT00620191|19485088|P1|3 Month Follow-up|Overall Study||39
7917618|NCT00620191|19485087|P2|STARTED|Overall Study||40
7917619|NCT00620191|19485088|P1|STARTED|Overall Study||40
7917620|NCT00620126|19485102|P2|NOT COMPLETED|Overall Study||5
7917621|NCT00620126|19485103|P1|NOT COMPLETED|Overall Study||11
7917622|NCT00620126|19485102|P2|COMPLETED|Overall Study||17
7917623|NCT00620126|19485103|P1|COMPLETED|Overall Study||14
7917624|NCT00620126|19485102|P2|STARTED|Overall Study||22
7917625|NCT00620126|19485103|P1|STARTED|Overall Study||25
7917626|NCT00620113|19485117|P4|NOT COMPLETED|Overall Study||10
7917627|NCT00620113|19485118|P3|NOT COMPLETED|Overall Study||5
7917628|NCT00620113|19485119|P2|NOT COMPLETED|Overall Study||7
7917629|NCT00620113|19485120|P1|NOT COMPLETED|Overall Study||13
7917630|NCT00620113|19485117|P4|COMPLETED|Overall Study||59
7917631|NCT00620113|19485118|P3|COMPLETED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|66
7917632|NCT00620113|19485119|P2|COMPLETED|Overall Study||67
7917633|NCT00620113|19485120|P1|COMPLETED|Overall Study||60
7917634|NCT00620113|19485117|P4|Efficacy/Safety Population|Overall Study||69
7917635|NCT00620113|19485118|P3|Efficacy/Safety Population|Overall Study||70
7917636|NCT00620113|19485119|P2|Efficacy/Safety Population|Overall Study||74
7917637|NCT00620113|19485120|P1|Efficacy/Safety Population|Overall Study||73
7917638|NCT00620113|19485117|P4|STARTED|Overall Study||69
7917639|NCT00620113|19485118|P3|STARTED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|71
7917640|NCT00620113|19485119|P2|STARTED|Overall Study||74
7917641|NCT00620113|19485120|P1|STARTED|Overall Study||73
7917642|NCT00620074|19485170|P1|NOT COMPLETED|Overall Study||1
7917643|NCT00620074|19485170|P1|COMPLETED|Overall Study||5
7917644|NCT00620074|19485170|P1|STARTED|Overall Study||6
7917645|NCT00620061|19485178|P1|NOT COMPLETED|Overall Study||153
7917646|NCT00620061|19485178|P1|COMPLETED|Overall Study||286
7917647|NCT00620061|19485178|P1|STARTED|Overall Study||439
7917648|NCT00620035|19485193|P1|NOT COMPLETED|Overall Study||145
7917649|NCT00620035|19485193|P1|COMPLETED|Overall Study||156
7917650|NCT00620035|19485193|P1|STARTED|Overall Study||301
7917651|NCT00620022|19485203|P2|NOT COMPLETED|Treatment Period 2||2
7917652|NCT00620022|19485204|P1|NOT COMPLETED|Treatment Period 2||2
7917653|NCT00620022|19485203|P2|COMPLETED|Treatment Period 2||35
7917654|NCT00620022|19485204|P1|COMPLETED|Treatment Period 2||39
7917655|NCT00620022|19485203|P2|STARTED|Treatment Period 2||37
7917656|NCT00620022|19485204|P1|STARTED|Treatment Period 2||41
7917657|NCT00620022|19485203|P2|NOT COMPLETED|Treatment Period 1||6
7917658|NCT00620022|19485204|P1|NOT COMPLETED|Treatment Period 1||5
7917659|NCT00620022|19485203|P2|COMPLETED|Treatment Period 1||37
7917660|NCT00620022|19485204|P1|COMPLETED|Treatment Period 1||41
7917661|NCT00620022|19485203|P2|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43
7917662|NCT00620022|19485204|P1|STARTED|Treatment Period 1||46
7917663|NCT00619983|19485216|P4|NOT COMPLETED|Gabapentin Alone||0
7917664|NCT00619983|19485217|P3|NOT COMPLETED|Gabapentin Alone||0
7917665|NCT00619983|19485218|P2|NOT COMPLETED|Gabapentin Alone||0
7917666|NCT00619983|19485219|P1|NOT COMPLETED|Gabapentin Alone||0
7917667|NCT00619983|19485216|P4|COMPLETED|Gabapentin Alone||3
7917668|NCT00619983|19485217|P3|COMPLETED|Gabapentin Alone||4
7917669|NCT00619983|19485218|P2|COMPLETED|Gabapentin Alone||4
7917670|NCT00619983|19485219|P1|COMPLETED|Gabapentin Alone||3
7917671|NCT00619983|19485216|P4|STARTED|Gabapentin Alone||3
7917672|NCT00619983|19485217|P3|STARTED|Gabapentin Alone||4
7917673|NCT00619983|19485218|P2|STARTED|Gabapentin Alone||4
7917674|NCT00619983|19485219|P1|STARTED|Gabapentin Alone||3
7917675|NCT00619983|19485216|P4|NOT COMPLETED|Test Drug Plus Gabapentin||0
7917676|NCT00619983|19485217|P3|NOT COMPLETED|Test Drug Plus Gabapentin||0
7917677|NCT00619983|19485218|P2|NOT COMPLETED|Test Drug Plus Gabapentin||0
7917678|NCT00619983|19485219|P1|NOT COMPLETED|Test Drug Plus Gabapentin||0
7917679|NCT00619983|19485216|P4|COMPLETED|Test Drug Plus Gabapentin||3
7917680|NCT00619983|19485217|P3|COMPLETED|Test Drug Plus Gabapentin||4
7917681|NCT00619983|19485218|P2|COMPLETED|Test Drug Plus Gabapentin||4
7917682|NCT00619983|19485219|P1|COMPLETED|Test Drug Plus Gabapentin||3
7917683|NCT00619983|19485216|P4|STARTED|Test Drug Plus Gabapentin||3
7917684|NCT00619983|19485217|P3|STARTED|Test Drug Plus Gabapentin||4
7917685|NCT00619983|19485218|P2|STARTED|Test Drug Plus Gabapentin||4
7917686|NCT00619983|19485219|P1|STARTED|Test Drug Plus Gabapentin||3
7917687|NCT00619983|19485216|P4|NOT COMPLETED|Test Drug Alone||3
7917688|NCT00619983|19485217|P3|NOT COMPLETED|Test Drug Alone||2
7917689|NCT00619983|19485218|P2|NOT COMPLETED|Test Drug Alone||1
7917690|NCT00619983|19485219|P1|NOT COMPLETED|Test Drug Alone||2
7917691|NCT00619983|19485216|P4|COMPLETED|Test Drug Alone||3
7917692|NCT00619983|19485217|P3|COMPLETED|Test Drug Alone||4
7917693|NCT00619983|19485218|P2|COMPLETED|Test Drug Alone||4
7917694|NCT00619983|19485219|P1|COMPLETED|Test Drug Alone||3
7917695|NCT00619983|19485216|P4|STARTED|Test Drug Alone||6
7917696|NCT00619983|19485217|P3|STARTED|Test Drug Alone||6
7917697|NCT00619983|19485218|P2|STARTED|Test Drug Alone||5
7917698|NCT00619983|19485219|P1|STARTED|Test Drug Alone||5
7917699|NCT00619970|19485232|P3|NOT COMPLETED|Overall Study||2
7917700|NCT00619970|19485233|P2|NOT COMPLETED|Overall Study||3
7917701|NCT00619970|19485234|P1|NOT COMPLETED|Overall Study||0
7917702|NCT00619970|19485232|P3|COMPLETED|Overall Study||24
7917703|NCT00619970|19485233|P2|COMPLETED|Overall Study||46
7917704|NCT00619970|19485234|P1|COMPLETED|Overall Study||40
7917705|NCT00619970|19485232|P3|STARTED|Overall Study||26
7917706|NCT00619970|19485233|P2|STARTED|Overall Study||49
7917707|NCT00619970|19485234|P1|STARTED|Overall Study||40
7917708|NCT00619957|19485246|P2|NOT COMPLETED|Month 48 Open-Label||17
7917709|NCT00619957|19485247|P1|NOT COMPLETED|Month 48 Open-Label||12
7917710|NCT00619957|19485246|P2|COMPLETED|Month 48 Open-Label||134
7917711|NCT00619957|19485247|P1|COMPLETED|Month 48 Open-Label||55
7917712|NCT00619957|19485246|P2|STARTED|Month 48 Open-Label||151
7917713|NCT00619957|19485247|P1|STARTED|Month 48 Open-Label||67
7917714|NCT00619957|19485246|P2|NOT COMPLETED|Month 24 Double-Blind||17
7917715|NCT00619957|19485247|P1|NOT COMPLETED|Month 24 Double-Blind||18
7917716|NCT00619957|19485246|P2|COMPLETED|Month 24 Double-Blind||175
7917717|NCT00619957|19485247|P1|COMPLETED|Month 24 Double-Blind||75
7917718|NCT00619957|19485246|P2|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191
7917719|NCT00619957|19485247|P1|Intent to Treat (ITT Population)|Month 24 Double-Blind||93
7917720|NCT00619957|19485246|P2|STARTED|Month 24 Double-Blind||192
7917721|NCT00619957|19485247|P1|STARTED|Month 24 Double-Blind||93
7917722|NCT00619918|19485329|P2|NOT COMPLETED|Overall Study||22
7917723|NCT00619918|19485330|P1|NOT COMPLETED|Overall Study||20
7917724|NCT00619918|19485329|P2|COMPLETED|Overall Study||195
7917725|NCT00619918|19485330|P1|COMPLETED|Overall Study||210
7917726|NCT00619918|19485329|P2|STARTED|Overall Study||217
7917727|NCT00619918|19485330|P1|STARTED|Overall Study||230
7917728|NCT00619892|19485340|P2|NOT COMPLETED|Overall Study||2
7917729|NCT00619892|19485341|P1|NOT COMPLETED|Overall Study||3
7917730|NCT00619892|19485340|P2|COMPLETED|Overall Study||11
7917731|NCT00619892|19485341|P1|COMPLETED|Overall Study||10
7917732|NCT00619892|19485340|P2|STARTED|Overall Study||13
7917733|NCT00619892|19485341|P1|STARTED|Overall Study||13
7917734|NCT00619866|19485352|P5|NOT COMPLETED|Weeks 13 - 24||2
7917735|NCT00619866|19485353|P4|NOT COMPLETED|Weeks 13 - 24||4
7917736|NCT00619866|19485354|P3|NOT COMPLETED|Weeks 13 - 24||5
7917737|NCT00619866|19485355|P2|NOT COMPLETED|Weeks 13 - 24||7
7917738|NCT00619866|19485356|P1|NOT COMPLETED|Weeks 13 - 24||0
7917739|NCT00619866|19485352|P5|COMPLETED|Weeks 13 - 24||18
7917740|NCT00619866|19485353|P4|COMPLETED|Weeks 13 - 24||14
7917741|NCT00619866|19485354|P3|COMPLETED|Weeks 13 - 24||37
7917742|NCT00619866|19485355|P2|COMPLETED|Weeks 13 - 24||38
7917743|NCT00619866|19485356|P1|COMPLETED|Weeks 13 - 24||0
7917744|NCT00619866|19485352|P5|STARTED|Weeks 13 - 24||20
7917745|NCT00619866|19485353|P4|STARTED|Weeks 13 - 24||18
7917746|NCT00619866|19485354|P3|STARTED|Weeks 13 - 24||42
7917747|NCT00619866|19485355|P2|STARTED|Weeks 13 - 24||45
7917748|NCT00619866|19485356|P1|STARTED|Weeks 13 - 24||0
7917749|NCT00619866|19485352|P5|NOT COMPLETED|Weeks 1 - 12||0
7917750|NCT00619866|19485353|P4|NOT COMPLETED|Weeks 1 - 12||0
7917751|NCT00619866|19485354|P3|NOT COMPLETED|Weeks 1 - 12||10
7917752|NCT00619866|19485355|P2|NOT COMPLETED|Weeks 1 - 12||6
7917753|NCT00619866|19485356|P1|NOT COMPLETED|Weeks 1 - 12||14
7917754|NCT00619866|19485352|P5|COMPLETED|Weeks 1 - 12||0
7917755|NCT00619866|19485353|P4|COMPLETED|Weeks 1 - 12||0
7917756|NCT00619866|19485354|P3|COMPLETED|Weeks 1 - 12||42
7917757|NCT00619866|19485355|P2|COMPLETED|Weeks 1 - 12||45
7917758|NCT00619866|19485356|P1|COMPLETED|Weeks 1 - 12||38
7917759|NCT00619866|19485352|P5|STARTED|Weeks 1 - 12||0
7917760|NCT00619866|19485353|P4|STARTED|Weeks 1 - 12||0
7917761|NCT00619866|19485354|P3|STARTED|Weeks 1 - 12||52
7917762|NCT00619866|19485355|P2|STARTED|Weeks 1 - 12||51
7917763|NCT00619866|19485356|P1|STARTED|Weeks 1 - 12||52
7917764|NCT00619827|19485443|P2|NOT COMPLETED|Overall Study||4
7917765|NCT00619827|19485444|P1|NOT COMPLETED|Overall Study||3
7917766|NCT00619827|19485443|P2|COMPLETED|Overall Study||40
7917767|NCT00619827|19485444|P1|COMPLETED|Overall Study||42
7917768|NCT00619827|19485443|P2|STARTED|Overall Study||44
7917769|NCT00619827|19485444|P1|STARTED|Overall Study||45
7917770|NCT00619801|19485452|P2|NOT COMPLETED|Overall Study||3
7917771|NCT00619801|19485453|P1|NOT COMPLETED|Overall Study||1
7917772|NCT00619801|19485452|P2|COMPLETED|Overall Study||111
7917773|NCT00619801|19485453|P1|COMPLETED|Overall Study||58
7917774|NCT00619801|19485452|P2|Safety Population|Overall Study||114
7917775|NCT00619801|19485453|P1|Safety Population|Overall Study||59
7917776|NCT00619801|19485452|P2|STARTED|Overall Study||114
7917777|NCT00619801|19485453|P1|STARTED|Overall Study||59
7917778|NCT00619762|19485483|P1|NOT COMPLETED|Overall Study||3
7917779|NCT00619762|19485483|P1|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14
7917780|NCT00619762|19485483|P1|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17
7917781|NCT00619723|19485490|P2|NOT COMPLETED|Overall Study||6
7917782|NCT00619723|19485491|P1|NOT COMPLETED|Overall Study||2
7917783|NCT00619723|19485490|P2|COMPLETED|Overall Study||61
7917784|NCT00619723|19485491|P1|COMPLETED|Overall Study||61
7917785|NCT00619723|19485490|P2|STARTED|Overall Study||67
7917786|NCT00619723|19485491|P1|STARTED|Overall Study||63
7917787|NCT00619684|19485501|P1|NOT COMPLETED|Overall Study||0
7917788|NCT00619684|19485501|P1|COMPLETED|Overall Study||18
7917789|NCT00619684|19485501|P1|STARTED|Overall Study||18
7917790|NCT00619645|19485510|P1|NOT COMPLETED|Overall Study||1
7917791|NCT00619645|19485510|P1|COMPLETED|Overall Study||7
7917792|NCT00619645|19485510|P1|STARTED|Overall Study||8
7917793|NCT00619619|19485524|P8|NOT COMPLETED|Overall Study||3
7917794|NCT00619619|19485525|P7|NOT COMPLETED|Overall Study||1
7917795|NCT00619619|19485526|P6|NOT COMPLETED|Overall Study||0
7917796|NCT00619619|19485527|P5|NOT COMPLETED|Overall Study||2
7917797|NCT00619619|19485528|P4|NOT COMPLETED|Overall Study||1
7917798|NCT00619619|19485529|P3|NOT COMPLETED|Overall Study||1
7917799|NCT00619619|19485530|P2|NOT COMPLETED|Overall Study||0
7917800|NCT00619619|19485531|P1|NOT COMPLETED|Overall Study||0
7917801|NCT00619619|19485524|P8|COMPLETED|Overall Study||5
7917802|NCT00619619|19485525|P7|COMPLETED|Overall Study||7
7917803|NCT00619619|19485526|P6|COMPLETED|Overall Study||7
7917804|NCT00619619|19485527|P5|COMPLETED|Overall Study||5
7917805|NCT00619619|19485528|P4|COMPLETED|Overall Study||6
7917806|NCT00619619|19485529|P3|COMPLETED|Overall Study||8
7917807|NCT00619619|19485530|P2|COMPLETED|Overall Study||7
7917808|NCT00619619|19485531|P1|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6
7917809|NCT00619619|19485524|P8|Entered the Extension Study|Overall Study||7
7917810|NCT00619619|19485525|P7|Entered the Extension Study|Overall Study||6
7917811|NCT00619619|19485526|P6|Entered the Extension Study|Overall Study||6
7917812|NCT00619619|19485527|P5|Entered the Extension Study|Overall Study||7
7917813|NCT00619619|19485528|P4|Entered the Extension Study|Overall Study||3
7917814|NCT00619619|19485529|P3|Entered the Extension Study|Overall Study||8
7917815|NCT00619619|19485530|P2|Entered the Extension Study|Overall Study||5
7917816|NCT00619619|19485531|P1|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6
7917817|NCT00619619|19485524|P8|STARTED|Overall Study||8
7917818|NCT00619619|19485525|P7|STARTED|Overall Study||8
7917819|NCT00619619|19485526|P6|STARTED|Overall Study||7
7917820|NCT00619619|19485527|P5|STARTED|Overall Study||7
7917821|NCT00619619|19485528|P4|STARTED|Overall Study||7
7917822|NCT00619619|19485529|P3|STARTED|Overall Study||9
7917823|NCT00619619|19485530|P2|STARTED|Overall Study||7
7917824|NCT00619619|19485531|P1|STARTED|Overall Study||6
7917825|NCT00619515|19485616|P1|NOT COMPLETED|Overall Study||73
7917826|NCT00619515|19485616|P1|COMPLETED|Overall Study||0
7917827|NCT00619515|19485616|P1|STARTED|Overall Study||73
7917828|NCT00619502|19485630|P2|NOT COMPLETED|Overall Study||10
7917829|NCT00619502|19485631|P1|NOT COMPLETED|Overall Study||8
7917830|NCT00619502|19485630|P2|COMPLETED|Overall Study||114
7917831|NCT00619502|19485631|P1|COMPLETED|Overall Study||122
7917832|NCT00619502|19485630|P2|STARTED|Overall Study||124
7917833|NCT00619502|19485631|P1|STARTED|Overall Study||130
7917834|NCT00619489|19485643|P2|NOT COMPLETED|Overall Study||34
7917835|NCT00619489|19485644|P1|NOT COMPLETED|Overall Study||23
7917836|NCT00619489|19485643|P2|COMPLETED|Overall Study||1
7917837|NCT00619489|19485644|P1|COMPLETED|Overall Study||14
7917838|NCT00619489|19485643|P2|STARTED|Overall Study||35
7917839|NCT00619489|19485644|P1|STARTED|Overall Study||37
7917840|NCT00619476|19485666|P4|NOT COMPLETED|Overall Study||34
7917841|NCT00619476|19485667|P3|NOT COMPLETED|Overall Study||24
7917842|NCT00619476|19485668|P2|NOT COMPLETED|Overall Study||22
7917843|NCT00619476|19485669|P1|NOT COMPLETED|Overall Study||31
7917844|NCT00619476|19485666|P4|COMPLETED|Overall Study||56
7917845|NCT00619476|19485667|P3|COMPLETED|Overall Study||60
7917846|NCT00619476|19485668|P2|COMPLETED|Overall Study||85
7917847|NCT00619476|19485669|P1|COMPLETED|Overall Study||64
7917848|NCT00619476|19485666|P4|Safety Population|Overall Study||87
7917849|NCT00619476|19485667|P3|Safety Population|Overall Study||82
7917850|NCT00619476|19485668|P2|Safety Population|Overall Study||107
7917851|NCT00619476|19485669|P1|Safety Population|Overall Study||95
7917852|NCT00619476|19485666|P4|Intent-to-Treat Population|Overall Study||87
7917853|NCT00619476|19485667|P3|Intent-to-Treat Population|Overall Study||82
7917854|NCT00619476|19485668|P2|Intent-to-Treat Population|Overall Study||107
7917855|NCT00619476|19485669|P1|Intent-to-Treat Population|Overall Study||95
7917856|NCT00619476|19485666|P4|STARTED|Overall Study||90
7917857|NCT00619476|19485667|P3|STARTED|Overall Study||84
7917858|NCT00619476|19485668|P2|STARTED|Overall Study||107
7917859|NCT00619476|19485669|P1|STARTED|Overall Study||95
7917860|NCT00619385|19485754|P3|NOT COMPLETED|Overall Study||4
7917861|NCT00619385|19485755|P2|NOT COMPLETED|Overall Study||2
7917862|NCT00619385|19485756|P1|NOT COMPLETED|Overall Study||1
7917863|NCT00619385|19485754|P3|COMPLETED|Overall Study||6
7917864|NCT00619385|19485755|P2|COMPLETED|Overall Study||6
7917865|NCT00619385|19485756|P1|COMPLETED|Overall Study||6
7917866|NCT00619385|19485754|P3|STARTED|Overall Study||10
7917867|NCT00619385|19485755|P2|STARTED|Overall Study||8
7917868|NCT00619385|19485756|P1|STARTED|Overall Study||7
7917869|NCT00619359|19485771|P2|NOT COMPLETED|Overall Study||81
7917870|NCT00619359|19485772|P1|NOT COMPLETED|Overall Study||67
7917871|NCT00619359|19485771|P2|COMPLETED|Overall Study||1094
7917872|NCT00619359|19485772|P1|COMPLETED|Overall Study||1080
7917873|NCT00619359|19485771|P2|STARTED|Overall Study||1175
7917874|NCT00619359|19485772|P1|STARTED|Overall Study||1147
7917875|NCT00619307|19485784|P2|NOT COMPLETED|Overall Study||4
7917876|NCT00619307|19485785|P1|NOT COMPLETED|Overall Study||4
7917877|NCT00619307|19485784|P2|COMPLETED|Overall Study||53
7917878|NCT00619307|19485785|P1|COMPLETED|Overall Study||56
7917879|NCT00619307|19485784|P2|STARTED|Overall Study||57
7917880|NCT00619307|19485785|P1|STARTED|Overall Study||60
7917881|NCT00619255|19485801|P2|NOT COMPLETED|Overall Study||0
7917882|NCT00619255|19485802|P1|NOT COMPLETED|Overall Study||2
7917883|NCT00619255|19485801|P2|COMPLETED|Overall Study||61
7917884|NCT00619255|19485802|P1|COMPLETED|Overall Study||57
7917885|NCT00619255|19485801|P2|STARTED|Overall Study||61
7917886|NCT00619255|19485802|P1|STARTED|Overall Study||59
7917887|NCT00619242|19485816|P1|NOT COMPLETED|Overall Study||0
7917888|NCT00619242|19485816|P1|COMPLETED|Overall Study||3
7917889|NCT00619242|19485816|P1|STARTED|Overall Study||3
7917890|NCT00619229|19485822|P2|NOT COMPLETED|Overall Study||2
7917891|NCT00619229|19485823|P1|NOT COMPLETED|Overall Study||4
7917892|NCT00619229|19485822|P2|COMPLETED|Overall Study||16
7917893|NCT00619229|19485823|P1|COMPLETED|Overall Study||14
7917894|NCT00619229|19485822|P2|Full Analysis Set (FAS)|Overall Study||17
7917895|NCT00619229|19485823|P1|Full Analysis Set (FAS)|Overall Study||16
7917896|NCT00619229|19485822|P2|STARTED|Overall Study||18
7917897|NCT00619229|19485823|P1|STARTED|Overall Study||18
7917898|NCT00619190|19485851|P2|NOT COMPLETED|Overall Study||0
7917899|NCT00619190|19485852|P1|NOT COMPLETED|Overall Study||1
7917900|NCT00619190|19485851|P2|COMPLETED|Overall Study||9
7917901|NCT00619190|19485852|P1|COMPLETED|Overall Study||20
7917902|NCT00619190|19485851|P2|STARTED|Overall Study||9
7917903|NCT00619190|19485852|P1|STARTED|Overall Study||21
7917904|NCT00619177|19485862|P1|NOT COMPLETED|Overall Study||508
7917905|NCT00619177|19485862|P1|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061
7917906|NCT00619177|19485862|P1|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569
7917907|NCT00619151|19485872|P2|NOT COMPLETED|Overall Study||0
7917908|NCT00619151|19485873|P1|NOT COMPLETED|Overall Study||1
7917909|NCT00619151|19485872|P2|COMPLETED|Overall Study||0
7917910|NCT00619151|19485873|P1|COMPLETED|Overall Study||1
7917911|NCT00619151|19485872|P2|STARTED|Overall Study||0
7917912|NCT00619151|19485873|P1|STARTED|Overall Study||2
7917913|NCT00619112|19485883|P2|NOT COMPLETED|Overall Study||2
7917914|NCT00619112|19485884|P1|NOT COMPLETED|Overall Study||1
7917915|NCT00619112|19485883|P2|COMPLETED|Overall Study|Data from patients who didn't complete study was still included in the final analysis.|18
7917916|NCT00619112|19485884|P1|COMPLETED|Overall Study|Data from patient who didn't complete study was still included in the final analysis.|39
7917917|NCT00619112|19485883|P2|STARTED|Overall Study||20
7917918|NCT00619112|19485884|P1|STARTED|Overall Study||40
7917919|NCT00619099|19485905|P2|NOT COMPLETED|Overall Study||19
7917920|NCT00619099|19485906|P1|NOT COMPLETED|Overall Study||33
7917921|NCT00619099|19485905|P2|COMPLETED|Overall Study||4
7917922|NCT00619099|19485906|P1|COMPLETED|Overall Study||11
7917923|NCT00619099|19485905|P2|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22
7917924|NCT00619099|19485906|P1|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43
7917925|NCT00619099|19485905|P2|STARTED|Overall Study|All randomized subjects|23
7917926|NCT00619099|19485906|P1|STARTED|Overall Study|All randomized subjects|44
7917927|NCT00619073|19485912|P2|NOT COMPLETED|Second Intervention - 60 Days||0
7917928|NCT00619073|19485913|P1|NOT COMPLETED|Second Intervention - 60 Days||0
7917929|NCT00619073|19485912|P2|COMPLETED|Second Intervention - 60 Days||8
7917930|NCT00619073|19485913|P1|COMPLETED|Second Intervention - 60 Days||8
7917931|NCT00619073|19485912|P2|STARTED|Second Intervention - 60 Days||8
7917932|NCT00619073|19485913|P1|STARTED|Second Intervention - 60 Days||8
7917933|NCT00619073|19485912|P2|NOT COMPLETED|Washout Period (30 Days)||0
7917934|NCT00619073|19485913|P1|NOT COMPLETED|Washout Period (30 Days)||0
7917935|NCT00619073|19485912|P2|COMPLETED|Washout Period (30 Days)||8
7917936|NCT00619073|19485913|P1|COMPLETED|Washout Period (30 Days)||8
7917937|NCT00619073|19485912|P2|STARTED|Washout Period (30 Days)||8
7917938|NCT00619073|19485913|P1|STARTED|Washout Period (30 Days)||8
7917939|NCT00619073|19485912|P2|NOT COMPLETED|First Intervention - 60 Days||0
7917940|NCT00619073|19485913|P1|NOT COMPLETED|First Intervention - 60 Days||0
7917941|NCT00619073|19485912|P2|COMPLETED|First Intervention - 60 Days||8
7917942|NCT00619073|19485913|P1|COMPLETED|First Intervention - 60 Days||8
7917943|NCT00619073|19485912|P2|STARTED|First Intervention - 60 Days||8
7917944|NCT00619073|19485913|P1|STARTED|First Intervention - 60 Days||8
7917945|NCT00619060|19485919|P2|NOT COMPLETED|Overall Study||0
7917946|NCT00619060|19485920|P1|NOT COMPLETED|Overall Study||0
7917947|NCT00619060|19485919|P2|COMPLETED|Overall Study||12
7917948|NCT00619060|19485920|P1|COMPLETED|Overall Study||10
7917949|NCT00619060|19485919|P2|STARTED|Overall Study||12
7917950|NCT00619060|19485920|P1|STARTED|Overall Study||10
7917951|NCT00618995|19485928|P4|NOT COMPLETED|Period 4||0
7917952|NCT00618995|19485929|P3|NOT COMPLETED|Period 4||0
7917953|NCT00618995|19485930|P2|NOT COMPLETED|Period 4||0
7917954|NCT00618995|19485931|P1|NOT COMPLETED|Period 4||1
7917955|NCT00618995|19485928|P4|COMPLETED|Period 4||6
7917956|NCT00618995|19485929|P3|COMPLETED|Period 4||4
7917957|NCT00618995|19485930|P2|COMPLETED|Period 4||6
7917958|NCT00618995|19485931|P1|COMPLETED|Period 4||5
7917959|NCT00618995|19485928|P4|STARTED|Period 4||6
7917960|NCT00618995|19485929|P3|STARTED|Period 4||4
7917961|NCT00618995|19485930|P2|STARTED|Period 4||6
7917962|NCT00618995|19485931|P1|STARTED|Period 4||6
7917963|NCT00618995|19485928|P4|NOT COMPLETED|Period 3||0
7917964|NCT00618995|19485929|P3|NOT COMPLETED|Period 3||0
7917965|NCT00618995|19485930|P2|NOT COMPLETED|Period 3||0
7917966|NCT00618995|19485931|P1|NOT COMPLETED|Period 3||0
7917967|NCT00618995|19485928|P4|COMPLETED|Period 3||6
7917968|NCT00618995|19485929|P3|COMPLETED|Period 3||4
7917969|NCT00618995|19485930|P2|COMPLETED|Period 3||6
7917970|NCT00618995|19485931|P1|COMPLETED|Period 3||6
7917971|NCT00618995|19485928|P4|STARTED|Period 3||6
7917972|NCT00618995|19485929|P3|STARTED|Period 3||4
7917973|NCT00618995|19485930|P2|STARTED|Period 3||6
7917974|NCT00618995|19485931|P1|STARTED|Period 3||6
7917975|NCT00618995|19485928|P4|NOT COMPLETED|Period 2||0
7917976|NCT00618995|19485929|P3|NOT COMPLETED|Period 2||1
7917977|NCT00618995|19485930|P2|NOT COMPLETED|Period 2||0
7917978|NCT00618995|19485931|P1|NOT COMPLETED|Period 2||0
7917979|NCT00618995|19485928|P4|COMPLETED|Period 2||6
7917980|NCT00618995|19485929|P3|COMPLETED|Period 2||4
7917981|NCT00618995|19485930|P2|COMPLETED|Period 2||6
7917982|NCT00618995|19485931|P1|COMPLETED|Period 2||6
7917983|NCT00618995|19485928|P4|STARTED|Period 2||6
7917984|NCT00618995|19485929|P3|STARTED|Period 2||5
7917985|NCT00618995|19485930|P2|STARTED|Period 2||6
7917986|NCT00618995|19485931|P1|STARTED|Period 2||6
7917987|NCT00618995|19485928|P4|NOT COMPLETED|Period 1||0
7917988|NCT00618995|19485929|P3|NOT COMPLETED|Period 1||2
7917989|NCT00618995|19485930|P2|NOT COMPLETED|Period 1||1
7917990|NCT00618995|19485931|P1|NOT COMPLETED|Period 1||0
7917991|NCT00618995|19485928|P4|COMPLETED|Period 1||6
7917992|NCT00618995|19485929|P3|COMPLETED|Period 1||5
7917993|NCT00618995|19485930|P2|COMPLETED|Period 1||6
7917994|NCT00618995|19485931|P1|COMPLETED|Period 1||6
7917995|NCT00618995|19485928|P4|STARTED|Period 1||6
7917996|NCT00618995|19485929|P3|STARTED|Period 1||7
7917997|NCT00618995|19485930|P2|STARTED|Period 1||7
7917998|NCT00618995|19485931|P1|STARTED|Period 1||6
7917999|NCT00618982|19485945|P1|NOT COMPLETED|Overall Study||50
7918000|NCT00618982|19485945|P1|COMPLETED|Overall Study||33
7918001|NCT00618982|19485945|P1|STARTED|Overall Study||83
7918002|NCT00618956|19485968|P2|NOT COMPLETED|Overall Study||50
7918003|NCT00618956|19485969|P1|NOT COMPLETED|Overall Study||25
7918004|NCT00618956|19485968|P2|COMPLETED|Overall Study||160
7918005|NCT00618956|19485969|P1|COMPLETED|Overall Study||86
7918006|NCT00618956|19485968|P2|STARTED|Overall Study||210
7918007|NCT00618956|19485969|P1|STARTED|Overall Study||111
7918008|NCT00618839|19485985|P1|NOT COMPLETED|Overall Study||0
7918009|NCT00618839|19485985|P1|COMPLETED|Overall Study||15
7918010|NCT00618839|19485985|P1|STARTED|Overall Study||15
7918011|NCT00618826|19485994|P1|NOT COMPLETED|Overall Study||1
7918012|NCT00618826|19485994|P1|COMPLETED|Overall Study||13
7918013|NCT00618826|19485994|P1|STARTED|Overall Study||14
7918014|NCT00618813|19485999|P1|NOT COMPLETED|Overall Study||4
7918015|NCT00618813|19485999|P1|COMPLETED|Overall Study||31
7918016|NCT00618813|19485999|P1|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33
7918017|NCT00618813|19485999|P1|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
7918018|NCT00618813|19485999|P1|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
7918019|NCT00618813|19485999|P1|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35
7918020|NCT00618813|19485999|P1|STARTED|Overall Study||35
7918021|NCT00618787|19486009|P2|NOT COMPLETED|Overall Study||2
7918022|NCT00618787|19486010|P1|NOT COMPLETED|Overall Study||3
7918023|NCT00618787|19486009|P2|COMPLETED|Overall Study||21
7918024|NCT00618787|19486010|P1|COMPLETED|Overall Study||19
7918025|NCT00618787|19486009|P2|STARTED|Overall Study||23
7918026|NCT00618787|19486010|P1|STARTED|Overall Study||22
7918027|NCT00618774|19486018|P2|NOT COMPLETED|Overall Study||3
7918028|NCT00618774|19486019|P1|NOT COMPLETED|Overall Study||6
7918029|NCT00618774|19486018|P2|COMPLETED|Overall Study||45
7918030|NCT00618774|19486019|P1|COMPLETED|Overall Study||205
7918031|NCT00618774|19486018|P2|STARTED|Overall Study||48
7918032|NCT00618774|19486019|P1|STARTED|Overall Study||211
7918033|NCT00618748|19486052|P3|NOT COMPLETED|Overall Study||14
7918034|NCT00618748|19486053|P2|NOT COMPLETED|Overall Study||5
7918035|NCT00618748|19486054|P1|NOT COMPLETED|Overall Study||11
7918036|NCT00618748|19486052|P3|COMPLETED|Overall Study||6
7918037|NCT00618748|19486053|P2|COMPLETED|Overall Study||20
7918038|NCT00618748|19486054|P1|COMPLETED|Overall Study||45
7918039|NCT00618748|19486052|P3|STARTED|Overall Study||20
7918040|NCT00618748|19486053|P2|STARTED|Overall Study||25
7918041|NCT00618748|19486054|P1|STARTED|Overall Study||56
7918042|NCT00618722|19486099|P4|NOT COMPLETED|Overall Study||4
7918043|NCT00618722|19486100|P3|NOT COMPLETED|Overall Study||3
7918044|NCT00618722|19486101|P2|NOT COMPLETED|Overall Study||2
7918045|NCT00618722|19486102|P1|NOT COMPLETED|Overall Study||3
7918046|NCT00618722|19486099|P4|COMPLETED|Overall Study||18
7918047|NCT00618722|19486100|P3|COMPLETED|Overall Study||19
7918048|NCT00618722|19486101|P2|COMPLETED|Overall Study||18
7918049|NCT00618722|19486102|P1|COMPLETED|Overall Study||18
7918050|NCT00618722|19486099|P4|Received Treatment|Overall Study||22
7918051|NCT00618722|19486100|P3|Received Treatment|Overall Study||22
7918052|NCT00618722|19486101|P2|Received Treatment|Overall Study||20
7918053|NCT00618722|19486102|P1|Received Treatment|Overall Study||20
7918054|NCT00618722|19486099|P4|STARTED|Overall Study||22
7918055|NCT00618722|19486100|P3|STARTED|Overall Study||22
7918056|NCT00618722|19486101|P2|STARTED|Overall Study||20
7918057|NCT00618722|19486102|P1|STARTED|Overall Study||21
7918058|NCT00618618|19486140|P4|NOT COMPLETED|Overall Study||1
7918059|NCT00618618|19486141|P3|NOT COMPLETED|Overall Study||3
7918060|NCT00618618|19486142|P2|NOT COMPLETED|Overall Study||3
7918061|NCT00618618|19486143|P1|NOT COMPLETED|Overall Study||4
7918062|NCT00618618|19486140|P4|COMPLETED|Overall Study||13
7918063|NCT00618618|19486141|P3|COMPLETED|Overall Study||18
7918064|NCT00618618|19486142|P2|COMPLETED|Overall Study||11
7918065|NCT00618618|19486143|P1|COMPLETED|Overall Study||20
7918066|NCT00618618|19486140|P4|Received Treatment|Overall Study||14
7918067|NCT00618618|19486141|P3|Received Treatment|Overall Study||20
7918068|NCT00618618|19486142|P2|Received Treatment|Overall Study||13
7918069|NCT00618618|19486143|P1|Received Treatment|Overall Study||24
7918070|NCT00618618|19486140|P4|STARTED|Overall Study||14
7918071|NCT00618618|19486141|P3|STARTED|Overall Study||21
7918072|NCT00618618|19486142|P2|STARTED|Overall Study||14
7918073|NCT00618618|19486143|P1|STARTED|Overall Study||24
7918074|NCT00618540|19486189|P1|NOT COMPLETED|Overall Study||0
7918075|NCT00618540|19486189|P1|COMPLETED|Overall Study||1
7918076|NCT00618540|19486189|P1|STARTED|Overall Study||1
7918077|NCT00618514|19486202|P3|NOT COMPLETED|Overall Study||4
7918078|NCT00618514|19486203|P2|NOT COMPLETED|Overall Study||12
7918079|NCT00618514|19486204|P1|NOT COMPLETED|Overall Study||11
7918080|NCT00618514|19486202|P3|COMPLETED|Overall Study||12
7918081|NCT00618514|19486203|P2|COMPLETED|Overall Study||26
7918082|NCT00618514|19486204|P1|COMPLETED|Overall Study||25
7918083|NCT00618514|19486202|P3|STARTED|Overall Study||16
7918084|NCT00618514|19486203|P2|STARTED|Overall Study||38
7918085|NCT00618514|19486204|P1|STARTED|Overall Study||36
7918086|NCT00618449|19486224|P2|NOT COMPLETED|Overall Study||110
7918087|NCT00618449|19486225|P1|NOT COMPLETED|Overall Study||98
7918088|NCT00618449|19486224|P2|COMPLETED|Overall Study||558
7918089|NCT00618449|19486225|P1|COMPLETED|Overall Study||581
7918090|NCT00618449|19486224|P2|1-year, Post-treatment|Overall Study||558
7918091|NCT00618449|19486225|P1|1-year, Post-treatment|Overall Study||581
7918092|NCT00618449|19486224|P2|1-month, Post-treatment|Overall Study||656
7918093|NCT00618449|19486225|P1|1-month, Post-treatment|Overall Study||666
7918094|NCT00618449|19486224|P2|STARTED|Overall Study||668
7918095|NCT00618449|19486225|P1|STARTED|Overall Study||679
7918096|NCT00618436|19486233|P2|NOT COMPLETED|Overall Study||0
7918097|NCT00618436|19486234|P1|NOT COMPLETED|Overall Study||0
7918098|NCT00618436|19486233|P2|COMPLETED|Overall Study||18
7918099|NCT00618436|19486234|P1|COMPLETED|Overall Study||34
7918100|NCT00618436|19486233|P2|STARTED|Overall Study||18
7918101|NCT00618436|19486234|P1|STARTED|Overall Study||34
7918102|NCT00618410|19486244|P2|NOT COMPLETED|Second Intervention||0
7918103|NCT00618410|19486245|P1|NOT COMPLETED|Second Intervention||0
7918104|NCT00618410|19486244|P2|COMPLETED|Second Intervention||5
7918105|NCT00618410|19486245|P1|COMPLETED|Second Intervention||7
7918106|NCT00618410|19486244|P2|STARTED|Second Intervention||5
7918107|NCT00618410|19486245|P1|STARTED|Second Intervention||7
7918108|NCT00618410|19486244|P2|NOT COMPLETED|Washout Period (2 Weeks)||1
7918109|NCT00618410|19486245|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
7918110|NCT00618410|19486244|P2|COMPLETED|Washout Period (2 Weeks)||5
7918111|NCT00618410|19486245|P1|COMPLETED|Washout Period (2 Weeks)||7
7918112|NCT00618410|19486244|P2|STARTED|Washout Period (2 Weeks)||6
7918113|NCT00618410|19486245|P1|STARTED|Washout Period (2 Weeks)||7
7918114|NCT00618410|19486244|P2|NOT COMPLETED|First Intervention||0
7918115|NCT00618410|19486245|P1|NOT COMPLETED|First Intervention||0
7918116|NCT00618410|19486244|P2|COMPLETED|First Intervention||6
7918117|NCT00618410|19486245|P1|COMPLETED|First Intervention||7
7918118|NCT00618410|19486244|P2|STARTED|First Intervention||6
7918119|NCT00618410|19486245|P1|STARTED|First Intervention||7
7918120|NCT00618371|19486261|P1|NOT COMPLETED|Overall Study||2
7918121|NCT00618371|19486261|P1|COMPLETED|Overall Study||10
7918122|NCT00618371|19486261|P1|STARTED|Overall Study||12
7918123|NCT00618332|19486268|P2|NOT COMPLETED|Overall Study||0
7918124|NCT00618332|19486269|P1|NOT COMPLETED|Overall Study||0
7918125|NCT00618332|19486268|P2|COMPLETED|Overall Study||20
7918126|NCT00618332|19486269|P1|COMPLETED|Overall Study||20
7918127|NCT00618332|19486268|P2|STARTED|Overall Study||20
7918128|NCT00618332|19486269|P1|STARTED|Overall Study||20
7918129|NCT00618072|19486294|P3|NOT COMPLETED|Overall Study||4
7918130|NCT00618072|19486295|P2|NOT COMPLETED|Overall Study||1
7918131|NCT00618072|19486296|P1|NOT COMPLETED|Overall Study||2
7918132|NCT00618072|19486294|P3|COMPLETED|Overall Study||11
7918133|NCT00618072|19486295|P2|COMPLETED|Overall Study||14
7918134|NCT00618072|19486296|P1|COMPLETED|Overall Study||14
7918135|NCT00618072|19486294|P3|STARTED|Overall Study||15
7918136|NCT00618072|19486295|P2|STARTED|Overall Study||15
7918137|NCT00618072|19486296|P1|STARTED|Overall Study||16
7918138|NCT00617981|19486330|P2|NOT COMPLETED|Overall Study||102
7918139|NCT00617981|19486331|P1|NOT COMPLETED|Overall Study||110
7918140|NCT00617981|19486330|P2|COMPLETED|Overall Study||245
7918141|NCT00617981|19486331|P1|COMPLETED|Overall Study||244
7918142|NCT00617981|19486330|P2|STARTED|Overall Study||347
7918143|NCT00617981|19486331|P1|STARTED|Overall Study||354
7918144|NCT00617942|19486339|P2|NOT COMPLETED|Overall Study||4
7918145|NCT00617942|19486340|P1|NOT COMPLETED|Overall Study||8
7918146|NCT00617942|19486339|P2|COMPLETED|Overall Study||19
7918147|NCT00617942|19486340|P1|COMPLETED|Overall Study||29
7918148|NCT00617942|19486339|P2|STARTED|Overall Study||23
7918149|NCT00617942|19486340|P1|STARTED|Overall Study||37
7918150|NCT00617929|19486352|P1|NOT COMPLETED|Overall Study||1
7918151|NCT00617929|19486352|P1|COMPLETED|Overall Study||11
7918152|NCT00617929|19486352|P1|STARTED|Overall Study||12
7918153|NCT00617903|19486364|P2|NOT COMPLETED|Overall Study||7
7918154|NCT00617903|19486365|P1|NOT COMPLETED|Overall Study||3
7918155|NCT00617903|19486364|P2|COMPLETED|Overall Study||35
7918156|NCT00617903|19486365|P1|COMPLETED|Overall Study||38
7918157|NCT00617903|19486364|P2|STARTED|Overall Study||42
7918158|NCT00617903|19486365|P1|STARTED|Overall Study||41
7918159|NCT00617890|19486411|P4|NOT COMPLETED|Overall Study||115
7918160|NCT00617890|19486412|P3|NOT COMPLETED|Overall Study||35
7918161|NCT00617890|19486413|P2|NOT COMPLETED|Overall Study||28
7918162|NCT00617890|19486414|P1|NOT COMPLETED|Overall Study||31
7918163|NCT00617890|19486411|P4|COMPLETED|Overall Study||1
7918164|NCT00617890|19486412|P3|COMPLETED|Overall Study||0
7918165|NCT00617890|19486413|P2|COMPLETED|Overall Study||5
7918166|NCT00617890|19486414|P1|COMPLETED|Overall Study||4
7918167|NCT00617890|19486411|P4|Received Treatment|Overall Study||115
7918168|NCT00617890|19486412|P3|Received Treatment|Overall Study||34
7918169|NCT00617890|19486413|P2|Received Treatment|Overall Study||33
7918170|NCT00617890|19486414|P1|Received Treatment|Overall Study||34
7918171|NCT00617890|19486411|P4|STARTED|Overall Study||116
7918172|NCT00617890|19486412|P3|STARTED|Overall Study||35
7918173|NCT00617890|19486413|P2|STARTED|Overall Study||33
7918174|NCT00617890|19486414|P1|STARTED|Overall Study||35
7918175|NCT00617851|19486450|P4|NOT COMPLETED|Overall Study||25
7918176|NCT00617851|19486451|P3|NOT COMPLETED|Overall Study||45
7918177|NCT00617851|19486452|P2|NOT COMPLETED|Overall Study||40
7918178|NCT00617851|19486453|P1|NOT COMPLETED|Overall Study||47
7918179|NCT00617851|19486450|P4|COMPLETED|Overall Study||192
7918180|NCT00617851|19486451|P3|COMPLETED|Overall Study||384
7918181|NCT00617851|19486452|P2|COMPLETED|Overall Study||391
7918182|NCT00617851|19486453|P1|COMPLETED|Overall Study||383
7918183|NCT00617851|19486450|P4|STARTED|Overall Study||217
7918184|NCT00617851|19486451|P3|STARTED|Overall Study||429
7918185|NCT00617851|19486452|P2|STARTED|Overall Study||431
7918186|NCT00617851|19486453|P1|STARTED|Overall Study||430
7918187|NCT00617773|19486491|P1|NOT COMPLETED|Overall Study||24
7918188|NCT00617773|19486491|P1|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7
7918189|NCT00617773|19486491|P1|STARTED|Overall Study||31
7918190|NCT00617734|19486508|P2|NOT COMPLETED|Overall Study||6
7918191|NCT00617734|19486509|P1|NOT COMPLETED|Overall Study||8
7918192|NCT00617734|19486508|P2|COMPLETED|Overall Study||42
7918193|NCT00617734|19486509|P1|COMPLETED|Overall Study||41
7918194|NCT00617734|19486508|P2|Received at Least 1 Dose of Study Drug|Overall Study||44
7918195|NCT00617734|19486509|P1|Received at Least 1 Dose of Study Drug|Overall Study||47
7918196|NCT00617734|19486508|P2|STARTED|Overall Study||48
7918197|NCT00617734|19486509|P1|STARTED|Overall Study||49
7918198|NCT00617708|19486530|P3|NOT COMPLETED|Overall Study||64
7918199|NCT00617708|19486531|P2|NOT COMPLETED|Overall Study||60
7918200|NCT00617708|19486532|P1|NOT COMPLETED|Overall Study||10
7918201|NCT00617708|19486530|P3|COMPLETED|Overall Study||0
7918202|NCT00617708|19486531|P2|COMPLETED|Overall Study||0
7918203|NCT00617708|19486532|P1|COMPLETED|Overall Study||0
7918204|NCT00617708|19486530|P3|Eligible and Began Protocol Therapy|Overall Study||59
7918205|NCT00617708|19486531|P2|Eligible and Began Protocol Therapy|Overall Study||57
7918206|NCT00617708|19486532|P1|Eligible and Began Protocol Therapy|Overall Study||9
7918207|NCT00617708|19486530|P3|STARTED|Overall Study||64
7918208|NCT00617708|19486531|P2|STARTED|Overall Study||60
7918209|NCT00617708|19486532|P1|STARTED|Overall Study||10
7918210|NCT00617669|19486549|P2|NOT COMPLETED|Overall Study||451
7918211|NCT00617669|19486550|P1|NOT COMPLETED|Overall Study||430
7918212|NCT00617669|19486549|P2|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77
7918213|NCT00617669|19486550|P1|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94
7918214|NCT00617669|19486549|P2|Patients Who Received IP|Overall Study||525
7918215|NCT00617669|19486550|P1|Patients Who Received IP|Overall Study||522
7918216|NCT00617669|19486549|P2|STARTED|Overall Study||528
7918217|NCT00617669|19486550|P1|STARTED|Overall Study||524
7918218|NCT00617604|19486572|P2|NOT COMPLETED|Overall Study||20
7918219|NCT00617604|19486573|P1|NOT COMPLETED|Overall Study||18
7918220|NCT00617604|19486572|P2|COMPLETED|Overall Study|Completed Month 6 assessment|88
7918221|NCT00617604|19486573|P1|COMPLETED|Overall Study|Completed Month 6 assessment|92
7918222|NCT00617604|19486572|P2|Completed 12 Weeks of Treatment|Overall Study||83
7918223|NCT00617604|19486573|P1|Completed 12 Weeks of Treatment|Overall Study||89
7918224|NCT00617604|19486572|P2|Received Treatment|Overall Study||105
7918225|NCT00617604|19486573|P1|Received Treatment|Overall Study||107
7918226|NCT00617604|19486572|P2|STARTED|Overall Study||108
7918227|NCT00617604|19486573|P1|STARTED|Overall Study||110
7918228|NCT00617591|19486617|P1|NOT COMPLETED|Overall Study||10
7918229|NCT00617591|19486617|P1|COMPLETED|Overall Study||47
7918230|NCT00617591|19486617|P1|STARTED|Overall Study||57
7918231|NCT00617539|19486625|P1|NOT COMPLETED|Overall Study||0
7918232|NCT00617539|19486625|P1|COMPLETED|Overall Study||30
7918233|NCT00617539|19486625|P1|STARTED|Overall Study||30
7918234|NCT00617461|19486633|P2|NOT COMPLETED|6-Day Down-Titration Period||2
7918235|NCT00617461|19486634|P1|NOT COMPLETED|6-Day Down-Titration Period||2
7918236|NCT00617461|19486633|P2|COMPLETED|6-Day Down-Titration Period||35
7918237|NCT00617461|19486634|P1|COMPLETED|6-Day Down-Titration Period||39
7918238|NCT00617461|19486633|P2|STARTED|6-Day Down-Titration Period||37
7918239|NCT00617461|19486634|P1|STARTED|6-Day Down-Titration Period||41
7918240|NCT00617461|19486633|P2|NOT COMPLETED|Second Treatment Intervention Period||4
7918241|NCT00617461|19486634|P1|NOT COMPLETED|Second Treatment Intervention Period||0
7918242|NCT00617461|19486633|P2|COMPLETED|Second Treatment Intervention Period||37
7918243|NCT00617461|19486634|P1|COMPLETED|Second Treatment Intervention Period||41
7918244|NCT00617461|19486633|P2|STARTED|Second Treatment Intervention Period||41
7918245|NCT00617461|19486634|P1|STARTED|Second Treatment Intervention Period||41
7918246|NCT00617461|19486633|P2|NOT COMPLETED|4-Day Crossover Period||0
7918247|NCT00617461|19486634|P1|NOT COMPLETED|4-Day Crossover Period||1
7918248|NCT00617461|19486633|P2|COMPLETED|4-Day Crossover Period||40
7918249|NCT00617461|19486634|P1|COMPLETED|4-Day Crossover Period||41
7918250|NCT00617461|19486633|P2|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40
7918251|NCT00617461|19486634|P1|STARTED|4-Day Crossover Period||42
7918252|NCT00617461|19486633|P2|NOT COMPLETED|First Treatment Intervention Period||3
7918253|NCT00617461|19486634|P1|NOT COMPLETED|First Treatment Intervention Period||10
7918254|NCT00617461|19486633|P2|COMPLETED|First Treatment Intervention Period||41
7918255|NCT00617461|19486634|P1|COMPLETED|First Treatment Intervention Period||42
7918256|NCT00617461|19486633|P2|STARTED|First Treatment Intervention Period||44
7918257|NCT00617461|19486634|P1|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52
7918258|NCT00617409|19486690|P3|NOT COMPLETED|Overall Study||27
7918259|NCT00617409|19486691|P2|NOT COMPLETED|Overall Study||18
7918260|NCT00617409|19486692|P1|NOT COMPLETED|Overall Study||16
7918261|NCT00617409|19486690|P3|COMPLETED|Overall Study||4
7918262|NCT00617409|19486691|P2|COMPLETED|Overall Study||2
7918263|NCT00617409|19486692|P1|COMPLETED|Overall Study||2
7918264|NCT00617409|19486690|P3|STARTED|Overall Study||31
7918265|NCT00617409|19486691|P2|STARTED|Overall Study||20
7918266|NCT00617409|19486692|P1|STARTED|Overall Study||18
7918267|NCT00617396|19486703|P1|NOT COMPLETED|Overall Study||0
7918268|NCT00617396|19486703|P1|COMPLETED|Overall Study||25
7918269|NCT00617396|19486703|P1|STARTED|Overall Study||25
7918270|NCT00617357|19486707|P1|NOT COMPLETED|Overall Study||16
7918271|NCT00617357|19486707|P1|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67
7918272|NCT00617357|19486707|P1|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83
7918273|NCT00617344|19486720|P3|NOT COMPLETED|Overall Study||8
7918274|NCT00617344|19486721|P2|NOT COMPLETED|Overall Study||22
7918275|NCT00617344|19486722|P1|NOT COMPLETED|Overall Study||25
7918276|NCT00617344|19486720|P3|COMPLETED|Overall Study||45
7918277|NCT00617344|19486721|P2|COMPLETED|Overall Study||81
7918278|NCT00617344|19486722|P1|COMPLETED|Overall Study||79
7918279|NCT00617344|19486720|P3|Received Vaccination 3|Overall Study||45
7918280|NCT00617344|19486721|P2|Received Vaccination 3|Overall Study||81
7918281|NCT00617344|19486722|P1|Received Vaccination 3|Overall Study||79
7918282|NCT00617344|19486720|P3|Received Vaccination 2|Overall Study||46
7918283|NCT00617344|19486721|P2|Received Vaccination 2|Overall Study||85
7918284|NCT00617344|19486722|P1|Received Vaccination 2|Overall Study||86
7918285|NCT00617344|19486720|P3|Received Vaccination 1|Overall Study||53
7918286|NCT00617344|19486721|P2|Received Vaccination 1|Overall Study||103
7918287|NCT00617344|19486722|P1|Received Vaccination 1|Overall Study||104
7918288|NCT00617344|19486720|P3|STARTED|Overall Study||53
7918289|NCT00617344|19486721|P2|STARTED|Overall Study||103
7918290|NCT00617344|19486722|P1|STARTED|Overall Study||104
7918291|NCT00617305|19486750|P3|NOT COMPLETED|Overall Study||1
7918292|NCT00617305|19486751|P2|NOT COMPLETED|Overall Study||0
7918293|NCT00617305|19486752|P1|NOT COMPLETED|Overall Study||8
7918294|NCT00617305|19486750|P3|COMPLETED|Overall Study||0
7918295|NCT00617305|19486751|P2|COMPLETED|Overall Study||4
7918296|NCT00617305|19486752|P1|COMPLETED|Overall Study||25
7918297|NCT00617305|19486750|P3|Completed 24-week Primary Analysis|Overall Study||0
7918298|NCT00617305|19486751|P2|Completed 24-week Primary Analysis|Overall Study||4
7918299|NCT00617305|19486752|P1|Completed 24-week Primary Analysis|Overall Study||31
7918300|NCT00617305|19486750|P3|STARTED|Overall Study||1
7918301|NCT00617305|19486751|P2|STARTED|Overall Study||4
7918302|NCT00617305|19486752|P1|STARTED|Overall Study||33
7918303|NCT00617279|19486808|P2|NOT COMPLETED|Overall Study||17
7918304|NCT00617279|19486809|P1|NOT COMPLETED|Overall Study||14
7918305|NCT00617279|19486808|P2|COMPLETED|Overall Study||0
7918306|NCT00617279|19486809|P1|COMPLETED|Overall Study||0
7918307|NCT00617279|19486808|P2|STARTED|Overall Study||17
7918308|NCT00617279|19486809|P1|STARTED|Overall Study||14
7918309|NCT00617240|19486865|P2|NOT COMPLETED|Overall Study||0
7918310|NCT00617240|19486866|P1|NOT COMPLETED|Overall Study||1
7918311|NCT00617240|19486865|P2|COMPLETED|Overall Study||4
7918312|NCT00617240|19486866|P1|COMPLETED|Overall Study||4
7918313|NCT00617240|19486865|P2|STARTED|Overall Study||4
7918314|NCT00617240|19486866|P1|STARTED|Overall Study||5
7918315|NCT00617201|19486886|P2|NOT COMPLETED|Overall Study||13
7918316|NCT00617201|19486887|P1|NOT COMPLETED|Overall Study||9
7918317|NCT00617201|19486886|P2|COMPLETED|Overall Study||12
7918318|NCT00617201|19486887|P1|COMPLETED|Overall Study||16
7918319|NCT00617201|19486886|P2|STARTED|Overall Study||25
7918320|NCT00617201|19486887|P1|STARTED|Overall Study||25
7918321|NCT00617188|19486895|P1|NOT COMPLETED|Overall Study||0
7918322|NCT00617188|19486895|P1|COMPLETED|Overall Study||26
7918323|NCT00617188|19486895|P1|STARTED|Overall Study||26
7918324|NCT00617175|19486906|P2|NOT COMPLETED|Overall Study||0
7918325|NCT00617175|19486907|P1|NOT COMPLETED|Overall Study||0
7918326|NCT00617175|19486906|P2|COMPLETED|Overall Study||948
7918327|NCT00617175|19486907|P1|COMPLETED|Overall Study||954
7918328|NCT00617175|19486906|P2|STARTED|Overall Study||948
7918329|NCT00617175|19486907|P1|STARTED|Overall Study||954
7918330|NCT00617123|19486915|P2|NOT COMPLETED|Study Treatment Period||16
7918331|NCT00617123|19486916|P1|NOT COMPLETED|Study Treatment Period||17
7918332|NCT00617123|19486915|P2|COMPLETED|Study Treatment Period||79
7918333|NCT00617123|19486916|P1|COMPLETED|Study Treatment Period||81
7918334|NCT00617123|19486915|P2|Treated|Study Treatment Period||95
7918335|NCT00617123|19486916|P1|Treated|Study Treatment Period|1 participant was not treated|97
7918336|NCT00617123|19486915|P2|STARTED|Study Treatment Period||95
7918337|NCT00617123|19486916|P1|STARTED|Study Treatment Period||98
7918338|NCT00617123|19486915|P2|NOT COMPLETED|Referral Screening Period||26
7918339|NCT00617123|19486916|P1|NOT COMPLETED|Referral Screening Period||39
7918340|NCT00617123|19486915|P2|COMPLETED|Referral Screening Period||95
7918341|NCT00617123|19486916|P1|COMPLETED|Referral Screening Period||98
7918342|NCT00617123|19486915|P2|STARTED|Referral Screening Period||121
7918343|NCT00617123|19486916|P1|STARTED|Referral Screening Period||137
7918344|NCT00617097|19486932|P2|NOT COMPLETED|Overall Study||0
7918345|NCT00617097|19486933|P1|NOT COMPLETED|Overall Study||0
7918346|NCT00617097|19486932|P2|COMPLETED|Overall Study||25
7918347|NCT00617097|19486933|P1|COMPLETED|Overall Study||25
7918348|NCT00617097|19486932|P2|STARTED|Overall Study||25
7918349|NCT00617097|19486933|P1|STARTED|Overall Study||25
7918350|NCT00617084|19486947|P2|NOT COMPLETED|Overall Study||26
7918351|NCT00617084|19486948|P1|NOT COMPLETED|Overall Study||21
7918352|NCT00617084|19486947|P2|COMPLETED|Overall Study||1126
7918353|NCT00617084|19486948|P1|COMPLETED|Overall Study||1119
7918354|NCT00617084|19486947|P2|STARTED|Overall Study||1152
7918355|NCT00617084|19486948|P1|STARTED|Overall Study||1140
7918356|NCT00617058|19486959|P3|NOT COMPLETED|Overall Study||0
7918357|NCT00617058|19486960|P2|NOT COMPLETED|Overall Study||0
7918358|NCT00617058|19486961|P1|NOT COMPLETED|Overall Study||0
7918359|NCT00617058|19486959|P3|COMPLETED|Overall Study||0
7918360|NCT00617058|19486960|P2|COMPLETED|Overall Study||0
7918361|NCT00617058|19486961|P1|COMPLETED|Overall Study||1
7918362|NCT00617058|19486959|P3|STARTED|Overall Study||0
7918363|NCT00617058|19486960|P2|STARTED|Overall Study||0
7918364|NCT00617058|19486961|P1|STARTED|Overall Study||1
7918365|NCT00616967|19487001|P3|NOT COMPLETED|Overall Study||1
7918366|NCT00616967|19487002|P2|NOT COMPLETED|Overall Study||0
7918367|NCT00616967|19487003|P1|NOT COMPLETED|Overall Study||0
7918368|NCT00616967|19487001|P3|COMPLETED|Overall Study||30
7918369|NCT00616967|19487002|P2|COMPLETED|Overall Study||31
7918370|NCT00616967|19487003|P1|COMPLETED|Overall Study||6
7918371|NCT00616967|19487001|P3|STARTED|Overall Study||31
7918372|NCT00616967|19487002|P2|STARTED|Overall Study||31
7918373|NCT00616967|19487003|P1|STARTED|Overall Study||6
7918374|NCT00616941|19487028|P3|NOT COMPLETED|Overall Study||6
7918375|NCT00616941|19487029|P2|NOT COMPLETED|Overall Study||5
7918376|NCT00616941|19487030|P1|NOT COMPLETED|Overall Study||1
7918377|NCT00616941|19487028|P3|COMPLETED|Overall Study||5
7918378|NCT00616941|19487029|P2|COMPLETED|Overall Study||8
7918379|NCT00616941|19487030|P1|COMPLETED|Overall Study||3
7918380|NCT00616941|19487028|P3|STARTED|Overall Study||11
7918381|NCT00616941|19487029|P2|STARTED|Overall Study||13
7918382|NCT00616941|19487030|P1|STARTED|Overall Study||4
7918383|NCT00616928|19487057|P4|NOT COMPLETED|Overall Study||7
7918384|NCT00616928|19487058|P3|NOT COMPLETED|Overall Study||17
7918385|NCT00616928|19487059|P2|NOT COMPLETED|Overall Study||18
7918386|NCT00616928|19487060|P1|NOT COMPLETED|Overall Study||62
7918387|NCT00616928|19487057|P4|COMPLETED|Overall Study||364
7918388|NCT00616928|19487058|P3|COMPLETED|Overall Study||1101
7918389|NCT00616928|19487059|P2|COMPLETED|Overall Study||750
7918390|NCT00616928|19487060|P1|COMPLETED|Overall Study||2242
7918391|NCT00616928|19487057|P4|STARTED|Overall Study||371
7918392|NCT00616928|19487058|P3|STARTED|Overall Study||1118
7918393|NCT00616928|19487059|P2|STARTED|Overall Study||768
7918394|NCT00616928|19487060|P1|STARTED|Overall Study||2304
7918395|NCT00616902|19487124|P2|NOT COMPLETED|Overall Study||6
7918396|NCT00616902|19487125|P1|NOT COMPLETED|Overall Study||6
7918397|NCT00616902|19487124|P2|COMPLETED|Overall Study||0
7918398|NCT00616902|19487125|P1|COMPLETED|Overall Study||0
7918399|NCT00616902|19487124|P2|STARTED|Overall Study||6
7918400|NCT00616902|19487125|P1|STARTED|Overall Study||6
7918401|NCT00616772|19487151|P2|NOT COMPLETED|Overall Study||102
7918402|NCT00616772|19487152|P1|NOT COMPLETED|Overall Study||115
7918403|NCT00616772|19487151|P2|COMPLETED|Overall Study||240
7918404|NCT00616772|19487152|P1|COMPLETED|Overall Study||225
7918405|NCT00616772|19487151|P2|Treated|Overall Study||339
7918406|NCT00616772|19487152|P1|Treated|Overall Study||337
7918407|NCT00616772|19487151|P2|STARTED|Overall Study||342
7918408|NCT00616772|19487152|P1|STARTED|Overall Study||340
7918409|NCT00616759|19487168|P2|NOT COMPLETED|Overall Study||2
7918410|NCT00616759|19487169|P1|NOT COMPLETED|Overall Study||3
7918411|NCT00616759|19487168|P2|COMPLETED|Overall Study||8
7918412|NCT00616759|19487169|P1|COMPLETED|Overall Study||7
7918413|NCT00616759|19487168|P2|STARTED|Overall Study||10
7918414|NCT00616759|19487169|P1|STARTED|Overall Study||10
7918415|NCT00616655|19487178|P3|NOT COMPLETED|Overall Study||48
7918416|NCT00616655|19487179|P2|NOT COMPLETED|Overall Study||41
7918417|NCT00616655|19487180|P1|NOT COMPLETED|Overall Study||35
7918418|NCT00616655|19487178|P3|COMPLETED|Overall Study||103
7918419|NCT00616655|19487179|P2|COMPLETED|Overall Study||112
7918420|NCT00616655|19487180|P1|COMPLETED|Overall Study||117
7918421|NCT00616655|19487178|P3|STARTED|Overall Study||151
7918422|NCT00616655|19487179|P2|STARTED|Overall Study||153
7918423|NCT00616655|19487180|P1|STARTED|Overall Study||152
7918424|NCT00616642|19487220|P2|NOT COMPLETED|Overall Study||1
7918425|NCT00616642|19487221|P1|NOT COMPLETED|Overall Study||0
7918426|NCT00616642|19487220|P2|COMPLETED|Overall Study||0
7918427|NCT00616642|19487221|P1|COMPLETED|Overall Study||0
7918428|NCT00616642|19487220|P2|STARTED|Overall Study||1
7918429|NCT00616642|19487221|P1|STARTED|Overall Study||0
7918430|NCT00616629|19487232|P5|NOT COMPLETED|Overall Study||0
7918431|NCT00616629|19487233|P4|NOT COMPLETED|Overall Study||0
7918432|NCT00616629|19487234|P3|NOT COMPLETED|Overall Study||1
7918433|NCT00616629|19487235|P2|NOT COMPLETED|Overall Study||2
7918434|NCT00616629|19487236|P1|NOT COMPLETED|Overall Study||2
7918435|NCT00616629|19487232|P5|COMPLETED|Overall Study||12
7918436|NCT00616629|19487233|P4|COMPLETED|Overall Study||2
7918437|NCT00616629|19487234|P3|COMPLETED|Overall Study||13
7918438|NCT00616629|19487235|P2|COMPLETED|Overall Study||12
7918439|NCT00616629|19487236|P1|COMPLETED|Overall Study||11
7918440|NCT00616629|19487232|P5|STARTED|Overall Study||12
7918441|NCT00616629|19487233|P4|STARTED|Overall Study||2
7918442|NCT00616629|19487234|P3|STARTED|Overall Study|One patient never received study drug|14
7918443|NCT00616629|19487235|P2|STARTED|Overall Study|Two patients never received study drug|14
7918444|NCT00616629|19487236|P1|STARTED|Overall Study|Two patients never received study drug|13
7918445|NCT00616603|19487281|P3|NOT COMPLETED|Overall Study||2
7918446|NCT00616603|19487282|P2|NOT COMPLETED|Overall Study||0
7918447|NCT00616603|19487283|P1|NOT COMPLETED|Overall Study||2
7918448|NCT00616603|19487281|P3|COMPLETED|Overall Study||13
7918449|NCT00616603|19487282|P2|COMPLETED|Overall Study||14
7918450|NCT00616603|19487283|P1|COMPLETED|Overall Study||12
7918451|NCT00616603|19487281|P3|STARTED|Overall Study||15
7918452|NCT00616603|19487282|P2|STARTED|Overall Study||14
7918453|NCT00616603|19487283|P1|STARTED|Overall Study||14
7918454|NCT00616577|19487294|P3|NOT COMPLETED|Overall Study||0
7918455|NCT00616577|19487295|P2|NOT COMPLETED|Overall Study||0
7918456|NCT00616577|19487296|P1|NOT COMPLETED|Overall Study||0
7918457|NCT00616577|19487294|P3|COMPLETED|Overall Study||7
7918458|NCT00616577|19487295|P2|COMPLETED|Overall Study||9
7918459|NCT00616577|19487296|P1|COMPLETED|Overall Study||6
7918460|NCT00616577|19487294|P3|STARTED|Overall Study||7
7918461|NCT00616577|19487295|P2|STARTED|Overall Study||9
7918462|NCT00616577|19487296|P1|STARTED|Overall Study||6
7918463|NCT00616434|19487306|P2|NOT COMPLETED|Overall Study||8
7918464|NCT00616434|19487307|P1|NOT COMPLETED|Overall Study||6
7918465|NCT00616434|19487306|P2|COMPLETED|Overall Study||53
7918466|NCT00616434|19487307|P1|COMPLETED|Overall Study||56
7918467|NCT00616434|19487306|P2|STARTED|Overall Study||61
7918468|NCT00616434|19487307|P1|STARTED|Overall Study||62
7918469|NCT00616421|19487320|P3|NOT COMPLETED|Overall Study||41
7918470|NCT00616421|19487321|P2|NOT COMPLETED|Overall Study||38
7918471|NCT00616421|19487322|P1|NOT COMPLETED|Overall Study||26
7918472|NCT00616421|19487320|P3|COMPLETED|Overall Study||1229
7918473|NCT00616421|19487321|P2|COMPLETED|Overall Study||1240
7918474|NCT00616421|19487322|P1|COMPLETED|Overall Study||333
7918475|NCT00616421|19487320|P3|STARTED|Overall Study||1270
7918476|NCT00616421|19487321|P2|STARTED|Overall Study||1278
7918477|NCT00616421|19487322|P1|STARTED|Overall Study||359
7918478|NCT00616343|19487359|P1|NOT COMPLETED|Overall Study||0
7918479|NCT00616343|19487359|P1|COMPLETED|Overall Study||9
7918480|NCT00616343|19487359|P1|STARTED|Overall Study||9
7918481|NCT00616239|19487363|P1|NOT COMPLETED|Overall Study||2
7918482|NCT00616239|19487363|P1|COMPLETED|Overall Study||18
7918483|NCT00616239|19487363|P1|STARTED|Overall Study||20
7918484|NCT00616200|19487367|P1|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3
7918485|NCT00616200|19487367|P1|COMPLETED|Four Week Very Low Carbohydrate Diet||13
7918486|NCT00616200|19487367|P1|STARTED|Four Week Very Low Carbohydrate Diet||16
7918487|NCT00616200|19487367|P1|NOT COMPLETED|Two Week Standard Diet||1
7918488|NCT00616200|19487367|P1|COMPLETED|Two Week Standard Diet||16
7918489|NCT00616200|19487367|P1|STARTED|Two Week Standard Diet||17
7918490|NCT00616122|19487373|P4|NOT COMPLETED|Overall Study||11
7918491|NCT00616122|19487374|P3|NOT COMPLETED|Overall Study||0
7918492|NCT00616122|19487375|P2|NOT COMPLETED|Overall Study||0
7918493|NCT00616122|19487376|P1|NOT COMPLETED|Overall Study||0
7918494|NCT00616122|19487373|P4|COMPLETED|Overall Study||0
7918495|NCT00616122|19487374|P3|COMPLETED|Overall Study||10
7918496|NCT00616122|19487375|P2|COMPLETED|Overall Study||7
7918497|NCT00616122|19487376|P1|COMPLETED|Overall Study||4
7918498|NCT00616122|19487373|P4|STARTED|Overall Study||11
7918499|NCT00616122|19487374|P3|STARTED|Overall Study||10
7918500|NCT00616122|19487375|P2|STARTED|Overall Study||7
7918501|NCT00616122|19487376|P1|STARTED|Overall Study||4
7918502|NCT00616109|19487386|P1|NOT COMPLETED|Overall Study||0
7918503|NCT00616109|19487386|P1|COMPLETED|Overall Study||16
7918504|NCT00616109|19487386|P1|STARTED|Overall Study||16
7918505|NCT00616018|19487393|P1|NOT COMPLETED|Overall Study||3
7918506|NCT00616018|19487393|P1|COMPLETED|Overall Study||24
7918507|NCT00616018|19487393|P1|STARTED|Overall Study||27
7918508|NCT00615992|19487398|P1|NOT COMPLETED|Overall Study||67
7918509|NCT00615992|19487398|P1|COMPLETED|Overall Study||687
7918510|NCT00615992|19487398|P1|STARTED|Overall Study||754
7918511|NCT00615927|19487409|P2|NOT COMPLETED|Overall Study||0
7918512|NCT00615927|19487410|P1|NOT COMPLETED|Overall Study||0
7918513|NCT00615927|19487409|P2|COMPLETED|Overall Study||32
7918514|NCT00615927|19487410|P1|COMPLETED|Overall Study||32
7918515|NCT00615927|19487409|P2|STARTED|Overall Study||32
7918516|NCT00615927|19487410|P1|STARTED|Overall Study||32
7918517|NCT00615914|19487424|P1|NOT COMPLETED|Overall Study||637
7918518|NCT00615914|19487424|P1|COMPLETED|Overall Study||1008
7918519|NCT00615914|19487424|P1|STARTED|Overall Study|The number of patients enrolled|1645
7918520|NCT00615901|19487431|P1|NOT COMPLETED|Overall Study||9
7918521|NCT00615901|19487431|P1|COMPLETED|Overall Study||29
7918522|NCT00615901|19487431|P1|STARTED|Overall Study||38
7918523|NCT00615836|19487439|P5|NOT COMPLETED|Extension Study (FE992026 CS31)||0
7918524|NCT00615836|19487440|P4|NOT COMPLETED|Extension Study (FE992026 CS31)||84
7918525|NCT00615836|19487441|P3|NOT COMPLETED|Extension Study (FE992026 CS31)||73
7918526|NCT00615836|19487442|P2|NOT COMPLETED|Extension Study (FE992026 CS31)||86
7918527|NCT00615836|19487443|P1|NOT COMPLETED|Extension Study (FE992026 CS31)||141
7918528|NCT00615836|19487439|P5|COMPLETED|Extension Study (FE992026 CS31)||0
7918529|NCT00615836|19487440|P4|COMPLETED|Extension Study (FE992026 CS31)||53
7918530|NCT00615836|19487441|P3|COMPLETED|Extension Study (FE992026 CS31)||59
7918531|NCT00615836|19487442|P2|COMPLETED|Extension Study (FE992026 CS31)||58
7918532|NCT00615836|19487443|P1|COMPLETED|Extension Study (FE992026 CS31)||0
7918533|NCT00615836|19487439|P5|STARTED|Extension Study (FE992026 CS31)||0
7918534|NCT00615836|19487440|P4|STARTED|Extension Study (FE992026 CS31)||137
7918535|NCT00615836|19487441|P3|STARTED|Extension Study (FE992026 CS31)||132
7918536|NCT00615836|19487442|P2|STARTED|Extension Study (FE992026 CS31)||144
7918537|NCT00615836|19487443|P1|STARTED|Extension Study (FE992026 CS31)||141
7918538|NCT00615836|19487439|P5|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15
7918539|NCT00615836|19487440|P4|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25
7918540|NCT00615836|19487441|P3|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20
7918541|NCT00615836|19487442|P2|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10
7918542|NCT00615836|19487443|P1|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19
7918543|NCT00615836|19487439|P5|COMPLETED|Part I of Core Study (FE992026 CS29)||145
7918544|NCT00615836|19487440|P4|COMPLETED|Part I of Core Study (FE992026 CS29)||135
7918545|NCT00615836|19487441|P3|COMPLETED|Part I of Core Study (FE992026 CS29)||138
7918546|NCT00615836|19487442|P2|COMPLETED|Part I of Core Study (FE992026 CS29)||148
7918547|NCT00615836|19487443|P1|COMPLETED|Part I of Core Study (FE992026 CS29)||144
7918548|NCT00615836|19487439|P5|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156
7918549|NCT00615836|19487440|P4|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146
7918550|NCT00615836|19487441|P3|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148
7918551|NCT00615836|19487442|P2|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152
7918552|NCT00615836|19487443|P1|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155
7918553|NCT00615836|19487439|P5|STARTED|Part I of Core Study (FE992026 CS29)||160
7918554|NCT00615836|19487440|P4|STARTED|Part I of Core Study (FE992026 CS29)||160
7918555|NCT00615836|19487441|P3|STARTED|Part I of Core Study (FE992026 CS29)||158
7918556|NCT00615836|19487442|P2|STARTED|Part I of Core Study (FE992026 CS29)||158
7918557|NCT00615836|19487443|P1|STARTED|Part I of Core Study (FE992026 CS29)||163
7918558|NCT00615784|19487503|P1|NOT COMPLETED|Overall Study||0
7918559|NCT00615784|19487503|P1|COMPLETED|Overall Study||24
7918560|NCT00615784|19487503|P1|STARTED|Overall Study||24
7918561|NCT00615719|19487508|P1|NOT COMPLETED|Overall Study||5
7918562|NCT00615719|19487508|P1|COMPLETED|Overall Study||30
7918563|NCT00615719|19487508|P1|STARTED|Overall Study||35
7918564|NCT00615589|19487512|P1|NOT COMPLETED|Overall Study||0
7918565|NCT00615589|19487512|P1|COMPLETED|Overall Study||22
7918566|NCT00615589|19487512|P1|STARTED|Overall Study||22
7918567|NCT00615550|19487522|P2|NOT COMPLETED|Overall Study||1
7918568|NCT00615550|19487523|P1|NOT COMPLETED|Overall Study||6
7918569|NCT00615550|19487522|P2|COMPLETED|Overall Study||235
7918570|NCT00615550|19487523|P1|COMPLETED|Overall Study||223
7918571|NCT00615550|19487522|P2|STARTED|Overall Study||236
7918572|NCT00615550|19487523|P1|STARTED|Overall Study||229
7918573|NCT00615472|19487539|P2|NOT COMPLETED|Overall Study||0
7918574|NCT00615472|19487540|P1|NOT COMPLETED|Overall Study||0
7918575|NCT00615472|19487539|P2|COMPLETED|Overall Study||28
7918576|NCT00615472|19487540|P1|COMPLETED|Overall Study||30
7918577|NCT00615472|19487539|P2|STARTED|Overall Study||28
7918578|NCT00615472|19487540|P1|STARTED|Overall Study||30
7918579|NCT00615459|19487546|P4|NOT COMPLETED|Period III||0
7918580|NCT00615459|19487547|P3|NOT COMPLETED|Period III||1
7918581|NCT00615459|19487548|P2|NOT COMPLETED|Period III||3
7918582|NCT00615459|19487549|P1|NOT COMPLETED|Period III||0
7918583|NCT00615459|19487546|P4|COMPLETED|Period III||41
7918584|NCT00615459|19487547|P3|COMPLETED|Period III||39
7918585|NCT00615459|19487548|P2|COMPLETED|Period III||37
7918586|NCT00615459|19487549|P1|COMPLETED|Period III||36
7918587|NCT00615459|19487546|P4|STARTED|Period III||41
7918588|NCT00615459|19487547|P3|STARTED|Period III||40
7918589|NCT00615459|19487548|P2|STARTED|Period III||40
7918590|NCT00615459|19487549|P1|STARTED|Period III||36
7918591|NCT00615459|19487546|P4|NOT COMPLETED|Period II||1
7918592|NCT00615459|19487547|P3|NOT COMPLETED|Period II||0
7918593|NCT00615459|19487548|P2|NOT COMPLETED|Period II||0
7918594|NCT00615459|19487549|P1|NOT COMPLETED|Period II||1
7918595|NCT00615459|19487546|P4|COMPLETED|Period II||41
7918596|NCT00615459|19487547|P3|COMPLETED|Period II||40
7918597|NCT00615459|19487548|P2|COMPLETED|Period II||40
7918598|NCT00615459|19487549|P1|COMPLETED|Period II||36
7918599|NCT00615459|19487546|P4|STARTED|Period II||42
7918600|NCT00615459|19487547|P3|STARTED|Period II||40
7918601|NCT00615459|19487548|P2|STARTED|Period II||40
7918602|NCT00615459|19487549|P1|STARTED|Period II||37
7918603|NCT00615459|19487546|P4|NOT COMPLETED|Period I||1
7918604|NCT00615459|19487547|P3|NOT COMPLETED|Period I||2
7918605|NCT00615459|19487548|P2|NOT COMPLETED|Period I||1
7918606|NCT00615459|19487549|P1|NOT COMPLETED|Period I||4
7918607|NCT00615459|19487546|P4|COMPLETED|Period I||42
7918608|NCT00615459|19487547|P3|COMPLETED|Period I||40
7918609|NCT00615459|19487548|P2|COMPLETED|Period I||40
7918610|NCT00615459|19487549|P1|COMPLETED|Period I||37
7918611|NCT00615459|19487546|P4|STARTED|Period I||43
7918612|NCT00615459|19487547|P3|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42
7918613|NCT00615459|19487548|P2|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41
7918614|NCT00615459|19487549|P1|STARTED|Period I||41
7918615|NCT00615433|19487567|P4|NOT COMPLETED|Overall Study||45
7918616|NCT00615433|19487568|P3|NOT COMPLETED|Overall Study||39
7918617|NCT00615433|19487569|P2|NOT COMPLETED|Overall Study||53
7918618|NCT00615433|19487570|P1|NOT COMPLETED|Overall Study||43
7918619|NCT00615433|19487567|P4|COMPLETED|Overall Study||71
7918620|NCT00615433|19487568|P3|COMPLETED|Overall Study||84
7918621|NCT00615433|19487569|P2|COMPLETED|Overall Study||66
7918622|NCT00615433|19487570|P1|COMPLETED|Overall Study||77
7918623|NCT00615433|19487567|P4|STARTED|Overall Study||116
7918624|NCT00615433|19487568|P3|STARTED|Overall Study||123
7918625|NCT00615433|19487569|P2|STARTED|Overall Study||119
7918626|NCT00615433|19487570|P1|STARTED|Overall Study||120
7918627|NCT00615420|19487586|P2|NOT COMPLETED|Overall Study||27
7918628|NCT00615420|19487587|P1|NOT COMPLETED|Overall Study||31
7918629|NCT00615420|19487586|P2|COMPLETED|Overall Study||25
7918630|NCT00615420|19487587|P1|COMPLETED|Overall Study||23
7918631|NCT00615420|19487586|P2|STARTED|Overall Study||52
7918632|NCT00615420|19487587|P1|STARTED|Overall Study||54
7918633|NCT00615290|19487595|P1|NOT COMPLETED|Overall Study||8
7918634|NCT00615290|19487595|P1|COMPLETED|Overall Study||34
7918635|NCT00615290|19487595|P1|STARTED|Overall Study||42
7918636|NCT00615264|19487609|P2|NOT COMPLETED|Overall Study||52
7918637|NCT00615264|19487610|P1|NOT COMPLETED|Overall Study||50
7918638|NCT00615264|19487609|P2|COMPLETED|Overall Study||180
7918639|NCT00615264|19487610|P1|COMPLETED|Overall Study||175
7918640|NCT00615264|19487609|P2|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213
7918641|NCT00615264|19487610|P1|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209
7918642|NCT00615264|19487609|P2|Received at Least One Dose (ITT)|Overall Study||231
7918643|NCT00615264|19487610|P1|Received at Least One Dose (ITT)|Overall Study||225
7918644|NCT00615264|19487609|P2|STARTED|Overall Study||232
7918645|NCT00615264|19487610|P1|STARTED|Overall Study||225
7918646|NCT00615199|19487622|P4|NOT COMPLETED|Overall Study||2
7918647|NCT00615199|19487623|P3|NOT COMPLETED|Overall Study||1
7918648|NCT00615199|19487624|P2|NOT COMPLETED|Overall Study||2
7918649|NCT00615199|19487625|P1|NOT COMPLETED|Overall Study||8
7918650|NCT00615199|19487622|P4|COMPLETED|Overall Study||33
7918651|NCT00615199|19487623|P3|COMPLETED|Overall Study||33
7918652|NCT00615199|19487624|P2|COMPLETED|Overall Study||34
7918653|NCT00615199|19487625|P1|COMPLETED|Overall Study||26
7918654|NCT00615199|19487622|P4|STARTED|Overall Study||35
7918655|NCT00615199|19487623|P3|STARTED|Overall Study||34
7918656|NCT00615199|19487624|P2|STARTED|Overall Study||36
7918657|NCT00615199|19487625|P1|STARTED|Overall Study||34
7918658|NCT00615108|19487659|P1|NOT COMPLETED|Overall Study||507
7918659|NCT00615108|19487659|P1|COMPLETED|Overall Study||2641
7918660|NCT00615108|19487659|P1|STARTED|Overall Study||3148
7918661|NCT00615069|19487674|P1|NOT COMPLETED|Overall Study||16
7918662|NCT00615069|19487674|P1|COMPLETED|Overall Study||19
7918663|NCT00615069|19487674|P1|STARTED|Overall Study||35
7918664|NCT00615056|19487683|P4|NOT COMPLETED|Overall Study||35
7918665|NCT00615056|19487684|P3|NOT COMPLETED|Overall Study||36
7918666|NCT00615056|19487685|P2|NOT COMPLETED|Overall Study||51
7918667|NCT00615056|19487686|P1|NOT COMPLETED|Overall Study||49
7918668|NCT00615056|19487683|P4|COMPLETED|Overall Study||0
7918669|NCT00615056|19487684|P3|COMPLETED|Overall Study||0
7918670|NCT00615056|19487685|P2|COMPLETED|Overall Study||0
7918671|NCT00615056|19487686|P1|COMPLETED|Overall Study||0
7918672|NCT00615056|19487683|P4|Treated|Overall Study||35
7918673|NCT00615056|19487684|P3|Treated|Overall Study||36
7918674|NCT00615056|19487685|P2|Treated|Overall Study||51
7918675|NCT00615056|19487686|P1|Treated|Overall Study||46
7918676|NCT00615056|19487683|P4|STARTED|Overall Study||35
7918677|NCT00615056|19487684|P3|STARTED|Overall Study||36
7918678|NCT00615056|19487685|P2|STARTED|Overall Study||51
7918679|NCT00615056|19487686|P1|STARTED|Overall Study||49
7918680|NCT00615030|19487716|P12|NOT COMPLETED|Period III||0
7918681|NCT00615030|19487717|P11|NOT COMPLETED|Period III||0
7918682|NCT00615030|19487718|P10|NOT COMPLETED|Period III||0
7918683|NCT00615030|19487719|P9|NOT COMPLETED|Period III||0
7918684|NCT00615030|19487720|P8|NOT COMPLETED|Period III||0
7918685|NCT00615030|19487721|P7|NOT COMPLETED|Period III||0
7918686|NCT00615030|19487722|P6|NOT COMPLETED|Period III||0
7918687|NCT00615030|19487723|P5|NOT COMPLETED|Period III||0
7918688|NCT00615030|19487724|P4|NOT COMPLETED|Period III||1
7918689|NCT00615030|19487725|P3|NOT COMPLETED|Period III||0
7918690|NCT00615030|19487726|P2|NOT COMPLETED|Period III||0
7918691|NCT00615030|19487727|P1|NOT COMPLETED|Period III||1
7918692|NCT00615030|19487716|P12|COMPLETED|Period III||6
7918693|NCT00615030|19487717|P11|COMPLETED|Period III||7
7918694|NCT00615030|19487718|P10|COMPLETED|Period III||8
7918695|NCT00615030|19487719|P9|COMPLETED|Period III||7
7918696|NCT00615030|19487720|P8|COMPLETED|Period III||7
7918697|NCT00615030|19487721|P7|COMPLETED|Period III||6
7918698|NCT00615030|19487722|P6|COMPLETED|Period III||5
7918699|NCT00615030|19487723|P5|COMPLETED|Period III||8
7918700|NCT00615030|19487724|P4|COMPLETED|Period III||6
7918701|NCT00615030|19487725|P3|COMPLETED|Period III||8
7918702|NCT00615030|19487726|P2|COMPLETED|Period III||8
7918703|NCT00615030|19487727|P1|COMPLETED|Period III||7
7918704|NCT00615030|19487716|P12|STARTED|Period III||6
7918705|NCT00615030|19487717|P11|STARTED|Period III||7
7918706|NCT00615030|19487718|P10|STARTED|Period III||8
7918707|NCT00615030|19487719|P9|STARTED|Period III||7
7918708|NCT00615030|19487720|P8|STARTED|Period III||7
7918709|NCT00615030|19487721|P7|STARTED|Period III||6
7918710|NCT00615030|19487722|P6|STARTED|Period III||5
7918711|NCT00615030|19487723|P5|STARTED|Period III||8
7918712|NCT00615030|19487724|P4|STARTED|Period III||7
7918713|NCT00615030|19487725|P3|STARTED|Period III||8
7918714|NCT00615030|19487726|P2|STARTED|Period III||8
7918715|NCT00615030|19487727|P1|STARTED|Period III||8
7918716|NCT00615030|19487716|P12|NOT COMPLETED|Period II||0
7918717|NCT00615030|19487717|P11|NOT COMPLETED|Period II||0
7918718|NCT00615030|19487718|P10|NOT COMPLETED|Period II||0
7918719|NCT00615030|19487719|P9|NOT COMPLETED|Period II||1
7918720|NCT00615030|19487720|P8|NOT COMPLETED|Period II||0
7918721|NCT00615030|19487721|P7|NOT COMPLETED|Period II||1
7918722|NCT00615030|19487722|P6|NOT COMPLETED|Period II||0
7918723|NCT00615030|19487723|P5|NOT COMPLETED|Period II||0
7918724|NCT00615030|19487724|P4|NOT COMPLETED|Period II||1
7918725|NCT00615030|19487725|P3|NOT COMPLETED|Period II||1
7918726|NCT00615030|19487726|P2|NOT COMPLETED|Period II||0
7918727|NCT00615030|19487727|P1|NOT COMPLETED|Period II||0
7918728|NCT00615030|19487716|P12|COMPLETED|Period II||6
7918729|NCT00615030|19487717|P11|COMPLETED|Period II||7
7918730|NCT00615030|19487718|P10|COMPLETED|Period II||8
7918731|NCT00615030|19487719|P9|COMPLETED|Period II||7
7918732|NCT00615030|19487720|P8|COMPLETED|Period II||7
7918733|NCT00615030|19487721|P7|COMPLETED|Period II||6
7918734|NCT00615030|19487722|P6|COMPLETED|Period II||5
7918735|NCT00615030|19487723|P5|COMPLETED|Period II||8
7918736|NCT00615030|19487724|P4|COMPLETED|Period II||7
7918737|NCT00615030|19487725|P3|COMPLETED|Period II||8
7918738|NCT00615030|19487726|P2|COMPLETED|Period II||8
7918739|NCT00615030|19487727|P1|COMPLETED|Period II||8
7918740|NCT00615030|19487716|P12|STARTED|Period II||6
7918741|NCT00615030|19487717|P11|STARTED|Period II||7
7918742|NCT00615030|19487718|P10|STARTED|Period II||8
7918743|NCT00615030|19487719|P9|STARTED|Period II||8
7918744|NCT00615030|19487720|P8|STARTED|Period II||7
7918745|NCT00615030|19487721|P7|STARTED|Period II||7
7918746|NCT00615030|19487722|P6|STARTED|Period II||5
7918747|NCT00615030|19487723|P5|STARTED|Period II||8
7918748|NCT00615030|19487724|P4|STARTED|Period II||8
7918749|NCT00615030|19487725|P3|STARTED|Period II||9
7918750|NCT00615030|19487726|P2|STARTED|Period II||8
7918751|NCT00615030|19487727|P1|STARTED|Period II||8
7918752|NCT00615030|19487716|P12|NOT COMPLETED|Period I||1
7918753|NCT00615030|19487717|P11|NOT COMPLETED|Period I||1
7918754|NCT00615030|19487718|P10|NOT COMPLETED|Period I||0
7918755|NCT00615030|19487719|P9|NOT COMPLETED|Period I||1
7918756|NCT00615030|19487720|P8|NOT COMPLETED|Period I||0
7918757|NCT00615030|19487721|P7|NOT COMPLETED|Period I||0
7918758|NCT00615030|19487722|P6|NOT COMPLETED|Period I||1
7918759|NCT00615030|19487723|P5|NOT COMPLETED|Period I||1
7918760|NCT00615030|19487724|P4|NOT COMPLETED|Period I||0
7918761|NCT00615030|19487725|P3|NOT COMPLETED|Period I||0
7918762|NCT00615030|19487726|P2|NOT COMPLETED|Period I||0
7918763|NCT00615030|19487727|P1|NOT COMPLETED|Period I||1
7918764|NCT00615030|19487716|P12|COMPLETED|Period I||6
7918765|NCT00615030|19487717|P11|COMPLETED|Period I||7
7918766|NCT00615030|19487718|P10|COMPLETED|Period I||8
7918767|NCT00615030|19487719|P9|COMPLETED|Period I||8
7918768|NCT00615030|19487720|P8|COMPLETED|Period I||7
7918769|NCT00615030|19487721|P7|COMPLETED|Period I||7
7918770|NCT00615030|19487722|P6|COMPLETED|Period I||5
7918771|NCT00615030|19487723|P5|COMPLETED|Period I||8
7918772|NCT00615030|19487724|P4|COMPLETED|Period I||8
7918773|NCT00615030|19487725|P3|COMPLETED|Period I||9
7918774|NCT00615030|19487726|P2|COMPLETED|Period I||8
7918775|NCT00615030|19487727|P1|COMPLETED|Period I||8
7918776|NCT00615030|19487716|P12|STARTED|Period I||7
7918777|NCT00615030|19487717|P11|STARTED|Period I||8
7918778|NCT00615030|19487718|P10|STARTED|Period I||8
7918779|NCT00615030|19487719|P9|STARTED|Period I||9
7918780|NCT00615030|19487720|P8|STARTED|Period I||7
7918781|NCT00615030|19487721|P7|STARTED|Period I||7
7918782|NCT00615030|19487722|P6|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6
7918783|NCT00615030|19487723|P5|STARTED|Period I||9
7918784|NCT00615030|19487724|P4|STARTED|Period I||8
7918785|NCT00615030|19487725|P3|STARTED|Period I||9
7918786|NCT00615030|19487726|P2|STARTED|Period I||8
7918787|NCT00615030|19487727|P1|STARTED|Period I||9
7918788|NCT00615017|19487747|P6|NOT COMPLETED|Overall Study||3
7918789|NCT00615017|19487748|P5|NOT COMPLETED|Overall Study||1
7918790|NCT00615017|19487749|P4|NOT COMPLETED|Overall Study||1
7918791|NCT00615017|19487750|P3|NOT COMPLETED|Overall Study||5
7918792|NCT00615017|19487751|P2|NOT COMPLETED|Overall Study||1
7918793|NCT00615017|19487752|P1|NOT COMPLETED|Overall Study||0
7918794|NCT00615017|19487747|P6|COMPLETED|Overall Study|Patient completed the study drug|20
7918795|NCT00615017|19487748|P5|COMPLETED|Overall Study|Patient completed the study drug|7
7918796|NCT00615017|19487749|P4|COMPLETED|Overall Study|Patient completed the study drug|9
7918797|NCT00615017|19487750|P3|COMPLETED|Overall Study|Patient completed the study drug|7
7918798|NCT00615017|19487751|P2|COMPLETED|Overall Study|Patient completed the study drug|8
7918799|NCT00615017|19487752|P1|COMPLETED|Overall Study|Patient completed the study drug|8
7918800|NCT00615017|19487747|P6|STARTED|Overall Study|Patients received treatment|23
7918801|NCT00615017|19487748|P5|STARTED|Overall Study|Patients received treatment|8
7918802|NCT00615017|19487749|P4|STARTED|Overall Study|Patients received treatment|10
7918803|NCT00615017|19487750|P3|STARTED|Overall Study|Patients received treatment|12
7918804|NCT00615017|19487751|P2|STARTED|Overall Study|Patients received treatment|9
7918805|NCT00615017|19487752|P1|STARTED|Overall Study|Patients received treatment|8
7918806|NCT00614991|19487910|P6|NOT COMPLETED|Overall Study||0
7918807|NCT00614991|19487911|P5|NOT COMPLETED|Overall Study||1
7918808|NCT00614991|19487912|P4|NOT COMPLETED|Overall Study||0
7918809|NCT00614991|19487913|P3|NOT COMPLETED|Overall Study||0
7918810|NCT00614991|19487914|P2|NOT COMPLETED|Overall Study||3
7918811|NCT00614991|19487915|P1|NOT COMPLETED|Overall Study||3
7918812|NCT00614991|19487910|P6|COMPLETED|Overall Study||6
7918813|NCT00614991|19487911|P5|COMPLETED|Overall Study||6
7918814|NCT00614991|19487912|P4|COMPLETED|Overall Study||7
7918815|NCT00614991|19487913|P3|COMPLETED|Overall Study||7
7918816|NCT00614991|19487914|P2|COMPLETED|Overall Study||6
7918817|NCT00614991|19487915|P1|COMPLETED|Overall Study||5
7918818|NCT00614991|19487910|P6|STARTED|Overall Study||6
7918819|NCT00614991|19487911|P5|STARTED|Overall Study||7
7918820|NCT00614991|19487912|P4|STARTED|Overall Study||7
7918821|NCT00614991|19487913|P3|STARTED|Overall Study||7
7918822|NCT00614991|19487914|P2|STARTED|Overall Study||9
7918823|NCT00614991|19487915|P1|STARTED|Overall Study||8
7918824|NCT00614939|19487949|P2|NOT COMPLETED|Overall Study||43
7918825|NCT00614939|19487950|P1|NOT COMPLETED|Overall Study||35
7918826|NCT00614939|19487949|P2|COMPLETED|Overall Study|Completed 52 weeks of treatment|42
7918827|NCT00614939|19487950|P1|COMPLETED|Overall Study|Completed 52 weeks of treatment|50
7918828|NCT00614939|19487949|P2|STARTED|Overall Study|Randomized and treated|85
7918829|NCT00614939|19487950|P1|STARTED|Overall Study|Randomized and treated|85
7918830|NCT00614926|19487984|P2|NOT COMPLETED|Overall Study||0
7918831|NCT00614926|19487985|P1|NOT COMPLETED|Overall Study||4
7918832|NCT00614926|19487984|P2|COMPLETED|Overall Study||7
7918833|NCT00614926|19487985|P1|COMPLETED|Overall Study||21
7918834|NCT00614926|19487984|P2|STARTED|Overall Study||7
7918835|NCT00614926|19487985|P1|STARTED|Overall Study||25
7918836|NCT00614913|19487993|P1|NOT COMPLETED|Overall Study||0
7918837|NCT00614913|19487993|P1|COMPLETED|Overall Study||76
7918838|NCT00614913|19487993|P1|STARTED|Overall Study||76
7918839|NCT00614874|19487998|P1|NOT COMPLETED|Overall Study||2
7918840|NCT00614874|19487998|P1|COMPLETED|Overall Study||14
7918841|NCT00614874|19487998|P1|STARTED|Overall Study||16
7918842|NCT00614822|19488005|P1|NOT COMPLETED|Overall Study||3
7918843|NCT00614822|19488005|P1|COMPLETED|Overall Study||47
7918844|NCT00614822|19488005|P1|STARTED|Overall Study||50
7918845|NCT00614744|19488014|P2|NOT COMPLETED|Overall Study||6
7918846|NCT00614744|19488015|P1|NOT COMPLETED|Overall Study||5
7918847|NCT00614744|19488014|P2|COMPLETED|Overall Study||79
7918848|NCT00614744|19488015|P1|COMPLETED|Overall Study||78
7918849|NCT00614744|19488014|P2|STARTED|Overall Study||85
7918850|NCT00614744|19488015|P1|STARTED|Overall Study||83
7918851|NCT00614614|19488041|P5|NOT COMPLETED|Booster Vaccination Phase||13
7918852|NCT00614614|19488042|P4|NOT COMPLETED|Booster Vaccination Phase||19
7918853|NCT00614614|19488043|P3|NOT COMPLETED|Booster Vaccination Phase||27
7918854|NCT00614614|19488044|P2|NOT COMPLETED|Booster Vaccination Phase||6
7918855|NCT00614614|19488045|P1|NOT COMPLETED|Booster Vaccination Phase||0
7918856|NCT00614614|19488041|P5|COMPLETED|Booster Vaccination Phase||396
7918857|NCT00614614|19488042|P4|COMPLETED|Booster Vaccination Phase||210
7918858|NCT00614614|19488043|P3|COMPLETED|Booster Vaccination Phase||405
7918859|NCT00614614|19488044|P2|COMPLETED|Booster Vaccination Phase||227
7918860|NCT00614614|19488045|P1|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
7918861|NCT00614614|19488041|P5|STARTED|Booster Vaccination Phase||409
7918862|NCT00614614|19488042|P4|STARTED|Booster Vaccination Phase||229
7918863|NCT00614614|19488043|P3|STARTED|Booster Vaccination Phase||432
7918864|NCT00614614|19488044|P2|STARTED|Booster Vaccination Phase||233
7918865|NCT00614614|19488045|P1|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
7918866|NCT00614614|19488041|P5|NOT COMPLETED|Primary Vaccination Phase||0
7918867|NCT00614614|19488042|P4|NOT COMPLETED|Primary Vaccination Phase||0
7918868|NCT00614614|19488043|P3|NOT COMPLETED|Primary Vaccination Phase||0
7918869|NCT00614614|19488044|P2|NOT COMPLETED|Primary Vaccination Phase||17
7918870|NCT00614614|19488045|P1|NOT COMPLETED|Primary Vaccination Phase||90
7918871|NCT00614614|19488041|P5|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
7918872|NCT00614614|19488042|P4|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
7918873|NCT00614614|19488043|P3|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
7918874|NCT00614614|19488044|P2|COMPLETED|Primary Vaccination Phase||265
7918875|NCT00614614|19488045|P1|COMPLETED|Primary Vaccination Phase||1182
7918876|NCT00614614|19488041|P5|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
7918877|NCT00614614|19488042|P4|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
7918878|NCT00614614|19488043|P3|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
7918879|NCT00614614|19488044|P2|STARTED|Primary Vaccination Phase||282
7918880|NCT00614614|19488045|P1|STARTED|Primary Vaccination Phase||1272
7918881|NCT00614575|19488168|P1|NOT COMPLETED|Overall Study||228
7918882|NCT00614575|19488168|P1|COMPLETED|Overall Study||861
7918883|NCT00614575|19488168|P1|STARTED|Overall Study|The number of patients enrolled.|1089
7918884|NCT00614523|19488179|P2|NOT COMPLETED|Overall Study||131
7918885|NCT00614523|19488180|P1|NOT COMPLETED|Overall Study||63
7918886|NCT00614523|19488179|P2|COMPLETED|Overall Study||36
7918887|NCT00614523|19488180|P1|COMPLETED|Overall Study||20
7918888|NCT00614523|19488179|P2|STARTED|Overall Study||167
7918889|NCT00614523|19488180|P1|STARTED|Overall Study||83
7918890|NCT00614484|19488204|P1|NOT COMPLETED|Overall Study||0
7918891|NCT00614484|19488204|P1|COMPLETED|Overall Study||28
7918892|NCT00614484|19488204|P1|STARTED|Overall Study||28
7918893|NCT00614458|19488209|P1|NOT COMPLETED|Overall Study||0
7918894|NCT00614458|19488209|P1|COMPLETED|Overall Study||6
7918895|NCT00614458|19488209|P1|STARTED|Overall Study||6
7918896|NCT00614445|19488215|P2|NOT COMPLETED|Overall Study||49
7918897|NCT00614445|19488216|P1|NOT COMPLETED|Overall Study||28
7918898|NCT00614445|19488215|P2|COMPLETED|Overall Study||91
7918899|NCT00614445|19488216|P1|COMPLETED|Overall Study||112
7918900|NCT00614445|19488215|P2|STARTED|Overall Study||140
7918901|NCT00614445|19488216|P1|STARTED|Overall Study||140
7918902|NCT00614432|19488224|P2|NOT COMPLETED|Overall Study||0
7918903|NCT00614432|19488225|P1|NOT COMPLETED|Overall Study||0
7918904|NCT00614432|19488224|P2|COMPLETED|Overall Study||6
7918905|NCT00614432|19488225|P1|COMPLETED|Overall Study||4
7918906|NCT00614432|19488224|P2|STARTED|Overall Study||6
7918907|NCT00614432|19488225|P1|STARTED|Overall Study||4
7918908|NCT00614406|19488233|P2|NOT COMPLETED|Overall Study||0
7918909|NCT00614406|19488234|P1|NOT COMPLETED|Overall Study||0
7918910|NCT00614406|19488233|P2|COMPLETED|Overall Study||4
7918911|NCT00614406|19488234|P1|COMPLETED|Overall Study||7
7918912|NCT00614406|19488233|P2|STARTED|Overall Study||4
7918913|NCT00614406|19488234|P1|STARTED|Overall Study||7
7918914|NCT00614393|19488245|P5|NOT COMPLETED|Overall Study||180
7918915|NCT00614393|19488246|P4|NOT COMPLETED|Overall Study||180
7918916|NCT00614393|19488247|P3|NOT COMPLETED|Overall Study||10
7918917|NCT00614393|19488248|P2|NOT COMPLETED|Overall Study||8
7918918|NCT00614393|19488249|P1|NOT COMPLETED|Overall Study||180
7918919|NCT00614393|19488245|P5|COMPLETED|Overall Study||0
7918920|NCT00614393|19488246|P4|COMPLETED|Overall Study||0
7918921|NCT00614393|19488247|P3|COMPLETED|Overall Study||0
7918922|NCT00614393|19488248|P2|COMPLETED|Overall Study||0
7918923|NCT00614393|19488249|P1|COMPLETED|Overall Study||0
7918924|NCT00614393|19488245|P5|Treated|Overall Study||178
7918925|NCT00614393|19488246|P4|Treated|Overall Study||180
7918926|NCT00614393|19488247|P3|Treated|Overall Study||10
7918927|NCT00614393|19488248|P2|Treated|Overall Study||8
7918928|NCT00614393|19488249|P1|Treated|Overall Study||180
7918929|NCT00614393|19488245|P5|STARTED|Overall Study||180
7918930|NCT00614393|19488246|P4|STARTED|Overall Study||180
7918931|NCT00614393|19488247|P3|STARTED|Overall Study||10
7918932|NCT00614393|19488248|P2|STARTED|Overall Study||8
7918933|NCT00614393|19488249|P1|STARTED|Overall Study||180
7918934|NCT00614380|19488295|P4|NOT COMPLETED|Overall Study||2
7918935|NCT00614380|19488296|P3|NOT COMPLETED|Overall Study||1
7918936|NCT00614380|19488297|P2|NOT COMPLETED|Overall Study||8
7918937|NCT00614380|19488298|P1|NOT COMPLETED|Overall Study||35
7918938|NCT00614380|19488295|P4|COMPLETED|Overall Study||179
7918939|NCT00614380|19488296|P3|COMPLETED|Overall Study||24
7918940|NCT00614380|19488297|P2|COMPLETED|Overall Study||198
7918941|NCT00614380|19488298|P1|COMPLETED|Overall Study||529
7918942|NCT00614380|19488295|P4|STARTED|Overall Study||181
7918943|NCT00614380|19488296|P3|STARTED|Overall Study||25
7918944|NCT00614380|19488297|P2|STARTED|Overall Study||206
7918945|NCT00614380|19488298|P1|STARTED|Overall Study||564
7918946|NCT00614315|19488347|P1|NOT COMPLETED|Overall Study||0
7918947|NCT00614315|19488347|P1|COMPLETED|Overall Study||30
7918948|NCT00614315|19488347|P1|STARTED|Overall Study||30
7918949|NCT00614198|19488354|P2|NOT COMPLETED|Stage 2||12
7918950|NCT00614198|19488355|P1|NOT COMPLETED|Stage 2||8
7918951|NCT00614198|19488354|P2|COMPLETED|Stage 2||17
7918952|NCT00614198|19488355|P1|COMPLETED|Stage 2||18
7918953|NCT00614198|19488354|P2|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29
7918954|NCT00614198|19488355|P1|STARTED|Stage 2||26
7918955|NCT00614198|19488354|P2|NOT COMPLETED|Stage 1||5
7918956|NCT00614198|19488355|P1|NOT COMPLETED|Stage 1||12
7918957|NCT00614198|19488354|P2|COMPLETED|Stage 1||29
7918958|NCT00614198|19488355|P1|COMPLETED|Stage 1||26
7918959|NCT00614198|19488354|P2|STARTED|Stage 1||34
7918960|NCT00614198|19488355|P1|STARTED|Stage 1||38
7918961|NCT00614120|19488365|P4|NOT COMPLETED|Overall Study||16
7918962|NCT00614120|19488366|P3|NOT COMPLETED|Overall Study||59
7918963|NCT00614120|19488367|P2|NOT COMPLETED|Overall Study||46
7918964|NCT00614120|19488368|P1|NOT COMPLETED|Overall Study||29
7918965|NCT00614120|19488365|P4|COMPLETED|Overall Study||215
7918966|NCT00614120|19488366|P3|COMPLETED|Overall Study||175
7918967|NCT00614120|19488367|P2|COMPLETED|Overall Study||187
7918968|NCT00614120|19488368|P1|COMPLETED|Overall Study||202
7918969|NCT00614120|19488365|P4|Exposed to Study Drug|Overall Study||231
7918970|NCT00614120|19488366|P3|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233
7918971|NCT00614120|19488367|P2|Exposed to Study Drug|Overall Study||233
7918972|NCT00614120|19488368|P1|Exposed to Study Drug|Overall Study||231
7918973|NCT00614120|19488365|P4|STARTED|Overall Study|Randomised|231
7918974|NCT00614120|19488366|P3|STARTED|Overall Study|Randomised|234
7918975|NCT00614120|19488367|P2|STARTED|Overall Study|Randomised|233
7918976|NCT00614120|19488368|P1|STARTED|Overall Study|Randomised|231
7918977|NCT00614055|19488409|P3|NOT COMPLETED|Overall Study||5
7918978|NCT00614055|19488410|P2|NOT COMPLETED|Overall Study||6
7918979|NCT00614055|19488411|P1|NOT COMPLETED|Overall Study||4
7918980|NCT00614055|19488409|P3|COMPLETED|Overall Study||55
7918981|NCT00614055|19488410|P2|COMPLETED|Overall Study||53
7918982|NCT00614055|19488411|P1|COMPLETED|Overall Study||55
7918983|NCT00614055|19488409|P3|Exposed|Overall Study||60
7918984|NCT00614055|19488410|P2|Exposed|Overall Study||59
7918985|NCT00614055|19488411|P1|Exposed|Overall Study||59
7918986|NCT00614055|19488409|P3|STARTED|Overall Study||60
7918987|NCT00614055|19488410|P2|STARTED|Overall Study||59
7918988|NCT00614055|19488411|P1|STARTED|Overall Study||59
7918989|NCT00613951|19488458|P3|NOT COMPLETED|Overall Study||5
7918990|NCT00613951|19488459|P2|NOT COMPLETED|Overall Study||5
7918991|NCT00613951|19488460|P1|NOT COMPLETED|Overall Study||7
7918992|NCT00613951|19488458|P3|COMPLETED|Overall Study||57
7918993|NCT00613951|19488459|P2|COMPLETED|Overall Study||54
7918994|NCT00613951|19488460|P1|COMPLETED|Overall Study||54
7918995|NCT00613951|19488458|P3|Exposed|Overall Study||62
7918996|NCT00613951|19488459|P2|Exposed|Overall Study||59
7918997|NCT00613951|19488460|P1|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60
7918998|NCT00613951|19488458|P3|STARTED|Overall Study||62
7918999|NCT00613951|19488459|P2|STARTED|Overall Study||59
7919000|NCT00613951|19488460|P1|STARTED|Overall Study||61
7919001|NCT00613938|19488505|P4|NOT COMPLETED|Overall Study||26
7919002|NCT00613938|19488506|P3|NOT COMPLETED|Overall Study||23
7919003|NCT00613938|19488507|P2|NOT COMPLETED|Overall Study||28
7919004|NCT00613938|19488508|P1|NOT COMPLETED|Overall Study||20
7919005|NCT00613938|19488505|P4|COMPLETED|Overall Study||253
7919006|NCT00613938|19488506|P3|COMPLETED|Overall Study||255
7919007|NCT00613938|19488507|P2|COMPLETED|Overall Study||247
7919008|NCT00613938|19488508|P1|COMPLETED|Overall Study||49
7919009|NCT00613938|19488505|P4|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279
7919010|NCT00613938|19488506|P3|STARTED|Overall Study||278
7919011|NCT00613938|19488507|P2|STARTED|Overall Study||275
7919012|NCT00613938|19488508|P1|STARTED|Overall Study||69
7919013|NCT00613925|19488540|P2|NOT COMPLETED|Overall Study||1
7919014|NCT00613925|19488541|P1|NOT COMPLETED|Overall Study||0
7919015|NCT00613925|19488540|P2|COMPLETED|Overall Study||32
7919016|NCT00613925|19488541|P1|COMPLETED|Overall Study||37
7919017|NCT00613925|19488540|P2|STARTED|Overall Study||33
7919018|NCT00613925|19488541|P1|STARTED|Overall Study||37
7919019|NCT00613834|19488551|P2|NOT COMPLETED|Overall Study||3
7919020|NCT00613834|19488552|P1|NOT COMPLETED|Overall Study||0
7919021|NCT00613834|19488551|P2|COMPLETED|Overall Study||26
7919022|NCT00613834|19488552|P1|COMPLETED|Overall Study||29
7919023|NCT00613834|19488551|P2|STARTED|Overall Study||29
7919024|NCT00613834|19488552|P1|STARTED|Overall Study||29
7919025|NCT00613821|19488564|P2|NOT COMPLETED|Overall Study||1
7919026|NCT00613821|19488565|P1|NOT COMPLETED|Overall Study||2
7919027|NCT00613821|19488564|P2|COMPLETED|Overall Study||39
7919028|NCT00613821|19488565|P1|COMPLETED|Overall Study||38
7919029|NCT00613821|19488564|P2|STARTED|Overall Study||40
7919030|NCT00613821|19488565|P1|STARTED|Overall Study||40
7919031|NCT00613730|19488571|P1|NOT COMPLETED|Overall Study||3
7919032|NCT00613730|19488571|P1|COMPLETED|Overall Study||0
7919033|NCT00613730|19488571|P1|STARTED|Overall Study||3
7919034|NCT00613626|19488580|P3|NOT COMPLETED|Overall Study||0
7919035|NCT00613626|19488581|P2|NOT COMPLETED|Overall Study||1
7919036|NCT00613626|19488582|P1|NOT COMPLETED|Overall Study||0
7919037|NCT00613626|19488580|P3|COMPLETED|Overall Study||7
7919038|NCT00613626|19488581|P2|COMPLETED|Overall Study||33
7919039|NCT00613626|19488582|P1|COMPLETED|Overall Study||33
7919040|NCT00613626|19488580|P3|1st Dose ZD6474|Overall Study||7
7919041|NCT00613626|19488581|P2|1st Dose ZD6474|Overall Study||34
7919042|NCT00613626|19488582|P1|1st Dose ZD6474|Overall Study||33
7919043|NCT00613626|19488580|P3|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7
7919044|NCT00613626|19488581|P2|STARTED|Overall Study||34
7919045|NCT00613626|19488582|P1|STARTED|Overall Study||33
7919046|NCT00613574|19488598|P1|NOT COMPLETED|Overall Study||6
7919047|NCT00613574|19488598|P1|COMPLETED|Overall Study||401
7919048|NCT00613574|19488598|P1|STARTED|Overall Study||407
7919049|NCT00613509|19488610|P2|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
7919050|NCT00613509|19488611|P1|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
7919051|NCT00613509|19488610|P2|COMPLETED|Cycle 2 (Group 2 = Crossover)||4
7919052|NCT00613509|19488611|P1|COMPLETED|Cycle 2 (Group 2 = Crossover)||11
7919053|NCT00613509|19488610|P2|STARTED|Cycle 2 (Group 2 = Crossover)||4
7919054|NCT00613509|19488611|P1|STARTED|Cycle 2 (Group 2 = Crossover)||11
7919055|NCT00613509|19488610|P2|NOT COMPLETED|Cycle 1||8
7919056|NCT00613509|19488611|P1|NOT COMPLETED|Cycle 1||5
7919057|NCT00613509|19488610|P2|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4
7919058|NCT00613509|19488611|P1|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6
7919059|NCT00613509|19488610|P2|STARTED|Cycle 1||12
7919060|NCT00613509|19488611|P1|STARTED|Cycle 1||11
7919061|NCT00613405|19488635|P2|NOT COMPLETED|Overall Study||0
7919062|NCT00613405|19488636|P1|NOT COMPLETED|Overall Study||0
7919063|NCT00613405|19488635|P2|COMPLETED|Overall Study||42
7919064|NCT00613405|19488636|P1|COMPLETED|Overall Study||45
7919065|NCT00613405|19488635|P2|STARTED|Overall Study||42
7919066|NCT00613405|19488636|P1|STARTED|Overall Study||45
7919067|NCT00613379|19488645|P3|NOT COMPLETED|Overall Study||0
7919068|NCT00613379|19488646|P2|NOT COMPLETED|Overall Study||0
7919069|NCT00613379|19488647|P1|NOT COMPLETED|Overall Study||0
7919070|NCT00613379|19488645|P3|COMPLETED|Overall Study||11
7919071|NCT00613379|19488646|P2|COMPLETED|Overall Study||10
7919072|NCT00613379|19488647|P1|COMPLETED|Overall Study||10
7919073|NCT00613379|19488645|P3|STARTED|Overall Study||11
7919074|NCT00613379|19488646|P2|STARTED|Overall Study||10
7919075|NCT00613379|19488647|P1|STARTED|Overall Study||10
7919076|NCT00613366|19488657|P2|NOT COMPLETED|Overall Study||2
7919077|NCT00613366|19488658|P1|NOT COMPLETED|Overall Study||3
7919078|NCT00613366|19488657|P2|COMPLETED|Overall Study||18
7919079|NCT00613366|19488658|P1|COMPLETED|Overall Study||17
7919080|NCT00613366|19488657|P2|STARTED|Overall Study||20
7919081|NCT00613366|19488658|P1|STARTED|Overall Study||20
7919082|NCT00613327|19488666|P1|NOT COMPLETED|Overall Study||101
7919083|NCT00613327|19488666|P1|COMPLETED|Overall Study||244
7919084|NCT00613327|19488666|P1|STARTED|Overall Study||345
7919085|NCT00613314|19488685|P1|NOT COMPLETED|Overall Study||155
7919086|NCT00613314|19488685|P1|COMPLETED|Overall Study||15113
7919087|NCT00613314|19488685|P1|STARTED|Overall Study||15268
7919088|NCT00613301|19488693|P1|NOT COMPLETED|Overall Study||228
7919089|NCT00613301|19488693|P1|COMPLETED|Overall Study||188
7919090|NCT00613301|19488693|P1|STARTED|Overall Study||416
7919091|NCT00613106|19488702|P2|NOT COMPLETED|Overall Study||9
7919092|NCT00613106|19488703|P1|NOT COMPLETED|Overall Study||20
7919093|NCT00613106|19488702|P2|COMPLETED|Overall Study||38
7919094|NCT00613106|19488703|P1|COMPLETED|Overall Study||112
7919095|NCT00613106|19488702|P2|STARTED|Overall Study||47
7919096|NCT00613106|19488703|P1|STARTED|Overall Study||132
7919097|NCT00613080|19488709|P1|NOT COMPLETED|Overall Study||11
7919098|NCT00613080|19488709|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68
7919099|NCT00613080|19488709|P1|STARTED|Overall Study||79
7919100|NCT00613028|19488723|P2|NOT COMPLETED|Overall Study||1
7919101|NCT00613028|19488724|P1|NOT COMPLETED|Overall Study||0
7919102|NCT00613028|19488723|P2|COMPLETED|Overall Study||12
7919103|NCT00613028|19488724|P1|COMPLETED|Overall Study||10
7919104|NCT00613028|19488723|P2|STARTED|Overall Study||13
7919105|NCT00613028|19488724|P1|STARTED|Overall Study||10
7919106|NCT00613015|19488744|P6|NOT COMPLETED|Overall Study||3
7919107|NCT00613015|19488745|P5|NOT COMPLETED|Overall Study||2
7919108|NCT00613015|19488746|P4|NOT COMPLETED|Overall Study||3
7919109|NCT00613015|19488747|P3|NOT COMPLETED|Overall Study||3
7919110|NCT00613015|19488748|P2|NOT COMPLETED|Overall Study||1
7919111|NCT00613015|19488749|P1|NOT COMPLETED|Overall Study||0
7919112|NCT00613015|19488744|P6|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16
7919113|NCT00613015|19488745|P5|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13
7919114|NCT00613015|19488746|P4|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21
7919115|NCT00613015|19488747|P3|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23
7919116|NCT00613015|19488748|P2|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11
7919117|NCT00613015|19488749|P1|COMPLETED|Overall Study||13
7919118|NCT00613015|19488744|P6|STARTED|Overall Study||19
7919119|NCT00613015|19488745|P5|STARTED|Overall Study||15
7919120|NCT00613015|19488746|P4|STARTED|Overall Study||24
7919121|NCT00613015|19488747|P3|STARTED|Overall Study||26
7919122|NCT00613015|19488748|P2|STARTED|Overall Study||12
7919123|NCT00613015|19488749|P1|STARTED|Overall Study||13
7919124|NCT00612924|19488771|P2|NOT COMPLETED|Overall Study||9
7919125|NCT00612924|19488772|P1|NOT COMPLETED|Overall Study||7
7919126|NCT00612924|19488771|P2|COMPLETED|Overall Study||85
7919127|NCT00612924|19488772|P1|COMPLETED|Overall Study||94
7919128|NCT00612924|19488771|P2|STARTED|Overall Study||94
7919129|NCT00612924|19488772|P1|STARTED|Overall Study||101
7919130|NCT00612807|19488785|P2|NOT COMPLETED|Overall Study||0
7919131|NCT00612807|19488786|P1|NOT COMPLETED|Overall Study||2
7919132|NCT00612807|19488785|P2|COMPLETED|Overall Study||28
7919133|NCT00612807|19488786|P1|COMPLETED|Overall Study||12
7919134|NCT00612807|19488785|P2|STARTED|Overall Study||28
7919135|NCT00612807|19488786|P1|STARTED|Overall Study||14
7919136|NCT00612768|19488794|P1|NOT COMPLETED|Overall Study||0
7919137|NCT00612768|19488794|P1|COMPLETED|Overall Study||50
7919138|NCT00612768|19488794|P1|STARTED|Overall Study||50
7919139|NCT00612716|19488819|P1|NOT COMPLETED|Overall Study||0
7919140|NCT00612716|19488819|P1|COMPLETED|Overall Study||6
7919141|NCT00612716|19488819|P1|STARTED|Overall Study||6
7919142|NCT00612690|19488833|P2|NOT COMPLETED|Overall Study||118
7919143|NCT00612690|19488834|P1|NOT COMPLETED|Overall Study||115
7919144|NCT00612690|19488833|P2|COMPLETED|Overall Study||89
7919145|NCT00612690|19488834|P1|COMPLETED|Overall Study||160
7919146|NCT00612690|19488833|P2|STARTED|Overall Study||207
7919147|NCT00612690|19488834|P1|STARTED|Overall Study||275
7919148|NCT00612677|19488842|P1|NOT COMPLETED|Overall Study||1
7919149|NCT00612677|19488842|P1|COMPLETED|Overall Study||0
7919150|NCT00612677|19488842|P1|STARTED|Overall Study||1
7919151|NCT00612586|19488850|P2|NOT COMPLETED|Overall Study||41
7919152|NCT00612586|19488851|P1|NOT COMPLETED|Overall Study||43
7919153|NCT00612586|19488850|P2|COMPLETED|Overall Study||18
7919154|NCT00612586|19488851|P1|COMPLETED|Overall Study||15
7919155|NCT00612586|19488850|P2|Received at Least 1 Dose|Overall Study||58
7919156|NCT00612586|19488851|P1|Received at Least 1 Dose|Overall Study||57
7919157|NCT00612586|19488850|P2|STARTED|Overall Study||59
7919158|NCT00612586|19488851|P1|STARTED|Overall Study||58
7919159|NCT00612573|19488869|P4|NOT COMPLETED|Overall Study||13
7919160|NCT00612573|19488870|P3|NOT COMPLETED|Overall Study||9
7919161|NCT00612573|19488871|P2|NOT COMPLETED|Overall Study||14
7919162|NCT00612573|19488872|P1|NOT COMPLETED|Overall Study||12
7919163|NCT00612573|19488869|P4|COMPLETED|Overall Study||54
7919164|NCT00612573|19488870|P3|COMPLETED|Overall Study||52
7919165|NCT00612573|19488871|P2|COMPLETED|Overall Study||51
7919166|NCT00612573|19488872|P1|COMPLETED|Overall Study||52
7919167|NCT00612573|19488869|P4|STARTED|Overall Study||67
7919168|NCT00612573|19488870|P3|STARTED|Overall Study||61
7919169|NCT00612573|19488871|P2|STARTED|Overall Study||65
7919170|NCT00612573|19488872|P1|STARTED|Overall Study||64
7919171|NCT00612560|19488898|P4|NOT COMPLETED|Overall Study||0
7919172|NCT00612560|19488899|P3|NOT COMPLETED|Overall Study||0
7919173|NCT00612560|19488900|P2|NOT COMPLETED|Overall Study||0
7919174|NCT00612560|19488901|P1|NOT COMPLETED|Overall Study||0
7919175|NCT00612560|19488898|P4|COMPLETED|Overall Study||6
7919176|NCT00612560|19488899|P3|COMPLETED|Overall Study||8
7919177|NCT00612560|19488900|P2|COMPLETED|Overall Study||7
7919178|NCT00612560|19488901|P1|COMPLETED|Overall Study||7
7919179|NCT00612560|19488898|P4|STARTED|Overall Study||6
7919180|NCT00612560|19488899|P3|STARTED|Overall Study||8
7919181|NCT00612560|19488900|P2|STARTED|Overall Study||7
7919182|NCT00612560|19488901|P1|STARTED|Overall Study||7
7919183|NCT00612534|19488927|P4|NOT COMPLETED|Overall Study||17
7919184|NCT00612534|19488928|P3|NOT COMPLETED|Overall Study||7
7919185|NCT00612534|19488929|P2|NOT COMPLETED|Overall Study||17
7919186|NCT00612534|19488930|P1|NOT COMPLETED|Overall Study||13
7919187|NCT00612534|19488927|P4|COMPLETED|Overall Study||7
7919188|NCT00612534|19488928|P3|COMPLETED|Overall Study||13
7919189|NCT00612534|19488929|P2|COMPLETED|Overall Study||9
7919190|NCT00612534|19488930|P1|COMPLETED|Overall Study||11
7919191|NCT00612534|19488927|P4|STARTED|Overall Study||24
7919192|NCT00612534|19488928|P3|STARTED|Overall Study||20
7919193|NCT00612534|19488929|P2|STARTED|Overall Study||26
7919194|NCT00612534|19488930|P1|STARTED|Overall Study||24
7919195|NCT00612508|19488942|P2|NOT COMPLETED|Overall Study||4
7919196|NCT00612508|19488943|P1|NOT COMPLETED|Overall Study||3
7919197|NCT00612508|19488942|P2|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3
7919198|NCT00612508|19488943|P1|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4
7919199|NCT00612508|19488942|P2|STARTED|Overall Study||7
7919200|NCT00612508|19488943|P1|STARTED|Overall Study||7
7919201|NCT00612456|19488954|P3|NOT COMPLETED|Overall Study||0
7919202|NCT00612456|19488955|P2|NOT COMPLETED|Overall Study||2
7919203|NCT00612456|19488956|P1|NOT COMPLETED|Overall Study||2
7919204|NCT00612456|19488954|P3|COMPLETED|Overall Study||16
7919205|NCT00612456|19488955|P2|COMPLETED|Overall Study||25
7919206|NCT00612456|19488956|P1|COMPLETED|Overall Study||25
7919207|NCT00612456|19488954|P3|STARTED|Overall Study||16
7919208|NCT00612456|19488955|P2|STARTED|Overall Study||27
7919209|NCT00612456|19488956|P1|STARTED|Overall Study||27
7919210|NCT00612430|19489002|P2|NOT COMPLETED|Overall Study||0
7919211|NCT00612430|19489003|P1|NOT COMPLETED|Overall Study||0
7919212|NCT00612430|19489002|P2|COMPLETED|Overall Study||27
7919213|NCT00612430|19489003|P1|COMPLETED|Overall Study||32
7919214|NCT00612430|19489002|P2|STARTED|Overall Study||27
7919215|NCT00612430|19489003|P1|STARTED|Overall Study||32
7919216|NCT00612352|19489019|P2|NOT COMPLETED|Overall Study||6
7919217|NCT00612352|19489020|P1|NOT COMPLETED|Overall Study||9
7919218|NCT00612352|19489019|P2|COMPLETED|Overall Study||109
7919219|NCT00612352|19489020|P1|COMPLETED|Overall Study||56
7919220|NCT00612352|19489019|P2|Placebo|Overall Study||4
7919221|NCT00612352|19489020|P1|Placebo|Overall Study||4
7919222|NCT00612352|19489019|P2|40%mg|Overall Study||0
7919223|NCT00612352|19489020|P1|40%mg|Overall Study||1
7919224|NCT00612352|19489019|P2|100%mg|Overall Study||1
7919225|NCT00612352|19489020|P1|100%mg|Overall Study||2
7919226|NCT00612352|19489019|P2|Placebo & 100%mg|Overall Study||0
7919227|NCT00612352|19489020|P1|Placebo & 100%mg|Overall Study||1
7919228|NCT00612352|19489019|P2|40%mg & 100%mg|Overall Study||1
7919229|NCT00612352|19489020|P1|40%mg & 100%mg|Overall Study||1
7919230|NCT00612352|19489019|P2|STARTED|Overall Study||115
7919231|NCT00612352|19489020|P1|STARTED|Overall Study||65
7919232|NCT00612339|19489134|P1|NOT COMPLETED|Overall Study||0
7919233|NCT00612339|19489134|P1|COMPLETED|Overall Study||41
7919234|NCT00612339|19489134|P1|STARTED|Overall Study||41
7919235|NCT00612313|19489140|P2|NOT COMPLETED|Overall Study||13
7919236|NCT00612313|19489141|P1|NOT COMPLETED|Overall Study||17
7919237|NCT00612313|19489140|P2|COMPLETED|Overall Study||62
7919238|NCT00612313|19489141|P1|COMPLETED|Overall Study||52
7919239|NCT00612313|19489140|P2|STARTED|Overall Study||75
7919240|NCT00612313|19489141|P1|STARTED|Overall Study||69
7919241|NCT00612235|19489161|P4|NOT COMPLETED|Overall Study||0
7919242|NCT00612235|19489162|P3|NOT COMPLETED|Overall Study||0
7919243|NCT00612235|19489163|P2|NOT COMPLETED|Overall Study||0
7919244|NCT00612235|19489164|P1|NOT COMPLETED|Overall Study||0
7919245|NCT00612235|19489161|P4|COMPLETED|Overall Study||20
7919246|NCT00612235|19489162|P3|COMPLETED|Overall Study||20
7919247|NCT00612235|19489163|P2|COMPLETED|Overall Study||20
7919248|NCT00612235|19489164|P1|COMPLETED|Overall Study||20
7919249|NCT00612235|19489161|P4|STARTED|Overall Study||20
7919250|NCT00612235|19489162|P3|STARTED|Overall Study||20
7919251|NCT00612235|19489163|P2|STARTED|Overall Study||20
7919252|NCT00612235|19489164|P1|STARTED|Overall Study||20
7919253|NCT00612222|19489175|P1|NOT COMPLETED|Overall Study||0
7919254|NCT00612222|19489175|P1|COMPLETED|Overall Study||4
7919255|NCT00612222|19489175|P1|STARTED|Overall Study||4
7919256|NCT00612105|19489183|P2|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0
7919257|NCT00612105|19489184|P1|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1
7919258|NCT00612105|19489183|P2|COMPLETED|Period Title 3: 3-Week Taper Phase||58
7919259|NCT00612105|19489184|P1|COMPLETED|Period Title 3: 3-Week Taper Phase||85
7919260|NCT00612105|19489183|P2|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58
7919348|NCT00611715|19489611|P2|NOT COMPLETED|Overall Study||6
7919261|NCT00612105|19489184|P1|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86
7919262|NCT00612105|19489183|P2|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2
7919263|NCT00612105|19489184|P1|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11
7919264|NCT00612105|19489183|P2|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55
7919265|NCT00612105|19489184|P1|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78
7919266|NCT00612105|19489183|P2|STARTED|Period Title 2: 4-Week Maintenance Phase||57
7919267|NCT00612105|19489184|P1|STARTED|Period Title 2: 4-Week Maintenance Phase||89
7919268|NCT00612105|19489183|P2|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5
7919269|NCT00612105|19489184|P1|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36
7919270|NCT00612105|19489183|P2|COMPLETED|Period Title 1: 6-Week Titration Phase||57
7919271|NCT00612105|19489184|P1|COMPLETED|Period Title 1: 6-Week Titration Phase||89
7919272|NCT00612105|19489183|P2|STARTED|Period Title 1: 6-Week Titration Phase||62
7919273|NCT00612105|19489184|P1|STARTED|Period Title 1: 6-Week Titration Phase||125
7919274|NCT00612066|19489234|P1|NOT COMPLETED|Overall Study||1
7919275|NCT00612066|19489234|P1|COMPLETED|Overall Study||1
7919276|NCT00612066|19489234|P1|STARTED|Overall Study||2
7919277|NCT00612040|19489241|P3|NOT COMPLETED|Overall Study||7
7919278|NCT00612040|19489242|P2|NOT COMPLETED|Overall Study||7
7919279|NCT00612040|19489243|P1|NOT COMPLETED|Overall Study||5
7919280|NCT00612040|19489241|P3|COMPLETED|Overall Study||52
7919281|NCT00612040|19489242|P2|COMPLETED|Overall Study||52
7919282|NCT00612040|19489243|P1|COMPLETED|Overall Study||55
7919283|NCT00612040|19489241|P3|Exposed|Overall Study||59
7919284|NCT00612040|19489242|P2|Exposed|Overall Study||59
7919285|NCT00612040|19489243|P1|Exposed|Overall Study||60
7919286|NCT00612040|19489241|P3|STARTED|Overall Study||59
7919287|NCT00612040|19489242|P2|STARTED|Overall Study||59
7919288|NCT00612040|19489243|P1|STARTED|Overall Study||60
7919289|NCT00611975|19489289|P2|NOT COMPLETED|Overall Study||8
7919290|NCT00611975|19489290|P1|NOT COMPLETED|Overall Study||5
7919291|NCT00611975|19489289|P2|COMPLETED|Overall Study||30
7919292|NCT00611975|19489290|P1|COMPLETED|Overall Study||40
7919293|NCT00611975|19489289|P2|STARTED|Overall Study||38
7919294|NCT00611975|19489290|P1|STARTED|Overall Study||45
7919295|NCT00611923|19489318|P2|NOT COMPLETED|Overall Study||2
7919296|NCT00611923|19489319|P1|NOT COMPLETED|Overall Study||2
7919297|NCT00611923|19489318|P2|COMPLETED|Overall Study||11
7919298|NCT00611923|19489319|P1|COMPLETED|Overall Study||10
7919299|NCT00611923|19489318|P2|STARTED|Overall Study||13
7919300|NCT00611923|19489319|P1|STARTED|Overall Study||12
7919301|NCT00611897|19489335|P2|NOT COMPLETED|Day 2: Crossover Treatment||0
7919302|NCT00611897|19489336|P1|NOT COMPLETED|Day 2: Crossover Treatment||0
7919303|NCT00611897|19489335|P2|COMPLETED|Day 2: Crossover Treatment||8
7919304|NCT00611897|19489336|P1|COMPLETED|Day 2: Crossover Treatment||8
7919305|NCT00611897|19489335|P2|STARTED|Day 2: Crossover Treatment||8
7919306|NCT00611897|19489336|P1|STARTED|Day 2: Crossover Treatment||8
7919307|NCT00611897|19489335|P2|NOT COMPLETED|Day 1: Initial Treatment||0
7919308|NCT00611897|19489336|P1|NOT COMPLETED|Day 1: Initial Treatment||0
7919309|NCT00611897|19489335|P2|COMPLETED|Day 1: Initial Treatment||8
7919310|NCT00611897|19489336|P1|COMPLETED|Day 1: Initial Treatment||8
7919311|NCT00611897|19489335|P2|STARTED|Day 1: Initial Treatment||8
7919312|NCT00611897|19489336|P1|STARTED|Day 1: Initial Treatment||8
7919313|NCT00611884|19489364|P4|NOT COMPLETED|Overall Study||6
7919314|NCT00611884|19489365|P3|NOT COMPLETED|Overall Study||4
7919315|NCT00611884|19489366|P2|NOT COMPLETED|Overall Study||9
7919316|NCT00611884|19489367|P1|NOT COMPLETED|Overall Study||9
7919317|NCT00611884|19489364|P4|COMPLETED|Overall Study||56
7919318|NCT00611884|19489365|P3|COMPLETED|Overall Study||58
7919319|NCT00611884|19489366|P2|COMPLETED|Overall Study||51
7919320|NCT00611884|19489367|P1|COMPLETED|Overall Study||52
7919321|NCT00611884|19489364|P4|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
7919322|NCT00611884|19489365|P3|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
7919323|NCT00611884|19489366|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59
7919324|NCT00611884|19489367|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58
7919325|NCT00611884|19489364|P4|STARTED|Overall Study||62
7919326|NCT00611884|19489365|P3|STARTED|Overall Study||62
7919327|NCT00611884|19489366|P2|STARTED|Overall Study||60
7919328|NCT00611884|19489367|P1|STARTED|Overall Study||61
7919329|NCT00611858|19489421|P1|NOT COMPLETED|Overall Study||4
7919330|NCT00611858|19489421|P1|COMPLETED|Overall Study||9
7919331|NCT00611858|19489421|P1|STARTED|Overall Study||13
7919332|NCT00611806|19489433|P2|NOT COMPLETED|Overall Study||3
7919333|NCT00611806|19489434|P1|NOT COMPLETED|Overall Study||16
7919334|NCT00611806|19489433|P2|COMPLETED|Overall Study||43
7919335|NCT00611806|19489434|P1|COMPLETED|Overall Study||78
7919336|NCT00611806|19489433|P2|STARTED|Overall Study||46
7919337|NCT00611806|19489434|P1|STARTED|Overall Study||94
7919338|NCT00611767|19489448|P2|NOT COMPLETED|Overall Study||2
7919339|NCT00611767|19489449|P1|NOT COMPLETED|Overall Study||9
7919340|NCT00611767|19489448|P2|COMPLETED|Overall Study||22
7919341|NCT00611767|19489449|P1|COMPLETED|Overall Study||40
7919342|NCT00611767|19489448|P2|Placebo Test Day|Overall Study||1
7919343|NCT00611767|19489449|P1|Placebo Test Day|Overall Study||6
7919344|NCT00611767|19489448|P2|Thiopental Test Day|Overall Study||1
7919345|NCT00611767|19489449|P1|Thiopental Test Day|Overall Study||3
7919346|NCT00611767|19489448|P2|STARTED|Overall Study||24
7919347|NCT00611767|19489449|P1|STARTED|Overall Study||49
7919349|NCT00611715|19489612|P1|NOT COMPLETED|Overall Study||41
7919350|NCT00611715|19489611|P2|COMPLETED|Overall Study||0
7919351|NCT00611715|19489612|P1|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1
7919352|NCT00611715|19489611|P2|STARTED|Overall Study||6
7919353|NCT00611715|19489612|P1|STARTED|Overall Study||42
7919354|NCT00611624|19489624|P1|NOT COMPLETED|Overall Study||0
7919355|NCT00611624|19489624|P1|COMPLETED|Overall Study||28
7919356|NCT00611624|19489624|P1|STARTED|Overall Study||28
7919357|NCT00611559|19489632|P3|NOT COMPLETED|Overall Study||1
7919358|NCT00611559|19489633|P2|NOT COMPLETED|Overall Study||1
7919359|NCT00611559|19489634|P1|NOT COMPLETED|Overall Study||1
7919360|NCT00611559|19489632|P3|COMPLETED|Overall Study||56
7919361|NCT00611559|19489633|P2|COMPLETED|Overall Study||114
7919362|NCT00611559|19489634|P1|COMPLETED|Overall Study||110
7919363|NCT00611559|19489632|P3|STARTED|Overall Study||57
7919364|NCT00611559|19489633|P2|STARTED|Overall Study||115
7919365|NCT00611559|19489634|P1|STARTED|Overall Study||111
7919366|NCT00611533|19489693|P2|NOT COMPLETED|Second Intervention (6 Weeks)||2
7919367|NCT00611533|19489694|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
7919368|NCT00611533|19489693|P2|COMPLETED|Second Intervention (6 Weeks)||4
7919369|NCT00611533|19489694|P1|COMPLETED|Second Intervention (6 Weeks)||8
7919370|NCT00611533|19489693|P2|STARTED|Second Intervention (6 Weeks)||6
7919371|NCT00611533|19489694|P1|STARTED|Second Intervention (6 Weeks)||8
7919372|NCT00611533|19489693|P2|NOT COMPLETED|First Intervention (6 Weeks)||2
7919373|NCT00611533|19489694|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
7919374|NCT00611533|19489693|P2|COMPLETED|First Intervention (6 Weeks)||6
7919375|NCT00611533|19489694|P1|COMPLETED|First Intervention (6 Weeks)||8
7919376|NCT00611533|19489693|P2|STARTED|First Intervention (6 Weeks)||8
7919377|NCT00611533|19489694|P1|STARTED|First Intervention (6 Weeks)||8
7919378|NCT00611468|19489713|P4|NOT COMPLETED|Overall Study||0
7919379|NCT00611468|19489714|P3|NOT COMPLETED|Overall Study||0
7919380|NCT00611468|19489715|P2|NOT COMPLETED|Overall Study||1
7919381|NCT00611468|19489716|P1|NOT COMPLETED|Overall Study||0
7919382|NCT00611468|19489713|P4|COMPLETED|Overall Study||13
7919383|NCT00611468|19489714|P3|COMPLETED|Overall Study||6
7919384|NCT00611468|19489715|P2|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6
7919385|NCT00611468|19489716|P1|COMPLETED|Overall Study||3
7919386|NCT00611468|19489713|P4|STARTED|Overall Study||13
7919387|NCT00611468|19489714|P3|STARTED|Overall Study||6
7919388|NCT00611468|19489715|P2|STARTED|Overall Study||7
7919389|NCT00611468|19489716|P1|STARTED|Overall Study||3
7919390|NCT00611455|19489728|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211
7919391|NCT00611455|19489729|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
7919392|NCT00611455|19489730|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
7919393|NCT00611455|19489728|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||49
7919394|NCT00611455|19489729|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
7919395|NCT00611455|19489730|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
7919396|NCT00611455|19489728|P3|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260
7919397|NCT00611455|19489729|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
7919398|NCT00611455|19489730|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
7919399|NCT00611455|19489728|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
7919400|NCT00611455|19489729|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||179
7919401|NCT00611455|19489730|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
7919402|NCT00611455|19489728|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
7919403|NCT00611455|19489729|P2|COMPLETED|OL Treatment Period (120 Weeks)||52
7919404|NCT00611455|19489730|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
7919405|NCT00611455|19489728|P3|STARTED|OL Treatment Period (120 Weeks)||0
7919406|NCT00611455|19489729|P2|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231
7919407|NCT00611455|19489730|P1|STARTED|OL Treatment Period (120 Weeks)||0
7919408|NCT00611455|19489728|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
7919409|NCT00611455|19489729|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||14
7919410|NCT00611455|19489730|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||13
7919411|NCT00611455|19489728|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
7919412|NCT00611455|19489729|P2|COMPLETED|DB Treatment Period (24 Weeks)||117
7919413|NCT00611455|19489730|P1|COMPLETED|DB Treatment Period (24 Weeks)||121
7919414|NCT00611455|19489728|P3|STARTED|DB Treatment Period (24 Weeks)||0
7919415|NCT00611455|19489729|P2|STARTED|DB Treatment Period (24 Weeks)||131
7919416|NCT00611455|19489730|P1|STARTED|DB Treatment Period (24 Weeks)||134
7919417|NCT00611442|19489858|P2|NOT COMPLETED|Overall Study||2
7919418|NCT00611442|19489859|P1|NOT COMPLETED|Overall Study||1
7919419|NCT00611442|19489858|P2|COMPLETED|Overall Study||94
7919420|NCT00611442|19489859|P1|COMPLETED|Overall Study||94
7919421|NCT00611442|19489858|P2|STARTED|Overall Study||96
7919422|NCT00611442|19489859|P1|STARTED|Overall Study||95
7919423|NCT00611403|19489873|P2|NOT COMPLETED|Post Treatment Extension Phase||1
7919424|NCT00611403|19489874|P1|NOT COMPLETED|Post Treatment Extension Phase||4
7919425|NCT00611403|19489873|P2|COMPLETED|Post Treatment Extension Phase||24
7919426|NCT00611403|19489874|P1|COMPLETED|Post Treatment Extension Phase||22
7919427|NCT00611403|19489873|P2|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25
7919428|NCT00611403|19489874|P1|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26
7919429|NCT00611403|19489873|P2|NOT COMPLETED|Treatment Phase||11
7919430|NCT00611403|19489874|P1|NOT COMPLETED|Treatment Phase||6
7919431|NCT00611403|19489873|P2|COMPLETED|Treatment Phase||58
7919432|NCT00611403|19489874|P1|COMPLETED|Treatment Phase||62
7919433|NCT00611403|19489873|P2|STARTED|Treatment Phase||69
7919434|NCT00611403|19489874|P1|STARTED|Treatment Phase||68
7919435|NCT00611351|19489884|P1|NOT COMPLETED|Overall Study||2
7919436|NCT00611351|19489884|P1|COMPLETED|Overall Study||3
7919437|NCT00611351|19489884|P1|STARTED|Overall Study||5
7919438|NCT00611325|19489893|P2|NOT COMPLETED|Overall Study||0
7919439|NCT00611325|19489894|P1|NOT COMPLETED|Overall Study||0
7919440|NCT00611325|19489893|P2|COMPLETED|Overall Study||28
7919441|NCT00611325|19489894|P1|COMPLETED|Overall Study||28
7919442|NCT00611325|19489893|P2|STARTED|Overall Study||28
7919443|NCT00611325|19489894|P1|STARTED|Overall Study||28
7919444|NCT00611247|19489910|P2|NOT COMPLETED|Overall Study||21
7919445|NCT00611247|19489911|P1|NOT COMPLETED|Overall Study||2
7919446|NCT00611247|19489910|P2|COMPLETED|Overall Study||10
7919447|NCT00611247|19489911|P1|COMPLETED|Overall Study||3
7919448|NCT00611247|19489910|P2|STARTED|Overall Study||31
7919449|NCT00611247|19489911|P1|STARTED|Overall Study||5
7919450|NCT00611130|19489923|P2|NOT COMPLETED|Overall Study||47
7919451|NCT00611130|19489924|P1|NOT COMPLETED|Overall Study||49
7919452|NCT00611130|19489923|P2|COMPLETED|Overall Study||47
7919453|NCT00611130|19489924|P1|COMPLETED|Overall Study||43
7919454|NCT00611130|19489923|P2|Completed 12 Week Treatment Phase|Overall Study||64
7919455|NCT00611130|19489924|P1|Completed 12 Week Treatment Phase|Overall Study||61
7919456|NCT00611130|19489923|P2|STARTED|Overall Study||94
7919457|NCT00611130|19489924|P1|STARTED|Overall Study||92
7919458|NCT00611026|19489934|P3|NOT COMPLETED|Double-blind Treatment Period||98
7919459|NCT00611026|19489935|P2|NOT COMPLETED|Double-blind Treatment Period||88
7919460|NCT00611026|19489936|P1|NOT COMPLETED|Double-blind Treatment Period||47
7919461|NCT00611026|19489934|P3|COMPLETED|Double-blind Treatment Period||862
7919462|NCT00611026|19489935|P2|COMPLETED|Double-blind Treatment Period||885
7919463|NCT00611026|19489936|P1|COMPLETED|Double-blind Treatment Period||431
7919464|NCT00611026|19489934|P3|STARTED|Double-blind Treatment Period||960
7919465|NCT00611026|19489935|P2|STARTED|Double-blind Treatment Period||973
7919466|NCT00611026|19489936|P1|STARTED|Double-blind Treatment Period||478
7919467|NCT00611026|19489934|P3|NOT COMPLETED|Randomized to Double-blind Treatment||3
7919468|NCT00611026|19489935|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
7919469|NCT00611026|19489936|P1|NOT COMPLETED|Randomized to Double-blind Treatment||2
7919470|NCT00611026|19489934|P3|COMPLETED|Randomized to Double-blind Treatment||960
7919471|NCT00611026|19489935|P2|COMPLETED|Randomized to Double-blind Treatment||973
7919472|NCT00611026|19489936|P1|COMPLETED|Randomized to Double-blind Treatment||478
7919473|NCT00611026|19489934|P3|STARTED|Randomized to Double-blind Treatment||963
7919474|NCT00611026|19489935|P2|STARTED|Randomized to Double-blind Treatment||974
7919475|NCT00611026|19489936|P1|STARTED|Randomized to Double-blind Treatment||480
7919476|NCT00610987|19490002|P2|NOT COMPLETED|Overall Study||0
7919477|NCT00610987|19490003|P1|NOT COMPLETED|Overall Study||0
7919478|NCT00610987|19490002|P2|COMPLETED|Overall Study||71
7919479|NCT00610987|19490003|P1|COMPLETED|Overall Study||75
7919480|NCT00610987|19490002|P2|STARTED|Overall Study||71
7919481|NCT00610987|19490003|P1|STARTED|Overall Study||75
7919482|NCT00610883|19490009|P1|NOT COMPLETED|Overall Study||0
7919483|NCT00610883|19490009|P1|COMPLETED|Overall Study||17
7919484|NCT00610883|19490009|P1|STARTED|Overall Study||17
7919485|NCT00610857|19490013|P1|NOT COMPLETED|Overall Study||2
7919486|NCT00610857|19490013|P1|COMPLETED|Overall Study||35
7919487|NCT00610857|19490013|P1|STARTED|Overall Study||37
7919488|NCT00610740|19490020|P1|NOT COMPLETED|Overall Study||0
7919489|NCT00610740|19490020|P1|COMPLETED|Overall Study||18
7919490|NCT00610740|19490020|P1|STARTED|Overall Study||18
7919491|NCT00610727|19490032|P6|NOT COMPLETED|Overall Study||0
7919492|NCT00610727|19490033|P5|NOT COMPLETED|Overall Study||0
7919493|NCT00610727|19490034|P4|NOT COMPLETED|Overall Study||0
7919494|NCT00610727|19490035|P3|NOT COMPLETED|Overall Study||0
7919495|NCT00610727|19490036|P2|NOT COMPLETED|Overall Study||0
7919496|NCT00610727|19490037|P1|NOT COMPLETED|Overall Study||0
7919497|NCT00610727|19490032|P6|COMPLETED|Overall Study||8
7919498|NCT00610727|19490033|P5|COMPLETED|Overall Study||8
7919499|NCT00610727|19490034|P4|COMPLETED|Overall Study||8
7919500|NCT00610727|19490035|P3|COMPLETED|Overall Study||8
7919501|NCT00610727|19490036|P2|COMPLETED|Overall Study||8
7919502|NCT00610727|19490037|P1|COMPLETED|Overall Study||14
7919503|NCT00610727|19490032|P6|STARTED|Overall Study||8
7919504|NCT00610727|19490033|P5|STARTED|Overall Study||8
7919505|NCT00610727|19490034|P4|STARTED|Overall Study||8
7919506|NCT00610727|19490035|P3|STARTED|Overall Study||8
7919507|NCT00610727|19490036|P2|STARTED|Overall Study||8
7919508|NCT00610727|19490037|P1|STARTED|Overall Study||14
7919509|NCT00610714|19490057|P2|NOT COMPLETED|Overall Study||24
7919510|NCT00610714|19490058|P1|NOT COMPLETED|Overall Study||26
7919511|NCT00610714|19490057|P2|COMPLETED|Overall Study||82
7919512|NCT00610714|19490058|P1|COMPLETED|Overall Study||79
7919513|NCT00610714|19490057|P2|STARTED|Overall Study||106
7919514|NCT00610714|19490058|P1|STARTED|Overall Study||105
7919515|NCT00610701|19490070|P2|NOT COMPLETED|Overall Study||11
7919516|NCT00610701|19490071|P1|NOT COMPLETED|Overall Study||10
7919517|NCT00610701|19490070|P2|COMPLETED|Overall Study||9
7919518|NCT00610701|19490071|P1|COMPLETED|Overall Study||5
7919519|NCT00610701|19490070|P2|STARTED|Overall Study||20
7919520|NCT00610701|19490071|P1|STARTED|Overall Study||15
7919521|NCT00610688|19490080|P3|NOT COMPLETED|Overall Study||8
7919522|NCT00610688|19490081|P2|NOT COMPLETED|Overall Study||13
7919523|NCT00610688|19490082|P1|NOT COMPLETED|Overall Study||9
7919524|NCT00610688|19490080|P3|COMPLETED|Overall Study||55
7919525|NCT00610688|19490081|P2|COMPLETED|Overall Study||52
7919526|NCT00610688|19490082|P1|COMPLETED|Overall Study||55
7919527|NCT00610688|19490080|P3|STARTED|Overall Study||63
7919528|NCT00610688|19490081|P2|STARTED|Overall Study||65
7919529|NCT00610688|19490082|P1|STARTED|Overall Study||64
7919530|NCT00610675|19490096|P1|NOT COMPLETED|Overall Study||220
7919531|NCT00610675|19490096|P1|COMPLETED|Overall Study||126
7919532|NCT00610675|19490096|P1|Treated|Overall Study||342
7919533|NCT00610675|19490096|P1|STARTED|Overall Study||346
7919534|NCT00610649|19490118|P11|NOT COMPLETED|Overall Study||1
7919535|NCT00610649|19490119|P10|NOT COMPLETED|Overall Study||1
7919536|NCT00610649|19490120|P9|NOT COMPLETED|Overall Study||0
7919537|NCT00610649|19490121|P8|NOT COMPLETED|Overall Study||0
7919538|NCT00610649|19490122|P7|NOT COMPLETED|Overall Study||0
7919539|NCT00610649|19490123|P6|NOT COMPLETED|Overall Study||0
7919540|NCT00610649|19490124|P5|NOT COMPLETED|Overall Study||0
7919541|NCT00610649|19490125|P4|NOT COMPLETED|Overall Study||0
7919542|NCT00610649|19490126|P3|NOT COMPLETED|Overall Study||0
7919543|NCT00610649|19490127|P2|NOT COMPLETED|Overall Study||1
7919544|NCT00610649|19490128|P1|NOT COMPLETED|Overall Study||1
7919545|NCT00610649|19490118|P11|COMPLETED|Overall Study||9
7919546|NCT00610649|19490119|P10|COMPLETED|Overall Study||9
7919547|NCT00610649|19490120|P9|COMPLETED|Overall Study||10
7919548|NCT00610649|19490121|P8|COMPLETED|Overall Study||2
7919549|NCT00610649|19490122|P7|COMPLETED|Overall Study||4
7919550|NCT00610649|19490123|P6|COMPLETED|Overall Study||2
7919551|NCT00610649|19490124|P5|COMPLETED|Overall Study||4
7919552|NCT00610649|19490125|P4|COMPLETED|Overall Study||2
7919553|NCT00610649|19490126|P3|COMPLETED|Overall Study||4
7919554|NCT00610649|19490127|P2|COMPLETED|Overall Study||1
7919555|NCT00610649|19490128|P1|COMPLETED|Overall Study||3
7919556|NCT00610649|19490118|P11|STARTED|Overall Study||10
7919557|NCT00610649|19490119|P10|STARTED|Overall Study||10
7919558|NCT00610649|19490120|P9|STARTED|Overall Study||10
7919559|NCT00610649|19490121|P8|STARTED|Overall Study||2
7919560|NCT00610649|19490122|P7|STARTED|Overall Study||4
7919561|NCT00610649|19490123|P6|STARTED|Overall Study||2
7919562|NCT00610649|19490124|P5|STARTED|Overall Study||4
7919563|NCT00610649|19490125|P4|STARTED|Overall Study||2
7919564|NCT00610649|19490126|P3|STARTED|Overall Study||4
7919565|NCT00610649|19490127|P2|STARTED|Overall Study||2
7919566|NCT00610649|19490128|P1|STARTED|Overall Study||4
7919567|NCT00610558|19490185|P3|NOT COMPLETED|Overall Study||6
7919568|NCT00610558|19490186|P2|NOT COMPLETED|Overall Study||6
7919569|NCT00610558|19490187|P1|NOT COMPLETED|Overall Study||5
7919570|NCT00610558|19490185|P3|COMPLETED|Overall Study||14
7919571|NCT00610558|19490186|P2|COMPLETED|Overall Study||14
7919572|NCT00610558|19490187|P1|COMPLETED|Overall Study||15
7919573|NCT00610558|19490185|P3|STARTED|Overall Study||20
7919574|NCT00610558|19490186|P2|STARTED|Overall Study||20
7919575|NCT00610558|19490187|P1|STARTED|Overall Study||20
7919576|NCT00610532|19490195|P1|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0
7919577|NCT00610532|19490195|P1|COMPLETED|Intravenous Phenytoin Plus Probenecid||7
7919578|NCT00610532|19490195|P1|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7
7919579|NCT00610532|19490195|P1|NOT COMPLETED|Intravenous Phenytoin Alone||0
7919580|NCT00610532|19490195|P1|COMPLETED|Intravenous Phenytoin Alone||8
7919581|NCT00610532|19490195|P1|STARTED|Intravenous Phenytoin Alone||8
7919582|NCT00610480|19490203|P2|NOT COMPLETED|Overall Study||0
7919583|NCT00610480|19490204|P1|NOT COMPLETED|Overall Study||0
7919584|NCT00610480|19490203|P2|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10
7919585|NCT00610480|19490204|P1|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10
7919586|NCT00610480|19490203|P2|STARTED|Overall Study|10 assigned patients x 2 interventions.|10
7919587|NCT00610480|19490204|P1|STARTED|Overall Study|10 assigned patients x 2 interventions.|10
7919588|NCT00610467|19490212|P2|NOT COMPLETED|Overall Study||0
7919589|NCT00610467|19490213|P1|NOT COMPLETED|Overall Study||0
7919590|NCT00610467|19490212|P2|COMPLETED|Overall Study||1
7919591|NCT00610467|19490213|P1|COMPLETED|Overall Study||1
7919592|NCT00610467|19490212|P2|STARTED|Overall Study||1
7919593|NCT00610467|19490213|P1|STARTED|Overall Study||1
7919594|NCT00610441|19490223|P4|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
7919595|NCT00610441|19490224|P3|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0
7919596|NCT00610441|19490225|P2|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1
7919597|NCT00610441|19490226|P1|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
7919598|NCT00610441|19490223|P4|COMPLETED|Treatment Period 2 - 3 Weeks||14
7919599|NCT00610441|19490224|P3|COMPLETED|Treatment Period 2 - 3 Weeks||9
7919600|NCT00610441|19490225|P2|COMPLETED|Treatment Period 2 - 3 Weeks||12
7919601|NCT00610441|19490226|P1|COMPLETED|Treatment Period 2 - 3 Weeks||10
7919602|NCT00610441|19490223|P4|STARTED|Treatment Period 2 - 3 Weeks||16
7919603|NCT00610441|19490224|P3|STARTED|Treatment Period 2 - 3 Weeks||9
7919604|NCT00610441|19490225|P2|STARTED|Treatment Period 2 - 3 Weeks||13
7919605|NCT00610441|19490226|P1|STARTED|Treatment Period 2 - 3 Weeks||12
7919606|NCT00610441|19490223|P4|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
7919607|NCT00610441|19490224|P3|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2
7919608|NCT00610441|19490225|P2|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1
7919609|NCT00610441|19490226|P1|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
7919610|NCT00610441|19490223|P4|COMPLETED|Placebo Washout Period - 2 Weeks||16
7919611|NCT00610441|19490224|P3|COMPLETED|Placebo Washout Period - 2 Weeks||9
7919612|NCT00610441|19490225|P2|COMPLETED|Placebo Washout Period - 2 Weeks||13
7919613|NCT00610441|19490226|P1|COMPLETED|Placebo Washout Period - 2 Weeks||12
7919614|NCT00610441|19490223|P4|STARTED|Placebo Washout Period - 2 Weeks||16
7919615|NCT00610441|19490224|P3|STARTED|Placebo Washout Period - 2 Weeks||11
7919616|NCT00610441|19490225|P2|STARTED|Placebo Washout Period - 2 Weeks||14
7919617|NCT00610441|19490226|P1|STARTED|Placebo Washout Period - 2 Weeks||12
7919618|NCT00610441|19490223|P4|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
7919619|NCT00610441|19490224|P3|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7
7919620|NCT00610441|19490225|P2|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
7919621|NCT00610441|19490226|P1|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3
7919622|NCT00610441|19490223|P4|COMPLETED|Treatment Period 1 - 3 Weeks||16
7919623|NCT00610441|19490224|P3|COMPLETED|Treatment Period 1 - 3 Weeks||11
7919624|NCT00610441|19490225|P2|COMPLETED|Treatment Period 1 - 3 Weeks||14
7919625|NCT00610441|19490226|P1|COMPLETED|Treatment Period 1 - 3 Weeks||12
7919626|NCT00610441|19490223|P4|STARTED|Treatment Period 1 - 3 Weeks||18
7919627|NCT00610441|19490224|P3|STARTED|Treatment Period 1 - 3 Weeks||18
7919628|NCT00610441|19490225|P2|STARTED|Treatment Period 1 - 3 Weeks||16
7919629|NCT00610441|19490226|P1|STARTED|Treatment Period 1 - 3 Weeks||15
7919630|NCT00610428|19490320|P3|NOT COMPLETED|Overall Study||2
7919631|NCT00610428|19490321|P2|NOT COMPLETED|Overall Study||1
7919632|NCT00610428|19490322|P1|NOT COMPLETED|Overall Study||0
7919633|NCT00610428|19490320|P3|COMPLETED|Overall Study||25
7919634|NCT00610428|19490321|P2|COMPLETED|Overall Study||23
7919635|NCT00610428|19490322|P1|COMPLETED|Overall Study||24
7919636|NCT00610428|19490320|P3|STARTED|Overall Study||27
7919637|NCT00610428|19490321|P2|STARTED|Overall Study||24
7919638|NCT00610428|19490322|P1|STARTED|Overall Study||24
7919639|NCT00610363|19490335|P2|NOT COMPLETED|Overall Study||3
7919640|NCT00610363|19490336|P1|NOT COMPLETED|Overall Study||11
7919641|NCT00610363|19490335|P2|COMPLETED|Overall Study||38
7919642|NCT00610363|19490336|P1|COMPLETED|Overall Study||31
7919643|NCT00610363|19490335|P2|STARTED|Overall Study||41
7919644|NCT00610363|19490336|P1|STARTED|Overall Study||42
7919645|NCT00610311|19490354|P1|NOT COMPLETED|Overall Study||0
7919646|NCT00610311|19490354|P1|COMPLETED|Overall Study||3
7919647|NCT00610311|19490354|P1|STARTED|Overall Study||3
7919648|NCT00610207|19490361|P1|NOT COMPLETED|Overall Study||3
7919649|NCT00610207|19490361|P1|COMPLETED|Overall Study||18
7919650|NCT00610207|19490361|P1|STARTED|Overall Study||21
7919651|NCT00610168|19490368|P2|NOT COMPLETED|Overall Study||0
7919652|NCT00610168|19490369|P1|NOT COMPLETED|Overall Study||2
7919653|NCT00610168|19490368|P2|COMPLETED|Overall Study||7
7919654|NCT00610168|19490369|P1|COMPLETED|Overall Study||73
7919655|NCT00610168|19490368|P2|STARTED|Overall Study||7
7919656|NCT00610168|19490369|P1|STARTED|Overall Study||75
7919657|NCT00610155|19490388|P6|NOT COMPLETED|Period 3||0
7919658|NCT00610155|19490389|P5|NOT COMPLETED|Period 3||0
7919659|NCT00610155|19490390|P4|NOT COMPLETED|Period 3||0
7919660|NCT00610155|19490391|P3|NOT COMPLETED|Period 3||0
7919661|NCT00610155|19490392|P2|NOT COMPLETED|Period 3||0
7919662|NCT00610155|19490393|P1|NOT COMPLETED|Period 3||1
7919663|NCT00610155|19490388|P6|COMPLETED|Period 3||1
7919664|NCT00610155|19490389|P5|COMPLETED|Period 3||3
7919665|NCT00610155|19490390|P4|COMPLETED|Period 3||3
7919666|NCT00610155|19490391|P3|COMPLETED|Period 3||3
7919667|NCT00610155|19490392|P2|COMPLETED|Period 3||3
7919668|NCT00610155|19490393|P1|COMPLETED|Period 3||3
7919669|NCT00610155|19490388|P6|STARTED|Period 3||1
7919670|NCT00610155|19490389|P5|STARTED|Period 3||3
7919671|NCT00610155|19490390|P4|STARTED|Period 3||3
7919672|NCT00610155|19490391|P3|STARTED|Period 3||3
7919673|NCT00610155|19490392|P2|STARTED|Period 3||3
7919674|NCT00610155|19490393|P1|STARTED|Period 3||4
7919675|NCT00610155|19490388|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
7919676|NCT00610155|19490389|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
7919677|NCT00610155|19490390|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
7919678|NCT00610155|19490391|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
7919679|NCT00610155|19490392|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
7919680|NCT00610155|19490393|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
7919681|NCT00610155|19490388|P6|COMPLETED|Washout Period 2 (7 Days)||1
7919682|NCT00610155|19490389|P5|COMPLETED|Washout Period 2 (7 Days)||3
7919683|NCT00610155|19490390|P4|COMPLETED|Washout Period 2 (7 Days)||3
7919684|NCT00610155|19490391|P3|COMPLETED|Washout Period 2 (7 Days)||3
7919685|NCT00610155|19490392|P2|COMPLETED|Washout Period 2 (7 Days)||3
7919686|NCT00610155|19490393|P1|COMPLETED|Washout Period 2 (7 Days)||4
7919687|NCT00610155|19490388|P6|STARTED|Washout Period 2 (7 Days)||1
7919688|NCT00610155|19490389|P5|STARTED|Washout Period 2 (7 Days)||3
7919689|NCT00610155|19490390|P4|STARTED|Washout Period 2 (7 Days)||3
7919690|NCT00610155|19490391|P3|STARTED|Washout Period 2 (7 Days)||3
7919691|NCT00610155|19490392|P2|STARTED|Washout Period 2 (7 Days)||3
7919692|NCT00610155|19490393|P1|STARTED|Washout Period 2 (7 Days)||4
7919693|NCT00610155|19490388|P6|NOT COMPLETED|Period 2||0
7919694|NCT00610155|19490389|P5|NOT COMPLETED|Period 2||0
7919695|NCT00610155|19490390|P4|NOT COMPLETED|Period 2||0
7919696|NCT00610155|19490391|P3|NOT COMPLETED|Period 2||0
7919697|NCT00610155|19490392|P2|NOT COMPLETED|Period 2||0
7919698|NCT00610155|19490393|P1|NOT COMPLETED|Period 2||0
7919699|NCT00610155|19490388|P6|COMPLETED|Period 2||1
7919700|NCT00610155|19490389|P5|COMPLETED|Period 2||3
7919701|NCT00610155|19490390|P4|COMPLETED|Period 2||3
7919702|NCT00610155|19490391|P3|COMPLETED|Period 2||3
7919703|NCT00610155|19490392|P2|COMPLETED|Period 2||3
7919704|NCT00610155|19490393|P1|COMPLETED|Period 2||4
7919705|NCT00610155|19490388|P6|STARTED|Period 2||1
7919706|NCT00610155|19490389|P5|STARTED|Period 2||3
7919707|NCT00610155|19490390|P4|STARTED|Period 2||3
7919708|NCT00610155|19490391|P3|STARTED|Period 2||3
7919709|NCT00610155|19490392|P2|STARTED|Period 2||3
7919710|NCT00610155|19490393|P1|STARTED|Period 2||4
7919711|NCT00610155|19490388|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
7919712|NCT00610155|19490389|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
7919713|NCT00610155|19490390|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
7919714|NCT00610155|19490391|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
7919715|NCT00610155|19490392|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
7919716|NCT00610155|19490393|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
7919717|NCT00610155|19490388|P6|COMPLETED|Washout Period 1 (7 Days)||1
7919718|NCT00610155|19490389|P5|COMPLETED|Washout Period 1 (7 Days)||3
7919719|NCT00610155|19490390|P4|COMPLETED|Washout Period 1 (7 Days)||3
7919720|NCT00610155|19490391|P3|COMPLETED|Washout Period 1 (7 Days)||3
7919721|NCT00610155|19490392|P2|COMPLETED|Washout Period 1 (7 Days)||3
7919722|NCT00610155|19490393|P1|COMPLETED|Washout Period 1 (7 Days)||4
7919723|NCT00610155|19490388|P6|STARTED|Washout Period 1 (7 Days)||1
7919724|NCT00610155|19490389|P5|STARTED|Washout Period 1 (7 Days)||3
7919725|NCT00610155|19490390|P4|STARTED|Washout Period 1 (7 Days)||3
7919726|NCT00610155|19490391|P3|STARTED|Washout Period 1 (7 Days)||3
7919727|NCT00610155|19490392|P2|STARTED|Washout Period 1 (7 Days)||3
7919728|NCT00610155|19490393|P1|STARTED|Washout Period 1 (7 Days)||4
7919729|NCT00610155|19490388|P6|NOT COMPLETED|Period 1||0
7919730|NCT00610155|19490389|P5|NOT COMPLETED|Period 1||0
7919731|NCT00610155|19490390|P4|NOT COMPLETED|Period 1||0
7919732|NCT00610155|19490391|P3|NOT COMPLETED|Period 1||1
7919733|NCT00610155|19490392|P2|NOT COMPLETED|Period 1||0
7919734|NCT00610155|19490393|P1|NOT COMPLETED|Period 1||0
7919735|NCT00610155|19490388|P6|COMPLETED|Period 1||1
7919736|NCT00610155|19490389|P5|COMPLETED|Period 1||3
7919737|NCT00610155|19490390|P4|COMPLETED|Period 1||3
7919738|NCT00610155|19490391|P3|COMPLETED|Period 1||3
7919739|NCT00610155|19490392|P2|COMPLETED|Period 1||3
7919740|NCT00610155|19490393|P1|COMPLETED|Period 1||4
7919741|NCT00610155|19490388|P6|STARTED|Period 1||1
7919742|NCT00610155|19490389|P5|STARTED|Period 1||3
7919743|NCT00610155|19490390|P4|STARTED|Period 1||3
7919744|NCT00610155|19490391|P3|STARTED|Period 1||4
7919745|NCT00610155|19490392|P2|STARTED|Period 1||3
7919746|NCT00610155|19490393|P1|STARTED|Period 1||4
7919747|NCT00610129|19490440|P1|NOT COMPLETED|Overall Study||3
7919748|NCT00610129|19490440|P1|COMPLETED|Overall Study||25
7919749|NCT00610129|19490440|P1|STARTED|Overall Study||28
7919750|NCT00609986|19490446|P2|NOT COMPLETED|Overall Study||3
7919751|NCT00609986|19490447|P1|NOT COMPLETED|Overall Study||8
7919752|NCT00609986|19490446|P2|COMPLETED|Overall Study||49
7919753|NCT00609986|19490447|P1|COMPLETED|Overall Study||44
7919754|NCT00609986|19490446|P2|Received Transplant|Overall Study||49
7919755|NCT00609986|19490447|P1|Received Transplant|Overall Study||44
7919756|NCT00609986|19490446|P2|STARTED|Overall Study||52
7919757|NCT00609986|19490447|P1|STARTED|Overall Study||52
7919758|NCT00609973|19490461|P2|NOT COMPLETED|Overall Study||6
7919759|NCT00609973|19490462|P1|NOT COMPLETED|Overall Study||8
7919760|NCT00609973|19490461|P2|COMPLETED|Overall Study||10
7919761|NCT00609973|19490462|P1|COMPLETED|Overall Study||9
7919762|NCT00609973|19490461|P2|STARTED|Overall Study||16
7919763|NCT00609973|19490462|P1|STARTED|Overall Study||17
7919764|NCT00609947|19490470|P1|NOT COMPLETED|Overall Study||1
7919765|NCT00609947|19490470|P1|COMPLETED|Overall Study|One death due to automobile accident.|240
7919766|NCT00609947|19490470|P1|STARTED|Overall Study||241
7919767|NCT00609869|19490475|P1|NOT COMPLETED|Overall Study||11
7919768|NCT00609869|19490475|P1|COMPLETED|Overall Study||18
7919769|NCT00609869|19490475|P1|STARTED|Overall Study||29
7919770|NCT00609804|19490483|P2|NOT COMPLETED|Overall Study||28
7919771|NCT00609804|19490484|P1|NOT COMPLETED|Overall Study||25
7919772|NCT00609804|19490483|P2|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
7919773|NCT00609804|19490484|P1|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
7919774|NCT00609804|19490483|P2|STARTED|Overall Study||28
7919775|NCT00609804|19490484|P1|STARTED|Overall Study||25
7919776|NCT00609765|19490494|P1|NOT COMPLETED|Overall Study||1
7919777|NCT00609765|19490494|P1|COMPLETED|Overall Study||0
7919778|NCT00609765|19490494|P1|STARTED|Overall Study||1
7919779|NCT00609739|19490499|P1|NOT COMPLETED|Overall Study||0
7919780|NCT00609739|19490499|P1|COMPLETED|Overall Study||1
7919781|NCT00609739|19490499|P1|STARTED|Overall Study||1
7919782|NCT00609674|19490508|P2|NOT COMPLETED|Overall Study||7
7919783|NCT00609674|19490509|P1|NOT COMPLETED|Overall Study||7
7919784|NCT00609674|19490508|P2|COMPLETED|Overall Study||153
7919785|NCT00609674|19490509|P1|COMPLETED|Overall Study||148
7919786|NCT00609674|19490508|P2|STARTED|Overall Study||160
7919787|NCT00609674|19490509|P1|STARTED|Overall Study||155
7919788|NCT00609622|19490545|P2|NOT COMPLETED|Overall Study||95
7919789|NCT00609622|19490546|P1|NOT COMPLETED|Overall Study||96
7919790|NCT00609622|19490545|P2|COMPLETED|Overall Study||0
7919791|NCT00609622|19490546|P1|COMPLETED|Overall Study||0
7919792|NCT00609622|19490545|P2|STARTED|Overall Study||95
7919793|NCT00609622|19490546|P1|STARTED|Overall Study||96
7919794|NCT00609609|19490568|P2|NOT COMPLETED|Overall Study||2
7919795|NCT00609609|19490569|P1|NOT COMPLETED|Overall Study||6
7919796|NCT00609609|19490568|P2|COMPLETED|Overall Study||49
7919797|NCT00609609|19490569|P1|COMPLETED|Overall Study||24
7919798|NCT00609609|19490568|P2|STARTED|Overall Study||51
7919799|NCT00609609|19490569|P1|STARTED|Overall Study||30
7919800|NCT00609518|19490581|P2|NOT COMPLETED|Overall Study||40
7919801|NCT00609518|19490582|P1|NOT COMPLETED|Overall Study||43
7919802|NCT00609518|19490581|P2|COMPLETED|Overall Study||17
7919803|NCT00609518|19490582|P1|COMPLETED|Overall Study||11
7919804|NCT00609518|19490581|P2|Completed 6 Treatment Cycles|Overall Study||22
7919805|NCT00609518|19490582|P1|Completed 6 Treatment Cycles|Overall Study||19
7919806|NCT00609518|19490581|P2|STARTED|Overall Study||57
7919807|NCT00609518|19490582|P1|STARTED|Overall Study||54
7919808|NCT00609492|19490597|P3|NOT COMPLETED|Overall Study||7
7919809|NCT00609492|19490598|P2|NOT COMPLETED|Overall Study||3
7919810|NCT00609492|19490599|P1|NOT COMPLETED|Overall Study||1
7919811|NCT00609492|19490597|P3|COMPLETED|Overall Study||122
7919812|NCT00609492|19490598|P2|COMPLETED|Overall Study||69
7919813|NCT00609492|19490599|P1|COMPLETED|Overall Study||43
7919814|NCT00609492|19490597|P3|STARTED|Overall Study||129
7919815|NCT00609492|19490598|P2|STARTED|Overall Study||72
7919816|NCT00609492|19490599|P1|STARTED|Overall Study||44
7919817|NCT00609466|19490684|P3|NOT COMPLETED|Overall Study||4
7919818|NCT00609466|19490685|P2|NOT COMPLETED|Overall Study||6
7919819|NCT00609466|19490686|P1|NOT COMPLETED|Overall Study||2
7919820|NCT00609466|19490684|P3|COMPLETED|Overall Study||95
7919821|NCT00609466|19490685|P2|COMPLETED|Overall Study||90
7919822|NCT00609466|19490686|P1|COMPLETED|Overall Study||94
7919823|NCT00609466|19490684|P3|STARTED|Overall Study||99
7919824|NCT00609466|19490685|P2|STARTED|Overall Study||96
7919825|NCT00609466|19490686|P1|STARTED|Overall Study||96
7919826|NCT00609362|19490714|P2|NOT COMPLETED|Overall Study||1
7919827|NCT00609362|19490715|P1|NOT COMPLETED|Overall Study||3
7919828|NCT00609362|19490714|P2|COMPLETED|Overall Study||27
7919829|NCT00609362|19490715|P1|COMPLETED|Overall Study||26
7919830|NCT00609362|19490714|P2|STARTED|Overall Study||28
7919831|NCT00609362|19490715|P1|STARTED|Overall Study||29
7919832|NCT00609336|19490725|P1|NOT COMPLETED|Overall Study||13
7919833|NCT00609336|19490725|P1|COMPLETED|Overall Study||22
7919834|NCT00609336|19490725|P1|Surgery|Overall Study||22
7919835|NCT00609336|19490725|P1|STARTED|Overall Study||35
7919836|NCT00609271|19490739|P2|NOT COMPLETED|Overall Study||13
7919837|NCT00609271|19490740|P1|NOT COMPLETED|Overall Study||16
7919838|NCT00609271|19490739|P2|COMPLETED|Overall Study||60
7919839|NCT00609271|19490740|P1|COMPLETED|Overall Study||59
7919840|NCT00609271|19490739|P2|STARTED|Overall Study||73
7919841|NCT00609271|19490740|P1|STARTED|Overall Study||75
7919842|NCT00609245|19490776|P1|NOT COMPLETED|Overall Study||1
7919843|NCT00609245|19490776|P1|COMPLETED|Overall Study||12
7919844|NCT00609245|19490776|P1|STARTED|Overall Study||13
7919845|NCT00609167|19490784|P2|NOT COMPLETED|Overall Study||7
7919846|NCT00609167|19490785|P1|NOT COMPLETED|Overall Study||8
7919847|NCT00609167|19490784|P2|COMPLETED|Overall Study||23
7919848|NCT00609167|19490785|P1|COMPLETED|Overall Study||25
7919849|NCT00609167|19490784|P2|STARTED|Overall Study||30
7919850|NCT00609167|19490785|P1|STARTED|Overall Study||33
7919851|NCT00609128|19490807|P1|NOT COMPLETED|Overall Study||0
7919852|NCT00609128|19490807|P1|COMPLETED|Overall Study||21
7919853|NCT00609128|19490807|P1|STARTED|Overall Study||21
7919854|NCT00608985|19490816|P4|NOT COMPLETED|Overall Study||9
7919855|NCT00608985|19490817|P3|NOT COMPLETED|Overall Study||6
7919856|NCT00608985|19490818|P2|NOT COMPLETED|Overall Study||13
7919857|NCT00608985|19490819|P1|NOT COMPLETED|Overall Study||16
7919858|NCT00608985|19490816|P4|COMPLETED|Overall Study|Completed follow-up|159
7919859|NCT00608985|19490817|P3|COMPLETED|Overall Study|Completed follow-up|170
7919860|NCT00608985|19490818|P2|COMPLETED|Overall Study|Completed follow-up|173
7919861|NCT00608985|19490819|P1|COMPLETED|Overall Study|Completed follow-up|161
7919862|NCT00608985|19490816|P4|Completed Double-blind Treatment|Overall Study||161
7919863|NCT00608985|19490817|P3|Completed Double-blind Treatment|Overall Study||171
7919864|NCT00608985|19490818|P2|Completed Double-blind Treatment|Overall Study||174
7919865|NCT00608985|19490819|P1|Completed Double-blind Treatment|Overall Study||163
7919866|NCT00608985|19490816|P4|STARTED|Overall Study|Randomized and started double-blind treatment|168
7919867|NCT00608985|19490817|P3|STARTED|Overall Study|Randomized and started double-blind treatment|176
7919868|NCT00608985|19490818|P2|STARTED|Overall Study|Randomized and started double-blind treatment|186
7919869|NCT00608985|19490819|P1|STARTED|Overall Study|Randomized and started double-blind treatment|177
7919870|NCT00608959|19490851|P1|NOT COMPLETED|Part 2||0
7919871|NCT00608959|19490851|P1|COMPLETED|Part 2||25
7919872|NCT00608959|19490851|P1|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25
7919873|NCT00608959|19490851|P1|NOT COMPLETED|Part 1||1
7919874|NCT00608959|19490851|P1|COMPLETED|Part 1||24
7919875|NCT00608959|19490851|P1|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25
7919876|NCT00608907|19490864|P3|NOT COMPLETED|Overall Study||1
7919877|NCT00608907|19490865|P2|NOT COMPLETED|Overall Study||0
7919878|NCT00608907|19490866|P1|NOT COMPLETED|Overall Study||12
7919879|NCT00608907|19490864|P3|COMPLETED|Overall Study||17
7919880|NCT00608907|19490865|P2|COMPLETED|Overall Study||13
7919881|NCT00608907|19490866|P1|COMPLETED|Overall Study||18
7919882|NCT00608907|19490864|P3|STARTED|Overall Study||18
7919883|NCT00608907|19490865|P2|STARTED|Overall Study||13
7919884|NCT00608907|19490866|P1|STARTED|Overall Study||30
7919885|NCT00608894|19490876|P2|NOT COMPLETED|Overall Study||2
7919886|NCT00608894|19490877|P1|NOT COMPLETED|Overall Study||0
7919887|NCT00608894|19490876|P2|COMPLETED|Overall Study|One patient was granted permission to crossover to LCP-Tacro due to treatment intolerance|4
7919888|NCT00608894|19490877|P1|COMPLETED|Overall Study||7
7919889|NCT00608894|19490876|P2|STARTED|Overall Study||6
7919890|NCT00608894|19490877|P1|STARTED|Overall Study||7
7919891|NCT00608881|19490889|P2|NOT COMPLETED|Overall Study||66
7919892|NCT00608881|19490890|P1|NOT COMPLETED|Overall Study||79
7919893|NCT00608881|19490889|P2|COMPLETED|Overall Study||240
7919894|NCT00608881|19490890|P1|COMPLETED|Overall Study||224
7919895|NCT00608881|19490889|P2|STARTED|Overall Study||306
7919896|NCT00608881|19490890|P1|STARTED|Overall Study||303
7919897|NCT00608868|19490924|P1|NOT COMPLETED|Overall Study||15
7919898|NCT00608868|19490924|P1|COMPLETED|Overall Study||141
7919899|NCT00608868|19490924|P1|Per Protocol (PP) Population|Overall Study||121
7919900|NCT00608868|19490924|P1|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138
7919901|NCT00608868|19490924|P1|Treatment Completed|Overall Study||141
7919902|NCT00608868|19490924|P1|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154
7919903|NCT00608868|19490924|P1|Enrolled|Overall Study||156
7919904|NCT00608868|19490924|P1|STARTED|Overall Study||156
7919905|NCT00608842|19490935|P4|NOT COMPLETED|Overall Study||1
7919906|NCT00608842|19490936|P3|NOT COMPLETED|Overall Study||2
7919907|NCT00608842|19490937|P2|NOT COMPLETED|Overall Study||1
7919908|NCT00608842|19490938|P1|NOT COMPLETED|Overall Study||1
7919909|NCT00608842|19490935|P4|COMPLETED|Overall Study||16
7919910|NCT00608842|19490936|P3|COMPLETED|Overall Study||13
7919911|NCT00608842|19490937|P2|COMPLETED|Overall Study||14
7919912|NCT00608842|19490938|P1|COMPLETED|Overall Study||14
7919913|NCT00608842|19490935|P4|STARTED|Overall Study||17
7919914|NCT00608842|19490936|P3|STARTED|Overall Study||15
7919915|NCT00608842|19490937|P2|STARTED|Overall Study||15
7919916|NCT00608842|19490938|P1|STARTED|Overall Study||15
7919917|NCT00608829|19490972|P1|NOT COMPLETED|Overall Study||15
7919918|NCT00608829|19490972|P1|COMPLETED|Overall Study||8
7919919|NCT00608829|19490972|P1|STARTED|Overall Study||23
7919920|NCT00608777|19490976|P1|NOT COMPLETED|Overall Study||0
7919921|NCT00608777|19490976|P1|COMPLETED|Overall Study||6
7919922|NCT00608777|19490976|P1|STARTED|Overall Study||6
7919923|NCT00608634|19490983|P3|NOT COMPLETED|Overall Study||1
7919924|NCT00608634|19490984|P2|NOT COMPLETED|Overall Study||1
7919925|NCT00608634|19490985|P1|NOT COMPLETED|Overall Study||2
7919926|NCT00608634|19490983|P3|COMPLETED|Overall Study||27
7919927|NCT00608634|19490984|P2|COMPLETED|Overall Study||26
7919928|NCT00608634|19490985|P1|COMPLETED|Overall Study||26
7919929|NCT00608634|19490983|P3|STARTED|Overall Study||28
7919930|NCT00608634|19490984|P2|STARTED|Overall Study||27
7919931|NCT00608634|19490985|P1|STARTED|Overall Study||28
7919932|NCT00608582|19490998|P2|NOT COMPLETED|Overall Study||4
7919933|NCT00608582|19490999|P1|NOT COMPLETED|Overall Study||4
7919934|NCT00608582|19490998|P2|COMPLETED|Overall Study||7
7919935|NCT00608582|19490999|P1|COMPLETED|Overall Study||10
7919936|NCT00608582|19490998|P2|STARTED|Overall Study||11
7919937|NCT00608582|19490999|P1|STARTED|Overall Study||14
7919938|NCT00608569|19491009|P2|NOT COMPLETED|Overall Study||9
7919939|NCT00608569|19491010|P1|NOT COMPLETED|Overall Study||10
7919940|NCT00608569|19491009|P2|COMPLETED|Overall Study||119
7919941|NCT00608569|19491010|P1|COMPLETED|Overall Study||119
7919942|NCT00608569|19491009|P2|STARTED|Overall Study||128
7919943|NCT00608569|19491010|P1|STARTED|Overall Study||129
7919944|NCT00608543|19491030|P1|NOT COMPLETED|Overall Study||4
7919945|NCT00608543|19491030|P1|COMPLETED|Overall Study||13
7919946|NCT00608543|19491030|P1|STARTED|Overall Study||17
7919947|NCT00608530|19491043|P4|NOT COMPLETED|Study 2 Nurse-delivered Treatments||7
7919948|NCT00608530|19491044|P3|NOT COMPLETED|Study 2 Nurse-delivered Treatments||12
7919949|NCT00608530|19491045|P2|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
7919950|NCT00608530|19491046|P1|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
7919951|NCT00608530|19491043|P4|COMPLETED|Study 2 Nurse-delivered Treatments||27
7919952|NCT00608530|19491044|P3|COMPLETED|Study 2 Nurse-delivered Treatments||21
7919953|NCT00608530|19491045|P2|COMPLETED|Study 2 Nurse-delivered Treatments||0
7919954|NCT00608530|19491046|P1|COMPLETED|Study 2 Nurse-delivered Treatments||0
7919955|NCT00608530|19491043|P4|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||31
7919956|NCT00608530|19491044|P3|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||30
7919957|NCT00608530|19491045|P2|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
7919958|NCT00608530|19491046|P1|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
7919959|NCT00608530|19491043|P4|STARTED|Study 2 Nurse-delivered Treatments||34
7919960|NCT00608530|19491044|P3|STARTED|Study 2 Nurse-delivered Treatments||33
7919961|NCT00608530|19491045|P2|STARTED|Study 2 Nurse-delivered Treatments||0
7919962|NCT00608530|19491046|P1|STARTED|Study 2 Nurse-delivered Treatments||0
7919963|NCT00608530|19491043|P4|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
7919964|NCT00608530|19491044|P3|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
7919965|NCT00608530|19491045|P2|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||5
7919966|NCT00608530|19491046|P1|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||11
7919967|NCT00608530|19491043|P4|COMPLETED|Study 1 Psychologist-delivered Treatment||0
7919968|NCT00608530|19491044|P3|COMPLETED|Study 1 Psychologist-delivered Treatment||0
7919969|NCT00608530|19491045|P2|COMPLETED|Study 1 Psychologist-delivered Treatment||28
7919970|NCT00608530|19491046|P1|COMPLETED|Study 1 Psychologist-delivered Treatment||22
7919971|NCT00608530|19491043|P4|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
7919972|NCT00608530|19491044|P3|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
7919973|NCT00608530|19491045|P2|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||31
7919974|NCT00608530|19491046|P1|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||28
7919975|NCT00608530|19491043|P4|STARTED|Study 1 Psychologist-delivered Treatment||0
7919976|NCT00608530|19491044|P3|STARTED|Study 1 Psychologist-delivered Treatment||0
7919977|NCT00608530|19491045|P2|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
7919978|NCT00608530|19491046|P1|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
7919979|NCT00608517|19491067|P3|NOT COMPLETED|Overall Study||0
7919980|NCT00608517|19491068|P2|NOT COMPLETED|Overall Study||0
7919981|NCT00608517|19491069|P1|NOT COMPLETED|Overall Study||1
7919982|NCT00608517|19491067|P3|COMPLETED|Overall Study||1
7919983|NCT00608517|19491068|P2|COMPLETED|Overall Study||3
7919984|NCT00608517|19491069|P1|COMPLETED|Overall Study||1
7919985|NCT00608517|19491067|P3|STARTED|Overall Study||1
7919986|NCT00608517|19491068|P2|STARTED|Overall Study||3
7919987|NCT00608517|19491069|P1|STARTED|Overall Study||2
7919988|NCT00608491|19491097|P2|NOT COMPLETED|Overall Study||22
7919989|NCT00608491|19491098|P1|NOT COMPLETED|Overall Study||21
7919990|NCT00608491|19491097|P2|COMPLETED|Overall Study||72
7919991|NCT00608491|19491098|P1|COMPLETED|Overall Study||73
7919992|NCT00608491|19491097|P2|STARTED|Overall Study||94
7919993|NCT00608491|19491098|P1|STARTED|Overall Study||94
7919994|NCT00608465|19491242|P1|NOT COMPLETED|Overall Study||0
7919995|NCT00608465|19491242|P1|COMPLETED|Overall Study||4
7919996|NCT00608465|19491242|P1|STARTED|Overall Study||4
7919997|NCT00608426|19491249|P2|NOT COMPLETED|Overall Study||905
7919998|NCT00608426|19491250|P1|NOT COMPLETED|Overall Study||836
7919999|NCT00608426|19491249|P2|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614
7920000|NCT00608426|19491250|P1|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768
7920001|NCT00608426|19491249|P2|STARTED|Overall Study||2519
7920002|NCT00608426|19491250|P1|STARTED|Overall Study||2604
7920003|NCT00608322|19491262|P2|NOT COMPLETED|Overall Study||1
7920004|NCT00608322|19491263|P1|NOT COMPLETED|Overall Study||2
7920005|NCT00608322|19491262|P2|COMPLETED|Overall Study||22
7920006|NCT00608322|19491263|P1|COMPLETED|Overall Study||24
7920007|NCT00608322|19491262|P2|STARTED|Overall Study||23
7920008|NCT00608322|19491263|P1|STARTED|Overall Study||26
7920009|NCT00608244|19491269|P1|NOT COMPLETED|Overall Study||2
7920010|NCT00608244|19491269|P1|COMPLETED|Overall Study||57
7920011|NCT00608244|19491269|P1|STARTED|Overall Study||59
7920012|NCT00608205|19491280|P2|NOT COMPLETED|Overall Study||3
7920013|NCT00608205|19491281|P1|NOT COMPLETED|Overall Study||3
7920014|NCT00608205|19491280|P2|COMPLETED|Overall Study||31
7920015|NCT00608205|19491281|P1|COMPLETED|Overall Study||32
7920016|NCT00608205|19491280|P2|STARTED|Overall Study||34
7920017|NCT00608205|19491281|P1|STARTED|Overall Study||35
7920018|NCT00608140|19491371|P2|NOT COMPLETED|Overall Study||1
7920019|NCT00608140|19491372|P1|NOT COMPLETED|Overall Study||1
7920020|NCT00608140|19491371|P2|COMPLETED|Overall Study|Study ended early due to low enrollment|0
7920021|NCT00608140|19491372|P1|COMPLETED|Overall Study|Study ended early due to low enrollment|0
7920022|NCT00608140|19491371|P2|STARTED|Overall Study||1
7920023|NCT00608140|19491372|P1|STARTED|Overall Study||1
7920024|NCT00608062|19491401|P6|NOT COMPLETED|Overall Study||0
7920025|NCT00608062|19491402|P5|NOT COMPLETED|Overall Study||0
7920026|NCT00608062|19491403|P4|NOT COMPLETED|Overall Study||0
7920027|NCT00608062|19491404|P3|NOT COMPLETED|Overall Study||0
7920028|NCT00608062|19491405|P2|NOT COMPLETED|Overall Study||0
7920029|NCT00608062|19491406|P1|NOT COMPLETED|Overall Study||0
7920030|NCT00608062|19491401|P6|COMPLETED|Overall Study||15
7920031|NCT00608062|19491402|P5|COMPLETED|Overall Study||13
7920032|NCT00608062|19491403|P4|COMPLETED|Overall Study||21
7920033|NCT00608062|19491404|P3|COMPLETED|Overall Study||19
7920034|NCT00608062|19491405|P2|COMPLETED|Overall Study||12
7920035|NCT00608062|19491406|P1|COMPLETED|Overall Study||12
7920036|NCT00608062|19491401|P6|STARTED|Overall Study||15
7920037|NCT00608062|19491402|P5|STARTED|Overall Study||13
7920038|NCT00608062|19491403|P4|STARTED|Overall Study||21
7920039|NCT00608062|19491404|P3|STARTED|Overall Study|43 women completed baseline testing, 3 women withdrew prior to randomization|19
7920040|NCT00608062|19491405|P2|STARTED|Overall Study||12
7920041|NCT00608062|19491406|P1|STARTED|Overall Study|25 women completed baseline testing, 4 women withdrew prior to randomization|12
7920042|NCT00608023|19491465|P3|NOT COMPLETED|Overall Study||14
7920043|NCT00608023|19491466|P2|NOT COMPLETED|Overall Study||22
7920044|NCT00608023|19491467|P1|NOT COMPLETED|Overall Study||12
7920045|NCT00608023|19491465|P3|COMPLETED|Overall Study||72
7920046|NCT00608023|19491466|P2|COMPLETED|Overall Study||63
7920047|NCT00608023|19491467|P1|COMPLETED|Overall Study||80
7920048|NCT00608023|19491465|P3|STARTED|Overall Study||86
7920049|NCT00608023|19491466|P2|STARTED|Overall Study||85
7920050|NCT00608023|19491467|P1|STARTED|Overall Study||92
7920051|NCT00607997|19491491|P4|NOT COMPLETED|Overall Study||16
7920052|NCT00607997|19491492|P3|NOT COMPLETED|Overall Study||24
7920053|NCT00607997|19491493|P2|NOT COMPLETED|Overall Study||27
7920054|NCT00607997|19491494|P1|NOT COMPLETED|Overall Study||27
7920055|NCT00607997|19491491|P4|COMPLETED|Overall Study||4
7920056|NCT00607997|19491492|P3|COMPLETED|Overall Study||5
7920057|NCT00607997|19491493|P2|COMPLETED|Overall Study||8
7920058|NCT00607997|19491494|P1|COMPLETED|Overall Study||2
7920059|NCT00607997|19491491|P4|STARTED|Overall Study||20
7920060|NCT00607997|19491492|P3|STARTED|Overall Study||29
7920061|NCT00607997|19491493|P2|STARTED|Overall Study||35
7920062|NCT00607997|19491494|P1|STARTED|Overall Study||29
7920063|NCT00607919|19491552|P2|NOT COMPLETED|Open-Label Phase||12
7920064|NCT00607919|19491553|P1|NOT COMPLETED|Open-Label Phase||10
7920065|NCT00607919|19491552|P2|COMPLETED|Open-Label Phase||59
7920066|NCT00607919|19491553|P1|COMPLETED|Open-Label Phase||74
7920067|NCT00607919|19491552|P2|STARTED|Open-Label Phase||71
7920068|NCT00607919|19491553|P1|STARTED|Open-Label Phase||84
7920069|NCT00607919|19491552|P2|NOT COMPLETED|Acute Phase||16
7920070|NCT00607919|19491553|P1|NOT COMPLETED|Acute Phase||34
7920071|NCT00607919|19491552|P2|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73
7920072|NCT00607919|19491553|P1|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86
7920073|NCT00607919|19491552|P2|STARTED|Acute Phase||89
7920074|NCT00607919|19491553|P1|STARTED|Acute Phase||120
7920075|NCT00607893|19491611|P2|NOT COMPLETED|Overall Study||4
7920076|NCT00607893|19491612|P1|NOT COMPLETED|Overall Study||6
7920077|NCT00607893|19491611|P2|COMPLETED|Overall Study||72
7920078|NCT00607893|19491612|P1|COMPLETED|Overall Study||71
7920079|NCT00607893|19491611|P2|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|29
7920080|NCT00607893|19491612|P1|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|0
7920081|NCT00607893|19491611|P2|Completed 8 Week Visit|Overall Study||72
7920082|NCT00607893|19491612|P1|Completed 8 Week Visit|Overall Study||71
7920083|NCT00607893|19491611|P2|Completed Baseline Visit|Overall Study||75
7920084|NCT00607893|19491612|P1|Completed Baseline Visit|Overall Study||74
7920085|NCT00607893|19491611|P2|STARTED|Overall Study||76
7920086|NCT00607893|19491612|P1|STARTED|Overall Study||77
7920087|NCT00607880|19491640|P2|NOT COMPLETED|Overall Study||0
7920088|NCT00607880|19491641|P1|NOT COMPLETED|Overall Study||1
7920089|NCT00607880|19491640|P2|COMPLETED|Overall Study||50
7920090|NCT00607880|19491641|P1|COMPLETED|Overall Study||49
7920091|NCT00607880|19491640|P2|STARTED|Overall Study||50
7920092|NCT00607880|19491641|P1|STARTED|Overall Study||50
7920093|NCT00607867|19491655|P2|NOT COMPLETED|Overall Study||0
7920094|NCT00607867|19491656|P1|NOT COMPLETED|Overall Study||0
7920095|NCT00607867|19491655|P2|COMPLETED|Overall Study||7
7920096|NCT00607867|19491656|P1|COMPLETED|Overall Study||7
7920097|NCT00607867|19491655|P2|STARTED|Overall Study||7
7920098|NCT00607867|19491656|P1|STARTED|Overall Study||7
7920099|NCT00607815|19491674|P2|NOT COMPLETED|Overall Study||11
7920100|NCT00607815|19491675|P1|NOT COMPLETED|Overall Study||23
7920101|NCT00607815|19491674|P2|COMPLETED|Overall Study||25
7920102|NCT00607815|19491675|P1|COMPLETED|Overall Study||20
7920103|NCT00607815|19491674|P2|STARTED|Overall Study||36
7920104|NCT00607815|19491675|P1|STARTED|Overall Study||43
7920105|NCT00607789|19491691|P2|NOT COMPLETED|Overall Study||6
7920106|NCT00607789|19491692|P1|NOT COMPLETED|Overall Study||7
7920107|NCT00607789|19491691|P2|COMPLETED|Overall Study||14
7920108|NCT00607789|19491692|P1|COMPLETED|Overall Study||13
7920109|NCT00607789|19491691|P2|STARTED|Overall Study||20
7920110|NCT00607789|19491692|P1|STARTED|Overall Study|20 participants were randomized in each group|20
7920111|NCT00607724|19491707|P7|NOT COMPLETED|Stage 2: Expanded Cohort||11
7920112|NCT00607724|19491708|P6|NOT COMPLETED|Stage 2: Expanded Cohort||12
7920113|NCT00607724|19491709|P5|NOT COMPLETED|Stage 2: Expanded Cohort||9
7920114|NCT00607724|19491710|P4|NOT COMPLETED|Stage 2: Expanded Cohort||5
7920115|NCT00607724|19491711|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
7920116|NCT00607724|19491712|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
7920117|NCT00607724|19491713|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
7920118|NCT00607724|19491707|P7|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
7920119|NCT00607724|19491708|P6|COMPLETED|Stage 2: Expanded Cohort||0
7920120|NCT00607724|19491709|P5|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
7920121|NCT00607724|19491710|P4|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|1
7920122|NCT00607724|19491711|P3|COMPLETED|Stage 2: Expanded Cohort||0
7920123|NCT00607724|19491712|P2|COMPLETED|Stage 2: Expanded Cohort||0
7920124|NCT00607724|19491713|P1|COMPLETED|Stage 2: Expanded Cohort||0
7920125|NCT00607724|19491707|P7|STARTED|Stage 2: Expanded Cohort||16
7920126|NCT00607724|19491708|P6|STARTED|Stage 2: Expanded Cohort||12
7920127|NCT00607724|19491709|P5|STARTED|Stage 2: Expanded Cohort||14
7920128|NCT00607724|19491710|P4|STARTED|Stage 2: Expanded Cohort||6
7920129|NCT00607724|19491711|P3|STARTED|Stage 2: Expanded Cohort||0
7920130|NCT00607724|19491712|P2|STARTED|Stage 2: Expanded Cohort||0
7920131|NCT00607724|19491713|P1|STARTED|Stage 2: Expanded Cohort||0
7920132|NCT00607724|19491707|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
7920133|NCT00607724|19491708|P6|NOT COMPLETED|Stage 1: Dose Escalation||0
7920134|NCT00607724|19491709|P5|NOT COMPLETED|Stage 1: Dose Escalation||0
7920135|NCT00607724|19491710|P4|NOT COMPLETED|Stage 1: Dose Escalation||0
7920136|NCT00607724|19491711|P3|NOT COMPLETED|Stage 1: Dose Escalation||4
7920137|NCT00607724|19491712|P2|NOT COMPLETED|Stage 1: Dose Escalation||8
7920138|NCT00607724|19491713|P1|NOT COMPLETED|Stage 1: Dose Escalation||7
7920139|NCT00607724|19491707|P7|COMPLETED|Stage 1: Dose Escalation||0
7920140|NCT00607724|19491708|P6|COMPLETED|Stage 1: Dose Escalation||0
7920141|NCT00607724|19491709|P5|COMPLETED|Stage 1: Dose Escalation||0
7920142|NCT00607724|19491710|P4|COMPLETED|Stage 1: Dose Escalation||0
7920143|NCT00607724|19491711|P3|COMPLETED|Stage 1: Dose Escalation||0
7920144|NCT00607724|19491712|P2|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered 'completers'.|1
7920145|NCT00607724|19491713|P1|COMPLETED|Stage 1: Dose Escalation||0
7920146|NCT00607724|19491707|P7|STARTED|Stage 1: Dose Escalation||0
7920147|NCT00607724|19491708|P6|STARTED|Stage 1: Dose Escalation||0
7920148|NCT00607724|19491709|P5|STARTED|Stage 1: Dose Escalation||0
7920149|NCT00607724|19491710|P4|STARTED|Stage 1: Dose Escalation||0
7920150|NCT00607724|19491711|P3|STARTED|Stage 1: Dose Escalation||4
7920151|NCT00607724|19491712|P2|STARTED|Stage 1: Dose Escalation||9
7920152|NCT00607724|19491713|P1|STARTED|Stage 1: Dose Escalation||7
7920153|NCT00607672|19491792|P3|NOT COMPLETED|Overall Study||5
7920154|NCT00607672|19491793|P2|NOT COMPLETED|Overall Study||3
7920155|NCT00607672|19491794|P1|NOT COMPLETED|Overall Study||4
7920156|NCT00607672|19491792|P3|COMPLETED|Overall Study||22
7920157|NCT00607672|19491793|P2|COMPLETED|Overall Study||24
7920158|NCT00607672|19491794|P1|COMPLETED|Overall Study||28
7920159|NCT00607672|19491792|P3|STARTED|Overall Study||27
7920160|NCT00607672|19491793|P2|STARTED|Overall Study||27
7920161|NCT00607672|19491794|P1|STARTED|Overall Study||32
7920162|NCT00607620|19491840|P2|NOT COMPLETED|Overall Study||0
7920163|NCT00607620|19491841|P1|NOT COMPLETED|Overall Study||0
7920164|NCT00607620|19491840|P2|COMPLETED|Overall Study||469
7920165|NCT00607620|19491841|P1|COMPLETED|Overall Study||409
7920166|NCT00607620|19491840|P2|STARTED|Overall Study||469
7920167|NCT00607620|19491841|P1|STARTED|Overall Study||409
7920168|NCT00607594|19491855|P1|NOT COMPLETED|Overall Study||0
7920169|NCT00607594|19491855|P1|COMPLETED|Overall Study||21
7920170|NCT00607594|19491855|P1|STARTED|Overall Study||21
7920171|NCT00607477|19491869|P2|NOT COMPLETED|Overall Study||0
7920172|NCT00607477|19491870|P1|NOT COMPLETED|Overall Study||0
7920173|NCT00607477|19491869|P2|COMPLETED|Overall Study||2
7920174|NCT00607477|19491870|P1|COMPLETED|Overall Study||0
7920175|NCT00607477|19491869|P2|STARTED|Overall Study||2
7920176|NCT00607477|19491870|P1|STARTED|Overall Study||0
7920177|NCT00607386|19491876|P1|NOT COMPLETED|Overall Study||1
7920178|NCT00607386|19491876|P1|COMPLETED|Overall Study||27
7920179|NCT00607386|19491876|P1|STARTED|Overall Study||28
7920180|NCT00607373|19491891|P2|NOT COMPLETED|Follow-up Period||5
7920181|NCT00607373|19491892|P1|NOT COMPLETED|Follow-up Period||1
7920182|NCT00607373|19491891|P2|COMPLETED|Follow-up Period||6
7920183|NCT00607373|19491892|P1|COMPLETED|Follow-up Period||0
7920184|NCT00607373|19491891|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11
7920185|NCT00607373|19491892|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1
7920186|NCT00607373|19491891|P2|NOT COMPLETED|Treatment Period||6
7920187|NCT00607373|19491892|P1|NOT COMPLETED|Treatment Period||0
7920188|NCT00607373|19491891|P2|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28
7920189|NCT00607373|19491892|P1|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17
7920190|NCT00607373|19491891|P2|STARTED|Treatment Period||34
7920191|NCT00607373|19491892|P1|STARTED|Treatment Period||17
7920192|NCT00607321|19491936|P1|NOT COMPLETED|Overall Study||0
7920193|NCT00607321|19491936|P1|COMPLETED|Overall Study||60
7920194|NCT00607321|19491936|P1|STARTED|Overall Study||60
7920195|NCT00607269|19491946|P2|NOT COMPLETED|Overall Study||0
7920196|NCT00607269|19491947|P1|NOT COMPLETED|Overall Study||0
7920197|NCT00607269|19491946|P2|COMPLETED|Overall Study||64
7920198|NCT00607269|19491947|P1|COMPLETED|Overall Study||67
7920199|NCT00607269|19491946|P2|STARTED|Overall Study||64
7920200|NCT00607269|19491947|P1|STARTED|Overall Study||67
7920201|NCT00607243|19491961|P2|NOT COMPLETED|Telephone Safety Assessment Period||2
7920202|NCT00607243|19491962|P1|NOT COMPLETED|Telephone Safety Assessment Period||5
7920203|NCT00607243|19491961|P2|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39
7920204|NCT00607243|19491962|P1|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77
7920205|NCT00607243|19491961|P2|STARTED|Telephone Safety Assessment Period||41
7920206|NCT00607243|19491962|P1|STARTED|Telephone Safety Assessment Period||82
7920207|NCT00607243|19491961|P2|NOT COMPLETED|Initial Post-vaccination Period||0
7920208|NCT00607243|19491962|P1|NOT COMPLETED|Initial Post-vaccination Period||0
7920209|NCT00607243|19491961|P2|COMPLETED|Initial Post-vaccination Period||41
7920210|NCT00607243|19491962|P1|COMPLETED|Initial Post-vaccination Period||82
7920211|NCT00607243|19491961|P2|STARTED|Initial Post-vaccination Period||41
7920212|NCT00607243|19491962|P1|STARTED|Initial Post-vaccination Period||82
7920213|NCT00607126|19491970|P2|NOT COMPLETED|Overall Study||0
7920214|NCT00607126|19491971|P1|NOT COMPLETED|Overall Study||0
7920215|NCT00607126|19491970|P2|COMPLETED|Overall Study||19
7920216|NCT00607126|19491971|P1|COMPLETED|Overall Study||17
7920217|NCT00607126|19491970|P2|STARTED|Overall Study||19
7920218|NCT00607126|19491971|P1|STARTED|Overall Study||17
7920219|NCT00607113|19491985|P2|NOT COMPLETED|Overall Study||0
7920220|NCT00607113|19491986|P1|NOT COMPLETED|Overall Study||0
7920221|NCT00607113|19491985|P2|COMPLETED|Overall Study||20
7920222|NCT00607113|19491986|P1|COMPLETED|Overall Study||19
7920223|NCT00607113|19491985|P2|STARTED|Overall Study||20
7920224|NCT00607113|19491986|P1|STARTED|Overall Study||19
7920225|NCT00607087|19491994|P3|NOT COMPLETED|Period 3||0
7920226|NCT00607087|19491995|P2|NOT COMPLETED|Period 3||2
7920227|NCT00607087|19491996|P1|NOT COMPLETED|Period 3||2
7920228|NCT00607087|19491994|P3|COMPLETED|Period 3||84
7920229|NCT00607087|19491995|P2|COMPLETED|Period 3||84
7920230|NCT00607087|19491996|P1|COMPLETED|Period 3||84
7920231|NCT00607087|19491994|P3|STARTED|Period 3||84
7920232|NCT00607087|19491995|P2|STARTED|Period 3||86
7920233|NCT00607087|19491996|P1|STARTED|Period 3||86
7920234|NCT00607087|19491994|P3|NOT COMPLETED|Period 2||5
7920235|NCT00607087|19491995|P2|NOT COMPLETED|Period 2||3
7920236|NCT00607087|19491996|P1|NOT COMPLETED|Period 2||1
7920237|NCT00607087|19491994|P3|COMPLETED|Period 2||84
7920238|NCT00607087|19491995|P2|COMPLETED|Period 2||86
7920239|NCT00607087|19491996|P1|COMPLETED|Period 2||86
7920240|NCT00607087|19491994|P3|STARTED|Period 2||89
7920241|NCT00607087|19491995|P2|STARTED|Period 2||89
7920242|NCT00607087|19491996|P1|STARTED|Period 2||87
7920243|NCT00607087|19491994|P3|NOT COMPLETED|Period 1||5
7920244|NCT00607087|19491995|P2|NOT COMPLETED|Period 1||6
7920245|NCT00607087|19491996|P1|NOT COMPLETED|Period 1||12
7920246|NCT00607087|19491994|P3|COMPLETED|Period 1||89
7920247|NCT00607087|19491995|P2|COMPLETED|Period 1||89
7920248|NCT00607087|19491996|P1|COMPLETED|Period 1||87
7920249|NCT00607087|19491994|P3|STARTED|Period 1||94
7920250|NCT00607087|19491995|P2|STARTED|Period 1||95
7920251|NCT00607087|19491996|P1|STARTED|Period 1||99
7920252|NCT00607087|19491994|P3|NOT COMPLETED|Overall Study||10
7920253|NCT00607087|19491995|P2|NOT COMPLETED|Overall Study||11
7920254|NCT00607087|19491996|P1|NOT COMPLETED|Overall Study||15
7920255|NCT00607087|19491994|P3|COMPLETED|Overall Study||84
7920256|NCT00607087|19491995|P2|COMPLETED|Overall Study||84
7920257|NCT00607087|19491996|P1|COMPLETED|Overall Study||84
7920258|NCT00607087|19491994|P3|STARTED|Overall Study||94
7920259|NCT00607087|19491995|P2|STARTED|Overall Study||95
7920260|NCT00607087|19491996|P1|STARTED|Overall Study||99
7920261|NCT00607048|19492054|P6|NOT COMPLETED|Overall Study||5
7920262|NCT00607048|19492055|P5|NOT COMPLETED|Overall Study||6
7920263|NCT00607048|19492056|P4|NOT COMPLETED|Overall Study||3
7920264|NCT00607048|19492057|P3|NOT COMPLETED|Overall Study||4
7920265|NCT00607048|19492058|P2|NOT COMPLETED|Overall Study||4
7920266|NCT00607048|19492059|P1|NOT COMPLETED|Overall Study||3
7920267|NCT00607048|19492054|P6|COMPLETED|Overall Study||2
7920268|NCT00607048|19492055|P5|COMPLETED|Overall Study||0
7920269|NCT00607048|19492056|P4|COMPLETED|Overall Study||0
7920270|NCT00607048|19492057|P3|COMPLETED|Overall Study||3
7920271|NCT00607048|19492058|P2|COMPLETED|Overall Study||2
7920272|NCT00607048|19492059|P1|COMPLETED|Overall Study||0
7920273|NCT00607048|19492054|P6|STARTED|Overall Study||7
7920274|NCT00607048|19492055|P5|STARTED|Overall Study||6
7920275|NCT00607048|19492056|P4|STARTED|Overall Study||3
7920276|NCT00607048|19492057|P3|STARTED|Overall Study||7
7920277|NCT00607048|19492058|P2|STARTED|Overall Study||6
7920278|NCT00607048|19492059|P1|STARTED|Overall Study||3
7920279|NCT00607022|19492144|P3|NOT COMPLETED|Overall Study||0
7920280|NCT00607022|19492145|P2|NOT COMPLETED|Overall Study||0
7920281|NCT00607022|19492146|P1|NOT COMPLETED|Overall Study||1
7920282|NCT00607022|19492144|P3|COMPLETED|Overall Study||19
7920283|NCT00607022|19492145|P2|COMPLETED|Overall Study||15
7920284|NCT00607022|19492146|P1|COMPLETED|Overall Study||6
7920285|NCT00607022|19492144|P3|STARTED|Overall Study||19
7920286|NCT00607022|19492145|P2|STARTED|Overall Study||15
7920287|NCT00607022|19492146|P1|STARTED|Overall Study||7
7920288|NCT00606944|19492156|P2|NOT COMPLETED|Overall Study||0
7920289|NCT00606944|19492157|P1|NOT COMPLETED|Overall Study||0
7920290|NCT00606944|19492156|P2|COMPLETED|Overall Study||100
7920291|NCT00606944|19492157|P1|COMPLETED|Overall Study||98
7920292|NCT00606944|19492156|P2|STARTED|Overall Study||100
7920293|NCT00606944|19492157|P1|STARTED|Overall Study||98
7920294|NCT00606931|19492163|P1|NOT COMPLETED|Overall Study||3
7920295|NCT00606931|19492163|P1|COMPLETED|Overall Study||19
7920296|NCT00606931|19492163|P1|STARTED|Overall Study||22
7920297|NCT00606905|19492171|P2|NOT COMPLETED|Overall Study||15
7920298|NCT00606905|19492172|P1|NOT COMPLETED|Overall Study||15
7920299|NCT00606905|19492171|P2|COMPLETED|Overall Study||24
7920300|NCT00606905|19492172|P1|COMPLETED|Overall Study||23
7920301|NCT00606905|19492171|P2|Pregnancy|Overall Study||33
7920302|NCT00606905|19492172|P1|Pregnancy|Overall Study||29
7920303|NCT00606905|19492171|P2|STARTED|Overall Study||39
7920304|NCT00606905|19492172|P1|STARTED|Overall Study||38
7920305|NCT00606892|19492178|P2|NOT COMPLETED|Second Intervention||0
7920306|NCT00606892|19492179|P1|NOT COMPLETED|Second Intervention||0
7920307|NCT00606892|19492178|P2|COMPLETED|Second Intervention||4
7920308|NCT00606892|19492179|P1|COMPLETED|Second Intervention||8
7920309|NCT00606892|19492178|P2|STARTED|Second Intervention||4
7920310|NCT00606892|19492179|P1|STARTED|Second Intervention||8
7920311|NCT00606892|19492178|P2|NOT COMPLETED|Washout Period||0
7920312|NCT00606892|19492179|P1|NOT COMPLETED|Washout Period||0
7920313|NCT00606892|19492178|P2|COMPLETED|Washout Period||4
7920314|NCT00606892|19492179|P1|COMPLETED|Washout Period||8
7920315|NCT00606892|19492178|P2|STARTED|Washout Period||4
7920316|NCT00606892|19492179|P1|STARTED|Washout Period||8
7920317|NCT00606892|19492178|P2|NOT COMPLETED|First Intervention||4
7920318|NCT00606892|19492179|P1|NOT COMPLETED|First Intervention||1
7920319|NCT00606892|19492178|P2|COMPLETED|First Intervention||4
7920320|NCT00606892|19492179|P1|COMPLETED|First Intervention||8
7920321|NCT00606892|19492178|P2|STARTED|First Intervention||8
7920322|NCT00606892|19492179|P1|STARTED|First Intervention||9
7920323|NCT00606892|19492178|P2|NOT COMPLETED|Adaptation||0
7920324|NCT00606892|19492179|P1|NOT COMPLETED|Adaptation||0
7920325|NCT00606892|19492178|P2|COMPLETED|Adaptation||8
7920326|NCT00606892|19492179|P1|COMPLETED|Adaptation||9
7920327|NCT00606892|19492178|P2|STARTED|Adaptation||8
7920328|NCT00606892|19492179|P1|STARTED|Adaptation||9
7920329|NCT00606801|19492213|P2|NOT COMPLETED|Intervention||3
7920330|NCT00606801|19492214|P1|NOT COMPLETED|Intervention||3
7920331|NCT00606801|19492213|P2|COMPLETED|Intervention||14
7920332|NCT00606801|19492214|P1|COMPLETED|Intervention||14
7920333|NCT00606801|19492213|P2|STARTED|Intervention||17
7920334|NCT00606801|19492214|P1|STARTED|Intervention||17
7920335|NCT00606801|19492213|P2|NOT COMPLETED|Adaptation||0
7920336|NCT00606801|19492214|P1|NOT COMPLETED|Adaptation||0
7920337|NCT00606801|19492213|P2|COMPLETED|Adaptation||17
7920338|NCT00606801|19492214|P1|COMPLETED|Adaptation||17
7920339|NCT00606801|19492213|P2|STARTED|Adaptation||17
7920340|NCT00606801|19492214|P1|STARTED|Adaptation||17
7920341|NCT00606684|19492242|P7|NOT COMPLETED|Double-Blind Treatment Period||8
7920342|NCT00606684|19492243|P6|NOT COMPLETED|Double-Blind Treatment Period||9
7920343|NCT00606684|19492244|P5|NOT COMPLETED|Double-Blind Treatment Period||9
7920344|NCT00606684|19492245|P4|NOT COMPLETED|Double-Blind Treatment Period||10
7920345|NCT00606684|19492246|P3|NOT COMPLETED|Double-Blind Treatment Period||11
7920346|NCT00606684|19492247|P2|NOT COMPLETED|Double-Blind Treatment Period||16
7920347|NCT00606684|19492248|P1|NOT COMPLETED|Double-Blind Treatment Period||0
7920348|NCT00606684|19492242|P7|COMPLETED|Double-Blind Treatment Period||91
7920349|NCT00606684|19492243|P6|COMPLETED|Double-Blind Treatment Period||92
7920350|NCT00606684|19492244|P5|COMPLETED|Double-Blind Treatment Period||92
7920351|NCT00606684|19492245|P4|COMPLETED|Double-Blind Treatment Period||91
7920352|NCT00606684|19492246|P3|COMPLETED|Double-Blind Treatment Period||88
7920353|NCT00606684|19492247|P2|COMPLETED|Double-Blind Treatment Period||85
7920354|NCT00606684|19492248|P1|COMPLETED|Double-Blind Treatment Period||0
7920355|NCT00606684|19492242|P7|STARTED|Double-Blind Treatment Period||99
7920356|NCT00606684|19492243|P6|STARTED|Double-Blind Treatment Period||101
7920357|NCT00606684|19492244|P5|STARTED|Double-Blind Treatment Period||101
7920358|NCT00606684|19492245|P4|STARTED|Double-Blind Treatment Period||101
7920359|NCT00606684|19492246|P3|STARTED|Double-Blind Treatment Period||99
7920360|NCT00606684|19492247|P2|STARTED|Double-Blind Treatment Period||101
7920361|NCT00606684|19492248|P1|STARTED|Double-Blind Treatment Period||0
7920362|NCT00606684|19492242|P7|NOT COMPLETED|2-week Single-Blind Run-in Period||0
7920363|NCT00606684|19492243|P6|NOT COMPLETED|2-week Single-Blind Run-in Period||0
7920364|NCT00606684|19492244|P5|NOT COMPLETED|2-week Single-Blind Run-in Period||0
7920365|NCT00606684|19492245|P4|NOT COMPLETED|2-week Single-Blind Run-in Period||0
7920366|NCT00606684|19492246|P3|NOT COMPLETED|2-week Single-Blind Run-in Period||0
7920367|NCT00606684|19492247|P2|NOT COMPLETED|2-week Single-Blind Run-in Period||0
7920368|NCT00606684|19492248|P1|NOT COMPLETED|2-week Single-Blind Run-in Period||246
7920369|NCT00606684|19492242|P7|COMPLETED|2-week Single-Blind Run-in Period||0
7920370|NCT00606684|19492243|P6|COMPLETED|2-week Single-Blind Run-in Period||0
7920371|NCT00606684|19492244|P5|COMPLETED|2-week Single-Blind Run-in Period||0
7920372|NCT00606684|19492245|P4|COMPLETED|2-week Single-Blind Run-in Period||0
7920373|NCT00606684|19492246|P3|COMPLETED|2-week Single-Blind Run-in Period||0
7920374|NCT00606684|19492247|P2|COMPLETED|2-week Single-Blind Run-in Period||0
7920375|NCT00606684|19492248|P1|COMPLETED|2-week Single-Blind Run-in Period||605
7920376|NCT00606684|19492242|P7|STARTED|2-week Single-Blind Run-in Period||0
7920377|NCT00606684|19492243|P6|STARTED|2-week Single-Blind Run-in Period||0
7920378|NCT00606684|19492244|P5|STARTED|2-week Single-Blind Run-in Period||0
7920379|NCT00606684|19492245|P4|STARTED|2-week Single-Blind Run-in Period||0
7920380|NCT00606684|19492246|P3|STARTED|2-week Single-Blind Run-in Period||0
7920381|NCT00606684|19492247|P2|STARTED|2-week Single-Blind Run-in Period||0
7920382|NCT00606684|19492248|P1|STARTED|2-week Single-Blind Run-in Period||851
7920383|NCT00606632|19492280|P1|NOT COMPLETED|Overall Study||22
7920384|NCT00606632|19492280|P1|COMPLETED|Overall Study||204
7920385|NCT00606632|19492280|P1|STARTED|Overall Study||226
7920386|NCT00606593|19492293|P10|NOT COMPLETED|Overall Study||0
7920387|NCT00606593|19492294|P9|NOT COMPLETED|Overall Study||1
7920388|NCT00606593|19492295|P8|NOT COMPLETED|Overall Study||2
7920389|NCT00606593|19492296|P7|NOT COMPLETED|Overall Study||1
7920390|NCT00606593|19492297|P6|NOT COMPLETED|Overall Study||0
7920391|NCT00606593|19492298|P5|NOT COMPLETED|Overall Study||1
7920392|NCT00606593|19492299|P4|NOT COMPLETED|Overall Study||1
7920393|NCT00606593|19492300|P3|NOT COMPLETED|Overall Study||2
7920394|NCT00606593|19492301|P2|NOT COMPLETED|Overall Study||0
7920395|NCT00606593|19492302|P1|NOT COMPLETED|Overall Study||1
7920396|NCT00606593|19492293|P10|COMPLETED|Overall Study||11
7920397|NCT00606593|19492294|P9|COMPLETED|Overall Study||11
7920398|NCT00606593|19492295|P8|COMPLETED|Overall Study||9
7920399|NCT00606593|19492296|P7|COMPLETED|Overall Study||10
7920400|NCT00606593|19492297|P6|COMPLETED|Overall Study||11
7920401|NCT00606593|19492298|P5|COMPLETED|Overall Study||11
7920402|NCT00606593|19492299|P4|COMPLETED|Overall Study||10
7920403|NCT00606593|19492300|P3|COMPLETED|Overall Study||9
7920404|NCT00606593|19492301|P2|COMPLETED|Overall Study||11
7920405|NCT00606593|19492302|P1|COMPLETED|Overall Study||10
7920406|NCT00606593|19492293|P10|5th Double-blind Treatment|Overall Study||11
7920407|NCT00606593|19492294|P9|5th Double-blind Treatment|Overall Study||11
7920408|NCT00606593|19492295|P8|5th Double-blind Treatment|Overall Study||9
7920409|NCT00606593|19492296|P7|5th Double-blind Treatment|Overall Study||10
7920410|NCT00606593|19492297|P6|5th Double-blind Treatment|Overall Study||11
7920411|NCT00606593|19492298|P5|5th Double-blind Treatment|Overall Study||11
7920412|NCT00606593|19492299|P4|5th Double-blind Treatment|Overall Study||10
7920413|NCT00606593|19492300|P3|5th Double-blind Treatment|Overall Study||9
7920414|NCT00606593|19492301|P2|5th Double-blind Treatment|Overall Study||11
7920415|NCT00606593|19492302|P1|5th Double-blind Treatment|Overall Study||10
7920416|NCT00606593|19492293|P10|4th Double-blind Treatment|Overall Study||11
7920417|NCT00606593|19492294|P9|4th Double-blind Treatment|Overall Study||11
7920418|NCT00606593|19492295|P8|4th Double-blind Treatment|Overall Study||9
7920419|NCT00606593|19492296|P7|4th Double-blind Treatment|Overall Study||10
7920420|NCT00606593|19492297|P6|4th Double-blind Treatment|Overall Study||11
7920421|NCT00606593|19492298|P5|4th Double-blind Treatment|Overall Study||11
7920422|NCT00606593|19492299|P4|4th Double-blind Treatment|Overall Study||10
7920423|NCT00606593|19492300|P3|4th Double-blind Treatment|Overall Study||10
7920424|NCT00606593|19492301|P2|4th Double-blind Treatment|Overall Study||11
7920425|NCT00606593|19492302|P1|4th Double-blind Treatment|Overall Study||10
7920426|NCT00606593|19492293|P10|3rd Double-blind Treatment|Overall Study||11
7920427|NCT00606593|19492294|P9|3rd Double-blind Treatment|Overall Study||12
7920428|NCT00606593|19492295|P8|3rd Double-blind Treatment|Overall Study||9
7920429|NCT00606593|19492296|P7|3rd Double-blind Treatment|Overall Study||10
7920430|NCT00606593|19492297|P6|3rd Double-blind Treatment|Overall Study||11
7920431|NCT00606593|19492298|P5|3rd Double-blind Treatment|Overall Study||11
7920432|NCT00606593|19492299|P4|3rd Double-blind Treatment|Overall Study||10
7920433|NCT00606593|19492300|P3|3rd Double-blind Treatment|Overall Study||10
7920434|NCT00606593|19492301|P2|3rd Double-blind Treatment|Overall Study||11
7920435|NCT00606593|19492302|P1|3rd Double-blind Treatment|Overall Study||11
7920436|NCT00606593|19492293|P10|2nd Double-blind Treatment|Overall Study||11
7920437|NCT00606593|19492294|P9|2nd Double-blind Treatment|Overall Study||12
7920438|NCT00606593|19492295|P8|2nd Double-blind Treatment|Overall Study||9
7920439|NCT00606593|19492296|P7|2nd Double-blind Treatment|Overall Study||10
7920440|NCT00606593|19492297|P6|2nd Double-blind Treatment|Overall Study||11
7920441|NCT00606593|19492298|P5|2nd Double-blind Treatment|Overall Study||12
7920442|NCT00606593|19492299|P4|2nd Double-blind Treatment|Overall Study||10
7920443|NCT00606593|19492300|P3|2nd Double-blind Treatment|Overall Study||11
7920444|NCT00606593|19492301|P2|2nd Double-blind Treatment|Overall Study||11
7920445|NCT00606593|19492302|P1|2nd Double-blind Treatment|Overall Study||11
7920446|NCT00606593|19492293|P10|1st Double-blind Treatment|Overall Study||11
7920447|NCT00606593|19492294|P9|1st Double-blind Treatment|Overall Study||12
7920448|NCT00606593|19492295|P8|1st Double-blind Treatment|Overall Study||11
7920449|NCT00606593|19492296|P7|1st Double-blind Treatment|Overall Study||11
7920450|NCT00606593|19492297|P6|1st Double-blind Treatment|Overall Study||11
7920451|NCT00606593|19492298|P5|1st Double-blind Treatment|Overall Study||12
7920452|NCT00606593|19492299|P4|1st Double-blind Treatment|Overall Study||11
7920453|NCT00606593|19492300|P3|1st Double-blind Treatment|Overall Study||11
7920454|NCT00606593|19492301|P2|1st Double-blind Treatment|Overall Study||11
7920455|NCT00606593|19492302|P1|1st Double-blind Treatment|Overall Study||11
7920456|NCT00606593|19492293|P10|STARTED|Overall Study|Randomized participants|11
7920457|NCT00606593|19492294|P9|STARTED|Overall Study|Randomized participants|12
7920458|NCT00606593|19492295|P8|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11
7920459|NCT00606593|19492296|P7|STARTED|Overall Study|Randomized participants|11
7920460|NCT00606593|19492297|P6|STARTED|Overall Study|Randomized participants|11
7920461|NCT00606593|19492298|P5|STARTED|Overall Study|Randomized participants|12
7920462|NCT00606593|19492299|P4|STARTED|Overall Study|Randomized participants|11
7920463|NCT00606593|19492300|P3|STARTED|Overall Study|Randomized participants|11
7920464|NCT00606593|19492301|P2|STARTED|Overall Study|Randomized participants|11
7920465|NCT00606593|19492302|P1|STARTED|Overall Study|Randomized participants|11
7920466|NCT00606580|19492323|P3|NOT COMPLETED|Overall Study||22
7920467|NCT00606580|19492324|P2|NOT COMPLETED|Overall Study||3
7920468|NCT00606580|19492325|P1|NOT COMPLETED|Overall Study||2
7920469|NCT00606580|19492323|P3|COMPLETED|Overall Study||103
7920470|NCT00606580|19492324|P2|COMPLETED|Overall Study||122
7920471|NCT00606580|19492325|P1|COMPLETED|Overall Study||123
7920472|NCT00606580|19492323|P3|STARTED|Overall Study||125
7920473|NCT00606580|19492324|P2|STARTED|Overall Study||125
7920474|NCT00606580|19492325|P1|STARTED|Overall Study||125
7920475|NCT00606554|19492368|P2|NOT COMPLETED|Overall Study||0
7920476|NCT00606554|19492369|P1|NOT COMPLETED|Overall Study||0
7920477|NCT00606554|19492368|P2|COMPLETED|Overall Study||18
7920478|NCT00606554|19492369|P1|COMPLETED|Overall Study||15
7920479|NCT00606554|19492368|P2|STARTED|Overall Study||18
7920480|NCT00606554|19492369|P1|STARTED|Overall Study||15
7920481|NCT00606502|19492391|P2|NOT COMPLETED|Treatment||3
7920482|NCT00606502|19492392|P1|NOT COMPLETED|Treatment||0
7920483|NCT00606502|19492391|P2|COMPLETED|Treatment||98
7920484|NCT00606502|19492392|P1|COMPLETED|Treatment||97
7920485|NCT00606502|19492391|P2|STARTED|Treatment||101
7920486|NCT00606502|19492392|P1|STARTED|Treatment||97
7920487|NCT00606502|19492391|P2|NOT COMPLETED|Randomization||0
7920488|NCT00606502|19492392|P1|NOT COMPLETED|Randomization||3
7920489|NCT00606502|19492391|P2|COMPLETED|Randomization||101
7920490|NCT00606502|19492392|P1|COMPLETED|Randomization||97
7920491|NCT00606502|19492391|P2|STARTED|Randomization||101
7920492|NCT00606502|19492392|P1|STARTED|Randomization||100
7920493|NCT00606489|19492406|P2|NOT COMPLETED|Overall Study||0
7920494|NCT00606489|19492407|P1|NOT COMPLETED|Overall Study||0
7920495|NCT00606489|19492406|P2|COMPLETED|Overall Study||40
7920496|NCT00606489|19492407|P1|COMPLETED|Overall Study||21
7920497|NCT00606489|19492406|P2|STARTED|Overall Study||40
7920498|NCT00606489|19492407|P1|STARTED|Overall Study||21
7920499|NCT00606320|19492413|P1|NOT COMPLETED|Overall Study||37
7920500|NCT00606320|19492413|P1|COMPLETED|Overall Study||22
7920501|NCT00606320|19492413|P1|STARTED|Overall Study||59
7920502|NCT00606307|19492418|P1|NOT COMPLETED|Overall Study||11
7920503|NCT00606307|19492418|P1|COMPLETED|Overall Study||18
7920504|NCT00606307|19492418|P1|STARTED|Overall Study||29
7920505|NCT00606294|19492426|P2|NOT COMPLETED|Overall Study||0
7920506|NCT00606294|19492427|P1|NOT COMPLETED|Overall Study||36
7920507|NCT00606294|19492426|P2|COMPLETED|Overall Study||19
7920508|NCT00606294|19492427|P1|COMPLETED|Overall Study||161
7920509|NCT00606294|19492426|P2|STARTED|Overall Study||19
7920510|NCT00606294|19492427|P1|STARTED|Overall Study||197
7920511|NCT00606281|19492441|P2|NOT COMPLETED|Overall Study||66
7920512|NCT00606281|19492442|P1|NOT COMPLETED|Overall Study||56
7920513|NCT00606281|19492441|P2|COMPLETED|Overall Study||64
7920514|NCT00606281|19492442|P1|COMPLETED|Overall Study||72
7920515|NCT00606281|19492441|P2|STARTED|Overall Study||130
7920516|NCT00606281|19492442|P1|STARTED|Overall Study||128
7920517|NCT00606229|19492450|P1|NOT COMPLETED|Overall Study||22
7920518|NCT00606229|19492450|P1|COMPLETED|Overall Study||19
7920519|NCT00606229|19492450|P1|STARTED|Overall Study||41
7920520|NCT00606177|19492457|P2|NOT COMPLETED|Overall Study||25
7920521|NCT00606177|19492458|P1|NOT COMPLETED|Overall Study||27
7920522|NCT00606177|19492457|P2|COMPLETED|Overall Study||19
7920523|NCT00606177|19492458|P1|COMPLETED|Overall Study||28
7920524|NCT00606177|19492457|P2|STARTED|Overall Study||44
7920525|NCT00606177|19492458|P1|STARTED|Overall Study||55
7920526|NCT00606138|19492468|P2|NOT COMPLETED|Overall Study||0
7920527|NCT00606138|19492469|P1|NOT COMPLETED|Overall Study||0
7920528|NCT00606138|19492468|P2|COMPLETED|Overall Study||2
7920529|NCT00606138|19492469|P1|COMPLETED|Overall Study||6
7920530|NCT00606138|19492468|P2|STARTED|Overall Study||2
7920531|NCT00606138|19492469|P1|STARTED|Overall Study||6
7920532|NCT00606086|19492485|P2|NOT COMPLETED|Overall Study||15
7920533|NCT00606086|19492486|P1|NOT COMPLETED|Overall Study||12
7920534|NCT00606086|19492485|P2|COMPLETED|Overall Study||53
7920535|NCT00606086|19492486|P1|COMPLETED|Overall Study||60
7920536|NCT00606086|19492485|P2|STARTED|Overall Study||68
7920537|NCT00606086|19492486|P1|STARTED|Overall Study||72
7920538|NCT00606047|19492492|P1|NOT COMPLETED|Overall Study||0
7920539|NCT00606047|19492492|P1|COMPLETED|Overall Study||200
7920540|NCT00606047|19492492|P1|STARTED|Overall Study||200
7920541|NCT00606034|19492496|P1|NOT COMPLETED|Overall Study||1
7920542|NCT00606034|19492496|P1|COMPLETED|Overall Study||20
7920543|NCT00606034|19492496|P1|STARTED|Overall Study||21
7920544|NCT00606021|19492504|P3|NOT COMPLETED|Maintenance Phase||17
7920545|NCT00606021|19492505|P2|NOT COMPLETED|Maintenance Phase||23
7920546|NCT00606021|19492506|P1|NOT COMPLETED|Maintenance Phase||0
7920547|NCT00606021|19492504|P3|COMPLETED|Maintenance Phase||10
7920548|NCT00606021|19492505|P2|COMPLETED|Maintenance Phase||5
7920549|NCT00606021|19492506|P1|COMPLETED|Maintenance Phase||0
7920550|NCT00606021|19492504|P3|STARTED|Maintenance Phase||27
7920551|NCT00606021|19492505|P2|STARTED|Maintenance Phase||28
7920552|NCT00606021|19492506|P1|STARTED|Maintenance Phase||0
7920553|NCT00606021|19492504|P3|NOT COMPLETED|Induction Phase||0
7920554|NCT00606021|19492505|P2|NOT COMPLETED|Induction Phase||0
7920555|NCT00606021|19492506|P1|NOT COMPLETED|Induction Phase||87
7920556|NCT00606021|19492504|P3|COMPLETED|Induction Phase||0
7920557|NCT00606021|19492505|P2|COMPLETED|Induction Phase||0
7920558|NCT00606021|19492506|P1|COMPLETED|Induction Phase||19
7920559|NCT00606021|19492504|P3|STARTED|Induction Phase||0
7920560|NCT00606021|19492505|P2|STARTED|Induction Phase||0
7920561|NCT00606021|19492506|P1|STARTED|Induction Phase||106
7920562|NCT00606008|19492524|P1|NOT COMPLETED|Overall Study||5
7920563|NCT00606008|19492524|P1|COMPLETED|Overall Study||25
7920564|NCT00606008|19492524|P1|STARTED|Overall Study||30
7920565|NCT00605917|19492538|P1|NOT COMPLETED|Overall Study||79
7920566|NCT00605917|19492538|P1|COMPLETED|Overall Study||908
7920567|NCT00605917|19492538|P1|STARTED|Overall Study||987
7920568|NCT00605904|19492579|P2|NOT COMPLETED|Infusion Sessions||3
7920569|NCT00605904|19492580|P1|NOT COMPLETED|Infusion Sessions||1
7920570|NCT00605904|19492579|P2|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13
7920571|NCT00605904|19492580|P1|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12
7920572|NCT00605904|19492579|P2|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15
7920573|NCT00605904|19492580|P1|Yohimbine Infusion|Infusion Sessions||12
7920574|NCT00605904|19492579|P2|mCPP Infusion|Infusion Sessions||13
7920575|NCT00605904|19492580|P1|mCPP Infusion|Infusion Sessions||12
7920576|NCT00605904|19492579|P2|Saline Infusion|Infusion Sessions||14
7920577|NCT00605904|19492580|P1|Saline Infusion|Infusion Sessions||13
7920578|NCT00605904|19492579|P2|STARTED|Infusion Sessions||16
7920579|NCT00605904|19492580|P1|STARTED|Infusion Sessions||13
7920580|NCT00605904|19492579|P2|NOT COMPLETED|Baseline Data Collection and Dosing||5
7920581|NCT00605904|19492580|P1|NOT COMPLETED|Baseline Data Collection and Dosing||0
7920582|NCT00605904|19492579|P2|COMPLETED|Baseline Data Collection and Dosing||16
7920583|NCT00605904|19492580|P1|COMPLETED|Baseline Data Collection and Dosing||13
7920584|NCT00605904|19492579|P2|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21
7920585|NCT00605904|19492580|P1|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13
7920586|NCT00605865|19492590|P1|NOT COMPLETED|Overall Study||115
7920587|NCT00605865|19492590|P1|COMPLETED|Overall Study||2157
7920588|NCT00605865|19492590|P1|STARTED|Overall Study||2272
7920589|NCT00605839|19492632|P3|NOT COMPLETED|Overall Study||0
7920590|NCT00605839|19492633|P2|NOT COMPLETED|Overall Study||0
7920591|NCT00605839|19492634|P1|NOT COMPLETED|Overall Study||1
7920592|NCT00605839|19492632|P3|COMPLETED|Overall Study||28
7920593|NCT00605839|19492633|P2|COMPLETED|Overall Study||37
7920594|NCT00605839|19492634|P1|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39
7920595|NCT00605839|19492632|P3|STARTED|Overall Study||28
7920596|NCT00605839|19492633|P2|STARTED|Overall Study||37
7920597|NCT00605839|19492634|P1|STARTED|Overall Study||40
7920598|NCT00605826|19492644|P2|NOT COMPLETED|Overall Study||10
7920599|NCT00605826|19492645|P1|NOT COMPLETED|Overall Study||7
7920600|NCT00605826|19492644|P2|COMPLETED|Overall Study||60
7920601|NCT00605826|19492645|P1|COMPLETED|Overall Study||129
7920602|NCT00605826|19492644|P2|STARTED|Overall Study||70
7920603|NCT00605826|19492645|P1|STARTED|Overall Study||136
7920604|NCT00605813|19492657|P1|NOT COMPLETED|Overall Study||25
7920605|NCT00605813|19492657|P1|COMPLETED|Overall Study||517
7920606|NCT00605813|19492657|P1|STARTED|Overall Study||542
7920607|NCT00605722|19492670|P1|NOT COMPLETED|Overall Study||51
7920608|NCT00605722|19492670|P1|COMPLETED|Overall Study|Completed=Completed Treatment.|0
7920609|NCT00605722|19492670|P1|STARTED|Overall Study||51
7920610|NCT00605696|19492682|P2|NOT COMPLETED|Overall Study||0
7920611|NCT00605696|19492683|P1|NOT COMPLETED|Overall Study||0
7920612|NCT00605696|19492682|P2|COMPLETED|Overall Study||11
7920613|NCT00605696|19492683|P1|COMPLETED|Overall Study||7
7920614|NCT00605696|19492682|P2|STARTED|Overall Study||11
7920615|NCT00605696|19492683|P1|STARTED|Overall Study||7
7920616|NCT00605657|19492691|P1|NOT COMPLETED|Overall Study||2
7920617|NCT00605657|19492691|P1|COMPLETED|Overall Study||3
7920618|NCT00605657|19492691|P1|STARTED|Overall Study||5
7920619|NCT00605644|19492701|P5|NOT COMPLETED|Overall Study||8
7920620|NCT00605644|19492702|P4|NOT COMPLETED|Overall Study||5
7920621|NCT00605644|19492703|P3|NOT COMPLETED|Overall Study||2
7920622|NCT00605644|19492704|P2|NOT COMPLETED|Overall Study||1
7920623|NCT00605644|19492705|P1|NOT COMPLETED|Overall Study||1
7920624|NCT00605644|19492701|P5|COMPLETED|Overall Study||22
7920625|NCT00605644|19492702|P4|COMPLETED|Overall Study||25
7920626|NCT00605644|19492703|P3|COMPLETED|Overall Study||18
7920627|NCT00605644|19492704|P2|COMPLETED|Overall Study||18
7920628|NCT00605644|19492705|P1|COMPLETED|Overall Study||28
7920629|NCT00605644|19492701|P5|STARTED|Overall Study||30
7920630|NCT00605644|19492702|P4|STARTED|Overall Study||30
7920631|NCT00605644|19492703|P3|STARTED|Overall Study||20
7920632|NCT00605644|19492704|P2|STARTED|Overall Study||19
7920633|NCT00605644|19492705|P1|STARTED|Overall Study||29
7920634|NCT00605566|19492717|P1|NOT COMPLETED|Overall Study||3
7920635|NCT00605566|19492717|P1|COMPLETED|Overall Study||19
7920636|NCT00605566|19492717|P1|STARTED|Overall Study||22
7920637|NCT00605540|19492725|P1|NOT COMPLETED|Overall Study||38
7920638|NCT00605540|19492725|P1|COMPLETED|Overall Study||95
7920639|NCT00605540|19492725|P1|STARTED|Overall Study||133
7920640|NCT00605475|19492743|P10|NOT COMPLETED|Overall Study||2
7920641|NCT00605475|19492744|P9|NOT COMPLETED|Overall Study||2
7920642|NCT00605475|19492745|P8|NOT COMPLETED|Overall Study||0
7920643|NCT00605475|19492746|P7|NOT COMPLETED|Overall Study||1
7920644|NCT00605475|19492747|P6|NOT COMPLETED|Overall Study||2
7920645|NCT00605475|19492748|P5|NOT COMPLETED|Overall Study||1
7920646|NCT00605475|19492749|P4|NOT COMPLETED|Overall Study||0
7920647|NCT00605475|19492750|P3|NOT COMPLETED|Overall Study||0
7920648|NCT00605475|19492751|P2|NOT COMPLETED|Overall Study||0
7920649|NCT00605475|19492752|P1|NOT COMPLETED|Overall Study||0
7920650|NCT00605475|19492743|P10|COMPLETED|Overall Study||8
7920651|NCT00605475|19492744|P9|COMPLETED|Overall Study||18
7920652|NCT00605475|19492745|P8|COMPLETED|Overall Study||24
7920653|NCT00605475|19492746|P7|COMPLETED|Overall Study||22
7920654|NCT00605475|19492747|P6|COMPLETED|Overall Study||22
7920655|NCT00605475|19492748|P5|COMPLETED|Overall Study||24
7920656|NCT00605475|19492749|P4|COMPLETED|Overall Study||45
7920657|NCT00605475|19492750|P3|COMPLETED|Overall Study||45
7920658|NCT00605475|19492751|P2|COMPLETED|Overall Study||5
7920659|NCT00605475|19492752|P1|COMPLETED|Overall Study||10
7920660|NCT00605475|19492743|P10|STARTED|Overall Study||10
7920661|NCT00605475|19492744|P9|STARTED|Overall Study||20
7920662|NCT00605475|19492745|P8|STARTED|Overall Study||24
7920663|NCT00605475|19492746|P7|STARTED|Overall Study||23
7920664|NCT00605475|19492747|P6|STARTED|Overall Study||24
7920665|NCT00605475|19492748|P5|STARTED|Overall Study||25
7920666|NCT00605475|19492749|P4|STARTED|Overall Study||45
7920667|NCT00605475|19492750|P3|STARTED|Overall Study||45
7920668|NCT00605475|19492751|P2|STARTED|Overall Study||5
7920669|NCT00605475|19492752|P1|STARTED|Overall Study||10
7920670|NCT00605423|19492876|P2|NOT COMPLETED|Overall Study||0
7920671|NCT00605423|19492877|P1|NOT COMPLETED|Overall Study||0
7920672|NCT00605423|19492876|P2|COMPLETED|Overall Study||2
7920673|NCT00605423|19492877|P1|COMPLETED|Overall Study||4
7920674|NCT00605423|19492876|P2|STARTED|Overall Study||2
7920675|NCT00605423|19492877|P1|STARTED|Overall Study||4
7920676|NCT00605384|19492889|P2|NOT COMPLETED|Overall Study||1
7920677|NCT00605384|19492890|P1|NOT COMPLETED|Overall Study||1
7920678|NCT00605384|19492889|P2|COMPLETED|Overall Study|study terminated early|0
7920679|NCT00605384|19492890|P1|COMPLETED|Overall Study|study terminated early|0
7920680|NCT00605384|19492889|P2|STARTED|Overall Study||1
7920681|NCT00605384|19492890|P1|STARTED|Overall Study||1
7920682|NCT00605358|19492920|P2|NOT COMPLETED|Overall Study||0
7920683|NCT00605358|19492921|P1|NOT COMPLETED|Overall Study||0
7920684|NCT00605358|19492920|P2|COMPLETED|Overall Study||80
7920685|NCT00605358|19492921|P1|COMPLETED|Overall Study||81
7920686|NCT00605358|19492920|P2|STARTED|Overall Study||80
7920687|NCT00605358|19492921|P1|STARTED|Overall Study||81
7920688|NCT00605345|19492929|P2|NOT COMPLETED|Overall Study||3
7920689|NCT00605345|19492930|P1|NOT COMPLETED|Overall Study||1
7920690|NCT00605345|19492929|P2|COMPLETED|Overall Study||22
7920691|NCT00605345|19492930|P1|COMPLETED|Overall Study||45
7920692|NCT00605345|19492929|P2|STARTED|Overall Study||25
7920693|NCT00605345|19492930|P1|STARTED|Overall Study||46
7920694|NCT00605319|19492946|P1|NOT COMPLETED|Overall Study||6
7920695|NCT00605319|19492946|P1|COMPLETED|Overall Study||11
7920696|NCT00605319|19492946|P1|STARTED|Overall Study||17
7920697|NCT00605306|19492958|P2|NOT COMPLETED|Overall Study||1
7920698|NCT00605306|19492959|P1|NOT COMPLETED|Overall Study||0
7920699|NCT00605306|19492958|P2|COMPLETED|Overall Study||13
7920700|NCT00605306|19492959|P1|COMPLETED|Overall Study||14
7920701|NCT00605306|19492958|P2|STARTED|Overall Study||14
7920702|NCT00605306|19492959|P1|STARTED|Overall Study||14
7920703|NCT00605293|19492973|P2|NOT COMPLETED|Overall Study||5
7920704|NCT00605293|19492974|P1|NOT COMPLETED|Overall Study||17
7920705|NCT00605293|19492973|P2|COMPLETED|Overall Study||31
7920706|NCT00605293|19492974|P1|COMPLETED|Overall Study||48
7920707|NCT00605293|19492973|P2|STARTED|Overall Study||36
7920708|NCT00605293|19492974|P1|STARTED|Overall Study||65
7920709|NCT00605280|19492994|P4|NOT COMPLETED|Year 3 Extension||9
7920710|NCT00605280|19492995|P3|NOT COMPLETED|Year 3 Extension||0
7920711|NCT00605280|19492996|P2|NOT COMPLETED|Year 3 Extension||0
7920712|NCT00605280|19492997|P1|NOT COMPLETED|Year 3 Extension||8
7920713|NCT00605280|19492994|P4|COMPLETED|Year 3 Extension||45
7920714|NCT00605280|19492995|P3|COMPLETED|Year 3 Extension||0
7920715|NCT00605280|19492996|P2|COMPLETED|Year 3 Extension||0
7920716|NCT00605280|19492997|P1|COMPLETED|Year 3 Extension||38
7920717|NCT00605280|19492994|P4|Received 0.3 mg Treatment|Year 3 Extension||54
7920718|NCT00605280|19492995|P3|Received 0.3 mg Treatment|Year 3 Extension||0
7920719|NCT00605280|19492996|P2|Received 0.3 mg Treatment|Year 3 Extension||0
7920720|NCT00605280|19492997|P1|Received 0.3 mg Treatment|Year 3 Extension||46
7920721|NCT00605280|19492994|P4|STARTED|Year 3 Extension||54
7920722|NCT00605280|19492995|P3|STARTED|Year 3 Extension||0
7920723|NCT00605280|19492996|P2|STARTED|Year 3 Extension||0
7920724|NCT00605280|19492997|P1|STARTED|Year 3 Extension||46
7920725|NCT00605280|19492994|P4|NOT COMPLETED|Year 2||22
7920726|NCT00605280|19492995|P3|NOT COMPLETED|Year 2||6
7920727|NCT00605280|19492996|P2|NOT COMPLETED|Year 2||6
7920728|NCT00605280|19492997|P1|NOT COMPLETED|Year 2||24
7920729|NCT00605280|19492994|P4|COMPLETED|Year 2||102
7920730|NCT00605280|19492995|P3|COMPLETED|Year 2||0
7920731|NCT00605280|19492996|P2|COMPLETED|Year 2||5
7920732|NCT00605280|19492997|P1|COMPLETED|Year 2||102
7920733|NCT00605280|19492994|P4|Received 0.3 mg Treatment|Year 2||0
7920734|NCT00605280|19492995|P3|Received 0.3 mg Treatment|Year 2||2
7920735|NCT00605280|19492996|P2|Received 0.3 mg Treatment|Year 2||3
7920736|NCT00605280|19492997|P1|Received 0.3 mg Treatment|Year 2||126
7920737|NCT00605280|19492994|P4|STARTED|Year 2||124
7920738|NCT00605280|19492995|P3|STARTED|Year 2||6
7920739|NCT00605280|19492996|P2|STARTED|Year 2||11
7920740|NCT00605280|19492997|P1|STARTED|Year 2||126
7920741|NCT00605280|19492994|P4|NOT COMPLETED|Year 1||19
7920742|NCT00605280|19492995|P3|NOT COMPLETED|Year 1||1
7920743|NCT00605280|19492996|P2|NOT COMPLETED|Year 1||11
7920744|NCT00605280|19492997|P1|NOT COMPLETED|Year 1||19
7920745|NCT00605280|19492994|P4|COMPLETED|Year 1||124
7920746|NCT00605280|19492995|P3|COMPLETED|Year 1||6
7920747|NCT00605280|19492996|P2|COMPLETED|Year 1||11
7920748|NCT00605280|19492997|P1|COMPLETED|Year 1||126
7920749|NCT00605280|19492994|P4|Received 0.3 mg Treatment|Year 1||0
7920750|NCT00605280|19492995|P3|Received 0.3 mg Treatment|Year 1||3
7920751|NCT00605280|19492996|P2|Received 0.3 mg Treatment|Year 1||13
7920752|NCT00605280|19492997|P1|Received 0.3 mg Treatment|Year 1||144
7920753|NCT00605280|19492994|P4|STARTED|Year 1||143
7920754|NCT00605280|19492995|P3|STARTED|Year 1||7
7920755|NCT00605280|19492996|P2|STARTED|Year 1||22
7920756|NCT00605280|19492997|P1|STARTED|Year 1||145
7920757|NCT00605267|19493031|P2|NOT COMPLETED|Overall Study||9
7920758|NCT00605267|19493032|P1|NOT COMPLETED|Overall Study||3
7920759|NCT00605267|19493031|P2|COMPLETED|Overall Study|Breast surgery performed|90
7920760|NCT00605267|19493032|P1|COMPLETED|Overall Study|Breast surgery performed|95
7920761|NCT00605267|19493031|P2|STARTED|Overall Study||99
7920762|NCT00605267|19493032|P1|STARTED|Overall Study||98
7920763|NCT00605202|19493070|P2|NOT COMPLETED|Second Intervention||0
7920764|NCT00605202|19493071|P1|NOT COMPLETED|Second Intervention||0
7920765|NCT00605202|19493070|P2|COMPLETED|Second Intervention||5
7920766|NCT00605202|19493071|P1|COMPLETED|Second Intervention||5
7920767|NCT00605202|19493070|P2|STARTED|Second Intervention||5
7920768|NCT00605202|19493071|P1|STARTED|Second Intervention||5
7920769|NCT00605202|19493070|P2|NOT COMPLETED|Washout Period of 3 Weeks||0
7920770|NCT00605202|19493071|P1|NOT COMPLETED|Washout Period of 3 Weeks||0
7920771|NCT00605202|19493070|P2|COMPLETED|Washout Period of 3 Weeks||5
7920772|NCT00605202|19493071|P1|COMPLETED|Washout Period of 3 Weeks||5
7920773|NCT00605202|19493070|P2|STARTED|Washout Period of 3 Weeks||5
7920774|NCT00605202|19493071|P1|STARTED|Washout Period of 3 Weeks||5
7920775|NCT00605202|19493070|P2|NOT COMPLETED|First Intervention||0
7920776|NCT00605202|19493071|P1|NOT COMPLETED|First Intervention||0
7920777|NCT00605202|19493070|P2|COMPLETED|First Intervention||5
7920778|NCT00605202|19493071|P1|COMPLETED|First Intervention||5
7920779|NCT00605202|19493070|P2|STARTED|First Intervention||5
7920780|NCT00605202|19493071|P1|STARTED|First Intervention||5
7920781|NCT00605189|19493080|P3|NOT COMPLETED|Overall Study||0
7920782|NCT00605189|19493081|P2|NOT COMPLETED|Overall Study||2
7920783|NCT00605189|19493082|P1|NOT COMPLETED|Overall Study||3
7920784|NCT00605189|19493080|P3|COMPLETED|Overall Study||9
7920785|NCT00605189|19493081|P2|COMPLETED|Overall Study||19
7920786|NCT00605189|19493082|P1|COMPLETED|Overall Study||17
7920787|NCT00605189|19493080|P3|STARTED|Overall Study||9
7920788|NCT00605189|19493081|P2|STARTED|Overall Study||21
7920789|NCT00605189|19493082|P1|STARTED|Overall Study||20
7920790|NCT00605176|19493093|P3|NOT COMPLETED|Overall Study||9
7920791|NCT00605176|19493094|P2|NOT COMPLETED|Overall Study||6
7920792|NCT00605176|19493095|P1|NOT COMPLETED|Overall Study||11
7920793|NCT00605176|19493093|P3|COMPLETED|Overall Study||150
7920794|NCT00605176|19493094|P2|COMPLETED|Overall Study||154
7920795|NCT00605176|19493095|P1|COMPLETED|Overall Study||149
7920796|NCT00605176|19493093|P3|STARTED|Overall Study||159
7920797|NCT00605176|19493094|P2|STARTED|Overall Study||160
7920798|NCT00605176|19493095|P1|STARTED|Overall Study||160
7920799|NCT00605150|19493112|P1|NOT COMPLETED|Overall Study||1
7920800|NCT00605150|19493112|P1|COMPLETED|Overall Study||10
7920801|NCT00605150|19493112|P1|STARTED|Overall Study|11 started|11
7920802|NCT00605085|19493119|P2|NOT COMPLETED|Overall Study||25
7920803|NCT00605085|19493120|P1|NOT COMPLETED|Overall Study||50
7920804|NCT00605085|19493119|P2|COMPLETED|Overall Study||638
7920805|NCT00605085|19493120|P1|COMPLETED|Overall Study||1962
7920806|NCT00605085|19493119|P2|STARTED|Overall Study||663
7920807|NCT00605085|19493120|P1|STARTED|Overall Study||2012
7920808|NCT00605072|19493129|P3|NOT COMPLETED|Overall Study||4
7920809|NCT00605072|19493130|P2|NOT COMPLETED|Overall Study||11
7920810|NCT00605072|19493131|P1|NOT COMPLETED|Overall Study||7
7920811|NCT00605072|19493129|P3|COMPLETED|Overall Study||11
7920812|NCT00605072|19493130|P2|COMPLETED|Overall Study||9
7920813|NCT00605072|19493131|P1|COMPLETED|Overall Study||11
7920814|NCT00605072|19493129|P3|STARTED|Overall Study||15
7920815|NCT00605072|19493130|P2|STARTED|Overall Study||20
7920816|NCT00605072|19493131|P1|STARTED|Overall Study||18
7920817|NCT00605033|19493153|P2|NOT COMPLETED|Overall Study||8
7920818|NCT00605033|19493154|P1|NOT COMPLETED|Overall Study||7
7920819|NCT00605033|19493153|P2|COMPLETED|Overall Study||90
7920820|NCT00605033|19493154|P1|COMPLETED|Overall Study||136
7920821|NCT00605033|19493153|P2|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98
7920822|NCT00605033|19493154|P1|STARTED|Overall Study||143
7920823|NCT00604968|19493160|P1|NOT COMPLETED|Overall Study||0
7920824|NCT00604968|19493160|P1|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25
7920825|NCT00604968|19493160|P1|STARTED|Overall Study||25
7920826|NCT00604890|19493177|P4|NOT COMPLETED|Overall Study||4
7920827|NCT00604890|19493178|P3|NOT COMPLETED|Overall Study||1
7920828|NCT00604890|19493179|P2|NOT COMPLETED|Overall Study||0
7920829|NCT00604890|19493180|P1|NOT COMPLETED|Overall Study||3
7920830|NCT00604890|19493177|P4|COMPLETED|Overall Study||42
7920831|NCT00604890|19493178|P3|COMPLETED|Overall Study||47
7920832|NCT00604890|19493179|P2|COMPLETED|Overall Study||45
7920833|NCT00604890|19493180|P1|COMPLETED|Overall Study||44
7920834|NCT00604890|19493177|P4|STARTED|Overall Study||46
7920835|NCT00604890|19493178|P3|STARTED|Overall Study||48
7920836|NCT00604890|19493179|P2|STARTED|Overall Study||45
7920837|NCT00604890|19493180|P1|STARTED|Overall Study||47
7920838|NCT00604825|19493198|P4|NOT COMPLETED|Overall Study||11
7920839|NCT00604825|19493199|P3|NOT COMPLETED|Overall Study||16
7920840|NCT00604825|19493200|P2|NOT COMPLETED|Overall Study||15
7920841|NCT00604825|19493201|P1|NOT COMPLETED|Overall Study||9
7920842|NCT00604825|19493198|P4|COMPLETED|Overall Study||79
7920843|NCT00604825|19493199|P3|COMPLETED|Overall Study||73
7920844|NCT00604825|19493200|P2|COMPLETED|Overall Study||72
7920845|NCT00604825|19493201|P1|COMPLETED|Overall Study||81
7920846|NCT00604825|19493198|P4|STARTED|Overall Study||90
7920847|NCT00604825|19493199|P3|STARTED|Overall Study||89
7920848|NCT00604825|19493200|P2|STARTED|Overall Study||87
7920849|NCT00604825|19493201|P1|STARTED|Overall Study||90
7920850|NCT00604812|19493402|P6|NOT COMPLETED|Overall Study||0
7920851|NCT00604812|19493403|P5|NOT COMPLETED|Overall Study||0
7920852|NCT00604812|19493404|P4|NOT COMPLETED|Overall Study||0
7920853|NCT00604812|19493405|P3|NOT COMPLETED|Overall Study||0
7920854|NCT00604812|19493406|P2|NOT COMPLETED|Overall Study||0
7920855|NCT00604812|19493407|P1|NOT COMPLETED|Overall Study||0
7920856|NCT00604812|19493402|P6|COMPLETED|Overall Study||1
7920857|NCT00604812|19493403|P5|COMPLETED|Overall Study||5
7920858|NCT00604812|19493404|P4|COMPLETED|Overall Study||3
7920859|NCT00604812|19493405|P3|COMPLETED|Overall Study||10
7920860|NCT00604812|19493406|P2|COMPLETED|Overall Study||3
7920861|NCT00604812|19493407|P1|COMPLETED|Overall Study||9
7920862|NCT00604812|19493402|P6|STARTED|Overall Study||1
7920863|NCT00604812|19493403|P5|STARTED|Overall Study||5
7920864|NCT00604812|19493404|P4|STARTED|Overall Study||3
7920865|NCT00604812|19493405|P3|STARTED|Overall Study||10
7920866|NCT00604812|19493406|P2|STARTED|Overall Study||3
7920867|NCT00604812|19493407|P1|STARTED|Overall Study||9
7920868|NCT00604786|19493429|P2|NOT COMPLETED|Overall Study||0
7920869|NCT00604786|19493430|P1|NOT COMPLETED|Overall Study||2
7920870|NCT00604786|19493429|P2|COMPLETED|Overall Study||4
7920871|NCT00604786|19493430|P1|COMPLETED|Overall Study||12
7920872|NCT00604786|19493429|P2|STARTED|Overall Study||4
7920873|NCT00604786|19493430|P1|STARTED|Overall Study||14
7920874|NCT00604721|19493436|P1|NOT COMPLETED|Overall Study||2
7920875|NCT00604721|19493436|P1|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17
7920876|NCT00604721|19493436|P1|STARTED|Overall Study||19
7920877|NCT00604708|19493444|P2|NOT COMPLETED|Overall Study||40
7920878|NCT00604708|19493445|P1|NOT COMPLETED|Overall Study||31
7920879|NCT00604708|19493444|P2|COMPLETED|Overall Study||397
7920880|NCT00604708|19493445|P1|COMPLETED|Overall Study||399
7920881|NCT00604708|19493444|P2|STARTED|Overall Study||437
7920882|NCT00604708|19493445|P1|STARTED|Overall Study||430
7920883|NCT00604695|19493455|P2|NOT COMPLETED|Overall Study||4
7920884|NCT00604695|19493456|P1|NOT COMPLETED|Overall Study||0
7920885|NCT00604695|19493455|P2|COMPLETED|Overall Study||16
7920886|NCT00604695|19493456|P1|COMPLETED|Overall Study||20
7920887|NCT00604695|19493455|P2|STARTED|Overall Study||20
7920888|NCT00604695|19493456|P1|STARTED|Overall Study||20
7920889|NCT00604669|19493478|P1|NOT COMPLETED|Overall Study||7
7920890|NCT00604669|19493478|P1|COMPLETED|Overall Study||163
7920891|NCT00604669|19493478|P1|STARTED|Overall Study||170
7920892|NCT00604565|19493484|P2|NOT COMPLETED|Overall Study||3
7920893|NCT00604565|19493485|P1|NOT COMPLETED|Overall Study||0
7920894|NCT00604565|19493484|P2|COMPLETED|Overall Study||4
7920895|NCT00604565|19493485|P1|COMPLETED|Overall Study||4
7920896|NCT00604565|19493484|P2|STARTED|Overall Study||7
7920897|NCT00604565|19493485|P1|STARTED|Overall Study||4
7920898|NCT00604552|19493495|P2|NOT COMPLETED|Overall Study||0
7920899|NCT00604552|19493496|P1|NOT COMPLETED|Overall Study||0
7920900|NCT00604552|19493495|P2|COMPLETED|Overall Study||160
7920901|NCT00604552|19493496|P1|COMPLETED|Overall Study||189
7920902|NCT00604552|19493495|P2|STARTED|Overall Study||160
7920903|NCT00604552|19493496|P1|STARTED|Overall Study||189
7920904|NCT00604500|19493504|P1|NOT COMPLETED|Overall Study||11
7920905|NCT00604500|19493504|P1|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261
7920906|NCT00604500|19493504|P1|STARTED|Overall Study||272
7920907|NCT00604461|19493511|P1|NOT COMPLETED|Overall Study||1
7920908|NCT00604461|19493511|P1|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12
7920909|NCT00604461|19493511|P1|STARTED|Overall Study||13
7920910|NCT00604383|19493518|P2|NOT COMPLETED|Overall Study||84
7920911|NCT00604383|19493519|P1|NOT COMPLETED|Overall Study||87
7920912|NCT00604383|19493518|P2|COMPLETED|Overall Study||256
7920913|NCT00604383|19493519|P1|COMPLETED|Overall Study||258
7920914|NCT00604383|19493518|P2|Received Extended Treatment|Overall Study||141
7920915|NCT00604383|19493519|P1|Received Extended Treatment|Overall Study||136
7920916|NCT00604383|19493518|P2|Received at Least 1 Dose of Study Drug|Overall Study||340
7920917|NCT00604383|19493519|P1|Received at Least 1 Dose of Study Drug|Overall Study||345
7920918|NCT00604383|19493518|P2|STARTED|Overall Study||340
7920919|NCT00604383|19493519|P1|STARTED|Overall Study||345
7920920|NCT00604279|19493535|P2|NOT COMPLETED|Overall Study||38
7920921|NCT00604279|19493536|P1|NOT COMPLETED|Overall Study||64
7920922|NCT00604279|19493535|P2|COMPLETED|Overall Study||185
7920923|NCT00604279|19493536|P1|COMPLETED|Overall Study||165
7920924|NCT00604279|19493535|P2|STARTED|Overall Study||223
7920925|NCT00604279|19493536|P1|STARTED|Overall Study||229
7920926|NCT00604214|19493552|P2|NOT COMPLETED|Day 91 to Day 180||32
7920927|NCT00604214|19493553|P1|NOT COMPLETED|Day 91 to Day 180||26
7920928|NCT00604214|19493552|P2|COMPLETED|Day 91 to Day 180||521
7920929|NCT00604214|19493553|P1|COMPLETED|Day 91 to Day 180||529
7920930|NCT00604214|19493552|P2|STARTED|Day 91 to Day 180||553
7920931|NCT00604214|19493553|P1|STARTED|Day 91 to Day 180||555
7920932|NCT00604214|19493552|P2|NOT COMPLETED|Day 29 to Day 90||79
7920933|NCT00604214|19493553|P1|NOT COMPLETED|Day 29 to Day 90||68
7920934|NCT00604214|19493552|P2|COMPLETED|Day 29 to Day 90||553
7920935|NCT00604214|19493553|P1|COMPLETED|Day 29 to Day 90||555
7920936|NCT00604214|19493552|P2|STARTED|Day 29 to Day 90||632
7920937|NCT00604214|19493553|P1|STARTED|Day 29 to Day 90||623
7920938|NCT00604214|19493552|P2|NOT COMPLETED|Baseline to Day 28||213
7920939|NCT00604214|19493553|P1|NOT COMPLETED|Baseline to Day 28||228
7920940|NCT00604214|19493552|P2|COMPLETED|Baseline to Day 28||632
7920941|NCT00604214|19493553|P1|COMPLETED|Baseline to Day 28||623
7920942|NCT00604214|19493552|P2|Received Study Drug|Baseline to Day 28||833
7920943|NCT00604214|19493553|P1|Received Study Drug|Baseline to Day 28||833
7920944|NCT00604214|19493552|P2|STARTED|Baseline to Day 28||845
7920945|NCT00604214|19493553|P1|STARTED|Baseline to Day 28||851
7920946|NCT00604201|19493583|P1|NOT COMPLETED|Overall Study||10
7920947|NCT00604201|19493583|P1|COMPLETED|Overall Study||21
7920948|NCT00604201|19493583|P1|STARTED|Overall Study||31
7920949|NCT00604188|19493601|P2|NOT COMPLETED|Overall Study||25
7920950|NCT00604188|19493602|P1|NOT COMPLETED|Overall Study||27
7920951|NCT00604188|19493601|P2|COMPLETED|Overall Study||70
7920952|NCT00604188|19493602|P1|COMPLETED|Overall Study||66
7920953|NCT00604188|19493601|P2|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95
7920954|NCT00604188|19493602|P1|STARTED|Overall Study||93
7920955|NCT00604175|19493625|P3|NOT COMPLETED|Week 29 Through Week 72||4
7920956|NCT00604175|19493626|P2|NOT COMPLETED|Week 29 Through Week 72||7
7920957|NCT00604175|19493627|P1|NOT COMPLETED|Week 29 Through Week 72||12
7920958|NCT00604175|19493625|P3|COMPLETED|Week 29 Through Week 72||89
7920959|NCT00604175|19493626|P2|COMPLETED|Week 29 Through Week 72||85
7920960|NCT00604175|19493627|P1|COMPLETED|Week 29 Through Week 72||108
7920961|NCT00604175|19493625|P3|STARTED|Week 29 Through Week 72||93
7920962|NCT00604175|19493626|P2|STARTED|Week 29 Through Week 72||92
7920963|NCT00604175|19493627|P1|STARTED|Week 29 Through Week 72||120
7920964|NCT00604175|19493625|P3|NOT COMPLETED|Entry Through Week 28||1
7920965|NCT00604175|19493626|P2|NOT COMPLETED|Entry Through Week 28||3
7920966|NCT00604175|19493627|P1|NOT COMPLETED|Entry Through Week 28||10
7920967|NCT00604175|19493625|P3|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93
7920968|NCT00604175|19493626|P2|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92
7920969|NCT00604175|19493627|P1|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120
7920970|NCT00604175|19493625|P3|STARTED|Entry Through Week 28||94
7920971|NCT00604175|19493626|P2|STARTED|Entry Through Week 28||95
7920972|NCT00604175|19493627|P1|STARTED|Entry Through Week 28||130
7920973|NCT00604162|19493680|P1|NOT COMPLETED|Overall Study||4
7920974|NCT00604162|19493680|P1|COMPLETED|Overall Study||328
7920975|NCT00604162|19493680|P1|STARTED|Overall Study||332
7920976|NCT00604045|19493693|P2|NOT COMPLETED|Overall Study||1
7920977|NCT00604045|19493694|P1|NOT COMPLETED|Overall Study||1
7920978|NCT00604045|19493693|P2|COMPLETED|Overall Study||9
7920979|NCT00604045|19493694|P1|COMPLETED|Overall Study||14
7920980|NCT00604045|19493693|P2|STARTED|Overall Study||10
7920981|NCT00604045|19493694|P1|STARTED|Overall Study||15
7920982|NCT00604019|19493702|P2|NOT COMPLETED|Overall Study||0
7920983|NCT00604019|19493703|P1|NOT COMPLETED|Overall Study||0
7920984|NCT00604019|19493702|P2|COMPLETED|Overall Study||118
7920985|NCT00604019|19493703|P1|COMPLETED|Overall Study||134
7920986|NCT00604019|19493702|P2|STARTED|Overall Study||118
7920987|NCT00604019|19493703|P1|STARTED|Overall Study||134
7920988|NCT00603993|19493709|P1|NOT COMPLETED|Overall Study||20
7920989|NCT00603993|19493709|P1|COMPLETED|Overall Study||68
7920990|NCT00603993|19493709|P1|STARTED|Overall Study||88
7920991|NCT00603980|19493722|P1|NOT COMPLETED|Main Study||1
7920992|NCT00603980|19493722|P1|COMPLETED|Main Study||14
7920993|NCT00603980|19493722|P1|STARTED|Main Study||15
7920994|NCT00603980|19493722|P1|NOT COMPLETED|Study Qualification||16
7920995|NCT00603980|19493722|P1|COMPLETED|Study Qualification||15
7920996|NCT00603980|19493722|P1|STARTED|Study Qualification||31
7920997|NCT00603941|19493841|P3|NOT COMPLETED|Overall Study||2
7920998|NCT00603941|19493842|P2|NOT COMPLETED|Overall Study||10
7920999|NCT00603941|19493843|P1|NOT COMPLETED|Overall Study||7
7921000|NCT00603941|19493841|P3|COMPLETED|Overall Study||0
7921001|NCT00603941|19493842|P2|COMPLETED|Overall Study||0
7921002|NCT00603941|19493843|P1|COMPLETED|Overall Study||0
7921003|NCT00603941|19493841|P3|STARTED|Overall Study||2
7921004|NCT00603941|19493842|P2|STARTED|Overall Study||10
7921005|NCT00603941|19493843|P1|STARTED|Overall Study||7
7921006|NCT00603915|19493854|P1|NOT COMPLETED|Overall Study||1
7921007|NCT00603915|19493854|P1|COMPLETED|Overall Study||19
7921008|NCT00603915|19493854|P1|STARTED|Overall Study||20
7921009|NCT00603902|19493862|P3|NOT COMPLETED|Overall Study||769
7921010|NCT00603902|19493863|P2|NOT COMPLETED|Overall Study||686
7921011|NCT00603902|19493864|P1|NOT COMPLETED|Overall Study||329
7921012|NCT00603902|19493862|P3|COMPLETED|Overall Study||834
7921013|NCT00603902|19493863|P2|COMPLETED|Overall Study||917
7921014|NCT00603902|19493864|P1|COMPLETED|Overall Study||473
7921015|NCT00603902|19493862|P3|STARTED|Overall Study||1603
7921016|NCT00603902|19493863|P2|STARTED|Overall Study||1603
7921017|NCT00603902|19493864|P1|STARTED|Overall Study||802
7921018|NCT00603889|19493875|P1|NOT COMPLETED|Overall Study||0
7921019|NCT00603889|19493875|P1|COMPLETED|Overall Study||12
7921020|NCT00603889|19493875|P1|STARTED|Overall Study||12
7921021|NCT00603837|19493884|P2|NOT COMPLETED|Overall Study||0
7921022|NCT00603837|19493885|P1|NOT COMPLETED|Overall Study||3
7921023|NCT00603837|19493884|P2|COMPLETED|Overall Study||19
7921024|NCT00603837|19493885|P1|COMPLETED|Overall Study||17
7921025|NCT00603837|19493884|P2|STARTED|Overall Study||19
7921026|NCT00603837|19493885|P1|STARTED|Overall Study||20
7921027|NCT00603798|19493894|P3|NOT COMPLETED|Overall Study||10
7921028|NCT00603798|19493895|P2|NOT COMPLETED|Overall Study||7
7921029|NCT00603798|19493896|P1|NOT COMPLETED|Overall Study||10
7921030|NCT00603798|19493894|P3|COMPLETED|Overall Study||154
7921031|NCT00603798|19493895|P2|COMPLETED|Overall Study||157
7921032|NCT00603798|19493896|P1|COMPLETED|Overall Study||152
7921033|NCT00603798|19493894|P3|STARTED|Overall Study||164
7921034|NCT00603798|19493895|P2|STARTED|Overall Study||164
7921035|NCT00603798|19493896|P1|STARTED|Overall Study||162
7921036|NCT00603746|19493919|P6|NOT COMPLETED|Overall Study||13
7921037|NCT00603746|19493920|P5|NOT COMPLETED|Overall Study||17
7921038|NCT00603746|19493921|P4|NOT COMPLETED|Overall Study||13
7921039|NCT00603746|19493922|P3|NOT COMPLETED|Overall Study||8
7921040|NCT00603746|19493923|P2|NOT COMPLETED|Overall Study||18
7921041|NCT00603746|19493924|P1|NOT COMPLETED|Overall Study||38
7921042|NCT00603746|19493919|P6|COMPLETED|Overall Study||97
7921043|NCT00603746|19493920|P5|COMPLETED|Overall Study||85
7921044|NCT00603746|19493921|P4|COMPLETED|Overall Study||94
7921045|NCT00603746|19493922|P3|COMPLETED|Overall Study||93
7921046|NCT00603746|19493923|P2|COMPLETED|Overall Study||81
7921047|NCT00603746|19493924|P1|COMPLETED|Overall Study||65
7921048|NCT00603746|19493919|P6|STARTED|Overall Study||110
7921049|NCT00603746|19493920|P5|STARTED|Overall Study||102
7921050|NCT00603746|19493921|P4|STARTED|Overall Study||107
7921051|NCT00603746|19493922|P3|STARTED|Overall Study||101
7921052|NCT00603746|19493923|P2|STARTED|Overall Study||99
7921053|NCT00603746|19493924|P1|STARTED|Overall Study||103
7921054|NCT00603733|19494072|P2|NOT COMPLETED|Maintenance Phase ITT||16
7921055|NCT00603733|19494073|P1|NOT COMPLETED|Maintenance Phase ITT||10
7921056|NCT00603733|19494072|P2|COMPLETED|Maintenance Phase ITT||66
7921057|NCT00603733|19494073|P1|COMPLETED|Maintenance Phase ITT||61
7921058|NCT00603733|19494072|P2|STARTED|Maintenance Phase ITT||82
7921059|NCT00603733|19494073|P1|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71
7921060|NCT00603733|19494072|P2|NOT COMPLETED|Run-In Phase - 4 Weeks||13
7921061|NCT00603733|19494073|P1|NOT COMPLETED|Run-In Phase - 4 Weeks||14
7921062|NCT00603733|19494072|P2|COMPLETED|Run-In Phase - 4 Weeks||36
7921063|NCT00603733|19494073|P1|COMPLETED|Run-In Phase - 4 Weeks||35
7921064|NCT00603733|19494072|P2|STARTED|Run-In Phase - 4 Weeks||49
7921065|NCT00603733|19494073|P1|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49
7921066|NCT00603733|19494072|P2|NOT COMPLETED|Active Phase ITT||17
7921067|NCT00603733|19494073|P1|NOT COMPLETED|Active Phase ITT||11
7921068|NCT00603733|19494072|P2|COMPLETED|Active Phase ITT||78
7921069|NCT00603733|19494073|P1|COMPLETED|Active Phase ITT||84
7921070|NCT00603733|19494072|P2|STARTED|Active Phase ITT||95
7921071|NCT00603733|19494073|P1|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95
7921072|NCT00603720|19494088|P5|NOT COMPLETED|Overall Study||0
7921073|NCT00603720|19494089|P4|NOT COMPLETED|Overall Study||0
7921074|NCT00603720|19494090|P3|NOT COMPLETED|Overall Study||0
7921075|NCT00603720|19494091|P2|NOT COMPLETED|Overall Study||0
7921076|NCT00603720|19494092|P1|NOT COMPLETED|Overall Study||0
7921077|NCT00603720|19494088|P5|COMPLETED|Overall Study||12
7921078|NCT00603720|19494089|P4|COMPLETED|Overall Study||10
7921079|NCT00603720|19494090|P3|COMPLETED|Overall Study||12
7921080|NCT00603720|19494091|P2|COMPLETED|Overall Study||10
7921081|NCT00603720|19494092|P1|COMPLETED|Overall Study||10
7921082|NCT00603720|19494088|P5|STARTED|Overall Study||12
7921083|NCT00603720|19494089|P4|STARTED|Overall Study||10
7921084|NCT00603720|19494090|P3|STARTED|Overall Study||12
7921085|NCT00603720|19494091|P2|STARTED|Overall Study||10
7921086|NCT00603720|19494092|P1|STARTED|Overall Study||10
7921087|NCT00603642|19494106|P2|NOT COMPLETED|Overall Study||0
7921088|NCT00603642|19494107|P1|NOT COMPLETED|Overall Study||0
7921089|NCT00603642|19494106|P2|COMPLETED|Overall Study||22
7921090|NCT00603642|19494107|P1|COMPLETED|Overall Study||12
7921091|NCT00603642|19494106|P2|STARTED|Overall Study||22
7921092|NCT00603642|19494107|P1|STARTED|Overall Study||12
7921093|NCT00603590|19494123|P2|NOT COMPLETED|Overall Study||51
7921094|NCT00603590|19494124|P1|NOT COMPLETED|Overall Study||76
7921095|NCT00603590|19494123|P2|COMPLETED|Overall Study||183
7921096|NCT00603590|19494124|P1|COMPLETED|Overall Study||165
7921097|NCT00603590|19494123|P2|Eight Months|Overall Study||194
7921098|NCT00603590|19494124|P1|Eight Months|Overall Study||178
7921099|NCT00603590|19494123|P2|Four Months|Overall Study||200
7921100|NCT00603590|19494124|P1|Four Months|Overall Study||187
7921101|NCT00603590|19494123|P2|One Month|Overall Study||212
7921102|NCT00603590|19494124|P1|One Month|Overall Study||204
7921103|NCT00603590|19494123|P2|STARTED|Overall Study||234
7921104|NCT00603590|19494124|P1|STARTED|Overall Study||241
7921105|NCT00603564|19494136|P2|NOT COMPLETED|Overall Study||0
7921106|NCT00603564|19494137|P1|NOT COMPLETED|Overall Study||0
7921107|NCT00603564|19494136|P2|COMPLETED|Overall Study|February 2008|27
7921108|NCT00603564|19494137|P1|COMPLETED|Overall Study|February 2008|20
7921109|NCT00603564|19494136|P2|STARTED|Overall Study|January 2006|27
7921110|NCT00603564|19494137|P1|STARTED|Overall Study|January 2006|20
7921111|NCT00603538|19494148|P3|NOT COMPLETED|Overall Study||2
7921112|NCT00603538|19494149|P2|NOT COMPLETED|Overall Study||4
7921113|NCT00603538|19494150|P1|NOT COMPLETED|Overall Study||3
7921114|NCT00603538|19494148|P3|COMPLETED|Overall Study||4
7921115|NCT00603538|19494149|P2|COMPLETED|Overall Study||3
7921116|NCT00603538|19494150|P1|COMPLETED|Overall Study||3
7921117|NCT00603538|19494148|P3|STARTED|Overall Study||6
7921118|NCT00603538|19494149|P2|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7
7921119|NCT00603538|19494150|P1|STARTED|Overall Study||6
7921120|NCT00603525|19494190|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111
7921121|NCT00603525|19494191|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
7921122|NCT00603525|19494192|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
7921123|NCT00603525|19494190|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||13
7921124|NCT00603525|19494191|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
7921125|NCT00603525|19494192|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
7921126|NCT00603525|19494190|P3|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111
7921127|NCT00603525|19494191|P2|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
7921128|NCT00603525|19494192|P1|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
7921129|NCT00603525|19494190|P3|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124
7921130|NCT00603525|19494191|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
7921131|NCT00603525|19494192|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
7921132|NCT00603525|19494190|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
7921133|NCT00603525|19494191|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||112
7921134|NCT00603525|19494192|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
7921135|NCT00603525|19494190|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
7921136|NCT00603525|19494191|P2|COMPLETED|OL Treatment Period (120 Weeks)||13
7921137|NCT00603525|19494192|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
7921138|NCT00603525|19494190|P3|STARTED|OL Treatment Period (120 Weeks)||0
7921139|NCT00603525|19494191|P2|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125
7921140|NCT00603525|19494192|P1|STARTED|OL Treatment Period (120 Weeks)||0
7921141|NCT00603525|19494190|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
7921142|NCT00603525|19494191|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||22
7921143|NCT00603525|19494192|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||17
7921144|NCT00603525|19494190|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
7921145|NCT00603525|19494191|P2|COMPLETED|DB Treatment Period (24 Weeks)||63
7921146|NCT00603525|19494192|P1|COMPLETED|DB Treatment Period (24 Weeks)||67
7921147|NCT00603525|19494190|P3|STARTED|DB Treatment Period (24 Weeks)||0
7921148|NCT00603525|19494191|P2|STARTED|DB Treatment Period (24 Weeks)||85
7921149|NCT00603525|19494192|P1|STARTED|DB Treatment Period (24 Weeks)||84
7921150|NCT00603512|19494324|P5|NOT COMPLETED|Overall Study||5
7921151|NCT00603512|19494325|P4|NOT COMPLETED|Overall Study||7
7921152|NCT00603512|19494326|P3|NOT COMPLETED|Overall Study||5
7921153|NCT00603512|19494327|P2|NOT COMPLETED|Overall Study||5
7921154|NCT00603512|19494328|P1|NOT COMPLETED|Overall Study||2
7921155|NCT00603512|19494324|P5|COMPLETED|Overall Study||23
7921156|NCT00603512|19494325|P4|COMPLETED|Overall Study||21
7921157|NCT00603512|19494326|P3|COMPLETED|Overall Study||23
7921158|NCT00603512|19494327|P2|COMPLETED|Overall Study||23
7921159|NCT00603512|19494328|P1|COMPLETED|Overall Study||26
7921160|NCT00603512|19494324|P5|Treated|Overall Study||28
7921161|NCT00603512|19494325|P4|Treated|Overall Study||26
7921162|NCT00603512|19494326|P3|Treated|Overall Study||27
7921163|NCT00603512|19494327|P2|Treated|Overall Study||27
7921164|NCT00603512|19494328|P1|Treated|Overall Study||28
7921165|NCT00603512|19494324|P5|STARTED|Overall Study||28
7921166|NCT00603512|19494325|P4|STARTED|Overall Study||28
7921167|NCT00603512|19494326|P3|STARTED|Overall Study||28
7921168|NCT00603512|19494327|P2|STARTED|Overall Study||28
7921169|NCT00603512|19494328|P1|STARTED|Overall Study||28
7921170|NCT00603473|19494470|P1|NOT COMPLETED|Overall Study||9
7921171|NCT00603473|19494470|P1|COMPLETED|Overall Study||80
7921172|NCT00603473|19494470|P1|STARTED|Overall Study||89
7921173|NCT00603447|19494483|P7|NOT COMPLETED|Overall Study||24
7921174|NCT00603447|19494484|P6|NOT COMPLETED|Overall Study||2
7921175|NCT00603447|19494485|P5|NOT COMPLETED|Overall Study||5
7921176|NCT00603447|19494486|P4|NOT COMPLETED|Overall Study||2
7921177|NCT00603447|19494487|P3|NOT COMPLETED|Overall Study||2
7921178|NCT00603447|19494488|P2|NOT COMPLETED|Overall Study||3
7921179|NCT00603447|19494489|P1|NOT COMPLETED|Overall Study||0
7921180|NCT00603447|19494483|P7|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20
7921181|NCT00603447|19494484|P6|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
7921182|NCT00603447|19494485|P5|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1
7921183|NCT00603447|19494486|P4|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4
7921184|NCT00603447|19494487|P3|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
7921185|NCT00603447|19494488|P2|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3
7921186|NCT00603447|19494489|P1|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
7921187|NCT00603447|19494483|P7|STARTED|Overall Study||44
7921188|NCT00603447|19494484|P6|STARTED|Overall Study||8
7921189|NCT00603447|19494485|P5|STARTED|Overall Study||6
7921190|NCT00603447|19494486|P4|STARTED|Overall Study||6
7921191|NCT00603447|19494487|P3|STARTED|Overall Study||8
7921192|NCT00603447|19494488|P2|STARTED|Overall Study||6
7921193|NCT00603447|19494489|P1|STARTED|Overall Study||6
7921194|NCT00603408|19494511|P1|NOT COMPLETED|Overall Study||0
7921195|NCT00603408|19494511|P1|COMPLETED|Overall Study||5
7921196|NCT00603408|19494511|P1|STARTED|Overall Study||5
7921197|NCT00603382|19494528|P6|NOT COMPLETED|Overall Study||18
7921198|NCT00603382|19494529|P5|NOT COMPLETED|Overall Study||9
7921199|NCT00603382|19494530|P4|NOT COMPLETED|Overall Study||12
7921200|NCT00603382|19494531|P3|NOT COMPLETED|Overall Study||9
7921201|NCT00603382|19494532|P2|NOT COMPLETED|Overall Study||14
7921202|NCT00603382|19494533|P1|NOT COMPLETED|Overall Study||18
7921203|NCT00603382|19494528|P6|COMPLETED|Overall Study||84
7921204|NCT00603382|19494529|P5|COMPLETED|Overall Study||86
7921205|NCT00603382|19494530|P4|COMPLETED|Overall Study||98
7921206|NCT00603382|19494531|P3|COMPLETED|Overall Study||91
7921207|NCT00603382|19494532|P2|COMPLETED|Overall Study||83
7921208|NCT00603382|19494533|P1|COMPLETED|Overall Study||76
7921209|NCT00603382|19494528|P6|STARTED|Overall Study||102
7921210|NCT00603382|19494529|P5|STARTED|Overall Study||95
7921211|NCT00603382|19494530|P4|STARTED|Overall Study||110
7921212|NCT00603382|19494531|P3|STARTED|Overall Study||100
7921213|NCT00603382|19494532|P2|STARTED|Overall Study||97
7921214|NCT00603382|19494533|P1|STARTED|Overall Study||94
7921215|NCT00603304|19494681|P2|NOT COMPLETED|Overall Study||31
7921216|NCT00603304|19494682|P1|NOT COMPLETED|Overall Study||32
7921217|NCT00603304|19494681|P2|COMPLETED|Overall Study||155
7921218|NCT00603304|19494682|P1|COMPLETED|Overall Study||151
7921219|NCT00603304|19494681|P2|STARTED|Overall Study||186
7921220|NCT00603304|19494682|P1|STARTED|Overall Study||183
7921221|NCT00603291|19494719|P3|NOT COMPLETED|Overall Study||96
7921222|NCT00603291|19494720|P2|NOT COMPLETED|Overall Study||87
7921223|NCT00603291|19494721|P1|NOT COMPLETED|Overall Study||20
7921224|NCT00603291|19494719|P3|COMPLETED|Overall Study||157
7921225|NCT00603291|19494720|P2|COMPLETED|Overall Study||169
7921226|NCT00603291|19494721|P1|COMPLETED|Overall Study||75
7921227|NCT00603291|19494719|P3|STARTED|Overall Study||253
7921228|NCT00603291|19494720|P2|STARTED|Overall Study||256
7921229|NCT00603291|19494721|P1|STARTED|Overall Study||95
7921230|NCT00603278|19494738|P6|NOT COMPLETED|Overall Study||19
7921231|NCT00603278|19494739|P5|NOT COMPLETED|Overall Study||13
7921232|NCT00603278|19494740|P4|NOT COMPLETED|Overall Study||11
7921233|NCT00603278|19494741|P3|NOT COMPLETED|Overall Study||14
7921234|NCT00603278|19494742|P2|NOT COMPLETED|Overall Study||17
7921235|NCT00603278|19494743|P1|NOT COMPLETED|Overall Study||41
7921236|NCT00603278|19494738|P6|COMPLETED|Overall Study||81
7921237|NCT00603278|19494739|P5|COMPLETED|Overall Study||86
7921238|NCT00603278|19494740|P4|COMPLETED|Overall Study||92
7921239|NCT00603278|19494741|P3|COMPLETED|Overall Study||87
7921240|NCT00603278|19494742|P2|COMPLETED|Overall Study||88
7921241|NCT00603278|19494743|P1|COMPLETED|Overall Study||66
7921242|NCT00603278|19494738|P6|STARTED|Overall Study||100
7921243|NCT00603278|19494739|P5|STARTED|Overall Study||99
7921244|NCT00603278|19494740|P4|STARTED|Overall Study||103
7921245|NCT00603278|19494741|P3|STARTED|Overall Study||101
7921246|NCT00603278|19494742|P2|STARTED|Overall Study||105
7921247|NCT00603278|19494743|P1|STARTED|Overall Study||107
7921248|NCT00603265|19494892|P3|NOT COMPLETED|Overall Study||5
7921249|NCT00603265|19494893|P2|NOT COMPLETED|Overall Study||16
7921250|NCT00603265|19494894|P1|NOT COMPLETED|Overall Study||7
7921251|NCT00603265|19494892|P3|COMPLETED|Overall Study||67
7921252|NCT00603265|19494893|P2|COMPLETED|Overall Study||62
7921253|NCT00603265|19494894|P1|COMPLETED|Overall Study||69
7921254|NCT00603265|19494892|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
7921255|NCT00603265|19494893|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
7921256|NCT00603265|19494894|P1|Received at Least 1 Dose of Study Drug|Overall Study||75
7921257|NCT00603265|19494892|P3|STARTED|Overall Study||72
7921258|NCT00603265|19494893|P2|STARTED|Overall Study||78
7921259|NCT00603265|19494894|P1|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76
7921260|NCT00603239|19494922|P2|NOT COMPLETED|Overall Study||4
7921261|NCT00603239|19494923|P1|NOT COMPLETED|Overall Study||15
7921262|NCT00603239|19494922|P2|COMPLETED|Overall Study||50
7921263|NCT00603239|19494923|P1|COMPLETED|Overall Study||96
7921264|NCT00603239|19494922|P2|STARTED|Overall Study||54
7921265|NCT00603239|19494923|P1|STARTED|Overall Study||111
7921266|NCT00603187|19494949|P1|NOT COMPLETED|Overall Study||0
7921267|NCT00603187|19494949|P1|COMPLETED|Overall Study||4
7921268|NCT00603187|19494949|P1|STARTED|Overall Study||4
7921269|NCT00603044|19494957|P2|NOT COMPLETED|Overall Study||0
7921270|NCT00603044|19494958|P1|NOT COMPLETED|Overall Study||0
7921271|NCT00603044|19494957|P2|COMPLETED|Overall Study||13
7921272|NCT00603044|19494958|P1|COMPLETED|Overall Study||11
7921273|NCT00603044|19494957|P2|STARTED|Overall Study||13
7921274|NCT00603044|19494958|P1|STARTED|Overall Study||11
7921275|NCT00603018|19494974|P1|NOT COMPLETED|Overall Study||0
7921276|NCT00603018|19494974|P1|COMPLETED|Overall Study||23
7921277|NCT00603018|19494974|P1|STARTED|Overall Study||23
7921278|NCT00602979|19494984|P5|NOT COMPLETED|Overall Study||3
7921279|NCT00602979|19494985|P4|NOT COMPLETED|Overall Study||3
7921280|NCT00602979|19494986|P3|NOT COMPLETED|Overall Study||3
7921281|NCT00602979|19494987|P2|NOT COMPLETED|Overall Study||3
7921282|NCT00602979|19494988|P1|NOT COMPLETED|Overall Study||3
7921283|NCT00602979|19494984|P5|COMPLETED|Overall Study||45
7921284|NCT00602979|19494985|P4|COMPLETED|Overall Study||45
7921285|NCT00602979|19494986|P3|COMPLETED|Overall Study||45
7921286|NCT00602979|19494987|P2|COMPLETED|Overall Study||45
7921287|NCT00602979|19494988|P1|COMPLETED|Overall Study||45
7921288|NCT00602979|19494984|P5|STARTED|Overall Study||48
7921289|NCT00602979|19494985|P4|STARTED|Overall Study||48
7921290|NCT00602979|19494986|P3|STARTED|Overall Study||48
7921291|NCT00602979|19494987|P2|STARTED|Overall Study||48
7921292|NCT00602979|19494988|P1|STARTED|Overall Study||48
7921293|NCT00602953|19495005|P5|NOT COMPLETED|Overall Study||0
7921294|NCT00602953|19495006|P4|NOT COMPLETED|Overall Study||0
7921295|NCT00602953|19495007|P3|NOT COMPLETED|Overall Study||0
7921296|NCT00602953|19495008|P2|NOT COMPLETED|Overall Study||0
7921297|NCT00602953|19495009|P1|NOT COMPLETED|Overall Study||0
7921298|NCT00602953|19495005|P5|COMPLETED|Overall Study||0
7921299|NCT00602953|19495006|P4|COMPLETED|Overall Study||13
7921300|NCT00602953|19495007|P3|COMPLETED|Overall Study||47
7921301|NCT00602953|19495008|P2|COMPLETED|Overall Study||26
7921302|NCT00602953|19495009|P1|COMPLETED|Overall Study||15
7921303|NCT00602953|19495005|P5|STARTED|Overall Study||0
7921304|NCT00602953|19495006|P4|STARTED|Overall Study||13
7921305|NCT00602953|19495007|P3|STARTED|Overall Study||47
7921306|NCT00602953|19495008|P2|STARTED|Overall Study||26
7921307|NCT00602953|19495009|P1|STARTED|Overall Study||15
7921308|NCT00602927|19495038|P2|NOT COMPLETED|Period 3: 13 Days||3
7921309|NCT00602927|19495039|P1|NOT COMPLETED|Period 3: 13 Days||2
7921310|NCT00602927|19495038|P2|COMPLETED|Period 3: 13 Days||9
7921311|NCT00602927|19495039|P1|COMPLETED|Period 3: 13 Days||13
7921312|NCT00602927|19495038|P2|STARTED|Period 3: 13 Days||12
7921313|NCT00602927|19495039|P1|STARTED|Period 3: 13 Days||15
7921314|NCT00602927|19495038|P2|NOT COMPLETED|Period 2: 14 Days||2
7921315|NCT00602927|19495039|P1|NOT COMPLETED|Period 2: 14 Days||0
7921316|NCT00602927|19495038|P2|COMPLETED|Period 2: 14 Days||12
7921317|NCT00602927|19495039|P1|COMPLETED|Period 2: 14 Days||15
7921318|NCT00602927|19495038|P2|STARTED|Period 2: 14 Days||14
7921319|NCT00602927|19495039|P1|STARTED|Period 2: 14 Days||15
7921320|NCT00602927|19495038|P2|NOT COMPLETED|Period 1: 13 Days||5
7921321|NCT00602927|19495039|P1|NOT COMPLETED|Period 1: 13 Days||4
7921322|NCT00602927|19495038|P2|COMPLETED|Period 1: 13 Days||14
7921323|NCT00602927|19495039|P1|COMPLETED|Period 1: 13 Days||15
7921324|NCT00602927|19495038|P2|STARTED|Period 1: 13 Days||19
7921325|NCT00602927|19495039|P1|STARTED|Period 1: 13 Days||19
7921326|NCT00602836|19495047|P1|NOT COMPLETED|Overall Study||5
7921327|NCT00602836|19495047|P1|COMPLETED|Overall Study||39
7921328|NCT00602836|19495047|P1|STARTED|Overall Study||44
7921329|NCT00602797|19495056|P1|NOT COMPLETED|Overall Study||1
7921330|NCT00602797|19495056|P1|COMPLETED|Overall Study||19
7921331|NCT00602797|19495056|P1|STARTED|Overall Study||20
7921332|NCT00602771|19495064|P2|NOT COMPLETED|Overall Study||0
7921333|NCT00602771|19495065|P1|NOT COMPLETED|Overall Study||1
7921334|NCT00602771|19495064|P2|COMPLETED|Overall Study||21
7921335|NCT00602771|19495065|P1|COMPLETED|Overall Study||62
7921336|NCT00602771|19495064|P2|STARTED|Overall Study||21
7921337|NCT00602771|19495065|P1|STARTED|Overall Study||63
7921338|NCT00602667|19495074|P3|NOT COMPLETED|Overall Study||63
7921339|NCT00602667|19495075|P2|NOT COMPLETED|Overall Study||81
7921340|NCT00602667|19495076|P1|NOT COMPLETED|Overall Study||19
7921341|NCT00602667|19495074|P3|COMPLETED|Overall Study||14
7921342|NCT00602667|19495075|P2|COMPLETED|Overall Study||75
7921343|NCT00602667|19495076|P1|COMPLETED|Overall Study||38
7921344|NCT00602667|19495074|P3|STARTED|Overall Study||77
7921345|NCT00602667|19495075|P2|STARTED|Overall Study||156
7921346|NCT00602667|19495076|P1|STARTED|Overall Study||57
7921347|NCT00602641|19495255|P2|NOT COMPLETED|Overall Study||152
7921348|NCT00602641|19495256|P1|NOT COMPLETED|Overall Study||154
7921349|NCT00602641|19495255|P2|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
7921350|NCT00602641|19495256|P1|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
7921351|NCT00602641|19495255|P2|Started Protocol Therapy|Overall Study||150
7921352|NCT00602641|19495256|P1|Started Protocol Therapy|Overall Study||148
7921353|NCT00602641|19495255|P2|STARTED|Overall Study||152
7921354|NCT00602641|19495256|P1|STARTED|Overall Study||154
7921355|NCT00602537|19495270|P2|NOT COMPLETED|Follow Up Study Comparison||3
7921356|NCT00602537|19495271|P1|NOT COMPLETED|Follow Up Study Comparison||11
7921357|NCT00602537|19495270|P2|COMPLETED|Follow Up Study Comparison||14
7921358|NCT00602537|19495271|P1|COMPLETED|Follow Up Study Comparison||31
7921359|NCT00602537|19495270|P2|STARTED|Follow Up Study Comparison||17
7921360|NCT00602537|19495271|P1|STARTED|Follow Up Study Comparison||42
7921361|NCT00602537|19495270|P2|NOT COMPLETED|12 Week Double Blind Comparison||47
7921362|NCT00602537|19495271|P1|NOT COMPLETED|12 Week Double Blind Comparison||23
7921363|NCT00602537|19495270|P2|COMPLETED|12 Week Double Blind Comparison||17
7921364|NCT00602537|19495271|P1|COMPLETED|12 Week Double Blind Comparison||42
7921365|NCT00602537|19495270|P2|Responded|12 Week Double Blind Comparison||22
7921366|NCT00602537|19495271|P1|Responded|12 Week Double Blind Comparison||44
7921367|NCT00602537|19495270|P2|STARTED|12 Week Double Blind Comparison||64
7921368|NCT00602537|19495271|P1|STARTED|12 Week Double Blind Comparison||65
7921369|NCT00602472|19495281|P2|NOT COMPLETED|Overall Study||58
7921370|NCT00602472|19495282|P1|NOT COMPLETED|Overall Study||21
7921371|NCT00602472|19495281|P2|COMPLETED|Overall Study|number who completed treatment|734
7921372|NCT00602472|19495282|P1|COMPLETED|Overall Study|number who completed treatment|242
7921373|NCT00602472|19495281|P2|STARTED|Overall Study|3 randomised patients never took medication.|792
7921374|NCT00602472|19495282|P1|STARTED|Overall Study|3 randomised patients never took medication.|263
7921375|NCT00602459|19495316|P4|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
7921376|NCT00602459|19495317|P3|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
7921377|NCT00602459|19495318|P2|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
7921378|NCT00602459|19495319|P1|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
7921379|NCT00602459|19495316|P4|COMPLETED|Re-assignment After Del(11q22.3) Testing||31
7921380|NCT00602459|19495317|P3|COMPLETED|Re-assignment After Del(11q22.3) Testing||137
7921381|NCT00602459|19495318|P2|COMPLETED|Re-assignment After Del(11q22.3) Testing||109
7921382|NCT00602459|19495319|P1|COMPLETED|Re-assignment After Del(11q22.3) Testing||123
7921383|NCT00602459|19495316|P4|STARTED|Re-assignment After Del(11q22.3) Testing||31
7921384|NCT00602459|19495317|P3|STARTED|Re-assignment After Del(11q22.3) Testing||137
7921385|NCT00602459|19495318|P2|STARTED|Re-assignment After Del(11q22.3) Testing||109
7921386|NCT00602459|19495319|P1|STARTED|Re-assignment After Del(11q22.3) Testing||123
7921387|NCT00602459|19495316|P4|NOT COMPLETED|Initial Registration/Randomization||0
7921388|NCT00602459|19495317|P3|NOT COMPLETED|Initial Registration/Randomization||3
7921389|NCT00602459|19495318|P2|NOT COMPLETED|Initial Registration/Randomization||10
7921390|NCT00602459|19495319|P1|NOT COMPLETED|Initial Registration/Randomization||5
7921391|NCT00602459|19495316|P4|COMPLETED|Initial Registration/Randomization||0
7921392|NCT00602459|19495317|P3|COMPLETED|Initial Registration/Randomization||137
7921393|NCT00602459|19495318|P2|COMPLETED|Initial Registration/Randomization||130
7921394|NCT00602459|19495319|P1|COMPLETED|Initial Registration/Randomization||133
7921395|NCT00602459|19495316|P4|STARTED|Initial Registration/Randomization||0
7921396|NCT00602459|19495317|P3|STARTED|Initial Registration/Randomization||140
7921397|NCT00602459|19495318|P2|STARTED|Initial Registration/Randomization||140
7921398|NCT00602459|19495319|P1|STARTED|Initial Registration/Randomization||138
7921399|NCT00602446|19495340|P1|NOT COMPLETED|Overall Study||0
7921400|NCT00602446|19495340|P1|COMPLETED|Overall Study||3
7921401|NCT00602446|19495340|P1|STARTED|Overall Study||3
7921402|NCT00602420|19495347|P2|NOT COMPLETED|Overall Study||24
7921403|NCT00602420|19495348|P1|NOT COMPLETED|Overall Study||25
7921404|NCT00602420|19495347|P2|COMPLETED|Overall Study||229
7921405|NCT00602420|19495348|P1|COMPLETED|Overall Study||232
7921406|NCT00602420|19495347|P2|STARTED|Overall Study||253
7921407|NCT00602420|19495348|P1|STARTED|Overall Study||257
7921408|NCT00602355|19495357|P3|NOT COMPLETED|Overall Study||10
7921409|NCT00602355|19495358|P2|NOT COMPLETED|Overall Study||18
7921410|NCT00602355|19495359|P1|NOT COMPLETED|Overall Study||9
7921411|NCT00602355|19495357|P3|COMPLETED|Overall Study||43
7921412|NCT00602355|19495358|P2|COMPLETED|Overall Study||38
7921413|NCT00602355|19495359|P1|COMPLETED|Overall Study||44
7921414|NCT00602355|19495357|P3|STARTED|Overall Study||53
7921415|NCT00602355|19495358|P2|STARTED|Overall Study||56
7921416|NCT00602355|19495359|P1|STARTED|Overall Study||53
7921417|NCT00602290|19495382|P3|NOT COMPLETED|Overall Study||1
7921418|NCT00602290|19495383|P2|NOT COMPLETED|Overall Study||2
7921419|NCT00602290|19495384|P1|NOT COMPLETED|Overall Study||2
7921420|NCT00602290|19495382|P3|COMPLETED|Overall Study||46
7921421|NCT00602290|19495383|P2|COMPLETED|Overall Study||46
7921422|NCT00602290|19495384|P1|COMPLETED|Overall Study||46
7921423|NCT00602290|19495382|P3|STARTED|Overall Study||47
7921424|NCT00602290|19495383|P2|STARTED|Overall Study||48
7921425|NCT00602290|19495384|P1|STARTED|Overall Study||48
7921426|NCT00602225|19495395|P1|NOT COMPLETED|Overall Study||0
7921427|NCT00602225|19495395|P1|COMPLETED|Overall Study||50
7921428|NCT00602225|19495395|P1|STARTED|Overall Study||50
7921429|NCT00602043|19495408|P1|NOT COMPLETED|Overall Study||5
7921430|NCT00602043|19495408|P1|COMPLETED|Overall Study||15
7921431|NCT00602043|19495408|P1|STARTED|Overall Study||20
7921432|NCT00601965|19495422|P4|NOT COMPLETED|Overall Study||1
7921433|NCT00601965|19495423|P3|NOT COMPLETED|Overall Study||0
7921434|NCT00601965|19495424|P2|NOT COMPLETED|Overall Study||2
7921435|NCT00601965|19495425|P1|NOT COMPLETED|Overall Study||0
7921436|NCT00601965|19495422|P4|COMPLETED|Overall Study||17
7921437|NCT00601965|19495423|P3|COMPLETED|Overall Study||19
7921438|NCT00601965|19495424|P2|COMPLETED|Overall Study||16
7921439|NCT00601965|19495425|P1|COMPLETED|Overall Study||18
7921440|NCT00601965|19495422|P4|STARTED|Overall Study||18
7921441|NCT00601965|19495423|P3|STARTED|Overall Study||19
7921442|NCT00601965|19495424|P2|STARTED|Overall Study||18
7921443|NCT00601965|19495425|P1|STARTED|Overall Study||18
7921444|NCT00601952|19495441|P2|NOT COMPLETED|Overall Study||0
7921445|NCT00601952|19495442|P1|NOT COMPLETED|Overall Study||2
7921446|NCT00601952|19495441|P2|COMPLETED|Overall Study||17
7921447|NCT00601952|19495442|P1|COMPLETED|Overall Study||12
7921448|NCT00601952|19495441|P2|STARTED|Overall Study||17
7921449|NCT00601952|19495442|P1|STARTED|Overall Study||14
7921450|NCT00601926|19495448|P1|NOT COMPLETED|Overall Study||0
7921451|NCT00601926|19495448|P1|COMPLETED|Overall Study||5
7921452|NCT00601926|19495448|P1|STARTED|Overall Study||5
7921453|NCT00601900|19495456|P2|NOT COMPLETED|Overall Study||3
7921454|NCT00601900|19495457|P1|NOT COMPLETED|Overall Study||0
7921455|NCT00601900|19495456|P2|COMPLETED|Overall Study||196
7921456|NCT00601900|19495457|P1|COMPLETED|Overall Study||195
7921457|NCT00601900|19495456|P2|STARTED|Overall Study||199
7921458|NCT00601900|19495457|P1|STARTED|Overall Study||195
7921459|NCT00601848|19495471|P1|NOT COMPLETED|Overall Study||9
7921460|NCT00601848|19495471|P1|COMPLETED|Overall Study||0
7921461|NCT00601848|19495471|P1|STARTED|Overall Study||9
7921462|NCT00601835|19495481|P2|NOT COMPLETED|Overall Study||14
7921463|NCT00601835|19495482|P1|NOT COMPLETED|Overall Study||60
7921464|NCT00601835|19495481|P2|COMPLETED|Overall Study||686
7921465|NCT00601835|19495482|P1|COMPLETED|Overall Study||2890
7921466|NCT00601835|19495481|P2|STARTED|Overall Study||700
7921467|NCT00601835|19495482|P1|STARTED|Overall Study||2950
7921468|NCT00601796|19495492|P1|NOT COMPLETED|Overall Study||0
7921469|NCT00601796|19495492|P1|COMPLETED|Overall Study||24
7921470|NCT00601796|19495492|P1|STARTED|Overall Study||24
7921471|NCT00601731|19495511|P4|NOT COMPLETED|Overall Study||1
7921472|NCT00601731|19495512|P3|NOT COMPLETED|Overall Study||15
7921473|NCT00601731|19495513|P2|NOT COMPLETED|Overall Study||0
7921474|NCT00601731|19495514|P1|NOT COMPLETED|Overall Study||23
7921475|NCT00601731|19495511|P4|COMPLETED|Overall Study||29
7921476|NCT00601731|19495512|P3|COMPLETED|Overall Study||151
7921477|NCT00601731|19495513|P2|COMPLETED|Overall Study||43
7921478|NCT00601731|19495514|P1|COMPLETED|Overall Study||120
7921479|NCT00601731|19495511|P4|STARTED|Overall Study||30
7921480|NCT00601731|19495512|P3|STARTED|Overall Study||166
7921481|NCT00601731|19495513|P2|STARTED|Overall Study||43
7921482|NCT00601731|19495514|P1|STARTED|Overall Study||143
7921483|NCT00601718|19495564|P1|NOT COMPLETED|Overall Study||0
7921484|NCT00601718|19495564|P1|COMPLETED|Overall Study||29
7921485|NCT00601718|19495564|P1|STARTED|Overall Study||29
7921486|NCT00601705|19495571|P1|NOT COMPLETED|Overall Study||1
7921487|NCT00601705|19495571|P1|COMPLETED|Overall Study||60
7921488|NCT00601705|19495571|P1|STARTED|Overall Study||61
7921489|NCT00601640|19495583|P3|NOT COMPLETED|Overall Study||10
7921490|NCT00601640|19495584|P2|NOT COMPLETED|Overall Study||5
7921491|NCT00601640|19495585|P1|NOT COMPLETED|Overall Study||5
7921492|NCT00601640|19495583|P3|COMPLETED|Overall Study||42
7921493|NCT00601640|19495584|P2|COMPLETED|Overall Study||47
7921494|NCT00601640|19495585|P1|COMPLETED|Overall Study||47
7921495|NCT00601640|19495583|P3|STARTED|Overall Study||52
7921496|NCT00601640|19495584|P2|STARTED|Overall Study||52
7921497|NCT00601640|19495585|P1|STARTED|Overall Study||52
7921498|NCT00601627|19495599|P1|NOT COMPLETED|Overall Study||0
7921499|NCT00601627|19495599|P1|COMPLETED|Overall Study||51
7921500|NCT00601627|19495599|P1|STARTED|Overall Study||51
7921501|NCT00601523|19495610|P2|NOT COMPLETED|Overall Study||26
7921502|NCT00601523|19495611|P1|NOT COMPLETED|Overall Study||77
7921503|NCT00601523|19495610|P2|COMPLETED|Overall Study||117
7921504|NCT00601523|19495611|P1|COMPLETED|Overall Study||291
7921505|NCT00601523|19495610|P2|STARTED|Overall Study||143
7921506|NCT00601523|19495611|P1|STARTED|Overall Study||368
7921507|NCT00601458|19495646|P3|NOT COMPLETED|Overall Study||2
7921508|NCT00601458|19495647|P2|NOT COMPLETED|Overall Study||5
7921509|NCT00601458|19495648|P1|NOT COMPLETED|Overall Study||4
7921510|NCT00601458|19495646|P3|COMPLETED|Overall Study||28
7921511|NCT00601458|19495647|P2|COMPLETED|Overall Study||29
7921512|NCT00601458|19495648|P1|COMPLETED|Overall Study||32
7921513|NCT00601458|19495646|P3|STARTED|Overall Study||30
7921514|NCT00601458|19495647|P2|STARTED|Overall Study||34
7921515|NCT00601458|19495648|P1|STARTED|Overall Study||36
7921516|NCT00601419|19495659|P1|NOT COMPLETED|Overall Study||4
7921517|NCT00601419|19495659|P1|COMPLETED|Overall Study||226
7921518|NCT00601419|19495659|P1|STARTED|Overall Study||230
7921519|NCT00601367|19495683|P1|NOT COMPLETED|Overall Study||187
7921520|NCT00601367|19495683|P1|COMPLETED|Overall Study||293
7921521|NCT00601367|19495683|P1|STARTED|Overall Study||480
7921522|NCT00601354|19495689|P2|NOT COMPLETED|Overall Study||5
7921523|NCT00601354|19495690|P1|NOT COMPLETED|Overall Study||4
7921524|NCT00601354|19495689|P2|COMPLETED|Overall Study||4
7921525|NCT00601354|19495690|P1|COMPLETED|Overall Study||4
7921526|NCT00601354|19495689|P2|STARTED|Overall Study||9
7921527|NCT00601354|19495690|P1|STARTED|Overall Study||8
7921528|NCT00601250|19495702|P2|NOT COMPLETED|Overall Study||39
7921529|NCT00601250|19495703|P1|NOT COMPLETED|Overall Study||14
7921530|NCT00601250|19495702|P2|COMPLETED|Overall Study|number who completed treatment|484
7921531|NCT00601250|19495703|P1|COMPLETED|Overall Study|number who completed treatment|163
7921532|NCT00601250|19495702|P2|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523
7921533|NCT00601250|19495703|P1|STARTED|Overall Study|number who started treatment|177
7921534|NCT00601172|19495739|P2|NOT COMPLETED|Overall Study||127
7921535|NCT00601172|19495740|P1|NOT COMPLETED|Overall Study||141
7921536|NCT00601172|19495739|P2|COMPLETED|Overall Study||228
7921537|NCT00601172|19495740|P1|COMPLETED|Overall Study||214
7921538|NCT00601172|19495739|P2|STARTED|Overall Study||355
7921539|NCT00601172|19495740|P1|STARTED|Overall Study||355
7921540|NCT00601146|19495789|P1|NOT COMPLETED|Overall Study||0
7921541|NCT00601146|19495789|P1|COMPLETED|Overall Study||39
7921542|NCT00601146|19495789|P1|STARTED|Overall Study||39
7921543|NCT00601107|19495797|P4|NOT COMPLETED|Overall Study||12
7921544|NCT00601107|19495798|P3|NOT COMPLETED|Overall Study||12
7921545|NCT00601107|19495799|P2|NOT COMPLETED|Overall Study||9
7921546|NCT00601107|19495800|P1|NOT COMPLETED|Overall Study||13
7921547|NCT00601107|19495797|P4|COMPLETED|Overall Study||13
7921548|NCT00601107|19495798|P3|COMPLETED|Overall Study||16
7921549|NCT00601107|19495799|P2|COMPLETED|Overall Study||22
7921550|NCT00601107|19495800|P1|COMPLETED|Overall Study||14
7921551|NCT00601107|19495797|P4|Treated|Overall Study||25
7921552|NCT00601107|19495798|P3|Treated|Overall Study||28
7921553|NCT00601107|19495799|P2|Treated|Overall Study||31
7921554|NCT00601107|19495800|P1|Treated|Overall Study||27
7921555|NCT00601107|19495797|P4|STARTED|Overall Study||25
7921556|NCT00601107|19495798|P3|STARTED|Overall Study||28
7921557|NCT00601107|19495799|P2|STARTED|Overall Study||31
7921558|NCT00601107|19495800|P1|STARTED|Overall Study|Randomized.|27
7921559|NCT00600938|19495820|P4|NOT COMPLETED|Extension Study||1
7921560|NCT00600938|19495821|P3|NOT COMPLETED|Extension Study||9
7921561|NCT00600938|19495822|P2|NOT COMPLETED|Extension Study||5
7921562|NCT00600938|19495823|P1|NOT COMPLETED|Extension Study||9
7921563|NCT00600938|19495820|P4|COMPLETED|Extension Study||0
7921564|NCT00600938|19495821|P3|COMPLETED|Extension Study||33
7921565|NCT00600938|19495822|P2|COMPLETED|Extension Study||24
7921566|NCT00600938|19495823|P1|COMPLETED|Extension Study||65
7921567|NCT00600938|19495820|P4|Extension Safety Set|Extension Study||1
7921568|NCT00600938|19495821|P3|Extension Safety Set|Extension Study||42
7921569|NCT00600938|19495822|P2|Extension Safety Set|Extension Study||29
7921570|NCT00600938|19495823|P1|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73
7921571|NCT00600938|19495820|P4|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1
7921572|NCT00600938|19495821|P3|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42
7921573|NCT00600938|19495822|P2|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29
7921574|NCT00600938|19495823|P1|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74
7921575|NCT00600938|19495820|P4|NOT COMPLETED|Core Study||0
7921576|NCT00600938|19495821|P3|NOT COMPLETED|Core Study||0
7921577|NCT00600938|19495822|P2|NOT COMPLETED|Core Study||21
7921578|NCT00600938|19495823|P1|NOT COMPLETED|Core Study||16
7921579|NCT00600938|19495820|P4|COMPLETED|Core Study||0
7921580|NCT00600938|19495821|P3|COMPLETED|Core Study||0
7921581|NCT00600938|19495822|P2|COMPLETED|Core Study||78
7921582|NCT00600938|19495823|P1|COMPLETED|Core Study||82
7921583|NCT00600938|19495820|P4|Per Protocol Set (PPS)|Core Study||0
7921584|NCT00600938|19495821|P3|Per Protocol Set (PPS)|Core Study||0
7921585|NCT00600938|19495822|P2|Per Protocol Set (PPS)|Core Study||81
7921586|NCT00600938|19495823|P1|Per Protocol Set (PPS)|Core Study||91
7921587|NCT00600938|19495820|P4|Core Safety Set|Core Study||0
7921588|NCT00600938|19495821|P3|Core Safety Set|Core Study||0
7921589|NCT00600938|19495822|P2|Core Safety Set|Core Study||91
7921590|NCT00600938|19495823|P1|Core Safety Set|Core Study||96
7921591|NCT00600938|19495820|P4|STARTED|Core Study||0
7921592|NCT00600938|19495821|P3|STARTED|Core Study||0
7921593|NCT00600938|19495822|P2|STARTED|Core Study||99
7921594|NCT00600938|19495823|P1|STARTED|Core Study||98
7921595|NCT00600886|19495887|P2|NOT COMPLETED|Extension - After Crossover (CAS)||13
7921596|NCT00600886|19495888|P1|NOT COMPLETED|Extension - After Crossover (CAS)||62
7921597|NCT00600886|19495887|P2|COMPLETED|Extension - After Crossover (CAS)|Completed the study|25
7921598|NCT00600886|19495888|P1|COMPLETED|Extension - After Crossover (CAS)|Completed after month 26: transferred to a roll-over protocol or commercial supply of Pas.LAR|19
7921599|NCT00600886|19495887|P2|Discontinued After M26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|0
7921600|NCT00600886|19495888|P1|Discontinued After M26|Extension - After Crossover (CAS)||31
7921601|NCT00600886|19495887|P2|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13
7921602|NCT00600886|19495888|P1|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31
7921603|NCT00600886|19495887|P2|Completed After Month 26|Extension - After Crossover (CAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in study after M26|0
7921604|NCT00600886|19495888|P1|Completed After Month 26|Extension - After Crossover (CAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|19
7921605|NCT00600886|19495887|P2|Completed Study at Month 26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|25
7921606|NCT00600886|19495888|P1|Completed Study at Month 26|Extension - After Crossover (CAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
7921607|NCT00600886|19495887|P2|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Octreotide LAR|38
7921608|NCT00600886|19495888|P1|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Pasireotide LAR|81
7921609|NCT00600886|19495887|P2|NOT COMPLETED|Extension - Same Treatment (FAS)||11
7921610|NCT00600886|19495888|P1|NOT COMPLETED|Extension - Same Treatment (FAS)||46
7921611|NCT00600886|19495887|P2|COMPLETED|Extension - Same Treatment (FAS)|Completed = completed the study|35
7921612|NCT00600886|19495888|P1|COMPLETED|Extension - Same Treatment (FAS)|Completed= completed after M26, switched to commercial pasireotide LAR or entered roll-over protocol|28
7921613|NCT00600886|19495887|P2|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10
7921614|NCT00600886|19495888|P1|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23
7921615|NCT00600886|19495887|P2|Discontinued After Month 26|Extension - Same Treatment (FAS)|Received treatment and discontinued after M26: Recorded as protocol deviation|1
7921616|NCT00600886|19495888|P1|Discontinued After Month 26|Extension - Same Treatment (FAS)||23
7921617|NCT00600886|19495887|P2|Completed Study After Month 26|Extension - Same Treatment (FAS)|Received treatment and completed after M26: Recorded as protocol deviation|4
7921618|NCT00600886|19495888|P1|Completed Study After Month 26|Extension - Same Treatment (FAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|28
7921619|NCT00600886|19495887|P2|Completed Study at Month 26|Extension - Same Treatment (FAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in the study after M26|31
7921620|NCT00600886|19495888|P1|Completed Study at Month 26|Extension - Same Treatment (FAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
7921621|NCT00600886|19495887|P2|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Octreotide LAR|46
7921622|NCT00600886|19495888|P1|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Pasireotide LAR|74
7921623|NCT00600886|19495887|P2|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26
7921624|NCT00600886|19495888|P1|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35
7921625|NCT00600886|19495887|P2|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|156
7921626|NCT00600886|19495888|P1|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|141
7921627|NCT00600886|19495887|P2|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46
7921628|NCT00600886|19495888|P1|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74
7921629|NCT00600886|19495887|P2|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81
7921630|NCT00600886|19495888|P1|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38
7921631|NCT00600886|19495887|P2|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
7921632|NCT00600886|19495888|P1|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
7921633|NCT00600886|19495887|P2|STARTED|Core Phase - Full Analysis Set (FAS)||182
7921634|NCT00600886|19495888|P1|STARTED|Core Phase - Full Analysis Set (FAS)||176
7921635|NCT00600821|19495952|P2|NOT COMPLETED|Overall Study||60
7921636|NCT00600821|19495953|P1|NOT COMPLETED|Overall Study||58
7921637|NCT00600821|19495952|P2|COMPLETED|Overall Study||0
7921638|NCT00600821|19495953|P1|COMPLETED|Overall Study||0
7921639|NCT00600821|19495952|P2|Treated|Overall Study||59
7921640|NCT00600821|19495953|P1|Treated|Overall Study||58
7921641|NCT00600821|19495952|P2|STARTED|Overall Study||60
7921642|NCT00600821|19495953|P1|STARTED|Overall Study||58
7921643|NCT00600756|19495981|P2|NOT COMPLETED|Overall Study Analysis After 12 Months||176
7921644|NCT00600756|19495982|P1|NOT COMPLETED|Overall Study Analysis After 12 Months||183
7921645|NCT00600756|19495981|P2|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227
7921646|NCT00600756|19495982|P1|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212
7921647|NCT00600756|19495981|P2|ITT Analysis|Overall Study Analysis After 12 Months||392
7921648|NCT00600756|19495982|P1|ITT Analysis|Overall Study Analysis After 12 Months||379
7921649|NCT00600756|19495981|P2|Safety Analysis|Overall Study Analysis After 12 Months||402
7921650|NCT00600756|19495982|P1|Safety Analysis|Overall Study Analysis After 12 Months||391
7921651|NCT00600756|19495981|P2|Randomized Analysis|Overall Study Analysis After 12 Months||403
7921652|NCT00600756|19495982|P1|Randomized Analysis|Overall Study Analysis After 12 Months||395
7921653|NCT00600756|19495981|P2|STARTED|Overall Study Analysis After 12 Months||403
7921654|NCT00600756|19495982|P1|STARTED|Overall Study Analysis After 12 Months||395
7921655|NCT00600756|19495981|P2|NOT COMPLETED|Analysis After 6 Months||120
7921656|NCT00600756|19495982|P1|NOT COMPLETED|Analysis After 6 Months||131
7921657|NCT00600756|19495981|P2|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283
7921658|NCT00600756|19495982|P1|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264
7921659|NCT00600756|19495981|P2|STARTED|Analysis After 6 Months||403
7921660|NCT00600756|19495982|P1|STARTED|Analysis After 6 Months||395
7921661|NCT00600743|19496052|P4|NOT COMPLETED|Overall Study||0
7921662|NCT00600743|19496053|P3|NOT COMPLETED|Overall Study||0
7921663|NCT00600743|19496054|P2|NOT COMPLETED|Overall Study||0
7921664|NCT00600743|19496055|P1|NOT COMPLETED|Overall Study||0
7921665|NCT00600743|19496052|P4|COMPLETED|Overall Study||7
7921666|NCT00600743|19496053|P3|COMPLETED|Overall Study||8
7921667|NCT00600743|19496054|P2|COMPLETED|Overall Study||4
7921668|NCT00600743|19496055|P1|COMPLETED|Overall Study||4
7921669|NCT00600743|19496052|P4|STARTED|Overall Study||7
7921670|NCT00600743|19496053|P3|STARTED|Overall Study||8
7921671|NCT00600743|19496054|P2|STARTED|Overall Study||4
7921672|NCT00600743|19496055|P1|STARTED|Overall Study||4
7921673|NCT00600704|19496084|P2|NOT COMPLETED|Overall Study||0
7921674|NCT00600704|19496085|P1|NOT COMPLETED|Overall Study||0
7921675|NCT00600704|19496084|P2|COMPLETED|Overall Study||92
7921676|NCT00600704|19496085|P1|COMPLETED|Overall Study||100
7921677|NCT00600704|19496084|P2|STARTED|Overall Study||92
7921678|NCT00600704|19496085|P1|STARTED|Overall Study||100
7921679|NCT00600613|19496091|P1|NOT COMPLETED|Overall Study||1
7921680|NCT00600613|19496091|P1|COMPLETED|Overall Study||5
7921681|NCT00600613|19496091|P1|STARTED|Overall Study||6
7921682|NCT00600353|19496097|P2|NOT COMPLETED|Overall Study||1
7921683|NCT00600353|19496098|P1|NOT COMPLETED|Overall Study||1
7921684|NCT00600353|19496097|P2|COMPLETED|Overall Study||9
7921685|NCT00600353|19496098|P1|COMPLETED|Overall Study||9
7921686|NCT00600353|19496097|P2|STARTED|Overall Study||10
7921687|NCT00600353|19496098|P1|STARTED|Overall Study||10
7921688|NCT00600340|19496112|P2|NOT COMPLETED|Overall Study||0
7921689|NCT00600340|19496113|P1|NOT COMPLETED|Overall Study||0
7921690|NCT00600340|19496112|P2|COMPLETED|Overall Study||279
7921691|NCT00600340|19496113|P1|COMPLETED|Overall Study||285
7921692|NCT00600340|19496112|P2|STARTED|Overall Study||279
7921693|NCT00600340|19496113|P1|STARTED|Overall Study||285
7921694|NCT00600171|19496161|P6|NOT COMPLETED|Overall Study||5
7921695|NCT00600171|19496162|P5|NOT COMPLETED|Overall Study||8
7921696|NCT00600171|19496163|P4|NOT COMPLETED|Overall Study||12
7921697|NCT00600171|19496164|P3|NOT COMPLETED|Overall Study||10
7921698|NCT00600171|19496165|P2|NOT COMPLETED|Overall Study||17
7921699|NCT00600171|19496166|P1|NOT COMPLETED|Overall Study||16
7921700|NCT00600171|19496161|P6|COMPLETED|Overall Study||97
7921701|NCT00600171|19496162|P5|COMPLETED|Overall Study||93
7921702|NCT00600171|19496163|P4|COMPLETED|Overall Study||88
7921703|NCT00600171|19496164|P3|COMPLETED|Overall Study||91
7921704|NCT00600171|19496165|P2|COMPLETED|Overall Study||84
7921705|NCT00600171|19496166|P1|COMPLETED|Overall Study||86
7921706|NCT00600171|19496161|P6|STARTED|Overall Study||102
7921707|NCT00600171|19496162|P5|STARTED|Overall Study||101
7921708|NCT00600171|19496163|P4|STARTED|Overall Study||100
7921709|NCT00600171|19496164|P3|STARTED|Overall Study||101
7921710|NCT00600171|19496165|P2|STARTED|Overall Study||101
7921711|NCT00600171|19496166|P1|STARTED|Overall Study||102
7921712|NCT00600119|19496240|P6|NOT COMPLETED|Follow-up Period||1
7921713|NCT00600119|19496241|P5|NOT COMPLETED|Follow-up Period||0
7921714|NCT00600119|19496242|P4|NOT COMPLETED|Follow-up Period||0
7921715|NCT00600119|19496243|P3|NOT COMPLETED|Follow-up Period||0
7921716|NCT00600119|19496244|P2|NOT COMPLETED|Follow-up Period||0
7921717|NCT00600119|19496245|P1|NOT COMPLETED|Follow-up Period||1
7921718|NCT00600119|19496240|P6|COMPLETED|Follow-up Period||20
7921719|NCT00600119|19496241|P5|COMPLETED|Follow-up Period||31
7921720|NCT00600119|19496242|P4|COMPLETED|Follow-up Period||28
7921721|NCT00600119|19496243|P3|COMPLETED|Follow-up Period||27
7921722|NCT00600119|19496244|P2|COMPLETED|Follow-up Period||28
7921723|NCT00600119|19496245|P1|COMPLETED|Follow-up Period||26
7921724|NCT00600119|19496240|P6|STARTED|Follow-up Period||21
7921725|NCT00600119|19496241|P5|STARTED|Follow-up Period||31
7921726|NCT00600119|19496242|P4|STARTED|Follow-up Period||28
7921727|NCT00600119|19496243|P3|STARTED|Follow-up Period||27
7921728|NCT00600119|19496244|P2|STARTED|Follow-up Period||28
7921729|NCT00600119|19496245|P1|STARTED|Follow-up Period||27
7921730|NCT00600119|19496240|P6|NOT COMPLETED|Double-blind Treatment Period||14
7921731|NCT00600119|19496241|P5|NOT COMPLETED|Double-blind Treatment Period||6
7921732|NCT00600119|19496242|P4|NOT COMPLETED|Double-blind Treatment Period||2
7921733|NCT00600119|19496243|P3|NOT COMPLETED|Double-blind Treatment Period||0
7921734|NCT00600119|19496244|P2|NOT COMPLETED|Double-blind Treatment Period||5
7921735|NCT00600119|19496245|P1|NOT COMPLETED|Double-blind Treatment Period||5
7921736|NCT00600119|19496240|P6|COMPLETED|Double-blind Treatment Period||21
7921737|NCT00600119|19496241|P5|COMPLETED|Double-blind Treatment Period||31
7921738|NCT00600119|19496242|P4|COMPLETED|Double-blind Treatment Period||28
7921739|NCT00600119|19496243|P3|COMPLETED|Double-blind Treatment Period||27
7921740|NCT00600119|19496244|P2|COMPLETED|Double-blind Treatment Period||28
7921741|NCT00600119|19496245|P1|COMPLETED|Double-blind Treatment Period||27
7921742|NCT00600119|19496240|P6|STARTED|Double-blind Treatment Period||35
7921743|NCT00600119|19496241|P5|STARTED|Double-blind Treatment Period||37
7921744|NCT00600119|19496242|P4|STARTED|Double-blind Treatment Period||30
7921745|NCT00600119|19496243|P3|STARTED|Double-blind Treatment Period||27
7921746|NCT00600119|19496244|P2|STARTED|Double-blind Treatment Period||33
7921747|NCT00600119|19496245|P1|STARTED|Double-blind Treatment Period||32
7921748|NCT00600119|19496240|P6|NOT COMPLETED|Single-blind Placebo run-in Period||2
7921749|NCT00600119|19496241|P5|NOT COMPLETED|Single-blind Placebo run-in Period||2
7921750|NCT00600119|19496242|P4|NOT COMPLETED|Single-blind Placebo run-in Period||1
7921751|NCT00600119|19496243|P3|NOT COMPLETED|Single-blind Placebo run-in Period||2
7921752|NCT00600119|19496244|P2|NOT COMPLETED|Single-blind Placebo run-in Period||2
7921753|NCT00600119|19496245|P1|NOT COMPLETED|Single-blind Placebo run-in Period||4
7921754|NCT00600119|19496240|P6|COMPLETED|Single-blind Placebo run-in Period||35
7921755|NCT00600119|19496241|P5|COMPLETED|Single-blind Placebo run-in Period||37
7921756|NCT00600119|19496242|P4|COMPLETED|Single-blind Placebo run-in Period||30
7921757|NCT00600119|19496243|P3|COMPLETED|Single-blind Placebo run-in Period||27
7921758|NCT00600119|19496244|P2|COMPLETED|Single-blind Placebo run-in Period||33
7921759|NCT00600119|19496245|P1|COMPLETED|Single-blind Placebo run-in Period||32
7921760|NCT00600119|19496240|P6|STARTED|Single-blind Placebo run-in Period||37
7921761|NCT00600119|19496241|P5|STARTED|Single-blind Placebo run-in Period||39
7921762|NCT00600119|19496242|P4|STARTED|Single-blind Placebo run-in Period||31
7921763|NCT00600119|19496243|P3|STARTED|Single-blind Placebo run-in Period||29
7921764|NCT00600119|19496244|P2|STARTED|Single-blind Placebo run-in Period||35
7921765|NCT00600119|19496245|P1|STARTED|Single-blind Placebo run-in Period||36
7921766|NCT00600106|19496279|P2|NOT COMPLETED|Overall Study||1
7921767|NCT00600106|19496280|P1|NOT COMPLETED|Overall Study||1
7921768|NCT00600106|19496279|P2|COMPLETED|Overall Study||18
7921769|NCT00600106|19496280|P1|COMPLETED|Overall Study||17
7921770|NCT00600106|19496279|P2|STARTED|Overall Study||19
7921771|NCT00600106|19496280|P1|STARTED|Overall Study||18
7921772|NCT00600080|19496312|P2|NOT COMPLETED|Period 2: One-week to Two-weeks||0
7921773|NCT00600080|19496313|P1|NOT COMPLETED|Period 2: One-week to Two-weeks||0
7921774|NCT00600080|19496312|P2|COMPLETED|Period 2: One-week to Two-weeks||32
7921775|NCT00600080|19496313|P1|COMPLETED|Period 2: One-week to Two-weeks||28
7921776|NCT00600080|19496312|P2|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32
7921777|NCT00600080|19496313|P1|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28
7921778|NCT00600080|19496312|P2|NOT COMPLETED|Period 1: Baseline to One-week||0
7921779|NCT00600080|19496313|P1|NOT COMPLETED|Period 1: Baseline to One-week||0
7921780|NCT00600080|19496312|P2|COMPLETED|Period 1: Baseline to One-week||32
7921781|NCT00600080|19496313|P1|COMPLETED|Period 1: Baseline to One-week||28
7921782|NCT00600080|19496312|P2|STARTED|Period 1: Baseline to One-week||32
7921783|NCT00600080|19496313|P1|STARTED|Period 1: Baseline to One-week||28
7921784|NCT00600067|19496327|P2|NOT COMPLETED|Overall Study||7
7921785|NCT00600067|19496328|P1|NOT COMPLETED|Overall Study||3
7921786|NCT00600067|19496327|P2|COMPLETED|Overall Study||68
7921787|NCT00600067|19496328|P1|COMPLETED|Overall Study||52
7921788|NCT00600067|19496327|P2|STARTED|Overall Study||75
7921789|NCT00600067|19496328|P1|STARTED|Overall Study||55
7921790|NCT00600028|19496338|P2|NOT COMPLETED|Second Intervention (12 Weeks)||2
7921791|NCT00600028|19496339|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
7921792|NCT00600028|19496338|P2|COMPLETED|Second Intervention (12 Weeks)||8
7921793|NCT00600028|19496339|P1|COMPLETED|Second Intervention (12 Weeks)||12
7921794|NCT00600028|19496338|P2|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|10
7921795|NCT00600028|19496339|P1|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|12
7921796|NCT00600028|19496338|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
7921797|NCT00600028|19496339|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
7921798|NCT00600028|19496338|P2|COMPLETED|First Intervention (12 Weeks)||10
7921799|NCT00600028|19496339|P1|COMPLETED|First Intervention (12 Weeks)||12
7921800|NCT00600028|19496338|P2|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|11
7921801|NCT00600028|19496339|P1|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|13
7921802|NCT00600015|19496353|P2|NOT COMPLETED|Overall Study||35
7921803|NCT00600015|19496354|P1|NOT COMPLETED|Overall Study||60
7921804|NCT00600015|19496353|P2|COMPLETED|Overall Study|Completed >=2 cycles|20
7921805|NCT00600015|19496354|P1|COMPLETED|Overall Study|Completed >=2 cycles|51
7921806|NCT00600015|19496353|P2|STARTED|Overall Study||55
7921807|NCT00600015|19496354|P1|STARTED|Overall Study||111
7921808|NCT00599924|19496369|P7|NOT COMPLETED|Overall Study||5
7921809|NCT00599924|19496370|P6|NOT COMPLETED|Overall Study||4
7921810|NCT00599924|19496371|P5|NOT COMPLETED|Overall Study||6
7921811|NCT00599924|19496372|P4|NOT COMPLETED|Overall Study||8
7921812|NCT00599924|19496373|P3|NOT COMPLETED|Overall Study||2
7921813|NCT00599924|19496374|P2|NOT COMPLETED|Overall Study||5
7921814|NCT00599924|19496375|P1|NOT COMPLETED|Overall Study||3
7921815|NCT00599924|19496369|P7|COMPLETED|Overall Study||3
7921816|NCT00599924|19496370|P6|COMPLETED|Overall Study||2
7921817|NCT00599924|19496371|P5|COMPLETED|Overall Study||3
7921818|NCT00599924|19496372|P4|COMPLETED|Overall Study||4
7921819|NCT00599924|19496373|P3|COMPLETED|Overall Study||3
7921820|NCT00599924|19496374|P2|COMPLETED|Overall Study||4
7921821|NCT00599924|19496375|P1|COMPLETED|Overall Study||1
7921822|NCT00599924|19496369|P7|STARTED|Overall Study||8
7921823|NCT00599924|19496370|P6|STARTED|Overall Study||6
7921824|NCT00599924|19496371|P5|STARTED|Overall Study||9
7921825|NCT00599924|19496372|P4|STARTED|Overall Study||12
7921826|NCT00599924|19496373|P3|STARTED|Overall Study||5
7921827|NCT00599924|19496374|P2|STARTED|Overall Study||9
7921828|NCT00599924|19496375|P1|STARTED|Overall Study||4
7921829|NCT00599872|19496462|P2|NOT COMPLETED|Overall Study||33
7921830|NCT00599872|19496463|P1|NOT COMPLETED|Overall Study||49
7921831|NCT00599872|19496462|P2|COMPLETED|Overall Study||181
7921832|NCT00599872|19496463|P1|COMPLETED|Overall Study||167
7921833|NCT00599872|19496462|P2|STARTED|Overall Study||214
7921834|NCT00599872|19496463|P1|STARTED|Overall Study||216
7921835|NCT00599755|19496479|P1|NOT COMPLETED|Overall Study||19
7921836|NCT00599755|19496479|P1|COMPLETED|Overall Study||49
7921837|NCT00599755|19496479|P1|STARTED|Overall Study||68
7921838|NCT00599521|19496490|P2|NOT COMPLETED|Overall Study||69
7921839|NCT00599521|19496491|P1|NOT COMPLETED|Overall Study||60
7921840|NCT00599521|19496490|P2|COMPLETED|Overall Study||462
7921841|NCT00599521|19496491|P1|COMPLETED|Overall Study||475
7921842|NCT00599521|19496490|P2|STARTED|Overall Study||531
7921843|NCT00599521|19496491|P1|STARTED|Overall Study||535
7921844|NCT00599339|19496505|P1|NOT COMPLETED|Overall Study||664
7921845|NCT00599339|19496505|P1|COMPLETED|Overall Study||1531
7921846|NCT00599339|19496505|P1|Safety Set|Overall Study||2179
7921847|NCT00599339|19496505|P1|STARTED|Overall Study||2195
7921848|NCT00599326|19496607|P1|NOT COMPLETED|Overall Study||2
7921849|NCT00599326|19496607|P1|COMPLETED|Overall Study||8
7921850|NCT00599326|19496607|P1|STARTED|Overall Study||10
7921851|NCT00599313|19496612|P1|NOT COMPLETED|Overall Study||36
7921852|NCT00599313|19496612|P1|COMPLETED|Overall Study||0
7921853|NCT00599313|19496612|P1|STARTED|Overall Study||36
7921854|NCT00599248|19496623|P4|NOT COMPLETED|Overall Study||0
7921855|NCT00599248|19496624|P3|NOT COMPLETED|Overall Study||0
7921856|NCT00599248|19496625|P2|NOT COMPLETED|Overall Study||0
7921857|NCT00599248|19496626|P1|NOT COMPLETED|Overall Study||0
7921858|NCT00599248|19496623|P4|COMPLETED|Overall Study||3
7921859|NCT00599248|19496624|P3|COMPLETED|Overall Study||3
7921860|NCT00599248|19496625|P2|COMPLETED|Overall Study||3
7921861|NCT00599248|19496626|P1|COMPLETED|Overall Study||3
7921862|NCT00599248|19496623|P4|STARTED|Overall Study||3
7921863|NCT00599248|19496624|P3|STARTED|Overall Study||3
7921864|NCT00599248|19496625|P2|STARTED|Overall Study||3
7921865|NCT00599248|19496626|P1|STARTED|Overall Study||3
7921866|NCT00599196|19496654|P1|NOT COMPLETED|Overall Study||381
7921867|NCT00599196|19496654|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
7921868|NCT00599196|19496654|P1|STARTED|Overall Study||381
7921869|NCT00599131|19496660|P1|NOT COMPLETED|Overall Study||0
7921870|NCT00599131|19496660|P1|COMPLETED|Overall Study||4
7921871|NCT00599131|19496660|P1|STARTED|Overall Study||4
7921872|NCT00599053|19496670|P2|NOT COMPLETED|Overall Study||0
7921873|NCT00599053|19496671|P1|NOT COMPLETED|Overall Study||0
7921874|NCT00599053|19496670|P2|COMPLETED|Overall Study||2
7921875|NCT00599053|19496671|P1|COMPLETED|Overall Study||5
7921876|NCT00599053|19496670|P2|STARTED|Overall Study||2
7921877|NCT00599053|19496671|P1|STARTED|Overall Study||5
7921878|NCT00599027|19496685|P2|NOT COMPLETED|Overall Study||3
7921879|NCT00599027|19496686|P1|NOT COMPLETED|Overall Study||1
7921880|NCT00599027|19496685|P2|COMPLETED|Overall Study||22
7921881|NCT00599027|19496686|P1|COMPLETED|Overall Study||25
7921882|NCT00599027|19496685|P2|STARTED|Overall Study||25
7921883|NCT00599027|19496686|P1|STARTED|Overall Study||26
7921884|NCT00599014|19496692|P1|NOT COMPLETED|Overall Study||0
7921885|NCT00599014|19496692|P1|COMPLETED|Overall Study||335
7921886|NCT00599014|19496692|P1|STARTED|Overall Study||335
7921887|NCT00598871|19496699|P2|NOT COMPLETED|Overall Study||1
7921888|NCT00598871|19496700|P1|NOT COMPLETED|Overall Study||0
7921889|NCT00598871|19496699|P2|COMPLETED|Overall Study||8
7921890|NCT00598871|19496700|P1|COMPLETED|Overall Study||3
7921891|NCT00598871|19496699|P2|STARTED|Overall Study||9
7921892|NCT00598871|19496700|P1|STARTED|Overall Study||3
7921893|NCT00598832|19496710|P2|NOT COMPLETED|Overall Study||82
7921894|NCT00598832|19496711|P1|NOT COMPLETED|Overall Study||62
7921895|NCT00598832|19496710|P2|COMPLETED|Overall Study||460
7921896|NCT00598832|19496711|P1|COMPLETED|Overall Study||471
7921897|NCT00598832|19496710|P2|STARTED|Overall Study||542
7921898|NCT00598832|19496711|P1|STARTED|Overall Study||533
7921899|NCT00598819|19496725|P1|NOT COMPLETED|Overall Study||0
7921900|NCT00598819|19496725|P1|COMPLETED|Overall Study||14
7921901|NCT00598819|19496725|P1|STARTED|Overall Study||14
7921902|NCT00598806|19496735|P2|NOT COMPLETED|Overall Study||64
7921903|NCT00598806|19496736|P1|NOT COMPLETED|Overall Study||73
7921904|NCT00598806|19496735|P2|COMPLETED|Overall Study||346
7921905|NCT00598806|19496736|P1|COMPLETED|Overall Study||329
7921906|NCT00598806|19496735|P2|STARTED|Overall Study||410
7921907|NCT00598806|19496736|P1|STARTED|Overall Study||402
7921908|NCT00598702|19496764|P8|NOT COMPLETED|Overall Study||0
7921909|NCT00598702|19496765|P7|NOT COMPLETED|Overall Study||1
7921910|NCT00598702|19496766|P6|NOT COMPLETED|Overall Study||12
7921911|NCT00598702|19496767|P5|NOT COMPLETED|Overall Study||3
7921912|NCT00598702|19496768|P4|NOT COMPLETED|Overall Study||8
7921913|NCT00598702|19496769|P3|NOT COMPLETED|Overall Study||2
7921914|NCT00598702|19496770|P2|NOT COMPLETED|Overall Study||2
7921915|NCT00598702|19496771|P1|NOT COMPLETED|Overall Study||0
7921916|NCT00598702|19496764|P8|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4
7921917|NCT00598702|19496765|P7|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0
7921918|NCT00598702|19496766|P6|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30
7921919|NCT00598702|19496767|P5|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6
7921920|NCT00598702|19496768|P4|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25
7921921|NCT00598702|19496769|P3|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5
7921922|NCT00598702|19496770|P2|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
7921923|NCT00598702|19496771|P1|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
7921924|NCT00598702|19496764|P8|STARTED|Overall Study||4
7921925|NCT00598702|19496765|P7|STARTED|Overall Study||1
7921926|NCT00598702|19496766|P6|STARTED|Overall Study||42
7921927|NCT00598702|19496767|P5|STARTED|Overall Study||9
7921928|NCT00598702|19496768|P4|STARTED|Overall Study||33
7921929|NCT00598702|19496769|P3|STARTED|Overall Study||7
7921930|NCT00598702|19496770|P2|STARTED|Overall Study||3
7921931|NCT00598702|19496771|P1|STARTED|Overall Study||1
7921932|NCT00598689|19496815|P2|NOT COMPLETED|Overall Study||0
7921933|NCT00598689|19496816|P1|NOT COMPLETED|Overall Study||0
7921934|NCT00598689|19496815|P2|COMPLETED|Overall Study||40
7921935|NCT00598689|19496816|P1|COMPLETED|Overall Study||40
7921936|NCT00598689|19496815|P2|STARTED|Overall Study||40
7921937|NCT00598689|19496816|P1|STARTED|Overall Study||40
7921938|NCT00598663|19496828|P2|NOT COMPLETED|Second Intervention (6 Months)||1
7921939|NCT00598663|19496829|P1|NOT COMPLETED|Second Intervention (6 Months)||4
7921940|NCT00598663|19496828|P2|COMPLETED|Second Intervention (6 Months)||69
7921941|NCT00598663|19496829|P1|COMPLETED|Second Intervention (6 Months)||69
7921942|NCT00598663|19496828|P2|STARTED|Second Intervention (6 Months)||70
7921943|NCT00598663|19496829|P1|STARTED|Second Intervention (6 Months)||73
7921944|NCT00598663|19496828|P2|NOT COMPLETED|Washout (4 Months)||1
7921945|NCT00598663|19496829|P1|NOT COMPLETED|Washout (4 Months)||0
7921946|NCT00598663|19496828|P2|COMPLETED|Washout (4 Months)||70
7921947|NCT00598663|19496829|P1|COMPLETED|Washout (4 Months)||73
7921948|NCT00598663|19496828|P2|STARTED|Washout (4 Months)||71
7921949|NCT00598663|19496829|P1|STARTED|Washout (4 Months)||73
7921950|NCT00598663|19496828|P2|NOT COMPLETED|First Intervention (6 Months)||6
7921951|NCT00598663|19496829|P1|NOT COMPLETED|First Intervention (6 Months)||3
7921952|NCT00598663|19496828|P2|COMPLETED|First Intervention (6 Months)||71
7921953|NCT00598663|19496829|P1|COMPLETED|First Intervention (6 Months)||73
7921954|NCT00598663|19496828|P2|STARTED|First Intervention (6 Months)||77
7921955|NCT00598663|19496829|P1|STARTED|First Intervention (6 Months)||76
7921956|NCT00598650|19496847|P1|NOT COMPLETED|Overall Study||27
7921957|NCT00598650|19496847|P1|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81
7921958|NCT00598650|19496847|P1|STARTED|Overall Study||108
7921959|NCT00598585|19496856|P2|NOT COMPLETED|Overall Study||0
7921960|NCT00598585|19496857|P1|NOT COMPLETED|Overall Study||1
7921961|NCT00598585|19496856|P2|COMPLETED|Overall Study||6
7921962|NCT00598585|19496857|P1|COMPLETED|Overall Study||5
7921963|NCT00598585|19496856|P2|STARTED|Overall Study||6
7921964|NCT00598585|19496857|P1|STARTED|Overall Study||6
7921965|NCT00598559|19496866|P3|NOT COMPLETED|Overall Study||3
7921966|NCT00598559|19496867|P2|NOT COMPLETED|Overall Study||28
7921967|NCT00598559|19496868|P1|NOT COMPLETED|Overall Study||27
7921968|NCT00598559|19496866|P3|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27
7921969|NCT00598559|19496867|P2|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63
7921970|NCT00598559|19496868|P1|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65
7921971|NCT00598559|19496866|P3|STARTED|Overall Study||30
7921972|NCT00598559|19496867|P2|STARTED|Overall Study||91
7921973|NCT00598559|19496868|P1|STARTED|Overall Study||92
7921974|NCT00598507|19496885|P1|NOT COMPLETED|Overall Study||0
7921975|NCT00598507|19496885|P1|COMPLETED|Overall Study||35
7921976|NCT00598507|19496885|P1|STARTED|Overall Study||35
7921977|NCT00598481|19496892|P1|NOT COMPLETED|Treatment||1
7921978|NCT00598481|19496892|P1|COMPLETED|Treatment||11
7921979|NCT00598481|19496892|P1|STARTED|Treatment||12
7921980|NCT00598481|19496892|P1|NOT COMPLETED|Baseline||0
7921981|NCT00598481|19496892|P1|COMPLETED|Baseline||12
7921982|NCT00598481|19496892|P1|STARTED|Baseline||12
7921983|NCT00598442|19496902|P3|NOT COMPLETED|Overall Study||24
7921984|NCT00598442|19496903|P2|NOT COMPLETED|Overall Study||39
7921985|NCT00598442|19496904|P1|NOT COMPLETED|Overall Study||43
7921986|NCT00598442|19496902|P3|COMPLETED|Overall Study||139
7921987|NCT00598442|19496903|P2|COMPLETED|Overall Study||124
7921988|NCT00598442|19496904|P1|COMPLETED|Overall Study||124
7921989|NCT00598442|19496902|P3|STARTED|Overall Study||163
7921990|NCT00598442|19496903|P2|STARTED|Overall Study||163
7921991|NCT00598442|19496904|P1|STARTED|Overall Study||167
7921992|NCT00598273|19496921|P3|NOT COMPLETED|Overall Study||39
7921993|NCT00598273|19496922|P2|NOT COMPLETED|Overall Study||38
7921994|NCT00598273|19496923|P1|NOT COMPLETED|Overall Study||41
7921995|NCT00598273|19496921|P3|COMPLETED|Overall Study||125
7921996|NCT00598273|19496922|P2|COMPLETED|Overall Study||127
7921997|NCT00598273|19496923|P1|COMPLETED|Overall Study||120
7921998|NCT00598273|19496921|P3|STARTED|Overall Study||164
7921999|NCT00598273|19496922|P2|STARTED|Overall Study||165
7922000|NCT00598273|19496923|P1|STARTED|Overall Study||161
7922001|NCT00598078|19496937|P2|NOT COMPLETED|Period 3 (Day 3)||0
7922002|NCT00598078|19496938|P1|NOT COMPLETED|Period 3 (Day 3)||0
7922003|NCT00598078|19496937|P2|COMPLETED|Period 3 (Day 3)||10
7922004|NCT00598078|19496938|P1|COMPLETED|Period 3 (Day 3)||9
7922005|NCT00598078|19496937|P2|STARTED|Period 3 (Day 3)||10
7922006|NCT00598078|19496938|P1|STARTED|Period 3 (Day 3)||9
7922007|NCT00598078|19496937|P2|NOT COMPLETED|Period 2 (Day 2)||0
7922008|NCT00598078|19496938|P1|NOT COMPLETED|Period 2 (Day 2)||1
7922009|NCT00598078|19496937|P2|COMPLETED|Period 2 (Day 2)||10
7922010|NCT00598078|19496938|P1|COMPLETED|Period 2 (Day 2)||9
7922011|NCT00598078|19496937|P2|STARTED|Period 2 (Day 2)||10
7922012|NCT00598078|19496938|P1|STARTED|Period 2 (Day 2)||10
7922013|NCT00598078|19496937|P2|NOT COMPLETED|Period 1 (Day 1)||0
7922014|NCT00598078|19496938|P1|NOT COMPLETED|Period 1 (Day 1)||0
7922015|NCT00598078|19496937|P2|COMPLETED|Period 1 (Day 1)||10
7922016|NCT00598078|19496938|P1|COMPLETED|Period 1 (Day 1)||10
7922017|NCT00598078|19496937|P2|STARTED|Period 1 (Day 1)||10
7922018|NCT00598078|19496938|P1|STARTED|Period 1 (Day 1)||10
7922019|NCT00597935|19496950|P4|NOT COMPLETED|6-Months to 24-Months||8
7922020|NCT00597935|19496951|P3|NOT COMPLETED|6-Months to 24-Months||10
7922021|NCT00597935|19496952|P2|NOT COMPLETED|6-Months to 24-Months||8
7922022|NCT00597935|19496953|P1|NOT COMPLETED|6-Months to 24-Months||17
7922023|NCT00597935|19496950|P4|COMPLETED|6-Months to 24-Months||85
7922024|NCT00597935|19496951|P3|COMPLETED|6-Months to 24-Months||77
7922025|NCT00597935|19496952|P2|COMPLETED|6-Months to 24-Months||79
7922026|NCT00597935|19496953|P1|COMPLETED|6-Months to 24-Months||76
7922027|NCT00597935|19496950|P4|STARTED|6-Months to 24-Months||93
7922028|NCT00597935|19496951|P3|STARTED|6-Months to 24-Months||87
7922029|NCT00597935|19496952|P2|STARTED|6-Months to 24-Months||87
7922030|NCT00597935|19496953|P1|STARTED|6-Months to 24-Months||93
7922031|NCT00597935|19496950|P4|NOT COMPLETED|Baseline to 6-Months||4
7922032|NCT00597935|19496951|P3|NOT COMPLETED|Baseline to 6-Months||4
7922033|NCT00597935|19496952|P2|NOT COMPLETED|Baseline to 6-Months||4
7922034|NCT00597935|19496953|P1|NOT COMPLETED|Baseline to 6-Months||2
7922035|NCT00597935|19496950|P4|COMPLETED|Baseline to 6-Months||93
7922036|NCT00597935|19496951|P3|COMPLETED|Baseline to 6-Months||87
7922037|NCT00597935|19496952|P2|COMPLETED|Baseline to 6-Months||87
7922038|NCT00597935|19496953|P1|COMPLETED|Baseline to 6-Months||93
7922039|NCT00597935|19496950|P4|STARTED|Baseline to 6-Months||97
7922040|NCT00597935|19496951|P3|STARTED|Baseline to 6-Months||91
7922041|NCT00597935|19496952|P2|STARTED|Baseline to 6-Months||91
7922042|NCT00597935|19496953|P1|STARTED|Baseline to 6-Months||95
7922043|NCT00597935|19496950|P4|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
7922044|NCT00597935|19496951|P3|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
7922045|NCT00597935|19496952|P2|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
7922046|NCT00597935|19496953|P1|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
7922047|NCT00597935|19496950|P4|COMPLETED|Randomized to Surgical and BPMT Arms||97
7922048|NCT00597935|19496951|P3|COMPLETED|Randomized to Surgical and BPMT Arms||91
7922049|NCT00597935|19496952|P2|COMPLETED|Randomized to Surgical and BPMT Arms||91
7922050|NCT00597935|19496953|P1|COMPLETED|Randomized to Surgical and BPMT Arms||95
7922051|NCT00597935|19496950|P4|STARTED|Randomized to Surgical and BPMT Arms||97
7922052|NCT00597935|19496951|P3|STARTED|Randomized to Surgical and BPMT Arms||91
7922053|NCT00597935|19496952|P2|STARTED|Randomized to Surgical and BPMT Arms||91
7922054|NCT00597935|19496953|P1|STARTED|Randomized to Surgical and BPMT Arms||95
7922055|NCT00597909|19497010|P3|NOT COMPLETED|Overall Study||0
7922056|NCT00597909|19497011|P2|NOT COMPLETED|Overall Study||0
7922057|NCT00597909|19497012|P1|NOT COMPLETED|Overall Study||0
7922058|NCT00597909|19497010|P3|COMPLETED|Overall Study||0
7922059|NCT00597909|19497011|P2|COMPLETED|Overall Study||0
7922060|NCT00597909|19497012|P1|COMPLETED|Overall Study||0
7922061|NCT00597909|19497010|P3|STARTED|Overall Study||0
7922062|NCT00597909|19497011|P2|STARTED|Overall Study||0
7922063|NCT00597909|19497012|P1|STARTED|Overall Study||0
7922064|NCT00597896|19497022|P2|NOT COMPLETED|Overall Study||2
7922065|NCT00597896|19497023|P1|NOT COMPLETED|Overall Study||3
7922066|NCT00597896|19497022|P2|COMPLETED|Overall Study||24
7922067|NCT00597896|19497023|P1|COMPLETED|Overall Study||21
7922068|NCT00597896|19497022|P2|STARTED|Overall Study||26
7922069|NCT00597896|19497023|P1|STARTED|Overall Study||24
7922070|NCT00597818|19497053|P4|NOT COMPLETED|Overall Study||10
7922071|NCT00597818|19497054|P3|NOT COMPLETED|Overall Study||19
7922072|NCT00597818|19497055|P2|NOT COMPLETED|Overall Study||16
7922073|NCT00597818|19497056|P1|NOT COMPLETED|Overall Study||18
7922074|NCT00597818|19497053|P4|COMPLETED|Overall Study||20
7922075|NCT00597818|19497054|P3|COMPLETED|Overall Study||12
7922076|NCT00597818|19497055|P2|COMPLETED|Overall Study||14
7922077|NCT00597818|19497056|P1|COMPLETED|Overall Study||12
7922078|NCT00597818|19497053|P4|STARTED|Overall Study||30
7922079|NCT00597818|19497054|P3|STARTED|Overall Study||31
7922080|NCT00597818|19497055|P2|STARTED|Overall Study||30
7922081|NCT00597818|19497056|P1|STARTED|Overall Study||30
7922082|NCT00597766|19497081|P3|NOT COMPLETED|Follow-up 3, Week 12||0
7922083|NCT00597766|19497082|P2|NOT COMPLETED|Follow-up 3, Week 12||0
7922084|NCT00597766|19497083|P1|NOT COMPLETED|Follow-up 3, Week 12||0
7922085|NCT00597766|19497081|P3|COMPLETED|Follow-up 3, Week 12||9
7922086|NCT00597766|19497082|P2|COMPLETED|Follow-up 3, Week 12||9
7922087|NCT00597766|19497083|P1|COMPLETED|Follow-up 3, Week 12||8
7922088|NCT00597766|19497081|P3|STARTED|Follow-up 3, Week 12||9
7922089|NCT00597766|19497082|P2|STARTED|Follow-up 3, Week 12||9
7922090|NCT00597766|19497083|P1|STARTED|Follow-up 3, Week 12||8
7922091|NCT00597766|19497081|P3|NOT COMPLETED|Follow-up 2, Week 8||1
7922092|NCT00597766|19497082|P2|NOT COMPLETED|Follow-up 2, Week 8||0
7922093|NCT00597766|19497083|P1|NOT COMPLETED|Follow-up 2, Week 8||0
7922094|NCT00597766|19497081|P3|COMPLETED|Follow-up 2, Week 8||9
7922095|NCT00597766|19497082|P2|COMPLETED|Follow-up 2, Week 8||9
7922096|NCT00597766|19497083|P1|COMPLETED|Follow-up 2, Week 8||8
7922097|NCT00597766|19497081|P3|STARTED|Follow-up 2, Week 8||10
7922098|NCT00597766|19497082|P2|STARTED|Follow-up 2, Week 8||9
7922099|NCT00597766|19497083|P1|STARTED|Follow-up 2, Week 8||8
7922100|NCT00597766|19497081|P3|NOT COMPLETED|Follow-up 1, Week 4||0
7922101|NCT00597766|19497082|P2|NOT COMPLETED|Follow-up 1, Week 4||0
7922102|NCT00597766|19497083|P1|NOT COMPLETED|Follow-up 1, Week 4||1
7922103|NCT00597766|19497081|P3|COMPLETED|Follow-up 1, Week 4||10
7922104|NCT00597766|19497082|P2|COMPLETED|Follow-up 1, Week 4||9
7922105|NCT00597766|19497083|P1|COMPLETED|Follow-up 1, Week 4||8
7922106|NCT00597766|19497081|P3|STARTED|Follow-up 1, Week 4||10
7922107|NCT00597766|19497082|P2|STARTED|Follow-up 1, Week 4||9
7922108|NCT00597766|19497083|P1|STARTED|Follow-up 1, Week 4||9
7922109|NCT00597766|19497081|P3|NOT COMPLETED|Enrolled||0
7922110|NCT00597766|19497082|P2|NOT COMPLETED|Enrolled||0
7922111|NCT00597766|19497083|P1|NOT COMPLETED|Enrolled||0
7922112|NCT00597766|19497081|P3|COMPLETED|Enrolled||10
7922113|NCT00597766|19497082|P2|COMPLETED|Enrolled||9
7922114|NCT00597766|19497083|P1|COMPLETED|Enrolled||9
7922115|NCT00597766|19497081|P3|STARTED|Enrolled||10
7922116|NCT00597766|19497082|P2|STARTED|Enrolled||9
7922117|NCT00597766|19497083|P1|STARTED|Enrolled||9
7922118|NCT00597753|19497102|P2|NOT COMPLETED|Overall Study||69
7922119|NCT00597753|19497103|P1|NOT COMPLETED|Overall Study||166
7922120|NCT00597753|19497102|P2|COMPLETED|Overall Study||202
7922121|NCT00597753|19497103|P1|COMPLETED|Overall Study||366
7922122|NCT00597753|19497102|P2|STARTED|Overall Study||271
7922123|NCT00597753|19497103|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532
7922124|NCT00597727|19497117|P5|NOT COMPLETED|Open-label Extended Maintenance Phase||2
7922125|NCT00597727|19497118|P4|NOT COMPLETED|Open-label Extended Maintenance Phase||3
7922126|NCT00597727|19497119|P3|NOT COMPLETED|Open-label Extended Maintenance Phase||6
7922127|NCT00597727|19497120|P2|NOT COMPLETED|Open-label Extended Maintenance Phase||0
7922128|NCT00597727|19497121|P1|NOT COMPLETED|Open-label Extended Maintenance Phase||0
7922129|NCT00597727|19497117|P5|COMPLETED|Open-label Extended Maintenance Phase||1
7922130|NCT00597727|19497118|P4|COMPLETED|Open-label Extended Maintenance Phase||14
7922131|NCT00597727|19497119|P3|COMPLETED|Open-label Extended Maintenance Phase||23
7922132|NCT00597727|19497120|P2|COMPLETED|Open-label Extended Maintenance Phase||0
7922133|NCT00597727|19497121|P1|COMPLETED|Open-label Extended Maintenance Phase||0
7922134|NCT00597727|19497117|P5|STARTED|Open-label Extended Maintenance Phase||3
7922135|NCT00597727|19497118|P4|STARTED|Open-label Extended Maintenance Phase||17
7922136|NCT00597727|19497119|P3|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding.|29
7922137|NCT00597727|19497120|P2|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
7922138|NCT00597727|19497121|P1|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
7922139|NCT00597727|19497117|P5|NOT COMPLETED|12 Month Blinded Phase||1
7922140|NCT00597727|19497118|P4|NOT COMPLETED|12 Month Blinded Phase||10
7922141|NCT00597727|19497119|P3|NOT COMPLETED|12 Month Blinded Phase||0
7922142|NCT00597727|19497120|P2|NOT COMPLETED|12 Month Blinded Phase||0
7922143|NCT00597727|19497121|P1|NOT COMPLETED|12 Month Blinded Phase||0
7922144|NCT00597727|19497117|P5|COMPLETED|12 Month Blinded Phase||3
7922145|NCT00597727|19497118|P4|COMPLETED|12 Month Blinded Phase||17
7922146|NCT00597727|19497119|P3|COMPLETED|12 Month Blinded Phase||0
7922147|NCT00597727|19497120|P2|COMPLETED|12 Month Blinded Phase||15
7922148|NCT00597727|19497121|P1|COMPLETED|12 Month Blinded Phase||14
7922149|NCT00597727|19497117|P5|STARTED|12 Month Blinded Phase||4
7922150|NCT00597727|19497118|P4|STARTED|12 Month Blinded Phase||27
7922151|NCT00597727|19497119|P3|STARTED|12 Month Blinded Phase||0
7922152|NCT00597727|19497120|P2|STARTED|12 Month Blinded Phase||15
7922153|NCT00597727|19497121|P1|STARTED|12 Month Blinded Phase||14
7922154|NCT00597714|19497137|P3|NOT COMPLETED|Overall Study||10
7922155|NCT00597714|19497138|P2|NOT COMPLETED|Overall Study||46
7922156|NCT00597714|19497139|P1|NOT COMPLETED|Overall Study||56
7922157|NCT00597714|19497137|P3|COMPLETED|Overall Study||84
7922158|NCT00597714|19497138|P2|COMPLETED|Overall Study||11
7922159|NCT00597714|19497139|P1|COMPLETED|Overall Study||24
7922160|NCT00597714|19497137|P3|STARTED|Overall Study||94
7922161|NCT00597714|19497138|P2|STARTED|Overall Study||57
7922162|NCT00597714|19497139|P1|STARTED|Overall Study||80
7922163|NCT00597701|19497151|P2|NOT COMPLETED|Overall Study||8
7922164|NCT00597701|19497152|P1|NOT COMPLETED|Overall Study||7
7922165|NCT00597701|19497151|P2|COMPLETED|Overall Study||13
7922166|NCT00597701|19497152|P1|COMPLETED|Overall Study||18
7922167|NCT00597701|19497151|P2|STARTED|Overall Study||21
7922168|NCT00597701|19497152|P1|STARTED|Overall Study||25
7922169|NCT00597675|19497160|P2|NOT COMPLETED|Open Label Phase||0
7922170|NCT00597675|19497161|P1|NOT COMPLETED|Open Label Phase||0
7922171|NCT00597675|19497160|P2|COMPLETED|Open Label Phase||5
7922172|NCT00597675|19497161|P1|COMPLETED|Open Label Phase||2
7922173|NCT00597675|19497160|P2|STARTED|Open Label Phase||5
7922174|NCT00597675|19497161|P1|STARTED|Open Label Phase|Patients previously on placebo were crossed over onto open label peanut OIT|2
7922175|NCT00597675|19497160|P2|NOT COMPLETED|Blinded Phase||1
7922176|NCT00597675|19497161|P1|NOT COMPLETED|Blinded Phase||2
7922177|NCT00597675|19497160|P2|COMPLETED|Blinded Phase||5
7922178|NCT00597675|19497161|P1|COMPLETED|Blinded Phase||2
7922179|NCT00597675|19497160|P2|STARTED|Blinded Phase||6
7922180|NCT00597675|19497161|P1|STARTED|Blinded Phase||4
7922181|NCT00597584|19497174|P2|NOT COMPLETED|Overall Study||63
7922182|NCT00597584|19497175|P1|NOT COMPLETED|Overall Study||128
7922183|NCT00597584|19497174|P2|COMPLETED|Overall Study||211
7922184|NCT00597584|19497175|P1|COMPLETED|Overall Study||421
7922185|NCT00597584|19497174|P2|STARTED|Overall Study||274
7922186|NCT00597584|19497175|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549
7922187|NCT00597558|19497185|P1|NOT COMPLETED|Overall Study||4
7922188|NCT00597558|19497185|P1|COMPLETED|Overall Study||9
7922189|NCT00597558|19497185|P1|STARTED|Overall Study||13
7922190|NCT00597545|19497193|P2|NOT COMPLETED|Overall Study||0
7922191|NCT00597545|19497194|P1|NOT COMPLETED|Overall Study||0
7922192|NCT00597545|19497193|P2|COMPLETED|Overall Study||6
7922193|NCT00597545|19497194|P1|COMPLETED|Overall Study||4
7922194|NCT00597545|19497193|P2|STARTED|Overall Study||6
7922195|NCT00597545|19497194|P1|STARTED|Overall Study||4
7922196|NCT00597519|19497200|P1|NOT COMPLETED|Overall Study||1
7922197|NCT00597519|19497200|P1|COMPLETED|Overall Study||27
7922198|NCT00597519|19497200|P1|STARTED|Overall Study||28
7922199|NCT00597506|19497204|P1|NOT COMPLETED|Overall Study||1
7922200|NCT00597506|19497204|P1|COMPLETED|Overall Study||49
7922201|NCT00597506|19497204|P1|STARTED|Overall Study||50
7922202|NCT00597493|19497209|P1|NOT COMPLETED|Overall Study||0
7922203|NCT00597493|19497209|P1|COMPLETED|Overall Study||32
7922204|NCT00597493|19497209|P1|STARTED|Overall Study||32
7922205|NCT00597428|19497228|P2|NOT COMPLETED|Overall Study||71
7922206|NCT00597428|19497229|P1|NOT COMPLETED|Overall Study||61
7922207|NCT00597428|19497228|P2|COMPLETED|Overall Study||152
7922208|NCT00597428|19497229|P1|COMPLETED|Overall Study||153
7922209|NCT00597428|19497228|P2|STARTED|Overall Study||223
7922210|NCT00597428|19497229|P1|STARTED|Overall Study||214
7922211|NCT00597402|19497245|P1|NOT COMPLETED|Overall Study||0
7922212|NCT00597402|19497245|P1|COMPLETED|Overall Study||125
7922213|NCT00597402|19497245|P1|STARTED|Overall Study||125
7922214|NCT00597376|19497254|P2|NOT COMPLETED|Overall Study||4
7922215|NCT00597376|19497255|P1|NOT COMPLETED|Overall Study||8
7922216|NCT00597376|19497254|P2|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49
7922217|NCT00597376|19497255|P1|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43
7922218|NCT00597376|19497254|P2|STARTED|Overall Study||53
7922219|NCT00597376|19497255|P1|STARTED|Overall Study||51
7922220|NCT00597272|19497272|P7|NOT COMPLETED|Overall Study||0
7922221|NCT00597272|19497273|P6|NOT COMPLETED|Overall Study||0
7922222|NCT00597272|19497274|P5|NOT COMPLETED|Overall Study||0
7922223|NCT00597272|19497275|P4|NOT COMPLETED|Overall Study||0
7922224|NCT00597272|19497276|P3|NOT COMPLETED|Overall Study||0
7922225|NCT00597272|19497277|P2|NOT COMPLETED|Overall Study||0
7922226|NCT00597272|19497278|P1|NOT COMPLETED|Overall Study||0
7922227|NCT00597272|19497272|P7|COMPLETED|Overall Study||10
7922228|NCT00597272|19497273|P6|COMPLETED|Overall Study||10
7922229|NCT00597272|19497274|P5|COMPLETED|Overall Study||1
7922230|NCT00597272|19497275|P4|COMPLETED|Overall Study||1
7922231|NCT00597272|19497276|P3|COMPLETED|Overall Study||10
7922232|NCT00597272|19497277|P2|COMPLETED|Overall Study||1
7922233|NCT00597272|19497278|P1|COMPLETED|Overall Study||1
7922234|NCT00597272|19497272|P7|STARTED|Overall Study||10
7922235|NCT00597272|19497273|P6|STARTED|Overall Study||10
7922236|NCT00597272|19497274|P5|STARTED|Overall Study||1
7922237|NCT00597272|19497275|P4|STARTED|Overall Study||1
7922238|NCT00597272|19497276|P3|STARTED|Overall Study||10
7922239|NCT00597272|19497277|P2|STARTED|Overall Study||1
7922240|NCT00597272|19497278|P1|STARTED|Overall Study||1
7922241|NCT00597246|19497294|P1|NOT COMPLETED|Overall Study||0
7922242|NCT00597246|19497294|P1|COMPLETED|Overall Study||30
7922243|NCT00597246|19497294|P1|STARTED|Overall Study||30
7922244|NCT00597207|19497301|P2|NOT COMPLETED|Overall Study||7
7922245|NCT00597207|19497302|P1|NOT COMPLETED|Overall Study||5
7922246|NCT00597207|19497301|P2|COMPLETED|Overall Study||2125
7922247|NCT00597207|19497302|P1|COMPLETED|Overall Study||2094
7922248|NCT00597207|19497301|P2|STARTED|Overall Study||2132
7922249|NCT00597207|19497302|P1|STARTED|Overall Study||2099
7922250|NCT00597116|19497310|P2|NOT COMPLETED|Overall Study||11
7922251|NCT00597116|19497311|P1|NOT COMPLETED|Overall Study||14
7922252|NCT00597116|19497310|P2|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
7922253|NCT00597116|19497311|P1|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
7922254|NCT00597116|19497310|P2|STARTED|Overall Study||11
7922255|NCT00597116|19497311|P1|STARTED|Overall Study||14
7922256|NCT00597038|19497325|P2|NOT COMPLETED|Overall Study||4
7922257|NCT00597038|19497326|P1|NOT COMPLETED|Overall Study||2
7922345|NCT00596440|19497562|P2|NOT COMPLETED|Overall Study||80
7922258|NCT00597038|19497325|P2|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30
7922259|NCT00597038|19497326|P1|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14
7922260|NCT00597038|19497325|P2|STARTED|Overall Study||34
7922261|NCT00597038|19497326|P1|STARTED|Overall Study||16
7922262|NCT00597012|19497337|P2|NOT COMPLETED|Overall Study||8
7922263|NCT00597012|19497338|P1|NOT COMPLETED|Overall Study||13
7922264|NCT00597012|19497337|P2|COMPLETED|Overall Study||169
7922265|NCT00597012|19497338|P1|COMPLETED|Overall Study||161
7922266|NCT00597012|19497337|P2|STARTED|Overall Study||177
7922267|NCT00597012|19497338|P1|STARTED|Overall Study||174
7922268|NCT00596960|19497354|P2|NOT COMPLETED|Overall Study||9
7922269|NCT00596960|19497355|P1|NOT COMPLETED|Overall Study||11
7922270|NCT00596960|19497354|P2|COMPLETED|Overall Study||60
7922271|NCT00596960|19497355|P1|COMPLETED|Overall Study||59
7922272|NCT00596960|19497354|P2|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69
7922273|NCT00596960|19497355|P1|STARTED|Overall Study||70
7922274|NCT00596947|19497367|P2|NOT COMPLETED|Overall Study||3
7922275|NCT00596947|19497368|P1|NOT COMPLETED|Overall Study||6
7922276|NCT00596947|19497367|P2|COMPLETED|Overall Study||6
7922277|NCT00596947|19497368|P1|COMPLETED|Overall Study||3
7922278|NCT00596947|19497367|P2|STARTED|Overall Study||9
7922279|NCT00596947|19497368|P1|STARTED|Overall Study||9
7922280|NCT00596934|19497408|P1|NOT COMPLETED|Overall Study||2
7922281|NCT00596934|19497408|P1|COMPLETED|Overall Study||7
7922282|NCT00596934|19497408|P1|STARTED|Overall Study||9
7922283|NCT00596830|19497421|P2|NOT COMPLETED|Overall Study||339
7922284|NCT00596830|19497422|P1|NOT COMPLETED|Overall Study||342
7922285|NCT00596830|19497421|P2|COMPLETED|Overall Study||0
7922286|NCT00596830|19497422|P1|COMPLETED|Overall Study||0
7922287|NCT00596830|19497421|P2|Treated|Overall Study||332
7922288|NCT00596830|19497422|P1|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339
7922289|NCT00596830|19497421|P2|STARTED|Overall Study||339
7922290|NCT00596830|19497422|P1|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342
7922291|NCT00596817|19497448|P2|NOT COMPLETED|Double-blind Period||79
7922292|NCT00596817|19497449|P1|NOT COMPLETED|Double-blind Period||88
7922293|NCT00596817|19497448|P2|COMPLETED|Double-blind Period||125
7922294|NCT00596817|19497449|P1|COMPLETED|Double-blind Period||104
7922295|NCT00596817|19497448|P2|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204
7922296|NCT00596817|19497449|P1|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192
7922297|NCT00596817|19497448|P2|NOT COMPLETED|Open-label Period to Double-blind Period||92
7922298|NCT00596817|19497449|P1|NOT COMPLETED|Open-label Period to Double-blind Period||0
7922299|NCT00596817|19497448|P2|COMPLETED|Open-label Period to Double-blind Period||400
7922300|NCT00596817|19497449|P1|COMPLETED|Open-label Period to Double-blind Period||0
7922301|NCT00596817|19497448|P2|STARTED|Open-label Period to Double-blind Period||492
7922302|NCT00596817|19497449|P1|STARTED|Open-label Period to Double-blind Period||0
7922303|NCT00596817|19497448|P2|NOT COMPLETED|Open-label Period||147
7922304|NCT00596817|19497449|P1|NOT COMPLETED|Open-label Period||0
7922305|NCT00596817|19497448|P2|COMPLETED|Open-label Period||492
7922306|NCT00596817|19497449|P1|COMPLETED|Open-label Period||0
7922307|NCT00596817|19497448|P2|STARTED|Open-label Period||639
7922308|NCT00596817|19497449|P1|STARTED|Open-label Period||0
7922309|NCT00596752|19497474|P2|NOT COMPLETED|Overall Study||143
7922310|NCT00596752|19497475|P1|NOT COMPLETED|Overall Study||126
7922311|NCT00596752|19497474|P2|COMPLETED|Overall Study||282
7922312|NCT00596752|19497475|P1|COMPLETED|Overall Study||289
7922313|NCT00596752|19497474|P2|Randomized and Treated|Overall Study||424
7922314|NCT00596752|19497475|P1|Randomized and Treated|Overall Study||415
7922315|NCT00596752|19497474|P2|STARTED|Overall Study||425
7922316|NCT00596752|19497475|P1|STARTED|Overall Study||415
7922317|NCT00596687|19497505|P2|NOT COMPLETED|Overall Study||9
7922318|NCT00596687|19497506|P1|NOT COMPLETED|Overall Study||14
7922319|NCT00596687|19497505|P2|COMPLETED|Overall Study||107
7922320|NCT00596687|19497506|P1|COMPLETED|Overall Study||104
7922321|NCT00596687|19497505|P2|STARTED|Overall Study||116
7922322|NCT00596687|19497506|P1|STARTED|Overall Study||118
7922323|NCT00596635|19497517|P3|NOT COMPLETED|Overall Study||8
7922324|NCT00596635|19497518|P2|NOT COMPLETED|Overall Study||13
7922325|NCT00596635|19497519|P1|NOT COMPLETED|Overall Study||7
7922326|NCT00596635|19497517|P3|COMPLETED|Overall Study||11
7922327|NCT00596635|19497518|P2|COMPLETED|Overall Study||7
7922328|NCT00596635|19497519|P1|COMPLETED|Overall Study||10
7922329|NCT00596635|19497517|P3|STARTED|Overall Study||19
7922330|NCT00596635|19497518|P2|STARTED|Overall Study||20
7922331|NCT00596635|19497519|P1|STARTED|Overall Study||17
7922332|NCT00596622|19497536|P1|NOT COMPLETED|Overall Study||13
7922333|NCT00596622|19497536|P1|COMPLETED|Overall Study||33
7922334|NCT00596622|19497536|P1|STARTED|Overall Study||46
7922335|NCT00596466|19497545|P1|NOT COMPLETED|Overall Study||17
7922336|NCT00596466|19497545|P1|COMPLETED|Overall Study||58
7922337|NCT00596466|19497545|P1|Enrolled, Treated|Overall Study||73
7922338|NCT00596466|19497545|P1|STARTED|Overall Study||75
7922339|NCT00596453|19497553|P2|NOT COMPLETED|Overall Study||3
7922340|NCT00596453|19497554|P1|NOT COMPLETED|Overall Study||1
7922341|NCT00596453|19497553|P2|COMPLETED|Overall Study||12
7922342|NCT00596453|19497554|P1|COMPLETED|Overall Study||12
7922343|NCT00596453|19497553|P2|STARTED|Overall Study||15
7922344|NCT00596453|19497554|P1|STARTED|Overall Study||13
7922346|NCT00596440|19497563|P1|NOT COMPLETED|Overall Study||65
7922347|NCT00596440|19497562|P2|COMPLETED|Overall Study||41
7922348|NCT00596440|19497563|P1|COMPLETED|Overall Study||48
7922349|NCT00596440|19497562|P2|Showed to First Treatment Session|Overall Study||52
7922350|NCT00596440|19497563|P1|Showed to First Treatment Session|Overall Study||61
7922351|NCT00596440|19497562|P2|Showed to Eligibility Visit|Overall Study||72
7922352|NCT00596440|19497563|P1|Showed to Eligibility Visit|Overall Study||85
7922353|NCT00596440|19497562|P2|STARTED|Overall Study||121
7922354|NCT00596440|19497563|P1|STARTED|Overall Study||113
7922355|NCT00596427|19497575|P2|NOT COMPLETED|Overall Study||2
7922356|NCT00596427|19497576|P1|NOT COMPLETED|Overall Study||4
7922357|NCT00596427|19497575|P2|COMPLETED|Overall Study||28
7922358|NCT00596427|19497576|P1|COMPLETED|Overall Study||26
7922359|NCT00596427|19497575|P2|STARTED|Overall Study||30
7922360|NCT00596427|19497576|P1|STARTED|Overall Study||30
7922361|NCT00596362|19497604|P1|NOT COMPLETED|Overall Study||1
7922362|NCT00596362|19497604|P1|COMPLETED|Overall Study||0
7922363|NCT00596362|19497604|P1|STARTED|Overall Study||1
7922364|NCT00596271|19497611|P3|NOT COMPLETED|Overall Study||1
7922365|NCT00596271|19497612|P2|NOT COMPLETED|Overall Study||6
7922366|NCT00596271|19497613|P1|NOT COMPLETED|Overall Study||5
7922367|NCT00596271|19497611|P3|COMPLETED|Overall Study||61
7922368|NCT00596271|19497612|P2|COMPLETED|Overall Study||59
7922369|NCT00596271|19497613|P1|COMPLETED|Overall Study||60
7922370|NCT00596271|19497611|P3|STARTED|Overall Study||62
7922371|NCT00596271|19497612|P2|STARTED|Overall Study||65
7922372|NCT00596271|19497613|P1|STARTED|Overall Study||65
7922373|NCT00596167|19497622|P1|NOT COMPLETED|Overall Study||0
7922374|NCT00596167|19497622|P1|COMPLETED|Overall Study||6
7922375|NCT00596167|19497622|P1|STARTED|Overall Study|All recruited subjects completed the study.|6
7922376|NCT00596102|19497629|P3|NOT COMPLETED|Up to Month 60||637
7922377|NCT00596102|19497630|P2|NOT COMPLETED|Up to Month 60||338
7922378|NCT00596102|19497631|P1|NOT COMPLETED|Up to Month 60||2181
7922379|NCT00596102|19497629|P3|COMPLETED|Up to Month 60||0
7922380|NCT00596102|19497630|P2|COMPLETED|Up to Month 60||0
7922381|NCT00596102|19497631|P1|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102
7922382|NCT00596102|19497629|P3|STARTED|Up to Month 60||637
7922383|NCT00596102|19497630|P2|STARTED|Up to Month 60||338
7922384|NCT00596102|19497631|P1|STARTED|Up to Month 60||2283
7922385|NCT00596102|19497629|P3|NOT COMPLETED|Up to Month 6||0
7922386|NCT00596102|19497630|P2|NOT COMPLETED|Up to Month 6||0
7922387|NCT00596102|19497631|P1|NOT COMPLETED|Up to Month 6||0
7922388|NCT00596102|19497629|P3|COMPLETED|Up to Month 6||637
7922389|NCT00596102|19497630|P2|COMPLETED|Up to Month 6||338
7922390|NCT00596102|19497631|P1|COMPLETED|Up to Month 6||2283
7922391|NCT00596102|19497629|P3|STARTED|Up to Month 6||637
7922392|NCT00596102|19497630|P2|STARTED|Up to Month 6||338
7922393|NCT00596102|19497631|P1|STARTED|Up to Month 6||2283
7922394|NCT00596011|19497640|P2|NOT COMPLETED|Overall Study||10
7922395|NCT00596011|19497641|P1|NOT COMPLETED|Overall Study||13
7922396|NCT00596011|19497640|P2|COMPLETED|Overall Study||38
7922397|NCT00596011|19497641|P1|COMPLETED|Overall Study||36
7922398|NCT00596011|19497640|P2|STARTED|Overall Study||48
7922399|NCT00596011|19497641|P1|STARTED|Overall Study||49
7922400|NCT00595959|19497657|P1|NOT COMPLETED|Overall Study||2
7922401|NCT00595959|19497657|P1|COMPLETED|Overall Study||63
7922402|NCT00595959|19497657|P1|STARTED|Overall Study||65
7922403|NCT00595946|19497674|P2|NOT COMPLETED|Overall Study||69
7922404|NCT00595946|19497675|P1|NOT COMPLETED|Overall Study||64
7922405|NCT00595946|19497674|P2|COMPLETED|Overall Study||152
7922406|NCT00595946|19497675|P1|COMPLETED|Overall Study||154
7922407|NCT00595946|19497674|P2|STARTED|Overall Study||221
7922408|NCT00595946|19497675|P1|STARTED|Overall Study||218
7922409|NCT00595920|19497691|P1|NOT COMPLETED|Overall Study||116
7922410|NCT00595920|19497691|P1|COMPLETED|Overall Study||0
7922411|NCT00595920|19497691|P1|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38
7922412|NCT00595920|19497691|P1|STARTED|Overall Study||116
7922413|NCT00595881|19497695|P1|NOT COMPLETED|Overall Study||0
7922414|NCT00595881|19497695|P1|COMPLETED|Overall Study||420
7922415|NCT00595881|19497695|P1|STARTED|Overall Study||420
7922416|NCT00595868|19497702|P2|NOT COMPLETED|Overall Study||50
7922417|NCT00595868|19497703|P1|NOT COMPLETED|Overall Study||45
7922418|NCT00595868|19497702|P2|COMPLETED|Overall Study||61
7922419|NCT00595868|19497703|P1|COMPLETED|Overall Study||62
7922420|NCT00595868|19497702|P2|STARTED|Overall Study||111
7922421|NCT00595868|19497703|P1|STARTED|Overall Study||107
7922422|NCT00595790|19497714|P3|NOT COMPLETED|Overall Study||3
7922423|NCT00595790|19497715|P2|NOT COMPLETED|Overall Study||1
7922424|NCT00595790|19497716|P1|NOT COMPLETED|Overall Study||2
7922425|NCT00595790|19497714|P3|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122
7922426|NCT00595790|19497715|P2|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
7922427|NCT00595790|19497716|P1|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
7922428|NCT00595790|19497714|P3|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125
7922429|NCT00595790|19497715|P2|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124
7922430|NCT00595790|19497716|P1|STARTED|Overall Study||125
7922431|NCT00595764|19497726|P2|NOT COMPLETED|Overall Study||43
7922432|NCT00595764|19497727|P1|NOT COMPLETED|Overall Study||39
7922433|NCT00595764|19497726|P2|COMPLETED|Overall Study||27
7922434|NCT00595764|19497727|P1|COMPLETED|Overall Study||32
7922435|NCT00595764|19497726|P2|STARTED|Overall Study||70
7922436|NCT00595764|19497727|P1|STARTED|Overall Study||71
7922437|NCT00595621|19497743|P2|NOT COMPLETED|Randomization and Study||1
7922438|NCT00595621|19497744|P1|NOT COMPLETED|Randomization and Study||2
7922439|NCT00595621|19497743|P2|COMPLETED|Randomization and Study||8
7922440|NCT00595621|19497744|P1|COMPLETED|Randomization and Study||8
7922441|NCT00595621|19497743|P2|STARTED|Randomization and Study||9
7922442|NCT00595621|19497744|P1|STARTED|Randomization and Study||10
7922443|NCT00595621|19497743|P2|NOT COMPLETED|Open Label Run in||0
7922444|NCT00595621|19497744|P1|NOT COMPLETED|Open Label Run in||3
7922445|NCT00595621|19497743|P2|COMPLETED|Open Label Run in||0
7922446|NCT00595621|19497744|P1|COMPLETED|Open Label Run in||19
7922447|NCT00595621|19497743|P2|STARTED|Open Label Run in||0
7922448|NCT00595621|19497744|P1|STARTED|Open Label Run in||22
7922449|NCT00595582|19497761|P1|NOT COMPLETED|Overall Study||10
7922450|NCT00595582|19497761|P1|COMPLETED|Overall Study||0
7922451|NCT00595582|19497761|P1|STARTED|Overall Study||10
7922452|NCT00595556|19497767|P2|NOT COMPLETED|Overall Study||1
7922453|NCT00595556|19497768|P1|NOT COMPLETED|Overall Study||3
7922454|NCT00595556|19497767|P2|COMPLETED|Overall Study||19
7922455|NCT00595556|19497768|P1|COMPLETED|Overall Study||17
7922456|NCT00595556|19497767|P2|STARTED|Overall Study||20
7922457|NCT00595556|19497768|P1|STARTED|Overall Study||20
7922458|NCT00595530|19497782|P1|NOT COMPLETED|Overall Study||0
7922459|NCT00595530|19497782|P1|COMPLETED|Overall Study||3
7922460|NCT00595530|19497782|P1|STARTED|Overall Study||3
7922461|NCT00595517|19497787|P1|NOT COMPLETED|Overall Study||19
7922462|NCT00595517|19497787|P1|COMPLETED|Overall Study||111
7922463|NCT00595517|19497787|P1|STARTED|Overall Study||130
7922464|NCT00595504|19497796|P2|NOT COMPLETED|Overall Study||3
7922465|NCT00595504|19497797|P1|NOT COMPLETED|Overall Study||2
7922466|NCT00595504|19497796|P2|COMPLETED|Overall Study||6
7922467|NCT00595504|19497797|P1|COMPLETED|Overall Study||14
7922468|NCT00595504|19497796|P2|STARTED|Overall Study||9
7922469|NCT00595504|19497797|P1|STARTED|Overall Study||16
7922470|NCT00595478|19497809|P2|NOT COMPLETED|36-week Follow-up Period||8
7922471|NCT00595478|19497810|P1|NOT COMPLETED|36-week Follow-up Period||9
7922472|NCT00595478|19497809|P2|COMPLETED|36-week Follow-up Period||30
7922473|NCT00595478|19497810|P1|COMPLETED|36-week Follow-up Period||28
7922474|NCT00595478|19497809|P2|STARTED|36-week Follow-up Period||38
7922475|NCT00595478|19497810|P1|STARTED|36-week Follow-up Period||37
7922476|NCT00595478|19497809|P2|NOT COMPLETED|Treatment||0
7922477|NCT00595478|19497810|P1|NOT COMPLETED|Treatment||0
7922478|NCT00595478|19497809|P2|COMPLETED|Treatment||38
7922479|NCT00595478|19497810|P1|COMPLETED|Treatment||37
7922480|NCT00595478|19497809|P2|STARTED|Treatment||38
7922481|NCT00595478|19497810|P1|STARTED|Treatment||37
7922482|NCT00595465|19497821|P3|NOT COMPLETED|Overall Study||7
7922483|NCT00595465|19497822|P2|NOT COMPLETED|Overall Study||4
7922484|NCT00595465|19497823|P1|NOT COMPLETED|Overall Study||6
7922485|NCT00595465|19497821|P3|COMPLETED|Overall Study||121
7922486|NCT00595465|19497822|P2|COMPLETED|Overall Study||125
7922487|NCT00595465|19497823|P1|COMPLETED|Overall Study||124
7922488|NCT00595465|19497821|P3|STARTED|Overall Study||128
7922489|NCT00595465|19497822|P2|STARTED|Overall Study||129
7922490|NCT00595465|19497823|P1|STARTED|Overall Study||130
7922491|NCT00595413|19497835|P4|NOT COMPLETED|Overall Study||4
7922492|NCT00595413|19497836|P3|NOT COMPLETED|Overall Study||8
7922493|NCT00595413|19497837|P2|NOT COMPLETED|Overall Study||5
7922494|NCT00595413|19497838|P1|NOT COMPLETED|Overall Study||7
7922495|NCT00595413|19497835|P4|COMPLETED|Overall Study||75
7922496|NCT00595413|19497836|P3|COMPLETED|Overall Study||70
7922497|NCT00595413|19497837|P2|COMPLETED|Overall Study||73
7922498|NCT00595413|19497838|P1|COMPLETED|Overall Study||69
7922499|NCT00595413|19497835|P4|STARTED|Overall Study||79
7922500|NCT00595413|19497836|P3|STARTED|Overall Study||78
7922501|NCT00595413|19497837|P2|STARTED|Overall Study||78
7922502|NCT00595413|19497838|P1|STARTED|Overall Study||76
7922503|NCT00595361|19497866|P2|NOT COMPLETED|Overall Study||0
7922504|NCT00595361|19497867|P1|NOT COMPLETED|Overall Study||0
7922505|NCT00595361|19497866|P2|COMPLETED|Overall Study||18
7922506|NCT00595361|19497867|P1|COMPLETED|Overall Study||12
7922507|NCT00595361|19497866|P2|STARTED|Overall Study||18
7922508|NCT00595361|19497867|P1|STARTED|Overall Study||12
7922509|NCT00595335|19497879|P2|NOT COMPLETED|Six Months to Twelve Months||1
7922510|NCT00595335|19497880|P1|NOT COMPLETED|Six Months to Twelve Months||1
7922511|NCT00595335|19497879|P2|COMPLETED|Six Months to Twelve Months||9
7922512|NCT00595335|19497880|P1|COMPLETED|Six Months to Twelve Months||10
7922513|NCT00595335|19497879|P2|STARTED|Six Months to Twelve Months||10
7922514|NCT00595335|19497880|P1|STARTED|Six Months to Twelve Months||11
7922515|NCT00595335|19497879|P2|NOT COMPLETED|Baseline to Six Months||2
7922516|NCT00595335|19497880|P1|NOT COMPLETED|Baseline to Six Months||2
7922517|NCT00595335|19497879|P2|COMPLETED|Baseline to Six Months||10
7922518|NCT00595335|19497880|P1|COMPLETED|Baseline to Six Months||11
7922519|NCT00595335|19497879|P2|STARTED|Baseline to Six Months||12
7922520|NCT00595335|19497880|P1|STARTED|Baseline to Six Months||13
7922521|NCT00595309|19497900|P1|NOT COMPLETED|Overall Study||4
7922522|NCT00595309|19497900|P1|COMPLETED|Overall Study||194
7922523|NCT00595309|19497900|P1|STARTED|Overall Study||198
7922524|NCT00595270|19497907|P3|NOT COMPLETED|Overall Study||8
7922525|NCT00595270|19497908|P2|NOT COMPLETED|Overall Study||10
7922526|NCT00595270|19497909|P1|NOT COMPLETED|Overall Study||6
7922527|NCT00595270|19497907|P3|COMPLETED|Overall Study||108
7922528|NCT00595270|19497908|P2|COMPLETED|Overall Study||107
7922529|NCT00595270|19497909|P1|COMPLETED|Overall Study||110
7922530|NCT00595270|19497907|P3|STARTED|Overall Study||116
7922531|NCT00595270|19497908|P2|STARTED|Overall Study||117
7922532|NCT00595270|19497909|P1|STARTED|Overall Study||116
7922533|NCT00595231|19497919|P2|NOT COMPLETED|Overall Study||5
7922534|NCT00595231|19497920|P1|NOT COMPLETED|Overall Study||5
7922535|NCT00595231|19497919|P2|COMPLETED|Overall Study||114
7922536|NCT00595231|19497920|P1|COMPLETED|Overall Study||115
7922537|NCT00595231|19497919|P2|STARTED|Overall Study||119
7922538|NCT00595231|19497920|P1|STARTED|Overall Study||120
7922539|NCT00595153|19497939|P3|NOT COMPLETED|Overall Study||25
7922540|NCT00595153|19497940|P2|NOT COMPLETED|Overall Study||16
7922541|NCT00595153|19497941|P1|NOT COMPLETED|Overall Study||4
7922542|NCT00595153|19497939|P3|COMPLETED|Overall Study||36
7922543|NCT00595153|19497940|P2|COMPLETED|Overall Study||26
7922544|NCT00595153|19497941|P1|COMPLETED|Overall Study||20
7922545|NCT00595153|19497939|P3|STARTED|Overall Study||61
7922546|NCT00595153|19497940|P2|STARTED|Overall Study||42
7922547|NCT00595153|19497941|P1|STARTED|Overall Study||24
7922548|NCT00595127|19497949|P1|NOT COMPLETED|Overall Study||10
7922549|NCT00595127|19497949|P1|COMPLETED|Overall Study||11
7922550|NCT00595127|19497949|P1|STARTED|Overall Study||21
7922551|NCT00595114|19497955|P2|NOT COMPLETED|Overall Study||0
7922552|NCT00595114|19497956|P1|NOT COMPLETED|Overall Study||0
7922553|NCT00595114|19497955|P2|COMPLETED|Overall Study||19
7922554|NCT00595114|19497956|P1|COMPLETED|Overall Study||24
7922555|NCT00595114|19497955|P2|STARTED|Overall Study||19
7922556|NCT00595114|19497956|P1|STARTED|Overall Study||24
7922557|NCT00595101|19497966|P4|NOT COMPLETED|Overall Study||0
7922558|NCT00595101|19497967|P3|NOT COMPLETED|Overall Study||0
7922559|NCT00595101|19497968|P2|NOT COMPLETED|Overall Study||1
7922560|NCT00595101|19497969|P1|NOT COMPLETED|Overall Study||0
7922561|NCT00595101|19497966|P4|COMPLETED|Overall Study||30
7922562|NCT00595101|19497967|P3|COMPLETED|Overall Study||29
7922563|NCT00595101|19497968|P2|COMPLETED|Overall Study||28
7922564|NCT00595101|19497969|P1|COMPLETED|Overall Study||29
7922565|NCT00595101|19497966|P4|STARTED|Overall Study||30
7922566|NCT00595101|19497967|P3|STARTED|Overall Study||29
7922567|NCT00595101|19497968|P2|STARTED|Overall Study||29
7922568|NCT00595101|19497969|P1|STARTED|Overall Study||29
7922569|NCT00595088|19497987|P1|NOT COMPLETED|Overall Study||40
7922570|NCT00595088|19497987|P1|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7
7922571|NCT00595088|19497987|P1|STARTED|Overall Study||47
7922572|NCT00595075|19497995|P2|NOT COMPLETED|Overall Study||0
7922573|NCT00595075|19497996|P1|NOT COMPLETED|Overall Study||1
7922574|NCT00595075|19497995|P2|COMPLETED|Overall Study||5
7922575|NCT00595075|19497996|P1|COMPLETED|Overall Study||5
7922576|NCT00595075|19497995|P2|STARTED|Overall Study||5
7922577|NCT00595075|19497996|P1|STARTED|Overall Study||6
7922578|NCT00594958|19498017|P3|NOT COMPLETED|Overall Study||10
7922579|NCT00594958|19498018|P2|NOT COMPLETED|Overall Study||3
7922580|NCT00594958|19498019|P1|NOT COMPLETED|Overall Study||14
7922581|NCT00594958|19498017|P3|COMPLETED|Overall Study||202
7922582|NCT00594958|19498018|P2|COMPLETED|Overall Study||210
7922583|NCT00594958|19498019|P1|COMPLETED|Overall Study||200
7922584|NCT00594958|19498017|P3|Randomized and at Least 1 Vaccination|Overall Study||211
7922585|NCT00594958|19498018|P2|Randomized and at Least 1 Vaccination|Overall Study||213
7922586|NCT00594958|19498019|P1|Randomized and at Least 1 Vaccination|Overall Study||212
7922587|NCT00594958|19498017|P3|STARTED|Overall Study||212
7922588|NCT00594958|19498018|P2|STARTED|Overall Study||213
7922589|NCT00594958|19498019|P1|STARTED|Overall Study||214
7922590|NCT00594945|19498030|P3|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
7922591|NCT00594945|19498031|P2|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
7922592|NCT00594945|19498032|P1|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
7922593|NCT00594945|19498030|P3|COMPLETED|Cohort 2 / Treatment Period 2||2
7922594|NCT00594945|19498031|P2|COMPLETED|Cohort 2 / Treatment Period 2||3
7922595|NCT00594945|19498032|P1|COMPLETED|Cohort 2 / Treatment Period 2||0
7922596|NCT00594945|19498030|P3|STARTED|Cohort 2 / Treatment Period 2||2
7922597|NCT00594945|19498031|P2|STARTED|Cohort 2 / Treatment Period 2||3
7922598|NCT00594945|19498032|P1|STARTED|Cohort 2 / Treatment Period 2||0
7922599|NCT00594945|19498030|P3|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
7922600|NCT00594945|19498031|P2|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
7922601|NCT00594945|19498032|P1|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
7922602|NCT00594945|19498030|P3|COMPLETED|Cohort 1 / Treatment Period 1||2
7922603|NCT00594945|19498031|P2|COMPLETED|Cohort 1 / Treatment Period 1||0
7922604|NCT00594945|19498032|P1|COMPLETED|Cohort 1 / Treatment Period 1||4
7922605|NCT00594945|19498030|P3|STARTED|Cohort 1 / Treatment Period 1||2
7922606|NCT00594945|19498031|P2|STARTED|Cohort 1 / Treatment Period 1||0
7922607|NCT00594945|19498032|P1|STARTED|Cohort 1 / Treatment Period 1||4
7922608|NCT00594932|19498040|P2|NOT COMPLETED|Final 3 Months||3
7922609|NCT00594932|19498041|P1|NOT COMPLETED|Final 3 Months||4
7922610|NCT00594932|19498040|P2|COMPLETED|Final 3 Months||8
7922611|NCT00594932|19498041|P1|COMPLETED|Final 3 Months||8
7922612|NCT00594932|19498040|P2|STARTED|Final 3 Months||11
7922613|NCT00594932|19498041|P1|STARTED|Final 3 Months||12
7922614|NCT00594932|19498040|P2|NOT COMPLETED|First 3 Months||3
7922615|NCT00594932|19498041|P1|NOT COMPLETED|First 3 Months||1
7922616|NCT00594932|19498040|P2|COMPLETED|First 3 Months||11
7922617|NCT00594932|19498041|P1|COMPLETED|First 3 Months||12
7922618|NCT00594932|19498040|P2|STARTED|First 3 Months||14
7922619|NCT00594932|19498041|P1|STARTED|First 3 Months||13
7922620|NCT00594906|19498053|P2|NOT COMPLETED|Overall Study||2
7922621|NCT00594906|19498054|P1|NOT COMPLETED|Overall Study||1
7922622|NCT00594906|19498053|P2|COMPLETED|Overall Study||1
7922623|NCT00594906|19498054|P1|COMPLETED|Overall Study||6
7922624|NCT00594906|19498053|P2|STARTED|Overall Study||3
7922625|NCT00594906|19498054|P1|STARTED|Overall Study||7
7922626|NCT00594880|19498062|P2|NOT COMPLETED|Overall Study||1
7922627|NCT00594880|19498063|P1|NOT COMPLETED|Overall Study||2
7922628|NCT00594880|19498062|P2|COMPLETED|Overall Study||10
7922629|NCT00594880|19498063|P1|COMPLETED|Overall Study||10
7922630|NCT00594880|19498062|P2|STARTED|Overall Study||11
7922631|NCT00594880|19498063|P1|STARTED|Overall Study||12
7922632|NCT00594854|19498075|P2|NOT COMPLETED|Overall Study||10
7922633|NCT00594854|19498076|P1|NOT COMPLETED|Overall Study||7
7922634|NCT00594854|19498075|P2|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1
7922635|NCT00594854|19498076|P1|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2
7922636|NCT00594854|19498075|P2|STARTED|Overall Study||11
7922637|NCT00594854|19498076|P1|STARTED|Overall Study||9
7922638|NCT00594815|19498086|P1|NOT COMPLETED|Overall Study||9
7922639|NCT00594815|19498086|P1|COMPLETED|Overall Study||43
7922640|NCT00594815|19498086|P1|STARTED|Overall Study||52
7922641|NCT00594685|19498091|P1|NOT COMPLETED|Overall Study||0
7922642|NCT00594685|19498091|P1|COMPLETED|Overall Study||10
7922643|NCT00594685|19498091|P1|STARTED|Overall Study||10
7922644|NCT00594659|19498111|P3|NOT COMPLETED|Overall Study||7
7922645|NCT00594659|19498112|P2|NOT COMPLETED|Overall Study||9
7922646|NCT00594659|19498113|P1|NOT COMPLETED|Overall Study||13
7922647|NCT00594659|19498111|P3|COMPLETED|Overall Study||9
7922648|NCT00594659|19498112|P2|COMPLETED|Overall Study||21
7922649|NCT00594659|19498113|P1|COMPLETED|Overall Study||16
7922650|NCT00594659|19498111|P3|STARTED|Overall Study||16
7922651|NCT00594659|19498112|P2|STARTED|Overall Study||30
7922652|NCT00594659|19498113|P1|STARTED|Overall Study||29
7922653|NCT00594646|19498124|P1|NOT COMPLETED|Overall Study||16
7922654|NCT00594646|19498124|P1|COMPLETED|Overall Study||84
7922655|NCT00594646|19498124|P1|STARTED|Overall Study||100
7922656|NCT00594568|19498132|P3|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42
7922657|NCT00594568|19498133|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55
7922658|NCT00594568|19498134|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61
7922659|NCT00594568|19498132|P3|COMPLETED|Safety Follow Up (SFU)-Optional||172
7922660|NCT00594568|19498133|P2|COMPLETED|Safety Follow Up (SFU)-Optional||168
7922661|NCT00594568|19498134|P1|COMPLETED|Safety Follow Up (SFU)-Optional||229
7922662|NCT00594568|19498132|P3|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214
7922663|NCT00594568|19498133|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223
7922664|NCT00594568|19498134|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290
7922665|NCT00594568|19498132|P3|NOT COMPLETED|Delayed Start||66
7922666|NCT00594568|19498133|P2|NOT COMPLETED|Delayed Start||77
7922667|NCT00594568|19498134|P1|NOT COMPLETED|Delayed Start||98
7922668|NCT00594568|19498132|P3|COMPLETED|Delayed Start||55
7922669|NCT00594568|19498133|P2|COMPLETED|Delayed Start||76
7922670|NCT00594568|19498134|P1|COMPLETED|Delayed Start||91
7922671|NCT00594568|19498132|P3|STARTED|Delayed Start||121
7922672|NCT00594568|19498133|P2|STARTED|Delayed Start||153
7922673|NCT00594568|19498134|P1|STARTED|Delayed Start||189
7922674|NCT00594568|19498132|P3|NOT COMPLETED|Initial Treatment||408
7922675|NCT00594568|19498133|P2|NOT COMPLETED|Initial Treatment||354
7922676|NCT00594568|19498134|P1|NOT COMPLETED|Initial Treatment||312
7922677|NCT00594568|19498132|P3|COMPLETED|Initial Treatment||121
7922678|NCT00594568|19498133|P2|COMPLETED|Initial Treatment||153
7922679|NCT00594568|19498134|P1|COMPLETED|Initial Treatment||189
7922680|NCT00594568|19498132|P3|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527
7922681|NCT00594568|19498133|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506
7922682|NCT00594568|19498134|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501
7922683|NCT00594568|19498132|P3|STARTED|Initial Treatment||529
7922684|NCT00594568|19498133|P2|STARTED|Initial Treatment||507
7922685|NCT00594568|19498134|P1|STARTED|Initial Treatment||501
7922686|NCT00594516|19498222|P3|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8
7922687|NCT00594516|19498223|P2|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7
7922688|NCT00594516|19498224|P1|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
7922689|NCT00594516|19498222|P3|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35
7922690|NCT00594516|19498223|P2|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37
7922691|NCT00594516|19498224|P1|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
7922692|NCT00594516|19498222|P3|STARTED|DB: Tapentadol IR to ER & ER to IR||43
7922693|NCT00594516|19498223|P2|STARTED|DB: Tapentadol IR to ER & ER to IR||44
7922694|NCT00594516|19498224|P1|STARTED|DB: Tapentadol IR to ER & ER to IR||0
7922695|NCT00594516|19498222|P3|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
7922696|NCT00594516|19498223|P2|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
7922697|NCT00594516|19498224|P1|NOT COMPLETED|Open Label (OL): Tapentadol IR||29
7922698|NCT00594516|19498222|P3|COMPLETED|Open Label (OL): Tapentadol IR||0
7922699|NCT00594516|19498223|P2|COMPLETED|Open Label (OL): Tapentadol IR||0
7922700|NCT00594516|19498224|P1|COMPLETED|Open Label (OL): Tapentadol IR||87
7922701|NCT00594516|19498222|P3|STARTED|Open Label (OL): Tapentadol IR||0
7922702|NCT00594516|19498223|P2|STARTED|Open Label (OL): Tapentadol IR||0
7922703|NCT00594516|19498224|P1|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116
7922704|NCT00594464|19498232|P1|NOT COMPLETED|Overall Study||3
7922705|NCT00594464|19498232|P1|COMPLETED|Overall Study||11
7922706|NCT00594464|19498232|P1|STARTED|Overall Study||14
7922707|NCT00594425|19498247|P3|NOT COMPLETED|Overall Study||10
7922708|NCT00594425|19498248|P2|NOT COMPLETED|Overall Study||14
7922709|NCT00594425|19498249|P1|NOT COMPLETED|Overall Study||7
7922710|NCT00594425|19498247|P3|COMPLETED|Overall Study||42
7922711|NCT00594425|19498248|P2|COMPLETED|Overall Study||34
7922712|NCT00594425|19498249|P1|COMPLETED|Overall Study||43
7922713|NCT00594425|19498247|P3|STARTED|Overall Study||52
7922714|NCT00594425|19498248|P2|STARTED|Overall Study||48
7922715|NCT00594425|19498249|P1|STARTED|Overall Study||50
7922716|NCT00594399|19498361|P3|NOT COMPLETED|Rerandomization Arm 1 Only||0
7922717|NCT00594399|19498362|P2|NOT COMPLETED|Rerandomization Arm 1 Only||4
7922718|NCT00594399|19498363|P1|NOT COMPLETED|Rerandomization Arm 1 Only||2
7922719|NCT00594399|19498361|P3|COMPLETED|Rerandomization Arm 1 Only||82
7922720|NCT00594399|19498362|P2|COMPLETED|Rerandomization Arm 1 Only||114
7922721|NCT00594399|19498363|P1|COMPLETED|Rerandomization Arm 1 Only||79
7922722|NCT00594399|19498361|P3|Rerandomization|Rerandomization Arm 1 Only||82
7922723|NCT00594399|19498362|P2|Rerandomization|Rerandomization Arm 1 Only||114
7922724|NCT00594399|19498363|P1|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81
7922725|NCT00594399|19498361|P3|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82
7922726|NCT00594399|19498362|P2|STARTED|Rerandomization Arm 1 Only||118
7922727|NCT00594399|19498363|P1|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81
7922728|NCT00594399|19498361|P3|NOT COMPLETED|Initial 3 Month Counseling||0
7922729|NCT00594399|19498362|P2|NOT COMPLETED|Initial 3 Month Counseling||4
7922730|NCT00594399|19498363|P1|NOT COMPLETED|Initial 3 Month Counseling||17
7922731|NCT00594399|19498361|P3|COMPLETED|Initial 3 Month Counseling||0
7922732|NCT00594399|19498362|P2|COMPLETED|Initial 3 Month Counseling||118
7922733|NCT00594399|19498363|P1|COMPLETED|Initial 3 Month Counseling||163
7922734|NCT00594399|19498361|P3|STARTED|Initial 3 Month Counseling||0
7922735|NCT00594399|19498362|P2|STARTED|Initial 3 Month Counseling||122
7922736|NCT00594399|19498363|P1|STARTED|Initial 3 Month Counseling||180
7922737|NCT00594386|19498385|P1|NOT COMPLETED|Overall Study||258
7922738|NCT00594386|19498385|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
7922739|NCT00594386|19498385|P1|STARTED|Overall Study||258
7922740|NCT00594308|19498391|P1|NOT COMPLETED|Overall Study||0
7922741|NCT00594308|19498391|P1|COMPLETED|Overall Study||10
7922742|NCT00594308|19498391|P1|STARTED|Overall Study||10
7922743|NCT00594256|19498399|P1|NOT COMPLETED|Overall Study||0
7922744|NCT00594256|19498399|P1|COMPLETED|Overall Study||8
7922745|NCT00594256|19498399|P1|STARTED|Overall Study||8
7922746|NCT00594230|19498409|P2|NOT COMPLETED|Overall Study||9
7922747|NCT00594230|19498410|P1|NOT COMPLETED|Overall Study||15
7922748|NCT00594230|19498409|P2|COMPLETED|Overall Study||1
7922749|NCT00594230|19498410|P1|COMPLETED|Overall Study||1
7922750|NCT00594230|19498409|P2|STARTED|Overall Study||10
7922751|NCT00594230|19498410|P1|STARTED|Overall Study||16
7922752|NCT00594204|19498418|P2|NOT COMPLETED|Overall Study||45
7922753|NCT00594204|19498419|P1|NOT COMPLETED|Overall Study||58
7922754|NCT00594204|19498418|P2|COMPLETED|Overall Study||154
7922755|NCT00594204|19498419|P1|COMPLETED|Overall Study||336
7922756|NCT00594204|19498418|P2|Received Treatment|Overall Study||198
7922757|NCT00594204|19498419|P1|Received Treatment|Overall Study||390
7922758|NCT00594204|19498418|P2|STARTED|Overall Study||199
7922759|NCT00594204|19498419|P1|STARTED|Overall Study||394
7922760|NCT00594178|19498429|P1|NOT COMPLETED|Overall Study||5
7922761|NCT00594178|19498429|P1|COMPLETED|Overall Study||12
7922762|NCT00594178|19498429|P1|STARTED|Overall Study||17
7922763|NCT00594165|19498434|P1|NOT COMPLETED|Overall Study||217
7922764|NCT00594165|19498434|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
7922765|NCT00594165|19498434|P1|STARTED|Overall Study||217
7922766|NCT00594100|19498440|P1|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12
7922767|NCT00594100|19498440|P1|COMPLETED|Follow-up Through 30 Days Post Procedure||224
7922768|NCT00594100|19498440|P1|STARTED|Follow-up Through 30 Days Post Procedure||236
7922769|NCT00594100|19498440|P1|NOT COMPLETED|Procedure||9
7922770|NCT00594100|19498440|P1|COMPLETED|Procedure||236
7922771|NCT00594100|19498440|P1|STARTED|Procedure||245
7922772|NCT00594061|19498449|P1|NOT COMPLETED|Overall Study||0
7922773|NCT00594061|19498449|P1|COMPLETED|Overall Study||9
7922774|NCT00594061|19498449|P1|STARTED|Overall Study||9
7922775|NCT00594035|19498456|P2|NOT COMPLETED|Overall Study||3
7922776|NCT00594035|19498457|P1|NOT COMPLETED|Overall Study||2
7922777|NCT00594035|19498456|P2|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53
7922778|NCT00594035|19498457|P1|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100
7922779|NCT00594035|19498456|P2|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56
7922780|NCT00594035|19498457|P1|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102
7922781|NCT00594022|19498465|P2|NOT COMPLETED|Overall Study||0
7922782|NCT00594022|19498466|P1|NOT COMPLETED|Overall Study||0
7922783|NCT00594022|19498465|P2|COMPLETED|Overall Study||173
7922784|NCT00594022|19498466|P1|COMPLETED|Overall Study||176
7922785|NCT00594022|19498465|P2|STARTED|Overall Study||173
7922786|NCT00594022|19498466|P1|STARTED|Overall Study||176
7922787|NCT00594009|19498480|P1|NOT COMPLETED|Overall Study||0
7922788|NCT00594009|19498480|P1|COMPLETED|Overall Study||1
7922789|NCT00594009|19498480|P1|STARTED|Overall Study||1
7922790|NCT00593957|19498487|P3|NOT COMPLETED|Overall Study||2
7922791|NCT00593957|19498488|P2|NOT COMPLETED|Overall Study||1
7922792|NCT00593957|19498489|P1|NOT COMPLETED|Overall Study||0
7922793|NCT00593957|19498487|P3|COMPLETED|Overall Study||10
7922794|NCT00593957|19498488|P2|COMPLETED|Overall Study||12
7922795|NCT00593957|19498489|P1|COMPLETED|Overall Study||13
7922796|NCT00593957|19498487|P3|STARTED|Overall Study||12
7922797|NCT00593957|19498488|P2|STARTED|Overall Study||13
7922798|NCT00593957|19498489|P1|STARTED|Overall Study||13
7922799|NCT00593918|19498513|P2|NOT COMPLETED|Overall Study||24
7922800|NCT00593918|19498514|P1|NOT COMPLETED|Overall Study||5
7922801|NCT00593918|19498513|P2|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50
7922802|NCT00593918|19498514|P1|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12
7922803|NCT00593918|19498513|P2|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74
7922804|NCT00593918|19498514|P1|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17
7922805|NCT00593866|19498522|P1|NOT COMPLETED|Overall Study||0
7922806|NCT00593866|19498522|P1|COMPLETED|Overall Study||50
7922807|NCT00593866|19498522|P1|STARTED|Overall Study||50
7922808|NCT00593840|19498527|P1|NOT COMPLETED|Overall Study||1
7922809|NCT00593840|19498527|P1|COMPLETED|Overall Study||72
7922810|NCT00593840|19498527|P1|STARTED|Overall Study||73
7922811|NCT00593827|19498539|P2|NOT COMPLETED|Overall Study||2
7922812|NCT00593827|19498540|P1|NOT COMPLETED|Overall Study||0
7922813|NCT00593827|19498539|P2|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89
7922814|NCT00593827|19498540|P1|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85
7922815|NCT00593827|19498539|P2|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89
7922816|NCT00593827|19498540|P1|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79
7922817|NCT00593827|19498539|P2|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89
7922818|NCT00593827|19498540|P1|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82
7922819|NCT00593827|19498539|P2|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91
7922820|NCT00593827|19498540|P1|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85
7922821|NCT00593814|19498564|P2|NOT COMPLETED|Overall Study||0
7922822|NCT00593814|19498565|P1|NOT COMPLETED|Overall Study||24
7922823|NCT00593814|19498564|P2|COMPLETED|Overall Study||120
7922824|NCT00593814|19498565|P1|COMPLETED|Overall Study||115
7922825|NCT00593814|19498564|P2|STARTED|Overall Study||120
7922826|NCT00593814|19498565|P1|STARTED|Overall Study||139
7922827|NCT00593736|19498577|P4|NOT COMPLETED|Treatment Period and Placebo Run-out||4
7922828|NCT00593736|19498578|P3|NOT COMPLETED|Treatment Period and Placebo Run-out||5
7922829|NCT00593736|19498579|P2|NOT COMPLETED|Treatment Period and Placebo Run-out||2
7922830|NCT00593736|19498580|P1|NOT COMPLETED|Treatment Period and Placebo Run-out||3
7922831|NCT00593736|19498577|P4|COMPLETED|Treatment Period and Placebo Run-out||28
7922832|NCT00593736|19498578|P3|COMPLETED|Treatment Period and Placebo Run-out||30
7922833|NCT00593736|19498579|P2|COMPLETED|Treatment Period and Placebo Run-out||31
7922834|NCT00593736|19498580|P1|COMPLETED|Treatment Period and Placebo Run-out||29
7922835|NCT00593736|19498577|P4|STARTED|Treatment Period and Placebo Run-out||32
7922836|NCT00593736|19498578|P3|STARTED|Treatment Period and Placebo Run-out||35
7922837|NCT00593736|19498579|P2|STARTED|Treatment Period and Placebo Run-out||33
7922838|NCT00593736|19498580|P1|STARTED|Treatment Period and Placebo Run-out||32
7922839|NCT00593736|19498577|P4|NOT COMPLETED|Screening Period and Placebo Run-in||417
7922840|NCT00593736|19498578|P3|NOT COMPLETED|Screening Period and Placebo Run-in||0
7922841|NCT00593736|19498579|P2|NOT COMPLETED|Screening Period and Placebo Run-in||0
7922842|NCT00593736|19498580|P1|NOT COMPLETED|Screening Period and Placebo Run-in||0
7922843|NCT00593736|19498577|P4|COMPLETED|Screening Period and Placebo Run-in||132
7922844|NCT00593736|19498578|P3|COMPLETED|Screening Period and Placebo Run-in||0
7922845|NCT00593736|19498579|P2|COMPLETED|Screening Period and Placebo Run-in||0
7922846|NCT00593736|19498580|P1|COMPLETED|Screening Period and Placebo Run-in||0
7922847|NCT00593736|19498577|P4|STARTED|Screening Period and Placebo Run-in||549
7922848|NCT00593736|19498578|P3|STARTED|Screening Period and Placebo Run-in||0
7922849|NCT00593736|19498579|P2|STARTED|Screening Period and Placebo Run-in||0
7922850|NCT00593736|19498580|P1|STARTED|Screening Period and Placebo Run-in||0
7922851|NCT00593684|19498828|P2|NOT COMPLETED|Overall Study||1
7922852|NCT00593684|19498829|P1|NOT COMPLETED|Overall Study||2
7922853|NCT00593684|19498828|P2|COMPLETED|Overall Study||24
7922854|NCT00593684|19498829|P1|COMPLETED|Overall Study||23
7922855|NCT00593684|19498828|P2|STARTED|Overall Study||25
7922856|NCT00593684|19498829|P1|STARTED|Overall Study||25
7922857|NCT00593645|19498841|P1|NOT COMPLETED|Overall Study||0
7922858|NCT00593645|19498841|P1|COMPLETED|Overall Study||7
7922859|NCT00593645|19498841|P1|STARTED|Overall Study||7
7922860|NCT00593606|19498855|P1|NOT COMPLETED|Overall Study||27
7922861|NCT00593606|19498855|P1|COMPLETED|Overall Study||97
7922862|NCT00593606|19498855|P1|Treatment Period Completed|Overall Study||99
7922863|NCT00593606|19498855|P1|Full Analysis Set|Overall Study||114
7922864|NCT00593606|19498855|P1|Start of Treatment - Safety Set|Overall Study||116
7922865|NCT00593606|19498855|P1|STARTED|Overall Study||124
7922866|NCT00593554|19498953|P2|NOT COMPLETED|Overall Study||5
7922867|NCT00593554|19498954|P1|NOT COMPLETED|Overall Study||3
7922868|NCT00593554|19498953|P2|COMPLETED|Overall Study||0
7922869|NCT00593554|19498954|P1|COMPLETED|Overall Study||0
7922870|NCT00593554|19498953|P2|STARTED|Overall Study||5
7922871|NCT00593554|19498954|P1|STARTED|Overall Study||3
7922872|NCT00593489|19498974|P2|NOT COMPLETED|Analysis||0
7922873|NCT00593489|19498975|P1|NOT COMPLETED|Analysis||0
7922874|NCT00593489|19498974|P2|COMPLETED|Analysis||78
7922875|NCT00593489|19498975|P1|COMPLETED|Analysis||73
7922876|NCT00593489|19498974|P2|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|78
7922877|NCT00593489|19498975|P1|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|73
7922878|NCT00593489|19498974|P2|NOT COMPLETED|Allocation||1
7922879|NCT00593489|19498975|P1|NOT COMPLETED|Allocation||2
7922880|NCT00593489|19498974|P2|COMPLETED|Allocation||78
7922881|NCT00593489|19498975|P1|COMPLETED|Allocation||73
7922882|NCT00593489|19498974|P2|STARTED|Allocation|allocated to usual care group|79
7922883|NCT00593489|19498975|P1|STARTED|Allocation|allocated to intervention group to receive the intervention|75
7922884|NCT00593450|19499005|P4|NOT COMPLETED|Overall Study||29
7922885|NCT00593450|19499006|P3|NOT COMPLETED|Overall Study||13
7922886|NCT00593450|19499007|P2|NOT COMPLETED|Overall Study||21
7922887|NCT00593450|19499008|P1|NOT COMPLETED|Overall Study||17
7922888|NCT00593450|19499005|P4|COMPLETED|Overall Study||271
7922889|NCT00593450|19499006|P3|COMPLETED|Overall Study||285
7922890|NCT00593450|19499007|P2|COMPLETED|Overall Study||265
7922891|NCT00593450|19499008|P1|COMPLETED|Overall Study||284
7922892|NCT00593450|19499005|P4|STARTED|Overall Study||300
7922893|NCT00593450|19499006|P3|STARTED|Overall Study||298
7922894|NCT00593450|19499007|P2|STARTED|Overall Study||286
7922895|NCT00593450|19499008|P1|STARTED|Overall Study||301
7922896|NCT00593385|19499078|P1|NOT COMPLETED|Overall Study||40
7922897|NCT00593385|19499078|P1|COMPLETED|Overall Study|125 of 165 enrolled patients completed the study.|125
7922898|NCT00593385|19499078|P1|Intention to Treat (ITT) Population|Overall Study|Excludes 13 subjects who did not meet inclusion/exclusion criteria.|152
7922899|NCT00593385|19499078|P1|STARTED|Overall Study||165
7922900|NCT00593372|19499115|P2|NOT COMPLETED|Overall Study||0
7922901|NCT00593372|19499116|P1|NOT COMPLETED|Overall Study||0
7922902|NCT00593372|19499115|P2|COMPLETED|Overall Study|Three evaluated and completed protocol.|3
7922903|NCT00593372|19499116|P1|COMPLETED|Overall Study|Eight completed behavioral treatment.|8
7922904|NCT00593372|19499115|P2|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3
7922905|NCT00593372|19499116|P1|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8
7922906|NCT00593346|19499122|P1|NOT COMPLETED|Overall Study||0
7922907|NCT00593346|19499122|P1|COMPLETED|Overall Study||151
7922908|NCT00593346|19499122|P1|STARTED|Overall Study||151
7922909|NCT00593333|19499139|P2|NOT COMPLETED|Overall Study||11
7922910|NCT00593333|19499140|P1|NOT COMPLETED|Overall Study||10
7922911|NCT00593333|19499139|P2|COMPLETED|Overall Study||45
7922912|NCT00593333|19499140|P1|COMPLETED|Overall Study||44
7922913|NCT00593333|19499139|P2|STARTED|Overall Study||56
7922914|NCT00593333|19499140|P1|STARTED|Overall Study||54
7922915|NCT00593320|19499148|P2|NOT COMPLETED|Overall Study||0
7922916|NCT00593320|19499149|P1|NOT COMPLETED|Overall Study||0
7922917|NCT00593320|19499148|P2|COMPLETED|Overall Study||1
7922918|NCT00593320|19499149|P1|COMPLETED|Overall Study||1
7922919|NCT00593320|19499148|P2|STARTED|Overall Study||1
7922920|NCT00593320|19499149|P1|STARTED|Overall Study||1
7922921|NCT00593112|19499163|P2|NOT COMPLETED|Overall Study||0
7922922|NCT00593112|19499164|P1|NOT COMPLETED|Overall Study||10
7922923|NCT00593112|19499163|P2|COMPLETED|Overall Study||12
7922924|NCT00593112|19499164|P1|COMPLETED|Overall Study||17
7922925|NCT00593112|19499163|P2|STARTED|Overall Study||12
7922926|NCT00593112|19499164|P1|STARTED|Overall Study||27
7922927|NCT00592943|19499176|P2|NOT COMPLETED|Overall Study||0
7922928|NCT00592943|19499177|P1|NOT COMPLETED|Overall Study||0
7922929|NCT00592943|19499176|P2|COMPLETED|Overall Study||6
7922930|NCT00592943|19499177|P1|COMPLETED|Overall Study||6
7922931|NCT00592943|19499176|P2|STARTED|Overall Study||6
7922932|NCT00592943|19499177|P1|STARTED|Overall Study||6
7922933|NCT00592904|19499191|P4|NOT COMPLETED|Overall Study||11
7922934|NCT00592904|19499192|P3|NOT COMPLETED|Overall Study||17
7922935|NCT00592904|19499193|P2|NOT COMPLETED|Overall Study||55
7922936|NCT00592904|19499194|P1|NOT COMPLETED|Overall Study||25
7922937|NCT00592904|19499191|P4|COMPLETED|Overall Study||19
7922938|NCT00592904|19499192|P3|COMPLETED|Overall Study||10
7922939|NCT00592904|19499193|P2|COMPLETED|Overall Study||93
7922940|NCT00592904|19499194|P1|COMPLETED|Overall Study||32
7922941|NCT00592904|19499191|P4|STARTED|Overall Study||30
7922942|NCT00592904|19499192|P3|STARTED|Overall Study||27
7922943|NCT00592904|19499193|P2|STARTED|Overall Study||148
7922944|NCT00592904|19499194|P1|STARTED|Overall Study||57
7922945|NCT00592852|19499220|P1|NOT COMPLETED|Overall Study||6
7922946|NCT00592852|19499220|P1|COMPLETED|Overall Study||7
7922947|NCT00592852|19499220|P1|STARTED|Overall Study||13
7922948|NCT00592839|19499228|P3|NOT COMPLETED|Overall Study||6
7922949|NCT00592839|19499229|P2|NOT COMPLETED|Overall Study||4
7922950|NCT00592839|19499230|P1|NOT COMPLETED|Overall Study||2
7922951|NCT00592839|19499228|P3|COMPLETED|Overall Study||46
7922952|NCT00592839|19499229|P2|COMPLETED|Overall Study||48
7922953|NCT00592839|19499230|P1|COMPLETED|Overall Study||51
7922954|NCT00592839|19499228|P3|STARTED|Overall Study||52
7922955|NCT00592839|19499229|P2|STARTED|Overall Study||52
7922956|NCT00592839|19499230|P1|STARTED|Overall Study||53
7922957|NCT00592774|19499258|P5|NOT COMPLETED|Overall Study||14
7922958|NCT00592774|19499259|P4|NOT COMPLETED|Overall Study||14
7922959|NCT00592774|19499260|P3|NOT COMPLETED|Overall Study||4
7922960|NCT00592774|19499261|P2|NOT COMPLETED|Overall Study||32
7922961|NCT00592774|19499262|P1|NOT COMPLETED|Overall Study||11
7922962|NCT00592774|19499258|P5|COMPLETED|Overall Study||9
7922963|NCT00592774|19499259|P4|COMPLETED|Overall Study||8
7922964|NCT00592774|19499260|P3|COMPLETED|Overall Study||18
7922965|NCT00592774|19499261|P2|COMPLETED|Overall Study||21
7922966|NCT00592774|19499262|P1|COMPLETED|Overall Study||15
7922967|NCT00592774|19499258|P5|STARTED|Overall Study||23
7922968|NCT00592774|19499259|P4|STARTED|Overall Study||22
7922969|NCT00592774|19499260|P3|STARTED|Overall Study||22
7922970|NCT00592774|19499261|P2|STARTED|Overall Study||53
7922971|NCT00592774|19499262|P1|STARTED|Overall Study||26
7922972|NCT00592761|19499319|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
7922973|NCT00592761|19499320|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
7922974|NCT00592761|19499319|P2|COMPLETED|Second Intervention (2 Weeks)||9
7922975|NCT00592761|19499320|P1|COMPLETED|Second Intervention (2 Weeks)||9
7922976|NCT00592761|19499319|P2|STARTED|Second Intervention (2 Weeks)||9
7922977|NCT00592761|19499320|P1|STARTED|Second Intervention (2 Weeks)||9
7922978|NCT00592761|19499319|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
7922979|NCT00592761|19499320|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
7922980|NCT00592761|19499319|P2|COMPLETED|First Intervention (2 Weeks)||9
7922981|NCT00592761|19499320|P1|COMPLETED|First Intervention (2 Weeks)||9
7922982|NCT00592761|19499319|P2|STARTED|First Intervention (2 Weeks)||9
7922983|NCT00592761|19499320|P1|STARTED|First Intervention (2 Weeks)||9
7922984|NCT00592683|19499334|P2|NOT COMPLETED|Overall Study||4
7922985|NCT00592683|19499335|P1|NOT COMPLETED|Overall Study||4
7922986|NCT00592683|19499334|P2|COMPLETED|Overall Study||6
7922987|NCT00592683|19499335|P1|COMPLETED|Overall Study||6
7922988|NCT00592683|19499334|P2|STARTED|Overall Study||10
7922989|NCT00592683|19499335|P1|STARTED|Overall Study||10
7922990|NCT00592631|19499345|P2|NOT COMPLETED|Overall Study||2
7922991|NCT00592631|19499346|P1|NOT COMPLETED|Overall Study||0
7922992|NCT00592631|19499345|P2|COMPLETED|Overall Study||9
7922993|NCT00592631|19499346|P1|COMPLETED|Overall Study||16
7922994|NCT00592631|19499345|P2|STARTED|Overall Study||11
7922995|NCT00592631|19499346|P1|STARTED|Overall Study||16
7922996|NCT00592553|19499355|P3|NOT COMPLETED|Overall Study||0
7922997|NCT00592553|19499356|P2|NOT COMPLETED|Overall Study||0
7922998|NCT00592553|19499357|P1|NOT COMPLETED|Overall Study||1
7922999|NCT00592553|19499355|P3|COMPLETED|Overall Study||57
7923000|NCT00592553|19499356|P2|COMPLETED|Overall Study||57
7923001|NCT00592553|19499357|P1|COMPLETED|Overall Study||59
7923002|NCT00592553|19499355|P3|ITT Population|Overall Study||57
7923003|NCT00592553|19499356|P2|ITT Population|Overall Study||57
7923004|NCT00592553|19499357|P1|ITT Population|Overall Study||60
7923005|NCT00592553|19499355|P3|As-treated Population|Overall Study||57
7923006|NCT00592553|19499356|P2|As-treated Population|Overall Study||57
7923007|NCT00592553|19499357|P1|As-treated Population|Overall Study||60
7923008|NCT00592553|19499355|P3|STARTED|Overall Study||57
7923009|NCT00592553|19499356|P2|STARTED|Overall Study||57
7923010|NCT00592553|19499357|P1|STARTED|Overall Study||60
7923011|NCT00592488|19499433|P2|NOT COMPLETED|Overall Study||0
7923012|NCT00592488|19499434|P1|NOT COMPLETED|Overall Study||0
7923013|NCT00592488|19499433|P2|COMPLETED|Overall Study||7
7923014|NCT00592488|19499434|P1|COMPLETED|Overall Study||6
7923015|NCT00592488|19499433|P2|STARTED|Overall Study||7
7923016|NCT00592488|19499434|P1|STARTED|Overall Study||6
7923017|NCT00592475|19499447|P3|NOT COMPLETED|Overall Study||0
7923018|NCT00592475|19499448|P2|NOT COMPLETED|Overall Study||0
7923019|NCT00592475|19499449|P1|NOT COMPLETED|Overall Study||0
7923020|NCT00592475|19499447|P3|COMPLETED|Overall Study||5
7923021|NCT00592475|19499448|P2|COMPLETED|Overall Study||9
7923022|NCT00592475|19499449|P1|COMPLETED|Overall Study||6
7923023|NCT00592475|19499447|P3|STARTED|Overall Study||5
7923024|NCT00592475|19499448|P2|STARTED|Overall Study||9
7923025|NCT00592475|19499449|P1|STARTED|Overall Study||6
7923026|NCT00592384|19499474|P2|NOT COMPLETED|Overall Study||6
7923027|NCT00592384|19499475|P1|NOT COMPLETED|Overall Study||5
7923028|NCT00592384|19499474|P2|COMPLETED|Overall Study||63
7923029|NCT00592384|19499475|P1|COMPLETED|Overall Study||59
7923030|NCT00592384|19499474|P2|STARTED|Overall Study||69
7923031|NCT00592384|19499475|P1|STARTED|Overall Study||64
7923032|NCT00592358|19499483|P1|NOT COMPLETED|Overall Study||6
7923033|NCT00592358|19499483|P1|COMPLETED|Overall Study||11
7923034|NCT00592358|19499483|P1|STARTED|Overall Study||17
7923035|NCT00592319|19499490|P2|NOT COMPLETED|Overall Study||3
7923036|NCT00592319|19499491|P1|NOT COMPLETED|Overall Study||0
7923037|NCT00592319|19499490|P2|COMPLETED|Overall Study||5
7923038|NCT00592319|19499491|P1|COMPLETED|Overall Study||2
7923039|NCT00592319|19499490|P2|STARTED|Overall Study||8
7923040|NCT00592319|19499491|P1|STARTED|Overall Study||2
7923041|NCT00592176|19499499|P1|NOT COMPLETED|Overall Study||0
7923042|NCT00592176|19499499|P1|COMPLETED|Overall Study||5
7923043|NCT00592176|19499499|P1|STARTED|Overall Study||5
7923044|NCT00592124|19499510|P6|NOT COMPLETED|Overall Study||3
7923045|NCT00592124|19499511|P5|NOT COMPLETED|Overall Study||3
7923046|NCT00592124|19499512|P4|NOT COMPLETED|Overall Study||3
7923047|NCT00592124|19499513|P3|NOT COMPLETED|Overall Study||6
7923048|NCT00592124|19499514|P2|NOT COMPLETED|Overall Study||5
7923049|NCT00592124|19499515|P1|NOT COMPLETED|Overall Study||4
7923050|NCT00592124|19499510|P6|COMPLETED|Overall Study||24
7923051|NCT00592124|19499511|P5|COMPLETED|Overall Study||24
7923052|NCT00592124|19499512|P4|COMPLETED|Overall Study||24
7923053|NCT00592124|19499513|P3|COMPLETED|Overall Study||24
7923054|NCT00592124|19499514|P2|COMPLETED|Overall Study||24
7923055|NCT00592124|19499515|P1|COMPLETED|Overall Study||24
7923056|NCT00592124|19499510|P6|STARTED|Overall Study||27
7923057|NCT00592124|19499511|P5|STARTED|Overall Study||27
7923058|NCT00592124|19499512|P4|STARTED|Overall Study||27
7923059|NCT00592124|19499513|P3|STARTED|Overall Study||30
7923060|NCT00592124|19499514|P2|STARTED|Overall Study||29
7923061|NCT00592124|19499515|P1|STARTED|Overall Study||28
7923062|NCT00592072|19499566|P2|NOT COMPLETED|Second Sequence||0
7923063|NCT00592072|19499567|P1|NOT COMPLETED|Second Sequence||0
7923064|NCT00592072|19499566|P2|COMPLETED|Second Sequence||5
7923065|NCT00592072|19499567|P1|COMPLETED|Second Sequence||5
7923066|NCT00592072|19499566|P2|STARTED|Second Sequence||5
7923067|NCT00592072|19499567|P1|STARTED|Second Sequence||5
7923068|NCT00592072|19499566|P2|NOT COMPLETED|Wash Out Period||1
7923069|NCT00592072|19499567|P1|NOT COMPLETED|Wash Out Period||1
7923070|NCT00592072|19499566|P2|COMPLETED|Wash Out Period||5
7923071|NCT00592072|19499567|P1|COMPLETED|Wash Out Period||5
7923072|NCT00592072|19499566|P2|STARTED|Wash Out Period||6
7923073|NCT00592072|19499567|P1|STARTED|Wash Out Period||6
7923074|NCT00592072|19499566|P2|NOT COMPLETED|First Sequence||0
7923075|NCT00592072|19499567|P1|NOT COMPLETED|First Sequence||0
7923076|NCT00592072|19499566|P2|COMPLETED|First Sequence||6
7923077|NCT00592072|19499567|P1|COMPLETED|First Sequence||6
7923078|NCT00592072|19499566|P2|STARTED|First Sequence||6
7923079|NCT00592072|19499567|P1|STARTED|First Sequence||6
7923080|NCT00592007|19499589|P1|NOT COMPLETED|Overall Study||2
7923081|NCT00592007|19499589|P1|COMPLETED|Overall Study||5
7923082|NCT00592007|19499589|P1|STARTED|Overall Study||7
7923083|NCT00591942|19499594|P2|NOT COMPLETED|Overall Study||0
7923084|NCT00591942|19499595|P1|NOT COMPLETED|Overall Study||0
7923085|NCT00591942|19499594|P2|COMPLETED|Overall Study||36
7923086|NCT00591942|19499595|P1|COMPLETED|Overall Study||36
7923087|NCT00591942|19499594|P2|STARTED|Overall Study||36
7923088|NCT00591942|19499595|P1|STARTED|Overall Study||36
7923089|NCT00591864|19499601|P1|NOT COMPLETED|Overall Study||5
7923090|NCT00591864|19499601|P1|COMPLETED|Overall Study||84
7923091|NCT00591864|19499601|P1|STARTED|Overall Study||89
7923092|NCT00591851|19499607|P1|NOT COMPLETED|Overall Study||6
7923093|NCT00591851|19499607|P1|COMPLETED|Overall Study||64
7923094|NCT00591851|19499607|P1|STARTED|Overall Study||70
7923095|NCT00591838|19499616|P5|NOT COMPLETED|Overall Study||0
7923096|NCT00591838|19499617|P4|NOT COMPLETED|Overall Study||1
7923097|NCT00591838|19499618|P3|NOT COMPLETED|Overall Study||0
7923098|NCT00591838|19499619|P2|NOT COMPLETED|Overall Study||0
7923099|NCT00591838|19499620|P1|NOT COMPLETED|Overall Study||0
7923100|NCT00591838|19499616|P5|COMPLETED|Overall Study||51
7923101|NCT00591838|19499617|P4|COMPLETED|Overall Study||5
7923102|NCT00591838|19499618|P3|COMPLETED|Overall Study||6
7923103|NCT00591838|19499619|P2|COMPLETED|Overall Study||6
7923104|NCT00591838|19499620|P1|COMPLETED|Overall Study||5
7923105|NCT00591838|19499616|P5|STARTED|Overall Study||51
7923106|NCT00591838|19499617|P4|STARTED|Overall Study||6
7923107|NCT00591838|19499618|P3|STARTED|Overall Study||6
7923108|NCT00591838|19499619|P2|STARTED|Overall Study||6
7923109|NCT00591838|19499620|P1|STARTED|Overall Study||5
7923110|NCT00591825|19499645|P4|NOT COMPLETED|Overall Study||0
7923111|NCT00591825|19499646|P3|NOT COMPLETED|Overall Study||0
7923112|NCT00591825|19499647|P2|NOT COMPLETED|Overall Study||0
7923113|NCT00591825|19499648|P1|NOT COMPLETED|Overall Study||0
7923114|NCT00591825|19499645|P4|COMPLETED|Overall Study||14
7923115|NCT00591825|19499646|P3|COMPLETED|Overall Study||13
7923116|NCT00591825|19499647|P2|COMPLETED|Overall Study||13
7923117|NCT00591825|19499648|P1|COMPLETED|Overall Study||14
7923118|NCT00591825|19499645|P4|STARTED|Overall Study||14
7923119|NCT00591825|19499646|P3|STARTED|Overall Study||13
7923120|NCT00591825|19499647|P2|STARTED|Overall Study||13
7923121|NCT00591825|19499648|P1|STARTED|Overall Study||14
7923122|NCT00591786|19499684|P10|NOT COMPLETED|Overall Study||0
7923123|NCT00591786|19499685|P9|NOT COMPLETED|Overall Study||0
7923124|NCT00591786|19499686|P8|NOT COMPLETED|Overall Study||0
7923125|NCT00591786|19499687|P7|NOT COMPLETED|Overall Study||0
7923126|NCT00591786|19499688|P6|NOT COMPLETED|Overall Study||0
7923127|NCT00591786|19499689|P5|NOT COMPLETED|Overall Study||0
7923128|NCT00591786|19499690|P4|NOT COMPLETED|Overall Study||0
7923129|NCT00591786|19499691|P3|NOT COMPLETED|Overall Study||1
7923130|NCT00591786|19499692|P2|NOT COMPLETED|Overall Study||0
7923131|NCT00591786|19499693|P1|NOT COMPLETED|Overall Study||0
7923132|NCT00591786|19499684|P10|COMPLETED|Overall Study||10
7923133|NCT00591786|19499685|P9|COMPLETED|Overall Study||10
7923134|NCT00591786|19499686|P8|COMPLETED|Overall Study||10
7923135|NCT00591786|19499687|P7|COMPLETED|Overall Study||10
7923136|NCT00591786|19499688|P6|COMPLETED|Overall Study||10
7923137|NCT00591786|19499689|P5|COMPLETED|Overall Study||10
7923138|NCT00591786|19499690|P4|COMPLETED|Overall Study||11
7923139|NCT00591786|19499691|P3|COMPLETED|Overall Study||10
7923140|NCT00591786|19499692|P2|COMPLETED|Overall Study||9
7923141|NCT00591786|19499693|P1|COMPLETED|Overall Study||9
7923142|NCT00591786|19499684|P10|Treated Participants|Overall Study||10
7923143|NCT00591786|19499685|P9|Treated Participants|Overall Study||10
7923144|NCT00591786|19499686|P8|Treated Participants|Overall Study||10
7923145|NCT00591786|19499687|P7|Treated Participants|Overall Study||10
7923146|NCT00591786|19499688|P6|Treated Participants|Overall Study||10
7923147|NCT00591786|19499689|P5|Treated Participants|Overall Study||10
7923148|NCT00591786|19499690|P4|Treated Participants|Overall Study||11
7923149|NCT00591786|19499691|P3|Treated Participants|Overall Study||10
7923150|NCT00591786|19499692|P2|Treated Participants|Overall Study||9
7923151|NCT00591786|19499693|P1|Treated Participants|Overall Study||9
7923152|NCT00591786|19499684|P10|STARTED|Overall Study||10
7923153|NCT00591786|19499685|P9|STARTED|Overall Study||10
7923154|NCT00591786|19499686|P8|STARTED|Overall Study||10
7923155|NCT00591786|19499687|P7|STARTED|Overall Study||10
7923156|NCT00591786|19499688|P6|STARTED|Overall Study||10
7923157|NCT00591786|19499689|P5|STARTED|Overall Study||10
7923158|NCT00591786|19499690|P4|STARTED|Overall Study||11
7923159|NCT00591786|19499691|P3|STARTED|Overall Study||11
7923160|NCT00591786|19499692|P2|STARTED|Overall Study||9
7923161|NCT00591786|19499693|P1|STARTED|Overall Study||9
7923162|NCT00591773|19499738|P3|NOT COMPLETED|Overall Study||16
7923163|NCT00591773|19499739|P2|NOT COMPLETED|Overall Study||24
7923164|NCT00591773|19499740|P1|NOT COMPLETED|Overall Study||16
7923165|NCT00591773|19499738|P3|COMPLETED|Overall Study||168
7923166|NCT00591773|19499739|P2|COMPLETED|Overall Study||158
7923167|NCT00591773|19499740|P1|COMPLETED|Overall Study||169
7923168|NCT00591773|19499738|P3|STARTED|Overall Study||184
7923169|NCT00591773|19499739|P2|STARTED|Overall Study||182
7923170|NCT00591773|19499740|P1|STARTED|Overall Study||185
7923171|NCT00591760|19499792|P2|NOT COMPLETED|Overall Study||0
7923172|NCT00591760|19499793|P1|NOT COMPLETED|Overall Study||0
7923173|NCT00591760|19499792|P2|COMPLETED|Overall Study||28
7923174|NCT00591760|19499793|P1|COMPLETED|Overall Study||28
7923175|NCT00591760|19499792|P2|STARTED|Overall Study||28
7923176|NCT00591760|19499793|P1|STARTED|Overall Study||28
7923177|NCT00591734|19499799|P1|NOT COMPLETED|Overall Study||53
7923178|NCT00591734|19499799|P1|COMPLETED|Overall Study||4
7923179|NCT00591734|19499799|P1|STARTED|Overall Study||57
7923180|NCT00591721|19499805|P2|NOT COMPLETED|Overall Study||22
7923181|NCT00591721|19499806|P1|NOT COMPLETED|Overall Study||21
7923182|NCT00591721|19499805|P2|COMPLETED|Overall Study||70
7923183|NCT00591721|19499806|P1|COMPLETED|Overall Study||68
7923184|NCT00591721|19499805|P2|STARTED|Overall Study||92
7923185|NCT00591721|19499806|P1|STARTED|Overall Study||89
7923186|NCT00591591|19499814|P2|NOT COMPLETED|Overall Study||39
7923187|NCT00591591|19499815|P1|NOT COMPLETED|Overall Study||11
7923188|NCT00591591|19499814|P2|COMPLETED|Overall Study||94
7923189|NCT00591591|19499815|P1|COMPLETED|Overall Study||165
7923190|NCT00591591|19499814|P2|STARTED|Overall Study||133
7923191|NCT00591591|19499815|P1|STARTED|Overall Study||176
7923192|NCT00591578|19499832|P3|NOT COMPLETED|Open-Label Extension Phase||0
7923193|NCT00591578|19499833|P2|NOT COMPLETED|Open-Label Extension Phase||10
7923194|NCT00591578|19499834|P1|NOT COMPLETED|Open-Label Extension Phase||6
7923195|NCT00591578|19499832|P3|COMPLETED|Open-Label Extension Phase||0
7923196|NCT00591578|19499833|P2|COMPLETED|Open-Label Extension Phase||105
7923197|NCT00591578|19499834|P1|COMPLETED|Open-Label Extension Phase||49
7923198|NCT00591578|19499832|P3|STARTED|Open-Label Extension Phase||0
7923199|NCT00591578|19499833|P2|STARTED|Open-Label Extension Phase||115
7923200|NCT00591578|19499834|P1|STARTED|Open-Label Extension Phase||55
7923201|NCT00591578|19499832|P3|NOT COMPLETED|Double-Blind Treatment Phase||84
7923202|NCT00591578|19499833|P2|NOT COMPLETED|Double-Blind Treatment Phase||80
7923203|NCT00591578|19499834|P1|NOT COMPLETED|Double-Blind Treatment Phase||78
7923204|NCT00591578|19499832|P3|COMPLETED|Double-Blind Treatment Phase||244
7923205|NCT00591578|19499833|P2|COMPLETED|Double-Blind Treatment Phase||249
7923206|NCT00591578|19499834|P1|COMPLETED|Double-Blind Treatment Phase||249
7923207|NCT00591578|19499832|P3|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328
7923208|NCT00591578|19499833|P2|STARTED|Double-Blind Treatment Phase||329
7923209|NCT00591578|19499834|P1|STARTED|Double-Blind Treatment Phase||327
7923210|NCT00591565|19499885|P1|NOT COMPLETED|Overall Study||5
7923211|NCT00591565|19499885|P1|COMPLETED|Overall Study||8
7923212|NCT00591565|19499885|P1|STARTED|Overall Study||13
7923213|NCT00591409|19499899|P10|NOT COMPLETED|Overall Study||1
7923214|NCT00591409|19499900|P9|NOT COMPLETED|Overall Study||0
7923215|NCT00591409|19499901|P8|NOT COMPLETED|Overall Study||0
7923216|NCT00591409|19499902|P7|NOT COMPLETED|Overall Study||0
7923217|NCT00591409|19499903|P6|NOT COMPLETED|Overall Study||0
7923218|NCT00591409|19499904|P5|NOT COMPLETED|Overall Study||1
7923219|NCT00591409|19499905|P4|NOT COMPLETED|Overall Study||0
7923220|NCT00591409|19499906|P3|NOT COMPLETED|Overall Study||0
7923221|NCT00591409|19499907|P2|NOT COMPLETED|Overall Study||0
7923222|NCT00591409|19499908|P1|NOT COMPLETED|Overall Study||0
7923223|NCT00591409|19499899|P10|COMPLETED|Overall Study||10
7923224|NCT00591409|19499900|P9|COMPLETED|Overall Study||9
7923225|NCT00591409|19499901|P8|COMPLETED|Overall Study||10
7923226|NCT00591409|19499902|P7|COMPLETED|Overall Study||10
7923227|NCT00591409|19499903|P6|COMPLETED|Overall Study||10
7923228|NCT00591409|19499904|P5|COMPLETED|Overall Study||9
7923229|NCT00591409|19499905|P4|COMPLETED|Overall Study||10
7923230|NCT00591409|19499906|P3|COMPLETED|Overall Study||10
7923231|NCT00591409|19499907|P2|COMPLETED|Overall Study||10
7923232|NCT00591409|19499908|P1|COMPLETED|Overall Study||10
7923233|NCT00591409|19499899|P10|Treated|Overall Study||10
7923234|NCT00591409|19499900|P9|Treated|Overall Study||9
7923235|NCT00591409|19499901|P8|Treated|Overall Study||10
7923236|NCT00591409|19499902|P7|Treated|Overall Study||10
7923237|NCT00591409|19499903|P6|Treated|Overall Study||10
7923238|NCT00591409|19499904|P5|Treated|Overall Study||9
7923239|NCT00591409|19499905|P4|Treated|Overall Study||10
7923240|NCT00591409|19499906|P3|Treated|Overall Study||10
7923241|NCT00591409|19499907|P2|Treated|Overall Study||10
7923242|NCT00591409|19499908|P1|Treated|Overall Study||10
7923243|NCT00591409|19499899|P10|STARTED|Overall Study||11
7923244|NCT00591409|19499900|P9|STARTED|Overall Study||9
7923245|NCT00591409|19499901|P8|STARTED|Overall Study||10
7923246|NCT00591409|19499902|P7|STARTED|Overall Study||10
7923247|NCT00591409|19499903|P6|STARTED|Overall Study||10
7923248|NCT00591409|19499904|P5|STARTED|Overall Study||10
7923249|NCT00591409|19499905|P4|STARTED|Overall Study||10
7923250|NCT00591409|19499906|P3|STARTED|Overall Study||10
7923251|NCT00591409|19499907|P2|STARTED|Overall Study||10
7923252|NCT00591409|19499908|P1|STARTED|Overall Study||10
7923253|NCT00591370|19499950|P1|NOT COMPLETED|Overall Study||2
7923254|NCT00591370|19499950|P1|COMPLETED|Overall Study||49
7923255|NCT00591370|19499950|P1|STARTED|Overall Study||51
7923256|NCT00591344|19499958|P2|NOT COMPLETED|Overall Study||8
7923257|NCT00591344|19499959|P1|NOT COMPLETED|Overall Study||5
7923258|NCT00591344|19499958|P2|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18
7923259|NCT00591344|19499959|P1|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20
7923260|NCT00591344|19499958|P2|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
7923261|NCT00591344|19499959|P1|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
7923262|NCT00591344|19499958|P2|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26
7923263|NCT00591344|19499959|P1|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25
7923264|NCT00591305|19499971|P2|NOT COMPLETED|Overall Study||0
7923265|NCT00591305|19499972|P1|NOT COMPLETED|Overall Study||0
7923266|NCT00591305|19499971|P2|COMPLETED|Overall Study||0
7923267|NCT00591305|19499972|P1|COMPLETED|Overall Study||1
7923268|NCT00591305|19499971|P2|1st Follow-up in 2 Wks After Surgery|Overall Study||0
7923269|NCT00591305|19499972|P1|1st Follow-up in 2 Wks After Surgery|Overall Study||1
7923270|NCT00591305|19499971|P2|STARTED|Overall Study||0
7923271|NCT00591305|19499972|P1|STARTED|Overall Study||1
7923272|NCT00591266|19499985|P3|NOT COMPLETED|Overall Study||14
7923273|NCT00591266|19499986|P2|NOT COMPLETED|Overall Study||11
7923274|NCT00591266|19499987|P1|NOT COMPLETED|Overall Study||9
7923275|NCT00591266|19499985|P3|COMPLETED|Overall Study||175
7923276|NCT00591266|19499986|P2|COMPLETED|Overall Study||177
7923277|NCT00591266|19499987|P1|COMPLETED|Overall Study||180
7923278|NCT00591266|19499985|P3|STARTED|Overall Study|Randomized only|189
7923279|NCT00591266|19499986|P2|STARTED|Overall Study|Randomized only|188
7923280|NCT00591266|19499987|P1|STARTED|Overall Study|Randomized only|189
7923281|NCT00591253|19500040|P3|NOT COMPLETED|Overall Study||15
7923282|NCT00591253|19500041|P2|NOT COMPLETED|Overall Study||21
7923283|NCT00591253|19500042|P1|NOT COMPLETED|Overall Study||14
7923284|NCT00591253|19500040|P3|COMPLETED|Overall Study||123
7923285|NCT00591253|19500041|P2|COMPLETED|Overall Study||116
7923286|NCT00591253|19500042|P1|COMPLETED|Overall Study||126
7923287|NCT00591253|19500040|P3|STARTED|Overall Study|Randomized or Treated|138
7923288|NCT00591253|19500041|P2|STARTED|Overall Study|Randomized or Treated|137
7923289|NCT00591253|19500042|P1|STARTED|Overall Study|Randomized or Treated|140
7923290|NCT00591240|19500094|P2|NOT COMPLETED|Overall Study||0
7923291|NCT00591240|19500095|P1|NOT COMPLETED|Overall Study||0
7923292|NCT00591240|19500094|P2|COMPLETED|Overall Study||222
7923293|NCT00591240|19500095|P1|COMPLETED|Overall Study||116
7923294|NCT00591240|19500094|P2|STARTED|Overall Study||222
7923295|NCT00591240|19500095|P1|STARTED|Overall Study||116
7923296|NCT00591227|19500103|P2|NOT COMPLETED|Overall Study||0
7923297|NCT00591227|19500104|P1|NOT COMPLETED|Overall Study||0
7923298|NCT00591227|19500103|P2|COMPLETED|Overall Study||87
7923299|NCT00591227|19500104|P1|COMPLETED|Overall Study||89
7923300|NCT00591227|19500103|P2|STARTED|Overall Study||87
7923301|NCT00591227|19500104|P1|STARTED|Overall Study||89
7923302|NCT00591214|19500110|P1|NOT COMPLETED|Overall Study||8
7923303|NCT00591214|19500110|P1|COMPLETED|Overall Study||2
7923304|NCT00591214|19500110|P1|STARTED|Overall Study||10
7923305|NCT00591149|19500119|P1|NOT COMPLETED|Overall Study||5
7923306|NCT00591149|19500119|P1|COMPLETED|Overall Study||11
7923307|NCT00591149|19500119|P1|STARTED|Overall Study||16
7923308|NCT00591019|19500123|P2|NOT COMPLETED|Intevention 2 (14 Days)||0
7923309|NCT00591019|19500124|P1|NOT COMPLETED|Intevention 2 (14 Days)||0
7923310|NCT00591019|19500123|P2|COMPLETED|Intevention 2 (14 Days)||3
7923311|NCT00591019|19500124|P1|COMPLETED|Intevention 2 (14 Days)||2
7923312|NCT00591019|19500123|P2|STARTED|Intevention 2 (14 Days)||3
7923313|NCT00591019|19500124|P1|STARTED|Intevention 2 (14 Days)||2
7923314|NCT00591019|19500123|P2|NOT COMPLETED|Intervention 1 (14 Days)||0
7923315|NCT00591019|19500124|P1|NOT COMPLETED|Intervention 1 (14 Days)||0
7923316|NCT00591019|19500123|P2|COMPLETED|Intervention 1 (14 Days)||3
7923317|NCT00591019|19500124|P1|COMPLETED|Intervention 1 (14 Days)||2
7923318|NCT00591019|19500123|P2|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3
7923319|NCT00591019|19500124|P1|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2
7923320|NCT00591019|19500123|P2|NOT COMPLETED|Baseline (1 Day)||0
7923321|NCT00591019|19500124|P1|NOT COMPLETED|Baseline (1 Day)||0
7923322|NCT00591019|19500123|P2|COMPLETED|Baseline (1 Day)||4
7923323|NCT00591019|19500124|P1|COMPLETED|Baseline (1 Day)||3
7923324|NCT00591019|19500123|P2|STARTED|Baseline (1 Day)||4
7923325|NCT00591019|19500124|P1|STARTED|Baseline (1 Day)||3
7923326|NCT00591006|19500135|P24|NOT COMPLETED|Overall Study||1
7923327|NCT00591006|19500136|P23|NOT COMPLETED|Overall Study||1
7923328|NCT00591006|19500137|P22|NOT COMPLETED|Overall Study||0
7923329|NCT00591006|19500138|P21|NOT COMPLETED|Overall Study||0
7923330|NCT00591006|19500139|P20|NOT COMPLETED|Overall Study||0
7923331|NCT00591006|19500140|P19|NOT COMPLETED|Overall Study||0
7923332|NCT00591006|19500141|P18|NOT COMPLETED|Overall Study||0
7923333|NCT00591006|19500142|P17|NOT COMPLETED|Overall Study||0
7923334|NCT00591006|19500143|P16|NOT COMPLETED|Overall Study||1
7923335|NCT00591006|19500144|P15|NOT COMPLETED|Overall Study||0
7923336|NCT00591006|19500145|P14|NOT COMPLETED|Overall Study||0
7923337|NCT00591006|19500146|P13|NOT COMPLETED|Overall Study||0
7923338|NCT00591006|19500147|P12|NOT COMPLETED|Overall Study||0
7923339|NCT00591006|19500148|P11|NOT COMPLETED|Overall Study||0
7923340|NCT00591006|19500149|P10|NOT COMPLETED|Overall Study||0
7923341|NCT00591006|19500150|P9|NOT COMPLETED|Overall Study||0
7923342|NCT00591006|19500151|P8|NOT COMPLETED|Overall Study||0
7923343|NCT00591006|19500152|P7|NOT COMPLETED|Overall Study||0
7923344|NCT00591006|19500153|P6|NOT COMPLETED|Overall Study||0
7923345|NCT00591006|19500154|P5|NOT COMPLETED|Overall Study||0
7923346|NCT00591006|19500155|P4|NOT COMPLETED|Overall Study||0
7923347|NCT00591006|19500156|P3|NOT COMPLETED|Overall Study||0
7923348|NCT00591006|19500157|P2|NOT COMPLETED|Overall Study||0
7923349|NCT00591006|19500158|P1|NOT COMPLETED|Overall Study||0
7923350|NCT00591006|19500135|P24|COMPLETED|Overall Study||0
7923351|NCT00591006|19500136|P23|COMPLETED|Overall Study||0
7923352|NCT00591006|19500137|P22|COMPLETED|Overall Study||1
7923353|NCT00591006|19500138|P21|COMPLETED|Overall Study||0
7923354|NCT00591006|19500139|P20|COMPLETED|Overall Study||1
7923355|NCT00591006|19500140|P19|COMPLETED|Overall Study||0
7923356|NCT00591006|19500141|P18|COMPLETED|Overall Study||1
7923357|NCT00591006|19500142|P17|COMPLETED|Overall Study||0
7923358|NCT00591006|19500143|P16|COMPLETED|Overall Study||0
7923359|NCT00591006|19500144|P15|COMPLETED|Overall Study||0
7923360|NCT00591006|19500145|P14|COMPLETED|Overall Study||2
7923361|NCT00591006|19500146|P13|COMPLETED|Overall Study||1
7923362|NCT00591006|19500147|P12|COMPLETED|Overall Study||1
7923363|NCT00591006|19500148|P11|COMPLETED|Overall Study||0
7923364|NCT00591006|19500149|P10|COMPLETED|Overall Study||1
7923365|NCT00591006|19500150|P9|COMPLETED|Overall Study||1
7923366|NCT00591006|19500151|P8|COMPLETED|Overall Study||0
7923367|NCT00591006|19500152|P7|COMPLETED|Overall Study||1
7923368|NCT00591006|19500153|P6|COMPLETED|Overall Study||0
7923369|NCT00591006|19500154|P5|COMPLETED|Overall Study||1
7923370|NCT00591006|19500155|P4|COMPLETED|Overall Study||1
7923371|NCT00591006|19500156|P3|COMPLETED|Overall Study||1
7923372|NCT00591006|19500157|P2|COMPLETED|Overall Study||0
7923373|NCT00591006|19500158|P1|COMPLETED|Overall Study||1
7923374|NCT00591006|19500135|P24|Treatment #4|Overall Study||0
7923375|NCT00591006|19500136|P23|Treatment #4|Overall Study||0
7923376|NCT00591006|19500137|P22|Treatment #4|Overall Study||1
7923377|NCT00591006|19500138|P21|Treatment #4|Overall Study||0
7923378|NCT00591006|19500139|P20|Treatment #4|Overall Study||1
7923379|NCT00591006|19500140|P19|Treatment #4|Overall Study||0
7923380|NCT00591006|19500141|P18|Treatment #4|Overall Study||1
7923381|NCT00591006|19500142|P17|Treatment #4|Overall Study||0
7923382|NCT00591006|19500143|P16|Treatment #4|Overall Study||0
7923383|NCT00591006|19500144|P15|Treatment #4|Overall Study||0
7923384|NCT00591006|19500145|P14|Treatment #4|Overall Study||2
7923385|NCT00591006|19500146|P13|Treatment #4|Overall Study||1
7923386|NCT00591006|19500147|P12|Treatment #4|Overall Study||1
7923387|NCT00591006|19500148|P11|Treatment #4|Overall Study||0
7923388|NCT00591006|19500149|P10|Treatment #4|Overall Study||1
7923389|NCT00591006|19500150|P9|Treatment #4|Overall Study||1
7923390|NCT00591006|19500151|P8|Treatment #4|Overall Study||0
7923391|NCT00591006|19500152|P7|Treatment #4|Overall Study||1
7923392|NCT00591006|19500153|P6|Treatment #4|Overall Study||0
7923393|NCT00591006|19500154|P5|Treatment #4|Overall Study||1
7923394|NCT00591006|19500155|P4|Treatment #4|Overall Study||1
7923395|NCT00591006|19500156|P3|Treatment #4|Overall Study||1
7923396|NCT00591006|19500157|P2|Treatment #4|Overall Study||0
7923397|NCT00591006|19500158|P1|Treatment #4|Overall Study||1
7923398|NCT00591006|19500135|P24|Treatment #3|Overall Study||1
7923399|NCT00591006|19500136|P23|Treatment #3|Overall Study||1
7923400|NCT00591006|19500137|P22|Treatment #3|Overall Study||1
7923401|NCT00591006|19500138|P21|Treatment #3|Overall Study||0
7923402|NCT00591006|19500139|P20|Treatment #3|Overall Study||1
7923403|NCT00591006|19500140|P19|Treatment #3|Overall Study||0
7923404|NCT00591006|19500141|P18|Treatment #3|Overall Study||1
7923405|NCT00591006|19500142|P17|Treatment #3|Overall Study||0
7923406|NCT00591006|19500143|P16|Treatment #3|Overall Study||0
7923407|NCT00591006|19500144|P15|Treatment #3|Overall Study||0
7923408|NCT00591006|19500145|P14|Treatment #3|Overall Study||2
7923409|NCT00591006|19500146|P13|Treatment #3|Overall Study||1
7923410|NCT00591006|19500147|P12|Treatment #3|Overall Study||1
7923411|NCT00591006|19500148|P11|Treatment #3|Overall Study||0
7923412|NCT00591006|19500149|P10|Treatment #3|Overall Study||1
7923413|NCT00591006|19500150|P9|Treatment #3|Overall Study||1
7923414|NCT00591006|19500151|P8|Treatment #3|Overall Study||0
7923415|NCT00591006|19500152|P7|Treatment #3|Overall Study||1
7923416|NCT00591006|19500153|P6|Treatment #3|Overall Study||0
7923417|NCT00591006|19500154|P5|Treatment #3|Overall Study||1
7923418|NCT00591006|19500155|P4|Treatment #3|Overall Study||1
7923419|NCT00591006|19500156|P3|Treatment #3|Overall Study||1
7923420|NCT00591006|19500157|P2|Treatment #3|Overall Study||0
7923421|NCT00591006|19500158|P1|Treatment #3|Overall Study||1
7923422|NCT00591006|19500135|P24|Treatment #2|Overall Study||1
7923423|NCT00591006|19500136|P23|Treatment #2|Overall Study||1
7923424|NCT00591006|19500137|P22|Treatment #2|Overall Study||1
7923425|NCT00591006|19500138|P21|Treatment #2|Overall Study||0
7923426|NCT00591006|19500139|P20|Treatment #2|Overall Study||1
7923427|NCT00591006|19500140|P19|Treatment #2|Overall Study||0
7923428|NCT00591006|19500141|P18|Treatment #2|Overall Study||1
7923429|NCT00591006|19500142|P17|Treatment #2|Overall Study||0
7923430|NCT00591006|19500143|P16|Treatment #2|Overall Study||0
7923431|NCT00591006|19500144|P15|Treatment #2|Overall Study||0
7923432|NCT00591006|19500145|P14|Treatment #2|Overall Study||2
7923433|NCT00591006|19500146|P13|Treatment #2|Overall Study||1
7923434|NCT00591006|19500147|P12|Treatment #2|Overall Study||1
7923435|NCT00591006|19500148|P11|Treatment #2|Overall Study||0
7923436|NCT00591006|19500149|P10|Treatment #2|Overall Study||1
7923437|NCT00591006|19500150|P9|Treatment #2|Overall Study||1
7923438|NCT00591006|19500151|P8|Treatment #2|Overall Study||0
7923439|NCT00591006|19500152|P7|Treatment #2|Overall Study||1
7923440|NCT00591006|19500153|P6|Treatment #2|Overall Study||0
7923441|NCT00591006|19500154|P5|Treatment #2|Overall Study||1
7923442|NCT00591006|19500155|P4|Treatment #2|Overall Study||1
7923443|NCT00591006|19500156|P3|Treatment #2|Overall Study||1
7923444|NCT00591006|19500157|P2|Treatment #2|Overall Study||0
7923445|NCT00591006|19500158|P1|Treatment #2|Overall Study||1
7923446|NCT00591006|19500135|P24|STARTED|Overall Study||1
7923447|NCT00591006|19500136|P23|STARTED|Overall Study||1
7923448|NCT00591006|19500137|P22|STARTED|Overall Study||1
7923449|NCT00591006|19500138|P21|STARTED|Overall Study||0
7923450|NCT00591006|19500139|P20|STARTED|Overall Study||1
7923451|NCT00591006|19500140|P19|STARTED|Overall Study||0
7923452|NCT00591006|19500141|P18|STARTED|Overall Study||1
7923453|NCT00591006|19500142|P17|STARTED|Overall Study||0
7923454|NCT00591006|19500143|P16|STARTED|Overall Study||1
7923455|NCT00591006|19500144|P15|STARTED|Overall Study||0
7923456|NCT00591006|19500145|P14|STARTED|Overall Study||2
7923457|NCT00591006|19500146|P13|STARTED|Overall Study||1
7923458|NCT00591006|19500147|P12|STARTED|Overall Study||1
7923459|NCT00591006|19500148|P11|STARTED|Overall Study||0
7923460|NCT00591006|19500149|P10|STARTED|Overall Study||1
7923461|NCT00591006|19500150|P9|STARTED|Overall Study||1
7923462|NCT00591006|19500151|P8|STARTED|Overall Study||0
7923463|NCT00591006|19500152|P7|STARTED|Overall Study||1
7923464|NCT00591006|19500153|P6|STARTED|Overall Study||0
7923465|NCT00591006|19500154|P5|STARTED|Overall Study||1
7923466|NCT00591006|19500155|P4|STARTED|Overall Study||1
7923467|NCT00591006|19500156|P3|STARTED|Overall Study||1
7923468|NCT00591006|19500157|P2|STARTED|Overall Study||0
7923469|NCT00591006|19500158|P1|STARTED|Overall Study||1
7923470|NCT00590980|19500176|P1|NOT COMPLETED|Overall Study||10
7923471|NCT00590980|19500176|P1|COMPLETED|Overall Study||72
7923472|NCT00590980|19500176|P1|STARTED|Overall Study||82
7923473|NCT00590967|19500182|P2|NOT COMPLETED|Overall Study||5
7923474|NCT00590967|19500183|P1|NOT COMPLETED|Overall Study||3
7923475|NCT00590967|19500182|P2|COMPLETED|Overall Study||20
7923476|NCT00590967|19500183|P1|COMPLETED|Overall Study||41
7923477|NCT00590967|19500182|P2|STARTED|Overall Study||25
7923478|NCT00590967|19500183|P1|STARTED|Overall Study||44
7923479|NCT00590954|19500195|P1|NOT COMPLETED|Overall Study||2
7923480|NCT00590954|19500195|P1|COMPLETED|Overall Study||30
7923481|NCT00590954|19500195|P1|STARTED|Overall Study||32
7923482|NCT00590902|19500201|P1|NOT COMPLETED|Overall Study||1
7923483|NCT00590902|19500201|P1|COMPLETED|Overall Study||80
7923484|NCT00590902|19500201|P1|STARTED|Overall Study||81
7923485|NCT00590889|19500207|P2|NOT COMPLETED|Overall Study||299
7923486|NCT00590889|19500208|P1|NOT COMPLETED|Overall Study||286
7923487|NCT00590889|19500207|P2|COMPLETED|Overall Study||104
7923488|NCT00590889|19500208|P1|COMPLETED|Overall Study||118
7923489|NCT00590889|19500207|P2|STARTED|Overall Study||403
7923490|NCT00590889|19500208|P1|STARTED|Overall Study||404
7923491|NCT00590863|19500217|P3|NOT COMPLETED|Overall Study||78
7923492|NCT00590863|19500218|P2|NOT COMPLETED|Overall Study||82
7923493|NCT00590863|19500219|P1|NOT COMPLETED|Overall Study||84
7923494|NCT00590863|19500217|P3|COMPLETED|Overall Study||146
7923495|NCT00590863|19500218|P2|COMPLETED|Overall Study||138
7923496|NCT00590863|19500219|P1|COMPLETED|Overall Study||137
7923497|NCT00590863|19500217|P3|STARTED|Overall Study||224
7923498|NCT00590863|19500218|P2|STARTED|Overall Study||220
7923499|NCT00590863|19500219|P1|STARTED|Overall Study||221
7923500|NCT00590824|19500234|P4|NOT COMPLETED|Overall Study||1
7923501|NCT00590824|19500235|P3|NOT COMPLETED|Overall Study||1
7923502|NCT00590824|19500236|P2|NOT COMPLETED|Overall Study||2
7923503|NCT00590824|19500237|P1|NOT COMPLETED|Overall Study||0
7923504|NCT00590824|19500234|P4|COMPLETED|Overall Study||0
7923505|NCT00590824|19500235|P3|COMPLETED|Overall Study||1
7923506|NCT00590824|19500236|P2|COMPLETED|Overall Study||7
7923507|NCT00590824|19500237|P1|COMPLETED|Overall Study||11
7923508|NCT00590824|19500234|P4|STARTED|Overall Study||1
7923509|NCT00590824|19500235|P3|STARTED|Overall Study||2
7923510|NCT00590824|19500236|P2|STARTED|Overall Study||9
7923511|NCT00590824|19500237|P1|STARTED|Overall Study||11
7923512|NCT00590772|19500257|P1|NOT COMPLETED|Overall Study||0
7923513|NCT00590772|19500257|P1|COMPLETED|Overall Study||31
7923514|NCT00590772|19500257|P1|STARTED|Overall Study||31
7923515|NCT00590759|19500263|P1|NOT COMPLETED|Overall Study||80
7923516|NCT00590759|19500263|P1|COMPLETED|Overall Study||70
7923517|NCT00590759|19500263|P1|STARTED|Overall Study||150
7923518|NCT00590720|19500270|P2|NOT COMPLETED|Overall Study||1
7923519|NCT00590720|19500271|P1|NOT COMPLETED|Overall Study||1
7923520|NCT00590720|19500270|P2|COMPLETED|Overall Study||6
7923521|NCT00590720|19500271|P1|COMPLETED|Overall Study||3
7923522|NCT00590720|19500270|P2|STARTED|Overall Study||7
7923523|NCT00590720|19500271|P1|STARTED|Overall Study||4
7923524|NCT00590707|19500315|P2|NOT COMPLETED|Overall Study||0
7923525|NCT00590707|19500316|P1|NOT COMPLETED|Overall Study||0
7923526|NCT00590707|19500315|P2|COMPLETED|Overall Study||100
7923527|NCT00590707|19500316|P1|COMPLETED|Overall Study||100
7923528|NCT00590707|19500315|P2|STARTED|Overall Study||100
7923529|NCT00590707|19500316|P1|STARTED|Overall Study||100
7923530|NCT00590590|19500333|P3|NOT COMPLETED|Overall Study||6
7923531|NCT00590590|19500334|P2|NOT COMPLETED|Overall Study||6
7923532|NCT00590590|19500335|P1|NOT COMPLETED|Overall Study||7
7923533|NCT00590590|19500333|P3|COMPLETED|Overall Study||21
7923534|NCT00590590|19500334|P2|COMPLETED|Overall Study||33
7923535|NCT00590590|19500335|P1|COMPLETED|Overall Study||32
7923536|NCT00590590|19500333|P3|STARTED|Overall Study||27
7923537|NCT00590590|19500334|P2|STARTED|Overall Study||39
7923538|NCT00590590|19500335|P1|STARTED|Overall Study||39
7923539|NCT00590577|19500362|P4|NOT COMPLETED|Overall Study||93
7923540|NCT00590577|19500363|P3|NOT COMPLETED|Overall Study||73
7923541|NCT00590577|19500364|P2|NOT COMPLETED|Overall Study||76
7923542|NCT00590577|19500365|P1|NOT COMPLETED|Overall Study||77
7923543|NCT00590577|19500362|P4|COMPLETED|Overall Study||71
7923544|NCT00590577|19500363|P3|COMPLETED|Overall Study||90
7923545|NCT00590577|19500364|P2|COMPLETED|Overall Study||89
7923546|NCT00590577|19500365|P1|COMPLETED|Overall Study||83
7923547|NCT00590577|19500362|P4|STARTED|Overall Study||164
7923548|NCT00590577|19500363|P3|STARTED|Overall Study||163
7923549|NCT00590577|19500364|P2|STARTED|Overall Study||165
7923550|NCT00590577|19500365|P1|STARTED|Overall Study||160
7923551|NCT00590564|19500383|P1|NOT COMPLETED|Overall Study||18
7923552|NCT00590564|19500383|P1|COMPLETED|Overall Study||24
7923553|NCT00590564|19500383|P1|STARTED|Overall Study||42
7923554|NCT00590538|19500387|P1|NOT COMPLETED|Overall Study||2
7923555|NCT00590538|19500387|P1|COMPLETED|Overall Study||7
7923556|NCT00590538|19500387|P1|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9
7923557|NCT00590460|19500395|P1|NOT COMPLETED|Overall Study||0
7923558|NCT00590460|19500395|P1|COMPLETED|Overall Study||5
7923559|NCT00590460|19500395|P1|STARTED|Overall Study||5
7923560|NCT00590395|19500408|P1|NOT COMPLETED|Overall Study||0
7923561|NCT00590395|19500408|P1|COMPLETED|Overall Study||19
7923562|NCT00590395|19500408|P1|STARTED|Overall Study||19
7923563|NCT00590369|19500414|P2|NOT COMPLETED|Overall Study||0
7923564|NCT00590369|19500415|P1|NOT COMPLETED|Overall Study||0
7923565|NCT00590369|19500414|P2|COMPLETED|Overall Study||5
7923566|NCT00590369|19500415|P1|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6
7923567|NCT00590369|19500414|P2|STARTED|Overall Study||5
7923568|NCT00590369|19500415|P1|STARTED|Overall Study||6
7923569|NCT00590317|19500433|P2|NOT COMPLETED|Overall Study||5
7923570|NCT00590317|19500434|P1|NOT COMPLETED|Overall Study||1
7923571|NCT00590317|19500433|P2|COMPLETED|Overall Study||27
7923572|NCT00590317|19500434|P1|COMPLETED|Overall Study||31
7923573|NCT00590317|19500433|P2|STARTED|Overall Study||32
7923574|NCT00590317|19500434|P1|STARTED|Overall Study||32
7923575|NCT00590226|19500446|P2|NOT COMPLETED|Overall Study||0
7923576|NCT00590226|19500447|P1|NOT COMPLETED|Overall Study||0
7923577|NCT00590226|19500446|P2|COMPLETED|Overall Study||63
7923578|NCT00590226|19500447|P1|COMPLETED|Overall Study||67
7923579|NCT00590226|19500446|P2|STARTED|Overall Study||63
7923580|NCT00590226|19500447|P1|STARTED|Overall Study||67
7923581|NCT00590161|19500457|P2|NOT COMPLETED|Overall Study||3
7923582|NCT00590161|19500458|P1|NOT COMPLETED|Overall Study||3
7923583|NCT00590161|19500457|P2|COMPLETED|Overall Study||26
7923584|NCT00590161|19500458|P1|COMPLETED|Overall Study||23
7923585|NCT00590161|19500457|P2|STARTED|Overall Study||29
7923586|NCT00590161|19500458|P1|STARTED|Overall Study||26
7923587|NCT00590135|19500464|P1|NOT COMPLETED|Overall Study||59
7923588|NCT00590135|19500464|P1|COMPLETED|Overall Study||0
7923589|NCT00590135|19500464|P1|STARTED|Overall Study||59
7923590|NCT00590044|19500474|P2|NOT COMPLETED|Overall Study||2
7923591|NCT00590044|19500475|P1|NOT COMPLETED|Overall Study||4
7923592|NCT00590044|19500474|P2|COMPLETED|Overall Study||34
7923593|NCT00590044|19500475|P1|COMPLETED|Overall Study||34
7923594|NCT00590044|19500474|P2|STARTED|Overall Study||36
7923595|NCT00590044|19500475|P1|STARTED|Overall Study||38
7923596|NCT00590031|19500487|P1|NOT COMPLETED|Overall Study||6
7923597|NCT00590031|19500487|P1|COMPLETED|Overall Study||55
7923598|NCT00590031|19500487|P1|STARTED|Overall Study||61
7923599|NCT00590018|19500494|P2|NOT COMPLETED|Overall Study||0
7923600|NCT00590018|19500495|P1|NOT COMPLETED|Overall Study||0
7923601|NCT00590018|19500494|P2|COMPLETED|Overall Study||9
7923602|NCT00590018|19500495|P1|COMPLETED|Overall Study||9
7923603|NCT00590018|19500494|P2|STARTED|Overall Study||9
7923604|NCT00590018|19500495|P1|STARTED|Overall Study||9
7923605|NCT00590005|19500503|P2|NOT COMPLETED|Overall Study||0
7923606|NCT00590005|19500504|P1|NOT COMPLETED|Overall Study||0
7923607|NCT00590005|19500503|P2|COMPLETED|Overall Study||119
7923608|NCT00590005|19500504|P1|COMPLETED|Overall Study||106
7923609|NCT00590005|19500503|P2|STARTED|Overall Study||119
7923610|NCT00590005|19500504|P1|STARTED|Overall Study||106
7923611|NCT00589979|19500514|P3|NOT COMPLETED|Double-Blind Treatment Period 3||1
7923612|NCT00589979|19500515|P2|NOT COMPLETED|Double-Blind Treatment Period 3||1
7923613|NCT00589979|19500516|P1|NOT COMPLETED|Double-Blind Treatment Period 3||0
7923614|NCT00589979|19500514|P3|COMPLETED|Double-Blind Treatment Period 3||38
7923615|NCT00589979|19500515|P2|COMPLETED|Double-Blind Treatment Period 3||46
7923616|NCT00589979|19500516|P1|COMPLETED|Double-Blind Treatment Period 3||0
7923617|NCT00589979|19500514|P3|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39
7923618|NCT00589979|19500515|P2|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47
7923619|NCT00589979|19500516|P1|STARTED|Double-Blind Treatment Period 3||0
7923620|NCT00589979|19500514|P3|NOT COMPLETED|Double-Blind Treatment Period 2||2
7923621|NCT00589979|19500515|P2|NOT COMPLETED|Double-Blind Treatment Period 2||1
7923622|NCT00589979|19500516|P1|NOT COMPLETED|Double-Blind Treatment Period 2||0
7923623|NCT00589979|19500514|P3|COMPLETED|Double-Blind Treatment Period 2||39
7923624|NCT00589979|19500515|P2|COMPLETED|Double-Blind Treatment Period 2||47
7923625|NCT00589979|19500516|P1|COMPLETED|Double-Blind Treatment Period 2||0
7923626|NCT00589979|19500514|P3|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41
7923627|NCT00589979|19500515|P2|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48
7923628|NCT00589979|19500516|P1|STARTED|Double-Blind Treatment Period 2||0
7923629|NCT00589979|19500514|P3|NOT COMPLETED|Double-Blind Treatment Period 1||2
7923630|NCT00589979|19500515|P2|NOT COMPLETED|Double-Blind Treatment Period 1||2
7923631|NCT00589979|19500516|P1|NOT COMPLETED|Double-Blind Treatment Period 1||0
7923632|NCT00589979|19500514|P3|COMPLETED|Double-Blind Treatment Period 1||41
7923633|NCT00589979|19500515|P2|COMPLETED|Double-Blind Treatment Period 1||48
7923634|NCT00589979|19500516|P1|COMPLETED|Double-Blind Treatment Period 1||0
7923635|NCT00589979|19500514|P3|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43
7923636|NCT00589979|19500515|P2|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50
7923637|NCT00589979|19500516|P1|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0
7923638|NCT00589979|19500514|P3|NOT COMPLETED|Run-In Period||0
7923639|NCT00589979|19500515|P2|NOT COMPLETED|Run-In Period||0
7923640|NCT00589979|19500516|P1|NOT COMPLETED|Run-In Period||76
7923641|NCT00589979|19500514|P3|COMPLETED|Run-In Period||0
7923642|NCT00589979|19500515|P2|COMPLETED|Run-In Period||0
7923643|NCT00589979|19500516|P1|COMPLETED|Run-In Period||93
7923644|NCT00589979|19500514|P3|STARTED|Run-In Period||0
7923645|NCT00589979|19500515|P2|STARTED|Run-In Period||0
7923646|NCT00589979|19500516|P1|STARTED|Run-In Period||169
7923647|NCT00589914|19500555|P2|NOT COMPLETED|Overall Study||137
7923648|NCT00589914|19500556|P1|NOT COMPLETED|Overall Study||150
7923649|NCT00589914|19500555|P2|COMPLETED|Overall Study||471
7923650|NCT00589914|19500556|P1|COMPLETED|Overall Study||456
7923651|NCT00589914|19500555|P2|STARTED|Overall Study||608
7923652|NCT00589914|19500556|P1|STARTED|Overall Study||606
7923653|NCT00589888|19500566|P5|NOT COMPLETED|64-gram Oral Fat Load||0
7923654|NCT00589888|19500567|P4|NOT COMPLETED|64-gram Oral Fat Load||0
7923655|NCT00589888|19500568|P3|NOT COMPLETED|64-gram Oral Fat Load||0
7923656|NCT00589888|19500569|P2|NOT COMPLETED|64-gram Oral Fat Load||0
7923657|NCT00589888|19500570|P1|NOT COMPLETED|64-gram Oral Fat Load||0
7923658|NCT00589888|19500566|P5|COMPLETED|64-gram Oral Fat Load||13
7923659|NCT00589888|19500567|P4|COMPLETED|64-gram Oral Fat Load||0
7923660|NCT00589888|19500568|P3|COMPLETED|64-gram Oral Fat Load||0
7923661|NCT00589888|19500569|P2|COMPLETED|64-gram Oral Fat Load||0
7923662|NCT00589888|19500570|P1|COMPLETED|64-gram Oral Fat Load||0
7923663|NCT00589888|19500566|P5|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
7923664|NCT00589888|19500567|P4|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
7923665|NCT00589888|19500568|P3|STARTED|64-gram Oral Fat Load||0
7923666|NCT00589888|19500569|P2|STARTED|64-gram Oral Fat Load||0
7923667|NCT00589888|19500570|P1|STARTED|64-gram Oral Fat Load||0
7923668|NCT00589888|19500566|P5|NOT COMPLETED|32-gram Oral Fat Load||0
7923669|NCT00589888|19500567|P4|NOT COMPLETED|32-gram Oral Fat Load||0
7923670|NCT00589888|19500568|P3|NOT COMPLETED|32-gram Oral Fat Load||0
7923671|NCT00589888|19500569|P2|NOT COMPLETED|32-gram Oral Fat Load||0
7923672|NCT00589888|19500570|P1|NOT COMPLETED|32-gram Oral Fat Load||0
7923673|NCT00589888|19500566|P5|COMPLETED|32-gram Oral Fat Load||0
7923674|NCT00589888|19500567|P4|COMPLETED|32-gram Oral Fat Load||13
7923675|NCT00589888|19500568|P3|COMPLETED|32-gram Oral Fat Load||0
7923676|NCT00589888|19500569|P2|COMPLETED|32-gram Oral Fat Load||0
7923677|NCT00589888|19500570|P1|COMPLETED|32-gram Oral Fat Load||0
7923678|NCT00589888|19500566|P5|STARTED|32-gram Oral Fat Load||0
7923679|NCT00589888|19500567|P4|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
7923680|NCT00589888|19500568|P3|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
7923681|NCT00589888|19500569|P2|STARTED|32-gram Oral Fat Load||0
7923682|NCT00589888|19500570|P1|STARTED|32-gram Oral Fat Load||0
7923683|NCT00589888|19500566|P5|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
7923684|NCT00589888|19500567|P4|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
7923685|NCT00589888|19500568|P3|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
7923686|NCT00589888|19500569|P2|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
7923687|NCT00589888|19500570|P1|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
7923688|NCT00589888|19500566|P5|COMPLETED|Intralipid 20% @ 40cc/Hour||0
7923689|NCT00589888|19500567|P4|COMPLETED|Intralipid 20% @ 40cc/Hour||0
7923690|NCT00589888|19500568|P3|COMPLETED|Intralipid 20% @ 40cc/Hour||13
7923691|NCT00589888|19500569|P2|COMPLETED|Intralipid 20% @ 40cc/Hour||0
7923692|NCT00589888|19500570|P1|COMPLETED|Intralipid 20% @ 40cc/Hour||0
7923693|NCT00589888|19500566|P5|STARTED|Intralipid 20% @ 40cc/Hour||0
7923694|NCT00589888|19500567|P4|STARTED|Intralipid 20% @ 40cc/Hour||0
7923695|NCT00589888|19500568|P3|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
7923696|NCT00589888|19500569|P2|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0
7923697|NCT00589888|19500570|P1|STARTED|Intralipid 20% @ 40cc/Hour||0
7923698|NCT00589888|19500566|P5|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
7923699|NCT00589888|19500567|P4|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
7923700|NCT00589888|19500568|P3|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
7923701|NCT00589888|19500569|P2|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
7923702|NCT00589888|19500570|P1|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
7923703|NCT00589888|19500566|P5|COMPLETED|Intralipid 20% @ 20cc/hr||0
7923704|NCT00589888|19500567|P4|COMPLETED|Intralipid 20% @ 20cc/hr||0
7923705|NCT00589888|19500568|P3|COMPLETED|Intralipid 20% @ 20cc/hr||0
7923706|NCT00589888|19500569|P2|COMPLETED|Intralipid 20% @ 20cc/hr||13
7923707|NCT00589888|19500570|P1|COMPLETED|Intralipid 20% @ 20cc/hr||0
7923708|NCT00589888|19500566|P5|STARTED|Intralipid 20% @ 20cc/hr||0
7923709|NCT00589888|19500567|P4|STARTED|Intralipid 20% @ 20cc/hr||0
7923710|NCT00589888|19500568|P3|STARTED|Intralipid 20% @ 20cc/hr||0
7923711|NCT00589888|19500569|P2|STARTED|Intralipid 20% @ 20cc/hr||13
7923712|NCT00589888|19500570|P1|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0
7923713|NCT00589888|19500566|P5|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
7923714|NCT00589888|19500567|P4|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
7923715|NCT00589888|19500568|P3|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
7923716|NCT00589888|19500569|P2|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
7923717|NCT00589888|19500570|P1|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
7923718|NCT00589888|19500566|P5|COMPLETED|Normal Saline @ 40cc/Hour||0
7923719|NCT00589888|19500567|P4|COMPLETED|Normal Saline @ 40cc/Hour||0
7923720|NCT00589888|19500568|P3|COMPLETED|Normal Saline @ 40cc/Hour||0
7923721|NCT00589888|19500569|P2|COMPLETED|Normal Saline @ 40cc/Hour||0
7923722|NCT00589888|19500570|P1|COMPLETED|Normal Saline @ 40cc/Hour||13
7923723|NCT00589888|19500566|P5|STARTED|Normal Saline @ 40cc/Hour||0
7923724|NCT00589888|19500567|P4|STARTED|Normal Saline @ 40cc/Hour||0
7923725|NCT00589888|19500568|P3|STARTED|Normal Saline @ 40cc/Hour||0
7923726|NCT00589888|19500569|P2|STARTED|Normal Saline @ 40cc/Hour||0
7923727|NCT00589888|19500570|P1|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
7923728|NCT00589849|19500602|P1|NOT COMPLETED|Overall Study||0
7923729|NCT00589849|19500602|P1|COMPLETED|Overall Study||32
7923730|NCT00589849|19500602|P1|STARTED|Overall Study||32
7923731|NCT00589836|19500606|P1|NOT COMPLETED|Overall Study||0
7923732|NCT00589836|19500606|P1|COMPLETED|Overall Study||20
7923733|NCT00589836|19500606|P1|STARTED|Overall Study||20
7923734|NCT00589797|19500612|P2|NOT COMPLETED|Overall Study||23
7923735|NCT00589797|19500613|P1|NOT COMPLETED|Overall Study||73
7923736|NCT00589797|19500612|P2|COMPLETED|Overall Study||89
7923737|NCT00589797|19500613|P1|COMPLETED|Overall Study||191
7923738|NCT00589797|19500612|P2|24 Months|Overall Study||89
7923739|NCT00589797|19500613|P1|24 Months|Overall Study||191
7923740|NCT00589797|19500612|P2|Baseline|Overall Study||106
7923741|NCT00589797|19500613|P1|Baseline|Overall Study||218
7923742|NCT00589797|19500612|P2|STARTED|Overall Study||112
7923743|NCT00589797|19500613|P1|STARTED|Overall Study||264
7923744|NCT00589784|19500637|P2|NOT COMPLETED|Overall Study||10
7923745|NCT00589784|19500638|P1|NOT COMPLETED|Overall Study||1
7923746|NCT00589784|19500637|P2|COMPLETED|Overall Study||4
7923747|NCT00589784|19500638|P1|COMPLETED|Overall Study||35
7923748|NCT00589784|19500637|P2|STARTED|Overall Study||14
7923749|NCT00589784|19500638|P1|STARTED|Overall Study||36
7923750|NCT00589693|19500645|P2|NOT COMPLETED|Overall Study||29
7923751|NCT00589693|19500646|P1|NOT COMPLETED|Overall Study||44
7923752|NCT00589693|19500645|P2|COMPLETED|Overall Study||83
7923753|NCT00589693|19500646|P1|COMPLETED|Overall Study||71
7923754|NCT00589693|19500645|P2|STARTED|Overall Study||112
7923755|NCT00589693|19500646|P1|STARTED|Overall Study||115
7923756|NCT00589667|19500660|P1|NOT COMPLETED|Overall Study||3
7923757|NCT00589667|19500660|P1|COMPLETED|Overall Study||23
7923758|NCT00589667|19500660|P1|STARTED|Overall Study||26
7923759|NCT00589628|19500667|P2|NOT COMPLETED|Overall Study||1
7923760|NCT00589628|19500668|P1|NOT COMPLETED|Overall Study||0
7923761|NCT00589628|19500667|P2|COMPLETED|Overall Study||5
7923762|NCT00589628|19500668|P1|COMPLETED|Overall Study||7
7923763|NCT00589628|19500667|P2|STARTED|Overall Study||6
7923764|NCT00589628|19500668|P1|STARTED|Overall Study||7
7923765|NCT00589602|19500674|P1|NOT COMPLETED|Overall Study||1
7923766|NCT00589602|19500674|P1|COMPLETED|Overall Study||12
7923767|NCT00589602|19500674|P1|STARTED|Overall Study||13
7923768|NCT00589563|19500682|P1|NOT COMPLETED|Overall Study||0
7923769|NCT00589563|19500682|P1|COMPLETED|Overall Study||32
7923770|NCT00589563|19500682|P1|STARTED|Overall Study||32
7923771|NCT00589550|19500699|P1|NOT COMPLETED|Overall Study||1
7923772|NCT00589550|19500699|P1|COMPLETED|Overall Study||0
7923773|NCT00589550|19500699|P1|Withdrew From Study|Overall Study||1
7923774|NCT00589550|19500699|P1|STARTED|Overall Study||1
7923775|NCT00589472|19500709|P1|NOT COMPLETED|Overall Study||1
7923776|NCT00589472|19500709|P1|COMPLETED|Overall Study||18
7923777|NCT00589472|19500709|P1|STARTED|Overall Study||19
7923778|NCT00589329|19500721|P2|NOT COMPLETED|Overall Study||0
7923779|NCT00589329|19500722|P1|NOT COMPLETED|Overall Study||0
7923780|NCT00589329|19500721|P2|COMPLETED|Overall Study||10
7923781|NCT00589329|19500722|P1|COMPLETED|Overall Study||10
7923782|NCT00589329|19500721|P2|STARTED|Overall Study||10
7923783|NCT00589329|19500722|P1|STARTED|Overall Study||10
7923784|NCT00589303|19500732|P2|NOT COMPLETED|Overall Study||1
7923785|NCT00589303|19500733|P1|NOT COMPLETED|Overall Study||2
7923786|NCT00589303|19500732|P2|COMPLETED|Overall Study||12
7923787|NCT00589303|19500733|P1|COMPLETED|Overall Study||12
7923788|NCT00589303|19500732|P2|STARTED|Overall Study||13
7923789|NCT00589303|19500733|P1|STARTED|Overall Study||14
7923790|NCT00589290|19500739|P1|NOT COMPLETED|Overall Study||1
7923791|NCT00589290|19500739|P1|COMPLETED|Overall Study||40
7923792|NCT00589290|19500739|P1|STARTED|Overall Study||41
7923793|NCT00589277|19500749|P2|NOT COMPLETED|Overall Study||286
7923794|NCT00589277|19500750|P1|NOT COMPLETED|Overall Study||460
7923795|NCT00589277|19500749|P2|COMPLETED|Overall Study||524
7923796|NCT00589277|19500750|P1|COMPLETED|Overall Study||762
7923797|NCT00589277|19500749|P2|Completed 3 Month Follow Up|Overall Study||524
7923798|NCT00589277|19500750|P1|Completed 3 Month Follow Up|Overall Study||762
7923799|NCT00589277|19500749|P2|Completed 2 Week Follow Up|Overall Study||424
7923800|NCT00589277|19500750|P1|Completed 2 Week Follow Up|Overall Study||603
7923801|NCT00589277|19500749|P2|STARTED|Overall Study||810
7923802|NCT00589277|19500750|P1|STARTED|Overall Study||1222
7923803|NCT00589121|19500762|P2|NOT COMPLETED|Overall Study||7
7923804|NCT00589121|19500763|P1|NOT COMPLETED|Overall Study||2
7923805|NCT00589121|19500762|P2|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|79
7923806|NCT00589121|19500763|P1|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|10
7923807|NCT00589121|19500762|P2|STARTED|Overall Study||86
7923808|NCT00589121|19500763|P1|STARTED|Overall Study||12
7923809|NCT00589108|19500785|P3|NOT COMPLETED|Overall Study||5
7923810|NCT00589108|19500786|P2|NOT COMPLETED|Overall Study||4
7923811|NCT00589108|19500787|P1|NOT COMPLETED|Overall Study||4
7923812|NCT00589108|19500785|P3|COMPLETED|Overall Study||75
7923813|NCT00589108|19500786|P2|COMPLETED|Overall Study||76
7923814|NCT00589108|19500787|P1|COMPLETED|Overall Study||76
7923815|NCT00589108|19500785|P3|STARTED|Overall Study||80
7923816|NCT00589108|19500786|P2|STARTED|Overall Study||80
7923817|NCT00589108|19500787|P1|STARTED|Overall Study||80
7923818|NCT00589056|19500807|P1|NOT COMPLETED|Overall Study||3
7923819|NCT00589056|19500807|P1|COMPLETED|Overall Study||52
7923820|NCT00589056|19500807|P1|STARTED|Overall Study||55
7923821|NCT00588965|19500813|P1|NOT COMPLETED|Overall Study||0
7923822|NCT00588965|19500813|P1|COMPLETED|Overall Study||35
7923823|NCT00588965|19500813|P1|STARTED|Overall Study||35
7923824|NCT00588952|19500823|P2|NOT COMPLETED|Overall Study||7
7923825|NCT00588952|19500824|P1|NOT COMPLETED|Overall Study||3
7923826|NCT00588952|19500823|P2|COMPLETED|Overall Study||63
7923827|NCT00588952|19500824|P1|COMPLETED|Overall Study||26
7923828|NCT00588952|19500823|P2|STARTED|Overall Study||70
7923829|NCT00588952|19500824|P1|STARTED|Overall Study||29
7923830|NCT00588900|19500844|P1|NOT COMPLETED|Overall Study||0
7923831|NCT00588900|19500844|P1|COMPLETED|Overall Study||5
7923832|NCT00588900|19500844|P1|STARTED|Overall Study||5
7923833|NCT00588861|19500852|P2|NOT COMPLETED|10 Years||114
7923834|NCT00588861|19500853|P1|NOT COMPLETED|10 Years||107
7923835|NCT00588861|19500852|P2|COMPLETED|10 Years||0
7923836|NCT00588861|19500853|P1|COMPLETED|10 Years||0
7923837|NCT00588861|19500852|P2|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114
7923838|NCT00588861|19500853|P1|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107
7923839|NCT00588861|19500852|P2|NOT COMPLETED|8 Years||114
7923840|NCT00588861|19500853|P1|NOT COMPLETED|8 Years||105
7923841|NCT00588861|19500852|P2|COMPLETED|8 Years||0
7923842|NCT00588861|19500853|P1|COMPLETED|8 Years||2
7923843|NCT00588861|19500852|P2|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114
7923844|NCT00588861|19500853|P1|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107
7923845|NCT00588861|19500852|P2|NOT COMPLETED|6 Years||109
7923846|NCT00588861|19500853|P1|NOT COMPLETED|6 Years||104
7923847|NCT00588861|19500852|P2|COMPLETED|6 Years||5
7923848|NCT00588861|19500853|P1|COMPLETED|6 Years||3
7923849|NCT00588861|19500852|P2|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114
7923850|NCT00588861|19500853|P1|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107
7923851|NCT00588861|19500852|P2|NOT COMPLETED|4 Years||103
7923852|NCT00588861|19500853|P1|NOT COMPLETED|4 Years||91
7923853|NCT00588861|19500852|P2|COMPLETED|4 Years||11
7923854|NCT00588861|19500853|P1|COMPLETED|4 Years||16
7923855|NCT00588861|19500852|P2|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114
7923856|NCT00588861|19500853|P1|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107
7923857|NCT00588861|19500852|P2|NOT COMPLETED|2 Years||87
7923858|NCT00588861|19500853|P1|NOT COMPLETED|2 Years||92
7923859|NCT00588861|19500852|P2|COMPLETED|2 Years||27
7923860|NCT00588861|19500853|P1|COMPLETED|2 Years||15
7923861|NCT00588861|19500852|P2|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114
7923862|NCT00588861|19500853|P1|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107
7923863|NCT00588861|19500852|P2|NOT COMPLETED|1 Year||82
7923864|NCT00588861|19500853|P1|NOT COMPLETED|1 Year||89
7923865|NCT00588861|19500852|P2|COMPLETED|1 Year||32
7923866|NCT00588861|19500853|P1|COMPLETED|1 Year||18
7923867|NCT00588861|19500852|P2|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114
7923868|NCT00588861|19500853|P1|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107
7923869|NCT00588861|19500852|P2|NOT COMPLETED|6 Months||73
7923870|NCT00588861|19500853|P1|NOT COMPLETED|6 Months||98
7923871|NCT00588861|19500852|P2|COMPLETED|6 Months||41
7923872|NCT00588861|19500853|P1|COMPLETED|6 Months||9
7923873|NCT00588861|19500852|P2|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114
7923874|NCT00588861|19500853|P1|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107
7923875|NCT00588861|19500852|P2|NOT COMPLETED|Pre-Operative||86
7923876|NCT00588861|19500853|P1|NOT COMPLETED|Pre-Operative||95
7923877|NCT00588861|19500852|P2|COMPLETED|Pre-Operative||114
7923878|NCT00588861|19500853|P1|COMPLETED|Pre-Operative||107
7923879|NCT00588861|19500852|P2|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200
7923880|NCT00588861|19500853|P1|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202
7923881|NCT00588848|19500863|P2|NOT COMPLETED|Overall Study||3
7923882|NCT00588848|19500864|P1|NOT COMPLETED|Overall Study||0
7923883|NCT00588848|19500863|P2|COMPLETED|Overall Study||5
7923884|NCT00588848|19500864|P1|COMPLETED|Overall Study||3
7923885|NCT00588848|19500863|P2|STARTED|Overall Study||8
7923886|NCT00588848|19500864|P1|STARTED|Overall Study||3
7923887|NCT00588822|19500874|P1|NOT COMPLETED|Overall Study||8
7923888|NCT00588822|19500874|P1|COMPLETED|Overall Study||13
7923889|NCT00588822|19500874|P1|STARTED|Overall Study||21
7923890|NCT00588809|19500883|P1|NOT COMPLETED|Overall Study||0
7923891|NCT00588809|19500883|P1|COMPLETED|Overall Study||47
7923892|NCT00588809|19500883|P1|STARTED|Overall Study||47
7923893|NCT00588770|19500894|P2|NOT COMPLETED|Overall Study||200
7923894|NCT00588770|19500895|P1|NOT COMPLETED|Overall Study||159
7923895|NCT00588770|19500894|P2|COMPLETED|Overall Study||3
7923896|NCT00588770|19500895|P1|COMPLETED|Overall Study||41
7923897|NCT00588770|19500894|P2|Start Protocol Therapy|Overall Study||194
7923898|NCT00588770|19500895|P1|Start Protocol Therapy|Overall Study||200
7923899|NCT00588770|19500894|P2|Eligible|Overall Study||183
7923900|NCT00588770|19500895|P1|Eligible|Overall Study||188
7923901|NCT00588770|19500894|P2|STARTED|Overall Study||203
7923902|NCT00588770|19500895|P1|STARTED|Overall Study||200
7923903|NCT00588731|19500907|P2|NOT COMPLETED|Overall Study||2
7923904|NCT00588731|19500908|P1|NOT COMPLETED|Overall Study||3
7923905|NCT00588731|19500907|P2|COMPLETED|Overall Study||18
7923906|NCT00588731|19500908|P1|COMPLETED|Overall Study||18
7923907|NCT00588731|19500907|P2|STARTED|Overall Study||20
7923908|NCT00588731|19500908|P1|STARTED|Overall Study||21
7923909|NCT00588692|19500918|P2|NOT COMPLETED|Overall Study||3
7923910|NCT00588692|19500919|P1|NOT COMPLETED|Overall Study||7
7923911|NCT00588692|19500918|P2|COMPLETED|Overall Study||27
7923912|NCT00588692|19500919|P1|COMPLETED|Overall Study||23
7923913|NCT00588692|19500918|P2|STARTED|Overall Study||30
7923914|NCT00588692|19500919|P1|STARTED|Overall Study||30
7923915|NCT00588666|19500955|P1|NOT COMPLETED|Overall Study||4
7923916|NCT00588666|19500955|P1|COMPLETED|Overall Study||47
7923917|NCT00588666|19500955|P1|STARTED|Overall Study||51
7923918|NCT00588640|19500960|P1|NOT COMPLETED|Overall Study||2
7923919|NCT00588640|19500960|P1|COMPLETED|Overall Study||8
7923920|NCT00588640|19500960|P1|STARTED|Overall Study||10
7923921|NCT00588536|19500964|P1|NOT COMPLETED|Overall Study||0
7923922|NCT00588536|19500964|P1|COMPLETED|Overall Study||5
7923923|NCT00588536|19500964|P1|STARTED|Overall Study||5
7923924|NCT00588471|19500970|P2|NOT COMPLETED|Overall Study||0
7923925|NCT00588471|19500971|P1|NOT COMPLETED|Overall Study||0
7923926|NCT00588471|19500970|P2|COMPLETED|Overall Study||29
7923927|NCT00588471|19500971|P1|COMPLETED|Overall Study||28
7923928|NCT00588471|19500970|P2|STARTED|Overall Study||29
7923929|NCT00588471|19500971|P1|STARTED|Overall Study||28
7923930|NCT00588445|19500979|P1|NOT COMPLETED|Overall Study||15
7923931|NCT00588445|19500979|P1|COMPLETED|Overall Study||50
7923932|NCT00588445|19500979|P1|STARTED|Overall Study||65
7923933|NCT00588406|19500987|P2|NOT COMPLETED|Overall Study||0
7923934|NCT00588406|19500988|P1|NOT COMPLETED|Overall Study||0
7923935|NCT00588406|19500987|P2|COMPLETED|Overall Study||49
7923936|NCT00588406|19500988|P1|COMPLETED|Overall Study||46
7923937|NCT00588406|19500987|P2|STARTED|Overall Study||49
7923938|NCT00588406|19500988|P1|STARTED|Overall Study||46
7923939|NCT00588380|19500996|P1|NOT COMPLETED|Overall Study||0
7923940|NCT00588380|19500996|P1|COMPLETED|Overall Study||88
7923941|NCT00588380|19500996|P1|STARTED|Overall Study||88
7923942|NCT00588354|19501003|P2|NOT COMPLETED|Baseline to 4 Weeks||1
7923943|NCT00588354|19501004|P1|NOT COMPLETED|Baseline to 4 Weeks||0
7923944|NCT00588354|19501003|P2|COMPLETED|Baseline to 4 Weeks||14
7923945|NCT00588354|19501004|P1|COMPLETED|Baseline to 4 Weeks||9
7923946|NCT00588354|19501003|P2|STARTED|Baseline to 4 Weeks||15
7923947|NCT00588354|19501004|P1|STARTED|Baseline to 4 Weeks||9
7923948|NCT00588354|19501003|P2|NOT COMPLETED|Baseline to 2 Weeks||0
7923949|NCT00588354|19501004|P1|NOT COMPLETED|Baseline to 2 Weeks||2
7923950|NCT00588354|19501003|P2|COMPLETED|Baseline to 2 Weeks||15
7923951|NCT00588354|19501004|P1|COMPLETED|Baseline to 2 Weeks||9
7923952|NCT00588354|19501003|P2|STARTED|Baseline to 2 Weeks||15
7923953|NCT00588354|19501004|P1|STARTED|Baseline to 2 Weeks||11
7923954|NCT00588341|19501024|P1|NOT COMPLETED|Overall Study||5
7923955|NCT00588341|19501024|P1|COMPLETED|Overall Study||19
7923956|NCT00588341|19501024|P1|STARTED|Overall Study||24
7923957|NCT00588237|19501028|P1|NOT COMPLETED|Overall Study||4
7923958|NCT00588237|19501028|P1|COMPLETED|Overall Study||38
7923959|NCT00588237|19501028|P1|STARTED|Overall Study||42
7923960|NCT00588159|19501034|P2|NOT COMPLETED|Overall Study||11
7923961|NCT00588159|19501035|P1|NOT COMPLETED|Overall Study||15
7923962|NCT00588159|19501034|P2|COMPLETED|Overall Study||63
7923963|NCT00588159|19501035|P1|COMPLETED|Overall Study||57
7923964|NCT00588159|19501034|P2|STARTED|Overall Study||74
7923965|NCT00588159|19501035|P1|STARTED|Overall Study||72
7923966|NCT00588146|19501051|P2|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
7923967|NCT00588146|19501052|P1|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
7923968|NCT00588146|19501051|P2|COMPLETED|Second Intervention (6 Months to 1 Year)||2
7923969|NCT00588146|19501052|P1|COMPLETED|Second Intervention (6 Months to 1 Year)||1
7923970|NCT00588146|19501051|P2|STARTED|Second Intervention (6 Months to 1 Year)||2
7923971|NCT00588146|19501052|P1|STARTED|Second Intervention (6 Months to 1 Year)||1
7923972|NCT00588146|19501051|P2|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3
7923973|NCT00588146|19501052|P1|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4
7923974|NCT00588146|19501051|P2|COMPLETED|First Intervention (Baseline to 6 mo)||2
7923975|NCT00588146|19501052|P1|COMPLETED|First Intervention (Baseline to 6 mo)||1
7923976|NCT00588146|19501051|P2|STARTED|First Intervention (Baseline to 6 mo)||5
7923977|NCT00588146|19501052|P1|STARTED|First Intervention (Baseline to 6 mo)||5
7923978|NCT00588094|19501058|P1|NOT COMPLETED|Overall Study||5
7923979|NCT00588094|19501058|P1|COMPLETED|Overall Study||15
7923980|NCT00588094|19501058|P1|STARTED|Overall Study||20
7923981|NCT00587990|19501065|P3|NOT COMPLETED|Overall Study||1
7923982|NCT00587990|19501066|P2|NOT COMPLETED|Overall Study||0
7923983|NCT00587990|19501067|P1|NOT COMPLETED|Overall Study||0
7923984|NCT00587990|19501065|P3|COMPLETED|Overall Study||2
7923985|NCT00587990|19501066|P2|COMPLETED|Overall Study||4
7923986|NCT00587990|19501067|P1|COMPLETED|Overall Study||2
7923987|NCT00587990|19501065|P3|STARTED|Overall Study||3
7923988|NCT00587990|19501066|P2|STARTED|Overall Study||4
7923989|NCT00587990|19501067|P1|STARTED|Overall Study||2
7923990|NCT00587964|19501110|P1|NOT COMPLETED|Overall Study||12
7923991|NCT00587964|19501110|P1|COMPLETED|Overall Study||39
7923992|NCT00587964|19501110|P1|STARTED|Overall Study||51
7923993|NCT00587860|19501116|P2|NOT COMPLETED|Overall Study||5
7923994|NCT00587860|19501117|P1|NOT COMPLETED|Overall Study||5
7923995|NCT00587860|19501116|P2|COMPLETED|Overall Study||30
7923996|NCT00587860|19501117|P1|COMPLETED|Overall Study||30
7923997|NCT00587860|19501116|P2|STARTED|Overall Study||35
7923998|NCT00587860|19501117|P1|STARTED|Overall Study||35
7923999|NCT00587847|19501137|P1|NOT COMPLETED|Overall Study||7
7924000|NCT00587847|19501137|P1|COMPLETED|Overall Study||5
7924001|NCT00587847|19501137|P1|STARTED|Overall Study||12
7924002|NCT00587834|19501142|P1|NOT COMPLETED|Overall Study||0
7924003|NCT00587834|19501142|P1|COMPLETED|Overall Study||96
7924004|NCT00587834|19501142|P1|STARTED|Overall Study||96
7924005|NCT00587795|19501160|P2|NOT COMPLETED|Overall Study||0
7924006|NCT00587795|19501161|P1|NOT COMPLETED|Overall Study||1
7924007|NCT00587795|19501160|P2|COMPLETED|Overall Study||0
7924008|NCT00587795|19501161|P1|COMPLETED|Overall Study||0
7924009|NCT00587795|19501160|P2|STARTED|Overall Study||0
7924010|NCT00587795|19501161|P1|STARTED|Overall Study||1
7924011|NCT00587769|19501167|P1|NOT COMPLETED|Overall Study||0
7924012|NCT00587769|19501167|P1|COMPLETED|Overall Study||38
7924013|NCT00587769|19501167|P1|STARTED|Overall Study||38
7924014|NCT00587678|19501175|P3|NOT COMPLETED|Overall Study||8
7924015|NCT00587678|19501176|P2|NOT COMPLETED|Overall Study||4
7924016|NCT00587678|19501177|P1|NOT COMPLETED|Overall Study||6
7924017|NCT00587678|19501175|P3|COMPLETED|Overall Study||33
7924018|NCT00587678|19501176|P2|COMPLETED|Overall Study||18
7924019|NCT00587678|19501177|P1|COMPLETED|Overall Study||16
7924020|NCT00587678|19501175|P3|STARTED|Overall Study||41
7924021|NCT00587678|19501176|P2|STARTED|Overall Study||22
7924022|NCT00587678|19501177|P1|STARTED|Overall Study||22
7924023|NCT00587639|19501215|P1|NOT COMPLETED|Overall Study||1
7924024|NCT00587639|19501215|P1|COMPLETED|Overall Study||7
7924025|NCT00587639|19501215|P1|STARTED|Overall Study||8
7924026|NCT00587587|19501222|P2|NOT COMPLETED|Overall Study||1
7924027|NCT00587587|19501223|P1|NOT COMPLETED|Overall Study||6
7924028|NCT00587587|19501222|P2|COMPLETED|Overall Study||12
7924029|NCT00587587|19501223|P1|COMPLETED|Overall Study||11
7924030|NCT00587587|19501222|P2|STARTED|Overall Study||13
7924031|NCT00587587|19501223|P1|STARTED|Overall Study||17
7924032|NCT00587483|19501246|P3|NOT COMPLETED|Overall Study||0
7924033|NCT00587483|19501247|P2|NOT COMPLETED|Overall Study||0
7924034|NCT00587483|19501248|P1|NOT COMPLETED|Overall Study||0
7924035|NCT00587483|19501246|P3|COMPLETED|Overall Study||112
7924036|NCT00587483|19501247|P2|COMPLETED|Overall Study||115
7924037|NCT00587483|19501248|P1|COMPLETED|Overall Study||115
7924038|NCT00587483|19501246|P3|STARTED|Overall Study||112
7924039|NCT00587483|19501247|P2|STARTED|Overall Study||115
7924040|NCT00587483|19501248|P1|STARTED|Overall Study||115
7924041|NCT00587457|19501277|P3|NOT COMPLETED|Overall Study||5
7924042|NCT00587457|19501278|P2|NOT COMPLETED|Overall Study||3
7924043|NCT00587457|19501279|P1|NOT COMPLETED|Overall Study||3
7924044|NCT00587457|19501277|P3|COMPLETED|Overall Study||0
7924045|NCT00587457|19501278|P2|COMPLETED|Overall Study||0
7924046|NCT00587457|19501279|P1|COMPLETED|Overall Study||0
7924047|NCT00587457|19501277|P3|STARTED|Overall Study||5
7924048|NCT00587457|19501278|P2|STARTED|Overall Study||3
7924049|NCT00587457|19501279|P1|STARTED|Overall Study||3
7924050|NCT00587431|19501316|P2|NOT COMPLETED|Overall Study||1
7924051|NCT00587431|19501317|P1|NOT COMPLETED|Overall Study||1
7924052|NCT00587431|19501316|P2|COMPLETED|Overall Study||38
7924053|NCT00587431|19501317|P1|COMPLETED|Overall Study||62
7924054|NCT00587431|19501316|P2|STARTED|Overall Study||39
7924055|NCT00587431|19501317|P1|STARTED|Overall Study||63
7924056|NCT00587288|19501328|P2|NOT COMPLETED|Overall Study||9
7924057|NCT00587288|19501329|P1|NOT COMPLETED|Overall Study||3
7924058|NCT00587288|19501328|P2|COMPLETED|Overall Study||44
7924059|NCT00587288|19501329|P1|COMPLETED|Overall Study||50
7924060|NCT00587288|19501328|P2|STARTED|Overall Study||53
7924061|NCT00587288|19501329|P1|STARTED|Overall Study||53
7924062|NCT00587223|19501347|P1|NOT COMPLETED|Overall Study||1
7924063|NCT00587223|19501347|P1|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0
7924064|NCT00587223|19501347|P1|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1
7924065|NCT00587171|19501364|P2|NOT COMPLETED|Overall Study||1
7924066|NCT00587171|19501365|P1|NOT COMPLETED|Overall Study||1
7924067|NCT00587171|19501364|P2|COMPLETED|Overall Study||9
7924068|NCT00587171|19501365|P1|COMPLETED|Overall Study||8
7924069|NCT00587171|19501364|P2|STARTED|Overall Study||10
7924070|NCT00587171|19501365|P1|STARTED|Overall Study||9
7924071|NCT00587158|19501395|P2|NOT COMPLETED|Overall Study||8
7924072|NCT00587158|19501396|P1|NOT COMPLETED|Overall Study||5
7924073|NCT00587158|19501395|P2|COMPLETED|Overall Study||43
7924074|NCT00587158|19501396|P1|COMPLETED|Overall Study||44
7924075|NCT00587158|19501395|P2|Continued in Study|Overall Study||46
7924076|NCT00587158|19501396|P1|Continued in Study|Overall Study||45
7924077|NCT00587158|19501395|P2|STARTED|Overall Study||51
7924078|NCT00587158|19501396|P1|STARTED|Overall Study||49
7924079|NCT00587132|19501430|P4|NOT COMPLETED|Overall Study||0
7924080|NCT00587132|19501431|P3|NOT COMPLETED|Overall Study||0
7924081|NCT00587132|19501432|P2|NOT COMPLETED|Overall Study||0
7924082|NCT00587132|19501433|P1|NOT COMPLETED|Overall Study||0
7924083|NCT00587132|19501430|P4|COMPLETED|Overall Study||0
7924084|NCT00587132|19501431|P3|COMPLETED|Overall Study||0
7924085|NCT00587132|19501432|P2|COMPLETED|Overall Study||0
7924086|NCT00587132|19501433|P1|COMPLETED|Overall Study||4
7924087|NCT00587132|19501430|P4|STARTED|Overall Study||0
7924088|NCT00587132|19501431|P3|STARTED|Overall Study||0
7924089|NCT00587132|19501432|P2|STARTED|Overall Study||0
7924090|NCT00587132|19501433|P1|STARTED|Overall Study||4
7924091|NCT00587067|19501443|P1|NOT COMPLETED|Overall Study||0
7924092|NCT00587067|19501443|P1|COMPLETED|Overall Study||34
7924093|NCT00587067|19501443|P1|STARTED|Overall Study||34
7924094|NCT00587054|19501449|P1|NOT COMPLETED|Overall Study||9
7924095|NCT00587054|19501449|P1|COMPLETED|Overall Study||120
7924096|NCT00587054|19501449|P1|STARTED|Overall Study||129
7924097|NCT00587041|19501456|P3|NOT COMPLETED|Overall Study||0
7924098|NCT00587041|19501457|P2|NOT COMPLETED|Overall Study||0
7924099|NCT00587041|19501458|P1|NOT COMPLETED|Overall Study||0
7924100|NCT00587041|19501456|P3|COMPLETED|Overall Study||14
7924101|NCT00587041|19501457|P2|COMPLETED|Overall Study||14
7924102|NCT00587041|19501458|P1|COMPLETED|Overall Study||12
7924103|NCT00587041|19501456|P3|STARTED|Overall Study||14
7924104|NCT00587041|19501457|P2|STARTED|Overall Study||14
7924105|NCT00587041|19501458|P1|STARTED|Overall Study||12
7924106|NCT00586924|19501475|P6|NOT COMPLETED|Overall Study||33
7924107|NCT00586924|19501476|P5|NOT COMPLETED|Overall Study||4
7924108|NCT00586924|19501477|P4|NOT COMPLETED|Overall Study||3
7924109|NCT00586924|19501478|P3|NOT COMPLETED|Overall Study||3
7924110|NCT00586924|19501479|P2|NOT COMPLETED|Overall Study||3
7924111|NCT00586924|19501480|P1|NOT COMPLETED|Overall Study||3
7924112|NCT00586924|19501475|P6|COMPLETED|Overall Study||0
7924113|NCT00586924|19501476|P5|COMPLETED|Overall Study||0
7924114|NCT00586924|19501477|P4|COMPLETED|Overall Study||0
7924115|NCT00586924|19501478|P3|COMPLETED|Overall Study||0
7924116|NCT00586924|19501479|P2|COMPLETED|Overall Study||0
7924117|NCT00586924|19501480|P1|COMPLETED|Overall Study||0
7924118|NCT00586924|19501475|P6|STARTED|Overall Study||33
7924119|NCT00586924|19501476|P5|STARTED|Overall Study||4
7924120|NCT00586924|19501477|P4|STARTED|Overall Study||3
7924121|NCT00586924|19501478|P3|STARTED|Overall Study||3
7924122|NCT00586924|19501479|P2|STARTED|Overall Study||3
7924123|NCT00586924|19501480|P1|STARTED|Overall Study||3
7924124|NCT00586898|19501680|P1|NOT COMPLETED|Overall Study||7
7924125|NCT00586898|19501680|P1|COMPLETED|Overall Study||29
7924126|NCT00586898|19501680|P1|STARTED|Overall Study||36
7924127|NCT00586846|19501684|P1|NOT COMPLETED|Overall Study||6
7924128|NCT00586846|19501684|P1|COMPLETED|Overall Study||34
7924129|NCT00586846|19501684|P1|STARTED|Overall Study||40
7924130|NCT00586820|19501690|P2|NOT COMPLETED|Overall Study||0
7924131|NCT00586820|19501691|P1|NOT COMPLETED|Overall Study||1
7924132|NCT00586820|19501690|P2|COMPLETED|Overall Study||11
7924133|NCT00586820|19501691|P1|COMPLETED|Overall Study||11
7924134|NCT00586820|19501690|P2|STARTED|Overall Study||11
7924135|NCT00586820|19501691|P1|STARTED|Overall Study||12
7924136|NCT00586729|19501701|P2|NOT COMPLETED|Overall Study||1
7924137|NCT00586729|19501702|P1|NOT COMPLETED|Overall Study||3
7924138|NCT00586729|19501701|P2|COMPLETED|Overall Study||8
7924139|NCT00586729|19501702|P1|COMPLETED|Overall Study||11
7924140|NCT00586729|19501701|P2|STARTED|Overall Study||9
7924141|NCT00586729|19501702|P1|STARTED|Overall Study||14
7924142|NCT00586716|19501714|P2|NOT COMPLETED|Overall Study||0
7924143|NCT00586716|19501715|P1|NOT COMPLETED|Overall Study||0
7924144|NCT00586716|19501714|P2|COMPLETED|Overall Study||8
7924145|NCT00586716|19501715|P1|COMPLETED|Overall Study||14
7924146|NCT00586716|19501714|P2|STARTED|Overall Study||8
7924147|NCT00586716|19501715|P1|STARTED|Overall Study||14
7924148|NCT00586703|19501722|P1|NOT COMPLETED|Overall Study||12
7924149|NCT00586703|19501722|P1|COMPLETED|Overall Study||4
7924150|NCT00586703|19501722|P1|STARTED|Overall Study||16
7924151|NCT00586690|19501729|P2|NOT COMPLETED|Overall Study||0
7924152|NCT00586690|19501730|P1|NOT COMPLETED|Overall Study||16
7924153|NCT00586690|19501729|P2|COMPLETED|Overall Study||22
7924154|NCT00586690|19501730|P1|COMPLETED|Overall Study||5
7924155|NCT00586690|19501729|P2|STARTED|Overall Study||22
7924156|NCT00586690|19501730|P1|STARTED|Overall Study|Four consented subjects were screen failures.|21
7924157|NCT00586664|19501740|P3|NOT COMPLETED|Overall Study||1
7924158|NCT00586664|19501741|P2|NOT COMPLETED|Overall Study||7
7924159|NCT00586664|19501742|P1|NOT COMPLETED|Overall Study||5
7924160|NCT00586664|19501740|P3|COMPLETED|Overall Study||43
7924161|NCT00586664|19501741|P2|COMPLETED|Overall Study||36
7924162|NCT00586664|19501742|P1|COMPLETED|Overall Study||38
7924163|NCT00586664|19501740|P3|STARTED|Overall Study||44
7924164|NCT00586664|19501741|P2|STARTED|Overall Study||43
7924165|NCT00586664|19501742|P1|STARTED|Overall Study||43
7924166|NCT00586625|19501788|P2|NOT COMPLETED|Overall Study||17
7924167|NCT00586625|19501789|P1|NOT COMPLETED|Overall Study||43
7924168|NCT00586625|19501788|P2|COMPLETED|Overall Study||269
7924169|NCT00586625|19501789|P1|COMPLETED|Overall Study||532
7924170|NCT00586625|19501788|P2|STARTED|Overall Study||286
7924171|NCT00586625|19501789|P1|STARTED|Overall Study||575
7924172|NCT00586612|19501797|P2|NOT COMPLETED|Booster Phase||1
7924173|NCT00586612|19501798|P1|NOT COMPLETED|Booster Phase||3
7924174|NCT00586612|19501797|P2|COMPLETED|Booster Phase||143
7924175|NCT00586612|19501798|P1|COMPLETED|Booster Phase||151
7924176|NCT00586612|19501797|P2|STARTED|Booster Phase||144
7924177|NCT00586612|19501798|P1|STARTED|Booster Phase||154
7924178|NCT00586612|19501797|P2|NOT COMPLETED|Primary Phase||3
7924179|NCT00586612|19501798|P1|NOT COMPLETED|Primary Phase||1
7924180|NCT00586612|19501797|P2|COMPLETED|Primary Phase||147
7924181|NCT00586612|19501798|P1|COMPLETED|Primary Phase||162
7924182|NCT00586612|19501797|P2|STARTED|Primary Phase||150
7924183|NCT00586612|19501798|P1|STARTED|Primary Phase||163
7924184|NCT00586573|19501864|P1|NOT COMPLETED|Overall Study||6
7924185|NCT00586573|19501864|P1|COMPLETED|Overall Study||28
7924186|NCT00586573|19501864|P1|STARTED|Overall Study||34
7924187|NCT00586521|19501868|P1|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0
7924188|NCT00586521|19501868|P1|COMPLETED|Prophylactic Treatment (Months 8-13)||19
7924189|NCT00586521|19501868|P1|STARTED|Prophylactic Treatment (Months 8-13)||19
7924190|NCT00586521|19501868|P1|NOT COMPLETED|On Demand Treatment (Months 1-6)||1
7924191|NCT00586521|19501868|P1|COMPLETED|On Demand Treatment (Months 1-6)||19
7924192|NCT00586521|19501868|P1|STARTED|On Demand Treatment (Months 1-6)||20
7924193|NCT00586508|19501877|P2|NOT COMPLETED|Overall Study||13
7924194|NCT00586508|19501878|P1|NOT COMPLETED|Overall Study||68
7924195|NCT00586508|19501877|P2|COMPLETED|Overall Study||0
7924196|NCT00586508|19501878|P1|COMPLETED|Overall Study||0
7924197|NCT00586508|19501877|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
7924198|NCT00586508|19501878|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
7924199|NCT00586508|19501877|P2|STARTED|Overall Study||13
7924200|NCT00586508|19501878|P1|STARTED|Overall Study||68
7924201|NCT00586495|19501894|P1|NOT COMPLETED|Follow-up||92
7924202|NCT00586495|19501894|P1|COMPLETED|Follow-up||0
7924203|NCT00586495|19501894|P1|STARTED|Follow-up||92
7924204|NCT00586495|19501894|P1|NOT COMPLETED|Treatment Period||95
7924205|NCT00586495|19501894|P1|COMPLETED|Treatment Period||0
7924206|NCT00586495|19501894|P1|STARTED|Treatment Period||95
7924207|NCT00586482|19501906|P2|NOT COMPLETED|Overall Study||0
7924208|NCT00586482|19501907|P1|NOT COMPLETED|Overall Study||0
7924209|NCT00586482|19501906|P2|COMPLETED|Overall Study||24
7924210|NCT00586482|19501907|P1|COMPLETED|Overall Study||22
7924211|NCT00586482|19501906|P2|STARTED|Overall Study||24
7924212|NCT00586482|19501907|P1|STARTED|Overall Study||22
7924213|NCT00586469|19501923|P2|NOT COMPLETED|Overall Study||1
7924214|NCT00586469|19501924|P1|NOT COMPLETED|Overall Study||0
7924215|NCT00586469|19501923|P2|COMPLETED|Overall Study||499
7924216|NCT00586469|19501924|P1|COMPLETED|Overall Study||500
7924217|NCT00586469|19501923|P2|STARTED|Overall Study||500
7924218|NCT00586469|19501924|P1|STARTED|Overall Study||500
7924219|NCT00586339|19501951|P3|NOT COMPLETED|Overall Study||6
7924220|NCT00586339|19501952|P2|NOT COMPLETED|Overall Study||7
7924221|NCT00586339|19501953|P1|NOT COMPLETED|Overall Study||7
7924222|NCT00586339|19501951|P3|COMPLETED|Overall Study||24
7924223|NCT00586339|19501952|P2|COMPLETED|Overall Study||52
7924224|NCT00586339|19501953|P1|COMPLETED|Overall Study||54
7924225|NCT00586339|19501951|P3|STARTED|Overall Study||30
7924226|NCT00586339|19501952|P2|STARTED|Overall Study||59
7924227|NCT00586339|19501953|P1|STARTED|Overall Study||61
7924228|NCT00586326|19502054|P1|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26
7924229|NCT00586326|19502054|P1|COMPLETED|Treated Through 5-yr Follow Up-Treated||74
7924230|NCT00586326|19502054|P1|STARTED|Treated Through 5-yr Follow Up-Treated||100
7924231|NCT00586326|19502054|P1|NOT COMPLETED|Device Placed toTreatment-ITT||18
7924232|NCT00586326|19502054|P1|COMPLETED|Device Placed toTreatment-ITT||100
7924233|NCT00586326|19502054|P1|STARTED|Device Placed toTreatment-ITT||118
7924234|NCT00586326|19502054|P1|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15
7924235|NCT00586326|19502054|P1|COMPLETED|Enrollment to Device Placement-Enrolled||118
7924236|NCT00586326|19502054|P1|STARTED|Enrollment to Device Placement-Enrolled||133
7924237|NCT00586313|19502065|P1|NOT COMPLETED|Overall Study||2
7924238|NCT00586313|19502065|P1|COMPLETED|Overall Study||19
7924239|NCT00586313|19502065|P1|STARTED|Overall Study||21
7924240|NCT00586261|19502072|P2|NOT COMPLETED|Overall Study||0
7924241|NCT00586261|19502073|P1|NOT COMPLETED|Overall Study||0
7924242|NCT00586261|19502072|P2|COMPLETED|Overall Study||19
7924243|NCT00586261|19502073|P1|COMPLETED|Overall Study||17
7924244|NCT00586261|19502072|P2|STARTED|Overall Study||19
7924245|NCT00586261|19502073|P1|STARTED|Overall Study||17
7924246|NCT00586196|19502081|P2|NOT COMPLETED|Overall Study||0
7924247|NCT00586196|19502082|P1|NOT COMPLETED|Overall Study||0
7924248|NCT00586196|19502081|P2|COMPLETED|Overall Study||9
7924249|NCT00586196|19502082|P1|COMPLETED|Overall Study||7
7924250|NCT00586196|19502081|P2|STARTED|Overall Study||9
7924251|NCT00586196|19502082|P1|STARTED|Overall Study||7
7924252|NCT00586170|19502092|P2|NOT COMPLETED|Overall Study||0
7924253|NCT00586170|19502093|P1|NOT COMPLETED|Overall Study||0
7924254|NCT00586170|19502092|P2|COMPLETED|Overall Study||3
7924255|NCT00586170|19502093|P1|COMPLETED|Overall Study||5
7924256|NCT00586170|19502092|P2|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3
7924257|NCT00586170|19502093|P1|STARTED|Overall Study||5
7924258|NCT00586157|19502101|P2|NOT COMPLETED|Second Intervention||1
7924259|NCT00586157|19502102|P1|NOT COMPLETED|Second Intervention||2
7924260|NCT00586157|19502101|P2|COMPLETED|Second Intervention||14
7924261|NCT00586157|19502102|P1|COMPLETED|Second Intervention||12
7924262|NCT00586157|19502101|P2|STARTED|Second Intervention||15
7924263|NCT00586157|19502102|P1|STARTED|Second Intervention||14
7924264|NCT00586157|19502101|P2|NOT COMPLETED|First Intervention||0
7924265|NCT00586157|19502102|P1|NOT COMPLETED|First Intervention||1
7924266|NCT00586157|19502101|P2|COMPLETED|First Intervention||15
7924267|NCT00586157|19502102|P1|COMPLETED|First Intervention||14
7924268|NCT00586157|19502101|P2|STARTED|First Intervention||15
7924269|NCT00586157|19502102|P1|STARTED|First Intervention||15
7924270|NCT00586105|19502112|P1|NOT COMPLETED|Overall Study||39
7924271|NCT00586105|19502112|P1|COMPLETED|Overall Study||0
7924272|NCT00586105|19502112|P1|STARTED|Overall Study||39
7924273|NCT00586066|19502127|P2|NOT COMPLETED|Overall Study||10
7924274|NCT00586066|19502128|P1|NOT COMPLETED|Overall Study||18
7924275|NCT00586066|19502127|P2|COMPLETED|Overall Study||14
7924276|NCT00586066|19502128|P1|COMPLETED|Overall Study||30
7924277|NCT00586066|19502127|P2|STARTED|Overall Study||24
7924278|NCT00586066|19502128|P1|STARTED|Overall Study||48
7924279|NCT00586001|19502140|P2|NOT COMPLETED|Overall Study||1
7924280|NCT00586001|19502141|P1|NOT COMPLETED|Overall Study||4
7924281|NCT00586001|19502140|P2|COMPLETED|Overall Study||10
7924282|NCT00586001|19502141|P1|COMPLETED|Overall Study||22
7924283|NCT00586001|19502140|P2|STARTED|Overall Study||11
7924284|NCT00586001|19502141|P1|STARTED|Overall Study||26
7924285|NCT00585975|19502185|P2|NOT COMPLETED|Overall Study||13
7924286|NCT00585975|19502186|P1|NOT COMPLETED|Overall Study||15
7924287|NCT00585975|19502185|P2|COMPLETED|Overall Study||278
7924288|NCT00585975|19502186|P1|COMPLETED|Overall Study||262
7924289|NCT00585975|19502185|P2|STARTED|Overall Study||291
7924290|NCT00585975|19502186|P1|STARTED|Overall Study||277
7924291|NCT00585923|19502196|P2|NOT COMPLETED|Overall Study||33
7924292|NCT00585923|19502197|P1|NOT COMPLETED|Overall Study||31
7924293|NCT00585923|19502196|P2|COMPLETED|Overall Study||26
7924294|NCT00585923|19502197|P1|COMPLETED|Overall Study||25
7924295|NCT00585923|19502196|P2|STARTED|Overall Study||59
7924296|NCT00585923|19502197|P1|STARTED|Overall Study||56
7924297|NCT00585910|19502211|P1|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9
7924298|NCT00585910|19502211|P1|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41
7924299|NCT00585910|19502211|P1|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50
7924300|NCT00585910|19502211|P1|NOT COMPLETED|Atomoxetine (ATMX) Alone||17
7924301|NCT00585910|19502211|P1|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55
7924302|NCT00585910|19502211|P1|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72
7924303|NCT00585780|19502221|P4|NOT COMPLETED|Overall Study||8
7924304|NCT00585780|19502222|P3|NOT COMPLETED|Overall Study||13
7924305|NCT00585780|19502223|P2|NOT COMPLETED|Overall Study||9
7924306|NCT00585780|19502224|P1|NOT COMPLETED|Overall Study||8
7924307|NCT00585780|19502221|P4|COMPLETED|Overall Study||14
7924308|NCT00585780|19502222|P3|COMPLETED|Overall Study||21
7924309|NCT00585780|19502223|P2|COMPLETED|Overall Study||14
7924310|NCT00585780|19502224|P1|COMPLETED|Overall Study||13
7924311|NCT00585780|19502221|P4|STARTED|Overall Study||22
7924312|NCT00585780|19502222|P3|STARTED|Overall Study||34
7924313|NCT00585780|19502223|P2|STARTED|Overall Study||23
7924314|NCT00585780|19502224|P1|STARTED|Overall Study||21
7924315|NCT00585715|19502240|P2|NOT COMPLETED|Overall Study||0
7924316|NCT00585715|19502241|P1|NOT COMPLETED|Overall Study||3
7924317|NCT00585715|19502240|P2|COMPLETED|Overall Study||11
7924318|NCT00585715|19502241|P1|COMPLETED|Overall Study||8
7924319|NCT00585715|19502240|P2|STARTED|Overall Study||11
7924320|NCT00585715|19502241|P1|STARTED|Overall Study||11
7924321|NCT00585689|19502249|P1|NOT COMPLETED|Overall Study||7
7924322|NCT00585689|19502249|P1|COMPLETED|Overall Study||22
7924323|NCT00585689|19502249|P1|STARTED|Overall Study||29
7924324|NCT00585650|19502255|P2|NOT COMPLETED|Overall Study||0
7924325|NCT00585650|19502256|P1|NOT COMPLETED|Overall Study||0
7924326|NCT00585650|19502255|P2|COMPLETED|Overall Study||12
7924327|NCT00585650|19502256|P1|COMPLETED|Overall Study||8
7924328|NCT00585650|19502255|P2|STARTED|Overall Study||12
7924329|NCT00585650|19502256|P1|STARTED|Overall Study||8
7924330|NCT00585637|19502266|P4|NOT COMPLETED|6-month Time Point||6
7924331|NCT00585637|19502267|P3|NOT COMPLETED|6-month Time Point||11
7924332|NCT00585637|19502268|P2|NOT COMPLETED|6-month Time Point||13
7924333|NCT00585637|19502269|P1|NOT COMPLETED|6-month Time Point||6
7924334|NCT00585637|19502266|P4|COMPLETED|6-month Time Point||77
7924335|NCT00585637|19502267|P3|COMPLETED|6-month Time Point||72
7924336|NCT00585637|19502268|P2|COMPLETED|6-month Time Point||68
7924337|NCT00585637|19502269|P1|COMPLETED|6-month Time Point||75
7924338|NCT00585637|19502266|P4|STARTED|6-month Time Point||83
7924339|NCT00585637|19502267|P3|STARTED|6-month Time Point||83
7924340|NCT00585637|19502268|P2|STARTED|6-month Time Point||81
7924341|NCT00585637|19502269|P1|STARTED|6-month Time Point||81
7924342|NCT00585637|19502266|P4|NOT COMPLETED|3-month Time Point||5
7924343|NCT00585637|19502267|P3|NOT COMPLETED|3-month Time Point||7
7924344|NCT00585637|19502268|P2|NOT COMPLETED|3-month Time Point||14
7924345|NCT00585637|19502269|P1|NOT COMPLETED|3-month Time Point||10
7924346|NCT00585637|19502266|P4|COMPLETED|3-month Time Point||78
7924347|NCT00585637|19502267|P3|COMPLETED|3-month Time Point||76
7924348|NCT00585637|19502268|P2|COMPLETED|3-month Time Point||67
7924349|NCT00585637|19502269|P1|COMPLETED|3-month Time Point||71
7924350|NCT00585637|19502266|P4|STARTED|3-month Time Point||83
7924351|NCT00585637|19502267|P3|STARTED|3-month Time Point||83
7924352|NCT00585637|19502268|P2|STARTED|3-month Time Point||81
7924353|NCT00585637|19502269|P1|STARTED|3-month Time Point||81
7924354|NCT00585637|19502266|P4|NOT COMPLETED|Baseline||0
7924355|NCT00585637|19502267|P3|NOT COMPLETED|Baseline||0
7924356|NCT00585637|19502268|P2|NOT COMPLETED|Baseline||0
7924357|NCT00585637|19502269|P1|NOT COMPLETED|Baseline||0
7924358|NCT00585637|19502266|P4|COMPLETED|Baseline||83
7924359|NCT00585637|19502267|P3|COMPLETED|Baseline||83
7924360|NCT00585637|19502268|P2|COMPLETED|Baseline||81
7924361|NCT00585637|19502269|P1|COMPLETED|Baseline||81
7924362|NCT00585637|19502266|P4|STARTED|Baseline||83
7924363|NCT00585637|19502267|P3|STARTED|Baseline||83
7924364|NCT00585637|19502268|P2|STARTED|Baseline||81
7924365|NCT00585637|19502269|P1|STARTED|Baseline||81
7924366|NCT00585611|19502297|P2|NOT COMPLETED|Overall Study||0
7924367|NCT00585611|19502298|P1|NOT COMPLETED|Overall Study||0
7924368|NCT00585611|19502297|P2|COMPLETED|Overall Study||0
7924369|NCT00585611|19502298|P1|COMPLETED|Overall Study||0
7924370|NCT00585611|19502297|P2|STARTED|Overall Study||0
7924371|NCT00585611|19502298|P1|STARTED|Overall Study||0
7924372|NCT00585585|19502308|P1|NOT COMPLETED|Overall Study||1
7924373|NCT00585585|19502308|P1|COMPLETED|Overall Study||0
7924374|NCT00585585|19502308|P1|Patients Receiving Drug|Overall Study||1
7924375|NCT00585585|19502308|P1|STARTED|Overall Study||1
7924376|NCT00585546|19502312|P1|NOT COMPLETED|Clenbuterol Treatment - up to 12 Months||4
7924377|NCT00585546|19502312|P1|COMPLETED|Clenbuterol Treatment - up to 12 Months||9
7924378|NCT00585546|19502312|P1|STARTED|Clenbuterol Treatment - up to 12 Months||13
7924379|NCT00585546|19502312|P1|NOT COMPLETED|LVAD Implantation Required for 4 Months||5
7924380|NCT00585546|19502312|P1|COMPLETED|LVAD Implantation Required for 4 Months||13
7924381|NCT00585546|19502312|P1|STARTED|LVAD Implantation Required for 4 Months||18
7924382|NCT00585533|19502326|P1|NOT COMPLETED|Overall Study||9
7924383|NCT00585533|19502326|P1|COMPLETED|Overall Study||31
7924384|NCT00585533|19502326|P1|STARTED|Overall Study||40
7924385|NCT00585494|19502331|P1|NOT COMPLETED|Overall Study||56
7924386|NCT00585494|19502331|P1|COMPLETED|Overall Study||244
7924387|NCT00585494|19502331|P1|STARTED|Overall Study||300
7924388|NCT00585468|19502335|P2|NOT COMPLETED|Second Intervention||0
7924389|NCT00585468|19502336|P1|NOT COMPLETED|Second Intervention||0
7924390|NCT00585468|19502335|P2|COMPLETED|Second Intervention||10
7924391|NCT00585468|19502336|P1|COMPLETED|Second Intervention||9
7924392|NCT00585468|19502335|P2|STARTED|Second Intervention||10
7924393|NCT00585468|19502336|P1|STARTED|Second Intervention||9
7924394|NCT00585468|19502335|P2|NOT COMPLETED|First Intervention||1
7924395|NCT00585468|19502336|P1|NOT COMPLETED|First Intervention||1
7924396|NCT00585468|19502335|P2|COMPLETED|First Intervention||10
7924397|NCT00585468|19502336|P1|COMPLETED|First Intervention||9
7924398|NCT00585468|19502335|P2|STARTED|First Intervention||11
7924399|NCT00585468|19502336|P1|STARTED|First Intervention||10
7924400|NCT00585377|19502356|P1|NOT COMPLETED|Overall Study||0
7924401|NCT00585377|19502356|P1|COMPLETED|Overall Study||50
7924402|NCT00585377|19502356|P1|STARTED|Overall Study||50
7924403|NCT00585351|19502368|P8|NOT COMPLETED|Enrollment Period (Intervention)||1
7924404|NCT00585351|19502369|P7|NOT COMPLETED|Enrollment Period (Intervention)||2
7924405|NCT00585351|19502370|P6|NOT COMPLETED|Enrollment Period (Intervention)||2
7924406|NCT00585351|19502371|P5|NOT COMPLETED|Enrollment Period (Intervention)||2
7924407|NCT00585351|19502372|P4|NOT COMPLETED|Enrollment Period (Intervention)||0
7924408|NCT00585351|19502373|P3|NOT COMPLETED|Enrollment Period (Intervention)||0
7924409|NCT00585351|19502374|P2|NOT COMPLETED|Enrollment Period (Intervention)||0
7924410|NCT00585351|19502375|P1|NOT COMPLETED|Enrollment Period (Intervention)||0
7924411|NCT00585351|19502368|P8|COMPLETED|Enrollment Period (Intervention)||2
7924412|NCT00585351|19502369|P7|COMPLETED|Enrollment Period (Intervention)||5
7924413|NCT00585351|19502370|P6|COMPLETED|Enrollment Period (Intervention)||5
7924414|NCT00585351|19502371|P5|COMPLETED|Enrollment Period (Intervention)||3
7924415|NCT00585351|19502372|P4|COMPLETED|Enrollment Period (Intervention)||15
7924416|NCT00585351|19502373|P3|COMPLETED|Enrollment Period (Intervention)||15
7924417|NCT00585351|19502374|P2|COMPLETED|Enrollment Period (Intervention)||0
7924418|NCT00585351|19502375|P1|COMPLETED|Enrollment Period (Intervention)||0
7924419|NCT00585351|19502368|P8|STARTED|Enrollment Period (Intervention)||3
7924420|NCT00585351|19502369|P7|STARTED|Enrollment Period (Intervention)||7
7924421|NCT00585351|19502370|P6|STARTED|Enrollment Period (Intervention)||7
7924422|NCT00585351|19502371|P5|STARTED|Enrollment Period (Intervention)||5
7924423|NCT00585351|19502372|P4|STARTED|Enrollment Period (Intervention)||15
7924424|NCT00585351|19502373|P3|STARTED|Enrollment Period (Intervention)||15
7924425|NCT00585351|19502374|P2|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0
7924426|NCT00585351|19502375|P1|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0
7924427|NCT00585351|19502368|P8|NOT COMPLETED|Notification Period (Informed Consent)||0
7924428|NCT00585351|19502369|P7|NOT COMPLETED|Notification Period (Informed Consent)||0
7924429|NCT00585351|19502370|P6|NOT COMPLETED|Notification Period (Informed Consent)||0
7924430|NCT00585351|19502371|P5|NOT COMPLETED|Notification Period (Informed Consent)||0
7924431|NCT00585351|19502372|P4|NOT COMPLETED|Notification Period (Informed Consent)||0
7924432|NCT00585351|19502373|P3|NOT COMPLETED|Notification Period (Informed Consent)||0
7924433|NCT00585351|19502374|P2|NOT COMPLETED|Notification Period (Informed Consent)||25
7924434|NCT00585351|19502375|P1|NOT COMPLETED|Notification Period (Informed Consent)||23
7924435|NCT00585351|19502368|P8|COMPLETED|Notification Period (Informed Consent)||0
7924436|NCT00585351|19502369|P7|COMPLETED|Notification Period (Informed Consent)||0
7924437|NCT00585351|19502370|P6|COMPLETED|Notification Period (Informed Consent)||0
7924438|NCT00585351|19502371|P5|COMPLETED|Notification Period (Informed Consent)||0
7924439|NCT00585351|19502372|P4|COMPLETED|Notification Period (Informed Consent)||0
7924440|NCT00585351|19502373|P3|COMPLETED|Notification Period (Informed Consent)||0
7924441|NCT00585351|19502374|P2|COMPLETED|Notification Period (Informed Consent)||25
7924442|NCT00585351|19502375|P1|COMPLETED|Notification Period (Informed Consent)||27
7924443|NCT00585351|19502368|P8|STARTED|Notification Period (Informed Consent)||0
7924444|NCT00585351|19502369|P7|STARTED|Notification Period (Informed Consent)||0
7924445|NCT00585351|19502370|P6|STARTED|Notification Period (Informed Consent)||0
7924446|NCT00585351|19502371|P5|STARTED|Notification Period (Informed Consent)||0
7924447|NCT00585351|19502372|P4|STARTED|Notification Period (Informed Consent)||0
7924448|NCT00585351|19502373|P3|STARTED|Notification Period (Informed Consent)||0
7924449|NCT00585351|19502374|P2|STARTED|Notification Period (Informed Consent)||50
7924450|NCT00585351|19502375|P1|STARTED|Notification Period (Informed Consent)||50
7924451|NCT00585325|19502391|P2|NOT COMPLETED|Overall Study||1
7924452|NCT00585325|19502392|P1|NOT COMPLETED|Overall Study||1
7924453|NCT00585325|19502391|P2|COMPLETED|Overall Study||12
7924454|NCT00585325|19502392|P1|COMPLETED|Overall Study||9
7924455|NCT00585325|19502391|P2|STARTED|Overall Study||13
7924456|NCT00585325|19502392|P1|STARTED|Overall Study||10
7924457|NCT00585312|19502400|P2|NOT COMPLETED|Overall Study||44
7924458|NCT00585312|19502401|P1|NOT COMPLETED|Overall Study||51
7924459|NCT00585312|19502400|P2|COMPLETED|Overall Study||7
7924460|NCT00585312|19502401|P1|COMPLETED|Overall Study||4
7924461|NCT00585312|19502400|P2|Treated|Overall Study||48
7924462|NCT00585312|19502401|P1|Treated|Overall Study||53
7924463|NCT00585312|19502400|P2|STARTED|Overall Study|STARTED=Randomized|51
7924464|NCT00585312|19502401|P1|STARTED|Overall Study|STARTED=Randomized|55
7924465|NCT00585286|19502413|P1|NOT COMPLETED|Overall Study||1
7924466|NCT00585286|19502413|P1|COMPLETED|Overall Study||14
7924467|NCT00585286|19502413|P1|STARTED|Overall Study||15
7924468|NCT00585247|19502422|P2|NOT COMPLETED|Overall Study||0
7924469|NCT00585247|19502423|P1|NOT COMPLETED|Overall Study||0
7924470|NCT00585247|19502422|P2|COMPLETED|Overall Study||13
7924471|NCT00585247|19502423|P1|COMPLETED|Overall Study||14
7924472|NCT00585247|19502422|P2|STARTED|Overall Study||13
7924473|NCT00585247|19502423|P1|STARTED|Overall Study||14
7924474|NCT00585221|19502429|P1|NOT COMPLETED|Overall Study||8
7924475|NCT00585221|19502429|P1|COMPLETED|Overall Study||0
7924476|NCT00585221|19502429|P1|STARTED|Overall Study||8
7924477|NCT00585182|19502434|P1|NOT COMPLETED|Overall Study||0
7924478|NCT00585182|19502434|P1|COMPLETED|Overall Study||28
7924479|NCT00585182|19502434|P1|STARTED|Overall Study||28
7924480|NCT00585169|19502439|P1|NOT COMPLETED|Overall Study||1
7924481|NCT00585169|19502439|P1|COMPLETED|Overall Study||28
7924482|NCT00585169|19502439|P1|STARTED|Overall Study||29
7924483|NCT00585104|19502445|P1|NOT COMPLETED|Overall Study||4
7924484|NCT00585104|19502445|P1|COMPLETED|Overall Study||6
7924485|NCT00585104|19502445|P1|STARTED|Overall Study||10
7924486|NCT00585078|19502449|P1|NOT COMPLETED|Overall Study||40
7924487|NCT00585078|19502449|P1|COMPLETED|Overall Study||0
7924488|NCT00585078|19502449|P1|Response Evaluable|Overall Study||24
7924489|NCT00585078|19502449|P1|Toxicity Evaluable|Overall Study||36
7924490|NCT00585078|19502449|P1|Treated|Overall Study||37
7924491|NCT00585078|19502449|P1|STARTED|Overall Study||40
7924492|NCT00585052|19502456|P1|NOT COMPLETED|Overall Study||1
7924493|NCT00585052|19502456|P1|COMPLETED|Overall Study||10
7924494|NCT00585052|19502456|P1|STARTED|Overall Study||11
7924495|NCT00585039|19502463|P2|NOT COMPLETED|Overall Study||0
7924496|NCT00585039|19502464|P1|NOT COMPLETED|Overall Study||2
7924497|NCT00585039|19502463|P2|COMPLETED|Overall Study||44
7924498|NCT00585039|19502464|P1|COMPLETED|Overall Study||55
7924499|NCT00585039|19502463|P2|STARTED|Overall Study||44
7924500|NCT00585039|19502464|P1|STARTED|Overall Study||57
7924501|NCT00585013|19502474|P2|NOT COMPLETED|Overall Study||0
7924502|NCT00585013|19502475|P1|NOT COMPLETED|Overall Study||0
7924503|NCT00585013|19502474|P2|COMPLETED|Overall Study||8
7924504|NCT00585013|19502475|P1|COMPLETED|Overall Study||8
7924505|NCT00585013|19502474|P2|STARTED|Overall Study||8
7924506|NCT00585013|19502475|P1|STARTED|Overall Study||8
7924507|NCT00584987|19502493|P4|NOT COMPLETED|Overall Study||1
7924508|NCT00584987|19502494|P3|NOT COMPLETED|Overall Study||1
7924509|NCT00584987|19502495|P2|NOT COMPLETED|Overall Study||1
7924510|NCT00584987|19502496|P1|NOT COMPLETED|Overall Study||1
7924511|NCT00584987|19502493|P4|COMPLETED|Overall Study||15
7924512|NCT00584987|19502494|P3|COMPLETED|Overall Study||16
7924513|NCT00584987|19502495|P2|COMPLETED|Overall Study||15
7924514|NCT00584987|19502496|P1|COMPLETED|Overall Study||14
7924515|NCT00584987|19502493|P4|STARTED|Overall Study||16
7924516|NCT00584987|19502494|P3|STARTED|Overall Study||17
7924517|NCT00584987|19502495|P2|STARTED|Overall Study||16
7924518|NCT00584987|19502496|P1|STARTED|Overall Study||15
7924519|NCT00584948|19502528|P2|NOT COMPLETED|Overall Study||11
7924520|NCT00584948|19502529|P1|NOT COMPLETED|Overall Study||13
7924521|NCT00584948|19502528|P2|COMPLETED|Overall Study||36
7924522|NCT00584948|19502529|P1|COMPLETED|Overall Study||34
7924523|NCT00584948|19502528|P2|STARTED|Overall Study||47
7924524|NCT00584948|19502529|P1|STARTED|Overall Study||47
7924525|NCT00584935|19502537|P1|NOT COMPLETED|Overall Study||0
7924526|NCT00584935|19502537|P1|COMPLETED|Overall Study||3
7924527|NCT00584935|19502537|P1|STARTED|Overall Study||3
7924528|NCT00584922|19502544|P1|NOT COMPLETED|Overall Study||0
7924529|NCT00584922|19502544|P1|COMPLETED|Overall Study||175
7924530|NCT00584922|19502544|P1|STARTED|Overall Study||175
7924531|NCT00584909|19502548|P1|NOT COMPLETED|Overall Study||4
7924532|NCT00584909|19502548|P1|COMPLETED|Overall Study||9
7924533|NCT00584909|19502548|P1|STARTED|Overall Study||13
7924534|NCT00584857|19502553|P1|NOT COMPLETED|Overall Study||0
7924535|NCT00584857|19502553|P1|COMPLETED|Overall Study||30
7924536|NCT00584857|19502553|P1|STARTED|Overall Study||30
7924537|NCT00584844|19502558|P1|NOT COMPLETED|Overall Study||79
7924538|NCT00584844|19502558|P1|COMPLETED|Overall Study||405
7924539|NCT00584844|19502558|P1|STARTED|Overall Study||484
7924540|NCT00584831|19502568|P19|NOT COMPLETED|Intervention 4||0
7924541|NCT00584831|19502569|P18|NOT COMPLETED|Intervention 4||0
7924542|NCT00584831|19502570|P17|NOT COMPLETED|Intervention 4||0
7924543|NCT00584831|19502571|P16|NOT COMPLETED|Intervention 4||0
7924544|NCT00584831|19502572|P15|NOT COMPLETED|Intervention 4||0
7924545|NCT00584831|19502573|P14|NOT COMPLETED|Intervention 4||0
7924546|NCT00584831|19502574|P13|NOT COMPLETED|Intervention 4||0
7924547|NCT00584831|19502575|P12|NOT COMPLETED|Intervention 4||0
7924548|NCT00584831|19502576|P11|NOT COMPLETED|Intervention 4||0
7924549|NCT00584831|19502577|P10|NOT COMPLETED|Intervention 4||0
7924550|NCT00584831|19502578|P9|NOT COMPLETED|Intervention 4||0
7924551|NCT00584831|19502579|P8|NOT COMPLETED|Intervention 4||0
7924552|NCT00584831|19502580|P7|NOT COMPLETED|Intervention 4||0
7924553|NCT00584831|19502581|P6|NOT COMPLETED|Intervention 4||0
7924554|NCT00584831|19502582|P5|NOT COMPLETED|Intervention 4||0
7924555|NCT00584831|19502583|P4|NOT COMPLETED|Intervention 4||0
7924556|NCT00584831|19502584|P3|NOT COMPLETED|Intervention 4||0
7924557|NCT00584831|19502585|P2|NOT COMPLETED|Intervention 4||0
7924558|NCT00584831|19502586|P1|NOT COMPLETED|Intervention 4||0
7924559|NCT00584831|19502568|P19|COMPLETED|Intervention 4||1
7924560|NCT00584831|19502569|P18|COMPLETED|Intervention 4||1
7924561|NCT00584831|19502570|P17|COMPLETED|Intervention 4||4
7924562|NCT00584831|19502571|P16|COMPLETED|Intervention 4||1
7924563|NCT00584831|19502572|P15|COMPLETED|Intervention 4||2
7924564|NCT00584831|19502573|P14|COMPLETED|Intervention 4||1
7924565|NCT00584831|19502574|P13|COMPLETED|Intervention 4||2
7924566|NCT00584831|19502575|P12|COMPLETED|Intervention 4||1
7924567|NCT00584831|19502576|P11|COMPLETED|Intervention 4||2
7924568|NCT00584831|19502577|P10|COMPLETED|Intervention 4||2
7924569|NCT00584831|19502578|P9|COMPLETED|Intervention 4||3
7924570|NCT00584831|19502579|P8|COMPLETED|Intervention 4||2
7924571|NCT00584831|19502580|P7|COMPLETED|Intervention 4||6
7924572|NCT00584831|19502581|P6|COMPLETED|Intervention 4||1
7924573|NCT00584831|19502582|P5|COMPLETED|Intervention 4||2
7924574|NCT00584831|19502583|P4|COMPLETED|Intervention 4||1
7924575|NCT00584831|19502584|P3|COMPLETED|Intervention 4||2
7924576|NCT00584831|19502585|P2|COMPLETED|Intervention 4||3
7924577|NCT00584831|19502586|P1|COMPLETED|Intervention 4||1
7924578|NCT00584831|19502568|P19|STARTED|Intervention 4||1
7924579|NCT00584831|19502569|P18|STARTED|Intervention 4||1
7924580|NCT00584831|19502570|P17|STARTED|Intervention 4||4
7924581|NCT00584831|19502571|P16|STARTED|Intervention 4||1
7924582|NCT00584831|19502572|P15|STARTED|Intervention 4||2
7924583|NCT00584831|19502573|P14|STARTED|Intervention 4||1
7924584|NCT00584831|19502574|P13|STARTED|Intervention 4||2
7924585|NCT00584831|19502575|P12|STARTED|Intervention 4||1
7924586|NCT00584831|19502576|P11|STARTED|Intervention 4||2
7924587|NCT00584831|19502577|P10|STARTED|Intervention 4||2
7924588|NCT00584831|19502578|P9|STARTED|Intervention 4||3
7924589|NCT00584831|19502579|P8|STARTED|Intervention 4||2
7924590|NCT00584831|19502580|P7|STARTED|Intervention 4||6
7924591|NCT00584831|19502581|P6|STARTED|Intervention 4||1
7924592|NCT00584831|19502582|P5|STARTED|Intervention 4||2
7924593|NCT00584831|19502583|P4|STARTED|Intervention 4||1
7924594|NCT00584831|19502584|P3|STARTED|Intervention 4||2
7924595|NCT00584831|19502585|P2|STARTED|Intervention 4||3
7924596|NCT00584831|19502586|P1|STARTED|Intervention 4||1
7924597|NCT00584831|19502568|P19|NOT COMPLETED|Intervention 3||0
7924598|NCT00584831|19502569|P18|NOT COMPLETED|Intervention 3||0
7924599|NCT00584831|19502570|P17|NOT COMPLETED|Intervention 3||0
7924600|NCT00584831|19502571|P16|NOT COMPLETED|Intervention 3||0
7924601|NCT00584831|19502572|P15|NOT COMPLETED|Intervention 3||0
7924602|NCT00584831|19502573|P14|NOT COMPLETED|Intervention 3||0
7924603|NCT00584831|19502574|P13|NOT COMPLETED|Intervention 3||0
7924604|NCT00584831|19502575|P12|NOT COMPLETED|Intervention 3||0
7924605|NCT00584831|19502576|P11|NOT COMPLETED|Intervention 3||0
7924606|NCT00584831|19502577|P10|NOT COMPLETED|Intervention 3||0
7924607|NCT00584831|19502578|P9|NOT COMPLETED|Intervention 3||0
7924608|NCT00584831|19502579|P8|NOT COMPLETED|Intervention 3||0
7924609|NCT00584831|19502580|P7|NOT COMPLETED|Intervention 3||0
7924610|NCT00584831|19502581|P6|NOT COMPLETED|Intervention 3||0
7924611|NCT00584831|19502582|P5|NOT COMPLETED|Intervention 3||0
7924612|NCT00584831|19502583|P4|NOT COMPLETED|Intervention 3||0
7924613|NCT00584831|19502584|P3|NOT COMPLETED|Intervention 3||0
7924614|NCT00584831|19502585|P2|NOT COMPLETED|Intervention 3||0
7924615|NCT00584831|19502586|P1|NOT COMPLETED|Intervention 3||0
7924616|NCT00584831|19502568|P19|COMPLETED|Intervention 3||1
7924617|NCT00584831|19502569|P18|COMPLETED|Intervention 3||1
7924618|NCT00584831|19502570|P17|COMPLETED|Intervention 3||4
7924619|NCT00584831|19502571|P16|COMPLETED|Intervention 3||1
7924620|NCT00584831|19502572|P15|COMPLETED|Intervention 3||3
7924621|NCT00584831|19502573|P14|COMPLETED|Intervention 3||1
7924622|NCT00584831|19502574|P13|COMPLETED|Intervention 3||2
7924623|NCT00584831|19502575|P12|COMPLETED|Intervention 3||1
7924624|NCT00584831|19502576|P11|COMPLETED|Intervention 3||2
7924625|NCT00584831|19502577|P10|COMPLETED|Intervention 3||2
7924626|NCT00584831|19502578|P9|COMPLETED|Intervention 3||4
7924627|NCT00584831|19502579|P8|COMPLETED|Intervention 3||2
7924628|NCT00584831|19502580|P7|COMPLETED|Intervention 3||6
7924629|NCT00584831|19502581|P6|COMPLETED|Intervention 3||1
7924630|NCT00584831|19502582|P5|COMPLETED|Intervention 3||2
7924631|NCT00584831|19502583|P4|COMPLETED|Intervention 3||1
7924632|NCT00584831|19502584|P3|COMPLETED|Intervention 3||2
7924633|NCT00584831|19502585|P2|COMPLETED|Intervention 3||3
7924634|NCT00584831|19502586|P1|COMPLETED|Intervention 3||1
7924635|NCT00584831|19502568|P19|STARTED|Intervention 3||1
7924636|NCT00584831|19502569|P18|STARTED|Intervention 3||1
7924637|NCT00584831|19502570|P17|STARTED|Intervention 3||4
7924638|NCT00584831|19502571|P16|STARTED|Intervention 3||1
7924639|NCT00584831|19502572|P15|STARTED|Intervention 3||3
7924640|NCT00584831|19502573|P14|STARTED|Intervention 3||1
7924641|NCT00584831|19502574|P13|STARTED|Intervention 3||2
7924642|NCT00584831|19502575|P12|STARTED|Intervention 3||1
7924643|NCT00584831|19502576|P11|STARTED|Intervention 3||2
7924644|NCT00584831|19502577|P10|STARTED|Intervention 3||2
7924645|NCT00584831|19502578|P9|STARTED|Intervention 3||4
7924646|NCT00584831|19502579|P8|STARTED|Intervention 3||2
7924647|NCT00584831|19502580|P7|STARTED|Intervention 3||6
7924648|NCT00584831|19502581|P6|STARTED|Intervention 3||1
7924649|NCT00584831|19502582|P5|STARTED|Intervention 3||2
7924650|NCT00584831|19502583|P4|STARTED|Intervention 3||1
7924651|NCT00584831|19502584|P3|STARTED|Intervention 3||2
7924652|NCT00584831|19502585|P2|STARTED|Intervention 3||3
7924653|NCT00584831|19502586|P1|STARTED|Intervention 3||1
7924654|NCT00584831|19502568|P19|NOT COMPLETED|Intervention 2||0
7924655|NCT00584831|19502569|P18|NOT COMPLETED|Intervention 2||0
7924656|NCT00584831|19502570|P17|NOT COMPLETED|Intervention 2||0
7924657|NCT00584831|19502571|P16|NOT COMPLETED|Intervention 2||0
7924658|NCT00584831|19502572|P15|NOT COMPLETED|Intervention 2||0
7924659|NCT00584831|19502573|P14|NOT COMPLETED|Intervention 2||0
7924660|NCT00584831|19502574|P13|NOT COMPLETED|Intervention 2||0
7924661|NCT00584831|19502575|P12|NOT COMPLETED|Intervention 2||0
7924662|NCT00584831|19502576|P11|NOT COMPLETED|Intervention 2||0
7924663|NCT00584831|19502577|P10|NOT COMPLETED|Intervention 2||0
7924664|NCT00584831|19502578|P9|NOT COMPLETED|Intervention 2||0
7924665|NCT00584831|19502579|P8|NOT COMPLETED|Intervention 2||0
7924666|NCT00584831|19502580|P7|NOT COMPLETED|Intervention 2||0
7924667|NCT00584831|19502581|P6|NOT COMPLETED|Intervention 2||0
7924668|NCT00584831|19502582|P5|NOT COMPLETED|Intervention 2||0
7924669|NCT00584831|19502583|P4|NOT COMPLETED|Intervention 2||0
7924670|NCT00584831|19502584|P3|NOT COMPLETED|Intervention 2||0
7924671|NCT00584831|19502585|P2|NOT COMPLETED|Intervention 2||0
7924672|NCT00584831|19502586|P1|NOT COMPLETED|Intervention 2||0
7924673|NCT00584831|19502568|P19|COMPLETED|Intervention 2||1
7924674|NCT00584831|19502569|P18|COMPLETED|Intervention 2||1
7924675|NCT00584831|19502570|P17|COMPLETED|Intervention 2||4
7924676|NCT00584831|19502571|P16|COMPLETED|Intervention 2||1
7924677|NCT00584831|19502572|P15|COMPLETED|Intervention 2||3
7924678|NCT00584831|19502573|P14|COMPLETED|Intervention 2||1
7924679|NCT00584831|19502574|P13|COMPLETED|Intervention 2||2
7924680|NCT00584831|19502575|P12|COMPLETED|Intervention 2||1
7924681|NCT00584831|19502576|P11|COMPLETED|Intervention 2||2
7924682|NCT00584831|19502577|P10|COMPLETED|Intervention 2||2
7924683|NCT00584831|19502578|P9|COMPLETED|Intervention 2||4
7924684|NCT00584831|19502579|P8|COMPLETED|Intervention 2||2
7924685|NCT00584831|19502580|P7|COMPLETED|Intervention 2||6
7924686|NCT00584831|19502581|P6|COMPLETED|Intervention 2||1
7924687|NCT00584831|19502582|P5|COMPLETED|Intervention 2||2
7924688|NCT00584831|19502583|P4|COMPLETED|Intervention 2||1
7924689|NCT00584831|19502584|P3|COMPLETED|Intervention 2||2
7924690|NCT00584831|19502585|P2|COMPLETED|Intervention 2||3
7924691|NCT00584831|19502586|P1|COMPLETED|Intervention 2||1
7924692|NCT00584831|19502568|P19|STARTED|Intervention 2||1
7924693|NCT00584831|19502569|P18|STARTED|Intervention 2||1
7924694|NCT00584831|19502570|P17|STARTED|Intervention 2||4
7924695|NCT00584831|19502571|P16|STARTED|Intervention 2||1
7924696|NCT00584831|19502572|P15|STARTED|Intervention 2||3
7924697|NCT00584831|19502573|P14|STARTED|Intervention 2||1
7924698|NCT00584831|19502574|P13|STARTED|Intervention 2||2
7924699|NCT00584831|19502575|P12|STARTED|Intervention 2||1
7924700|NCT00584831|19502576|P11|STARTED|Intervention 2||2
7924701|NCT00584831|19502577|P10|STARTED|Intervention 2||2
7924702|NCT00584831|19502578|P9|STARTED|Intervention 2||4
7924703|NCT00584831|19502579|P8|STARTED|Intervention 2||2
7924704|NCT00584831|19502580|P7|STARTED|Intervention 2||6
7924705|NCT00584831|19502581|P6|STARTED|Intervention 2||1
7924706|NCT00584831|19502582|P5|STARTED|Intervention 2||2
7924707|NCT00584831|19502583|P4|STARTED|Intervention 2||1
7924708|NCT00584831|19502584|P3|STARTED|Intervention 2||2
7924709|NCT00584831|19502585|P2|STARTED|Intervention 2||3
7924710|NCT00584831|19502586|P1|STARTED|Intervention 2||1
7924711|NCT00584831|19502568|P19|NOT COMPLETED|Intervention 1||0
7924712|NCT00584831|19502569|P18|NOT COMPLETED|Intervention 1||0
7924713|NCT00584831|19502570|P17|NOT COMPLETED|Intervention 1||0
7924714|NCT00584831|19502571|P16|NOT COMPLETED|Intervention 1||0
7924715|NCT00584831|19502572|P15|NOT COMPLETED|Intervention 1||0
7924716|NCT00584831|19502573|P14|NOT COMPLETED|Intervention 1||0
7924717|NCT00584831|19502574|P13|NOT COMPLETED|Intervention 1||0
7924718|NCT00584831|19502575|P12|NOT COMPLETED|Intervention 1||0
7924719|NCT00584831|19502576|P11|NOT COMPLETED|Intervention 1||0
7924720|NCT00584831|19502577|P10|NOT COMPLETED|Intervention 1||0
7924721|NCT00584831|19502578|P9|NOT COMPLETED|Intervention 1||0
7924722|NCT00584831|19502579|P8|NOT COMPLETED|Intervention 1||0
7924723|NCT00584831|19502580|P7|NOT COMPLETED|Intervention 1||0
7924724|NCT00584831|19502581|P6|NOT COMPLETED|Intervention 1||0
7924725|NCT00584831|19502582|P5|NOT COMPLETED|Intervention 1||0
7924726|NCT00584831|19502583|P4|NOT COMPLETED|Intervention 1||0
7924727|NCT00584831|19502584|P3|NOT COMPLETED|Intervention 1||0
7924728|NCT00584831|19502585|P2|NOT COMPLETED|Intervention 1||0
7924729|NCT00584831|19502586|P1|NOT COMPLETED|Intervention 1||0
7924730|NCT00584831|19502568|P19|COMPLETED|Intervention 1||1
7924731|NCT00584831|19502569|P18|COMPLETED|Intervention 1||1
7924732|NCT00584831|19502570|P17|COMPLETED|Intervention 1||4
7924733|NCT00584831|19502571|P16|COMPLETED|Intervention 1||1
7924734|NCT00584831|19502572|P15|COMPLETED|Intervention 1||3
7924735|NCT00584831|19502573|P14|COMPLETED|Intervention 1||1
7924736|NCT00584831|19502574|P13|COMPLETED|Intervention 1||2
7924737|NCT00584831|19502575|P12|COMPLETED|Intervention 1||1
7924738|NCT00584831|19502576|P11|COMPLETED|Intervention 1||2
7924739|NCT00584831|19502577|P10|COMPLETED|Intervention 1||2
7924740|NCT00584831|19502578|P9|COMPLETED|Intervention 1||4
7924741|NCT00584831|19502579|P8|COMPLETED|Intervention 1||2
7924742|NCT00584831|19502580|P7|COMPLETED|Intervention 1||6
7924743|NCT00584831|19502581|P6|COMPLETED|Intervention 1||1
7924744|NCT00584831|19502582|P5|COMPLETED|Intervention 1||2
7924745|NCT00584831|19502583|P4|COMPLETED|Intervention 1||1
7924746|NCT00584831|19502584|P3|COMPLETED|Intervention 1||2
7924747|NCT00584831|19502585|P2|COMPLETED|Intervention 1||3
7924748|NCT00584831|19502586|P1|COMPLETED|Intervention 1||1
7924749|NCT00584831|19502568|P19|STARTED|Intervention 1||1
7924750|NCT00584831|19502569|P18|STARTED|Intervention 1||1
7924751|NCT00584831|19502570|P17|STARTED|Intervention 1||4
7924752|NCT00584831|19502571|P16|STARTED|Intervention 1||1
7924753|NCT00584831|19502572|P15|STARTED|Intervention 1||3
7924754|NCT00584831|19502573|P14|STARTED|Intervention 1||1
7924755|NCT00584831|19502574|P13|STARTED|Intervention 1||2
7924756|NCT00584831|19502575|P12|STARTED|Intervention 1||1
7924757|NCT00584831|19502576|P11|STARTED|Intervention 1||2
7924758|NCT00584831|19502577|P10|STARTED|Intervention 1||2
7924759|NCT00584831|19502578|P9|STARTED|Intervention 1||4
7924760|NCT00584831|19502579|P8|STARTED|Intervention 1||2
7924761|NCT00584831|19502580|P7|STARTED|Intervention 1||6
7924762|NCT00584831|19502581|P6|STARTED|Intervention 1||1
7924763|NCT00584831|19502582|P5|STARTED|Intervention 1||2
7924764|NCT00584831|19502583|P4|STARTED|Intervention 1||1
7924765|NCT00584831|19502584|P3|STARTED|Intervention 1||2
7924766|NCT00584831|19502585|P2|STARTED|Intervention 1||3
7924767|NCT00584831|19502586|P1|STARTED|Intervention 1||1
7924768|NCT00584805|19502608|P1|NOT COMPLETED|Overall Study||99
7924769|NCT00584805|19502608|P1|COMPLETED|Overall Study||39
7924770|NCT00584805|19502608|P1|STARTED|Overall Study||138
7924771|NCT00584740|19502621|P2|NOT COMPLETED|Overall Study||6
7924772|NCT00584740|19502622|P1|NOT COMPLETED|Overall Study||12
7924773|NCT00584740|19502621|P2|COMPLETED|Overall Study||14
7924774|NCT00584740|19502622|P1|COMPLETED|Overall Study||27
7924775|NCT00584740|19502621|P2|STARTED|Overall Study||20
7924776|NCT00584740|19502622|P1|STARTED|Overall Study||39
7924777|NCT00584727|19502640|P6|NOT COMPLETED|Third Intervention||2
7924778|NCT00584727|19502641|P5|NOT COMPLETED|Third Intervention||4
7924779|NCT00584727|19502642|P4|NOT COMPLETED|Third Intervention||0
7924780|NCT00584727|19502643|P3|NOT COMPLETED|Third Intervention||1
7924781|NCT00584727|19502644|P2|NOT COMPLETED|Third Intervention||0
7924782|NCT00584727|19502645|P1|NOT COMPLETED|Third Intervention||0
7924783|NCT00584727|19502640|P6|COMPLETED|Third Intervention||14
7924784|NCT00584727|19502641|P5|COMPLETED|Third Intervention||12
7924785|NCT00584727|19502642|P4|COMPLETED|Third Intervention||14
7924786|NCT00584727|19502643|P3|COMPLETED|Third Intervention||14
7924787|NCT00584727|19502644|P2|COMPLETED|Third Intervention||17
7924788|NCT00584727|19502645|P1|COMPLETED|Third Intervention||17
7924789|NCT00584727|19502640|P6|STARTED|Third Intervention||16
7924790|NCT00584727|19502641|P5|STARTED|Third Intervention||16
7924791|NCT00584727|19502642|P4|STARTED|Third Intervention||14
7924792|NCT00584727|19502643|P3|STARTED|Third Intervention||15
7924793|NCT00584727|19502644|P2|STARTED|Third Intervention||17
7924794|NCT00584727|19502645|P1|STARTED|Third Intervention||17
7924795|NCT00584727|19502640|P6|NOT COMPLETED|Second Intervention||0
7924796|NCT00584727|19502641|P5|NOT COMPLETED|Second Intervention||0
7924797|NCT00584727|19502642|P4|NOT COMPLETED|Second Intervention||0
7924798|NCT00584727|19502643|P3|NOT COMPLETED|Second Intervention||0
7924799|NCT00584727|19502644|P2|NOT COMPLETED|Second Intervention||0
7924800|NCT00584727|19502645|P1|NOT COMPLETED|Second Intervention||0
7924801|NCT00584727|19502640|P6|COMPLETED|Second Intervention||16
7924802|NCT00584727|19502641|P5|COMPLETED|Second Intervention||16
7924803|NCT00584727|19502642|P4|COMPLETED|Second Intervention||14
7924804|NCT00584727|19502643|P3|COMPLETED|Second Intervention||15
7924805|NCT00584727|19502644|P2|COMPLETED|Second Intervention||17
7924806|NCT00584727|19502645|P1|COMPLETED|Second Intervention||17
7924807|NCT00584727|19502640|P6|STARTED|Second Intervention||16
7924808|NCT00584727|19502641|P5|STARTED|Second Intervention||16
7924809|NCT00584727|19502642|P4|STARTED|Second Intervention||14
7924810|NCT00584727|19502643|P3|STARTED|Second Intervention||15
7924811|NCT00584727|19502644|P2|STARTED|Second Intervention||17
7924812|NCT00584727|19502645|P1|STARTED|Second Intervention||17
7924813|NCT00584727|19502640|P6|NOT COMPLETED|First Intervention||0
7924814|NCT00584727|19502641|P5|NOT COMPLETED|First Intervention||0
7924815|NCT00584727|19502642|P4|NOT COMPLETED|First Intervention||0
7924816|NCT00584727|19502643|P3|NOT COMPLETED|First Intervention||1
7924817|NCT00584727|19502644|P2|NOT COMPLETED|First Intervention||0
7924818|NCT00584727|19502645|P1|NOT COMPLETED|First Intervention||0
7924819|NCT00584727|19502640|P6|COMPLETED|First Intervention||16
7924820|NCT00584727|19502641|P5|COMPLETED|First Intervention||16
7924821|NCT00584727|19502642|P4|COMPLETED|First Intervention||14
7924822|NCT00584727|19502643|P3|COMPLETED|First Intervention||15
7924823|NCT00584727|19502644|P2|COMPLETED|First Intervention||17
7924824|NCT00584727|19502645|P1|COMPLETED|First Intervention||17
7924825|NCT00584727|19502640|P6|STARTED|First Intervention||16
7924826|NCT00584727|19502641|P5|STARTED|First Intervention||16
7924827|NCT00584727|19502642|P4|STARTED|First Intervention||14
7924828|NCT00584727|19502643|P3|STARTED|First Intervention||16
7924829|NCT00584727|19502644|P2|STARTED|First Intervention||17
7924830|NCT00584727|19502645|P1|STARTED|First Intervention||17
7924831|NCT00584701|19502669|P1|NOT COMPLETED|Follow-up||12
7924832|NCT00584701|19502669|P1|COMPLETED|Follow-up||34
7924833|NCT00584701|19502669|P1|STARTED|Follow-up||46
7924834|NCT00584701|19502669|P1|NOT COMPLETED|Active Risperidone||3
7924835|NCT00584701|19502669|P1|COMPLETED|Active Risperidone||46
7924836|NCT00584701|19502669|P1|STARTED|Active Risperidone||49
7924837|NCT00584558|19502674|P1|NOT COMPLETED|Overall Study||0
7924838|NCT00584558|19502674|P1|COMPLETED|Overall Study||2420
7924839|NCT00584558|19502674|P1|STARTED|Overall Study||2420
7924840|NCT00584480|19502679|P1|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0
7924841|NCT00584480|19502679|P1|COMPLETED|Second 8 Weeks (40 Treatments)||10
7924842|NCT00584480|19502679|P1|STARTED|Second 8 Weeks (40 Treatments)||10
7924843|NCT00584480|19502679|P1|NOT COMPLETED|4-Week Break From Treatment||0
7924844|NCT00584480|19502679|P1|COMPLETED|4-Week Break From Treatment||10
7924845|NCT00584480|19502679|P1|STARTED|4-Week Break From Treatment||10
7924846|NCT00584480|19502679|P1|NOT COMPLETED|First 8 Weeks (40 Treatments)||0
7924847|NCT00584480|19502679|P1|COMPLETED|First 8 Weeks (40 Treatments)||10
7924848|NCT00584480|19502679|P1|STARTED|First 8 Weeks (40 Treatments)||10
7924849|NCT00584454|19502683|P1|NOT COMPLETED|Overall Study||4
7924850|NCT00584454|19502683|P1|COMPLETED|Overall Study||6
7924851|NCT00584454|19502683|P1|STARTED|Overall Study||10
7924852|NCT00584415|19502687|P1|NOT COMPLETED|Overall Study||7
7924853|NCT00584415|19502687|P1|COMPLETED|Overall Study||112
7924854|NCT00584415|19502687|P1|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119
7924855|NCT00584402|19502692|P1|NOT COMPLETED|Overall Study||0
7924856|NCT00584402|19502692|P1|COMPLETED|Overall Study||8
7924857|NCT00584402|19502692|P1|STARTED|Overall Study||8
7924858|NCT00584285|19502697|P1|NOT COMPLETED|Overall Study||0
7924859|NCT00584285|19502697|P1|COMPLETED|Overall Study||18
7924860|NCT00584285|19502697|P1|STARTED|Overall Study||18
7924861|NCT00584220|19502701|P2|NOT COMPLETED|Second Period||0
7924862|NCT00584220|19502702|P1|NOT COMPLETED|Second Period||0
7924863|NCT00584220|19502701|P2|COMPLETED|Second Period||39
7924864|NCT00584220|19502702|P1|COMPLETED|Second Period||48
7924865|NCT00584220|19502701|P2|STARTED|Second Period||39
7924866|NCT00584220|19502702|P1|STARTED|Second Period||48
7924867|NCT00584220|19502701|P2|NOT COMPLETED|First Period||0
7924868|NCT00584220|19502702|P1|NOT COMPLETED|First Period||0
7924869|NCT00584220|19502701|P2|COMPLETED|First Period||39
7924870|NCT00584220|19502702|P1|COMPLETED|First Period||48
7924871|NCT00584220|19502701|P2|STARTED|First Period||39
7924872|NCT00584220|19502702|P1|STARTED|First Period||48
7924873|NCT00584194|19502710|P1|NOT COMPLETED|Overall Study||135
7924874|NCT00584194|19502710|P1|COMPLETED|Overall Study||143
7924875|NCT00584194|19502710|P1|STARTED|Overall Study||278
7924876|NCT00584077|19502718|P1|NOT COMPLETED|Overall Study||0
7924877|NCT00584077|19502718|P1|COMPLETED|Overall Study||15
7924878|NCT00584077|19502718|P1|STARTED|Overall Study||15
7924879|NCT00584012|19502723|P1|NOT COMPLETED|Overall Study||1
7924880|NCT00584012|19502723|P1|COMPLETED|Overall Study||8
7924881|NCT00584012|19502723|P1|STARTED|Overall Study||9
7924882|NCT00583947|19502729|P2|NOT COMPLETED|Open Label Period||0
7924883|NCT00583947|19502730|P1|NOT COMPLETED|Open Label Period||0
7924884|NCT00583947|19502729|P2|COMPLETED|Open Label Period||24
7924885|NCT00583947|19502730|P1|COMPLETED|Open Label Period||22
7924886|NCT00583947|19502729|P2|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24
7924887|NCT00583947|19502730|P1|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22
7924888|NCT00583947|19502729|P2|NOT COMPLETED|Washout||0
7924889|NCT00583947|19502730|P1|NOT COMPLETED|Washout||0
7924890|NCT00583947|19502729|P2|COMPLETED|Washout||24
7924891|NCT00583947|19502730|P1|COMPLETED|Washout||22
7924892|NCT00583947|19502729|P2|STARTED|Washout||24
7924893|NCT00583947|19502730|P1|STARTED|Washout||22
7924894|NCT00583947|19502729|P2|NOT COMPLETED|Cross-over Period||2
7924895|NCT00583947|19502730|P1|NOT COMPLETED|Cross-over Period||5
7924896|NCT00583947|19502729|P2|COMPLETED|Cross-over Period||24
7924897|NCT00583947|19502730|P1|COMPLETED|Cross-over Period||22
7924898|NCT00583947|19502729|P2|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26
7924899|NCT00583947|19502730|P1|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27
7924900|NCT00583908|19502780|P12|NOT COMPLETED|Period 4 - Fourth Intervention||0
7924901|NCT00583908|19502781|P11|NOT COMPLETED|Period 4 - Fourth Intervention||0
7924902|NCT00583908|19502782|P10|NOT COMPLETED|Period 4 - Fourth Intervention||0
7924903|NCT00583908|19502783|P9|NOT COMPLETED|Period 4 - Fourth Intervention||0
7924904|NCT00583908|19502784|P8|NOT COMPLETED|Period 4 - Fourth Intervention||0
7924905|NCT00583908|19502785|P7|NOT COMPLETED|Period 4 - Fourth Intervention||0
7924906|NCT00583908|19502786|P6|NOT COMPLETED|Period 4 - Fourth Intervention||0
7924907|NCT00583908|19502787|P5|NOT COMPLETED|Period 4 - Fourth Intervention||0
7924908|NCT00583908|19502788|P4|NOT COMPLETED|Period 4 - Fourth Intervention||0
7924909|NCT00583908|19502789|P3|NOT COMPLETED|Period 4 - Fourth Intervention||0
7924910|NCT00583908|19502790|P2|NOT COMPLETED|Period 4 - Fourth Intervention||0
7924911|NCT00583908|19502791|P1|NOT COMPLETED|Period 4 - Fourth Intervention||0
7924912|NCT00583908|19502780|P12|COMPLETED|Period 4 - Fourth Intervention||1
7924913|NCT00583908|19502781|P11|COMPLETED|Period 4 - Fourth Intervention||1
7924914|NCT00583908|19502782|P10|COMPLETED|Period 4 - Fourth Intervention||1
7924915|NCT00583908|19502783|P9|COMPLETED|Period 4 - Fourth Intervention||1
7924916|NCT00583908|19502784|P8|COMPLETED|Period 4 - Fourth Intervention||1
7924917|NCT00583908|19502785|P7|COMPLETED|Period 4 - Fourth Intervention||1
7924918|NCT00583908|19502786|P6|COMPLETED|Period 4 - Fourth Intervention||1
7924919|NCT00583908|19502787|P5|COMPLETED|Period 4 - Fourth Intervention||2
7924920|NCT00583908|19502788|P4|COMPLETED|Period 4 - Fourth Intervention||1
7924921|NCT00583908|19502789|P3|COMPLETED|Period 4 - Fourth Intervention||1
7924922|NCT00583908|19502790|P2|COMPLETED|Period 4 - Fourth Intervention||2
7924923|NCT00583908|19502791|P1|COMPLETED|Period 4 - Fourth Intervention||1
7924924|NCT00583908|19502780|P12|STARTED|Period 4 - Fourth Intervention||1
7924925|NCT00583908|19502781|P11|STARTED|Period 4 - Fourth Intervention||1
7924926|NCT00583908|19502782|P10|STARTED|Period 4 - Fourth Intervention||1
7924927|NCT00583908|19502783|P9|STARTED|Period 4 - Fourth Intervention||1
7924928|NCT00583908|19502784|P8|STARTED|Period 4 - Fourth Intervention||1
7924929|NCT00583908|19502785|P7|STARTED|Period 4 - Fourth Intervention||1
7924930|NCT00583908|19502786|P6|STARTED|Period 4 - Fourth Intervention||1
7924931|NCT00583908|19502787|P5|STARTED|Period 4 - Fourth Intervention||2
7924932|NCT00583908|19502788|P4|STARTED|Period 4 - Fourth Intervention||1
7924933|NCT00583908|19502789|P3|STARTED|Period 4 - Fourth Intervention||1
7924934|NCT00583908|19502790|P2|STARTED|Period 4 - Fourth Intervention||2
7924935|NCT00583908|19502791|P1|STARTED|Period 4 - Fourth Intervention||1
7924936|NCT00583908|19502780|P12|NOT COMPLETED|Period 3 - Third Intervention||0
7924937|NCT00583908|19502781|P11|NOT COMPLETED|Period 3 - Third Intervention||0
7924938|NCT00583908|19502782|P10|NOT COMPLETED|Period 3 - Third Intervention||0
7924939|NCT00583908|19502783|P9|NOT COMPLETED|Period 3 - Third Intervention||0
7924940|NCT00583908|19502784|P8|NOT COMPLETED|Period 3 - Third Intervention||0
7924941|NCT00583908|19502785|P7|NOT COMPLETED|Period 3 - Third Intervention||0
7924942|NCT00583908|19502786|P6|NOT COMPLETED|Period 3 - Third Intervention||0
7924943|NCT00583908|19502787|P5|NOT COMPLETED|Period 3 - Third Intervention||0
7924944|NCT00583908|19502788|P4|NOT COMPLETED|Period 3 - Third Intervention||0
7924945|NCT00583908|19502789|P3|NOT COMPLETED|Period 3 - Third Intervention||0
7924946|NCT00583908|19502790|P2|NOT COMPLETED|Period 3 - Third Intervention||0
7924947|NCT00583908|19502791|P1|NOT COMPLETED|Period 3 - Third Intervention||0
7924948|NCT00583908|19502780|P12|COMPLETED|Period 3 - Third Intervention||1
7924949|NCT00583908|19502781|P11|COMPLETED|Period 3 - Third Intervention||1
7924950|NCT00583908|19502782|P10|COMPLETED|Period 3 - Third Intervention||1
7924951|NCT00583908|19502783|P9|COMPLETED|Period 3 - Third Intervention||1
7924952|NCT00583908|19502784|P8|COMPLETED|Period 3 - Third Intervention||1
7924953|NCT00583908|19502785|P7|COMPLETED|Period 3 - Third Intervention||1
7924954|NCT00583908|19502786|P6|COMPLETED|Period 3 - Third Intervention||1
7924955|NCT00583908|19502787|P5|COMPLETED|Period 3 - Third Intervention||2
7924956|NCT00583908|19502788|P4|COMPLETED|Period 3 - Third Intervention||1
7924957|NCT00583908|19502789|P3|COMPLETED|Period 3 - Third Intervention||1
7924958|NCT00583908|19502790|P2|COMPLETED|Period 3 - Third Intervention||2
7924959|NCT00583908|19502791|P1|COMPLETED|Period 3 - Third Intervention||1
7924960|NCT00583908|19502780|P12|STARTED|Period 3 - Third Intervention||1
7924961|NCT00583908|19502781|P11|STARTED|Period 3 - Third Intervention||1
7924962|NCT00583908|19502782|P10|STARTED|Period 3 - Third Intervention||1
7924963|NCT00583908|19502783|P9|STARTED|Period 3 - Third Intervention||1
7924964|NCT00583908|19502784|P8|STARTED|Period 3 - Third Intervention||1
7924965|NCT00583908|19502785|P7|STARTED|Period 3 - Third Intervention||1
7924966|NCT00583908|19502786|P6|STARTED|Period 3 - Third Intervention||1
7924967|NCT00583908|19502787|P5|STARTED|Period 3 - Third Intervention||2
7924968|NCT00583908|19502788|P4|STARTED|Period 3 - Third Intervention||1
7924969|NCT00583908|19502789|P3|STARTED|Period 3 - Third Intervention||1
7924970|NCT00583908|19502790|P2|STARTED|Period 3 - Third Intervention||2
7924971|NCT00583908|19502791|P1|STARTED|Period 3 - Third Intervention||1
7924972|NCT00583908|19502780|P12|NOT COMPLETED|Period 2 - Second Intervention||0
7924973|NCT00583908|19502781|P11|NOT COMPLETED|Period 2 - Second Intervention||0
7924974|NCT00583908|19502782|P10|NOT COMPLETED|Period 2 - Second Intervention||0
7924975|NCT00583908|19502783|P9|NOT COMPLETED|Period 2 - Second Intervention||0
7924976|NCT00583908|19502784|P8|NOT COMPLETED|Period 2 - Second Intervention||0
7924977|NCT00583908|19502785|P7|NOT COMPLETED|Period 2 - Second Intervention||0
7924978|NCT00583908|19502786|P6|NOT COMPLETED|Period 2 - Second Intervention||0
7924979|NCT00583908|19502787|P5|NOT COMPLETED|Period 2 - Second Intervention||0
7924980|NCT00583908|19502788|P4|NOT COMPLETED|Period 2 - Second Intervention||0
7924981|NCT00583908|19502789|P3|NOT COMPLETED|Period 2 - Second Intervention||0
7924982|NCT00583908|19502790|P2|NOT COMPLETED|Period 2 - Second Intervention||0
7924983|NCT00583908|19502791|P1|NOT COMPLETED|Period 2 - Second Intervention||0
7924984|NCT00583908|19502780|P12|COMPLETED|Period 2 - Second Intervention||1
7924985|NCT00583908|19502781|P11|COMPLETED|Period 2 - Second Intervention||1
7924986|NCT00583908|19502782|P10|COMPLETED|Period 2 - Second Intervention||1
7924987|NCT00583908|19502783|P9|COMPLETED|Period 2 - Second Intervention||1
7924988|NCT00583908|19502784|P8|COMPLETED|Period 2 - Second Intervention||1
7924989|NCT00583908|19502785|P7|COMPLETED|Period 2 - Second Intervention||1
7924990|NCT00583908|19502786|P6|COMPLETED|Period 2 - Second Intervention||1
7924991|NCT00583908|19502787|P5|COMPLETED|Period 2 - Second Intervention||2
7924992|NCT00583908|19502788|P4|COMPLETED|Period 2 - Second Intervention||1
7924993|NCT00583908|19502789|P3|COMPLETED|Period 2 - Second Intervention||1
7924994|NCT00583908|19502790|P2|COMPLETED|Period 2 - Second Intervention||2
7924995|NCT00583908|19502791|P1|COMPLETED|Period 2 - Second Intervention||1
7924996|NCT00583908|19502780|P12|STARTED|Period 2 - Second Intervention||1
7924997|NCT00583908|19502781|P11|STARTED|Period 2 - Second Intervention||1
7924998|NCT00583908|19502782|P10|STARTED|Period 2 - Second Intervention||1
7924999|NCT00583908|19502783|P9|STARTED|Period 2 - Second Intervention||1
7925000|NCT00583908|19502784|P8|STARTED|Period 2 - Second Intervention||1
7925001|NCT00583908|19502785|P7|STARTED|Period 2 - Second Intervention||1
7925002|NCT00583908|19502786|P6|STARTED|Period 2 - Second Intervention||1
7925003|NCT00583908|19502787|P5|STARTED|Period 2 - Second Intervention||2
7925004|NCT00583908|19502788|P4|STARTED|Period 2 - Second Intervention||1
7925005|NCT00583908|19502789|P3|STARTED|Period 2 - Second Intervention||1
7925006|NCT00583908|19502790|P2|STARTED|Period 2 - Second Intervention||2
7925007|NCT00583908|19502791|P1|STARTED|Period 2 - Second Intervention||1
7925008|NCT00583908|19502780|P12|NOT COMPLETED|Period 1 - First Intervention||0
7925009|NCT00583908|19502781|P11|NOT COMPLETED|Period 1 - First Intervention||0
7925010|NCT00583908|19502782|P10|NOT COMPLETED|Period 1 - First Intervention||0
7925011|NCT00583908|19502783|P9|NOT COMPLETED|Period 1 - First Intervention||0
7925012|NCT00583908|19502784|P8|NOT COMPLETED|Period 1 - First Intervention||0
7925013|NCT00583908|19502785|P7|NOT COMPLETED|Period 1 - First Intervention||0
7925014|NCT00583908|19502786|P6|NOT COMPLETED|Period 1 - First Intervention||0
7925015|NCT00583908|19502787|P5|NOT COMPLETED|Period 1 - First Intervention||0
7925016|NCT00583908|19502788|P4|NOT COMPLETED|Period 1 - First Intervention||0
7925017|NCT00583908|19502789|P3|NOT COMPLETED|Period 1 - First Intervention||0
7925018|NCT00583908|19502790|P2|NOT COMPLETED|Period 1 - First Intervention||0
7925019|NCT00583908|19502791|P1|NOT COMPLETED|Period 1 - First Intervention||0
7925020|NCT00583908|19502780|P12|COMPLETED|Period 1 - First Intervention||1
7925021|NCT00583908|19502781|P11|COMPLETED|Period 1 - First Intervention||1
7925022|NCT00583908|19502782|P10|COMPLETED|Period 1 - First Intervention||1
7925023|NCT00583908|19502783|P9|COMPLETED|Period 1 - First Intervention||1
7925024|NCT00583908|19502784|P8|COMPLETED|Period 1 - First Intervention||1
7925025|NCT00583908|19502785|P7|COMPLETED|Period 1 - First Intervention||1
7925026|NCT00583908|19502786|P6|COMPLETED|Period 1 - First Intervention||1
7925027|NCT00583908|19502787|P5|COMPLETED|Period 1 - First Intervention||2
7925028|NCT00583908|19502788|P4|COMPLETED|Period 1 - First Intervention||1
7925029|NCT00583908|19502789|P3|COMPLETED|Period 1 - First Intervention||1
7925030|NCT00583908|19502790|P2|COMPLETED|Period 1 - First Intervention||2
7925031|NCT00583908|19502791|P1|COMPLETED|Period 1 - First Intervention||1
7925032|NCT00583908|19502780|P12|STARTED|Period 1 - First Intervention||1
7925033|NCT00583908|19502781|P11|STARTED|Period 1 - First Intervention||1
7925034|NCT00583908|19502782|P10|STARTED|Period 1 - First Intervention||1
7925035|NCT00583908|19502783|P9|STARTED|Period 1 - First Intervention||1
7925036|NCT00583908|19502784|P8|STARTED|Period 1 - First Intervention||1
7925037|NCT00583908|19502785|P7|STARTED|Period 1 - First Intervention||1
7925038|NCT00583908|19502786|P6|STARTED|Period 1 - First Intervention||1
7925039|NCT00583908|19502787|P5|STARTED|Period 1 - First Intervention||2
7925040|NCT00583908|19502788|P4|STARTED|Period 1 - First Intervention||1
7925041|NCT00583908|19502789|P3|STARTED|Period 1 - First Intervention||1
7925042|NCT00583908|19502790|P2|STARTED|Period 1 - First Intervention||2
7925043|NCT00583908|19502791|P1|STARTED|Period 1 - First Intervention||1
7925044|NCT00583804|19502845|P1|NOT COMPLETED|Overall Study||0
7925045|NCT00583804|19502845|P1|COMPLETED|Overall Study|Subjects were considered enrolled when they underwent implantation of the device. All completed.|10
7925046|NCT00583804|19502845|P1|STARTED|Overall Study||10
7925047|NCT00583791|19502851|P1|NOT COMPLETED|Overall Study||73
7925048|NCT00583791|19502851|P1|COMPLETED|Overall Study||18
7925049|NCT00583791|19502851|P1|STARTED|Overall Study||91
7925050|NCT00583713|19502858|P3|NOT COMPLETED|Overall Study||0
7925051|NCT00583713|19502859|P2|NOT COMPLETED|Overall Study||0
7925052|NCT00583713|19502860|P1|NOT COMPLETED|Overall Study||0
7925053|NCT00583713|19502858|P3|COMPLETED|Overall Study||6
7925054|NCT00583713|19502859|P2|COMPLETED|Overall Study||6
7925055|NCT00583713|19502860|P1|COMPLETED|Overall Study||6
7925056|NCT00583713|19502858|P3|STARTED|Overall Study||6
7925057|NCT00583713|19502859|P2|STARTED|Overall Study||6
7925058|NCT00583713|19502860|P1|STARTED|Overall Study||6
7925059|NCT00583700|19502885|P2|NOT COMPLETED|Overall Study||4
7925060|NCT00583700|19502886|P1|NOT COMPLETED|Overall Study||3
7925061|NCT00583700|19502885|P2|COMPLETED|Overall Study||23
7925062|NCT00583700|19502886|P1|COMPLETED|Overall Study||24
7925063|NCT00583700|19502885|P2|STARTED|Overall Study||27
7925064|NCT00583700|19502886|P1|STARTED|Overall Study||27
7925065|NCT00583661|19502894|P1|NOT COMPLETED|Overall Study||0
7925066|NCT00583661|19502894|P1|COMPLETED|Overall Study||48
7925067|NCT00583661|19502894|P1|STARTED|Overall Study||48
7925068|NCT00583622|19502901|P1|NOT COMPLETED|Overall Study||0
7925069|NCT00583622|19502901|P1|COMPLETED|Overall Study||12
7925070|NCT00583622|19502901|P1|STARTED|Overall Study||12
7925071|NCT00583596|19502906|P1|NOT COMPLETED|Overall Study||284
7925072|NCT00583596|19502906|P1|COMPLETED|Overall Study||152
7925073|NCT00583596|19502906|P1|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436
7925074|NCT00583557|19502911|P1|NOT COMPLETED|Overall Study||70
7925075|NCT00583557|19502911|P1|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85
7925076|NCT00583557|19502911|P1|Received at Least 1 Dose Belimumab|Overall Study||153
7925077|NCT00583557|19502911|P1|STARTED|Overall Study||155
7925078|NCT00583492|19502917|P2|NOT COMPLETED|Overall Study||0
7925079|NCT00583492|19502918|P1|NOT COMPLETED|Overall Study||0
7925080|NCT00583492|19502917|P2|COMPLETED|Overall Study||23
7925081|NCT00583492|19502918|P1|COMPLETED|Overall Study||21
7925082|NCT00583492|19502917|P2|STARTED|Overall Study||23
7925083|NCT00583492|19502918|P1|STARTED|Overall Study||21
7925084|NCT00583466|19502934|P1|NOT COMPLETED|Overall Study||0
7925085|NCT00583466|19502934|P1|COMPLETED|Overall Study||18
7925086|NCT00583466|19502934|P1|STARTED|Overall Study||18
7925087|NCT00583453|19502942|P2|NOT COMPLETED|Overall Study||2
7925088|NCT00583453|19502943|P1|NOT COMPLETED|Overall Study||0
7925089|NCT00583453|19502942|P2|COMPLETED|Overall Study||6
7925090|NCT00583453|19502943|P1|COMPLETED|Overall Study||9
7925091|NCT00583453|19502942|P2|STARTED|Overall Study||8
7925092|NCT00583453|19502943|P1|STARTED|Overall Study||9
7925093|NCT00583414|19502957|P1|NOT COMPLETED|Overall Study||0
7925094|NCT00583414|19502957|P1|COMPLETED|Overall Study||401
7925095|NCT00583414|19502957|P1|STARTED|Overall Study||401
7925096|NCT00583375|19502963|P2|NOT COMPLETED|Overall Study||0
7925097|NCT00583375|19502964|P1|NOT COMPLETED|Overall Study||0
7925098|NCT00583375|19502963|P2|COMPLETED|Overall Study||272
7925099|NCT00583375|19502964|P1|COMPLETED|Overall Study||142
7925100|NCT00583375|19502963|P2|STARTED|Overall Study||272
7925101|NCT00583375|19502964|P1|STARTED|Overall Study||142
7925102|NCT00583362|19502980|P1|NOT COMPLETED|Overall Study||202
7925103|NCT00583362|19502980|P1|COMPLETED|Overall Study||96
7925104|NCT00583362|19502980|P1|STARTED|Overall Study||298
7925105|NCT00583219|19503004|P1|NOT COMPLETED|Phase 2||1
7925106|NCT00583219|19503004|P1|COMPLETED|Phase 2||21
7925107|NCT00583219|19503004|P1|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22
7925108|NCT00583219|19503004|P1|NOT COMPLETED|Phase 1||0
7925109|NCT00583219|19503004|P1|COMPLETED|Phase 1||9
7925110|NCT00583219|19503004|P1|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9
7925111|NCT00583115|19503021|P1|NOT COMPLETED|Overall Study||1
7925112|NCT00583115|19503021|P1|COMPLETED|Overall Study||0
7925113|NCT00583115|19503021|P1|STARTED|Overall Study||1
7925114|NCT00583102|19503026|P1|NOT COMPLETED|Overall Study||3
7925115|NCT00583102|19503026|P1|COMPLETED|Overall Study||20
7925116|NCT00583102|19503026|P1|STARTED|Overall Study||23
7925117|NCT00583050|19503030|P1|NOT COMPLETED|Overall Study||0
7925118|NCT00583050|19503030|P1|COMPLETED|Overall Study||1366
7925119|NCT00583050|19503030|P1|STARTED|Overall Study||1366
7925120|NCT00582998|19503036|P2|NOT COMPLETED|Overall Study||0
7925121|NCT00582998|19503037|P1|NOT COMPLETED|Overall Study||0
7925122|NCT00582998|19503036|P2|COMPLETED|Overall Study||130
7925123|NCT00582998|19503037|P1|COMPLETED|Overall Study||119
7925124|NCT00582998|19503036|P2|STARTED|Overall Study||130
7925125|NCT00582998|19503037|P1|STARTED|Overall Study||119
7925126|NCT00582972|19503043|P1|NOT COMPLETED|Overall Study||2
7925127|NCT00582972|19503043|P1|COMPLETED|Overall Study||21
7925128|NCT00582972|19503043|P1|STARTED|Overall Study||23
7925129|NCT00582946|19503048|P1|NOT COMPLETED|Overall Study||0
7925130|NCT00582946|19503048|P1|COMPLETED|Overall Study||16
7925131|NCT00582946|19503048|P1|STARTED|Overall Study||16
7925132|NCT00582933|19503052|P1|NOT COMPLETED|Overall Study||3
7925133|NCT00582933|19503052|P1|COMPLETED|Overall Study||92
7925134|NCT00582933|19503052|P1|STARTED|Overall Study||95
7925135|NCT00582907|19503056|P4|NOT COMPLETED|4th Course||0
7925136|NCT00582907|19503057|P3|NOT COMPLETED|4th Course||0
7925137|NCT00582907|19503058|P2|NOT COMPLETED|4th Course||0
7925138|NCT00582907|19503059|P1|NOT COMPLETED|4th Course||0
7925139|NCT00582907|19503056|P4|COMPLETED|4th Course||3
7925140|NCT00582907|19503057|P3|COMPLETED|4th Course||3
7925141|NCT00582907|19503058|P2|COMPLETED|4th Course||3
7925142|NCT00582907|19503059|P1|COMPLETED|4th Course||2
7925143|NCT00582907|19503056|P4|STARTED|4th Course||3
7925144|NCT00582907|19503057|P3|STARTED|4th Course||3
7925145|NCT00582907|19503058|P2|STARTED|4th Course||3
7925146|NCT00582907|19503059|P1|STARTED|4th Course||2
7925147|NCT00582907|19503056|P4|NOT COMPLETED|3rd Course||0
7925148|NCT00582907|19503057|P3|NOT COMPLETED|3rd Course||0
7925149|NCT00582907|19503058|P2|NOT COMPLETED|3rd Course||0
7925150|NCT00582907|19503059|P1|NOT COMPLETED|3rd Course||0
7925151|NCT00582907|19503056|P4|COMPLETED|3rd Course||3
7925152|NCT00582907|19503057|P3|COMPLETED|3rd Course||3
7925153|NCT00582907|19503058|P2|COMPLETED|3rd Course||3
7925154|NCT00582907|19503059|P1|COMPLETED|3rd Course||2
7925155|NCT00582907|19503056|P4|STARTED|3rd Course||3
7925156|NCT00582907|19503057|P3|STARTED|3rd Course||3
7925157|NCT00582907|19503058|P2|STARTED|3rd Course||3
7925158|NCT00582907|19503059|P1|STARTED|3rd Course||2
7925159|NCT00582907|19503056|P4|NOT COMPLETED|2nd Course||0
7925160|NCT00582907|19503057|P3|NOT COMPLETED|2nd Course||0
7925161|NCT00582907|19503058|P2|NOT COMPLETED|2nd Course||0
7925162|NCT00582907|19503059|P1|NOT COMPLETED|2nd Course||1
7925163|NCT00582907|19503056|P4|COMPLETED|2nd Course||3
7925164|NCT00582907|19503057|P3|COMPLETED|2nd Course||3
7925165|NCT00582907|19503058|P2|COMPLETED|2nd Course||3
7925166|NCT00582907|19503059|P1|COMPLETED|2nd Course||2
7925167|NCT00582907|19503056|P4|STARTED|2nd Course||3
7925168|NCT00582907|19503057|P3|STARTED|2nd Course||3
7925169|NCT00582907|19503058|P2|STARTED|2nd Course||3
7925170|NCT00582907|19503059|P1|STARTED|2nd Course||3
7925171|NCT00582907|19503056|P4|NOT COMPLETED|1st Course||1
7925172|NCT00582907|19503057|P3|NOT COMPLETED|1st Course||0
7925173|NCT00582907|19503058|P2|NOT COMPLETED|1st Course||0
7925174|NCT00582907|19503059|P1|NOT COMPLETED|1st Course||1
7925175|NCT00582907|19503056|P4|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3
7925176|NCT00582907|19503057|P3|COMPLETED|1st Course||3
7925177|NCT00582907|19503058|P2|COMPLETED|1st Course||3
7925178|NCT00582907|19503059|P1|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3
7925179|NCT00582907|19503056|P4|STARTED|1st Course||4
7925180|NCT00582907|19503057|P3|STARTED|1st Course||3
7925181|NCT00582907|19503058|P2|STARTED|1st Course||3
7925182|NCT00582907|19503059|P1|STARTED|1st Course||4
7925183|NCT00582894|19503091|P1|NOT COMPLETED|Overall Study||0
7925184|NCT00582894|19503091|P1|COMPLETED|Overall Study||17
7925185|NCT00582894|19503091|P1|Day 100 Post Transplant|Overall Study||17
7925186|NCT00582894|19503091|P1|STARTED|Overall Study||17
7925187|NCT00582816|19503098|P1|NOT COMPLETED|Overall Study||3
7925188|NCT00582816|19503098|P1|COMPLETED|Overall Study|"Completed here means patients stably engrafted with donor cells."|6
7925189|NCT00582816|19503098|P1|STARTED|Overall Study||9
7925190|NCT00582790|19503108|P1|NOT COMPLETED|Overall Study||1
7925191|NCT00582790|19503108|P1|COMPLETED|Overall Study||11
7925192|NCT00582790|19503108|P1|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12
7925193|NCT00582738|19503117|P2|NOT COMPLETED|Overall Study||18
7925194|NCT00582738|19503118|P1|NOT COMPLETED|Overall Study||9
7925195|NCT00582738|19503117|P2|COMPLETED|Overall Study||4
7925196|NCT00582738|19503118|P1|COMPLETED|Overall Study||12
7925197|NCT00582738|19503117|P2|STARTED|Overall Study||22
7925198|NCT00582738|19503118|P1|STARTED|Overall Study||21
7925199|NCT00582712|19503142|P1|NOT COMPLETED|Overall Study||4
7925200|NCT00582712|19503142|P1|COMPLETED|Overall Study||1
7925201|NCT00582712|19503142|P1|STARTED|Overall Study||5
7925202|NCT00582660|19503148|P2|NOT COMPLETED|Overall Study||0
7925203|NCT00582660|19503149|P1|NOT COMPLETED|Overall Study||0
7925204|NCT00582660|19503148|P2|COMPLETED|Overall Study||20
7925205|NCT00582660|19503149|P1|COMPLETED|Overall Study||20
7925206|NCT00582660|19503148|P2|STARTED|Overall Study||20
7925207|NCT00582660|19503149|P1|STARTED|Overall Study||20
7925208|NCT00582608|19503157|P1|NOT COMPLETED|Overall Study||12
7925209|NCT00582608|19503157|P1|COMPLETED|Overall Study||0
7925210|NCT00582608|19503157|P1|STARTED|Overall Study||12
7925211|NCT00582556|19503164|P3|NOT COMPLETED|Overall Study||2
7925212|NCT00582556|19503165|P2|NOT COMPLETED|Overall Study||1
7925213|NCT00582556|19503166|P1|NOT COMPLETED|Overall Study||0
7925214|NCT00582556|19503164|P3|COMPLETED|Overall Study||12
7925215|NCT00582556|19503165|P2|COMPLETED|Overall Study||14
7925216|NCT00582556|19503166|P1|COMPLETED|Overall Study||14
7925217|NCT00582556|19503164|P3|STARTED|Overall Study||14
7925218|NCT00582556|19503165|P2|STARTED|Overall Study||15
7925219|NCT00582556|19503166|P1|STARTED|Overall Study||14
7925220|NCT00582517|19503185|P2|NOT COMPLETED|Overall Study||0
7925221|NCT00582517|19503186|P1|NOT COMPLETED|Overall Study||0
7925222|NCT00582517|19503185|P2|COMPLETED|Overall Study||55
7925223|NCT00582517|19503186|P1|COMPLETED|Overall Study||45
7925224|NCT00582517|19503185|P2|STARTED|Overall Study||55
7925225|NCT00582517|19503186|P1|STARTED|Overall Study||45
7925226|NCT00582491|19503194|P2|NOT COMPLETED|Overall Study||0
7925227|NCT00582491|19503195|P1|NOT COMPLETED|Overall Study||1
7925228|NCT00582491|19503194|P2|COMPLETED|Overall Study||10
7925229|NCT00582491|19503195|P1|COMPLETED|Overall Study||10
7925230|NCT00582491|19503194|P2|STARTED|Overall Study||10
7925231|NCT00582491|19503195|P1|STARTED|Overall Study||11
7925232|NCT00582426|19503219|P2|NOT COMPLETED|Overall Study||13
7925233|NCT00582426|19503220|P1|NOT COMPLETED|Overall Study||20
7925234|NCT00582426|19503219|P2|COMPLETED|Overall Study||58
7925235|NCT00582426|19503220|P1|COMPLETED|Overall Study||48
7925236|NCT00582426|19503219|P2|STARTED|Overall Study||71
7925237|NCT00582426|19503220|P1|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68
7925238|NCT00582400|19503246|P1|NOT COMPLETED|Overall Study||3
7925239|NCT00582400|19503246|P1|COMPLETED|Overall Study||6
7925240|NCT00582400|19503246|P1|STARTED|Overall Study||9
7925241|NCT00582361|19503255|P2|NOT COMPLETED|Overall Study||0
7925242|NCT00582361|19503256|P1|NOT COMPLETED|Overall Study||0
7925243|NCT00582361|19503255|P2|COMPLETED|Overall Study||38
7925244|NCT00582361|19503256|P1|COMPLETED|Overall Study||25
7925245|NCT00582361|19503255|P2|STARTED|Overall Study||38
7925246|NCT00582361|19503256|P1|STARTED|Overall Study||25
7925247|NCT00582309|19503267|P3|NOT COMPLETED|Overall Study||2
7925248|NCT00582309|19503268|P2|NOT COMPLETED|Overall Study||0
7925249|NCT00582309|19503269|P1|NOT COMPLETED|Overall Study||0
7925250|NCT00582309|19503267|P3|COMPLETED|Overall Study|2 did not have enough data collected to be used|44
7925251|NCT00582309|19503268|P2|COMPLETED|Overall Study||49
7925252|NCT00582309|19503269|P1|COMPLETED|Overall Study||56
7925253|NCT00582309|19503267|P3|STARTED|Overall Study||46
7925254|NCT00582309|19503268|P2|STARTED|Overall Study||49
7925255|NCT00582309|19503269|P1|STARTED|Overall Study||56
7925256|NCT00582205|19503277|P1|NOT COMPLETED|Overall Study||10
7925257|NCT00582205|19503277|P1|COMPLETED|Overall Study||11
7925258|NCT00582205|19503277|P1|STARTED|Overall Study||21
7925259|NCT00582166|19503282|P1|NOT COMPLETED|Overall Study||2
7925260|NCT00582166|19503282|P1|COMPLETED|Overall Study||16
7925261|NCT00582166|19503282|P1|STARTED|Overall Study||18
7925262|NCT00582114|19503292|P2|NOT COMPLETED|Overall Study||54
7925263|NCT00582114|19503293|P1|NOT COMPLETED|Overall Study||42
7925264|NCT00582114|19503292|P2|COMPLETED|Overall Study||46
7925265|NCT00582114|19503293|P1|COMPLETED|Overall Study||58
7925266|NCT00582114|19503292|P2|STARTED|Overall Study||100
7925267|NCT00582114|19503293|P1|STARTED|Overall Study||100
7925268|NCT00582075|19503301|P1|NOT COMPLETED|Overall Study||0
7925269|NCT00582075|19503301|P1|COMPLETED|Overall Study||25
7925270|NCT00582075|19503301|P1|STARTED|Overall Study||25
7925271|NCT00582036|19503308|P2|NOT COMPLETED|Overall Study||1
7925272|NCT00582036|19503309|P1|NOT COMPLETED|Overall Study||0
7925273|NCT00582036|19503308|P2|COMPLETED|Overall Study|One patient withdrew consent|5
7925274|NCT00582036|19503309|P1|COMPLETED|Overall Study||5
7925275|NCT00582036|19503308|P2|STARTED|Overall Study||6
7925276|NCT00582036|19503309|P1|STARTED|Overall Study||5
7925277|NCT00582010|19503317|P2|NOT COMPLETED|Overall Study||1
7925278|NCT00582010|19503318|P1|NOT COMPLETED|Overall Study||0
7925279|NCT00582010|19503317|P2|COMPLETED|Overall Study||39
7925280|NCT00582010|19503318|P1|COMPLETED|Overall Study||40
7925281|NCT00582010|19503317|P2|STARTED|Overall Study||40
7925282|NCT00582010|19503318|P1|STARTED|Overall Study||40
7925283|NCT00581971|19503340|P1|NOT COMPLETED|Overall Study||0
7925284|NCT00581971|19503340|P1|COMPLETED|Overall Study||30
7925285|NCT00581971|19503340|P1|STARTED|Overall Study||30
7925286|NCT00581945|19503347|P2|NOT COMPLETED|Overall Study||10
7925287|NCT00581945|19503348|P1|NOT COMPLETED|Overall Study||9
7925288|NCT00581945|19503347|P2|COMPLETED|Overall Study||63
7925289|NCT00581945|19503348|P1|COMPLETED|Overall Study||65
7925290|NCT00581945|19503347|P2|STARTED|Overall Study||73
7925291|NCT00581945|19503348|P1|STARTED|Overall Study||74
7925292|NCT00581919|19503364|P1|NOT COMPLETED|Overall Study||24
7925293|NCT00581919|19503364|P1|COMPLETED|Overall Study||8
7925294|NCT00581919|19503364|P1|STARTED|Overall Study||32
7925295|NCT00581867|19503370|P2|NOT COMPLETED|Second Intervention||0
7925296|NCT00581867|19503371|P1|NOT COMPLETED|Second Intervention||0
7925297|NCT00581867|19503370|P2|COMPLETED|Second Intervention||14
7925298|NCT00581867|19503371|P1|COMPLETED|Second Intervention||15
7925299|NCT00581867|19503370|P2|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14
7925300|NCT00581867|19503371|P1|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15
7925301|NCT00581867|19503370|P2|NOT COMPLETED|First Intervention||0
7925302|NCT00581867|19503371|P1|NOT COMPLETED|First Intervention||0
7925303|NCT00581867|19503370|P2|COMPLETED|First Intervention||15
7925304|NCT00581867|19503371|P1|COMPLETED|First Intervention||16
7925305|NCT00581867|19503370|P2|STARTED|First Intervention||15
7925306|NCT00581867|19503371|P1|STARTED|First Intervention||16
7925307|NCT00581854|19503379|P1|NOT COMPLETED|Overall Study||0
7925308|NCT00581854|19503379|P1|COMPLETED|Overall Study||22
7925309|NCT00581854|19503379|P1|STARTED|Overall Study||22
7925310|NCT00581828|19503383|P1|NOT COMPLETED|Overall Study||1
7925311|NCT00581828|19503383|P1|COMPLETED|Overall Study||18
7925312|NCT00581828|19503383|P1|STARTED|Overall Study||19
7925313|NCT00581776|19503387|P1|NOT COMPLETED|Overall Study||3
7925314|NCT00581776|19503387|P1|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27
7925315|NCT00581776|19503387|P1|STARTED|Overall Study||30
7925316|NCT00581581|19503396|P2|NOT COMPLETED|Overall Study||0
7925317|NCT00581581|19503397|P1|NOT COMPLETED|Overall Study||0
7925318|NCT00581581|19503396|P2|COMPLETED|Overall Study||30
7925319|NCT00581581|19503397|P1|COMPLETED|Overall Study||32
7925320|NCT00581581|19503396|P2|STARTED|Overall Study||30
7925321|NCT00581581|19503397|P1|STARTED|Overall Study||32
7925322|NCT00581555|19503405|P2|NOT COMPLETED|Overall Study||20
7925323|NCT00581555|19503406|P1|NOT COMPLETED|Overall Study||43
7925324|NCT00581555|19503405|P2|COMPLETED|Overall Study||38
7925325|NCT00581555|19503406|P1|COMPLETED|Overall Study||19
7925326|NCT00581555|19503405|P2|STARTED|Overall Study||58
7925327|NCT00581555|19503406|P1|STARTED|Overall Study||62
7925328|NCT00581542|19503430|P2|NOT COMPLETED|Overall Study||23
7925329|NCT00581542|19503431|P1|NOT COMPLETED|Overall Study||11
7925330|NCT00581542|19503430|P2|COMPLETED|Overall Study||39
7925331|NCT00581542|19503431|P1|COMPLETED|Overall Study||51
7925332|NCT00581542|19503430|P2|STARTED|Overall Study||62
7925333|NCT00581542|19503431|P1|STARTED|Overall Study||62
7925334|NCT00581529|19503439|P1|NOT COMPLETED|Overall Study||0
7925335|NCT00581529|19503439|P1|COMPLETED|Overall Study||34
7925336|NCT00581529|19503439|P1|STARTED|Overall Study||34
7925337|NCT00581399|19503448|P2|NOT COMPLETED|Overall Study||0
7925338|NCT00581399|19503449|P1|NOT COMPLETED|Overall Study||0
7925339|NCT00581399|19503448|P2|COMPLETED|Overall Study||48
7925340|NCT00581399|19503449|P1|COMPLETED|Overall Study||46
7925341|NCT00581399|19503448|P2|STARTED|Overall Study||48
7925342|NCT00581399|19503449|P1|STARTED|Overall Study||46
7925343|NCT00581386|19503460|P3|NOT COMPLETED|Overall Study||0
7925344|NCT00581386|19503461|P2|NOT COMPLETED|Overall Study||0
7925345|NCT00581386|19503462|P1|NOT COMPLETED|Overall Study||0
7925346|NCT00581386|19503460|P3|COMPLETED|Overall Study|04/15/2009|72
7925347|NCT00581386|19503461|P2|COMPLETED|Overall Study|04/15/2009|73
7925348|NCT00581386|19503462|P1|COMPLETED|Overall Study|04/15/2009|73
7925349|NCT00581386|19503460|P3|STARTED|Overall Study|05/30/2007|72
7925350|NCT00581386|19503461|P2|STARTED|Overall Study|05/30/2007|73
7925351|NCT00581386|19503462|P1|STARTED|Overall Study|05/30/2007|73
7925352|NCT00581360|19503485|P1|NOT COMPLETED|Overall Study||1
7925353|NCT00581360|19503485|P1|COMPLETED|Overall Study||9
7925354|NCT00581360|19503485|P1|STARTED|Overall Study||10
7925355|NCT00581347|19503495|P2|NOT COMPLETED|Overall Study||0
7925356|NCT00581347|19503496|P1|NOT COMPLETED|Overall Study||0
7925357|NCT00581347|19503495|P2|COMPLETED|Overall Study||3707
7925358|NCT00581347|19503496|P1|COMPLETED|Overall Study||3839
7925359|NCT00581347|19503495|P2|STARTED|Overall Study||3707
7925360|NCT00581347|19503496|P1|STARTED|Overall Study||3839
7925361|NCT00581308|19503504|P1|NOT COMPLETED|60 Months||3
7925362|NCT00581308|19503504|P1|COMPLETED|60 Months||158
7925363|NCT00581308|19503504|P1|STARTED|60 Months||161
7925364|NCT00581308|19503504|P1|NOT COMPLETED|48 Months||9
7925365|NCT00581308|19503504|P1|COMPLETED|48 Months||161
7925366|NCT00581308|19503504|P1|STARTED|48 Months||170
7925367|NCT00581308|19503504|P1|NOT COMPLETED|36 Months||6
7925368|NCT00581308|19503504|P1|COMPLETED|36 Months||170
7925369|NCT00581308|19503504|P1|STARTED|36 Months||176
7925370|NCT00581308|19503504|P1|NOT COMPLETED|24 Months||6
7925371|NCT00581308|19503504|P1|COMPLETED|24 Months||176
7925372|NCT00581308|19503504|P1|STARTED|24 Months||182
7925373|NCT00581308|19503504|P1|NOT COMPLETED|Month 12||20
7925374|NCT00581308|19503504|P1|COMPLETED|Month 12||182
7925375|NCT00581308|19503504|P1|STARTED|Month 12||202
7925376|NCT00581308|19503504|P1|NOT COMPLETED|Month 6||3
7925377|NCT00581308|19503504|P1|COMPLETED|Month 6||202
7925378|NCT00581308|19503504|P1|STARTED|Month 6||205
7925379|NCT00581308|19503504|P1|NOT COMPLETED|Month 1||8
7925380|NCT00581308|19503504|P1|COMPLETED|Month 1||205
7925381|NCT00581308|19503504|P1|STARTED|Month 1||213
7925382|NCT00581308|19503504|P1|NOT COMPLETED|Pre Discharge||2
7925383|NCT00581308|19503504|P1|COMPLETED|Pre Discharge||213
7925384|NCT00581308|19503504|P1|STARTED|Pre Discharge||215
7925385|NCT00581256|19503513|P2|NOT COMPLETED|Overall Study||0
7925386|NCT00581256|19503514|P1|NOT COMPLETED|Overall Study||0
7925387|NCT00581256|19503513|P2|COMPLETED|Overall Study||26
7925388|NCT00581256|19503514|P1|COMPLETED|Overall Study||28
7925389|NCT00581256|19503513|P2|STARTED|Overall Study||26
7925390|NCT00581256|19503514|P1|STARTED|Overall Study||28
7925391|NCT00581230|19503526|P1|NOT COMPLETED|Overall Study||0
7925392|NCT00581230|19503526|P1|COMPLETED|Overall Study||51
7925393|NCT00581230|19503526|P1|Laryngoscopy With RAMP|Overall Study||51
7925394|NCT00581230|19503526|P1|Laryngoscopy Without RAMP|Overall Study||51
7925395|NCT00581230|19503526|P1|STARTED|Overall Study||51
7925396|NCT00581113|19503535|P2|NOT COMPLETED|Overall Study||1
7925397|NCT00581113|19503536|P1|NOT COMPLETED|Overall Study||0
7925398|NCT00581113|19503535|P2|COMPLETED|Overall Study||3
7925399|NCT00581113|19503536|P1|COMPLETED|Overall Study||4
7925400|NCT00581113|19503535|P2|STARTED|Overall Study||4
7925401|NCT00581113|19503536|P1|STARTED|Overall Study||4
7925402|NCT00581100|19503546|P2|NOT COMPLETED|Overall Study||5
7925403|NCT00581100|19503547|P1|NOT COMPLETED|Overall Study||7
7925404|NCT00581100|19503546|P2|COMPLETED|Overall Study||29
7925405|NCT00581100|19503547|P1|COMPLETED|Overall Study||31
7925406|NCT00581100|19503546|P2|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33
7925407|NCT00581100|19503547|P1|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36
7925408|NCT00581100|19503546|P2|STARTED|Overall Study||34
7925409|NCT00581100|19503547|P1|STARTED|Overall Study||38
7925410|NCT00581061|19503583|P1|NOT COMPLETED|Overall Study||0
7925411|NCT00581061|19503583|P1|COMPLETED|Overall Study||13
7925412|NCT00581061|19503583|P1|STARTED|Overall Study||13
7925413|NCT00581048|19503589|P1|NOT COMPLETED|Overall Study||0
7925414|NCT00581048|19503589|P1|COMPLETED|Overall Study||33
7925415|NCT00581048|19503589|P1|STARTED|Overall Study||33
7925416|NCT00580983|19503600|P1|NOT COMPLETED|Overall Study||7
7925417|NCT00580983|19503600|P1|COMPLETED|Overall Study||73
7925418|NCT00580983|19503600|P1|STARTED|Overall Study||80
7925419|NCT00580970|19503607|P1|NOT COMPLETED|Treatment (Lovastatin)||19
7925420|NCT00580970|19503607|P1|COMPLETED|Treatment (Lovastatin)||53
7925421|NCT00580970|19503607|P1|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53
7925422|NCT00580970|19503607|P1|STARTED|Treatment (Lovastatin)||72
7925423|NCT00580970|19503607|P1|NOT COMPLETED|Pre-treatment||1
7925424|NCT00580970|19503607|P1|COMPLETED|Pre-treatment||72
7925425|NCT00580970|19503607|P1|STARTED|Pre-treatment||73
7925426|NCT00580957|19503613|P2|NOT COMPLETED|Overall Study||7
7925427|NCT00580957|19503614|P1|NOT COMPLETED|Overall Study||7
7925428|NCT00580957|19503613|P2|COMPLETED|Overall Study||21
7925429|NCT00580957|19503614|P1|COMPLETED|Overall Study||21
7925430|NCT00580957|19503613|P2|STARTED|Overall Study||28
7925431|NCT00580957|19503614|P1|STARTED|Overall Study||28
7925432|NCT00580866|19503622|P2|NOT COMPLETED|Overall Study||2
7925433|NCT00580866|19503623|P1|NOT COMPLETED|Overall Study||2
7925434|NCT00580866|19503622|P2|COMPLETED|Overall Study||5
7925435|NCT00580866|19503623|P1|COMPLETED|Overall Study||8
7925436|NCT00580866|19503622|P2|STARTED|Overall Study||7
7925437|NCT00580866|19503623|P1|STARTED|Overall Study||10
7925438|NCT00580853|19503634|P3|NOT COMPLETED|Overall Study||0
7925439|NCT00580853|19503635|P2|NOT COMPLETED|Overall Study||0
7925440|NCT00580853|19503636|P1|NOT COMPLETED|Overall Study||0
7925441|NCT00580853|19503634|P3|COMPLETED|Overall Study||21
7925442|NCT00580853|19503635|P2|COMPLETED|Overall Study||21
7925443|NCT00580853|19503636|P1|COMPLETED|Overall Study||20
7925444|NCT00580853|19503634|P3|STARTED|Overall Study||21
7925445|NCT00580853|19503635|P2|STARTED|Overall Study||21
7925446|NCT00580853|19503636|P1|STARTED|Overall Study||20
7925447|NCT00580840|19503647|P4|NOT COMPLETED|Double-Blind||15
7925448|NCT00580840|19503648|P3|NOT COMPLETED|Double-Blind||9
7925449|NCT00580840|19503649|P2|NOT COMPLETED|Double-Blind||7
7925450|NCT00580840|19503650|P1|NOT COMPLETED|Double-Blind||0
7925451|NCT00580840|19503647|P4|COMPLETED|Double-Blind||54
7925452|NCT00580840|19503648|P3|COMPLETED|Double-Blind||61
7925453|NCT00580840|19503649|P2|COMPLETED|Double-Blind||63
7925454|NCT00580840|19503650|P1|COMPLETED|Double-Blind||0
7925455|NCT00580840|19503647|P4|STARTED|Double-Blind||69
7925456|NCT00580840|19503648|P3|STARTED|Double-Blind||70
7925457|NCT00580840|19503649|P2|STARTED|Double-Blind||70
7925458|NCT00580840|19503650|P1|STARTED|Double-Blind||0
7925459|NCT00580840|19503647|P4|NOT COMPLETED|Run-in||0
7925460|NCT00580840|19503648|P3|NOT COMPLETED|Run-in||0
7925461|NCT00580840|19503649|P2|NOT COMPLETED|Run-in||0
7925462|NCT00580840|19503650|P1|NOT COMPLETED|Run-in||124
7925463|NCT00580840|19503647|P4|COMPLETED|Run-in||0
7925464|NCT00580840|19503648|P3|COMPLETED|Run-in||0
7925465|NCT00580840|19503649|P2|COMPLETED|Run-in||0
7925466|NCT00580840|19503650|P1|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209
7925467|NCT00580840|19503647|P4|STARTED|Run-in||0
7925468|NCT00580840|19503648|P3|STARTED|Run-in||0
7925469|NCT00580840|19503649|P2|STARTED|Run-in||0
7925470|NCT00580840|19503650|P1|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333
7925471|NCT00580801|19503758|P3|NOT COMPLETED|Overall Study||3
7925472|NCT00580801|19503759|P2|NOT COMPLETED|Overall Study||1
7925473|NCT00580801|19503760|P1|NOT COMPLETED|Overall Study||6
7925474|NCT00580801|19503758|P3|COMPLETED|Overall Study||5
7925475|NCT00580801|19503759|P2|COMPLETED|Overall Study||7
7925476|NCT00580801|19503760|P1|COMPLETED|Overall Study||2
7925477|NCT00580801|19503758|P3|STARTED|Overall Study||8
7925478|NCT00580801|19503759|P2|STARTED|Overall Study||8
7925479|NCT00580801|19503760|P1|STARTED|Overall Study||8
7925480|NCT00580788|19503799|P4|NOT COMPLETED|Overall Study||1
7925481|NCT00580788|19503800|P3|NOT COMPLETED|Overall Study||0
7925482|NCT00580788|19503801|P2|NOT COMPLETED|Overall Study||0
7925483|NCT00580788|19503802|P1|NOT COMPLETED|Overall Study||0
7925484|NCT00580788|19503799|P4|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1
7925485|NCT00580788|19503800|P3|COMPLETED|Overall Study||3
7925486|NCT00580788|19503801|P2|COMPLETED|Overall Study||6
7925487|NCT00580788|19503802|P1|COMPLETED|Overall Study||3
7925488|NCT00580788|19503799|P4|STARTED|Overall Study||2
7925489|NCT00580788|19503800|P3|STARTED|Overall Study||3
7925490|NCT00580788|19503801|P2|STARTED|Overall Study||6
7925491|NCT00580788|19503802|P1|STARTED|Overall Study||3
7925492|NCT00580723|19503860|P1|NOT COMPLETED|Overall Study||8
7925493|NCT00580723|19503860|P1|COMPLETED|Overall Study||16
7925494|NCT00580723|19503860|P1|STARTED|Overall Study||24
7925495|NCT00580671|19503869|P3|NOT COMPLETED|Overall Study||17
7925496|NCT00580671|19503870|P2|NOT COMPLETED|Overall Study||16
7925497|NCT00580671|19503871|P1|NOT COMPLETED|Overall Study||16
7925498|NCT00580671|19503869|P3|COMPLETED|Overall Study||34
7925499|NCT00580671|19503870|P2|COMPLETED|Overall Study||35
7925500|NCT00580671|19503871|P1|COMPLETED|Overall Study||35
7925501|NCT00580671|19503869|P3|STARTED|Overall Study||51
7925502|NCT00580671|19503870|P2|STARTED|Overall Study||51
7925503|NCT00580671|19503871|P1|STARTED|Overall Study||51
7925504|NCT00580645|19503888|P3|NOT COMPLETED|Overall Study||0
7925505|NCT00580645|19503889|P2|NOT COMPLETED|Overall Study||0
7925506|NCT00580645|19503890|P1|NOT COMPLETED|Overall Study||0
7925507|NCT00580645|19503888|P3|COMPLETED|Overall Study||20
7925508|NCT00580645|19503889|P2|COMPLETED|Overall Study||20
7925509|NCT00580645|19503890|P1|COMPLETED|Overall Study||20
7925510|NCT00580645|19503888|P3|STARTED|Overall Study||20
7925511|NCT00580645|19503889|P2|STARTED|Overall Study||20
7925512|NCT00580645|19503890|P1|STARTED|Overall Study||20
7925513|NCT00580606|19503903|P2|NOT COMPLETED|Open Label (OL)||12
7925514|NCT00580606|19503904|P1|NOT COMPLETED|Open Label (OL)||9
7925515|NCT00580606|19503903|P2|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5
7925516|NCT00580606|19503904|P1|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9
7925517|NCT00580606|19503903|P2|Had Week 172 Oral Food Challenge|Open Label (OL)||2
7925518|NCT00580606|19503904|P1|Had Week 172 Oral Food Challenge|Open Label (OL)||2
7925519|NCT00580606|19503903|P2|Had Week 164 Oral Food Challenge|Open Label (OL)||5
7925520|NCT00580606|19503904|P1|Had Week 164 Oral Food Challenge|Open Label (OL)||9
7925521|NCT00580606|19503903|P2|Had Week 116 Oral Food Challenge|Open Label (OL)||6
7925522|NCT00580606|19503904|P1|Had Week 116 Oral Food Challenge|Open Label (OL)||13
7925523|NCT00580606|19503903|P2|Had Week 68 Oral Food Challenge|Open Label (OL)||12
7925524|NCT00580606|19503904|P1|Had Week 68 Oral Food Challenge|Open Label (OL)||15
7925525|NCT00580606|19503903|P2|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12
7925526|NCT00580606|19503904|P1|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0
7925527|NCT00580606|19503903|P2|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17
7925528|NCT00580606|19503904|P1|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18
7925529|NCT00580606|19503903|P2|NOT COMPLETED|Double Blind (DB)||0
7925530|NCT00580606|19503904|P1|NOT COMPLETED|Double Blind (DB)||0
7925531|NCT00580606|19503903|P2|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
7925532|NCT00580606|19503904|P1|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
7925533|NCT00580606|19503903|P2|Had Week 44 Oral Food Challenge|Double Blind (DB)||19
7925534|NCT00580606|19503904|P1|Had Week 44 Oral Food Challenge|Double Blind (DB)||18
7925535|NCT00580606|19503903|P2|STARTED|Double Blind (DB)||20
7925536|NCT00580606|19503904|P1|STARTED|Double Blind (DB)||20
7925537|NCT00580502|19503922|P1|NOT COMPLETED|Overall Study||0
7925538|NCT00580502|19503922|P1|COMPLETED|Overall Study||50
7925539|NCT00580502|19503922|P1|STARTED|Overall Study||50
7925540|NCT00580398|19503931|P2|NOT COMPLETED|Overall Study||0
7925541|NCT00580398|19503932|P1|NOT COMPLETED|Overall Study||0
7925542|NCT00580398|19503931|P2|COMPLETED|Overall Study||32
7925543|NCT00580398|19503932|P1|COMPLETED|Overall Study||17
7925544|NCT00580398|19503931|P2|STARTED|Overall Study||32
7925545|NCT00580398|19503932|P1|STARTED|Overall Study||17
7925546|NCT00580372|19503940|P1|NOT COMPLETED|Overall Study||0
7925547|NCT00580372|19503940|P1|COMPLETED|Overall Study||231
7925548|NCT00580372|19503940|P1|STARTED|Overall Study||231
7925549|NCT00580333|19503944|P1|NOT COMPLETED|Overall Study||0
7925550|NCT00580333|19503944|P1|COMPLETED|Overall Study||51
7925551|NCT00580333|19503944|P1|STARTED|Overall Study||51
7925552|NCT00580294|19503951|P1|NOT COMPLETED|Overall Study||0
7925553|NCT00580294|19503951|P1|COMPLETED|Overall Study||12
7925554|NCT00580294|19503951|P1|STARTED|Overall Study||12
7925555|NCT00580229|19503955|P1|NOT COMPLETED|Overall Study||0
7925556|NCT00580229|19503955|P1|COMPLETED|Overall Study||50
7925557|NCT00580229|19503955|P1|STARTED|Overall Study||50
7925558|NCT00580151|19503963|P2|NOT COMPLETED|Overall Study||0
7925559|NCT00580151|19503964|P1|NOT COMPLETED|Overall Study||0
7925560|NCT00580151|19503963|P2|COMPLETED|Overall Study||0
7925561|NCT00580151|19503964|P1|COMPLETED|Overall Study||9
7925562|NCT00580151|19503963|P2|STARTED|Overall Study||0
7925563|NCT00580151|19503964|P1|STARTED|Overall Study||9
7925564|NCT00580138|19503972|P1|NOT COMPLETED|Overall Study||0
7925565|NCT00580138|19503972|P1|COMPLETED|Overall Study||30
7925566|NCT00580138|19503972|P1|STARTED|Overall Study||30
7925567|NCT00580073|19503976|P1|NOT COMPLETED|Overall Study||0
7925568|NCT00580073|19503976|P1|COMPLETED|Overall Study||6
7925569|NCT00580073|19503976|P1|STARTED|Overall Study||6
7925570|NCT00580047|19503985|P3|NOT COMPLETED|Overall Study||2
7925571|NCT00580047|19503986|P2|NOT COMPLETED|Overall Study||2
7925572|NCT00580047|19503987|P1|NOT COMPLETED|Overall Study||3
7925573|NCT00580047|19503985|P3|COMPLETED|Overall Study||10
7925574|NCT00580047|19503986|P2|COMPLETED|Overall Study||21
7925575|NCT00580047|19503987|P1|COMPLETED|Overall Study||21
7925576|NCT00580047|19503985|P3|STARTED|Overall Study||12
7925577|NCT00580047|19503986|P2|STARTED|Overall Study||23
7925578|NCT00580047|19503987|P1|STARTED|Overall Study||24
7925579|NCT00580034|19503998|P2|NOT COMPLETED|Overall Study||0
7925580|NCT00580034|19503999|P1|NOT COMPLETED|Overall Study||10
7925581|NCT00580034|19503998|P2|COMPLETED|Overall Study||88
7925582|NCT00580034|19503999|P1|COMPLETED|Overall Study||78
7925583|NCT00580034|19503998|P2|STARTED|Overall Study||88
7925584|NCT00580034|19503999|P1|STARTED|Overall Study||88
7925585|NCT00579982|19504005|P1|NOT COMPLETED|Overall Study||8
7925586|NCT00579982|19504005|P1|COMPLETED|Overall Study||89
7925587|NCT00579982|19504005|P1|STARTED|Overall Study||97
7925588|NCT00579878|19504027|P3|NOT COMPLETED|Overall Study||10
7925589|NCT00579878|19504028|P2|NOT COMPLETED|Overall Study||3
7925590|NCT00579878|19504029|P1|NOT COMPLETED|Overall Study||7
7925591|NCT00579878|19504027|P3|COMPLETED|Overall Study||14
7925592|NCT00579878|19504028|P2|COMPLETED|Overall Study||20
7925593|NCT00579878|19504029|P1|COMPLETED|Overall Study||15
7925594|NCT00579878|19504027|P3|STARTED|Overall Study||24
7925595|NCT00579878|19504028|P2|STARTED|Overall Study||23
7925596|NCT00579878|19504029|P1|STARTED|Overall Study||22
7925597|NCT00579826|19504039|P2|NOT COMPLETED|Overall Study||3
7925598|NCT00579826|19504040|P1|NOT COMPLETED|Overall Study||5
7925599|NCT00579826|19504039|P2|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|23
7925600|NCT00579826|19504040|P1|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|24
7925601|NCT00579826|19504039|P2|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|25
7925602|NCT00579826|19504040|P1|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|28
7925603|NCT00579826|19504039|P2|STARTED|Overall Study||26
7925604|NCT00579826|19504040|P1|STARTED|Overall Study||29
7925605|NCT00579813|19504052|P2|NOT COMPLETED|Overall Study||0
7925606|NCT00579813|19504053|P1|NOT COMPLETED|Overall Study||0
7925607|NCT00579813|19504052|P2|COMPLETED|Overall Study||10
7925608|NCT00579813|19504053|P1|COMPLETED|Overall Study||60
7925609|NCT00579813|19504052|P2|STARTED|Overall Study||10
7925610|NCT00579813|19504053|P1|STARTED|Overall Study||60
7925611|NCT00579670|19504074|P5|NOT COMPLETED|Overall Study||0
7925612|NCT00579670|19504075|P4|NOT COMPLETED|Overall Study||22
7925613|NCT00579670|19504076|P3|NOT COMPLETED|Overall Study||4
7925614|NCT00579670|19504077|P2|NOT COMPLETED|Overall Study||1
7925615|NCT00579670|19504078|P1|NOT COMPLETED|Overall Study||2
7925616|NCT00579670|19504074|P5|COMPLETED|Overall Study||5
7925617|NCT00579670|19504075|P4|COMPLETED|Overall Study||263
7925618|NCT00579670|19504076|P3|COMPLETED|Overall Study||84
7925619|NCT00579670|19504077|P2|COMPLETED|Overall Study||56
7925620|NCT00579670|19504078|P1|COMPLETED|Overall Study||13
7925621|NCT00579670|19504074|P5|Population: Within SmPC (Completed)|Overall Study||0
7925622|NCT00579670|19504075|P4|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147
7925623|NCT00579670|19504076|P3|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79
7925624|NCT00579670|19504077|P2|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55
7925625|NCT00579670|19504078|P1|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13
7925626|NCT00579670|19504074|P5|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0
7925627|NCT00579670|19504075|P4|Population: Within SmPC (Started)|Overall Study||159
7925628|NCT00579670|19504076|P3|Population: Within SmPC (Started)|Overall Study||83
7925629|NCT00579670|19504077|P2|Population: Within SmPC (Started)|Overall Study||56
7925630|NCT00579670|19504078|P1|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15
7925631|NCT00579670|19504074|P5|STARTED|Overall Study||5
7925632|NCT00579670|19504075|P4|STARTED|Overall Study||285
7925633|NCT00579670|19504076|P3|STARTED|Overall Study||88
7925634|NCT00579670|19504077|P2|STARTED|Overall Study||57
7925635|NCT00579670|19504078|P1|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15
7925636|NCT00579527|19504290|P1|NOT COMPLETED|Overall Study||4
7925637|NCT00579527|19504290|P1|COMPLETED|Overall Study||10
7925638|NCT00579527|19504290|P1|STARTED|Overall Study||14
7925639|NCT00579501|19504302|P1|NOT COMPLETED|Overall Study||29
7925640|NCT00579501|19504302|P1|COMPLETED|Overall Study||0
7925641|NCT00579501|19504302|P1|STARTED|Overall Study||29
7925642|NCT00579436|19504309|P2|NOT COMPLETED|Overall Study||0
7925643|NCT00579436|19504310|P1|NOT COMPLETED|Overall Study||0
7925644|NCT00579436|19504309|P2|COMPLETED|Overall Study||14
7925645|NCT00579436|19504310|P1|COMPLETED|Overall Study||19
7925646|NCT00579436|19504309|P2|STARTED|Overall Study||14
7925647|NCT00579436|19504310|P1|STARTED|Overall Study||19
7925648|NCT00579345|19504330|P8|NOT COMPLETED|Overall Study||2
7925649|NCT00579345|19504331|P7|NOT COMPLETED|Overall Study||0
7925650|NCT00579345|19504332|P6|NOT COMPLETED|Overall Study||0
7925651|NCT00579345|19504333|P5|NOT COMPLETED|Overall Study||0
7925652|NCT00579345|19504334|P4|NOT COMPLETED|Overall Study||1
7925653|NCT00579345|19504335|P3|NOT COMPLETED|Overall Study||2
7925654|NCT00579345|19504336|P2|NOT COMPLETED|Overall Study||1
7925655|NCT00579345|19504337|P1|NOT COMPLETED|Overall Study||5
7925656|NCT00579345|19504330|P8|COMPLETED|Overall Study||42
7925657|NCT00579345|19504331|P7|COMPLETED|Overall Study||57
7925658|NCT00579345|19504332|P6|COMPLETED|Overall Study||78
7925659|NCT00579345|19504333|P5|COMPLETED|Overall Study||90
7925660|NCT00579345|19504334|P4|COMPLETED|Overall Study||143
7925661|NCT00579345|19504335|P3|COMPLETED|Overall Study||389
7925662|NCT00579345|19504336|P2|COMPLETED|Overall Study||168
7925663|NCT00579345|19504337|P1|COMPLETED|Overall Study||544
7925664|NCT00579345|19504330|P8|STARTED|Overall Study||44
7925665|NCT00579345|19504331|P7|STARTED|Overall Study||57
7925666|NCT00579345|19504332|P6|STARTED|Overall Study||78
7925667|NCT00579345|19504333|P5|STARTED|Overall Study||90
7925668|NCT00579345|19504334|P4|STARTED|Overall Study||144
7925669|NCT00579345|19504335|P3|STARTED|Overall Study||391
7925670|NCT00579345|19504336|P2|STARTED|Overall Study||169
7925671|NCT00579345|19504337|P1|STARTED|Overall Study||549
7925672|NCT00579280|19504372|P3|NOT COMPLETED|Overall Study||0
7925673|NCT00579280|19504373|P2|NOT COMPLETED|Overall Study||3
7925674|NCT00579280|19504374|P1|NOT COMPLETED|Overall Study||2
7925675|NCT00579280|19504372|P3|COMPLETED|Overall Study|LOCF evaluable sample|51
7925676|NCT00579280|19504373|P2|COMPLETED|Overall Study|LOCF evaluable sample|46
7925677|NCT00579280|19504374|P1|COMPLETED|Overall Study|LOCF evaluable sample|47
7925678|NCT00579280|19504372|P3|STARTED|Overall Study||51
7925679|NCT00579280|19504373|P2|STARTED|Overall Study||49
7925680|NCT00579280|19504374|P1|STARTED|Overall Study||49
7925681|NCT00579254|19504412|P1|NOT COMPLETED|Overall Study||112
7925682|NCT00579254|19504412|P1|COMPLETED|Overall Study||0
7925683|NCT00579254|19504412|P1|STARTED|Overall Study||112
7925684|NCT00579137|19504416|P1|NOT COMPLETED|Overall Study||0
7925685|NCT00579137|19504416|P1|COMPLETED|Overall Study||3
7925686|NCT00579137|19504416|P1|STARTED|Overall Study||3
7925687|NCT00579111|19504425|P2|NOT COMPLETED|Overall Study||1
7925688|NCT00579111|19504426|P1|NOT COMPLETED|Overall Study||2
7925689|NCT00579111|19504425|P2|COMPLETED|Overall Study||0
7925690|NCT00579111|19504426|P1|COMPLETED|Overall Study||1
7925691|NCT00579111|19504425|P2|STARTED|Overall Study||1
7925692|NCT00579111|19504426|P1|STARTED|Overall Study||3
7925693|NCT00579098|19504436|P2|NOT COMPLETED|Overall Study||8
7925694|NCT00579098|19504437|P1|NOT COMPLETED|Overall Study||9
7925695|NCT00579098|19504436|P2|COMPLETED|Overall Study||55
7925696|NCT00579098|19504437|P1|COMPLETED|Overall Study||53
7925697|NCT00579098|19504436|P2|STARTED|Overall Study||63
7925698|NCT00579098|19504437|P1|STARTED|Overall Study||62
7925699|NCT00579059|19504453|P2|NOT COMPLETED|Overall Study||10
7925700|NCT00579059|19504454|P1|NOT COMPLETED|Overall Study||21
7925701|NCT00579059|19504453|P2|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
7925702|NCT00579059|19504454|P1|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
7925703|NCT00579059|19504453|P2|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
7925704|NCT00579059|19504454|P1|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
7925705|NCT00579059|19504453|P2|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
7925706|NCT00579059|19504454|P1|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
7925707|NCT00579059|19504453|P2|1 Year|Overall Study|7 patients didn't return for follow-up.|3
7925708|NCT00579059|19504454|P1|1 Year|Overall Study|13 patients didn't return for follow-up.|8
7925709|NCT00579059|19504453|P2|6 Months|Overall Study|6 patients didn't return for follow-up.|4
7925710|NCT00579059|19504454|P1|6 Months|Overall Study|10 Patients didn't return for follow-up.|11
7925711|NCT00579059|19504453|P2|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9
7925712|NCT00579059|19504454|P1|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20
7925713|NCT00579059|19504453|P2|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10
7925714|NCT00579059|19504454|P1|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21
7925715|NCT00578968|19504465|P3|NOT COMPLETED|Intervention||0
7925716|NCT00578968|19504466|P2|NOT COMPLETED|Intervention||0
7925717|NCT00578968|19504467|P1|NOT COMPLETED|Intervention||0
7925718|NCT00578968|19504465|P3|COMPLETED|Intervention||0
7925719|NCT00578968|19504466|P2|COMPLETED|Intervention||12
7925720|NCT00578968|19504467|P1|COMPLETED|Intervention||12
7925721|NCT00578968|19504465|P3|STARTED|Intervention||0
7925722|NCT00578968|19504466|P2|STARTED|Intervention||12
7925723|NCT00578968|19504467|P1|STARTED|Intervention||12
7925724|NCT00578968|19504465|P3|NOT COMPLETED|Baseline (Prior to Intervention)||0
7925725|NCT00578968|19504466|P2|NOT COMPLETED|Baseline (Prior to Intervention)||0
7925726|NCT00578968|19504467|P1|NOT COMPLETED|Baseline (Prior to Intervention)||0
7925727|NCT00578968|19504465|P3|COMPLETED|Baseline (Prior to Intervention)||12
7925728|NCT00578968|19504466|P2|COMPLETED|Baseline (Prior to Intervention)||12
7925729|NCT00578968|19504467|P1|COMPLETED|Baseline (Prior to Intervention)||12
7925730|NCT00578968|19504465|P3|STARTED|Baseline (Prior to Intervention)||12
7925731|NCT00578968|19504466|P2|STARTED|Baseline (Prior to Intervention)||12
7925732|NCT00578968|19504467|P1|STARTED|Baseline (Prior to Intervention)||12
7925733|NCT00578942|19504528|P1|NOT COMPLETED|Overall Study||1
7925734|NCT00578942|19504528|P1|COMPLETED|Overall Study||47
7925735|NCT00578942|19504528|P1|STARTED|Overall Study||48
7925736|NCT00578929|19504538|P4|NOT COMPLETED|Randomized Period||14
7925737|NCT00578929|19504539|P3|NOT COMPLETED|Randomized Period||8
7925738|NCT00578929|19504540|P2|NOT COMPLETED|Randomized Period||14
7925739|NCT00578929|19504541|P1|NOT COMPLETED|Randomized Period||17
7925740|NCT00578929|19504538|P4|COMPLETED|Randomized Period||283
7925741|NCT00578929|19504539|P3|COMPLETED|Randomized Period||288
7925742|NCT00578929|19504540|P2|COMPLETED|Randomized Period||283
7925743|NCT00578929|19504541|P1|COMPLETED|Randomized Period||281
7925744|NCT00578929|19504538|P4|STARTED|Randomized Period||297
7925745|NCT00578929|19504539|P3|STARTED|Randomized Period||296
7925746|NCT00578929|19504540|P2|STARTED|Randomized Period||297
7925747|NCT00578929|19504541|P1|STARTED|Randomized Period||298
7925748|NCT00578929|19504538|P4|NOT COMPLETED|Vehicle Run-In Period||0
7925749|NCT00578929|19504539|P3|NOT COMPLETED|Vehicle Run-In Period||0
7925750|NCT00578929|19504540|P2|NOT COMPLETED|Vehicle Run-In Period||0
7925751|NCT00578929|19504541|P1|NOT COMPLETED|Vehicle Run-In Period||0
7925752|NCT00578929|19504538|P4|COMPLETED|Vehicle Run-In Period||0
7925753|NCT00578929|19504539|P3|COMPLETED|Vehicle Run-In Period||0
7925754|NCT00578929|19504540|P2|COMPLETED|Vehicle Run-In Period||2388
7925755|NCT00578929|19504541|P1|COMPLETED|Vehicle Run-In Period||0
7925756|NCT00578929|19504538|P4|STARTED|Vehicle Run-In Period||0
7925757|NCT00578929|19504539|P3|STARTED|Vehicle Run-In Period||0
7925758|NCT00578929|19504540|P2|STARTED|Vehicle Run-In Period||2388
7925759|NCT00578929|19504541|P1|STARTED|Vehicle Run-In Period||0
7925760|NCT00578903|19504556|P1|NOT COMPLETED|Overall Study||0
7925761|NCT00578903|19504556|P1|COMPLETED|Overall Study||22
7925762|NCT00578903|19504556|P1|STARTED|Overall Study||22
7925763|NCT00578877|19504567|P2|NOT COMPLETED|Overall Study||128
7925764|NCT00578877|19504568|P1|NOT COMPLETED|Overall Study||81
7925765|NCT00578877|19504567|P2|COMPLETED|Overall Study||172
7925766|NCT00578877|19504568|P1|COMPLETED|Overall Study||69
7925767|NCT00578877|19504567|P2|STARTED|Overall Study||300
7925768|NCT00578877|19504568|P1|STARTED|Overall Study||150
7925769|NCT00578864|19504576|P2|NOT COMPLETED|Overall Study||0
7925770|NCT00578864|19504577|P1|NOT COMPLETED|Overall Study||1
7925771|NCT00578864|19504576|P2|COMPLETED|Overall Study||6
7925772|NCT00578864|19504577|P1|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6
7925773|NCT00578864|19504576|P2|STARTED|Overall Study||6
7925774|NCT00578864|19504577|P1|STARTED|Overall Study||7
7925775|NCT00578812|19504593|P2|NOT COMPLETED|Overall Study||7
7925776|NCT00578812|19504594|P1|NOT COMPLETED|Overall Study||6
7925777|NCT00578812|19504593|P2|COMPLETED|Overall Study||185
7925778|NCT00578812|19504594|P1|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218
7925779|NCT00578812|19504593|P2|STARTED|Overall Study||192
7925780|NCT00578812|19504594|P1|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224
7925781|NCT00578786|19504633|P3|NOT COMPLETED|Overall Study||30
7925782|NCT00578786|19504634|P2|NOT COMPLETED|Overall Study||66
7925783|NCT00578786|19504635|P1|NOT COMPLETED|Overall Study||39
7925784|NCT00578786|19504633|P3|COMPLETED|Overall Study||67
7925785|NCT00578786|19504634|P2|COMPLETED|Overall Study||124
7925786|NCT00578786|19504635|P1|COMPLETED|Overall Study||57
7925787|NCT00578786|19504633|P3|STARTED|Overall Study||97
7925788|NCT00578786|19504634|P2|STARTED|Overall Study||190
7925789|NCT00578786|19504635|P1|STARTED|Overall Study||96
7925790|NCT00578734|19504716|P2|NOT COMPLETED|Overall Study||0
7925791|NCT00578734|19504717|P1|NOT COMPLETED|Overall Study||0
7925792|NCT00578734|19504716|P2|COMPLETED|Overall Study||81
7925793|NCT00578734|19504717|P1|COMPLETED|Overall Study||84
7925794|NCT00578734|19504716|P2|STARTED|Overall Study||81
7925795|NCT00578734|19504717|P1|STARTED|Overall Study||84
7925796|NCT00578669|19504727|P2|NOT COMPLETED|Overall Study||0
7925797|NCT00578669|19504728|P1|NOT COMPLETED|Overall Study||0
7925798|NCT00578669|19504727|P2|COMPLETED|Overall Study||99
7925799|NCT00578669|19504728|P1|COMPLETED|Overall Study||107
7925800|NCT00578669|19504727|P2|STARTED|Overall Study||99
7925801|NCT00578669|19504728|P1|STARTED|Overall Study||107
7925802|NCT00578643|19504736|P1|NOT COMPLETED|Overall Study||2
7925803|NCT00578643|19504736|P1|COMPLETED|Overall Study||13
7925804|NCT00578643|19504736|P1|STARTED|Overall Study||15
7925805|NCT00578617|19504745|P2|NOT COMPLETED|Overall Study||0
7925806|NCT00578617|19504746|P1|NOT COMPLETED|Overall Study||0
7925807|NCT00578617|19504745|P2|COMPLETED|Overall Study||29
7925808|NCT00578617|19504746|P1|COMPLETED|Overall Study||31
7925809|NCT00578617|19504745|P2|STARTED|Overall Study||29
7925810|NCT00578617|19504746|P1|STARTED|Overall Study||31
7925811|NCT00578565|19504752|P1|NOT COMPLETED|Overall Study||3
7925812|NCT00578565|19504752|P1|COMPLETED|Overall Study||7
7925813|NCT00578565|19504752|P1|STARTED|Overall Study||10
7925814|NCT00578552|19504764|P3|NOT COMPLETED|Overall Study||15
7925815|NCT00578552|19504765|P2|NOT COMPLETED|Overall Study||14
7925816|NCT00578552|19504766|P1|NOT COMPLETED|Overall Study||15
7925817|NCT00578552|19504764|P3|COMPLETED|Overall Study||11
7925818|NCT00578552|19504765|P2|COMPLETED|Overall Study||13
7925819|NCT00578552|19504766|P1|COMPLETED|Overall Study||12
7925820|NCT00578552|19504764|P3|STARTED|Overall Study||26
7925821|NCT00578552|19504765|P2|STARTED|Overall Study||27
7925822|NCT00578552|19504766|P1|STARTED|Overall Study||27
7925823|NCT00578539|19504774|P1|NOT COMPLETED|Overall Study||0
7925824|NCT00578539|19504774|P1|COMPLETED|Overall Study||24
7925825|NCT00578539|19504774|P1|STARTED|Overall Study||24
7925826|NCT00578461|19504778|P1|NOT COMPLETED|Overall Study||0
7925827|NCT00578461|19504778|P1|COMPLETED|Overall Study||26
7925828|NCT00578461|19504778|P1|STARTED|Overall Study||26
7925829|NCT00578448|19504782|P1|NOT COMPLETED|1 Year Long Term Extension (LTE)||1
7925830|NCT00578448|19504782|P1|COMPLETED|1 Year Long Term Extension (LTE)||8
7925831|NCT00578448|19504782|P1|STARTED|1 Year Long Term Extension (LTE)||9
7925832|NCT00578448|19504782|P1|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3
7925833|NCT00578448|19504782|P1|COMPLETED|Day 1 up to 3 Years of Planned Study||9
7925834|NCT00578448|19504782|P1|STARTED|Day 1 up to 3 Years of Planned Study||12
7925835|NCT00578383|19504800|P4|NOT COMPLETED|Overall Study||6
7925836|NCT00578383|19504801|P3|NOT COMPLETED|Overall Study||6
7925837|NCT00578383|19504802|P2|NOT COMPLETED|Overall Study||16
7925838|NCT00578383|19504803|P1|NOT COMPLETED|Overall Study||16
7925839|NCT00578383|19504800|P4|COMPLETED|Overall Study||9
7925840|NCT00578383|19504801|P3|COMPLETED|Overall Study||13
7925841|NCT00578383|19504802|P2|COMPLETED|Overall Study||20
7925842|NCT00578383|19504803|P1|COMPLETED|Overall Study||21
7925843|NCT00578383|19504800|P4|STARTED|Overall Study||15
7925844|NCT00578383|19504801|P3|STARTED|Overall Study||19
7925845|NCT00578383|19504802|P2|STARTED|Overall Study||36
7925846|NCT00578383|19504803|P1|STARTED|Overall Study||37
7925847|NCT00578344|19504833|P1|NOT COMPLETED|Overall Study||2
7925848|NCT00578344|19504833|P1|COMPLETED|Overall Study||6
7925849|NCT00578344|19504833|P1|STARTED|Overall Study||8
7925850|NCT00578331|19504841|P2|NOT COMPLETED|Overall Study||125
7925851|NCT00578331|19504842|P1|NOT COMPLETED|Overall Study||116
7925852|NCT00578331|19504841|P2|COMPLETED|Overall Study||320
7925853|NCT00578331|19504842|P1|COMPLETED|Overall Study||329
7925854|NCT00578331|19504841|P2|STARTED|Overall Study||445
7925855|NCT00578331|19504842|P1|STARTED|Overall Study||445
7925856|NCT00578318|19504852|P2|NOT COMPLETED|Overall Study||0
7925857|NCT00578318|19504853|P1|NOT COMPLETED|Overall Study||3
7925858|NCT00578318|19504852|P2|COMPLETED|Overall Study||8
7925859|NCT00578318|19504853|P1|COMPLETED|Overall Study||5
7925860|NCT00578318|19504852|P2|STARTED|Overall Study||8
7925861|NCT00578318|19504853|P1|STARTED|Overall Study||8
7925862|NCT00578305|19504862|P3|NOT COMPLETED|Safety Follow-up Phase||46
7925863|NCT00578305|19504863|P2|NOT COMPLETED|Safety Follow-up Phase||45
7925864|NCT00578305|19504864|P1|NOT COMPLETED|Safety Follow-up Phase||46
7925865|NCT00578305|19504862|P3|COMPLETED|Safety Follow-up Phase||8
7925866|NCT00578305|19504863|P2|COMPLETED|Safety Follow-up Phase||9
7925867|NCT00578305|19504864|P1|COMPLETED|Safety Follow-up Phase||11
7925868|NCT00578305|19504862|P3|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
7925869|NCT00578305|19504863|P2|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
7925870|NCT00578305|19504864|P1|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57
7925871|NCT00578305|19504862|P3|NOT COMPLETED|Extension Phase||3
7925872|NCT00578305|19504863|P2|NOT COMPLETED|Extension Phase||1
7925873|NCT00578305|19504864|P1|NOT COMPLETED|Extension Phase||4
7925874|NCT00578305|19504862|P3|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40
7925875|NCT00578305|19504863|P2|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
7925876|NCT00578305|19504864|P1|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
7925877|NCT00578305|19504862|P3|STARTED|Extension Phase||43
7925878|NCT00578305|19504863|P2|STARTED|Extension Phase||50
7925879|NCT00578305|19504864|P1|STARTED|Extension Phase||53
7925880|NCT00578305|19504862|P3|NOT COMPLETED|Double-blind Treatment Phase||14
7925881|NCT00578305|19504863|P2|NOT COMPLETED|Double-blind Treatment Phase||4
7925882|NCT00578305|19504864|P1|NOT COMPLETED|Double-blind Treatment Phase||3
7925883|NCT00578305|19504862|P3|COMPLETED|Double-blind Treatment Phase||49
7925884|NCT00578305|19504863|P2|COMPLETED|Double-blind Treatment Phase||56
7925885|NCT00578305|19504864|P1|COMPLETED|Double-blind Treatment Phase||59
7925886|NCT00578305|19504862|P3|Treated|Double-blind Treatment Phase||63
7925887|NCT00578305|19504863|P2|Treated|Double-blind Treatment Phase||60
7925888|NCT00578305|19504864|P1|Treated|Double-blind Treatment Phase||62
7925889|NCT00578305|19504862|P3|STARTED|Double-blind Treatment Phase||63
7925890|NCT00578305|19504863|P2|STARTED|Double-blind Treatment Phase||60
7925891|NCT00578305|19504864|P1|STARTED|Double-blind Treatment Phase||62
7925892|NCT00578292|19504923|P1|NOT COMPLETED|Overall Study||3
7925893|NCT00578292|19504923|P1|COMPLETED|Overall Study||7
7925894|NCT00578292|19504923|P1|STARTED|Overall Study||10
7925895|NCT00578279|19504937|P2|NOT COMPLETED|Overall Study||0
7925896|NCT00578279|19504938|P1|NOT COMPLETED|Overall Study||0
7925897|NCT00578279|19504937|P2|COMPLETED|Overall Study||10
7925898|NCT00578279|19504938|P1|COMPLETED|Overall Study||10
7925899|NCT00578279|19504937|P2|STARTED|Overall Study||10
7925900|NCT00578279|19504938|P1|STARTED|Overall Study||10
7925901|NCT00578227|19504947|P3|NOT COMPLETED|Overall Study||4
7925902|NCT00578227|19504948|P2|NOT COMPLETED|Overall Study||2
7925903|NCT00578227|19504949|P1|NOT COMPLETED|Overall Study||5
7925904|NCT00578227|19504947|P3|COMPLETED|Overall Study||267
7925905|NCT00578227|19504948|P2|COMPLETED|Overall Study||268
7925906|NCT00578227|19504949|P1|COMPLETED|Overall Study||267
7925907|NCT00578227|19504947|P3|STARTED|Overall Study||271
7925908|NCT00578227|19504948|P2|STARTED|Overall Study||270
7925909|NCT00578227|19504949|P1|STARTED|Overall Study||272
7925910|NCT00578214|19505022|P3|NOT COMPLETED|Overall Study||0
7925911|NCT00578214|19505023|P2|NOT COMPLETED|Overall Study||0
7925912|NCT00578214|19505024|P1|NOT COMPLETED|Overall Study||0
7925913|NCT00578214|19505022|P3|COMPLETED|Overall Study||31
7925914|NCT00578214|19505023|P2|COMPLETED|Overall Study||22
7925915|NCT00578214|19505024|P1|COMPLETED|Overall Study||22
7925916|NCT00578214|19505022|P3|STARTED|Overall Study||31
7925917|NCT00578214|19505023|P2|STARTED|Overall Study||22
7925918|NCT00578214|19505024|P1|STARTED|Overall Study||22
7925919|NCT00578175|19505074|P3|NOT COMPLETED|Overall Study||24
7925920|NCT00578175|19505075|P2|NOT COMPLETED|Overall Study||43
7925921|NCT00578175|19505076|P1|NOT COMPLETED|Overall Study||70
7925922|NCT00578175|19505074|P3|COMPLETED|Overall Study||365
7925923|NCT00578175|19505075|P2|COMPLETED|Overall Study||646
7925924|NCT00578175|19505076|P1|COMPLETED|Overall Study||635
7925925|NCT00578175|19505074|P3|STARTED|Overall Study||389
7925926|NCT00578175|19505075|P2|STARTED|Overall Study||689
7925927|NCT00578175|19505076|P1|STARTED|Overall Study||705
7925928|NCT00578136|19505155|P2|NOT COMPLETED|Overall Study||1
7925929|NCT00578136|19505156|P1|NOT COMPLETED|Overall Study||1
7925930|NCT00578136|19505155|P2|COMPLETED|Overall Study||26
7925931|NCT00578136|19505156|P1|COMPLETED|Overall Study||26
7925932|NCT00578136|19505155|P2|STARTED|Overall Study||27
7925933|NCT00578136|19505156|P1|STARTED|Overall Study||27
7925934|NCT00578071|19505164|P1|NOT COMPLETED|Overall Study||0
7925935|NCT00578071|19505164|P1|COMPLETED|Overall Study||29
7925936|NCT00578071|19505164|P1|STARTED|Overall Study||29
7925937|NCT00577993|19505174|P3|NOT COMPLETED|Overall Study||3
7925938|NCT00577993|19505175|P2|NOT COMPLETED|Overall Study||10
7925939|NCT00577993|19505176|P1|NOT COMPLETED|Overall Study||7
7925940|NCT00577993|19505174|P3|COMPLETED|Overall Study||32
7925941|NCT00577993|19505175|P2|COMPLETED|Overall Study||80
7925942|NCT00577993|19505176|P1|COMPLETED|Overall Study||78
7925943|NCT00577993|19505174|P3|STARTED|Overall Study||35
7925944|NCT00577993|19505175|P2|STARTED|Overall Study||90
7925945|NCT00577993|19505176|P1|STARTED|Overall Study||85
7925946|NCT00577889|19505187|P3|NOT COMPLETED|Overall Study||0
7925947|NCT00577889|19505188|P2|NOT COMPLETED|Overall Study||0
7925948|NCT00577889|19505189|P1|NOT COMPLETED|Overall Study||1
7925949|NCT00577889|19505187|P3|COMPLETED|Overall Study||6
7925950|NCT00577889|19505188|P2|COMPLETED|Overall Study||6
7925951|NCT00577889|19505189|P1|COMPLETED|Overall Study||8
7925952|NCT00577889|19505187|P3|STARTED|Overall Study||6
7925953|NCT00577889|19505188|P2|STARTED|Overall Study||6
7925954|NCT00577889|19505189|P1|STARTED|Overall Study||9
7925955|NCT00577863|19505208|P2|NOT COMPLETED|Overall Study||14
7925956|NCT00577863|19505209|P1|NOT COMPLETED|Overall Study||10
7925957|NCT00577863|19505208|P2|COMPLETED|Overall Study||94
7925958|NCT00577863|19505209|P1|COMPLETED|Overall Study||82
7925959|NCT00577863|19505208|P2|Received at Least One Injection|Overall Study||107
7925960|NCT00577863|19505209|P1|Received at Least One Injection|Overall Study||92
7925961|NCT00577863|19505208|P2|STARTED|Overall Study||108
7925962|NCT00577863|19505209|P1|STARTED|Overall Study||92
7925963|NCT00577824|19505251|P3|NOT COMPLETED|Overall Study||2
7925964|NCT00577824|19505252|P2|NOT COMPLETED|Overall Study||20
7925965|NCT00577824|19505253|P1|NOT COMPLETED|Overall Study||7
7925966|NCT00577824|19505251|P3|COMPLETED|Overall Study||34
7925967|NCT00577824|19505252|P2|COMPLETED|Overall Study||53
7925968|NCT00577824|19505253|P1|COMPLETED|Overall Study||65
7925969|NCT00577824|19505251|P3|Full Analysis Set|Overall Study||35
7925970|NCT00577824|19505252|P2|Full Analysis Set|Overall Study||72
7925971|NCT00577824|19505253|P1|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72
7925972|NCT00577824|19505251|P3|STARTED|Overall Study||36
7925973|NCT00577824|19505252|P2|STARTED|Overall Study||73
7925974|NCT00577824|19505253|P1|STARTED|Overall Study|Started=Randomized|72
7925975|NCT00577772|19505311|P2|NOT COMPLETED|Overall Study||1
7925976|NCT00577772|19505312|P1|NOT COMPLETED|Overall Study||0
7925977|NCT00577772|19505311|P2|COMPLETED|Overall Study||6
7925978|NCT00577772|19505312|P1|COMPLETED|Overall Study||10
7925979|NCT00577772|19505311|P2|STARTED|Overall Study||7
7925980|NCT00577772|19505312|P1|STARTED|Overall Study||10
7925981|NCT00577720|19505322|P4|NOT COMPLETED|Overall Study||7
7925982|NCT00577720|19505323|P3|NOT COMPLETED|Overall Study||1
7925983|NCT00577720|19505324|P2|NOT COMPLETED|Overall Study||1
7925984|NCT00577720|19505325|P1|NOT COMPLETED|Overall Study||4
7925985|NCT00577720|19505322|P4|COMPLETED|Overall Study||65
7925986|NCT00577720|19505323|P3|COMPLETED|Overall Study||35
7925987|NCT00577720|19505324|P2|COMPLETED|Overall Study||35
7925988|NCT00577720|19505325|P1|COMPLETED|Overall Study||33
7925989|NCT00577720|19505322|P4|ITT (Intent to Treat) Population|Overall Study||65
7925990|NCT00577720|19505323|P3|ITT (Intent to Treat) Population|Overall Study||35
7925991|NCT00577720|19505324|P2|ITT (Intent to Treat) Population|Overall Study||35
7925992|NCT00577720|19505325|P1|ITT (Intent to Treat) Population|Overall Study||34
7925993|NCT00577720|19505322|P4|STARTED|Overall Study||72
7925994|NCT00577720|19505323|P3|STARTED|Overall Study||36
7925995|NCT00577720|19505324|P2|STARTED|Overall Study||36
7925996|NCT00577720|19505325|P1|STARTED|Overall Study||37
7925997|NCT00577707|19505343|P1|NOT COMPLETED|Overall Study||3
7925998|NCT00577707|19505343|P1|COMPLETED|Overall Study||6
7925999|NCT00577707|19505343|P1|STARTED|Overall Study||9
7926000|NCT00577655|19505351|P2|NOT COMPLETED|Overall Study||4
7926001|NCT00577655|19505352|P1|NOT COMPLETED|Overall Study||1
7926002|NCT00577655|19505351|P2|COMPLETED|Overall Study||47
7926003|NCT00577655|19505352|P1|COMPLETED|Overall Study||51
7926004|NCT00577655|19505351|P2|STARTED|Overall Study|This number represents the number of participants randomized.|51
7926005|NCT00577655|19505352|P1|STARTED|Overall Study|This number represents the number of participants randomized.|52
7926006|NCT00577642|19505390|P1|NOT COMPLETED|Overall Study||1
7926007|NCT00577642|19505390|P1|COMPLETED|Overall Study||28
7926008|NCT00577642|19505390|P1|STARTED|Overall Study||29
7926009|NCT00577629|19505394|P1|NOT COMPLETED|Long Term Follow-Up||25
7926010|NCT00577629|19505394|P1|COMPLETED|Long Term Follow-Up||13
7926011|NCT00577629|19505394|P1|STARTED|Long Term Follow-Up||38
7926012|NCT00577629|19505394|P1|NOT COMPLETED|Treatment Period||1
7926013|NCT00577629|19505394|P1|COMPLETED|Treatment Period||38
7926014|NCT00577629|19505394|P1|STARTED|Treatment Period||39
7926015|NCT00577590|19505405|P3|NOT COMPLETED|Overall Study||0
7926016|NCT00577590|19505406|P2|NOT COMPLETED|Overall Study||0
7926017|NCT00577590|19505407|P1|NOT COMPLETED|Overall Study||0
7926018|NCT00577590|19505405|P3|COMPLETED|Overall Study||23
7926019|NCT00577590|19505406|P2|COMPLETED|Overall Study||27
7926020|NCT00577590|19505407|P1|COMPLETED|Overall Study||28
7926021|NCT00577590|19505405|P3|STARTED|Overall Study||23
7926022|NCT00577590|19505406|P2|STARTED|Overall Study||27
7926023|NCT00577590|19505407|P1|STARTED|Overall Study||28
7926024|NCT00577512|19505415|P1|NOT COMPLETED|Overall Study||4
7926025|NCT00577512|19505415|P1|COMPLETED|Overall Study||0
7926026|NCT00577512|19505415|P1|STARTED|Overall Study||4
7926027|NCT00577473|19505421|P2|NOT COMPLETED|Overall Study||24
7926028|NCT00577473|19505422|P1|NOT COMPLETED|Overall Study||21
7926029|NCT00577473|19505421|P2|COMPLETED|Overall Study||123
7926030|NCT00577473|19505422|P1|COMPLETED|Overall Study||133
7926031|NCT00577473|19505421|P2|ITT Population|Overall Study||136
7926032|NCT00577473|19505422|P1|ITT Population|Overall Study||150
7926033|NCT00577473|19505421|P2|STARTED|Overall Study||147
7926034|NCT00577473|19505422|P1|STARTED|Overall Study||154
7926035|NCT00577460|19505453|P3|NOT COMPLETED|Overall Study||27
7926036|NCT00577460|19505454|P2|NOT COMPLETED|Overall Study||19
7926037|NCT00577460|19505455|P1|NOT COMPLETED|Overall Study||16
7926038|NCT00577460|19505453|P3|COMPLETED|Overall Study||112
7926039|NCT00577460|19505454|P2|COMPLETED|Overall Study||104
7926040|NCT00577460|19505455|P1|COMPLETED|Overall Study||113
7926041|NCT00577460|19505453|P3|STARTED|Overall Study||139
7926042|NCT00577460|19505454|P2|STARTED|Overall Study||123
7926043|NCT00577460|19505455|P1|STARTED|Overall Study||129
7926044|NCT00577408|19505564|P2|NOT COMPLETED|Overall Study||23
7926045|NCT00577408|19505565|P1|NOT COMPLETED|Overall Study||12
7926046|NCT00577408|19505564|P2|COMPLETED|Overall Study||9
7926047|NCT00577408|19505565|P1|COMPLETED|Overall Study||16
7926048|NCT00577408|19505564|P2|STARTED|Overall Study||32
7926049|NCT00577408|19505565|P1|STARTED|Overall Study||28
7926050|NCT00577395|19505573|P2|NOT COMPLETED|Overall Study||6
7926051|NCT00577395|19505574|P1|NOT COMPLETED|Overall Study||7
7926052|NCT00577395|19505573|P2|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
7926053|NCT00577395|19505574|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
7926054|NCT00577395|19505573|P2|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6
7926055|NCT00577395|19505574|P1|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7
7926056|NCT00577382|19505584|P2|NOT COMPLETED|Overall Study||31
7926057|NCT00577382|19505585|P1|NOT COMPLETED|Overall Study||21
7926058|NCT00577382|19505584|P2|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
7926059|NCT00577382|19505585|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
7926060|NCT00577382|19505584|P2|STARTED|Overall Study||31
7926061|NCT00577382|19505585|P1|STARTED|Overall Study||21
7926062|NCT00577356|19505597|P1|NOT COMPLETED|Overall Study||0
7926063|NCT00577356|19505597|P1|COMPLETED|Overall Study||6
7926064|NCT00577356|19505597|P1|STARTED|Overall Study||6
7926065|NCT00577135|19505605|P4|NOT COMPLETED|Overall Study||0
7926066|NCT00577135|19505606|P3|NOT COMPLETED|Overall Study||0
7926067|NCT00577135|19505607|P2|NOT COMPLETED|Overall Study||0
7926068|NCT00577135|19505608|P1|NOT COMPLETED|Overall Study||0
7926069|NCT00577135|19505605|P4|COMPLETED|Overall Study||75
7926070|NCT00577135|19505606|P3|COMPLETED|Overall Study||77
7926071|NCT00577135|19505607|P2|COMPLETED|Overall Study||82
7926072|NCT00577135|19505608|P1|COMPLETED|Overall Study||74
7926073|NCT00577135|19505605|P4|STARTED|Overall Study||75
7926074|NCT00577135|19505606|P3|STARTED|Overall Study||77
7926075|NCT00577135|19505607|P2|STARTED|Overall Study||82
7926076|NCT00577135|19505608|P1|STARTED|Overall Study||74
7926077|NCT00577122|19505728|P2|NOT COMPLETED|Overall Study||16
7926078|NCT00577122|19505729|P1|NOT COMPLETED|Overall Study||14
7926079|NCT00577122|19505728|P2|COMPLETED|Overall Study||0
7926080|NCT00577122|19505729|P1|COMPLETED|Overall Study||0
7926081|NCT00577122|19505728|P2|STARTED|Overall Study||16
7926082|NCT00577122|19505729|P1|STARTED|Overall Study||14
7926083|NCT00577096|19505743|P2|NOT COMPLETED|Long Term Participation||0
7926084|NCT00577096|19505744|P1|NOT COMPLETED|Long Term Participation||0
7926085|NCT00577096|19505743|P2|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35
7926086|NCT00577096|19505744|P1|COMPLETED|Long Term Participation||34
7926087|NCT00577096|19505743|P2|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35
7926088|NCT00577096|19505744|P1|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34
7926089|NCT00577096|19505743|P2|NOT COMPLETED|Short Term Participation||8
7926090|NCT00577096|19505744|P1|NOT COMPLETED|Short Term Participation||7
7926091|NCT00577096|19505743|P2|COMPLETED|Short Term Participation||58
7926092|NCT00577096|19505744|P1|COMPLETED|Short Term Participation||62
7926093|NCT00577096|19505743|P2|STARTED|Short Term Participation||66
7926094|NCT00577096|19505744|P1|STARTED|Short Term Participation||69
7926095|NCT00577083|19505770|P2|NOT COMPLETED|Second Intervention (14days)||0
7926096|NCT00577083|19505771|P1|NOT COMPLETED|Second Intervention (14days)||0
7926097|NCT00577083|19505770|P2|COMPLETED|Second Intervention (14days)||52
7926098|NCT00577083|19505771|P1|COMPLETED|Second Intervention (14days)||48
7926099|NCT00577083|19505770|P2|STARTED|Second Intervention (14days)||52
7926100|NCT00577083|19505771|P1|STARTED|Second Intervention (14days)||48
7926101|NCT00577083|19505770|P2|NOT COMPLETED|Washout (14 Days)||0
7926102|NCT00577083|19505771|P1|NOT COMPLETED|Washout (14 Days)||0
7926103|NCT00577083|19505770|P2|COMPLETED|Washout (14 Days)||52
7926104|NCT00577083|19505771|P1|COMPLETED|Washout (14 Days)||48
7926105|NCT00577083|19505770|P2|STARTED|Washout (14 Days)||52
7926106|NCT00577083|19505771|P1|STARTED|Washout (14 Days)||48
7926107|NCT00577083|19505770|P2|NOT COMPLETED|First Intervention (14 Days)||0
7926108|NCT00577083|19505771|P1|NOT COMPLETED|First Intervention (14 Days)||0
7926109|NCT00577083|19505770|P2|COMPLETED|First Intervention (14 Days)||52
7926110|NCT00577083|19505771|P1|COMPLETED|First Intervention (14 Days)||48
7926111|NCT00577083|19505770|P2|STARTED|First Intervention (14 Days)||52
7926112|NCT00577083|19505771|P1|STARTED|First Intervention (14 Days)||48
7926113|NCT00577031|19505783|P1|NOT COMPLETED|Overall Study||205
7926114|NCT00577031|19505783|P1|COMPLETED|Overall Study||0
7926115|NCT00577031|19505783|P1|STARTED|Overall Study||205
7926116|NCT00577005|19505804|P2|NOT COMPLETED|Overall Study||3
7926117|NCT00577005|19505805|P1|NOT COMPLETED|Overall Study||5
7926118|NCT00577005|19505804|P2|COMPLETED|Overall Study||9
7926119|NCT00577005|19505805|P1|COMPLETED|Overall Study||11
7926120|NCT00577005|19505804|P2|STARTED|Overall Study||12
7926121|NCT00577005|19505805|P1|STARTED|Overall Study||16
7926122|NCT00576927|19505819|P1|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0
7926123|NCT00576927|19505819|P1|COMPLETED|Randomization 1:1 Placebo or Active Drug||22
7926124|NCT00576927|19505819|P1|STARTED|Randomization 1:1 Placebo or Active Drug||22
7926125|NCT00576927|19505819|P1|NOT COMPLETED|Sleep Hygiene With Study Drug||0
7926126|NCT00576927|19505819|P1|COMPLETED|Sleep Hygiene With Study Drug||22
7926127|NCT00576927|19505819|P1|STARTED|Sleep Hygiene With Study Drug||22
7926128|NCT00576927|19505819|P1|NOT COMPLETED|Sleep Hygiene With the Placebo||1
7926129|NCT00576927|19505819|P1|COMPLETED|Sleep Hygiene With the Placebo||22
7926130|NCT00576927|19505819|P1|STARTED|Sleep Hygiene With the Placebo||23
7926131|NCT00576927|19505819|P1|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7
7926132|NCT00576927|19505819|P1|COMPLETED|Sleep Hygiene Behavioral Intervention||23
7926133|NCT00576927|19505819|P1|STARTED|Sleep Hygiene Behavioral Intervention||30
7926134|NCT00576927|19505819|P1|NOT COMPLETED|Baseline||13
7926135|NCT00576927|19505819|P1|COMPLETED|Baseline||30
7926136|NCT00576927|19505819|P1|STARTED|Baseline||43
7926137|NCT00576927|19505819|P1|NOT COMPLETED|Clinical Assessment||36
7926138|NCT00576927|19505819|P1|COMPLETED|Clinical Assessment||43
7926139|NCT00576927|19505819|P1|STARTED|Clinical Assessment||79
7926140|NCT00576901|19505831|P1|NOT COMPLETED|Overall Study||3
7926141|NCT00576901|19505831|P1|COMPLETED|Overall Study||20
7926142|NCT00576901|19505831|P1|STARTED|Overall Study||23
7926143|NCT00576836|19505839|P2|NOT COMPLETED|Overall Study||2
7926144|NCT00576836|19505840|P1|NOT COMPLETED|Overall Study||0
7926145|NCT00576836|19505839|P2|COMPLETED|Overall Study||5
7926146|NCT00576836|19505840|P1|COMPLETED|Overall Study||0
7926147|NCT00576836|19505839|P2|STARTED|Overall Study||7
7926148|NCT00576836|19505840|P1|STARTED|Overall Study||0
7926149|NCT00576823|19505855|P3|NOT COMPLETED|40-week Safety Extension Phase||0
7926150|NCT00576823|19505856|P2|NOT COMPLETED|40-week Safety Extension Phase||0
7926151|NCT00576823|19505857|P1|NOT COMPLETED|40-week Safety Extension Phase||1
7926152|NCT00576823|19505855|P3|COMPLETED|40-week Safety Extension Phase||6
7926153|NCT00576823|19505856|P2|COMPLETED|40-week Safety Extension Phase||6
7926154|NCT00576823|19505857|P1|COMPLETED|40-week Safety Extension Phase||10
7926155|NCT00576823|19505855|P3|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6
7926156|NCT00576823|19505856|P2|STARTED|40-week Safety Extension Phase||6
7926157|NCT00576823|19505857|P1|STARTED|40-week Safety Extension Phase||11
7926158|NCT00576823|19505855|P3|NOT COMPLETED|12-week Efficacy Phase||0
7926159|NCT00576823|19505856|P2|NOT COMPLETED|12-week Efficacy Phase||0
7926160|NCT00576823|19505857|P1|NOT COMPLETED|12-week Efficacy Phase||1
7926161|NCT00576823|19505855|P3|COMPLETED|12-week Efficacy Phase||7
7926162|NCT00576823|19505856|P2|COMPLETED|12-week Efficacy Phase||6
7926163|NCT00576823|19505857|P1|COMPLETED|12-week Efficacy Phase||11
7926164|NCT00576823|19505855|P3|STARTED|12-week Efficacy Phase||7
7926165|NCT00576823|19505856|P2|STARTED|12-week Efficacy Phase||6
7926166|NCT00576823|19505857|P1|STARTED|12-week Efficacy Phase||12
7926167|NCT00576758|19505873|P2|NOT COMPLETED|Follow-up Period||17
7926168|NCT00576758|19505874|P1|NOT COMPLETED|Follow-up Period||27
7926169|NCT00576758|19505873|P2|COMPLETED|Follow-up Period||34
7926170|NCT00576758|19505874|P1|COMPLETED|Follow-up Period||28
7926171|NCT00576758|19505873|P2|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51
7926172|NCT00576758|19505874|P1|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55
7926173|NCT00576758|19505873|P2|NOT COMPLETED|Extension Treatment Period||43
7926174|NCT00576758|19505874|P1|NOT COMPLETED|Extension Treatment Period||42
7926175|NCT00576758|19505873|P2|COMPLETED|Extension Treatment Period||30
7926176|NCT00576758|19505874|P1|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30
7926177|NCT00576758|19505873|P2|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73
7926178|NCT00576758|19505874|P1|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72
7926179|NCT00576758|19505873|P2|NOT COMPLETED|Induction Treatment Period||5
7926180|NCT00576758|19505874|P1|NOT COMPLETED|Induction Treatment Period||8
7926181|NCT00576758|19505873|P2|COMPLETED|Induction Treatment Period||83
7926182|NCT00576758|19505874|P1|COMPLETED|Induction Treatment Period||79
7926183|NCT00576758|19505873|P2|Received Treatment|Induction Treatment Period||87
7926184|NCT00576758|19505874|P1|Received Treatment|Induction Treatment Period||86
7926185|NCT00576758|19505873|P2|STARTED|Induction Treatment Period||88
7926186|NCT00576758|19505874|P1|STARTED|Induction Treatment Period||87
7926187|NCT00576732|19505920|P6|NOT COMPLETED|OPEN LABEL||8
7926188|NCT00576732|19505921|P5|NOT COMPLETED|OPEN LABEL||4
7926189|NCT00576732|19505922|P4|NOT COMPLETED|OPEN LABEL||11
7926190|NCT00576732|19505923|P3|NOT COMPLETED|OPEN LABEL||0
7926191|NCT00576732|19505924|P2|NOT COMPLETED|OPEN LABEL||0
7926192|NCT00576732|19505925|P1|NOT COMPLETED|OPEN LABEL||0
7926193|NCT00576732|19505920|P6|COMPLETED|OPEN LABEL||17
7926194|NCT00576732|19505921|P5|COMPLETED|OPEN LABEL||20
7926195|NCT00576732|19505922|P4|COMPLETED|OPEN LABEL||19
7926196|NCT00576732|19505923|P3|COMPLETED|OPEN LABEL||0
7926197|NCT00576732|19505924|P2|COMPLETED|OPEN LABEL||0
7926198|NCT00576732|19505925|P1|COMPLETED|OPEN LABEL||0
7926199|NCT00576732|19505920|P6|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25
7926200|NCT00576732|19505921|P5|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24
7926201|NCT00576732|19505922|P4|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30
7926202|NCT00576732|19505923|P3|STARTED|OPEN LABEL||0
7926203|NCT00576732|19505924|P2|STARTED|OPEN LABEL||0
7926204|NCT00576732|19505925|P1|STARTED|OPEN LABEL||0
7926205|NCT00576732|19505920|P6|NOT COMPLETED|DOUBLE BLIND||0
7926206|NCT00576732|19505921|P5|NOT COMPLETED|DOUBLE BLIND||0
7926207|NCT00576732|19505922|P4|NOT COMPLETED|DOUBLE BLIND||0
7926208|NCT00576732|19505923|P3|NOT COMPLETED|DOUBLE BLIND||6
7926209|NCT00576732|19505924|P2|NOT COMPLETED|DOUBLE BLIND||5
7926210|NCT00576732|19505925|P1|NOT COMPLETED|DOUBLE BLIND||8
7926211|NCT00576732|19505920|P6|COMPLETED|DOUBLE BLIND||0
7926212|NCT00576732|19505921|P5|COMPLETED|DOUBLE BLIND||0
7926213|NCT00576732|19505922|P4|COMPLETED|DOUBLE BLIND||0
7926214|NCT00576732|19505923|P3|COMPLETED|DOUBLE BLIND||25
7926215|NCT00576732|19505924|P2|COMPLETED|DOUBLE BLIND||25
7926216|NCT00576732|19505925|P1|COMPLETED|DOUBLE BLIND||27
7926217|NCT00576732|19505920|P6|STARTED|DOUBLE BLIND||0
7926218|NCT00576732|19505921|P5|STARTED|DOUBLE BLIND||0
7926219|NCT00576732|19505922|P4|STARTED|DOUBLE BLIND||0
7926220|NCT00576732|19505923|P3|STARTED|DOUBLE BLIND||31
7926221|NCT00576732|19505924|P2|STARTED|DOUBLE BLIND||30
7926222|NCT00576732|19505925|P1|STARTED|DOUBLE BLIND||35
7926223|NCT00576693|19505957|P2|NOT COMPLETED|Overall Study||24
7926224|NCT00576693|19505958|P1|NOT COMPLETED|Overall Study||10
7926225|NCT00576693|19505957|P2|COMPLETED|Overall Study||203
7926226|NCT00576693|19505958|P1|COMPLETED|Overall Study||214
7926227|NCT00576693|19505957|P2|STARTED|Overall Study||227
7926228|NCT00576693|19505958|P1|STARTED|Overall Study||224
7926229|NCT00576680|19505964|P1|NOT COMPLETED|Overall Study||0
7926230|NCT00576680|19505964|P1|COMPLETED|Overall Study||43
7926231|NCT00576680|19505964|P1|STARTED|Overall Study||43
7926232|NCT00576628|19505970|P1|NOT COMPLETED|Overall Study||43
7926233|NCT00576628|19505970|P1|COMPLETED|Overall Study||82
7926234|NCT00576628|19505970|P1|STARTED|Overall Study||125
7926235|NCT00576576|19505990|P1|NOT COMPLETED|Overall Study||7
7926236|NCT00576576|19505990|P1|COMPLETED|Overall Study||20
7926237|NCT00576576|19505990|P1|STARTED|Overall Study||27
7926238|NCT00576524|19505998|P2|NOT COMPLETED|Overall Study||0
7926239|NCT00576524|19505999|P1|NOT COMPLETED|Overall Study||0
7926240|NCT00576524|19505998|P2|COMPLETED|Overall Study||0
7926241|NCT00576524|19505999|P1|COMPLETED|Overall Study||2
7926242|NCT00576524|19505998|P2|STARTED|Overall Study||0
7926243|NCT00576524|19505999|P1|STARTED|Overall Study||2
7926244|NCT00576472|19506024|P15|NOT COMPLETED|MPH Home Maintenance Phase||23
7926245|NCT00576472|19506025|P14|NOT COMPLETED|MPH Home Maintenance Phase||27
7926246|NCT00576472|19506026|P13|NOT COMPLETED|MPH Home Maintenance Phase||0
7926247|NCT00576472|19506027|P12|NOT COMPLETED|MPH Home Maintenance Phase||0
7926248|NCT00576472|19506028|P11|NOT COMPLETED|MPH Home Maintenance Phase||0
7926249|NCT00576472|19506029|P10|NOT COMPLETED|MPH Home Maintenance Phase||0
7926250|NCT00576472|19506030|P9|NOT COMPLETED|MPH Home Maintenance Phase||0
7926251|NCT00576472|19506031|P8|NOT COMPLETED|MPH Home Maintenance Phase||0
7926252|NCT00576472|19506032|P7|NOT COMPLETED|MPH Home Maintenance Phase||0
7926253|NCT00576472|19506033|P6|NOT COMPLETED|MPH Home Maintenance Phase||0
7926254|NCT00576472|19506034|P5|NOT COMPLETED|MPH Home Maintenance Phase||0
7926255|NCT00576472|19506035|P4|NOT COMPLETED|MPH Home Maintenance Phase||0
7926256|NCT00576472|19506036|P3|NOT COMPLETED|MPH Home Maintenance Phase||0
7926257|NCT00576472|19506037|P2|NOT COMPLETED|MPH Home Maintenance Phase||0
7926258|NCT00576472|19506038|P1|NOT COMPLETED|MPH Home Maintenance Phase||0
7926259|NCT00576472|19506024|P15|COMPLETED|MPH Home Maintenance Phase||68
7926260|NCT00576472|19506025|P14|COMPLETED|MPH Home Maintenance Phase||0
7926261|NCT00576472|19506026|P13|COMPLETED|MPH Home Maintenance Phase||0
7926262|NCT00576472|19506027|P12|COMPLETED|MPH Home Maintenance Phase||0
7926263|NCT00576472|19506028|P11|COMPLETED|MPH Home Maintenance Phase||0
7926264|NCT00576472|19506029|P10|COMPLETED|MPH Home Maintenance Phase||0
7926265|NCT00576472|19506030|P9|COMPLETED|MPH Home Maintenance Phase||0
7926266|NCT00576472|19506031|P8|COMPLETED|MPH Home Maintenance Phase||0
7926267|NCT00576472|19506032|P7|COMPLETED|MPH Home Maintenance Phase||0
7926268|NCT00576472|19506033|P6|COMPLETED|MPH Home Maintenance Phase||0
7926269|NCT00576472|19506034|P5|COMPLETED|MPH Home Maintenance Phase||0
7926270|NCT00576472|19506035|P4|COMPLETED|MPH Home Maintenance Phase||0
7926271|NCT00576472|19506036|P3|COMPLETED|MPH Home Maintenance Phase||0
7926272|NCT00576472|19506037|P2|COMPLETED|MPH Home Maintenance Phase||0
7926273|NCT00576472|19506038|P1|COMPLETED|MPH Home Maintenance Phase||0
7926274|NCT00576472|19506024|P15|STARTED|MPH Home Maintenance Phase||91
7926275|NCT00576472|19506025|P14|STARTED|MPH Home Maintenance Phase||27
7926276|NCT00576472|19506026|P13|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
7926277|NCT00576472|19506027|P12|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
7926278|NCT00576472|19506028|P11|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
7926279|NCT00576472|19506029|P10|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
7926280|NCT00576472|19506030|P9|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
7926281|NCT00576472|19506031|P8|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
7926282|NCT00576472|19506032|P7|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
7926283|NCT00576472|19506033|P6|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
7926284|NCT00576472|19506034|P5|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
7926285|NCT00576472|19506035|P4|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
7926286|NCT00576472|19506036|P3|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
7926287|NCT00576472|19506037|P2|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
7926288|NCT00576472|19506038|P1|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
7926289|NCT00576472|19506024|P15|NOT COMPLETED|MPH Cross Over Phase||0
7926290|NCT00576472|19506025|P14|NOT COMPLETED|MPH Cross Over Phase||0
7926291|NCT00576472|19506026|P13|NOT COMPLETED|MPH Cross Over Phase||0
7926292|NCT00576472|19506027|P12|NOT COMPLETED|MPH Cross Over Phase||1
7926293|NCT00576472|19506028|P11|NOT COMPLETED|MPH Cross Over Phase||1
7926294|NCT00576472|19506029|P10|NOT COMPLETED|MPH Cross Over Phase||0
7926295|NCT00576472|19506030|P9|NOT COMPLETED|MPH Cross Over Phase||2
7926296|NCT00576472|19506031|P8|NOT COMPLETED|MPH Cross Over Phase||0
7926297|NCT00576472|19506032|P7|NOT COMPLETED|MPH Cross Over Phase||12
7926298|NCT00576472|19506033|P6|NOT COMPLETED|MPH Cross Over Phase||0
7926299|NCT00576472|19506034|P5|NOT COMPLETED|MPH Cross Over Phase||0
7926300|NCT00576472|19506035|P4|NOT COMPLETED|MPH Cross Over Phase||0
7926301|NCT00576472|19506036|P3|NOT COMPLETED|MPH Cross Over Phase||0
7926302|NCT00576472|19506037|P2|NOT COMPLETED|MPH Cross Over Phase||0
7926303|NCT00576472|19506038|P1|NOT COMPLETED|MPH Cross Over Phase||0
7926304|NCT00576472|19506024|P15|COMPLETED|MPH Cross Over Phase||0
7926305|NCT00576472|19506025|P14|COMPLETED|MPH Cross Over Phase||0
7926306|NCT00576472|19506026|P13|COMPLETED|MPH Cross Over Phase||21
7926307|NCT00576472|19506027|P12|COMPLETED|MPH Cross Over Phase||17
7926308|NCT00576472|19506028|P11|COMPLETED|MPH Cross Over Phase||22
7926309|NCT00576472|19506029|P10|COMPLETED|MPH Cross Over Phase||22
7926310|NCT00576472|19506030|P9|COMPLETED|MPH Cross Over Phase||16
7926311|NCT00576472|19506031|P8|COMPLETED|MPH Cross Over Phase||20
7926312|NCT00576472|19506032|P7|COMPLETED|MPH Cross Over Phase||0
7926313|NCT00576472|19506033|P6|COMPLETED|MPH Cross Over Phase||0
7926314|NCT00576472|19506034|P5|COMPLETED|MPH Cross Over Phase||0
7926315|NCT00576472|19506035|P4|COMPLETED|MPH Cross Over Phase||0
7926316|NCT00576472|19506036|P3|COMPLETED|MPH Cross Over Phase||0
7926317|NCT00576472|19506037|P2|COMPLETED|MPH Cross Over Phase||0
7926318|NCT00576472|19506038|P1|COMPLETED|MPH Cross Over Phase||0
7926319|NCT00576472|19506024|P15|STARTED|MPH Cross Over Phase||0
7926320|NCT00576472|19506025|P14|STARTED|MPH Cross Over Phase||0
7926321|NCT00576472|19506026|P13|STARTED|MPH Cross Over Phase||21
7926322|NCT00576472|19506027|P12|STARTED|MPH Cross Over Phase||18
7926323|NCT00576472|19506028|P11|STARTED|MPH Cross Over Phase||23
7926324|NCT00576472|19506029|P10|STARTED|MPH Cross Over Phase||22
7926325|NCT00576472|19506030|P9|STARTED|MPH Cross Over Phase||18
7926326|NCT00576472|19506031|P8|STARTED|MPH Cross Over Phase||20
7926327|NCT00576472|19506032|P7|STARTED|MPH Cross Over Phase||12
7926328|NCT00576472|19506033|P6|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
7926329|NCT00576472|19506034|P5|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
7926330|NCT00576472|19506035|P4|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
7926331|NCT00576472|19506036|P3|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
7926332|NCT00576472|19506037|P2|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
7926333|NCT00576472|19506038|P1|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
7926334|NCT00576472|19506024|P15|NOT COMPLETED|MPH In-Lab Phase||0
7926335|NCT00576472|19506025|P14|NOT COMPLETED|MPH In-Lab Phase||0
7926336|NCT00576472|19506026|P13|NOT COMPLETED|MPH In-Lab Phase||0
7926337|NCT00576472|19506027|P12|NOT COMPLETED|MPH In-Lab Phase||0
7926338|NCT00576472|19506028|P11|NOT COMPLETED|MPH In-Lab Phase||0
7926339|NCT00576472|19506029|P10|NOT COMPLETED|MPH In-Lab Phase||0
7926340|NCT00576472|19506030|P9|NOT COMPLETED|MPH In-Lab Phase||0
7926341|NCT00576472|19506031|P8|NOT COMPLETED|MPH In-Lab Phase||0
7926342|NCT00576472|19506032|P7|NOT COMPLETED|MPH In-Lab Phase||0
7926343|NCT00576472|19506033|P6|NOT COMPLETED|MPH In-Lab Phase||0
7926344|NCT00576472|19506034|P5|NOT COMPLETED|MPH In-Lab Phase||0
7926345|NCT00576472|19506035|P4|NOT COMPLETED|MPH In-Lab Phase||335
7926346|NCT00576472|19506036|P3|NOT COMPLETED|MPH In-Lab Phase||0
7926347|NCT00576472|19506037|P2|NOT COMPLETED|MPH In-Lab Phase||0
7926348|NCT00576472|19506038|P1|NOT COMPLETED|MPH In-Lab Phase||0
7926349|NCT00576472|19506024|P15|COMPLETED|MPH In-Lab Phase||0
7926350|NCT00576472|19506025|P14|COMPLETED|MPH In-Lab Phase||0
7926351|NCT00576472|19506026|P13|COMPLETED|MPH In-Lab Phase||0
7926352|NCT00576472|19506027|P12|COMPLETED|MPH In-Lab Phase||0
7926353|NCT00576472|19506028|P11|COMPLETED|MPH In-Lab Phase||0
7926354|NCT00576472|19506029|P10|COMPLETED|MPH In-Lab Phase||0
7926355|NCT00576472|19506030|P9|COMPLETED|MPH In-Lab Phase||0
7926356|NCT00576472|19506031|P8|COMPLETED|MPH In-Lab Phase||0
7926357|NCT00576472|19506032|P7|COMPLETED|MPH In-Lab Phase||0
7926358|NCT00576472|19506033|P6|COMPLETED|MPH In-Lab Phase||67
7926359|NCT00576472|19506034|P5|COMPLETED|MPH In-Lab Phase||67
7926360|NCT00576472|19506035|P4|COMPLETED|MPH In-Lab Phase||0
7926361|NCT00576472|19506036|P3|COMPLETED|MPH In-Lab Phase||0
7926362|NCT00576472|19506037|P2|COMPLETED|MPH In-Lab Phase||0
7926363|NCT00576472|19506038|P1|COMPLETED|MPH In-Lab Phase||0
7926364|NCT00576472|19506024|P15|STARTED|MPH In-Lab Phase||0
7926365|NCT00576472|19506025|P14|STARTED|MPH In-Lab Phase||0
7926366|NCT00576472|19506026|P13|STARTED|MPH In-Lab Phase||0
7926367|NCT00576472|19506027|P12|STARTED|MPH In-Lab Phase||0
7926368|NCT00576472|19506028|P11|STARTED|MPH In-Lab Phase||0
7926369|NCT00576472|19506029|P10|STARTED|MPH In-Lab Phase||0
7926370|NCT00576472|19506030|P9|STARTED|MPH In-Lab Phase||0
7926371|NCT00576472|19506031|P8|STARTED|MPH In-Lab Phase||0
7926372|NCT00576472|19506032|P7|STARTED|MPH In-Lab Phase||0
7926373|NCT00576472|19506033|P6|STARTED|MPH In-Lab Phase||67
7926374|NCT00576472|19506034|P5|STARTED|MPH In-Lab Phase||67
7926375|NCT00576472|19506035|P4|STARTED|MPH In-Lab Phase||335
7926376|NCT00576472|19506036|P3|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
7926377|NCT00576472|19506037|P2|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
7926378|NCT00576472|19506038|P1|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
7926379|NCT00576472|19506024|P15|NOT COMPLETED|Initial Screening||0
7926380|NCT00576472|19506025|P14|NOT COMPLETED|Initial Screening||0
7926381|NCT00576472|19506026|P13|NOT COMPLETED|Initial Screening||0
7926382|NCT00576472|19506027|P12|NOT COMPLETED|Initial Screening||0
7926383|NCT00576472|19506028|P11|NOT COMPLETED|Initial Screening||0
7926384|NCT00576472|19506029|P10|NOT COMPLETED|Initial Screening||0
7926385|NCT00576472|19506030|P9|NOT COMPLETED|Initial Screening||0
7926386|NCT00576472|19506031|P8|NOT COMPLETED|Initial Screening||0
7926387|NCT00576472|19506032|P7|NOT COMPLETED|Initial Screening||0
7926388|NCT00576472|19506033|P6|NOT COMPLETED|Initial Screening||0
7926389|NCT00576472|19506034|P5|NOT COMPLETED|Initial Screening||0
7926390|NCT00576472|19506035|P4|NOT COMPLETED|Initial Screening||0
7926391|NCT00576472|19506036|P3|NOT COMPLETED|Initial Screening||0
7926392|NCT00576472|19506037|P2|NOT COMPLETED|Initial Screening||0
7926393|NCT00576472|19506038|P1|NOT COMPLETED|Initial Screening||0
7926394|NCT00576472|19506024|P15|COMPLETED|Initial Screening||0
7926395|NCT00576472|19506025|P14|COMPLETED|Initial Screening||0
7926396|NCT00576472|19506026|P13|COMPLETED|Initial Screening||0
7926397|NCT00576472|19506027|P12|COMPLETED|Initial Screening||0
7926398|NCT00576472|19506028|P11|COMPLETED|Initial Screening||0
7926399|NCT00576472|19506029|P10|COMPLETED|Initial Screening||0
7926400|NCT00576472|19506030|P9|COMPLETED|Initial Screening||0
7926401|NCT00576472|19506031|P8|COMPLETED|Initial Screening||0
7926402|NCT00576472|19506032|P7|COMPLETED|Initial Screening||0
7926403|NCT00576472|19506033|P6|COMPLETED|Initial Screening||0
7926404|NCT00576472|19506034|P5|COMPLETED|Initial Screening||0
7926405|NCT00576472|19506035|P4|COMPLETED|Initial Screening||0
7926406|NCT00576472|19506036|P3|COMPLETED|Initial Screening||199
7926407|NCT00576472|19506037|P2|COMPLETED|Initial Screening||40
7926408|NCT00576472|19506038|P1|COMPLETED|Initial Screening||230
7926409|NCT00576472|19506024|P15|STARTED|Initial Screening||0
7926410|NCT00576472|19506025|P14|STARTED|Initial Screening||0
7926411|NCT00576472|19506026|P13|STARTED|Initial Screening||0
7926412|NCT00576472|19506027|P12|STARTED|Initial Screening||0
7926413|NCT00576472|19506028|P11|STARTED|Initial Screening||0
7926414|NCT00576472|19506029|P10|STARTED|Initial Screening||0
7926415|NCT00576472|19506030|P9|STARTED|Initial Screening||0
7926416|NCT00576472|19506031|P8|STARTED|Initial Screening||0
7926417|NCT00576472|19506032|P7|STARTED|Initial Screening||0
7926418|NCT00576472|19506033|P6|STARTED|Initial Screening||0
7926419|NCT00576472|19506034|P5|STARTED|Initial Screening||0
7926420|NCT00576472|19506035|P4|STARTED|Initial Screening||0
7926421|NCT00576472|19506036|P3|STARTED|Initial Screening||199
7926422|NCT00576472|19506037|P2|STARTED|Initial Screening||40
7926423|NCT00576472|19506038|P1|STARTED|Initial Screening||230
7926424|NCT00576420|19506131|P3|NOT COMPLETED|Overall Study||1
7926425|NCT00576420|19506132|P2|NOT COMPLETED|Overall Study||0
7926426|NCT00576420|19506133|P1|NOT COMPLETED|Overall Study||0
7926427|NCT00576420|19506131|P3|COMPLETED|Overall Study||22
7926428|NCT00576420|19506132|P2|COMPLETED|Overall Study||24
7926429|NCT00576420|19506133|P1|COMPLETED|Overall Study||26
7926430|NCT00576420|19506131|P3|STARTED|Overall Study||23
7926431|NCT00576420|19506132|P2|STARTED|Overall Study||24
7926432|NCT00576420|19506133|P1|STARTED|Overall Study||26
7926433|NCT00576407|19506298|P1|NOT COMPLETED|Overall Study||8
7926434|NCT00576407|19506298|P1|COMPLETED|Overall Study||18
7926435|NCT00576407|19506298|P1|STARTED|Overall Study||26
7926436|NCT00576381|19506310|P1|NOT COMPLETED|Overall Study||7
7926437|NCT00576381|19506310|P1|COMPLETED|Overall Study||23
7926438|NCT00576381|19506310|P1|STARTED|Overall Study||30
7926439|NCT00576316|19506314|P1|NOT COMPLETED|Overall Study||20
7926440|NCT00576316|19506314|P1|COMPLETED|Overall Study|Number of patients who completed study|181
7926441|NCT00576316|19506314|P1|STARTED|Overall Study|Number of patients recruited|201
7926442|NCT00576303|19506319|P1|NOT COMPLETED|Long Term Safety Period||16
7926443|NCT00576303|19506319|P1|COMPLETED|Long Term Safety Period||162
7926444|NCT00576303|19506319|P1|STARTED|Long Term Safety Period||178
7926445|NCT00576303|19506319|P1|NOT COMPLETED|Efficacy Evaluation Period||5
7926446|NCT00576303|19506319|P1|COMPLETED|Efficacy Evaluation Period||178
7926447|NCT00576303|19506319|P1|STARTED|Efficacy Evaluation Period||183
7926448|NCT00576303|19506319|P1|NOT COMPLETED|Dose Titration Period||17
7926449|NCT00576303|19506319|P1|COMPLETED|Dose Titration Period||183
7926450|NCT00576303|19506319|P1|STARTED|Dose Titration Period||200
7926451|NCT00576251|19506330|P2|NOT COMPLETED|Overall Study||1
7926452|NCT00576251|19506331|P1|NOT COMPLETED|Overall Study||1
7926453|NCT00576251|19506330|P2|COMPLETED|Overall Study||111
7926454|NCT00576251|19506331|P1|COMPLETED|Overall Study||108
7926455|NCT00576251|19506330|P2|STARTED|Overall Study||112
7926456|NCT00576251|19506331|P1|STARTED|Overall Study||109
7926457|NCT00576199|19506337|P1|NOT COMPLETED|Overall Study||30
7926458|NCT00576199|19506337|P1|COMPLETED|Overall Study||0
7926459|NCT00576199|19506337|P1|STARTED|Overall Study||30
7926460|NCT00576147|19506346|P1|NOT COMPLETED|Overall Study||0
7926461|NCT00576147|19506346|P1|COMPLETED|Overall Study||431
7926462|NCT00576147|19506346|P1|STARTED|Overall Study||431
7926463|NCT00576056|19506350|P1|NOT COMPLETED|Overall Study||14
7926464|NCT00576056|19506350|P1|COMPLETED|Overall Study||5
7926465|NCT00576056|19506350|P1|STARTED|Overall Study||19
7926466|NCT00575965|19506355|P1|NOT COMPLETED|Overall Study||0
7926467|NCT00575965|19506355|P1|COMPLETED|Overall Study||18
7926468|NCT00575965|19506355|P1|STARTED|Overall Study||18
7926469|NCT00575887|19506360|P1|NOT COMPLETED|Overall Study||0
7926470|NCT00575887|19506360|P1|COMPLETED|Overall Study||25
7926471|NCT00575887|19506360|P1|STARTED|Overall Study||25
7926472|NCT00575666|19506366|P2|NOT COMPLETED|Overall Study||3
7926473|NCT00575666|19506367|P1|NOT COMPLETED|Overall Study||4
7926474|NCT00575666|19506366|P2|COMPLETED|Overall Study||21
7926475|NCT00575666|19506367|P1|COMPLETED|Overall Study||17
7926476|NCT00575666|19506366|P2|STARTED|Overall Study||24
7926477|NCT00575666|19506367|P1|STARTED|Overall Study||21
7926478|NCT00575588|19506407|P2|NOT COMPLETED|Overall Study||283
7926479|NCT00575588|19506408|P1|NOT COMPLETED|Overall Study||263
7926480|NCT00575588|19506407|P2|COMPLETED|Overall Study|Completed 104 weeks of treatment|147
7926481|NCT00575588|19506408|P1|COMPLETED|Overall Study|Completed 104 weeks of treatment|165
7926482|NCT00575588|19506407|P2|STARTED|Overall Study|Randomized and treated|430
7926483|NCT00575588|19506408|P1|STARTED|Overall Study|Randomized and treated|428
7926484|NCT00575510|19506431|P3|NOT COMPLETED|Overall Study||17
7926485|NCT00575510|19506432|P2|NOT COMPLETED|Overall Study||13
7926486|NCT00575510|19506433|P1|NOT COMPLETED|Overall Study||12
7926487|NCT00575510|19506431|P3|COMPLETED|Overall Study||96
7926488|NCT00575510|19506432|P2|COMPLETED|Overall Study||101
7926489|NCT00575510|19506433|P1|COMPLETED|Overall Study||102
7926490|NCT00575510|19506431|P3|STARTED|Overall Study||113
7926491|NCT00575510|19506432|P2|STARTED|Overall Study||114
7926492|NCT00575510|19506433|P1|STARTED|Overall Study||114
7926493|NCT00575380|19506446|P2|NOT COMPLETED|Overall Study||3
7926494|NCT00575380|19506447|P1|NOT COMPLETED|Overall Study||1
7926495|NCT00575380|19506446|P2|COMPLETED|Overall Study||55
7926496|NCT00575380|19506447|P1|COMPLETED|Overall Study||57
7926497|NCT00575380|19506446|P2|STARTED|Overall Study||58
7926498|NCT00575380|19506447|P1|STARTED|Overall Study||58
7926499|NCT00575367|19506457|P2|NOT COMPLETED|Overall Study||0
7926500|NCT00575367|19506458|P1|NOT COMPLETED|Overall Study||0
7926501|NCT00575367|19506457|P2|COMPLETED|Overall Study||18
7926502|NCT00575367|19506458|P1|COMPLETED|Overall Study||19
7926503|NCT00575367|19506457|P2|STARTED|Overall Study||18
7926504|NCT00575367|19506458|P1|STARTED|Overall Study||19
7926505|NCT00575328|19506466|P2|NOT COMPLETED|Overall Study||2
7926506|NCT00575328|19506467|P1|NOT COMPLETED|Overall Study||3
7926507|NCT00575328|19506466|P2|COMPLETED|Overall Study||2
7926508|NCT00575328|19506467|P1|COMPLETED|Overall Study||1
7926509|NCT00575328|19506466|P2|STARTED|Overall Study||4
7926510|NCT00575328|19506467|P1|STARTED|Overall Study||4
7926511|NCT00575185|19506477|P2|NOT COMPLETED|Overall Study||0
7926512|NCT00575185|19506478|P1|NOT COMPLETED|Overall Study||0
7926513|NCT00575185|19506477|P2|COMPLETED|Overall Study||11
7926514|NCT00575185|19506478|P1|COMPLETED|Overall Study||12
7926515|NCT00575185|19506477|P2|STARTED|Overall Study||11
7926516|NCT00575185|19506478|P1|STARTED|Overall Study||12
7926517|NCT00575159|19506486|P1|NOT COMPLETED|Overall Study||0
7926518|NCT00575159|19506486|P1|COMPLETED|Overall Study||10
7926519|NCT00575159|19506486|P1|STARTED|Overall Study||10
7926520|NCT00575146|19506594|P1|NOT COMPLETED|Overall Study||3
7926521|NCT00575146|19506594|P1|COMPLETED|Overall Study||17
7926522|NCT00575146|19506594|P1|STARTED|Overall Study||20
7926523|NCT00575094|19506600|P1|NOT COMPLETED|Overall Study||3
7926524|NCT00575094|19506600|P1|COMPLETED|Overall Study||6
7926525|NCT00575094|19506600|P1|STARTED|Overall Study||9
7926526|NCT00575042|19506604|P1|NOT COMPLETED|Overall Study||3
7926527|NCT00575042|19506604|P1|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17
7926528|NCT00575042|19506604|P1|STARTED|Overall Study||20
7926529|NCT00575029|19506609|P1|NOT COMPLETED|Overall Study||0
7926530|NCT00575029|19506609|P1|COMPLETED|Overall Study||7
7926531|NCT00575029|19506609|P1|STARTED|Overall Study||7
7926532|NCT00575016|19506618|P4|NOT COMPLETED|Treatment Cycle 2||0
7926533|NCT00575016|19506619|P3|NOT COMPLETED|Treatment Cycle 2||0
7926534|NCT00575016|19506620|P2|NOT COMPLETED|Treatment Cycle 2||0
7926535|NCT00575016|19506621|P1|NOT COMPLETED|Treatment Cycle 2||1
7926536|NCT00575016|19506618|P4|COMPLETED|Treatment Cycle 2||0
7926537|NCT00575016|19506619|P3|COMPLETED|Treatment Cycle 2||0
7926538|NCT00575016|19506620|P2|COMPLETED|Treatment Cycle 2||0
7926539|NCT00575016|19506621|P1|COMPLETED|Treatment Cycle 2||30
7926540|NCT00575016|19506618|P4|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
7926541|NCT00575016|19506619|P3|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
7926542|NCT00575016|19506620|P2|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
7926543|NCT00575016|19506621|P1|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31
7926544|NCT00575016|19506618|P4|NOT COMPLETED|Treatment Cycle 1||5
7926545|NCT00575016|19506619|P3|NOT COMPLETED|Treatment Cycle 1||4
7926546|NCT00575016|19506620|P2|NOT COMPLETED|Treatment Cycle 1||5
7926547|NCT00575016|19506621|P1|NOT COMPLETED|Treatment Cycle 1||9
7926548|NCT00575016|19506618|P4|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12
7926549|NCT00575016|19506619|P3|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15
7926550|NCT00575016|19506620|P2|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16
7926551|NCT00575016|19506621|P1|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8
7926552|NCT00575016|19506618|P4|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17
7926553|NCT00575016|19506619|P3|STARTED|Treatment Cycle 1||19
7926554|NCT00575016|19506620|P2|STARTED|Treatment Cycle 1||21
7926555|NCT00575016|19506621|P1|STARTED|Treatment Cycle 1||17
7926556|NCT00574990|19506642|P3|NOT COMPLETED|Overall Study||0
7926557|NCT00574990|19506643|P2|NOT COMPLETED|Overall Study||0
7926558|NCT00574990|19506644|P1|NOT COMPLETED|Overall Study||0
7926559|NCT00574990|19506642|P3|COMPLETED|Overall Study||8
7926560|NCT00574990|19506643|P2|COMPLETED|Overall Study||19
7926561|NCT00574990|19506644|P1|COMPLETED|Overall Study||12
7926562|NCT00574990|19506642|P3|STARTED|Overall Study||8
7926563|NCT00574990|19506643|P2|STARTED|Overall Study||19
7926564|NCT00574990|19506644|P1|STARTED|Overall Study||12
7926565|NCT00574951|19506655|P1|NOT COMPLETED|Overall Study||1
7926566|NCT00574951|19506655|P1|COMPLETED|Overall Study||22
7926567|NCT00574951|19506655|P1|STARTED|Overall Study||23
7926568|NCT00574912|19506663|P1|NOT COMPLETED|Overall Study||8
7926569|NCT00574912|19506663|P1|COMPLETED|Overall Study||12
7926570|NCT00574912|19506663|P1|Completed 2.0|Overall Study||12
7926571|NCT00574912|19506663|P1|Completed 1.5|Overall Study||12
7926572|NCT00574912|19506663|P1|Completed 1.0|Overall Study||12
7926573|NCT00574912|19506663|P1|Completed 0.5|Overall Study||12
7926574|NCT00574912|19506663|P1|Completed Placebo|Overall Study|12 original participants started the trial.|12
7926575|NCT00574912|19506663|P1|STARTED|Overall Study||20
7926576|NCT00574873|19506677|P2|NOT COMPLETED|Overall Study||251
7926577|NCT00574873|19506678|P1|NOT COMPLETED|Overall Study||238
7926578|NCT00574873|19506677|P2|COMPLETED|Overall Study||1
7926579|NCT00574873|19506678|P1|COMPLETED|Overall Study||12
7926580|NCT00574873|19506677|P2|Treated|Overall Study||251
7926581|NCT00574873|19506678|P1|Treated|Overall Study||248
7926582|NCT00574873|19506677|P2|STARTED|Overall Study||252
7926583|NCT00574873|19506678|P1|STARTED|Overall Study||250
7926584|NCT00574847|19506696|P2|NOT COMPLETED|Overall Study||7
7926585|NCT00574847|19506697|P1|NOT COMPLETED|Overall Study||8
7926586|NCT00574847|19506696|P2|COMPLETED|Overall Study||56
7926587|NCT00574847|19506697|P1|COMPLETED|Overall Study||56
7926588|NCT00574847|19506696|P2|STARTED|Overall Study||63
7926589|NCT00574847|19506697|P1|STARTED|Overall Study||64
7926590|NCT00574834|19506732|P3|NOT COMPLETED|Overall Study||0
7926591|NCT00574834|19506733|P2|NOT COMPLETED|Overall Study||0
7926592|NCT00574834|19506734|P1|NOT COMPLETED|Overall Study||0
7926593|NCT00574834|19506732|P3|COMPLETED|Overall Study||4
7926594|NCT00574834|19506733|P2|COMPLETED|Overall Study||4
7926595|NCT00574834|19506734|P1|COMPLETED|Overall Study||9
7926596|NCT00574834|19506732|P3|STARTED|Overall Study||4
7926597|NCT00574834|19506733|P2|STARTED|Overall Study||4
7926598|NCT00574834|19506734|P1|STARTED|Overall Study||9
7926599|NCT00574795|19506742|P1|NOT COMPLETED|Toddler Dose||1
7926600|NCT00574795|19506742|P1|COMPLETED|Toddler Dose||184
7926601|NCT00574795|19506742|P1|STARTED|Toddler Dose||185
7926602|NCT00574795|19506742|P1|NOT COMPLETED|After Infant Series||3
7926603|NCT00574795|19506742|P1|COMPLETED|After Infant Series||185
7926604|NCT00574795|19506742|P1|STARTED|After Infant Series||188
7926605|NCT00574795|19506742|P1|NOT COMPLETED|Infant Series||5
7926606|NCT00574795|19506742|P1|COMPLETED|Infant Series||188
7926607|NCT00574795|19506742|P1|Vaccinated Dose 3|Infant Series||190
7926608|NCT00574795|19506742|P1|Vaccinated Dose 2|Infant Series||190
7926609|NCT00574795|19506742|P1|Vaccinated Dose 1|Infant Series||193
7926610|NCT00574795|19506742|P1|STARTED|Infant Series||193
7926611|NCT00574704|19506763|P4|NOT COMPLETED|Overall Study||0
7926612|NCT00574704|19506764|P3|NOT COMPLETED|Overall Study||1
7926613|NCT00574704|19506765|P2|NOT COMPLETED|Overall Study||0
7926614|NCT00574704|19506766|P1|NOT COMPLETED|Overall Study||0
7926615|NCT00574704|19506763|P4|COMPLETED|Overall Study||10
7926616|NCT00574704|19506764|P3|COMPLETED|Overall Study||9
7926617|NCT00574704|19506765|P2|COMPLETED|Overall Study||10
7926618|NCT00574704|19506766|P1|COMPLETED|Overall Study||10
7926619|NCT00574704|19506763|P4|STARTED|Overall Study||10
7926620|NCT00574704|19506764|P3|STARTED|Overall Study||10
7926621|NCT00574704|19506765|P2|STARTED|Overall Study||10
7926622|NCT00574704|19506766|P1|STARTED|Overall Study||10
7926623|NCT00574587|19506780|P4|NOT COMPLETED|Overall Study||0
7926624|NCT00574587|19506781|P3|NOT COMPLETED|Overall Study||0
7926625|NCT00574587|19506782|P2|NOT COMPLETED|Overall Study||0
7926626|NCT00574587|19506783|P1|NOT COMPLETED|Overall Study||0
7926627|NCT00574587|19506780|P4|COMPLETED|Overall Study||13
7926628|NCT00574587|19506781|P3|COMPLETED|Overall Study||16
7926629|NCT00574587|19506782|P2|COMPLETED|Overall Study||23
7926630|NCT00574587|19506783|P1|COMPLETED|Overall Study||3
7926631|NCT00574587|19506780|P4|STARTED|Overall Study||13
7926632|NCT00574587|19506781|P3|STARTED|Overall Study||16
7926633|NCT00574587|19506782|P2|STARTED|Overall Study||23
7926634|NCT00574587|19506783|P1|STARTED|Overall Study||3
7926635|NCT00574548|19506796|P2|NOT COMPLETED|Overall Study||16
7926636|NCT00574548|19506797|P1|NOT COMPLETED|Overall Study||61
7926637|NCT00574548|19506796|P2|COMPLETED|Overall Study||222
7926638|NCT00574548|19506797|P1|COMPLETED|Overall Study||421
7926639|NCT00574548|19506796|P2|Completed Vax 2 (6 Month Contact)|Overall Study||222
7926640|NCT00574548|19506797|P1|Completed Vax 2 (6 Month Contact)|Overall Study||421
7926641|NCT00574548|19506796|P2|Received Vax 2|Overall Study||223
7926642|NCT00574548|19506797|P1|Received Vax 2|Overall Study||427
7926643|NCT00574548|19506796|P2|Withdrawn Before Vax 2|Overall Study||11
7926644|NCT00574548|19506797|P1|Withdrawn Before Vax 2|Overall Study||41
7926645|NCT00574548|19506796|P2|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3
7926646|NCT00574548|19506797|P1|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7
7926647|NCT00574548|19506796|P2|Completed Vax 1 (6 Month Contact)|Overall Study||234
7926648|NCT00574548|19506797|P1|Completed Vax 1 (6 Month Contact)|Overall Study||468
7926649|NCT00574548|19506796|P2|Received Vaccination 1 (Vax 1)|Overall Study||237
7926650|NCT00574548|19506797|P1|Received Vaccination 1 (Vax 1)|Overall Study||478
7926651|NCT00574548|19506796|P2|STARTED|Overall Study||238
7926652|NCT00574548|19506797|P1|STARTED|Overall Study||482
7926653|NCT00574405|19506843|P2|NOT COMPLETED|Overall Study||2
7926654|NCT00574405|19506844|P1|NOT COMPLETED|Overall Study||3
7926655|NCT00574405|19506843|P2|COMPLETED|Overall Study||10
7926656|NCT00574405|19506844|P1|COMPLETED|Overall Study||9
7926657|NCT00574405|19506843|P2|STARTED|Overall Study||12
7926658|NCT00574405|19506844|P1|STARTED|Overall Study||12
7926659|NCT00574340|19506850|P2|NOT COMPLETED|Study 2 (2 Days)||0
7926660|NCT00574340|19506851|P1|NOT COMPLETED|Study 2 (2 Days)||0
7926661|NCT00574340|19506850|P2|COMPLETED|Study 2 (2 Days)||6
7926662|NCT00574340|19506851|P1|COMPLETED|Study 2 (2 Days)||6
7926663|NCT00574340|19506850|P2|STARTED|Study 2 (2 Days)||6
7926664|NCT00574340|19506851|P1|STARTED|Study 2 (2 Days)||6
7926665|NCT00574340|19506850|P2|NOT COMPLETED|Study 1 (2 Days)||0
7926666|NCT00574340|19506851|P1|NOT COMPLETED|Study 1 (2 Days)||0
7926667|NCT00574340|19506850|P2|COMPLETED|Study 1 (2 Days)||10
7926668|NCT00574340|19506851|P1|COMPLETED|Study 1 (2 Days)||10
7926669|NCT00574340|19506850|P2|STARTED|Study 1 (2 Days)||10
7926670|NCT00574340|19506851|P1|STARTED|Study 1 (2 Days)||10
7926671|NCT00574288|19506864|P7|NOT COMPLETED|Overall Study||28
7926672|NCT00574288|19506865|P6|NOT COMPLETED|Overall Study||26
7926673|NCT00574288|19506866|P5|NOT COMPLETED|Overall Study||2
7926674|NCT00574288|19506867|P4|NOT COMPLETED|Overall Study||2
7926675|NCT00574288|19506868|P3|NOT COMPLETED|Overall Study||3
7926676|NCT00574288|19506869|P2|NOT COMPLETED|Overall Study||3
7926677|NCT00574288|19506870|P1|NOT COMPLETED|Overall Study||20
7926678|NCT00574288|19506864|P7|COMPLETED|Overall Study||14
7926679|NCT00574288|19506865|P6|COMPLETED|Overall Study||4
7926680|NCT00574288|19506866|P5|COMPLETED|Overall Study||1
7926681|NCT00574288|19506867|P4|COMPLETED|Overall Study||1
7926682|NCT00574288|19506868|P3|COMPLETED|Overall Study||0
7926683|NCT00574288|19506869|P2|COMPLETED|Overall Study||0
7926684|NCT00574288|19506870|P1|COMPLETED|Overall Study||0
7926685|NCT00574288|19506864|P7|STARTED|Overall Study||42
7926686|NCT00574288|19506865|P6|STARTED|Overall Study||30
7926687|NCT00574288|19506866|P5|STARTED|Overall Study||3
7926688|NCT00574288|19506867|P4|STARTED|Overall Study||3
7926689|NCT00574288|19506868|P3|STARTED|Overall Study||3
7926690|NCT00574288|19506869|P2|STARTED|Overall Study||3
7926691|NCT00574288|19506870|P1|STARTED|Overall Study||20
7926692|NCT00574275|19506908|P2|NOT COMPLETED|Overall Study||271
7926693|NCT00574275|19506909|P1|NOT COMPLETED|Overall Study||275
7926694|NCT00574275|19506908|P2|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
7926695|NCT00574275|19506909|P1|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
7926696|NCT00574275|19506908|P2|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270
7926697|NCT00574275|19506909|P1|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271
7926698|NCT00574275|19506908|P2|TREATED|Overall Study||268
7926699|NCT00574275|19506909|P1|TREATED|Overall Study||273
7926700|NCT00574275|19506908|P2|STARTED|Overall Study||271
7926701|NCT00574275|19506909|P1|STARTED|Overall Study||275
7926702|NCT00574249|19506927|P2|NOT COMPLETED|Overall Study||28
7926703|NCT00574249|19506928|P1|NOT COMPLETED|Overall Study||26
7926704|NCT00574249|19506927|P2|COMPLETED|Overall Study||338
7926705|NCT00574249|19506928|P1|COMPLETED|Overall Study||338
7926706|NCT00574249|19506927|P2|STARTED|Overall Study||366
7926707|NCT00574249|19506928|P1|STARTED|Overall Study||364
7926708|NCT00574236|19506968|P1|NOT COMPLETED|Overall Study||0
7926709|NCT00574236|19506968|P1|COMPLETED|Overall Study||4
7926710|NCT00574236|19506968|P1|STARTED|Overall Study||4
7926711|NCT00574197|19506973|P1|NOT COMPLETED|Overall Study||5
7926712|NCT00574197|19506973|P1|COMPLETED|Overall Study||6
7926713|NCT00574197|19506973|P1|STARTED|Overall Study||11
7926714|NCT00574171|19506978|P1|NOT COMPLETED|Overall Study||0
7926715|NCT00574171|19506978|P1|COMPLETED|Overall Study||29
7926716|NCT00574171|19506978|P1|STARTED|Overall Study||29
7926717|NCT00574145|19506984|P2|NOT COMPLETED|Overall Study||1
7926718|NCT00574145|19506985|P1|NOT COMPLETED|Overall Study||2
7926719|NCT00574145|19506984|P2|COMPLETED|Overall Study||21
7926720|NCT00574145|19506985|P1|COMPLETED|Overall Study||20
7926721|NCT00574145|19506984|P2|STARTED|Overall Study||22
7926722|NCT00574145|19506985|P1|STARTED|Overall Study||22
7926723|NCT00574119|19506995|P1|NOT COMPLETED|Overall Study||4
7926724|NCT00574119|19506995|P1|COMPLETED|Overall Study||12
7926725|NCT00574119|19506995|P1|STARTED|Overall Study||16
7926726|NCT00574080|19507009|P2|NOT COMPLETED|Overall Study||10
7926727|NCT00574080|19507010|P1|NOT COMPLETED|Overall Study||10
7926728|NCT00574080|19507009|P2|COMPLETED|Overall Study||0
7926729|NCT00574080|19507010|P1|COMPLETED|Overall Study||0
7926730|NCT00574080|19507009|P2|STARTED|Overall Study||10
7926731|NCT00574080|19507010|P1|STARTED|Overall Study||10
7926732|NCT00574067|19507020|P4|NOT COMPLETED|Overall Study||0
7926733|NCT00574067|19507021|P3|NOT COMPLETED|Overall Study||0
7926734|NCT00574067|19507022|P2|NOT COMPLETED|Overall Study||1
7926735|NCT00574067|19507023|P1|NOT COMPLETED|Overall Study||1
7926736|NCT00574067|19507020|P4|COMPLETED|Overall Study||53
7926737|NCT00574067|19507021|P3|COMPLETED|Overall Study||54
7926738|NCT00574067|19507022|P2|COMPLETED|Overall Study||52
7926739|NCT00574067|19507023|P1|COMPLETED|Overall Study||52
7926740|NCT00574067|19507020|P4|STARTED|Overall Study||53
7926741|NCT00574067|19507021|P3|STARTED|Overall Study||54
7926742|NCT00574067|19507022|P2|STARTED|Overall Study||53
7926743|NCT00574067|19507023|P1|STARTED|Overall Study||53
7926744|NCT00573989|19507057|P4|NOT COMPLETED|Erlotinib 125mg- Phase II||0
7926745|NCT00573989|19507058|P3|NOT COMPLETED|Erlotinib 125mg- Phase II||0
7926746|NCT00573989|19507059|P2|NOT COMPLETED|Erlotinib 125mg- Phase II||0
7926747|NCT00573989|19507060|P1|NOT COMPLETED|Erlotinib 125mg- Phase II||0
7926748|NCT00573989|19507057|P4|COMPLETED|Erlotinib 125mg- Phase II||12
7926749|NCT00573989|19507058|P3|COMPLETED|Erlotinib 125mg- Phase II||0
7926750|NCT00573989|19507059|P2|COMPLETED|Erlotinib 125mg- Phase II||0
7926751|NCT00573989|19507060|P1|COMPLETED|Erlotinib 125mg- Phase II||0
7926752|NCT00573989|19507057|P4|STARTED|Erlotinib 125mg- Phase II||12
7926753|NCT00573989|19507058|P3|STARTED|Erlotinib 125mg- Phase II||0
7926754|NCT00573989|19507059|P2|STARTED|Erlotinib 125mg- Phase II||0
7926755|NCT00573989|19507060|P1|STARTED|Erlotinib 125mg- Phase II||0
7926756|NCT00573989|19507057|P4|NOT COMPLETED|Erlotinib Phase I||0
7926757|NCT00573989|19507058|P3|NOT COMPLETED|Erlotinib Phase I||0
7926758|NCT00573989|19507059|P2|NOT COMPLETED|Erlotinib Phase I||0
7926759|NCT00573989|19507060|P1|NOT COMPLETED|Erlotinib Phase I||0
7926760|NCT00573989|19507057|P4|COMPLETED|Erlotinib Phase I||0
7926761|NCT00573989|19507058|P3|COMPLETED|Erlotinib Phase I||5
7926762|NCT00573989|19507059|P2|COMPLETED|Erlotinib Phase I||6
7926763|NCT00573989|19507060|P1|COMPLETED|Erlotinib Phase I||4
7926764|NCT00573989|19507057|P4|STARTED|Erlotinib Phase I||0
7926765|NCT00573989|19507058|P3|STARTED|Erlotinib Phase I||5
7926766|NCT00573989|19507059|P2|STARTED|Erlotinib Phase I||6
7926767|NCT00573989|19507060|P1|STARTED|Erlotinib Phase I||4
7926768|NCT00573937|19507079|P2|NOT COMPLETED|Overall Study||1
7926769|NCT00573937|19507080|P1|NOT COMPLETED|Overall Study||0
7926770|NCT00573937|19507079|P2|COMPLETED|Overall Study||0
7926771|NCT00573937|19507080|P1|COMPLETED|Overall Study||0
7926772|NCT00573937|19507079|P2|STARTED|Overall Study||1
7926773|NCT00573937|19507080|P1|STARTED|Overall Study||0
7926774|NCT00573872|19507088|P1|NOT COMPLETED|Overall Study||11
7926775|NCT00573872|19507088|P1|COMPLETED|Overall Study|# of patients that completed treatment|32
7926776|NCT00573872|19507088|P1|STARTED|Overall Study|# of patients that signed consent|43
7926777|NCT00573859|19507094|P1|NOT COMPLETED|Smoking Versus Abstinence||12
7926778|NCT00573859|19507094|P1|COMPLETED|Smoking Versus Abstinence||15
7926779|NCT00573859|19507094|P1|STARTED|Smoking Versus Abstinence||27
7926780|NCT00573859|19507094|P1|NOT COMPLETED|Medication Versus Placebo||12
7926781|NCT00573859|19507094|P1|COMPLETED|Medication Versus Placebo||15
7926782|NCT00573859|19507094|P1|STARTED|Medication Versus Placebo||27
7926783|NCT00573833|19507100|P1|NOT COMPLETED|Overall Study||2
7926784|NCT00573833|19507100|P1|COMPLETED|Overall Study||21
7926785|NCT00573833|19507100|P1|STARTED|Overall Study||23
7926786|NCT00573794|19507107|P1|NOT COMPLETED|Overall Study||330
7926787|NCT00573794|19507107|P1|COMPLETED|Overall Study||255
7926788|NCT00573794|19507107|P1|STARTED|Overall Study||585
7926789|NCT00573768|19507138|P3|NOT COMPLETED|Overall Study||4
7926790|NCT00573768|19507139|P2|NOT COMPLETED|Overall Study||2
7926791|NCT00573768|19507140|P1|NOT COMPLETED|Overall Study||2
7926792|NCT00573768|19507138|P3|COMPLETED|Overall Study||87
7926793|NCT00573768|19507139|P2|COMPLETED|Overall Study||89
7926794|NCT00573768|19507140|P1|COMPLETED|Overall Study||87
7926795|NCT00573768|19507138|P3|STARTED|Overall Study||91
7926796|NCT00573768|19507139|P2|STARTED|Overall Study||91
7926797|NCT00573768|19507140|P1|STARTED|Overall Study||89
7926798|NCT00573755|19507150|P2|NOT COMPLETED|Overall Study||0
7926799|NCT00573755|19507151|P1|NOT COMPLETED|Overall Study||1
7926800|NCT00573755|19507150|P2|COMPLETED|Overall Study||2
7926801|NCT00573755|19507151|P1|COMPLETED|Overall Study||1
7926802|NCT00573755|19507150|P2|STARTED|Overall Study||2
7926803|NCT00573755|19507151|P1|STARTED|Overall Study||2
7926804|NCT00573534|19507167|P1|NOT COMPLETED|Overall Study||3
7926805|NCT00573534|19507167|P1|COMPLETED|Overall Study||5
7926806|NCT00573534|19507167|P1|STARTED|Overall Study||8
7926807|NCT00573508|19507174|P2|NOT COMPLETED|Overall Study||41
7926808|NCT00573508|19507175|P1|NOT COMPLETED|Overall Study||64
7926809|NCT00573508|19507174|P2|COMPLETED|Overall Study||345
7926810|NCT00573508|19507175|P1|COMPLETED|Overall Study||318
7926811|NCT00573508|19507174|P2|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377
7926812|NCT00573508|19507175|P1|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374
7926813|NCT00573508|19507174|P2|STARTED|Overall Study||386
7926814|NCT00573508|19507175|P1|STARTED|Overall Study||382
7926815|NCT00573469|19507208|P3|NOT COMPLETED|Overall Study||4
7926816|NCT00573469|19507209|P2|NOT COMPLETED|Overall Study||4
7926817|NCT00573469|19507210|P1|NOT COMPLETED|Overall Study||6
7926818|NCT00573469|19507208|P3|COMPLETED|Overall Study||22
7926819|NCT00573469|19507209|P2|COMPLETED|Overall Study||21
7926820|NCT00573469|19507210|P1|COMPLETED|Overall Study||20
7926821|NCT00573469|19507208|P3|STARTED|Overall Study||26
7926822|NCT00573469|19507209|P2|STARTED|Overall Study||25
7926823|NCT00573469|19507210|P1|STARTED|Overall Study||26
7926824|NCT00573443|19507233|P3|NOT COMPLETED|Open-Label Extension Phase||0
7926825|NCT00573443|19507234|P2|NOT COMPLETED|Open-Label Extension Phase||0
7926826|NCT00573443|19507235|P1|NOT COMPLETED|Open-Label Extension Phase||18
7926827|NCT00573443|19507233|P3|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
7926828|NCT00573443|19507234|P2|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
7926829|NCT00573443|19507235|P1|COMPLETED|Open-Label Extension Phase||235
7926830|NCT00573443|19507233|P3|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
7926831|NCT00573443|19507234|P2|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
7926832|NCT00573443|19507235|P1|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107
7926833|NCT00573443|19507233|P3|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
7926834|NCT00573443|19507234|P2|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
7926835|NCT00573443|19507235|P1|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146
7926836|NCT00573443|19507233|P3|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
7926837|NCT00573443|19507234|P2|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
7926838|NCT00573443|19507235|P1|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253
7926839|NCT00573443|19507233|P3|NOT COMPLETED|Double-Blind Phase||15
7926840|NCT00573443|19507234|P2|NOT COMPLETED|Double-Blind Phase||19
7926841|NCT00573443|19507235|P1|NOT COMPLETED|Double-Blind Phase||9
7926842|NCT00573443|19507233|P3|COMPLETED|Double-Blind Phase||94
7926843|NCT00573443|19507234|P2|COMPLETED|Double-Blind Phase||88
7926844|NCT00573443|19507235|P1|COMPLETED|Double-Blind Phase||101
7926845|NCT00573443|19507233|P3|Subjects With PBA Secondary to MS|Double-Blind Phase||45
7926846|NCT00573443|19507234|P2|Subjects With PBA Secondary to MS|Double-Blind Phase||39
7926847|NCT00573443|19507235|P1|Subjects With PBA Secondary to MS|Double-Blind Phase||45
7926848|NCT00573443|19507233|P3|Subjects With PBA Secondary to ALS|Double-Blind Phase||64
7926849|NCT00573443|19507234|P2|Subjects With PBA Secondary to ALS|Double-Blind Phase||68
7926850|NCT00573443|19507235|P1|Subjects With PBA Secondary to ALS|Double-Blind Phase||65
7926851|NCT00573443|19507233|P3|STARTED|Double-Blind Phase||109
7926852|NCT00573443|19507234|P2|STARTED|Double-Blind Phase||107
7926853|NCT00573443|19507235|P1|STARTED|Double-Blind Phase||110
7926854|NCT00573430|19507265|P3|NOT COMPLETED|Overall Study||10
7926855|NCT00573430|19507266|P2|NOT COMPLETED|Overall Study||5
7926856|NCT00573430|19507267|P1|NOT COMPLETED|Overall Study||1
7926857|NCT00573430|19507265|P3|COMPLETED|Overall Study||33
7926858|NCT00573430|19507266|P2|COMPLETED|Overall Study||40
7926859|NCT00573430|19507267|P1|COMPLETED|Overall Study||39
7926860|NCT00573430|19507265|P3|STARTED|Overall Study|randomized|43
7926861|NCT00573430|19507266|P2|STARTED|Overall Study|randomized|45
7926862|NCT00573430|19507267|P1|STARTED|Overall Study|randomized|40
7926863|NCT00573391|19507289|P2|NOT COMPLETED|Overall Study||2
7926864|NCT00573391|19507290|P1|NOT COMPLETED|Overall Study||3
7926865|NCT00573391|19507289|P2|COMPLETED|Overall Study||0
7926866|NCT00573391|19507290|P1|COMPLETED|Overall Study||0
7926867|NCT00573391|19507289|P2|STARTED|Overall Study||2
7926868|NCT00573391|19507290|P1|STARTED|Overall Study||3
7926869|NCT00573313|19507300|P4|NOT COMPLETED|Overall Study||0
7926870|NCT00573313|19507301|P3|NOT COMPLETED|Overall Study||6
7926871|NCT00573313|19507302|P2|NOT COMPLETED|Overall Study||0
7926872|NCT00573313|19507303|P1|NOT COMPLETED|Overall Study||5
7926873|NCT00573313|19507300|P4|COMPLETED|Overall Study||26
7926874|NCT00573313|19507301|P3|COMPLETED|Overall Study||13
7926875|NCT00573313|19507302|P2|COMPLETED|Overall Study||28
7926876|NCT00573313|19507303|P1|COMPLETED|Overall Study||13
7926877|NCT00573313|19507300|P4|STARTED|Overall Study||26
7926878|NCT00573313|19507301|P3|STARTED|Overall Study|Nineteen recruited to start.|19
7926879|NCT00573313|19507302|P2|STARTED|Overall Study||28
7926880|NCT00573313|19507303|P1|STARTED|Overall Study|Eighteen participants recruited to start.|18
7926881|NCT00573287|19507313|P2|NOT COMPLETED|Overall Study||3
7926882|NCT00573287|19507314|P1|NOT COMPLETED|Overall Study||4
7926883|NCT00573287|19507313|P2|COMPLETED|Overall Study||4
7926884|NCT00573287|19507314|P1|COMPLETED|Overall Study||3
7926885|NCT00573287|19507313|P2|STARTED|Overall Study||7
7926886|NCT00573287|19507314|P1|STARTED|Overall Study||7
7926887|NCT00573261|19507324|P2|NOT COMPLETED|Overall Study||5
7926888|NCT00573261|19507325|P1|NOT COMPLETED|Overall Study||6
7926889|NCT00573261|19507324|P2|COMPLETED|Overall Study||15
7926890|NCT00573261|19507325|P1|COMPLETED|Overall Study||14
7926891|NCT00573261|19507324|P2|STARTED|Overall Study||20
7926892|NCT00573261|19507325|P1|STARTED|Overall Study||20
7926893|NCT00573248|19507353|P2|NOT COMPLETED|Overall Study||11
7926894|NCT00573248|19507354|P1|NOT COMPLETED|Overall Study||15
7926895|NCT00573248|19507353|P2|COMPLETED|Overall Study||27
7926896|NCT00573248|19507354|P1|COMPLETED|Overall Study||25
7926897|NCT00573248|19507353|P2|Nicotine Patches and Placebo Patches|Overall Study||27
7926898|NCT00573248|19507354|P1|Nicotine Patches and Placebo Patches|Overall Study||25
7926899|NCT00573248|19507353|P2|STARTED|Overall Study||38
7926900|NCT00573248|19507354|P1|STARTED|Overall Study||40
7926901|NCT00573183|19507368|P2|NOT COMPLETED|Overall Study||63
7926902|NCT00573183|19507369|P1|NOT COMPLETED|Overall Study||72
7926903|NCT00573183|19507368|P2|COMPLETED|Overall Study||174
7926904|NCT00573183|19507369|P1|COMPLETED|Overall Study||162
7926905|NCT00573183|19507368|P2|STARTED|Overall Study||237
7926906|NCT00573183|19507369|P1|STARTED|Overall Study||234
7926907|NCT00573170|19507377|P6|NOT COMPLETED|Third Treatment Period||2
7926908|NCT00573170|19507378|P5|NOT COMPLETED|Third Treatment Period||0
7926909|NCT00573170|19507379|P4|NOT COMPLETED|Third Treatment Period||0
7926910|NCT00573170|19507380|P3|NOT COMPLETED|Third Treatment Period||0
7926911|NCT00573170|19507381|P2|NOT COMPLETED|Third Treatment Period||0
7926912|NCT00573170|19507382|P1|NOT COMPLETED|Third Treatment Period||1
7926913|NCT00573170|19507377|P6|COMPLETED|Third Treatment Period||51
7926914|NCT00573170|19507378|P5|COMPLETED|Third Treatment Period||51
7926915|NCT00573170|19507379|P4|COMPLETED|Third Treatment Period||56
7926916|NCT00573170|19507380|P3|COMPLETED|Third Treatment Period||55
7926917|NCT00573170|19507381|P2|COMPLETED|Third Treatment Period||54
7926918|NCT00573170|19507382|P1|COMPLETED|Third Treatment Period||50
7926919|NCT00573170|19507377|P6|STARTED|Third Treatment Period||53
7926920|NCT00573170|19507378|P5|STARTED|Third Treatment Period||51
7926921|NCT00573170|19507379|P4|STARTED|Third Treatment Period||56
7926922|NCT00573170|19507380|P3|STARTED|Third Treatment Period||55
7926923|NCT00573170|19507381|P2|STARTED|Third Treatment Period||54
7926924|NCT00573170|19507382|P1|STARTED|Third Treatment Period||51
7926925|NCT00573170|19507377|P6|NOT COMPLETED|Second Washout Period||2
7926926|NCT00573170|19507378|P5|NOT COMPLETED|Second Washout Period||8
7926927|NCT00573170|19507379|P4|NOT COMPLETED|Second Washout Period||5
7926928|NCT00573170|19507380|P3|NOT COMPLETED|Second Washout Period||4
7926929|NCT00573170|19507381|P2|NOT COMPLETED|Second Washout Period||4
7926930|NCT00573170|19507382|P1|NOT COMPLETED|Second Washout Period||5
7926931|NCT00573170|19507377|P6|COMPLETED|Second Washout Period||53
7926932|NCT00573170|19507378|P5|COMPLETED|Second Washout Period||51
7926933|NCT00573170|19507379|P4|COMPLETED|Second Washout Period||56
7926934|NCT00573170|19507380|P3|COMPLETED|Second Washout Period||55
7926935|NCT00573170|19507381|P2|COMPLETED|Second Washout Period||54
7926936|NCT00573170|19507382|P1|COMPLETED|Second Washout Period||51
7926937|NCT00573170|19507377|P6|STARTED|Second Washout Period||55
7926938|NCT00573170|19507378|P5|STARTED|Second Washout Period||59
7926939|NCT00573170|19507379|P4|STARTED|Second Washout Period||61
7926940|NCT00573170|19507380|P3|STARTED|Second Washout Period||59
7926941|NCT00573170|19507381|P2|STARTED|Second Washout Period||58
7926942|NCT00573170|19507382|P1|STARTED|Second Washout Period||56
7926943|NCT00573170|19507377|P6|NOT COMPLETED|Second Treatment Period||0
7926944|NCT00573170|19507378|P5|NOT COMPLETED|Second Treatment Period||0
7926945|NCT00573170|19507379|P4|NOT COMPLETED|Second Treatment Period||0
7926946|NCT00573170|19507380|P3|NOT COMPLETED|Second Treatment Period||0
7926947|NCT00573170|19507381|P2|NOT COMPLETED|Second Treatment Period||0
7926948|NCT00573170|19507382|P1|NOT COMPLETED|Second Treatment Period||0
7926949|NCT00573170|19507377|P6|COMPLETED|Second Treatment Period||55
7926950|NCT00573170|19507378|P5|COMPLETED|Second Treatment Period||59
7926951|NCT00573170|19507379|P4|COMPLETED|Second Treatment Period||61
7926952|NCT00573170|19507380|P3|COMPLETED|Second Treatment Period||59
7926953|NCT00573170|19507381|P2|COMPLETED|Second Treatment Period||58
7926954|NCT00573170|19507382|P1|COMPLETED|Second Treatment Period||56
7926955|NCT00573170|19507377|P6|STARTED|Second Treatment Period||55
7926956|NCT00573170|19507378|P5|STARTED|Second Treatment Period||59
7926957|NCT00573170|19507379|P4|STARTED|Second Treatment Period||61
7926958|NCT00573170|19507380|P3|STARTED|Second Treatment Period||59
7926959|NCT00573170|19507381|P2|STARTED|Second Treatment Period||58
7926960|NCT00573170|19507382|P1|STARTED|Second Treatment Period||56
7926961|NCT00573170|19507377|P6|NOT COMPLETED|First Washout Period||7
7926962|NCT00573170|19507378|P5|NOT COMPLETED|First Washout Period||3
7926963|NCT00573170|19507379|P4|NOT COMPLETED|First Washout Period||5
7926964|NCT00573170|19507380|P3|NOT COMPLETED|First Washout Period||1
7926965|NCT00573170|19507381|P2|NOT COMPLETED|First Washout Period||2
7926966|NCT00573170|19507382|P1|NOT COMPLETED|First Washout Period||8
7926967|NCT00573170|19507377|P6|COMPLETED|First Washout Period||55
7926968|NCT00573170|19507378|P5|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59
7926969|NCT00573170|19507379|P4|COMPLETED|First Washout Period||61
7926970|NCT00573170|19507380|P3|COMPLETED|First Washout Period||59
7926971|NCT00573170|19507381|P2|COMPLETED|First Washout Period||58
7926972|NCT00573170|19507382|P1|COMPLETED|First Washout Period||56
7926973|NCT00573170|19507377|P6|STARTED|First Washout Period||62
7926974|NCT00573170|19507378|P5|STARTED|First Washout Period||62
7926975|NCT00573170|19507379|P4|STARTED|First Washout Period||66
7926976|NCT00573170|19507380|P3|STARTED|First Washout Period||60
7926977|NCT00573170|19507381|P2|STARTED|First Washout Period||60
7926978|NCT00573170|19507382|P1|STARTED|First Washout Period||64
7926979|NCT00573170|19507377|P6|NOT COMPLETED|First Treatment Period||0
7926980|NCT00573170|19507378|P5|NOT COMPLETED|First Treatment Period||1
7926981|NCT00573170|19507379|P4|NOT COMPLETED|First Treatment Period||0
7926982|NCT00573170|19507380|P3|NOT COMPLETED|First Treatment Period||0
7926983|NCT00573170|19507381|P2|NOT COMPLETED|First Treatment Period||0
7926984|NCT00573170|19507382|P1|NOT COMPLETED|First Treatment Period||0
7926985|NCT00573170|19507377|P6|COMPLETED|First Treatment Period||62
7926986|NCT00573170|19507378|P5|COMPLETED|First Treatment Period||62
7926987|NCT00573170|19507379|P4|COMPLETED|First Treatment Period||66
7926988|NCT00573170|19507380|P3|COMPLETED|First Treatment Period||60
7926989|NCT00573170|19507381|P2|COMPLETED|First Treatment Period||60
7926990|NCT00573170|19507382|P1|COMPLETED|First Treatment Period||64
7926991|NCT00573170|19507377|P6|STARTED|First Treatment Period||62
7926992|NCT00573170|19507378|P5|STARTED|First Treatment Period||63
7926993|NCT00573170|19507379|P4|STARTED|First Treatment Period||66
7926994|NCT00573170|19507380|P3|STARTED|First Treatment Period||60
7926995|NCT00573170|19507381|P2|STARTED|First Treatment Period||60
7926996|NCT00573170|19507382|P1|STARTED|First Treatment Period||64
7926997|NCT00573157|19507458|P2|NOT COMPLETED|Overall Study||2
7926998|NCT00573157|19507459|P1|NOT COMPLETED|Overall Study||4
7926999|NCT00573157|19507458|P2|COMPLETED|Overall Study||0
7927000|NCT00573157|19507459|P1|COMPLETED|Overall Study||0
7927001|NCT00573157|19507458|P2|STARTED|Overall Study||2
7927002|NCT00573157|19507459|P1|STARTED|Overall Study||4
7927003|NCT00573144|19507471|P2|NOT COMPLETED|Overall Study||3
7927004|NCT00573144|19507472|P1|NOT COMPLETED|Overall Study||2
7927005|NCT00573144|19507471|P2|COMPLETED|Overall Study||25
7927006|NCT00573144|19507472|P1|COMPLETED|Overall Study||28
7927007|NCT00573144|19507471|P2|STARTED|Overall Study||28
7927008|NCT00573144|19507472|P1|STARTED|Overall Study||30
7927009|NCT00573131|19507484|P2|NOT COMPLETED|Overall Study||8
7927010|NCT00573131|19507485|P1|NOT COMPLETED|Overall Study||10
7927011|NCT00573131|19507484|P2|COMPLETED|Overall Study||57
7927012|NCT00573131|19507485|P1|COMPLETED|Overall Study||62
7927013|NCT00573131|19507484|P2|STARTED|Overall Study||65
7927014|NCT00573131|19507485|P1|STARTED|Overall Study||72
7927015|NCT00573066|19507491|P1|NOT COMPLETED|Overall Study||20
7927016|NCT00573066|19507491|P1|COMPLETED|Overall Study||36
7927017|NCT00573066|19507491|P1|STARTED|Overall Study||56
7927018|NCT00572936|19507495|P6|NOT COMPLETED|Third Intervention||0
7927019|NCT00572936|19507496|P5|NOT COMPLETED|Third Intervention||0
7927020|NCT00572936|19507497|P4|NOT COMPLETED|Third Intervention||0
7927021|NCT00572936|19507498|P3|NOT COMPLETED|Third Intervention||0
7927022|NCT00572936|19507499|P2|NOT COMPLETED|Third Intervention||0
7927023|NCT00572936|19507500|P1|NOT COMPLETED|Third Intervention||0
7927024|NCT00572936|19507495|P6|COMPLETED|Third Intervention||5
7927025|NCT00572936|19507496|P5|COMPLETED|Third Intervention||3
7927026|NCT00572936|19507497|P4|COMPLETED|Third Intervention||5
7927027|NCT00572936|19507498|P3|COMPLETED|Third Intervention||4
7927028|NCT00572936|19507499|P2|COMPLETED|Third Intervention||3
7927029|NCT00572936|19507500|P1|COMPLETED|Third Intervention||4
7927030|NCT00572936|19507495|P6|STARTED|Third Intervention||5
7927031|NCT00572936|19507496|P5|STARTED|Third Intervention|1 participant dropped out between second intervention and third intervention due to increased IOP|3
7927032|NCT00572936|19507497|P4|STARTED|Third Intervention||5
7927033|NCT00572936|19507498|P3|STARTED|Third Intervention||4
7927034|NCT00572936|19507499|P2|STARTED|Third Intervention||3
7927035|NCT00572936|19507500|P1|STARTED|Third Intervention||4
7927036|NCT00572936|19507495|P6|NOT COMPLETED|Second Intervention||0
7927037|NCT00572936|19507496|P5|NOT COMPLETED|Second Intervention||0
7927038|NCT00572936|19507497|P4|NOT COMPLETED|Second Intervention||0
7927039|NCT00572936|19507498|P3|NOT COMPLETED|Second Intervention||0
7927040|NCT00572936|19507499|P2|NOT COMPLETED|Second Intervention||0
7927041|NCT00572936|19507500|P1|NOT COMPLETED|Second Intervention||0
7927042|NCT00572936|19507495|P6|COMPLETED|Second Intervention||5
7927043|NCT00572936|19507496|P5|COMPLETED|Second Intervention||4
7927044|NCT00572936|19507497|P4|COMPLETED|Second Intervention||5
7927045|NCT00572936|19507498|P3|COMPLETED|Second Intervention||4
7927046|NCT00572936|19507499|P2|COMPLETED|Second Intervention||3
7927047|NCT00572936|19507500|P1|COMPLETED|Second Intervention||4
7927048|NCT00572936|19507495|P6|STARTED|Second Intervention||5
7927049|NCT00572936|19507496|P5|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
7927050|NCT00572936|19507497|P4|STARTED|Second Intervention||5
7927051|NCT00572936|19507498|P3|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
7927052|NCT00572936|19507499|P2|STARTED|Second Intervention|1 participant dropped out between the first and second intervention due to car accident|3
7927053|NCT00572936|19507500|P1|STARTED|Second Intervention||4
7927054|NCT00572936|19507495|P6|NOT COMPLETED|First Intervention||0
7927055|NCT00572936|19507496|P5|NOT COMPLETED|First Intervention||0
7927056|NCT00572936|19507497|P4|NOT COMPLETED|First Intervention||0
7927057|NCT00572936|19507498|P3|NOT COMPLETED|First Intervention||0
7927058|NCT00572936|19507499|P2|NOT COMPLETED|First Intervention||0
7927059|NCT00572936|19507500|P1|NOT COMPLETED|First Intervention||0
7927060|NCT00572936|19507495|P6|COMPLETED|First Intervention||5
7927061|NCT00572936|19507496|P5|COMPLETED|First Intervention||5
7927062|NCT00572936|19507497|P4|COMPLETED|First Intervention||5
7927063|NCT00572936|19507498|P3|COMPLETED|First Intervention||5
7927064|NCT00572936|19507499|P2|COMPLETED|First Intervention||4
7927065|NCT00572936|19507500|P1|COMPLETED|First Intervention||4
7927066|NCT00572936|19507495|P6|STARTED|First Intervention||5
7927067|NCT00572936|19507496|P5|STARTED|First Intervention||5
7927068|NCT00572936|19507497|P4|STARTED|First Intervention||5
7927069|NCT00572936|19507498|P3|STARTED|First Intervention||5
7927070|NCT00572936|19507499|P2|STARTED|First Intervention||4
7927071|NCT00572936|19507500|P1|STARTED|First Intervention||4
7927072|NCT00572910|19507535|P11|NOT COMPLETED|Overall Study||3
7927073|NCT00572910|19507536|P10|NOT COMPLETED|Overall Study||6
7927074|NCT00572910|19507537|P9|NOT COMPLETED|Overall Study||3
7927075|NCT00572910|19507538|P8|NOT COMPLETED|Overall Study||4
7927076|NCT00572910|19507539|P7|NOT COMPLETED|Overall Study||4
7927077|NCT00572910|19507540|P6|NOT COMPLETED|Overall Study||3
7927078|NCT00572910|19507541|P5|NOT COMPLETED|Overall Study||2
7927079|NCT00572910|19507542|P4|NOT COMPLETED|Overall Study||4
7927080|NCT00572910|19507543|P3|NOT COMPLETED|Overall Study||2
7927081|NCT00572910|19507544|P2|NOT COMPLETED|Overall Study||3
7927082|NCT00572910|19507545|P1|NOT COMPLETED|Overall Study||4
7927083|NCT00572910|19507535|P11|COMPLETED|Overall Study||15
7927084|NCT00572910|19507536|P10|COMPLETED|Overall Study||13
7927085|NCT00572910|19507537|P9|COMPLETED|Overall Study||16
7927086|NCT00572910|19507538|P8|COMPLETED|Overall Study||15
7927087|NCT00572910|19507539|P7|COMPLETED|Overall Study||15
7927088|NCT00572910|19507540|P6|COMPLETED|Overall Study||16
7927089|NCT00572910|19507541|P5|COMPLETED|Overall Study||17
7927090|NCT00572910|19507542|P4|COMPLETED|Overall Study||14
7927091|NCT00572910|19507543|P3|COMPLETED|Overall Study||17
7927092|NCT00572910|19507544|P2|COMPLETED|Overall Study||15
7927093|NCT00572910|19507545|P1|COMPLETED|Overall Study||15
7927094|NCT00572910|19507535|P11|STARTED|Overall Study||18
7927095|NCT00572910|19507536|P10|STARTED|Overall Study||19
7927096|NCT00572910|19507537|P9|STARTED|Overall Study||19
7927097|NCT00572910|19507538|P8|STARTED|Overall Study||19
7927098|NCT00572910|19507539|P7|STARTED|Overall Study||19
7927099|NCT00572910|19507540|P6|STARTED|Overall Study||19
7927100|NCT00572910|19507541|P5|STARTED|Overall Study||19
7927101|NCT00572910|19507542|P4|STARTED|Overall Study||18
7927102|NCT00572910|19507543|P3|STARTED|Overall Study||19
7927103|NCT00572910|19507544|P2|STARTED|Overall Study||18
7927104|NCT00572910|19507545|P1|STARTED|Overall Study||19
7927105|NCT00572897|19507593|P2|NOT COMPLETED|Overall Study||0
7927106|NCT00572897|19507594|P1|NOT COMPLETED|Overall Study||0
7927107|NCT00572897|19507593|P2|COMPLETED|Overall Study||34
7927108|NCT00572897|19507594|P1|COMPLETED|Overall Study||32
7927109|NCT00572897|19507593|P2|STARTED|Overall Study||34
7927110|NCT00572897|19507594|P1|STARTED|Overall Study||32
7927111|NCT00572832|19507612|P2|NOT COMPLETED|Overall Study||12
7927112|NCT00572832|19507613|P1|NOT COMPLETED|Overall Study||0
7927113|NCT00572832|19507612|P2|COMPLETED|Overall Study||88
7927114|NCT00572832|19507613|P1|COMPLETED|Overall Study||100
7927115|NCT00572832|19507612|P2|STARTED|Overall Study||100
7927116|NCT00572832|19507613|P1|STARTED|Overall Study||100
7927117|NCT00572728|19507619|P1|NOT COMPLETED|Overall Study||39
7927118|NCT00572728|19507619|P1|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51
7927119|NCT00572728|19507619|P1|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35
7927120|NCT00572728|19507619|P1|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38
7927121|NCT00572728|19507619|P1|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43
7927122|NCT00572728|19507619|P1|Pathology Complete|Overall Study||51
7927123|NCT00572728|19507619|P1|Second Chemotherapy Initiated After FLT2|Overall Study||52
7927124|NCT00572728|19507619|P1|Second Chemotherapy Initiated|Overall Study||59
7927125|NCT00572728|19507619|P1|Completed FLT2 Scan|Overall Study||60
7927126|NCT00572728|19507619|P1|First Therapy Initiated|Overall Study||65
7927127|NCT00572728|19507619|P1|Completed FLT1 Scan|Overall Study||67
7927128|NCT00572728|19507619|P1|On Study|Overall Study||71
7927129|NCT00572728|19507619|P1|Did Not Withdraw|Overall Study||72
7927130|NCT00572728|19507619|P1|Enrolled Under Amendment 5 or Later|Overall Study||82
7927131|NCT00572728|19507619|P1|Eligible|Overall Study||87
7927132|NCT00572728|19507619|P1|STARTED|Overall Study|Registered|90
7927133|NCT00572624|19507633|P2|NOT COMPLETED|Overall Study||4
7927134|NCT00572624|19507634|P1|NOT COMPLETED|Overall Study||17
7927135|NCT00572624|19507633|P2|COMPLETED|Overall Study||10
7927136|NCT00572624|19507634|P1|COMPLETED|Overall Study||20
7927137|NCT00572624|19507633|P2|STARTED|Overall Study||14
7927138|NCT00572624|19507634|P1|STARTED|Overall Study||37
7927139|NCT00572572|19507662|P2|NOT COMPLETED|Overall Study||6
7927140|NCT00572572|19507663|P1|NOT COMPLETED|Overall Study||3
7927141|NCT00572572|19507662|P2|COMPLETED|Overall Study||28
7927142|NCT00572572|19507663|P1|COMPLETED|Overall Study||32
7927143|NCT00572572|19507662|P2|STARTED|Overall Study||34
7927144|NCT00572572|19507663|P1|STARTED|Overall Study||35
7927145|NCT00572533|19507681|P2|NOT COMPLETED|Overall Study||3
7927146|NCT00572533|19507682|P1|NOT COMPLETED|Overall Study||7
7927147|NCT00572533|19507681|P2|COMPLETED|Overall Study||28
7927148|NCT00572533|19507682|P1|COMPLETED|Overall Study||24
7927149|NCT00572533|19507681|P2|STARTED|Overall Study||31
7927150|NCT00572533|19507682|P1|STARTED|Overall Study||31
7927151|NCT00572468|19507704|P2|NOT COMPLETED|Overall Study||4
7927152|NCT00572468|19507705|P1|NOT COMPLETED|Overall Study||2
7927153|NCT00572468|19507704|P2|COMPLETED|Overall Study||16
7927154|NCT00572468|19507705|P1|COMPLETED|Overall Study||20
7927155|NCT00572468|19507704|P2|STARTED|Overall Study||20
7927156|NCT00572468|19507705|P1|STARTED|Overall Study||22
7927157|NCT00572260|19507713|P1|NOT COMPLETED|Overall Study||0
7927158|NCT00572260|19507713|P1|COMPLETED|Overall Study||11
7927159|NCT00572260|19507713|P1|STARTED|Overall Study||11
7927160|NCT00572234|19507719|P2|NOT COMPLETED|Overall Study||5
7927161|NCT00572234|19507720|P1|NOT COMPLETED|Overall Study||1
7927162|NCT00572234|19507719|P2|COMPLETED|Overall Study||16
7927163|NCT00572234|19507720|P1|COMPLETED|Overall Study||18
7927164|NCT00572234|19507719|P2|STARTED|Overall Study||21
7927165|NCT00572234|19507720|P1|STARTED|Overall Study||19
7927166|NCT00572195|19507726|P1|NOT COMPLETED|Overall Study||68
7927167|NCT00572195|19507726|P1|COMPLETED|Overall Study||162
7927168|NCT00572195|19507726|P1|STARTED|Overall Study||230
7927169|NCT00572156|19507738|P4|NOT COMPLETED|Overall Study||25
7927170|NCT00572156|19507739|P3|NOT COMPLETED|Overall Study||27
7927171|NCT00572156|19507740|P2|NOT COMPLETED|Overall Study||26
7927172|NCT00572156|19507741|P1|NOT COMPLETED|Overall Study||26
7927173|NCT00572156|19507738|P4|COMPLETED|Overall Study||1
7927174|NCT00572156|19507739|P3|COMPLETED|Overall Study||0
7927175|NCT00572156|19507740|P2|COMPLETED|Overall Study||1
7927176|NCT00572156|19507741|P1|COMPLETED|Overall Study||0
7927177|NCT00572156|19507738|P4|STARTED|Overall Study||26
7927178|NCT00572156|19507739|P3|STARTED|Overall Study||27
7927179|NCT00572156|19507740|P2|STARTED|Overall Study||27
7927180|NCT00572156|19507741|P1|STARTED|Overall Study||26
7927181|NCT00572117|19507801|P2|NOT COMPLETED|Overall Study||2
7927182|NCT00572117|19507802|P1|NOT COMPLETED|Overall Study||2
7927183|NCT00572117|19507801|P2|COMPLETED|Overall Study||5
7927184|NCT00572117|19507802|P1|COMPLETED|Overall Study||3
7927185|NCT00572117|19507801|P2|STARTED|Overall Study||7
7927186|NCT00572117|19507802|P1|STARTED|Overall Study||5
7927187|NCT00572039|19507812|P2|NOT COMPLETED|Overall Study||10
7927188|NCT00572039|19507813|P1|NOT COMPLETED|Overall Study||16
7927189|NCT00572039|19507812|P2|COMPLETED|Overall Study||110
7927190|NCT00572039|19507813|P1|COMPLETED|Overall Study||105
7927191|NCT00572039|19507812|P2|STARTED|Overall Study||120
7927192|NCT00572039|19507813|P1|STARTED|Overall Study||121
7927193|NCT00571987|19507825|P1|NOT COMPLETED|Overall Study||7
7927194|NCT00571987|19507825|P1|COMPLETED|Overall Study||100
7927195|NCT00571987|19507825|P1|STARTED|Overall Study||107
7927196|NCT00571974|19507832|P2|NOT COMPLETED|Phase II||4
7927197|NCT00571974|19507833|P1|NOT COMPLETED|Phase II||0
7927198|NCT00571974|19507832|P2|COMPLETED|Phase II||17
7927199|NCT00571974|19507833|P1|COMPLETED|Phase II||0
7927200|NCT00571974|19507832|P2|STARTED|Phase II|3 participants are from phase I|21
7927201|NCT00571974|19507833|P1|STARTED|Phase II||0
7927202|NCT00571974|19507832|P2|NOT COMPLETED|Phase I||0
7927203|NCT00571974|19507833|P1|NOT COMPLETED|Phase I||0
7927204|NCT00571974|19507832|P2|COMPLETED|Phase I||0
7927205|NCT00571974|19507833|P1|COMPLETED|Phase I||9
7927206|NCT00571974|19507832|P2|STARTED|Phase I||0
7927207|NCT00571974|19507833|P1|STARTED|Phase I||9
7927208|NCT00571961|19507839|P1|NOT COMPLETED|Overall Study||0
7927209|NCT00571961|19507839|P1|COMPLETED|Overall Study||12
7927210|NCT00571961|19507839|P1|STARTED|Overall Study||12
7927211|NCT00571948|19507845|P2|NOT COMPLETED|Overall Study||14
7927212|NCT00571948|19507846|P1|NOT COMPLETED|Overall Study||11
7927213|NCT00571948|19507845|P2|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52
7927214|NCT00571948|19507846|P1|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55
7927215|NCT00571948|19507845|P2|STARTED|Overall Study||66
7927216|NCT00571948|19507846|P1|STARTED|Overall Study||66
7927217|NCT00571922|19507854|P2|NOT COMPLETED|Overall Study||36
7927218|NCT00571922|19507855|P1|NOT COMPLETED|Overall Study||36
7927219|NCT00571922|19507854|P2|COMPLETED|Overall Study||0
7927220|NCT00571922|19507855|P1|COMPLETED|Overall Study||0
7927221|NCT00571922|19507854|P2|STARTED|Overall Study||36
7927222|NCT00571922|19507855|P1|STARTED|Overall Study||36
7927223|NCT00571701|19507865|P2|NOT COMPLETED|Second Intervention 12 Months||1
7927224|NCT00571701|19507866|P1|NOT COMPLETED|Second Intervention 12 Months||3
7927225|NCT00571701|19507865|P2|COMPLETED|Second Intervention 12 Months||20
7927226|NCT00571701|19507866|P1|COMPLETED|Second Intervention 12 Months||13
7927227|NCT00571701|19507865|P2|STARTED|Second Intervention 12 Months||21
7927228|NCT00571701|19507866|P1|STARTED|Second Intervention 12 Months||16
7927229|NCT00571701|19507865|P2|NOT COMPLETED|First Intervention 12 Months||1
7927230|NCT00571701|19507866|P1|NOT COMPLETED|First Intervention 12 Months||3
7927231|NCT00571701|19507865|P2|COMPLETED|First Intervention 12 Months||21
7927232|NCT00571701|19507866|P1|COMPLETED|First Intervention 12 Months||16
7927233|NCT00571701|19507865|P2|STARTED|First Intervention 12 Months||22
7927234|NCT00571701|19507866|P1|STARTED|First Intervention 12 Months||19
7927235|NCT00571688|19507892|P2|NOT COMPLETED|Overall Study||6
7927236|NCT00571688|19507893|P1|NOT COMPLETED|Overall Study||5
7927237|NCT00571688|19507892|P2|COMPLETED|Overall Study||19
7927238|NCT00571688|19507893|P1|COMPLETED|Overall Study||20
7927239|NCT00571688|19507892|P2|STARTED|Overall Study||25
7927240|NCT00571688|19507893|P1|STARTED|Overall Study||25
7927241|NCT00571662|19507899|P1|NOT COMPLETED|Overall Study||8
7927242|NCT00571662|19507899|P1|COMPLETED|Overall Study||68
7927243|NCT00571662|19507899|P1|STARTED|Overall Study||76
7927244|NCT00571649|19507910|P2|NOT COMPLETED|Follow-up Period||528
7927245|NCT00571649|19507911|P1|NOT COMPLETED|Follow-up Period||545
7927246|NCT00571649|19507910|P2|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107
7927247|NCT00571649|19507911|P1|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038
7927248|NCT00571649|19507910|P2|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635
7927249|NCT00571649|19507911|P1|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583
7927250|NCT00571649|19507910|P2|NOT COMPLETED|Treatment Period||1004
7927251|NCT00571649|19507911|P1|NOT COMPLETED|Treatment Period||1092
7927252|NCT00571649|19507910|P2|COMPLETED|Treatment Period||3047
7927253|NCT00571649|19507911|P1|COMPLETED|Treatment Period||2958
7927254|NCT00571649|19507910|P2|Day 35|Treatment Period||3115
7927255|NCT00571649|19507911|P1|Day 35|Treatment Period||3033
7927256|NCT00571649|19507910|P2|Day 10|Treatment Period||3499
7927257|NCT00571649|19507911|P1|Day 10|Treatment Period||3454
7927258|NCT00571649|19507910|P2|Participants Received Treatment|Treatment Period||4001
7927259|NCT00571649|19507911|P1|Participants Received Treatment|Treatment Period||3997
7927260|NCT00571649|19507910|P2|STARTED|Treatment Period||4051
7927261|NCT00571649|19507911|P1|STARTED|Treatment Period||4050
7927262|NCT00571493|19507943|P7|NOT COMPLETED|Overall Study||0
7927263|NCT00571493|19507944|P6|NOT COMPLETED|Overall Study||0
7927264|NCT00571493|19507945|P5|NOT COMPLETED|Overall Study||0
7927265|NCT00571493|19507946|P4|NOT COMPLETED|Overall Study||0
7927266|NCT00571493|19507947|P3|NOT COMPLETED|Overall Study||0
7927267|NCT00571493|19507948|P2|NOT COMPLETED|Overall Study||0
7927268|NCT00571493|19507949|P1|NOT COMPLETED|Overall Study||0
7927269|NCT00571493|19507943|P7|COMPLETED|Overall Study||6
7927270|NCT00571493|19507944|P6|COMPLETED|Overall Study||12
7927271|NCT00571493|19507945|P5|COMPLETED|Overall Study||11
7927272|NCT00571493|19507946|P4|COMPLETED|Overall Study||3
7927273|NCT00571493|19507947|P3|COMPLETED|Overall Study||3
7927274|NCT00571493|19507948|P2|COMPLETED|Overall Study||4
7927275|NCT00571493|19507949|P1|COMPLETED|Overall Study||3
7927276|NCT00571493|19507943|P7|STARTED|Overall Study||6
7927277|NCT00571493|19507944|P6|STARTED|Overall Study||12
7927278|NCT00571493|19507945|P5|STARTED|Overall Study||11
7927279|NCT00571493|19507946|P4|STARTED|Overall Study||3
7927280|NCT00571493|19507947|P3|STARTED|Overall Study||3
7927281|NCT00571493|19507948|P2|STARTED|Overall Study||4
7927282|NCT00571493|19507949|P1|STARTED|Overall Study||3
7927283|NCT00571428|19507959|P2|NOT COMPLETED|Overall Study||0
7927284|NCT00571428|19507960|P1|NOT COMPLETED|Overall Study||0
7927285|NCT00571428|19507959|P2|COMPLETED|Overall Study||18
7927286|NCT00571428|19507960|P1|COMPLETED|Overall Study||15
7927287|NCT00571428|19507959|P2|STARTED|Overall Study||18
7927288|NCT00571428|19507960|P1|STARTED|Overall Study||15
7927289|NCT00571324|19507992|P2|NOT COMPLETED|Intervention 2 (7 Hours)||0
7927290|NCT00571324|19507993|P1|NOT COMPLETED|Intervention 2 (7 Hours)||0
7927291|NCT00571324|19507992|P2|COMPLETED|Intervention 2 (7 Hours)||4
7927292|NCT00571324|19507993|P1|COMPLETED|Intervention 2 (7 Hours)||5
7927293|NCT00571324|19507992|P2|STARTED|Intervention 2 (7 Hours)||4
7927294|NCT00571324|19507993|P1|STARTED|Intervention 2 (7 Hours)||5
7927295|NCT00571324|19507992|P2|NOT COMPLETED|Intervention 1 (7 Hours)||0
7927296|NCT00571324|19507993|P1|NOT COMPLETED|Intervention 1 (7 Hours)||0
7927297|NCT00571324|19507992|P2|COMPLETED|Intervention 1 (7 Hours)||4
7927298|NCT00571324|19507993|P1|COMPLETED|Intervention 1 (7 Hours)||5
7927299|NCT00571324|19507992|P2|STARTED|Intervention 1 (7 Hours)||4
7927300|NCT00571324|19507993|P1|STARTED|Intervention 1 (7 Hours)||5
7927301|NCT00571194|19508005|P1|NOT COMPLETED|Overall Study||0
7927302|NCT00571194|19508005|P1|COMPLETED|Overall Study||7
7927303|NCT00571194|19508005|P1|STARTED|Overall Study||7
7927304|NCT00571103|19508009|P1|NOT COMPLETED|Overall Study||2
7927305|NCT00571103|19508009|P1|COMPLETED|Overall Study|Of the 28 participants, 1 subject withdrew and 1 was lost to follow-up after their baseline visit.|26
7927306|NCT00571103|19508009|P1|STARTED|Overall Study||28
7927307|NCT00571064|19508014|P1|NOT COMPLETED|Overall Study||21
7927308|NCT00571064|19508014|P1|COMPLETED|Overall Study||76
7927309|NCT00571064|19508014|P1|STARTED|Overall Study||97
7927310|NCT00571038|19508029|P2|NOT COMPLETED|Overall Study||14
7927311|NCT00571038|19508030|P1|NOT COMPLETED|Overall Study||11
7927312|NCT00571038|19508029|P2|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171
7927313|NCT00571038|19508030|P1|COMPLETED|Overall Study|"7 died 2 moved
~1 asked to be withdrawn
~1 unable to reach"|208
7927314|NCT00571038|19508029|P2|18 Month Survey Only|Overall Study||163
7927315|NCT00571038|19508030|P1|18 Month Survey Only|Overall Study||199
7927316|NCT00571038|19508029|P2|6 Month Follow up|Overall Study||176
7927317|NCT00571038|19508030|P1|6 Month Follow up|Overall Study||208
7927318|NCT00571038|19508029|P2|STARTED|Overall Study||185
7927319|NCT00571038|19508030|P1|STARTED|Overall Study||219
7927320|NCT00570960|19508078|P2|NOT COMPLETED|Overall Study||0
7927321|NCT00570960|19508079|P1|NOT COMPLETED|Overall Study||0
7927322|NCT00570960|19508078|P2|COMPLETED|Overall Study||4
7927323|NCT00570960|19508079|P1|COMPLETED|Overall Study||4
7927324|NCT00570960|19508078|P2|STARTED|Overall Study||4
7927325|NCT00570960|19508079|P1|STARTED|Overall Study||4
7927326|NCT00570921|19508085|P1|NOT COMPLETED|Overall Study||2
7927327|NCT00570921|19508085|P1|COMPLETED|Overall Study||31
7927328|NCT00570921|19508085|P1|STARTED|Overall Study||33
7927329|NCT00570908|19508091|P1|NOT COMPLETED|Overall Study||7
7927330|NCT00570908|19508091|P1|COMPLETED|Overall Study|5 patients progressed during the study treatment|5
7927331|NCT00570908|19508091|P1|STARTED|Overall Study||12
7927332|NCT00570778|19508095|P4|NOT COMPLETED|Overall Study||4
7927333|NCT00570778|19508096|P3|NOT COMPLETED|Overall Study||7
7927334|NCT00570778|19508097|P2|NOT COMPLETED|Overall Study||4
7927335|NCT00570778|19508098|P1|NOT COMPLETED|Overall Study||4
7927336|NCT00570778|19508095|P4|COMPLETED|Overall Study||34
7927337|NCT00570778|19508096|P3|COMPLETED|Overall Study||30
7927338|NCT00570778|19508097|P2|COMPLETED|Overall Study||34
7927339|NCT00570778|19508098|P1|COMPLETED|Overall Study||37
7927340|NCT00570778|19508095|P4|Modified Intent-to-treat Population|Overall Study||37
7927341|NCT00570778|19508096|P3|Modified Intent-to-treat Population|Overall Study||35
7927342|NCT00570778|19508097|P2|Modified Intent-to-treat Population|Overall Study||37
7927343|NCT00570778|19508098|P1|Modified Intent-to-treat Population|Overall Study||40
7927344|NCT00570778|19508095|P4|Safety Population: Received Study Drug|Overall Study||38
7927345|NCT00570778|19508096|P3|Safety Population: Received Study Drug|Overall Study||36
7927346|NCT00570778|19508097|P2|Safety Population: Received Study Drug|Overall Study||38
7927347|NCT00570778|19508098|P1|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41
7927348|NCT00570778|19508095|P4|STARTED|Overall Study||38
7927349|NCT00570778|19508096|P3|STARTED|Overall Study||37
7927350|NCT00570778|19508097|P2|STARTED|Overall Study||38
7927351|NCT00570778|19508098|P1|STARTED|Overall Study||41
7927352|NCT00570765|19508119|P3|NOT COMPLETED|Overall Study||0
7927353|NCT00570765|19508120|P2|NOT COMPLETED|Overall Study||7
7927354|NCT00570765|19508121|P1|NOT COMPLETED|Overall Study||4
7927355|NCT00570765|19508119|P3|COMPLETED|Overall Study||23
7927356|NCT00570765|19508120|P2|COMPLETED|Overall Study||9
7927357|NCT00570765|19508121|P1|COMPLETED|Overall Study||16
7927358|NCT00570765|19508119|P3|STARTED|Overall Study||23
7927359|NCT00570765|19508120|P2|STARTED|Overall Study||16
7927360|NCT00570765|19508121|P1|STARTED|Overall Study||20
7927361|NCT00570739|19508139|P4|NOT COMPLETED|Overall Study||12
7927362|NCT00570739|19508140|P3|NOT COMPLETED|Overall Study||16
7927363|NCT00570739|19508141|P2|NOT COMPLETED|Overall Study||21
7927364|NCT00570739|19508142|P1|NOT COMPLETED|Overall Study||21
7927365|NCT00570739|19508139|P4|COMPLETED|Overall Study||96
7927366|NCT00570739|19508140|P3|COMPLETED|Overall Study||92
7927367|NCT00570739|19508141|P2|COMPLETED|Overall Study||124
7927368|NCT00570739|19508142|P1|COMPLETED|Overall Study||120
7927369|NCT00570739|19508139|P4|STARTED|Overall Study||108
7927370|NCT00570739|19508140|P3|STARTED|Overall Study||108
7927371|NCT00570739|19508141|P2|STARTED|Overall Study||145
7927372|NCT00570739|19508142|P1|STARTED|Overall Study||141
7927373|NCT00570713|19508294|P2|NOT COMPLETED|Overall Study||77
7927374|NCT00570713|19508295|P1|NOT COMPLETED|Overall Study||78
7927375|NCT00570713|19508294|P2|COMPLETED|Overall Study||0
7927376|NCT00570713|19508295|P1|COMPLETED|Overall Study||0
7927377|NCT00570713|19508294|P2|STARTED|Overall Study||77
7927378|NCT00570713|19508295|P1|STARTED|Overall Study||78
7927379|NCT00570700|19508305|P1|NOT COMPLETED|Overall Study||11
7927380|NCT00570700|19508305|P1|COMPLETED|Overall Study||27
7927381|NCT00570700|19508305|P1|STARTED|Overall Study||38
7927382|NCT00570687|19508313|P10|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
7927383|NCT00570687|19508314|P9|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
7927384|NCT00570687|19508315|P8|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
7927385|NCT00570687|19508316|P7|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
7927386|NCT00570687|19508317|P6|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
7927387|NCT00570687|19508318|P5|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
7927388|NCT00570687|19508319|P4|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
7927389|NCT00570687|19508320|P3|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
7927390|NCT00570687|19508321|P2|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
7927391|NCT00570687|19508322|P1|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
7927392|NCT00570687|19508313|P10|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
7927393|NCT00570687|19508314|P9|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
7927394|NCT00570687|19508315|P8|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
7927395|NCT00570687|19508316|P7|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
7927396|NCT00570687|19508317|P6|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
7927397|NCT00570687|19508318|P5|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
7927398|NCT00570687|19508319|P4|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
7927399|NCT00570687|19508320|P3|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
7927400|NCT00570687|19508321|P2|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
7927401|NCT00570687|19508322|P1|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
7927402|NCT00570687|19508313|P10|STARTED|Clamp 2 (1 Day) - Amendment 1||0
7927403|NCT00570687|19508314|P9|STARTED|Clamp 2 (1 Day) - Amendment 1||0
7927404|NCT00570687|19508315|P8|STARTED|Clamp 2 (1 Day) - Amendment 1||0
7927405|NCT00570687|19508316|P7|STARTED|Clamp 2 (1 Day) - Amendment 1||0
7927406|NCT00570687|19508317|P6|STARTED|Clamp 2 (1 Day) - Amendment 1||0
7927407|NCT00570687|19508318|P5|STARTED|Clamp 2 (1 Day) - Amendment 1||0
7927408|NCT00570687|19508319|P4|STARTED|Clamp 2 (1 Day) - Amendment 1||4
7927409|NCT00570687|19508320|P3|STARTED|Clamp 2 (1 Day) - Amendment 1||2
7927410|NCT00570687|19508321|P2|STARTED|Clamp 2 (1 Day) - Amendment 1||2
7927411|NCT00570687|19508322|P1|STARTED|Clamp 2 (1 Day) - Amendment 1||4
7927412|NCT00570687|19508313|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
7927413|NCT00570687|19508314|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
7927414|NCT00570687|19508315|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
7927415|NCT00570687|19508316|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
7927416|NCT00570687|19508317|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
7927417|NCT00570687|19508318|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
7927418|NCT00570687|19508319|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
7927419|NCT00570687|19508320|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
7927420|NCT00570687|19508321|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
7927421|NCT00570687|19508322|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
7927422|NCT00570687|19508313|P10|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
7927423|NCT00570687|19508314|P9|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
7927424|NCT00570687|19508315|P8|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
7927425|NCT00570687|19508316|P7|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
7927426|NCT00570687|19508317|P6|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
7927427|NCT00570687|19508318|P5|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
7927428|NCT00570687|19508319|P4|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
7927429|NCT00570687|19508320|P3|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
7927430|NCT00570687|19508321|P2|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
7927431|NCT00570687|19508322|P1|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
7927432|NCT00570687|19508313|P10|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
7927433|NCT00570687|19508314|P9|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
7927434|NCT00570687|19508315|P8|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
7927435|NCT00570687|19508316|P7|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
7927436|NCT00570687|19508317|P6|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
7927437|NCT00570687|19508318|P5|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
7927438|NCT00570687|19508319|P4|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
7927439|NCT00570687|19508320|P3|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
7927440|NCT00570687|19508321|P2|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
7927441|NCT00570687|19508322|P1|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
7927442|NCT00570687|19508313|P10|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
7927443|NCT00570687|19508314|P9|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
7927444|NCT00570687|19508315|P8|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
7927445|NCT00570687|19508316|P7|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
7927446|NCT00570687|19508317|P6|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
7927447|NCT00570687|19508318|P5|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
7927448|NCT00570687|19508319|P4|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
7927449|NCT00570687|19508320|P3|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
7927450|NCT00570687|19508321|P2|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
7927451|NCT00570687|19508322|P1|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
7927452|NCT00570687|19508313|P10|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
7927453|NCT00570687|19508314|P9|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
7927454|NCT00570687|19508315|P8|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
7927455|NCT00570687|19508316|P7|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
7927456|NCT00570687|19508317|P6|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
7927457|NCT00570687|19508318|P5|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
7927458|NCT00570687|19508319|P4|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
7927459|NCT00570687|19508320|P3|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
7927460|NCT00570687|19508321|P2|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
7927461|NCT00570687|19508322|P1|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
7927462|NCT00570687|19508313|P10|STARTED|Clamp 1 (1 Day) - Amendment 1||0
7927463|NCT00570687|19508314|P9|STARTED|Clamp 1 (1 Day) - Amendment 1||0
7927464|NCT00570687|19508315|P8|STARTED|Clamp 1 (1 Day) - Amendment 1||0
7927465|NCT00570687|19508316|P7|STARTED|Clamp 1 (1 Day) - Amendment 1||0
7927466|NCT00570687|19508317|P6|STARTED|Clamp 1 (1 Day) - Amendment 1||0
7927467|NCT00570687|19508318|P5|STARTED|Clamp 1 (1 Day) - Amendment 1||0
7927468|NCT00570687|19508319|P4|STARTED|Clamp 1 (1 Day) - Amendment 1||4
7927469|NCT00570687|19508320|P3|STARTED|Clamp 1 (1 Day) - Amendment 1||2
7927470|NCT00570687|19508321|P2|STARTED|Clamp 1 (1 Day) - Amendment 1||2
7927471|NCT00570687|19508322|P1|STARTED|Clamp 1 (1 Day) - Amendment 1||4
7927472|NCT00570687|19508313|P10|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
7927473|NCT00570687|19508314|P9|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
7927474|NCT00570687|19508315|P8|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
7927475|NCT00570687|19508316|P7|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
7927476|NCT00570687|19508317|P6|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
7927477|NCT00570687|19508318|P5|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
7927478|NCT00570687|19508319|P4|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
7927479|NCT00570687|19508320|P3|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
7927480|NCT00570687|19508321|P2|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
7927481|NCT00570687|19508322|P1|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
7927482|NCT00570687|19508313|P10|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
7927483|NCT00570687|19508314|P9|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
7927484|NCT00570687|19508315|P8|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
7927485|NCT00570687|19508316|P7|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
7927486|NCT00570687|19508317|P6|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
7927487|NCT00570687|19508318|P5|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
7927488|NCT00570687|19508319|P4|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
7927489|NCT00570687|19508320|P3|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
7927490|NCT00570687|19508321|P2|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
7927491|NCT00570687|19508322|P1|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
7927492|NCT00570687|19508313|P10|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
7927493|NCT00570687|19508314|P9|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
7927494|NCT00570687|19508315|P8|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
7927495|NCT00570687|19508316|P7|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
7927496|NCT00570687|19508317|P6|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
7927497|NCT00570687|19508318|P5|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
7927498|NCT00570687|19508319|P4|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
7927499|NCT00570687|19508320|P3|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
7927500|NCT00570687|19508321|P2|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
7927501|NCT00570687|19508322|P1|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
7927502|NCT00570687|19508313|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927503|NCT00570687|19508314|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927504|NCT00570687|19508315|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927505|NCT00570687|19508316|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927506|NCT00570687|19508317|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927507|NCT00570687|19508318|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927508|NCT00570687|19508319|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927509|NCT00570687|19508320|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927510|NCT00570687|19508321|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927511|NCT00570687|19508322|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927512|NCT00570687|19508313|P10|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927513|NCT00570687|19508314|P9|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927514|NCT00570687|19508315|P8|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927515|NCT00570687|19508316|P7|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927516|NCT00570687|19508317|P6|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927517|NCT00570687|19508318|P5|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927518|NCT00570687|19508319|P4|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
7927519|NCT00570687|19508320|P3|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
7927520|NCT00570687|19508321|P2|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
7927521|NCT00570687|19508322|P1|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
7927522|NCT00570687|19508313|P10|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927523|NCT00570687|19508314|P9|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927524|NCT00570687|19508315|P8|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927525|NCT00570687|19508316|P7|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927526|NCT00570687|19508317|P6|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927527|NCT00570687|19508318|P5|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
7927528|NCT00570687|19508319|P4|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
7927529|NCT00570687|19508320|P3|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
7927530|NCT00570687|19508321|P2|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
7927531|NCT00570687|19508322|P1|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
7927532|NCT00570687|19508313|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
7927533|NCT00570687|19508314|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
7927534|NCT00570687|19508315|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
7927535|NCT00570687|19508316|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
7927536|NCT00570687|19508317|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
7927537|NCT00570687|19508318|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
7927538|NCT00570687|19508319|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
7927539|NCT00570687|19508320|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
7927540|NCT00570687|19508321|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
7927541|NCT00570687|19508322|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
7927542|NCT00570687|19508313|P10|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
7927543|NCT00570687|19508314|P9|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
7927544|NCT00570687|19508315|P8|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
7927545|NCT00570687|19508316|P7|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
7927546|NCT00570687|19508317|P6|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
7927547|NCT00570687|19508318|P5|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
7927548|NCT00570687|19508319|P4|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
7927549|NCT00570687|19508320|P3|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
7927550|NCT00570687|19508321|P2|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
7927551|NCT00570687|19508322|P1|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
7927552|NCT00570687|19508313|P10|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
7927553|NCT00570687|19508314|P9|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
7927554|NCT00570687|19508315|P8|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
7927555|NCT00570687|19508316|P7|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
7927556|NCT00570687|19508317|P6|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
7927557|NCT00570687|19508318|P5|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
7927558|NCT00570687|19508319|P4|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
7927559|NCT00570687|19508320|P3|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
7927560|NCT00570687|19508321|P2|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
7927561|NCT00570687|19508322|P1|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
7927562|NCT00570687|19508313|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927563|NCT00570687|19508314|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927564|NCT00570687|19508315|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927565|NCT00570687|19508316|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927566|NCT00570687|19508317|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927567|NCT00570687|19508318|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927568|NCT00570687|19508319|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927569|NCT00570687|19508320|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927570|NCT00570687|19508321|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927571|NCT00570687|19508322|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927572|NCT00570687|19508313|P10|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927573|NCT00570687|19508314|P9|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927574|NCT00570687|19508315|P8|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927575|NCT00570687|19508316|P7|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927576|NCT00570687|19508317|P6|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927577|NCT00570687|19508318|P5|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927578|NCT00570687|19508319|P4|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
7927579|NCT00570687|19508320|P3|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
7927580|NCT00570687|19508321|P2|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
7927581|NCT00570687|19508322|P1|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
7927582|NCT00570687|19508313|P10|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927583|NCT00570687|19508314|P9|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927584|NCT00570687|19508315|P8|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927585|NCT00570687|19508316|P7|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927586|NCT00570687|19508317|P6|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927587|NCT00570687|19508318|P5|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
7927588|NCT00570687|19508319|P4|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
7927589|NCT00570687|19508320|P3|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
7927590|NCT00570687|19508321|P2|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
7927591|NCT00570687|19508322|P1|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
7927592|NCT00570687|19508313|P10|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
7927593|NCT00570687|19508314|P9|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
7927594|NCT00570687|19508315|P8|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
7927595|NCT00570687|19508316|P7|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1
7927596|NCT00570687|19508317|P6|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
7927597|NCT00570687|19508318|P5|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
7927598|NCT00570687|19508319|P4|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
7927599|NCT00570687|19508320|P3|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
7927600|NCT00570687|19508321|P2|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
7927601|NCT00570687|19508322|P1|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
7927602|NCT00570687|19508313|P10|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
7927603|NCT00570687|19508314|P9|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
7927604|NCT00570687|19508315|P8|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
7927605|NCT00570687|19508316|P7|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
7927606|NCT00570687|19508317|P6|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
7927607|NCT00570687|19508318|P5|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
7927608|NCT00570687|19508319|P4|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
7927609|NCT00570687|19508320|P3|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
7927610|NCT00570687|19508321|P2|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
7927611|NCT00570687|19508322|P1|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
7927612|NCT00570687|19508313|P10|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
7927613|NCT00570687|19508314|P9|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
7927614|NCT00570687|19508315|P8|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
7927615|NCT00570687|19508316|P7|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1
7927616|NCT00570687|19508317|P6|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
7927617|NCT00570687|19508318|P5|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
7927618|NCT00570687|19508319|P4|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
7927619|NCT00570687|19508320|P3|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
7927620|NCT00570687|19508321|P2|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
7927621|NCT00570687|19508322|P1|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
7927622|NCT00570687|19508313|P10|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
7927623|NCT00570687|19508314|P9|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
7927624|NCT00570687|19508315|P8|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
7927625|NCT00570687|19508316|P7|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
7927626|NCT00570687|19508317|P6|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
7927627|NCT00570687|19508318|P5|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
7927628|NCT00570687|19508319|P4|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
7927629|NCT00570687|19508320|P3|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
7927630|NCT00570687|19508321|P2|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
7927631|NCT00570687|19508322|P1|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
7927632|NCT00570687|19508313|P10|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
7927633|NCT00570687|19508314|P9|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
7927634|NCT00570687|19508315|P8|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
7927635|NCT00570687|19508316|P7|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1
7927636|NCT00570687|19508317|P6|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
7927637|NCT00570687|19508318|P5|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
7927638|NCT00570687|19508319|P4|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
7927639|NCT00570687|19508320|P3|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
7927640|NCT00570687|19508321|P2|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
7927641|NCT00570687|19508322|P1|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
7927642|NCT00570687|19508313|P10|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
7927643|NCT00570687|19508314|P9|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
7927644|NCT00570687|19508315|P8|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
7927645|NCT00570687|19508316|P7|STARTED|Clamp 2 (1 Day) - Orig Protocol||1
7927646|NCT00570687|19508317|P6|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
7927647|NCT00570687|19508318|P5|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
7927648|NCT00570687|19508319|P4|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
7927649|NCT00570687|19508320|P3|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
7927650|NCT00570687|19508321|P2|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
7927651|NCT00570687|19508322|P1|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
7927652|NCT00570687|19508313|P10|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
7927653|NCT00570687|19508314|P9|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
7927654|NCT00570687|19508315|P8|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
7927655|NCT00570687|19508316|P7|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
7927656|NCT00570687|19508317|P6|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
7927657|NCT00570687|19508318|P5|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
7927658|NCT00570687|19508319|P4|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
7927659|NCT00570687|19508320|P3|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
7927660|NCT00570687|19508321|P2|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
7927661|NCT00570687|19508322|P1|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
7927662|NCT00570687|19508313|P10|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
7927663|NCT00570687|19508314|P9|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
7927664|NCT00570687|19508315|P8|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
7927665|NCT00570687|19508316|P7|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
7927666|NCT00570687|19508317|P6|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
7927667|NCT00570687|19508318|P5|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
7927668|NCT00570687|19508319|P4|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
7927669|NCT00570687|19508320|P3|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
7927670|NCT00570687|19508321|P2|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
7927671|NCT00570687|19508322|P1|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
7927672|NCT00570687|19508313|P10|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
7927673|NCT00570687|19508314|P9|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
7927674|NCT00570687|19508315|P8|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
7927675|NCT00570687|19508316|P7|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
7927676|NCT00570687|19508317|P6|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
7927677|NCT00570687|19508318|P5|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
7927678|NCT00570687|19508319|P4|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
7927679|NCT00570687|19508320|P3|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
7927680|NCT00570687|19508321|P2|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
7927681|NCT00570687|19508322|P1|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
7927682|NCT00570687|19508313|P10|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
7927683|NCT00570687|19508314|P9|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
7927684|NCT00570687|19508315|P8|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
7927685|NCT00570687|19508316|P7|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
7927686|NCT00570687|19508317|P6|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
7927687|NCT00570687|19508318|P5|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
7927688|NCT00570687|19508319|P4|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
7927689|NCT00570687|19508320|P3|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
7927690|NCT00570687|19508321|P2|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
7927691|NCT00570687|19508322|P1|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
7927692|NCT00570687|19508313|P10|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
7927693|NCT00570687|19508314|P9|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
7927694|NCT00570687|19508315|P8|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
7927695|NCT00570687|19508316|P7|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
7927696|NCT00570687|19508317|P6|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
7927697|NCT00570687|19508318|P5|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
7927698|NCT00570687|19508319|P4|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
7927699|NCT00570687|19508320|P3|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
7927700|NCT00570687|19508321|P2|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
7927701|NCT00570687|19508322|P1|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
7927702|NCT00570687|19508313|P10|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
7927703|NCT00570687|19508314|P9|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
7927704|NCT00570687|19508315|P8|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
7927705|NCT00570687|19508316|P7|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
7927706|NCT00570687|19508317|P6|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
7927707|NCT00570687|19508318|P5|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
7927708|NCT00570687|19508319|P4|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
7927709|NCT00570687|19508320|P3|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
7927710|NCT00570687|19508321|P2|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
7927711|NCT00570687|19508322|P1|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
7927712|NCT00570687|19508313|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
7927713|NCT00570687|19508314|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
7927714|NCT00570687|19508315|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
7927715|NCT00570687|19508316|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
7927716|NCT00570687|19508317|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
7927717|NCT00570687|19508318|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
7927718|NCT00570687|19508319|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
7927719|NCT00570687|19508320|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
7927720|NCT00570687|19508321|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
7927721|NCT00570687|19508322|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
7927722|NCT00570687|19508313|P10|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
7927723|NCT00570687|19508314|P9|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
7927724|NCT00570687|19508315|P8|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
7927725|NCT00570687|19508316|P7|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
7927726|NCT00570687|19508317|P6|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
7927727|NCT00570687|19508318|P5|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
7927728|NCT00570687|19508319|P4|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
7927729|NCT00570687|19508320|P3|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
7927730|NCT00570687|19508321|P2|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
7927731|NCT00570687|19508322|P1|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
7927732|NCT00570687|19508313|P10|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
7927733|NCT00570687|19508314|P9|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
7927734|NCT00570687|19508315|P8|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
7927735|NCT00570687|19508316|P7|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
7927736|NCT00570687|19508317|P6|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
7927737|NCT00570687|19508318|P5|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
7927738|NCT00570687|19508319|P4|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
7927739|NCT00570687|19508320|P3|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
7927740|NCT00570687|19508321|P2|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
7927741|NCT00570687|19508322|P1|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
7927742|NCT00570687|19508313|P10|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
7927743|NCT00570687|19508314|P9|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
7927744|NCT00570687|19508315|P8|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
7927745|NCT00570687|19508316|P7|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
7927746|NCT00570687|19508317|P6|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
7927747|NCT00570687|19508318|P5|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
7927748|NCT00570687|19508319|P4|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
7927749|NCT00570687|19508320|P3|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
7927750|NCT00570687|19508321|P2|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
7927751|NCT00570687|19508322|P1|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
7927752|NCT00570687|19508313|P10|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
7927753|NCT00570687|19508314|P9|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
7927754|NCT00570687|19508315|P8|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
7927755|NCT00570687|19508316|P7|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
7927756|NCT00570687|19508317|P6|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
7927757|NCT00570687|19508318|P5|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
7927758|NCT00570687|19508319|P4|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
7927759|NCT00570687|19508320|P3|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
7927760|NCT00570687|19508321|P2|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
7927761|NCT00570687|19508322|P1|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
7927762|NCT00570687|19508313|P10|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
7927763|NCT00570687|19508314|P9|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
7927764|NCT00570687|19508315|P8|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
7927765|NCT00570687|19508316|P7|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
7927766|NCT00570687|19508317|P6|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
7927767|NCT00570687|19508318|P5|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
7927768|NCT00570687|19508319|P4|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
7927769|NCT00570687|19508320|P3|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
7927770|NCT00570687|19508321|P2|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
7927771|NCT00570687|19508322|P1|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
7927772|NCT00570687|19508313|P10|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
7927773|NCT00570687|19508314|P9|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
7927774|NCT00570687|19508315|P8|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
7927775|NCT00570687|19508316|P7|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
7927776|NCT00570687|19508317|P6|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
7927777|NCT00570687|19508318|P5|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
7927778|NCT00570687|19508319|P4|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
7927779|NCT00570687|19508320|P3|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
7927780|NCT00570687|19508321|P2|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
7927781|NCT00570687|19508322|P1|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
7927782|NCT00570687|19508313|P10|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
7927783|NCT00570687|19508314|P9|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
7927784|NCT00570687|19508315|P8|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
7927785|NCT00570687|19508316|P7|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
7927786|NCT00570687|19508317|P6|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
7927787|NCT00570687|19508318|P5|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
7927788|NCT00570687|19508319|P4|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
7927789|NCT00570687|19508320|P3|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
7927790|NCT00570687|19508321|P2|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
7927791|NCT00570687|19508322|P1|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
7927792|NCT00570687|19508313|P10|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
7927793|NCT00570687|19508314|P9|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
7927794|NCT00570687|19508315|P8|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
7927795|NCT00570687|19508316|P7|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
7927796|NCT00570687|19508317|P6|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
7927797|NCT00570687|19508318|P5|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
7927798|NCT00570687|19508319|P4|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
7927799|NCT00570687|19508320|P3|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
7927800|NCT00570687|19508321|P2|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
7927801|NCT00570687|19508322|P1|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
7927802|NCT00570687|19508313|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
7927803|NCT00570687|19508314|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
7927804|NCT00570687|19508315|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
7927805|NCT00570687|19508316|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
7927806|NCT00570687|19508317|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
7927807|NCT00570687|19508318|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
7927808|NCT00570687|19508319|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
7927809|NCT00570687|19508320|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
7927810|NCT00570687|19508321|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
7927811|NCT00570687|19508322|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
7927812|NCT00570687|19508313|P10|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
7927813|NCT00570687|19508314|P9|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
7927814|NCT00570687|19508315|P8|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
7927815|NCT00570687|19508316|P7|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
7927816|NCT00570687|19508317|P6|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
7927817|NCT00570687|19508318|P5|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
7927818|NCT00570687|19508319|P4|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
7927819|NCT00570687|19508320|P3|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
7927820|NCT00570687|19508321|P2|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
7927821|NCT00570687|19508322|P1|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
7927822|NCT00570687|19508313|P10|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
7927823|NCT00570687|19508314|P9|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
7927824|NCT00570687|19508315|P8|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
7927825|NCT00570687|19508316|P7|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
7927826|NCT00570687|19508317|P6|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
7927827|NCT00570687|19508318|P5|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
7927828|NCT00570687|19508319|P4|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
7927829|NCT00570687|19508320|P3|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
7927830|NCT00570687|19508321|P2|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
7927831|NCT00570687|19508322|P1|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
7927832|NCT00570687|19508313|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
7927833|NCT00570687|19508314|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
7927834|NCT00570687|19508315|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
7927835|NCT00570687|19508316|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
7927836|NCT00570687|19508317|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
7927837|NCT00570687|19508318|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
7927838|NCT00570687|19508319|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
7927839|NCT00570687|19508320|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
7927840|NCT00570687|19508321|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
7927841|NCT00570687|19508322|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
7927842|NCT00570687|19508313|P10|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
7927843|NCT00570687|19508314|P9|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
7927844|NCT00570687|19508315|P8|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
7927845|NCT00570687|19508316|P7|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
7927846|NCT00570687|19508317|P6|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
7927847|NCT00570687|19508318|P5|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
7927848|NCT00570687|19508319|P4|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
7927849|NCT00570687|19508320|P3|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
7927850|NCT00570687|19508321|P2|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
7927851|NCT00570687|19508322|P1|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
7927852|NCT00570687|19508313|P10|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
7927853|NCT00570687|19508314|P9|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
7927854|NCT00570687|19508315|P8|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
7927855|NCT00570687|19508316|P7|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
7927856|NCT00570687|19508317|P6|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
7927857|NCT00570687|19508318|P5|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
7927858|NCT00570687|19508319|P4|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
7927859|NCT00570687|19508320|P3|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
7927860|NCT00570687|19508321|P2|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
7927861|NCT00570687|19508322|P1|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
7927862|NCT00570687|19508313|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
7927863|NCT00570687|19508314|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
7927864|NCT00570687|19508315|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
7927865|NCT00570687|19508316|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
7927866|NCT00570687|19508317|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
7927867|NCT00570687|19508318|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
7927868|NCT00570687|19508319|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
7927869|NCT00570687|19508320|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
7927870|NCT00570687|19508321|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
7927871|NCT00570687|19508322|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
7927872|NCT00570687|19508313|P10|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
7927873|NCT00570687|19508314|P9|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
7927874|NCT00570687|19508315|P8|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
7927875|NCT00570687|19508316|P7|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
7927876|NCT00570687|19508317|P6|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
7927877|NCT00570687|19508318|P5|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
7927878|NCT00570687|19508319|P4|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
7927879|NCT00570687|19508320|P3|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
7927880|NCT00570687|19508321|P2|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
7927881|NCT00570687|19508322|P1|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
7927882|NCT00570687|19508313|P10|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
7927883|NCT00570687|19508314|P9|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
7927884|NCT00570687|19508315|P8|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
7927885|NCT00570687|19508316|P7|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
7927886|NCT00570687|19508317|P6|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
7927887|NCT00570687|19508318|P5|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
7927888|NCT00570687|19508319|P4|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
7927889|NCT00570687|19508320|P3|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
7927890|NCT00570687|19508321|P2|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
7927891|NCT00570687|19508322|P1|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
7927892|NCT00570674|19508348|P7|NOT COMPLETED|Overall Study||0
7927893|NCT00570674|19508349|P6|NOT COMPLETED|Overall Study||0
7927894|NCT00570674|19508350|P5|NOT COMPLETED|Overall Study||0
7927895|NCT00570674|19508351|P4|NOT COMPLETED|Overall Study||0
7927896|NCT00570674|19508352|P3|NOT COMPLETED|Overall Study||1
7927897|NCT00570674|19508353|P2|NOT COMPLETED|Overall Study||0
7927898|NCT00570674|19508354|P1|NOT COMPLETED|Overall Study||0
7927899|NCT00570674|19508348|P7|COMPLETED|Overall Study||0
7927900|NCT00570674|19508349|P6|COMPLETED|Overall Study||10
7927901|NCT00570674|19508350|P5|COMPLETED|Overall Study||3
7927902|NCT00570674|19508351|P4|COMPLETED|Overall Study||3
7927903|NCT00570674|19508352|P3|COMPLETED|Overall Study||3
7927904|NCT00570674|19508353|P2|COMPLETED|Overall Study||3
7927905|NCT00570674|19508354|P1|COMPLETED|Overall Study||6
7927906|NCT00570674|19508348|P7|PEG Evaluable|Overall Study||0
7927907|NCT00570674|19508349|P6|PEG Evaluable|Overall Study||10
7927908|NCT00570674|19508350|P5|PEG Evaluable|Overall Study||2
7927909|NCT00570674|19508351|P4|PEG Evaluable|Overall Study||3
7927910|NCT00570674|19508352|P3|PEG Evaluable|Overall Study||3
7927911|NCT00570674|19508353|P2|PEG Evaluable|Overall Study||3
7927912|NCT00570674|19508354|P1|PEG Evaluable|Overall Study||6
7927913|NCT00570674|19508348|P7|Treated|Overall Study||0
7927914|NCT00570674|19508349|P6|Treated|Overall Study||10
7927915|NCT00570674|19508350|P5|Treated|Overall Study||3
7927916|NCT00570674|19508351|P4|Treated|Overall Study||3
7927917|NCT00570674|19508352|P3|Treated|Overall Study||3
7927918|NCT00570674|19508353|P2|Treated|Overall Study||3
7927919|NCT00570674|19508354|P1|Treated|Overall Study||6
7927920|NCT00570674|19508348|P7|STARTED|Overall Study|The study did not continue beyond phase I.|0
7927921|NCT00570674|19508349|P6|STARTED|Overall Study||10
7927922|NCT00570674|19508350|P5|STARTED|Overall Study||3
7927923|NCT00570674|19508351|P4|STARTED|Overall Study||3
7927924|NCT00570674|19508352|P3|STARTED|Overall Study||4
7927925|NCT00570674|19508353|P2|STARTED|Overall Study||3
7927926|NCT00570674|19508354|P1|STARTED|Overall Study||6
7927927|NCT00570531|19508371|P1|NOT COMPLETED|Overall Study||0
7927928|NCT00570531|19508371|P1|COMPLETED|Overall Study||6
7927929|NCT00570531|19508371|P1|STARTED|Overall Study||6
7927930|NCT00570505|19508377|P1|NOT COMPLETED|Overall Study||41
7927931|NCT00570505|19508377|P1|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108
7927932|NCT00570505|19508377|P1|STARTED|Overall Study||149
7927933|NCT00570492|19508390|P3|NOT COMPLETED|52-week Double-blind Treatment Period||51
7927934|NCT00570492|19508391|P2|NOT COMPLETED|52-week Double-blind Treatment Period||50
7927935|NCT00570492|19508392|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
7927936|NCT00570492|19508390|P3|COMPLETED|52-week Double-blind Treatment Period||186
7927937|NCT00570492|19508391|P2|COMPLETED|52-week Double-blind Treatment Period||187
7927938|NCT00570492|19508392|P1|COMPLETED|52-week Double-blind Treatment Period||0
7927939|NCT00570492|19508390|P3|STARTED|52-week Double-blind Treatment Period||237
7927940|NCT00570492|19508391|P2|STARTED|52-week Double-blind Treatment Period||237
7927941|NCT00570492|19508392|P1|STARTED|52-week Double-blind Treatment Period||0
7927942|NCT00570492|19508390|P3|NOT COMPLETED|16-week Single-blind Baseline Period||0
7927943|NCT00570492|19508391|P2|NOT COMPLETED|16-week Single-blind Baseline Period||0
7927944|NCT00570492|19508392|P1|NOT COMPLETED|16-week Single-blind Baseline Period||436
7927945|NCT00570492|19508390|P3|COMPLETED|16-week Single-blind Baseline Period||0
7927946|NCT00570492|19508391|P2|COMPLETED|16-week Single-blind Baseline Period||0
7927947|NCT00570492|19508392|P1|COMPLETED|16-week Single-blind Baseline Period||474
7927948|NCT00570492|19508390|P3|STARTED|16-week Single-blind Baseline Period||0
7927949|NCT00570492|19508391|P2|STARTED|16-week Single-blind Baseline Period||0
7927950|NCT00570492|19508392|P1|STARTED|16-week Single-blind Baseline Period||910
7927951|NCT00570401|19508430|P1|NOT COMPLETED|Overall Study||2
7927952|NCT00570401|19508430|P1|COMPLETED|Overall Study||19
7927953|NCT00570401|19508430|P1|STARTED|Overall Study||21
7927954|NCT00570362|19508436|P2|NOT COMPLETED|Overall Study||0
7927955|NCT00570362|19508437|P1|NOT COMPLETED|Overall Study||0
7927956|NCT00570362|19508436|P2|COMPLETED|Overall Study||30
7927957|NCT00570362|19508437|P1|COMPLETED|Overall Study||19
7927958|NCT00570362|19508436|P2|STARTED|Overall Study||30
7927959|NCT00570362|19508437|P1|STARTED|Overall Study||19
7927960|NCT00570349|19508446|P3|NOT COMPLETED|Overall Study||0
7927961|NCT00570349|19508447|P2|NOT COMPLETED|Overall Study||0
7927962|NCT00570349|19508448|P1|NOT COMPLETED|Overall Study||0
7927963|NCT00570349|19508446|P3|COMPLETED|Overall Study||6
7927964|NCT00570349|19508447|P2|COMPLETED|Overall Study||6
7927965|NCT00570349|19508448|P1|COMPLETED|Overall Study||6
7927966|NCT00570349|19508446|P3|STARTED|Overall Study||6
7927967|NCT00570349|19508447|P2|STARTED|Overall Study||6
7927968|NCT00570349|19508448|P1|STARTED|Overall Study||6
7927969|NCT00570323|19508464|P2|NOT COMPLETED|Complete Study After Start||1
7927970|NCT00570323|19508465|P1|NOT COMPLETED|Complete Study After Start||3
7927971|NCT00570323|19508464|P2|COMPLETED|Complete Study After Start||34
7927972|NCT00570323|19508465|P1|COMPLETED|Complete Study After Start||31
7927973|NCT00570323|19508464|P2|STARTED|Complete Study After Start||35
7927974|NCT00570323|19508465|P1|STARTED|Complete Study After Start||34
7927975|NCT00570323|19508464|P2|NOT COMPLETED|Started Treatment After Randomization||1
7927976|NCT00570323|19508465|P1|NOT COMPLETED|Started Treatment After Randomization||2
7927977|NCT00570323|19508464|P2|COMPLETED|Started Treatment After Randomization||35
7927978|NCT00570323|19508465|P1|COMPLETED|Started Treatment After Randomization||34
7927979|NCT00570323|19508464|P2|STARTED|Started Treatment After Randomization||36
7927980|NCT00570323|19508465|P1|STARTED|Started Treatment After Randomization||36
7927981|NCT00570310|19508477|P2|NOT COMPLETED|Overall Study||6
7927982|NCT00570310|19508478|P1|NOT COMPLETED|Overall Study||2
7927983|NCT00570310|19508477|P2|COMPLETED|Overall Study||45
7927984|NCT00570310|19508478|P1|COMPLETED|Overall Study||51
7927985|NCT00570310|19508477|P2|STARTED|Overall Study||51
7927986|NCT00570310|19508478|P1|STARTED|Overall Study||53
7927987|NCT00570258|19508488|P2|NOT COMPLETED|Overall Study||15
7927988|NCT00570258|19508489|P1|NOT COMPLETED|Overall Study||12
7927989|NCT00570258|19508488|P2|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
7927990|NCT00570258|19508489|P1|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
7927991|NCT00570258|19508488|P2|STARTED|Overall Study||15
7927992|NCT00570258|19508489|P1|STARTED|Overall Study||12
7927993|NCT00570232|19508497|P1|NOT COMPLETED|Overall Study||23
7927994|NCT00570232|19508497|P1|COMPLETED|Overall Study||8
7927995|NCT00570232|19508497|P1|STARTED|Overall Study||31
7927996|NCT00570141|19508503|P1|NOT COMPLETED|Overall Study||3
7927997|NCT00570141|19508503|P1|COMPLETED|Overall Study||10
7927998|NCT00570141|19508503|P1|STARTED|Overall Study||13
7927999|NCT00570089|19508508|P2|NOT COMPLETED|Perod 2||0
7928000|NCT00570089|19508509|P1|NOT COMPLETED|Perod 2||0
7928001|NCT00570089|19508508|P2|COMPLETED|Perod 2||10
7928002|NCT00570089|19508509|P1|COMPLETED|Perod 2||10
7928003|NCT00570089|19508508|P2|STARTED|Perod 2||10
7928004|NCT00570089|19508509|P1|STARTED|Perod 2||10
7928005|NCT00570089|19508508|P2|NOT COMPLETED|Period 1||0
7928006|NCT00570089|19508509|P1|NOT COMPLETED|Period 1||0
7928007|NCT00570089|19508508|P2|COMPLETED|Period 1||10
7928008|NCT00570089|19508509|P1|COMPLETED|Period 1||10
7928009|NCT00570089|19508508|P2|STARTED|Period 1||10
7928010|NCT00570089|19508509|P1|STARTED|Period 1||10
7928011|NCT00570063|19508519|P2|NOT COMPLETED|Overall Study||8
7928012|NCT00570063|19508520|P1|NOT COMPLETED|Overall Study||15
7928013|NCT00570063|19508519|P2|COMPLETED|Overall Study||3
7928014|NCT00570063|19508520|P1|COMPLETED|Overall Study||9
7928015|NCT00570063|19508519|P2|STARTED|Overall Study||11
7928016|NCT00570063|19508520|P1|STARTED|Overall Study||24
7928017|NCT00570037|19508586|P2|NOT COMPLETED|Overall Study||69
7928018|NCT00570037|19508587|P1|NOT COMPLETED|Overall Study||44
7928019|NCT00570037|19508586|P2|COMPLETED|Overall Study||237
7928020|NCT00570037|19508587|P1|COMPLETED|Overall Study||194
7928021|NCT00570037|19508586|P2|STARTED|Overall Study||306
7928022|NCT00570037|19508587|P1|STARTED|Overall Study||238
7928023|NCT00569946|19508597|P1|NOT COMPLETED|Overall Study||59
7928024|NCT00569946|19508597|P1|COMPLETED|Overall Study||5
7928025|NCT00569946|19508597|P1|STARTED|Overall Study||64
7928026|NCT00569868|19508613|P1|NOT COMPLETED|Overall Study||0
7928027|NCT00569868|19508613|P1|COMPLETED|Overall Study||11
7928028|NCT00569868|19508613|P1|STARTED|Overall Study||11
7928029|NCT00569855|19508617|P1|NOT COMPLETED|Overall Study||0
7928030|NCT00569855|19508617|P1|COMPLETED|Overall Study|785 subjects treated with study drug|785
7928031|NCT00569855|19508617|P1|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785
7928032|NCT00569803|19508629|P8|NOT COMPLETED|Overall Study||1
7928033|NCT00569803|19508630|P7|NOT COMPLETED|Overall Study||0
7928034|NCT00569803|19508631|P6|NOT COMPLETED|Overall Study||0
7928035|NCT00569803|19508632|P5|NOT COMPLETED|Overall Study||0
7928036|NCT00569803|19508633|P4|NOT COMPLETED|Overall Study||1
7928037|NCT00569803|19508634|P3|NOT COMPLETED|Overall Study||0
7928038|NCT00569803|19508635|P2|NOT COMPLETED|Overall Study||0
7928039|NCT00569803|19508636|P1|NOT COMPLETED|Overall Study||1
7928040|NCT00569803|19508629|P8|COMPLETED|Overall Study||5
7928041|NCT00569803|19508630|P7|COMPLETED|Overall Study||10
7928042|NCT00569803|19508631|P6|COMPLETED|Overall Study||5
7928043|NCT00569803|19508632|P5|COMPLETED|Overall Study||5
7928044|NCT00569803|19508633|P4|COMPLETED|Overall Study||5
7928045|NCT00569803|19508634|P3|COMPLETED|Overall Study||5
7928046|NCT00569803|19508635|P2|COMPLETED|Overall Study||5
7928047|NCT00569803|19508636|P1|COMPLETED|Overall Study||4
7928048|NCT00569803|19508629|P8|STARTED|Overall Study||6
7928049|NCT00569803|19508630|P7|STARTED|Overall Study||10
7928050|NCT00569803|19508631|P6|STARTED|Overall Study||5
7928051|NCT00569803|19508632|P5|STARTED|Overall Study||5
7928052|NCT00569803|19508633|P4|STARTED|Overall Study||6
7928053|NCT00569803|19508634|P3|STARTED|Overall Study||5
7928054|NCT00569803|19508635|P2|STARTED|Overall Study||5
7928055|NCT00569803|19508636|P1|STARTED|Overall Study||5
7928056|NCT00569777|19508763|P2|NOT COMPLETED|Overall Study||3
7928057|NCT00569777|19508764|P1|NOT COMPLETED|Overall Study||10
7928058|NCT00569777|19508763|P2|COMPLETED|Overall Study||101
7928059|NCT00569777|19508764|P1|COMPLETED|Overall Study||196
7928060|NCT00569777|19508763|P2|STARTED|Overall Study||104
7928061|NCT00569777|19508764|P1|STARTED|Overall Study||206
7928062|NCT00569673|19508806|P1|NOT COMPLETED|Overall Study||0
7928063|NCT00569673|19508806|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71
7928064|NCT00569673|19508806|P1|STARTED|Overall Study|Total number participants enrolled on study|71
7928065|NCT00569660|19508811|P1|NOT COMPLETED|Overall Study||0
7928066|NCT00569660|19508811|P1|COMPLETED|Overall Study||34
7928067|NCT00569660|19508811|P1|STARTED|Overall Study||34
7928068|NCT00569582|19508815|P1|NOT COMPLETED|Overall Study||16
7928069|NCT00569582|19508815|P1|COMPLETED|Overall Study||34
7928070|NCT00569582|19508815|P1|STARTED|Overall Study||50
7928071|NCT00569530|19508822|P2|NOT COMPLETED|Overall Study||0
7928072|NCT00569530|19508823|P1|NOT COMPLETED|Overall Study||0
7928073|NCT00569530|19508822|P2|COMPLETED|Overall Study||42
7928074|NCT00569530|19508823|P1|COMPLETED|Overall Study||43
7928075|NCT00569530|19508822|P2|STARTED|Overall Study||42
7928076|NCT00569530|19508823|P1|STARTED|Overall Study||43
7928077|NCT00569374|19508831|P1|NOT COMPLETED|Overall Study||4
7928078|NCT00569374|19508831|P1|COMPLETED|Overall Study||4
7928079|NCT00569374|19508831|P1|STARTED|Overall Study||8
7928080|NCT00569309|19508841|P1|NOT COMPLETED|Overall Study||0
7928081|NCT00569309|19508841|P1|COMPLETED|Overall Study||30
7928082|NCT00569309|19508841|P1|STARTED|Overall Study||30
7928083|NCT00569270|19508850|P2|NOT COMPLETED|Period: Second Intervention||0
7928084|NCT00569270|19508851|P1|NOT COMPLETED|Period: Second Intervention||0
7928085|NCT00569270|19508850|P2|COMPLETED|Period: Second Intervention||14
7928086|NCT00569270|19508851|P1|COMPLETED|Period: Second Intervention||15
7928087|NCT00569270|19508850|P2|29 Days|Period: Second Intervention||14
7928088|NCT00569270|19508851|P1|29 Days|Period: Second Intervention||15
7928089|NCT00569270|19508850|P2|STARTED|Period: Second Intervention||14
7928090|NCT00569270|19508851|P1|STARTED|Period: Second Intervention||15
7928091|NCT00569270|19508850|P2|NOT COMPLETED|Period: First Intervention||1
7928092|NCT00569270|19508851|P1|NOT COMPLETED|Period: First Intervention||0
7928093|NCT00569270|19508850|P2|COMPLETED|Period: First Intervention||14
7928094|NCT00569270|19508851|P1|COMPLETED|Period: First Intervention||15
7928095|NCT00569270|19508850|P2|STARTED|Period: First Intervention||15
7928096|NCT00569270|19508851|P1|STARTED|Period: First Intervention|randomized cross over study|15
7928097|NCT00569231|19508886|P1|NOT COMPLETED|Overall Study||7
7928098|NCT00569231|19508886|P1|COMPLETED|Overall Study||11
7928099|NCT00569231|19508886|P1|STARTED|Overall Study||18
7928100|NCT00569192|19508896|P3|NOT COMPLETED|Overall Study||25
7928101|NCT00569192|19508897|P2|NOT COMPLETED|Overall Study||20
7928102|NCT00569192|19508898|P1|NOT COMPLETED|Overall Study||23
7928103|NCT00569192|19508896|P3|COMPLETED|Overall Study||99
7928104|NCT00569192|19508897|P2|COMPLETED|Overall Study||105
7928105|NCT00569192|19508898|P1|COMPLETED|Overall Study||88
7928106|NCT00569192|19508896|P3|STARTED|Overall Study||124
7928107|NCT00569192|19508897|P2|STARTED|Overall Study||125
7928108|NCT00569192|19508898|P1|STARTED|Overall Study||111
7928109|NCT00569166|19508924|P3|NOT COMPLETED|Overall Study||4
7928110|NCT00569166|19508925|P2|NOT COMPLETED|Overall Study||6
7928111|NCT00569166|19508926|P1|NOT COMPLETED|Overall Study||9
7928112|NCT00569166|19508924|P3|COMPLETED|Overall Study||27
7928113|NCT00569166|19508925|P2|COMPLETED|Overall Study||25
7928114|NCT00569166|19508926|P1|COMPLETED|Overall Study||21
7928115|NCT00569166|19508924|P3|STARTED|Overall Study||31
7928116|NCT00569166|19508925|P2|STARTED|Overall Study||31
7928117|NCT00569166|19508926|P1|STARTED|Overall Study||30
7928118|NCT00569127|19508960|P2|NOT COMPLETED|Overall Study||213
7928119|NCT00569127|19508961|P1|NOT COMPLETED|Overall Study||214
7928120|NCT00569127|19508960|P2|COMPLETED|Overall Study||0
7928121|NCT00569127|19508961|P1|COMPLETED|Overall Study||0
7928122|NCT00569127|19508960|P2|Eligible|Overall Study||202
7928123|NCT00569127|19508961|P1|Eligible|Overall Study||200
7928124|NCT00569127|19508960|P2|STARTED|Overall Study||213
7928125|NCT00569127|19508961|P1|STARTED|Overall Study||214
7928126|NCT00569010|19508981|P4|NOT COMPLETED|Overall Study||0
7928127|NCT00569010|19508982|P3|NOT COMPLETED|Overall Study||0
7928128|NCT00569010|19508983|P2|NOT COMPLETED|Overall Study||0
7928129|NCT00569010|19508984|P1|NOT COMPLETED|Overall Study||0
7928130|NCT00569010|19508981|P4|COMPLETED|Overall Study||11
7928131|NCT00569010|19508982|P3|COMPLETED|Overall Study||11
7928132|NCT00569010|19508983|P2|COMPLETED|Overall Study||6
7928133|NCT00569010|19508984|P1|COMPLETED|Overall Study||6
7928134|NCT00569010|19508981|P4|STARTED|Overall Study||11
7928135|NCT00569010|19508982|P3|STARTED|Overall Study||11
7928136|NCT00569010|19508983|P2|STARTED|Overall Study||6
7928137|NCT00569010|19508984|P1|STARTED|Overall Study||6
7928138|NCT00568958|19508996|P2|NOT COMPLETED|Follow-Up||7
7928139|NCT00568958|19508997|P1|NOT COMPLETED|Follow-Up||9
7928140|NCT00568958|19508996|P2|COMPLETED|Follow-Up||60
7928141|NCT00568958|19508997|P1|COMPLETED|Follow-Up||52
7928142|NCT00568958|19508996|P2|STARTED|Follow-Up||67
7928143|NCT00568958|19508997|P1|STARTED|Follow-Up||61
7928144|NCT00568958|19508996|P2|NOT COMPLETED|Allocation||3
7928145|NCT00568958|19508997|P1|NOT COMPLETED|Allocation||9
7928146|NCT00568958|19508996|P2|COMPLETED|Allocation||67
7928147|NCT00568958|19508997|P1|COMPLETED|Allocation||61
7928148|NCT00568958|19508996|P2|STARTED|Allocation||70
7928149|NCT00568958|19508997|P1|STARTED|Allocation||70
7928150|NCT00568854|19509017|P2|NOT COMPLETED|Overall Study||0
7928151|NCT00568854|19509018|P1|NOT COMPLETED|Overall Study||0
7928152|NCT00568854|19509017|P2|COMPLETED|Overall Study||4
7928153|NCT00568854|19509018|P1|COMPLETED|Overall Study||6
7928154|NCT00568854|19509017|P2|STARTED|Overall Study||4
7928155|NCT00568854|19509018|P1|STARTED|Overall Study||6
7928156|NCT00568802|19509026|P1|NOT COMPLETED|Overall Study||3
7928157|NCT00568802|19509026|P1|COMPLETED|Overall Study||24
7928158|NCT00568802|19509026|P1|STARTED|Overall Study||27
7928159|NCT00568776|19509044|P4|NOT COMPLETED|Overall Study||72
7928160|NCT00568776|19509045|P3|NOT COMPLETED|Overall Study||74
7928161|NCT00568776|19509046|P2|NOT COMPLETED|Overall Study||36
7928162|NCT00568776|19509047|P1|NOT COMPLETED|Overall Study||30
7928163|NCT00568776|19509044|P4|COMPLETED|Overall Study||19
7928164|NCT00568776|19509045|P3|COMPLETED|Overall Study||15
7928165|NCT00568776|19509046|P2|COMPLETED|Overall Study||52
7928166|NCT00568776|19509047|P1|COMPLETED|Overall Study||53
7928167|NCT00568776|19509044|P4|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91
7928168|NCT00568776|19509045|P3|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89
7928169|NCT00568776|19509046|P2|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88
7928170|NCT00568776|19509047|P1|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83
7928171|NCT00568698|19509081|P1|NOT COMPLETED|Overall Study||11
7928172|NCT00568698|19509081|P1|COMPLETED|Overall Study||18
7928173|NCT00568698|19509081|P1|STARTED|Overall Study||29
7928174|NCT00568685|19509096|P3|NOT COMPLETED|Overall Study||5
7928175|NCT00568685|19509097|P2|NOT COMPLETED|Overall Study||5
7928176|NCT00568685|19509098|P1|NOT COMPLETED|Overall Study||10
7928177|NCT00568685|19509096|P3|COMPLETED|Overall Study||46
7928178|NCT00568685|19509097|P2|COMPLETED|Overall Study||46
7928179|NCT00568685|19509098|P1|COMPLETED|Overall Study||41
7928180|NCT00568685|19509096|P3|STARTED|Overall Study||51
7928181|NCT00568685|19509097|P2|STARTED|Overall Study||51
7928182|NCT00568685|19509098|P1|STARTED|Overall Study||51
7928183|NCT00568633|19509132|P2|NOT COMPLETED|Overall Study||0
7928184|NCT00568633|19509133|P1|NOT COMPLETED|Overall Study||0
7928185|NCT00568633|19509132|P2|COMPLETED|Overall Study||33
7928186|NCT00568633|19509133|P1|COMPLETED|Overall Study||25
7928187|NCT00568633|19509132|P2|STARTED|Overall Study||33
7928188|NCT00568633|19509133|P1|STARTED|Overall Study||25
7928189|NCT00568555|19509155|P2|NOT COMPLETED|Overall Study||1
7928190|NCT00568555|19509156|P1|NOT COMPLETED|Overall Study||1
7928191|NCT00568555|19509155|P2|COMPLETED|Overall Study||14
7928192|NCT00568555|19509156|P1|COMPLETED|Overall Study||15
7928193|NCT00568555|19509155|P2|STARTED|Overall Study||15
7928194|NCT00568555|19509156|P1|STARTED|Overall Study||16
7928195|NCT00568451|19509174|P4|NOT COMPLETED|Overall Study||7
7928196|NCT00568451|19509175|P3|NOT COMPLETED|Overall Study||2
7928197|NCT00568451|19509176|P2|NOT COMPLETED|Overall Study||0
7928198|NCT00568451|19509177|P1|NOT COMPLETED|Overall Study||0
7928199|NCT00568451|19509174|P4|COMPLETED|Overall Study||2
7928200|NCT00568451|19509175|P3|COMPLETED|Overall Study||0
7928201|NCT00568451|19509176|P2|COMPLETED|Overall Study||0
7928202|NCT00568451|19509177|P1|COMPLETED|Overall Study||0
7928203|NCT00568451|19509174|P4|STARTED|Overall Study||9
7928204|NCT00568451|19509175|P3|STARTED|Overall Study||2
7928205|NCT00568451|19509176|P2|STARTED|Overall Study||0
7928206|NCT00568451|19509177|P1|STARTED|Overall Study||0
7928207|NCT00568399|19509193|P1|NOT COMPLETED|Overall Study||15
7928208|NCT00568399|19509193|P1|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22
7928209|NCT00568399|19509193|P1|STARTED|Overall Study||37
7928210|NCT00568386|19509199|P2|NOT COMPLETED|Overall Study||0
7928211|NCT00568386|19509200|P1|NOT COMPLETED|Overall Study||0
7928212|NCT00568386|19509199|P2|COMPLETED|Overall Study||20
7928213|NCT00568386|19509200|P1|COMPLETED|Overall Study||20
7928214|NCT00568386|19509199|P2|STARTED|Overall Study||20
7928215|NCT00568386|19509200|P1|STARTED|Overall Study||20
7928216|NCT00568334|19509208|P2|NOT COMPLETED|Overall Study||1
7928217|NCT00568334|19509209|P1|NOT COMPLETED|Overall Study||1
7928218|NCT00568334|19509208|P2|COMPLETED|Overall Study||121
7928219|NCT00568334|19509209|P1|COMPLETED|Overall Study||121
7928220|NCT00568334|19509208|P2|STARTED|Overall Study||122
7928221|NCT00568334|19509209|P1|STARTED|Overall Study||122
7928222|NCT00568178|19509235|P6|NOT COMPLETED|Open Label Extension||80
7928223|NCT00568178|19509236|P5|NOT COMPLETED|Open Label Extension||79
7928224|NCT00568178|19509237|P4|NOT COMPLETED|Open Label Extension||0
7928225|NCT00568178|19509238|P3|NOT COMPLETED|Open Label Extension||0
7928226|NCT00568178|19509239|P2|NOT COMPLETED|Open Label Extension||0
7928227|NCT00568178|19509240|P1|NOT COMPLETED|Open Label Extension||0
7928228|NCT00568178|19509235|P6|COMPLETED|Open Label Extension||54
7928229|NCT00568178|19509236|P5|COMPLETED|Open Label Extension||55
7928230|NCT00568178|19509237|P4|COMPLETED|Open Label Extension||0
7928231|NCT00568178|19509238|P3|COMPLETED|Open Label Extension||0
7928232|NCT00568178|19509239|P2|COMPLETED|Open Label Extension||0
7928233|NCT00568178|19509240|P1|COMPLETED|Open Label Extension||0
7928234|NCT00568178|19509235|P6|STARTED|Open Label Extension||134
7928235|NCT00568178|19509236|P5|STARTED|Open Label Extension||134
7928236|NCT00568178|19509237|P4|STARTED|Open Label Extension||0
7928237|NCT00568178|19509238|P3|STARTED|Open Label Extension||0
7928238|NCT00568178|19509239|P2|STARTED|Open Label Extension||0
7928239|NCT00568178|19509240|P1|STARTED|Open Label Extension||0
7928240|NCT00568178|19509235|P6|NOT COMPLETED|Double Blind Base Study||0
7928241|NCT00568178|19509236|P5|NOT COMPLETED|Double Blind Base Study||0
7928242|NCT00568178|19509237|P4|NOT COMPLETED|Double Blind Base Study||5
7928243|NCT00568178|19509238|P3|NOT COMPLETED|Double Blind Base Study||1
7928244|NCT00568178|19509239|P2|NOT COMPLETED|Double Blind Base Study||6
7928245|NCT00568178|19509240|P1|NOT COMPLETED|Double Blind Base Study||6
7928246|NCT00568178|19509235|P6|COMPLETED|Double Blind Base Study||0
7928247|NCT00568178|19509236|P5|COMPLETED|Double Blind Base Study||0
7928248|NCT00568178|19509237|P4|COMPLETED|Double Blind Base Study||25
7928249|NCT00568178|19509238|P3|COMPLETED|Double Blind Base Study||29
7928250|NCT00568178|19509239|P2|COMPLETED|Double Blind Base Study||118
7928251|NCT00568178|19509240|P1|COMPLETED|Double Blind Base Study||116
7928252|NCT00568178|19509235|P6|STARTED|Double Blind Base Study||0
7928253|NCT00568178|19509236|P5|STARTED|Double Blind Base Study||0
7928254|NCT00568178|19509237|P4|STARTED|Double Blind Base Study||30
7928255|NCT00568178|19509238|P3|STARTED|Double Blind Base Study||30
7928256|NCT00568178|19509239|P2|STARTED|Double Blind Base Study||124
7928257|NCT00568178|19509240|P1|STARTED|Double Blind Base Study||122
7928258|NCT00568126|19509258|P2|NOT COMPLETED|Overall Study||9
7928259|NCT00568126|19509259|P1|NOT COMPLETED|Overall Study||11
7928260|NCT00568126|19509258|P2|COMPLETED|Overall Study||12
7928261|NCT00568126|19509259|P1|COMPLETED|Overall Study||13
7928262|NCT00568126|19509258|P2|STARTED|Overall Study||21
7928263|NCT00568126|19509259|P1|STARTED|Overall Study||24
7928264|NCT00568087|19509269|P2|NOT COMPLETED|Overall Study||7
7928265|NCT00568087|19509270|P1|NOT COMPLETED|Overall Study||7
7928266|NCT00568087|19509269|P2|COMPLETED|Overall Study||17
7928267|NCT00568087|19509270|P1|COMPLETED|Overall Study||15
7928268|NCT00568087|19509269|P2|Received Intervention|Overall Study||23
7928269|NCT00568087|19509270|P1|Received Intervention|Overall Study||21
7928270|NCT00568087|19509269|P2|STARTED|Overall Study||24
7928271|NCT00568087|19509270|P1|STARTED|Overall Study||22
7928272|NCT00568061|19509284|P2|NOT COMPLETED|Overall Study||2
7928273|NCT00568061|19509285|P1|NOT COMPLETED|Overall Study||5
7928274|NCT00568061|19509284|P2|COMPLETED|Overall Study||14
7928275|NCT00568061|19509285|P1|COMPLETED|Overall Study||8
7928276|NCT00568061|19509284|P2|STARTED|Overall Study||16
7928277|NCT00568061|19509285|P1|STARTED|Overall Study||13
7928278|NCT00568022|19509313|P3|NOT COMPLETED|Overall Study||0
7928279|NCT00568022|19509314|P2|NOT COMPLETED|Overall Study||0
7928280|NCT00568022|19509315|P1|NOT COMPLETED|Overall Study||0
7928281|NCT00568022|19509313|P3|COMPLETED|Overall Study||3
7928282|NCT00568022|19509314|P2|COMPLETED|Overall Study||3
7928283|NCT00568022|19509315|P1|COMPLETED|Overall Study||3
7928284|NCT00568022|19509313|P3|STARTED|Overall Study||3
7928285|NCT00568022|19509314|P2|STARTED|Overall Study||3
7928286|NCT00568022|19509315|P1|STARTED|Overall Study||3
7928287|NCT00567996|19509348|P3|NOT COMPLETED|Overall Study||70
7928288|NCT00567996|19509349|P2|NOT COMPLETED|Overall Study||50
7928289|NCT00567996|19509350|P1|NOT COMPLETED|Overall Study||44
7928290|NCT00567996|19509348|P3|COMPLETED|Overall Study||265
7928291|NCT00567996|19509349|P2|COMPLETED|Overall Study||284
7928292|NCT00567996|19509350|P1|COMPLETED|Overall Study||289
7928293|NCT00567996|19509348|P3|Intent-to-treat: Received Study Drug|Overall Study||335
7928294|NCT00567996|19509349|P2|Intent-to-treat: Received Study Drug|Overall Study||333
7928295|NCT00567996|19509350|P1|Intent-to-treat: Received Study Drug|Overall Study||330
7928296|NCT00567996|19509348|P3|STARTED|Overall Study||335
7928297|NCT00567996|19509349|P2|STARTED|Overall Study||334
7928298|NCT00567996|19509350|P1|STARTED|Overall Study|Randomized participants|333
7928299|NCT00567892|19509366|P4|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1
7928300|NCT00567892|19509367|P3|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
7928301|NCT00567892|19509368|P2|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
7928302|NCT00567892|19509369|P1|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
7928303|NCT00567892|19509366|P4|COMPLETED|Second Treatment (2 or 4 Weeks)||5
7928304|NCT00567892|19509367|P3|COMPLETED|Second Treatment (2 or 4 Weeks)||9
7928305|NCT00567892|19509368|P2|COMPLETED|Second Treatment (2 or 4 Weeks)||7
7928306|NCT00567892|19509369|P1|COMPLETED|Second Treatment (2 or 4 Weeks)||7
7928307|NCT00567892|19509366|P4|STARTED|Second Treatment (2 or 4 Weeks)||6
7928308|NCT00567892|19509367|P3|STARTED|Second Treatment (2 or 4 Weeks)||9
7928309|NCT00567892|19509368|P2|STARTED|Second Treatment (2 or 4 Weeks)||7
7928310|NCT00567892|19509369|P1|STARTED|Second Treatment (2 or 4 Weeks)||7
7928311|NCT00567892|19509366|P4|NOT COMPLETED|Washout (2 Weeks)||0
7928312|NCT00567892|19509367|P3|NOT COMPLETED|Washout (2 Weeks)||0
7928313|NCT00567892|19509368|P2|NOT COMPLETED|Washout (2 Weeks)||0
7928314|NCT00567892|19509369|P1|NOT COMPLETED|Washout (2 Weeks)||0
7928315|NCT00567892|19509366|P4|COMPLETED|Washout (2 Weeks)||6
7928316|NCT00567892|19509367|P3|COMPLETED|Washout (2 Weeks)||9
7928317|NCT00567892|19509368|P2|COMPLETED|Washout (2 Weeks)||7
7928318|NCT00567892|19509369|P1|COMPLETED|Washout (2 Weeks)||7
7928319|NCT00567892|19509366|P4|STARTED|Washout (2 Weeks)||6
7928320|NCT00567892|19509367|P3|STARTED|Washout (2 Weeks)||9
7928321|NCT00567892|19509368|P2|STARTED|Washout (2 Weeks)||7
7928322|NCT00567892|19509369|P1|STARTED|Washout (2 Weeks)||7
7928323|NCT00567892|19509366|P4|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4
7928324|NCT00567892|19509367|P3|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1
7928325|NCT00567892|19509368|P2|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
7928326|NCT00567892|19509369|P1|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
7928327|NCT00567892|19509366|P4|COMPLETED|First Treatment (2 or 4 Weeks)||6
7928328|NCT00567892|19509367|P3|COMPLETED|First Treatment (2 or 4 Weeks)||9
7928329|NCT00567892|19509368|P2|COMPLETED|First Treatment (2 or 4 Weeks)||7
7928330|NCT00567892|19509369|P1|COMPLETED|First Treatment (2 or 4 Weeks)||7
7928331|NCT00567892|19509366|P4|STARTED|First Treatment (2 or 4 Weeks)||10
7928332|NCT00567892|19509367|P3|STARTED|First Treatment (2 or 4 Weeks)||10
7928333|NCT00567892|19509368|P2|STARTED|First Treatment (2 or 4 Weeks)||7
7928334|NCT00567892|19509369|P1|STARTED|First Treatment (2 or 4 Weeks)||7
7928335|NCT00567879|19509387|P6|NOT COMPLETED|Overall Study||3
7928336|NCT00567879|19509388|P5|NOT COMPLETED|Overall Study||12
7928337|NCT00567879|19509389|P4|NOT COMPLETED|Overall Study||6
7928338|NCT00567879|19509390|P3|NOT COMPLETED|Overall Study||21
7928339|NCT00567879|19509391|P2|NOT COMPLETED|Overall Study||7
7928340|NCT00567879|19509392|P1|NOT COMPLETED|Overall Study||7
7928341|NCT00567879|19509387|P6|COMPLETED|Overall Study||0
7928342|NCT00567879|19509388|P5|COMPLETED|Overall Study||0
7928343|NCT00567879|19509389|P4|COMPLETED|Overall Study||0
7928344|NCT00567879|19509390|P3|COMPLETED|Overall Study||0
7928345|NCT00567879|19509391|P2|COMPLETED|Overall Study||0
7928346|NCT00567879|19509392|P1|COMPLETED|Overall Study||0
7928347|NCT00567879|19509387|P6|Maximum Tolerated Dose Determining Set|Overall Study||3
7928348|NCT00567879|19509388|P5|Maximum Tolerated Dose Determining Set|Overall Study||12
7928349|NCT00567879|19509389|P4|Maximum Tolerated Dose Determining Set|Overall Study||6
7928350|NCT00567879|19509390|P3|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18
7928351|NCT00567879|19509391|P2|Maximum Tolerated Dose Determining Set|Overall Study||7
7928352|NCT00567879|19509392|P1|Maximum Tolerated Dose Determining Set|Overall Study||5
7928353|NCT00567879|19509387|P6|STARTED|Overall Study||3
7928354|NCT00567879|19509388|P5|STARTED|Overall Study||12
7928355|NCT00567879|19509389|P4|STARTED|Overall Study||6
7928356|NCT00567879|19509390|P3|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21
7928357|NCT00567879|19509391|P2|STARTED|Overall Study||7
7928358|NCT00567879|19509392|P1|STARTED|Overall Study||7
7928359|NCT00567840|19509418|P5|NOT COMPLETED|Overall Study||0
7928360|NCT00567840|19509419|P4|NOT COMPLETED|Overall Study||1
7928361|NCT00567840|19509420|P3|NOT COMPLETED|Overall Study||1
7928362|NCT00567840|19509421|P2|NOT COMPLETED|Overall Study||0
7928363|NCT00567840|19509422|P1|NOT COMPLETED|Overall Study||2
7928364|NCT00567840|19509418|P5|COMPLETED|Overall Study||8
7928365|NCT00567840|19509419|P4|COMPLETED|Overall Study||14
7928366|NCT00567840|19509420|P3|COMPLETED|Overall Study||15
7928367|NCT00567840|19509421|P2|COMPLETED|Overall Study||15
7928368|NCT00567840|19509422|P1|COMPLETED|Overall Study||13
7928369|NCT00567840|19509418|P5|STARTED|Overall Study||8
7928370|NCT00567840|19509419|P4|STARTED|Overall Study||15
7928371|NCT00567840|19509420|P3|STARTED|Overall Study||16
7928372|NCT00567840|19509421|P2|STARTED|Overall Study||15
7928373|NCT00567840|19509422|P1|STARTED|Overall Study||15
7928374|NCT00567593|19509459|P1|NOT COMPLETED|Overall Study||2
7928375|NCT00567593|19509459|P1|COMPLETED|Overall Study||10
7928376|NCT00567593|19509459|P1|STARTED|Overall Study||12
7928377|NCT00567567|19509466|P3|NOT COMPLETED|Overall Study||278
7928378|NCT00567567|19509467|P2|NOT COMPLETED|Overall Study||134
7928379|NCT00567567|19509468|P1|NOT COMPLETED|Overall Study||152
7928380|NCT00567567|19509466|P3|COMPLETED|Overall Study||1
7928381|NCT00567567|19509467|P2|COMPLETED|Overall Study||42
7928382|NCT00567567|19509468|P1|COMPLETED|Overall Study||58
7928383|NCT00567567|19509466|P3|STARTED|Overall Study||279
7928384|NCT00567567|19509467|P2|STARTED|Overall Study||176
7928385|NCT00567567|19509468|P1|STARTED|Overall Study||210
7928386|NCT00567541|19509516|P2|NOT COMPLETED|Overall Study||1
7928387|NCT00567541|19509517|P1|NOT COMPLETED|Overall Study||0
7928388|NCT00567541|19509516|P2|COMPLETED|Overall Study||8
7928389|NCT00567541|19509517|P1|COMPLETED|Overall Study||7
7928390|NCT00567541|19509516|P2|STARTED|Overall Study||9
7928391|NCT00567541|19509517|P1|STARTED|Overall Study||7
7928392|NCT00567502|19509527|P4|NOT COMPLETED|Overall Study||87
7928393|NCT00567502|19509528|P3|NOT COMPLETED|Overall Study||908
7928394|NCT00567502|19509529|P2|NOT COMPLETED|Overall Study||33
7928395|NCT00567502|19509530|P1|NOT COMPLETED|Overall Study||241
7928396|NCT00567502|19509527|P4|COMPLETED|Overall Study||23
7928397|NCT00567502|19509528|P3|COMPLETED|Overall Study||1758
7928398|NCT00567502|19509529|P2|COMPLETED|Overall Study||108
7928399|NCT00567502|19509530|P1|COMPLETED|Overall Study||563
7928400|NCT00567502|19509527|P4|Initiated Treatment|Overall Study||38
7928401|NCT00567502|19509528|P3|Initiated Treatment|Overall Study||2666
7928402|NCT00567502|19509529|P2|Initiated Treatment|Overall Study||141
7928403|NCT00567502|19509530|P1|Initiated Treatment|Overall Study||804
7928404|NCT00567502|19509527|P4|STARTED|Overall Study||110
7928405|NCT00567502|19509528|P3|STARTED|Overall Study||2666
7928406|NCT00567502|19509529|P2|STARTED|Overall Study||141
7928407|NCT00567502|19509530|P1|STARTED|Overall Study||804
7928408|NCT00567489|19509567|P2|NOT COMPLETED|Overall Study||23
7928409|NCT00567489|19509568|P1|NOT COMPLETED|Overall Study||7
7928410|NCT00567489|19509567|P2|COMPLETED|Overall Study||101
7928411|NCT00567489|19509568|P1|COMPLETED|Overall Study||120
7928412|NCT00567489|19509567|P2|STARTED|Overall Study||124
7928413|NCT00567489|19509568|P1|STARTED|Overall Study||127
7928414|NCT00567476|19509618|P2|NOT COMPLETED|Overall Study||4
7928415|NCT00567476|19509619|P1|NOT COMPLETED|Overall Study||8
7928416|NCT00567476|19509618|P2|COMPLETED|Overall Study||34
7928417|NCT00567476|19509619|P1|COMPLETED|Overall Study||70
7928418|NCT00567476|19509618|P2|STARTED|Overall Study||38
7928419|NCT00567476|19509619|P1|STARTED|Overall Study||78
7928420|NCT00567398|19509645|P2|NOT COMPLETED|Overall Study||23
7928421|NCT00567398|19509646|P1|NOT COMPLETED|Overall Study||7
7928422|NCT00567398|19509645|P2|COMPLETED|Overall Study||101
7928423|NCT00567398|19509646|P1|COMPLETED|Overall Study||120
7928424|NCT00567398|19509645|P2|STARTED|Overall Study||124
7928425|NCT00567398|19509646|P1|STARTED|Overall Study||127
7928426|NCT00567359|19509694|P1|NOT COMPLETED|Overall Study||1
7928427|NCT00567359|19509694|P1|COMPLETED|Overall Study||99
7928428|NCT00567359|19509694|P1|STARTED|Overall Study||100
7928429|NCT00567320|19509703|P2|NOT COMPLETED|Overall Study||0
7928430|NCT00567320|19509704|P1|NOT COMPLETED|Overall Study||0
7928431|NCT00567320|19509703|P2|COMPLETED|Overall Study||18
7928432|NCT00567320|19509704|P1|COMPLETED|Overall Study||13
7928433|NCT00567320|19509703|P2|STARTED|Overall Study||18
7928434|NCT00567320|19509704|P1|STARTED|Overall Study||13
7928435|NCT00567307|19509712|P2|NOT COMPLETED|Overall Study||1
7928436|NCT00567307|19509713|P1|NOT COMPLETED|Overall Study||12
7928437|NCT00567307|19509712|P2|COMPLETED|Overall Study||104
7928438|NCT00567307|19509713|P1|COMPLETED|Overall Study||99
7928439|NCT00567307|19509712|P2|STARTED|Overall Study||105
7928440|NCT00567307|19509713|P1|STARTED|Overall Study||111
7928441|NCT00567268|19509719|P1|NOT COMPLETED|Overall Study||50
7928442|NCT00567268|19509719|P1|COMPLETED|Overall Study||1144
7928443|NCT00567268|19509719|P1|STARTED|Overall Study||1194
7928444|NCT00567255|19509770|P2|NOT COMPLETED|Overall Study||228
7928445|NCT00567255|19509771|P1|NOT COMPLETED|Overall Study||463
7928446|NCT00567255|19509770|P2|COMPLETED|Overall Study||267
7928447|NCT00567255|19509771|P1|COMPLETED|Overall Study||538
7928448|NCT00567255|19509770|P2|STARTED|Overall Study||495
7928449|NCT00567255|19509771|P1|STARTED|Overall Study||1001
7928450|NCT00567242|19509817|P2|NOT COMPLETED|Overall Study||0
7928451|NCT00567242|19509818|P1|NOT COMPLETED|Overall Study||0
7928452|NCT00567242|19509817|P2|COMPLETED|Overall Study||7
7928453|NCT00567242|19509818|P1|COMPLETED|Overall Study||7
7928454|NCT00567242|19509817|P2|STARTED|Overall Study||7
7928455|NCT00567242|19509818|P1|STARTED|Overall Study||7
7928456|NCT00567229|19509828|P1|NOT COMPLETED|Overall Study||0
7928457|NCT00567229|19509828|P1|COMPLETED|Overall Study||3
7928458|NCT00567229|19509828|P1|STARTED|Overall Study||3
7928459|NCT00567190|19509834|P2|NOT COMPLETED|Overall Study||333
7928460|NCT00567190|19509835|P1|NOT COMPLETED|Overall Study||283
7928461|NCT00567190|19509834|P2|COMPLETED|Overall Study||73
7928462|NCT00567190|19509835|P1|COMPLETED|Overall Study||119
7928463|NCT00567190|19509834|P2|Crossover From Placebo to Pertuzumab|Overall Study|From July 2012, 50 participants randomized to Placebo arm crossed over to open-label pertuzumab.|50
7928464|NCT00567190|19509835|P1|Crossover From Placebo to Pertuzumab|Overall Study||0
7928465|NCT00567190|19509834|P2|Received at Least One Dose of Placebo|Overall Study||395
7928466|NCT00567190|19509835|P1|Received at Least One Dose of Placebo|Overall Study|1 participant randomized to the Pertuzumab arm actually received placebo at every treatment cycle.|1
7928467|NCT00567190|19509834|P2|Received at Least One Dose of Pertuzumab|Overall Study|9 participants randomized to the Placebo arm actually received at least one dose of pertuzumab.|9
7928468|NCT00567190|19509835|P1|Received at Least One Dose of Pertuzumab|Overall Study||399
7928469|NCT00567190|19509834|P2|Did Not Receive Any Study Treatment|Overall Study||2
7928470|NCT00567190|19509835|P1|Did Not Receive Any Study Treatment|Overall Study||2
7928471|NCT00567190|19509834|P2|STARTED|Overall Study||406
7928472|NCT00567190|19509835|P1|STARTED|Overall Study||402
7928473|NCT00567164|19509886|P3|NOT COMPLETED|Overall Study||72
7928474|NCT00567164|19509887|P2|NOT COMPLETED|Overall Study||73
7928475|NCT00567164|19509888|P1|NOT COMPLETED|Overall Study||546
7928476|NCT00567164|19509886|P3|COMPLETED|Overall Study||160
7928477|NCT00567164|19509887|P2|COMPLETED|Overall Study||161
7928478|NCT00567164|19509888|P1|COMPLETED|Overall Study||875
7928479|NCT00567164|19509886|P3|Subjects Received Treatment|Overall Study|Full Analysis Set|226
7928480|NCT00567164|19509887|P2|Subjects Received Treatment|Overall Study|Full Analysis Set|232
7928481|NCT00567164|19509888|P1|Subjects Received Treatment|Overall Study|Full Analysis Set|1406
7928482|NCT00567164|19509886|P3|STARTED|Overall Study||232
7928483|NCT00567164|19509887|P2|STARTED|Overall Study||234
7928484|NCT00567164|19509888|P1|STARTED|Overall Study||1421
7928485|NCT00567112|19509960|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
7928486|NCT00567112|19509961|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
7928487|NCT00567112|19509962|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
7928488|NCT00567112|19509960|P3|COMPLETED|Treatment Period 4 (3 Days)||3
7928489|NCT00567112|19509961|P2|COMPLETED|Treatment Period 4 (3 Days)||7
7928490|NCT00567112|19509962|P1|COMPLETED|Treatment Period 4 (3 Days)||4
7928491|NCT00567112|19509960|P3|STARTED|Treatment Period 4 (3 Days)||3
7928492|NCT00567112|19509961|P2|STARTED|Treatment Period 4 (3 Days)||7
7928493|NCT00567112|19509962|P1|STARTED|Treatment Period 4 (3 Days)||4
7928494|NCT00567112|19509960|P3|NOT COMPLETED|Washout Period 3 (3 Days)||0
7928495|NCT00567112|19509961|P2|NOT COMPLETED|Washout Period 3 (3 Days)||0
7928496|NCT00567112|19509962|P1|NOT COMPLETED|Washout Period 3 (3 Days)||3
7928497|NCT00567112|19509960|P3|COMPLETED|Washout Period 3 (3 Days)||3
7928498|NCT00567112|19509961|P2|COMPLETED|Washout Period 3 (3 Days)||7
7928499|NCT00567112|19509962|P1|COMPLETED|Washout Period 3 (3 Days)||4
7928500|NCT00567112|19509960|P3|STARTED|Washout Period 3 (3 Days)||3
7928501|NCT00567112|19509961|P2|STARTED|Washout Period 3 (3 Days)||7
7928502|NCT00567112|19509962|P1|STARTED|Washout Period 3 (3 Days)||7
7928503|NCT00567112|19509960|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
7928504|NCT00567112|19509961|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
7928505|NCT00567112|19509962|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
7928506|NCT00567112|19509960|P3|COMPLETED|Treatment Period 3 (3 Days)||3
7928507|NCT00567112|19509961|P2|COMPLETED|Treatment Period 3 (3 Days)||7
7928508|NCT00567112|19509962|P1|COMPLETED|Treatment Period 3 (3 Days)||7
7928509|NCT00567112|19509960|P3|STARTED|Treatment Period 3 (3 Days)||3
7928510|NCT00567112|19509961|P2|STARTED|Treatment Period 3 (3 Days)||7
7928511|NCT00567112|19509962|P1|STARTED|Treatment Period 3 (3 Days)||7
7928512|NCT00567112|19509960|P3|NOT COMPLETED|Washout Period 2 (3 Days)||0
7928513|NCT00567112|19509961|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
7928514|NCT00567112|19509962|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
7928515|NCT00567112|19509960|P3|COMPLETED|Washout Period 2 (3 Days)||3
7928516|NCT00567112|19509961|P2|COMPLETED|Washout Period 2 (3 Days)||7
7928517|NCT00567112|19509962|P1|COMPLETED|Washout Period 2 (3 Days)||7
7928518|NCT00567112|19509960|P3|STARTED|Washout Period 2 (3 Days)||3
7928519|NCT00567112|19509961|P2|STARTED|Washout Period 2 (3 Days)||7
7928520|NCT00567112|19509962|P1|STARTED|Washout Period 2 (3 Days)||7
7928521|NCT00567112|19509960|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
7928522|NCT00567112|19509961|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||1
7928523|NCT00567112|19509962|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
7928524|NCT00567112|19509960|P3|COMPLETED|Treatment Period 2 (3 Days)||3
7928525|NCT00567112|19509961|P2|COMPLETED|Treatment Period 2 (3 Days)||7
7928526|NCT00567112|19509962|P1|COMPLETED|Treatment Period 2 (3 Days)||7
7928527|NCT00567112|19509960|P3|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3
7928528|NCT00567112|19509961|P2|STARTED|Treatment Period 2 (3 Days)||8
7928529|NCT00567112|19509962|P1|STARTED|Treatment Period 2 (3 Days)||7
7928530|NCT00567112|19509960|P3|NOT COMPLETED|Washout Period 1 (3 Days)||0
7928531|NCT00567112|19509961|P2|NOT COMPLETED|Washout Period 1 (3 Days)||0
7928532|NCT00567112|19509962|P1|NOT COMPLETED|Washout Period 1 (3 Days)||0
7928533|NCT00567112|19509960|P3|COMPLETED|Washout Period 1 (3 Days)||0
7928534|NCT00567112|19509961|P2|COMPLETED|Washout Period 1 (3 Days)||8
7928535|NCT00567112|19509962|P1|COMPLETED|Washout Period 1 (3 Days)||7
7928536|NCT00567112|19509960|P3|STARTED|Washout Period 1 (3 Days)||0
7928537|NCT00567112|19509961|P2|STARTED|Washout Period 1 (3 Days)||8
7928538|NCT00567112|19509962|P1|STARTED|Washout Period 1 (3 Days)||7
7928539|NCT00567112|19509960|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
7928540|NCT00567112|19509961|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
7928541|NCT00567112|19509962|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
7928542|NCT00567112|19509960|P3|COMPLETED|Treatment Period 1 (3 Days)||0
7928543|NCT00567112|19509961|P2|COMPLETED|Treatment Period 1 (3 Days)||8
7928544|NCT00567112|19509962|P1|COMPLETED|Treatment Period 1 (3 Days)||7
7928545|NCT00567112|19509960|P3|STARTED|Treatment Period 1 (3 Days)||0
7928546|NCT00567112|19509961|P2|STARTED|Treatment Period 1 (3 Days)||8
7928547|NCT00567112|19509962|P1|STARTED|Treatment Period 1 (3 Days)||7
7928548|NCT00567008|19509986|P2|NOT COMPLETED|Overall Study||1
7928549|NCT00567008|19509987|P1|NOT COMPLETED|Overall Study||1
7928550|NCT00567008|19509986|P2|COMPLETED|Overall Study||18
7928551|NCT00567008|19509987|P1|COMPLETED|Overall Study||17
7928552|NCT00567008|19509986|P2|STARTED|Overall Study||19
7928553|NCT00567008|19509987|P1|STARTED|Overall Study||18
7928554|NCT00566995|19509993|P1|NOT COMPLETED|Overall Study||7
7928555|NCT00566995|19509993|P1|COMPLETED|Overall Study||30
7928556|NCT00566995|19509993|P1|STARTED|Overall Study||37
7928557|NCT00566982|19510008|P2|NOT COMPLETED|Overall Study||69
7928558|NCT00566982|19510009|P1|NOT COMPLETED|Overall Study||8
7928559|NCT00566982|19510008|P2|COMPLETED|Overall Study||294
7928560|NCT00566982|19510009|P1|COMPLETED|Overall Study||55
7928561|NCT00566982|19510008|P2|STARTED|Overall Study||363
7928562|NCT00566982|19510009|P1|STARTED|Overall Study||63
7928563|NCT00566969|19510034|P3|NOT COMPLETED|Overall Study||12
7928564|NCT00566969|19510035|P2|NOT COMPLETED|Overall Study||9
7928565|NCT00566969|19510036|P1|NOT COMPLETED|Overall Study||15
7928566|NCT00566969|19510034|P3|COMPLETED|Overall Study||23
7928567|NCT00566969|19510035|P2|COMPLETED|Overall Study||28
7928568|NCT00566969|19510036|P1|COMPLETED|Overall Study||19
7928569|NCT00566969|19510034|P3|STARTED|Overall Study||35
7928570|NCT00566969|19510035|P2|STARTED|Overall Study||37
7928571|NCT00566969|19510036|P1|STARTED|Overall Study||34
7928572|NCT00566943|19510046|P2|NOT COMPLETED|Overall Study||0
7928573|NCT00566943|19510047|P1|NOT COMPLETED|Overall Study||0
7928574|NCT00566943|19510046|P2|COMPLETED|Overall Study||49
7928575|NCT00566943|19510047|P1|COMPLETED|Overall Study||52
7928576|NCT00566943|19510046|P2|STARTED|Overall Study||49
7928577|NCT00566943|19510047|P1|STARTED|Overall Study||52
7928578|NCT00566930|19510062|P3|NOT COMPLETED|Overall Study||1
7928579|NCT00566930|19510063|P2|NOT COMPLETED|Overall Study||4
7928580|NCT00566930|19510064|P1|NOT COMPLETED|Overall Study||2
7928581|NCT00566930|19510062|P3|COMPLETED|Overall Study||32
7928582|NCT00566930|19510063|P2|COMPLETED|Overall Study||32
7928583|NCT00566930|19510064|P1|COMPLETED|Overall Study||27
7928584|NCT00566930|19510062|P3|STARTED|Overall Study||33
7928585|NCT00566930|19510063|P2|STARTED|Overall Study||36
7928586|NCT00566930|19510064|P1|STARTED|Overall Study||29
7928587|NCT00566852|19510074|P2|NOT COMPLETED|Overall Study||198
7928588|NCT00566852|19510075|P1|NOT COMPLETED|Overall Study||207
7928675|NCT00566501|19510265|P2|Discontinued|Overall Study||122
7928589|NCT00566852|19510074|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|78
7928590|NCT00566852|19510075|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|71
7928591|NCT00566852|19510074|P2|STARTED|Overall Study||276
7928592|NCT00566852|19510075|P1|STARTED|Overall Study||278
7928593|NCT00566813|19510093|P2|NOT COMPLETED|Overall Study||0
7928594|NCT00566813|19510094|P1|NOT COMPLETED|Overall Study||0
7928595|NCT00566813|19510093|P2|COMPLETED|Overall Study||6
7928596|NCT00566813|19510094|P1|COMPLETED|Overall Study||4
7928597|NCT00566813|19510093|P2|STARTED|Overall Study||6
7928598|NCT00566813|19510094|P1|STARTED|Overall Study||4
7928599|NCT00566735|19510106|P2|NOT COMPLETED|Overall Study||7
7928600|NCT00566735|19510107|P1|NOT COMPLETED|Overall Study||2
7928601|NCT00566735|19510106|P2|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12
7928602|NCT00566735|19510107|P1|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18
7928603|NCT00566735|19510106|P2|Withdrew Before Baseline Measures|Overall Study||7
7928604|NCT00566735|19510107|P1|Withdrew Before Baseline Measures|Overall Study||2
7928605|NCT00566735|19510106|P2|STARTED|Overall Study||19
7928606|NCT00566735|19510107|P1|STARTED|Overall Study||20
7928607|NCT00566722|19510120|P3|NOT COMPLETED|Overall Study||9
7928608|NCT00566722|19510121|P2|NOT COMPLETED|Overall Study||5
7928609|NCT00566722|19510122|P1|NOT COMPLETED|Overall Study||2
7928610|NCT00566722|19510120|P3|COMPLETED|Overall Study||73
7928611|NCT00566722|19510121|P2|COMPLETED|Overall Study||24
7928612|NCT00566722|19510122|P1|COMPLETED|Overall Study||39
7928613|NCT00566722|19510120|P3|STARTED|Overall Study||82
7928614|NCT00566722|19510121|P2|STARTED|Overall Study||29
7928615|NCT00566722|19510122|P1|STARTED|Overall Study||41
7928616|NCT00566709|19510168|P2|NOT COMPLETED|Overall Study||0
7928617|NCT00566709|19510169|P1|NOT COMPLETED|Overall Study||5
7928618|NCT00566709|19510168|P2|COMPLETED|Overall Study||51
7928619|NCT00566709|19510169|P1|COMPLETED|Overall Study||46
7928620|NCT00566709|19510168|P2|STARTED|Overall Study||51
7928621|NCT00566709|19510169|P1|STARTED|Overall Study||51
7928622|NCT00566696|19510185|P1|NOT COMPLETED|Overall Study||42
7928623|NCT00566696|19510185|P1|COMPLETED|Overall Study||31
7928624|NCT00566696|19510185|P1|STARTED|Overall Study||73
7928625|NCT00566631|19510195|P1|NOT COMPLETED|Part 2: Extension Phase||82
7928626|NCT00566631|19510195|P1|COMPLETED|Part 2: Extension Phase||57
7928627|NCT00566631|19510195|P1|STARTED|Part 2: Extension Phase||139
7928628|NCT00566631|19510195|P1|NOT COMPLETED|Between Treatment and Extension Phase||95
7928629|NCT00566631|19510195|P1|COMPLETED|Between Treatment and Extension Phase||139
7928630|NCT00566631|19510195|P1|STARTED|Between Treatment and Extension Phase||234
7928631|NCT00566631|19510195|P1|NOT COMPLETED|Part 1: Core Treatment Phase||60
7928632|NCT00566631|19510195|P1|COMPLETED|Part 1: Core Treatment Phase||234
7928633|NCT00566631|19510195|P1|STARTED|Part 1: Core Treatment Phase||294
7928634|NCT00566579|19510212|P2|NOT COMPLETED|Overall Study||0
7928635|NCT00566579|19510213|P1|NOT COMPLETED|Overall Study||0
7928636|NCT00566579|19510212|P2|COMPLETED|Overall Study||31
7928637|NCT00566579|19510213|P1|COMPLETED|Overall Study||29
7928638|NCT00566579|19510212|P2|STARTED|Overall Study||31
7928639|NCT00566579|19510213|P1|STARTED|Overall Study||29
7928640|NCT00566527|19510222|P3|NOT COMPLETED|Overall Study||78
7928641|NCT00566527|19510223|P2|NOT COMPLETED|Overall Study||66
7928642|NCT00566527|19510224|P1|NOT COMPLETED|Overall Study||17
7928643|NCT00566527|19510222|P3|COMPLETED|Overall Study||461
7928644|NCT00566527|19510223|P2|COMPLETED|Overall Study||474
7928645|NCT00566527|19510224|P1|COMPLETED|Overall Study||524
7928646|NCT00566527|19510222|P3|Received ProQuad® Dose 2|Overall Study||462
7928647|NCT00566527|19510223|P2|Received ProQuad® Dose 2|Overall Study||478
7928648|NCT00566527|19510224|P1|Received ProQuad® Dose 2|Overall Study||525
7928649|NCT00566527|19510222|P3|Received ProQuad® Dose 1|Overall Study||470
7928650|NCT00566527|19510223|P2|Received ProQuad® Dose 1|Overall Study||484
7928651|NCT00566527|19510224|P1|Received ProQuad® Dose 1|Overall Study||529
7928652|NCT00566527|19510222|P3|STARTED|Overall Study|Number randomized.|539
7928653|NCT00566527|19510223|P2|STARTED|Overall Study|Number randomized.|540
7928654|NCT00566527|19510224|P1|STARTED|Overall Study|Number randomized.|541
7928655|NCT00566501|19510265|P2|NOT COMPLETED|Overall Study||126
7928656|NCT00566501|19510266|P1|NOT COMPLETED|Overall Study||156
7928657|NCT00566501|19510265|P2|COMPLETED|Overall Study||210
7928658|NCT00566501|19510266|P1|COMPLETED|Overall Study||423
7928659|NCT00566501|19510265|P2|Not Determined|Overall Study||0
7928660|NCT00566501|19510266|P1|Not Determined|Overall Study||1
7928661|NCT00566501|19510265|P2|Other ( Not Specified)|Overall Study||21
7928662|NCT00566501|19510266|P1|Other ( Not Specified)|Overall Study||24
7928663|NCT00566501|19510265|P2|Medication Non-compliance|Overall Study||0
7928664|NCT00566501|19510266|P1|Medication Non-compliance|Overall Study||5
7928665|NCT00566501|19510265|P2|Protocol Violation|Overall Study||2
7928666|NCT00566501|19510266|P1|Protocol Violation|Overall Study||2
7928667|NCT00566501|19510265|P2|Request of Investigator or Sponsor|Overall Study||7
7928668|NCT00566501|19510266|P1|Request of Investigator or Sponsor|Overall Study||6
7928669|NCT00566501|19510265|P2|Withdraw of Consent by Subject|Overall Study||30
7928670|NCT00566501|19510266|P1|Withdraw of Consent by Subject|Overall Study||33
7928671|NCT00566501|19510265|P2|Lack of Efficacy|Overall Study||3
7928672|NCT00566501|19510266|P1|Lack of Efficacy|Overall Study||8
7928673|NCT00566501|19510265|P2|Adverse Event|Overall Study||59
7928674|NCT00566501|19510266|P1|Adverse Event|Overall Study||68
7928676|NCT00566501|19510266|P1|Discontinued|Overall Study||146
7928677|NCT00566501|19510265|P2|Safety Population|Overall Study||332
7928678|NCT00566501|19510266|P1|Safety Population|Overall Study||570
7928679|NCT00566501|19510265|P2|STARTED|Overall Study||336
7928680|NCT00566501|19510266|P1|STARTED|Overall Study||579
7928681|NCT00566462|19510274|P2|NOT COMPLETED|Overall Study||0
7928682|NCT00566462|19510275|P1|NOT COMPLETED|Overall Study||0
7928683|NCT00566462|19510274|P2|COMPLETED|Overall Study||0
7928684|NCT00566462|19510275|P1|COMPLETED|Overall Study||1
7928685|NCT00566462|19510274|P2|STARTED|Overall Study||0
7928686|NCT00566462|19510275|P1|STARTED|Overall Study||1
7928687|NCT00566254|19510285|P2|NOT COMPLETED|Overall Study||14
7928688|NCT00566254|19510286|P1|NOT COMPLETED|Overall Study||10
7928689|NCT00566254|19510285|P2|COMPLETED|Overall Study||93
7928690|NCT00566254|19510286|P1|COMPLETED|Overall Study||90
7928691|NCT00566254|19510285|P2|STARTED|Overall Study||107
7928692|NCT00566254|19510286|P1|STARTED|Overall Study||100
7928693|NCT00566228|19510300|P2|NOT COMPLETED|Overall Study||5
7928694|NCT00566228|19510301|P1|NOT COMPLETED|Overall Study||6
7928695|NCT00566228|19510300|P2|COMPLETED|Overall Study||55
7928696|NCT00566228|19510301|P1|COMPLETED|Overall Study||56
7928697|NCT00566228|19510300|P2|STARTED|Overall Study||60
7928698|NCT00566228|19510301|P1|STARTED|Overall Study||62
7928699|NCT00566150|19510319|P2|NOT COMPLETED|Overall Study||5
7928700|NCT00566150|19510320|P1|NOT COMPLETED|Overall Study||9
7928701|NCT00566150|19510319|P2|COMPLETED|Overall Study||11
7928702|NCT00566150|19510320|P1|COMPLETED|Overall Study||10
7928703|NCT00566150|19510319|P2|STARTED|Overall Study||16
7928704|NCT00566150|19510320|P1|STARTED|Overall Study||19
7928705|NCT00566111|19510334|P2|NOT COMPLETED|Overall Study||2
7928706|NCT00566111|19510335|P1|NOT COMPLETED|Overall Study||0
7928707|NCT00566111|19510334|P2|COMPLETED|Overall Study||1
7928708|NCT00566111|19510335|P1|COMPLETED|Overall Study||2
7928709|NCT00566111|19510334|P2|STARTED|Overall Study||3
7928710|NCT00566111|19510335|P1|STARTED|Overall Study||2
7928711|NCT00566098|19510349|P1|NOT COMPLETED|Administration of ASCT+MILs||18
7928712|NCT00566098|19510349|P1|COMPLETED|Administration of ASCT+MILs||4
7928713|NCT00566098|19510349|P1|STARTED|Administration of ASCT+MILs||22
7928714|NCT00566098|19510349|P1|NOT COMPLETED|Generation of MILs Product||1
7928715|NCT00566098|19510349|P1|COMPLETED|Generation of MILs Product||22
7928716|NCT00566098|19510349|P1|STARTED|Generation of MILs Product||23
7928717|NCT00566098|19510349|P1|NOT COMPLETED|Collection of MILs||2
7928718|NCT00566098|19510349|P1|COMPLETED|Collection of MILs||23
7928719|NCT00566098|19510349|P1|STARTED|Collection of MILs||25
7928720|NCT00566020|19510359|P2|NOT COMPLETED|46-week Long-term Administration Phase||17
7928721|NCT00566020|19510360|P1|NOT COMPLETED|46-week Long-term Administration Phase||0
7928722|NCT00566020|19510359|P2|COMPLETED|46-week Long-term Administration Phase||68
7928723|NCT00566020|19510360|P1|COMPLETED|46-week Long-term Administration Phase||0
7928724|NCT00566020|19510359|P2|STARTED|46-week Long-term Administration Phase||85
7928725|NCT00566020|19510360|P1|STARTED|46-week Long-term Administration Phase||0
7928726|NCT00566020|19510359|P2|NOT COMPLETED|6-week Dosage Adjustment Phase||0
7928727|NCT00566020|19510360|P1|NOT COMPLETED|6-week Dosage Adjustment Phase||7
7928728|NCT00566020|19510359|P2|COMPLETED|6-week Dosage Adjustment Phase||0
7928729|NCT00566020|19510360|P1|COMPLETED|6-week Dosage Adjustment Phase||85
7928730|NCT00566020|19510359|P2|STARTED|6-week Dosage Adjustment Phase||0
7928731|NCT00566020|19510360|P1|STARTED|6-week Dosage Adjustment Phase||92
7928732|NCT00565916|19510387|P2|NOT COMPLETED|Overall Study||0
7928733|NCT00565916|19510388|P1|NOT COMPLETED|Overall Study||0
7928734|NCT00565916|19510387|P2|COMPLETED|Overall Study||11
7928735|NCT00565916|19510388|P1|COMPLETED|Overall Study||11
7928736|NCT00565916|19510387|P2|STARTED|Overall Study||11
7928737|NCT00565916|19510388|P1|STARTED|Overall Study||11
7928738|NCT00565864|19510397|P3|NOT COMPLETED|Overall Study||11
7928739|NCT00565864|19510398|P2|NOT COMPLETED|Overall Study||12
7928740|NCT00565864|19510399|P1|NOT COMPLETED|Overall Study||12
7928741|NCT00565864|19510397|P3|COMPLETED|Overall Study||45
7928742|NCT00565864|19510398|P2|COMPLETED|Overall Study||47
7928743|NCT00565864|19510399|P1|COMPLETED|Overall Study||46
7928744|NCT00565864|19510397|P3|STARTED|Overall Study||56
7928745|NCT00565864|19510398|P2|STARTED|Overall Study||59
7928746|NCT00565864|19510399|P1|STARTED|Overall Study||58
7928747|NCT00565851|19510454|P8|NOT COMPLETED|Chemotherapy Assignment||3
7928748|NCT00565851|19510455|P7|NOT COMPLETED|Chemotherapy Assignment||0
7928749|NCT00565851|19510456|P6|NOT COMPLETED|Chemotherapy Assignment||3
7928750|NCT00565851|19510457|P5|NOT COMPLETED|Chemotherapy Assignment||0
7928751|NCT00565851|19510458|P4|NOT COMPLETED|Chemotherapy Assignment||36
7928752|NCT00565851|19510459|P3|NOT COMPLETED|Chemotherapy Assignment||3
7928753|NCT00565851|19510460|P2|NOT COMPLETED|Chemotherapy Assignment||23
7928754|NCT00565851|19510461|P1|NOT COMPLETED|Chemotherapy Assignment||9
7928755|NCT00565851|19510454|P8|COMPLETED|Chemotherapy Assignment||34
7928756|NCT00565851|19510455|P7|COMPLETED|Chemotherapy Assignment||5
7928757|NCT00565851|19510456|P6|COMPLETED|Chemotherapy Assignment||31
7928758|NCT00565851|19510457|P5|COMPLETED|Chemotherapy Assignment||6
7928759|NCT00565851|19510458|P4|COMPLETED|Chemotherapy Assignment||129
7928760|NCT00565851|19510459|P3|COMPLETED|Chemotherapy Assignment||30
7928761|NCT00565851|19510460|P2|COMPLETED|Chemotherapy Assignment||433
7928762|NCT00565851|19510461|P1|COMPLETED|Chemotherapy Assignment||307
7928763|NCT00565851|19510454|P8|Pre-specified Chemo|Chemotherapy Assignment||37
7928764|NCT00565851|19510455|P7|Pre-specified Chemo|Chemotherapy Assignment||5
7928765|NCT00565851|19510456|P6|Pre-specified Chemo|Chemotherapy Assignment||34
7928766|NCT00565851|19510457|P5|Pre-specified Chemo|Chemotherapy Assignment||6
7928767|NCT00565851|19510458|P4|Pre-specified Chemo|Chemotherapy Assignment||139
7928768|NCT00565851|19510459|P3|Pre-specified Chemo|Chemotherapy Assignment||6
7928769|NCT00565851|19510460|P2|Pre-specified Chemo|Chemotherapy Assignment||145
7928770|NCT00565851|19510461|P1|Pre-specified Chemo|Chemotherapy Assignment||6
7928771|NCT00565851|19510454|P8|Randomized to Chemo|Chemotherapy Assignment||0
7928772|NCT00565851|19510455|P7|Randomized to Chemo|Chemotherapy Assignment||0
7928773|NCT00565851|19510456|P6|Randomized to Chemo|Chemotherapy Assignment||0
7928774|NCT00565851|19510457|P5|Randomized to Chemo|Chemotherapy Assignment||0
7928775|NCT00565851|19510458|P4|Randomized to Chemo|Chemotherapy Assignment||26
7928776|NCT00565851|19510459|P3|Randomized to Chemo|Chemotherapy Assignment||27
7928777|NCT00565851|19510460|P2|Randomized to Chemo|Chemotherapy Assignment||311
7928778|NCT00565851|19510461|P1|Randomized to Chemo|Chemotherapy Assignment||310
7928779|NCT00565851|19510454|P8|STARTED|Chemotherapy Assignment||37
7928780|NCT00565851|19510455|P7|STARTED|Chemotherapy Assignment||5
7928781|NCT00565851|19510456|P6|STARTED|Chemotherapy Assignment||34
7928782|NCT00565851|19510457|P5|STARTED|Chemotherapy Assignment||6
7928783|NCT00565851|19510458|P4|STARTED|Chemotherapy Assignment||165
7928784|NCT00565851|19510459|P3|STARTED|Chemotherapy Assignment||33
7928785|NCT00565851|19510460|P2|STARTED|Chemotherapy Assignment||456
7928786|NCT00565851|19510461|P1|STARTED|Chemotherapy Assignment||316
7928787|NCT00565851|19510454|P8|NOT COMPLETED|Surgical Assignment||2
7928788|NCT00565851|19510455|P7|NOT COMPLETED|Surgical Assignment||0
7928789|NCT00565851|19510456|P6|NOT COMPLETED|Surgical Assignment||0
7928790|NCT00565851|19510457|P5|NOT COMPLETED|Surgical Assignment||0
7928791|NCT00565851|19510458|P4|NOT COMPLETED|Surgical Assignment||11
7928792|NCT00565851|19510459|P3|NOT COMPLETED|Surgical Assignment||2
7928793|NCT00565851|19510460|P2|NOT COMPLETED|Surgical Assignment||2
7928794|NCT00565851|19510461|P1|NOT COMPLETED|Surgical Assignment||3
7928795|NCT00565851|19510454|P8|COMPLETED|Surgical Assignment||35
7928796|NCT00565851|19510455|P7|COMPLETED|Surgical Assignment||5
7928797|NCT00565851|19510456|P6|COMPLETED|Surgical Assignment||34
7928798|NCT00565851|19510457|P5|COMPLETED|Surgical Assignment||6
7928799|NCT00565851|19510458|P4|COMPLETED|Surgical Assignment||154
7928800|NCT00565851|19510459|P3|COMPLETED|Surgical Assignment||31
7928801|NCT00565851|19510460|P2|COMPLETED|Surgical Assignment||454
7928802|NCT00565851|19510461|P1|COMPLETED|Surgical Assignment||313
7928803|NCT00565851|19510454|P8|Not Surgical Candidate|Surgical Assignment||0
7928804|NCT00565851|19510455|P7|Not Surgical Candidate|Surgical Assignment||0
7928805|NCT00565851|19510456|P6|Not Surgical Candidate|Surgical Assignment||0
7928806|NCT00565851|19510457|P5|Not Surgical Candidate|Surgical Assignment||0
7928807|NCT00565851|19510458|P4|Not Surgical Candidate|Surgical Assignment||0
7928808|NCT00565851|19510459|P3|Not Surgical Candidate|Surgical Assignment||0
7928809|NCT00565851|19510460|P2|Not Surgical Candidate|Surgical Assignment||284
7928810|NCT00565851|19510461|P1|Not Surgical Candidate|Surgical Assignment||283
7928811|NCT00565851|19510454|P8|Randomized - no Surgery|Surgical Assignment||0
7928812|NCT00565851|19510455|P7|Randomized - no Surgery|Surgical Assignment||0
7928813|NCT00565851|19510456|P6|Randomized - no Surgery|Surgical Assignment||34
7928814|NCT00565851|19510457|P5|Randomized - no Surgery|Surgical Assignment||6
7928815|NCT00565851|19510458|P4|Randomized - no Surgery|Surgical Assignment||0
7928816|NCT00565851|19510459|P3|Randomized - no Surgery|Surgical Assignment||0
7928817|NCT00565851|19510460|P2|Randomized - no Surgery|Surgical Assignment||172
7928818|NCT00565851|19510461|P1|Randomized - no Surgery|Surgical Assignment||33
7928819|NCT00565851|19510454|P8|Randomized - Yes Surgery|Surgical Assignment||37
7928820|NCT00565851|19510455|P7|Randomized - Yes Surgery|Surgical Assignment||5
7928821|NCT00565851|19510456|P6|Randomized - Yes Surgery|Surgical Assignment||0
7928822|NCT00565851|19510457|P5|Randomized - Yes Surgery|Surgical Assignment||0
7928823|NCT00565851|19510458|P4|Randomized - Yes Surgery|Surgical Assignment||165
7928824|NCT00565851|19510459|P3|Randomized - Yes Surgery|Surgical Assignment||33
7928825|NCT00565851|19510460|P2|Randomized - Yes Surgery|Surgical Assignment||0
7928826|NCT00565851|19510461|P1|Randomized - Yes Surgery|Surgical Assignment||0
7928827|NCT00565851|19510454|P8|STARTED|Surgical Assignment||37
7928828|NCT00565851|19510455|P7|STARTED|Surgical Assignment||5
7928829|NCT00565851|19510456|P6|STARTED|Surgical Assignment||34
7928830|NCT00565851|19510457|P5|STARTED|Surgical Assignment||6
7928831|NCT00565851|19510458|P4|STARTED|Surgical Assignment||165
7928832|NCT00565851|19510459|P3|STARTED|Surgical Assignment||33
7928833|NCT00565851|19510460|P2|STARTED|Surgical Assignment||456
7928834|NCT00565851|19510461|P1|STARTED|Surgical Assignment||316
7928835|NCT00565812|19510498|P3|NOT COMPLETED|Overall Study||130
7928836|NCT00565812|19510499|P2|NOT COMPLETED|Overall Study||135
7928837|NCT00565812|19510500|P1|NOT COMPLETED|Overall Study||144
7928838|NCT00565812|19510498|P3|COMPLETED|Overall Study||356
7928839|NCT00565812|19510499|P2|COMPLETED|Overall Study||351
7928840|NCT00565812|19510500|P1|COMPLETED|Overall Study||341
7928841|NCT00565812|19510498|P3|STARTED|Overall Study||486
7928842|NCT00565812|19510499|P2|STARTED|Overall Study||486
7928843|NCT00565812|19510500|P1|STARTED|Overall Study||485
7928844|NCT00565773|19510637|P1|NOT COMPLETED|Overall Study||2
7928845|NCT00565773|19510637|P1|COMPLETED|Overall Study||38
7928846|NCT00565773|19510637|P1|STARTED|Overall Study||40
7928847|NCT00565747|19510649|P2|NOT COMPLETED|Overall Study||73
7928848|NCT00565747|19510650|P1|NOT COMPLETED|Overall Study||67
7928849|NCT00565747|19510649|P2|COMPLETED|Overall Study|Completed with an embryo transfer|605
7928850|NCT00565747|19510650|P1|COMPLETED|Overall Study|Completed with an embryo transfer|587
7928851|NCT00565747|19510649|P2|STARTED|Overall Study||678
7928852|NCT00565747|19510650|P1|STARTED|Overall Study||654
7928853|NCT00565721|19510660|P1|NOT COMPLETED|Overall Study||17
7928854|NCT00565721|19510660|P1|COMPLETED|Overall Study||16
7928855|NCT00565721|19510660|P1|STARTED|Overall Study||33
7928856|NCT00565669|19510681|P2|NOT COMPLETED|Overall Study||0
7928857|NCT00565669|19510682|P1|NOT COMPLETED|Overall Study||0
7928858|NCT00565669|19510681|P2|COMPLETED|Overall Study||9
7928859|NCT00565669|19510682|P1|COMPLETED|Overall Study||11
7928860|NCT00565669|19510681|P2|STARTED|Overall Study||9
7928861|NCT00565669|19510682|P1|STARTED|Overall Study||11
7928862|NCT00565643|19510690|P2|NOT COMPLETED|Overall Study||0
7928863|NCT00565643|19510691|P1|NOT COMPLETED|Overall Study||0
7928864|NCT00565643|19510690|P2|COMPLETED|Overall Study||373
7928865|NCT00565643|19510691|P1|COMPLETED|Overall Study||380
7928866|NCT00565643|19510690|P2|Primary Outcome (Subsequent Cesarean)|Overall Study||92
7928867|NCT00565643|19510691|P1|Primary Outcome (Subsequent Cesarean)|Overall Study||80
7928868|NCT00565643|19510690|P2|Safety Data|Overall Study||373
7928869|NCT00565643|19510691|P1|Safety Data|Overall Study||380
7928870|NCT00565643|19510690|P2|STARTED|Overall Study||373
7928871|NCT00565643|19510691|P1|STARTED|Overall Study||380
7928872|NCT00565617|19510709|P1|NOT COMPLETED|Overall Study||1
7928873|NCT00565617|19510709|P1|COMPLETED|Overall Study||5
7928874|NCT00565617|19510709|P1|STARTED|Overall Study||6
7928875|NCT00565604|19510713|P1|NOT COMPLETED|Overall Study||4
7928876|NCT00565604|19510713|P1|COMPLETED|Overall Study||39
7928877|NCT00565604|19510713|P1|6 Month|Overall Study||39
7928878|NCT00565604|19510713|P1|6 Week|Overall Study||39
7928879|NCT00565604|19510713|P1|2 Week|Overall Study||41
7928880|NCT00565604|19510713|P1|7 Day|Overall Study||41
7928881|NCT00565604|19510713|P1|STARTED|Overall Study||43
7928882|NCT00565461|19510724|P4|NOT COMPLETED|Overall Study||3
7928883|NCT00565461|19510725|P3|NOT COMPLETED|Overall Study||1
7928884|NCT00565461|19510726|P2|NOT COMPLETED|Overall Study||1
7928885|NCT00565461|19510727|P1|NOT COMPLETED|Overall Study||0
7928886|NCT00565461|19510724|P4|COMPLETED|Overall Study||37
7928887|NCT00565461|19510725|P3|COMPLETED|Overall Study||39
7928888|NCT00565461|19510726|P2|COMPLETED|Overall Study||39
7928889|NCT00565461|19510727|P1|COMPLETED|Overall Study||40
7928890|NCT00565461|19510724|P4|STARTED|Overall Study||40
7928891|NCT00565461|19510725|P3|STARTED|Overall Study||40
7928892|NCT00565461|19510726|P2|STARTED|Overall Study||40
7928893|NCT00565461|19510727|P1|STARTED|Overall Study||40
7928894|NCT00565448|19510759|P2|NOT COMPLETED|Overall Study||2
7928895|NCT00565448|19510760|P1|NOT COMPLETED|Overall Study||3
7928896|NCT00565448|19510759|P2|COMPLETED|Overall Study|Completed induction period as per protocol.|23
7928897|NCT00565448|19510760|P1|COMPLETED|Overall Study|Completed induction period as per protocol.|47
7928898|NCT00565448|19510759|P2|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25
7928899|NCT00565448|19510760|P1|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50
7928900|NCT00565409|19510771|P4|NOT COMPLETED|Period 2 Double-Blind||59
7928901|NCT00565409|19510772|P3|NOT COMPLETED|Period 2 Double-Blind||27
7928902|NCT00565409|19510773|P2|NOT COMPLETED|Period 2 Double-Blind||21
7928903|NCT00565409|19510774|P1|NOT COMPLETED|Period 2 Double-Blind||0
7928904|NCT00565409|19510771|P4|COMPLETED|Period 2 Double-Blind||141
7928905|NCT00565409|19510772|P3|COMPLETED|Period 2 Double-Blind||175
7928906|NCT00565409|19510773|P2|COMPLETED|Period 2 Double-Blind||181
7928907|NCT00565409|19510774|P1|COMPLETED|Period 2 Double-Blind||0
7928908|NCT00565409|19510771|P4|STARTED|Period 2 Double-Blind||200
7928909|NCT00565409|19510772|P3|STARTED|Period 2 Double-Blind||202
7928910|NCT00565409|19510773|P2|STARTED|Period 2 Double-Blind||202
7928911|NCT00565409|19510774|P1|STARTED|Period 2 Double-Blind||0
7928912|NCT00565409|19510771|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
7928913|NCT00565409|19510772|P3|NOT COMPLETED|After Period 1, Prior to Period 2||0
7928914|NCT00565409|19510773|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
7928915|NCT00565409|19510774|P1|NOT COMPLETED|After Period 1, Prior to Period 2||152
7928916|NCT00565409|19510771|P4|COMPLETED|After Period 1, Prior to Period 2||0
7928917|NCT00565409|19510772|P3|COMPLETED|After Period 1, Prior to Period 2||0
7928918|NCT00565409|19510773|P2|COMPLETED|After Period 1, Prior to Period 2||0
7928919|NCT00565409|19510774|P1|COMPLETED|After Period 1, Prior to Period 2||604
7928920|NCT00565409|19510771|P4|STARTED|After Period 1, Prior to Period 2||0
7928921|NCT00565409|19510772|P3|STARTED|After Period 1, Prior to Period 2||0
7928922|NCT00565409|19510773|P2|STARTED|After Period 1, Prior to Period 2||0
7928923|NCT00565409|19510774|P1|STARTED|After Period 1, Prior to Period 2||756
7928924|NCT00565409|19510771|P4|NOT COMPLETED|Period 1 Open Label||0
7928925|NCT00565409|19510772|P3|NOT COMPLETED|Period 1 Open Label||0
7928926|NCT00565409|19510773|P2|NOT COMPLETED|Period 1 Open Label||0
7928927|NCT00565409|19510774|P1|NOT COMPLETED|Period 1 Open Label||78
7928928|NCT00565409|19510771|P4|COMPLETED|Period 1 Open Label||0
7928929|NCT00565409|19510772|P3|COMPLETED|Period 1 Open Label||0
7928930|NCT00565409|19510773|P2|COMPLETED|Period 1 Open Label||0
7928931|NCT00565409|19510774|P1|COMPLETED|Period 1 Open Label||756
7928932|NCT00565409|19510771|P4|STARTED|Period 1 Open Label||0
7928933|NCT00565409|19510772|P3|STARTED|Period 1 Open Label||0
7928934|NCT00565409|19510773|P2|STARTED|Period 1 Open Label||0
7928935|NCT00565409|19510774|P1|STARTED|Period 1 Open Label||834
7928936|NCT00565370|19510876|P1|NOT COMPLETED|Overall Study||0
7928937|NCT00565370|19510876|P1|COMPLETED|Overall Study||21
7928938|NCT00565370|19510876|P1|STARTED|Overall Study||21
7928939|NCT00565266|19510884|P1|NOT COMPLETED|Overall Study||36
7928940|NCT00565266|19510884|P1|COMPLETED|Overall Study||174
7928941|NCT00565266|19510884|P1|STARTED|Overall Study||210
7928942|NCT00565136|19510910|P1|NOT COMPLETED|Overall Study||3
7928943|NCT00565136|19510910|P1|COMPLETED|Overall Study||26
7928944|NCT00565136|19510910|P1|STARTED|Overall Study||29
7928945|NCT00565110|19510930|P2|NOT COMPLETED|Overall Study||131
7928946|NCT00565110|19510931|P1|NOT COMPLETED|Overall Study||131
7928947|NCT00565110|19510930|P2|COMPLETED|Overall Study||111
7928948|NCT00565110|19510931|P1|COMPLETED|Overall Study||99
7928949|NCT00565110|19510930|P2|12-Month|Overall Study||144
7928950|NCT00565110|19510931|P1|12-Month|Overall Study||114
7928951|NCT00565110|19510930|P2|STARTED|Overall Study||242
7928952|NCT00565110|19510931|P1|STARTED|Overall Study||230
7928953|NCT00565084|19510939|P3|NOT COMPLETED|Third Treatment Period||0
7928954|NCT00565084|19510940|P2|NOT COMPLETED|Third Treatment Period||0
7928955|NCT00565084|19510941|P1|NOT COMPLETED|Third Treatment Period||0
7928956|NCT00565084|19510939|P3|COMPLETED|Third Treatment Period||11
7928957|NCT00565084|19510940|P2|COMPLETED|Third Treatment Period||11
7928958|NCT00565084|19510941|P1|COMPLETED|Third Treatment Period||11
7928959|NCT00565084|19510939|P3|STARTED|Third Treatment Period||11
7928960|NCT00565084|19510940|P2|STARTED|Third Treatment Period||11
7928961|NCT00565084|19510941|P1|STARTED|Third Treatment Period||11
7928962|NCT00565084|19510939|P3|NOT COMPLETED|Second Treatment Period||0
7928963|NCT00565084|19510940|P2|NOT COMPLETED|Second Treatment Period||0
7928964|NCT00565084|19510941|P1|NOT COMPLETED|Second Treatment Period||0
7928965|NCT00565084|19510939|P3|COMPLETED|Second Treatment Period||11
7928966|NCT00565084|19510940|P2|COMPLETED|Second Treatment Period||11
7928967|NCT00565084|19510941|P1|COMPLETED|Second Treatment Period||11
7928968|NCT00565084|19510939|P3|STARTED|Second Treatment Period||11
7928969|NCT00565084|19510940|P2|STARTED|Second Treatment Period||11
7928970|NCT00565084|19510941|P1|STARTED|Second Treatment Period||11
7928971|NCT00565084|19510939|P3|NOT COMPLETED|First Treatment Period||0
7928972|NCT00565084|19510940|P2|NOT COMPLETED|First Treatment Period||0
7928973|NCT00565084|19510941|P1|NOT COMPLETED|First Treatment Period||0
7928974|NCT00565084|19510939|P3|COMPLETED|First Treatment Period||11
7928975|NCT00565084|19510940|P2|COMPLETED|First Treatment Period||11
7928976|NCT00565084|19510941|P1|COMPLETED|First Treatment Period||11
7928977|NCT00565084|19510939|P3|STARTED|First Treatment Period||11
7928978|NCT00565084|19510940|P2|STARTED|First Treatment Period||11
7928979|NCT00565084|19510941|P1|STARTED|First Treatment Period||11
7928980|NCT00565058|19510951|P2|NOT COMPLETED|Overall Study||0
7928981|NCT00565058|19510952|P1|NOT COMPLETED|Overall Study||1
7928982|NCT00565058|19510951|P2|COMPLETED|Overall Study||15
7928983|NCT00565058|19510952|P1|COMPLETED|Overall Study||9
7928984|NCT00565058|19510951|P2|STARTED|Overall Study||15
7928985|NCT00565058|19510952|P1|STARTED|Overall Study||10
7928986|NCT00565045|19510962|P2|NOT COMPLETED|Overall Study||3
7928987|NCT00565045|19510963|P1|NOT COMPLETED|Overall Study||1
7928988|NCT00565045|19510962|P2|COMPLETED|Overall Study||8
7928989|NCT00565045|19510963|P1|COMPLETED|Overall Study||9
7928990|NCT00565045|19510962|P2|STARTED|Overall Study||11
7928991|NCT00565045|19510963|P1|STARTED|Overall Study||10
7928992|NCT00564954|19510979|P2|NOT COMPLETED|Period 2- 1 Week||0
7928993|NCT00564954|19510980|P1|NOT COMPLETED|Period 2- 1 Week||0
7928994|NCT00564954|19510979|P2|COMPLETED|Period 2- 1 Week||42
7928995|NCT00564954|19510980|P1|COMPLETED|Period 2- 1 Week||44
7928996|NCT00564954|19510979|P2|STARTED|Period 2- 1 Week||42
7928997|NCT00564954|19510980|P1|STARTED|Period 2- 1 Week||44
7928998|NCT00564954|19510979|P2|NOT COMPLETED|Period 1- 1 Week||0
7928999|NCT00564954|19510980|P1|NOT COMPLETED|Period 1- 1 Week||0
7929000|NCT00564954|19510979|P2|COMPLETED|Period 1- 1 Week||42
7929001|NCT00564954|19510980|P1|COMPLETED|Period 1- 1 Week||44
7929002|NCT00564954|19510979|P2|STARTED|Period 1- 1 Week||42
7929003|NCT00564954|19510980|P1|STARTED|Period 1- 1 Week||44
7929004|NCT00564902|19510999|P3|NOT COMPLETED|Overall Study||4
7929005|NCT00564902|19511000|P2|NOT COMPLETED|Overall Study||4
7929006|NCT00564902|19511001|P1|NOT COMPLETED|Overall Study||1
7929007|NCT00564902|19510999|P3|COMPLETED|Overall Study||21
7929008|NCT00564902|19511000|P2|COMPLETED|Overall Study||21
7929009|NCT00564902|19511001|P1|COMPLETED|Overall Study||9
7929010|NCT00564902|19510999|P3|12 Months|Overall Study||21
7929011|NCT00564902|19511000|P2|12 Months|Overall Study||21
7929012|NCT00564902|19511001|P1|12 Months|Overall Study||9
7929013|NCT00564902|19510999|P3|8 Months|Overall Study||21
7929014|NCT00564902|19511000|P2|8 Months|Overall Study||22
7929015|NCT00564902|19511001|P1|8 Months|Overall Study||9
7929016|NCT00564902|19510999|P3|4 Months|Overall Study||23
7929017|NCT00564902|19511000|P2|4 Months|Overall Study||24
7929018|NCT00564902|19511001|P1|4 Months|Overall Study||9
7929019|NCT00564902|19510999|P3|STARTED|Overall Study||25
7929020|NCT00564902|19511000|P2|STARTED|Overall Study||25
7929021|NCT00564902|19511001|P1|STARTED|Overall Study||10
7929022|NCT00564889|19511033|P1|NOT COMPLETED|Overall Study||29
7929023|NCT00564889|19511033|P1|COMPLETED|Overall Study||6
7929024|NCT00564889|19511033|P1|STARTED|Overall Study||35
7929025|NCT00564876|19511041|P1|NOT COMPLETED|Overall Study||0
7929026|NCT00564876|19511041|P1|COMPLETED|Overall Study||2
7929027|NCT00564876|19511041|P1|STARTED|Overall Study||2
7929028|NCT00564850|19511048|P1|NOT COMPLETED|Overall Study||2
7929029|NCT00564850|19511048|P1|COMPLETED|Overall Study||35
7929030|NCT00564850|19511048|P1|STARTED|Overall Study||37
7929031|NCT00564733|19511066|P1|NOT COMPLETED|Overall Study||9
7929032|NCT00564733|19511066|P1|COMPLETED|Overall Study||46
7929033|NCT00564733|19511066|P1|STARTED|Overall Study||55
7929034|NCT00564681|19511074|P4|NOT COMPLETED|Overall Study||2
7929035|NCT00564681|19511075|P3|NOT COMPLETED|Overall Study||3
7929036|NCT00564681|19511076|P2|NOT COMPLETED|Overall Study||3
7929037|NCT00564681|19511077|P1|NOT COMPLETED|Overall Study||11
7929038|NCT00564681|19511074|P4|COMPLETED|Overall Study||19
7929039|NCT00564681|19511075|P3|COMPLETED|Overall Study||40
7929040|NCT00564681|19511076|P2|COMPLETED|Overall Study||58
7929041|NCT00564681|19511077|P1|COMPLETED|Overall Study||106
7929042|NCT00564681|19511074|P4|STARTED|Overall Study||21
7929043|NCT00564681|19511075|P3|STARTED|Overall Study||43
7929044|NCT00564681|19511076|P2|STARTED|Overall Study||61
7929045|NCT00564681|19511077|P1|STARTED|Overall Study||117
7929046|NCT00564629|19511100|P2|NOT COMPLETED|Overall Study||9
7929047|NCT00564629|19511101|P1|NOT COMPLETED|Overall Study||15
7929048|NCT00564629|19511100|P2|COMPLETED|Overall Study||45
7929049|NCT00564629|19511101|P1|COMPLETED|Overall Study||36
7929050|NCT00564629|19511100|P2|STARTED|Overall Study||54
7929051|NCT00564629|19511101|P1|STARTED|Overall Study||51
7929052|NCT00564486|19511126|P4|NOT COMPLETED|Overall Study||7
7929053|NCT00564486|19511127|P3|NOT COMPLETED|Overall Study||3
7929054|NCT00564486|19511128|P2|NOT COMPLETED|Overall Study||1
7929055|NCT00564486|19511129|P1|NOT COMPLETED|Overall Study||7
7929056|NCT00564486|19511126|P4|COMPLETED|Overall Study||60
7929057|NCT00564486|19511127|P3|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39
7929058|NCT00564486|19511128|P2|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91
7929059|NCT00564486|19511129|P1|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36
7929060|NCT00564486|19511126|P4|STARTED|Overall Study||67
7929061|NCT00564486|19511127|P3|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42
7929062|NCT00564486|19511128|P2|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92
7929063|NCT00564486|19511129|P1|STARTED|Overall Study||43
7929064|NCT00564447|19511153|P8|NOT COMPLETED|Overall Study||0
7929065|NCT00564447|19511154|P7|NOT COMPLETED|Overall Study||0
7929066|NCT00564447|19511155|P6|NOT COMPLETED|Overall Study||0
7929067|NCT00564447|19511156|P5|NOT COMPLETED|Overall Study||0
7929068|NCT00564447|19511157|P4|NOT COMPLETED|Overall Study||0
7929069|NCT00564447|19511158|P3|NOT COMPLETED|Overall Study||0
7929070|NCT00564447|19511159|P2|NOT COMPLETED|Overall Study||0
7929071|NCT00564447|19511160|P1|NOT COMPLETED|Overall Study||0
7929072|NCT00564447|19511153|P8|COMPLETED|Overall Study||6
7929073|NCT00564447|19511154|P7|COMPLETED|Overall Study||6
7929074|NCT00564447|19511155|P6|COMPLETED|Overall Study||6
7929075|NCT00564447|19511156|P5|COMPLETED|Overall Study||6
7929076|NCT00564447|19511157|P4|COMPLETED|Overall Study||6
7929077|NCT00564447|19511158|P3|COMPLETED|Overall Study||6
7929078|NCT00564447|19511159|P2|COMPLETED|Overall Study||6
7929079|NCT00564447|19511160|P1|COMPLETED|Overall Study||6
7929080|NCT00564447|19511153|P8|STARTED|Overall Study||6
7929081|NCT00564447|19511154|P7|STARTED|Overall Study||6
7929082|NCT00564447|19511155|P6|STARTED|Overall Study||6
7929083|NCT00564447|19511156|P5|STARTED|Overall Study||6
7929084|NCT00564447|19511157|P4|STARTED|Overall Study||6
7929085|NCT00564447|19511158|P3|STARTED|Overall Study||6
7929086|NCT00564447|19511159|P2|STARTED|Overall Study||6
7929087|NCT00564447|19511160|P1|STARTED|Overall Study||6
7929088|NCT00564395|19511178|P2|NOT COMPLETED|Second Intervention (10 Days)||0
7929089|NCT00564395|19511179|P1|NOT COMPLETED|Second Intervention (10 Days)||0
7929090|NCT00564395|19511178|P2|COMPLETED|Second Intervention (10 Days)||7
7929091|NCT00564395|19511179|P1|COMPLETED|Second Intervention (10 Days)||7
7929092|NCT00564395|19511178|P2|STARTED|Second Intervention (10 Days)||7
7929093|NCT00564395|19511179|P1|STARTED|Second Intervention (10 Days)||7
7929094|NCT00564395|19511178|P2|NOT COMPLETED|First Intervention (10 Days)||2
7929095|NCT00564395|19511179|P1|NOT COMPLETED|First Intervention (10 Days)||2
7929096|NCT00564395|19511178|P2|COMPLETED|First Intervention (10 Days)||7
7929097|NCT00564395|19511179|P1|COMPLETED|First Intervention (10 Days)||7
7929098|NCT00564395|19511178|P2|Received Intervention|First Intervention (10 Days)||7
7929099|NCT00564395|19511179|P1|Received Intervention|First Intervention (10 Days)||7
7929100|NCT00564395|19511178|P2|STARTED|First Intervention (10 Days)||9
7929101|NCT00564395|19511179|P1|STARTED|First Intervention (10 Days)||9
7929102|NCT00564278|19511187|P2|NOT COMPLETED|Overall Study||42
7929103|NCT00564278|19511188|P1|NOT COMPLETED|Overall Study||47
7929104|NCT00564278|19511187|P2|COMPLETED|Overall Study||56
7929105|NCT00564278|19511188|P1|COMPLETED|Overall Study||50
7929106|NCT00564278|19511187|P2|STARTED|Overall Study||98
7929107|NCT00564278|19511188|P1|STARTED|Overall Study||97
7929108|NCT00564265|19511204|P1|NOT COMPLETED|Overall Study||0
7929109|NCT00564265|19511204|P1|COMPLETED|Overall Study||24
7929110|NCT00564265|19511204|P1|STARTED|Overall Study||24
7929111|NCT00564070|19511210|P2|NOT COMPLETED|Overall Study||7
7929112|NCT00564070|19511211|P1|NOT COMPLETED|Overall Study||12
7929113|NCT00564070|19511210|P2|COMPLETED|Overall Study||38
7929114|NCT00564070|19511211|P1|COMPLETED|Overall Study||30
7929115|NCT00564070|19511210|P2|STARTED|Overall Study||45
7929116|NCT00564070|19511211|P1|STARTED|Overall Study||42
7929117|NCT00564018|19511238|P3|NOT COMPLETED|Overall Study||1
7929118|NCT00564018|19511239|P2|NOT COMPLETED|Overall Study||3
7929119|NCT00564018|19511240|P1|NOT COMPLETED|Overall Study||2
7929120|NCT00564018|19511238|P3|COMPLETED|Overall Study||11
7929121|NCT00564018|19511239|P2|COMPLETED|Overall Study||7
7929122|NCT00564018|19511240|P1|COMPLETED|Overall Study||9
7929123|NCT00564018|19511238|P3|STARTED|Overall Study||12
7929124|NCT00564018|19511239|P2|STARTED|Overall Study||10
7929125|NCT00564018|19511240|P1|STARTED|Overall Study||11
7929126|NCT00563797|19511253|P2|NOT COMPLETED|Overall Study||2
7929127|NCT00563797|19511254|P1|NOT COMPLETED|Overall Study||7
7929128|NCT00563797|19511253|P2|COMPLETED|Overall Study||8
7929129|NCT00563797|19511254|P1|COMPLETED|Overall Study||4
7929130|NCT00563797|19511253|P2|Follow-Up|Overall Study||10
7929131|NCT00563797|19511254|P1|Follow-Up|Overall Study||11
7929132|NCT00563797|19511253|P2|Received Allocated Intervention|Overall Study||10
7929133|NCT00563797|19511254|P1|Received Allocated Intervention|Overall Study||11
7929134|NCT00563797|19511253|P2|STARTED|Overall Study||10
7929135|NCT00563797|19511254|P1|STARTED|Overall Study||11
7929136|NCT00563784|19511266|P1|NOT COMPLETED|Overall Study||22
7929137|NCT00563784|19511266|P1|COMPLETED|Overall Study||46
7929138|NCT00563784|19511266|P1|STARTED|Overall Study||68
7929139|NCT00563706|19511280|P9|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
7929140|NCT00563706|19511281|P8|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
7929141|NCT00563706|19511282|P7|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
7929142|NCT00563706|19511283|P6|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
7929143|NCT00563706|19511284|P5|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
7929144|NCT00563706|19511285|P4|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
7929145|NCT00563706|19511286|P3|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
7929146|NCT00563706|19511287|P2|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
7929147|NCT00563706|19511288|P1|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
7929148|NCT00563706|19511280|P9|COMPLETED|Taper Phase (Day 29 up to Day 35)||32
7929149|NCT00563706|19511281|P8|COMPLETED|Taper Phase (Day 29 up to Day 35)||16
7929150|NCT00563706|19511282|P7|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
7929151|NCT00563706|19511283|P6|COMPLETED|Taper Phase (Day 29 up to Day 35)||14
7929152|NCT00563706|19511284|P5|COMPLETED|Taper Phase (Day 29 up to Day 35)||11
7929153|NCT00563706|19511285|P4|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
7929154|NCT00563706|19511286|P3|COMPLETED|Taper Phase (Day 29 up to Day 35)||3
7929155|NCT00563706|19511287|P2|COMPLETED|Taper Phase (Day 29 up to Day 35)||13
7929156|NCT00563706|19511288|P1|COMPLETED|Taper Phase (Day 29 up to Day 35)||20
7929157|NCT00563706|19511280|P9|STARTED|Taper Phase (Day 29 up to Day 35)||32
7929158|NCT00563706|19511281|P8|STARTED|Taper Phase (Day 29 up to Day 35)||16
7929159|NCT00563706|19511282|P7|STARTED|Taper Phase (Day 29 up to Day 35)||9
7929160|NCT00563706|19511283|P6|STARTED|Taper Phase (Day 29 up to Day 35)||14
7929161|NCT00563706|19511284|P5|STARTED|Taper Phase (Day 29 up to Day 35)||11
7929162|NCT00563706|19511285|P4|STARTED|Taper Phase (Day 29 up to Day 35)||9
7929163|NCT00563706|19511286|P3|STARTED|Taper Phase (Day 29 up to Day 35)||3
7929164|NCT00563706|19511287|P2|STARTED|Taper Phase (Day 29 up to Day 35)||13
7929165|NCT00563706|19511288|P1|STARTED|Taper Phase (Day 29 up to Day 35)||20
7929166|NCT00563706|19511280|P9|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
7929167|NCT00563706|19511281|P8|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
7929168|NCT00563706|19511282|P7|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
7929169|NCT00563706|19511283|P6|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
7929170|NCT00563706|19511284|P5|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
7929171|NCT00563706|19511285|P4|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10
7929172|NCT00563706|19511286|P3|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
7929173|NCT00563706|19511287|P2|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
7929174|NCT00563706|19511288|P1|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17
7929175|NCT00563706|19511280|P9|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32
7929176|NCT00563706|19511281|P8|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16
7929177|NCT00563706|19511282|P7|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
7929178|NCT00563706|19511283|P6|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
7929179|NCT00563706|19511284|P5|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
7929180|NCT00563706|19511285|P4|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
7929181|NCT00563706|19511286|P3|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
7929182|NCT00563706|19511287|P2|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13
7929183|NCT00563706|19511288|P1|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20
7929184|NCT00563706|19511280|P9|STARTED|DB Treatment Period (Day 1 up to Day 28)||43
7929185|NCT00563706|19511281|P8|STARTED|DB Treatment Period (Day 1 up to Day 28)||30
7929186|NCT00563706|19511282|P7|STARTED|DB Treatment Period (Day 1 up to Day 28)||12
7929187|NCT00563706|19511283|P6|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
7929188|NCT00563706|19511284|P5|STARTED|DB Treatment Period (Day 1 up to Day 28)||16
7929189|NCT00563706|19511285|P4|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
7929190|NCT00563706|19511286|P3|STARTED|DB Treatment Period (Day 1 up to Day 28)||8
7929191|NCT00563706|19511287|P2|STARTED|DB Treatment Period (Day 1 up to Day 28)||18
7929192|NCT00563706|19511288|P1|STARTED|DB Treatment Period (Day 1 up to Day 28)||37
7929193|NCT00563576|19511391|P2|NOT COMPLETED|Overall Study||14
7929194|NCT00563576|19511392|P1|NOT COMPLETED|Overall Study||14
7929195|NCT00563576|19511391|P2|COMPLETED|Overall Study||22
7929196|NCT00563576|19511392|P1|COMPLETED|Overall Study||21
7929197|NCT00563576|19511391|P2|STARTED|Overall Study||36
7929198|NCT00563576|19511392|P1|STARTED|Overall Study||35
7929199|NCT00563381|19511406|P2|NOT COMPLETED|Overall Study||648
7929200|NCT00563381|19511407|P1|NOT COMPLETED|Overall Study||585
7929201|NCT00563381|19511406|P2|COMPLETED|Overall Study|Completed treatment|3021
7929202|NCT00563381|19511407|P1|COMPLETED|Overall Study|Completed treatment|3122
7929203|NCT00563381|19511406|P2|STARTED|Overall Study|Started treatment|3669
7929204|NCT00563381|19511407|P1|STARTED|Overall Study|Started treatment|3707
7929205|NCT00563368|19511480|P7|NOT COMPLETED|Overall Study||33
7929206|NCT00563368|19511481|P6|NOT COMPLETED|Overall Study||30
7929207|NCT00563368|19511482|P5|NOT COMPLETED|Overall Study||28
7929208|NCT00563368|19511483|P4|NOT COMPLETED|Overall Study||29
7929209|NCT00563368|19511484|P3|NOT COMPLETED|Overall Study||30
7929210|NCT00563368|19511485|P2|NOT COMPLETED|Overall Study||30
7929211|NCT00563368|19511486|P1|NOT COMPLETED|Overall Study||35
7929212|NCT00563368|19511480|P7|COMPLETED|Overall Study||75
7929213|NCT00563368|19511481|P6|COMPLETED|Overall Study||77
7929214|NCT00563368|19511482|P5|COMPLETED|Overall Study||80
7929215|NCT00563368|19511483|P4|COMPLETED|Overall Study||78
7929216|NCT00563368|19511484|P3|COMPLETED|Overall Study||78
7929217|NCT00563368|19511485|P2|COMPLETED|Overall Study||79
7929218|NCT00563368|19511486|P1|COMPLETED|Overall Study||74
7929219|NCT00563368|19511480|P7|STARTED|Overall Study||108
7929220|NCT00563368|19511481|P6|STARTED|Overall Study||107
7929221|NCT00563368|19511482|P5|STARTED|Overall Study||108
7929222|NCT00563368|19511483|P4|STARTED|Overall Study||107
7929223|NCT00563368|19511484|P3|STARTED|Overall Study||108
7929224|NCT00563368|19511485|P2|STARTED|Overall Study||109
7929225|NCT00563368|19511486|P1|STARTED|Overall Study||109
7929226|NCT00563316|19511509|P1|NOT COMPLETED|Overall Study||12
7929227|NCT00563316|19511509|P1|COMPLETED|Overall Study||16
7929228|NCT00563316|19511509|P1|Received Investigational Product|Overall Study||27
7929229|NCT00563316|19511509|P1|STARTED|Overall Study||28
7929230|NCT00563290|19511522|P2|NOT COMPLETED|Overall Study||0
7929231|NCT00563290|19511523|P1|NOT COMPLETED|Overall Study||0
7929232|NCT00563290|19511522|P2|COMPLETED|Overall Study||4
7929233|NCT00563290|19511523|P1|COMPLETED|Overall Study||3
7929234|NCT00563290|19511522|P2|STARTED|Overall Study||4
7929235|NCT00563290|19511523|P1|STARTED|Overall Study||3
7929236|NCT00563186|19511534|P2|NOT COMPLETED|Overall Study||75
7929237|NCT00563186|19511535|P1|NOT COMPLETED|Overall Study||98
7929238|NCT00563186|19511534|P2|COMPLETED|Overall Study||604
7929239|NCT00563186|19511535|P1|COMPLETED|Overall Study||910
7929240|NCT00563186|19511534|P2|STARTED|Overall Study|Patients allocated to the Traditional Hospital Ward|679
7929241|NCT00563186|19511535|P1|STARTED|Overall Study|Patients allocated to the Novel Hospital Ward|1008
7929242|NCT00562965|19511546|P2|NOT COMPLETED|Overall Study||6
7929243|NCT00562965|19511547|P1|NOT COMPLETED|Overall Study||3
7929244|NCT00562965|19511546|P2|COMPLETED|Overall Study||8
7929245|NCT00562965|19511547|P1|COMPLETED|Overall Study||12
7929246|NCT00562965|19511546|P2|Treated|Overall Study||13
7929247|NCT00562965|19511547|P1|Treated|Overall Study||15
7929248|NCT00562965|19511546|P2|STARTED|Overall Study||14
7929249|NCT00562965|19511547|P1|STARTED|Overall Study||15
7929250|NCT00562861|19511568|P2|NOT COMPLETED|Overall Study||11
7929251|NCT00562861|19511569|P1|NOT COMPLETED|Overall Study||20
7929252|NCT00562861|19511568|P2|COMPLETED|Overall Study||48
7929253|NCT00562861|19511569|P1|COMPLETED|Overall Study||40
7929254|NCT00562861|19511568|P2|STARTED|Overall Study||59
7929255|NCT00562861|19511569|P1|STARTED|Overall Study||60
7929256|NCT00562718|19511575|P1|NOT COMPLETED|Overall Study||11
7929257|NCT00562718|19511575|P1|COMPLETED|Overall Study||39
7929258|NCT00562718|19511575|P1|STARTED|Overall Study||50
7929259|NCT00562627|19511584|P3|NOT COMPLETED|Overall Study||1
7929260|NCT00562627|19511585|P2|NOT COMPLETED|Overall Study||1
7929261|NCT00562627|19511586|P1|NOT COMPLETED|Overall Study||1
7929262|NCT00562627|19511584|P3|COMPLETED|Overall Study||33
7929263|NCT00562627|19511585|P2|COMPLETED|Overall Study||33
7929264|NCT00562627|19511586|P1|COMPLETED|Overall Study||33
7929265|NCT00562627|19511584|P3|STARTED|Overall Study||34
7929266|NCT00562627|19511585|P2|STARTED|Overall Study||34
7929267|NCT00562627|19511586|P1|STARTED|Overall Study||34
7929268|NCT00562588|19511602|P2|NOT COMPLETED|Overall Study||99
7929269|NCT00562588|19511603|P1|NOT COMPLETED|Overall Study||92
7929270|NCT00562588|19511602|P2|COMPLETED|Overall Study||184
7929271|NCT00562588|19511603|P1|COMPLETED|Overall Study||168
7929272|NCT00562588|19511602|P2|STARTED|Overall Study||283
7929273|NCT00562588|19511603|P1|STARTED|Overall Study||260
7929274|NCT00562484|19511633|P2|NOT COMPLETED|Overall Study||104
7929275|NCT00562484|19511634|P1|NOT COMPLETED|Overall Study||206
7929276|NCT00562484|19511633|P2|COMPLETED|Overall Study||4907
7929277|NCT00562484|19511634|P1|COMPLETED|Overall Study||9827
7929278|NCT00562484|19511633|P2|STARTED|Overall Study||5011
7929279|NCT00562484|19511634|P1|STARTED|Overall Study||10033
7929280|NCT00562354|19511666|P2|NOT COMPLETED|Overall Study||2
7929281|NCT00562354|19511667|P1|NOT COMPLETED|Overall Study||0
7929282|NCT00562354|19511666|P2|COMPLETED|Overall Study||135
7929283|NCT00562354|19511667|P1|COMPLETED|Overall Study||134
7929284|NCT00562354|19511666|P2|Evaluable Immunogenicity Population|Overall Study||134
7929285|NCT00562354|19511667|P1|Evaluable Immunogenicity Population|Overall Study||134
7929286|NCT00562354|19511666|P2|Received Study Treatment|Overall Study||136
7929287|NCT00562354|19511667|P1|Received Study Treatment|Overall Study||134
7929288|NCT00562354|19511666|P2|STARTED|Overall Study||137
7929289|NCT00562354|19511667|P1|STARTED|Overall Study||134
7929290|NCT00562328|19511708|P1|NOT COMPLETED|Overall Study||0
7929291|NCT00562328|19511708|P1|COMPLETED|Overall Study||33
7929292|NCT00562328|19511708|P1|STARTED|Overall Study||33
7929293|NCT00562315|19511716|P1|NOT COMPLETED|Overall Study||0
7929294|NCT00562315|19511716|P1|COMPLETED|Overall Study||93
7929295|NCT00562315|19511716|P1|STARTED|Overall Study||93
7929296|NCT00562302|19511733|P2|NOT COMPLETED|Overall Study||32
7929297|NCT00562302|19511734|P1|NOT COMPLETED|Overall Study||20
7929298|NCT00562302|19511733|P2|COMPLETED|Overall Study||137
7929299|NCT00562302|19511734|P1|COMPLETED|Overall Study||150
7929300|NCT00562302|19511733|P2|STARTED|Overall Study||169
7929301|NCT00562302|19511734|P1|STARTED|Overall Study||170
7929302|NCT00562159|19511756|P2|NOT COMPLETED|Overall Study||33
7929303|NCT00562159|19511757|P1|NOT COMPLETED|Overall Study||38
7929304|NCT00562159|19511756|P2|COMPLETED|Overall Study||192
7929305|NCT00562159|19511757|P1|COMPLETED|Overall Study||175
7929306|NCT00562159|19511756|P2|STARTED|Overall Study||225
7929307|NCT00562159|19511757|P1|STARTED|Overall Study||213
7929308|NCT00562120|19511769|P4|NOT COMPLETED|Fourth Intervention Period||0
7929309|NCT00562120|19511770|P3|NOT COMPLETED|Fourth Intervention Period||0
7929310|NCT00562120|19511771|P2|NOT COMPLETED|Fourth Intervention Period||0
7929311|NCT00562120|19511772|P1|NOT COMPLETED|Fourth Intervention Period||0
7929312|NCT00562120|19511769|P4|COMPLETED|Fourth Intervention Period||5
7929313|NCT00562120|19511770|P3|COMPLETED|Fourth Intervention Period||5
7929314|NCT00562120|19511771|P2|COMPLETED|Fourth Intervention Period||5
7929315|NCT00562120|19511772|P1|COMPLETED|Fourth Intervention Period||4
7929316|NCT00562120|19511769|P4|STARTED|Fourth Intervention Period||5
7929317|NCT00562120|19511770|P3|STARTED|Fourth Intervention Period||5
7929318|NCT00562120|19511771|P2|STARTED|Fourth Intervention Period||5
7929319|NCT00562120|19511772|P1|STARTED|Fourth Intervention Period||4
7929320|NCT00562120|19511769|P4|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
7929321|NCT00562120|19511770|P3|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
7929322|NCT00562120|19511771|P2|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
7929323|NCT00562120|19511772|P1|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
7929324|NCT00562120|19511769|P4|COMPLETED|Washout Period 3 (At Least 14 Days)||5
7929325|NCT00562120|19511770|P3|COMPLETED|Washout Period 3 (At Least 14 Days)||5
7929326|NCT00562120|19511771|P2|COMPLETED|Washout Period 3 (At Least 14 Days)||5
7929327|NCT00562120|19511772|P1|COMPLETED|Washout Period 3 (At Least 14 Days)||4
7929328|NCT00562120|19511769|P4|STARTED|Washout Period 3 (At Least 14 Days)||5
7929329|NCT00562120|19511770|P3|STARTED|Washout Period 3 (At Least 14 Days)||5
7929330|NCT00562120|19511771|P2|STARTED|Washout Period 3 (At Least 14 Days)||5
7929331|NCT00562120|19511772|P1|STARTED|Washout Period 3 (At Least 14 Days)||4
7929332|NCT00562120|19511769|P4|NOT COMPLETED|Third Intervention Period||0
7929333|NCT00562120|19511770|P3|NOT COMPLETED|Third Intervention Period||0
7929334|NCT00562120|19511771|P2|NOT COMPLETED|Third Intervention Period||0
7929335|NCT00562120|19511772|P1|NOT COMPLETED|Third Intervention Period||0
7929336|NCT00562120|19511769|P4|COMPLETED|Third Intervention Period||5
7929337|NCT00562120|19511770|P3|COMPLETED|Third Intervention Period||5
7929338|NCT00562120|19511771|P2|COMPLETED|Third Intervention Period||5
7929339|NCT00562120|19511772|P1|COMPLETED|Third Intervention Period||4
7929340|NCT00562120|19511769|P4|STARTED|Third Intervention Period||5
7929341|NCT00562120|19511770|P3|STARTED|Third Intervention Period||5
7929342|NCT00562120|19511771|P2|STARTED|Third Intervention Period||5
7929343|NCT00562120|19511772|P1|STARTED|Third Intervention Period||4
7929344|NCT00562120|19511769|P4|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
7929345|NCT00562120|19511770|P3|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
7929346|NCT00562120|19511771|P2|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
7929347|NCT00562120|19511772|P1|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
7929348|NCT00562120|19511769|P4|COMPLETED|Washout Period 2 (At Least 14 Days)||5
7929349|NCT00562120|19511770|P3|COMPLETED|Washout Period 2 (At Least 14 Days)||5
7929350|NCT00562120|19511771|P2|COMPLETED|Washout Period 2 (At Least 14 Days)||5
7929351|NCT00562120|19511772|P1|COMPLETED|Washout Period 2 (At Least 14 Days)||4
7929352|NCT00562120|19511769|P4|STARTED|Washout Period 2 (At Least 14 Days)||5
7929353|NCT00562120|19511770|P3|STARTED|Washout Period 2 (At Least 14 Days)||5
7929354|NCT00562120|19511771|P2|STARTED|Washout Period 2 (At Least 14 Days)||5
7929355|NCT00562120|19511772|P1|STARTED|Washout Period 2 (At Least 14 Days)||4
7929356|NCT00562120|19511769|P4|NOT COMPLETED|Second Intervention Period||0
7929357|NCT00562120|19511770|P3|NOT COMPLETED|Second Intervention Period||0
7929358|NCT00562120|19511771|P2|NOT COMPLETED|Second Intervention Period||0
7929359|NCT00562120|19511772|P1|NOT COMPLETED|Second Intervention Period||0
7929360|NCT00562120|19511769|P4|COMPLETED|Second Intervention Period||5
7929361|NCT00562120|19511770|P3|COMPLETED|Second Intervention Period||5
7929362|NCT00562120|19511771|P2|COMPLETED|Second Intervention Period||5
7929363|NCT00562120|19511772|P1|COMPLETED|Second Intervention Period||4
7929364|NCT00562120|19511769|P4|STARTED|Second Intervention Period||5
7929365|NCT00562120|19511770|P3|STARTED|Second Intervention Period||5
7929366|NCT00562120|19511771|P2|STARTED|Second Intervention Period||5
7929367|NCT00562120|19511772|P1|STARTED|Second Intervention Period||4
7929368|NCT00562120|19511769|P4|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
7929369|NCT00562120|19511770|P3|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
7929370|NCT00562120|19511771|P2|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
7929371|NCT00562120|19511772|P1|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
7929372|NCT00562120|19511769|P4|COMPLETED|Washout Period 1 (At Least 14 Days)||5
7929373|NCT00562120|19511770|P3|COMPLETED|Washout Period 1 (At Least 14 Days)||5
7929374|NCT00562120|19511771|P2|COMPLETED|Washout Period 1 (At Least 14 Days)||5
7929375|NCT00562120|19511772|P1|COMPLETED|Washout Period 1 (At Least 14 Days)||4
7929376|NCT00562120|19511769|P4|STARTED|Washout Period 1 (At Least 14 Days)||5
7929377|NCT00562120|19511770|P3|STARTED|Washout Period 1 (At Least 14 Days)||5
7929378|NCT00562120|19511771|P2|STARTED|Washout Period 1 (At Least 14 Days)||5
7929379|NCT00562120|19511772|P1|STARTED|Washout Period 1 (At Least 14 Days)||4
7929380|NCT00562120|19511769|P4|NOT COMPLETED|First Intervention Period||0
7929381|NCT00562120|19511770|P3|NOT COMPLETED|First Intervention Period||0
7929382|NCT00562120|19511771|P2|NOT COMPLETED|First Intervention Period||0
7929383|NCT00562120|19511772|P1|NOT COMPLETED|First Intervention Period||2
7929384|NCT00562120|19511769|P4|COMPLETED|First Intervention Period||5
7929385|NCT00562120|19511770|P3|COMPLETED|First Intervention Period||5
7929386|NCT00562120|19511771|P2|COMPLETED|First Intervention Period||5
7929387|NCT00562120|19511772|P1|COMPLETED|First Intervention Period||4
7929388|NCT00562120|19511769|P4|Treated|First Intervention Period||5
7929389|NCT00562120|19511770|P3|Treated|First Intervention Period||5
7929390|NCT00562120|19511771|P2|Treated|First Intervention Period||5
7929391|NCT00562120|19511772|P1|Treated|First Intervention Period||5
7929392|NCT00562120|19511769|P4|STARTED|First Intervention Period||5
7929393|NCT00562120|19511770|P3|STARTED|First Intervention Period||5
7929394|NCT00562120|19511771|P2|STARTED|First Intervention Period||5
7929395|NCT00562120|19511772|P1|STARTED|First Intervention Period||6
7929396|NCT00562094|19511804|P1|NOT COMPLETED|Overall Study||62
7929397|NCT00562094|19511804|P1|COMPLETED|Overall Study||8554
7929398|NCT00562094|19511804|P1|STARTED|Overall Study||8616
7929399|NCT00561977|19511819|P3|NOT COMPLETED|Overall Study||2
7929400|NCT00561977|19511820|P2|NOT COMPLETED|Overall Study||3
7929401|NCT00561977|19511821|P1|NOT COMPLETED|Overall Study||0
7929402|NCT00561977|19511819|P3|COMPLETED|Overall Study||10
7929403|NCT00561977|19511820|P2|COMPLETED|Overall Study||9
7929404|NCT00561977|19511821|P1|COMPLETED|Overall Study||12
7929405|NCT00561977|19511819|P3|STARTED|Overall Study||12
7929406|NCT00561977|19511820|P2|STARTED|Overall Study||12
7929407|NCT00561977|19511821|P1|STARTED|Overall Study||12
7929408|NCT00561951|19511847|P3|NOT COMPLETED|Overall Study||32
7929409|NCT00561951|19511848|P2|NOT COMPLETED|Overall Study||34
7929410|NCT00561951|19511849|P1|NOT COMPLETED|Overall Study||33
7929411|NCT00561951|19511847|P3|COMPLETED|Overall Study||281
7929412|NCT00561951|19511848|P2|COMPLETED|Overall Study||286
7929413|NCT00561951|19511849|P1|COMPLETED|Overall Study||285
7929414|NCT00561951|19511847|P3|STARTED|Overall Study||313
7929415|NCT00561951|19511848|P2|STARTED|Overall Study||320
7929416|NCT00561951|19511849|P1|STARTED|Overall Study||318
7929417|NCT00561925|19511905|P5|NOT COMPLETED|Open-Label Extension Period||50
7929418|NCT00561925|19511906|P4|NOT COMPLETED|Open-Label Extension Period||43
7929419|NCT00561925|19511907|P3|NOT COMPLETED|Open-Label Extension Period||0
7929420|NCT00561925|19511908|P2|NOT COMPLETED|Open-Label Extension Period||0
7929421|NCT00561925|19511909|P1|NOT COMPLETED|Open-Label Extension Period||0
7929422|NCT00561925|19511905|P5|COMPLETED|Open-Label Extension Period||328
7929423|NCT00561925|19511906|P4|COMPLETED|Open-Label Extension Period||315
7929424|NCT00561925|19511907|P3|COMPLETED|Open-Label Extension Period||0
7929425|NCT00561925|19511908|P2|COMPLETED|Open-Label Extension Period||1
7929426|NCT00561925|19511909|P1|COMPLETED|Open-Label Extension Period||0
7929427|NCT00561925|19511905|P5|STARTED|Open-Label Extension Period||378
7929428|NCT00561925|19511906|P4|STARTED|Open-Label Extension Period||358
7929429|NCT00561925|19511907|P3|STARTED|Open-Label Extension Period||0
7929430|NCT00561925|19511908|P2|STARTED|Open-Label Extension Period||1
7929431|NCT00561925|19511909|P1|STARTED|Open-Label Extension Period||0
7929432|NCT00561925|19511905|P5|NOT COMPLETED|144-week Double-blind, Double-dummy||0
7929433|NCT00561925|19511906|P4|NOT COMPLETED|144-week Double-blind, Double-dummy||0
7929434|NCT00561925|19511907|P3|NOT COMPLETED|144-week Double-blind, Double-dummy||127
7929435|NCT00561925|19511908|P2|NOT COMPLETED|144-week Double-blind, Double-dummy||150
7929436|NCT00561925|19511909|P1|NOT COMPLETED|144-week Double-blind, Double-dummy||0
7929437|NCT00561925|19511905|P5|COMPLETED|144-week Double-blind, Double-dummy||0
7929438|NCT00561925|19511906|P4|COMPLETED|144-week Double-blind, Double-dummy||0
7929439|NCT00561925|19511907|P3|COMPLETED|144-week Double-blind, Double-dummy||378
7929440|NCT00561925|19511908|P2|COMPLETED|144-week Double-blind, Double-dummy||358
7929441|NCT00561925|19511909|P1|COMPLETED|144-week Double-blind, Double-dummy||0
7929442|NCT00561925|19511905|P5|STARTED|144-week Double-blind, Double-dummy||0
7929443|NCT00561925|19511906|P4|STARTED|144-week Double-blind, Double-dummy||0
7929444|NCT00561925|19511907|P3|STARTED|144-week Double-blind, Double-dummy||505
7929445|NCT00561925|19511908|P2|STARTED|144-week Double-blind, Double-dummy||508
7929446|NCT00561925|19511909|P1|STARTED|144-week Double-blind, Double-dummy||0
7929447|NCT00561925|19511905|P5|NOT COMPLETED|14 Day Lead-In Period||0
7929448|NCT00561925|19511906|P4|NOT COMPLETED|14 Day Lead-In Period||0
7929449|NCT00561925|19511907|P3|NOT COMPLETED|14 Day Lead-In Period||0
7929450|NCT00561925|19511908|P2|NOT COMPLETED|14 Day Lead-In Period||0
7929451|NCT00561925|19511909|P1|NOT COMPLETED|14 Day Lead-In Period||55
7929452|NCT00561925|19511905|P5|COMPLETED|14 Day Lead-In Period||0
7929453|NCT00561925|19511906|P4|COMPLETED|14 Day Lead-In Period||0
7929454|NCT00561925|19511907|P3|COMPLETED|14 Day Lead-In Period||0
7929455|NCT00561925|19511908|P2|COMPLETED|14 Day Lead-In Period||0
7929456|NCT00561925|19511909|P1|COMPLETED|14 Day Lead-In Period||1013
7929457|NCT00561925|19511905|P5|STARTED|14 Day Lead-In Period||0
7929458|NCT00561925|19511906|P4|STARTED|14 Day Lead-In Period||0
7929459|NCT00561925|19511907|P3|STARTED|14 Day Lead-In Period||0
7929460|NCT00561925|19511908|P2|STARTED|14 Day Lead-In Period||0
7929461|NCT00561925|19511909|P1|STARTED|14 Day Lead-In Period||1068
7929462|NCT00561912|19511958|P1|NOT COMPLETED|Overall Study||1
7929463|NCT00561912|19511958|P1|COMPLETED|Overall Study||1
7929464|NCT00561912|19511958|P1|STARTED|Overall Study||2
7929465|NCT00561834|19511962|P1|NOT COMPLETED|Overall Study||0
7929466|NCT00561834|19511962|P1|COMPLETED|Overall Study||2
7929467|NCT00561834|19511962|P1|STARTED|Overall Study||2
7929468|NCT00561821|19511970|P4|NOT COMPLETED|Overall Study||3
7929469|NCT00561821|19511971|P3|NOT COMPLETED|Overall Study||2
7929470|NCT00561821|19511972|P2|NOT COMPLETED|Overall Study||6
7929471|NCT00561821|19511973|P1|NOT COMPLETED|Overall Study||5
7929472|NCT00561821|19511970|P4|COMPLETED|Overall Study||133
7929473|NCT00561821|19511971|P3|COMPLETED|Overall Study||132
7929474|NCT00561821|19511972|P2|COMPLETED|Overall Study||130
7929475|NCT00561821|19511973|P1|COMPLETED|Overall Study||127
7929476|NCT00561821|19511970|P4|Treated|Overall Study||136
7929477|NCT00561821|19511971|P3|Treated|Overall Study||133
7929478|NCT00561821|19511972|P2|Treated|Overall Study||136
7929479|NCT00561821|19511973|P1|Treated|Overall Study||132
7929480|NCT00561821|19511970|P4|STARTED|Overall Study||136
7929481|NCT00561821|19511971|P3|STARTED|Overall Study||134
7929482|NCT00561821|19511972|P2|STARTED|Overall Study||136
7929483|NCT00561821|19511973|P1|STARTED|Overall Study||132
7929484|NCT00561795|19512049|P4|NOT COMPLETED|Overall Study||0
7929485|NCT00561795|19512050|P3|NOT COMPLETED|Overall Study||0
7929486|NCT00561795|19512051|P2|NOT COMPLETED|Overall Study||6
7929487|NCT00561795|19512052|P1|NOT COMPLETED|Overall Study||4
7929488|NCT00561795|19512049|P4|COMPLETED|Overall Study||0
7929489|NCT00561795|19512050|P3|COMPLETED|Overall Study||0
7929490|NCT00561795|19512051|P2|COMPLETED|Overall Study||0
7929491|NCT00561795|19512052|P1|COMPLETED|Overall Study||2
7929492|NCT00561795|19512049|P4|STARTED|Overall Study||0
7929493|NCT00561795|19512050|P3|STARTED|Overall Study||0
7929494|NCT00561795|19512051|P2|STARTED|Overall Study||6
7929495|NCT00561795|19512052|P1|STARTED|Overall Study||6
7929496|NCT00561730|19512072|P1|NOT COMPLETED|Overall Study||9
7929497|NCT00561730|19512072|P1|COMPLETED|Overall Study||1986
7929498|NCT00561730|19512072|P1|STARTED|Overall Study||1995
7929499|NCT00561678|19512088|P2|NOT COMPLETED|Overall Study||6
7929500|NCT00561678|19512089|P1|NOT COMPLETED|Overall Study||8
7929501|NCT00561678|19512088|P2|COMPLETED|Overall Study||201
7929502|NCT00561678|19512089|P1|COMPLETED|Overall Study||189
7929503|NCT00561678|19512088|P2|STARTED|Overall Study||207
7929504|NCT00561678|19512089|P1|STARTED|Overall Study||197
7929505|NCT00561652|19512107|P2|NOT COMPLETED|Overall Study||1
7929506|NCT00561652|19512108|P1|NOT COMPLETED|Overall Study||0
7929507|NCT00561652|19512107|P2|COMPLETED|Overall Study||19
7929508|NCT00561652|19512108|P1|COMPLETED|Overall Study||10
7929509|NCT00561652|19512107|P2|STARTED|Overall Study||20
7929510|NCT00561652|19512108|P1|STARTED|Overall Study||10
7929511|NCT00561600|19512128|P2|NOT COMPLETED|Overall Study||16
7929512|NCT00561600|19512129|P1|NOT COMPLETED|Overall Study||18
7929513|NCT00561600|19512128|P2|COMPLETED|Overall Study||119
7929514|NCT00561600|19512129|P1|COMPLETED|Overall Study||112
7929515|NCT00561600|19512128|P2|STARTED|Overall Study||135
7929516|NCT00561600|19512129|P1|STARTED|Overall Study||130
7929517|NCT00561574|19512191|P2|NOT COMPLETED|Overall Study||58
7929518|NCT00561574|19512192|P1|NOT COMPLETED|Overall Study||48
7929519|NCT00561574|19512191|P2|COMPLETED|Overall Study||73
7929520|NCT00561574|19512192|P1|COMPLETED|Overall Study||80
7929521|NCT00561574|19512191|P2|STARTED|Overall Study||131
7929522|NCT00561574|19512192|P1|STARTED|Overall Study||128
7929523|NCT00561470|19512218|P2|NOT COMPLETED|Overall Study||612
7929524|NCT00561470|19512219|P1|NOT COMPLETED|Overall Study||614
7929525|NCT00561470|19512218|P2|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
7929526|NCT00561470|19512219|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
7929527|NCT00561470|19512218|P2|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14
7929528|NCT00561470|19512219|P1|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11
7929529|NCT00561470|19512218|P2|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611
7929530|NCT00561470|19512219|P1|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605
7929531|NCT00561470|19512218|P2|TREATED|Overall Study||607
7929532|NCT00561470|19512219|P1|TREATED|Overall Study||609
7929533|NCT00561470|19512218|P2|STARTED|Overall Study||612
7929534|NCT00561470|19512219|P1|STARTED|Overall Study||614
7929535|NCT00561457|19512233|P1|NOT COMPLETED|Overall Study||24
7929536|NCT00561457|19512233|P1|COMPLETED|Overall Study||110
7929537|NCT00561457|19512233|P1|STARTED|Overall Study||134
7929538|NCT00561431|19512239|P2|NOT COMPLETED|Overall Study||0
7929539|NCT00561431|19512240|P1|NOT COMPLETED|Overall Study||0
7929540|NCT00561431|19512239|P2|COMPLETED|Overall Study||100
7929541|NCT00561431|19512240|P1|COMPLETED|Overall Study||100
7929542|NCT00561431|19512239|P2|STARTED|Overall Study||100
7929543|NCT00561431|19512240|P1|STARTED|Overall Study||100
7929544|NCT00561418|19512248|P1|NOT COMPLETED|Overall Study||0
7929545|NCT00561418|19512248|P1|COMPLETED|Overall Study||23
7929546|NCT00561418|19512248|P1|STARTED|Overall Study||23
7929547|NCT00561392|19512255|P1|NOT COMPLETED|Overall Study||53
7929548|NCT00561392|19512255|P1|COMPLETED|Overall Study||155
7929549|NCT00561392|19512255|P1|STARTED|Overall Study||208
7929550|NCT00561353|19512277|P10|NOT COMPLETED|Overall Study||2
7929551|NCT00561353|19512278|P9|NOT COMPLETED|Overall Study||7
7929552|NCT00561353|19512279|P8|NOT COMPLETED|Overall Study||4
7929553|NCT00561353|19512280|P7|NOT COMPLETED|Overall Study||6
7929554|NCT00561353|19512281|P6|NOT COMPLETED|Overall Study||6
7929555|NCT00561353|19512282|P5|NOT COMPLETED|Overall Study||1
7929556|NCT00561353|19512283|P4|NOT COMPLETED|Overall Study||6
7929557|NCT00561353|19512284|P3|NOT COMPLETED|Overall Study||3
7929558|NCT00561353|19512285|P2|NOT COMPLETED|Overall Study||3
7929559|NCT00561353|19512286|P1|NOT COMPLETED|Overall Study||5
7929560|NCT00561353|19512277|P10|COMPLETED|Overall Study||3
7929561|NCT00561353|19512278|P9|COMPLETED|Overall Study||2
7929562|NCT00561353|19512279|P8|COMPLETED|Overall Study||6
7929563|NCT00561353|19512280|P7|COMPLETED|Overall Study||3
7929564|NCT00561353|19512281|P6|COMPLETED|Overall Study||3
7929565|NCT00561353|19512282|P5|COMPLETED|Overall Study||5
7929566|NCT00561353|19512283|P4|COMPLETED|Overall Study||12
7929567|NCT00561353|19512284|P3|COMPLETED|Overall Study||10
7929568|NCT00561353|19512285|P2|COMPLETED|Overall Study||16
7929569|NCT00561353|19512286|P1|COMPLETED|Overall Study||13
7929570|NCT00561353|19512277|P10|STARTED|Overall Study||5
7929571|NCT00561353|19512278|P9|STARTED|Overall Study||9
7929572|NCT00561353|19512279|P8|STARTED|Overall Study||10
7929573|NCT00561353|19512280|P7|STARTED|Overall Study||9
7929574|NCT00561353|19512281|P6|STARTED|Overall Study||9
7929575|NCT00561353|19512282|P5|STARTED|Overall Study||6
7929576|NCT00561353|19512283|P4|STARTED|Overall Study||18
7929577|NCT00561353|19512284|P3|STARTED|Overall Study||13
7929578|NCT00561353|19512285|P2|STARTED|Overall Study||19
7929579|NCT00561353|19512286|P1|STARTED|Overall Study||18
7929580|NCT00561340|19512441|P2|NOT COMPLETED|Overall Study||0
7929581|NCT00561340|19512442|P1|NOT COMPLETED|Overall Study||6
7929582|NCT00561340|19512441|P2|COMPLETED|Overall Study||16
7929583|NCT00561340|19512442|P1|COMPLETED|Overall Study||7
7929584|NCT00561340|19512441|P2|STARTED|Overall Study||16
7929585|NCT00561340|19512442|P1|STARTED|Overall Study||13
7929586|NCT00561145|19512452|P2|NOT COMPLETED|Overall Study||0
7929587|NCT00561145|19512453|P1|NOT COMPLETED|Overall Study||0
7929588|NCT00561145|19512452|P2|COMPLETED|Overall Study||17
7929589|NCT00561145|19512453|P1|COMPLETED|Overall Study||15
7929590|NCT00561145|19512452|P2|STARTED|Overall Study||17
7929591|NCT00561145|19512453|P1|STARTED|Overall Study||15
7929592|NCT00561080|19512462|P3|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
7929593|NCT00561080|19512463|P2|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
7929594|NCT00561080|19512464|P1|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
7929595|NCT00561080|19512462|P3|COMPLETED|36 Month Post Last Dose Follow-up||0
7929596|NCT00561080|19512463|P2|COMPLETED|36 Month Post Last Dose Follow-up||0
7929597|NCT00561080|19512464|P1|COMPLETED|36 Month Post Last Dose Follow-up||0
7929598|NCT00561080|19512462|P3|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
7929599|NCT00561080|19512463|P2|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
7929600|NCT00561080|19512464|P1|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
7929601|NCT00561080|19512462|P3|NOT COMPLETED|24-month Post Last Dose Follow-up||0
7929602|NCT00561080|19512463|P2|NOT COMPLETED|24-month Post Last Dose Follow-up||0
7929603|NCT00561080|19512464|P1|NOT COMPLETED|24-month Post Last Dose Follow-up||0
7929604|NCT00561080|19512462|P3|COMPLETED|24-month Post Last Dose Follow-up||0
7929605|NCT00561080|19512463|P2|COMPLETED|24-month Post Last Dose Follow-up||0
7929606|NCT00561080|19512464|P1|COMPLETED|24-month Post Last Dose Follow-up||0
7929607|NCT00561080|19512462|P3|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
7929608|NCT00561080|19512463|P2|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
7929609|NCT00561080|19512464|P1|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
7929610|NCT00561080|19512462|P3|NOT COMPLETED|12-month Post Last Dose Follow-up||10
7929611|NCT00561080|19512463|P2|NOT COMPLETED|12-month Post Last Dose Follow-up||9
7929612|NCT00561080|19512464|P1|NOT COMPLETED|12-month Post Last Dose Follow-up||7
7929613|NCT00561080|19512462|P3|COMPLETED|12-month Post Last Dose Follow-up||215
7929614|NCT00561080|19512463|P2|COMPLETED|12-month Post Last Dose Follow-up||220
7929615|NCT00561080|19512464|P1|COMPLETED|12-month Post Last Dose Follow-up||243
7929616|NCT00561080|19512462|P3|STARTED|12-month Post Last Dose Follow-up||225
7929617|NCT00561080|19512463|P2|STARTED|12-month Post Last Dose Follow-up||229
7929618|NCT00561080|19512464|P1|STARTED|12-month Post Last Dose Follow-up||250
7929619|NCT00561080|19512462|P3|NOT COMPLETED|Vaccination Period (up to Month 4)||26
7929620|NCT00561080|19512463|P2|NOT COMPLETED|Vaccination Period (up to Month 4)||26
7929621|NCT00561080|19512464|P1|NOT COMPLETED|Vaccination Period (up to Month 4)||3
7929622|NCT00561080|19512462|P3|COMPLETED|Vaccination Period (up to Month 4)||225
7929623|NCT00561080|19512463|P2|COMPLETED|Vaccination Period (up to Month 4)||229
7929624|NCT00561080|19512464|P1|COMPLETED|Vaccination Period (up to Month 4)||250
7929625|NCT00561080|19512462|P3|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||250
7929626|NCT00561080|19512463|P2|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||254
7929627|NCT00561080|19512464|P1|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||253
7929628|NCT00561080|19512462|P3|STARTED|Vaccination Period (up to Month 4)||251
7929629|NCT00561080|19512463|P2|STARTED|Vaccination Period (up to Month 4)||255
7929630|NCT00561080|19512464|P1|STARTED|Vaccination Period (up to Month 4)||253
7929631|NCT00561015|19512541|P6|NOT COMPLETED|Overall Study||3
7929632|NCT00561015|19512542|P5|NOT COMPLETED|Overall Study||1
7929633|NCT00561015|19512543|P4|NOT COMPLETED|Overall Study||1
7929634|NCT00561015|19512544|P3|NOT COMPLETED|Overall Study||0
7929635|NCT00561015|19512545|P2|NOT COMPLETED|Overall Study||0
7929636|NCT00561015|19512546|P1|NOT COMPLETED|Overall Study||4
7929637|NCT00561015|19512541|P6|COMPLETED|Overall Study||6
7929638|NCT00561015|19512542|P5|COMPLETED|Overall Study||8
7929639|NCT00561015|19512543|P4|COMPLETED|Overall Study||7
7929640|NCT00561015|19512544|P3|COMPLETED|Overall Study||9
7929641|NCT00561015|19512545|P2|COMPLETED|Overall Study||5
7929642|NCT00561015|19512546|P1|COMPLETED|Overall Study||5
7929643|NCT00561015|19512541|P6|STARTED|Overall Study||9
7929644|NCT00561015|19512542|P5|STARTED|Overall Study||9
7929645|NCT00561015|19512543|P4|STARTED|Overall Study||8
7929646|NCT00561015|19512544|P3|STARTED|Overall Study||9
7929647|NCT00561015|19512545|P2|STARTED|Overall Study||5
7929648|NCT00561015|19512546|P1|STARTED|Overall Study||9
7929649|NCT00561002|19512622|P2|NOT COMPLETED|Overall Study||0
7929650|NCT00561002|19512623|P1|NOT COMPLETED|Overall Study||0
7929651|NCT00561002|19512622|P2|COMPLETED|Overall Study||9
7929652|NCT00561002|19512623|P1|COMPLETED|Overall Study||23
7929653|NCT00561002|19512622|P2|STARTED|Overall Study||9
7929654|NCT00561002|19512623|P1|STARTED|Overall Study||23
7929655|NCT00560950|19512637|P2|NOT COMPLETED|Overall Study||0
7929656|NCT00560950|19512638|P1|NOT COMPLETED|Overall Study||1
7929657|NCT00560950|19512637|P2|COMPLETED|Overall Study||71
7929658|NCT00560950|19512638|P1|COMPLETED|Overall Study||71
7929659|NCT00560950|19512637|P2|STARTED|Overall Study||71
7929660|NCT00560950|19512638|P1|STARTED|Overall Study||72
7929661|NCT00560937|19512676|P2|NOT COMPLETED|Overall Study||2
7929662|NCT00560937|19512677|P1|NOT COMPLETED|Overall Study||1
7929663|NCT00560937|19512676|P2|COMPLETED|Overall Study||9
7929664|NCT00560937|19512677|P1|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9
7929665|NCT00560937|19512676|P2|STARTED|Overall Study||11
7929666|NCT00560937|19512677|P1|STARTED|Overall Study||10
7929667|NCT00560885|19512693|P1|NOT COMPLETED|Overall Study||8
7929668|NCT00560885|19512693|P1|COMPLETED|Overall Study||47
7929669|NCT00560885|19512693|P1|2 Year Follow-up|Overall Study||47
7929670|NCT00560885|19512693|P1|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48
7929671|NCT00560885|19512693|P1|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50
7929672|NCT00560885|19512693|P1|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51
7929673|NCT00560885|19512693|P1|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53
7929674|NCT00560885|19512693|P1|STARTED|Overall Study||55
7929675|NCT00560859|19512702|P2|NOT COMPLETED|Overall Study||24
7929676|NCT00560859|19512703|P1|NOT COMPLETED|Overall Study||32
7929677|NCT00560859|19512702|P2|COMPLETED|Overall Study||203
7929678|NCT00560859|19512703|P1|COMPLETED|Overall Study||194
7929679|NCT00560859|19512702|P2|STARTED|Overall Study||227
7929680|NCT00560859|19512703|P1|STARTED|Overall Study||226
7929681|NCT00560833|19512718|P5|NOT COMPLETED|Overall Study||42
7929682|NCT00560833|19512719|P4|NOT COMPLETED|Overall Study||31
7929683|NCT00560833|19512720|P3|NOT COMPLETED|Overall Study||39
7929684|NCT00560833|19512721|P2|NOT COMPLETED|Overall Study||26
7929685|NCT00560833|19512722|P1|NOT COMPLETED|Overall Study||44
7929686|NCT00560833|19512718|P5|COMPLETED|Overall Study||114
7929687|NCT00560833|19512719|P4|COMPLETED|Overall Study||124
7929688|NCT00560833|19512720|P3|COMPLETED|Overall Study||121
7929689|NCT00560833|19512721|P2|COMPLETED|Overall Study||129
7929690|NCT00560833|19512722|P1|COMPLETED|Overall Study||273
7929691|NCT00560833|19512718|P5|Treated|Overall Study|One participant was randomized but not treated|155
7929692|NCT00560833|19512719|P4|Treated|Overall Study||155
7929693|NCT00560833|19512720|P3|Treated|Overall Study||160
7929694|NCT00560833|19512721|P2|Treated|Overall Study|One participant was randomized but not treated|154
7929695|NCT00560833|19512722|P1|Treated|Overall Study|One participant was not randomized but was treated with placebo|317
7929696|NCT00560833|19512718|P5|STARTED|Overall Study||156
7929697|NCT00560833|19512719|P4|STARTED|Overall Study||155
7929698|NCT00560833|19512720|P3|STARTED|Overall Study||160
7929699|NCT00560833|19512721|P2|STARTED|Overall Study||155
7929700|NCT00560833|19512722|P1|STARTED|Overall Study||317
7929701|NCT00560794|19512754|P1|NOT COMPLETED|Overall Study||11
7929702|NCT00560794|19512754|P1|COMPLETED|Overall Study||10
7929703|NCT00560794|19512754|P1|Completed 1 Treatment Cycle|Overall Study||20
7929704|NCT00560794|19512754|P1|STARTED|Overall Study||21
7929705|NCT00560755|19512771|P1|NOT COMPLETED|Overall Study||60
7929706|NCT00560755|19512771|P1|COMPLETED|Overall Study||3328
7929707|NCT00560755|19512771|P1|ProQuad® Dose 1 and Dose 2|Overall Study||3346
7929708|NCT00560755|19512771|P1|STARTED|Overall Study|Vaccinated (at least one ProQuad® dose)|3388
7929709|NCT00560703|19512792|P2|NOT COMPLETED|Overall Study||6
7929710|NCT00560703|19512793|P1|NOT COMPLETED|Overall Study||0
7929711|NCT00560703|19512792|P2|COMPLETED|Overall Study||18
7929712|NCT00560703|19512793|P1|COMPLETED|Overall Study||46
7929713|NCT00560703|19512792|P2|STARTED|Overall Study||24
7929714|NCT00560703|19512793|P1|STARTED|Overall Study||46
7929715|NCT00560612|19512803|P2|NOT COMPLETED|Overall Study||0
7929716|NCT00560612|19512804|P1|NOT COMPLETED|Overall Study||0
7929717|NCT00560612|19512803|P2|COMPLETED|Overall Study||7
7929718|NCT00560612|19512804|P1|COMPLETED|Overall Study||5
7929719|NCT00560612|19512803|P2|STARTED|Overall Study||7
7929720|NCT00560612|19512804|P1|STARTED|Overall Study||5
7929721|NCT00560573|19512816|P6|NOT COMPLETED|Overall Study||13
7929722|NCT00560573|19512817|P5|NOT COMPLETED|Overall Study||7
7929723|NCT00560573|19512818|P4|NOT COMPLETED|Overall Study||10
7929724|NCT00560573|19512819|P3|NOT COMPLETED|Overall Study||6
7929725|NCT00560573|19512820|P2|NOT COMPLETED|Overall Study||3
7929726|NCT00560573|19512821|P1|NOT COMPLETED|Overall Study||6
7929727|NCT00560573|19512816|P6|COMPLETED|Overall Study||0
7929728|NCT00560573|19512817|P5|COMPLETED|Overall Study||1
7929729|NCT00560573|19512818|P4|COMPLETED|Overall Study||0
7929730|NCT00560573|19512819|P3|COMPLETED|Overall Study||0
7929731|NCT00560573|19512820|P2|COMPLETED|Overall Study||0
7929732|NCT00560573|19512821|P1|COMPLETED|Overall Study||0
7929733|NCT00560573|19512816|P6|Treated|Overall Study||13
7929734|NCT00560573|19512817|P5|Treated|Overall Study||7
7929735|NCT00560573|19512818|P4|Treated|Overall Study||10
7929736|NCT00560573|19512819|P3|Treated|Overall Study||6
7929737|NCT00560573|19512820|P2|Treated|Overall Study||3
7929738|NCT00560573|19512821|P1|Treated|Overall Study||6
7929739|NCT00560573|19512816|P6|STARTED|Overall Study||13
7929740|NCT00560573|19512817|P5|STARTED|Overall Study||8
7929741|NCT00560573|19512818|P4|STARTED|Overall Study||10
7929742|NCT00560573|19512819|P3|STARTED|Overall Study||6
7929743|NCT00560573|19512820|P2|STARTED|Overall Study||3
7929744|NCT00560573|19512821|P1|STARTED|Overall Study||6
7929745|NCT00560560|19512875|P2|NOT COMPLETED|Overall Study||83
7929746|NCT00560560|19512876|P1|NOT COMPLETED|Overall Study||85
7929747|NCT00560560|19512875|P2|COMPLETED|Overall Study||0
7929748|NCT00560560|19512876|P1|COMPLETED|Overall Study||0
7929749|NCT00560560|19512875|P2|STARTED|Overall Study||83
7929750|NCT00560560|19512876|P1|STARTED|Overall Study||85
7929751|NCT00560508|19512898|P2|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11
7929752|NCT00560508|19512899|P1|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8
7929753|NCT00560508|19512898|P2|COMPLETED|52-week Open-label Period Pramipexole ER||42
7929754|NCT00560508|19512899|P1|COMPLETED|52-week Open-label Period Pramipexole ER||43
7929755|NCT00560508|19512898|P2|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53
7929756|NCT00560508|19512899|P1|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51
7929757|NCT00560508|19512898|P2|NOT COMPLETED|12 Week Double-blind Period||3
7929758|NCT00560508|19512899|P1|NOT COMPLETED|12 Week Double-blind Period||5
7929759|NCT00560508|19512898|P2|COMPLETED|12 Week Double-blind Period||53
7929760|NCT00560508|19512899|P1|COMPLETED|12 Week Double-blind Period||51
7929761|NCT00560508|19512898|P2|STARTED|12 Week Double-blind Period||56
7929762|NCT00560508|19512899|P1|STARTED|12 Week Double-blind Period||56
7929763|NCT00560417|19512958|P2|NOT COMPLETED|Overall Study||17
7929764|NCT00560417|19512959|P1|NOT COMPLETED|Overall Study||17
7929765|NCT00560417|19512958|P2|COMPLETED|Overall Study||151
7929766|NCT00560417|19512959|P1|COMPLETED|Overall Study||154
7929767|NCT00560417|19512958|P2|Intention to Treat (ITT) Population|Overall Study||167
7929768|NCT00560417|19512959|P1|Intention to Treat (ITT) Population|Overall Study||170
7929769|NCT00560417|19512958|P2|STARTED|Overall Study||168
7929770|NCT00560417|19512959|P1|STARTED|Overall Study||171
7929771|NCT00560404|19512987|P2|NOT COMPLETED|Overall Study||21
7929772|NCT00560404|19512988|P1|NOT COMPLETED|Overall Study||36
7929773|NCT00560404|19512987|P2|COMPLETED|Overall Study||100
7929774|NCT00560404|19512988|P1|COMPLETED|Overall Study||76
7929775|NCT00560404|19512987|P2|STARTED|Overall Study||121
7929776|NCT00560404|19512988|P1|STARTED|Overall Study||112
7929777|NCT00560391|19513035|P5|NOT COMPLETED|Overall Study||2
7929778|NCT00560391|19513036|P4|NOT COMPLETED|Overall Study||1
7929779|NCT00560391|19513037|P3|NOT COMPLETED|Overall Study||0
7929780|NCT00560391|19513038|P2|NOT COMPLETED|Overall Study||0
7929781|NCT00560391|19513039|P1|NOT COMPLETED|Overall Study||0
7929782|NCT00560391|19513035|P5|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15
7929783|NCT00560391|19513036|P4|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5
7929784|NCT00560391|19513037|P3|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3
7929785|NCT00560391|19513038|P2|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3
7929786|NCT00560391|19513039|P1|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6
7929787|NCT00560391|19513035|P5|STARTED|Overall Study|Participants who received treatment|17
7929788|NCT00560391|19513036|P4|STARTED|Overall Study|Participants who received treatment|6
7929789|NCT00560391|19513037|P3|STARTED|Overall Study|Participants who received treatment|3
7929790|NCT00560391|19513038|P2|STARTED|Overall Study|Participants who received treatment|3
7929791|NCT00560391|19513039|P1|STARTED|Overall Study|Participants who received treatment|6
7929792|NCT00560352|19513095|P3|NOT COMPLETED|Overall Study||4
7929793|NCT00560352|19513096|P2|NOT COMPLETED|Overall Study||3
7929794|NCT00560352|19513097|P1|NOT COMPLETED|Overall Study||7
7929795|NCT00560352|19513095|P3|COMPLETED|Overall Study||0
7929796|NCT00560352|19513096|P2|COMPLETED|Overall Study||0
7929797|NCT00560352|19513097|P1|COMPLETED|Overall Study||0
7929798|NCT00560352|19513095|P3|STARTED|Overall Study||4
7929799|NCT00560352|19513096|P2|STARTED|Overall Study||3
7929800|NCT00560352|19513097|P1|STARTED|Overall Study||7
7929801|NCT00560313|19513114|P1|NOT COMPLETED|Overall Study||6
7929802|NCT00560313|19513114|P1|COMPLETED|Overall Study||48
7929803|NCT00560313|19513114|P1|STARTED|Overall Study||54
7929804|NCT00560235|19513141|P3|NOT COMPLETED|Phase 2||97
7929805|NCT00560235|19513142|P2|NOT COMPLETED|Phase 2||0
7929806|NCT00560235|19513143|P1|NOT COMPLETED|Phase 2||0
7929807|NCT00560235|19513141|P3|COMPLETED|Phase 2||10
7929808|NCT00560235|19513142|P2|COMPLETED|Phase 2||0
7929809|NCT00560235|19513143|P1|COMPLETED|Phase 2||0
7929810|NCT00560235|19513141|P3|STARTED|Phase 2||107
7929811|NCT00560235|19513142|P2|STARTED|Phase 2||0
7929812|NCT00560235|19513143|P1|STARTED|Phase 2||0
7929813|NCT00560235|19513141|P3|NOT COMPLETED|Phase 1B||0
7929814|NCT00560235|19513142|P2|NOT COMPLETED|Phase 1B||19
7929815|NCT00560235|19513143|P1|NOT COMPLETED|Phase 1B||0
7929816|NCT00560235|19513141|P3|COMPLETED|Phase 1B||0
7929817|NCT00560235|19513142|P2|COMPLETED|Phase 1B||2
7929818|NCT00560235|19513143|P1|COMPLETED|Phase 1B||0
7929819|NCT00560235|19513141|P3|STARTED|Phase 1B||0
7929820|NCT00560235|19513142|P2|STARTED|Phase 1B||21
7929821|NCT00560235|19513143|P1|STARTED|Phase 1B||0
7929822|NCT00560235|19513141|P3|NOT COMPLETED|Phase 1||0
7929823|NCT00560235|19513142|P2|NOT COMPLETED|Phase 1||0
7929824|NCT00560235|19513143|P1|NOT COMPLETED|Phase 1||8
7929825|NCT00560235|19513141|P3|COMPLETED|Phase 1||0
7929826|NCT00560235|19513142|P2|COMPLETED|Phase 1||0
7929827|NCT00560235|19513143|P1|COMPLETED|Phase 1||2
7929828|NCT00560235|19513141|P3|STARTED|Phase 1||0
7929829|NCT00560235|19513142|P2|STARTED|Phase 1||0
7929830|NCT00560235|19513143|P1|STARTED|Phase 1||10
7929831|NCT00560105|19513174|P2|NOT COMPLETED|Overall Study||2
7929832|NCT00560105|19513175|P1|NOT COMPLETED|Overall Study||1
7929833|NCT00560105|19513174|P2|COMPLETED|Overall Study||18
7929834|NCT00560105|19513175|P1|COMPLETED|Overall Study||19
7929835|NCT00560105|19513174|P2|STARTED|Overall Study||20
7929836|NCT00560105|19513175|P1|STARTED|Overall Study||20
7929837|NCT00560066|19513189|P2|NOT COMPLETED|Overall Study||22
7929838|NCT00560066|19513190|P1|NOT COMPLETED|Overall Study||6
7929839|NCT00560066|19513189|P2|COMPLETED|Overall Study||980
7929840|NCT00560066|19513190|P1|COMPLETED|Overall Study||390
7929841|NCT00560066|19513189|P2|STARTED|Overall Study||1002
7929842|NCT00560066|19513190|P1|STARTED|Overall Study||396
7929843|NCT00559988|19513222|P2|NOT COMPLETED|Overall Study||352
7929844|NCT00559988|19513223|P1|NOT COMPLETED|Overall Study||351
7929845|NCT00559988|19513222|P2|COMPLETED|Overall Study||1009
7929846|NCT00559988|19513223|P1|COMPLETED|Overall Study||1006
7929847|NCT00559988|19513222|P2|STARTED|Overall Study||1361
7929848|NCT00559988|19513223|P1|STARTED|Overall Study||1357
7929849|NCT00559962|19513253|P8|NOT COMPLETED|Overall Study||4
7929850|NCT00559962|19513254|P7|NOT COMPLETED|Overall Study||5
7929851|NCT00559962|19513255|P6|NOT COMPLETED|Overall Study||5
7929852|NCT00559962|19513256|P5|NOT COMPLETED|Overall Study||14
7929853|NCT00559962|19513257|P4|NOT COMPLETED|Overall Study||5
7929854|NCT00559962|19513258|P3|NOT COMPLETED|Overall Study||10
7929855|NCT00559962|19513259|P2|NOT COMPLETED|Overall Study||9
7929856|NCT00559962|19513260|P1|NOT COMPLETED|Overall Study||2
7929857|NCT00559962|19513253|P8|COMPLETED|Overall Study||25
7929858|NCT00559962|19513254|P7|COMPLETED|Overall Study||28
7929859|NCT00559962|19513255|P6|COMPLETED|Overall Study||23
7929860|NCT00559962|19513256|P5|COMPLETED|Overall Study||21
7929861|NCT00559962|19513257|P4|COMPLETED|Overall Study||29
7929862|NCT00559962|19513258|P3|COMPLETED|Overall Study||24
7929863|NCT00559962|19513259|P2|COMPLETED|Overall Study||25
7929864|NCT00559962|19513260|P1|COMPLETED|Overall Study||31
7929865|NCT00559962|19513253|P8|STARTED|Overall Study||29
7929866|NCT00559962|19513254|P7|STARTED|Overall Study||33
7929867|NCT00559962|19513255|P6|STARTED|Overall Study||28
7929868|NCT00559962|19513256|P5|STARTED|Overall Study||35
7929869|NCT00559962|19513257|P4|STARTED|Overall Study||34
7929870|NCT00559962|19513258|P3|STARTED|Overall Study||34
7929871|NCT00559962|19513259|P2|STARTED|Overall Study||34
7929872|NCT00559962|19513260|P1|STARTED|Overall Study||33
7929873|NCT00559949|19513280|P1|NOT COMPLETED|Overall Study||7
7929874|NCT00559949|19513280|P1|COMPLETED|Overall Study||32
7929875|NCT00559949|19513280|P1|STARTED|Overall Study||39
7929876|NCT00559936|19513287|P1|NOT COMPLETED|Overall Study||4
7929877|NCT00559936|19513287|P1|COMPLETED|Overall Study||20
7929878|NCT00559936|19513287|P1|STARTED|Overall Study||24
7929879|NCT00559897|19513292|P1|NOT COMPLETED|Overall Study||0
7929880|NCT00559897|19513292|P1|COMPLETED|Overall Study||6
7929881|NCT00559897|19513292|P1|STARTED|Overall Study||6
7929882|NCT00559845|19513296|P1|NOT COMPLETED|Overall Study||7
7929883|NCT00559845|19513296|P1|COMPLETED|Overall Study||49
7929884|NCT00559845|19513296|P1|STARTED|Overall Study||56
7929885|NCT00559754|19513305|P1|NOT COMPLETED|Overall Study||11
7929886|NCT00559754|19513305|P1|COMPLETED|Overall Study||61
7929887|NCT00559754|19513305|P1|STARTED|Overall Study||72
7929888|NCT00559637|19513329|P1|NOT COMPLETED|Overall Study||54
7929889|NCT00559637|19513329|P1|COMPLETED|Overall Study||130
7929890|NCT00559637|19513329|P1|STARTED|Overall Study||184
7929891|NCT00559585|19513342|P2|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0
7929892|NCT00559585|19513343|P1|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428
7929893|NCT00559585|19513342|P2|COMPLETED|Open Label LT Period Main + Sub-Study||0
7929894|NCT00559585|19513343|P1|COMPLETED|Open Label LT Period Main + Sub-Study||945
7929895|NCT00559585|19513342|P2|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0
7929896|NCT00559585|19513343|P1|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373
7929897|NCT00559585|19513342|P2|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
7929898|NCT00559585|19513343|P1|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
7929899|NCT00559585|19513342|P2|COMPLETED|Anti-TNF Sub-Study in ST Period||9
7929900|NCT00559585|19513343|P1|COMPLETED|Anti-TNF Sub-Study in ST Period||7
7929901|NCT00559585|19513342|P2|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10
7929902|NCT00559585|19513343|P1|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8
7929903|NCT00559585|19513342|P2|NOT COMPLETED|Double Blind ST Period Main Study||45
7929904|NCT00559585|19513343|P1|NOT COMPLETED|Double Blind ST Period Main Study||43
7929905|NCT00559585|19513342|P2|COMPLETED|Double Blind ST Period Main Study||676
7929906|NCT00559585|19513343|P1|COMPLETED|Double Blind ST Period Main Study||693
7929907|NCT00559585|19513342|P2|STARTED|Double Blind ST Period Main Study|Randomized and treated|721
7929908|NCT00559585|19513343|P1|STARTED|Double Blind ST Period Main Study|Randomized and treated|736
7929909|NCT00559507|19513403|P1|NOT COMPLETED|Overall Study||3
7929910|NCT00559507|19513403|P1|COMPLETED|Overall Study||9
7929911|NCT00559507|19513403|P1|STARTED|Overall Study||12
7929912|NCT00559468|19513411|P2|NOT COMPLETED|Overall Study||1
7929913|NCT00559468|19513412|P1|NOT COMPLETED|Overall Study||0
7929914|NCT00559468|19513411|P2|COMPLETED|Overall Study||25
7929915|NCT00559468|19513412|P1|COMPLETED|Overall Study||26
7929916|NCT00559468|19513411|P2|Treated|Overall Study||25
7929917|NCT00559468|19513412|P1|Treated|Overall Study||26
7929918|NCT00559468|19513411|P2|STARTED|Overall Study||26
7929919|NCT00559468|19513412|P1|STARTED|Overall Study||26
7929920|NCT00559377|19513422|P1|NOT COMPLETED|Overall Study||9
7929921|NCT00559377|19513422|P1|COMPLETED|Overall Study||7
7929922|NCT00559377|19513422|P1|STARTED|Overall Study||16
7929923|NCT00559364|19513432|P2|NOT COMPLETED|Overall Study||0
7929924|NCT00559364|19513433|P1|NOT COMPLETED|Overall Study||1
7929925|NCT00559364|19513432|P2|COMPLETED|Overall Study||20
7929926|NCT00559364|19513433|P1|COMPLETED|Overall Study||29
7929927|NCT00559364|19513432|P2|STARTED|Overall Study||20
7929928|NCT00559364|19513433|P1|STARTED|Overall Study||30
7929929|NCT00559273|19513445|P2|NOT COMPLETED|Evaluation Period (8 Weeks)||5
7929930|NCT00559273|19513446|P1|NOT COMPLETED|Evaluation Period (8 Weeks)||3
7929931|NCT00559273|19513445|P2|COMPLETED|Evaluation Period (8 Weeks)||137
7929932|NCT00559273|19513446|P1|COMPLETED|Evaluation Period (8 Weeks)||141
7929933|NCT00559273|19513445|P2|STARTED|Evaluation Period (8 Weeks)||142
7929934|NCT00559273|19513446|P1|STARTED|Evaluation Period (8 Weeks)||144
7929935|NCT00559273|19513445|P2|NOT COMPLETED|Correction Period (20 Weeks)||12
7929936|NCT00559273|19513446|P1|NOT COMPLETED|Correction Period (20 Weeks)||9
7929937|NCT00559273|19513445|P2|COMPLETED|Correction Period (20 Weeks)||142
7929938|NCT00559273|19513446|P1|COMPLETED|Correction Period (20 Weeks)||144
7929939|NCT00559273|19513445|P2|Treated|Correction Period (20 Weeks)||154
7929940|NCT00559273|19513446|P1|Treated|Correction Period (20 Weeks)||151
7929941|NCT00559273|19513445|P2|STARTED|Correction Period (20 Weeks)||154
7929942|NCT00559273|19513446|P1|STARTED|Correction Period (20 Weeks)||153
7929943|NCT00559104|19513468|P2|NOT COMPLETED|Overall Study||0
7929944|NCT00559104|19513469|P1|NOT COMPLETED|Overall Study||9
7929945|NCT00559104|19513468|P2|COMPLETED|Overall Study||5
7929946|NCT00559104|19513469|P1|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46
7929947|NCT00559104|19513468|P2|STARTED|Overall Study||5
7929948|NCT00559104|19513469|P1|STARTED|Overall Study||55
7929949|NCT00559013|19513479|P1|NOT COMPLETED|Overall Study||0
7929950|NCT00559013|19513479|P1|COMPLETED|Overall Study||38
7929951|NCT00559013|19513479|P1|STARTED|Overall Study||38
7929952|NCT00558896|19513490|P7|NOT COMPLETED|Overall Study||24
7929953|NCT00558896|19513491|P6|NOT COMPLETED|Overall Study||52
7929954|NCT00558896|19513492|P5|NOT COMPLETED|Overall Study||23
7929955|NCT00558896|19513493|P4|NOT COMPLETED|Overall Study||12
7929956|NCT00558896|19513494|P3|NOT COMPLETED|Overall Study||5
7929957|NCT00558896|19513495|P2|NOT COMPLETED|Overall Study||7
7929958|NCT00558896|19513496|P1|NOT COMPLETED|Overall Study||21
7929959|NCT00558896|19513490|P7|COMPLETED|Overall Study||9
7929960|NCT00558896|19513491|P6|COMPLETED|Overall Study||68
7929961|NCT00558896|19513492|P5|COMPLETED|Overall Study||37
7929962|NCT00558896|19513493|P4|COMPLETED|Overall Study||23
7929963|NCT00558896|19513494|P3|COMPLETED|Overall Study||30
7929964|NCT00558896|19513495|P2|COMPLETED|Overall Study||27
7929965|NCT00558896|19513496|P1|COMPLETED|Overall Study||39
7929966|NCT00558896|19513490|P7|STARTED|Overall Study||33
7929967|NCT00558896|19513491|P6|STARTED|Overall Study||120
7929968|NCT00558896|19513492|P5|STARTED|Overall Study||60
7929969|NCT00558896|19513493|P4|STARTED|Overall Study||35
7929970|NCT00558896|19513494|P3|STARTED|Overall Study||35
7929971|NCT00558896|19513495|P2|STARTED|Overall Study||34
7929972|NCT00558896|19513496|P1|STARTED|Overall Study||60
7929973|NCT00558870|19513528|P2|NOT COMPLETED|Overall Study||0
7929974|NCT00558870|19513529|P1|NOT COMPLETED|Overall Study||0
7929975|NCT00558870|19513528|P2|COMPLETED|Overall Study||2
7929976|NCT00558870|19513529|P1|COMPLETED|Overall Study||2
7929977|NCT00558870|19513528|P2|STARTED|Overall Study||2
7929978|NCT00558870|19513529|P1|STARTED|Overall Study||2
7929979|NCT00558844|19513542|P5|NOT COMPLETED|Overall Study||1
7929980|NCT00558844|19513543|P4|NOT COMPLETED|Overall Study||0
7929981|NCT00558844|19513544|P3|NOT COMPLETED|Overall Study||1
7929982|NCT00558844|19513545|P2|NOT COMPLETED|Overall Study||0
7929983|NCT00558844|19513546|P1|NOT COMPLETED|Overall Study||3
7929984|NCT00558844|19513542|P5|COMPLETED|Overall Study||6
7929985|NCT00558844|19513543|P4|COMPLETED|Overall Study||5
7929986|NCT00558844|19513544|P3|COMPLETED|Overall Study||6
7929987|NCT00558844|19513545|P2|COMPLETED|Overall Study||7
7929988|NCT00558844|19513546|P1|COMPLETED|Overall Study||12
7929989|NCT00558844|19513542|P5|STARTED|Overall Study||7
7929990|NCT00558844|19513543|P4|STARTED|Overall Study||5
7929991|NCT00558844|19513544|P3|STARTED|Overall Study||7
7929992|NCT00558844|19513545|P2|STARTED|Overall Study||7
7929993|NCT00558844|19513546|P1|STARTED|Overall Study||15
7929994|NCT00558831|19513598|P1|NOT COMPLETED|Overall Study||1
7929995|NCT00558831|19513598|P1|COMPLETED|Overall Study||10
7929996|NCT00558831|19513598|P1|STARTED|Overall Study||11
7929997|NCT00558792|19513607|P3|NOT COMPLETED|Overall Study||0
7929998|NCT00558792|19513608|P2|NOT COMPLETED|Overall Study||0
7929999|NCT00558792|19513609|P1|NOT COMPLETED|Overall Study||0
7930000|NCT00558792|19513607|P3|COMPLETED|Overall Study||60
7930001|NCT00558792|19513608|P2|COMPLETED|Overall Study||63
7930002|NCT00558792|19513609|P1|COMPLETED|Overall Study||68
7930003|NCT00558792|19513607|P3|STARTED|Overall Study||60
7930004|NCT00558792|19513608|P2|STARTED|Overall Study||63
7930005|NCT00558792|19513609|P1|STARTED|Overall Study||68
7930006|NCT00558753|19513655|P2|NOT COMPLETED|Overall Study||7
7930007|NCT00558753|19513656|P1|NOT COMPLETED|Overall Study||5
7930008|NCT00558753|19513655|P2|COMPLETED|Overall Study||113
7930009|NCT00558753|19513656|P1|COMPLETED|Overall Study||115
7930010|NCT00558753|19513655|P2|STARTED|Overall Study||120
7930011|NCT00558753|19513656|P1|STARTED|Overall Study||120
7930012|NCT00558701|19513668|P2|NOT COMPLETED|Overall Study||4
7930013|NCT00558701|19513669|P1|NOT COMPLETED|Overall Study||1
7930014|NCT00558701|19513668|P2|COMPLETED|Overall Study||11
7930015|NCT00558701|19513669|P1|COMPLETED|Overall Study||14
7930016|NCT00558701|19513668|P2|STARTED|Overall Study||15
7930017|NCT00558701|19513669|P1|STARTED|Overall Study||15
7930018|NCT00558636|19513677|P2|NOT COMPLETED|Follow-up||7
7930019|NCT00558636|19513678|P1|NOT COMPLETED|Follow-up||12
7930020|NCT00558636|19513677|P2|COMPLETED|Follow-up|Study was prematurely terminated|0
7930021|NCT00558636|19513678|P1|COMPLETED|Follow-up|Study was prematurely terminated|0
7930022|NCT00558636|19513677|P2|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7
7930023|NCT00558636|19513678|P1|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12
7930024|NCT00558636|19513677|P2|NOT COMPLETED|Treatment||44
7930025|NCT00558636|19513678|P1|NOT COMPLETED|Treatment||47
7930026|NCT00558636|19513677|P2|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
7930027|NCT00558636|19513678|P1|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
7930028|NCT00558636|19513677|P2|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2
7930029|NCT00558636|19513678|P1|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2
7930030|NCT00558636|19513677|P2|STARTED|Treatment||44
7930031|NCT00558636|19513678|P1|STARTED|Treatment|up to 6 cycles of combination therapy|47
7930032|NCT00558571|19513700|P4|NOT COMPLETED|Overall Study||0
7930033|NCT00558571|19513701|P3|NOT COMPLETED|Overall Study||0
7930034|NCT00558571|19513702|P2|NOT COMPLETED|Overall Study||0
7930035|NCT00558571|19513703|P1|NOT COMPLETED|Overall Study||0
7930036|NCT00558571|19513700|P4|COMPLETED|Overall Study||30
7930037|NCT00558571|19513701|P3|COMPLETED|Overall Study||16
7930038|NCT00558571|19513702|P2|COMPLETED|Overall Study||16
7930039|NCT00558571|19513703|P1|COMPLETED|Overall Study||16
7930040|NCT00558571|19513700|P4|STARTED|Overall Study||30
7930041|NCT00558571|19513701|P3|STARTED|Overall Study||16
7930042|NCT00558571|19513702|P2|STARTED|Overall Study||16
7930043|NCT00558571|19513703|P1|STARTED|Overall Study||16
7930044|NCT00558558|19513778|P1|NOT COMPLETED|Overall Study||6
7930045|NCT00558558|19513778|P1|COMPLETED|Overall Study||0
7930046|NCT00558558|19513778|P1|STARTED|Overall Study||6
7930047|NCT00558519|19513782|P1|NOT COMPLETED|Overall Study||23
7930048|NCT00558519|19513782|P1|COMPLETED|Overall Study||295
7930049|NCT00558519|19513782|P1|STARTED|Overall Study||318
7930050|NCT00558467|19513792|P2|NOT COMPLETED|Overall Study||4
7930051|NCT00558467|19513793|P1|NOT COMPLETED|Overall Study||1
7930052|NCT00558467|19513792|P2|COMPLETED|Overall Study||39
7930053|NCT00558467|19513793|P1|COMPLETED|Overall Study||19
7930054|NCT00558467|19513792|P2|STARTED|Overall Study||43
7930055|NCT00558467|19513793|P1|STARTED|Overall Study||20
7930056|NCT00558428|19513853|P4|NOT COMPLETED|Overall Study||11
7930057|NCT00558428|19513854|P3|NOT COMPLETED|Overall Study||4
7930058|NCT00558428|19513855|P2|NOT COMPLETED|Overall Study||24
7930059|NCT00558428|19513856|P1|NOT COMPLETED|Overall Study||12
7930060|NCT00558428|19513853|P4|COMPLETED|Overall Study||266
7930061|NCT00558428|19513854|P3|COMPLETED|Overall Study||273
7930062|NCT00558428|19513855|P2|COMPLETED|Overall Study||252
7930063|NCT00558428|19513856|P1|COMPLETED|Overall Study||255
7930064|NCT00558428|19513853|P4|STARTED|Overall Study||277
7930065|NCT00558428|19513854|P3|STARTED|Overall Study||277
7930066|NCT00558428|19513855|P2|STARTED|Overall Study||276
7930067|NCT00558428|19513856|P1|STARTED|Overall Study||267
7930068|NCT00558363|19513896|P2|NOT COMPLETED|Overall Study||36
7930069|NCT00558363|19513897|P1|NOT COMPLETED|Overall Study||71
7930070|NCT00558363|19513896|P2|COMPLETED|Overall Study||111
7930071|NCT00558363|19513897|P1|COMPLETED|Overall Study||76
7930072|NCT00558363|19513896|P2|STARTED|Overall Study||147
7930073|NCT00558363|19513897|P1|STARTED|Overall Study||147
7930074|NCT00558285|19513952|P5|NOT COMPLETED|Overall Study||4
7930075|NCT00558285|19513953|P4|NOT COMPLETED|Overall Study||4
7930076|NCT00558285|19513954|P3|NOT COMPLETED|Overall Study||5
7930077|NCT00558285|19513955|P2|NOT COMPLETED|Overall Study||3
7930078|NCT00558285|19513956|P1|NOT COMPLETED|Overall Study||6
7930079|NCT00558285|19513952|P5|COMPLETED|Overall Study||49
7930080|NCT00558285|19513953|P4|COMPLETED|Overall Study||48
7930081|NCT00558285|19513954|P3|COMPLETED|Overall Study||46
7930082|NCT00558285|19513955|P2|COMPLETED|Overall Study||48
7930083|NCT00558285|19513956|P1|COMPLETED|Overall Study||44
7930084|NCT00558285|19513952|P5|Safety: Received Study Drug|Overall Study||53
7930085|NCT00558285|19513953|P4|Safety: Received Study Drug|Overall Study||51
7930086|NCT00558285|19513954|P3|Safety: Received Study Drug|Overall Study||51
7930087|NCT00558285|19513955|P2|Safety: Received Study Drug|Overall Study||51
7930088|NCT00558285|19513956|P1|Safety: Received Study Drug|Overall Study||49
7930089|NCT00558285|19513952|P5|STARTED|Overall Study||53
7930090|NCT00558285|19513953|P4|STARTED|Overall Study||52
7930091|NCT00558285|19513954|P3|STARTED|Overall Study||51
7930092|NCT00558285|19513955|P2|STARTED|Overall Study||51
7930093|NCT00558285|19513956|P1|STARTED|Overall Study||50
7930094|NCT00558272|19514000|P2|NOT COMPLETED|Overall Study||2
7930095|NCT00558272|19514001|P1|NOT COMPLETED|Overall Study||13
7930096|NCT00558272|19514000|P2|COMPLETED|Overall Study|4-week treatment period|68
7930097|NCT00558272|19514001|P1|COMPLETED|Overall Study|4-week treatment period|56
7930098|NCT00558272|19514000|P2|30 Days Follow-up|Overall Study|30 days after last dose|67
7930099|NCT00558272|19514001|P1|30 Days Follow-up|Overall Study|30 days after last dose|41
7930100|NCT00558272|19514000|P2|STARTED|Overall Study|Randomised|70
7930101|NCT00558272|19514001|P1|STARTED|Overall Study|Randomised|69
7930102|NCT00558259|19514041|P2|NOT COMPLETED|Overall Study||99
7930103|NCT00558259|19514042|P1|NOT COMPLETED|Overall Study||71
7930104|NCT00558259|19514041|P2|COMPLETED|Overall Study|Completed treatment.|563
7930105|NCT00558259|19514042|P1|COMPLETED|Overall Study|Completed treatment.|610
7930106|NCT00558259|19514041|P2|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662
7930107|NCT00558259|19514042|P1|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681
7930108|NCT00558246|19514062|P1|NOT COMPLETED|Overall Study||0
7930109|NCT00558246|19514062|P1|COMPLETED|Overall Study||79
7930110|NCT00558246|19514062|P1|STARTED|Overall Study||79
7930111|NCT00558103|19514082|P6|NOT COMPLETED|Monotherapy Extension Phase||9
7930112|NCT00558103|19514083|P5|NOT COMPLETED|Monotherapy Extension Phase||0
7930113|NCT00558103|19514084|P4|NOT COMPLETED|Monotherapy Extension Phase||0
7930114|NCT00558103|19514085|P3|NOT COMPLETED|Monotherapy Extension Phase||0
7930115|NCT00558103|19514086|P2|NOT COMPLETED|Monotherapy Extension Phase||0
7930116|NCT00558103|19514087|P1|NOT COMPLETED|Monotherapy Extension Phase||0
7930117|NCT00558103|19514082|P6|COMPLETED|Monotherapy Extension Phase||0
7930118|NCT00558103|19514083|P5|COMPLETED|Monotherapy Extension Phase||0
7930119|NCT00558103|19514084|P4|COMPLETED|Monotherapy Extension Phase||0
7930120|NCT00558103|19514085|P3|COMPLETED|Monotherapy Extension Phase||0
7930121|NCT00558103|19514086|P2|COMPLETED|Monotherapy Extension Phase||0
7930122|NCT00558103|19514087|P1|COMPLETED|Monotherapy Extension Phase||0
7930123|NCT00558103|19514082|P6|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9
7930124|NCT00558103|19514083|P5|STARTED|Monotherapy Extension Phase||0
7930125|NCT00558103|19514084|P4|STARTED|Monotherapy Extension Phase||0
7930126|NCT00558103|19514085|P3|STARTED|Monotherapy Extension Phase||0
7930127|NCT00558103|19514086|P2|STARTED|Monotherapy Extension Phase||0
7930128|NCT00558103|19514087|P1|STARTED|Monotherapy Extension Phase||0
7930129|NCT00558103|19514082|P6|NOT COMPLETED|Randomized Treatment Phase||0
7930130|NCT00558103|19514083|P5|NOT COMPLETED|Randomized Treatment Phase||5
7930131|NCT00558103|19514084|P4|NOT COMPLETED|Randomized Treatment Phase||2
7930132|NCT00558103|19514085|P3|NOT COMPLETED|Randomized Treatment Phase||3
7930133|NCT00558103|19514086|P2|NOT COMPLETED|Randomized Treatment Phase||4
7930134|NCT00558103|19514087|P1|NOT COMPLETED|Randomized Treatment Phase||5
7930135|NCT00558103|19514082|P6|COMPLETED|Randomized Treatment Phase||0
7930136|NCT00558103|19514083|P5|COMPLETED|Randomized Treatment Phase||33
7930137|NCT00558103|19514084|P4|COMPLETED|Randomized Treatment Phase||11
7930138|NCT00558103|19514085|P3|COMPLETED|Randomized Treatment Phase||33
7930139|NCT00558103|19514086|P2|COMPLETED|Randomized Treatment Phase||34
7930140|NCT00558103|19514087|P1|COMPLETED|Randomized Treatment Phase||33
7930141|NCT00558103|19514082|P6|STARTED|Randomized Treatment Phase||0
7930142|NCT00558103|19514083|P5|STARTED|Randomized Treatment Phase||38
7930143|NCT00558103|19514084|P4|STARTED|Randomized Treatment Phase||13
7930144|NCT00558103|19514085|P3|STARTED|Randomized Treatment Phase||36
7930145|NCT00558103|19514086|P2|STARTED|Randomized Treatment Phase||38
7930146|NCT00558103|19514087|P1|STARTED|Randomized Treatment Phase||38
7930147|NCT00558064|19514117|P2|NOT COMPLETED|Overall Study||5
7930148|NCT00558064|19514118|P1|NOT COMPLETED|Overall Study||5
7930149|NCT00558064|19514117|P2|COMPLETED|Overall Study||257
7930150|NCT00558064|19514118|P1|COMPLETED|Overall Study||264
7930151|NCT00558064|19514117|P2|STARTED|Overall Study||262
7930152|NCT00558064|19514118|P1|STARTED|Overall Study||269
7930153|NCT00558025|19514140|P2|NOT COMPLETED|Overall Study||3
7930154|NCT00558025|19514141|P1|NOT COMPLETED|Overall Study||4
7930155|NCT00558025|19514140|P2|COMPLETED|Overall Study||49
7930156|NCT00558025|19514141|P1|COMPLETED|Overall Study||100
7930157|NCT00558025|19514140|P2|STARTED|Overall Study||52
7930158|NCT00558025|19514141|P1|STARTED|Overall Study||104
7930159|NCT00558012|19514165|P2|NOT COMPLETED|Overall Study||18
7930160|NCT00558012|19514166|P1|NOT COMPLETED|Overall Study||25
7930161|NCT00558012|19514165|P2|COMPLETED|Overall Study||74
7930162|NCT00558012|19514166|P1|COMPLETED|Overall Study||64
7930163|NCT00558012|19514165|P2|STARTED|Overall Study||92
7930164|NCT00558012|19514166|P1|STARTED|Overall Study||89
7930165|NCT00557947|19514172|P1|NOT COMPLETED|Overall Study||0
7930166|NCT00557947|19514172|P1|COMPLETED|Overall Study||83
7930167|NCT00557947|19514172|P1|STARTED|Overall Study||83
7930168|NCT00557882|19514190|P2|NOT COMPLETED|Overall Study||0
7930169|NCT00557882|19514191|P1|NOT COMPLETED|Overall Study||5
7930170|NCT00557882|19514190|P2|COMPLETED|Overall Study||33
7930171|NCT00557882|19514191|P1|COMPLETED|Overall Study||27
7930172|NCT00557882|19514190|P2|STARTED|Overall Study||33
7930173|NCT00557882|19514191|P1|STARTED|Overall Study||32
7930174|NCT00557856|19514197|P9|NOT COMPLETED|Part 2: Exploratory Phase||24
7930175|NCT00557856|19514198|P8|NOT COMPLETED|Part 2: Exploratory Phase||0
7930176|NCT00557856|19514199|P7|NOT COMPLETED|Part 2: Exploratory Phase||0
7930177|NCT00557856|19514200|P6|NOT COMPLETED|Part 2: Exploratory Phase||0
7930178|NCT00557856|19514201|P5|NOT COMPLETED|Part 2: Exploratory Phase||0
7930179|NCT00557856|19514202|P4|NOT COMPLETED|Part 2: Exploratory Phase||0
7930180|NCT00557856|19514203|P3|NOT COMPLETED|Part 2: Exploratory Phase||0
7930181|NCT00557856|19514204|P2|NOT COMPLETED|Part 2: Exploratory Phase||0
7930182|NCT00557856|19514205|P1|NOT COMPLETED|Part 2: Exploratory Phase||0
7930183|NCT00557856|19514197|P9|COMPLETED|Part 2: Exploratory Phase||0
7930184|NCT00557856|19514198|P8|COMPLETED|Part 2: Exploratory Phase||0
7930185|NCT00557856|19514199|P7|COMPLETED|Part 2: Exploratory Phase||0
7930186|NCT00557856|19514200|P6|COMPLETED|Part 2: Exploratory Phase||0
7930187|NCT00557856|19514201|P5|COMPLETED|Part 2: Exploratory Phase||0
7930188|NCT00557856|19514202|P4|COMPLETED|Part 2: Exploratory Phase||0
7930189|NCT00557856|19514203|P3|COMPLETED|Part 2: Exploratory Phase||0
7930190|NCT00557856|19514204|P2|COMPLETED|Part 2: Exploratory Phase||0
7930191|NCT00557856|19514205|P1|COMPLETED|Part 2: Exploratory Phase||0
7930192|NCT00557856|19514197|P9|STARTED|Part 2: Exploratory Phase||24
7930193|NCT00557856|19514198|P8|STARTED|Part 2: Exploratory Phase||0
7930194|NCT00557856|19514199|P7|STARTED|Part 2: Exploratory Phase||0
7930195|NCT00557856|19514200|P6|STARTED|Part 2: Exploratory Phase||0
7930196|NCT00557856|19514201|P5|STARTED|Part 2: Exploratory Phase||0
7930197|NCT00557856|19514202|P4|STARTED|Part 2: Exploratory Phase||0
7930198|NCT00557856|19514203|P3|STARTED|Part 2: Exploratory Phase||0
7930199|NCT00557856|19514204|P2|STARTED|Part 2: Exploratory Phase||0
7930200|NCT00557856|19514205|P1|STARTED|Part 2: Exploratory Phase||0
7930201|NCT00557856|19514197|P9|NOT COMPLETED|Part 1: Dose Escalation Phase||0
7930202|NCT00557856|19514198|P8|NOT COMPLETED|Part 1: Dose Escalation Phase||6
7930203|NCT00557856|19514199|P7|NOT COMPLETED|Part 1: Dose Escalation Phase||7
7930204|NCT00557856|19514200|P6|NOT COMPLETED|Part 1: Dose Escalation Phase||8
7930205|NCT00557856|19514201|P5|NOT COMPLETED|Part 1: Dose Escalation Phase||4
7930206|NCT00557856|19514202|P4|NOT COMPLETED|Part 1: Dose Escalation Phase||3
7930207|NCT00557856|19514203|P3|NOT COMPLETED|Part 1: Dose Escalation Phase||6
7930208|NCT00557856|19514204|P2|NOT COMPLETED|Part 1: Dose Escalation Phase||5
7930209|NCT00557856|19514205|P1|NOT COMPLETED|Part 1: Dose Escalation Phase||7
7930210|NCT00557856|19514197|P9|COMPLETED|Part 1: Dose Escalation Phase||0
7930211|NCT00557856|19514198|P8|COMPLETED|Part 1: Dose Escalation Phase||0
7930212|NCT00557856|19514199|P7|COMPLETED|Part 1: Dose Escalation Phase||0
7930213|NCT00557856|19514200|P6|COMPLETED|Part 1: Dose Escalation Phase||0
7930214|NCT00557856|19514201|P5|COMPLETED|Part 1: Dose Escalation Phase||0
7930215|NCT00557856|19514202|P4|COMPLETED|Part 1: Dose Escalation Phase||0
7930216|NCT00557856|19514203|P3|COMPLETED|Part 1: Dose Escalation Phase||0
7930217|NCT00557856|19514204|P2|COMPLETED|Part 1: Dose Escalation Phase||0
7930218|NCT00557856|19514205|P1|COMPLETED|Part 1: Dose Escalation Phase||0
7930219|NCT00557856|19514197|P9|Treated|Part 1: Dose Escalation Phase||0
7930220|NCT00557856|19514198|P8|Treated|Part 1: Dose Escalation Phase||6
7930221|NCT00557856|19514199|P7|Treated|Part 1: Dose Escalation Phase||7
7930222|NCT00557856|19514200|P6|Treated|Part 1: Dose Escalation Phase||8
7930223|NCT00557856|19514201|P5|Treated|Part 1: Dose Escalation Phase||4
7930224|NCT00557856|19514202|P4|Treated|Part 1: Dose Escalation Phase||3
7930225|NCT00557856|19514203|P3|Treated|Part 1: Dose Escalation Phase||6
7930226|NCT00557856|19514204|P2|Treated|Part 1: Dose Escalation Phase||5
7930227|NCT00557856|19514205|P1|Treated|Part 1: Dose Escalation Phase||5
7930228|NCT00557856|19514197|P9|STARTED|Part 1: Dose Escalation Phase||0
7930229|NCT00557856|19514198|P8|STARTED|Part 1: Dose Escalation Phase||6
7930230|NCT00557856|19514199|P7|STARTED|Part 1: Dose Escalation Phase||7
7930231|NCT00557856|19514200|P6|STARTED|Part 1: Dose Escalation Phase||8
7930232|NCT00557856|19514201|P5|STARTED|Part 1: Dose Escalation Phase||4
7930233|NCT00557856|19514202|P4|STARTED|Part 1: Dose Escalation Phase||3
7930234|NCT00557856|19514203|P3|STARTED|Part 1: Dose Escalation Phase||6
7930235|NCT00557856|19514204|P2|STARTED|Part 1: Dose Escalation Phase||5
7930236|NCT00557856|19514205|P1|STARTED|Part 1: Dose Escalation Phase||7
7930237|NCT00557830|19514404|P3|NOT COMPLETED|Treatment Phase||0
7930238|NCT00557830|19514405|P2|NOT COMPLETED|Treatment Phase||0
7930239|NCT00557830|19514406|P1|NOT COMPLETED|Treatment Phase||0
7930240|NCT00557830|19514404|P3|COMPLETED|Treatment Phase||2
7930241|NCT00557830|19514405|P2|COMPLETED|Treatment Phase||4
7930242|NCT00557830|19514406|P1|COMPLETED|Treatment Phase||0
7930243|NCT00557830|19514404|P3|STARTED|Treatment Phase||2
7930244|NCT00557830|19514405|P2|STARTED|Treatment Phase||4
7930245|NCT00557830|19514406|P1|STARTED|Treatment Phase||0
7930246|NCT00557830|19514404|P3|NOT COMPLETED|Screening Treatment Phase||0
7930247|NCT00557830|19514405|P2|NOT COMPLETED|Screening Treatment Phase||0
7930248|NCT00557830|19514406|P1|NOT COMPLETED|Screening Treatment Phase||6
7930249|NCT00557830|19514404|P3|COMPLETED|Screening Treatment Phase||0
7930250|NCT00557830|19514405|P2|COMPLETED|Screening Treatment Phase||0
7930251|NCT00557830|19514406|P1|COMPLETED|Screening Treatment Phase||6
7930252|NCT00557830|19514404|P3|STARTED|Screening Treatment Phase||0
7930253|NCT00557830|19514405|P2|STARTED|Screening Treatment Phase||0
7930254|NCT00557830|19514406|P1|STARTED|Screening Treatment Phase||12
7930255|NCT00557622|19514428|P2|NOT COMPLETED|12-Week Treatment Phase||1
7930256|NCT00557622|19514429|P1|NOT COMPLETED|12-Week Treatment Phase||0
7930257|NCT00557622|19514428|P2|COMPLETED|12-Week Treatment Phase||1
7930258|NCT00557622|19514429|P1|COMPLETED|12-Week Treatment Phase||1
7930259|NCT00557622|19514428|P2|STARTED|12-Week Treatment Phase||2
7930260|NCT00557622|19514429|P1|STARTED|12-Week Treatment Phase||1
7930261|NCT00557622|19514428|P2|NOT COMPLETED|4-Week Run-in Phase||0
7930262|NCT00557622|19514429|P1|NOT COMPLETED|4-Week Run-in Phase||2
7930263|NCT00557622|19514428|P2|COMPLETED|4-Week Run-in Phase||0
7930264|NCT00557622|19514429|P1|COMPLETED|4-Week Run-in Phase||3
7930265|NCT00557622|19514428|P2|STARTED|4-Week Run-in Phase||0
7930266|NCT00557622|19514429|P1|STARTED|4-Week Run-in Phase||5
7930267|NCT00557505|19514458|P9|NOT COMPLETED|Overall Study||17
7930268|NCT00557505|19514459|P8|NOT COMPLETED|Overall Study||5
7930269|NCT00557505|19514460|P7|NOT COMPLETED|Overall Study||3
7930270|NCT00557505|19514461|P6|NOT COMPLETED|Overall Study||3
7930271|NCT00557505|19514462|P5|NOT COMPLETED|Overall Study||2
7930272|NCT00557505|19514463|P4|NOT COMPLETED|Overall Study||3
7930273|NCT00557505|19514464|P3|NOT COMPLETED|Overall Study||4
7930274|NCT00557505|19514465|P2|NOT COMPLETED|Overall Study||3
7930275|NCT00557505|19514466|P1|NOT COMPLETED|Overall Study||3
7930276|NCT00557505|19514458|P9|COMPLETED|Overall Study||0
7930277|NCT00557505|19514459|P8|COMPLETED|Overall Study||0
7930278|NCT00557505|19514460|P7|COMPLETED|Overall Study||0
7930279|NCT00557505|19514461|P6|COMPLETED|Overall Study||0
7930280|NCT00557505|19514462|P5|COMPLETED|Overall Study||0
7930281|NCT00557505|19514463|P4|COMPLETED|Overall Study||0
7930282|NCT00557505|19514464|P3|COMPLETED|Overall Study||0
7930283|NCT00557505|19514465|P2|COMPLETED|Overall Study||0
7930284|NCT00557505|19514466|P1|COMPLETED|Overall Study||0
7930285|NCT00557505|19514458|P9|STARTED|Overall Study||17
7930286|NCT00557505|19514459|P8|STARTED|Overall Study||5
7930287|NCT00557505|19514460|P7|STARTED|Overall Study||3
7930288|NCT00557505|19514461|P6|STARTED|Overall Study||3
7930289|NCT00557505|19514462|P5|STARTED|Overall Study||2
7930290|NCT00557505|19514463|P4|STARTED|Overall Study||3
7930291|NCT00557505|19514464|P3|STARTED|Overall Study||4
7930292|NCT00557505|19514465|P2|STARTED|Overall Study||3
7930293|NCT00557505|19514466|P1|STARTED|Overall Study||3
7930294|NCT00557492|19514630|P1|NOT COMPLETED|Overall Study||1
7930295|NCT00557492|19514630|P1|COMPLETED|Overall Study|Evaluable for outcomes|58
7930296|NCT00557492|19514630|P1|STARTED|Overall Study||59
7930297|NCT00557466|19514648|P6|NOT COMPLETED|Overall Study||6
7930298|NCT00557466|19514649|P5|NOT COMPLETED|Overall Study||3
7930299|NCT00557466|19514650|P4|NOT COMPLETED|Overall Study||4
7930300|NCT00557466|19514651|P3|NOT COMPLETED|Overall Study||6
7930301|NCT00557466|19514652|P2|NOT COMPLETED|Overall Study||5
7930302|NCT00557466|19514653|P1|NOT COMPLETED|Overall Study||4
7930303|NCT00557466|19514648|P6|COMPLETED|Overall Study||85
7930304|NCT00557466|19514649|P5|COMPLETED|Overall Study||87
7930305|NCT00557466|19514650|P4|COMPLETED|Overall Study||92
7930306|NCT00557466|19514651|P3|COMPLETED|Overall Study||95
7930307|NCT00557466|19514652|P2|COMPLETED|Overall Study||87
7930308|NCT00557466|19514653|P1|COMPLETED|Overall Study||94
7930309|NCT00557466|19514648|P6|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89
7930310|NCT00557466|19514649|P5|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87
7930311|NCT00557466|19514650|P4|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93
7930312|NCT00557466|19514651|P3|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
7930313|NCT00557466|19514652|P2|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91
7930314|NCT00557466|19514653|P1|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
7930315|NCT00557466|19514648|P6|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91
7930316|NCT00557466|19514649|P5|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90
7930317|NCT00557466|19514650|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96
7930318|NCT00557466|19514651|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101
7930319|NCT00557466|19514652|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92
7930320|NCT00557466|19514653|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98
7930321|NCT00557466|19514648|P6|STARTED|Overall Study||91
7930322|NCT00557466|19514649|P5|STARTED|Overall Study||90
7930323|NCT00557466|19514650|P4|STARTED|Overall Study||96
7930324|NCT00557466|19514651|P3|STARTED|Overall Study||101
7930325|NCT00557466|19514652|P2|STARTED|Overall Study||92
7930326|NCT00557466|19514653|P1|STARTED|Overall Study||98
7930327|NCT00557440|19514706|P3|NOT COMPLETED|Treatment Period 3||0
7930328|NCT00557440|19514707|P2|NOT COMPLETED|Treatment Period 3||0
7930329|NCT00557440|19514708|P1|NOT COMPLETED|Treatment Period 3||0
7930330|NCT00557440|19514706|P3|COMPLETED|Treatment Period 3||12
7930331|NCT00557440|19514707|P2|COMPLETED|Treatment Period 3||12
7930332|NCT00557440|19514708|P1|COMPLETED|Treatment Period 3||12
7930333|NCT00557440|19514706|P3|STARTED|Treatment Period 3||12
7930334|NCT00557440|19514707|P2|STARTED|Treatment Period 3||12
7930335|NCT00557440|19514708|P1|STARTED|Treatment Period 3||12
7930336|NCT00557440|19514706|P3|NOT COMPLETED|Treatment Period 2||0
7930337|NCT00557440|19514707|P2|NOT COMPLETED|Treatment Period 2||0
7930338|NCT00557440|19514708|P1|NOT COMPLETED|Treatment Period 2||0
7930339|NCT00557440|19514706|P3|COMPLETED|Treatment Period 2||12
7930340|NCT00557440|19514707|P2|COMPLETED|Treatment Period 2||12
7930341|NCT00557440|19514708|P1|COMPLETED|Treatment Period 2||12
7930342|NCT00557440|19514706|P3|STARTED|Treatment Period 2||12
7930343|NCT00557440|19514707|P2|STARTED|Treatment Period 2||12
7930344|NCT00557440|19514708|P1|STARTED|Treatment Period 2||12
7930345|NCT00557440|19514706|P3|NOT COMPLETED|Treatment Period 1||1
7930346|NCT00557440|19514707|P2|NOT COMPLETED|Treatment Period 1||0
7930347|NCT00557440|19514708|P1|NOT COMPLETED|Treatment Period 1||0
7930348|NCT00557440|19514706|P3|COMPLETED|Treatment Period 1||12
7930349|NCT00557440|19514707|P2|COMPLETED|Treatment Period 1||12
7930350|NCT00557440|19514708|P1|COMPLETED|Treatment Period 1||12
7930351|NCT00557440|19514706|P3|STARTED|Treatment Period 1||13
7930352|NCT00557440|19514707|P2|STARTED|Treatment Period 1||12
7930353|NCT00557440|19514708|P1|STARTED|Treatment Period 1||12
7930354|NCT00557362|19514732|P4|NOT COMPLETED|Overall Study||3
7930355|NCT00557362|19514733|P3|NOT COMPLETED|Overall Study||4
7930356|NCT00557362|19514734|P2|NOT COMPLETED|Overall Study||2
7930357|NCT00557362|19514735|P1|NOT COMPLETED|Overall Study||2
7930358|NCT00557362|19514732|P4|COMPLETED|Overall Study||27
7930359|NCT00557362|19514733|P3|COMPLETED|Overall Study||26
7930360|NCT00557362|19514734|P2|COMPLETED|Overall Study||28
7930361|NCT00557362|19514735|P1|COMPLETED|Overall Study||28
7930362|NCT00557362|19514732|P4|STARTED|Overall Study||30
7930363|NCT00557362|19514733|P3|STARTED|Overall Study||30
7930364|NCT00557362|19514734|P2|STARTED|Overall Study||30
7930365|NCT00557362|19514735|P1|STARTED|Overall Study||30
7930366|NCT00557349|19514753|P2|NOT COMPLETED|Overall Study||5
7930367|NCT00557349|19514754|P1|NOT COMPLETED|Overall Study||5
7930368|NCT00557349|19514753|P2|COMPLETED|Overall Study||13
7930369|NCT00557349|19514754|P1|COMPLETED|Overall Study||17
7930370|NCT00557349|19514753|P2|STARTED|Overall Study||18
7930371|NCT00557349|19514754|P1|STARTED|Overall Study|omeprazole/bicarb|22
7930372|NCT00557323|19514762|P1|NOT COMPLETED|Overall Study||7
7930373|NCT00557323|19514762|P1|COMPLETED|Overall Study||27
7930374|NCT00557323|19514762|P1|STARTED|Overall Study||34
7930375|NCT00557310|19514767|P1|NOT COMPLETED|Extension Phase (18 - 24 Months)||5
7930376|NCT00557310|19514767|P1|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25
7930377|NCT00557310|19514767|P1|STARTED|Extension Phase (18 - 24 Months)||30
7930378|NCT00557310|19514767|P1|NOT COMPLETED|Main Study (0 - 18 Months)||5
7930379|NCT00557310|19514767|P1|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30
7930380|NCT00557310|19514767|P1|STARTED|Main Study (0 - 18 Months)||35
7930381|NCT00557284|19514789|P2|NOT COMPLETED|Overall Study||0
7930382|NCT00557284|19514790|P1|NOT COMPLETED|Overall Study||0
7930383|NCT00557284|19514789|P2|COMPLETED|Overall Study||11
7930384|NCT00557284|19514790|P1|COMPLETED|Overall Study||9
7930385|NCT00557284|19514789|P2|STARTED|Overall Study||11
7930386|NCT00557284|19514790|P1|STARTED|Overall Study||9
7930387|NCT00557245|19514813|P3|NOT COMPLETED|Overall Study||12
7930388|NCT00557245|19514814|P2|NOT COMPLETED|Overall Study||12
7930389|NCT00557245|19514815|P1|NOT COMPLETED|Overall Study||12
7930390|NCT00557245|19514813|P3|COMPLETED|Overall Study||1574
7930391|NCT00557245|19514814|P2|COMPLETED|Overall Study||1571
7930392|NCT00557245|19514815|P1|COMPLETED|Overall Study||1577
7930393|NCT00557245|19514813|P3|STARTED|Overall Study||1586
7930394|NCT00557245|19514814|P2|STARTED|Overall Study||1583
7930395|NCT00557245|19514815|P1|STARTED|Overall Study||1589
7930396|NCT00557193|19514853|P6|NOT COMPLETED|Post Induction Therapy by Tx Assignment||37
7930397|NCT00557193|19514854|P5|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
7930398|NCT00557193|19514855|P4|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
7930399|NCT00557193|19514856|P3|NOT COMPLETED|Post Induction Therapy by Tx Assignment||32
7930400|NCT00557193|19514857|P2|NOT COMPLETED|Post Induction Therapy by Tx Assignment||10
7930401|NCT00557193|19514858|P1|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
7930402|NCT00557193|19514853|P6|COMPLETED|Post Induction Therapy by Tx Assignment||19
7930403|NCT00557193|19514854|P5|COMPLETED|Post Induction Therapy by Tx Assignment||4
7930404|NCT00557193|19514855|P4|COMPLETED|Post Induction Therapy by Tx Assignment||4
7930405|NCT00557193|19514856|P3|COMPLETED|Post Induction Therapy by Tx Assignment||22
7930406|NCT00557193|19514857|P2|COMPLETED|Post Induction Therapy by Tx Assignment||50
7930407|NCT00557193|19514858|P1|COMPLETED|Post Induction Therapy by Tx Assignment||0
7930408|NCT00557193|19514853|P6|STARTED|Post Induction Therapy by Tx Assignment||56
7930409|NCT00557193|19514854|P5|STARTED|Post Induction Therapy by Tx Assignment||11
7930410|NCT00557193|19514855|P4|STARTED|Post Induction Therapy by Tx Assignment||11
7930411|NCT00557193|19514856|P3|STARTED|Post Induction Therapy by Tx Assignment||54
7930412|NCT00557193|19514857|P2|STARTED|Post Induction Therapy by Tx Assignment||60
7930413|NCT00557193|19514858|P1|STARTED|Post Induction Therapy by Tx Assignment||0
7930414|NCT00557193|19514853|P6|NOT COMPLETED|Induction||0
7930415|NCT00557193|19514854|P5|NOT COMPLETED|Induction||0
7930416|NCT00557193|19514855|P4|NOT COMPLETED|Induction||0
7930417|NCT00557193|19514856|P3|NOT COMPLETED|Induction||0
7930418|NCT00557193|19514857|P2|NOT COMPLETED|Induction||0
7930419|NCT00557193|19514858|P1|NOT COMPLETED|Induction||26
7930420|NCT00557193|19514853|P6|COMPLETED|Induction||0
7930421|NCT00557193|19514854|P5|COMPLETED|Induction||0
7930422|NCT00557193|19514855|P4|COMPLETED|Induction||0
7930423|NCT00557193|19514856|P3|COMPLETED|Induction||0
7930424|NCT00557193|19514857|P2|COMPLETED|Induction||0
7930425|NCT00557193|19514858|P1|COMPLETED|Induction||192
7930426|NCT00557193|19514853|P6|STARTED|Induction||0
7930427|NCT00557193|19514854|P5|STARTED|Induction||0
7930428|NCT00557193|19514855|P4|STARTED|Induction||0
7930429|NCT00557193|19514856|P3|STARTED|Induction||0
7930430|NCT00557193|19514857|P2|STARTED|Induction||0
7930431|NCT00557193|19514858|P1|STARTED|Induction||218
7930432|NCT00557076|19514898|P2|NOT COMPLETED|Overall Study||1
7930433|NCT00557076|19514899|P1|NOT COMPLETED|Overall Study||0
7930434|NCT00557076|19514898|P2|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7
7930435|NCT00557076|19514899|P1|COMPLETED|Overall Study||8
7930436|NCT00557076|19514898|P2|STARTED|Overall Study||8
7930437|NCT00557076|19514899|P1|STARTED|Overall Study||8
7930438|NCT00556998|19514907|P1|NOT COMPLETED|Voriconazole Oral||2
7930439|NCT00556998|19514907|P1|COMPLETED|Voriconazole Oral||20
7930440|NCT00556998|19514907|P1|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22
7930441|NCT00556998|19514907|P1|NOT COMPLETED|Voriconazole Intravenous (IV)||5
7930442|NCT00556998|19514907|P1|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21
7930443|NCT00556998|19514907|P1|Treated|Voriconazole Intravenous (IV)||26
7930444|NCT00556998|19514907|P1|STARTED|Voriconazole Intravenous (IV)||26
7930445|NCT00556972|19514927|P1|NOT COMPLETED|Overall Study||0
7930446|NCT00556972|19514927|P1|COMPLETED|Overall Study||4
7930447|NCT00556972|19514927|P1|STARTED|Overall Study||4
7930448|NCT00556946|19514934|P1|NOT COMPLETED|Overall Study||1
7930449|NCT00556946|19514934|P1|COMPLETED|Overall Study||16
7930450|NCT00556946|19514934|P1|STARTED|Overall Study||17
7930451|NCT00556933|19514942|P4|NOT COMPLETED|CNI Withdrawal vs. Minimization||2
7930452|NCT00556933|19514943|P3|NOT COMPLETED|CNI Withdrawal vs. Minimization||3
7930453|NCT00556933|19514944|P2|NOT COMPLETED|CNI Withdrawal vs. Minimization||4
7930454|NCT00556933|19514945|P1|NOT COMPLETED|CNI Withdrawal vs. Minimization||1
7930455|NCT00556933|19514942|P4|COMPLETED|CNI Withdrawal vs. Minimization||41
7930456|NCT00556933|19514943|P3|COMPLETED|CNI Withdrawal vs. Minimization||36
7930457|NCT00556933|19514944|P2|COMPLETED|CNI Withdrawal vs. Minimization||33
7930458|NCT00556933|19514945|P1|COMPLETED|CNI Withdrawal vs. Minimization||42
7930459|NCT00556933|19514942|P4|STARTED|CNI Withdrawal vs. Minimization||43
7930460|NCT00556933|19514943|P3|STARTED|CNI Withdrawal vs. Minimization||39
7930461|NCT00556933|19514944|P2|STARTED|CNI Withdrawal vs. Minimization||37
7930462|NCT00556933|19514945|P1|STARTED|CNI Withdrawal vs. Minimization||43
7930463|NCT00556933|19514942|P4|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
7930464|NCT00556933|19514943|P3|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6
7930465|NCT00556933|19514944|P2|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8
7930466|NCT00556933|19514945|P1|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
7930467|NCT00556933|19514942|P4|COMPLETED|Single vs. Divided-dose rATG Induction||43
7930468|NCT00556933|19514943|P3|COMPLETED|Single vs. Divided-dose rATG Induction||39
7930469|NCT00556933|19514944|P2|COMPLETED|Single vs. Divided-dose rATG Induction||37
7930470|NCT00556933|19514945|P1|COMPLETED|Single vs. Divided-dose rATG Induction||43
7930471|NCT00556933|19514942|P4|STARTED|Single vs. Divided-dose rATG Induction||45
7930472|NCT00556933|19514943|P3|STARTED|Single vs. Divided-dose rATG Induction||45
7930473|NCT00556933|19514944|P2|STARTED|Single vs. Divided-dose rATG Induction||45
7930474|NCT00556933|19514945|P1|STARTED|Single vs. Divided-dose rATG Induction||45
7930475|NCT00556894|19515002|P3|NOT COMPLETED|Overall Study||19
7930476|NCT00556894|19515003|P2|NOT COMPLETED|Overall Study||19
7930477|NCT00556894|19515004|P1|NOT COMPLETED|Overall Study||16
7930478|NCT00556894|19515002|P3|COMPLETED|Overall Study||65
7930479|NCT00556894|19515003|P2|COMPLETED|Overall Study||68
7930480|NCT00556894|19515004|P1|COMPLETED|Overall Study||66
7930481|NCT00556894|19515002|P3|STARTED|Overall Study||84
7930482|NCT00556894|19515003|P2|STARTED|Overall Study||87
7930483|NCT00556894|19515004|P1|STARTED|Overall Study||82
7930484|NCT00556842|19515014|P2|NOT COMPLETED|Overall Study||23
7930485|NCT00556842|19515015|P1|NOT COMPLETED|Overall Study||31
7930486|NCT00556842|19515014|P2|COMPLETED|Overall Study||723
7930487|NCT00556842|19515015|P1|COMPLETED|Overall Study||718
7930488|NCT00556842|19515014|P2|STARTED|Overall Study||746
7930489|NCT00556842|19515015|P1|STARTED|Overall Study||749
7930490|NCT00556712|19515033|P2|NOT COMPLETED|Overall Study||438
7930491|NCT00556712|19515034|P1|NOT COMPLETED|Overall Study||451
7930492|NCT00556712|19515033|P2|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
7930493|NCT00556712|19515034|P1|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
7930494|NCT00556712|19515033|P2|STARTED|Overall Study||438
7930495|NCT00556712|19515034|P1|STARTED|Overall Study||451
7930496|NCT00556673|19515112|P2|NOT COMPLETED|Overall Study||2
7930497|NCT00556673|19515113|P1|NOT COMPLETED|Overall Study||3
7930498|NCT00556673|19515112|P2|COMPLETED|Overall Study||13
7930499|NCT00556673|19515113|P1|COMPLETED|Overall Study||13
7930500|NCT00556673|19515112|P2|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12
7930501|NCT00556673|19515113|P1|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12
7930502|NCT00556673|19515112|P2|STARTED|Overall Study||15
7930503|NCT00556673|19515113|P1|STARTED|Overall Study||16
7930504|NCT00556543|19515149|P1|NOT COMPLETED|Overall Study||0
7930505|NCT00556543|19515149|P1|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10
7930506|NCT00556543|19515149|P1|STARTED|Overall Study||10
7930507|NCT00556504|19515167|P2|NOT COMPLETED|Overall Study||9
7930508|NCT00556504|19515168|P1|NOT COMPLETED|Overall Study||8
7930509|NCT00556504|19515167|P2|COMPLETED|Overall Study||33
7930510|NCT00556504|19515168|P1|COMPLETED|Overall Study||34
7930511|NCT00556504|19515167|P2|Safety Population|Overall Study||42
7930512|NCT00556504|19515168|P1|Safety Population|Overall Study||41
7930513|NCT00556504|19515167|P2|Intend-to Treat Population|Overall Study||42
7930514|NCT00556504|19515168|P1|Intend-to Treat Population|Overall Study||42
7930515|NCT00556504|19515167|P2|STARTED|Overall Study||42
7930516|NCT00556504|19515168|P1|STARTED|Overall Study||42
7930517|NCT00556491|19515188|P2|NOT COMPLETED|Overall Study||1
7930518|NCT00556491|19515189|P1|NOT COMPLETED|Overall Study||1
7930519|NCT00556491|19515188|P2|COMPLETED|Overall Study||19
7930520|NCT00556491|19515189|P1|COMPLETED|Overall Study||19
7930521|NCT00556491|19515188|P2|STARTED|Overall Study||20
7930522|NCT00556491|19515189|P1|STARTED|Overall Study|January 2008|20
7930523|NCT00556478|19515207|P2|NOT COMPLETED|Open-Label Phase||10
7930524|NCT00556478|19515208|P1|NOT COMPLETED|Open-Label Phase||14
7930525|NCT00556478|19515207|P2|COMPLETED|Open-Label Phase||67
7930526|NCT00556478|19515208|P1|COMPLETED|Open-Label Phase||132
7930527|NCT00556478|19515207|P2|Treated in Open-label|Open-Label Phase||71
7930528|NCT00556478|19515208|P1|Treated in Open-label|Open-Label Phase||142
7930529|NCT00556478|19515207|P2|STARTED|Open-Label Phase||77
7930530|NCT00556478|19515208|P1|STARTED|Open-Label Phase||146
7930531|NCT00556478|19515207|P2|NOT COMPLETED|Double-blind Phase||8
7930532|NCT00556478|19515208|P1|NOT COMPLETED|Double-blind Phase||21
7930533|NCT00556478|19515207|P2|COMPLETED|Double-blind Phase||77
7930534|NCT00556478|19515208|P1|COMPLETED|Double-blind Phase||150
7930535|NCT00556478|19515207|P2|ITT|Double-blind Phase||82
7930536|NCT00556478|19515208|P1|ITT|Double-blind Phase||167
7930537|NCT00556478|19515207|P2|STARTED|Double-blind Phase||85
7930538|NCT00556478|19515208|P1|STARTED|Double-blind Phase||171
7930539|NCT00556452|19515236|P3|NOT COMPLETED|Overall Study||0
7930540|NCT00556452|19515237|P2|NOT COMPLETED|Overall Study||0
7930541|NCT00556452|19515238|P1|NOT COMPLETED|Overall Study||0
7930542|NCT00556452|19515236|P3|COMPLETED|Overall Study||19
7930543|NCT00556452|19515237|P2|COMPLETED|Overall Study||21
7930544|NCT00556452|19515238|P1|COMPLETED|Overall Study||6
7930545|NCT00556452|19515236|P3|STARTED|Overall Study||19
7930546|NCT00556452|19515237|P2|STARTED|Overall Study||21
7930547|NCT00556452|19515238|P1|STARTED|Overall Study||6
7930548|NCT00556439|19515249|P4|NOT COMPLETED|After Week 12 (Randomized Study Period)||1
7930549|NCT00556439|19515250|P3|NOT COMPLETED|After Week 12 (Randomized Study Period)||0
7930550|NCT00556439|19515251|P2|NOT COMPLETED|After Week 12 (Randomized Study Period)||4
7930551|NCT00556439|19515252|P1|NOT COMPLETED|After Week 12 (Randomized Study Period)||3
7930552|NCT00556439|19515249|P4|COMPLETED|After Week 12 (Randomized Study Period)||14
7930553|NCT00556439|19515250|P3|COMPLETED|After Week 12 (Randomized Study Period)||11
7930554|NCT00556439|19515251|P2|COMPLETED|After Week 12 (Randomized Study Period)||17
7930555|NCT00556439|19515252|P1|COMPLETED|After Week 12 (Randomized Study Period)||17
7930556|NCT00556439|19515249|P4|STARTED|After Week 12 (Randomized Study Period)||15
7930557|NCT00556439|19515250|P3|STARTED|After Week 12 (Randomized Study Period)||11
7930558|NCT00556439|19515251|P2|STARTED|After Week 12 (Randomized Study Period)||21
7930559|NCT00556439|19515252|P1|STARTED|After Week 12 (Randomized Study Period)||20
7930560|NCT00556439|19515249|P4|NOT COMPLETED|Study Entry to Week 12||0
7930561|NCT00556439|19515250|P3|NOT COMPLETED|Study Entry to Week 12||8
7930562|NCT00556439|19515251|P2|NOT COMPLETED|Study Entry to Week 12||0
7930563|NCT00556439|19515252|P1|NOT COMPLETED|Study Entry to Week 12||8
7930564|NCT00556439|19515249|P4|COMPLETED|Study Entry to Week 12||0
7930565|NCT00556439|19515250|P3|COMPLETED|Study Entry to Week 12||26
7930566|NCT00556439|19515251|P2|COMPLETED|Study Entry to Week 12||0
7930567|NCT00556439|19515252|P1|COMPLETED|Study Entry to Week 12||41
7930568|NCT00556439|19515249|P4|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
7930569|NCT00556439|19515250|P3|STARTED|Study Entry to Week 12|39 signed informed consent with 5 not being eligible. The remaining 34 received study drug.|34
7930570|NCT00556439|19515251|P2|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
7930571|NCT00556439|19515252|P1|STARTED|Study Entry to Week 12|58 signed informed consent with 9 not being eligible. The remaining 49 received study drug.|49
7930572|NCT00556426|19515262|P1|NOT COMPLETED|Overall Study||9
7930573|NCT00556426|19515262|P1|COMPLETED|Overall Study||91
7930574|NCT00556426|19515262|P1|STARTED|Overall Study||100
7930575|NCT00556400|19515272|P2|NOT COMPLETED|Overall Study||0
7930576|NCT00556400|19515273|P1|NOT COMPLETED|Overall Study||0
7930577|NCT00556400|19515272|P2|COMPLETED|Overall Study||0
7930578|NCT00556400|19515273|P1|COMPLETED|Overall Study||1
7930579|NCT00556400|19515272|P2|STARTED|Overall Study||0
7930580|NCT00556400|19515273|P1|STARTED|Overall Study||1
7930581|NCT00556374|19515284|P2|NOT COMPLETED|Overall Study||220
7930582|NCT00556374|19515285|P1|NOT COMPLETED|Overall Study||247
7930583|NCT00556374|19515284|P2|COMPLETED|Overall Study|Indicates participants continuing study|1491
7930584|NCT00556374|19515285|P1|COMPLETED|Overall Study|Indicates participants continuing study|1462
7930585|NCT00556374|19515284|P2|Received Study Drug|Overall Study||1700
7930586|NCT00556374|19515285|P1|Received Study Drug|Overall Study||1699
7930587|NCT00556374|19515284|P2|STARTED|Overall Study||1711
7930588|NCT00556374|19515285|P1|STARTED|Overall Study||1709
7930589|NCT00556322|19515305|P2|NOT COMPLETED|Overall Study||203
7930590|NCT00556322|19515306|P1|NOT COMPLETED|Overall Study||221
7930591|NCT00556322|19515305|P2|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
7930592|NCT00556322|19515306|P1|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
7930593|NCT00556322|19515305|P2|STARTED|Overall Study||203
7930594|NCT00556322|19515306|P1|STARTED|Overall Study||221
7930595|NCT00556166|19515354|P1|NOT COMPLETED|Overall Study||1
7930596|NCT00556166|19515354|P1|COMPLETED|Overall Study||3
7930597|NCT00556166|19515354|P1|STARTED|Overall Study||4
7930598|NCT00556140|19515359|P1|NOT COMPLETED|Overall Study||3
7930599|NCT00556140|19515359|P1|COMPLETED|Overall Study||13
7930600|NCT00556140|19515359|P1|STARTED|Overall Study||16
7930601|NCT00556075|19515367|P3|NOT COMPLETED|Overall Study||8
7930602|NCT00556075|19515368|P2|NOT COMPLETED|Overall Study||9
7930603|NCT00556075|19515369|P1|NOT COMPLETED|Overall Study||13
7930604|NCT00556075|19515367|P3|COMPLETED|Overall Study||15
7930605|NCT00556075|19515368|P2|COMPLETED|Overall Study||13
7930606|NCT00556075|19515369|P1|COMPLETED|Overall Study||9
7930607|NCT00556075|19515367|P3|STARTED|Overall Study||23
7930608|NCT00556075|19515368|P2|STARTED|Overall Study||22
7930609|NCT00556075|19515369|P1|STARTED|Overall Study||22
7930610|NCT00556049|19515392|P1|NOT COMPLETED|Overall Study||0
7930611|NCT00556049|19515392|P1|COMPLETED|Overall Study||72
7930612|NCT00556049|19515392|P1|STARTED|Overall Study||72
7930613|NCT00555997|19515399|P4|NOT COMPLETED|Phase 2 SPCD||3
7930614|NCT00555997|19515400|P3|NOT COMPLETED|Phase 2 SPCD||7
7930615|NCT00555997|19515401|P2|NOT COMPLETED|Phase 2 SPCD||0
7930616|NCT00555997|19515402|P1|NOT COMPLETED|Phase 2 SPCD||0
7930617|NCT00555997|19515399|P4|COMPLETED|Phase 2 SPCD||22
7930618|NCT00555997|19515400|P3|COMPLETED|Phase 2 SPCD||31
7930619|NCT00555997|19515401|P2|COMPLETED|Phase 2 SPCD||0
7930620|NCT00555997|19515402|P1|COMPLETED|Phase 2 SPCD||0
7930621|NCT00555997|19515399|P4|STARTED|Phase 2 SPCD||25
7930622|NCT00555997|19515400|P3|STARTED|Phase 2 SPCD||38
7930623|NCT00555997|19515401|P2|STARTED|Phase 2 SPCD||0
7930624|NCT00555997|19515402|P1|STARTED|Phase 2 SPCD||0
7930625|NCT00555997|19515399|P4|NOT COMPLETED|Phase 1 SPCD||0
7930626|NCT00555997|19515400|P3|NOT COMPLETED|Phase 1 SPCD||0
7930627|NCT00555997|19515401|P2|NOT COMPLETED|Phase 1 SPCD||15
7930628|NCT00555997|19515402|P1|NOT COMPLETED|Phase 1 SPCD||12
7930629|NCT00555997|19515399|P4|COMPLETED|Phase 1 SPCD||0
7930630|NCT00555997|19515400|P3|COMPLETED|Phase 1 SPCD||0
7930631|NCT00555997|19515401|P2|COMPLETED|Phase 1 SPCD||76
7930632|NCT00555997|19515402|P1|COMPLETED|Phase 1 SPCD||17
7930633|NCT00555997|19515399|P4|STARTED|Phase 1 SPCD||0
7930634|NCT00555997|19515400|P3|STARTED|Phase 1 SPCD||0
7930635|NCT00555997|19515401|P2|STARTED|Phase 1 SPCD||91
7930636|NCT00555997|19515402|P1|STARTED|Phase 1 SPCD||29
7930637|NCT00555971|19515420|P2|NOT COMPLETED|Overall Study||1
7930638|NCT00555971|19515421|P1|NOT COMPLETED|Overall Study||1
7930639|NCT00555971|19515420|P2|COMPLETED|Overall Study||7
7930640|NCT00555971|19515421|P1|COMPLETED|Overall Study||4
7930641|NCT00555971|19515420|P2|STARTED|Overall Study||8
7930642|NCT00555971|19515421|P1|STARTED|Overall Study||5
7930643|NCT00555906|19515432|P5|NOT COMPLETED|Phase 2||32
7930644|NCT00555906|19515433|P4|NOT COMPLETED|Phase 2||0
7930645|NCT00555906|19515434|P3|NOT COMPLETED|Phase 2||0
7930646|NCT00555906|19515435|P2|NOT COMPLETED|Phase 2||0
7930647|NCT00555906|19515436|P1|NOT COMPLETED|Phase 2||0
7930648|NCT00555906|19515432|P5|COMPLETED|Phase 2||0
7930649|NCT00555906|19515433|P4|COMPLETED|Phase 2||0
7930650|NCT00555906|19515434|P3|COMPLETED|Phase 2||0
7930651|NCT00555906|19515435|P2|COMPLETED|Phase 2||0
7930652|NCT00555906|19515436|P1|COMPLETED|Phase 2||0
7930653|NCT00555906|19515432|P5|Treated|Phase 2||30
7930654|NCT00555906|19515433|P4|Treated|Phase 2||0
7930655|NCT00555906|19515434|P3|Treated|Phase 2||0
7930656|NCT00555906|19515435|P2|Treated|Phase 2||0
7930657|NCT00555906|19515436|P1|Treated|Phase 2||0
7930658|NCT00555906|19515432|P5|STARTED|Phase 2||32
7930659|NCT00555906|19515433|P4|STARTED|Phase 2||0
7930660|NCT00555906|19515434|P3|STARTED|Phase 2||0
7930661|NCT00555906|19515435|P2|STARTED|Phase 2||0
7930662|NCT00555906|19515436|P1|STARTED|Phase 2||0
7930663|NCT00555906|19515432|P5|NOT COMPLETED|Phase 1||0
7930664|NCT00555906|19515433|P4|NOT COMPLETED|Phase 1||5
7930665|NCT00555906|19515434|P3|NOT COMPLETED|Phase 1||7
7930666|NCT00555906|19515435|P2|NOT COMPLETED|Phase 1||6
7930667|NCT00555906|19515436|P1|NOT COMPLETED|Phase 1||3
7930668|NCT00555906|19515432|P5|COMPLETED|Phase 1||0
7930669|NCT00555906|19515433|P4|COMPLETED|Phase 1||0
7930670|NCT00555906|19515434|P3|COMPLETED|Phase 1||0
7930671|NCT00555906|19515435|P2|COMPLETED|Phase 1||0
7930672|NCT00555906|19515436|P1|COMPLETED|Phase 1||0
7930673|NCT00555906|19515432|P5|STARTED|Phase 1||0
7930674|NCT00555906|19515433|P4|STARTED|Phase 1||5
7930675|NCT00555906|19515434|P3|STARTED|Phase 1||7
7930676|NCT00555906|19515435|P2|STARTED|Phase 1||6
7930677|NCT00555906|19515436|P1|STARTED|Phase 1||3
7930678|NCT00555893|19515468|P2|NOT COMPLETED|Overall Study||0
7930679|NCT00555893|19515469|P1|NOT COMPLETED|Overall Study||0
7930680|NCT00555893|19515468|P2|COMPLETED|Overall Study||63
7930681|NCT00555893|19515469|P1|COMPLETED|Overall Study||130
7930682|NCT00555893|19515468|P2|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51
7930683|NCT00555893|19515469|P1|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114
7930684|NCT00555893|19515468|P2|STARTED|Overall Study||63
7930685|NCT00555893|19515469|P1|STARTED|Overall Study||130
7930686|NCT00555880|19515485|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7930687|NCT00555880|19515486|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
7930688|NCT00555880|19515485|P2|COMPLETED|Treatment Period 2 (1 Day)||11
7930689|NCT00555880|19515486|P1|COMPLETED|Treatment Period 2 (1 Day)||13
7930690|NCT00555880|19515485|P2|STARTED|Treatment Period 2 (1 Day)||11
7930691|NCT00555880|19515486|P1|STARTED|Treatment Period 2 (1 Day)||13
7930692|NCT00555880|19515485|P2|NOT COMPLETED|Washout (1 Day)||0
7930693|NCT00555880|19515486|P1|NOT COMPLETED|Washout (1 Day)||0
7930694|NCT00555880|19515485|P2|COMPLETED|Washout (1 Day)||11
7930695|NCT00555880|19515486|P1|COMPLETED|Washout (1 Day)||13
7930696|NCT00555880|19515485|P2|STARTED|Washout (1 Day)||11
7930697|NCT00555880|19515486|P1|STARTED|Washout (1 Day)||13
7930698|NCT00555880|19515485|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7930699|NCT00555880|19515486|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
7930700|NCT00555880|19515485|P2|COMPLETED|Treatment Period 1 (1 Day)||11
7930701|NCT00555880|19515486|P1|COMPLETED|Treatment Period 1 (1 Day)||13
7930702|NCT00555880|19515485|P2|STARTED|Treatment Period 1 (1 Day)||11
7930703|NCT00555880|19515486|P1|STARTED|Treatment Period 1 (1 Day)||13
7930704|NCT00555750|19515525|P2|NOT COMPLETED|Overall Study||0
7930705|NCT00555750|19515526|P1|NOT COMPLETED|Overall Study||0
7930706|NCT00555750|19515525|P2|COMPLETED|Overall Study||10
7930707|NCT00555750|19515526|P1|COMPLETED|Overall Study||10
7930708|NCT00555750|19515525|P2|STARTED|Overall Study||10
7930709|NCT00555750|19515526|P1|STARTED|Overall Study||10
7930710|NCT00555672|19515558|P2|NOT COMPLETED|Overall Study||10
7930711|NCT00555672|19515559|P1|NOT COMPLETED|Overall Study||24
7930712|NCT00555672|19515558|P2|COMPLETED|Overall Study||0
7930713|NCT00555672|19515559|P1|COMPLETED|Overall Study||0
7930714|NCT00555672|19515558|P2|STARTED|Overall Study||10
7930715|NCT00555672|19515559|P1|STARTED|Overall Study||24
7930716|NCT00555620|19515584|P6|NOT COMPLETED|Overall Study||22
7930717|NCT00555620|19515585|P5|NOT COMPLETED|Overall Study||3
7930718|NCT00555620|19515586|P4|NOT COMPLETED|Overall Study||23
7930719|NCT00555620|19515587|P3|NOT COMPLETED|Overall Study||15
7930720|NCT00555620|19515588|P2|NOT COMPLETED|Overall Study||7
7930721|NCT00555620|19515589|P1|NOT COMPLETED|Overall Study||6
7930722|NCT00555620|19515584|P6|COMPLETED|Overall Study||0
7930723|NCT00555620|19515585|P5|COMPLETED|Overall Study||0
7930724|NCT00555620|19515586|P4|COMPLETED|Overall Study||0
7930725|NCT00555620|19515587|P3|COMPLETED|Overall Study||0
7930726|NCT00555620|19515588|P2|COMPLETED|Overall Study||0
7930727|NCT00555620|19515589|P1|COMPLETED|Overall Study||0
7930728|NCT00555620|19515584|P6|STARTED|Overall Study||22
7930729|NCT00555620|19515585|P5|STARTED|Overall Study||3
7930730|NCT00555620|19515586|P4|STARTED|Overall Study||23
7930731|NCT00555620|19515587|P3|STARTED|Overall Study||15
7930732|NCT00555620|19515588|P2|STARTED|Overall Study||7
7930733|NCT00555620|19515589|P1|STARTED|Overall Study||6
7930734|NCT00555581|19515701|P1|NOT COMPLETED|Overall Study||6
7930735|NCT00555581|19515701|P1|COMPLETED|Overall Study||24
7930736|NCT00555581|19515701|P1|STARTED|Overall Study||30
7930737|NCT00555568|19515713|P3|NOT COMPLETED|Overall Study||16
7930738|NCT00555568|19515714|P2|NOT COMPLETED|Overall Study||16
7930739|NCT00555568|19515715|P1|NOT COMPLETED|Overall Study||26
7930740|NCT00555568|19515713|P3|COMPLETED|Overall Study||84
7930741|NCT00555568|19515714|P2|COMPLETED|Overall Study||82
7930742|NCT00555568|19515715|P1|COMPLETED|Overall Study||74
7930743|NCT00555568|19515713|P3|STARTED|Overall Study||100
7930744|NCT00555568|19515714|P2|STARTED|Overall Study||98
7930745|NCT00555568|19515715|P1|STARTED|Overall Study||100
7930746|NCT00555477|19515737|P2|NOT COMPLETED|Overall Study||13
7930747|NCT00555477|19515738|P1|NOT COMPLETED|Overall Study||2
7930748|NCT00555477|19515737|P2|COMPLETED|Overall Study||32
7930749|NCT00555477|19515738|P1|COMPLETED|Overall Study||12
7930750|NCT00555477|19515737|P2|STARTED|Overall Study||45
7930751|NCT00555477|19515738|P1|STARTED|Overall Study||14
7930752|NCT00555464|19515745|P2|NOT COMPLETED|Overall Study||3
7930753|NCT00555464|19515746|P1|NOT COMPLETED|Overall Study||0
7930754|NCT00555464|19515745|P2|COMPLETED|Overall Study||1
7930755|NCT00555464|19515746|P1|COMPLETED|Overall Study||4
7930756|NCT00555464|19515745|P2|STARTED|Overall Study||4
7930757|NCT00555464|19515746|P1|STARTED|Overall Study||4
7930758|NCT00555438|19515754|P1|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5
7930759|NCT00555438|19515754|P1|COMPLETED|Between 10 Days and 30 Days Postoperativ||433
7930760|NCT00555438|19515754|P1|STARTED|Between 10 Days and 30 Days Postoperativ||438
7930761|NCT00555438|19515754|P1|NOT COMPLETED|10 Days Post-operative||4
7930762|NCT00555438|19515754|P1|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438
7930763|NCT00555438|19515754|P1|STARTED|10 Days Post-operative||442
7930764|NCT00555425|19515764|P2|NOT COMPLETED|Overall Study||19
7930765|NCT00555425|19515765|P1|NOT COMPLETED|Overall Study||51
7930766|NCT00555425|19515764|P2|COMPLETED|Overall Study||37
7930767|NCT00555425|19515765|P1|COMPLETED|Overall Study||6
7930768|NCT00555425|19515764|P2|STARTED|Overall Study||56
7930769|NCT00555425|19515765|P1|STARTED|Overall Study||57
7930770|NCT00555360|19515785|P2|NOT COMPLETED|Overall Study||36
7930771|NCT00555360|19515786|P1|NOT COMPLETED|Overall Study||27
7930772|NCT00555360|19515785|P2|COMPLETED|Overall Study||153
7930773|NCT00555360|19515786|P1|COMPLETED|Overall Study||156
7930774|NCT00555360|19515785|P2|STARTED|Overall Study||189
7930775|NCT00555360|19515786|P1|STARTED|Overall Study||183
7930776|NCT00555321|19515801|P5|NOT COMPLETED|Long-term Extension Phase||26
7930777|NCT00555321|19515802|P4|NOT COMPLETED|Long-term Extension Phase||38
7930778|NCT00555321|19515803|P3|NOT COMPLETED|Long-term Extension Phase||24
7930779|NCT00555321|19515804|P2|NOT COMPLETED|Long-term Extension Phase||27
7930780|NCT00555321|19515805|P1|NOT COMPLETED|Long-term Extension Phase||30
7930781|NCT00555321|19515801|P5|COMPLETED|Long-term Extension Phase||0
7930782|NCT00555321|19515802|P4|COMPLETED|Long-term Extension Phase||0
7930783|NCT00555321|19515803|P3|COMPLETED|Long-term Extension Phase||0
7930784|NCT00555321|19515804|P2|COMPLETED|Long-term Extension Phase||0
7930785|NCT00555321|19515805|P1|COMPLETED|Long-term Extension Phase||0
7930786|NCT00555321|19515801|P5|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26
7930787|NCT00555321|19515802|P4|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38
7930788|NCT00555321|19515803|P3|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24
7930789|NCT00555321|19515804|P2|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27
7930790|NCT00555321|19515805|P1|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30
7930791|NCT00555321|19515801|P5|NOT COMPLETED|Treatment Phase up to 12-months||22
7930792|NCT00555321|19515802|P4|NOT COMPLETED|Treatment Phase up to 12-months||7
7930793|NCT00555321|19515803|P3|NOT COMPLETED|Treatment Phase up to 12-months||24
7930794|NCT00555321|19515804|P2|NOT COMPLETED|Treatment Phase up to 12-months||22
7930795|NCT00555321|19515805|P1|NOT COMPLETED|Treatment Phase up to 12-months||21
7930796|NCT00555321|19515801|P5|COMPLETED|Treatment Phase up to 12-months||32
7930797|NCT00555321|19515802|P4|COMPLETED|Treatment Phase up to 12-months||46
7930798|NCT00555321|19515803|P3|COMPLETED|Treatment Phase up to 12-months||26
7930799|NCT00555321|19515804|P2|COMPLETED|Treatment Phase up to 12-months||29
7930800|NCT00555321|19515805|P1|COMPLETED|Treatment Phase up to 12-months||31
7930801|NCT00555321|19515801|P5|Received Transplant and Treated|Treatment Phase up to 12-months||50
7930802|NCT00555321|19515802|P4|Received Transplant and Treated|Treatment Phase up to 12-months||53
7930803|NCT00555321|19515803|P3|Received Transplant and Treated|Treatment Phase up to 12-months||49
7930804|NCT00555321|19515804|P2|Received Transplant and Treated|Treatment Phase up to 12-months||48
7930805|NCT00555321|19515805|P1|Received Transplant and Treated|Treatment Phase up to 12-months||50
7930806|NCT00555321|19515801|P5|STARTED|Treatment Phase up to 12-months||54
7930807|NCT00555321|19515802|P4|STARTED|Treatment Phase up to 12-months||53
7930808|NCT00555321|19515803|P3|STARTED|Treatment Phase up to 12-months||50
7930809|NCT00555321|19515804|P2|STARTED|Treatment Phase up to 12-months||51
7930810|NCT00555321|19515805|P1|STARTED|Treatment Phase up to 12-months||52
7930811|NCT00555217|19516109|P2|NOT COMPLETED|Overall Study||68
7930812|NCT00555217|19516110|P1|NOT COMPLETED|Overall Study||75
7930813|NCT00555217|19516109|P2|COMPLETED|Overall Study||656
7930814|NCT00555217|19516110|P1|COMPLETED|Overall Study||649
7930815|NCT00555217|19516109|P2|STARTED|Overall Study||724
7930816|NCT00555217|19516110|P1|STARTED|Overall Study||724
7930817|NCT00555152|19516122|P4|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
7930818|NCT00555152|19516123|P3|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
7930819|NCT00555152|19516124|P2|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
7930820|NCT00555152|19516125|P1|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
7930821|NCT00555152|19516122|P4|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9
7930822|NCT00555152|19516123|P3|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
7930823|NCT00555152|19516124|P2|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10
7930824|NCT00555152|19516125|P1|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
7930825|NCT00555152|19516122|P4|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9
7930826|NCT00555152|19516123|P3|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0
7930827|NCT00555152|19516124|P2|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10
7930828|NCT00555152|19516125|P1|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0
7930829|NCT00555152|19516122|P4|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
7930830|NCT00555152|19516123|P3|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
7930831|NCT00555152|19516124|P2|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
7930832|NCT00555152|19516125|P1|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
7930833|NCT00555152|19516122|P4|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1
7930834|NCT00555152|19516123|P3|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
7930835|NCT00555152|19516124|P2|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
7930836|NCT00555152|19516125|P1|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2
7930837|NCT00555152|19516122|P4|STARTED|Period Open at BCM: 1/17/08-3/8/10||1
7930838|NCT00555152|19516123|P3|STARTED|Period Open at BCM: 1/17/08-3/8/10||0
7930839|NCT00555152|19516124|P2|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0
7930840|NCT00555152|19516125|P1|STARTED|Period Open at BCM: 1/17/08-3/8/10||2
7930841|NCT00555061|19516147|P1|NOT COMPLETED|Overall Study||9
7930842|NCT00555061|19516147|P1|COMPLETED|Overall Study||78
7930843|NCT00555061|19516147|P1|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87
7930844|NCT00555048|19516154|P1|NOT COMPLETED|Overall Study||0
7930845|NCT00555048|19516154|P1|COMPLETED|Overall Study||1
7930846|NCT00555048|19516154|P1|STARTED|Overall Study||1
7930847|NCT00555009|19516166|P2|NOT COMPLETED|Overall Study||6
7930848|NCT00555009|19516167|P1|NOT COMPLETED|Overall Study||2
7930849|NCT00555009|19516166|P2|COMPLETED|Overall Study||0
7930850|NCT00555009|19516167|P1|COMPLETED|Overall Study||2
7930851|NCT00555009|19516166|P2|STARTED|Overall Study||6
7930852|NCT00555009|19516167|P1|STARTED|Overall Study||4
7930853|NCT00554996|19516189|P1|NOT COMPLETED|Overall Study||0
7930854|NCT00554996|19516189|P1|COMPLETED|Overall Study||10
7930855|NCT00554996|19516189|P1|STARTED|Overall Study||10
7930856|NCT00554970|19516197|P4|NOT COMPLETED|Period 2||0
7930857|NCT00554970|19516198|P3|NOT COMPLETED|Period 2||1
7930858|NCT00554970|19516199|P2|NOT COMPLETED|Period 2||0
7930859|NCT00554970|19516200|P1|NOT COMPLETED|Period 2||0
7930860|NCT00554970|19516197|P4|COMPLETED|Period 2||8
7930861|NCT00554970|19516198|P3|COMPLETED|Period 2||7
7930862|NCT00554970|19516199|P2|COMPLETED|Period 2||8
7930863|NCT00554970|19516200|P1|COMPLETED|Period 2||7
7930864|NCT00554970|19516197|P4|STARTED|Period 2||8
7930865|NCT00554970|19516198|P3|STARTED|Period 2||8
7930866|NCT00554970|19516199|P2|STARTED|Period 2||8
7930867|NCT00554970|19516200|P1|STARTED|Period 2||7
7930868|NCT00554970|19516197|P4|NOT COMPLETED|Period 1||0
7930869|NCT00554970|19516198|P3|NOT COMPLETED|Period 1||0
7930870|NCT00554970|19516199|P2|NOT COMPLETED|Period 1||0
7930871|NCT00554970|19516200|P1|NOT COMPLETED|Period 1||1
7930872|NCT00554970|19516197|P4|COMPLETED|Period 1||8
7930873|NCT00554970|19516198|P3|COMPLETED|Period 1||8
7930874|NCT00554970|19516199|P2|COMPLETED|Period 1||8
7930875|NCT00554970|19516200|P1|COMPLETED|Period 1||7
7930876|NCT00554970|19516197|P4|STARTED|Period 1||8
7930877|NCT00554970|19516198|P3|STARTED|Period 1||8
7930878|NCT00554970|19516199|P2|STARTED|Period 1||8
7930879|NCT00554970|19516200|P1|STARTED|Period 1||8
7930880|NCT00554853|19516232|P2|NOT COMPLETED|Crossover Arm (3 Months)||2
7930881|NCT00554853|19516233|P1|NOT COMPLETED|Crossover Arm (3 Months)||3
7930882|NCT00554853|19516232|P2|COMPLETED|Crossover Arm (3 Months)||55
7930883|NCT00554853|19516233|P1|COMPLETED|Crossover Arm (3 Months)||53
7930884|NCT00554853|19516232|P2|STARTED|Crossover Arm (3 Months)||57
7930885|NCT00554853|19516233|P1|STARTED|Crossover Arm (3 Months)||56
7930886|NCT00554853|19516232|P2|NOT COMPLETED|Washout Period (2 Weeks)||7
7930887|NCT00554853|19516233|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
7930888|NCT00554853|19516232|P2|COMPLETED|Washout Period (2 Weeks)||57
7930889|NCT00554853|19516233|P1|COMPLETED|Washout Period (2 Weeks)||56
7930890|NCT00554853|19516232|P2|STARTED|Washout Period (2 Weeks)||64
7930891|NCT00554853|19516233|P1|STARTED|Washout Period (2 Weeks)||56
7930892|NCT00554853|19516232|P2|NOT COMPLETED|First Arm of Study||7
7930893|NCT00554853|19516233|P1|NOT COMPLETED|First Arm of Study||16
7930894|NCT00554853|19516232|P2|COMPLETED|First Arm of Study||64
7930895|NCT00554853|19516233|P1|COMPLETED|First Arm of Study||56
7930896|NCT00554853|19516232|P2|STARTED|First Arm of Study||71
7930897|NCT00554853|19516233|P1|STARTED|First Arm of Study||72
7930898|NCT00554840|19516247|P2|NOT COMPLETED|Overall Study||1
7930899|NCT00554840|19516248|P1|NOT COMPLETED|Overall Study||0
7930900|NCT00554840|19516247|P2|COMPLETED|Overall Study||4
7930901|NCT00554840|19516248|P1|COMPLETED|Overall Study||4
7930902|NCT00554840|19516247|P2|STARTED|Overall Study||5
7930903|NCT00554840|19516248|P1|STARTED|Overall Study||4
7930904|NCT00554801|19516266|P2|NOT COMPLETED|Overall Study||0
7930905|NCT00554801|19516267|P1|NOT COMPLETED|Overall Study||19
7930906|NCT00554801|19516266|P2|COMPLETED|Overall Study||29
7930907|NCT00554801|19516267|P1|COMPLETED|Overall Study||36
7930908|NCT00554801|19516266|P2|STARTED|Overall Study||29
7930909|NCT00554801|19516267|P1|STARTED|Overall Study||55
7930910|NCT00554788|19516278|P3|NOT COMPLETED|Overall Study||14
7930911|NCT00554788|19516279|P2|NOT COMPLETED|Overall Study||6
7930912|NCT00554788|19516280|P1|NOT COMPLETED|Overall Study||7
7930913|NCT00554788|19516278|P3|COMPLETED|Overall Study||7
7930914|NCT00554788|19516279|P2|COMPLETED|Overall Study||12
7930915|NCT00554788|19516280|P1|COMPLETED|Overall Study||14
7930916|NCT00554788|19516278|P3|STARTED|Overall Study||21
7930917|NCT00554788|19516279|P2|STARTED|Overall Study||18
7930918|NCT00554788|19516280|P1|STARTED|Overall Study||21
7930919|NCT00554749|19516292|P1|NOT COMPLETED|Overall Study||0
7930920|NCT00554749|19516292|P1|COMPLETED|Overall Study||7
7930921|NCT00554749|19516292|P1|STARTED|Overall Study||7
7930922|NCT00554671|19516299|P2|NOT COMPLETED|Overall Study||16
7930923|NCT00554671|19516300|P1|NOT COMPLETED|Overall Study||20
7930924|NCT00554671|19516299|P2|COMPLETED|Overall Study||117
7930925|NCT00554671|19516300|P1|COMPLETED|Overall Study||97
7930926|NCT00554671|19516299|P2|STARTED|Overall Study||133
7930927|NCT00554671|19516300|P1|STARTED|Overall Study||117
7930928|NCT00554619|19516312|P1|NOT COMPLETED|Overall Study||3
7930929|NCT00554619|19516312|P1|COMPLETED|Overall Study||18
7930930|NCT00554619|19516312|P1|STARTED|Overall Study||21
7930931|NCT00554515|19516324|P1|NOT COMPLETED|Overall Study||118
7930932|NCT00554515|19516324|P1|COMPLETED|Overall Study||5
7930933|NCT00554515|19516324|P1|Treated|Overall Study||120
7930934|NCT00554515|19516324|P1|STARTED|Overall Study||123
7930935|NCT00554463|19516353|P1|NOT COMPLETED|Overall Study||0
7930936|NCT00554463|19516353|P1|COMPLETED|Overall Study||5
7930937|NCT00554463|19516353|P1|STARTED|Overall Study||5
7930938|NCT00554372|19516365|P2|NOT COMPLETED|Overall Study||0
7930939|NCT00554372|19516366|P1|NOT COMPLETED|Overall Study||0
7930940|NCT00554372|19516365|P2|COMPLETED|Overall Study||16
7930941|NCT00554372|19516366|P1|COMPLETED|Overall Study||14
7930942|NCT00554372|19516365|P2|STARTED|Overall Study||16
7930943|NCT00554372|19516366|P1|STARTED|Overall Study||14
7930944|NCT00554294|19516380|P2|NOT COMPLETED|Overall Study||80
7930945|NCT00554294|19516381|P1|NOT COMPLETED|Overall Study||160
7930946|NCT00554294|19516380|P2|COMPLETED|Overall Study||1641
7930947|NCT00554294|19516381|P1|COMPLETED|Overall Study||1309
7930948|NCT00554294|19516380|P2|STARTED|Overall Study||1721
7930949|NCT00554294|19516381|P1|STARTED|Overall Study||1469
7930950|NCT00554229|19516387|P2|NOT COMPLETED|Overall Study||225
7930951|NCT00554229|19516388|P1|NOT COMPLETED|Overall Study||226
7930952|NCT00554229|19516387|P2|COMPLETED|Overall Study||70
7930953|NCT00554229|19516388|P1|COMPLETED|Overall Study||73
7930954|NCT00554229|19516387|P2|Patients Who Received Treatment|Overall Study||295
7930955|NCT00554229|19516388|P1|Patients Who Received Treatment|Overall Study||298
7930956|NCT00554229|19516387|P2|STARTED|Overall Study||295
7930957|NCT00554229|19516388|P1|STARTED|Overall Study||299
7930958|NCT00554216|19516413|P3|NOT COMPLETED|Overall Study||172
7930959|NCT00554216|19516414|P2|NOT COMPLETED|Overall Study||94
7930960|NCT00554216|19516415|P1|NOT COMPLETED|Overall Study||242
7930961|NCT00554216|19516413|P3|COMPLETED|Overall Study||340
7930962|NCT00554216|19516414|P2|COMPLETED|Overall Study||147
7930963|NCT00554216|19516415|P1|COMPLETED|Overall Study||272
7930964|NCT00554216|19516413|P3|STARTED|Overall Study||512
7930965|NCT00554216|19516414|P2|STARTED|Overall Study||241
7930966|NCT00554216|19516415|P1|STARTED|Overall Study||514
7930967|NCT00554190|19516426|P1|NOT COMPLETED|Overall Study||10
7930968|NCT00554190|19516426|P1|COMPLETED|Overall Study|10 subjects did not complete the Termination Study Forms|19
7930969|NCT00554190|19516426|P1|STARTED|Overall Study|29 subjects treated.|29
7930970|NCT00554099|19516435|P3|NOT COMPLETED|Non-Treatment Phase (9 Months)||3
7930971|NCT00554099|19516436|P2|NOT COMPLETED|Non-Treatment Phase (9 Months)||5
7930972|NCT00554099|19516437|P1|NOT COMPLETED|Non-Treatment Phase (9 Months)||7
7930973|NCT00554099|19516435|P3|COMPLETED|Non-Treatment Phase (9 Months)||24
7930974|NCT00554099|19516436|P2|COMPLETED|Non-Treatment Phase (9 Months)||27
7930975|NCT00554099|19516437|P1|COMPLETED|Non-Treatment Phase (9 Months)||22
7930976|NCT00554099|19516435|P3|STARTED|Non-Treatment Phase (9 Months)||27
7930977|NCT00554099|19516436|P2|STARTED|Non-Treatment Phase (9 Months)||32
7930978|NCT00554099|19516437|P1|STARTED|Non-Treatment Phase (9 Months)||29
7930979|NCT00554099|19516435|P3|NOT COMPLETED|Treatment Period (12 Weeks)||9
7930980|NCT00554099|19516436|P2|NOT COMPLETED|Treatment Period (12 Weeks)||8
7930981|NCT00554099|19516437|P1|NOT COMPLETED|Treatment Period (12 Weeks)||12
7930982|NCT00554099|19516435|P3|COMPLETED|Treatment Period (12 Weeks)||27
7930983|NCT00554099|19516436|P2|COMPLETED|Treatment Period (12 Weeks)||32
7930984|NCT00554099|19516437|P1|COMPLETED|Treatment Period (12 Weeks)||29
7930985|NCT00554099|19516435|P3|STARTED|Treatment Period (12 Weeks)||36
7930986|NCT00554099|19516436|P2|STARTED|Treatment Period (12 Weeks)||40
7930987|NCT00554099|19516437|P1|STARTED|Treatment Period (12 Weeks)||41
7930988|NCT00553969|19516470|P4|NOT COMPLETED|Overall Study||1
7930989|NCT00553969|19516471|P3|NOT COMPLETED|Overall Study||1
7930990|NCT00553969|19516472|P2|NOT COMPLETED|Overall Study||0
7930991|NCT00553969|19516473|P1|NOT COMPLETED|Overall Study||8
7930992|NCT00553969|19516470|P4|COMPLETED|Overall Study||23
7930993|NCT00553969|19516471|P3|COMPLETED|Overall Study||21
7930994|NCT00553969|19516472|P2|COMPLETED|Overall Study||24
7930995|NCT00553969|19516473|P1|COMPLETED|Overall Study||23
7930996|NCT00553969|19516470|P4|STARTED|Overall Study||24
7930997|NCT00553969|19516471|P3|STARTED|Overall Study||22
7930998|NCT00553969|19516472|P2|STARTED|Overall Study||24
7930999|NCT00553969|19516473|P1|STARTED|Overall Study||31
7931000|NCT00553839|19516483|P1|NOT COMPLETED|Overall Study||0
7931001|NCT00553839|19516483|P1|COMPLETED|Overall Study||21
7931002|NCT00553839|19516483|P1|STARTED|Overall Study||21
7931003|NCT00553787|19516492|P3|NOT COMPLETED|Overall Study||262
7931004|NCT00553787|19516493|P2|NOT COMPLETED|Overall Study||124
7931005|NCT00553787|19516494|P1|NOT COMPLETED|Overall Study||378
7931006|NCT00553787|19516492|P3|COMPLETED|Overall Study||733
7931007|NCT00553787|19516493|P2|COMPLETED|Overall Study||374
7931008|NCT00553787|19516494|P1|COMPLETED|Overall Study||616
7931009|NCT00553787|19516492|P3|STARTED|Overall Study||995
7931010|NCT00553787|19516493|P2|STARTED|Overall Study||498
7931011|NCT00553787|19516494|P1|STARTED|Overall Study||994
7931012|NCT00553735|19516505|P1|NOT COMPLETED|Overall Study||7
7931013|NCT00553735|19516505|P1|COMPLETED|Overall Study||1
7931014|NCT00553735|19516505|P1|STARTED|Overall Study||8
7931015|NCT00553696|19516526|P4|NOT COMPLETED|Overall Study||1
7931016|NCT00553696|19516527|P3|NOT COMPLETED|Overall Study||6
7931017|NCT00553696|19516528|P2|NOT COMPLETED|Overall Study||16
7931018|NCT00553696|19516529|P1|NOT COMPLETED|Overall Study||4
7931019|NCT00553696|19516526|P4|COMPLETED|Overall Study||0
7931020|NCT00553696|19516527|P3|COMPLETED|Overall Study||0
7931021|NCT00553696|19516528|P2|COMPLETED|Overall Study||0
7931022|NCT00553696|19516529|P1|COMPLETED|Overall Study||0
7931023|NCT00553696|19516526|P4|STARTED|Overall Study||1
7931024|NCT00553696|19516527|P3|STARTED|Overall Study||6
7931025|NCT00553696|19516528|P2|STARTED|Overall Study||16
7931026|NCT00553696|19516529|P1|STARTED|Overall Study||4
7931027|NCT00553644|19516567|P1|NOT COMPLETED|Overall Study||28
7931028|NCT00553644|19516567|P1|COMPLETED|Overall Study||25
7931029|NCT00553644|19516567|P1|STARTED|Overall Study||53
7931030|NCT00553631|19516576|P2|NOT COMPLETED|Overall Study||1
7931031|NCT00553631|19516577|P1|NOT COMPLETED|Overall Study||1
7931032|NCT00553631|19516576|P2|COMPLETED|Overall Study||16
7931033|NCT00553631|19516577|P1|COMPLETED|Overall Study||16
7931034|NCT00553631|19516576|P2|STARTED|Overall Study|Intent-to-treat (ITT) population|17
7931035|NCT00553631|19516577|P1|STARTED|Overall Study|Intent-to-treat (ITT) population|17
7931036|NCT00553605|19516599|P2|NOT COMPLETED|Overall Study||3
7931037|NCT00553605|19516600|P1|NOT COMPLETED|Overall Study||4
7931038|NCT00553605|19516599|P2|COMPLETED|Overall Study||161
7931039|NCT00553605|19516600|P1|COMPLETED|Overall Study||172
7931040|NCT00553605|19516599|P2|Treated|Overall Study||164
7931041|NCT00553605|19516600|P1|Treated|Overall Study||174
7931042|NCT00553605|19516599|P2|STARTED|Overall Study||164
7931043|NCT00553605|19516600|P1|STARTED|Overall Study||176
7931044|NCT00553540|19516626|P2|NOT COMPLETED|Overall Study||5
7931045|NCT00553540|19516627|P1|NOT COMPLETED|Overall Study||2
7931046|NCT00553540|19516626|P2|COMPLETED|Overall Study||20
7931047|NCT00553540|19516627|P1|COMPLETED|Overall Study||23
7931048|NCT00553540|19516626|P2|STARTED|Overall Study||25
7931049|NCT00553540|19516627|P1|STARTED|Overall Study||25
7931050|NCT00553514|19516638|P5|NOT COMPLETED|Overall Study||7
7931051|NCT00553514|19516639|P4|NOT COMPLETED|Overall Study||7
7931052|NCT00553514|19516640|P3|NOT COMPLETED|Overall Study||6
7931053|NCT00553514|19516641|P2|NOT COMPLETED|Overall Study||8
7931054|NCT00553514|19516642|P1|NOT COMPLETED|Overall Study||8
7931055|NCT00553514|19516638|P5|COMPLETED|Overall Study||8
7931056|NCT00553514|19516639|P4|COMPLETED|Overall Study||6
7931057|NCT00553514|19516640|P3|COMPLETED|Overall Study||9
7931058|NCT00553514|19516641|P2|COMPLETED|Overall Study||6
7931059|NCT00553514|19516642|P1|COMPLETED|Overall Study||6
7931060|NCT00553514|19516638|P5|STARTED|Overall Study||15
7931061|NCT00553514|19516639|P4|STARTED|Overall Study||13
7931062|NCT00553514|19516640|P3|STARTED|Overall Study||15
7931063|NCT00553514|19516641|P2|STARTED|Overall Study||14
7931064|NCT00553514|19516642|P1|STARTED|Overall Study||14
7931065|NCT00553501|19516679|P1|NOT COMPLETED|Overall Study||4
7931066|NCT00553501|19516679|P1|COMPLETED|Overall Study||55
7931067|NCT00553501|19516679|P1|STARTED|Overall Study||59
7931068|NCT00553475|19516688|P3|NOT COMPLETED|Overall Study||13
7931069|NCT00553475|19516689|P2|NOT COMPLETED|Overall Study||20
7931070|NCT00553475|19516690|P1|NOT COMPLETED|Overall Study||16
7931071|NCT00553475|19516688|P3|COMPLETED|Overall Study||32
7931072|NCT00553475|19516689|P2|COMPLETED|Overall Study||114
7931073|NCT00553475|19516690|P1|COMPLETED|Overall Study||119
7931074|NCT00553475|19516688|P3|STARTED|Overall Study||45
7931075|NCT00553475|19516689|P2|STARTED|Overall Study||134
7931076|NCT00553475|19516690|P1|STARTED|Overall Study||135
7931077|NCT00553462|19516812|P1|NOT COMPLETED|Overall Study||14
7931078|NCT00553462|19516812|P1|COMPLETED|Overall Study||61
7931079|NCT00553462|19516812|P1|STARTED|Overall Study||75
7931080|NCT00553436|19516818|P1|NOT COMPLETED|Overall Study||1
7931081|NCT00553436|19516818|P1|COMPLETED|Overall Study|09 April 2009|6
7931082|NCT00553436|19516818|P1|STARTED|Overall Study|20 August 2007|7
7931083|NCT00553410|19516826|P2|NOT COMPLETED|Overall Study||18
7931084|NCT00553410|19516827|P1|NOT COMPLETED|Overall Study||15
7931085|NCT00553410|19516826|P2|COMPLETED|Overall Study||2425
7931086|NCT00553410|19516827|P1|COMPLETED|Overall Study||2426
7931087|NCT00553410|19516826|P2|STARTED|Overall Study||2443
7931088|NCT00553410|19516827|P1|STARTED|Overall Study||2441
7931089|NCT00553358|19516842|P3|NOT COMPLETED|Overall Study||60
7931090|NCT00553358|19516843|P2|NOT COMPLETED|Overall Study||12
7931091|NCT00553358|19516844|P1|NOT COMPLETED|Overall Study||53
7931092|NCT00553358|19516842|P3|COMPLETED|Overall Study||92
7931093|NCT00553358|19516843|P2|COMPLETED|Overall Study||137
7931094|NCT00553358|19516844|P1|COMPLETED|Overall Study||101
7931095|NCT00553358|19516842|P3|STARTED|Overall Study||152
7931096|NCT00553358|19516843|P2|STARTED|Overall Study||149
7931097|NCT00553358|19516844|P1|STARTED|Overall Study||154
7931098|NCT00553332|19516870|P1|NOT COMPLETED|Overall Study||1
7931099|NCT00553332|19516870|P1|COMPLETED|Overall Study|evaluable for response|28
7931100|NCT00553332|19516870|P1|STARTED|Overall Study||29
7931101|NCT00553319|19516882|P3|NOT COMPLETED|Overall Study||9
7931102|NCT00553319|19516883|P2|NOT COMPLETED|Overall Study||10
7931103|NCT00553319|19516884|P1|NOT COMPLETED|Overall Study||14
7931104|NCT00553319|19516882|P3|COMPLETED|Overall Study||34
7931105|NCT00553319|19516883|P2|COMPLETED|Overall Study||30
7931106|NCT00553319|19516884|P1|COMPLETED|Overall Study||29
7931107|NCT00553319|19516882|P3|STARTED|Overall Study||43
7931108|NCT00553319|19516883|P2|STARTED|Overall Study||40
7931109|NCT00553319|19516884|P1|STARTED|Overall Study||43
7931110|NCT00553280|19516895|P1|NOT COMPLETED|Overall Study||26
7931111|NCT00553280|19516895|P1|COMPLETED|Overall Study||97
7931112|NCT00553280|19516895|P1|STARTED|Overall Study||123
7931113|NCT00553267|19516907|P3|NOT COMPLETED|Overall Study||10
7931114|NCT00553267|19516908|P2|NOT COMPLETED|Overall Study||18
7931115|NCT00553267|19516909|P1|NOT COMPLETED|Overall Study||14
7931116|NCT00553267|19516907|P3|COMPLETED|Overall Study||307
7931117|NCT00553267|19516908|P2|COMPLETED|Overall Study||297
7931118|NCT00553267|19516909|P1|COMPLETED|Overall Study||301
7931119|NCT00553267|19516907|P3|STARTED|Overall Study||317
7931120|NCT00553267|19516908|P2|STARTED|Overall Study||315
7931121|NCT00553267|19516909|P1|STARTED|Overall Study||315
7931122|NCT00553254|19516946|P3|NOT COMPLETED|Overall Study||43
7931123|NCT00553254|19516947|P2|NOT COMPLETED|Overall Study||6
7931124|NCT00553254|19516948|P1|NOT COMPLETED|Overall Study||6
7931125|NCT00553254|19516946|P3|COMPLETED|Overall Study||0
7931126|NCT00553254|19516947|P2|COMPLETED|Overall Study||0
7931127|NCT00553254|19516948|P1|COMPLETED|Overall Study||0
7931128|NCT00553254|19516946|P3|STARTED|Overall Study||43
7931129|NCT00553254|19516947|P2|STARTED|Overall Study||6
7931130|NCT00553254|19516948|P1|STARTED|Overall Study||6
7931131|NCT00553202|19516990|P1|NOT COMPLETED|Overall Study||68
7931132|NCT00553202|19516990|P1|COMPLETED|Overall Study||90
7931133|NCT00553202|19516990|P1|STARTED|Overall Study||158
7931134|NCT00553163|19517000|P2|NOT COMPLETED|Overall Study||0
7931135|NCT00553163|19517001|P1|NOT COMPLETED|Overall Study||0
7931136|NCT00553163|19517000|P2|COMPLETED|Overall Study||10
7931137|NCT00553163|19517001|P1|COMPLETED|Overall Study||16
7931138|NCT00553163|19517000|P2|STARTED|Overall Study||10
7931139|NCT00553163|19517001|P1|STARTED|Overall Study||16
7931140|NCT00553150|19517017|P4|NOT COMPLETED|Overall Study||4
7931141|NCT00553150|19517018|P3|NOT COMPLETED|Overall Study||0
7931142|NCT00553150|19517019|P2|NOT COMPLETED|Overall Study||0
7931143|NCT00553150|19517020|P1|NOT COMPLETED|Overall Study||0
7931144|NCT00553150|19517017|P4|COMPLETED|Overall Study||100
7931145|NCT00553150|19517018|P3|COMPLETED|Overall Study||6
7931146|NCT00553150|19517019|P2|COMPLETED|Overall Study||6
7931147|NCT00553150|19517020|P1|COMPLETED|Overall Study||6
7931148|NCT00553150|19517017|P4|STARTED|Overall Study||104
7931149|NCT00553150|19517018|P3|STARTED|Overall Study||6
7931150|NCT00553150|19517019|P2|STARTED|Overall Study||6
7931151|NCT00553150|19517020|P1|STARTED|Overall Study||6
7931152|NCT00553098|19517032|P1|NOT COMPLETED|Overall Study||1
7931153|NCT00553098|19517032|P1|COMPLETED|Overall Study||28
7931154|NCT00553098|19517032|P1|STARTED|Overall Study||29
7931155|NCT00553059|19517048|P2|NOT COMPLETED|Overall Study||2
7931156|NCT00553059|19517049|P1|NOT COMPLETED|Overall Study||1
7931157|NCT00553059|19517048|P2|COMPLETED|Overall Study||29
7931158|NCT00553059|19517049|P1|COMPLETED|Overall Study||30
7931159|NCT00553059|19517048|P2|STARTED|Overall Study||31
7931160|NCT00553059|19517049|P1|STARTED|Overall Study||31
7931161|NCT00552929|19517077|P10|NOT COMPLETED|Overall Study||0
7931162|NCT00552929|19517078|P9|NOT COMPLETED|Overall Study||1
7931163|NCT00552929|19517079|P8|NOT COMPLETED|Overall Study||0
7931164|NCT00552929|19517080|P7|NOT COMPLETED|Overall Study||0
7931165|NCT00552929|19517081|P6|NOT COMPLETED|Overall Study||1
7931166|NCT00552929|19517082|P5|NOT COMPLETED|Overall Study||0
7931167|NCT00552929|19517083|P4|NOT COMPLETED|Overall Study||0
7931168|NCT00552929|19517084|P3|NOT COMPLETED|Overall Study||0
7931169|NCT00552929|19517085|P2|NOT COMPLETED|Overall Study||0
7931170|NCT00552929|19517086|P1|NOT COMPLETED|Overall Study||0
7931171|NCT00552929|19517077|P10|COMPLETED|Overall Study||11
7931172|NCT00552929|19517078|P9|COMPLETED|Overall Study||9
7931173|NCT00552929|19517079|P8|COMPLETED|Overall Study||11
7931174|NCT00552929|19517080|P7|COMPLETED|Overall Study||10
7931175|NCT00552929|19517081|P6|COMPLETED|Overall Study||9
7931176|NCT00552929|19517082|P5|COMPLETED|Overall Study||10
7931177|NCT00552929|19517083|P4|COMPLETED|Overall Study||11
7931178|NCT00552929|19517084|P3|COMPLETED|Overall Study||10
7931179|NCT00552929|19517085|P2|COMPLETED|Overall Study||10
7931180|NCT00552929|19517086|P1|COMPLETED|Overall Study||9
7931181|NCT00552929|19517077|P10|Participants as Treated|Overall Study||11
7931182|NCT00552929|19517078|P9|Participants as Treated|Overall Study||10
7931183|NCT00552929|19517079|P8|Participants as Treated|Overall Study||11
7931184|NCT00552929|19517080|P7|Participants as Treated|Overall Study||10
7931185|NCT00552929|19517081|P6|Participants as Treated|Overall Study||9
7931186|NCT00552929|19517082|P5|Participants as Treated|Overall Study||10
7931187|NCT00552929|19517083|P4|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|11
7931188|NCT00552929|19517084|P3|Participants as Treated|Overall Study||10
7931189|NCT00552929|19517085|P2|Participants as Treated|Overall Study||10
7931190|NCT00552929|19517086|P1|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|9
7931191|NCT00552929|19517077|P10|STARTED|Overall Study||11
7931192|NCT00552929|19517078|P9|STARTED|Overall Study||10
7931193|NCT00552929|19517079|P8|STARTED|Overall Study||11
7931194|NCT00552929|19517080|P7|STARTED|Overall Study||10
7931195|NCT00552929|19517081|P6|STARTED|Overall Study||10
7931196|NCT00552929|19517082|P5|STARTED|Overall Study||10
7931197|NCT00552929|19517083|P4|STARTED|Overall Study||11
7931198|NCT00552929|19517084|P3|STARTED|Overall Study||10
7931199|NCT00552929|19517085|P2|STARTED|Overall Study||10
7931200|NCT00552929|19517086|P1|STARTED|Overall Study||9
7931201|NCT00552812|19517138|P1|NOT COMPLETED|Overall Study||20
7931202|NCT00552812|19517138|P1|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85
7931203|NCT00552812|19517138|P1|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105
7931204|NCT00552786|19517146|P2|NOT COMPLETED|Second Intervention||0
7931205|NCT00552786|19517147|P1|NOT COMPLETED|Second Intervention||0
7931206|NCT00552786|19517146|P2|COMPLETED|Second Intervention||28
7931207|NCT00552786|19517147|P1|COMPLETED|Second Intervention||25
7931208|NCT00552786|19517146|P2|STARTED|Second Intervention||28
7931209|NCT00552786|19517147|P1|STARTED|Second Intervention||25
7931210|NCT00552786|19517146|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
7931211|NCT00552786|19517147|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
7931212|NCT00552786|19517146|P2|COMPLETED|Washout Period of 2 Weeks||28
7931213|NCT00552786|19517147|P1|COMPLETED|Washout Period of 2 Weeks||25
7931214|NCT00552786|19517146|P2|STARTED|Washout Period of 2 Weeks||28
7931215|NCT00552786|19517147|P1|STARTED|Washout Period of 2 Weeks||25
7931216|NCT00552786|19517146|P2|NOT COMPLETED|First Intervention||0
7931217|NCT00552786|19517147|P1|NOT COMPLETED|First Intervention||0
7931218|NCT00552786|19517146|P2|COMPLETED|First Intervention||28
7931219|NCT00552786|19517147|P1|COMPLETED|First Intervention||25
7931220|NCT00552786|19517146|P2|Medication and Hearing Evaluation|First Intervention||28
7931221|NCT00552786|19517147|P1|Medication and Hearing Evaluation|First Intervention||25
7931222|NCT00552786|19517146|P2|STARTED|First Intervention||28
7931223|NCT00552786|19517147|P1|STARTED|First Intervention||25
7931224|NCT00552760|19517157|P2|NOT COMPLETED|Overall Study||33
7931225|NCT00552760|19517158|P1|NOT COMPLETED|Overall Study||26
7931226|NCT00552760|19517157|P2|COMPLETED|Overall Study||8
7931227|NCT00552760|19517158|P1|COMPLETED|Overall Study||16
7931228|NCT00552760|19517157|P2|STARTED|Overall Study||41
7931229|NCT00552760|19517158|P1|STARTED|Overall Study||42
7931230|NCT00552695|19517174|P2|NOT COMPLETED|Overall Study||0
7931231|NCT00552695|19517175|P1|NOT COMPLETED|Overall Study||0
7931232|NCT00552695|19517174|P2|COMPLETED|Overall Study|September 2007|23
7931233|NCT00552695|19517175|P1|COMPLETED|Overall Study|September 2007|22
7931234|NCT00552695|19517174|P2|STARTED|Overall Study|August 2007|23
7931235|NCT00552695|19517175|P1|STARTED|Overall Study|August 2007|22
7931236|NCT00552669|19517185|P2|NOT COMPLETED|Overall Study||7
7931237|NCT00552669|19517186|P1|NOT COMPLETED|Overall Study||3
7931238|NCT00552669|19517185|P2|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93
7931239|NCT00552669|19517186|P1|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97
7931240|NCT00552669|19517185|P2|STARTED|Overall Study|patients|100
7931241|NCT00552669|19517186|P1|STARTED|Overall Study|patients|100
7931242|NCT00552617|19517206|P10|NOT COMPLETED|Overall Study||1
7931243|NCT00552617|19517207|P9|NOT COMPLETED|Overall Study||2
7931244|NCT00552617|19517208|P8|NOT COMPLETED|Overall Study||0
7931245|NCT00552617|19517209|P7|NOT COMPLETED|Overall Study||0
7931246|NCT00552617|19517210|P6|NOT COMPLETED|Overall Study||2
7931247|NCT00552617|19517211|P5|NOT COMPLETED|Overall Study||0
7931248|NCT00552617|19517212|P4|NOT COMPLETED|Overall Study||1
7931249|NCT00552617|19517213|P3|NOT COMPLETED|Overall Study||1
7931250|NCT00552617|19517214|P2|NOT COMPLETED|Overall Study||0
7931251|NCT00552617|19517215|P1|NOT COMPLETED|Overall Study||0
7931252|NCT00552617|19517206|P10|COMPLETED|Overall Study||9
7931253|NCT00552617|19517207|P9|COMPLETED|Overall Study||8
7931254|NCT00552617|19517208|P8|COMPLETED|Overall Study||10
7931255|NCT00552617|19517209|P7|COMPLETED|Overall Study||10
7931256|NCT00552617|19517210|P6|COMPLETED|Overall Study||8
7931257|NCT00552617|19517211|P5|COMPLETED|Overall Study||10
7931258|NCT00552617|19517212|P4|COMPLETED|Overall Study||9
7931259|NCT00552617|19517213|P3|COMPLETED|Overall Study||9
7931260|NCT00552617|19517214|P2|COMPLETED|Overall Study||10
7931261|NCT00552617|19517215|P1|COMPLETED|Overall Study||10
7931262|NCT00552617|19517206|P10|Treated|Overall Study||9
7931263|NCT00552617|19517207|P9|Treated|Overall Study||10
7931264|NCT00552617|19517208|P8|Treated|Overall Study||10
7931265|NCT00552617|19517209|P7|Treated|Overall Study||10
7931266|NCT00552617|19517210|P6|Treated|Overall Study||10
7931267|NCT00552617|19517211|P5|Treated|Overall Study||10
7931268|NCT00552617|19517212|P4|Treated|Overall Study||10
7931269|NCT00552617|19517213|P3|Treated|Overall Study||9
7931270|NCT00552617|19517214|P2|Treated|Overall Study||10
7931271|NCT00552617|19517215|P1|Treated|Overall Study||10
7931272|NCT00552617|19517206|P10|STARTED|Overall Study||10
7931273|NCT00552617|19517207|P9|STARTED|Overall Study||10
7931274|NCT00552617|19517208|P8|STARTED|Overall Study||10
7931275|NCT00552617|19517209|P7|STARTED|Overall Study||10
7931276|NCT00552617|19517210|P6|STARTED|Overall Study||10
7931277|NCT00552617|19517211|P5|STARTED|Overall Study||10
7931278|NCT00552617|19517212|P4|STARTED|Overall Study||10
7931279|NCT00552617|19517213|P3|STARTED|Overall Study||10
7931280|NCT00552617|19517214|P2|STARTED|Overall Study||10
7931281|NCT00552617|19517215|P1|STARTED|Overall Study||10
7931282|NCT00552578|19517259|P2|NOT COMPLETED|Overall Study||1
7931283|NCT00552578|19517260|P1|NOT COMPLETED|Overall Study||1
7931284|NCT00552578|19517259|P2|COMPLETED|Overall Study||5
7931285|NCT00552578|19517260|P1|COMPLETED|Overall Study||5
7931286|NCT00552578|19517259|P2|STARTED|Overall Study||6
7931287|NCT00552578|19517260|P1|STARTED|Overall Study||6
7931288|NCT00552513|19517272|P2|NOT COMPLETED|Overall Study||1
7931289|NCT00552513|19517273|P1|NOT COMPLETED|Overall Study||5
7931290|NCT00552513|19517272|P2|COMPLETED|Overall Study||1437
7931291|NCT00552513|19517273|P1|COMPLETED|Overall Study||1588
7931292|NCT00552513|19517272|P2|STARTED|Overall Study||1438
7931293|NCT00552513|19517273|P1|STARTED|Overall Study||1593
7931294|NCT00552448|19517285|P2|NOT COMPLETED|Overall Study||0
7931295|NCT00552448|19517286|P1|NOT COMPLETED|Overall Study||1
7931296|NCT00552448|19517285|P2|COMPLETED|Overall Study||16
7931297|NCT00552448|19517286|P1|COMPLETED|Overall Study||19
7931298|NCT00552448|19517285|P2|STARTED|Overall Study||16
7931299|NCT00552448|19517286|P1|STARTED|Overall Study||20
7931300|NCT00552422|19517298|P1|NOT COMPLETED|Overall Study||0
7931301|NCT00552422|19517298|P1|COMPLETED|Overall Study||6
7931302|NCT00552422|19517298|P1|STARTED|Overall Study||6
7931303|NCT00552409|19517304|P2|NOT COMPLETED|Overall Study||2
7931304|NCT00552409|19517305|P1|NOT COMPLETED|Overall Study||1
7931305|NCT00552409|19517304|P2|COMPLETED|Overall Study||9
7931306|NCT00552409|19517305|P1|COMPLETED|Overall Study||10
7931307|NCT00552409|19517304|P2|STARTED|Overall Study||11
7931308|NCT00552409|19517305|P1|STARTED|Overall Study||11
7931309|NCT00552396|19517318|P7|NOT COMPLETED|Overall Study||9
7931310|NCT00552396|19517319|P6|NOT COMPLETED|Overall Study||3
7931311|NCT00552396|19517320|P5|NOT COMPLETED|Overall Study||3
7931312|NCT00552396|19517321|P4|NOT COMPLETED|Overall Study||6
7931313|NCT00552396|19517322|P3|NOT COMPLETED|Overall Study||3
7931314|NCT00552396|19517323|P2|NOT COMPLETED|Overall Study||3
7931315|NCT00552396|19517324|P1|NOT COMPLETED|Overall Study||3
7931316|NCT00552396|19517318|P7|COMPLETED|Overall Study||1
7931317|NCT00552396|19517319|P6|COMPLETED|Overall Study||0
7931318|NCT00552396|19517320|P5|COMPLETED|Overall Study||0
7931319|NCT00552396|19517321|P4|COMPLETED|Overall Study||0
7931320|NCT00552396|19517322|P3|COMPLETED|Overall Study||0
7931321|NCT00552396|19517323|P2|COMPLETED|Overall Study||0
7931322|NCT00552396|19517324|P1|COMPLETED|Overall Study||1
7931323|NCT00552396|19517318|P7|STARTED|Overall Study||10
7931324|NCT00552396|19517319|P6|STARTED|Overall Study||3
7931325|NCT00552396|19517320|P5|STARTED|Overall Study||3
7931326|NCT00552396|19517321|P4|STARTED|Overall Study||6
7931327|NCT00552396|19517322|P3|STARTED|Overall Study||3
7931328|NCT00552396|19517323|P2|STARTED|Overall Study||3
7931329|NCT00552396|19517324|P1|STARTED|Overall Study||4
7931330|NCT00552344|19517361|P1|NOT COMPLETED|Overall Study||315
7931331|NCT00552344|19517361|P1|COMPLETED|Overall Study||87
7931332|NCT00552344|19517361|P1|STARTED|Overall Study||402
7931333|NCT00552305|19517370|P1|NOT COMPLETED|Overall Study||250
7931334|NCT00552305|19517370|P1|COMPLETED|Overall Study||120
7931335|NCT00552305|19517370|P1|STARTED|Overall Study||370
7931336|NCT00552279|19517380|P2|NOT COMPLETED|Overall Study||3
7931337|NCT00552279|19517381|P1|NOT COMPLETED|Overall Study||14
7931338|NCT00552279|19517380|P2|COMPLETED|Overall Study||398
7931339|NCT00552279|19517381|P1|COMPLETED|Overall Study||389
7931340|NCT00552279|19517380|P2|STARTED|Overall Study||401
7931341|NCT00552279|19517381|P1|STARTED|Overall Study||403
7931342|NCT00552240|19517407|P2|NOT COMPLETED|Overall Study||18
7931343|NCT00552240|19517408|P1|NOT COMPLETED|Overall Study||24
7931344|NCT00552240|19517407|P2|COMPLETED|Overall Study||59
7931345|NCT00552240|19517408|P1|COMPLETED|Overall Study||51
7931346|NCT00552240|19517407|P2|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77
7931347|NCT00552240|19517408|P1|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75
7931348|NCT00552188|19517510|P2|NOT COMPLETED|Overall Study||5
7931349|NCT00552188|19517511|P1|NOT COMPLETED|Overall Study||2
7931350|NCT00552188|19517510|P2|COMPLETED|Overall Study||21
7931351|NCT00552188|19517511|P1|COMPLETED|Overall Study||24
7931352|NCT00552188|19517510|P2|STARTED|Overall Study||26
7931353|NCT00552188|19517511|P1|STARTED|Overall Study||26
7931354|NCT00552175|19517522|P3|NOT COMPLETED|Overall Study||14
7931355|NCT00552175|19517523|P2|NOT COMPLETED|Overall Study||13
7931356|NCT00552175|19517524|P1|NOT COMPLETED|Overall Study||17
7931357|NCT00552175|19517522|P3|COMPLETED|Overall Study||72
7931358|NCT00552175|19517523|P2|COMPLETED|Overall Study||73
7931359|NCT00552175|19517524|P1|COMPLETED|Overall Study||150
7931360|NCT00552175|19517522|P3|Full Analysis Set Population|Overall Study||86
7931361|NCT00552175|19517523|P2|Full Analysis Set Population|Overall Study||85
7931362|NCT00552175|19517524|P1|Full Analysis Set Population|Overall Study||167
7931363|NCT00552175|19517522|P3|STARTED|Overall Study||86
7931364|NCT00552175|19517523|P2|STARTED|Overall Study||86
7931365|NCT00552175|19517524|P1|STARTED|Overall Study||167
7931366|NCT00552110|19517564|P5|NOT COMPLETED|Overall Study||9
7931367|NCT00552110|19517565|P4|NOT COMPLETED|Overall Study||8
7931368|NCT00552110|19517566|P3|NOT COMPLETED|Overall Study||2
7931369|NCT00552110|19517567|P2|NOT COMPLETED|Overall Study||5
7931370|NCT00552110|19517568|P1|NOT COMPLETED|Overall Study||4
7931371|NCT00552110|19517564|P5|COMPLETED|Overall Study||133
7931372|NCT00552110|19517565|P4|COMPLETED|Overall Study||133
7931373|NCT00552110|19517566|P3|COMPLETED|Overall Study||137
7931374|NCT00552110|19517567|P2|COMPLETED|Overall Study||134
7931375|NCT00552110|19517568|P1|COMPLETED|Overall Study||142
7931376|NCT00552110|19517564|P5|STARTED|Overall Study||142
7931377|NCT00552110|19517565|P4|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141
7931378|NCT00552110|19517566|P3|STARTED|Overall Study||139
7931379|NCT00552110|19517567|P2|STARTED|Overall Study||139
7931380|NCT00552110|19517568|P1|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146
7931381|NCT00552084|19517587|P2|NOT COMPLETED|Overall Study||9
7931382|NCT00552084|19517588|P1|NOT COMPLETED|Overall Study||8
7931383|NCT00552084|19517587|P2|COMPLETED|Overall Study||55
7931384|NCT00552084|19517588|P1|COMPLETED|Overall Study||118
7931385|NCT00552084|19517587|P2|STARTED|Overall Study||64
7931386|NCT00552084|19517588|P1|STARTED|Overall Study||126
7931387|NCT00552071|19517596|P2|NOT COMPLETED|Overall Study||2
7931388|NCT00552071|19517597|P1|NOT COMPLETED|Overall Study||4
7931389|NCT00552071|19517596|P2|COMPLETED|Overall Study||9
7931390|NCT00552071|19517597|P1|COMPLETED|Overall Study||6
7931391|NCT00552071|19517596|P2|STARTED|Overall Study||11
7931392|NCT00552071|19517597|P1|STARTED|Overall Study||10
7931393|NCT00552058|19517607|P2|NOT COMPLETED|Overall Study||24
7931394|NCT00552058|19517608|P1|NOT COMPLETED|Overall Study||16
7931395|NCT00552058|19517607|P2|COMPLETED|Overall Study||192
7931396|NCT00552058|19517608|P1|COMPLETED|Overall Study||207
7931397|NCT00552058|19517607|P2|STARTED|Overall Study||216
7931398|NCT00552058|19517608|P1|STARTED|Overall Study||223
7931399|NCT00552032|19517648|P2|NOT COMPLETED|Overall Study||19
7931400|NCT00552032|19517649|P1|NOT COMPLETED|Overall Study||17
7931401|NCT00552032|19517648|P2|COMPLETED|Overall Study||47
7931402|NCT00552032|19517649|P1|COMPLETED|Overall Study||49
7931403|NCT00552032|19517648|P2|STARTED|Overall Study||66
7931404|NCT00552032|19517649|P1|STARTED|Overall Study||66
7931405|NCT00551759|19517693|P1|NOT COMPLETED|Overall Study||13
7931406|NCT00551759|19517693|P1|COMPLETED|Overall Study||9
7931407|NCT00551759|19517693|P1|Received Adjuvant Therapy|Overall Study||12
7931408|NCT00551759|19517693|P1|Underwent Surgery|Overall Study||17
7931409|NCT00551759|19517693|P1|Eligible and Began Treatment|Overall Study||21
7931410|NCT00551759|19517693|P1|STARTED|Overall Study||22
7931411|NCT00551746|19517699|P2|NOT COMPLETED|Overall Study||8
7931412|NCT00551746|19517700|P1|NOT COMPLETED|Overall Study||11
7931413|NCT00551746|19517699|P2|COMPLETED|Overall Study||26
7931414|NCT00551746|19517700|P1|COMPLETED|Overall Study||25
7931415|NCT00551746|19517699|P2|STARTED|Overall Study||34
7931416|NCT00551746|19517700|P1|STARTED|Overall Study||36
7931417|NCT00551707|19517711|P5|NOT COMPLETED|Overall Study||1
7931418|NCT00551707|19517712|P4|NOT COMPLETED|Overall Study||4
7931419|NCT00551707|19517713|P3|NOT COMPLETED|Overall Study||3
7931420|NCT00551707|19517714|P2|NOT COMPLETED|Overall Study||6
7931421|NCT00551707|19517715|P1|NOT COMPLETED|Overall Study||0
7931422|NCT00551707|19517711|P5|COMPLETED|Overall Study||3
7931423|NCT00551707|19517712|P4|COMPLETED|Overall Study||4
7931424|NCT00551707|19517713|P3|COMPLETED|Overall Study||10
7931425|NCT00551707|19517714|P2|COMPLETED|Overall Study||16
7931426|NCT00551707|19517715|P1|COMPLETED|Overall Study||4
7931427|NCT00551707|19517711|P5|STARTED|Overall Study||4
7931428|NCT00551707|19517712|P4|STARTED|Overall Study||8
7931429|NCT00551707|19517713|P3|STARTED|Overall Study||13
7931430|NCT00551707|19517714|P2|STARTED|Overall Study||22
7931431|NCT00551707|19517715|P1|STARTED|Overall Study||4
7931432|NCT00551642|19517734|P2|NOT COMPLETED|Overall Study||63
7931433|NCT00551642|19517735|P1|NOT COMPLETED|Overall Study||61
7931434|NCT00551642|19517734|P2|COMPLETED|Overall Study||338
7931435|NCT00551642|19517735|P1|COMPLETED|Overall Study||338
7931436|NCT00551642|19517734|P2|STARTED|Overall Study||401
7931437|NCT00551642|19517735|P1|STARTED|Overall Study||399
7931438|NCT00551525|19517741|P1|NOT COMPLETED|Overall Study||5
7931439|NCT00551525|19517741|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study|62
7931440|NCT00551525|19517741|P1|STARTED|Overall Study||67
7931441|NCT00551460|19517750|P1|NOT COMPLETED|Overall Study||18
7931442|NCT00551460|19517750|P1|COMPLETED|Overall Study||60
7931443|NCT00551460|19517750|P1|STARTED|Overall Study||78
7931444|NCT00551421|19517756|P1|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1
7931445|NCT00551421|19517756|P1|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13
7931446|NCT00551421|19517756|P1|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14
7931447|NCT00551421|19517756|P1|NOT COMPLETED|Original Protocol, Dose Level 1||0
7931448|NCT00551421|19517756|P1|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3
7931449|NCT00551421|19517756|P1|STARTED|Original Protocol, Dose Level 1||3
7931450|NCT00551369|19517763|P1|NOT COMPLETED|Overall Study||7
7931451|NCT00551369|19517763|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26
7931452|NCT00551369|19517763|P1|STARTED|Overall Study||33
7931453|NCT00551291|19517772|P1|NOT COMPLETED|Overall Study||1
7931454|NCT00551291|19517772|P1|COMPLETED|Overall Study||9
7931455|NCT00551291|19517772|P1|STARTED|Overall Study||10
7931456|NCT00551213|19517780|P2|NOT COMPLETED|Overall Study||17
7931457|NCT00551213|19517781|P1|NOT COMPLETED|Overall Study||50
7931458|NCT00551213|19517780|P2|COMPLETED|Overall Study||0
7931459|NCT00551213|19517781|P1|COMPLETED|Overall Study||0
7931460|NCT00551213|19517780|P2|Treated|Overall Study||15
7931461|NCT00551213|19517781|P1|Treated|Overall Study||49
7931462|NCT00551213|19517780|P2|STARTED|Overall Study||17
7931463|NCT00551213|19517781|P1|STARTED|Overall Study||50
7931464|NCT00551200|19517797|P1|NOT COMPLETED|Overall Study||4
7931465|NCT00551200|19517797|P1|COMPLETED|Overall Study||10
7931466|NCT00551200|19517797|P1|STARTED|Overall Study||14
7931467|NCT00551174|19517812|P2|NOT COMPLETED|Overall Study||6
7931468|NCT00551174|19517813|P1|NOT COMPLETED|Overall Study||19
7931469|NCT00551174|19517812|P2|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394
7931470|NCT00551174|19517813|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362
7931471|NCT00551174|19517812|P2|STARTED|Overall Study||400
7931472|NCT00551174|19517813|P1|STARTED|Overall Study||381
7931473|NCT00551161|19517825|P1|NOT COMPLETED|Overall Study||1
7931474|NCT00551161|19517825|P1|COMPLETED|Overall Study||11
7931475|NCT00551161|19517825|P1|STARTED|Overall Study||12
7931476|NCT00551135|19517833|P4|NOT COMPLETED|Overall Study||5
7931477|NCT00551135|19517834|P3|NOT COMPLETED|Overall Study||5
7931478|NCT00551135|19517835|P2|NOT COMPLETED|Overall Study||2
7931479|NCT00551135|19517836|P1|NOT COMPLETED|Overall Study||5
7931480|NCT00551135|19517833|P4|COMPLETED|Overall Study||103
7931481|NCT00551135|19517834|P3|COMPLETED|Overall Study||98
7931482|NCT00551135|19517835|P2|COMPLETED|Overall Study||104
7931483|NCT00551135|19517836|P1|COMPLETED|Overall Study||103
7931484|NCT00551135|19517833|P4|STARTED|Overall Study||108
7931485|NCT00551135|19517834|P3|STARTED|Overall Study||103
7931486|NCT00551135|19517835|P2|STARTED|Overall Study||106
7931487|NCT00551135|19517836|P1|STARTED|Overall Study||108
7931488|NCT00551070|19517950|P1|NOT COMPLETED|Overall Study||0
7931489|NCT00551070|19517950|P1|COMPLETED|Overall Study||52
7931490|NCT00551070|19517950|P1|STARTED|Overall Study||52
7931491|NCT00551031|19517965|P5|NOT COMPLETED|Overall Study||1
7931492|NCT00551031|19517966|P4|NOT COMPLETED|Overall Study||3
7931493|NCT00551031|19517967|P3|NOT COMPLETED|Overall Study||2
7931494|NCT00551031|19517968|P2|NOT COMPLETED|Overall Study||11
7931495|NCT00551031|19517969|P1|NOT COMPLETED|Overall Study||2
7931496|NCT00551031|19517965|P5|COMPLETED|Overall Study||185
7931497|NCT00551031|19517966|P4|COMPLETED|Overall Study||317
7931498|NCT00551031|19517967|P3|COMPLETED|Overall Study||317
7931499|NCT00551031|19517968|P2|COMPLETED|Overall Study||625
7931500|NCT00551031|19517969|P1|COMPLETED|Overall Study||635
7931501|NCT00551031|19517965|P5|STARTED|Overall Study||186
7931502|NCT00551031|19517966|P4|STARTED|Overall Study||320
7931503|NCT00551031|19517967|P3|STARTED|Overall Study||319
7931504|NCT00551031|19517968|P2|STARTED|Overall Study||636
7931505|NCT00551031|19517969|P1|STARTED|Overall Study||637
7931506|NCT00550953|19517998|P2|NOT COMPLETED|Overall Study||6
7931507|NCT00550953|19517999|P1|NOT COMPLETED|Overall Study||6
7931508|NCT00550953|19517998|P2|COMPLETED|Overall Study||152
7931509|NCT00550953|19517999|P1|COMPLETED|Overall Study||150
7931510|NCT00550953|19517998|P2|STARTED|Overall Study||158
7931511|NCT00550953|19517999|P1|STARTED|Overall Study||156
7931512|NCT00550862|19518023|P4|NOT COMPLETED|Overall Study||1
7931513|NCT00550862|19518024|P3|NOT COMPLETED|Overall Study||16
7931514|NCT00550862|19518025|P2|NOT COMPLETED|Overall Study||6
7931515|NCT00550862|19518026|P1|NOT COMPLETED|Overall Study||6
7931516|NCT00550862|19518023|P4|COMPLETED|Overall Study||37
7931517|NCT00550862|19518024|P3|COMPLETED|Overall Study||25
7931518|NCT00550862|19518025|P2|COMPLETED|Overall Study||42
7931519|NCT00550862|19518026|P1|COMPLETED|Overall Study||32
7931520|NCT00550862|19518023|P4|STARTED|Overall Study||38
7931521|NCT00550862|19518024|P3|STARTED|Overall Study||41
7931522|NCT00550862|19518025|P2|STARTED|Overall Study||48
7931523|NCT00550862|19518026|P1|STARTED|Overall Study||38
7931524|NCT00550836|19518046|P2|NOT COMPLETED|Overall Study||9
7931525|NCT00550836|19518047|P1|NOT COMPLETED|Overall Study||3
7931526|NCT00550836|19518046|P2|COMPLETED|Overall Study||46
7931527|NCT00550836|19518047|P1|COMPLETED|Overall Study||46
7931528|NCT00550836|19518046|P2|STARTED|Overall Study||55
7931529|NCT00550836|19518047|P1|STARTED|Overall Study||49
7931530|NCT00550771|19518063|P2|NOT COMPLETED|Overall Study||10
7931531|NCT00550771|19518064|P1|NOT COMPLETED|Overall Study||17
7931532|NCT00550771|19518063|P2|COMPLETED|Overall Study||50
7931533|NCT00550771|19518064|P1|COMPLETED|Overall Study||104
7931534|NCT00550771|19518063|P2|STARTED|Overall Study||60
7931535|NCT00550771|19518064|P1|STARTED|Overall Study||121
7931536|NCT00550745|19518078|P2|NOT COMPLETED|Overall Study||60
7931537|NCT00550745|19518079|P1|NOT COMPLETED|Overall Study||87
7931538|NCT00550745|19518078|P2|COMPLETED|Overall Study||5939
7931539|NCT00550745|19518079|P1|COMPLETED|Overall Study||5913
7931540|NCT00550745|19518078|P2|STARTED|Overall Study||5999
7931541|NCT00550745|19518079|P1|STARTED|Overall Study||6000
7931542|NCT00550732|19518087|P1|NOT COMPLETED|Overall Study||11
7931543|NCT00550732|19518087|P1|COMPLETED|Overall Study||29
7931544|NCT00550732|19518087|P1|STARTED|Overall Study||40
7931545|NCT00550680|19518098|P1|NOT COMPLETED|Overall Study||56
7931546|NCT00550680|19518098|P1|COMPLETED|Overall Study||152
7931547|NCT00550680|19518098|P1|STARTED|Overall Study||208
7931548|NCT00550654|19518107|P1|NOT COMPLETED|Overall Study||0
7931549|NCT00550654|19518107|P1|COMPLETED|Overall Study||1
7931550|NCT00550654|19518107|P1|STARTED|Overall Study||1
7931551|NCT00550615|19518119|P4|NOT COMPLETED|Overall Study||10
7931552|NCT00550615|19518120|P3|NOT COMPLETED|Overall Study||4
7931553|NCT00550615|19518121|P2|NOT COMPLETED|Overall Study||0
7931554|NCT00550615|19518122|P1|NOT COMPLETED|Overall Study||0
7931555|NCT00550615|19518119|P4|COMPLETED|Overall Study||12
7931556|NCT00550615|19518120|P3|COMPLETED|Overall Study||6
7931557|NCT00550615|19518121|P2|COMPLETED|Overall Study||3
7931558|NCT00550615|19518122|P1|COMPLETED|Overall Study||3
7931559|NCT00550615|19518119|P4|STARTED|Overall Study||22
7931560|NCT00550615|19518120|P3|STARTED|Overall Study||10
7931561|NCT00550615|19518121|P2|STARTED|Overall Study||3
7931562|NCT00550615|19518122|P1|STARTED|Overall Study||3
7931563|NCT00550589|19518128|P1|NOT COMPLETED|Overall Study||0
7931564|NCT00550589|19518128|P1|COMPLETED|Overall Study||33
7931565|NCT00550589|19518128|P1|STARTED|Overall Study||33
7931566|NCT00550550|19518141|P2|NOT COMPLETED|Overall Study||29
7931567|NCT00550550|19518142|P1|NOT COMPLETED|Overall Study||34
7931568|NCT00550550|19518141|P2|COMPLETED|Overall Study||140
7931569|NCT00550550|19518142|P1|COMPLETED|Overall Study||142
7931570|NCT00550550|19518141|P2|Number Treated|Overall Study||169
7931571|NCT00550550|19518142|P1|Number Treated|Overall Study||175
7931572|NCT00550550|19518141|P2|STARTED|Overall Study||169
7931573|NCT00550550|19518142|P1|STARTED|Overall Study||176
7931574|NCT00550537|19518154|P1|NOT COMPLETED|Overall Study||104
7931575|NCT00550537|19518154|P1|COMPLETED|Overall Study||12
7931576|NCT00550537|19518154|P1|STARTED|Overall Study||116
7931577|NCT00550459|19518171|P2|NOT COMPLETED|Overall Study||3
7931578|NCT00550459|19518172|P1|NOT COMPLETED|Overall Study||1
7931579|NCT00550459|19518171|P2|COMPLETED|Overall Study||26
7931580|NCT00550459|19518172|P1|COMPLETED|Overall Study||27
7931581|NCT00550459|19518171|P2|STARTED|Overall Study||29
7931582|NCT00550459|19518172|P1|STARTED|Overall Study||28
7931583|NCT00550446|19518241|P11|NOT COMPLETED|Post Week 12||1
7931584|NCT00550446|19518242|P10|NOT COMPLETED|Post Week 12||7
7931585|NCT00550446|19518243|P9|NOT COMPLETED|Post Week 12||2
7931586|NCT00550446|19518244|P8|NOT COMPLETED|Post Week 12||1
7931587|NCT00550446|19518245|P7|NOT COMPLETED|Post Week 12||2
7931588|NCT00550446|19518246|P6|NOT COMPLETED|Post Week 12||1
7931589|NCT00550446|19518247|P5|NOT COMPLETED|Post Week 12||2
7931590|NCT00550446|19518248|P4|NOT COMPLETED|Post Week 12||3
7931591|NCT00550446|19518249|P3|NOT COMPLETED|Post Week 12||3
7931592|NCT00550446|19518250|P2|NOT COMPLETED|Post Week 12||2
7931593|NCT00550446|19518251|P1|NOT COMPLETED|Post Week 12||3
7931594|NCT00550446|19518241|P11|COMPLETED|Post Week 12||24
7931595|NCT00550446|19518242|P10|COMPLETED|Post Week 12||37
7931596|NCT00550446|19518243|P9|COMPLETED|Post Week 12||15
7931597|NCT00550446|19518244|P8|COMPLETED|Post Week 12||16
7931598|NCT00550446|19518245|P7|COMPLETED|Post Week 12||19
7931599|NCT00550446|19518246|P6|COMPLETED|Post Week 12||0
7931600|NCT00550446|19518247|P5|COMPLETED|Post Week 12||52
7931601|NCT00550446|19518248|P4|COMPLETED|Post Week 12||55
7931602|NCT00550446|19518249|P3|COMPLETED|Post Week 12||43
7931603|NCT00550446|19518250|P2|COMPLETED|Post Week 12||28
7931604|NCT00550446|19518251|P1|COMPLETED|Post Week 12||24
7931605|NCT00550446|19518241|P11|STARTED|Post Week 12||25
7931606|NCT00550446|19518242|P10|STARTED|Post Week 12||44
7931607|NCT00550446|19518243|P9|STARTED|Post Week 12||17
7931608|NCT00550446|19518244|P8|STARTED|Post Week 12||17
7931609|NCT00550446|19518245|P7|STARTED|Post Week 12||21
7931610|NCT00550446|19518246|P6|STARTED|Post Week 12||1
7931611|NCT00550446|19518247|P5|STARTED|Post Week 12||54
7931612|NCT00550446|19518248|P4|STARTED|Post Week 12||58
7931613|NCT00550446|19518249|P3|STARTED|Post Week 12||46
7931614|NCT00550446|19518250|P2|STARTED|Post Week 12||30
7931615|NCT00550446|19518251|P1|STARTED|Post Week 12||27
7931616|NCT00550446|19518241|P11|NOT COMPLETED|Up To Week 12||0
7931617|NCT00550446|19518242|P10|NOT COMPLETED|Up To Week 12||0
7931618|NCT00550446|19518243|P9|NOT COMPLETED|Up To Week 12||0
7931619|NCT00550446|19518244|P8|NOT COMPLETED|Up To Week 12||0
7931620|NCT00550446|19518245|P7|NOT COMPLETED|Up To Week 12||13
7931621|NCT00550446|19518246|P6|NOT COMPLETED|Up To Week 12||8
7931622|NCT00550446|19518247|P5|NOT COMPLETED|Up To Week 12||3
7931623|NCT00550446|19518248|P4|NOT COMPLETED|Up To Week 12||3
7931624|NCT00550446|19518249|P3|NOT COMPLETED|Up To Week 12||4
7931625|NCT00550446|19518250|P2|NOT COMPLETED|Up To Week 12||5
7931626|NCT00550446|19518251|P1|NOT COMPLETED|Up To Week 12||10
7931627|NCT00550446|19518241|P11|COMPLETED|Up To Week 12||0
7931628|NCT00550446|19518242|P10|COMPLETED|Up To Week 12||0
7931629|NCT00550446|19518243|P9|COMPLETED|Up To Week 12||0
7931630|NCT00550446|19518244|P8|COMPLETED|Up To Week 12||0
7931631|NCT00550446|19518245|P7|COMPLETED|Up To Week 12||46
7931632|NCT00550446|19518246|P6|COMPLETED|Up To Week 12||45
7931633|NCT00550446|19518247|P5|COMPLETED|Up To Week 12||54
7931634|NCT00550446|19518248|P4|COMPLETED|Up To Week 12||58
7931635|NCT00550446|19518249|P3|COMPLETED|Up To Week 12||46
7931636|NCT00550446|19518250|P2|COMPLETED|Up To Week 12||47
7931637|NCT00550446|19518251|P1|COMPLETED|Up To Week 12||44
7931638|NCT00550446|19518241|P11|Treated|Up To Week 12||0
7931639|NCT00550446|19518242|P10|Treated|Up To Week 12||0
7931640|NCT00550446|19518243|P9|Treated|Up To Week 12||0
7931641|NCT00550446|19518244|P8|Treated|Up To Week 12||0
7931642|NCT00550446|19518245|P7|Treated|Up To Week 12||59
7931643|NCT00550446|19518246|P6|Treated|Up To Week 12||53
7931644|NCT00550446|19518247|P5|Treated|Up To Week 12||57
7931645|NCT00550446|19518248|P4|Treated|Up To Week 12||61
7931646|NCT00550446|19518249|P3|Treated|Up To Week 12||49
7931647|NCT00550446|19518250|P2|Treated|Up To Week 12||51
7931648|NCT00550446|19518251|P1|Treated|Up To Week 12||54
7931649|NCT00550446|19518241|P11|STARTED|Up To Week 12||0
7931650|NCT00550446|19518242|P10|STARTED|Up To Week 12||0
7931651|NCT00550446|19518243|P9|STARTED|Up To Week 12||0
7931652|NCT00550446|19518244|P8|STARTED|Up To Week 12||0
7931653|NCT00550446|19518245|P7|STARTED|Up To Week 12||59
7931654|NCT00550446|19518246|P6|STARTED|Up To Week 12||53
7931655|NCT00550446|19518247|P5|STARTED|Up To Week 12||57
7931656|NCT00550446|19518248|P4|STARTED|Up To Week 12||61
7931657|NCT00550446|19518249|P3|STARTED|Up To Week 12||50
7931658|NCT00550446|19518250|P2|STARTED|Up To Week 12||52
7931659|NCT00550446|19518251|P1|STARTED|Up To Week 12||54
7931660|NCT00550420|19518683|P1|NOT COMPLETED|Overall Study||305
7931661|NCT00550420|19518683|P1|COMPLETED|Overall Study||26
7931662|NCT00550420|19518683|P1|STARTED|Overall Study||331
7931663|NCT00550407|19518706|P3|NOT COMPLETED|26-Week Randomized Phase||24
7931664|NCT00550407|19518707|P2|NOT COMPLETED|26-Week Randomized Phase||43
7931665|NCT00550407|19518708|P1|NOT COMPLETED|26-Week Randomized Phase||0
7931666|NCT00550407|19518706|P3|COMPLETED|26-Week Randomized Phase||21
7931667|NCT00550407|19518707|P2|COMPLETED|26-Week Randomized Phase||15
7931668|NCT00550407|19518708|P1|COMPLETED|26-Week Randomized Phase||0
7931669|NCT00550407|19518706|P3|STARTED|26-Week Randomized Phase||45
7931670|NCT00550407|19518707|P2|STARTED|26-Week Randomized Phase||58
7931671|NCT00550407|19518708|P1|STARTED|26-Week Randomized Phase||0
7931672|NCT00550407|19518706|P3|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
7931673|NCT00550407|19518707|P2|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
7931674|NCT00550407|19518708|P1|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112
7931675|NCT00550407|19518706|P3|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
7931676|NCT00550407|19518707|P2|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
7931677|NCT00550407|19518708|P1|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103
7931678|NCT00550407|19518706|P3|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
7931679|NCT00550407|19518707|P2|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
7931680|NCT00550407|19518708|P1|STARTED|8-16 Week Preliminary (Open-Label) Phase||215
7931681|NCT00550394|19518743|P2|NOT COMPLETED|Overall Study||13
7931682|NCT00550394|19518744|P1|NOT COMPLETED|Overall Study||12
7931683|NCT00550394|19518743|P2|COMPLETED|Overall Study||5
7931684|NCT00550394|19518744|P1|COMPLETED|Overall Study||9
7931685|NCT00550394|19518743|P2|STARTED|Overall Study||18
7931686|NCT00550394|19518744|P1|STARTED|Overall Study||21
7931687|NCT00550368|19518758|P2|NOT COMPLETED|Overall Study||0
7931688|NCT00550368|19518759|P1|NOT COMPLETED|Overall Study||0
7931689|NCT00550368|19518758|P2|COMPLETED|Overall Study||19
7931690|NCT00550368|19518759|P1|COMPLETED|Overall Study||26
7931691|NCT00550368|19518758|P2|STARTED|Overall Study||19
7931692|NCT00550368|19518759|P1|STARTED|Overall Study||26
7931693|NCT00550290|19518769|P2|NOT COMPLETED|Overall Study||0
7931694|NCT00550290|19518770|P1|NOT COMPLETED|Overall Study||0
7931695|NCT00550290|19518769|P2|COMPLETED|Overall Study||8
7931696|NCT00550290|19518770|P1|COMPLETED|Overall Study||10
7931697|NCT00550290|19518769|P2|STARTED|Overall Study||8
7931698|NCT00550290|19518770|P1|STARTED|Overall Study||10
7931699|NCT00550277|19518776|P1|NOT COMPLETED|Overall Study||9
7931700|NCT00550277|19518776|P1|COMPLETED|Overall Study||11
7931701|NCT00550277|19518776|P1|STARTED|Overall Study||20
7931702|NCT00550238|19518780|P1|NOT COMPLETED|Overall Study||459
7931703|NCT00550238|19518780|P1|COMPLETED|Overall Study||0
7931704|NCT00550238|19518780|P1|STARTED|Overall Study||459
7931705|NCT00550173|19518787|P3|NOT COMPLETED|Overall Study||73
7931706|NCT00550173|19518788|P2|NOT COMPLETED|Overall Study||63
7931707|NCT00550173|19518789|P1|NOT COMPLETED|Overall Study||72
7931708|NCT00550173|19518787|P3|COMPLETED|Overall Study||11
7931709|NCT00550173|19518788|P2|COMPLETED|Overall Study||19
7931710|NCT00550173|19518789|P1|COMPLETED|Overall Study||9
7931711|NCT00550173|19518787|P3|Not Discontinued at 18 Months|Overall Study||11
7931712|NCT00550173|19518788|P2|Not Discontinued at 18 Months|Overall Study||19
7931713|NCT00550173|19518789|P1|Not Discontinued at 18 Months|Overall Study||9
7931714|NCT00550173|19518787|P3|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80
7931715|NCT00550173|19518788|P2|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82
7931716|NCT00550173|19518789|P1|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78
7931717|NCT00550173|19518787|P3|STARTED|Overall Study||84
7931718|NCT00550173|19518788|P2|STARTED|Overall Study||82
7931719|NCT00550173|19518789|P1|STARTED|Overall Study||81
7931720|NCT00550147|19518818|P1|NOT COMPLETED|Quetiapine Addition Treatment Period||6
7931721|NCT00550147|19518818|P1|COMPLETED|Quetiapine Addition Treatment Period||18
7931722|NCT00550147|19518818|P1|STARTED|Quetiapine Addition Treatment Period||24
7931723|NCT00550147|19518818|P1|NOT COMPLETED|OROS Methylphenidate Monotherapy||6
7931724|NCT00550147|19518818|P1|COMPLETED|OROS Methylphenidate Monotherapy||24
7931725|NCT00550147|19518818|P1|STARTED|OROS Methylphenidate Monotherapy||30
7931726|NCT00550043|19518841|P5|NOT COMPLETED|Overall Study||1
7931727|NCT00550043|19518842|P4|NOT COMPLETED|Overall Study||2
7931728|NCT00550043|19518843|P3|NOT COMPLETED|Overall Study||1
7931729|NCT00550043|19518844|P2|NOT COMPLETED|Overall Study||3
7931730|NCT00550043|19518845|P1|NOT COMPLETED|Overall Study||0
7931731|NCT00550043|19518841|P5|COMPLETED|Overall Study||9
7931732|NCT00550043|19518842|P4|COMPLETED|Overall Study||8
7931733|NCT00550043|19518843|P3|COMPLETED|Overall Study||8
7931734|NCT00550043|19518844|P2|COMPLETED|Overall Study||9
7931735|NCT00550043|19518845|P1|COMPLETED|Overall Study||9
7931736|NCT00550043|19518841|P5|STARTED|Overall Study||10
7931737|NCT00550043|19518842|P4|STARTED|Overall Study||10
7931738|NCT00550043|19518843|P3|STARTED|Overall Study||9
7931739|NCT00550043|19518844|P2|STARTED|Overall Study||12
7931740|NCT00550043|19518845|P1|STARTED|Overall Study||9
7931741|NCT00549939|19518900|P3|NOT COMPLETED|40-week Open Label Treatment Period||5
7931742|NCT00549939|19518901|P2|NOT COMPLETED|40-week Open Label Treatment Period||5
7931743|NCT00549939|19518902|P1|NOT COMPLETED|40-week Open Label Treatment Period||0
7931744|NCT00549939|19518900|P3|COMPLETED|40-week Open Label Treatment Period||78
7931745|NCT00549939|19518901|P2|COMPLETED|40-week Open Label Treatment Period||75
7931746|NCT00549939|19518902|P1|COMPLETED|40-week Open Label Treatment Period||0
7931747|NCT00549939|19518900|P3|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83
7931748|NCT00549939|19518901|P2|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80
7931749|NCT00549939|19518902|P1|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0
7931750|NCT00549939|19518900|P3|NOT COMPLETED|12-week Double Blind Treatment Period||2
7931751|NCT00549939|19518901|P2|NOT COMPLETED|12-week Double Blind Treatment Period||2
7931752|NCT00549939|19518902|P1|NOT COMPLETED|12-week Double Blind Treatment Period||1
7931753|NCT00549939|19518900|P3|COMPLETED|12-week Double Blind Treatment Period||56
7931754|NCT00549939|19518901|P2|COMPLETED|12-week Double Blind Treatment Period||55
7931755|NCT00549939|19518902|P1|COMPLETED|12-week Double Blind Treatment Period||56
7931756|NCT00549939|19518900|P3|STARTED|12-week Double Blind Treatment Period||58
7931757|NCT00549939|19518901|P2|STARTED|12-week Double Blind Treatment Period||57
7931758|NCT00549939|19518902|P1|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57
7931759|NCT00549900|19518929|P1|NOT COMPLETED|Overall Study||1
7931760|NCT00549900|19518929|P1|COMPLETED|Overall Study||29
7931761|NCT00549900|19518929|P1|STARTED|Overall Study||30
7931762|NCT00549822|19518938|P1|NOT COMPLETED|Overall Study||0
7931763|NCT00549822|19518938|P1|COMPLETED|Overall Study||3
7931764|NCT00549822|19518938|P1|STARTED|Overall Study||3
7931765|NCT00549783|19518946|P2|NOT COMPLETED|Overall Study||13
7931766|NCT00549783|19518947|P1|NOT COMPLETED|Overall Study||8
7931767|NCT00549783|19518946|P2|COMPLETED|Overall Study||122
7931768|NCT00549783|19518947|P1|COMPLETED|Overall Study||131
7931769|NCT00549783|19518946|P2|STARTED|Overall Study||135
7931770|NCT00549783|19518947|P1|STARTED|Overall Study||139
7931771|NCT00549770|19518985|P8|NOT COMPLETED|Overall Study||25
7931772|NCT00549770|19518986|P7|NOT COMPLETED|Overall Study||14
7931773|NCT00549770|19518987|P6|NOT COMPLETED|Overall Study||13
7931774|NCT00549770|19518988|P5|NOT COMPLETED|Overall Study||17
7931775|NCT00549770|19518989|P4|NOT COMPLETED|Overall Study||16
7931776|NCT00549770|19518990|P3|NOT COMPLETED|Overall Study||10
7931777|NCT00549770|19518991|P2|NOT COMPLETED|Overall Study||11
7931778|NCT00549770|19518992|P1|NOT COMPLETED|Overall Study||7
7931779|NCT00549770|19518985|P8|COMPLETED|Overall Study||148
7931780|NCT00549770|19518986|P7|COMPLETED|Overall Study||151
7931781|NCT00549770|19518987|P6|COMPLETED|Overall Study||151
7931782|NCT00549770|19518988|P5|COMPLETED|Overall Study||149
7931783|NCT00549770|19518989|P4|COMPLETED|Overall Study||147
7931784|NCT00549770|19518990|P3|COMPLETED|Overall Study||162
7931785|NCT00549770|19518991|P2|COMPLETED|Overall Study||158
7931786|NCT00549770|19518992|P1|COMPLETED|Overall Study||149
7931787|NCT00549770|19518985|P8|Ambulatory Blood Pressure Monitoring|Overall Study||57
7931788|NCT00549770|19518986|P7|Ambulatory Blood Pressure Monitoring|Overall Study||50
7931789|NCT00549770|19518987|P6|Ambulatory Blood Pressure Monitoring|Overall Study||54
7931790|NCT00549770|19518988|P5|Ambulatory Blood Pressure Monitoring|Overall Study||49
7931791|NCT00549770|19518989|P4|Ambulatory Blood Pressure Monitoring|Overall Study||55
7931792|NCT00549770|19518990|P3|Ambulatory Blood Pressure Monitoring|Overall Study||53
7931793|NCT00549770|19518991|P2|Ambulatory Blood Pressure Monitoring|Overall Study||61
7931794|NCT00549770|19518992|P1|Ambulatory Blood Pressure Monitoring|Overall Study||48
7931795|NCT00549770|19518985|P8|Intent-to-treat Population|Overall Study||172
7931796|NCT00549770|19518986|P7|Intent-to-treat Population|Overall Study||164
7931797|NCT00549770|19518987|P6|Intent-to-treat Population|Overall Study||163
7931798|NCT00549770|19518988|P5|Intent-to-treat Population|Overall Study||163
7931799|NCT00549770|19518989|P4|Intent-to-treat Population|Overall Study||163
7931800|NCT00549770|19518990|P3|Intent-to-treat Population|Overall Study||170
7931801|NCT00549770|19518991|P2|Intent-to-treat Population|Overall Study||168
7931802|NCT00549770|19518992|P1|Intent-to-treat Population|Overall Study||154
7931803|NCT00549770|19518985|P8|STARTED|Overall Study||173
7931804|NCT00549770|19518986|P7|STARTED|Overall Study||165
7931805|NCT00549770|19518987|P6|STARTED|Overall Study||164
7931806|NCT00549770|19518988|P5|STARTED|Overall Study||166
7931807|NCT00549770|19518989|P4|STARTED|Overall Study||163
7931808|NCT00549770|19518990|P3|STARTED|Overall Study||172
7931809|NCT00549770|19518991|P2|STARTED|Overall Study||169
7931810|NCT00549770|19518992|P1|STARTED|Overall Study||156
7931811|NCT00549757|19519076|P2|NOT COMPLETED|Extension Period (in Average 9 Months)||635
7931812|NCT00549757|19519077|P1|NOT COMPLETED|Extension Period (in Average 9 Months)||625
7931813|NCT00549757|19519076|P2|COMPLETED|Extension Period (in Average 9 Months)||3182
7931814|NCT00549757|19519077|P1|COMPLETED|Extension Period (in Average 9 Months)||3148
7931815|NCT00549757|19519076|P2|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817
7931816|NCT00549757|19519077|P1|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773
7931817|NCT00549757|19519076|P2|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310
7931818|NCT00549757|19519077|P1|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296
7931819|NCT00549757|19519076|P2|COMPLETED|Active Treatment Phase: Max. 50 Months||0
7931820|NCT00549757|19519077|P1|COMPLETED|Active Treatment Phase: Max. 50 Months||0
7931821|NCT00549757|19519076|P2|Safety Set|Active Treatment Phase: Max. 50 Months||4285
7931822|NCT00549757|19519077|P1|Safety Set|Active Treatment Phase: Max. 50 Months||4272
7931823|NCT00549757|19519076|P2|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287
7931824|NCT00549757|19519077|P1|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274
7931825|NCT00549757|19519076|P2|STARTED|Active Treatment Phase: Max. 50 Months||4310
7931826|NCT00549757|19519077|P1|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296
7931827|NCT00549718|19519139|P4|NOT COMPLETED|Overall Study||55
7931828|NCT00549718|19519140|P3|NOT COMPLETED|Overall Study||39
7931829|NCT00549718|19519141|P2|NOT COMPLETED|Overall Study||37
7931830|NCT00549718|19519142|P1|NOT COMPLETED|Overall Study||41
7931831|NCT00549718|19519139|P4|COMPLETED|Overall Study||73
7931832|NCT00549718|19519140|P3|COMPLETED|Overall Study||85
7931833|NCT00549718|19519141|P2|COMPLETED|Overall Study||86
7931834|NCT00549718|19519142|P1|COMPLETED|Overall Study||84
7931835|NCT00549718|19519139|P4|STARTED|Overall Study||128
7931836|NCT00549718|19519140|P3|STARTED|Overall Study||124
7931837|NCT00549718|19519141|P2|STARTED|Overall Study||123
7931838|NCT00549718|19519142|P1|STARTED|Overall Study||125
7931839|NCT00549640|19519158|P2|NOT COMPLETED|Overall Study||16
7931840|NCT00549640|19519159|P1|NOT COMPLETED|Overall Study||18
7931841|NCT00549640|19519158|P2|COMPLETED|Overall Study||24
7931842|NCT00549640|19519159|P1|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22
7931843|NCT00549640|19519158|P2|STARTED|Overall Study||40
7931844|NCT00549640|19519159|P1|STARTED|Overall Study||40
7931845|NCT00549601|19519172|P3|NOT COMPLETED|Received Study Drug||4
7931846|NCT00549601|19519173|P2|NOT COMPLETED|Received Study Drug||11
7931847|NCT00549601|19519174|P1|NOT COMPLETED|Received Study Drug||7
7931848|NCT00549601|19519172|P3|COMPLETED|Received Study Drug||45
7931849|NCT00549601|19519173|P2|COMPLETED|Received Study Drug||36
7931850|NCT00549601|19519174|P1|COMPLETED|Received Study Drug||36
7931851|NCT00549601|19519172|P3|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49
7931852|NCT00549601|19519173|P2|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47
7931853|NCT00549601|19519174|P1|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43
7931854|NCT00549601|19519172|P3|NOT COMPLETED|Randomized||2
7931855|NCT00549601|19519173|P2|NOT COMPLETED|Randomized||1
7931856|NCT00549601|19519174|P1|NOT COMPLETED|Randomized||0
7931857|NCT00549601|19519172|P3|COMPLETED|Randomized||49
7931858|NCT00549601|19519173|P2|COMPLETED|Randomized||47
7931859|NCT00549601|19519174|P1|COMPLETED|Randomized||43
7931860|NCT00549601|19519172|P3|STARTED|Randomized||51
7931861|NCT00549601|19519173|P2|STARTED|Randomized||48
7931862|NCT00549601|19519174|P1|STARTED|Randomized||43
7931863|NCT00549562|19519196|P1|NOT COMPLETED|Overall Study||2
7931864|NCT00549562|19519196|P1|COMPLETED|Overall Study||23
7931865|NCT00549562|19519196|P1|STARTED|Overall Study||25
7931866|NCT00549549|19519208|P4|NOT COMPLETED|Overall Study||25
7931867|NCT00549549|19519209|P3|NOT COMPLETED|Overall Study||17
7931868|NCT00549549|19519210|P2|NOT COMPLETED|Overall Study||22
7931869|NCT00549549|19519211|P1|NOT COMPLETED|Overall Study||24
7931870|NCT00549549|19519208|P4|COMPLETED|Overall Study||78
7931871|NCT00549549|19519209|P3|COMPLETED|Overall Study||82
7931872|NCT00549549|19519210|P2|COMPLETED|Overall Study||77
7931873|NCT00549549|19519211|P1|COMPLETED|Overall Study||77
7931874|NCT00549549|19519208|P4|Treated|Overall Study||102
7931875|NCT00549549|19519209|P3|Treated|Overall Study||98
7931876|NCT00549549|19519210|P2|Treated|Overall Study||99
7931877|NCT00549549|19519211|P1|Treated|Overall Study||101
7931878|NCT00549549|19519208|P4|STARTED|Overall Study||103
7931879|NCT00549549|19519209|P3|STARTED|Overall Study||99
7931880|NCT00549549|19519210|P2|STARTED|Overall Study||99
7931881|NCT00549549|19519211|P1|STARTED|Overall Study||101
7931882|NCT00549445|19519279|P2|NOT COMPLETED|Overall Study||17
7931883|NCT00549445|19519280|P1|NOT COMPLETED|Overall Study||15
7931884|NCT00549445|19519279|P2|COMPLETED|Overall Study||13
7931885|NCT00549445|19519280|P1|COMPLETED|Overall Study||8
7931886|NCT00549445|19519279|P2|STARTED|Overall Study||30
7931887|NCT00549445|19519280|P1|STARTED|Overall Study||23
7931888|NCT00549393|19519288|P2|NOT COMPLETED|Period 3 (6 Months)||0
7931889|NCT00549393|19519289|P1|NOT COMPLETED|Period 3 (6 Months)||0
7931890|NCT00549393|19519288|P2|COMPLETED|Period 3 (6 Months)||1326
7931891|NCT00549393|19519289|P1|COMPLETED|Period 3 (6 Months)||1103
7931892|NCT00549393|19519288|P2|Per Protocol|Period 3 (6 Months)||1326
7931893|NCT00549393|19519289|P1|Per Protocol|Period 3 (6 Months)||667
7931894|NCT00549393|19519288|P2|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1326
7931895|NCT00549393|19519289|P1|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1103
7931896|NCT00549393|19519288|P2|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
7931897|NCT00549393|19519289|P1|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
7931898|NCT00549393|19519288|P2|COMPLETED|Period 2 Washout (2 Weeks)||0
7931899|NCT00549393|19519289|P1|COMPLETED|Period 2 Washout (2 Weeks)||0
7931900|NCT00549393|19519288|P2|STARTED|Period 2 Washout (2 Weeks)||0
7931901|NCT00549393|19519289|P1|STARTED|Period 2 Washout (2 Weeks)||0
7931902|NCT00549393|19519288|P2|NOT COMPLETED|Period 1 (6 Months)||0
7931903|NCT00549393|19519289|P1|NOT COMPLETED|Period 1 (6 Months)||0
7931904|NCT00549393|19519288|P2|COMPLETED|Period 1 (6 Months)||1199
7931905|NCT00549393|19519289|P1|COMPLETED|Period 1 (6 Months)||1319
7931906|NCT00549393|19519288|P2|Per Protocol|Period 1 (6 Months)||1199
7931907|NCT00549393|19519289|P1|Per Protocol|Period 1 (6 Months)||880
7931908|NCT00549393|19519288|P2|STARTED|Period 1 (6 Months)|ITT|1199
7931909|NCT00549393|19519289|P1|STARTED|Period 1 (6 Months)|intention to treat (ITT)|1319
7931910|NCT00549328|19519299|P1|NOT COMPLETED|Overall Study||14
7931911|NCT00549328|19519299|P1|COMPLETED|Overall Study||0
7931912|NCT00549328|19519299|P1|STARTED|Overall Study||14
7931913|NCT00549302|19519310|P3|NOT COMPLETED|Open-Label||69
7931914|NCT00549302|19519311|P2|NOT COMPLETED|Open-Label||0
7931915|NCT00549302|19519312|P1|NOT COMPLETED|Open-Label||0
7931916|NCT00549302|19519310|P3|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217
7931917|NCT00549302|19519311|P2|COMPLETED|Open-Label||0
7931918|NCT00549302|19519312|P1|COMPLETED|Open-Label||0
7931919|NCT00549302|19519310|P3|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286
7931920|NCT00549302|19519311|P2|STARTED|Open-Label||0
7931921|NCT00549302|19519312|P1|STARTED|Open-Label||0
7931922|NCT00549302|19519310|P3|NOT COMPLETED|Double-Blind||0
7931923|NCT00549302|19519311|P2|NOT COMPLETED|Double-Blind||53
7931924|NCT00549302|19519312|P1|NOT COMPLETED|Double-Blind||11
7931925|NCT00549302|19519310|P3|COMPLETED|Double-Blind||0
7931926|NCT00549302|19519311|P2|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241
7931927|NCT00549302|19519312|P1|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52
7931928|NCT00549302|19519310|P3|Received at Least One Dose of Study Drug|Double-Blind||0
7931929|NCT00549302|19519311|P2|Received at Least One Dose of Study Drug|Double-Blind||294
7931930|NCT00549302|19519312|P1|Received at Least One Dose of Study Drug|Double-Blind||63
7931931|NCT00549302|19519310|P3|STARTED|Double-Blind||0
7931932|NCT00549302|19519311|P2|STARTED|Double-Blind||294
7931933|NCT00549302|19519312|P1|STARTED|Double-Blind||63
7931934|NCT00549198|19519324|P2|NOT COMPLETED|Overall Study||63
7931935|NCT00549198|19519325|P1|NOT COMPLETED|Overall Study||80
7931936|NCT00549198|19519324|P2|COMPLETED|Overall Study||134
7931937|NCT00549198|19519325|P1|COMPLETED|Overall Study||115
7931938|NCT00549198|19519324|P2|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197
7931939|NCT00549198|19519325|P1|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195
7931940|NCT00549172|19519447|P2|NOT COMPLETED|Overall Study||0
7931941|NCT00549172|19519448|P1|NOT COMPLETED|Overall Study||0
7931942|NCT00549172|19519447|P2|COMPLETED|Overall Study||76
7931943|NCT00549172|19519448|P1|COMPLETED|Overall Study||70
7931944|NCT00549172|19519447|P2|STARTED|Overall Study||76
7931945|NCT00549172|19519448|P1|STARTED|Overall Study||70
7931946|NCT00549055|19519462|P1|NOT COMPLETED|Overall Study||35
7931947|NCT00549055|19519462|P1|COMPLETED|Overall Study||3
7931948|NCT00549055|19519462|P1|STARTED|Overall Study||38
7931949|NCT00549042|19519474|P2|NOT COMPLETED|Double-blind Phase||90
7931950|NCT00549042|19519475|P1|NOT COMPLETED|Double-blind Phase||68
7931951|NCT00549042|19519474|P2|COMPLETED|Double-blind Phase||44
7931952|NCT00549042|19519475|P1|COMPLETED|Double-blind Phase||66
7931953|NCT00549042|19519474|P2|STARTED|Double-blind Phase||134
7931954|NCT00549042|19519475|P1|STARTED|Double-blind Phase||134
7931955|NCT00549042|19519474|P2|NOT COMPLETED|Conversion and Titration Phase||0
7931956|NCT00549042|19519475|P1|NOT COMPLETED|Conversion and Titration Phase||191
7931957|NCT00549042|19519474|P2|COMPLETED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
7931958|NCT00549042|19519475|P1|COMPLETED|Conversion and Titration Phase||268
7931959|NCT00549042|19519474|P2|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
7931960|NCT00549042|19519475|P1|STARTED|Conversion and Titration Phase||459
7931961|NCT00548886|19519492|P1|NOT COMPLETED|Overall Study||0
7931962|NCT00548886|19519492|P1|COMPLETED|Overall Study||7
7931963|NCT00548886|19519492|P1|STARTED|Overall Study||7
7931964|NCT00548860|19519499|P2|NOT COMPLETED|Overall Study||175
7931965|NCT00548860|19519500|P1|NOT COMPLETED|Overall Study||136
7931966|NCT00548860|19519499|P2|COMPLETED|Overall Study||847
7931967|NCT00548860|19519500|P1|COMPLETED|Overall Study||860
7931968|NCT00548860|19519499|P2|STARTED|Overall Study||1022
7931969|NCT00548860|19519500|P1|STARTED|Overall Study||996
7931970|NCT00548847|19519506|P1|NOT COMPLETED|Overall Study||7
7931971|NCT00548847|19519506|P1|COMPLETED|Overall Study||8
7931972|NCT00548847|19519506|P1|STARTED|Overall Study||15
7931973|NCT00548808|19519513|P2|NOT COMPLETED|Overall Study||26
7931974|NCT00548808|19519514|P1|NOT COMPLETED|Overall Study||42
7931975|NCT00548808|19519513|P2|COMPLETED|Overall Study||186
7931976|NCT00548808|19519514|P1|COMPLETED|Overall Study||172
7931977|NCT00548808|19519513|P2|Per-Protocol Set|Overall Study||184
7931978|NCT00548808|19519514|P1|Per-Protocol Set|Overall Study||177
7931979|NCT00548808|19519513|P2|Full Analysis Set|Overall Study||212
7931980|NCT00548808|19519514|P1|Full Analysis Set|Overall Study||211
7931981|NCT00548808|19519513|P2|STARTED|Overall Study||212
7931982|NCT00548808|19519514|P1|STARTED|Overall Study||214
7931983|NCT00548717|19519538|P2|NOT COMPLETED|Overall Study||2
7931984|NCT00548717|19519539|P1|NOT COMPLETED|Overall Study||9
7931985|NCT00548717|19519538|P2|COMPLETED|Overall Study||0
7931986|NCT00548717|19519539|P1|COMPLETED|Overall Study||4
7931987|NCT00548717|19519538|P2|STARTED|Overall Study||2
7931988|NCT00548717|19519539|P1|STARTED|Overall Study||13
7931989|NCT00548691|19519558|P2|NOT COMPLETED|Overall Study||9
7931990|NCT00548691|19519559|P1|NOT COMPLETED|Overall Study||7
7931991|NCT00548691|19519558|P2|COMPLETED|Overall Study||250
7931992|NCT00548691|19519559|P1|COMPLETED|Overall Study||251
7931993|NCT00548691|19519558|P2|STARTED|Overall Study||259
7931994|NCT00548691|19519559|P1|STARTED|Overall Study||258
7931995|NCT00548652|19519568|P3|NOT COMPLETED|Overall Study||11
7931996|NCT00548652|19519569|P2|NOT COMPLETED|Overall Study||9
7931997|NCT00548652|19519570|P1|NOT COMPLETED|Overall Study||2
7931998|NCT00548652|19519568|P3|COMPLETED|Overall Study||34
7931999|NCT00548652|19519569|P2|COMPLETED|Overall Study||29
7932000|NCT00548652|19519570|P1|COMPLETED|Overall Study||16
7932001|NCT00548652|19519568|P3|STARTED|Overall Study||45
7932002|NCT00548652|19519569|P2|STARTED|Overall Study||38
7932003|NCT00548652|19519570|P1|STARTED|Overall Study||18
7932004|NCT00548548|19519583|P2|NOT COMPLETED|Overall Study||366
7932005|NCT00548548|19519584|P1|NOT COMPLETED|Overall Study||362
7932006|NCT00548548|19519583|P2|COMPLETED|Overall Study||21
7932007|NCT00548548|19519584|P1|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25
7932008|NCT00548548|19519583|P2|Safety Population|Overall Study||381
7932009|NCT00548548|19519584|P1|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386
7932010|NCT00548548|19519583|P2|Treated|Overall Study||384
7932011|NCT00548548|19519584|P1|Treated|Overall Study||383
7932012|NCT00548548|19519583|P2|STARTED|Overall Study||387
7932013|NCT00548548|19519584|P1|STARTED|Overall Study||387
7932014|NCT00548470|19519604|P1|NOT COMPLETED|Overall Study||2
7932015|NCT00548470|19519604|P1|COMPLETED|Overall Study||12
7932016|NCT00548470|19519604|P1|STARTED|Overall Study||14
7932017|NCT00548431|19519612|P1|NOT COMPLETED|Overall Study||0
7932018|NCT00548431|19519612|P1|COMPLETED|Overall Study||38
7932019|NCT00548431|19519612|P1|STARTED|Overall Study||38
7932020|NCT00548418|19519616|P1|NOT COMPLETED|Overall Study||0
7932021|NCT00548418|19519616|P1|COMPLETED|Overall Study||27
7932022|NCT00548418|19519616|P1|STARTED|Overall Study||27
7932023|NCT00548405|19519627|P3|NOT COMPLETED|Overall Study||9
7932024|NCT00548405|19519628|P2|NOT COMPLETED|Overall Study||20
7932025|NCT00548405|19519629|P1|NOT COMPLETED|Overall Study||56
7932026|NCT00548405|19519627|P3|COMPLETED|Overall Study||164
7932027|NCT00548405|19519628|P2|COMPLETED|Overall Study||416
7932028|NCT00548405|19519629|P1|COMPLETED|Overall Study||175
7932029|NCT00548405|19519627|P3|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170
7932030|NCT00548405|19519628|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426
7932031|NCT00548405|19519629|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202
7932032|NCT00548405|19519627|P3|STARTED|Overall Study|Randomized.|173
7932033|NCT00548405|19519628|P2|STARTED|Overall Study|Randomized.|436
7932034|NCT00548405|19519629|P1|STARTED|Overall Study|Randomized.|231
7932035|NCT00548340|19519650|P3|NOT COMPLETED|Overall Study||9
7932036|NCT00548340|19519651|P2|NOT COMPLETED|Overall Study||11
7932037|NCT00548340|19519652|P1|NOT COMPLETED|Overall Study||8
7932038|NCT00548340|19519650|P3|COMPLETED|Overall Study||95
7932039|NCT00548340|19519651|P2|COMPLETED|Overall Study||98
7932040|NCT00548340|19519652|P1|COMPLETED|Overall Study||101
7932041|NCT00548340|19519650|P3|STARTED|Overall Study||104
7932042|NCT00548340|19519651|P2|STARTED|Overall Study||109
7932043|NCT00548340|19519652|P1|STARTED|Overall Study||109
7932044|NCT00548327|19519671|P2|NOT COMPLETED|Overall Study||1
7932045|NCT00548327|19519672|P1|NOT COMPLETED|Overall Study||0
7932046|NCT00548327|19519671|P2|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4
7932047|NCT00548327|19519672|P1|COMPLETED|Overall Study||6
7932048|NCT00548327|19519671|P2|STARTED|Overall Study||5
7932049|NCT00548327|19519672|P1|STARTED|Overall Study||6
7932050|NCT00548262|19519690|P1|NOT COMPLETED|Overall Study||32
7932051|NCT00548262|19519690|P1|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22
7932052|NCT00548262|19519690|P1|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54
7932053|NCT00548249|19519720|P5|NOT COMPLETED|Overall Study||21
7932054|NCT00548249|19519721|P4|NOT COMPLETED|Overall Study||13
7932055|NCT00548249|19519722|P3|NOT COMPLETED|Overall Study||20
7932056|NCT00548249|19519723|P2|NOT COMPLETED|Overall Study||13
7932057|NCT00548249|19519724|P1|NOT COMPLETED|Overall Study||16
7932058|NCT00548249|19519720|P5|COMPLETED|Overall Study||7
7932059|NCT00548249|19519721|P4|COMPLETED|Overall Study||9
7932060|NCT00548249|19519722|P3|COMPLETED|Overall Study||9
7932061|NCT00548249|19519723|P2|COMPLETED|Overall Study||13
7932062|NCT00548249|19519724|P1|COMPLETED|Overall Study||10
7932063|NCT00548249|19519720|P5|STARTED|Overall Study||28
7932064|NCT00548249|19519721|P4|STARTED|Overall Study||22
7932065|NCT00548249|19519722|P3|STARTED|Overall Study||29
7932066|NCT00548249|19519723|P2|STARTED|Overall Study||26
7932067|NCT00548249|19519724|P1|STARTED|Overall Study||26
7932068|NCT00548197|19519763|P2|NOT COMPLETED|Overall Study||0
7932069|NCT00548197|19519764|P1|NOT COMPLETED|Overall Study||0
7932070|NCT00548197|19519763|P2|COMPLETED|Overall Study||22
7932071|NCT00548197|19519764|P1|COMPLETED|Overall Study||18
7932072|NCT00548197|19519763|P2|STARTED|Overall Study||22
7932073|NCT00548197|19519764|P1|STARTED|Overall Study||18
7932074|NCT00548184|19519772|P1|NOT COMPLETED|Overall Study||5
7932075|NCT00548184|19519772|P1|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60
7932076|NCT00548184|19519772|P1|STARTED|Overall Study||65
7932077|NCT00548171|19519778|P2|NOT COMPLETED|Overall Study||0
7932078|NCT00548171|19519779|P1|NOT COMPLETED|Overall Study||0
7932079|NCT00548171|19519778|P2|COMPLETED|Overall Study||39
7932080|NCT00548171|19519779|P1|COMPLETED|Overall Study||164
7932081|NCT00548171|19519778|P2|STARTED|Overall Study||39
7932082|NCT00548171|19519779|P1|STARTED|Overall Study||164
7932083|NCT00548145|19519820|P2|NOT COMPLETED|Overall Study||4
7932084|NCT00548145|19519821|P1|NOT COMPLETED|Overall Study||1
7932085|NCT00548145|19519820|P2|COMPLETED|Overall Study||16
7932086|NCT00548145|19519821|P1|COMPLETED|Overall Study||17
7932087|NCT00548145|19519820|P2|STARTED|Overall Study||20
7932088|NCT00548145|19519821|P1|STARTED|Overall Study||18
7932089|NCT00548132|19519829|P2|NOT COMPLETED|Overall Study||0
7932090|NCT00548132|19519830|P1|NOT COMPLETED|Overall Study||0
7932091|NCT00548132|19519829|P2|COMPLETED|Overall Study||554
7932092|NCT00548132|19519830|P1|COMPLETED|Overall Study||534
7932093|NCT00548132|19519829|P2|Consented to Study|Overall Study||554
7932094|NCT00548132|19519830|P1|Consented to Study|Overall Study||534
7932095|NCT00548132|19519829|P2|STARTED|Overall Study||554
7932096|NCT00548132|19519830|P1|STARTED|Overall Study||534
7932097|NCT00548093|19519840|P2|NOT COMPLETED|Overall Study||16
7932098|NCT00548093|19519841|P1|NOT COMPLETED|Overall Study||50
7932099|NCT00548093|19519840|P2|COMPLETED|Overall Study||0
7932100|NCT00548093|19519841|P1|COMPLETED|Overall Study||0
7932101|NCT00548093|19519840|P2|STARTED|Overall Study||16
7932102|NCT00548093|19519841|P1|STARTED|Overall Study||50
7932103|NCT00548041|19519871|P1|NOT COMPLETED|Overall Study||0
7932104|NCT00548041|19519871|P1|COMPLETED|Overall Study||100
7932105|NCT00548041|19519871|P1|STARTED|Overall Study||100
7932106|NCT00547911|19519879|P6|NOT COMPLETED|Overall Study||0
7932107|NCT00547911|19519880|P5|NOT COMPLETED|Overall Study||0
7932108|NCT00547911|19519881|P4|NOT COMPLETED|Overall Study||1
7932109|NCT00547911|19519882|P3|NOT COMPLETED|Overall Study||0
7932110|NCT00547911|19519883|P2|NOT COMPLETED|Overall Study||0
7932111|NCT00547911|19519884|P1|NOT COMPLETED|Overall Study||0
7932112|NCT00547911|19519879|P6|COMPLETED|Overall Study||3
7932113|NCT00547911|19519880|P5|COMPLETED|Overall Study||3
7932114|NCT00547911|19519881|P4|COMPLETED|Overall Study||1
7932115|NCT00547911|19519882|P3|COMPLETED|Overall Study||2
7932116|NCT00547911|19519883|P2|COMPLETED|Overall Study||2
7932117|NCT00547911|19519884|P1|COMPLETED|Overall Study||2
7932118|NCT00547911|19519879|P6|STARTED|Overall Study||3
7932119|NCT00547911|19519880|P5|STARTED|Overall Study||3
7932120|NCT00547911|19519881|P4|STARTED|Overall Study||2
7932121|NCT00547911|19519882|P3|STARTED|Overall Study||2
7932122|NCT00547911|19519883|P2|STARTED|Overall Study||2
7932123|NCT00547911|19519884|P1|STARTED|Overall Study||2
7932124|NCT00547898|19519917|P4|NOT COMPLETED|Overall Study||6
7932125|NCT00547898|19519918|P3|NOT COMPLETED|Overall Study||0
7932126|NCT00547898|19519919|P2|NOT COMPLETED|Overall Study||10
7932127|NCT00547898|19519920|P1|NOT COMPLETED|Overall Study||9
7932128|NCT00547898|19519917|P4|COMPLETED|Overall Study||40
7932129|NCT00547898|19519918|P3|COMPLETED|Overall Study||54
7932130|NCT00547898|19519919|P2|COMPLETED|Overall Study||126
7932131|NCT00547898|19519920|P1|COMPLETED|Overall Study||129
7932132|NCT00547898|19519917|P4|STARTED|Overall Study||46
7932133|NCT00547898|19519918|P3|STARTED|Overall Study||54
7932134|NCT00547898|19519919|P2|STARTED|Overall Study||136
7932135|NCT00547898|19519920|P1|STARTED|Overall Study||138
7932136|NCT00547703|19519934|P2|NOT COMPLETED|Overall Study||0
7932137|NCT00547703|19519935|P1|NOT COMPLETED|Overall Study||1
7932138|NCT00547703|19519934|P2|COMPLETED|Overall Study||1
7932139|NCT00547703|19519935|P1|COMPLETED|Overall Study||3
7932140|NCT00547703|19519934|P2|STARTED|Overall Study||1
7932141|NCT00547703|19519935|P1|STARTED|Overall Study||4
7932142|NCT00547638|19519943|P2|NOT COMPLETED|Overall Study||14
7932143|NCT00547638|19519944|P1|NOT COMPLETED|Overall Study||24
7932144|NCT00547638|19519943|P2|COMPLETED|Overall Study||59
7932145|NCT00547638|19519944|P1|COMPLETED|Overall Study||119
7932146|NCT00547638|19519943|P2|STARTED|Overall Study||73
7932147|NCT00547638|19519944|P1|STARTED|Overall Study||143
7932148|NCT00547586|19519965|P5|NOT COMPLETED|Overall Study||3
7932149|NCT00547586|19519966|P4|NOT COMPLETED|Overall Study||6
7932150|NCT00547586|19519967|P3|NOT COMPLETED|Overall Study||1
7932151|NCT00547586|19519968|P2|NOT COMPLETED|Overall Study||1
7932152|NCT00547586|19519969|P1|NOT COMPLETED|Overall Study||5
7932153|NCT00547586|19519965|P5|COMPLETED|Overall Study||32
7932154|NCT00547586|19519966|P4|COMPLETED|Overall Study||27
7932155|NCT00547586|19519967|P3|COMPLETED|Overall Study||13
7932156|NCT00547586|19519968|P2|COMPLETED|Overall Study||6
7932157|NCT00547586|19519969|P1|COMPLETED|Overall Study||28
7932158|NCT00547586|19519965|P5|STARTED|Overall Study||35
7932159|NCT00547586|19519966|P4|STARTED|Overall Study||33
7932160|NCT00547586|19519967|P3|STARTED|Overall Study||14
7932161|NCT00547586|19519968|P2|STARTED|Overall Study||7
7932162|NCT00547586|19519969|P1|STARTED|Overall Study||33
7932163|NCT00547534|19519981|P1|NOT COMPLETED|Overall Study||11
7932164|NCT00547534|19519981|P1|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19
7932165|NCT00547534|19519981|P1|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30
7932166|NCT00547521|19519989|P2|NOT COMPLETED|Long Term Extension (LTE) Study||31
7932167|NCT00547521|19519990|P1|NOT COMPLETED|Long Term Extension (LTE) Study||0
7932168|NCT00547521|19519989|P2|COMPLETED|Long Term Extension (LTE) Study||59
7932169|NCT00547521|19519990|P1|COMPLETED|Long Term Extension (LTE) Study||0
7932170|NCT00547521|19519989|P2|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90
7932171|NCT00547521|19519990|P1|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0
7932172|NCT00547521|19519989|P2|NOT COMPLETED|Short Term Study (4 Months)||4
7932173|NCT00547521|19519990|P1|NOT COMPLETED|Short Term Study (4 Months)||1
7932174|NCT00547521|19519989|P2|COMPLETED|Short Term Study (4 Months)||45
7932175|NCT00547521|19519990|P1|COMPLETED|Short Term Study (4 Months)||50
7932176|NCT00547521|19519989|P2|STARTED|Short Term Study (4 Months)|Number of participants treated.|49
7932177|NCT00547521|19519990|P1|STARTED|Short Term Study (4 Months)|Number of participants treated.|51
7932178|NCT00547456|19520060|P1|NOT COMPLETED|Overall Study||0
7932179|NCT00547456|19520060|P1|COMPLETED|Overall Study||20
7932180|NCT00547456|19520060|P1|STARTED|Overall Study||20
7932181|NCT00547378|19520067|P3|NOT COMPLETED|All Implanted Cohort||70
7932182|NCT00547378|19520068|P2|NOT COMPLETED|All Implanted Cohort||18
7932183|NCT00547378|19520069|P1|NOT COMPLETED|All Implanted Cohort||15
7932184|NCT00547378|19520067|P3|COMPLETED|All Implanted Cohort||111
7932185|NCT00547378|19520068|P2|COMPLETED|All Implanted Cohort||22
7932186|NCT00547378|19520069|P1|COMPLETED|All Implanted Cohort||36
7932187|NCT00547378|19520067|P3|Month 60|All Implanted Cohort||114
7932188|NCT00547378|19520068|P2|Month 60|All Implanted Cohort||23
7932189|NCT00547378|19520069|P1|Month 60|All Implanted Cohort||36
7932190|NCT00547378|19520067|P3|Month 48|All Implanted Cohort||136
7932191|NCT00547378|19520068|P2|Month 48|All Implanted Cohort||27
7932192|NCT00547378|19520069|P1|Month 48|All Implanted Cohort||38
7932193|NCT00547378|19520067|P3|Month 36|All Implanted Cohort||146
7932194|NCT00547378|19520068|P2|Month 36|All Implanted Cohort||29
7932195|NCT00547378|19520069|P1|Month 36|All Implanted Cohort||42
7932196|NCT00547378|19520067|P3|Month 24|All Implanted Cohort||161
7932197|NCT00547378|19520068|P2|Month 24|All Implanted Cohort||30
7932198|NCT00547378|19520069|P1|Month 24|All Implanted Cohort||42
7932199|NCT00547378|19520067|P3|Month 12|All Implanted Cohort||175
7932200|NCT00547378|19520068|P2|Month 12|All Implanted Cohort||32
7932201|NCT00547378|19520069|P1|Month 12|All Implanted Cohort||48
7932202|NCT00547378|19520067|P3|Month 6|All Implanted Cohort||178
7932203|NCT00547378|19520068|P2|Month 6|All Implanted Cohort||36
7932204|NCT00547378|19520069|P1|Month 6|All Implanted Cohort||50
7932205|NCT00547378|19520067|P3|Month 3|All Implanted Cohort||178
7932206|NCT00547378|19520068|P2|Month 3|All Implanted Cohort||39
7932207|NCT00547378|19520069|P1|Month 3|All Implanted Cohort||51
7932208|NCT00547378|19520067|P3|STARTED|All Implanted Cohort|This included subjects who received full system implant from non-randomized subjects.|181
7932209|NCT00547378|19520068|P2|STARTED|All Implanted Cohort|This included SMT subjects who received full system implant after completing randomization period.|40
7932210|NCT00547378|19520069|P1|STARTED|All Implanted Cohort|This included subjects who received full system implant after randomized to IST.|51
7932211|NCT00547378|19520067|P3|NOT COMPLETED|Randomized Cohort||0
7932212|NCT00547378|19520068|P2|NOT COMPLETED|Randomized Cohort||6
7932213|NCT00547378|19520069|P1|NOT COMPLETED|Randomized Cohort||11
7932214|NCT00547378|19520067|P3|COMPLETED|Randomized Cohort||0
7932215|NCT00547378|19520068|P2|COMPLETED|Randomized Cohort||71
7932216|NCT00547378|19520069|P1|COMPLETED|Randomized Cohort||59
7932217|NCT00547378|19520067|P3|Month 6|Randomized Cohort||0
7932218|NCT00547378|19520068|P2|Month 6|Randomized Cohort|This included SMT subjects who reached SMT Month 6 visit.|71
7932219|NCT00547378|19520069|P1|Month 6|Randomized Cohort|This includes IST subjects reached Month 6 visit, regardless of implant or not.|59
7932220|NCT00547378|19520067|P3|Month 3|Randomized Cohort||0
7932221|NCT00547378|19520068|P2|Month 3|Randomized Cohort|This included SMT subjects who reached SMT Month 3 visit.|72
7932222|NCT00547378|19520069|P1|Month 3|Randomized Cohort|This includes IST subjects reached Month 3 visit, regardless of implant or not.|62
7932223|NCT00547378|19520067|P3|STARTED|Randomized Cohort||0
7932224|NCT00547378|19520068|P2|STARTED|Randomized Cohort||77
7932225|NCT00547378|19520069|P1|STARTED|Randomized Cohort||70
7932226|NCT00547365|19520079|P1|NOT COMPLETED|Overall Study||8
7932227|NCT00547365|19520079|P1|COMPLETED|Overall Study||2
7932228|NCT00547365|19520079|P1|STARTED|Overall Study||10
7932229|NCT00547300|19520086|P2|NOT COMPLETED|Overall Study||26
7932230|NCT00547300|19520087|P1|NOT COMPLETED|Overall Study||25
7932231|NCT00547300|19520086|P2|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
7932232|NCT00547300|19520087|P1|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
7932233|NCT00547300|19520086|P2|STARTED|Overall Study|Two (2) patients were randomized in error, but no study medication taken.|26
7932234|NCT00547300|19520087|P1|STARTED|Overall Study||25
7932235|NCT00547248|19520101|P4|NOT COMPLETED|Overall Study||2
7932236|NCT00547248|19520102|P3|NOT COMPLETED|Overall Study||10
7932237|NCT00547248|19520103|P2|NOT COMPLETED|Overall Study||0
7932238|NCT00547248|19520104|P1|NOT COMPLETED|Overall Study||0
7932239|NCT00547248|19520101|P4|COMPLETED|Overall Study||96
7932240|NCT00547248|19520102|P3|COMPLETED|Overall Study||275
7932241|NCT00547248|19520103|P2|COMPLETED|Overall Study||93
7932242|NCT00547248|19520104|P1|COMPLETED|Overall Study||280
7932243|NCT00547248|19520101|P4|STARTED|Overall Study||98
7932244|NCT00547248|19520102|P3|STARTED|Overall Study||285
7932245|NCT00547248|19520103|P2|STARTED|Overall Study||93
7932246|NCT00547248|19520104|P1|STARTED|Overall Study||280
7932247|NCT00547157|19520222|P2|NOT COMPLETED|Overall Study||23
7932248|NCT00547157|19520223|P1|NOT COMPLETED|Overall Study||49
7932249|NCT00547157|19520222|P2|COMPLETED|Overall Study||39
7932250|NCT00547157|19520223|P1|COMPLETED|Overall Study||41
7932251|NCT00547157|19520222|P2|STARTED|Overall Study||62
7932252|NCT00547157|19520223|P1|STARTED|Overall Study||90
7932253|NCT00547118|19520241|P2|NOT COMPLETED|Overall Study||9
7932254|NCT00547118|19520242|P1|NOT COMPLETED|Overall Study||8
7932255|NCT00547118|19520241|P2|COMPLETED|Overall Study||0
7932256|NCT00547118|19520242|P1|COMPLETED|Overall Study||0
7932257|NCT00547118|19520241|P2|STARTED|Overall Study||9
7932258|NCT00547118|19520242|P1|STARTED|Overall Study||8
7932259|NCT00547105|19520274|P1|NOT COMPLETED|Overall Study||0
7932260|NCT00547105|19520274|P1|COMPLETED|Overall Study||24
7932261|NCT00547105|19520274|P1|STARTED|Overall Study||24
7932262|NCT00546910|19520286|P2|NOT COMPLETED|Overall Study||11
7932263|NCT00546910|19520287|P1|NOT COMPLETED|Overall Study||9
7932264|NCT00546910|19520286|P2|COMPLETED|Overall Study||51
7932265|NCT00546910|19520287|P1|COMPLETED|Overall Study||54
7932266|NCT00546910|19520286|P2|STARTED|Overall Study||62
7932267|NCT00546910|19520287|P1|STARTED|Overall Study||63
7932268|NCT00546897|19520307|P2|NOT COMPLETED|Overall Study||0
7932269|NCT00546897|19520308|P1|NOT COMPLETED|Overall Study||0
7932270|NCT00546897|19520307|P2|COMPLETED|Overall Study||33
7932271|NCT00546897|19520308|P1|COMPLETED|Overall Study||15
7932272|NCT00546897|19520307|P2|STARTED|Overall Study||33
7932273|NCT00546897|19520308|P1|STARTED|Overall Study||15
7932274|NCT00546884|19520346|P2|NOT COMPLETED|Overall Study||0
7932275|NCT00546884|19520347|P1|NOT COMPLETED|Overall Study||0
7932276|NCT00546884|19520346|P2|COMPLETED|Overall Study||117
7932277|NCT00546884|19520347|P1|COMPLETED|Overall Study||145
7932278|NCT00546884|19520346|P2|STARTED|Overall Study||117
7932279|NCT00546884|19520347|P1|STARTED|Overall Study||145
7932280|NCT00546871|19520353|P2|NOT COMPLETED|Study Extension Period||1
7932281|NCT00546871|19520354|P1|NOT COMPLETED|Study Extension Period||1
7932282|NCT00546871|19520353|P2|COMPLETED|Study Extension Period||25
7932283|NCT00546871|19520354|P1|COMPLETED|Study Extension Period||9
7932284|NCT00546871|19520353|P2|STARTED|Study Extension Period|6 withdrawn after Part 3b|26
7932285|NCT00546871|19520354|P1|STARTED|Study Extension Period|2 withdrawn after Part 3b|10
7932286|NCT00546871|19520353|P2|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
7932287|NCT00546871|19520354|P1|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
7932288|NCT00546871|19520353|P2|COMPLETED|Part 3b - SC IGIV 12 Weeks||32
7932289|NCT00546871|19520354|P1|COMPLETED|Part 3b - SC IGIV 12 Weeks||12
7932290|NCT00546871|19520353|P2|STARTED|Part 3b - SC IGIV 12 Weeks||32
7932291|NCT00546871|19520354|P1|STARTED|Part 3b - SC IGIV 12 Weeks||12
7932292|NCT00546871|19520353|P2|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
7932293|NCT00546871|19520354|P1|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
7932294|NCT00546871|19520353|P2|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
7932295|NCT00546871|19520354|P1|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
7932296|NCT00546871|19520353|P2|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
7932297|NCT00546871|19520354|P1|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
7932298|NCT00546871|19520353|P2|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3
7932299|NCT00546871|19520354|P1|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1
7932300|NCT00546871|19520353|P2|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32
7932301|NCT00546871|19520354|P1|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12
7932302|NCT00546871|19520353|P2|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35
7932303|NCT00546871|19520354|P1|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13
7932304|NCT00546871|19520353|P2|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0
7932305|NCT00546871|19520354|P1|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1
7932306|NCT00546871|19520353|P2|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35
7932307|NCT00546871|19520354|P1|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13
7932308|NCT00546871|19520353|P2|STARTED|Part 1 - IV Infusions of IGIV, PK||35
7932309|NCT00546871|19520354|P1|STARTED|Part 1 - IV Infusions of IGIV, PK||14
7932310|NCT00546819|19520459|P2|NOT COMPLETED|Overall Study||6
7932311|NCT00546819|19520460|P1|NOT COMPLETED|Overall Study||8
7932312|NCT00546819|19520459|P2|COMPLETED|Overall Study||96
7932313|NCT00546819|19520460|P1|COMPLETED|Overall Study||199
7932314|NCT00546819|19520459|P2|VACCINATED|Overall Study||100
7932315|NCT00546819|19520460|P1|VACCINATED|Overall Study||206
7932316|NCT00546819|19520459|P2|STARTED|Overall Study||102
7932317|NCT00546819|19520460|P1|STARTED|Overall Study||207
7932318|NCT00546754|19520472|P2|NOT COMPLETED|Overall Study||49
7932319|NCT00546754|19520473|P1|NOT COMPLETED|Overall Study||50
7932320|NCT00546754|19520472|P2|COMPLETED|Overall Study||334
7932321|NCT00546754|19520473|P1|COMPLETED|Overall Study||375
7932322|NCT00546754|19520472|P2|Week 12|Overall Study||334
7932323|NCT00546754|19520473|P1|Week 12|Overall Study||375
7932324|NCT00546754|19520472|P2|Week 6|Overall Study||347
7932325|NCT00546754|19520473|P1|Week 6|Overall Study||396
7932326|NCT00546754|19520472|P2|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373
7932327|NCT00546754|19520473|P1|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416
7932328|NCT00546754|19520472|P2|STARTED|Overall Study|Number of patients enrolled and randomized|383
7932329|NCT00546754|19520473|P1|STARTED|Overall Study|Number of patients enrolled and randomized|425
7932330|NCT00546728|19520505|P2|NOT COMPLETED|Overall Study||0
7932331|NCT00546728|19520506|P1|NOT COMPLETED|Overall Study||0
7932332|NCT00546728|19520505|P2|COMPLETED|Overall Study||25
7932333|NCT00546728|19520506|P1|COMPLETED|Overall Study||25
7932334|NCT00546728|19520505|P2|STARTED|Overall Study||25
7932335|NCT00546728|19520506|P1|STARTED|Overall Study||25
7932336|NCT00546715|19520516|P4|NOT COMPLETED|Overall Study||0
7932337|NCT00546715|19520517|P3|NOT COMPLETED|Overall Study||0
7932338|NCT00546715|19520518|P2|NOT COMPLETED|Overall Study||1
7932339|NCT00546715|19520519|P1|NOT COMPLETED|Overall Study||0
7932340|NCT00546715|19520516|P4|COMPLETED|Overall Study||2
7932341|NCT00546715|19520517|P3|COMPLETED|Overall Study||5
7932342|NCT00546715|19520518|P2|COMPLETED|Overall Study||4
7932343|NCT00546715|19520519|P1|COMPLETED|Overall Study||6
7932344|NCT00546715|19520516|P4|STARTED|Overall Study||2
7932345|NCT00546715|19520517|P3|STARTED|Overall Study||5
7932346|NCT00546715|19520518|P2|STARTED|Overall Study||5
7932347|NCT00546715|19520519|P1|STARTED|Overall Study||6
7932348|NCT00546637|19520574|P2|NOT COMPLETED|Overall Study||49
7932349|NCT00546637|19520575|P1|NOT COMPLETED|Overall Study||73
7932350|NCT00546637|19520574|P2|COMPLETED|Overall Study||424
7932351|NCT00546637|19520575|P1|COMPLETED|Overall Study||401
7932352|NCT00546637|19520574|P2|Received Treatment|Overall Study||472
7932353|NCT00546637|19520575|P1|Received Treatment|Overall Study||471
7932354|NCT00546637|19520574|P2|STARTED|Overall Study||473
7932355|NCT00546637|19520575|P1|STARTED|Overall Study||474
7932356|NCT00546572|19520649|P2|NOT COMPLETED|Vax 2 / Year 1||2
7932357|NCT00546572|19520650|P1|NOT COMPLETED|Vax 2 / Year 1||4
7932358|NCT00546572|19520649|P2|COMPLETED|Vax 2 / Year 1||402
7932359|NCT00546572|19520650|P1|COMPLETED|Vax 2 / Year 1||387
7932360|NCT00546572|19520649|P2|Received Vax 2|Vax 2 / Year 1||404
7932361|NCT00546572|19520650|P1|Received Vax 2|Vax 2 / Year 1||391
7932362|NCT00546572|19520649|P2|STARTED|Vax 2 / Year 1||404
7932363|NCT00546572|19520650|P1|STARTED|Vax 2 / Year 1||391
7932364|NCT00546572|19520649|P2|NOT COMPLETED|Vax 1 / Year 0||70
7932365|NCT00546572|19520650|P1|NOT COMPLETED|Vax 1 / Year 0||73
7932366|NCT00546572|19520649|P2|COMPLETED|Vax 1 / Year 0||404
7932367|NCT00546572|19520650|P1|COMPLETED|Vax 1 / Year 0||391
7932368|NCT00546572|19520649|P2|Received Vax 1|Vax 1 / Year 0||473
7932369|NCT00546572|19520650|P1|Received Vax 1|Vax 1 / Year 0||463
7932370|NCT00546572|19520649|P2|STARTED|Vax 1 / Year 0||474
7932371|NCT00546572|19520650|P1|STARTED|Vax 1 / Year 0||464
7932372|NCT00546481|19520694|P3|NOT COMPLETED|Maintenance Phase (CERA)||4
7932373|NCT00546481|19520695|P2|NOT COMPLETED|Maintenance Phase (CERA)||0
7932374|NCT00546481|19520696|P1|NOT COMPLETED|Maintenance Phase (CERA)||0
7932375|NCT00546481|19520694|P3|COMPLETED|Maintenance Phase (CERA)||50
7932376|NCT00546481|19520695|P2|COMPLETED|Maintenance Phase (CERA)||0
7932377|NCT00546481|19520696|P1|COMPLETED|Maintenance Phase (CERA)||0
7932378|NCT00546481|19520694|P3|STARTED|Maintenance Phase (CERA)||54
7932379|NCT00546481|19520695|P2|STARTED|Maintenance Phase (CERA)||0
7932380|NCT00546481|19520696|P1|STARTED|Maintenance Phase (CERA)||0
7932381|NCT00546481|19520694|P3|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
7932382|NCT00546481|19520695|P2|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5
7932383|NCT00546481|19520696|P1|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6
7932384|NCT00546481|19520694|P3|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
7932385|NCT00546481|19520695|P2|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36
7932386|NCT00546481|19520696|P1|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33
7932387|NCT00546481|19520694|P3|STARTED|Correction Phase (CERA or Epoetin Beta)||0
7932388|NCT00546481|19520695|P2|STARTED|Correction Phase (CERA or Epoetin Beta)||41
7932389|NCT00546481|19520696|P1|STARTED|Correction Phase (CERA or Epoetin Beta)||39
7932390|NCT00546429|19520719|P1|NOT COMPLETED|Overall Study||30
7932391|NCT00546429|19520719|P1|COMPLETED|Overall Study||32
7932392|NCT00546429|19520719|P1|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62
7932393|NCT00546390|19520725|P2|NOT COMPLETED|Overall Study||0
7932394|NCT00546390|19520726|P1|NOT COMPLETED|Overall Study||0
7932395|NCT00546390|19520725|P2|COMPLETED|Overall Study||28
7932396|NCT00546390|19520726|P1|COMPLETED|Overall Study||27
7932397|NCT00546390|19520725|P2|STARTED|Overall Study||28
7932398|NCT00546390|19520726|P1|STARTED|Overall Study||27
7932399|NCT00546377|19520734|P1|NOT COMPLETED|Overall Study||7
7932400|NCT00546377|19520734|P1|COMPLETED|Overall Study||43
7932401|NCT00546377|19520734|P1|STARTED|Overall Study||50
7932402|NCT00546364|19520742|P3|NOT COMPLETED|Overall Study||17
7932403|NCT00546364|19520743|P2|NOT COMPLETED|Overall Study||18
7932404|NCT00546364|19520744|P1|NOT COMPLETED|Overall Study||17
7932405|NCT00546364|19520742|P3|COMPLETED|Overall Study|Still on treatment|3
7932406|NCT00546364|19520743|P2|COMPLETED|Overall Study|Still on treatment|4
7932407|NCT00546364|19520744|P1|COMPLETED|Overall Study|Still on treatment|3
7932408|NCT00546364|19520742|P3|Never Treated|Overall Study||0
7932409|NCT00546364|19520743|P2|Never Treated|Overall Study||0
7932410|NCT00546364|19520744|P1|Never Treated|Overall Study||0
7932411|NCT00546364|19520742|P3|STARTED|Overall Study||20
7932412|NCT00546364|19520743|P2|STARTED|Overall Study||22
7932413|NCT00546364|19520744|P1|STARTED|Overall Study||20
7932414|NCT00546351|19520779|P1|NOT COMPLETED|Overall Study||236
7932415|NCT00546351|19520779|P1|COMPLETED|Overall Study||385
7932416|NCT00546351|19520779|P1|STARTED|Overall Study||621
7932417|NCT00546273|19520812|P5|NOT COMPLETED|IV||0
7932418|NCT00546273|19520813|P4|NOT COMPLETED|IV||0
7932419|NCT00546273|19520814|P3|NOT COMPLETED|IV||0
7932420|NCT00546273|19520815|P2|NOT COMPLETED|IV||0
7932421|NCT00546273|19520816|P1|NOT COMPLETED|IV||0
7932422|NCT00546273|19520812|P5|COMPLETED|IV||2
7932423|NCT00546273|19520813|P4|COMPLETED|IV||4
7932424|NCT00546273|19520814|P3|COMPLETED|IV||0
7932425|NCT00546273|19520815|P2|COMPLETED|IV||0
7932426|NCT00546273|19520816|P1|COMPLETED|IV||0
7932427|NCT00546273|19520812|P5|STARTED|IV||2
7932428|NCT00546273|19520813|P4|STARTED|IV||4
7932429|NCT00546273|19520814|P3|STARTED|IV||0
7932430|NCT00546273|19520815|P2|STARTED|IV||0
7932431|NCT00546273|19520816|P1|STARTED|IV||0
7932432|NCT00546273|19520812|P5|NOT COMPLETED|III||0
7932433|NCT00546273|19520813|P4|NOT COMPLETED|III||0
7932434|NCT00546273|19520814|P3|NOT COMPLETED|III||0
7932435|NCT00546273|19520815|P2|NOT COMPLETED|III||0
7932436|NCT00546273|19520816|P1|NOT COMPLETED|III||0
7932437|NCT00546273|19520812|P5|COMPLETED|III||2
7932438|NCT00546273|19520813|P4|COMPLETED|III||0
7932439|NCT00546273|19520814|P3|COMPLETED|III||4
7932440|NCT00546273|19520815|P2|COMPLETED|III||0
7932441|NCT00546273|19520816|P1|COMPLETED|III||0
7932442|NCT00546273|19520812|P5|STARTED|III||2
7932443|NCT00546273|19520813|P4|STARTED|III||0
7932444|NCT00546273|19520814|P3|STARTED|III||4
7932445|NCT00546273|19520815|P2|STARTED|III||0
7932446|NCT00546273|19520816|P1|STARTED|III||0
7932447|NCT00546273|19520812|P5|NOT COMPLETED|II||0
7932448|NCT00546273|19520813|P4|NOT COMPLETED|II||0
7932449|NCT00546273|19520814|P3|NOT COMPLETED|II||0
7932450|NCT00546273|19520815|P2|NOT COMPLETED|II||0
7932451|NCT00546273|19520816|P1|NOT COMPLETED|II||0
7932452|NCT00546273|19520812|P5|COMPLETED|II||2
7932453|NCT00546273|19520813|P4|COMPLETED|II||0
7932454|NCT00546273|19520814|P3|COMPLETED|II||0
7932455|NCT00546273|19520815|P2|COMPLETED|II||4
7932456|NCT00546273|19520816|P1|COMPLETED|II||0
7932457|NCT00546273|19520812|P5|STARTED|II||2
7932458|NCT00546273|19520813|P4|STARTED|II||0
7932459|NCT00546273|19520814|P3|STARTED|II||0
7932460|NCT00546273|19520815|P2|STARTED|II||4
7932461|NCT00546273|19520816|P1|STARTED|II||0
7932462|NCT00546273|19520812|P5|NOT COMPLETED|I||0
7932463|NCT00546273|19520813|P4|NOT COMPLETED|I||0
7932464|NCT00546273|19520814|P3|NOT COMPLETED|I||0
7932465|NCT00546273|19520815|P2|NOT COMPLETED|I||0
7932466|NCT00546273|19520816|P1|NOT COMPLETED|I||0
7932467|NCT00546273|19520812|P5|COMPLETED|I||2
7932468|NCT00546273|19520813|P4|COMPLETED|I||0
7932469|NCT00546273|19520814|P3|COMPLETED|I||0
7932470|NCT00546273|19520815|P2|COMPLETED|I||0
7932471|NCT00546273|19520816|P1|COMPLETED|I||4
7932472|NCT00546273|19520812|P5|STARTED|I||2
7932473|NCT00546273|19520813|P4|STARTED|I||0
7932474|NCT00546273|19520814|P3|STARTED|I||0
7932475|NCT00546273|19520815|P2|STARTED|I||0
7932476|NCT00546273|19520816|P1|STARTED|I||4
7932477|NCT00546260|19520825|P2|NOT COMPLETED|Overall Study||2
7932478|NCT00546260|19520826|P1|NOT COMPLETED|Overall Study||8
7932479|NCT00546260|19520825|P2|COMPLETED|Overall Study||32
7932480|NCT00546260|19520826|P1|COMPLETED|Overall Study||28
7932481|NCT00546260|19520825|P2|STARTED|Overall Study||34
7932482|NCT00546260|19520826|P1|STARTED|Overall Study||36
7932483|NCT00546156|19520838|P2|NOT COMPLETED|Overall Study||1
7932484|NCT00546156|19520839|P1|NOT COMPLETED|Overall Study||14
7932485|NCT00546156|19520838|P2|COMPLETED|Overall Study||19
7932486|NCT00546156|19520839|P1|COMPLETED|Overall Study||70
7932487|NCT00546156|19520838|P2|STARTED|Overall Study||20
7932488|NCT00546156|19520839|P1|STARTED|Overall Study||84
7932489|NCT00546117|19520848|P2|NOT COMPLETED|Overall Study||0
7932490|NCT00546117|19520849|P1|NOT COMPLETED|Overall Study||4
7932491|NCT00546117|19520848|P2|COMPLETED|Overall Study||7
7932492|NCT00546117|19520849|P1|COMPLETED|Overall Study||5
7932493|NCT00546117|19520848|P2|STARTED|Overall Study||7
7932494|NCT00546117|19520849|P1|STARTED|Overall Study||9
7932495|NCT00546104|19520863|P1|NOT COMPLETED|Overall Study||0
7932496|NCT00546104|19520863|P1|COMPLETED|Overall Study||31
7932497|NCT00546104|19520863|P1|STARTED|Overall Study||31
7932498|NCT00546078|19520874|P2|NOT COMPLETED|Overall Study||7
7932499|NCT00546078|19520875|P1|NOT COMPLETED|Overall Study||4
7932500|NCT00546078|19520874|P2|COMPLETED|Overall Study||43
7932501|NCT00546078|19520875|P1|COMPLETED|Overall Study||61
7932502|NCT00546078|19520874|P2|Month 18|Overall Study||45
7932503|NCT00546078|19520875|P1|Month 18|Overall Study||61
7932504|NCT00546078|19520874|P2|STARTED|Overall Study||50
7932505|NCT00546078|19520875|P1|STARTED|Overall Study||65
7932506|NCT00546052|19520913|P1|NOT COMPLETED|Overall Study||227
7932507|NCT00546052|19520913|P1|COMPLETED|Overall Study||1511
7932508|NCT00546052|19520913|P1|Week 52|Overall Study||1511
7932509|NCT00546052|19520913|P1|Week 32|Overall Study||1583
7932510|NCT00546052|19520913|P1|Week 12|Overall Study||1650
7932511|NCT00546052|19520913|P1|Week 8|Overall Study||1680
7932512|NCT00546052|19520913|P1|Week 4|Overall Study||1714
7932513|NCT00546052|19520913|P1|STARTED|Overall Study||1738
7932514|NCT00546000|19520931|P1|NOT COMPLETED|Overall Study||4
7932515|NCT00546000|19520931|P1|COMPLETED|Overall Study||52
7932516|NCT00546000|19520931|P1|STARTED|Overall Study||56
7932517|NCT00545974|19520938|P2|NOT COMPLETED|Overall Study||3
7932518|NCT00545974|19520939|P1|NOT COMPLETED|Overall Study||2
7932519|NCT00545974|19520938|P2|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39
7932520|NCT00545974|19520939|P1|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37
7932521|NCT00545974|19520938|P2|STARTED|Overall Study|subjects randomized to placebo cohort|42
7932522|NCT00545974|19520939|P1|STARTED|Overall Study|subjects randomized to memantine cohort|39
7932523|NCT00545948|19520956|P3|NOT COMPLETED|Overall Study||7
7932524|NCT00545948|19520957|P2|NOT COMPLETED|Overall Study||1
7932525|NCT00545948|19520958|P1|NOT COMPLETED|Overall Study||1
7932526|NCT00545948|19520956|P3|COMPLETED|Overall Study||0
7932527|NCT00545948|19520957|P2|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14
7932528|NCT00545948|19520958|P1|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8
7932529|NCT00545948|19520956|P3|Assigned Treatment|Overall Study||0
7932530|NCT00545948|19520957|P2|Assigned Treatment|Overall Study||15
7932531|NCT00545948|19520958|P1|Assigned Treatment|Overall Study||9
7932532|NCT00545948|19520956|P3|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7
7932533|NCT00545948|19520957|P2|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15
7932534|NCT00545948|19520958|P1|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9
7932535|NCT00545844|19520968|P1|NOT COMPLETED|Overall Study||12
7932536|NCT00545844|19520968|P1|COMPLETED|Overall Study||301
7932537|NCT00545844|19520968|P1|STARTED|Overall Study||313
7932538|NCT00545818|19520984|P2|NOT COMPLETED|Overall Study||7
7932539|NCT00545818|19520985|P1|NOT COMPLETED|Overall Study||3
7932540|NCT00545818|19520984|P2|COMPLETED|Overall Study||39
7932541|NCT00545818|19520985|P1|COMPLETED|Overall Study||46
7932542|NCT00545818|19520984|P2|STARTED|Overall Study||46
7932543|NCT00545818|19520985|P1|STARTED|Overall Study||49
7932544|NCT00545792|19520999|P1|NOT COMPLETED|Overall Study||1
7932545|NCT00545792|19520999|P1|COMPLETED|Overall Study||20
7932546|NCT00545792|19520999|P1|STARTED|Overall Study||21
7932547|NCT00545779|19521004|P1|NOT COMPLETED|Overall Study||44
7932548|NCT00545779|19521004|P1|COMPLETED|Overall Study||633
7932549|NCT00545779|19521004|P1|STARTED|Overall Study||677
7932550|NCT00545766|19521017|P1|NOT COMPLETED|Overall Study||5
7932551|NCT00545766|19521017|P1|COMPLETED|Overall Study||36
7932552|NCT00545766|19521017|P1|STARTED|Overall Study||41
7932553|NCT00545753|19521024|P3|NOT COMPLETED|Overall Study||26
7932554|NCT00545753|19521025|P2|NOT COMPLETED|Overall Study||5
7932555|NCT00545753|19521026|P1|NOT COMPLETED|Overall Study||16
7932556|NCT00545753|19521024|P3|COMPLETED|Overall Study||230
7932557|NCT00545753|19521025|P2|COMPLETED|Overall Study||54
7932558|NCT00545753|19521026|P1|COMPLETED|Overall Study||227
7932559|NCT00545753|19521024|P3|STARTED|Overall Study||256
7932560|NCT00545753|19521025|P2|STARTED|Overall Study||59
7932561|NCT00545753|19521026|P1|STARTED|Overall Study||243
7932562|NCT00545740|19521039|P4|NOT COMPLETED|Overall Study||71
7932563|NCT00545740|19521040|P3|NOT COMPLETED|Overall Study||96
7932564|NCT00545740|19521041|P2|NOT COMPLETED|Overall Study||83
7932565|NCT00545740|19521042|P1|NOT COMPLETED|Overall Study||75
7932566|NCT00545740|19521039|P4|COMPLETED|Overall Study||78
7932567|NCT00545740|19521040|P3|COMPLETED|Overall Study||55
7932568|NCT00545740|19521041|P2|COMPLETED|Overall Study||62
7932569|NCT00545740|19521042|P1|COMPLETED|Overall Study||70
7932570|NCT00545740|19521039|P4|STARTED|Overall Study||149
7932571|NCT00545740|19521040|P3|STARTED|Overall Study||151
7932572|NCT00545740|19521041|P2|STARTED|Overall Study||145
7932573|NCT00545740|19521042|P1|STARTED|Overall Study||145
7932574|NCT00545714|19521076|P1|NOT COMPLETED|Maintenance Phase (36 Months)||32
7932575|NCT00545714|19521076|P1|COMPLETED|Maintenance Phase (36 Months)||42
7932576|NCT00545714|19521076|P1|STARTED|Maintenance Phase (36 Months)||74
7932577|NCT00545714|19521076|P1|NOT COMPLETED|Induction Phase (6 Months)||12
7932578|NCT00545714|19521076|P1|COMPLETED|Induction Phase (6 Months)||74
7932579|NCT00545714|19521076|P1|Intent-to-Treat (ITT) Population|Induction Phase (6 Months)||84
7932580|NCT00545714|19521076|P1|Safety Population|Induction Phase (6 Months)||86
7932581|NCT00545714|19521076|P1|STARTED|Induction Phase (6 Months)||86
7932582|NCT00545688|19521097|P4|NOT COMPLETED|Follow-Up Period||27
7932583|NCT00545688|19521098|P3|NOT COMPLETED|Follow-Up Period||20
7932584|NCT00545688|19521099|P2|NOT COMPLETED|Follow-Up Period||19
7932585|NCT00545688|19521100|P1|NOT COMPLETED|Follow-Up Period||21
7932586|NCT00545688|19521097|P4|COMPLETED|Follow-Up Period||60
7932587|NCT00545688|19521098|P3|COMPLETED|Follow-Up Period||78
7932588|NCT00545688|19521099|P2|COMPLETED|Follow-Up Period||83
7932589|NCT00545688|19521100|P1|COMPLETED|Follow-Up Period||77
7932590|NCT00545688|19521097|P4|STARTED|Follow-Up Period||87
7932591|NCT00545688|19521098|P3|STARTED|Follow-Up Period||98
7932592|NCT00545688|19521099|P2|STARTED|Follow-Up Period||102
7932593|NCT00545688|19521100|P1|STARTED|Follow-Up Period||98
7932594|NCT00545688|19521097|P4|NOT COMPLETED|Adjuvant Treatment Period||14
7932595|NCT00545688|19521098|P3|NOT COMPLETED|Adjuvant Treatment Period||4
7932596|NCT00545688|19521099|P2|NOT COMPLETED|Adjuvant Treatment Period||8
7932597|NCT00545688|19521100|P1|NOT COMPLETED|Adjuvant Treatment Period||5
7932598|NCT00545688|19521097|P4|COMPLETED|Adjuvant Treatment Period||74
7932599|NCT00545688|19521098|P3|COMPLETED|Adjuvant Treatment Period||90
7932600|NCT00545688|19521099|P2|COMPLETED|Adjuvant Treatment Period||94
7932601|NCT00545688|19521100|P1|COMPLETED|Adjuvant Treatment Period||98
7932602|NCT00545688|19521097|P4|STARTED|Adjuvant Treatment Period||88
7932603|NCT00545688|19521098|P3|STARTED|Adjuvant Treatment Period||94
7932604|NCT00545688|19521099|P2|STARTED|Adjuvant Treatment Period||102
7932605|NCT00545688|19521100|P1|STARTED|Adjuvant Treatment Period||103
7932606|NCT00545688|19521097|P4|NOT COMPLETED|Neo-Adjuvant Treatment Period||6
7932607|NCT00545688|19521098|P3|NOT COMPLETED|Neo-Adjuvant Treatment Period||14
7932608|NCT00545688|19521099|P2|NOT COMPLETED|Neo-Adjuvant Treatment Period||5
7932609|NCT00545688|19521100|P1|NOT COMPLETED|Neo-Adjuvant Treatment Period||4
7932610|NCT00545688|19521097|P4|COMPLETED|Neo-Adjuvant Treatment Period||88
7932611|NCT00545688|19521098|P3|COMPLETED|Neo-Adjuvant Treatment Period||94
7932612|NCT00545688|19521099|P2|COMPLETED|Neo-Adjuvant Treatment Period||102
7932613|NCT00545688|19521100|P1|COMPLETED|Neo-Adjuvant Treatment Period||103
7932614|NCT00545688|19521097|P4|STARTED|Neo-Adjuvant Treatment Period||94
7932615|NCT00545688|19521098|P3|STARTED|Neo-Adjuvant Treatment Period||108
7932616|NCT00545688|19521099|P2|STARTED|Neo-Adjuvant Treatment Period||107
7932617|NCT00545688|19521100|P1|STARTED|Neo-Adjuvant Treatment Period||107
7932618|NCT00545662|19521172|P2|NOT COMPLETED|Overall Study||79
7932619|NCT00545662|19521173|P1|NOT COMPLETED|Overall Study||85
7932620|NCT00545662|19521172|P2|COMPLETED|Overall Study||528
7932621|NCT00545662|19521173|P1|COMPLETED|Overall Study||521
7932622|NCT00545662|19521172|P2|STARTED|Overall Study||607
7932623|NCT00545662|19521173|P1|STARTED|Overall Study||606
7932624|NCT00545623|19521183|P4|NOT COMPLETED|Overall Study||11
7932625|NCT00545623|19521184|P3|NOT COMPLETED|Overall Study||13
7932626|NCT00545623|19521185|P2|NOT COMPLETED|Overall Study||10
7932627|NCT00545623|19521186|P1|NOT COMPLETED|Overall Study||7
7932628|NCT00545623|19521183|P4|COMPLETED|Overall Study||23
7932629|NCT00545623|19521184|P3|COMPLETED|Overall Study||20
7932630|NCT00545623|19521185|P2|COMPLETED|Overall Study||21
7932631|NCT00545623|19521186|P1|COMPLETED|Overall Study||25
7932632|NCT00545623|19521183|P4|STARTED|Overall Study||34
7932633|NCT00545623|19521184|P3|STARTED|Overall Study||33
7932634|NCT00545623|19521185|P2|STARTED|Overall Study||31
7932635|NCT00545623|19521186|P1|STARTED|Overall Study||32
7932636|NCT00545584|19521199|P3|NOT COMPLETED|Overall Study||56
7932637|NCT00545584|19521200|P2|NOT COMPLETED|Overall Study||80
7932638|NCT00545584|19521201|P1|NOT COMPLETED|Overall Study||79
7932639|NCT00545584|19521199|P3|COMPLETED|Overall Study||250
7932640|NCT00545584|19521200|P2|COMPLETED|Overall Study||334
7932641|NCT00545584|19521201|P1|COMPLETED|Overall Study||333
7932642|NCT00545584|19521199|P3|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306
7932643|NCT00545584|19521200|P2|STARTED|Overall Study||414
7932644|NCT00545584|19521201|P1|STARTED|Overall Study||412
7932645|NCT00545571|19521212|P1|NOT COMPLETED|Overall Study||67
7932646|NCT00545571|19521212|P1|COMPLETED|Overall Study||53
7932647|NCT00545571|19521212|P1|STARTED|Overall Study||120
7932648|NCT00545532|19521227|P2|NOT COMPLETED|Overall Study||10
7932649|NCT00545532|19521228|P1|NOT COMPLETED|Overall Study||6
7932650|NCT00545532|19521227|P2|COMPLETED|Overall Study||100
7932651|NCT00545532|19521228|P1|COMPLETED|Overall Study||99
7932652|NCT00545532|19521227|P2|STARTED|Overall Study||110
7932653|NCT00545532|19521228|P1|STARTED|Overall Study||105
7932654|NCT00545506|19521310|P2|NOT COMPLETED|Overall Study||0
7932655|NCT00545506|19521311|P1|NOT COMPLETED|Overall Study||0
7932656|NCT00545506|19521310|P2|COMPLETED|Overall Study||3
7932657|NCT00545506|19521311|P1|COMPLETED|Overall Study||3
7932658|NCT00545506|19521310|P2|STARTED|Overall Study||3
7932659|NCT00545506|19521311|P1|STARTED|Overall Study||3
7932660|NCT00545441|19521319|P2|NOT COMPLETED|Overall Study||16
7932661|NCT00545441|19521320|P1|NOT COMPLETED|Overall Study||18
7932662|NCT00545441|19521319|P2|COMPLETED|Overall Study||26
7932663|NCT00545441|19521320|P1|COMPLETED|Overall Study||26
7932664|NCT00545441|19521319|P2|STARTED|Overall Study||42
7932665|NCT00545441|19521320|P1|STARTED|Overall Study||44
7932666|NCT00545402|19521328|P2|NOT COMPLETED|Overall Study||29
7932667|NCT00545402|19521329|P1|NOT COMPLETED|Overall Study||34
7932668|NCT00545402|19521328|P2|COMPLETED|Overall Study||61
7932669|NCT00545402|19521329|P1|COMPLETED|Overall Study||56
7932670|NCT00545402|19521328|P2|STARTED|Overall Study||90
7932671|NCT00545402|19521329|P1|STARTED|Overall Study||90
7932672|NCT00545363|19521347|P2|NOT COMPLETED|Overall Study||15
7932673|NCT00545363|19521348|P1|NOT COMPLETED|Overall Study||19
7932674|NCT00545363|19521347|P2|COMPLETED|Overall Study||343
7932675|NCT00545363|19521348|P1|COMPLETED|Overall Study||339
7932676|NCT00545363|19521347|P2|Treated|Overall Study||357
7932677|NCT00545363|19521348|P1|Treated|Overall Study||354
7932678|NCT00545363|19521347|P2|STARTED|Overall Study||358
7932679|NCT00545363|19521348|P1|STARTED|Overall Study||358
7932680|NCT00545298|19521363|P3|NOT COMPLETED|Overall Study||1
7932681|NCT00545298|19521364|P2|NOT COMPLETED|Overall Study||0
7932682|NCT00545298|19521365|P1|NOT COMPLETED|Overall Study||2
7932683|NCT00545298|19521363|P3|COMPLETED|Overall Study||0
7932684|NCT00545298|19521364|P2|COMPLETED|Overall Study||1
7932685|NCT00545298|19521365|P1|COMPLETED|Overall Study||0
7932686|NCT00545298|19521363|P3|STARTED|Overall Study||1
7932687|NCT00545298|19521364|P2|STARTED|Overall Study||1
7932688|NCT00545298|19521365|P1|STARTED|Overall Study||2
7932689|NCT00545272|19521382|P6|NOT COMPLETED|Overall Study||3
7932690|NCT00545272|19521383|P5|NOT COMPLETED|Overall Study||2
7932691|NCT00545272|19521384|P4|NOT COMPLETED|Overall Study||1
7932692|NCT00545272|19521385|P3|NOT COMPLETED|Overall Study||1
7932693|NCT00545272|19521386|P2|NOT COMPLETED|Overall Study||1
7932694|NCT00545272|19521387|P1|NOT COMPLETED|Overall Study||0
7932695|NCT00545272|19521382|P6|COMPLETED|Overall Study||59
7932696|NCT00545272|19521383|P5|COMPLETED|Overall Study||62
7932697|NCT00545272|19521384|P4|COMPLETED|Overall Study||71
7932698|NCT00545272|19521385|P3|COMPLETED|Overall Study||64
7932699|NCT00545272|19521386|P2|COMPLETED|Overall Study||67
7932700|NCT00545272|19521387|P1|COMPLETED|Overall Study||61
7932701|NCT00545272|19521382|P6|STARTED|Overall Study||62
7932702|NCT00545272|19521383|P5|STARTED|Overall Study||64
7932703|NCT00545272|19521384|P4|STARTED|Overall Study||72
7932704|NCT00545272|19521385|P3|STARTED|Overall Study||65
7932705|NCT00545272|19521386|P2|STARTED|Overall Study||68
7932706|NCT00545272|19521387|P1|STARTED|Overall Study||61
7932707|NCT00545233|19521439|P2|NOT COMPLETED|Overall Study||35
7932708|NCT00545233|19521440|P1|NOT COMPLETED|Overall Study||46
7932709|NCT00545233|19521439|P2|COMPLETED|Overall Study||41
7932710|NCT00545233|19521440|P1|COMPLETED|Overall Study||33
7932711|NCT00545233|19521439|P2|Intent-to-Treat (ITT)|Overall Study||73
7932712|NCT00545233|19521440|P1|Intent-to-Treat (ITT)|Overall Study||77
7932713|NCT00545233|19521439|P2|Safety Set|Overall Study||75
7932714|NCT00545233|19521440|P1|Safety Set|Overall Study||77
7932715|NCT00545233|19521439|P2|STARTED|Overall Study||76
7932716|NCT00545233|19521440|P1|STARTED|Overall Study||79
7932717|NCT00545181|19521489|P2|NOT COMPLETED|Overall Study||0
7932718|NCT00545181|19521490|P1|NOT COMPLETED|Overall Study||0
7932719|NCT00545181|19521489|P2|COMPLETED|Overall Study||25
7932720|NCT00545181|19521490|P1|COMPLETED|Overall Study||29
7932721|NCT00545181|19521489|P2|STARTED|Overall Study||25
7932722|NCT00545181|19521490|P1|STARTED|Overall Study||29
7932723|NCT00545168|19521499|P3|NOT COMPLETED|Overall Study||21
7932724|NCT00545168|19521500|P2|NOT COMPLETED|Overall Study||5
7932725|NCT00545168|19521501|P1|NOT COMPLETED|Overall Study||16
7932726|NCT00545168|19521499|P3|COMPLETED|Overall Study||193
7932727|NCT00545168|19521500|P2|COMPLETED|Overall Study||58
7932728|NCT00545168|19521501|P1|COMPLETED|Overall Study||187
7932729|NCT00545168|19521499|P3|STARTED|Overall Study||214
7932730|NCT00545168|19521500|P2|STARTED|Overall Study||63
7932731|NCT00545168|19521501|P1|STARTED|Overall Study||203
7932732|NCT00545155|19521510|P1|NOT COMPLETED|Overall Study||0
7932733|NCT00545155|19521510|P1|COMPLETED|Overall Study||187
7932734|NCT00545155|19521510|P1|STARTED|Overall Study||187
7932735|NCT00545103|19521527|P4|NOT COMPLETED|Overall Study||70
7932736|NCT00545103|19521528|P3|NOT COMPLETED|Overall Study||76
7932737|NCT00545103|19521529|P2|NOT COMPLETED|Overall Study||78
7932738|NCT00545103|19521530|P1|NOT COMPLETED|Overall Study||75
7932739|NCT00545103|19521527|P4|COMPLETED|Overall Study||76
7932740|NCT00545103|19521528|P3|COMPLETED|Overall Study||74
7932741|NCT00545103|19521529|P2|COMPLETED|Overall Study||70
7932742|NCT00545103|19521530|P1|COMPLETED|Overall Study||73
7932743|NCT00545103|19521527|P4|STARTED|Overall Study||146
7932744|NCT00545103|19521528|P3|STARTED|Overall Study||150
7932745|NCT00545103|19521529|P2|STARTED|Overall Study||148
7932746|NCT00545103|19521530|P1|STARTED|Overall Study||148
7932747|NCT00545077|19521566|P2|NOT COMPLETED|Overall Study||155
7932748|NCT00545077|19521567|P1|NOT COMPLETED|Overall Study||148
7932749|NCT00545077|19521566|P2|COMPLETED|Overall Study||36
7932750|NCT00545077|19521567|P1|COMPLETED|Overall Study||41
7932751|NCT00545077|19521566|P2|STARTED|Overall Study||191
7932752|NCT00545077|19521567|P1|STARTED|Overall Study||189
7932753|NCT00545064|19521583|P1|NOT COMPLETED|Overall Study||8
7932754|NCT00545064|19521583|P1|COMPLETED|Overall Study||170
7932755|NCT00545064|19521583|P1|Visit 3 (Week 8)|Overall Study|8 patients didn't complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176
7932756|NCT00545064|19521583|P1|Visit 2 (Week 4)|Overall Study||169
7932757|NCT00545064|19521583|P1|Visit 1 (Baseline)|Overall Study||178
7932758|NCT00545064|19521583|P1|STARTED|Overall Study||178
7932759|NCT00545051|19521594|P2|NOT COMPLETED|Overall Study||7
7932760|NCT00545051|19521595|P1|NOT COMPLETED|Overall Study||9
7932761|NCT00545051|19521594|P2|COMPLETED|Overall Study||65
7932762|NCT00545051|19521595|P1|COMPLETED|Overall Study||59
7932763|NCT00545051|19521594|P2|STARTED|Overall Study||72
7932764|NCT00545051|19521595|P1|STARTED|Overall Study||68
7932765|NCT00545025|19521611|P2|NOT COMPLETED|Overall Study||0
7932766|NCT00545025|19521612|P1|NOT COMPLETED|Overall Study||0
7932767|NCT00545025|19521611|P2|COMPLETED|Overall Study||83
7932768|NCT00545025|19521612|P1|COMPLETED|Overall Study||160
7932769|NCT00545025|19521611|P2|STARTED|Overall Study||83
7932770|NCT00545025|19521612|P1|STARTED|Overall Study||160
7932771|NCT00544908|19521632|P1|NOT COMPLETED|Overall Study||0
7932772|NCT00544908|19521632|P1|COMPLETED|Overall Study||7
7932773|NCT00544908|19521632|P1|STARTED|Overall Study||7
7932774|NCT00544882|19521639|P3|NOT COMPLETED|Cycle 3: Follow-up||0
7932775|NCT00544882|19521640|P2|NOT COMPLETED|Cycle 3: Follow-up||2
7932776|NCT00544882|19521641|P1|NOT COMPLETED|Cycle 3: Follow-up||0
7932777|NCT00544882|19521639|P3|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28
7932778|NCT00544882|19521640|P2|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26
7932779|NCT00544882|19521641|P1|COMPLETED|Cycle 3: Follow-up||0
7932780|NCT00544882|19521639|P3|STARTED|Cycle 3: Follow-up||28
7932781|NCT00544882|19521640|P2|STARTED|Cycle 3: Follow-up||28
7932782|NCT00544882|19521641|P1|STARTED|Cycle 3: Follow-up||0
7932783|NCT00544882|19521639|P3|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
7932784|NCT00544882|19521640|P2|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
7932785|NCT00544882|19521641|P1|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0
7932786|NCT00544882|19521639|P3|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
7932787|NCT00544882|19521640|P2|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
7932788|NCT00544882|19521641|P1|COMPLETED|Cycle 2: Randomized Treatment Cycle||0
7932789|NCT00544882|19521639|P3|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28
7932790|NCT00544882|19521640|P2|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28
7932791|NCT00544882|19521641|P1|Treated|Cycle 2: Randomized Treatment Cycle||0
7932792|NCT00544882|19521639|P3|STARTED|Cycle 2: Randomized Treatment Cycle||29
7932793|NCT00544882|19521640|P2|STARTED|Cycle 2: Randomized Treatment Cycle||29
7932794|NCT00544882|19521641|P1|STARTED|Cycle 2: Randomized Treatment Cycle||0
7932795|NCT00544882|19521639|P3|NOT COMPLETED|Cycle 1: Run-in Cycle||0
7932796|NCT00544882|19521640|P2|NOT COMPLETED|Cycle 1: Run-in Cycle||0
7932797|NCT00544882|19521641|P1|NOT COMPLETED|Cycle 1: Run-in Cycle||3
7932798|NCT00544882|19521639|P3|COMPLETED|Cycle 1: Run-in Cycle||0
7932799|NCT00544882|19521640|P2|COMPLETED|Cycle 1: Run-in Cycle||0
7932800|NCT00544882|19521641|P1|COMPLETED|Cycle 1: Run-in Cycle||58
7932801|NCT00544882|19521639|P3|STARTED|Cycle 1: Run-in Cycle||0
7932802|NCT00544882|19521640|P2|STARTED|Cycle 1: Run-in Cycle||0
7932803|NCT00544882|19521641|P1|STARTED|Cycle 1: Run-in Cycle||61
7932804|NCT00544869|19521666|P3|NOT COMPLETED|Overall Study||0
7932805|NCT00544869|19521667|P2|NOT COMPLETED|Overall Study||2
7932806|NCT00544869|19521668|P1|NOT COMPLETED|Overall Study||12
7932807|NCT00544869|19521666|P3|COMPLETED|Overall Study||2
7932808|NCT00544869|19521667|P2|COMPLETED|Overall Study||12
7932809|NCT00544869|19521668|P1|COMPLETED|Overall Study||24
7932810|NCT00544869|19521666|P3|STARTED|Overall Study||2
7932811|NCT00544869|19521667|P2|STARTED|Overall Study||14
7932812|NCT00544869|19521668|P1|STARTED|Overall Study||36
7932813|NCT00544817|19521676|P1|NOT COMPLETED|Follow-up Systemic Therapy||19
7932814|NCT00544817|19521676|P1|COMPLETED|Follow-up Systemic Therapy||9
7932815|NCT00544817|19521676|P1|STARTED|Follow-up Systemic Therapy||28
7932816|NCT00544817|19521676|P1|NOT COMPLETED|No Treatment Interval||12
7932817|NCT00544817|19521676|P1|COMPLETED|No Treatment Interval||28
7932818|NCT00544817|19521676|P1|STARTED|No Treatment Interval||40
7932819|NCT00544817|19521676|P1|NOT COMPLETED|Combined Modality||7
7932820|NCT00544817|19521676|P1|COMPLETED|Combined Modality||40
7932821|NCT00544817|19521676|P1|STARTED|Combined Modality||47
7932822|NCT00544778|19521682|P1|NOT COMPLETED|Overall Study||0
7932823|NCT00544778|19521682|P1|COMPLETED|Overall Study||7
7932824|NCT00544778|19521682|P1|STARTED|Overall Study||7
7932825|NCT00544713|19521688|P2|NOT COMPLETED|Overall Study||5
7932826|NCT00544713|19521689|P1|NOT COMPLETED|Overall Study||3
7932827|NCT00544713|19521688|P2|COMPLETED|Overall Study||109
7932828|NCT00544713|19521689|P1|COMPLETED|Overall Study||111
7932829|NCT00544713|19521688|P2|STARTED|Overall Study||114
7932830|NCT00544713|19521689|P1|STARTED|Overall Study||114
7932831|NCT00544674|19521719|P1|NOT COMPLETED|Overall Study||1
7932832|NCT00544674|19521719|P1|COMPLETED|Overall Study||4
7932833|NCT00544674|19521719|P1|STARTED|Overall Study|1 subject registered and expired prior to dosing|5
7932834|NCT00544648|19521725|P2|NOT COMPLETED|Overall Study||1
7932835|NCT00544648|19521726|P1|NOT COMPLETED|Overall Study||3
7932836|NCT00544648|19521725|P2|COMPLETED|Overall Study||1
7932837|NCT00544648|19521726|P1|COMPLETED|Overall Study||8
7932838|NCT00544648|19521725|P2|STARTED|Overall Study||2
7932839|NCT00544648|19521726|P1|STARTED|Overall Study||11
7932840|NCT00544557|19521740|P1|NOT COMPLETED|Overall Study||434
7932841|NCT00544557|19521740|P1|COMPLETED|Overall Study||1251
7932842|NCT00544557|19521740|P1|STARTED|Overall Study||1685
7932843|NCT00544544|19521771|P1|NOT COMPLETED|Overall Study||3
7932844|NCT00544544|19521771|P1|COMPLETED|Overall Study||11
7932845|NCT00544544|19521771|P1|STARTED|Overall Study||14
7932846|NCT00544440|19521778|P1|NOT COMPLETED|Overall Study||57
7932847|NCT00544440|19521778|P1|COMPLETED|Overall Study||0
7932848|NCT00544440|19521778|P1|STARTED|Overall Study||57
7932849|NCT00544167|19521785|P1|NOT COMPLETED|Overall Study||29
7932850|NCT00544167|19521785|P1|COMPLETED|Overall Study||16
7932851|NCT00544167|19521785|P1|STARTED|Overall Study||45
7932852|NCT00544076|19521792|P3|NOT COMPLETED|Overall Study||11
7932853|NCT00544076|19521793|P2|NOT COMPLETED|Overall Study||16
7932854|NCT00544076|19521794|P1|NOT COMPLETED|Overall Study||17
7932855|NCT00544076|19521792|P3|COMPLETED|Overall Study||20
7932856|NCT00544076|19521793|P2|COMPLETED|Overall Study||19
7932857|NCT00544076|19521794|P1|COMPLETED|Overall Study||17
7932858|NCT00544076|19521792|P3|STARTED|Overall Study||31
7932859|NCT00544076|19521793|P2|STARTED|Overall Study||35
7932860|NCT00544076|19521794|P1|STARTED|Overall Study||34
7932861|NCT00543985|19521811|P1|NOT COMPLETED|Overall Study||4
7932862|NCT00543985|19521811|P1|COMPLETED|Overall Study||32
7932863|NCT00543985|19521811|P1|STARTED|Overall Study||36
7932864|NCT00543855|19521822|P4|NOT COMPLETED|Overall Study||4
7932865|NCT00543855|19521823|P3|NOT COMPLETED|Overall Study||6
7932866|NCT00543855|19521824|P2|NOT COMPLETED|Overall Study||2
7932867|NCT00543855|19521825|P1|NOT COMPLETED|Overall Study||4
7932868|NCT00543855|19521822|P4|COMPLETED|Overall Study||30
7932869|NCT00543855|19521823|P3|COMPLETED|Overall Study||31
7932870|NCT00543855|19521824|P2|COMPLETED|Overall Study||31
7932871|NCT00543855|19521825|P1|COMPLETED|Overall Study||31
7932872|NCT00543855|19521822|P4|STARTED|Overall Study||34
7932873|NCT00543855|19521823|P3|STARTED|Overall Study||37
7932874|NCT00543855|19521824|P2|STARTED|Overall Study||33
7932875|NCT00543855|19521825|P1|STARTED|Overall Study||35
7932876|NCT00543803|19521847|P1|NOT COMPLETED|Overall Study||142
7932877|NCT00543803|19521847|P1|COMPLETED|Overall Study||192
7932878|NCT00543803|19521847|P1|STARTED|Overall Study||334
7932879|NCT00543764|19521866|P2|NOT COMPLETED|Overall Study||0
7932880|NCT00543764|19521867|P1|NOT COMPLETED|Overall Study||0
7932881|NCT00543764|19521866|P2|COMPLETED|Overall Study||50
7932882|NCT00543764|19521867|P1|COMPLETED|Overall Study||100
7932883|NCT00543764|19521866|P2|STARTED|Overall Study||50
7932884|NCT00543764|19521867|P1|STARTED|Overall Study||100
7932885|NCT00543725|19521875|P2|NOT COMPLETED|Overall Study||74
7932886|NCT00543725|19521876|P1|NOT COMPLETED|Overall Study||68
7932887|NCT00543725|19521875|P2|COMPLETED|Overall Study||264
7932888|NCT00543725|19521876|P1|COMPLETED|Overall Study||272
7932889|NCT00543725|19521875|P2|STARTED|Overall Study||338
7932890|NCT00543725|19521876|P1|STARTED|Overall Study||340
7932891|NCT00543569|19521902|P4|NOT COMPLETED|Overall Study||9
7932892|NCT00543569|19521903|P3|NOT COMPLETED|Overall Study||20
7932893|NCT00543569|19521904|P2|NOT COMPLETED|Overall Study||8
7932894|NCT00543569|19521905|P1|NOT COMPLETED|Overall Study||12
7932895|NCT00543569|19521902|P4|COMPLETED|Overall Study||72
7932896|NCT00543569|19521903|P3|COMPLETED|Overall Study||60
7932897|NCT00543569|19521904|P2|COMPLETED|Overall Study||72
7932898|NCT00543569|19521905|P1|COMPLETED|Overall Study||70
7932899|NCT00543569|19521902|P4|Received Treatment|Overall Study||78
7932900|NCT00543569|19521903|P3|Received Treatment|Overall Study||75
7932901|NCT00543569|19521904|P2|Received Treatment|Overall Study||77
7932902|NCT00543569|19521905|P1|Received Treatment|Overall Study||79
7932903|NCT00543569|19521902|P4|STARTED|Overall Study||81
7932904|NCT00543569|19521903|P3|STARTED|Overall Study||80
7932905|NCT00543569|19521904|P2|STARTED|Overall Study||80
7932906|NCT00543569|19521905|P1|STARTED|Overall Study||82
7932907|NCT00543543|19522011|P4|NOT COMPLETED|Extension Study||226
7932908|NCT00543543|19522012|P3|NOT COMPLETED|Extension Study||0
7932909|NCT00543543|19522013|P2|NOT COMPLETED|Extension Study||0
7932910|NCT00543543|19522014|P1|NOT COMPLETED|Extension Study||0
7932911|NCT00543543|19522011|P4|COMPLETED|Extension Study||2824
7932912|NCT00543543|19522012|P3|COMPLETED|Extension Study||0
7932913|NCT00543543|19522013|P2|COMPLETED|Extension Study||150
7932914|NCT00543543|19522014|P1|COMPLETED|Extension Study||0
7932915|NCT00543543|19522011|P4|STARTED|Extension Study|Cohort 2|3050
7932916|NCT00543543|19522012|P3|STARTED|Extension Study|This group did not participate in the Extension Study|0
7932917|NCT00543543|19522013|P2|STARTED|Extension Study|Cohort 1|150
7932918|NCT00543543|19522014|P1|STARTED|Extension Study|This group did not participate in the Extension Study|0
7932919|NCT00543543|19522011|P4|NOT COMPLETED|Base Study||1222
7932920|NCT00543543|19522012|P3|NOT COMPLETED|Base Study||14
7932921|NCT00543543|19522013|P2|NOT COMPLETED|Base Study||1252
7932922|NCT00543543|19522014|P1|NOT COMPLETED|Base Study||20
7932923|NCT00543543|19522011|P4|COMPLETED|Base Study|Follow-up was up to 54 months|5887
7932924|NCT00543543|19522012|P3|COMPLETED|Base Study|Follow-up was up to 7 months|296
7932925|NCT00543543|19522013|P2|COMPLETED|Base Study|Follow-up was up to 54 months|5854
7932926|NCT00543543|19522014|P1|COMPLETED|Base Study|Follow-up was up to 7 months|295
7932927|NCT00543543|19522011|P4|Completed 3 Vaccinations|Base Study||6934
7932928|NCT00543543|19522012|P3|Completed 3 Vaccinations|Base Study||297
7932929|NCT00543543|19522013|P2|Completed 3 Vaccinations|Base Study||6928
7932930|NCT00543543|19522014|P1|Completed 3 Vaccinations|Base Study||300
7932931|NCT00543543|19522011|P4|STARTED|Base Study||7109
7932932|NCT00543543|19522012|P3|STARTED|Base Study||310
7932933|NCT00543543|19522013|P2|STARTED|Base Study||7106
7932934|NCT00543543|19522014|P1|STARTED|Base Study||315
7932935|NCT00543439|19522058|P3|NOT COMPLETED|Period 2||2
7932936|NCT00543439|19522059|P2|NOT COMPLETED|Period 2||1
7932937|NCT00543439|19522060|P1|NOT COMPLETED|Period 2||1
7932938|NCT00543439|19522058|P3|COMPLETED|Period 2||23
7932939|NCT00543439|19522059|P2|COMPLETED|Period 2||25
7932940|NCT00543439|19522060|P1|COMPLETED|Period 2||8
7932941|NCT00543439|19522058|P3|STARTED|Period 2||25
7932942|NCT00543439|19522059|P2|STARTED|Period 2||26
7932943|NCT00543439|19522060|P1|STARTED|Period 2||9
7932944|NCT00543439|19522058|P3|NOT COMPLETED|Period 1||2
7932945|NCT00543439|19522059|P2|NOT COMPLETED|Period 1||3
7932946|NCT00543439|19522060|P1|NOT COMPLETED|Period 1||1
7932947|NCT00543439|19522058|P3|COMPLETED|Period 1||25
7932948|NCT00543439|19522059|P2|COMPLETED|Period 1||26
7932949|NCT00543439|19522060|P1|COMPLETED|Period 1||9
7932950|NCT00543439|19522058|P3|Treated|Period 1||27
7932951|NCT00543439|19522059|P2|Treated|Period 1||29
7932952|NCT00543439|19522060|P1|Treated|Period 1||9
7932953|NCT00543439|19522058|P3|STARTED|Period 1||27
7932954|NCT00543439|19522059|P2|STARTED|Period 1||29
7932955|NCT00543439|19522060|P1|STARTED|Period 1||10
7932956|NCT00543400|19522107|P4|NOT COMPLETED|Overall Study||5
7932957|NCT00543400|19522108|P3|NOT COMPLETED|Overall Study||4
7932958|NCT00543400|19522109|P2|NOT COMPLETED|Overall Study||1
7932959|NCT00543400|19522110|P1|NOT COMPLETED|Overall Study||5
7932960|NCT00543400|19522107|P4|COMPLETED|Overall Study||151
7932961|NCT00543400|19522108|P3|COMPLETED|Overall Study||148
7932962|NCT00543400|19522109|P2|COMPLETED|Overall Study||43
7932963|NCT00543400|19522110|P1|COMPLETED|Overall Study||146
7932964|NCT00543400|19522107|P4|STARTED|Overall Study||156
7932965|NCT00543400|19522108|P3|STARTED|Overall Study||152
7932966|NCT00543400|19522109|P2|STARTED|Overall Study||44
7932967|NCT00543400|19522110|P1|STARTED|Overall Study||151
7932968|NCT00543387|19522129|P11|NOT COMPLETED|Crossover Participants||3
7932969|NCT00543387|19522130|P10|NOT COMPLETED|Crossover Participants||1
7932970|NCT00543387|19522131|P9|NOT COMPLETED|Crossover Participants||0
7932971|NCT00543387|19522132|P8|NOT COMPLETED|Crossover Participants||0
7932972|NCT00543387|19522133|P7|NOT COMPLETED|Crossover Participants||0
7932973|NCT00543387|19522134|P6|NOT COMPLETED|Crossover Participants||0
7932974|NCT00543387|19522135|P5|NOT COMPLETED|Crossover Participants||0
7932975|NCT00543387|19522136|P4|NOT COMPLETED|Crossover Participants||0
7932976|NCT00543387|19522137|P3|NOT COMPLETED|Crossover Participants||0
7932977|NCT00543387|19522138|P2|NOT COMPLETED|Crossover Participants||0
7932978|NCT00543387|19522139|P1|NOT COMPLETED|Crossover Participants||0
7932979|NCT00543387|19522129|P11|COMPLETED|Crossover Participants||0
7932980|NCT00543387|19522130|P10|COMPLETED|Crossover Participants||0
7932981|NCT00543387|19522131|P9|COMPLETED|Crossover Participants||0
7932982|NCT00543387|19522132|P8|COMPLETED|Crossover Participants||0
7932983|NCT00543387|19522133|P7|COMPLETED|Crossover Participants||0
7932984|NCT00543387|19522134|P6|COMPLETED|Crossover Participants||0
7932985|NCT00543387|19522135|P5|COMPLETED|Crossover Participants||0
7932986|NCT00543387|19522136|P4|COMPLETED|Crossover Participants||0
7932987|NCT00543387|19522137|P3|COMPLETED|Crossover Participants||0
7932988|NCT00543387|19522138|P2|COMPLETED|Crossover Participants||0
7932989|NCT00543387|19522139|P1|COMPLETED|Crossover Participants||0
7932990|NCT00543387|19522129|P11|STARTED|Crossover Participants|3 participants originally treated with 1500 (2) and 1800 mg (1) MK-5108 in Panel 1 Period 1|3
7932991|NCT00543387|19522130|P10|STARTED|Crossover Participants|Participant originally treated in MK-5108 400 mg BID (Panel 1) in Period 1|1
7932992|NCT00543387|19522131|P9|STARTED|Crossover Participants||0
7932993|NCT00543387|19522132|P8|STARTED|Crossover Participants||0
7932994|NCT00543387|19522133|P7|STARTED|Crossover Participants||0
7932995|NCT00543387|19522134|P6|STARTED|Crossover Participants||0
7932996|NCT00543387|19522135|P5|STARTED|Crossover Participants||0
7932997|NCT00543387|19522136|P4|STARTED|Crossover Participants||0
7932998|NCT00543387|19522137|P3|STARTED|Crossover Participants||0
7932999|NCT00543387|19522138|P2|STARTED|Crossover Participants||0
7933000|NCT00543387|19522139|P1|STARTED|Crossover Participants||0
7933001|NCT00543387|19522129|P11|NOT COMPLETED|Panel 1 + Panel 2||0
7933002|NCT00543387|19522130|P10|NOT COMPLETED|Panel 1 + Panel 2||0
7933003|NCT00543387|19522131|P9|NOT COMPLETED|Panel 1 + Panel 2||5
7933004|NCT00543387|19522132|P8|NOT COMPLETED|Panel 1 + Panel 2||6
7933005|NCT00543387|19522133|P7|NOT COMPLETED|Panel 1 + Panel 2||6
7933006|NCT00543387|19522134|P6|NOT COMPLETED|Panel 1 + Panel 2||3
7933007|NCT00543387|19522135|P5|NOT COMPLETED|Panel 1 + Panel 2||3
7933008|NCT00543387|19522136|P4|NOT COMPLETED|Panel 1 + Panel 2||3
7933009|NCT00543387|19522137|P3|NOT COMPLETED|Panel 1 + Panel 2||3
7933010|NCT00543387|19522138|P2|NOT COMPLETED|Panel 1 + Panel 2||3
7933011|NCT00543387|19522139|P1|NOT COMPLETED|Panel 1 + Panel 2||3
7933012|NCT00543387|19522129|P11|COMPLETED|Panel 1 + Panel 2||0
7933013|NCT00543387|19522130|P10|COMPLETED|Panel 1 + Panel 2||0
7933014|NCT00543387|19522131|P9|COMPLETED|Panel 1 + Panel 2||0
7933015|NCT00543387|19522132|P8|COMPLETED|Panel 1 + Panel 2||0
7933016|NCT00543387|19522133|P7|COMPLETED|Panel 1 + Panel 2||0
7933017|NCT00543387|19522134|P6|COMPLETED|Panel 1 + Panel 2||0
7933018|NCT00543387|19522135|P5|COMPLETED|Panel 1 + Panel 2||0
7933019|NCT00543387|19522136|P4|COMPLETED|Panel 1 + Panel 2||0
7933020|NCT00543387|19522137|P3|COMPLETED|Panel 1 + Panel 2||0
7933021|NCT00543387|19522138|P2|COMPLETED|Panel 1 + Panel 2||0
7933022|NCT00543387|19522139|P1|COMPLETED|Panel 1 + Panel 2||0
7933023|NCT00543387|19522129|P11|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
7933024|NCT00543387|19522130|P10|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
7933025|NCT00543387|19522131|P9|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
7933026|NCT00543387|19522132|P8|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
7933027|NCT00543387|19522133|P7|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
7933028|NCT00543387|19522134|P6|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
7933029|NCT00543387|19522135|P5|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||2
7933030|NCT00543387|19522136|P4|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
7933031|NCT00543387|19522137|P3|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
7933032|NCT00543387|19522138|P2|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
7933033|NCT00543387|19522139|P1|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
7933034|NCT00543387|19522129|P11|STARTED|Panel 1 + Panel 2||0
7933035|NCT00543387|19522130|P10|STARTED|Panel 1 + Panel 2||0
7933036|NCT00543387|19522131|P9|STARTED|Panel 1 + Panel 2||5
7933037|NCT00543387|19522132|P8|STARTED|Panel 1 + Panel 2||6
7933038|NCT00543387|19522133|P7|STARTED|Panel 1 + Panel 2||6
7933039|NCT00543387|19522134|P6|STARTED|Panel 1 + Panel 2||3
7933040|NCT00543387|19522135|P5|STARTED|Panel 1 + Panel 2||3
7933041|NCT00543387|19522136|P4|STARTED|Panel 1 + Panel 2||3
7933042|NCT00543387|19522137|P3|STARTED|Panel 1 + Panel 2||3
7933043|NCT00543387|19522138|P2|STARTED|Panel 1 + Panel 2||3
7933044|NCT00543387|19522139|P1|STARTED|Panel 1 + Panel 2||3
7933045|NCT00543309|19522177|P3|NOT COMPLETED|Overall Study||0
7933046|NCT00543309|19522178|P2|NOT COMPLETED|Overall Study||1
7933047|NCT00543309|19522179|P1|NOT COMPLETED|Overall Study||0
7933048|NCT00543309|19522177|P3|COMPLETED|Overall Study||35
7933049|NCT00543309|19522178|P2|COMPLETED|Overall Study||35
7933050|NCT00543309|19522179|P1|COMPLETED|Overall Study||35
7933051|NCT00543309|19522177|P3|STARTED|Overall Study||35
7933052|NCT00543309|19522178|P2|STARTED|Overall Study||36
7933053|NCT00543309|19522179|P1|STARTED|Overall Study||35
7933054|NCT00543296|19522229|P1|NOT COMPLETED|Overall Study||7
7933055|NCT00543296|19522229|P1|COMPLETED|Overall Study||14
7933056|NCT00543296|19522229|P1|STARTED|Overall Study||21
7933057|NCT00543140|19522236|P1|NOT COMPLETED|Overall Study||72
7933058|NCT00543140|19522236|P1|COMPLETED|Overall Study||231
7933059|NCT00543140|19522236|P1|STARTED|Overall Study||303
7933060|NCT00543127|19522246|P2|NOT COMPLETED|Overall Study||87
7933061|NCT00543127|19522247|P1|NOT COMPLETED|Overall Study||130
7933062|NCT00543127|19522246|P2|COMPLETED|Overall Study||350
7933063|NCT00543127|19522247|P1|COMPLETED|Overall Study||303
7933064|NCT00543127|19522246|P2|STARTED|Overall Study||437
7933065|NCT00543127|19522247|P1|STARTED|Overall Study||433
7933066|NCT00543101|19522261|P2|NOT COMPLETED|Overall Study||0
7933067|NCT00543101|19522262|P1|NOT COMPLETED|Overall Study||0
7933068|NCT00543101|19522261|P2|COMPLETED|Overall Study||12
7933069|NCT00543101|19522262|P1|COMPLETED|Overall Study||12
7933070|NCT00543101|19522261|P2|STARTED|Overall Study||12
7933071|NCT00543101|19522262|P1|STARTED|Overall Study||12
7933072|NCT00543062|19522274|P4|NOT COMPLETED|Overall Study||1
7933073|NCT00543062|19522275|P3|NOT COMPLETED|Overall Study||3
7933074|NCT00543062|19522276|P2|NOT COMPLETED|Overall Study||1
7933075|NCT00543062|19522277|P1|NOT COMPLETED|Overall Study||2
7933076|NCT00543062|19522274|P4|COMPLETED|Overall Study||11
7933077|NCT00543062|19522275|P3|COMPLETED|Overall Study||9
7933078|NCT00543062|19522276|P2|COMPLETED|Overall Study||11
7933079|NCT00543062|19522277|P1|COMPLETED|Overall Study||10
7933080|NCT00543062|19522274|P4|STARTED|Overall Study||12
7933081|NCT00543062|19522275|P3|STARTED|Overall Study||12
7933082|NCT00543062|19522276|P2|STARTED|Overall Study||12
7933083|NCT00543062|19522277|P1|STARTED|Overall Study||12
7933084|NCT00542997|19522299|P1|NOT COMPLETED|Efficacy Period||3
7933085|NCT00542997|19522299|P1|COMPLETED|Efficacy Period||43
7933086|NCT00542997|19522299|P1|STARTED|Efficacy Period||46
7933087|NCT00542997|19522299|P1|NOT COMPLETED|Wash in / Wash Out Period||5
7933088|NCT00542997|19522299|P1|COMPLETED|Wash in / Wash Out Period||46
7933089|NCT00542997|19522299|P1|STARTED|Wash in / Wash Out Period||51
7933090|NCT00542971|19522314|P1|NOT COMPLETED|Overall Study||0
7933091|NCT00542971|19522314|P1|COMPLETED|Overall Study||75
7933092|NCT00542971|19522314|P1|STARTED|Overall Study||75
7933093|NCT00542919|19522322|P3|NOT COMPLETED|Overall Study||6
7933094|NCT00542919|19522323|P2|NOT COMPLETED|Overall Study||7
7933095|NCT00542919|19522324|P1|NOT COMPLETED|Overall Study||7
7933096|NCT00542919|19522322|P3|COMPLETED|Overall Study||9
7933097|NCT00542919|19522323|P2|COMPLETED|Overall Study||12
7933098|NCT00542919|19522324|P1|COMPLETED|Overall Study||16
7933099|NCT00542919|19522322|P3|Death|Overall Study||2
7933100|NCT00542919|19522323|P2|Death|Overall Study||1
7933101|NCT00542919|19522324|P1|Death|Overall Study||1
7933102|NCT00542919|19522322|P3|Progressive Disease|Overall Study||7
7933103|NCT00542919|19522323|P2|Progressive Disease|Overall Study||11
7933104|NCT00542919|19522324|P1|Progressive Disease|Overall Study||15
7933105|NCT00542919|19522322|P3|Received At Least One Dose of Study Drug|Overall Study||15
7933106|NCT00542919|19522323|P2|Received At Least One Dose of Study Drug|Overall Study||19
7933107|NCT00542919|19522324|P1|Received At Least One Dose of Study Drug|Overall Study||23
7933108|NCT00542919|19522322|P3|STARTED|Overall Study||15
7933109|NCT00542919|19522323|P2|STARTED|Overall Study||19
7933110|NCT00542919|19522324|P1|STARTED|Overall Study||23
7933111|NCT00542880|19522369|P2|NOT COMPLETED|Period 3||2
7933112|NCT00542880|19522370|P1|NOT COMPLETED|Period 3||0
7933113|NCT00542880|19522369|P2|COMPLETED|Period 3||201
7933114|NCT00542880|19522370|P1|COMPLETED|Period 3||204
7933115|NCT00542880|19522369|P2|STARTED|Period 3||203
7933116|NCT00542880|19522370|P1|STARTED|Period 3||204
7933117|NCT00542880|19522369|P2|NOT COMPLETED|Period 2||10
7933118|NCT00542880|19522370|P1|NOT COMPLETED|Period 2||7
7933119|NCT00542880|19522369|P2|COMPLETED|Period 2||203
7933120|NCT00542880|19522370|P1|COMPLETED|Period 2||204
7933121|NCT00542880|19522369|P2|STARTED|Period 2||213
7933122|NCT00542880|19522370|P1|STARTED|Period 2||211
7933123|NCT00542880|19522369|P2|NOT COMPLETED|Period 1||12
7933124|NCT00542880|19522370|P1|NOT COMPLETED|Period 1||6
7933125|NCT00542880|19522369|P2|COMPLETED|Period 1||213
7933126|NCT00542880|19522370|P1|COMPLETED|Period 1||211
7933127|NCT00542880|19522369|P2|STARTED|Period 1||225
7933128|NCT00542880|19522370|P1|STARTED|Period 1|This was a cross-over study|217
7933129|NCT00542828|19522406|P1|NOT COMPLETED|Overall Study||13
7933213|NCT00542386|19522586|P2|STARTED|Overall Study||102
7933130|NCT00542828|19522406|P1|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3
7933131|NCT00542828|19522406|P1|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16
7933132|NCT00542815|19522424|P3|NOT COMPLETED|Overall Study||32
7933133|NCT00542815|19522425|P2|NOT COMPLETED|Overall Study||32
7933134|NCT00542815|19522426|P1|NOT COMPLETED|Overall Study||106
7933135|NCT00542815|19522424|P3|COMPLETED|Overall Study||92
7933136|NCT00542815|19522425|P2|COMPLETED|Overall Study||44
7933137|NCT00542815|19522426|P1|COMPLETED|Overall Study||326
7933138|NCT00542815|19522424|P3|STARTED|Overall Study||124
7933139|NCT00542815|19522425|P2|STARTED|Overall Study||76
7933140|NCT00542815|19522426|P1|STARTED|Overall Study||432
7933141|NCT00542789|19522439|P2|NOT COMPLETED|Overall Study||78
7933142|NCT00542789|19522440|P1|NOT COMPLETED|Overall Study||41
7933143|NCT00542789|19522439|P2|COMPLETED|Overall Study||90
7933144|NCT00542789|19522440|P1|COMPLETED|Overall Study||134
7933145|NCT00542789|19522439|P2|STARTED|Overall Study|Randomised|168
7933146|NCT00542789|19522440|P1|STARTED|Overall Study|Randomised|175
7933147|NCT00542750|19522450|P1|NOT COMPLETED|Overall Study||0
7933148|NCT00542750|19522450|P1|COMPLETED|Overall Study||24
7933149|NCT00542750|19522450|P1|STARTED|Overall Study||24
7933150|NCT00542620|19522456|P2|NOT COMPLETED|Overall Study||0
7933151|NCT00542620|19522457|P1|NOT COMPLETED|Overall Study||0
7933152|NCT00542620|19522456|P2|COMPLETED|Overall Study||12
7933153|NCT00542620|19522457|P1|COMPLETED|Overall Study||13
7933154|NCT00542620|19522456|P2|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13
7933155|NCT00542620|19522457|P1|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12
7933156|NCT00542620|19522456|P2|STARTED|Overall Study||12
7933157|NCT00542620|19522457|P1|STARTED|Overall Study||13
7933158|NCT00542542|19522523|P2|NOT COMPLETED|Overall Study||0
7933159|NCT00542542|19522524|P1|NOT COMPLETED|Overall Study||0
7933160|NCT00542542|19522523|P2|COMPLETED|Overall Study||44
7933161|NCT00542542|19522524|P1|COMPLETED|Overall Study||44
7933162|NCT00542542|19522523|P2|STARTED|Overall Study||44
7933163|NCT00542542|19522524|P1|STARTED|Overall Study||44
7933164|NCT00542490|19522530|P1|NOT COMPLETED|Overall Study||2
7933165|NCT00542490|19522530|P1|COMPLETED|Overall Study||21
7933166|NCT00542490|19522530|P1|STARTED|Overall Study||23
7933167|NCT00542425|19522540|P5|NOT COMPLETED|Extended 24 Weeks of Treatment||1
7933168|NCT00542425|19522541|P4|NOT COMPLETED|Extended 24 Weeks of Treatment||1
7933169|NCT00542425|19522542|P3|NOT COMPLETED|Extended 24 Weeks of Treatment||2
7933170|NCT00542425|19522543|P2|NOT COMPLETED|Extended 24 Weeks of Treatment||2
7933171|NCT00542425|19522544|P1|NOT COMPLETED|Extended 24 Weeks of Treatment||1
7933172|NCT00542425|19522540|P5|COMPLETED|Extended 24 Weeks of Treatment||13
7933173|NCT00542425|19522541|P4|COMPLETED|Extended 24 Weeks of Treatment||6
7933174|NCT00542425|19522542|P3|COMPLETED|Extended 24 Weeks of Treatment||8
7933175|NCT00542425|19522543|P2|COMPLETED|Extended 24 Weeks of Treatment||11
7933176|NCT00542425|19522544|P1|COMPLETED|Extended 24 Weeks of Treatment||10
7933177|NCT00542425|19522540|P5|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14
7933178|NCT00542425|19522541|P4|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7
7933179|NCT00542425|19522542|P3|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10
7933180|NCT00542425|19522543|P2|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13
7933181|NCT00542425|19522544|P1|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11
7933182|NCT00542425|19522540|P5|NOT COMPLETED|Initial 24 Weeks||6
7933183|NCT00542425|19522541|P4|NOT COMPLETED|Initial 24 Weeks||11
7933184|NCT00542425|19522542|P3|NOT COMPLETED|Initial 24 Weeks||7
7933185|NCT00542425|19522543|P2|NOT COMPLETED|Initial 24 Weeks||10
7933186|NCT00542425|19522544|P1|NOT COMPLETED|Initial 24 Weeks||4
7933187|NCT00542425|19522540|P5|COMPLETED|Initial 24 Weeks||39
7933188|NCT00542425|19522541|P4|COMPLETED|Initial 24 Weeks||34
7933189|NCT00542425|19522542|P3|COMPLETED|Initial 24 Weeks||36
7933190|NCT00542425|19522543|P2|COMPLETED|Initial 24 Weeks||33
7933191|NCT00542425|19522544|P1|COMPLETED|Initial 24 Weeks||42
7933192|NCT00542425|19522540|P5|STARTED|Initial 24 Weeks||45
7933193|NCT00542425|19522541|P4|STARTED|Initial 24 Weeks||45
7933194|NCT00542425|19522542|P3|STARTED|Initial 24 Weeks||43
7933195|NCT00542425|19522543|P2|STARTED|Initial 24 Weeks||43
7933196|NCT00542425|19522544|P1|STARTED|Initial 24 Weeks||46
7933197|NCT00542386|19522582|P6|NOT COMPLETED|Overall Study||50
7933198|NCT00542386|19522583|P5|NOT COMPLETED|Overall Study||40
7933199|NCT00542386|19522584|P4|NOT COMPLETED|Overall Study||38
7933200|NCT00542386|19522585|P3|NOT COMPLETED|Overall Study||33
7933201|NCT00542386|19522586|P2|NOT COMPLETED|Overall Study||28
7933202|NCT00542386|19522587|P1|NOT COMPLETED|Overall Study||43
7933203|NCT00542386|19522582|P6|COMPLETED|Overall Study||82
7933204|NCT00542386|19522583|P5|COMPLETED|Overall Study||62
7933205|NCT00542386|19522584|P4|COMPLETED|Overall Study||65
7933206|NCT00542386|19522585|P3|COMPLETED|Overall Study||66
7933207|NCT00542386|19522586|P2|COMPLETED|Overall Study||74
7933208|NCT00542386|19522587|P1|COMPLETED|Overall Study||61
7933209|NCT00542386|19522582|P6|STARTED|Overall Study||132
7933210|NCT00542386|19522583|P5|STARTED|Overall Study||102
7933211|NCT00542386|19522584|P4|STARTED|Overall Study||103
7933212|NCT00542386|19522585|P3|STARTED|Overall Study||99
7933214|NCT00542386|19522587|P1|STARTED|Overall Study||104
7933215|NCT00542321|19522609|P2|NOT COMPLETED|Overall Study||1
7933216|NCT00542321|19522610|P1|NOT COMPLETED|Overall Study||0
7933217|NCT00542321|19522609|P2|COMPLETED|Overall Study||7
7933218|NCT00542321|19522610|P1|COMPLETED|Overall Study||8
7933219|NCT00542321|19522609|P2|STARTED|Overall Study||8
7933220|NCT00542321|19522610|P1|STARTED|Overall Study||8
7933221|NCT00542308|19522624|P1|NOT COMPLETED|Overall Study||0
7933222|NCT00542308|19522624|P1|COMPLETED|Overall Study||90
7933223|NCT00542308|19522624|P1|STARTED|Overall Study||90
7933224|NCT00542269|19522632|P3|NOT COMPLETED|Overall Study||6
7933225|NCT00542269|19522633|P2|NOT COMPLETED|Overall Study||6
7933226|NCT00542269|19522634|P1|NOT COMPLETED|Overall Study||13
7933227|NCT00542269|19522632|P3|COMPLETED|Overall Study||51
7933228|NCT00542269|19522633|P2|COMPLETED|Overall Study||54
7933229|NCT00542269|19522634|P1|COMPLETED|Overall Study||48
7933230|NCT00542269|19522632|P3|STARTED|Overall Study||57
7933231|NCT00542269|19522633|P2|STARTED|Overall Study||60
7933232|NCT00542269|19522634|P1|STARTED|Overall Study||61
7933233|NCT00542191|19522663|P1|NOT COMPLETED|Overall Study||3
7933234|NCT00542191|19522663|P1|COMPLETED|Overall Study||18
7933235|NCT00542191|19522663|P1|STARTED|Overall Study||21
7933236|NCT00542178|19522673|P8|NOT COMPLETED|Overall Study||85
7933237|NCT00542178|19522674|P7|NOT COMPLETED|Overall Study||87
7933238|NCT00542178|19522675|P6|NOT COMPLETED|Overall Study||89
7933239|NCT00542178|19522676|P5|NOT COMPLETED|Overall Study||64
7933240|NCT00542178|19522677|P4|NOT COMPLETED|Overall Study||62
7933241|NCT00542178|19522678|P3|NOT COMPLETED|Overall Study||74
7933242|NCT00542178|19522679|P2|NOT COMPLETED|Overall Study||80
7933243|NCT00542178|19522680|P1|NOT COMPLETED|Overall Study||75
7933244|NCT00542178|19522673|P8|COMPLETED|Overall Study||381
7933245|NCT00542178|19522674|P7|COMPLETED|Overall Study||406
7933246|NCT00542178|19522675|P6|COMPLETED|Overall Study||406
7933247|NCT00542178|19522676|P5|COMPLETED|Overall Study||400
7933248|NCT00542178|19522677|P4|COMPLETED|Overall Study||308
7933249|NCT00542178|19522678|P3|COMPLETED|Overall Study||308
7933250|NCT00542178|19522679|P2|COMPLETED|Overall Study||332
7933251|NCT00542178|19522680|P1|COMPLETED|Overall Study||315
7933252|NCT00542178|19522673|P8|STARTED|Overall Study||466
7933253|NCT00542178|19522674|P7|STARTED|Overall Study||493
7933254|NCT00542178|19522675|P6|STARTED|Overall Study||495
7933255|NCT00542178|19522676|P5|STARTED|Overall Study||464
7933256|NCT00542178|19522677|P4|STARTED|Overall Study||370
7933257|NCT00542178|19522678|P3|STARTED|Overall Study||382
7933258|NCT00542178|19522679|P2|STARTED|Overall Study||412
7933259|NCT00542178|19522680|P1|STARTED|Overall Study||390
7933260|NCT00541970|19522716|P4|NOT COMPLETED|Month 60||72
7933261|NCT00541970|19522717|P3|NOT COMPLETED|Month 60||82
7933262|NCT00541970|19522718|P2|NOT COMPLETED|Month 60||77
7933263|NCT00541970|19522719|P1|NOT COMPLETED|Month 60||78
7933264|NCT00541970|19522716|P4|COMPLETED|Month 60||167
7933265|NCT00541970|19522717|P3|COMPLETED|Month 60||158
7933266|NCT00541970|19522718|P2|COMPLETED|Month 60||164
7933267|NCT00541970|19522719|P1|COMPLETED|Month 60||162
7933268|NCT00541970|19522716|P4|STARTED|Month 60||239
7933269|NCT00541970|19522717|P3|STARTED|Month 60||240
7933270|NCT00541970|19522718|P2|STARTED|Month 60||241
7933271|NCT00541970|19522719|P1|STARTED|Month 60||240
7933272|NCT00541970|19522716|P4|NOT COMPLETED|Month 48||75
7933273|NCT00541970|19522717|P3|NOT COMPLETED|Month 48||73
7933274|NCT00541970|19522718|P2|NOT COMPLETED|Month 48||73
7933275|NCT00541970|19522719|P1|NOT COMPLETED|Month 48||71
7933276|NCT00541970|19522716|P4|COMPLETED|Month 48||164
7933277|NCT00541970|19522717|P3|COMPLETED|Month 48||167
7933278|NCT00541970|19522718|P2|COMPLETED|Month 48||168
7933279|NCT00541970|19522719|P1|COMPLETED|Month 48||169
7933280|NCT00541970|19522716|P4|STARTED|Month 48||239
7933281|NCT00541970|19522717|P3|STARTED|Month 48||240
7933282|NCT00541970|19522718|P2|STARTED|Month 48||241
7933283|NCT00541970|19522719|P1|STARTED|Month 48||240
7933284|NCT00541970|19522716|P4|NOT COMPLETED|Month 36||60
7933285|NCT00541970|19522717|P3|NOT COMPLETED|Month 36||66
7933286|NCT00541970|19522718|P2|NOT COMPLETED|Month 36||66
7933287|NCT00541970|19522719|P1|NOT COMPLETED|Month 36||61
7933288|NCT00541970|19522716|P4|COMPLETED|Month 36||179
7933289|NCT00541970|19522717|P3|COMPLETED|Month 36||174
7933290|NCT00541970|19522718|P2|COMPLETED|Month 36||175
7933291|NCT00541970|19522719|P1|COMPLETED|Month 36||179
7933292|NCT00541970|19522716|P4|STARTED|Month 36||239
7933293|NCT00541970|19522717|P3|STARTED|Month 36||240
7933294|NCT00541970|19522718|P2|STARTED|Month 36||241
7933295|NCT00541970|19522719|P1|STARTED|Month 36||240
7933296|NCT00541970|19522716|P4|NOT COMPLETED|Month 24||22
7933297|NCT00541970|19522717|P3|NOT COMPLETED|Month 24||32
7933298|NCT00541970|19522718|P2|NOT COMPLETED|Month 24||32
7933299|NCT00541970|19522719|P1|NOT COMPLETED|Month 24||29
7933300|NCT00541970|19522716|P4|COMPLETED|Month 24||217
7933301|NCT00541970|19522717|P3|COMPLETED|Month 24||208
7933302|NCT00541970|19522718|P2|COMPLETED|Month 24||209
7933303|NCT00541970|19522719|P1|COMPLETED|Month 24||211
7933304|NCT00541970|19522716|P4|STARTED|Month 24||239
7933305|NCT00541970|19522717|P3|STARTED|Month 24||240
7933306|NCT00541970|19522718|P2|STARTED|Month 24||241
7933307|NCT00541970|19522719|P1|STARTED|Month 24||240
7933308|NCT00541970|19522716|P4|NOT COMPLETED|Month 18||17
7933309|NCT00541970|19522717|P3|NOT COMPLETED|Month 18||25
7933310|NCT00541970|19522718|P2|NOT COMPLETED|Month 18||24
7933311|NCT00541970|19522719|P1|NOT COMPLETED|Month 18||14
7933312|NCT00541970|19522716|P4|COMPLETED|Month 18||222
7933313|NCT00541970|19522717|P3|COMPLETED|Month 18||215
7933314|NCT00541970|19522718|P2|COMPLETED|Month 18||217
7933315|NCT00541970|19522719|P1|COMPLETED|Month 18||226
7933316|NCT00541970|19522716|P4|STARTED|Month 18||239
7933317|NCT00541970|19522717|P3|STARTED|Month 18||240
7933318|NCT00541970|19522718|P2|STARTED|Month 18||241
7933319|NCT00541970|19522719|P1|STARTED|Month 18||240
7933320|NCT00541970|19522716|P4|NOT COMPLETED|Month 12||16
7933321|NCT00541970|19522717|P3|NOT COMPLETED|Month 12||21
7933322|NCT00541970|19522718|P2|NOT COMPLETED|Month 12||22
7933323|NCT00541970|19522719|P1|NOT COMPLETED|Month 12||12
7933324|NCT00541970|19522716|P4|COMPLETED|Month 12||223
7933325|NCT00541970|19522717|P3|COMPLETED|Month 12||219
7933326|NCT00541970|19522718|P2|COMPLETED|Month 12||219
7933327|NCT00541970|19522719|P1|COMPLETED|Month 12||228
7933328|NCT00541970|19522716|P4|STARTED|Month 12||239
7933329|NCT00541970|19522717|P3|STARTED|Month 12||240
7933330|NCT00541970|19522718|P2|STARTED|Month 12||241
7933331|NCT00541970|19522719|P1|STARTED|Month 12||240
7933332|NCT00541970|19522716|P4|NOT COMPLETED|Month 7||5
7933333|NCT00541970|19522717|P3|NOT COMPLETED|Month 7||11
7933334|NCT00541970|19522718|P2|NOT COMPLETED|Month 7||13
7933335|NCT00541970|19522719|P1|NOT COMPLETED|Month 7||9
7933336|NCT00541970|19522716|P4|COMPLETED|Month 7||234
7933337|NCT00541970|19522717|P3|COMPLETED|Month 7||229
7933338|NCT00541970|19522718|P2|COMPLETED|Month 7||228
7933339|NCT00541970|19522719|P1|COMPLETED|Month 7||231
7933340|NCT00541970|19522716|P4|STARTED|Month 7||239
7933341|NCT00541970|19522717|P3|STARTED|Month 7||240
7933342|NCT00541970|19522718|P2|STARTED|Month 7||241
7933343|NCT00541970|19522719|P1|STARTED|Month 7||240
7933344|NCT00541931|19522870|P2|NOT COMPLETED|Overall Study||4
7933345|NCT00541931|19522871|P1|NOT COMPLETED|Overall Study||5
7933346|NCT00541931|19522870|P2|COMPLETED|Overall Study||11
7933347|NCT00541931|19522871|P1|COMPLETED|Overall Study||17
7933348|NCT00541931|19522870|P2|STARTED|Overall Study||15
7933349|NCT00541931|19522871|P1|STARTED|Overall Study||22
7933350|NCT00541866|19522884|P5|NOT COMPLETED|Overall Study||15
7933351|NCT00541866|19522885|P4|NOT COMPLETED|Overall Study||16
7933352|NCT00541866|19522886|P3|NOT COMPLETED|Overall Study||15
7933353|NCT00541866|19522887|P2|NOT COMPLETED|Overall Study||18
7933354|NCT00541866|19522888|P1|NOT COMPLETED|Overall Study||34
7933355|NCT00541866|19522884|P5|COMPLETED|Overall Study||3
7933356|NCT00541866|19522885|P4|COMPLETED|Overall Study||0
7933357|NCT00541866|19522886|P3|COMPLETED|Overall Study||2
7933358|NCT00541866|19522887|P2|COMPLETED|Overall Study||0
7933359|NCT00541866|19522888|P1|COMPLETED|Overall Study||7
7933360|NCT00541866|19522884|P5|STARTED|Overall Study||18
7933361|NCT00541866|19522885|P4|STARTED|Overall Study||16
7933362|NCT00541866|19522886|P3|STARTED|Overall Study||17
7933363|NCT00541866|19522887|P2|STARTED|Overall Study||18
7933364|NCT00541866|19522888|P1|STARTED|Overall Study|41 started, but only 39 treated|41
7933365|NCT00541775|19522929|P3|NOT COMPLETED|Overall Study||8
7933366|NCT00541775|19522930|P2|NOT COMPLETED|Overall Study||2
7933367|NCT00541775|19522931|P1|NOT COMPLETED|Overall Study||9
7933368|NCT00541775|19522929|P3|COMPLETED|Overall Study||84
7933369|NCT00541775|19522930|P2|COMPLETED|Overall Study||85
7933370|NCT00541775|19522931|P1|COMPLETED|Overall Study||85
7933371|NCT00541775|19522929|P3|STARTED|Overall Study||92
7933372|NCT00541775|19522930|P2|STARTED|Overall Study||87
7933373|NCT00541775|19522931|P1|STARTED|Overall Study||94
7933374|NCT00541671|19522947|P2|NOT COMPLETED|Overall Study||0
7933375|NCT00541671|19522948|P1|NOT COMPLETED|Overall Study||0
7933376|NCT00541671|19522947|P2|COMPLETED|Overall Study||12
7933377|NCT00541671|19522948|P1|COMPLETED|Overall Study||13
7933378|NCT00541671|19522947|P2|STARTED|Overall Study||12
7933379|NCT00541671|19522948|P1|STARTED|Overall Study||13
7933380|NCT00541658|19522957|P3|NOT COMPLETED|Overall Study||68
7933381|NCT00541658|19522958|P2|NOT COMPLETED|Overall Study||73
7933382|NCT00541658|19522959|P1|NOT COMPLETED|Overall Study||60
7933383|NCT00541658|19522957|P3|COMPLETED|Overall Study||240
7933384|NCT00541658|19522958|P2|COMPLETED|Overall Study||234
7933385|NCT00541658|19522959|P1|COMPLETED|Overall Study||248
7933386|NCT00541658|19522957|P3|ITT Population|Overall Study||308
7933387|NCT00541658|19522958|P2|ITT Population|Overall Study||307
7933388|NCT00541658|19522959|P1|ITT Population|Overall Study||307
7933389|NCT00541658|19522957|P3|STARTED|Overall Study||308
7933390|NCT00541658|19522958|P2|STARTED|Overall Study||307
7933391|NCT00541658|19522959|P1|STARTED|Overall Study||308
7933392|NCT00541593|19523116|P1|NOT COMPLETED|Overall Study||0
7933393|NCT00541593|19523116|P1|COMPLETED|Overall Study||5
7933394|NCT00541593|19523116|P1|STARTED|Overall Study||5
7933395|NCT00541450|19523122|P2|NOT COMPLETED|Phase B||31
7933396|NCT00541450|19523123|P1|NOT COMPLETED|Phase B||37
7933397|NCT00541450|19523122|P2|COMPLETED|Phase B||200
7933398|NCT00541450|19523123|P1|COMPLETED|Phase B||187
7933399|NCT00541450|19523122|P2|STARTED|Phase B||231
7933400|NCT00541450|19523123|P1|STARTED|Phase B||224
7933401|NCT00541450|19523122|P2|NOT COMPLETED|Phase A||17
7933402|NCT00541450|19523123|P1|NOT COMPLETED|Phase A||20
7933403|NCT00541450|19523122|P2|COMPLETED|Phase A||231
7933404|NCT00541450|19523123|P1|COMPLETED|Phase A||224
7933405|NCT00541450|19523122|P2|STARTED|Phase A||248
7933406|NCT00541450|19523123|P1|STARTED|Phase A||244
7933407|NCT00541346|19523141|P1|NOT COMPLETED|Follow-up||1
7933408|NCT00541346|19523141|P1|COMPLETED|Follow-up||15
7933409|NCT00541346|19523141|P1|STARTED|Follow-up||16
7933410|NCT00541346|19523141|P1|NOT COMPLETED|Baseline||0
7933411|NCT00541346|19523141|P1|COMPLETED|Baseline||16
7933412|NCT00541346|19523141|P1|STARTED|Baseline||16
7933413|NCT00541307|19523155|P1|NOT COMPLETED|Overall Study||24
7933414|NCT00541307|19523155|P1|COMPLETED|Overall Study||95
7933415|NCT00541307|19523155|P1|STARTED|Overall Study||119
7933416|NCT00541242|19523165|P2|NOT COMPLETED|Treatment Period 2||7
7933417|NCT00541242|19523166|P1|NOT COMPLETED|Treatment Period 2||9
7933418|NCT00541242|19523165|P2|COMPLETED|Treatment Period 2||266
7933419|NCT00541242|19523166|P1|COMPLETED|Treatment Period 2||261
7933420|NCT00541242|19523165|P2|STARTED|Treatment Period 2||273
7933421|NCT00541242|19523166|P1|STARTED|Treatment Period 2||270
7933422|NCT00541242|19523165|P2|NOT COMPLETED|Treatment Period 1||0
7933423|NCT00541242|19523166|P1|NOT COMPLETED|Treatment Period 1||0
7933424|NCT00541242|19523165|P2|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586
7933425|NCT00541242|19523166|P1|COMPLETED|Treatment Period 1||0
7933426|NCT00541242|19523165|P2|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586
7933427|NCT00541242|19523166|P1|STARTED|Treatment Period 1||0
7933428|NCT00541229|19523180|P6|NOT COMPLETED|Treatment Period III (Week 11)||1
7933429|NCT00541229|19523181|P5|NOT COMPLETED|Treatment Period III (Week 11)||1
7933430|NCT00541229|19523182|P4|NOT COMPLETED|Treatment Period III (Week 11)||0
7933431|NCT00541229|19523183|P3|NOT COMPLETED|Treatment Period III (Week 11)||1
7933432|NCT00541229|19523184|P2|NOT COMPLETED|Treatment Period III (Week 11)||0
7933433|NCT00541229|19523185|P1|NOT COMPLETED|Treatment Period III (Week 11)||0
7933434|NCT00541229|19523180|P6|COMPLETED|Treatment Period III (Week 11)||4
7933435|NCT00541229|19523181|P5|COMPLETED|Treatment Period III (Week 11)||6
7933436|NCT00541229|19523182|P4|COMPLETED|Treatment Period III (Week 11)||8
7933437|NCT00541229|19523183|P3|COMPLETED|Treatment Period III (Week 11)||9
7933438|NCT00541229|19523184|P2|COMPLETED|Treatment Period III (Week 11)||8
7933439|NCT00541229|19523185|P1|COMPLETED|Treatment Period III (Week 11)||7
7933440|NCT00541229|19523180|P6|STARTED|Treatment Period III (Week 11)||5
7933441|NCT00541229|19523181|P5|STARTED|Treatment Period III (Week 11)||7
7933442|NCT00541229|19523182|P4|STARTED|Treatment Period III (Week 11)||8
7933443|NCT00541229|19523183|P3|STARTED|Treatment Period III (Week 11)||10
7933444|NCT00541229|19523184|P2|STARTED|Treatment Period III (Week 11)||8
7933445|NCT00541229|19523185|P1|STARTED|Treatment Period III (Week 11)||7
7933446|NCT00541229|19523180|P6|NOT COMPLETED|Washout Period II (Week 7-10)||3
7933447|NCT00541229|19523181|P5|NOT COMPLETED|Washout Period II (Week 7-10)||4
7933448|NCT00541229|19523182|P4|NOT COMPLETED|Washout Period II (Week 7-10)||4
7933449|NCT00541229|19523183|P3|NOT COMPLETED|Washout Period II (Week 7-10)||2
7933450|NCT00541229|19523184|P2|NOT COMPLETED|Washout Period II (Week 7-10)||4
7933451|NCT00541229|19523185|P1|NOT COMPLETED|Washout Period II (Week 7-10)||4
7933452|NCT00541229|19523180|P6|COMPLETED|Washout Period II (Week 7-10)||5
7933453|NCT00541229|19523181|P5|COMPLETED|Washout Period II (Week 7-10)||7
7933454|NCT00541229|19523182|P4|COMPLETED|Washout Period II (Week 7-10)||8
7933455|NCT00541229|19523183|P3|COMPLETED|Washout Period II (Week 7-10)||10
7933456|NCT00541229|19523184|P2|COMPLETED|Washout Period II (Week 7-10)||8
7933457|NCT00541229|19523185|P1|COMPLETED|Washout Period II (Week 7-10)||7
7933458|NCT00541229|19523180|P6|STARTED|Washout Period II (Week 7-10)||8
7933459|NCT00541229|19523181|P5|STARTED|Washout Period II (Week 7-10)||11
7933460|NCT00541229|19523182|P4|STARTED|Washout Period II (Week 7-10)||12
7933461|NCT00541229|19523183|P3|STARTED|Washout Period II (Week 7-10)||12
7933462|NCT00541229|19523184|P2|STARTED|Washout Period II (Week 7-10)||12
7933463|NCT00541229|19523185|P1|STARTED|Washout Period II (Week 7-10)||11
7933464|NCT00541229|19523180|P6|NOT COMPLETED|Treatment Period II (Week 6)||3
7933465|NCT00541229|19523181|P5|NOT COMPLETED|Treatment Period II (Week 6)||2
7933466|NCT00541229|19523182|P4|NOT COMPLETED|Treatment Period II (Week 6)||1
7933467|NCT00541229|19523183|P3|NOT COMPLETED|Treatment Period II (Week 6)||1
7933468|NCT00541229|19523184|P2|NOT COMPLETED|Treatment Period II (Week 6)||1
7933469|NCT00541229|19523185|P1|NOT COMPLETED|Treatment Period II (Week 6)||2
7933470|NCT00541229|19523180|P6|COMPLETED|Treatment Period II (Week 6)||8
7933471|NCT00541229|19523181|P5|COMPLETED|Treatment Period II (Week 6)||11
7933472|NCT00541229|19523182|P4|COMPLETED|Treatment Period II (Week 6)||12
7933473|NCT00541229|19523183|P3|COMPLETED|Treatment Period II (Week 6)||12
7933474|NCT00541229|19523184|P2|COMPLETED|Treatment Period II (Week 6)||12
7933475|NCT00541229|19523185|P1|COMPLETED|Treatment Period II (Week 6)||11
7933476|NCT00541229|19523180|P6|STARTED|Treatment Period II (Week 6)||11
7933477|NCT00541229|19523181|P5|STARTED|Treatment Period II (Week 6)||13
7933478|NCT00541229|19523182|P4|STARTED|Treatment Period II (Week 6)||13
7933479|NCT00541229|19523183|P3|STARTED|Treatment Period II (Week 6)||13
7933480|NCT00541229|19523184|P2|STARTED|Treatment Period II (Week 6)||13
7933481|NCT00541229|19523185|P1|STARTED|Treatment Period II (Week 6)||13
7933482|NCT00541229|19523180|P6|NOT COMPLETED|Washout Period I (Week 2-5)||5
7933483|NCT00541229|19523181|P5|NOT COMPLETED|Washout Period I (Week 2-5)||1
7933484|NCT00541229|19523182|P4|NOT COMPLETED|Washout Period I (Week 2-5)||4
7933485|NCT00541229|19523183|P3|NOT COMPLETED|Washout Period I (Week 2-5)||4
7933486|NCT00541229|19523184|P2|NOT COMPLETED|Washout Period I (Week 2-5)||2
7933487|NCT00541229|19523185|P1|NOT COMPLETED|Washout Period I (Week 2-5)||4
7933488|NCT00541229|19523180|P6|COMPLETED|Washout Period I (Week 2-5)||11
7933489|NCT00541229|19523181|P5|COMPLETED|Washout Period I (Week 2-5)||13
7933490|NCT00541229|19523182|P4|COMPLETED|Washout Period I (Week 2-5)||13
7933491|NCT00541229|19523183|P3|COMPLETED|Washout Period I (Week 2-5)||13
7933492|NCT00541229|19523184|P2|COMPLETED|Washout Period I (Week 2-5)||13
7933493|NCT00541229|19523185|P1|COMPLETED|Washout Period I (Week 2-5)||13
7933494|NCT00541229|19523180|P6|STARTED|Washout Period I (Week 2-5)||16
7933495|NCT00541229|19523181|P5|STARTED|Washout Period I (Week 2-5)||14
7933496|NCT00541229|19523182|P4|STARTED|Washout Period I (Week 2-5)||17
7933497|NCT00541229|19523183|P3|STARTED|Washout Period I (Week 2-5)||17
7933498|NCT00541229|19523184|P2|STARTED|Washout Period I (Week 2-5)||15
7933499|NCT00541229|19523185|P1|STARTED|Washout Period I (Week 2-5)||17
7933500|NCT00541229|19523180|P6|NOT COMPLETED|Treatment Period I (Week 1)||2
7933501|NCT00541229|19523181|P5|NOT COMPLETED|Treatment Period I (Week 1)||0
7933502|NCT00541229|19523182|P4|NOT COMPLETED|Treatment Period I (Week 1)||1
7933503|NCT00541229|19523183|P3|NOT COMPLETED|Treatment Period I (Week 1)||3
7933504|NCT00541229|19523184|P2|NOT COMPLETED|Treatment Period I (Week 1)||1
7933505|NCT00541229|19523185|P1|NOT COMPLETED|Treatment Period I (Week 1)||0
7933506|NCT00541229|19523180|P6|COMPLETED|Treatment Period I (Week 1)||16
7933507|NCT00541229|19523181|P5|COMPLETED|Treatment Period I (Week 1)||14
7933508|NCT00541229|19523182|P4|COMPLETED|Treatment Period I (Week 1)||17
7933509|NCT00541229|19523183|P3|COMPLETED|Treatment Period I (Week 1)||17
7933510|NCT00541229|19523184|P2|COMPLETED|Treatment Period I (Week 1)||15
7933511|NCT00541229|19523185|P1|COMPLETED|Treatment Period I (Week 1)||17
7933512|NCT00541229|19523180|P6|STARTED|Treatment Period I (Week 1)||18
7933513|NCT00541229|19523181|P5|STARTED|Treatment Period I (Week 1)||14
7933514|NCT00541229|19523182|P4|STARTED|Treatment Period I (Week 1)||18
7933515|NCT00541229|19523183|P3|STARTED|Treatment Period I (Week 1)||20
7933516|NCT00541229|19523184|P2|STARTED|Treatment Period I (Week 1)||16
7933517|NCT00541229|19523185|P1|STARTED|Treatment Period I (Week 1)||17
7933518|NCT00541190|19523195|P2|NOT COMPLETED|Overall Study||0
7933519|NCT00541190|19523196|P1|NOT COMPLETED|Overall Study||0
7933520|NCT00541190|19523195|P2|COMPLETED|Overall Study||11
7933521|NCT00541190|19523196|P1|COMPLETED|Overall Study||10
7933522|NCT00541190|19523195|P2|STARTED|Overall Study||11
7933523|NCT00541190|19523196|P1|STARTED|Overall Study||10
7933524|NCT00541099|19523204|P1|NOT COMPLETED|Overall Study||3
7933525|NCT00541099|19523204|P1|COMPLETED|Overall Study||8
7933526|NCT00541099|19523204|P1|STARTED|Overall Study||11
7933527|NCT00541034|19523212|P1|NOT COMPLETED|Overall Study||3
7933528|NCT00541034|19523212|P1|COMPLETED|Overall Study||46
7933529|NCT00541034|19523212|P1|STARTED|Overall Study||49
7933530|NCT00540982|19523216|P1|NOT COMPLETED|Overall Study||0
7933531|NCT00540982|19523216|P1|COMPLETED|Overall Study||47
7933532|NCT00540982|19523216|P1|Severe Liver Dysfunction|Overall Study||12
7933533|NCT00540982|19523216|P1|Moderate Liver Dysfunction|Overall Study||18
7933534|NCT00540982|19523216|P1|Mild Liver Dysfunction|Overall Study||6
7933535|NCT00540982|19523216|P1|Normal Liver Function|Overall Study||11
7933536|NCT00540982|19523216|P1|STARTED|Overall Study||47
7933537|NCT00540969|19523240|P2|NOT COMPLETED|Overall Study||0
7933538|NCT00540969|19523241|P1|NOT COMPLETED|Overall Study||0
7933539|NCT00540969|19523240|P2|COMPLETED|Overall Study||1
7933540|NCT00540969|19523241|P1|COMPLETED|Overall Study||2
7933541|NCT00540969|19523240|P2|STARTED|Overall Study||1
7933542|NCT00540969|19523241|P1|STARTED|Overall Study||2
7933543|NCT00540722|19523251|P1|NOT COMPLETED|Overall Study||0
7933544|NCT00540722|19523251|P1|COMPLETED|Overall Study||56
7933545|NCT00540722|19523251|P1|STARTED|Overall Study||56
7933546|NCT00540644|19523261|P2|NOT COMPLETED|Overall Study||9
7933547|NCT00540644|19523262|P1|NOT COMPLETED|Overall Study||9
7933548|NCT00540644|19523261|P2|COMPLETED|Overall Study||13
7933549|NCT00540644|19523262|P1|COMPLETED|Overall Study||39
7933550|NCT00540644|19523261|P2|STARTED|Overall Study||22
7933551|NCT00540644|19523262|P1|STARTED|Overall Study||48
7933552|NCT00540592|19523282|P10|NOT COMPLETED|Overall Study||2
7933553|NCT00540592|19523283|P9|NOT COMPLETED|Overall Study||1
7933554|NCT00540592|19523284|P8|NOT COMPLETED|Overall Study||1
7933555|NCT00540592|19523285|P7|NOT COMPLETED|Overall Study||0
7933556|NCT00540592|19523286|P6|NOT COMPLETED|Overall Study||0
7933557|NCT00540592|19523287|P5|NOT COMPLETED|Overall Study||1
7933558|NCT00540592|19523288|P4|NOT COMPLETED|Overall Study||1
7933559|NCT00540592|19523289|P3|NOT COMPLETED|Overall Study||1
7933560|NCT00540592|19523290|P2|NOT COMPLETED|Overall Study||1
7933561|NCT00540592|19523291|P1|NOT COMPLETED|Overall Study||2
7933562|NCT00540592|19523282|P10|COMPLETED|Overall Study||201
7933563|NCT00540592|19523283|P9|COMPLETED|Overall Study||199
7933564|NCT00540592|19523284|P8|COMPLETED|Overall Study||198
7933565|NCT00540592|19523285|P7|COMPLETED|Overall Study||198
7933566|NCT00540592|19523286|P6|COMPLETED|Overall Study||198
7933567|NCT00540592|19523287|P5|COMPLETED|Overall Study||198
7933568|NCT00540592|19523288|P4|COMPLETED|Overall Study||201
7933569|NCT00540592|19523289|P3|COMPLETED|Overall Study||201
7933570|NCT00540592|19523290|P2|COMPLETED|Overall Study||201
7933571|NCT00540592|19523291|P1|COMPLETED|Overall Study||202
7933572|NCT00540592|19523282|P10|Completed at Day 180|Overall Study||189
7933573|NCT00540592|19523283|P9|Completed at Day 180|Overall Study||198
7933574|NCT00540592|19523284|P8|Completed at Day 180|Overall Study||193
7933575|NCT00540592|19523285|P7|Completed at Day 180|Overall Study||196
7933576|NCT00540592|19523286|P6|Completed at Day 180|Overall Study||198
7933577|NCT00540592|19523287|P5|Completed at Day 180|Overall Study||195
7933578|NCT00540592|19523288|P4|Completed at Day 180|Overall Study||197
7933579|NCT00540592|19523289|P3|Completed at Day 180|Overall Study||197
7933580|NCT00540592|19523290|P2|Completed at Day 180|Overall Study||201
7933581|NCT00540592|19523291|P1|Completed at Day 180|Overall Study||200
7933582|NCT00540592|19523282|P10|STARTED|Overall Study||203
7933583|NCT00540592|19523283|P9|STARTED|Overall Study||200
7933584|NCT00540592|19523284|P8|STARTED|Overall Study||199
7933585|NCT00540592|19523285|P7|STARTED|Overall Study||198
7933586|NCT00540592|19523286|P6|STARTED|Overall Study||198
7933587|NCT00540592|19523287|P5|STARTED|Overall Study||199
7933588|NCT00540592|19523288|P4|STARTED|Overall Study||202
7933589|NCT00540592|19523289|P3|STARTED|Overall Study||202
7933590|NCT00540592|19523290|P2|STARTED|Overall Study||202
7933591|NCT00540592|19523291|P1|STARTED|Overall Study||204
7933592|NCT00540579|19523523|P1|NOT COMPLETED|Overall Study||0
7933593|NCT00540579|19523523|P1|COMPLETED|Overall Study||23
7933594|NCT00540579|19523523|P1|STARTED|Overall Study||23
7933595|NCT00540514|19523530|P2|NOT COMPLETED|Overall Study||266
7933596|NCT00540514|19523531|P1|NOT COMPLETED|Overall Study||246
7933597|NCT00540514|19523530|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265
7933598|NCT00540514|19523531|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275
7933599|NCT00540514|19523530|P2|Biomarker Population|Overall Study||36
7933600|NCT00540514|19523531|P1|Biomarker Population|Overall Study||35
7933601|NCT00540514|19523530|P2|Treated|Overall Study||524
7933602|NCT00540514|19523531|P1|Treated|Overall Study||514
7933603|NCT00540514|19523530|P2|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531
7933604|NCT00540514|19523531|P1|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521
7933605|NCT00540449|19523563|P2|NOT COMPLETED|Overall Study||78
7933606|NCT00540449|19523564|P1|NOT COMPLETED|Overall Study||84
7933607|NCT00540449|19523563|P2|COMPLETED|Overall Study||266
7933608|NCT00540449|19523564|P1|COMPLETED|Overall Study||262
7933609|NCT00540449|19523563|P2|STARTED|Overall Study||344
7933610|NCT00540449|19523564|P1|STARTED|Overall Study||346
7933611|NCT00540436|19523586|P1|NOT COMPLETED|Second 12-Week Treatment Period||1
7933612|NCT00540436|19523586|P1|COMPLETED|Second 12-Week Treatment Period||21
7933613|NCT00540436|19523586|P1|STARTED|Second 12-Week Treatment Period||22
7933614|NCT00540436|19523586|P1|NOT COMPLETED|First 12-Week Treatment Period||3
7933615|NCT00540436|19523586|P1|COMPLETED|First 12-Week Treatment Period||22
7933616|NCT00540436|19523586|P1|STARTED|First 12-Week Treatment Period||25
7933617|NCT00540423|19523601|P3|NOT COMPLETED|Open-Label Treatment Period||2
7933618|NCT00540423|19523602|P2|NOT COMPLETED|Open-Label Treatment Period||0
7933619|NCT00540423|19523603|P1|NOT COMPLETED|Open-Label Treatment Period||0
7933620|NCT00540423|19523601|P3|COMPLETED|Open-Label Treatment Period||20
7933621|NCT00540423|19523602|P2|COMPLETED|Open-Label Treatment Period||0
7933622|NCT00540423|19523603|P1|COMPLETED|Open-Label Treatment Period||0
7933623|NCT00540423|19523601|P3|STARTED|Open-Label Treatment Period||22
7933624|NCT00540423|19523602|P2|STARTED|Open-Label Treatment Period||0
7933625|NCT00540423|19523603|P1|STARTED|Open-Label Treatment Period||0
7933626|NCT00540423|19523601|P3|NOT COMPLETED|Double-Blind Treatment Period||0
7933627|NCT00540423|19523602|P2|NOT COMPLETED|Double-Blind Treatment Period||1
7933628|NCT00540423|19523603|P1|NOT COMPLETED|Double-Blind Treatment Period||0
7933629|NCT00540423|19523601|P3|COMPLETED|Double-Blind Treatment Period||0
7933630|NCT00540423|19523602|P2|COMPLETED|Double-Blind Treatment Period||14
7933631|NCT00540423|19523603|P1|COMPLETED|Double-Blind Treatment Period||8
7933632|NCT00540423|19523601|P3|STARTED|Double-Blind Treatment Period||0
7933633|NCT00540423|19523602|P2|STARTED|Double-Blind Treatment Period||15
7933634|NCT00540423|19523603|P1|STARTED|Double-Blind Treatment Period||8
7933635|NCT00540293|19523653|P1|NOT COMPLETED|Overall Study||35
7933636|NCT00540293|19523653|P1|COMPLETED|Overall Study||390
7933637|NCT00540293|19523653|P1|STARTED|Overall Study||425
7933638|NCT00540228|19523701|P5|NOT COMPLETED|Overall Study||0
7933639|NCT00540228|19523702|P4|NOT COMPLETED|Overall Study||0
7933640|NCT00540228|19523703|P3|NOT COMPLETED|Overall Study||0
7933641|NCT00540228|19523704|P2|NOT COMPLETED|Overall Study||1
7933642|NCT00540228|19523705|P1|NOT COMPLETED|Overall Study||3
7933643|NCT00540228|19523701|P5|COMPLETED|Overall Study||202
7933644|NCT00540228|19523702|P4|COMPLETED|Overall Study||202
7933645|NCT00540228|19523703|P3|COMPLETED|Overall Study||204
7933646|NCT00540228|19523704|P2|COMPLETED|Overall Study||197
7933647|NCT00540228|19523705|P1|COMPLETED|Overall Study||197
7933648|NCT00540228|19523701|P5|STARTED|Overall Study||202
7933649|NCT00540228|19523702|P4|STARTED|Overall Study||202
7933650|NCT00540228|19523703|P3|STARTED|Overall Study||204
7933651|NCT00540228|19523704|P2|STARTED|Overall Study||198
7933652|NCT00540228|19523705|P1|STARTED|Overall Study||200
7933653|NCT00540124|19523775|P3|NOT COMPLETED|Overall Study||1
7933654|NCT00540124|19523776|P2|NOT COMPLETED|Overall Study||3
7933655|NCT00540124|19523777|P1|NOT COMPLETED|Overall Study||4
7933656|NCT00540124|19523775|P3|COMPLETED|Overall Study||48
7933657|NCT00540124|19523776|P2|COMPLETED|Overall Study||48
7933658|NCT00540124|19523777|P1|COMPLETED|Overall Study||47
7933659|NCT00540124|19523775|P3|STARTED|Overall Study||49
7933660|NCT00540124|19523776|P2|STARTED|Overall Study||51
7933661|NCT00540124|19523777|P1|STARTED|Overall Study||51
7933662|NCT00540046|19523823|P2|NOT COMPLETED|Overall Study||23
7933663|NCT00540046|19523824|P1|NOT COMPLETED|Overall Study||33
7933664|NCT00540046|19523823|P2|COMPLETED|Overall Study||88
7933665|NCT00540046|19523824|P1|COMPLETED|Overall Study||71
7933666|NCT00540046|19523823|P2|STARTED|Overall Study||111
7933667|NCT00540046|19523824|P1|STARTED|Overall Study||104
7933668|NCT00540007|19523834|P2|NOT COMPLETED|Overall Study||0
7933669|NCT00540007|19523835|P1|NOT COMPLETED|Overall Study||0
7933670|NCT00540007|19523834|P2|COMPLETED|Overall Study||42
7933671|NCT00540007|19523835|P1|COMPLETED|Overall Study||38
7933672|NCT00540007|19523834|P2|STARTED|Overall Study||42
7933673|NCT00540007|19523835|P1|STARTED|Overall Study||38
7933674|NCT00539994|19523860|P3|NOT COMPLETED|Overall Study||2
7933675|NCT00539994|19523861|P2|NOT COMPLETED|Overall Study||1
7933676|NCT00539994|19523862|P1|NOT COMPLETED|Overall Study||3
7933677|NCT00539994|19523860|P3|COMPLETED|Overall Study||13
7933678|NCT00539994|19523861|P2|COMPLETED|Overall Study||18
7933679|NCT00539994|19523862|P1|COMPLETED|Overall Study||20
7933680|NCT00539994|19523860|P3|STARTED|Overall Study||15
7933681|NCT00539994|19523861|P2|STARTED|Overall Study||19
7933682|NCT00539994|19523862|P1|STARTED|Overall Study||23
7933683|NCT00539942|19523901|P2|NOT COMPLETED|Overall Study||0
7933684|NCT00539942|19523902|P1|NOT COMPLETED|Overall Study||0
7933685|NCT00539942|19523901|P2|COMPLETED|Overall Study||3
7933686|NCT00539942|19523902|P1|COMPLETED|Overall Study||4
7933687|NCT00539942|19523901|P2|STARTED|Overall Study||3
7933688|NCT00539942|19523902|P1|STARTED|Overall Study||4
7933689|NCT00539864|19523912|P2|NOT COMPLETED|Overall Study||2
7933690|NCT00539864|19523913|P1|NOT COMPLETED|Overall Study||1
7933691|NCT00539864|19523912|P2|COMPLETED|Overall Study||300
7933692|NCT00539864|19523913|P1|COMPLETED|Overall Study||299
7933693|NCT00539864|19523912|P2|STARTED|Overall Study||302
7933694|NCT00539864|19523913|P1|STARTED|Overall Study||300
7933695|NCT00539838|19523928|P3|NOT COMPLETED|Overall Study||9
7933696|NCT00539838|19523929|P2|NOT COMPLETED|Overall Study||6
7933697|NCT00539838|19523930|P1|NOT COMPLETED|Overall Study||7
7933698|NCT00539838|19523928|P3|COMPLETED|Overall Study||1
7933699|NCT00539838|19523929|P2|COMPLETED|Overall Study||5
7933700|NCT00539838|19523930|P1|COMPLETED|Overall Study||5
7933701|NCT00539838|19523928|P3|STARTED|Overall Study||10
7933702|NCT00539838|19523929|P2|STARTED|Overall Study||11
7933703|NCT00539838|19523930|P1|STARTED|Overall Study||12
7933704|NCT00539734|19523980|P1|NOT COMPLETED|Overall Study||1
7933705|NCT00539734|19523980|P1|COMPLETED|Overall Study||25
7933706|NCT00539734|19523980|P1|STARTED|Overall Study||26
7933707|NCT00539695|19523985|P1|NOT COMPLETED|Overall Study||13
7933708|NCT00539695|19523985|P1|COMPLETED|Overall Study||12
7933709|NCT00539695|19523985|P1|Evaluable Patients|Overall Study|Patients who received IL-2.|22
7933710|NCT00539695|19523985|P1|STARTED|Overall Study||25
7933711|NCT00539656|19523991|P1|NOT COMPLETED|Overall Study||0
7933712|NCT00539656|19523991|P1|COMPLETED|Overall Study||3
7933713|NCT00539656|19523991|P1|STARTED|Overall Study||3
7933714|NCT00539617|19523997|P1|NOT COMPLETED|Treatment Period||0
7933715|NCT00539617|19523997|P1|COMPLETED|Treatment Period||3
7933716|NCT00539617|19523997|P1|STARTED|Treatment Period||3
7933717|NCT00539617|19523997|P1|NOT COMPLETED|Run-In Period||1
7933718|NCT00539617|19523997|P1|COMPLETED|Run-In Period||3
7933719|NCT00539617|19523997|P1|STARTED|Run-In Period||4
7933720|NCT00539617|19523997|P1|NOT COMPLETED|Pre-screening Period||3
7933721|NCT00539617|19523997|P1|COMPLETED|Pre-screening Period||4
7933722|NCT00539617|19523997|P1|STARTED|Pre-screening Period||7
7933723|NCT00539591|19524006|P3|NOT COMPLETED|Overall Study||3
7933724|NCT00539591|19524007|P2|NOT COMPLETED|Overall Study||2
7933725|NCT00539591|19524008|P1|NOT COMPLETED|Overall Study||5
7933726|NCT00539591|19524006|P3|COMPLETED|Overall Study||1
7933727|NCT00539591|19524007|P2|COMPLETED|Overall Study||0
7933728|NCT00539591|19524008|P1|COMPLETED|Overall Study||18
7933729|NCT00539591|19524006|P3|STARTED|Overall Study||4
7933730|NCT00539591|19524007|P2|STARTED|Overall Study||2
7933731|NCT00539591|19524008|P1|STARTED|Overall Study||23
7933732|NCT00539539|19524118|P2|NOT COMPLETED|Overall Study||0
7933733|NCT00539539|19524119|P1|NOT COMPLETED|Overall Study||0
7933734|NCT00539539|19524118|P2|COMPLETED|Overall Study||771
7933735|NCT00539539|19524119|P1|COMPLETED|Overall Study||815
7933736|NCT00539539|19524118|P2|STARTED|Overall Study||771
7933737|NCT00539539|19524119|P1|STARTED|Overall Study||815
7933738|NCT00539526|19524142|P3|NOT COMPLETED|Overall Study||2
7933739|NCT00539526|19524143|P2|NOT COMPLETED|Overall Study||2
7933740|NCT00539526|19524144|P1|NOT COMPLETED|Overall Study||3
7933741|NCT00539526|19524142|P3|COMPLETED|Overall Study||36
7933742|NCT00539526|19524143|P2|COMPLETED|Overall Study||31
7933743|NCT00539526|19524144|P1|COMPLETED|Overall Study||32
7933744|NCT00539526|19524142|P3|STARTED|Overall Study||38
7933745|NCT00539526|19524143|P2|STARTED|Overall Study||33
7933746|NCT00539526|19524144|P1|STARTED|Overall Study||35
7933747|NCT00539513|19524160|P2|NOT COMPLETED|Overall Study||2
7933748|NCT00539513|19524161|P1|NOT COMPLETED|Overall Study||2
7933749|NCT00539513|19524160|P2|COMPLETED|Overall Study||3
7933750|NCT00539513|19524161|P1|COMPLETED|Overall Study||3
7933751|NCT00539513|19524160|P2|Received Allocated Intervention|Overall Study||4
7933752|NCT00539513|19524161|P1|Received Allocated Intervention|Overall Study||3
7933753|NCT00539513|19524160|P2|STARTED|Overall Study||5
7933754|NCT00539513|19524161|P1|STARTED|Overall Study||5
7933755|NCT00539500|19524173|P1|NOT COMPLETED|Overall Study||3
7933756|NCT00539500|19524173|P1|COMPLETED|Overall Study||0
7933757|NCT00539500|19524173|P1|STARTED|Overall Study||3
7933758|NCT00539305|19524181|P2|NOT COMPLETED|Overall Study||2
7933759|NCT00539305|19524182|P1|NOT COMPLETED|Overall Study||1
7933760|NCT00539305|19524181|P2|COMPLETED|Overall Study||10
7933761|NCT00539305|19524182|P1|COMPLETED|Overall Study||9
7933762|NCT00539305|19524181|P2|STARTED|Overall Study||12
7933763|NCT00539305|19524182|P1|STARTED|Overall Study||10
7933764|NCT00539279|19524196|P2|NOT COMPLETED|6-Month Follow-Up Assessment||7
7933765|NCT00539279|19524197|P1|NOT COMPLETED|6-Month Follow-Up Assessment||1
7933766|NCT00539279|19524196|P2|COMPLETED|6-Month Follow-Up Assessment||22
7933767|NCT00539279|19524197|P1|COMPLETED|6-Month Follow-Up Assessment||17
7933768|NCT00539279|19524196|P2|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29
7933769|NCT00539279|19524197|P1|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18
7933770|NCT00539279|19524196|P2|NOT COMPLETED|Post-Treatment Assessment||9
7933771|NCT00539279|19524197|P1|NOT COMPLETED|Post-Treatment Assessment||12
7933772|NCT00539279|19524196|P2|COMPLETED|Post-Treatment Assessment||29
7933773|NCT00539279|19524197|P1|COMPLETED|Post-Treatment Assessment||18
7933774|NCT00539279|19524196|P2|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38
7933775|NCT00539279|19524197|P1|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30
7933776|NCT00539279|19524196|P2|NOT COMPLETED|Treatment||8
7933777|NCT00539279|19524197|P1|NOT COMPLETED|Treatment||11
7933778|NCT00539279|19524196|P2|COMPLETED|Treatment||38
7933779|NCT00539279|19524197|P1|COMPLETED|Treatment||30
7933780|NCT00539279|19524196|P2|STARTED|Treatment||46
7933781|NCT00539279|19524197|P1|STARTED|Treatment||41
7933782|NCT00539253|19524215|P1|NOT COMPLETED|Overall Study||26
7933783|NCT00539253|19524215|P1|COMPLETED|Overall Study||19
7933784|NCT00539253|19524215|P1|STARTED|Overall Study||45
7933785|NCT00539240|19524223|P3|NOT COMPLETED|Overall Study||15
7933786|NCT00539240|19524224|P2|NOT COMPLETED|Overall Study||7
7933787|NCT00539240|19524225|P1|NOT COMPLETED|Overall Study||6
7933788|NCT00539240|19524223|P3|COMPLETED|Overall Study||39
7933789|NCT00539240|19524224|P2|COMPLETED|Overall Study||48
7933790|NCT00539240|19524225|P1|COMPLETED|Overall Study||53
7933791|NCT00539240|19524223|P3|STARTED|Overall Study||54
7933792|NCT00539240|19524224|P2|STARTED|Overall Study||55
7933793|NCT00539240|19524225|P1|STARTED|Overall Study||59
7933794|NCT00539188|19524244|P2|NOT COMPLETED|Overall Study||1
7933795|NCT00539188|19524245|P1|NOT COMPLETED|Overall Study||3
7933796|NCT00539188|19524244|P2|COMPLETED|Overall Study||1
7933797|NCT00539188|19524245|P1|COMPLETED|Overall Study||1
7933798|NCT00539188|19524244|P2|Received Allocated Intervention|Overall Study||2
7933799|NCT00539188|19524245|P1|Received Allocated Intervention|Overall Study||3
7933800|NCT00539188|19524244|P2|STARTED|Overall Study||2
7933801|NCT00539188|19524245|P1|STARTED|Overall Study||4
7933802|NCT00539110|19524259|P2|NOT COMPLETED|Overall Study||0
7933803|NCT00539110|19524260|P1|NOT COMPLETED|Overall Study||0
7933804|NCT00539110|19524259|P2|COMPLETED|Overall Study||5
7933805|NCT00539110|19524260|P1|COMPLETED|Overall Study||5
7933806|NCT00539110|19524259|P2|STARTED|Overall Study||5
7933807|NCT00539110|19524260|P1|STARTED|Overall Study||5
7933808|NCT00539032|19524268|P2|NOT COMPLETED|Overall Study||1
7933809|NCT00539032|19524269|P1|NOT COMPLETED|Overall Study||2
7933810|NCT00539032|19524268|P2|COMPLETED|Overall Study||84
7933811|NCT00539032|19524269|P1|COMPLETED|Overall Study||151
7933812|NCT00539032|19524268|P2|STARTED|Overall Study||85
7933813|NCT00539032|19524269|P1|STARTED|Overall Study||153
7933814|NCT00539006|19524283|P4|NOT COMPLETED|Post-Study||0
7933815|NCT00539006|19524284|P3|NOT COMPLETED|Post-Study||0
7933816|NCT00539006|19524285|P2|NOT COMPLETED|Post-Study||0
7933817|NCT00539006|19524286|P1|NOT COMPLETED|Post-Study||0
7933818|NCT00539006|19524283|P4|COMPLETED|Post-Study||81
7933819|NCT00539006|19524284|P3|COMPLETED|Post-Study||77
7933820|NCT00539006|19524285|P2|COMPLETED|Post-Study||83
7933821|NCT00539006|19524286|P1|COMPLETED|Post-Study||75
7933822|NCT00539006|19524283|P4|STARTED|Post-Study||81
7933823|NCT00539006|19524284|P3|STARTED|Post-Study||77
7933824|NCT00539006|19524285|P2|STARTED|Post-Study||83
7933825|NCT00539006|19524286|P1|STARTED|Post-Study||75
7933826|NCT00539006|19524283|P4|NOT COMPLETED|Treatment Period 2||0
7933827|NCT00539006|19524284|P3|NOT COMPLETED|Treatment Period 2||0
7933828|NCT00539006|19524285|P2|NOT COMPLETED|Treatment Period 2||1
7933829|NCT00539006|19524286|P1|NOT COMPLETED|Treatment Period 2||1
7933830|NCT00539006|19524283|P4|COMPLETED|Treatment Period 2||81
7933831|NCT00539006|19524284|P3|COMPLETED|Treatment Period 2||77
7933832|NCT00539006|19524285|P2|COMPLETED|Treatment Period 2||83
7933833|NCT00539006|19524286|P1|COMPLETED|Treatment Period 2||75
7933834|NCT00539006|19524283|P4|STARTED|Treatment Period 2||81
7933835|NCT00539006|19524284|P3|STARTED|Treatment Period 2||77
7933836|NCT00539006|19524285|P2|STARTED|Treatment Period 2||84
7933837|NCT00539006|19524286|P1|STARTED|Treatment Period 2||76
7933838|NCT00539006|19524283|P4|NOT COMPLETED|Washout||9
7933839|NCT00539006|19524284|P3|NOT COMPLETED|Washout||16
7933840|NCT00539006|19524285|P2|NOT COMPLETED|Washout||10
7933841|NCT00539006|19524286|P1|NOT COMPLETED|Washout||20
7933842|NCT00539006|19524283|P4|COMPLETED|Washout||81
7933843|NCT00539006|19524284|P3|COMPLETED|Washout||77
7933844|NCT00539006|19524285|P2|COMPLETED|Washout||84
7933845|NCT00539006|19524286|P1|COMPLETED|Washout||76
7933846|NCT00539006|19524283|P4|STARTED|Washout||90
7933847|NCT00539006|19524284|P3|STARTED|Washout||93
7933848|NCT00539006|19524285|P2|STARTED|Washout||94
7933849|NCT00539006|19524286|P1|STARTED|Washout||96
7933850|NCT00539006|19524283|P4|NOT COMPLETED|Treatment Period 1||1
7933851|NCT00539006|19524284|P3|NOT COMPLETED|Treatment Period 1||2
7933852|NCT00539006|19524285|P2|NOT COMPLETED|Treatment Period 1||0
7933853|NCT00539006|19524286|P1|NOT COMPLETED|Treatment Period 1||0
7933854|NCT00539006|19524283|P4|COMPLETED|Treatment Period 1||90
7933855|NCT00539006|19524284|P3|COMPLETED|Treatment Period 1||93
7933856|NCT00539006|19524285|P2|COMPLETED|Treatment Period 1||94
7933857|NCT00539006|19524286|P1|COMPLETED|Treatment Period 1||96
7933858|NCT00539006|19524283|P4|STARTED|Treatment Period 1||91
7933859|NCT00539006|19524284|P3|STARTED|Treatment Period 1||95
7933860|NCT00539006|19524285|P2|STARTED|Treatment Period 1||94
7933861|NCT00539006|19524286|P1|STARTED|Treatment Period 1||96
7933862|NCT00539006|19524283|P4|NOT COMPLETED|Pre-treatment||0
7933863|NCT00539006|19524284|P3|NOT COMPLETED|Pre-treatment||0
7933864|NCT00539006|19524285|P2|NOT COMPLETED|Pre-treatment||1
7933865|NCT00539006|19524286|P1|NOT COMPLETED|Pre-treatment||0
7933866|NCT00539006|19524283|P4|COMPLETED|Pre-treatment||91
7933867|NCT00539006|19524284|P3|COMPLETED|Pre-treatment||95
7933868|NCT00539006|19524285|P2|COMPLETED|Pre-treatment||94
7933869|NCT00539006|19524286|P1|COMPLETED|Pre-treatment||96
7933870|NCT00539006|19524283|P4|STARTED|Pre-treatment||91
7933871|NCT00539006|19524284|P3|STARTED|Pre-treatment||95
7933872|NCT00539006|19524285|P2|STARTED|Pre-treatment||95
7933873|NCT00539006|19524286|P1|STARTED|Pre-treatment||96
7933874|NCT00538980|19524316|P1|NOT COMPLETED|Overall Study||10
7933875|NCT00538980|19524316|P1|COMPLETED|Overall Study||0
7933876|NCT00538980|19524316|P1|STARTED|Overall Study||10
7933877|NCT00538915|19524324|P1|NOT COMPLETED|Overall Study||11
7933878|NCT00538915|19524324|P1|COMPLETED|Overall Study||52
7933879|NCT00538915|19524324|P1|STARTED|Overall Study||63
7933880|NCT00538902|19524331|P3|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
7933881|NCT00538902|19524332|P2|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
7933882|NCT00538902|19524333|P1|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36
7933883|NCT00538902|19524331|P3|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52
7933884|NCT00538902|19524332|P2|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55
7933885|NCT00538902|19524333|P1|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23
7933886|NCT00538902|19524331|P3|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116
7933887|NCT00538902|19524332|P2|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119
7933888|NCT00538902|19524333|P1|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59
7933889|NCT00538902|19524331|P3|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5
7933890|NCT00538902|19524332|P2|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2
7933891|NCT00538902|19524333|P1|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1
7933892|NCT00538902|19524331|P3|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116
7933893|NCT00538902|19524332|P2|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119
7933894|NCT00538902|19524333|P1|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59
7933895|NCT00538902|19524331|P3|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
7933896|NCT00538902|19524332|P2|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
7933897|NCT00538902|19524333|P1|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60
7933898|NCT00538863|19524368|P1|NOT COMPLETED|Open-label Maintenance||106
7933899|NCT00538863|19524368|P1|COMPLETED|Open-label Maintenance||163
7933900|NCT00538863|19524368|P1|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269
7933901|NCT00538863|19524368|P1|NOT COMPLETED|Open-label Titration||45
7933902|NCT00538863|19524368|P1|COMPLETED|Open-label Titration||184
7933903|NCT00538863|19524368|P1|STARTED|Open-label Titration||229
7933904|NCT00538850|19524374|P3|NOT COMPLETED|Placebo - Double-blind||3
7933905|NCT00538850|19524375|P2|NOT COMPLETED|Placebo - Double-blind||0
7933906|NCT00538850|19524376|P1|NOT COMPLETED|Placebo - Double-blind||0
7933907|NCT00538850|19524374|P3|COMPLETED|Placebo - Double-blind||95
7933908|NCT00538850|19524375|P2|COMPLETED|Placebo - Double-blind||0
7933909|NCT00538850|19524376|P1|COMPLETED|Placebo - Double-blind||0
7933910|NCT00538850|19524374|P3|STARTED|Placebo - Double-blind||98
7933911|NCT00538850|19524375|P2|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
7933912|NCT00538850|19524376|P1|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
7933913|NCT00538850|19524374|P3|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
7933914|NCT00538850|19524375|P2|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3
7933915|NCT00538850|19524376|P1|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
7933916|NCT00538850|19524374|P3|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
7933917|NCT00538850|19524375|P2|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95
7933918|NCT00538850|19524376|P1|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
7933919|NCT00538850|19524374|P3|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
7933920|NCT00538850|19524375|P2|STARTED|Fentanyl Sublingual Spray - Double-blind||98
7933921|NCT00538850|19524376|P1|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
7933922|NCT00538850|19524374|P3|NOT COMPLETED|Titration Period||0
7933923|NCT00538850|19524375|P2|NOT COMPLETED|Titration Period||0
7933924|NCT00538850|19524376|P1|NOT COMPLETED|Titration Period||32
7933925|NCT00538850|19524374|P3|COMPLETED|Titration Period||0
7933926|NCT00538850|19524375|P2|COMPLETED|Titration Period||0
7933927|NCT00538850|19524376|P1|COMPLETED|Titration Period||98
7933928|NCT00538850|19524374|P3|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
7933929|NCT00538850|19524375|P2|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
7933930|NCT00538850|19524376|P1|STARTED|Titration Period||130
7933931|NCT00538824|19524388|P1|NOT COMPLETED|Overall Study||0
7933932|NCT00538824|19524388|P1|COMPLETED|Overall Study||5
7933933|NCT00538824|19524388|P1|Progression of Disease|Overall Study||2
7933934|NCT00538824|19524388|P1|STARTED|Overall Study||5
7933935|NCT00538785|19524394|P2|NOT COMPLETED|Overall Study||17
7933936|NCT00538785|19524395|P1|NOT COMPLETED|Overall Study||19
7933937|NCT00538785|19524394|P2|COMPLETED|Overall Study||595
7933938|NCT00538785|19524395|P1|COMPLETED|Overall Study||604
7933939|NCT00538785|19524394|P2|STARTED|Overall Study||612
7933940|NCT00538785|19524395|P1|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623
7933941|NCT00538759|19524418|P2|NOT COMPLETED|Overall Study||0
7933942|NCT00538759|19524419|P1|NOT COMPLETED|Overall Study||0
7933943|NCT00538759|19524418|P2|COMPLETED|Overall Study||8
7933944|NCT00538759|19524419|P1|COMPLETED|Overall Study||13
7933945|NCT00538759|19524418|P2|STARTED|Overall Study||8
7933946|NCT00538759|19524419|P1|STARTED|Overall Study||13
7933947|NCT00538733|19524437|P1|NOT COMPLETED|Overall Study||12
7933948|NCT00538733|19524437|P1|COMPLETED|Overall Study||14
7933949|NCT00538733|19524437|P1|Removed to Pursue Alternative Theray|Overall Study||2
7933950|NCT00538733|19524437|P1|Removed to Pursue a Stem Cell Transplant|Overall Study||11
7933951|NCT00538733|19524437|P1|Removed Due to Progression of Disease|Overall Study||1
7933952|NCT00538733|19524437|P1|STARTED|Overall Study||26
7933953|NCT00538681|19524449|P4|NOT COMPLETED|Overall Study||11
7933954|NCT00538681|19524450|P3|NOT COMPLETED|Overall Study||11
7933955|NCT00538681|19524451|P2|NOT COMPLETED|Overall Study||4
7933956|NCT00538681|19524452|P1|NOT COMPLETED|Overall Study||9
7933957|NCT00538681|19524449|P4|COMPLETED|Overall Study||0
7933958|NCT00538681|19524450|P3|COMPLETED|Overall Study||0
7933959|NCT00538681|19524451|P2|COMPLETED|Overall Study||0
7933960|NCT00538681|19524452|P1|COMPLETED|Overall Study||0
7933961|NCT00538681|19524449|P4|Received ≥1 Dose of Any Study Drug|Overall Study||11
7933962|NCT00538681|19524450|P3|Received ≥1 Dose of Any Study Drug|Overall Study||11
7933963|NCT00538681|19524451|P2|Received ≥1 Dose of Any Study Drug|Overall Study||4
7933964|NCT00538681|19524452|P1|Received ≥1 Dose of Any Study Drug|Overall Study||9
7933965|NCT00538681|19524449|P4|STARTED|Overall Study|One (1) participant received pemetrexed and cisplatin only before the study was closed.|11
7933966|NCT00538681|19524450|P3|STARTED|Overall Study||11
7933967|NCT00538681|19524451|P2|STARTED|Overall Study||4
7933968|NCT00538681|19524452|P1|STARTED|Overall Study||9
7933969|NCT00538642|19524477|P2|NOT COMPLETED|Overall Study||5
7933970|NCT00538642|19524478|P1|NOT COMPLETED|Overall Study||1
7933971|NCT00538642|19524477|P2|COMPLETED|Overall Study||9
7933972|NCT00538642|19524478|P1|COMPLETED|Overall Study||9
7933973|NCT00538642|19524477|P2|STARTED|Overall Study||14
7933974|NCT00538642|19524478|P1|STARTED|Overall Study||10
7933975|NCT00538629|19524518|P1|NOT COMPLETED|Overall Study||22
7933976|NCT00538629|19524518|P1|COMPLETED|Overall Study||449
7933977|NCT00538629|19524518|P1|STARTED|Overall Study||471
7933978|NCT00538616|19524565|P2|NOT COMPLETED|Overall Study||0
7933979|NCT00538616|19524566|P1|NOT COMPLETED|Overall Study||0
7933980|NCT00538616|19524565|P2|COMPLETED|Overall Study||3
7933981|NCT00538616|19524566|P1|COMPLETED|Overall Study||5
7933982|NCT00538616|19524565|P2|STARTED|Overall Study||3
7933983|NCT00538616|19524566|P1|STARTED|Overall Study||5
7933984|NCT00538590|19524574|P2|NOT COMPLETED|Overall Study||0
7933985|NCT00538590|19524575|P1|NOT COMPLETED|Overall Study||1
7933986|NCT00538590|19524574|P2|COMPLETED|Overall Study||10
7933987|NCT00538590|19524575|P1|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9
7933988|NCT00538590|19524574|P2|STARTED|Overall Study||10
7933989|NCT00538590|19524575|P1|STARTED|Overall Study||10
7933990|NCT00538512|19524592|P3|NOT COMPLETED|Overall Study||13
7933991|NCT00538512|19524593|P2|NOT COMPLETED|Overall Study||30
7933992|NCT00538512|19524594|P1|NOT COMPLETED|Overall Study||27
7933993|NCT00538512|19524592|P3|COMPLETED|Overall Study||312
7933994|NCT00538512|19524593|P2|COMPLETED|Overall Study||783
7933995|NCT00538512|19524594|P1|COMPLETED|Overall Study||787
7933996|NCT00538512|19524592|P3|STARTED|Overall Study||325
7933997|NCT00538512|19524593|P2|STARTED|Overall Study||813
7933998|NCT00538512|19524594|P1|STARTED|Overall Study||814
7933999|NCT00538473|19524613|P2|NOT COMPLETED|Overall Study||0
7934000|NCT00538473|19524614|P1|NOT COMPLETED|Overall Study||1
7934001|NCT00538473|19524613|P2|COMPLETED|Overall Study||35
7934002|NCT00538473|19524614|P1|COMPLETED|Overall Study||32
7934003|NCT00538473|19524613|P2|STARTED|Overall Study||35
7934004|NCT00538473|19524614|P1|STARTED|Overall Study||33
7934005|NCT00538434|19524650|P4|NOT COMPLETED|Overall Study||6
7934006|NCT00538434|19524651|P3|NOT COMPLETED|Overall Study||7
7934007|NCT00538434|19524652|P2|NOT COMPLETED|Overall Study||11
7934008|NCT00538434|19524653|P1|NOT COMPLETED|Overall Study||9
7934009|NCT00538434|19524650|P4|COMPLETED|Overall Study|Completed all scheduled study visits|51
7934010|NCT00538434|19524651|P3|COMPLETED|Overall Study|Completed all scheduled study visits|50
7934011|NCT00538434|19524652|P2|COMPLETED|Overall Study|Completed all scheduled study visits|46
7934012|NCT00538434|19524653|P1|COMPLETED|Overall Study|Completed all scheduled study visits|47
7934013|NCT00538434|19524650|P4|Intent-to-treat (ITT) Population|Overall Study||57
7934014|NCT00538434|19524651|P3|Intent-to-treat (ITT) Population|Overall Study||57
7934015|NCT00538434|19524652|P2|Intent-to-treat (ITT) Population|Overall Study||57
7934016|NCT00538434|19524653|P1|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55
7934017|NCT00538434|19524650|P4|STARTED|Overall Study||57
7934018|NCT00538434|19524651|P3|STARTED|Overall Study||57
7934019|NCT00538434|19524652|P2|STARTED|Overall Study||57
7934020|NCT00538434|19524653|P1|STARTED|Overall Study||56
7934021|NCT00538304|19524677|P2|NOT COMPLETED|Overall Study||5
7934022|NCT00538304|19524678|P1|NOT COMPLETED|Overall Study||7
7934023|NCT00538304|19524677|P2|COMPLETED|Overall Study||66
7934024|NCT00538304|19524678|P1|COMPLETED|Overall Study||144
7934025|NCT00538304|19524677|P2|STARTED|Overall Study||71
7934026|NCT00538304|19524678|P1|STARTED|Overall Study||151
7934027|NCT00538291|19524694|P1|NOT COMPLETED|Overall Study||3
7934028|NCT00538291|19524694|P1|COMPLETED|Overall Study||10
7934029|NCT00538291|19524694|P1|STARTED|Overall Study||13
7934030|NCT00538213|19524701|P3|NOT COMPLETED|Overall Study||0
7934031|NCT00538213|19524702|P2|NOT COMPLETED|Overall Study||0
7934032|NCT00538213|19524703|P1|NOT COMPLETED|Overall Study||0
7934033|NCT00538213|19524701|P3|COMPLETED|Overall Study||38
7934034|NCT00538213|19524702|P2|COMPLETED|Overall Study||40
7934035|NCT00538213|19524703|P1|COMPLETED|Overall Study||55
7934036|NCT00538213|19524701|P3|STARTED|Overall Study||38
7934037|NCT00538213|19524702|P2|STARTED|Overall Study||40
7934038|NCT00538213|19524703|P1|STARTED|Overall Study||55
7934039|NCT00537979|19524752|P2|NOT COMPLETED|Overall Study||20
7934040|NCT00537979|19524753|P1|NOT COMPLETED|Overall Study||6
7934041|NCT00537979|19524752|P2|COMPLETED|Overall Study||89
7934042|NCT00537979|19524753|P1|COMPLETED|Overall Study||32
7934043|NCT00537979|19524752|P2|STARTED|Overall Study||109
7934044|NCT00537979|19524753|P1|STARTED|Overall Study||38
7934045|NCT00537940|19524769|P2|NOT COMPLETED|Overall Study||179
7934046|NCT00537940|19524770|P1|NOT COMPLETED|Overall Study||183
7934047|NCT00537940|19524769|P2|COMPLETED|Overall Study||62
7934048|NCT00537940|19524770|P1|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58
7934049|NCT00537940|19524769|P2|Entered Opt Blinded Continuation Phase|Overall Study||139
7934050|NCT00537940|19524770|P1|Entered Opt Blinded Continuation Phase|Overall Study||140
7934051|NCT00537940|19524769|P2|Completed Maintenance Phase|Overall Study||172
7934052|NCT00537940|19524770|P1|Completed Maintenance Phase|Overall Study||187
7934053|NCT00537940|19524769|P2|Completed Titration Phase|Overall Study||210
7934054|NCT00537940|19524770|P1|Completed Titration Phase|Overall Study||213
7934055|NCT00537940|19524769|P2|STARTED|Overall Study||241
7934056|NCT00537940|19524770|P1|STARTED|Overall Study||241
7934057|NCT00537823|19524794|P2|NOT COMPLETED|Overall Study||0
7934058|NCT00537823|19524795|P1|NOT COMPLETED|Overall Study||2
7934059|NCT00537823|19524794|P2|COMPLETED|Overall Study||2
7934060|NCT00537823|19524795|P1|COMPLETED|Overall Study||5
7934061|NCT00537823|19524794|P2|STARTED|Overall Study||2
7934062|NCT00537823|19524795|P1|STARTED|Overall Study||7
7934063|NCT00537810|19524821|P4|NOT COMPLETED|Overall Study||4
7934064|NCT00537810|19524822|P3|NOT COMPLETED|Overall Study||4
7934065|NCT00537810|19524823|P2|NOT COMPLETED|Overall Study||13
7934066|NCT00537810|19524824|P1|NOT COMPLETED|Overall Study||6
7934067|NCT00537810|19524821|P4|COMPLETED|Overall Study||22
7934068|NCT00537810|19524822|P3|COMPLETED|Overall Study||21
7934069|NCT00537810|19524823|P2|COMPLETED|Overall Study||14
7934070|NCT00537810|19524824|P1|COMPLETED|Overall Study||20
7934071|NCT00537810|19524821|P4|STARTED|Overall Study||26
7934072|NCT00537810|19524822|P3|STARTED|Overall Study||25
7934073|NCT00537810|19524823|P2|STARTED|Overall Study||27
7934074|NCT00537810|19524824|P1|STARTED|Overall Study||26
7934075|NCT00537771|19524840|P2|NOT COMPLETED|Overall Study||61
7934076|NCT00537771|19524841|P1|NOT COMPLETED|Overall Study||29
7934077|NCT00537771|19524840|P2|COMPLETED|Overall Study||114
7934078|NCT00537771|19524841|P1|COMPLETED|Overall Study||149
7934079|NCT00537771|19524840|P2|STARTED|Overall Study||175
7934080|NCT00537771|19524841|P1|STARTED|Overall Study||178
7934081|NCT00537745|19524851|P1|NOT COMPLETED|Overall Study||5
7934082|NCT00537745|19524851|P1|COMPLETED|Overall Study||9
7934083|NCT00537745|19524851|P1|Began Intervention|Overall Study||11
7934084|NCT00537745|19524851|P1|STARTED|Overall Study|There were three screen fails and two early terminations.|14
7934085|NCT00537680|19524859|P3|NOT COMPLETED|Overall Study||0
7934086|NCT00537680|19524860|P2|NOT COMPLETED|Overall Study||2
7934087|NCT00537680|19524861|P1|NOT COMPLETED|Overall Study||0
7934088|NCT00537680|19524859|P3|COMPLETED|Overall Study||24
7934089|NCT00537680|19524860|P2|COMPLETED|Overall Study||22
7934090|NCT00537680|19524861|P1|COMPLETED|Overall Study||22
7934091|NCT00537680|19524859|P3|STARTED|Overall Study||24
7934092|NCT00537680|19524860|P2|STARTED|Overall Study||24
7934093|NCT00537680|19524861|P1|STARTED|Overall Study||22
7934094|NCT00537576|19524875|P6|NOT COMPLETED|Overall Study||0
7934095|NCT00537576|19524876|P5|NOT COMPLETED|Overall Study||0
7934096|NCT00537576|19524877|P4|NOT COMPLETED|Overall Study||0
7934097|NCT00537576|19524878|P3|NOT COMPLETED|Overall Study||0
7934098|NCT00537576|19524879|P2|NOT COMPLETED|Overall Study||0
7934099|NCT00537576|19524880|P1|NOT COMPLETED|Overall Study||0
7934100|NCT00537576|19524875|P6|COMPLETED|Overall Study||1
7934101|NCT00537576|19524876|P5|COMPLETED|Overall Study||1
7934102|NCT00537576|19524877|P4|COMPLETED|Overall Study||1
7934103|NCT00537576|19524878|P3|COMPLETED|Overall Study||3
7934104|NCT00537576|19524879|P2|COMPLETED|Overall Study||3
7934105|NCT00537576|19524880|P1|COMPLETED|Overall Study||3
7934106|NCT00537576|19524875|P6|STARTED|Overall Study||1
7934107|NCT00537576|19524876|P5|STARTED|Overall Study||1
7934108|NCT00537576|19524877|P4|STARTED|Overall Study||1
7934109|NCT00537576|19524878|P3|STARTED|Overall Study||3
7934110|NCT00537576|19524879|P2|STARTED|Overall Study||3
7934111|NCT00537576|19524880|P1|STARTED|Overall Study||3
7934112|NCT00537511|19524906|P1|NOT COMPLETED|Maintenance Phase (Monotherapy)||8
7934113|NCT00537511|19524906|P1|COMPLETED|Maintenance Phase (Monotherapy)||0
7934114|NCT00537511|19524906|P1|STARTED|Maintenance Phase (Monotherapy)||8
7934115|NCT00537511|19524906|P1|NOT COMPLETED|Recovery Period (Monotherapy)||8
7934116|NCT00537511|19524906|P1|COMPLETED|Recovery Period (Monotherapy)||3
7934117|NCT00537511|19524906|P1|STARTED|Recovery Period (Monotherapy)||11
7934118|NCT00537511|19524906|P1|NOT COMPLETED|Extension Period (Combination)||6
7934119|NCT00537511|19524906|P1|COMPLETED|Extension Period (Combination)||11
7934120|NCT00537511|19524906|P1|STARTED|Extension Period (Combination)||17
7934121|NCT00537511|19524906|P1|NOT COMPLETED|Treatment Period (Combination)||5
7934122|NCT00537511|19524906|P1|COMPLETED|Treatment Period (Combination)||17
7934123|NCT00537511|19524906|P1|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22
7934124|NCT00537511|19524906|P1|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22
7934125|NCT00537511|19524906|P1|STARTED|Treatment Period (Combination)||22
7934126|NCT00537485|19524933|P2|NOT COMPLETED|Overall Study||10
7934127|NCT00537485|19524934|P1|NOT COMPLETED|Overall Study||15
7934128|NCT00537485|19524933|P2|COMPLETED|Overall Study||80
7934129|NCT00537485|19524934|P1|COMPLETED|Overall Study||75
7934130|NCT00537485|19524933|P2|STARTED|Overall Study||90
7934131|NCT00537485|19524934|P1|STARTED|Overall Study||90
7934132|NCT00537446|19524958|P1|NOT COMPLETED|Overall Study||0
7934133|NCT00537446|19524958|P1|COMPLETED|Overall Study||8
7934134|NCT00537446|19524958|P1|STARTED|Overall Study||8
7934135|NCT00537407|19524973|P5|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7
7934136|NCT00537407|19524974|P4|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6
7934137|NCT00537407|19524975|P3|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9
7934138|NCT00537407|19524976|P2|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
7934139|NCT00537407|19524977|P1|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
7934140|NCT00537407|19524973|P5|COMPLETED|Part 2 Weeks 5-48 or 72||3
7934141|NCT00537407|19524974|P4|COMPLETED|Part 2 Weeks 5-48 or 72||4
7934142|NCT00537407|19524975|P3|COMPLETED|Part 2 Weeks 5-48 or 72||2
7934143|NCT00537407|19524976|P2|COMPLETED|Part 2 Weeks 5-48 or 72||1
7934144|NCT00537407|19524977|P1|COMPLETED|Part 2 Weeks 5-48 or 72||2
7934145|NCT00537407|19524973|P5|STARTED|Part 2 Weeks 5-48 or 72||10
7934146|NCT00537407|19524974|P4|STARTED|Part 2 Weeks 5-48 or 72||10
7934147|NCT00537407|19524975|P3|STARTED|Part 2 Weeks 5-48 or 72||11
7934148|NCT00537407|19524976|P2|STARTED|Part 2 Weeks 5-48 or 72||9
7934149|NCT00537407|19524977|P1|STARTED|Part 2 Weeks 5-48 or 72||10
7934150|NCT00537407|19524973|P5|NOT COMPLETED|Part 1 Weeks 1-4||0
7934151|NCT00537407|19524974|P4|NOT COMPLETED|Part 1 Weeks 1-4||0
7934152|NCT00537407|19524975|P3|NOT COMPLETED|Part 1 Weeks 1-4||0
7934153|NCT00537407|19524976|P2|NOT COMPLETED|Part 1 Weeks 1-4||0
7934154|NCT00537407|19524977|P1|NOT COMPLETED|Part 1 Weeks 1-4||0
7934155|NCT00537407|19524973|P5|COMPLETED|Part 1 Weeks 1-4||10
7934156|NCT00537407|19524974|P4|COMPLETED|Part 1 Weeks 1-4||10
7934157|NCT00537407|19524975|P3|COMPLETED|Part 1 Weeks 1-4||11
7934158|NCT00537407|19524976|P2|COMPLETED|Part 1 Weeks 1-4||9
7934159|NCT00537407|19524977|P1|COMPLETED|Part 1 Weeks 1-4||10
7934160|NCT00537407|19524973|P5|STARTED|Part 1 Weeks 1-4||10
7934161|NCT00537407|19524974|P4|STARTED|Part 1 Weeks 1-4||10
7934162|NCT00537407|19524975|P3|STARTED|Part 1 Weeks 1-4||11
7934163|NCT00537407|19524976|P2|STARTED|Part 1 Weeks 1-4||9
7934164|NCT00537407|19524977|P1|STARTED|Part 1 Weeks 1-4||10
7934165|NCT00537394|19525017|P3|NOT COMPLETED|2nd Year of Follow-up||6
7934166|NCT00537394|19525018|P2|NOT COMPLETED|2nd Year of Follow-up||9
7934167|NCT00537394|19525019|P1|NOT COMPLETED|2nd Year of Follow-up||11
7934168|NCT00537394|19525017|P3|COMPLETED|2nd Year of Follow-up||44
7934169|NCT00537394|19525018|P2|COMPLETED|2nd Year of Follow-up||159
7934170|NCT00537394|19525019|P1|COMPLETED|2nd Year of Follow-up||158
7934171|NCT00537394|19525017|P3|STARTED|2nd Year of Follow-up||50
7934172|NCT00537394|19525018|P2|STARTED|2nd Year of Follow-up||168
7934173|NCT00537394|19525019|P1|STARTED|2nd Year of Follow-up||169
7934174|NCT00537394|19525017|P3|NOT COMPLETED|First Year of Follow-up||3
7934175|NCT00537394|19525018|P2|NOT COMPLETED|First Year of Follow-up||11
7934176|NCT00537394|19525019|P1|NOT COMPLETED|First Year of Follow-up||12
7934177|NCT00537394|19525017|P3|COMPLETED|First Year of Follow-up||50
7934178|NCT00537394|19525018|P2|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168
7934179|NCT00537394|19525019|P1|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169
7934180|NCT00537394|19525017|P3|STARTED|First Year of Follow-up||53
7934181|NCT00537394|19525018|P2|STARTED|First Year of Follow-up||179
7934182|NCT00537394|19525019|P1|STARTED|First Year of Follow-up||181
7934183|NCT00537381|19525055|P2|NOT COMPLETED|Overall Study||62
7934184|NCT00537381|19525056|P1|NOT COMPLETED|Overall Study||56
7934185|NCT00537381|19525055|P2|COMPLETED|Overall Study||4
7934186|NCT00537381|19525056|P1|COMPLETED|Overall Study||9
7934187|NCT00537381|19525055|P2|STARTED|Overall Study||66
7934188|NCT00537381|19525056|P1|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65
7934189|NCT00537329|19525076|P1|NOT COMPLETED|Overall Study||26
7934190|NCT00537329|19525076|P1|COMPLETED|Overall Study||17
7934191|NCT00537329|19525076|P1|STARTED|Overall Study||43
7934192|NCT00537316|19525096|P7|NOT COMPLETED|Part 2||2
7934193|NCT00537316|19525097|P6|NOT COMPLETED|Part 2||4
7934194|NCT00537316|19525098|P5|NOT COMPLETED|Part 2||1
7934195|NCT00537316|19525099|P4|NOT COMPLETED|Part 2||3
7934196|NCT00537316|19525100|P3|NOT COMPLETED|Part 2||32
7934197|NCT00537316|19525101|P2|NOT COMPLETED|Part 2||9
7934198|NCT00537316|19525102|P1|NOT COMPLETED|Part 2||26
7934199|NCT00537316|19525096|P7|COMPLETED|Part 2||0
7934200|NCT00537316|19525097|P6|COMPLETED|Part 2||0
7934201|NCT00537316|19525098|P5|COMPLETED|Part 2||1
7934202|NCT00537316|19525099|P4|COMPLETED|Part 2||2
7934203|NCT00537316|19525100|P3|COMPLETED|Part 2||16
7934204|NCT00537316|19525101|P2|COMPLETED|Part 2||1
7934205|NCT00537316|19525102|P1|COMPLETED|Part 2||11
7934206|NCT00537316|19525096|P7|STARTED|Part 2||2
7934207|NCT00537316|19525097|P6|STARTED|Part 2||4
7934208|NCT00537316|19525098|P5|STARTED|Part 2||2
7934209|NCT00537316|19525099|P4|STARTED|Part 2||5
7934210|NCT00537316|19525100|P3|STARTED|Part 2||48
7934211|NCT00537316|19525101|P2|STARTED|Part 2||10
7934212|NCT00537316|19525102|P1|STARTED|Part 2||37
7934213|NCT00537316|19525096|P7|NOT COMPLETED|Part 1||0
7934214|NCT00537316|19525097|P6|NOT COMPLETED|Part 1||0
7934215|NCT00537316|19525098|P5|NOT COMPLETED|Part 1||0
7934216|NCT00537316|19525099|P4|NOT COMPLETED|Part 1||0
7934217|NCT00537316|19525100|P3|NOT COMPLETED|Part 1||17
7934218|NCT00537316|19525101|P2|NOT COMPLETED|Part 1||27
7934219|NCT00537316|19525102|P1|NOT COMPLETED|Part 1||14
7934220|NCT00537316|19525096|P7|COMPLETED|Part 1||0
7934221|NCT00537316|19525097|P6|COMPLETED|Part 1||0
7934222|NCT00537316|19525098|P5|COMPLETED|Part 1||0
7934223|NCT00537316|19525099|P4|COMPLETED|Part 1||0
7934224|NCT00537316|19525100|P3|COMPLETED|Part 1||63
7934225|NCT00537316|19525101|P2|COMPLETED|Part 1||53
7934226|NCT00537316|19525102|P1|COMPLETED|Part 1||65
7934227|NCT00537316|19525096|P7|STARTED|Part 1||0
7934228|NCT00537316|19525097|P6|STARTED|Part 1||0
7934229|NCT00537316|19525098|P5|STARTED|Part 1||0
7934230|NCT00537316|19525099|P4|STARTED|Part 1||0
7934231|NCT00537316|19525100|P3|STARTED|Part 1||80
7934232|NCT00537316|19525101|P2|STARTED|Part 1||80
7934233|NCT00537316|19525102|P1|STARTED|Part 1||79
7934234|NCT00537303|19525129|P2|NOT COMPLETED|Overall Study||25
7934235|NCT00537303|19525130|P1|NOT COMPLETED|Overall Study||26
7934236|NCT00537303|19525129|P2|COMPLETED|Overall Study||125
7934237|NCT00537303|19525130|P1|COMPLETED|Overall Study||120
7934238|NCT00537303|19525129|P2|STARTED|Overall Study||150
7934239|NCT00537303|19525130|P1|STARTED|Overall Study||146
7934240|NCT00537290|19525146|P1|NOT COMPLETED|Overall Study||0
7934241|NCT00537290|19525146|P1|COMPLETED|Overall Study||19
7934242|NCT00537290|19525146|P1|STARTED|Overall Study||19
7934243|NCT00537277|19525151|P1|NOT COMPLETED|Overall Study||49
7934244|NCT00537277|19525151|P1|COMPLETED|Overall Study||112
7934245|NCT00537277|19525151|P1|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160
7934246|NCT00537277|19525151|P1|STARTED|Overall Study||161
7934247|NCT00537238|19525162|P2|NOT COMPLETED|Overall Study||173
7934248|NCT00537238|19525163|P1|NOT COMPLETED|Overall Study||174
7934249|NCT00537238|19525162|P2|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82
7934250|NCT00537238|19525163|P1|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80
7934251|NCT00537238|19525162|P2|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195
7934252|NCT00537238|19525163|P1|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185
7934253|NCT00537238|19525162|P2|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210
7934254|NCT00537238|19525163|P1|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208
7934255|NCT00537238|19525162|P2|Completed Titration Phase|Overall Study||236
7934256|NCT00537238|19525163|P1|Completed Titration Phase|Overall Study||226
7934257|NCT00537238|19525162|P2|STARTED|Overall Study||255
7934258|NCT00537238|19525163|P1|STARTED|Overall Study||254
7934259|NCT00537199|19525183|P1|NOT COMPLETED|Overall Study||1
7934260|NCT00537199|19525183|P1|COMPLETED|Overall Study||0
7934261|NCT00537199|19525183|P1|STARTED|Overall Study||1
7934262|NCT00537095|19525189|P2|NOT COMPLETED|Overall Study||57
7934263|NCT00537095|19525190|P1|NOT COMPLETED|Overall Study||51
7934264|NCT00537095|19525189|P2|COMPLETED|Overall Study||16
7934265|NCT00537095|19525190|P1|COMPLETED|Overall Study||21
7934266|NCT00537095|19525189|P2|STARTED|Overall Study||73
7934267|NCT00537095|19525190|P1|STARTED|Overall Study||72
7934268|NCT00537082|19525205|P3|NOT COMPLETED|Overall Study||6
7934269|NCT00537082|19525206|P2|NOT COMPLETED|Overall Study||9
7934270|NCT00537082|19525207|P1|NOT COMPLETED|Overall Study||9
7934271|NCT00537082|19525205|P3|COMPLETED|Overall Study||51
7934272|NCT00537082|19525206|P2|COMPLETED|Overall Study||48
7934273|NCT00537082|19525207|P1|COMPLETED|Overall Study||48
7934274|NCT00537082|19525205|P3|STARTED|Overall Study||57
7934275|NCT00537082|19525206|P2|STARTED|Overall Study||57
7934276|NCT00537082|19525207|P1|STARTED|Overall Study||57
7934277|NCT00537056|19525224|P1|NOT COMPLETED|12-month Follow-up||0
7934278|NCT00537056|19525224|P1|COMPLETED|12-month Follow-up||17
7934279|NCT00537056|19525224|P1|STARTED|12-month Follow-up||17
7934280|NCT00537056|19525224|P1|NOT COMPLETED|Interim PET/CT||5
7934281|NCT00537056|19525224|P1|COMPLETED|Interim PET/CT||12
7934282|NCT00537056|19525224|P1|STARTED|Interim PET/CT||17
7934283|NCT00537056|19525224|P1|NOT COMPLETED|Baseline PET/CT||0
7934284|NCT00537056|19525224|P1|COMPLETED|Baseline PET/CT||17
7934285|NCT00537056|19525224|P1|STARTED|Baseline PET/CT||17
7934286|NCT00537030|19525236|P1|NOT COMPLETED|Overall Study||16
7934287|NCT00537030|19525236|P1|COMPLETED|Overall Study||43
7934288|NCT00537030|19525236|P1|STARTED|Overall Study||59
7934289|NCT00537017|19525243|P1|NOT COMPLETED|Follow-up Phase||9
7934290|NCT00537017|19525243|P1|COMPLETED|Follow-up Phase||126
7934291|NCT00537017|19525243|P1|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135
7934292|NCT00537017|19525243|P1|NOT COMPLETED|Treatment Phase||34
7934293|NCT00537017|19525243|P1|COMPLETED|Treatment Phase||106
7934294|NCT00537017|19525243|P1|STARTED|Treatment Phase||140
7934295|NCT00536991|19525254|P1|NOT COMPLETED|Overall Study||13
7934296|NCT00536991|19525254|P1|COMPLETED|Overall Study||38
7934297|NCT00536991|19525254|P1|STARTED|Overall Study||51
7934298|NCT00536978|19525261|P1|NOT COMPLETED|Overall Study||22
7934299|NCT00536978|19525261|P1|COMPLETED|Overall Study||0
7934300|NCT00536978|19525261|P1|STARTED|Overall Study||22
7934301|NCT00536939|19525265|P2|NOT COMPLETED|Overall Study||0
7934302|NCT00536939|19525266|P1|NOT COMPLETED|Overall Study||2
7934303|NCT00536939|19525265|P2|COMPLETED|Overall Study||0
7934304|NCT00536939|19525266|P1|COMPLETED|Overall Study||0
7934305|NCT00536939|19525265|P2|Randomized|Overall Study||0
7934306|NCT00536939|19525266|P1|Randomized|Overall Study||0
7934307|NCT00536939|19525265|P2|Entered Safety lead-in|Overall Study||0
7934308|NCT00536939|19525266|P1|Entered Safety lead-in|Overall Study||2
7934309|NCT00536939|19525265|P2|STARTED|Overall Study||0
7934310|NCT00536939|19525266|P1|STARTED|Overall Study||2
7934311|NCT00536913|19525274|P2|NOT COMPLETED|Overall Study||0
7934312|NCT00536913|19525275|P1|NOT COMPLETED|Overall Study||0
7934313|NCT00536913|19525274|P2|COMPLETED|Overall Study||52
7934314|NCT00536913|19525275|P1|COMPLETED|Overall Study||55
7934315|NCT00536913|19525274|P2|STARTED|Overall Study||52
7934316|NCT00536913|19525275|P1|STARTED|Overall Study||55
7934317|NCT00536874|19525297|P1|NOT COMPLETED|Overall Study||4
7934318|NCT00536874|19525297|P1|COMPLETED|Overall Study||35
7934319|NCT00536874|19525297|P1|STARTED|Overall Study||39
7934320|NCT00536809|19525307|P1|NOT COMPLETED|Phase II||2
7934321|NCT00536809|19525307|P1|COMPLETED|Phase II||0
7934322|NCT00536809|19525307|P1|STARTED|Phase II||2
7934323|NCT00536809|19525307|P1|NOT COMPLETED|Phase I (Dose-finding Phase)||0
7934324|NCT00536809|19525307|P1|COMPLETED|Phase I (Dose-finding Phase)||10
7934325|NCT00536809|19525307|P1|STARTED|Phase I (Dose-finding Phase)||10
7934326|NCT00536744|19525330|P2|NOT COMPLETED|Overall Study||28
7934327|NCT00536744|19525331|P1|NOT COMPLETED|Overall Study||29
7934328|NCT00536744|19525330|P2|COMPLETED|Overall Study||71
7934329|NCT00536744|19525331|P1|COMPLETED|Overall Study||78
7934330|NCT00536744|19525330|P2|STARTED|Overall Study||99
7934331|NCT00536744|19525331|P1|STARTED|Overall Study||107
7934332|NCT00536731|19525340|P3|NOT COMPLETED|Overall Study||5
7934333|NCT00536731|19525341|P2|NOT COMPLETED|Overall Study||5
7934334|NCT00536731|19525342|P1|NOT COMPLETED|Overall Study||4
7934335|NCT00536731|19525340|P3|COMPLETED|Overall Study||238
7934336|NCT00536731|19525341|P2|COMPLETED|Overall Study||241
7934337|NCT00536731|19525342|P1|COMPLETED|Overall Study||249
7934338|NCT00536731|19525340|P3|STARTED|Overall Study||243
7934339|NCT00536731|19525341|P2|STARTED|Overall Study||246
7934340|NCT00536731|19525342|P1|STARTED|Overall Study||253
7934341|NCT00536575|19525386|P1|NOT COMPLETED|Overall Study||2
7934342|NCT00536575|19525386|P1|COMPLETED|Overall Study||11
7934343|NCT00536575|19525386|P1|STARTED|Overall Study||13
7934344|NCT00536510|19525392|P2|NOT COMPLETED|Overall Study||29
7934345|NCT00536510|19525393|P1|NOT COMPLETED|Overall Study||82
7934346|NCT00536510|19525392|P2|COMPLETED|Overall Study||295
7934347|NCT00536510|19525393|P1|COMPLETED|Overall Study||240
7934348|NCT00536510|19525392|P2|STARTED|Overall Study||324
7934349|NCT00536510|19525393|P1|STARTED|Overall Study||322
7934350|NCT00536484|19525403|P2|NOT COMPLETED|Overall Study||56
7934351|NCT00536484|19525404|P1|NOT COMPLETED|Overall Study||60
7934352|NCT00536484|19525403|P2|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382
7934353|NCT00536484|19525404|P1|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385
7934354|NCT00536484|19525403|P2|STARTED|Overall Study|448 participants randomised; 10 not treated|438
7934355|NCT00536484|19525404|P1|STARTED|Overall Study|448 participants randomised; 3 not treated|445
7934356|NCT00536471|19525438|P4|NOT COMPLETED|Overall Study||74
7934357|NCT00536471|19525439|P3|NOT COMPLETED|Overall Study||139
7934358|NCT00536471|19525440|P2|NOT COMPLETED|Overall Study||84
7934359|NCT00536471|19525441|P1|NOT COMPLETED|Overall Study||156
7934360|NCT00536471|19525438|P4|COMPLETED|Overall Study||57
7934361|NCT00536471|19525439|P3|COMPLETED|Overall Study||122
7934362|NCT00536471|19525440|P2|COMPLETED|Overall Study||43
7934363|NCT00536471|19525441|P1|COMPLETED|Overall Study||101
7934364|NCT00536471|19525438|P4|STARTED|Overall Study||131
7934365|NCT00536471|19525439|P3|STARTED|Overall Study||261
7934366|NCT00536471|19525440|P2|STARTED|Overall Study||127
7934367|NCT00536471|19525441|P1|STARTED|Overall Study||257
7934368|NCT00536380|19525686|P3|NOT COMPLETED|Overall Study||10
7934369|NCT00536380|19525687|P2|NOT COMPLETED|Overall Study||9
7934370|NCT00536380|19525688|P1|NOT COMPLETED|Overall Study||12
7934371|NCT00536380|19525686|P3|COMPLETED|Overall Study||94
7934372|NCT00536380|19525687|P2|COMPLETED|Overall Study||95
7934373|NCT00536380|19525688|P1|COMPLETED|Overall Study||94
7934374|NCT00536380|19525686|P3|STARTED|Overall Study||104
7934375|NCT00536380|19525687|P2|STARTED|Overall Study||104
7934376|NCT00536380|19525688|P1|STARTED|Overall Study||106
7934377|NCT00536341|19525698|P2|NOT COMPLETED|Overall Study||11
7934378|NCT00536341|19525699|P1|NOT COMPLETED|Overall Study||5
7934379|NCT00536341|19525698|P2|COMPLETED|Overall Study||43
7934380|NCT00536341|19525699|P1|COMPLETED|Overall Study||5
7934381|NCT00536341|19525698|P2|STARTED|Overall Study||54
7934382|NCT00536341|19525699|P1|STARTED|Overall Study||10
7934383|NCT00536263|19525712|P3|NOT COMPLETED|Overall Study||21
7934384|NCT00536263|19525713|P2|NOT COMPLETED|Overall Study||14
7934385|NCT00536263|19525714|P1|NOT COMPLETED|Overall Study||11
7934386|NCT00536263|19525712|P3|COMPLETED|Overall Study||204
7934387|NCT00536263|19525713|P2|COMPLETED|Overall Study||207
7934388|NCT00536263|19525714|P1|COMPLETED|Overall Study||214
7934661|NCT00535288|19526264|P3|COMPLETED|Overall Study||127
7934389|NCT00536263|19525712|P3|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225
7934390|NCT00536263|19525713|P2|STARTED|Overall Study||221
7934391|NCT00536263|19525714|P1|STARTED|Overall Study||225
7934392|NCT00536198|19525754|P2|NOT COMPLETED|Overall Study||39
7934393|NCT00536198|19525755|P1|NOT COMPLETED|Overall Study||37
7934394|NCT00536198|19525754|P2|COMPLETED|Overall Study||88
7934395|NCT00536198|19525755|P1|COMPLETED|Overall Study||88
7934396|NCT00536198|19525754|P2|Cycle 6|Overall Study||88
7934397|NCT00536198|19525755|P1|Cycle 6|Overall Study||88
7934398|NCT00536198|19525754|P2|Cycle 5|Overall Study||85
7934399|NCT00536198|19525755|P1|Cycle 5|Overall Study||88
7934400|NCT00536198|19525754|P2|Cycle 4|Overall Study||98
7934401|NCT00536198|19525755|P1|Cycle 4|Overall Study||95
7934402|NCT00536198|19525754|P2|Cycle 3|Overall Study||101
7934403|NCT00536198|19525755|P1|Cycle 3|Overall Study||100
7934404|NCT00536198|19525754|P2|Cycle 2|Overall Study||112
7934405|NCT00536198|19525755|P1|Cycle 2|Overall Study||104
7934406|NCT00536198|19525754|P2|Cycle 1|Overall Study||123
7934407|NCT00536198|19525755|P1|Cycle 1|Overall Study||110
7934408|NCT00536198|19525754|P2|STARTED|Overall Study||127
7934409|NCT00536198|19525755|P1|STARTED|Overall Study||125
7934410|NCT00536172|19525785|P2|NOT COMPLETED|Overall Study||9
7934411|NCT00536172|19525786|P1|NOT COMPLETED|Overall Study||14
7934412|NCT00536172|19525785|P2|COMPLETED|Overall Study||65
7934413|NCT00536172|19525786|P1|COMPLETED|Overall Study||60
7934414|NCT00536172|19525785|P2|STARTED|Overall Study||74
7934415|NCT00536172|19525786|P1|STARTED|Overall Study||74
7934416|NCT00536120|19525794|P2|NOT COMPLETED|Overall Study||3
7934417|NCT00536120|19525795|P1|NOT COMPLETED|Overall Study||6
7934418|NCT00536120|19525794|P2|COMPLETED|Overall Study||27
7934419|NCT00536120|19525795|P1|COMPLETED|Overall Study||24
7934420|NCT00536120|19525794|P2|STARTED|Overall Study||30
7934421|NCT00536120|19525795|P1|STARTED|Overall Study||30
7934422|NCT00536107|19525809|P2|NOT COMPLETED|Overall Study||6
7934423|NCT00536107|19525810|P1|NOT COMPLETED|Overall Study||8
7934424|NCT00536107|19525809|P2|COMPLETED|Overall Study||0
7934425|NCT00536107|19525810|P1|COMPLETED|Overall Study||0
7934426|NCT00536107|19525809|P2|STARTED|Overall Study||6
7934427|NCT00536107|19525810|P1|STARTED|Overall Study||8
7934428|NCT00535938|19525820|P2|NOT COMPLETED|Overall Study||462
7934429|NCT00535938|19525821|P1|NOT COMPLETED|Overall Study||391
7934430|NCT00535938|19525820|P2|COMPLETED|Overall Study||404
7934431|NCT00535938|19525821|P1|COMPLETED|Overall Study||115
7934432|NCT00535938|19525820|P2|STARTED|Overall Study||866
7934433|NCT00535938|19525821|P1|STARTED|Overall Study||506
7934434|NCT00535925|19525859|P2|NOT COMPLETED|Overall Study||8
7934435|NCT00535925|19525860|P1|NOT COMPLETED|Overall Study||19
7934436|NCT00535925|19525859|P2|COMPLETED|Overall Study||199
7934437|NCT00535925|19525860|P1|COMPLETED|Overall Study||169
7934438|NCT00535925|19525859|P2|STARTED|Overall Study||207
7934439|NCT00535925|19525860|P1|STARTED|Overall Study||188
7934440|NCT00535873|19525868|P1|NOT COMPLETED|Overall Study||0
7934441|NCT00535873|19525868|P1|COMPLETED|Overall Study||60
7934442|NCT00535873|19525868|P1|STARTED|Overall Study||60
7934443|NCT00535847|19525875|P3|NOT COMPLETED|Overall Study||2
7934444|NCT00535847|19525876|P2|NOT COMPLETED|Overall Study||14
7934445|NCT00535847|19525877|P1|NOT COMPLETED|Overall Study||22
7934446|NCT00535847|19525875|P3|COMPLETED|Overall Study||0
7934447|NCT00535847|19525876|P2|COMPLETED|Overall Study||20
7934448|NCT00535847|19525877|P1|COMPLETED|Overall Study||59
7934449|NCT00535847|19525875|P3|STARTED|Overall Study||2
7934450|NCT00535847|19525876|P2|STARTED|Overall Study||34
7934451|NCT00535847|19525877|P1|STARTED|Overall Study||81
7934452|NCT00535821|19525903|P2|NOT COMPLETED|Overall Study||0
7934453|NCT00535821|19525904|P1|NOT COMPLETED|Overall Study||0
7934454|NCT00535821|19525903|P2|COMPLETED|Overall Study||3
7934455|NCT00535821|19525904|P1|COMPLETED|Overall Study||2
7934456|NCT00535821|19525903|P2|STARTED|Overall Study||3
7934457|NCT00535821|19525904|P1|STARTED|Overall Study||2
7934458|NCT00535782|19525912|P3|NOT COMPLETED|Part 2: 80-Week Open-label Period||26
7934459|NCT00535782|19525913|P2|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
7934460|NCT00535782|19525914|P1|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
7934461|NCT00535782|19525912|P3|COMPLETED|Part 2: 80-Week Open-label Period||98
7934462|NCT00535782|19525913|P2|COMPLETED|Part 2: 80-Week Open-label Period||0
7934463|NCT00535782|19525914|P1|COMPLETED|Part 2: 80-Week Open-label Period||0
7934464|NCT00535782|19525912|P3|STARTED|Part 2: 80-Week Open-label Period||124
7934465|NCT00535782|19525913|P2|STARTED|Part 2: 80-Week Open-label Period||0
7934466|NCT00535782|19525914|P1|STARTED|Part 2: 80-Week Open-label Period||0
7934467|NCT00535782|19525912|P3|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0
7934468|NCT00535782|19525913|P2|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
7934469|NCT00535782|19525914|P1|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
7934470|NCT00535782|19525912|P3|COMPLETED|Part 1: 24-Week Double-blind Period||0
7934471|NCT00535782|19525913|P2|COMPLETED|Part 1: 24-Week Double-blind Period||59
7934472|NCT00535782|19525914|P1|COMPLETED|Part 1: 24-Week Double-blind Period||65
7934473|NCT00535782|19525912|P3|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
7934474|NCT00535782|19525913|P2|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62
7934475|NCT00535782|19525914|P1|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
7934476|NCT00535782|19525912|P3|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0
7934477|NCT00535782|19525913|P2|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2
7934478|NCT00535782|19525914|P1|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69
7934479|NCT00535782|19525912|P3|STARTED|Part 1: 24-Week Double-blind Period||0
7934480|NCT00535782|19525913|P2|STARTED|Part 1: 24-Week Double-blind Period||63
7934481|NCT00535782|19525914|P1|STARTED|Part 1: 24-Week Double-blind Period||69
7934482|NCT00535769|19525931|P2|NOT COMPLETED|Overall Study||0
7934483|NCT00535769|19525932|P1|NOT COMPLETED|Overall Study||0
7934484|NCT00535769|19525931|P2|COMPLETED|Overall Study||35
7934485|NCT00535769|19525932|P1|COMPLETED|Overall Study||35
7934486|NCT00535769|19525931|P2|STARTED|Overall Study||35
7934487|NCT00535769|19525932|P1|STARTED|Overall Study||35
7934488|NCT00535743|19525965|P24|NOT COMPLETED|Overall Study||0
7934489|NCT00535743|19525966|P23|NOT COMPLETED|Overall Study||0
7934490|NCT00535743|19525967|P22|NOT COMPLETED|Overall Study||1
7934491|NCT00535743|19525968|P21|NOT COMPLETED|Overall Study||0
7934492|NCT00535743|19525969|P20|NOT COMPLETED|Overall Study||0
7934493|NCT00535743|19525970|P19|NOT COMPLETED|Overall Study||0
7934494|NCT00535743|19525971|P18|NOT COMPLETED|Overall Study||0
7934495|NCT00535743|19525972|P17|NOT COMPLETED|Overall Study||0
7934496|NCT00535743|19525973|P16|NOT COMPLETED|Overall Study||0
7934497|NCT00535743|19525974|P15|NOT COMPLETED|Overall Study||0
7934498|NCT00535743|19525975|P14|NOT COMPLETED|Overall Study||0
7934499|NCT00535743|19525976|P13|NOT COMPLETED|Overall Study||0
7934500|NCT00535743|19525977|P12|NOT COMPLETED|Overall Study||0
7934501|NCT00535743|19525978|P11|NOT COMPLETED|Overall Study||0
7934502|NCT00535743|19525979|P10|NOT COMPLETED|Overall Study||1
7934503|NCT00535743|19525980|P9|NOT COMPLETED|Overall Study||1
7934504|NCT00535743|19525981|P8|NOT COMPLETED|Overall Study||0
7934505|NCT00535743|19525982|P7|NOT COMPLETED|Overall Study||0
7934506|NCT00535743|19525983|P6|NOT COMPLETED|Overall Study||0
7934507|NCT00535743|19525984|P5|NOT COMPLETED|Overall Study||0
7934508|NCT00535743|19525985|P4|NOT COMPLETED|Overall Study||0
7934509|NCT00535743|19525986|P3|NOT COMPLETED|Overall Study||0
7934510|NCT00535743|19525987|P2|NOT COMPLETED|Overall Study||0
7934511|NCT00535743|19525988|P1|NOT COMPLETED|Overall Study||0
7934512|NCT00535743|19525965|P24|COMPLETED|Overall Study||5
7934513|NCT00535743|19525966|P23|COMPLETED|Overall Study||6
7934514|NCT00535743|19525967|P22|COMPLETED|Overall Study||4
7934515|NCT00535743|19525968|P21|COMPLETED|Overall Study||5
7934516|NCT00535743|19525969|P20|COMPLETED|Overall Study||5
7934517|NCT00535743|19525970|P19|COMPLETED|Overall Study||3
7934518|NCT00535743|19525971|P18|COMPLETED|Overall Study||11
7934519|NCT00535743|19525972|P17|COMPLETED|Overall Study||10
7934520|NCT00535743|19525973|P16|COMPLETED|Overall Study||13
7934521|NCT00535743|19525974|P15|COMPLETED|Overall Study||9
7934522|NCT00535743|19525975|P14|COMPLETED|Overall Study||10
7934523|NCT00535743|19525976|P13|COMPLETED|Overall Study||5
7934524|NCT00535743|19525977|P12|COMPLETED|Overall Study||5
7934525|NCT00535743|19525978|P11|COMPLETED|Overall Study||5
7934526|NCT00535743|19525979|P10|COMPLETED|Overall Study||4
7934527|NCT00535743|19525980|P9|COMPLETED|Overall Study||4
7934528|NCT00535743|19525981|P8|COMPLETED|Overall Study||5
7934529|NCT00535743|19525982|P7|COMPLETED|Overall Study||3
7934530|NCT00535743|19525983|P6|COMPLETED|Overall Study||10
7934531|NCT00535743|19525984|P5|COMPLETED|Overall Study||11
7934532|NCT00535743|19525985|P4|COMPLETED|Overall Study||11
7934533|NCT00535743|19525986|P3|COMPLETED|Overall Study||11
7934534|NCT00535743|19525987|P2|COMPLETED|Overall Study||11
7934535|NCT00535743|19525988|P1|COMPLETED|Overall Study||5
7934536|NCT00535743|19525965|P24|Treated|Overall Study||5
7934537|NCT00535743|19525966|P23|Treated|Overall Study|N=1 (randomized to Arm Q) rec'd 12 mg/kg Sugammadex, 29 min after 1.2 mg/kg Esmeron®|6
7934538|NCT00535743|19525967|P22|Treated|Overall Study||5
7934539|NCT00535743|19525968|P21|Treated|Overall Study||5
7934540|NCT00535743|19525969|P20|Treated|Overall Study||5
7934541|NCT00535743|19525970|P19|Treated|Overall Study||3
7934542|NCT00535743|19525971|P18|Treated|Overall Study||11
7934543|NCT00535743|19525972|P17|Treated|Overall Study||10
7934544|NCT00535743|19525973|P16|Treated|Overall Study|N=2 (randomized to Arm O) rec'd 8 mg/kg Sugammadex, 3 min after 1.2 mg/kg Esmeron®|13
7934545|NCT00535743|19525974|P15|Treated|Overall Study||9
7934546|NCT00535743|19525975|P14|Treated|Overall Study||10
7934547|NCT00535743|19525976|P13|Treated|Overall Study||5
7934548|NCT00535743|19525977|P12|Treated|Overall Study||5
7934549|NCT00535743|19525978|P11|Treated|Overall Study||5
7934550|NCT00535743|19525979|P10|Treated|Overall Study||5
7934551|NCT00535743|19525980|P9|Treated|Overall Study||4
7934552|NCT00535743|19525981|P8|Treated|Overall Study||5
7934553|NCT00535743|19525982|P7|Treated|Overall Study||3
7934554|NCT00535743|19525983|P6|Treated|Overall Study||10
7934555|NCT00535743|19525984|P5|Treated|Overall Study||11
7934556|NCT00535743|19525985|P4|Treated|Overall Study||11
7934557|NCT00535743|19525986|P3|Treated|Overall Study||11
7934558|NCT00535743|19525987|P2|Treated|Overall Study||11
7934559|NCT00535743|19525988|P1|Treated|Overall Study||5
7934560|NCT00535743|19525965|P24|STARTED|Overall Study||5
7934561|NCT00535743|19525966|P23|STARTED|Overall Study|N=5 randomized to Arm W. An additional N=1 (randomized to Arm Q) is counted as Started in Arm W|6
7934562|NCT00535743|19525967|P22|STARTED|Overall Study||5
7934563|NCT00535743|19525968|P21|STARTED|Overall Study||5
7934564|NCT00535743|19525969|P20|STARTED|Overall Study||5
7934565|NCT00535743|19525970|P19|STARTED|Overall Study||3
7934566|NCT00535743|19525971|P18|STARTED|Overall Study||11
7934567|NCT00535743|19525972|P17|STARTED|Overall Study||10
7934662|NCT00535288|19526265|P2|COMPLETED|Overall Study||130
7934568|NCT00535743|19525973|P16|STARTED|Overall Study|N=11 randomized to Arm P. An additional N=2 (randomized to Arm O) are counted as Started in Arm P|13
7934569|NCT00535743|19525974|P15|STARTED|Overall Study||9
7934570|NCT00535743|19525975|P14|STARTED|Overall Study||10
7934571|NCT00535743|19525976|P13|STARTED|Overall Study||5
7934572|NCT00535743|19525977|P12|STARTED|Overall Study||5
7934573|NCT00535743|19525978|P11|STARTED|Overall Study||5
7934574|NCT00535743|19525979|P10|STARTED|Overall Study||5
7934575|NCT00535743|19525980|P9|STARTED|Overall Study||5
7934576|NCT00535743|19525981|P8|STARTED|Overall Study||5
7934577|NCT00535743|19525982|P7|STARTED|Overall Study||3
7934578|NCT00535743|19525983|P6|STARTED|Overall Study||10
7934579|NCT00535743|19525984|P5|STARTED|Overall Study||11
7934580|NCT00535743|19525985|P4|STARTED|Overall Study||11
7934581|NCT00535743|19525986|P3|STARTED|Overall Study||11
7934582|NCT00535743|19525987|P2|STARTED|Overall Study||11
7934583|NCT00535743|19525988|P1|STARTED|Overall Study||5
7934584|NCT00535730|19526112|P2|NOT COMPLETED|Overall Study||7
7934585|NCT00535730|19526113|P1|NOT COMPLETED|Overall Study||2
7934586|NCT00535730|19526112|P2|COMPLETED|Overall Study||230
7934587|NCT00535730|19526113|P1|COMPLETED|Overall Study||234
7934588|NCT00535730|19526112|P2|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237
7934589|NCT00535730|19526113|P1|STARTED|Overall Study||236
7934590|NCT00535652|19526130|P1|NOT COMPLETED|Overall Study||3
7934591|NCT00535652|19526130|P1|COMPLETED|Overall Study||20
7934592|NCT00535652|19526130|P1|STARTED|Overall Study||23
7934593|NCT00535626|19526134|P1|NOT COMPLETED|Overall Study||105
7934594|NCT00535626|19526134|P1|COMPLETED|Overall Study||85
7934595|NCT00535626|19526134|P1|STARTED|Overall Study||190
7934596|NCT00535613|19526146|P2|NOT COMPLETED|Overall Study||0
7934597|NCT00535613|19526147|P1|NOT COMPLETED|Overall Study||0
7934598|NCT00535613|19526146|P2|COMPLETED|Overall Study||50
7934599|NCT00535613|19526147|P1|COMPLETED|Overall Study||49
7934600|NCT00535613|19526146|P2|STARTED|Overall Study||50
7934601|NCT00535613|19526147|P1|STARTED|Overall Study||49
7934602|NCT00535587|19526161|P4|NOT COMPLETED|Overall Study||13
7934603|NCT00535587|19526162|P3|NOT COMPLETED|Overall Study||8
7934604|NCT00535587|19526163|P2|NOT COMPLETED|Overall Study||11
7934605|NCT00535587|19526164|P1|NOT COMPLETED|Overall Study||10
7934606|NCT00535587|19526161|P4|COMPLETED|Overall Study||41
7934607|NCT00535587|19526162|P3|COMPLETED|Overall Study||39
7934608|NCT00535587|19526163|P2|COMPLETED|Overall Study||42
7934609|NCT00535587|19526164|P1|COMPLETED|Overall Study||43
7934610|NCT00535587|19526161|P4|STARTED|Overall Study||54
7934611|NCT00535587|19526162|P3|STARTED|Overall Study||47
7934612|NCT00535587|19526163|P2|STARTED|Overall Study||53
7934613|NCT00535587|19526164|P1|STARTED|Overall Study||53
7934614|NCT00535496|19526174|P4|NOT COMPLETED|Overall Study||0
7934615|NCT00535496|19526175|P3|NOT COMPLETED|Overall Study||0
7934616|NCT00535496|19526176|P2|NOT COMPLETED|Overall Study||2
7934617|NCT00535496|19526177|P1|NOT COMPLETED|Overall Study||0
7934618|NCT00535496|19526174|P4|COMPLETED|Overall Study||31
7934619|NCT00535496|19526175|P3|COMPLETED|Overall Study||30
7934620|NCT00535496|19526176|P2|COMPLETED|Overall Study||13
7934621|NCT00535496|19526177|P1|COMPLETED|Overall Study||15
7934622|NCT00535496|19526174|P4|All-Subjects-Treated (AST) Group|Overall Study||31
7934623|NCT00535496|19526175|P3|All-Subjects-Treated (AST) Group|Overall Study||30
7934624|NCT00535496|19526176|P2|All-Subjects-Treated (AST) Group|Overall Study||14
7934625|NCT00535496|19526177|P1|All-Subjects-Treated (AST) Group|Overall Study||15
7934626|NCT00535496|19526174|P4|STARTED|Overall Study||31
7934627|NCT00535496|19526175|P3|STARTED|Overall Study||30
7934628|NCT00535496|19526176|P2|STARTED|Overall Study||15
7934629|NCT00535496|19526177|P1|STARTED|Overall Study||15
7934630|NCT00535405|19526197|P5|NOT COMPLETED|Overall Study||16
7934631|NCT00535405|19526198|P4|NOT COMPLETED|Overall Study||22
7934632|NCT00535405|19526199|P3|NOT COMPLETED|Overall Study||18
7934633|NCT00535405|19526200|P2|NOT COMPLETED|Overall Study||26
7934634|NCT00535405|19526201|P1|NOT COMPLETED|Overall Study||17
7934635|NCT00535405|19526197|P5|COMPLETED|Overall Study||241
7934636|NCT00535405|19526198|P4|COMPLETED|Overall Study||235
7934637|NCT00535405|19526199|P3|COMPLETED|Overall Study||241
7934638|NCT00535405|19526200|P2|COMPLETED|Overall Study||233
7934639|NCT00535405|19526201|P1|COMPLETED|Overall Study||240
7934640|NCT00535405|19526197|P5|STARTED|Overall Study||257
7934641|NCT00535405|19526198|P4|STARTED|Overall Study||257
7934642|NCT00535405|19526199|P3|STARTED|Overall Study||259
7934643|NCT00535405|19526200|P2|STARTED|Overall Study||259
7934644|NCT00535405|19526201|P1|STARTED|Overall Study||257
7934645|NCT00535392|19526238|P1|NOT COMPLETED|Overall Study||0
7934646|NCT00535392|19526238|P1|COMPLETED|Overall Study||33
7934647|NCT00535392|19526238|P1|STARTED|Overall Study||33
7934648|NCT00535301|19526246|P2|NOT COMPLETED|Overall Study||5
7934649|NCT00535301|19526247|P1|NOT COMPLETED|Overall Study||5
7934650|NCT00535301|19526246|P2|COMPLETED|Overall Study||33
7934651|NCT00535301|19526247|P1|COMPLETED|Overall Study||33
7934652|NCT00535301|19526246|P2|STARTED|Overall Study||38
7934653|NCT00535301|19526247|P1|STARTED|Overall Study||38
7934654|NCT00535288|19526262|P5|NOT COMPLETED|Overall Study||42
7934655|NCT00535288|19526263|P4|NOT COMPLETED|Overall Study||29
7934656|NCT00535288|19526264|P3|NOT COMPLETED|Overall Study||33
7934657|NCT00535288|19526265|P2|NOT COMPLETED|Overall Study||32
7934658|NCT00535288|19526266|P1|NOT COMPLETED|Overall Study||54
7934659|NCT00535288|19526262|P5|COMPLETED|Overall Study||116
7934660|NCT00535288|19526263|P4|COMPLETED|Overall Study||122
7934663|NCT00535288|19526266|P1|COMPLETED|Overall Study||260
7934664|NCT00535288|19526262|P5|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158
7934665|NCT00535288|19526263|P4|STARTED|Overall Study||151
7934666|NCT00535288|19526264|P3|STARTED|Overall Study||160
7934667|NCT00535288|19526265|P2|STARTED|Overall Study||162
7934668|NCT00535288|19526266|P1|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314
7934669|NCT00535262|19526343|P1|NOT COMPLETED|Overall Study||3
7934670|NCT00535262|19526343|P1|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0
7934671|NCT00535262|19526343|P1|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3
7934672|NCT00535236|19526357|P10|NOT COMPLETED|Overall Study||4
7934673|NCT00535236|19526358|P9|NOT COMPLETED|Overall Study||13
7934674|NCT00535236|19526359|P8|NOT COMPLETED|Overall Study||1
7934675|NCT00535236|19526360|P7|NOT COMPLETED|Overall Study||11
7934676|NCT00535236|19526361|P6|NOT COMPLETED|Overall Study||1
7934677|NCT00535236|19526362|P5|NOT COMPLETED|Overall Study||12
7934678|NCT00535236|19526363|P4|NOT COMPLETED|Overall Study||4
7934679|NCT00535236|19526364|P3|NOT COMPLETED|Overall Study||12
7934680|NCT00535236|19526365|P2|NOT COMPLETED|Overall Study||2
7934681|NCT00535236|19526366|P1|NOT COMPLETED|Overall Study||7
7934682|NCT00535236|19526357|P10|COMPLETED|Overall Study||16
7934683|NCT00535236|19526358|P9|COMPLETED|Overall Study||47
7934684|NCT00535236|19526359|P8|COMPLETED|Overall Study||18
7934685|NCT00535236|19526360|P7|COMPLETED|Overall Study||51
7934686|NCT00535236|19526361|P6|COMPLETED|Overall Study||19
7934687|NCT00535236|19526362|P5|COMPLETED|Overall Study||47
7934688|NCT00535236|19526363|P4|COMPLETED|Overall Study||6
7934689|NCT00535236|19526364|P3|COMPLETED|Overall Study||29
7934690|NCT00535236|19526365|P2|COMPLETED|Overall Study||8
7934691|NCT00535236|19526366|P1|COMPLETED|Overall Study||33
7934692|NCT00535236|19526357|P10|Vaccination 4|Overall Study||17
7934693|NCT00535236|19526358|P9|Vaccination 4|Overall Study||50
7934694|NCT00535236|19526359|P8|Vaccination 4|Overall Study||18
7934695|NCT00535236|19526360|P7|Vaccination 4|Overall Study||51
7934696|NCT00535236|19526361|P6|Vaccination 4|Overall Study||19
7934697|NCT00535236|19526362|P5|Vaccination 4|Overall Study||47
7934698|NCT00535236|19526363|P4|Vaccination 4|Overall Study||6
7934699|NCT00535236|19526364|P3|Vaccination 4|Overall Study||32
7934700|NCT00535236|19526365|P2|Vaccination 4|Overall Study||10
7934701|NCT00535236|19526366|P1|Vaccination 4|Overall Study||34
7934702|NCT00535236|19526357|P10|Vaccination 3|Overall Study||18
7934703|NCT00535236|19526358|P9|Vaccination 3|Overall Study||53
7934704|NCT00535236|19526359|P8|Vaccination 3|Overall Study||18
7934705|NCT00535236|19526360|P7|Vaccination 3|Overall Study||51
7934706|NCT00535236|19526361|P6|Vaccination 3|Overall Study||19
7934707|NCT00535236|19526362|P5|Vaccination 3|Overall Study||48
7934708|NCT00535236|19526363|P4|Vaccination 3|Overall Study||8
7934709|NCT00535236|19526364|P3|Vaccination 3|Overall Study||35
7934710|NCT00535236|19526365|P2|Vaccination 3|Overall Study||10
7934711|NCT00535236|19526366|P1|Vaccination 3|Overall Study||34
7934712|NCT00535236|19526357|P10|Vaccination 2|Overall Study||19
7934713|NCT00535236|19526358|P9|Vaccination 2|Overall Study||57
7934714|NCT00535236|19526359|P8|Vaccination 2|Overall Study||19
7934715|NCT00535236|19526360|P7|Vaccination 2|Overall Study||58
7934716|NCT00535236|19526361|P6|Vaccination 2|Overall Study||19
7934717|NCT00535236|19526362|P5|Vaccination 2|Overall Study||52
7934718|NCT00535236|19526363|P4|Vaccination 2|Overall Study||8
7934719|NCT00535236|19526364|P3|Vaccination 2|Overall Study||37
7934720|NCT00535236|19526365|P2|Vaccination 2|Overall Study||10
7934721|NCT00535236|19526366|P1|Vaccination 2|Overall Study||35
7934722|NCT00535236|19526357|P10|Vaccination 1|Overall Study||20
7934723|NCT00535236|19526358|P9|Vaccination 1|Overall Study||60
7934724|NCT00535236|19526359|P8|Vaccination 1|Overall Study||19
7934725|NCT00535236|19526360|P7|Vaccination 1|Overall Study||61
7934726|NCT00535236|19526361|P6|Vaccination 1|Overall Study||19
7934727|NCT00535236|19526362|P5|Vaccination 1|Overall Study||58
7934728|NCT00535236|19526363|P4|Vaccination 1|Overall Study||10
7934729|NCT00535236|19526364|P3|Vaccination 1|Overall Study||40
7934730|NCT00535236|19526365|P2|Vaccination 1|Overall Study||10
7934731|NCT00535236|19526366|P1|Vaccination 1|Overall Study||40
7934732|NCT00535236|19526357|P10|STARTED|Overall Study||20
7934733|NCT00535236|19526358|P9|STARTED|Overall Study||60
7934734|NCT00535236|19526359|P8|STARTED|Overall Study||19
7934735|NCT00535236|19526360|P7|STARTED|Overall Study||62
7934736|NCT00535236|19526361|P6|STARTED|Overall Study||20
7934737|NCT00535236|19526362|P5|STARTED|Overall Study||59
7934738|NCT00535236|19526363|P4|STARTED|Overall Study||10
7934739|NCT00535236|19526364|P3|STARTED|Overall Study||41
7934740|NCT00535236|19526365|P2|STARTED|Overall Study||10
7934741|NCT00535236|19526366|P1|STARTED|Overall Study||40
7934742|NCT00535223|19526426|P2|NOT COMPLETED|Overall Study||1
7934743|NCT00535223|19526427|P1|NOT COMPLETED|Overall Study||4
7934744|NCT00535223|19526426|P2|COMPLETED|Overall Study||39
7934745|NCT00535223|19526427|P1|COMPLETED|Overall Study||37
7934746|NCT00535223|19526426|P2|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40
7934747|NCT00535223|19526427|P1|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41
7934748|NCT00535145|19526435|P1|NOT COMPLETED|Phase II||15
7934749|NCT00535145|19526435|P1|COMPLETED|Phase II||69
7934750|NCT00535145|19526435|P1|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84
7934751|NCT00535145|19526435|P1|NOT COMPLETED|Phase I||29
7934752|NCT00535145|19526435|P1|COMPLETED|Phase I||85
7934753|NCT00535145|19526435|P1|STARTED|Phase I||114
7934754|NCT00535132|19526447|P2|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
7934755|NCT00535132|19526448|P1|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
7934756|NCT00535132|19526447|P2|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96
7934757|NCT00535132|19526448|P1|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95
7934758|NCT00535132|19526447|P2|STARTED|Intent-to-Treat (ITT) Analysis Set||99
7934759|NCT00535132|19526448|P1|STARTED|Intent-to-Treat (ITT) Analysis Set||98
7934760|NCT00535132|19526447|P2|NOT COMPLETED|Safety Analysis Set||2
7934761|NCT00535132|19526448|P1|NOT COMPLETED|Safety Analysis Set||2
7934762|NCT00535132|19526447|P2|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99
7934763|NCT00535132|19526448|P1|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98
7934764|NCT00535132|19526447|P2|STARTED|Safety Analysis Set||101
7934765|NCT00535132|19526448|P1|STARTED|Safety Analysis Set||100
7934766|NCT00535132|19526447|P2|NOT COMPLETED|Randomized Population||0
7934767|NCT00535132|19526448|P1|NOT COMPLETED|Randomized Population||0
7934768|NCT00535132|19526447|P2|COMPLETED|Randomized Population||101
7934769|NCT00535132|19526448|P1|COMPLETED|Randomized Population||100
7934770|NCT00535132|19526447|P2|STARTED|Randomized Population|Number of Subjects Randomized|101
7934771|NCT00535132|19526448|P1|STARTED|Randomized Population|Number of Subjects Randomized|100
7934772|NCT00535002|19526506|P8|NOT COMPLETED|Overall Study||0
7934773|NCT00535002|19526507|P7|NOT COMPLETED|Overall Study||0
7934774|NCT00535002|19526508|P6|NOT COMPLETED|Overall Study||0
7934775|NCT00535002|19526509|P5|NOT COMPLETED|Overall Study||0
7934776|NCT00535002|19526510|P4|NOT COMPLETED|Overall Study||0
7934777|NCT00535002|19526511|P3|NOT COMPLETED|Overall Study||0
7934778|NCT00535002|19526512|P2|NOT COMPLETED|Overall Study||0
7934779|NCT00535002|19526513|P1|NOT COMPLETED|Overall Study||0
7934780|NCT00535002|19526506|P8|COMPLETED|Overall Study||16
7934781|NCT00535002|19526507|P7|COMPLETED|Overall Study||12
7934782|NCT00535002|19526508|P6|COMPLETED|Overall Study||17
7934783|NCT00535002|19526509|P5|COMPLETED|Overall Study||9
7934784|NCT00535002|19526510|P4|COMPLETED|Overall Study||14
7934785|NCT00535002|19526511|P3|COMPLETED|Overall Study||13
7934786|NCT00535002|19526512|P2|COMPLETED|Overall Study||12
7934787|NCT00535002|19526513|P1|COMPLETED|Overall Study||19
7934788|NCT00535002|19526506|P8|STARTED|Overall Study||16
7934789|NCT00535002|19526507|P7|STARTED|Overall Study||12
7934790|NCT00535002|19526508|P6|STARTED|Overall Study||17
7934791|NCT00535002|19526509|P5|STARTED|Overall Study||9
7934792|NCT00535002|19526510|P4|STARTED|Overall Study||14
7934793|NCT00535002|19526511|P3|STARTED|Overall Study||13
7934794|NCT00535002|19526512|P2|STARTED|Overall Study||12
7934795|NCT00535002|19526513|P1|STARTED|Overall Study||19
7934796|NCT00534976|19526529|P2|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0
7934797|NCT00534976|19526530|P1|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2
7934798|NCT00534976|19526529|P2|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32
7934799|NCT00534976|19526530|P1|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31
7934800|NCT00534976|19526529|P2|STARTED|Period 3: Crossover Placebo/ Montelukast||32
7934801|NCT00534976|19526530|P1|STARTED|Period 3: Crossover Placebo/ Montelukast||33
7934802|NCT00534976|19526529|P2|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1
7934803|NCT00534976|19526530|P1|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0
7934804|NCT00534976|19526529|P2|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32
7934805|NCT00534976|19526530|P1|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33
7934806|NCT00534976|19526529|P2|STARTED|Period 2: Treatment Montelukast/ Placebo||33
7934807|NCT00534976|19526530|P1|STARTED|Period 2: Treatment Montelukast/ Placebo||33
7934808|NCT00534976|19526529|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
7934809|NCT00534976|19526530|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
7934810|NCT00534976|19526529|P2|COMPLETED|Period 1: Placebo Run-in||33
7934811|NCT00534976|19526530|P1|COMPLETED|Period 1: Placebo Run-in||33
7934812|NCT00534976|19526529|P2|STARTED|Period 1: Placebo Run-in||33
7934813|NCT00534976|19526530|P1|STARTED|Period 1: Placebo Run-in||33
7934814|NCT00534937|19526552|P2|NOT COMPLETED|Overall Study||12
7934815|NCT00534937|19526553|P1|NOT COMPLETED|Overall Study||8
7934816|NCT00534937|19526552|P2|COMPLETED|Overall Study||35
7934817|NCT00534937|19526553|P1|COMPLETED|Overall Study||34
7934818|NCT00534937|19526552|P2|STARTED|Overall Study||47
7934819|NCT00534937|19526553|P1|STARTED|Overall Study||42
7934820|NCT00534833|19526567|P2|NOT COMPLETED|Overall Study||0
7934821|NCT00534833|19526568|P1|NOT COMPLETED|Overall Study||0
7934822|NCT00534833|19526567|P2|COMPLETED|Overall Study||180
7934823|NCT00534833|19526568|P1|COMPLETED|Overall Study||182
7934824|NCT00534833|19526567|P2|STARTED|Overall Study||180
7934825|NCT00534833|19526568|P1|STARTED|Overall Study||182
7934826|NCT00534794|19526580|P2|NOT COMPLETED|Overall Study||0
7934827|NCT00534794|19526581|P1|NOT COMPLETED|Overall Study||0
7934828|NCT00534794|19526580|P2|COMPLETED|Overall Study||39
7934829|NCT00534794|19526581|P1|COMPLETED|Overall Study||40
7934830|NCT00534794|19526580|P2|STARTED|Overall Study||39
7934831|NCT00534794|19526581|P1|STARTED|Overall Study||40
7934832|NCT00534703|19526591|P2|NOT COMPLETED|Overall Study||0
7934833|NCT00534703|19526592|P1|NOT COMPLETED|Overall Study||0
7934834|NCT00534703|19526591|P2|COMPLETED|Overall Study||1
7934835|NCT00534703|19526592|P1|COMPLETED|Overall Study||4
7934836|NCT00534703|19526591|P2|STARTED|Overall Study||1
7934837|NCT00534703|19526592|P1|STARTED|Overall Study||4
7934838|NCT00534638|19526610|P2|NOT COMPLETED|Overall Study||11791
7934839|NCT00534638|19526611|P1|NOT COMPLETED|Overall Study||6491
7934840|NCT00534638|19526610|P2|COMPLETED|Overall Study||5547
7934841|NCT00534638|19526611|P1|COMPLETED|Overall Study||8346
7934842|NCT00534638|19526610|P2|STARTED|Overall Study||17338
7934843|NCT00534638|19526611|P1|STARTED|Overall Study||14837
7934844|NCT00534599|19526649|P2|NOT COMPLETED|Overall Study||32
7934845|NCT00534599|19526650|P1|NOT COMPLETED|Overall Study||57
7934846|NCT00534599|19526649|P2|COMPLETED|Overall Study||168
7934847|NCT00534599|19526650|P1|COMPLETED|Overall Study||152
7934848|NCT00534599|19526649|P2|STARTED|Overall Study|Randomized|200
7934849|NCT00534599|19526650|P1|STARTED|Overall Study|Randomized|209
7934850|NCT00534495|19526686|P3|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11
7934851|NCT00534495|19526687|P2|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
7934852|NCT00534495|19526688|P1|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
7934853|NCT00534495|19526686|P3|COMPLETED|Long Term Ext. Phase Week 24-month 21||29
7934854|NCT00534495|19526687|P2|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
7934855|NCT00534495|19526688|P1|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
7934856|NCT00534495|19526686|P3|STARTED|Long Term Ext. Phase Week 24-month 21||40
7934857|NCT00534495|19526687|P2|STARTED|Long Term Ext. Phase Week 24-month 21||0
7934858|NCT00534495|19526688|P1|STARTED|Long Term Ext. Phase Week 24-month 21||0
7934859|NCT00534495|19526686|P3|NOT COMPLETED|All Active Treatment Phase Week 4-24||0
7934860|NCT00534495|19526687|P2|NOT COMPLETED|All Active Treatment Phase Week 4-24||9
7934861|NCT00534495|19526688|P1|NOT COMPLETED|All Active Treatment Phase Week 4-24||4
7934862|NCT00534495|19526686|P3|COMPLETED|All Active Treatment Phase Week 4-24||0
7934863|NCT00534495|19526687|P2|COMPLETED|All Active Treatment Phase Week 4-24||25
7934864|NCT00534495|19526688|P1|COMPLETED|All Active Treatment Phase Week 4-24||32
7934865|NCT00534495|19526686|P3|STARTED|All Active Treatment Phase Week 4-24||0
7934866|NCT00534495|19526687|P2|STARTED|All Active Treatment Phase Week 4-24||34
7934867|NCT00534495|19526688|P1|STARTED|All Active Treatment Phase Week 4-24||36
7934868|NCT00534495|19526686|P3|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
7934869|NCT00534495|19526687|P2|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1
7934870|NCT00534495|19526688|P1|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
7934871|NCT00534495|19526686|P3|COMPLETED|Double Blind Placebo Phase Week 0-4||0
7934872|NCT00534495|19526687|P2|COMPLETED|Double Blind Placebo Phase Week 0-4||34
7934873|NCT00534495|19526688|P1|COMPLETED|Double Blind Placebo Phase Week 0-4||36
7934874|NCT00534495|19526686|P3|STARTED|Double Blind Placebo Phase Week 0-4||0
7934875|NCT00534495|19526687|P2|STARTED|Double Blind Placebo Phase Week 0-4||35
7934876|NCT00534495|19526688|P1|STARTED|Double Blind Placebo Phase Week 0-4||36
7934877|NCT00534417|19526711|P1|NOT COMPLETED|Overall Study||0
7934878|NCT00534417|19526711|P1|COMPLETED|Overall Study||41
7934879|NCT00534417|19526711|P1|STARTED|Overall Study||41
7934880|NCT00534404|19526726|P3|NOT COMPLETED|Overall Study||242
7934881|NCT00534404|19526727|P2|NOT COMPLETED|Overall Study||143
7934882|NCT00534404|19526728|P1|NOT COMPLETED|Overall Study||180
7934883|NCT00534404|19526726|P3|COMPLETED|Overall Study||586
7934884|NCT00534404|19526727|P2|COMPLETED|Overall Study||687
7934885|NCT00534404|19526728|P1|COMPLETED|Overall Study||647
7934886|NCT00534404|19526726|P3|3-month Follow up Completed|Overall Study||593
7934887|NCT00534404|19526727|P2|3-month Follow up Completed|Overall Study||731
7934888|NCT00534404|19526728|P1|3-month Follow up Completed|Overall Study||682
7934889|NCT00534404|19526726|P3|1-month Follow up Completed|Overall Study||626
7934890|NCT00534404|19526727|P2|1-month Follow up Completed|Overall Study||781
7934891|NCT00534404|19526728|P1|1-month Follow up Completed|Overall Study||742
7934892|NCT00534404|19526726|P3|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
7934893|NCT00534404|19526727|P2|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
7934894|NCT00534404|19526728|P1|Completed at Least 1 Counseling Call|Overall Study||813
7934895|NCT00534404|19526726|P3|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0
7934896|NCT00534404|19526727|P2|Completed Second NRT Order|Overall Study||789
7934897|NCT00534404|19526728|P1|Completed Second NRT Order|Overall Study||640
7934898|NCT00534404|19526726|P3|Completed First NRT Order|Overall Study|NRT was not available for this arm|0
7934899|NCT00534404|19526727|P2|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821
7934900|NCT00534404|19526728|P1|Completed First NRT Order|Overall Study||765
7934901|NCT00534404|19526726|P3|Completed at Least 1 Online Session|Overall Study||658
7934902|NCT00534404|19526727|P2|Completed at Least 1 Online Session|Overall Study||813
7934903|NCT00534404|19526728|P1|Completed at Least 1 Online Session|Overall Study||781
7934904|NCT00534404|19526726|P3|STARTED|Overall Study||828
7934905|NCT00534404|19526727|P2|STARTED|Overall Study||830
7934906|NCT00534404|19526728|P1|STARTED|Overall Study||827
7934907|NCT00534365|19526744|P2|NOT COMPLETED|Overall Study||7
7934908|NCT00534365|19526745|P1|NOT COMPLETED|Overall Study||0
7934909|NCT00534365|19526744|P2|COMPLETED|Overall Study||129
7934910|NCT00534365|19526745|P1|COMPLETED|Overall Study||127
7934911|NCT00534365|19526744|P2|Included in Intent to Treat Analysis|Overall Study||136
7934912|NCT00534365|19526745|P1|Included in Intent to Treat Analysis|Overall Study||127
7934913|NCT00534365|19526744|P2|Follow up at 12 Months or More|Overall Study||128
7934914|NCT00534365|19526745|P1|Follow up at 12 Months or More|Overall Study||119
7934915|NCT00534365|19526744|P2|Any Follow up|Overall Study||135
7934916|NCT00534365|19526745|P1|Any Follow up|Overall Study||126
7934917|NCT00534365|19526744|P2|Received Procedure|Overall Study|7 patients excluded due to receipt of sling other than mini-sling|129
7934918|NCT00534365|19526745|P1|Received Procedure|Overall Study||127
7934919|NCT00534365|19526744|P2|STARTED|Overall Study||136
7934920|NCT00534365|19526745|P1|STARTED|Overall Study||127
7934921|NCT00534352|19526759|P1|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4
7934922|NCT00534352|19526759|P1|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14
7934923|NCT00534352|19526759|P1|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18
7934924|NCT00534352|19526759|P1|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1
7934925|NCT00534352|19526759|P1|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20
7934926|NCT00534352|19526759|P1|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21
7934927|NCT00534352|19526759|P1|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0
7934928|NCT00534352|19526759|P1|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
7934929|NCT00534352|19526759|P1|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
7934930|NCT00534352|19526759|P1|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2
7934931|NCT00534352|19526759|P1|COMPLETED|Treatment A: TMC125 + TDF/FTC||21
7934932|NCT00534352|19526759|P1|STARTED|Treatment A: TMC125 + TDF/FTC||23
7934933|NCT00534313|19526803|P4|NOT COMPLETED|Long-term Period||33
7934934|NCT00534313|19526804|P3|NOT COMPLETED|Long-term Period||43
7934935|NCT00534313|19526805|P2|NOT COMPLETED|Long-term Period||34
7934936|NCT00534313|19526806|P1|NOT COMPLETED|Long-term Period||37
7934937|NCT00534313|19526803|P4|COMPLETED|Long-term Period||0
7934938|NCT00534313|19526804|P3|COMPLETED|Long-term Period||0
7934939|NCT00534313|19526805|P2|COMPLETED|Long-term Period||0
7934940|NCT00534313|19526806|P1|COMPLETED|Long-term Period||0
7934941|NCT00534313|19526803|P4|STARTED|Long-term Period||33
7934942|NCT00534313|19526804|P3|STARTED|Long-term Period||43
7934943|NCT00534313|19526805|P2|STARTED|Long-term Period||34
7934944|NCT00534313|19526806|P1|STARTED|Long-term Period||37
7934945|NCT00534313|19526803|P4|NOT COMPLETED|Short-term Period||9
7934946|NCT00534313|19526804|P3|NOT COMPLETED|Short-term Period||2
7934947|NCT00534313|19526805|P2|NOT COMPLETED|Short-term Period||6
7934948|NCT00534313|19526806|P1|NOT COMPLETED|Short-term Period||6
7934949|NCT00534313|19526803|P4|COMPLETED|Short-term Period|Completed the short-term study|33
7934950|NCT00534313|19526804|P3|COMPLETED|Short-term Period|Completed the short-term study|43
7934951|NCT00534313|19526805|P2|COMPLETED|Short-term Period|Completed the short-term study|34
7934952|NCT00534313|19526806|P1|COMPLETED|Short-term Period|Completed the short-term study|37
7934953|NCT00534313|19526803|P4|STARTED|Short-term Period||42
7934954|NCT00534313|19526804|P3|STARTED|Short-term Period||45
7934955|NCT00534313|19526805|P2|STARTED|Short-term Period||40
7934956|NCT00534313|19526806|P1|STARTED|Short-term Period||43
7934957|NCT00534248|19526901|P2|NOT COMPLETED|Overall Study||673
7934958|NCT00534248|19526902|P1|NOT COMPLETED|Overall Study||661
7934959|NCT00534248|19526901|P2|COMPLETED|Overall Study||10555
7934960|NCT00534248|19526902|P1|COMPLETED|Overall Study||10550
7934961|NCT00534248|19526901|P2|VACCINATED|Overall Study||11210
7934962|NCT00534248|19526902|P1|VACCINATED|Overall Study||11186
7934963|NCT00534248|19526901|P2|STARTED|Overall Study||11228
7934964|NCT00534248|19526902|P1|STARTED|Overall Study||11211
7934965|NCT00534235|19526914|P2|NOT COMPLETED|Overall Study||23
7934966|NCT00534235|19526915|P1|NOT COMPLETED|Overall Study||16
7934967|NCT00534235|19526914|P2|COMPLETED|Overall Study||192
7934968|NCT00534235|19526915|P1|COMPLETED|Overall Study||91
7934969|NCT00534235|19526914|P2|STARTED|Overall Study||215
7934970|NCT00534235|19526915|P1|STARTED|Overall Study||107
7934971|NCT00534209|19527039|P1|NOT COMPLETED|Overall Study||0
7934972|NCT00534209|19527039|P1|COMPLETED|Overall Study||1
7934973|NCT00534209|19527039|P1|STARTED|Overall Study||1
7934974|NCT00534118|19527059|P2|NOT COMPLETED|Overall Study||0
7934975|NCT00534118|19527060|P1|NOT COMPLETED|Overall Study||0
7934976|NCT00534118|19527059|P2|COMPLETED|Overall Study||22
7934977|NCT00534118|19527060|P1|COMPLETED|Overall Study||17
7934978|NCT00534118|19527059|P2|STARTED|Overall Study||22
7934979|NCT00534118|19527060|P1|STARTED|Overall Study||17
7934980|NCT00534105|19527072|P2|NOT COMPLETED|Overall Study||39
7934981|NCT00534105|19527073|P1|NOT COMPLETED|Overall Study||23
7934982|NCT00534105|19527072|P2|COMPLETED|Overall Study||20
7934983|NCT00534105|19527073|P1|COMPLETED|Overall Study||24
7934984|NCT00534105|19527072|P2|STARTED|Overall Study||59
7934985|NCT00534105|19527073|P1|STARTED|Overall Study||47
7934986|NCT00534092|19527087|P2|NOT COMPLETED|Overall Study||0
7934987|NCT00534092|19527088|P1|NOT COMPLETED|Overall Study||2
7934988|NCT00534092|19527087|P2|COMPLETED|Overall Study||14
7934989|NCT00534092|19527088|P1|COMPLETED|Overall Study||53
7934990|NCT00534092|19527087|P2|STARTED|Overall Study||14
7934991|NCT00534092|19527088|P1|STARTED|Overall Study||55
7934992|NCT00534001|19527113|P2|NOT COMPLETED|Overall Study||4
7934993|NCT00534001|19527114|P1|NOT COMPLETED|Overall Study||5
7934994|NCT00534001|19527113|P2|COMPLETED|Overall Study||43
7934995|NCT00534001|19527114|P1|COMPLETED|Overall Study||43
7934996|NCT00534001|19527113|P2|STARTED|Overall Study||47
7934997|NCT00534001|19527114|P1|STARTED|Overall Study||48
7934998|NCT00533949|19527126|P4|NOT COMPLETED|Overall Study||10
7934999|NCT00533949|19527127|P3|NOT COMPLETED|Overall Study||10
7935000|NCT00533949|19527128|P2|NOT COMPLETED|Overall Study||14
7935001|NCT00533949|19527129|P1|NOT COMPLETED|Overall Study||15
7935002|NCT00533949|19527126|P4|COMPLETED|Overall Study||100
7935003|NCT00533949|19527127|P3|COMPLETED|Overall Study||137
7935004|NCT00533949|19527128|P2|COMPLETED|Overall Study||107
7935005|NCT00533949|19527129|P1|COMPLETED|Overall Study||151
7935006|NCT00533949|19527126|P4|STARTED|Overall Study||110
7935007|NCT00533949|19527127|P3|STARTED|Overall Study||147
7935008|NCT00533949|19527128|P2|STARTED|Overall Study||121
7935009|NCT00533949|19527129|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|166
7935010|NCT00533910|19527169|P2|NOT COMPLETED|Overall Study||0
7935011|NCT00533910|19527170|P1|NOT COMPLETED|Overall Study||0
7935012|NCT00533910|19527169|P2|COMPLETED|Overall Study||21
7935013|NCT00533910|19527170|P1|COMPLETED|Overall Study||21
7935014|NCT00533910|19527169|P2|STARTED|Overall Study||21
7935015|NCT00533910|19527170|P1|STARTED|Overall Study||21
7935016|NCT00533897|19527183|P8|NOT COMPLETED|Long Term Extension (LTE)||25
7935017|NCT00533897|19527184|P7|NOT COMPLETED|Long Term Extension (LTE)||13
7935018|NCT00533897|19527185|P6|NOT COMPLETED|Long Term Extension (LTE)||0
7935019|NCT00533897|19527186|P5|NOT COMPLETED|Long Term Extension (LTE)||0
7935020|NCT00533897|19527187|P4|NOT COMPLETED|Long Term Extension (LTE)||0
7935021|NCT00533897|19527188|P3|NOT COMPLETED|Long Term Extension (LTE)||0
7935022|NCT00533897|19527189|P2|NOT COMPLETED|Long Term Extension (LTE)||0
7935023|NCT00533897|19527190|P1|NOT COMPLETED|Long Term Extension (LTE)||0
7935024|NCT00533897|19527183|P8|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88
7935025|NCT00533897|19527184|P7|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24
7935026|NCT00533897|19527185|P6|COMPLETED|Long Term Extension (LTE)||0
7935027|NCT00533897|19527186|P5|COMPLETED|Long Term Extension (LTE)||0
7935028|NCT00533897|19527187|P4|COMPLETED|Long Term Extension (LTE)||0
7935029|NCT00533897|19527188|P3|COMPLETED|Long Term Extension (LTE)||0
7935030|NCT00533897|19527189|P2|COMPLETED|Long Term Extension (LTE)||0
7935031|NCT00533897|19527190|P1|COMPLETED|Long Term Extension (LTE)||0
7935032|NCT00533897|19527183|P8|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113
7935033|NCT00533897|19527184|P7|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37
7935034|NCT00533897|19527185|P6|STARTED|Long Term Extension (LTE)||0
7935035|NCT00533897|19527186|P5|STARTED|Long Term Extension (LTE)||0
7935036|NCT00533897|19527187|P4|STARTED|Long Term Extension (LTE)||0
7935037|NCT00533897|19527188|P3|STARTED|Long Term Extension (LTE)||0
7935038|NCT00533897|19527189|P2|STARTED|Long Term Extension (LTE)||0
7935039|NCT00533897|19527190|P1|STARTED|Long Term Extension (LTE)||0
7935040|NCT00533897|19527183|P8|NOT COMPLETED|Re-introduction (RI) Period 3||0
7935041|NCT00533897|19527184|P7|NOT COMPLETED|Re-introduction (RI) Period 3||0
7935042|NCT00533897|19527185|P6|NOT COMPLETED|Re-introduction (RI) Period 3||2
7935043|NCT00533897|19527186|P5|NOT COMPLETED|Re-introduction (RI) Period 3||0
7935044|NCT00533897|19527187|P4|NOT COMPLETED|Re-introduction (RI) Period 3||0
7935045|NCT00533897|19527188|P3|NOT COMPLETED|Re-introduction (RI) Period 3||0
7935046|NCT00533897|19527189|P2|NOT COMPLETED|Re-introduction (RI) Period 3||0
7935047|NCT00533897|19527190|P1|NOT COMPLETED|Re-introduction (RI) Period 3||0
7935048|NCT00533897|19527183|P8|COMPLETED|Re-introduction (RI) Period 3||0
7935049|NCT00533897|19527184|P7|COMPLETED|Re-introduction (RI) Period 3||0
7935050|NCT00533897|19527185|P6|COMPLETED|Re-introduction (RI) Period 3||42
7935051|NCT00533897|19527186|P5|COMPLETED|Re-introduction (RI) Period 3||35
7935052|NCT00533897|19527187|P4|COMPLETED|Re-introduction (RI) Period 3||40
7935053|NCT00533897|19527188|P3|COMPLETED|Re-introduction (RI) Period 3||0
7935054|NCT00533897|19527189|P2|COMPLETED|Re-introduction (RI) Period 3||0
7935055|NCT00533897|19527190|P1|COMPLETED|Re-introduction (RI) Period 3||0
7935056|NCT00533897|19527183|P8|STARTED|Re-introduction (RI) Period 3||0
7935057|NCT00533897|19527184|P7|STARTED|Re-introduction (RI) Period 3||0
7935058|NCT00533897|19527185|P6|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44
7935059|NCT00533897|19527186|P5|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35
7935060|NCT00533897|19527187|P4|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40
7935061|NCT00533897|19527188|P3|STARTED|Re-introduction (RI) Period 3||0
7935062|NCT00533897|19527189|P2|STARTED|Re-introduction (RI) Period 3||0
7935063|NCT00533897|19527190|P1|STARTED|Re-introduction (RI) Period 3||0
7935064|NCT00533897|19527183|P8|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
7935065|NCT00533897|19527184|P7|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
7935066|NCT00533897|19527185|P6|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
7935067|NCT00533897|19527186|P5|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
7935068|NCT00533897|19527187|P4|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
7935069|NCT00533897|19527188|P3|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3
7935070|NCT00533897|19527189|P2|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1
7935071|NCT00533897|19527190|P1|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
7935072|NCT00533897|19527183|P8|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
7935073|NCT00533897|19527184|P7|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
7935074|NCT00533897|19527185|P6|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
7935075|NCT00533897|19527186|P5|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
7935076|NCT00533897|19527187|P4|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
7935077|NCT00533897|19527188|P3|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77
7935078|NCT00533897|19527189|P2|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39
7935079|NCT00533897|19527190|P1|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
7935080|NCT00533897|19527183|P8|STARTED|Double-blind Withdrawal (DBW) Period 2||0
7935081|NCT00533897|19527184|P7|STARTED|Double-blind Withdrawal (DBW) Period 2||0
7935082|NCT00533897|19527185|P6|STARTED|Double-blind Withdrawal (DBW) Period 2||0
7935083|NCT00533897|19527186|P5|STARTED|Double-blind Withdrawal (DBW) Period 2||0
7935084|NCT00533897|19527187|P4|STARTED|Double-blind Withdrawal (DBW) Period 2||0
7935085|NCT00533897|19527188|P3|STARTED|Double-blind Withdrawal (DBW) Period 2||80
7935086|NCT00533897|19527189|P2|STARTED|Double-blind Withdrawal (DBW) Period 2||40
7935087|NCT00533897|19527190|P1|STARTED|Double-blind Withdrawal (DBW) Period 2||0
7935088|NCT00533897|19527183|P8|NOT COMPLETED|Lead-in (LI) Period 1||0
7935089|NCT00533897|19527184|P7|NOT COMPLETED|Lead-in (LI) Period 1||0
7935090|NCT00533897|19527185|P6|NOT COMPLETED|Lead-in (LI) Period 1||0
7935091|NCT00533897|19527186|P5|NOT COMPLETED|Lead-in (LI) Period 1||0
7935092|NCT00533897|19527187|P4|NOT COMPLETED|Lead-in (LI) Period 1||0
7935093|NCT00533897|19527188|P3|NOT COMPLETED|Lead-in (LI) Period 1||0
7935094|NCT00533897|19527189|P2|NOT COMPLETED|Lead-in (LI) Period 1||0
7935095|NCT00533897|19527190|P1|NOT COMPLETED|Lead-in (LI) Period 1||10
7935096|NCT00533897|19527183|P8|COMPLETED|Lead-in (LI) Period 1||0
7935097|NCT00533897|19527184|P7|COMPLETED|Lead-in (LI) Period 1||0
7935098|NCT00533897|19527185|P6|COMPLETED|Lead-in (LI) Period 1||0
7935099|NCT00533897|19527186|P5|COMPLETED|Lead-in (LI) Period 1||0
7935100|NCT00533897|19527187|P4|COMPLETED|Lead-in (LI) Period 1||0
7935101|NCT00533897|19527188|P3|COMPLETED|Lead-in (LI) Period 1||0
7935102|NCT00533897|19527189|P2|COMPLETED|Lead-in (LI) Period 1||0
7935103|NCT00533897|19527190|P1|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157
7935104|NCT00533897|19527183|P8|STARTED|Lead-in (LI) Period 1||0
7935105|NCT00533897|19527184|P7|STARTED|Lead-in (LI) Period 1||0
7935106|NCT00533897|19527185|P6|STARTED|Lead-in (LI) Period 1||0
7935107|NCT00533897|19527186|P5|STARTED|Lead-in (LI) Period 1||0
7935108|NCT00533897|19527187|P4|STARTED|Lead-in (LI) Period 1||0
7935109|NCT00533897|19527188|P3|STARTED|Lead-in (LI) Period 1||0
7935110|NCT00533897|19527189|P2|STARTED|Lead-in (LI) Period 1||0
7935111|NCT00533897|19527190|P1|STARTED|Lead-in (LI) Period 1||167
7935112|NCT00533845|19527330|P2|NOT COMPLETED|Overall Study||0
7935113|NCT00533845|19527331|P1|NOT COMPLETED|Overall Study||1
7935114|NCT00533845|19527330|P2|COMPLETED|Overall Study||15
7935115|NCT00533845|19527331|P1|COMPLETED|Overall Study||14
7935116|NCT00533845|19527330|P2|STARTED|Overall Study||15
7935117|NCT00533845|19527331|P1|STARTED|Overall Study||15
7935118|NCT00533702|19527339|P2|NOT COMPLETED|Overall Study||2
7935119|NCT00533702|19527340|P1|NOT COMPLETED|Overall Study||5
7935120|NCT00533702|19527339|P2|COMPLETED|Overall Study||50
7935121|NCT00533702|19527340|P1|COMPLETED|Overall Study||49
7935122|NCT00533702|19527339|P2|Received Any Quantity of Study Drug|Overall Study||50
7935123|NCT00533702|19527340|P1|Received Any Quantity of Study Drug|Overall Study||52
7935124|NCT00533702|19527339|P2|STARTED|Overall Study||52
7935125|NCT00533702|19527340|P1|STARTED|Overall Study||54
7935126|NCT00533546|19527364|P1|NOT COMPLETED|Overall Study||0
7935127|NCT00533546|19527364|P1|COMPLETED|Overall Study||12
7935128|NCT00533546|19527364|P1|STARTED|Overall Study||12
7935129|NCT00533507|19527371|P1|NOT COMPLETED|Overall Study||1
7935130|NCT00533507|19527371|P1|COMPLETED|Overall Study||229
7935131|NCT00533507|19527371|P1|STARTED|Overall Study||230
7935132|NCT00533442|19527392|P2|NOT COMPLETED|Follow-up||10
7935133|NCT00533442|19527393|P1|NOT COMPLETED|Follow-up||9
7935134|NCT00533442|19527392|P2|COMPLETED|Follow-up||74
7935135|NCT00533442|19527393|P1|COMPLETED|Follow-up||77
7935136|NCT00533442|19527392|P2|STARTED|Follow-up|Ongoing Follow-up at 17-124 months (N=74); Lost to Follow-up (N=10, at 5-67 months).|84
7935137|NCT00533442|19527393|P1|STARTED|Follow-up|Ongoing Follow-up at 13-123 months (N=77); Lost to Follow-up (N=9, at 5-100 months).|86
7935138|NCT00533442|19527392|P2|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
7935139|NCT00533442|19527393|P1|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
7935140|NCT00533442|19527392|P2|COMPLETED|Allocation and Intent to Treat Analysis||84
7935141|NCT00533442|19527393|P1|COMPLETED|Allocation and Intent to Treat Analysis||86
7935142|NCT00533442|19527392|P2|STARTED|Allocation and Intent to Treat Analysis||84
7935143|NCT00533442|19527393|P1|STARTED|Allocation and Intent to Treat Analysis||86
7935144|NCT00533351|19527405|P2|NOT COMPLETED|Period 3||0
7935145|NCT00533351|19527406|P1|NOT COMPLETED|Period 3||0
7935146|NCT00533351|19527405|P2|COMPLETED|Period 3||0
7935147|NCT00533351|19527406|P1|COMPLETED|Period 3||3
7935148|NCT00533351|19527405|P2|STARTED|Period 3|No patients continued to Period 3|0
7935149|NCT00533351|19527406|P1|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3
7935150|NCT00533351|19527405|P2|NOT COMPLETED|Period 2||0
7935151|NCT00533351|19527406|P1|NOT COMPLETED|Period 2||0
7935152|NCT00533351|19527405|P2|COMPLETED|Period 2||1
7935153|NCT00533351|19527406|P1|COMPLETED|Period 2||5
7935154|NCT00533351|19527405|P2|STARTED|Period 2||1
7935155|NCT00533351|19527406|P1|STARTED|Period 2||5
7935156|NCT00533351|19527405|P2|NOT COMPLETED|Period 1||1
7935157|NCT00533351|19527406|P1|NOT COMPLETED|Period 1||2
7935158|NCT00533351|19527405|P2|COMPLETED|Period 1||1
7935159|NCT00533351|19527406|P1|COMPLETED|Period 1||5
7935160|NCT00533351|19527405|P2|STARTED|Period 1||2
7935161|NCT00533351|19527406|P1|STARTED|Period 1||7
7935162|NCT00533273|19527416|P2|NOT COMPLETED|Open-label||0
7935163|NCT00533273|19527417|P1|NOT COMPLETED|Open-label||6
7935164|NCT00533273|19527416|P2|COMPLETED|Open-label||0
7935165|NCT00533273|19527417|P1|COMPLETED|Open-label||58
7935166|NCT00533273|19527416|P2|STARTED|Open-label|no placebo - this phase was open label|0
7935167|NCT00533273|19527417|P1|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64
7935168|NCT00533273|19527416|P2|NOT COMPLETED|Double-blind||2
7935169|NCT00533273|19527417|P1|NOT COMPLETED|Double-blind||0
7935170|NCT00533273|19527416|P2|COMPLETED|Double-blind||19
7935171|NCT00533273|19527417|P1|COMPLETED|Double-blind||45
7935172|NCT00533273|19527416|P2|STARTED|Double-blind||21
7935173|NCT00533273|19527417|P1|STARTED|Double-blind||45
7935174|NCT00533117|19527452|P4|NOT COMPLETED|Overall Study||5
7935175|NCT00533117|19527453|P3|NOT COMPLETED|Overall Study||6
7935176|NCT00533117|19527454|P2|NOT COMPLETED|Overall Study||5
7935177|NCT00533117|19527455|P1|NOT COMPLETED|Overall Study||4
7935178|NCT00533117|19527452|P4|COMPLETED|Overall Study||13
7935179|NCT00533117|19527453|P3|COMPLETED|Overall Study||14
7935180|NCT00533117|19527454|P2|COMPLETED|Overall Study||14
7935181|NCT00533117|19527455|P1|COMPLETED|Overall Study||14
7935182|NCT00533117|19527452|P4|STARTED|Overall Study||18
7935183|NCT00533117|19527453|P3|STARTED|Overall Study||20
7935184|NCT00533117|19527454|P2|STARTED|Overall Study||19
7935185|NCT00533117|19527455|P1|STARTED|Overall Study||18
7935186|NCT00532948|19527468|P3|NOT COMPLETED|Overall Study||4
7935187|NCT00532948|19527469|P2|NOT COMPLETED|Overall Study||5
7935188|NCT00532948|19527470|P1|NOT COMPLETED|Overall Study||4
7935189|NCT00532948|19527468|P3|COMPLETED|Overall Study||2
7935190|NCT00532948|19527469|P2|COMPLETED|Overall Study||9
7935191|NCT00532948|19527470|P1|COMPLETED|Overall Study||0
7935192|NCT00532948|19527468|P3|STARTED|Overall Study||6
7935193|NCT00532948|19527469|P2|STARTED|Overall Study||14
7935194|NCT00532948|19527470|P1|STARTED|Overall Study||4
7935195|NCT00532935|19527502|P2|NOT COMPLETED|Overall Study||52
7935196|NCT00532935|19527503|P1|NOT COMPLETED|Overall Study||51
7935197|NCT00532935|19527502|P2|COMPLETED|Overall Study||204
7935198|NCT00532935|19527503|P1|COMPLETED|Overall Study||210
7935199|NCT00532935|19527502|P2|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256
7935200|NCT00532935|19527503|P1|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261
7935201|NCT00532883|19527521|P4|NOT COMPLETED|Overall Study||5
7935202|NCT00532883|19527522|P3|NOT COMPLETED|Overall Study||4
7935203|NCT00532883|19527523|P2|NOT COMPLETED|Overall Study||7
7935204|NCT00532883|19527524|P1|NOT COMPLETED|Overall Study||6
7935205|NCT00532883|19527521|P4|COMPLETED|Overall Study|Study terminated early.|6
7935206|NCT00532883|19527522|P3|COMPLETED|Overall Study|Study terminated early.|6
7935207|NCT00532883|19527523|P2|COMPLETED|Overall Study|Study terminated early.|5
7935208|NCT00532883|19527524|P1|COMPLETED|Overall Study|Study terminated early.|5
7935209|NCT00532883|19527521|P4|STARTED|Overall Study||11
7935210|NCT00532883|19527522|P3|STARTED|Overall Study||10
7935211|NCT00532883|19527523|P2|STARTED|Overall Study||12
7935212|NCT00532883|19527524|P1|STARTED|Overall Study||11
7935213|NCT00532779|19527537|P3|NOT COMPLETED|Overall Study||291
7935214|NCT00532779|19527538|P2|NOT COMPLETED|Overall Study||287
7935215|NCT00532779|19527539|P1|NOT COMPLETED|Overall Study||294
7935216|NCT00532779|19527537|P3|COMPLETED|Overall Study||290
7935217|NCT00532779|19527538|P2|COMPLETED|Overall Study||296
7935218|NCT00532779|19527539|P1|COMPLETED|Overall Study||284
7935219|NCT00532779|19527537|P3|STARTED|Overall Study||581
7935220|NCT00532779|19527538|P2|STARTED|Overall Study||583
7935221|NCT00532779|19527539|P1|STARTED|Overall Study||578
7935222|NCT00532493|19527600|P2|NOT COMPLETED|Overall Study||29
7935223|NCT00532493|19527601|P1|NOT COMPLETED|Overall Study||30
7935224|NCT00532493|19527600|P2|COMPLETED|Overall Study||123
7935225|NCT00532493|19527601|P1|COMPLETED|Overall Study||122
7935226|NCT00532493|19527600|P2|STARTED|Overall Study||152
7935227|NCT00532493|19527601|P1|STARTED|Overall Study||152
7935228|NCT00532480|19527631|P1|NOT COMPLETED|Overall Study||3
7935229|NCT00532480|19527631|P1|COMPLETED|Overall Study||7
7935230|NCT00532480|19527631|P1|STARTED|Overall Study||10
7935231|NCT00532441|19527635|P2|NOT COMPLETED|Overall Study||0
7935232|NCT00532441|19527636|P1|NOT COMPLETED|Overall Study||1
7935233|NCT00532441|19527635|P2|COMPLETED|Overall Study||11
7935234|NCT00532441|19527636|P1|COMPLETED|Overall Study||13
7935235|NCT00532441|19527635|P2|STARTED|Overall Study||11
7935236|NCT00532441|19527636|P1|STARTED|Overall Study||14
7935237|NCT00532298|19527651|P6|NOT COMPLETED|Overall Study||2
7935238|NCT00532298|19527652|P5|NOT COMPLETED|Overall Study||1
7935239|NCT00532298|19527653|P4|NOT COMPLETED|Overall Study||0
7935240|NCT00532298|19527654|P3|NOT COMPLETED|Overall Study||1
7935241|NCT00532298|19527655|P2|NOT COMPLETED|Overall Study||1
7935242|NCT00532298|19527656|P1|NOT COMPLETED|Overall Study||2
7935243|NCT00532298|19527651|P6|COMPLETED|Overall Study||261
7935244|NCT00532298|19527652|P5|COMPLETED|Overall Study||267
7935245|NCT00532298|19527653|P4|COMPLETED|Overall Study||264
7935246|NCT00532298|19527654|P3|COMPLETED|Overall Study||263
7935247|NCT00532298|19527655|P2|COMPLETED|Overall Study||265
7935248|NCT00532298|19527656|P1|COMPLETED|Overall Study||267
7935249|NCT00532298|19527651|P6|STARTED|Overall Study||263
7935250|NCT00532298|19527652|P5|STARTED|Overall Study||268
7935251|NCT00532298|19527653|P4|STARTED|Overall Study||264
7935252|NCT00532298|19527654|P3|STARTED|Overall Study||264
7935253|NCT00532298|19527655|P2|STARTED|Overall Study||266
7935254|NCT00532298|19527656|P1|STARTED|Overall Study||269
7935255|NCT00532259|19527736|P1|NOT COMPLETED|Overall Study||32
7935256|NCT00532259|19527736|P1|COMPLETED|Overall Study||40
7935257|NCT00532259|19527736|P1|STARTED|Overall Study||72
7935258|NCT00532155|19527743|P2|NOT COMPLETED|Overall Study||456
7935259|NCT00532155|19527744|P1|NOT COMPLETED|Overall Study||457
7935260|NCT00532155|19527743|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
7935342|NCT00531752|19527974|P1|STARTED|Wash-out Period (at Least 7 Days)||11
7935261|NCT00532155|19527744|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
7935262|NCT00532155|19527743|P2|SAFETY POPULATION|Overall Study||450
7935263|NCT00532155|19527744|P1|SAFETY POPULATION|Overall Study||455
7935264|NCT00532155|19527743|P2|STARTED|Overall Study||456
7935265|NCT00532155|19527744|P1|STARTED|Overall Study||457
7935266|NCT00532129|19527758|P1|NOT COMPLETED|Follow-up Period||65
7935267|NCT00532129|19527758|P1|COMPLETED|Follow-up Period||33
7935268|NCT00532129|19527758|P1|STARTED|Follow-up Period||98
7935269|NCT00532129|19527758|P1|NOT COMPLETED|Treatment Period||49
7935270|NCT00532129|19527758|P1|COMPLETED|Treatment Period||51
7935271|NCT00532129|19527758|P1|STARTED|Treatment Period||100
7935272|NCT00531960|19527778|P2|NOT COMPLETED|Overall Study||63
7935273|NCT00531960|19527779|P1|NOT COMPLETED|Overall Study||61
7935274|NCT00531960|19527778|P2|COMPLETED|Overall Study||0
7935275|NCT00531960|19527779|P1|COMPLETED|Overall Study||0
7935276|NCT00531960|19527778|P2|STARTED|Overall Study||63
7935277|NCT00531960|19527779|P1|STARTED|Overall Study||61
7935278|NCT00531947|19527797|P2|NOT COMPLETED|Overall Study||51
7935279|NCT00531947|19527798|P1|NOT COMPLETED|Overall Study||42
7935280|NCT00531947|19527797|P2|COMPLETED|Overall Study||101
7935281|NCT00531947|19527798|P1|COMPLETED|Overall Study||114
7935282|NCT00531947|19527797|P2|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152
7935283|NCT00531947|19527798|P1|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156
7935284|NCT00531934|19527842|P2|NOT COMPLETED|Overall Study||63
7935285|NCT00531934|19527843|P1|NOT COMPLETED|Overall Study||66
7935286|NCT00531934|19527842|P2|COMPLETED|Overall Study||11
7935287|NCT00531934|19527843|P1|COMPLETED|Overall Study||7
7935288|NCT00531934|19527842|P2|STARTED|Overall Study||74
7935289|NCT00531934|19527843|P1|STARTED|Overall Study||73
7935290|NCT00531882|19527914|P3|NOT COMPLETED|Overall Study||0
7935291|NCT00531882|19527915|P2|NOT COMPLETED|Overall Study||0
7935292|NCT00531882|19527916|P1|NOT COMPLETED|Overall Study||0
7935293|NCT00531882|19527914|P3|COMPLETED|Overall Study||5
7935294|NCT00531882|19527915|P2|COMPLETED|Overall Study||10
7935295|NCT00531882|19527916|P1|COMPLETED|Overall Study||10
7935296|NCT00531882|19527914|P3|STARTED|Overall Study||5
7935297|NCT00531882|19527915|P2|STARTED|Overall Study||10
7935298|NCT00531882|19527916|P1|STARTED|Overall Study||10
7935299|NCT00531843|19527926|P2|NOT COMPLETED|Overall Study||0
7935300|NCT00531843|19527927|P1|NOT COMPLETED|Overall Study||0
7935301|NCT00531843|19527926|P2|COMPLETED|Overall Study||6
7935302|NCT00531843|19527927|P1|COMPLETED|Overall Study||81
7935303|NCT00531843|19527926|P2|STARTED|Overall Study||6
7935304|NCT00531843|19527927|P1|STARTED|Overall Study||81
7935305|NCT00531817|19527939|P2|NOT COMPLETED|Entered Extended Treatment Period||57
7935306|NCT00531817|19527940|P1|NOT COMPLETED|Entered Extended Treatment Period||137
7935307|NCT00531817|19527939|P2|COMPLETED|Entered Extended Treatment Period||113
7935308|NCT00531817|19527940|P1|COMPLETED|Entered Extended Treatment Period||206
7935309|NCT00531817|19527939|P2|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|170
7935310|NCT00531817|19527940|P1|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|343
7935311|NCT00531817|19527939|P2|NOT COMPLETED|Randomized||34
7935312|NCT00531817|19527940|P1|NOT COMPLETED|Randomized||59
7935313|NCT00531817|19527939|P2|COMPLETED|Randomized||173
7935314|NCT00531817|19527940|P1|COMPLETED|Randomized||353
7935315|NCT00531817|19527939|P2|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205
7935316|NCT00531817|19527940|P1|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409
7935317|NCT00531817|19527939|P2|STARTED|Randomized||207
7935318|NCT00531817|19527940|P1|STARTED|Randomized||412
7935319|NCT00531752|19527971|P4|NOT COMPLETED|Second Double-blind Intervention Period||2
7935320|NCT00531752|19527972|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
7935321|NCT00531752|19527973|P2|NOT COMPLETED|Second Double-blind Intervention Period||2
7935322|NCT00531752|19527974|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
7935323|NCT00531752|19527971|P4|COMPLETED|Second Double-blind Intervention Period||11
7935324|NCT00531752|19527972|P3|COMPLETED|Second Double-blind Intervention Period||9
7935325|NCT00531752|19527973|P2|COMPLETED|Second Double-blind Intervention Period||11
7935326|NCT00531752|19527974|P1|COMPLETED|Second Double-blind Intervention Period||9
7935327|NCT00531752|19527971|P4|STARTED|Second Double-blind Intervention Period||13
7935328|NCT00531752|19527972|P3|STARTED|Second Double-blind Intervention Period||9
7935329|NCT00531752|19527973|P2|STARTED|Second Double-blind Intervention Period||13
7935330|NCT00531752|19527974|P1|STARTED|Second Double-blind Intervention Period||11
7935331|NCT00531752|19527971|P4|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
7935332|NCT00531752|19527972|P3|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
7935333|NCT00531752|19527973|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
7935334|NCT00531752|19527974|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
7935335|NCT00531752|19527971|P4|COMPLETED|Wash-out Period (at Least 7 Days)||13
7935336|NCT00531752|19527972|P3|COMPLETED|Wash-out Period (at Least 7 Days)||9
7935337|NCT00531752|19527973|P2|COMPLETED|Wash-out Period (at Least 7 Days)||13
7935338|NCT00531752|19527974|P1|COMPLETED|Wash-out Period (at Least 7 Days)||11
7935339|NCT00531752|19527971|P4|STARTED|Wash-out Period (at Least 7 Days)||13
7935340|NCT00531752|19527972|P3|STARTED|Wash-out Period (at Least 7 Days)||9
7935341|NCT00531752|19527973|P2|STARTED|Wash-out Period (at Least 7 Days)||13
7935343|NCT00531752|19527971|P4|NOT COMPLETED|First Double-blind Intervention Period||3
7935344|NCT00531752|19527972|P3|NOT COMPLETED|First Double-blind Intervention Period||7
7935345|NCT00531752|19527973|P2|NOT COMPLETED|First Double-blind Intervention Period||4
7935346|NCT00531752|19527974|P1|NOT COMPLETED|First Double-blind Intervention Period||6
7935347|NCT00531752|19527971|P4|COMPLETED|First Double-blind Intervention Period||13
7935348|NCT00531752|19527972|P3|COMPLETED|First Double-blind Intervention Period||9
7935349|NCT00531752|19527973|P2|COMPLETED|First Double-blind Intervention Period||13
7935350|NCT00531752|19527974|P1|COMPLETED|First Double-blind Intervention Period||11
7935351|NCT00531752|19527971|P4|Treated|First Double-blind Intervention Period||16
7935352|NCT00531752|19527972|P3|Treated|First Double-blind Intervention Period||16
7935353|NCT00531752|19527973|P2|Treated|First Double-blind Intervention Period||17
7935354|NCT00531752|19527974|P1|Treated|First Double-blind Intervention Period||16
7935355|NCT00531752|19527971|P4|STARTED|First Double-blind Intervention Period||16
7935356|NCT00531752|19527972|P3|STARTED|First Double-blind Intervention Period||16
7935357|NCT00531752|19527973|P2|STARTED|First Double-blind Intervention Period||17
7935358|NCT00531752|19527974|P1|STARTED|First Double-blind Intervention Period||17
7935359|NCT00531661|19528053|P2|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57
7935360|NCT00531661|19528054|P1|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58
7935361|NCT00531661|19528053|P2|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197
7935362|NCT00531661|19528054|P1|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186
7935363|NCT00531661|19528053|P2|STARTED|Study Duration: 15 Months Avg. Follow-up||254
7935364|NCT00531661|19528054|P1|STARTED|Study Duration: 15 Months Avg. Follow-up||244
7935365|NCT00531661|19528053|P2|NOT COMPLETED|6 Months||26
7935366|NCT00531661|19528054|P1|NOT COMPLETED|6 Months||26
7935367|NCT00531661|19528053|P2|COMPLETED|6 Months||254
7935368|NCT00531661|19528054|P1|COMPLETED|6 Months||244
7935369|NCT00531661|19528053|P2|STARTED|6 Months||280
7935370|NCT00531661|19528054|P1|STARTED|6 Months||270
7935371|NCT00531518|19528076|P2|NOT COMPLETED|Overall Study||71
7935372|NCT00531518|19528077|P1|NOT COMPLETED|Overall Study||32
7935373|NCT00531518|19528076|P2|COMPLETED|Overall Study||134
7935374|NCT00531518|19528077|P1|COMPLETED|Overall Study||55
7935375|NCT00531518|19528076|P2|STARTED|Overall Study||205
7935376|NCT00531518|19528077|P1|STARTED|Overall Study||87
7935377|NCT00531479|19528085|P2|NOT COMPLETED|Overall Study||83
7935378|NCT00531479|19528086|P1|NOT COMPLETED|Overall Study||76
7935379|NCT00531479|19528085|P2|COMPLETED|Overall Study||146
7935380|NCT00531479|19528086|P1|COMPLETED|Overall Study||154
7935381|NCT00531479|19528085|P2|Treated|Overall Study||226
7935382|NCT00531479|19528086|P1|Treated|Overall Study||228
7935383|NCT00531479|19528085|P2|STARTED|Overall Study||229
7935384|NCT00531479|19528086|P1|STARTED|Overall Study||230
7935385|NCT00531453|19528106|P2|NOT COMPLETED|Overall Study||0
7935386|NCT00531453|19528107|P1|NOT COMPLETED|Overall Study||0
7935387|NCT00531453|19528106|P2|COMPLETED|Overall Study|10 April 2009|49
7935388|NCT00531453|19528107|P1|COMPLETED|Overall Study|10 April 2009|49
7935389|NCT00531453|19528106|P2|STARTED|Overall Study|02 October 2007|49
7935390|NCT00531453|19528107|P1|STARTED|Overall Study|02 October 2007|49
7935391|NCT00531427|19528117|P2|NOT COMPLETED|Overall Study||94
7935392|NCT00531427|19528118|P1|NOT COMPLETED|Overall Study||73
7935393|NCT00531427|19528117|P2|COMPLETED|Overall Study||191
7935394|NCT00531427|19528118|P1|COMPLETED|Overall Study||209
7935395|NCT00531427|19528117|P2|STARTED|Overall Study||285
7935396|NCT00531427|19528118|P1|STARTED|Overall Study||282
7935397|NCT00531284|19528146|P17|NOT COMPLETED|Overall Study||8
7935398|NCT00531284|19528147|P16|NOT COMPLETED|Overall Study||12
7935399|NCT00531284|19528148|P15|NOT COMPLETED|Overall Study||4
7935400|NCT00531284|19528149|P14|NOT COMPLETED|Overall Study||3
7935401|NCT00531284|19528150|P13|NOT COMPLETED|Overall Study||2
7935402|NCT00531284|19528151|P12|NOT COMPLETED|Overall Study||24
7935403|NCT00531284|19528152|P11|NOT COMPLETED|Overall Study||3
7935404|NCT00531284|19528153|P10|NOT COMPLETED|Overall Study||4
7935405|NCT00531284|19528154|P9|NOT COMPLETED|Overall Study||11
7935406|NCT00531284|19528155|P8|NOT COMPLETED|Overall Study||10
7935407|NCT00531284|19528156|P7|NOT COMPLETED|Overall Study||6
7935408|NCT00531284|19528157|P6|NOT COMPLETED|Overall Study||7
7935409|NCT00531284|19528158|P5|NOT COMPLETED|Overall Study||6
7935410|NCT00531284|19528159|P4|NOT COMPLETED|Overall Study||63
7935411|NCT00531284|19528160|P3|NOT COMPLETED|Overall Study||6
7935412|NCT00531284|19528161|P2|NOT COMPLETED|Overall Study||4
7935413|NCT00531284|19528162|P1|NOT COMPLETED|Overall Study||3
7935414|NCT00531284|19528146|P17|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
7935415|NCT00531284|19528147|P16|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2
7935416|NCT00531284|19528148|P15|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3
7935417|NCT00531284|19528149|P14|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
7935418|NCT00531284|19528150|P13|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
7935419|NCT00531284|19528151|P12|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
7935420|NCT00531284|19528152|P11|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
7935421|NCT00531284|19528153|P10|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
7935509|NCT00531050|19528346|P2|NOT COMPLETED|Part 1: Period 3||0
7935422|NCT00531284|19528154|P9|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
7935423|NCT00531284|19528155|P8|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
7935424|NCT00531284|19528156|P7|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
7935425|NCT00531284|19528157|P6|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
7935426|NCT00531284|19528158|P5|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
7935427|NCT00531284|19528159|P4|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2
7935428|NCT00531284|19528160|P3|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1
7935429|NCT00531284|19528161|P2|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
7935430|NCT00531284|19528162|P1|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
7935431|NCT00531284|19528146|P17|STARTED|Overall Study||8
7935432|NCT00531284|19528147|P16|STARTED|Overall Study||14
7935433|NCT00531284|19528148|P15|STARTED|Overall Study||7
7935434|NCT00531284|19528149|P14|STARTED|Overall Study||3
7935435|NCT00531284|19528150|P13|STARTED|Overall Study||2
7935436|NCT00531284|19528151|P12|STARTED|Overall Study||24
7935437|NCT00531284|19528152|P11|STARTED|Overall Study||3
7935438|NCT00531284|19528153|P10|STARTED|Overall Study||4
7935439|NCT00531284|19528154|P9|STARTED|Overall Study||11
7935440|NCT00531284|19528155|P8|STARTED|Overall Study||10
7935441|NCT00531284|19528156|P7|STARTED|Overall Study||6
7935442|NCT00531284|19528157|P6|STARTED|Overall Study||7
7935443|NCT00531284|19528158|P5|STARTED|Overall Study||6
7935444|NCT00531284|19528159|P4|STARTED|Overall Study||65
7935445|NCT00531284|19528160|P3|STARTED|Overall Study||7
7935446|NCT00531284|19528161|P2|STARTED|Overall Study||4
7935447|NCT00531284|19528162|P1|STARTED|Overall Study||3
7935448|NCT00531206|19528312|P1|NOT COMPLETED|Overall Study||20
7935449|NCT00531206|19528312|P1|COMPLETED|Overall Study||45
7935450|NCT00531206|19528312|P1|STARTED|Overall Study||65
7935451|NCT00531050|19528342|P6|NOT COMPLETED|Part 2: Period 3||1
7935452|NCT00531050|19528343|P5|NOT COMPLETED|Part 2: Period 3||0
7935453|NCT00531050|19528344|P4|NOT COMPLETED|Part 2: Period 3||0
7935454|NCT00531050|19528345|P3|NOT COMPLETED|Part 2: Period 3||0
7935455|NCT00531050|19528346|P2|NOT COMPLETED|Part 2: Period 3||0
7935456|NCT00531050|19528347|P1|NOT COMPLETED|Part 2: Period 3||1
7935457|NCT00531050|19528342|P6|COMPLETED|Part 2: Period 3||3
7935458|NCT00531050|19528343|P5|COMPLETED|Part 2: Period 3||4
7935459|NCT00531050|19528344|P4|COMPLETED|Part 2: Period 3||4
7935460|NCT00531050|19528345|P3|COMPLETED|Part 2: Period 3||4
7935461|NCT00531050|19528346|P2|COMPLETED|Part 2: Period 3||4
7935462|NCT00531050|19528347|P1|COMPLETED|Part 2: Period 3||2
7935463|NCT00531050|19528342|P6|STARTED|Part 2: Period 3||4
7935464|NCT00531050|19528343|P5|STARTED|Part 2: Period 3||4
7935465|NCT00531050|19528344|P4|STARTED|Part 2: Period 3||4
7935466|NCT00531050|19528345|P3|STARTED|Part 2: Period 3||4
7935467|NCT00531050|19528346|P2|STARTED|Part 2: Period 3||4
7935468|NCT00531050|19528347|P1|STARTED|Part 2: Period 3||3
7935469|NCT00531050|19528342|P6|NOT COMPLETED|Part 2: Period 2||0
7935470|NCT00531050|19528343|P5|NOT COMPLETED|Part 2: Period 2||0
7935471|NCT00531050|19528344|P4|NOT COMPLETED|Part 2: Period 2||0
7935472|NCT00531050|19528345|P3|NOT COMPLETED|Part 2: Period 2||0
7935473|NCT00531050|19528346|P2|NOT COMPLETED|Part 2: Period 2||0
7935474|NCT00531050|19528347|P1|NOT COMPLETED|Part 2: Period 2||0
7935475|NCT00531050|19528342|P6|COMPLETED|Part 2: Period 2||4
7935476|NCT00531050|19528343|P5|COMPLETED|Part 2: Period 2||4
7935477|NCT00531050|19528344|P4|COMPLETED|Part 2: Period 2||4
7935478|NCT00531050|19528345|P3|COMPLETED|Part 2: Period 2||4
7935479|NCT00531050|19528346|P2|COMPLETED|Part 2: Period 2||4
7935480|NCT00531050|19528347|P1|COMPLETED|Part 2: Period 2||3
7935481|NCT00531050|19528342|P6|STARTED|Part 2: Period 2||4
7935482|NCT00531050|19528343|P5|STARTED|Part 2: Period 2||4
7935483|NCT00531050|19528344|P4|STARTED|Part 2: Period 2||4
7935484|NCT00531050|19528345|P3|STARTED|Part 2: Period 2||4
7935485|NCT00531050|19528346|P2|STARTED|Part 2: Period 2||4
7935486|NCT00531050|19528347|P1|STARTED|Part 2: Period 2||3
7935487|NCT00531050|19528342|P6|NOT COMPLETED|Part 2: Period 1||1
7935488|NCT00531050|19528343|P5|NOT COMPLETED|Part 2: Period 1||0
7935489|NCT00531050|19528344|P4|NOT COMPLETED|Part 2: Period 1||0
7935490|NCT00531050|19528345|P3|NOT COMPLETED|Part 2: Period 1||0
7935491|NCT00531050|19528346|P2|NOT COMPLETED|Part 2: Period 1||0
7935492|NCT00531050|19528347|P1|NOT COMPLETED|Part 2: Period 1||0
7935493|NCT00531050|19528342|P6|COMPLETED|Part 2: Period 1||4
7935494|NCT00531050|19528343|P5|COMPLETED|Part 2: Period 1||4
7935495|NCT00531050|19528344|P4|COMPLETED|Part 2: Period 1||4
7935496|NCT00531050|19528345|P3|COMPLETED|Part 2: Period 1||4
7935497|NCT00531050|19528346|P2|COMPLETED|Part 2: Period 1||4
7935498|NCT00531050|19528347|P1|COMPLETED|Part 2: Period 1||3
7935499|NCT00531050|19528342|P6|STARTED|Part 2: Period 1||5
7935500|NCT00531050|19528343|P5|STARTED|Part 2: Period 1||4
7935501|NCT00531050|19528344|P4|STARTED|Part 2: Period 1||4
7935502|NCT00531050|19528345|P3|STARTED|Part 2: Period 1||4
7935503|NCT00531050|19528346|P2|STARTED|Part 2: Period 1||4
7935504|NCT00531050|19528347|P1|STARTED|Part 2: Period 1||3
7935505|NCT00531050|19528342|P6|NOT COMPLETED|Part 1: Period 3||0
7935506|NCT00531050|19528343|P5|NOT COMPLETED|Part 1: Period 3||0
7935507|NCT00531050|19528344|P4|NOT COMPLETED|Part 1: Period 3||0
7935508|NCT00531050|19528345|P3|NOT COMPLETED|Part 1: Period 3||0
7935510|NCT00531050|19528347|P1|NOT COMPLETED|Part 1: Period 3||1
7935511|NCT00531050|19528342|P6|COMPLETED|Part 1: Period 3||5
7935512|NCT00531050|19528343|P5|COMPLETED|Part 1: Period 3||4
7935513|NCT00531050|19528344|P4|COMPLETED|Part 1: Period 3||4
7935514|NCT00531050|19528345|P3|COMPLETED|Part 1: Period 3||4
7935515|NCT00531050|19528346|P2|COMPLETED|Part 1: Period 3||4
7935516|NCT00531050|19528347|P1|COMPLETED|Part 1: Period 3||3
7935517|NCT00531050|19528342|P6|STARTED|Part 1: Period 3||5
7935518|NCT00531050|19528343|P5|STARTED|Part 1: Period 3||4
7935519|NCT00531050|19528344|P4|STARTED|Part 1: Period 3||4
7935520|NCT00531050|19528345|P3|STARTED|Part 1: Period 3||4
7935521|NCT00531050|19528346|P2|STARTED|Part 1: Period 3||4
7935522|NCT00531050|19528347|P1|STARTED|Part 1: Period 3||4
7935523|NCT00531050|19528342|P6|NOT COMPLETED|Part 1: Period 2||0
7935524|NCT00531050|19528343|P5|NOT COMPLETED|Part 1: Period 2||0
7935525|NCT00531050|19528344|P4|NOT COMPLETED|Part 1: Period 2||0
7935526|NCT00531050|19528345|P3|NOT COMPLETED|Part 1: Period 2||0
7935527|NCT00531050|19528346|P2|NOT COMPLETED|Part 1: Period 2||0
7935528|NCT00531050|19528347|P1|NOT COMPLETED|Part 1: Period 2||0
7935529|NCT00531050|19528342|P6|COMPLETED|Part 1: Period 2||5
7935530|NCT00531050|19528343|P5|COMPLETED|Part 1: Period 2||4
7935531|NCT00531050|19528344|P4|COMPLETED|Part 1: Period 2||4
7935532|NCT00531050|19528345|P3|COMPLETED|Part 1: Period 2||4
7935533|NCT00531050|19528346|P2|COMPLETED|Part 1: Period 2||4
7935534|NCT00531050|19528347|P1|COMPLETED|Part 1: Period 2||4
7935535|NCT00531050|19528342|P6|STARTED|Part 1: Period 2||5
7935536|NCT00531050|19528343|P5|STARTED|Part 1: Period 2||4
7935537|NCT00531050|19528344|P4|STARTED|Part 1: Period 2||4
7935538|NCT00531050|19528345|P3|STARTED|Part 1: Period 2||4
7935539|NCT00531050|19528346|P2|STARTED|Part 1: Period 2||4
7935540|NCT00531050|19528347|P1|STARTED|Part 1: Period 2||4
7935541|NCT00531050|19528342|P6|NOT COMPLETED|Part 1: Period 1||0
7935542|NCT00531050|19528343|P5|NOT COMPLETED|Part 1: Period 1||0
7935543|NCT00531050|19528344|P4|NOT COMPLETED|Part 1: Period 1||1
7935544|NCT00531050|19528345|P3|NOT COMPLETED|Part 1: Period 1||0
7935545|NCT00531050|19528346|P2|NOT COMPLETED|Part 1: Period 1||1
7935546|NCT00531050|19528347|P1|NOT COMPLETED|Part 1: Period 1||0
7935547|NCT00531050|19528342|P6|COMPLETED|Part 1: Period 1||5
7935548|NCT00531050|19528343|P5|COMPLETED|Part 1: Period 1||4
7935549|NCT00531050|19528344|P4|COMPLETED|Part 1: Period 1||4
7935550|NCT00531050|19528345|P3|COMPLETED|Part 1: Period 1||4
7935551|NCT00531050|19528346|P2|COMPLETED|Part 1: Period 1||4
7935552|NCT00531050|19528347|P1|COMPLETED|Part 1: Period 1||4
7935553|NCT00531050|19528342|P6|STARTED|Part 1: Period 1||5
7935554|NCT00531050|19528343|P5|STARTED|Part 1: Period 1||4
7935555|NCT00531050|19528344|P4|STARTED|Part 1: Period 1||5
7935556|NCT00531050|19528345|P3|STARTED|Part 1: Period 1||4
7935557|NCT00531050|19528346|P2|STARTED|Part 1: Period 1||5
7935558|NCT00531050|19528347|P1|STARTED|Part 1: Period 1||4
7935559|NCT00531011|19528376|P2|NOT COMPLETED|Overall Study||7
7935560|NCT00531011|19528377|P1|NOT COMPLETED|Overall Study||4
7935561|NCT00531011|19528376|P2|COMPLETED|Overall Study||90
7935562|NCT00531011|19528377|P1|COMPLETED|Overall Study||99
7935563|NCT00531011|19528376|P2|STARTED|Overall Study||97
7935564|NCT00531011|19528377|P1|STARTED|Overall Study||103
7935565|NCT00530946|19528423|P4|NOT COMPLETED|Overall Study||2
7935566|NCT00530946|19528424|P3|NOT COMPLETED|Overall Study||1
7935567|NCT00530946|19528425|P2|NOT COMPLETED|Overall Study||2
7935568|NCT00530946|19528426|P1|NOT COMPLETED|Overall Study||2
7935569|NCT00530946|19528423|P4|COMPLETED|Overall Study||38
7935570|NCT00530946|19528424|P3|COMPLETED|Overall Study||40
7935571|NCT00530946|19528425|P2|COMPLETED|Overall Study||39
7935572|NCT00530946|19528426|P1|COMPLETED|Overall Study||41
7935573|NCT00530946|19528423|P4|STARTED|Overall Study||40
7935574|NCT00530946|19528424|P3|STARTED|Overall Study||41
7935575|NCT00530946|19528425|P2|STARTED|Overall Study||41
7935576|NCT00530946|19528426|P1|STARTED|Overall Study||43
7935577|NCT00530920|19528479|P3|NOT COMPLETED|Overall Study||4
7935578|NCT00530920|19528480|P2|NOT COMPLETED|Overall Study||2
7935579|NCT00530920|19528481|P1|NOT COMPLETED|Overall Study||0
7935580|NCT00530920|19528479|P3|COMPLETED|Overall Study||24
7935581|NCT00530920|19528480|P2|COMPLETED|Overall Study||25
7935582|NCT00530920|19528481|P1|COMPLETED|Overall Study||30
7935583|NCT00530920|19528479|P3|STARTED|Overall Study||28
7935584|NCT00530920|19528480|P2|STARTED|Overall Study||27
7935585|NCT00530920|19528481|P1|STARTED|Overall Study||30
7935586|NCT00530894|19528541|P4|NOT COMPLETED|Overall Study||94
7935587|NCT00530894|19528542|P3|NOT COMPLETED|Overall Study||55
7935588|NCT00530894|19528543|P2|NOT COMPLETED|Overall Study||115
7935589|NCT00530894|19528544|P1|NOT COMPLETED|Overall Study||88
7935590|NCT00530894|19528541|P4|COMPLETED|Overall Study||85
7935591|NCT00530894|19528542|P3|COMPLETED|Overall Study||124
7935592|NCT00530894|19528543|P2|COMPLETED|Overall Study||236
7935593|NCT00530894|19528544|P1|COMPLETED|Overall Study||260
7935594|NCT00530894|19528541|P4|STARTED|Overall Study||179
7935595|NCT00530894|19528542|P3|STARTED|Overall Study||179
7935596|NCT00530894|19528543|P2|STARTED|Overall Study||351
7935597|NCT00530894|19528544|P1|STARTED|Overall Study||348
7935598|NCT00530855|19528572|P1|NOT COMPLETED|Overall Study||112
7935599|NCT00530855|19528572|P1|COMPLETED|Overall Study||210
7935600|NCT00530855|19528572|P1|STARTED|Overall Study||322
7935601|NCT00530842|19528581|P2|NOT COMPLETED|Period 2||9
7935602|NCT00530842|19528582|P1|NOT COMPLETED|Period 2||8
7935603|NCT00530842|19528581|P2|COMPLETED|Period 2||151
7935604|NCT00530842|19528582|P1|COMPLETED|Period 2||149
7935605|NCT00530842|19528581|P2|STARTED|Period 2||160
7935606|NCT00530842|19528582|P1|STARTED|Period 2||157
7935607|NCT00530842|19528581|P2|NOT COMPLETED|Period 1||11
7935608|NCT00530842|19528582|P1|NOT COMPLETED|Period 1||14
7935609|NCT00530842|19528581|P2|COMPLETED|Period 1||161
7935610|NCT00530842|19528582|P1|COMPLETED|Period 1||158
7935611|NCT00530842|19528581|P2|STARTED|Period 1||172
7935612|NCT00530842|19528582|P1|STARTED|Period 1||172
7935613|NCT00530842|19528581|P2|NOT COMPLETED|Overall Study||21
7935614|NCT00530842|19528582|P1|NOT COMPLETED|Overall Study||23
7935615|NCT00530842|19528581|P2|COMPLETED|Overall Study||151
7935616|NCT00530842|19528582|P1|COMPLETED|Overall Study||149
7935617|NCT00530842|19528581|P2|STARTED|Overall Study||172
7935618|NCT00530842|19528582|P1|STARTED|Overall Study||172
7935619|NCT00530816|19528709|P3|NOT COMPLETED|Overall Study||41
7935620|NCT00530816|19528710|P2|NOT COMPLETED|Overall Study||42
7935621|NCT00530816|19528711|P1|NOT COMPLETED|Overall Study||26
7935622|NCT00530816|19528709|P3|COMPLETED|Overall Study||29
7935623|NCT00530816|19528710|P2|COMPLETED|Overall Study||17
7935624|NCT00530816|19528711|P1|COMPLETED|Overall Study||9
7935625|NCT00530816|19528709|P3|STARTED|Overall Study||70
7935626|NCT00530816|19528710|P2|STARTED|Overall Study||59
7935627|NCT00530816|19528711|P1|STARTED|Overall Study||35
7935628|NCT00530803|19528739|P2|NOT COMPLETED|Overall Study||0
7935629|NCT00530803|19528740|P1|NOT COMPLETED|Overall Study||0
7935630|NCT00530803|19528739|P2|COMPLETED|Overall Study||50
7935631|NCT00530803|19528740|P1|COMPLETED|Overall Study||50
7935632|NCT00530803|19528739|P2|STARTED|Overall Study||50
7935633|NCT00530803|19528740|P1|STARTED|Overall Study||50
7935634|NCT00530790|19528754|P1|NOT COMPLETED|Overall Study||5
7935635|NCT00530790|19528754|P1|COMPLETED|Overall Study||30
7935636|NCT00530790|19528754|P1|STARTED|Overall Study||35
7935637|NCT00530777|19528776|P2|NOT COMPLETED|Overall Study||5
7935638|NCT00530777|19528777|P1|NOT COMPLETED|Overall Study||7
7935639|NCT00530777|19528776|P2|COMPLETED|Overall Study||69
7935640|NCT00530777|19528777|P1|COMPLETED|Overall Study||67
7935641|NCT00530777|19528776|P2|STARTED|Overall Study||74
7935642|NCT00530777|19528777|P1|STARTED|Overall Study||74
7935643|NCT00530764|19528789|P4|NOT COMPLETED|Overall Study||25
7935644|NCT00530764|19528790|P3|NOT COMPLETED|Overall Study||20
7935645|NCT00530764|19528791|P2|NOT COMPLETED|Overall Study||21
7935646|NCT00530764|19528792|P1|NOT COMPLETED|Overall Study||31
7935647|NCT00530764|19528789|P4|COMPLETED|Overall Study||66
7935648|NCT00530764|19528790|P3|COMPLETED|Overall Study||71
7935649|NCT00530764|19528791|P2|COMPLETED|Overall Study||67
7935650|NCT00530764|19528792|P1|COMPLETED|Overall Study||59
7935651|NCT00530764|19528789|P4|STARTED|Overall Study||91
7935652|NCT00530764|19528790|P3|STARTED|Overall Study||91
7935653|NCT00530764|19528791|P2|STARTED|Overall Study||88
7935654|NCT00530764|19528792|P1|STARTED|Overall Study||90
7935655|NCT00530712|19528834|P1|NOT COMPLETED|12 Month Follow-up Visit||24
7935656|NCT00530712|19528834|P1|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263
7935657|NCT00530712|19528834|P1|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287
7935658|NCT00530712|19528834|P1|NOT COMPLETED|6 Month Follow-up Visit||12
7935659|NCT00530712|19528834|P1|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275
7935660|NCT00530712|19528834|P1|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287
7935661|NCT00530712|19528834|P1|NOT COMPLETED|30 Day Follow-up Visit||7
7935662|NCT00530712|19528834|P1|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280
7935663|NCT00530712|19528834|P1|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287
7935664|NCT00530712|19528834|P1|NOT COMPLETED|Enrollment||0
7935665|NCT00530712|19528834|P1|COMPLETED|Enrollment|Subjects Available at Discharge|287
7935666|NCT00530712|19528834|P1|STARTED|Enrollment|Total Enrolled Subjects|287
7935667|NCT00530634|19528851|P1|NOT COMPLETED|Overall Study||0
7935668|NCT00530634|19528851|P1|COMPLETED|Overall Study||3
7935669|NCT00530634|19528851|P1|STARTED|Overall Study||3
7935670|NCT00530621|19528857|P2|NOT COMPLETED|Overall Study||80
7935671|NCT00530621|19528858|P1|NOT COMPLETED|Overall Study||80
7935672|NCT00530621|19528857|P2|COMPLETED|Overall Study||0
7935673|NCT00530621|19528858|P1|COMPLETED|Overall Study||0
7935674|NCT00530621|19528857|P2|Received at Least 1 Dose of Study Drug|Overall Study||80
7935675|NCT00530621|19528858|P1|Received at Least 1 Dose of Study Drug|Overall Study||79
7935676|NCT00530621|19528857|P2|STARTED|Overall Study||80
7935677|NCT00530621|19528858|P1|STARTED|Overall Study||80
7935678|NCT00530504|19528879|P1|NOT COMPLETED|Overall Study||152
7935679|NCT00530504|19528879|P1|COMPLETED|Overall Study||1348
7935680|NCT00530504|19528879|P1|STARTED|Overall Study||1500
7935681|NCT00530439|19528885|P2|NOT COMPLETED|Overall Study||26
7935682|NCT00530439|19528886|P1|NOT COMPLETED|Overall Study||30
7935683|NCT00530439|19528885|P2|COMPLETED|Overall Study||154
7935684|NCT00530439|19528886|P1|COMPLETED|Overall Study||150
7935685|NCT00530439|19528885|P2|STARTED|Overall Study||180
7935686|NCT00530439|19528886|P1|STARTED|Overall Study||180
7935687|NCT00530348|19528894|P2|NOT COMPLETED|Overall Study||19
7935688|NCT00530348|19528895|P1|NOT COMPLETED|Overall Study||22
7935689|NCT00530348|19528894|P2|COMPLETED|Overall Study||367
7935690|NCT00530348|19528895|P1|COMPLETED|Overall Study||173
7935691|NCT00530348|19528894|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376
7935692|NCT00530348|19528895|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187
7935693|NCT00530348|19528894|P2|STARTED|Overall Study|Randomized.|386
7935694|NCT00530348|19528895|P1|STARTED|Overall Study|Randomized.|195
7935695|NCT00530335|19528911|P1|NOT COMPLETED|Overall Study||6
7935696|NCT00530335|19528911|P1|COMPLETED|Overall Study||39
7935697|NCT00530335|19528911|P1|STARTED|Overall Study||45
7935698|NCT00530270|19528928|P2|NOT COMPLETED|Overall Study||0
7935699|NCT00530270|19528929|P1|NOT COMPLETED|Overall Study||1
7935700|NCT00530270|19528928|P2|COMPLETED|Overall Study||6
7935701|NCT00530270|19528929|P1|COMPLETED|Overall Study||5
7935702|NCT00530270|19528928|P2|STARTED|Overall Study||6
7935703|NCT00530270|19528929|P1|STARTED|Overall Study||6
7935704|NCT00530257|19528943|P1|NOT COMPLETED|Overall Study||1
7935705|NCT00530257|19528943|P1|COMPLETED|Overall Study||30
7935706|NCT00530257|19528943|P1|STARTED|Overall Study||31
7935707|NCT00530218|19528971|P1|NOT COMPLETED|Overall Study||25
7935708|NCT00530218|19528971|P1|COMPLETED|Overall Study|CMV Reactivation Was Detected|36
7935709|NCT00530218|19528971|P1|STARTED|Overall Study||61
7935710|NCT00530088|19528978|P1|NOT COMPLETED|Overall Study||10
7935711|NCT00530088|19528978|P1|COMPLETED|Overall Study||20
7935712|NCT00530088|19528978|P1|STARTED|Overall Study||30
7935713|NCT00530075|19528983|P1|NOT COMPLETED|Overall Study||7
7935714|NCT00530075|19528983|P1|COMPLETED|Overall Study||38
7935715|NCT00530075|19528983|P1|STARTED|Overall Study||45
7935716|NCT00530023|19528996|P2|NOT COMPLETED|Overall Study||1
7935717|NCT00530023|19528997|P1|NOT COMPLETED|Overall Study||0
7935718|NCT00530023|19528996|P2|COMPLETED|Overall Study||14
7935719|NCT00530023|19528997|P1|COMPLETED|Overall Study||14
7935720|NCT00530023|19528996|P2|STARTED|Overall Study||15
7935721|NCT00530023|19528997|P1|STARTED|Overall Study||14
7935722|NCT00529958|19529014|P3|NOT COMPLETED|5-Year Follow-up||1
7935723|NCT00529958|19529015|P2|NOT COMPLETED|5-Year Follow-up||3
7935724|NCT00529958|19529016|P1|NOT COMPLETED|5-Year Follow-up||3
7935725|NCT00529958|19529014|P3|COMPLETED|5-Year Follow-up||107
7935726|NCT00529958|19529015|P2|COMPLETED|5-Year Follow-up||105
7935727|NCT00529958|19529016|P1|COMPLETED|5-Year Follow-up||103
7935728|NCT00529958|19529014|P3|STARTED|5-Year Follow-up|108 DB patients available for 5-year follow-up includes n=1 cross-over with a single-bundle HT graft|108
7935729|NCT00529958|19529015|P2|STARTED|5-Year Follow-up|108 HT patients available for 5-year follow-up excludes n=1 cross-over patient from the DB group|108
7935730|NCT00529958|19529016|P1|STARTED|5-Year Follow-up||106
7935731|NCT00529958|19529014|P3|NOT COMPLETED|2-Year Follow-up||2
7935732|NCT00529958|19529015|P2|NOT COMPLETED|2-Year Follow-up||2
7935733|NCT00529958|19529016|P1|NOT COMPLETED|2-Year Follow-up||4
7935734|NCT00529958|19529014|P3|COMPLETED|2-Year Follow-up|108 DB patients analyzed include 1 cross-over with HT graft (analyzed on intention-to-treat basis).|108
7935735|NCT00529958|19529015|P2|COMPLETED|2-Year Follow-up|108 HT patients analyzed excludes n=1 cross-over patient (analyzed on intention-to-treat basis).|108
7935736|NCT00529958|19529016|P1|COMPLETED|2-Year Follow-up||106
7935737|NCT00529958|19529014|P3|STARTED|2-Year Follow-up|110 randomized to DB, but there was (n=1) cross-over to the HT group|110
7935738|NCT00529958|19529015|P2|STARTED|2-Year Follow-up|110 randomized to HT, but there was (n=1) cross-over from the DB group|110
7935739|NCT00529958|19529016|P1|STARTED|2-Year Follow-up||110
7935740|NCT00529802|19529057|P1|NOT COMPLETED|Evaluable for Secondary Endpoint||2
7935741|NCT00529802|19529057|P1|COMPLETED|Evaluable for Secondary Endpoint||48
7935742|NCT00529802|19529057|P1|STARTED|Evaluable for Secondary Endpoint||50
7935743|NCT00529802|19529057|P1|NOT COMPLETED|Evaluable for Primary Endpoint||10
7935744|NCT00529802|19529057|P1|COMPLETED|Evaluable for Primary Endpoint|Evaluable for primary endpoint|50
7935745|NCT00529802|19529057|P1|STARTED|Evaluable for Primary Endpoint|60 patients started trial|60
7935746|NCT00529789|19529063|P1|NOT COMPLETED|Study Period IV||6
7935747|NCT00529789|19529063|P1|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42
7935748|NCT00529789|19529063|P1|STARTED|Study Period IV||48
7935749|NCT00529789|19529063|P1|NOT COMPLETED|Study Period II/III||24
7935750|NCT00529789|19529063|P1|COMPLETED|Study Period II/III||48
7935751|NCT00529789|19529063|P1|STARTED|Study Period II/III||72
7935752|NCT00529763|19529088|P3|NOT COMPLETED|Overall Study||7
7935753|NCT00529763|19529089|P2|NOT COMPLETED|Overall Study||33
7935754|NCT00529763|19529090|P1|NOT COMPLETED|Overall Study||10
7935755|NCT00529763|19529088|P3|COMPLETED|Overall Study|52 participants still on treatment; not completed = off treatment (n=7)|52
7935756|NCT00529763|19529089|P2|COMPLETED|Overall Study|4 participants still on treatment; not completed = off treatment (n=33)|4
7935757|NCT00529763|19529090|P1|COMPLETED|Overall Study|15 participants still on treatment; not completed = off treatment (n=10)|15
7935758|NCT00529763|19529088|P3|STARTED|Overall Study||59
7935759|NCT00529763|19529089|P2|STARTED|Overall Study|38 participants were enrolled; 37 were treated in this cohort|37
7935760|NCT00529763|19529090|P1|STARTED|Overall Study||25
7935761|NCT00529659|19529128|P2|NOT COMPLETED|Overall Study||23
7935762|NCT00529659|19529129|P1|NOT COMPLETED|Overall Study||11
7935763|NCT00529659|19529128|P2|COMPLETED|Overall Study||66
7935764|NCT00529659|19529129|P1|COMPLETED|Overall Study||70
7935765|NCT00529659|19529128|P2|STARTED|Overall Study||89
7935766|NCT00529659|19529129|P1|STARTED|Overall Study||81
7935767|NCT00529633|19529147|P2|NOT COMPLETED|Overall Study||1
7935768|NCT00529633|19529148|P1|NOT COMPLETED|Overall Study||1
7935769|NCT00529633|19529147|P2|COMPLETED|Overall Study||1
7935770|NCT00529633|19529148|P1|COMPLETED|Overall Study||1
7935771|NCT00529633|19529147|P2|STARTED|Overall Study||2
7935772|NCT00529633|19529148|P1|STARTED|Overall Study||2
7935773|NCT00529568|19529160|P3|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102
7935774|NCT00529568|19529161|P2|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48
7935775|NCT00529568|19529162|P1|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0
7935776|NCT00529568|19529160|P3|COMPLETED|Double-bilnd Antiviral Treatment Phase||404
7935777|NCT00529568|19529161|P2|COMPLETED|Double-bilnd Antiviral Treatment Phase||205
7935778|NCT00529568|19529162|P1|COMPLETED|Double-bilnd Antiviral Treatment Phase||0
7935779|NCT00529568|19529160|P3|STARTED|Double-bilnd Antiviral Treatment Phase||506
7935780|NCT00529568|19529161|P2|STARTED|Double-bilnd Antiviral Treatment Phase||253
7935781|NCT00529568|19529162|P1|STARTED|Double-bilnd Antiviral Treatment Phase||0
7935782|NCT00529568|19529160|P3|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
7935783|NCT00529568|19529161|P2|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
7935784|NCT00529568|19529162|P1|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46
7935785|NCT00529568|19529160|P3|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
7935786|NCT00529568|19529161|P2|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
7935787|NCT00529568|19529162|P1|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759
7935788|NCT00529568|19529160|P3|STARTED|Open-label Pre-Antiviral Treatment Phase||0
7935789|NCT00529568|19529161|P2|STARTED|Open-label Pre-Antiviral Treatment Phase||0
7935790|NCT00529568|19529162|P1|STARTED|Open-label Pre-Antiviral Treatment Phase||805
7935791|NCT00529555|19529213|P3|NOT COMPLETED|Overall Study||26
7935792|NCT00529555|19529214|P2|NOT COMPLETED|Overall Study||30
7935793|NCT00529555|19529215|P1|NOT COMPLETED|Overall Study||29
7935794|NCT00529555|19529213|P3|COMPLETED|Overall Study||174
7935795|NCT00529555|19529214|P2|COMPLETED|Overall Study||172
7935796|NCT00529555|19529215|P1|COMPLETED|Overall Study||171
7935797|NCT00529555|19529213|P3|STARTED|Overall Study||200
7935798|NCT00529555|19529214|P2|STARTED|Overall Study||202
7935799|NCT00529555|19529215|P1|STARTED|Overall Study||200
7935800|NCT00529542|19529225|P2|NOT COMPLETED|Overall Study||1
7935801|NCT00529542|19529226|P1|NOT COMPLETED|Overall Study||1
7935802|NCT00529542|19529225|P2|COMPLETED|Overall Study||10
7935803|NCT00529542|19529226|P1|COMPLETED|Overall Study||8
7935804|NCT00529542|19529225|P2|STARTED|Overall Study||11
7935805|NCT00529542|19529226|P1|STARTED|Overall Study||9
7935806|NCT00529529|19529269|P3|NOT COMPLETED|Overall Study||31
7935807|NCT00529529|19529270|P2|NOT COMPLETED|Overall Study||43
7935808|NCT00529529|19529271|P1|NOT COMPLETED|Overall Study||43
7935809|NCT00529529|19529269|P3|COMPLETED|Overall Study||238
7935810|NCT00529529|19529270|P2|COMPLETED|Overall Study||225
7935811|NCT00529529|19529271|P1|COMPLETED|Overall Study||225
7935812|NCT00529529|19529269|P3|STARTED|Overall Study||269
7935813|NCT00529529|19529270|P2|STARTED|Overall Study||268
7935814|NCT00529529|19529271|P1|STARTED|Overall Study||268
7935815|NCT00529516|19529330|P3|NOT COMPLETED|Overall Study||1
7935816|NCT00529516|19529331|P2|NOT COMPLETED|Overall Study||2
7935817|NCT00529516|19529332|P1|NOT COMPLETED|Overall Study||3
7935818|NCT00529516|19529330|P3|COMPLETED|Overall Study||288
7935819|NCT00529516|19529331|P2|COMPLETED|Overall Study||486
7935820|NCT00529516|19529332|P1|COMPLETED|Overall Study||472
7935821|NCT00529516|19529330|P3|STARTED|Overall Study||289
7935822|NCT00529516|19529331|P2|STARTED|Overall Study||488
7935823|NCT00529516|19529332|P1|STARTED|Overall Study||475
7935824|NCT00529464|19529403|P3|NOT COMPLETED|Overall Study||0
7935825|NCT00529464|19529404|P2|NOT COMPLETED|Overall Study||0
7935826|NCT00529464|19529405|P1|NOT COMPLETED|Overall Study||0
7935827|NCT00529464|19529403|P3|COMPLETED|Overall Study||0
7935828|NCT00529464|19529404|P2|COMPLETED|Overall Study||0
7935829|NCT00529464|19529405|P1|COMPLETED|Overall Study||0
7935830|NCT00529464|19529403|P3|STARTED|Overall Study||0
7935831|NCT00529464|19529404|P2|STARTED|Overall Study||0
7935832|NCT00529464|19529405|P1|STARTED|Overall Study||0
7935833|NCT00529451|19529417|P4|NOT COMPLETED|Overall Study||31
7935834|NCT00529451|19529418|P3|NOT COMPLETED|Overall Study||40
7935835|NCT00529451|19529419|P2|NOT COMPLETED|Overall Study||48
7935836|NCT00529451|19529420|P1|NOT COMPLETED|Overall Study||37
7935837|NCT00529451|19529417|P4|COMPLETED|Overall Study||299
7935838|NCT00529451|19529418|P3|COMPLETED|Overall Study||292
7935839|NCT00529451|19529419|P2|COMPLETED|Overall Study||275
7935840|NCT00529451|19529420|P1|COMPLETED|Overall Study||294
7935841|NCT00529451|19529417|P4|STARTED|Overall Study||330
7935842|NCT00529451|19529418|P3|STARTED|Overall Study||332
7935843|NCT00529451|19529419|P2|STARTED|Overall Study||323
7935844|NCT00529451|19529420|P1|STARTED|Overall Study||331
7935845|NCT00529399|19529447|P3|NOT COMPLETED|Overall Study||2
7935846|NCT00529399|19529448|P2|NOT COMPLETED|Overall Study||1
7935847|NCT00529399|19529449|P1|NOT COMPLETED|Overall Study||2
7935848|NCT00529399|19529447|P3|COMPLETED|Overall Study||46
7935849|NCT00529399|19529448|P2|COMPLETED|Overall Study||48
7935850|NCT00529399|19529449|P1|COMPLETED|Overall Study||46
7935851|NCT00529399|19529447|P3|STARTED|Overall Study||48
7935852|NCT00529399|19529448|P2|STARTED|Overall Study||49
7935853|NCT00529399|19529449|P1|STARTED|Overall Study||48
7935854|NCT00529386|19529457|P1|NOT COMPLETED|Overall Study||1
7935855|NCT00529386|19529457|P1|COMPLETED|Overall Study|Study discontinued after 7 patients enrolled and analyzed|6
7935856|NCT00529386|19529457|P1|STARTED|Overall Study|Study has been discontinued|7
7935857|NCT00529373|19529463|P2|NOT COMPLETED|Second Extension Study||197
7935858|NCT00529373|19529464|P1|NOT COMPLETED|Second Extension Study||300
7935859|NCT00529373|19529463|P2|COMPLETED|Second Extension Study||2112
7935860|NCT00529373|19529464|P1|COMPLETED|Second Extension Study||2844
7935861|NCT00529373|19529463|P2|STARTED|Second Extension Study||2309
7935862|NCT00529373|19529464|P1|STARTED|Second Extension Study||3144
7935863|NCT00529373|19529463|P2|NOT COMPLETED|First Extension Study||1651
7935864|NCT00529373|19529464|P1|NOT COMPLETED|First Extension Study||1153
7935865|NCT00529373|19529463|P2|COMPLETED|First Extension Study||2309
7935866|NCT00529373|19529464|P1|COMPLETED|First Extension Study||3144
7935867|NCT00529373|19529463|P2|STARTED|First Extension Study||3960
7935868|NCT00529373|19529464|P1|STARTED|First Extension Study||4297
7935869|NCT00529373|19529463|P2|NOT COMPLETED|Base Study||4068
7935870|NCT00529373|19529464|P1|NOT COMPLETED|Base Study||3746
7935871|NCT00529373|19529463|P2|COMPLETED|Base Study||3960
7935872|NCT00529373|19529464|P1|COMPLETED|Base Study||4297
7935873|NCT00529373|19529463|P2|STARTED|Base Study||8028
7935874|NCT00529373|19529464|P1|STARTED|Base Study||8043
7935875|NCT00529308|19529658|P2|NOT COMPLETED|Overall Study||1
7935876|NCT00529308|19529659|P1|NOT COMPLETED|Overall Study||1
7935877|NCT00529308|19529658|P2|COMPLETED|Overall Study||10
7935878|NCT00529308|19529659|P1|COMPLETED|Overall Study||8
7935879|NCT00529308|19529658|P2|STARTED|Overall Study||11
7935880|NCT00529308|19529659|P1|STARTED|Overall Study||9
7935881|NCT00529282|19529675|P2|NOT COMPLETED|Overall Study||0
7935882|NCT00529282|19529676|P1|NOT COMPLETED|Overall Study||0
7935883|NCT00529282|19529675|P2|COMPLETED|Overall Study||2
7935884|NCT00529282|19529676|P1|COMPLETED|Overall Study||0
7935885|NCT00529282|19529675|P2|STARTED|Overall Study||2
7935886|NCT00529282|19529676|P1|STARTED|Overall Study||0
7935887|NCT00529243|19529688|P1|NOT COMPLETED|Overall Study||3
7935888|NCT00529243|19529688|P1|COMPLETED|Overall Study||49
7935889|NCT00529243|19529688|P1|STARTED|Overall Study||52
7935890|NCT00529217|19529693|P1|NOT COMPLETED|Overall Study||4
7935891|NCT00529217|19529693|P1|COMPLETED|Overall Study||8
7935892|NCT00529217|19529693|P1|STARTED|Overall Study||12
7935893|NCT00529204|19529698|P1|NOT COMPLETED|Overall Study||0
7935894|NCT00529204|19529698|P1|COMPLETED|Overall Study||1
7935895|NCT00529204|19529698|P1|STARTED|Overall Study||1
7935896|NCT00529191|19529706|P2|NOT COMPLETED|Overall Study||0
7935897|NCT00529191|19529707|P1|NOT COMPLETED|Overall Study||3
7935898|NCT00529191|19529706|P2|COMPLETED|Overall Study||13
7935899|NCT00529191|19529707|P1|COMPLETED|Overall Study||24
7935900|NCT00529191|19529706|P2|STARTED|Overall Study||13
7935901|NCT00529191|19529707|P1|STARTED|Overall Study||27
7935902|NCT00529152|19529729|P1|NOT COMPLETED|Overall Study||5
7935903|NCT00529152|19529729|P1|COMPLETED|Overall Study||95
7935904|NCT00529152|19529729|P1|STARTED|Overall Study||100
7935905|NCT00529126|19529737|P4|NOT COMPLETED|Overall Study||0
7935906|NCT00529126|19529738|P3|NOT COMPLETED|Overall Study||0
7935907|NCT00529126|19529739|P2|NOT COMPLETED|Overall Study||0
7935908|NCT00529126|19529740|P1|NOT COMPLETED|Overall Study||0
7935909|NCT00529126|19529737|P4|COMPLETED|Overall Study||26
7935910|NCT00529126|19529738|P3|COMPLETED|Overall Study||24
7935911|NCT00529126|19529739|P2|COMPLETED|Overall Study||25
7935912|NCT00529126|19529740|P1|COMPLETED|Overall Study||25
7935913|NCT00529126|19529737|P4|STARTED|Overall Study||26
7935914|NCT00529126|19529738|P3|STARTED|Overall Study||24
7935915|NCT00529126|19529739|P2|STARTED|Overall Study||25
7935916|NCT00529126|19529740|P1|STARTED|Overall Study||25
7935917|NCT00529100|19529753|P2|NOT COMPLETED|Overall Study||9
7935918|NCT00529100|19529754|P1|NOT COMPLETED|Overall Study||0
7935919|NCT00529100|19529753|P2|COMPLETED|Overall Study||24
7935920|NCT00529100|19529754|P1|COMPLETED|Overall Study||16
7935921|NCT00529100|19529753|P2|Received at Least 1 Dose of Study Drug|Overall Study||33
7935922|NCT00529100|19529754|P1|Received at Least 1 Dose of Study Drug|Overall Study||16
7935923|NCT00529100|19529753|P2|STARTED|Overall Study||33
7935924|NCT00529100|19529754|P1|STARTED|Overall Study||16
7935925|NCT00529087|19529771|P3|NOT COMPLETED|Overall Study||16
7935926|NCT00529087|19529772|P2|NOT COMPLETED|Overall Study||28
7935927|NCT00529087|19529773|P1|NOT COMPLETED|Overall Study||28
7935928|NCT00529087|19529771|P3|COMPLETED|Overall Study||146
7935929|NCT00529087|19529772|P2|COMPLETED|Overall Study||120
7935930|NCT00529087|19529773|P1|COMPLETED|Overall Study||122
7935931|NCT00529087|19529771|P3|STARTED|Overall Study||162
7935932|NCT00529087|19529772|P2|STARTED|Overall Study||148
7935933|NCT00529087|19529773|P1|STARTED|Overall Study||150
7935934|NCT00529035|19529837|P1|NOT COMPLETED|Overall Study||1
7935935|NCT00529035|19529837|P1|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28
7935936|NCT00529035|19529837|P1|STARTED|Overall Study|29 enrolled|29
7935937|NCT00528970|19529851|P3|NOT COMPLETED|Overall Study||20
7935938|NCT00528970|19529852|P2|NOT COMPLETED|Overall Study||15
7935939|NCT00528970|19529853|P1|NOT COMPLETED|Overall Study||14
7935940|NCT00528970|19529851|P3|COMPLETED|Overall Study||105
7935941|NCT00528970|19529852|P2|COMPLETED|Overall Study||110
7935942|NCT00528970|19529853|P1|COMPLETED|Overall Study||110
7935943|NCT00528970|19529851|P3|Received at Least 1 Dose of Study Drug|Overall Study||124
7935944|NCT00528970|19529852|P2|Received at Least 1 Dose of Study Drug|Overall Study||125
7935945|NCT00528970|19529853|P1|Received at Least 1 Dose of Study Drug|Overall Study||124
7935946|NCT00528970|19529851|P3|STARTED|Overall Study||125
7935947|NCT00528970|19529852|P2|STARTED|Overall Study||125
7935948|NCT00528970|19529853|P1|STARTED|Overall Study||124
7935949|NCT00528957|19529872|P2|NOT COMPLETED|Long-Term Extension (Week 336 and On)||17
7935950|NCT00528957|19529873|P1|NOT COMPLETED|Long-Term Extension (Week 336 and On)||10
7935951|NCT00528957|19529872|P2|COMPLETED|Long-Term Extension (Week 336 and On)||8
7935952|NCT00528957|19529873|P1|COMPLETED|Long-Term Extension (Week 336 and On)||9
7935953|NCT00528957|19529872|P2|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|25
7935954|NCT00528957|19529873|P1|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|19
7935955|NCT00528957|19529872|P2|NOT COMPLETED|Third Extension (Week 240 to Week 336)||10
7936032|NCT00528606|19530155|P1|NOT COMPLETED|Overall Study||13
7935956|NCT00528957|19529873|P1|NOT COMPLETED|Third Extension (Week 240 to Week 336)||6
7935957|NCT00528957|19529872|P2|COMPLETED|Third Extension (Week 240 to Week 336)||27
7935958|NCT00528957|19529873|P1|COMPLETED|Third Extension (Week 240 to Week 336)||21
7935959|NCT00528957|19529872|P2|STARTED|Third Extension (Week 240 to Week 336)||37
7935960|NCT00528957|19529873|P1|STARTED|Third Extension (Week 240 to Week 336)||27
7935961|NCT00528957|19529872|P2|NOT COMPLETED|Second Extension (Week 144 to Week 240)||3
7935962|NCT00528957|19529873|P1|NOT COMPLETED|Second Extension (Week 144 to Week 240)||7
7935963|NCT00528957|19529872|P2|COMPLETED|Second Extension (Week 144 to Week 240)||37
7935964|NCT00528957|19529873|P1|COMPLETED|Second Extension (Week 144 to Week 240)||27
7935965|NCT00528957|19529872|P2|STARTED|Second Extension (Week 144 to Week 240)||40
7935966|NCT00528957|19529873|P1|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34
7935967|NCT00528957|19529872|P2|NOT COMPLETED|First Extension (Week 48 to Week 144)||1
7935968|NCT00528957|19529873|P1|NOT COMPLETED|First Extension (Week 48 to Week 144)||3
7935969|NCT00528957|19529872|P2|COMPLETED|First Extension (Week 48 to Week 144)||40
7935970|NCT00528957|19529873|P1|COMPLETED|First Extension (Week 48 to Week 144)||35
7935971|NCT00528957|19529872|P2|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41
7935972|NCT00528957|19529873|P1|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38
7935973|NCT00528957|19529872|P2|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1
7935974|NCT00528957|19529873|P1|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4
7935975|NCT00528957|19529872|P2|COMPLETED|Randomized Phase (Baseline to Week 48)||48
7935976|NCT00528957|19529873|P1|COMPLETED|Randomized Phase (Baseline to Week 48)||44
7935977|NCT00528957|19529872|P2|STARTED|Randomized Phase (Baseline to Week 48)||49
7935978|NCT00528957|19529873|P1|STARTED|Randomized Phase (Baseline to Week 48)||48
7935979|NCT00528931|19530014|P1|NOT COMPLETED|Overall Study||1
7935980|NCT00528931|19530014|P1|COMPLETED|Overall Study||15
7935981|NCT00528931|19530014|P1|STARTED|Overall Study||16
7935982|NCT00528879|19530026|P4|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24
7935983|NCT00528879|19530027|P3|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33
7935984|NCT00528879|19530028|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38
7935985|NCT00528879|19530029|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42
7935986|NCT00528879|19530026|P4|COMPLETED|Long-term Period (Weeks 24 to 102)||95
7935987|NCT00528879|19530027|P3|COMPLETED|Long-term Period (Weeks 24 to 102)||89
7935988|NCT00528879|19530028|P2|COMPLETED|Long-term Period (Weeks 24 to 102)||82
7935989|NCT00528879|19530029|P1|COMPLETED|Long-term Period (Weeks 24 to 102)||73
7935990|NCT00528879|19530026|P4|STARTED|Long-term Period (Weeks 24 to 102)||119
7935991|NCT00528879|19530027|P3|STARTED|Long-term Period (Weeks 24 to 102)||122
7935992|NCT00528879|19530028|P2|STARTED|Long-term Period (Weeks 24 to 102)||120
7935993|NCT00528879|19530029|P1|STARTED|Long-term Period (Weeks 24 to 102)||115
7935994|NCT00528879|19530026|P4|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16
7935995|NCT00528879|19530027|P3|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15
7935996|NCT00528879|19530028|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17
7935997|NCT00528879|19530029|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22
7935998|NCT00528879|19530026|P4|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119
7935999|NCT00528879|19530027|P3|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122
7936000|NCT00528879|19530028|P2|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120
7936001|NCT00528879|19530029|P1|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115
7936002|NCT00528879|19530026|P4|Completed the Period|Short-term Period (Day 1 to Week 24)||121
7936003|NCT00528879|19530027|P3|Completed the Period|Short-term Period (Day 1 to Week 24)||122
7936004|NCT00528879|19530028|P2|Completed the Period|Short-term Period (Day 1 to Week 24)||121
7936005|NCT00528879|19530029|P1|Completed the Period|Short-term Period (Day 1 to Week 24)||119
7936006|NCT00528879|19530026|P4|STARTED|Short-term Period (Day 1 to Week 24)||135
7936007|NCT00528879|19530027|P3|STARTED|Short-term Period (Day 1 to Week 24)||137
7936008|NCT00528879|19530028|P2|STARTED|Short-term Period (Day 1 to Week 24)||137
7936009|NCT00528879|19530029|P1|STARTED|Short-term Period (Day 1 to Week 24)||137
7936010|NCT00528866|19530095|P1|NOT COMPLETED|Overall Study||6
7936011|NCT00528866|19530095|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|74
7936012|NCT00528866|19530095|P1|STARTED|Overall Study||80
7936013|NCT00528840|19530108|P1|NOT COMPLETED|Overall Study||33
7936014|NCT00528840|19530108|P1|COMPLETED|Overall Study||168
7936015|NCT00528840|19530108|P1|STARTED|Overall Study||201
7936016|NCT00528801|19530122|P2|NOT COMPLETED|Overall Study||11
7936017|NCT00528801|19530123|P1|NOT COMPLETED|Overall Study||27
7936018|NCT00528801|19530122|P2|COMPLETED|Overall Study||41
7936019|NCT00528801|19530123|P1|COMPLETED|Overall Study||133
7936020|NCT00528801|19530122|P2|STARTED|Overall Study||52
7936021|NCT00528801|19530123|P1|STARTED|Overall Study||160
7936022|NCT00528788|19530133|P1|NOT COMPLETED|Overall Study||4
7936023|NCT00528788|19530133|P1|COMPLETED|Overall Study||20
7936024|NCT00528788|19530133|P1|STARTED|Overall Study||24
7936025|NCT00528775|19530137|P1|NOT COMPLETED|Overall Study||1
7936026|NCT00528775|19530137|P1|COMPLETED|Overall Study||5
7936027|NCT00528775|19530137|P1|STARTED|Overall Study||6
7936028|NCT00528645|19530145|P1|NOT COMPLETED|Overall Study||3
7936029|NCT00528645|19530145|P1|COMPLETED|Overall Study||20
7936030|NCT00528645|19530145|P1|STARTED|Overall Study||23
7936031|NCT00528606|19530154|P2|NOT COMPLETED|Overall Study||4
7936033|NCT00528606|19530154|P2|COMPLETED|Overall Study||100
7936034|NCT00528606|19530155|P1|COMPLETED|Overall Study||191
7936035|NCT00528606|19530154|P2|STARTED|Overall Study||104
7936036|NCT00528606|19530155|P1|STARTED|Overall Study||204
7936037|NCT00528580|19530179|P2|NOT COMPLETED|Overall Study||0
7936038|NCT00528580|19530180|P1|NOT COMPLETED|Overall Study||0
7936039|NCT00528580|19530179|P2|COMPLETED|Overall Study||34
7936040|NCT00528580|19530180|P1|COMPLETED|Overall Study||34
7936041|NCT00528580|19530179|P2|STARTED|Overall Study||34
7936042|NCT00528580|19530180|P1|STARTED|Overall Study||34
7936043|NCT00528567|19530188|P2|NOT COMPLETED|Overall Study||308
7936044|NCT00528567|19530189|P1|NOT COMPLETED|Overall Study||431
7936045|NCT00528567|19530188|P2|COMPLETED|Overall Study||982
7936046|NCT00528567|19530189|P1|COMPLETED|Overall Study||870
7936047|NCT00528567|19530188|P2|Safety Population|Overall Study||1271
7936048|NCT00528567|19530189|P1|Safety Population|Overall Study||1288
7936049|NCT00528567|19530188|P2|Intention to Treat|Overall Study||1290
7936050|NCT00528567|19530189|P1|Intention to Treat|Overall Study||1301
7936051|NCT00528567|19530188|P2|STARTED|Overall Study||1290
7936052|NCT00528567|19530189|P1|STARTED|Overall Study||1301
7936053|NCT00528541|19530229|P2|NOT COMPLETED|Overall Study||1
7936054|NCT00528541|19530230|P1|NOT COMPLETED|Overall Study||2
7936055|NCT00528541|19530229|P2|COMPLETED|Overall Study||69
7936056|NCT00528541|19530230|P1|COMPLETED|Overall Study||73
7936057|NCT00528541|19530229|P2|STARTED|Overall Study||70
7936058|NCT00528541|19530230|P1|STARTED|Overall Study||75
7936059|NCT00528528|19530256|P4|NOT COMPLETED|Overall Study||3
7936060|NCT00528528|19530257|P3|NOT COMPLETED|Overall Study||3
7936061|NCT00528528|19530258|P2|NOT COMPLETED|Overall Study||3
7936062|NCT00528528|19530259|P1|NOT COMPLETED|Overall Study||3
7936063|NCT00528528|19530256|P4|COMPLETED|Overall Study||36
7936064|NCT00528528|19530257|P3|COMPLETED|Overall Study||37
7936065|NCT00528528|19530258|P2|COMPLETED|Overall Study||39
7936066|NCT00528528|19530259|P1|COMPLETED|Overall Study||37
7936067|NCT00528528|19530256|P4|Ongoing at Time of Cut-off|Overall Study||0
7936068|NCT00528528|19530257|P3|Ongoing at Time of Cut-off|Overall Study||1
7936069|NCT00528528|19530258|P2|Ongoing at Time of Cut-off|Overall Study||0
7936070|NCT00528528|19530259|P1|Ongoing at Time of Cut-off|Overall Study||0
7936071|NCT00528528|19530256|P4|STARTED|Overall Study||39
7936072|NCT00528528|19530257|P3|STARTED|Overall Study||40
7936073|NCT00528528|19530258|P2|STARTED|Overall Study||42
7936074|NCT00528528|19530259|P1|STARTED|Overall Study||40
7936075|NCT00528450|19530293|P1|NOT COMPLETED|Overall Study||0
7936076|NCT00528450|19530293|P1|COMPLETED|Overall Study||1
7936077|NCT00528450|19530293|P1|STARTED|Overall Study||1
7936078|NCT00528424|19530297|P1|NOT COMPLETED|Overall Study||29
7936079|NCT00528424|19530297|P1|COMPLETED|Overall Study||257
7936080|NCT00528424|19530297|P1|STARTED|Overall Study||286
7936081|NCT00528411|19530312|P3|NOT COMPLETED|Overall Study||1
7936082|NCT00528411|19530313|P2|NOT COMPLETED|Overall Study||3
7936083|NCT00528411|19530314|P1|NOT COMPLETED|Overall Study||5
7936084|NCT00528411|19530312|P3|COMPLETED|Overall Study||11
7936085|NCT00528411|19530313|P2|COMPLETED|Overall Study||51
7936086|NCT00528411|19530314|P1|COMPLETED|Overall Study||52
7936087|NCT00528411|19530312|P3|STARTED|Overall Study||12
7936088|NCT00528411|19530313|P2|STARTED|Overall Study||54
7936089|NCT00528411|19530314|P1|STARTED|Overall Study||57
7936090|NCT00528398|19530437|P1|NOT COMPLETED|Overall Study||0
7936091|NCT00528398|19530437|P1|COMPLETED|Overall Study||111
7936092|NCT00528398|19530437|P1|STARTED|Overall Study||111
7936093|NCT00528372|19530451|P9|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
7936094|NCT00528372|19530452|P8|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
7936095|NCT00528372|19530453|P7|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17
7936096|NCT00528372|19530454|P6|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15
7936097|NCT00528372|19530455|P5|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21
7936098|NCT00528372|19530456|P4|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14
7936099|NCT00528372|19530457|P3|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8
7936100|NCT00528372|19530458|P2|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19
7936101|NCT00528372|19530459|P1|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20
7936102|NCT00528372|19530451|P9|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27
7936103|NCT00528372|19530452|P8|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22
7936104|NCT00528372|19530453|P7|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48
7936105|NCT00528372|19530454|P6|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
7936106|NCT00528372|19530455|P5|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37
7936107|NCT00528372|19530456|P4|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
7936108|NCT00528372|19530457|P3|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43
7936109|NCT00528372|19530458|P2|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40
7936110|NCT00528372|19530459|P1|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
7936111|NCT00528372|19530451|P9|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33
7936112|NCT00528372|19530452|P8|STARTED|Long-term (LT) Period (Weeks 24-102)||28
7936113|NCT00528372|19530453|P7|STARTED|Long-term (LT) Period (Weeks 24-102)||65
7936114|NCT00528372|19530454|P6|STARTED|Long-term (LT) Period (Weeks 24-102)||57
7936115|NCT00528372|19530455|P5|STARTED|Long-term (LT) Period (Weeks 24-102)||58
7936116|NCT00528372|19530456|P4|STARTED|Long-term (LT) Period (Weeks 24-102)||56
7936117|NCT00528372|19530457|P3|STARTED|Long-term (LT) Period (Weeks 24-102)||51
7936118|NCT00528372|19530458|P2|STARTED|Long-term (LT) Period (Weeks 24-102)||59
7936119|NCT00528372|19530459|P1|STARTED|Long-term (LT) Period (Weeks 24-102)||62
7936120|NCT00528372|19530451|P9|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
7936121|NCT00528372|19530452|P8|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6
7936122|NCT00528372|19530453|P7|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
7936123|NCT00528372|19530454|P6|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
7936124|NCT00528372|19530455|P5|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9
7936125|NCT00528372|19530456|P4|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13
7936126|NCT00528372|19530457|P3|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
7936127|NCT00528372|19530458|P2|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
7936128|NCT00528372|19530459|P1|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
7936129|NCT00528372|19530451|P9|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34
7936130|NCT00528372|19530452|P8|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28
7936131|NCT00528372|19530453|P7|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65
7936132|NCT00528372|19530454|P6|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
7936133|NCT00528372|19530455|P5|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58
7936134|NCT00528372|19530456|P4|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
7936135|NCT00528372|19530457|P3|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52
7936136|NCT00528372|19530458|P2|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60
7936137|NCT00528372|19530459|P1|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63
7936138|NCT00528372|19530451|P9|STARTED|Short-term (ST) Period (Day 1-Week 24)||39
7936139|NCT00528372|19530452|P8|STARTED|Short-term (ST) Period (Day 1-Week 24)||34
7936140|NCT00528372|19530453|P7|STARTED|Short-term (ST) Period (Day 1-Week 24)||76
7936141|NCT00528372|19530454|P6|STARTED|Short-term (ST) Period (Day 1-Week 24)||68
7936142|NCT00528372|19530455|P5|STARTED|Short-term (ST) Period (Day 1-Week 24)||67
7936143|NCT00528372|19530456|P4|STARTED|Short-term (ST) Period (Day 1-Week 24)||70
7936144|NCT00528372|19530457|P3|STARTED|Short-term (ST) Period (Day 1-Week 24)||64
7936145|NCT00528372|19530458|P2|STARTED|Short-term (ST) Period (Day 1-Week 24)||65
7936146|NCT00528372|19530459|P1|STARTED|Short-term (ST) Period (Day 1-Week 24)||75
7936147|NCT00528268|19530573|P2|NOT COMPLETED|Overall Study||1
7936148|NCT00528268|19530574|P1|NOT COMPLETED|Overall Study||1
7936149|NCT00528268|19530573|P2|COMPLETED|Overall Study||7
7936150|NCT00528268|19530574|P1|COMPLETED|Overall Study||5
7936151|NCT00528268|19530573|P2|STARTED|Overall Study||8
7936152|NCT00528268|19530574|P1|STARTED|Overall Study||6
7936153|NCT00528190|19530582|P2|NOT COMPLETED|Overall Study||1
7936154|NCT00528190|19530583|P1|NOT COMPLETED|Overall Study||0
7936155|NCT00528190|19530582|P2|COMPLETED|Overall Study||16
7936156|NCT00528190|19530583|P1|COMPLETED|Overall Study||18
7936157|NCT00528190|19530582|P2|STARTED|Overall Study||17
7936158|NCT00528190|19530583|P1|STARTED|Overall Study||18
7936159|NCT00528112|19530591|P2|NOT COMPLETED|Extension Phase||157
7936160|NCT00528112|19530592|P1|NOT COMPLETED|Extension Phase||0
7936161|NCT00528112|19530591|P2|COMPLETED|Extension Phase||550
7936162|NCT00528112|19530592|P1|COMPLETED|Extension Phase||0
7936163|NCT00528112|19530591|P2|STARTED|Extension Phase||707
7936164|NCT00528112|19530592|P1|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0
7936165|NCT00528112|19530591|P2|NOT COMPLETED|Treatment up to 3 Years||583
7936166|NCT00528112|19530592|P1|NOT COMPLETED|Treatment up to 3 Years||613
7936167|NCT00528112|19530591|P2|COMPLETED|Treatment up to 3 Years||870
7936168|NCT00528112|19530592|P1|COMPLETED|Treatment up to 3 Years||819
7936169|NCT00528112|19530591|P2|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452
7936170|NCT00528112|19530592|P1|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432
7936171|NCT00528112|19530591|P2|STARTED|Treatment up to 3 Years||1453
7936172|NCT00528112|19530592|P1|STARTED|Treatment up to 3 Years||1432
7936173|NCT00528021|19530650|P4|NOT COMPLETED|Overall Study||9
7936174|NCT00528021|19530651|P3|NOT COMPLETED|Overall Study||7
7936175|NCT00528021|19530652|P2|NOT COMPLETED|Overall Study||13
7936176|NCT00528021|19530653|P1|NOT COMPLETED|Overall Study||17
7936177|NCT00528021|19530650|P4|COMPLETED|Overall Study||47
7936178|NCT00528021|19530651|P3|COMPLETED|Overall Study||49
7936179|NCT00528021|19530652|P2|COMPLETED|Overall Study||46
7936180|NCT00528021|19530653|P1|COMPLETED|Overall Study||42
7936181|NCT00528021|19530650|P4|STARTED|Overall Study||56
7936182|NCT00528021|19530651|P3|STARTED|Overall Study||56
7936183|NCT00528021|19530652|P2|STARTED|Overall Study||59
7936184|NCT00528021|19530653|P1|STARTED|Overall Study||59
7936185|NCT00527982|19530665|P2|NOT COMPLETED|Overall Study||0
7936186|NCT00527982|19530666|P1|NOT COMPLETED|Overall Study||1
7936187|NCT00527982|19530665|P2|COMPLETED|Overall Study||0
7936188|NCT00527982|19530666|P1|COMPLETED|Overall Study||0
7936189|NCT00527982|19530665|P2|STARTED|Overall Study||0
7936190|NCT00527982|19530666|P1|STARTED|Overall Study||1
7936191|NCT00527943|19530674|P2|NOT COMPLETED|Overall Study||146
7936192|NCT00527943|19530675|P1|NOT COMPLETED|Overall Study||160
7936193|NCT00527943|19530674|P2|COMPLETED|Overall Study||6327
7936194|NCT00527943|19530675|P1|COMPLETED|Overall Study||6311
7936195|NCT00527943|19530674|P2|Received Treatment|Overall Study||6446
7936196|NCT00527943|19530675|P1|Received Treatment|Overall Study||6441
7936197|NCT00527943|19530674|P2|STARTED|Overall Study||6473
7936198|NCT00527943|19530675|P1|STARTED|Overall Study||6471
7936199|NCT00527904|19530707|P1|NOT COMPLETED|Overall Study||96
7936200|NCT00527904|19530707|P1|COMPLETED|Overall Study||143
7936201|NCT00527904|19530707|P1|STARTED|Overall Study||239
7936202|NCT00527878|19530711|P2|NOT COMPLETED|Intervention 2||0
7936203|NCT00527878|19530712|P1|NOT COMPLETED|Intervention 2||0
7936204|NCT00527878|19530711|P2|COMPLETED|Intervention 2||4
7936205|NCT00527878|19530712|P1|COMPLETED|Intervention 2||5
7936206|NCT00527878|19530711|P2|STARTED|Intervention 2||4
7936207|NCT00527878|19530712|P1|STARTED|Intervention 2||5
7936208|NCT00527878|19530711|P2|NOT COMPLETED|Intervention 1||3
7936209|NCT00527878|19530712|P1|NOT COMPLETED|Intervention 1||2
7936210|NCT00527878|19530711|P2|COMPLETED|Intervention 1||4
7936211|NCT00527878|19530712|P1|COMPLETED|Intervention 1||5
7936212|NCT00527878|19530711|P2|STARTED|Intervention 1||7
7936213|NCT00527878|19530712|P1|STARTED|Intervention 1||7
7936214|NCT00527826|19530726|P2|NOT COMPLETED|Overall Study||26
7936215|NCT00527826|19530727|P1|NOT COMPLETED|Overall Study||21
7936216|NCT00527826|19530726|P2|COMPLETED|Overall Study||80
7936217|NCT00527826|19530727|P1|COMPLETED|Overall Study||87
7936218|NCT00527826|19530726|P2|STARTED|Overall Study||106
7936219|NCT00527826|19530727|P1|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108
7936220|NCT00527787|19530776|P2|NOT COMPLETED|Overall Study||63
7936221|NCT00527787|19530777|P1|NOT COMPLETED|Overall Study||38
7936222|NCT00527787|19530776|P2|COMPLETED|Overall Study||153
7936223|NCT00527787|19530777|P1|COMPLETED|Overall Study||180
7936224|NCT00527787|19530776|P2|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216
7936225|NCT00527787|19530777|P1|STARTED|Overall Study||218
7936226|NCT00527748|19530799|P1|NOT COMPLETED|Overall Study||3
7936227|NCT00527748|19530799|P1|COMPLETED|Overall Study||23
7936228|NCT00527748|19530799|P1|STARTED|Overall Study||26
7936229|NCT00527735|19530806|P3|NOT COMPLETED|Overall Study||107
7936230|NCT00527735|19530807|P2|NOT COMPLETED|Overall Study||107
7936231|NCT00527735|19530808|P1|NOT COMPLETED|Overall Study||108
7936232|NCT00527735|19530806|P3|COMPLETED|Overall Study|Still on treatment|2
7936233|NCT00527735|19530807|P2|COMPLETED|Overall Study|Still on treatment|2
7936234|NCT00527735|19530808|P1|COMPLETED|Overall Study|Still on treatment|5
7936235|NCT00527735|19530806|P3|STARTED|Overall Study|Treated|109
7936236|NCT00527735|19530807|P2|STARTED|Overall Study|Treated|109
7936237|NCT00527735|19530808|P1|STARTED|Overall Study|Treated|113
7936238|NCT00527722|19530882|P2|NOT COMPLETED|Overall Study||0
7936239|NCT00527722|19530883|P1|NOT COMPLETED|Overall Study||0
7936240|NCT00527722|19530882|P2|COMPLETED|Overall Study||25
7936241|NCT00527722|19530883|P1|COMPLETED|Overall Study||22
7936242|NCT00527722|19530882|P2|STARTED|Overall Study||25
7936243|NCT00527722|19530883|P1|STARTED|Overall Study||22
7936244|NCT00527644|19530889|P1|NOT COMPLETED|Overall Study||0
7936245|NCT00527644|19530889|P1|COMPLETED|Overall Study||14
7936246|NCT00527644|19530889|P1|STARTED|Overall Study||14
7936247|NCT00527618|19530894|P2|NOT COMPLETED|Week 15-18 (Second Intervention)||3
7936248|NCT00527618|19530895|P1|NOT COMPLETED|Week 15-18 (Second Intervention)||0
7936249|NCT00527618|19530894|P2|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13
7936250|NCT00527618|19530895|P1|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12
7936251|NCT00527618|19530894|P2|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16
7936252|NCT00527618|19530895|P1|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12
7936253|NCT00527618|19530894|P2|NOT COMPLETED|Week 13-14 (Washout)||0
7936254|NCT00527618|19530895|P1|NOT COMPLETED|Week 13-14 (Washout)||1
7936255|NCT00527618|19530894|P2|COMPLETED|Week 13-14 (Washout)||16
7936256|NCT00527618|19530895|P1|COMPLETED|Week 13-14 (Washout)||12
7936257|NCT00527618|19530894|P2|STARTED|Week 13-14 (Washout)||16
7936258|NCT00527618|19530895|P1|STARTED|Week 13-14 (Washout)||13
7936259|NCT00527618|19530894|P2|NOT COMPLETED|Week 1-12 (First Intervention)||2
7936260|NCT00527618|19530895|P1|NOT COMPLETED|Week 1-12 (First Intervention)||3
7936261|NCT00527618|19530894|P2|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16
7936262|NCT00527618|19530895|P1|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13
7936263|NCT00527618|19530894|P2|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18
7936264|NCT00527618|19530895|P1|STARTED|Week 1-12 (First Intervention)|Acyclovir|16
7936265|NCT00527605|19530910|P2|NOT COMPLETED|Overall Study||11
7936266|NCT00527605|19530911|P1|NOT COMPLETED|Overall Study||13
7936267|NCT00527605|19530910|P2|COMPLETED|Overall Study||116
7936268|NCT00527605|19530911|P1|COMPLETED|Overall Study||113
7936269|NCT00527605|19530910|P2|STARTED|Overall Study||127
7936270|NCT00527605|19530911|P1|STARTED|Overall Study||126
7936271|NCT00527592|19530947|P1|NOT COMPLETED|Overall Study||0
7936272|NCT00527592|19530947|P1|COMPLETED|Overall Study||54
7936273|NCT00527592|19530947|P1|STARTED|Overall Study||54
7936274|NCT00527566|19530953|P1|NOT COMPLETED|Overall Study||0
7936275|NCT00527566|19530953|P1|COMPLETED|Overall Study||10
7936276|NCT00527566|19530953|P1|STARTED|Overall Study||10
7936277|NCT00527514|19530962|P1|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2
7936278|NCT00527514|19530962|P1|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132
7936279|NCT00527514|19530962|P1|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134
7936280|NCT00527514|19530962|P1|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3
7936281|NCT00527514|19530962|P1|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158
7936282|NCT00527514|19530962|P1|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161
7936283|NCT00527514|19530962|P1|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2
7936284|NCT00527514|19530962|P1|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178
7936285|NCT00527514|19530962|P1|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180
7936286|NCT00527514|19530962|P1|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1
7936380|NCT00526656|19531240|P1|COMPLETED|Overall Study||7
7936287|NCT00527514|19530962|P1|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184
7936288|NCT00527514|19530962|P1|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185
7936289|NCT00527488|19530978|P4|NOT COMPLETED|Overall Study||0
7936290|NCT00527488|19530979|P3|NOT COMPLETED|Overall Study||1
7936291|NCT00527488|19530980|P2|NOT COMPLETED|Overall Study||1
7936292|NCT00527488|19530981|P1|NOT COMPLETED|Overall Study||0
7936293|NCT00527488|19530978|P4|COMPLETED|Overall Study||13
7936294|NCT00527488|19530979|P3|COMPLETED|Overall Study||12
7936295|NCT00527488|19530980|P2|COMPLETED|Overall Study||12
7936296|NCT00527488|19530981|P1|COMPLETED|Overall Study||13
7936297|NCT00527488|19530978|P4|STARTED|Overall Study||13
7936298|NCT00527488|19530979|P3|STARTED|Overall Study||13
7936299|NCT00527488|19530980|P2|STARTED|Overall Study||13
7936300|NCT00527488|19530981|P1|STARTED|Overall Study||13
7936301|NCT00527475|19531057|P2|NOT COMPLETED|Overall Study||1
7936302|NCT00527475|19531058|P1|NOT COMPLETED|Overall Study||3
7936303|NCT00527475|19531057|P2|COMPLETED|Overall Study||29
7936304|NCT00527475|19531058|P1|COMPLETED|Overall Study||27
7936305|NCT00527475|19531057|P2|STARTED|Overall Study||30
7936306|NCT00527475|19531058|P1|STARTED|Overall Study||30
7936307|NCT00527423|19531064|P1|NOT COMPLETED|Overall Study||37
7936308|NCT00527423|19531064|P1|COMPLETED|Overall Study||120
7936309|NCT00527423|19531064|P1|STARTED|Overall Study||157
7936310|NCT00527397|19531070|P1|NOT COMPLETED|Overall Study||24
7936311|NCT00527397|19531070|P1|COMPLETED|Overall Study||0
7936312|NCT00527397|19531070|P1|STARTED|Overall Study||24
7936313|NCT00527332|19531096|P2|NOT COMPLETED|Overall Study||9
7936314|NCT00527332|19531097|P1|NOT COMPLETED|Overall Study||9
7936315|NCT00527332|19531096|P2|COMPLETED|Overall Study||80
7936316|NCT00527332|19531097|P1|COMPLETED|Overall Study||82
7936317|NCT00527332|19531096|P2|STARTED|Overall Study||89
7936318|NCT00527332|19531097|P1|STARTED|Overall Study||91
7936319|NCT00527319|19531106|P3|NOT COMPLETED|Overall Study||6
7936320|NCT00527319|19531107|P2|NOT COMPLETED|Overall Study||4
7936321|NCT00527319|19531108|P1|NOT COMPLETED|Overall Study||6
7936322|NCT00527319|19531106|P3|COMPLETED|Overall Study||7
7936323|NCT00527319|19531107|P2|COMPLETED|Overall Study||8
7936324|NCT00527319|19531108|P1|COMPLETED|Overall Study||6
7936325|NCT00527319|19531106|P3|STARTED|Overall Study||13
7936326|NCT00527319|19531107|P2|STARTED|Overall Study||12
7936327|NCT00527319|19531108|P1|STARTED|Overall Study||12
7936328|NCT00527124|19531121|P2|NOT COMPLETED|Overall Study||0
7936329|NCT00527124|19531122|P1|NOT COMPLETED|Overall Study||0
7936330|NCT00527124|19531121|P2|COMPLETED|Overall Study||28
7936331|NCT00527124|19531122|P1|COMPLETED|Overall Study||29
7936332|NCT00527124|19531121|P2|STARTED|Overall Study||28
7936333|NCT00527124|19531122|P1|STARTED|Overall Study||29
7936334|NCT00527111|19531138|P2|NOT COMPLETED|Overall Study||22
7936335|NCT00527111|19531139|P1|NOT COMPLETED|Overall Study||20
7936336|NCT00527111|19531138|P2|COMPLETED|Overall Study||47
7936337|NCT00527111|19531139|P1|COMPLETED|Overall Study||50
7936338|NCT00527111|19531138|P2|STARTED|Overall Study||69
7936339|NCT00527111|19531139|P1|STARTED|Overall Study||70
7936340|NCT00527098|19531155|P2|NOT COMPLETED|Overall Study||0
7936341|NCT00527098|19531156|P1|NOT COMPLETED|Overall Study||0
7936342|NCT00527098|19531155|P2|COMPLETED|Overall Study||83
7936343|NCT00527098|19531156|P1|COMPLETED|Overall Study||36
7936344|NCT00527098|19531155|P2|STARTED|Overall Study||83
7936345|NCT00527098|19531156|P1|STARTED|Overall Study||36
7936346|NCT00527072|19531161|P1|NOT COMPLETED|Overall Study||36
7936347|NCT00527072|19531161|P1|COMPLETED|Overall Study||179
7936348|NCT00527072|19531161|P1|STARTED|Overall Study||215
7936349|NCT00526994|19531170|P3|NOT COMPLETED|Overall Study||107
7936350|NCT00526994|19531171|P2|NOT COMPLETED|Overall Study||121
7936351|NCT00526994|19531172|P1|NOT COMPLETED|Overall Study||108
7936352|NCT00526994|19531170|P3|COMPLETED|Overall Study||791
7936353|NCT00526994|19531171|P2|COMPLETED|Overall Study||772
7936354|NCT00526994|19531172|P1|COMPLETED|Overall Study||801
7936355|NCT00526994|19531170|P3|STARTED|Overall Study||898
7936356|NCT00526994|19531171|P2|STARTED|Overall Study||893
7936357|NCT00526994|19531172|P1|STARTED|Overall Study||909
7936358|NCT00526890|19531189|P1|NOT COMPLETED|Overall Study||2
7936359|NCT00526890|19531189|P1|COMPLETED|Overall Study||14
7936360|NCT00526890|19531189|P1|STARTED|Overall Study||16
7936361|NCT00526799|19531201|P2|NOT COMPLETED|Overall Study||1
7936362|NCT00526799|19531202|P1|NOT COMPLETED|Overall Study||1
7936363|NCT00526799|19531201|P2|COMPLETED|Overall Study||13
7936364|NCT00526799|19531202|P1|COMPLETED|Overall Study||15
7936365|NCT00526799|19531201|P2|STARTED|Overall Study||14
7936366|NCT00526799|19531202|P1|STARTED|Overall Study||16
7936367|NCT00526669|19531210|P2|NOT COMPLETED|Combined Treatment Phase||8
7936368|NCT00526669|19531211|P1|NOT COMPLETED|Combined Treatment Phase||0
7936369|NCT00526669|19531210|P2|COMPLETED|Combined Treatment Phase||59
7936370|NCT00526669|19531211|P1|COMPLETED|Combined Treatment Phase||0
7936371|NCT00526669|19531210|P2|STARTED|Combined Treatment Phase||67
7936372|NCT00526669|19531211|P1|STARTED|Combined Treatment Phase||0
7936373|NCT00526669|19531210|P2|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
7936374|NCT00526669|19531211|P1|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
7936375|NCT00526669|19531210|P2|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
7936376|NCT00526669|19531211|P1|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67
7936377|NCT00526669|19531210|P2|STARTED|7-Day Run-in Monotherapy Treatment Phase||0
7936378|NCT00526669|19531211|P1|STARTED|7-Day Run-in Monotherapy Treatment Phase||67
7936379|NCT00526656|19531240|P1|NOT COMPLETED|Overall Study||2
7936381|NCT00526656|19531240|P1|STARTED|Overall Study||9
7936382|NCT00526630|19531246|P2|NOT COMPLETED|Second Intervention Period - 12 Weeks||1
7936383|NCT00526630|19531247|P1|NOT COMPLETED|Second Intervention Period - 12 Weeks||2
7936384|NCT00526630|19531246|P2|COMPLETED|Second Intervention Period - 12 Weeks||7
7936385|NCT00526630|19531247|P1|COMPLETED|Second Intervention Period - 12 Weeks||10
7936386|NCT00526630|19531246|P2|STARTED|Second Intervention Period - 12 Weeks||8
7936387|NCT00526630|19531247|P1|STARTED|Second Intervention Period - 12 Weeks||12
7936388|NCT00526630|19531246|P2|NOT COMPLETED|First Intervention Period - 12 Weeks||3
7936389|NCT00526630|19531247|P1|NOT COMPLETED|First Intervention Period - 12 Weeks||0
7936390|NCT00526630|19531246|P2|COMPLETED|First Intervention Period - 12 Weeks||8
7936391|NCT00526630|19531247|P1|COMPLETED|First Intervention Period - 12 Weeks||12
7936392|NCT00526630|19531246|P2|STARTED|First Intervention Period - 12 Weeks||11
7936393|NCT00526630|19531247|P1|STARTED|First Intervention Period - 12 Weeks||12
7936394|NCT00526591|19531277|P2|NOT COMPLETED|Overall Study||0
7936395|NCT00526591|19531278|P1|NOT COMPLETED|Overall Study||0
7936396|NCT00526591|19531277|P2|COMPLETED|Overall Study||9
7936397|NCT00526591|19531278|P1|COMPLETED|Overall Study||8
7936398|NCT00526591|19531277|P2|STARTED|Overall Study||9
7936399|NCT00526591|19531278|P1|STARTED|Overall Study||8
7936400|NCT00526474|19531290|P2|NOT COMPLETED|Overall Study||272
7936401|NCT00526474|19531291|P1|NOT COMPLETED|Overall Study||292
7936402|NCT00526474|19531290|P2|COMPLETED|Overall Study||12953
7936403|NCT00526474|19531291|P1|COMPLETED|Overall Study||12932
7936404|NCT00526474|19531290|P2|Received Study Drug|Overall Study||13186
7936405|NCT00526474|19531291|P1|Received Study Drug|Overall Study||13166
7936406|NCT00526474|19531290|P2|STARTED|Overall Study||13225
7936407|NCT00526474|19531291|P1|STARTED|Overall Study||13224
7936408|NCT00526331|19531359|P1|NOT COMPLETED|Overall Study||55
7936409|NCT00526331|19531359|P1|COMPLETED|Overall Study||0
7936410|NCT00526331|19531359|P1|STARTED|Overall Study||55
7936411|NCT00526292|19531363|P1|NOT COMPLETED|Overall Study||0
7936412|NCT00526292|19531363|P1|COMPLETED|Overall Study||6
7936413|NCT00526292|19531363|P1|STARTED|Overall Study||6
7936414|NCT00526227|19531367|P1|NOT COMPLETED|Overall Study||2
7936415|NCT00526227|19531367|P1|COMPLETED|Overall Study||79
7936416|NCT00526227|19531367|P1|STARTED|Overall Study||81
7936417|NCT00526188|19531374|P1|NOT COMPLETED|Overall Study||0
7936418|NCT00526188|19531374|P1|COMPLETED|Overall Study||234
7936419|NCT00526188|19531374|P1|STARTED|Overall Study||234
7936420|NCT00526162|19531380|P1|NOT COMPLETED|Overall Study||3
7936421|NCT00526162|19531380|P1|COMPLETED|Overall Study||80
7936422|NCT00526162|19531380|P1|STARTED|Overall Study||83
7936423|NCT00526123|19531390|P2|NOT COMPLETED|Overall Study||246
7936424|NCT00526123|19531391|P1|NOT COMPLETED|Overall Study||264
7936425|NCT00526123|19531390|P2|COMPLETED|Overall Study||50
7936426|NCT00526123|19531391|P1|COMPLETED|Overall Study||39
7936427|NCT00526123|19531390|P2|STARTED|Overall Study|Intent-to-Treat population|296
7936428|NCT00526123|19531391|P1|STARTED|Overall Study|Intent-to-Treat population|303
7936429|NCT00526110|19531413|P2|NOT COMPLETED|Overall Study||41
7936430|NCT00526110|19531414|P1|NOT COMPLETED|Overall Study||2
7936431|NCT00526110|19531413|P2|COMPLETED|Overall Study||4
7936432|NCT00526110|19531414|P1|COMPLETED|Overall Study||51
7936433|NCT00526110|19531413|P2|STARTED|Overall Study||45
7936434|NCT00526110|19531414|P1|STARTED|Overall Study||53
7936435|NCT00526097|19531423|P2|NOT COMPLETED|Overall Study||56
7936436|NCT00526097|19531424|P1|NOT COMPLETED|Overall Study||15
7936437|NCT00526097|19531423|P2|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191
7936438|NCT00526097|19531424|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106
7936439|NCT00526097|19531423|P2|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247
7936440|NCT00526097|19531424|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121
7936441|NCT00526071|19531600|P1|NOT COMPLETED|Overall Study||6
7936442|NCT00526071|19531600|P1|COMPLETED|Overall Study||17
7936443|NCT00526071|19531600|P1|Non-amenable Population; Women|Overall Study||4
7936444|NCT00526071|19531600|P1|Non-amenable Population; Men|Overall Study||3
7936445|NCT00526071|19531600|P1|Amenable Population; Women|Overall Study||5
7936446|NCT00526071|19531600|P1|Amenable Population; Men|Overall Study||11
7936447|NCT00526071|19531600|P1|Pharmacodynamic (PD) Population|Overall Study||23
7936448|NCT00526071|19531600|P1|Safety Population|Overall Study||23
7936449|NCT00526071|19531600|P1|STARTED|Overall Study||23
7936450|NCT00526058|19531611|P2|NOT COMPLETED|Period: Second Intervention||0
7936451|NCT00526058|19531612|P1|NOT COMPLETED|Period: Second Intervention||0
7936452|NCT00526058|19531611|P2|COMPLETED|Period: Second Intervention||9
7936453|NCT00526058|19531612|P1|COMPLETED|Period: Second Intervention||9
7936454|NCT00526058|19531611|P2|STARTED|Period: Second Intervention||9
7936455|NCT00526058|19531612|P1|STARTED|Period: Second Intervention||9
7936456|NCT00526058|19531611|P2|NOT COMPLETED|Period: First Intervention||0
7936457|NCT00526058|19531612|P1|NOT COMPLETED|Period: First Intervention||0
7936458|NCT00526058|19531611|P2|COMPLETED|Period: First Intervention||9
7936459|NCT00526058|19531612|P1|COMPLETED|Period: First Intervention||9
7936460|NCT00526058|19531611|P2|STARTED|Period: First Intervention||9
7936461|NCT00526058|19531612|P1|STARTED|Period: First Intervention||9
7936462|NCT00525915|19531626|P2|NOT COMPLETED|Overall Study||9
7936463|NCT00525915|19531627|P1|NOT COMPLETED|Overall Study||8
7936464|NCT00525915|19531626|P2|COMPLETED|Overall Study||54
7936465|NCT00525915|19531627|P1|COMPLETED|Overall Study|Participants who underwent surgery.|55
7936466|NCT00525915|19531626|P2|STARTED|Overall Study||63
7936467|NCT00525915|19531627|P1|STARTED|Overall Study||63
7936468|NCT00525902|19531633|P1|NOT COMPLETED|Overall Study||1
7936469|NCT00525902|19531633|P1|COMPLETED|Overall Study||30
7936470|NCT00525902|19531633|P1|50 Weeks|Overall Study||12
7936471|NCT00525902|19531633|P1|10 Weeks|Overall Study||30
7936472|NCT00525902|19531633|P1|STARTED|Overall Study||31
7936473|NCT00525876|19531640|P2|NOT COMPLETED|Overall Study||0
7936474|NCT00525876|19531641|P1|NOT COMPLETED|Overall Study||0
7936475|NCT00525876|19531640|P2|COMPLETED|Overall Study||20
7936476|NCT00525876|19531641|P1|COMPLETED|Overall Study||16
7936477|NCT00525876|19531640|P2|STARTED|Overall Study||20
7936478|NCT00525876|19531641|P1|STARTED|Overall Study||16
7936479|NCT00525837|19531647|P1|NOT COMPLETED|Overall Study||4
7936480|NCT00525837|19531647|P1|COMPLETED|Overall Study||14
7936481|NCT00525837|19531647|P1|STARTED|Overall Study||18
7936482|NCT00525824|19531657|P4|NOT COMPLETED|Overall Study||15
7936483|NCT00525824|19531658|P3|NOT COMPLETED|Overall Study||19
7936484|NCT00525824|19531659|P2|NOT COMPLETED|Overall Study||28
7936485|NCT00525824|19531660|P1|NOT COMPLETED|Overall Study||19
7936486|NCT00525824|19531657|P4|COMPLETED|Overall Study||188
7936487|NCT00525824|19531658|P3|COMPLETED|Overall Study||183
7936488|NCT00525824|19531659|P2|COMPLETED|Overall Study||186
7936489|NCT00525824|19531660|P1|COMPLETED|Overall Study||195
7936490|NCT00525824|19531657|P4|STARTED|Overall Study|Randomized population|203
7936491|NCT00525824|19531658|P3|STARTED|Overall Study|Randomized population|202
7936492|NCT00525824|19531659|P2|STARTED|Overall Study|Randomized population|214
7936493|NCT00525824|19531660|P1|STARTED|Overall Study|Randomized population|214
7936494|NCT00525798|19531724|P2|NOT COMPLETED|Overall Study||599
7936495|NCT00525798|19531725|P1|NOT COMPLETED|Overall Study||756
7936496|NCT00525798|19531724|P2|COMPLETED|Overall Study||1732
7936497|NCT00525798|19531725|P1|COMPLETED|Overall Study||1578
7936498|NCT00525798|19531724|P2|STARTED|Overall Study||2331
7936499|NCT00525798|19531725|P1|STARTED|Overall Study||2334
7936500|NCT00525785|19531733|P1|NOT COMPLETED|Overall Study||3
7936501|NCT00525785|19531733|P1|COMPLETED|Overall Study||55
7936502|NCT00525785|19531733|P1|STARTED|Overall Study||58
7936503|NCT00525733|19531739|P2|NOT COMPLETED|Overall Study||3
7936504|NCT00525733|19531740|P1|NOT COMPLETED|Overall Study||3
7936505|NCT00525733|19531739|P2|COMPLETED|Overall Study||23
7936506|NCT00525733|19531740|P1|COMPLETED|Overall Study||11
7936507|NCT00525733|19531739|P2|STARTED|Overall Study||26
7936508|NCT00525733|19531740|P1|STARTED|Overall Study||14
7936509|NCT00525629|19531746|P2|NOT COMPLETED|Second Intervention||15
7936510|NCT00525629|19531747|P1|NOT COMPLETED|Second Intervention||15
7936511|NCT00525629|19531746|P2|COMPLETED|Second Intervention||0
7936512|NCT00525629|19531747|P1|COMPLETED|Second Intervention||0
7936513|NCT00525629|19531746|P2|STARTED|Second Intervention||15
7936514|NCT00525629|19531747|P1|STARTED|Second Intervention||15
7936515|NCT00525629|19531746|P2|NOT COMPLETED|Washout||0
7936516|NCT00525629|19531747|P1|NOT COMPLETED|Washout||0
7936517|NCT00525629|19531746|P2|COMPLETED|Washout||15
7936518|NCT00525629|19531747|P1|COMPLETED|Washout||15
7936519|NCT00525629|19531746|P2|STARTED|Washout||15
7936520|NCT00525629|19531747|P1|STARTED|Washout||15
7936521|NCT00525629|19531746|P2|NOT COMPLETED|First Intervention||5
7936522|NCT00525629|19531747|P1|NOT COMPLETED|First Intervention||5
7936523|NCT00525629|19531746|P2|COMPLETED|First Intervention||15
7936524|NCT00525629|19531747|P1|COMPLETED|First Intervention||15
7936525|NCT00525629|19531746|P2|STARTED|First Intervention||20
7936526|NCT00525629|19531747|P1|STARTED|First Intervention||20
7936527|NCT00525603|19531753|P1|NOT COMPLETED|Overall Study||0
7936528|NCT00525603|19531753|P1|COMPLETED|Overall Study||60
7936529|NCT00525603|19531753|P1|STARTED|Overall Study||60
7936530|NCT00525590|19531757|P1|NOT COMPLETED|Overall Study||45
7936531|NCT00525590|19531757|P1|COMPLETED|Overall Study||14
7936532|NCT00525590|19531757|P1|STARTED|Overall Study||59
7936533|NCT00525525|19531775|P2|NOT COMPLETED|Overall Study||0
7936534|NCT00525525|19531776|P1|NOT COMPLETED|Overall Study||0
7936535|NCT00525525|19531775|P2|COMPLETED|Overall Study||15
7936536|NCT00525525|19531776|P1|COMPLETED|Overall Study||59
7936537|NCT00525525|19531775|P2|STARTED|Overall Study||15
7936538|NCT00525525|19531776|P1|STARTED|Overall Study||59
7936539|NCT00525512|19531785|P4|NOT COMPLETED|Open-Label Phase||5
7936540|NCT00525512|19531786|P3|NOT COMPLETED|Open-Label Phase||6
7936541|NCT00525512|19531787|P2|NOT COMPLETED|Open-Label Phase||0
7936542|NCT00525512|19531788|P1|NOT COMPLETED|Open-Label Phase||0
7936543|NCT00525512|19531785|P4|COMPLETED|Open-Label Phase||189
7936544|NCT00525512|19531786|P3|COMPLETED|Open-Label Phase||158
7936545|NCT00525512|19531787|P2|COMPLETED|Open-Label Phase||0
7936546|NCT00525512|19531788|P1|COMPLETED|Open-Label Phase||0
7936547|NCT00525512|19531785|P4|STARTED|Open-Label Phase||194
7936548|NCT00525512|19531786|P3|STARTED|Open-Label Phase||164
7936549|NCT00525512|19531787|P2|STARTED|Open-Label Phase||0
7936550|NCT00525512|19531788|P1|STARTED|Open-Label Phase||0
7936551|NCT00525512|19531785|P4|NOT COMPLETED|Double-Blind Phase||0
7936552|NCT00525512|19531786|P3|NOT COMPLETED|Double-Blind Phase||0
7936553|NCT00525512|19531787|P2|NOT COMPLETED|Double-Blind Phase||66
7936554|NCT00525512|19531788|P1|NOT COMPLETED|Double-Blind Phase||96
7936555|NCT00525512|19531785|P4|COMPLETED|Double-Blind Phase||0
7936556|NCT00525512|19531786|P3|COMPLETED|Double-Blind Phase||0
7936557|NCT00525512|19531787|P2|COMPLETED|Double-Blind Phase||194
7936558|NCT00525512|19531788|P1|COMPLETED|Double-Blind Phase||163
7936559|NCT00525512|19531785|P4|STARTED|Double-Blind Phase||0
7936560|NCT00525512|19531786|P3|STARTED|Double-Blind Phase||0
7936561|NCT00525512|19531787|P2|STARTED|Double-Blind Phase||260
7936562|NCT00525512|19531788|P1|STARTED|Double-Blind Phase||259
7936563|NCT00525499|19531930|P4|NOT COMPLETED|Overall Study||7
7936564|NCT00525499|19531931|P3|NOT COMPLETED|Overall Study||7
7936565|NCT00525499|19531932|P2|NOT COMPLETED|Overall Study||7
7936566|NCT00525499|19531933|P1|NOT COMPLETED|Overall Study||7
7936567|NCT00525499|19531930|P4|COMPLETED|Overall Study||39
7936568|NCT00525499|19531931|P3|COMPLETED|Overall Study||40
7936569|NCT00525499|19531932|P2|COMPLETED|Overall Study||39
7936570|NCT00525499|19531933|P1|COMPLETED|Overall Study||40
7936571|NCT00525499|19531930|P4|STARTED|Overall Study||46
7936572|NCT00525499|19531931|P3|STARTED|Overall Study||47
7936573|NCT00525499|19531932|P2|STARTED|Overall Study||46
7936574|NCT00525499|19531933|P1|STARTED|Overall Study||47
7936575|NCT00525421|19531949|P2|NOT COMPLETED|Overall Study||0
7936576|NCT00525421|19531950|P1|NOT COMPLETED|Overall Study||0
7936577|NCT00525421|19531949|P2|COMPLETED|Overall Study||10
7936578|NCT00525421|19531950|P1|COMPLETED|Overall Study||10
7936579|NCT00525421|19531949|P2|STARTED|Overall Study||10
7936580|NCT00525421|19531950|P1|STARTED|Overall Study|Enrollment started october 2007|10
7936581|NCT00525265|19531960|P2|NOT COMPLETED|Overall Study||0
7936582|NCT00525265|19531961|P1|NOT COMPLETED|Overall Study||1
7936583|NCT00525265|19531960|P2|COMPLETED|Overall Study||10
7936584|NCT00525265|19531961|P1|COMPLETED|Overall Study||9
7936585|NCT00525265|19531960|P2|STARTED|Overall Study||10
7936586|NCT00525265|19531961|P1|STARTED|Overall Study||10
7936587|NCT00525174|19531969|P2|NOT COMPLETED|Overall Study||8
7936588|NCT00525174|19531970|P1|NOT COMPLETED|Overall Study||9
7936589|NCT00525174|19531969|P2|COMPLETED|Overall Study||81
7936590|NCT00525174|19531970|P1|COMPLETED|Overall Study||88
7936591|NCT00525174|19531969|P2|STARTED|Overall Study||89
7936592|NCT00525174|19531970|P1|STARTED|Overall Study||97
7936593|NCT00525161|19532018|P1|NOT COMPLETED|Overall Study||1
7936594|NCT00525161|19532018|P1|COMPLETED|Overall Study||10
7936595|NCT00525161|19532018|P1|STARTED|Overall Study||11
7936596|NCT00525148|19532028|P4|NOT COMPLETED|Overall Study||61
7936597|NCT00525148|19532029|P3|NOT COMPLETED|Overall Study||7
7936598|NCT00525148|19532030|P2|NOT COMPLETED|Overall Study||38
7936599|NCT00525148|19532031|P1|NOT COMPLETED|Overall Study||23
7936600|NCT00525148|19532028|P4|COMPLETED|Overall Study||0
7936601|NCT00525148|19532029|P3|COMPLETED|Overall Study||0
7936602|NCT00525148|19532030|P2|COMPLETED|Overall Study||0
7936603|NCT00525148|19532031|P1|COMPLETED|Overall Study||0
7936604|NCT00525148|19532028|P4|STARTED|Overall Study|entered and treated|61
7936605|NCT00525148|19532029|P3|STARTED|Overall Study|entered and treated|7
7936606|NCT00525148|19532030|P2|STARTED|Overall Study|entered and treated|38
7936607|NCT00525148|19532031|P1|STARTED|Overall Study|entered and treated|23
7936608|NCT00525135|19532049|P1|NOT COMPLETED|Overall Study||0
7936609|NCT00525135|19532049|P1|COMPLETED|Overall Study||5
7936610|NCT00525135|19532049|P1|STARTED|Overall Study||5
7936611|NCT00525044|19532059|P2|NOT COMPLETED|Overall Study||1
7936612|NCT00525044|19532060|P1|NOT COMPLETED|Overall Study||0
7936613|NCT00525044|19532059|P2|COMPLETED|Overall Study||124
7936614|NCT00525044|19532060|P1|COMPLETED|Overall Study||124
7936615|NCT00525044|19532059|P2|STARTED|Overall Study||125
7936616|NCT00525044|19532060|P1|STARTED|Overall Study||124
7936617|NCT00525031|19532076|P2|NOT COMPLETED|Overall Study||1
7936618|NCT00525031|19532077|P1|NOT COMPLETED|Overall Study||1
7936619|NCT00525031|19532076|P2|COMPLETED|Overall Study||24
7936620|NCT00525031|19532077|P1|COMPLETED|Overall Study||26
7936621|NCT00525031|19532076|P2|STARTED|Overall Study||25
7936622|NCT00525031|19532077|P1|STARTED|Overall Study||27
7936623|NCT00524940|19532084|P1|NOT COMPLETED|Overall Study||0
7936624|NCT00524940|19532084|P1|COMPLETED|Overall Study||124
7936625|NCT00524940|19532084|P1|STARTED|Overall Study||124
7936626|NCT00524771|19532091|P2|NOT COMPLETED|Overall Study||585
7936627|NCT00524771|19532092|P1|NOT COMPLETED|Overall Study||220
7936628|NCT00524771|19532091|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431
7936629|NCT00524771|19532092|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864
7936630|NCT00524771|19532091|P2|STARTED|Overall Study||17016
7936631|NCT00524771|19532092|P1|STARTED|Overall Study||17084
7936632|NCT00524745|19532106|P4|NOT COMPLETED|Overall Study||22
7936633|NCT00524745|19532107|P3|NOT COMPLETED|Overall Study||29
7936634|NCT00524745|19532108|P2|NOT COMPLETED|Overall Study||13
7936635|NCT00524745|19532109|P1|NOT COMPLETED|Overall Study||34
7936636|NCT00524745|19532106|P4|COMPLETED|Overall Study||205
7936637|NCT00524745|19532107|P3|COMPLETED|Overall Study||212
7936638|NCT00524745|19532108|P2|COMPLETED|Overall Study||193
7936639|NCT00524745|19532109|P1|COMPLETED|Overall Study||195
7936640|NCT00524745|19532106|P4|STARTED|Overall Study||227
7936641|NCT00524745|19532107|P3|STARTED|Overall Study||241
7936642|NCT00524745|19532108|P2|STARTED|Overall Study||206
7936643|NCT00524745|19532109|P1|STARTED|Overall Study||229
7936644|NCT00524680|19532135|P4|NOT COMPLETED|Overall Study||6
7936645|NCT00524680|19532136|P3|NOT COMPLETED|Overall Study||3
7936646|NCT00524680|19532137|P2|NOT COMPLETED|Overall Study||1
7936647|NCT00524680|19532138|P1|NOT COMPLETED|Overall Study||3
7936648|NCT00524680|19532135|P4|COMPLETED|Overall Study||34
7936649|NCT00524680|19532136|P3|COMPLETED|Overall Study||33
7936650|NCT00524680|19532137|P2|COMPLETED|Overall Study||34
7936651|NCT00524680|19532138|P1|COMPLETED|Overall Study||34
7936652|NCT00524680|19532135|P4|STARTED|Overall Study||40
7936653|NCT00524680|19532136|P3|STARTED|Overall Study||36
7936654|NCT00524680|19532137|P2|STARTED|Overall Study||35
7936655|NCT00524680|19532138|P1|STARTED|Overall Study||37
7936656|NCT00524589|19532160|P1|NOT COMPLETED|Overall Study||18
7936657|NCT00524589|19532160|P1|COMPLETED|Overall Study||0
7936658|NCT00524589|19532160|P1|STARTED|Overall Study||18
7936659|NCT00524576|19532167|P2|NOT COMPLETED|Overall Study||0
7936660|NCT00524576|19532168|P1|NOT COMPLETED|Overall Study||0
7936661|NCT00524576|19532167|P2|COMPLETED|Overall Study||47
7936662|NCT00524576|19532168|P1|COMPLETED|Overall Study||97
7936663|NCT00524576|19532167|P2|STARTED|Overall Study||47
7936664|NCT00524576|19532168|P1|STARTED|Overall Study||97
7936665|NCT00524537|19532186|P1|NOT COMPLETED|Overall Study||2574
7936666|NCT00524537|19532186|P1|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451
7936667|NCT00524537|19532186|P1|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102
7936668|NCT00524537|19532186|P1|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339
7936669|NCT00524537|19532186|P1|Discontinued|Overall Study|Discontinued from study|2811
7936670|NCT00524537|19532186|P1|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025
7936671|NCT00524511|19532202|P2|NOT COMPLETED|Overall Study||7
7936672|NCT00524511|19532203|P1|NOT COMPLETED|Overall Study||4
7936673|NCT00524511|19532202|P2|COMPLETED|Overall Study||61
7936674|NCT00524511|19532203|P1|COMPLETED|Overall Study||64
7936675|NCT00524511|19532202|P2|STARTED|Overall Study||68
7936676|NCT00524511|19532203|P1|STARTED|Overall Study||68
7936677|NCT00524485|19532211|P1|NOT COMPLETED|Overall Study||5
7936678|NCT00524485|19532211|P1|COMPLETED|Overall Study||7
7936679|NCT00524485|19532211|P1|STARTED|Overall Study||12
7936680|NCT00524472|19532223|P2|NOT COMPLETED|Overall Study||0
7936681|NCT00524472|19532224|P1|NOT COMPLETED|Overall Study||0
7936682|NCT00524472|19532223|P2|COMPLETED|Overall Study||730
7936683|NCT00524472|19532224|P1|COMPLETED|Overall Study||709
7936684|NCT00524472|19532223|P2|STARTED|Overall Study||730
7936685|NCT00524472|19532224|P1|STARTED|Overall Study||709
7936686|NCT00524459|19532240|P1|NOT COMPLETED|Overall Study||2
7936687|NCT00524459|19532240|P1|COMPLETED|Overall Study||4
7936688|NCT00524459|19532240|P1|STARTED|Overall Study||6
7936689|NCT00524420|19532250|P2|NOT COMPLETED|Overall Study||0
7936690|NCT00524420|19532251|P1|NOT COMPLETED|Overall Study||1
7936691|NCT00524420|19532250|P2|COMPLETED|Overall Study||11
7936692|NCT00524420|19532251|P1|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7
7936693|NCT00524420|19532250|P2|STARTED|Overall Study||11
7936694|NCT00524420|19532251|P1|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8
7936695|NCT00524394|19532263|P1|NOT COMPLETED|Overall Study||1
7936696|NCT00524394|19532263|P1|COMPLETED|Overall Study||1
7936697|NCT00524394|19532263|P1|STARTED|Overall Study||2
7936698|NCT00524368|19532269|P2|NOT COMPLETED|Overall Study||48
7936699|NCT00524368|19532270|P1|NOT COMPLETED|Overall Study||41
7936700|NCT00524368|19532269|P2|COMPLETED|Overall Study||248
7936701|NCT00524368|19532270|P1|COMPLETED|Overall Study||253
7936702|NCT00524368|19532269|P2|STARTED|Overall Study||296
7936703|NCT00524368|19532270|P1|STARTED|Overall Study||294
7936704|NCT00524342|19532298|P1|NOT COMPLETED|Overall Study||0
7936705|NCT00524342|19532298|P1|COMPLETED|Overall Study||7
7936706|NCT00524342|19532298|P1|STARTED|Overall Study||7
7936707|NCT00524316|19532304|P1|NOT COMPLETED|Overall Study||16
7936708|NCT00524316|19532304|P1|COMPLETED|Overall Study||0
7936709|NCT00524316|19532304|P1|STARTED|Overall Study||16
7936710|NCT00524303|19532316|P3|NOT COMPLETED|Overall Study||18
7936711|NCT00524303|19532317|P2|NOT COMPLETED|Overall Study||10
7936712|NCT00524303|19532318|P1|NOT COMPLETED|Overall Study||12
7936713|NCT00524303|19532316|P3|COMPLETED|Overall Study||15
7936714|NCT00524303|19532317|P2|COMPLETED|Overall Study||24
7936715|NCT00524303|19532318|P1|COMPLETED|Overall Study||21
7936716|NCT00524303|19532316|P3|STARTED|Overall Study||33
7936717|NCT00524303|19532317|P2|STARTED|Overall Study||34
7936718|NCT00524303|19532318|P1|STARTED|Overall Study||33
7936719|NCT00524264|19532348|P2|NOT COMPLETED|Overall Study||27
7936720|NCT00524264|19532349|P1|NOT COMPLETED|Overall Study||20
7936721|NCT00524264|19532348|P2|COMPLETED|Overall Study||57
7936722|NCT00524264|19532349|P1|COMPLETED|Overall Study||144
7936723|NCT00524264|19532348|P2|STARTED|Overall Study||84
7936724|NCT00524264|19532349|P1|STARTED|Overall Study||164
7936725|NCT00524225|19532361|P1|NOT COMPLETED|Overall Study||0
7936726|NCT00524225|19532361|P1|COMPLETED|Overall Study||3
7936727|NCT00524225|19532361|P1|STARTED|Overall Study||3
7936728|NCT00524173|19532370|P2|NOT COMPLETED|Overall Study||2
7936729|NCT00524173|19532371|P1|NOT COMPLETED|Overall Study||5
7936730|NCT00524173|19532370|P2|COMPLETED|Overall Study||13
7936731|NCT00524173|19532371|P1|COMPLETED|Overall Study||12
7936732|NCT00524173|19532370|P2|STARTED|Overall Study||15
7936733|NCT00524173|19532371|P1|STARTED|Overall Study||17
7936734|NCT00524134|19532383|P1|NOT COMPLETED|Overall Study||2
7936735|NCT00524134|19532383|P1|COMPLETED|Overall Study||4
7936736|NCT00524134|19532383|P1|STARTED|Overall Study||6
7936737|NCT00524121|19532390|P1|NOT COMPLETED|Overall Study||19
7936738|NCT00524121|19532390|P1|COMPLETED|Overall Study||3
7936739|NCT00524121|19532390|P1|STARTED|Overall Study||22
7936740|NCT00524043|19532410|P3|NOT COMPLETED|Overall Study||31
7936741|NCT00524043|19532411|P2|NOT COMPLETED|Overall Study||28
7936742|NCT00524043|19532412|P1|NOT COMPLETED|Overall Study||30
7936743|NCT00524043|19532410|P3|COMPLETED|Overall Study||35
7936744|NCT00524043|19532411|P2|COMPLETED|Overall Study||42
7936745|NCT00524043|19532412|P1|COMPLETED|Overall Study||34
7936746|NCT00524043|19532410|P3|STARTED|Overall Study||66
7936747|NCT00524043|19532411|P2|STARTED|Overall Study||70
7936748|NCT00524043|19532412|P1|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64
7936749|NCT00524030|19532434|P2|NOT COMPLETED|Overall Study||59
7936750|NCT00524030|19532435|P1|NOT COMPLETED|Overall Study||17
7936751|NCT00524030|19532434|P2|COMPLETED|Overall Study||70
7936752|NCT00524030|19532435|P1|COMPLETED|Overall Study||15
7936753|NCT00524030|19532434|P2|Completed Taper/Titration Phase|Overall Study||70
7936754|NCT00524030|19532435|P1|Completed Taper/Titration Phase|Overall Study||15
7936755|NCT00524030|19532434|P2|Completed Double-Blind Treatment Phase|Overall Study||70
7936756|NCT00524030|19532435|P1|Completed Double-Blind Treatment Phase|Overall Study||15
7936757|NCT00524030|19532434|P2|STARTED|Overall Study||129
7936758|NCT00524030|19532435|P1|STARTED|Overall Study||32
7936759|NCT00524017|19532455|P2|NOT COMPLETED|Overall Study||1
7936760|NCT00524017|19532456|P1|NOT COMPLETED|Overall Study||0
7936761|NCT00524017|19532455|P2|COMPLETED|Overall Study||5
7936762|NCT00524017|19532456|P1|COMPLETED|Overall Study||13
7936763|NCT00524017|19532455|P2|STARTED|Overall Study||6
7936764|NCT00524017|19532456|P1|STARTED|Overall Study||13
7936765|NCT00523991|19532474|P2|NOT COMPLETED|Overall Study||27
7936766|NCT00523991|19532475|P1|NOT COMPLETED|Overall Study||21
7936767|NCT00523991|19532474|P2|COMPLETED|Overall Study||211
7936768|NCT00523991|19532475|P1|COMPLETED|Overall Study||198
7936769|NCT00523991|19532474|P2|STARTED|Overall Study||238
7936770|NCT00523991|19532475|P1|STARTED|Overall Study||219
7936771|NCT00523978|19532755|P2|NOT COMPLETED|Overall Study||8
7936772|NCT00523978|19532756|P1|NOT COMPLETED|Overall Study||9
7936773|NCT00523978|19532755|P2|COMPLETED|Overall Study||79
7936774|NCT00523978|19532756|P1|COMPLETED|Overall Study||162
7936775|NCT00523978|19532755|P2|STARTED|Overall Study||87
7936776|NCT00523978|19532756|P1|STARTED|Overall Study||171
7936777|NCT00523939|19532770|P2|NOT COMPLETED|Overall Study||0
7936778|NCT00523939|19532771|P1|NOT COMPLETED|Overall Study||0
7936779|NCT00523939|19532770|P2|COMPLETED|Overall Study||2
7936780|NCT00523939|19532771|P1|COMPLETED|Overall Study||2
7936781|NCT00523939|19532770|P2|STARTED|Overall Study||2
7936782|NCT00523939|19532771|P1|STARTED|Overall Study||2
7936783|NCT00523848|19532778|P1|NOT COMPLETED|Overall Study||24
7936784|NCT00523848|19532778|P1|COMPLETED|Overall Study||22
7936785|NCT00523848|19532778|P1|Treated With Study Therapy|Overall Study||44
7936786|NCT00523848|19532778|P1|STARTED|Overall Study||46
7936787|NCT00523809|19532784|P1|NOT COMPLETED|Overall Study||0
7936788|NCT00523809|19532784|P1|COMPLETED|Overall Study||5
7936789|NCT00523809|19532784|P1|STARTED|Overall Study||5
7936790|NCT00523744|19532788|P1|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0
7936791|NCT00523744|19532788|P1|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91
7936792|NCT00523744|19532788|P1|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91
7936793|NCT00523744|19532788|P1|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3
7936794|NCT00523744|19532788|P1|COMPLETED|Phase 2 - Amlodipine+Valsartan||173
7936795|NCT00523744|19532788|P1|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176
7936796|NCT00523744|19532788|P1|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6
7936797|NCT00523744|19532788|P1|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251
7936798|NCT00523744|19532788|P1|STARTED|Phase 1 - Amlodipine+Olmesartan||257
7936799|NCT00523718|19532807|P2|NOT COMPLETED|Overall Study||0
7936800|NCT00523718|19532808|P1|NOT COMPLETED|Overall Study||3
7936801|NCT00523718|19532807|P2|COMPLETED|Overall Study||18
7936802|NCT00523718|19532808|P1|COMPLETED|Overall Study||17
7936803|NCT00523718|19532807|P2|STARTED|Overall Study||18
7936804|NCT00523718|19532808|P1|STARTED|Overall Study||20
7936805|NCT00523705|19532822|P2|NOT COMPLETED|Overall Study||1
7936806|NCT00523705|19532823|P1|NOT COMPLETED|Overall Study||0
7936807|NCT00523705|19532822|P2|COMPLETED|Overall Study|1 withdrew due to no time|3
7936808|NCT00523705|19532823|P1|COMPLETED|Overall Study||7
7936809|NCT00523705|19532822|P2|STARTED|Overall Study||4
7936810|NCT00523705|19532823|P1|STARTED|Overall Study||7
7936811|NCT00523640|19532835|P1|NOT COMPLETED|Overall Study||1
7936812|NCT00523640|19532835|P1|COMPLETED|Overall Study|1 patient died before starting treatment|29
7936813|NCT00523640|19532835|P1|STARTED|Overall Study||30
7936814|NCT00523614|19532843|P2|NOT COMPLETED|Overall Study||0
7936815|NCT00523614|19532844|P1|NOT COMPLETED|Overall Study||0
7936816|NCT00523614|19532843|P2|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
7936817|NCT00523614|19532844|P1|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
7936818|NCT00523614|19532843|P2|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
7936819|NCT00523614|19532844|P1|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
7936820|NCT00523549|19532852|P2|NOT COMPLETED|Overall Study||16
7936821|NCT00523549|19532853|P1|NOT COMPLETED|Overall Study||19
7936822|NCT00523549|19532852|P2|COMPLETED|Overall Study||99
7936823|NCT00523549|19532853|P1|COMPLETED|Overall Study||95
7936824|NCT00523549|19532852|P2|STARTED|Overall Study||115
7936825|NCT00523549|19532853|P1|STARTED|Overall Study||114
7936826|NCT00523419|19532871|P1|NOT COMPLETED|Overall Study||32
7936827|NCT00523419|19532871|P1|COMPLETED|Overall Study||0
7936828|NCT00523419|19532871|P1|STARTED|Overall Study||32
7936829|NCT00523367|19532881|P1|NOT COMPLETED|Overall Study||23
7936830|NCT00523367|19532881|P1|COMPLETED|Overall Study||2
7936831|NCT00523367|19532881|P1|STARTED|Overall Study||25
7936832|NCT00523341|19532887|P2|NOT COMPLETED|Overall Study||1000
7936833|NCT00523341|19532888|P1|NOT COMPLETED|Overall Study||924
7936834|NCT00523341|19532887|P2|COMPLETED|Overall Study||1343
7936835|NCT00523341|19532888|P1|COMPLETED|Overall Study||1283
7936836|NCT00523341|19532887|P2|Received Treatment|Overall Study||2343
7936837|NCT00523341|19532888|P1|Received Treatment|Overall Study||2206
7936838|NCT00523341|19532887|P2|STARTED|Overall Study||2343
7936839|NCT00523341|19532888|P1|STARTED|Overall Study||2207
7936840|NCT00523302|19532990|P2|NOT COMPLETED|Overall Study||0
7936841|NCT00523302|19532991|P1|NOT COMPLETED|Overall Study||0
7936842|NCT00523302|19532990|P2|COMPLETED|Overall Study||10
7936843|NCT00523302|19532991|P1|COMPLETED|Overall Study||10
7936844|NCT00523302|19532990|P2|STARTED|Overall Study||10
7936845|NCT00523302|19532991|P1|STARTED|Overall Study||10
7936846|NCT00523237|19533001|P1|NOT COMPLETED|Overall Study||0
7936847|NCT00523237|19533001|P1|COMPLETED|Overall Study||14
7936848|NCT00523237|19533001|P1|STARTED|Overall Study||14
7936849|NCT00522951|19533005|P2|NOT COMPLETED|Period 2||1
7936850|NCT00522951|19533006|P1|NOT COMPLETED|Period 2||2
7936851|NCT00522951|19533005|P2|COMPLETED|Period 2||75
7936852|NCT00522951|19533006|P1|COMPLETED|Period 2||84
7936853|NCT00522951|19533005|P2|Subjects Received Treatment|Period 2||75
7936854|NCT00522951|19533006|P1|Subjects Received Treatment|Period 2||84
7936855|NCT00522951|19533005|P2|STARTED|Period 2||76
7936856|NCT00522951|19533006|P1|STARTED|Period 2||86
7936857|NCT00522951|19533005|P2|NOT COMPLETED|Washout Period||2
7936858|NCT00522951|19533006|P1|NOT COMPLETED|Washout Period||0
7936859|NCT00522951|19533005|P2|COMPLETED|Washout Period||76
7936860|NCT00522951|19533006|P1|COMPLETED|Washout Period||86
7936861|NCT00522951|19533005|P2|STARTED|Washout Period||78
7936862|NCT00522951|19533006|P1|STARTED|Washout Period||86
7936863|NCT00522951|19533005|P2|NOT COMPLETED|Period 1||1
7936864|NCT00522951|19533006|P1|NOT COMPLETED|Period 1||0
7936865|NCT00522951|19533005|P2|COMPLETED|Period 1||78
7936866|NCT00522951|19533006|P1|COMPLETED|Period 1||86
7936867|NCT00522951|19533005|P2|Received Treatment|Period 1||78
7936868|NCT00522951|19533006|P1|Received Treatment|Period 1||86
7936869|NCT00522951|19533005|P2|STARTED|Period 1||79
7936870|NCT00522951|19533006|P1|STARTED|Period 1||86
7936871|NCT00522925|19533049|P3|NOT COMPLETED|Overall Study||2
7936872|NCT00522925|19533050|P2|NOT COMPLETED|Overall Study||1
7936873|NCT00522925|19533051|P1|NOT COMPLETED|Overall Study||8
7936874|NCT00522925|19533049|P3|COMPLETED|Overall Study||36
7936875|NCT00522925|19533050|P2|COMPLETED|Overall Study||38
7936876|NCT00522925|19533051|P1|COMPLETED|Overall Study||28
7936877|NCT00522925|19533049|P3|STARTED|Overall Study||38
7936878|NCT00522925|19533050|P2|STARTED|Overall Study||39
7936879|NCT00522925|19533051|P1|STARTED|Overall Study||36
7936880|NCT00522873|19533061|P2|NOT COMPLETED|Overall Study||44
7936881|NCT00522873|19533062|P1|NOT COMPLETED|Overall Study||96
7936882|NCT00522873|19533061|P2|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128
7936883|NCT00522873|19533062|P1|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394
7936884|NCT00522873|19533061|P2|Received Treatment|Overall Study||172
7936885|NCT00522873|19533062|P1|Received Treatment|Overall Study||489
7936886|NCT00522873|19533061|P2|STARTED|Overall Study||172
7936887|NCT00522873|19533062|P1|STARTED|Overall Study||490
7936888|NCT00522795|19533071|P1|NOT COMPLETED|Overall Study||0
7936889|NCT00522795|19533071|P1|COMPLETED|Overall Study||40
7936890|NCT00522795|19533071|P1|STARTED|Overall Study||40
7936891|NCT00522626|19533075|P1|NOT COMPLETED|Overall Study||7
7936892|NCT00522626|19533075|P1|COMPLETED|Overall Study||12
7936893|NCT00522626|19533075|P1|STARTED|Overall Study||19
7936894|NCT00522548|19533081|P2|NOT COMPLETED|Overall Study||4
7936895|NCT00522548|19533082|P1|NOT COMPLETED|Overall Study||2
7936896|NCT00522548|19533081|P2|COMPLETED|Overall Study||15
7936897|NCT00522548|19533082|P1|COMPLETED|Overall Study||16
7936898|NCT00522548|19533081|P2|Completed 2/2 PK Visits|Overall Study||5
7936899|NCT00522548|19533082|P1|Completed 2/2 PK Visits|Overall Study||7
7936900|NCT00522548|19533081|P2|Completed 1/2 PK Visits|Overall Study||1
7936901|NCT00522548|19533082|P1|Completed 1/2 PK Visits|Overall Study||1
7936902|NCT00522548|19533081|P2|Completed 0/2 PK Visits|Overall Study||4
7936903|NCT00522548|19533082|P1|Completed 0/2 PK Visits|Overall Study||3
7936904|NCT00522548|19533081|P2|Consented to Pharmacokinetic Study|Overall Study||10
7936905|NCT00522548|19533082|P1|Consented to Pharmacokinetic Study|Overall Study||11
7936906|NCT00522548|19533081|P2|STARTED|Overall Study||19
7936907|NCT00522548|19533082|P1|STARTED|Overall Study||18
7936908|NCT00522457|19533110|P1|NOT COMPLETED|Overall Study||18
7936909|NCT00522457|19533110|P1|COMPLETED|Overall Study||1
7936910|NCT00522457|19533110|P1|STARTED|Overall Study||19
7936911|NCT00522431|19533116|P1|NOT COMPLETED|Overall Study||11
7936912|NCT00522431|19533116|P1|COMPLETED|Overall Study||138
7936913|NCT00522431|19533116|P1|STARTED|Overall Study||149
7936914|NCT00522418|19533123|P2|NOT COMPLETED|Overall Study||58
7936915|NCT00522418|19533124|P1|NOT COMPLETED|Overall Study||57
7936916|NCT00522418|19533123|P2|COMPLETED|Overall Study|Completed 2-year follow-up|5
7936917|NCT00522418|19533124|P1|COMPLETED|Overall Study|Completed 2-year follow-up|2
7936918|NCT00522418|19533123|P2|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29
7936919|NCT00522418|19533124|P1|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31
7937006|NCT00521885|19533370|P1|STARTED|Overall Study||0
7936920|NCT00522418|19533123|P2|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35
7936921|NCT00522418|19533124|P1|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33
7936922|NCT00522418|19533123|P2|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45
7936923|NCT00522418|19533124|P1|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38
7936924|NCT00522418|19533123|P2|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
7936925|NCT00522418|19533124|P1|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
7936926|NCT00522418|19533123|P2|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
7936927|NCT00522418|19533124|P1|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
7936928|NCT00522418|19533123|P2|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|58
7936929|NCT00522418|19533124|P1|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|54
7936930|NCT00522418|19533123|P2|STARTED|Overall Study||63
7936931|NCT00522418|19533124|P1|STARTED|Overall Study||59
7936932|NCT00522392|19533172|P2|NOT COMPLETED|Overall Study||13
7936933|NCT00522392|19533173|P1|NOT COMPLETED|Overall Study||8
7936934|NCT00522392|19533172|P2|COMPLETED|Overall Study||12
7936935|NCT00522392|19533173|P1|COMPLETED|Overall Study||15
7936936|NCT00522392|19533172|P2|Pts w/ QOL Assessments Complete|Overall Study||8
7936937|NCT00522392|19533173|P1|Pts w/ QOL Assessments Complete|Overall Study||12
7936938|NCT00522392|19533172|P2|Pts w/ Measurable Disease at Baseline|Overall Study||16
7936939|NCT00522392|19533173|P1|Pts w/ Measurable Disease at Baseline|Overall Study||16
7936940|NCT00522392|19533172|P2|STARTED|Overall Study||25
7936941|NCT00522392|19533173|P1|STARTED|Overall Study||23
7936942|NCT00522379|19533190|P5|NOT COMPLETED|Overall Study||27
7936943|NCT00522379|19533191|P4|NOT COMPLETED|Overall Study||14
7936944|NCT00522379|19533192|P3|NOT COMPLETED|Overall Study||22
7936945|NCT00522379|19533193|P2|NOT COMPLETED|Overall Study||23
7936946|NCT00522379|19533194|P1|NOT COMPLETED|Overall Study||22
7936947|NCT00522379|19533190|P5|COMPLETED|Overall Study||81
7936948|NCT00522379|19533191|P4|COMPLETED|Overall Study||80
7936949|NCT00522379|19533192|P3|COMPLETED|Overall Study||82
7936950|NCT00522379|19533193|P2|COMPLETED|Overall Study||84
7936951|NCT00522379|19533194|P1|COMPLETED|Overall Study||79
7936952|NCT00522379|19533190|P5|STARTED|Overall Study||108
7936953|NCT00522379|19533191|P4|STARTED|Overall Study||94
7936954|NCT00522379|19533192|P3|STARTED|Overall Study||104
7936955|NCT00522379|19533193|P2|STARTED|Overall Study||107
7936956|NCT00522379|19533194|P1|STARTED|Overall Study||101
7936957|NCT00522301|19533296|P1|NOT COMPLETED|Overall Study||6
7936958|NCT00522301|19533296|P1|COMPLETED|Overall Study||0
7936959|NCT00522301|19533296|P1|STARTED|Overall Study||6
7936960|NCT00522275|19533300|P1|NOT COMPLETED|Overall Study||170
7936961|NCT00522275|19533300|P1|COMPLETED|Overall Study||138
7936962|NCT00522275|19533300|P1|STARTED|Overall Study||308
7936963|NCT00522171|19533310|P2|NOT COMPLETED|Overall Study||0
7936964|NCT00522171|19533311|P1|NOT COMPLETED|Overall Study||0
7936965|NCT00522171|19533310|P2|COMPLETED|Overall Study||15
7936966|NCT00522171|19533311|P1|COMPLETED|Overall Study||15
7936967|NCT00522171|19533310|P2|STARTED|Overall Study||15
7936968|NCT00522171|19533311|P1|STARTED|Overall Study||15
7936969|NCT00522041|19533321|P2|NOT COMPLETED|Overall Study||12
7936970|NCT00522041|19533322|P1|NOT COMPLETED|Overall Study||17
7936971|NCT00522041|19533321|P2|COMPLETED|Overall Study||113
7936972|NCT00522041|19533322|P1|COMPLETED|Overall Study||106
7936973|NCT00522041|19533321|P2|Received Treatment|Overall Study||124
7936974|NCT00522041|19533322|P1|Received Treatment|Overall Study||123
7936975|NCT00522041|19533321|P2|STARTED|Overall Study||125
7936976|NCT00522041|19533322|P1|STARTED|Overall Study||123
7936977|NCT00521989|19533337|P5|NOT COMPLETED|Overall Study||23
7936978|NCT00521989|19533338|P4|NOT COMPLETED|Overall Study||12
7936979|NCT00521989|19533339|P3|NOT COMPLETED|Overall Study||16
7936980|NCT00521989|19533340|P2|NOT COMPLETED|Overall Study||17
7936981|NCT00521989|19533341|P1|NOT COMPLETED|Overall Study||20
7936982|NCT00521989|19533337|P5|COMPLETED|Overall Study||35
7936983|NCT00521989|19533338|P4|COMPLETED|Overall Study||42
7936984|NCT00521989|19533339|P3|COMPLETED|Overall Study||41
7936985|NCT00521989|19533340|P2|COMPLETED|Overall Study||37
7936986|NCT00521989|19533341|P1|COMPLETED|Overall Study||36
7936987|NCT00521989|19533337|P5|STARTED|Overall Study||58
7936988|NCT00521989|19533338|P4|STARTED|Overall Study||54
7936989|NCT00521989|19533339|P3|STARTED|Overall Study||57
7936990|NCT00521989|19533340|P2|STARTED|Overall Study||54
7936991|NCT00521989|19533341|P1|STARTED|Overall Study||56
7936992|NCT00521976|19533353|P1|NOT COMPLETED|Overall Study||0
7936993|NCT00521976|19533353|P1|COMPLETED|Overall Study||871
7936994|NCT00521976|19533353|P1|STARTED|Overall Study||871
7936995|NCT00521924|19533360|P2|NOT COMPLETED|Overall Study||4
7936996|NCT00521924|19533361|P1|NOT COMPLETED|Overall Study||4
7936997|NCT00521924|19533360|P2|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0
7936998|NCT00521924|19533361|P1|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0
7936999|NCT00521924|19533360|P2|STARTED|Overall Study|Subjects randomized|4
7937000|NCT00521924|19533361|P1|STARTED|Overall Study|Subjects randomized|4
7937001|NCT00521885|19533369|P2|NOT COMPLETED|Overall Study||0
7937002|NCT00521885|19533370|P1|NOT COMPLETED|Overall Study||0
7937003|NCT00521885|19533369|P2|COMPLETED|Overall Study||0
7937004|NCT00521885|19533370|P1|COMPLETED|Overall Study||0
7937005|NCT00521885|19533369|P2|STARTED|Overall Study||0
7937007|NCT00521599|19533381|P3|NOT COMPLETED|Overall Study||36
7937008|NCT00521599|19533382|P2|NOT COMPLETED|Overall Study||29
7937009|NCT00521599|19533383|P1|NOT COMPLETED|Overall Study||25
7937010|NCT00521599|19533381|P3|COMPLETED|Overall Study||100
7937011|NCT00521599|19533382|P2|COMPLETED|Overall Study||239
7937012|NCT00521599|19533383|P1|COMPLETED|Overall Study||243
7937013|NCT00521599|19533381|P3|STARTED|Overall Study||136
7937014|NCT00521599|19533382|P2|STARTED|Overall Study||268
7937015|NCT00521599|19533383|P1|STARTED|Overall Study||268
7937016|NCT00521586|19533394|P2|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12
7937017|NCT00521586|19533395|P1|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3
7937018|NCT00521586|19533394|P2|COMPLETED|Revaccination With 13vPnC (Year 5)||351
7937019|NCT00521586|19533395|P1|COMPLETED|Revaccination With 13vPnC (Year 5)||361
7937020|NCT00521586|19533394|P2|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351
7937021|NCT00521586|19533395|P1|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361
7937022|NCT00521586|19533394|P2|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359
7937023|NCT00521586|19533395|P1|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363
7937024|NCT00521586|19533394|P2|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363
7937025|NCT00521586|19533395|P1|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364
7937026|NCT00521586|19533394|P2|STARTED|Revaccination With 13vPnC (Year 5)||363
7937027|NCT00521586|19533395|P1|STARTED|Revaccination With 13vPnC (Year 5)||364
7937028|NCT00521586|19533394|P2|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170
7937029|NCT00521586|19533395|P1|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169
7937030|NCT00521586|19533394|P2|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363
7937031|NCT00521586|19533395|P1|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364
7937032|NCT00521586|19533394|P2|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
7937033|NCT00521586|19533395|P1|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
7937034|NCT00521586|19533394|P2|NOT COMPLETED|Initial Vaccination (Year 0)||29
7937035|NCT00521586|19533395|P1|NOT COMPLETED|Initial Vaccination (Year 0)||21
7937036|NCT00521586|19533394|P2|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
7937037|NCT00521586|19533395|P1|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
7937038|NCT00521586|19533394|P2|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529
7937039|NCT00521586|19533395|P1|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531
7937040|NCT00521586|19533394|P2|Vaccinated Dose 2|Initial Vaccination (Year 0)||543
7937041|NCT00521586|19533395|P1|Vaccinated Dose 2|Initial Vaccination (Year 0)||538
7937042|NCT00521586|19533394|P2|Vaccinated Dose 1|Initial Vaccination (Year 0)||560
7937043|NCT00521586|19533395|P1|Vaccinated Dose 1|Initial Vaccination (Year 0)||551
7937044|NCT00521586|19533394|P2|STARTED|Initial Vaccination (Year 0)||562
7937045|NCT00521586|19533395|P1|STARTED|Initial Vaccination (Year 0)||554
7937046|NCT00521456|19533455|P2|NOT COMPLETED|Overall Study||28
7937047|NCT00521456|19533456|P1|NOT COMPLETED|Overall Study||13
7937048|NCT00521456|19533455|P2|COMPLETED|Overall Study||59
7937049|NCT00521456|19533456|P1|COMPLETED|Overall Study||163
7937050|NCT00521456|19533455|P2|STARTED|Overall Study||87
7937051|NCT00521456|19533456|P1|STARTED|Overall Study||176
7937052|NCT00521404|19533468|P1|NOT COMPLETED|Overall Study||62
7937053|NCT00521404|19533468|P1|COMPLETED|Overall Study||0
7937054|NCT00521404|19533468|P1|STARTED|Overall Study||62
7937055|NCT00521365|19533477|P1|NOT COMPLETED|Overall Study||20
7937056|NCT00521365|19533477|P1|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68
7937057|NCT00521365|19533477|P1|Safety Analysis Set|Overall Study|All participants who received study treatment|88
7937058|NCT00521365|19533477|P1|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68
7937059|NCT00521365|19533477|P1|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88
7937060|NCT00521365|19533477|P1|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88
7937061|NCT00521352|19533496|P2|NOT COMPLETED|Overall Study||3
7937062|NCT00521352|19533497|P1|NOT COMPLETED|Overall Study||1
7937063|NCT00521352|19533496|P2|COMPLETED|Overall Study||10
7937064|NCT00521352|19533497|P1|COMPLETED|Overall Study||11
7937065|NCT00521352|19533496|P2|STARTED|Overall Study||13
7937066|NCT00521352|19533497|P1|STARTED|Overall Study||12
7937067|NCT00521339|19533507|P3|NOT COMPLETED|Observational Follow Up Phase||0
7937068|NCT00521339|19533508|P2|NOT COMPLETED|Observational Follow Up Phase||0
7937069|NCT00521339|19533509|P1|NOT COMPLETED|Observational Follow Up Phase||0
7937070|NCT00521339|19533507|P3|COMPLETED|Observational Follow Up Phase||4
7937071|NCT00521339|19533508|P2|COMPLETED|Observational Follow Up Phase||4
7937072|NCT00521339|19533509|P1|COMPLETED|Observational Follow Up Phase||14
7937073|NCT00521339|19533507|P3|STARTED|Observational Follow Up Phase||4
7937074|NCT00521339|19533508|P2|STARTED|Observational Follow Up Phase||4
7937075|NCT00521339|19533509|P1|STARTED|Observational Follow Up Phase||14
7937076|NCT00521339|19533507|P3|NOT COMPLETED|Treatment Extension Phase||3
7937077|NCT00521339|19533508|P2|NOT COMPLETED|Treatment Extension Phase||0
7937078|NCT00521339|19533509|P1|NOT COMPLETED|Treatment Extension Phase||0
7937079|NCT00521339|19533507|P3|COMPLETED|Treatment Extension Phase||4
7937080|NCT00521339|19533508|P2|COMPLETED|Treatment Extension Phase||4
7937081|NCT00521339|19533509|P1|COMPLETED|Treatment Extension Phase||0
7937082|NCT00521339|19533507|P3|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7
7937083|NCT00521339|19533508|P2|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4
7937084|NCT00521339|19533509|P1|STARTED|Treatment Extension Phase||0
7937085|NCT00521339|19533507|P3|NOT COMPLETED|Treatment Phase||0
7937086|NCT00521339|19533508|P2|NOT COMPLETED|Treatment Phase||0
7937087|NCT00521339|19533509|P1|NOT COMPLETED|Treatment Phase||12
7937088|NCT00521339|19533507|P3|COMPLETED|Treatment Phase||0
7937089|NCT00521339|19533508|P2|COMPLETED|Treatment Phase||0
7937090|NCT00521339|19533509|P1|COMPLETED|Treatment Phase||19
7937091|NCT00521339|19533507|P3|Received Apremilast|Treatment Phase||0
7937092|NCT00521339|19533508|P2|Received Apremilast|Treatment Phase||0
7937093|NCT00521339|19533509|P1|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30
7937094|NCT00521339|19533507|P3|STARTED|Treatment Phase||0
7937095|NCT00521339|19533508|P2|STARTED|Treatment Phase||0
7937096|NCT00521339|19533509|P1|STARTED|Treatment Phase||31
7937097|NCT00521144|19533577|P5|NOT COMPLETED|Overall Study||7
7937098|NCT00521144|19533578|P4|NOT COMPLETED|Overall Study||1
7937099|NCT00521144|19533579|P3|NOT COMPLETED|Overall Study||2
7937100|NCT00521144|19533580|P2|NOT COMPLETED|Overall Study||3
7937101|NCT00521144|19533581|P1|NOT COMPLETED|Overall Study||4
7937102|NCT00521144|19533577|P5|COMPLETED|Overall Study||0
7937103|NCT00521144|19533578|P4|COMPLETED|Overall Study||0
7937104|NCT00521144|19533579|P3|COMPLETED|Overall Study||1
7937105|NCT00521144|19533580|P2|COMPLETED|Overall Study||2
7937106|NCT00521144|19533581|P1|COMPLETED|Overall Study||2
7937107|NCT00521144|19533577|P5|STARTED|Overall Study||7
7937108|NCT00521144|19533578|P4|STARTED|Overall Study||1
7937109|NCT00521144|19533579|P3|STARTED|Overall Study||3
7937110|NCT00521144|19533580|P2|STARTED|Overall Study||5
7937111|NCT00521144|19533581|P1|STARTED|Overall Study||6
7937112|NCT00521079|19533595|P2|NOT COMPLETED|Overall Study||5
7937113|NCT00521079|19533596|P1|NOT COMPLETED|Overall Study||14
7937114|NCT00521079|19533595|P2|COMPLETED|Overall Study||97
7937115|NCT00521079|19533596|P1|COMPLETED|Overall Study||178
7937116|NCT00521079|19533595|P2|Surgical Roll-In|Overall Study||5
7937117|NCT00521079|19533596|P1|Surgical Roll-In|Overall Study||9
7937118|NCT00521079|19533595|P2|STARTED|Overall Study||102
7937119|NCT00521079|19533596|P1|STARTED|Overall Study||192
7937120|NCT00521053|19533606|P1|NOT COMPLETED|Observation Phase||68
7937121|NCT00521053|19533606|P1|COMPLETED|Observation Phase||12
7937122|NCT00521053|19533606|P1|STARTED|Observation Phase||80
7937123|NCT00521053|19533606|P1|NOT COMPLETED|Treatment Phase||0
7937124|NCT00521053|19533606|P1|COMPLETED|Treatment Phase||80
7937125|NCT00521053|19533606|P1|Received 4 Cycles of PV-10|Treatment Phase||3
7937126|NCT00521053|19533606|P1|Received 3 Cycles of PV-10|Treatment Phase||16
7937127|NCT00521053|19533606|P1|Received 2 Cycles of PV-10|Treatment Phase||26
7937128|NCT00521053|19533606|P1|Received 1 Cycle of PV-10|Treatment Phase||35
7937129|NCT00521053|19533606|P1|STARTED|Treatment Phase||80
7937130|NCT00521014|19533616|P1|NOT COMPLETED|Overall Study||1
7937131|NCT00521014|19533616|P1|COMPLETED|Overall Study||13
7937132|NCT00521014|19533616|P1|STARTED|Overall Study||14
7937133|NCT00521001|19533620|P1|NOT COMPLETED|Overall Study||1
7937134|NCT00521001|19533620|P1|COMPLETED|Overall Study||48
7937135|NCT00521001|19533620|P1|STARTED|Overall Study||49
7937136|NCT00520975|19533629|P2|NOT COMPLETED|Overall Study||48
7937137|NCT00520975|19533630|P1|NOT COMPLETED|Overall Study||48
7937138|NCT00520975|19533629|P2|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
7937139|NCT00520975|19533630|P1|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
7937140|NCT00520975|19533629|P2|Treated and Reported Adverse Events Data|Overall Study||45
7937141|NCT00520975|19533630|P1|Treated and Reported Adverse Events Data|Overall Study||47
7937142|NCT00520975|19533629|P2|STARTED|Overall Study||48
7937143|NCT00520975|19533630|P1|STARTED|Overall Study||48
7937144|NCT00520936|19533662|P8|NOT COMPLETED|Overall Study||1
7937145|NCT00520936|19533663|P7|NOT COMPLETED|Overall Study||4
7937146|NCT00520936|19533664|P6|NOT COMPLETED|Overall Study||0
7937147|NCT00520936|19533665|P5|NOT COMPLETED|Overall Study||1
7937148|NCT00520936|19533666|P4|NOT COMPLETED|Overall Study||0
7937149|NCT00520936|19533667|P3|NOT COMPLETED|Overall Study||2
7937150|NCT00520936|19533668|P2|NOT COMPLETED|Overall Study||4
7937151|NCT00520936|19533669|P1|NOT COMPLETED|Overall Study||0
7937152|NCT00520936|19533662|P8|COMPLETED|Overall Study||9
7937153|NCT00520936|19533663|P7|COMPLETED|Overall Study||7
7937154|NCT00520936|19533664|P6|COMPLETED|Overall Study||10
7937155|NCT00520936|19533665|P5|COMPLETED|Overall Study||5
7937156|NCT00520936|19533666|P4|COMPLETED|Overall Study||5
7937157|NCT00520936|19533667|P3|COMPLETED|Overall Study||7
7937158|NCT00520936|19533668|P2|COMPLETED|Overall Study||7
7937159|NCT00520936|19533669|P1|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10
7937160|NCT00520936|19533662|P8|STARTED|Overall Study||10
7937161|NCT00520936|19533663|P7|STARTED|Overall Study||11
7937162|NCT00520936|19533664|P6|STARTED|Overall Study||10
7937163|NCT00520936|19533665|P5|STARTED|Overall Study||6
7937164|NCT00520936|19533666|P4|STARTED|Overall Study||5
7937165|NCT00520936|19533667|P3|STARTED|Overall Study||9
7937166|NCT00520936|19533668|P2|STARTED|Overall Study||11
7937167|NCT00520936|19533669|P1|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10
7937168|NCT00520910|19533698|P2|NOT COMPLETED|Overall Study||0
7937169|NCT00520910|19533699|P1|NOT COMPLETED|Overall Study||0
7937170|NCT00520910|19533698|P2|COMPLETED|Overall Study||5
7937171|NCT00520910|19533699|P1|COMPLETED|Overall Study||5
7937172|NCT00520910|19533698|P2|STARTED|Overall Study||5
7937173|NCT00520910|19533699|P1|STARTED|Overall Study||5
7937174|NCT00520884|19533709|P4|NOT COMPLETED|Overall Study||0
7937175|NCT00520884|19533710|P3|NOT COMPLETED|Overall Study||0
7937176|NCT00520884|19533711|P2|NOT COMPLETED|Overall Study||0
7937177|NCT00520884|19533712|P1|NOT COMPLETED|Overall Study||0
7937178|NCT00520884|19533709|P4|COMPLETED|Overall Study||3
7937179|NCT00520884|19533710|P3|COMPLETED|Overall Study||2
7937180|NCT00520884|19533711|P2|COMPLETED|Overall Study||2
7937181|NCT00520884|19533712|P1|COMPLETED|Overall Study||3
7937182|NCT00520884|19533709|P4|STARTED|Overall Study||3
7937183|NCT00520884|19533710|P3|STARTED|Overall Study||2
7937184|NCT00520884|19533711|P2|STARTED|Overall Study||2
7937185|NCT00520884|19533712|P1|STARTED|Overall Study||3
7937186|NCT00520845|19533724|P1|NOT COMPLETED|Overall Study||22
7937187|NCT00520845|19533724|P1|COMPLETED|Overall Study||1
7937188|NCT00520845|19533724|P1|STARTED|Overall Study||23
7937189|NCT00520767|19533732|P1|NOT COMPLETED|Overall Study||2
7937190|NCT00520767|19533732|P1|COMPLETED|Overall Study||33
7937191|NCT00520767|19533732|P1|STARTED|Overall Study||35
7937192|NCT00520741|19533738|P2|NOT COMPLETED|Overall Study||125
7937193|NCT00520741|19533739|P1|NOT COMPLETED|Overall Study||37
7937194|NCT00520741|19533738|P2|COMPLETED|Overall Study||194
7937195|NCT00520741|19533739|P1|COMPLETED|Overall Study||69
7937196|NCT00520741|19533738|P2|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319
7937197|NCT00520741|19533739|P1|STARTED|Overall Study||106
7937198|NCT00520676|19533757|P2|NOT COMPLETED|Overall Study||103
7937199|NCT00520676|19533758|P1|NOT COMPLETED|Overall Study||101
7937200|NCT00520676|19533757|P2|COMPLETED|Overall Study||29
7937201|NCT00520676|19533758|P1|COMPLETED|Overall Study||27
7937202|NCT00520676|19533757|P2|Qualified Intent-to-treat (Q-ITT)|Overall Study||105
7937203|NCT00520676|19533758|P1|Qualified Intent-to-treat (Q-ITT)|Overall Study||106
7937204|NCT00520676|19533757|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
7937205|NCT00520676|19533758|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
7937206|NCT00520676|19533757|P2|STARTED|Overall Study||132
7937207|NCT00520676|19533758|P1|STARTED|Overall Study||128
7937208|NCT00520572|19533784|P6|NOT COMPLETED|Overall Study||2
7937209|NCT00520572|19533785|P5|NOT COMPLETED|Overall Study||12
7937210|NCT00520572|19533786|P4|NOT COMPLETED|Overall Study||14
7937211|NCT00520572|19533787|P3|NOT COMPLETED|Overall Study||15
7937212|NCT00520572|19533788|P2|NOT COMPLETED|Overall Study||14
7937213|NCT00520572|19533789|P1|NOT COMPLETED|Overall Study||12
7937214|NCT00520572|19533784|P6|COMPLETED|Overall Study|Participants completed the study.|62
7937215|NCT00520572|19533785|P5|COMPLETED|Overall Study|Participants completed the study.|53
7937216|NCT00520572|19533786|P4|COMPLETED|Overall Study|Participants completed the study.|50
7937217|NCT00520572|19533787|P3|COMPLETED|Overall Study|Participants completed the study.|49
7937218|NCT00520572|19533788|P2|COMPLETED|Overall Study|Participants completed the study.|50
7937219|NCT00520572|19533789|P1|COMPLETED|Overall Study|Participants completed the study.|52
7937220|NCT00520572|19533784|P6|STARTED|Overall Study|Participants randomised.|64
7937221|NCT00520572|19533785|P5|STARTED|Overall Study|Participants randomised.|65
7937222|NCT00520572|19533786|P4|STARTED|Overall Study|Participants randomised.|64
7937223|NCT00520572|19533787|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
7937224|NCT00520572|19533788|P2|STARTED|Overall Study|Participants randomised.|64
7937225|NCT00520572|19533789|P1|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
7937226|NCT00520546|19533827|P1|NOT COMPLETED|Overall Study||6
7937227|NCT00520546|19533827|P1|COMPLETED|Overall Study||38
7937228|NCT00520546|19533827|P1|STARTED|Overall Study||44
7937229|NCT00520494|19533842|P1|NOT COMPLETED|Overall Study||1
7937230|NCT00520494|19533842|P1|COMPLETED|Overall Study||17
7937231|NCT00520494|19533842|P1|STARTED|Overall Study||18
7937232|NCT00520481|19533867|P2|NOT COMPLETED|Overall Study||1
7937233|NCT00520481|19533868|P1|NOT COMPLETED|Overall Study||7
7937234|NCT00520481|19533867|P2|COMPLETED|Overall Study||9
7937235|NCT00520481|19533868|P1|COMPLETED|Overall Study||24
7937236|NCT00520481|19533867|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
7937237|NCT00520481|19533868|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
7937238|NCT00520481|19533867|P2|STARTED|Overall Study||10
7937239|NCT00520481|19533868|P1|STARTED|Overall Study||31
7937240|NCT00520468|19533888|P1|NOT COMPLETED|Overall Study||0
7937241|NCT00520468|19533888|P1|COMPLETED|Overall Study||14
7937242|NCT00520468|19533888|P1|STARTED|Overall Study||14
7937243|NCT00520403|19533892|P1|NOT COMPLETED|Bevacizumab Monotherapy||2
7937244|NCT00520403|19533892|P1|COMPLETED|Bevacizumab Monotherapy||0
7937245|NCT00520403|19533892|P1|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2
7937246|NCT00520403|19533892|P1|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18
7937247|NCT00520403|19533892|P1|COMPLETED|Bevacizumab + IFN/Vinblastine||7
7937248|NCT00520403|19533892|P1|STARTED|Bevacizumab + IFN/Vinblastine||25
7937249|NCT00520351|19533901|P2|NOT COMPLETED|Second Intervention||0
7937250|NCT00520351|19533902|P1|NOT COMPLETED|Second Intervention||0
7937251|NCT00520351|19533901|P2|COMPLETED|Second Intervention||14
7937252|NCT00520351|19533902|P1|COMPLETED|Second Intervention||14
7937253|NCT00520351|19533901|P2|STARTED|Second Intervention||14
7937254|NCT00520351|19533902|P1|STARTED|Second Intervention||14
7937255|NCT00520351|19533901|P2|NOT COMPLETED|First Intervention||1
7937256|NCT00520351|19533902|P1|NOT COMPLETED|First Intervention||1
7937257|NCT00520351|19533901|P2|COMPLETED|First Intervention|End date is Feb.25, 2008|14
7937258|NCT00520351|19533902|P1|COMPLETED|First Intervention|End date is Feb.25, 2008|14
7937259|NCT00520351|19533901|P2|STARTED|First Intervention|Start date is Sep.06, 2007|15
7937260|NCT00520351|19533902|P1|STARTED|First Intervention|Start date is Sep.06, 2007|15
7937261|NCT00520299|19533917|P3|NOT COMPLETED|Overall Study||6
7937262|NCT00520299|19533918|P2|NOT COMPLETED|Overall Study||3
7937263|NCT00520299|19533919|P1|NOT COMPLETED|Overall Study||0
7937264|NCT00520299|19533917|P3|COMPLETED|Overall Study||13
7937265|NCT00520299|19533918|P2|COMPLETED|Overall Study||3
7937266|NCT00520299|19533919|P1|COMPLETED|Overall Study|Defined as completion of 1 treatment cycle|6
7937267|NCT00520299|19533917|P3|STARTED|Overall Study||19
7937268|NCT00520299|19533918|P2|STARTED|Overall Study||6
7937269|NCT00520299|19533919|P1|STARTED|Overall Study||6
7937270|NCT00520286|19533950|P2|NOT COMPLETED|Overall Study||32
7937271|NCT00520286|19533951|P1|NOT COMPLETED|Overall Study||66
7937272|NCT00520286|19533950|P2|COMPLETED|Overall Study||36
7937273|NCT00520286|19533951|P1|COMPLETED|Overall Study||76
7937274|NCT00520286|19533950|P2|STARTED|Overall Study||68
7937275|NCT00520286|19533951|P1|STARTED|Overall Study||142
7937276|NCT00520234|19533961|P2|NOT COMPLETED|Overall Study||2
7937277|NCT00520234|19533962|P1|NOT COMPLETED|Overall Study||1
7937278|NCT00520234|19533961|P2|COMPLETED|Overall Study||102
7937279|NCT00520234|19533962|P1|COMPLETED|Overall Study||117
7937280|NCT00520234|19533961|P2|STARTED|Overall Study||104
7937281|NCT00520234|19533962|P1|STARTED|Overall Study||118
7937282|NCT00520130|19533974|P2|NOT COMPLETED|Overall Study||1
7937283|NCT00520130|19533975|P1|NOT COMPLETED|Overall Study||5
7937284|NCT00520130|19533974|P2|COMPLETED|Overall Study||44
7937285|NCT00520130|19533975|P1|COMPLETED|Overall Study||39
7937286|NCT00520130|19533974|P2|STARTED|Overall Study||45
7937287|NCT00520130|19533975|P1|STARTED|Overall Study||44
7937288|NCT00520039|19534017|P2|NOT COMPLETED|Overall Study||5
7937289|NCT00520039|19534018|P1|NOT COMPLETED|Overall Study||7
7937290|NCT00520039|19534017|P2|COMPLETED|Overall Study||19
7937291|NCT00520039|19534018|P1|COMPLETED|Overall Study||21
7937292|NCT00520039|19534017|P2|STARTED|Overall Study||24
7937293|NCT00520039|19534018|P1|STARTED|Overall Study||28
7937294|NCT00520013|19534031|P3|NOT COMPLETED|Overall Study||11
7937295|NCT00520013|19534032|P2|NOT COMPLETED|Overall Study||15
7937296|NCT00520013|19534033|P1|NOT COMPLETED|Overall Study||12
7937297|NCT00520013|19534031|P3|COMPLETED|Overall Study||0
7937298|NCT00520013|19534032|P2|COMPLETED|Overall Study||10
7937299|NCT00520013|19534033|P1|COMPLETED|Overall Study||11
7937300|NCT00520013|19534031|P3|Treated|Overall Study||11
7937301|NCT00520013|19534032|P2|Treated|Overall Study||25
7937302|NCT00520013|19534033|P1|Treated|Overall Study||23
7937303|NCT00520013|19534031|P3|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11
7937304|NCT00520013|19534032|P2|STARTED|Overall Study||25
7937305|NCT00520013|19534033|P1|STARTED|Overall Study||23
7937306|NCT00519896|19534043|P1|NOT COMPLETED|Overall Study||2
7937307|NCT00519896|19534043|P1|COMPLETED|Overall Study||33
7937308|NCT00519896|19534043|P1|STARTED|Overall Study||35
7937309|NCT00519831|19534049|P1|NOT COMPLETED|Overall Study||3
7937310|NCT00519831|19534049|P1|COMPLETED|Overall Study||13
7937311|NCT00519831|19534049|P1|STARTED|Overall Study||16
7937312|NCT00519818|19534056|P1|NOT COMPLETED|Overall Study||0
7937313|NCT00519818|19534056|P1|COMPLETED|Overall Study||14
7937314|NCT00519818|19534056|P1|STARTED|Overall Study||14
7937315|NCT00519779|19534066|P2|NOT COMPLETED|Overall Study||1
7937316|NCT00519779|19534067|P1|NOT COMPLETED|Overall Study||0
7937317|NCT00519779|19534066|P2|COMPLETED|Overall Study||33
7937318|NCT00519779|19534067|P1|COMPLETED|Overall Study||34
7937319|NCT00519779|19534066|P2|STARTED|Overall Study||34
7937320|NCT00519779|19534067|P1|STARTED|Overall Study||34
7937321|NCT00519649|19534083|P1|NOT COMPLETED|Overall Study||1
7937322|NCT00519649|19534083|P1|COMPLETED|Overall Study||299
7937323|NCT00519649|19534083|P1|STARTED|Overall Study||300
7937324|NCT00519636|19534096|P4|NOT COMPLETED|Post Study Period||1
7937325|NCT00519636|19534097|P3|NOT COMPLETED|Post Study Period||0
7937326|NCT00519636|19534098|P2|NOT COMPLETED|Post Study Period||0
7937327|NCT00519636|19534099|P1|NOT COMPLETED|Post Study Period||0
7937328|NCT00519636|19534096|P4|COMPLETED|Post Study Period||85
7937329|NCT00519636|19534097|P3|COMPLETED|Post Study Period||74
7937330|NCT00519636|19534098|P2|COMPLETED|Post Study Period||71
7937331|NCT00519636|19534099|P1|COMPLETED|Post Study Period||69
7937332|NCT00519636|19534096|P4|STARTED|Post Study Period||86
7937333|NCT00519636|19534097|P3|STARTED|Post Study Period||74
7937334|NCT00519636|19534098|P2|STARTED|Post Study Period||71
7937335|NCT00519636|19534099|P1|STARTED|Post Study Period||69
7937336|NCT00519636|19534096|P4|NOT COMPLETED|Treatment Period 2||2
7937337|NCT00519636|19534097|P3|NOT COMPLETED|Treatment Period 2||1
7937338|NCT00519636|19534098|P2|NOT COMPLETED|Treatment Period 2||1
7937339|NCT00519636|19534099|P1|NOT COMPLETED|Treatment Period 2||0
7937340|NCT00519636|19534096|P4|COMPLETED|Treatment Period 2||86
7937341|NCT00519636|19534097|P3|COMPLETED|Treatment Period 2||74
7937342|NCT00519636|19534098|P2|COMPLETED|Treatment Period 2||71
7937343|NCT00519636|19534099|P1|COMPLETED|Treatment Period 2||69
7937344|NCT00519636|19534096|P4|STARTED|Treatment Period 2||88
7937345|NCT00519636|19534097|P3|STARTED|Treatment Period 2||75
7937346|NCT00519636|19534098|P2|STARTED|Treatment Period 2||72
7937347|NCT00519636|19534099|P1|STARTED|Treatment Period 2||69
7937348|NCT00519636|19534096|P4|NOT COMPLETED|Washout Period||5
7937349|NCT00519636|19534097|P3|NOT COMPLETED|Washout Period||14
7937350|NCT00519636|19534098|P2|NOT COMPLETED|Washout Period||14
7937351|NCT00519636|19534099|P1|NOT COMPLETED|Washout Period||20
7937352|NCT00519636|19534096|P4|COMPLETED|Washout Period||88
7937353|NCT00519636|19534097|P3|COMPLETED|Washout Period||75
7937354|NCT00519636|19534098|P2|COMPLETED|Washout Period||72
7937355|NCT00519636|19534099|P1|COMPLETED|Washout Period||69
7937356|NCT00519636|19534096|P4|STARTED|Washout Period||93
7937357|NCT00519636|19534097|P3|STARTED|Washout Period||89
7937358|NCT00519636|19534098|P2|STARTED|Washout Period||86
7937359|NCT00519636|19534099|P1|STARTED|Washout Period||89
7937360|NCT00519636|19534096|P4|NOT COMPLETED|Treatment Period 1||0
7937361|NCT00519636|19534097|P3|NOT COMPLETED|Treatment Period 1||1
7937362|NCT00519636|19534098|P2|NOT COMPLETED|Treatment Period 1||0
7937363|NCT00519636|19534099|P1|NOT COMPLETED|Treatment Period 1||2
7937364|NCT00519636|19534096|P4|COMPLETED|Treatment Period 1||93
7937365|NCT00519636|19534097|P3|COMPLETED|Treatment Period 1||89
7937366|NCT00519636|19534098|P2|COMPLETED|Treatment Period 1||86
7937367|NCT00519636|19534099|P1|COMPLETED|Treatment Period 1||89
7937368|NCT00519636|19534096|P4|STARTED|Treatment Period 1||93
7937369|NCT00519636|19534097|P3|STARTED|Treatment Period 1||90
7937370|NCT00519636|19534098|P2|STARTED|Treatment Period 1||86
7937371|NCT00519636|19534099|P1|STARTED|Treatment Period 1||91
7937372|NCT00519623|19534129|P1|NOT COMPLETED|Overall Study||1
7937373|NCT00519623|19534129|P1|COMPLETED|Overall Study||8
7937374|NCT00519623|19534129|P1|STARTED|Overall Study||9
7937375|NCT00519584|19534138|P4|NOT COMPLETED|Overall Study||0
7937376|NCT00519584|19534139|P3|NOT COMPLETED|Overall Study||0
7937377|NCT00519584|19534140|P2|NOT COMPLETED|Overall Study||0
7937378|NCT00519584|19534141|P1|NOT COMPLETED|Overall Study||0
7937379|NCT00519584|19534138|P4|COMPLETED|Overall Study||56
7937380|NCT00519584|19534139|P3|COMPLETED|Overall Study||54
7937381|NCT00519584|19534140|P2|COMPLETED|Overall Study||54
7937382|NCT00519584|19534141|P1|COMPLETED|Overall Study||54
7937383|NCT00519584|19534138|P4|STARTED|Overall Study||56
7937384|NCT00519584|19534139|P3|STARTED|Overall Study||54
7937385|NCT00519584|19534140|P2|STARTED|Overall Study||54
7937386|NCT00519584|19534141|P1|STARTED|Overall Study||54
7937387|NCT00519532|19534163|P1|NOT COMPLETED|Overall Study||18
7937388|NCT00519532|19534163|P1|COMPLETED|Overall Study||66
7937389|NCT00519532|19534163|P1|STARTED|Overall Study||84
7937390|NCT00519428|19534173|P3|NOT COMPLETED|Overall Study||25
7937391|NCT00519428|19534174|P2|NOT COMPLETED|Overall Study||15
7937392|NCT00519428|19534175|P1|NOT COMPLETED|Overall Study||21
7937393|NCT00519428|19534173|P3|COMPLETED|Overall Study||58
7937394|NCT00519428|19534174|P2|COMPLETED|Overall Study||69
7937395|NCT00519428|19534175|P1|COMPLETED|Overall Study||57
7937396|NCT00519428|19534173|P3|STARTED|Overall Study||83
7937397|NCT00519428|19534174|P2|STARTED|Overall Study||84
7937398|NCT00519428|19534175|P1|STARTED|Overall Study||78
7937399|NCT00519376|19534195|P16|NOT COMPLETED|Treatment Period 4||0
7937400|NCT00519376|19534196|P15|NOT COMPLETED|Treatment Period 4||0
7937401|NCT00519376|19534197|P14|NOT COMPLETED|Treatment Period 4||0
7937402|NCT00519376|19534198|P13|NOT COMPLETED|Treatment Period 4||0
7937403|NCT00519376|19534199|P12|NOT COMPLETED|Treatment Period 4||0
7937404|NCT00519376|19534200|P11|NOT COMPLETED|Treatment Period 4||0
7937405|NCT00519376|19534201|P10|NOT COMPLETED|Treatment Period 4||0
7937406|NCT00519376|19534202|P9|NOT COMPLETED|Treatment Period 4||0
7937407|NCT00519376|19534203|P8|NOT COMPLETED|Treatment Period 4||0
7937408|NCT00519376|19534204|P7|NOT COMPLETED|Treatment Period 4||0
7937409|NCT00519376|19534205|P6|NOT COMPLETED|Treatment Period 4||0
7937410|NCT00519376|19534206|P5|NOT COMPLETED|Treatment Period 4||0
7937411|NCT00519376|19534207|P4|NOT COMPLETED|Treatment Period 4||0
7937412|NCT00519376|19534208|P3|NOT COMPLETED|Treatment Period 4||1
7937413|NCT00519376|19534209|P2|NOT COMPLETED|Treatment Period 4||0
7937414|NCT00519376|19534210|P1|NOT COMPLETED|Treatment Period 4||0
7937415|NCT00519376|19534195|P16|COMPLETED|Treatment Period 4||1
7937416|NCT00519376|19534196|P15|COMPLETED|Treatment Period 4||1
7937417|NCT00519376|19534197|P14|COMPLETED|Treatment Period 4||1
7937418|NCT00519376|19534198|P13|COMPLETED|Treatment Period 4||0
7937419|NCT00519376|19534199|P12|COMPLETED|Treatment Period 4||1
7937420|NCT00519376|19534200|P11|COMPLETED|Treatment Period 4||1
7937421|NCT00519376|19534201|P10|COMPLETED|Treatment Period 4||1
7937422|NCT00519376|19534202|P9|COMPLETED|Treatment Period 4||1
7937423|NCT00519376|19534203|P8|COMPLETED|Treatment Period 4||1
7937424|NCT00519376|19534204|P7|COMPLETED|Treatment Period 4||1
7937425|NCT00519376|19534205|P6|COMPLETED|Treatment Period 4||1
7937426|NCT00519376|19534206|P5|COMPLETED|Treatment Period 4||1
7937427|NCT00519376|19534207|P4|COMPLETED|Treatment Period 4||2
7937428|NCT00519376|19534208|P3|COMPLETED|Treatment Period 4||1
7937429|NCT00519376|19534209|P2|COMPLETED|Treatment Period 4||2
7937430|NCT00519376|19534210|P1|COMPLETED|Treatment Period 4||2
7937431|NCT00519376|19534195|P16|STARTED|Treatment Period 4||1
7937432|NCT00519376|19534196|P15|STARTED|Treatment Period 4||1
7937433|NCT00519376|19534197|P14|STARTED|Treatment Period 4||1
7937434|NCT00519376|19534198|P13|STARTED|Treatment Period 4||0
7937435|NCT00519376|19534199|P12|STARTED|Treatment Period 4||1
7937436|NCT00519376|19534200|P11|STARTED|Treatment Period 4||1
7937437|NCT00519376|19534201|P10|STARTED|Treatment Period 4||1
7937438|NCT00519376|19534202|P9|STARTED|Treatment Period 4||1
7937439|NCT00519376|19534203|P8|STARTED|Treatment Period 4||1
7937440|NCT00519376|19534204|P7|STARTED|Treatment Period 4||1
7937441|NCT00519376|19534205|P6|STARTED|Treatment Period 4||1
7937442|NCT00519376|19534206|P5|STARTED|Treatment Period 4||1
7937443|NCT00519376|19534207|P4|STARTED|Treatment Period 4||2
7937444|NCT00519376|19534208|P3|STARTED|Treatment Period 4||2
7937445|NCT00519376|19534209|P2|STARTED|Treatment Period 4||2
7937446|NCT00519376|19534210|P1|STARTED|Treatment Period 4||2
7937447|NCT00519376|19534195|P16|NOT COMPLETED|Washout Period 3||0
7937448|NCT00519376|19534196|P15|NOT COMPLETED|Washout Period 3||0
7937449|NCT00519376|19534197|P14|NOT COMPLETED|Washout Period 3||0
7937450|NCT00519376|19534198|P13|NOT COMPLETED|Washout Period 3||0
7937451|NCT00519376|19534199|P12|NOT COMPLETED|Washout Period 3||0
7937452|NCT00519376|19534200|P11|NOT COMPLETED|Washout Period 3||0
7937453|NCT00519376|19534201|P10|NOT COMPLETED|Washout Period 3||0
7937454|NCT00519376|19534202|P9|NOT COMPLETED|Washout Period 3||0
7937455|NCT00519376|19534203|P8|NOT COMPLETED|Washout Period 3||0
7937456|NCT00519376|19534204|P7|NOT COMPLETED|Washout Period 3||0
7937457|NCT00519376|19534205|P6|NOT COMPLETED|Washout Period 3||0
7937458|NCT00519376|19534206|P5|NOT COMPLETED|Washout Period 3||0
7937459|NCT00519376|19534207|P4|NOT COMPLETED|Washout Period 3||0
7937460|NCT00519376|19534208|P3|NOT COMPLETED|Washout Period 3||0
7937461|NCT00519376|19534209|P2|NOT COMPLETED|Washout Period 3||0
7937462|NCT00519376|19534210|P1|NOT COMPLETED|Washout Period 3||0
7937463|NCT00519376|19534195|P16|COMPLETED|Washout Period 3||1
7937464|NCT00519376|19534196|P15|COMPLETED|Washout Period 3||1
7937465|NCT00519376|19534197|P14|COMPLETED|Washout Period 3||1
7937466|NCT00519376|19534198|P13|COMPLETED|Washout Period 3||0
7937467|NCT00519376|19534199|P12|COMPLETED|Washout Period 3||1
7937468|NCT00519376|19534200|P11|COMPLETED|Washout Period 3||1
7937469|NCT00519376|19534201|P10|COMPLETED|Washout Period 3||1
7937470|NCT00519376|19534202|P9|COMPLETED|Washout Period 3||1
7937471|NCT00519376|19534203|P8|COMPLETED|Washout Period 3||1
7937472|NCT00519376|19534204|P7|COMPLETED|Washout Period 3||1
7937473|NCT00519376|19534205|P6|COMPLETED|Washout Period 3||1
7937474|NCT00519376|19534206|P5|COMPLETED|Washout Period 3||1
7937475|NCT00519376|19534207|P4|COMPLETED|Washout Period 3||2
7937476|NCT00519376|19534208|P3|COMPLETED|Washout Period 3||2
7937477|NCT00519376|19534209|P2|COMPLETED|Washout Period 3||2
7937478|NCT00519376|19534210|P1|COMPLETED|Washout Period 3||2
7937479|NCT00519376|19534195|P16|STARTED|Washout Period 3||1
7937480|NCT00519376|19534196|P15|STARTED|Washout Period 3||1
7937481|NCT00519376|19534197|P14|STARTED|Washout Period 3||1
7937482|NCT00519376|19534198|P13|STARTED|Washout Period 3||0
7937483|NCT00519376|19534199|P12|STARTED|Washout Period 3||1
7937484|NCT00519376|19534200|P11|STARTED|Washout Period 3||1
7937485|NCT00519376|19534201|P10|STARTED|Washout Period 3||1
7937486|NCT00519376|19534202|P9|STARTED|Washout Period 3||1
7937487|NCT00519376|19534203|P8|STARTED|Washout Period 3||1
7937488|NCT00519376|19534204|P7|STARTED|Washout Period 3||1
7937489|NCT00519376|19534205|P6|STARTED|Washout Period 3||1
7937490|NCT00519376|19534206|P5|STARTED|Washout Period 3||1
7937491|NCT00519376|19534207|P4|STARTED|Washout Period 3||2
7937492|NCT00519376|19534208|P3|STARTED|Washout Period 3||2
7937493|NCT00519376|19534209|P2|STARTED|Washout Period 3||2
7937494|NCT00519376|19534210|P1|STARTED|Washout Period 3||2
7937495|NCT00519376|19534195|P16|NOT COMPLETED|Treatment Period 3||0
7937496|NCT00519376|19534196|P15|NOT COMPLETED|Treatment Period 3||0
7937497|NCT00519376|19534197|P14|NOT COMPLETED|Treatment Period 3||0
7937498|NCT00519376|19534198|P13|NOT COMPLETED|Treatment Period 3||0
7937499|NCT00519376|19534199|P12|NOT COMPLETED|Treatment Period 3||0
7937500|NCT00519376|19534200|P11|NOT COMPLETED|Treatment Period 3||0
7937501|NCT00519376|19534201|P10|NOT COMPLETED|Treatment Period 3||0
7937502|NCT00519376|19534202|P9|NOT COMPLETED|Treatment Period 3||0
7937503|NCT00519376|19534203|P8|NOT COMPLETED|Treatment Period 3||0
7937504|NCT00519376|19534204|P7|NOT COMPLETED|Treatment Period 3||0
7937505|NCT00519376|19534205|P6|NOT COMPLETED|Treatment Period 3||0
7937506|NCT00519376|19534206|P5|NOT COMPLETED|Treatment Period 3||0
7937507|NCT00519376|19534207|P4|NOT COMPLETED|Treatment Period 3||0
7937508|NCT00519376|19534208|P3|NOT COMPLETED|Treatment Period 3||0
7937509|NCT00519376|19534209|P2|NOT COMPLETED|Treatment Period 3||0
7937510|NCT00519376|19534210|P1|NOT COMPLETED|Treatment Period 3||0
7937511|NCT00519376|19534195|P16|COMPLETED|Treatment Period 3||1
7937512|NCT00519376|19534196|P15|COMPLETED|Treatment Period 3||1
7937513|NCT00519376|19534197|P14|COMPLETED|Treatment Period 3||1
7937514|NCT00519376|19534198|P13|COMPLETED|Treatment Period 3||0
7937515|NCT00519376|19534199|P12|COMPLETED|Treatment Period 3||1
7937516|NCT00519376|19534200|P11|COMPLETED|Treatment Period 3||1
7937517|NCT00519376|19534201|P10|COMPLETED|Treatment Period 3||1
7937518|NCT00519376|19534202|P9|COMPLETED|Treatment Period 3||1
7937519|NCT00519376|19534203|P8|COMPLETED|Treatment Period 3||1
7937520|NCT00519376|19534204|P7|COMPLETED|Treatment Period 3||1
7937521|NCT00519376|19534205|P6|COMPLETED|Treatment Period 3||1
7937522|NCT00519376|19534206|P5|COMPLETED|Treatment Period 3||1
7937523|NCT00519376|19534207|P4|COMPLETED|Treatment Period 3||2
7937524|NCT00519376|19534208|P3|COMPLETED|Treatment Period 3||2
7937525|NCT00519376|19534209|P2|COMPLETED|Treatment Period 3||2
7937526|NCT00519376|19534210|P1|COMPLETED|Treatment Period 3||2
7937527|NCT00519376|19534195|P16|STARTED|Treatment Period 3||1
7937528|NCT00519376|19534196|P15|STARTED|Treatment Period 3||1
7937529|NCT00519376|19534197|P14|STARTED|Treatment Period 3||1
7937530|NCT00519376|19534198|P13|STARTED|Treatment Period 3||0
7937531|NCT00519376|19534199|P12|STARTED|Treatment Period 3||1
7937532|NCT00519376|19534200|P11|STARTED|Treatment Period 3||1
7937533|NCT00519376|19534201|P10|STARTED|Treatment Period 3||1
7937534|NCT00519376|19534202|P9|STARTED|Treatment Period 3||1
7937535|NCT00519376|19534203|P8|STARTED|Treatment Period 3||1
7937536|NCT00519376|19534204|P7|STARTED|Treatment Period 3||1
7937537|NCT00519376|19534205|P6|STARTED|Treatment Period 3||1
7937538|NCT00519376|19534206|P5|STARTED|Treatment Period 3||1
7937539|NCT00519376|19534207|P4|STARTED|Treatment Period 3||2
7937540|NCT00519376|19534208|P3|STARTED|Treatment Period 3||2
7937541|NCT00519376|19534209|P2|STARTED|Treatment Period 3||2
7937542|NCT00519376|19534210|P1|STARTED|Treatment Period 3||2
7937543|NCT00519376|19534195|P16|NOT COMPLETED|Washout Period 2||0
7937544|NCT00519376|19534196|P15|NOT COMPLETED|Washout Period 2||0
7937545|NCT00519376|19534197|P14|NOT COMPLETED|Washout Period 2||0
7937546|NCT00519376|19534198|P13|NOT COMPLETED|Washout Period 2||0
7937547|NCT00519376|19534199|P12|NOT COMPLETED|Washout Period 2||0
7937548|NCT00519376|19534200|P11|NOT COMPLETED|Washout Period 2||0
7937549|NCT00519376|19534201|P10|NOT COMPLETED|Washout Period 2||0
7937550|NCT00519376|19534202|P9|NOT COMPLETED|Washout Period 2||0
7937551|NCT00519376|19534203|P8|NOT COMPLETED|Washout Period 2||0
7937552|NCT00519376|19534204|P7|NOT COMPLETED|Washout Period 2||0
7937553|NCT00519376|19534205|P6|NOT COMPLETED|Washout Period 2||0
7937554|NCT00519376|19534206|P5|NOT COMPLETED|Washout Period 2||0
7937555|NCT00519376|19534207|P4|NOT COMPLETED|Washout Period 2||0
7937556|NCT00519376|19534208|P3|NOT COMPLETED|Washout Period 2||0
7937557|NCT00519376|19534209|P2|NOT COMPLETED|Washout Period 2||0
7937558|NCT00519376|19534210|P1|NOT COMPLETED|Washout Period 2||0
7937559|NCT00519376|19534195|P16|COMPLETED|Washout Period 2||1
7937560|NCT00519376|19534196|P15|COMPLETED|Washout Period 2||1
7937561|NCT00519376|19534197|P14|COMPLETED|Washout Period 2||1
7937562|NCT00519376|19534198|P13|COMPLETED|Washout Period 2||0
7937563|NCT00519376|19534199|P12|COMPLETED|Washout Period 2||1
7937564|NCT00519376|19534200|P11|COMPLETED|Washout Period 2||1
7937565|NCT00519376|19534201|P10|COMPLETED|Washout Period 2||1
7937566|NCT00519376|19534202|P9|COMPLETED|Washout Period 2||1
7937567|NCT00519376|19534203|P8|COMPLETED|Washout Period 2||1
7937568|NCT00519376|19534204|P7|COMPLETED|Washout Period 2||1
7937569|NCT00519376|19534205|P6|COMPLETED|Washout Period 2||1
7937570|NCT00519376|19534206|P5|COMPLETED|Washout Period 2||1
7937571|NCT00519376|19534207|P4|COMPLETED|Washout Period 2||2
7937572|NCT00519376|19534208|P3|COMPLETED|Washout Period 2||2
7937573|NCT00519376|19534209|P2|COMPLETED|Washout Period 2||2
7937574|NCT00519376|19534210|P1|COMPLETED|Washout Period 2||2
7937575|NCT00519376|19534195|P16|STARTED|Washout Period 2||1
7937576|NCT00519376|19534196|P15|STARTED|Washout Period 2||1
7937577|NCT00519376|19534197|P14|STARTED|Washout Period 2||1
7937578|NCT00519376|19534198|P13|STARTED|Washout Period 2||0
7937579|NCT00519376|19534199|P12|STARTED|Washout Period 2||1
7937580|NCT00519376|19534200|P11|STARTED|Washout Period 2||1
7937581|NCT00519376|19534201|P10|STARTED|Washout Period 2||1
7937582|NCT00519376|19534202|P9|STARTED|Washout Period 2||1
7937583|NCT00519376|19534203|P8|STARTED|Washout Period 2||1
7937584|NCT00519376|19534204|P7|STARTED|Washout Period 2||1
7937585|NCT00519376|19534205|P6|STARTED|Washout Period 2||1
7937586|NCT00519376|19534206|P5|STARTED|Washout Period 2||1
7937587|NCT00519376|19534207|P4|STARTED|Washout Period 2||2
7937588|NCT00519376|19534208|P3|STARTED|Washout Period 2||2
7937589|NCT00519376|19534209|P2|STARTED|Washout Period 2||2
7937590|NCT00519376|19534210|P1|STARTED|Washout Period 2||2
7937591|NCT00519376|19534195|P16|NOT COMPLETED|Treatment Period 2||0
7937592|NCT00519376|19534196|P15|NOT COMPLETED|Treatment Period 2||0
7937593|NCT00519376|19534197|P14|NOT COMPLETED|Treatment Period 2||0
7937594|NCT00519376|19534198|P13|NOT COMPLETED|Treatment Period 2||1
7937595|NCT00519376|19534199|P12|NOT COMPLETED|Treatment Period 2||0
7937596|NCT00519376|19534200|P11|NOT COMPLETED|Treatment Period 2||0
7937597|NCT00519376|19534201|P10|NOT COMPLETED|Treatment Period 2||0
7937598|NCT00519376|19534202|P9|NOT COMPLETED|Treatment Period 2||0
7937599|NCT00519376|19534203|P8|NOT COMPLETED|Treatment Period 2||0
7937600|NCT00519376|19534204|P7|NOT COMPLETED|Treatment Period 2||0
7937601|NCT00519376|19534205|P6|NOT COMPLETED|Treatment Period 2||0
7937602|NCT00519376|19534206|P5|NOT COMPLETED|Treatment Period 2||0
7937603|NCT00519376|19534207|P4|NOT COMPLETED|Treatment Period 2||0
7937604|NCT00519376|19534208|P3|NOT COMPLETED|Treatment Period 2||0
7937605|NCT00519376|19534209|P2|NOT COMPLETED|Treatment Period 2||0
7937606|NCT00519376|19534210|P1|NOT COMPLETED|Treatment Period 2||0
7937607|NCT00519376|19534195|P16|COMPLETED|Treatment Period 2||1
7937608|NCT00519376|19534196|P15|COMPLETED|Treatment Period 2||1
7937609|NCT00519376|19534197|P14|COMPLETED|Treatment Period 2||1
7937610|NCT00519376|19534198|P13|COMPLETED|Treatment Period 2||0
7937611|NCT00519376|19534199|P12|COMPLETED|Treatment Period 2||1
7937612|NCT00519376|19534200|P11|COMPLETED|Treatment Period 2||1
7937613|NCT00519376|19534201|P10|COMPLETED|Treatment Period 2||1
7937614|NCT00519376|19534202|P9|COMPLETED|Treatment Period 2||1
7937615|NCT00519376|19534203|P8|COMPLETED|Treatment Period 2||1
7937616|NCT00519376|19534204|P7|COMPLETED|Treatment Period 2||1
7937617|NCT00519376|19534205|P6|COMPLETED|Treatment Period 2||1
7937618|NCT00519376|19534206|P5|COMPLETED|Treatment Period 2||1
7937619|NCT00519376|19534207|P4|COMPLETED|Treatment Period 2||2
7937620|NCT00519376|19534208|P3|COMPLETED|Treatment Period 2||2
7937621|NCT00519376|19534209|P2|COMPLETED|Treatment Period 2||2
7937622|NCT00519376|19534210|P1|COMPLETED|Treatment Period 2||2
7937623|NCT00519376|19534195|P16|STARTED|Treatment Period 2||1
7937624|NCT00519376|19534196|P15|STARTED|Treatment Period 2||1
7937625|NCT00519376|19534197|P14|STARTED|Treatment Period 2||1
7937626|NCT00519376|19534198|P13|STARTED|Treatment Period 2||1
7937627|NCT00519376|19534199|P12|STARTED|Treatment Period 2||1
7937628|NCT00519376|19534200|P11|STARTED|Treatment Period 2||1
7937629|NCT00519376|19534201|P10|STARTED|Treatment Period 2||1
7937630|NCT00519376|19534202|P9|STARTED|Treatment Period 2||1
7937631|NCT00519376|19534203|P8|STARTED|Treatment Period 2||1
7937632|NCT00519376|19534204|P7|STARTED|Treatment Period 2||1
7937633|NCT00519376|19534205|P6|STARTED|Treatment Period 2||1
7937634|NCT00519376|19534206|P5|STARTED|Treatment Period 2||1
7937635|NCT00519376|19534207|P4|STARTED|Treatment Period 2||2
7937636|NCT00519376|19534208|P3|STARTED|Treatment Period 2||2
7937637|NCT00519376|19534209|P2|STARTED|Treatment Period 2||2
7937638|NCT00519376|19534210|P1|STARTED|Treatment Period 2||2
7937639|NCT00519376|19534195|P16|NOT COMPLETED|Washout Period 1||0
7937640|NCT00519376|19534196|P15|NOT COMPLETED|Washout Period 1||0
7937641|NCT00519376|19534197|P14|NOT COMPLETED|Washout Period 1||0
7937642|NCT00519376|19534198|P13|NOT COMPLETED|Washout Period 1||0
7937643|NCT00519376|19534199|P12|NOT COMPLETED|Washout Period 1||0
7937644|NCT00519376|19534200|P11|NOT COMPLETED|Washout Period 1||0
7937645|NCT00519376|19534201|P10|NOT COMPLETED|Washout Period 1||0
7937646|NCT00519376|19534202|P9|NOT COMPLETED|Washout Period 1||0
7937647|NCT00519376|19534203|P8|NOT COMPLETED|Washout Period 1||0
7937648|NCT00519376|19534204|P7|NOT COMPLETED|Washout Period 1||0
7937649|NCT00519376|19534205|P6|NOT COMPLETED|Washout Period 1||0
7937650|NCT00519376|19534206|P5|NOT COMPLETED|Washout Period 1||0
7937651|NCT00519376|19534207|P4|NOT COMPLETED|Washout Period 1||0
7937652|NCT00519376|19534208|P3|NOT COMPLETED|Washout Period 1||0
7937653|NCT00519376|19534209|P2|NOT COMPLETED|Washout Period 1||0
7937654|NCT00519376|19534210|P1|NOT COMPLETED|Washout Period 1||0
7937655|NCT00519376|19534195|P16|COMPLETED|Washout Period 1||1
7937656|NCT00519376|19534196|P15|COMPLETED|Washout Period 1||1
7937657|NCT00519376|19534197|P14|COMPLETED|Washout Period 1||1
7937658|NCT00519376|19534198|P13|COMPLETED|Washout Period 1||1
7937659|NCT00519376|19534199|P12|COMPLETED|Washout Period 1||1
7937660|NCT00519376|19534200|P11|COMPLETED|Washout Period 1||1
7937661|NCT00519376|19534201|P10|COMPLETED|Washout Period 1||1
7937662|NCT00519376|19534202|P9|COMPLETED|Washout Period 1||1
7937663|NCT00519376|19534203|P8|COMPLETED|Washout Period 1||1
7937664|NCT00519376|19534204|P7|COMPLETED|Washout Period 1||1
7937665|NCT00519376|19534205|P6|COMPLETED|Washout Period 1||1
7937666|NCT00519376|19534206|P5|COMPLETED|Washout Period 1||1
7937667|NCT00519376|19534207|P4|COMPLETED|Washout Period 1||2
7937668|NCT00519376|19534208|P3|COMPLETED|Washout Period 1||2
7937669|NCT00519376|19534209|P2|COMPLETED|Washout Period 1||2
7937670|NCT00519376|19534210|P1|COMPLETED|Washout Period 1||2
7937671|NCT00519376|19534195|P16|STARTED|Washout Period 1||1
7937672|NCT00519376|19534196|P15|STARTED|Washout Period 1||1
7937673|NCT00519376|19534197|P14|STARTED|Washout Period 1||1
7937674|NCT00519376|19534198|P13|STARTED|Washout Period 1||1
7937675|NCT00519376|19534199|P12|STARTED|Washout Period 1||1
7937676|NCT00519376|19534200|P11|STARTED|Washout Period 1||1
7937677|NCT00519376|19534201|P10|STARTED|Washout Period 1||1
7937678|NCT00519376|19534202|P9|STARTED|Washout Period 1||1
7937679|NCT00519376|19534203|P8|STARTED|Washout Period 1||1
7937680|NCT00519376|19534204|P7|STARTED|Washout Period 1||1
7937681|NCT00519376|19534205|P6|STARTED|Washout Period 1||1
7937682|NCT00519376|19534206|P5|STARTED|Washout Period 1||1
7937683|NCT00519376|19534207|P4|STARTED|Washout Period 1||2
7937684|NCT00519376|19534208|P3|STARTED|Washout Period 1||2
7937685|NCT00519376|19534209|P2|STARTED|Washout Period 1||2
7937686|NCT00519376|19534210|P1|STARTED|Washout Period 1||2
7937687|NCT00519376|19534195|P16|NOT COMPLETED|Treatment Period 1||0
7937688|NCT00519376|19534196|P15|NOT COMPLETED|Treatment Period 1||0
7937689|NCT00519376|19534197|P14|NOT COMPLETED|Treatment Period 1||0
7937690|NCT00519376|19534198|P13|NOT COMPLETED|Treatment Period 1||0
7937691|NCT00519376|19534199|P12|NOT COMPLETED|Treatment Period 1||0
7937692|NCT00519376|19534200|P11|NOT COMPLETED|Treatment Period 1||0
7937693|NCT00519376|19534201|P10|NOT COMPLETED|Treatment Period 1||0
7937694|NCT00519376|19534202|P9|NOT COMPLETED|Treatment Period 1||0
7937695|NCT00519376|19534203|P8|NOT COMPLETED|Treatment Period 1||0
7937696|NCT00519376|19534204|P7|NOT COMPLETED|Treatment Period 1||0
7937697|NCT00519376|19534205|P6|NOT COMPLETED|Treatment Period 1||0
7937698|NCT00519376|19534206|P5|NOT COMPLETED|Treatment Period 1||0
7937699|NCT00519376|19534207|P4|NOT COMPLETED|Treatment Period 1||0
7937700|NCT00519376|19534208|P3|NOT COMPLETED|Treatment Period 1||0
7937701|NCT00519376|19534209|P2|NOT COMPLETED|Treatment Period 1||0
7937702|NCT00519376|19534210|P1|NOT COMPLETED|Treatment Period 1||0
7937703|NCT00519376|19534195|P16|COMPLETED|Treatment Period 1||1
7937704|NCT00519376|19534196|P15|COMPLETED|Treatment Period 1||1
7937705|NCT00519376|19534197|P14|COMPLETED|Treatment Period 1||1
7937706|NCT00519376|19534198|P13|COMPLETED|Treatment Period 1||1
7937707|NCT00519376|19534199|P12|COMPLETED|Treatment Period 1||1
7937708|NCT00519376|19534200|P11|COMPLETED|Treatment Period 1||1
7937709|NCT00519376|19534201|P10|COMPLETED|Treatment Period 1||1
7937710|NCT00519376|19534202|P9|COMPLETED|Treatment Period 1||1
7937711|NCT00519376|19534203|P8|COMPLETED|Treatment Period 1||1
7937712|NCT00519376|19534204|P7|COMPLETED|Treatment Period 1||1
7937713|NCT00519376|19534205|P6|COMPLETED|Treatment Period 1||1
7937714|NCT00519376|19534206|P5|COMPLETED|Treatment Period 1||1
7937715|NCT00519376|19534207|P4|COMPLETED|Treatment Period 1||2
7937716|NCT00519376|19534208|P3|COMPLETED|Treatment Period 1||2
7937717|NCT00519376|19534209|P2|COMPLETED|Treatment Period 1||2
7937718|NCT00519376|19534210|P1|COMPLETED|Treatment Period 1||2
7937719|NCT00519376|19534195|P16|STARTED|Treatment Period 1||1
7937720|NCT00519376|19534196|P15|STARTED|Treatment Period 1||1
7937721|NCT00519376|19534197|P14|STARTED|Treatment Period 1||1
7937722|NCT00519376|19534198|P13|STARTED|Treatment Period 1||1
7937723|NCT00519376|19534199|P12|STARTED|Treatment Period 1||1
7937724|NCT00519376|19534200|P11|STARTED|Treatment Period 1||1
7937725|NCT00519376|19534201|P10|STARTED|Treatment Period 1||1
7937726|NCT00519376|19534202|P9|STARTED|Treatment Period 1||1
7937727|NCT00519376|19534203|P8|STARTED|Treatment Period 1||1
7937728|NCT00519376|19534204|P7|STARTED|Treatment Period 1||1
7937729|NCT00519376|19534205|P6|STARTED|Treatment Period 1||1
7937730|NCT00519376|19534206|P5|STARTED|Treatment Period 1||1
7937731|NCT00519376|19534207|P4|STARTED|Treatment Period 1||2
7937732|NCT00519376|19534208|P3|STARTED|Treatment Period 1||2
7937733|NCT00519376|19534209|P2|STARTED|Treatment Period 1||2
7937734|NCT00519376|19534210|P1|STARTED|Treatment Period 1||2
7937735|NCT00519285|19534334|P2|NOT COMPLETED|Overall Study||612
7937736|NCT00519285|19534335|P1|NOT COMPLETED|Overall Study||612
7937737|NCT00519285|19534334|P2|COMPLETED|Overall Study||0
7937738|NCT00519285|19534335|P1|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0
7937739|NCT00519285|19534334|P2|Still Treated at Cut-off Date|Overall Study||2
7937740|NCT00519285|19534335|P1|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1
7937741|NCT00519285|19534334|P2|TREATED|Overall Study|Received at least part of one dose of aflibercept|605
7937742|NCT00519285|19534335|P1|TREATED|Overall Study|Received at least part of one dose of placebo|604
7937743|NCT00519285|19534334|P2|STARTED|Overall Study|Randomized|612
7937744|NCT00519285|19534335|P1|STARTED|Overall Study|Randomized|612
7937745|NCT00519194|19534361|P1|NOT COMPLETED|Overall Study||21
7937746|NCT00519194|19534361|P1|COMPLETED|Overall Study||91
7937747|NCT00519194|19534361|P1|STARTED|Overall Study||112
7937748|NCT00519090|19534367|P2|NOT COMPLETED|Overall Study||0
7937749|NCT00519090|19534368|P1|NOT COMPLETED|Overall Study||0
7937750|NCT00519090|19534367|P2|COMPLETED|Overall Study||4
7937751|NCT00519090|19534368|P1|COMPLETED|Overall Study||2
7937752|NCT00519090|19534367|P2|STARTED|Overall Study||4
7937753|NCT00519090|19534368|P1|STARTED|Overall Study||2
7937754|NCT00519077|19534376|P1|NOT COMPLETED|Overall Study||8
7937755|NCT00519077|19534376|P1|COMPLETED|Overall Study||36
7937756|NCT00519077|19534376|P1|STARTED|Overall Study||44
7937757|NCT00518986|19534383|P2|NOT COMPLETED|Overall Study||26
7937758|NCT00518986|19534384|P1|NOT COMPLETED|Overall Study||26
7937759|NCT00518986|19534383|P2|COMPLETED|Overall Study||98
7937760|NCT00518986|19534384|P1|COMPLETED|Overall Study||99
7937761|NCT00518986|19534383|P2|STARTED|Overall Study||124
7937762|NCT00518986|19534384|P1|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125
7937763|NCT00518973|19534510|P2|NOT COMPLETED|Overall Study||2
7937764|NCT00518973|19534511|P1|NOT COMPLETED|Overall Study||3
7937765|NCT00518973|19534510|P2|COMPLETED|Overall Study||4
7937766|NCT00518973|19534511|P1|COMPLETED|Overall Study||6
7937767|NCT00518973|19534510|P2|STARTED|Overall Study||6
7937768|NCT00518973|19534511|P1|STARTED|Overall Study||9
7937769|NCT00518882|19534527|P2|NOT COMPLETED|Open-Label Extension, Week 26-78||49
7937770|NCT00518882|19534528|P1|NOT COMPLETED|Open-Label Extension, Week 26-78||41
7937771|NCT00518882|19534527|P2|COMPLETED|Open-Label Extension, Week 26-78||138
7937772|NCT00518882|19534528|P1|COMPLETED|Open-Label Extension, Week 26-78||161
7937773|NCT00518882|19534527|P2|STARTED|Open-Label Extension, Week 26-78||187
7937774|NCT00518882|19534528|P1|STARTED|Open-Label Extension, Week 26-78||202
7937775|NCT00518882|19534527|P2|NOT COMPLETED|Double-Blind, Week 0-26||45
7937776|NCT00518882|19534528|P1|NOT COMPLETED|Double-Blind, Week 0-26||33
7937777|NCT00518882|19534527|P2|COMPLETED|Double-Blind, Week 0-26||187
7937778|NCT00518882|19534528|P1|COMPLETED|Double-Blind, Week 0-26||202
7937779|NCT00518882|19534527|P2|Randomised|Double-Blind, Week 0-26||231
7937780|NCT00518882|19534528|P1|Randomised|Double-Blind, Week 0-26||233
7937781|NCT00518882|19534527|P2|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232
7937782|NCT00518882|19534528|P1|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235
7937783|NCT00518713|19534646|P4|NOT COMPLETED|Overall Study||18
7937784|NCT00518713|19534647|P3|NOT COMPLETED|Overall Study||18
7937785|NCT00518713|19534648|P2|NOT COMPLETED|Overall Study||17
7937786|NCT00518713|19534649|P1|NOT COMPLETED|Overall Study||8
7937787|NCT00518713|19534646|P4|COMPLETED|Overall Study||41
7937788|NCT00518713|19534647|P3|COMPLETED|Overall Study||41
7937789|NCT00518713|19534648|P2|COMPLETED|Overall Study||45
7937790|NCT00518713|19534649|P1|COMPLETED|Overall Study||50
7937791|NCT00518713|19534646|P4|Modified Intent-to-Treat Population|Overall Study||57
7937792|NCT00518713|19534647|P3|Modified Intent-to-Treat Population|Overall Study||49
7937793|NCT00518713|19534648|P2|Modified Intent-to-Treat Population|Overall Study||58
7937794|NCT00518713|19534649|P1|Modified Intent-to-Treat Population|Overall Study||53
7937795|NCT00518713|19534646|P4|STARTED|Overall Study||59
7937796|NCT00518713|19534647|P3|STARTED|Overall Study||59
7937797|NCT00518713|19534648|P2|STARTED|Overall Study||62
7937798|NCT00518713|19534649|P1|STARTED|Overall Study||58
7937799|NCT00518687|19534709|P2|NOT COMPLETED|Overall Study||1420
7937800|NCT00518687|19534710|P1|NOT COMPLETED|Overall Study||1437
7937801|NCT00518687|19534709|P2|COMPLETED|Overall Study||2585
7937802|NCT00518687|19534710|P1|COMPLETED|Overall Study||2568
7937803|NCT00518687|19534709|P2|Vaccinated|Overall Study||3982
7937804|NCT00518687|19534710|P1|Vaccinated|Overall Study||3981
7937805|NCT00518687|19534709|P2|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005
7937806|NCT00518687|19534710|P1|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005
7937807|NCT00518622|19534730|P8|NOT COMPLETED|Overall Study||0
7937808|NCT00518622|19534731|P7|NOT COMPLETED|Overall Study||0
7937809|NCT00518622|19534732|P6|NOT COMPLETED|Overall Study||0
7937810|NCT00518622|19534733|P5|NOT COMPLETED|Overall Study||0
7937811|NCT00518622|19534734|P4|NOT COMPLETED|Overall Study||0
7937812|NCT00518622|19534735|P3|NOT COMPLETED|Overall Study||1
7937813|NCT00518622|19534736|P2|NOT COMPLETED|Overall Study||1
7937814|NCT00518622|19534737|P1|NOT COMPLETED|Overall Study||0
7937815|NCT00518622|19534730|P8|COMPLETED|Overall Study||5
7937816|NCT00518622|19534731|P7|COMPLETED|Overall Study||4
7937817|NCT00518622|19534732|P6|COMPLETED|Overall Study||5
7937818|NCT00518622|19534733|P5|COMPLETED|Overall Study||6
7937819|NCT00518622|19534734|P4|COMPLETED|Overall Study||5
7937820|NCT00518622|19534735|P3|COMPLETED|Overall Study||5
7937821|NCT00518622|19534736|P2|COMPLETED|Overall Study||5
7937822|NCT00518622|19534737|P1|COMPLETED|Overall Study||3
7937823|NCT00518622|19534730|P8|Discontinued Therapy|Overall Study||0
7937824|NCT00518622|19534731|P7|Discontinued Therapy|Overall Study||0
7937825|NCT00518622|19534732|P6|Discontinued Therapy|Overall Study||0
7937826|NCT00518622|19534733|P5|Discontinued Therapy|Overall Study||0
7937827|NCT00518622|19534734|P4|Discontinued Therapy|Overall Study||0
7937828|NCT00518622|19534735|P3|Discontinued Therapy|Overall Study||0
7937829|NCT00518622|19534736|P2|Discontinued Therapy|Overall Study||1
7937830|NCT00518622|19534737|P1|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0
7937831|NCT00518622|19534730|P8|Completed Therapy|Overall Study||5
7937832|NCT00518622|19534731|P7|Completed Therapy|Overall Study||4
7937833|NCT00518622|19534732|P6|Completed Therapy|Overall Study||5
7937834|NCT00518622|19534733|P5|Completed Therapy|Overall Study||6
7937835|NCT00518622|19534734|P4|Completed Therapy|Overall Study||5
7937836|NCT00518622|19534735|P3|Completed Therapy|Overall Study||6
7937837|NCT00518622|19534736|P2|Completed Therapy|Overall Study||5
7937838|NCT00518622|19534737|P1|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3
7937839|NCT00518622|19534730|P8|STARTED|Overall Study||5
7937840|NCT00518622|19534731|P7|STARTED|Overall Study||4
7937841|NCT00518622|19534732|P6|STARTED|Overall Study||5
7937842|NCT00518622|19534733|P5|STARTED|Overall Study||6
7937843|NCT00518622|19534734|P4|STARTED|Overall Study||5
7937844|NCT00518622|19534735|P3|STARTED|Overall Study||6
7937845|NCT00518622|19534736|P2|STARTED|Overall Study||6
7937846|NCT00518622|19534737|P1|STARTED|Overall Study||3
7937847|NCT00518531|19534765|P2|NOT COMPLETED|Treatment Period 2||20
7937848|NCT00518531|19534766|P1|NOT COMPLETED|Treatment Period 2||3
7937849|NCT00518531|19534765|P2|COMPLETED|Treatment Period 2||95
7937850|NCT00518531|19534766|P1|COMPLETED|Treatment Period 2||103
7937851|NCT00518531|19534765|P2|Received Treatment|Treatment Period 2||110
7937852|NCT00518531|19534766|P1|Received Treatment|Treatment Period 2||106
7937853|NCT00518531|19534765|P2|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115
7937854|NCT00518531|19534766|P1|STARTED|Treatment Period 2||106
7937855|NCT00518531|19534765|P2|NOT COMPLETED|Treatment Period 1||12
7937856|NCT00518531|19534766|P1|NOT COMPLETED|Treatment Period 1||18
7937857|NCT00518531|19534765|P2|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114
7937858|NCT00518531|19534766|P1|COMPLETED|Treatment Period 1||106
7937859|NCT00518531|19534765|P2|Received Treatment|Treatment Period 1||124
7937860|NCT00518531|19534766|P1|Received Treatment|Treatment Period 1||119
7937861|NCT00518531|19534765|P2|STARTED|Treatment Period 1||126
7937862|NCT00518531|19534766|P1|STARTED|Treatment Period 1||124
7937863|NCT00518349|19534802|P2|NOT COMPLETED|Overall Study||0
7937864|NCT00518349|19534803|P1|NOT COMPLETED|Overall Study||0
7937865|NCT00518349|19534802|P2|COMPLETED|Overall Study||60
7937866|NCT00518349|19534803|P1|COMPLETED|Overall Study||60
7937867|NCT00518349|19534802|P2|STARTED|Overall Study||60
7937868|NCT00518349|19534803|P1|STARTED|Overall Study||60
7937869|NCT00518336|19534811|P2|NOT COMPLETED|Year 9||1
7937870|NCT00518336|19534812|P1|NOT COMPLETED|Year 9||5
7937871|NCT00518336|19534811|P2|COMPLETED|Year 9||212
7937872|NCT00518336|19534812|P1|COMPLETED|Year 9||219
7937873|NCT00518336|19534811|P2|STARTED|Year 9||213
7937874|NCT00518336|19534812|P1|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224
7937875|NCT00518336|19534811|P2|NOT COMPLETED|Year 8||2
7937876|NCT00518336|19534812|P1|NOT COMPLETED|Year 8||1
7937877|NCT00518336|19534811|P2|COMPLETED|Year 8||211
7937878|NCT00518336|19534812|P1|COMPLETED|Year 8||222
7937879|NCT00518336|19534811|P2|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213
7937880|NCT00518336|19534812|P1|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223
7937881|NCT00518336|19534811|P2|NOT COMPLETED|Year 7||3
7937882|NCT00518336|19534812|P1|NOT COMPLETED|Year 7||2
7937883|NCT00518336|19534811|P2|COMPLETED|Year 7||208
7937884|NCT00518336|19534812|P1|COMPLETED|Year 7||220
7937885|NCT00518336|19534811|P2|STARTED|Year 7||211
7937886|NCT00518336|19534812|P1|STARTED|Year 7||222
7937887|NCT00518323|19534978|P4|NOT COMPLETED|Overall Study||25
7937888|NCT00518323|19534979|P3|NOT COMPLETED|Overall Study||11
7937889|NCT00518323|19534980|P2|NOT COMPLETED|Overall Study||8
7937890|NCT00518323|19534981|P1|NOT COMPLETED|Overall Study||19
7937891|NCT00518323|19534978|P4|COMPLETED|Overall Study||26
7937892|NCT00518323|19534979|P3|COMPLETED|Overall Study||37
7937893|NCT00518323|19534980|P2|COMPLETED|Overall Study||40
7937894|NCT00518323|19534981|P1|COMPLETED|Overall Study||35
7937895|NCT00518323|19534978|P4|STARTED|Overall Study||51
7937896|NCT00518323|19534979|P3|STARTED|Overall Study||48
7937897|NCT00518323|19534980|P2|STARTED|Overall Study||48
7937898|NCT00518323|19534981|P1|STARTED|Overall Study||54
7937899|NCT00518284|19535011|P4|NOT COMPLETED|Overall Study||2
7937900|NCT00518284|19535012|P3|NOT COMPLETED|Overall Study||1
7937901|NCT00518284|19535013|P2|NOT COMPLETED|Overall Study||3
7937902|NCT00518284|19535014|P1|NOT COMPLETED|Overall Study||0
7937903|NCT00518284|19535011|P4|COMPLETED|Overall Study||0
7937904|NCT00518284|19535012|P3|COMPLETED|Overall Study||0
7937905|NCT00518284|19535013|P2|COMPLETED|Overall Study||0
7937906|NCT00518284|19535014|P1|COMPLETED|Overall Study||0
7937907|NCT00518284|19535011|P4|STARTED|Overall Study||2
7937908|NCT00518284|19535012|P3|STARTED|Overall Study||1
7937909|NCT00518284|19535013|P2|STARTED|Overall Study||3
7937910|NCT00518284|19535014|P1|STARTED|Overall Study||0
7937911|NCT00518206|19535070|P2|NOT COMPLETED|Overall Study||6
7937912|NCT00518206|19535071|P1|NOT COMPLETED|Overall Study||11
7937913|NCT00518206|19535070|P2|COMPLETED|Overall Study||13
7937914|NCT00518206|19535071|P1|COMPLETED|Overall Study||16
7937915|NCT00518206|19535070|P2|STARTED|Overall Study||19
7937916|NCT00518206|19535071|P1|STARTED|Overall Study||27
7937917|NCT00518180|19535088|P3|NOT COMPLETED|Overall Study||82
7937918|NCT00518180|19535089|P2|NOT COMPLETED|Overall Study||69
7937919|NCT00518180|19535090|P1|NOT COMPLETED|Overall Study||65
7937920|NCT00518180|19535088|P3|COMPLETED|Overall Study||457
7937921|NCT00518180|19535089|P2|COMPLETED|Overall Study||472
7937922|NCT00518180|19535090|P1|COMPLETED|Overall Study||475
7937923|NCT00518180|19535088|P3|STARTED|Overall Study||539
7937924|NCT00518180|19535089|P2|STARTED|Overall Study||541
7937925|NCT00518180|19535090|P1|STARTED|Overall Study||540
7937926|NCT00518154|19535132|P1|NOT COMPLETED|Overall Study||0
7937927|NCT00518154|19535132|P1|COMPLETED|Overall Study||7
7937928|NCT00518154|19535132|P1|STARTED|Overall Study||7
7937929|NCT00518115|19535146|P10|NOT COMPLETED|Overall Study||15
7937930|NCT00518115|19535147|P9|NOT COMPLETED|Overall Study||5
7937931|NCT00518115|19535148|P8|NOT COMPLETED|Overall Study||15
7937932|NCT00518115|19535149|P7|NOT COMPLETED|Overall Study||8
7937933|NCT00518115|19535150|P6|NOT COMPLETED|Overall Study||15
7937934|NCT00518115|19535151|P5|NOT COMPLETED|Overall Study||10
7937935|NCT00518115|19535152|P4|NOT COMPLETED|Overall Study||11
7937936|NCT00518115|19535153|P3|NOT COMPLETED|Overall Study||17
7937937|NCT00518115|19535154|P2|NOT COMPLETED|Overall Study||6
7937938|NCT00518115|19535155|P1|NOT COMPLETED|Overall Study||12
7937939|NCT00518115|19535146|P10|COMPLETED|Overall Study||20
7937940|NCT00518115|19535147|P9|COMPLETED|Overall Study||30
7937941|NCT00518115|19535148|P8|COMPLETED|Overall Study||20
7937942|NCT00518115|19535149|P7|COMPLETED|Overall Study||25
7937943|NCT00518115|19535150|P6|COMPLETED|Overall Study||19
7937944|NCT00518115|19535151|P5|COMPLETED|Overall Study||21
7937945|NCT00518115|19535152|P4|COMPLETED|Overall Study||24
7937946|NCT00518115|19535153|P3|COMPLETED|Overall Study||19
7937947|NCT00518115|19535154|P2|COMPLETED|Overall Study||29
7937948|NCT00518115|19535155|P1|COMPLETED|Overall Study||40
7937949|NCT00518115|19535146|P10|Safety Population|Overall Study|These participants received at least one dose of study drug.|34
7937950|NCT00518115|19535147|P9|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
7937951|NCT00518115|19535148|P8|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
7937952|NCT00518115|19535149|P7|Safety Population|Overall Study|These participants received at least one dose of study drug.|32
7937953|NCT00518115|19535150|P6|Safety Population|Overall Study|These participants received at least one dose of study drug.|33
7937954|NCT00518115|19535151|P5|Safety Population|Overall Study|These participants received at least one dose of study drug.|31
7937955|NCT00518115|19535152|P4|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
7937956|NCT00518115|19535153|P3|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
7937957|NCT00518115|19535154|P2|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
7937958|NCT00518115|19535155|P1|Safety Population|Overall Study|These participants received at least one dose of study drug.|51
7937959|NCT00518115|19535146|P10|STARTED|Overall Study||35
7937960|NCT00518115|19535147|P9|STARTED|Overall Study||35
7937961|NCT00518115|19535148|P8|STARTED|Overall Study||35
7937962|NCT00518115|19535149|P7|STARTED|Overall Study||33
7937963|NCT00518115|19535150|P6|STARTED|Overall Study||34
7937964|NCT00518115|19535151|P5|STARTED|Overall Study||31
7937965|NCT00518115|19535152|P4|STARTED|Overall Study||35
7937966|NCT00518115|19535153|P3|STARTED|Overall Study||36
7937967|NCT00518115|19535154|P2|STARTED|Overall Study||35
7937968|NCT00518115|19535155|P1|STARTED|Overall Study||52
7937969|NCT00518089|19535313|P2|NOT COMPLETED|Overall Study||31
7937970|NCT00518089|19535314|P1|NOT COMPLETED|Overall Study||28
7937971|NCT00518089|19535313|P2|COMPLETED|Overall Study||398
7937972|NCT00518089|19535314|P1|COMPLETED|Overall Study||402
7937973|NCT00518089|19535313|P2|STARTED|Overall Study||429
7937974|NCT00518089|19535314|P1|STARTED|Overall Study||430
7937975|NCT00518011|19535330|P2|NOT COMPLETED|Overall Study||8
7937976|NCT00518011|19535331|P1|NOT COMPLETED|Overall Study||9
7937977|NCT00518011|19535330|P2|COMPLETED|Overall Study||0
7937978|NCT00518011|19535331|P1|COMPLETED|Overall Study||0
7937979|NCT00518011|19535330|P2|STARTED|Overall Study||8
7937980|NCT00518011|19535331|P1|STARTED|Overall Study||9
7937981|NCT00517933|19535353|P2|NOT COMPLETED|Period 2||13
7937982|NCT00517933|19535354|P1|NOT COMPLETED|Period 2||6
7937983|NCT00517933|19535353|P2|COMPLETED|Period 2||70
7937984|NCT00517933|19535354|P1|COMPLETED|Period 2||73
7937985|NCT00517933|19535353|P2|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83
7937986|NCT00517933|19535354|P1|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79
7937987|NCT00517933|19535353|P2|NOT COMPLETED|Period 1||6
7937988|NCT00517933|19535354|P1|NOT COMPLETED|Period 1||8
7937989|NCT00517933|19535353|P2|COMPLETED|Period 1||85
7937990|NCT00517933|19535354|P1|COMPLETED|Period 1||81
7937991|NCT00517933|19535353|P2|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91
7937992|NCT00517933|19535354|P1|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89
7937993|NCT00517881|19535418|P1|NOT COMPLETED|Overall Study||5
7937994|NCT00517881|19535418|P1|COMPLETED|Overall Study||24
7937995|NCT00517881|19535418|P1|STARTED|Overall Study||29
7937996|NCT00517829|19535430|P2|NOT COMPLETED|Overall Study||75
7937997|NCT00517829|19535431|P1|NOT COMPLETED|Overall Study||75
7937998|NCT00517829|19535430|P2|COMPLETED|Overall Study||0
7937999|NCT00517829|19535431|P1|COMPLETED|Overall Study||0
7938000|NCT00517829|19535430|P2|STARTED|Overall Study||75
7938001|NCT00517829|19535431|P1|STARTED|Overall Study||75
7938002|NCT00517751|19535445|P1|NOT COMPLETED|Overall Study||129
7938003|NCT00517751|19535445|P1|COMPLETED|Overall Study||33
7938004|NCT00517751|19535445|P1|STARTED|Overall Study||162
7938005|NCT00517699|19535468|P1|NOT COMPLETED|Overall Study||5
7938006|NCT00517699|19535468|P1|COMPLETED|Overall Study||0
7938007|NCT00517699|19535468|P1|STARTED|Overall Study||5
7938008|NCT00517634|19535476|P6|NOT COMPLETED|Third Treatment Period||0
7938009|NCT00517634|19535477|P5|NOT COMPLETED|Third Treatment Period||0
7938010|NCT00517634|19535478|P4|NOT COMPLETED|Third Treatment Period||0
7938011|NCT00517634|19535479|P3|NOT COMPLETED|Third Treatment Period||0
7938012|NCT00517634|19535480|P2|NOT COMPLETED|Third Treatment Period||0
7938013|NCT00517634|19535481|P1|NOT COMPLETED|Third Treatment Period||0
7938014|NCT00517634|19535476|P6|COMPLETED|Third Treatment Period||4
7938015|NCT00517634|19535477|P5|COMPLETED|Third Treatment Period||3
7938016|NCT00517634|19535478|P4|COMPLETED|Third Treatment Period||3
7938017|NCT00517634|19535479|P3|COMPLETED|Third Treatment Period||4
7938018|NCT00517634|19535480|P2|COMPLETED|Third Treatment Period||4
7938019|NCT00517634|19535481|P1|COMPLETED|Third Treatment Period||4
7938020|NCT00517634|19535476|P6|STARTED|Third Treatment Period||4
7938021|NCT00517634|19535477|P5|STARTED|Third Treatment Period||3
7938022|NCT00517634|19535478|P4|STARTED|Third Treatment Period||3
7938023|NCT00517634|19535479|P3|STARTED|Third Treatment Period||4
7938024|NCT00517634|19535480|P2|STARTED|Third Treatment Period||4
7938025|NCT00517634|19535481|P1|STARTED|Third Treatment Period||4
7938026|NCT00517634|19535476|P6|NOT COMPLETED|Second Treatment Period||0
7938027|NCT00517634|19535477|P5|NOT COMPLETED|Second Treatment Period||1
7938028|NCT00517634|19535478|P4|NOT COMPLETED|Second Treatment Period||0
7938029|NCT00517634|19535479|P3|NOT COMPLETED|Second Treatment Period||0
7938030|NCT00517634|19535480|P2|NOT COMPLETED|Second Treatment Period||0
7938031|NCT00517634|19535481|P1|NOT COMPLETED|Second Treatment Period||0
7938032|NCT00517634|19535476|P6|COMPLETED|Second Treatment Period||4
7938033|NCT00517634|19535477|P5|COMPLETED|Second Treatment Period||3
7938034|NCT00517634|19535478|P4|COMPLETED|Second Treatment Period||3
7938035|NCT00517634|19535479|P3|COMPLETED|Second Treatment Period||4
7938036|NCT00517634|19535480|P2|COMPLETED|Second Treatment Period||4
7938037|NCT00517634|19535481|P1|COMPLETED|Second Treatment Period||4
7938038|NCT00517634|19535476|P6|STARTED|Second Treatment Period||4
7938039|NCT00517634|19535477|P5|STARTED|Second Treatment Period||4
7938040|NCT00517634|19535478|P4|STARTED|Second Treatment Period||3
7938041|NCT00517634|19535479|P3|STARTED|Second Treatment Period||4
7938042|NCT00517634|19535480|P2|STARTED|Second Treatment Period||4
7938043|NCT00517634|19535481|P1|STARTED|Second Treatment Period||4
7938044|NCT00517634|19535476|P6|NOT COMPLETED|First Treatment Period||0
7938045|NCT00517634|19535477|P5|NOT COMPLETED|First Treatment Period||0
7938046|NCT00517634|19535478|P4|NOT COMPLETED|First Treatment Period||0
7938047|NCT00517634|19535479|P3|NOT COMPLETED|First Treatment Period||0
7938048|NCT00517634|19535480|P2|NOT COMPLETED|First Treatment Period||0
7938049|NCT00517634|19535481|P1|NOT COMPLETED|First Treatment Period||0
7938050|NCT00517634|19535476|P6|COMPLETED|First Treatment Period||4
7938051|NCT00517634|19535477|P5|COMPLETED|First Treatment Period||4
7938052|NCT00517634|19535478|P4|COMPLETED|First Treatment Period||3
7938053|NCT00517634|19535479|P3|COMPLETED|First Treatment Period||4
7938054|NCT00517634|19535480|P2|COMPLETED|First Treatment Period||4
7938055|NCT00517634|19535481|P1|COMPLETED|First Treatment Period||4
7938056|NCT00517634|19535476|P6|STARTED|First Treatment Period||4
7938057|NCT00517634|19535477|P5|STARTED|First Treatment Period||4
7938058|NCT00517634|19535478|P4|STARTED|First Treatment Period||3
7938059|NCT00517634|19535479|P3|STARTED|First Treatment Period||4
7938060|NCT00517634|19535480|P2|STARTED|First Treatment Period||4
7938061|NCT00517634|19535481|P1|STARTED|First Treatment Period||4
7938062|NCT00517595|19535492|P1|NOT COMPLETED|Overall Study||0
7938063|NCT00517595|19535492|P1|COMPLETED|Overall Study||48
7938064|NCT00517595|19535492|P1|STARTED|Overall Study||48
7938065|NCT00517556|19535503|P2|NOT COMPLETED|Overall Study||5
7938066|NCT00517556|19535504|P1|NOT COMPLETED|Overall Study||4
7938067|NCT00517556|19535503|P2|COMPLETED|Overall Study||14
7938068|NCT00517556|19535504|P1|COMPLETED|Overall Study||15
7938069|NCT00517556|19535503|P2|STARTED|Overall Study||19
7938070|NCT00517556|19535504|P1|STARTED|Overall Study||19
7938071|NCT00517530|19535517|P7|NOT COMPLETED|Overall Study||19
7938072|NCT00517530|19535518|P6|NOT COMPLETED|Overall Study||19
7938073|NCT00517530|19535519|P5|NOT COMPLETED|Overall Study||20
7938074|NCT00517530|19535520|P4|NOT COMPLETED|Overall Study||21
7938075|NCT00517530|19535521|P3|NOT COMPLETED|Overall Study||18
7938076|NCT00517530|19535522|P2|NOT COMPLETED|Overall Study||13
7938077|NCT00517530|19535523|P1|NOT COMPLETED|Overall Study||19
7938078|NCT00517530|19535517|P7|COMPLETED|Overall Study||1
7938079|NCT00517530|19535518|P6|COMPLETED|Overall Study||0
7938080|NCT00517530|19535519|P5|COMPLETED|Overall Study||1
7938081|NCT00517530|19535520|P4|COMPLETED|Overall Study||1
7938082|NCT00517530|19535521|P3|COMPLETED|Overall Study||0
7938083|NCT00517530|19535522|P2|COMPLETED|Overall Study||0
7938084|NCT00517530|19535523|P1|COMPLETED|Overall Study||2
7938085|NCT00517530|19535517|P7|Retreated Population|Overall Study||0
7938086|NCT00517530|19535518|P6|Retreated Population|Overall Study||2
7938087|NCT00517530|19535519|P5|Retreated Population|Overall Study||2
7938088|NCT00517530|19535520|P4|Retreated Population|Overall Study||4
7938089|NCT00517530|19535521|P3|Retreated Population|Overall Study||1
7938090|NCT00517530|19535522|P2|Retreated Population|Overall Study||2
7938091|NCT00517530|19535523|P1|Retreated Population|Overall Study||2
7938092|NCT00517530|19535517|P7|Completed Follow-up|Overall Study||1
7938093|NCT00517530|19535518|P6|Completed Follow-up|Overall Study||0
7938094|NCT00517530|19535519|P5|Completed Follow-up|Overall Study||0
7938095|NCT00517530|19535520|P4|Completed Follow-up|Overall Study||1
7938096|NCT00517530|19535521|P3|Completed Follow-up|Overall Study||0
7938097|NCT00517530|19535522|P2|Completed Follow-up|Overall Study||0
7938098|NCT00517530|19535523|P1|Completed Follow-up|Overall Study||2
7938099|NCT00517530|19535517|P7|Started Follow-up|Overall Study||19
7938100|NCT00517530|19535518|P6|Started Follow-up|Overall Study||16
7938101|NCT00517530|19535519|P5|Started Follow-up|Overall Study||17
7938102|NCT00517530|19535520|P4|Started Follow-up|Overall Study||21
7938103|NCT00517530|19535521|P3|Started Follow-up|Overall Study||17
7938104|NCT00517530|19535522|P2|Started Follow-up|Overall Study||13
7938105|NCT00517530|19535523|P1|Started Follow-up|Overall Study||20
7938106|NCT00517530|19535517|P7|Completed Treatment|Overall Study||13
7938107|NCT00517530|19535518|P6|Completed Treatment|Overall Study||9
7938108|NCT00517530|19535519|P5|Completed Treatment|Overall Study||9
7938109|NCT00517530|19535520|P4|Completed Treatment|Overall Study||18
7938110|NCT00517530|19535521|P3|Completed Treatment|Overall Study||13
7938111|NCT00517530|19535522|P2|Completed Treatment|Overall Study||13
7938112|NCT00517530|19535523|P1|Completed Treatment|Overall Study||11
7938113|NCT00517530|19535517|P7|STARTED|Overall Study||20
7938114|NCT00517530|19535518|P6|STARTED|Overall Study||19
7938115|NCT00517530|19535519|P5|STARTED|Overall Study||21
7938116|NCT00517530|19535520|P4|STARTED|Overall Study||22
7938117|NCT00517530|19535521|P3|STARTED|Overall Study||18
7938118|NCT00517530|19535522|P2|STARTED|Overall Study||13
7938119|NCT00517530|19535523|P1|STARTED|Overall Study||21
7938120|NCT00517413|19535583|P1|NOT COMPLETED|Overall Study||61
7938121|NCT00517413|19535583|P1|COMPLETED|Overall Study||102
7938122|NCT00517413|19535583|P1|STARTED|Overall Study||163
7938123|NCT00517361|19535604|P1|NOT COMPLETED|Overall Study||11
7938124|NCT00517361|19535604|P1|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0
7938125|NCT00517361|19535604|P1|STARTED|Overall Study||11
7938126|NCT00517296|19535613|P2|NOT COMPLETED|Overall Study||0
7938127|NCT00517296|19535614|P1|NOT COMPLETED|Overall Study||1
7938128|NCT00517296|19535613|P2|COMPLETED|Overall Study||11
7938129|NCT00517296|19535614|P1|COMPLETED|Overall Study||9
7938130|NCT00517296|19535613|P2|STARTED|Overall Study||11
7938131|NCT00517296|19535614|P1|STARTED|Overall Study||10
7938132|NCT00517192|19535626|P2|NOT COMPLETED|Overall Study||20
7938133|NCT00517192|19535627|P1|NOT COMPLETED|Overall Study||19
7938134|NCT00517192|19535626|P2|COMPLETED|Overall Study||0
7938135|NCT00517192|19535627|P1|COMPLETED|Overall Study||0
7938136|NCT00517192|19535626|P2|STARTED|Overall Study||20
7938137|NCT00517192|19535627|P1|STARTED|Overall Study||19
7938138|NCT00517075|19535679|P4|NOT COMPLETED|Overall Study||0
7938139|NCT00517075|19535680|P3|NOT COMPLETED|Overall Study||0
7938140|NCT00517075|19535681|P2|NOT COMPLETED|Overall Study||0
7938141|NCT00517075|19535682|P1|NOT COMPLETED|Overall Study||0
7938142|NCT00517075|19535679|P4|COMPLETED|Overall Study||0
7938143|NCT00517075|19535680|P3|COMPLETED|Overall Study||0
7938144|NCT00517075|19535681|P2|COMPLETED|Overall Study||0
7938145|NCT00517075|19535682|P1|COMPLETED|Overall Study||0
7938146|NCT00517075|19535679|P4|STARTED|Overall Study||0
7938147|NCT00517075|19535680|P3|STARTED|Overall Study||0
7938148|NCT00517075|19535681|P2|STARTED|Overall Study||0
7938149|NCT00517075|19535682|P1|STARTED|Overall Study||0
7938150|NCT00517010|19535720|P1|NOT COMPLETED|Overall Study||1
7938151|NCT00517010|19535720|P1|COMPLETED|Overall Study||5
7938152|NCT00517010|19535720|P1|STARTED|Overall Study||6
7938153|NCT00516919|19535725|P2|NOT COMPLETED|Overall Study||7
7938154|NCT00516919|19535726|P1|NOT COMPLETED|Overall Study||10
7938155|NCT00516919|19535725|P2|COMPLETED|Overall Study||32
7938156|NCT00516919|19535726|P1|COMPLETED|Overall Study||30
7938157|NCT00516919|19535725|P2|STARTED|Overall Study||39
7938158|NCT00516919|19535726|P1|STARTED|Overall Study||40
7938159|NCT00516906|19535734|P2|NOT COMPLETED|Overall Study||2
7938160|NCT00516906|19535735|P1|NOT COMPLETED|Overall Study||6
7938161|NCT00516906|19535734|P2|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
7938162|NCT00516906|19535735|P1|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
7938163|NCT00516906|19535734|P2|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32
7938164|NCT00516906|19535735|P1|STARTED|Overall Study||36
7938165|NCT00516893|19535745|P1|NOT COMPLETED|Overall Study||21
7938166|NCT00516893|19535745|P1|COMPLETED|Overall Study||92
7938167|NCT00516893|19535745|P1|Received Study Treatment|Overall Study||112
7938168|NCT00516893|19535745|P1|STARTED|Overall Study||113
7938169|NCT00516737|19535754|P2|NOT COMPLETED|Overall Study||8
7938170|NCT00516737|19535755|P1|NOT COMPLETED|Overall Study||11
7938171|NCT00516737|19535754|P2|COMPLETED|Overall Study||96
7938172|NCT00516737|19535755|P1|COMPLETED|Overall Study||92
7938173|NCT00516737|19535754|P2|STARTED|Overall Study||104
7938174|NCT00516737|19535755|P1|STARTED|Overall Study||103
7938175|NCT00516503|19535775|P2|NOT COMPLETED|Overall Study||0
7938176|NCT00516503|19535776|P1|NOT COMPLETED|Overall Study||0
7938177|NCT00516503|19535775|P2|COMPLETED|Overall Study||102
7938178|NCT00516503|19535776|P1|COMPLETED|Overall Study||101
7938179|NCT00516503|19535775|P2|STARTED|Overall Study||102
7938180|NCT00516503|19535776|P1|STARTED|Overall Study||101
7938181|NCT00516386|19535794|P1|NOT COMPLETED|Overall Study||6
7938182|NCT00516386|19535794|P1|COMPLETED|Overall Study||10
7938183|NCT00516386|19535794|P1|STARTED|Overall Study||16
7938184|NCT00516321|19535801|P3|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54
7938185|NCT00516321|19535802|P2|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35
7938186|NCT00516321|19535803|P1|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0
7938187|NCT00516321|19535801|P3|COMPLETED|Double-blind (DB) Antiviral Treatment||396
7938188|NCT00516321|19535802|P2|COMPLETED|Double-blind (DB) Antiviral Treatment||197
7938189|NCT00516321|19535803|P1|COMPLETED|Double-blind (DB) Antiviral Treatment||0
7938190|NCT00516321|19535801|P3|STARTED|Double-blind (DB) Antiviral Treatment||450
7938191|NCT00516321|19535802|P2|STARTED|Double-blind (DB) Antiviral Treatment||232
7938192|NCT00516321|19535803|P1|STARTED|Double-blind (DB) Antiviral Treatment||0
7938193|NCT00516321|19535801|P3|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
7938194|NCT00516321|19535802|P2|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
7938195|NCT00516321|19535803|P1|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33
7938196|NCT00516321|19535801|P3|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
7938197|NCT00516321|19535802|P2|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
7938198|NCT00516321|19535803|P1|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682
7938199|NCT00516321|19535801|P3|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
7938200|NCT00516321|19535802|P2|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
7938201|NCT00516321|19535803|P1|STARTED|Open-label (OL) Pre-Antiviral Treatment||715
7938202|NCT00516295|19535854|P3|NOT COMPLETED|Overall Study||0
7938203|NCT00516295|19535855|P2|NOT COMPLETED|Overall Study||0
7938204|NCT00516295|19535856|P1|NOT COMPLETED|Overall Study||3
7938205|NCT00516295|19535854|P3|COMPLETED|Overall Study||0
7938206|NCT00516295|19535855|P2|COMPLETED|Overall Study||0
7938207|NCT00516295|19535856|P1|COMPLETED|Overall Study||4
7938208|NCT00516295|19535854|P3|STARTED|Overall Study||0
7938209|NCT00516295|19535855|P2|STARTED|Overall Study||0
7938210|NCT00516295|19535856|P1|STARTED|Overall Study||7
7938211|NCT00516269|19535869|P2|NOT COMPLETED|Overall Study||3
7938212|NCT00516269|19535870|P1|NOT COMPLETED|Overall Study||2
7938213|NCT00516269|19535869|P2|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16
7938214|NCT00516269|19535870|P1|COMPLETED|Overall Study|2 patients had an early termination|17
7938215|NCT00516269|19535869|P2|STARTED|Overall Study||19
7938216|NCT00516269|19535870|P1|STARTED|Overall Study||19
7938217|NCT00516217|19535876|P1|NOT COMPLETED|Overall Study||0
7938218|NCT00516217|19535876|P1|COMPLETED|Overall Study||29
7938219|NCT00516217|19535876|P1|STARTED|Overall Study||29
7938220|NCT00516165|19535882|P1|NOT COMPLETED|Overall Study||0
7938221|NCT00516165|19535882|P1|COMPLETED|Overall Study||28
7938222|NCT00516165|19535882|P1|STARTED|Overall Study||28
7938223|NCT00516139|19535891|P1|NOT COMPLETED|Overall Study||38
7938224|NCT00516139|19535891|P1|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84
7938225|NCT00516139|19535891|P1|STARTED|Overall Study||122
7938226|NCT00516074|19535922|P2|NOT COMPLETED|Overall Study||3
7938227|NCT00516074|19535923|P1|NOT COMPLETED|Overall Study||6
7938228|NCT00516074|19535922|P2|COMPLETED|Overall Study||23
7938229|NCT00516074|19535923|P1|COMPLETED|Overall Study||22
7938230|NCT00516074|19535922|P2|STARTED|Overall Study||26
7938231|NCT00516074|19535923|P1|STARTED|Overall Study||28
7938232|NCT00516048|19535941|P3|NOT COMPLETED|Overall Study||1
7938233|NCT00516048|19535942|P2|NOT COMPLETED|Overall Study||2
7938234|NCT00516048|19535943|P1|NOT COMPLETED|Overall Study||0
7938235|NCT00516048|19535941|P3|COMPLETED|Overall Study||0
7938236|NCT00516048|19535942|P2|COMPLETED|Overall Study||40
7938237|NCT00516048|19535943|P1|COMPLETED|Overall Study||15
7938238|NCT00516048|19535941|P3|STARTED|Overall Study||1
7938239|NCT00516048|19535942|P2|STARTED|Overall Study||42
7938240|NCT00516048|19535943|P1|STARTED|Overall Study||15
7938241|NCT00515879|19535959|P2|NOT COMPLETED|Overall Study||20
7938242|NCT00515879|19535960|P1|NOT COMPLETED|Overall Study||25
7938243|NCT00515879|19535959|P2|COMPLETED|Overall Study||62
7938244|NCT00515879|19535960|P1|COMPLETED|Overall Study||62
7938245|NCT00515879|19535959|P2|STARTED|Overall Study||82
7938246|NCT00515879|19535960|P1|STARTED|Overall Study||87
7938247|NCT00515827|19535978|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
7938248|NCT00515827|19535979|P1|NOT COMPLETED|Second Intervention (12 Weeks)||1
7938249|NCT00515827|19535978|P2|COMPLETED|Second Intervention (12 Weeks)||25
7938250|NCT00515827|19535979|P1|COMPLETED|Second Intervention (12 Weeks)||25
7938251|NCT00515827|19535978|P2|STARTED|Second Intervention (12 Weeks)||25
7938252|NCT00515827|19535979|P1|STARTED|Second Intervention (12 Weeks)||26
7938253|NCT00515827|19535978|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
7938254|NCT00515827|19535979|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
7938255|NCT00515827|19535978|P2|COMPLETED|First Intervention (12 Weeks)||25
7938256|NCT00515827|19535979|P1|COMPLETED|First Intervention (12 Weeks)||26
7938257|NCT00515827|19535978|P2|STARTED|First Intervention (12 Weeks)||26
7938258|NCT00515827|19535979|P1|STARTED|First Intervention (12 Weeks)||27
7938259|NCT00515723|19536005|P4|NOT COMPLETED|Overall Study||6
7938260|NCT00515723|19536006|P3|NOT COMPLETED|Overall Study||1
7938261|NCT00515723|19536007|P2|NOT COMPLETED|Overall Study||1
7938262|NCT00515723|19536008|P1|NOT COMPLETED|Overall Study||5
7938263|NCT00515723|19536005|P4|COMPLETED|Overall Study||21
7938264|NCT00515723|19536006|P3|COMPLETED|Overall Study||21
7938265|NCT00515723|19536007|P2|COMPLETED|Overall Study||21
7938266|NCT00515723|19536008|P1|COMPLETED|Overall Study||20
7938267|NCT00515723|19536005|P4|STARTED|Overall Study||27
7938268|NCT00515723|19536006|P3|STARTED|Overall Study||22
7938269|NCT00515723|19536007|P2|STARTED|Overall Study||22
7938270|NCT00515723|19536008|P1|STARTED|Overall Study||25
7938271|NCT00515697|19536024|P1|NOT COMPLETED|Overall Study||0
7938272|NCT00515697|19536024|P1|COMPLETED|Overall Study||39
7938273|NCT00515697|19536024|P1|Received at Least 1 Dose of Study Drug|Overall Study||39
7938274|NCT00515697|19536024|P1|STARTED|Overall Study||39
7938275|NCT00515671|19536037|P2|NOT COMPLETED|Overall Study||17
7938276|NCT00515671|19536038|P1|NOT COMPLETED|Overall Study||17
7938277|NCT00515671|19536037|P2|COMPLETED|Overall Study||41
7938278|NCT00515671|19536038|P1|COMPLETED|Overall Study||43
7938279|NCT00515671|19536037|P2|STARTED|Overall Study||58
7938280|NCT00515671|19536038|P1|STARTED|Overall Study||60
7938281|NCT00515619|19536046|P1|NOT COMPLETED|Overall Study||216
7938282|NCT00515619|19536046|P1|COMPLETED|Overall Study||160
7938283|NCT00515619|19536046|P1|Safety Set|Overall Study||376
7938284|NCT00515619|19536046|P1|STARTED|Overall Study||376
7938285|NCT00515541|19536058|P4|NOT COMPLETED|Overall Study||5
7938286|NCT00515541|19536059|P3|NOT COMPLETED|Overall Study||0
7938287|NCT00515541|19536060|P2|NOT COMPLETED|Overall Study||5
7938288|NCT00515541|19536061|P1|NOT COMPLETED|Overall Study||0
7938289|NCT00515541|19536058|P4|COMPLETED|Overall Study||6
7938290|NCT00515541|19536059|P3|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
7938291|NCT00515541|19536060|P2|COMPLETED|Overall Study||7
7938292|NCT00515541|19536061|P1|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
7938293|NCT00515541|19536058|P4|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6
7938294|NCT00515541|19536059|P3|24 Weeks (8 gm Lovaza)|Overall Study||10
7938295|NCT00515541|19536060|P2|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7
7938296|NCT00515541|19536061|P1|24 Weeks (8 gm Lovaza)|Overall Study||10
7938297|NCT00515541|19536058|P4|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9
7938298|NCT00515541|19536059|P3|18 Weeks (4 gm Lovaza)|Overall Study||10
7938299|NCT00515541|19536060|P2|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9
7938300|NCT00515541|19536061|P1|18 Weeks (4 gm Lovaza)|Overall Study||10
7938301|NCT00515541|19536058|P4|12 Weeks (2 gm Lovaza)|Overall Study||10
7938302|NCT00515541|19536059|P3|12 Weeks (2 gm Lovaza)|Overall Study||10
7938303|NCT00515541|19536060|P2|12 Weeks (2 gm Lovaza)|Overall Study||10
7938304|NCT00515541|19536061|P1|12 Weeks (2 gm Lovaza)|Overall Study||10
7938305|NCT00515541|19536058|P4|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10
7938306|NCT00515541|19536059|P3|6 Weeks (1 gm Lovaza)|Overall Study||10
7938307|NCT00515541|19536060|P2|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10
7938308|NCT00515541|19536061|P1|6 Weeks (1 gm Lovaza)|Overall Study||10
7938309|NCT00515541|19536058|P4|STARTED|Overall Study||11
7938310|NCT00515541|19536059|P3|STARTED|Overall Study||10
7938311|NCT00515541|19536060|P2|STARTED|Overall Study||12
7938312|NCT00515541|19536061|P1|STARTED|Overall Study||10
7938313|NCT00515528|19536085|P2|NOT COMPLETED|Overall Study||0
7938314|NCT00515528|19536086|P1|NOT COMPLETED|Overall Study||0
7938315|NCT00515528|19536085|P2|COMPLETED|Overall Study||7
7938316|NCT00515528|19536086|P1|COMPLETED|Overall Study||10
7938317|NCT00515528|19536085|P2|STARTED|Overall Study||7
7938318|NCT00515528|19536086|P1|STARTED|Overall Study||10
7938319|NCT00515502|19536092|P12|NOT COMPLETED|Treatment Period 4||0
7938320|NCT00515502|19536093|P11|NOT COMPLETED|Treatment Period 4||0
7938321|NCT00515502|19536094|P10|NOT COMPLETED|Treatment Period 4||0
7938322|NCT00515502|19536095|P9|NOT COMPLETED|Treatment Period 4||0
7938323|NCT00515502|19536096|P8|NOT COMPLETED|Treatment Period 4||0
7938324|NCT00515502|19536097|P7|NOT COMPLETED|Treatment Period 4||0
7938325|NCT00515502|19536098|P6|NOT COMPLETED|Treatment Period 4||0
7938326|NCT00515502|19536099|P5|NOT COMPLETED|Treatment Period 4||0
7938327|NCT00515502|19536100|P4|NOT COMPLETED|Treatment Period 4||0
7938328|NCT00515502|19536101|P3|NOT COMPLETED|Treatment Period 4||0
7938329|NCT00515502|19536102|P2|NOT COMPLETED|Treatment Period 4||0
7938330|NCT00515502|19536103|P1|NOT COMPLETED|Treatment Period 4||0
7938331|NCT00515502|19536092|P12|COMPLETED|Treatment Period 4||0
7938332|NCT00515502|19536093|P11|COMPLETED|Treatment Period 4||1
7938333|NCT00515502|19536094|P10|COMPLETED|Treatment Period 4||2
7938334|NCT00515502|19536095|P9|COMPLETED|Treatment Period 4||0
7938335|NCT00515502|19536096|P8|COMPLETED|Treatment Period 4||1
7938336|NCT00515502|19536097|P7|COMPLETED|Treatment Period 4||1
7938337|NCT00515502|19536098|P6|COMPLETED|Treatment Period 4||1
7938338|NCT00515502|19536099|P5|COMPLETED|Treatment Period 4||3
7938339|NCT00515502|19536100|P4|COMPLETED|Treatment Period 4||3
7938340|NCT00515502|19536101|P3|COMPLETED|Treatment Period 4||4
7938341|NCT00515502|19536102|P2|COMPLETED|Treatment Period 4||3
7938342|NCT00515502|19536103|P1|COMPLETED|Treatment Period 4||1
7938343|NCT00515502|19536092|P12|STARTED|Treatment Period 4||0
7938344|NCT00515502|19536093|P11|STARTED|Treatment Period 4||1
7938345|NCT00515502|19536094|P10|STARTED|Treatment Period 4||2
7938346|NCT00515502|19536095|P9|STARTED|Treatment Period 4||0
7938347|NCT00515502|19536096|P8|STARTED|Treatment Period 4||1
7938348|NCT00515502|19536097|P7|STARTED|Treatment Period 4||1
7938349|NCT00515502|19536098|P6|STARTED|Treatment Period 4||1
7938350|NCT00515502|19536099|P5|STARTED|Treatment Period 4||3
7938351|NCT00515502|19536100|P4|STARTED|Treatment Period 4||3
7938352|NCT00515502|19536101|P3|STARTED|Treatment Period 4||4
7938353|NCT00515502|19536102|P2|STARTED|Treatment Period 4||3
7938354|NCT00515502|19536103|P1|STARTED|Treatment Period 4||1
7938355|NCT00515502|19536092|P12|NOT COMPLETED|Washout Period 3||0
7938356|NCT00515502|19536093|P11|NOT COMPLETED|Washout Period 3||0
7938357|NCT00515502|19536094|P10|NOT COMPLETED|Washout Period 3||0
7938358|NCT00515502|19536095|P9|NOT COMPLETED|Washout Period 3||0
7938359|NCT00515502|19536096|P8|NOT COMPLETED|Washout Period 3||0
7938360|NCT00515502|19536097|P7|NOT COMPLETED|Washout Period 3||0
7938361|NCT00515502|19536098|P6|NOT COMPLETED|Washout Period 3||0
7938362|NCT00515502|19536099|P5|NOT COMPLETED|Washout Period 3||0
7938363|NCT00515502|19536100|P4|NOT COMPLETED|Washout Period 3||0
7938364|NCT00515502|19536101|P3|NOT COMPLETED|Washout Period 3||0
7938365|NCT00515502|19536102|P2|NOT COMPLETED|Washout Period 3||0
7938366|NCT00515502|19536103|P1|NOT COMPLETED|Washout Period 3||0
7938367|NCT00515502|19536092|P12|COMPLETED|Washout Period 3||0
7938368|NCT00515502|19536093|P11|COMPLETED|Washout Period 3||1
7938369|NCT00515502|19536094|P10|COMPLETED|Washout Period 3||2
7938370|NCT00515502|19536095|P9|COMPLETED|Washout Period 3||0
7938371|NCT00515502|19536096|P8|COMPLETED|Washout Period 3||1
7938372|NCT00515502|19536097|P7|COMPLETED|Washout Period 3||1
7938373|NCT00515502|19536098|P6|COMPLETED|Washout Period 3||1
7938374|NCT00515502|19536099|P5|COMPLETED|Washout Period 3||3
7938375|NCT00515502|19536100|P4|COMPLETED|Washout Period 3||3
7938376|NCT00515502|19536101|P3|COMPLETED|Washout Period 3||4
7938377|NCT00515502|19536102|P2|COMPLETED|Washout Period 3||3
7938378|NCT00515502|19536103|P1|COMPLETED|Washout Period 3||1
7938379|NCT00515502|19536092|P12|STARTED|Washout Period 3||0
7938380|NCT00515502|19536093|P11|STARTED|Washout Period 3||1
7938381|NCT00515502|19536094|P10|STARTED|Washout Period 3||2
7938382|NCT00515502|19536095|P9|STARTED|Washout Period 3||0
7938383|NCT00515502|19536096|P8|STARTED|Washout Period 3||1
7938384|NCT00515502|19536097|P7|STARTED|Washout Period 3||1
7938385|NCT00515502|19536098|P6|STARTED|Washout Period 3||1
7938386|NCT00515502|19536099|P5|STARTED|Washout Period 3||3
7938387|NCT00515502|19536100|P4|STARTED|Washout Period 3||3
7938388|NCT00515502|19536101|P3|STARTED|Washout Period 3||4
7938389|NCT00515502|19536102|P2|STARTED|Washout Period 3||3
7938390|NCT00515502|19536103|P1|STARTED|Washout Period 3||1
7938391|NCT00515502|19536092|P12|NOT COMPLETED|Treatment Period 3||0
7938392|NCT00515502|19536093|P11|NOT COMPLETED|Treatment Period 3||0
7938393|NCT00515502|19536094|P10|NOT COMPLETED|Treatment Period 3||0
7938394|NCT00515502|19536095|P9|NOT COMPLETED|Treatment Period 3||0
7938395|NCT00515502|19536096|P8|NOT COMPLETED|Treatment Period 3||0
7938396|NCT00515502|19536097|P7|NOT COMPLETED|Treatment Period 3||0
7938397|NCT00515502|19536098|P6|NOT COMPLETED|Treatment Period 3||0
7938398|NCT00515502|19536099|P5|NOT COMPLETED|Treatment Period 3||0
7938399|NCT00515502|19536100|P4|NOT COMPLETED|Treatment Period 3||0
7938400|NCT00515502|19536101|P3|NOT COMPLETED|Treatment Period 3||0
7938401|NCT00515502|19536102|P2|NOT COMPLETED|Treatment Period 3||0
7938402|NCT00515502|19536103|P1|NOT COMPLETED|Treatment Period 3||0
7938403|NCT00515502|19536092|P12|COMPLETED|Treatment Period 3||0
7938404|NCT00515502|19536093|P11|COMPLETED|Treatment Period 3||1
7938405|NCT00515502|19536094|P10|COMPLETED|Treatment Period 3||2
7938406|NCT00515502|19536095|P9|COMPLETED|Treatment Period 3||0
7938407|NCT00515502|19536096|P8|COMPLETED|Treatment Period 3||1
7938408|NCT00515502|19536097|P7|COMPLETED|Treatment Period 3||1
7938409|NCT00515502|19536098|P6|COMPLETED|Treatment Period 3||1
7938410|NCT00515502|19536099|P5|COMPLETED|Treatment Period 3||3
7938411|NCT00515502|19536100|P4|COMPLETED|Treatment Period 3||3
7938412|NCT00515502|19536101|P3|COMPLETED|Treatment Period 3||4
7938413|NCT00515502|19536102|P2|COMPLETED|Treatment Period 3||3
7938414|NCT00515502|19536103|P1|COMPLETED|Treatment Period 3||1
7938415|NCT00515502|19536092|P12|STARTED|Treatment Period 3||0
7938416|NCT00515502|19536093|P11|STARTED|Treatment Period 3||1
7938417|NCT00515502|19536094|P10|STARTED|Treatment Period 3||2
7938418|NCT00515502|19536095|P9|STARTED|Treatment Period 3||0
7938419|NCT00515502|19536096|P8|STARTED|Treatment Period 3||1
7938420|NCT00515502|19536097|P7|STARTED|Treatment Period 3||1
7938421|NCT00515502|19536098|P6|STARTED|Treatment Period 3||1
7938422|NCT00515502|19536099|P5|STARTED|Treatment Period 3||3
7938423|NCT00515502|19536100|P4|STARTED|Treatment Period 3||3
7938424|NCT00515502|19536101|P3|STARTED|Treatment Period 3||4
7938425|NCT00515502|19536102|P2|STARTED|Treatment Period 3||3
7938426|NCT00515502|19536103|P1|STARTED|Treatment Period 3||1
7938427|NCT00515502|19536092|P12|NOT COMPLETED|Washout Period 2||0
7938428|NCT00515502|19536093|P11|NOT COMPLETED|Washout Period 2||0
7938429|NCT00515502|19536094|P10|NOT COMPLETED|Washout Period 2||0
7938430|NCT00515502|19536095|P9|NOT COMPLETED|Washout Period 2||0
7938431|NCT00515502|19536096|P8|NOT COMPLETED|Washout Period 2||0
7938432|NCT00515502|19536097|P7|NOT COMPLETED|Washout Period 2||0
7938433|NCT00515502|19536098|P6|NOT COMPLETED|Washout Period 2||0
7938434|NCT00515502|19536099|P5|NOT COMPLETED|Washout Period 2||0
7938435|NCT00515502|19536100|P4|NOT COMPLETED|Washout Period 2||0
7938436|NCT00515502|19536101|P3|NOT COMPLETED|Washout Period 2||0
7938437|NCT00515502|19536102|P2|NOT COMPLETED|Washout Period 2||0
7938438|NCT00515502|19536103|P1|NOT COMPLETED|Washout Period 2||0
7938439|NCT00515502|19536092|P12|COMPLETED|Washout Period 2||0
7938440|NCT00515502|19536093|P11|COMPLETED|Washout Period 2||1
7938441|NCT00515502|19536094|P10|COMPLETED|Washout Period 2||2
7938442|NCT00515502|19536095|P9|COMPLETED|Washout Period 2||0
7938443|NCT00515502|19536096|P8|COMPLETED|Washout Period 2||1
7938444|NCT00515502|19536097|P7|COMPLETED|Washout Period 2||1
7938445|NCT00515502|19536098|P6|COMPLETED|Washout Period 2||1
7938446|NCT00515502|19536099|P5|COMPLETED|Washout Period 2||3
7938447|NCT00515502|19536100|P4|COMPLETED|Washout Period 2||3
7938448|NCT00515502|19536101|P3|COMPLETED|Washout Period 2||4
7938449|NCT00515502|19536102|P2|COMPLETED|Washout Period 2||3
7938450|NCT00515502|19536103|P1|COMPLETED|Washout Period 2||1
7938451|NCT00515502|19536092|P12|STARTED|Washout Period 2||0
7938452|NCT00515502|19536093|P11|STARTED|Washout Period 2||1
7938453|NCT00515502|19536094|P10|STARTED|Washout Period 2||2
7938454|NCT00515502|19536095|P9|STARTED|Washout Period 2||0
7938455|NCT00515502|19536096|P8|STARTED|Washout Period 2||1
7938456|NCT00515502|19536097|P7|STARTED|Washout Period 2||1
7938457|NCT00515502|19536098|P6|STARTED|Washout Period 2||1
7938458|NCT00515502|19536099|P5|STARTED|Washout Period 2||3
7938459|NCT00515502|19536100|P4|STARTED|Washout Period 2||3
7938460|NCT00515502|19536101|P3|STARTED|Washout Period 2||4
7938461|NCT00515502|19536102|P2|STARTED|Washout Period 2||3
7938462|NCT00515502|19536103|P1|STARTED|Washout Period 2||1
7938463|NCT00515502|19536092|P12|NOT COMPLETED|Treatment Period 2||0
7938464|NCT00515502|19536093|P11|NOT COMPLETED|Treatment Period 2||0
7938465|NCT00515502|19536094|P10|NOT COMPLETED|Treatment Period 2||0
7938466|NCT00515502|19536095|P9|NOT COMPLETED|Treatment Period 2||0
7938467|NCT00515502|19536096|P8|NOT COMPLETED|Treatment Period 2||0
7938468|NCT00515502|19536097|P7|NOT COMPLETED|Treatment Period 2||0
7938469|NCT00515502|19536098|P6|NOT COMPLETED|Treatment Period 2||0
7938470|NCT00515502|19536099|P5|NOT COMPLETED|Treatment Period 2||0
7938471|NCT00515502|19536100|P4|NOT COMPLETED|Treatment Period 2||0
7938472|NCT00515502|19536101|P3|NOT COMPLETED|Treatment Period 2||0
7938473|NCT00515502|19536102|P2|NOT COMPLETED|Treatment Period 2||1
7938474|NCT00515502|19536103|P1|NOT COMPLETED|Treatment Period 2||0
7938475|NCT00515502|19536092|P12|COMPLETED|Treatment Period 2||0
7938476|NCT00515502|19536093|P11|COMPLETED|Treatment Period 2||1
7938477|NCT00515502|19536094|P10|COMPLETED|Treatment Period 2||2
7938478|NCT00515502|19536095|P9|COMPLETED|Treatment Period 2||0
7938479|NCT00515502|19536096|P8|COMPLETED|Treatment Period 2||1
7938480|NCT00515502|19536097|P7|COMPLETED|Treatment Period 2||1
7938481|NCT00515502|19536098|P6|COMPLETED|Treatment Period 2||1
7938482|NCT00515502|19536099|P5|COMPLETED|Treatment Period 2||3
7938483|NCT00515502|19536100|P4|COMPLETED|Treatment Period 2||3
7938484|NCT00515502|19536101|P3|COMPLETED|Treatment Period 2||4
7938485|NCT00515502|19536102|P2|COMPLETED|Treatment Period 2||3
7938486|NCT00515502|19536103|P1|COMPLETED|Treatment Period 2||1
7938487|NCT00515502|19536092|P12|STARTED|Treatment Period 2||0
7938488|NCT00515502|19536093|P11|STARTED|Treatment Period 2||1
7938489|NCT00515502|19536094|P10|STARTED|Treatment Period 2||2
7938490|NCT00515502|19536095|P9|STARTED|Treatment Period 2||0
7938491|NCT00515502|19536096|P8|STARTED|Treatment Period 2||1
7938492|NCT00515502|19536097|P7|STARTED|Treatment Period 2||1
7938493|NCT00515502|19536098|P6|STARTED|Treatment Period 2||1
7938494|NCT00515502|19536099|P5|STARTED|Treatment Period 2||3
7938495|NCT00515502|19536100|P4|STARTED|Treatment Period 2||3
7938496|NCT00515502|19536101|P3|STARTED|Treatment Period 2||4
7938497|NCT00515502|19536102|P2|STARTED|Treatment Period 2||4
7938498|NCT00515502|19536103|P1|STARTED|Treatment Period 2||1
7938499|NCT00515502|19536092|P12|NOT COMPLETED|Washout Period 1||0
7938500|NCT00515502|19536093|P11|NOT COMPLETED|Washout Period 1||0
7938501|NCT00515502|19536094|P10|NOT COMPLETED|Washout Period 1||0
7938502|NCT00515502|19536095|P9|NOT COMPLETED|Washout Period 1||0
7938503|NCT00515502|19536096|P8|NOT COMPLETED|Washout Period 1||0
7938504|NCT00515502|19536097|P7|NOT COMPLETED|Washout Period 1||0
7938505|NCT00515502|19536098|P6|NOT COMPLETED|Washout Period 1||0
7938506|NCT00515502|19536099|P5|NOT COMPLETED|Washout Period 1||0
7938507|NCT00515502|19536100|P4|NOT COMPLETED|Washout Period 1||0
7938508|NCT00515502|19536101|P3|NOT COMPLETED|Washout Period 1||0
7938509|NCT00515502|19536102|P2|NOT COMPLETED|Washout Period 1||0
7938510|NCT00515502|19536103|P1|NOT COMPLETED|Washout Period 1||0
7938511|NCT00515502|19536092|P12|COMPLETED|Washout Period 1||0
7938512|NCT00515502|19536093|P11|COMPLETED|Washout Period 1||1
7938513|NCT00515502|19536094|P10|COMPLETED|Washout Period 1||2
7938514|NCT00515502|19536095|P9|COMPLETED|Washout Period 1||0
7938515|NCT00515502|19536096|P8|COMPLETED|Washout Period 1||1
7938516|NCT00515502|19536097|P7|COMPLETED|Washout Period 1||1
7938517|NCT00515502|19536098|P6|COMPLETED|Washout Period 1||1
7938518|NCT00515502|19536099|P5|COMPLETED|Washout Period 1||3
7938519|NCT00515502|19536100|P4|COMPLETED|Washout Period 1||3
7938520|NCT00515502|19536101|P3|COMPLETED|Washout Period 1||4
7938521|NCT00515502|19536102|P2|COMPLETED|Washout Period 1||4
7938522|NCT00515502|19536103|P1|COMPLETED|Washout Period 1||1
7938523|NCT00515502|19536092|P12|STARTED|Washout Period 1||0
7938524|NCT00515502|19536093|P11|STARTED|Washout Period 1||1
7938525|NCT00515502|19536094|P10|STARTED|Washout Period 1||2
7938526|NCT00515502|19536095|P9|STARTED|Washout Period 1||0
7938527|NCT00515502|19536096|P8|STARTED|Washout Period 1||1
7938528|NCT00515502|19536097|P7|STARTED|Washout Period 1||1
7938529|NCT00515502|19536098|P6|STARTED|Washout Period 1||1
7938530|NCT00515502|19536099|P5|STARTED|Washout Period 1||3
7938531|NCT00515502|19536100|P4|STARTED|Washout Period 1||3
7938532|NCT00515502|19536101|P3|STARTED|Washout Period 1||4
7938533|NCT00515502|19536102|P2|STARTED|Washout Period 1||4
7938534|NCT00515502|19536103|P1|STARTED|Washout Period 1||1
7938535|NCT00515502|19536092|P12|NOT COMPLETED|Treatment Period 1||1
7938536|NCT00515502|19536093|P11|NOT COMPLETED|Treatment Period 1||0
7938537|NCT00515502|19536094|P10|NOT COMPLETED|Treatment Period 1||0
7938538|NCT00515502|19536095|P9|NOT COMPLETED|Treatment Period 1||1
7938539|NCT00515502|19536096|P8|NOT COMPLETED|Treatment Period 1||0
7938540|NCT00515502|19536097|P7|NOT COMPLETED|Treatment Period 1||1
7938541|NCT00515502|19536098|P6|NOT COMPLETED|Treatment Period 1||0
7938542|NCT00515502|19536099|P5|NOT COMPLETED|Treatment Period 1||0
7938543|NCT00515502|19536100|P4|NOT COMPLETED|Treatment Period 1||0
7938544|NCT00515502|19536101|P3|NOT COMPLETED|Treatment Period 1||0
7938545|NCT00515502|19536102|P2|NOT COMPLETED|Treatment Period 1||0
7938546|NCT00515502|19536103|P1|NOT COMPLETED|Treatment Period 1||0
7938547|NCT00515502|19536092|P12|COMPLETED|Treatment Period 1||0
7938548|NCT00515502|19536093|P11|COMPLETED|Treatment Period 1||1
7938549|NCT00515502|19536094|P10|COMPLETED|Treatment Period 1||2
7938550|NCT00515502|19536095|P9|COMPLETED|Treatment Period 1||0
7938551|NCT00515502|19536096|P8|COMPLETED|Treatment Period 1||1
7938552|NCT00515502|19536097|P7|COMPLETED|Treatment Period 1||1
7938553|NCT00515502|19536098|P6|COMPLETED|Treatment Period 1||1
7938554|NCT00515502|19536099|P5|COMPLETED|Treatment Period 1||3
7938555|NCT00515502|19536100|P4|COMPLETED|Treatment Period 1||3
7938556|NCT00515502|19536101|P3|COMPLETED|Treatment Period 1||4
7938557|NCT00515502|19536102|P2|COMPLETED|Treatment Period 1||4
7938558|NCT00515502|19536103|P1|COMPLETED|Treatment Period 1||1
7938559|NCT00515502|19536092|P12|STARTED|Treatment Period 1||1
7938560|NCT00515502|19536093|P11|STARTED|Treatment Period 1||1
7938561|NCT00515502|19536094|P10|STARTED|Treatment Period 1||2
7938562|NCT00515502|19536095|P9|STARTED|Treatment Period 1||1
7938563|NCT00515502|19536096|P8|STARTED|Treatment Period 1||1
7938564|NCT00515502|19536097|P7|STARTED|Treatment Period 1||2
7938565|NCT00515502|19536098|P6|STARTED|Treatment Period 1||1
7938566|NCT00515502|19536099|P5|STARTED|Treatment Period 1||3
7938567|NCT00515502|19536100|P4|STARTED|Treatment Period 1||3
7938568|NCT00515502|19536101|P3|STARTED|Treatment Period 1||4
7938569|NCT00515502|19536102|P2|STARTED|Treatment Period 1||4
7938570|NCT00515502|19536103|P1|STARTED|Treatment Period 1||1
7938571|NCT00515463|19536263|P2|NOT COMPLETED|Overall Study||14
7938572|NCT00515463|19536264|P1|NOT COMPLETED|Overall Study||14
7938573|NCT00515463|19536263|P2|COMPLETED|Overall Study||142
7938574|NCT00515463|19536264|P1|COMPLETED|Overall Study||141
7938575|NCT00515463|19536263|P2|Received Study Medication|Overall Study||156
7938576|NCT00515463|19536264|P1|Received Study Medication|Overall Study||154
7938577|NCT00515463|19536263|P2|STARTED|Overall Study||156
7938578|NCT00515463|19536264|P1|STARTED|Overall Study||155
7938579|NCT00515437|19536418|P4|NOT COMPLETED|Overall Study||1
7938580|NCT00515437|19536419|P3|NOT COMPLETED|Overall Study||0
7938581|NCT00515437|19536420|P2|NOT COMPLETED|Overall Study||0
7938582|NCT00515437|19536421|P1|NOT COMPLETED|Overall Study||0
7938583|NCT00515437|19536418|P4|COMPLETED|Overall Study||14
7938584|NCT00515437|19536419|P3|COMPLETED|Overall Study||13
7938585|NCT00515437|19536420|P2|COMPLETED|Overall Study||12
7938586|NCT00515437|19536421|P1|COMPLETED|Overall Study||14
7938587|NCT00515437|19536418|P4|STARTED|Overall Study||15
7938588|NCT00515437|19536419|P3|STARTED|Overall Study||13
7938589|NCT00515437|19536420|P2|STARTED|Overall Study||12
7938590|NCT00515437|19536421|P1|STARTED|Overall Study||14
7938591|NCT00515411|19536446|P3|NOT COMPLETED|Overall Study||0
7938592|NCT00515411|19536447|P2|NOT COMPLETED|Overall Study||0
7938593|NCT00515411|19536448|P1|NOT COMPLETED|Overall Study||0
7938594|NCT00515411|19536446|P3|COMPLETED|Overall Study||26
7938595|NCT00515411|19536447|P2|COMPLETED|Overall Study||31
7938596|NCT00515411|19536448|P1|COMPLETED|Overall Study||54
7938597|NCT00515411|19536446|P3|STARTED|Overall Study||26
7938598|NCT00515411|19536447|P2|STARTED|Overall Study||31
7938599|NCT00515411|19536448|P1|STARTED|Overall Study||54
7938600|NCT00515294|19536463|P4|NOT COMPLETED|Overall Study||4
7938601|NCT00515294|19536464|P3|NOT COMPLETED|Overall Study||11
7938602|NCT00515294|19536465|P2|NOT COMPLETED|Overall Study||3
7938603|NCT00515294|19536466|P1|NOT COMPLETED|Overall Study||9
7938604|NCT00515294|19536463|P4|COMPLETED|Overall Study||35
7938605|NCT00515294|19536464|P3|COMPLETED|Overall Study||27
7938606|NCT00515294|19536465|P2|COMPLETED|Overall Study||36
7938607|NCT00515294|19536466|P1|COMPLETED|Overall Study||29
7938608|NCT00515294|19536463|P4|STARTED|Overall Study||39
7938609|NCT00515294|19536464|P3|STARTED|Overall Study||38
7938610|NCT00515294|19536465|P2|STARTED|Overall Study||39
7938611|NCT00515294|19536466|P1|STARTED|Overall Study||38
7938612|NCT00515216|19536480|P1|NOT COMPLETED|Overall Study||1
7938613|NCT00515216|19536480|P1|COMPLETED|Overall Study||25
7938614|NCT00515216|19536480|P1|STARTED|Overall Study||26
7938615|NCT00515203|19536504|P2|NOT COMPLETED|Overall Study||0
7938616|NCT00515203|19536505|P1|NOT COMPLETED|Overall Study||0
7938617|NCT00515203|19536504|P2|COMPLETED|Overall Study||5
7938618|NCT00515203|19536505|P1|COMPLETED|Overall Study||17
7938619|NCT00515203|19536504|P2|STARTED|Overall Study||5
7938620|NCT00515203|19536505|P1|STARTED|Overall Study||17
7938621|NCT00515177|19536523|P2|NOT COMPLETED|Overall Study||1
7938622|NCT00515177|19536524|P1|NOT COMPLETED|Overall Study||2
7938623|NCT00515177|19536523|P2|COMPLETED|Overall Study||9
7938624|NCT00515177|19536524|P1|COMPLETED|Overall Study||18
7938625|NCT00515177|19536523|P2|STARTED|Overall Study||10
7938626|NCT00515177|19536524|P1|STARTED|Overall Study||20
7938627|NCT00515112|19536542|P2|NOT COMPLETED|Overall Study||3
7938628|NCT00515112|19536543|P1|NOT COMPLETED|Overall Study||3
7938629|NCT00515112|19536542|P2|COMPLETED|Overall Study||0
7938630|NCT00515112|19536543|P1|COMPLETED|Overall Study||0
7938631|NCT00515112|19536542|P2|STARTED|Overall Study||3
7938632|NCT00515112|19536543|P1|STARTED|Overall Study||3
7938633|NCT00515099|19536553|P2|NOT COMPLETED|Overall Study||4
7938634|NCT00515099|19536554|P1|NOT COMPLETED|Overall Study||3
7938635|NCT00515099|19536553|P2|COMPLETED|Overall Study||16
7938636|NCT00515099|19536554|P1|COMPLETED|Overall Study||35
7938637|NCT00515099|19536553|P2|STARTED|Overall Study||20
7938638|NCT00515099|19536554|P1|STARTED|Overall Study||38
7938639|NCT00515086|19536576|P4|NOT COMPLETED|Overall Study||6
7938640|NCT00515086|19536577|P3|NOT COMPLETED|Overall Study||5
7938641|NCT00515086|19536578|P2|NOT COMPLETED|Overall Study||6
7938642|NCT00515086|19536579|P1|NOT COMPLETED|Overall Study||24
7938643|NCT00515086|19536576|P4|COMPLETED|Overall Study||0
7938644|NCT00515086|19536577|P3|COMPLETED|Overall Study||0
7938645|NCT00515086|19536578|P2|COMPLETED|Overall Study||0
7938646|NCT00515086|19536579|P1|COMPLETED|Overall Study||0
7938647|NCT00515086|19536576|P4|STARTED|Overall Study||6
7938648|NCT00515086|19536577|P3|STARTED|Overall Study||5
7938649|NCT00515086|19536578|P2|STARTED|Overall Study||6
7938650|NCT00515086|19536579|P1|STARTED|Overall Study||24
7938651|NCT00515073|19536606|P1|NOT COMPLETED|Overall Study||2
7938652|NCT00515073|19536606|P1|COMPLETED|Overall Study||28
7938653|NCT00515073|19536606|P1|STARTED|Overall Study||30
7938654|NCT00515034|19536614|P4|NOT COMPLETED|Overall Study||5
7938655|NCT00515034|19536615|P3|NOT COMPLETED|Overall Study||8
7938656|NCT00515034|19536616|P2|NOT COMPLETED|Overall Study||2
7938657|NCT00515034|19536617|P1|NOT COMPLETED|Overall Study||8
7938658|NCT00515034|19536614|P4|COMPLETED|Overall Study||15
7938659|NCT00515034|19536615|P3|COMPLETED|Overall Study||54
7938660|NCT00515034|19536616|P2|COMPLETED|Overall Study||13
7938661|NCT00515034|19536617|P1|COMPLETED|Overall Study||41
7938662|NCT00515034|19536614|P4|TREATED|Overall Study||19
7938663|NCT00515034|19536615|P3|TREATED|Overall Study||61
7938664|NCT00515034|19536616|P2|TREATED|Overall Study||15
7938665|NCT00515034|19536617|P1|TREATED|Overall Study||48
7938666|NCT00515034|19536614|P4|STARTED|Overall Study||20
7938667|NCT00515034|19536615|P3|STARTED|Overall Study||62
7938668|NCT00515034|19536616|P2|STARTED|Overall Study||15
7938669|NCT00515034|19536617|P1|STARTED|Overall Study||49
7938670|NCT00515021|19536637|P2|NOT COMPLETED|Overall Study||0
7938671|NCT00515021|19536638|P1|NOT COMPLETED|Overall Study||0
7938672|NCT00515021|19536637|P2|COMPLETED|Overall Study||11
7938673|NCT00515021|19536638|P1|COMPLETED|Overall Study||9
7938674|NCT00515021|19536637|P2|STARTED|Overall Study||11
7938675|NCT00515021|19536638|P1|STARTED|Overall Study||9
7938676|NCT00515008|19536648|P2|NOT COMPLETED|Overall Study||4
7938677|NCT00515008|19536649|P1|NOT COMPLETED|Overall Study||3
7938678|NCT00515008|19536648|P2|COMPLETED|Overall Study||29
7938679|NCT00515008|19536649|P1|COMPLETED|Overall Study||30
7938680|NCT00515008|19536648|P2|Completed 12 Week Evaluation|Overall Study||29
7938681|NCT00515008|19536649|P1|Completed 12 Week Evaluation|Overall Study||32
7938682|NCT00515008|19536648|P2|STARTED|Overall Study||33
7938683|NCT00515008|19536649|P1|STARTED|Overall Study||33
7938684|NCT00514943|19536673|P2|NOT COMPLETED|Stage 2||36
7938685|NCT00514943|19536674|P1|NOT COMPLETED|Stage 2||32
7938686|NCT00514943|19536673|P2|COMPLETED|Stage 2||0
7938687|NCT00514943|19536674|P1|COMPLETED|Stage 2||0
7938688|NCT00514943|19536673|P2|STARTED|Stage 2||36
7938689|NCT00514943|19536674|P1|STARTED|Stage 2||32
7938690|NCT00514943|19536673|P2|NOT COMPLETED|Stage 1||26
7938691|NCT00514943|19536674|P1|NOT COMPLETED|Stage 1||30
7938692|NCT00514943|19536673|P2|COMPLETED|Stage 1||36
7938693|NCT00514943|19536674|P1|COMPLETED|Stage 1||32
7938694|NCT00514943|19536673|P2|STARTED|Stage 1|2 randomized patients were not treated|62
7938695|NCT00514943|19536674|P1|STARTED|Stage 1|1 randomized patient was not treated|62
7938696|NCT00514917|19536732|P2|NOT COMPLETED|Overall Study||115
7938697|NCT00514917|19536733|P1|NOT COMPLETED|Overall Study||126
7938698|NCT00514917|19536732|P2|COMPLETED|Overall Study||91
7938699|NCT00514917|19536733|P1|COMPLETED|Overall Study||81
7938700|NCT00514917|19536732|P2|Testosterone-Specific Evaluable|Overall Study||124
7938701|NCT00514917|19536733|P1|Testosterone-Specific Evaluable|Overall Study||122
7938702|NCT00514917|19536732|P2|Completed Study Treatment|Overall Study||182
7938703|NCT00514917|19536733|P1|Completed Study Treatment|Overall Study||170
7938704|NCT00514917|19536732|P2|Treated|Overall Study||204
7938705|NCT00514917|19536733|P1|Treated|Overall Study||196
7938706|NCT00514917|19536732|P2|STARTED|Overall Study||206
7938707|NCT00514917|19536733|P1|STARTED|Overall Study||207
7938708|NCT00514904|19536761|P2|NOT COMPLETED|Overall Study||5
7938709|NCT00514904|19536762|P1|NOT COMPLETED|Overall Study||24
7938710|NCT00514904|19536761|P2|COMPLETED|Overall Study||371
7938711|NCT00514904|19536762|P1|COMPLETED|Overall Study||1101
7938712|NCT00514904|19536761|P2|STARTED|Overall Study||376
7938713|NCT00514904|19536762|P1|STARTED|Overall Study||1125
7938714|NCT00514852|19536798|P2|NOT COMPLETED|Overall Study||5
7938715|NCT00514852|19536799|P1|NOT COMPLETED|Overall Study||5
7938716|NCT00514852|19536798|P2|COMPLETED|Overall Study||154
7938717|NCT00514852|19536799|P1|COMPLETED|Overall Study||152
7938718|NCT00514852|19536798|P2|STARTED|Overall Study||159
7938719|NCT00514852|19536799|P1|STARTED|Overall Study||157
7938720|NCT00514813|19536827|P4|NOT COMPLETED|Overall Study||4
7938721|NCT00514813|19536828|P3|NOT COMPLETED|Overall Study||47
7938722|NCT00514813|19536829|P2|NOT COMPLETED|Overall Study||86
7938723|NCT00514813|19536830|P1|NOT COMPLETED|Overall Study||15
7938724|NCT00514813|19536827|P4|COMPLETED|Overall Study||0
7938725|NCT00514813|19536828|P3|COMPLETED|Overall Study||0
7938726|NCT00514813|19536829|P2|COMPLETED|Overall Study||0
7938727|NCT00514813|19536830|P1|COMPLETED|Overall Study||0
7938728|NCT00514813|19536827|P4|STARTED|Overall Study||4
7938729|NCT00514813|19536828|P3|STARTED|Overall Study||47
7938730|NCT00514813|19536829|P2|STARTED|Overall Study||86
7938731|NCT00514813|19536830|P1|STARTED|Overall Study||15
7938732|NCT00514735|19536850|P2|NOT COMPLETED|Overall Study||6
7938733|NCT00514735|19536851|P1|NOT COMPLETED|Overall Study||14
7938734|NCT00514735|19536850|P2|COMPLETED|Overall Study||66
7938735|NCT00514735|19536851|P1|COMPLETED|Overall Study||124
7938736|NCT00514735|19536850|P2|STARTED|Overall Study||72
7938737|NCT00514735|19536851|P1|STARTED|Overall Study||138
7938738|NCT00514709|19536871|P2|NOT COMPLETED|Overall Study||0
7938739|NCT00514709|19536872|P1|NOT COMPLETED|Overall Study||0
7938740|NCT00514709|19536871|P2|COMPLETED|Overall Study||613
7938741|NCT00514709|19536872|P1|COMPLETED|Overall Study||1230
7938742|NCT00514709|19536871|P2|STARTED|Overall Study||613
7938743|NCT00514709|19536872|P1|STARTED|Overall Study||1230
7938744|NCT00514683|19536887|P5|NOT COMPLETED|Overall Study||33
7938745|NCT00514683|19536888|P4|NOT COMPLETED|Overall Study||14
7938746|NCT00514683|19536889|P3|NOT COMPLETED|Overall Study||18
7938747|NCT00514683|19536890|P2|NOT COMPLETED|Overall Study||25
7938748|NCT00514683|19536891|P1|NOT COMPLETED|Overall Study||26
7938749|NCT00514683|19536887|P5|COMPLETED|Overall Study||53
7938750|NCT00514683|19536888|P4|COMPLETED|Overall Study||72
7938751|NCT00514683|19536889|P3|COMPLETED|Overall Study||68
7938752|NCT00514683|19536890|P2|COMPLETED|Overall Study||62
7938753|NCT00514683|19536891|P1|COMPLETED|Overall Study||61
7938754|NCT00514683|19536887|P5|STARTED|Overall Study|Randomised|86
7938755|NCT00514683|19536888|P4|STARTED|Overall Study|Randomised|86
7938756|NCT00514683|19536889|P3|STARTED|Overall Study|Randomised|86
7938757|NCT00514683|19536890|P2|STARTED|Overall Study|Randomised|87
7938758|NCT00514683|19536891|P1|STARTED|Overall Study|Randomised|87
7938759|NCT00514592|19537082|P1|NOT COMPLETED|Overall Study||0
7938760|NCT00514592|19537082|P1|COMPLETED|Overall Study||230
7938761|NCT00514592|19537082|P1|STARTED|Overall Study||230
7938762|NCT00514540|19537087|P1|NOT COMPLETED|Second-Line||31
7938763|NCT00514540|19537087|P1|COMPLETED|Second-Line||74
7938764|NCT00514540|19537087|P1|STARTED|Second-Line||105
7938765|NCT00514540|19537087|P1|NOT COMPLETED|First-Line Chemo||8
7938766|NCT00514540|19537087|P1|COMPLETED|First-Line Chemo||105
7938767|NCT00514540|19537087|P1|STARTED|First-Line Chemo||113
7938768|NCT00514514|19537098|P3|NOT COMPLETED|Extension - 4 Years||21
7938769|NCT00514514|19537099|P2|NOT COMPLETED|Extension - 4 Years||22
7938770|NCT00514514|19537100|P1|NOT COMPLETED|Extension - 4 Years||37
7938771|NCT00514514|19537098|P3|COMPLETED|Extension - 4 Years||113
7938772|NCT00514514|19537099|P2|COMPLETED|Extension - 4 Years||117
7938773|NCT00514514|19537100|P1|COMPLETED|Extension - 4 Years||108
7938774|NCT00514514|19537098|P3|Non-randomized (Followed)|Extension - 4 Years||0
7938775|NCT00514514|19537099|P2|Non-randomized (Followed)|Extension - 4 Years||0
7938776|NCT00514514|19537100|P1|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95
7938777|NCT00514514|19537098|P3|STARTED|Extension - 4 Years||134
7938778|NCT00514514|19537099|P2|STARTED|Extension - 4 Years||139
7938779|NCT00514514|19537100|P1|STARTED|Extension - 4 Years||145
7938780|NCT00514514|19537098|P3|NOT COMPLETED|Randomized - 9 Month||38
7938781|NCT00514514|19537099|P2|NOT COMPLETED|Randomized - 9 Month||61
7938782|NCT00514514|19537100|P1|NOT COMPLETED|Randomized - 9 Month||39
7938783|NCT00514514|19537098|P3|COMPLETED|Randomized - 9 Month||124
7938784|NCT00514514|19537099|P2|COMPLETED|Randomized - 9 Month||110
7938785|NCT00514514|19537100|P1|COMPLETED|Randomized - 9 Month||127
7938786|NCT00514514|19537098|P3|Randomized - Received Treatment|Randomized - 9 Month||161
7938787|NCT00514514|19537099|P2|Randomized - Received Treatment|Randomized - 9 Month||171
7938788|NCT00514514|19537100|P1|Randomized - Received Treatment|Randomized - 9 Month||165
7938789|NCT00514514|19537098|P3|STARTED|Randomized - 9 Month||162
7938790|NCT00514514|19537099|P2|STARTED|Randomized - 9 Month||171
7938791|NCT00514514|19537100|P1|STARTED|Randomized - 9 Month||166
7938792|NCT00514514|19537098|P3|NOT COMPLETED|Pre-phase||0
7938793|NCT00514514|19537099|P2|NOT COMPLETED|Pre-phase||0
7938794|NCT00514514|19537100|P1|NOT COMPLETED|Pre-phase||303
7938795|NCT00514514|19537098|P3|COMPLETED|Pre-phase||0
7938796|NCT00514514|19537099|P2|COMPLETED|Pre-phase||0
7938797|NCT00514514|19537100|P1|COMPLETED|Pre-phase||499
7938798|NCT00514514|19537098|P3|STARTED|Pre-phase||0
7938799|NCT00514514|19537099|P2|STARTED|Pre-phase||0
7938800|NCT00514514|19537100|P1|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802
7938801|NCT00514501|19537144|P1|NOT COMPLETED|Overall Study||3
7938802|NCT00514501|19537144|P1|COMPLETED|Overall Study||507
7938803|NCT00514501|19537144|P1|STARTED|Overall Study||510
7938804|NCT00514449|19537152|P2|NOT COMPLETED|Overall Study||4
7938805|NCT00514449|19537153|P1|NOT COMPLETED|Overall Study||3
7938806|NCT00514449|19537152|P2|COMPLETED|Overall Study||8
7938807|NCT00514449|19537153|P1|COMPLETED|Overall Study||9
7938808|NCT00514449|19537152|P2|STARTED|Overall Study||12
7938809|NCT00514449|19537153|P1|STARTED|Overall Study||12
7938810|NCT00514215|19537163|P1|NOT COMPLETED|Overall Study||0
7938811|NCT00514215|19537163|P1|COMPLETED|Overall Study||8
7938812|NCT00514215|19537163|P1|STARTED|Overall Study||8
7938813|NCT00514137|19537170|P1|NOT COMPLETED|Overall Study||0
7938814|NCT00514137|19537170|P1|COMPLETED|Overall Study||13
7938815|NCT00514137|19537170|P1|STARTED|Overall Study||13
7938816|NCT00514046|19537186|P9|NOT COMPLETED|Overall Study||1
7938817|NCT00514046|19537187|P8|NOT COMPLETED|Overall Study||1
7938818|NCT00514046|19537188|P7|NOT COMPLETED|Overall Study||0
7938819|NCT00514046|19537189|P6|NOT COMPLETED|Overall Study||1
7938820|NCT00514046|19537190|P5|NOT COMPLETED|Overall Study||1
7938821|NCT00514046|19537191|P4|NOT COMPLETED|Overall Study||0
7938822|NCT00514046|19537192|P3|NOT COMPLETED|Overall Study||5
7938823|NCT00514046|19537193|P2|NOT COMPLETED|Overall Study||1
7938824|NCT00514046|19537194|P1|NOT COMPLETED|Overall Study||3
7938825|NCT00514046|19537186|P9|COMPLETED|Overall Study||0
7938826|NCT00514046|19537187|P8|COMPLETED|Overall Study||0
7938827|NCT00514046|19537188|P7|COMPLETED|Overall Study||1
7938828|NCT00514046|19537189|P6|COMPLETED|Overall Study||0
7938829|NCT00514046|19537190|P5|COMPLETED|Overall Study||0
7938830|NCT00514046|19537191|P4|COMPLETED|Overall Study||1
7938831|NCT00514046|19537192|P3|COMPLETED|Overall Study||0
7938832|NCT00514046|19537193|P2|COMPLETED|Overall Study||0
7938833|NCT00514046|19537194|P1|COMPLETED|Overall Study||2
7938834|NCT00514046|19537186|P9|STARTED|Overall Study||1
7938835|NCT00514046|19537187|P8|STARTED|Overall Study||1
7938836|NCT00514046|19537188|P7|STARTED|Overall Study||1
7938837|NCT00514046|19537189|P6|STARTED|Overall Study||1
7938838|NCT00514046|19537190|P5|STARTED|Overall Study||1
7938839|NCT00514046|19537191|P4|STARTED|Overall Study||1
7938840|NCT00514046|19537192|P3|STARTED|Overall Study||5
7938841|NCT00514046|19537193|P2|STARTED|Overall Study||1
7938842|NCT00514046|19537194|P1|STARTED|Overall Study||5
7938843|NCT00514020|19537236|P1|NOT COMPLETED|Overall Study||28
7938844|NCT00514020|19537236|P1|COMPLETED|Overall Study||5
7938845|NCT00514020|19537236|P1|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33
7938846|NCT00513799|19537244|P4|NOT COMPLETED|Four-Month Follow-Up||3
7938847|NCT00513799|19537245|P3|NOT COMPLETED|Four-Month Follow-Up||7
7938848|NCT00513799|19537246|P2|NOT COMPLETED|Four-Month Follow-Up||5
7938849|NCT00513799|19537247|P1|NOT COMPLETED|Four-Month Follow-Up||0
7938850|NCT00513799|19537244|P4|COMPLETED|Four-Month Follow-Up||51
7938851|NCT00513799|19537245|P3|COMPLETED|Four-Month Follow-Up||57
7938852|NCT00513799|19537246|P2|COMPLETED|Four-Month Follow-Up||57
7938853|NCT00513799|19537247|P1|COMPLETED|Four-Month Follow-Up||64
7938854|NCT00513799|19537244|P4|STARTED|Four-Month Follow-Up||54
7938855|NCT00513799|19537245|P3|STARTED|Four-Month Follow-Up||64
7938856|NCT00513799|19537246|P2|STARTED|Four-Month Follow-Up||62
7938857|NCT00513799|19537247|P1|STARTED|Four-Month Follow-Up||64
7938858|NCT00513799|19537244|P4|NOT COMPLETED|One-Month Follow-Up||21
7938859|NCT00513799|19537245|P3|NOT COMPLETED|One-Month Follow-Up||11
7938860|NCT00513799|19537246|P2|NOT COMPLETED|One-Month Follow-Up||13
7938861|NCT00513799|19537247|P1|NOT COMPLETED|One-Month Follow-Up||11
7938862|NCT00513799|19537244|P4|COMPLETED|One-Month Follow-Up||54
7938863|NCT00513799|19537245|P3|COMPLETED|One-Month Follow-Up||64
7938864|NCT00513799|19537246|P2|COMPLETED|One-Month Follow-Up||62
7938865|NCT00513799|19537247|P1|COMPLETED|One-Month Follow-Up||64
7938866|NCT00513799|19537244|P4|STARTED|One-Month Follow-Up||75
7938867|NCT00513799|19537245|P3|STARTED|One-Month Follow-Up||75
7938868|NCT00513799|19537246|P2|STARTED|One-Month Follow-Up||75
7938869|NCT00513799|19537247|P1|STARTED|One-Month Follow-Up||75
7938870|NCT00513747|19537268|P3|NOT COMPLETED|Overall Study||0
7938871|NCT00513747|19537269|P2|NOT COMPLETED|Overall Study||0
7938872|NCT00513747|19537270|P1|NOT COMPLETED|Overall Study||0
7938873|NCT00513747|19537268|P3|COMPLETED|Overall Study||55
7938874|NCT00513747|19537269|P2|COMPLETED|Overall Study||11
7938875|NCT00513747|19537270|P1|COMPLETED|Overall Study||17
7938876|NCT00513747|19537268|P3|Received at Least One Dose of Treatment|Overall Study||40
7938877|NCT00513747|19537269|P2|Received at Least One Dose of Treatment|Overall Study||11
7938878|NCT00513747|19537270|P1|Received at Least One Dose of Treatment|Overall Study||9
7938879|NCT00513747|19537268|P3|STARTED|Overall Study||55
7938880|NCT00513747|19537269|P2|STARTED|Overall Study||11
7938881|NCT00513747|19537270|P1|STARTED|Overall Study||17
7938882|NCT00513708|19537290|P3|NOT COMPLETED|Overall Study||4
7938883|NCT00513708|19537291|P2|NOT COMPLETED|Overall Study||4
7938884|NCT00513708|19537292|P1|NOT COMPLETED|Overall Study||4
7938885|NCT00513708|19537290|P3|COMPLETED|Overall Study||46
7938886|NCT00513708|19537291|P2|COMPLETED|Overall Study||46
7938887|NCT00513708|19537292|P1|COMPLETED|Overall Study||46
7938888|NCT00513708|19537290|P3|STARTED|Overall Study||50
7938889|NCT00513708|19537291|P2|STARTED|Overall Study||50
7938890|NCT00513708|19537292|P1|STARTED|Overall Study||50
7938891|NCT00513695|19537306|P1|NOT COMPLETED|Overall Study||5
7938892|NCT00513695|19537306|P1|COMPLETED|Overall Study||63
7938893|NCT00513695|19537306|P1|STARTED|Overall Study||68
7938894|NCT00513682|19537315|P1|NOT COMPLETED|Treatment Phase||0
7938895|NCT00513682|19537315|P1|COMPLETED|Treatment Phase||7
7938896|NCT00513682|19537315|P1|STARTED|Treatment Phase||7
7938897|NCT00513682|19537315|P1|NOT COMPLETED|Washout Phase||2
7938898|NCT00513682|19537315|P1|COMPLETED|Washout Phase||7
7938899|NCT00513682|19537315|P1|STARTED|Washout Phase||9
7938900|NCT00513682|19537315|P1|NOT COMPLETED|Screening Phase||0
7938901|NCT00513682|19537315|P1|COMPLETED|Screening Phase||9
7938902|NCT00513682|19537315|P1|STARTED|Screening Phase||9
7938903|NCT00513617|19537327|P3|NOT COMPLETED|Overall Study||8
7938904|NCT00513617|19537328|P2|NOT COMPLETED|Overall Study||10
7938905|NCT00513617|19537329|P1|NOT COMPLETED|Overall Study||11
7938906|NCT00513617|19537327|P3|COMPLETED|Overall Study||30
7938907|NCT00513617|19537328|P2|COMPLETED|Overall Study||25
7938908|NCT00513617|19537329|P1|COMPLETED|Overall Study||25
7938909|NCT00513617|19537327|P3|STARTED|Overall Study||38
7938910|NCT00513617|19537328|P2|STARTED|Overall Study||35
7938911|NCT00513617|19537329|P1|STARTED|Overall Study||36
7938912|NCT00513604|19537345|P5|NOT COMPLETED|Overall Study||0
7938913|NCT00513604|19537346|P4|NOT COMPLETED|Overall Study||0
7938914|NCT00513604|19537347|P3|NOT COMPLETED|Overall Study||3
7938915|NCT00513604|19537348|P2|NOT COMPLETED|Overall Study||3
7938916|NCT00513604|19537349|P1|NOT COMPLETED|Overall Study||2
7938917|NCT00513604|19537345|P5|COMPLETED|Overall Study||35
7938918|NCT00513604|19537346|P4|COMPLETED|Overall Study||34
7938919|NCT00513604|19537347|P3|COMPLETED|Overall Study||21
7938920|NCT00513604|19537348|P2|COMPLETED|Overall Study||36
7938921|NCT00513604|19537349|P1|COMPLETED|Overall Study||24
7938922|NCT00513604|19537345|P5|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35
7938923|NCT00513604|19537346|P4|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34
7938924|NCT00513604|19537347|P3|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24
7938925|NCT00513604|19537348|P2|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39
7938926|NCT00513604|19537349|P1|STARTED|Overall Study|Cohort 1 = unselected TIL|26
7938927|NCT00513526|19537366|P1|NOT COMPLETED|Overall Study||17
7938928|NCT00513526|19537366|P1|COMPLETED|Overall Study||92
7938929|NCT00513526|19537366|P1|STARTED|Overall Study||109
7938930|NCT00513500|19537383|P2|NOT COMPLETED|Overall Study||54
7938931|NCT00513500|19537384|P1|NOT COMPLETED|Overall Study||41
7938932|NCT00513500|19537383|P2|COMPLETED|Overall Study||2054
7938933|NCT00513500|19537384|P1|COMPLETED|Overall Study||976
7938934|NCT00513500|19537383|P2|STARTED|Overall Study||2108
7938935|NCT00513500|19537384|P1|STARTED|Overall Study||1017
7938936|NCT00513474|19537396|P2|NOT COMPLETED|Overall Study||9
7938937|NCT00513474|19537397|P1|NOT COMPLETED|Overall Study||7
7938938|NCT00513474|19537396|P2|COMPLETED|Overall Study||12
7938939|NCT00513474|19537397|P1|COMPLETED|Overall Study||18
7938940|NCT00513474|19537396|P2|Received Rasburicase Per Protocol|Overall Study||0
7938941|NCT00513474|19537397|P1|Received Rasburicase Per Protocol|Overall Study||24
7938942|NCT00513474|19537396|P2|STARTED|Overall Study||21
7938943|NCT00513474|19537397|P1|STARTED|Overall Study||25
7938944|NCT00513461|19537411|P2|NOT COMPLETED|Overall Study||10
7938945|NCT00513461|19537412|P1|NOT COMPLETED|Overall Study||13
7938946|NCT00513461|19537411|P2|COMPLETED|Overall Study||43
7938947|NCT00513461|19537412|P1|COMPLETED|Overall Study||44
7938948|NCT00513461|19537411|P2|STARTED|Overall Study||53
7938949|NCT00513461|19537412|P1|STARTED|Overall Study||57
7938950|NCT00513435|19537446|P1|NOT COMPLETED|Overall Study||0
7938951|NCT00513435|19537446|P1|COMPLETED|Overall Study||9
7938952|NCT00513435|19537446|P1|STARTED|Overall Study||9
7938953|NCT00513409|19537453|P2|NOT COMPLETED|Overall Study||6
7938954|NCT00513409|19537454|P1|NOT COMPLETED|Overall Study||2
7938955|NCT00513409|19537453|P2|COMPLETED|Overall Study||73
7938956|NCT00513409|19537454|P1|COMPLETED|Overall Study||82
7938957|NCT00513409|19537453|P2|STARTED|Overall Study||79
7938958|NCT00513409|19537454|P1|STARTED|Overall Study||84
7938959|NCT00513370|19537480|P1|NOT COMPLETED|Overall Study||24
7938960|NCT00513370|19537480|P1|COMPLETED|Overall Study||179
7938961|NCT00513370|19537480|P1|STARTED|Overall Study||203
7938962|NCT00513357|19537510|P2|NOT COMPLETED|Overall Study||10
7938963|NCT00513357|19537511|P1|NOT COMPLETED|Overall Study||15
7938964|NCT00513357|19537510|P2|COMPLETED|Overall Study||25
7938965|NCT00513357|19537511|P1|COMPLETED|Overall Study||23
7938966|NCT00513357|19537510|P2|STARTED|Overall Study||35
7938967|NCT00513357|19537511|P1|STARTED|Overall Study||38
7938968|NCT00513344|19537517|P1|NOT COMPLETED|3rd Intervention 1 Day||0
7938969|NCT00513344|19537517|P1|COMPLETED|3rd Intervention 1 Day||5
7938970|NCT00513344|19537517|P1|STARTED|3rd Intervention 1 Day||5
7938971|NCT00513344|19537517|P1|NOT COMPLETED|Washout Period 3 Days||0
7938972|NCT00513344|19537517|P1|COMPLETED|Washout Period 3 Days||5
7938973|NCT00513344|19537517|P1|STARTED|Washout Period 3 Days||5
7938974|NCT00513344|19537517|P1|NOT COMPLETED|2nd Intervention 1 Day||0
7938975|NCT00513344|19537517|P1|COMPLETED|2nd Intervention 1 Day||5
7938976|NCT00513344|19537517|P1|STARTED|2nd Intervention 1 Day||5
7938977|NCT00513344|19537517|P1|NOT COMPLETED|Washout Period 3 Days||0
7938978|NCT00513344|19537517|P1|COMPLETED|Washout Period 3 Days||5
7938979|NCT00513344|19537517|P1|STARTED|Washout Period 3 Days||5
7938980|NCT00513344|19537517|P1|NOT COMPLETED|1st Intervention 1 Day||0
7938981|NCT00513344|19537517|P1|COMPLETED|1st Intervention 1 Day||5
7938982|NCT00513344|19537517|P1|STARTED|1st Intervention 1 Day||5
7938983|NCT00513344|19537517|P1|NOT COMPLETED|Diet Restriction (3 Days)||0
7938984|NCT00513344|19537517|P1|COMPLETED|Diet Restriction (3 Days)||5
7938985|NCT00513344|19537517|P1|STARTED|Diet Restriction (3 Days)||5
7938986|NCT00513305|19537530|P2|NOT COMPLETED|Overall Study||27
7938987|NCT00513305|19537531|P1|NOT COMPLETED|Overall Study||28
7938988|NCT00513305|19537530|P2|COMPLETED|Overall Study||7
7938989|NCT00513305|19537531|P1|COMPLETED|Overall Study||5
7938990|NCT00513305|19537530|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34
7938991|NCT00513305|19537531|P1|STARTED|Overall Study||33
7938992|NCT00513292|19537549|P2|NOT COMPLETED|Overall Study||0
7938993|NCT00513292|19537550|P1|NOT COMPLETED|Overall Study||0
7938994|NCT00513292|19537549|P2|COMPLETED|Overall Study||142
7938995|NCT00513292|19537550|P1|COMPLETED|Overall Study||138
7938996|NCT00513292|19537549|P2|STARTED|Overall Study||142
7938997|NCT00513292|19537550|P1|STARTED|Overall Study||138
7938998|NCT00513240|19537574|P2|NOT COMPLETED|Overall Study||7
7938999|NCT00513240|19537575|P1|NOT COMPLETED|Overall Study||13
7939000|NCT00513240|19537574|P2|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20
7939001|NCT00513240|19537575|P1|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22
7939002|NCT00513240|19537574|P2|Clinical Data Collection &Pre/Postop MRI|Overall Study||27
7939003|NCT00513240|19537575|P1|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32
7939004|NCT00513240|19537574|P2|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27
7939005|NCT00513240|19537575|P1|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35
7939006|NCT00513071|19537588|P1|NOT COMPLETED|Overall Study||5
7939007|NCT00513071|19537588|P1|COMPLETED|Overall Study||23
7939008|NCT00513071|19537588|P1|STARTED|Overall Study||28
7939009|NCT00513019|19537600|P2|NOT COMPLETED|Overall Study||5
7939010|NCT00513019|19537601|P1|NOT COMPLETED|Overall Study||5
7939011|NCT00513019|19537600|P2|COMPLETED|Overall Study||13
7939012|NCT00513019|19537601|P1|COMPLETED|Overall Study||12
7939013|NCT00513019|19537600|P2|STARTED|Overall Study||18
7939014|NCT00513019|19537601|P1|STARTED|Overall Study||17
7939015|NCT00512902|19537607|P1|NOT COMPLETED|Overall Study||8
7939016|NCT00512902|19537607|P1|COMPLETED|Overall Study||12
7939017|NCT00512902|19537607|P1|STARTED|Overall Study||20
7939018|NCT00512876|19537615|P1|NOT COMPLETED|Overall Study||4
7939019|NCT00512876|19537615|P1|COMPLETED|Overall Study||20
7939020|NCT00512876|19537615|P1|STARTED|Overall Study||24
7939021|NCT00512798|19537622|P2|NOT COMPLETED|Overall Study||27
7939022|NCT00512798|19537623|P1|NOT COMPLETED|Overall Study||19
7939023|NCT00512798|19537622|P2|COMPLETED|Overall Study||1
7939024|NCT00512798|19537623|P1|COMPLETED|Overall Study||0
7939025|NCT00512798|19537622|P2|STARTED|Overall Study||28
7939026|NCT00512798|19537623|P1|STARTED|Overall Study||19
7939027|NCT00512707|19537634|P2|NOT COMPLETED|Overall Study||12
7939028|NCT00512707|19537635|P1|NOT COMPLETED|Overall Study||10
7939029|NCT00512707|19537634|P2|COMPLETED|Overall Study||58
7939030|NCT00512707|19537635|P1|COMPLETED|Overall Study||60
7939031|NCT00512707|19537634|P2|STARTED|Overall Study||70
7939032|NCT00512707|19537635|P1|STARTED|Overall Study||70
7939033|NCT00512278|19537667|P2|NOT COMPLETED|Overall Study||17
7939034|NCT00512278|19537668|P1|NOT COMPLETED|Overall Study||28
7939035|NCT00512278|19537667|P2|COMPLETED|Overall Study||56
7939036|NCT00512278|19537668|P1|COMPLETED|Overall Study||45
7939037|NCT00512278|19537667|P2|STARTED|Overall Study||73
7939038|NCT00512278|19537668|P1|STARTED|Overall Study||73
7939039|NCT00512252|19537685|P3|NOT COMPLETED|Overall Study||3
7939040|NCT00512252|19537686|P2|NOT COMPLETED|Overall Study||0
7939041|NCT00512252|19537687|P1|NOT COMPLETED|Overall Study||0
7939042|NCT00512252|19537685|P3|COMPLETED|Overall Study||43
7939043|NCT00512252|19537686|P2|COMPLETED|Overall Study||3
7939044|NCT00512252|19537687|P1|COMPLETED|Overall Study||3
7939045|NCT00512252|19537685|P3|STARTED|Overall Study||46
7939046|NCT00512252|19537686|P2|STARTED|Overall Study||3
7939047|NCT00512252|19537687|P1|STARTED|Overall Study||3
7939048|NCT00512148|19537715|P1|NOT COMPLETED|Long Term Follow Up Period||6
7939049|NCT00512148|19537715|P1|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0
7939050|NCT00512148|19537715|P1|STARTED|Long Term Follow Up Period||6
7939051|NCT00512148|19537715|P1|NOT COMPLETED|Primay Study Period||1
7939052|NCT00512148|19537715|P1|COMPLETED|Primay Study Period||6
7939053|NCT00512148|19537715|P1|STARTED|Primay Study Period||7
7939054|NCT00512096|19537721|P1|NOT COMPLETED|Overall Study||7
7939055|NCT00512096|19537721|P1|COMPLETED|Overall Study||23
7939056|NCT00512096|19537721|P1|STARTED|Overall Study||30
7939057|NCT00511992|19537725|P1|NOT COMPLETED|Overall Study||7
7939058|NCT00511992|19537725|P1|COMPLETED|Overall Study||13
7939059|NCT00511992|19537725|P1|STARTED|Overall Study||20
7939060|NCT00511914|19537732|P2|NOT COMPLETED|Overall Study||0
7939061|NCT00511914|19537733|P1|NOT COMPLETED|Overall Study||0
7939062|NCT00511914|19537732|P2|COMPLETED|Overall Study||67
7939063|NCT00511914|19537733|P1|COMPLETED|Overall Study||68
7939064|NCT00511914|19537732|P2|STARTED|Overall Study||67
7939065|NCT00511914|19537733|P1|STARTED|Overall Study||68
7939066|NCT00511901|19537749|P2|NOT COMPLETED|Overall Study||3
7939067|NCT00511901|19537750|P1|NOT COMPLETED|Overall Study||1
7939068|NCT00511901|19537749|P2|COMPLETED|Overall Study||8
7939069|NCT00511901|19537750|P1|COMPLETED|Overall Study||10
7939070|NCT00511901|19537749|P2|STARTED|Overall Study||11
7939071|NCT00511901|19537750|P1|STARTED|Overall Study||11
7939072|NCT00511875|19537772|P2|NOT COMPLETED|Overall Study||0
7939073|NCT00511875|19537773|P1|NOT COMPLETED|Overall Study||5
7939074|NCT00511875|19537772|P2|COMPLETED|Overall Study||15
7939075|NCT00511875|19537773|P1|COMPLETED|Overall Study||10
7939076|NCT00511875|19537772|P2|STARTED|Overall Study||15
7939077|NCT00511875|19537773|P1|STARTED|Overall Study||15
7939078|NCT00511862|19537798|P3|NOT COMPLETED|Overall Study||0
7939079|NCT00511862|19537799|P2|NOT COMPLETED|Overall Study||0
7939080|NCT00511862|19537800|P1|NOT COMPLETED|Overall Study||0
7939081|NCT00511862|19537798|P3|COMPLETED|Overall Study||47
7939082|NCT00511862|19537799|P2|COMPLETED|Overall Study||43
7939083|NCT00511862|19537800|P1|COMPLETED|Overall Study||61
7939084|NCT00511862|19537798|P3|STARTED|Overall Study||47
7939085|NCT00511862|19537799|P2|STARTED|Overall Study||43
7939086|NCT00511862|19537800|P1|STARTED|Overall Study||61
7939087|NCT00511836|19537813|P2|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0
7939088|NCT00511836|19537814|P1|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16
7939089|NCT00511836|19537813|P2|COMPLETED|Optional Open-label VIVITROL (2 Months)||0
7939090|NCT00511836|19537814|P1|COMPLETED|Optional Open-label VIVITROL (2 Months)||6
7939091|NCT00511836|19537813|P2|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0
7939092|NCT00511836|19537814|P1|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22
7939093|NCT00511836|19537813|P2|NOT COMPLETED|Double-blind Period||0
7939094|NCT00511836|19537814|P1|NOT COMPLETED|Double-blind Period||1
7939095|NCT00511836|19537813|P2|COMPLETED|Double-blind Period||15
7939096|NCT00511836|19537814|P1|COMPLETED|Double-blind Period||15
7939097|NCT00511836|19537813|P2|STARTED|Double-blind Period||15
7939098|NCT00511836|19537814|P1|STARTED|Double-blind Period||16
7939099|NCT00511810|19537831|P2|NOT COMPLETED|Overall Study||5
7939100|NCT00511810|19537832|P1|NOT COMPLETED|Overall Study||1
7939101|NCT00511810|19537831|P2|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7
7939102|NCT00511810|19537832|P1|COMPLETED|Overall Study||7
7939103|NCT00511810|19537831|P2|STARTED|Overall Study||12
7939104|NCT00511810|19537832|P1|STARTED|Overall Study||8
7939105|NCT00511797|19537842|P4|NOT COMPLETED|Overall Study||15
7939106|NCT00511797|19537843|P3|NOT COMPLETED|Overall Study||11
7939107|NCT00511797|19537844|P2|NOT COMPLETED|Overall Study||8
7939108|NCT00511797|19537845|P1|NOT COMPLETED|Overall Study||7
7939109|NCT00511797|19537842|P4|COMPLETED|Overall Study||47
7939110|NCT00511797|19537843|P3|COMPLETED|Overall Study||51
7939111|NCT00511797|19537844|P2|COMPLETED|Overall Study||55
7939112|NCT00511797|19537845|P1|COMPLETED|Overall Study||55
7939113|NCT00511797|19537842|P4|Subjects Received Treatment|Overall Study|FAS|58
7939114|NCT00511797|19537843|P3|Subjects Received Treatment|Overall Study|FAS|61
7939115|NCT00511797|19537844|P2|Subjects Received Treatment|Overall Study|FAS|62
7939116|NCT00511797|19537845|P1|Subjects Received Treatment|Overall Study|FAS|61
7939117|NCT00511797|19537842|P4|Subjects Dispensed Drugs|Overall Study||59
7939118|NCT00511797|19537843|P3|Subjects Dispensed Drugs|Overall Study||61
7939119|NCT00511797|19537844|P2|Subjects Dispensed Drugs|Overall Study||63
7939120|NCT00511797|19537845|P1|Subjects Dispensed Drugs|Overall Study||61
7939121|NCT00511797|19537842|P4|STARTED|Overall Study||62
7939122|NCT00511797|19537843|P3|STARTED|Overall Study||62
7939123|NCT00511797|19537844|P2|STARTED|Overall Study||63
7939124|NCT00511797|19537845|P1|STARTED|Overall Study||62
7939125|NCT00511706|19537949|P2|NOT COMPLETED|Overall Study||5
7939126|NCT00511706|19537950|P1|NOT COMPLETED|Overall Study||8
7939127|NCT00511706|19537949|P2|COMPLETED|Overall Study||115
7939128|NCT00511706|19537950|P1|COMPLETED|Overall Study||115
7939129|NCT00511706|19537949|P2|STARTED|Overall Study||120
7939130|NCT00511706|19537950|P1|STARTED|Overall Study||123
7939131|NCT00511667|19537964|P2|NOT COMPLETED|Overall Study||3
7939132|NCT00511667|19537965|P1|NOT COMPLETED|Overall Study||12
7939133|NCT00511667|19537964|P2|COMPLETED|Overall Study||15
7939134|NCT00511667|19537965|P1|COMPLETED|Overall Study||40
7939135|NCT00511667|19537964|P2|STARTED|Overall Study||18
7939136|NCT00511667|19537965|P1|STARTED|Overall Study||52
7939137|NCT00511472|19538000|P2|NOT COMPLETED|Overall Study||6
7939138|NCT00511472|19538001|P1|NOT COMPLETED|Overall Study||3
7939139|NCT00511472|19538000|P2|COMPLETED|Overall Study||17
7939140|NCT00511472|19538001|P1|COMPLETED|Overall Study||44
7939141|NCT00511472|19538000|P2|STARTED|Overall Study||23
7939142|NCT00511472|19538001|P1|STARTED|Overall Study||47
7939143|NCT00511433|19538020|P2|NOT COMPLETED|Overall Study||1
7939144|NCT00511433|19538021|P1|NOT COMPLETED|Overall Study||6
7939145|NCT00511433|19538020|P2|COMPLETED|Overall Study||15
7939146|NCT00511433|19538021|P1|COMPLETED|Overall Study||26
7939147|NCT00511433|19538020|P2|STARTED|Overall Study||16
7939148|NCT00511433|19538021|P1|STARTED|Overall Study||32
7939149|NCT00511355|19538061|P2|NOT COMPLETED|Overall Study||9
7939150|NCT00511355|19538062|P1|NOT COMPLETED|Overall Study||7
7939151|NCT00511355|19538061|P2|COMPLETED|Overall Study||52
7939152|NCT00511355|19538062|P1|COMPLETED|Overall Study||53
7939153|NCT00511355|19538061|P2|STARTED|Overall Study||61
7939154|NCT00511355|19538062|P1|STARTED|Overall Study||60
7939155|NCT00511342|19538162|P2|NOT COMPLETED|Overall Study||22
7939156|NCT00511342|19538163|P1|NOT COMPLETED|Overall Study||13
7939157|NCT00511342|19538162|P2|COMPLETED|Overall Study||32
7939158|NCT00511342|19538163|P1|COMPLETED|Overall Study||43
7939159|NCT00511342|19538162|P2|STARTED|Overall Study||54
7939160|NCT00511342|19538163|P1|STARTED|Overall Study||56
7939161|NCT00511329|19538187|P1|NOT COMPLETED|Overall Study||0
7939162|NCT00511329|19538187|P1|COMPLETED|Overall Study||0
7939163|NCT00511329|19538187|P1|STARTED|Overall Study||0
7939164|NCT00511238|19538194|P2|NOT COMPLETED|Overall Study||226
7939165|NCT00511238|19538195|P1|NOT COMPLETED|Overall Study||42
7939166|NCT00511238|19538194|P2|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40
7939167|NCT00511238|19538195|P1|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4
7939168|NCT00511238|19538194|P2|STARTED|Overall Study||266
7939169|NCT00511238|19538195|P1|STARTED|Overall Study||46
7939170|NCT00511199|19538214|P2|NOT COMPLETED|Overall Study||125
7939171|NCT00511199|19538215|P1|NOT COMPLETED|Overall Study||449
7939172|NCT00511199|19538214|P2|COMPLETED|Overall Study||410
7939173|NCT00511199|19538215|P1|COMPLETED|Overall Study||1142
7939174|NCT00511199|19538214|P2|STARTED|Overall Study||535
7939175|NCT00511199|19538215|P1|STARTED|Overall Study||1591
7939176|NCT00511173|19538239|P1|NOT COMPLETED|Overall Study||0
7939177|NCT00511173|19538239|P1|COMPLETED|Overall Study||102
7939178|NCT00511173|19538239|P1|STARTED|Overall Study||102
7939179|NCT00511147|19538244|P1|NOT COMPLETED|Overall Study||7
7939180|NCT00511147|19538244|P1|COMPLETED|Overall Study||57
7939181|NCT00511147|19538244|P1|STARTED|Overall Study||64
7939182|NCT00511134|19538253|P2|NOT COMPLETED|Overall Study||2
7939183|NCT00511134|19538254|P1|NOT COMPLETED|Overall Study||0
7939184|NCT00511134|19538253|P2|COMPLETED|Overall Study||1
7939185|NCT00511134|19538254|P1|COMPLETED|Overall Study||1
7939186|NCT00511134|19538253|P2|STARTED|Overall Study||3
7939187|NCT00511134|19538254|P1|STARTED|Overall Study||1
7939188|NCT00511108|19538266|P4|NOT COMPLETED|Overall Study||5
7939189|NCT00511108|19538267|P3|NOT COMPLETED|Overall Study||5
7939190|NCT00511108|19538268|P2|NOT COMPLETED|Overall Study||2
7939191|NCT00511108|19538269|P1|NOT COMPLETED|Overall Study||6
7939192|NCT00511108|19538266|P4|COMPLETED|Overall Study||48
7939193|NCT00511108|19538267|P3|COMPLETED|Overall Study||47
7939194|NCT00511108|19538268|P2|COMPLETED|Overall Study||52
7939195|NCT00511108|19538269|P1|COMPLETED|Overall Study||46
7939196|NCT00511108|19538266|P4|STARTED|Overall Study||53
7939197|NCT00511108|19538267|P3|STARTED|Overall Study||52
7939198|NCT00511108|19538268|P2|STARTED|Overall Study||54
7939199|NCT00511108|19538269|P1|STARTED|Overall Study||52
7939200|NCT00511095|19538287|P1|NOT COMPLETED|Overall Study||11
7939201|NCT00511095|19538287|P1|COMPLETED|Overall Study||196
7939202|NCT00511095|19538287|P1|STARTED|Overall Study||207
7939203|NCT00511004|19538300|P3|NOT COMPLETED|Overall Study||4
7939204|NCT00511004|19538301|P2|NOT COMPLETED|Overall Study||0
7939205|NCT00511004|19538302|P1|NOT COMPLETED|Overall Study||0
7939206|NCT00511004|19538300|P3|COMPLETED|Overall Study||10
7939207|NCT00511004|19538301|P2|COMPLETED|Overall Study||13
7939208|NCT00511004|19538302|P1|COMPLETED|Overall Study||13
7939209|NCT00511004|19538300|P3|STARTED|Overall Study||14
7939210|NCT00511004|19538301|P2|STARTED|Overall Study||13
7939211|NCT00511004|19538302|P1|STARTED|Overall Study||13
7939212|NCT00510952|19538321|P2|NOT COMPLETED|Overall Study||16
7939213|NCT00510952|19538322|P1|NOT COMPLETED|Overall Study||26
7939214|NCT00510952|19538321|P2|COMPLETED|Overall Study||220
7939215|NCT00510952|19538322|P1|COMPLETED|Overall Study||209
7939216|NCT00510952|19538321|P2|Full Analysis Set (Intent to Treat)|Overall Study||229
7939217|NCT00510952|19538322|P1|Full Analysis Set (Intent to Treat)|Overall Study||229
7939218|NCT00510952|19538321|P2|STARTED|Overall Study||236
7939219|NCT00510952|19538322|P1|STARTED|Overall Study||235
7939220|NCT00510887|19538348|P1|NOT COMPLETED|Overall Study||1
7939221|NCT00510887|19538348|P1|COMPLETED|Overall Study||11
7939222|NCT00510887|19538348|P1|STARTED|Overall Study||12
7939223|NCT00510874|19538364|P7|NOT COMPLETED|Overall Study||1
7939224|NCT00510874|19538365|P6|NOT COMPLETED|Overall Study||0
7939225|NCT00510874|19538366|P5|NOT COMPLETED|Overall Study||7
7939226|NCT00510874|19538367|P4|NOT COMPLETED|Overall Study||3
7939227|NCT00510874|19538368|P3|NOT COMPLETED|Overall Study||1
7939228|NCT00510874|19538369|P2|NOT COMPLETED|Overall Study||4
7939229|NCT00510874|19538370|P1|NOT COMPLETED|Overall Study||3
7939230|NCT00510874|19538364|P7|COMPLETED|Overall Study|Upto Day 182|49
7939231|NCT00510874|19538365|P6|COMPLETED|Overall Study|Upto Day 182|50
7939232|NCT00510874|19538366|P5|COMPLETED|Overall Study|Upto Day 182|141
7939233|NCT00510874|19538367|P4|COMPLETED|Overall Study|Upto Day 182|148
7939234|NCT00510874|19538368|P3|COMPLETED|Overall Study|Upto Day 182|150
7939235|NCT00510874|19538369|P2|COMPLETED|Overall Study|Upto Day 182|148
7939236|NCT00510874|19538370|P1|COMPLETED|Overall Study|Upto Day 182|75
7939237|NCT00510874|19538364|P7|STARTED|Overall Study||50
7939238|NCT00510874|19538365|P6|STARTED|Overall Study||50
7939239|NCT00510874|19538366|P5|STARTED|Overall Study||148
7939240|NCT00510874|19538367|P4|STARTED|Overall Study||151
7939241|NCT00510874|19538368|P3|STARTED|Overall Study||151
7939242|NCT00510874|19538369|P2|STARTED|Overall Study||152
7939243|NCT00510874|19538370|P1|STARTED|Overall Study||78
7939244|NCT00510835|19538473|P3|NOT COMPLETED|Overall Study||2
7939245|NCT00510835|19538474|P2|NOT COMPLETED|Overall Study||2
7939246|NCT00510835|19538475|P1|NOT COMPLETED|Overall Study||6
7939247|NCT00510835|19538473|P3|COMPLETED|Overall Study||456
7939248|NCT00510835|19538474|P2|COMPLETED|Overall Study||446
7939249|NCT00510835|19538475|P1|COMPLETED|Overall Study||439
7939250|NCT00510835|19538473|P3|STARTED|Overall Study||458
7939251|NCT00510835|19538474|P2|STARTED|Overall Study||448
7939252|NCT00510835|19538475|P1|STARTED|Overall Study||445
7939253|NCT00510809|19538486|P3|NOT COMPLETED|Overall Study||0
7939254|NCT00510809|19538487|P2|NOT COMPLETED|Overall Study||0
7939255|NCT00510809|19538488|P1|NOT COMPLETED|Overall Study||0
7939256|NCT00510809|19538486|P3|COMPLETED|Overall Study||18
7939257|NCT00510809|19538487|P2|COMPLETED|Overall Study||18
7939258|NCT00510809|19538488|P1|COMPLETED|Overall Study||18
7939259|NCT00510809|19538486|P3|STARTED|Overall Study||18
7939260|NCT00510809|19538487|P2|STARTED|Overall Study||18
7939261|NCT00510809|19538488|P1|STARTED|Overall Study||18
7939262|NCT00510783|19538501|P2|NOT COMPLETED|Overall Study||29
7939263|NCT00510783|19538502|P1|NOT COMPLETED|Overall Study||31
7939264|NCT00510783|19538501|P2|COMPLETED|Overall Study||47
7939265|NCT00510783|19538502|P1|COMPLETED|Overall Study||51
7939266|NCT00510783|19538501|P2|STARTED|Overall Study||76
7939267|NCT00510783|19538502|P1|STARTED|Overall Study||82
7939268|NCT00510744|19538508|P1|NOT COMPLETED|Overall Study||0
7939269|NCT00510744|19538508|P1|COMPLETED|Overall Study||5
7939270|NCT00510744|19538508|P1|STARTED|Overall Study||5
7939271|NCT00510718|19538519|P2|NOT COMPLETED|Multiple Dose Period: 12 Weeks||32
7939272|NCT00510718|19538520|P1|NOT COMPLETED|Multiple Dose Period: 12 Weeks||15
7939273|NCT00510718|19538519|P2|COMPLETED|Multiple Dose Period: 12 Weeks||43
7939274|NCT00510718|19538520|P1|COMPLETED|Multiple Dose Period: 12 Weeks||50
7939275|NCT00510718|19538519|P2|600 mg/Day|Multiple Dose Period: 12 Weeks||3
7939276|NCT00510718|19538520|P1|600 mg/Day|Multiple Dose Period: 12 Weeks||0
7939277|NCT00510718|19538519|P2|480 mg/Day|Multiple Dose Period: 12 Weeks||22
7939278|NCT00510718|19538520|P1|480 mg/Day|Multiple Dose Period: 12 Weeks||0
7939279|NCT00510718|19538519|P2|360 mg/Day|Multiple Dose Period: 12 Weeks||13
7939280|NCT00510718|19538520|P1|360 mg/Day|Multiple Dose Period: 12 Weeks||15
7939281|NCT00510718|19538519|P2|240 mg/Day|Multiple Dose Period: 12 Weeks||12
7939282|NCT00510718|19538520|P1|240 mg/Day|Multiple Dose Period: 12 Weeks||17
7939283|NCT00510718|19538519|P2|150/160 mg/Day|Multiple Dose Period: 12 Weeks||13
7939284|NCT00510718|19538520|P1|150/160 mg/Day|Multiple Dose Period: 12 Weeks||15
7939285|NCT00510718|19538519|P2|60 mg/Day|Multiple Dose Period: 12 Weeks||12
7939286|NCT00510718|19538520|P1|60 mg/Day|Multiple Dose Period: 12 Weeks||15
7939287|NCT00510718|19538519|P2|30 mg/Day|Multiple Dose Period: 12 Weeks||0
7939288|NCT00510718|19538520|P1|30 mg/Day|Multiple Dose Period: 12 Weeks||3
7939289|NCT00510718|19538519|P2|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|75
7939290|NCT00510718|19538520|P1|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|65
7939291|NCT00510718|19538519|P2|NOT COMPLETED|Single Dose Period: 1 Week||0
7939292|NCT00510718|19538520|P1|NOT COMPLETED|Single Dose Period: 1 Week||0
7939293|NCT00510718|19538519|P2|COMPLETED|Single Dose Period: 1 Week||12
7939294|NCT00510718|19538520|P1|COMPLETED|Single Dose Period: 1 Week||15
7939295|NCT00510718|19538519|P2|600 mg/Day|Single Dose Period: 1 Week||3
7939296|NCT00510718|19538520|P1|600 mg/Day|Single Dose Period: 1 Week||0
7939297|NCT00510718|19538519|P2|480 mg/Day|Single Dose Period: 1 Week||6
7939298|NCT00510718|19538520|P1|480 mg/Day|Single Dose Period: 1 Week||0
7939299|NCT00510718|19538519|P2|360 mg/Day|Single Dose Period: 1 Week||2
7939300|NCT00510718|19538520|P1|360 mg/Day|Single Dose Period: 1 Week||4
7939301|NCT00510718|19538519|P2|240 mg/Day|Single Dose Period: 1 Week||0
7939302|NCT00510718|19538520|P1|240 mg/Day|Single Dose Period: 1 Week||3
7939303|NCT00510718|19538519|P2|150/160 mg/Day|Single Dose Period: 1 Week||1
7939304|NCT00510718|19538520|P1|150/160 mg/Day|Single Dose Period: 1 Week||2
7939305|NCT00510718|19538519|P2|60 mg/Day|Single Dose Period: 1 Week||0
7939306|NCT00510718|19538520|P1|60 mg/Day|Single Dose Period: 1 Week||3
7939307|NCT00510718|19538519|P2|30 mg/Day|Single Dose Period: 1 Week||0
7939308|NCT00510718|19538520|P1|30 mg/Day|Single Dose Period: 1 Week||3
7939309|NCT00510718|19538519|P2|STARTED|Single Dose Period: 1 Week||12
7939310|NCT00510718|19538520|P1|STARTED|Single Dose Period: 1 Week||15
7939311|NCT00510692|19538646|P2|NOT COMPLETED|Overall Study||3
7939312|NCT00510692|19538647|P1|NOT COMPLETED|Overall Study||2
7939313|NCT00510692|19538646|P2|COMPLETED|Overall Study||26
7939314|NCT00510692|19538647|P1|COMPLETED|Overall Study||27
7939315|NCT00510692|19538646|P2|STARTED|Overall Study||29
7939316|NCT00510692|19538647|P1|STARTED|Overall Study||29
7939317|NCT00510653|19538661|P1|NOT COMPLETED|Overall Study||11
7939318|NCT00510653|19538661|P1|COMPLETED|Overall Study||13
7939319|NCT00510653|19538661|P1|STARTED|Overall Study||24
7939320|NCT00510510|19538668|P3|NOT COMPLETED|Overall Study||17
7939321|NCT00510510|19538669|P2|NOT COMPLETED|Overall Study||9
7939322|NCT00510510|19538670|P1|NOT COMPLETED|Overall Study||5
7939323|NCT00510510|19538668|P3|COMPLETED|Overall Study||74
7939324|NCT00510510|19538669|P2|COMPLETED|Overall Study||89
7939325|NCT00510510|19538670|P1|COMPLETED|Overall Study||87
7939326|NCT00510510|19538668|P3|STARTED|Overall Study||91
7939327|NCT00510510|19538669|P2|STARTED|Overall Study||98
7939328|NCT00510510|19538670|P1|STARTED|Overall Study||92
7939329|NCT00510497|19538681|P1|NOT COMPLETED|Overall Study||3
7939330|NCT00510497|19538681|P1|COMPLETED|Overall Study||8
7939331|NCT00510497|19538681|P1|STARTED|Overall Study||11
7939332|NCT00510484|19538688|P2|NOT COMPLETED|Period 2||0
7939333|NCT00510484|19538689|P1|NOT COMPLETED|Period 2||0
7939334|NCT00510484|19538688|P2|COMPLETED|Period 2||15
7939335|NCT00510484|19538689|P1|COMPLETED|Period 2||16
7939336|NCT00510484|19538688|P2|STARTED|Period 2||15
7939337|NCT00510484|19538689|P1|STARTED|Period 2||16
7939338|NCT00510484|19538688|P2|NOT COMPLETED|Wash-out Period||1
7939339|NCT00510484|19538689|P1|NOT COMPLETED|Wash-out Period||0
7939340|NCT00510484|19538688|P2|COMPLETED|Wash-out Period||15
7939341|NCT00510484|19538689|P1|COMPLETED|Wash-out Period||16
7939342|NCT00510484|19538688|P2|STARTED|Wash-out Period||16
7939343|NCT00510484|19538689|P1|STARTED|Wash-out Period||16
7939344|NCT00510484|19538688|P2|NOT COMPLETED|Period 1||0
7939345|NCT00510484|19538689|P1|NOT COMPLETED|Period 1||0
7939346|NCT00510484|19538688|P2|COMPLETED|Period 1||16
7939347|NCT00510484|19538689|P1|COMPLETED|Period 1||16
7939348|NCT00510484|19538688|P2|STARTED|Period 1||16
7939349|NCT00510484|19538689|P1|STARTED|Period 1||16
7939350|NCT00510458|19538709|P1|NOT COMPLETED|Overall Study||47
7939351|NCT00510458|19538709|P1|COMPLETED|Overall Study||27
7939352|NCT00510458|19538709|P1|STARTED|Overall Study||74
7939353|NCT00510289|19538722|P1|NOT COMPLETED|Overall Study||12
7939354|NCT00510289|19538722|P1|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7
7939355|NCT00510289|19538722|P1|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16
7939356|NCT00510289|19538722|P1|STARTED|Overall Study|All patients who consented|19
7939357|NCT00510276|19538732|P2|NOT COMPLETED|Extension Open-Label Phase||48
7939358|NCT00510276|19538733|P1|NOT COMPLETED|Extension Open-Label Phase||33
7939359|NCT00510276|19538732|P2|COMPLETED|Extension Open-Label Phase||81
7939360|NCT00510276|19538733|P1|COMPLETED|Extension Open-Label Phase||78
7939361|NCT00510276|19538732|P2|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129
7939362|NCT00510276|19538733|P1|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111
7939363|NCT00510276|19538732|P2|NOT COMPLETED|Acute Double-Blind Phase||95
7939364|NCT00510276|19538733|P1|NOT COMPLETED|Acute Double-Blind Phase||105
7939365|NCT00510276|19538732|P2|COMPLETED|Acute Double-Blind Phase||130
7939366|NCT00510276|19538733|P1|COMPLETED|Acute Double-Blind Phase||115
7939367|NCT00510276|19538732|P2|STARTED|Acute Double-Blind Phase||225
7939368|NCT00510276|19538733|P1|STARTED|Acute Double-Blind Phase||220
7939369|NCT00510224|19538818|P1|NOT COMPLETED|Overall Study||3
7939370|NCT00510224|19538818|P1|COMPLETED|Overall Study||10
7939371|NCT00510224|19538818|P1|STARTED|Overall Study||13
7939372|NCT00510198|19538827|P2|NOT COMPLETED|Overall Study||4
7939373|NCT00510198|19538828|P1|NOT COMPLETED|Overall Study||5
7939374|NCT00510198|19538827|P2|COMPLETED|Overall Study||54
7939375|NCT00510198|19538828|P1|COMPLETED|Overall Study||54
7939376|NCT00510198|19538827|P2|STARTED|Overall Study||58
7939377|NCT00510198|19538828|P1|STARTED|Overall Study||59
7939378|NCT00510146|19538842|P2|NOT COMPLETED|Open-Label Treatment||26
7939379|NCT00510146|19538843|P1|NOT COMPLETED|Open-Label Treatment||71
7939380|NCT00510146|19538842|P2|COMPLETED|Open-Label Treatment||96
7939381|NCT00510146|19538843|P1|COMPLETED|Open-Label Treatment||196
7939382|NCT00510146|19538842|P2|STARTED|Open-Label Treatment||122
7939383|NCT00510146|19538843|P1|STARTED|Open-Label Treatment||267
7939384|NCT00510146|19538842|P2|NOT COMPLETED|Double-Blind Treatment||49
7939385|NCT00510146|19538843|P1|NOT COMPLETED|Double-Blind Treatment||76
7939386|NCT00510146|19538842|P2|COMPLETED|Double-Blind Treatment||122
7939387|NCT00510146|19538843|P1|COMPLETED|Double-Blind Treatment||267
7939388|NCT00510146|19538842|P2|STARTED|Double-Blind Treatment||171
7939389|NCT00510146|19538843|P1|STARTED|Double-Blind Treatment||343
7939390|NCT00510068|19538932|P2|NOT COMPLETED|Open-label Period||0
7939391|NCT00510068|19538933|P1|NOT COMPLETED|Open-label Period||225
7939392|NCT00510068|19538932|P2|COMPLETED|Open-label Period||0
7939393|NCT00510068|19538933|P1|COMPLETED|Open-label Period||0
7939394|NCT00510068|19538932|P2|STARTED|Open-label Period||0
7939395|NCT00510068|19538933|P1|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225
7939396|NCT00510068|19538932|P2|NOT COMPLETED|Double-blind Period||203
7939397|NCT00510068|19538933|P1|NOT COMPLETED|Double-blind Period||207
7939398|NCT00510068|19538932|P2|COMPLETED|Double-blind Period||0
7939399|NCT00510068|19538933|P1|COMPLETED|Double-blind Period||0
7939400|NCT00510068|19538932|P2|Safety Population|Double-blind Period||203
7939401|NCT00510068|19538933|P1|Safety Population|Double-blind Period||204
7939402|NCT00510068|19538932|P2|STARTED|Double-blind Period||203
7939403|NCT00510068|19538933|P1|STARTED|Double-blind Period||207
7939404|NCT00509925|19538974|P2|NOT COMPLETED|Overall Study||1
7939405|NCT00509925|19538975|P1|NOT COMPLETED|Overall Study||0
7939406|NCT00509925|19538974|P2|COMPLETED|Overall Study||10
7939407|NCT00509925|19538975|P1|COMPLETED|Overall Study||12
7939408|NCT00509925|19538974|P2|STARTED|Overall Study||11
7939409|NCT00509925|19538975|P1|STARTED|Overall Study||12
7939410|NCT00509899|19539023|P8|NOT COMPLETED|Overall Study||1
7939411|NCT00509899|19539024|P7|NOT COMPLETED|Overall Study||1
7939412|NCT00509899|19539025|P6|NOT COMPLETED|Overall Study||10
7939413|NCT00509899|19539026|P5|NOT COMPLETED|Overall Study||5
7939414|NCT00509899|19539027|P4|NOT COMPLETED|Overall Study||4
7939415|NCT00509899|19539028|P3|NOT COMPLETED|Overall Study||20
7939416|NCT00509899|19539029|P2|NOT COMPLETED|Overall Study||9
7939417|NCT00509899|19539030|P1|NOT COMPLETED|Overall Study||16
7939418|NCT00509899|19539023|P8|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2
7939419|NCT00509899|19539024|P7|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5
7939420|NCT00509899|19539025|P6|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12
7939421|NCT00509899|19539026|P5|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
7939422|NCT00509899|19539027|P4|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
7939423|NCT00509899|19539028|P3|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27
7939424|NCT00509899|19539029|P2|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26
7939425|NCT00509899|19539030|P1|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14
7939426|NCT00509899|19539023|P8|STARTED|Overall Study||3
7939427|NCT00509899|19539024|P7|STARTED|Overall Study||6
7939428|NCT00509899|19539025|P6|STARTED|Overall Study||22
7939429|NCT00509899|19539026|P5|STARTED|Overall Study||6
7939430|NCT00509899|19539027|P4|STARTED|Overall Study||5
7939431|NCT00509899|19539028|P3|STARTED|Overall Study||47
7939432|NCT00509899|19539029|P2|STARTED|Overall Study||35
7939433|NCT00509899|19539030|P1|STARTED|Overall Study||30
7939434|NCT00509873|19539070|P2|NOT COMPLETED|Overall Study||15
7939435|NCT00509873|19539071|P1|NOT COMPLETED|Overall Study||11
7939436|NCT00509873|19539070|P2|COMPLETED|Overall Study||276
7939437|NCT00509873|19539071|P1|COMPLETED|Overall Study||276
7939438|NCT00509873|19539070|P2|STARTED|Overall Study||291
7939439|NCT00509873|19539071|P1|STARTED|Overall Study||287
7939440|NCT00509821|19539087|P2|NOT COMPLETED|Study Period 4 (Follow Up)||0
7939441|NCT00509821|19539088|P1|NOT COMPLETED|Study Period 4 (Follow Up)||0
7939442|NCT00509821|19539087|P2|COMPLETED|Study Period 4 (Follow Up)||50
7939443|NCT00509821|19539088|P1|COMPLETED|Study Period 4 (Follow Up)||2
7939444|NCT00509821|19539087|P2|STARTED|Study Period 4 (Follow Up)|1 Participant completed Radiation Phase, did not enter Maintenance Phase but entered Follow Up.|50
7939445|NCT00509821|19539088|P1|STARTED|Study Period 4 (Follow Up)|1 Participant completed Maintenance Phase but did not enter Follow-Up.|2
7939446|NCT00509821|19539087|P2|NOT COMPLETED|Study Period 3 (Maintenance)||49
7939447|NCT00509821|19539088|P1|NOT COMPLETED|Study Period 3 (Maintenance)||0
7939448|NCT00509821|19539087|P2|COMPLETED|Study Period 3 (Maintenance)||0
7939449|NCT00509821|19539088|P1|COMPLETED|Study Period 3 (Maintenance)||3
7939450|NCT00509821|19539087|P2|STARTED|Study Period 3 (Maintenance)|4 participants completed Radiation Phase but did not enter Maintenance Phase.|49
7939451|NCT00509821|19539088|P1|STARTED|Study Period 3 (Maintenance)||3
7939452|NCT00509821|19539087|P2|NOT COMPLETED|Study Period 2 (Radiation)||53
7939453|NCT00509821|19539088|P1|NOT COMPLETED|Study Period 2 (Radiation)||0
7939454|NCT00509821|19539087|P2|COMPLETED|Study Period 2 (Radiation)||0
7939455|NCT00509821|19539088|P1|COMPLETED|Study Period 2 (Radiation)||3
7939456|NCT00509821|19539087|P2|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|53
7939457|NCT00509821|19539088|P1|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|3
7939458|NCT00509821|19539087|P2|NOT COMPLETED|Study Period 1 (Induction)||4
7939459|NCT00509821|19539088|P1|NOT COMPLETED|Study Period 1 (Induction)||0
7939460|NCT00509821|19539087|P2|COMPLETED|Study Period 1 (Induction)||53
7939461|NCT00509821|19539088|P1|COMPLETED|Study Period 1 (Induction)||3
7939462|NCT00509821|19539087|P2|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||57
7939463|NCT00509821|19539088|P1|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||3
7939464|NCT00509821|19539087|P2|STARTED|Study Period 1 (Induction)||57
7939465|NCT00509821|19539088|P1|STARTED|Study Period 1 (Induction)||3
7939466|NCT00509795|19539106|P4|NOT COMPLETED|Overall Study||27
7939467|NCT00509795|19539107|P3|NOT COMPLETED|Overall Study||27
7939468|NCT00509795|19539108|P2|NOT COMPLETED|Overall Study||11
7939469|NCT00509795|19539109|P1|NOT COMPLETED|Overall Study||22
7939470|NCT00509795|19539106|P4|COMPLETED|Overall Study||276
7939471|NCT00509795|19539107|P3|COMPLETED|Overall Study||277
7939472|NCT00509795|19539108|P2|COMPLETED|Overall Study||293
7939473|NCT00509795|19539109|P1|COMPLETED|Overall Study||284
7939474|NCT00509795|19539106|P4|Per Protocol Set (PPS) Population|Overall Study||265
7939475|NCT00509795|19539107|P3|Per Protocol Set (PPS) Population|Overall Study||270
7939476|NCT00509795|19539108|P2|Per Protocol Set (PPS) Population|Overall Study||285
7939477|NCT00509795|19539109|P1|Per Protocol Set (PPS) Population|Overall Study||269
7939478|NCT00509795|19539106|P4|Full Analysis Set (FAS) Population|Overall Study||301
7939479|NCT00509795|19539107|P3|Full Analysis Set (FAS) Population|Overall Study||301
7939480|NCT00509795|19539108|P2|Full Analysis Set (FAS) Population|Overall Study||304
7939481|NCT00509795|19539109|P1|Full Analysis Set (FAS) Population|Overall Study||304
7939482|NCT00509795|19539106|P4|Patients Received Treatment (SAF)|Overall Study||303
7939483|NCT00509795|19539107|P3|Patients Received Treatment (SAF)|Overall Study||304
7939484|NCT00509795|19539108|P2|Patients Received Treatment (SAF)|Overall Study||304
7939485|NCT00509795|19539109|P1|Patients Received Treatment (SAF)|Overall Study||304
7939486|NCT00509795|19539106|P4|STARTED|Overall Study||303
7939487|NCT00509795|19539107|P3|STARTED|Overall Study||304
7939488|NCT00509795|19539108|P2|STARTED|Overall Study||304
7939489|NCT00509795|19539109|P1|STARTED|Overall Study||306
7939490|NCT00509769|19539140|P1|NOT COMPLETED|Overall Study||91
7939491|NCT00509769|19539140|P1|COMPLETED|Overall Study||21
7939492|NCT00509769|19539140|P1|STARTED|Overall Study||112
7939493|NCT00509665|19539149|P1|NOT COMPLETED|Overall Study||0
7939494|NCT00509665|19539149|P1|COMPLETED|Overall Study||18
7939495|NCT00509665|19539149|P1|STARTED|Overall Study||18
7939496|NCT00509600|19539159|P1|NOT COMPLETED|Overall Study||1
7939497|NCT00509600|19539159|P1|COMPLETED|Overall Study||0
7939498|NCT00509600|19539159|P1|STARTED|Overall Study||1
7939499|NCT00509587|19539163|P1|NOT COMPLETED|Overall Study||0
7939500|NCT00509587|19539163|P1|COMPLETED|Overall Study||21
7939501|NCT00509587|19539163|P1|STARTED|Overall Study||21
7939502|NCT00509496|19539174|P2|NOT COMPLETED|Overall Study||0
7939503|NCT00509496|19539175|P1|NOT COMPLETED|Overall Study||0
7939504|NCT00509496|19539174|P2|COMPLETED|Overall Study||2
7939505|NCT00509496|19539175|P1|COMPLETED|Overall Study||19
7939506|NCT00509496|19539174|P2|STARTED|Overall Study||2
7939507|NCT00509496|19539175|P1|STARTED|Overall Study||19
7939508|NCT00509392|19539185|P3|NOT COMPLETED|Overall Study||0
7939509|NCT00509392|19539186|P2|NOT COMPLETED|Overall Study||0
7939510|NCT00509392|19539187|P1|NOT COMPLETED|Overall Study||0
7939511|NCT00509392|19539185|P3|COMPLETED|Overall Study||4
7939512|NCT00509392|19539186|P2|COMPLETED|Overall Study||33
7939513|NCT00509392|19539187|P1|COMPLETED|Overall Study||32
7939514|NCT00509392|19539185|P3|STARTED|Overall Study||4
7939515|NCT00509392|19539186|P2|STARTED|Overall Study||33
7939516|NCT00509392|19539187|P1|STARTED|Overall Study||32
7939517|NCT00509366|19539238|P5|NOT COMPLETED|Overall Study||0
7939518|NCT00509366|19539239|P4|NOT COMPLETED|Overall Study||0
7939519|NCT00509366|19539240|P3|NOT COMPLETED|Overall Study||1
7939520|NCT00509366|19539241|P2|NOT COMPLETED|Overall Study||1
7939521|NCT00509366|19539242|P1|NOT COMPLETED|Overall Study||1
7939522|NCT00509366|19539238|P5|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51
7939523|NCT00509366|19539239|P4|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2
7939524|NCT00509366|19539240|P3|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21
7939525|NCT00509366|19539241|P2|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7
7939526|NCT00509366|19539242|P1|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17
7939527|NCT00509366|19539238|P5|Assigned Treatment|Overall Study||0
7939528|NCT00509366|19539239|P4|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2
7939529|NCT00509366|19539240|P3|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22
7939530|NCT00509366|19539241|P2|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8
7939531|NCT00509366|19539242|P1|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18
7939532|NCT00509366|19539238|P5|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51
7939533|NCT00509366|19539239|P4|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2
7939534|NCT00509366|19539240|P3|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22
7939535|NCT00509366|19539241|P2|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8
7939536|NCT00509366|19539242|P1|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18
7939537|NCT00509288|19539255|P2|NOT COMPLETED|Overall Study||0
7939538|NCT00509288|19539256|P1|NOT COMPLETED|Overall Study||0
7939539|NCT00509288|19539255|P2|COMPLETED|Overall Study||3
7939540|NCT00509288|19539256|P1|COMPLETED|Overall Study||21
7939541|NCT00509288|19539255|P2|STARTED|Overall Study||3
7939542|NCT00509288|19539256|P1|STARTED|Overall Study||21
7939543|NCT00509262|19539266|P2|NOT COMPLETED|Overall Study||42
7939544|NCT00509262|19539267|P1|NOT COMPLETED|Overall Study||47
7939545|NCT00509262|19539266|P2|COMPLETED|Overall Study||170
7939546|NCT00509262|19539267|P1|COMPLETED|Overall Study||164
7939547|NCT00509262|19539266|P2|STARTED|Overall Study||212
7939548|NCT00509262|19539267|P1|STARTED|Overall Study||211
7939549|NCT00509249|19539279|P1|NOT COMPLETED|Overall Study||0
7939550|NCT00509249|19539279|P1|COMPLETED|Overall Study||18
7939551|NCT00509249|19539279|P1|STARTED|Overall Study||18
7939552|NCT00509236|19539285|P2|NOT COMPLETED|Overall Study||20
7939553|NCT00509236|19539286|P1|NOT COMPLETED|Overall Study||17
7939554|NCT00509236|19539285|P2|COMPLETED|Overall Study||45
7939555|NCT00509236|19539286|P1|COMPLETED|Overall Study||47
7939556|NCT00509236|19539285|P2|STARTED|Overall Study||65
7939557|NCT00509236|19539286|P1|STARTED|Overall Study||64
7939558|NCT00509223|19539301|P2|NOT COMPLETED|Overall Study||72
7939559|NCT00509223|19539302|P1|NOT COMPLETED|Overall Study||88
7939560|NCT00509223|19539301|P2|COMPLETED|Overall Study||137
7939561|NCT00509223|19539302|P1|COMPLETED|Overall Study||119
7939562|NCT00509223|19539301|P2|STARTED|Overall Study||209
7939563|NCT00509223|19539302|P1|STARTED|Overall Study||207
7939564|NCT00509197|19539310|P2|NOT COMPLETED|Overall Study||0
7939565|NCT00509197|19539311|P1|NOT COMPLETED|Overall Study||0
7939566|NCT00509197|19539310|P2|COMPLETED|Overall Study||6
7939567|NCT00509197|19539311|P1|COMPLETED|Overall Study||6
7939568|NCT00509197|19539310|P2|STARTED|Overall Study||6
7939569|NCT00509197|19539311|P1|STARTED|Overall Study||6
7939570|NCT00509171|19539325|P2|NOT COMPLETED|Overall Study||0
7939571|NCT00509171|19539326|P1|NOT COMPLETED|Overall Study||0
7939572|NCT00509171|19539325|P2|COMPLETED|Overall Study||11
7939573|NCT00509171|19539326|P1|COMPLETED|Overall Study||11
7939574|NCT00509171|19539325|P2|STARTED|Overall Study||11
7939575|NCT00509171|19539326|P1|STARTED|Overall Study||11
7939576|NCT00509106|19539334|P2|NOT COMPLETED|Overall Study||29
7939577|NCT00509106|19539335|P1|NOT COMPLETED|Overall Study||31
7939578|NCT00509106|19539334|P2|COMPLETED|Overall Study||278
7939579|NCT00509106|19539335|P1|COMPLETED|Overall Study||284
7939580|NCT00509106|19539334|P2|STARTED|Overall Study||307
7939581|NCT00509106|19539335|P1|STARTED|Overall Study||315
7939582|NCT00509093|19539341|P1|NOT COMPLETED|Overall Study||24
7939583|NCT00509093|19539341|P1|COMPLETED|Overall Study||8
7939584|NCT00509093|19539341|P1|STARTED|Overall Study||32
7939585|NCT00509067|19539351|P2|NOT COMPLETED|Overall Study||5
7939586|NCT00509067|19539352|P1|NOT COMPLETED|Overall Study||4
7939587|NCT00509067|19539351|P2|COMPLETED|Overall Study||19
7939588|NCT00509067|19539352|P1|COMPLETED|Overall Study||15
7939589|NCT00509067|19539351|P2|STARTED|Overall Study||24
7939590|NCT00509067|19539352|P1|STARTED|Overall Study||19
7939591|NCT00509041|19539362|P1|NOT COMPLETED|Overall Study||0
7939592|NCT00509041|19539362|P1|COMPLETED|Overall Study||43
7939593|NCT00509041|19539362|P1|STARTED|Overall Study||43
7939594|NCT00509028|19539371|P2|NOT COMPLETED|Overall Study||7
7939595|NCT00509028|19539372|P1|NOT COMPLETED|Overall Study||12
7939596|NCT00509028|19539371|P2|COMPLETED|Overall Study||113
7939597|NCT00509028|19539372|P1|COMPLETED|Overall Study||109
7939598|NCT00509028|19539371|P2|STARTED|Overall Study||120
7939599|NCT00509028|19539372|P1|STARTED|Overall Study||121
7939600|NCT00509002|19539404|P1|NOT COMPLETED|Overall Study||0
7939601|NCT00509002|19539404|P1|COMPLETED|Overall Study||37
7939602|NCT00509002|19539404|P1|STARTED|Overall Study||37
7939603|NCT00508924|19539412|P4|NOT COMPLETED|Overall Study||1
7939604|NCT00508924|19539413|P3|NOT COMPLETED|Overall Study||1
7939605|NCT00508924|19539414|P2|NOT COMPLETED|Overall Study||0
7939606|NCT00508924|19539415|P1|NOT COMPLETED|Overall Study||0
7939607|NCT00508924|19539412|P4|COMPLETED|Overall Study||33
7939608|NCT00508924|19539413|P3|COMPLETED|Overall Study||31
7939609|NCT00508924|19539414|P2|COMPLETED|Overall Study||38
7939610|NCT00508924|19539415|P1|COMPLETED|Overall Study||36
7939611|NCT00508924|19539412|P4|STARTED|Overall Study||34
7939612|NCT00508924|19539413|P3|STARTED|Overall Study||32
7939613|NCT00508924|19539414|P2|STARTED|Overall Study||38
7939614|NCT00508924|19539415|P1|STARTED|Overall Study||36
7939615|NCT00508872|19539429|P1|NOT COMPLETED|Overall Study||2
7939616|NCT00508872|19539429|P1|COMPLETED|Overall Study||0
7939617|NCT00508872|19539429|P1|STARTED|Overall Study||2
7939618|NCT00508820|19539435|P2|NOT COMPLETED|Overall Study||64
7939619|NCT00508820|19539436|P1|NOT COMPLETED|Overall Study||55
7939620|NCT00508820|19539435|P2|COMPLETED|Overall Study||175
7939621|NCT00508820|19539436|P1|COMPLETED|Overall Study||113
7939622|NCT00508820|19539435|P2|STARTED|Overall Study||239
7939623|NCT00508820|19539436|P1|STARTED|Overall Study||168
7939624|NCT00508755|19539446|P1|NOT COMPLETED|Overall Study||1
7939625|NCT00508755|19539446|P1|COMPLETED|Overall Study||5
7939626|NCT00508755|19539446|P1|STARTED|Overall Study||6
7939627|NCT00508742|19539454|P2|NOT COMPLETED|Period 3: Toddler Dose||15
7939628|NCT00508742|19539455|P1|NOT COMPLETED|Period 3: Toddler Dose||25
7939629|NCT00508742|19539454|P2|COMPLETED|Period 3: Toddler Dose||863
7939630|NCT00508742|19539455|P1|COMPLETED|Period 3: Toddler Dose||858
7939631|NCT00508742|19539454|P2|STARTED|Period 3: Toddler Dose||878
7939632|NCT00508742|19539455|P1|STARTED|Period 3: Toddler Dose||883
7939633|NCT00508742|19539454|P2|NOT COMPLETED|Period 2: After Infant Series||11
7939634|NCT00508742|19539455|P1|NOT COMPLETED|Period 2: After Infant Series||7
7939635|NCT00508742|19539454|P2|COMPLETED|Period 2: After Infant Series||878
7939636|NCT00508742|19539455|P1|COMPLETED|Period 2: After Infant Series||883
7939637|NCT00508742|19539454|P2|STARTED|Period 2: After Infant Series||889
7939638|NCT00508742|19539455|P1|STARTED|Period 2: After Infant Series||890
7939639|NCT00508742|19539454|P2|NOT COMPLETED|Period 1: Infant Series||45
7939640|NCT00508742|19539455|P1|NOT COMPLETED|Period 1: Infant Series||42
7939641|NCT00508742|19539454|P2|COMPLETED|Period 1: Infant Series||889
7939642|NCT00508742|19539455|P1|COMPLETED|Period 1: Infant Series||890
7939643|NCT00508742|19539454|P2|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892
7939644|NCT00508742|19539455|P1|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898
7939645|NCT00508742|19539454|P2|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902
7939646|NCT00508742|19539455|P1|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904
7939647|NCT00508742|19539454|P2|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933
7939648|NCT00508742|19539455|P1|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930
7939649|NCT00508742|19539454|P2|STARTED|Period 1: Infant Series||934
7939650|NCT00508742|19539455|P1|STARTED|Period 1: Infant Series||932
7939651|NCT00508716|19539471|P2|NOT COMPLETED|Overall Study||0
7939652|NCT00508716|19539472|P1|NOT COMPLETED|Overall Study||0
7939653|NCT00508716|19539471|P2|COMPLETED|Overall Study||63
7939654|NCT00508716|19539472|P1|COMPLETED|Overall Study||61
7939655|NCT00508716|19539471|P2|STARTED|Overall Study||63
7939656|NCT00508716|19539472|P1|STARTED|Overall Study||61
7939657|NCT00508651|19539480|P2|NOT COMPLETED|Overall Study||2
7939658|NCT00508651|19539481|P1|NOT COMPLETED|Overall Study||4
7939659|NCT00508651|19539480|P2|COMPLETED|Overall Study||8
7939660|NCT00508651|19539481|P1|COMPLETED|Overall Study||16
7939661|NCT00508651|19539480|P2|STARTED|Overall Study||10
7939662|NCT00508651|19539481|P1|STARTED|Overall Study||20
7939663|NCT00508521|19539555|P1|NOT COMPLETED|Overall Study||0
7939664|NCT00508521|19539555|P1|COMPLETED|Overall Study||4
7939665|NCT00508521|19539555|P1|STARTED|Overall Study||4
7939666|NCT00508482|19539562|P3|NOT COMPLETED|at the 12th Week of Follow-up||0
7939667|NCT00508482|19539563|P2|NOT COMPLETED|at the 12th Week of Follow-up||0
7939668|NCT00508482|19539564|P1|NOT COMPLETED|at the 12th Week of Follow-up||0
7939669|NCT00508482|19539562|P3|COMPLETED|at the 12th Week of Follow-up||98
7939670|NCT00508482|19539563|P2|COMPLETED|at the 12th Week of Follow-up||96
7939671|NCT00508482|19539564|P1|COMPLETED|at the 12th Week of Follow-up||196
7939672|NCT00508482|19539562|P3|STARTED|at the 12th Week of Follow-up||98
7939673|NCT00508482|19539563|P2|STARTED|at the 12th Week of Follow-up||96
7939674|NCT00508482|19539564|P1|STARTED|at the 12th Week of Follow-up||196
7939675|NCT00508482|19539562|P3|NOT COMPLETED|at the 4th Week of Follow-up||1
7939676|NCT00508482|19539563|P2|NOT COMPLETED|at the 4th Week of Follow-up||6
7939677|NCT00508482|19539564|P1|NOT COMPLETED|at the 4th Week of Follow-up||20
7939678|NCT00508482|19539562|P3|COMPLETED|at the 4th Week of Follow-up||98
7939679|NCT00508482|19539563|P2|COMPLETED|at the 4th Week of Follow-up||96
7939680|NCT00508482|19539564|P1|COMPLETED|at the 4th Week of Follow-up||196
7939681|NCT00508482|19539562|P3|STARTED|at the 4th Week of Follow-up||99
7939682|NCT00508482|19539563|P2|STARTED|at the 4th Week of Follow-up||102
7939683|NCT00508482|19539564|P1|STARTED|at the 4th Week of Follow-up||216
7939684|NCT00508482|19539562|P3|NOT COMPLETED|Over 4 Weeks of Treatment||20
7939685|NCT00508482|19539563|P2|NOT COMPLETED|Over 4 Weeks of Treatment||17
7939686|NCT00508482|19539564|P1|NOT COMPLETED|Over 4 Weeks of Treatment||21
7939687|NCT00508482|19539562|P3|COMPLETED|Over 4 Weeks of Treatment||99
7939688|NCT00508482|19539563|P2|COMPLETED|Over 4 Weeks of Treatment||102
7939689|NCT00508482|19539564|P1|COMPLETED|Over 4 Weeks of Treatment||216
7939690|NCT00508482|19539562|P3|STARTED|Over 4 Weeks of Treatment||119
7939691|NCT00508482|19539563|P2|STARTED|Over 4 Weeks of Treatment||119
7939692|NCT00508482|19539564|P1|STARTED|Over 4 Weeks of Treatment||237
7939693|NCT00508469|19539601|P2|NOT COMPLETED|Overall Study||10
7939694|NCT00508469|19539602|P1|NOT COMPLETED|Overall Study||17
7939695|NCT00508469|19539601|P2|COMPLETED|Overall Study||40
7939696|NCT00508469|19539602|P1|COMPLETED|Overall Study||35
7939697|NCT00508469|19539601|P2|STARTED|Overall Study||50
7939698|NCT00508469|19539602|P1|STARTED|Overall Study||52
7939699|NCT00508404|19539608|P1|NOT COMPLETED|Overall Study||42
7939700|NCT00508404|19539608|P1|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112
7939701|NCT00508404|19539608|P1|STARTED|Overall Study||154
7939702|NCT00508391|19539635|P2|NOT COMPLETED|Second Treatment||0
7939703|NCT00508391|19539636|P1|NOT COMPLETED|Second Treatment||2
7939704|NCT00508391|19539635|P2|COMPLETED|Second Treatment||59
7939705|NCT00508391|19539636|P1|COMPLETED|Second Treatment||52
7939706|NCT00508391|19539635|P2|STARTED|Second Treatment||59
7939707|NCT00508391|19539636|P1|STARTED|Second Treatment||54
7939708|NCT00508391|19539635|P2|NOT COMPLETED|First Treatment||3
7939709|NCT00508391|19539636|P1|NOT COMPLETED|First Treatment||6
7939710|NCT00508391|19539635|P2|COMPLETED|First Treatment||59
7939711|NCT00508391|19539636|P1|COMPLETED|First Treatment||54
7939712|NCT00508391|19539635|P2|STARTED|First Treatment||62
7939713|NCT00508391|19539636|P1|STARTED|First Treatment||60
7939714|NCT00508300|19539649|P2|NOT COMPLETED|Overall Study||4
7939715|NCT00508300|19539650|P1|NOT COMPLETED|Overall Study||2
7939716|NCT00508300|19539649|P2|COMPLETED|Overall Study||57
7939717|NCT00508300|19539650|P1|COMPLETED|Overall Study||65
7939718|NCT00508300|19539649|P2|STARTED|Overall Study||61
7939719|NCT00508300|19539650|P1|STARTED|Overall Study||67
7939720|NCT00508274|19539656|P1|NOT COMPLETED|Overall Study||2
7939721|NCT00508274|19539656|P1|COMPLETED|Overall Study||50
7939722|NCT00508274|19539656|P1|STARTED|Overall Study||52
7939723|NCT00508261|19539669|P4|NOT COMPLETED|Overall Study||1
7939724|NCT00508261|19539670|P3|NOT COMPLETED|Overall Study||6
7939725|NCT00508261|19539671|P2|NOT COMPLETED|Overall Study||8
7939726|NCT00508261|19539672|P1|NOT COMPLETED|Overall Study||3
7939727|NCT00508261|19539669|P4|COMPLETED|Overall Study||126
7939728|NCT00508261|19539670|P3|COMPLETED|Overall Study||218
7939729|NCT00508261|19539671|P2|COMPLETED|Overall Study||212
7939730|NCT00508261|19539672|P1|COMPLETED|Overall Study||219
7939731|NCT00508261|19539669|P4|STARTED|Overall Study||127
7939732|NCT00508261|19539670|P3|STARTED|Overall Study||224
7939733|NCT00508261|19539671|P2|STARTED|Overall Study||220
7939734|NCT00508261|19539672|P1|STARTED|Overall Study||222
7939735|NCT00508196|19539782|P2|NOT COMPLETED|Overall Study||0
7939736|NCT00508196|19539783|P1|NOT COMPLETED|Overall Study||0
7939737|NCT00508196|19539782|P2|COMPLETED|Overall Study||11
7939738|NCT00508196|19539783|P1|COMPLETED|Overall Study||11
7939739|NCT00508196|19539782|P2|STARTED|Overall Study||11
7939740|NCT00508196|19539783|P1|STARTED|Overall Study||11
7939741|NCT00508183|19539795|P2|NOT COMPLETED|Overall Study||8
7939742|NCT00508183|19539796|P1|NOT COMPLETED|Overall Study||9
7939743|NCT00508183|19539795|P2|COMPLETED|Overall Study||34
7939744|NCT00508183|19539796|P1|COMPLETED|Overall Study||39
7939745|NCT00508183|19539795|P2|STARTED|Overall Study||42
7939746|NCT00508183|19539796|P1|STARTED|Overall Study||48
7939747|NCT00508157|19539812|P2|NOT COMPLETED|Overall Study||3
7939748|NCT00508157|19539813|P1|NOT COMPLETED|Overall Study||2
7939749|NCT00508157|19539812|P2|COMPLETED|Overall Study||23
7939750|NCT00508157|19539813|P1|COMPLETED|Overall Study||24
7939751|NCT00508157|19539812|P2|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25
7939752|NCT00508157|19539813|P1|Safety Sample|Overall Study||26
7939753|NCT00508157|19539812|P2|Randomized Sample|Overall Study||26
7939754|NCT00508157|19539813|P1|Randomized Sample|Overall Study||26
7939755|NCT00508157|19539812|P2|STARTED|Overall Study||26
7939756|NCT00508157|19539813|P1|STARTED|Overall Study||26
7939757|NCT00508144|19539835|P1|NOT COMPLETED|Overall Study||11
7939758|NCT00508144|19539835|P1|COMPLETED|Overall Study||53
7939759|NCT00508144|19539835|P1|STARTED|Overall Study||64
7939760|NCT00508118|19539841|P2|NOT COMPLETED|Overall Study||0
7939761|NCT00508118|19539842|P1|NOT COMPLETED|Overall Study||0
7939762|NCT00508118|19539841|P2|COMPLETED|Overall Study||4
7939763|NCT00508118|19539842|P1|COMPLETED|Overall Study||3
7939764|NCT00508118|19539841|P2|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4
7939765|NCT00508118|19539842|P1|STARTED|Overall Study||3
7939766|NCT00508105|19539863|P2|NOT COMPLETED|Overall Study||6
7939767|NCT00508105|19539864|P1|NOT COMPLETED|Overall Study||4
7939768|NCT00508105|19539863|P2|COMPLETED|Overall Study||37
7939769|NCT00508105|19539864|P1|COMPLETED|Overall Study||40
7939770|NCT00508105|19539863|P2|STARTED|Overall Study||43
7939771|NCT00508105|19539864|P1|STARTED|Overall Study||44
7939772|NCT00508027|19539874|P1|NOT COMPLETED|Dose Level 3||0
7939773|NCT00508027|19539874|P1|COMPLETED|Dose Level 3||2
7939774|NCT00508027|19539874|P1|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2
7939775|NCT00508027|19539874|P1|NOT COMPLETED|Dose Level 2||4
7939776|NCT00508027|19539874|P1|COMPLETED|Dose Level 2||16
7939777|NCT00508027|19539874|P1|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20
7939778|NCT00508027|19539874|P1|NOT COMPLETED|Dose Level 1||8
7939779|NCT00508027|19539874|P1|COMPLETED|Dose Level 1||12
7939780|NCT00508027|19539874|P1|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20
7939781|NCT00508001|19539915|P3|NOT COMPLETED|Overall Study||7
7939782|NCT00508001|19539916|P2|NOT COMPLETED|Overall Study||12
7939783|NCT00508001|19539917|P1|NOT COMPLETED|Overall Study||19
7939784|NCT00508001|19539915|P3|COMPLETED|Overall Study||16
7939785|NCT00508001|19539916|P2|COMPLETED|Overall Study||13
7939786|NCT00508001|19539917|P1|COMPLETED|Overall Study||0
7939787|NCT00508001|19539915|P3|Secondary Treatment Phase|Overall Study||16
7939788|NCT00508001|19539916|P2|Secondary Treatment Phase|Overall Study||13
7939789|NCT00508001|19539917|P1|Secondary Treatment Phase|Overall Study||0
7939790|NCT00508001|19539915|P3|STARTED|Overall Study||23
7939791|NCT00508001|19539916|P2|STARTED|Overall Study||25
7939792|NCT00508001|19539917|P1|STARTED|Overall Study||19
7939793|NCT00507819|19539934|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
7939794|NCT00507819|19539935|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
7939795|NCT00507819|19539934|P2|COMPLETED|Second Intervention (6 Weeks)||14
7939796|NCT00507819|19539935|P1|COMPLETED|Second Intervention (6 Weeks)||13
7939797|NCT00507819|19539934|P2|STARTED|Second Intervention (6 Weeks)||14
7939798|NCT00507819|19539935|P1|STARTED|Second Intervention (6 Weeks)||13
7939799|NCT00507819|19539934|P2|NOT COMPLETED|Washout (6 Weeks)||0
7939800|NCT00507819|19539935|P1|NOT COMPLETED|Washout (6 Weeks)||1
7939801|NCT00507819|19539934|P2|COMPLETED|Washout (6 Weeks)||14
7939802|NCT00507819|19539935|P1|COMPLETED|Washout (6 Weeks)||13
7939803|NCT00507819|19539934|P2|STARTED|Washout (6 Weeks)||14
7939804|NCT00507819|19539935|P1|STARTED|Washout (6 Weeks)||14
7939805|NCT00507819|19539934|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
7939806|NCT00507819|19539935|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
7939807|NCT00507819|19539934|P2|COMPLETED|First Intervention (6 Weeks)||14
7939808|NCT00507819|19539935|P1|COMPLETED|First Intervention (6 Weeks)||14
7939809|NCT00507819|19539934|P2|STARTED|First Intervention (6 Weeks)||14
7939810|NCT00507819|19539935|P1|STARTED|First Intervention (6 Weeks)||14
7939811|NCT00507767|19539947|P1|NOT COMPLETED|Overall Study||0
7939812|NCT00507767|19539947|P1|COMPLETED|Overall Study||15
7939813|NCT00507767|19539947|P1|STARTED|Overall Study||15
7939814|NCT00507689|19539954|P2|NOT COMPLETED|Randomized Period||2
7939815|NCT00507689|19539955|P1|NOT COMPLETED|Randomized Period||1
7939816|NCT00507689|19539954|P2|COMPLETED|Randomized Period||16
7939817|NCT00507689|19539955|P1|COMPLETED|Randomized Period||18
7939818|NCT00507689|19539954|P2|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18
7939819|NCT00507689|19539955|P1|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19
7939820|NCT00507689|19539954|P2|NOT COMPLETED|Pre-Randomization Period||0
7939821|NCT00507689|19539955|P1|NOT COMPLETED|Pre-Randomization Period||3
7939822|NCT00507689|19539954|P2|COMPLETED|Pre-Randomization Period||0
7939823|NCT00507689|19539955|P1|COMPLETED|Pre-Randomization Period||37
7939824|NCT00507689|19539954|P2|STARTED|Pre-Randomization Period||0
7939825|NCT00507689|19539955|P1|STARTED|Pre-Randomization Period||40
7939826|NCT00507559|19539972|P1|NOT COMPLETED|Overall Study||71
7939827|NCT00507559|19539972|P1|COMPLETED|Overall Study||84
7939828|NCT00507559|19539972|P1|STARTED|Overall Study||155
7939829|NCT00507546|19539987|P2|NOT COMPLETED|Overall Study||1
7939830|NCT00507546|19539988|P1|NOT COMPLETED|Overall Study||2
7939831|NCT00507546|19539987|P2|COMPLETED|Overall Study||3
7939832|NCT00507546|19539988|P1|COMPLETED|Overall Study||2
7939833|NCT00507546|19539987|P2|STARTED|Overall Study||4
7939834|NCT00507546|19539988|P1|STARTED|Overall Study||4
7939835|NCT00507507|19539998|P2|NOT COMPLETED|24-week Treatment-free Follow-up Period||17
7939836|NCT00507507|19539999|P1|NOT COMPLETED|24-week Treatment-free Follow-up Period||10
7939837|NCT00507507|19539998|P2|COMPLETED|24-week Treatment-free Follow-up Period||12
7939838|NCT00507507|19539999|P1|COMPLETED|24-week Treatment-free Follow-up Period||16
7939839|NCT00507507|19539998|P2|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29
7939840|NCT00507507|19539999|P1|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26
7939841|NCT00507507|19539998|P2|NOT COMPLETED|Treatment Period||53
7939842|NCT00507507|19539999|P1|NOT COMPLETED|Treatment Period||52
7939843|NCT00507507|19539998|P2|COMPLETED|Treatment Period||9
7939844|NCT00507507|19539999|P1|COMPLETED|Treatment Period||12
7939845|NCT00507507|19539998|P2|Completed 192 Weeks of Treatment|Treatment Period||52
7939846|NCT00507507|19539999|P1|Completed 192 Weeks of Treatment|Treatment Period||52
7939847|NCT00507507|19539998|P2|STARTED|Treatment Period||62
7939848|NCT00507507|19539999|P1|STARTED|Treatment Period||64
7939849|NCT00507455|19540034|P3|NOT COMPLETED|Overall Study||12
7939850|NCT00507455|19540035|P2|NOT COMPLETED|Overall Study||6
7939851|NCT00507455|19540036|P1|NOT COMPLETED|Overall Study||12
7939852|NCT00507455|19540034|P3|COMPLETED|Overall Study||62
7939853|NCT00507455|19540035|P2|COMPLETED|Overall Study||68
7939854|NCT00507455|19540036|P1|COMPLETED|Overall Study||62
7939855|NCT00507455|19540034|P3|STARTED|Overall Study||74
7939856|NCT00507455|19540035|P2|STARTED|Overall Study||74
7939857|NCT00507455|19540036|P1|STARTED|Overall Study||74
7939858|NCT00507442|19540099|P4|NOT COMPLETED|Overall Study||5
7939859|NCT00507442|19540100|P3|NOT COMPLETED|Overall Study||15
7939860|NCT00507442|19540101|P2|NOT COMPLETED|Overall Study||27
7939861|NCT00507442|19540102|P1|NOT COMPLETED|Overall Study||16
7939862|NCT00507442|19540099|P4|COMPLETED|Overall Study||12
7939863|NCT00507442|19540100|P3|COMPLETED|Overall Study||18
7939864|NCT00507442|19540101|P2|COMPLETED|Overall Study||39
7939865|NCT00507442|19540102|P1|COMPLETED|Overall Study||26
7939866|NCT00507442|19540099|P4|STARTED|Overall Study||17
7939867|NCT00507442|19540100|P3|STARTED|Overall Study||33
7939868|NCT00507442|19540101|P2|STARTED|Overall Study||66
7939869|NCT00507442|19540102|P1|STARTED|Overall Study||42
7939870|NCT00507429|19540154|P2|NOT COMPLETED|Maintenance Phase||0
7939871|NCT00507429|19540155|P1|NOT COMPLETED|Maintenance Phase||14
7939872|NCT00507429|19540154|P2|COMPLETED|Maintenance Phase||0
7939873|NCT00507429|19540155|P1|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2
7939874|NCT00507429|19540154|P2|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0
7939875|NCT00507429|19540155|P1|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16
7939876|NCT00507429|19540154|P2|NOT COMPLETED|Treatment Phase||18
7939877|NCT00507429|19540155|P1|NOT COMPLETED|Treatment Phase||37
7939878|NCT00507429|19540154|P2|COMPLETED|Treatment Phase||7
7939879|NCT00507429|19540155|P1|COMPLETED|Treatment Phase||18
7939880|NCT00507429|19540154|P2|STARTED|Treatment Phase|Randomized|25
7939881|NCT00507429|19540155|P1|STARTED|Treatment Phase|Randomized|55
7939882|NCT00507416|19540166|P3|NOT COMPLETED|Overall Study||114
7939883|NCT00507416|19540167|P2|NOT COMPLETED|Overall Study||125
7939884|NCT00507416|19540168|P1|NOT COMPLETED|Overall Study||118
7939885|NCT00507416|19540166|P3|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53
7939886|NCT00507416|19540167|P2|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42
7939887|NCT00507416|19540168|P1|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50
7939888|NCT00507416|19540166|P3|Completed 8 Treatment Cycles|Overall Study||69
7939889|NCT00507416|19540167|P2|Completed 8 Treatment Cycles|Overall Study||60
7939890|NCT00507416|19540168|P1|Completed 8 Treatment Cycles|Overall Study||82
7939891|NCT00507416|19540166|P3|Treated (Safety Population)|Overall Study||163
7939892|NCT00507416|19540167|P2|Treated (Safety Population)|Overall Study||158
7939893|NCT00507416|19540168|P1|Treated (Safety Population)|Overall Study||165
7939894|NCT00507416|19540166|P3|STARTED|Overall Study||167
7939895|NCT00507416|19540167|P2|STARTED|Overall Study||167
7939896|NCT00507416|19540168|P1|STARTED|Overall Study||168
7939897|NCT00507208|19540199|P2|NOT COMPLETED|Overall Study||0
7939898|NCT00507208|19540200|P1|NOT COMPLETED|Overall Study||0
7939899|NCT00507208|19540199|P2|COMPLETED|Overall Study||26
7939900|NCT00507208|19540200|P1|COMPLETED|Overall Study||27
7939901|NCT00507208|19540199|P2|Received Dynasplint in Crossover|Overall Study||3
7939902|NCT00507208|19540200|P1|Received Dynasplint in Crossover|Overall Study||0
7939903|NCT00507208|19540199|P2|STARTED|Overall Study||26
7939904|NCT00507208|19540200|P1|STARTED|Overall Study||27
7939905|NCT00507130|19540210|P4|NOT COMPLETED|Overall Study||1
7939906|NCT00507130|19540211|P3|NOT COMPLETED|Overall Study||1
7939907|NCT00507130|19540212|P2|NOT COMPLETED|Overall Study||0
7939908|NCT00507130|19540213|P1|NOT COMPLETED|Overall Study||1
7939909|NCT00507130|19540210|P4|COMPLETED|Overall Study||8
7939910|NCT00507130|19540211|P3|COMPLETED|Overall Study||8
7939911|NCT00507130|19540212|P2|COMPLETED|Overall Study||9
7939912|NCT00507130|19540213|P1|COMPLETED|Overall Study||8
7939913|NCT00507130|19540210|P4|STARTED|Overall Study||9
7939914|NCT00507130|19540211|P3|STARTED|Overall Study||9
7939915|NCT00507130|19540212|P2|STARTED|Overall Study||9
7939916|NCT00507130|19540213|P1|STARTED|Overall Study||9
7939917|NCT00506948|19540255|P1|NOT COMPLETED|Overall Study||10
7939918|NCT00506948|19540255|P1|COMPLETED|Overall Study||0
7939919|NCT00506948|19540255|P1|STARTED|Overall Study||10
7939920|NCT00506922|19540264|P5|NOT COMPLETED|Overall Study||1
7939921|NCT00506922|19540265|P4|NOT COMPLETED|Overall Study||2
7939922|NCT00506922|19540266|P3|NOT COMPLETED|Overall Study||0
7939923|NCT00506922|19540267|P2|NOT COMPLETED|Overall Study||0
7939924|NCT00506922|19540268|P1|NOT COMPLETED|Overall Study||0
7939925|NCT00506922|19540264|P5|COMPLETED|Overall Study||10
7939926|NCT00506922|19540265|P4|COMPLETED|Overall Study||61
7939927|NCT00506922|19540266|P3|COMPLETED|Overall Study||29
7939928|NCT00506922|19540267|P2|COMPLETED|Overall Study||10
7939929|NCT00506922|19540268|P1|COMPLETED|Overall Study||37
7939930|NCT00506922|19540264|P5|STARTED|Overall Study||11
7939931|NCT00506922|19540265|P4|STARTED|Overall Study||63
7939932|NCT00506922|19540266|P3|STARTED|Overall Study||29
7939933|NCT00506922|19540267|P2|STARTED|Overall Study||10
7939934|NCT00506922|19540268|P1|STARTED|Overall Study||37
7939935|NCT00506909|19540276|P1|NOT COMPLETED|Overall Study||0
7939936|NCT00506909|19540276|P1|COMPLETED|Overall Study||0
7939937|NCT00506909|19540276|P1|STARTED|Overall Study||0
7939938|NCT00506883|19540295|P3|NOT COMPLETED|Overall Study||4
7939939|NCT00506883|19540296|P2|NOT COMPLETED|Overall Study||3
7939940|NCT00506883|19540297|P1|NOT COMPLETED|Overall Study||7
7939941|NCT00506883|19540295|P3|COMPLETED|Overall Study||55
7939942|NCT00506883|19540296|P2|COMPLETED|Overall Study||71
7939943|NCT00506883|19540297|P1|COMPLETED|Overall Study||45
7939944|NCT00506883|19540295|P3|STARTED|Overall Study||59
7939945|NCT00506883|19540296|P2|STARTED|Overall Study||74
7939946|NCT00506883|19540297|P1|STARTED|Overall Study||52
7939947|NCT00506857|19540305|P1|NOT COMPLETED|Overall Study||0
7939948|NCT00506857|19540305|P1|COMPLETED|Overall Study||80
7939949|NCT00506857|19540305|P1|STARTED|Overall Study||80
7939950|NCT00506831|19540310|P1|NOT COMPLETED|Overall Study||2
7939951|NCT00506831|19540310|P1|COMPLETED|Overall Study||7
7939952|NCT00506831|19540310|P1|STARTED|Overall Study||9
7939953|NCT00506779|19540323|P4|NOT COMPLETED|Overall Study||1
7939954|NCT00506779|19540324|P3|NOT COMPLETED|Overall Study||2
7939955|NCT00506779|19540325|P2|NOT COMPLETED|Overall Study||1
7939956|NCT00506779|19540326|P1|NOT COMPLETED|Overall Study||1
7939957|NCT00506779|19540323|P4|COMPLETED|Overall Study||4
7939958|NCT00506779|19540324|P3|COMPLETED|Overall Study||0
7939959|NCT00506779|19540325|P2|COMPLETED|Overall Study||5
7939960|NCT00506779|19540326|P1|COMPLETED|Overall Study||3
7939961|NCT00506779|19540323|P4|STARTED|Overall Study||5
7939962|NCT00506779|19540324|P3|STARTED|Overall Study||2
7939963|NCT00506779|19540325|P2|STARTED|Overall Study||6
7939964|NCT00506779|19540326|P1|STARTED|Overall Study||4
7939965|NCT00506753|19540341|P2|NOT COMPLETED|Overall Study||15
7939966|NCT00506753|19540342|P1|NOT COMPLETED|Overall Study||21
7939967|NCT00506753|19540341|P2|COMPLETED|Overall Study||84
7939968|NCT00506753|19540342|P1|COMPLETED|Overall Study||79
7939969|NCT00506753|19540341|P2|STARTED|Overall Study||99
7939970|NCT00506753|19540342|P1|STARTED|Overall Study||100
7939971|NCT00506714|19540354|P2|NOT COMPLETED|Overall Study||0
7939972|NCT00506714|19540355|P1|NOT COMPLETED|Overall Study||0
7939973|NCT00506714|19540354|P2|COMPLETED|Overall Study||13
7939974|NCT00506714|19540355|P1|COMPLETED|Overall Study||13
7939975|NCT00506714|19540354|P2|STARTED|Overall Study||13
7939976|NCT00506714|19540355|P1|STARTED|Overall Study||13
7939977|NCT00506675|19540365|P2|NOT COMPLETED|Overall Study||0
7939978|NCT00506675|19540366|P1|NOT COMPLETED|Overall Study||0
7939979|NCT00506675|19540365|P2|COMPLETED|Overall Study||28
7939980|NCT00506675|19540366|P1|COMPLETED|Overall Study||27
7939981|NCT00506675|19540365|P2|STARTED|Overall Study||28
7939982|NCT00506675|19540366|P1|STARTED|Overall Study||27
7939983|NCT00506662|19540380|P2|NOT COMPLETED|Overall Study||28
7939984|NCT00506662|19540381|P1|NOT COMPLETED|Overall Study||17
7939985|NCT00506662|19540380|P2|COMPLETED|Overall Study||20
7939986|NCT00506662|19540381|P1|COMPLETED|Overall Study||21
7939987|NCT00506662|19540380|P2|STARTED|Overall Study||48
7939988|NCT00506662|19540381|P1|STARTED|Overall Study||38
7939989|NCT00506597|19540411|P1|NOT COMPLETED|Overall Study||0
7939990|NCT00506597|19540411|P1|COMPLETED|Overall Study||33
7939991|NCT00506597|19540411|P1|STARTED|Overall Study||33
7939992|NCT00506493|19540415|P1|NOT COMPLETED|Overall Study||11
7939993|NCT00506493|19540415|P1|COMPLETED|Overall Study||64
7939994|NCT00506493|19540415|P1|STARTED|Overall Study||75
7939995|NCT00506454|19540424|P2|NOT COMPLETED|Overall Study||1
7939996|NCT00506454|19540425|P1|NOT COMPLETED|Overall Study||1
7939997|NCT00506454|19540424|P2|COMPLETED|Overall Study||10
7939998|NCT00506454|19540425|P1|COMPLETED|Overall Study||10
7939999|NCT00506454|19540424|P2|STARTED|Overall Study||11
7940000|NCT00506454|19540425|P1|STARTED|Overall Study||11
7940001|NCT00506441|19540431|P2|NOT COMPLETED|Period 2; Double-blind Period||5
7940002|NCT00506441|19540432|P1|NOT COMPLETED|Period 2; Double-blind Period||3
7940003|NCT00506441|19540431|P2|COMPLETED|Period 2; Double-blind Period||79
7940004|NCT00506441|19540432|P1|COMPLETED|Period 2; Double-blind Period||82
7940005|NCT00506441|19540431|P2|STARTED|Period 2; Double-blind Period||84
7940006|NCT00506441|19540432|P1|STARTED|Period 2; Double-blind Period||85
7940007|NCT00506441|19540431|P2|NOT COMPLETED|Period 1; Open-label Period||0
7940008|NCT00506441|19540432|P1|NOT COMPLETED|Period 1; Open-label Period||76
7940009|NCT00506441|19540431|P2|COMPLETED|Period 1; Open-label Period||0
7940010|NCT00506441|19540432|P1|COMPLETED|Period 1; Open-label Period||169
7940011|NCT00506441|19540431|P2|STARTED|Period 1; Open-label Period||0
7940012|NCT00506441|19540432|P1|STARTED|Period 1; Open-label Period||245
7940013|NCT00506415|19540440|P4|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62
7940014|NCT00506415|19540441|P3|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
7940015|NCT00506415|19540442|P2|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
7940016|NCT00506415|19540443|P1|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
7940017|NCT00506415|19540440|P4|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395
7940018|NCT00506415|19540441|P3|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
7940019|NCT00506415|19540442|P2|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
7940020|NCT00506415|19540443|P1|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
7940021|NCT00506415|19540440|P4|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457
7940022|NCT00506415|19540441|P3|STARTED|Extended Open Label (Maximum 48 Weeks)||0
7940023|NCT00506415|19540442|P2|STARTED|Extended Open Label (Maximum 48 Weeks)||0
7940024|NCT00506415|19540443|P1|STARTED|Extended Open Label (Maximum 48 Weeks)||0
7940025|NCT00506415|19540440|P4|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
7940026|NCT00506415|19540441|P3|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73
7940027|NCT00506415|19540442|P2|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83
7940028|NCT00506415|19540443|P1|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
7940029|NCT00506415|19540440|P4|COMPLETED|Double Blind (Maximum 48 Weeks )||0
7940030|NCT00506415|19540441|P3|COMPLETED|Double Blind (Maximum 48 Weeks )||207
7940031|NCT00506415|19540442|P2|COMPLETED|Double Blind (Maximum 48 Weeks )||203
7940032|NCT00506415|19540443|P1|COMPLETED|Double Blind (Maximum 48 Weeks )||0
7940033|NCT00506415|19540440|P4|STARTED|Double Blind (Maximum 48 Weeks )||0
7940034|NCT00506415|19540441|P3|STARTED|Double Blind (Maximum 48 Weeks )||280
7940035|NCT00506415|19540442|P2|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286
7940036|NCT00506415|19540443|P1|STARTED|Double Blind (Maximum 48 Weeks )||0
7940037|NCT00506415|19540440|P4|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
7940038|NCT00506415|19540441|P3|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
7940039|NCT00506415|19540442|P2|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
7940040|NCT00506415|19540443|P1|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499
7940041|NCT00506415|19540440|P4|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
7940042|NCT00506415|19540441|P3|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
7940043|NCT00506415|19540442|P2|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
7940044|NCT00506415|19540443|P1|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085
7940045|NCT00506415|19540440|P4|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
7940046|NCT00506415|19540441|P3|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
7940047|NCT00506415|19540442|P2|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
7940048|NCT00506415|19540443|P1|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582
7940049|NCT00506415|19540440|P4|STARTED|Initial Open Label (Maximum 48 Weeks)||0
7940050|NCT00506415|19540441|P3|STARTED|Initial Open Label (Maximum 48 Weeks)||0
7940051|NCT00506415|19540442|P2|STARTED|Initial Open Label (Maximum 48 Weeks)||0
7940052|NCT00506415|19540443|P1|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584
7940053|NCT00506389|19540468|P3|NOT COMPLETED|Follow-up Period||0
7940054|NCT00506389|19540469|P2|NOT COMPLETED|Follow-up Period||0
7940055|NCT00506389|19540470|P1|NOT COMPLETED|Follow-up Period||0
7940056|NCT00506389|19540468|P3|COMPLETED|Follow-up Period||136
7940057|NCT00506389|19540469|P2|COMPLETED|Follow-up Period||138
7940058|NCT00506389|19540470|P1|COMPLETED|Follow-up Period||139
7940059|NCT00506389|19540468|P3|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136
7940060|NCT00506389|19540469|P2|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138
7940061|NCT00506389|19540470|P1|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139
7940062|NCT00506389|19540468|P3|NOT COMPLETED|In-treatment Period||12
7940063|NCT00506389|19540469|P2|NOT COMPLETED|In-treatment Period||15
7940064|NCT00506389|19540470|P1|NOT COMPLETED|In-treatment Period||26
7940065|NCT00506389|19540468|P3|COMPLETED|In-treatment Period||125
7940066|NCT00506389|19540469|P2|COMPLETED|In-treatment Period||124
7940067|NCT00506389|19540470|P1|COMPLETED|In-treatment Period||117
7940068|NCT00506389|19540468|P3|All Participants Treated|In-treatment Period||136
7940069|NCT00506389|19540469|P2|All Participants Treated|In-treatment Period||138
7940070|NCT00506389|19540470|P1|All Participants Treated|In-treatment Period||139
7940071|NCT00506389|19540468|P3|STARTED|In-treatment Period||137
7940072|NCT00506389|19540469|P2|STARTED|In-treatment Period||139
7940073|NCT00506389|19540470|P1|STARTED|In-treatment Period||143
7940074|NCT00506350|19540496|P9|NOT COMPLETED|Overall Study||5
7940075|NCT00506350|19540497|P8|NOT COMPLETED|Overall Study||5
7940076|NCT00506350|19540498|P7|NOT COMPLETED|Overall Study||2
7940077|NCT00506350|19540499|P6|NOT COMPLETED|Overall Study||2
7940078|NCT00506350|19540500|P5|NOT COMPLETED|Overall Study||10
7940079|NCT00506350|19540501|P4|NOT COMPLETED|Overall Study||2
7940080|NCT00506350|19540502|P3|NOT COMPLETED|Overall Study||6
7940081|NCT00506350|19540503|P2|NOT COMPLETED|Overall Study||3
7940082|NCT00506350|19540504|P1|NOT COMPLETED|Overall Study||3
7940083|NCT00506350|19540496|P9|COMPLETED|Overall Study||30
7940084|NCT00506350|19540497|P8|COMPLETED|Overall Study||36
7940085|NCT00506350|19540498|P7|COMPLETED|Overall Study||33
7940086|NCT00506350|19540499|P6|COMPLETED|Overall Study||38
7940087|NCT00506350|19540500|P5|COMPLETED|Overall Study||40
7940088|NCT00506350|19540501|P4|COMPLETED|Overall Study||34
7940089|NCT00506350|19540502|P3|COMPLETED|Overall Study||31
7940090|NCT00506350|19540503|P2|COMPLETED|Overall Study||37
7940091|NCT00506350|19540504|P1|COMPLETED|Overall Study||33
7940092|NCT00506350|19540496|P9|STARTED|Overall Study||35
7940093|NCT00506350|19540497|P8|STARTED|Overall Study||41
7940094|NCT00506350|19540498|P7|STARTED|Overall Study||35
7940095|NCT00506350|19540499|P6|STARTED|Overall Study||40
7940096|NCT00506350|19540500|P5|STARTED|Overall Study||50
7940097|NCT00506350|19540501|P4|STARTED|Overall Study||36
7940098|NCT00506350|19540502|P3|STARTED|Overall Study||37
7940099|NCT00506350|19540503|P2|STARTED|Overall Study||40
7940100|NCT00506350|19540504|P1|STARTED|Overall Study||36
7940101|NCT00506285|19540651|P2|NOT COMPLETED|6-month Open Label Phase||12
7940102|NCT00506285|19540652|P1|NOT COMPLETED|6-month Open Label Phase||10
7940103|NCT00506285|19540651|P2|COMPLETED|6-month Open Label Phase||19
7940104|NCT00506285|19540652|P1|COMPLETED|6-month Open Label Phase||10
7940105|NCT00506285|19540651|P2|STARTED|6-month Open Label Phase||31
7940106|NCT00506285|19540652|P1|STARTED|6-month Open Label Phase||20
7940107|NCT00506285|19540651|P2|NOT COMPLETED|Double Blind Cross-Over Phase||5
7940108|NCT00506285|19540652|P1|NOT COMPLETED|Double Blind Cross-Over Phase||9
7940109|NCT00506285|19540651|P2|COMPLETED|Double Blind Cross-Over Phase||31
7940110|NCT00506285|19540652|P1|COMPLETED|Double Blind Cross-Over Phase||20
7940111|NCT00506285|19540651|P2|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31
7940112|NCT00506285|19540652|P1|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29
7940113|NCT00506285|19540651|P2|STARTED|Double Blind Cross-Over Phase||36
7940114|NCT00506285|19540652|P1|STARTED|Double Blind Cross-Over Phase||29
7940115|NCT00506285|19540651|P2|NOT COMPLETED|3 Week Screening Phase||10
7940116|NCT00506285|19540652|P1|NOT COMPLETED|3 Week Screening Phase||17
7940117|NCT00506285|19540651|P2|COMPLETED|3 Week Screening Phase||36
7940118|NCT00506285|19540652|P1|COMPLETED|3 Week Screening Phase||29
7940119|NCT00506285|19540651|P2|STARTED|3 Week Screening Phase||46
7940120|NCT00506285|19540652|P1|STARTED|3 Week Screening Phase||46
7940121|NCT00506155|19540660|P1|NOT COMPLETED|Overall Study||0
7940122|NCT00506155|19540660|P1|COMPLETED|Overall Study||60
7940123|NCT00506155|19540660|P1|STARTED|Overall Study||60
7940124|NCT00506142|19540667|P2|NOT COMPLETED|Overall Study||19
7940125|NCT00506142|19540668|P1|NOT COMPLETED|Overall Study||35
7940126|NCT00506142|19540667|P2|COMPLETED|Overall Study||0
7940127|NCT00506142|19540668|P1|COMPLETED|Overall Study||0
7940128|NCT00506142|19540667|P2|STARTED|Overall Study||19
7940129|NCT00506142|19540668|P1|STARTED|Overall Study||35
7940130|NCT00506129|19540674|P1|NOT COMPLETED|Overall Study||22
7940131|NCT00506129|19540674|P1|COMPLETED|Overall Study||11
7940132|NCT00506129|19540674|P1|STARTED|Overall Study||33
7940133|NCT00506077|19540681|P2|NOT COMPLETED|Treatment Period 2||1
7940134|NCT00506077|19540682|P1|NOT COMPLETED|Treatment Period 2||1
7940135|NCT00506077|19540681|P2|COMPLETED|Treatment Period 2||23
7940136|NCT00506077|19540682|P1|COMPLETED|Treatment Period 2||23
7940137|NCT00506077|19540681|P2|STARTED|Treatment Period 2||24
7940138|NCT00506077|19540682|P1|STARTED|Treatment Period 2||24
7940139|NCT00506077|19540681|P2|NOT COMPLETED|Washout||0
7940140|NCT00506077|19540682|P1|NOT COMPLETED|Washout||0
7940141|NCT00506077|19540681|P2|COMPLETED|Washout||24
7940142|NCT00506077|19540682|P1|COMPLETED|Washout||24
7940143|NCT00506077|19540681|P2|STARTED|Washout||24
7940144|NCT00506077|19540682|P1|STARTED|Washout||24
7940145|NCT00506077|19540681|P2|NOT COMPLETED|Treatment Period 1||3
7940146|NCT00506077|19540682|P1|NOT COMPLETED|Treatment Period 1||4
7940147|NCT00506077|19540681|P2|COMPLETED|Treatment Period 1||24
7940148|NCT00506077|19540682|P1|COMPLETED|Treatment Period 1||24
7940149|NCT00506077|19540681|P2|STARTED|Treatment Period 1||27
7940150|NCT00506077|19540682|P1|STARTED|Treatment Period 1||28
7940151|NCT00506064|19540704|P2|NOT COMPLETED|Overall Study||0
7940152|NCT00506064|19540705|P1|NOT COMPLETED|Overall Study||0
7940153|NCT00506064|19540704|P2|COMPLETED|Overall Study||0
7940154|NCT00506064|19540705|P1|COMPLETED|Overall Study||1
7940155|NCT00506064|19540704|P2|STARTED|Overall Study||0
7940156|NCT00506064|19540705|P1|STARTED|Overall Study||1
7940157|NCT00506025|19540714|P3|NOT COMPLETED|Overall Study||0
7940158|NCT00506025|19540715|P2|NOT COMPLETED|Overall Study||0
7940159|NCT00506025|19540716|P1|NOT COMPLETED|Overall Study||0
7940160|NCT00506025|19540714|P3|COMPLETED|Overall Study||8
7940161|NCT00506025|19540715|P2|COMPLETED|Overall Study||9
7940162|NCT00506025|19540716|P1|COMPLETED|Overall Study||10
7940163|NCT00506025|19540714|P3|STARTED|Overall Study||8
7940164|NCT00506025|19540715|P2|STARTED|Overall Study||9
7940165|NCT00506025|19540716|P1|STARTED|Overall Study||10
7940166|NCT00505934|19540724|P1|NOT COMPLETED|Overall Study||3
7940167|NCT00505934|19540724|P1|COMPLETED|Overall Study||16
7940168|NCT00505934|19540724|P1|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19
7940169|NCT00505921|19540730|P1|NOT COMPLETED|Overall Study||9
7940170|NCT00505921|19540730|P1|COMPLETED|Overall Study||18
7940171|NCT00505921|19540730|P1|STARTED|Overall Study||27
7940172|NCT00505895|19540736|P2|NOT COMPLETED|Overall Study||0
7940173|NCT00505895|19540737|P1|NOT COMPLETED|Overall Study||0
7940174|NCT00505895|19540736|P2|COMPLETED|Overall Study||23
7940175|NCT00505895|19540737|P1|COMPLETED|Overall Study||27
7940176|NCT00505895|19540736|P2|STARTED|Overall Study||23
7940177|NCT00505895|19540737|P1|STARTED|Overall Study||27
7940178|NCT00505778|19540747|P2|NOT COMPLETED|Overall Study||135
7940179|NCT00505778|19540748|P1|NOT COMPLETED|Overall Study||134
7940180|NCT00505778|19540747|P2|COMPLETED|Overall Study||378
7940181|NCT00505778|19540748|P1|COMPLETED|Overall Study||380
7940182|NCT00505778|19540747|P2|Intent to Treat (ITT) Population|Overall Study||511
7940183|NCT00505778|19540748|P1|Intent to Treat (ITT) Population|Overall Study||512
7940184|NCT00505778|19540747|P2|STARTED|Overall Study||513
7940185|NCT00505778|19540748|P1|STARTED|Overall Study||514
7940186|NCT00505765|19540767|P3|NOT COMPLETED|Overall Study||3
7940187|NCT00505765|19540768|P2|NOT COMPLETED|Overall Study||3
7940188|NCT00505765|19540769|P1|NOT COMPLETED|Overall Study||2
7940189|NCT00505765|19540767|P3|COMPLETED|Overall Study||19
7940190|NCT00505765|19540768|P2|COMPLETED|Overall Study||17
7940191|NCT00505765|19540769|P1|COMPLETED|Overall Study||19
7940192|NCT00505765|19540767|P3|Mid-Point Assessment|Overall Study||21
7940193|NCT00505765|19540768|P2|Mid-Point Assessment|Overall Study||19
7940194|NCT00505765|19540769|P1|Mid-Point Assessment|Overall Study||20
7940195|NCT00505765|19540767|P3|STARTED|Overall Study||22
7940196|NCT00505765|19540768|P2|STARTED|Overall Study||20
7940197|NCT00505765|19540769|P1|STARTED|Overall Study||21
7940198|NCT00505752|19540796|P4|NOT COMPLETED|Overall Study||6
7940199|NCT00505752|19540797|P3|NOT COMPLETED|Overall Study||8
7940200|NCT00505752|19540798|P2|NOT COMPLETED|Overall Study||9
7940201|NCT00505752|19540799|P1|NOT COMPLETED|Overall Study||6
7940202|NCT00505752|19540796|P4|COMPLETED|Overall Study||126
7940203|NCT00505752|19540797|P3|COMPLETED|Overall Study||120
7940204|NCT00505752|19540798|P2|COMPLETED|Overall Study||119
7940205|NCT00505752|19540799|P1|COMPLETED|Overall Study||126
7940206|NCT00505752|19540796|P4|STARTED|Overall Study||132
7940207|NCT00505752|19540797|P3|STARTED|Overall Study||128
7940208|NCT00505752|19540798|P2|STARTED|Overall Study||128
7940209|NCT00505752|19540799|P1|STARTED|Overall Study||132
7940210|NCT00505687|19540813|P1|NOT COMPLETED|Overall Study||95
7940211|NCT00505687|19540813|P1|COMPLETED|Overall Study||91
7940212|NCT00505687|19540813|P1|STARTED|Overall Study||186
7940213|NCT00505661|19540819|P1|NOT COMPLETED|Overall Study||4
7940214|NCT00505661|19540819|P1|COMPLETED|Overall Study||12
7940215|NCT00505661|19540819|P1|STARTED|Overall Study||16
7940216|NCT00505635|19540823|P1|NOT COMPLETED|Overall Study||0
7940217|NCT00505635|19540823|P1|COMPLETED|Overall Study||5
7940218|NCT00505635|19540823|P1|STARTED|Overall Study||5
7940219|NCT00505622|19540830|P3|NOT COMPLETED|Overall Study||96
7940220|NCT00505622|19540831|P2|NOT COMPLETED|Overall Study||108
7940221|NCT00505622|19540832|P1|NOT COMPLETED|Overall Study||121
7940222|NCT00505622|19540830|P3|COMPLETED|Overall Study||0
7940223|NCT00505622|19540831|P2|COMPLETED|Overall Study||0
7940224|NCT00505622|19540832|P1|COMPLETED|Overall Study||0
7940225|NCT00505622|19540830|P3|STARTED|Overall Study||96
7940226|NCT00505622|19540831|P2|STARTED|Overall Study||108
7940227|NCT00505622|19540832|P1|STARTED|Overall Study||121
7940228|NCT00505518|19540849|P1|NOT COMPLETED|Overall Study||0
7940229|NCT00505518|19540849|P1|COMPLETED|Overall Study||9
7940230|NCT00505518|19540849|P1|STARTED|Overall Study||9
7940231|NCT00505414|19540857|P5|NOT COMPLETED|Maintenance Phase||0
7940232|NCT00505414|19540858|P4|NOT COMPLETED|Maintenance Phase||0
7940233|NCT00505414|19540859|P3|NOT COMPLETED|Maintenance Phase||8
7940234|NCT00505414|19540860|P2|NOT COMPLETED|Maintenance Phase||5
7940235|NCT00505414|19540861|P1|NOT COMPLETED|Maintenance Phase||6
7940236|NCT00505414|19540857|P5|COMPLETED|Maintenance Phase||0
7940237|NCT00505414|19540858|P4|COMPLETED|Maintenance Phase||0
7940238|NCT00505414|19540859|P3|COMPLETED|Maintenance Phase||6
7940239|NCT00505414|19540860|P2|COMPLETED|Maintenance Phase||10
7940240|NCT00505414|19540861|P1|COMPLETED|Maintenance Phase||12
7940241|NCT00505414|19540857|P5|Did Not Qualify for Maintenance Phase|Maintenance Phase||1
7940242|NCT00505414|19540858|P4|Did Not Qualify for Maintenance Phase|Maintenance Phase||3
7940243|NCT00505414|19540859|P3|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
7940244|NCT00505414|19540860|P2|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
7940245|NCT00505414|19540861|P1|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
7940246|NCT00505414|19540857|P5|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0
7940247|NCT00505414|19540858|P4|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0
7940248|NCT00505414|19540859|P3|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14
7940249|NCT00505414|19540860|P2|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15
7940250|NCT00505414|19540861|P1|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18
7940251|NCT00505414|19540857|P5|NOT COMPLETED|Titration Phase||12
7940252|NCT00505414|19540858|P4|NOT COMPLETED|Titration Phase||30
7940253|NCT00505414|19540859|P3|NOT COMPLETED|Titration Phase||0
7940254|NCT00505414|19540860|P2|NOT COMPLETED|Titration Phase||0
7940255|NCT00505414|19540861|P1|NOT COMPLETED|Titration Phase||0
7940256|NCT00505414|19540857|P5|COMPLETED|Titration Phase||19
7940257|NCT00505414|19540858|P4|COMPLETED|Titration Phase||32
7940258|NCT00505414|19540859|P3|COMPLETED|Titration Phase||0
7940259|NCT00505414|19540860|P2|COMPLETED|Titration Phase||0
7940260|NCT00505414|19540861|P1|COMPLETED|Titration Phase||0
7940261|NCT00505414|19540857|P5|STARTED|Titration Phase||31
7940262|NCT00505414|19540858|P4|STARTED|Titration Phase||62
7940263|NCT00505414|19540859|P3|STARTED|Titration Phase||0
7940264|NCT00505414|19540860|P2|STARTED|Titration Phase||0
7940265|NCT00505414|19540861|P1|STARTED|Titration Phase||0
7940266|NCT00505375|19540878|P2|NOT COMPLETED|Overall Study||5
7940267|NCT00505375|19540879|P1|NOT COMPLETED|Overall Study||4
7940268|NCT00505375|19540878|P2|COMPLETED|Overall Study||30
7940269|NCT00505375|19540879|P1|COMPLETED|Overall Study||73
7940270|NCT00505375|19540878|P2|STARTED|Overall Study||35
7940271|NCT00505375|19540879|P1|STARTED|Overall Study||77
7940272|NCT00505362|19540887|P2|NOT COMPLETED|Overall Study||0
7940273|NCT00505362|19540888|P1|NOT COMPLETED|Overall Study||0
7940274|NCT00505362|19540887|P2|COMPLETED|Overall Study||28
7940275|NCT00505362|19540888|P1|COMPLETED|Overall Study||35
7940276|NCT00505362|19540887|P2|STARTED|Overall Study||28
7940277|NCT00505362|19540888|P1|STARTED|Overall Study||35
7940278|NCT00505284|19540901|P5|NOT COMPLETED|Overall Study||33
7940279|NCT00505284|19540902|P4|NOT COMPLETED|Overall Study||19
7940280|NCT00505284|19540903|P3|NOT COMPLETED|Overall Study||12
7940281|NCT00505284|19540904|P2|NOT COMPLETED|Overall Study||16
7940282|NCT00505284|19540905|P1|NOT COMPLETED|Overall Study||10
7940283|NCT00505284|19540901|P5|COMPLETED|Overall Study||37
7940284|NCT00505284|19540902|P4|COMPLETED|Overall Study||49
7940285|NCT00505284|19540903|P3|COMPLETED|Overall Study||57
7940286|NCT00505284|19540904|P2|COMPLETED|Overall Study||56
7940287|NCT00505284|19540905|P1|COMPLETED|Overall Study||63
7940288|NCT00505284|19540901|P5|STARTED|Overall Study||70
7940289|NCT00505284|19540902|P4|STARTED|Overall Study||68
7940290|NCT00505284|19540903|P3|STARTED|Overall Study||69
7940291|NCT00505284|19540904|P2|STARTED|Overall Study||72
7940292|NCT00505284|19540905|P1|STARTED|Overall Study||73
7940293|NCT00505076|19540975|P3|NOT COMPLETED|Overall Study||5
7940294|NCT00505076|19540976|P2|NOT COMPLETED|Overall Study||2
7940295|NCT00505076|19540977|P1|NOT COMPLETED|Overall Study||3
7940296|NCT00505076|19540975|P3|COMPLETED|Overall Study||17
7940297|NCT00505076|19540976|P2|COMPLETED|Overall Study||17
7940298|NCT00505076|19540977|P1|COMPLETED|Overall Study||19
7940299|NCT00505076|19540975|P3|STARTED|Overall Study||22
7940300|NCT00505076|19540976|P2|STARTED|Overall Study||19
7940301|NCT00505076|19540977|P1|STARTED|Overall Study||22
7940302|NCT00504985|19540991|P1|NOT COMPLETED|Overall Study||0
7940303|NCT00504985|19540991|P1|COMPLETED|Overall Study||14
7940304|NCT00504985|19540991|P1|STARTED|Overall Study||14
7940305|NCT00504894|19540997|P2|NOT COMPLETED|Overall Study||0
7940306|NCT00504894|19540998|P1|NOT COMPLETED|Overall Study||0
7940307|NCT00504894|19540997|P2|COMPLETED|Overall Study||18
7940308|NCT00504894|19540998|P1|COMPLETED|Overall Study||17
7940309|NCT00504894|19540997|P2|STARTED|Overall Study||18
7940310|NCT00504894|19540998|P1|STARTED|Overall Study||17
7940311|NCT00504881|19541006|P2|NOT COMPLETED|Overall Study||36
7940312|NCT00504881|19541007|P1|NOT COMPLETED|Overall Study||10
7940313|NCT00504881|19541006|P2|COMPLETED|Overall Study||323
7940314|NCT00504881|19541007|P1|COMPLETED|Overall Study||111
7940315|NCT00504881|19541006|P2|STARTED|Overall Study||359
7940316|NCT00504881|19541007|P1|STARTED|Overall Study||121
7940317|NCT00504829|19541060|P3|NOT COMPLETED|Overall Study||10
7940318|NCT00504829|19541061|P2|NOT COMPLETED|Overall Study||4
7940319|NCT00504829|19541062|P1|NOT COMPLETED|Overall Study||6
7940320|NCT00504829|19541060|P3|COMPLETED|Overall Study||63
7940321|NCT00504829|19541061|P2|COMPLETED|Overall Study||70
7940322|NCT00504829|19541062|P1|COMPLETED|Overall Study||67
7940323|NCT00504829|19541060|P3|STARTED|Overall Study||73
7940324|NCT00504829|19541061|P2|STARTED|Overall Study||74
7940325|NCT00504829|19541062|P1|STARTED|Overall Study||73
7940326|NCT00504777|19541071|P1|NOT COMPLETED|Overall Study||1
7940327|NCT00504777|19541071|P1|COMPLETED|Overall Study||35
7940328|NCT00504777|19541071|P1|STARTED|Overall Study||36
7940329|NCT00504751|19541078|P1|NOT COMPLETED|Overall Study||0
7940330|NCT00504751|19541078|P1|COMPLETED|Overall Study||15
7940331|NCT00504751|19541078|P1|STARTED|Overall Study||15
7940332|NCT00504725|19541084|P2|NOT COMPLETED|Overall Study||0
7940333|NCT00504725|19541085|P1|NOT COMPLETED|Overall Study||1
7940334|NCT00504725|19541084|P2|COMPLETED|Overall Study||20
7940335|NCT00504725|19541085|P1|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20
7940336|NCT00504725|19541084|P2|STARTED|Overall Study||20
7940337|NCT00504725|19541085|P1|STARTED|Overall Study||21
7940338|NCT00504660|19541097|P2|NOT COMPLETED|Overall Study||0
7940339|NCT00504660|19541098|P1|NOT COMPLETED|Overall Study||0
7940340|NCT00504660|19541097|P2|COMPLETED|Overall Study||43
7940341|NCT00504660|19541098|P1|COMPLETED|Overall Study||31
7940342|NCT00504660|19541097|P2|STARTED|Overall Study||43
7940343|NCT00504660|19541098|P1|STARTED|Overall Study||31
7940344|NCT00504595|19541108|P4|NOT COMPLETED|Overall Study||0
7940345|NCT00504595|19541109|P3|NOT COMPLETED|Overall Study||2
7940346|NCT00504595|19541110|P2|NOT COMPLETED|Overall Study||0
7940347|NCT00504595|19541111|P1|NOT COMPLETED|Overall Study||1
7940348|NCT00504595|19541108|P4|COMPLETED|Overall Study||10
7940349|NCT00504595|19541109|P3|COMPLETED|Overall Study||8
7940350|NCT00504595|19541110|P2|COMPLETED|Overall Study||10
7940351|NCT00504595|19541111|P1|COMPLETED|Overall Study||49
7940352|NCT00504595|19541108|P4|STARTED|Overall Study||10
7940353|NCT00504595|19541109|P3|STARTED|Overall Study||10
7940354|NCT00504595|19541110|P2|STARTED|Overall Study||10
7940355|NCT00504595|19541111|P1|STARTED|Overall Study||50
7940356|NCT00504556|19541128|P5|NOT COMPLETED|Overall Study||25
7940357|NCT00504556|19541129|P4|NOT COMPLETED|Overall Study||128
7940358|NCT00504556|19541130|P3|NOT COMPLETED|Overall Study||31
7940359|NCT00504556|19541131|P2|NOT COMPLETED|Overall Study||38
7940360|NCT00504556|19541132|P1|NOT COMPLETED|Overall Study||35
7940361|NCT00504556|19541128|P5|COMPLETED|Overall Study||226
7940362|NCT00504556|19541129|P4|COMPLETED|Overall Study||52
7940363|NCT00504556|19541130|P3|COMPLETED|Overall Study||204
7940364|NCT00504556|19541131|P2|COMPLETED|Overall Study||207
7940365|NCT00504556|19541132|P1|COMPLETED|Overall Study||200
7940366|NCT00504556|19541128|P5|Pharmacodynamic Analysis Set|Overall Study||244
7940367|NCT00504556|19541129|P4|Pharmacodynamic Analysis Set|Overall Study||170
7940368|NCT00504556|19541130|P3|Pharmacodynamic Analysis Set|Overall Study||228
7940369|NCT00504556|19541131|P2|Pharmacodynamic Analysis Set|Overall Study||236
7940370|NCT00504556|19541132|P1|Pharmacodynamic Analysis Set|Overall Study||230
7940371|NCT00504556|19541128|P5|Per Protocol Analysis Set|Overall Study||250
7940372|NCT00504556|19541129|P4|Per Protocol Analysis Set|Overall Study||180
7940373|NCT00504556|19541130|P3|Per Protocol Analysis Set|Overall Study||234
7940374|NCT00504556|19541131|P2|Per Protocol Analysis Set|Overall Study||243
7940375|NCT00504556|19541132|P1|Per Protocol Analysis Set|Overall Study||235
7940376|NCT00504556|19541128|P5|Safety Analysis Set|Overall Study||250
7940377|NCT00504556|19541129|P4|Safety Analysis Set|Overall Study||180
7940378|NCT00504556|19541130|P3|Safety Analysis Set|Overall Study||234
7940379|NCT00504556|19541131|P2|Safety Analysis Set|Overall Study||244
7940380|NCT00504556|19541132|P1|Safety Analysis Set|Overall Study||235
7940381|NCT00504556|19541128|P5|STARTED|Overall Study||251
7940382|NCT00504556|19541129|P4|STARTED|Overall Study||180
7940383|NCT00504556|19541130|P3|STARTED|Overall Study||235
7940384|NCT00504556|19541131|P2|STARTED|Overall Study||245
7940385|NCT00504556|19541132|P1|STARTED|Overall Study||235
7940386|NCT00504504|19541192|P1|NOT COMPLETED|Overall Study||0
7940387|NCT00504504|19541192|P1|COMPLETED|Overall Study||82
7940388|NCT00504504|19541192|P1|STARTED|Overall Study||82
7940389|NCT00504426|19541200|P4|NOT COMPLETED|Overall Study||0
7940390|NCT00504426|19541201|P3|NOT COMPLETED|Overall Study||4
7940391|NCT00504426|19541202|P2|NOT COMPLETED|Overall Study||1
7940392|NCT00504426|19541203|P1|NOT COMPLETED|Overall Study||3
7940393|NCT00504426|19541200|P4|COMPLETED|Overall Study||24
7940394|NCT00504426|19541201|P3|COMPLETED|Overall Study||18
7940395|NCT00504426|19541202|P2|COMPLETED|Overall Study||22
7940396|NCT00504426|19541203|P1|COMPLETED|Overall Study||29
7940397|NCT00504426|19541200|P4|STARTED|Overall Study||24
7940398|NCT00504426|19541201|P3|STARTED|Overall Study||22
7940399|NCT00504426|19541202|P2|STARTED|Overall Study||23
7940400|NCT00504426|19541203|P1|STARTED|Overall Study||32
7940401|NCT00504348|19541217|P1|NOT COMPLETED|Overall Study||8
7940402|NCT00504348|19541217|P1|COMPLETED|Overall Study||17
7940403|NCT00504348|19541217|P1|STARTED|Overall Study||25
7940404|NCT00504309|19541228|P6|NOT COMPLETED|Overall Study||0
7940405|NCT00504309|19541229|P5|NOT COMPLETED|Overall Study||1
7940406|NCT00504309|19541230|P4|NOT COMPLETED|Overall Study||0
7940407|NCT00504309|19541231|P3|NOT COMPLETED|Overall Study||1
7940408|NCT00504309|19541232|P2|NOT COMPLETED|Overall Study||0
7940409|NCT00504309|19541233|P1|NOT COMPLETED|Overall Study||0
7940410|NCT00504309|19541228|P6|COMPLETED|Overall Study||3
7940411|NCT00504309|19541229|P5|COMPLETED|Overall Study|Participant died during washout after 2nd period|7
7940412|NCT00504309|19541230|P4|COMPLETED|Overall Study||3
7940413|NCT00504309|19541231|P3|COMPLETED|Overall Study|Participant dropped out during second period|1
7940414|NCT00504309|19541232|P2|COMPLETED|Overall Study||5
7940415|NCT00504309|19541233|P1|COMPLETED|Overall Study||7
7940416|NCT00504309|19541228|P6|STARTED|Overall Study||3
7940417|NCT00504309|19541229|P5|STARTED|Overall Study||8
7940418|NCT00504309|19541230|P4|STARTED|Overall Study||3
7940419|NCT00504309|19541231|P3|STARTED|Overall Study||2
7940420|NCT00504309|19541232|P2|STARTED|Overall Study||5
7940421|NCT00504309|19541233|P1|STARTED|Overall Study||7
7940422|NCT00504257|19541271|P1|NOT COMPLETED|Overall Study||4
7940423|NCT00504257|19541271|P1|COMPLETED|Overall Study||41
7940424|NCT00504257|19541271|P1|STARTED|Overall Study||45
7940425|NCT00504231|19541283|P4|NOT COMPLETED|Overall Study||0
7940426|NCT00504231|19541284|P3|NOT COMPLETED|Overall Study||1
7940427|NCT00504231|19541285|P2|NOT COMPLETED|Overall Study||0
7940428|NCT00504231|19541286|P1|NOT COMPLETED|Overall Study||0
7940429|NCT00504231|19541283|P4|COMPLETED|Overall Study||65
7940430|NCT00504231|19541284|P3|COMPLETED|Overall Study||63
7940431|NCT00504231|19541285|P2|COMPLETED|Overall Study||64
7940432|NCT00504231|19541286|P1|COMPLETED|Overall Study||65
7940433|NCT00504231|19541283|P4|STARTED|Overall Study||65
7940434|NCT00504231|19541284|P3|STARTED|Overall Study||64
7940435|NCT00504231|19541285|P2|STARTED|Overall Study||64
7940436|NCT00504231|19541286|P1|STARTED|Overall Study||65
7940437|NCT00504166|19541306|P2|NOT COMPLETED|Overall Study||14
7940438|NCT00504166|19541307|P1|NOT COMPLETED|Overall Study||6
7940439|NCT00504166|19541306|P2|COMPLETED|Overall Study||13
7940440|NCT00504166|19541307|P1|COMPLETED|Overall Study||20
7940441|NCT00504166|19541306|P2|STARTED|Overall Study||27
7940442|NCT00504166|19541307|P1|STARTED|Overall Study||26
7940443|NCT00504153|19541313|P1|NOT COMPLETED|Overall Study||6
7940444|NCT00504153|19541313|P1|COMPLETED|Overall Study||13
7940445|NCT00504153|19541313|P1|STARTED|Overall Study||19
7940446|NCT00504075|19541321|P1|NOT COMPLETED|Overall Study||8
7940447|NCT00504075|19541321|P1|COMPLETED|Overall Study||27
7940448|NCT00504075|19541321|P1|STARTED|Overall Study||35
7940449|NCT00504023|19541327|P1|NOT COMPLETED|Overall Study||0
7940450|NCT00504023|19541327|P1|COMPLETED|Overall Study||8
7940451|NCT00504023|19541327|P1|STARTED|Overall Study||8
7940452|NCT00503997|19541331|P1|NOT COMPLETED|Overall Study||8
7940453|NCT00503997|19541331|P1|COMPLETED|Overall Study||34
7940454|NCT00503997|19541331|P1|STARTED|Overall Study||42
7940455|NCT00503984|19541337|P6|NOT COMPLETED|Overall Study||0
7940456|NCT00503984|19541338|P5|NOT COMPLETED|Overall Study||1
7940457|NCT00503984|19541339|P4|NOT COMPLETED|Overall Study||0
7940458|NCT00503984|19541340|P3|NOT COMPLETED|Overall Study||0
7940459|NCT00503984|19541341|P2|NOT COMPLETED|Overall Study||2
7940460|NCT00503984|19541342|P1|NOT COMPLETED|Overall Study||0
7940461|NCT00503984|19541337|P6|COMPLETED|Overall Study||1
7940462|NCT00503984|19541338|P5|COMPLETED|Overall Study||5
7940463|NCT00503984|19541339|P4|COMPLETED|Overall Study||6
7940464|NCT00503984|19541340|P3|COMPLETED|Overall Study||3
7940465|NCT00503984|19541341|P2|COMPLETED|Overall Study||1
7940466|NCT00503984|19541342|P1|COMPLETED|Overall Study||3
7940467|NCT00503984|19541337|P6|STARTED|Overall Study||1
7940468|NCT00503984|19541338|P5|STARTED|Overall Study||6
7940469|NCT00503984|19541339|P4|STARTED|Overall Study||6
7940470|NCT00503984|19541340|P3|STARTED|Overall Study||3
7940471|NCT00503984|19541341|P2|STARTED|Overall Study||3
7940472|NCT00503984|19541342|P1|STARTED|Overall Study||3
7940473|NCT00503906|19541368|P1|NOT COMPLETED|Overall Study||1
7940474|NCT00503906|19541368|P1|COMPLETED|Overall Study||29
7940475|NCT00503906|19541368|P1|STARTED|Overall Study||30
7940476|NCT00503880|19541377|P5|NOT COMPLETED|Overall Study||0
7940477|NCT00503880|19541378|P4|NOT COMPLETED|Overall Study||0
7940478|NCT00503880|19541379|P3|NOT COMPLETED|Overall Study||0
7940479|NCT00503880|19541380|P2|NOT COMPLETED|Overall Study||0
7940480|NCT00503880|19541381|P1|NOT COMPLETED|Overall Study||2
7940481|NCT00503880|19541377|P5|COMPLETED|Overall Study||0
7940482|NCT00503880|19541378|P4|COMPLETED|Overall Study||0
7940483|NCT00503880|19541379|P3|COMPLETED|Overall Study||0
7940484|NCT00503880|19541380|P2|COMPLETED|Overall Study||0
7940485|NCT00503880|19541381|P1|COMPLETED|Overall Study||0
7940486|NCT00503880|19541377|P5|STARTED|Overall Study||0
7940487|NCT00503880|19541378|P4|STARTED|Overall Study||0
7940488|NCT00503880|19541379|P3|STARTED|Overall Study||0
7940489|NCT00503880|19541380|P2|STARTED|Overall Study||0
7940490|NCT00503880|19541381|P1|STARTED|Overall Study||2
7940491|NCT00503867|19541390|P1|NOT COMPLETED|Overall Study||2
7940492|NCT00503867|19541390|P1|COMPLETED|Overall Study||8
7940493|NCT00503867|19541390|P1|STARTED|Overall Study||10
7940494|NCT00503841|19541398|P1|NOT COMPLETED|Overall Study||44
7940495|NCT00503841|19541398|P1|COMPLETED|Overall Study||0
7940496|NCT00503841|19541398|P1|STARTED|Overall Study||44
7940497|NCT00503776|19541409|P4|NOT COMPLETED|Overall Study||2
7940498|NCT00503776|19541410|P3|NOT COMPLETED|Overall Study||2
7940499|NCT00503776|19541411|P2|NOT COMPLETED|Overall Study||0
7940500|NCT00503776|19541412|P1|NOT COMPLETED|Overall Study||1
7940501|NCT00503776|19541409|P4|COMPLETED|Overall Study||8
7940502|NCT00503776|19541410|P3|COMPLETED|Overall Study||10
7940503|NCT00503776|19541411|P2|COMPLETED|Overall Study||12
7940504|NCT00503776|19541412|P1|COMPLETED|Overall Study||7
7940505|NCT00503776|19541409|P4|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10
7940506|NCT00503776|19541410|P3|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12
7940507|NCT00503776|19541411|P2|STARTED|Overall Study||12
7940508|NCT00503776|19541412|P1|STARTED|Overall Study||8
7940509|NCT00503750|19541438|P1|NOT COMPLETED|Overall Study||0
7940510|NCT00503750|19541438|P1|COMPLETED|Overall Study||27
7940511|NCT00503750|19541438|P1|STARTED|Overall Study||27
7940512|NCT00503698|19541445|P2|NOT COMPLETED|Overall Study||355
7940513|NCT00503698|19541446|P1|NOT COMPLETED|Overall Study||357
7940514|NCT00503698|19541445|P2|COMPLETED|Overall Study|Trial prematurely terminated|0
7940515|NCT00503698|19541446|P1|COMPLETED|Overall Study|Trial prematurely terminated|0
7940516|NCT00503698|19541445|P2|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349
7940517|NCT00503698|19541446|P1|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346
7940518|NCT00503698|19541445|P2|STARTED|Overall Study|Randomised|355
7940519|NCT00503698|19541446|P1|STARTED|Overall Study|Randomised|357
7940520|NCT00503685|19541463|P3|NOT COMPLETED|Overall Study||2
7940521|NCT00503685|19541464|P2|NOT COMPLETED|Overall Study||3
7940522|NCT00503685|19541465|P1|NOT COMPLETED|Overall Study||0
7940523|NCT00503685|19541463|P3|COMPLETED|Overall Study||18
7940524|NCT00503685|19541464|P2|COMPLETED|Overall Study||19
7940525|NCT00503685|19541465|P1|COMPLETED|Overall Study||23
7940526|NCT00503685|19541463|P3|Received at Least 1 Dose of Study Drug|Overall Study||20
7940527|NCT00503685|19541464|P2|Received at Least 1 Dose of Study Drug|Overall Study||21
7940528|NCT00503685|19541465|P1|Received at Least 1 Dose of Study Drug|Overall Study||23
7940529|NCT00503685|19541463|P3|STARTED|Overall Study||20
7940530|NCT00503685|19541464|P2|STARTED|Overall Study||22
7940531|NCT00503685|19541465|P1|STARTED|Overall Study||23
7940532|NCT00503581|19541510|P3|NOT COMPLETED|Overall Study||2
7940533|NCT00503581|19541511|P2|NOT COMPLETED|Overall Study||4
7940534|NCT00503581|19541512|P1|NOT COMPLETED|Overall Study||3
7940535|NCT00503581|19541510|P3|COMPLETED|Overall Study||0
7940536|NCT00503581|19541511|P2|COMPLETED|Overall Study||0
7940537|NCT00503581|19541512|P1|COMPLETED|Overall Study||0
7940538|NCT00503581|19541510|P3|STARTED|Overall Study||2
7940539|NCT00503581|19541511|P2|STARTED|Overall Study||4
7940540|NCT00503581|19541512|P1|STARTED|Overall Study||3
7940541|NCT00503425|19541523|P1|NOT COMPLETED|Overall Study||54
7940542|NCT00503425|19541523|P1|COMPLETED|Overall Study||161
7940543|NCT00503425|19541523|P1|STARTED|Overall Study||215
7940544|NCT00503399|19541533|P2|NOT COMPLETED|Overall Study||8
7940545|NCT00503399|19541534|P1|NOT COMPLETED|Overall Study||7
7940546|NCT00503399|19541533|P2|COMPLETED|Overall Study||39
7940547|NCT00503399|19541534|P1|COMPLETED|Overall Study||38
7940548|NCT00503399|19541533|P2|STARTED|Overall Study||47
7940549|NCT00503399|19541534|P1|STARTED|Overall Study||45
7940550|NCT00503308|19541558|P2|NOT COMPLETED|Overall Study||1
7940551|NCT00503308|19541559|P1|NOT COMPLETED|Overall Study||2
7940552|NCT00503308|19541558|P2|COMPLETED|Overall Study||134
7940553|NCT00503308|19541559|P1|COMPLETED|Overall Study||144
7940554|NCT00503308|19541558|P2|STARTED|Overall Study||135
7940555|NCT00503308|19541559|P1|STARTED|Overall Study||146
7940556|NCT00503139|19541565|P1|NOT COMPLETED|Overall Study||8
7940557|NCT00503139|19541565|P1|COMPLETED|Overall Study||676
7940558|NCT00503139|19541565|P1|STARTED|Overall Study||684
7940559|NCT00503113|19541579|P3|NOT COMPLETED|Overall Study||28
7940560|NCT00503113|19541580|P2|NOT COMPLETED|Overall Study||28
7940561|NCT00503113|19541581|P1|NOT COMPLETED|Overall Study||33
7940562|NCT00503113|19541579|P3|COMPLETED|Overall Study||241
7940563|NCT00503113|19541580|P2|COMPLETED|Overall Study||236
7940564|NCT00503113|19541581|P1|COMPLETED|Overall Study||235
7940565|NCT00503113|19541579|P3|Safety Population|Overall Study||267
7940566|NCT00503113|19541580|P2|Safety Population|Overall Study||263
7940567|NCT00503113|19541581|P1|Safety Population|Overall Study||263
7940568|NCT00503113|19541579|P3|Per Protocol Population (PP)|Overall Study||241
7940569|NCT00503113|19541580|P2|Per Protocol Population (PP)|Overall Study||243
7940570|NCT00503113|19541581|P1|Per Protocol Population (PP)|Overall Study||246
7940571|NCT00503113|19541579|P3|Intent to Treat Population (ITT)|Overall Study||268
7940572|NCT00503113|19541580|P2|Intent to Treat Population (ITT)|Overall Study||261
7940573|NCT00503113|19541581|P1|Intent to Treat Population (ITT)|Overall Study||262
7940574|NCT00503113|19541579|P3|STARTED|Overall Study||269
7940575|NCT00503113|19541580|P2|STARTED|Overall Study||264
7940576|NCT00503113|19541581|P1|STARTED|Overall Study||268
7940577|NCT00503009|19541613|P3|NOT COMPLETED|Overall Study||3
7940578|NCT00503009|19541614|P2|NOT COMPLETED|Overall Study||2
7940579|NCT00503009|19541615|P1|NOT COMPLETED|Overall Study||1
7940580|NCT00503009|19541613|P3|COMPLETED|Overall Study||3
7940581|NCT00503009|19541614|P2|COMPLETED|Overall Study||3
7940582|NCT00503009|19541615|P1|COMPLETED|Overall Study||4
7940583|NCT00503009|19541613|P3|STARTED|Overall Study||6
7940584|NCT00503009|19541614|P2|STARTED|Overall Study||5
7940585|NCT00503009|19541615|P1|STARTED|Overall Study||5
7940586|NCT00502996|19541632|P1|NOT COMPLETED|Overall Study||44
7940587|NCT00502996|19541632|P1|COMPLETED|Overall Study||188
7940588|NCT00502996|19541632|P1|STARTED|Overall Study||232
7940589|NCT00502944|19541658|P2|NOT COMPLETED|Overall Study||1766
7940590|NCT00502944|19541659|P1|NOT COMPLETED|Overall Study||1064
7940591|NCT00502944|19541658|P2|COMPLETED|Overall Study||643
7940592|NCT00502944|19541659|P1|COMPLETED|Overall Study||1382
7940593|NCT00502944|19541658|P2|STARTED|Overall Study||2409
7940594|NCT00502944|19541659|P1|STARTED|Overall Study||2446
7940595|NCT00502905|19541671|P1|NOT COMPLETED|Overall Study||0
7940596|NCT00502905|19541671|P1|COMPLETED|Overall Study||196
7940597|NCT00502905|19541671|P1|STARTED|Overall Study||196
7940598|NCT00502853|19541675|P1|NOT COMPLETED|Overall Study||0
7940599|NCT00502853|19541675|P1|COMPLETED|Overall Study||10
7940600|NCT00502853|19541675|P1|STARTED|Overall Study||10
7940601|NCT00502840|19541700|P1|NOT COMPLETED|Overall Study||100
7940602|NCT00502840|19541700|P1|COMPLETED|Overall Study||93
7940603|NCT00502840|19541700|P1|STARTED|Overall Study||193
7940604|NCT00502801|19541728|P1|NOT COMPLETED|End of Therapy to Test of Cure||8
7940605|NCT00502801|19541728|P1|COMPLETED|End of Therapy to Test of Cure||121
7940606|NCT00502801|19541728|P1|STARTED|End of Therapy to Test of Cure||129
7940607|NCT00502801|19541728|P1|NOT COMPLETED|Treatment Period||54
7940608|NCT00502801|19541728|P1|COMPLETED|Treatment Period||129
7940609|NCT00502801|19541728|P1|STARTED|Treatment Period||183
7940610|NCT00502775|19541736|P3|NOT COMPLETED|Overall Study||13
7940611|NCT00502775|19541737|P2|NOT COMPLETED|Overall Study||15
7940612|NCT00502775|19541738|P1|NOT COMPLETED|Overall Study||10
7940613|NCT00502775|19541736|P3|COMPLETED|Overall Study||214
7940614|NCT00502775|19541737|P2|COMPLETED|Overall Study||209
7940615|NCT00502775|19541738|P1|COMPLETED|Overall Study||219
7940616|NCT00502775|19541736|P3|STARTED|Overall Study||227
7940617|NCT00502775|19541737|P2|STARTED|Overall Study||224
7940618|NCT00502775|19541738|P1|STARTED|Overall Study||229
7940619|NCT00502697|19541781|P2|NOT COMPLETED|Overall Study||12
7940620|NCT00502697|19541782|P1|NOT COMPLETED|Overall Study||13
7940621|NCT00502697|19541781|P2|COMPLETED|Overall Study||102
7940622|NCT00502697|19541782|P1|COMPLETED|Overall Study||109
7940623|NCT00502697|19541781|P2|STARTED|Overall Study||114
7940624|NCT00502697|19541782|P1|STARTED|Overall Study||122
7940625|NCT00502671|19541790|P1|NOT COMPLETED|Overall Study||77
7940626|NCT00502671|19541790|P1|COMPLETED|Overall Study||151
7940627|NCT00502671|19541790|P1|STARTED|Overall Study||228
7940628|NCT00502593|19541807|P12|NOT COMPLETED|Overall Study||0
7940629|NCT00502593|19541808|P11|NOT COMPLETED|Overall Study||2
7940630|NCT00502593|19541809|P10|NOT COMPLETED|Overall Study||0
7940631|NCT00502593|19541810|P9|NOT COMPLETED|Overall Study||6
7940632|NCT00502593|19541811|P8|NOT COMPLETED|Overall Study||0
7940633|NCT00502593|19541812|P7|NOT COMPLETED|Overall Study||5
7940634|NCT00502593|19541813|P6|NOT COMPLETED|Overall Study||0
7940635|NCT00502593|19541814|P5|NOT COMPLETED|Overall Study||4
7940636|NCT00502593|19541815|P4|NOT COMPLETED|Overall Study||4
7940637|NCT00502593|19541816|P3|NOT COMPLETED|Overall Study||10
7940638|NCT00502593|19541817|P2|NOT COMPLETED|Overall Study||2
7940639|NCT00502593|19541818|P1|NOT COMPLETED|Overall Study||3
7940640|NCT00502593|19541807|P12|COMPLETED|Overall Study||18
7940641|NCT00502593|19541808|P11|COMPLETED|Overall Study||47
7940642|NCT00502593|19541809|P10|COMPLETED|Overall Study||17
7940643|NCT00502593|19541810|P9|COMPLETED|Overall Study||43
7940644|NCT00502593|19541811|P8|COMPLETED|Overall Study||17
7940645|NCT00502593|19541812|P7|COMPLETED|Overall Study||44
7940646|NCT00502593|19541813|P6|COMPLETED|Overall Study||17
7940647|NCT00502593|19541814|P5|COMPLETED|Overall Study||47
7940648|NCT00502593|19541815|P4|COMPLETED|Overall Study||14
7940649|NCT00502593|19541816|P3|COMPLETED|Overall Study||41
7940650|NCT00502593|19541817|P2|COMPLETED|Overall Study||16
7940651|NCT00502593|19541818|P1|COMPLETED|Overall Study||48
7940652|NCT00502593|19541807|P12|STARTED|Overall Study||18
7940653|NCT00502593|19541808|P11|STARTED|Overall Study||49
7940654|NCT00502593|19541809|P10|STARTED|Overall Study||17
7940655|NCT00502593|19541810|P9|STARTED|Overall Study||49
7940656|NCT00502593|19541811|P8|STARTED|Overall Study||17
7940657|NCT00502593|19541812|P7|STARTED|Overall Study||49
7940658|NCT00502593|19541813|P6|STARTED|Overall Study||17
7940659|NCT00502593|19541814|P5|STARTED|Overall Study||51
7940660|NCT00502593|19541815|P4|STARTED|Overall Study||18
7940661|NCT00502593|19541816|P3|STARTED|Overall Study||51
7940662|NCT00502593|19541817|P2|STARTED|Overall Study||18
7940663|NCT00502593|19541818|P1|STARTED|Overall Study||51
7940664|NCT00502320|19542334|P2|NOT COMPLETED|Overall Study||7
7940665|NCT00502320|19542335|P1|NOT COMPLETED|Overall Study||6
7940666|NCT00502320|19542334|P2|COMPLETED|Overall Study||18
7940667|NCT00502320|19542335|P1|COMPLETED|Overall Study||19
7940668|NCT00502320|19542334|P2|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24
7940669|NCT00502320|19542335|P1|Screening Visit|Overall Study||25
7940670|NCT00502320|19542334|P2|STARTED|Overall Study||25
7940671|NCT00502320|19542335|P1|STARTED|Overall Study||25
7940672|NCT00502307|19542345|P3|NOT COMPLETED|Maintenance Period||0
7940673|NCT00502307|19542346|P2|NOT COMPLETED|Maintenance Period||0
7940674|NCT00502307|19542347|P1|NOT COMPLETED|Maintenance Period||148
7940675|NCT00502307|19542345|P3|COMPLETED|Maintenance Period||0
7940676|NCT00502307|19542346|P2|COMPLETED|Maintenance Period||0
7940677|NCT00502307|19542347|P1|COMPLETED|Maintenance Period||0
7940678|NCT00502307|19542345|P3|STARTED|Maintenance Period||0
7940679|NCT00502307|19542346|P2|STARTED|Maintenance Period||0
7940680|NCT00502307|19542347|P1|STARTED|Maintenance Period||148
7940681|NCT00502307|19542345|P3|NOT COMPLETED|Double-Blind Period (12 Weeks)||9
7940682|NCT00502307|19542346|P2|NOT COMPLETED|Double-Blind Period (12 Weeks)||26
7940683|NCT00502307|19542347|P1|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
7940684|NCT00502307|19542345|P3|COMPLETED|Double-Blind Period (12 Weeks)||48
7940685|NCT00502307|19542346|P2|COMPLETED|Double-Blind Period (12 Weeks)||35
7940686|NCT00502307|19542347|P1|COMPLETED|Double-Blind Period (12 Weeks)||0
7940687|NCT00502307|19542345|P3|STARTED|Double-Blind Period (12 Weeks)||57
7940688|NCT00502307|19542346|P2|STARTED|Double-Blind Period (12 Weeks)||61
7940689|NCT00502307|19542347|P1|STARTED|Double-Blind Period (12 Weeks)||0
7940690|NCT00502307|19542345|P3|NOT COMPLETED|Open Label Period (16 Weeks)||0
7940691|NCT00502307|19542346|P2|NOT COMPLETED|Open Label Period (16 Weeks)||0
7940692|NCT00502307|19542347|P1|NOT COMPLETED|Open Label Period (16 Weeks)||76
7940693|NCT00502307|19542345|P3|COMPLETED|Open Label Period (16 Weeks)||0
7940694|NCT00502307|19542346|P2|COMPLETED|Open Label Period (16 Weeks)||0
7940695|NCT00502307|19542347|P1|COMPLETED|Open Label Period (16 Weeks)||196
7940696|NCT00502307|19542345|P3|STARTED|Open Label Period (16 Weeks)||0
7940697|NCT00502307|19542346|P2|STARTED|Open Label Period (16 Weeks)||0
7940698|NCT00502307|19542347|P1|STARTED|Open Label Period (16 Weeks)||272
7940699|NCT00502242|19542374|P2|NOT COMPLETED|Overall Study||56
7940700|NCT00502242|19542375|P1|NOT COMPLETED|Overall Study||51
7940701|NCT00502242|19542374|P2|COMPLETED|Overall Study||84
7940702|NCT00502242|19542375|P1|COMPLETED|Overall Study||104
7940703|NCT00502242|19542374|P2|STARTED|Overall Study||140
7940704|NCT00502242|19542375|P1|STARTED|Overall Study||155
7940705|NCT00502216|19542428|P2|NOT COMPLETED|Overall Study||0
7940706|NCT00502216|19542429|P1|NOT COMPLETED|Overall Study||0
7940707|NCT00502216|19542428|P2|COMPLETED|Overall Study||19
7940708|NCT00502216|19542429|P1|COMPLETED|Overall Study||21
7940709|NCT00502216|19542428|P2|STARTED|Overall Study||19
7940710|NCT00502216|19542429|P1|STARTED|Overall Study||21
7940711|NCT00502203|19542439|P1|NOT COMPLETED|Overall Study||1
7940712|NCT00502203|19542439|P1|COMPLETED|Overall Study||22
7940713|NCT00502203|19542439|P1|STARTED|Overall Study||23
7940714|NCT00501995|19542443|P1|NOT COMPLETED|Overall Study||1
7940715|NCT00501995|19542443|P1|COMPLETED|Overall Study||5
7940716|NCT00501995|19542443|P1|STARTED|Overall Study||6
7940717|NCT00501969|19542448|P1|NOT COMPLETED|Overall Study||206
7940718|NCT00501969|19542448|P1|COMPLETED|Overall Study||189
7940719|NCT00501969|19542448|P1|STARTED|Overall Study||395
7940720|NCT00501943|19542456|P2|NOT COMPLETED|Overall Study||3
7940721|NCT00501943|19542457|P1|NOT COMPLETED|Overall Study||2
7940722|NCT00501943|19542456|P2|COMPLETED|Overall Study||18
7940723|NCT00501943|19542457|P1|COMPLETED|Overall Study||20
7940724|NCT00501943|19542456|P2|STARTED|Overall Study||21
7940725|NCT00501943|19542457|P1|STARTED|Overall Study||22
7940726|NCT00501891|19542473|P1|NOT COMPLETED|Overall Study||0
7940727|NCT00501891|19542473|P1|COMPLETED|Overall Study||32
7940728|NCT00501891|19542473|P1|STARTED|Overall Study||32
7940729|NCT00501852|19542480|P1|NOT COMPLETED|Overall Study||5
7940730|NCT00501852|19542480|P1|COMPLETED|Overall Study||78
7940731|NCT00501852|19542480|P1|Tiotropium|Overall Study||55
7940732|NCT00501852|19542480|P1|Placebo|Overall Study||55
7940733|NCT00501852|19542480|P1|NVA237 100µg|Overall Study||54
7940734|NCT00501852|19542480|P1|NVA237 50µg|Overall Study||53
7940735|NCT00501852|19542480|P1|NVA237 25µg|Overall Study||51
7940736|NCT00501852|19542480|P1|NVA237 12.5µg|Overall Study||55
7940737|NCT00501852|19542480|P1|STARTED|Overall Study||83
7940738|NCT00501644|19542500|P1|NOT COMPLETED|Overall Study||5
7940739|NCT00501644|19542500|P1|COMPLETED|Overall Study||54
7940740|NCT00501644|19542500|P1|STARTED|Overall Study||59
7940741|NCT00501631|19542506|P2|NOT COMPLETED|Part B (Open-label Period)||51
7940742|NCT00501631|19542507|P1|NOT COMPLETED|Part B (Open-label Period)||53
7940743|NCT00501631|19542506|P2|COMPLETED|Part B (Open-label Period)||48
7940744|NCT00501631|19542507|P1|COMPLETED|Part B (Open-label Period)||37
7940745|NCT00501631|19542506|P2|STARTED|Part B (Open-label Period)||99
7940746|NCT00501631|19542507|P1|STARTED|Part B (Open-label Period)||90
7940747|NCT00501631|19542506|P2|NOT COMPLETED|Part A (Double-blind Period)||49
7940748|NCT00501631|19542507|P1|NOT COMPLETED|Part A (Double-blind Period)||62
7940749|NCT00501631|19542506|P2|COMPLETED|Part A (Double-blind Period)||99
7940750|NCT00501631|19542507|P1|COMPLETED|Part A (Double-blind Period)||90
7940751|NCT00501631|19542506|P2|STARTED|Part A (Double-blind Period)||148
7940752|NCT00501631|19542507|P1|STARTED|Part A (Double-blind Period)||152
7940753|NCT00501592|19542516|P3|NOT COMPLETED|Overall Study||3
7940754|NCT00501592|19542517|P2|NOT COMPLETED|Overall Study||5
7940755|NCT00501592|19542518|P1|NOT COMPLETED|Overall Study||0
7940756|NCT00501592|19542516|P3|COMPLETED|Overall Study||20
7940757|NCT00501592|19542517|P2|COMPLETED|Overall Study||16
7940758|NCT00501592|19542518|P1|COMPLETED|Overall Study||20
7940759|NCT00501592|19542516|P3|STARTED|Overall Study||23
7940760|NCT00501592|19542517|P2|STARTED|Overall Study||21
7940761|NCT00501592|19542518|P1|STARTED|Overall Study||20
7940762|NCT00501540|19542529|P1|NOT COMPLETED|Overall Study||5
7940763|NCT00501540|19542529|P1|COMPLETED|Overall Study||10
7940764|NCT00501540|19542529|P1|STARTED|Overall Study||15
7940765|NCT00501345|19542535|P1|NOT COMPLETED|Overall Study||0
7940766|NCT00501345|19542535|P1|COMPLETED|Overall Study||5
7940767|NCT00501345|19542535|P1|STARTED|Overall Study||5
7940768|NCT00501293|19542541|P2|NOT COMPLETED|Maintenance Period||28
7940769|NCT00501293|19542542|P1|NOT COMPLETED|Maintenance Period||46
7940770|NCT00501293|19542541|P2|COMPLETED|Maintenance Period||25
7940771|NCT00501293|19542542|P1|COMPLETED|Maintenance Period||63
7940772|NCT00501293|19542541|P2|STARTED|Maintenance Period||53
7940773|NCT00501293|19542542|P1|STARTED|Maintenance Period||109
7940774|NCT00501293|19542541|P2|NOT COMPLETED|Optimization Period||0
7940775|NCT00501293|19542542|P1|NOT COMPLETED|Optimization Period||1
7940776|NCT00501293|19542541|P2|COMPLETED|Optimization Period||53
7940777|NCT00501293|19542542|P1|COMPLETED|Optimization Period||109
7940778|NCT00501293|19542541|P2|STARTED|Optimization Period||53
7940779|NCT00501293|19542542|P1|STARTED|Optimization Period||110
7940780|NCT00501228|19542569|P1|NOT COMPLETED|Overall Study||1
7940781|NCT00501228|19542569|P1|COMPLETED|Overall Study||1
7940782|NCT00501228|19542569|P1|STARTED|Overall Study||2
7940783|NCT00501085|19542573|P1|NOT COMPLETED|Overall Study||432
7940784|NCT00501085|19542573|P1|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83
7940785|NCT00501085|19542573|P1|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515
7940786|NCT00501059|19542583|P2|NOT COMPLETED|Overall Study||1892
7940787|NCT00501059|19542584|P1|NOT COMPLETED|Overall Study||1868
7940788|NCT00501059|19542583|P2|COMPLETED|Overall Study||4384
7940789|NCT00501059|19542584|P1|COMPLETED|Overall Study||4402
7940790|NCT00501059|19542583|P2|STARTED|Overall Study||6276
7940791|NCT00501059|19542584|P1|STARTED|Overall Study||6270
7940792|NCT00501046|19542608|P2|NOT COMPLETED|Overall Study||294
7940793|NCT00501046|19542609|P1|NOT COMPLETED|Overall Study||270
7940794|NCT00501046|19542608|P2|COMPLETED|Overall Study||213
7940795|NCT00501046|19542609|P1|COMPLETED|Overall Study||238
7940796|NCT00501046|19542608|P2|STARTED|Overall Study||507
7940797|NCT00501046|19542609|P1|STARTED|Overall Study||508
7940798|NCT00501007|19542615|P2|NOT COMPLETED|Overall Study||25
7940799|NCT00501007|19542616|P1|NOT COMPLETED|Overall Study||29
7940800|NCT00501007|19542615|P2|COMPLETED|Overall Study||78
7940801|NCT00501007|19542616|P1|COMPLETED|Overall Study||71
7940802|NCT00501007|19542615|P2|STARTED|Overall Study||103
7940803|NCT00501007|19542616|P1|STARTED|Overall Study||100
7940804|NCT00500903|19542625|P3|NOT COMPLETED|Overall Study||20
7940805|NCT00500903|19542626|P2|NOT COMPLETED|Overall Study||2
7940806|NCT00500903|19542627|P1|NOT COMPLETED|Overall Study||65
7940807|NCT00500903|19542625|P3|COMPLETED|Overall Study||0
7940808|NCT00500903|19542626|P2|COMPLETED|Overall Study||0
7940809|NCT00500903|19542627|P1|COMPLETED|Overall Study||0
7940810|NCT00500903|19542625|P3|STARTED|Overall Study||20
7940811|NCT00500903|19542626|P2|STARTED|Overall Study||2
7940812|NCT00500903|19542627|P1|STARTED|Overall Study||65
7940813|NCT00500890|19542808|P2|NOT COMPLETED|Overall Study||0
7940814|NCT00500890|19542809|P1|NOT COMPLETED|Overall Study||0
7940815|NCT00500890|19542808|P2|COMPLETED|Overall Study||1
7940816|NCT00500890|19542809|P1|COMPLETED|Overall Study||1
7940817|NCT00500890|19542808|P2|STARTED|Overall Study||1
7940818|NCT00500890|19542809|P1|STARTED|Overall Study||1
7940819|NCT00500760|19542823|P2|NOT COMPLETED|Overall Study||24
7940820|NCT00500760|19542824|P1|NOT COMPLETED|Overall Study||43
7940821|NCT00500760|19542823|P2|COMPLETED|Overall Study||40
7940822|NCT00500760|19542824|P1|COMPLETED|Overall Study||46
7940823|NCT00500760|19542823|P2|Received Treatment|Overall Study||63
7940824|NCT00500760|19542824|P1|Received Treatment|Overall Study||87
7940825|NCT00500760|19542823|P2|STARTED|Overall Study||64
7940826|NCT00500760|19542824|P1|STARTED|Overall Study||89
7940827|NCT00500682|19542844|P2|NOT COMPLETED|Overall Study||287
7940828|NCT00500682|19542845|P1|NOT COMPLETED|Overall Study||306
7940829|NCT00500682|19542844|P2|COMPLETED|Overall Study||223
7940830|NCT00500682|19542845|P1|COMPLETED|Overall Study||204
7940831|NCT00500682|19542844|P2|STARTED|Overall Study||510
7940832|NCT00500682|19542845|P1|STARTED|Overall Study||510
7940833|NCT00500656|19542855|P4|NOT COMPLETED|Open Label Extension (OLE) Phase||2
7940834|NCT00500656|19542856|P3|NOT COMPLETED|Open Label Extension (OLE) Phase||1
7940835|NCT00500656|19542857|P2|NOT COMPLETED|Open Label Extension (OLE) Phase||12
7940836|NCT00500656|19542858|P1|NOT COMPLETED|Open Label Extension (OLE) Phase||7
7940837|NCT00500656|19542855|P4|COMPLETED|Open Label Extension (OLE) Phase||6
7940838|NCT00500656|19542856|P3|COMPLETED|Open Label Extension (OLE) Phase||1
7940839|NCT00500656|19542857|P2|COMPLETED|Open Label Extension (OLE) Phase||9
7940840|NCT00500656|19542858|P1|COMPLETED|Open Label Extension (OLE) Phase||16
7940924|NCT00500292|19543130|P2|STARTED|Overall Study|randomised patients|35
7940841|NCT00500656|19542855|P4|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8
7940842|NCT00500656|19542856|P3|STARTED|Open Label Extension (OLE) Phase||2
7940843|NCT00500656|19542857|P2|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21
7940844|NCT00500656|19542858|P1|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23
7940845|NCT00500656|19542855|P4|NOT COMPLETED|Controlled Phase||8
7940846|NCT00500656|19542856|P3|NOT COMPLETED|Controlled Phase||1
7940847|NCT00500656|19542857|P2|NOT COMPLETED|Controlled Phase||10
7940848|NCT00500656|19542858|P1|NOT COMPLETED|Controlled Phase||10
7940849|NCT00500656|19542855|P4|COMPLETED|Controlled Phase||0
7940850|NCT00500656|19542856|P3|COMPLETED|Controlled Phase||2
7940851|NCT00500656|19542857|P2|COMPLETED|Controlled Phase||28
7940852|NCT00500656|19542858|P1|COMPLETED|Controlled Phase||26
7940853|NCT00500656|19542855|P4|STARTED|Controlled Phase||8
7940854|NCT00500656|19542856|P3|STARTED|Controlled Phase||3
7940855|NCT00500656|19542857|P2|STARTED|Controlled Phase||38
7940856|NCT00500656|19542858|P1|STARTED|Controlled Phase||36
7940857|NCT00500578|19542872|P2|NOT COMPLETED|Overall Study||0
7940858|NCT00500578|19542873|P1|NOT COMPLETED|Overall Study||0
7940859|NCT00500578|19542872|P2|COMPLETED|Overall Study|All completed|32
7940860|NCT00500578|19542873|P1|COMPLETED|Overall Study|All completed|18
7940861|NCT00500578|19542872|P2|STARTED|Overall Study||32
7940862|NCT00500578|19542873|P1|STARTED|Overall Study||18
7940863|NCT00500539|19542879|P1|NOT COMPLETED|Follow-up Period (16 Weeks)||12
7940864|NCT00500539|19542879|P1|COMPLETED|Follow-up Period (16 Weeks)||136
7940865|NCT00500539|19542879|P1|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148
7940866|NCT00500539|19542879|P1|NOT COMPLETED|Treatment Period (24 Weeks)||15
7940867|NCT00500539|19542879|P1|COMPLETED|Treatment Period (24 Weeks)||140
7940868|NCT00500539|19542879|P1|STARTED|Treatment Period (24 Weeks)||155
7940869|NCT00500448|19542888|P2|NOT COMPLETED|Overall Study||0
7940870|NCT00500448|19542889|P1|NOT COMPLETED|Overall Study||0
7940871|NCT00500448|19542888|P2|COMPLETED|Overall Study||16
7940872|NCT00500448|19542889|P1|COMPLETED|Overall Study||14
7940873|NCT00500448|19542888|P2|STARTED|Overall Study||16
7940874|NCT00500448|19542889|P1|STARTED|Overall Study||14
7940875|NCT00500370|19542905|P2|NOT COMPLETED|Overall Study||34
7940876|NCT00500370|19542906|P1|NOT COMPLETED|Overall Study||33
7940877|NCT00500370|19542905|P2|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49
7940878|NCT00500370|19542906|P1|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47
7940879|NCT00500370|19542905|P2|Treatment Complete (Week 24)|Overall Study||54
7940880|NCT00500370|19542906|P1|Treatment Complete (Week 24)|Overall Study||48
7940881|NCT00500370|19542905|P2|Treatment Start-Baseline (Week 0)|Overall Study||79
7940882|NCT00500370|19542906|P1|Treatment Start-Baseline (Week 0)|Overall Study||73
7940883|NCT00500370|19542905|P2|STARTED|Overall Study||83
7940884|NCT00500370|19542906|P1|STARTED|Overall Study||80
7940885|NCT00500357|19542942|P1|NOT COMPLETED|Overall Study||1
7940886|NCT00500357|19542942|P1|COMPLETED|Overall Study||104
7940887|NCT00500357|19542942|P1|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98
7940888|NCT00500357|19542942|P1|Received 13vPnC (Vax 3)|Overall Study||105
7940889|NCT00500357|19542942|P1|STARTED|Overall Study||105
7940890|NCT00500331|19542968|P7|NOT COMPLETED|Overall Study||2
7940891|NCT00500331|19542969|P6|NOT COMPLETED|Overall Study||5
7940892|NCT00500331|19542970|P5|NOT COMPLETED|Overall Study||4
7940893|NCT00500331|19542971|P4|NOT COMPLETED|Overall Study||10
7940894|NCT00500331|19542972|P3|NOT COMPLETED|Overall Study||5
7940895|NCT00500331|19542973|P2|NOT COMPLETED|Overall Study||5
7940896|NCT00500331|19542974|P1|NOT COMPLETED|Overall Study||15
7940897|NCT00500331|19542968|P7|COMPLETED|Overall Study||46
7940898|NCT00500331|19542969|P6|COMPLETED|Overall Study||42
7940899|NCT00500331|19542970|P5|COMPLETED|Overall Study||44
7940900|NCT00500331|19542971|P4|COMPLETED|Overall Study||38
7940901|NCT00500331|19542972|P3|COMPLETED|Overall Study||43
7940902|NCT00500331|19542973|P2|COMPLETED|Overall Study||42
7940903|NCT00500331|19542974|P1|COMPLETED|Overall Study||33
7940904|NCT00500331|19542968|P7|STARTED|Overall Study||48
7940905|NCT00500331|19542969|P6|STARTED|Overall Study||47
7940906|NCT00500331|19542970|P5|STARTED|Overall Study||48
7940907|NCT00500331|19542971|P4|STARTED|Overall Study||48
7940908|NCT00500331|19542972|P3|STARTED|Overall Study||48
7940909|NCT00500331|19542973|P2|STARTED|Overall Study||47
7940910|NCT00500331|19542974|P1|STARTED|Overall Study||48
7940911|NCT00500318|19543111|P2|NOT COMPLETED|Overall Study||17
7940912|NCT00500318|19543112|P1|NOT COMPLETED|Overall Study||5
7940913|NCT00500318|19543111|P2|COMPLETED|Overall Study||78
7940914|NCT00500318|19543112|P1|COMPLETED|Overall Study||81
7940915|NCT00500318|19543111|P2|STARTED|Overall Study||95
7940916|NCT00500318|19543112|P1|STARTED|Overall Study||86
7940917|NCT00500292|19543129|P3|NOT COMPLETED|Overall Study||27
7940918|NCT00500292|19543130|P2|NOT COMPLETED|Overall Study||31
7940919|NCT00500292|19543131|P1|NOT COMPLETED|Overall Study||25
7940920|NCT00500292|19543129|P3|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|10
7940921|NCT00500292|19543130|P2|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|4
7940922|NCT00500292|19543131|P1|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|7
7940923|NCT00500292|19543129|P3|STARTED|Overall Study|randomised patients|37
7940925|NCT00500292|19543131|P1|STARTED|Overall Study|randomised patients|32
7940926|NCT00500240|19543141|P2|NOT COMPLETED|Overall Study||0
7940927|NCT00500240|19543142|P1|NOT COMPLETED|Overall Study||0
7940928|NCT00500240|19543141|P2|COMPLETED|Overall Study||26
7940929|NCT00500240|19543142|P1|COMPLETED|Overall Study||25
7940930|NCT00500240|19543141|P2|STARTED|Overall Study||26
7940931|NCT00500240|19543142|P1|STARTED|Overall Study||25
7940932|NCT00500149|19543152|P2|NOT COMPLETED|Second Intervention (Cross-over Phase)||0
7940933|NCT00500149|19543153|P1|NOT COMPLETED|Second Intervention (Cross-over Phase)||2
7940934|NCT00500149|19543152|P2|COMPLETED|Second Intervention (Cross-over Phase)||57
7940935|NCT00500149|19543153|P1|COMPLETED|Second Intervention (Cross-over Phase)||54
7940936|NCT00500149|19543152|P2|STARTED|Second Intervention (Cross-over Phase)||57
7940937|NCT00500149|19543153|P1|STARTED|Second Intervention (Cross-over Phase)||56
7940938|NCT00500149|19543152|P2|NOT COMPLETED|First Intervention (Cross-over Phase)||2
7940939|NCT00500149|19543153|P1|NOT COMPLETED|First Intervention (Cross-over Phase)||2
7940940|NCT00500149|19543152|P2|COMPLETED|First Intervention (Cross-over Phase)||57
7940941|NCT00500149|19543153|P1|COMPLETED|First Intervention (Cross-over Phase)||56
7940942|NCT00500149|19543152|P2|STARTED|First Intervention (Cross-over Phase)||59
7940943|NCT00500149|19543153|P1|STARTED|First Intervention (Cross-over Phase)||58
7940944|NCT00500149|19543152|P2|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0
7940945|NCT00500149|19543153|P1|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12
7940946|NCT00500149|19543152|P2|COMPLETED|Enrolled (Dose-optimization Phase)||0
7940947|NCT00500149|19543153|P1|COMPLETED|Enrolled (Dose-optimization Phase)||117
7940948|NCT00500149|19543152|P2|STARTED|Enrolled (Dose-optimization Phase)||0
7940949|NCT00500149|19543153|P1|STARTED|Enrolled (Dose-optimization Phase)||129
7940950|NCT00500110|19543161|P1|NOT COMPLETED|Overall Study||3
7940951|NCT00500110|19543161|P1|COMPLETED|Overall Study||36
7940952|NCT00500110|19543161|P1|STARTED|Overall Study||39
7940953|NCT00500071|19543165|P1|NOT COMPLETED|30-day Safety Follow-up||17
7940954|NCT00500071|19543165|P1|COMPLETED|30-day Safety Follow-up||278
7940955|NCT00500071|19543165|P1|STARTED|30-day Safety Follow-up||295
7940956|NCT00500071|19543165|P1|NOT COMPLETED|Dose-optimization and Maintenance Phase||22
7940957|NCT00500071|19543165|P1|COMPLETED|Dose-optimization and Maintenance Phase||295
7940958|NCT00500071|19543165|P1|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317
7940959|NCT00500071|19543165|P1|NOT COMPLETED|Screening and Washout Phase||1
7940960|NCT00500071|19543165|P1|COMPLETED|Screening and Washout Phase||317
7940961|NCT00500071|19543165|P1|STARTED|Screening and Washout Phase||318
7940962|NCT00500045|19543174|P1|NOT COMPLETED|Overall Study||0
7940963|NCT00500045|19543174|P1|COMPLETED|Overall Study||0
7940964|NCT00500045|19543174|P1|STARTED|Overall Study||0
7940965|NCT00499915|19543181|P2|NOT COMPLETED|Overall Study||6
7940966|NCT00499915|19543182|P1|NOT COMPLETED|Overall Study||15
7940967|NCT00499915|19543181|P2|COMPLETED|Overall Study||76
7940968|NCT00499915|19543182|P1|COMPLETED|Overall Study||68
7940969|NCT00499915|19543181|P2|STARTED|Overall Study||82
7940970|NCT00499915|19543182|P1|STARTED|Overall Study||83
7940971|NCT00499889|19543188|P1|NOT COMPLETED|Overall Study||1
7940972|NCT00499889|19543188|P1|COMPLETED|Overall Study||41
7940973|NCT00499889|19543188|P1|STARTED|Overall Study||42
7940974|NCT00499863|19543196|P2|NOT COMPLETED|Overall Study||43
7940975|NCT00499863|19543197|P1|NOT COMPLETED|Overall Study||50
7940976|NCT00499863|19543196|P2|COMPLETED|Overall Study||29
7940977|NCT00499863|19543197|P1|COMPLETED|Overall Study||95
7940978|NCT00499863|19543196|P2|STARTED|Overall Study||72
7940979|NCT00499863|19543197|P1|STARTED|Overall Study||145
7940980|NCT00500266|19543225|P1|NOT COMPLETED|Overall Study||13
7940981|NCT00500266|19543225|P1|COMPLETED|Overall Study||1040
7940982|NCT00500266|19543225|P1|Treated|Overall Study||1049
7940983|NCT00500266|19543225|P1|STARTED|Overall Study||1053
7940984|NCT00499746|19543232|P1|NOT COMPLETED|Phase 3 (9-14 One Day Sessions)||0
7940985|NCT00499746|19543232|P1|COMPLETED|Phase 3 (9-14 One Day Sessions)||8
7940986|NCT00499746|19543232|P1|STARTED|Phase 3 (9-14 One Day Sessions)||8
7940987|NCT00499746|19543232|P1|NOT COMPLETED|Phase 2 (6-9 One Day Sessions)||0
7940988|NCT00499746|19543232|P1|COMPLETED|Phase 2 (6-9 One Day Sessions)||8
7940989|NCT00499746|19543232|P1|STARTED|Phase 2 (6-9 One Day Sessions)||8
7940990|NCT00499746|19543232|P1|NOT COMPLETED|Phase 1(6-9 One Day Sessions)||12
7940991|NCT00499746|19543232|P1|COMPLETED|Phase 1(6-9 One Day Sessions)||8
7940992|NCT00499746|19543232|P1|STARTED|Phase 1(6-9 One Day Sessions)||20
7940993|NCT00499694|19543301|P1|NOT COMPLETED|Overall Study||1
7940994|NCT00499694|19543301|P1|COMPLETED|Overall Study||30
7940995|NCT00499694|19543301|P1|STARTED|Overall Study||31
7940996|NCT00499681|19543310|P2|NOT COMPLETED|Overall Study||2
7940997|NCT00499681|19543311|P1|NOT COMPLETED|Overall Study||0
7940998|NCT00499681|19543310|P2|COMPLETED|Overall Study||0
7940999|NCT00499681|19543311|P1|COMPLETED|Overall Study||4
7941000|NCT00499681|19543310|P2|STARTED|Overall Study||2
7941001|NCT00499681|19543311|P1|STARTED|Overall Study||4
7941002|NCT00499655|19543319|P2|NOT COMPLETED|Overall Study||0
7941003|NCT00499655|19543320|P1|NOT COMPLETED|Overall Study||0
7941004|NCT00499655|19543319|P2|COMPLETED|Overall Study||54
7941005|NCT00499655|19543320|P1|COMPLETED|Overall Study||53
7941006|NCT00499655|19543319|P2|STARTED|Overall Study||54
7941007|NCT00499655|19543320|P1|STARTED|Overall Study||53
7941008|NCT00499616|19543338|P4|NOT COMPLETED|Overall Study||57
7941009|NCT00499616|19543339|P3|NOT COMPLETED|Overall Study||36
7941010|NCT00499616|19543340|P2|NOT COMPLETED|Overall Study||28
7941011|NCT00499616|19543341|P1|NOT COMPLETED|Overall Study||15
7941012|NCT00499616|19543338|P4|COMPLETED|Overall Study||0
7941013|NCT00499616|19543339|P3|COMPLETED|Overall Study||53
7941014|NCT00499616|19543340|P2|COMPLETED|Overall Study||114
7941015|NCT00499616|19543341|P1|COMPLETED|Overall Study||161
7941016|NCT00499616|19543338|P4|STARTED|Overall Study||57
7941017|NCT00499616|19543339|P3|STARTED|Overall Study||89
7941018|NCT00499616|19543340|P2|STARTED|Overall Study||142
7941019|NCT00499616|19543341|P1|STARTED|Overall Study||176
7941020|NCT00499603|19543386|P2|NOT COMPLETED|Overall Study||1
7941021|NCT00499603|19543387|P1|NOT COMPLETED|Overall Study||0
7941022|NCT00499603|19543386|P2|COMPLETED|Overall Study||22
7941023|NCT00499603|19543387|P1|COMPLETED|Overall Study||27
7941024|NCT00499603|19543386|P2|STARTED|Overall Study||23
7941025|NCT00499603|19543387|P1|STARTED|Overall Study||27
7941026|NCT00499590|19543400|P3|NOT COMPLETED|Overall Study||113
7941027|NCT00499590|19543401|P2|NOT COMPLETED|Overall Study||112
7941028|NCT00499590|19543402|P1|NOT COMPLETED|Overall Study||113
7941029|NCT00499590|19543400|P3|COMPLETED|Overall Study||0
7941030|NCT00499590|19543401|P2|COMPLETED|Overall Study||0
7941031|NCT00499590|19543402|P1|COMPLETED|Overall Study||0
7941032|NCT00499590|19543400|P3|STARTED|Overall Study||113
7941033|NCT00499590|19543401|P2|STARTED|Overall Study||112
7941034|NCT00499590|19543402|P1|STARTED|Overall Study||113
7941035|NCT00499486|19543413|P1|NOT COMPLETED|Overall Study||16
7941036|NCT00499486|19543413|P1|COMPLETED|Overall Study||31
7941037|NCT00499486|19543413|P1|STARTED|Overall Study||47
7941038|NCT00499473|19543421|P2|NOT COMPLETED|Overall Study||0
7941039|NCT00499473|19543422|P1|NOT COMPLETED|Overall Study||6
7941040|NCT00499473|19543421|P2|COMPLETED|Overall Study||4
7941041|NCT00499473|19543422|P1|COMPLETED|Overall Study|Patients evaluable|21
7941042|NCT00499473|19543421|P2|STARTED|Overall Study||4
7941043|NCT00499473|19543422|P1|STARTED|Overall Study||27
7941044|NCT00499460|19543440|P2|NOT COMPLETED|Intervention 2 (30 Days)||1
7941045|NCT00499460|19543441|P1|NOT COMPLETED|Intervention 2 (30 Days)||0
7941046|NCT00499460|19543440|P2|COMPLETED|Intervention 2 (30 Days)||6
7941047|NCT00499460|19543441|P1|COMPLETED|Intervention 2 (30 Days)||6
7941048|NCT00499460|19543440|P2|STARTED|Intervention 2 (30 Days)||7
7941049|NCT00499460|19543441|P1|STARTED|Intervention 2 (30 Days)||6
7941050|NCT00499460|19543440|P2|NOT COMPLETED|Intervention 1 (30 Days)||0
7941051|NCT00499460|19543441|P1|NOT COMPLETED|Intervention 1 (30 Days)||2
7941052|NCT00499460|19543440|P2|COMPLETED|Intervention 1 (30 Days)||7
7941053|NCT00499460|19543441|P1|COMPLETED|Intervention 1 (30 Days)||6
7941054|NCT00499460|19543440|P2|STARTED|Intervention 1 (30 Days)||7
7941055|NCT00499460|19543441|P1|STARTED|Intervention 1 (30 Days)||8
7941056|NCT00499447|19543457|P1|NOT COMPLETED|Overall Study||0
7941057|NCT00499447|19543457|P1|COMPLETED|Overall Study||13
7941058|NCT00499447|19543457|P1|STARTED|Overall Study||13
7941059|NCT00499408|19543461|P1|NOT COMPLETED|Overall Study||0
7941060|NCT00499408|19543461|P1|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26
7941061|NCT00499408|19543461|P1|STARTED|Overall Study||26
7941062|NCT00499369|19543474|P5|NOT COMPLETED|Overall Study||12
7941063|NCT00499369|19543475|P4|NOT COMPLETED|Overall Study||9
7941064|NCT00499369|19543476|P3|NOT COMPLETED|Overall Study||17
7941065|NCT00499369|19543477|P2|NOT COMPLETED|Overall Study||18
7941066|NCT00499369|19543478|P1|NOT COMPLETED|Overall Study||16
7941067|NCT00499369|19543474|P5|COMPLETED|Overall Study||0
7941068|NCT00499369|19543475|P4|COMPLETED|Overall Study||0
7941069|NCT00499369|19543476|P3|COMPLETED|Overall Study||0
7941070|NCT00499369|19543477|P2|COMPLETED|Overall Study||0
7941071|NCT00499369|19543478|P1|COMPLETED|Overall Study||0
7941072|NCT00499369|19543474|P5|Eligible|Overall Study||12
7941073|NCT00499369|19543475|P4|Eligible|Overall Study||8
7941074|NCT00499369|19543476|P3|Eligible|Overall Study||16
7941075|NCT00499369|19543477|P2|Eligible|Overall Study||16
7941076|NCT00499369|19543478|P1|Eligible|Overall Study||14
7941077|NCT00499369|19543474|P5|STARTED|Overall Study||12
7941078|NCT00499369|19543475|P4|STARTED|Overall Study||9
7941079|NCT00499369|19543476|P3|STARTED|Overall Study||17
7941080|NCT00499369|19543477|P2|STARTED|Overall Study||18
7941081|NCT00499369|19543478|P1|STARTED|Overall Study||16
7941082|NCT00499343|19543507|P2|NOT COMPLETED|Overall Study||0
7941083|NCT00499343|19543508|P1|NOT COMPLETED|Overall Study||0
7941084|NCT00499343|19543507|P2|COMPLETED|Overall Study||43
7941085|NCT00499343|19543508|P1|COMPLETED|Overall Study||41
7941086|NCT00499343|19543507|P2|STARTED|Overall Study||43
7941087|NCT00499343|19543508|P1|STARTED|Overall Study||41
7941088|NCT00499252|19543514|P1|NOT COMPLETED|Overall Study||12
7941089|NCT00499252|19543514|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39
7941090|NCT00499252|19543514|P1|STARTED|Overall Study||51
7941091|NCT00499122|19543524|P1|NOT COMPLETED|Overall Study||2
7941092|NCT00499122|19543524|P1|COMPLETED|Overall Study||39
7941093|NCT00499122|19543524|P1|STARTED|Overall Study||41
7941094|NCT00499109|19543532|P2|NOT COMPLETED|Overall Study||7
7941095|NCT00499109|19543533|P1|NOT COMPLETED|Overall Study||18
7941096|NCT00499109|19543532|P2|COMPLETED|Overall Study||85
7941097|NCT00499109|19543533|P1|COMPLETED|Overall Study||165
7941098|NCT00499109|19543532|P2|STARTED|Overall Study||92
7941099|NCT00499109|19543533|P1|STARTED|Overall Study||183
7941100|NCT00499096|19543548|P2|NOT COMPLETED|Overall Study||20
7941101|NCT00499096|19543549|P1|NOT COMPLETED|Overall Study||23
7941102|NCT00499096|19543548|P2|COMPLETED|Overall Study||40
7941103|NCT00499096|19543549|P1|COMPLETED|Overall Study||35
7941104|NCT00499096|19543548|P2|STARTED|Overall Study||60
7941105|NCT00499096|19543549|P1|STARTED|Overall Study||58
7941106|NCT00499083|19543567|P1|NOT COMPLETED|Overall Study||3
7941107|NCT00499083|19543567|P1|COMPLETED|Overall Study||14
7941108|NCT00499083|19543567|P1|Participants at Moffitt Cancer Center|Overall Study||14
7941109|NCT00499083|19543567|P1|Participants at UNMC|Overall Study||3
7941110|NCT00499083|19543567|P1|STARTED|Overall Study||17
7941111|NCT00499031|19543574|P1|NOT COMPLETED|Overall Study||3
7941112|NCT00499031|19543574|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35
7941113|NCT00499031|19543574|P1|STARTED|Overall Study|Total number participants enrolled on study|38
7941114|NCT00498940|19543581|P2|NOT COMPLETED|Overall Study||0
7941115|NCT00498940|19543582|P1|NOT COMPLETED|Overall Study||0
7941116|NCT00498940|19543581|P2|COMPLETED|Overall Study||31
7941117|NCT00498940|19543582|P1|COMPLETED|Overall Study||30
7941118|NCT00498940|19543581|P2|STARTED|Overall Study||31
7941119|NCT00498940|19543582|P1|STARTED|Overall Study||30
7941120|NCT00498927|19543590|P1|NOT COMPLETED|Overall Study||0
7941121|NCT00498927|19543590|P1|COMPLETED|Overall Study||47
7941122|NCT00498927|19543590|P1|STARTED|Overall Study||47
7941123|NCT00498797|19543597|P2|NOT COMPLETED|Overall Study||29
7941124|NCT00498797|19543598|P1|NOT COMPLETED|Overall Study||38
7941125|NCT00498797|19543597|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
7941126|NCT00498797|19543598|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
7941127|NCT00498797|19543597|P2|STARTED|Overall Study|randomised patients|43
7941128|NCT00498797|19543598|P1|STARTED|Overall Study|randomised patients|43
7941129|NCT00498706|19543608|P2|NOT COMPLETED|Overall Study||0
7941130|NCT00498706|19543609|P1|NOT COMPLETED|Overall Study||0
7941131|NCT00498706|19543608|P2|COMPLETED|Overall Study||162
7941132|NCT00498706|19543609|P1|COMPLETED|Overall Study||163
7941133|NCT00498706|19543608|P2|Post Treatment Week 18|Overall Study||162
7941134|NCT00498706|19543609|P1|Post Treatment Week 18|Overall Study||163
7941135|NCT00498706|19543608|P2|STARTED|Overall Study||162
7941136|NCT00498706|19543609|P1|STARTED|Overall Study||163
7941137|NCT00498628|19543623|P2|NOT COMPLETED|Overall Study||21
7941138|NCT00498628|19543624|P1|NOT COMPLETED|Overall Study||15
7941139|NCT00498628|19543623|P2|COMPLETED|Overall Study||92
7941140|NCT00498628|19543624|P1|COMPLETED|Overall Study||90
7941141|NCT00498628|19543623|P2|STARTED|Overall Study||113
7941142|NCT00498628|19543624|P1|STARTED|Overall Study||105
7941143|NCT00498615|19543656|P6|NOT COMPLETED|Placebo||0
7941144|NCT00498615|19543657|P5|NOT COMPLETED|Placebo||0
7941145|NCT00498615|19543658|P4|NOT COMPLETED|Placebo||0
7941146|NCT00498615|19543659|P3|NOT COMPLETED|Placebo||0
7941147|NCT00498615|19543660|P2|NOT COMPLETED|Placebo||0
7941148|NCT00498615|19543661|P1|NOT COMPLETED|Placebo||0
7941149|NCT00498615|19543656|P6|COMPLETED|Placebo||3
7941150|NCT00498615|19543657|P5|COMPLETED|Placebo||3
7941151|NCT00498615|19543658|P4|COMPLETED|Placebo||2
7941152|NCT00498615|19543659|P3|COMPLETED|Placebo||3
7941153|NCT00498615|19543660|P2|COMPLETED|Placebo||4
7941154|NCT00498615|19543661|P1|COMPLETED|Placebo||2
7941155|NCT00498615|19543656|P6|STARTED|Placebo||3
7941156|NCT00498615|19543657|P5|STARTED|Placebo||3
7941157|NCT00498615|19543658|P4|STARTED|Placebo||2
7941158|NCT00498615|19543659|P3|STARTED|Placebo||3
7941159|NCT00498615|19543660|P2|STARTED|Placebo||4
7941160|NCT00498615|19543661|P1|STARTED|Placebo||2
7941161|NCT00498615|19543656|P6|NOT COMPLETED|Fasudil 40mg||0
7941162|NCT00498615|19543657|P5|NOT COMPLETED|Fasudil 40mg||0
7941163|NCT00498615|19543658|P4|NOT COMPLETED|Fasudil 40mg||0
7941164|NCT00498615|19543659|P3|NOT COMPLETED|Fasudil 40mg||0
7941165|NCT00498615|19543660|P2|NOT COMPLETED|Fasudil 40mg||0
7941166|NCT00498615|19543661|P1|NOT COMPLETED|Fasudil 40mg||0
7941167|NCT00498615|19543656|P6|COMPLETED|Fasudil 40mg||3
7941168|NCT00498615|19543657|P5|COMPLETED|Fasudil 40mg||3
7941169|NCT00498615|19543658|P4|COMPLETED|Fasudil 40mg||2
7941170|NCT00498615|19543659|P3|COMPLETED|Fasudil 40mg||3
7941171|NCT00498615|19543660|P2|COMPLETED|Fasudil 40mg||4
7941172|NCT00498615|19543661|P1|COMPLETED|Fasudil 40mg||2
7941173|NCT00498615|19543656|P6|STARTED|Fasudil 40mg||3
7941174|NCT00498615|19543657|P5|STARTED|Fasudil 40mg||3
7941175|NCT00498615|19543658|P4|STARTED|Fasudil 40mg||2
7941176|NCT00498615|19543659|P3|STARTED|Fasudil 40mg||3
7941177|NCT00498615|19543660|P2|STARTED|Fasudil 40mg||4
7941178|NCT00498615|19543661|P1|STARTED|Fasudil 40mg||2
7941179|NCT00498615|19543656|P6|NOT COMPLETED|Fasudil 80mg||0
7941180|NCT00498615|19543657|P5|NOT COMPLETED|Fasudil 80mg||0
7941181|NCT00498615|19543658|P4|NOT COMPLETED|Fasudil 80mg||0
7941182|NCT00498615|19543659|P3|NOT COMPLETED|Fasudil 80mg||0
7941183|NCT00498615|19543660|P2|NOT COMPLETED|Fasudil 80mg||0
7941184|NCT00498615|19543661|P1|NOT COMPLETED|Fasudil 80mg||0
7941185|NCT00498615|19543656|P6|COMPLETED|Fasudil 80mg||3
7941186|NCT00498615|19543657|P5|COMPLETED|Fasudil 80mg||3
7941187|NCT00498615|19543658|P4|COMPLETED|Fasudil 80mg||2
7941188|NCT00498615|19543659|P3|COMPLETED|Fasudil 80mg||3
7941189|NCT00498615|19543660|P2|COMPLETED|Fasudil 80mg||4
7941190|NCT00498615|19543661|P1|COMPLETED|Fasudil 80mg||2
7941191|NCT00498615|19543656|P6|STARTED|Fasudil 80mg||3
7941192|NCT00498615|19543657|P5|STARTED|Fasudil 80mg||3
7941193|NCT00498615|19543658|P4|STARTED|Fasudil 80mg||2
7941194|NCT00498615|19543659|P3|STARTED|Fasudil 80mg||3
7941195|NCT00498615|19543660|P2|STARTED|Fasudil 80mg||4
7941196|NCT00498615|19543661|P1|STARTED|Fasudil 80mg||2
7941197|NCT00498602|19543682|P7|NOT COMPLETED|Overall Study||2
7941198|NCT00498602|19543683|P6|NOT COMPLETED|Overall Study||13
7941199|NCT00498602|19543684|P5|NOT COMPLETED|Overall Study||4
7941200|NCT00498602|19543685|P4|NOT COMPLETED|Overall Study||5
7941201|NCT00498602|19543686|P3|NOT COMPLETED|Overall Study||8
7941202|NCT00498602|19543687|P2|NOT COMPLETED|Overall Study||10
7941203|NCT00498602|19543688|P1|NOT COMPLETED|Overall Study||10
7941204|NCT00498602|19543682|P7|COMPLETED|Overall Study||15
7941205|NCT00498602|19543683|P6|COMPLETED|Overall Study||31
7941206|NCT00498602|19543684|P5|COMPLETED|Overall Study||8
7941207|NCT00498602|19543685|P4|COMPLETED|Overall Study||30
7941208|NCT00498602|19543686|P3|COMPLETED|Overall Study||32
7941209|NCT00498602|19543687|P2|COMPLETED|Overall Study||51
7941210|NCT00498602|19543688|P1|COMPLETED|Overall Study||26
7941211|NCT00498602|19543682|P7|Treated|Overall Study||17
7941212|NCT00498602|19543683|P6|Treated|Overall Study||44
7941213|NCT00498602|19543684|P5|Treated|Overall Study||12
7941214|NCT00498602|19543685|P4|Treated|Overall Study||35
7941215|NCT00498602|19543686|P3|Treated|Overall Study||40
7941216|NCT00498602|19543687|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
7941217|NCT00498602|19543688|P1|Treated|Overall Study||36
7941218|NCT00498602|19543682|P7|STARTED|Overall Study||17
7941219|NCT00498602|19543683|P6|STARTED|Overall Study||44
7941220|NCT00498602|19543684|P5|STARTED|Overall Study||12
7941221|NCT00498602|19543685|P4|STARTED|Overall Study||35
7941222|NCT00498602|19543686|P3|STARTED|Overall Study||40
7941223|NCT00498602|19543687|P2|STARTED|Overall Study||61
7941224|NCT00498602|19543688|P1|STARTED|Overall Study||36
7941225|NCT00498550|19543727|P2|NOT COMPLETED|Overall Study||1
7941226|NCT00498550|19543728|P1|NOT COMPLETED|Overall Study||0
7941227|NCT00498550|19543727|P2|COMPLETED|Overall Study||15
7941228|NCT00498550|19543728|P1|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15
7941229|NCT00498550|19543727|P2|STARTED|Overall Study||16
7941230|NCT00498550|19543728|P1|STARTED|Overall Study||15
7941231|NCT00498485|19543736|P2|NOT COMPLETED|Overall Study||5
7941232|NCT00498485|19543737|P1|NOT COMPLETED|Overall Study||1
7941233|NCT00498485|19543736|P2|COMPLETED|Overall Study||5
7941234|NCT00498485|19543737|P1|COMPLETED|Overall Study||6
7941235|NCT00498485|19543736|P2|STARTED|Overall Study||10
7941236|NCT00498485|19543737|P1|STARTED|Overall Study||7
7941237|NCT00498433|19543748|P3|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
7941238|NCT00498433|19543749|P2|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
7941239|NCT00498433|19543750|P1|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
7941240|NCT00498433|19543748|P3|COMPLETED|Part 2: Double Blind (12 Weeks)||8
7941241|NCT00498433|19543749|P2|COMPLETED|Part 2: Double Blind (12 Weeks)||8
7941242|NCT00498433|19543750|P1|COMPLETED|Part 2: Double Blind (12 Weeks)||0
7941243|NCT00498433|19543748|P3|STARTED|Part 2: Double Blind (12 Weeks)||8
7941244|NCT00498433|19543749|P2|STARTED|Part 2: Double Blind (12 Weeks)||8
7941245|NCT00498433|19543750|P1|STARTED|Part 2: Double Blind (12 Weeks)||0
7941246|NCT00498433|19543748|P3|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
7941247|NCT00498433|19543749|P2|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
7941248|NCT00498433|19543750|P1|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20
7941249|NCT00498433|19543748|P3|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
7941250|NCT00498433|19543749|P2|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
7941251|NCT00498433|19543750|P1|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16
7941252|NCT00498433|19543748|P3|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
7941253|NCT00498433|19543749|P2|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
7941254|NCT00498433|19543750|P1|STARTED|Part 2: Placebo Run-in (2 Weeks)||36
7941255|NCT00498433|19543748|P3|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
7941256|NCT00498433|19543749|P2|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
7941257|NCT00498433|19543750|P1|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
7941258|NCT00498433|19543748|P3|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
7941259|NCT00498433|19543749|P2|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
7941260|NCT00498433|19543750|P1|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
7941261|NCT00498433|19543748|P3|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
7941262|NCT00498433|19543749|P2|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
7941263|NCT00498433|19543750|P1|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
7941264|NCT00498433|19543748|P3|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
7941265|NCT00498433|19543749|P2|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
7941266|NCT00498433|19543750|P1|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
7941267|NCT00498433|19543748|P3|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
7941268|NCT00498433|19543749|P2|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10
7941269|NCT00498433|19543750|P1|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
7941270|NCT00498433|19543748|P3|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
7941271|NCT00498433|19543749|P2|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10
7941272|NCT00498433|19543750|P1|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
7941273|NCT00498433|19543748|P3|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
7941274|NCT00498433|19543749|P2|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
7941275|NCT00498433|19543750|P1|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
7941276|NCT00498433|19543748|P3|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
7941277|NCT00498433|19543749|P2|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
7941278|NCT00498433|19543750|P1|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
7941279|NCT00498433|19543748|P3|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
7941280|NCT00498433|19543749|P2|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
7941281|NCT00498433|19543750|P1|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
7941282|NCT00498368|19543795|P2|NOT COMPLETED|Overall Study||2
7941283|NCT00498368|19543796|P1|NOT COMPLETED|Overall Study||3
7941284|NCT00498368|19543795|P2|COMPLETED|Overall Study||15
7941285|NCT00498368|19543796|P1|COMPLETED|Overall Study||14
7941286|NCT00498368|19543795|P2|STARTED|Overall Study||17
7941287|NCT00498368|19543796|P1|STARTED|Overall Study||17
7941288|NCT00498355|19543808|P1|NOT COMPLETED|Overall Study||1
7941289|NCT00498355|19543808|P1|COMPLETED|Overall Study||6
7941290|NCT00498355|19543808|P1|STARTED|Overall Study||7
7941291|NCT00498186|19543816|P1|NOT COMPLETED|Overall Study||173
7941292|NCT00498186|19543816|P1|COMPLETED|Overall Study||122
7941293|NCT00498186|19543816|P1|STARTED|Overall Study||295
7941294|NCT00498173|19543823|P3|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
7941295|NCT00498173|19543824|P2|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
7941296|NCT00498173|19543825|P1|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
7941297|NCT00498173|19543823|P3|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
7941298|NCT00498173|19543824|P2|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
7941299|NCT00498173|19543825|P1|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
7941300|NCT00498173|19543823|P3|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
7941301|NCT00498173|19543824|P2|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
7941302|NCT00498173|19543825|P1|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
7941303|NCT00498173|19543823|P3|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
7941304|NCT00498173|19543824|P2|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||1
7941305|NCT00498173|19543825|P1|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||2
7941306|NCT00498173|19543823|P3|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
7941307|NCT00498173|19543824|P2|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||30
7941308|NCT00498173|19543825|P1|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||27
7941309|NCT00498173|19543823|P3|STARTED|Phase 1-Blinded Randomization (8 Weeks)||0
7941310|NCT00498173|19543824|P2|STARTED|Phase 1-Blinded Randomization (8 Weeks)||31
7941311|NCT00498173|19543825|P1|STARTED|Phase 1-Blinded Randomization (8 Weeks)||29
7941312|NCT00497874|19543855|P2|NOT COMPLETED|Overall Study||116
7941313|NCT00497874|19543856|P1|NOT COMPLETED|Overall Study||147
7941314|NCT00497874|19543855|P2|COMPLETED|Overall Study||343
7941315|NCT00497874|19543856|P1|COMPLETED|Overall Study||296
7941316|NCT00497874|19543855|P2|STARTED|Overall Study||459
7941317|NCT00497874|19543856|P1|STARTED|Overall Study||443
7941318|NCT00497796|19543874|P2|NOT COMPLETED|Overall Study||59
7941319|NCT00497796|19543875|P1|NOT COMPLETED|Overall Study||85
7941320|NCT00497796|19543874|P2|COMPLETED|Overall Study||101
7941321|NCT00497796|19543875|P1|COMPLETED|Overall Study||62
7941322|NCT00497796|19543874|P2|STARTED|Overall Study||160
7941323|NCT00497796|19543875|P1|STARTED|Overall Study||147
7941324|NCT00497770|19543907|P4|NOT COMPLETED|Overall Study||0
7941325|NCT00497770|19543908|P3|NOT COMPLETED|Overall Study||0
7941326|NCT00497770|19543909|P2|NOT COMPLETED|Overall Study||0
7941327|NCT00497770|19543910|P1|NOT COMPLETED|Overall Study||0
7941328|NCT00497770|19543907|P4|COMPLETED|Overall Study||28
7941329|NCT00497770|19543908|P3|COMPLETED|Overall Study||37
7941330|NCT00497770|19543909|P2|COMPLETED|Overall Study||65
7941331|NCT00497770|19543910|P1|COMPLETED|Overall Study||304
7941332|NCT00497770|19543907|P4|STARTED|Overall Study||28
7941333|NCT00497770|19543908|P3|STARTED|Overall Study||37
7941334|NCT00497770|19543909|P2|STARTED|Overall Study||65
7941335|NCT00497770|19543910|P1|STARTED|Overall Study||304
7941336|NCT00497198|19543962|P2|NOT COMPLETED|Overall Study||5
7941337|NCT00497198|19543963|P1|NOT COMPLETED|Overall Study||5
7941338|NCT00497198|19543962|P2|COMPLETED|Overall Study||86
7941339|NCT00497198|19543963|P1|COMPLETED|Overall Study||87
7941340|NCT00497198|19543962|P2|STARTED|Overall Study||91
7941341|NCT00497198|19543963|P1|STARTED|Overall Study||92
7941342|NCT00497146|19543979|P2|NOT COMPLETED|Long-term Follow-up Period||6
7941343|NCT00497146|19543980|P1|NOT COMPLETED|Long-term Follow-up Period||15
7941344|NCT00497146|19543979|P2|COMPLETED|Long-term Follow-up Period||66
7941345|NCT00497146|19543980|P1|COMPLETED|Long-term Follow-up Period||50
7941346|NCT00497146|19543979|P2|STARTED|Long-term Follow-up Period||72
7941347|NCT00497146|19543980|P1|STARTED|Long-term Follow-up Period||65
7941348|NCT00497146|19543979|P2|NOT COMPLETED|Treatment Period||21
7941349|NCT00497146|19543980|P1|NOT COMPLETED|Treatment Period||27
7941350|NCT00497146|19543979|P2|COMPLETED|Treatment Period||91
7941351|NCT00497146|19543980|P1|COMPLETED|Treatment Period||88
7941352|NCT00497146|19543979|P2|STARTED|Treatment Period||112
7941353|NCT00497146|19543980|P1|STARTED|Treatment Period||115
7941354|NCT00497081|19544022|P2|NOT COMPLETED|Overall Study||2
7941355|NCT00497081|19544023|P1|NOT COMPLETED|Overall Study||2
7941356|NCT00497081|19544022|P2|COMPLETED|Overall Study||28
7941357|NCT00497081|19544023|P1|COMPLETED|Overall Study||28
7941358|NCT00497081|19544022|P2|STARTED|Overall Study||30
7941359|NCT00497081|19544023|P1|STARTED|Overall Study||30
7941360|NCT00497055|19544035|P2|NOT COMPLETED|Overall Study||5
7941361|NCT00497055|19544036|P1|NOT COMPLETED|Overall Study||10
7941362|NCT00497055|19544035|P2|COMPLETED|Overall Study||40
7941363|NCT00497055|19544036|P1|COMPLETED|Overall Study||35
7941364|NCT00497055|19544035|P2|STARTED|Overall Study||45
7941365|NCT00497055|19544036|P1|STARTED|Overall Study||45
7941366|NCT00496964|19544048|P2|NOT COMPLETED|Overall Study||1
7941367|NCT00496964|19544049|P1|NOT COMPLETED|Overall Study||0
7941368|NCT00496964|19544048|P2|COMPLETED|Overall Study||3
7941369|NCT00496964|19544049|P1|COMPLETED|Overall Study||1
7941370|NCT00496964|19544048|P2|STARTED|Overall Study||4
7941371|NCT00496964|19544049|P1|STARTED|Overall Study||1
7941372|NCT00496873|19544067|P1|NOT COMPLETED|Overall Study||7
7941373|NCT00496873|19544067|P1|COMPLETED|Overall Study||78
7941374|NCT00496873|19544067|P1|STARTED|Overall Study||85
7941375|NCT00496860|19544076|P3|NOT COMPLETED|Overall Study||0
7941376|NCT00496860|19544077|P2|NOT COMPLETED|Overall Study||1
7941377|NCT00496860|19544078|P1|NOT COMPLETED|Overall Study||1
7941378|NCT00496860|19544076|P3|COMPLETED|Overall Study||6
7941379|NCT00496860|19544077|P2|COMPLETED|Overall Study||15
7941380|NCT00496860|19544078|P1|COMPLETED|Overall Study||3
7941381|NCT00496860|19544076|P3|STARTED|Overall Study||6
7941382|NCT00496860|19544077|P2|STARTED|Overall Study||16
7941383|NCT00496860|19544078|P1|STARTED|Overall Study||4
7941384|NCT00496834|19544100|P2|NOT COMPLETED|Overall Study||13
7941385|NCT00496834|19544101|P1|NOT COMPLETED|Overall Study||18
7941386|NCT00496834|19544100|P2|COMPLETED|Overall Study||87
7941387|NCT00496834|19544101|P1|COMPLETED|Overall Study||83
7941388|NCT00496834|19544100|P2|STARTED|Overall Study||100
7941389|NCT00496834|19544101|P1|STARTED|Overall Study||101
7941390|NCT00496808|19544113|P1|NOT COMPLETED|Overall Study||0
7941391|NCT00496808|19544113|P1|COMPLETED|Overall Study||69
7941392|NCT00496808|19544113|P1|STARTED|Overall Study||69
7941393|NCT00496782|19544120|P2|NOT COMPLETED|Overall Study||2
7941394|NCT00496782|19544121|P1|NOT COMPLETED|Overall Study||1
7941395|NCT00496782|19544120|P2|COMPLETED|Overall Study||5
7941396|NCT00496782|19544121|P1|COMPLETED|Overall Study||8
7941397|NCT00496782|19544120|P2|STARTED|Overall Study||7
7941398|NCT00496782|19544121|P1|STARTED|Overall Study||9
7941399|NCT00496769|19544155|P3|NOT COMPLETED|Open Label||1011
7941400|NCT00496769|19544156|P2|NOT COMPLETED|Open Label||0
7941401|NCT00496769|19544157|P1|NOT COMPLETED|Open Label||0
7941402|NCT00496769|19544155|P3|COMPLETED|Open Label||2264
7941403|NCT00496769|19544156|P2|COMPLETED|Open Label||0
7941404|NCT00496769|19544157|P1|COMPLETED|Open Label||0
7941405|NCT00496769|19544155|P3|STARTED|Open Label||3275
7941406|NCT00496769|19544156|P2|STARTED|Open Label||0
7941407|NCT00496769|19544157|P1|STARTED|Open Label||0
7941408|NCT00496769|19544155|P3|NOT COMPLETED|Double Blind||0
7941409|NCT00496769|19544156|P2|NOT COMPLETED|Double Blind||649
7941410|NCT00496769|19544157|P1|NOT COMPLETED|Double Blind||558
7941411|NCT00496769|19544155|P3|COMPLETED|Double Blind||0
7941412|NCT00496769|19544156|P2|COMPLETED|Double Blind||2142
7941413|NCT00496769|19544157|P1|COMPLETED|Double Blind||2249
7941414|NCT00496769|19544155|P3|Received Treatment|Double Blind||0
7941415|NCT00496769|19544156|P2|Received Treatment|Double Blind||2708
7941416|NCT00496769|19544157|P1|Received Treatment|Double Blind||2798
7941417|NCT00496769|19544155|P3|STARTED|Double Blind||0
7941418|NCT00496769|19544156|P2|STARTED|Double Blind|Randomized|2791
7941419|NCT00496769|19544157|P1|STARTED|Double Blind|Randomized|2807
7941420|NCT00496756|19544180|P1|NOT COMPLETED|Overall Study||3
7941421|NCT00496756|19544180|P1|COMPLETED|Overall Study||11
7941422|NCT00496756|19544180|P1|STARTED|Overall Study||14
7941423|NCT00496730|19544187|P2|NOT COMPLETED|Overall Study||5
7941424|NCT00496730|19544188|P1|NOT COMPLETED|Overall Study||6
7941425|NCT00496730|19544187|P2|COMPLETED|Overall Study||121
7941426|NCT00496730|19544188|P1|COMPLETED|Overall Study||124
7941427|NCT00496730|19544187|P2|STARTED|Overall Study||126
7941428|NCT00496730|19544188|P1|STARTED|Overall Study||130
7941429|NCT00496626|19544200|P2|NOT COMPLETED|Overall Study||6
7941430|NCT00496626|19544201|P1|NOT COMPLETED|Overall Study||6
7941431|NCT00496626|19544200|P2|COMPLETED|Overall Study||292
7941432|NCT00496626|19544201|P1|COMPLETED|Overall Study||296
7941433|NCT00496626|19544200|P2|STARTED|Overall Study||298
7941434|NCT00496626|19544201|P1|STARTED|Overall Study||302
7941435|NCT00496587|19544213|P1|NOT COMPLETED|Overall Study||31
7941436|NCT00496587|19544213|P1|COMPLETED|Overall Study||3
7941437|NCT00496587|19544213|P1|STARTED|Overall Study||34
7941438|NCT00496483|19544219|P1|NOT COMPLETED|Overall Study||12
7941439|NCT00496483|19544219|P1|COMPLETED|Overall Study||48
7941440|NCT00496483|19544219|P1|Dosed|Overall Study||51
7941441|NCT00496483|19544219|P1|STARTED|Overall Study||60
7941442|NCT00496470|19544236|P2|NOT COMPLETED|Overall Study||29
7941443|NCT00496470|19544237|P1|NOT COMPLETED|Overall Study||26
7941444|NCT00496470|19544236|P2|COMPLETED|Overall Study||302
7941445|NCT00496470|19544237|P1|COMPLETED|Overall Study||303
7941446|NCT00496470|19544236|P2|Received Study Medication|Overall Study||330
7941447|NCT00496470|19544237|P1|Received Study Medication|Overall Study||329
7941448|NCT00496470|19544236|P2|STARTED|Overall Study||331
7941449|NCT00496470|19544237|P1|STARTED|Overall Study||329
7941450|NCT00496379|19544315|P1|NOT COMPLETED|Overall Study||0
7941451|NCT00496379|19544315|P1|COMPLETED|Overall Study||15
7941452|NCT00496379|19544315|P1|STARTED|Overall Study||15
7941453|NCT00496366|19544323|P1|NOT COMPLETED|Overall Study||1
7941454|NCT00496366|19544323|P1|COMPLETED|Overall Study||10
7941455|NCT00496366|19544323|P1|STARTED|Overall Study||11
7941456|NCT00496340|19544328|P1|NOT COMPLETED|Overall Study||0
7941457|NCT00496340|19544328|P1|COMPLETED|Overall Study||42
7941458|NCT00496340|19544328|P1|STARTED|Overall Study||42
7941459|NCT00496262|19544341|P1|NOT COMPLETED|Overall Study||0
7941460|NCT00496262|19544341|P1|COMPLETED|Overall Study||15
7941461|NCT00496262|19544341|P1|STARTED|Overall Study||15
7941462|NCT00496197|19544354|P1|NOT COMPLETED|Overall Study||122
7941463|NCT00496197|19544354|P1|COMPLETED|Overall Study||160
7941464|NCT00496197|19544354|P1|STARTED|Overall Study||282
7941465|NCT00496080|19544381|P1|NOT COMPLETED|Overall Study||27
7941466|NCT00496080|19544381|P1|COMPLETED|Overall Study||60
7941467|NCT00496080|19544381|P1|STARTED|Overall Study||87
7941468|NCT00496054|19544391|P1|NOT COMPLETED|Overall Study||8
7941469|NCT00496054|19544391|P1|COMPLETED|Overall Study||102
7941470|NCT00496054|19544391|P1|STARTED|Overall Study||110
7941471|NCT00496015|19544423|P5|NOT COMPLETED|Overall Study||0
7941472|NCT00496015|19544424|P4|NOT COMPLETED|Overall Study||1
7941473|NCT00496015|19544425|P3|NOT COMPLETED|Overall Study||0
7941474|NCT00496015|19544426|P2|NOT COMPLETED|Overall Study||0
7941475|NCT00496015|19544427|P1|NOT COMPLETED|Overall Study||1
7941476|NCT00496015|19544423|P5|COMPLETED|Overall Study||336
7941477|NCT00496015|19544424|P4|COMPLETED|Overall Study||36
7941478|NCT00496015|19544425|P3|COMPLETED|Overall Study||172
7941479|NCT00496015|19544426|P2|COMPLETED|Overall Study||27
7941480|NCT00496015|19544427|P1|COMPLETED|Overall Study||177
7941481|NCT00496015|19544423|P5|STARTED|Overall Study||336
7941482|NCT00496015|19544424|P4|STARTED|Overall Study||37
7941483|NCT00496015|19544425|P3|STARTED|Overall Study||172
7941484|NCT00496015|19544426|P2|STARTED|Overall Study||27
7941485|NCT00496015|19544427|P1|STARTED|Overall Study||178
7941486|NCT00495820|19544551|P2|NOT COMPLETED|Overall Study||1
7941487|NCT00495820|19544552|P1|NOT COMPLETED|Overall Study||1
7941488|NCT00495820|19544551|P2|COMPLETED|Overall Study||29
7941489|NCT00495820|19544552|P1|COMPLETED|Overall Study||29
7941490|NCT00495820|19544551|P2|STARTED|Overall Study||30
7941491|NCT00495820|19544552|P1|STARTED|Overall Study||30
7941492|NCT00495794|19544564|P2|NOT COMPLETED|Overall Study||0
7941493|NCT00495794|19544565|P1|NOT COMPLETED|Overall Study||522
7941494|NCT00495794|19544564|P2|COMPLETED|Overall Study||2303
7941495|NCT00495794|19544565|P1|COMPLETED|Overall Study||1797
7941496|NCT00495794|19544564|P2|STARTED|Overall Study||2303
7941497|NCT00495794|19544565|P1|STARTED|Overall Study||2319
7941498|NCT00495755|19544575|P1|NOT COMPLETED|Overall Study||3
7941499|NCT00495755|19544575|P1|COMPLETED|Overall Study||10
7941500|NCT00495755|19544575|P1|STARTED|Overall Study||13
7941501|NCT00495716|19544582|P2|NOT COMPLETED|Overall Study||13
7941502|NCT00495716|19544583|P1|NOT COMPLETED|Overall Study||15
7941503|NCT00495716|19544582|P2|COMPLETED|Overall Study||24
7941504|NCT00495716|19544583|P1|COMPLETED|Overall Study||20
7941505|NCT00495716|19544582|P2|STARTED|Overall Study||37
7941506|NCT00495716|19544583|P1|STARTED|Overall Study||35
7941507|NCT00495677|19544596|P7|NOT COMPLETED|Stage 2 (25 Days)||0
7941508|NCT00495677|19544597|P6|NOT COMPLETED|Stage 2 (25 Days)||0
7941509|NCT00495677|19544598|P5|NOT COMPLETED|Stage 2 (25 Days)||0
7941510|NCT00495677|19544599|P4|NOT COMPLETED|Stage 2 (25 Days)||0
7941511|NCT00495677|19544600|P3|NOT COMPLETED|Stage 2 (25 Days)||0
7941512|NCT00495677|19544601|P2|NOT COMPLETED|Stage 2 (25 Days)||0
7941513|NCT00495677|19544602|P1|NOT COMPLETED|Stage 2 (25 Days)||0
7941514|NCT00495677|19544596|P7|COMPLETED|Stage 2 (25 Days)||7
7941515|NCT00495677|19544597|P6|COMPLETED|Stage 2 (25 Days)||8
7941516|NCT00495677|19544598|P5|COMPLETED|Stage 2 (25 Days)||8
7941517|NCT00495677|19544599|P4|COMPLETED|Stage 2 (25 Days)||0
7941518|NCT00495677|19544600|P3|COMPLETED|Stage 2 (25 Days)||0
7941519|NCT00495677|19544601|P2|COMPLETED|Stage 2 (25 Days)||0
7941520|NCT00495677|19544602|P1|COMPLETED|Stage 2 (25 Days)||0
7941521|NCT00495677|19544596|P7|STARTED|Stage 2 (25 Days)||7
7941522|NCT00495677|19544597|P6|STARTED|Stage 2 (25 Days)||8
7941523|NCT00495677|19544598|P5|STARTED|Stage 2 (25 Days)||8
7941524|NCT00495677|19544599|P4|STARTED|Stage 2 (25 Days)||0
7941525|NCT00495677|19544600|P3|STARTED|Stage 2 (25 Days)||0
7941526|NCT00495677|19544601|P2|STARTED|Stage 2 (25 Days)||0
7941527|NCT00495677|19544602|P1|STARTED|Stage 2 (25 Days)||0
7941528|NCT00495677|19544596|P7|NOT COMPLETED|Stage 1 (25 Days)||0
7941529|NCT00495677|19544597|P6|NOT COMPLETED|Stage 1 (25 Days)||0
7941530|NCT00495677|19544598|P5|NOT COMPLETED|Stage 1 (25 Days)||0
7941531|NCT00495677|19544599|P4|NOT COMPLETED|Stage 1 (25 Days)||0
7941532|NCT00495677|19544600|P3|NOT COMPLETED|Stage 1 (25 Days)||1
7941533|NCT00495677|19544601|P2|NOT COMPLETED|Stage 1 (25 Days)||0
7941534|NCT00495677|19544602|P1|NOT COMPLETED|Stage 1 (25 Days)||0
7941535|NCT00495677|19544596|P7|COMPLETED|Stage 1 (25 Days)||0
7941536|NCT00495677|19544597|P6|COMPLETED|Stage 1 (25 Days)||0
7941537|NCT00495677|19544598|P5|COMPLETED|Stage 1 (25 Days)||0
7941538|NCT00495677|19544599|P4|COMPLETED|Stage 1 (25 Days)||6
7941539|NCT00495677|19544600|P3|COMPLETED|Stage 1 (25 Days)||5
7941540|NCT00495677|19544601|P2|COMPLETED|Stage 1 (25 Days)||6
7941541|NCT00495677|19544602|P1|COMPLETED|Stage 1 (25 Days)||2
7941542|NCT00495677|19544596|P7|STARTED|Stage 1 (25 Days)||0
7941543|NCT00495677|19544597|P6|STARTED|Stage 1 (25 Days)||0
7941544|NCT00495677|19544598|P5|STARTED|Stage 1 (25 Days)||0
7941545|NCT00495677|19544599|P4|STARTED|Stage 1 (25 Days)||6
7941546|NCT00495677|19544600|P3|STARTED|Stage 1 (25 Days)||6
7941547|NCT00495677|19544601|P2|STARTED|Stage 1 (25 Days)||6
7941548|NCT00495677|19544602|P1|STARTED|Stage 1 (25 Days)||2
7941549|NCT00495625|19544657|P1|NOT COMPLETED|Overall Study||10
7941550|NCT00495625|19544657|P1|COMPLETED|Overall Study||23
7941551|NCT00495625|19544657|P1|STARTED|Overall Study||33
7941552|NCT00495612|19544668|P2|NOT COMPLETED|Overall Study||0
7941553|NCT00495612|19544669|P1|NOT COMPLETED|Overall Study||4
7941554|NCT00495612|19544668|P2|COMPLETED|Overall Study||33
7941555|NCT00495612|19544669|P1|COMPLETED|Overall Study||32
7941556|NCT00495612|19544668|P2|STARTED|Overall Study||33
7941557|NCT00495612|19544669|P1|STARTED|Overall Study||36
7941558|NCT00495586|19544687|P2|NOT COMPLETED|Overall Study||4
7941559|NCT00495586|19544688|P1|NOT COMPLETED|Overall Study||4
7941560|NCT00495586|19544687|P2|COMPLETED|Overall Study||158
7941561|NCT00495586|19544688|P1|COMPLETED|Overall Study||152
7941562|NCT00495586|19544687|P2|STARTED|Overall Study||162
7941563|NCT00495586|19544688|P1|STARTED|Overall Study||156
7941564|NCT00495521|19544698|P2|NOT COMPLETED|Overall Study||1
7941565|NCT00495521|19544699|P1|NOT COMPLETED|Overall Study||0
7941566|NCT00495521|19544698|P2|COMPLETED|Overall Study||0
7941567|NCT00495521|19544699|P1|COMPLETED|Overall Study||1
7941568|NCT00495521|19544698|P2|STARTED|Overall Study||1
7941569|NCT00495521|19544699|P1|STARTED|Overall Study||1
7941570|NCT00495495|19544729|P1|NOT COMPLETED|Overall Study||99
7941571|NCT00495495|19544729|P1|COMPLETED|Overall Study||295
7941572|NCT00495495|19544729|P1|STARTED|Overall Study||394
7941573|NCT00495469|19544749|P7|NOT COMPLETED|Overall Study||5
7941574|NCT00495469|19544750|P6|NOT COMPLETED|Overall Study||5
7941575|NCT00495469|19544751|P5|NOT COMPLETED|Overall Study||5
7941576|NCT00495469|19544752|P4|NOT COMPLETED|Overall Study||4
7941577|NCT00495469|19544753|P3|NOT COMPLETED|Overall Study||7
7941578|NCT00495469|19544754|P2|NOT COMPLETED|Overall Study||7
7941579|NCT00495469|19544755|P1|NOT COMPLETED|Overall Study||6
7941580|NCT00495469|19544749|P7|COMPLETED|Overall Study||30
7941581|NCT00495469|19544750|P6|COMPLETED|Overall Study||31
7941582|NCT00495469|19544751|P5|COMPLETED|Overall Study||31
7941583|NCT00495469|19544752|P4|COMPLETED|Overall Study||32
7941584|NCT00495469|19544753|P3|COMPLETED|Overall Study||27
7941585|NCT00495469|19544754|P2|COMPLETED|Overall Study||30
7941586|NCT00495469|19544755|P1|COMPLETED|Overall Study||30
7941587|NCT00495469|19544749|P7|STARTED|Overall Study||35
7941588|NCT00495469|19544750|P6|STARTED|Overall Study||36
7941589|NCT00495469|19544751|P5|STARTED|Overall Study||36
7941590|NCT00495469|19544752|P4|STARTED|Overall Study||36
7941591|NCT00495469|19544753|P3|STARTED|Overall Study||34
7941592|NCT00495469|19544754|P2|STARTED|Overall Study||37
7941593|NCT00495469|19544755|P1|STARTED|Overall Study||36
7941594|NCT00495391|19544899|P2|NOT COMPLETED|Overall Study||21
7941595|NCT00495391|19544900|P1|NOT COMPLETED|Overall Study||36
7941596|NCT00495391|19544899|P2|COMPLETED|Overall Study||1
7941597|NCT00495391|19544900|P1|COMPLETED|Overall Study||6
7941598|NCT00495391|19544899|P2|From Baseline to End of Follow up|Overall Study||1
7941599|NCT00495391|19544900|P1|From Baseline to End of Follow up|Overall Study||6
7941600|NCT00495391|19544899|P2|From Baseline to End of Treatment|Overall Study||1
7941601|NCT00495391|19544900|P1|From Baseline to End of Treatment|Overall Study||6
7941602|NCT00495391|19544899|P2|From Baseline to Week 16|Overall Study||11
7941603|NCT00495391|19544900|P1|From Baseline to Week 16|Overall Study||24
7941604|NCT00495391|19544899|P2|From Baseline to Week 8|Overall Study||20
7941605|NCT00495391|19544900|P1|From Baseline to Week 8|Overall Study||31
7941606|NCT00495391|19544899|P2|STARTED|Overall Study||22
7941607|NCT00495391|19544900|P1|STARTED|Overall Study||42
7941608|NCT00495222|19544920|P1|NOT COMPLETED|Overall Study||0
7941609|NCT00495222|19544920|P1|COMPLETED|Overall Study||9
7941610|NCT00495222|19544920|P1|STARTED|Overall Study||9
7941611|NCT00495170|19544923|P1|NOT COMPLETED|Overall Study||20
7941612|NCT00495170|19544923|P1|COMPLETED|Overall Study||64
7941613|NCT00495170|19544923|P1|STARTED|Overall Study||84
7941614|NCT00495157|19544930|P3|NOT COMPLETED|Overall Study||13
7941615|NCT00495157|19544931|P2|NOT COMPLETED|Overall Study||23
7941616|NCT00495157|19544932|P1|NOT COMPLETED|Overall Study||16
7941617|NCT00495157|19544930|P3|COMPLETED|Overall Study||101
7941618|NCT00495157|19544931|P2|COMPLETED|Overall Study||92
7941619|NCT00495157|19544932|P1|COMPLETED|Overall Study||97
7941620|NCT00495157|19544930|P3|STARTED|Overall Study||114
7941621|NCT00495157|19544931|P2|STARTED|Overall Study||115
7941622|NCT00495157|19544932|P1|STARTED|Overall Study||113
7941623|NCT00495131|19544942|P2|NOT COMPLETED|Overall Study||6
7941624|NCT00495131|19544943|P1|NOT COMPLETED|Overall Study||7
7941625|NCT00495131|19544942|P2|COMPLETED|Overall Study||148
7941626|NCT00495131|19544943|P1|COMPLETED|Overall Study||147
7941627|NCT00495131|19544942|P2|STARTED|Overall Study||154
7941628|NCT00495131|19544943|P1|STARTED|Overall Study||154
7941629|NCT00495079|19544953|P1|NOT COMPLETED|Overall Study||0
7941630|NCT00495079|19544953|P1|COMPLETED|Overall Study||65
7941631|NCT00495079|19544953|P1|STARTED|Overall Study||65
7941632|NCT00495040|19544960|P1|NOT COMPLETED|Overall Study||3
7941633|NCT00495040|19544960|P1|COMPLETED|Overall Study||35
7941634|NCT00495040|19544960|P1|STARTED|Overall Study||38
7941635|NCT00494975|19544966|P2|NOT COMPLETED|Overall Study||1
7941636|NCT00494975|19544967|P1|NOT COMPLETED|Overall Study||2
7941637|NCT00494975|19544966|P2|COMPLETED|Overall Study||10
7941638|NCT00494975|19544967|P1|COMPLETED|Overall Study||8
7941639|NCT00494975|19544966|P2|STARTED|Overall Study||11
7941640|NCT00494975|19544967|P1|STARTED|Overall Study||10
7941641|NCT00494871|19544975|P2|NOT COMPLETED|Follow-up (FU) Period||23
7941642|NCT00494871|19544976|P1|NOT COMPLETED|Follow-up (FU) Period||29
7941643|NCT00494871|19544975|P2|COMPLETED|Follow-up (FU) Period||616
7941644|NCT00494871|19544976|P1|COMPLETED|Follow-up (FU) Period||610
7941645|NCT00494871|19544975|P2|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630
7941646|NCT00494871|19544976|P1|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628
7941647|NCT00494871|19544975|P2|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
7941648|NCT00494871|19544976|P1|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
7941649|NCT00494871|19544975|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||172
7941650|NCT00494871|19544976|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||160
7941651|NCT00494871|19544975|P2|COMPLETED|Double-blind (DB) Treatment Period||468
7941652|NCT00494871|19544976|P1|COMPLETED|Double-blind (DB) Treatment Period||480
7941653|NCT00494871|19544975|P2|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
7941654|NCT00494871|19544976|P1|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
7941655|NCT00494871|19544975|P2|STARTED|Double-blind (DB) Treatment Period||640
7941656|NCT00494871|19544976|P1|STARTED|Double-blind (DB) Treatment Period||640
7941657|NCT00494806|19545008|P2|NOT COMPLETED|Overall Study||0
7941658|NCT00494806|19545009|P1|NOT COMPLETED|Overall Study||0
7941659|NCT00494806|19545008|P2|COMPLETED|Overall Study||32
7941660|NCT00494806|19545009|P1|COMPLETED|Overall Study||34
7941661|NCT00494806|19545008|P2|STARTED|Overall Study||32
7941662|NCT00494806|19545009|P1|STARTED|Overall Study||34
7941663|NCT00494780|19545017|P2|NOT COMPLETED|Overall Study||13
7941664|NCT00494780|19545018|P1|NOT COMPLETED|Overall Study||11
7941665|NCT00494780|19545017|P2|COMPLETED|Overall Study||17
7941666|NCT00494780|19545018|P1|COMPLETED|Overall Study||18
7941667|NCT00494780|19545017|P2|STARTED|Overall Study||30
7941668|NCT00494780|19545018|P1|STARTED|Overall Study||29
7941669|NCT00494676|19545056|P2|NOT COMPLETED|Second Intervention||1
7941670|NCT00494676|19545057|P1|NOT COMPLETED|Second Intervention||1
7941671|NCT00494676|19545056|P2|COMPLETED|Second Intervention||28
7941672|NCT00494676|19545057|P1|COMPLETED|Second Intervention||33
7941673|NCT00494676|19545056|P2|STARTED|Second Intervention||29
7941674|NCT00494676|19545057|P1|STARTED|Second Intervention||34
7941675|NCT00494676|19545056|P2|NOT COMPLETED|First Intervention||3
7941676|NCT00494676|19545057|P1|NOT COMPLETED|First Intervention||1
7941677|NCT00494676|19545056|P2|COMPLETED|First Intervention||29
7941678|NCT00494676|19545057|P1|COMPLETED|First Intervention||34
7941679|NCT00494676|19545056|P2|STARTED|First Intervention||32
7941680|NCT00494676|19545057|P1|STARTED|First Intervention||35
7941681|NCT00494676|19545056|P2|NOT COMPLETED|Allocation||4
7941682|NCT00494676|19545057|P1|NOT COMPLETED|Allocation||2
7941683|NCT00494676|19545056|P2|COMPLETED|Allocation||32
7941684|NCT00494676|19545057|P1|COMPLETED|Allocation||35
7941685|NCT00494676|19545056|P2|STARTED|Allocation||36
7941686|NCT00494676|19545057|P1|STARTED|Allocation||37
7941687|NCT00494585|19545064|P1|NOT COMPLETED|Overall Study||0
7941688|NCT00494585|19545064|P1|COMPLETED|Overall Study||22
7941689|NCT00494585|19545064|P1|STARTED|Overall Study||22
7941690|NCT00494507|19545072|P4|NOT COMPLETED|Open-Label Phase||5
7941691|NCT00494507|19545073|P3|NOT COMPLETED|Open-Label Phase||5
7941692|NCT00494507|19545074|P2|NOT COMPLETED|Open-Label Phase||1
7941693|NCT00494507|19545075|P1|NOT COMPLETED|Open-Label Phase||0
7941694|NCT00494507|19545072|P4|COMPLETED|Open-Label Phase||14
7941695|NCT00494507|19545073|P3|COMPLETED|Open-Label Phase||17
7941696|NCT00494507|19545074|P2|COMPLETED|Open-Label Phase||7
7941697|NCT00494507|19545075|P1|COMPLETED|Open-Label Phase||9
7941698|NCT00494507|19545072|P4|STARTED|Open-Label Phase||19
7941699|NCT00494507|19545073|P3|STARTED|Open-Label Phase||22
7941700|NCT00494507|19545074|P2|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8
7941701|NCT00494507|19545075|P1|STARTED|Open-Label Phase||9
7941702|NCT00494507|19545072|P4|NOT COMPLETED|Double-Blind Phase||1
7941703|NCT00494507|19545073|P3|NOT COMPLETED|Double-Blind Phase||2
7941704|NCT00494507|19545074|P2|NOT COMPLETED|Double-Blind Phase||0
7941705|NCT00494507|19545075|P1|NOT COMPLETED|Double-Blind Phase||3
7941706|NCT00494507|19545072|P4|COMPLETED|Double-Blind Phase||19
7941707|NCT00494507|19545073|P3|COMPLETED|Double-Blind Phase||22
7941708|NCT00494507|19545074|P2|COMPLETED|Double-Blind Phase||9
7941709|NCT00494507|19545075|P1|COMPLETED|Double-Blind Phase||9
7941710|NCT00494507|19545072|P4|Reached Endpoint of Acute Worsening|Double-Blind Phase||5
7941711|NCT00494507|19545073|P3|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
7941712|NCT00494507|19545074|P2|Reached Endpoint of Acute Worsening|Double-Blind Phase||2
7941713|NCT00494507|19545075|P1|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
7941714|NCT00494507|19545072|P4|STARTED|Double-Blind Phase||20
7941715|NCT00494507|19545073|P3|STARTED|Double-Blind Phase||24
7941716|NCT00494507|19545074|P2|STARTED|Double-Blind Phase||9
7941717|NCT00494507|19545075|P1|STARTED|Double-Blind Phase||12
7941718|NCT00494494|19545125|P2|NOT COMPLETED|Overall Study||0
7941719|NCT00494494|19545126|P1|NOT COMPLETED|Overall Study||0
7941720|NCT00494494|19545125|P2|COMPLETED|Overall Study||39
7941721|NCT00494494|19545126|P1|COMPLETED|Overall Study||40
7941722|NCT00494494|19545125|P2|STARTED|Overall Study||39
7941723|NCT00494494|19545126|P1|STARTED|Overall Study||40
7941724|NCT00494481|19545142|P2|NOT COMPLETED|Overall Study||24
7941725|NCT00494481|19545143|P1|NOT COMPLETED|Overall Study||29
7941726|NCT00494481|19545142|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
7941727|NCT00494481|19545143|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6
7941728|NCT00494481|19545142|P2|STARTED|Overall Study|randomised patients|29
7941729|NCT00494481|19545143|P1|STARTED|Overall Study|randomised patients|35
7941730|NCT00494442|19545151|P2|NOT COMPLETED|Overall Study||16
7941731|NCT00494442|19545152|P1|NOT COMPLETED|Overall Study||17
7941732|NCT00494442|19545151|P2|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17
7941733|NCT00494442|19545152|P1|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7
7941734|NCT00494442|19545151|P2|STARTED|Overall Study|Patients received treatment|33
7941735|NCT00494442|19545152|P1|STARTED|Overall Study|Patients received treatment|24
7941736|NCT00494299|19545168|P2|NOT COMPLETED|Overall Study||229
7941737|NCT00494299|19545169|P1|NOT COMPLETED|Overall Study||229
7941738|NCT00494299|19545168|P2|COMPLETED|Overall Study||0
7941739|NCT00494299|19545169|P1|COMPLETED|Overall Study||0
7941740|NCT00494299|19545168|P2|Received Treatment|Overall Study||227
7941741|NCT00494299|19545169|P1|Received Treatment|Overall Study||229
7941742|NCT00494299|19545168|P2|STARTED|Overall Study||229
7941743|NCT00494299|19545169|P1|STARTED|Overall Study||229
7941744|NCT00494234|19545181|P2|NOT COMPLETED|Overall Study||10
7941745|NCT00494234|19545182|P1|NOT COMPLETED|Overall Study||15
7941746|NCT00494234|19545181|P2|COMPLETED|Overall Study||17
7941747|NCT00494234|19545182|P1|COMPLETED|Overall Study||12
7941748|NCT00494234|19545181|P2|STARTED|Overall Study||27
7941749|NCT00494234|19545182|P1|STARTED|Overall Study||27
7941750|NCT00494221|19545201|P3|NOT COMPLETED|Overall Study||14
7941751|NCT00494221|19545202|P2|NOT COMPLETED|Overall Study||11
7941752|NCT00494221|19545203|P1|NOT COMPLETED|Overall Study||16
7941753|NCT00494221|19545201|P3|COMPLETED|Overall Study||44
7941754|NCT00494221|19545202|P2|COMPLETED|Overall Study||45
7941755|NCT00494221|19545203|P1|COMPLETED|Overall Study||42
7941756|NCT00494221|19545201|P3|STARTED|Overall Study||58
7941757|NCT00494221|19545202|P2|STARTED|Overall Study||56
7941758|NCT00494221|19545203|P1|STARTED|Overall Study||58
7941759|NCT00494143|19545223|P6|NOT COMPLETED|Overall Study||0
7941760|NCT00494143|19545224|P5|NOT COMPLETED|Overall Study||0
7941761|NCT00494143|19545225|P4|NOT COMPLETED|Overall Study||0
7941762|NCT00494143|19545226|P3|NOT COMPLETED|Overall Study||0
7941763|NCT00494143|19545227|P2|NOT COMPLETED|Overall Study||0
7941764|NCT00494143|19545228|P1|NOT COMPLETED|Overall Study||0
7941765|NCT00494143|19545223|P6|COMPLETED|Overall Study||0
7941766|NCT00494143|19545224|P5|COMPLETED|Overall Study||1
7941767|NCT00494143|19545225|P4|COMPLETED|Overall Study||0
7941768|NCT00494143|19545226|P3|COMPLETED|Overall Study||3
7941769|NCT00494143|19545227|P2|COMPLETED|Overall Study||2
7941770|NCT00494143|19545228|P1|COMPLETED|Overall Study||1
7941771|NCT00494143|19545223|P6|STARTED|Overall Study||0
7941772|NCT00494143|19545224|P5|STARTED|Overall Study||1
7941773|NCT00494143|19545225|P4|STARTED|Overall Study||0
7941774|NCT00494143|19545226|P3|STARTED|Overall Study||3
7941775|NCT00494143|19545227|P2|STARTED|Overall Study||2
7941776|NCT00494143|19545228|P1|STARTED|Overall Study||1
7941777|NCT00494091|19545244|P2|NOT COMPLETED|Overall Study||76
7941778|NCT00494091|19545245|P1|NOT COMPLETED|Overall Study||6
7941779|NCT00494091|19545244|P2|COMPLETED|Overall Study||0
7941780|NCT00494091|19545245|P1|COMPLETED|Overall Study||0
7941781|NCT00494091|19545244|P2|STARTED|Overall Study||76
7941782|NCT00494091|19545245|P1|STARTED|Overall Study||6
7941783|NCT00494026|19545267|P1|NOT COMPLETED|Overall Study||4
7941784|NCT00494026|19545267|P1|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0
7941785|NCT00494026|19545267|P1|STARTED|Overall Study||4
7941786|NCT00494013|19545277|P2|NOT COMPLETED|Overall Study||36
7941787|NCT00494013|19545278|P1|NOT COMPLETED|Overall Study||30
7941788|NCT00494013|19545277|P2|COMPLETED|Overall Study||183
7941789|NCT00494013|19545278|P1|COMPLETED|Overall Study||193
7941790|NCT00494013|19545277|P2|Full Analysis Set (Intent to Treat)|Overall Study||210
7941791|NCT00494013|19545278|P1|Full Analysis Set (Intent to Treat)|Overall Study||219
7941792|NCT00494013|19545277|P2|STARTED|Overall Study||219
7941793|NCT00494013|19545278|P1|STARTED|Overall Study||223
7941794|NCT00493974|19545308|P2|NOT COMPLETED|Overall Study||14
7941795|NCT00493974|19545309|P1|NOT COMPLETED|Overall Study||13
7941796|NCT00493974|19545308|P2|COMPLETED|Overall Study||45
7941797|NCT00493974|19545309|P1|COMPLETED|Overall Study||47
7941798|NCT00493974|19545308|P2|STARTED|Overall Study||59
7941799|NCT00493974|19545309|P1|STARTED|Overall Study||60
7941800|NCT00493805|19545327|P2|NOT COMPLETED|Overall Study||0
7941801|NCT00493805|19545328|P1|NOT COMPLETED|Overall Study||0
7941802|NCT00493805|19545327|P2|COMPLETED|Overall Study||42
7941803|NCT00493805|19545328|P1|COMPLETED|Overall Study||17
7941804|NCT00493805|19545327|P2|STARTED|Overall Study||42
7941805|NCT00493805|19545328|P1|STARTED|Overall Study||17
7941806|NCT00493779|19545336|P1|NOT COMPLETED|Overall Study||1
7941807|NCT00493779|19545336|P1|COMPLETED|Overall Study|Completed follow-up phase|97
7941808|NCT00493779|19545336|P1|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98
7941809|NCT00493649|19545343|P1|NOT COMPLETED|Overall Study||82
7941810|NCT00493649|19545343|P1|COMPLETED|Overall Study||411
7941811|NCT00493649|19545343|P1|STARTED|Overall Study||493
7941812|NCT00493636|19545356|P2|NOT COMPLETED|Overall Study||2
7941813|NCT00493636|19545357|P1|NOT COMPLETED|Overall Study||2
7941814|NCT00493636|19545356|P2|COMPLETED|Overall Study||77
7941815|NCT00493636|19545357|P1|COMPLETED|Overall Study||79
7941816|NCT00493636|19545356|P2|STARTED|Overall Study||79
7941817|NCT00493636|19545357|P1|STARTED|Overall Study||81
7941818|NCT00493467|19545371|P1|NOT COMPLETED|Overall Study||1
7941819|NCT00493467|19545371|P1|COMPLETED|Overall Study||30
7941820|NCT00493467|19545371|P1|STARTED|Overall Study||31
7941821|NCT00493454|19545376|P1|NOT COMPLETED|Overall Study||1
7941822|NCT00493454|19545376|P1|COMPLETED|Overall Study||5
7941823|NCT00493454|19545376|P1|STARTED|Overall Study||6
7941824|NCT00493311|19545382|P2|NOT COMPLETED|Overall Study||2
7941825|NCT00493311|19545383|P1|NOT COMPLETED|Overall Study||2
7941826|NCT00493311|19545382|P2|COMPLETED|Overall Study||29
7941827|NCT00493311|19545383|P1|COMPLETED|Overall Study||27
7941828|NCT00493311|19545382|P2|STARTED|Overall Study||31
7941829|NCT00493311|19545383|P1|STARTED|Overall Study||29
7941830|NCT00493285|19545403|P6|NOT COMPLETED|Overall Study||0
7941831|NCT00493285|19545404|P5|NOT COMPLETED|Overall Study||1
7941832|NCT00493285|19545405|P4|NOT COMPLETED|Overall Study||0
7941833|NCT00493285|19545406|P3|NOT COMPLETED|Overall Study||0
7941834|NCT00493285|19545407|P2|NOT COMPLETED|Overall Study||0
7941835|NCT00493285|19545408|P1|NOT COMPLETED|Overall Study||0
7941836|NCT00493285|19545403|P6|COMPLETED|Overall Study||5
7941837|NCT00493285|19545404|P5|COMPLETED|Overall Study||9
7941838|NCT00493285|19545405|P4|COMPLETED|Overall Study||6
7941839|NCT00493285|19545406|P3|COMPLETED|Overall Study||9
7941840|NCT00493285|19545407|P2|COMPLETED|Overall Study||6
7941841|NCT00493285|19545408|P1|COMPLETED|Overall Study||13
7941842|NCT00493285|19545403|P6|STARTED|Overall Study||5
7941843|NCT00493285|19545404|P5|STARTED|Overall Study||10
7941844|NCT00493285|19545405|P4|STARTED|Overall Study||6
7941845|NCT00493285|19545406|P3|STARTED|Overall Study||9
7941846|NCT00493285|19545407|P2|STARTED|Overall Study||6
7941847|NCT00493285|19545408|P1|STARTED|Overall Study||13
7941848|NCT00493246|19545640|P8|NOT COMPLETED|Overall Study||0
7941849|NCT00493246|19545641|P7|NOT COMPLETED|Overall Study||1
7941850|NCT00493246|19545642|P6|NOT COMPLETED|Overall Study||1
7941851|NCT00493246|19545643|P5|NOT COMPLETED|Overall Study||1
7941852|NCT00493246|19545644|P4|NOT COMPLETED|Overall Study||0
7941853|NCT00493246|19545645|P3|NOT COMPLETED|Overall Study||0
7941854|NCT00493246|19545646|P2|NOT COMPLETED|Overall Study||0
7941855|NCT00493246|19545647|P1|NOT COMPLETED|Overall Study||0
7941856|NCT00493246|19545640|P8|COMPLETED|Overall Study|Completed study 30 days after the last dose|10
7941857|NCT00493246|19545641|P7|COMPLETED|Overall Study|Completed study 30 days after the last dose|11
7941858|NCT00493246|19545642|P6|COMPLETED|Overall Study|Completed study 30 days after the last dose|15
7941859|NCT00493246|19545643|P5|COMPLETED|Overall Study|Completed study 30 days after the last dose|8
7941860|NCT00493246|19545644|P4|COMPLETED|Overall Study|Completed study 30 days after the last dose|13
7941861|NCT00493246|19545645|P3|COMPLETED|Overall Study|Completed study 30 days after the last dose|12
7941862|NCT00493246|19545646|P2|COMPLETED|Overall Study|Completed study 30 days after the last dose|1
7941863|NCT00493246|19545647|P1|COMPLETED|Overall Study|Completed study 30 days after the last dose|2
7941864|NCT00493246|19545640|P8|STARTED|Overall Study|All subjects who were randomized.|10
7941865|NCT00493246|19545641|P7|STARTED|Overall Study|All subjects who were randomized.|12
7941866|NCT00493246|19545642|P6|STARTED|Overall Study|All subjects who were randomized.|16
7941867|NCT00493246|19545643|P5|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9
7941868|NCT00493246|19545644|P4|STARTED|Overall Study||13
7941869|NCT00493246|19545645|P3|STARTED|Overall Study||12
7941870|NCT00493246|19545646|P2|STARTED|Overall Study||1
7941871|NCT00493246|19545647|P1|STARTED|Overall Study||2
7941872|NCT00493220|19545711|P6|NOT COMPLETED|Final 7-Day Safety Follow-up||0
7941873|NCT00493220|19545712|P5|NOT COMPLETED|Final 7-Day Safety Follow-up||0
7941874|NCT00493220|19545713|P4|NOT COMPLETED|Final 7-Day Safety Follow-up||0
7941875|NCT00493220|19545714|P3|NOT COMPLETED|Final 7-Day Safety Follow-up||0
7941876|NCT00493220|19545715|P2|NOT COMPLETED|Final 7-Day Safety Follow-up||0
7941877|NCT00493220|19545716|P1|NOT COMPLETED|Final 7-Day Safety Follow-up||0
7941878|NCT00493220|19545711|P6|COMPLETED|Final 7-Day Safety Follow-up||5
7941879|NCT00493220|19545712|P5|COMPLETED|Final 7-Day Safety Follow-up||5
7941880|NCT00493220|19545713|P4|COMPLETED|Final 7-Day Safety Follow-up||5
7941881|NCT00493220|19545714|P3|COMPLETED|Final 7-Day Safety Follow-up||5
7941882|NCT00493220|19545715|P2|COMPLETED|Final 7-Day Safety Follow-up||5
7941883|NCT00493220|19545716|P1|COMPLETED|Final 7-Day Safety Follow-up||4
7941884|NCT00493220|19545711|P6|STARTED|Final 7-Day Safety Follow-up||5
7941885|NCT00493220|19545712|P5|STARTED|Final 7-Day Safety Follow-up||5
7941886|NCT00493220|19545713|P4|STARTED|Final 7-Day Safety Follow-up||5
7941887|NCT00493220|19545714|P3|STARTED|Final 7-Day Safety Follow-up||5
7941888|NCT00493220|19545715|P2|STARTED|Final 7-Day Safety Follow-up||5
7941889|NCT00493220|19545716|P1|STARTED|Final 7-Day Safety Follow-up||4
7941890|NCT00493220|19545711|P6|NOT COMPLETED|Third Intervention||0
7941891|NCT00493220|19545712|P5|NOT COMPLETED|Third Intervention||0
7941892|NCT00493220|19545713|P4|NOT COMPLETED|Third Intervention||0
7941893|NCT00493220|19545714|P3|NOT COMPLETED|Third Intervention||0
7941894|NCT00493220|19545715|P2|NOT COMPLETED|Third Intervention||0
7941895|NCT00493220|19545716|P1|NOT COMPLETED|Third Intervention||1
7941896|NCT00493220|19545711|P6|COMPLETED|Third Intervention||5
7941897|NCT00493220|19545712|P5|COMPLETED|Third Intervention||5
7941898|NCT00493220|19545713|P4|COMPLETED|Third Intervention||5
7941899|NCT00493220|19545714|P3|COMPLETED|Third Intervention||5
7941900|NCT00493220|19545715|P2|COMPLETED|Third Intervention||5
7941901|NCT00493220|19545716|P1|COMPLETED|Third Intervention||4
7941902|NCT00493220|19545711|P6|STARTED|Third Intervention||5
7941903|NCT00493220|19545712|P5|STARTED|Third Intervention||5
7941904|NCT00493220|19545713|P4|STARTED|Third Intervention||5
7941905|NCT00493220|19545714|P3|STARTED|Third Intervention||5
7941906|NCT00493220|19545715|P2|STARTED|Third Intervention||5
7941907|NCT00493220|19545716|P1|STARTED|Third Intervention||5
7941908|NCT00493220|19545711|P6|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
7941909|NCT00493220|19545712|P5|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
7941910|NCT00493220|19545713|P4|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
7941911|NCT00493220|19545714|P3|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
7941912|NCT00493220|19545715|P2|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
7941913|NCT00493220|19545716|P1|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
7941914|NCT00493220|19545711|P6|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
7941915|NCT00493220|19545712|P5|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
7941916|NCT00493220|19545713|P4|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
7941917|NCT00493220|19545714|P3|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
7941918|NCT00493220|19545715|P2|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
7941919|NCT00493220|19545716|P1|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
7941920|NCT00493220|19545711|P6|STARTED|Second 7-Day Washout & Safety Follow-up||5
7941921|NCT00493220|19545712|P5|STARTED|Second 7-Day Washout & Safety Follow-up||5
7941922|NCT00493220|19545713|P4|STARTED|Second 7-Day Washout & Safety Follow-up||5
7941923|NCT00493220|19545714|P3|STARTED|Second 7-Day Washout & Safety Follow-up||5
7941924|NCT00493220|19545715|P2|STARTED|Second 7-Day Washout & Safety Follow-up||5
7941925|NCT00493220|19545716|P1|STARTED|Second 7-Day Washout & Safety Follow-up||5
7941926|NCT00493220|19545711|P6|NOT COMPLETED|Second Intervention||0
7941927|NCT00493220|19545712|P5|NOT COMPLETED|Second Intervention||0
7941928|NCT00493220|19545713|P4|NOT COMPLETED|Second Intervention||0
7941929|NCT00493220|19545714|P3|NOT COMPLETED|Second Intervention||0
7941930|NCT00493220|19545715|P2|NOT COMPLETED|Second Intervention||0
7941931|NCT00493220|19545716|P1|NOT COMPLETED|Second Intervention||0
7941932|NCT00493220|19545711|P6|COMPLETED|Second Intervention||5
7941933|NCT00493220|19545712|P5|COMPLETED|Second Intervention||5
7941934|NCT00493220|19545713|P4|COMPLETED|Second Intervention||5
7941935|NCT00493220|19545714|P3|COMPLETED|Second Intervention||5
7941936|NCT00493220|19545715|P2|COMPLETED|Second Intervention||5
7941937|NCT00493220|19545716|P1|COMPLETED|Second Intervention||5
7941938|NCT00493220|19545711|P6|STARTED|Second Intervention||5
7941939|NCT00493220|19545712|P5|STARTED|Second Intervention||5
7941940|NCT00493220|19545713|P4|STARTED|Second Intervention||5
7941941|NCT00493220|19545714|P3|STARTED|Second Intervention||5
7941942|NCT00493220|19545715|P2|STARTED|Second Intervention||5
7941943|NCT00493220|19545716|P1|STARTED|Second Intervention||5
7941944|NCT00493220|19545711|P6|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
7941945|NCT00493220|19545712|P5|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
7941946|NCT00493220|19545713|P4|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
7941947|NCT00493220|19545714|P3|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
7941948|NCT00493220|19545715|P2|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
7941949|NCT00493220|19545716|P1|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
7941950|NCT00493220|19545711|P6|COMPLETED|First 7-Day Washout & Safety Follow-up||5
7941951|NCT00493220|19545712|P5|COMPLETED|First 7-Day Washout & Safety Follow-up||5
7941952|NCT00493220|19545713|P4|COMPLETED|First 7-Day Washout & Safety Follow-up||5
7941953|NCT00493220|19545714|P3|COMPLETED|First 7-Day Washout & Safety Follow-up||5
7941954|NCT00493220|19545715|P2|COMPLETED|First 7-Day Washout & Safety Follow-up||5
7941955|NCT00493220|19545716|P1|COMPLETED|First 7-Day Washout & Safety Follow-up||5
7941956|NCT00493220|19545711|P6|STARTED|First 7-Day Washout & Safety Follow-up||5
7941957|NCT00493220|19545712|P5|STARTED|First 7-Day Washout & Safety Follow-up||5
7941958|NCT00493220|19545713|P4|STARTED|First 7-Day Washout & Safety Follow-up||5
7941959|NCT00493220|19545714|P3|STARTED|First 7-Day Washout & Safety Follow-up||5
7941960|NCT00493220|19545715|P2|STARTED|First 7-Day Washout & Safety Follow-up||5
7941961|NCT00493220|19545716|P1|STARTED|First 7-Day Washout & Safety Follow-up||5
7941962|NCT00493220|19545711|P6|NOT COMPLETED|First Intervention||0
7941963|NCT00493220|19545712|P5|NOT COMPLETED|First Intervention||0
7941964|NCT00493220|19545713|P4|NOT COMPLETED|First Intervention||0
7941965|NCT00493220|19545714|P3|NOT COMPLETED|First Intervention||0
7941966|NCT00493220|19545715|P2|NOT COMPLETED|First Intervention||0
7941967|NCT00493220|19545716|P1|NOT COMPLETED|First Intervention||0
7941968|NCT00493220|19545711|P6|COMPLETED|First Intervention||5
7941969|NCT00493220|19545712|P5|COMPLETED|First Intervention||5
7941970|NCT00493220|19545713|P4|COMPLETED|First Intervention||5
7941971|NCT00493220|19545714|P3|COMPLETED|First Intervention||5
7941972|NCT00493220|19545715|P2|COMPLETED|First Intervention||5
7941973|NCT00493220|19545716|P1|COMPLETED|First Intervention||5
7941974|NCT00493220|19545711|P6|STARTED|First Intervention||5
7941975|NCT00493220|19545712|P5|STARTED|First Intervention||5
7941976|NCT00493220|19545713|P4|STARTED|First Intervention||5
7941977|NCT00493220|19545714|P3|STARTED|First Intervention||5
7941978|NCT00493220|19545715|P2|STARTED|First Intervention||5
7941979|NCT00493220|19545716|P1|STARTED|First Intervention||5
7941980|NCT00493181|19545733|P1|NOT COMPLETED|Overall Study||0
7941981|NCT00493181|19545733|P1|COMPLETED|Overall Study||8
7941982|NCT00493181|19545733|P1|STARTED|Overall Study||8
7941983|NCT00493064|19545737|P1|NOT COMPLETED|Overall Study||11
7941984|NCT00493064|19545737|P1|COMPLETED|Overall Study||52
7941985|NCT00493064|19545737|P1|STARTED|Overall Study||63
7941986|NCT00493038|19545744|P2|NOT COMPLETED|Follow-up||0
7941987|NCT00493038|19545745|P1|NOT COMPLETED|Follow-up||1
7941988|NCT00493038|19545744|P2|COMPLETED|Follow-up||126
7941989|NCT00493038|19545745|P1|COMPLETED|Follow-up||122
7941990|NCT00493038|19545744|P2|STARTED|Follow-up||126
7941991|NCT00493038|19545745|P1|STARTED|Follow-up||123
7941992|NCT00493038|19545744|P2|NOT COMPLETED|Treatment||20
7941993|NCT00493038|19545745|P1|NOT COMPLETED|Treatment||24
7941994|NCT00493038|19545744|P2|COMPLETED|Treatment||126
7941995|NCT00493038|19545745|P1|COMPLETED|Treatment||123
7941996|NCT00493038|19545744|P2|Test-of-Cure Visit|Treatment||126
7941997|NCT00493038|19545745|P1|Test-of-Cure Visit|Treatment||123
7941998|NCT00493038|19545744|P2|Treated With Study Medication|Treatment||142
7941999|NCT00493038|19545745|P1|Treated With Study Medication|Treatment||145
7942000|NCT00493038|19545744|P2|Randomization|Treatment||146
7942001|NCT00493038|19545745|P1|Randomization|Treatment||147
7942002|NCT00493038|19545744|P2|STARTED|Treatment||146
7942003|NCT00493038|19545745|P1|STARTED|Treatment||147
7942004|NCT00493025|19545759|P1|NOT COMPLETED|Overall Study||19
7942005|NCT00493025|19545759|P1|COMPLETED|Overall Study|Trial stopped due to early stopping rule|0
7942006|NCT00493025|19545759|P1|STARTED|Overall Study||19
7942007|NCT00493012|19545770|P2|NOT COMPLETED|Overall Study||17
7942008|NCT00493012|19545771|P1|NOT COMPLETED|Overall Study||18
7942009|NCT00493012|19545770|P2|COMPLETED|Overall Study||83
7942010|NCT00493012|19545771|P1|COMPLETED|Overall Study||82
7942011|NCT00493012|19545770|P2|STARTED|Overall Study||100
7942012|NCT00493012|19545771|P1|STARTED|Overall Study||100
7942013|NCT00492973|19545799|P2|NOT COMPLETED|Overall Study||1
7942014|NCT00492973|19545800|P1|NOT COMPLETED|Overall Study||0
7942015|NCT00492973|19545799|P2|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38
7942016|NCT00492973|19545800|P1|COMPLETED|Overall Study||37
7942017|NCT00492973|19545799|P2|STARTED|Overall Study||39
7942018|NCT00492973|19545800|P1|STARTED|Overall Study||37
7942019|NCT00492921|19545814|P3|NOT COMPLETED|Overall Study||1
7942020|NCT00492921|19545815|P2|NOT COMPLETED|Overall Study||0
7942021|NCT00492921|19545816|P1|NOT COMPLETED|Overall Study||1
7942022|NCT00492921|19545814|P3|COMPLETED|Overall Study||2
7942023|NCT00492921|19545815|P2|COMPLETED|Overall Study||4
7942024|NCT00492921|19545816|P1|COMPLETED|Overall Study||4
7942025|NCT00492921|19545814|P3|STARTED|Overall Study||3
7942026|NCT00492921|19545815|P2|STARTED|Overall Study||4
7942027|NCT00492921|19545816|P1|STARTED|Overall Study||5
7942028|NCT00492856|19545827|P4|NOT COMPLETED|Post-consolidation||1
7942029|NCT00492856|19545828|P3|NOT COMPLETED|Post-consolidation||27
7942030|NCT00492856|19545829|P2|NOT COMPLETED|Post-consolidation||12
7942031|NCT00492856|19545830|P1|NOT COMPLETED|Post-consolidation||0
7942032|NCT00492856|19545827|P4|COMPLETED|Post-consolidation||0
7942033|NCT00492856|19545828|P3|COMPLETED|Post-consolidation||0
7942034|NCT00492856|19545829|P2|COMPLETED|Post-consolidation||29
7942035|NCT00492856|19545830|P1|COMPLETED|Post-consolidation||0
7942036|NCT00492856|19545827|P4|STARTED|Post-consolidation||1
7942037|NCT00492856|19545828|P3|STARTED|Post-consolidation||27
7942038|NCT00492856|19545829|P2|STARTED|Post-consolidation||41
7942039|NCT00492856|19545830|P1|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0
7942040|NCT00492856|19545827|P4|NOT COMPLETED|Consolidation||0
7942041|NCT00492856|19545828|P3|NOT COMPLETED|Consolidation||0
7942042|NCT00492856|19545829|P2|NOT COMPLETED|Consolidation||0
7942043|NCT00492856|19545830|P1|NOT COMPLETED|Consolidation||9
7942044|NCT00492856|19545827|P4|COMPLETED|Consolidation||0
7942045|NCT00492856|19545828|P3|COMPLETED|Consolidation||0
7942046|NCT00492856|19545829|P2|COMPLETED|Consolidation||0
7942047|NCT00492856|19545830|P1|COMPLETED|Consolidation||83
7942048|NCT00492856|19545827|P4|STARTED|Consolidation||0
7942049|NCT00492856|19545828|P3|STARTED|Consolidation||0
7942050|NCT00492856|19545829|P2|STARTED|Consolidation||0
7942051|NCT00492856|19545830|P1|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92
7942052|NCT00492856|19545827|P4|NOT COMPLETED|Induction||0
7942053|NCT00492856|19545828|P3|NOT COMPLETED|Induction||0
7942054|NCT00492856|19545829|P2|NOT COMPLETED|Induction||0
7942055|NCT00492856|19545830|P1|NOT COMPLETED|Induction||6
7942056|NCT00492856|19545827|P4|COMPLETED|Induction||0
7942057|NCT00492856|19545828|P3|COMPLETED|Induction||0
7942058|NCT00492856|19545829|P2|COMPLETED|Induction||0
7942059|NCT00492856|19545830|P1|COMPLETED|Induction||99
7942060|NCT00492856|19545827|P4|STARTED|Induction||0
7942061|NCT00492856|19545828|P3|STARTED|Induction||0
7942062|NCT00492856|19545829|P2|STARTED|Induction||0
7942063|NCT00492856|19545830|P1|STARTED|Induction||105
7942064|NCT00492752|19545844|P4|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6
7942065|NCT00492752|19545845|P3|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47
7942066|NCT00492752|19545846|P2|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16
7942067|NCT00492752|19545847|P1|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86
7942068|NCT00492752|19545844|P4|COMPLETED|Follow-up and/or Open Label Sorafenib||0
7942069|NCT00492752|19545845|P3|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20
7942070|NCT00492752|19545846|P2|COMPLETED|Follow-up and/or Open Label Sorafenib||0
7942071|NCT00492752|19545847|P1|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34
7942072|NCT00492752|19545844|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6
7942073|NCT00492752|19545845|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
7942074|NCT00492752|19545846|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16
7942075|NCT00492752|19545847|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
7942076|NCT00492752|19545844|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
7942077|NCT00492752|19545845|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67
7942078|NCT00492752|19545846|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
7942079|NCT00492752|19545847|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120
7942080|NCT00492752|19545844|P4|STARTED|Follow-up and/or Open Label Sorafenib||6
7942081|NCT00492752|19545845|P3|STARTED|Follow-up and/or Open Label Sorafenib||67
7942082|NCT00492752|19545846|P2|STARTED|Follow-up and/or Open Label Sorafenib||16
7942083|NCT00492752|19545847|P1|STARTED|Follow-up and/or Open Label Sorafenib||120
7942084|NCT00492752|19545844|P4|NOT COMPLETED|Double Blind Treatment||0
7942085|NCT00492752|19545845|P3|NOT COMPLETED|Double Blind Treatment||3
7942086|NCT00492752|19545846|P2|NOT COMPLETED|Double Blind Treatment||0
7942087|NCT00492752|19545847|P1|NOT COMPLETED|Double Blind Treatment||14
7942088|NCT00492752|19545844|P4|COMPLETED|Double Blind Treatment||6
7942089|NCT00492752|19545845|P3|COMPLETED|Double Blind Treatment||67
7942090|NCT00492752|19545846|P2|COMPLETED|Double Blind Treatment||16
7942091|NCT00492752|19545847|P1|COMPLETED|Double Blind Treatment||120
7942092|NCT00492752|19545844|P4|Received Treatment|Double Blind Treatment|Safety Population|6
7942093|NCT00492752|19545845|P3|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69
7942094|NCT00492752|19545846|P2|Received Treatment|Double Blind Treatment|Safety Population|16
7942095|NCT00492752|19545847|P1|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133
7942096|NCT00492752|19545844|P4|STARTED|Double Blind Treatment||6
7942097|NCT00492752|19545845|P3|STARTED|Double Blind Treatment||70
7942098|NCT00492752|19545846|P2|STARTED|Double Blind Treatment||16
7942099|NCT00492752|19545847|P1|STARTED|Double Blind Treatment||134
7942100|NCT00492726|19545882|P2|NOT COMPLETED|Overall Study||36
7942101|NCT00492726|19545883|P1|NOT COMPLETED|Overall Study||50
7942102|NCT00492726|19545882|P2|COMPLETED|Overall Study||358
7942103|NCT00492726|19545883|P1|COMPLETED|Overall Study||360
7942104|NCT00492726|19545882|P2|End of Study|Overall Study||358
7942105|NCT00492726|19545883|P1|End of Study|Overall Study||360
7942106|NCT00492726|19545882|P2|End of Treatment (EOT, Day 5 to 14)|Overall Study||377
7942107|NCT00492726|19545883|P1|End of Treatment (EOT, Day 5 to 14)|Overall Study||387
7942108|NCT00492726|19545882|P2|STARTED|Overall Study||394
7942109|NCT00492726|19545883|P1|STARTED|Overall Study||410
7942110|NCT00492648|19545909|P2|NOT COMPLETED|Month 42 (109674 Study)||0
7942111|NCT00492648|19545910|P1|NOT COMPLETED|Month 42 (109674 Study)||0
7942112|NCT00492648|19545909|P2|COMPLETED|Month 42 (109674 Study)||20
7942113|NCT00492648|19545910|P1|COMPLETED|Month 42 (109674 Study)||3
7942114|NCT00492648|19545909|P2|STARTED|Month 42 (109674 Study)||20
7942115|NCT00492648|19545910|P1|STARTED|Month 42 (109674 Study)||3
7942116|NCT00492648|19545909|P2|NOT COMPLETED|Month 30 (109671 Study)||1
7942117|NCT00492648|19545910|P1|NOT COMPLETED|Month 30 (109671 Study)||0
7942118|NCT00492648|19545909|P2|COMPLETED|Month 30 (109671 Study)||29
7942119|NCT00492648|19545910|P1|COMPLETED|Month 30 (109671 Study)||4
7942120|NCT00492648|19545909|P2|STARTED|Month 30 (109671 Study)||30
7942121|NCT00492648|19545910|P1|STARTED|Month 30 (109671 Study)||4
7942122|NCT00492622|19545936|P1|NOT COMPLETED|Overall Study||0
7942123|NCT00492622|19545936|P1|COMPLETED|Overall Study||12
7942124|NCT00492622|19545936|P1|STARTED|Overall Study|all subjects received the immediate release formulation|12
7942125|NCT00492583|19545948|P2|NOT COMPLETED|Overall Study||0
7942126|NCT00492583|19545949|P1|NOT COMPLETED|Overall Study||0
7942127|NCT00492583|19545948|P2|COMPLETED|Overall Study||87
7942128|NCT00492583|19545949|P1|COMPLETED|Overall Study||95
7942129|NCT00492583|19545948|P2|STARTED|Overall Study||87
7942130|NCT00492583|19545949|P1|STARTED|Overall Study||95
7942131|NCT00492557|19545957|P2|NOT COMPLETED|Overall Study||23
7942132|NCT00492557|19545958|P1|NOT COMPLETED|Overall Study||24
7942133|NCT00492557|19545957|P2|COMPLETED|Overall Study||557
7942134|NCT00492557|19545958|P1|COMPLETED|Overall Study||556
7942135|NCT00492557|19545957|P2|Vaccinated Dose 2|Overall Study||558
7942136|NCT00492557|19545958|P1|Vaccinated Dose 2|Overall Study||560
7942137|NCT00492557|19545957|P2|Vaccinated Dose 1|Overall Study||575
7942138|NCT00492557|19545958|P1|Vaccinated Dose 1|Overall Study||577
7942139|NCT00492557|19545957|P2|STARTED|Overall Study||580
7942140|NCT00492557|19545958|P1|STARTED|Overall Study||580
7942141|NCT00492544|19545974|P1|NOT COMPLETED|Overall Study||0
7942142|NCT00492544|19545974|P1|COMPLETED|Overall Study||100
7942143|NCT00492544|19545974|P1|STARTED|Overall Study||100
7942144|NCT00492531|19545988|P2|NOT COMPLETED|Overall Study||23
7942145|NCT00492531|19545989|P1|NOT COMPLETED|Overall Study||22
7942146|NCT00492531|19545988|P2|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14
7942147|NCT00492531|19545989|P1|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15
7942148|NCT00492531|19545988|P2|STARTED|Overall Study||37
7942149|NCT00492531|19545989|P1|STARTED|Overall Study||37
7942150|NCT00492401|19546001|P1|NOT COMPLETED|Overall Study||0
7942151|NCT00492401|19546001|P1|COMPLETED|Overall Study||55
7942152|NCT00492401|19546001|P1|STARTED|Overall Study||55
7942153|NCT00492349|19546012|P2|NOT COMPLETED|Overall Study||7
7942154|NCT00492349|19546013|P1|NOT COMPLETED|Overall Study||3
7942155|NCT00492349|19546012|P2|COMPLETED|Overall Study||27
7942156|NCT00492349|19546013|P1|COMPLETED|Overall Study||32
7942157|NCT00492349|19546012|P2|Week 8|Overall Study||27
7942158|NCT00492349|19546013|P1|Week 8|Overall Study||32
7942159|NCT00492349|19546012|P2|Week 2|Overall Study||33
7942160|NCT00492349|19546013|P1|Week 2|Overall Study||32
7942161|NCT00492349|19546012|P2|STARTED|Overall Study||34
7942162|NCT00492349|19546013|P1|STARTED|Overall Study||35
7942163|NCT00492336|19546035|P2|NOT COMPLETED|Overall Study||6
7942164|NCT00492336|19546036|P1|NOT COMPLETED|Overall Study||2
7942165|NCT00492336|19546035|P2|COMPLETED|Overall Study||23
7942166|NCT00492336|19546036|P1|COMPLETED|Overall Study||26
7942167|NCT00492336|19546035|P2|STARTED|Overall Study||29
7942168|NCT00492336|19546036|P1|STARTED|Overall Study||28
7942169|NCT00492297|19546062|P1|NOT COMPLETED|Survival Only Follow-up||59
7942170|NCT00492297|19546062|P1|COMPLETED|Survival Only Follow-up||0
7942171|NCT00492297|19546062|P1|STARTED|Survival Only Follow-up||59
7942172|NCT00492297|19546062|P1|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19
7942173|NCT00492297|19546062|P1|COMPLETED|Active Follow-up 30(+4) Days Duration||59
7942174|NCT00492297|19546062|P1|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78
7942175|NCT00492297|19546062|P1|NOT COMPLETED|Treatment||5
7942176|NCT00492297|19546062|P1|COMPLETED|Treatment||78
7942177|NCT00492297|19546062|P1|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51
7942178|NCT00492297|19546062|P1|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32
7942179|NCT00492297|19546062|P1|STARTED|Treatment||83
7942180|NCT00492284|19546080|P4|NOT COMPLETED|Overall Study||10
7942181|NCT00492284|19546081|P3|NOT COMPLETED|Overall Study||6
7942182|NCT00492284|19546082|P2|NOT COMPLETED|Overall Study||4
7942183|NCT00492284|19546083|P1|NOT COMPLETED|Overall Study||1
7942184|NCT00492284|19546080|P4|COMPLETED|Overall Study||31
7942185|NCT00492284|19546081|P3|COMPLETED|Overall Study||37
7942186|NCT00492284|19546082|P2|COMPLETED|Overall Study||35
7942187|NCT00492284|19546083|P1|COMPLETED|Overall Study||38
7942188|NCT00492284|19546080|P4|STARTED|Overall Study||41
7942189|NCT00492284|19546081|P3|STARTED|Overall Study||43
7942190|NCT00492284|19546082|P2|STARTED|Overall Study||39
7942191|NCT00492284|19546083|P1|STARTED|Overall Study||39
7942192|NCT00492232|19546127|P2|NOT COMPLETED|Open-Label Treatment||0
7942193|NCT00492232|19546128|P1|NOT COMPLETED|Open-Label Treatment||1
7942194|NCT00492232|19546127|P2|COMPLETED|Open-Label Treatment||0
7942195|NCT00492232|19546128|P1|COMPLETED|Open-Label Treatment||88
7942196|NCT00492232|19546127|P2|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0
7942197|NCT00492232|19546128|P1|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89
7942198|NCT00492232|19546127|P2|NOT COMPLETED|Double-Blind Treatment||25
7942199|NCT00492232|19546128|P1|NOT COMPLETED|Double-Blind Treatment||18
7942200|NCT00492232|19546127|P2|COMPLETED|Double-Blind Treatment||45
7942201|NCT00492232|19546128|P1|COMPLETED|Double-Blind Treatment||47
7942202|NCT00492232|19546127|P2|STARTED|Double-Blind Treatment||70
7942203|NCT00492232|19546128|P1|STARTED|Double-Blind Treatment||65
7942204|NCT00492232|19546127|P2|NOT COMPLETED|Placebo Run-in||70
7942205|NCT00492232|19546128|P1|NOT COMPLETED|Placebo Run-in||0
7942206|NCT00492232|19546127|P2|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135
7942207|NCT00492232|19546128|P1|COMPLETED|Placebo Run-in||0
7942208|NCT00492232|19546127|P2|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205
7942209|NCT00492232|19546128|P1|STARTED|Placebo Run-in||0
7942210|NCT00492206|19546160|P1|NOT COMPLETED|Overall Study||0
7942211|NCT00492206|19546160|P1|COMPLETED|Overall Study||40
7942212|NCT00492206|19546160|P1|STARTED|Overall Study||40
7942213|NCT00492115|19546169|P2|NOT COMPLETED|Overall Study||4
7942214|NCT00492115|19546170|P1|NOT COMPLETED|Overall Study||3
7942215|NCT00492115|19546169|P2|COMPLETED|Overall Study|4 dropped due to not being able to tolerate CPAP|15
7942216|NCT00492115|19546170|P1|COMPLETED|Overall Study|3 dropped due to anxiety or not being able to tolerate CPAP|16
7942217|NCT00492115|19546169|P2|STARTED|Overall Study||19
7942218|NCT00492115|19546170|P1|STARTED|Overall Study||19
7942219|NCT00492089|19546180|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
7942220|NCT00492089|19546181|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
7942221|NCT00492089|19546180|P2|COMPLETED|Second Intervention (6 Weeks)||6
7942222|NCT00492089|19546181|P1|COMPLETED|Second Intervention (6 Weeks)||5
7942223|NCT00492089|19546180|P2|STARTED|Second Intervention (6 Weeks)||6
7942224|NCT00492089|19546181|P1|STARTED|Second Intervention (6 Weeks)||5
7942225|NCT00492089|19546180|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
7942226|NCT00492089|19546181|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
7942227|NCT00492089|19546180|P2|COMPLETED|First Intervention (6 Weeks)||6
7942228|NCT00492089|19546181|P1|COMPLETED|First Intervention (6 Weeks)||5
7942229|NCT00492089|19546180|P2|STARTED|First Intervention (6 Weeks)||6
7942230|NCT00492089|19546181|P1|STARTED|First Intervention (6 Weeks)||5
7942231|NCT00492063|19546191|P4|NOT COMPLETED|Overall Study||10
7942232|NCT00492063|19546192|P3|NOT COMPLETED|Overall Study||11
7942233|NCT00492063|19546193|P2|NOT COMPLETED|Overall Study||14
7942234|NCT00492063|19546194|P1|NOT COMPLETED|Overall Study||10
7942235|NCT00492063|19546191|P4|COMPLETED|Overall Study||666
7942236|NCT00492063|19546192|P3|COMPLETED|Overall Study||667
7942237|NCT00492063|19546193|P2|COMPLETED|Overall Study||634
7942238|NCT00492063|19546194|P1|COMPLETED|Overall Study||642
7942239|NCT00492063|19546191|P4|STARTED|Overall Study||676
7942240|NCT00492063|19546192|P3|STARTED|Overall Study||678
7942241|NCT00492063|19546193|P2|STARTED|Overall Study||648
7942242|NCT00492063|19546194|P1|STARTED|Overall Study||652
7942243|NCT00492024|19546218|P2|NOT COMPLETED|Follow up||2
7942244|NCT00492024|19546219|P1|NOT COMPLETED|Follow up||1
7942245|NCT00492024|19546218|P2|COMPLETED|Follow up||99
7942246|NCT00492024|19546219|P1|COMPLETED|Follow up||221
7942247|NCT00492024|19546218|P2|STARTED|Follow up||101
7942248|NCT00492024|19546219|P1|STARTED|Follow up||222
7942249|NCT00492024|19546218|P2|NOT COMPLETED|Treatment||22
7942250|NCT00492024|19546219|P1|NOT COMPLETED|Treatment||29
7942251|NCT00492024|19546218|P2|COMPLETED|Treatment||101
7942252|NCT00492024|19546219|P1|COMPLETED|Treatment||222
7942253|NCT00492024|19546218|P2|STARTED|Treatment||123
7942254|NCT00492024|19546219|P1|STARTED|Treatment||251
7942255|NCT00491894|19546235|P1|NOT COMPLETED|Overall Study||34
7942256|NCT00491894|19546235|P1|COMPLETED|Overall Study||103
7942257|NCT00491894|19546235|P1|STARTED|Overall Study||137
7942258|NCT00491829|19546246|P3|NOT COMPLETED|Overall Study||75
7942259|NCT00491829|19546247|P2|NOT COMPLETED|Overall Study||114
7942260|NCT00491829|19546248|P1|NOT COMPLETED|Overall Study||95
7942261|NCT00491829|19546246|P3|COMPLETED|Overall Study||243
7942262|NCT00491829|19546247|P2|COMPLETED|Overall Study||202
7942263|NCT00491829|19546248|P1|COMPLETED|Overall Study||216
7942264|NCT00491829|19546246|P3|STARTED|Overall Study||318
7942265|NCT00491829|19546247|P2|STARTED|Overall Study||316
7942266|NCT00491829|19546248|P1|STARTED|Overall Study||311
7942267|NCT00491764|19546262|P6|NOT COMPLETED|Overall Study||9
7942268|NCT00491764|19546263|P5|NOT COMPLETED|Overall Study||3
7942269|NCT00491764|19546264|P4|NOT COMPLETED|Overall Study||8
7942270|NCT00491764|19546265|P3|NOT COMPLETED|Overall Study||8
7942271|NCT00491764|19546266|P2|NOT COMPLETED|Overall Study||7
7942272|NCT00491764|19546267|P1|NOT COMPLETED|Overall Study||5
7942273|NCT00491764|19546262|P6|COMPLETED|Overall Study||27
7942274|NCT00491764|19546263|P5|COMPLETED|Overall Study||33
7942275|NCT00491764|19546264|P4|COMPLETED|Overall Study||28
7942276|NCT00491764|19546265|P3|COMPLETED|Overall Study||28
7942277|NCT00491764|19546266|P2|COMPLETED|Overall Study||30
7942278|NCT00491764|19546267|P1|COMPLETED|Overall Study||32
7942279|NCT00491764|19546262|P6|STARTED|Overall Study||36
7942280|NCT00491764|19546263|P5|STARTED|Overall Study||36
7942281|NCT00491764|19546264|P4|STARTED|Overall Study||36
7942282|NCT00491764|19546265|P3|STARTED|Overall Study||36
7942283|NCT00491764|19546266|P2|STARTED|Overall Study||37
7942284|NCT00491764|19546267|P1|STARTED|Overall Study||37
7942285|NCT00491751|19546296|P3|NOT COMPLETED|Overall Study||0
7942286|NCT00491751|19546297|P2|NOT COMPLETED|Overall Study||0
7942287|NCT00491751|19546298|P1|NOT COMPLETED|Overall Study||0
7942288|NCT00491751|19546296|P3|COMPLETED|Overall Study||42
7942289|NCT00491751|19546297|P2|COMPLETED|Overall Study||44
7942290|NCT00491751|19546298|P1|COMPLETED|Overall Study||22
7942291|NCT00491751|19546296|P3|STARTED|Overall Study||42
7942292|NCT00491751|19546297|P2|STARTED|Overall Study||44
7942293|NCT00491751|19546298|P1|STARTED|Overall Study||22
7942294|NCT00491738|19546310|P2|NOT COMPLETED|Overall Study||0
7942295|NCT00491738|19546311|P1|NOT COMPLETED|Overall Study||0
7942296|NCT00491738|19546310|P2|COMPLETED|Overall Study||9
7942297|NCT00491738|19546311|P1|COMPLETED|Overall Study||7
7942298|NCT00491738|19546310|P2|STARTED|Overall Study||9
7942299|NCT00491738|19546311|P1|STARTED|Overall Study||7
7942300|NCT00491608|19546315|P1|NOT COMPLETED|Overall Study||3
7942301|NCT00491608|19546315|P1|COMPLETED|Overall Study||206
7942302|NCT00491608|19546315|P1|STARTED|Overall Study|Participants who received treatment|209
7942303|NCT00491556|19546326|P2|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5
7942304|NCT00491556|19546327|P1|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24
7942305|NCT00491556|19546326|P2|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22
7942306|NCT00491556|19546327|P1|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25
7942307|NCT00491556|19546326|P2|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27
7942308|NCT00491556|19546327|P1|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49
7942309|NCT00491556|19546326|P2|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0
7942310|NCT00491556|19546327|P1|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26
7942311|NCT00491556|19546326|P2|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27
7942312|NCT00491556|19546327|P1|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49
7942313|NCT00491556|19546326|P2|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27
7942314|NCT00491556|19546327|P1|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53
7942315|NCT00491556|19546326|P2|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27
7942316|NCT00491556|19546327|P1|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75
7942317|NCT00491530|19546386|P3|NOT COMPLETED|Overall Study||5
7942318|NCT00491530|19546387|P2|NOT COMPLETED|Overall Study||6
7942319|NCT00491530|19546388|P1|NOT COMPLETED|Overall Study||12
7942320|NCT00491530|19546386|P3|COMPLETED|Overall Study||81
7942321|NCT00491530|19546387|P2|COMPLETED|Overall Study||44
7942322|NCT00491530|19546388|P1|COMPLETED|Overall Study||162
7942323|NCT00491530|19546386|P3|STARTED|Overall Study||86
7942324|NCT00491530|19546387|P2|STARTED|Overall Study||50
7942325|NCT00491530|19546388|P1|STARTED|Overall Study||174
7942326|NCT00491504|19546418|P4|NOT COMPLETED|Overall Study||4
7942327|NCT00491504|19546419|P3|NOT COMPLETED|Overall Study||4
7942328|NCT00491504|19546420|P2|NOT COMPLETED|Overall Study||1
7942329|NCT00491504|19546421|P1|NOT COMPLETED|Overall Study||0
7942330|NCT00491504|19546418|P4|COMPLETED|Overall Study||73
7942331|NCT00491504|19546419|P3|COMPLETED|Overall Study||74
7942332|NCT00491504|19546420|P2|COMPLETED|Overall Study||77
7942333|NCT00491504|19546421|P1|COMPLETED|Overall Study||77
7942334|NCT00491504|19546418|P4|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77
7942335|NCT00491504|19546419|P3|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78
7942336|NCT00491504|19546420|P2|STARTED|Overall Study|All subjects who received placebo only on Day 1|78
7942337|NCT00491504|19546421|P1|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77
7942338|NCT00491491|19546431|P2|NOT COMPLETED|Overall Study||0
7942339|NCT00491491|19546432|P1|NOT COMPLETED|Overall Study||0
7942340|NCT00491491|19546431|P2|COMPLETED|Overall Study||21
7942341|NCT00491491|19546432|P1|COMPLETED|Overall Study||22
7942342|NCT00491491|19546431|P2|STARTED|Overall Study||21
7942343|NCT00491491|19546432|P1|STARTED|Overall Study||22
7942344|NCT00491400|19546450|P2|NOT COMPLETED|Overall Study||4
7942345|NCT00491400|19546451|P1|NOT COMPLETED|Overall Study||5
7942346|NCT00491400|19546450|P2|COMPLETED|Overall Study||9
7942347|NCT00491400|19546451|P1|COMPLETED|Overall Study||10
7942348|NCT00491400|19546450|P2|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9
7942349|NCT00491400|19546451|P1|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10
7942350|NCT00491400|19546450|P2|Started Second Treatment|Overall Study|None withdrew during the washout period|9
7942351|NCT00491400|19546451|P1|Started Second Treatment|Overall Study|2 withdrew during washout period|12
7942352|NCT00491400|19546450|P2|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9
7942353|NCT00491400|19546451|P1|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14
7942354|NCT00491400|19546450|P2|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13
7942355|NCT00491400|19546451|P1|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14
7942356|NCT00491400|19546450|P2|STARTED|Overall Study||13
7942357|NCT00491400|19546451|P1|STARTED|Overall Study||15
7942358|NCT00491387|19546459|P1|NOT COMPLETED|Overall Study||20
7942359|NCT00491387|19546459|P1|COMPLETED|Overall Study||4
7942360|NCT00491387|19546459|P1|Study Enrollment|Overall Study||24
7942361|NCT00491387|19546459|P1|STARTED|Overall Study||24
7942362|NCT00491374|19546465|P2|NOT COMPLETED|Overall Study||0
7942363|NCT00491374|19546466|P1|NOT COMPLETED|Overall Study||0
7942364|NCT00491374|19546465|P2|COMPLETED|Overall Study||0
7942365|NCT00491374|19546466|P1|COMPLETED|Overall Study||0
7942366|NCT00491374|19546465|P2|STARTED|Overall Study||0
7942367|NCT00491374|19546466|P1|STARTED|Overall Study||0
7942368|NCT00491322|19546474|P2|NOT COMPLETED|Overall Study||1
7942369|NCT00491322|19546475|P1|NOT COMPLETED|Overall Study||1
7942370|NCT00491322|19546474|P2|COMPLETED|Overall Study||50
7942371|NCT00491322|19546475|P1|COMPLETED|Overall Study||40
7942372|NCT00491322|19546474|P2|STARTED|Overall Study||51
7942373|NCT00491322|19546475|P1|STARTED|Overall Study||41
7942374|NCT00491244|19546483|P2|NOT COMPLETED|Overall Study||20
7942375|NCT00491244|19546484|P1|NOT COMPLETED|Overall Study||27
7942376|NCT00491244|19546483|P2|COMPLETED|Overall Study||168
7942377|NCT00491244|19546484|P1|COMPLETED|Overall Study||162
7942378|NCT00491244|19546483|P2|STARTED|Overall Study||188
7942379|NCT00491244|19546484|P1|STARTED|Overall Study||189
7942380|NCT00491179|19546494|P2|NOT COMPLETED|Overall Study||2
7942381|NCT00491179|19546495|P1|NOT COMPLETED|Overall Study||7
7942382|NCT00491179|19546494|P2|COMPLETED|Overall Study||8
7942383|NCT00491179|19546495|P1|COMPLETED|Overall Study||18
7942384|NCT00491179|19546494|P2|STARTED|Overall Study||10
7942385|NCT00491179|19546495|P1|STARTED|Overall Study||25
7942386|NCT00491075|19546503|P1|NOT COMPLETED|Overall Study||2
7942387|NCT00491075|19546503|P1|COMPLETED|Overall Study||14
7942388|NCT00491075|19546503|P1|STARTED|Overall Study||16
7942389|NCT00490971|19546509|P5|NOT COMPLETED|Maintenance||39
7942390|NCT00490971|19546510|P4|NOT COMPLETED|Maintenance||53
7942391|NCT00490971|19546511|P3|NOT COMPLETED|Maintenance||51
7942392|NCT00490971|19546512|P2|NOT COMPLETED|Maintenance||0
7942393|NCT00490971|19546513|P1|NOT COMPLETED|Maintenance||0
7942394|NCT00490971|19546509|P5|COMPLETED|Maintenance||44
7942395|NCT00490971|19546510|P4|COMPLETED|Maintenance||96
7942396|NCT00490971|19546511|P3|COMPLETED|Maintenance||96
7942397|NCT00490971|19546512|P2|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
7942398|NCT00490971|19546513|P1|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
7942399|NCT00490971|19546509|P5|STARTED|Maintenance||83
7942400|NCT00490971|19546510|P4|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149
7942401|NCT00490971|19546511|P3|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147
7942402|NCT00490971|19546512|P2|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
7942403|NCT00490971|19546513|P1|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
7942404|NCT00490971|19546509|P5|NOT COMPLETED|Acute/Continuation||0
7942405|NCT00490971|19546510|P4|NOT COMPLETED|Acute/Continuation||0
7942406|NCT00490971|19546511|P3|NOT COMPLETED|Acute/Continuation||0
7942407|NCT00490971|19546512|P2|NOT COMPLETED|Acute/Continuation||62
7942408|NCT00490971|19546513|P1|NOT COMPLETED|Acute/Continuation||306
7942409|NCT00490971|19546509|P5|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
7942410|NCT00490971|19546510|P4|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
7942411|NCT00490971|19546511|P3|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
7942412|NCT00490971|19546512|P2|COMPLETED|Acute/Continuation||86
7942413|NCT00490971|19546513|P1|COMPLETED|Acute/Continuation||308
7942414|NCT00490971|19546509|P5|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
7942415|NCT00490971|19546510|P4|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
7942416|NCT00490971|19546511|P3|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
7942417|NCT00490971|19546512|P2|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148
7942418|NCT00490971|19546513|P1|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614
7942419|NCT00490945|19546560|P5|NOT COMPLETED|Overall Study||0
7942420|NCT00490945|19546561|P4|NOT COMPLETED|Overall Study||0
7942421|NCT00490945|19546562|P3|NOT COMPLETED|Overall Study||0
7942422|NCT00490945|19546563|P2|NOT COMPLETED|Overall Study||1
7942423|NCT00490945|19546564|P1|NOT COMPLETED|Overall Study||0
7942424|NCT00490945|19546560|P5|COMPLETED|Overall Study||7
7942425|NCT00490945|19546561|P4|COMPLETED|Overall Study||7
7942426|NCT00490945|19546562|P3|COMPLETED|Overall Study||8
7942427|NCT00490945|19546563|P2|COMPLETED|Overall Study||8
7942428|NCT00490945|19546564|P1|COMPLETED|Overall Study||8
7942429|NCT00490945|19546560|P5|STARTED|Overall Study||7
7942430|NCT00490945|19546561|P4|STARTED|Overall Study||7
7942431|NCT00490945|19546562|P3|STARTED|Overall Study||8
7942432|NCT00490945|19546563|P2|STARTED|Overall Study||9
7942433|NCT00490945|19546564|P1|STARTED|Overall Study||8
7942434|NCT00490919|19546600|P3|NOT COMPLETED|Double-blind Phase||84
7942435|NCT00490919|19546601|P2|NOT COMPLETED|Double-blind Phase||86
7942436|NCT00490919|19546602|P1|NOT COMPLETED|Double-blind Phase||0
7942437|NCT00490919|19546600|P3|COMPLETED|Double-blind Phase||199
7942438|NCT00490919|19546601|P2|COMPLETED|Double-blind Phase||170
7942439|NCT00490919|19546602|P1|COMPLETED|Double-blind Phase||0
7942440|NCT00490919|19546600|P3|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283
7942441|NCT00490919|19546601|P2|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256
7942442|NCT00490919|19546602|P1|STARTED|Double-blind Phase||0
7942443|NCT00490919|19546600|P3|NOT COMPLETED|Open-label Run-in Period||0
7942444|NCT00490919|19546601|P2|NOT COMPLETED|Open-label Run-in Period||0
7942445|NCT00490919|19546602|P1|NOT COMPLETED|Open-label Run-in Period||483
7942446|NCT00490919|19546600|P3|COMPLETED|Open-label Run-in Period||0
7942447|NCT00490919|19546601|P2|COMPLETED|Open-label Run-in Period||0
7942448|NCT00490919|19546602|P1|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541
7942449|NCT00490919|19546600|P3|STARTED|Open-label Run-in Period||0
7942450|NCT00490919|19546601|P2|STARTED|Open-label Run-in Period||0
7942451|NCT00490919|19546602|P1|STARTED|Open-label Run-in Period||1024
7942452|NCT00490841|19546613|P1|NOT COMPLETED|Overall Study||13
7942453|NCT00490841|19546613|P1|COMPLETED|Overall Study||189
7942454|NCT00490841|19546613|P1|STARTED|Overall Study||202
7942455|NCT00490815|19546635|P2|NOT COMPLETED|Overall Study||9
7942456|NCT00490815|19546636|P1|NOT COMPLETED|Overall Study||8
7942457|NCT00490815|19546635|P2|COMPLETED|Overall Study||8
7942458|NCT00490815|19546636|P1|COMPLETED|Overall Study||12
7942459|NCT00490815|19546635|P2|STARTED|Overall Study||17
7942460|NCT00490815|19546636|P1|STARTED|Overall Study||20
7942461|NCT00490802|19546646|P2|NOT COMPLETED|Overall Study||2
7942462|NCT00490802|19546647|P1|NOT COMPLETED|Overall Study||1
7942463|NCT00490802|19546646|P2|COMPLETED|Overall Study||7
7942464|NCT00490802|19546647|P1|COMPLETED|Overall Study||9
7942465|NCT00490802|19546646|P2|STARTED|Overall Study||9
7942466|NCT00490802|19546647|P1|STARTED|Overall Study||10
7942467|NCT00490724|19546664|P3|NOT COMPLETED|Period II||3
7942468|NCT00490724|19546665|P2|NOT COMPLETED|Period II||1
7942469|NCT00490724|19546666|P1|NOT COMPLETED|Period II||3
7942470|NCT00490724|19546664|P3|COMPLETED|Period II||16
7942471|NCT00490724|19546665|P2|COMPLETED|Period II||19
7942472|NCT00490724|19546666|P1|COMPLETED|Period II||18
7942473|NCT00490724|19546664|P3|STARTED|Period II||19
7942474|NCT00490724|19546665|P2|STARTED|Period II||20
7942475|NCT00490724|19546666|P1|STARTED|Period II||21
7942476|NCT00490724|19546664|P3|NOT COMPLETED|Period I||1
7942477|NCT00490724|19546665|P2|NOT COMPLETED|Period I||0
7942478|NCT00490724|19546666|P1|NOT COMPLETED|Period I||0
7942479|NCT00490724|19546664|P3|COMPLETED|Period I||19
7942480|NCT00490724|19546665|P2|COMPLETED|Period I||20
7942481|NCT00490724|19546666|P1|COMPLETED|Period I||21
7942482|NCT00490724|19546664|P3|STARTED|Period I||20
7942483|NCT00490724|19546665|P2|STARTED|Period I||20
7942484|NCT00490724|19546666|P1|STARTED|Period I||21
7942485|NCT00490698|19546731|P1|NOT COMPLETED|Overall Study||10
7942486|NCT00490698|19546731|P1|COMPLETED|Overall Study||1
7942487|NCT00490698|19546731|P1|STARTED|Overall Study||11
7942488|NCT00490646|19546737|P2|NOT COMPLETED|Overall Study||2
7942489|NCT00490646|19546738|P1|NOT COMPLETED|Overall Study||2
7942490|NCT00490646|19546737|P2|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23
7942491|NCT00490646|19546738|P1|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23
7942492|NCT00490646|19546737|P2|Treated|Overall Study||24
7942493|NCT00490646|19546738|P1|Treated|Overall Study||24
7942494|NCT00490646|19546737|P2|STARTED|Overall Study||25
7942495|NCT00490646|19546738|P1|STARTED|Overall Study||25
7942496|NCT00490568|19546758|P1|NOT COMPLETED|Overall Study||1364
7942497|NCT00490568|19546758|P1|COMPLETED|Overall Study||97
7942498|NCT00490568|19546758|P1|STARTED|Overall Study||1461
7942499|NCT00490555|19546782|P4|NOT COMPLETED|Overall Study||0
7942500|NCT00490555|19546783|P3|NOT COMPLETED|Overall Study||2
7942501|NCT00490555|19546784|P2|NOT COMPLETED|Overall Study||0
7942502|NCT00490555|19546785|P1|NOT COMPLETED|Overall Study||0
7942503|NCT00490555|19546782|P4|COMPLETED|Overall Study||7
7942504|NCT00490555|19546783|P3|COMPLETED|Overall Study||7
7942505|NCT00490555|19546784|P2|COMPLETED|Overall Study||8
7942506|NCT00490555|19546785|P1|COMPLETED|Overall Study||8
7942507|NCT00490555|19546782|P4|STARTED|Overall Study||7
7942508|NCT00490555|19546783|P3|STARTED|Overall Study||9
7942509|NCT00490555|19546784|P2|STARTED|Overall Study||8
7942510|NCT00490555|19546785|P1|STARTED|Overall Study||8
7942511|NCT00490542|19546813|P2|NOT COMPLETED|Overall Study||4
7942512|NCT00490542|19546814|P1|NOT COMPLETED|Overall Study||7
7942513|NCT00490542|19546813|P2|COMPLETED|Overall Study||31
7942514|NCT00490542|19546814|P1|COMPLETED|Overall Study||31
7942515|NCT00490542|19546813|P2|STARTED|Overall Study||35
7942516|NCT00490542|19546814|P1|STARTED|Overall Study||38
7942517|NCT00490529|19546820|P1|NOT COMPLETED|Treatment With CpG-MCL Vaccine||1
7942518|NCT00490529|19546820|P1|COMPLETED|Treatment With CpG-MCL Vaccine||47
7942519|NCT00490529|19546820|P1|STARTED|Treatment With CpG-MCL Vaccine||48
7942520|NCT00490529|19546820|P1|NOT COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||11
7942521|NCT00490529|19546820|P1|COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||48
7942522|NCT00490529|19546820|P1|STARTED|Completed Pre-CpG-MCL Vaccine Procedures||59
7942523|NCT00490490|19546828|P1|NOT COMPLETED|Completed Assessment for TTP||3
7942524|NCT00490490|19546828|P1|COMPLETED|Completed Assessment for TTP||5
7942525|NCT00490490|19546828|P1|STARTED|Completed Assessment for TTP||8
7942526|NCT00490490|19546828|P1|NOT COMPLETED|Completed Assessment for CR||0
7942527|NCT00490490|19546828|P1|COMPLETED|Completed Assessment for CR||8
7942528|NCT00490490|19546828|P1|STARTED|Completed Assessment for CR||8
7942529|NCT00490477|19546836|P2|NOT COMPLETED|Overall Study||0
7942530|NCT00490477|19546837|P1|NOT COMPLETED|Overall Study||0
7942531|NCT00490477|19546836|P2|COMPLETED|Overall Study||8
7942532|NCT00490477|19546837|P1|COMPLETED|Overall Study||8
7942533|NCT00490477|19546836|P2|STARTED|Overall Study||8
7942534|NCT00490477|19546837|P1|STARTED|Overall Study||8
7942535|NCT00490451|19546845|P2|NOT COMPLETED|Overall Study||38
7942536|NCT00490451|19546846|P1|NOT COMPLETED|Overall Study||63
7942537|NCT00490451|19546845|P2|COMPLETED|Overall Study||0
7942538|NCT00490451|19546846|P1|COMPLETED|Overall Study||0
7942539|NCT00490451|19546845|P2|STARTED|Overall Study||38
7942540|NCT00490451|19546846|P1|STARTED|Overall Study||63
7942541|NCT00490282|19546866|P1|NOT COMPLETED|Overall Study||3
7942542|NCT00490282|19546866|P1|COMPLETED|Overall Study||22
7942543|NCT00490282|19546866|P1|STARTED|Overall Study||25
7942544|NCT00490269|19546874|P2|NOT COMPLETED|Placebo Then Dronabinol||0
7942545|NCT00490269|19546875|P1|NOT COMPLETED|Placebo Then Dronabinol||0
7942546|NCT00490269|19546874|P2|COMPLETED|Placebo Then Dronabinol||6
7942547|NCT00490269|19546875|P1|COMPLETED|Placebo Then Dronabinol||6
7942548|NCT00490269|19546874|P2|STARTED|Placebo Then Dronabinol||6
7942549|NCT00490269|19546875|P1|STARTED|Placebo Then Dronabinol||6
7942550|NCT00490269|19546874|P2|NOT COMPLETED|Dronabinol Then Placebo||0
7942551|NCT00490269|19546875|P1|NOT COMPLETED|Dronabinol Then Placebo||0
7942552|NCT00490269|19546874|P2|COMPLETED|Dronabinol Then Placebo||6
7942553|NCT00490269|19546875|P1|COMPLETED|Dronabinol Then Placebo||6
7942554|NCT00490269|19546874|P2|STARTED|Dronabinol Then Placebo||6
7942555|NCT00490269|19546875|P1|STARTED|Dronabinol Then Placebo||6
7942556|NCT00490256|19546883|P2|NOT COMPLETED|Overall Study||0
7942557|NCT00490256|19546884|P1|NOT COMPLETED|Overall Study||0
7942558|NCT00490256|19546883|P2|COMPLETED|Overall Study||7
7942559|NCT00490256|19546884|P1|COMPLETED|Overall Study||7
7942560|NCT00490256|19546883|P2|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
7942561|NCT00490256|19546884|P1|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
7942562|NCT00490256|19546883|P2|STARTED|Overall Study||7
7942563|NCT00490256|19546884|P1|STARTED|Overall Study||7
7942564|NCT00490139|19546894|P4|NOT COMPLETED|Overall Study||307
7942565|NCT00490139|19546895|P3|NOT COMPLETED|Overall Study||434
7942566|NCT00490139|19546896|P2|NOT COMPLETED|Overall Study||275
7942567|NCT00490139|19546897|P1|NOT COMPLETED|Overall Study||308
7942568|NCT00490139|19546894|P4|COMPLETED|Overall Study||1790
7942569|NCT00490139|19546895|P3|COMPLETED|Overall Study||1666
7942570|NCT00490139|19546896|P2|COMPLETED|Overall Study||1816
7942571|NCT00490139|19546897|P1|COMPLETED|Overall Study||1785
7942572|NCT00490139|19546894|P4|STARTED|Overall Study||2097
7942573|NCT00490139|19546895|P3|STARTED|Overall Study||2100
7942574|NCT00490139|19546896|P2|STARTED|Overall Study||2091
7942575|NCT00490139|19546897|P1|STARTED|Overall Study||2093
7942576|NCT00490100|19546927|P1|NOT COMPLETED|Overall Study||3
7942577|NCT00490100|19546927|P1|COMPLETED|Overall Study||3
7942578|NCT00490100|19546927|P1|STARTED|Overall Study||6
7942579|NCT00490061|19546932|P1|NOT COMPLETED|Overall Study||1
7942580|NCT00490061|19546932|P1|COMPLETED|Overall Study||16
7942581|NCT00490061|19546932|P1|STARTED|Overall Study||17
7942582|NCT00490035|19546941|P4|NOT COMPLETED|Overall Study||6
7942583|NCT00490035|19546942|P3|NOT COMPLETED|Overall Study||12
7942584|NCT00490035|19546943|P2|NOT COMPLETED|Overall Study||6
7942585|NCT00490035|19546944|P1|NOT COMPLETED|Overall Study||8
7942586|NCT00490035|19546941|P4|COMPLETED|Overall Study||94
7942587|NCT00490035|19546942|P3|COMPLETED|Overall Study||88
7942588|NCT00490035|19546943|P2|COMPLETED|Overall Study||93
7942589|NCT00490035|19546944|P1|COMPLETED|Overall Study||92
7942590|NCT00490035|19546941|P4|STARTED|Overall Study||100
7942591|NCT00490035|19546942|P3|STARTED|Overall Study||100
7942592|NCT00490035|19546943|P2|STARTED|Overall Study||99
7942593|NCT00490035|19546944|P1|STARTED|Overall Study||100
7942594|NCT00490022|19547044|P2|NOT COMPLETED|Overall Study||3
7942595|NCT00490022|19547045|P1|NOT COMPLETED|Overall Study||1
7942596|NCT00490022|19547044|P2|COMPLETED|Overall Study||12
7942597|NCT00490022|19547045|P1|COMPLETED|Overall Study||15
7942598|NCT00490022|19547044|P2|STARTED|Overall Study||15
7942599|NCT00490022|19547045|P1|STARTED|Overall Study||16
7942600|NCT00490009|19547053|P1|NOT COMPLETED|Overall Study||0
7942601|NCT00490009|19547053|P1|COMPLETED|Overall Study||9
7942602|NCT00490009|19547053|P1|STARTED|Overall Study||9
7942603|NCT00489970|19547062|P3|NOT COMPLETED|Persistence Year 9||5
7942604|NCT00489970|19547063|P2|NOT COMPLETED|Persistence Year 9||2
7942605|NCT00489970|19547064|P1|NOT COMPLETED|Persistence Year 9||3
7942606|NCT00489970|19547062|P3|COMPLETED|Persistence Year 9||357
7942607|NCT00489970|19547063|P2|COMPLETED|Persistence Year 9||136
7942608|NCT00489970|19547064|P1|COMPLETED|Persistence Year 9||306
7942609|NCT00489970|19547062|P3|STARTED|Persistence Year 9|Number of subjects who received the first dose at Year 9.|362
7942610|NCT00489970|19547063|P2|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|138
7942611|NCT00489970|19547064|P1|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|309
7942612|NCT00489970|19547062|P3|NOT COMPLETED|Persistence Year 5||0
7942613|NCT00489970|19547063|P2|NOT COMPLETED|Persistence Year 5||0
7942614|NCT00489970|19547064|P1|NOT COMPLETED|Persistence Year 5||0
7942615|NCT00489970|19547062|P3|COMPLETED|Persistence Year 5||0
7942616|NCT00489970|19547063|P2|COMPLETED|Persistence Year 5||401
7942617|NCT00489970|19547064|P1|COMPLETED|Persistence Year 5||856
7942618|NCT00489970|19547062|P3|STARTED|Persistence Year 5||0
7942619|NCT00489970|19547063|P2|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401
7942620|NCT00489970|19547064|P1|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856
7942621|NCT00489970|19547062|P3|NOT COMPLETED|Persistence Year 3||0
7942622|NCT00489970|19547063|P2|NOT COMPLETED|Persistence Year 3||0
7942623|NCT00489970|19547064|P1|NOT COMPLETED|Persistence Year 3||0
7942624|NCT00489970|19547062|P3|COMPLETED|Persistence Year 3||0
7942625|NCT00489970|19547063|P2|COMPLETED|Persistence Year 3||486
7942626|NCT00489970|19547064|P1|COMPLETED|Persistence Year 3||1019
7942627|NCT00489970|19547062|P3|STARTED|Persistence Year 3||0
7942628|NCT00489970|19547063|P2|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486
7942629|NCT00489970|19547064|P1|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019
7942630|NCT00489970|19547062|P3|NOT COMPLETED|Persistence Year 1||0
7942631|NCT00489970|19547063|P2|NOT COMPLETED|Persistence Year 1||0
7942632|NCT00489970|19547064|P1|NOT COMPLETED|Persistence Year 1||0
7942633|NCT00489970|19547062|P3|COMPLETED|Persistence Year 1||0
7942634|NCT00489970|19547063|P2|COMPLETED|Persistence Year 1||523
7942635|NCT00489970|19547064|P1|COMPLETED|Persistence Year 1||1069
7942636|NCT00489970|19547062|P3|STARTED|Persistence Year 1||0
7942637|NCT00489970|19547063|P2|STARTED|Persistence Year 1||523
7942638|NCT00489970|19547064|P1|STARTED|Persistence Year 1||1069
7942639|NCT00489918|19547168|P5|NOT COMPLETED|Overall Study||1
7942640|NCT00489918|19547169|P4|NOT COMPLETED|Overall Study||1
7942641|NCT00489918|19547170|P3|NOT COMPLETED|Overall Study||4
7942642|NCT00489918|19547171|P2|NOT COMPLETED|Overall Study||2
7942643|NCT00489918|19547172|P1|NOT COMPLETED|Overall Study||2
7942644|NCT00489918|19547168|P5|COMPLETED|Overall Study||32
7942645|NCT00489918|19547169|P4|COMPLETED|Overall Study||32
7942646|NCT00489918|19547170|P3|COMPLETED|Overall Study||28
7942647|NCT00489918|19547171|P2|COMPLETED|Overall Study||32
7942648|NCT00489918|19547172|P1|COMPLETED|Overall Study||31
7942649|NCT00489918|19547168|P5|STARTED|Overall Study||33
7942650|NCT00489918|19547169|P4|STARTED|Overall Study||33
7942651|NCT00489918|19547170|P3|STARTED|Overall Study||32
7942652|NCT00489918|19547171|P2|STARTED|Overall Study||34
7942653|NCT00489918|19547172|P1|STARTED|Overall Study||33
7942654|NCT00489866|19547206|P2|NOT COMPLETED|Overall Study||0
7942655|NCT00489866|19547207|P1|NOT COMPLETED|Overall Study||2
7942656|NCT00489866|19547206|P2|COMPLETED|Overall Study||7
7942657|NCT00489866|19547207|P1|COMPLETED|Overall Study||5
7942658|NCT00489866|19547206|P2|STARTED|Overall Study||7
7942659|NCT00489866|19547207|P1|STARTED|Overall Study||7
7942660|NCT00489853|19547221|P3|NOT COMPLETED|Follow-up Period||0
7942661|NCT00489853|19547222|P2|NOT COMPLETED|Follow-up Period||0
7942662|NCT00489853|19547223|P1|NOT COMPLETED|Follow-up Period||0
7942663|NCT00489853|19547221|P3|COMPLETED|Follow-up Period||33
7942664|NCT00489853|19547222|P2|COMPLETED|Follow-up Period||29
7942665|NCT00489853|19547223|P1|COMPLETED|Follow-up Period||29
7942666|NCT00489853|19547221|P3|STARTED|Follow-up Period||33
7942667|NCT00489853|19547222|P2|STARTED|Follow-up Period||29
7942668|NCT00489853|19547223|P1|STARTED|Follow-up Period||29
7942669|NCT00489853|19547221|P3|NOT COMPLETED|Treatment Period 3||0
7942670|NCT00489853|19547222|P2|NOT COMPLETED|Treatment Period 3||1
7942671|NCT00489853|19547223|P1|NOT COMPLETED|Treatment Period 3||0
7942672|NCT00489853|19547221|P3|COMPLETED|Treatment Period 3||33
7942673|NCT00489853|19547222|P2|COMPLETED|Treatment Period 3||29
7942674|NCT00489853|19547223|P1|COMPLETED|Treatment Period 3||29
7942675|NCT00489853|19547221|P3|STARTED|Treatment Period 3||33
7942676|NCT00489853|19547222|P2|STARTED|Treatment Period 3||30
7942677|NCT00489853|19547223|P1|STARTED|Treatment Period 3||29
7942678|NCT00489853|19547221|P3|NOT COMPLETED|Wash-out Period 2||2
7942679|NCT00489853|19547222|P2|NOT COMPLETED|Wash-out Period 2||3
7942680|NCT00489853|19547223|P1|NOT COMPLETED|Wash-out Period 2||4
7942681|NCT00489853|19547221|P3|COMPLETED|Wash-out Period 2||31
7942682|NCT00489853|19547222|P2|COMPLETED|Wash-out Period 2||32
7942683|NCT00489853|19547223|P1|COMPLETED|Wash-out Period 2||29
7942684|NCT00489853|19547221|P3|STARTED|Wash-out Period 2||33
7942685|NCT00489853|19547222|P2|STARTED|Wash-out Period 2||35
7942686|NCT00489853|19547223|P1|STARTED|Wash-out Period 2||33
7942687|NCT00489853|19547221|P3|NOT COMPLETED|Treatment Period 2||0
7942688|NCT00489853|19547222|P2|NOT COMPLETED|Treatment Period 2||0
7942689|NCT00489853|19547223|P1|NOT COMPLETED|Treatment Period 2||0
7942690|NCT00489853|19547221|P3|COMPLETED|Treatment Period 2||33
7942691|NCT00489853|19547222|P2|COMPLETED|Treatment Period 2||35
7942692|NCT00489853|19547223|P1|COMPLETED|Treatment Period 2||33
7942693|NCT00489853|19547221|P3|STARTED|Treatment Period 2||33
7942694|NCT00489853|19547222|P2|STARTED|Treatment Period 2||35
7942695|NCT00489853|19547223|P1|STARTED|Treatment Period 2||33
7942696|NCT00489853|19547221|P3|NOT COMPLETED|Wash-out Period 1||6
7942697|NCT00489853|19547222|P2|NOT COMPLETED|Wash-out Period 1||3
7942698|NCT00489853|19547223|P1|NOT COMPLETED|Wash-out Period 1||1
7942699|NCT00489853|19547221|P3|COMPLETED|Wash-out Period 1||32
7942700|NCT00489853|19547222|P2|COMPLETED|Wash-out Period 1||34
7942701|NCT00489853|19547223|P1|COMPLETED|Wash-out Period 1||35
7942702|NCT00489853|19547221|P3|STARTED|Wash-out Period 1||38
7942703|NCT00489853|19547222|P2|STARTED|Wash-out Period 1||37
7942704|NCT00489853|19547223|P1|STARTED|Wash-out Period 1||36
7942705|NCT00489853|19547221|P3|NOT COMPLETED|Treatment Period 1||0
7942706|NCT00489853|19547222|P2|NOT COMPLETED|Treatment Period 1||0
7942707|NCT00489853|19547223|P1|NOT COMPLETED|Treatment Period 1||0
7942708|NCT00489853|19547221|P3|COMPLETED|Treatment Period 1||38
7942709|NCT00489853|19547222|P2|COMPLETED|Treatment Period 1||37
7942710|NCT00489853|19547223|P1|COMPLETED|Treatment Period 1||36
7942711|NCT00489853|19547221|P3|STARTED|Treatment Period 1||38
7942712|NCT00489853|19547222|P2|STARTED|Treatment Period 1||37
7942713|NCT00489853|19547223|P1|STARTED|Treatment Period 1||36
7942714|NCT00489827|19547320|P2|NOT COMPLETED|Overall Study||2
7942715|NCT00489827|19547321|P1|NOT COMPLETED|Overall Study||2
7942716|NCT00489827|19547320|P2|COMPLETED|Overall Study||433
7942717|NCT00489827|19547321|P1|COMPLETED|Overall Study||428
7942718|NCT00489827|19547320|P2|STARTED|Overall Study||435
7942719|NCT00489827|19547321|P1|STARTED|Overall Study||430
7942720|NCT00489736|19547345|P2|NOT COMPLETED|Overall Study||69
7942721|NCT00489736|19547346|P1|NOT COMPLETED|Overall Study||96
7942722|NCT00489736|19547345|P2|COMPLETED|Overall Study|completed study drug period|186
7942723|NCT00489736|19547346|P1|COMPLETED|Overall Study|completed study drug period|153
7942724|NCT00489736|19547345|P2|STARTED|Overall Study|Randomized and treated patients|255
7942725|NCT00489736|19547346|P1|STARTED|Overall Study|Randomized and treated patients|249
7942726|NCT00489554|19547356|P1|NOT COMPLETED|Overall Study||4
7942727|NCT00489554|19547356|P1|COMPLETED|Overall Study||226
7942728|NCT00489554|19547356|P1|STARTED|Overall Study||230
7942729|NCT00489541|19547376|P2|NOT COMPLETED|9-Month Angiographic Follow-up||17
7942730|NCT00489541|19547377|P1|NOT COMPLETED|9-Month Angiographic Follow-up||27
7942731|NCT00489541|19547376|P2|COMPLETED|9-Month Angiographic Follow-up||108
7942732|NCT00489541|19547377|P1|COMPLETED|9-Month Angiographic Follow-up||197
7942733|NCT00489541|19547376|P2|STARTED|9-Month Angiographic Follow-up||125
7942734|NCT00489541|19547377|P1|STARTED|9-Month Angiographic Follow-up||224
7942735|NCT00489541|19547376|P2|NOT COMPLETED|12-Month Clinical Follow-up||5
7942736|NCT00489541|19547377|P1|NOT COMPLETED|12-Month Clinical Follow-up||9
7942737|NCT00489541|19547376|P2|COMPLETED|12-Month Clinical Follow-up||120
7942738|NCT00489541|19547377|P1|COMPLETED|12-Month Clinical Follow-up||215
7942739|NCT00489541|19547376|P2|STARTED|12-Month Clinical Follow-up||125
7942740|NCT00489541|19547377|P1|STARTED|12-Month Clinical Follow-up||224
7942741|NCT00489489|19547388|P3|NOT COMPLETED|Overall Study||3
7942742|NCT00489489|19547389|P2|NOT COMPLETED|Overall Study||5
7942743|NCT00489489|19547390|P1|NOT COMPLETED|Overall Study||3
7942744|NCT00489489|19547388|P3|COMPLETED|Overall Study|completed treatment period|37
7942745|NCT00489489|19547389|P2|COMPLETED|Overall Study|completed treatment period|32
7942746|NCT00489489|19547390|P1|COMPLETED|Overall Study|completed treatment period|38
7942747|NCT00489489|19547388|P3|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39
7942748|NCT00489489|19547389|P2|Treated|Overall Study||36
7942749|NCT00489489|19547390|P1|Treated|Overall Study||41
7942750|NCT00489489|19547388|P3|STARTED|Overall Study|randomized|40
7942751|NCT00489489|19547389|P2|STARTED|Overall Study|randomized|37
7942752|NCT00489489|19547390|P1|STARTED|Overall Study|randomized|41
7942753|NCT00489476|19547422|P4|NOT COMPLETED|Overall Study||0
7942754|NCT00489476|19547423|P3|NOT COMPLETED|Overall Study||0
7942755|NCT00489476|19547424|P2|NOT COMPLETED|Overall Study||1
7942756|NCT00489476|19547425|P1|NOT COMPLETED|Overall Study||0
7942757|NCT00489476|19547422|P4|COMPLETED|Overall Study||43
7942758|NCT00489476|19547423|P3|COMPLETED|Overall Study||43
7942759|NCT00489476|19547424|P2|COMPLETED|Overall Study||42
7942760|NCT00489476|19547425|P1|COMPLETED|Overall Study||39
7942761|NCT00489476|19547422|P4|STARTED|Overall Study||43
7942762|NCT00489476|19547423|P3|STARTED|Overall Study||43
7942763|NCT00489476|19547424|P2|STARTED|Overall Study||43
7942764|NCT00489476|19547425|P1|STARTED|Overall Study||39
7942765|NCT00489424|19547446|P3|NOT COMPLETED|Overall Study||5
7942766|NCT00489424|19547447|P2|NOT COMPLETED|Overall Study||5
7942767|NCT00489424|19547448|P1|NOT COMPLETED|Overall Study||4
7942768|NCT00489424|19547446|P3|COMPLETED|Overall Study||257
7942769|NCT00489424|19547447|P2|COMPLETED|Overall Study||259
7942770|NCT00489424|19547448|P1|COMPLETED|Overall Study||263
7942771|NCT00489424|19547446|P3|STARTED|Overall Study||262
7942772|NCT00489424|19547447|P2|STARTED|Overall Study||264
7942773|NCT00489424|19547448|P1|STARTED|Overall Study||267
7942774|NCT00489411|19547479|P2|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19
7942775|NCT00489411|19547480|P1|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18
7942776|NCT00489411|19547479|P2|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74
7942777|NCT00489411|19547480|P1|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67
7942778|NCT00489411|19547479|P2|STARTED|Crossover Treatment Period (Weeks 8-12)||93
7942779|NCT00489411|19547480|P1|STARTED|Crossover Treatment Period (Weeks 8-12)||85
7942780|NCT00489411|19547479|P2|NOT COMPLETED|Washout Period (Weeks 6-7)||1
7942781|NCT00489411|19547480|P1|NOT COMPLETED|Washout Period (Weeks 6-7)||2
7942782|NCT00489411|19547479|P2|COMPLETED|Washout Period (Weeks 6-7)||93
7942783|NCT00489411|19547480|P1|COMPLETED|Washout Period (Weeks 6-7)||85
7942784|NCT00489411|19547479|P2|STARTED|Washout Period (Weeks 6-7)||94
7942785|NCT00489411|19547480|P1|STARTED|Washout Period (Weeks 6-7)||87
7942786|NCT00489411|19547479|P2|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22
7942787|NCT00489411|19547480|P1|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28
7942788|NCT00489411|19547479|P2|COMPLETED|Initial Treatment Period (Weeks 1-5)||94
7942789|NCT00489411|19547480|P1|COMPLETED|Initial Treatment Period (Weeks 1-5)||87
7942790|NCT00489411|19547479|P2|STARTED|Initial Treatment Period (Weeks 1-5)||116
7942791|NCT00489411|19547480|P1|STARTED|Initial Treatment Period (Weeks 1-5)||115
7942792|NCT00489359|19547494|P2|NOT COMPLETED|Overall Study||29
7942793|NCT00489359|19547495|P1|NOT COMPLETED|Overall Study||7
7942794|NCT00489359|19547494|P2|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37
7942795|NCT00489359|19547495|P1|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13
7942796|NCT00489359|19547494|P2|STARTED|Overall Study||66
7942797|NCT00489359|19547495|P1|STARTED|Overall Study||20
7942798|NCT00489281|19547520|P2|NOT COMPLETED|Overall Study||0
7942799|NCT00489281|19547521|P1|NOT COMPLETED|Overall Study||0
7942800|NCT00489281|19547520|P2|COMPLETED|Overall Study||13
7942801|NCT00489281|19547521|P1|COMPLETED|Overall Study||29
7942802|NCT00489281|19547520|P2|STARTED|Overall Study||13
7942803|NCT00489281|19547521|P1|STARTED|Overall Study||29
7942804|NCT00489268|19547538|P5|NOT COMPLETED|Overall Study||20
7942805|NCT00489268|19547539|P4|NOT COMPLETED|Overall Study||0
7942806|NCT00489268|19547540|P3|NOT COMPLETED|Overall Study||1
7942807|NCT00489268|19547541|P2|NOT COMPLETED|Overall Study||0
7942808|NCT00489268|19547542|P1|NOT COMPLETED|Overall Study||0
7942809|NCT00489268|19547538|P5|COMPLETED|Overall Study||50
7942810|NCT00489268|19547539|P4|COMPLETED|Overall Study||11
7942811|NCT00489268|19547540|P3|COMPLETED|Overall Study||9
7942812|NCT00489268|19547541|P2|COMPLETED|Overall Study||10
7942813|NCT00489268|19547542|P1|COMPLETED|Overall Study||1
7942814|NCT00489268|19547538|P5|STARTED|Overall Study||70
7942815|NCT00489268|19547539|P4|STARTED|Overall Study||11
7942816|NCT00489268|19547540|P3|STARTED|Overall Study||10
7942817|NCT00489268|19547541|P2|STARTED|Overall Study||10
7942818|NCT00489268|19547542|P1|STARTED|Overall Study||1
7942819|NCT00489255|19547571|P2|NOT COMPLETED|Period 3: Days 57 to 84||4
7942820|NCT00489255|19547572|P1|NOT COMPLETED|Period 3: Days 57 to 84||4
7942821|NCT00489255|19547571|P2|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78
7942822|NCT00489255|19547572|P1|COMPLETED|Period 3: Days 57 to 84||24
7942823|NCT00489255|19547571|P2|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82
7942824|NCT00489255|19547572|P1|STARTED|Period 3: Days 57 to 84||28
7942825|NCT00489255|19547571|P2|NOT COMPLETED|Period 2: Days 29 to 56||4
7942826|NCT00489255|19547572|P1|NOT COMPLETED|Period 2: Days 29 to 56||3
7942827|NCT00489255|19547571|P2|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55
7942828|NCT00489255|19547572|P1|COMPLETED|Period 2: Days 29 to 56||61
7942829|NCT00489255|19547571|P2|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3
7942830|NCT00489255|19547572|P1|Completed But Discontinued Study|Period 2: Days 29 to 56||3
7942831|NCT00489255|19547571|P2|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52
7942832|NCT00489255|19547572|P1|Completed and Follow Period 3|Period 2: Days 29 to 56||58
7942833|NCT00489255|19547571|P2|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59
7942834|NCT00489255|19547572|P1|STARTED|Period 2: Days 29 to 56||64
7942835|NCT00489255|19547571|P2|NOT COMPLETED|Period 1: Days 1 to 28||12
7942836|NCT00489255|19547572|P1|NOT COMPLETED|Period 1: Days 1 to 28||29
7942837|NCT00489255|19547571|P2|COMPLETED|Period 1: Days 1 to 28||34
7942838|NCT00489255|19547572|P1|COMPLETED|Period 1: Days 1 to 28||107
7942839|NCT00489255|19547571|P2|Completed But Discontinued Study|Period 1: Days 1 to 28||5
7942840|NCT00489255|19547572|P1|Completed But Discontinued Study|Period 1: Days 1 to 28||13
7942841|NCT00489255|19547571|P2|Completed and Follow Period 2|Period 1: Days 1 to 28||29
7942842|NCT00489255|19547572|P1|Completed and Follow Period 2|Period 1: Days 1 to 28||94
7942843|NCT00489255|19547571|P2|STARTED|Period 1: Days 1 to 28||46
7942844|NCT00489255|19547572|P1|STARTED|Period 1: Days 1 to 28||136
7942845|NCT00489255|19547571|P2|NOT COMPLETED|Screening and Initial Randomization||3
7942846|NCT00489255|19547572|P1|NOT COMPLETED|Screening and Initial Randomization||9
7942847|NCT00489255|19547571|P2|COMPLETED|Screening and Initial Randomization||46
7942848|NCT00489255|19547572|P1|COMPLETED|Screening and Initial Randomization||136
7942849|NCT00489255|19547571|P2|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49
7942850|NCT00489255|19547572|P1|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145
7942851|NCT00489216|19547620|P1|NOT COMPLETED|Overall Study||1
7942852|NCT00489216|19547620|P1|COMPLETED|Overall Study||1
7942853|NCT00489216|19547620|P1|STARTED|Overall Study||2
7942854|NCT00489086|19547629|P1|NOT COMPLETED|Overall Study||23
7942855|NCT00489086|19547629|P1|COMPLETED|Overall Study||13
7942856|NCT00489086|19547629|P1|Completed 18 Months|Overall Study||23
7942857|NCT00489086|19547629|P1|STARTED|Overall Study||36
7942858|NCT00488982|19547637|P3|NOT COMPLETED|Response to Course 3||3
7942859|NCT00488982|19547638|P2|NOT COMPLETED|Response to Course 3||1
7942860|NCT00488982|19547639|P1|NOT COMPLETED|Response to Course 3||0
7942861|NCT00488982|19547637|P3|COMPLETED|Response to Course 3||0
7942862|NCT00488982|19547638|P2|COMPLETED|Response to Course 3||1
7942863|NCT00488982|19547639|P1|COMPLETED|Response to Course 3||0
7942864|NCT00488982|19547637|P3|STARTED|Response to Course 3||3
7942865|NCT00488982|19547638|P2|STARTED|Response to Course 3||2
7942866|NCT00488982|19547639|P1|STARTED|Response to Course 3||0
7942867|NCT00488982|19547637|P3|NOT COMPLETED|Course 3||5
7942868|NCT00488982|19547638|P2|NOT COMPLETED|Course 3||2
7942869|NCT00488982|19547639|P1|NOT COMPLETED|Course 3||0
7942870|NCT00488982|19547637|P3|COMPLETED|Course 3||3
7942871|NCT00488982|19547638|P2|COMPLETED|Course 3||2
7942872|NCT00488982|19547639|P1|COMPLETED|Course 3||0
7942873|NCT00488982|19547637|P3|STARTED|Course 3||8
7942874|NCT00488982|19547638|P2|STARTED|Course 3||4
7942875|NCT00488982|19547639|P1|STARTED|Course 3||0
7942876|NCT00488982|19547637|P3|NOT COMPLETED|Course 2||5
7942877|NCT00488982|19547638|P2|NOT COMPLETED|Course 2||9
7942878|NCT00488982|19547639|P1|NOT COMPLETED|Course 2||0
7942879|NCT00488982|19547637|P3|COMPLETED|Course 2||8
7942880|NCT00488982|19547638|P2|COMPLETED|Course 2||4
7942881|NCT00488982|19547639|P1|COMPLETED|Course 2||0
7942882|NCT00488982|19547637|P3|STARTED|Course 2||13
7942883|NCT00488982|19547638|P2|STARTED|Course 2||13
7942884|NCT00488982|19547639|P1|STARTED|Course 2||0
7942885|NCT00488982|19547637|P3|NOT COMPLETED|Course 1||14
7942886|NCT00488982|19547638|P2|NOT COMPLETED|Course 1||12
7942887|NCT00488982|19547639|P1|NOT COMPLETED|Course 1||0
7942888|NCT00488982|19547637|P3|COMPLETED|Course 1||13
7942889|NCT00488982|19547638|P2|COMPLETED|Course 1||13
7942890|NCT00488982|19547639|P1|COMPLETED|Course 1||0
7942891|NCT00488982|19547637|P3|STARTED|Course 1||27
7942892|NCT00488982|19547638|P2|STARTED|Course 1||25
7942893|NCT00488982|19547639|P1|STARTED|Course 1||0
7942894|NCT00488982|19547637|P3|NOT COMPLETED|Induction Chemotherapy||0
7942895|NCT00488982|19547638|P2|NOT COMPLETED|Induction Chemotherapy||0
7942896|NCT00488982|19547639|P1|NOT COMPLETED|Induction Chemotherapy||73
7942897|NCT00488982|19547637|P3|COMPLETED|Induction Chemotherapy||0
7942898|NCT00488982|19547638|P2|COMPLETED|Induction Chemotherapy||0
7942899|NCT00488982|19547639|P1|COMPLETED|Induction Chemotherapy||52
7942900|NCT00488982|19547637|P3|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
7942901|NCT00488982|19547638|P2|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
7942902|NCT00488982|19547639|P1|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||52
7942903|NCT00488982|19547637|P3|6 Cycles Completed|Induction Chemotherapy||0
7942904|NCT00488982|19547638|P2|6 Cycles Completed|Induction Chemotherapy||0
7942905|NCT00488982|19547639|P1|6 Cycles Completed|Induction Chemotherapy||94
7942906|NCT00488982|19547637|P3|STARTED|Induction Chemotherapy||0
7942907|NCT00488982|19547638|P2|STARTED|Induction Chemotherapy||0
7942908|NCT00488982|19547639|P1|STARTED|Induction Chemotherapy||125
7942909|NCT00488865|19547653|P1|NOT COMPLETED|Overall Study||0
7942910|NCT00488865|19547653|P1|COMPLETED|Overall Study||100
7942911|NCT00488865|19547653|P1|STARTED|Overall Study||100
7942912|NCT00488826|19547662|P3|NOT COMPLETED|Overall Study||26
7942913|NCT00488826|19547663|P2|NOT COMPLETED|Overall Study||52
7942914|NCT00488826|19547664|P1|NOT COMPLETED|Overall Study||56
7942915|NCT00488826|19547662|P3|COMPLETED|Overall Study||178
7942916|NCT00488826|19547663|P2|COMPLETED|Overall Study||244
7942917|NCT00488826|19547664|P1|COMPLETED|Overall Study||244
7942918|NCT00488826|19547662|P3|STARTED|Overall Study||204
7942919|NCT00488826|19547663|P2|STARTED|Overall Study||296
7942920|NCT00488826|19547664|P1|STARTED|Overall Study||300
7942921|NCT00488774|19547679|P4|NOT COMPLETED|Overall Study||3
7942922|NCT00488774|19547680|P3|NOT COMPLETED|Overall Study||5
7942923|NCT00488774|19547681|P2|NOT COMPLETED|Overall Study||5
7942924|NCT00488774|19547682|P1|NOT COMPLETED|Overall Study||8
7942925|NCT00488774|19547679|P4|COMPLETED|Overall Study||74
7942926|NCT00488774|19547680|P3|COMPLETED|Overall Study||70
7942927|NCT00488774|19547681|P2|COMPLETED|Overall Study||57
7942928|NCT00488774|19547682|P1|COMPLETED|Overall Study||69
7942929|NCT00488774|19547679|P4|STARTED|Overall Study||77
7942930|NCT00488774|19547680|P3|STARTED|Overall Study||75
7942931|NCT00488774|19547681|P2|STARTED|Overall Study||62
7942932|NCT00488774|19547682|P1|STARTED|Overall Study||77
7942933|NCT00488683|19547699|P3|NOT COMPLETED|Overall Study||2
7942934|NCT00488683|19547700|P2|NOT COMPLETED|Overall Study||6
7942935|NCT00488683|19547701|P1|NOT COMPLETED|Overall Study||12
7942936|NCT00488683|19547699|P3|COMPLETED|Overall Study||52
7942937|NCT00488683|19547700|P2|COMPLETED|Overall Study||48
7942938|NCT00488683|19547701|P1|COMPLETED|Overall Study||96
7942939|NCT00488683|19547699|P3|STARTED|Overall Study||54
7942940|NCT00488683|19547700|P2|STARTED|Overall Study||54
7942941|NCT00488683|19547701|P1|STARTED|Overall Study||108
7942942|NCT00488644|19547760|P1|NOT COMPLETED|Overall Study||2
7942943|NCT00488644|19547760|P1|COMPLETED|Overall Study||10
7942944|NCT00488644|19547760|P1|STARTED|Overall Study||12
7942945|NCT00488631|19547770|P10|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3
7942946|NCT00488631|19547771|P9|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182
7942947|NCT00488631|19547772|P8|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27
7942948|NCT00488631|19547773|P7|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80
7942949|NCT00488631|19547774|P6|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
7942950|NCT00488631|19547775|P5|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
7942951|NCT00488631|19547776|P4|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
7942952|NCT00488631|19547777|P3|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
7942953|NCT00488631|19547778|P2|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
7942954|NCT00488631|19547779|P1|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
7942955|NCT00488631|19547770|P10|COMPLETED|Open Label Study Extension (Week 54-228)||4
7942956|NCT00488631|19547771|P9|COMPLETED|Open Label Study Extension (Week 54-228)||288
7942957|NCT00488631|19547772|P8|COMPLETED|Open Label Study Extension (Week 54-228)||66
7942958|NCT00488631|19547773|P7|COMPLETED|Open Label Study Extension (Week 54-228)||16
7942959|NCT00488631|19547774|P6|COMPLETED|Open Label Study Extension (Week 54-228)||0
7942960|NCT00488631|19547775|P5|COMPLETED|Open Label Study Extension (Week 54-228)||0
7942961|NCT00488631|19547776|P4|COMPLETED|Open Label Study Extension (Week 54-228)||0
7942962|NCT00488631|19547777|P3|COMPLETED|Open Label Study Extension (Week 54-228)||0
7942963|NCT00488631|19547778|P2|COMPLETED|Open Label Study Extension (Week 54-228)||0
7942964|NCT00488631|19547779|P1|COMPLETED|Open Label Study Extension (Week 54-228)||0
7942965|NCT00488631|19547770|P10|STARTED|Open Label Study Extension (Week 54-228)||7
7942966|NCT00488631|19547771|P9|STARTED|Open Label Study Extension (Week 54-228)||470
7942967|NCT00488631|19547772|P8|STARTED|Open Label Study Extension (Week 54-228)||93
7942968|NCT00488631|19547773|P7|STARTED|Open Label Study Extension (Week 54-228)||96
7942969|NCT00488631|19547774|P6|STARTED|Open Label Study Extension (Week 54-228)||0
7942970|NCT00488631|19547775|P5|STARTED|Open Label Study Extension (Week 54-228)||0
7942971|NCT00488631|19547776|P4|STARTED|Open Label Study Extension (Week 54-228)||0
7942972|NCT00488631|19547777|P3|STARTED|Open Label Study Extension (Week 54-228)||0
7942973|NCT00488631|19547778|P2|STARTED|Open Label Study Extension (Week 54-228)||0
7942974|NCT00488631|19547779|P1|STARTED|Open Label Study Extension (Week 54-228)||0
7942975|NCT00488631|19547770|P10|NOT COMPLETED|Double Blind Period (Week 0-54)||0
7942976|NCT00488631|19547771|P9|NOT COMPLETED|Double Blind Period (Week 0-54)||0
7942977|NCT00488631|19547772|P8|NOT COMPLETED|Double Blind Period (Week 0-54)||0
7942978|NCT00488631|19547773|P7|NOT COMPLETED|Double Blind Period (Week 0-54)||0
7942979|NCT00488631|19547774|P6|NOT COMPLETED|Double Blind Period (Week 0-54)||216
7942980|NCT00488631|19547775|P5|NOT COMPLETED|Double Blind Period (Week 0-54)||103
7942981|NCT00488631|19547776|P4|NOT COMPLETED|Double Blind Period (Week 0-54)||41
7942982|NCT00488631|19547777|P3|NOT COMPLETED|Double Blind Period (Week 0-54)||45
7942983|NCT00488631|19547778|P2|NOT COMPLETED|Double Blind Period (Week 0-54)||43
7942984|NCT00488631|19547779|P1|NOT COMPLETED|Double Blind Period (Week 0-54)||43
7942985|NCT00488631|19547770|P10|COMPLETED|Double Blind Period (Week 0-54)||0
7942986|NCT00488631|19547771|P9|COMPLETED|Double Blind Period (Week 0-54)||0
7942987|NCT00488631|19547772|P8|COMPLETED|Double Blind Period (Week 0-54)||0
7942988|NCT00488631|19547773|P7|COMPLETED|Double Blind Period (Week 0-54)||0
7942989|NCT00488631|19547774|P6|COMPLETED|Double Blind Period (Week 0-54)||189
7942990|NCT00488631|19547775|P5|COMPLETED|Double Blind Period (Week 0-54)||127
7942991|NCT00488631|19547776|P4|COMPLETED|Double Blind Period (Week 0-54)||88
7942992|NCT00488631|19547777|P3|COMPLETED|Double Blind Period (Week 0-54)||109
7942993|NCT00488631|19547778|P2|COMPLETED|Double Blind Period (Week 0-54)||111
7942994|NCT00488631|19547779|P1|COMPLETED|Double Blind Period (Week 0-54)||113
7942995|NCT00488631|19547770|P10|STARTED|Double Blind Period (Week 0-54)||0
7942996|NCT00488631|19547771|P9|STARTED|Double Blind Period (Week 0-54)||0
7942997|NCT00488631|19547772|P8|STARTED|Double Blind Period (Week 0-54)||0
7942998|NCT00488631|19547773|P7|STARTED|Double Blind Period (Week 0-54)||0
7942999|NCT00488631|19547774|P6|STARTED|Double Blind Period (Week 0-54)||405
7943000|NCT00488631|19547775|P5|STARTED|Double Blind Period (Week 0-54)||230
7943001|NCT00488631|19547776|P4|STARTED|Double Blind Period (Week 0-54)||129
7943002|NCT00488631|19547777|P3|STARTED|Double Blind Period (Week 0-54)||154
7943003|NCT00488631|19547778|P2|STARTED|Double Blind Period (Week 0-54)||154
7943004|NCT00488631|19547779|P1|STARTED|Double Blind Period (Week 0-54)||156
7943005|NCT00488618|19547816|P2|NOT COMPLETED|Overall Study||43
7943006|NCT00488618|19547817|P1|NOT COMPLETED|Overall Study||47
7943007|NCT00488618|19547816|P2|COMPLETED|Overall Study||75
7943008|NCT00488618|19547817|P1|COMPLETED|Overall Study||73
7943009|NCT00488618|19547816|P2|Safety Population: Received Study Drug|Overall Study||118
7943010|NCT00488618|19547817|P1|Safety Population: Received Study Drug|Overall Study||118
7943011|NCT00488618|19547816|P2|STARTED|Overall Study||118
7943012|NCT00488618|19547817|P1|STARTED|Overall Study||120
7943013|NCT00488592|19547825|P1|NOT COMPLETED|Overall Study||3
7943014|NCT00488592|19547825|P1|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7
7943015|NCT00488592|19547825|P1|STARTED|Overall Study|10 subjects were accrued|10
7943016|NCT00488514|19547829|P1|NOT COMPLETED|Overall Study||293
7943017|NCT00488514|19547829|P1|COMPLETED|Overall Study||363
7943018|NCT00488514|19547829|P1|STARTED|Overall Study||656
7943019|NCT00488488|19547902|P1|NOT COMPLETED|Overall Study||268
7943020|NCT00488488|19547902|P1|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760
7943021|NCT00488488|19547902|P1|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025
7943022|NCT00488488|19547902|P1|STARTED|Overall Study||1028
7943023|NCT00488475|19547917|P1|NOT COMPLETED|Overall Study||1754
7943024|NCT00488475|19547917|P1|COMPLETED|Overall Study||3191
7943025|NCT00488475|19547917|P1|STARTED|Overall Study||4945
7943026|NCT00488345|19547946|P3|NOT COMPLETED|Overall Study||3
7943027|NCT00488345|19547947|P2|NOT COMPLETED|Overall Study||4
7943028|NCT00488345|19547948|P1|NOT COMPLETED|Overall Study||0
7943029|NCT00488345|19547946|P3|COMPLETED|Overall Study||17
7943030|NCT00488345|19547947|P2|COMPLETED|Overall Study||17
7943031|NCT00488345|19547948|P1|COMPLETED|Overall Study||17
7943032|NCT00488345|19547946|P3|STARTED|Overall Study||20
7943033|NCT00488345|19547947|P2|STARTED|Overall Study||21
7943034|NCT00488345|19547948|P1|STARTED|Overall Study||17
7943035|NCT00488319|19547974|P3|NOT COMPLETED|Overall Study||122
7943036|NCT00488319|19547975|P2|NOT COMPLETED|Overall Study||43
7943037|NCT00488319|19547976|P1|NOT COMPLETED|Overall Study||15
7943038|NCT00488319|19547974|P3|COMPLETED|Overall Study||121
7943039|NCT00488319|19547975|P2|COMPLETED|Overall Study||75
7943040|NCT00488319|19547976|P1|COMPLETED|Overall Study||24
7943041|NCT00488319|19547974|P3|STARTED|Overall Study||243
7943042|NCT00488319|19547975|P2|STARTED|Overall Study||118
7943043|NCT00488319|19547976|P1|STARTED|Overall Study||39
7943044|NCT00488293|19548063|P2|NOT COMPLETED|Overall Study||30
7943045|NCT00488293|19548064|P1|NOT COMPLETED|Overall Study||36
7943046|NCT00488293|19548063|P2|COMPLETED|Overall Study||166
7943047|NCT00488293|19548064|P1|COMPLETED|Overall Study||160
7943048|NCT00488293|19548063|P2|STARTED|Overall Study||196
7943049|NCT00488293|19548064|P1|STARTED|Overall Study||196
7943050|NCT00488059|19548088|P3|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4
7943051|NCT00488059|19548089|P2|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
7943052|NCT00488059|19548090|P1|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
7943053|NCT00488059|19548088|P3|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1
7943054|NCT00488059|19548089|P2|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
7943055|NCT00488059|19548090|P1|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
7943056|NCT00488059|19548088|P3|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5
7943057|NCT00488059|19548089|P2|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
7943058|NCT00488059|19548090|P1|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
7943059|NCT00488059|19548088|P3|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
7943060|NCT00488059|19548089|P2|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2
7943061|NCT00488059|19548090|P1|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
7943062|NCT00488059|19548088|P3|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
7943063|NCT00488059|19548089|P2|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7
7943064|NCT00488059|19548090|P1|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
7943065|NCT00488059|19548088|P3|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
7943066|NCT00488059|19548089|P2|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9
7943067|NCT00488059|19548090|P1|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
7943068|NCT00488059|19548088|P3|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
7943069|NCT00488059|19548089|P2|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
7943070|NCT00488059|19548090|P1|NOT COMPLETED|Phase I: ENF 90mg SC BID||15
7943071|NCT00488059|19548088|P3|COMPLETED|Phase I: ENF 90mg SC BID||0
7943072|NCT00488059|19548089|P2|COMPLETED|Phase I: ENF 90mg SC BID||0
7943073|NCT00488059|19548090|P1|COMPLETED|Phase I: ENF 90mg SC BID||14
7943074|NCT00488059|19548088|P3|STARTED|Phase I: ENF 90mg SC BID||0
7943075|NCT00488059|19548089|P2|STARTED|Phase I: ENF 90mg SC BID||0
7943076|NCT00488059|19548090|P1|STARTED|Phase I: ENF 90mg SC BID||29
7943077|NCT00488033|19548109|P2|NOT COMPLETED|Overall Study||0
7943078|NCT00488033|19548110|P1|NOT COMPLETED|Overall Study||1
7943079|NCT00488033|19548109|P2|COMPLETED|Overall Study||452
7943080|NCT00488033|19548110|P1|COMPLETED|Overall Study||447
7943081|NCT00488033|19548109|P2|STARTED|Overall Study||452
7943082|NCT00488033|19548110|P1|STARTED|Overall Study||448
7943083|NCT00487981|19548126|P1|NOT COMPLETED|Overall Study||1
7943084|NCT00487981|19548126|P1|COMPLETED|Overall Study||0
7943085|NCT00487981|19548126|P1|STARTED|Overall Study||1
7943086|NCT00487942|19548134|P4|NOT COMPLETED|Overall Study||2
7943087|NCT00487942|19548135|P3|NOT COMPLETED|Overall Study||3
7943088|NCT00487942|19548136|P2|NOT COMPLETED|Overall Study||3
7943089|NCT00487942|19548137|P1|NOT COMPLETED|Overall Study||3
7943090|NCT00487942|19548134|P4|COMPLETED|Overall Study||13
7943091|NCT00487942|19548135|P3|COMPLETED|Overall Study||12
7943092|NCT00487942|19548136|P2|COMPLETED|Overall Study||12
7943093|NCT00487942|19548137|P1|COMPLETED|Overall Study||12
7943094|NCT00487942|19548134|P4|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15
7943095|NCT00487942|19548135|P3|STARTED|Overall Study||15
7943096|NCT00487942|19548136|P2|STARTED|Overall Study||15
7943097|NCT00487942|19548137|P1|STARTED|Overall Study||15
7943098|NCT00487825|19548521|P2|NOT COMPLETED|Overall Study||5
7943099|NCT00487825|19548522|P1|NOT COMPLETED|Overall Study||6
7943100|NCT00487825|19548521|P2|COMPLETED|Overall Study||21
7943101|NCT00487825|19548522|P1|COMPLETED|Overall Study||46
7943102|NCT00487825|19548521|P2|STARTED|Overall Study||26
7943103|NCT00487825|19548522|P1|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52
7943104|NCT00487747|19548534|P1|NOT COMPLETED|Overall Study||11
7943105|NCT00487747|19548534|P1|COMPLETED|Overall Study||7
7943106|NCT00487747|19548534|P1|STARTED|Overall Study||18
7943107|NCT00487721|19548545|P2|NOT COMPLETED|Overall Study||0
7943108|NCT00487721|19548546|P1|NOT COMPLETED|Overall Study||0
7943109|NCT00487721|19548545|P2|COMPLETED|Overall Study||6
7943110|NCT00487721|19548546|P1|COMPLETED|Overall Study||6
7943111|NCT00487721|19548545|P2|STARTED|Overall Study||6
7943112|NCT00487721|19548546|P1|STARTED|Overall Study||6
7943113|NCT00487695|19548551|P2|NOT COMPLETED|Second Procedure||3
7943114|NCT00487695|19548552|P1|NOT COMPLETED|Second Procedure||1
7943115|NCT00487695|19548551|P2|COMPLETED|Second Procedure||20
7943116|NCT00487695|19548552|P1|COMPLETED|Second Procedure||19
7943117|NCT00487695|19548551|P2|STARTED|Second Procedure||23
7943118|NCT00487695|19548552|P1|STARTED|Second Procedure||20
7943119|NCT00487695|19548551|P2|NOT COMPLETED|First Procedure||0
7943120|NCT00487695|19548552|P1|NOT COMPLETED|First Procedure||3
7943121|NCT00487695|19548551|P2|COMPLETED|First Procedure||23
7943122|NCT00487695|19548552|P1|COMPLETED|First Procedure||20
7943123|NCT00487695|19548551|P2|STARTED|First Procedure||23
7943124|NCT00487695|19548552|P1|STARTED|First Procedure||23
7943125|NCT00487669|19548568|P1|NOT COMPLETED|Overall Study||0
7943126|NCT00487669|19548568|P1|COMPLETED|Overall Study||12
7943127|NCT00487669|19548568|P1|STARTED|Overall Study||12
7943128|NCT00487578|19548580|P2|NOT COMPLETED|Overall Study||4
7943129|NCT00487578|19548581|P1|NOT COMPLETED|Overall Study||1
7943130|NCT00487578|19548580|P2|COMPLETED|Overall Study||5
7943131|NCT00487578|19548581|P1|COMPLETED|Overall Study||2
7943132|NCT00487578|19548580|P2|STARTED|Overall Study||9
7943133|NCT00487578|19548581|P1|STARTED|Overall Study||3
7943134|NCT00487565|19548597|P1|NOT COMPLETED|Overall Study||28
7943135|NCT00487565|19548597|P1|COMPLETED|Overall Study||182
7943136|NCT00487565|19548597|P1|STARTED|Overall Study||210
7943137|NCT00487552|19548601|P1|NOT COMPLETED|Overall Study||6
7943138|NCT00487552|19548601|P1|COMPLETED|Overall Study||12
7943139|NCT00487552|19548601|P1|STARTED|Overall Study||18
7943140|NCT00487539|19548610|P4|NOT COMPLETED|Overall Study||4
7943141|NCT00487539|19548611|P3|NOT COMPLETED|Overall Study||3
7943142|NCT00487539|19548612|P2|NOT COMPLETED|Overall Study||3
7943143|NCT00487539|19548613|P1|NOT COMPLETED|Overall Study||7
7943144|NCT00487539|19548610|P4|COMPLETED|Overall Study||327
7943145|NCT00487539|19548611|P3|COMPLETED|Overall Study||328
7943146|NCT00487539|19548612|P2|COMPLETED|Overall Study||69
7943147|NCT00487539|19548613|P1|COMPLETED|Overall Study||324
7943148|NCT00487539|19548610|P4|STARTED|Overall Study||331
7943149|NCT00487539|19548611|P3|STARTED|Overall Study||331
7943150|NCT00487539|19548612|P2|STARTED|Overall Study||72
7943151|NCT00487539|19548613|P1|STARTED|Overall Study||331
7943152|NCT00487461|19548634|P3|NOT COMPLETED|Overall Study||4
7943153|NCT00487461|19548635|P2|NOT COMPLETED|Overall Study||2
7943154|NCT00487461|19548636|P1|NOT COMPLETED|Overall Study||0
7943155|NCT00487461|19548634|P3|COMPLETED|Overall Study||7
7943156|NCT00487461|19548635|P2|COMPLETED|Overall Study||10
7943157|NCT00487461|19548636|P1|COMPLETED|Overall Study||2
7943158|NCT00487461|19548634|P3|STARTED|Overall Study||11
7943159|NCT00487461|19548635|P2|STARTED|Overall Study||12
7943160|NCT00487461|19548636|P1|STARTED|Overall Study||2
7943161|NCT00487435|19548647|P1|NOT COMPLETED|Overall Study||485
7943162|NCT00487435|19548647|P1|COMPLETED|Overall Study||669
7943163|NCT00487435|19548647|P1|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154
7943164|NCT00487396|19548652|P1|NOT COMPLETED|Overall Study||3
7943165|NCT00487396|19548652|P1|COMPLETED|Overall Study||95
7943166|NCT00487396|19548652|P1|STARTED|Overall Study||98
7943167|NCT00487279|19548663|P2|NOT COMPLETED|Overall Study||2
7943168|NCT00487279|19548664|P1|NOT COMPLETED|Overall Study||1
7943169|NCT00487279|19548663|P2|COMPLETED|Overall Study||35
7943170|NCT00487279|19548664|P1|COMPLETED|Overall Study||43
7943171|NCT00487279|19548663|P2|STARTED|Overall Study||37
7943172|NCT00487279|19548664|P1|STARTED|Overall Study||44
7943173|NCT00487240|19548674|P2|NOT COMPLETED|Overall Study||26
7943174|NCT00487240|19548675|P1|NOT COMPLETED|Overall Study||31
7943175|NCT00487240|19548674|P2|COMPLETED|Overall Study||166
7943176|NCT00487240|19548675|P1|COMPLETED|Overall Study||164
7943177|NCT00487240|19548674|P2|Full Analysis Set (ITT Population)|Overall Study||189
7943178|NCT00487240|19548675|P1|Full Analysis Set (ITT Population)|Overall Study||192
7943179|NCT00487240|19548674|P2|STARTED|Overall Study||192
7943180|NCT00487240|19548675|P1|STARTED|Overall Study||195
7943181|NCT00487188|19548703|P3|NOT COMPLETED|Maintenance Phase||1
7943182|NCT00487188|19548704|P2|NOT COMPLETED|Maintenance Phase||0
7943183|NCT00487188|19548705|P1|NOT COMPLETED|Maintenance Phase||3
7943184|NCT00487188|19548703|P3|COMPLETED|Maintenance Phase||8
7943185|NCT00487188|19548704|P2|COMPLETED|Maintenance Phase||8
7943186|NCT00487188|19548705|P1|COMPLETED|Maintenance Phase||7
7943187|NCT00487188|19548703|P3|STARTED|Maintenance Phase||9
7943188|NCT00487188|19548704|P2|STARTED|Maintenance Phase||8
7943189|NCT00487188|19548705|P1|STARTED|Maintenance Phase||10
7943190|NCT00487188|19548703|P3|NOT COMPLETED|Induction Phase||0
7943191|NCT00487188|19548704|P2|NOT COMPLETED|Induction Phase||7
7943192|NCT00487188|19548705|P1|NOT COMPLETED|Induction Phase||9
7943193|NCT00487188|19548703|P3|COMPLETED|Induction Phase||0
7943194|NCT00487188|19548704|P2|COMPLETED|Induction Phase||9
7943195|NCT00487188|19548705|P1|COMPLETED|Induction Phase||22
7943196|NCT00487188|19548703|P3|Safety Population|Induction Phase||0
7943197|NCT00487188|19548704|P2|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18
7943198|NCT00487188|19548705|P1|Safety Population|Induction Phase||29
7943199|NCT00487188|19548703|P3|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0
7943200|NCT00487188|19548704|P2|STARTED|Induction Phase||16
7943201|NCT00487188|19548705|P1|STARTED|Induction Phase||31
7943202|NCT00487162|19548744|P2|NOT COMPLETED|Overall Study||5
7943203|NCT00487162|19548745|P1|NOT COMPLETED|Overall Study||2
7943204|NCT00487162|19548744|P2|COMPLETED|Overall Study||21
7943205|NCT00487162|19548745|P1|COMPLETED|Overall Study||28
7943206|NCT00487162|19548744|P2|STARTED|Overall Study||26
7943207|NCT00487162|19548745|P1|STARTED|Overall Study||30
7943208|NCT00487084|19548756|P3|NOT COMPLETED|Overall Study||5
7943209|NCT00487084|19548757|P2|NOT COMPLETED|Overall Study||3
7943210|NCT00487084|19548758|P1|NOT COMPLETED|Overall Study||4
7943211|NCT00487084|19548756|P3|COMPLETED|Overall Study||28
7943212|NCT00487084|19548757|P2|COMPLETED|Overall Study||30
7943213|NCT00487084|19548758|P1|COMPLETED|Overall Study||29
7943214|NCT00487084|19548756|P3|STARTED|Overall Study||33
7943215|NCT00487084|19548757|P2|STARTED|Overall Study||33
7943216|NCT00487084|19548758|P1|STARTED|Overall Study||33
7943217|NCT00486954|19548779|P5|NOT COMPLETED|Randomized Part||14
7943218|NCT00486954|19548780|P4|NOT COMPLETED|Randomized Part||20
7943219|NCT00486954|19548781|P3|NOT COMPLETED|Randomized Part||0
7943220|NCT00486954|19548782|P2|NOT COMPLETED|Randomized Part||0
7943221|NCT00486954|19548783|P1|NOT COMPLETED|Randomized Part||0
7943222|NCT00486954|19548779|P5|COMPLETED|Randomized Part||115
7943223|NCT00486954|19548780|P4|COMPLETED|Randomized Part||112
7943224|NCT00486954|19548781|P3|COMPLETED|Randomized Part||0
7943225|NCT00486954|19548782|P2|COMPLETED|Randomized Part||0
7943226|NCT00486954|19548783|P1|COMPLETED|Randomized Part||0
7943227|NCT00486954|19548779|P5|STARTED|Randomized Part||129
7943228|NCT00486954|19548780|P4|STARTED|Randomized Part||132
7943229|NCT00486954|19548781|P3|STARTED|Randomized Part||0
7943230|NCT00486954|19548782|P2|STARTED|Randomized Part||0
7943231|NCT00486954|19548783|P1|STARTED|Randomized Part||0
7943232|NCT00486954|19548779|P5|NOT COMPLETED|Pilot Part||0
7943233|NCT00486954|19548780|P4|NOT COMPLETED|Pilot Part||0
7943234|NCT00486954|19548781|P3|NOT COMPLETED|Pilot Part||6
7943235|NCT00486954|19548782|P2|NOT COMPLETED|Pilot Part||0
7943236|NCT00486954|19548783|P1|NOT COMPLETED|Pilot Part||6
7943237|NCT00486954|19548779|P5|COMPLETED|Pilot Part||0
7943238|NCT00486954|19548780|P4|COMPLETED|Pilot Part||0
7943239|NCT00486954|19548781|P3|COMPLETED|Pilot Part||0
7943240|NCT00486954|19548782|P2|COMPLETED|Pilot Part||0
7943241|NCT00486954|19548783|P1|COMPLETED|Pilot Part||0
7943242|NCT00486954|19548779|P5|STARTED|Pilot Part||0
7943243|NCT00486954|19548780|P4|STARTED|Pilot Part||0
7943244|NCT00486954|19548781|P3|STARTED|Pilot Part||6
7943245|NCT00486954|19548782|P2|STARTED|Pilot Part||0
7943246|NCT00486954|19548783|P1|STARTED|Pilot Part||6
7943247|NCT00486902|19548881|P2|NOT COMPLETED|Overall Study||5
7943248|NCT00486902|19548882|P1|NOT COMPLETED|Overall Study||9
7943249|NCT00486902|19548881|P2|COMPLETED|Overall Study||89
7943250|NCT00486902|19548882|P1|COMPLETED|Overall Study||85
7943251|NCT00486902|19548881|P2|STARTED|Overall Study||94
7943252|NCT00486902|19548882|P1|STARTED|Overall Study||94
7943253|NCT00486863|19548904|P2|NOT COMPLETED|Overall Study||3
7943254|NCT00486863|19548905|P1|NOT COMPLETED|Overall Study||1
7943255|NCT00486863|19548904|P2|COMPLETED|Overall Study||183
7943256|NCT00486863|19548905|P1|COMPLETED|Overall Study||183
7943257|NCT00486863|19548904|P2|STARTED|Overall Study||186
7943258|NCT00486863|19548905|P1|STARTED|Overall Study||184
7943259|NCT00486837|19548949|P2|NOT COMPLETED|Overall Study||7
7943260|NCT00486837|19548950|P1|NOT COMPLETED|Overall Study||9
7943261|NCT00486837|19548949|P2|COMPLETED|Overall Study||28
7943262|NCT00486837|19548950|P1|COMPLETED|Overall Study||28
7943263|NCT00486837|19548949|P2|STARTED|Overall Study||35
7943264|NCT00486837|19548950|P1|STARTED|Overall Study||37
7943265|NCT00486824|19548968|P2|NOT COMPLETED|Overall Study||2
7943266|NCT00486824|19548969|P1|NOT COMPLETED|Overall Study||2
7943267|NCT00486824|19548968|P2|COMPLETED|Overall Study||3
7943268|NCT00486824|19548969|P1|COMPLETED|Overall Study||3
7943269|NCT00486824|19548968|P2|STARTED|Overall Study||5
7943270|NCT00486824|19548969|P1|STARTED|Overall Study||5
7943271|NCT00486811|19548990|P3|NOT COMPLETED|Overall Study||214
7943272|NCT00486811|19548991|P2|NOT COMPLETED|Overall Study||141
7943273|NCT00486811|19548992|P1|NOT COMPLETED|Overall Study||122
7943274|NCT00486811|19548990|P3|COMPLETED|Overall Study||119
7943275|NCT00486811|19548991|P2|COMPLETED|Overall Study||179
7943276|NCT00486811|19548992|P1|COMPLETED|Overall Study||215
7943277|NCT00486811|19548990|P3|STARTED|Overall Study|Two participants were not eligible to be dosed.|333
7943278|NCT00486811|19548991|P2|STARTED|Overall Study|One participant was not eligible to be dosed.|320
7943279|NCT00486811|19548992|P1|STARTED|Overall Study||337
7943280|NCT00486759|19549035|P2|NOT COMPLETED|Safety Follow-up||118
7943281|NCT00486759|19549036|P1|NOT COMPLETED|Safety Follow-up||139
7943282|NCT00486759|19549035|P2|COMPLETED|Safety Follow-up||142
7943283|NCT00486759|19549036|P1|COMPLETED|Safety Follow-up||64
7943284|NCT00486759|19549035|P2|STARTED|Safety Follow-up||260
7943285|NCT00486759|19549036|P1|STARTED|Safety Follow-up||203
7943286|NCT00486759|19549035|P2|NOT COMPLETED|Treatment||137
7943287|NCT00486759|19549036|P1|NOT COMPLETED|Treatment||187
7943288|NCT00486759|19549035|P2|COMPLETED|Treatment||260
7943289|NCT00486759|19549036|P1|COMPLETED|Treatment||203
7943290|NCT00486759|19549035|P2|STARTED|Treatment||397
7943291|NCT00486759|19549036|P1|STARTED|Treatment||390
7943292|NCT00486720|19549048|P2|NOT COMPLETED|Overall Study||12
7943293|NCT00486720|19549049|P1|NOT COMPLETED|Overall Study||10
7943294|NCT00486720|19549048|P2|COMPLETED|Overall Study||0
7943295|NCT00486720|19549049|P1|COMPLETED|Overall Study||0
7943296|NCT00486720|19549048|P2|STARTED|Overall Study||12
7943297|NCT00486720|19549049|P1|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10
7943298|NCT00486642|19549059|P2|NOT COMPLETED|Overall Study||0
7943299|NCT00486642|19549060|P1|NOT COMPLETED|Overall Study||0
7943300|NCT00486642|19549059|P2|COMPLETED|Overall Study||13
7943301|NCT00486642|19549060|P1|COMPLETED|Overall Study||10
7943302|NCT00486642|19549059|P2|STARTED|Overall Study||13
7943303|NCT00486642|19549060|P1|STARTED|Overall Study||10
7943304|NCT00486603|19549084|P5|NOT COMPLETED|Overall Study||0
7943305|NCT00486603|19549085|P4|NOT COMPLETED|Overall Study||0
7943306|NCT00486603|19549086|P3|NOT COMPLETED|Overall Study||0
7943307|NCT00486603|19549087|P2|NOT COMPLETED|Overall Study||1
7943308|NCT00486603|19549088|P1|NOT COMPLETED|Overall Study||1
7943309|NCT00486603|19549084|P5|COMPLETED|Overall Study||76
7943310|NCT00486603|19549085|P4|COMPLETED|Overall Study||3
7943311|NCT00486603|19549086|P3|COMPLETED|Overall Study||3
7943312|NCT00486603|19549087|P2|COMPLETED|Overall Study||6
7943313|NCT00486603|19549088|P1|COMPLETED|Overall Study||2
7943314|NCT00486603|19549084|P5|STARTED|Overall Study||76
7943315|NCT00486603|19549085|P4|STARTED|Overall Study||3
7943316|NCT00486603|19549086|P3|STARTED|Overall Study||3
7943317|NCT00486603|19549087|P2|STARTED|Overall Study||7
7943318|NCT00486603|19549088|P1|STARTED|Overall Study||3
7943319|NCT00486525|19549112|P2|NOT COMPLETED|Overall Study||13
7943320|NCT00486525|19549113|P1|NOT COMPLETED|Overall Study||6
7943321|NCT00486525|19549112|P2|COMPLETED|Overall Study||87
7943322|NCT00486525|19549113|P1|COMPLETED|Overall Study||94
7943323|NCT00486525|19549112|P2|STARTED|Overall Study||100
7943324|NCT00486525|19549113|P1|STARTED|Overall Study||100
7943325|NCT00486447|19549129|P1|NOT COMPLETED|Overall Study||0
7943326|NCT00486447|19549129|P1|COMPLETED|Overall Study||249
7943327|NCT00486447|19549129|P1|STARTED|Overall Study||249
7943328|NCT00486434|19549136|P2|NOT COMPLETED|Overall Study||134
7943329|NCT00486434|19549137|P1|NOT COMPLETED|Overall Study||194
7943330|NCT00486434|19549136|P2|COMPLETED|Overall Study||454
7943331|NCT00486434|19549137|P1|COMPLETED|Overall Study||394
7943332|NCT00486434|19549136|P2|STARTED|Overall Study||588
7943333|NCT00486434|19549137|P1|STARTED|Overall Study||588
7943334|NCT00486330|19549156|P1|NOT COMPLETED|Overall Study||2
7943335|NCT00486330|19549156|P1|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10
7943336|NCT00486330|19549156|P1|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12
7943337|NCT00486291|19549162|P2|NOT COMPLETED|Overall Study||29
7943338|NCT00486291|19549163|P1|NOT COMPLETED|Overall Study||16
7943339|NCT00486291|19549162|P2|COMPLETED|Overall Study||76
7943340|NCT00486291|19549163|P1|COMPLETED|Overall Study||89
7943341|NCT00486291|19549162|P2|STARTED|Overall Study|1 subject discontinued prior to first dose|105
7943342|NCT00486291|19549163|P1|STARTED|Overall Study|3 subjects discontinued prior to first dose|105
7943343|NCT00486278|19549171|P1|NOT COMPLETED|Overall Study||9
7943344|NCT00486278|19549171|P1|COMPLETED|Overall Study||42
7943345|NCT00486278|19549171|P1|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51
7943346|NCT00486265|19549305|P1|NOT COMPLETED|Overall Study||9
7943347|NCT00486265|19549305|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0
7943348|NCT00486265|19549305|P1|STARTED|Overall Study|Partipants dosed on day 1.|9
7943349|NCT00486252|19549309|P1|NOT COMPLETED|Overall Study||58
7943350|NCT00486252|19549309|P1|COMPLETED|Overall Study||938
7943351|NCT00486252|19549309|P1|STARTED|Overall Study||996
7943352|NCT00486226|19549324|P1|NOT COMPLETED|Overall Study||13
7943353|NCT00486226|19549324|P1|COMPLETED|Overall Study||92
7943354|NCT00486226|19549324|P1|STARTED|Overall Study||105
7943355|NCT00486044|19549334|P2|NOT COMPLETED|Overall Study||3
7943356|NCT00486044|19549335|P1|NOT COMPLETED|Overall Study||2
7943357|NCT00486044|19549334|P2|COMPLETED|Overall Study|21 completed MRI sub-study|46
7943358|NCT00486044|19549335|P1|COMPLETED|Overall Study|27 completed MRI sub-study|49
7943359|NCT00486044|19549334|P2|STARTED|Overall Study|23 in MRI sub-study|49
7943360|NCT00486044|19549335|P1|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51
7943361|NCT00486031|19549347|P1|NOT COMPLETED|Overall Study||3
7943362|NCT00486031|19549347|P1|COMPLETED|Overall Study||440
7943363|NCT00486031|19549347|P1|STARTED|Overall Study||443
7943364|NCT00486018|19549355|P3|NOT COMPLETED|Overall Study||6
7943365|NCT00486018|19549356|P2|NOT COMPLETED|Overall Study||6
7943366|NCT00486018|19549357|P1|NOT COMPLETED|Overall Study||9
7943367|NCT00486018|19549355|P3|COMPLETED|Overall Study||125
7943368|NCT00486018|19549356|P2|COMPLETED|Overall Study||128
7943369|NCT00486018|19549357|P1|COMPLETED|Overall Study||123
7943370|NCT00486018|19549355|P3|Received Drug (Safety Population)|Overall Study||130
7943371|NCT00486018|19549356|P2|Received Drug (Safety Population)|Overall Study||134
7943372|NCT00486018|19549357|P1|Received Drug (Safety Population)|Overall Study||131
7943373|NCT00486018|19549355|P3|STARTED|Overall Study||131
7943374|NCT00486018|19549356|P2|STARTED|Overall Study||134
7943375|NCT00486018|19549357|P1|STARTED|Overall Study||132
7943376|NCT00485953|19549385|P2|NOT COMPLETED|Overall Study||7
7943377|NCT00485953|19549386|P1|NOT COMPLETED|Overall Study||7
7943378|NCT00485953|19549385|P2|COMPLETED|Overall Study||47
7943379|NCT00485953|19549386|P1|COMPLETED|Overall Study||48
7943380|NCT00485953|19549385|P2|STARTED|Overall Study||54
7943381|NCT00485953|19549386|P1|STARTED|Overall Study||55
7943382|NCT00485836|19549399|P3|NOT COMPLETED|Overall Study||11
7943383|NCT00485836|19549400|P2|NOT COMPLETED|Overall Study||3
7943384|NCT00485836|19549401|P1|NOT COMPLETED|Overall Study||15
7943385|NCT00485836|19549399|P3|COMPLETED|Overall Study||119
7943386|NCT00485836|19549400|P2|COMPLETED|Overall Study||129
7943387|NCT00485836|19549401|P1|COMPLETED|Overall Study||115
7943388|NCT00485836|19549399|P3|Received Study Drug (Safety Population)|Overall Study||129
7943389|NCT00485836|19549400|P2|Received Study Drug (Safety Population)|Overall Study||132
7943390|NCT00485836|19549401|P1|Received Study Drug (Safety Population)|Overall Study||129
7943391|NCT00485836|19549399|P3|STARTED|Overall Study||130
7943392|NCT00485836|19549400|P2|STARTED|Overall Study||132
7943393|NCT00485836|19549401|P1|STARTED|Overall Study||130
7943394|NCT00485758|19549429|P2|NOT COMPLETED|Overall Study||65
7943395|NCT00485758|19549430|P1|NOT COMPLETED|Overall Study||156
7943396|NCT00485758|19549429|P2|COMPLETED|Overall Study||277
7943397|NCT00485758|19549430|P1|COMPLETED|Overall Study||298
7943398|NCT00485758|19549429|P2|STARTED|Overall Study||342
7943399|NCT00485758|19549430|P1|STARTED|Overall Study||454
7943400|NCT00485732|19549442|P2|NOT COMPLETED|Overall Study||9
7943401|NCT00485732|19549443|P1|NOT COMPLETED|Overall Study||8
7943402|NCT00485732|19549442|P2|COMPLETED|Overall Study||67
7943403|NCT00485732|19549443|P1|COMPLETED|Overall Study||141
7943404|NCT00485732|19549442|P2|STARTED|Overall Study||76
7943405|NCT00485732|19549443|P1|STARTED|Overall Study||149
7943406|NCT00485693|19549465|P2|NOT COMPLETED|Overall Study||0
7943407|NCT00485693|19549466|P1|NOT COMPLETED|Overall Study||0
7943408|NCT00485693|19549465|P2|COMPLETED|Overall Study||104
7943409|NCT00485693|19549466|P1|COMPLETED|Overall Study||34
7943410|NCT00485693|19549465|P2|STARTED|Overall Study||104
7943411|NCT00485693|19549466|P1|STARTED|Overall Study||34
7943412|NCT00485589|19549478|P3|NOT COMPLETED|Overall Study||18
7943413|NCT00485589|19549479|P2|NOT COMPLETED|Overall Study||20
7943414|NCT00485589|19549480|P1|NOT COMPLETED|Overall Study||27
7943415|NCT00485589|19549478|P3|COMPLETED|Overall Study||185
7943416|NCT00485589|19549479|P2|COMPLETED|Overall Study||180
7943417|NCT00485589|19549480|P1|COMPLETED|Overall Study||183
7943418|NCT00485589|19549478|P3|STARTED|Overall Study||203
7943419|NCT00485589|19549479|P2|STARTED|Overall Study||200
7943420|NCT00485589|19549480|P1|STARTED|Overall Study||210
7943421|NCT00485485|19549506|P1|NOT COMPLETED|Overall Study||0
7943422|NCT00485485|19549506|P1|COMPLETED|Overall Study||7
7943423|NCT00485485|19549506|P1|STARTED|Overall Study||7
7943424|NCT00485472|19549512|P2|NOT COMPLETED|Overall Study||12
7943425|NCT00485472|19549513|P1|NOT COMPLETED|Overall Study||16
7943426|NCT00485472|19549512|P2|COMPLETED|Overall Study||64
7943427|NCT00485472|19549513|P1|COMPLETED|Overall Study||57
7943428|NCT00485472|19549512|P2|Entered Maintenance Phase|Overall Study||67
7943429|NCT00485472|19549513|P1|Entered Maintenance Phase|Overall Study||65
7943430|NCT00485472|19549512|P2|STARTED|Overall Study||76
7943431|NCT00485472|19549513|P1|STARTED|Overall Study||73
7943432|NCT00485433|19549539|P4|NOT COMPLETED|Overall Study||0
7943433|NCT00485433|19549540|P3|NOT COMPLETED|Overall Study||0
7943434|NCT00485433|19549541|P2|NOT COMPLETED|Overall Study||0
7943435|NCT00485433|19549542|P1|NOT COMPLETED|Overall Study||0
7943436|NCT00485433|19549539|P4|COMPLETED|Overall Study||25
7943437|NCT00485433|19549540|P3|COMPLETED|Overall Study||24
7943438|NCT00485433|19549541|P2|COMPLETED|Overall Study||25
7943439|NCT00485433|19549542|P1|COMPLETED|Overall Study||24
7943440|NCT00485433|19549539|P4|STARTED|Overall Study||25
7943441|NCT00485433|19549540|P3|STARTED|Overall Study||24
7943442|NCT00485433|19549541|P2|STARTED|Overall Study||25
7943443|NCT00485433|19549542|P1|STARTED|Overall Study||24
7943444|NCT00485303|19549550|P1|NOT COMPLETED|Overall Study||56
7943445|NCT00485303|19549550|P1|COMPLETED|Overall Study||2
7943446|NCT00485303|19549550|P1|STARTED|Overall Study||58
7943447|NCT00485264|19549568|P6|NOT COMPLETED|Overall Study||7
7943448|NCT00485264|19549569|P5|NOT COMPLETED|Overall Study||6
7943449|NCT00485264|19549570|P4|NOT COMPLETED|Overall Study||4
7943450|NCT00485264|19549571|P3|NOT COMPLETED|Overall Study||6
7943451|NCT00485264|19549572|P2|NOT COMPLETED|Overall Study||7
7943452|NCT00485264|19549573|P1|NOT COMPLETED|Overall Study||36
7943453|NCT00485264|19549568|P6|COMPLETED|Overall Study||5
7943454|NCT00485264|19549569|P5|COMPLETED|Overall Study||9
7943455|NCT00485264|19549570|P4|COMPLETED|Overall Study||17
7943456|NCT00485264|19549571|P3|COMPLETED|Overall Study||12
7943457|NCT00485264|19549572|P2|COMPLETED|Overall Study||9
7943458|NCT00485264|19549573|P1|COMPLETED|Overall Study||35
7943459|NCT00485264|19549568|P6|Completed Week 24|Overall Study||11
7943460|NCT00485264|19549569|P5|Completed Week 24|Overall Study||14
7943461|NCT00485264|19549570|P4|Completed Week 24|Overall Study||21
7943462|NCT00485264|19549571|P3|Completed Week 24|Overall Study||18
7943463|NCT00485264|19549572|P2|Completed Week 24|Overall Study||16
7943464|NCT00485264|19549573|P1|Completed Week 24|Overall Study||67
7943465|NCT00485264|19549568|P6|STARTED|Overall Study||12
7943466|NCT00485264|19549569|P5|STARTED|Overall Study||15
7943467|NCT00485264|19549570|P4|STARTED|Overall Study||21
7943468|NCT00485264|19549571|P3|STARTED|Overall Study||18
7943469|NCT00485264|19549572|P2|STARTED|Overall Study||16
7943470|NCT00485264|19549573|P1|STARTED|Overall Study||71
7943471|NCT00485173|19549661|P2|NOT COMPLETED|Overall Study||64
7943472|NCT00485173|19549662|P1|NOT COMPLETED|Overall Study||36
7943473|NCT00485173|19549661|P2|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422
7943474|NCT00485173|19549662|P1|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188
7943475|NCT00485173|19549661|P2|STARTED|Overall Study||486
7943476|NCT00485173|19549662|P1|STARTED|Overall Study||224
7943477|NCT00485134|19549710|P8|NOT COMPLETED|Overall Study||1
7943478|NCT00485134|19549711|P7|NOT COMPLETED|Overall Study||3
7943479|NCT00485134|19549712|P6|NOT COMPLETED|Overall Study||4
7943480|NCT00485134|19549713|P5|NOT COMPLETED|Overall Study||3
7943481|NCT00485134|19549714|P4|NOT COMPLETED|Overall Study||1
7943482|NCT00485134|19549715|P3|NOT COMPLETED|Overall Study||3
7943483|NCT00485134|19549716|P2|NOT COMPLETED|Overall Study||2
7943484|NCT00485134|19549717|P1|NOT COMPLETED|Overall Study||1
7943485|NCT00485134|19549710|P8|COMPLETED|Overall Study||20
7943486|NCT00485134|19549711|P7|COMPLETED|Overall Study||28
7943487|NCT00485134|19549712|P6|COMPLETED|Overall Study||3
7943488|NCT00485134|19549713|P5|COMPLETED|Overall Study||7
7943489|NCT00485134|19549714|P4|COMPLETED|Overall Study||7
7943490|NCT00485134|19549715|P3|COMPLETED|Overall Study||9
7943491|NCT00485134|19549716|P2|COMPLETED|Overall Study||10
7943492|NCT00485134|19549717|P1|COMPLETED|Overall Study||11
7943493|NCT00485134|19549710|P8|STARTED|Overall Study||21
7943494|NCT00485134|19549711|P7|STARTED|Overall Study||31
7943495|NCT00485134|19549712|P6|STARTED|Overall Study||7
7943496|NCT00485134|19549713|P5|STARTED|Overall Study||10
7943497|NCT00485134|19549714|P4|STARTED|Overall Study||8
7943498|NCT00485134|19549715|P3|STARTED|Overall Study||12
7943499|NCT00485134|19549716|P2|STARTED|Overall Study||12
7943500|NCT00485134|19549717|P1|STARTED|Overall Study||12
7943501|NCT00485069|19549739|P2|NOT COMPLETED|Overall Study||12
7943502|NCT00485069|19549740|P1|NOT COMPLETED|Overall Study||18
7943503|NCT00485069|19549739|P2|COMPLETED|Overall Study||46
7943504|NCT00485069|19549740|P1|COMPLETED|Overall Study||47
7943505|NCT00485069|19549739|P2|STARTED|Overall Study||58
7943506|NCT00485069|19549740|P1|STARTED|Overall Study||65
7943507|NCT00484939|19549785|P2|NOT COMPLETED|Overall Study||140
7943508|NCT00484939|19549786|P1|NOT COMPLETED|Overall Study||140
7943509|NCT00484939|19549785|P2|COMPLETED|Overall Study||0
7943510|NCT00484939|19549786|P1|COMPLETED|Overall Study||0
7943511|NCT00484939|19549785|P2|STARTED|Overall Study||140
7943512|NCT00484939|19549786|P1|STARTED|Overall Study||140
7943513|NCT00484874|19549806|P1|NOT COMPLETED|Overall Study||0
7943514|NCT00484874|19549806|P1|COMPLETED|Overall Study||12
7943515|NCT00484874|19549806|P1|STARTED|Overall Study||12
7943516|NCT00484679|19549813|P1|NOT COMPLETED|Overall Study||3
7943517|NCT00484679|19549813|P1|COMPLETED|Overall Study||15
7943518|NCT00484679|19549813|P1|STARTED|Overall Study||18
7943519|NCT00484419|19549820|P3|NOT COMPLETED|Overall Study||11
7943520|NCT00484419|19549821|P2|NOT COMPLETED|Overall Study||5
7943521|NCT00484419|19549822|P1|NOT COMPLETED|Overall Study||12
7943522|NCT00484419|19549820|P3|COMPLETED|Overall Study||45
7943523|NCT00484419|19549821|P2|COMPLETED|Overall Study||51
7943524|NCT00484419|19549822|P1|COMPLETED|Overall Study||45
7943525|NCT00484419|19549820|P3|STARTED|Overall Study||56
7943526|NCT00484419|19549821|P2|STARTED|Overall Study||56
7943527|NCT00484419|19549822|P1|STARTED|Overall Study||57
7943528|NCT00484393|19549880|P2|NOT COMPLETED|Overall Study||0
7943529|NCT00484393|19549881|P1|NOT COMPLETED|Overall Study||0
7943530|NCT00484393|19549880|P2|COMPLETED|Overall Study||3
7943531|NCT00484393|19549881|P1|COMPLETED|Overall Study||4
7943532|NCT00484393|19549880|P2|STARTED|Overall Study||3
7943533|NCT00484393|19549881|P1|STARTED|Overall Study||4
7943534|NCT00484354|19549889|P2|NOT COMPLETED|Overall Study||2
7943535|NCT00484354|19549890|P1|NOT COMPLETED|Overall Study||1
7943536|NCT00484354|19549889|P2|COMPLETED|Overall Study||57
7943537|NCT00484354|19549890|P1|COMPLETED|Overall Study||63
7943538|NCT00484354|19549889|P2|STARTED|Overall Study||59
7943539|NCT00484354|19549890|P1|STARTED|Overall Study||64
7943540|NCT00484315|19549906|P2|NOT COMPLETED|9-Month Angiographic Follow-up||13
7943541|NCT00484315|19549907|P1|NOT COMPLETED|9-Month Angiographic Follow-up||28
7943542|NCT00484315|19549906|P2|COMPLETED|9-Month Angiographic Follow-up||61
7943543|NCT00484315|19549907|P1|COMPLETED|9-Month Angiographic Follow-up||228
7943544|NCT00484315|19549906|P2|STARTED|9-Month Angiographic Follow-up||74
7943545|NCT00484315|19549907|P1|STARTED|9-Month Angiographic Follow-up||256
7943546|NCT00484315|19549906|P2|NOT COMPLETED|12-Month Clinical Follow-up||9
7943547|NCT00484315|19549907|P1|NOT COMPLETED|12-Month Clinical Follow-up||28
7943548|NCT00484315|19549906|P2|COMPLETED|12-Month Clinical Follow-up||311
7943549|NCT00484315|19549907|P1|COMPLETED|12-Month Clinical Follow-up||914
7943550|NCT00484315|19549906|P2|STARTED|12-Month Clinical Follow-up||320
7943551|NCT00484315|19549907|P1|STARTED|12-Month Clinical Follow-up||942
7943552|NCT00484289|19549918|P3|NOT COMPLETED|Post Marketing Phase||0
7943553|NCT00484289|19549919|P2|NOT COMPLETED|Post Marketing Phase||1
7943554|NCT00484289|19549920|P1|NOT COMPLETED|Post Marketing Phase||0
7943555|NCT00484289|19549918|P3|COMPLETED|Post Marketing Phase||10
7943556|NCT00484289|19549919|P2|COMPLETED|Post Marketing Phase||141
7943557|NCT00484289|19549920|P1|COMPLETED|Post Marketing Phase||10
7943558|NCT00484289|19549918|P3|STARTED|Post Marketing Phase||10
7943559|NCT00484289|19549919|P2|STARTED|Post Marketing Phase||142
7943560|NCT00484289|19549920|P1|STARTED|Post Marketing Phase||10
7943561|NCT00484289|19549918|P3|NOT COMPLETED|Long Term Phase||16
7943562|NCT00484289|19549919|P2|NOT COMPLETED|Long Term Phase||36
7943563|NCT00484289|19549920|P1|NOT COMPLETED|Long Term Phase||3
7943564|NCT00484289|19549918|P3|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
7943565|NCT00484289|19549919|P2|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142
7943566|NCT00484289|19549920|P1|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
7943567|NCT00484289|19549918|P3|STARTED|Long Term Phase||26
7943568|NCT00484289|19549919|P2|STARTED|Long Term Phase||178
7943569|NCT00484289|19549920|P1|STARTED|Long Term Phase||13
7943570|NCT00484185|19549992|P1|NOT COMPLETED|Overall Study||71
7943571|NCT00484185|19549992|P1|COMPLETED|Overall Study||112
7943572|NCT00484185|19549992|P1|Treated|Overall Study||178
7943573|NCT00484185|19549992|P1|STARTED|Overall Study||183
7943574|NCT00484159|19550014|P3|NOT COMPLETED|Overall Study||0
7943575|NCT00484159|19550015|P2|NOT COMPLETED|Overall Study||1
7943576|NCT00484159|19550016|P1|NOT COMPLETED|Overall Study||1
7943577|NCT00484159|19550014|P3|COMPLETED|Overall Study||51
7943578|NCT00484159|19550015|P2|COMPLETED|Overall Study||49
7943579|NCT00484159|19550016|P1|COMPLETED|Overall Study||49
7943580|NCT00484159|19550014|P3|STARTED|Overall Study||51
7943581|NCT00484159|19550015|P2|STARTED|Overall Study||50
7943582|NCT00484159|19550016|P1|STARTED|Overall Study||50
7943583|NCT00484094|19550027|P1|NOT COMPLETED|Overall Study||42
7943584|NCT00484094|19550027|P1|COMPLETED|Overall Study||167
7943585|NCT00484094|19550027|P1|STARTED|Overall Study||209
7943586|NCT00483938|19550043|P7|NOT COMPLETED|Overall Study||40
7943587|NCT00483938|19550044|P6|NOT COMPLETED|Overall Study||8
7943588|NCT00483938|19550045|P5|NOT COMPLETED|Overall Study||2
7943589|NCT00483938|19550046|P4|NOT COMPLETED|Overall Study||6
7943590|NCT00483938|19550047|P3|NOT COMPLETED|Overall Study||0
7943591|NCT00483938|19550048|P2|NOT COMPLETED|Overall Study||19
7943592|NCT00483938|19550049|P1|NOT COMPLETED|Overall Study||5
7943593|NCT00483938|19550043|P7|COMPLETED|Overall Study||0
7943594|NCT00483938|19550044|P6|COMPLETED|Overall Study||18
7943595|NCT00483938|19550045|P5|COMPLETED|Overall Study||23
7943596|NCT00483938|19550046|P4|COMPLETED|Overall Study||25
7943597|NCT00483938|19550047|P3|COMPLETED|Overall Study||30
7943598|NCT00483938|19550048|P2|COMPLETED|Overall Study||24
7943599|NCT00483938|19550049|P1|COMPLETED|Overall Study||36
7943600|NCT00483938|19550043|P7|STARTED|Overall Study||40
7943601|NCT00483938|19550044|P6|STARTED|Overall Study||26
7943602|NCT00483938|19550045|P5|STARTED|Overall Study||25
7943603|NCT00483938|19550046|P4|STARTED|Overall Study||31
7943604|NCT00483938|19550047|P3|STARTED|Overall Study||30
7943605|NCT00483938|19550048|P2|STARTED|Overall Study||43
7943606|NCT00483938|19550049|P1|STARTED|Overall Study||41
7943607|NCT00483756|19550073|P3|NOT COMPLETED|Overall Study||52
7943608|NCT00483756|19550074|P2|NOT COMPLETED|Overall Study||50
7943609|NCT00483756|19550075|P1|NOT COMPLETED|Overall Study||33
7943610|NCT00483756|19550073|P3|COMPLETED|Overall Study||59
7943611|NCT00483756|19550074|P2|COMPLETED|Overall Study||60
7943612|NCT00483756|19550075|P1|COMPLETED|Overall Study||77
7943613|NCT00483756|19550073|P3|Treated|Overall Study||107
7943614|NCT00483756|19550074|P2|Treated|Overall Study||106
7943615|NCT00483756|19550075|P1|Treated|Overall Study||109
7943616|NCT00483756|19550073|P3|STARTED|Overall Study||111
7943617|NCT00483756|19550074|P2|STARTED|Overall Study||110
7943618|NCT00483756|19550075|P1|STARTED|Overall Study||110
7943619|NCT00483717|19550139|P2|NOT COMPLETED|Overall Study||21
7943620|NCT00483717|19550140|P1|NOT COMPLETED|Overall Study||24
7943621|NCT00483717|19550139|P2|COMPLETED|Overall Study||65
7943622|NCT00483717|19550140|P1|COMPLETED|Overall Study||63
7943623|NCT00483717|19550139|P2|STARTED|Overall Study||86
7943624|NCT00483717|19550140|P1|STARTED|Overall Study||87
7943625|NCT00483704|19550163|P3|NOT COMPLETED|Treatment||156
7943626|NCT00483704|19550164|P2|NOT COMPLETED|Treatment||129
7943627|NCT00483704|19550165|P1|NOT COMPLETED|Treatment||129
7943628|NCT00483704|19550163|P3|COMPLETED|Treatment||399
7943629|NCT00483704|19550164|P2|COMPLETED|Treatment||420
7943630|NCT00483704|19550165|P1|COMPLETED|Treatment||444
7943631|NCT00483704|19550163|P3|STARTED|Treatment||555
7943632|NCT00483704|19550164|P2|STARTED|Treatment||549
7943633|NCT00483704|19550165|P1|STARTED|Treatment||573
7943634|NCT00483704|19550163|P3|NOT COMPLETED|Randomization||91
7943635|NCT00483704|19550164|P2|NOT COMPLETED|Randomization||96
7943636|NCT00483704|19550165|P1|NOT COMPLETED|Randomization||71
7943637|NCT00483704|19550163|P3|COMPLETED|Randomization||555
7943638|NCT00483704|19550164|P2|COMPLETED|Randomization||549
7943639|NCT00483704|19550165|P1|COMPLETED|Randomization||573
7943640|NCT00483704|19550163|P3|STARTED|Randomization||646
7943641|NCT00483704|19550164|P2|STARTED|Randomization||645
7943642|NCT00483704|19550165|P1|STARTED|Randomization||644
7943643|NCT00483652|19550211|P2|NOT COMPLETED|Post-study Follow-up||0
7943644|NCT00483652|19550212|P1|NOT COMPLETED|Post-study Follow-up||0
7943645|NCT00483652|19550211|P2|COMPLETED|Post-study Follow-up||114
7943646|NCT00483652|19550212|P1|COMPLETED|Post-study Follow-up||113
7943647|NCT00483652|19550211|P2|STARTED|Post-study Follow-up||114
7943648|NCT00483652|19550212|P1|STARTED|Post-study Follow-up||113
7943649|NCT00483652|19550211|P2|NOT COMPLETED|Double-blind Treatment Period||5
7943650|NCT00483652|19550212|P1|NOT COMPLETED|Double-blind Treatment Period||7
7943651|NCT00483652|19550211|P2|COMPLETED|Double-blind Treatment Period||114
7943652|NCT00483652|19550212|P1|COMPLETED|Double-blind Treatment Period||113
7943653|NCT00483652|19550211|P2|STARTED|Double-blind Treatment Period||119
7943654|NCT00483652|19550212|P1|STARTED|Double-blind Treatment Period||120
7943655|NCT00483574|19550222|P2|NOT COMPLETED|Overall Study||13
7943656|NCT00483574|19550223|P1|NOT COMPLETED|Overall Study||102
7943657|NCT00483574|19550222|P2|COMPLETED|Overall Study||308
7943658|NCT00483574|19550223|P1|COMPLETED|Overall Study||951
7943659|NCT00483574|19550222|P2|STARTED|Overall Study||321
7943660|NCT00483574|19550223|P1|STARTED|Overall Study||1053
7943661|NCT00483561|19550231|P1|NOT COMPLETED|Overall Study||11
7943662|NCT00483561|19550231|P1|COMPLETED|Overall Study||15
7943663|NCT00483561|19550231|P1|STARTED|Overall Study||26
7943664|NCT00483548|19550238|P2|NOT COMPLETED|Overall Study||46
7943665|NCT00483548|19550239|P1|NOT COMPLETED|Overall Study||60
7943666|NCT00483548|19550238|P2|COMPLETED|Overall Study||104
7943667|NCT00483548|19550239|P1|COMPLETED|Overall Study||88
7943668|NCT00483548|19550238|P2|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147
7943669|NCT00483548|19550239|P1|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147
7943670|NCT00483548|19550238|P2|STARTED|Overall Study||150
7943671|NCT00483548|19550239|P1|STARTED|Overall Study||148
7943672|NCT00483509|19550277|P1|NOT COMPLETED|Overall Study||0
7943673|NCT00483509|19550277|P1|COMPLETED|Overall Study||28
7943674|NCT00483509|19550277|P1|STARTED|Overall Study||28
7943675|NCT00483496|19550285|P1|NOT COMPLETED|Overall Study||1
7943676|NCT00483496|19550285|P1|COMPLETED|Overall Study||15
7943677|NCT00483496|19550285|P1|STARTED|Overall Study||16
7943678|NCT00483405|19550297|P1|NOT COMPLETED|Overall Study||28
7943679|NCT00483405|19550297|P1|COMPLETED|Overall Study||0
7943680|NCT00483405|19550297|P1|STARTED|Overall Study||28
7943681|NCT00483379|19550306|P2|NOT COMPLETED|Extension Period||0
7943682|NCT00483379|19550307|P1|NOT COMPLETED|Extension Period||0
7943683|NCT00483379|19550306|P2|COMPLETED|Extension Period||2
7943684|NCT00483379|19550307|P1|COMPLETED|Extension Period||1
7943685|NCT00483379|19550306|P2|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2
7943686|NCT00483379|19550307|P1|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1
7943687|NCT00483379|19550306|P2|NOT COMPLETED|Treatment Period||0
7943688|NCT00483379|19550307|P1|NOT COMPLETED|Treatment Period||2
7943689|NCT00483379|19550306|P2|COMPLETED|Treatment Period||7
7943690|NCT00483379|19550307|P1|COMPLETED|Treatment Period||4
7943691|NCT00483379|19550306|P2|STARTED|Treatment Period||7
7943692|NCT00483379|19550307|P1|STARTED|Treatment Period||6
7943693|NCT00483327|19550343|P1|NOT COMPLETED|Overall Study||10
7943694|NCT00483327|19550343|P1|COMPLETED|Overall Study||20
7943695|NCT00483327|19550343|P1|STARTED|Overall Study||30
7943696|NCT00483262|19550354|P2|NOT COMPLETED|Overall Study||0
7943697|NCT00483262|19550355|P1|NOT COMPLETED|Overall Study||0
7943698|NCT00483262|19550354|P2|COMPLETED|Overall Study||43
7943699|NCT00483262|19550355|P1|COMPLETED|Overall Study||20
7943700|NCT00483262|19550354|P2|STARTED|Overall Study||43
7943701|NCT00483262|19550355|P1|STARTED|Overall Study||20
7943702|NCT00483223|19550365|P1|NOT COMPLETED|Overall Study||0
7943703|NCT00483223|19550365|P1|COMPLETED|Overall Study||86
7943704|NCT00483223|19550365|P1|STARTED|Overall Study||86
7943705|NCT00483184|19550375|P3|NOT COMPLETED|Overall Study||3
7943706|NCT00483184|19550376|P2|NOT COMPLETED|Overall Study||4
7943707|NCT00483184|19550377|P1|NOT COMPLETED|Overall Study||5
7943708|NCT00483184|19550375|P3|COMPLETED|Overall Study||23
7943709|NCT00483184|19550376|P2|COMPLETED|Overall Study||27
7943710|NCT00483184|19550377|P1|COMPLETED|Overall Study||22
7943711|NCT00483184|19550375|P3|STARTED|Overall Study||26
7943712|NCT00483184|19550376|P2|STARTED|Overall Study||31
7943713|NCT00483184|19550377|P1|STARTED|Overall Study||27
7943714|NCT00483119|19550387|P2|NOT COMPLETED|Overall Study||1
7943715|NCT00483119|19550388|P1|NOT COMPLETED|Overall Study||1
7943716|NCT00483119|19550387|P2|COMPLETED|Overall Study||3
7943717|NCT00483119|19550388|P1|COMPLETED|Overall Study||4
7943718|NCT00483119|19550387|P2|STARTED|Overall Study||4
7943719|NCT00483119|19550388|P1|STARTED|Overall Study||5
7943720|NCT00483041|19550402|P2|NOT COMPLETED|Overall Study||1
7943721|NCT00483041|19550403|P1|NOT COMPLETED|Overall Study||0
7943722|NCT00483041|19550402|P2|COMPLETED|Overall Study||5
7943723|NCT00483041|19550403|P1|COMPLETED|Overall Study||5
7943724|NCT00483041|19550402|P2|STARTED|Overall Study||6
7943725|NCT00483041|19550403|P1|STARTED|Overall Study||5
7943726|NCT00483002|19550433|P1|NOT COMPLETED|Overall Study||2554
7943727|NCT00483002|19550433|P1|COMPLETED|Overall Study||1165
7943728|NCT00483002|19550433|P1|STARTED|Overall Study||3719
7943729|NCT00482911|19550441|P2|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
7943730|NCT00482911|19550442|P1|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
7943731|NCT00482911|19550441|P2|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7
7943732|NCT00482911|19550442|P1|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
7943733|NCT00482911|19550441|P2|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7
7943734|NCT00482911|19550442|P1|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0
7943735|NCT00482911|19550441|P2|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
7943736|NCT00482911|19550442|P1|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
7943737|NCT00482911|19550441|P2|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2
7943738|NCT00482911|19550442|P1|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3
7943739|NCT00482911|19550441|P2|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2
7943740|NCT00482911|19550442|P1|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3
7943741|NCT00482911|19550441|P2|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
7943742|NCT00482911|19550442|P1|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
7943743|NCT00482911|19550441|P2|COMPLETED|Dosing Schedule 1: Len & Cyc||0
7943744|NCT00482911|19550442|P1|COMPLETED|Dosing Schedule 1: Len & Cyc||3
7943745|NCT00482911|19550441|P2|STARTED|Dosing Schedule 1: Len & Cyc||0
7943746|NCT00482911|19550442|P1|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3
7943747|NCT00482729|19550458|P2|NOT COMPLETED|Overall Study||218
7943748|NCT00482729|19550459|P1|NOT COMPLETED|Overall Study||217
7943749|NCT00482729|19550458|P2|COMPLETED|Overall Study||406
7943750|NCT00482729|19550459|P1|COMPLETED|Overall Study||409
7943751|NCT00482729|19550458|P2|Completed Phase B|Overall Study||406
7943752|NCT00482729|19550459|P1|Completed Phase B|Overall Study||409
7943753|NCT00482729|19550458|P2|Completed Phase A|Overall Study||482
7943754|NCT00482729|19550459|P1|Completed Phase A|Overall Study||484
7943755|NCT00482729|19550458|P2|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624
7943842|NCT00482014|19550748|P3|STARTED|Overall Study||46
7943756|NCT00482729|19550459|P1|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626
7943757|NCT00482703|19550475|P2|NOT COMPLETED|Overall Study||0
7943758|NCT00482703|19550476|P1|NOT COMPLETED|Overall Study||1
7943759|NCT00482703|19550475|P2|COMPLETED|Overall Study||12
7943760|NCT00482703|19550476|P1|COMPLETED|Overall Study||10
7943761|NCT00482703|19550475|P2|STARTED|Overall Study|number enrolled, randomized and treated|12
7943762|NCT00482703|19550476|P1|STARTED|Overall Study|number enrolled, randomized and treated|11
7943763|NCT00482677|19550523|P2|NOT COMPLETED|Overall Study||0
7943764|NCT00482677|19550524|P1|NOT COMPLETED|Overall Study||0
7943765|NCT00482677|19550523|P2|COMPLETED|Overall Study||281
7943766|NCT00482677|19550524|P1|COMPLETED|Overall Study||281
7943767|NCT00482677|19550523|P2|STARTED|Overall Study||281
7943768|NCT00482677|19550524|P1|STARTED|Overall Study||281
7943769|NCT00482625|19550534|P1|NOT COMPLETED|Overall Study||0
7943770|NCT00482625|19550534|P1|COMPLETED|Overall Study||6
7943771|NCT00482625|19550534|P1|STARTED|Overall Study||6
7943772|NCT00482612|19550547|P4|NOT COMPLETED|Follow-up Period||8
7943773|NCT00482612|19550548|P3|NOT COMPLETED|Follow-up Period||22
7943774|NCT00482612|19550549|P2|NOT COMPLETED|Follow-up Period||18
7943775|NCT00482612|19550550|P1|NOT COMPLETED|Follow-up Period||14
7943776|NCT00482612|19550547|P4|COMPLETED|Follow-up Period||127
7943777|NCT00482612|19550548|P3|COMPLETED|Follow-up Period||106
7943778|NCT00482612|19550549|P2|COMPLETED|Follow-up Period||107
7943779|NCT00482612|19550550|P1|COMPLETED|Follow-up Period||123
7943780|NCT00482612|19550547|P4|STARTED|Follow-up Period||135
7943781|NCT00482612|19550548|P3|STARTED|Follow-up Period||128
7943782|NCT00482612|19550549|P2|STARTED|Follow-up Period||125
7943783|NCT00482612|19550550|P1|STARTED|Follow-up Period||137
7943784|NCT00482612|19550547|P4|NOT COMPLETED|In-treatment Period||0
7943785|NCT00482612|19550548|P3|NOT COMPLETED|In-treatment Period||1
7943786|NCT00482612|19550549|P2|NOT COMPLETED|In-treatment Period||0
7943787|NCT00482612|19550550|P1|NOT COMPLETED|In-treatment Period||0
7943788|NCT00482612|19550547|P4|COMPLETED|In-treatment Period||135
7943789|NCT00482612|19550548|P3|COMPLETED|In-treatment Period||128
7943790|NCT00482612|19550549|P2|COMPLETED|In-treatment Period||125
7943791|NCT00482612|19550550|P1|COMPLETED|In-treatment Period||137
7943792|NCT00482612|19550547|P4|Treated|In-treatment Period||135
7943793|NCT00482612|19550548|P3|Treated|In-treatment Period||128
7943794|NCT00482612|19550549|P2|Treated|In-treatment Period||125
7943795|NCT00482612|19550550|P1|Treated|In-treatment Period||137
7943796|NCT00482612|19550547|P4|STARTED|In-treatment Period||135
7943797|NCT00482612|19550548|P3|STARTED|In-treatment Period||129
7943798|NCT00482612|19550549|P2|STARTED|In-treatment Period||125
7943799|NCT00482612|19550550|P1|STARTED|In-treatment Period||137
7943800|NCT00482547|19550578|P2|NOT COMPLETED|Overall Study||161
7943801|NCT00482547|19550579|P1|NOT COMPLETED|Overall Study||173
7943802|NCT00482547|19550578|P2|COMPLETED|Overall Study||428
7943803|NCT00482547|19550579|P1|COMPLETED|Overall Study||426
7943804|NCT00482547|19550578|P2|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428
7943805|NCT00482547|19550579|P1|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426
7943806|NCT00482547|19550578|P2|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568
7943807|NCT00482547|19550579|P1|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565
7943808|NCT00482547|19550578|P2|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589
7943809|NCT00482547|19550579|P1|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599
7943810|NCT00482391|19550599|P1|NOT COMPLETED|Overall Study||3
7943811|NCT00482391|19550599|P1|COMPLETED|Overall Study||92
7943812|NCT00482391|19550599|P1|STARTED|Overall Study||95
7943813|NCT00482274|19550604|P1|NOT COMPLETED|Overall Study||1
7943814|NCT00482274|19550604|P1|COMPLETED|Overall Study||2
7943815|NCT00482274|19550604|P1|STARTED|Overall Study||3
7943816|NCT00482170|19550614|P2|NOT COMPLETED|Overall Study||20
7943817|NCT00482170|19550615|P1|NOT COMPLETED|Overall Study||15
7943818|NCT00482170|19550614|P2|COMPLETED|Overall Study||194
7943819|NCT00482170|19550615|P1|COMPLETED|Overall Study||192
7943820|NCT00482170|19550614|P2|Treated|Overall Study||211
7943821|NCT00482170|19550615|P1|Treated|Overall Study||207
7943822|NCT00482170|19550614|P2|STARTED|Overall Study||214
7943823|NCT00482170|19550615|P1|STARTED|Overall Study||207
7943824|NCT00482053|19550733|P1|NOT COMPLETED|Allogeneic Peripheral Stem Cells||0
7943825|NCT00482053|19550733|P1|COMPLETED|Allogeneic Peripheral Stem Cells||2
7943826|NCT00482053|19550733|P1|STARTED|Allogeneic Peripheral Stem Cells||2
7943827|NCT00482053|19550733|P1|NOT COMPLETED|Inter-treatment Period||1
7943828|NCT00482053|19550733|P1|COMPLETED|Inter-treatment Period||2
7943829|NCT00482053|19550733|P1|STARTED|Inter-treatment Period||3
7943830|NCT00482053|19550733|P1|NOT COMPLETED|Autologous Peripheral Stem Cells||0
7943831|NCT00482053|19550733|P1|COMPLETED|Autologous Peripheral Stem Cells||3
7943832|NCT00482053|19550733|P1|STARTED|Autologous Peripheral Stem Cells||3
7943833|NCT00482014|19550747|P4|NOT COMPLETED|Overall Study||23
7943834|NCT00482014|19550748|P3|NOT COMPLETED|Overall Study||11
7943835|NCT00482014|19550749|P2|NOT COMPLETED|Overall Study||6
7943836|NCT00482014|19550750|P1|NOT COMPLETED|Overall Study||7
7943837|NCT00482014|19550747|P4|COMPLETED|Overall Study||29
7943838|NCT00482014|19550748|P3|COMPLETED|Overall Study||35
7943839|NCT00482014|19550749|P2|COMPLETED|Overall Study||7
7943840|NCT00482014|19550750|P1|COMPLETED|Overall Study||2
7943841|NCT00482014|19550747|P4|STARTED|Overall Study||52
7943843|NCT00482014|19550749|P2|STARTED|Overall Study||13
7943844|NCT00482014|19550750|P1|STARTED|Overall Study||9
7943845|NCT00482001|19550774|P2|NOT COMPLETED|Overall Study||1
7943846|NCT00482001|19550775|P1|NOT COMPLETED|Overall Study||1
7943847|NCT00482001|19550774|P2|COMPLETED|Overall Study||10
7943848|NCT00482001|19550775|P1|COMPLETED|Overall Study||10
7943849|NCT00482001|19550774|P2|STARTED|Overall Study||11
7943850|NCT00482001|19550775|P1|STARTED|Overall Study||11
7943851|NCT00481988|19550795|P2|NOT COMPLETED|Overall Study||1
7943852|NCT00481988|19550796|P1|NOT COMPLETED|Overall Study||1
7943853|NCT00481988|19550795|P2|COMPLETED|Overall Study||8
7943854|NCT00481988|19550796|P1|COMPLETED|Overall Study||11
7943855|NCT00481988|19550795|P2|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8
7943856|NCT00481988|19550796|P1|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11
7943857|NCT00481988|19550795|P2|STARTED|Overall Study|one patient was dropped from the study before randomization|9
7943858|NCT00481988|19550796|P1|STARTED|Overall Study||12
7943859|NCT00481871|19550809|P5|NOT COMPLETED|Overall Study||0
7943860|NCT00481871|19550810|P4|NOT COMPLETED|Overall Study||0
7943861|NCT00481871|19550811|P3|NOT COMPLETED|Overall Study||1
7943862|NCT00481871|19550812|P2|NOT COMPLETED|Overall Study||0
7943863|NCT00481871|19550813|P1|NOT COMPLETED|Overall Study||0
7943864|NCT00481871|19550809|P5|COMPLETED|Overall Study||34
7943865|NCT00481871|19550810|P4|COMPLETED|Overall Study||38
7943866|NCT00481871|19550811|P3|COMPLETED|Overall Study||17
7943867|NCT00481871|19550812|P2|COMPLETED|Overall Study||10
7943868|NCT00481871|19550813|P1|COMPLETED|Overall Study||7
7943869|NCT00481871|19550809|P5|STARTED|Overall Study||34
7943870|NCT00481871|19550810|P4|STARTED|Overall Study||38
7943871|NCT00481871|19550811|P3|STARTED|Overall Study||18
7943872|NCT00481871|19550812|P2|STARTED|Overall Study||10
7943873|NCT00481871|19550813|P1|STARTED|Overall Study||7
7943874|NCT00481845|19550829|P2|NOT COMPLETED|Overall Study||0
7943875|NCT00481845|19550830|P1|NOT COMPLETED|Overall Study||0
7943876|NCT00481845|19550829|P2|COMPLETED|Overall Study||0
7943877|NCT00481845|19550830|P1|COMPLETED|Overall Study||1
7943878|NCT00481845|19550829|P2|STARTED|Overall Study||0
7943879|NCT00481845|19550830|P1|STARTED|Overall Study||1
7943880|NCT00481832|19550838|P1|NOT COMPLETED|Allogenic Hematopoietic Cell Transplant||0
7943881|NCT00481832|19550838|P1|COMPLETED|Allogenic Hematopoietic Cell Transplant||13
7943882|NCT00481832|19550838|P1|STARTED|Allogenic Hematopoietic Cell Transplant||13
7943883|NCT00481832|19550838|P1|NOT COMPLETED|Inter-transplant Period||27
7943884|NCT00481832|19550838|P1|COMPLETED|Inter-transplant Period||13
7943885|NCT00481832|19550838|P1|STARTED|Inter-transplant Period||40
7943886|NCT00481832|19550838|P1|NOT COMPLETED|Autologous Hematopoietic Cell Transplant||0
7943887|NCT00481832|19550838|P1|COMPLETED|Autologous Hematopoietic Cell Transplant||40
7943888|NCT00481832|19550838|P1|STARTED|Autologous Hematopoietic Cell Transplant||40
7943889|NCT00481832|19550838|P1|NOT COMPLETED|Enrollment||10
7943890|NCT00481832|19550838|P1|COMPLETED|Enrollment||40
7943891|NCT00481832|19550838|P1|STARTED|Enrollment||50
7943892|NCT00481767|19550853|P2|NOT COMPLETED|Overall Study||21
7943893|NCT00481767|19550854|P1|NOT COMPLETED|Overall Study||32
7943894|NCT00481767|19550853|P2|COMPLETED|Overall Study||205
7943895|NCT00481767|19550854|P1|COMPLETED|Overall Study||418
7943896|NCT00481767|19550853|P2|STARTED|Overall Study||226
7943897|NCT00481767|19550854|P1|STARTED|Overall Study||450
7943898|NCT00481676|19550888|P2|NOT COMPLETED|Overall Study||5
7943899|NCT00481676|19550889|P1|NOT COMPLETED|Overall Study||2
7943900|NCT00481676|19550888|P2|COMPLETED|Overall Study||17
7943901|NCT00481676|19550889|P1|COMPLETED|Overall Study||25
7943902|NCT00481676|19550888|P2|STARTED|Overall Study||22
7943903|NCT00481676|19550889|P1|STARTED|Overall Study||27
7943904|NCT00481507|19550913|P2|NOT COMPLETED|Overall Study||0
7943905|NCT00481507|19550914|P1|NOT COMPLETED|Overall Study||0
7943906|NCT00481507|19550913|P2|COMPLETED|Overall Study||61
7943907|NCT00481507|19550914|P1|COMPLETED|Overall Study||64
7943908|NCT00481507|19550913|P2|STARTED|Overall Study||61
7943909|NCT00481507|19550914|P1|STARTED|Overall Study||64
7943910|NCT00481351|19550924|P2|NOT COMPLETED|Overall Study||0
7943911|NCT00481351|19550925|P1|NOT COMPLETED|Overall Study||0
7943912|NCT00481351|19550924|P2|COMPLETED|Overall Study||12
7943913|NCT00481351|19550925|P1|COMPLETED|Overall Study||13
7943914|NCT00481351|19550924|P2|STARTED|Overall Study||12
7943915|NCT00481351|19550925|P1|STARTED|Overall Study||13
7943916|NCT00481247|19550941|P2|NOT COMPLETED|Overall Study||260
7943917|NCT00481247|19550942|P1|NOT COMPLETED|Overall Study||259
7943918|NCT00481247|19550941|P2|COMPLETED|Overall Study||0
7943919|NCT00481247|19550942|P1|COMPLETED|Overall Study||0
7943920|NCT00481247|19550941|P2|Received Treatment|Overall Study||258
7943921|NCT00481247|19550942|P1|Received Treatment|Overall Study||258
7943922|NCT00481247|19550941|P2|STARTED|Overall Study|Randomized|260
7943923|NCT00481247|19550942|P1|STARTED|Overall Study|Randomized|259
7943924|NCT00481195|19550966|P2|NOT COMPLETED|Overall Study||39
7943925|NCT00481195|19550967|P1|NOT COMPLETED|Overall Study||39
7943926|NCT00481195|19550966|P2|COMPLETED|Overall Study||90
7943927|NCT00481195|19550967|P1|COMPLETED|Overall Study||89
7943928|NCT00481195|19550966|P2|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129
7943929|NCT00481195|19550967|P1|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128
7943930|NCT00481078|19551053|P2|NOT COMPLETED|Overall Study||20
7943931|NCT00481078|19551054|P1|NOT COMPLETED|Overall Study||42
7943932|NCT00481078|19551053|P2|COMPLETED|Overall Study||12
7943933|NCT00481078|19551054|P1|COMPLETED|Overall Study||20
7943934|NCT00481078|19551053|P2|STARTED|Overall Study||32
7943935|NCT00481078|19551054|P1|STARTED|Overall Study||62
7943936|NCT00481065|19551072|P8|NOT COMPLETED|Overall Study||19
7943937|NCT00481065|19551073|P7|NOT COMPLETED|Overall Study||16
7943938|NCT00481065|19551074|P6|NOT COMPLETED|Overall Study||24
7943939|NCT00481065|19551075|P5|NOT COMPLETED|Overall Study||23
7943940|NCT00481065|19551076|P4|NOT COMPLETED|Overall Study||15
7943941|NCT00481065|19551077|P3|NOT COMPLETED|Overall Study||19
7943942|NCT00481065|19551078|P2|NOT COMPLETED|Overall Study||17
7943943|NCT00481065|19551079|P1|NOT COMPLETED|Overall Study||22
7943944|NCT00481065|19551072|P8|COMPLETED|Overall Study||30
7943945|NCT00481065|19551073|P7|COMPLETED|Overall Study||34
7943946|NCT00481065|19551074|P6|COMPLETED|Overall Study||27
7943947|NCT00481065|19551075|P5|COMPLETED|Overall Study||28
7943948|NCT00481065|19551076|P4|COMPLETED|Overall Study||37
7943949|NCT00481065|19551077|P3|COMPLETED|Overall Study||32
7943950|NCT00481065|19551078|P2|COMPLETED|Overall Study||33
7943951|NCT00481065|19551079|P1|COMPLETED|Overall Study||29
7943952|NCT00481065|19551072|P8|STARTED|Overall Study||49
7943953|NCT00481065|19551073|P7|STARTED|Overall Study||50
7943954|NCT00481065|19551074|P6|STARTED|Overall Study||51
7943955|NCT00481065|19551075|P5|STARTED|Overall Study||51
7943956|NCT00481065|19551076|P4|STARTED|Overall Study||52
7943957|NCT00481065|19551077|P3|STARTED|Overall Study||51
7943958|NCT00481065|19551078|P2|STARTED|Overall Study||50
7943959|NCT00481065|19551079|P1|STARTED|Overall Study||51
7943960|NCT00480987|19551165|P1|NOT COMPLETED|Overall Study||0
7943961|NCT00480987|19551165|P1|COMPLETED|Overall Study||27
7943962|NCT00480987|19551165|P1|STARTED|Overall Study||27
7943963|NCT00480857|19551169|P1|NOT COMPLETED|Overall Study||2
7943964|NCT00480857|19551169|P1|COMPLETED|Overall Study||17
7943965|NCT00480857|19551169|P1|STARTED|Overall Study||19
7943966|NCT00480779|19551179|P2|NOT COMPLETED|Overall Study||3
7943967|NCT00480779|19551180|P1|NOT COMPLETED|Overall Study||2
7943968|NCT00480779|19551179|P2|COMPLETED|Overall Study||19
7943969|NCT00480779|19551180|P1|COMPLETED|Overall Study||24
7943970|NCT00480779|19551179|P2|STARTED|Overall Study||22
7943971|NCT00480779|19551180|P1|STARTED|Overall Study||26
7943972|NCT00480740|19551207|P3|NOT COMPLETED|Overall Study||0
7943973|NCT00480740|19551208|P2|NOT COMPLETED|Overall Study||0
7943974|NCT00480740|19551209|P1|NOT COMPLETED|Overall Study||0
7943975|NCT00480740|19551207|P3|COMPLETED|Overall Study||6
7943976|NCT00480740|19551208|P2|COMPLETED|Overall Study||9
7943977|NCT00480740|19551209|P1|COMPLETED|Overall Study||26
7943978|NCT00480740|19551207|P3|STARTED|Overall Study||6
7943979|NCT00480740|19551208|P2|STARTED|Overall Study||9
7943980|NCT00480740|19551209|P1|STARTED|Overall Study||26
7943981|NCT00480636|19551217|P1|NOT COMPLETED|Overall Study||19
7943982|NCT00480636|19551217|P1|COMPLETED|Overall Study||83
7943983|NCT00480636|19551217|P1|STARTED|Overall Study||102
7943984|NCT00480532|19551229|P4|NOT COMPLETED|Overall Study||1
7943985|NCT00480532|19551230|P3|NOT COMPLETED|Overall Study||4
7943986|NCT00480532|19551231|P2|NOT COMPLETED|Overall Study||4
7943987|NCT00480532|19551232|P1|NOT COMPLETED|Overall Study||2
7943988|NCT00480532|19551229|P4|COMPLETED|Overall Study||31
7943989|NCT00480532|19551230|P3|COMPLETED|Overall Study||29
7943990|NCT00480532|19551231|P2|COMPLETED|Overall Study||29
7943991|NCT00480532|19551232|P1|COMPLETED|Overall Study||31
7943992|NCT00480532|19551229|P4|STARTED|Overall Study||32
7943993|NCT00480532|19551230|P3|STARTED|Overall Study||33
7943994|NCT00480532|19551231|P2|STARTED|Overall Study||33
7943995|NCT00480532|19551232|P1|STARTED|Overall Study||33
7943996|NCT00480493|19551252|P2|NOT COMPLETED|Overall Study||7
7943997|NCT00480493|19551253|P1|NOT COMPLETED|Overall Study||2
7943998|NCT00480493|19551252|P2|COMPLETED|Overall Study||21
7943999|NCT00480493|19551253|P1|COMPLETED|Overall Study||30
7944000|NCT00480493|19551252|P2|Randomized|Overall Study||28
7944001|NCT00480493|19551253|P1|Randomized|Overall Study||32
7944002|NCT00480493|19551252|P2|STARTED|Overall Study||28
7944003|NCT00480493|19551253|P1|STARTED|Overall Study||32
7944004|NCT00480441|19551265|P3|NOT COMPLETED|Randomization||2
7944005|NCT00480441|19551266|P2|NOT COMPLETED|Randomization||7
7944006|NCT00480441|19551267|P1|NOT COMPLETED|Randomization||0
7944007|NCT00480441|19551265|P3|COMPLETED|Randomization||9
7944008|NCT00480441|19551266|P2|COMPLETED|Randomization||6
7944009|NCT00480441|19551267|P1|COMPLETED|Randomization||0
7944010|NCT00480441|19551265|P3|STARTED|Randomization||11
7944011|NCT00480441|19551266|P2|STARTED|Randomization||13
7944012|NCT00480441|19551267|P1|STARTED|Randomization||0
7944013|NCT00480441|19551265|P3|NOT COMPLETED|Baseline Functional MRI||0
7944014|NCT00480441|19551266|P2|NOT COMPLETED|Baseline Functional MRI||0
7944015|NCT00480441|19551267|P1|NOT COMPLETED|Baseline Functional MRI||12
7944016|NCT00480441|19551265|P3|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
7944017|NCT00480441|19551266|P2|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
7944018|NCT00480441|19551267|P1|COMPLETED|Baseline Functional MRI||12
7944019|NCT00480441|19551265|P3|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
7944020|NCT00480441|19551266|P2|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
7944021|NCT00480441|19551267|P1|STARTED|Baseline Functional MRI|All non-randomized participants who also met specific eligibility for baseline functional MRI|24
7944022|NCT00480441|19551265|P3|NOT COMPLETED|Screening||0
7944023|NCT00480441|19551266|P2|NOT COMPLETED|Screening||0
7944024|NCT00480441|19551267|P1|NOT COMPLETED|Screening||37
7944025|NCT00480441|19551265|P3|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
7944026|NCT00480441|19551266|P2|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
7944027|NCT00480441|19551267|P1|COMPLETED|Screening||24
7944028|NCT00480441|19551265|P3|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
7944029|NCT00480441|19551266|P2|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
7944030|NCT00480441|19551267|P1|STARTED|Screening||61
7944031|NCT00480324|19551276|P2|NOT COMPLETED|Overall Study||16
7944032|NCT00480324|19551277|P1|NOT COMPLETED|Overall Study||32
7944033|NCT00480324|19551276|P2|COMPLETED|Overall Study||241
7944034|NCT00480324|19551277|P1|COMPLETED|Overall Study||476
7944035|NCT00480324|19551276|P2|STARTED|Overall Study||257
7944036|NCT00480324|19551277|P1|STARTED|Overall Study||508
7944037|NCT00480077|19551305|P2|NOT COMPLETED|Overall Study||26
7944038|NCT00480077|19551306|P1|NOT COMPLETED|Overall Study||31
7944039|NCT00480077|19551305|P2|COMPLETED|Overall Study||141
7944040|NCT00480077|19551306|P1|COMPLETED|Overall Study||137
7944041|NCT00480077|19551305|P2|STARTED|Overall Study||167
7944042|NCT00480077|19551306|P1|STARTED|Overall Study||168
7944043|NCT00480025|19551314|P2|NOT COMPLETED|Overall Study||369
7944044|NCT00480025|19551315|P1|NOT COMPLETED|Overall Study||752
7944045|NCT00480025|19551314|P2|COMPLETED|Overall Study||388
7944046|NCT00480025|19551315|P1|COMPLETED|Overall Study||763
7944047|NCT00480025|19551314|P2|STARTED|Overall Study||757
7944048|NCT00480025|19551315|P1|STARTED|Overall Study||1515
7944049|NCT00479882|19551387|P4|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18
7944050|NCT00479882|19551388|P3|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20
7944051|NCT00479882|19551389|P2|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21
7944052|NCT00479882|19551390|P1|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25
7944053|NCT00479882|19551387|P4|COMPLETED|Crossover: Period III (Weeks 13-20)||447
7944054|NCT00479882|19551388|P3|COMPLETED|Crossover: Period III (Weeks 13-20)||420
7944055|NCT00479882|19551389|P2|COMPLETED|Crossover: Period III (Weeks 13-20)||419
7944056|NCT00479882|19551390|P1|COMPLETED|Crossover: Period III (Weeks 13-20)||447
7944057|NCT00479882|19551387|P4|STARTED|Crossover: Period III (Weeks 13-20)||465
7944058|NCT00479882|19551388|P3|STARTED|Crossover: Period III (Weeks 13-20)||440
7944059|NCT00479882|19551389|P2|STARTED|Crossover: Period III (Weeks 13-20)||440
7944060|NCT00479882|19551390|P1|STARTED|Crossover: Period III (Weeks 13-20)||472
7944061|NCT00479882|19551387|P4|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140
7944062|NCT00479882|19551388|P3|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157
7944063|NCT00479882|19551389|P2|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162
7944064|NCT00479882|19551390|P1|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138
7944065|NCT00479882|19551387|P4|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465
7944066|NCT00479882|19551388|P3|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
7944067|NCT00479882|19551389|P2|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
7944068|NCT00479882|19551390|P1|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472
7944069|NCT00479882|19551387|P4|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605
7944070|NCT00479882|19551388|P3|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597
7944071|NCT00479882|19551389|P2|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602
7944072|NCT00479882|19551390|P1|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610
7944073|NCT00479856|19551520|P1|NOT COMPLETED|Overall Study||3
7944074|NCT00479856|19551520|P1|COMPLETED|Overall Study||6
7944075|NCT00479856|19551520|P1|STARTED|Overall Study||9
7944076|NCT00479765|19551529|P1|NOT COMPLETED|Overall Study||4
7944077|NCT00479765|19551529|P1|COMPLETED|Overall Study||0
7944078|NCT00479765|19551529|P1|STARTED|Overall Study||4
7944079|NCT00479713|19551535|P2|NOT COMPLETED|Overall Study||9
7944080|NCT00479713|19551536|P1|NOT COMPLETED|Overall Study||13
7944081|NCT00479713|19551535|P2|COMPLETED|Overall Study||295
7944082|NCT00479713|19551536|P1|COMPLETED|Overall Study||301
7944083|NCT00479713|19551535|P2|STARTED|Overall Study||304
7944084|NCT00479713|19551536|P1|STARTED|Overall Study||314
7944085|NCT00479674|19551560|P1|NOT COMPLETED|Overall Study||41
7944086|NCT00479674|19551560|P1|COMPLETED|Overall Study||0
7944087|NCT00479674|19551560|P1|STARTED|Overall Study||41
7944088|NCT00479557|19551575|P7|NOT COMPLETED|Overall Study||2
7944089|NCT00479557|19551576|P6|NOT COMPLETED|Overall Study||13
7944090|NCT00479557|19551577|P5|NOT COMPLETED|Overall Study||4
7944091|NCT00479557|19551578|P4|NOT COMPLETED|Overall Study||5
7944092|NCT00479557|19551579|P3|NOT COMPLETED|Overall Study||8
7944093|NCT00479557|19551580|P2|NOT COMPLETED|Overall Study||10
7944094|NCT00479557|19551581|P1|NOT COMPLETED|Overall Study||10
7944095|NCT00479557|19551575|P7|COMPLETED|Overall Study||15
7944096|NCT00479557|19551576|P6|COMPLETED|Overall Study||31
7944097|NCT00479557|19551577|P5|COMPLETED|Overall Study||8
7944098|NCT00479557|19551578|P4|COMPLETED|Overall Study||30
7944099|NCT00479557|19551579|P3|COMPLETED|Overall Study||32
7944100|NCT00479557|19551580|P2|COMPLETED|Overall Study||51
7944101|NCT00479557|19551581|P1|COMPLETED|Overall Study||26
7944102|NCT00479557|19551575|P7|Treated|Overall Study||17
7944103|NCT00479557|19551576|P6|Treated|Overall Study||44
7944104|NCT00479557|19551577|P5|Treated|Overall Study||12
7944105|NCT00479557|19551578|P4|Treated|Overall Study||35
7944106|NCT00479557|19551579|P3|Treated|Overall Study||40
7944107|NCT00479557|19551580|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
7944108|NCT00479557|19551581|P1|Treated|Overall Study||36
7944109|NCT00479557|19551575|P7|STARTED|Overall Study||17
7944110|NCT00479557|19551576|P6|STARTED|Overall Study||44
7944111|NCT00479557|19551577|P5|STARTED|Overall Study||12
7944112|NCT00479557|19551578|P4|STARTED|Overall Study||35
7944113|NCT00479557|19551579|P3|STARTED|Overall Study||40
7944114|NCT00479557|19551580|P2|STARTED|Overall Study||61
7944115|NCT00479557|19551581|P1|STARTED|Overall Study||36
7944116|NCT00479466|19551624|P6|NOT COMPLETED|Overall Study||4
7944117|NCT00479466|19551625|P5|NOT COMPLETED|Overall Study||8
7944118|NCT00479466|19551626|P4|NOT COMPLETED|Overall Study||3
7944119|NCT00479466|19551627|P3|NOT COMPLETED|Overall Study||3
7944120|NCT00479466|19551628|P2|NOT COMPLETED|Overall Study||8
7944121|NCT00479466|19551629|P1|NOT COMPLETED|Overall Study||13
7944122|NCT00479466|19551624|P6|COMPLETED|Overall Study||53
7944123|NCT00479466|19551625|P5|COMPLETED|Overall Study||48
7944124|NCT00479466|19551626|P4|COMPLETED|Overall Study||55
7944125|NCT00479466|19551627|P3|COMPLETED|Overall Study||54
7944126|NCT00479466|19551628|P2|COMPLETED|Overall Study||49
7944127|NCT00479466|19551629|P1|COMPLETED|Overall Study||44
7944128|NCT00479466|19551624|P6|STARTED|Overall Study||57
7944129|NCT00479466|19551625|P5|STARTED|Overall Study||56
7944130|NCT00479466|19551626|P4|STARTED|Overall Study||58
7944131|NCT00479466|19551627|P3|STARTED|Overall Study||57
7944132|NCT00479466|19551628|P2|STARTED|Overall Study||57
7944133|NCT00479466|19551629|P1|STARTED|Overall Study||57
7944134|NCT00479401|19551658|P3|NOT COMPLETED|Overall Study||12
7944135|NCT00479401|19551659|P2|NOT COMPLETED|Overall Study||37
7944136|NCT00479401|19551660|P1|NOT COMPLETED|Overall Study||49
7944137|NCT00479401|19551658|P3|COMPLETED|Overall Study||91
7944138|NCT00479401|19551659|P2|COMPLETED|Overall Study||176
7944139|NCT00479401|19551660|P1|COMPLETED|Overall Study||174
7944140|NCT00479401|19551658|P3|STARTED|Overall Study||103
7944141|NCT00479401|19551659|P2|STARTED|Overall Study||213
7944142|NCT00479401|19551660|P1|STARTED|Overall Study||223
7944143|NCT00479388|19551715|P2|NOT COMPLETED|Overall Study||73
7944144|NCT00479388|19551716|P1|NOT COMPLETED|Overall Study||132
7944145|NCT00479388|19551715|P2|COMPLETED|Overall Study||537
7944146|NCT00479388|19551716|P1|COMPLETED|Overall Study||474
7944147|NCT00479388|19551715|P2|STARTED|Overall Study||610
7944148|NCT00479388|19551716|P1|STARTED|Overall Study||606
7944149|NCT00479336|19551730|P4|NOT COMPLETED|Overall Study||5
7944150|NCT00479336|19551731|P3|NOT COMPLETED|Overall Study||1
7944151|NCT00479336|19551732|P2|NOT COMPLETED|Overall Study||6
7944152|NCT00479336|19551733|P1|NOT COMPLETED|Overall Study||4
7944153|NCT00479336|19551730|P4|COMPLETED|Overall Study||21
7944154|NCT00479336|19551731|P3|COMPLETED|Overall Study||24
7944155|NCT00479336|19551732|P2|COMPLETED|Overall Study||20
7944156|NCT00479336|19551733|P1|COMPLETED|Overall Study||23
7944157|NCT00479336|19551730|P4|STARTED|Overall Study||26
7944158|NCT00479336|19551731|P3|STARTED|Overall Study||25
7944159|NCT00479336|19551732|P2|STARTED|Overall Study||26
7944160|NCT00479336|19551733|P1|STARTED|Overall Study||27
7944161|NCT00479258|19551749|P2|NOT COMPLETED|Overall Study||0
7944162|NCT00479258|19551750|P1|NOT COMPLETED|Overall Study||0
7944163|NCT00479258|19551749|P2|COMPLETED|Overall Study||0
7944164|NCT00479258|19551750|P1|COMPLETED|Overall Study||0
7944165|NCT00479258|19551749|P2|STARTED|Overall Study||0
7944166|NCT00479258|19551750|P1|STARTED|Overall Study||0
7944167|NCT00479232|19551756|P6|NOT COMPLETED|Overall Study||30
7944168|NCT00479232|19551757|P5|NOT COMPLETED|Overall Study||4
7944169|NCT00479232|19551758|P4|NOT COMPLETED|Overall Study||3
7944170|NCT00479232|19551759|P3|NOT COMPLETED|Overall Study||28
7944171|NCT00479232|19551760|P2|NOT COMPLETED|Overall Study||3
7944172|NCT00479232|19551761|P1|NOT COMPLETED|Overall Study||3
7944173|NCT00479232|19551756|P6|COMPLETED|Overall Study||0
7944174|NCT00479232|19551757|P5|COMPLETED|Overall Study||0
7944175|NCT00479232|19551758|P4|COMPLETED|Overall Study||0
7944176|NCT00479232|19551759|P3|COMPLETED|Overall Study||0
7944177|NCT00479232|19551760|P2|COMPLETED|Overall Study||0
7944178|NCT00479232|19551761|P1|COMPLETED|Overall Study||0
7944179|NCT00479232|19551756|P6|STARTED|Overall Study||30
7944180|NCT00479232|19551757|P5|STARTED|Overall Study||4
7944181|NCT00479232|19551758|P4|STARTED|Overall Study||3
7944182|NCT00479232|19551759|P3|STARTED|Overall Study||28
7944183|NCT00479232|19551760|P2|STARTED|Overall Study||3
7944184|NCT00479232|19551761|P1|STARTED|Overall Study||3
7944185|NCT00479154|19551781|P2|NOT COMPLETED|Overall Study||0
7944186|NCT00479154|19551782|P1|NOT COMPLETED|Overall Study||0
7944187|NCT00479154|19551781|P2|COMPLETED|Overall Study||3
7944188|NCT00479154|19551782|P1|COMPLETED|Overall Study||3
7944189|NCT00479154|19551781|P2|STARTED|Overall Study||3
7944190|NCT00479154|19551782|P1|STARTED|Overall Study||3
7944191|NCT00479115|19551788|P1|NOT COMPLETED|Overall Study||0
7944192|NCT00479115|19551788|P1|COMPLETED|Overall Study||1
7944193|NCT00479115|19551788|P1|STARTED|Overall Study||1
7944194|NCT00479089|19551799|P2|NOT COMPLETED|Overall Study||0
7944195|NCT00479089|19551800|P1|NOT COMPLETED|Overall Study||0
7944196|NCT00479089|19551799|P2|COMPLETED|Overall Study||25
7944197|NCT00479089|19551800|P1|COMPLETED|Overall Study||25
7944198|NCT00479089|19551799|P2|STARTED|Overall Study||25
7944199|NCT00479089|19551800|P1|STARTED|Overall Study||25
7944200|NCT00479037|19551812|P2|NOT COMPLETED|Overall Study||6
7944201|NCT00479037|19551813|P1|NOT COMPLETED|Overall Study||3
7944202|NCT00479037|19551812|P2|COMPLETED|Overall Study||34
7944203|NCT00479037|19551813|P1|COMPLETED|Overall Study||38
7944204|NCT00479037|19551812|P2|STARTED|Overall Study||40
7944205|NCT00479037|19551813|P1|STARTED|Overall Study||41
7944206|NCT00478933|19551823|P1|NOT COMPLETED|Overall Study||78
7944207|NCT00478933|19551823|P1|COMPLETED|Overall Study||1145
7944208|NCT00478933|19551823|P1|STARTED|Overall Study||1223
7944209|NCT00478881|19551849|P2|NOT COMPLETED|Overall Study||22
7944210|NCT00478881|19551850|P1|NOT COMPLETED|Overall Study||39
7944211|NCT00478881|19551849|P2|COMPLETED|Overall Study||176
7944212|NCT00478881|19551850|P1|COMPLETED|Overall Study||160
7944213|NCT00478881|19551849|P2|Received Medication|Overall Study||198
7944214|NCT00478881|19551850|P1|Received Medication|Overall Study||198
7944215|NCT00478881|19551849|P2|STARTED|Overall Study||198
7944216|NCT00478881|19551850|P1|STARTED|Overall Study||199
7944217|NCT00478777|19551874|P1|NOT COMPLETED|Overall Study||77
7944218|NCT00478777|19551874|P1|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73
7944219|NCT00478777|19551874|P1|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144
7944220|NCT00478777|19551874|P1|STARTED|Overall Study||150
7944221|NCT00478673|19551881|P1|NOT COMPLETED|12-Months Post-Procedure||64
7944222|NCT00478673|19551881|P1|COMPLETED|12-Months Post-Procedure||231
7944223|NCT00478673|19551881|P1|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295
7944224|NCT00478673|19551881|P1|NOT COMPLETED|30-Days Post-Procedure||10
7944225|NCT00478673|19551881|P1|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288
7944226|NCT00478673|19551881|P1|STARTED|30-Days Post-Procedure||298
7944227|NCT00478647|19551886|P1|NOT COMPLETED|Overall Study||2
7944228|NCT00478647|19551886|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38
7944229|NCT00478647|19551886|P1|STARTED|Overall Study||40
7944230|NCT00478608|19551894|P1|NOT COMPLETED|Overall Study||20
7944231|NCT00478608|19551894|P1|COMPLETED|Overall Study||59
7944232|NCT00478608|19551894|P1|STARTED|Overall Study||79
7944233|NCT00478569|19551902|P1|NOT COMPLETED|Overall Study||409
7944234|NCT00478569|19551902|P1|COMPLETED|Overall Study||761
7944235|NCT00478569|19551902|P1|STARTED|Overall Study||1170
7944236|NCT00478556|19551918|P2|NOT COMPLETED|Overall Study||0
7944237|NCT00478556|19551919|P1|NOT COMPLETED|Overall Study||0
7944238|NCT00478556|19551918|P2|COMPLETED|Overall Study||149
7944239|NCT00478556|19551919|P1|COMPLETED|Overall Study||151
7944240|NCT00478556|19551918|P2|STARTED|Overall Study||149
7944241|NCT00478556|19551919|P1|STARTED|Overall Study||151
7944242|NCT00478426|19551927|P1|NOT COMPLETED|Overall Study||1
7944243|NCT00478426|19551927|P1|COMPLETED|Overall Study||33
7944244|NCT00478426|19551927|P1|STARTED|Overall Study||34
7944245|NCT00478361|19551935|P1|NOT COMPLETED|Overall Study||0
7944246|NCT00478361|19551935|P1|COMPLETED|Overall Study||39
7944247|NCT00478361|19551935|P1|STARTED|Overall Study||39
7944248|NCT00478335|19551943|P2|NOT COMPLETED|Period 2 (4 Days)||0
7944249|NCT00478335|19551944|P1|NOT COMPLETED|Period 2 (4 Days)||0
7944250|NCT00478335|19551943|P2|COMPLETED|Period 2 (4 Days)||2
7944251|NCT00478335|19551944|P1|COMPLETED|Period 2 (4 Days)||2
7944252|NCT00478335|19551943|P2|STARTED|Period 2 (4 Days)||2
7944253|NCT00478335|19551944|P1|STARTED|Period 2 (4 Days)||2
7944254|NCT00478335|19551943|P2|NOT COMPLETED|Period 1 (4 Days)||0
7944255|NCT00478335|19551944|P1|NOT COMPLETED|Period 1 (4 Days)||0
7944256|NCT00478335|19551943|P2|COMPLETED|Period 1 (4 Days)||2
7944257|NCT00478335|19551944|P1|COMPLETED|Period 1 (4 Days)||2
7944258|NCT00478335|19551943|P2|STARTED|Period 1 (4 Days)||2
7944259|NCT00478335|19551944|P1|STARTED|Period 1 (4 Days)||2
7944260|NCT00478257|19551952|P2|NOT COMPLETED|Overall Study||3
7944261|NCT00478257|19551953|P1|NOT COMPLETED|Overall Study||8
7944262|NCT00478257|19551952|P2|COMPLETED|Overall Study||13
7944263|NCT00478257|19551953|P1|COMPLETED|Overall Study||15
7944264|NCT00478257|19551952|P2|STARTED|Overall Study||16
7944265|NCT00478257|19551953|P1|STARTED|Overall Study||23
7944266|NCT00478244|19551959|P1|NOT COMPLETED|Overall Study||1
7944267|NCT00478244|19551959|P1|COMPLETED|Overall Study||6
7944268|NCT00478244|19551959|P1|STARTED|Overall Study||7
7944269|NCT00478231|19551972|P1|NOT COMPLETED|Overall Study||84
7944270|NCT00478231|19551972|P1|COMPLETED|Overall Study||125
7944271|NCT00478231|19551972|P1|Treated|Overall Study||206
7944272|NCT00478231|19551972|P1|STARTED|Overall Study||209
7944273|NCT00478218|19551993|P2|NOT COMPLETED|Overall Study||0
7944274|NCT00478218|19551994|P1|NOT COMPLETED|Overall Study||0
7944275|NCT00478218|19551993|P2|COMPLETED|Overall Study||19
7944276|NCT00478218|19551994|P1|COMPLETED|Overall Study||34
7944277|NCT00478218|19551993|P2|STARTED|Overall Study||19
7944278|NCT00478218|19551994|P1|STARTED|Overall Study||34
7944279|NCT00478205|19552008|P2|NOT COMPLETED|Overall Study||87
7944280|NCT00478205|19552009|P1|NOT COMPLETED|Overall Study||296
7944281|NCT00478205|19552008|P2|COMPLETED|Overall Study||399
7944282|NCT00478205|19552009|P1|COMPLETED|Overall Study||685
7944283|NCT00478205|19552008|P2|STARTED|Overall Study||486
7944284|NCT00478205|19552009|P1|STARTED|Overall Study||981
7944285|NCT00478192|19552024|P3|NOT COMPLETED|Overall Study||2
7944286|NCT00478192|19552025|P2|NOT COMPLETED|Overall Study||5
7944287|NCT00478192|19552026|P1|NOT COMPLETED|Overall Study||4
7944288|NCT00478192|19552024|P3|COMPLETED|Overall Study||8
7944289|NCT00478192|19552025|P2|COMPLETED|Overall Study||15
7944290|NCT00478192|19552026|P1|COMPLETED|Overall Study||16
7944291|NCT00478192|19552024|P3|End of Treatment|Overall Study||8
7944292|NCT00478192|19552025|P2|End of Treatment|Overall Study||16
7944293|NCT00478192|19552026|P1|End of Treatment|Overall Study||18
7944294|NCT00478192|19552024|P3|Full Analysis Set / Safety Analysis Set|Overall Study||9
7944295|NCT00478192|19552025|P2|Full Analysis Set / Safety Analysis Set|Overall Study||20
7944296|NCT00478192|19552026|P1|Full Analysis Set / Safety Analysis Set|Overall Study||20
7944297|NCT00478192|19552024|P3|STARTED|Overall Study||10
7944298|NCT00478192|19552025|P2|STARTED|Overall Study||20
7944299|NCT00478192|19552026|P1|STARTED|Overall Study||20
7944300|NCT00478140|19552053|P1|NOT COMPLETED|Overall Study||1
7944301|NCT00478140|19552053|P1|COMPLETED|Overall Study||3
7944302|NCT00478140|19552053|P1|STARTED|Overall Study||4
7944303|NCT00478062|19552060|P1|NOT COMPLETED|Overall Study||0
7944304|NCT00478062|19552060|P1|COMPLETED|Overall Study||1
7944305|NCT00478062|19552060|P1|STARTED|Overall Study||1
7944306|NCT00478036|19552070|P3|NOT COMPLETED|Overall Study||0
7944307|NCT00478036|19552071|P2|NOT COMPLETED|Overall Study||0
7944308|NCT00478036|19552072|P1|NOT COMPLETED|Overall Study||0
7944309|NCT00478036|19552070|P3|COMPLETED|Overall Study||14
7944310|NCT00478036|19552071|P2|COMPLETED|Overall Study||7
7944311|NCT00478036|19552072|P1|COMPLETED|Overall Study||10
7944312|NCT00478036|19552070|P3|STARTED|Overall Study||14
7944313|NCT00478036|19552071|P2|STARTED|Overall Study||7
7944314|NCT00478036|19552072|P1|STARTED|Overall Study||10
7944315|NCT00478023|19552085|P5|NOT COMPLETED|Overall Study||55
7944316|NCT00478023|19552086|P4|NOT COMPLETED|Overall Study||30
7944317|NCT00478023|19552087|P3|NOT COMPLETED|Overall Study||20
7944318|NCT00478023|19552088|P2|NOT COMPLETED|Overall Study||24
7944319|NCT00478023|19552089|P1|NOT COMPLETED|Overall Study||35
7944320|NCT00478023|19552085|P5|COMPLETED|Overall Study||114
7944321|NCT00478023|19552086|P4|COMPLETED|Overall Study||146
7944322|NCT00478023|19552087|P3|COMPLETED|Overall Study||151
7944323|NCT00478023|19552088|P2|COMPLETED|Overall Study||144
7944324|NCT00478023|19552089|P1|COMPLETED|Overall Study||135
7944325|NCT00478023|19552085|P5|STARTED|Overall Study||169
7944326|NCT00478023|19552086|P4|STARTED|Overall Study||176
7944327|NCT00478023|19552087|P3|STARTED|Overall Study||171
7944328|NCT00478023|19552088|P2|STARTED|Overall Study||168
7944329|NCT00478023|19552089|P1|STARTED|Overall Study||170
7944330|NCT00477971|19552108|P2|NOT COMPLETED|Overall Study||6
7944331|NCT00477971|19552109|P1|NOT COMPLETED|Overall Study||17
7944332|NCT00477971|19552108|P2|COMPLETED|Overall Study||49
7944333|NCT00477971|19552109|P1|COMPLETED|Overall Study||17
7944334|NCT00477971|19552108|P2|STARTED|Overall Study||55
7944335|NCT00477971|19552109|P1|STARTED|Overall Study||34
7944336|NCT00477750|19552121|P1|NOT COMPLETED|Overall Study||11
7944337|NCT00477750|19552121|P1|COMPLETED|Overall Study||15
7944338|NCT00477750|19552121|P1|STARTED|Overall Study||26
7944339|NCT00477685|19552129|P1|NOT COMPLETED|Overall Study||0
7944340|NCT00477685|19552129|P1|COMPLETED|Overall Study||10
7944341|NCT00477685|19552129|P1|STARTED|Overall Study||10
7944342|NCT00477672|19552137|P3|NOT COMPLETED|Overall Study||16
7944343|NCT00477672|19552138|P2|NOT COMPLETED|Overall Study||16
7944344|NCT00477672|19552139|P1|NOT COMPLETED|Overall Study||7
7944345|NCT00477672|19552137|P3|COMPLETED|Overall Study||83
7944346|NCT00477672|19552138|P2|COMPLETED|Overall Study||85
7944347|NCT00477672|19552139|P1|COMPLETED|Overall Study||91
7944348|NCT00477672|19552137|P3|STARTED|Overall Study||99
7944349|NCT00477672|19552138|P2|STARTED|Overall Study||101
7944350|NCT00477672|19552139|P1|STARTED|Overall Study||98
7944351|NCT00477633|19552150|P1|NOT COMPLETED|Overall Study||709
7944352|NCT00477633|19552150|P1|COMPLETED|Overall Study||991
7944353|NCT00477633|19552150|P1|STARTED|Overall Study||1700
7944354|NCT00477607|19552158|P2|NOT COMPLETED|Overall Study||7
7944355|NCT00477607|19552159|P1|NOT COMPLETED|Overall Study||7
7944356|NCT00477607|19552158|P2|COMPLETED|Overall Study||13
7944357|NCT00477607|19552159|P1|COMPLETED|Overall Study||12
7944358|NCT00477607|19552158|P2|STARTED|Overall Study||20
7944359|NCT00477607|19552159|P1|STARTED|Overall Study||19
7944360|NCT00477594|19552171|P2|NOT COMPLETED|Follow-up Period||1
7944361|NCT00477594|19552172|P1|NOT COMPLETED|Follow-up Period||3
7944362|NCT00477594|19552171|P2|COMPLETED|Follow-up Period||4
7944363|NCT00477594|19552172|P1|COMPLETED|Follow-up Period||13
7944364|NCT00477594|19552171|P2|STARTED|Follow-up Period||5
7944365|NCT00477594|19552172|P1|STARTED|Follow-up Period||16
7944366|NCT00477594|19552171|P2|NOT COMPLETED|Year 3||0
7944367|NCT00477594|19552172|P1|NOT COMPLETED|Year 3||2
7944368|NCT00477594|19552171|P2|COMPLETED|Year 3||0
7944369|NCT00477594|19552172|P1|COMPLETED|Year 3||2
7944370|NCT00477594|19552171|P2|STARTED|Year 3||0
7944371|NCT00477594|19552172|P1|STARTED|Year 3||4
7944372|NCT00477594|19552171|P2|NOT COMPLETED|Year 1 and Year 2||4
7944373|NCT00477594|19552172|P1|NOT COMPLETED|Year 1 and Year 2||9
7944374|NCT00477594|19552171|P2|COMPLETED|Year 1 and Year 2||1
7944375|NCT00477594|19552172|P1|COMPLETED|Year 1 and Year 2||7
7944376|NCT00477594|19552171|P2|STARTED|Year 1 and Year 2||5
7944377|NCT00477594|19552172|P1|STARTED|Year 1 and Year 2||16
7944378|NCT00477490|19552233|P9|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8
7944379|NCT00477490|19552234|P8|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
7944380|NCT00477490|19552235|P7|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
7944381|NCT00477490|19552236|P6|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6
7944382|NCT00477490|19552237|P5|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20
7944383|NCT00477490|19552238|P4|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12
7944384|NCT00477490|19552239|P3|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15
7944385|NCT00477490|19552240|P2|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28
7944386|NCT00477490|19552241|P1|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0
7944387|NCT00477490|19552233|P9|COMPLETED|Part II: Extension Week 5 up to Day 169||26
7944388|NCT00477490|19552234|P8|COMPLETED|Part II: Extension Week 5 up to Day 169||29
7944389|NCT00477490|19552235|P7|COMPLETED|Part II: Extension Week 5 up to Day 169||32
7944390|NCT00477490|19552236|P6|COMPLETED|Part II: Extension Week 5 up to Day 169||25
7944391|NCT00477490|19552237|P5|COMPLETED|Part II: Extension Week 5 up to Day 169||107
7944392|NCT00477490|19552238|P4|COMPLETED|Part II: Extension Week 5 up to Day 169||120
7944393|NCT00477490|19552239|P3|COMPLETED|Part II: Extension Week 5 up to Day 169||120
7944394|NCT00477490|19552240|P2|COMPLETED|Part II: Extension Week 5 up to Day 169||107
7944395|NCT00477490|19552241|P1|COMPLETED|Part II: Extension Week 5 up to Day 169||0
7944396|NCT00477490|19552233|P9|STARTED|Part II: Extension Week 5 up to Day 169||34
7944397|NCT00477490|19552234|P8|STARTED|Part II: Extension Week 5 up to Day 169||34
7944398|NCT00477490|19552235|P7|STARTED|Part II: Extension Week 5 up to Day 169||37
7944399|NCT00477490|19552236|P6|STARTED|Part II: Extension Week 5 up to Day 169||31
7944400|NCT00477490|19552237|P5|STARTED|Part II: Extension Week 5 up to Day 169||127
7944401|NCT00477490|19552238|P4|STARTED|Part II: Extension Week 5 up to Day 169||132
7944402|NCT00477490|19552239|P3|STARTED|Part II: Extension Week 5 up to Day 169||135
7944403|NCT00477490|19552240|P2|STARTED|Part II: Extension Week 5 up to Day 169||135
7944404|NCT00477490|19552241|P1|STARTED|Part II: Extension Week 5 up to Day 169||0
7944405|NCT00477490|19552233|P9|NOT COMPLETED|Part I: 4 Week Efficacy||0
7944406|NCT00477490|19552234|P8|NOT COMPLETED|Part I: 4 Week Efficacy||0
7944407|NCT00477490|19552235|P7|NOT COMPLETED|Part I: 4 Week Efficacy||0
7944408|NCT00477490|19552236|P6|NOT COMPLETED|Part I: 4 Week Efficacy||0
7944409|NCT00477490|19552237|P5|NOT COMPLETED|Part I: 4 Week Efficacy||25
7944410|NCT00477490|19552238|P4|NOT COMPLETED|Part I: 4 Week Efficacy||20
7944411|NCT00477490|19552239|P3|NOT COMPLETED|Part I: 4 Week Efficacy||10
7944412|NCT00477490|19552240|P2|NOT COMPLETED|Part I: 4 Week Efficacy||19
7944413|NCT00477490|19552241|P1|NOT COMPLETED|Part I: 4 Week Efficacy||15
7944414|NCT00477490|19552233|P9|COMPLETED|Part I: 4 Week Efficacy||0
7944415|NCT00477490|19552234|P8|COMPLETED|Part I: 4 Week Efficacy||0
7944416|NCT00477490|19552235|P7|COMPLETED|Part I: 4 Week Efficacy||0
7944417|NCT00477490|19552236|P6|COMPLETED|Part I: 4 Week Efficacy||0
7944418|NCT00477490|19552237|P5|COMPLETED|Part I: 4 Week Efficacy||135
7944419|NCT00477490|19552238|P4|COMPLETED|Part I: 4 Week Efficacy||138
7944420|NCT00477490|19552239|P3|COMPLETED|Part I: 4 Week Efficacy||148
7944421|NCT00477490|19552240|P2|COMPLETED|Part I: 4 Week Efficacy||144
7944422|NCT00477490|19552241|P1|COMPLETED|Part I: 4 Week Efficacy||145
7944423|NCT00477490|19552233|P9|ITT Population|Part I: 4 Week Efficacy||0
7944424|NCT00477490|19552234|P8|ITT Population|Part I: 4 Week Efficacy||0
7944425|NCT00477490|19552235|P7|ITT Population|Part I: 4 Week Efficacy||0
7944426|NCT00477490|19552236|P6|ITT Population|Part I: 4 Week Efficacy||0
7944427|NCT00477490|19552237|P5|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146
7944428|NCT00477490|19552238|P4|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148
7944429|NCT00477490|19552239|P3|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152
7944430|NCT00477490|19552240|P2|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155
7944431|NCT00477490|19552241|P1|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156
7944432|NCT00477490|19552233|P9|STARTED|Part I: 4 Week Efficacy||0
7944433|NCT00477490|19552234|P8|STARTED|Part I: 4 Week Efficacy||0
7944434|NCT00477490|19552235|P7|STARTED|Part I: 4 Week Efficacy||0
7944435|NCT00477490|19552236|P6|STARTED|Part I: 4 Week Efficacy||0
7944436|NCT00477490|19552237|P5|STARTED|Part I: 4 Week Efficacy||160
7944437|NCT00477490|19552238|P4|STARTED|Part I: 4 Week Efficacy||158
7944438|NCT00477490|19552239|P3|STARTED|Part I: 4 Week Efficacy||158
7944439|NCT00477490|19552240|P2|STARTED|Part I: 4 Week Efficacy||163
7944440|NCT00477490|19552241|P1|STARTED|Part I: 4 Week Efficacy||160
7944441|NCT00477464|19552325|P1|NOT COMPLETED|Overall Study||51
7944442|NCT00477464|19552325|P1|COMPLETED|Overall Study||0
7944443|NCT00477464|19552325|P1|STARTED|Overall Study||51
7944444|NCT00477451|19552352|P4|NOT COMPLETED|Overall Study||0
7944445|NCT00477451|19552353|P3|NOT COMPLETED|Overall Study||0
7944446|NCT00477451|19552354|P2|NOT COMPLETED|Overall Study||0
7944447|NCT00477451|19552355|P1|NOT COMPLETED|Overall Study||0
7944448|NCT00477451|19552352|P4|COMPLETED|Overall Study||2
7944449|NCT00477451|19552353|P3|COMPLETED|Overall Study||7
7944450|NCT00477451|19552354|P2|COMPLETED|Overall Study||20
7944451|NCT00477451|19552355|P1|COMPLETED|Overall Study||20
7944452|NCT00477451|19552352|P4|STARTED|Overall Study||2
7944453|NCT00477451|19552353|P3|STARTED|Overall Study||7
7944454|NCT00477451|19552354|P2|STARTED|Overall Study||20
7944455|NCT00477451|19552355|P1|STARTED|Overall Study||20
7944456|NCT00477386|19552369|P2|NOT COMPLETED|Overall Study||17
7944457|NCT00477386|19552370|P1|NOT COMPLETED|Overall Study||11
7944458|NCT00477386|19552369|P2|COMPLETED|Overall Study||0
7944459|NCT00477386|19552370|P1|COMPLETED|Overall Study||0
7944460|NCT00477386|19552369|P2|STARTED|Overall Study||17
7944461|NCT00477386|19552370|P1|STARTED|Overall Study||11
7944462|NCT00477334|19552380|P2|NOT COMPLETED|Overall Study||76
7944463|NCT00477334|19552381|P1|NOT COMPLETED|Overall Study||170
7944464|NCT00477334|19552380|P2|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75
7944465|NCT00477334|19552381|P1|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142
7944466|NCT00477334|19552380|P2|Modified Intent to Treat Population|Overall Study||78
7944467|NCT00477334|19552381|P1|Modified Intent to Treat Population|Overall Study||152
7944468|NCT00477334|19552380|P2|Participants Completing First Recurrence|Overall Study||92
7944469|NCT00477334|19552381|P1|Participants Completing First Recurrence|Overall Study||187
7944470|NCT00477334|19552380|P2|Intent to Treat Population|Overall Study||98
7944471|NCT00477334|19552381|P1|Intent to Treat Population|Overall Study||201
7944472|NCT00477334|19552380|P2|Randomized and Took Study Drug|Overall Study||98
7944473|NCT00477334|19552381|P1|Randomized and Took Study Drug|Overall Study||206
7944474|NCT00477334|19552380|P2|STARTED|Overall Study||151
7944475|NCT00477334|19552381|P1|STARTED|Overall Study||312
7944476|NCT00477295|19552407|P2|NOT COMPLETED|Overall Study||109
7944477|NCT00477295|19552408|P1|NOT COMPLETED|Overall Study||121
7944478|NCT00477295|19552407|P2|COMPLETED|Overall Study||192
7944479|NCT00477295|19552408|P1|COMPLETED|Overall Study||161
7944480|NCT00477295|19552407|P2|STARTED|Overall Study||301
7944481|NCT00477295|19552408|P1|STARTED|Overall Study||282
7944482|NCT00477269|19552436|P3|NOT COMPLETED|Open Label Extension||13
7944483|NCT00477269|19552437|P2|NOT COMPLETED|Open Label Extension||0
7944484|NCT00477269|19552438|P1|NOT COMPLETED|Open Label Extension||0
7944485|NCT00477269|19552436|P3|COMPLETED|Open Label Extension||9
7944486|NCT00477269|19552437|P2|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
7944487|NCT00477269|19552438|P1|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
7944488|NCT00477269|19552436|P3|STARTED|Open Label Extension||22
7944489|NCT00477269|19552437|P2|STARTED|Open Label Extension|Arm in the Core study not extension|0
7944490|NCT00477269|19552438|P1|STARTED|Open Label Extension|Arm in the Core study not extension|0
7944491|NCT00477269|19552436|P3|NOT COMPLETED|Core Study||0
7944492|NCT00477269|19552437|P2|NOT COMPLETED|Core Study||8
7944493|NCT00477269|19552438|P1|NOT COMPLETED|Core Study||9
7944494|NCT00477269|19552436|P3|COMPLETED|Core Study||0
7944495|NCT00477269|19552437|P2|COMPLETED|Core Study||23
7944496|NCT00477269|19552438|P1|COMPLETED|Core Study||19
7944497|NCT00477269|19552436|P3|STARTED|Core Study||0
7944498|NCT00477269|19552437|P2|STARTED|Core Study||31
7944499|NCT00477269|19552438|P1|STARTED|Core Study||28
7944500|NCT00477230|19552492|P2|NOT COMPLETED|Overall Study||31
7944501|NCT00477230|19552493|P1|NOT COMPLETED|Overall Study||20
7944502|NCT00477230|19552492|P2|COMPLETED|Overall Study||1
7944503|NCT00477230|19552493|P1|COMPLETED|Overall Study||12
7944504|NCT00477230|19552492|P2|STARTED|Overall Study||32
7944505|NCT00477230|19552493|P1|STARTED|Overall Study||32
7944506|NCT00477204|19552501|P2|NOT COMPLETED|Overall Study||0
7944507|NCT00477204|19552502|P1|NOT COMPLETED|Overall Study||0
7944508|NCT00477204|19552501|P2|COMPLETED|Overall Study||5
7944509|NCT00477204|19552502|P1|COMPLETED|Overall Study||4
7944510|NCT00477204|19552501|P2|STARTED|Overall Study||5
7944511|NCT00477204|19552502|P1|STARTED|Overall Study||4
7944512|NCT00477191|19552508|P1|NOT COMPLETED|Overall Study||5
7944513|NCT00477191|19552508|P1|COMPLETED|Overall Study||13
7944514|NCT00477191|19552508|P1|STARTED|Overall Study||18
7944515|NCT00477165|19552517|P2|NOT COMPLETED|Overall Study||2
7944516|NCT00477165|19552518|P1|NOT COMPLETED|Overall Study||7
7944517|NCT00477165|19552517|P2|COMPLETED|Overall Study||25
7944518|NCT00477165|19552518|P1|COMPLETED|Overall Study||20
7944519|NCT00477165|19552517|P2|STARTED|Overall Study||27
7944520|NCT00477165|19552518|P1|STARTED|Overall Study||27
7944521|NCT00477152|19552530|P1|NOT COMPLETED|Overall Study||3
7944522|NCT00477152|19552530|P1|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49
7944523|NCT00477152|19552530|P1|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52
7944524|NCT00477087|19552537|P1|NOT COMPLETED|Overall Study||0
7944525|NCT00477087|19552537|P1|COMPLETED|Overall Study||10
7944526|NCT00477087|19552537|P1|STARTED|Overall Study||10
7944527|NCT00476996|19552546|P4|NOT COMPLETED|OLE Phase (From Week 48)||664
7944528|NCT00476996|19552547|P3|NOT COMPLETED|OLE Phase (From Week 48)||0
7944529|NCT00476996|19552548|P2|NOT COMPLETED|OLE Phase (From Week 48)||0
7944530|NCT00476996|19552549|P1|NOT COMPLETED|OLE Phase (From Week 48)||0
7944531|NCT00476996|19552546|P4|COMPLETED|OLE Phase (From Week 48)||0
7944532|NCT00476996|19552547|P3|COMPLETED|OLE Phase (From Week 48)||0
7944533|NCT00476996|19552548|P2|COMPLETED|OLE Phase (From Week 48)||0
7944534|NCT00476996|19552549|P1|COMPLETED|OLE Phase (From Week 48)||0
7944535|NCT00476996|19552546|P4|STARTED|OLE Phase (From Week 48)||664
7944536|NCT00476996|19552547|P3|STARTED|OLE Phase (From Week 48)||0
7944537|NCT00476996|19552548|P2|STARTED|OLE Phase (From Week 48)||0
7944538|NCT00476996|19552549|P1|STARTED|OLE Phase (From Week 48)||0
7944539|NCT00476996|19552546|P4|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||0
7944540|NCT00476996|19552547|P3|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||45
7944541|NCT00476996|19552548|P2|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||55
7944542|NCT00476996|19552549|P1|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||72
7944543|NCT00476996|19552546|P4|COMPLETED|Blinded Treatment Phase (up to Week 48)||0
7944544|NCT00476996|19552547|P3|COMPLETED|Blinded Treatment Phase (up to Week 48)||237
7944545|NCT00476996|19552548|P2|COMPLETED|Blinded Treatment Phase (up to Week 48)||222
7944546|NCT00476996|19552549|P1|COMPLETED|Blinded Treatment Phase (up to Week 48)||205
7944547|NCT00476996|19552546|P4|STARTED|Blinded Treatment Phase (up to Week 48)||0
7944548|NCT00476996|19552547|P3|STARTED|Blinded Treatment Phase (up to Week 48)||282
7944549|NCT00476996|19552548|P2|STARTED|Blinded Treatment Phase (up to Week 48)||277
7944550|NCT00476996|19552549|P1|STARTED|Blinded Treatment Phase (up to Week 48)||277
7944551|NCT00476957|19552581|P2|NOT COMPLETED|Overall Study||193
7944552|NCT00476957|19552582|P1|NOT COMPLETED|Overall Study||176
7944553|NCT00476957|19552581|P2|COMPLETED|Overall Study||4159
7944554|NCT00476957|19552582|P1|COMPLETED|Overall Study||4181
7944555|NCT00476957|19552581|P2|STARTED|Overall Study||4352
7944556|NCT00476957|19552582|P1|STARTED|Overall Study||4357
7944557|NCT00476827|19552596|P6|NOT COMPLETED|Overall Study||0
7944558|NCT00476827|19552597|P5|NOT COMPLETED|Overall Study||0
7944559|NCT00476827|19552598|P4|NOT COMPLETED|Overall Study||0
7944560|NCT00476827|19552599|P3|NOT COMPLETED|Overall Study||0
7944561|NCT00476827|19552600|P2|NOT COMPLETED|Overall Study||0
7944562|NCT00476827|19552601|P1|NOT COMPLETED|Overall Study||0
7944563|NCT00476827|19552596|P6|COMPLETED|Overall Study||2
7944564|NCT00476827|19552597|P5|COMPLETED|Overall Study||2
7944565|NCT00476827|19552598|P4|COMPLETED|Overall Study||0
7944566|NCT00476827|19552599|P3|COMPLETED|Overall Study||1
7944567|NCT00476827|19552600|P2|COMPLETED|Overall Study||0
7944568|NCT00476827|19552601|P1|COMPLETED|Overall Study||3
7944569|NCT00476827|19552596|P6|STARTED|Overall Study||2
7944570|NCT00476827|19552597|P5|STARTED|Overall Study||2
7944571|NCT00476827|19552598|P4|STARTED|Overall Study||0
7944572|NCT00476827|19552599|P3|STARTED|Overall Study||1
7944573|NCT00476827|19552600|P2|STARTED|Overall Study||0
7944574|NCT00476827|19552601|P1|STARTED|Overall Study||3
7944575|NCT00476788|19552631|P1|NOT COMPLETED|Overall Study||3
7944576|NCT00476788|19552631|P1|COMPLETED|Overall Study||11
7944577|NCT00476788|19552631|P1|STARTED|Overall Study||14
7944578|NCT00476645|19552636|P1|NOT COMPLETED|Overall Study||0
7944579|NCT00476645|19552636|P1|COMPLETED|Overall Study||10
7944580|NCT00476645|19552636|P1|STARTED|Overall Study||10
7944581|NCT00476593|19552646|P4|NOT COMPLETED|Overall Study||22
7944582|NCT00476593|19552647|P3|NOT COMPLETED|Overall Study||8
7944583|NCT00476593|19552648|P2|NOT COMPLETED|Overall Study||2
7944584|NCT00476593|19552649|P1|NOT COMPLETED|Overall Study||10
7944585|NCT00476593|19552646|P4|COMPLETED|Overall Study||107
7944586|NCT00476593|19552647|P3|COMPLETED|Overall Study||30
7944587|NCT00476593|19552648|P2|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17
7944588|NCT00476593|19552649|P1|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22
7944589|NCT00476593|19552646|P4|STARTED|Overall Study||129
7944590|NCT00476593|19552647|P3|STARTED|Overall Study||38
7944591|NCT00476593|19552648|P2|STARTED|Overall Study||19
7944592|NCT00476593|19552649|P1|STARTED|Overall Study||32
7944593|NCT00476476|19552661|P2|NOT COMPLETED|Overall Study||24
7944594|NCT00476476|19552662|P1|NOT COMPLETED|Overall Study||2
7944595|NCT00476476|19552661|P2|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0
7944596|NCT00476476|19552662|P1|COMPLETED|Overall Study||15
7944597|NCT00476476|19552661|P2|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23
7944598|NCT00476476|19552662|P1|Response Evaluable|Overall Study||17
7944599|NCT00476476|19552661|P2|STARTED|Overall Study||24
7944600|NCT00476476|19552662|P1|STARTED|Overall Study||17
7944601|NCT00476242|19552669|P2|NOT COMPLETED|Overall Study||16
7944602|NCT00476242|19552670|P1|NOT COMPLETED|Overall Study||8
7944603|NCT00476242|19552669|P2|COMPLETED|Overall Study||12
7944604|NCT00476242|19552670|P1|COMPLETED|Overall Study||19
7944605|NCT00476242|19552669|P2|STARTED|Overall Study||28
7944606|NCT00476242|19552670|P1|STARTED|Overall Study||27
7944607|NCT00476229|19552680|P1|NOT COMPLETED|Overall Study||1
7944608|NCT00476229|19552680|P1|COMPLETED|Overall Study||19
7944609|NCT00476229|19552680|P1|STARTED|Overall Study||20
7944610|NCT00476151|19552686|P2|NOT COMPLETED|Overall Study||7
7944611|NCT00476151|19552687|P1|NOT COMPLETED|Overall Study||3
7944612|NCT00476151|19552686|P2|COMPLETED|Overall Study||107
7944613|NCT00476151|19552687|P1|COMPLETED|Overall Study||109
7944614|NCT00476151|19552686|P2|STARTED|Overall Study||114
7944615|NCT00476151|19552687|P1|STARTED|Overall Study||112
7944616|NCT00476086|19552693|P1|NOT COMPLETED|Overall Study||5
7944617|NCT00476086|19552693|P1|COMPLETED|Overall Study||15
7944618|NCT00476086|19552693|P1|Received Radiation|Overall Study||15
7944619|NCT00476086|19552693|P1|Received Chemotherapy|Overall Study||19
7944620|NCT00476086|19552693|P1|STARTED|Overall Study||20
7944621|NCT00476047|19552699|P1|NOT COMPLETED|Overall Study||1
7944622|NCT00476047|19552699|P1|COMPLETED|Overall Study||15
7944623|NCT00476047|19552699|P1|Completed Treatment|Overall Study||16
7944624|NCT00476047|19552699|P1|STARTED|Overall Study||16
7944625|NCT00476021|19552708|P2|NOT COMPLETED|Overall Study||0
7944626|NCT00476021|19552709|P1|NOT COMPLETED|Overall Study||0
7944627|NCT00476021|19552708|P2|COMPLETED|Overall Study||51
7944628|NCT00476021|19552709|P1|COMPLETED|Overall Study||51
7944629|NCT00476021|19552708|P2|STARTED|Overall Study||51
7944630|NCT00476021|19552709|P1|STARTED|Overall Study||51
7944631|NCT00476008|19552725|P2|NOT COMPLETED|Overall Study||8
7944632|NCT00476008|19552726|P1|NOT COMPLETED|Overall Study||9
7944633|NCT00476008|19552725|P2|COMPLETED|Overall Study||13
7944634|NCT00476008|19552726|P1|COMPLETED|Overall Study||13
7944635|NCT00476008|19552725|P2|6 Month Testing|Overall Study||14
7944636|NCT00476008|19552726|P1|6 Month Testing|Overall Study||15
7944637|NCT00476008|19552725|P2|STARTED|Overall Study||21
7944638|NCT00476008|19552726|P1|STARTED|Overall Study||22
7944639|NCT00475982|19552752|P2|NOT COMPLETED|Overall Study||3
7944640|NCT00475982|19552753|P1|NOT COMPLETED|Overall Study||7
7944641|NCT00475982|19552752|P2|COMPLETED|Overall Study||18
7944642|NCT00475982|19552753|P1|COMPLETED|Overall Study||16
7944643|NCT00475982|19552752|P2|STARTED|Overall Study||21
7944644|NCT00475982|19552753|P1|STARTED|Overall Study||23
7944645|NCT00475904|19552774|P3|NOT COMPLETED|Overall Study||4
7944646|NCT00475904|19552775|P2|NOT COMPLETED|Overall Study||13
7944647|NCT00475904|19552776|P1|NOT COMPLETED|Overall Study||15
7944648|NCT00475904|19552774|P3|COMPLETED|Overall Study||72
7944649|NCT00475904|19552775|P2|COMPLETED|Overall Study||131
7944650|NCT00475904|19552776|P1|COMPLETED|Overall Study||125
7944651|NCT00475904|19552774|P3|STARTED|Overall Study||76
7944652|NCT00475904|19552775|P2|STARTED|Overall Study||144
7944653|NCT00475904|19552776|P1|STARTED|Overall Study||140
7944654|NCT00475878|19552789|P2|NOT COMPLETED|Overall Study||0
7944655|NCT00475878|19552790|P1|NOT COMPLETED|Overall Study||0
7944656|NCT00475878|19552789|P2|COMPLETED|Overall Study||72
7944657|NCT00475878|19552790|P1|COMPLETED|Overall Study||75
7944658|NCT00475878|19552789|P2|STARTED|Overall Study||72
7944659|NCT00475878|19552790|P1|STARTED|Overall Study||75
7944660|NCT00475865|19552801|P3|NOT COMPLETED|Overall Study||6
7944661|NCT00475865|19552802|P2|NOT COMPLETED|Overall Study||5
7944662|NCT00475865|19552803|P1|NOT COMPLETED|Overall Study||2
7944663|NCT00475865|19552801|P3|COMPLETED|Overall Study|completed treatment period|34
7944664|NCT00475865|19552802|P2|COMPLETED|Overall Study|completed treatment period|37
7944665|NCT00475865|19552803|P1|COMPLETED|Overall Study||39
7944666|NCT00475865|19552801|P3|Treated|Overall Study||40
7944667|NCT00475865|19552802|P2|Treated|Overall Study||42
7944668|NCT00475865|19552803|P1|Treated|Overall Study|completed treatment period|41
7944669|NCT00475865|19552801|P3|STARTED|Overall Study|randomized|40
7944670|NCT00475865|19552802|P2|STARTED|Overall Study|randomized|42
7944671|NCT00475865|19552803|P1|STARTED|Overall Study|randomized|41
7944672|NCT00475852|19552833|P2|NOT COMPLETED|Overall Study||548
7944673|NCT00475852|19552834|P1|NOT COMPLETED|Overall Study||517
7944674|NCT00475852|19552833|P2|COMPLETED|Overall Study||3029
7944675|NCT00475852|19552834|P1|COMPLETED|Overall Study||3047
7944676|NCT00475852|19552833|P2|STARTED|Overall Study||3577
7944677|NCT00475852|19552834|P1|STARTED|Overall Study||3564
7944678|NCT00475787|19552864|P2|NOT COMPLETED|Overall Study||7
7944679|NCT00475787|19552865|P1|NOT COMPLETED|Overall Study||8
7944680|NCT00475787|19552864|P2|COMPLETED|Overall Study||60
7944681|NCT00475787|19552865|P1|COMPLETED|Overall Study||61
7944682|NCT00475787|19552864|P2|STARTED|Overall Study||67
7944683|NCT00475787|19552865|P1|STARTED|Overall Study||69
7944684|NCT00475735|19552885|P6|NOT COMPLETED|Treatment Period 2||1
7944685|NCT00475735|19552886|P5|NOT COMPLETED|Treatment Period 2||1
7944686|NCT00475735|19552887|P4|NOT COMPLETED|Treatment Period 2||2
7944687|NCT00475735|19552888|P3|NOT COMPLETED|Treatment Period 2||0
7944688|NCT00475735|19552889|P2|NOT COMPLETED|Treatment Period 2||1
7944689|NCT00475735|19552890|P1|NOT COMPLETED|Treatment Period 2||0
7944690|NCT00475735|19552885|P6|COMPLETED|Treatment Period 2||13
7944691|NCT00475735|19552886|P5|COMPLETED|Treatment Period 2||15
7944692|NCT00475735|19552887|P4|COMPLETED|Treatment Period 2||4
7944693|NCT00475735|19552888|P3|COMPLETED|Treatment Period 2||7
7944694|NCT00475735|19552889|P2|COMPLETED|Treatment Period 2||9
7944695|NCT00475735|19552890|P1|COMPLETED|Treatment Period 2||10
7944696|NCT00475735|19552885|P6|STARTED|Treatment Period 2||14
7944697|NCT00475735|19552886|P5|STARTED|Treatment Period 2||16
7944698|NCT00475735|19552887|P4|STARTED|Treatment Period 2||6
7944699|NCT00475735|19552888|P3|STARTED|Treatment Period 2||7
7944700|NCT00475735|19552889|P2|STARTED|Treatment Period 2||10
7944701|NCT00475735|19552890|P1|STARTED|Treatment Period 2||10
7944702|NCT00475735|19552885|P6|NOT COMPLETED|Treatment Washout||0
7944703|NCT00475735|19552886|P5|NOT COMPLETED|Treatment Washout||0
7944704|NCT00475735|19552887|P4|NOT COMPLETED|Treatment Washout||0
7944705|NCT00475735|19552888|P3|NOT COMPLETED|Treatment Washout||0
7944706|NCT00475735|19552889|P2|NOT COMPLETED|Treatment Washout||2
7944707|NCT00475735|19552890|P1|NOT COMPLETED|Treatment Washout||0
7944708|NCT00475735|19552885|P6|COMPLETED|Treatment Washout||14
7944709|NCT00475735|19552886|P5|COMPLETED|Treatment Washout||16
7944710|NCT00475735|19552887|P4|COMPLETED|Treatment Washout||6
7944711|NCT00475735|19552888|P3|COMPLETED|Treatment Washout||7
7944712|NCT00475735|19552889|P2|COMPLETED|Treatment Washout||10
7944713|NCT00475735|19552890|P1|COMPLETED|Treatment Washout||10
7944714|NCT00475735|19552885|P6|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14
7944715|NCT00475735|19552886|P5|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16
7944716|NCT00475735|19552887|P4|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6
7944717|NCT00475735|19552888|P3|STARTED|Treatment Washout||7
7944718|NCT00475735|19552889|P2|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12
7944719|NCT00475735|19552890|P1|STARTED|Treatment Washout||10
7944720|NCT00475735|19552885|P6|NOT COMPLETED|Treatment Period 1||3
7944721|NCT00475735|19552886|P5|NOT COMPLETED|Treatment Period 1||2
7944722|NCT00475735|19552887|P4|NOT COMPLETED|Treatment Period 1||2
7944723|NCT00475735|19552888|P3|NOT COMPLETED|Treatment Period 1||0
7944724|NCT00475735|19552889|P2|NOT COMPLETED|Treatment Period 1||2
7944725|NCT00475735|19552890|P1|NOT COMPLETED|Treatment Period 1||4
7944726|NCT00475735|19552885|P6|COMPLETED|Treatment Period 1||12
7944727|NCT00475735|19552886|P5|COMPLETED|Treatment Period 1||14
7944728|NCT00475735|19552887|P4|COMPLETED|Treatment Period 1||5
7944729|NCT00475735|19552888|P3|COMPLETED|Treatment Period 1||7
7944730|NCT00475735|19552889|P2|COMPLETED|Treatment Period 1||11
7944731|NCT00475735|19552890|P1|COMPLETED|Treatment Period 1||10
7944732|NCT00475735|19552885|P6|STARTED|Treatment Period 1||15
7944733|NCT00475735|19552886|P5|STARTED|Treatment Period 1||16
7944734|NCT00475735|19552887|P4|STARTED|Treatment Period 1||7
7944735|NCT00475735|19552888|P3|STARTED|Treatment Period 1||7
7944736|NCT00475735|19552889|P2|STARTED|Treatment Period 1||13
7944737|NCT00475735|19552890|P1|STARTED|Treatment Period 1||14
7944738|NCT00475722|19552903|P2|NOT COMPLETED|Overall Study||12
7944739|NCT00475722|19552904|P1|NOT COMPLETED|Overall Study||15
7944740|NCT00475722|19552903|P2|COMPLETED|Overall Study||47
7944741|NCT00475722|19552904|P1|COMPLETED|Overall Study||46
7944742|NCT00475722|19552903|P2|STARTED|Overall Study||59
7944743|NCT00475722|19552904|P1|STARTED|Overall Study||61
7944744|NCT00475709|19552910|P1|NOT COMPLETED|Overall Study||76
7944745|NCT00475709|19552910|P1|COMPLETED|Overall Study||946
7944746|NCT00475709|19552910|P1|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014
7944747|NCT00475709|19552910|P1|STARTED|Overall Study||1022
7944748|NCT00475670|19552918|P2|NOT COMPLETED|Overall Study||41
7944749|NCT00475670|19552919|P1|NOT COMPLETED|Overall Study||3
7944750|NCT00475670|19552918|P2|COMPLETED|Overall Study||0
7944751|NCT00475670|19552919|P1|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0
7944752|NCT00475670|19552918|P2|STARTED|Overall Study||41
7944753|NCT00475670|19552919|P1|STARTED|Overall Study||3
7944754|NCT00475657|19552943|P1|NOT COMPLETED|Overall Study||4
7944755|NCT00475657|19552943|P1|COMPLETED|Overall Study||1
7944756|NCT00475657|19552943|P1|STARTED|Overall Study||5
7944757|NCT00475644|19552951|P1|NOT COMPLETED|Overall Study||13
7944758|NCT00475644|19552951|P1|COMPLETED|Overall Study||53
7944759|NCT00475644|19552951|P1|Received at Least One Dose of Study Drug|Overall Study||66
7944760|NCT00475644|19552951|P1|STARTED|Overall Study||66
7944761|NCT00475501|19552963|P4|NOT COMPLETED|Overall Study||4
7944762|NCT00475501|19552964|P3|NOT COMPLETED|Overall Study||4
7944763|NCT00475501|19552965|P2|NOT COMPLETED|Overall Study||5
7944764|NCT00475501|19552966|P1|NOT COMPLETED|Overall Study||7
7944765|NCT00475501|19552963|P4|COMPLETED|Overall Study||12
7944766|NCT00475501|19552964|P3|COMPLETED|Overall Study||13
7944767|NCT00475501|19552965|P2|COMPLETED|Overall Study||8
7944768|NCT00475501|19552966|P1|COMPLETED|Overall Study||7
7944769|NCT00475501|19552963|P4|STARTED|Overall Study||16
7944770|NCT00475501|19552964|P3|STARTED|Overall Study||17
7944771|NCT00475501|19552965|P2|STARTED|Overall Study||13
7944772|NCT00475501|19552966|P1|STARTED|Overall Study||14
7944773|NCT00475423|19553016|P1|NOT COMPLETED|Overall Study||32
7944774|NCT00475423|19553016|P1|COMPLETED|Overall Study||90
7944775|NCT00475423|19553016|P1|STARTED|Overall Study||122
7944776|NCT00475332|19553037|P1|NOT COMPLETED|Overall Study||0
7944777|NCT00475332|19553037|P1|COMPLETED|Overall Study||2
7944778|NCT00475332|19553037|P1|STARTED|Overall Study||2
7944779|NCT00475319|19553045|P3|NOT COMPLETED|Overall Study||4
7944780|NCT00475319|19553046|P2|NOT COMPLETED|Overall Study||1
7944781|NCT00475319|19553047|P1|NOT COMPLETED|Overall Study||2
7944782|NCT00475319|19553045|P3|COMPLETED|Overall Study||99
7944783|NCT00475319|19553046|P2|COMPLETED|Overall Study||101
7944784|NCT00475319|19553047|P1|COMPLETED|Overall Study||101
7944785|NCT00475319|19553045|P3|STARTED|Overall Study||103
7944786|NCT00475319|19553046|P2|STARTED|Overall Study||102
7944787|NCT00475319|19553047|P1|STARTED|Overall Study||103
7944788|NCT00475306|19553062|P4|NOT COMPLETED|Overall Study||1
7944789|NCT00475306|19553063|P3|NOT COMPLETED|Overall Study||0
7944790|NCT00475306|19553064|P2|NOT COMPLETED|Overall Study||1
7944791|NCT00475306|19553065|P1|NOT COMPLETED|Overall Study||1
7944792|NCT00475306|19553062|P4|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71
7944793|NCT00475306|19553063|P3|COMPLETED|Overall Study||72
7944794|NCT00475306|19553064|P2|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71
7944795|NCT00475306|19553065|P1|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72
7944796|NCT00475306|19553062|P4|STARTED|Overall Study||72
7944797|NCT00475306|19553063|P3|STARTED|Overall Study||72
7944798|NCT00475306|19553064|P2|STARTED|Overall Study||72
7944799|NCT00475306|19553065|P1|STARTED|Overall Study||73
7944800|NCT00475241|19553081|P2|NOT COMPLETED|Overall Study||3
7944801|NCT00475241|19553082|P1|NOT COMPLETED|Overall Study||7
7944802|NCT00475241|19553081|P2|COMPLETED|Overall Study||15
7944803|NCT00475241|19553082|P1|COMPLETED|Overall Study||11
7944804|NCT00475241|19553081|P2|STARTED|Overall Study||18
7944805|NCT00475241|19553082|P1|STARTED|Overall Study||18
7944806|NCT00475228|19553096|P2|NOT COMPLETED|Overall Study||17
7944807|NCT00475228|19553097|P1|NOT COMPLETED|Overall Study||17
7944808|NCT00475228|19553096|P2|COMPLETED|Overall Study||27
7944809|NCT00475228|19553097|P1|COMPLETED|Overall Study||27
7944810|NCT00475228|19553096|P2|STARTED|Overall Study||44
7944811|NCT00475228|19553097|P1|STARTED|Overall Study||44
7944812|NCT00475215|19553109|P2|NOT COMPLETED|Overall Study||4
7944813|NCT00475215|19553110|P1|NOT COMPLETED|Overall Study||5
7944814|NCT00475215|19553109|P2|COMPLETED|Overall Study||38
7944815|NCT00475215|19553110|P1|COMPLETED|Overall Study||39
7944816|NCT00475215|19553109|P2|Treated|Overall Study||38
7944817|NCT00475215|19553110|P1|Treated|Overall Study||39
7944818|NCT00475215|19553109|P2|STARTED|Overall Study||42
7944819|NCT00475215|19553110|P1|STARTED|Overall Study||44
7944820|NCT00475176|19553136|P1|NOT COMPLETED|Overall Study||4
7944821|NCT00475176|19553136|P1|COMPLETED|Overall Study||20
7944822|NCT00475176|19553136|P1|STARTED|Overall Study||24
7944823|NCT00475150|19553143|P2|NOT COMPLETED|Overall Study||0
7944824|NCT00475150|19553144|P1|NOT COMPLETED|Overall Study||0
7944825|NCT00475150|19553143|P2|COMPLETED|Overall Study||16
7944826|NCT00475150|19553144|P1|COMPLETED|Overall Study||23
7944827|NCT00475150|19553143|P2|STARTED|Overall Study||16
7944828|NCT00475150|19553144|P1|STARTED|Overall Study||23
7944829|NCT00475085|19553161|P4|NOT COMPLETED|Overall Study||20
7944830|NCT00475085|19553162|P3|NOT COMPLETED|Overall Study||19
7944831|NCT00475085|19553163|P2|NOT COMPLETED|Overall Study||20
7944832|NCT00475085|19553164|P1|NOT COMPLETED|Overall Study||18
7944833|NCT00475085|19553161|P4|COMPLETED|Overall Study||234
7944834|NCT00475085|19553162|P3|COMPLETED|Overall Study||241
7944835|NCT00475085|19553163|P2|COMPLETED|Overall Study||234
7944836|NCT00475085|19553164|P1|COMPLETED|Overall Study||235
7944837|NCT00475085|19553161|P4|STARTED|Overall Study||254
7944838|NCT00475085|19553162|P3|STARTED|Overall Study||260
7944839|NCT00475085|19553163|P2|STARTED|Overall Study||254
7944840|NCT00475085|19553164|P1|STARTED|Overall Study||253
7944841|NCT00475033|19553176|P2|NOT COMPLETED|Toddler Dose||0
7944842|NCT00475033|19553177|P1|NOT COMPLETED|Toddler Dose||4
7944843|NCT00475033|19553176|P2|COMPLETED|Toddler Dose||282
7944844|NCT00475033|19553177|P1|COMPLETED|Toddler Dose||283
7944845|NCT00475033|19553176|P2|STARTED|Toddler Dose|Vaccinated Toddler Dose|282
7944846|NCT00475033|19553177|P1|STARTED|Toddler Dose|Vaccinated Toddler Dose|287
7944847|NCT00475033|19553176|P2|NOT COMPLETED|After the Infant Series||8
7944848|NCT00475033|19553177|P1|NOT COMPLETED|After the Infant Series||6
7944849|NCT00475033|19553176|P2|COMPLETED|After the Infant Series||282
7944850|NCT00475033|19553177|P1|COMPLETED|After the Infant Series||287
7944851|NCT00475033|19553176|P2|Withdrawn After Infant Series|After the Infant Series||8
7944852|NCT00475033|19553177|P1|Withdrawn After Infant Series|After the Infant Series||6
7944853|NCT00475033|19553176|P2|STARTED|After the Infant Series||290
7944854|NCT00475033|19553177|P1|STARTED|After the Infant Series||293
7944855|NCT00475033|19553176|P2|NOT COMPLETED|Infant Series||13
7944856|NCT00475033|19553177|P1|NOT COMPLETED|Infant Series||7
7944857|NCT00475033|19553176|P2|COMPLETED|Infant Series||290
7944858|NCT00475033|19553177|P1|COMPLETED|Infant Series||293
7944859|NCT00475033|19553176|P2|Vaccinated Dose 3|Infant Series||294
7944860|NCT00475033|19553177|P1|Vaccinated Dose 3|Infant Series||293
7944861|NCT00475033|19553176|P2|Vaccinated Dose 2|Infant Series||296
7944862|NCT00475033|19553177|P1|Vaccinated Dose 2|Infant Series||297
7944863|NCT00475033|19553176|P2|Vaccinated Dose 1|Infant Series||303
7944864|NCT00475033|19553177|P1|Vaccinated Dose 1|Infant Series||300
7944865|NCT00475033|19553176|P2|STARTED|Infant Series||303
7944866|NCT00475033|19553177|P1|STARTED|Infant Series||300
7944867|NCT00475020|19553225|P1|NOT COMPLETED|Overall Study||5
7944868|NCT00475020|19553225|P1|COMPLETED|Overall Study||58
7944869|NCT00475020|19553225|P1|STARTED|Overall Study||63
7944870|NCT00474994|19553230|P1|NOT COMPLETED|Overall Study||5
7944871|NCT00474994|19553230|P1|COMPLETED|Overall Study||48
7944872|NCT00474994|19553230|P1|STARTED|Overall Study||53
7944873|NCT00474968|19553236|P2|NOT COMPLETED|Overall Study||16
7944874|NCT00474968|19553237|P1|NOT COMPLETED|Overall Study||18
7944875|NCT00474968|19553236|P2|COMPLETED|Overall Study||355
7944876|NCT00474968|19553237|P1|COMPLETED|Overall Study||348
7944877|NCT00474968|19553236|P2|STARTED|Overall Study||371
7944878|NCT00474968|19553237|P1|STARTED|Overall Study||366
7944879|NCT00474955|19553247|P1|NOT COMPLETED|Overall Study||8
7944880|NCT00474955|19553247|P1|COMPLETED|Overall Study||19
7944881|NCT00474955|19553247|P1|STARTED|Overall Study||27
7944882|NCT00474929|19553263|P5|NOT COMPLETED|Overall Study||0
7944883|NCT00474929|19553264|P4|NOT COMPLETED|Overall Study||2
7944884|NCT00474929|19553265|P3|NOT COMPLETED|Overall Study||2
7944885|NCT00474929|19553266|P2|NOT COMPLETED|Overall Study||1
7944886|NCT00474929|19553267|P1|NOT COMPLETED|Overall Study||0
7944887|NCT00474929|19553263|P5|COMPLETED|Overall Study||77
7944888|NCT00474929|19553264|P4|COMPLETED|Overall Study||5
7944889|NCT00474929|19553265|P3|COMPLETED|Overall Study||5
7944890|NCT00474929|19553266|P2|COMPLETED|Overall Study||5
7944891|NCT00474929|19553267|P1|COMPLETED|Overall Study||6
7944892|NCT00474929|19553263|P5|STARTED|Overall Study||77
7944893|NCT00474929|19553264|P4|STARTED|Overall Study||7
7944894|NCT00474929|19553265|P3|STARTED|Overall Study||7
7944895|NCT00474929|19553266|P2|STARTED|Overall Study||6
7944896|NCT00474929|19553267|P1|STARTED|Overall Study||6
7944897|NCT00474903|19553284|P3|NOT COMPLETED|Overall Study||2
7944898|NCT00474903|19553285|P2|NOT COMPLETED|Overall Study||5
7944899|NCT00474903|19553286|P1|NOT COMPLETED|Overall Study||1
7944900|NCT00474903|19553284|P3|COMPLETED|Overall Study||43
7944901|NCT00474903|19553285|P2|COMPLETED|Overall Study||42
7944902|NCT00474903|19553286|P1|COMPLETED|Overall Study||29
7944903|NCT00474903|19553284|P3|STARTED|Overall Study||45
7944904|NCT00474903|19553285|P2|STARTED|Overall Study||47
7944905|NCT00474903|19553286|P1|STARTED|Overall Study||30
7944906|NCT00474851|19553299|P2|NOT COMPLETED|Overall Study||11
7944907|NCT00474851|19553300|P1|NOT COMPLETED|Overall Study||8
7944908|NCT00474851|19553299|P2|COMPLETED|Overall Study||16
7944909|NCT00474851|19553300|P1|COMPLETED|Overall Study||18
7944910|NCT00474851|19553299|P2|Completed Baseline|Overall Study||26
7944911|NCT00474851|19553300|P1|Completed Baseline|Overall Study||25
7944912|NCT00474851|19553299|P2|STARTED|Overall Study||27
7944913|NCT00474851|19553300|P1|STARTED|Overall Study||26
7944914|NCT00474812|19553308|P1|NOT COMPLETED|Overall Study||7
7944915|NCT00474812|19553308|P1|COMPLETED|Overall Study||44
7944916|NCT00474812|19553308|P1|STARTED|Overall Study||51
7944917|NCT00474786|19553318|P2|NOT COMPLETED|Overall Study||253
7944918|NCT00474786|19553319|P1|NOT COMPLETED|Overall Study||259
7944919|NCT00474786|19553318|P2|COMPLETED|Overall Study||0
7944920|NCT00474786|19553319|P1|COMPLETED|Overall Study||0
7944921|NCT00474786|19553318|P2|STARTED|Overall Study||253
7944922|NCT00474786|19553319|P1|STARTED|Overall Study||259
7944923|NCT00474760|19553344|P7|NOT COMPLETED|Overall Study||10
7944924|NCT00474760|19553345|P6|NOT COMPLETED|Overall Study||29
7944925|NCT00474760|19553346|P5|NOT COMPLETED|Overall Study||12
7944926|NCT00474760|19553347|P4|NOT COMPLETED|Overall Study||3
7944927|NCT00474760|19553348|P3|NOT COMPLETED|Overall Study||3
7944928|NCT00474760|19553349|P2|NOT COMPLETED|Overall Study||3
7944929|NCT00474760|19553350|P1|NOT COMPLETED|Overall Study||3
7944930|NCT00474760|19553344|P7|COMPLETED|Overall Study||1
7944931|NCT00474760|19553345|P6|COMPLETED|Overall Study||0
7944932|NCT00474760|19553346|P5|COMPLETED|Overall Study||1
7944933|NCT00474760|19553347|P4|COMPLETED|Overall Study||0
7944934|NCT00474760|19553348|P3|COMPLETED|Overall Study||0
7944935|NCT00474760|19553349|P2|COMPLETED|Overall Study||0
7944936|NCT00474760|19553350|P1|COMPLETED|Overall Study||0
7944937|NCT00474760|19553344|P7|STARTED|Overall Study||11
7944938|NCT00474760|19553345|P6|STARTED|Overall Study||29
7944939|NCT00474760|19553346|P5|STARTED|Overall Study||13
7944940|NCT00474760|19553347|P4|STARTED|Overall Study||3
7944941|NCT00474760|19553348|P3|STARTED|Overall Study||3
7944942|NCT00474760|19553349|P2|STARTED|Overall Study||3
7944943|NCT00474760|19553350|P1|STARTED|Overall Study||3
7944944|NCT00474708|19553457|P2|NOT COMPLETED|Overall Study||25
7944945|NCT00474708|19553458|P1|NOT COMPLETED|Overall Study||57
7944946|NCT00474708|19553457|P2|COMPLETED|Overall Study||342
7944947|NCT00474708|19553458|P1|COMPLETED|Overall Study||734
7944948|NCT00474708|19553457|P2|STARTED|Overall Study||367
7944949|NCT00474708|19553458|P1|STARTED|Overall Study||791
7944950|NCT00474630|19553468|P2|NOT COMPLETED|Overall Study||70
7944951|NCT00474630|19553469|P1|NOT COMPLETED|Overall Study||160
7944952|NCT00474630|19553468|P2|COMPLETED|Overall Study||100
7944953|NCT00474630|19553469|P1|COMPLETED|Overall Study||175
7944954|NCT00474630|19553468|P2|STARTED|Overall Study||170
7944955|NCT00474630|19553469|P1|STARTED|Overall Study||335
7944956|NCT00474617|19553526|P3|NOT COMPLETED|Overall Study||2
7944957|NCT00474617|19553527|P2|NOT COMPLETED|Overall Study||3
7944958|NCT00474617|19553528|P1|NOT COMPLETED|Overall Study||8
7944959|NCT00474617|19553526|P3|COMPLETED|Overall Study||40
7944960|NCT00474617|19553527|P2|COMPLETED|Overall Study||61
7944961|NCT00474617|19553528|P1|COMPLETED|Overall Study||48
7944962|NCT00474617|19553526|P3|Treated|Overall Study||40
7944963|NCT00474617|19553527|P2|Treated|Overall Study||62
7944964|NCT00474617|19553528|P1|Treated|Overall Study||48
7944965|NCT00474617|19553526|P3|STARTED|Overall Study||42
7944966|NCT00474617|19553527|P2|STARTED|Overall Study||64
7944967|NCT00474617|19553528|P1|STARTED|Overall Study||56
7944968|NCT00474539|19553562|P2|NOT COMPLETED|Toddler Dose||0
7944969|NCT00474539|19553563|P1|NOT COMPLETED|Toddler Dose||1
7944970|NCT00474539|19553562|P2|COMPLETED|Toddler Dose||220
7944971|NCT00474539|19553563|P1|COMPLETED|Toddler Dose||208
7944972|NCT00474539|19553562|P2|STARTED|Toddler Dose||220
7944973|NCT00474539|19553563|P1|STARTED|Toddler Dose||209
7944974|NCT00474539|19553562|P2|NOT COMPLETED|After Infant Series||0
7944975|NCT00474539|19553563|P1|NOT COMPLETED|After Infant Series||4
7944976|NCT00474539|19553562|P2|COMPLETED|After Infant Series||220
7944977|NCT00474539|19553563|P1|COMPLETED|After Infant Series||209
7944978|NCT00474539|19553562|P2|STARTED|After Infant Series||220
7944979|NCT00474539|19553563|P1|STARTED|After Infant Series||213
7944980|NCT00474539|19553562|P2|NOT COMPLETED|Infant Series||6
7944981|NCT00474539|19553563|P1|NOT COMPLETED|Infant Series||10
7944982|NCT00474539|19553562|P2|COMPLETED|Infant Series||220
7944983|NCT00474539|19553563|P1|COMPLETED|Infant Series||213
7944984|NCT00474539|19553562|P2|Vaccinated Dose 3|Infant Series||221
7944985|NCT00474539|19553563|P1|Vaccinated Dose 3|Infant Series||214
7944986|NCT00474539|19553562|P2|Vaccinated Dose 2|Infant Series||222
7944987|NCT00474539|19553563|P1|Vaccinated Dose 2|Infant Series||217
7944988|NCT00474539|19553562|P2|Vaccinated Dose 1|Infant Series||226
7944989|NCT00474539|19553563|P1|Vaccinated Dose 1|Infant Series||218
7944990|NCT00474539|19553562|P2|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226
7944991|NCT00474539|19553563|P1|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223
7944992|NCT00474526|19553628|P17|NOT COMPLETED|Overall Study||9
7944993|NCT00474526|19553629|P16|NOT COMPLETED|Overall Study||18
7944994|NCT00474526|19553630|P15|NOT COMPLETED|Overall Study||77
7944995|NCT00474526|19553631|P14|NOT COMPLETED|Overall Study||156
7944996|NCT00474526|19553632|P13|NOT COMPLETED|Overall Study||15
7944997|NCT00474526|19553633|P12|NOT COMPLETED|Overall Study||11
7944998|NCT00474526|19553634|P11|NOT COMPLETED|Overall Study||10
7944999|NCT00474526|19553635|P10|NOT COMPLETED|Overall Study||27
7945000|NCT00474526|19553636|P9|NOT COMPLETED|Overall Study||6
7945001|NCT00474526|19553637|P8|NOT COMPLETED|Overall Study||6
7945002|NCT00474526|19553638|P7|NOT COMPLETED|Overall Study||25
7945003|NCT00474526|19553639|P6|NOT COMPLETED|Overall Study||16
7945004|NCT00474526|19553640|P5|NOT COMPLETED|Overall Study||68
7945005|NCT00474526|19553641|P4|NOT COMPLETED|Overall Study||119
7945006|NCT00474526|19553642|P3|NOT COMPLETED|Overall Study||49
7945007|NCT00474526|19553643|P2|NOT COMPLETED|Overall Study||46
7945008|NCT00474526|19553644|P1|NOT COMPLETED|Overall Study||33
7945009|NCT00474526|19553628|P17|COMPLETED|Overall Study||174
7945010|NCT00474526|19553629|P16|COMPLETED|Overall Study||152
7945011|NCT00474526|19553630|P15|COMPLETED|Overall Study||281
7945012|NCT00474526|19553631|P14|COMPLETED|Overall Study||1270
7945013|NCT00474526|19553632|P13|COMPLETED|Overall Study||135
7945014|NCT00474526|19553633|P12|COMPLETED|Overall Study||139
7945015|NCT00474526|19553634|P11|COMPLETED|Overall Study||141
7945016|NCT00474526|19553635|P10|COMPLETED|Overall Study||121
7945017|NCT00474526|19553636|P9|COMPLETED|Overall Study||144
7945018|NCT00474526|19553637|P8|COMPLETED|Overall Study||145
7945019|NCT00474526|19553638|P7|COMPLETED|Overall Study||178
7945020|NCT00474526|19553639|P6|COMPLETED|Overall Study||54
7945021|NCT00474526|19553640|P5|COMPLETED|Overall Study||8
7945022|NCT00474526|19553641|P4|COMPLETED|Overall Study||561
7945023|NCT00474526|19553642|P3|COMPLETED|Overall Study||110
7945024|NCT00474526|19553643|P2|COMPLETED|Overall Study||120
7945025|NCT00474526|19553644|P1|COMPLETED|Overall Study||121
7945026|NCT00474526|19553628|P17|STARTED|Overall Study||183
7945027|NCT00474526|19553629|P16|STARTED|Overall Study||170
7945028|NCT00474526|19553630|P15|STARTED|Overall Study||358
7945029|NCT00474526|19553631|P14|STARTED|Overall Study||1426
7945030|NCT00474526|19553632|P13|STARTED|Overall Study||150
7945031|NCT00474526|19553633|P12|STARTED|Overall Study||150
7945032|NCT00474526|19553634|P11|STARTED|Overall Study||151
7945033|NCT00474526|19553635|P10|STARTED|Overall Study||148
7945034|NCT00474526|19553636|P9|STARTED|Overall Study||150
7945035|NCT00474526|19553637|P8|STARTED|Overall Study||151
7945036|NCT00474526|19553638|P7|STARTED|Overall Study||203
7945037|NCT00474526|19553639|P6|STARTED|Overall Study||70
7945038|NCT00474526|19553640|P5|STARTED|Overall Study||76
7945039|NCT00474526|19553641|P4|STARTED|Overall Study||680
7945040|NCT00474526|19553642|P3|STARTED|Overall Study||159
7945041|NCT00474526|19553643|P2|STARTED|Overall Study||166
7945042|NCT00474526|19553644|P1|STARTED|Overall Study||154
7945043|NCT00474487|19553809|P4|NOT COMPLETED|Overall Study||0
7945044|NCT00474487|19553810|P3|NOT COMPLETED|Overall Study||14
7945045|NCT00474487|19553811|P2|NOT COMPLETED|Overall Study||2
7945046|NCT00474487|19553812|P1|NOT COMPLETED|Overall Study||30
7945047|NCT00474487|19553809|P4|COMPLETED|Overall Study||109
7945048|NCT00474487|19553810|P3|COMPLETED|Overall Study||885
7945049|NCT00474487|19553811|P2|COMPLETED|Overall Study||215
7945050|NCT00474487|19553812|P1|COMPLETED|Overall Study||1576
7945051|NCT00474487|19553809|P4|STARTED|Overall Study||109
7945052|NCT00474487|19553810|P3|STARTED|Overall Study||899
7945053|NCT00474487|19553811|P2|STARTED|Overall Study||217
7945054|NCT00474487|19553812|P1|STARTED|Overall Study||1606
7945055|NCT00474383|19553832|P2|NOT COMPLETED|Extension||5
7945056|NCT00474383|19553833|P1|NOT COMPLETED|Extension||0
7945057|NCT00474383|19553832|P2|COMPLETED|Extension||0
7945058|NCT00474383|19553833|P1|COMPLETED|Extension||0
7945059|NCT00474383|19553832|P2|STARTED|Extension||5
7945060|NCT00474383|19553833|P1|STARTED|Extension||0
7945061|NCT00474383|19553832|P2|NOT COMPLETED|Between Main Study and Extension||0
7945062|NCT00474383|19553833|P1|NOT COMPLETED|Between Main Study and Extension||6
7945063|NCT00474383|19553832|P2|COMPLETED|Between Main Study and Extension||0
7945064|NCT00474383|19553833|P1|COMPLETED|Between Main Study and Extension||5
7945065|NCT00474383|19553832|P2|STARTED|Between Main Study and Extension||0
7945066|NCT00474383|19553833|P1|STARTED|Between Main Study and Extension||11
7945067|NCT00474383|19553832|P2|NOT COMPLETED|Main Study||0
7945068|NCT00474383|19553833|P1|NOT COMPLETED|Main Study||36
7945069|NCT00474383|19553832|P2|COMPLETED|Main Study||0
7945070|NCT00474383|19553833|P1|COMPLETED|Main Study||11
7945071|NCT00474383|19553832|P2|STARTED|Main Study||0
7945072|NCT00474383|19553833|P1|STARTED|Main Study||47
7945073|NCT00474266|19553848|P4|NOT COMPLETED|Overall Study||7
7945074|NCT00474266|19553849|P3|NOT COMPLETED|Overall Study||4
7945075|NCT00474266|19553850|P2|NOT COMPLETED|Overall Study||20
7945076|NCT00474266|19553851|P1|NOT COMPLETED|Overall Study||7
7945077|NCT00474266|19553848|P4|COMPLETED|Overall Study||118
7945078|NCT00474266|19553849|P3|COMPLETED|Overall Study||122
7945079|NCT00474266|19553850|P2|COMPLETED|Overall Study||354
7945080|NCT00474266|19553851|P1|COMPLETED|Overall Study||368
7945081|NCT00474266|19553848|P4|STARTED|Overall Study||125
7945082|NCT00474266|19553849|P3|STARTED|Overall Study||126
7945083|NCT00474266|19553850|P2|STARTED|Overall Study||374
7945084|NCT00474266|19553851|P1|STARTED|Overall Study||375
7945085|NCT00474253|19553955|P2|NOT COMPLETED|Overall Study||4
7945086|NCT00474253|19553956|P1|NOT COMPLETED|Overall Study||3
7945087|NCT00474253|19553955|P2|COMPLETED|Overall Study|Based on actual treatment received.|53
7945088|NCT00474253|19553956|P1|COMPLETED|Overall Study|Based on actual treatment received.|55
7945089|NCT00474253|19553955|P2|Treated|Overall Study|Based on actual treatment received.|54
7945090|NCT00474253|19553956|P1|Treated|Overall Study|Based on actual treatment received.|56
7945091|NCT00474253|19553955|P2|STARTED|Overall Study|Includes 1 participant randomized to rocuronium + sugammadex group who received succinylcholine.|57
7945092|NCT00474253|19553956|P1|STARTED|Overall Study|Includes 2 participants randomized to succinylcholine group who received rocuronium + sugammadex.|58
7945093|NCT00474240|19553980|P6|NOT COMPLETED|Overall Study||18
7945094|NCT00474240|19553981|P5|NOT COMPLETED|Overall Study||8
7945095|NCT00474240|19553982|P4|NOT COMPLETED|Overall Study||16
7945096|NCT00474240|19553983|P3|NOT COMPLETED|Overall Study||9
7945097|NCT00474240|19553984|P2|NOT COMPLETED|Overall Study||1
7945098|NCT00474240|19553985|P1|NOT COMPLETED|Overall Study||1
7945099|NCT00474240|19553980|P6|COMPLETED|Overall Study||8
7945100|NCT00474240|19553981|P5|COMPLETED|Overall Study||18
7945101|NCT00474240|19553982|P4|COMPLETED|Overall Study||10
7945102|NCT00474240|19553983|P3|COMPLETED|Overall Study||17
7945103|NCT00474240|19553984|P2|COMPLETED|Overall Study||25
7945104|NCT00474240|19553985|P1|COMPLETED|Overall Study||26
7945105|NCT00474240|19553980|P6|STARTED|Overall Study||26
7945106|NCT00474240|19553981|P5|STARTED|Overall Study||26
7945107|NCT00474240|19553982|P4|STARTED|Overall Study||26
7945108|NCT00474240|19553983|P3|STARTED|Overall Study||26
7945109|NCT00474240|19553984|P2|STARTED|Overall Study||26
7945110|NCT00474240|19553985|P1|STARTED|Overall Study||27
7945111|NCT00474201|19554005|P1|NOT COMPLETED|Overall Study||0
7945112|NCT00474201|19554005|P1|COMPLETED|Overall Study||15
7945113|NCT00474201|19554005|P1|STARTED|Overall Study||15
7945114|NCT00474188|19554010|P1|NOT COMPLETED|Overall Study||6
7945115|NCT00474188|19554010|P1|COMPLETED|Overall Study|Disease progression=15, adverse event=4, death=1|20
7945116|NCT00474188|19554010|P1|STARTED|Overall Study||26
7945117|NCT00474175|19554020|P3|NOT COMPLETED|Overall Study||4
7945118|NCT00474175|19554021|P2|NOT COMPLETED|Overall Study||7
7945119|NCT00474175|19554022|P1|NOT COMPLETED|Overall Study||1
7945120|NCT00474175|19554020|P3|COMPLETED|Overall Study||225
7945121|NCT00474175|19554021|P2|COMPLETED|Overall Study||226
7945122|NCT00474175|19554022|P1|COMPLETED|Overall Study||114
7945123|NCT00474175|19554020|P3|Treated|Overall Study||228
7945124|NCT00474175|19554021|P2|Treated|Overall Study||233
7945125|NCT00474175|19554022|P1|Treated|Overall Study||115
7945126|NCT00474175|19554020|P3|STARTED|Overall Study||229
7945127|NCT00474175|19554021|P2|STARTED|Overall Study||233
7945128|NCT00474175|19554022|P1|STARTED|Overall Study||115
7945129|NCT00474123|19554059|P2|NOT COMPLETED|Overall Study||0
7945130|NCT00474123|19554060|P1|NOT COMPLETED|Overall Study||0
7945131|NCT00474123|19554059|P2|COMPLETED|Overall Study||40
7945132|NCT00474123|19554060|P1|COMPLETED|Overall Study||38
7945133|NCT00474123|19554059|P2|STARTED|Overall Study||40
7945134|NCT00474123|19554060|P1|STARTED|Overall Study||38
7945135|NCT00474058|19554086|P2|NOT COMPLETED|Overall Study||17
7945136|NCT00474058|19554087|P1|NOT COMPLETED|Overall Study||24
7945137|NCT00474058|19554086|P2|COMPLETED|Overall Study||80
7945138|NCT00474058|19554087|P1|COMPLETED|Overall Study||166
7945139|NCT00474058|19554086|P2|STARTED|Overall Study||97
7945140|NCT00474058|19554087|P1|STARTED|Overall Study||190
7945141|NCT00474045|19554101|P2|NOT COMPLETED|Overall Study||101
7945142|NCT00474045|19554102|P1|NOT COMPLETED|Overall Study||106
7945143|NCT00474045|19554101|P2|COMPLETED|Overall Study||136
7945144|NCT00474045|19554102|P1|COMPLETED|Overall Study||127
7945145|NCT00474045|19554101|P2|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160
7945146|NCT00474045|19554102|P1|Pregnancies (for Exposed-pregnant)|Overall Study||152
7945147|NCT00474045|19554101|P2|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158
7945148|NCT00474045|19554102|P1|Exposed-Pregnant Subjects|Overall Study||152
7945149|NCT00474045|19554101|P2|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232
7945150|NCT00474045|19554102|P1|Exposed-All Subjects|Overall Study||233
7945151|NCT00474045|19554101|P2|STARTED|Overall Study||237
7945152|NCT00474045|19554102|P1|STARTED|Overall Study||233
7945153|NCT00473889|19554202|P2|NOT COMPLETED|Overall Study||64
7945154|NCT00473889|19554203|P1|NOT COMPLETED|Overall Study||83
7945155|NCT00473889|19554202|P2|COMPLETED|Overall Study||63
7945156|NCT00473889|19554203|P1|COMPLETED|Overall Study||43
7945157|NCT00473889|19554202|P2|STARTED|Overall Study||127
7945158|NCT00473889|19554203|P1|STARTED|Overall Study||126
7945159|NCT00473876|19554215|P2|NOT COMPLETED|Overall Study||1
7945160|NCT00473876|19554216|P1|NOT COMPLETED|Overall Study||3
7945161|NCT00473876|19554215|P2|COMPLETED|Overall Study||22
7945162|NCT00473876|19554216|P1|COMPLETED|Overall Study||36
7945163|NCT00473876|19554215|P2|STARTED|Overall Study||23
7945164|NCT00473876|19554216|P1|STARTED|Overall Study||39
7945165|NCT00473837|19554226|P2|NOT COMPLETED|Overall Study||3
7945166|NCT00473837|19554227|P1|NOT COMPLETED|Overall Study||1
7945167|NCT00473837|19554226|P2|COMPLETED|Overall Study||43
7945168|NCT00473837|19554227|P1|COMPLETED|Overall Study||49
7945169|NCT00473837|19554226|P2|STARTED|Overall Study||46
7945170|NCT00473837|19554227|P1|STARTED|Overall Study||50
7945171|NCT00473824|19554235|P2|NOT COMPLETED|Overall Study||0
7945172|NCT00473824|19554236|P1|NOT COMPLETED|Overall Study||5
7945173|NCT00473824|19554235|P2|COMPLETED|Overall Study|Study Completion/Early Termination Date|2
7945174|NCT00473824|19554236|P1|COMPLETED|Overall Study|Study Completion/Early Termination Date|0
7945175|NCT00473824|19554235|P2|STARTED|Overall Study||2
7945176|NCT00473824|19554236|P1|STARTED|Overall Study||5
7945177|NCT00473746|19554247|P5|NOT COMPLETED|Period 2 (Phase 2)||27
7945178|NCT00473746|19554248|P4|NOT COMPLETED|Period 2 (Phase 2)||0
7945179|NCT00473746|19554249|P3|NOT COMPLETED|Period 2 (Phase 2)||0
7945180|NCT00473746|19554250|P2|NOT COMPLETED|Period 2 (Phase 2)||0
7945181|NCT00473746|19554251|P1|NOT COMPLETED|Period 2 (Phase 2)||0
7945182|NCT00473746|19554247|P5|COMPLETED|Period 2 (Phase 2)||6
7945183|NCT00473746|19554248|P4|COMPLETED|Period 2 (Phase 2)||0
7945184|NCT00473746|19554249|P3|COMPLETED|Period 2 (Phase 2)||0
7945185|NCT00473746|19554250|P2|COMPLETED|Period 2 (Phase 2)||0
7945186|NCT00473746|19554251|P1|COMPLETED|Period 2 (Phase 2)||0
7945187|NCT00473746|19554247|P5|STARTED|Period 2 (Phase 2)||33
7945188|NCT00473746|19554248|P4|STARTED|Period 2 (Phase 2)||0
7945189|NCT00473746|19554249|P3|STARTED|Period 2 (Phase 2)||0
7945190|NCT00473746|19554250|P2|STARTED|Period 2 (Phase 2)||0
7945191|NCT00473746|19554251|P1|STARTED|Period 2 (Phase 2)||0
7945192|NCT00473746|19554247|P5|NOT COMPLETED|Period 1 (Phase 1)||0
7945193|NCT00473746|19554248|P4|NOT COMPLETED|Period 1 (Phase 1)||10
7945194|NCT00473746|19554249|P3|NOT COMPLETED|Period 1 (Phase 1)||6
7945195|NCT00473746|19554250|P2|NOT COMPLETED|Period 1 (Phase 1)||9
7945196|NCT00473746|19554251|P1|NOT COMPLETED|Period 1 (Phase 1)||6
7945197|NCT00473746|19554247|P5|COMPLETED|Period 1 (Phase 1)||0
7945198|NCT00473746|19554248|P4|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2
7945199|NCT00473746|19554249|P3|COMPLETED|Period 1 (Phase 1)||0
7945200|NCT00473746|19554250|P2|COMPLETED|Period 1 (Phase 1)||0
7945201|NCT00473746|19554251|P1|COMPLETED|Period 1 (Phase 1)||0
7945202|NCT00473746|19554247|P5|STARTED|Period 1 (Phase 1)||0
7945203|NCT00473746|19554248|P4|STARTED|Period 1 (Phase 1)||12
7945204|NCT00473746|19554249|P3|STARTED|Period 1 (Phase 1)||6
7945205|NCT00473746|19554250|P2|STARTED|Period 1 (Phase 1)||9
7945206|NCT00473746|19554251|P1|STARTED|Period 1 (Phase 1)||6
7945207|NCT00473694|19554300|P4|NOT COMPLETED|Overall Study||7
7945208|NCT00473694|19554301|P3|NOT COMPLETED|Overall Study||5
7945209|NCT00473694|19554302|P2|NOT COMPLETED|Overall Study||4
7945210|NCT00473694|19554303|P1|NOT COMPLETED|Overall Study||11
7945211|NCT00473694|19554300|P4|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|35
7945212|NCT00473694|19554301|P3|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|46
7945213|NCT00473694|19554302|P2|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
7945214|NCT00473694|19554303|P1|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
7945215|NCT00473694|19554300|P4|Treated|Overall Study|Number of participants treated was based on actual treatment received.|36
7945216|NCT00473694|19554301|P3|Treated|Overall Study|Number of participants treated was based on actual treatment received.|46
7945217|NCT00473694|19554302|P2|Treated|Overall Study|Number of participants treated was based on actual treatment received.|38
7945218|NCT00473694|19554303|P1|Treated|Overall Study|Number of participants treated was based on actual treatment received.|37
7945219|NCT00473694|19554300|P4|STARTED|Overall Study||42
7945220|NCT00473694|19554301|P3|STARTED|Overall Study||51
7945221|NCT00473694|19554302|P2|STARTED|Overall Study|Includes 1 participant randomized to vecuronium+sugammadex but treated with rocuronium+neostigmine|41
7945222|NCT00473694|19554303|P1|STARTED|Overall Study||48
7945223|NCT00473668|19554344|P3|NOT COMPLETED|Overall Study||10
7945224|NCT00473668|19554345|P2|NOT COMPLETED|Overall Study||11
7945225|NCT00473668|19554346|P1|NOT COMPLETED|Overall Study||5
7945226|NCT00473668|19554344|P3|COMPLETED|Overall Study||89
7945227|NCT00473668|19554345|P2|COMPLETED|Overall Study||89
7945228|NCT00473668|19554346|P1|COMPLETED|Overall Study||95
7945229|NCT00473668|19554344|P3|STARTED|Overall Study||99
7945230|NCT00473668|19554345|P2|STARTED|Overall Study||100
7945231|NCT00473668|19554346|P1|STARTED|Overall Study||100
7945232|NCT00473655|19554399|P3|NOT COMPLETED|Overall Study||8
7945233|NCT00473655|19554400|P2|NOT COMPLETED|Overall Study||5
7945234|NCT00473655|19554401|P1|NOT COMPLETED|Overall Study||9
7945235|NCT00473655|19554399|P3|COMPLETED|Overall Study|8 participants were lost of follow up|103
7945236|NCT00473655|19554400|P2|COMPLETED|Overall Study|5 participants were lost of follow up|107
7945237|NCT00473655|19554401|P1|COMPLETED|Overall Study|9 participants were lost of follow up|102
7945238|NCT00473655|19554399|P3|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
7945239|NCT00473655|19554400|P2|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112
7945240|NCT00473655|19554401|P1|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
7945241|NCT00473642|19554436|P3|NOT COMPLETED|Overall Study||2
7945242|NCT00473642|19554437|P2|NOT COMPLETED|Overall Study||1
7945243|NCT00473642|19554438|P1|NOT COMPLETED|Overall Study||2
7945244|NCT00473642|19554436|P3|COMPLETED|Overall Study||8
7945245|NCT00473642|19554437|P2|COMPLETED|Overall Study||10
7945246|NCT00473642|19554438|P1|COMPLETED|Overall Study||8
7945247|NCT00473642|19554436|P3|STARTED|Overall Study||10
7945248|NCT00473642|19554437|P2|STARTED|Overall Study||11
7945249|NCT00473642|19554438|P1|STARTED|Overall Study||10
7945250|NCT00473590|19554462|P2|NOT COMPLETED|Overall Study||38
7945251|NCT00473590|19554463|P1|NOT COMPLETED|Overall Study||45
7945252|NCT00473590|19554462|P2|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11
7945253|NCT00473590|19554463|P1|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8
7945254|NCT00473590|19554462|P2|Safety Population|Overall Study||50
7945255|NCT00473590|19554463|P1|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50
7945256|NCT00473590|19554462|P2|Treated|Overall Study||48
7945257|NCT00473590|19554463|P1|Treated|Overall Study||52
7945258|NCT00473590|19554462|P2|STARTED|Overall Study||49
7945259|NCT00473590|19554463|P1|STARTED|Overall Study||53
7945260|NCT00473564|19554479|P1|NOT COMPLETED|Overall Study||23
7945261|NCT00473564|19554479|P1|COMPLETED|Overall Study||147
7945262|NCT00473564|19554479|P1|STARTED|Overall Study||170
7945263|NCT00473512|19554489|P5|NOT COMPLETED|Period 2 (Phase 2)||2
7945264|NCT00473512|19554490|P4|NOT COMPLETED|Period 2 (Phase 2)||23
7945265|NCT00473512|19554491|P3|NOT COMPLETED|Period 2 (Phase 2)||2
7945266|NCT00473512|19554492|P2|NOT COMPLETED|Period 2 (Phase 2)||2
7945267|NCT00473512|19554493|P1|NOT COMPLETED|Period 2 (Phase 2)||1
7945268|NCT00473512|19554489|P5|COMPLETED|Period 2 (Phase 2)||0
7945269|NCT00473512|19554490|P4|COMPLETED|Period 2 (Phase 2)||0
7945270|NCT00473512|19554491|P3|COMPLETED|Period 2 (Phase 2)||0
7945271|NCT00473512|19554492|P2|COMPLETED|Period 2 (Phase 2)||0
7945272|NCT00473512|19554493|P1|COMPLETED|Period 2 (Phase 2)||0
7945273|NCT00473512|19554489|P5|STARTED|Period 2 (Phase 2)||2
7945274|NCT00473512|19554490|P4|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23
7945275|NCT00473512|19554491|P3|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2
7945276|NCT00473512|19554492|P2|STARTED|Period 2 (Phase 2)||2
7945350|NCT00473265|19554733|P1|NOT COMPLETED|Overall Study||20
7945277|NCT00473512|19554493|P1|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1
7945278|NCT00473512|19554489|P5|NOT COMPLETED|Period 1 (Phase 1)||1
7945279|NCT00473512|19554490|P4|NOT COMPLETED|Period 1 (Phase 1)||17
7945280|NCT00473512|19554491|P3|NOT COMPLETED|Period 1 (Phase 1)||0
7945281|NCT00473512|19554492|P2|NOT COMPLETED|Period 1 (Phase 1)||1
7945282|NCT00473512|19554493|P1|NOT COMPLETED|Period 1 (Phase 1)||1
7945283|NCT00473512|19554489|P5|COMPLETED|Period 1 (Phase 1)||2
7945284|NCT00473512|19554490|P4|COMPLETED|Period 1 (Phase 1)||25
7945285|NCT00473512|19554491|P3|COMPLETED|Period 1 (Phase 1)||3
7945286|NCT00473512|19554492|P2|COMPLETED|Period 1 (Phase 1)||2
7945287|NCT00473512|19554493|P1|COMPLETED|Period 1 (Phase 1)||2
7945288|NCT00473512|19554489|P5|STARTED|Period 1 (Phase 1)||3
7945289|NCT00473512|19554490|P4|STARTED|Period 1 (Phase 1)||42
7945290|NCT00473512|19554491|P3|STARTED|Period 1 (Phase 1)||3
7945291|NCT00473512|19554492|P2|STARTED|Period 1 (Phase 1)||3
7945292|NCT00473512|19554493|P1|STARTED|Period 1 (Phase 1)||3
7945293|NCT00473434|19554551|P1|NOT COMPLETED|Overall Study||32
7945294|NCT00473434|19554551|P1|COMPLETED|Overall Study||32
7945295|NCT00473434|19554551|P1|STARTED|Overall Study||64
7945296|NCT00473382|19554616|P3|NOT COMPLETED|Open-label Extension Through Month 60||82
7945297|NCT00473382|19554617|P2|NOT COMPLETED|Open-label Extension Through Month 60||82
7945298|NCT00473382|19554618|P1|NOT COMPLETED|Open-label Extension Through Month 60||86
7945299|NCT00473382|19554616|P3|COMPLETED|Open-label Extension Through Month 60||2
7945300|NCT00473382|19554617|P2|COMPLETED|Open-label Extension Through Month 60||1
7945301|NCT00473382|19554618|P1|COMPLETED|Open-label Extension Through Month 60||2
7945302|NCT00473382|19554616|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84
7945303|NCT00473382|19554617|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83
7945304|NCT00473382|19554618|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88
7945305|NCT00473382|19554616|P3|NOT COMPLETED|Open-label Extension Through Month 48||47
7945306|NCT00473382|19554617|P2|NOT COMPLETED|Open-label Extension Through Month 48||41
7945307|NCT00473382|19554618|P1|NOT COMPLETED|Open-label Extension Through Month 48||50
7945308|NCT00473382|19554616|P3|COMPLETED|Open-label Extension Through Month 48||37
7945309|NCT00473382|19554617|P2|COMPLETED|Open-label Extension Through Month 48||42
7945310|NCT00473382|19554618|P1|COMPLETED|Open-label Extension Through Month 48||38
7945311|NCT00473382|19554616|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84
7945312|NCT00473382|19554617|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83
7945313|NCT00473382|19554618|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88
7945314|NCT00473382|19554616|P3|NOT COMPLETED|Core Study||29
7945315|NCT00473382|19554617|P2|NOT COMPLETED|Core Study||27
7945316|NCT00473382|19554618|P1|NOT COMPLETED|Core Study||28
7945317|NCT00473382|19554616|P3|COMPLETED|Core Study||98
7945318|NCT00473382|19554617|P2|COMPLETED|Core Study||98
7945319|NCT00473382|19554618|P1|COMPLETED|Core Study||102
7945320|NCT00473382|19554616|P3|STARTED|Core Study||127
7945321|NCT00473382|19554617|P2|STARTED|Core Study||125
7945322|NCT00473382|19554618|P1|STARTED|Core Study||130
7945323|NCT00473330|19554676|P3|NOT COMPLETED|Open-label Extension Through Month 60||77
7945324|NCT00473330|19554677|P2|NOT COMPLETED|Open-label Extension Through Month 60||78
7945325|NCT00473330|19554678|P1|NOT COMPLETED|Open-label Extension Through Month 60||88
7945326|NCT00473330|19554676|P3|COMPLETED|Open-label Extension Through Month 60||0
7945327|NCT00473330|19554677|P2|COMPLETED|Open-label Extension Through Month 60||1
7945328|NCT00473330|19554678|P1|COMPLETED|Open-label Extension Through Month 60||1
7945329|NCT00473330|19554676|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77
7945330|NCT00473330|19554677|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79
7945331|NCT00473330|19554678|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89
7945332|NCT00473330|19554676|P3|NOT COMPLETED|Open-label Extension Through Month 48||27
7945333|NCT00473330|19554677|P2|NOT COMPLETED|Open-label Extension Through Month 48||20
7945334|NCT00473330|19554678|P1|NOT COMPLETED|Open-label Extension Through Month 48||26
7945335|NCT00473330|19554676|P3|COMPLETED|Open-label Extension Through Month 48||50
7945336|NCT00473330|19554677|P2|COMPLETED|Open-label Extension Through Month 48||59
7945337|NCT00473330|19554678|P1|COMPLETED|Open-label Extension Through Month 48||63
7945338|NCT00473330|19554676|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77
7945339|NCT00473330|19554677|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79
7945340|NCT00473330|19554678|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89
7945341|NCT00473330|19554676|P3|NOT COMPLETED|Core Study||41
7945342|NCT00473330|19554677|P2|NOT COMPLETED|Core Study||25
7945343|NCT00473330|19554678|P1|NOT COMPLETED|Core Study||27
7945344|NCT00473330|19554676|P3|COMPLETED|Core Study||86
7945345|NCT00473330|19554677|P2|COMPLETED|Core Study||100
7945346|NCT00473330|19554678|P1|COMPLETED|Core Study||98
7945347|NCT00473330|19554676|P3|STARTED|Core Study||127
7945348|NCT00473330|19554677|P2|STARTED|Core Study||125
7945349|NCT00473330|19554678|P1|STARTED|Core Study||125
7945351|NCT00473265|19554733|P1|COMPLETED|Overall Study||48
7945352|NCT00473265|19554733|P1|STARTED|Overall Study||68
7945353|NCT00473083|19554745|P3|NOT COMPLETED|Overall Study||0
7945354|NCT00473083|19554746|P2|NOT COMPLETED|Overall Study||0
7945355|NCT00473083|19554747|P1|NOT COMPLETED|Overall Study||1
7945356|NCT00473083|19554745|P3|COMPLETED|Overall Study||50
7945357|NCT00473083|19554746|P2|COMPLETED|Overall Study||50
7945358|NCT00473083|19554747|P1|COMPLETED|Overall Study|One patient (2%) from treatment arm 1 discontinued the study drug as a result of a TEAE (dizziness)|49
7945359|NCT00473083|19554745|P3|STARTED|Overall Study||50
7945360|NCT00473083|19554746|P2|STARTED|Overall Study||50
7945361|NCT00473083|19554747|P1|STARTED|Overall Study||50
7945362|NCT00472849|19554775|P2|NOT COMPLETED|Overall Study||0
7945363|NCT00472849|19554776|P1|NOT COMPLETED|Overall Study||0
7945364|NCT00472849|19554775|P2|COMPLETED|Overall Study||78
7945365|NCT00472849|19554776|P1|COMPLETED|Overall Study||12
7945366|NCT00472849|19554775|P2|STARTED|Overall Study||78
7945367|NCT00472849|19554776|P1|STARTED|Overall Study||12
7945368|NCT00472797|19554784|P2|NOT COMPLETED|Overall Study||1
7945369|NCT00472797|19554785|P1|NOT COMPLETED|Overall Study||4
7945370|NCT00472797|19554784|P2|COMPLETED|Overall Study||112
7945371|NCT00472797|19554785|P1|COMPLETED|Overall Study||115
7945372|NCT00472797|19554784|P2|STARTED|Overall Study||113
7945373|NCT00472797|19554785|P1|STARTED|Overall Study||119
7945374|NCT00472732|19554811|P2|NOT COMPLETED|Overall Study||0
7945375|NCT00472732|19554812|P1|NOT COMPLETED|Overall Study||0
7945376|NCT00472732|19554811|P2|COMPLETED|Overall Study||22
7945377|NCT00472732|19554812|P1|COMPLETED|Overall Study||24
7945378|NCT00472732|19554811|P2|STARTED|Overall Study||22
7945379|NCT00472732|19554812|P1|STARTED|Overall Study||24
7945380|NCT00472641|19554822|P1|NOT COMPLETED|Overall Study||7
7945381|NCT00472641|19554822|P1|COMPLETED|Overall Study||18
7945382|NCT00472641|19554822|P1|STARTED|Overall Study||25
7945383|NCT00472576|19554829|P2|NOT COMPLETED|Second Intervention||0
7945384|NCT00472576|19554830|P1|NOT COMPLETED|Second Intervention||0
7945385|NCT00472576|19554829|P2|COMPLETED|Second Intervention||3
7945386|NCT00472576|19554830|P1|COMPLETED|Second Intervention||2
7945387|NCT00472576|19554829|P2|STARTED|Second Intervention||3
7945388|NCT00472576|19554830|P1|STARTED|Second Intervention||2
7945389|NCT00472576|19554829|P2|NOT COMPLETED|First Intervention||0
7945390|NCT00472576|19554830|P1|NOT COMPLETED|First Intervention||0
7945391|NCT00472576|19554829|P2|COMPLETED|First Intervention||3
7945392|NCT00472576|19554830|P1|COMPLETED|First Intervention||2
7945393|NCT00472576|19554829|P2|STARTED|First Intervention||3
7945394|NCT00472576|19554830|P1|STARTED|First Intervention||2
7945395|NCT00472446|19554842|P4|NOT COMPLETED|Overall Study||6
7945396|NCT00472446|19554843|P3|NOT COMPLETED|Overall Study||7
7945397|NCT00472446|19554844|P2|NOT COMPLETED|Overall Study||6
7945398|NCT00472446|19554845|P1|NOT COMPLETED|Overall Study||5
7945399|NCT00472446|19554842|P4|COMPLETED|Overall Study||39
7945400|NCT00472446|19554843|P3|COMPLETED|Overall Study||38
7945401|NCT00472446|19554844|P2|COMPLETED|Overall Study||41
7945402|NCT00472446|19554845|P1|COMPLETED|Overall Study||41
7945403|NCT00472446|19554842|P4|STARTED|Overall Study||45
7945404|NCT00472446|19554843|P3|STARTED|Overall Study||45
7945405|NCT00472446|19554844|P2|STARTED|Overall Study||47
7945406|NCT00472446|19554845|P1|STARTED|Overall Study||46
7945407|NCT00472420|19554875|P1|NOT COMPLETED|Follow-up Period||17
7945408|NCT00472420|19554875|P1|COMPLETED|Follow-up Period||15
7945409|NCT00472420|19554875|P1|STARTED|Follow-up Period||32
7945410|NCT00472420|19554875|P1|NOT COMPLETED|Induction Treatment Period||16
7945411|NCT00472420|19554875|P1|COMPLETED|Induction Treatment Period||32
7945412|NCT00472420|19554875|P1|STARTED|Induction Treatment Period||48
7945413|NCT00472303|19554883|P3|NOT COMPLETED|Maintenance Phase||17
7945414|NCT00472303|19554884|P2|NOT COMPLETED|Maintenance Phase||16
7945415|NCT00472303|19554885|P1|NOT COMPLETED|Maintenance Phase||17
7945416|NCT00472303|19554883|P3|COMPLETED|Maintenance Phase||95
7945417|NCT00472303|19554884|P2|COMPLETED|Maintenance Phase||93
7945418|NCT00472303|19554885|P1|COMPLETED|Maintenance Phase||89
7945419|NCT00472303|19554883|P3|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112
7945420|NCT00472303|19554884|P2|STARTED|Maintenance Phase||109
7945421|NCT00472303|19554885|P1|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106
7945422|NCT00472303|19554883|P3|NOT COMPLETED|Discontinuations After Titration Phase||0
7945423|NCT00472303|19554884|P2|NOT COMPLETED|Discontinuations After Titration Phase||20
7945424|NCT00472303|19554885|P1|NOT COMPLETED|Discontinuations After Titration Phase||61
7945425|NCT00472303|19554883|P3|COMPLETED|Discontinuations After Titration Phase||0
7945426|NCT00472303|19554884|P2|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109
7945427|NCT00472303|19554885|P1|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218
7945428|NCT00472303|19554883|P3|STARTED|Discontinuations After Titration Phase||0
7945429|NCT00472303|19554884|P2|STARTED|Discontinuations After Titration Phase||129
7945430|NCT00472303|19554885|P1|STARTED|Discontinuations After Titration Phase||279
7945431|NCT00472303|19554883|P3|NOT COMPLETED|Titration Phase||0
7945432|NCT00472303|19554884|P2|NOT COMPLETED|Titration Phase||29
7945433|NCT00472303|19554885|P1|NOT COMPLETED|Titration Phase||59
7945434|NCT00472303|19554883|P3|COMPLETED|Titration Phase||0
7945435|NCT00472303|19554884|P2|COMPLETED|Titration Phase||129
7945436|NCT00472303|19554885|P1|COMPLETED|Titration Phase||279
7945437|NCT00472303|19554883|P3|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0
7945438|NCT00472303|19554884|P2|STARTED|Titration Phase||158
7945439|NCT00472303|19554885|P1|STARTED|Titration Phase||338
7945440|NCT00472290|19554948|P1|NOT COMPLETED|Overall Study||72
7945441|NCT00472290|19554948|P1|COMPLETED|Overall Study||0
7945442|NCT00472290|19554948|P1|STARTED|Overall Study||72
7945443|NCT00472199|19554960|P2|NOT COMPLETED|Overall Study||60
7945444|NCT00472199|19554961|P1|NOT COMPLETED|Overall Study||35
7945445|NCT00472199|19554960|P2|COMPLETED|Overall Study||103
7945446|NCT00472199|19554961|P1|COMPLETED|Overall Study||131
7945447|NCT00472199|19554960|P2|STARTED|Overall Study||163
7945448|NCT00472199|19554961|P1|STARTED|Overall Study||166
7945449|NCT00472082|19555027|P1|NOT COMPLETED|Overall Study||5
7945450|NCT00472082|19555027|P1|COMPLETED|Overall Study||0
7945451|NCT00472082|19555027|P1|STARTED|Overall Study||5
7945452|NCT00472056|19555036|P4|NOT COMPLETED|Overall Study||0
7945453|NCT00472056|19555037|P3|NOT COMPLETED|Overall Study||0
7945454|NCT00472056|19555038|P2|NOT COMPLETED|Overall Study||0
7945455|NCT00472056|19555039|P1|NOT COMPLETED|Overall Study||0
7945456|NCT00472056|19555036|P4|COMPLETED|Overall Study||17
7945457|NCT00472056|19555037|P3|COMPLETED|Overall Study||32
7945458|NCT00472056|19555038|P2|COMPLETED|Overall Study||19
7945459|NCT00472056|19555039|P1|COMPLETED|Overall Study||25
7945460|NCT00472056|19555036|P4|STARTED|Overall Study||17
7945461|NCT00472056|19555037|P3|STARTED|Overall Study||32
7945462|NCT00472056|19555038|P2|STARTED|Overall Study||19
7945463|NCT00472056|19555039|P1|STARTED|Overall Study||25
7945464|NCT00472030|19555049|P2|NOT COMPLETED|Overall Study||0
7945465|NCT00472030|19555050|P1|NOT COMPLETED|Overall Study||1
7945466|NCT00472030|19555049|P2|COMPLETED|Overall Study||0
7945467|NCT00472030|19555050|P1|COMPLETED|Overall Study||1
7945468|NCT00472030|19555049|P2|STARTED|Overall Study||0
7945469|NCT00472030|19555050|P1|STARTED|Overall Study||2
7945470|NCT00471887|19555066|P1|NOT COMPLETED|Overall Study||9
7945471|NCT00471887|19555066|P1|COMPLETED|Overall Study||23
7945472|NCT00471887|19555066|P1|STARTED|Overall Study||32
7945473|NCT00471822|19555075|P1|NOT COMPLETED|Overall Study||2
7945474|NCT00471822|19555075|P1|COMPLETED|Overall Study||9705
7945475|NCT00471822|19555075|P1|Treated|Overall Study||9705
7945476|NCT00471822|19555075|P1|STARTED|Overall Study||9707
7945477|NCT00471718|19555083|P1|NOT COMPLETED|Overall Study||27
7945478|NCT00471718|19555083|P1|COMPLETED|Overall Study||0
7945479|NCT00471718|19555083|P1|STARTED|Overall Study||27
7945480|NCT00471705|19555095|P3|NOT COMPLETED|Overall Study||15
7945481|NCT00471705|19555096|P2|NOT COMPLETED|Overall Study||22
7945482|NCT00471705|19555097|P1|NOT COMPLETED|Overall Study||24
7945483|NCT00471705|19555095|P3|COMPLETED|Overall Study||134
7945484|NCT00471705|19555096|P2|COMPLETED|Overall Study||121
7945485|NCT00471705|19555097|P1|COMPLETED|Overall Study||121
7945486|NCT00471705|19555095|P3|STARTED|Overall Study||149
7945487|NCT00471705|19555096|P2|STARTED|Overall Study||143
7945488|NCT00471705|19555097|P1|STARTED|Overall Study||145
7945489|NCT00471536|19555111|P1|NOT COMPLETED|Overall Study||1
7945490|NCT00471536|19555111|P1|COMPLETED|Overall Study||18
7945491|NCT00471536|19555111|P1|STARTED|Overall Study||19
7945492|NCT00471497|19555123|P3|NOT COMPLETED|Extension Phase||1
7945493|NCT00471497|19555124|P2|NOT COMPLETED|Extension Phase||14
7945494|NCT00471497|19555125|P1|NOT COMPLETED|Extension Phase||27
7945495|NCT00471497|19555123|P3|COMPLETED|Extension Phase||2
7945496|NCT00471497|19555124|P2|COMPLETED|Extension Phase||12
7945497|NCT00471497|19555125|P1|COMPLETED|Extension Phase||21
7945498|NCT00471497|19555123|P3|STARTED|Extension Phase||3
7945499|NCT00471497|19555124|P2|STARTED|Extension Phase||26
7945500|NCT00471497|19555125|P1|STARTED|Extension Phase||48
7945501|NCT00471497|19555123|P3|NOT COMPLETED|Core Treatment Phase||182
7945502|NCT00471497|19555124|P2|NOT COMPLETED|Core Treatment Phase||175
7945503|NCT00471497|19555125|P1|NOT COMPLETED|Core Treatment Phase||184
7945504|NCT00471497|19555123|P3|COMPLETED|Core Treatment Phase||99
7945505|NCT00471497|19555124|P2|COMPLETED|Core Treatment Phase||107
7945506|NCT00471497|19555125|P1|COMPLETED|Core Treatment Phase||99
7945507|NCT00471497|19555123|P3|Discontinued Core/Entered Ext.|Core Treatment Phase||3
7945508|NCT00471497|19555124|P2|Discontinued Core/Entered Ext.|Core Treatment Phase||26
7945509|NCT00471497|19555125|P1|Discontinued Core/Entered Ext.|Core Treatment Phase||48
7945510|NCT00471497|19555123|P3|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||278
7945511|NCT00471497|19555124|P2|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||256
7945512|NCT00471497|19555125|P1|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||235
7945513|NCT00471497|19555123|P3|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|277
7945514|NCT00471497|19555124|P2|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|279
7945515|NCT00471497|19555125|P1|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|280
7945516|NCT00471497|19555123|P3|STARTED|Core Treatment Phase||281
7945517|NCT00471497|19555124|P2|STARTED|Core Treatment Phase||282
7945518|NCT00471497|19555125|P1|STARTED|Core Treatment Phase||283
7945519|NCT00471445|19555221|P2|NOT COMPLETED|Overall Study||2
7945520|NCT00471445|19555222|P1|NOT COMPLETED|Overall Study||2
7945521|NCT00471445|19555221|P2|COMPLETED|Overall Study||231
7945522|NCT00471445|19555222|P1|COMPLETED|Overall Study||227
7945523|NCT00471445|19555221|P2|STARTED|Overall Study||233
7945524|NCT00471445|19555222|P1|STARTED|Overall Study||229
7945525|NCT00471380|19555228|P2|NOT COMPLETED|Third Intervention||2
7945526|NCT00471380|19555229|P1|NOT COMPLETED|Third Intervention||1
7945527|NCT00471380|19555228|P2|COMPLETED|Third Intervention||14
7945528|NCT00471380|19555229|P1|COMPLETED|Third Intervention||17
7945529|NCT00471380|19555228|P2|STARTED|Third Intervention||16
7945530|NCT00471380|19555229|P1|STARTED|Third Intervention||18
7945531|NCT00471380|19555228|P2|NOT COMPLETED|Second Intervention||4
7945532|NCT00471380|19555229|P1|NOT COMPLETED|Second Intervention||0
7945533|NCT00471380|19555228|P2|COMPLETED|Second Intervention||16
7945534|NCT00471380|19555229|P1|COMPLETED|Second Intervention||18
7945535|NCT00471380|19555228|P2|STARTED|Second Intervention||20
7945536|NCT00471380|19555229|P1|STARTED|Second Intervention||18
7945537|NCT00471380|19555228|P2|NOT COMPLETED|First Intervention||4
7945538|NCT00471380|19555229|P1|NOT COMPLETED|First Intervention||4
7945539|NCT00471380|19555228|P2|COMPLETED|First Intervention||20
7945540|NCT00471380|19555229|P1|COMPLETED|First Intervention||18
7945541|NCT00471380|19555228|P2|STARTED|First Intervention||24
7945542|NCT00471380|19555229|P1|STARTED|First Intervention||22
7945543|NCT00471354|19555235|P1|NOT COMPLETED|Overall Study||52
7945544|NCT00471354|19555235|P1|COMPLETED|Overall Study||176
7945545|NCT00471354|19555235|P1|STARTED|Overall Study||228
7945546|NCT00471328|19555247|P2|NOT COMPLETED|Extension Phase||67
7945547|NCT00471328|19555248|P1|NOT COMPLETED|Extension Phase||41
7945548|NCT00471328|19555247|P2|COMPLETED|Extension Phase||0
7945549|NCT00471328|19555248|P1|COMPLETED|Extension Phase||0
7945550|NCT00471328|19555247|P2|Started:CrossOver During Extension|Extension Phase||10
7945551|NCT00471328|19555248|P1|Started:CrossOver During Extension|Extension Phase||0
7945552|NCT00471328|19555247|P2|Started:CrossOver After PrimaryAnalysis|Extension Phase||4
7945553|NCT00471328|19555248|P1|Started:CrossOver After PrimaryAnalysis|Extension Phase||0
7945554|NCT00471328|19555247|P2|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53
7945555|NCT00471328|19555248|P1|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0
7945556|NCT00471328|19555247|P2|STARTED|Extension Phase||67
7945557|NCT00471328|19555248|P1|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41
7945558|NCT00471328|19555247|P2|NOT COMPLETED|Core Phase||67
7945559|NCT00471328|19555248|P1|NOT COMPLETED|Core Phase||107
7945560|NCT00471328|19555247|P2|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16
7945561|NCT00471328|19555248|P1|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58
7945562|NCT00471328|19555247|P2|Crossover to Nilotinib:Started Extension|Core Phase||53
7945563|NCT00471328|19555248|P1|Crossover to Nilotinib:Started Extension|Core Phase||0
7945564|NCT00471328|19555247|P2|STARTED|Core Phase||83
7945565|NCT00471328|19555248|P1|STARTED|Core Phase||165
7945566|NCT00471315|19555267|P1|NOT COMPLETED|Overall Study||8
7945567|NCT00471315|19555267|P1|COMPLETED|Overall Study||10
7945568|NCT00471315|19555267|P1|STARTED|Overall Study||18
7945569|NCT00471276|19555272|P1|NOT COMPLETED|Overall Study||83
7945570|NCT00471276|19555272|P1|COMPLETED|Overall Study||0
7945571|NCT00471276|19555272|P1|STARTED|Overall Study||83
7945572|NCT00471237|19555302|P7|NOT COMPLETED|Overall Study||3
7945573|NCT00471237|19555303|P6|NOT COMPLETED|Overall Study||39
7945574|NCT00471237|19555304|P5|NOT COMPLETED|Overall Study||41
7945575|NCT00471237|19555305|P4|NOT COMPLETED|Overall Study||45
7945576|NCT00471237|19555306|P3|NOT COMPLETED|Overall Study||34
7945577|NCT00471237|19555307|P2|NOT COMPLETED|Overall Study||42
7945578|NCT00471237|19555308|P1|NOT COMPLETED|Overall Study||41
7945579|NCT00471237|19555302|P7|COMPLETED|Overall Study||38
7945580|NCT00471237|19555303|P6|COMPLETED|Overall Study||50
7945581|NCT00471237|19555304|P5|COMPLETED|Overall Study||46
7945582|NCT00471237|19555305|P4|COMPLETED|Overall Study||43
7945583|NCT00471237|19555306|P3|COMPLETED|Overall Study||48
7945584|NCT00471237|19555307|P2|COMPLETED|Overall Study||45
7945585|NCT00471237|19555308|P1|COMPLETED|Overall Study||49
7945586|NCT00471237|19555302|P7|STARTED|Overall Study||41
7945587|NCT00471237|19555303|P6|STARTED|Overall Study||89
7945588|NCT00471237|19555304|P5|STARTED|Overall Study||87
7945589|NCT00471237|19555305|P4|STARTED|Overall Study||88
7945590|NCT00471237|19555306|P3|STARTED|Overall Study||82
7945591|NCT00471237|19555307|P2|STARTED|Overall Study||87
7945592|NCT00471237|19555308|P1|STARTED|Overall Study||90
7945593|NCT00471146|19555458|P2|NOT COMPLETED|Overall Study||174
7945594|NCT00471146|19555459|P1|NOT COMPLETED|Overall Study||172
7945595|NCT00471146|19555458|P2|COMPLETED|Overall Study||142
7945596|NCT00471146|19555459|P1|COMPLETED|Overall Study||142
7945597|NCT00471146|19555458|P2|Treated|Overall Study||308
7945598|NCT00471146|19555459|P1|Treated|Overall Study||305
7945599|NCT00471146|19555458|P2|STARTED|Overall Study||316
7945600|NCT00471146|19555459|P1|STARTED|Overall Study||314
7945601|NCT00471107|19555484|P3|NOT COMPLETED|Overall Study||3
7945602|NCT00471107|19555485|P2|NOT COMPLETED|Overall Study||1
7945603|NCT00471107|19555486|P1|NOT COMPLETED|Overall Study||3
7945604|NCT00471107|19555484|P3|COMPLETED|Overall Study||12
7945605|NCT00471107|19555485|P2|COMPLETED|Overall Study||14
7945606|NCT00471107|19555486|P1|COMPLETED|Overall Study||12
7945607|NCT00471107|19555484|P3|STARTED|Overall Study||15
7945608|NCT00471107|19555485|P2|STARTED|Overall Study||15
7945609|NCT00471107|19555486|P1|STARTED|Overall Study||15
7945610|NCT00471081|19555496|P2|NOT COMPLETED|Extended Safety Follow-Up||13
7945611|NCT00471081|19555497|P1|NOT COMPLETED|Extended Safety Follow-Up||2
7945612|NCT00471081|19555496|P2|COMPLETED|Extended Safety Follow-Up||176
7945613|NCT00471081|19555497|P1|COMPLETED|Extended Safety Follow-Up||158
7945614|NCT00471081|19555496|P2|STARTED|Extended Safety Follow-Up||189
7945615|NCT00471081|19555497|P1|STARTED|Extended Safety Follow-Up||160
7945616|NCT00471081|19555496|P2|NOT COMPLETED|Active Phase||13
7945617|NCT00471081|19555497|P1|NOT COMPLETED|Active Phase||2
7945618|NCT00471081|19555496|P2|COMPLETED|Active Phase||176
7945619|NCT00471081|19555497|P1|COMPLETED|Active Phase||158
7945620|NCT00471081|19555496|P2|STARTED|Active Phase||189
7945621|NCT00471081|19555497|P1|STARTED|Active Phase||160
7945622|NCT00471068|19555536|P2|NOT COMPLETED|Overall Study||1
7945623|NCT00471068|19555537|P1|NOT COMPLETED|Overall Study||1
7945624|NCT00471068|19555536|P2|COMPLETED|Overall Study||24
7945625|NCT00471068|19555537|P1|COMPLETED|Overall Study||20
7945626|NCT00471068|19555536|P2|STARTED|Overall Study||25
7945627|NCT00471068|19555537|P1|STARTED|Overall Study||21
7945628|NCT00470847|19555543|P1|NOT COMPLETED|Overall Study||1
7945629|NCT00470847|19555543|P1|COMPLETED|Overall Study||34
7945630|NCT00470847|19555543|P1|STARTED|Overall Study||35
7945631|NCT00470834|19555556|P2|NOT COMPLETED|Extension Period (24 Months)||23
7945632|NCT00470834|19555557|P1|NOT COMPLETED|Extension Period (24 Months)||15
7945633|NCT00470834|19555556|P2|COMPLETED|Extension Period (24 Months)||7
7945634|NCT00470834|19555557|P1|COMPLETED|Extension Period (24 Months)||11
7945635|NCT00470834|19555556|P2|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30
7945636|NCT00470834|19555557|P1|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26
7945637|NCT00470834|19555556|P2|NOT COMPLETED|Treatment Period (18 Months)||31
7945638|NCT00470834|19555557|P1|NOT COMPLETED|Treatment Period (18 Months)||38
7945639|NCT00470834|19555556|P2|COMPLETED|Treatment Period (18 Months)||31
7945640|NCT00470834|19555557|P1|COMPLETED|Treatment Period (18 Months)||27
7945641|NCT00470834|19555556|P2|STARTED|Treatment Period (18 Months)||62
7945642|NCT00470834|19555557|P1|STARTED|Treatment Period (18 Months)||65
7945643|NCT00470626|19555571|P1|NOT COMPLETED|Overall Study||17
7945644|NCT00470626|19555571|P1|COMPLETED|Overall Study||112
7945645|NCT00470626|19555571|P1|STARTED|Overall Study||129
7945646|NCT00470600|19555579|P2|NOT COMPLETED|Overall Study||0
7945647|NCT00470600|19555580|P1|NOT COMPLETED|Overall Study||0
7945648|NCT00470600|19555579|P2|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99
7945649|NCT00470600|19555580|P1|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86
7945650|NCT00470600|19555579|P2|STARTED|Overall Study||99
7945651|NCT00470600|19555580|P1|STARTED|Overall Study||86
7945652|NCT00470574|19555590|P1|NOT COMPLETED|Overall Study||0
7945653|NCT00470574|19555590|P1|COMPLETED|Overall Study||7
7945654|NCT00470574|19555590|P1|STARTED|Overall Study||7
7945655|NCT00470548|19555598|P4|NOT COMPLETED|Overall Study||0
7945656|NCT00470548|19555599|P3|NOT COMPLETED|Overall Study||0
7945657|NCT00470548|19555600|P2|NOT COMPLETED|Overall Study||0
7945658|NCT00470548|19555601|P1|NOT COMPLETED|Overall Study||0
7945659|NCT00470548|19555598|P4|COMPLETED|Overall Study||37
7945660|NCT00470548|19555599|P3|COMPLETED|Overall Study||6
7945661|NCT00470548|19555600|P2|COMPLETED|Overall Study||3
7945662|NCT00470548|19555601|P1|COMPLETED|Overall Study||3
7945663|NCT00470548|19555598|P4|STARTED|Overall Study||37
7945664|NCT00470548|19555599|P3|STARTED|Overall Study||6
7945665|NCT00470548|19555600|P2|STARTED|Overall Study||3
7945666|NCT00470548|19555601|P1|STARTED|Overall Study||3
7945667|NCT00470535|19555619|P1|NOT COMPLETED|Overall Study||18
7945668|NCT00470535|19555619|P1|COMPLETED|Overall Study||0
7945669|NCT00470535|19555619|P1|STARTED|Overall Study||18
7945670|NCT00470470|19555628|P1|NOT COMPLETED|Overall Study||5
7945671|NCT00470470|19555628|P1|COMPLETED|Overall Study||25
7945672|NCT00470470|19555628|P1|STARTED|Overall Study||30
7945673|NCT00470418|19555635|P2|NOT COMPLETED|Overall Study||0
7945674|NCT00470418|19555636|P1|NOT COMPLETED|Overall Study||1
7945675|NCT00470418|19555635|P2|COMPLETED|Overall Study||3
7945676|NCT00470418|19555636|P1|COMPLETED|Overall Study||6
7945677|NCT00470418|19555635|P2|STARTED|Overall Study||3
7945678|NCT00470418|19555636|P1|STARTED|Overall Study||7
7945679|NCT00470392|19555646|P2|NOT COMPLETED|Overall Study||0
7945680|NCT00470392|19555647|P1|NOT COMPLETED|Overall Study||0
7945681|NCT00470392|19555646|P2|COMPLETED|Overall Study||2
7945682|NCT00470392|19555647|P1|COMPLETED|Overall Study||7
7945683|NCT00470392|19555646|P2|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2
7945684|NCT00470392|19555647|P1|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7
7945685|NCT00470366|19555657|P1|NOT COMPLETED|Overall Study||4
7945686|NCT00470366|19555657|P1|COMPLETED|Overall Study||56
7945687|NCT00470366|19555657|P1|STARTED|Overall Study||60
7945688|NCT00470301|19555664|P1|NOT COMPLETED|Overall Study||5
7945689|NCT00470301|19555664|P1|COMPLETED|Overall Study||55
7945690|NCT00470301|19555664|P1|STARTED|Overall Study||60
7945691|NCT00470275|19555668|P1|NOT COMPLETED|Overall Study||10
7945692|NCT00470275|19555668|P1|COMPLETED|Overall Study||0
7945693|NCT00470275|19555668|P1|STARTED|Overall Study||10
7945694|NCT00470262|19555674|P2|NOT COMPLETED|Overall Study||0
7945695|NCT00470262|19555675|P1|NOT COMPLETED|Overall Study||2
7945696|NCT00470262|19555674|P2|COMPLETED|Overall Study||12
7945697|NCT00470262|19555675|P1|COMPLETED|Overall Study||13
7945698|NCT00470262|19555674|P2|STARTED|Overall Study||12
7945699|NCT00470262|19555675|P1|STARTED|Overall Study||15
7945700|NCT00470184|19555683|P1|NOT COMPLETED|Overall Study||22
7945701|NCT00470184|19555683|P1|COMPLETED|Overall Study||19
7945702|NCT00470184|19555683|P1|Treated With Study Therapy|Overall Study||36
7945703|NCT00470184|19555683|P1|STARTED|Overall Study||41
7945704|NCT00470158|19555695|P5|NOT COMPLETED|Overall Study||6
7945705|NCT00470158|19555696|P4|NOT COMPLETED|Overall Study||5
7945706|NCT00470158|19555697|P3|NOT COMPLETED|Overall Study||8
7945707|NCT00470158|19555698|P2|NOT COMPLETED|Overall Study||8
7945708|NCT00470158|19555699|P1|NOT COMPLETED|Overall Study||8
7945709|NCT00470158|19555695|P5|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195
7945710|NCT00470158|19555696|P4|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
7945711|NCT00470158|19555697|P3|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
7945712|NCT00470158|19555698|P2|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191
7945713|NCT00470158|19555699|P1|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
7945714|NCT00470158|19555695|P5|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
7945715|NCT00470158|19555696|P4|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198
7945716|NCT00470158|19555697|P3|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
7945717|NCT00470158|19555698|P2|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199
7945718|NCT00470158|19555699|P1|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
7945719|NCT00470106|19555715|P4|NOT COMPLETED|Overall Study||2
7945720|NCT00470106|19555716|P3|NOT COMPLETED|Overall Study||7
7945721|NCT00470106|19555717|P2|NOT COMPLETED|Overall Study||5
7945722|NCT00470106|19555718|P1|NOT COMPLETED|Overall Study||3
7945723|NCT00470106|19555715|P4|COMPLETED|Overall Study||19
7945724|NCT00470106|19555716|P3|COMPLETED|Overall Study||14
7945725|NCT00470106|19555717|P2|COMPLETED|Overall Study||19
7945726|NCT00470106|19555718|P1|COMPLETED|Overall Study||16
7945727|NCT00470106|19555715|P4|STARTED|Overall Study||21
7945728|NCT00470106|19555716|P3|STARTED|Overall Study||21
7945729|NCT00470106|19555717|P2|STARTED|Overall Study||24
7945730|NCT00470106|19555718|P1|STARTED|Overall Study||19
7945731|NCT00470093|19555732|P1|NOT COMPLETED|Overall Study||2
7945732|NCT00470093|19555732|P1|COMPLETED|Overall Study||0
7945733|NCT00470093|19555732|P1|STARTED|Overall Study||2
7945734|NCT00470067|19555739|P1|NOT COMPLETED|Overall Study||7
7945735|NCT00470067|19555739|P1|COMPLETED|Overall Study||2
7945736|NCT00470067|19555739|P1|STARTED|Overall Study||9
7945737|NCT00470054|19555743|P1|NOT COMPLETED|Overall Study||1
7945738|NCT00470054|19555743|P1|COMPLETED|Overall Study||43
7945739|NCT00470054|19555743|P1|STARTED|Overall Study||44
7945740|NCT00469911|19555753|P2|NOT COMPLETED|Overall Study||0
7945741|NCT00469911|19555754|P1|NOT COMPLETED|Overall Study||0
7945742|NCT00469911|19555753|P2|COMPLETED|Overall Study||10
7945743|NCT00469911|19555754|P1|COMPLETED|Overall Study||8
7945744|NCT00469911|19555753|P2|STARTED|Overall Study||10
7945745|NCT00469911|19555754|P1|STARTED|Overall Study||8
7945746|NCT00469898|19555759|P1|NOT COMPLETED|Overall Study||25
7945747|NCT00469898|19555759|P1|COMPLETED|Overall Study||25
7945748|NCT00469898|19555759|P1|STARTED|Overall Study||50
7945749|NCT00469859|19555768|P2|NOT COMPLETED|Overall Study||2
7945750|NCT00469859|19555769|P1|NOT COMPLETED|Overall Study||0
7945751|NCT00469859|19555768|P2|COMPLETED|Overall Study||6
7945752|NCT00469859|19555769|P1|COMPLETED|Overall Study||6
7945753|NCT00469859|19555768|P2|STARTED|Overall Study||8
7945754|NCT00469859|19555769|P1|STARTED|Overall Study||6
7945755|NCT00469833|19555777|P1|NOT COMPLETED|Overall Study||2
7945756|NCT00469833|19555777|P1|COMPLETED|Overall Study||15
7945757|NCT00469833|19555777|P1|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17
7945758|NCT00469612|19555789|P2|NOT COMPLETED|Overall Study||0
7945759|NCT00469612|19555790|P1|NOT COMPLETED|Overall Study||2
7945760|NCT00469612|19555789|P2|COMPLETED|Overall Study||0
7945761|NCT00469612|19555790|P1|COMPLETED|Overall Study|Subjects enrolled, but no data collected. Study terminated before data collection.|0
7945762|NCT00469612|19555789|P2|STARTED|Overall Study||0
7945763|NCT00469612|19555790|P1|STARTED|Overall Study||2
7945764|NCT00469508|19555802|P2|NOT COMPLETED|Overall Study||24
7945765|NCT00469508|19555803|P1|NOT COMPLETED|Overall Study||20
7945766|NCT00469508|19555802|P2|COMPLETED|Overall Study||13
7945767|NCT00469508|19555803|P1|COMPLETED|Overall Study||14
7945768|NCT00469508|19555802|P2|STARTED|Overall Study||37
7945769|NCT00469508|19555803|P1|STARTED|Overall Study||34
7945770|NCT00469456|19555817|P2|NOT COMPLETED|Overall Study||4
7945771|NCT00469456|19555818|P1|NOT COMPLETED|Overall Study||9
7945772|NCT00469456|19555817|P2|COMPLETED|Overall Study||131
7945773|NCT00469456|19555818|P1|COMPLETED|Overall Study||120
7945774|NCT00469456|19555817|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135
7945775|NCT00469456|19555818|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129
7945776|NCT00469391|19555828|P2|NOT COMPLETED|Overall Study||5
7945777|NCT00469391|19555829|P1|NOT COMPLETED|Overall Study||14
7945778|NCT00469391|19555828|P2|COMPLETED|Overall Study||24
7945779|NCT00469391|19555829|P1|COMPLETED|Overall Study||13
7945780|NCT00469391|19555828|P2|Patient Preference|Overall Study||1
7945781|NCT00469391|19555829|P1|Patient Preference|Overall Study||0
7945782|NCT00469391|19555828|P2|Lost to Follow up|Overall Study||1
7945783|NCT00469391|19555829|P1|Lost to Follow up|Overall Study||0
7945784|NCT00469391|19555828|P2|Adverse Event|Overall Study||0
7945785|NCT00469391|19555829|P1|Adverse Event|Overall Study||8
7945786|NCT00469391|19555828|P2|Unsuccessful Implant Procedure|Overall Study||0
7945787|NCT00469391|19555829|P1|Unsuccessful Implant Procedure|Overall Study||4
7945788|NCT00469391|19555828|P2|Discontinued Prior to Procedure|Overall Study||3
7945789|NCT00469391|19555829|P1|Discontinued Prior to Procedure|Overall Study||2
7945790|NCT00469391|19555828|P2|STARTED|Overall Study||29
7945791|NCT00469391|19555829|P1|STARTED|Overall Study||27
7945792|NCT00469274|19555837|P2|NOT COMPLETED|Overall Study||0
7945793|NCT00469274|19555838|P1|NOT COMPLETED|Overall Study||0
7945794|NCT00469274|19555837|P2|COMPLETED|Overall Study||42
7945795|NCT00469274|19555838|P1|COMPLETED|Overall Study||44
7945796|NCT00469274|19555837|P2|STARTED|Overall Study||42
7945797|NCT00469274|19555838|P1|STARTED|Overall Study||44
7945798|NCT00469209|19555847|P3|NOT COMPLETED|Overall Study||1
7945799|NCT00469209|19555848|P2|NOT COMPLETED|Overall Study||0
7945800|NCT00469209|19555849|P1|NOT COMPLETED|Overall Study||1
7945801|NCT00469209|19555847|P3|COMPLETED|Overall Study||19
7945802|NCT00469209|19555848|P2|COMPLETED|Overall Study||20
7945803|NCT00469209|19555849|P1|COMPLETED|Overall Study||19
7945804|NCT00469209|19555847|P3|STARTED|Overall Study||20
7945805|NCT00469209|19555848|P2|STARTED|Overall Study||20
7945806|NCT00469209|19555849|P1|STARTED|Overall Study||20
7945807|NCT00469092|19555859|P2|NOT COMPLETED|Overall Study||21
7945808|NCT00469092|19555860|P1|NOT COMPLETED|Overall Study||26
7945809|NCT00469092|19555859|P2|COMPLETED|Overall Study||220
7945810|NCT00469092|19555860|P1|COMPLETED|Overall Study||213
7945811|NCT00469092|19555859|P2|Exposed to Study Drug|Overall Study||238
7945812|NCT00469092|19555860|P1|Exposed to Study Drug|Overall Study||231
7945813|NCT00469092|19555859|P2|STARTED|Overall Study||241
7945814|NCT00469092|19555860|P1|STARTED|Overall Study||239
7945815|NCT00469079|19555879|P3|NOT COMPLETED|Overall Study||19
7945816|NCT00469079|19555880|P2|NOT COMPLETED|Overall Study||22
7945817|NCT00469079|19555881|P1|NOT COMPLETED|Overall Study||9
7945818|NCT00469079|19555879|P3|COMPLETED|Overall Study||32
7945819|NCT00469079|19555880|P2|COMPLETED|Overall Study||30
7945820|NCT00469079|19555881|P1|COMPLETED|Overall Study||18
7945821|NCT00469079|19555879|P3|STARTED|Overall Study||51
7945822|NCT00469079|19555880|P2|STARTED|Overall Study||52
7945823|NCT00469079|19555881|P1|STARTED|Overall Study||27
7945824|NCT00468910|19555900|P2|NOT COMPLETED|Overall Study||3
7945825|NCT00468910|19555901|P1|NOT COMPLETED|Overall Study||4
7945826|NCT00468910|19555900|P2|COMPLETED|Overall Study||36
7945827|NCT00468910|19555901|P1|COMPLETED|Overall Study||36
7945828|NCT00468910|19555900|P2|Follow-up|Overall Study||36
7945829|NCT00468910|19555901|P1|Follow-up|Overall Study||36
7945830|NCT00468910|19555900|P2|Post-Treatment Biopsy|Overall Study||36
7945831|NCT00468910|19555901|P1|Post-Treatment Biopsy|Overall Study||36
7945832|NCT00468910|19555900|P2|Treatment|Overall Study||36
7945833|NCT00468910|19555901|P1|Treatment|Overall Study||36
7945834|NCT00468910|19555900|P2|Randomization|Overall Study||39
7945835|NCT00468910|19555901|P1|Randomization|Overall Study||40
7945836|NCT00468910|19555900|P2|STARTED|Overall Study||39
7945837|NCT00468910|19555901|P1|STARTED|Overall Study||40
7945838|NCT00468858|19555920|P3|NOT COMPLETED|Overall Study||14
7945839|NCT00468858|19555921|P2|NOT COMPLETED|Overall Study||10
7945840|NCT00468858|19555922|P1|NOT COMPLETED|Overall Study||9
7945841|NCT00468858|19555920|P3|COMPLETED|Overall Study||199
7945842|NCT00468858|19555921|P2|COMPLETED|Overall Study||202
7945843|NCT00468858|19555922|P1|COMPLETED|Overall Study||202
7945844|NCT00468858|19555920|P3|STARTED|Overall Study||213
7945845|NCT00468858|19555921|P2|STARTED|Overall Study||212
7945846|NCT00468858|19555922|P1|STARTED|Overall Study||211
7945847|NCT00468845|19556043|P3|NOT COMPLETED|Overall Study||30
7945848|NCT00468845|19556044|P2|NOT COMPLETED|Overall Study||34
7945849|NCT00468845|19556045|P1|NOT COMPLETED|Overall Study||21
7945850|NCT00468845|19556043|P3|COMPLETED|Overall Study||139
7945851|NCT00468845|19556044|P2|COMPLETED|Overall Study||136
7945852|NCT00468845|19556045|P1|COMPLETED|Overall Study||141
7945853|NCT00468845|19556043|P3|Received Treatment|Overall Study||167
7945854|NCT00468845|19556044|P2|Received Treatment|Overall Study||166
7945855|NCT00468845|19556045|P1|Received Treatment|Overall Study||161
7945856|NCT00468845|19556043|P3|STARTED|Overall Study||169
7945857|NCT00468845|19556044|P2|STARTED|Overall Study||170
7945858|NCT00468845|19556045|P1|STARTED|Overall Study||162
7945859|NCT00468819|19556182|P3|NOT COMPLETED|Overall Study||2
7945860|NCT00468819|19556183|P2|NOT COMPLETED|Overall Study||0
7945861|NCT00468819|19556184|P1|NOT COMPLETED|Overall Study||6
7945862|NCT00468819|19556182|P3|COMPLETED|Overall Study||46
7945863|NCT00468819|19556183|P2|COMPLETED|Overall Study||44
7945864|NCT00468819|19556184|P1|COMPLETED|Overall Study||42
7945865|NCT00468819|19556182|P3|Treatment Received/ Safety Follow-up|Overall Study|FAS|48
7945866|NCT00468819|19556183|P2|Treatment Received/ Safety Follow-up|Overall Study|FAS|44
7945867|NCT00468819|19556184|P1|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46
7945868|NCT00468819|19556182|P3|STARTED|Overall Study|Enrolled participants|48
7945869|NCT00468819|19556183|P2|STARTED|Overall Study|Enrolled participants|44
7945870|NCT00468819|19556184|P1|STARTED|Overall Study|Enrolled participants|48
7945871|NCT00468728|19556264|P2|NOT COMPLETED|Follow-up||31
7945872|NCT00468728|19556265|P1|NOT COMPLETED|Follow-up||34
7945873|NCT00468728|19556264|P2|COMPLETED|Follow-up||222
7945874|NCT00468728|19556265|P1|COMPLETED|Follow-up||222
7945875|NCT00468728|19556264|P2|STARTED|Follow-up||253
7945876|NCT00468728|19556265|P1|STARTED|Follow-up||256
7945877|NCT00468728|19556264|P2|NOT COMPLETED|Treatment||11
7945878|NCT00468728|19556265|P1|NOT COMPLETED|Treatment||4
7945879|NCT00468728|19556264|P2|COMPLETED|Treatment||253
7945880|NCT00468728|19556265|P1|COMPLETED|Treatment||256
7945881|NCT00468728|19556264|P2|STARTED|Treatment||264
7945882|NCT00468728|19556265|P1|STARTED|Treatment||260
7945883|NCT00468728|19556264|P2|NOT COMPLETED|Enrollment||7
7945884|NCT00468728|19556265|P1|NOT COMPLETED|Enrollment||4
7945885|NCT00468728|19556264|P2|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264
7945886|NCT00468728|19556265|P1|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260
7945887|NCT00468728|19556264|P2|STARTED|Enrollment||271
7945888|NCT00468728|19556265|P1|STARTED|Enrollment||264
7945889|NCT00468676|19556277|P2|NOT COMPLETED|Overall Study||12
7945890|NCT00468676|19556278|P1|NOT COMPLETED|Overall Study||16
7945891|NCT00468676|19556277|P2|COMPLETED|Overall Study||94
7945892|NCT00468676|19556278|P1|COMPLETED|Overall Study||92
7945893|NCT00468676|19556277|P2|STARTED|Overall Study||106
7945894|NCT00468676|19556278|P1|STARTED|Overall Study||108
7945895|NCT00468650|19556295|P1|NOT COMPLETED|Overall Study||7
7945896|NCT00468650|19556295|P1|COMPLETED|Overall Study||110
7945897|NCT00468650|19556295|P1|STARTED|Overall Study||117
7945898|NCT00468585|19556343|P4|NOT COMPLETED|Overall Study||1
7945899|NCT00468585|19556344|P3|NOT COMPLETED|Overall Study||5
7945900|NCT00468585|19556345|P2|NOT COMPLETED|Overall Study||0
7945901|NCT00468585|19556346|P1|NOT COMPLETED|Overall Study||1
7945902|NCT00468585|19556343|P4|COMPLETED|Overall Study||5
7945903|NCT00468585|19556344|P3|COMPLETED|Overall Study||45
7945904|NCT00468585|19556345|P2|COMPLETED|Overall Study||3
7945905|NCT00468585|19556346|P1|COMPLETED|Overall Study||3
7945906|NCT00468585|19556343|P4|STARTED|Overall Study||6
7945907|NCT00468585|19556344|P3|STARTED|Overall Study||50
7945908|NCT00468585|19556345|P2|STARTED|Overall Study||3
7945909|NCT00468585|19556346|P1|STARTED|Overall Study||4
7945910|NCT00468559|19556358|P3|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17
7945911|NCT00468559|19556359|P2|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10
7945912|NCT00468559|19556360|P1|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0
7945913|NCT00468559|19556358|P3|COMPLETED|Double-blind, Treatment-withdrawal Phase||24
7945914|NCT00468559|19556359|P2|COMPLETED|Double-blind, Treatment-withdrawal Phase||29
7945915|NCT00468559|19556360|P1|COMPLETED|Double-blind, Treatment-withdrawal Phase||0
7945916|NCT00468559|19556358|P3|STARTED|Double-blind, Treatment-withdrawal Phase||41
7945917|NCT00468559|19556359|P2|STARTED|Double-blind, Treatment-withdrawal Phase||39
7945918|NCT00468559|19556360|P1|STARTED|Double-blind, Treatment-withdrawal Phase||0
7945919|NCT00468559|19556358|P3|NOT COMPLETED|Open-label Treatment Phase||0
7945920|NCT00468559|19556359|P2|NOT COMPLETED|Open-label Treatment Phase||0
7945921|NCT00468559|19556360|P1|NOT COMPLETED|Open-label Treatment Phase||18
7945922|NCT00468559|19556358|P3|COMPLETED|Open-label Treatment Phase||0
7945923|NCT00468559|19556359|P2|COMPLETED|Open-label Treatment Phase||0
7945924|NCT00468559|19556360|P1|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80
7945925|NCT00468559|19556358|P3|STARTED|Open-label Treatment Phase||0
7945926|NCT00468559|19556359|P2|STARTED|Open-label Treatment Phase||0
7945927|NCT00468559|19556360|P1|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98
7945928|NCT00468546|19556388|P2|NOT COMPLETED|Week 24 to Week 104 Analysis||225
7945929|NCT00468546|19556389|P1|NOT COMPLETED|Week 24 to Week 104 Analysis||105
7945930|NCT00468546|19556388|P2|COMPLETED|Week 24 to Week 104 Analysis||83
7945931|NCT00468546|19556389|P1|COMPLETED|Week 24 to Week 104 Analysis||103
7945932|NCT00468546|19556388|P2|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308
7945933|NCT00468546|19556389|P1|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208
7945934|NCT00468546|19556388|P2|NOT COMPLETED|Week 24 Analysis||55
7945935|NCT00468546|19556389|P1|NOT COMPLETED|Week 24 Analysis||97
7945936|NCT00468546|19556388|P2|COMPLETED|Week 24 Analysis||253
7945937|NCT00468546|19556389|P1|COMPLETED|Week 24 Analysis||111
7945938|NCT00468546|19556388|P2|STARTED|Week 24 Analysis||308
7945939|NCT00468546|19556389|P1|STARTED|Week 24 Analysis||208
7945940|NCT00468481|19556419|P2|NOT COMPLETED|Overall Study||24
7945941|NCT00468481|19556420|P1|NOT COMPLETED|Overall Study||88
7945942|NCT00468481|19556419|P2|COMPLETED|Overall Study||70
7945943|NCT00468481|19556420|P1|COMPLETED|Overall Study||203
7945944|NCT00468481|19556419|P2|Subjects Treated|Overall Study||94
7945945|NCT00468481|19556420|P1|Subjects Treated|Overall Study||285
7945946|NCT00468481|19556419|P2|STARTED|Overall Study||94
7945947|NCT00468481|19556420|P1|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291
7945948|NCT00468312|19556520|P2|NOT COMPLETED|Overall Study||5
7945949|NCT00468312|19556521|P1|NOT COMPLETED|Overall Study||4
7945950|NCT00468312|19556520|P2|COMPLETED|Overall Study||204
7945951|NCT00468312|19556521|P1|COMPLETED|Overall Study||216
7945952|NCT00468312|19556520|P2|STARTED|Overall Study||209
7945953|NCT00468312|19556521|P1|STARTED|Overall Study||220
7945954|NCT00468299|19556537|P2|NOT COMPLETED|Overall Study||1
7945955|NCT00468299|19556538|P1|NOT COMPLETED|Overall Study||0
7945956|NCT00468299|19556537|P2|COMPLETED|Overall Study||7
7945957|NCT00468299|19556538|P1|COMPLETED|Overall Study||9
7945958|NCT00468299|19556537|P2|STARTED|Overall Study||8
7945959|NCT00468299|19556538|P1|STARTED|Overall Study||9
7945960|NCT00468286|19556548|P2|NOT COMPLETED|Overall Study||12
7945961|NCT00468286|19556549|P1|NOT COMPLETED|Overall Study||7
7945962|NCT00468286|19556548|P2|COMPLETED|Overall Study||54
7945963|NCT00468286|19556549|P1|COMPLETED|Overall Study||60
7945964|NCT00468286|19556548|P2|STARTED|Overall Study||66
7945965|NCT00468286|19556549|P1|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67
7945966|NCT00468208|19556571|P1|NOT COMPLETED|Overall Study||0
7945967|NCT00468208|19556571|P1|COMPLETED|Overall Study|All patients reached common closing or early termination|20
7945968|NCT00468208|19556571|P1|STARTED|Overall Study||20
7945969|NCT00468169|19556581|P2|NOT COMPLETED|Overall Study||0
7945970|NCT00468169|19556582|P1|NOT COMPLETED|Overall Study||1
7945971|NCT00468169|19556581|P2|COMPLETED|Overall Study||53
7945972|NCT00468169|19556582|P1|COMPLETED|Overall Study||56
7945973|NCT00468169|19556581|P2|STARTED|Overall Study||53
7945974|NCT00468169|19556582|P1|STARTED|Overall Study||57
7945975|NCT00468143|19556598|P2|NOT COMPLETED|Second Intervention (3 Weeks)||3
7945976|NCT00468143|19556599|P1|NOT COMPLETED|Second Intervention (3 Weeks)||3
7945977|NCT00468143|19556598|P2|COMPLETED|Second Intervention (3 Weeks)||24
7945978|NCT00468143|19556599|P1|COMPLETED|Second Intervention (3 Weeks)||25
7945979|NCT00468143|19556598|P2|STARTED|Second Intervention (3 Weeks)||27
7945980|NCT00468143|19556599|P1|STARTED|Second Intervention (3 Weeks)||28
7945981|NCT00468143|19556598|P2|NOT COMPLETED|First Intervention (3 Weeks)||4
7945982|NCT00468143|19556599|P1|NOT COMPLETED|First Intervention (3 Weeks)||3
7945983|NCT00468143|19556598|P2|COMPLETED|First Intervention (3 Weeks)||27
7945984|NCT00468143|19556599|P1|COMPLETED|First Intervention (3 Weeks)||28
7945985|NCT00468143|19556598|P2|STARTED|First Intervention (3 Weeks)||31
7945986|NCT00468143|19556599|P1|STARTED|First Intervention (3 Weeks)||31
7945987|NCT00468104|19556613|P2|NOT COMPLETED|Second Intervention||4
7945988|NCT00468104|19556614|P1|NOT COMPLETED|Second Intervention||5
7945989|NCT00468104|19556613|P2|COMPLETED|Second Intervention||37
7945990|NCT00468104|19556614|P1|COMPLETED|Second Intervention||3
7945991|NCT00468104|19556613|P2|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41
7945992|NCT00468104|19556614|P1|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8
7945993|NCT00468104|19556613|P2|NOT COMPLETED|First Intervention||1
7945994|NCT00468104|19556614|P1|NOT COMPLETED|First Intervention||9
7945995|NCT00468104|19556613|P2|COMPLETED|First Intervention||45
7945996|NCT00468104|19556614|P1|COMPLETED|First Intervention||45
7945997|NCT00468104|19556613|P2|STARTED|First Intervention||46
7945998|NCT00468104|19556614|P1|STARTED|First Intervention||54
7945999|NCT00468052|19556631|P2|NOT COMPLETED|Overall Study||8
7946000|NCT00468052|19556632|P1|NOT COMPLETED|Overall Study||7
7946001|NCT00468052|19556631|P2|COMPLETED|Overall Study||61
7946002|NCT00468052|19556632|P1|COMPLETED|Overall Study||61
7946003|NCT00468052|19556631|P2|Target Enrollment|Overall Study||70
7946004|NCT00468052|19556632|P1|Target Enrollment|Overall Study||70
7946005|NCT00468052|19556631|P2|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69
7946006|NCT00468052|19556632|P1|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68
7946007|NCT00467961|19556650|P1|NOT COMPLETED|Overall Study||7
7946008|NCT00467961|19556650|P1|COMPLETED|Overall Study||24
7946009|NCT00467961|19556650|P1|STARTED|Overall Study||31
7946010|NCT00467896|19556654|P1|NOT COMPLETED|Overall Study||51
7946011|NCT00467896|19556654|P1|COMPLETED|Overall Study||11
7946012|NCT00467896|19556654|P1|STARTED|Overall Study||62
7946013|NCT00467870|19556680|P6|NOT COMPLETED|Overall Study||2
7946014|NCT00467870|19556681|P5|NOT COMPLETED|Overall Study||37
7946015|NCT00467870|19556682|P4|NOT COMPLETED|Overall Study||33
7946016|NCT00467870|19556683|P3|NOT COMPLETED|Overall Study||4
7946017|NCT00467870|19556684|P2|NOT COMPLETED|Overall Study||43
7946018|NCT00467870|19556685|P1|NOT COMPLETED|Overall Study||45
7946019|NCT00467870|19556680|P6|COMPLETED|Overall Study||21
7946020|NCT00467870|19556681|P5|COMPLETED|Overall Study||93
7946021|NCT00467870|19556682|P4|COMPLETED|Overall Study||79
7946022|NCT00467870|19556683|P3|COMPLETED|Overall Study||18
7946023|NCT00467870|19556684|P2|COMPLETED|Overall Study||74
7946024|NCT00467870|19556685|P1|COMPLETED|Overall Study||75
7946025|NCT00467870|19556680|P6|STARTED|Overall Study||23
7946026|NCT00467870|19556681|P5|STARTED|Overall Study||130
7946027|NCT00467870|19556682|P4|STARTED|Overall Study||112
7946028|NCT00467870|19556683|P3|STARTED|Overall Study||22
7946029|NCT00467870|19556684|P2|STARTED|Overall Study||117
7946030|NCT00467870|19556685|P1|STARTED|Overall Study||120
7946031|NCT00467857|19556728|P2|NOT COMPLETED|Overall Study||8
7946032|NCT00467857|19556729|P1|NOT COMPLETED|Overall Study||3
7946033|NCT00467857|19556728|P2|COMPLETED|Overall Study||139
7946034|NCT00467857|19556729|P1|COMPLETED|Overall Study||143
7946035|NCT00467857|19556728|P2|STARTED|Overall Study||147
7946036|NCT00467857|19556729|P1|STARTED|Overall Study||146
7946037|NCT00467844|19556764|P3|NOT COMPLETED|Overall Study||14
7946038|NCT00467844|19556765|P2|NOT COMPLETED|Overall Study||20
7946039|NCT00467844|19556766|P1|NOT COMPLETED|Overall Study||19
7946040|NCT00467844|19556764|P3|COMPLETED|Overall Study||38
7946041|NCT00467844|19556765|P2|COMPLETED|Overall Study||34
7946042|NCT00467844|19556766|P1|COMPLETED|Overall Study||34
7946043|NCT00467844|19556764|P3|STARTED|Overall Study||52
7946044|NCT00467844|19556765|P2|STARTED|Overall Study||54
7946045|NCT00467844|19556766|P1|STARTED|Overall Study||53
7946046|NCT00467831|19556777|P1|NOT COMPLETED|Overall Study||3
7946047|NCT00467831|19556777|P1|COMPLETED|Overall Study||0
7946048|NCT00467831|19556777|P1|STARTED|Overall Study||3
7946049|NCT00467818|19556783|P2|NOT COMPLETED|Overall Study||2
7946050|NCT00467818|19556784|P1|NOT COMPLETED|Overall Study||3
7946051|NCT00467818|19556783|P2|COMPLETED|Overall Study||6
7946052|NCT00467818|19556784|P1|COMPLETED|Overall Study||6
7946053|NCT00467818|19556783|P2|STARTED|Overall Study||8
7946054|NCT00467818|19556784|P1|STARTED|Overall Study||9
7946055|NCT00467779|19556813|P15|NOT COMPLETED|Stage 3||17
7946056|NCT00467779|19556814|P14|NOT COMPLETED|Stage 3||0
7946057|NCT00467779|19556815|P13|NOT COMPLETED|Stage 3||0
7946058|NCT00467779|19556816|P12|NOT COMPLETED|Stage 3||0
7946059|NCT00467779|19556817|P11|NOT COMPLETED|Stage 3||0
7946060|NCT00467779|19556818|P10|NOT COMPLETED|Stage 3||0
7946061|NCT00467779|19556819|P9|NOT COMPLETED|Stage 3||0
7946062|NCT00467779|19556820|P8|NOT COMPLETED|Stage 3||0
7946063|NCT00467779|19556821|P7|NOT COMPLETED|Stage 3||0
7946064|NCT00467779|19556822|P6|NOT COMPLETED|Stage 3||0
7946065|NCT00467779|19556823|P5|NOT COMPLETED|Stage 3||0
7946066|NCT00467779|19556824|P4|NOT COMPLETED|Stage 3||0
7946067|NCT00467779|19556825|P3|NOT COMPLETED|Stage 3||0
7946068|NCT00467779|19556826|P2|NOT COMPLETED|Stage 3||0
7946069|NCT00467779|19556827|P1|NOT COMPLETED|Stage 3||0
7946070|NCT00467779|19556813|P15|COMPLETED|Stage 3||3
7946071|NCT00467779|19556814|P14|COMPLETED|Stage 3||0
7946072|NCT00467779|19556815|P13|COMPLETED|Stage 3||0
7946073|NCT00467779|19556816|P12|COMPLETED|Stage 3||0
7946074|NCT00467779|19556817|P11|COMPLETED|Stage 3||0
7946075|NCT00467779|19556818|P10|COMPLETED|Stage 3||0
7946076|NCT00467779|19556819|P9|COMPLETED|Stage 3||0
7946077|NCT00467779|19556820|P8|COMPLETED|Stage 3||0
7946078|NCT00467779|19556821|P7|COMPLETED|Stage 3||0
7946079|NCT00467779|19556822|P6|COMPLETED|Stage 3||0
7946080|NCT00467779|19556823|P5|COMPLETED|Stage 3||0
7946081|NCT00467779|19556824|P4|COMPLETED|Stage 3||0
7946082|NCT00467779|19556825|P3|COMPLETED|Stage 3||0
7946083|NCT00467779|19556826|P2|COMPLETED|Stage 3||0
7946084|NCT00467779|19556827|P1|COMPLETED|Stage 3||0
7946085|NCT00467779|19556813|P15|STARTED|Stage 3||20
7946086|NCT00467779|19556814|P14|STARTED|Stage 3||0
7946087|NCT00467779|19556815|P13|STARTED|Stage 3||0
7946088|NCT00467779|19556816|P12|STARTED|Stage 3||0
7946089|NCT00467779|19556817|P11|STARTED|Stage 3||0
7946090|NCT00467779|19556818|P10|STARTED|Stage 3||0
7946091|NCT00467779|19556819|P9|STARTED|Stage 3||0
7946092|NCT00467779|19556820|P8|STARTED|Stage 3||0
7946093|NCT00467779|19556821|P7|STARTED|Stage 3||0
7946094|NCT00467779|19556822|P6|STARTED|Stage 3||0
7946095|NCT00467779|19556823|P5|STARTED|Stage 3||0
7946096|NCT00467779|19556824|P4|STARTED|Stage 3||0
7946097|NCT00467779|19556825|P3|STARTED|Stage 3||0
7946098|NCT00467779|19556826|P2|STARTED|Stage 3||0
7946099|NCT00467779|19556827|P1|STARTED|Stage 3||0
7946100|NCT00467779|19556813|P15|NOT COMPLETED|Stage 2A||0
7946101|NCT00467779|19556814|P14|NOT COMPLETED|Stage 2A||21
7946102|NCT00467779|19556815|P13|NOT COMPLETED|Stage 2A||0
7946103|NCT00467779|19556816|P12|NOT COMPLETED|Stage 2A||0
7946104|NCT00467779|19556817|P11|NOT COMPLETED|Stage 2A||0
7946105|NCT00467779|19556818|P10|NOT COMPLETED|Stage 2A||0
7946106|NCT00467779|19556819|P9|NOT COMPLETED|Stage 2A||0
7946107|NCT00467779|19556820|P8|NOT COMPLETED|Stage 2A||0
7946108|NCT00467779|19556821|P7|NOT COMPLETED|Stage 2A||0
7946109|NCT00467779|19556822|P6|NOT COMPLETED|Stage 2A||0
7946110|NCT00467779|19556823|P5|NOT COMPLETED|Stage 2A||0
7946111|NCT00467779|19556824|P4|NOT COMPLETED|Stage 2A||0
7946112|NCT00467779|19556825|P3|NOT COMPLETED|Stage 2A||0
7946113|NCT00467779|19556826|P2|NOT COMPLETED|Stage 2A||0
7946114|NCT00467779|19556827|P1|NOT COMPLETED|Stage 2A||0
7946115|NCT00467779|19556813|P15|COMPLETED|Stage 2A||0
7946116|NCT00467779|19556814|P14|COMPLETED|Stage 2A||1
7946117|NCT00467779|19556815|P13|COMPLETED|Stage 2A||0
7946118|NCT00467779|19556816|P12|COMPLETED|Stage 2A||0
7946119|NCT00467779|19556817|P11|COMPLETED|Stage 2A||0
7946120|NCT00467779|19556818|P10|COMPLETED|Stage 2A||0
7946121|NCT00467779|19556819|P9|COMPLETED|Stage 2A||0
7946122|NCT00467779|19556820|P8|COMPLETED|Stage 2A||0
7946123|NCT00467779|19556821|P7|COMPLETED|Stage 2A||0
7946124|NCT00467779|19556822|P6|COMPLETED|Stage 2A||0
7946125|NCT00467779|19556823|P5|COMPLETED|Stage 2A||0
7946126|NCT00467779|19556824|P4|COMPLETED|Stage 2A||0
7946127|NCT00467779|19556825|P3|COMPLETED|Stage 2A||0
7946128|NCT00467779|19556826|P2|COMPLETED|Stage 2A||0
7946129|NCT00467779|19556827|P1|COMPLETED|Stage 2A||0
7946130|NCT00467779|19556813|P15|STARTED|Stage 2A||0
7946131|NCT00467779|19556814|P14|STARTED|Stage 2A||22
7946132|NCT00467779|19556815|P13|STARTED|Stage 2A||0
7946133|NCT00467779|19556816|P12|STARTED|Stage 2A||0
7946134|NCT00467779|19556817|P11|STARTED|Stage 2A||0
7946135|NCT00467779|19556818|P10|STARTED|Stage 2A||0
7946136|NCT00467779|19556819|P9|STARTED|Stage 2A||0
7946137|NCT00467779|19556820|P8|STARTED|Stage 2A||0
7946138|NCT00467779|19556821|P7|STARTED|Stage 2A||0
7946139|NCT00467779|19556822|P6|STARTED|Stage 2A||0
7946140|NCT00467779|19556823|P5|STARTED|Stage 2A||0
7946141|NCT00467779|19556824|P4|STARTED|Stage 2A||0
7946142|NCT00467779|19556825|P3|STARTED|Stage 2A||0
7946143|NCT00467779|19556826|P2|STARTED|Stage 2A||0
7946144|NCT00467779|19556827|P1|STARTED|Stage 2A||0
7946145|NCT00467779|19556813|P15|NOT COMPLETED|Stage 2||0
7946146|NCT00467779|19556814|P14|NOT COMPLETED|Stage 2||0
7946147|NCT00467779|19556815|P13|NOT COMPLETED|Stage 2||0
7946148|NCT00467779|19556816|P12|NOT COMPLETED|Stage 2||0
7946149|NCT00467779|19556817|P11|NOT COMPLETED|Stage 2||0
7946150|NCT00467779|19556818|P10|NOT COMPLETED|Stage 2||0
7946151|NCT00467779|19556819|P9|NOT COMPLETED|Stage 2||21
7946152|NCT00467779|19556820|P8|NOT COMPLETED|Stage 2||0
7946153|NCT00467779|19556821|P7|NOT COMPLETED|Stage 2||0
7946154|NCT00467779|19556822|P6|NOT COMPLETED|Stage 2||0
7946155|NCT00467779|19556823|P5|NOT COMPLETED|Stage 2||0
7946156|NCT00467779|19556824|P4|NOT COMPLETED|Stage 2||0
7946157|NCT00467779|19556825|P3|NOT COMPLETED|Stage 2||0
7946158|NCT00467779|19556826|P2|NOT COMPLETED|Stage 2||0
7946159|NCT00467779|19556827|P1|NOT COMPLETED|Stage 2||0
7946160|NCT00467779|19556813|P15|COMPLETED|Stage 2||0
7946161|NCT00467779|19556814|P14|COMPLETED|Stage 2||0
7946162|NCT00467779|19556815|P13|COMPLETED|Stage 2||0
7946163|NCT00467779|19556816|P12|COMPLETED|Stage 2||0
7946164|NCT00467779|19556817|P11|COMPLETED|Stage 2||0
7946165|NCT00467779|19556818|P10|COMPLETED|Stage 2||0
7946166|NCT00467779|19556819|P9|COMPLETED|Stage 2||0
7946167|NCT00467779|19556820|P8|COMPLETED|Stage 2||0
7946168|NCT00467779|19556821|P7|COMPLETED|Stage 2||0
7946169|NCT00467779|19556822|P6|COMPLETED|Stage 2||0
7946170|NCT00467779|19556823|P5|COMPLETED|Stage 2||0
7946171|NCT00467779|19556824|P4|COMPLETED|Stage 2||0
7946172|NCT00467779|19556825|P3|COMPLETED|Stage 2||0
7946173|NCT00467779|19556826|P2|COMPLETED|Stage 2||0
7946174|NCT00467779|19556827|P1|COMPLETED|Stage 2||0
7946175|NCT00467779|19556813|P15|STARTED|Stage 2||0
7946176|NCT00467779|19556814|P14|STARTED|Stage 2||0
7946177|NCT00467779|19556815|P13|STARTED|Stage 2||0
7946178|NCT00467779|19556816|P12|STARTED|Stage 2||0
7946179|NCT00467779|19556817|P11|STARTED|Stage 2||0
7946180|NCT00467779|19556818|P10|STARTED|Stage 2||0
7946181|NCT00467779|19556819|P9|STARTED|Stage 2||21
7946182|NCT00467779|19556820|P8|STARTED|Stage 2||0
7946183|NCT00467779|19556821|P7|STARTED|Stage 2||0
7946184|NCT00467779|19556822|P6|STARTED|Stage 2||0
7946185|NCT00467779|19556823|P5|STARTED|Stage 2||0
7946186|NCT00467779|19556824|P4|STARTED|Stage 2||0
7946187|NCT00467779|19556825|P3|STARTED|Stage 2||0
7946188|NCT00467779|19556826|P2|STARTED|Stage 2||0
7946189|NCT00467779|19556827|P1|STARTED|Stage 2||0
7946190|NCT00467779|19556813|P15|NOT COMPLETED|Stage 1A||0
7946191|NCT00467779|19556814|P14|NOT COMPLETED|Stage 1A||0
7946192|NCT00467779|19556815|P13|NOT COMPLETED|Stage 1A||6
7946193|NCT00467779|19556816|P12|NOT COMPLETED|Stage 1A||8
7946194|NCT00467779|19556817|P11|NOT COMPLETED|Stage 1A||3
7946195|NCT00467779|19556818|P10|NOT COMPLETED|Stage 1A||3
7946196|NCT00467779|19556819|P9|NOT COMPLETED|Stage 1A||0
7946197|NCT00467779|19556820|P8|NOT COMPLETED|Stage 1A||0
7946198|NCT00467779|19556821|P7|NOT COMPLETED|Stage 1A||0
7946199|NCT00467779|19556822|P6|NOT COMPLETED|Stage 1A||0
7946200|NCT00467779|19556823|P5|NOT COMPLETED|Stage 1A||0
7946201|NCT00467779|19556824|P4|NOT COMPLETED|Stage 1A||0
7946202|NCT00467779|19556825|P3|NOT COMPLETED|Stage 1A||0
7946203|NCT00467779|19556826|P2|NOT COMPLETED|Stage 1A||0
7946204|NCT00467779|19556827|P1|NOT COMPLETED|Stage 1A||0
7946205|NCT00467779|19556813|P15|COMPLETED|Stage 1A||0
7946206|NCT00467779|19556814|P14|COMPLETED|Stage 1A||0
7946207|NCT00467779|19556815|P13|COMPLETED|Stage 1A||0
7946208|NCT00467779|19556816|P12|COMPLETED|Stage 1A||0
7946209|NCT00467779|19556817|P11|COMPLETED|Stage 1A||0
7946210|NCT00467779|19556818|P10|COMPLETED|Stage 1A||0
7946211|NCT00467779|19556819|P9|COMPLETED|Stage 1A||0
7946212|NCT00467779|19556820|P8|COMPLETED|Stage 1A||0
7946213|NCT00467779|19556821|P7|COMPLETED|Stage 1A||0
7946214|NCT00467779|19556822|P6|COMPLETED|Stage 1A||0
7946215|NCT00467779|19556823|P5|COMPLETED|Stage 1A||0
7946216|NCT00467779|19556824|P4|COMPLETED|Stage 1A||0
7946217|NCT00467779|19556825|P3|COMPLETED|Stage 1A||0
7946218|NCT00467779|19556826|P2|COMPLETED|Stage 1A||0
7946219|NCT00467779|19556827|P1|COMPLETED|Stage 1A||0
7946220|NCT00467779|19556813|P15|STARTED|Stage 1A||0
7946221|NCT00467779|19556814|P14|STARTED|Stage 1A||0
7946222|NCT00467779|19556815|P13|STARTED|Stage 1A||6
7946223|NCT00467779|19556816|P12|STARTED|Stage 1A||8
7946224|NCT00467779|19556817|P11|STARTED|Stage 1A||3
7946225|NCT00467779|19556818|P10|STARTED|Stage 1A||3
7946226|NCT00467779|19556819|P9|STARTED|Stage 1A||0
7946227|NCT00467779|19556820|P8|STARTED|Stage 1A||0
7946228|NCT00467779|19556821|P7|STARTED|Stage 1A||0
7946229|NCT00467779|19556822|P6|STARTED|Stage 1A||0
7946230|NCT00467779|19556823|P5|STARTED|Stage 1A||0
7946231|NCT00467779|19556824|P4|STARTED|Stage 1A||0
7946232|NCT00467779|19556825|P3|STARTED|Stage 1A||0
7946233|NCT00467779|19556826|P2|STARTED|Stage 1A||0
7946234|NCT00467779|19556827|P1|STARTED|Stage 1A||0
7946235|NCT00467779|19556813|P15|NOT COMPLETED|Stage 1||0
7946236|NCT00467779|19556814|P14|NOT COMPLETED|Stage 1||0
7946237|NCT00467779|19556815|P13|NOT COMPLETED|Stage 1||0
7946238|NCT00467779|19556816|P12|NOT COMPLETED|Stage 1||0
7946239|NCT00467779|19556817|P11|NOT COMPLETED|Stage 1||0
7946240|NCT00467779|19556818|P10|NOT COMPLETED|Stage 1||0
7946241|NCT00467779|19556819|P9|NOT COMPLETED|Stage 1||0
7946242|NCT00467779|19556820|P8|NOT COMPLETED|Stage 1||7
7946243|NCT00467779|19556821|P7|NOT COMPLETED|Stage 1||7
7946244|NCT00467779|19556822|P6|NOT COMPLETED|Stage 1||5
7946245|NCT00467779|19556823|P5|NOT COMPLETED|Stage 1||3
7946246|NCT00467779|19556824|P4|NOT COMPLETED|Stage 1||3
7946247|NCT00467779|19556825|P3|NOT COMPLETED|Stage 1||3
7946248|NCT00467779|19556826|P2|NOT COMPLETED|Stage 1||3
7946249|NCT00467779|19556827|P1|NOT COMPLETED|Stage 1||4
7946250|NCT00467779|19556813|P15|COMPLETED|Stage 1||0
7946251|NCT00467779|19556814|P14|COMPLETED|Stage 1||0
7946252|NCT00467779|19556815|P13|COMPLETED|Stage 1||0
7946253|NCT00467779|19556816|P12|COMPLETED|Stage 1||0
7946254|NCT00467779|19556817|P11|COMPLETED|Stage 1||0
7946255|NCT00467779|19556818|P10|COMPLETED|Stage 1||0
7946256|NCT00467779|19556819|P9|COMPLETED|Stage 1||0
7946257|NCT00467779|19556820|P8|COMPLETED|Stage 1||0
7946258|NCT00467779|19556821|P7|COMPLETED|Stage 1||0
7946259|NCT00467779|19556822|P6|COMPLETED|Stage 1||1
7946260|NCT00467779|19556823|P5|COMPLETED|Stage 1||0
7946261|NCT00467779|19556824|P4|COMPLETED|Stage 1||0
7946262|NCT00467779|19556825|P3|COMPLETED|Stage 1||0
7946263|NCT00467779|19556826|P2|COMPLETED|Stage 1||0
7946264|NCT00467779|19556827|P1|COMPLETED|Stage 1||0
7946265|NCT00467779|19556813|P15|STARTED|Stage 1||0
7946266|NCT00467779|19556814|P14|STARTED|Stage 1||0
7946267|NCT00467779|19556815|P13|STARTED|Stage 1||0
7946268|NCT00467779|19556816|P12|STARTED|Stage 1||0
7946269|NCT00467779|19556817|P11|STARTED|Stage 1||0
7946270|NCT00467779|19556818|P10|STARTED|Stage 1||0
7946271|NCT00467779|19556819|P9|STARTED|Stage 1||0
7946272|NCT00467779|19556820|P8|STARTED|Stage 1||7
7946273|NCT00467779|19556821|P7|STARTED|Stage 1||7
7946274|NCT00467779|19556822|P6|STARTED|Stage 1||6
7946275|NCT00467779|19556823|P5|STARTED|Stage 1||3
7946276|NCT00467779|19556824|P4|STARTED|Stage 1||3
7946277|NCT00467779|19556825|P3|STARTED|Stage 1||3
7946278|NCT00467779|19556826|P2|STARTED|Stage 1||3
7946279|NCT00467779|19556827|P1|STARTED|Stage 1||4
7946280|NCT00467753|19557001|P2|NOT COMPLETED|Overall Study||2
7946281|NCT00467753|19557002|P1|NOT COMPLETED|Overall Study||3
7946282|NCT00467753|19557001|P2|COMPLETED|Overall Study||0
7946283|NCT00467753|19557002|P1|COMPLETED|Overall Study||0
7946284|NCT00467753|19557001|P2|STARTED|Overall Study||2
7946285|NCT00467753|19557002|P1|STARTED|Overall Study||3
7946286|NCT00467740|19557013|P5|NOT COMPLETED|Overall Study||0
7946287|NCT00467740|19557014|P4|NOT COMPLETED|Overall Study||1
7946288|NCT00467740|19557015|P3|NOT COMPLETED|Overall Study||2
7946289|NCT00467740|19557016|P2|NOT COMPLETED|Overall Study||3
7946290|NCT00467740|19557017|P1|NOT COMPLETED|Overall Study||1
7946291|NCT00467740|19557013|P5|COMPLETED|Overall Study||61
7946292|NCT00467740|19557014|P4|COMPLETED|Overall Study||59
7946293|NCT00467740|19557015|P3|COMPLETED|Overall Study||58
7946294|NCT00467740|19557016|P2|COMPLETED|Overall Study||58
7946295|NCT00467740|19557017|P1|COMPLETED|Overall Study||53
7946296|NCT00467740|19557013|P5|STARTED|Overall Study||61
7946297|NCT00467740|19557014|P4|STARTED|Overall Study||60
7946298|NCT00467740|19557015|P3|STARTED|Overall Study||60
7946299|NCT00467740|19557016|P2|STARTED|Overall Study||61
7946300|NCT00467740|19557017|P1|STARTED|Overall Study||54
7946301|NCT00467649|19557206|P6|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1
7946302|NCT00467649|19557207|P5|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
7946303|NCT00467649|19557208|P4|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2
7946304|NCT00467649|19557209|P3|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
7946305|NCT00467649|19557210|P2|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
7946306|NCT00467649|19557211|P1|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
7946307|NCT00467649|19557206|P6|COMPLETED|Phase 2 (Intent-to-Treat Population)||35
7946308|NCT00467649|19557207|P5|COMPLETED|Phase 2 (Intent-to-Treat Population)||14
7946309|NCT00467649|19557208|P4|COMPLETED|Phase 2 (Intent-to-Treat Population)||29
7946310|NCT00467649|19557209|P3|COMPLETED|Phase 2 (Intent-to-Treat Population)||17
7946311|NCT00467649|19557210|P2|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
7946312|NCT00467649|19557211|P1|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
7946313|NCT00467649|19557206|P6|STARTED|Phase 2 (Intent-to-Treat Population)||36
7946314|NCT00467649|19557207|P5|STARTED|Phase 2 (Intent-to-Treat Population)||14
7946315|NCT00467649|19557208|P4|STARTED|Phase 2 (Intent-to-Treat Population)||31
7946316|NCT00467649|19557209|P3|STARTED|Phase 2 (Intent-to-Treat Population)||17
7946317|NCT00467649|19557210|P2|STARTED|Phase 2 (Intent-to-Treat Population)||0
7946318|NCT00467649|19557211|P1|STARTED|Phase 2 (Intent-to-Treat Population)||0
7946319|NCT00467649|19557206|P6|NOT COMPLETED|Phase 1 (Randomized Population)||0
7946320|NCT00467649|19557207|P5|NOT COMPLETED|Phase 1 (Randomized Population)||0
7946321|NCT00467649|19557208|P4|NOT COMPLETED|Phase 1 (Randomized Population)||0
7946322|NCT00467649|19557209|P3|NOT COMPLETED|Phase 1 (Randomized Population)||0
7946323|NCT00467649|19557210|P2|NOT COMPLETED|Phase 1 (Randomized Population)||6
7946324|NCT00467649|19557211|P1|NOT COMPLETED|Phase 1 (Randomized Population)||9
7946325|NCT00467649|19557206|P6|COMPLETED|Phase 1 (Randomized Population)||0
7946326|NCT00467649|19557207|P5|COMPLETED|Phase 1 (Randomized Population)||0
7946327|NCT00467649|19557208|P4|COMPLETED|Phase 1 (Randomized Population)||0
7946328|NCT00467649|19557209|P3|COMPLETED|Phase 1 (Randomized Population)||0
7946329|NCT00467649|19557210|P2|COMPLETED|Phase 1 (Randomized Population)||50
7946330|NCT00467649|19557211|P1|COMPLETED|Phase 1 (Randomized Population)||48
7946331|NCT00467649|19557206|P6|Intent to Treat|Phase 1 (Randomized Population)||0
7946332|NCT00467649|19557207|P5|Intent to Treat|Phase 1 (Randomized Population)||0
7946333|NCT00467649|19557208|P4|Intent to Treat|Phase 1 (Randomized Population)||0
7946334|NCT00467649|19557209|P3|Intent to Treat|Phase 1 (Randomized Population)||0
7946335|NCT00467649|19557210|P2|Intent to Treat|Phase 1 (Randomized Population)||56
7946336|NCT00467649|19557211|P1|Intent to Treat|Phase 1 (Randomized Population)||56
7946337|NCT00467649|19557206|P6|STARTED|Phase 1 (Randomized Population)||0
7946338|NCT00467649|19557207|P5|STARTED|Phase 1 (Randomized Population)||0
7946339|NCT00467649|19557208|P4|STARTED|Phase 1 (Randomized Population)||0
7946340|NCT00467649|19557209|P3|STARTED|Phase 1 (Randomized Population)||0
7946341|NCT00467649|19557210|P2|STARTED|Phase 1 (Randomized Population)||56
7946342|NCT00467649|19557211|P1|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57
7946343|NCT00467610|19557251|P1|NOT COMPLETED|Overall Study||1
7946344|NCT00467610|19557251|P1|COMPLETED|Overall Study||5
7946345|NCT00467610|19557251|P1|STARTED|Overall Study||6
7946346|NCT00467597|19557262|P2|NOT COMPLETED|Overall Study||0
7946347|NCT00467597|19557263|P1|NOT COMPLETED|Overall Study||2
7946348|NCT00467597|19557262|P2|COMPLETED|Overall Study||6
7946349|NCT00467597|19557263|P1|COMPLETED|Overall Study||24
7946350|NCT00467597|19557262|P2|STARTED|Overall Study||6
7946351|NCT00467597|19557263|P1|STARTED|Overall Study||26
7946352|NCT00467584|19557276|P3|NOT COMPLETED|Overall Study||1
7946353|NCT00467584|19557277|P2|NOT COMPLETED|Overall Study||5
7946354|NCT00467584|19557278|P1|NOT COMPLETED|Overall Study||4
7946355|NCT00467584|19557276|P3|COMPLETED|Overall Study||20
7946356|NCT00467584|19557277|P2|COMPLETED|Overall Study||15
7946357|NCT00467584|19557278|P1|COMPLETED|Overall Study||17
7946358|NCT00467584|19557276|P3|STARTED|Overall Study||21
7946359|NCT00467584|19557277|P2|STARTED|Overall Study||20
7946360|NCT00467584|19557278|P1|STARTED|Overall Study||21
7946361|NCT00467558|19557288|P2|NOT COMPLETED|Overall Study||0
7946362|NCT00467558|19557289|P1|NOT COMPLETED|Overall Study||2
7946363|NCT00467558|19557288|P2|COMPLETED|Overall Study||3
7946364|NCT00467558|19557289|P1|COMPLETED|Overall Study||2
7946365|NCT00467558|19557288|P2|STARTED|Overall Study||3
7946366|NCT00467558|19557289|P1|STARTED|Overall Study||4
7946367|NCT00467519|19557299|P2|NOT COMPLETED|Overall Study||23
7946368|NCT00467519|19557300|P1|NOT COMPLETED|Overall Study||14
7946369|NCT00467519|19557299|P2|COMPLETED|Overall Study||488
7946370|NCT00467519|19557300|P1|COMPLETED|Overall Study||517
7946371|NCT00467519|19557299|P2|STARTED|Overall Study||511
7946372|NCT00467519|19557300|P1|STARTED|Overall Study||531
7946373|NCT00467389|19557316|P2|NOT COMPLETED|Overall Study||0
7946374|NCT00467389|19557317|P1|NOT COMPLETED|Overall Study||0
7946375|NCT00467389|19557316|P2|COMPLETED|Overall Study||6
7946376|NCT00467389|19557317|P1|COMPLETED|Overall Study||6
7946377|NCT00467389|19557316|P2|STARTED|Overall Study||6
7946378|NCT00467389|19557317|P1|STARTED|Overall Study||6
7946379|NCT00467363|19557329|P2|NOT COMPLETED|Overall Study||70
7946380|NCT00467363|19557330|P1|NOT COMPLETED|Overall Study||80
7946381|NCT00467363|19557329|P2|COMPLETED|Overall Study||543
7946382|NCT00467363|19557330|P1|COMPLETED|Overall Study||535
7946383|NCT00467363|19557329|P2|STARTED|Overall Study||613
7946384|NCT00467363|19557330|P1|STARTED|Overall Study||615
7946385|NCT00467350|19557366|P2|NOT COMPLETED|Overall Study||0
7946386|NCT00467350|19557367|P1|NOT COMPLETED|Overall Study||1
7946387|NCT00467350|19557366|P2|COMPLETED|Overall Study||39
7946388|NCT00467350|19557367|P1|COMPLETED|Overall Study||40
7946389|NCT00467350|19557366|P2|STARTED|Overall Study||39
7946390|NCT00467350|19557367|P1|STARTED|Overall Study||41
7946391|NCT00467298|19557375|P2|NOT COMPLETED|Overall Study||6
7946392|NCT00467298|19557376|P1|NOT COMPLETED|Overall Study||4
7946393|NCT00467298|19557375|P2|COMPLETED|Overall Study||38
7946394|NCT00467298|19557376|P1|COMPLETED|Overall Study||42
7946395|NCT00467298|19557375|P2|STARTED|Overall Study||44
7946396|NCT00467298|19557376|P1|STARTED|Overall Study||46
7946397|NCT00467285|19557386|P2|NOT COMPLETED|Overall Study||4
7946398|NCT00467285|19557387|P1|NOT COMPLETED|Overall Study||4
7946399|NCT00467285|19557386|P2|COMPLETED|Overall Study||60
7946400|NCT00467285|19557387|P1|COMPLETED|Overall Study||28
7946401|NCT00467285|19557386|P2|STARTED|Overall Study||64
7946402|NCT00467285|19557387|P1|STARTED|Overall Study||32
7946403|NCT00467259|19557407|P2|NOT COMPLETED|Overall Study||242
7946404|NCT00467259|19557408|P1|NOT COMPLETED|Overall Study||75
7946405|NCT00467259|19557407|P2|COMPLETED|Overall Study||778
7946406|NCT00467259|19557408|P1|COMPLETED|Overall Study||176
7946407|NCT00467259|19557407|P2|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019
7946408|NCT00467259|19557408|P1|ITT Population|Overall Study||251
7946409|NCT00467259|19557407|P2|STARTED|Overall Study||1020
7946410|NCT00467259|19557408|P1|STARTED|Overall Study||251
7946411|NCT00467077|19557418|P1|NOT COMPLETED|Overall Study||0
7946412|NCT00467077|19557418|P1|COMPLETED|Overall Study||21
7946413|NCT00467077|19557418|P1|STARTED|Overall Study||21
7946414|NCT00467051|19557425|P1|NOT COMPLETED|Overall Study||2
7946415|NCT00467051|19557425|P1|COMPLETED|Overall Study||18
7946416|NCT00467051|19557425|P1|STARTED|Overall Study||20
7946417|NCT00467038|19557432|P2|NOT COMPLETED|Overall Study||0
7946418|NCT00467038|19557433|P1|NOT COMPLETED|Overall Study||0
7946419|NCT00467038|19557432|P2|COMPLETED|Overall Study||11
7946420|NCT00467038|19557433|P1|COMPLETED|Overall Study||11
7946421|NCT00467038|19557432|P2|STARTED|Overall Study||11
7946422|NCT00467038|19557433|P1|STARTED|Overall Study||11
7946423|NCT00466960|19557441|P1|NOT COMPLETED|Overall Study||0
7946424|NCT00466960|19557441|P1|COMPLETED|Overall Study||21
7946425|NCT00466960|19557441|P1|STARTED|Overall Study||21
7946426|NCT00466947|19557452|P2|NOT COMPLETED|Study End Analysis Period||2534
7946427|NCT00466947|19557453|P1|NOT COMPLETED|Study End Analysis Period||2496
7946428|NCT00466947|19557452|P2|COMPLETED|Study End Analysis Period||9265
7946429|NCT00466947|19557453|P1|COMPLETED|Study End Analysis Period||9302
7946430|NCT00466947|19557452|P2|STARTED|Study End Analysis Period||11799
7946431|NCT00466947|19557453|P1|STARTED|Study End Analysis Period||11798
7946432|NCT00466947|19557452|P2|NOT COMPLETED|Primary Outcome Analysis Period||11863
7946433|NCT00466947|19557453|P1|NOT COMPLETED|Primary Outcome Analysis Period||11875
7946434|NCT00466947|19557452|P2|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
7946435|NCT00466947|19557453|P1|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
7946436|NCT00466947|19557452|P2|Ongoing|Primary Outcome Analysis Period||11863
7946437|NCT00466947|19557453|P1|Ongoing|Primary Outcome Analysis Period||11875
7946438|NCT00466947|19557452|P2|STARTED|Primary Outcome Analysis Period||11863
7946439|NCT00466947|19557453|P1|STARTED|Primary Outcome Analysis Period||11875
7946440|NCT00466921|19557575|P1|NOT COMPLETED|Follow up for a Minimum of 1 Year||6
7946441|NCT00466921|19557575|P1|COMPLETED|Follow up for a Minimum of 1 Year||27
7946442|NCT00466921|19557575|P1|STARTED|Follow up for a Minimum of 1 Year||33
7946443|NCT00466921|19557575|P1|NOT COMPLETED|Continued Treatment||0
7946444|NCT00466921|19557575|P1|COMPLETED|Continued Treatment||21
7946445|NCT00466921|19557575|P1|STARTED|Continued Treatment||21
7946446|NCT00466921|19557575|P1|NOT COMPLETED|Completed 4 Cycles/Reached 1st Response||5
7946447|NCT00466921|19557575|P1|COMPLETED|Completed 4 Cycles/Reached 1st Response||21
7946448|NCT00466921|19557575|P1|Completed 4 Cycles/1st Response|Completed 4 Cycles/Reached 1st Response||21
7946449|NCT00466921|19557575|P1|STARTED|Completed 4 Cycles/Reached 1st Response||26
7946450|NCT00466921|19557575|P1|NOT COMPLETED|First 3 Cycles of Treatment||7
7946451|NCT00466921|19557575|P1|COMPLETED|First 3 Cycles of Treatment||26
7946452|NCT00466921|19557575|P1|Completed 3 Cycles|First 3 Cycles of Treatment||26
7946453|NCT00466921|19557575|P1|Started Cycle 2|First 3 Cycles of Treatment||31
7946454|NCT00466921|19557575|P1|Completed 1 Cycle|First 3 Cycles of Treatment||32
7946455|NCT00466921|19557575|P1|STARTED|First 3 Cycles of Treatment|One patient completed only a few days of treatment|33
7946456|NCT00466817|19557584|P2|NOT COMPLETED|Overall Study||4
7946457|NCT00466817|19557585|P1|NOT COMPLETED|Overall Study||5
7946458|NCT00466817|19557584|P2|COMPLETED|Overall Study||43
7946459|NCT00466817|19557585|P1|COMPLETED|Overall Study||44
7946460|NCT00466817|19557584|P2|STARTED|Overall Study||47
7946461|NCT00466817|19557585|P1|STARTED|Overall Study||49
7946462|NCT00466752|19557640|P2|NOT COMPLETED|Overall Study||0
7946463|NCT00466752|19557641|P1|NOT COMPLETED|Overall Study||0
7946464|NCT00466752|19557640|P2|COMPLETED|Overall Study||0
7946465|NCT00466752|19557641|P1|COMPLETED|Overall Study||5
7946466|NCT00466752|19557640|P2|STARTED|Overall Study||0
7946467|NCT00466752|19557641|P1|STARTED|Overall Study||5
7946468|NCT00466726|19557651|P1|NOT COMPLETED|Overall Study||14
7946469|NCT00466726|19557651|P1|COMPLETED|Overall Study||43
7946470|NCT00466726|19557651|P1|STARTED|Overall Study||57
7946471|NCT00466687|19557657|P1|NOT COMPLETED|Overall Study||34
7946472|NCT00466687|19557657|P1|COMPLETED|Overall Study||0
7946473|NCT00466687|19557657|P1|STARTED|Overall Study||34
7946474|NCT00466661|19557666|P2|NOT COMPLETED|Overall Study||6
7946475|NCT00466661|19557667|P1|NOT COMPLETED|Overall Study||4
7946476|NCT00466661|19557666|P2|COMPLETED|Overall Study||11
7946477|NCT00466661|19557667|P1|COMPLETED|Overall Study||12
7946478|NCT00466661|19557666|P2|At Least 1 Postrandomization Visit|Overall Study||16
7946479|NCT00466661|19557667|P1|At Least 1 Postrandomization Visit|Overall Study||14
7946480|NCT00466661|19557666|P2|STARTED|Overall Study||17
7946481|NCT00466661|19557667|P1|STARTED|Overall Study||16
7946482|NCT00466505|19557689|P1|NOT COMPLETED|Overall Study||17
7946483|NCT00466505|19557689|P1|COMPLETED|Overall Study||0
7946484|NCT00466505|19557689|P1|STARTED|Overall Study||17
7946485|NCT00466440|19557704|P3|NOT COMPLETED|Overall Study||12
7946486|NCT00466440|19557705|P2|NOT COMPLETED|Overall Study||12
7946487|NCT00466440|19557706|P1|NOT COMPLETED|Overall Study||14
7946488|NCT00466440|19557704|P3|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|34
7946489|NCT00466440|19557705|P2|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|36
7946490|NCT00466440|19557706|P1|COMPLETED|Overall Study||0
7946491|NCT00466440|19557704|P3|Received at Least One Dose of Study Drug|Overall Study||41
7946492|NCT00466440|19557705|P2|Received at Least One Dose of Study Drug|Overall Study||47
7946493|NCT00466440|19557706|P1|Received at Least One Dose of Study Drug|Overall Study||14
7946494|NCT00466440|19557704|P3|STARTED|Overall Study||46
7946495|NCT00466440|19557705|P2|STARTED|Overall Study||48
7946496|NCT00466440|19557706|P1|STARTED|Overall Study||14
7946497|NCT00466323|19557745|P2|NOT COMPLETED|Overall Study||23
7946498|NCT00466323|19557746|P1|NOT COMPLETED|Overall Study||28
7946499|NCT00466323|19557745|P2|COMPLETED|Overall Study||92
7946500|NCT00466323|19557746|P1|COMPLETED|Overall Study||89
7946501|NCT00466323|19557745|P2|STARTED|Overall Study||115
7946502|NCT00466323|19557746|P1|STARTED|Overall Study||117
7946503|NCT00466310|19557761|P3|NOT COMPLETED|Overall Study||0
7946504|NCT00466310|19557762|P2|NOT COMPLETED|Overall Study||0
7946505|NCT00466310|19557763|P1|NOT COMPLETED|Overall Study||0
7946506|NCT00466310|19557761|P3|COMPLETED|Overall Study||31
7946507|NCT00466310|19557762|P2|COMPLETED|Overall Study||20
7946508|NCT00466310|19557763|P1|COMPLETED|Overall Study||20
7946509|NCT00466310|19557761|P3|STARTED|Overall Study||31
7946510|NCT00466310|19557762|P2|STARTED|Overall Study||20
7946511|NCT00466310|19557763|P1|STARTED|Overall Study||20
7946512|NCT00466206|19557771|P1|NOT COMPLETED|Overall Study||0
7946513|NCT00466206|19557771|P1|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10
7946514|NCT00466206|19557771|P1|STARTED|Overall Study||10
7946515|NCT00466193|19557781|P2|NOT COMPLETED|Overall Study||8
7946516|NCT00466193|19557782|P1|NOT COMPLETED|Overall Study||12
7946517|NCT00466193|19557781|P2|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137
7946518|NCT00466193|19557782|P1|COMPLETED|Overall Study||138
7946519|NCT00466193|19557781|P2|STARTED|Overall Study||145
7946520|NCT00466193|19557782|P1|STARTED|Overall Study||150
7946521|NCT00466167|19557809|P3|NOT COMPLETED|Overall Study||21
7946522|NCT00466167|19557810|P2|NOT COMPLETED|Overall Study||12
7946523|NCT00466167|19557811|P1|NOT COMPLETED|Overall Study||20
7946524|NCT00466167|19557809|P3|COMPLETED|Overall Study||157
7946525|NCT00466167|19557810|P2|COMPLETED|Overall Study||163
7946526|NCT00466167|19557811|P1|COMPLETED|Overall Study||145
7946527|NCT00466167|19557809|P3|STARTED|Overall Study||178
7946528|NCT00466167|19557810|P2|STARTED|Overall Study||175
7946529|NCT00466167|19557811|P1|STARTED|Overall Study||165
7946530|NCT00465998|19557867|P1|NOT COMPLETED|Overall Study||0
7946531|NCT00465998|19557867|P1|COMPLETED|Overall Study||275
7946532|NCT00465998|19557867|P1|STARTED|Overall Study||275
7946533|NCT00465985|19557872|P2|NOT COMPLETED|Part III - Open-label Treatment Period||0
7946534|NCT00465985|19557873|P1|NOT COMPLETED|Part III - Open-label Treatment Period||2
7946535|NCT00465985|19557872|P2|COMPLETED|Part III - Open-label Treatment Period||0
7946536|NCT00465985|19557873|P1|COMPLETED|Part III - Open-label Treatment Period||29
7946537|NCT00465985|19557872|P2|STARTED|Part III - Open-label Treatment Period||0
7946538|NCT00465985|19557873|P1|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31
7946539|NCT00465985|19557872|P2|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12
7946540|NCT00465985|19557873|P1|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0
7946541|NCT00465985|19557872|P2|COMPLETED|Part II - 1:1 ACZ885:Placebo||4
7946542|NCT00465985|19557873|P1|COMPLETED|Part II - 1:1 ACZ885:Placebo||15
7946543|NCT00465985|19557872|P2|STARTED|Part II - 1:1 ACZ885:Placebo||16
7946544|NCT00465985|19557873|P1|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15
7946545|NCT00465985|19557872|P2|NOT COMPLETED|Part I - Open-label Treatment Period||0
7946546|NCT00465985|19557873|P1|NOT COMPLETED|Part I - Open-label Treatment Period||4
7946547|NCT00465985|19557872|P2|COMPLETED|Part I - Open-label Treatment Period||0
7946548|NCT00465985|19557873|P1|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31
7946549|NCT00465985|19557872|P2|STARTED|Part I - Open-label Treatment Period||0
7946550|NCT00465985|19557873|P1|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35
7946551|NCT00465972|19557896|P2|NOT COMPLETED|Overall Study||1
7946552|NCT00465972|19557897|P1|NOT COMPLETED|Overall Study||2
7946553|NCT00465972|19557896|P2|COMPLETED|Overall Study||23
7946554|NCT00465972|19557897|P1|COMPLETED|Overall Study||18
7946555|NCT00465972|19557896|P2|STARTED|Overall Study||24
7946556|NCT00465972|19557897|P1|STARTED|Overall Study||20
7946557|NCT00465894|19557907|P2|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
7946558|NCT00465894|19557908|P1|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
7946559|NCT00465894|19557907|P2|COMPLETED|Treatment From 24 Weeks to 52 Weeks||14
7946560|NCT00465894|19557908|P1|COMPLETED|Treatment From 24 Weeks to 52 Weeks||11
7946561|NCT00465894|19557907|P2|STARTED|Treatment From 24 Weeks to 52 Weeks||14
7946562|NCT00465894|19557908|P1|STARTED|Treatment From 24 Weeks to 52 Weeks|We included data only from participants that had complete data sets.|11
7946563|NCT00465894|19557907|P2|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
7946564|NCT00465894|19557908|P1|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
7946565|NCT00465894|19557907|P2|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
7946566|NCT00465894|19557908|P1|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
7946567|NCT00465894|19557907|P2|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
7946568|NCT00465894|19557908|P1|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
7946569|NCT00465894|19557907|P2|NOT COMPLETED|Treatment For 12 Weeks||3
7946570|NCT00465894|19557908|P1|NOT COMPLETED|Treatment For 12 Weeks||5
7946571|NCT00465894|19557907|P2|COMPLETED|Treatment For 12 Weeks||25
7946572|NCT00465894|19557908|P1|COMPLETED|Treatment For 12 Weeks||25
7946573|NCT00465894|19557907|P2|STARTED|Treatment For 12 Weeks||28
7946574|NCT00465894|19557908|P1|STARTED|Treatment For 12 Weeks||30
7946575|NCT00465816|19557941|P3|NOT COMPLETED|Overall Study||2
7946576|NCT00465816|19557942|P2|NOT COMPLETED|Overall Study||0
7946577|NCT00465816|19557943|P1|NOT COMPLETED|Overall Study||0
7946578|NCT00465816|19557941|P3|COMPLETED|Overall Study||120
7946579|NCT00465816|19557942|P2|COMPLETED|Overall Study||122
7946580|NCT00465816|19557943|P1|COMPLETED|Overall Study||367
7946581|NCT00465816|19557941|P3|STARTED|Overall Study||122
7946582|NCT00465816|19557942|P2|STARTED|Overall Study||122
7946583|NCT00465816|19557943|P1|STARTED|Overall Study||367
7946584|NCT00465738|19558006|P2|NOT COMPLETED|Overall Study||6
7946585|NCT00465738|19558007|P1|NOT COMPLETED|Overall Study||6
7946586|NCT00465738|19558006|P2|COMPLETED|Overall Study||89
7946587|NCT00465738|19558007|P1|COMPLETED|Overall Study||91
7946588|NCT00465738|19558006|P2|STARTED|Overall Study||95
7946589|NCT00465738|19558007|P1|STARTED|Overall Study||97
7946590|NCT00465647|19558101|P4|NOT COMPLETED|Overall Study||13
7946591|NCT00465647|19558102|P3|NOT COMPLETED|Overall Study||11
7946592|NCT00465647|19558103|P2|NOT COMPLETED|Overall Study||8
7946593|NCT00465647|19558104|P1|NOT COMPLETED|Overall Study||13
7946594|NCT00465647|19558101|P4|COMPLETED|Overall Study||12
7946595|NCT00465647|19558102|P3|COMPLETED|Overall Study||18
7946596|NCT00465647|19558103|P2|COMPLETED|Overall Study||15
7946597|NCT00465647|19558104|P1|COMPLETED|Overall Study||26
7946598|NCT00465647|19558101|P4|STARTED|Overall Study||25
7946599|NCT00465647|19558102|P3|STARTED|Overall Study||29
7946600|NCT00465647|19558103|P2|STARTED|Overall Study||23
7946601|NCT00465647|19558104|P1|STARTED|Overall Study||39
7946602|NCT00465595|19558129|P2|NOT COMPLETED|Overall Study||5
7946603|NCT00465595|19558130|P1|NOT COMPLETED|Overall Study||5
7946604|NCT00465595|19558129|P2|COMPLETED|Overall Study||24
7946605|NCT00465595|19558130|P1|COMPLETED|Overall Study||22
7946606|NCT00465595|19558129|P2|STARTED|Overall Study||29
7946607|NCT00465595|19558130|P1|STARTED|Overall Study||27
7946608|NCT00465569|19558152|P2|NOT COMPLETED|Overall Study||0
7946609|NCT00465569|19558153|P1|NOT COMPLETED|Overall Study||1
7946610|NCT00465569|19558152|P2|COMPLETED|Overall Study||7
7946611|NCT00465569|19558153|P1|COMPLETED|Overall Study||12
7946612|NCT00465569|19558152|P2|STARTED|Overall Study||7
7946613|NCT00465569|19558153|P1|STARTED|Overall Study||13
7946614|NCT00465530|19558165|P2|NOT COMPLETED|Overall Study||4
7946615|NCT00465530|19558166|P1|NOT COMPLETED|Overall Study||2
7946616|NCT00465530|19558165|P2|COMPLETED|Overall Study||15
7946617|NCT00465530|19558166|P1|COMPLETED|Overall Study||19
7946618|NCT00465530|19558165|P2|STARTED|Overall Study||19
7946619|NCT00465530|19558166|P1|STARTED|Overall Study||21
7946620|NCT00465361|19558176|P1|NOT COMPLETED|Post-Intervention Assessment||0
7946621|NCT00465361|19558176|P1|COMPLETED|Post-Intervention Assessment||3
7946622|NCT00465361|19558176|P1|STARTED|Post-Intervention Assessment||3
7946623|NCT00465361|19558176|P1|NOT COMPLETED|Baseline Assessment||4
7946624|NCT00465361|19558176|P1|COMPLETED|Baseline Assessment||3
7946625|NCT00465361|19558176|P1|STARTED|Baseline Assessment||7
7946626|NCT00465270|19558182|P2|NOT COMPLETED|Overall Study||160
7946627|NCT00465270|19558183|P1|NOT COMPLETED|Overall Study||104
7946628|NCT00465270|19558182|P2|COMPLETED|Overall Study||321
7946629|NCT00465270|19558183|P1|COMPLETED|Overall Study||395
7946630|NCT00465270|19558182|P2|STARTED|Overall Study||481
7946631|NCT00465270|19558183|P1|STARTED|Overall Study||499
7946632|NCT00465179|19558192|P1|NOT COMPLETED|Overall Study||53
7946633|NCT00465179|19558192|P1|COMPLETED|Overall Study||4
7946634|NCT00465179|19558192|P1|STARTED|Overall Study||57
7946635|NCT00465101|19558198|P1|NOT COMPLETED|Overall Study||59
7946636|NCT00465101|19558198|P1|COMPLETED|Overall Study||91
7946637|NCT00465101|19558198|P1|STARTED|Overall Study||150
7946638|NCT00465088|19558233|P2|NOT COMPLETED|Overall Study||9
7946639|NCT00465088|19558234|P1|NOT COMPLETED|Overall Study||32
7946640|NCT00465088|19558233|P2|COMPLETED|Overall Study||70
7946641|NCT00465088|19558234|P1|COMPLETED|Overall Study||82
7946642|NCT00465088|19558233|P2|STARTED|Overall Study||79
7946643|NCT00465088|19558234|P1|STARTED|Overall Study|For both arms, started means treated.|114
7946644|NCT00464945|19558268|P2|NOT COMPLETED|Toddler Dose||1
7946645|NCT00464945|19558269|P1|NOT COMPLETED|Toddler Dose||0
7946646|NCT00464945|19558268|P2|COMPLETED|Toddler Dose||130
7946647|NCT00464945|19558269|P1|COMPLETED|Toddler Dose||131
7946648|NCT00464945|19558268|P2|STARTED|Toddler Dose||131
7946649|NCT00464945|19558269|P1|STARTED|Toddler Dose||131
7946650|NCT00464945|19558268|P2|NOT COMPLETED|After Infant Series||2
7946651|NCT00464945|19558269|P1|NOT COMPLETED|After Infant Series||0
7946652|NCT00464945|19558268|P2|COMPLETED|After Infant Series||131
7946653|NCT00464945|19558269|P1|COMPLETED|After Infant Series||131
7946654|NCT00464945|19558268|P2|STARTED|After Infant Series||133
7946655|NCT00464945|19558269|P1|STARTED|After Infant Series||131
7946656|NCT00464945|19558268|P2|NOT COMPLETED|Infant Series||1
7946657|NCT00464945|19558269|P1|NOT COMPLETED|Infant Series||4
7946658|NCT00464945|19558268|P2|COMPLETED|Infant Series||133
7946659|NCT00464945|19558269|P1|COMPLETED|Infant Series||131
7946660|NCT00464945|19558268|P2|Vaccinated Dose 3|Infant Series||133
7946661|NCT00464945|19558269|P1|Vaccinated Dose 3|Infant Series||132
7946662|NCT00464945|19558268|P2|Vaccinated Dose 2|Infant Series||133
7946663|NCT00464945|19558269|P1|Vaccinated Dose 2|Infant Series||132
7946664|NCT00464945|19558268|P2|Vaccinated Dose 1|Infant Series||134
7946665|NCT00464945|19558269|P1|Vaccinated Dose 1|Infant Series||134
7946666|NCT00464945|19558268|P2|STARTED|Infant Series||134
7946667|NCT00464945|19558269|P1|STARTED|Infant Series||135
7946668|NCT00464815|19558299|P2|NOT COMPLETED|Overall Study||3
7946669|NCT00464815|19558300|P1|NOT COMPLETED|Overall Study||6
7946670|NCT00464815|19558299|P2|COMPLETED|Overall Study||254
7946671|NCT00464815|19558300|P1|COMPLETED|Overall Study||762
7946672|NCT00464815|19558299|P2|STARTED|Overall Study||257
7946673|NCT00464815|19558300|P1|STARTED|Overall Study||768
7946674|NCT00464737|19558333|P3|NOT COMPLETED|Overall Study||55
7946675|NCT00464737|19558334|P2|NOT COMPLETED|Overall Study||32
7946676|NCT00464737|19558335|P1|NOT COMPLETED|Overall Study||32
7946677|NCT00464737|19558333|P3|COMPLETED|Overall Study||19
7946678|NCT00464737|19558334|P2|COMPLETED|Overall Study||42
7946679|NCT00464737|19558335|P1|COMPLETED|Overall Study||50
7946680|NCT00464737|19558333|P3|STARTED|Overall Study||74
7946681|NCT00464737|19558334|P2|STARTED|Overall Study||74
7946682|NCT00464737|19558335|P1|STARTED|Overall Study||82
7946683|NCT00464711|19558382|P1|NOT COMPLETED|Overall Study||15
7946684|NCT00464711|19558382|P1|COMPLETED|Overall Study||25
7946685|NCT00464711|19558382|P1|STARTED|Overall Study||40
7946686|NCT00464698|19558386|P1|NOT COMPLETED|Period 3: 120mg||2
7946687|NCT00464698|19558386|P1|COMPLETED|Period 3: 120mg||12
7946688|NCT00464698|19558386|P1|STARTED|Period 3: 120mg||14
7946689|NCT00464698|19558386|P1|NOT COMPLETED|Period 2: 60 mg||0
7946690|NCT00464698|19558386|P1|COMPLETED|Period 2: 60 mg||17
7946691|NCT00464698|19558386|P1|STARTED|Period 2: 60 mg||17
7946692|NCT00464698|19558386|P1|NOT COMPLETED|Period 1: 30 mg||3
7946693|NCT00464698|19558386|P1|COMPLETED|Period 1: 30 mg||17
7946694|NCT00464698|19558386|P1|STARTED|Period 1: 30 mg||20
7946695|NCT00464685|19558398|P2|NOT COMPLETED|Overall Study||33
7946696|NCT00464685|19558399|P1|NOT COMPLETED|Overall Study||23
7946697|NCT00464685|19558398|P2|COMPLETED|Overall Study||94
7946698|NCT00464685|19558399|P1|COMPLETED|Overall Study||103
7946699|NCT00464685|19558398|P2|STARTED|Overall Study||127
7946700|NCT00464685|19558399|P1|STARTED|Overall Study||126
7946701|NCT00464672|19558415|P6|NOT COMPLETED|Overall Study||4
7946702|NCT00464672|19558416|P5|NOT COMPLETED|Overall Study||10
7946703|NCT00464672|19558417|P4|NOT COMPLETED|Overall Study||1
7946704|NCT00464672|19558418|P3|NOT COMPLETED|Overall Study||0
7946705|NCT00464672|19558419|P2|NOT COMPLETED|Overall Study||10
7946706|NCT00464672|19558420|P1|NOT COMPLETED|Overall Study||25
7946707|NCT00464672|19558415|P6|COMPLETED|Overall Study||195
7946708|NCT00464672|19558416|P5|COMPLETED|Overall Study||392
7946709|NCT00464672|19558417|P4|COMPLETED|Overall Study||199
7946710|NCT00464672|19558418|P3|COMPLETED|Overall Study||400
7946711|NCT00464672|19558419|P2|COMPLETED|Overall Study||222
7946712|NCT00464672|19558420|P1|COMPLETED|Overall Study||435
7946713|NCT00464672|19558415|P6|STARTED|Overall Study||199
7946714|NCT00464672|19558416|P5|STARTED|Overall Study||402
7946715|NCT00464672|19558417|P4|STARTED|Overall Study||200
7946716|NCT00464672|19558418|P3|STARTED|Overall Study||400
7946717|NCT00464672|19558419|P2|STARTED|Overall Study||232
7946718|NCT00464672|19558420|P1|STARTED|Overall Study||460
7946719|NCT00464646|19558492|P2|NOT COMPLETED|Overall Study||0
7946720|NCT00464646|19558493|P1|NOT COMPLETED|Overall Study||0
7946721|NCT00464646|19558492|P2|COMPLETED|Overall Study||29
7946722|NCT00464646|19558493|P1|COMPLETED|Overall Study||76
7946723|NCT00464646|19558492|P2|STARTED|Overall Study||29
7946724|NCT00464646|19558493|P1|STARTED|Overall Study||76
7946725|NCT00464620|19558499|P3|NOT COMPLETED|Overall Study||7
7946726|NCT00464620|19558500|P2|NOT COMPLETED|Overall Study||2
7946727|NCT00464620|19558501|P1|NOT COMPLETED|Overall Study||2
7946728|NCT00464620|19558499|P3|COMPLETED|Overall Study||109
7946729|NCT00464620|19558500|P2|COMPLETED|Overall Study||198
7946730|NCT00464620|19558501|P1|COMPLETED|Overall Study|48 patients were evaluable.|48
7946731|NCT00464620|19558499|P3|STARTED|Overall Study||116
7946732|NCT00464620|19558500|P2|STARTED|Overall Study||200
7946733|NCT00464620|19558501|P1|STARTED|Overall Study||50
7946734|NCT00464568|19558528|P1|NOT COMPLETED|Overall Study||2
7946735|NCT00464568|19558528|P1|COMPLETED|Overall Study||30
7946736|NCT00464568|19558528|P1|STARTED|Overall Study||32
7946737|NCT00464542|19558601|P1|NOT COMPLETED|Post-treatment||0
7946738|NCT00464542|19558601|P1|COMPLETED|Post-treatment||10
7946739|NCT00464542|19558601|P1|STARTED|Post-treatment||10
7946740|NCT00464542|19558601|P1|NOT COMPLETED|Pre-treatment||2
7946741|NCT00464542|19558601|P1|COMPLETED|Pre-treatment||10
7946742|NCT00464542|19558601|P1|STARTED|Pre-treatment||12
7946743|NCT00464490|19558608|P2|NOT COMPLETED|Overall Study||11
7946744|NCT00464490|19558609|P1|NOT COMPLETED|Overall Study||11
7946745|NCT00464490|19558608|P2|COMPLETED|Overall Study||10
7946746|NCT00464490|19558609|P1|COMPLETED|Overall Study||10
7946747|NCT00464490|19558608|P2|STARTED|Overall Study||21
7946748|NCT00464490|19558609|P1|STARTED|Overall Study||21
7946749|NCT00464464|19558617|P2|NOT COMPLETED|Overall Study||3
7946750|NCT00464464|19558618|P1|NOT COMPLETED|Overall Study||5
7946751|NCT00464464|19558617|P2|COMPLETED|Overall Study||36
7946752|NCT00464464|19558618|P1|COMPLETED|Overall Study||36
7946753|NCT00464464|19558617|P2|STARTED|Overall Study||39
7946754|NCT00464464|19558618|P1|STARTED|Overall Study||41
7946755|NCT00464438|19558632|P2|NOT COMPLETED|Overall Study||6
7946756|NCT00464438|19558633|P1|NOT COMPLETED|Overall Study||2
7946757|NCT00464438|19558632|P2|COMPLETED|Overall Study||80
7946758|NCT00464438|19558633|P1|COMPLETED|Overall Study||83
7946759|NCT00464438|19558632|P2|STARTED|Overall Study||86
7946760|NCT00464438|19558633|P1|STARTED|Overall Study||85
7946761|NCT00464334|19558656|P11|NOT COMPLETED|Overall Study||4
7946762|NCT00464334|19558657|P10|NOT COMPLETED|Overall Study||1
7946763|NCT00464334|19558658|P9|NOT COMPLETED|Overall Study||6
7946764|NCT00464334|19558659|P8|NOT COMPLETED|Overall Study||1
7946765|NCT00464334|19558660|P7|NOT COMPLETED|Overall Study||3
7946766|NCT00464334|19558661|P6|NOT COMPLETED|Overall Study||4
7946767|NCT00464334|19558662|P5|NOT COMPLETED|Overall Study||4
7946768|NCT00464334|19558663|P4|NOT COMPLETED|Overall Study||4
7946769|NCT00464334|19558664|P3|NOT COMPLETED|Overall Study||5
7946770|NCT00464334|19558665|P2|NOT COMPLETED|Overall Study||8
7946771|NCT00464334|19558666|P1|NOT COMPLETED|Overall Study||1
7946772|NCT00464334|19558656|P11|COMPLETED|Overall Study||4
7946773|NCT00464334|19558657|P10|COMPLETED|Overall Study||4
7946774|NCT00464334|19558658|P9|COMPLETED|Overall Study||2
7946775|NCT00464334|19558659|P8|COMPLETED|Overall Study||7
7946776|NCT00464334|19558660|P7|COMPLETED|Overall Study||6
7946777|NCT00464334|19558661|P6|COMPLETED|Overall Study||3
7946778|NCT00464334|19558662|P5|COMPLETED|Overall Study||3
7946779|NCT00464334|19558663|P4|COMPLETED|Overall Study||4
7946780|NCT00464334|19558664|P3|COMPLETED|Overall Study||3
7946781|NCT00464334|19558665|P2|COMPLETED|Overall Study||5
7946782|NCT00464334|19558666|P1|COMPLETED|Overall Study||4
7946783|NCT00464334|19558656|P11|STARTED|Overall Study||8
7946784|NCT00464334|19558657|P10|STARTED|Overall Study||5
7946785|NCT00464334|19558658|P9|STARTED|Overall Study||8
7946786|NCT00464334|19558659|P8|STARTED|Overall Study||8
7946787|NCT00464334|19558660|P7|STARTED|Overall Study||9
7946788|NCT00464334|19558661|P6|STARTED|Overall Study||7
7946789|NCT00464334|19558662|P5|STARTED|Overall Study||7
7946790|NCT00464334|19558663|P4|STARTED|Overall Study||8
7946791|NCT00464334|19558664|P3|STARTED|Overall Study||8
7946792|NCT00464334|19558665|P2|STARTED|Overall Study||13
7946793|NCT00464334|19558666|P1|STARTED|Overall Study||5
7946794|NCT00464308|19558726|P3|NOT COMPLETED|Overall Study||59
7946795|NCT00464308|19558727|P2|NOT COMPLETED|Overall Study||63
7946796|NCT00464308|19558728|P1|NOT COMPLETED|Overall Study||69
7946797|NCT00464308|19558726|P3|COMPLETED|Overall Study||400
7946798|NCT00464308|19558727|P2|COMPLETED|Overall Study||406
7946799|NCT00464308|19558728|P1|COMPLETED|Overall Study||395
7946800|NCT00464308|19558726|P3|STARTED|Overall Study||459
7946801|NCT00464308|19558727|P2|STARTED|Overall Study||469
7946802|NCT00464308|19558728|P1|STARTED|Overall Study||464
7946803|NCT00464269|19558758|P4|NOT COMPLETED|Overall Study||9
7946804|NCT00464269|19558759|P3|NOT COMPLETED|Overall Study||7
7946805|NCT00464269|19558760|P2|NOT COMPLETED|Overall Study||17
7946806|NCT00464269|19558761|P1|NOT COMPLETED|Overall Study||6
7946807|NCT00464269|19558758|P4|COMPLETED|Overall Study||93
7946808|NCT00464269|19558759|P3|COMPLETED|Overall Study||93
7946809|NCT00464269|19558760|P2|COMPLETED|Overall Study||82
7946810|NCT00464269|19558761|P1|COMPLETED|Overall Study||93
7946811|NCT00464269|19558758|P4|STARTED|Overall Study||102
7946812|NCT00464269|19558759|P3|STARTED|Overall Study||100
7946813|NCT00464269|19558760|P2|STARTED|Overall Study||99
7946814|NCT00464269|19558761|P1|STARTED|Overall Study||99
7946815|NCT00464204|19558861|P2|NOT COMPLETED|Overall Study||32
7946816|NCT00464204|19558862|P1|NOT COMPLETED|Overall Study||49
7946817|NCT00464204|19558861|P2|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64
7946818|NCT00464204|19558862|P1|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51
7946819|NCT00464204|19558861|P2|Withdrawal Due to Discharge From ICU|Overall Study||11
7946820|NCT00464204|19558862|P1|Withdrawal Due to Discharge From ICU|Overall Study||18
7946821|NCT00464204|19558861|P2|Day 90 Follow-up Performed|Overall Study||74
7946822|NCT00464204|19558862|P1|Day 90 Follow-up Performed|Overall Study||69
7946823|NCT00464204|19558861|P2|Day 30 Follow-up Performed|Overall Study||83
7946824|NCT00464204|19558862|P1|Day 30 Follow-up Performed|Overall Study||89
7946825|NCT00464204|19558861|P2|Completed Treatment|Overall Study||83
7946826|NCT00464204|19558862|P1|Completed Treatment|Overall Study||81
7946827|NCT00464204|19558861|P2|STARTED|Overall Study||96
7946828|NCT00464204|19558862|P1|STARTED|Overall Study||100
7946829|NCT00464087|19558899|P3|NOT COMPLETED|Overall Study||29
7946830|NCT00464087|19558900|P2|NOT COMPLETED|Overall Study||0
7946831|NCT00464087|19558901|P1|NOT COMPLETED|Overall Study||0
7946832|NCT00464087|19558899|P3|COMPLETED|Overall Study||0
7946833|NCT00464087|19558900|P2|COMPLETED|Overall Study||51
7946834|NCT00464087|19558901|P1|COMPLETED|Overall Study||49
7946835|NCT00464087|19558899|P3|STARTED|Overall Study||29
7946836|NCT00464087|19558900|P2|STARTED|Overall Study||51
7946837|NCT00464087|19558901|P1|STARTED|Overall Study||49
7946838|NCT00463866|19558919|P2|NOT COMPLETED|Overall Study||340
7946839|NCT00463866|19558920|P1|NOT COMPLETED|Overall Study||309
7946840|NCT00463866|19558919|P2|COMPLETED|Overall Study||3705
7946841|NCT00463866|19558920|P1|COMPLETED|Overall Study||3699
7946842|NCT00463866|19558919|P2|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045
7946843|NCT00463866|19558920|P1|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008
7946844|NCT00463840|19558940|P1|NOT COMPLETED|Overall Study||12
7946845|NCT00463840|19558940|P1|COMPLETED|Overall Study||12
7946846|NCT00463840|19558940|P1|STARTED|Overall Study||24
7946847|NCT00463801|19558945|P1|NOT COMPLETED|Overall Study||13
7946848|NCT00463801|19558945|P1|COMPLETED|Overall Study||39
7946849|NCT00463801|19558945|P1|STARTED|Overall Study||52
7946850|NCT00463788|19558951|P2|NOT COMPLETED|Overall Study||54
7946851|NCT00463788|19558952|P1|NOT COMPLETED|Overall Study||109
7946852|NCT00463788|19558951|P2|COMPLETED|Overall Study||4
7946853|NCT00463788|19558952|P1|COMPLETED|Overall Study||6
7946854|NCT00463788|19558951|P2|Treated|Overall Study||57
7946855|NCT00463788|19558952|P1|Treated|Overall Study||114
7946856|NCT00463788|19558951|P2|STARTED|Overall Study||58
7946857|NCT00463788|19558952|P1|STARTED|Overall Study||115
7946858|NCT00463684|19558967|P1|NOT COMPLETED|Overall Study||4
7946859|NCT00463684|19558967|P1|COMPLETED|Overall Study||274
7946860|NCT00463684|19558967|P1|STARTED|Overall Study||278
7946861|NCT00463606|19558985|P3|NOT COMPLETED|Overall Study||20
7946862|NCT00463606|19558986|P2|NOT COMPLETED|Overall Study||34
7946863|NCT00463606|19558987|P1|NOT COMPLETED|Overall Study||41
7946864|NCT00463606|19558985|P3|COMPLETED|Overall Study||231
7946865|NCT00463606|19558986|P2|COMPLETED|Overall Study||220
7946866|NCT00463606|19558987|P1|COMPLETED|Overall Study||212
7946867|NCT00463606|19558985|P3|STARTED|Overall Study||251
7946868|NCT00463606|19558986|P2|STARTED|Overall Study||254
7946869|NCT00463606|19558987|P1|STARTED|Overall Study||253
7946870|NCT00463580|19559012|P2|NOT COMPLETED|Overall Study||2
7946871|NCT00463580|19559013|P1|NOT COMPLETED|Overall Study||3
7946872|NCT00463580|19559012|P2|COMPLETED|Overall Study||28
7946873|NCT00463580|19559013|P1|COMPLETED|Overall Study||27
7946874|NCT00463580|19559012|P2|STARTED|Overall Study||30
7946875|NCT00463580|19559013|P1|STARTED|Overall Study||30
7946876|NCT00463567|19559046|P7|NOT COMPLETED|Overall Study||11
7946877|NCT00463567|19559047|P6|NOT COMPLETED|Overall Study||21
7946878|NCT00463567|19559048|P5|NOT COMPLETED|Overall Study||23
7946879|NCT00463567|19559049|P4|NOT COMPLETED|Overall Study||131
7946880|NCT00463567|19559050|P3|NOT COMPLETED|Overall Study||89
7946881|NCT00463567|19559051|P2|NOT COMPLETED|Overall Study||77
7946882|NCT00463567|19559052|P1|NOT COMPLETED|Overall Study||95
7946883|NCT00463567|19559046|P7|COMPLETED|Overall Study||112
7946884|NCT00463567|19559047|P6|COMPLETED|Overall Study||102
7946885|NCT00463567|19559048|P5|COMPLETED|Overall Study||107
7946886|NCT00463567|19559049|P4|COMPLETED|Overall Study||294
7946887|NCT00463567|19559050|P3|COMPLETED|Overall Study||331
7946888|NCT00463567|19559051|P2|COMPLETED|Overall Study||341
7946889|NCT00463567|19559052|P1|COMPLETED|Overall Study||325
7946890|NCT00463567|19559046|P7|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
7946891|NCT00463567|19559047|P6|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
7946892|NCT00463567|19559048|P5|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127
7946893|NCT00463567|19559049|P4|Safety Population: Received Study Drug|Overall Study||418
7946894|NCT00463567|19559050|P3|Safety Population: Received Study Drug|Overall Study||415
7946895|NCT00463567|19559051|P2|Safety Population: Received Study Drug|Overall Study||416
7946896|NCT00463567|19559052|P1|Safety Population: Received Study Drug|Overall Study||416
7946897|NCT00463567|19559046|P7|STARTED|Overall Study||123
7946898|NCT00463567|19559047|P6|STARTED|Overall Study||123
7946899|NCT00463567|19559048|P5|STARTED|Overall Study||130
7946900|NCT00463567|19559049|P4|STARTED|Overall Study||425
7946901|NCT00463567|19559050|P3|STARTED|Overall Study||420
7946902|NCT00463567|19559051|P2|STARTED|Overall Study||418
7946903|NCT00463567|19559052|P1|STARTED|Overall Study|Randomized Participants|420
7946904|NCT00463476|19559085|P2|NOT COMPLETED|Overall Study||3
7946905|NCT00463476|19559086|P1|NOT COMPLETED|Overall Study||2
7946906|NCT00463476|19559085|P2|COMPLETED|Overall Study||151
7946907|NCT00463476|19559086|P1|COMPLETED|Overall Study||149
7946908|NCT00463476|19559085|P2|STARTED|Overall Study||154
7946909|NCT00463476|19559086|P1|STARTED|Overall Study||151
7946910|NCT00463437|19559106|P4|NOT COMPLETED|Overall Study||7
7946911|NCT00463437|19559107|P3|NOT COMPLETED|Overall Study||6
7946912|NCT00463437|19559108|P2|NOT COMPLETED|Overall Study||11
7946913|NCT00463437|19559109|P1|NOT COMPLETED|Overall Study||4
7946914|NCT00463437|19559106|P4|COMPLETED|Overall Study||350
7946915|NCT00463437|19559107|P3|COMPLETED|Overall Study||352
7946916|NCT00463437|19559108|P2|COMPLETED|Overall Study||352
7946917|NCT00463437|19559109|P1|COMPLETED|Overall Study||355
7946918|NCT00463437|19559106|P4|STARTED|Overall Study||357
7946919|NCT00463437|19559107|P3|STARTED|Overall Study||358
7946920|NCT00463437|19559108|P2|STARTED|Overall Study||363
7946921|NCT00463437|19559109|P1|STARTED|Overall Study||359
7946922|NCT00463385|19559175|P4|NOT COMPLETED|Overall Study||22
7946923|NCT00463385|19559176|P3|NOT COMPLETED|Overall Study||22
7946924|NCT00463385|19559177|P2|NOT COMPLETED|Overall Study||22
7946925|NCT00463385|19559178|P1|NOT COMPLETED|Overall Study||22
7946926|NCT00463385|19559175|P4|COMPLETED|Overall Study||0
7946927|NCT00463385|19559176|P3|COMPLETED|Overall Study||0
7946928|NCT00463385|19559177|P2|COMPLETED|Overall Study||0
7946929|NCT00463385|19559178|P1|COMPLETED|Overall Study||0
7946930|NCT00463385|19559175|P4|Treated|Overall Study||22
7946931|NCT00463385|19559176|P3|Treated|Overall Study||19
7946932|NCT00463385|19559177|P2|Treated|Overall Study||22
7946933|NCT00463385|19559178|P1|Treated|Overall Study||22
7946934|NCT00463385|19559175|P4|STARTED|Overall Study||22
7946935|NCT00463385|19559176|P3|STARTED|Overall Study||22
7946936|NCT00463385|19559177|P2|STARTED|Overall Study||22
7946937|NCT00463385|19559178|P1|STARTED|Overall Study||22
7946938|NCT00463346|19559230|P2|NOT COMPLETED|Overall Study||3
7946939|NCT00463346|19559231|P1|NOT COMPLETED|Overall Study||3
7946940|NCT00463346|19559230|P2|COMPLETED|Overall Study||8
7946941|NCT00463346|19559231|P1|COMPLETED|Overall Study||9
7946942|NCT00463346|19559230|P2|STARTED|Overall Study||11
7946943|NCT00463346|19559231|P1|STARTED|Overall Study||12
7946944|NCT00463229|19559241|P2|NOT COMPLETED|Overall Study||10
7946945|NCT00463229|19559242|P1|NOT COMPLETED|Overall Study||9
7946946|NCT00463229|19559241|P2|COMPLETED|Overall Study||39
7946947|NCT00463229|19559242|P1|COMPLETED|Overall Study||43
7946948|NCT00463229|19559241|P2|STARTED|Overall Study||49
7946949|NCT00463229|19559242|P1|STARTED|Overall Study||52
7946950|NCT00463060|19559262|P1|NOT COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||1
7946951|NCT00463060|19559262|P1|COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||25
7946952|NCT00463060|19559262|P1|STARTED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Not all patients participated in both Phase 1 and Phase II|26
7946953|NCT00463060|19559262|P1|NOT COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
7946954|NCT00463060|19559262|P1|COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||0
7946955|NCT00463060|19559262|P1|STARTED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
7946956|NCT00463060|19559262|P1|NOT COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||0
7946957|NCT00463060|19559262|P1|COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
7946958|NCT00463060|19559262|P1|STARTED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
7946959|NCT00463060|19559262|P1|NOT COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||0
7946960|NCT00463060|19559262|P1|COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
7946961|NCT00463060|19559262|P1|STARTED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
7946962|NCT00463060|19559262|P1|NOT COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||0
7946963|NCT00463060|19559262|P1|COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
7946964|NCT00463060|19559262|P1|STARTED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
7946965|NCT00463047|19559276|P2|NOT COMPLETED|Double-Blind Treatment Period 2||2
7946966|NCT00463047|19559277|P1|NOT COMPLETED|Double-Blind Treatment Period 2||1
7946967|NCT00463047|19559276|P2|COMPLETED|Double-Blind Treatment Period 2||88
7946968|NCT00463047|19559277|P1|COMPLETED|Double-Blind Treatment Period 2||92
7946969|NCT00463047|19559276|P2|STARTED|Double-Blind Treatment Period 2||90
7946970|NCT00463047|19559277|P1|STARTED|Double-Blind Treatment Period 2||93
7946971|NCT00463047|19559276|P2|NOT COMPLETED|Double-Blind Treatment Period 1||4
7946972|NCT00463047|19559277|P1|NOT COMPLETED|Double-Blind Treatment Period 1||3
7946973|NCT00463047|19559276|P2|COMPLETED|Double-Blind Treatment Period 1||90
7946974|NCT00463047|19559277|P1|COMPLETED|Double-Blind Treatment Period 1||93
7947063|NCT00462735|19559586|P1|COMPLETED|Overall Study||33
7946975|NCT00463047|19559276|P2|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94
7946976|NCT00463047|19559277|P1|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96
7946977|NCT00463047|19559276|P2|NOT COMPLETED|Titration Period 2||23
7946978|NCT00463047|19559277|P1|NOT COMPLETED|Titration Period 2||30
7946979|NCT00463047|19559276|P2|COMPLETED|Titration Period 2||98
7946980|NCT00463047|19559277|P1|COMPLETED|Titration Period 2||93
7946981|NCT00463047|19559276|P2|STARTED|Titration Period 2||121
7946982|NCT00463047|19559277|P1|STARTED|Titration Period 2||123
7946983|NCT00463047|19559276|P2|NOT COMPLETED|Titration Period 1||39
7946984|NCT00463047|19559277|P1|NOT COMPLETED|Titration Period 1||37
7946985|NCT00463047|19559276|P2|COMPLETED|Titration Period 1||121
7946986|NCT00463047|19559277|P1|COMPLETED|Titration Period 1||123
7946987|NCT00463047|19559276|P2|STARTED|Titration Period 1||160
7946988|NCT00463047|19559277|P1|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160
7946989|NCT00462982|19559362|P1|NOT COMPLETED|Overall Study||3
7946990|NCT00462982|19559362|P1|COMPLETED|Overall Study||5
7946991|NCT00462982|19559362|P1|STARTED|Overall Study||8
7946992|NCT00462943|19559369|P3|NOT COMPLETED|Overall Study||23
7946993|NCT00462943|19559370|P2|NOT COMPLETED|Overall Study||30
7946994|NCT00462943|19559371|P1|NOT COMPLETED|Overall Study||45
7946995|NCT00462943|19559369|P3|COMPLETED|Overall Study||0
7946996|NCT00462943|19559370|P2|COMPLETED|Overall Study||1
7946997|NCT00462943|19559371|P1|COMPLETED|Overall Study||1
7946998|NCT00462943|19559369|P3|STARTED|Overall Study||23
7946999|NCT00462943|19559370|P2|STARTED|Overall Study||31
7947000|NCT00462943|19559371|P1|STARTED|Overall Study||46
7947001|NCT00462917|19559442|P4|NOT COMPLETED|Overall Study||11
7947002|NCT00462917|19559443|P3|NOT COMPLETED|Overall Study||12
7947003|NCT00462917|19559444|P2|NOT COMPLETED|Overall Study||10
7947004|NCT00462917|19559445|P1|NOT COMPLETED|Overall Study||10
7947005|NCT00462917|19559442|P4|COMPLETED|Overall Study||66
7947006|NCT00462917|19559443|P3|COMPLETED|Overall Study||54
7947007|NCT00462917|19559444|P2|COMPLETED|Overall Study||65
7947008|NCT00462917|19559445|P1|COMPLETED|Overall Study||62
7947009|NCT00462917|19559442|P4|Completed 6 Month Follow-up|Overall Study||66
7947010|NCT00462917|19559443|P3|Completed 6 Month Follow-up|Overall Study||55
7947011|NCT00462917|19559444|P2|Completed 6 Month Follow-up|Overall Study||68
7947012|NCT00462917|19559445|P1|Completed 6 Month Follow-up|Overall Study||63
7947013|NCT00462917|19559442|P4|Completed 6 Week Follow-up|Overall Study||68
7947014|NCT00462917|19559443|P3|Completed 6 Week Follow-up|Overall Study||55
7947015|NCT00462917|19559444|P2|Completed 6 Week Follow-up|Overall Study||70
7947016|NCT00462917|19559445|P1|Completed 6 Week Follow-up|Overall Study||63
7947017|NCT00462917|19559442|P4|Received Risk Information|Overall Study||68
7947018|NCT00462917|19559443|P3|Received Risk Information|Overall Study||55
7947019|NCT00462917|19559444|P2|Received Risk Information|Overall Study||70
7947020|NCT00462917|19559445|P1|Received Risk Information|Overall Study||64
7947021|NCT00462917|19559442|P4|Met With Genetic Counselor|Overall Study||71
7947022|NCT00462917|19559443|P3|Met With Genetic Counselor|Overall Study||56
7947023|NCT00462917|19559444|P2|Met With Genetic Counselor|Overall Study||71
7947024|NCT00462917|19559445|P1|Met With Genetic Counselor|Overall Study||66
7947025|NCT00462917|19559442|P4|STARTED|Overall Study||77
7947026|NCT00462917|19559443|P3|STARTED|Overall Study||66
7947027|NCT00462917|19559444|P2|STARTED|Overall Study||75
7947028|NCT00462917|19559445|P1|STARTED|Overall Study||72
7947029|NCT00462904|19559463|P1|NOT COMPLETED|Overall Study||1
7947030|NCT00462904|19559463|P1|COMPLETED|Overall Study||3
7947031|NCT00462904|19559463|P1|STARTED|Overall Study||4
7947032|NCT00462865|19559468|P1|NOT COMPLETED|Overall Study||1
7947033|NCT00462865|19559468|P1|COMPLETED|Overall Study||17
7947034|NCT00462865|19559468|P1|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18
7947035|NCT00462839|19559475|P2|NOT COMPLETED|Viewed Second||0
7947036|NCT00462839|19559476|P1|NOT COMPLETED|Viewed Second||0
7947037|NCT00462839|19559475|P2|COMPLETED|Viewed Second||53
7947038|NCT00462839|19559476|P1|COMPLETED|Viewed Second||53
7947039|NCT00462839|19559475|P2|STARTED|Viewed Second||53
7947040|NCT00462839|19559476|P1|STARTED|Viewed Second||53
7947041|NCT00462839|19559475|P2|NOT COMPLETED|Viewed First||0
7947042|NCT00462839|19559476|P1|NOT COMPLETED|Viewed First||0
7947043|NCT00462839|19559475|P2|COMPLETED|Viewed First||53
7947044|NCT00462839|19559476|P1|COMPLETED|Viewed First||53
7947045|NCT00462839|19559475|P2|STARTED|Viewed First||53
7947046|NCT00462839|19559476|P1|STARTED|Viewed First||53
7947047|NCT00462826|19559488|P1|NOT COMPLETED|Overall Study||5
7947048|NCT00462826|19559488|P1|COMPLETED|Overall Study||44
7947049|NCT00462826|19559488|P1|STARTED|Overall Study||49
7947050|NCT00462761|19559501|P1|NOT COMPLETED|Overall Study||76
7947051|NCT00462761|19559501|P1|COMPLETED|Overall Study||0
7947052|NCT00462761|19559501|P1|STARTED|Overall Study||76
7947053|NCT00462748|19559576|P3|NOT COMPLETED|Overall Study||11
7947054|NCT00462748|19559577|P2|NOT COMPLETED|Overall Study||11
7947055|NCT00462748|19559578|P1|NOT COMPLETED|Overall Study||12
7947056|NCT00462748|19559576|P3|COMPLETED|Overall Study||251
7947057|NCT00462748|19559577|P2|COMPLETED|Overall Study||252
7947058|NCT00462748|19559578|P1|COMPLETED|Overall Study||249
7947059|NCT00462748|19559576|P3|STARTED|Overall Study||262
7947060|NCT00462748|19559577|P2|STARTED|Overall Study||263
7947061|NCT00462748|19559578|P1|STARTED|Overall Study||261
7947062|NCT00462735|19559586|P1|NOT COMPLETED|Overall Study||0
7947064|NCT00462735|19559586|P1|STARTED|Overall Study||33
7947065|NCT00462722|19559597|P3|NOT COMPLETED|Overall Study||12
7947066|NCT00462722|19559598|P2|NOT COMPLETED|Overall Study||4
7947067|NCT00462722|19559599|P1|NOT COMPLETED|Overall Study||13
7947068|NCT00462722|19559597|P3|COMPLETED|Overall Study||42
7947069|NCT00462722|19559598|P2|COMPLETED|Overall Study||51
7947070|NCT00462722|19559599|P1|COMPLETED|Overall Study||37
7947071|NCT00462722|19559597|P3|STARTED|Overall Study||54
7947072|NCT00462722|19559598|P2|STARTED|Overall Study||55
7947073|NCT00462722|19559599|P1|STARTED|Overall Study||50
7947074|NCT00462709|19559631|P1|NOT COMPLETED|Overall Study||67
7947075|NCT00462709|19559631|P1|COMPLETED|Overall Study||79
7947076|NCT00462709|19559631|P1|STARTED|Overall Study||146
7947077|NCT00462670|19559640|P2|NOT COMPLETED|Overall Study||7
7947078|NCT00462670|19559641|P1|NOT COMPLETED|Overall Study||5
7947079|NCT00462670|19559640|P2|COMPLETED|Overall Study||46
7947080|NCT00462670|19559641|P1|COMPLETED|Overall Study||52
7947081|NCT00462670|19559640|P2|STARTED|Overall Study||53
7947082|NCT00462670|19559641|P1|STARTED|Overall Study||57
7947083|NCT00462644|19559651|P2|NOT COMPLETED|Overall Study||0
7947084|NCT00462644|19559652|P1|NOT COMPLETED|Overall Study||0
7947085|NCT00462644|19559651|P2|COMPLETED|Overall Study||12
7947086|NCT00462644|19559652|P1|COMPLETED|Overall Study||18
7947087|NCT00462644|19559651|P2|STARTED|Overall Study||12
7947088|NCT00462644|19559652|P1|STARTED|Overall Study||18
7947089|NCT00462605|19559670|P1|NOT COMPLETED|Overall Study||14
7947090|NCT00462605|19559670|P1|COMPLETED|Overall Study||10
7947091|NCT00462605|19559670|P1|STARTED|Overall Study||24
7947092|NCT00462501|19559678|P1|NOT COMPLETED|Overall Study||5
7947093|NCT00462501|19559678|P1|COMPLETED|Overall Study||30
7947094|NCT00462501|19559678|P1|STARTED|Overall Study||35
7947095|NCT00462488|19559684|P2|NOT COMPLETED|Overall Study||17
7947096|NCT00462488|19559685|P1|NOT COMPLETED|Overall Study||20
7947097|NCT00462488|19559684|P2|COMPLETED|Overall Study||6
7947098|NCT00462488|19559685|P1|COMPLETED|Overall Study||3
7947099|NCT00462488|19559684|P2|Completed Maintenance 2|Overall Study||6
7947100|NCT00462488|19559685|P1|Completed Maintenance 2|Overall Study||7
7947101|NCT00462488|19559684|P2|Completed Induction 2/Maintenance 1|Overall Study||9
7947102|NCT00462488|19559685|P1|Completed Induction 2/Maintenance 1|Overall Study||18
7947103|NCT00462488|19559684|P2|Completed Induction Phase|Overall Study||23
7947104|NCT00462488|19559685|P1|Completed Induction Phase|Overall Study||22
7947105|NCT00462488|19559684|P2|STARTED|Overall Study||23
7947106|NCT00462488|19559685|P1|STARTED|Overall Study||23
7947107|NCT00462462|19559693|P2|NOT COMPLETED|Overall Study||1
7947108|NCT00462462|19559694|P1|NOT COMPLETED|Overall Study||0
7947109|NCT00462462|19559693|P2|COMPLETED|Overall Study||13
7947110|NCT00462462|19559694|P1|COMPLETED|Overall Study||17
7947111|NCT00462462|19559693|P2|STARTED|Overall Study||14
7947112|NCT00462462|19559694|P1|STARTED|Overall Study||17
7947113|NCT00462449|19559704|P2|NOT COMPLETED|Overall Study||0
7947114|NCT00462449|19559705|P1|NOT COMPLETED|Overall Study||0
7947115|NCT00462449|19559704|P2|COMPLETED|Overall Study||10
7947116|NCT00462449|19559705|P1|COMPLETED|Overall Study||13
7947117|NCT00462449|19559704|P2|STARTED|Overall Study||10
7947118|NCT00462449|19559705|P1|STARTED|Overall Study||13
7947119|NCT00462423|19559715|P1|NOT COMPLETED|Overall Study||0
7947120|NCT00462423|19559715|P1|COMPLETED|Overall Study||50
7947121|NCT00462423|19559715|P1|STARTED|Overall Study||50
7947122|NCT00462384|19559722|P1|NOT COMPLETED|Overall Study||9
7947123|NCT00462384|19559722|P1|COMPLETED|Overall Study||30
7947124|NCT00462384|19559722|P1|STARTED|Overall Study||39
7947125|NCT00462345|19559730|P1|NOT COMPLETED|Overall Study||3
7947126|NCT00462345|19559730|P1|COMPLETED|Overall Study||37
7947127|NCT00462345|19559730|P1|Completed First Course|Overall Study||38
7947128|NCT00462345|19559730|P1|STARTED|Overall Study||40
7947129|NCT00462332|19559754|P2|NOT COMPLETED|Overall Study||0
7947130|NCT00462332|19559755|P1|NOT COMPLETED|Overall Study||0
7947131|NCT00462332|19559754|P2|COMPLETED|Overall Study||41
7947132|NCT00462332|19559755|P1|COMPLETED|Overall Study||45
7947133|NCT00462332|19559754|P2|STARTED|Overall Study||41
7947134|NCT00462332|19559755|P1|STARTED|Overall Study||45
7947135|NCT00462306|19559765|P2|NOT COMPLETED|Overall Study||13
7947136|NCT00462306|19559766|P1|NOT COMPLETED|Overall Study||0
7947137|NCT00462306|19559765|P2|COMPLETED|Overall Study||490
7947138|NCT00462306|19559766|P1|COMPLETED|Overall Study||4074
7947139|NCT00462306|19559765|P2|STARTED|Overall Study||503
7947140|NCT00462306|19559766|P1|STARTED|Overall Study||4074
7947141|NCT00462280|19559778|P4|NOT COMPLETED|Overall Study||3
7947142|NCT00462280|19559779|P3|NOT COMPLETED|Overall Study||0
7947143|NCT00462280|19559780|P2|NOT COMPLETED|Overall Study||7
7947144|NCT00462280|19559781|P1|NOT COMPLETED|Overall Study||10
7947145|NCT00462280|19559778|P4|COMPLETED|Overall Study||4
7947146|NCT00462280|19559779|P3|COMPLETED|Overall Study||7
7947147|NCT00462280|19559780|P2|COMPLETED|Overall Study||25
7947148|NCT00462280|19559781|P1|COMPLETED|Overall Study||24
7947149|NCT00462280|19559778|P4|STARTED|Overall Study||7
7947150|NCT00462280|19559779|P3|STARTED|Overall Study||7
7947151|NCT00462280|19559780|P2|STARTED|Overall Study||32
7947152|NCT00462280|19559781|P1|STARTED|Overall Study||34
7947153|NCT00462228|19559841|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
7947154|NCT00462228|19559841|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
7947155|NCT00462228|19559841|P1|STARTED|No Treatment (Washout) 4 Weeks||11
7947156|NCT00462228|19559841|P1|NOT COMPLETED|Placebo or Memantine 12 Weeks||0
7947157|NCT00462228|19559841|P1|COMPLETED|Placebo or Memantine 12 Weeks||11
7947158|NCT00462228|19559841|P1|STARTED|Placebo or Memantine 12 Weeks||11
7947159|NCT00462228|19559841|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
7947160|NCT00462228|19559841|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
7947161|NCT00462228|19559841|P1|STARTED|No Treatment (Washout) 4 Weeks||11
7947162|NCT00462228|19559841|P1|NOT COMPLETED|Memantine or Placebo 12 Weeks||0
7947163|NCT00462228|19559841|P1|COMPLETED|Memantine or Placebo 12 Weeks||11
7947164|NCT00462228|19559841|P1|STARTED|Memantine or Placebo 12 Weeks||11
7947165|NCT00462124|19559862|P1|NOT COMPLETED|Overall Study||1
7947166|NCT00462124|19559862|P1|COMPLETED|Overall Study|One implant was misplaced and was disacitivated by puncture.|6
7947167|NCT00462124|19559862|P1|STARTED|Overall Study||7
7947168|NCT00462072|19559870|P3|NOT COMPLETED|Week 10||0
7947169|NCT00462072|19559871|P2|NOT COMPLETED|Week 10||0
7947170|NCT00462072|19559872|P1|NOT COMPLETED|Week 10||0
7947171|NCT00462072|19559870|P3|COMPLETED|Week 10||9
7947172|NCT00462072|19559871|P2|COMPLETED|Week 10||12
7947173|NCT00462072|19559872|P1|COMPLETED|Week 10||10
7947174|NCT00462072|19559870|P3|STARTED|Week 10||9
7947175|NCT00462072|19559871|P2|STARTED|Week 10||12
7947176|NCT00462072|19559872|P1|STARTED|Week 10||10
7947177|NCT00462072|19559870|P3|NOT COMPLETED|Baseline (Week 0)||0
7947178|NCT00462072|19559871|P2|NOT COMPLETED|Baseline (Week 0)||0
7947179|NCT00462072|19559872|P1|NOT COMPLETED|Baseline (Week 0)||0
7947180|NCT00462072|19559870|P3|COMPLETED|Baseline (Week 0)||9
7947181|NCT00462072|19559871|P2|COMPLETED|Baseline (Week 0)||12
7947182|NCT00462072|19559872|P1|COMPLETED|Baseline (Week 0)||10
7947183|NCT00462072|19559870|P3|STARTED|Baseline (Week 0)||9
7947184|NCT00462072|19559871|P2|STARTED|Baseline (Week 0)||12
7947185|NCT00462072|19559872|P1|STARTED|Baseline (Week 0)||10
7947186|NCT00462020|19559888|P2|NOT COMPLETED|Overall Study||0
7947187|NCT00462020|19559889|P1|NOT COMPLETED|Overall Study||0
7947188|NCT00462020|19559888|P2|COMPLETED|Overall Study||50
7947189|NCT00462020|19559889|P1|COMPLETED|Overall Study||52
7947190|NCT00462020|19559888|P2|STARTED|Overall Study||50
7947191|NCT00462020|19559889|P1|STARTED|Overall Study||52
7947192|NCT00461981|19559897|P2|NOT COMPLETED|Overall Study||9
7947193|NCT00461981|19559898|P1|NOT COMPLETED|Overall Study||11
7947194|NCT00461981|19559897|P2|COMPLETED|Overall Study||42
7947195|NCT00461981|19559898|P1|COMPLETED|Overall Study||39
7947196|NCT00461981|19559897|P2|STARTED|Overall Study||51
7947197|NCT00461981|19559898|P1|STARTED|Overall Study||50
7947198|NCT00461851|19560008|P1|NOT COMPLETED|Overall Study||0
7947199|NCT00461851|19560008|P1|COMPLETED|Overall Study||17
7947200|NCT00461851|19560008|P1|STARTED|Overall Study||17
7947201|NCT00461812|19560014|P1|NOT COMPLETED|Overall Study||10
7947202|NCT00461812|19560014|P1|COMPLETED|Overall Study||0
7947203|NCT00461812|19560014|P1|STARTED|Overall Study||10
7947204|NCT00461786|19560019|P1|NOT COMPLETED|Overall Study||3
7947205|NCT00461786|19560019|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48
7947206|NCT00461786|19560019|P1|STARTED|Overall Study||51
7947207|NCT00461734|19560029|P2|NOT COMPLETED|Overall Study||60
7947208|NCT00461734|19560030|P1|NOT COMPLETED|Overall Study||58
7947209|NCT00461734|19560029|P2|COMPLETED|Overall Study||60
7947210|NCT00461734|19560030|P1|COMPLETED|Overall Study||62
7947211|NCT00461734|19560029|P2|STARTED|Overall Study||120
7947212|NCT00461734|19560030|P1|STARTED|Overall Study||120
7947213|NCT00461708|19560064|P2|NOT COMPLETED|Overall Study||38
7947214|NCT00461708|19560065|P1|NOT COMPLETED|Overall Study||115
7947215|NCT00461708|19560064|P2|COMPLETED|Overall Study||0
7947216|NCT00461708|19560065|P1|COMPLETED|Overall Study||0
7947217|NCT00461708|19560064|P2|STARTED|Overall Study||38
7947218|NCT00461708|19560065|P1|STARTED|Overall Study||115
7947219|NCT00461682|19560091|P1|NOT COMPLETED|Overall Study||1
7947220|NCT00461682|19560091|P1|COMPLETED|Overall Study||0
7947221|NCT00461682|19560091|P1|STARTED|Overall Study||1
7947222|NCT00461630|19560119|P2|NOT COMPLETED|Overall Study||827
7947223|NCT00461630|19560120|P1|NOT COMPLETED|Overall Study||906
7947224|NCT00461630|19560119|P2|COMPLETED|Overall Study||12008
7947225|NCT00461630|19560120|P1|COMPLETED|Overall Study||11932
7947226|NCT00461630|19560119|P2|STARTED|Overall Study||12835
7947227|NCT00461630|19560120|P1|STARTED|Overall Study||12838
7947228|NCT00461591|19560136|P2|NOT COMPLETED|Overall Study||85
7947229|NCT00461591|19560137|P1|NOT COMPLETED|Overall Study||89
7947230|NCT00461591|19560136|P2|COMPLETED|Overall Study||311
7947231|NCT00461591|19560137|P1|COMPLETED|Overall Study||317
7947232|NCT00461591|19560136|P2|STARTED|Overall Study||396
7947233|NCT00461591|19560137|P1|STARTED|Overall Study||406
7947234|NCT00461552|19560159|P2|NOT COMPLETED|Overall Study||2
7947235|NCT00461552|19560160|P1|NOT COMPLETED|Overall Study||0
7947236|NCT00461552|19560159|P2|COMPLETED|Overall Study||5
7947237|NCT00461552|19560160|P1|COMPLETED|Overall Study||7
7947238|NCT00461552|19560159|P2|STARTED|Overall Study||7
7947239|NCT00461552|19560160|P1|STARTED|Overall Study||7
7947240|NCT00461513|19560170|P2|NOT COMPLETED|Overall Study||25
7947241|NCT00461513|19560171|P1|NOT COMPLETED|Overall Study||22
7947242|NCT00461513|19560170|P2|COMPLETED|Overall Study||172
7947243|NCT00461513|19560171|P1|COMPLETED|Overall Study||165
7947244|NCT00461513|19560170|P2|STARTED|Overall Study|2 patients dropped at time of randomization|197
7947245|NCT00461513|19560171|P1|STARTED|Overall Study|6 patients dropped at time of randomization|187
7947246|NCT00461500|19560183|P2|NOT COMPLETED|Overall Study||6
7947247|NCT00461500|19560184|P1|NOT COMPLETED|Overall Study||7
7947248|NCT00461500|19560183|P2|COMPLETED|Overall Study||38
7947249|NCT00461500|19560184|P1|COMPLETED|Overall Study||30
7947250|NCT00461500|19560183|P2|STARTED|Overall Study||44
7947251|NCT00461500|19560184|P1|STARTED|Overall Study||37
7947252|NCT00461331|19560214|P2|NOT COMPLETED|Intervention 2||0
7947253|NCT00461331|19560215|P1|NOT COMPLETED|Intervention 2||0
7947254|NCT00461331|19560214|P2|COMPLETED|Intervention 2||10
7947255|NCT00461331|19560215|P1|COMPLETED|Intervention 2||10
7947256|NCT00461331|19560214|P2|STARTED|Intervention 2||10
7947257|NCT00461331|19560215|P1|STARTED|Intervention 2||10
7947258|NCT00461331|19560214|P2|NOT COMPLETED|Washout||0
7947259|NCT00461331|19560215|P1|NOT COMPLETED|Washout||0
7947260|NCT00461331|19560214|P2|COMPLETED|Washout||10
7947261|NCT00461331|19560215|P1|COMPLETED|Washout||10
7947262|NCT00461331|19560214|P2|STARTED|Washout||10
7947263|NCT00461331|19560215|P1|STARTED|Washout||10
7947264|NCT00461331|19560214|P2|NOT COMPLETED|Intervention 1||0
7947265|NCT00461331|19560215|P1|NOT COMPLETED|Intervention 1||0
7947266|NCT00461331|19560214|P2|COMPLETED|Intervention 1||10
7947267|NCT00461331|19560215|P1|COMPLETED|Intervention 1||10
7947268|NCT00461331|19560214|P2|STARTED|Intervention 1||10
7947269|NCT00461331|19560215|P1|STARTED|Intervention 1||10
7947270|NCT00461305|19560227|P2|NOT COMPLETED|Continued Treatment||0
7947271|NCT00461305|19560228|P1|NOT COMPLETED|Continued Treatment||95
7947272|NCT00461305|19560227|P2|COMPLETED|Continued Treatment||0
7947273|NCT00461305|19560228|P1|COMPLETED|Continued Treatment||254
7947274|NCT00461305|19560227|P2|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0
7947275|NCT00461305|19560228|P1|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349
7947276|NCT00461305|19560227|P2|NOT COMPLETED|Treatment||9
7947277|NCT00461305|19560228|P1|NOT COMPLETED|Treatment||101
7947278|NCT00461305|19560227|P2|COMPLETED|Treatment||56
7947279|NCT00461305|19560228|P1|COMPLETED|Treatment||254
7947280|NCT00461305|19560227|P2|Subjects Received Treatment|Treatment|FAS, safety population|65
7947281|NCT00461305|19560228|P1|Subjects Received Treatment|Treatment|FAS, safety population|349
7947282|NCT00461305|19560227|P2|Subjects Dispensed Drugs|Treatment||65
7947283|NCT00461305|19560228|P1|Subjects Dispensed Drugs|Treatment||350
7947284|NCT00461305|19560227|P2|STARTED|Treatment|Enrolled|65
7947285|NCT00461305|19560228|P1|STARTED|Treatment|Enrolled|355
7947286|NCT00461292|19560291|P3|NOT COMPLETED|Treatment Cycle 2||0
7947287|NCT00461292|19560292|P2|NOT COMPLETED|Treatment Cycle 2||2
7947288|NCT00461292|19560293|P1|NOT COMPLETED|Treatment Cycle 2||5
7947289|NCT00461292|19560291|P3|COMPLETED|Treatment Cycle 2||0
7947290|NCT00461292|19560292|P2|COMPLETED|Treatment Cycle 2||72
7947291|NCT00461292|19560293|P1|COMPLETED|Treatment Cycle 2||58
7947292|NCT00461292|19560291|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0
7947293|NCT00461292|19560292|P2|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74
7947294|NCT00461292|19560293|P1|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63
7947295|NCT00461292|19560291|P3|NOT COMPLETED|Treatment Cycle 1||11
7947296|NCT00461292|19560292|P2|NOT COMPLETED|Treatment Cycle 1||12
7947297|NCT00461292|19560293|P1|NOT COMPLETED|Treatment Cycle 1||15
7947298|NCT00461292|19560291|P3|COMPLETED|Treatment Cycle 1||81
7947299|NCT00461292|19560292|P2|COMPLETED|Treatment Cycle 1||80
7947300|NCT00461292|19560293|P1|COMPLETED|Treatment Cycle 1||76
7947301|NCT00461292|19560291|P3|STARTED|Treatment Cycle 1||92
7947302|NCT00461292|19560292|P2|STARTED|Treatment Cycle 1||92
7947303|NCT00461292|19560293|P1|STARTED|Treatment Cycle 1||91
7947304|NCT00461253|19560312|P2|NOT COMPLETED|Overall Study||19798
7947305|NCT00461253|19560313|P1|NOT COMPLETED|Overall Study||4980
7947306|NCT00461253|19560312|P2|COMPLETED|Overall Study|Analyzed controls|20452
7947307|NCT00461253|19560313|P1|COMPLETED|Overall Study|Analyzed cases|5113
7947308|NCT00461253|19560312|P2|STARTED|Overall Study|Identified controls|40250
7947309|NCT00461253|19560313|P1|STARTED|Overall Study|Identified cases|10093
7947310|NCT00461175|19560321|P2|NOT COMPLETED|Overall Study||365
7947311|NCT00461175|19560322|P1|NOT COMPLETED|Overall Study||522
7947312|NCT00461175|19560321|P2|COMPLETED|Overall Study||18370
7947313|NCT00461175|19560322|P1|COMPLETED|Overall Study||43078
7947314|NCT00461175|19560321|P2|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735
7947315|NCT00461175|19560322|P1|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600
7947316|NCT00461123|19560332|P2|NOT COMPLETED|Overall Study||6
7947317|NCT00461123|19560333|P1|NOT COMPLETED|Overall Study||6
7947318|NCT00461123|19560332|P2|COMPLETED|Overall Study||19
7947319|NCT00461123|19560333|P1|COMPLETED|Overall Study||19
7947320|NCT00461123|19560332|P2|STARTED|Overall Study||25
7947321|NCT00461123|19560333|P1|STARTED|Overall Study||25
7947322|NCT00461097|19560349|P2|NOT COMPLETED|Overall Study||0
7947323|NCT00461097|19560350|P1|NOT COMPLETED|Overall Study||0
7947324|NCT00461097|19560349|P2|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15
7947325|NCT00461097|19560350|P1|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40
7947326|NCT00461097|19560349|P2|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0
7947327|NCT00461097|19560350|P1|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7
7947328|NCT00461097|19560349|P2|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0
7947329|NCT00461097|19560350|P1|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16
7947330|NCT00461097|19560349|P2|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1
7947331|NCT00461097|19560350|P1|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34
7947332|NCT00461097|19560349|P2|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13
7947425|NCT00460603|19560531|P2|COMPLETED|Phase 2||0
7947333|NCT00461097|19560350|P1|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35
7947334|NCT00461097|19560349|P2|STARTED|Overall Study||15
7947335|NCT00461097|19560350|P1|STARTED|Overall Study||40
7947336|NCT00461045|19560366|P1|NOT COMPLETED|Overall Study||0
7947337|NCT00461045|19560366|P1|COMPLETED|Overall Study||15
7947338|NCT00461045|19560366|P1|STARTED|Overall Study||15
7947339|NCT00461032|19560378|P2|NOT COMPLETED|Overall Study||44
7947340|NCT00461032|19560379|P1|NOT COMPLETED|Overall Study||37
7947341|NCT00461032|19560378|P2|COMPLETED|Overall Study||536
7947342|NCT00461032|19560379|P1|COMPLETED|Overall Study||545
7947343|NCT00461032|19560378|P2|STARTED|Overall Study||580
7947344|NCT00461032|19560379|P1|STARTED|Overall Study||582
7947345|NCT00460993|19560393|P2|NOT COMPLETED|Phase 2 (6 Days)||0
7947346|NCT00460993|19560394|P1|NOT COMPLETED|Phase 2 (6 Days)||0
7947347|NCT00460993|19560393|P2|COMPLETED|Phase 2 (6 Days)||17
7947348|NCT00460993|19560394|P1|COMPLETED|Phase 2 (6 Days)||14
7947349|NCT00460993|19560393|P2|STARTED|Phase 2 (6 Days)||17
7947350|NCT00460993|19560394|P1|STARTED|Phase 2 (6 Days)||14
7947351|NCT00460993|19560393|P2|NOT COMPLETED|Phase 1 (6 Days)||0
7947352|NCT00460993|19560394|P1|NOT COMPLETED|Phase 1 (6 Days)||0
7947353|NCT00460993|19560393|P2|COMPLETED|Phase 1 (6 Days)||17
7947354|NCT00460993|19560394|P1|COMPLETED|Phase 1 (6 Days)||14
7947355|NCT00460993|19560393|P2|STARTED|Phase 1 (6 Days)||17
7947356|NCT00460993|19560394|P1|STARTED|Phase 1 (6 Days)||14
7947357|NCT00460811|19560405|P5|NOT COMPLETED|Overall Study||20
7947358|NCT00460811|19560406|P4|NOT COMPLETED|Overall Study||18
7947359|NCT00460811|19560407|P3|NOT COMPLETED|Overall Study||14
7947360|NCT00460811|19560408|P2|NOT COMPLETED|Overall Study||15
7947361|NCT00460811|19560409|P1|NOT COMPLETED|Overall Study||16
7947362|NCT00460811|19560405|P5|COMPLETED|Overall Study||65
7947363|NCT00460811|19560406|P4|COMPLETED|Overall Study||71
7947364|NCT00460811|19560407|P3|COMPLETED|Overall Study||71
7947365|NCT00460811|19560408|P2|COMPLETED|Overall Study||67
7947366|NCT00460811|19560409|P1|COMPLETED|Overall Study||63
7947367|NCT00460811|19560405|P5|STARTED|Overall Study||85
7947368|NCT00460811|19560406|P4|STARTED|Overall Study||89
7947369|NCT00460811|19560407|P3|STARTED|Overall Study||85
7947370|NCT00460811|19560408|P2|STARTED|Overall Study||82
7947371|NCT00460811|19560409|P1|STARTED|Overall Study||79
7947372|NCT00460798|19560451|P1|NOT COMPLETED|Overall Study||340
7947373|NCT00460798|19560451|P1|COMPLETED|Overall Study||108
7947374|NCT00460798|19560451|P1|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421
7947375|NCT00460798|19560451|P1|STARTED|Overall Study||448
7947376|NCT00460746|19560459|P1|NOT COMPLETED|Overall Study||2
7947377|NCT00460746|19560459|P1|COMPLETED|Overall Study||8
7947378|NCT00460746|19560459|P1|STARTED|Overall Study||10
7947379|NCT00460655|19560474|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
7947380|NCT00460655|19560475|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||7
7947381|NCT00460655|19560476|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
7947382|NCT00460655|19560477|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
7947383|NCT00460655|19560474|P4|COMPLETED|Open-Label Phase (36 Weeks)||52
7947384|NCT00460655|19560475|P3|COMPLETED|Open-Label Phase (36 Weeks)||45
7947385|NCT00460655|19560476|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
7947386|NCT00460655|19560477|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
7947387|NCT00460655|19560474|P4|STARTED|Open-Label Phase (36 Weeks)||61
7947388|NCT00460655|19560475|P3|STARTED|Open-Label Phase (36 Weeks)||52
7947389|NCT00460655|19560476|P2|STARTED|Open-Label Phase (36 Weeks)||0
7947390|NCT00460655|19560477|P1|STARTED|Open-Label Phase (36 Weeks)||0
7947391|NCT00460655|19560474|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
7947392|NCT00460655|19560475|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
7947393|NCT00460655|19560476|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
7947394|NCT00460655|19560477|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6
7947395|NCT00460655|19560474|P4|COMPLETED|Double-Blind Phase (12 Weeks)||0
7947396|NCT00460655|19560475|P3|COMPLETED|Double-Blind Phase (12 Weeks)||0
7947397|NCT00460655|19560476|P2|COMPLETED|Double-Blind Phase (12 Weeks)||61
7947398|NCT00460655|19560477|P1|COMPLETED|Double-Blind Phase (12 Weeks)||52
7947399|NCT00460655|19560474|P4|STARTED|Double-Blind Phase (12 Weeks)||0
7947400|NCT00460655|19560475|P3|STARTED|Double-Blind Phase (12 Weeks)||0
7947401|NCT00460655|19560476|P2|STARTED|Double-Blind Phase (12 Weeks)||62
7947402|NCT00460655|19560477|P1|STARTED|Double-Blind Phase (12 Weeks)||58
7947403|NCT00460603|19560521|P12|NOT COMPLETED|Phase 2||41
7947404|NCT00460603|19560522|P11|NOT COMPLETED|Phase 2||43
7947405|NCT00460603|19560523|P10|NOT COMPLETED|Phase 2||42
7947406|NCT00460603|19560524|P9|NOT COMPLETED|Phase 2||0
7947407|NCT00460603|19560525|P8|NOT COMPLETED|Phase 2||0
7947408|NCT00460603|19560526|P7|NOT COMPLETED|Phase 2||0
7947409|NCT00460603|19560527|P6|NOT COMPLETED|Phase 2||0
7947410|NCT00460603|19560528|P5|NOT COMPLETED|Phase 2||0
7947411|NCT00460603|19560529|P4|NOT COMPLETED|Phase 2||0
7947412|NCT00460603|19560530|P3|NOT COMPLETED|Phase 2||0
7947413|NCT00460603|19560531|P2|NOT COMPLETED|Phase 2||0
7947414|NCT00460603|19560532|P1|NOT COMPLETED|Phase 2||0
7947415|NCT00460603|19560521|P12|COMPLETED|Phase 2||0
7947416|NCT00460603|19560522|P11|COMPLETED|Phase 2||0
7947417|NCT00460603|19560523|P10|COMPLETED|Phase 2||0
7947418|NCT00460603|19560524|P9|COMPLETED|Phase 2||0
7947419|NCT00460603|19560525|P8|COMPLETED|Phase 2||0
7947420|NCT00460603|19560526|P7|COMPLETED|Phase 2||0
7947421|NCT00460603|19560527|P6|COMPLETED|Phase 2||0
7947422|NCT00460603|19560528|P5|COMPLETED|Phase 2||0
7947423|NCT00460603|19560529|P4|COMPLETED|Phase 2||0
7947424|NCT00460603|19560530|P3|COMPLETED|Phase 2||0
7947426|NCT00460603|19560532|P1|COMPLETED|Phase 2||0
7947427|NCT00460603|19560521|P12|Treated|Phase 2||41
7947428|NCT00460603|19560522|P11|Treated|Phase 2||43
7947429|NCT00460603|19560523|P10|Treated|Phase 2||39
7947430|NCT00460603|19560524|P9|Treated|Phase 2||0
7947431|NCT00460603|19560525|P8|Treated|Phase 2||0
7947432|NCT00460603|19560526|P7|Treated|Phase 2||0
7947433|NCT00460603|19560527|P6|Treated|Phase 2||0
7947434|NCT00460603|19560528|P5|Treated|Phase 2||0
7947435|NCT00460603|19560529|P4|Treated|Phase 2||0
7947436|NCT00460603|19560530|P3|Treated|Phase 2||0
7947437|NCT00460603|19560531|P2|Treated|Phase 2||0
7947438|NCT00460603|19560532|P1|Treated|Phase 2||0
7947439|NCT00460603|19560521|P12|STARTED|Phase 2||41
7947440|NCT00460603|19560522|P11|STARTED|Phase 2||43
7947441|NCT00460603|19560523|P10|STARTED|Phase 2||42
7947442|NCT00460603|19560524|P9|STARTED|Phase 2||0
7947443|NCT00460603|19560525|P8|STARTED|Phase 2||0
7947444|NCT00460603|19560526|P7|STARTED|Phase 2||0
7947445|NCT00460603|19560527|P6|STARTED|Phase 2||0
7947446|NCT00460603|19560528|P5|STARTED|Phase 2||0
7947447|NCT00460603|19560529|P4|STARTED|Phase 2||0
7947448|NCT00460603|19560530|P3|STARTED|Phase 2||0
7947449|NCT00460603|19560531|P2|STARTED|Phase 2||0
7947450|NCT00460603|19560532|P1|STARTED|Phase 2||0
7947451|NCT00460603|19560521|P12|NOT COMPLETED|Phase 1||0
7947452|NCT00460603|19560522|P11|NOT COMPLETED|Phase 1||0
7947453|NCT00460603|19560523|P10|NOT COMPLETED|Phase 1||0
7947454|NCT00460603|19560524|P9|NOT COMPLETED|Phase 1||18
7947455|NCT00460603|19560525|P8|NOT COMPLETED|Phase 1||3
7947456|NCT00460603|19560526|P7|NOT COMPLETED|Phase 1||6
7947457|NCT00460603|19560527|P6|NOT COMPLETED|Phase 1||4
7947458|NCT00460603|19560528|P5|NOT COMPLETED|Phase 1||6
7947459|NCT00460603|19560529|P4|NOT COMPLETED|Phase 1||8
7947460|NCT00460603|19560530|P3|NOT COMPLETED|Phase 1||4
7947461|NCT00460603|19560531|P2|NOT COMPLETED|Phase 1||6
7947462|NCT00460603|19560532|P1|NOT COMPLETED|Phase 1||6
7947463|NCT00460603|19560521|P12|COMPLETED|Phase 1||0
7947464|NCT00460603|19560522|P11|COMPLETED|Phase 1||0
7947465|NCT00460603|19560523|P10|COMPLETED|Phase 1||0
7947466|NCT00460603|19560524|P9|COMPLETED|Phase 1||0
7947467|NCT00460603|19560525|P8|COMPLETED|Phase 1||0
7947468|NCT00460603|19560526|P7|COMPLETED|Phase 1||0
7947469|NCT00460603|19560527|P6|COMPLETED|Phase 1||0
7947470|NCT00460603|19560528|P5|COMPLETED|Phase 1||0
7947471|NCT00460603|19560529|P4|COMPLETED|Phase 1||0
7947472|NCT00460603|19560530|P3|COMPLETED|Phase 1||0
7947473|NCT00460603|19560531|P2|COMPLETED|Phase 1||0
7947474|NCT00460603|19560532|P1|COMPLETED|Phase 1||0
7947475|NCT00460603|19560521|P12|STARTED|Phase 1||0
7947476|NCT00460603|19560522|P11|STARTED|Phase 1||0
7947477|NCT00460603|19560523|P10|STARTED|Phase 1||0
7947478|NCT00460603|19560524|P9|STARTED|Phase 1||18
7947479|NCT00460603|19560525|P8|STARTED|Phase 1||3
7947480|NCT00460603|19560526|P7|STARTED|Phase 1||6
7947481|NCT00460603|19560527|P6|STARTED|Phase 1||4
7947482|NCT00460603|19560528|P5|STARTED|Phase 1||6
7947483|NCT00460603|19560529|P4|STARTED|Phase 1||8
7947484|NCT00460603|19560530|P3|STARTED|Phase 1||4
7947485|NCT00460603|19560531|P2|STARTED|Phase 1||6
7947486|NCT00460603|19560532|P1|STARTED|Phase 1||6
7947487|NCT00460577|19560626|P2|NOT COMPLETED|Overall Study||6
7947488|NCT00460577|19560627|P1|NOT COMPLETED|Overall Study||2
7947489|NCT00460577|19560626|P2|COMPLETED|Overall Study||24
7947490|NCT00460577|19560627|P1|COMPLETED|Overall Study||28
7947491|NCT00460577|19560626|P2|STARTED|Overall Study||30
7947492|NCT00460577|19560627|P1|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30
7947493|NCT00460564|19560645|P8|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
7947494|NCT00460564|19560646|P7|NOT COMPLETED|Open-Label Phase (36 Weeks)||2
7947495|NCT00460564|19560647|P6|NOT COMPLETED|Open-Label Phase (36 Weeks)||6
7947496|NCT00460564|19560648|P5|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
7947497|NCT00460564|19560649|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
7947498|NCT00460564|19560650|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
7947499|NCT00460564|19560651|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
7947500|NCT00460564|19560652|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
7947501|NCT00460564|19560645|P8|COMPLETED|Open-Label Phase (36 Weeks)||11
7947502|NCT00460564|19560646|P7|COMPLETED|Open-Label Phase (36 Weeks)||19
7947503|NCT00460564|19560647|P6|COMPLETED|Open-Label Phase (36 Weeks)||19
7947504|NCT00460564|19560648|P5|COMPLETED|Open-Label Phase (36 Weeks)||38
7947505|NCT00460564|19560649|P4|COMPLETED|Open-Label Phase (36 Weeks)||0
7947506|NCT00460564|19560650|P3|COMPLETED|Open-Label Phase (36 Weeks)||0
7947507|NCT00460564|19560651|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
7947508|NCT00460564|19560652|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
7947509|NCT00460564|19560645|P8|STARTED|Open-Label Phase (36 Weeks)||11
7947510|NCT00460564|19560646|P7|STARTED|Open-Label Phase (36 Weeks)||21
7947511|NCT00460564|19560647|P6|STARTED|Open-Label Phase (36 Weeks)||25
7947512|NCT00460564|19560648|P5|STARTED|Open-Label Phase (36 Weeks)||47
7947513|NCT00460564|19560649|P4|STARTED|Open-Label Phase (36 Weeks)||0
7947514|NCT00460564|19560650|P3|STARTED|Open-Label Phase (36 Weeks)||0
7947515|NCT00460564|19560651|P2|STARTED|Open-Label Phase (36 Weeks)||0
7947516|NCT00460564|19560652|P1|STARTED|Open-Label Phase (36 Weeks)||0
7947517|NCT00460564|19560645|P8|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
7947518|NCT00460564|19560646|P7|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
7947519|NCT00460564|19560647|P6|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
7947520|NCT00460564|19560648|P5|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
7947521|NCT00460564|19560649|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
7947522|NCT00460564|19560650|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
7947523|NCT00460564|19560651|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
7947524|NCT00460564|19560652|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4
7947525|NCT00460564|19560645|P8|COMPLETED|Double-Blind Phase (12 Weeks)||0
7947526|NCT00460564|19560646|P7|COMPLETED|Double-Blind Phase (12 Weeks)||0
7947527|NCT00460564|19560647|P6|COMPLETED|Double-Blind Phase (12 Weeks)||0
7947528|NCT00460564|19560648|P5|COMPLETED|Double-Blind Phase (12 Weeks)||0
7947529|NCT00460564|19560649|P4|COMPLETED|Double-Blind Phase (12 Weeks)||11
7947530|NCT00460564|19560650|P3|COMPLETED|Double-Blind Phase (12 Weeks)||21
7947531|NCT00460564|19560651|P2|COMPLETED|Double-Blind Phase (12 Weeks)||25
7947532|NCT00460564|19560652|P1|COMPLETED|Double-Blind Phase (12 Weeks)||47
7947533|NCT00460564|19560645|P8|STARTED|Double-Blind Phase (12 Weeks)||0
7947534|NCT00460564|19560646|P7|STARTED|Double-Blind Phase (12 Weeks)||0
7947535|NCT00460564|19560647|P6|STARTED|Double-Blind Phase (12 Weeks)||0
7947536|NCT00460564|19560648|P5|STARTED|Double-Blind Phase (12 Weeks)||0
7947537|NCT00460564|19560649|P4|STARTED|Double-Blind Phase (12 Weeks)||11
7947538|NCT00460564|19560650|P3|STARTED|Double-Blind Phase (12 Weeks)||21
7947539|NCT00460564|19560651|P2|STARTED|Double-Blind Phase (12 Weeks)||26
7947540|NCT00460564|19560652|P1|STARTED|Double-Blind Phase (12 Weeks)||51
7947541|NCT00460551|19560746|P1|NOT COMPLETED|Overall Study||0
7947542|NCT00460551|19560746|P1|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13
7947543|NCT00460551|19560746|P1|STARTED|Overall Study||13
7947544|NCT00460525|19560753|P2|NOT COMPLETED|Overall Study||5
7947545|NCT00460525|19560754|P1|NOT COMPLETED|Overall Study||11
7947546|NCT00460525|19560753|P2|COMPLETED|Overall Study||194
7947547|NCT00460525|19560754|P1|COMPLETED|Overall Study||190
7947548|NCT00460525|19560753|P2|STARTED|Overall Study||199
7947549|NCT00460525|19560754|P1|STARTED|Overall Study||201
7947550|NCT00460434|19560796|P2|NOT COMPLETED|Overall Study||7
7947551|NCT00460434|19560797|P1|NOT COMPLETED|Overall Study||3
7947552|NCT00460434|19560796|P2|COMPLETED|Overall Study||165
7947553|NCT00460434|19560797|P1|COMPLETED|Overall Study||162
7947554|NCT00460434|19560796|P2|12 Months|Overall Study||165
7947555|NCT00460434|19560797|P1|12 Months|Overall Study||162
7947556|NCT00460434|19560796|P2|3 Months|Overall Study||171
7947557|NCT00460434|19560797|P1|3 Months|Overall Study||163
7947558|NCT00460434|19560796|P2|STARTED|Overall Study||172
7947559|NCT00460434|19560797|P1|STARTED|Overall Study||165
7947560|NCT00460421|19560826|P3|NOT COMPLETED|Overall Study||0
7947561|NCT00460421|19560827|P2|NOT COMPLETED|Overall Study||0
7947562|NCT00460421|19560828|P1|NOT COMPLETED|Overall Study||0
7947563|NCT00460421|19560826|P3|COMPLETED|Overall Study||9
7947564|NCT00460421|19560827|P2|COMPLETED|Overall Study||9
7947565|NCT00460421|19560828|P1|COMPLETED|Overall Study||9
7947566|NCT00460421|19560826|P3|STARTED|Overall Study||9
7947567|NCT00460421|19560827|P2|STARTED|Overall Study||9
7947568|NCT00460421|19560828|P1|STARTED|Overall Study||9
7947569|NCT00460408|19560876|P4|NOT COMPLETED|Overall Study||0
7947570|NCT00460408|19560877|P3|NOT COMPLETED|Overall Study||6
7947571|NCT00460408|19560878|P2|NOT COMPLETED|Overall Study||3
7947572|NCT00460408|19560879|P1|NOT COMPLETED|Overall Study||67
7947573|NCT00460408|19560876|P4|COMPLETED|Overall Study||7
7947574|NCT00460408|19560877|P3|COMPLETED|Overall Study||69
7947575|NCT00460408|19560878|P2|COMPLETED|Overall Study||13
7947576|NCT00460408|19560879|P1|COMPLETED|Overall Study||336
7947577|NCT00460408|19560876|P4|STARTED|Overall Study||7
7947578|NCT00460408|19560877|P3|STARTED|Overall Study||75
7947579|NCT00460408|19560878|P2|STARTED|Overall Study||16
7947580|NCT00460408|19560879|P1|STARTED|Overall Study||403
7947581|NCT00460265|19560916|P2|NOT COMPLETED|Overall Study||89
7947582|NCT00460265|19560917|P1|NOT COMPLETED|Overall Study||85
7947583|NCT00460265|19560916|P2|COMPLETED|Overall Study|Completed study=death|241
7947584|NCT00460265|19560917|P1|COMPLETED|Overall Study|Completed study=death|243
7947585|NCT00460265|19560916|P2|Received Study Medication|Overall Study||325
7947586|NCT00460265|19560917|P1|Received Study Medication|Overall Study||325
7947587|NCT00460265|19560916|P2|Randomized While Alive|Overall Study||330
7947588|NCT00460265|19560917|P1|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327
7947589|NCT00460265|19560916|P2|STARTED|Overall Study||330
7947590|NCT00460265|19560917|P1|STARTED|Overall Study||328
7947591|NCT00460239|19560933|P9|NOT COMPLETED|Overall Study||0
7947592|NCT00460239|19560934|P8|NOT COMPLETED|Overall Study||0
7947593|NCT00460239|19560935|P7|NOT COMPLETED|Overall Study||0
7947594|NCT00460239|19560936|P6|NOT COMPLETED|Overall Study||3
7947595|NCT00460239|19560937|P5|NOT COMPLETED|Overall Study||0
7947596|NCT00460239|19560938|P4|NOT COMPLETED|Overall Study||0
7947597|NCT00460239|19560939|P3|NOT COMPLETED|Overall Study||0
7947598|NCT00460239|19560940|P2|NOT COMPLETED|Overall Study||1
7947599|NCT00460239|19560941|P1|NOT COMPLETED|Overall Study||0
7947600|NCT00460239|19560933|P9|COMPLETED|Overall Study||1
7947601|NCT00460239|19560934|P8|COMPLETED|Overall Study||1
7947602|NCT00460239|19560935|P7|COMPLETED|Overall Study||1
7947603|NCT00460239|19560936|P6|COMPLETED|Overall Study||1
7947604|NCT00460239|19560937|P5|COMPLETED|Overall Study||1
7947605|NCT00460239|19560938|P4|COMPLETED|Overall Study||0
7947606|NCT00460239|19560939|P3|COMPLETED|Overall Study||1
7947607|NCT00460239|19560940|P2|COMPLETED|Overall Study||2
7947608|NCT00460239|19560941|P1|COMPLETED|Overall Study||0
7947609|NCT00460239|19560933|P9|STARTED|Overall Study||1
7947610|NCT00460239|19560934|P8|STARTED|Overall Study||1
7947611|NCT00460239|19560935|P7|STARTED|Overall Study||1
7947612|NCT00460239|19560936|P6|STARTED|Overall Study||4
7947613|NCT00460239|19560937|P5|STARTED|Overall Study||1
7947614|NCT00460239|19560938|P4|STARTED|Overall Study||0
7947615|NCT00460239|19560939|P3|STARTED|Overall Study||1
7947616|NCT00460239|19560940|P2|STARTED|Overall Study||3
7947617|NCT00460239|19560941|P1|STARTED|Overall Study||0
7947618|NCT00460109|19561010|P1|NOT COMPLETED|Overall Study||1
7947619|NCT00460109|19561010|P1|COMPLETED|Overall Study||23
7947620|NCT00460109|19561010|P1|STARTED|Overall Study||24
7947621|NCT00460031|19561018|P1|NOT COMPLETED|Overall Study||11
7947622|NCT00460031|19561018|P1|COMPLETED|Overall Study||23
7947623|NCT00460031|19561018|P1|STARTED|Overall Study||34
7947624|NCT00459979|19561026|P1|NOT COMPLETED|Overall Study||2
7947625|NCT00459979|19561026|P1|COMPLETED|Overall Study||28
7947626|NCT00459979|19561026|P1|STARTED|Overall Study||30
7947627|NCT00459953|19561038|P2|NOT COMPLETED|Overall Study||1
7947628|NCT00459953|19561039|P1|NOT COMPLETED|Overall Study||1
7947629|NCT00459953|19561038|P2|COMPLETED|Overall Study||70
7947630|NCT00459953|19561039|P1|COMPLETED|Overall Study||71
7947631|NCT00459953|19561038|P2|STARTED|Overall Study||71
7947632|NCT00459953|19561039|P1|STARTED|Overall Study||72
7947633|NCT00459875|19561045|P1|NOT COMPLETED|Overall Study||3
7947634|NCT00459875|19561045|P1|COMPLETED|Overall Study||21
7947635|NCT00459875|19561045|P1|STARTED|Overall Study||24
7947636|NCT00459862|19561049|P1|NOT COMPLETED|Overall Study||0
7947637|NCT00459862|19561049|P1|COMPLETED|Overall Study||34
7947638|NCT00459862|19561049|P1|STARTED|Overall Study||34
7947639|NCT00459810|19561058|P1|NOT COMPLETED|Overall Study||0
7947640|NCT00459810|19561058|P1|COMPLETED|Overall Study||21
7947641|NCT00459810|19561058|P1|STARTED|Overall Study||21
7947642|NCT00459732|19561068|P2|NOT COMPLETED|Overall Study||3
7947643|NCT00459732|19561069|P1|NOT COMPLETED|Overall Study||4
7947644|NCT00459732|19561068|P2|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14
7947645|NCT00459732|19561069|P1|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19
7947646|NCT00459732|19561068|P2|STARTED|Overall Study||17
7947647|NCT00459732|19561069|P1|STARTED|Overall Study||23
7947648|NCT00459706|19561081|P2|NOT COMPLETED|Overall Study||21
7947649|NCT00459706|19561082|P1|NOT COMPLETED|Overall Study||26
7947650|NCT00459706|19561081|P2|COMPLETED|Overall Study||294
7947651|NCT00459706|19561082|P1|COMPLETED|Overall Study||299
7947652|NCT00459706|19561081|P2|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313
7947653|NCT00459706|19561082|P1|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324
7947654|NCT00459706|19561081|P2|STARTED|Overall Study||315
7947655|NCT00459706|19561082|P1|STARTED|Overall Study||325
7947656|NCT00459667|19561225|P3|NOT COMPLETED|Overall Study||20
7947657|NCT00459667|19561226|P2|NOT COMPLETED|Overall Study||47
7947658|NCT00459667|19561227|P1|NOT COMPLETED|Overall Study||38
7947659|NCT00459667|19561225|P3|COMPLETED|Overall Study||161
7947660|NCT00459667|19561226|P2|COMPLETED|Overall Study||600
7947661|NCT00459667|19561227|P1|COMPLETED|Overall Study||554
7947662|NCT00459667|19561225|P3|Started Treatment|Overall Study||180
7947663|NCT00459667|19561226|P2|Started Treatment|Overall Study||644
7947664|NCT00459667|19561227|P1|Started Treatment|Overall Study||586
7947665|NCT00459667|19561225|P3|Study Medication Dispensed|Overall Study||180
7947666|NCT00459667|19561226|P2|Study Medication Dispensed|Overall Study||645
7947667|NCT00459667|19561227|P1|Study Medication Dispensed|Overall Study||586
7947668|NCT00459667|19561225|P3|STARTED|Overall Study||181
7947669|NCT00459667|19561226|P2|STARTED|Overall Study||647
7947670|NCT00459667|19561227|P1|STARTED|Overall Study||592
7947671|NCT00459537|19561249|P2|NOT COMPLETED|Overall Study||76
7947672|NCT00459537|19561250|P1|NOT COMPLETED|Overall Study||66
7947673|NCT00459537|19561249|P2|COMPLETED|Overall Study||446
7947674|NCT00459537|19561250|P1|COMPLETED|Overall Study||441
7947675|NCT00459537|19561249|P2|Safety Population|Overall Study||512
7947676|NCT00459537|19561250|P1|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493
7947677|NCT00459537|19561249|P2|STARTED|Overall Study||522
7947678|NCT00459537|19561250|P1|STARTED|Overall Study||507
7947679|NCT00459381|19561264|P1|NOT COMPLETED|Overall Study||0
7947680|NCT00459381|19561264|P1|COMPLETED|Overall Study||35
7947681|NCT00459381|19561264|P1|STARTED|Overall Study||35
7947682|NCT00459368|19561276|P2|NOT COMPLETED|Overall Study||329
7947683|NCT00459368|19561277|P1|NOT COMPLETED|Overall Study||295
7947684|NCT00459368|19561276|P2|COMPLETED|Overall Study||1034
7947685|NCT00459368|19561277|P1|COMPLETED|Overall Study||1040
7947686|NCT00459368|19561276|P2|STARTED|Overall Study||1363
7947687|NCT00459368|19561277|P1|STARTED|Overall Study||1335
7947688|NCT00459355|19561285|P2|NOT COMPLETED|Overall Study||18
7947689|NCT00459355|19561286|P1|NOT COMPLETED|Overall Study||20
7947690|NCT00459355|19561285|P2|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96
7947691|NCT00459355|19561286|P1|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120
7947692|NCT00459355|19561285|P2|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114
7947693|NCT00459355|19561286|P1|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140
7947694|NCT00459342|19561298|P1|NOT COMPLETED|Overall Study||1
7947695|NCT00459342|19561298|P1|COMPLETED|Overall Study||34
7947696|NCT00459342|19561298|P1|STARTED|Overall Study||35
7947697|NCT00459316|19561311|P3|NOT COMPLETED|Step 3||1
7947698|NCT00459316|19561312|P2|NOT COMPLETED|Step 3||0
7947699|NCT00459316|19561313|P1|NOT COMPLETED|Step 3||3
7947700|NCT00459316|19561311|P3|COMPLETED|Step 3||39
7947701|NCT00459316|19561312|P2|COMPLETED|Step 3||0
7947702|NCT00459316|19561313|P1|COMPLETED|Step 3||149
7947703|NCT00459316|19561311|P3|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40
7947704|NCT00459316|19561312|P2|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0
7947705|NCT00459316|19561313|P1|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152
7947706|NCT00459316|19561311|P3|NOT COMPLETED|Steps 1 & 2||2
7947707|NCT00459316|19561312|P2|NOT COMPLETED|Steps 1 & 2||7
7947708|NCT00459316|19561313|P1|NOT COMPLETED|Steps 1 & 2||21
7947709|NCT00459316|19561311|P3|COMPLETED|Steps 1 & 2||57
7947710|NCT00459316|19561312|P2|COMPLETED|Steps 1 & 2||32
7947711|NCT00459316|19561313|P1|COMPLETED|Steps 1 & 2||259
7947712|NCT00459316|19561311|P3|STARTED|Steps 1 & 2||59
7947713|NCT00459316|19561312|P2|STARTED|Steps 1 & 2||39
7947714|NCT00459316|19561313|P1|STARTED|Steps 1 & 2||280
7947715|NCT00459303|19561367|P1|NOT COMPLETED|Overall Study||0
7947716|NCT00459303|19561367|P1|COMPLETED|Overall Study||20
7947717|NCT00459303|19561367|P1|STARTED|Overall Study||20
7947718|NCT00459290|19561378|P1|NOT COMPLETED|Overall Study||5
7947719|NCT00459290|19561378|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19
7947720|NCT00459290|19561378|P1|STARTED|Overall Study||24
7947721|NCT00459186|19561393|P1|NOT COMPLETED|Combination RAD001 + Docetaxel||0
7947722|NCT00459186|19561393|P1|COMPLETED|Combination RAD001 + Docetaxel||15
7947723|NCT00459186|19561393|P1|STARTED|Combination RAD001 + Docetaxel||15
7947724|NCT00459186|19561393|P1|NOT COMPLETED|PET Imaging and Assessment||3
7947725|NCT00459186|19561393|P1|COMPLETED|PET Imaging and Assessment||15
7947726|NCT00459186|19561393|P1|STARTED|PET Imaging and Assessment||18
7947727|NCT00459186|19561393|P1|NOT COMPLETED|Single Agent RAD001||1
7947728|NCT00459186|19561393|P1|COMPLETED|Single Agent RAD001||18
7947729|NCT00459186|19561393|P1|STARTED|Single Agent RAD001||19
7947730|NCT00459134|19561400|P2|NOT COMPLETED|Overall Study||25
7947731|NCT00459134|19561401|P1|NOT COMPLETED|Overall Study||23
7947732|NCT00459134|19561400|P2|COMPLETED|Overall Study||67
7947733|NCT00459134|19561401|P1|COMPLETED|Overall Study||71
7947734|NCT00459134|19561400|P2|STARTED|Overall Study||92
7947735|NCT00459134|19561401|P1|STARTED|Overall Study||94
7947736|NCT00459121|19561409|P1|NOT COMPLETED|Overall Study||0
7947737|NCT00459121|19561409|P1|COMPLETED|Overall Study||2
7947738|NCT00459121|19561409|P1|STARTED|Overall Study||2
7947739|NCT00459108|19561417|P1|NOT COMPLETED|Overall Study||11
7947740|NCT00459108|19561417|P1|COMPLETED|Overall Study||14
7947741|NCT00459108|19561417|P1|STARTED|Overall Study||25
7947742|NCT00459056|19561427|P2|NOT COMPLETED|Second Intervention (Final Three Months)||0
7947743|NCT00459056|19561428|P1|NOT COMPLETED|Second Intervention (Final Three Months)||0
7947744|NCT00459056|19561427|P2|COMPLETED|Second Intervention (Final Three Months)||14
7947745|NCT00459056|19561428|P1|COMPLETED|Second Intervention (Final Three Months)||9
7947746|NCT00459056|19561427|P2|STARTED|Second Intervention (Final Three Months)||14
7947747|NCT00459056|19561428|P1|STARTED|Second Intervention (Final Three Months)||9
7947748|NCT00459056|19561427|P2|NOT COMPLETED|Washout (1 Month)||0
7947749|NCT00459056|19561428|P1|NOT COMPLETED|Washout (1 Month)||0
7947750|NCT00459056|19561427|P2|COMPLETED|Washout (1 Month)||14
7947751|NCT00459056|19561428|P1|COMPLETED|Washout (1 Month)||9
7947752|NCT00459056|19561427|P2|STARTED|Washout (1 Month)||14
7947753|NCT00459056|19561428|P1|STARTED|Washout (1 Month)||9
7947754|NCT00459056|19561427|P2|NOT COMPLETED|First Intervention (First Three Months)||1
7947755|NCT00459056|19561428|P1|NOT COMPLETED|First Intervention (First Three Months)||1
7947756|NCT00459056|19561427|P2|COMPLETED|First Intervention (First Three Months)||14
7947757|NCT00459056|19561428|P1|COMPLETED|First Intervention (First Three Months)||9
7947758|NCT00459056|19561427|P2|STARTED|First Intervention (First Three Months)||15
7947759|NCT00459056|19561428|P1|STARTED|First Intervention (First Three Months)||10
7947760|NCT00459043|19561436|P2|NOT COMPLETED|Overall Study||0
7947761|NCT00459043|19561437|P1|NOT COMPLETED|Overall Study||1
7947762|NCT00459043|19561436|P2|COMPLETED|Overall Study||15
7947763|NCT00459043|19561437|P1|COMPLETED|Overall Study||14
7947764|NCT00459043|19561436|P2|STARTED|Overall Study||15
7947765|NCT00459043|19561437|P1|STARTED|Overall Study||15
7947766|NCT00458952|19561449|P2|NOT COMPLETED|Overall Study||5
7947767|NCT00458952|19561450|P1|NOT COMPLETED|Overall Study||2
7947768|NCT00458952|19561449|P2|COMPLETED|Overall Study||9
7947769|NCT00458952|19561450|P1|COMPLETED|Overall Study||5
7947770|NCT00458952|19561449|P2|STARTED|Overall Study||14
7947771|NCT00458952|19561450|P1|STARTED|Overall Study||7
7947772|NCT00458848|19561454|P1|NOT COMPLETED|Overall Study||0
7947773|NCT00458848|19561454|P1|COMPLETED|Overall Study||51
7947774|NCT00458848|19561454|P1|STARTED|Overall Study||51
7947775|NCT00458822|19561460|P1|NOT COMPLETED|Overall Study||0
7947776|NCT00458822|19561460|P1|COMPLETED|Overall Study||40
7947777|NCT00458822|19561460|P1|STARTED|Overall Study||40
7947778|NCT00458705|19561464|P1|NOT COMPLETED|Overall Study||5
7947779|NCT00458705|19561464|P1|COMPLETED|Overall Study||40
7947780|NCT00458705|19561464|P1|STARTED|Overall Study||45
7947781|NCT00458536|19561468|P1|NOT COMPLETED|Overall Study||19
7947782|NCT00458536|19561468|P1|COMPLETED|Overall Study||19
7947783|NCT00458536|19561468|P1|STARTED|Overall Study||38
7947784|NCT00458484|19561479|P7|NOT COMPLETED|Overall Study||0
7947785|NCT00458484|19561480|P6|NOT COMPLETED|Overall Study||1
7947786|NCT00458484|19561481|P5|NOT COMPLETED|Overall Study||0
7947787|NCT00458484|19561482|P4|NOT COMPLETED|Overall Study||0
7947788|NCT00458484|19561483|P3|NOT COMPLETED|Overall Study||0
7947789|NCT00458484|19561484|P2|NOT COMPLETED|Overall Study||0
7947790|NCT00458484|19561485|P1|NOT COMPLETED|Overall Study||0
7947791|NCT00458484|19561479|P7|COMPLETED|Overall Study||3
7947792|NCT00458484|19561480|P6|COMPLETED|Overall Study||4
7947793|NCT00458484|19561481|P5|COMPLETED|Overall Study||4
7947794|NCT00458484|19561482|P4|COMPLETED|Overall Study||6
7947795|NCT00458484|19561483|P3|COMPLETED|Overall Study||3
7947796|NCT00458484|19561484|P2|COMPLETED|Overall Study||6
7947797|NCT00458484|19561485|P1|COMPLETED|Overall Study||4
7947798|NCT00458484|19561479|P7|STARTED|Overall Study||3
7947799|NCT00458484|19561480|P6|STARTED|Overall Study||5
7947800|NCT00458484|19561481|P5|STARTED|Overall Study||4
7947801|NCT00458484|19561482|P4|STARTED|Overall Study||6
7947802|NCT00458484|19561483|P3|STARTED|Overall Study||3
7947803|NCT00458484|19561484|P2|STARTED|Overall Study||6
7947804|NCT00458484|19561485|P1|STARTED|Overall Study||4
7947805|NCT00458406|19561526|P2|NOT COMPLETED|Month 3||0
7947806|NCT00458406|19561527|P1|NOT COMPLETED|Month 3||0
7947807|NCT00458406|19561526|P2|COMPLETED|Month 3||13
7947808|NCT00458406|19561527|P1|COMPLETED|Month 3||43
7947809|NCT00458406|19561526|P2|STARTED|Month 3||13
7947810|NCT00458406|19561527|P1|STARTED|Month 3||43
7947811|NCT00458406|19561526|P2|NOT COMPLETED|Month 1||0
7947812|NCT00458406|19561527|P1|NOT COMPLETED|Month 1||0
7947813|NCT00458406|19561526|P2|COMPLETED|Month 1||13
7947814|NCT00458406|19561527|P1|COMPLETED|Month 1||43
7947815|NCT00458406|19561526|P2|STARTED|Month 1||13
7947816|NCT00458406|19561527|P1|STARTED|Month 1||43
7947817|NCT00458393|19561551|P2|NOT COMPLETED|Overall Study||295
7947818|NCT00458393|19561552|P1|NOT COMPLETED|Overall Study||309
7947819|NCT00458393|19561551|P2|COMPLETED|Overall Study||953
7947820|NCT00458393|19561552|P1|COMPLETED|Overall Study||942
7947821|NCT00458393|19561551|P2|STARTED|Overall Study||1248
7947822|NCT00458393|19561552|P1|STARTED|Overall Study||1251
7947823|NCT00458341|19561600|P2|NOT COMPLETED|Cycle 2||0
7947824|NCT00458341|19561601|P1|NOT COMPLETED|Cycle 2||0
7947825|NCT00458341|19561600|P2|COMPLETED|Cycle 2||15
7947826|NCT00458341|19561601|P1|COMPLETED|Cycle 2||15
7947827|NCT00458341|19561600|P2|Received at Least 1 Dose of Study Drug|Cycle 2||15
7947828|NCT00458341|19561601|P1|Received at Least 1 Dose of Study Drug|Cycle 2||15
7947829|NCT00458341|19561600|P2|STARTED|Cycle 2||15
7947830|NCT00458341|19561601|P1|STARTED|Cycle 2|The participant who did not complete Cycle 1 was eligible for Cycle 2 and completed Cycle 2.|15
7947831|NCT00458341|19561600|P2|NOT COMPLETED|Cycle 1||0
7947832|NCT00458341|19561601|P1|NOT COMPLETED|Cycle 1||1
7947833|NCT00458341|19561600|P2|COMPLETED|Cycle 1||15
7947834|NCT00458341|19561601|P1|COMPLETED|Cycle 1|1 participant did not complete Cycle 1 since all procedures were not performed due to adverse event.|14
7947835|NCT00458341|19561600|P2|Received at Least 1 Dose of Study Drug|Cycle 1||15
7947836|NCT00458341|19561601|P1|Received at Least 1 Dose of Study Drug|Cycle 1||15
7947837|NCT00458341|19561600|P2|STARTED|Cycle 1||15
7947838|NCT00458341|19561601|P1|STARTED|Cycle 1||15
7947839|NCT00458302|19561641|P2|NOT COMPLETED|Overall Study||24
7947840|NCT00458302|19561642|P1|NOT COMPLETED|Overall Study||20
7947841|NCT00458302|19561641|P2|COMPLETED|Overall Study||103
7947842|NCT00458302|19561642|P1|COMPLETED|Overall Study||109
7947843|NCT00458302|19561641|P2|STARTED|Overall Study||127
7947844|NCT00458302|19561642|P1|STARTED|Overall Study||129
7947845|NCT00458237|19561676|P3|NOT COMPLETED|Overall Study||0
7947846|NCT00458237|19561677|P2|NOT COMPLETED|Overall Study||0
7947847|NCT00458237|19561678|P1|NOT COMPLETED|Overall Study||0
7947848|NCT00458237|19561676|P3|COMPLETED|Overall Study||5
7947849|NCT00458237|19561677|P2|COMPLETED|Overall Study||3
7947850|NCT00458237|19561678|P1|COMPLETED|Overall Study||3
7947851|NCT00458237|19561676|P3|STARTED|Overall Study||5
7947852|NCT00458237|19561677|P2|STARTED|Overall Study||3
7947853|NCT00458237|19561678|P1|STARTED|Overall Study||3
7947854|NCT00458211|19561687|P1|NOT COMPLETED|Overall Study||16
7947855|NCT00458211|19561687|P1|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24
7947856|NCT00458211|19561687|P1|STARTED|Overall Study||40
7947857|NCT00457977|19561708|P2|NOT COMPLETED|Overall Study||25
7947858|NCT00457977|19561709|P1|NOT COMPLETED|Overall Study||28
7947859|NCT00457977|19561708|P2|COMPLETED|Overall Study||66
7947860|NCT00457977|19561709|P1|COMPLETED|Overall Study||62
7947861|NCT00457977|19561708|P2|2-Year|Overall Study||66
7947862|NCT00457977|19561709|P1|2-Year|Overall Study||62
7947863|NCT00457977|19561708|P2|1-Year|Overall Study||76
7947864|NCT00457977|19561709|P1|1-Year|Overall Study||69
7947865|NCT00457977|19561708|P2|1-Month|Overall Study||87
7947866|NCT00457977|19561709|P1|1-Month|Overall Study||88
7947867|NCT00457977|19561708|P2|STARTED|Overall Study||91
7947868|NCT00457977|19561709|P1|STARTED|Overall Study||90
7947869|NCT00457951|19561720|P3|NOT COMPLETED|Overall Study||12
7947870|NCT00457951|19561721|P2|NOT COMPLETED|Overall Study||16
7947871|NCT00457951|19561722|P1|NOT COMPLETED|Overall Study||0
7947872|NCT00457951|19561720|P3|COMPLETED|Overall Study||60
7947873|NCT00457951|19561721|P2|COMPLETED|Overall Study||50
7947874|NCT00457951|19561722|P1|COMPLETED|Overall Study||13
7947875|NCT00457951|19561720|P3|STARTED|Overall Study||72
7947876|NCT00457951|19561721|P2|STARTED|Overall Study||66
7947877|NCT00457951|19561722|P1|STARTED|Overall Study||13
7947878|NCT00457821|19561737|P8|NOT COMPLETED|Part 2||1
7947879|NCT00457821|19561738|P7|NOT COMPLETED|Part 2||0
7947880|NCT00457821|19561739|P6|NOT COMPLETED|Part 2||0
7947881|NCT00457821|19561740|P5|NOT COMPLETED|Part 2||0
7947882|NCT00457821|19561741|P4|NOT COMPLETED|Part 2||0
7947883|NCT00457821|19561742|P3|NOT COMPLETED|Part 2||0
7947884|NCT00457821|19561743|P2|NOT COMPLETED|Part 2||0
7947885|NCT00457821|19561744|P1|NOT COMPLETED|Part 2||0
7947886|NCT00457821|19561737|P8|COMPLETED|Part 2||4
7947887|NCT00457821|19561738|P7|COMPLETED|Part 2||7
7947888|NCT00457821|19561739|P6|COMPLETED|Part 2||8
7947889|NCT00457821|19561740|P5|COMPLETED|Part 2||0
7947890|NCT00457821|19561741|P4|COMPLETED|Part 2||0
7947891|NCT00457821|19561742|P3|COMPLETED|Part 2||0
7947892|NCT00457821|19561743|P2|COMPLETED|Part 2||0
7947893|NCT00457821|19561744|P1|COMPLETED|Part 2||0
7947894|NCT00457821|19561737|P8|Completed Study Drug Treatment|Part 2||4
7947895|NCT00457821|19561738|P7|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7
7947896|NCT00457821|19561739|P6|Completed Study Drug Treatment|Part 2||8
7947897|NCT00457821|19561740|P5|Completed Study Drug Treatment|Part 2||0
7947898|NCT00457821|19561741|P4|Completed Study Drug Treatment|Part 2||0
7947899|NCT00457821|19561742|P3|Completed Study Drug Treatment|Part 2||0
7947900|NCT00457821|19561743|P2|Completed Study Drug Treatment|Part 2||0
7947901|NCT00457821|19561744|P1|Completed Study Drug Treatment|Part 2||0
7947902|NCT00457821|19561737|P8|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5
7947903|NCT00457821|19561738|P7|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7
7947904|NCT00457821|19561739|P6|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8
7947905|NCT00457821|19561740|P5|STARTED|Part 2|Arm in Part 1 only|0
7947906|NCT00457821|19561741|P4|STARTED|Part 2|Arm in Part 1 only|0
7947907|NCT00457821|19561742|P3|STARTED|Part 2|Arm in Part 1 only|0
7947908|NCT00457821|19561743|P2|STARTED|Part 2|Arm in Part 1 only|0
7947909|NCT00457821|19561744|P1|STARTED|Part 2|Arm in Part 1 only|0
7947910|NCT00457821|19561737|P8|NOT COMPLETED|Part 1||0
7947911|NCT00457821|19561738|P7|NOT COMPLETED|Part 1||0
7947912|NCT00457821|19561739|P6|NOT COMPLETED|Part 1||0
7947913|NCT00457821|19561740|P5|NOT COMPLETED|Part 1||0
7947914|NCT00457821|19561741|P4|NOT COMPLETED|Part 1||0
7947915|NCT00457821|19561742|P3|NOT COMPLETED|Part 1||1
7947916|NCT00457821|19561743|P2|NOT COMPLETED|Part 1||0
7947917|NCT00457821|19561744|P1|NOT COMPLETED|Part 1||0
7947918|NCT00457821|19561737|P8|COMPLETED|Part 1||0
7947919|NCT00457821|19561738|P7|COMPLETED|Part 1||0
7947920|NCT00457821|19561739|P6|COMPLETED|Part 1||0
7947921|NCT00457821|19561740|P5|COMPLETED|Part 1||4
7947922|NCT00457821|19561741|P4|COMPLETED|Part 1||4
7947923|NCT00457821|19561742|P3|COMPLETED|Part 1||4
7947924|NCT00457821|19561743|P2|COMPLETED|Part 1||4
7947925|NCT00457821|19561744|P1|COMPLETED|Part 1||4
7947926|NCT00457821|19561737|P8|STARTED|Part 1|Arm in Part 2 only|0
7947927|NCT00457821|19561738|P7|STARTED|Part 1|Arm in Part 2 only|0
7947928|NCT00457821|19561739|P6|STARTED|Part 1|Arm in Part 2 only|0
7947929|NCT00457821|19561740|P5|STARTED|Part 1|Number of subjects randomized|4
7947930|NCT00457821|19561741|P4|STARTED|Part 1|Number of subjects randomized|4
7947931|NCT00457821|19561742|P3|STARTED|Part 1|Number of subjects randomized|5
7947932|NCT00457821|19561743|P2|STARTED|Part 1|Number of subjects randomized|4
7947933|NCT00457821|19561744|P1|STARTED|Part 1|Number of subjects randomized|4
7947934|NCT00457795|19561773|P1|NOT COMPLETED|Overall Study||0
7947935|NCT00457795|19561773|P1|COMPLETED|Overall Study||15
7947936|NCT00457795|19561773|P1|STARTED|Overall Study||15
7947937|NCT00457743|19561783|P3|NOT COMPLETED|Overall Study||3
7947938|NCT00457743|19561784|P2|NOT COMPLETED|Overall Study||27
7947939|NCT00457743|19561785|P1|NOT COMPLETED|Overall Study||3
7947940|NCT00457743|19561783|P3|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0
7947941|NCT00457743|19561784|P2|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3
7947942|NCT00457743|19561785|P1|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0
7947943|NCT00457743|19561783|P3|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
7947944|NCT00457743|19561784|P2|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30
7947945|NCT00457743|19561785|P1|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
7947946|NCT00457743|19561783|P3|Completed Phase 1|Overall Study||3
7947947|NCT00457743|19561784|P2|Completed Phase 1|Overall Study||6
7947948|NCT00457743|19561785|P1|Completed Phase 1|Overall Study||3
7947949|NCT00457743|19561783|P3|Enrolled in Phase 1|Overall Study||3
7947950|NCT00457743|19561784|P2|Enrolled in Phase 1|Overall Study||6
7947951|NCT00457743|19561785|P1|Enrolled in Phase 1|Overall Study||3
7947952|NCT00457743|19561783|P3|STARTED|Overall Study|Overall study|3
7947953|NCT00457743|19561784|P2|STARTED|Overall Study|Overall study|30
7947954|NCT00457743|19561785|P1|STARTED|Overall Study|Overall study|3
7947955|NCT00457730|19561829|P2|NOT COMPLETED|Overall Study||1
7947956|NCT00457730|19561830|P1|NOT COMPLETED|Overall Study||4
7947957|NCT00457730|19561829|P2|COMPLETED|Overall Study||19
7947958|NCT00457730|19561830|P1|COMPLETED|Overall Study||14
7947959|NCT00457730|19561829|P2|STARTED|Overall Study||20
7947960|NCT00457730|19561830|P1|STARTED|Overall Study||18
7947961|NCT00457691|19561842|P2|NOT COMPLETED|Overall Study||382
7947962|NCT00457691|19561843|P1|NOT COMPLETED|Overall Study||386
7947963|NCT00457691|19561842|P2|COMPLETED|Overall Study||0
7947964|NCT00457691|19561843|P1|COMPLETED|Overall Study||0
7947965|NCT00457691|19561842|P2|STARTED|Overall Study||382
7947966|NCT00457691|19561843|P1|STARTED|Overall Study||386
7947967|NCT00457665|19561865|P2|NOT COMPLETED|24 Months||8
7947968|NCT00457665|19561866|P1|NOT COMPLETED|24 Months||5
7947969|NCT00457665|19561865|P2|COMPLETED|24 Months||11
7947970|NCT00457665|19561866|P1|COMPLETED|24 Months||15
7947971|NCT00457665|19561865|P2|STARTED|24 Months||19
7947972|NCT00457665|19561866|P1|STARTED|24 Months||20
7947973|NCT00457665|19561865|P2|NOT COMPLETED|12 Months||9
7947974|NCT00457665|19561866|P1|NOT COMPLETED|12 Months||8
7947975|NCT00457665|19561865|P2|COMPLETED|12 Months||19
7947976|NCT00457665|19561866|P1|COMPLETED|12 Months||20
7947977|NCT00457665|19561865|P2|STARTED|12 Months||28
7947978|NCT00457665|19561866|P1|STARTED|12 Months||28
7947979|NCT00457639|19561872|P2|NOT COMPLETED|Intervention 2 (6 Months)||1
7947980|NCT00457639|19561873|P1|NOT COMPLETED|Intervention 2 (6 Months)||0
7947981|NCT00457639|19561872|P2|COMPLETED|Intervention 2 (6 Months)||6
7947982|NCT00457639|19561873|P1|COMPLETED|Intervention 2 (6 Months)||6
7947983|NCT00457639|19561872|P2|STARTED|Intervention 2 (6 Months)||7
7947984|NCT00457639|19561873|P1|STARTED|Intervention 2 (6 Months)||6
7947985|NCT00457639|19561872|P2|NOT COMPLETED|Intervention 1 (6 Months)||2
7947986|NCT00457639|19561873|P1|NOT COMPLETED|Intervention 1 (6 Months)||3
7947987|NCT00457639|19561872|P2|COMPLETED|Intervention 1 (6 Months)|Number of patients completing Placebo Phase|7
7947988|NCT00457639|19561873|P1|COMPLETED|Intervention 1 (6 Months)|Number of Patients completing Cholic Acid Phase|6
7947989|NCT00457639|19561872|P2|STARTED|Intervention 1 (6 Months)|6 months on Placebo and crossover to cholic acid for 6 months|9
7947990|NCT00457639|19561873|P1|STARTED|Intervention 1 (6 Months)|6 months on Cholic Acid and crossover to Placebo for 6 months|9
7947991|NCT00457418|19561881|P1|NOT COMPLETED|Post PK Maintenance||28
7947992|NCT00457418|19561881|P1|COMPLETED|Post PK Maintenance||3
7947993|NCT00457418|19561881|P1|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31
7947994|NCT00457418|19561881|P1|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5
7947995|NCT00457418|19561881|P1|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27
7947996|NCT00457418|19561881|P1|STARTED|Pharmacokinetic (PK) Sampling Phase||32
7947997|NCT00457392|19561893|P2|NOT COMPLETED|Overall Study||480
7947998|NCT00457392|19561894|P1|NOT COMPLETED|Overall Study||480
7947999|NCT00457392|19561893|P2|COMPLETED|Overall Study||0
7948000|NCT00457392|19561894|P1|COMPLETED|Overall Study||0
7948001|NCT00457392|19561893|P2|Treated|Overall Study||477
7948002|NCT00457392|19561894|P1|Treated|Overall Study||473
7948003|NCT00457392|19561893|P2|STARTED|Overall Study||480
7948004|NCT00457392|19561894|P1|STARTED|Overall Study||480
7948005|NCT00457366|19561912|P2|NOT COMPLETED|Overall Study||0
7948006|NCT00457366|19561913|P1|NOT COMPLETED|Overall Study||0
7948007|NCT00457366|19561912|P2|COMPLETED|Overall Study||32
7948008|NCT00457366|19561913|P1|COMPLETED|Overall Study||40
7948009|NCT00457366|19561912|P2|STARTED|Overall Study||32
7948010|NCT00457366|19561913|P1|STARTED|Overall Study||40
7948011|NCT00457301|19561921|P2|NOT COMPLETED|Overall Study||24
7948012|NCT00457301|19561922|P1|NOT COMPLETED|Overall Study||23
7948013|NCT00457301|19561921|P2|COMPLETED|Overall Study||84
7948014|NCT00457301|19561922|P1|COMPLETED|Overall Study||82
7948015|NCT00457301|19561921|P2|STARTED|Overall Study||108
7948016|NCT00457301|19561922|P1|STARTED|Overall Study||105
7948017|NCT00457249|19561936|P2|NOT COMPLETED|Overall Study||2
7948018|NCT00457249|19561937|P1|NOT COMPLETED|Overall Study||12
7948019|NCT00457249|19561936|P2|COMPLETED|Overall Study||389
7948020|NCT00457249|19561937|P1|COMPLETED|Overall Study||1158
7948021|NCT00457249|19561936|P2|STARTED|Overall Study||391
7948022|NCT00457249|19561937|P1|STARTED|Overall Study||1170
7948023|NCT00457197|19561951|P2|NOT COMPLETED|Overall Study||1
7948024|NCT00457197|19561952|P1|NOT COMPLETED|Overall Study||1
7948025|NCT00457197|19561951|P2|COMPLETED|Overall Study||44
7948026|NCT00457197|19561952|P1|COMPLETED|Overall Study||44
7948027|NCT00457197|19561951|P2|STARTED|Overall Study||45
7948028|NCT00457197|19561952|P1|STARTED|Overall Study||45
7948029|NCT00457015|19561976|P2|NOT COMPLETED|Overall Study||1
7948030|NCT00457015|19561977|P1|NOT COMPLETED|Overall Study||0
7948031|NCT00457015|19561976|P2|COMPLETED|Overall Study||47
7948032|NCT00457015|19561977|P1|COMPLETED|Overall Study||48
7948033|NCT00457015|19561976|P2|STARTED|Overall Study||48
7948034|NCT00457015|19561977|P1|STARTED|Overall Study||48
7948035|NCT00457002|19561993|P2|NOT COMPLETED|Overall Study||757
7948036|NCT00457002|19561994|P1|NOT COMPLETED|Overall Study||813
7948037|NCT00457002|19561993|P2|COMPLETED|Overall Study||2516
7948038|NCT00457002|19561994|P1|COMPLETED|Overall Study||2442
7948039|NCT00457002|19561993|P2|STARTED|Overall Study||3273
7948040|NCT00457002|19561994|P1|STARTED|Overall Study||3255
7948041|NCT00456989|19562062|P1|NOT COMPLETED|Overall Study||0
7948042|NCT00456989|19562062|P1|COMPLETED|Overall Study||39
7948043|NCT00456989|19562062|P1|STARTED|Overall Study||39
7948044|NCT00456885|19562067|P2|NOT COMPLETED|Second Treatment Period, 16 Weeks||0
7948045|NCT00456885|19562068|P1|NOT COMPLETED|Second Treatment Period, 16 Weeks||1
7948046|NCT00456885|19562067|P2|COMPLETED|Second Treatment Period, 16 Weeks||17
7948047|NCT00456885|19562068|P1|COMPLETED|Second Treatment Period, 16 Weeks||23
7948048|NCT00456885|19562067|P2|STARTED|Second Treatment Period, 16 Weeks||17
7948049|NCT00456885|19562068|P1|STARTED|Second Treatment Period, 16 Weeks||24
7948050|NCT00456885|19562067|P2|NOT COMPLETED|Washout, 3 Weeks||0
7948051|NCT00456885|19562068|P1|NOT COMPLETED|Washout, 3 Weeks||0
7948052|NCT00456885|19562067|P2|COMPLETED|Washout, 3 Weeks||17
7948053|NCT00456885|19562068|P1|COMPLETED|Washout, 3 Weeks||24
7948054|NCT00456885|19562067|P2|STARTED|Washout, 3 Weeks||17
7948055|NCT00456885|19562068|P1|STARTED|Washout, 3 Weeks||24
7948056|NCT00456885|19562067|P2|NOT COMPLETED|First Treatment Period, 16 Weeks||0
7948057|NCT00456885|19562068|P1|NOT COMPLETED|First Treatment Period, 16 Weeks||0
7948058|NCT00456885|19562067|P2|COMPLETED|First Treatment Period, 16 Weeks||17
7948059|NCT00456885|19562068|P1|COMPLETED|First Treatment Period, 16 Weeks||24
7948060|NCT00456885|19562067|P2|STARTED|First Treatment Period, 16 Weeks||17
7948061|NCT00456885|19562068|P1|STARTED|First Treatment Period, 16 Weeks||24
7948062|NCT00456846|19562099|P2|NOT COMPLETED|Overall Study||28
7948063|NCT00456846|19562100|P1|NOT COMPLETED|Overall Study||16
7948064|NCT00456846|19562099|P2|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48
7948065|NCT00456846|19562100|P1|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31
7948066|NCT00456846|19562099|P2|STARTED|Overall Study||76
7948067|NCT00456846|19562100|P1|STARTED|Overall Study||47
7948068|NCT00456807|19562122|P2|NOT COMPLETED|Overall Study||0
7948069|NCT00456807|19562123|P1|NOT COMPLETED|Overall Study||1
7948070|NCT00456807|19562122|P2|COMPLETED|Overall Study||47
7948071|NCT00456807|19562123|P1|COMPLETED|Overall Study||52
7948072|NCT00456807|19562122|P2|STARTED|Overall Study||47
7948073|NCT00456807|19562123|P1|STARTED|Overall Study||53
7948074|NCT00456755|19562141|P2|NOT COMPLETED|Overall Study||1
7948075|NCT00456755|19562142|P1|NOT COMPLETED|Overall Study||2
7948076|NCT00456755|19562141|P2|COMPLETED|Overall Study||62
7948077|NCT00456755|19562142|P1|COMPLETED|Overall Study||61
7948078|NCT00456755|19562141|P2|STARTED|Overall Study||63
7948079|NCT00456755|19562142|P1|STARTED|Overall Study||63
7948080|NCT00456625|19562150|P1|NOT COMPLETED|Overall Study||0
7948081|NCT00456625|19562150|P1|COMPLETED|Overall Study||76
7948082|NCT00456625|19562150|P1|STARTED|Overall Study||76
7948083|NCT00456612|19562156|P1|NOT COMPLETED|Overall Study||3
7948084|NCT00456612|19562156|P1|COMPLETED|Overall Study||1
7948085|NCT00456612|19562156|P1|STARTED|Overall Study||4
7948086|NCT00456599|19562161|P1|NOT COMPLETED|Overall Study||3
7948087|NCT00456599|19562161|P1|COMPLETED|Overall Study||68
7948088|NCT00456599|19562161|P1|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24
7948089|NCT00456599|19562161|P1|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26
7948090|NCT00456599|19562161|P1|Completed Resection|Overall Study|43 patients underwent resection.|43
7948091|NCT00456599|19562161|P1|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48
7948092|NCT00456599|19562161|P1|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61
7948093|NCT00456599|19562161|P1|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66
7948094|NCT00456599|19562161|P1|STARTED|Overall Study||71
7948095|NCT00456547|19562169|P2|NOT COMPLETED|Overall Study||0
7948096|NCT00456547|19562170|P1|NOT COMPLETED|Overall Study||0
7948097|NCT00456547|19562169|P2|COMPLETED|Overall Study||12
7948098|NCT00456547|19562170|P1|COMPLETED|Overall Study||12
7948099|NCT00456547|19562169|P2|STARTED|Overall Study||12
7948100|NCT00456547|19562170|P1|STARTED|Overall Study||12
7948101|NCT00456521|19562184|P2|NOT COMPLETED|Overall Study||84
7948102|NCT00456521|19562185|P1|NOT COMPLETED|Overall Study||249
7948103|NCT00456521|19562184|P2|COMPLETED|Overall Study||118
7948104|NCT00456521|19562185|P1|COMPLETED|Overall Study||342
7948105|NCT00456521|19562184|P2|STARTED|Overall Study||202
7948106|NCT00456521|19562185|P1|STARTED|Overall Study||591
7948107|NCT00456508|19562225|P1|NOT COMPLETED|Overall Study||0
7948108|NCT00456508|19562225|P1|COMPLETED|Overall Study||147
7948109|NCT00456508|19562225|P1|STARTED|Overall Study||147
7948110|NCT00456495|19562231|P1|NOT COMPLETED|Overall Study||2
7948111|NCT00456495|19562231|P1|COMPLETED|Overall Study||3
7948112|NCT00456495|19562231|P1|STARTED|Overall Study||5
7948113|NCT00456365|19562238|P2|NOT COMPLETED|Overall Study||12
7948114|NCT00456365|19562239|P1|NOT COMPLETED|Overall Study||7
7948115|NCT00456365|19562238|P2|COMPLETED|Overall Study||42
7948116|NCT00456365|19562239|P1|COMPLETED|Overall Study||49
7948117|NCT00456365|19562238|P2|STARTED|Overall Study||54
7948118|NCT00456365|19562239|P1|STARTED|Overall Study||56
7948119|NCT00456300|19562251|P2|NOT COMPLETED|Overall Study||0
7948120|NCT00456300|19562252|P1|NOT COMPLETED|Overall Study||1
7948121|NCT00456300|19562251|P2|COMPLETED|Overall Study||4
7948122|NCT00456300|19562252|P1|COMPLETED|Overall Study||4
7948123|NCT00456300|19562251|P2|STARTED|Overall Study||4
7948124|NCT00456300|19562252|P1|STARTED|Overall Study||5
7948125|NCT00456261|19562262|P2|NOT COMPLETED|Maintenance Therapy||0
7948126|NCT00456261|19562263|P1|NOT COMPLETED|Maintenance Therapy||0
7948127|NCT00456261|19562262|P2|COMPLETED|Maintenance Therapy||29
7948128|NCT00456261|19562263|P1|COMPLETED|Maintenance Therapy||3
7948129|NCT00456261|19562262|P2|STARTED|Maintenance Therapy||29
7948130|NCT00456261|19562263|P1|STARTED|Maintenance Therapy||3
7948131|NCT00456261|19562262|P2|NOT COMPLETED|Combination Therapy||26
7948132|NCT00456261|19562263|P1|NOT COMPLETED|Combination Therapy||52
7948133|NCT00456261|19562262|P2|COMPLETED|Combination Therapy||29
7948134|NCT00456261|19562263|P1|COMPLETED|Combination Therapy||3
7948135|NCT00456261|19562262|P2|STARTED|Combination Therapy||55
7948136|NCT00456261|19562263|P1|STARTED|Combination Therapy||55
7948137|NCT00456092|19562276|P5|NOT COMPLETED|Treatment Phase (12 Weeks)||0
7948138|NCT00456092|19562277|P4|NOT COMPLETED|Treatment Phase (12 Weeks)||0
7948139|NCT00456092|19562278|P3|NOT COMPLETED|Treatment Phase (12 Weeks)||18
7948140|NCT00456092|19562279|P2|NOT COMPLETED|Treatment Phase (12 Weeks)||14
7948141|NCT00456092|19562280|P1|NOT COMPLETED|Treatment Phase (12 Weeks)||7
7948142|NCT00456092|19562276|P5|COMPLETED|Treatment Phase (12 Weeks)||0
7948143|NCT00456092|19562277|P4|COMPLETED|Treatment Phase (12 Weeks)||0
7948144|NCT00456092|19562278|P3|COMPLETED|Treatment Phase (12 Weeks)||50
7948145|NCT00456092|19562279|P2|COMPLETED|Treatment Phase (12 Weeks)||55
7948146|NCT00456092|19562280|P1|COMPLETED|Treatment Phase (12 Weeks)||60
7948147|NCT00456092|19562276|P5|STARTED|Treatment Phase (12 Weeks)||0
7948148|NCT00456092|19562277|P4|STARTED|Treatment Phase (12 Weeks)||0
7948149|NCT00456092|19562278|P3|STARTED|Treatment Phase (12 Weeks)||68
7948150|NCT00456092|19562279|P2|STARTED|Treatment Phase (12 Weeks)||69
7948151|NCT00456092|19562280|P1|STARTED|Treatment Phase (12 Weeks)||67
7948152|NCT00456092|19562276|P5|NOT COMPLETED|Extension Phase||7
7948153|NCT00456092|19562277|P4|NOT COMPLETED|Extension Phase||1
7948154|NCT00456092|19562278|P3|NOT COMPLETED|Extension Phase||0
7948155|NCT00456092|19562279|P2|NOT COMPLETED|Extension Phase||4
7948156|NCT00456092|19562280|P1|NOT COMPLETED|Extension Phase||11
7948157|NCT00456092|19562276|P5|COMPLETED|Extension Phase||13
7948158|NCT00456092|19562277|P4|COMPLETED|Extension Phase||19
7948159|NCT00456092|19562278|P3|COMPLETED|Extension Phase||0
7948160|NCT00456092|19562279|P2|COMPLETED|Extension Phase||36
7948161|NCT00456092|19562280|P1|COMPLETED|Extension Phase||35
7948162|NCT00456092|19562276|P5|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
7948163|NCT00456092|19562277|P4|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
7948164|NCT00456092|19562278|P3|STARTED|Extension Phase||0
7948165|NCT00456092|19562279|P2|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|40
7948166|NCT00456092|19562280|P1|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|46
7948167|NCT00456014|19562430|P1|NOT COMPLETED|Tricyclic Phase||3
7948168|NCT00456014|19562430|P1|COMPLETED|Tricyclic Phase||1
7948169|NCT00456014|19562430|P1|STARTED|Tricyclic Phase|Only non-remitters from phase 1 were eligible for phase 2, and not all those eligible continued.|4
7948170|NCT00456014|19562430|P1|NOT COMPLETED|SSRI Phase||9
7948171|NCT00456014|19562430|P1|COMPLETED|SSRI Phase||28
7948172|NCT00456014|19562430|P1|STARTED|SSRI Phase||37
7948173|NCT00455975|19562438|P2|NOT COMPLETED|Overall Study||21
7948174|NCT00455975|19562439|P1|NOT COMPLETED|Overall Study||18
7948175|NCT00455975|19562438|P2|COMPLETED|Overall Study||40
7948176|NCT00455975|19562439|P1|COMPLETED|Overall Study||40
7948177|NCT00455975|19562438|P2|STARTED|Overall Study||61
7948178|NCT00455975|19562439|P1|STARTED|Overall Study||58
7948179|NCT00455962|19562453|P2|NOT COMPLETED|Overall Study||0
7948180|NCT00455962|19562454|P1|NOT COMPLETED|Overall Study||0
7948181|NCT00455962|19562453|P2|COMPLETED|Overall Study||13
7948182|NCT00455962|19562454|P1|COMPLETED|Overall Study||10
7948183|NCT00455962|19562453|P2|STARTED|Overall Study||13
7948184|NCT00455962|19562454|P1|STARTED|Overall Study||10
7948185|NCT00455923|19562462|P2|NOT COMPLETED|Overall Study||3
7948186|NCT00455923|19562463|P1|NOT COMPLETED|Overall Study||3
7948187|NCT00455923|19562462|P2|COMPLETED|Overall Study||47
7948188|NCT00455923|19562463|P1|COMPLETED|Overall Study||47
7948189|NCT00455923|19562462|P2|STARTED|Overall Study||50
7948190|NCT00455923|19562463|P1|STARTED|Overall Study||50
7948191|NCT00455858|19562479|P1|NOT COMPLETED|Overall Study||6
7948192|NCT00455858|19562479|P1|COMPLETED|Overall Study||81
7948193|NCT00455858|19562479|P1|STARTED|Overall Study|Enrolled in study and exposed to study drug|87
7948194|NCT00455741|19562489|P2|NOT COMPLETED|Overall Study||1
7948195|NCT00455741|19562490|P1|NOT COMPLETED|Overall Study||0
7948196|NCT00455741|19562489|P2|COMPLETED|Overall Study||11
7948197|NCT00455741|19562490|P1|COMPLETED|Overall Study||13
7948198|NCT00455741|19562489|P2|STARTED|Overall Study||12
7948199|NCT00455741|19562490|P1|STARTED|Overall Study||13
7948200|NCT00455702|19562508|P2|NOT COMPLETED|Overall Study||3
7948201|NCT00455702|19562509|P1|NOT COMPLETED|Overall Study||3
7948202|NCT00455702|19562508|P2|COMPLETED|Overall Study||16
7948203|NCT00455702|19562509|P1|COMPLETED|Overall Study||16
7948204|NCT00455702|19562508|P2|STARTED|Overall Study||19
7948205|NCT00455702|19562509|P1|STARTED|Overall Study||19
7948206|NCT00455689|19562519|P2|NOT COMPLETED|Overall Study||0
7948207|NCT00455689|19562520|P1|NOT COMPLETED|Overall Study||0
7948208|NCT00455689|19562519|P2|COMPLETED|Overall Study||6
7948209|NCT00455689|19562520|P1|COMPLETED|Overall Study||14
7948210|NCT00455689|19562519|P2|STARTED|Overall Study||6
7948211|NCT00455689|19562520|P1|STARTED|Overall Study||14
7948212|NCT00455663|19562530|P3|NOT COMPLETED|Overall Study||3
7948213|NCT00455663|19562531|P2|NOT COMPLETED|Overall Study||4
7948214|NCT00455663|19562532|P1|NOT COMPLETED|Overall Study||3
7948215|NCT00455663|19562530|P3|COMPLETED|Overall Study||29
7948216|NCT00455663|19562531|P2|COMPLETED|Overall Study||32
7948217|NCT00455663|19562532|P1|COMPLETED|Overall Study||34
7948218|NCT00455663|19562530|P3|STARTED|Overall Study||32
7948219|NCT00455663|19562531|P2|STARTED|Overall Study||36
7948220|NCT00455663|19562532|P1|STARTED|Overall Study||37
7948221|NCT00455650|19562551|P6|NOT COMPLETED|Week 3||0
7948222|NCT00455650|19562552|P5|NOT COMPLETED|Week 3||0
7948223|NCT00455650|19562553|P4|NOT COMPLETED|Week 3||0
7948224|NCT00455650|19562554|P3|NOT COMPLETED|Week 3||0
7948225|NCT00455650|19562555|P2|NOT COMPLETED|Week 3||0
7948226|NCT00455650|19562556|P1|NOT COMPLETED|Week 3||0
7948227|NCT00455650|19562551|P6|COMPLETED|Week 3||13
7948228|NCT00455650|19562552|P5|COMPLETED|Week 3||14
7948229|NCT00455650|19562553|P4|COMPLETED|Week 3||14
7948230|NCT00455650|19562554|P3|COMPLETED|Week 3||10
7948231|NCT00455650|19562555|P2|COMPLETED|Week 3||10
7948232|NCT00455650|19562556|P1|COMPLETED|Week 3||10
7948233|NCT00455650|19562551|P6|STARTED|Week 3||13
7948234|NCT00455650|19562552|P5|STARTED|Week 3||14
7948235|NCT00455650|19562553|P4|STARTED|Week 3||14
7948236|NCT00455650|19562554|P3|STARTED|Week 3||10
7948237|NCT00455650|19562555|P2|STARTED|Week 3||10
7948238|NCT00455650|19562556|P1|STARTED|Week 3||10
7948239|NCT00455650|19562551|P6|NOT COMPLETED|Week 2||0
7948240|NCT00455650|19562552|P5|NOT COMPLETED|Week 2||0
7948241|NCT00455650|19562553|P4|NOT COMPLETED|Week 2||0
7948242|NCT00455650|19562554|P3|NOT COMPLETED|Week 2||0
7948243|NCT00455650|19562555|P2|NOT COMPLETED|Week 2||0
7948244|NCT00455650|19562556|P1|NOT COMPLETED|Week 2||0
7948245|NCT00455650|19562551|P6|COMPLETED|Week 2||13
7948246|NCT00455650|19562552|P5|COMPLETED|Week 2||14
7948247|NCT00455650|19562553|P4|COMPLETED|Week 2||14
7948248|NCT00455650|19562554|P3|COMPLETED|Week 2||10
7948249|NCT00455650|19562555|P2|COMPLETED|Week 2||10
7948250|NCT00455650|19562556|P1|COMPLETED|Week 2||10
7948251|NCT00455650|19562551|P6|STARTED|Week 2||13
7948252|NCT00455650|19562552|P5|STARTED|Week 2||14
7948253|NCT00455650|19562553|P4|STARTED|Week 2||14
7948254|NCT00455650|19562554|P3|STARTED|Week 2||10
7948255|NCT00455650|19562555|P2|STARTED|Week 2||10
7948256|NCT00455650|19562556|P1|STARTED|Week 2||10
7948257|NCT00455650|19562551|P6|NOT COMPLETED|Week 1||0
7948258|NCT00455650|19562552|P5|NOT COMPLETED|Week 1||0
7948259|NCT00455650|19562553|P4|NOT COMPLETED|Week 1||0
7948260|NCT00455650|19562554|P3|NOT COMPLETED|Week 1||0
7948261|NCT00455650|19562555|P2|NOT COMPLETED|Week 1||0
7948262|NCT00455650|19562556|P1|NOT COMPLETED|Week 1||0
7948263|NCT00455650|19562551|P6|COMPLETED|Week 1||13
7948264|NCT00455650|19562552|P5|COMPLETED|Week 1||14
7948265|NCT00455650|19562553|P4|COMPLETED|Week 1||14
7948266|NCT00455650|19562554|P3|COMPLETED|Week 1||10
7948267|NCT00455650|19562555|P2|COMPLETED|Week 1||10
7948268|NCT00455650|19562556|P1|COMPLETED|Week 1||10
7948269|NCT00455650|19562551|P6|STARTED|Week 1||13
7948270|NCT00455650|19562552|P5|STARTED|Week 1||14
7948271|NCT00455650|19562553|P4|STARTED|Week 1||14
7948272|NCT00455650|19562554|P3|STARTED|Week 1||10
7948273|NCT00455650|19562555|P2|STARTED|Week 1||10
7948274|NCT00455650|19562556|P1|STARTED|Week 1||10
7948275|NCT00455533|19562586|P3|NOT COMPLETED|Period Two: Randomized Period||6
7948276|NCT00455533|19562587|P2|NOT COMPLETED|Period Two: Randomized Period||6
7948277|NCT00455533|19562588|P1|NOT COMPLETED|Period Two: Randomized Period||0
7948278|NCT00455533|19562586|P3|COMPLETED|Period Two: Randomized Period||138
7948279|NCT00455533|19562587|P2|COMPLETED|Period Two: Randomized Period||139
7948280|NCT00455533|19562588|P1|COMPLETED|Period Two: Randomized Period||0
7948281|NCT00455533|19562586|P3|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144
7948282|NCT00455533|19562587|P2|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145
7948283|NCT00455533|19562588|P1|STARTED|Period Two: Randomized Period||0
7948284|NCT00455533|19562586|P3|NOT COMPLETED|Period One: Initial Chemotherapy||0
7948285|NCT00455533|19562587|P2|NOT COMPLETED|Period One: Initial Chemotherapy||0
7948286|NCT00455533|19562588|P1|NOT COMPLETED|Period One: Initial Chemotherapy||18
7948287|NCT00455533|19562586|P3|COMPLETED|Period One: Initial Chemotherapy||0
7948288|NCT00455533|19562587|P2|COMPLETED|Period One: Initial Chemotherapy||0
7948289|NCT00455533|19562588|P1|COMPLETED|Period One: Initial Chemotherapy||295
7948290|NCT00455533|19562586|P3|STARTED|Period One: Initial Chemotherapy||0
7948291|NCT00455533|19562587|P2|STARTED|Period One: Initial Chemotherapy||0
7948292|NCT00455533|19562588|P1|STARTED|Period One: Initial Chemotherapy||313
7948293|NCT00455520|19562637|P2|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62
7948294|NCT00455520|19562638|P1|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63
7948295|NCT00455520|19562637|P2|COMPLETED|Double Blind Tapentadol ER vs Placebo||131
7948296|NCT00455520|19562638|P1|COMPLETED|Double Blind Tapentadol ER vs Placebo||133
7948297|NCT00455520|19562637|P2|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193
7948298|NCT00455520|19562638|P1|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196
7948299|NCT00455520|19562637|P2|NOT COMPLETED|Open Label Tapentadol Extended Release||0
7948300|NCT00455520|19562638|P1|NOT COMPLETED|Open Label Tapentadol Extended Release||196
7948301|NCT00455520|19562637|P2|COMPLETED|Open Label Tapentadol Extended Release||0
7948302|NCT00455520|19562638|P1|COMPLETED|Open Label Tapentadol Extended Release||395
7948303|NCT00455520|19562637|P2|STARTED|Open Label Tapentadol Extended Release||0
7948304|NCT00455520|19562638|P1|STARTED|Open Label Tapentadol Extended Release||591
7948305|NCT00455455|19562654|P2|NOT COMPLETED|Second Intervention||0
7948306|NCT00455455|19562655|P1|NOT COMPLETED|Second Intervention||0
7948307|NCT00455455|19562654|P2|COMPLETED|Second Intervention||24
7948308|NCT00455455|19562655|P1|COMPLETED|Second Intervention||24
7948309|NCT00455455|19562654|P2|STARTED|Second Intervention||24
7948310|NCT00455455|19562655|P1|STARTED|Second Intervention||24
7948311|NCT00455455|19562654|P2|NOT COMPLETED|Washout||0
7948312|NCT00455455|19562655|P1|NOT COMPLETED|Washout||1
7948313|NCT00455455|19562654|P2|COMPLETED|Washout||24
7948314|NCT00455455|19562655|P1|COMPLETED|Washout||24
7948315|NCT00455455|19562654|P2|STARTED|Washout||24
7948316|NCT00455455|19562655|P1|STARTED|Washout||25
7948317|NCT00455455|19562654|P2|NOT COMPLETED|First Intervention||0
7948318|NCT00455455|19562655|P1|NOT COMPLETED|First Intervention||0
7948319|NCT00455455|19562654|P2|COMPLETED|First Intervention||24
7948320|NCT00455455|19562655|P1|COMPLETED|First Intervention||25
7948321|NCT00455455|19562654|P2|STARTED|First Intervention||24
7948322|NCT00455455|19562655|P1|STARTED|First Intervention||25
7948323|NCT00455455|19562654|P2|NOT COMPLETED|Washout||1
7948324|NCT00455455|19562655|P1|NOT COMPLETED|Washout||0
7948325|NCT00455455|19562654|P2|COMPLETED|Washout||24
7948326|NCT00455455|19562655|P1|COMPLETED|Washout||25
7948327|NCT00455455|19562654|P2|STARTED|Washout||25
7948328|NCT00455455|19562655|P1|STARTED|Washout||25
7948329|NCT00455429|19562675|P4|NOT COMPLETED|Overall Study||14
7948330|NCT00455429|19562676|P3|NOT COMPLETED|Overall Study||1
7948331|NCT00455429|19562677|P2|NOT COMPLETED|Overall Study||5
7948332|NCT00455429|19562678|P1|NOT COMPLETED|Overall Study||2
7948333|NCT00455429|19562675|P4|COMPLETED|Overall Study||20
7948334|NCT00455429|19562676|P3|COMPLETED|Overall Study||16
7948335|NCT00455429|19562677|P2|COMPLETED|Overall Study||10
7948336|NCT00455429|19562678|P1|COMPLETED|Overall Study||16
7948337|NCT00455429|19562675|P4|Treated|Overall Study||32
7948338|NCT00455429|19562676|P3|Treated|Overall Study||17
7948339|NCT00455429|19562677|P2|Treated|Overall Study||15
7948340|NCT00455429|19562678|P1|Treated|Overall Study||18
7948341|NCT00455429|19562675|P4|STARTED|Overall Study||34
7948342|NCT00455429|19562676|P3|STARTED|Overall Study||17
7948343|NCT00455429|19562677|P2|STARTED|Overall Study||15
7948344|NCT00455429|19562678|P1|STARTED|Overall Study||18
7948345|NCT00455312|19562737|P2|NOT COMPLETED|Overall Study||1
7948346|NCT00455312|19562738|P1|NOT COMPLETED|Overall Study||0
7948347|NCT00455312|19562737|P2|COMPLETED|Overall Study||20
7948348|NCT00455312|19562738|P1|COMPLETED|Overall Study||15
7948349|NCT00455312|19562737|P2|STARTED|Overall Study||21
7948350|NCT00455312|19562738|P1|STARTED|Overall Study||15
7948351|NCT00455195|19562764|P2|NOT COMPLETED|Extension Study AGLU03206||0
7948352|NCT00455195|19562765|P1|NOT COMPLETED|Extension Study AGLU03206||0
7948353|NCT00455195|19562764|P2|COMPLETED|Extension Study AGLU03206||26
7948354|NCT00455195|19562765|P1|COMPLETED|Extension Study AGLU03206||55
7948355|NCT00455195|19562764|P2|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26
7948356|NCT00455195|19562765|P1|STARTED|Extension Study AGLU03206||55
7948357|NCT00455195|19562764|P2|NOT COMPLETED|Double-blind Study AGLU02704||4
7948358|NCT00455195|19562765|P1|NOT COMPLETED|Double-blind Study AGLU02704||5
7948359|NCT00455195|19562764|P2|COMPLETED|Double-blind Study AGLU02704||26
7948360|NCT00455195|19562765|P1|COMPLETED|Double-blind Study AGLU02704||55
7948361|NCT00455195|19562764|P2|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30
7948362|NCT00455195|19562765|P1|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60
7948363|NCT00455143|19562779|P1|NOT COMPLETED|Overall Study||6
7948364|NCT00455143|19562779|P1|COMPLETED|Overall Study||21
7948365|NCT00455143|19562779|P1|STARTED|Overall Study||27
7948366|NCT00455013|19562803|P3|NOT COMPLETED|Long Term Extension (LTE)||7
7948367|NCT00455013|19562804|P2|NOT COMPLETED|Long Term Extension (LTE)||3
7948368|NCT00455013|19562805|P1|NOT COMPLETED|Long Term Extension (LTE)||2
7948369|NCT00455013|19562803|P3|COMPLETED|Long Term Extension (LTE)||20
7948370|NCT00455013|19562804|P2|COMPLETED|Long Term Extension (LTE)||16
7948371|NCT00455013|19562805|P1|COMPLETED|Long Term Extension (LTE)||25
7948372|NCT00455013|19562803|P3|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27
7948373|NCT00455013|19562804|P2|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19
7948374|NCT00455013|19562805|P1|STARTED|Long Term Extension (LTE)||27
7948375|NCT00455013|19562803|P3|NOT COMPLETED|Short Term Period||2
7948376|NCT00455013|19562804|P2|NOT COMPLETED|Short Term Period||5
7948377|NCT00455013|19562805|P1|NOT COMPLETED|Short Term Period||6
7948378|NCT00455013|19562803|P3|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28
7948379|NCT00455013|19562804|P2|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21
7948380|NCT00455013|19562805|P1|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27
7948381|NCT00455013|19562803|P3|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30
7948382|NCT00455013|19562804|P2|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26
7948383|NCT00455013|19562805|P1|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33
7948384|NCT00454987|19562873|P3|NOT COMPLETED|Year 4 (NCT00454987)||0
7948385|NCT00454987|19562874|P2|NOT COMPLETED|Year 4 (NCT00454987)||0
7948386|NCT00454987|19562875|P1|NOT COMPLETED|Year 4 (NCT00454987)||0
7948387|NCT00454987|19562873|P3|COMPLETED|Year 4 (NCT00454987)||0
7948388|NCT00454987|19562874|P2|COMPLETED|Year 4 (NCT00454987)||62
7948389|NCT00454987|19562875|P1|COMPLETED|Year 4 (NCT00454987)||206
7948390|NCT00454987|19562873|P3|STARTED|Year 4 (NCT00454987)||0
7948391|NCT00454987|19562874|P2|STARTED|Year 4 (NCT00454987)||62
7948392|NCT00454987|19562875|P1|STARTED|Year 4 (NCT00454987)||206
7948393|NCT00454987|19562873|P3|NOT COMPLETED|Year 2 (NCT00454987)||0
7948394|NCT00454987|19562874|P2|NOT COMPLETED|Year 2 (NCT00454987)||0
7948395|NCT00454987|19562875|P1|NOT COMPLETED|Year 2 (NCT00454987)||0
7948396|NCT00454987|19562873|P3|COMPLETED|Year 2 (NCT00454987)||74
7948397|NCT00454987|19562874|P2|COMPLETED|Year 2 (NCT00454987)||77
7948398|NCT00454987|19562875|P1|COMPLETED|Year 2 (NCT00454987)||235
7948399|NCT00454987|19562873|P3|STARTED|Year 2 (NCT00454987)||74
7948400|NCT00454987|19562874|P2|STARTED|Year 2 (NCT00454987)||77
7948401|NCT00454987|19562875|P1|STARTED|Year 2 (NCT00454987)||235
7948402|NCT00454987|19562873|P3|NOT COMPLETED|Year 1 (NCT00454987)||0
7948403|NCT00454987|19562874|P2|NOT COMPLETED|Year 1 (NCT00454987)||0
7948404|NCT00454987|19562875|P1|NOT COMPLETED|Year 1 (NCT00454987)||0
7948405|NCT00454987|19562873|P3|COMPLETED|Year 1 (NCT00454987)||0
7948406|NCT00454987|19562874|P2|COMPLETED|Year 1 (NCT00454987)||67
7948407|NCT00454987|19562875|P1|COMPLETED|Year 1 (NCT00454987)||221
7948408|NCT00454987|19562873|P3|STARTED|Year 1 (NCT00454987)||0
7948409|NCT00454987|19562874|P2|STARTED|Year 1 (NCT00454987)||67
7948410|NCT00454987|19562875|P1|STARTED|Year 1 (NCT00454987)||221
7948411|NCT00454987|19562873|P3|NOT COMPLETED|Booster Period (NCT00258700)||0
7948412|NCT00454987|19562874|P2|NOT COMPLETED|Booster Period (NCT00258700)||1
7948413|NCT00454987|19562875|P1|NOT COMPLETED|Booster Period (NCT00258700)||2
7948414|NCT00454987|19562873|P3|COMPLETED|Booster Period (NCT00258700)||0
7948415|NCT00454987|19562874|P2|COMPLETED|Booster Period (NCT00258700)||116
7948416|NCT00454987|19562875|P1|COMPLETED|Booster Period (NCT00258700)||357
7948417|NCT00454987|19562873|P3|STARTED|Booster Period (NCT00258700)||0
7948418|NCT00454987|19562874|P2|STARTED|Booster Period (NCT00258700)||117
7948419|NCT00454987|19562875|P1|STARTED|Booster Period (NCT00258700)||359
7948420|NCT00454909|19562949|P3|NOT COMPLETED|Overall Study||2
7948421|NCT00454909|19562950|P2|NOT COMPLETED|Overall Study||3
7948422|NCT00454909|19562951|P1|NOT COMPLETED|Overall Study||7
7948423|NCT00454909|19562949|P3|COMPLETED|Overall Study||86
7948424|NCT00454909|19562950|P2|COMPLETED|Overall Study||194
7948425|NCT00454909|19562951|P1|COMPLETED|Overall Study||580
7948426|NCT00454909|19562949|P3|STARTED|Overall Study||88
7948427|NCT00454909|19562950|P2|STARTED|Overall Study||197
7948428|NCT00454909|19562951|P1|STARTED|Overall Study||587
7948429|NCT00454857|19562989|P1|NOT COMPLETED|Overall Study||54
7948430|NCT00454857|19562989|P1|COMPLETED|Overall Study||272
7948431|NCT00454857|19562989|P1|Completed ≥1 Observational Study Visit|Overall Study||319
7948432|NCT00454857|19562989|P1|Completed Retrospective Chart Review|Overall Study||324
7948433|NCT00454857|19562989|P1|STARTED|Overall Study||326
7948434|NCT00454818|19563014|P5|NOT COMPLETED|Phase 2: Randomized Double-blind||4
7948435|NCT00454818|19563015|P4|NOT COMPLETED|Phase 2: Randomized Double-blind||1
7948436|NCT00454818|19563016|P3|NOT COMPLETED|Phase 2: Randomized Double-blind||3
7948437|NCT00454818|19563017|P2|NOT COMPLETED|Phase 2: Randomized Double-blind||2
7948438|NCT00454818|19563018|P1|NOT COMPLETED|Phase 2: Randomized Double-blind||0
7948439|NCT00454818|19563014|P5|COMPLETED|Phase 2: Randomized Double-blind||10
7948440|NCT00454818|19563015|P4|COMPLETED|Phase 2: Randomized Double-blind||8
7948441|NCT00454818|19563016|P3|COMPLETED|Phase 2: Randomized Double-blind||5
7948442|NCT00454818|19563017|P2|COMPLETED|Phase 2: Randomized Double-blind||6
7948443|NCT00454818|19563018|P1|COMPLETED|Phase 2: Randomized Double-blind||0
7948444|NCT00454818|19563014|P5|STARTED|Phase 2: Randomized Double-blind||14
7948445|NCT00454818|19563015|P4|STARTED|Phase 2: Randomized Double-blind||9
7948446|NCT00454818|19563016|P3|STARTED|Phase 2: Randomized Double-blind||8
7948447|NCT00454818|19563017|P2|STARTED|Phase 2: Randomized Double-blind||8
7948448|NCT00454818|19563018|P1|STARTED|Phase 2: Randomized Double-blind||0
7948449|NCT00454818|19563014|P5|NOT COMPLETED|Phase I: Open-label Dose-escalation||0
7948450|NCT00454818|19563015|P4|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
7948451|NCT00454818|19563016|P3|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
7948452|NCT00454818|19563017|P2|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
7948453|NCT00454818|19563018|P1|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
7948454|NCT00454818|19563014|P5|COMPLETED|Phase I: Open-label Dose-escalation||0
7948455|NCT00454818|19563015|P4|COMPLETED|Phase I: Open-label Dose-escalation||2
7948456|NCT00454818|19563016|P3|COMPLETED|Phase I: Open-label Dose-escalation||2
7948457|NCT00454818|19563017|P2|COMPLETED|Phase I: Open-label Dose-escalation||2
7948458|NCT00454818|19563018|P1|COMPLETED|Phase I: Open-label Dose-escalation||2
7948459|NCT00454818|19563014|P5|STARTED|Phase I: Open-label Dose-escalation||0
7948460|NCT00454818|19563015|P4|STARTED|Phase I: Open-label Dose-escalation||3
7948461|NCT00454818|19563016|P3|STARTED|Phase I: Open-label Dose-escalation||3
7948462|NCT00454818|19563017|P2|STARTED|Phase I: Open-label Dose-escalation||3
7948463|NCT00454818|19563018|P1|STARTED|Phase I: Open-label Dose-escalation||3
7948464|NCT00454805|19563097|P2|NOT COMPLETED|Overall Study||23
7948465|NCT00454805|19563098|P1|NOT COMPLETED|Overall Study||26
7948466|NCT00454805|19563097|P2|COMPLETED|Overall Study|Ongoing at data cut-off|8
7948467|NCT00454805|19563098|P1|COMPLETED|Overall Study|Ongoing at data cut-off|5
7948468|NCT00454805|19563097|P2|STARTED|Overall Study|Randomised|31
7948469|NCT00454805|19563098|P1|STARTED|Overall Study|Randomised|31
7948470|NCT00454779|19563114|P2|NOT COMPLETED|Second-line Treatment Phase||3
7948471|NCT00454779|19563115|P1|NOT COMPLETED|Second-line Treatment Phase||0
7948472|NCT00454779|19563114|P2|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27
7948473|NCT00454779|19563115|P1|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0
7948474|NCT00454779|19563114|P2|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30
7948475|NCT00454779|19563115|P1|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0
7948476|NCT00454779|19563114|P2|NOT COMPLETED|First-line Treatment Phase||8
7948477|NCT00454779|19563115|P1|NOT COMPLETED|First-line Treatment Phase||5
7948478|NCT00454779|19563114|P2|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49
7948479|NCT00454779|19563115|P1|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51
7948480|NCT00454779|19563114|P2|Received Study Medication|First-line Treatment Phase||55
7948481|NCT00454779|19563115|P1|Received Study Medication|First-line Treatment Phase||56
7948482|NCT00454779|19563114|P2|STARTED|First-line Treatment Phase||57
7948483|NCT00454779|19563115|P1|STARTED|First-line Treatment Phase||56
7948484|NCT00454649|19563153|P10|NOT COMPLETED|Overall Study||5
7948485|NCT00454649|19563154|P9|NOT COMPLETED|Overall Study||20
7948486|NCT00454649|19563155|P8|NOT COMPLETED|Overall Study||19
7948487|NCT00454649|19563156|P7|NOT COMPLETED|Overall Study||9
7948488|NCT00454649|19563157|P6|NOT COMPLETED|Overall Study||7
7948489|NCT00454649|19563158|P5|NOT COMPLETED|Overall Study||1
7948490|NCT00454649|19563159|P4|NOT COMPLETED|Overall Study||6
7948491|NCT00454649|19563160|P3|NOT COMPLETED|Overall Study||19
7948492|NCT00454649|19563161|P2|NOT COMPLETED|Overall Study||4
7948493|NCT00454649|19563162|P1|NOT COMPLETED|Overall Study||3
7948494|NCT00454649|19563153|P10|COMPLETED|Overall Study||1
7948495|NCT00454649|19563154|P9|COMPLETED|Overall Study||1
7948496|NCT00454649|19563155|P8|COMPLETED|Overall Study||0
7948497|NCT00454649|19563156|P7|COMPLETED|Overall Study||0
7948498|NCT00454649|19563157|P6|COMPLETED|Overall Study||0
7948499|NCT00454649|19563158|P5|COMPLETED|Overall Study||0
7948500|NCT00454649|19563159|P4|COMPLETED|Overall Study||1
7948501|NCT00454649|19563160|P3|COMPLETED|Overall Study||1
7948502|NCT00454649|19563161|P2|COMPLETED|Overall Study||1
7948503|NCT00454649|19563162|P1|COMPLETED|Overall Study||0
7948504|NCT00454649|19563153|P10|STARTED|Overall Study||6
7948505|NCT00454649|19563154|P9|STARTED|Overall Study||21
7948506|NCT00454649|19563155|P8|STARTED|Overall Study||19
7948507|NCT00454649|19563156|P7|STARTED|Overall Study||9
7948508|NCT00454649|19563157|P6|STARTED|Overall Study||7
7948509|NCT00454649|19563158|P5|STARTED|Overall Study||1
7948510|NCT00454649|19563159|P4|STARTED|Overall Study||7
7948511|NCT00454649|19563160|P3|STARTED|Overall Study||20
7948512|NCT00454649|19563161|P2|STARTED|Overall Study||5
7948513|NCT00454649|19563162|P1|STARTED|Overall Study||3
7948514|NCT00454636|19563291|P4|NOT COMPLETED|Overall Study||32
7948515|NCT00454636|19563292|P3|NOT COMPLETED|Overall Study||20
7948516|NCT00454636|19563293|P2|NOT COMPLETED|Overall Study||23
7948517|NCT00454636|19563294|P1|NOT COMPLETED|Overall Study||31
7948518|NCT00454636|19563291|P4|COMPLETED|Overall Study||26
7948519|NCT00454636|19563292|P3|COMPLETED|Overall Study||7
7948520|NCT00454636|19563293|P2|COMPLETED|Overall Study||9
7948521|NCT00454636|19563294|P1|COMPLETED|Overall Study||10
7948522|NCT00454636|19563291|P4|STARTED|Overall Study||58
7948523|NCT00454636|19563292|P3|STARTED|Overall Study||27
7948524|NCT00454636|19563293|P2|STARTED|Overall Study||32
7948525|NCT00454636|19563294|P1|STARTED|Overall Study||41
7948526|NCT00454584|19563327|P6|NOT COMPLETED|After Controlled Period||32
7948527|NCT00454584|19563328|P5|NOT COMPLETED|After Controlled Period||12
7948528|NCT00454584|19563329|P4|NOT COMPLETED|After Controlled Period||26
7948529|NCT00454584|19563330|P3|NOT COMPLETED|After Controlled Period||0
7948530|NCT00454584|19563331|P2|NOT COMPLETED|After Controlled Period||0
7948531|NCT00454584|19563332|P1|NOT COMPLETED|After Controlled Period||0
7948532|NCT00454584|19563327|P6|COMPLETED|After Controlled Period||310
7948533|NCT00454584|19563328|P5|COMPLETED|After Controlled Period||189
7948534|NCT00454584|19563329|P4|COMPLETED|After Controlled Period||310
7948535|NCT00454584|19563330|P3|COMPLETED|After Controlled Period||0
7948536|NCT00454584|19563331|P2|COMPLETED|After Controlled Period||0
7948537|NCT00454584|19563332|P1|COMPLETED|After Controlled Period||0
7948538|NCT00454584|19563327|P6|STARTED|After Controlled Period||342
7948539|NCT00454584|19563328|P5|STARTED|After Controlled Period||201
7948540|NCT00454584|19563329|P4|STARTED|After Controlled Period||336
7948541|NCT00454584|19563330|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
7948542|NCT00454584|19563331|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
7948543|NCT00454584|19563332|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
7948544|NCT00454584|19563327|P6|NOT COMPLETED|Controlled Period||0
7948545|NCT00454584|19563328|P5|NOT COMPLETED|Controlled Period||0
7948546|NCT00454584|19563329|P4|NOT COMPLETED|Controlled Period||0
7948547|NCT00454584|19563330|P3|NOT COMPLETED|Controlled Period||5
7948548|NCT00454584|19563331|P2|NOT COMPLETED|Controlled Period||8
7948549|NCT00454584|19563332|P1|NOT COMPLETED|Controlled Period||11
7948550|NCT00454584|19563327|P6|COMPLETED|Controlled Period||0
7948551|NCT00454584|19563328|P5|COMPLETED|Controlled Period||0
7948552|NCT00454584|19563329|P4|COMPLETED|Controlled Period||0
7948553|NCT00454584|19563330|P3|COMPLETED|Controlled Period||342
7948554|NCT00454584|19563331|P2|COMPLETED|Controlled Period||201
7948555|NCT00454584|19563332|P1|COMPLETED|Controlled Period||336
7948556|NCT00454584|19563327|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
7948557|NCT00454584|19563328|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
7948558|NCT00454584|19563329|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
7948559|NCT00454584|19563330|P3|STARTED|Controlled Period||347
7948560|NCT00454584|19563331|P2|STARTED|Controlled Period||209
7948561|NCT00454584|19563332|P1|STARTED|Controlled Period||347
7948562|NCT00454571|19563354|P2|NOT COMPLETED|Overall Study||6
7948563|NCT00454571|19563355|P1|NOT COMPLETED|Overall Study||13
7948564|NCT00454571|19563354|P2|COMPLETED|Overall Study||13
7948565|NCT00454571|19563355|P1|COMPLETED|Overall Study||5
7948566|NCT00454571|19563354|P2|STARTED|Overall Study||19
7948567|NCT00454571|19563355|P1|STARTED|Overall Study||18
7948568|NCT00454532|19563367|P4|NOT COMPLETED|Overall Study||0
7948569|NCT00454532|19563368|P3|NOT COMPLETED|Overall Study||0
7948570|NCT00454532|19563369|P2|NOT COMPLETED|Overall Study||0
7948571|NCT00454532|19563370|P1|NOT COMPLETED|Overall Study||0
7948572|NCT00454532|19563367|P4|COMPLETED|Overall Study||7
7948573|NCT00454532|19563368|P3|COMPLETED|Overall Study||3
7948574|NCT00454532|19563369|P2|COMPLETED|Overall Study||6
7948575|NCT00454532|19563370|P1|COMPLETED|Overall Study||11
7948576|NCT00454532|19563367|P4|STARTED|Overall Study||7
7948577|NCT00454532|19563368|P3|STARTED|Overall Study||3
7948578|NCT00454532|19563369|P2|STARTED|Overall Study||6
7948579|NCT00454532|19563370|P1|STARTED|Overall Study||11
7948580|NCT00454363|19563390|P2|NOT COMPLETED|Overall Study||2
7948581|NCT00454363|19563391|P1|NOT COMPLETED|Overall Study||5
7948582|NCT00454363|19563390|P2|COMPLETED|Overall Study||29
7948583|NCT00454363|19563391|P1|COMPLETED|Overall Study||15
7948584|NCT00454363|19563390|P2|STARTED|Overall Study||31
7948585|NCT00454363|19563391|P1|STARTED|Overall Study||20
7948586|NCT00454324|19563404|P2|NOT COMPLETED|Overall Study||0
7948587|NCT00454324|19563405|P1|NOT COMPLETED|Overall Study||0
7948588|NCT00454324|19563404|P2|COMPLETED|Overall Study||13
7948589|NCT00454324|19563405|P1|COMPLETED|Overall Study||14
7948590|NCT00454324|19563404|P2|STARTED|Overall Study||13
7948591|NCT00454324|19563405|P1|STARTED|Overall Study||14
7948592|NCT00454246|19563420|P3|NOT COMPLETED|Overall Study||9
7948593|NCT00454246|19563421|P2|NOT COMPLETED|Overall Study||29
7948594|NCT00454246|19563422|P1|NOT COMPLETED|Overall Study||73
7948595|NCT00454246|19563420|P3|COMPLETED|Overall Study||0
7948596|NCT00454246|19563421|P2|COMPLETED|Overall Study||0
7948597|NCT00454246|19563422|P1|COMPLETED|Overall Study||0
7948598|NCT00454246|19563420|P3|STARTED|Overall Study||9
7948599|NCT00454246|19563421|P2|STARTED|Overall Study||29
7948600|NCT00454246|19563422|P1|STARTED|Overall Study||73
7948601|NCT00454207|19563438|P2|NOT COMPLETED|Overall Study||2
7948602|NCT00454207|19563439|P1|NOT COMPLETED|Overall Study||4
7948603|NCT00454207|19563438|P2|COMPLETED|Overall Study||21
7948604|NCT00454207|19563439|P1|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17
7948605|NCT00454207|19563438|P2|STARTED|Overall Study||23
7948606|NCT00454207|19563439|P1|STARTED|Overall Study||21
7948607|NCT00454194|19563484|P2|NOT COMPLETED|Overall Study||14
7948608|NCT00454194|19563485|P1|NOT COMPLETED|Overall Study||22
7948609|NCT00454194|19563484|P2|COMPLETED|Overall Study||37
7948610|NCT00454194|19563485|P1|COMPLETED|Overall Study||25
7948611|NCT00454194|19563484|P2|STARTED|Overall Study||51
7948612|NCT00454194|19563485|P1|STARTED|Overall Study||47
7948613|NCT00454181|19563503|P2|NOT COMPLETED|Overall Study||3
7948614|NCT00454181|19563504|P1|NOT COMPLETED|Overall Study||15
7948615|NCT00454181|19563503|P2|COMPLETED|Overall Study||11
7948616|NCT00454181|19563504|P1|COMPLETED|Overall Study||30
7948617|NCT00454181|19563503|P2|STARTED|Overall Study||14
7948618|NCT00454181|19563504|P1|STARTED|Overall Study||45
7948619|NCT00454142|19563520|P1|NOT COMPLETED|Overall Study||1
7948620|NCT00454142|19563520|P1|COMPLETED|Overall Study||32
7948621|NCT00454142|19563520|P1|STARTED|Overall Study||33
7948622|NCT00454116|19563538|P3|NOT COMPLETED|Overall Study||28
7948623|NCT00454116|19563539|P2|NOT COMPLETED|Overall Study||29
7948624|NCT00454116|19563540|P1|NOT COMPLETED|Overall Study||27
7948625|NCT00454116|19563538|P3|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
7948626|NCT00454116|19563539|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
7948627|NCT00454116|19563540|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8
7948628|NCT00454116|19563538|P3|STARTED|Overall Study|randomised patients|35
7948629|NCT00454116|19563539|P2|STARTED|Overall Study|randomised patients|36
7948630|NCT00454116|19563540|P1|STARTED|Overall Study|randomised patients|35
7948631|NCT00454051|19563550|P2|NOT COMPLETED|Overall Study||3
7948632|NCT00454051|19563551|P1|NOT COMPLETED|Overall Study||3
7948633|NCT00454051|19563550|P2|COMPLETED|Overall Study||8
7948634|NCT00454051|19563551|P1|COMPLETED|Overall Study||17
7948635|NCT00454051|19563550|P2|STARTED|Overall Study||11
7948636|NCT00454051|19563551|P1|STARTED|Overall Study||20
7948637|NCT00453999|19563584|P3|NOT COMPLETED|Overall Study||3
7948638|NCT00453999|19563585|P2|NOT COMPLETED|Overall Study||5
7948639|NCT00453999|19563586|P1|NOT COMPLETED|Overall Study||5
7948640|NCT00453999|19563584|P3|COMPLETED|Overall Study||43
7948641|NCT00453999|19563585|P2|COMPLETED|Overall Study||41
7948642|NCT00453999|19563586|P1|COMPLETED|Overall Study||40
7948643|NCT00453999|19563584|P3|STARTED|Overall Study||46
7948644|NCT00453999|19563585|P2|STARTED|Overall Study||46
7948645|NCT00453999|19563586|P1|STARTED|Overall Study||45
7948646|NCT00453986|19563614|P5|NOT COMPLETED|Overall Study||0
7948647|NCT00453986|19563615|P4|NOT COMPLETED|Overall Study||2
7948648|NCT00453986|19563616|P3|NOT COMPLETED|Overall Study||6
7948649|NCT00453986|19563617|P2|NOT COMPLETED|Overall Study||5
7948650|NCT00453986|19563618|P1|NOT COMPLETED|Overall Study||6
7948651|NCT00453986|19563614|P5|COMPLETED|Overall Study||105
7948652|NCT00453986|19563615|P4|COMPLETED|Overall Study||310
7948653|NCT00453986|19563616|P3|COMPLETED|Overall Study||307
7948654|NCT00453986|19563617|P2|COMPLETED|Overall Study||306
7948655|NCT00453986|19563618|P1|COMPLETED|Overall Study||305
7948656|NCT00453986|19563614|P5|STARTED|Overall Study||105
7948657|NCT00453986|19563615|P4|STARTED|Overall Study||312
7948658|NCT00453986|19563616|P3|STARTED|Overall Study||313
7948659|NCT00453986|19563617|P2|STARTED|Overall Study||311
7948660|NCT00453986|19563618|P1|STARTED|Overall Study||311
7948661|NCT00453973|19563711|P2|NOT COMPLETED|Overall Study||48
7948662|NCT00453973|19563712|P1|NOT COMPLETED|Overall Study||51
7948663|NCT00453973|19563711|P2|COMPLETED|Overall Study||15
7948664|NCT00453973|19563712|P1|COMPLETED|Overall Study||0
7948665|NCT00453973|19563711|P2|STARTED|Overall Study||63
7948666|NCT00453973|19563712|P1|STARTED|Overall Study||51
7948667|NCT00453921|19563722|P4|NOT COMPLETED|Overall Study||1
7948668|NCT00453921|19563723|P3|NOT COMPLETED|Overall Study||2
7948669|NCT00453921|19563724|P2|NOT COMPLETED|Overall Study||1
7948670|NCT00453921|19563725|P1|NOT COMPLETED|Overall Study||1
7948671|NCT00453921|19563722|P4|COMPLETED|Overall Study||18
7948672|NCT00453921|19563723|P3|COMPLETED|Overall Study||18
7948673|NCT00453921|19563724|P2|COMPLETED|Overall Study||17
7948674|NCT00453921|19563725|P1|COMPLETED|Overall Study||18
7948675|NCT00453921|19563722|P4|STARTED|Overall Study||19
7948676|NCT00453921|19563723|P3|STARTED|Overall Study||20
7948677|NCT00453921|19563724|P2|STARTED|Overall Study||18
7948678|NCT00453921|19563725|P1|STARTED|Overall Study||19
7948679|NCT00453895|19563759|P1|NOT COMPLETED|Overall Study||0
7948680|NCT00453895|19563759|P1|COMPLETED|Overall Study||39
7948681|NCT00453895|19563759|P1|STARTED|Overall Study||39
7948682|NCT00453479|19563770|P3|NOT COMPLETED|Overall Study||0
7948683|NCT00453479|19563771|P2|NOT COMPLETED|Overall Study||0
7948684|NCT00453479|19563772|P1|NOT COMPLETED|Overall Study||0
7948685|NCT00453479|19563770|P3|COMPLETED|Overall Study||8
7948686|NCT00453479|19563771|P2|COMPLETED|Overall Study||9
7948687|NCT00453479|19563772|P1|COMPLETED|Overall Study||6
7948688|NCT00453479|19563770|P3|STARTED|Overall Study||8
7948689|NCT00453479|19563771|P2|STARTED|Overall Study||9
7948690|NCT00453479|19563772|P1|STARTED|Overall Study||6
7948691|NCT00453388|19563847|P4|NOT COMPLETED|Overall Study||0
7948692|NCT00453388|19563848|P3|NOT COMPLETED|Overall Study||0
7948693|NCT00453388|19563849|P2|NOT COMPLETED|Overall Study||0
7948694|NCT00453388|19563850|P1|NOT COMPLETED|Overall Study||0
7948695|NCT00453388|19563847|P4|COMPLETED|Overall Study||0
7948696|NCT00453388|19563848|P3|COMPLETED|Overall Study||1
7948697|NCT00453388|19563849|P2|COMPLETED|Overall Study||5
7948698|NCT00453388|19563850|P1|COMPLETED|Overall Study||0
7948699|NCT00453388|19563847|P4|STARTED|Overall Study||0
7948700|NCT00453388|19563848|P3|STARTED|Overall Study||1
7948701|NCT00453388|19563849|P2|STARTED|Overall Study||5
7948702|NCT00453388|19563850|P1|STARTED|Overall Study||0
7948703|NCT00453362|19563872|P1|NOT COMPLETED|Overall Study||87
7948704|NCT00453362|19563872|P1|COMPLETED|Overall Study||1
7948705|NCT00453362|19563872|P1|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50
7948706|NCT00453362|19563872|P1|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51
7948707|NCT00453362|19563872|P1|Treated With Erlotinib|Overall Study||74
7948708|NCT00453362|19563872|P1|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88
7948709|NCT00453349|19563898|P2|NOT COMPLETED|Completed Study||34
7948710|NCT00453349|19563899|P1|NOT COMPLETED|Completed Study||27
7948711|NCT00453349|19563898|P2|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198
7948712|NCT00453349|19563899|P1|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201
7948713|NCT00453349|19563898|P2|Completed Study Treatment|Completed Study|23 terminated prematurely|209
7948714|NCT00453349|19563899|P1|Completed Study Treatment|Completed Study|25 terminated prematurely|203
7948715|NCT00453349|19563898|P2|STARTED|Completed Study||232
7948716|NCT00453349|19563899|P1|STARTED|Completed Study||228
7948717|NCT00453349|19563898|P2|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11
7948718|NCT00453349|19563899|P1|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10
7948719|NCT00453349|19563898|P2|COMPLETED|Reaching of Primary Endpoint (TOC)||219
7948720|NCT00453349|19563899|P1|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215
7948721|NCT00453349|19563898|P2|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190
7948722|NCT00453349|19563899|P1|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194
7948723|NCT00453349|19563898|P2|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230
7948724|NCT00453349|19563899|P1|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225
7948725|NCT00453349|19563898|P2|NOT COMPLETED|Randomized||23
7948726|NCT00453349|19563899|P1|NOT COMPLETED|Randomized||25
7948727|NCT00453349|19563898|P2|COMPLETED|Randomized||209
7948728|NCT00453349|19563899|P1|COMPLETED|Randomized||203
7948729|NCT00453349|19563898|P2|STARTED|Randomized||232
7948730|NCT00453349|19563899|P1|STARTED|Randomized||228
7948731|NCT00453336|19563925|P1|NOT COMPLETED|Overall Study||0
7948732|NCT00453336|19563925|P1|COMPLETED|Overall Study||45
7948733|NCT00453336|19563925|P1|STARTED|Overall Study||45
7948734|NCT00453310|19563930|P1|NOT COMPLETED|Overall Study||10
7948735|NCT00453310|19563930|P1|COMPLETED|Overall Study||0
7948736|NCT00453310|19563930|P1|STARTED|Overall Study||10
7948737|NCT00453206|19563934|P1|NOT COMPLETED|Overall Study||1
7948738|NCT00453206|19563934|P1|COMPLETED|Overall Study||65
7948739|NCT00453206|19563934|P1|STARTED|Overall Study||66
7948740|NCT00453193|19563938|P1|NOT COMPLETED|Overall Study||0
7948741|NCT00453193|19563938|P1|COMPLETED|Overall Study||24
7948742|NCT00453193|19563938|P1|STARTED|Overall Study||24
7948743|NCT00453180|19563944|P2|NOT COMPLETED|Overall Study||3
7948744|NCT00453180|19563945|P1|NOT COMPLETED|Overall Study||3
7948745|NCT00453180|19563944|P2|COMPLETED|Overall Study||12
7948746|NCT00453180|19563945|P1|COMPLETED|Overall Study||13
7948747|NCT00453180|19563944|P2|STARTED|Overall Study||15
7948748|NCT00453180|19563945|P1|STARTED|Overall Study||16
7948749|NCT00453154|19563964|P4|NOT COMPLETED|Open Label Sunitinib Crossover||0
7948750|NCT00453154|19563965|P3|NOT COMPLETED|Open Label Sunitinib Crossover||0
7948751|NCT00453154|19563966|P2|NOT COMPLETED|Open Label Sunitinib Crossover||0
7948752|NCT00453154|19563967|P1|NOT COMPLETED|Open Label Sunitinib Crossover||0
7948753|NCT00453154|19563964|P4|COMPLETED|Open Label Sunitinib Crossover||0
7948754|NCT00453154|19563965|P3|COMPLETED|Open Label Sunitinib Crossover||18
7948755|NCT00453154|19563966|P2|COMPLETED|Open Label Sunitinib Crossover||0
7948756|NCT00453154|19563967|P1|COMPLETED|Open Label Sunitinib Crossover||0
7948757|NCT00453154|19563964|P4|STARTED|Open Label Sunitinib Crossover||0
7948758|NCT00453154|19563965|P3|STARTED|Open Label Sunitinib Crossover||18
7948759|NCT00453154|19563966|P2|STARTED|Open Label Sunitinib Crossover||0
7948760|NCT00453154|19563967|P1|STARTED|Open Label Sunitinib Crossover||0
7948761|NCT00453154|19563964|P4|NOT COMPLETED|Double BIind Maintenance||49
7948762|NCT00453154|19563965|P3|NOT COMPLETED|Double BIind Maintenance||46
7948763|NCT00453154|19563966|P2|NOT COMPLETED|Double BIind Maintenance||0
7948764|NCT00453154|19563967|P1|NOT COMPLETED|Double BIind Maintenance||0
7948765|NCT00453154|19563964|P4|COMPLETED|Double BIind Maintenance||0
7948766|NCT00453154|19563965|P3|COMPLETED|Double BIind Maintenance||0
7948767|NCT00453154|19563966|P2|COMPLETED|Double BIind Maintenance||0
7948768|NCT00453154|19563967|P1|COMPLETED|Double BIind Maintenance||0
7948769|NCT00453154|19563964|P4|STARTED|Double BIind Maintenance||49
7948770|NCT00453154|19563965|P3|STARTED|Double BIind Maintenance||46
7948771|NCT00453154|19563966|P2|STARTED|Double BIind Maintenance||0
7948772|NCT00453154|19563967|P1|STARTED|Double BIind Maintenance||0
7948773|NCT00453154|19563964|P4|NOT COMPLETED|Combination Chemotherapy||0
7948774|NCT00453154|19563965|P3|NOT COMPLETED|Combination Chemotherapy||0
7948775|NCT00453154|19563966|P2|NOT COMPLETED|Combination Chemotherapy||49
7948776|NCT00453154|19563967|P1|NOT COMPLETED|Combination Chemotherapy||0
7948777|NCT00453154|19563964|P4|COMPLETED|Combination Chemotherapy||0
7948778|NCT00453154|19563965|P3|COMPLETED|Combination Chemotherapy||0
7948779|NCT00453154|19563966|P2|COMPLETED|Combination Chemotherapy||95
7948780|NCT00453154|19563967|P1|COMPLETED|Combination Chemotherapy||12
7948781|NCT00453154|19563964|P4|STARTED|Combination Chemotherapy||0
7948782|NCT00453154|19563965|P3|STARTED|Combination Chemotherapy||0
7948783|NCT00453154|19563966|P2|STARTED|Combination Chemotherapy||144
7948784|NCT00453154|19563967|P1|STARTED|Combination Chemotherapy||12
7948785|NCT00453102|19563980|P1|NOT COMPLETED|Overall Study||2
7948786|NCT00453102|19563980|P1|COMPLETED|Overall Study||16
7948787|NCT00453102|19563980|P1|STARTED|Overall Study||18
7948788|NCT00453063|19563991|P2|NOT COMPLETED|Overall Study||3
7948789|NCT00453063|19563992|P1|NOT COMPLETED|Overall Study||3
7948790|NCT00453063|19563991|P2|COMPLETED|Overall Study||212
7948791|NCT00453063|19563992|P1|COMPLETED|Overall Study||208
7948792|NCT00453063|19563991|P2|STARTED|Overall Study||215
7948793|NCT00453063|19563992|P1|STARTED|Overall Study||211
7948794|NCT00452868|19564006|P1|NOT COMPLETED|Overall Study||2
7948795|NCT00452868|19564006|P1|COMPLETED|Overall Study||11
7948796|NCT00452868|19564006|P1|STARTED|Overall Study||13
7948797|NCT00452790|19564012|P2|NOT COMPLETED|Toddler Dose||2
7948798|NCT00452790|19564013|P1|NOT COMPLETED|Toddler Dose||0
7948799|NCT00452790|19564012|P2|COMPLETED|Toddler Dose||198
7948800|NCT00452790|19564013|P1|COMPLETED|Toddler Dose||198
7948801|NCT00452790|19564012|P2|STARTED|Toddler Dose||200
7948802|NCT00452790|19564013|P1|STARTED|Toddler Dose||198
7948803|NCT00452790|19564012|P2|NOT COMPLETED|After Infant Series||14
7948804|NCT00452790|19564013|P1|NOT COMPLETED|After Infant Series||21
7948805|NCT00452790|19564012|P2|COMPLETED|After Infant Series||200
7948806|NCT00452790|19564013|P1|COMPLETED|After Infant Series||198
7948807|NCT00452790|19564012|P2|STARTED|After Infant Series||214
7948808|NCT00452790|19564013|P1|STARTED|After Infant Series||219
7948809|NCT00452790|19564012|P2|NOT COMPLETED|Infant Series||141
7948810|NCT00452790|19564013|P1|NOT COMPLETED|Infant Series||135
7948811|NCT00452790|19564012|P2|COMPLETED|Infant Series||214
7948812|NCT00452790|19564013|P1|COMPLETED|Infant Series||219
7948813|NCT00452790|19564012|P2|Vaccinated Dose 3|Infant Series||218
7948814|NCT00452790|19564013|P1|Vaccinated Dose 3|Infant Series||221
7948815|NCT00452790|19564012|P2|Vaccinated Dose 2|Infant Series||300
7948816|NCT00452790|19564013|P1|Vaccinated Dose 2|Infant Series||300
7948817|NCT00452790|19564012|P2|Vaccinated Dose 1|Infant Series||353
7948818|NCT00452790|19564013|P1|Vaccinated Dose 1|Infant Series||353
7948819|NCT00452790|19564012|P2|STARTED|Infant Series||355
7948820|NCT00452790|19564013|P1|STARTED|Infant Series||354
7948821|NCT00452699|19564049|P2|NOT COMPLETED|Overall Study||73
7948822|NCT00452699|19564050|P1|NOT COMPLETED|Overall Study||81
7948823|NCT00452699|19564049|P2|COMPLETED|Overall Study||242
7948824|NCT00452699|19564050|P1|COMPLETED|Overall Study||225
7948825|NCT00452699|19564049|P2|STARTED|Overall Study||315
7948826|NCT00452699|19564050|P1|STARTED|Overall Study||306
7948827|NCT00452673|19564066|P5|NOT COMPLETED|Dose Expansion Period||21
7948828|NCT00452673|19564067|P4|NOT COMPLETED|Dose Expansion Period||0
7948829|NCT00452673|19564068|P3|NOT COMPLETED|Dose Expansion Period||0
7948830|NCT00452673|19564069|P2|NOT COMPLETED|Dose Expansion Period||0
7948831|NCT00452673|19564070|P1|NOT COMPLETED|Dose Expansion Period||0
7948832|NCT00452673|19564066|P5|COMPLETED|Dose Expansion Period||0
7948833|NCT00452673|19564067|P4|COMPLETED|Dose Expansion Period||0
7948834|NCT00452673|19564068|P3|COMPLETED|Dose Expansion Period||0
7948835|NCT00452673|19564069|P2|COMPLETED|Dose Expansion Period||0
7948836|NCT00452673|19564070|P1|COMPLETED|Dose Expansion Period||0
7948837|NCT00452673|19564066|P5|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21
7948838|NCT00452673|19564067|P4|STARTED|Dose Expansion Period||0
7948839|NCT00452673|19564068|P3|STARTED|Dose Expansion Period||0
7948840|NCT00452673|19564069|P2|STARTED|Dose Expansion Period||0
7948841|NCT00452673|19564070|P1|STARTED|Dose Expansion Period||0
7948842|NCT00452673|19564066|P5|NOT COMPLETED|Dose Escalation Period||0
7948843|NCT00452673|19564067|P4|NOT COMPLETED|Dose Escalation Period||9
7948844|NCT00452673|19564068|P3|NOT COMPLETED|Dose Escalation Period||6
7948845|NCT00452673|19564069|P2|NOT COMPLETED|Dose Escalation Period||9
7948846|NCT00452673|19564070|P1|NOT COMPLETED|Dose Escalation Period||7
7948847|NCT00452673|19564066|P5|COMPLETED|Dose Escalation Period||0
7948848|NCT00452673|19564067|P4|COMPLETED|Dose Escalation Period||0
7948849|NCT00452673|19564068|P3|COMPLETED|Dose Escalation Period||0
7948850|NCT00452673|19564069|P2|COMPLETED|Dose Escalation Period||0
7948851|NCT00452673|19564070|P1|COMPLETED|Dose Escalation Period||0
7948852|NCT00452673|19564066|P5|STARTED|Dose Escalation Period||0
7948853|NCT00452673|19564067|P4|STARTED|Dose Escalation Period||9
7948854|NCT00452673|19564068|P3|STARTED|Dose Escalation Period||6
7948855|NCT00452673|19564069|P2|STARTED|Dose Escalation Period||9
7948856|NCT00452673|19564070|P1|STARTED|Dose Escalation Period||7
7948857|NCT00452543|19564102|P2|NOT COMPLETED|Overall Study||6
7948858|NCT00452543|19564103|P1|NOT COMPLETED|Overall Study||5
7948859|NCT00452543|19564102|P2|COMPLETED|Overall Study||5
7948860|NCT00452543|19564103|P1|COMPLETED|Overall Study||7
7948861|NCT00452543|19564102|P2|STARTED|Overall Study||11
7948862|NCT00452543|19564103|P1|STARTED|Overall Study||12
7948863|NCT00452530|19564117|P2|NOT COMPLETED|Overall Study||136
7948864|NCT00452530|19564118|P1|NOT COMPLETED|Overall Study||136
7948865|NCT00452530|19564117|P2|COMPLETED|Overall Study||1393
7948866|NCT00452530|19564118|P1|COMPLETED|Overall Study||1392
7948867|NCT00452530|19564117|P2|Primary Participants|Overall Study||997
7948868|NCT00452530|19564118|P1|Primary Participants|Overall Study||976
7948869|NCT00452530|19564117|P2|Evaluable Participants|Overall Study||921
7948870|NCT00452530|19564118|P1|Evaluable Participants|Overall Study||907
7948871|NCT00452530|19564117|P2|Received Treatment|Overall Study||1508
7948872|NCT00452530|19564118|P1|Received Treatment|Overall Study||1501
7948873|NCT00452530|19564117|P2|STARTED|Overall Study|Randomized|1529
7948874|NCT00452530|19564118|P1|STARTED|Overall Study|Randomized|1528
7948875|NCT00452452|19564139|P3|NOT COMPLETED|Overall Study||1
7948876|NCT00452452|19564140|P2|NOT COMPLETED|Overall Study||0
7948877|NCT00452452|19564141|P1|NOT COMPLETED|Overall Study||2
7948878|NCT00452452|19564139|P3|COMPLETED|Overall Study||152
7948879|NCT00452452|19564140|P2|COMPLETED|Overall Study||112
7948880|NCT00452452|19564141|P1|COMPLETED|Overall Study||88
7948881|NCT00452452|19564139|P3|Vaccinated Dose 3|Overall Study||0
7948882|NCT00452452|19564140|P2|Vaccinated Dose 3|Overall Study||0
7948883|NCT00452452|19564141|P1|Vaccinated Dose 3|Overall Study||89
7948884|NCT00452452|19564139|P3|Vaccinated Dose 2|Overall Study||0
7948885|NCT00452452|19564140|P2|Vaccinated Dose 2|Overall Study||112
7948886|NCT00452452|19564141|P1|Vaccinated Dose 2|Overall Study||90
7948887|NCT00452452|19564139|P3|Vaccinated Dose 1|Overall Study||152
7948888|NCT00452452|19564140|P2|Vaccinated Dose 1|Overall Study||112
7948889|NCT00452452|19564141|P1|Vaccinated Dose 1|Overall Study||90
7948890|NCT00452452|19564139|P3|STARTED|Overall Study||153
7948891|NCT00452452|19564140|P2|STARTED|Overall Study||112
7948892|NCT00452452|19564141|P1|STARTED|Overall Study||90
7948893|NCT00452439|19564166|P2|NOT COMPLETED|Overall Study||7
7948894|NCT00452439|19564167|P1|NOT COMPLETED|Overall Study||14
7948895|NCT00452439|19564166|P2|COMPLETED|Overall Study||29
7948896|NCT00452439|19564167|P1|COMPLETED|Overall Study||22
7948897|NCT00452439|19564166|P2|STARTED|Overall Study||36
7948898|NCT00452439|19564167|P1|STARTED|Overall Study||36
7948899|NCT00452426|19564177|P2|NOT COMPLETED|Overall Study||11
7948900|NCT00452426|19564178|P1|NOT COMPLETED|Overall Study||7
7948901|NCT00452426|19564177|P2|COMPLETED|Overall Study||493
7948902|NCT00452426|19564178|P1|COMPLETED|Overall Study||489
7948903|NCT00452426|19564177|P2|STARTED|Overall Study||504
7948904|NCT00452426|19564178|P1|STARTED|Overall Study||496
7948905|NCT00452400|19564197|P5|NOT COMPLETED|Overall Study||3
7948906|NCT00452400|19564198|P4|NOT COMPLETED|Overall Study||1
7948907|NCT00452400|19564199|P3|NOT COMPLETED|Overall Study||7
7948908|NCT00452400|19564200|P2|NOT COMPLETED|Overall Study||1
7948909|NCT00452400|19564201|P1|NOT COMPLETED|Overall Study||5
7948910|NCT00452400|19564197|P5|COMPLETED|Overall Study||76
7948911|NCT00452400|19564198|P4|COMPLETED|Overall Study||85
7948912|NCT00452400|19564199|P3|COMPLETED|Overall Study||73
7948913|NCT00452400|19564200|P2|COMPLETED|Overall Study||80
7948914|NCT00452400|19564201|P1|COMPLETED|Overall Study||74
7948915|NCT00452400|19564197|P5|STARTED|Overall Study||79
7948916|NCT00452400|19564198|P4|STARTED|Overall Study||86
7948917|NCT00452400|19564199|P3|STARTED|Overall Study||80
7948918|NCT00452400|19564200|P2|STARTED|Overall Study||81
7948919|NCT00452400|19564201|P1|STARTED|Overall Study||79
7948920|NCT00452387|19564373|P1|NOT COMPLETED|Overall Study||0
7948921|NCT00452387|19564373|P1|COMPLETED|Overall Study||22
7948922|NCT00452387|19564373|P1|STARTED|Overall Study||22
7948923|NCT00452374|19564381|P1|NOT COMPLETED|Overall Study||0
7948924|NCT00452374|19564381|P1|COMPLETED|Overall Study||48
7948925|NCT00452374|19564381|P1|STARTED|Overall Study||48
7948926|NCT00452361|19564388|P2|NOT COMPLETED|Overall Study||10
7948927|NCT00452361|19564389|P1|NOT COMPLETED|Overall Study||21
7948928|NCT00452361|19564388|P2|COMPLETED|Overall Study||0
7948929|NCT00452361|19564389|P1|COMPLETED|Overall Study||0
7948930|NCT00452361|19564388|P2|STARTED|Overall Study||10
7948931|NCT00452361|19564389|P1|STARTED|Overall Study||21
7948932|NCT00452348|19564433|P2|NOT COMPLETED|Overall Study||84
7948933|NCT00452348|19564434|P1|NOT COMPLETED|Overall Study||79
7948934|NCT00452348|19564433|P2|COMPLETED|Overall Study||234
7948935|NCT00452348|19564434|P1|COMPLETED|Overall Study||231
7948936|NCT00452348|19564433|P2|STARTED|Overall Study||318
7948937|NCT00452348|19564434|P1|STARTED|Overall Study||310
7948938|NCT00452335|19564449|P3|NOT COMPLETED|Overall Study||9
7948939|NCT00452335|19564450|P2|NOT COMPLETED|Overall Study||4
7948940|NCT00452335|19564451|P1|NOT COMPLETED|Overall Study||2
7948941|NCT00452335|19564449|P3|COMPLETED|Overall Study||23
7948942|NCT00452335|19564450|P2|COMPLETED|Overall Study||61
7948943|NCT00452335|19564451|P1|COMPLETED|Overall Study||25
7948944|NCT00452335|19564449|P3|STARTED|Overall Study||32
7948945|NCT00452335|19564450|P2|STARTED|Overall Study||65
7948946|NCT00452335|19564451|P1|STARTED|Overall Study||27
7948947|NCT00452114|19564488|P2|NOT COMPLETED|Overall Study||3
7948948|NCT00452114|19564489|P1|NOT COMPLETED|Overall Study||3
7948949|NCT00452114|19564488|P2|COMPLETED|Overall Study||10
7948950|NCT00452114|19564489|P1|COMPLETED|Overall Study||12
7948951|NCT00452114|19564488|P2|STARTED|Overall Study||13
7948952|NCT00452114|19564489|P1|STARTED|Overall Study||15
7948953|NCT00451958|19564505|P5|NOT COMPLETED|CS21A (NCT00451958)||0
7948954|NCT00451958|19564506|P4|NOT COMPLETED|CS21A (NCT00451958)||39
7948955|NCT00451958|19564507|P3|NOT COMPLETED|CS21A (NCT00451958)||42
7948956|NCT00451958|19564508|P2|NOT COMPLETED|CS21A (NCT00451958)||77
7948957|NCT00451958|19564509|P1|NOT COMPLETED|CS21A (NCT00451958)||65
7948958|NCT00451958|19564505|P5|COMPLETED|CS21A (NCT00451958)||0
7948959|NCT00451958|19564506|P4|COMPLETED|CS21A (NCT00451958)||27
7948960|NCT00451958|19564507|P3|COMPLETED|CS21A (NCT00451958)||27
7948961|NCT00451958|19564508|P2|COMPLETED|CS21A (NCT00451958)||49
7948962|NCT00451958|19564509|P1|COMPLETED|CS21A (NCT00451958)||60
7948963|NCT00451958|19564505|P5|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0
7948964|NCT00451958|19564506|P4|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66
7948965|NCT00451958|19564507|P3|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69
7948966|NCT00451958|19564508|P2|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126
7948967|NCT00451958|19564509|P1|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125
7948968|NCT00451958|19564505|P5|NOT COMPLETED|CS21 (NCT00295750)||32
7948969|NCT00451958|19564506|P4|NOT COMPLETED|CS21 (NCT00295750)||0
7948970|NCT00451958|19564507|P3|NOT COMPLETED|CS21 (NCT00295750)||0
7948971|NCT00451958|19564508|P2|NOT COMPLETED|CS21 (NCT00295750)||43
7948972|NCT00451958|19564509|P1|NOT COMPLETED|CS21 (NCT00295750)||41
7948973|NCT00451958|19564505|P5|COMPLETED|CS21 (NCT00295750)||172
7948974|NCT00451958|19564506|P4|COMPLETED|CS21 (NCT00295750)||0
7948975|NCT00451958|19564507|P3|COMPLETED|CS21 (NCT00295750)||0
7948976|NCT00451958|19564508|P2|COMPLETED|CS21 (NCT00295750)||163
7948977|NCT00451958|19564509|P1|COMPLETED|CS21 (NCT00295750)||169
7948978|NCT00451958|19564505|P5|STARTED|CS21 (NCT00295750)||204
7948979|NCT00451958|19564506|P4|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
7948980|NCT00451958|19564507|P3|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
7948981|NCT00451958|19564508|P2|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206
7948982|NCT00451958|19564509|P1|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210
7948983|NCT00451906|19564539|P1|NOT COMPLETED|Overall Study||2239
7948984|NCT00451906|19564539|P1|COMPLETED|Overall Study||13
7948985|NCT00451906|19564539|P1|STARTED|Overall Study||2252
7948986|NCT00451698|19564549|P2|NOT COMPLETED|Overall Study||0
7948987|NCT00451698|19564550|P1|NOT COMPLETED|Overall Study||0
7948988|NCT00451698|19564549|P2|COMPLETED|Overall Study||6
7948989|NCT00451698|19564550|P1|COMPLETED|Overall Study||3
7948990|NCT00451698|19564549|P2|STARTED|Overall Study||6
7948991|NCT00451698|19564550|P1|STARTED|Overall Study||3
7948992|NCT00451555|19564567|P2|NOT COMPLETED|Overall Study||4
7948993|NCT00451555|19564568|P1|NOT COMPLETED|Overall Study||13
7948994|NCT00451555|19564567|P2|COMPLETED|Overall Study||56
7948995|NCT00451555|19564568|P1|COMPLETED|Overall Study||83
7948996|NCT00451555|19564567|P2|Death|Overall Study||0
7948997|NCT00451555|19564568|P1|Death|Overall Study||2
7948998|NCT00451555|19564567|P2|Progressive Disease|Overall Study||54
7948999|NCT00451555|19564568|P1|Progressive Disease|Overall Study||75
7949000|NCT00451555|19564567|P2|Enzastaurin Once Daily Dosing (QD)|Overall Study||0
7949001|NCT00451555|19564568|P1|Enzastaurin Once Daily Dosing (QD)|Overall Study||55
7949002|NCT00451555|19564567|P2|Enzastaurin Twice Daily Dosing (BID)|Overall Study||0
7949003|NCT00451555|19564568|P1|Enzastaurin Twice Daily Dosing (BID)|Overall Study||39
7949004|NCT00451555|19564567|P2|Received at Least One Dose of Study Drug|Overall Study||58
7949005|NCT00451555|19564568|P1|Received at Least One Dose of Study Drug|Overall Study||94
7949006|NCT00451555|19564567|P2|STARTED|Overall Study||60
7949007|NCT00451555|19564568|P1|STARTED|Overall Study||96
7949008|NCT00451451|19564602|P4|NOT COMPLETED|Overall Study||58
7949009|NCT00451451|19564603|P3|NOT COMPLETED|Overall Study||72
7949010|NCT00451451|19564604|P2|NOT COMPLETED|Overall Study||75
7949011|NCT00451451|19564605|P1|NOT COMPLETED|Overall Study||85
7949012|NCT00451451|19564602|P4|COMPLETED|Overall Study||292
7949013|NCT00451451|19564603|P3|COMPLETED|Overall Study||273
7949014|NCT00451451|19564604|P2|COMPLETED|Overall Study||284
7949015|NCT00451451|19564605|P1|COMPLETED|Overall Study||278
7949016|NCT00451451|19564602|P4|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350
7949017|NCT00451451|19564603|P3|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345
7949018|NCT00451451|19564604|P2|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359
7949019|NCT00451451|19564605|P1|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363
7949020|NCT00451321|19564640|P8|NOT COMPLETED|Overall Study||6
7949021|NCT00451321|19564641|P7|NOT COMPLETED|Overall Study||6
7949022|NCT00451321|19564642|P6|NOT COMPLETED|Overall Study||9
7949023|NCT00451321|19564643|P5|NOT COMPLETED|Overall Study||7
7949024|NCT00451321|19564644|P4|NOT COMPLETED|Overall Study||12
7949025|NCT00451321|19564645|P3|NOT COMPLETED|Overall Study||18
7949026|NCT00451321|19564646|P2|NOT COMPLETED|Overall Study||5
7949027|NCT00451321|19564647|P1|NOT COMPLETED|Overall Study||7
7949028|NCT00451321|19564640|P8|COMPLETED|Overall Study||0
7949029|NCT00451321|19564641|P7|COMPLETED|Overall Study||0
7949030|NCT00451321|19564642|P6|COMPLETED|Overall Study||0
7949031|NCT00451321|19564643|P5|COMPLETED|Overall Study||0
7949032|NCT00451321|19564644|P4|COMPLETED|Overall Study||7
7949033|NCT00451321|19564645|P3|COMPLETED|Overall Study||0
7949034|NCT00451321|19564646|P2|COMPLETED|Overall Study||10
7949035|NCT00451321|19564647|P1|COMPLETED|Overall Study||1
7949036|NCT00451321|19564640|P8|STARTED|Overall Study||6
7949037|NCT00451321|19564641|P7|STARTED|Overall Study||6
7949038|NCT00451321|19564642|P6|STARTED|Overall Study||9
7949039|NCT00451321|19564643|P5|STARTED|Overall Study||7
7949040|NCT00451321|19564644|P4|STARTED|Overall Study||19
7949041|NCT00451321|19564645|P3|STARTED|Overall Study||18
7949042|NCT00451321|19564646|P2|STARTED|Overall Study||15
7949043|NCT00451321|19564647|P1|STARTED|Overall Study||8
7949044|NCT00451282|19564819|P2|NOT COMPLETED|Overall Study||5
7949045|NCT00451282|19564820|P1|NOT COMPLETED|Overall Study||6
7949046|NCT00451282|19564819|P2|COMPLETED|Overall Study||34
7949047|NCT00451282|19564820|P1|COMPLETED|Overall Study||40
7949048|NCT00451282|19564819|P2|STARTED|Overall Study||39
7949049|NCT00451282|19564820|P1|STARTED|Overall Study||46
7949050|NCT00451217|19564836|P4|NOT COMPLETED|Overall Study||5
7949051|NCT00451217|19564837|P3|NOT COMPLETED|Overall Study||4
7949052|NCT00451217|19564838|P2|NOT COMPLETED|Overall Study||2
7949053|NCT00451217|19564839|P1|NOT COMPLETED|Overall Study||2
7949054|NCT00451217|19564836|P4|COMPLETED|Overall Study||44
7949055|NCT00451217|19564837|P3|COMPLETED|Overall Study||47
7949056|NCT00451217|19564838|P2|COMPLETED|Overall Study||47
7949057|NCT00451217|19564839|P1|COMPLETED|Overall Study||47
7949058|NCT00451217|19564836|P4|Treated|Overall Study||45
7949059|NCT00451217|19564837|P3|Treated|Overall Study||48
7949060|NCT00451217|19564838|P2|Treated|Overall Study||48
7949061|NCT00451217|19564839|P1|Treated|Overall Study||48
7949062|NCT00451217|19564836|P4|STARTED|Overall Study||49
7949063|NCT00451217|19564837|P3|STARTED|Overall Study||51
7949064|NCT00451217|19564838|P2|STARTED|Overall Study||49
7949065|NCT00451217|19564839|P1|STARTED|Overall Study||49
7949066|NCT00451204|19564867|P2|NOT COMPLETED|Overall Study||20
7949067|NCT00451204|19564868|P1|NOT COMPLETED|Overall Study||22
7949068|NCT00451204|19564867|P2|COMPLETED|Overall Study||56
7949069|NCT00451204|19564868|P1|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60
7949070|NCT00451204|19564867|P2|STARTED|Overall Study||76
7949071|NCT00451204|19564868|P1|STARTED|Overall Study||82
7949072|NCT00451191|19564886|P2|NOT COMPLETED|Overall Study||11
7949073|NCT00451191|19564887|P1|NOT COMPLETED|Overall Study||15
7949074|NCT00451191|19564886|P2|COMPLETED|Overall Study||55
7949075|NCT00451191|19564887|P1|COMPLETED|Overall Study||53
7949076|NCT00451191|19564886|P2|STARTED|Overall Study||66
7949077|NCT00451191|19564887|P1|STARTED|Overall Study||68
7949078|NCT00451178|19564895|P2|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||26
7949079|NCT00451178|19564896|P1|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||6
7949080|NCT00451178|19564895|P2|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
7949081|NCT00451178|19564896|P1|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
7949082|NCT00451178|19564895|P2|STARTED|Long-Term Follow-Up (Up to 2 Years)||26
7949083|NCT00451178|19564896|P1|STARTED|Long-Term Follow-Up (Up to 2 Years)||6
7949084|NCT00451178|19564895|P2|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||0
7949085|NCT00451178|19564896|P1|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||30
7949086|NCT00451178|19564895|P2|COMPLETED|Maintenance Therapy (up to 3 Years)||0
7949087|NCT00451178|19564896|P1|COMPLETED|Maintenance Therapy (up to 3 Years)||6
7949088|NCT00451178|19564895|P2|STARTED|Maintenance Therapy (up to 3 Years)|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
7949089|NCT00451178|19564896|P1|STARTED|Maintenance Therapy (up to 3 Years)||36
7949090|NCT00451178|19564895|P2|NOT COMPLETED|Prior to Maintenance Therapy||0
7949091|NCT00451178|19564896|P1|NOT COMPLETED|Prior to Maintenance Therapy||4
7949092|NCT00451178|19564895|P2|COMPLETED|Prior to Maintenance Therapy||0
7949093|NCT00451178|19564896|P1|COMPLETED|Prior to Maintenance Therapy||36
7949094|NCT00451178|19564895|P2|STARTED|Prior to Maintenance Therapy|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
7949095|NCT00451178|19564896|P1|STARTED|Prior to Maintenance Therapy||40
7949096|NCT00451178|19564895|P2|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||17
7949097|NCT00451178|19564896|P1|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||18
7949098|NCT00451178|19564895|P2|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||26
7949099|NCT00451178|19564896|P1|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||40
7949100|NCT00451178|19564895|P2|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||43
7949101|NCT00451178|19564896|P1|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||57
7949102|NCT00451178|19564895|P2|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||43
7949103|NCT00451178|19564896|P1|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||58
7949104|NCT00451048|19564922|P1|NOT COMPLETED|Overall Study||0
7949105|NCT00451048|19564922|P1|COMPLETED|Overall Study||10
7949106|NCT00451048|19564922|P1|STARTED|Overall Study||10
7949107|NCT00450983|19564931|P1|NOT COMPLETED|Overall Study||0
7949108|NCT00450983|19564931|P1|COMPLETED|Overall Study||1
7949109|NCT00450983|19564931|P1|STARTED|Overall Study||1
7949110|NCT00450866|19564943|P2|NOT COMPLETED|Overall Study||3
7949111|NCT00450866|19564944|P1|NOT COMPLETED|Overall Study||7
7949112|NCT00450866|19564943|P2|COMPLETED|Overall Study||7
7949113|NCT00450866|19564944|P1|COMPLETED|Overall Study||38
7949114|NCT00450866|19564943|P2|STARTED|Overall Study||10
7949115|NCT00450866|19564944|P1|STARTED|Overall Study||45
7949116|NCT00450814|19564964|P11|NOT COMPLETED|Overall Study||0
7949117|NCT00450814|19564965|P10|NOT COMPLETED|Overall Study||1
7949118|NCT00450814|19564966|P9|NOT COMPLETED|Overall Study||0
7949119|NCT00450814|19564967|P8|NOT COMPLETED|Overall Study||0
7949120|NCT00450814|19564968|P7|NOT COMPLETED|Overall Study||0
7949121|NCT00450814|19564969|P6|NOT COMPLETED|Overall Study||1
7949122|NCT00450814|19564970|P5|NOT COMPLETED|Overall Study||1
7949123|NCT00450814|19564971|P4|NOT COMPLETED|Overall Study||1
7949124|NCT00450814|19564972|P3|NOT COMPLETED|Overall Study||0
7949125|NCT00450814|19564973|P2|NOT COMPLETED|Overall Study||0
7949126|NCT00450814|19564974|P1|NOT COMPLETED|Overall Study||0
7949127|NCT00450814|19564964|P11|COMPLETED|Overall Study||4
7949128|NCT00450814|19564965|P10|COMPLETED|Overall Study||11
7949129|NCT00450814|19564966|P9|COMPLETED|Overall Study||2
7949130|NCT00450814|19564967|P8|COMPLETED|Overall Study||3
7949131|NCT00450814|19564968|P7|COMPLETED|Overall Study||3
7949132|NCT00450814|19564969|P6|COMPLETED|Overall Study||6
7949133|NCT00450814|19564970|P5|COMPLETED|Overall Study||3
7949134|NCT00450814|19564971|P4|COMPLETED|Overall Study||3
7949135|NCT00450814|19564972|P3|COMPLETED|Overall Study||3
7949136|NCT00450814|19564973|P2|COMPLETED|Overall Study||3
7949137|NCT00450814|19564974|P1|COMPLETED|Overall Study||3
7949138|NCT00450814|19564964|P11|STARTED|Overall Study||4
7949139|NCT00450814|19564965|P10|STARTED|Overall Study||12
7949140|NCT00450814|19564966|P9|STARTED|Overall Study||2
7949141|NCT00450814|19564967|P8|STARTED|Overall Study||3
7949142|NCT00450814|19564968|P7|STARTED|Overall Study||3
7949143|NCT00450814|19564969|P6|STARTED|Overall Study||7
7949144|NCT00450814|19564970|P5|STARTED|Overall Study||4
7949145|NCT00450814|19564971|P4|STARTED|Overall Study||4
7949146|NCT00450814|19564972|P3|STARTED|Overall Study||3
7949147|NCT00450814|19564973|P2|STARTED|Overall Study||3
7949148|NCT00450814|19564974|P1|STARTED|Overall Study||3
7949149|NCT00450801|19565008|P1|NOT COMPLETED|Overall Study||1
7949150|NCT00450801|19565008|P1|COMPLETED|Overall Study||21
7949151|NCT00450801|19565008|P1|STARTED|Overall Study||22
7949152|NCT00450749|19565022|P3|NOT COMPLETED|Overall Study||2
7949153|NCT00450749|19565023|P2|NOT COMPLETED|Overall Study||1
7949154|NCT00450749|19565024|P1|NOT COMPLETED|Overall Study||0
7949155|NCT00450749|19565022|P3|COMPLETED|Overall Study||2
7949156|NCT00450749|19565023|P2|COMPLETED|Overall Study||2
7949157|NCT00450749|19565024|P1|COMPLETED|Overall Study||3
7949158|NCT00450749|19565022|P3|STARTED|Overall Study||4
7949159|NCT00450749|19565023|P2|STARTED|Overall Study||3
7949160|NCT00450749|19565024|P1|STARTED|Overall Study||3
7949161|NCT00450723|19565062|P1|NOT COMPLETED|Overall Study||5
7949162|NCT00450723|19565062|P1|COMPLETED|Overall Study||34
7949163|NCT00450723|19565062|P1|STARTED|Overall Study||39
7949164|NCT00450658|19565070|P2|NOT COMPLETED|Overall Study||90
7949165|NCT00450658|19565071|P1|NOT COMPLETED|Overall Study||143
7949166|NCT00450658|19565070|P2|COMPLETED|Overall Study||122
7949167|NCT00450658|19565071|P1|COMPLETED|Overall Study||272
7949168|NCT00450658|19565070|P2|STARTED|Overall Study||212
7949169|NCT00450658|19565071|P1|STARTED|Overall Study||415
7949170|NCT00450619|19565085|P2|NOT COMPLETED|Overall Study||1
7949171|NCT00450619|19565086|P1|NOT COMPLETED|Overall Study||4
7949172|NCT00450619|19565085|P2|COMPLETED|Overall Study||21
7949173|NCT00450619|19565086|P1|COMPLETED|Overall Study||18
7949174|NCT00450619|19565085|P2|STARTED|Overall Study||22
7949175|NCT00450619|19565086|P1|STARTED|Overall Study||22
7949176|NCT00450580|19565112|P2|NOT COMPLETED|Overall Study||16
7949177|NCT00450580|19565113|P1|NOT COMPLETED|Overall Study||16
7949178|NCT00450580|19565112|P2|COMPLETED|Overall Study||90
7949179|NCT00450580|19565113|P1|COMPLETED|Overall Study||90
7949180|NCT00450580|19565112|P2|STARTED|Overall Study||106
7949181|NCT00450580|19565113|P1|STARTED|Overall Study||106
7949182|NCT00450463|19565133|P2|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
7949183|NCT00450463|19565134|P1|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
7949184|NCT00450463|19565133|P2|COMPLETED|Progressed to Receive Vaccine Alone||0
7949185|NCT00450463|19565134|P1|COMPLETED|Progressed to Receive Vaccine Alone||11
7949186|NCT00450463|19565133|P2|STARTED|Progressed to Receive Vaccine Alone||0
7949187|NCT00450463|19565134|P1|STARTED|Progressed to Receive Vaccine Alone||11
7949188|NCT00450463|19565133|P2|NOT COMPLETED|Initial Drug Administration||0
7949189|NCT00450463|19565134|P1|NOT COMPLETED|Initial Drug Administration||0
7949190|NCT00450463|19565133|P2|COMPLETED|Initial Drug Administration||31
7949191|NCT00450463|19565134|P1|COMPLETED|Initial Drug Administration||33
7949192|NCT00450463|19565133|P2|STARTED|Initial Drug Administration||31
7949193|NCT00450463|19565134|P1|STARTED|Initial Drug Administration||33
7949194|NCT00450450|19565150|P2|NOT COMPLETED|Overall Study||3
7949195|NCT00450450|19565151|P1|NOT COMPLETED|Overall Study||5
7949196|NCT00450450|19565150|P2|COMPLETED|Overall Study||11
7949197|NCT00450450|19565151|P1|COMPLETED|Overall Study||8
7949198|NCT00450450|19565150|P2|STARTED|Overall Study||14
7949199|NCT00450450|19565151|P1|STARTED|Overall Study||13
7949200|NCT00450437|19565175|P4|NOT COMPLETED|Overall Study||11
7949201|NCT00450437|19565176|P3|NOT COMPLETED|Overall Study||24
7949202|NCT00450437|19565177|P2|NOT COMPLETED|Overall Study||16
7949203|NCT00450437|19565178|P1|NOT COMPLETED|Overall Study||46
7949204|NCT00450437|19565175|P4|COMPLETED|Overall Study||325
7949205|NCT00450437|19565176|P3|COMPLETED|Overall Study||999
7949206|NCT00450437|19565177|P2|COMPLETED|Overall Study||524
7949207|NCT00450437|19565178|P1|COMPLETED|Overall Study||1594
7949208|NCT00450437|19565175|P4|STARTED|Overall Study||336
7949209|NCT00450437|19565176|P3|STARTED|Overall Study||1023
7949210|NCT00450437|19565177|P2|STARTED|Overall Study||540
7949211|NCT00450437|19565178|P1|STARTED|Overall Study||1640
7949212|NCT00450424|19565202|P2|NOT COMPLETED|Overall Study||11
7949213|NCT00450424|19565203|P1|NOT COMPLETED|Overall Study||20
7949214|NCT00450424|19565202|P2|COMPLETED|Overall Study||106
7949215|NCT00450424|19565203|P1|COMPLETED|Overall Study||102
7949216|NCT00450424|19565202|P2|STARTED|Overall Study||117
7949217|NCT00450424|19565203|P1|STARTED|Overall Study||122
7949218|NCT00450411|19565209|P1|NOT COMPLETED|Overall Study||8
7949219|NCT00450411|19565209|P1|COMPLETED|Overall Study||92
7949220|NCT00450411|19565209|P1|STARTED|Overall Study||100
7949221|NCT00450385|19565214|P1|NOT COMPLETED|Overall Study||13
7949222|NCT00450385|19565214|P1|COMPLETED|Overall Study||44
7949223|NCT00450385|19565214|P1|STARTED|Overall Study||57
7949224|NCT00450372|19565223|P1|NOT COMPLETED|Overall Study||1
7949225|NCT00450372|19565223|P1|COMPLETED|Overall Study||37
7949226|NCT00450372|19565223|P1|STARTED|Overall Study||38
7949227|NCT00450333|19565236|P4|NOT COMPLETED|Overall Study||28
7949228|NCT00450333|19565237|P3|NOT COMPLETED|Overall Study||25
7949229|NCT00450333|19565238|P2|NOT COMPLETED|Overall Study||63
7949230|NCT00450333|19565239|P1|NOT COMPLETED|Overall Study||54
7949231|NCT00450333|19565236|P4|COMPLETED|Overall Study||74
7949232|NCT00450333|19565237|P3|COMPLETED|Overall Study||75
7949233|NCT00450333|19565238|P2|COMPLETED|Overall Study||44
7949234|NCT00450333|19565239|P1|COMPLETED|Overall Study||44
7949235|NCT00450333|19565236|P4|STARTED|Overall Study||102
7949236|NCT00450333|19565237|P3|STARTED|Overall Study||100
7949237|NCT00450333|19565238|P2|STARTED|Overall Study||107
7949238|NCT00450333|19565239|P1|STARTED|Overall Study||98
7949239|NCT00450294|19565257|P1|NOT COMPLETED|Overall Study||0
7949240|NCT00450294|19565257|P1|COMPLETED|Overall Study||10
7949241|NCT00450294|19565257|P1|STARTED|Overall Study||10
7949242|NCT00450255|19565262|P1|NOT COMPLETED|Overall Study||1
7949243|NCT00450255|19565262|P1|COMPLETED|Overall Study||40
7949244|NCT00450255|19565262|P1|STARTED|Overall Study||41
7949245|NCT00450242|19565272|P2|NOT COMPLETED|Overall Study||1
7949246|NCT00450242|19565273|P1|NOT COMPLETED|Overall Study||3
7949247|NCT00450242|19565272|P2|COMPLETED|Overall Study||6
7949248|NCT00450242|19565273|P1|COMPLETED|Overall Study||4
7949249|NCT00450242|19565272|P2|STARTED|Overall Study||7
7949250|NCT00450242|19565273|P1|STARTED|Overall Study||7
7949251|NCT00450216|19565287|P2|NOT COMPLETED|Overall Study||129
7949252|NCT00450216|19565288|P1|NOT COMPLETED|Overall Study||174
7949253|NCT00450216|19565287|P2|COMPLETED|Overall Study||170
7949254|NCT00450216|19565288|P1|COMPLETED|Overall Study||433
7949255|NCT00450216|19565287|P2|STARTED|Overall Study||299
7949256|NCT00450216|19565288|P1|STARTED|Overall Study||607
7949257|NCT00450190|19565300|P1|NOT COMPLETED|Overall Study||2
7949258|NCT00450190|19565300|P1|COMPLETED|Overall Study||18
7949259|NCT00450190|19565300|P1|STARTED|Overall Study||20
7949260|NCT00450177|19565310|P2|NOT COMPLETED|Overall Study||11
7949261|NCT00450177|19565311|P1|NOT COMPLETED|Overall Study||9
7949262|NCT00450177|19565310|P2|COMPLETED|Overall Study||92
7949263|NCT00450177|19565311|P1|COMPLETED|Overall Study||88
7949264|NCT00450177|19565310|P2|STARTED|Overall Study||103
7949265|NCT00450177|19565311|P1|STARTED|Overall Study||97
7949266|NCT00450112|19565337|P2|NOT COMPLETED|Overall Study||6
7949267|NCT00450112|19565338|P1|NOT COMPLETED|Overall Study||13
7949268|NCT00450112|19565337|P2|COMPLETED|Overall Study||71
7949269|NCT00450112|19565338|P1|COMPLETED|Overall Study||112
7949270|NCT00450112|19565337|P2|Analyzed Participants|Overall Study||74
7949271|NCT00450112|19565338|P1|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122
7949272|NCT00450112|19565337|P2|Received Injection|Overall Study||74
7949273|NCT00450112|19565338|P1|Received Injection|Overall Study||125
7949274|NCT00450112|19565337|P2|STARTED|Overall Study||77
7949275|NCT00450112|19565338|P1|STARTED|Overall Study||125
7949276|NCT00450073|19565363|P3|NOT COMPLETED|Overall Study||1
7949277|NCT00450073|19565364|P2|NOT COMPLETED|Overall Study||0
7949278|NCT00450073|19565365|P1|NOT COMPLETED|Overall Study||1
7949279|NCT00450073|19565363|P3|COMPLETED|Overall Study||9
7949280|NCT00450073|19565364|P2|COMPLETED|Overall Study||10
7949281|NCT00450073|19565365|P1|COMPLETED|Overall Study||9
7949282|NCT00450073|19565363|P3|STARTED|Overall Study||10
7949283|NCT00450073|19565364|P2|STARTED|Overall Study||10
7949284|NCT00450073|19565365|P1|STARTED|Overall Study||10
7949285|NCT00449956|19565376|P3|NOT COMPLETED|Overall Study||9
7949286|NCT00449956|19565377|P2|NOT COMPLETED|Overall Study||4
7949287|NCT00449956|19565378|P1|NOT COMPLETED|Overall Study||10
7949288|NCT00449956|19565376|P3|COMPLETED|Overall Study||184
7949289|NCT00449956|19565377|P2|COMPLETED|Overall Study||88
7949290|NCT00449956|19565378|P1|COMPLETED|Overall Study||179
7949291|NCT00449956|19565376|P3|STARTED|Overall Study||193
7949292|NCT00449956|19565377|P2|STARTED|Overall Study||92
7949293|NCT00449956|19565378|P1|STARTED|Overall Study||189
7949294|NCT00449930|19565394|P2|NOT COMPLETED|Overall Study||75
7949295|NCT00449930|19565395|P1|NOT COMPLETED|Overall Study||61
7949296|NCT00449930|19565394|P2|COMPLETED|Overall Study||447
7949297|NCT00449930|19565395|P1|COMPLETED|Overall Study||467
7949298|NCT00449930|19565394|P2|STARTED|Overall Study||522
7949299|NCT00449930|19565395|P1|STARTED|Overall Study||528
7949300|NCT00449865|19565411|P2|NOT COMPLETED|Overall Study||534
7949301|NCT00449865|19565412|P1|NOT COMPLETED|Overall Study||522
7949302|NCT00449865|19565411|P2|COMPLETED|Overall Study|477 Expected at Year 5|340
7949303|NCT00449865|19565412|P1|COMPLETED|Overall Study|478 Expected at Year 5|345
7949304|NCT00449865|19565411|P2|Completed Year 4|Overall Study|686 Expected at Year 4|523
7949305|NCT00449865|19565412|P1|Completed Year 4|Overall Study|679 Expected at Year 4|521
7949306|NCT00449865|19565411|P2|Completed Year 3|Overall Study|874 Expected at Year 3|715
7949307|NCT00449865|19565412|P1|Completed Year 3|Overall Study|867 Expected at Year 3|719
7949308|NCT00449865|19565411|P2|Completed Year 2|Overall Study|874 Expected at Year 2|766
7949309|NCT00449865|19565412|P1|Completed Year 2|Overall Study|867 Expected at Year 2|768
7949310|NCT00449865|19565411|P2|Completed Year 1|Overall Study|874 Expected at Year 1|822
7949311|NCT00449865|19565412|P1|Completed Year 1|Overall Study|867 Expected at Year 1|802
7949312|NCT00449865|19565411|P2|STARTED|Overall Study||874
7949313|NCT00449865|19565412|P1|STARTED|Overall Study||867
7949314|NCT00449787|19565420|P2|NOT COMPLETED|Overall Study||100
7949315|NCT00449787|19565421|P1|NOT COMPLETED|Overall Study||105
7949316|NCT00449787|19565420|P2|COMPLETED|Overall Study||98
7949317|NCT00449787|19565421|P1|COMPLETED|Overall Study||98
7949318|NCT00449787|19565420|P2|STARTED|Overall Study||198
7949319|NCT00449787|19565421|P1|STARTED|Overall Study||203
7949320|NCT00449748|19565431|P1|NOT COMPLETED|Overall Study||0
7949321|NCT00449748|19565431|P1|COMPLETED|Overall Study||10
7949322|NCT00449748|19565431|P1|STARTED|Overall Study||10
7949323|NCT00449696|19565437|P2|NOT COMPLETED|Overall Study||9
7949324|NCT00449696|19565438|P1|NOT COMPLETED|Overall Study||20
7949325|NCT00449696|19565437|P2|COMPLETED|Overall Study||119
7949326|NCT00449696|19565438|P1|COMPLETED|Overall Study||231
7949327|NCT00449696|19565437|P2|Analyzed Participants|Overall Study||128
7949328|NCT00449696|19565438|P1|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247
7949329|NCT00449696|19565437|P2|Received Injection|Overall Study||128
7949330|NCT00449696|19565438|P1|Received Injection|Overall Study||249
7949331|NCT00449696|19565437|P2|STARTED|Overall Study||128
7949332|NCT00449696|19565438|P1|STARTED|Overall Study||251
7949333|NCT00449670|19565462|P2|NOT COMPLETED|Booster Phase (Study no.109873)||3
7949334|NCT00449670|19565463|P1|NOT COMPLETED|Booster Phase (Study no.109873)||0
7949335|NCT00449670|19565462|P2|COMPLETED|Booster Phase (Study no.109873)||233
7949336|NCT00449670|19565463|P1|COMPLETED|Booster Phase (Study no.109873)||265
7949337|NCT00449670|19565462|P2|STARTED|Booster Phase (Study no.109873)||236
7949338|NCT00449670|19565463|P1|STARTED|Booster Phase (Study no.109873)||265
7949339|NCT00449670|19565462|P2|NOT COMPLETED|Primary Phase (Study no.109630)||2
7949340|NCT00449670|19565463|P1|NOT COMPLETED|Primary Phase (Study no.109630)||14
7949341|NCT00449670|19565462|P2|COMPLETED|Primary Phase (Study no.109630)||243
7949342|NCT00449670|19565463|P1|COMPLETED|Primary Phase (Study no.109630)||947
7949343|NCT00449670|19565462|P2|STARTED|Primary Phase (Study no.109630)||245
7949344|NCT00449670|19565463|P1|STARTED|Primary Phase (Study no.109630)||961
7949345|NCT00449644|19565576|P4|NOT COMPLETED|Overall Study||32
7949346|NCT00449644|19565577|P3|NOT COMPLETED|Overall Study||29
7949347|NCT00449644|19565578|P2|NOT COMPLETED|Overall Study||13
7949348|NCT00449644|19565579|P1|NOT COMPLETED|Overall Study||10
7949349|NCT00449644|19565576|P4|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49
7949350|NCT00449644|19565577|P3|COMPLETED|Overall Study||50
7949351|NCT00449644|19565578|P2|COMPLETED|Overall Study||11
7949352|NCT00449644|19565579|P1|COMPLETED|Overall Study||13
7949353|NCT00449644|19565576|P4|Rollover|Overall Study||1
7949354|NCT00449644|19565577|P3|Rollover|Overall Study||0
7949355|NCT00449644|19565578|P2|Rollover|Overall Study||0
7949356|NCT00449644|19565579|P1|Rollover|Overall Study||0
7949357|NCT00449644|19565576|P4|STARTED|Overall Study||81
7949358|NCT00449644|19565577|P3|STARTED|Overall Study||79
7949359|NCT00449644|19565578|P2|STARTED|Overall Study||24
7949360|NCT00449644|19565579|P1|STARTED|Overall Study||23
7949361|NCT00449540|19565599|P3|NOT COMPLETED|Treatment Phase||17
7949362|NCT00449540|19565600|P2|NOT COMPLETED|Treatment Phase||20
7949363|NCT00449540|19565601|P1|NOT COMPLETED|Treatment Phase||0
7949364|NCT00449540|19565599|P3|COMPLETED|Treatment Phase||82
7949365|NCT00449540|19565600|P2|COMPLETED|Treatment Phase||82
7949366|NCT00449540|19565601|P1|COMPLETED|Treatment Phase||0
7949367|NCT00449540|19565599|P3|STARTED|Treatment Phase||99
7949368|NCT00449540|19565600|P2|STARTED|Treatment Phase||102
7949369|NCT00449540|19565601|P1|STARTED|Treatment Phase||0
7949370|NCT00449540|19565599|P3|NOT COMPLETED|Pretreatment Phase||0
7949371|NCT00449540|19565600|P2|NOT COMPLETED|Pretreatment Phase||0
7949372|NCT00449540|19565601|P1|NOT COMPLETED|Pretreatment Phase||66
7949373|NCT00449540|19565599|P3|COMPLETED|Pretreatment Phase||0
7949374|NCT00449540|19565600|P2|COMPLETED|Pretreatment Phase||0
7949375|NCT00449540|19565601|P1|COMPLETED|Pretreatment Phase||201
7949376|NCT00449540|19565599|P3|STARTED|Pretreatment Phase||0
7949377|NCT00449540|19565600|P2|STARTED|Pretreatment Phase||0
7949378|NCT00449540|19565601|P1|STARTED|Pretreatment Phase||267
7949379|NCT00449176|19565618|P3|NOT COMPLETED|Overall Study||167
7949380|NCT00449176|19565619|P2|NOT COMPLETED|Overall Study||195
7949381|NCT00449176|19565620|P1|NOT COMPLETED|Overall Study||152
7949382|NCT00449176|19565618|P3|COMPLETED|Overall Study||152
7949383|NCT00449176|19565619|P2|COMPLETED|Overall Study||133
7949384|NCT00449176|19565620|P1|COMPLETED|Overall Study||166
7949385|NCT00449176|19565618|P3|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319
7949386|NCT00449176|19565619|P2|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328
7949387|NCT00449176|19565620|P1|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318
7949388|NCT00449163|19565646|P1|NOT COMPLETED|Overall Study||3
7949389|NCT00449163|19565646|P1|COMPLETED|Overall Study||22
7949390|NCT00449163|19565646|P1|STARTED|Overall Study||25
7949391|NCT00449150|19565656|P3|NOT COMPLETED|Overall Study||47
7949392|NCT00449150|19565657|P2|NOT COMPLETED|Overall Study||53
7949393|NCT00449150|19565658|P1|NOT COMPLETED|Overall Study||46
7949394|NCT00449150|19565656|P3|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171
7949395|NCT00449150|19565657|P2|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177
7949396|NCT00449150|19565658|P1|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173
7949397|NCT00449150|19565656|P3|STARTED|Overall Study||218
7949398|NCT00449150|19565657|P2|STARTED|Overall Study||230
7949399|NCT00449150|19565658|P1|STARTED|Overall Study||219
7949400|NCT00449072|19565671|P2|NOT COMPLETED|Overall Study||42
7949401|NCT00449072|19565672|P1|NOT COMPLETED|Overall Study||41
7949402|NCT00449072|19565671|P2|COMPLETED|Overall Study||109
7949403|NCT00449072|19565672|P1|COMPLETED|Overall Study||107
7949404|NCT00449072|19565671|P2|STARTED|Overall Study||151
7949405|NCT00449072|19565672|P1|STARTED|Overall Study||148
7949406|NCT00449046|19565696|P1|NOT COMPLETED|Overall Study||0
7949407|NCT00449046|19565696|P1|COMPLETED|Overall Study||40
7949408|NCT00449046|19565696|P1|STARTED|Overall Study||40
7949409|NCT00449033|19565709|P2|NOT COMPLETED|Follow-up Period||434
7949410|NCT00449033|19565710|P1|NOT COMPLETED|Follow-up Period||425
7949411|NCT00449033|19565709|P2|COMPLETED|Follow-up Period||0
7949412|NCT00449033|19565710|P1|COMPLETED|Follow-up Period||0
7949413|NCT00449033|19565709|P2|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434
7949414|NCT00449033|19565710|P1|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425
7949415|NCT00449033|19565709|P2|NOT COMPLETED|Treatment Period||452
7949416|NCT00449033|19565710|P1|NOT COMPLETED|Treatment Period||452
7949417|NCT00449033|19565709|P2|COMPLETED|Treatment Period||0
7949418|NCT00449033|19565710|P1|COMPLETED|Treatment Period||0
7949419|NCT00449033|19565709|P2|Received Treatment|Treatment Period||449
7949420|NCT00449033|19565710|P1|Received Treatment|Treatment Period||452
7949421|NCT00449033|19565709|P2|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452
7949422|NCT00449033|19565710|P1|STARTED|Treatment Period||452
7949423|NCT00448916|19565748|P4|NOT COMPLETED|Overall Study||6
7949424|NCT00448916|19565749|P3|NOT COMPLETED|Overall Study||6
7949425|NCT00448916|19565750|P2|NOT COMPLETED|Overall Study||6
7949426|NCT00448916|19565751|P1|NOT COMPLETED|Overall Study||7
7949427|NCT00448916|19565748|P4|COMPLETED|Overall Study||5
7949428|NCT00448916|19565749|P3|COMPLETED|Overall Study||6
7949429|NCT00448916|19565750|P2|COMPLETED|Overall Study||9
7949430|NCT00448916|19565751|P1|COMPLETED|Overall Study||9
7949431|NCT00448916|19565748|P4|STARTED|Overall Study||11
7949432|NCT00448916|19565749|P3|STARTED|Overall Study||12
7949433|NCT00448916|19565750|P2|STARTED|Overall Study||15
7949434|NCT00448916|19565751|P1|STARTED|Overall Study||16
7949435|NCT00448864|19565825|P3|NOT COMPLETED|Overall Study||1
7949436|NCT00448864|19565826|P2|NOT COMPLETED|Overall Study||5
7949437|NCT00448864|19565827|P1|NOT COMPLETED|Overall Study||5
7949438|NCT00448864|19565825|P3|COMPLETED|Overall Study||18
7949439|NCT00448864|19565826|P2|COMPLETED|Overall Study||24
7949440|NCT00448864|19565827|P1|COMPLETED|Overall Study||22
7949441|NCT00448864|19565825|P3|Completed Post-operative Period|Overall Study||18
7949442|NCT00448864|19565826|P2|Completed Post-operative Period|Overall Study||25
7949443|NCT00448864|19565827|P1|Completed Post-operative Period|Overall Study||26
7949444|NCT00448864|19565825|P3|Started Post-operative Period|Overall Study||18
7949445|NCT00448864|19565826|P2|Started Post-operative Period|Overall Study||25
7949446|NCT00448864|19565827|P1|Started Post-operative Period|Overall Study||26
7949447|NCT00448864|19565825|P3|Received at Least 1 Dose of Study Drug|Overall Study||18
7949448|NCT00448864|19565826|P2|Received at Least 1 Dose of Study Drug|Overall Study||25
7949449|NCT00448864|19565827|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
7949450|NCT00448864|19565825|P3|STARTED|Overall Study||19
7949451|NCT00448864|19565826|P2|STARTED|Overall Study||29
7949452|NCT00448864|19565827|P1|STARTED|Overall Study||27
7949453|NCT00448760|19565843|P1|NOT COMPLETED|Overall Study||3
7949454|NCT00448760|19565843|P1|COMPLETED|Overall Study||26
7949455|NCT00448760|19565843|P1|STARTED|Overall Study||29
7949456|NCT00448747|19565852|P2|NOT COMPLETED|Overall Study||0
7949457|NCT00448747|19565853|P1|NOT COMPLETED|Overall Study||1
7949458|NCT00448747|19565852|P2|COMPLETED|Overall Study||48
7949459|NCT00448747|19565853|P1|COMPLETED|Overall Study||52
7949460|NCT00448747|19565852|P2|Per Protocol Population (PPS)|Overall Study||48
7949461|NCT00448747|19565853|P1|Per Protocol Population (PPS)|Overall Study||50
7949462|NCT00448747|19565852|P2|Received L-ARG-GHRH and AEZS-130|Overall Study||10
7949463|NCT00448747|19565853|P1|Received L-ARG-GHRH and AEZS-130|Overall Study||42
7949464|NCT00448747|19565852|P2|Received L-ARG-GHRH|Overall Study||10
7949465|NCT00448747|19565853|P1|Received L-ARG-GHRH|Overall Study||43
7949466|NCT00448747|19565852|P2|Received AEZS-130|Overall Study||48
7949467|NCT00448747|19565853|P1|Received AEZS-130|Overall Study||52
7949468|NCT00448747|19565852|P2|Received Second Drug Administration|Overall Study||10
7949469|NCT00448747|19565853|P1|Received Second Drug Administration|Overall Study||42
7949470|NCT00448747|19565852|P2|Received First Drug Administration|Overall Study||48
7949471|NCT00448747|19565853|P1|Received First Drug Administration|Overall Study||53
7949472|NCT00448747|19565852|P2|STARTED|Overall Study||48
7949473|NCT00448747|19565853|P1|STARTED|Overall Study||53
7949474|NCT00448708|19565871|P2|NOT COMPLETED|Overall Study||31
7949475|NCT00448708|19565872|P1|NOT COMPLETED|Overall Study||35
7949476|NCT00448708|19565871|P2|COMPLETED|Overall Study||79
7949477|NCT00448708|19565872|P1|COMPLETED|Overall Study||77
7949478|NCT00448708|19565871|P2|STARTED|Overall Study||110
7949479|NCT00448708|19565872|P1|STARTED|Overall Study||112
7949480|NCT00448682|19565880|P1|NOT COMPLETED|Overall Study||0
7949481|NCT00448682|19565880|P1|COMPLETED|Overall Study||25
7949482|NCT00448682|19565880|P1|STARTED|Overall Study||25
7949483|NCT00448669|19565888|P2|NOT COMPLETED|Overall Study||198
7949484|NCT00448669|19565889|P1|NOT COMPLETED|Overall Study||218
7949485|NCT00448669|19565888|P2|COMPLETED|Overall Study||410
7949486|NCT00448669|19565889|P1|COMPLETED|Overall Study||393
7949487|NCT00448669|19565888|P2|STARTED|Overall Study||608
7949488|NCT00448669|19565889|P1|STARTED|Overall Study||611
7949489|NCT00448630|19565905|P1|NOT COMPLETED|Overall Study||27
7949490|NCT00448630|19565905|P1|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301
7949491|NCT00448630|19565905|P1|STARTED|Overall Study||328
7949492|NCT00448591|19565950|P1|NOT COMPLETED|Overall Study||2296
7949493|NCT00448591|19565950|P1|COMPLETED|Overall Study||0
7949494|NCT00448591|19565950|P1|STARTED|Overall Study||2296
7949495|NCT00448539|19565961|P2|NOT COMPLETED|Overall Study||152
7949496|NCT00448539|19565962|P1|NOT COMPLETED|Overall Study||134
7949497|NCT00448539|19565961|P2|COMPLETED|Overall Study||0
7949498|NCT00448539|19565962|P1|COMPLETED|Overall Study||0
7949499|NCT00448539|19565961|P2|STARTED|Overall Study||152
7949500|NCT00448539|19565962|P1|STARTED|Overall Study||134
7949501|NCT00448448|19565970|P2|NOT COMPLETED|Overall Study||41
7949502|NCT00448448|19565971|P1|NOT COMPLETED|Overall Study||100
7949503|NCT00448448|19565970|P2|COMPLETED|Overall Study||96
7949504|NCT00448448|19565971|P1|COMPLETED|Overall Study||146
7949505|NCT00448448|19565970|P2|STARTED|Overall Study||137
7949506|NCT00448448|19565971|P1|STARTED|Overall Study||246
7949507|NCT00448435|19565977|P2|NOT COMPLETED|Extension Period - 20 Weeks||0
7949508|NCT00448435|19565978|P1|NOT COMPLETED|Extension Period - 20 Weeks||0
7949509|NCT00448435|19565977|P2|COMPLETED|Extension Period - 20 Weeks||0
7949510|NCT00448435|19565978|P1|COMPLETED|Extension Period - 20 Weeks||50
7949511|NCT00448435|19565977|P2|STARTED|Extension Period - 20 Weeks||0
7949512|NCT00448435|19565978|P1|STARTED|Extension Period - 20 Weeks||50
7949513|NCT00448435|19565977|P2|NOT COMPLETED|Treatment Period II - 4 Weeks||0
7949514|NCT00448435|19565978|P1|NOT COMPLETED|Treatment Period II - 4 Weeks||0
7949515|NCT00448435|19565977|P2|COMPLETED|Treatment Period II - 4 Weeks||25
7949516|NCT00448435|19565978|P1|COMPLETED|Treatment Period II - 4 Weeks||25
7949517|NCT00448435|19565977|P2|STARTED|Treatment Period II - 4 Weeks||25
7949518|NCT00448435|19565978|P1|STARTED|Treatment Period II - 4 Weeks||25
7949519|NCT00448435|19565977|P2|NOT COMPLETED|Washout Period - 2 Weeks||0
7949520|NCT00448435|19565978|P1|NOT COMPLETED|Washout Period - 2 Weeks||1
7949521|NCT00448435|19565977|P2|COMPLETED|Washout Period - 2 Weeks||25
7949522|NCT00448435|19565978|P1|COMPLETED|Washout Period - 2 Weeks||25
7949523|NCT00448435|19565977|P2|STARTED|Washout Period - 2 Weeks||25
7949524|NCT00448435|19565978|P1|STARTED|Washout Period - 2 Weeks||26
7949525|NCT00448435|19565977|P2|NOT COMPLETED|Treatment Period I - 4 Weeks||0
7949526|NCT00448435|19565978|P1|NOT COMPLETED|Treatment Period I - 4 Weeks||0
7949527|NCT00448435|19565977|P2|COMPLETED|Treatment Period I - 4 Weeks||25
7949528|NCT00448435|19565978|P1|COMPLETED|Treatment Period I - 4 Weeks||26
7949529|NCT00448435|19565977|P2|STARTED|Treatment Period I - 4 Weeks||25
7949530|NCT00448435|19565978|P1|STARTED|Treatment Period I - 4 Weeks||26
7949531|NCT00448357|19566004|P1|NOT COMPLETED|Overall Study||0
7949532|NCT00448357|19566004|P1|COMPLETED|Overall Study||54
7949533|NCT00448357|19566004|P1|STARTED|Overall Study||54
7949534|NCT00448344|19566029|P2|NOT COMPLETED|Overall Study||36
7949535|NCT00448344|19566030|P1|NOT COMPLETED|Overall Study||30
7949536|NCT00448344|19566029|P2|COMPLETED|Overall Study||200
7949537|NCT00448344|19566030|P1|COMPLETED|Overall Study||205
7949538|NCT00448344|19566029|P2|STARTED|Overall Study||236
7949539|NCT00448344|19566030|P1|STARTED|Overall Study||235
7949540|NCT00448279|19566040|P2|NOT COMPLETED|Overall Study||29
7949541|NCT00448279|19566041|P1|NOT COMPLETED|Overall Study||29
7949542|NCT00448279|19566040|P2|COMPLETED|Overall Study||0
7949543|NCT00448279|19566041|P1|COMPLETED|Overall Study||0
7949544|NCT00448279|19566040|P2|STARTED|Overall Study||29
7949545|NCT00448279|19566041|P1|STARTED|Overall Study||29
7949546|NCT00448227|19566057|P1|NOT COMPLETED|Overall Study||0
7949547|NCT00448227|19566057|P1|COMPLETED|Overall Study||18
7949548|NCT00448227|19566057|P1|STARTED|Overall Study||18
7949549|NCT00448201|19566084|P1|NOT COMPLETED|Overall Study||0
7949550|NCT00448201|19566084|P1|COMPLETED|Overall Study||71
7949551|NCT00448201|19566084|P1|STARTED|Overall Study||71
7949552|NCT00448175|19566095|P2|NOT COMPLETED|Continued PTNS Through 12 Months||0
7949553|NCT00448175|19566096|P1|NOT COMPLETED|Continued PTNS Through 12 Months||10
7949554|NCT00448175|19566095|P2|COMPLETED|Continued PTNS Through 12 Months||0
7949555|NCT00448175|19566096|P1|COMPLETED|Continued PTNS Through 12 Months||25
7949556|NCT00448175|19566095|P2|STARTED|Continued PTNS Through 12 Months||0
7949557|NCT00448175|19566096|P1|STARTED|Continued PTNS Through 12 Months||35
7949558|NCT00448175|19566095|P2|NOT COMPLETED|12 Weeks PTNS vs. Drug||7
7949559|NCT00448175|19566096|P1|NOT COMPLETED|12 Weeks PTNS vs. Drug||9
7949560|NCT00448175|19566095|P2|COMPLETED|12 Weeks PTNS vs. Drug||43
7949561|NCT00448175|19566096|P1|COMPLETED|12 Weeks PTNS vs. Drug||41
7949562|NCT00448175|19566095|P2|STARTED|12 Weeks PTNS vs. Drug||50
7949563|NCT00448175|19566096|P1|STARTED|12 Weeks PTNS vs. Drug||50
7949564|NCT00448136|19566104|P2|NOT COMPLETED|Overall Study||8
7949565|NCT00448136|19566105|P1|NOT COMPLETED|Overall Study||4
7949566|NCT00448136|19566104|P2|COMPLETED|Overall Study||41
7949567|NCT00448136|19566105|P1|COMPLETED|Overall Study||30
7949568|NCT00448136|19566104|P2|STARTED|Overall Study||49
7949569|NCT00448136|19566105|P1|STARTED|Overall Study||34
7949570|NCT00448123|19566143|P2|NOT COMPLETED|Overall Study||12
7949571|NCT00448123|19566144|P1|NOT COMPLETED|Overall Study||15
7949572|NCT00448123|19566143|P2|COMPLETED|Overall Study||53
7949573|NCT00448123|19566144|P1|COMPLETED|Overall Study||47
7949574|NCT00448123|19566143|P2|STARTED|Overall Study||65
7949575|NCT00448123|19566144|P1|STARTED|Overall Study||62
7949576|NCT00448019|19566154|P1|NOT COMPLETED|Overall Study||7
7949577|NCT00448019|19566154|P1|COMPLETED|Overall Study||57
7949578|NCT00448019|19566154|P1|STARTED|Overall Study||64
7949579|NCT00447902|19566162|P2|NOT COMPLETED|Overall Study||6
7949580|NCT00447902|19566163|P1|NOT COMPLETED|Overall Study||4
7949581|NCT00447902|19566162|P2|COMPLETED|Overall Study||0
7949582|NCT00447902|19566163|P1|COMPLETED|Overall Study||1
7949583|NCT00447902|19566162|P2|STARTED|Overall Study||6
7949584|NCT00447902|19566163|P1|STARTED|Overall Study||5
7949585|NCT00447876|19566205|P2|NOT COMPLETED|Overall Study||4
7949586|NCT00447876|19566206|P1|NOT COMPLETED|Overall Study||3
7949587|NCT00447876|19566205|P2|COMPLETED|Overall Study||16
7949588|NCT00447876|19566206|P1|COMPLETED|Overall Study||17
7949589|NCT00447876|19566205|P2|STARTED|Overall Study||20
7949590|NCT00447876|19566206|P1|STARTED|Overall Study||20
7949591|NCT00447772|19566236|P1|NOT COMPLETED|Overall Study||27
7949592|NCT00447772|19566236|P1|COMPLETED|Overall Study||489
7949593|NCT00447772|19566236|P1|STARTED|Overall Study||516
7949594|NCT00447603|19566256|P3|NOT COMPLETED|Filter Period||15
7949595|NCT00447603|19566257|P2|NOT COMPLETED|Filter Period||4
7949596|NCT00447603|19566258|P1|NOT COMPLETED|Filter Period||0
7949597|NCT00447603|19566256|P3|COMPLETED|Filter Period||0
7949598|NCT00447603|19566257|P2|COMPLETED|Filter Period||0
7949599|NCT00447603|19566258|P1|COMPLETED|Filter Period||0
7949600|NCT00447603|19566256|P3|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15
7949601|NCT00447603|19566257|P2|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4
7949602|NCT00447603|19566258|P1|STARTED|Filter Period||0
7949603|NCT00447603|19566256|P3|NOT COMPLETED|Screening||0
7949604|NCT00447603|19566257|P2|NOT COMPLETED|Screening||0
7949605|NCT00447603|19566258|P1|NOT COMPLETED|Screening||21
7949606|NCT00447603|19566256|P3|COMPLETED|Screening||0
7949607|NCT00447603|19566257|P2|COMPLETED|Screening||0
7949608|NCT00447603|19566258|P1|COMPLETED|Screening||19
7949609|NCT00447603|19566256|P3|STARTED|Screening||0
7949610|NCT00447603|19566257|P2|STARTED|Screening||0
7949611|NCT00447603|19566258|P1|STARTED|Screening||40
7949612|NCT00447590|19566278|P1|NOT COMPLETED|Overall Study||60
7949613|NCT00447590|19566278|P1|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93
7949614|NCT00447590|19566278|P1|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153
7949615|NCT00447499|19566287|P1|NOT COMPLETED|Overall Study||7
7949616|NCT00447499|19566287|P1|COMPLETED|Overall Study||52
7949617|NCT00447499|19566287|P1|STARTED|Overall Study||59
7949618|NCT00447421|19566297|P1|NOT COMPLETED|Overall Study||6
7949619|NCT00447421|19566297|P1|COMPLETED|Overall Study||3
7949620|NCT00447421|19566297|P1|STARTED|Overall Study||9
7949621|NCT00447382|19566309|P2|NOT COMPLETED|Overall Study||6
7949622|NCT00447382|19566310|P1|NOT COMPLETED|Overall Study||6
7949623|NCT00447382|19566309|P2|COMPLETED|Overall Study||160
7949624|NCT00447382|19566310|P1|COMPLETED|Overall Study||158
7949625|NCT00447382|19566309|P2|STARTED|Overall Study||166
7949626|NCT00447382|19566310|P1|STARTED|Overall Study||164
7949627|NCT00447330|19566362|P1|NOT COMPLETED|Overall Study||2
7949628|NCT00447330|19566362|P1|COMPLETED|Overall Study||58
7949629|NCT00447330|19566362|P1|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60
7949630|NCT00447278|19566371|P2|NOT COMPLETED|Period III (Optional 6 Month Extension)||15
7949631|NCT00447278|19566372|P1|NOT COMPLETED|Period III (Optional 6 Month Extension)||30
7949632|NCT00447278|19566371|P2|COMPLETED|Period III (Optional 6 Month Extension)||140
7949633|NCT00447278|19566372|P1|COMPLETED|Period III (Optional 6 Month Extension)||109
7949634|NCT00447278|19566371|P2|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155
7949635|NCT00447278|19566372|P1|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139
7949636|NCT00447278|19566371|P2|NOT COMPLETED|Period II (6 Month Open-Label)||29
7949637|NCT00447278|19566372|P1|NOT COMPLETED|Period II (6 Month Open-Label)||42
7949638|NCT00447278|19566371|P2|COMPLETED|Period II (6 Month Open-Label)||171
7949639|NCT00447278|19566372|P1|COMPLETED|Period II (6 Month Open-Label)||157
7949640|NCT00447278|19566371|P2|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199
7949641|NCT00447278|19566372|P1|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199
7949642|NCT00447278|19566371|P2|STARTED|Period II (6 Month Open-Label)||200
7949643|NCT00447278|19566372|P1|STARTED|Period II (6 Month Open-Label)||199
7949644|NCT00447265|19566393|P2|NOT COMPLETED|Overall Study||0
7949645|NCT00447265|19566394|P1|NOT COMPLETED|Overall Study||1
7949646|NCT00447265|19566393|P2|COMPLETED|Overall Study||0
7949647|NCT00447265|19566394|P1|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0
7949648|NCT00447265|19566393|P2|STARTED|Overall Study||0
7949649|NCT00447265|19566394|P1|STARTED|Overall Study||1
7949650|NCT00447226|19566407|P2|NOT COMPLETED|Double-blind Phase||3
7949651|NCT00447226|19566408|P1|NOT COMPLETED|Double-blind Phase||4
7949652|NCT00447226|19566407|P2|COMPLETED|Double-blind Phase||0
7949653|NCT00447226|19566408|P1|COMPLETED|Double-blind Phase||0
7949654|NCT00447226|19566407|P2|STARTED|Double-blind Phase||3
7949655|NCT00447226|19566408|P1|STARTED|Double-blind Phase||4
7949656|NCT00447226|19566407|P2|NOT COMPLETED|12-Week Open-label Phase||25
7949657|NCT00447226|19566408|P1|NOT COMPLETED|12-Week Open-label Phase||0
7949658|NCT00447226|19566407|P2|COMPLETED|12-Week Open-label Phase||7
7949659|NCT00447226|19566408|P1|COMPLETED|12-Week Open-label Phase||0
7949660|NCT00447226|19566407|P2|STARTED|12-Week Open-label Phase||32
7949661|NCT00447226|19566408|P1|STARTED|12-Week Open-label Phase||0
7949662|NCT00447122|19566426|P1|NOT COMPLETED|Overall Study||2
7949663|NCT00447122|19566426|P1|COMPLETED|Overall Study|29 evaluable thus 29 represented in efficacy and safety portion|29
7949664|NCT00447122|19566426|P1|STARTED|Overall Study||31
7949665|NCT00447083|19566432|P4|NOT COMPLETED|Phase II||1
7949666|NCT00447083|19566433|P3|NOT COMPLETED|Phase II||1
7949667|NCT00447083|19566434|P2|NOT COMPLETED|Phase II||0
7949668|NCT00447083|19566435|P1|NOT COMPLETED|Phase II||0
7949669|NCT00447083|19566432|P4|COMPLETED|Phase II||7
7949670|NCT00447083|19566433|P3|COMPLETED|Phase II||7
7949671|NCT00447083|19566434|P2|COMPLETED|Phase II||0
7949672|NCT00447083|19566435|P1|COMPLETED|Phase II||0
7949673|NCT00447083|19566432|P4|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
7949674|NCT00447083|19566433|P3|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
7949675|NCT00447083|19566434|P2|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
7949676|NCT00447083|19566435|P1|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
7949677|NCT00447083|19566432|P4|NOT COMPLETED|Phase I||0
7949678|NCT00447083|19566433|P3|NOT COMPLETED|Phase I||0
7949679|NCT00447083|19566434|P2|NOT COMPLETED|Phase I||0
7949680|NCT00447083|19566435|P1|NOT COMPLETED|Phase I||0
7949681|NCT00447083|19566432|P4|COMPLETED|Phase I||0
7949682|NCT00447083|19566433|P3|COMPLETED|Phase I||0
7949683|NCT00447083|19566434|P2|COMPLETED|Phase I|1 participant did not acclimate to phase II|9
7949684|NCT00447083|19566435|P1|COMPLETED|Phase I|2 participants did not acclimate to phase II|10
7949685|NCT00447083|19566432|P4|STARTED|Phase I||0
7949686|NCT00447083|19566433|P3|STARTED|Phase I||0
7949687|NCT00447083|19566434|P2|STARTED|Phase I||9
7949688|NCT00447083|19566435|P1|STARTED|Phase I||10
7949689|NCT00447057|19566451|P4|NOT COMPLETED|Overall Study||26
7949690|NCT00447057|19566452|P3|NOT COMPLETED|Overall Study||19
7949691|NCT00447057|19566453|P2|NOT COMPLETED|Overall Study||73
7949692|NCT00447057|19566454|P1|NOT COMPLETED|Overall Study||83
7949693|NCT00447057|19566451|P4|COMPLETED|Overall Study||0
7949694|NCT00447057|19566452|P3|COMPLETED|Overall Study||0
7949695|NCT00447057|19566453|P2|COMPLETED|Overall Study||3
7949696|NCT00447057|19566454|P1|COMPLETED|Overall Study||0
7949697|NCT00447057|19566451|P4|STARTED|Overall Study||26
7949698|NCT00447057|19566452|P3|STARTED|Overall Study||19
7949699|NCT00447057|19566453|P2|STARTED|Overall Study||76
7949700|NCT00447057|19566454|P1|STARTED|Overall Study||83
7949701|NCT00447005|19566472|P1|NOT COMPLETED|Overall Study||12
7949702|NCT00447005|19566472|P1|COMPLETED|Overall Study||0
7949703|NCT00447005|19566472|P1|STARTED|Overall Study||12
7949704|NCT00446992|19566486|P1|NOT COMPLETED|Overall Study||16
7949705|NCT00446992|19566486|P1|COMPLETED|Overall Study|Intervention Completion|14
7949706|NCT00446992|19566486|P1|STARTED|Overall Study|Beginning of Intervention|30
7949707|NCT00446966|19566500|P2|NOT COMPLETED|Overall Study||7
7949708|NCT00446966|19566501|P1|NOT COMPLETED|Overall Study||10
7949709|NCT00446966|19566500|P2|COMPLETED|Overall Study||123
7949710|NCT00446966|19566501|P1|COMPLETED|Overall Study||120
7949711|NCT00446966|19566500|P2|STARTED|Overall Study||130
7949712|NCT00446966|19566501|P1|STARTED|Overall Study||130
7949713|NCT00446849|19566507|P1|NOT COMPLETED|Maintenance Phase||70
7949714|NCT00446849|19566507|P1|COMPLETED|Maintenance Phase||138
7949715|NCT00446849|19566507|P1|STARTED|Maintenance Phase||208
7949716|NCT00446849|19566507|P1|NOT COMPLETED|Acute Phase||82
7949717|NCT00446849|19566507|P1|COMPLETED|Acute Phase||56
7949718|NCT00446849|19566507|P1|STARTED|Acute Phase||138
7949719|NCT00446797|19566519|P2|NOT COMPLETED|Overall Study||12
7949720|NCT00446797|19566520|P1|NOT COMPLETED|Overall Study||8
7949721|NCT00446797|19566519|P2|COMPLETED|Overall Study||125
7949722|NCT00446797|19566520|P1|COMPLETED|Overall Study||133
7949723|NCT00446797|19566519|P2|STARTED|Overall Study||137
7949724|NCT00446797|19566520|P1|STARTED|Overall Study||141
7949725|NCT00446654|19566566|P2|NOT COMPLETED|Overall Study||0
7949726|NCT00446654|19566567|P1|NOT COMPLETED|Overall Study||2
7949727|NCT00446654|19566566|P2|COMPLETED|Overall Study||22
7949728|NCT00446654|19566567|P1|COMPLETED|Overall Study||19
7949729|NCT00446654|19566566|P2|STARTED|Overall Study||22
7949730|NCT00446654|19566567|P1|STARTED|Overall Study||21
7949731|NCT00446641|19566575|P2|NOT COMPLETED|Overall Study||10
7949732|NCT00446641|19566576|P1|NOT COMPLETED|Overall Study||17
7949733|NCT00446641|19566575|P2|COMPLETED|Overall Study||109
7949734|NCT00446641|19566576|P1|COMPLETED|Overall Study||108
7949735|NCT00446641|19566575|P2|STARTED|Overall Study||119
7949736|NCT00446641|19566576|P1|STARTED|Overall Study||125
7949737|NCT00446563|19566596|P2|NOT COMPLETED|Overall Study||9
7949738|NCT00446563|19566597|P1|NOT COMPLETED|Overall Study||7
7949739|NCT00446563|19566596|P2|COMPLETED|Overall Study||38
7949740|NCT00446563|19566597|P1|COMPLETED|Overall Study||36
7949741|NCT00446563|19566596|P2|STARTED|Overall Study||47
7949742|NCT00446563|19566597|P1|STARTED|Overall Study||43
7949743|NCT00446550|19566633|P2|NOT COMPLETED|Overall Study||0
7949744|NCT00446550|19566634|P1|NOT COMPLETED|Overall Study||1
7949745|NCT00446550|19566633|P2|COMPLETED|Overall Study||8
7949746|NCT00446550|19566634|P1|COMPLETED|Overall Study||10
7949747|NCT00446550|19566633|P2|PD Population|Overall Study||8
7949748|NCT00446550|19566634|P1|PD Population|Overall Study||11
7949749|NCT00446550|19566633|P2|Safety Population|Overall Study||8
7949750|NCT00446550|19566634|P1|Safety Population|Overall Study||11
7949751|NCT00446550|19566633|P2|STARTED|Overall Study||8
7949752|NCT00446550|19566634|P1|STARTED|Overall Study||11
7949753|NCT00446511|19566646|P4|NOT COMPLETED|Overall Study||6
7949754|NCT00446511|19566647|P3|NOT COMPLETED|Overall Study||7
7949755|NCT00446511|19566648|P2|NOT COMPLETED|Overall Study||2
7949756|NCT00446511|19566649|P1|NOT COMPLETED|Overall Study||10
7949757|NCT00446511|19566646|P4|COMPLETED|Overall Study||103
7949758|NCT00446511|19566647|P3|COMPLETED|Overall Study||96
7949759|NCT00446511|19566648|P2|COMPLETED|Overall Study||15
7949760|NCT00446511|19566649|P1|COMPLETED|Overall Study||11
7949761|NCT00446511|19566646|P4|STARTED|Overall Study||109
7949762|NCT00446511|19566647|P3|STARTED|Overall Study||103
7949763|NCT00446511|19566648|P2|STARTED|Overall Study||17
7949764|NCT00446511|19566649|P1|STARTED|Overall Study||21
7949765|NCT00446459|19566673|P1|NOT COMPLETED|12 Months||18
7949766|NCT00446459|19566673|P1|COMPLETED|12 Months|4 subjects remained at month 12|4
7949767|NCT00446459|19566673|P1|STARTED|12 Months|22 subjects remained on-study at month 8|22
7949768|NCT00446459|19566673|P1|NOT COMPLETED|8 Months||12
7949769|NCT00446459|19566673|P1|COMPLETED|8 Months|22 subjects were on study at month 8.|22
7949770|NCT00446459|19566673|P1|STARTED|8 Months|34 subjects received any amount of MMF.|34
7949771|NCT00446446|19566681|P1|NOT COMPLETED|Overall Study||24
7949772|NCT00446446|19566681|P1|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28
7949773|NCT00446446|19566681|P1|STARTED|Overall Study||52
7949774|NCT00446290|19566692|P1|NOT COMPLETED|Overall Study||0
7949775|NCT00446290|19566692|P1|COMPLETED|Overall Study||22
7949776|NCT00446290|19566692|P1|STARTED|Overall Study||22
7949777|NCT00446264|19566696|P1|NOT COMPLETED|Overall Study||0
7949778|NCT00446264|19566696|P1|COMPLETED|Overall Study||14
7949779|NCT00446264|19566696|P1|STARTED|Overall Study||14
7949780|NCT00446251|19566705|P1|NOT COMPLETED|Overall Study||5
7949781|NCT00446251|19566705|P1|COMPLETED|Overall Study||9
7949782|NCT00446251|19566705|P1|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14
7949783|NCT00446199|19566715|P4|NOT COMPLETED|Overall Study||30
7949784|NCT00446199|19566716|P3|NOT COMPLETED|Overall Study||27
7949785|NCT00446199|19566717|P2|NOT COMPLETED|Overall Study||20
7949786|NCT00446199|19566718|P1|NOT COMPLETED|Overall Study||23
7949787|NCT00446199|19566715|P4|COMPLETED|Overall Study||153
7949788|NCT00446199|19566716|P3|COMPLETED|Overall Study||158
7949789|NCT00446199|19566717|P2|COMPLETED|Overall Study||164
7949790|NCT00446199|19566718|P1|COMPLETED|Overall Study||160
7949791|NCT00446199|19566715|P4|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176
7949792|NCT00446199|19566716|P3|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179
7949793|NCT00446199|19566717|P2|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177
7949794|NCT00446199|19566718|P1|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178
7949795|NCT00446199|19566715|P4|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180
7949796|NCT00446199|19566716|P3|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182
7949797|NCT00446199|19566717|P2|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183
7949798|NCT00446199|19566718|P1|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181
7949799|NCT00446199|19566715|P4|STARTED|Overall Study||183
7949800|NCT00446199|19566716|P3|STARTED|Overall Study||185
7949801|NCT00446199|19566717|P2|STARTED|Overall Study||184
7949802|NCT00446199|19566718|P1|STARTED|Overall Study||183
7949803|NCT00446147|19566798|P2|NOT COMPLETED|Overall Study||14
7949804|NCT00446147|19566799|P1|NOT COMPLETED|Overall Study||15
7949805|NCT00446147|19566798|P2|COMPLETED|Overall Study||180
7949806|NCT00446147|19566799|P1|COMPLETED|Overall Study||180
7949807|NCT00446147|19566798|P2|STARTED|Overall Study||194
7949808|NCT00446147|19566799|P1|STARTED|Overall Study||195
7949809|NCT00446134|19566811|P4|NOT COMPLETED|Overall Study||45
7949810|NCT00446134|19566812|P3|NOT COMPLETED|Overall Study||43
7949811|NCT00446134|19566813|P2|NOT COMPLETED|Overall Study||45
7949812|NCT00446134|19566814|P1|NOT COMPLETED|Overall Study||34
7949813|NCT00446134|19566811|P4|COMPLETED|Overall Study||25
7949814|NCT00446134|19566812|P3|COMPLETED|Overall Study||26
7949815|NCT00446134|19566813|P2|COMPLETED|Overall Study||25
7949816|NCT00446134|19566814|P1|COMPLETED|Overall Study||35
7949817|NCT00446134|19566811|P4|STARTED|Overall Study||70
7949818|NCT00446134|19566812|P3|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69
7949819|NCT00446134|19566813|P2|STARTED|Overall Study||70
7949820|NCT00446134|19566814|P1|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69
7949821|NCT00446095|19566841|P5|NOT COMPLETED|Phase I (28 Days)||3
7949822|NCT00446095|19566842|P4|NOT COMPLETED|Phase I (28 Days)||1
7949823|NCT00446095|19566843|P3|NOT COMPLETED|Phase I (28 Days)||0
7949824|NCT00446095|19566844|P2|NOT COMPLETED|Phase I (28 Days)||0
7949825|NCT00446095|19566845|P1|NOT COMPLETED|Phase I (28 Days)||0
7949826|NCT00446095|19566841|P5|COMPLETED|Phase I (28 Days)||4
7949827|NCT00446095|19566842|P4|COMPLETED|Phase I (28 Days)||5
7949828|NCT00446095|19566843|P3|COMPLETED|Phase I (28 Days)||0
7949829|NCT00446095|19566844|P2|COMPLETED|Phase I (28 Days)||0
7949830|NCT00446095|19566845|P1|COMPLETED|Phase I (28 Days)||0
7949831|NCT00446095|19566841|P5|STARTED|Phase I (28 Days)||7
7949832|NCT00446095|19566842|P4|STARTED|Phase I (28 Days)||6
7949833|NCT00446095|19566843|P3|STARTED|Phase I (28 Days)||0
7949834|NCT00446095|19566844|P2|STARTED|Phase I (28 Days)||0
7949835|NCT00446095|19566845|P1|STARTED|Phase I (28 Days)||0
7949836|NCT00446095|19566841|P5|NOT COMPLETED|Phase II (8 Weeks)||0
7949837|NCT00446095|19566842|P4|NOT COMPLETED|Phase II (8 Weeks)||0
7949838|NCT00446095|19566843|P3|NOT COMPLETED|Phase II (8 Weeks)||3
7949839|NCT00446095|19566844|P2|NOT COMPLETED|Phase II (8 Weeks)||3
7949840|NCT00446095|19566845|P1|NOT COMPLETED|Phase II (8 Weeks)||12
7949841|NCT00446095|19566841|P5|COMPLETED|Phase II (8 Weeks)||0
7949842|NCT00446095|19566842|P4|COMPLETED|Phase II (8 Weeks)||0
7949843|NCT00446095|19566843|P3|COMPLETED|Phase II (8 Weeks)||21
7949844|NCT00446095|19566844|P2|COMPLETED|Phase II (8 Weeks)||18
7949845|NCT00446095|19566845|P1|COMPLETED|Phase II (8 Weeks)||11
7949846|NCT00446095|19566841|P5|STARTED|Phase II (8 Weeks)||0
7949847|NCT00446095|19566842|P4|STARTED|Phase II (8 Weeks)||0
7949848|NCT00446095|19566843|P3|STARTED|Phase II (8 Weeks)||24
7949849|NCT00446095|19566844|P2|STARTED|Phase II (8 Weeks)||21
7949850|NCT00446095|19566845|P1|STARTED|Phase II (8 Weeks)||23
7949851|NCT00446030|19566868|P2|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9
7949852|NCT00446030|19566869|P1|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30
7949853|NCT00446030|19566868|P2|COMPLETED|FOLLOW-UP (up to 2-years)||25
7949854|NCT00446030|19566869|P1|COMPLETED|FOLLOW-UP (up to 2-years)||63
7949855|NCT00446030|19566868|P2|STARTED|FOLLOW-UP (up to 2-years)||34
7949856|NCT00446030|19566869|P1|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93
7949857|NCT00446030|19566868|P2|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9
7949858|NCT00446030|19566869|P1|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44
7949859|NCT00446030|19566868|P2|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25
7949860|NCT00446030|19566869|P1|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49
7949861|NCT00446030|19566868|P2|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34
7949862|NCT00446030|19566869|P1|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92
7949863|NCT00446030|19566868|P2|STARTED|TREATMENT (up to 52 Weeks)||34
7949864|NCT00446030|19566869|P1|STARTED|TREATMENT (up to 52 Weeks)||93
7949865|NCT00445939|19566880|P4|NOT COMPLETED|Period B - Week 4 - Week 8||1
7949866|NCT00445939|19566881|P3|NOT COMPLETED|Period B - Week 4 - Week 8||0
7949867|NCT00445939|19566882|P2|NOT COMPLETED|Period B - Week 4 - Week 8||0
7949868|NCT00445939|19566883|P1|NOT COMPLETED|Period B - Week 4 - Week 8||2
7949869|NCT00445939|19566880|P4|COMPLETED|Period B - Week 4 - Week 8||20
7949870|NCT00445939|19566881|P3|COMPLETED|Period B - Week 4 - Week 8||0
7949871|NCT00445939|19566882|P2|COMPLETED|Period B - Week 4 - Week 8||0
7949872|NCT00445939|19566883|P1|COMPLETED|Period B - Week 4 - Week 8||14
7949873|NCT00445939|19566880|P4|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21
7949874|NCT00445939|19566881|P3|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0
7949875|NCT00445939|19566882|P2|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0
7949876|NCT00445939|19566883|P1|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16
7949877|NCT00445939|19566880|P4|NOT COMPLETED|Period A - Week 0 - Week 4||0
7949878|NCT00445939|19566881|P3|NOT COMPLETED|Period A - Week 0 - Week 4||0
7949879|NCT00445939|19566882|P2|NOT COMPLETED|Period A - Week 0 - Week 4||2
7949880|NCT00445939|19566883|P1|NOT COMPLETED|Period A - Week 0 - Week 4||1
7949881|NCT00445939|19566880|P4|COMPLETED|Period A - Week 0 - Week 4||0
7949882|NCT00445939|19566881|P3|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23
7949883|NCT00445939|19566882|P2|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32
7949884|NCT00445939|19566883|P1|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32
7949885|NCT00445939|19566880|P4|STARTED|Period A - Week 0 - Week 4||0
7949886|NCT00445939|19566881|P3|STARTED|Period A - Week 0 - Week 4||23
7949887|NCT00445939|19566882|P2|STARTED|Period A - Week 0 - Week 4||34
7949888|NCT00445939|19566883|P1|STARTED|Period A - Week 0 - Week 4||33
7949889|NCT00445887|19566908|P2|NOT COMPLETED|Overall Study||0
7949890|NCT00445887|19566909|P1|NOT COMPLETED|Overall Study||0
7949891|NCT00445887|19566908|P2|COMPLETED|Overall Study||31
7949892|NCT00445887|19566909|P1|COMPLETED|Overall Study||33
7949893|NCT00445887|19566908|P2|STARTED|Overall Study||31
7949894|NCT00445887|19566909|P1|STARTED|Overall Study||33
7949895|NCT00445848|19566931|P1|NOT COMPLETED|Overall Study||85
7949896|NCT00445848|19566931|P1|COMPLETED|Overall Study||0
7949897|NCT00445848|19566931|P1|STARTED|Overall Study||85
7949898|NCT00445770|19566941|P3|NOT COMPLETED|Overall Study||31
7949899|NCT00445770|19566942|P2|NOT COMPLETED|Overall Study||35
7949900|NCT00445770|19566943|P1|NOT COMPLETED|Overall Study||53
7949901|NCT00445770|19566941|P3|COMPLETED|Overall Study||151
7949902|NCT00445770|19566942|P2|COMPLETED|Overall Study||157
7949903|NCT00445770|19566943|P1|COMPLETED|Overall Study||123
7949904|NCT00445770|19566941|P3|STARTED|Overall Study||182
7949905|NCT00445770|19566942|P2|STARTED|Overall Study||192
7949906|NCT00445770|19566943|P1|STARTED|Overall Study||176
7949907|NCT00445744|19567010|P1|NOT COMPLETED|Overall Study||1
7949908|NCT00445744|19567010|P1|COMPLETED|Overall Study||51
7949909|NCT00445744|19567010|P1|STARTED|Overall Study||52
7949910|NCT00445705|19567019|P4|NOT COMPLETED|Overall Study||14
7949911|NCT00445705|19567020|P3|NOT COMPLETED|Overall Study||11
7949912|NCT00445705|19567021|P2|NOT COMPLETED|Overall Study||11
7949913|NCT00445705|19567022|P1|NOT COMPLETED|Overall Study||9
7949914|NCT00445705|19567019|P4|COMPLETED|Overall Study||39
7949915|NCT00445705|19567020|P3|COMPLETED|Overall Study||41
7949916|NCT00445705|19567021|P2|COMPLETED|Overall Study||42
7949917|NCT00445705|19567022|P1|COMPLETED|Overall Study||44
7949918|NCT00445705|19567019|P4|STARTED|Overall Study||53
7949919|NCT00445705|19567020|P3|STARTED|Overall Study||52
7949920|NCT00445705|19567021|P2|STARTED|Overall Study||53
7949921|NCT00445705|19567022|P1|STARTED|Overall Study||53
7949922|NCT00445692|19567044|P1|NOT COMPLETED|Overall Study||16
7949923|NCT00445692|19567044|P1|COMPLETED|Overall Study||15
7949924|NCT00445692|19567044|P1|STARTED|Overall Study||31
7949925|NCT00445679|19567054|P4|NOT COMPLETED|Overall Study||47
7949926|NCT00445679|19567055|P3|NOT COMPLETED|Overall Study||66
7949927|NCT00445679|19567056|P2|NOT COMPLETED|Overall Study||46
7949928|NCT00445679|19567057|P1|NOT COMPLETED|Overall Study||48
7949929|NCT00445679|19567054|P4|COMPLETED|Overall Study||149
7949930|NCT00445679|19567055|P3|COMPLETED|Overall Study||139
7949931|NCT00445679|19567056|P2|COMPLETED|Overall Study||157
7949932|NCT00445679|19567057|P1|COMPLETED|Overall Study||155
7949933|NCT00445679|19567054|P4|STARTED|Overall Study||196
7949934|NCT00445679|19567055|P3|STARTED|Overall Study||205
7949935|NCT00445679|19567056|P2|STARTED|Overall Study||203
7949936|NCT00445679|19567057|P1|STARTED|Overall Study||203
7949937|NCT00445601|19567093|P2|NOT COMPLETED|Overall Study||28
7949938|NCT00445601|19567094|P1|NOT COMPLETED|Overall Study||33
7949939|NCT00445601|19567093|P2|COMPLETED|Overall Study||177
7949940|NCT00445601|19567094|P1|COMPLETED|Overall Study||168
7949941|NCT00445601|19567093|P2|Received TURBT|Overall Study||193
7949942|NCT00445601|19567094|P1|Received TURBT|Overall Study||190
7949943|NCT00445601|19567093|P2|STARTED|Overall Study||205
7949944|NCT00445601|19567094|P1|STARTED|Overall Study||201
7949945|NCT00445588|19567106|P1|NOT COMPLETED|Overall Study||0
7949946|NCT00445588|19567106|P1|COMPLETED|Overall Study||56
7949947|NCT00445588|19567106|P1|STARTED|Overall Study||56
7949948|NCT00445549|19567111|P1|NOT COMPLETED|Overall Study||12
7949949|NCT00445549|19567111|P1|COMPLETED|Overall Study||0
7949950|NCT00445549|19567111|P1|STARTED|Overall Study||12
7949951|NCT00445484|19567118|P2|NOT COMPLETED|Overall Study||1
7949952|NCT00445484|19567119|P1|NOT COMPLETED|Overall Study||4
7949953|NCT00445484|19567118|P2|COMPLETED|Overall Study||10
7949954|NCT00445484|19567119|P1|COMPLETED|Overall Study||7
7949955|NCT00445484|19567118|P2|STARTED|Overall Study||11
7949956|NCT00445484|19567119|P1|STARTED|Overall Study||11
7949957|NCT00445458|19567135|P4|NOT COMPLETED|Overall Study||28
7949958|NCT00445458|19567136|P3|NOT COMPLETED|Overall Study||68
7949959|NCT00445458|19567137|P2|NOT COMPLETED|Overall Study||5
7949960|NCT00445458|19567138|P1|NOT COMPLETED|Overall Study||3
7949961|NCT00445458|19567135|P4|COMPLETED|Overall Study||3
7949962|NCT00445458|19567136|P3|COMPLETED|Overall Study||3
7949963|NCT00445458|19567137|P2|COMPLETED|Overall Study||0
7949964|NCT00445458|19567138|P1|COMPLETED|Overall Study||0
7949965|NCT00445458|19567135|P4|STARTED|Overall Study||31
7949966|NCT00445458|19567136|P3|STARTED|Overall Study||71
7949967|NCT00445458|19567137|P2|STARTED|Overall Study||5
7949968|NCT00445458|19567138|P1|STARTED|Overall Study||3
7949969|NCT00445432|19567156|P4|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44
7949970|NCT00445432|19567157|P3|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
7949971|NCT00445432|19567158|P2|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
7949972|NCT00445432|19567159|P1|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
7949973|NCT00445432|19567156|P4|COMPLETED|148 Weeks of Adalimumab Treatment||35
7949974|NCT00445432|19567157|P3|COMPLETED|148 Weeks of Adalimumab Treatment||0
7949975|NCT00445432|19567158|P2|COMPLETED|148 Weeks of Adalimumab Treatment||0
7949976|NCT00445432|19567159|P1|COMPLETED|148 Weeks of Adalimumab Treatment||0
7949977|NCT00445432|19567156|P4|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79
7949978|NCT00445432|19567157|P3|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
7949979|NCT00445432|19567158|P2|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
7949980|NCT00445432|19567159|P1|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
7949981|NCT00445432|19567156|P4|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
7949982|NCT00445432|19567157|P3|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11
7949983|NCT00445432|19567158|P2|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23
7949984|NCT00445432|19567159|P1|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15
7949985|NCT00445432|19567156|P4|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
7949986|NCT00445432|19567157|P3|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21
7949987|NCT00445432|19567158|P2|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2
7949988|NCT00445432|19567159|P1|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10
7949989|NCT00445432|19567156|P4|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0
7949990|NCT00445432|19567157|P3|STARTED|Through Week 52 of NCT00445432 (M06-837)||32
7949991|NCT00445432|19567158|P2|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
7949992|NCT00445432|19567159|P1|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
7949993|NCT00445341|19567192|P1|NOT COMPLETED|Overall Study||2
7949994|NCT00445341|19567192|P1|COMPLETED|Overall Study||26
7949995|NCT00445341|19567192|P1|STARTED|Overall Study||28
7949996|NCT00445328|19567199|P2|NOT COMPLETED|Overall Study||6
7949997|NCT00445328|19567200|P1|NOT COMPLETED|Overall Study||3
7949998|NCT00445328|19567199|P2|COMPLETED|Overall Study||36
7949999|NCT00445328|19567200|P1|COMPLETED|Overall Study||39
7950000|NCT00445328|19567199|P2|Received Treatment|Overall Study||42
7950001|NCT00445328|19567200|P1|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41
7950002|NCT00445328|19567199|P2|STARTED|Overall Study||42
7950003|NCT00445328|19567200|P1|STARTED|Overall Study||42
7950004|NCT00445315|19567223|P5|NOT COMPLETED|Overall Study||0
7950005|NCT00445315|19567224|P4|NOT COMPLETED|Overall Study||0
7950006|NCT00445315|19567225|P3|NOT COMPLETED|Overall Study||0
7950007|NCT00445315|19567226|P2|NOT COMPLETED|Overall Study||0
7950008|NCT00445315|19567227|P1|NOT COMPLETED|Overall Study||0
7950009|NCT00445315|19567223|P5|COMPLETED|Overall Study||8
7950010|NCT00445315|19567224|P4|COMPLETED|Overall Study||6
7950011|NCT00445315|19567225|P3|COMPLETED|Overall Study||6
7950012|NCT00445315|19567226|P2|COMPLETED|Overall Study||6
7950013|NCT00445315|19567227|P1|COMPLETED|Overall Study||6
7950014|NCT00445315|19567223|P5|STARTED|Overall Study||8
7950015|NCT00445315|19567224|P4|STARTED|Overall Study||6
7950016|NCT00445315|19567225|P3|STARTED|Overall Study||6
7950017|NCT00445315|19567226|P2|STARTED|Overall Study||6
7950018|NCT00445315|19567227|P1|STARTED|Overall Study||6
7950019|NCT00445302|19567321|P4|NOT COMPLETED|Overall Study||0
7950020|NCT00445302|19567322|P3|NOT COMPLETED|Overall Study||0
7950021|NCT00445302|19567323|P2|NOT COMPLETED|Overall Study||0
7950022|NCT00445302|19567324|P1|NOT COMPLETED|Overall Study||0
7950023|NCT00445302|19567321|P4|COMPLETED|Overall Study||6
7950024|NCT00445302|19567322|P3|COMPLETED|Overall Study||6
7950025|NCT00445302|19567323|P2|COMPLETED|Overall Study||5
7950026|NCT00445302|19567324|P1|COMPLETED|Overall Study||6
7950027|NCT00445302|19567321|P4|STARTED|Overall Study||6
7950028|NCT00445302|19567322|P3|STARTED|Overall Study||6
7950029|NCT00445302|19567323|P2|STARTED|Overall Study||5
7950030|NCT00445302|19567324|P1|STARTED|Overall Study||6
7950031|NCT00445263|19567352|P2|NOT COMPLETED|Overall Study||1
7950032|NCT00445263|19567353|P1|NOT COMPLETED|Overall Study||0
7950033|NCT00445263|19567352|P2|COMPLETED|Overall Study||86
7950034|NCT00445263|19567353|P1|COMPLETED|Overall Study||83
7950035|NCT00445263|19567352|P2|STARTED|Overall Study||87
7950036|NCT00445263|19567353|P1|STARTED|Overall Study||83
7950037|NCT00445224|19567361|P2|NOT COMPLETED|Combined Exercises||0
7950038|NCT00445224|19567362|P1|NOT COMPLETED|Combined Exercises||0
7950039|NCT00445224|19567361|P2|COMPLETED|Combined Exercises||13
7950040|NCT00445224|19567362|P1|COMPLETED|Combined Exercises||13
7950041|NCT00445224|19567361|P2|STARTED|Combined Exercises||13
7950042|NCT00445224|19567362|P1|STARTED|Combined Exercises||13
7950043|NCT00445224|19567361|P2|NOT COMPLETED|Specific Exercises||3
7950044|NCT00445224|19567362|P1|NOT COMPLETED|Specific Exercises||4
7950045|NCT00445224|19567361|P2|COMPLETED|Specific Exercises|No adverse event occurred|13
7950046|NCT00445224|19567362|P1|COMPLETED|Specific Exercises|No adverse event occurred|13
7950047|NCT00445224|19567361|P2|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13
7950048|NCT00445224|19567362|P1|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14
7950049|NCT00445224|19567361|P2|Baseline|Specific Exercises||16
7950050|NCT00445224|19567362|P1|Baseline|Specific Exercises||17
7950051|NCT00445224|19567361|P2|STARTED|Specific Exercises||16
7950052|NCT00445224|19567362|P1|STARTED|Specific Exercises||17
7950053|NCT00445211|19567374|P2|NOT COMPLETED|Overall Study||0
7950054|NCT00445211|19567375|P1|NOT COMPLETED|Overall Study||0
7950055|NCT00445211|19567374|P2|COMPLETED|Overall Study||23
7950056|NCT00445211|19567375|P1|COMPLETED|Overall Study||23
7950057|NCT00445211|19567374|P2|STARTED|Overall Study||23
7950058|NCT00445211|19567375|P1|STARTED|Overall Study||23
7950059|NCT00445146|19567389|P1|NOT COMPLETED|Overall Study||119
7950060|NCT00445146|19567389|P1|COMPLETED|Overall Study||73
7950061|NCT00445146|19567389|P1|STARTED|Overall Study||192
7950062|NCT00445003|19567411|P3|NOT COMPLETED|Overall Study||4
7950063|NCT00445003|19567412|P2|NOT COMPLETED|Overall Study||10
7950064|NCT00445003|19567413|P1|NOT COMPLETED|Overall Study||5
7950065|NCT00445003|19567411|P3|COMPLETED|Overall Study||105
7950066|NCT00445003|19567412|P2|COMPLETED|Overall Study||103
7950067|NCT00445003|19567413|P1|COMPLETED|Overall Study||118
7950068|NCT00445003|19567411|P3|STARTED|Overall Study||109
7950069|NCT00445003|19567412|P2|STARTED|Overall Study||113
7950070|NCT00445003|19567413|P1|STARTED|Overall Study||123
7950071|NCT00444951|19567445|P3|NOT COMPLETED|Overall Study||3
7950072|NCT00444951|19567446|P2|NOT COMPLETED|Overall Study||6
7950073|NCT00444951|19567447|P1|NOT COMPLETED|Overall Study||5
7950074|NCT00444951|19567445|P3|COMPLETED|Overall Study||160
7950075|NCT00444951|19567446|P2|COMPLETED|Overall Study||136
7950076|NCT00444951|19567447|P1|COMPLETED|Overall Study||140
7950077|NCT00444951|19567445|P3|STARTED|Overall Study||163
7950078|NCT00444951|19567446|P2|STARTED|Overall Study||142
7950079|NCT00444951|19567447|P1|STARTED|Overall Study||145
7950080|NCT00444925|19567464|P3|NOT COMPLETED|Double-blind Treatment Period||81
7950081|NCT00444925|19567465|P2|NOT COMPLETED|Double-blind Treatment Period||56
7950082|NCT00444925|19567466|P1|NOT COMPLETED|Double-blind Treatment Period||30
7950083|NCT00444925|19567464|P3|COMPLETED|Double-blind Treatment Period||598
7950084|NCT00444925|19567465|P2|COMPLETED|Double-blind Treatment Period||628
7950085|NCT00444925|19567466|P1|COMPLETED|Double-blind Treatment Period||304
7950086|NCT00444925|19567464|P3|STARTED|Double-blind Treatment Period||679
7950087|NCT00444925|19567465|P2|STARTED|Double-blind Treatment Period||684
7950088|NCT00444925|19567466|P1|STARTED|Double-blind Treatment Period||334
7950089|NCT00444925|19567464|P3|NOT COMPLETED|Randomized to Double-blind Treatment||6
7950090|NCT00444925|19567465|P2|NOT COMPLETED|Randomized to Double-blind Treatment||6
7950091|NCT00444925|19567466|P1|NOT COMPLETED|Randomized to Double-blind Treatment||3
7950092|NCT00444925|19567464|P3|COMPLETED|Randomized to Double-blind Treatment||679
7950093|NCT00444925|19567465|P2|COMPLETED|Randomized to Double-blind Treatment||684
7950094|NCT00444925|19567466|P1|COMPLETED|Randomized to Double-blind Treatment||334
7950095|NCT00444925|19567464|P3|STARTED|Randomized to Double-blind Treatment||685
7950096|NCT00444925|19567465|P2|STARTED|Randomized to Double-blind Treatment||690
7950097|NCT00444925|19567466|P1|STARTED|Randomized to Double-blind Treatment||337
7950098|NCT00444925|19567464|P3|NOT COMPLETED|Single-blind Placebo Run-In Period||0
7950099|NCT00444925|19567465|P2|NOT COMPLETED|Single-blind Placebo Run-In Period||0
7950100|NCT00444925|19567466|P1|NOT COMPLETED|Single-blind Placebo Run-In Period||734
7950101|NCT00444925|19567464|P3|COMPLETED|Single-blind Placebo Run-In Period||0
7950102|NCT00444925|19567465|P2|COMPLETED|Single-blind Placebo Run-In Period||0
7950103|NCT00444925|19567466|P1|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712
7950104|NCT00444925|19567464|P3|STARTED|Single-blind Placebo Run-In Period||0
7950105|NCT00444925|19567465|P2|STARTED|Single-blind Placebo Run-In Period||0
7950106|NCT00444925|19567466|P1|STARTED|Single-blind Placebo Run-In Period||2446
7950107|NCT00444912|19567530|P2|NOT COMPLETED|Overall Study||2
7950108|NCT00444912|19567531|P1|NOT COMPLETED|Overall Study||3
7950109|NCT00444912|19567530|P2|COMPLETED|Overall Study||13
7950110|NCT00444912|19567531|P1|COMPLETED|Overall Study||12
7950111|NCT00444912|19567530|P2|Received Transplant|Overall Study||14
7950112|NCT00444912|19567531|P1|Received Transplant|Overall Study||14
7950113|NCT00444912|19567530|P2|Received Plerixafor|Overall Study||15
7950114|NCT00444912|19567531|P1|Received Plerixafor|Overall Study||15
7950115|NCT00444912|19567530|P2|STARTED|Overall Study||15
7950116|NCT00444912|19567531|P1|STARTED|Overall Study||15
7950117|NCT00444821|19567561|P2|NOT COMPLETED|Overall Study||366
7950118|NCT00444821|19567562|P1|NOT COMPLETED|Overall Study||362
7950119|NCT00444821|19567561|P2|COMPLETED|Overall Study||0
7950120|NCT00444821|19567562|P1|COMPLETED|Overall Study||0
7950121|NCT00444821|19567561|P2|Received AAA Repair|Overall Study|Underwent AAA repair per protocol|326
7950122|NCT00444821|19567562|P1|Received AAA Repair|Overall Study|Crossed over to AAA repair|122
7950123|NCT00444821|19567561|P2|STARTED|Overall Study||366
7950124|NCT00444821|19567562|P1|STARTED|Overall Study||362
7950125|NCT00444795|19567572|P1|NOT COMPLETED|Overall Study||3
7950126|NCT00444795|19567572|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617
7950127|NCT00444795|19567572|P1|STARTED|Overall Study||620
7950128|NCT00444678|19567577|P1|NOT COMPLETED|Overall Study||31
7950129|NCT00444678|19567577|P1|COMPLETED|Overall Study||5
7950130|NCT00444678|19567577|P1|STARTED|Overall Study||36
7950131|NCT00444626|19567584|P1|NOT COMPLETED|Repeat Treatment Period||0
7950132|NCT00444626|19567584|P1|COMPLETED|Repeat Treatment Period||105
7950133|NCT00444626|19567584|P1|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105
7950134|NCT00444626|19567584|P1|NOT COMPLETED|Initial Treatment Period||12
7950135|NCT00444626|19567584|P1|COMPLETED|Initial Treatment Period||128
7950136|NCT00444626|19567584|P1|STARTED|Initial Treatment Period||140
7950137|NCT00444600|19567614|P4|NOT COMPLETED|Overall Study||10
7950138|NCT00444600|19567615|P3|NOT COMPLETED|Overall Study||10
7950139|NCT00444600|19567616|P2|NOT COMPLETED|Overall Study||16
7950140|NCT00444600|19567617|P1|NOT COMPLETED|Overall Study||19
7950141|NCT00444600|19567614|P4|COMPLETED|Overall Study|Number of eyes|176
7950142|NCT00444600|19567615|P3|COMPLETED|Overall Study|Number of eyes|178
7950143|NCT00444600|19567616|P2|COMPLETED|Overall Study|Number of eyes|171
7950144|NCT00444600|19567617|P1|COMPLETED|Overall Study|Number of eyes|274
7950145|NCT00444600|19567614|P4|STARTED|Overall Study|Number of eyes|186
7950146|NCT00444600|19567615|P3|STARTED|Overall Study|Number of eyes|188
7950147|NCT00444600|19567616|P2|STARTED|Overall Study|Number of eyes|187
7950148|NCT00444600|19567617|P1|STARTED|Overall Study|Number of eyes|293
7950149|NCT00444587|19567709|P2|NOT COMPLETED|Overall Study||15
7950150|NCT00444587|19567710|P1|NOT COMPLETED|Overall Study||83
7950151|NCT00444587|19567709|P2|COMPLETED|Overall Study||1
7950152|NCT00444587|19567710|P1|COMPLETED|Overall Study||10
7950153|NCT00444587|19567709|P2|STARTED|Overall Study||16
7950154|NCT00444587|19567710|P1|STARTED|Overall Study||93
7950155|NCT00444535|19567731|P1|NOT COMPLETED|Overall Study||24
7950156|NCT00444535|19567731|P1|COMPLETED|Overall Study||28
7950157|NCT00444535|19567731|P1|STARTED|Overall Study||52
7950158|NCT00444457|19567742|P4|NOT COMPLETED|Toddler Dose||8
7950159|NCT00444457|19567743|P3|NOT COMPLETED|Toddler Dose||4
7950160|NCT00444457|19567744|P2|NOT COMPLETED|Toddler Dose||6
7950161|NCT00444457|19567745|P1|NOT COMPLETED|Toddler Dose||7
7950162|NCT00444457|19567742|P4|COMPLETED|Toddler Dose||200
7950163|NCT00444457|19567743|P3|COMPLETED|Toddler Dose||404
7950164|NCT00444457|19567744|P2|COMPLETED|Toddler Dose||391
7950165|NCT00444457|19567745|P1|COMPLETED|Toddler Dose||408
7950166|NCT00444457|19567742|P4|STARTED|Toddler Dose|Vaccinated toddler dose|208
7950167|NCT00444457|19567743|P3|STARTED|Toddler Dose|Vaccinated toddler dose|408
7950168|NCT00444457|19567744|P2|STARTED|Toddler Dose|Vaccinated toddler dose|397
7950169|NCT00444457|19567745|P1|STARTED|Toddler Dose|Vaccinated toddler dose|415
7950170|NCT00444457|19567742|P4|NOT COMPLETED|After Infant Series||10
7950171|NCT00444457|19567743|P3|NOT COMPLETED|After Infant Series||19
7950172|NCT00444457|19567744|P2|NOT COMPLETED|After Infant Series||30
7950173|NCT00444457|19567745|P1|NOT COMPLETED|After Infant Series||20
7950174|NCT00444457|19567742|P4|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208
7950175|NCT00444457|19567743|P3|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408
7950176|NCT00444457|19567744|P2|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397
7950177|NCT00444457|19567745|P1|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415
7950178|NCT00444457|19567742|P4|STARTED|After Infant Series||218
7950179|NCT00444457|19567743|P3|STARTED|After Infant Series||427
7950180|NCT00444457|19567744|P2|STARTED|After Infant Series||427
7950181|NCT00444457|19567745|P1|STARTED|After Infant Series||435
7950182|NCT00444457|19567742|P4|NOT COMPLETED|Infant Series||28
7950183|NCT00444457|19567743|P3|NOT COMPLETED|Infant Series||61
7950184|NCT00444457|19567744|P2|NOT COMPLETED|Infant Series||61
7950185|NCT00444457|19567745|P1|NOT COMPLETED|Infant Series||54
7950186|NCT00444457|19567742|P4|COMPLETED|Infant Series||218
7950187|NCT00444457|19567743|P3|COMPLETED|Infant Series||428
7950188|NCT00444457|19567744|P2|COMPLETED|Infant Series||427
7950189|NCT00444457|19567745|P1|COMPLETED|Infant Series||435
7950190|NCT00444457|19567742|P4|Vaccinated Dose 3|Infant Series||225
7950191|NCT00444457|19567743|P3|Vaccinated Dose 3|Infant Series||438
7950192|NCT00444457|19567744|P2|Vaccinated Dose 3|Infant Series||435
7950193|NCT00444457|19567745|P1|Vaccinated Dose 3|Infant Series||442
7950194|NCT00444457|19567742|P4|Vaccinated Dose 2|Infant Series||228
7950195|NCT00444457|19567743|P3|Vaccinated Dose 2|Infant Series||455
7950196|NCT00444457|19567744|P2|Vaccinated Dose 2|Infant Series||447
7950197|NCT00444457|19567745|P1|Vaccinated Dose 2|Infant Series||455
7950198|NCT00444457|19567742|P4|Vaccinated Dose 1|Infant Series||244
7950199|NCT00444457|19567743|P3|Vaccinated Dose 1|Infant Series||485
7950200|NCT00444457|19567744|P2|Vaccinated Dose 1|Infant Series||484
7950201|NCT00444457|19567745|P1|Vaccinated Dose 1|Infant Series||486
7950202|NCT00444457|19567742|P4|STARTED|Infant Series||246
7950203|NCT00444457|19567743|P3|STARTED|Infant Series||489
7950204|NCT00444457|19567744|P2|STARTED|Infant Series||488
7950205|NCT00444457|19567745|P1|STARTED|Infant Series||489
7950206|NCT00444275|19567810|P5|NOT COMPLETED|Maintenance Treatment Phase||179
7950207|NCT00444275|19567811|P4|NOT COMPLETED|Maintenance Treatment Phase||133
7950208|NCT00444275|19567812|P3|NOT COMPLETED|Maintenance Treatment Phase||161
7950209|NCT00444275|19567813|P2|NOT COMPLETED|Maintenance Treatment Phase||0
7950210|NCT00444275|19567814|P1|NOT COMPLETED|Maintenance Treatment Phase||0
7950211|NCT00444275|19567810|P5|COMPLETED|Maintenance Treatment Phase||701
7950212|NCT00444275|19567811|P4|COMPLETED|Maintenance Treatment Phase||764
7950213|NCT00444275|19567812|P3|COMPLETED|Maintenance Treatment Phase||747
7950214|NCT00444275|19567813|P2|COMPLETED|Maintenance Treatment Phase||0
7950215|NCT00444275|19567814|P1|COMPLETED|Maintenance Treatment Phase||0
7950216|NCT00444275|19567810|P5|STARTED|Maintenance Treatment Phase||880
7950217|NCT00444275|19567811|P4|STARTED|Maintenance Treatment Phase||897
7950218|NCT00444275|19567812|P3|STARTED|Maintenance Treatment Phase||908
7950219|NCT00444275|19567813|P2|STARTED|Maintenance Treatment Phase||0
7950220|NCT00444275|19567814|P1|STARTED|Maintenance Treatment Phase||0
7950221|NCT00444275|19567810|P5|NOT COMPLETED|Initial Treatment Phase||0
7950222|NCT00444275|19567811|P4|NOT COMPLETED|Initial Treatment Phase||0
7950223|NCT00444275|19567812|P3|NOT COMPLETED|Initial Treatment Phase||0
7950224|NCT00444275|19567813|P2|NOT COMPLETED|Initial Treatment Phase||96
7950225|NCT00444275|19567814|P1|NOT COMPLETED|Initial Treatment Phase||248
7950226|NCT00444275|19567810|P5|COMPLETED|Initial Treatment Phase||0
7950227|NCT00444275|19567811|P4|COMPLETED|Initial Treatment Phase||0
7950228|NCT00444275|19567812|P3|COMPLETED|Initial Treatment Phase||0
7950229|NCT00444275|19567813|P2|COMPLETED|Initial Treatment Phase||777
7950230|NCT00444275|19567814|P1|COMPLETED|Initial Treatment Phase||1908
7950231|NCT00444275|19567810|P5|STARTED|Initial Treatment Phase||0
7950232|NCT00444275|19567811|P4|STARTED|Initial Treatment Phase||0
7950233|NCT00444275|19567812|P3|STARTED|Initial Treatment Phase||0
7950234|NCT00444275|19567813|P2|STARTED|Initial Treatment Phase||873
7950235|NCT00444275|19567814|P1|STARTED|Initial Treatment Phase||2156
7950236|NCT00444145|19567864|P1|NOT COMPLETED|Overall Study||19
7950237|NCT00444145|19567864|P1|COMPLETED|Overall Study||19
7950238|NCT00444145|19567864|P1|STARTED|Overall Study||38
7950239|NCT00444106|19567871|P3|NOT COMPLETED|Overall Study||1
7950240|NCT00444106|19567872|P2|NOT COMPLETED|Overall Study||1
7950241|NCT00444106|19567873|P1|NOT COMPLETED|Overall Study||2
7950242|NCT00444106|19567871|P3|COMPLETED|Overall Study||52
7950243|NCT00444106|19567872|P2|COMPLETED|Overall Study||52
7950244|NCT00444106|19567873|P1|COMPLETED|Overall Study||157
7950245|NCT00444106|19567871|P3|Completed Treatment Period|Overall Study||53
7950246|NCT00444106|19567872|P2|Completed Treatment Period|Overall Study||53
7950247|NCT00444106|19567873|P1|Completed Treatment Period|Overall Study||159
7950248|NCT00444106|19567871|P3|STARTED|Overall Study||53
7950249|NCT00444106|19567872|P2|STARTED|Overall Study||53
7950250|NCT00444106|19567873|P1|STARTED|Overall Study||159
7950251|NCT00444080|19567890|P2|NOT COMPLETED|Overall Study||0
7950252|NCT00444080|19567891|P1|NOT COMPLETED|Overall Study||0
7950253|NCT00444080|19567890|P2|COMPLETED|Overall Study||59
7950254|NCT00444080|19567891|P1|COMPLETED|Overall Study||61
7950255|NCT00444080|19567890|P2|STARTED|Overall Study||59
7950256|NCT00444080|19567891|P1|STARTED|Overall Study||61
7950257|NCT00444067|19567905|P2|NOT COMPLETED|Overall Study||1
7950258|NCT00444067|19567906|P1|NOT COMPLETED|Overall Study||0
7950259|NCT00444067|19567905|P2|COMPLETED|Overall Study||23
7950260|NCT00444067|19567906|P1|COMPLETED|Overall Study||74
7950261|NCT00444067|19567905|P2|STARTED|Overall Study||24
7950262|NCT00444067|19567906|P1|STARTED|Overall Study||74
7950263|NCT00444028|19567922|P6|NOT COMPLETED|Overall Study||0
7950264|NCT00444028|19567923|P5|NOT COMPLETED|Overall Study||0
7950265|NCT00444028|19567924|P4|NOT COMPLETED|Overall Study||0
7950266|NCT00444028|19567925|P3|NOT COMPLETED|Overall Study||0
7950267|NCT00444028|19567926|P2|NOT COMPLETED|Overall Study||0
7950268|NCT00444028|19567927|P1|NOT COMPLETED|Overall Study||0
7950269|NCT00444028|19567922|P6|COMPLETED|Overall Study||8
7950270|NCT00444028|19567923|P5|COMPLETED|Overall Study||7
7950271|NCT00444028|19567924|P4|COMPLETED|Overall Study||6
7950272|NCT00444028|19567925|P3|COMPLETED|Overall Study||8
7950273|NCT00444028|19567926|P2|COMPLETED|Overall Study||7
7950274|NCT00444028|19567927|P1|COMPLETED|Overall Study||14
7950275|NCT00444028|19567922|P6|STARTED|Overall Study||8
7950276|NCT00444028|19567923|P5|STARTED|Overall Study||7
7950277|NCT00444028|19567924|P4|STARTED|Overall Study||6
7950278|NCT00444028|19567925|P3|STARTED|Overall Study||8
7950279|NCT00444028|19567926|P2|STARTED|Overall Study||7
7950280|NCT00444028|19567927|P1|STARTED|Overall Study||14
7950281|NCT00443898|19567969|P4|NOT COMPLETED|Overall Study||18
7950282|NCT00443898|19567970|P3|NOT COMPLETED|Overall Study||29
7950283|NCT00443898|19567971|P2|NOT COMPLETED|Overall Study||25
7950284|NCT00443898|19567972|P1|NOT COMPLETED|Overall Study||24
7950285|NCT00443898|19567969|P4|COMPLETED|Overall Study||110
7950286|NCT00443898|19567970|P3|COMPLETED|Overall Study||107
7950287|NCT00443898|19567971|P2|COMPLETED|Overall Study||103
7950288|NCT00443898|19567972|P1|COMPLETED|Overall Study||102
7950289|NCT00443898|19567969|P4|STARTED|Overall Study||128
7950290|NCT00443898|19567970|P3|STARTED|Overall Study||136
7950291|NCT00443898|19567971|P2|STARTED|Overall Study||128
7950292|NCT00443898|19567972|P1|STARTED|Overall Study||126
7950293|NCT00443872|19567994|P1|NOT COMPLETED|Overall Study||17
7950294|NCT00443872|19567994|P1|COMPLETED|Overall Study||60
7950295|NCT00443872|19567994|P1|STARTED|Overall Study||77
7950296|NCT00443846|19568009|P2|NOT COMPLETED|Overall Study||6
7950297|NCT00443846|19568010|P1|NOT COMPLETED|Overall Study||11
7950298|NCT00443846|19568009|P2|COMPLETED|Overall Study||117
7950299|NCT00443846|19568010|P1|COMPLETED|Overall Study||113
7950300|NCT00443846|19568009|P2|Vaccinated|Overall Study||123
7950301|NCT00443846|19568010|P1|Vaccinated|Overall Study||116
7950302|NCT00443846|19568009|P2|STARTED|Overall Study||123
7950303|NCT00443846|19568010|P1|STARTED|Overall Study||124
7950304|NCT00443820|19568020|P4|NOT COMPLETED|Overall Study||17
7950305|NCT00443820|19568021|P3|NOT COMPLETED|Overall Study||18
7950306|NCT00443820|19568022|P2|NOT COMPLETED|Overall Study||19
7950307|NCT00443820|19568023|P1|NOT COMPLETED|Overall Study||21
7950308|NCT00443820|19568020|P4|COMPLETED|Overall Study||111
7950309|NCT00443820|19568021|P3|COMPLETED|Overall Study||117
7950310|NCT00443820|19568022|P2|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111
7950311|NCT00443820|19568023|P1|COMPLETED|Overall Study||112
7950312|NCT00443820|19568020|P4|Safety Population|Overall Study||126
7950313|NCT00443820|19568021|P3|Safety Population|Overall Study||134
7950314|NCT00443820|19568022|P2|Safety Population|Overall Study||129
7950315|NCT00443820|19568023|P1|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131
7950316|NCT00443820|19568020|P4|STARTED|Overall Study||128
7950317|NCT00443820|19568021|P3|STARTED|Overall Study||135
7950318|NCT00443820|19568022|P2|STARTED|Overall Study||130
7950319|NCT00443820|19568023|P1|STARTED|Overall Study||133
7950320|NCT00443781|19568045|P1|NOT COMPLETED|Overall Study||25
7950321|NCT00443781|19568045|P1|COMPLETED|Overall Study||37
7950322|NCT00443781|19568045|P1|STARTED|Overall Study||62
7950323|NCT00443755|19568051|P2|NOT COMPLETED|Overall Study||1
7950324|NCT00443755|19568052|P1|NOT COMPLETED|Overall Study||2
7950325|NCT00443755|19568051|P2|COMPLETED|Overall Study||13
7950326|NCT00443755|19568052|P1|COMPLETED|Overall Study||12
7950327|NCT00443755|19568051|P2|STARTED|Overall Study||14
7950328|NCT00443755|19568052|P1|STARTED|Overall Study||14
7950329|NCT00443729|19568086|P2|NOT COMPLETED|Overall Study||7
7950330|NCT00443729|19568087|P1|NOT COMPLETED|Overall Study||10
7950331|NCT00443729|19568086|P2|COMPLETED|Overall Study||172
7950332|NCT00443729|19568087|P1|COMPLETED|Overall Study||166
7950333|NCT00443729|19568086|P2|Treated|Overall Study||178
7950334|NCT00443729|19568087|P1|Treated|Overall Study||176
7950335|NCT00443729|19568086|P2|STARTED|Overall Study||179
7950336|NCT00443729|19568087|P1|STARTED|Overall Study||176
7950337|NCT00443703|19568135|P2|NOT COMPLETED|Overall Study||18
7950338|NCT00443703|19568136|P1|NOT COMPLETED|Overall Study||28
7950339|NCT00443703|19568135|P2|COMPLETED|Overall Study||157
7950340|NCT00443703|19568136|P1|COMPLETED|Overall Study||149
7950341|NCT00443703|19568135|P2|Treated|Overall Study||174
7950342|NCT00443703|19568136|P1|Treated|Overall Study||174
7950343|NCT00443703|19568135|P2|STARTED|Overall Study||175
7950344|NCT00443703|19568136|P1|STARTED|Overall Study||177
7950345|NCT00443651|19568188|P2|NOT COMPLETED|Overall Study||58
7950346|NCT00443651|19568189|P1|NOT COMPLETED|Overall Study||95
7950347|NCT00443651|19568188|P2|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118
7950348|NCT00443651|19568189|P1|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306
7950349|NCT00443651|19568188|P2|Week 48|Overall Study||134
7950350|NCT00443651|19568189|P1|Week 48|Overall Study||338
7950351|NCT00443651|19568188|P2|Week 24|Overall Study||160
7950352|NCT00443651|19568189|P1|Week 24|Overall Study||376
7950353|NCT00443651|19568188|P2|STARTED|Overall Study||176
7950354|NCT00443651|19568189|P1|STARTED|Overall Study||401
7950355|NCT00443599|19568209|P2|NOT COMPLETED|Overall Study||3
7950356|NCT00443599|19568210|P1|NOT COMPLETED|Overall Study||6
7950357|NCT00443599|19568209|P2|COMPLETED|Overall Study|Included in per-protocol analysis|490
7950358|NCT00443599|19568210|P1|COMPLETED|Overall Study|Included in per-protocol analysis|490
7950359|NCT00443599|19568209|P2|STARTED|Overall Study|Randomly Assigned to Standard Care|493
7950360|NCT00443599|19568210|P1|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496
7950361|NCT00443560|19568244|P2|NOT COMPLETED|Overall Study||30
7950362|NCT00443560|19568245|P1|NOT COMPLETED|Overall Study||60
7950363|NCT00443560|19568244|P2|COMPLETED|Overall Study||1051
7950364|NCT00443560|19568245|P1|COMPLETED|Overall Study||1021
7950365|NCT00443560|19568244|P2|STARTED|Overall Study||1081
7950366|NCT00443560|19568245|P1|STARTED|Overall Study||1081
7950367|NCT00443547|19568259|P4|NOT COMPLETED|Overall Study||2
7950368|NCT00443547|19568260|P3|NOT COMPLETED|Overall Study||21
7950369|NCT00443547|19568261|P2|NOT COMPLETED|Overall Study||42
7950370|NCT00443547|19568262|P1|NOT COMPLETED|Overall Study||45
7950371|NCT00443547|19568259|P4|COMPLETED|Overall Study||4
7950372|NCT00443547|19568260|P3|COMPLETED|Overall Study||27
7950373|NCT00443547|19568261|P2|COMPLETED|Overall Study||46
7950374|NCT00443547|19568262|P1|COMPLETED|Overall Study||44
7950375|NCT00443547|19568259|P4|Evaluated at 12 Months|Overall Study||5
7950376|NCT00443547|19568260|P3|Evaluated at 12 Months|Overall Study||37
7950377|NCT00443547|19568261|P2|Evaluated at 12 Months|Overall Study||55
7950378|NCT00443547|19568262|P1|Evaluated at 12 Months|Overall Study||58
7950379|NCT00443547|19568259|P4|STARTED|Overall Study|Enrolled and Treated Per Protocol|6
7950380|NCT00443547|19568260|P3|STARTED|Overall Study|Enrolled and Treated Per Protocol|48
7950381|NCT00443547|19568261|P2|STARTED|Overall Study|Enrolled and Treated Per Protocol|88
7950382|NCT00443547|19568262|P1|STARTED|Overall Study|Enrolled and Treated Per Protocol|89
7950383|NCT00443534|19568280|P1|NOT COMPLETED|Overall Study||123
7950384|NCT00443534|19568280|P1|COMPLETED|Overall Study||0
7950385|NCT00443534|19568280|P1|Treated|Overall Study||122
7950386|NCT00443534|19568280|P1|STARTED|Overall Study||123
7950387|NCT00443456|19568287|P1|NOT COMPLETED|Overall Study||18
7950388|NCT00443456|19568287|P1|COMPLETED|Overall Study||116
7950389|NCT00443456|19568287|P1|STARTED|Overall Study||134
7950390|NCT00443430|19568322|P2|NOT COMPLETED|Overall Study||4
7950391|NCT00443430|19568323|P1|NOT COMPLETED|Overall Study||4
7950392|NCT00443430|19568322|P2|COMPLETED|Overall Study||38
7950393|NCT00443430|19568323|P1|COMPLETED|Overall Study||39
7950394|NCT00443430|19568322|P2|STARTED|Overall Study||42
7950395|NCT00443430|19568323|P1|STARTED|Overall Study||43
7950396|NCT00443352|19568333|P1|NOT COMPLETED|Overall Study||5
7950397|NCT00443352|19568333|P1|COMPLETED|Overall Study||22
7950398|NCT00443352|19568333|P1|STARTED|Overall Study||27
7950399|NCT00443261|19568337|P1|NOT COMPLETED|Overall Study||1
7950400|NCT00443261|19568337|P1|COMPLETED|Overall Study|Study terminated due to poor accrual and only patient enrolled died|0
7950401|NCT00443261|19568337|P1|Accrual in 10 Months|Overall Study|Patient died due to progressive disease after cycle 1 of treatment|1
7950402|NCT00443261|19568337|P1|STARTED|Overall Study||1
7950403|NCT00443209|19568343|P2|NOT COMPLETED|Months 13 to 18 Treatment Period||47
7950404|NCT00443209|19568344|P1|NOT COMPLETED|Months 13 to 18 Treatment Period||99
7950405|NCT00443209|19568343|P2|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39
7950406|NCT00443209|19568344|P1|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87
7950407|NCT00443209|19568343|P2|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86
7950408|NCT00443209|19568344|P1|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186
7950409|NCT00443209|19568343|P2|NOT COMPLETED|Months 1 to 12 Treatment Period||154
7950410|NCT00443209|19568344|P1|NOT COMPLETED|Months 1 to 12 Treatment Period||345
7950411|NCT00443209|19568343|P2|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202
7950412|NCT00443209|19568344|P1|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367
7950413|NCT00443209|19568343|P2|Treated|Months 1 to 12 Treatment Period||313
7950414|NCT00443209|19568344|P1|Treated|Months 1 to 12 Treatment Period||641
7950415|NCT00443209|19568343|P2|STARTED|Months 1 to 12 Treatment Period||356
7950416|NCT00443209|19568344|P1|STARTED|Months 1 to 12 Treatment Period||712
7950417|NCT00443118|19568361|P3|NOT COMPLETED|Overall Study||0
7950418|NCT00443118|19568362|P2|NOT COMPLETED|Overall Study||1
7950419|NCT00443118|19568363|P1|NOT COMPLETED|Overall Study||4
7950420|NCT00443118|19568361|P3|COMPLETED|Overall Study||226
7950421|NCT00443118|19568362|P2|COMPLETED|Overall Study||290
7950422|NCT00443118|19568363|P1|COMPLETED|Overall Study||511
7950423|NCT00443118|19568361|P3|STARTED|Overall Study||226
7950424|NCT00443118|19568362|P2|STARTED|Overall Study||291
7950425|NCT00443118|19568363|P1|STARTED|Overall Study||515
7950426|NCT00443053|19568412|P2|NOT COMPLETED|Overall Study||33
7950427|NCT00443053|19568413|P1|NOT COMPLETED|Overall Study||21
7950428|NCT00443053|19568412|P2|COMPLETED|Overall Study||1467
7950429|NCT00443053|19568413|P1|COMPLETED|Overall Study||1481
7950430|NCT00443053|19568412|P2|STARTED|Overall Study||1500
7950431|NCT00443053|19568413|P1|STARTED|Overall Study||1502
7950432|NCT00443040|19568434|P3|NOT COMPLETED|Overall Study||1
7950433|NCT00443040|19568435|P2|NOT COMPLETED|Overall Study||0
7950434|NCT00443040|19568436|P1|NOT COMPLETED|Overall Study||4
7950435|NCT00443040|19568434|P3|COMPLETED|Overall Study||9
7950436|NCT00443040|19568435|P2|COMPLETED|Overall Study||11
7950437|NCT00443040|19568436|P1|COMPLETED|Overall Study||10
7950438|NCT00443040|19568434|P3|STARTED|Overall Study||10
7950439|NCT00443040|19568435|P2|STARTED|Overall Study||11
7950440|NCT00443040|19568436|P1|STARTED|Overall Study||14
7950441|NCT00442962|19568444|P1|NOT COMPLETED|Overall Study||8
7950442|NCT00442962|19568444|P1|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46
7950443|NCT00442962|19568444|P1|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52
7950444|NCT00442962|19568444|P1|STARTED|Overall Study||54
7950445|NCT00442936|19568462|P4|NOT COMPLETED|Overall Study||1
7950446|NCT00442936|19568463|P3|NOT COMPLETED|Overall Study||1
7950447|NCT00442936|19568464|P2|NOT COMPLETED|Overall Study||0
7950448|NCT00442936|19568465|P1|NOT COMPLETED|Overall Study||1
7950449|NCT00442936|19568462|P4|COMPLETED|Overall Study||347
7950450|NCT00442936|19568463|P3|COMPLETED|Overall Study||344
7950451|NCT00442936|19568464|P2|COMPLETED|Overall Study||354
7950452|NCT00442936|19568465|P1|COMPLETED|Overall Study||332
7950453|NCT00442936|19568462|P4|STARTED|Overall Study||348
7950454|NCT00442936|19568463|P3|STARTED|Overall Study||345
7950455|NCT00442936|19568464|P2|STARTED|Overall Study||354
7950456|NCT00442936|19568465|P1|STARTED|Overall Study||333
7950457|NCT00442897|19568513|P2|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
7950458|NCT00442897|19568514|P1|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
7950459|NCT00442897|19568513|P2|COMPLETED|24 Weeks Follow-up (3 Centers)||28
7950460|NCT00442897|19568514|P1|COMPLETED|24 Weeks Follow-up (3 Centers)||29
7950461|NCT00442897|19568513|P2|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34
7950462|NCT00442897|19568514|P1|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35
7950463|NCT00442897|19568513|P2|NOT COMPLETED|Base Study (12 Week Follow-up)||12
7950464|NCT00442897|19568514|P1|NOT COMPLETED|Base Study (12 Week Follow-up)||17
7950465|NCT00442897|19568513|P2|COMPLETED|Base Study (12 Week Follow-up)||99
7950466|NCT00442897|19568514|P1|COMPLETED|Base Study (12 Week Follow-up)||101
7950467|NCT00442897|19568513|P2|STARTED|Base Study (12 Week Follow-up)||111
7950468|NCT00442897|19568514|P1|STARTED|Base Study (12 Week Follow-up)||118
7950469|NCT00442767|19568522|P1|NOT COMPLETED|Overall Study||0
7950470|NCT00442767|19568522|P1|COMPLETED|Overall Study||8
7950471|NCT00442767|19568522|P1|STARTED|Overall Study||8
7950472|NCT00442702|19568532|P2|NOT COMPLETED|Evaluation Period||4
7950473|NCT00442702|19568533|P1|NOT COMPLETED|Evaluation Period||5
7950474|NCT00442702|19568532|P2|COMPLETED|Evaluation Period||107
7950475|NCT00442702|19568533|P1|COMPLETED|Evaluation Period||97
7950476|NCT00442702|19568532|P2|STARTED|Evaluation Period||111
7950477|NCT00442702|19568533|P1|STARTED|Evaluation Period||102
7950478|NCT00442702|19568532|P2|NOT COMPLETED|Titration Period||3
7950479|NCT00442702|19568533|P1|NOT COMPLETED|Titration Period||12
7950480|NCT00442702|19568532|P2|COMPLETED|Titration Period||111
7950481|NCT00442702|19568533|P1|COMPLETED|Titration Period||102
7950482|NCT00442702|19568532|P2|Safety Population|Titration Period||113
7950483|NCT00442702|19568533|P1|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115
7950484|NCT00442702|19568532|P2|STARTED|Titration Period||114
7950485|NCT00442702|19568533|P1|STARTED|Titration Period||114
7950486|NCT00442689|19568548|P3|NOT COMPLETED|Overall Study||9
7950487|NCT00442689|19568549|P2|NOT COMPLETED|Overall Study||11
7950488|NCT00442689|19568550|P1|NOT COMPLETED|Overall Study||10
7950489|NCT00442689|19568548|P3|COMPLETED|Overall Study||13
7950490|NCT00442689|19568549|P2|COMPLETED|Overall Study||13
7950491|NCT00442689|19568550|P1|COMPLETED|Overall Study||11
7950492|NCT00442689|19568548|P3|STARTED|Overall Study||22
7950493|NCT00442689|19568549|P2|STARTED|Overall Study||24
7950494|NCT00442689|19568550|P1|STARTED|Overall Study||21
7950495|NCT00442611|19568578|P2|NOT COMPLETED|Overall Study||0
7950496|NCT00442611|19568579|P1|NOT COMPLETED|Overall Study||1
7950497|NCT00442611|19568578|P2|COMPLETED|Overall Study||3
7950498|NCT00442611|19568579|P1|COMPLETED|Overall Study||6
7950499|NCT00442611|19568578|P2|STARTED|Overall Study||3
7950500|NCT00442611|19568579|P1|STARTED|Overall Study||7
7950501|NCT00442598|19568598|P3|NOT COMPLETED|Overall Study||0
7950502|NCT00442598|19568599|P2|NOT COMPLETED|Overall Study||8
7950503|NCT00442598|19568600|P1|NOT COMPLETED|Overall Study||6
7950504|NCT00442598|19568598|P3|COMPLETED|Overall Study||0
7950505|NCT00442598|19568599|P2|COMPLETED|Overall Study||2
7950506|NCT00442598|19568600|P1|COMPLETED|Overall Study||1
7950507|NCT00442598|19568598|P3|Two Cycles|Overall Study||0
7950508|NCT00442598|19568599|P2|Two Cycles|Overall Study||6
7950509|NCT00442598|19568600|P1|Two Cycles|Overall Study||5
7950510|NCT00442598|19568598|P3|STARTED|Overall Study||0
7950511|NCT00442598|19568599|P2|STARTED|Overall Study||10
7950512|NCT00442598|19568600|P1|STARTED|Overall Study||7
7950513|NCT00442572|19568618|P2|NOT COMPLETED|Overall Study||3
7950514|NCT00442572|19568619|P1|NOT COMPLETED|Overall Study||8
7950515|NCT00442572|19568618|P2|COMPLETED|Overall Study||1
7950516|NCT00442572|19568619|P1|COMPLETED|Overall Study||9
7950517|NCT00442572|19568618|P2|STARTED|Overall Study||4
7950518|NCT00442572|19568619|P1|STARTED|Overall Study||17
7950519|NCT00442559|19568659|P2|NOT COMPLETED|Overall Study||35
7950520|NCT00442559|19568660|P1|NOT COMPLETED|Overall Study||34
7950521|NCT00442559|19568659|P2|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56
7950522|NCT00442559|19568660|P1|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66
7950523|NCT00442559|19568659|P2|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60
7950524|NCT00442559|19568660|P1|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68
7950525|NCT00442559|19568659|P2|STARTED|Overall Study||91
7950526|NCT00442559|19568660|P1|STARTED|Overall Study||100
7950527|NCT00442546|19568675|P3|NOT COMPLETED|Overall Study||33
7950528|NCT00442546|19568676|P2|NOT COMPLETED|Overall Study||37
7950529|NCT00442546|19568677|P1|NOT COMPLETED|Overall Study||26
7950530|NCT00442546|19568675|P3|COMPLETED|Overall Study||71
7950531|NCT00442546|19568676|P2|COMPLETED|Overall Study||63
7950532|NCT00442546|19568677|P1|COMPLETED|Overall Study||77
7950533|NCT00442546|19568675|P3|Received Treatment|Overall Study||98
7950534|NCT00442546|19568676|P2|Received Treatment|Overall Study||96
7950535|NCT00442546|19568677|P1|Received Treatment|Overall Study||98
7950536|NCT00442546|19568675|P3|STARTED|Overall Study||104
7950537|NCT00442546|19568676|P2|STARTED|Overall Study||100
7950538|NCT00442546|19568677|P1|STARTED|Overall Study||103
7950539|NCT00442507|19568799|P1|NOT COMPLETED|Overall Study||0
7950540|NCT00442507|19568799|P1|COMPLETED|Overall Study||6
7950541|NCT00442507|19568799|P1|STARTED|Overall Study||6
7950542|NCT00442468|19568806|P1|NOT COMPLETED|Overall Study||183
7950543|NCT00442468|19568806|P1|COMPLETED|Overall Study||1100
7950544|NCT00442468|19568806|P1|STARTED|Overall Study||1283
7950545|NCT00442416|19568836|P2|NOT COMPLETED|Overall Study||39
7950546|NCT00442416|19568837|P1|NOT COMPLETED|Overall Study||37
7950547|NCT00442416|19568836|P2|COMPLETED|Overall Study||2
7950548|NCT00442416|19568837|P1|COMPLETED|Overall Study||2
7950549|NCT00442416|19568836|P2|STARTED|Overall Study||41
7950550|NCT00442416|19568837|P1|STARTED|Overall Study||39
7950551|NCT00442364|19568870|P1|NOT COMPLETED|Overall Study||0
7950552|NCT00442364|19568870|P1|COMPLETED|Overall Study||60
7950553|NCT00442364|19568870|P1|STARTED|Overall Study||60
7950554|NCT00442351|19568876|P2|NOT COMPLETED|Overall Study||6
7950555|NCT00442351|19568877|P1|NOT COMPLETED|Overall Study||7
7950556|NCT00442351|19568876|P2|COMPLETED|Overall Study||3
7950557|NCT00442351|19568877|P1|COMPLETED|Overall Study||10
7950558|NCT00442351|19568876|P2|STARTED|Overall Study||9
7950559|NCT00442351|19568877|P1|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17
7950560|NCT00442338|19568886|P3|NOT COMPLETED|Overall Study||0
7950561|NCT00442338|19568887|P2|NOT COMPLETED|Overall Study||0
7950562|NCT00442338|19568888|P1|NOT COMPLETED|Overall Study||0
7950563|NCT00442338|19568886|P3|COMPLETED|Overall Study||31
7950564|NCT00442338|19568887|P2|COMPLETED|Overall Study||30
7950565|NCT00442338|19568888|P1|COMPLETED|Overall Study||30
7950566|NCT00442338|19568886|P3|STARTED|Overall Study||31
7950567|NCT00442338|19568887|P2|STARTED|Overall Study||30
7950568|NCT00442338|19568888|P1|STARTED|Overall Study||30
7950569|NCT00442286|19568899|P2|NOT COMPLETED|Overall Study||2
7950570|NCT00442286|19568900|P1|NOT COMPLETED|Overall Study||7
7950571|NCT00442286|19568899|P2|COMPLETED|Overall Study||82
7950572|NCT00442286|19568900|P1|COMPLETED|Overall Study||174
7950573|NCT00442286|19568899|P2|12 Months|Overall Study||82
7950574|NCT00442286|19568900|P1|12 Months|Overall Study||174
7950575|NCT00442286|19568899|P2|6 Months|Overall Study||83
7950576|NCT00442286|19568900|P1|6 Months|Overall Study||177
7950577|NCT00442286|19568899|P2|STARTED|Overall Study||84
7950578|NCT00442286|19568900|P1|STARTED|Overall Study||181
7950579|NCT00442169|19568917|P6|NOT COMPLETED|Part 2||0
7950580|NCT00442169|19568918|P5|NOT COMPLETED|Part 2||0
7950581|NCT00442169|19568919|P4|NOT COMPLETED|Part 2||0
7950582|NCT00442169|19568920|P3|NOT COMPLETED|Part 2||0
7950583|NCT00442169|19568921|P2|NOT COMPLETED|Part 2||0
7950584|NCT00442169|19568922|P1|NOT COMPLETED|Part 2||0
7950585|NCT00442169|19568917|P6|COMPLETED|Part 2||57
7950586|NCT00442169|19568918|P5|COMPLETED|Part 2||25
7950587|NCT00442169|19568919|P4|COMPLETED|Part 2||0
7950588|NCT00442169|19568920|P3|COMPLETED|Part 2||0
7950589|NCT00442169|19568921|P2|COMPLETED|Part 2||0
7950590|NCT00442169|19568922|P1|COMPLETED|Part 2||0
7950591|NCT00442169|19568917|P6|STARTED|Part 2||57
7950592|NCT00442169|19568918|P5|STARTED|Part 2||25
7950593|NCT00442169|19568919|P4|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
7950594|NCT00442169|19568920|P3|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
7950595|NCT00442169|19568921|P2|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
7950596|NCT00442169|19568922|P1|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
7950597|NCT00442169|19568917|P6|NOT COMPLETED|Part 1||0
7950598|NCT00442169|19568918|P5|NOT COMPLETED|Part 1||0
7950599|NCT00442169|19568919|P4|NOT COMPLETED|Part 1||0
7950600|NCT00442169|19568920|P3|NOT COMPLETED|Part 1||0
7950601|NCT00442169|19568921|P2|NOT COMPLETED|Part 1||0
7950602|NCT00442169|19568922|P1|NOT COMPLETED|Part 1||0
7950603|NCT00442169|19568917|P6|COMPLETED|Part 1||0
7950604|NCT00442169|19568918|P5|COMPLETED|Part 1||0
7950605|NCT00442169|19568919|P4|COMPLETED|Part 1||31
7950606|NCT00442169|19568920|P3|COMPLETED|Part 1||40
7950607|NCT00442169|19568921|P2|COMPLETED|Part 1||24
7950608|NCT00442169|19568922|P1|COMPLETED|Part 1||17
7950609|NCT00442169|19568917|P6|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
7950610|NCT00442169|19568918|P5|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
7950611|NCT00442169|19568919|P4|STARTED|Part 1||31
7950612|NCT00442169|19568920|P3|STARTED|Part 1||40
7950613|NCT00442169|19568921|P2|STARTED|Part 1||24
7950614|NCT00442169|19568922|P1|STARTED|Part 1||17
7950615|NCT00442117|19568962|P2|NOT COMPLETED|Overall Study||38
7950616|NCT00442117|19568963|P1|NOT COMPLETED|Overall Study||38
7950617|NCT00442117|19568962|P2|COMPLETED|Overall Study||49
7950618|NCT00442117|19568963|P1|COMPLETED|Overall Study||47
7950619|NCT00442117|19568962|P2|STARTED|Overall Study||87
7950620|NCT00442117|19568963|P1|STARTED|Overall Study||85
7950621|NCT00442013|19568977|P2|NOT COMPLETED|Overall Study||17
7950622|NCT00442013|19568978|P1|NOT COMPLETED|Overall Study||26
7950623|NCT00442013|19568977|P2|COMPLETED|Overall Study||132
7950624|NCT00442013|19568978|P1|COMPLETED|Overall Study||131
7950625|NCT00442013|19568977|P2|STARTED|Overall Study||149
7950626|NCT00442013|19568978|P1|STARTED|Overall Study||157
7950627|NCT00441974|19568994|P1|NOT COMPLETED|Overall Study||128
7950628|NCT00441974|19568994|P1|COMPLETED|Overall Study||1342
7950629|NCT00441974|19568994|P1|STARTED|Overall Study||1470
7950630|NCT00441883|19569013|P5|NOT COMPLETED|Overall Study||2
7950631|NCT00441883|19569014|P4|NOT COMPLETED|Overall Study||0
7950632|NCT00441883|19569015|P3|NOT COMPLETED|Overall Study||0
7950633|NCT00441883|19569016|P2|NOT COMPLETED|Overall Study||0
7950634|NCT00441883|19569017|P1|NOT COMPLETED|Overall Study||1
7950635|NCT00441883|19569013|P5|COMPLETED|Overall Study||43
7950636|NCT00441883|19569014|P4|COMPLETED|Overall Study||28
7950637|NCT00441883|19569015|P3|COMPLETED|Overall Study||28
7950638|NCT00441883|19569016|P2|COMPLETED|Overall Study||32
7950639|NCT00441883|19569017|P1|COMPLETED|Overall Study||42
7950640|NCT00441883|19569013|P5|Safety Population|Overall Study||45
7950641|NCT00441883|19569014|P4|Safety Population|Overall Study||28
7950642|NCT00441883|19569015|P3|Safety Population|Overall Study||28
7950643|NCT00441883|19569016|P2|Safety Population|Overall Study||32
7950644|NCT00441883|19569017|P1|Safety Population|Overall Study||43
7950645|NCT00441883|19569013|P5|Per Protocol Population|Overall Study||38
7950646|NCT00441883|19569014|P4|Per Protocol Population|Overall Study||24
7950647|NCT00441883|19569015|P3|Per Protocol Population|Overall Study||25
7950648|NCT00441883|19569016|P2|Per Protocol Population|Overall Study||29
7950649|NCT00441883|19569017|P1|Per Protocol Population|Overall Study||38
7950650|NCT00441883|19569013|P5|ITT Population|Overall Study||43
7950651|NCT00441883|19569014|P4|ITT Population|Overall Study||30
7950652|NCT00441883|19569015|P3|ITT Population|Overall Study||30
7950653|NCT00441883|19569016|P2|ITT Population|Overall Study||30
7950654|NCT00441883|19569017|P1|ITT Population|Overall Study||43
7950655|NCT00441883|19569013|P5|STARTED|Overall Study||45
7950656|NCT00441883|19569014|P4|STARTED|Overall Study||28
7950657|NCT00441883|19569015|P3|STARTED|Overall Study||28
7950658|NCT00441883|19569016|P2|STARTED|Overall Study||32
7950659|NCT00441883|19569017|P1|STARTED|Overall Study||43
7950660|NCT00441792|19569041|P2|NOT COMPLETED|Overall Study||2
7950661|NCT00441792|19569042|P1|NOT COMPLETED|Overall Study||0
7950662|NCT00441792|19569041|P2|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61
7950663|NCT00441792|19569042|P1|COMPLETED|Overall Study||59
7950664|NCT00441792|19569041|P2|STARTED|Overall Study||63
7950665|NCT00441792|19569042|P1|STARTED|Overall Study||59
7950666|NCT00441766|19569054|P4|NOT COMPLETED|Overall Study||6
7950667|NCT00441766|19569055|P3|NOT COMPLETED|Overall Study||9
7950668|NCT00441766|19569056|P2|NOT COMPLETED|Overall Study||7
7950669|NCT00441766|19569057|P1|NOT COMPLETED|Overall Study||14
7950670|NCT00441766|19569054|P4|COMPLETED|Overall Study||48
7950671|NCT00441766|19569055|P3|COMPLETED|Overall Study||44
7950672|NCT00441766|19569056|P2|COMPLETED|Overall Study||46
7950673|NCT00441766|19569057|P1|COMPLETED|Overall Study||39
7950674|NCT00441766|19569054|P4|STARTED|Overall Study||54
7950675|NCT00441766|19569055|P3|STARTED|Overall Study||53
7950676|NCT00441766|19569056|P2|STARTED|Overall Study||53
7950677|NCT00441766|19569057|P1|STARTED|Overall Study||53
7950678|NCT00441727|19569082|P3|NOT COMPLETED|Overall Study||168
7950679|NCT00441727|19569083|P2|NOT COMPLETED|Overall Study||118
7950680|NCT00441727|19569084|P1|NOT COMPLETED|Overall Study||106
7950681|NCT00441727|19569082|P3|COMPLETED|Overall Study|ITT/randomised|637
7950682|NCT00441727|19569083|P2|COMPLETED|Overall Study|ITT/randomised|686
7950683|NCT00441727|19569084|P1|COMPLETED|Overall Study|ITT/randomised|711
7950684|NCT00441727|19569082|P3|STARTED|Overall Study|ITT/randomised|805
7950685|NCT00441727|19569083|P2|STARTED|Overall Study|ITT/randomised|804
7950686|NCT00441727|19569084|P1|STARTED|Overall Study|ITT/randomised|817
7950687|NCT00441701|19569117|P10|NOT COMPLETED|Overall Study||0
7950688|NCT00441701|19569118|P9|NOT COMPLETED|Overall Study||0
7950689|NCT00441701|19569119|P8|NOT COMPLETED|Overall Study||0
7950690|NCT00441701|19569120|P7|NOT COMPLETED|Overall Study||0
7950691|NCT00441701|19569121|P6|NOT COMPLETED|Overall Study||3
7950692|NCT00441701|19569122|P5|NOT COMPLETED|Overall Study||2
7950693|NCT00441701|19569123|P4|NOT COMPLETED|Overall Study||3
7950694|NCT00441701|19569124|P3|NOT COMPLETED|Overall Study||4
7950695|NCT00441701|19569125|P2|NOT COMPLETED|Overall Study||4
7950696|NCT00441701|19569126|P1|NOT COMPLETED|Overall Study||5
7950697|NCT00441701|19569117|P10|COMPLETED|Overall Study||0
7950698|NCT00441701|19569118|P9|COMPLETED|Overall Study||0
7950699|NCT00441701|19569119|P8|COMPLETED|Overall Study||0
7950700|NCT00441701|19569120|P7|COMPLETED|Overall Study||0
7950701|NCT00441701|19569121|P6|COMPLETED|Overall Study||8
7950702|NCT00441701|19569122|P5|COMPLETED|Overall Study||20
7950703|NCT00441701|19569123|P4|COMPLETED|Overall Study||8
7950704|NCT00441701|19569124|P3|COMPLETED|Overall Study||18
7950705|NCT00441701|19569125|P2|COMPLETED|Overall Study||7
7950706|NCT00441701|19569126|P1|COMPLETED|Overall Study||17
7950707|NCT00441701|19569117|P10|STARTED|Overall Study||0
7950708|NCT00441701|19569118|P9|STARTED|Overall Study||0
7950709|NCT00441701|19569119|P8|STARTED|Overall Study||0
7950710|NCT00441701|19569120|P7|STARTED|Overall Study||0
7950711|NCT00441701|19569121|P6|STARTED|Overall Study||11
7950712|NCT00441701|19569122|P5|STARTED|Overall Study||22
7950713|NCT00441701|19569123|P4|STARTED|Overall Study||11
7950714|NCT00441701|19569124|P3|STARTED|Overall Study||22
7950715|NCT00441701|19569125|P2|STARTED|Overall Study||11
7950716|NCT00441701|19569126|P1|STARTED|Overall Study||22
7950717|NCT00441584|19569208|P1|NOT COMPLETED|Overall Study||105
7950718|NCT00441584|19569208|P1|COMPLETED|Overall Study||12
7950719|NCT00441584|19569208|P1|STARTED|Overall Study||117
7950720|NCT00441558|19569212|P1|NOT COMPLETED|Overall Study||1056
7950721|NCT00441558|19569212|P1|COMPLETED|Overall Study||667
7950722|NCT00441558|19569212|P1|STARTED|Overall Study||1723
7950723|NCT00441545|19569216|P2|NOT COMPLETED|Second Intervention||7
7950724|NCT00441545|19569217|P1|NOT COMPLETED|Second Intervention||12
7950725|NCT00441545|19569216|P2|COMPLETED|Second Intervention||68
7950726|NCT00441545|19569217|P1|COMPLETED|Second Intervention||65
7950727|NCT00441545|19569216|P2|STARTED|Second Intervention||75
7950728|NCT00441545|19569217|P1|STARTED|Second Intervention||77
7950729|NCT00441545|19569216|P2|NOT COMPLETED|Washout||0
7950730|NCT00441545|19569217|P1|NOT COMPLETED|Washout||0
7950731|NCT00441545|19569216|P2|COMPLETED|Washout||75
7950732|NCT00441545|19569217|P1|COMPLETED|Washout||77
7950733|NCT00441545|19569216|P2|STARTED|Washout||75
7950734|NCT00441545|19569217|P1|STARTED|Washout||77
7950735|NCT00441545|19569216|P2|NOT COMPLETED|First Intervention||12
7950736|NCT00441545|19569217|P1|NOT COMPLETED|First Intervention||18
7950737|NCT00441545|19569216|P2|COMPLETED|First Intervention||75
7950738|NCT00441545|19569217|P1|COMPLETED|First Intervention||77
7950739|NCT00441545|19569216|P2|STARTED|First Intervention||87
7950740|NCT00441545|19569217|P1|STARTED|First Intervention||95
7950741|NCT00441480|19569231|P2|NOT COMPLETED|Overall Study||4
7950742|NCT00441480|19569232|P1|NOT COMPLETED|Overall Study||3
7950743|NCT00441480|19569231|P2|COMPLETED|Overall Study||41
7950744|NCT00441480|19569232|P1|COMPLETED|Overall Study||43
7950745|NCT00441480|19569231|P2|STARTED|Overall Study||45
7950746|NCT00441480|19569232|P1|STARTED|Overall Study||46
7950747|NCT00441467|19569264|P1|NOT COMPLETED|Overall Study||18
7950748|NCT00441467|19569264|P1|COMPLETED|Overall Study||4
7950749|NCT00441467|19569264|P1|4 Cycles|Overall Study||7
7950750|NCT00441467|19569264|P1|2 Cycles|Overall Study||17
7950751|NCT00441467|19569264|P1|STARTED|Overall Study||22
7950752|NCT00441441|19569272|P2|NOT COMPLETED|Overall Study||14
7950753|NCT00441441|19569273|P1|NOT COMPLETED|Overall Study||11
7950754|NCT00441441|19569272|P2|COMPLETED|Overall Study||163
7950755|NCT00441441|19569273|P1|COMPLETED|Overall Study||162
7950756|NCT00441441|19569272|P2|STARTED|Overall Study||177
7950757|NCT00441441|19569273|P1|STARTED|Overall Study||173
7950758|NCT00441363|19569333|P2|NOT COMPLETED|Overall Study||15
7950759|NCT00441363|19569334|P1|NOT COMPLETED|Overall Study||17
7950760|NCT00441363|19569333|P2|COMPLETED|Overall Study||19
7950761|NCT00441363|19569334|P1|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15
7950762|NCT00441363|19569333|P2|STARTED|Overall Study||34
7950763|NCT00441363|19569334|P1|STARTED|Overall Study||32
7950764|NCT00441337|19569346|P4|NOT COMPLETED|Overall Study||21
7950765|NCT00441337|19569347|P3|NOT COMPLETED|Overall Study||6
7950766|NCT00441337|19569348|P2|NOT COMPLETED|Overall Study||6
7950767|NCT00441337|19569349|P1|NOT COMPLETED|Overall Study||6
7950768|NCT00441337|19569346|P4|COMPLETED|Overall Study||0
7950769|NCT00441337|19569347|P3|COMPLETED|Overall Study||0
7950770|NCT00441337|19569348|P2|COMPLETED|Overall Study||0
7950771|NCT00441337|19569349|P1|COMPLETED|Overall Study||0
7950772|NCT00441337|19569346|P4|STARTED|Overall Study||21
7950773|NCT00441337|19569347|P3|STARTED|Overall Study||6
7950774|NCT00441337|19569348|P2|STARTED|Overall Study||6
7950775|NCT00441337|19569349|P1|STARTED|Overall Study||6
7950776|NCT00441285|19569432|P5|NOT COMPLETED|Overall Study||0
7950777|NCT00441285|19569433|P4|NOT COMPLETED|Overall Study||0
7950778|NCT00441285|19569434|P3|NOT COMPLETED|Overall Study||0
7950779|NCT00441285|19569435|P2|NOT COMPLETED|Overall Study||0
7950780|NCT00441285|19569436|P1|NOT COMPLETED|Overall Study||0
7950781|NCT00441285|19569432|P5|COMPLETED|Overall Study||43
7950782|NCT00441285|19569433|P4|COMPLETED|Overall Study||40
7950783|NCT00441285|19569434|P3|COMPLETED|Overall Study||41
7950784|NCT00441285|19569435|P2|COMPLETED|Overall Study||16
7950785|NCT00441285|19569436|P1|COMPLETED|Overall Study||16
7950786|NCT00441285|19569432|P5|STARTED|Overall Study||43
7950787|NCT00441285|19569433|P4|STARTED|Overall Study||40
7950788|NCT00441285|19569434|P3|STARTED|Overall Study||41
7950789|NCT00441285|19569435|P2|STARTED|Overall Study||16
7950790|NCT00441285|19569436|P1|STARTED|Overall Study||16
7950791|NCT00441272|19569462|P2|NOT COMPLETED|Overall Study||25
7950792|NCT00441272|19569463|P1|NOT COMPLETED|Overall Study||25
7950793|NCT00441272|19569462|P2|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
7950794|NCT00441272|19569463|P1|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
7950795|NCT00441272|19569462|P2|STARTED|Overall Study||25
7950796|NCT00441272|19569463|P1|STARTED|Overall Study||25
7950797|NCT00441259|19569471|P2|NOT COMPLETED|Overall Study||0
7950798|NCT00441259|19569472|P1|NOT COMPLETED|Overall Study||0
7950799|NCT00441259|19569471|P2|COMPLETED|Overall Study||48
7950800|NCT00441259|19569472|P1|COMPLETED|Overall Study||48
7950801|NCT00441259|19569471|P2|STARTED|Overall Study||48
7950802|NCT00441259|19569472|P1|STARTED|Overall Study||48
7950803|NCT00441168|19569490|P2|NOT COMPLETED|Follow-up Period||9
7950804|NCT00441168|19569491|P1|NOT COMPLETED|Follow-up Period||12
7950805|NCT00441168|19569490|P2|COMPLETED|Follow-up Period||4
7950806|NCT00441168|19569491|P1|COMPLETED|Follow-up Period||5
7950807|NCT00441168|19569490|P2|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13
7950808|NCT00441168|19569491|P1|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17
7950809|NCT00441168|19569490|P2|NOT COMPLETED|Treatment Period||6
7950810|NCT00441168|19569491|P1|NOT COMPLETED|Treatment Period||11
7950811|NCT00441168|19569490|P2|COMPLETED|Treatment Period||7
7950812|NCT00441168|19569491|P1|COMPLETED|Treatment Period||6
7950813|NCT00441168|19569490|P2|TREATED|Treatment Period||13
7950814|NCT00441168|19569491|P1|TREATED|Treatment Period||16
7950815|NCT00441168|19569490|P2|STARTED|Treatment Period||13
7950816|NCT00441168|19569491|P1|STARTED|Treatment Period||17
7950817|NCT00441142|19569505|P4|NOT COMPLETED|Overall Study||68
7950818|NCT00441142|19569506|P3|NOT COMPLETED|Overall Study||22
7950819|NCT00441142|19569507|P2|NOT COMPLETED|Overall Study||7
7950820|NCT00441142|19569508|P1|NOT COMPLETED|Overall Study||6
7950821|NCT00441142|19569505|P4|COMPLETED|Overall Study||1
7950822|NCT00441142|19569506|P3|COMPLETED|Overall Study||7
7950823|NCT00441142|19569507|P2|COMPLETED|Overall Study||0
7950824|NCT00441142|19569508|P1|COMPLETED|Overall Study||0
7950825|NCT00441142|19569505|P4|STARTED|Overall Study||69
7950826|NCT00441142|19569506|P3|STARTED|Overall Study||29
7950827|NCT00441142|19569507|P2|STARTED|Overall Study||7
7950828|NCT00441142|19569508|P1|STARTED|Overall Study||6
7950829|NCT00441129|19569530|P2|NOT COMPLETED|Overall Study||14
7950830|NCT00441129|19569531|P1|NOT COMPLETED|Overall Study||6
7950831|NCT00441129|19569530|P2|COMPLETED|Overall Study||41
7950832|NCT00441129|19569531|P1|COMPLETED|Overall Study||54
7950833|NCT00441129|19569530|P2|STARTED|Overall Study||55
7950834|NCT00441129|19569531|P1|STARTED|Overall Study||60
7950835|NCT00441116|19569543|P2|NOT COMPLETED|Overall Study||2
7950836|NCT00441116|19569544|P1|NOT COMPLETED|Overall Study||3
7950837|NCT00441116|19569543|P2|COMPLETED|Overall Study||75
7950838|NCT00441116|19569544|P1|COMPLETED|Overall Study||73
7950839|NCT00441116|19569543|P2|STARTED|Overall Study||77
7950840|NCT00441116|19569544|P1|STARTED|Overall Study||76
7950841|NCT00441103|19569612|P2|NOT COMPLETED|Overall Study||4
7950842|NCT00441103|19569613|P1|NOT COMPLETED|Overall Study||11
7950843|NCT00441103|19569612|P2|COMPLETED|Overall Study||56
7950844|NCT00441103|19569613|P1|COMPLETED|Overall Study||109
7950845|NCT00441103|19569612|P2|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60
7950846|NCT00441103|19569613|P1|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120
7950847|NCT00441090|19569629|P5|NOT COMPLETED|Overall Study||0
7950848|NCT00441090|19569630|P4|NOT COMPLETED|Overall Study||2
7950849|NCT00441090|19569631|P3|NOT COMPLETED|Overall Study||2
7950850|NCT00441090|19569632|P2|NOT COMPLETED|Overall Study||1
7950851|NCT00441090|19569633|P1|NOT COMPLETED|Overall Study||2
7950852|NCT00441090|19569629|P5|COMPLETED|Overall Study||5
7950853|NCT00441090|19569630|P4|COMPLETED|Overall Study||13
7950854|NCT00441090|19569631|P3|COMPLETED|Overall Study||12
7950855|NCT00441090|19569632|P2|COMPLETED|Overall Study||14
7950856|NCT00441090|19569633|P1|COMPLETED|Overall Study||13
7950857|NCT00441090|19569629|P5|STARTED|Overall Study||5
7950858|NCT00441090|19569630|P4|STARTED|Overall Study||15
7950859|NCT00441090|19569631|P3|STARTED|Overall Study||14
7950860|NCT00441090|19569632|P2|STARTED|Overall Study||15
7950861|NCT00441090|19569633|P1|STARTED|Overall Study||15
7950862|NCT00441064|19569677|P2|NOT COMPLETED|Overall Study||7
7950863|NCT00441064|19569678|P1|NOT COMPLETED|Overall Study||10
7950864|NCT00441064|19569677|P2|COMPLETED|Overall Study||56
7950865|NCT00441064|19569678|P1|COMPLETED|Overall Study||59
7950866|NCT00441064|19569677|P2|Intent-to-treat (ITT) Population|Overall Study||57
7950867|NCT00441064|19569678|P1|Intent-to-treat (ITT) Population|Overall Study||61
7950868|NCT00441064|19569677|P2|Safety Population (SP)|Overall Study||63
7950869|NCT00441064|19569678|P1|Safety Population (SP)|Overall Study||69
7950870|NCT00441064|19569677|P2|STARTED|Overall Study||63
7950871|NCT00441064|19569678|P1|STARTED|Overall Study||69
7950872|NCT00441012|19569690|P2|NOT COMPLETED|Overall Study||13
7950873|NCT00441012|19569691|P1|NOT COMPLETED|Overall Study||18
7950874|NCT00441012|19569690|P2|COMPLETED|Overall Study||263
7950875|NCT00441012|19569691|P1|COMPLETED|Overall Study||252
7950876|NCT00441012|19569690|P2|Vaccination Visit 3|Overall Study||269
7950877|NCT00441012|19569691|P1|Vaccination Visit 3|Overall Study||265
7950878|NCT00441012|19569690|P2|Vaccination Visit 2|Overall Study||272
7950879|NCT00441012|19569691|P1|Vaccination Visit 2|Overall Study||267
7950880|NCT00441012|19569690|P2|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276
7950881|NCT00441012|19569691|P1|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269
7950882|NCT00441012|19569690|P2|STARTED|Overall Study||276
7950883|NCT00441012|19569691|P1|STARTED|Overall Study||270
7950884|NCT00440947|19569705|P5|NOT COMPLETED|Optional 60-Week Extension Phase||26
7950885|NCT00440947|19569706|P4|NOT COMPLETED|Optional 60-Week Extension Phase||29
7950886|NCT00440947|19569707|P3|NOT COMPLETED|Optional 60-Week Extension Phase||0
7950887|NCT00440947|19569708|P2|NOT COMPLETED|Optional 60-Week Extension Phase||0
7950888|NCT00440947|19569709|P1|NOT COMPLETED|Optional 60-Week Extension Phase||0
7950889|NCT00440947|19569705|P5|COMPLETED|Optional 60-Week Extension Phase||154
7950890|NCT00440947|19569706|P4|COMPLETED|Optional 60-Week Extension Phase||160
7950891|NCT00440947|19569707|P3|COMPLETED|Optional 60-Week Extension Phase||0
7950892|NCT00440947|19569708|P2|COMPLETED|Optional 60-Week Extension Phase||0
7950893|NCT00440947|19569709|P1|COMPLETED|Optional 60-Week Extension Phase||0
7950894|NCT00440947|19569705|P5|STARTED|Optional 60-Week Extension Phase||180
7950895|NCT00440947|19569706|P4|STARTED|Optional 60-Week Extension Phase||189
7950896|NCT00440947|19569707|P3|STARTED|Optional 60-Week Extension Phase||0
7950897|NCT00440947|19569708|P2|STARTED|Optional 60-Week Extension Phase||0
7950898|NCT00440947|19569709|P1|STARTED|Optional 60-Week Extension Phase||0
7950899|NCT00440947|19569705|P5|NOT COMPLETED|48-Week Randomization Phase||0
7950900|NCT00440947|19569706|P4|NOT COMPLETED|48-Week Randomization Phase||0
7950901|NCT00440947|19569707|P3|NOT COMPLETED|48-Week Randomization Phase||24
7950902|NCT00440947|19569708|P2|NOT COMPLETED|48-Week Randomization Phase||16
7950903|NCT00440947|19569709|P1|NOT COMPLETED|48-Week Randomization Phase||0
7950904|NCT00440947|19569705|P5|COMPLETED|48-Week Randomization Phase||0
7950905|NCT00440947|19569706|P4|COMPLETED|48-Week Randomization Phase||0
7950906|NCT00440947|19569707|P3|COMPLETED|48-Week Randomization Phase||185
7950907|NCT00440947|19569708|P2|COMPLETED|48-Week Randomization Phase||194
7950908|NCT00440947|19569709|P1|COMPLETED|48-Week Randomization Phase||0
7950909|NCT00440947|19569705|P5|STARTED|48-Week Randomization Phase||0
7950910|NCT00440947|19569706|P4|STARTED|48-Week Randomization Phase||0
7950911|NCT00440947|19569707|P3|STARTED|48-Week Randomization Phase||209
7950912|NCT00440947|19569708|P2|STARTED|48-Week Randomization Phase||210
7950913|NCT00440947|19569709|P1|STARTED|48-Week Randomization Phase||0
7950914|NCT00440947|19569705|P5|NOT COMPLETED|36-Week Induction Phase||0
7950915|NCT00440947|19569706|P4|NOT COMPLETED|36-Week Induction Phase||0
7950916|NCT00440947|19569707|P3|NOT COMPLETED|36-Week Induction Phase||0
7950917|NCT00440947|19569708|P2|NOT COMPLETED|36-Week Induction Phase||0
7950918|NCT00440947|19569709|P1|NOT COMPLETED|36-Week Induction Phase||73
7950919|NCT00440947|19569705|P5|COMPLETED|36-Week Induction Phase||0
7950920|NCT00440947|19569706|P4|COMPLETED|36-Week Induction Phase||0
7950921|NCT00440947|19569707|P3|COMPLETED|36-Week Induction Phase||0
7950922|NCT00440947|19569708|P2|COMPLETED|36-Week Induction Phase||0
7950923|NCT00440947|19569709|P1|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn't be randomized but weren't withdrawn.|442
7950924|NCT00440947|19569705|P5|STARTED|36-Week Induction Phase||0
7950925|NCT00440947|19569706|P4|STARTED|36-Week Induction Phase||0
7950926|NCT00440947|19569707|P3|STARTED|36-Week Induction Phase||0
7950927|NCT00440947|19569708|P2|STARTED|36-Week Induction Phase||0
7950928|NCT00440947|19569709|P1|STARTED|36-Week Induction Phase||515
7950929|NCT00440830|19569764|P4|NOT COMPLETED|Overall Study||0
7950930|NCT00440830|19569765|P3|NOT COMPLETED|Overall Study||0
7950931|NCT00440830|19569766|P2|NOT COMPLETED|Overall Study||0
7950932|NCT00440830|19569767|P1|NOT COMPLETED|Overall Study||0
7950933|NCT00440830|19569764|P4|COMPLETED|Overall Study||10
7950934|NCT00440830|19569765|P3|COMPLETED|Overall Study||30
7950935|NCT00440830|19569766|P2|COMPLETED|Overall Study||8
7950936|NCT00440830|19569767|P1|COMPLETED|Overall Study||20
7950937|NCT00440830|19569764|P4|STARTED|Overall Study||10
7950938|NCT00440830|19569765|P3|STARTED|Overall Study||30
7950939|NCT00440830|19569766|P2|STARTED|Overall Study||8
7950940|NCT00440830|19569767|P1|STARTED|Overall Study||20
7950941|NCT00440726|19569784|P3|NOT COMPLETED|Phase 2||2
7950942|NCT00440726|19569785|P2|NOT COMPLETED|Phase 2||0
7950943|NCT00440726|19569786|P1|NOT COMPLETED|Phase 2||0
7950944|NCT00440726|19569784|P3|COMPLETED|Phase 2||20
7950945|NCT00440726|19569785|P2|COMPLETED|Phase 2||0
7950946|NCT00440726|19569786|P1|COMPLETED|Phase 2||0
7950947|NCT00440726|19569784|P3|STARTED|Phase 2||22
7950948|NCT00440726|19569785|P2|STARTED|Phase 2||0
7950949|NCT00440726|19569786|P1|STARTED|Phase 2||0
7950950|NCT00440726|19569784|P3|NOT COMPLETED|Phase 1||0
7950951|NCT00440726|19569785|P2|NOT COMPLETED|Phase 1||1
7950952|NCT00440726|19569786|P1|NOT COMPLETED|Phase 1||1
7950953|NCT00440726|19569784|P3|COMPLETED|Phase 1||0
7950954|NCT00440726|19569785|P2|COMPLETED|Phase 1||5
7950955|NCT00440726|19569786|P1|COMPLETED|Phase 1||3
7950956|NCT00440726|19569784|P3|STARTED|Phase 1||0
7950957|NCT00440726|19569785|P2|STARTED|Phase 1||6
7950958|NCT00440726|19569786|P1|STARTED|Phase 1||4
7950959|NCT00440700|19569800|P3|NOT COMPLETED|Overall Study||4
7950960|NCT00440700|19569801|P2|NOT COMPLETED|Overall Study||8
7950961|NCT00440700|19569802|P1|NOT COMPLETED|Overall Study||8
7950962|NCT00440700|19569800|P3|COMPLETED|Overall Study||120
7950963|NCT00440700|19569801|P2|COMPLETED|Overall Study||110
7950964|NCT00440700|19569802|P1|COMPLETED|Overall Study||114
7950965|NCT00440700|19569800|P3|STARTED|Overall Study||124
7950966|NCT00440700|19569801|P2|STARTED|Overall Study||118
7950967|NCT00440700|19569802|P1|STARTED|Overall Study||122
7950968|NCT00440596|19569824|P2|NOT COMPLETED|Overall Study||11
7950969|NCT00440596|19569825|P1|NOT COMPLETED|Overall Study||7
7950970|NCT00440596|19569824|P2|COMPLETED|Overall Study||17
7950971|NCT00440596|19569825|P1|COMPLETED|Overall Study||21
7950972|NCT00440596|19569824|P2|STARTED|Overall Study||28
7950973|NCT00440596|19569825|P1|STARTED|Overall Study||28
7950974|NCT00440557|19569836|P3|NOT COMPLETED|Overall Study||35
7950975|NCT00440557|19569837|P2|NOT COMPLETED|Overall Study||29
7950976|NCT00440557|19569838|P1|NOT COMPLETED|Overall Study||25
7950977|NCT00440557|19569836|P3|COMPLETED|Overall Study||90
7950978|NCT00440557|19569837|P2|COMPLETED|Overall Study||96
7950979|NCT00440557|19569838|P1|COMPLETED|Overall Study||98
7950980|NCT00440557|19569836|P3|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
7950981|NCT00440557|19569837|P2|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
7950982|NCT00440557|19569838|P1|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123
7950983|NCT00440531|19569870|P3|NOT COMPLETED|Overall Study||7
7950984|NCT00440531|19569871|P2|NOT COMPLETED|Overall Study||5
7950985|NCT00440531|19569872|P1|NOT COMPLETED|Overall Study||10
7950986|NCT00440531|19569870|P3|COMPLETED|Overall Study||165
7950987|NCT00440531|19569871|P2|COMPLETED|Overall Study||178
7950988|NCT00440531|19569872|P1|COMPLETED|Overall Study||175
7950989|NCT00440531|19569870|P3|Vaccination 3|Overall Study||166
7950990|NCT00440531|19569871|P2|Vaccination 3|Overall Study||178
7950991|NCT00440531|19569872|P1|Vaccination 3|Overall Study||176
7950992|NCT00440531|19569870|P3|Vaccination 2|Overall Study||171
7950993|NCT00440531|19569871|P2|Vaccination 2|Overall Study||182
7950994|NCT00440531|19569872|P1|Vaccination 2|Overall Study||181
7950995|NCT00440531|19569870|P3|Vaccination 1|Overall Study||172
7950996|NCT00440531|19569871|P2|Vaccination 1|Overall Study||183
7950997|NCT00440531|19569872|P1|Vaccination 1|Overall Study||183
7950998|NCT00440531|19569870|P3|STARTED|Overall Study||172
7950999|NCT00440531|19569871|P2|STARTED|Overall Study||183
7951000|NCT00440531|19569872|P1|STARTED|Overall Study||185
7951001|NCT00440518|19569889|P3|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15
7951002|NCT00440518|19569890|P2|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12
7951003|NCT00440518|19569891|P1|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7
7951004|NCT00440518|19569889|P3|COMPLETED|Maintenance and Safety Follow-up Periods||55
7951005|NCT00440518|19569890|P2|COMPLETED|Maintenance and Safety Follow-up Periods||51
7951006|NCT00440518|19569891|P1|COMPLETED|Maintenance and Safety Follow-up Periods||52
7951007|NCT00440518|19569889|P3|STARTED|Maintenance and Safety Follow-up Periods||70
7951008|NCT00440518|19569890|P2|STARTED|Maintenance and Safety Follow-up Periods||63
7951009|NCT00440518|19569891|P1|STARTED|Maintenance and Safety Follow-up Periods||59
7951010|NCT00440518|19569889|P3|NOT COMPLETED|Randomized /Titration Period||4
7951011|NCT00440518|19569890|P2|NOT COMPLETED|Randomized /Titration Period||9
7951012|NCT00440518|19569891|P1|NOT COMPLETED|Randomized /Titration Period||13
7951013|NCT00440518|19569889|P3|COMPLETED|Randomized /Titration Period||70
7951014|NCT00440518|19569890|P2|COMPLETED|Randomized /Titration Period||63
7951015|NCT00440518|19569891|P1|COMPLETED|Randomized /Titration Period||59
7951016|NCT00440518|19569889|P3|STARTED|Randomized /Titration Period||74
7951017|NCT00440518|19569890|P2|STARTED|Randomized /Titration Period||72
7951018|NCT00440518|19569891|P1|STARTED|Randomized /Titration Period||72
7951019|NCT00440505|19569911|P6|NOT COMPLETED|Third Intervention||0
7951020|NCT00440505|19569912|P5|NOT COMPLETED|Third Intervention||0
7951021|NCT00440505|19569913|P4|NOT COMPLETED|Third Intervention||1
7951022|NCT00440505|19569914|P3|NOT COMPLETED|Third Intervention||0
7951023|NCT00440505|19569915|P2|NOT COMPLETED|Third Intervention||0
7951024|NCT00440505|19569916|P1|NOT COMPLETED|Third Intervention||0
7951025|NCT00440505|19569911|P6|COMPLETED|Third Intervention||5
7951026|NCT00440505|19569912|P5|COMPLETED|Third Intervention||5
7951027|NCT00440505|19569913|P4|COMPLETED|Third Intervention||1
7951028|NCT00440505|19569914|P3|COMPLETED|Third Intervention||1
7951029|NCT00440505|19569915|P2|COMPLETED|Third Intervention||2
7951030|NCT00440505|19569916|P1|COMPLETED|Third Intervention||5
7951031|NCT00440505|19569911|P6|STARTED|Third Intervention||5
7951032|NCT00440505|19569912|P5|STARTED|Third Intervention||5
7951033|NCT00440505|19569913|P4|STARTED|Third Intervention||2
7951034|NCT00440505|19569914|P3|STARTED|Third Intervention||1
7951035|NCT00440505|19569915|P2|STARTED|Third Intervention||2
7951036|NCT00440505|19569916|P1|STARTED|Third Intervention||5
7951037|NCT00440505|19569911|P6|NOT COMPLETED|Second Intervention||0
7951038|NCT00440505|19569912|P5|NOT COMPLETED|Second Intervention||0
7951039|NCT00440505|19569913|P4|NOT COMPLETED|Second Intervention||0
7951040|NCT00440505|19569914|P3|NOT COMPLETED|Second Intervention||0
7951041|NCT00440505|19569915|P2|NOT COMPLETED|Second Intervention||0
7951042|NCT00440505|19569916|P1|NOT COMPLETED|Second Intervention||0
7951043|NCT00440505|19569911|P6|COMPLETED|Second Intervention||5
7951044|NCT00440505|19569912|P5|COMPLETED|Second Intervention||5
7951045|NCT00440505|19569913|P4|COMPLETED|Second Intervention||2
7951046|NCT00440505|19569914|P3|COMPLETED|Second Intervention||1
7951047|NCT00440505|19569915|P2|COMPLETED|Second Intervention||2
7951048|NCT00440505|19569916|P1|COMPLETED|Second Intervention||5
7951049|NCT00440505|19569911|P6|STARTED|Second Intervention||5
7951050|NCT00440505|19569912|P5|STARTED|Second Intervention||5
7951051|NCT00440505|19569913|P4|STARTED|Second Intervention||2
7951052|NCT00440505|19569914|P3|STARTED|Second Intervention||1
7951053|NCT00440505|19569915|P2|STARTED|Second Intervention||2
7951054|NCT00440505|19569916|P1|STARTED|Second Intervention||5
7951055|NCT00440505|19569911|P6|NOT COMPLETED|First Intervention||0
7951056|NCT00440505|19569912|P5|NOT COMPLETED|First Intervention||0
7951057|NCT00440505|19569913|P4|NOT COMPLETED|First Intervention||0
7951058|NCT00440505|19569914|P3|NOT COMPLETED|First Intervention||0
7951059|NCT00440505|19569915|P2|NOT COMPLETED|First Intervention||0
7951060|NCT00440505|19569916|P1|NOT COMPLETED|First Intervention||0
7951061|NCT00440505|19569911|P6|COMPLETED|First Intervention||5
7951062|NCT00440505|19569912|P5|COMPLETED|First Intervention||5
7951063|NCT00440505|19569913|P4|COMPLETED|First Intervention||2
7951064|NCT00440505|19569914|P3|COMPLETED|First Intervention||1
7951065|NCT00440505|19569915|P2|COMPLETED|First Intervention||2
7951066|NCT00440505|19569916|P1|COMPLETED|First Intervention||5
7951067|NCT00440505|19569911|P6|STARTED|First Intervention||5
7951068|NCT00440505|19569912|P5|STARTED|First Intervention||5
7951069|NCT00440505|19569913|P4|STARTED|First Intervention||2
7951070|NCT00440505|19569914|P3|STARTED|First Intervention||1
7951071|NCT00440505|19569915|P2|STARTED|First Intervention||2
7951072|NCT00440505|19569916|P1|STARTED|First Intervention||5
7951073|NCT00440466|19569936|P3|NOT COMPLETED|Overall Study||41
7951074|NCT00440466|19569937|P2|NOT COMPLETED|Overall Study||15
7951075|NCT00440466|19569938|P1|NOT COMPLETED|Overall Study||13
7951076|NCT00440466|19569936|P3|COMPLETED|Overall Study||174
7951077|NCT00440466|19569937|P2|COMPLETED|Overall Study||92
7951078|NCT00440466|19569938|P1|COMPLETED|Overall Study||95
7951079|NCT00440466|19569936|P3|STARTED|Overall Study||215
7951080|NCT00440466|19569937|P2|STARTED|Overall Study||107
7951081|NCT00440466|19569938|P1|STARTED|Overall Study||108
7951082|NCT00440401|19569972|P2|NOT COMPLETED|Overall Study||6
7951083|NCT00440401|19569973|P1|NOT COMPLETED|Overall Study||4
7951084|NCT00440401|19569972|P2|COMPLETED|Overall Study||54
7951085|NCT00440401|19569973|P1|COMPLETED|Overall Study||55
7951086|NCT00440401|19569972|P2|STARTED|Overall Study||60
7951087|NCT00440401|19569973|P1|STARTED|Overall Study||59
7951088|NCT00440310|19569983|P2|NOT COMPLETED|Overall Study||30
7951089|NCT00440310|19569984|P1|NOT COMPLETED|Overall Study||28
7951090|NCT00440310|19569983|P2|COMPLETED|Overall Study||209
7951091|NCT00440310|19569984|P1|COMPLETED|Overall Study||216
7951092|NCT00440310|19569983|P2|Treated|Overall Study||232
7951093|NCT00440310|19569984|P1|Treated|Overall Study||222
7951094|NCT00440310|19569983|P2|STARTED|Overall Study||239
7951095|NCT00440310|19569984|P1|STARTED|Overall Study||244
7951096|NCT00440297|19569992|P2|NOT COMPLETED|Overall Study||18
7951097|NCT00440297|19569993|P1|NOT COMPLETED|Overall Study||23
7951098|NCT00440297|19569992|P2|COMPLETED|Overall Study||120
7951099|NCT00440297|19569993|P1|COMPLETED|Overall Study||116
7951100|NCT00440297|19569992|P2|Vaccination Visit 4|Overall Study||122
7951101|NCT00440297|19569993|P1|Vaccination Visit 4|Overall Study||116
7951102|NCT00440297|19569992|P2|Vaccination Visit 3|Overall Study||125
7951103|NCT00440297|19569993|P1|Vaccination Visit 3|Overall Study||124
7951104|NCT00440297|19569992|P2|Vaccination Visit 2|Overall Study||134
7951105|NCT00440297|19569993|P1|Vaccination Visit 2|Overall Study||136
7951106|NCT00440297|19569992|P2|Vaccination Visit 1|Overall Study||138
7951107|NCT00440297|19569993|P1|Vaccination Visit 1|Overall Study||138
7951108|NCT00440297|19569992|P2|STARTED|Overall Study||138
7951109|NCT00440297|19569993|P1|STARTED|Overall Study||139
7951110|NCT00440271|19570009|P2|NOT COMPLETED|Overall Study||15
7951111|NCT00440271|19570010|P1|NOT COMPLETED|Overall Study||12
7951112|NCT00440271|19570009|P2|COMPLETED|Overall Study||3
7951113|NCT00440271|19570010|P1|COMPLETED|Overall Study||3
7951114|NCT00440271|19570009|P2|STARTED|Overall Study||18
7951115|NCT00440271|19570010|P1|STARTED|Overall Study||15
7951116|NCT00440232|19570044|P2|NOT COMPLETED|Overall Study||4
7951117|NCT00440232|19570045|P1|NOT COMPLETED|Overall Study||3
7951118|NCT00440232|19570044|P2|COMPLETED|Overall Study||34
7951119|NCT00440232|19570045|P1|COMPLETED|Overall Study||33
7951120|NCT00440232|19570044|P2|STARTED|Overall Study||38
7951121|NCT00440232|19570045|P1|STARTED|Overall Study||36
7951122|NCT00440193|19570055|P2|NOT COMPLETED|Observational Period||38
7951123|NCT00440193|19570056|P1|NOT COMPLETED|Observational Period||45
7951124|NCT00440193|19570055|P2|COMPLETED|Observational Period||1369
7951125|NCT00440193|19570056|P1|COMPLETED|Observational Period||1380
7951126|NCT00440193|19570055|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407
7951127|NCT00440193|19570056|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425
7951128|NCT00440193|19570055|P2|NOT COMPLETED|Treatment Period||351
7951129|NCT00440193|19570056|P1|NOT COMPLETED|Treatment Period||305
7951130|NCT00440193|19570055|P2|COMPLETED|Treatment Period||1367
7951131|NCT00440193|19570056|P1|COMPLETED|Treatment Period||1426
7951132|NCT00440193|19570055|P2|Participants Received Treatment|Treatment Period||1711
7951133|NCT00440193|19570056|P1|Participants Received Treatment|Treatment Period||1718
7951134|NCT00440193|19570055|P2|STARTED|Treatment Period||1718
7951135|NCT00440193|19570056|P1|STARTED|Treatment Period||1731
7951136|NCT00440180|19570092|P2|NOT COMPLETED|Overall Study||0
7951137|NCT00440180|19570093|P1|NOT COMPLETED|Overall Study||0
7951138|NCT00440180|19570092|P2|COMPLETED|Overall Study||10
7951139|NCT00440180|19570093|P1|COMPLETED|Overall Study||10
7951140|NCT00440180|19570092|P2|STARTED|Overall Study||10
7951141|NCT00440180|19570093|P1|STARTED|Overall Study||10
7951142|NCT00440115|19570102|P3|NOT COMPLETED|Overall Study||6
7951143|NCT00440115|19570103|P2|NOT COMPLETED|Overall Study||11
7951144|NCT00440115|19570104|P1|NOT COMPLETED|Overall Study||7
7951145|NCT00440115|19570102|P3|COMPLETED|Overall Study||244
7951146|NCT00440115|19570103|P2|COMPLETED|Overall Study||238
7951147|NCT00440115|19570104|P1|COMPLETED|Overall Study||244
7951148|NCT00440115|19570102|P3|STARTED|Overall Study||250
7951149|NCT00440115|19570103|P2|STARTED|Overall Study||249
7951150|NCT00440115|19570104|P1|STARTED|Overall Study||251
7951151|NCT00440050|19570120|P2|NOT COMPLETED|Overall Study||67
7951152|NCT00440050|19570121|P1|NOT COMPLETED|Overall Study||40
7951153|NCT00440050|19570120|P2|COMPLETED|Overall Study||171
7951154|NCT00440050|19570121|P1|COMPLETED|Overall Study||124
7951155|NCT00440050|19570120|P2|STARTED|Overall Study||238
7951156|NCT00440050|19570121|P1|STARTED|Overall Study||164
7951157|NCT00440037|19570133|P1|NOT COMPLETED|Overall Study||9
7951158|NCT00440037|19570133|P1|COMPLETED|Overall Study||35
7951159|NCT00440037|19570133|P1|STARTED|Overall Study||44
7951160|NCT00440011|19570143|P2|NOT COMPLETED|Overall Study||3
7951161|NCT00440011|19570144|P1|NOT COMPLETED|Overall Study||4
7951162|NCT00440011|19570143|P2|COMPLETED|Overall Study||132
7951163|NCT00440011|19570144|P1|COMPLETED|Overall Study||127
7951164|NCT00440011|19570143|P2|STARTED|Overall Study||135
7951165|NCT00440011|19570144|P1|STARTED|Overall Study||131
7951166|NCT00439946|19570152|P1|NOT COMPLETED|Overall Study||0
7951167|NCT00439946|19570152|P1|COMPLETED|Overall Study||8
7951168|NCT00439946|19570152|P1|STARTED|Overall Study||8
7951169|NCT00439777|19570171|P2|NOT COMPLETED|Observational Period||41
7951170|NCT00439777|19570172|P1|NOT COMPLETED|Observational Period||41
7951171|NCT00439777|19570171|P2|COMPLETED|Observational Period||2156
7951172|NCT00439777|19570172|P1|COMPLETED|Observational Period||2165
7951173|NCT00439777|19570171|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197
7951174|NCT00439777|19570172|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206
7951175|NCT00439777|19570171|P2|NOT COMPLETED|Treatment Period||459
7951176|NCT00439777|19570172|P1|NOT COMPLETED|Treatment Period||419
7951177|NCT00439777|19570171|P2|COMPLETED|Treatment Period||1954
7951178|NCT00439777|19570172|P1|COMPLETED|Treatment Period||2001
7951179|NCT00439777|19570171|P2|Participants Received Treatment|Treatment Period||2405
7951180|NCT00439777|19570172|P1|Participants Received Treatment|Treatment Period||2412
7951181|NCT00439777|19570171|P2|STARTED|Treatment Period||2413
7951182|NCT00439777|19570172|P1|STARTED|Treatment Period||2420
7951183|NCT00439738|19570210|P2|NOT COMPLETED|Overall Study||28
7951184|NCT00439738|19570211|P1|NOT COMPLETED|Overall Study||36
7951185|NCT00439738|19570210|P2|COMPLETED|Overall Study||178
7951186|NCT00439738|19570211|P1|COMPLETED|Overall Study||170
7951187|NCT00439738|19570210|P2|STARTED|Overall Study||206
7951188|NCT00439738|19570211|P1|STARTED|Overall Study||206
7951189|NCT00439725|19570229|P2|NOT COMPLETED|Observational Period||7
7951190|NCT00439725|19570230|P1|NOT COMPLETED|Observational Period||8
7951191|NCT00439725|19570229|P2|COMPLETED|Observational Period||553
7951192|NCT00439725|19570230|P1|COMPLETED|Observational Period||569
7951193|NCT00439725|19570229|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560
7951194|NCT00439725|19570230|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577
7951195|NCT00439725|19570229|P2|NOT COMPLETED|Treatment Period||246
7951196|NCT00439725|19570230|P1|NOT COMPLETED|Treatment Period||236
7951197|NCT00439725|19570229|P2|COMPLETED|Treatment Period||349
7951198|NCT00439725|19570230|P1|COMPLETED|Treatment Period||366
7951199|NCT00439725|19570229|P2|Participants Received Treatment|Treatment Period|Safety population|590
7951200|NCT00439725|19570230|P1|Participants Received Treatment|Treatment Period|Safety population|598
7951201|NCT00439725|19570229|P2|STARTED|Treatment Period||595
7951202|NCT00439725|19570230|P1|STARTED|Treatment Period||602
7951203|NCT00439673|19570274|P1|NOT COMPLETED|Overall Study||36
7951204|NCT00439673|19570274|P1|COMPLETED|Overall Study||26
7951205|NCT00439673|19570274|P1|STARTED|Overall Study||62
7951206|NCT00439647|19570281|P2|NOT COMPLETED|Overall Study||71
7951207|NCT00439647|19570282|P1|NOT COMPLETED|Overall Study||58
7951208|NCT00439647|19570281|P2|COMPLETED|Overall Study||540
7951209|NCT00439647|19570282|P1|COMPLETED|Overall Study||530
7951210|NCT00439647|19570281|P2|Modified Intent to Treat (mITT)|Overall Study||574
7951211|NCT00439647|19570282|P1|Modified Intent to Treat (mITT)|Overall Study||553
7951212|NCT00439647|19570281|P2|STARTED|Overall Study||611
7951213|NCT00439647|19570282|P1|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588
7951214|NCT00439608|19570314|P1|NOT COMPLETED|Overall Study||0
7951215|NCT00439608|19570314|P1|COMPLETED|Overall Study||60
7951216|NCT00439608|19570314|P1|STARTED|Overall Study||60
7951217|NCT00439569|19570319|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1
7951218|NCT00439569|19570319|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
7951219|NCT00439569|19570319|P1|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2
7951220|NCT00439569|19570319|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4
7951221|NCT00439569|19570319|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)||3
7951222|NCT00439569|19570319|P1|STARTED|Cohort 1 (500 mg/kg/Day)||7
7951223|NCT00439556|19570333|P3|NOT COMPLETED|Overall Study||0
7951224|NCT00439556|19570334|P2|NOT COMPLETED|Overall Study||1
7951225|NCT00439556|19570335|P1|NOT COMPLETED|Overall Study||0
7951226|NCT00439556|19570333|P3|COMPLETED|Overall Study||0
7951227|NCT00439556|19570334|P2|COMPLETED|Overall Study||3
7951228|NCT00439556|19570335|P1|COMPLETED|Overall Study||36
7951229|NCT00439556|19570333|P3|STARTED|Overall Study||0
7951230|NCT00439556|19570334|P2|STARTED|Overall Study||4
7951231|NCT00439556|19570335|P1|STARTED|Overall Study||36
7951232|NCT00439517|19570348|P2|NOT COMPLETED|Overall Study||0
7951233|NCT00439517|19570349|P1|NOT COMPLETED|Overall Study||2
7951234|NCT00439517|19570348|P2|COMPLETED|Overall Study||150
7951235|NCT00439517|19570349|P1|COMPLETED|Overall Study||150
7951236|NCT00439517|19570348|P2|STARTED|Overall Study||150
7951237|NCT00439517|19570349|P1|STARTED|Overall Study||152
7951238|NCT00439465|19570371|P1|NOT COMPLETED|Overall Study||4
7951239|NCT00439465|19570371|P1|COMPLETED|Overall Study||19
7951240|NCT00439465|19570371|P1|STARTED|Overall Study||23
7951241|NCT00439413|19570383|P2|NOT COMPLETED|Overall Study||37
7951242|NCT00439413|19570384|P1|NOT COMPLETED|Overall Study||31
7951243|NCT00439413|19570383|P2|COMPLETED|Overall Study||88
7951244|NCT00439413|19570384|P1|COMPLETED|Overall Study||90
7951245|NCT00439413|19570383|P2|STARTED|Overall Study||125
7951246|NCT00439413|19570384|P1|STARTED|Overall Study||121
7951247|NCT00439374|19570394|P2|NOT COMPLETED|Overall Study||0
7951248|NCT00439374|19570395|P1|NOT COMPLETED|Overall Study||0
7951249|NCT00439374|19570394|P2|COMPLETED|Overall Study||330
7951250|NCT00439374|19570395|P1|COMPLETED|Overall Study||327
7951251|NCT00439374|19570394|P2|STARTED|Overall Study||330
7951252|NCT00439374|19570395|P1|STARTED|Overall Study||327
7951253|NCT00439335|19570455|P2|NOT COMPLETED|Overall Study||0
7951254|NCT00439335|19570456|P1|NOT COMPLETED|Overall Study||2
7951255|NCT00439335|19570455|P2|COMPLETED|Overall Study||114
7951256|NCT00439335|19570456|P1|COMPLETED|Overall Study||111
7951257|NCT00439335|19570455|P2|STARTED|Overall Study||114
7951258|NCT00439335|19570456|P1|STARTED|Overall Study||113
7951259|NCT00439309|19570488|P2|NOT COMPLETED|Follow-Up||2
7951260|NCT00439309|19570489|P1|NOT COMPLETED|Follow-Up||3
7951261|NCT00439309|19570488|P2|COMPLETED|Follow-Up||13
7951262|NCT00439309|19570489|P1|COMPLETED|Follow-Up||51
7951263|NCT00439309|19570488|P2|STARTED|Follow-Up||15
7951264|NCT00439309|19570489|P1|STARTED|Follow-Up||54
7951265|NCT00439309|19570488|P2|NOT COMPLETED|Treatment||0
7951266|NCT00439309|19570489|P1|NOT COMPLETED|Treatment||0
7951267|NCT00439309|19570488|P2|COMPLETED|Treatment||15
7951268|NCT00439309|19570489|P1|COMPLETED|Treatment||54
7951269|NCT00439309|19570488|P2|STARTED|Treatment||15
7951270|NCT00439309|19570489|P1|STARTED|Treatment||54
7951271|NCT00439296|19570505|P2|NOT COMPLETED|Overall Study||0
7951272|NCT00439296|19570506|P1|NOT COMPLETED|Overall Study||0
7951273|NCT00439296|19570505|P2|COMPLETED|Overall Study||4
7951274|NCT00439296|19570506|P1|COMPLETED|Overall Study||5
7951275|NCT00439296|19570505|P2|Treatment Course 2|Overall Study||1
7951276|NCT00439296|19570506|P1|Treatment Course 2|Overall Study||1
7951277|NCT00439296|19570505|P2|Treatment Course 1|Overall Study||3
7951278|NCT00439296|19570506|P1|Treatment Course 1|Overall Study||5
7951279|NCT00439296|19570505|P2|STARTED|Overall Study||4
7951280|NCT00439296|19570506|P1|STARTED|Overall Study||5
7951281|NCT00439270|19570521|P5|NOT COMPLETED|Phase 2 (51.6 Months)||0
7951282|NCT00439270|19570522|P4|NOT COMPLETED|Phase 2 (51.6 Months)||34
7951283|NCT00439270|19570523|P3|NOT COMPLETED|Phase 2 (51.6 Months)||0
7951284|NCT00439270|19570524|P2|NOT COMPLETED|Phase 2 (51.6 Months)||0
7951285|NCT00439270|19570525|P1|NOT COMPLETED|Phase 2 (51.6 Months)||0
7951286|NCT00439270|19570521|P5|COMPLETED|Phase 2 (51.6 Months)||0
7951287|NCT00439270|19570522|P4|COMPLETED|Phase 2 (51.6 Months)||0
7951288|NCT00439270|19570523|P3|COMPLETED|Phase 2 (51.6 Months)||0
7951289|NCT00439270|19570524|P2|COMPLETED|Phase 2 (51.6 Months)||0
7951290|NCT00439270|19570525|P1|COMPLETED|Phase 2 (51.6 Months)||0
7951291|NCT00439270|19570521|P5|STARTED|Phase 2 (51.6 Months)||0
7951292|NCT00439270|19570522|P4|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34
7951293|NCT00439270|19570523|P3|STARTED|Phase 2 (51.6 Months)||0
7951294|NCT00439270|19570524|P2|STARTED|Phase 2 (51.6 Months)||0
7951295|NCT00439270|19570525|P1|STARTED|Phase 2 (51.6 Months)||0
7951296|NCT00439270|19570521|P5|NOT COMPLETED|Phase 1 (18.1 Months)||3
7951297|NCT00439270|19570522|P4|NOT COMPLETED|Phase 1 (18.1 Months)||0
7951298|NCT00439270|19570523|P3|NOT COMPLETED|Phase 1 (18.1 Months)||3
7951299|NCT00439270|19570524|P2|NOT COMPLETED|Phase 1 (18.1 Months)||3
7951300|NCT00439270|19570525|P1|NOT COMPLETED|Phase 1 (18.1 Months)||3
7951301|NCT00439270|19570521|P5|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
7951302|NCT00439270|19570522|P4|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4
7951303|NCT00439270|19570523|P3|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
7951304|NCT00439270|19570524|P2|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
7951305|NCT00439270|19570525|P1|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
7951306|NCT00439270|19570521|P5|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
7951307|NCT00439270|19570522|P4|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4
7951308|NCT00439270|19570523|P3|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
7951309|NCT00439270|19570524|P2|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
7951310|NCT00439270|19570525|P1|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
7951311|NCT00439244|19570567|P3|NOT COMPLETED|Overall Study||7
7951312|NCT00439244|19570568|P2|NOT COMPLETED|Overall Study||6
7951313|NCT00439244|19570569|P1|NOT COMPLETED|Overall Study||11
7951314|NCT00439244|19570567|P3|COMPLETED|Overall Study||131
7951315|NCT00439244|19570568|P2|COMPLETED|Overall Study||131
7951316|NCT00439244|19570569|P1|COMPLETED|Overall Study||126
7951317|NCT00439244|19570567|P3|Safety Population|Overall Study||137
7951318|NCT00439244|19570568|P2|Safety Population|Overall Study||137
7951319|NCT00439244|19570569|P1|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137
7951320|NCT00439244|19570567|P3|STARTED|Overall Study||138
7951321|NCT00439244|19570568|P2|STARTED|Overall Study||137
7951322|NCT00439244|19570569|P1|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137
7951323|NCT00439231|19570589|P1|NOT COMPLETED|Overall Study||28
7951324|NCT00439231|19570589|P1|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5
7951325|NCT00439231|19570589|P1|STARTED|Overall Study||33
7951326|NCT00439218|19570593|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0
7951327|NCT00439218|19570593|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
7951328|NCT00439218|19570593|P1|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1
7951329|NCT00439218|19570593|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1
7951330|NCT00439218|19570593|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3
7951331|NCT00439218|19570593|P1|STARTED|Cohort 1 (500 mg/kg/Day)||4
7951332|NCT00439179|19570608|P4|NOT COMPLETED|Overall Study||0
7951333|NCT00439179|19570609|P3|NOT COMPLETED|Overall Study||0
7951334|NCT00439179|19570610|P2|NOT COMPLETED|Overall Study||2
7951335|NCT00439179|19570611|P1|NOT COMPLETED|Overall Study||0
7951336|NCT00439179|19570608|P4|COMPLETED|Overall Study||5
7951337|NCT00439179|19570609|P3|COMPLETED|Overall Study||6
7951338|NCT00439179|19570610|P2|COMPLETED|Overall Study||11
7951339|NCT00439179|19570611|P1|COMPLETED|Overall Study||3
7951340|NCT00439179|19570608|P4|STARTED|Overall Study|2 with biliry|5
7951341|NCT00439179|19570609|P3|STARTED|Overall Study|2 with biliary|6
7951342|NCT00439179|19570610|P2|STARTED|Overall Study|2 with biliary|13
7951343|NCT00439179|19570611|P1|STARTED|Overall Study|1 with biliary|3
7951344|NCT00439140|19570628|P3|NOT COMPLETED|Treatment Cycle 2||0
7951345|NCT00439140|19570629|P2|NOT COMPLETED|Treatment Cycle 2||1
7951346|NCT00439140|19570630|P1|NOT COMPLETED|Treatment Cycle 2||2
7951347|NCT00439140|19570628|P3|COMPLETED|Treatment Cycle 2||0
7951348|NCT00439140|19570629|P2|COMPLETED|Treatment Cycle 2||6
7951349|NCT00439140|19570630|P1|COMPLETED|Treatment Cycle 2||11
7951350|NCT00439140|19570628|P3|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0
7951351|NCT00439140|19570629|P2|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7
7951352|NCT00439140|19570630|P1|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13
7951353|NCT00439140|19570628|P3|NOT COMPLETED|Treatment Cycle 1||1
7951354|NCT00439140|19570629|P2|NOT COMPLETED|Treatment Cycle 1||4
7951355|NCT00439140|19570630|P1|NOT COMPLETED|Treatment Cycle 1||1
7951356|NCT00439140|19570628|P3|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11
7951357|NCT00439140|19570629|P2|COMPLETED|Treatment Cycle 1||10
7951358|NCT00439140|19570630|P1|COMPLETED|Treatment Cycle 1||14
7951359|NCT00439140|19570628|P3|STARTED|Treatment Cycle 1||12
7951360|NCT00439140|19570629|P2|STARTED|Treatment Cycle 1||14
7951361|NCT00439140|19570630|P1|STARTED|Treatment Cycle 1||15
7951362|NCT00438971|19570659|P1|NOT COMPLETED|Overall Study||2
7951363|NCT00438971|19570659|P1|COMPLETED|Overall Study||15
7951364|NCT00438971|19570659|P1|STARTED|Overall Study||17
7951365|NCT00438932|19570674|P4|NOT COMPLETED|Overall Study||0
7951366|NCT00438932|19570675|P3|NOT COMPLETED|Overall Study||0
7951367|NCT00438932|19570676|P2|NOT COMPLETED|Overall Study||0
7951368|NCT00438932|19570677|P1|NOT COMPLETED|Overall Study||0
7951369|NCT00438932|19570674|P4|COMPLETED|Overall Study||4
7951370|NCT00438932|19570675|P3|COMPLETED|Overall Study||4
7951371|NCT00438932|19570676|P2|COMPLETED|Overall Study||4
7951372|NCT00438932|19570677|P1|COMPLETED|Overall Study||4
7951373|NCT00438932|19570674|P4|STARTED|Overall Study||4
7951374|NCT00438932|19570675|P3|STARTED|Overall Study||4
7951375|NCT00438932|19570676|P2|STARTED|Overall Study||4
7951376|NCT00438932|19570677|P1|STARTED|Overall Study||4
7951377|NCT00438880|19570693|P2|NOT COMPLETED|Overall Study||0
7951378|NCT00438880|19570694|P1|NOT COMPLETED|Overall Study||0
7951379|NCT00438880|19570693|P2|COMPLETED|Overall Study||8
7951380|NCT00438880|19570694|P1|COMPLETED|Overall Study||30
7951381|NCT00438880|19570693|P2|STARTED|Overall Study||8
7951382|NCT00438880|19570694|P1|STARTED|Overall Study||30
7951383|NCT00438854|19570706|P1|NOT COMPLETED|Overall Study||0
7951384|NCT00438854|19570706|P1|COMPLETED|Overall Study||15
7951385|NCT00438854|19570706|P1|STARTED|Overall Study||15
7951386|NCT00438815|19570713|P1|NOT COMPLETED|Overall Study||70
7951387|NCT00438815|19570713|P1|COMPLETED|Overall Study||43
7951388|NCT00438815|19570713|P1|STARTED|Overall Study||113
7951389|NCT00438802|19570726|P3|NOT COMPLETED|Overall Study||0
7951390|NCT00438802|19570727|P2|NOT COMPLETED|Overall Study||0
7951391|NCT00438802|19570728|P1|NOT COMPLETED|Overall Study||0
7951392|NCT00438802|19570726|P3|COMPLETED|Overall Study||9
7951393|NCT00438802|19570727|P2|COMPLETED|Overall Study||8
7951394|NCT00438802|19570728|P1|COMPLETED|Overall Study||6
7951395|NCT00438802|19570726|P3|STARTED|Overall Study||9
7951396|NCT00438802|19570727|P2|STARTED|Overall Study||8
7951397|NCT00438802|19570728|P1|STARTED|Overall Study||6
7951398|NCT00438750|19570742|P2|NOT COMPLETED|Overall Study||9
7951399|NCT00438750|19570743|P1|NOT COMPLETED|Overall Study||9
7951400|NCT00438750|19570742|P2|COMPLETED|Overall Study||37
7951401|NCT00438750|19570743|P1|COMPLETED|Overall Study||39
7951402|NCT00438750|19570742|P2|STARTED|Overall Study||46
7951403|NCT00438750|19570743|P1|STARTED|Overall Study||48
7951404|NCT00438672|19570763|P2|NOT COMPLETED|Overall Study||9
7951405|NCT00438672|19570764|P1|NOT COMPLETED|Overall Study||7
7951406|NCT00438672|19570763|P2|COMPLETED|Overall Study||24
7951407|NCT00438672|19570764|P1|COMPLETED|Overall Study||24
7951408|NCT00438672|19570763|P2|STARTED|Overall Study||33
7951409|NCT00438672|19570764|P1|STARTED|Overall Study||31
7951410|NCT00438659|19570774|P2|NOT COMPLETED|Overall Study||4
7951411|NCT00438659|19570775|P1|NOT COMPLETED|Overall Study||6
7951412|NCT00438659|19570774|P2|COMPLETED|Overall Study||82
7951413|NCT00438659|19570775|P1|COMPLETED|Overall Study||84
7951414|NCT00438659|19570774|P2|STARTED|Overall Study||86
7951415|NCT00438659|19570775|P1|STARTED|Overall Study||90
7951416|NCT00438633|19570799|P2|NOT COMPLETED|Overall Study||17
7951417|NCT00438633|19570800|P1|NOT COMPLETED|Overall Study||16
7951418|NCT00438633|19570799|P2|COMPLETED|Overall Study||14
7951419|NCT00438633|19570800|P1|COMPLETED|Overall Study||16
7951420|NCT00438633|19570799|P2|3-month Follow-up|Overall Study||24
7951421|NCT00438633|19570800|P1|3-month Follow-up|Overall Study||26
7951422|NCT00438633|19570799|P2|STARTED|Overall Study||31
7951423|NCT00438633|19570800|P1|STARTED|Overall Study||32
7951424|NCT00438490|19570816|P2|NOT COMPLETED|Overall Study||0
7951425|NCT00438490|19570817|P1|NOT COMPLETED|Overall Study||0
7951426|NCT00438490|19570816|P2|COMPLETED|Overall Study||9
7951427|NCT00438490|19570817|P1|COMPLETED|Overall Study||12
7951428|NCT00438490|19570816|P2|STARTED|Overall Study||9
7951429|NCT00438490|19570817|P1|STARTED|Overall Study||12
7951430|NCT00438464|19570831|P2|NOT COMPLETED|Overall Study||7
7951431|NCT00438464|19570832|P1|NOT COMPLETED|Overall Study||14
7951432|NCT00438464|19570831|P2|COMPLETED|Overall Study||94
7951433|NCT00438464|19570832|P1|COMPLETED|Overall Study||89
7951434|NCT00438464|19570831|P2|Received Assigned Intervention|Overall Study||94
7951435|NCT00438464|19570832|P1|Received Assigned Intervention|Overall Study||89
7951436|NCT00438464|19570831|P2|STARTED|Overall Study||101
7951437|NCT00438464|19570832|P1|STARTED|Overall Study||103
7951438|NCT00438451|19570887|P3|NOT COMPLETED|Overall Study||53
7951439|NCT00438451|19570888|P2|NOT COMPLETED|Overall Study||66
7951440|NCT00438451|19570889|P1|NOT COMPLETED|Overall Study||47
7951441|NCT00438451|19570887|P3|COMPLETED|Overall Study||65
7951442|NCT00438451|19570888|P2|COMPLETED|Overall Study||55
7951443|NCT00438451|19570889|P1|COMPLETED|Overall Study||75
7951444|NCT00438451|19570887|P3|Maintenance Phase (Week 7-58)|Overall Study||93
7951445|NCT00438451|19570888|P2|Maintenance Phase (Week 7-58)|Overall Study||89
7951446|NCT00438451|19570889|P1|Maintenance Phase (Week 7-58)|Overall Study||93
7951447|NCT00438451|19570887|P3|ITT Population|Overall Study||117
7951448|NCT00438451|19570888|P2|ITT Population|Overall Study||120
7951449|NCT00438451|19570889|P1|ITT Population|Overall Study||122
7951450|NCT00438451|19570887|P3|Safety Population|Overall Study||117
7951451|NCT00438451|19570888|P2|Safety Population|Overall Study||121
7951452|NCT00438451|19570889|P1|Safety Population|Overall Study||122
7951453|NCT00438451|19570887|P3|STARTED|Overall Study||118
7951454|NCT00438451|19570888|P2|STARTED|Overall Study||121
7951455|NCT00438451|19570889|P1|STARTED|Overall Study||122
7951456|NCT00438399|19570933|P6|NOT COMPLETED|Overall Study||6
7951457|NCT00438399|19570934|P5|NOT COMPLETED|Overall Study||3
7951458|NCT00438399|19570935|P4|NOT COMPLETED|Overall Study||4
7951459|NCT00438399|19570936|P3|NOT COMPLETED|Overall Study||7
7951460|NCT00438399|19570937|P2|NOT COMPLETED|Overall Study||8
7951461|NCT00438399|19570938|P1|NOT COMPLETED|Overall Study||8
7951462|NCT00438399|19570933|P6|COMPLETED|Overall Study||31
7951463|NCT00438399|19570934|P5|COMPLETED|Overall Study||30
7951464|NCT00438399|19570935|P4|COMPLETED|Overall Study||32
7951465|NCT00438399|19570936|P3|COMPLETED|Overall Study||28
7951466|NCT00438399|19570937|P2|COMPLETED|Overall Study||32
7951467|NCT00438399|19570938|P1|COMPLETED|Overall Study||30
7951468|NCT00438399|19570933|P6|TREATED & ANALYZED|Overall Study||31
7951469|NCT00438399|19570934|P5|TREATED & ANALYZED|Overall Study||30
7951470|NCT00438399|19570935|P4|TREATED & ANALYZED|Overall Study||32
7951471|NCT00438399|19570936|P3|TREATED & ANALYZED|Overall Study||28
7951472|NCT00438399|19570937|P2|TREATED & ANALYZED|Overall Study||32
7951473|NCT00438399|19570938|P1|TREATED & ANALYZED|Overall Study||30
7951474|NCT00438399|19570933|P6|STARTED|Overall Study||37
7951475|NCT00438399|19570934|P5|STARTED|Overall Study||33
7951476|NCT00438399|19570935|P4|STARTED|Overall Study||36
7951477|NCT00438399|19570936|P3|STARTED|Overall Study||35
7951478|NCT00438399|19570937|P2|STARTED|Overall Study||40
7951479|NCT00438399|19570938|P1|STARTED|Overall Study||38
7951480|NCT00438360|19570949|P2|NOT COMPLETED|Overall Study||43
7951481|NCT00438360|19570950|P1|NOT COMPLETED|Overall Study||72
7951482|NCT00438360|19570949|P2|COMPLETED|Overall Study||38
7951483|NCT00438360|19570950|P1|COMPLETED|Overall Study||90
7951484|NCT00438360|19570949|P2|Intention to Treat (ITT) Population|Overall Study||79
7951485|NCT00438360|19570950|P1|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160
7951486|NCT00438360|19570949|P2|STARTED|Overall Study||81
7951487|NCT00438360|19570950|P1|STARTED|Overall Study|"Started indicates randomized patients."|162
7951488|NCT00438256|19570964|P4|NOT COMPLETED|Overall Study||9
7951489|NCT00438256|19570965|P3|NOT COMPLETED|Overall Study||1
7951490|NCT00438256|19570966|P2|NOT COMPLETED|Overall Study||1
7951491|NCT00438256|19570967|P1|NOT COMPLETED|Overall Study||2
7951492|NCT00438256|19570964|P4|COMPLETED|Overall Study||32
7951493|NCT00438256|19570965|P3|COMPLETED|Overall Study||2
7951494|NCT00438256|19570966|P2|COMPLETED|Overall Study||2
7951495|NCT00438256|19570967|P1|COMPLETED|Overall Study||1
7951496|NCT00438256|19570964|P4|Surgical Resection|Overall Study||34
7951497|NCT00438256|19570965|P3|Surgical Resection|Overall Study||2
7951498|NCT00438256|19570966|P2|Surgical Resection|Overall Study||2
7951499|NCT00438256|19570967|P1|Surgical Resection|Overall Study||1
7951500|NCT00438256|19570964|P4|STARTED|Overall Study||41
7951501|NCT00438256|19570965|P3|STARTED|Overall Study||3
7951502|NCT00438256|19570966|P2|STARTED|Overall Study||3
7951503|NCT00438256|19570967|P1|STARTED|Overall Study||3
7951504|NCT00438204|19570983|P1|NOT COMPLETED|Overall Study||0
7951505|NCT00438204|19570983|P1|COMPLETED|Overall Study||39
7951506|NCT00438204|19570983|P1|STARTED|Overall Study||39
7951507|NCT00438191|19570993|P2|NOT COMPLETED|Overall Study||14
7951508|NCT00438191|19570994|P1|NOT COMPLETED|Overall Study||11
7951509|NCT00438191|19570993|P2|COMPLETED|Overall Study||26
7951510|NCT00438191|19570994|P1|COMPLETED|Overall Study||32
7951511|NCT00438191|19570993|P2|STARTED|Overall Study||40
7951512|NCT00438191|19570994|P1|STARTED|Overall Study||43
7951513|NCT00438100|19571008|P2|NOT COMPLETED|Overall Study||4
7951514|NCT00438100|19571009|P1|NOT COMPLETED|Overall Study||2
7951515|NCT00438100|19571008|P2|COMPLETED|Overall Study||65
7951516|NCT00438100|19571009|P1|COMPLETED|Overall Study||71
7951517|NCT00438100|19571008|P2|STARTED|Overall Study||69
7951518|NCT00438100|19571009|P1|STARTED|Overall Study||73
7951519|NCT00437983|19571017|P2|NOT COMPLETED|Overall Study||13
7951520|NCT00437983|19571018|P1|NOT COMPLETED|Overall Study||13
7951521|NCT00437983|19571017|P2|COMPLETED|Overall Study||65
7951522|NCT00437983|19571018|P1|COMPLETED|Overall Study||66
7951523|NCT00437983|19571017|P2|STARTED|Overall Study||78
7951524|NCT00437983|19571018|P1|STARTED|Overall Study||79
7951525|NCT00437658|19571031|P3|NOT COMPLETED|Post-treatment Period (24 Weeks)||14
7951526|NCT00437658|19571032|P2|NOT COMPLETED|Post-treatment Period (24 Weeks)||8
7951527|NCT00437658|19571033|P1|NOT COMPLETED|Post-treatment Period (24 Weeks)||24
7951528|NCT00437658|19571031|P3|COMPLETED|Post-treatment Period (24 Weeks)||37
7951529|NCT00437658|19571032|P2|COMPLETED|Post-treatment Period (24 Weeks)||54
7951530|NCT00437658|19571033|P1|COMPLETED|Post-treatment Period (24 Weeks)||32
7951531|NCT00437658|19571031|P3|STARTED|Post-treatment Period (24 Weeks)||51
7951532|NCT00437658|19571032|P2|STARTED|Post-treatment Period (24 Weeks)||62
7951533|NCT00437658|19571033|P1|STARTED|Post-treatment Period (24 Weeks)||56
7951534|NCT00437658|19571031|P3|NOT COMPLETED|Treatment Period (24 Weeks)||33
7951535|NCT00437658|19571032|P2|NOT COMPLETED|Treatment Period (24 Weeks)||22
7951536|NCT00437658|19571033|P1|NOT COMPLETED|Treatment Period (24 Weeks)||28
7951537|NCT00437658|19571031|P3|COMPLETED|Treatment Period (24 Weeks)||51
7951538|NCT00437658|19571032|P2|COMPLETED|Treatment Period (24 Weeks)||62
7951539|NCT00437658|19571033|P1|COMPLETED|Treatment Period (24 Weeks)||56
7951540|NCT00437658|19571031|P3|Received Study Drug|Treatment Period (24 Weeks)||84
7951541|NCT00437658|19571032|P2|Received Study Drug|Treatment Period (24 Weeks)||84
7951542|NCT00437658|19571033|P1|Received Study Drug|Treatment Period (24 Weeks)||84
7951543|NCT00437658|19571031|P3|STARTED|Treatment Period (24 Weeks)||84
7951544|NCT00437658|19571032|P2|STARTED|Treatment Period (24 Weeks)||84
7951545|NCT00437658|19571033|P1|STARTED|Treatment Period (24 Weeks)||84
7951546|NCT00437645|19571127|P2|NOT COMPLETED|Overall Study||115
7951547|NCT00437645|19571128|P1|NOT COMPLETED|Overall Study||35
7951548|NCT00437645|19571127|P2|COMPLETED|Overall Study||476
7951549|NCT00437645|19571128|P1|COMPLETED|Overall Study||557
7951550|NCT00437645|19571127|P2|STARTED|Overall Study||591
7951551|NCT00437645|19571128|P1|STARTED|Overall Study||592
7951552|NCT00437489|19571144|P2|NOT COMPLETED|Overall Study||22
7951553|NCT00437489|19571145|P1|NOT COMPLETED|Overall Study||23
7951554|NCT00437489|19571144|P2|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
7951555|NCT00437489|19571145|P1|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
7951556|NCT00437489|19571144|P2|STARTED|Overall Study||24
7951557|NCT00437489|19571145|P1|STARTED|Overall Study||25
7951558|NCT00437398|19571157|P1|NOT COMPLETED|Overall Study||0
7951559|NCT00437398|19571157|P1|COMPLETED|Overall Study||2
7951560|NCT00437398|19571157|P1|STARTED|Overall Study||2
7951561|NCT00437294|19571164|P2|NOT COMPLETED|Overall Study||43
7951562|NCT00437294|19571165|P1|NOT COMPLETED|Overall Study||43
7951563|NCT00437294|19571164|P2|COMPLETED|Overall Study||0
7951564|NCT00437294|19571165|P1|COMPLETED|Overall Study||0
7951565|NCT00437294|19571164|P2|Received at Least 1 Dose of Study Drug|Overall Study||43
7951566|NCT00437294|19571165|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
7951567|NCT00437294|19571164|P2|STARTED|Overall Study||43
7951568|NCT00437294|19571165|P1|STARTED|Overall Study||43
7951569|NCT00437281|19571206|P20|NOT COMPLETED|Overall Study||1
7951570|NCT00437281|19571207|P19|NOT COMPLETED|Overall Study||1
7951571|NCT00437281|19571208|P18|NOT COMPLETED|Overall Study||0
7951572|NCT00437281|19571209|P17|NOT COMPLETED|Overall Study||0
7951573|NCT00437281|19571210|P16|NOT COMPLETED|Overall Study||0
7951574|NCT00437281|19571211|P15|NOT COMPLETED|Overall Study||1
7951575|NCT00437281|19571212|P14|NOT COMPLETED|Overall Study||1
7951576|NCT00437281|19571213|P13|NOT COMPLETED|Overall Study||0
7951577|NCT00437281|19571214|P12|NOT COMPLETED|Overall Study||0
7951578|NCT00437281|19571215|P11|NOT COMPLETED|Overall Study||0
7951579|NCT00437281|19571216|P10|NOT COMPLETED|Overall Study||1
7951580|NCT00437281|19571217|P9|NOT COMPLETED|Overall Study||0
7951581|NCT00437281|19571218|P8|NOT COMPLETED|Overall Study||0
7951582|NCT00437281|19571219|P7|NOT COMPLETED|Overall Study||0
7951583|NCT00437281|19571220|P6|NOT COMPLETED|Overall Study||1
7951584|NCT00437281|19571221|P5|NOT COMPLETED|Overall Study||0
7951585|NCT00437281|19571222|P4|NOT COMPLETED|Overall Study||1
7951586|NCT00437281|19571223|P3|NOT COMPLETED|Overall Study||0
7951587|NCT00437281|19571224|P2|NOT COMPLETED|Overall Study||0
7951588|NCT00437281|19571225|P1|NOT COMPLETED|Overall Study||0
7951589|NCT00437281|19571206|P20|COMPLETED|Overall Study||2
7951590|NCT00437281|19571207|P19|COMPLETED|Overall Study||1
7951591|NCT00437281|19571208|P18|COMPLETED|Overall Study||4
7951592|NCT00437281|19571209|P17|COMPLETED|Overall Study||3
7951593|NCT00437281|19571210|P16|COMPLETED|Overall Study||3
7951594|NCT00437281|19571211|P15|COMPLETED|Overall Study||4
7951595|NCT00437281|19571212|P14|COMPLETED|Overall Study||2
7951596|NCT00437281|19571213|P13|COMPLETED|Overall Study||2
7951597|NCT00437281|19571214|P12|COMPLETED|Overall Study||3
7951598|NCT00437281|19571215|P11|COMPLETED|Overall Study||3
7951599|NCT00437281|19571216|P10|COMPLETED|Overall Study||4
7951600|NCT00437281|19571217|P9|COMPLETED|Overall Study||3
7951601|NCT00437281|19571218|P8|COMPLETED|Overall Study||3
7951602|NCT00437281|19571219|P7|COMPLETED|Overall Study||3
7951603|NCT00437281|19571220|P6|COMPLETED|Overall Study||3
7951604|NCT00437281|19571221|P5|COMPLETED|Overall Study||4
7951605|NCT00437281|19571222|P4|COMPLETED|Overall Study||2
7951606|NCT00437281|19571223|P3|COMPLETED|Overall Study||3
7951607|NCT00437281|19571224|P2|COMPLETED|Overall Study||3
7951608|NCT00437281|19571225|P1|COMPLETED|Overall Study||3
7951609|NCT00437281|19571206|P20|STARTED|Overall Study||3
7951610|NCT00437281|19571207|P19|STARTED|Overall Study||2
7951611|NCT00437281|19571208|P18|STARTED|Overall Study||4
7951612|NCT00437281|19571209|P17|STARTED|Overall Study||3
7951613|NCT00437281|19571210|P16|STARTED|Overall Study||3
7951614|NCT00437281|19571211|P15|STARTED|Overall Study||5
7951615|NCT00437281|19571212|P14|STARTED|Overall Study||3
7951616|NCT00437281|19571213|P13|STARTED|Overall Study||2
7951617|NCT00437281|19571214|P12|STARTED|Overall Study||3
7951618|NCT00437281|19571215|P11|STARTED|Overall Study||3
7951619|NCT00437281|19571216|P10|STARTED|Overall Study||5
7951620|NCT00437281|19571217|P9|STARTED|Overall Study||3
7951621|NCT00437281|19571218|P8|STARTED|Overall Study||3
7951622|NCT00437281|19571219|P7|STARTED|Overall Study||3
7951623|NCT00437281|19571220|P6|STARTED|Overall Study||4
7951624|NCT00437281|19571221|P5|STARTED|Overall Study||4
7951625|NCT00437281|19571222|P4|STARTED|Overall Study||3
7951626|NCT00437281|19571223|P3|STARTED|Overall Study||3
7951627|NCT00437281|19571224|P2|STARTED|Overall Study||3
7951628|NCT00437281|19571225|P1|STARTED|Overall Study||3
7951629|NCT00437268|19571521|P2|NOT COMPLETED|Overall Study||13
7951630|NCT00437268|19571522|P1|NOT COMPLETED|Overall Study||13
7951631|NCT00437268|19571521|P2|COMPLETED|Overall Study||0
7951632|NCT00437268|19571522|P1|COMPLETED|Overall Study||0
7951633|NCT00437268|19571521|P2|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|12
7951634|NCT00437268|19571522|P1|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|13
7951635|NCT00437268|19571521|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
7951636|NCT00437268|19571522|P1|Received at Least 1 Dose of Study Drug|Overall Study||13
7951637|NCT00437268|19571521|P2|STARTED|Overall Study||13
7951638|NCT00437268|19571522|P1|STARTED|Overall Study||13
7951639|NCT00437203|19571548|P10|NOT COMPLETED|Overall Study||4
7951640|NCT00437203|19571549|P9|NOT COMPLETED|Overall Study||3
7951641|NCT00437203|19571550|P8|NOT COMPLETED|Overall Study||3
7951642|NCT00437203|19571551|P7|NOT COMPLETED|Overall Study||7
7951643|NCT00437203|19571552|P6|NOT COMPLETED|Overall Study||3
7951644|NCT00437203|19571553|P5|NOT COMPLETED|Overall Study||3
7951645|NCT00437203|19571554|P4|NOT COMPLETED|Overall Study||3
7951646|NCT00437203|19571555|P3|NOT COMPLETED|Overall Study||3
7951647|NCT00437203|19571556|P2|NOT COMPLETED|Overall Study||8
7951648|NCT00437203|19571557|P1|NOT COMPLETED|Overall Study||6
7951649|NCT00437203|19571548|P10|COMPLETED|Overall Study||0
7951650|NCT00437203|19571549|P9|COMPLETED|Overall Study||0
7951651|NCT00437203|19571550|P8|COMPLETED|Overall Study||0
7951652|NCT00437203|19571551|P7|COMPLETED|Overall Study||0
7951653|NCT00437203|19571552|P6|COMPLETED|Overall Study||0
7951654|NCT00437203|19571553|P5|COMPLETED|Overall Study||0
7951655|NCT00437203|19571554|P4|COMPLETED|Overall Study||0
7951656|NCT00437203|19571555|P3|COMPLETED|Overall Study||0
7951657|NCT00437203|19571556|P2|COMPLETED|Overall Study||0
7951658|NCT00437203|19571557|P1|COMPLETED|Overall Study||0
7951659|NCT00437203|19571548|P10|STARTED|Overall Study||4
7951660|NCT00437203|19571549|P9|STARTED|Overall Study||3
7951661|NCT00437203|19571550|P8|STARTED|Overall Study||3
7951662|NCT00437203|19571551|P7|STARTED|Overall Study||7
7951663|NCT00437203|19571552|P6|STARTED|Overall Study||3
7951664|NCT00437203|19571553|P5|STARTED|Overall Study||3
7951665|NCT00437203|19571554|P4|STARTED|Overall Study||3
7951666|NCT00437203|19571555|P3|STARTED|Overall Study||3
7951667|NCT00437203|19571556|P2|STARTED|Overall Study||8
7951668|NCT00437203|19571557|P1|STARTED|Overall Study||6
7951669|NCT00437125|19571661|P1|NOT COMPLETED|Overall Study||32
7951670|NCT00437125|19571661|P1|COMPLETED|Overall Study||119
7951671|NCT00437125|19571661|P1|STARTED|Overall Study||151
7951672|NCT00437073|19571682|P2|NOT COMPLETED|Overall Study||1
7951673|NCT00437073|19571683|P1|NOT COMPLETED|Overall Study||1
7951674|NCT00437073|19571682|P2|COMPLETED|Overall Study||8
7951675|NCT00437073|19571683|P1|COMPLETED|Overall Study||12
7951676|NCT00437073|19571682|P2|STARTED|Overall Study||9
7951677|NCT00437073|19571683|P1|STARTED|Overall Study||13
7951678|NCT00437034|19571711|P1|NOT COMPLETED|Overall Study||6
7951679|NCT00437034|19571711|P1|COMPLETED|Overall Study||0
7951680|NCT00437034|19571711|P1|STARTED|Overall Study||6
7951681|NCT00436982|19571717|P2|NOT COMPLETED|Overall Study||4
7951682|NCT00436982|19571718|P1|NOT COMPLETED|Overall Study||4
7951683|NCT00436982|19571717|P2|COMPLETED|Overall Study||26
7951684|NCT00436982|19571718|P1|COMPLETED|Overall Study||26
7951685|NCT00436982|19571717|P2|STARTED|Overall Study||30
7951686|NCT00436982|19571718|P1|STARTED|Overall Study||30
7951687|NCT00436969|19571740|P2|NOT COMPLETED|Overall Study||52
7951688|NCT00436969|19571741|P1|NOT COMPLETED|Overall Study||22
7951689|NCT00436969|19571740|P2|COMPLETED|Overall Study||134
7951690|NCT00436969|19571741|P1|COMPLETED|Overall Study||66
7951691|NCT00436969|19571740|P2|Randomized But Not Treated|Overall Study||3
7951692|NCT00436969|19571741|P1|Randomized But Not Treated|Overall Study||1
7951693|NCT00436969|19571740|P2|STARTED|Overall Study||186
7951694|NCT00436969|19571741|P1|STARTED|Overall Study||88
7951695|NCT00436956|19571789|P2|NOT COMPLETED|Overall Study||0
7951696|NCT00436956|19571790|P1|NOT COMPLETED|Overall Study||1
7951697|NCT00436956|19571789|P2|COMPLETED|Overall Study||23
7951698|NCT00436956|19571790|P1|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35
7951699|NCT00436956|19571789|P2|STARTED|Overall Study||23
7951700|NCT00436956|19571790|P1|STARTED|Overall Study||36
7951701|NCT00436917|19571804|P1|NOT COMPLETED|Overall Study||21
7951702|NCT00436917|19571804|P1|COMPLETED|Overall Study||32
7951703|NCT00436917|19571804|P1|STARTED|Overall Study|7 participants (1 cancellation, 1 major violation, 5 ineligibles) were excluded from all analysis.|53
7951704|NCT00436904|19571819|P1|NOT COMPLETED|Overall Study||0
7951705|NCT00436904|19571819|P1|COMPLETED|Overall Study||30
7951706|NCT00436904|19571819|P1|STARTED|Overall Study||30
7951707|NCT00436852|19571830|P2|NOT COMPLETED|Overall Study||45
7951708|NCT00436852|19571831|P1|NOT COMPLETED|Overall Study||35
7951709|NCT00436852|19571830|P2|COMPLETED|Overall Study||2
7951710|NCT00436852|19571831|P1|COMPLETED|Overall Study||10
7951711|NCT00436852|19571830|P2|STARTED|Overall Study||47
7951712|NCT00436852|19571831|P1|STARTED|Overall Study||45
7951713|NCT00436826|19571850|P6|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7
7951714|NCT00436826|19571851|P5|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51
7951715|NCT00436826|19571852|P4|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
7951716|NCT00436826|19571853|P3|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
7951717|NCT00436826|19571854|P2|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
7951718|NCT00436826|19571855|P1|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
7951719|NCT00436826|19571850|P6|COMPLETED|Ext. Period (No Cladribine Treatment)||0
7951720|NCT00436826|19571851|P5|COMPLETED|Ext. Period (No Cladribine Treatment)||1
7951721|NCT00436826|19571852|P4|COMPLETED|Ext. Period (No Cladribine Treatment)||0
7951722|NCT00436826|19571853|P3|COMPLETED|Ext. Period (No Cladribine Treatment)||0
7951723|NCT00436826|19571854|P2|COMPLETED|Ext. Period (No Cladribine Treatment)||0
7951724|NCT00436826|19571855|P1|COMPLETED|Ext. Period (No Cladribine Treatment)||0
7951725|NCT00436826|19571850|P6|STARTED|Ext. Period (No Cladribine Treatment)||7
7951726|NCT00436826|19571851|P5|STARTED|Ext. Period (No Cladribine Treatment)||52
7951727|NCT00436826|19571852|P4|STARTED|Ext. Period (No Cladribine Treatment)||0
7951728|NCT00436826|19571853|P3|STARTED|Ext. Period (No Cladribine Treatment)||0
7951729|NCT00436826|19571854|P2|STARTED|Ext. Period (No Cladribine Treatment)||0
7951730|NCT00436826|19571855|P1|STARTED|Ext. Period (No Cladribine Treatment)||0
7951731|NCT00436826|19571850|P6|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
7951732|NCT00436826|19571851|P5|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
7951733|NCT00436826|19571852|P4|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||26
7951734|NCT00436826|19571853|P3|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||46
7951735|NCT00436826|19571854|P2|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
7951736|NCT00436826|19571855|P1|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
7951737|NCT00436826|19571850|P6|COMPLETED|Ext. Period (With Cladribine Treatment)||0
7951738|NCT00436826|19571851|P5|COMPLETED|Ext. Period (With Cladribine Treatment)||0
7951739|NCT00436826|19571852|P4|COMPLETED|Ext. Period (With Cladribine Treatment)||2
7951740|NCT00436826|19571853|P3|COMPLETED|Ext. Period (With Cladribine Treatment)||1
7951741|NCT00436826|19571854|P2|COMPLETED|Ext. Period (With Cladribine Treatment)||0
7951742|NCT00436826|19571855|P1|COMPLETED|Ext. Period (With Cladribine Treatment)||0
7951743|NCT00436826|19571850|P6|STARTED|Ext. Period (With Cladribine Treatment)||0
7951744|NCT00436826|19571851|P5|STARTED|Ext. Period (With Cladribine Treatment)||0
7951745|NCT00436826|19571852|P4|STARTED|Ext. Period (With Cladribine Treatment)||28
7951746|NCT00436826|19571853|P3|STARTED|Ext. Period (With Cladribine Treatment)||47
7951747|NCT00436826|19571854|P2|STARTED|Ext. Period (With Cladribine Treatment)||0
7951748|NCT00436826|19571855|P1|STARTED|Ext. Period (With Cladribine Treatment)||0
7951749|NCT00436826|19571850|P6|NOT COMPLETED|Double Blind Period (DBP)||0
7951750|NCT00436826|19571851|P5|NOT COMPLETED|Double Blind Period (DBP)||0
7951751|NCT00436826|19571852|P4|NOT COMPLETED|Double Blind Period (DBP)||0
7951752|NCT00436826|19571853|P3|NOT COMPLETED|Double Blind Period (DBP)||0
7951753|NCT00436826|19571854|P2|NOT COMPLETED|Double Blind Period (DBP)||11
7951754|NCT00436826|19571855|P1|NOT COMPLETED|Double Blind Period (DBP)||13
7951755|NCT00436826|19571850|P6|COMPLETED|Double Blind Period (DBP)||0
7951756|NCT00436826|19571851|P5|COMPLETED|Double Blind Period (DBP)||0
7951757|NCT00436826|19571852|P4|COMPLETED|Double Blind Period (DBP)||0
7951758|NCT00436826|19571853|P3|COMPLETED|Double Blind Period (DBP)||0
7951759|NCT00436826|19571854|P2|COMPLETED|Double Blind Period (DBP)||37
7951760|NCT00436826|19571855|P1|COMPLETED|Double Blind Period (DBP)||111
7951761|NCT00436826|19571850|P6|STARTED|Double Blind Period (DBP)||0
7951762|NCT00436826|19571851|P5|STARTED|Double Blind Period (DBP)||0
7951763|NCT00436826|19571852|P4|STARTED|Double Blind Period (DBP)||0
7951764|NCT00436826|19571853|P3|STARTED|Double Blind Period (DBP)||0
7951765|NCT00436826|19571854|P2|STARTED|Double Blind Period (DBP)||48
7951766|NCT00436826|19571855|P1|STARTED|Double Blind Period (DBP)||124
7951767|NCT00436748|19571953|P2|NOT COMPLETED|Overall Study||12
7951768|NCT00436748|19571954|P1|NOT COMPLETED|Overall Study||11
7951769|NCT00436748|19571953|P2|COMPLETED|Overall Study||45
7951770|NCT00436748|19571954|P1|COMPLETED|Overall Study||48
7951771|NCT00436748|19571953|P2|Received Treatment|Overall Study||56
7951772|NCT00436748|19571954|P1|Received Treatment|Overall Study||58
7951773|NCT00436748|19571953|P2|STARTED|Overall Study||57
7951774|NCT00436748|19571954|P1|STARTED|Overall Study||59
7951775|NCT00436644|19571988|P1|NOT COMPLETED|Overall Study||3
7951776|NCT00436644|19571988|P1|COMPLETED|Overall Study||15
7951777|NCT00436644|19571988|P1|STARTED|Overall Study||18
7951778|NCT00436618|19571998|P3|NOT COMPLETED|Overall Study||61
7951779|NCT00436618|19571999|P2|NOT COMPLETED|Overall Study||27
7951780|NCT00436618|19572000|P1|NOT COMPLETED|Overall Study||30
7951781|NCT00436618|19571998|P3|COMPLETED|Overall Study||46
7951782|NCT00436618|19571999|P2|COMPLETED|Overall Study||28
7951783|NCT00436618|19572000|P1|COMPLETED|Overall Study||84
7951784|NCT00436618|19571998|P3|STARTED|Overall Study||107
7951785|NCT00436618|19571999|P2|STARTED|Overall Study||55
7951786|NCT00436618|19572000|P1|STARTED|Overall Study||114
7951787|NCT00436605|19572017|P1|NOT COMPLETED|Overall Study||3
7951788|NCT00436605|19572017|P1|COMPLETED|Overall Study||36
7951789|NCT00436605|19572017|P1|STARTED|Overall Study||39
7951790|NCT00436566|19572022|P1|NOT COMPLETED|Overall Study||3
7951791|NCT00436566|19572022|P1|COMPLETED|Overall Study||109
7951792|NCT00436566|19572022|P1|STARTED|Overall Study||112
7951793|NCT00436553|19572029|P3|NOT COMPLETED|Overall Study||10
7951794|NCT00436553|19572030|P2|NOT COMPLETED|Overall Study||12
7951795|NCT00436553|19572031|P1|NOT COMPLETED|Overall Study||13
7951796|NCT00436553|19572029|P3|COMPLETED|Overall Study||102
7951797|NCT00436553|19572030|P2|COMPLETED|Overall Study||93
7951798|NCT00436553|19572031|P1|COMPLETED|Overall Study|Completed the 12 month study phase.|91
7951799|NCT00436553|19572029|P3|STARTED|Overall Study||112
7951800|NCT00436553|19572030|P2|STARTED|Overall Study||105
7951801|NCT00436553|19572031|P1|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104
7951802|NCT00436501|19572052|P2|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3
7951803|NCT00436501|19572053|P1|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
7951804|NCT00436501|19572052|P2|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46
7951805|NCT00436501|19572053|P1|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
7951806|NCT00436501|19572052|P2|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49
7951807|NCT00436501|19572053|P1|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0
7951808|NCT00436501|19572052|P2|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
7951809|NCT00436501|19572053|P1|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
7951810|NCT00436501|19572052|P2|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
7951811|NCT00436501|19572053|P1|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9
7951812|NCT00436501|19572052|P2|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0
7951813|NCT00436501|19572053|P1|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
7951814|NCT00436501|19572052|P2|NOT COMPLETED|Complete Study Participation||0
7951815|NCT00436501|19572053|P1|NOT COMPLETED|Complete Study Participation||0
7951816|NCT00436501|19572052|P2|COMPLETED|Complete Study Participation||49
7951817|NCT00436501|19572053|P1|COMPLETED|Complete Study Participation||9
7951818|NCT00436501|19572052|P2|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49
7951819|NCT00436501|19572053|P1|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
7951820|NCT00436475|19572072|P4|NOT COMPLETED|Overall Study||2
7951821|NCT00436475|19572073|P3|NOT COMPLETED|Overall Study||1
7951822|NCT00436475|19572074|P2|NOT COMPLETED|Overall Study||1
7951823|NCT00436475|19572075|P1|NOT COMPLETED|Overall Study||0
7951824|NCT00436475|19572072|P4|COMPLETED|Overall Study||22
7951825|NCT00436475|19572073|P3|COMPLETED|Overall Study||21
7951826|NCT00436475|19572074|P2|COMPLETED|Overall Study||22
7951827|NCT00436475|19572075|P1|COMPLETED|Overall Study||23
7951828|NCT00436475|19572072|P4|STARTED|Overall Study||24
7951829|NCT00436475|19572073|P3|STARTED|Overall Study||22
7951830|NCT00436475|19572074|P2|STARTED|Overall Study||23
7951831|NCT00436475|19572075|P1|STARTED|Overall Study||23
7951832|NCT00436436|19572089|P1|NOT COMPLETED|Overall Study||12
7951833|NCT00436436|19572089|P1|COMPLETED|Overall Study||0
7951834|NCT00436436|19572089|P1|STARTED|Overall Study||12
7951835|NCT00436345|19572100|P2|NOT COMPLETED|Overall Study||0
7951836|NCT00436345|19572101|P1|NOT COMPLETED|Overall Study||3
7951837|NCT00436345|19572100|P2|COMPLETED|Overall Study||18
7951838|NCT00436345|19572101|P1|COMPLETED|Overall Study||18
7951839|NCT00436345|19572100|P2|STARTED|Overall Study||18
7951840|NCT00436345|19572101|P1|STARTED|Overall Study||21
7951841|NCT00436332|19572154|P1|NOT COMPLETED|Overall Study||83
7951842|NCT00436332|19572154|P1|COMPLETED|Overall Study||1
7951843|NCT00436332|19572154|P1|Eligible and Began Protocol Therapy|Overall Study||79
7951844|NCT00436332|19572154|P1|Eligible|Overall Study||82
7951845|NCT00436332|19572154|P1|STARTED|Overall Study||84
7951846|NCT00436280|19572161|P1|NOT COMPLETED|Period 3: Maintenance||18
7951847|NCT00436280|19572161|P1|COMPLETED|Period 3: Maintenance||5
7951848|NCT00436280|19572161|P1|STARTED|Period 3: Maintenance||23
7951849|NCT00436280|19572161|P1|NOT COMPLETED|Period 2: Consolidation||17
7951850|NCT00436280|19572161|P1|COMPLETED|Period 2: Consolidation||23
7951851|NCT00436280|19572161|P1|STARTED|Period 2: Consolidation||40
7951852|NCT00436280|19572161|P1|NOT COMPLETED|Period 1: Induction||28
7951853|NCT00436280|19572161|P1|COMPLETED|Period 1: Induction||40
7951854|NCT00436280|19572161|P1|Received at Least 1 Dose of Study Drug|Period 1: Induction||68
7951855|NCT00436280|19572161|P1|STARTED|Period 1: Induction||68
7951856|NCT00436215|19572175|P1|NOT COMPLETED|Overall Study||4
7951857|NCT00436215|19572175|P1|COMPLETED|Overall Study||51
7951858|NCT00436215|19572175|P1|STARTED|Overall Study||55
7951859|NCT00436163|19572181|P1|NOT COMPLETED|Overall Study||3
7951860|NCT00436163|19572181|P1|COMPLETED|Overall Study||36
7951861|NCT00436163|19572181|P1|STARTED|Overall Study||39
7951862|NCT00436046|19572195|P3|NOT COMPLETED|Overall Study||0
7951863|NCT00436046|19572196|P2|NOT COMPLETED|Overall Study||0
7951864|NCT00436046|19572197|P1|NOT COMPLETED|Overall Study||0
7951865|NCT00436046|19572195|P3|COMPLETED|Overall Study||31
7951866|NCT00436046|19572196|P2|COMPLETED|Overall Study||32
7951867|NCT00436046|19572197|P1|COMPLETED|Overall Study||32
7951868|NCT00436046|19572195|P3|STARTED|Overall Study||31
7951869|NCT00436046|19572196|P2|STARTED|Overall Study||32
7951870|NCT00436046|19572197|P1|STARTED|Overall Study||32
7951871|NCT00436007|19572229|P3|NOT COMPLETED|Overall Study||23
7951872|NCT00436007|19572230|P2|NOT COMPLETED|Overall Study||14
7951873|NCT00436007|19572231|P1|NOT COMPLETED|Overall Study||19
7951874|NCT00436007|19572229|P3|COMPLETED|Overall Study||148
7951875|NCT00436007|19572230|P2|COMPLETED|Overall Study||156
7951876|NCT00436007|19572231|P1|COMPLETED|Overall Study||151
7951877|NCT00436007|19572229|P3|STARTED|Overall Study||171
7951878|NCT00436007|19572230|P2|STARTED|Overall Study||170
7951879|NCT00436007|19572231|P1|STARTED|Overall Study||170
7951880|NCT00435994|19572279|P3|NOT COMPLETED|Overall Study||0
7951881|NCT00435994|19572280|P2|NOT COMPLETED|Overall Study||0
7951882|NCT00435994|19572281|P1|NOT COMPLETED|Overall Study||7
7951883|NCT00435994|19572279|P3|COMPLETED|Overall Study||12
7951884|NCT00435994|19572280|P2|COMPLETED|Overall Study||25
7951885|NCT00435994|19572281|P1|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15
7951886|NCT00435994|19572279|P3|STARTED|Overall Study||12
7951887|NCT00435994|19572280|P2|STARTED|Overall Study||25
7951888|NCT00435994|19572281|P1|STARTED|Overall Study||22
7951889|NCT00435942|19572292|P2|NOT COMPLETED|Overall Study||27
7951890|NCT00435942|19572293|P1|NOT COMPLETED|Overall Study||23
7951891|NCT00435942|19572292|P2|COMPLETED|Overall Study||33
7951892|NCT00435942|19572293|P1|COMPLETED|Overall Study||97
7951893|NCT00435942|19572292|P2|STARTED|Overall Study||60
7951894|NCT00435942|19572293|P1|STARTED|Overall Study||120
7951895|NCT00435929|19572302|P2|NOT COMPLETED|Overall Study||0
7951896|NCT00435929|19572303|P1|NOT COMPLETED|Overall Study||0
7951897|NCT00435929|19572302|P2|COMPLETED|Overall Study||9
7951898|NCT00435929|19572303|P1|COMPLETED|Overall Study||7
7951899|NCT00435929|19572302|P2|STARTED|Overall Study||9
7951900|NCT00435929|19572303|P1|STARTED|Overall Study||7
7951901|NCT00435825|19572333|P4|NOT COMPLETED|Overall Study||16
7951902|NCT00435825|19572334|P3|NOT COMPLETED|Overall Study||11
7951903|NCT00435825|19572335|P2|NOT COMPLETED|Overall Study||12
7951904|NCT00435825|19572336|P1|NOT COMPLETED|Overall Study||18
7951905|NCT00435825|19572333|P4|COMPLETED|Overall Study||120
7951906|NCT00435825|19572334|P3|COMPLETED|Overall Study||127
7951907|NCT00435825|19572335|P2|COMPLETED|Overall Study||124
7951908|NCT00435825|19572336|P1|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123
7951909|NCT00435825|19572333|P4|Completed 48 Weeks Treatment|Overall Study||117
7951910|NCT00435825|19572334|P3|Completed 48 Weeks Treatment|Overall Study||124
7951911|NCT00435825|19572335|P2|Completed 48 Weeks Treatment|Overall Study||0
7951912|NCT00435825|19572336|P1|Completed 48 Weeks Treatment|Overall Study||0
7951913|NCT00435825|19572333|P4|Completed 24 Weeks Treatment|Overall Study||131
7951914|NCT00435825|19572334|P3|Completed 24 Weeks Treatment|Overall Study||134
7951915|NCT00435825|19572335|P2|Completed 24 Weeks Treatment|Overall Study||126
7951916|NCT00435825|19572336|P1|Completed 24 Weeks Treatment|Overall Study||128
7951917|NCT00435825|19572333|P4|Entered Follow-up|Overall Study||133
7951918|NCT00435825|19572334|P3|Entered Follow-up|Overall Study||135
7951919|NCT00435825|19572335|P2|Entered Follow-up|Overall Study||132
7951920|NCT00435825|19572336|P1|Entered Follow-up|Overall Study||140
7951921|NCT00435825|19572333|P4|Received Study Drug|Overall Study||136
7951922|NCT00435825|19572334|P3|Received Study Drug|Overall Study||136
7951923|NCT00435825|19572335|P2|Received Study Drug|Overall Study||136
7951924|NCT00435825|19572336|P1|Received Study Drug|Overall Study||140
7951925|NCT00435825|19572333|P4|STARTED|Overall Study||136
7951926|NCT00435825|19572334|P3|STARTED|Overall Study||138
7951927|NCT00435825|19572335|P2|STARTED|Overall Study||136
7951928|NCT00435825|19572336|P1|STARTED|Overall Study||141
7951929|NCT00435812|19572392|P2|NOT COMPLETED|Overall Study||18
7951930|NCT00435812|19572393|P1|NOT COMPLETED|Overall Study||63
7951931|NCT00435812|19572392|P2|COMPLETED|Overall Study||590
7951932|NCT00435812|19572393|P1|COMPLETED|Overall Study||1757
7951933|NCT00435812|19572392|P2|STARTED|Overall Study||608
7951934|NCT00435812|19572393|P1|STARTED|Overall Study||1820
7951935|NCT00435591|19572405|P4|NOT COMPLETED|Overall Study||11
7951936|NCT00435591|19572406|P3|NOT COMPLETED|Overall Study||5
7951937|NCT00435591|19572407|P2|NOT COMPLETED|Overall Study||4
7951938|NCT00435591|19572408|P1|NOT COMPLETED|Overall Study||7
7951939|NCT00435591|19572405|P4|COMPLETED|Overall Study||19
7951940|NCT00435591|19572406|P3|COMPLETED|Overall Study||25
7951941|NCT00435591|19572407|P2|COMPLETED|Overall Study||27
7951942|NCT00435591|19572408|P1|COMPLETED|Overall Study||23
7951943|NCT00435591|19572405|P4|End of Treatment|Overall Study||23
7951944|NCT00435591|19572406|P3|End of Treatment|Overall Study||27
7951945|NCT00435591|19572407|P2|End of Treatment|Overall Study||27
7951946|NCT00435591|19572408|P1|End of Treatment|Overall Study||25
7951947|NCT00435591|19572405|P4|Full Analysis Set|Overall Study||29
7951948|NCT00435591|19572406|P3|Full Analysis Set|Overall Study||30
7951949|NCT00435591|19572407|P2|Full Analysis Set|Overall Study||29
7951950|NCT00435591|19572408|P1|Full Analysis Set|Overall Study||28
7951951|NCT00435591|19572405|P4|Safety Analysis Set|Overall Study||29
7951952|NCT00435591|19572406|P3|Safety Analysis Set|Overall Study||30
7951953|NCT00435591|19572407|P2|Safety Analysis Set|Overall Study||30
7951954|NCT00435591|19572408|P1|Safety Analysis Set|Overall Study||28
7951955|NCT00435591|19572405|P4|STARTED|Overall Study||30
7951956|NCT00435591|19572406|P3|STARTED|Overall Study||30
7951957|NCT00435591|19572407|P2|STARTED|Overall Study||31
7951958|NCT00435591|19572408|P1|STARTED|Overall Study||30
7951959|NCT00435539|19572438|P5|NOT COMPLETED|Overall Study||0
7951960|NCT00435539|19572439|P4|NOT COMPLETED|Overall Study||0
7951961|NCT00435539|19572440|P3|NOT COMPLETED|Overall Study||0
7951962|NCT00435539|19572441|P2|NOT COMPLETED|Overall Study||0
7951963|NCT00435539|19572442|P1|NOT COMPLETED|Overall Study||0
7951964|NCT00435539|19572438|P5|COMPLETED|Overall Study||12
7951965|NCT00435539|19572439|P4|COMPLETED|Overall Study||12
7951966|NCT00435539|19572440|P3|COMPLETED|Overall Study||11
7951967|NCT00435539|19572441|P2|COMPLETED|Overall Study||13
7951968|NCT00435539|19572442|P1|COMPLETED|Overall Study||12
7951969|NCT00435539|19572438|P5|STARTED|Overall Study||12
7951970|NCT00435539|19572439|P4|STARTED|Overall Study||12
7951971|NCT00435539|19572440|P3|STARTED|Overall Study||11
7951972|NCT00435539|19572441|P2|STARTED|Overall Study||13
7951973|NCT00435539|19572442|P1|STARTED|Overall Study||12
7951974|NCT00435487|19572459|P2|NOT COMPLETED|Overall Study||15
7951975|NCT00435487|19572460|P1|NOT COMPLETED|Overall Study||12
7951976|NCT00435487|19572459|P2|COMPLETED|Overall Study||71
7951977|NCT00435487|19572460|P1|COMPLETED|Overall Study||76
7951978|NCT00435487|19572459|P2|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83
7951979|NCT00435487|19572460|P1|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88
7951980|NCT00435487|19572459|P2|STARTED|Overall Study||86
7951981|NCT00435487|19572460|P1|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88
7951982|NCT00435461|19572479|P3|NOT COMPLETED|Overall Study||24
7951983|NCT00435461|19572480|P2|NOT COMPLETED|Overall Study||14
7951984|NCT00435461|19572481|P1|NOT COMPLETED|Overall Study||23
7951985|NCT00435461|19572479|P3|COMPLETED|Overall Study||287
7951986|NCT00435461|19572480|P2|COMPLETED|Overall Study||298
7951987|NCT00435461|19572481|P1|COMPLETED|Overall Study||290
7951988|NCT00435461|19572479|P3|STARTED|Overall Study||311
7951989|NCT00435461|19572480|P2|STARTED|Overall Study||312
7951990|NCT00435461|19572481|P1|STARTED|Overall Study||313
7951991|NCT00435409|19572518|P3|NOT COMPLETED|Overall Study||78
7951992|NCT00435409|19572519|P2|NOT COMPLETED|Overall Study||143
7951993|NCT00435409|19572520|P1|NOT COMPLETED|Overall Study||221
7951994|NCT00435409|19572518|P3|COMPLETED|Overall Study||0
7951995|NCT00435409|19572519|P2|COMPLETED|Overall Study||0
7951996|NCT00435409|19572520|P1|COMPLETED|Overall Study||0
7951997|NCT00435409|19572518|P3|Treated|Overall Study||78
7951998|NCT00435409|19572519|P2|Treated|Overall Study||139
7951999|NCT00435409|19572520|P1|Treated|Overall Study||217
7952000|NCT00435409|19572518|P3|STARTED|Overall Study||78
7952001|NCT00435409|19572519|P2|STARTED|Overall Study||143
7952002|NCT00435409|19572520|P1|STARTED|Overall Study||221
7952003|NCT00435370|19572542|P2|NOT COMPLETED|Overall Study||20
7952004|NCT00435370|19572543|P1|NOT COMPLETED|Overall Study||22
7952005|NCT00435370|19572542|P2|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69
7952006|NCT00435370|19572543|P1|COMPLETED|Overall Study||68
7952007|NCT00435370|19572542|P2|STARTED|Overall Study|The recruitment restarted in August, 2010.|89
7952008|NCT00435370|19572543|P1|STARTED|Overall Study||90
7952009|NCT00435188|19572551|P2|NOT COMPLETED|Overall Study||23
7952010|NCT00435188|19572552|P1|NOT COMPLETED|Overall Study||22
7952011|NCT00435188|19572551|P2|COMPLETED|Overall Study||176
7952012|NCT00435188|19572552|P1|COMPLETED|Overall Study||177
7952013|NCT00435188|19572551|P2|STARTED|Overall Study||199
7952014|NCT00435188|19572552|P1|STARTED|Overall Study||199
7952015|NCT00435162|19572595|P6|NOT COMPLETED|Period 2 (2 Weeks)||0
7952016|NCT00435162|19572596|P5|NOT COMPLETED|Period 2 (2 Weeks)||0
7952017|NCT00435162|19572597|P4|NOT COMPLETED|Period 2 (2 Weeks)||0
7952018|NCT00435162|19572598|P3|NOT COMPLETED|Period 2 (2 Weeks)||0
7952019|NCT00435162|19572599|P2|NOT COMPLETED|Period 2 (2 Weeks)||1
7952020|NCT00435162|19572600|P1|NOT COMPLETED|Period 2 (2 Weeks)||0
7952021|NCT00435162|19572595|P6|COMPLETED|Period 2 (2 Weeks)||15
7952022|NCT00435162|19572596|P5|COMPLETED|Period 2 (2 Weeks)||15
7952023|NCT00435162|19572597|P4|COMPLETED|Period 2 (2 Weeks)||8
7952024|NCT00435162|19572598|P3|COMPLETED|Period 2 (2 Weeks)||6
7952025|NCT00435162|19572599|P2|COMPLETED|Period 2 (2 Weeks)||14
7952026|NCT00435162|19572600|P1|COMPLETED|Period 2 (2 Weeks)||15
7952027|NCT00435162|19572595|P6|STARTED|Period 2 (2 Weeks)||15
7952028|NCT00435162|19572596|P5|STARTED|Period 2 (2 Weeks)||15
7952029|NCT00435162|19572597|P4|STARTED|Period 2 (2 Weeks)||8
7952030|NCT00435162|19572598|P3|STARTED|Period 2 (2 Weeks)||6
7952031|NCT00435162|19572599|P2|STARTED|Period 2 (2 Weeks)||15
7952032|NCT00435162|19572600|P1|STARTED|Period 2 (2 Weeks)||15
7952033|NCT00435162|19572595|P6|NOT COMPLETED|Period 1 (6 Weeks)||0
7952034|NCT00435162|19572596|P5|NOT COMPLETED|Period 1 (6 Weeks)||0
7952035|NCT00435162|19572597|P4|NOT COMPLETED|Period 1 (6 Weeks)||0
7952036|NCT00435162|19572598|P3|NOT COMPLETED|Period 1 (6 Weeks)||0
7952037|NCT00435162|19572599|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
7952038|NCT00435162|19572600|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
7952039|NCT00435162|19572595|P6|COMPLETED|Period 1 (6 Weeks)||15
7952040|NCT00435162|19572596|P5|COMPLETED|Period 1 (6 Weeks)||15
7952041|NCT00435162|19572597|P4|COMPLETED|Period 1 (6 Weeks)||8
7952042|NCT00435162|19572598|P3|COMPLETED|Period 1 (6 Weeks)||6
7952043|NCT00435162|19572599|P2|COMPLETED|Period 1 (6 Weeks)||15
7952044|NCT00435162|19572600|P1|COMPLETED|Period 1 (6 Weeks)||15
7952045|NCT00435162|19572595|P6|STARTED|Period 1 (6 Weeks)||15
7952046|NCT00435162|19572596|P5|STARTED|Period 1 (6 Weeks)||15
7952047|NCT00435162|19572597|P4|STARTED|Period 1 (6 Weeks)||8
7952048|NCT00435162|19572598|P3|STARTED|Period 1 (6 Weeks)||6
7952049|NCT00435162|19572599|P2|STARTED|Period 1 (6 Weeks)||15
7952050|NCT00435162|19572600|P1|STARTED|Period 1 (6 Weeks)||15
7952051|NCT00435045|19572620|P2|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2
7952052|NCT00435045|19572621|P1|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5
7952053|NCT00435045|19572620|P2|COMPLETED|Weeks 13-16 / 40mg Dose Level||111
7952054|NCT00435045|19572621|P1|COMPLETED|Weeks 13-16 / 40mg Dose Level||108
7952055|NCT00435045|19572620|P2|STARTED|Weeks 13-16 / 40mg Dose Level||113
7952056|NCT00435045|19572621|P1|STARTED|Weeks 13-16 / 40mg Dose Level||113
7952057|NCT00435045|19572620|P2|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
7952058|NCT00435045|19572621|P1|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
7952059|NCT00435045|19572620|P2|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
7952060|NCT00435045|19572621|P1|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
7952061|NCT00435045|19572620|P2|STARTED|Weeks 9-12 / 20mg Dose Level||118
7952062|NCT00435045|19572621|P1|STARTED|Weeks 9-12 / 20mg Dose Level||118
7952063|NCT00435045|19572620|P2|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4
7952064|NCT00435045|19572621|P1|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5
7952065|NCT00435045|19572620|P2|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
7952066|NCT00435045|19572621|P1|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
7952067|NCT00435045|19572620|P2|STARTED|Weeks 1-8 / 10 mg Dose Level||122
7952068|NCT00435045|19572621|P1|STARTED|Weeks 1-8 / 10 mg Dose Level||123
7952069|NCT00435019|19572677|P2|NOT COMPLETED|Overall Study||10
7952070|NCT00435019|19572678|P1|NOT COMPLETED|Overall Study||13
7952071|NCT00435019|19572677|P2|COMPLETED|Overall Study||161
7952072|NCT00435019|19572678|P1|COMPLETED|Overall Study||164
7952073|NCT00435019|19572677|P2|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170
7952074|NCT00435019|19572678|P1|Exposed to Study Drug|Overall Study||177
7952075|NCT00435019|19572677|P2|STARTED|Overall Study|Randomised|171
7952076|NCT00435019|19572678|P1|STARTED|Overall Study|Randomised|177
7952077|NCT00434993|19572690|P2|NOT COMPLETED|Overall Study||0
7952078|NCT00434993|19572691|P1|NOT COMPLETED|Overall Study||0
7952079|NCT00434993|19572690|P2|COMPLETED|Overall Study||130
7952080|NCT00434993|19572691|P1|COMPLETED|Overall Study||152
7952081|NCT00434993|19572690|P2|STARTED|Overall Study||130
7952082|NCT00434993|19572691|P1|STARTED|Overall Study||152
7952083|NCT00434967|19572719|P4|NOT COMPLETED|Overall Study||14
7952084|NCT00434967|19572720|P3|NOT COMPLETED|Overall Study||9
7952085|NCT00434967|19572721|P2|NOT COMPLETED|Overall Study||8
7952086|NCT00434967|19572722|P1|NOT COMPLETED|Overall Study||7
7952087|NCT00434967|19572719|P4|COMPLETED|Overall Study||478
7952088|NCT00434967|19572720|P3|COMPLETED|Overall Study||461
7952089|NCT00434967|19572721|P2|COMPLETED|Overall Study||457
7952090|NCT00434967|19572722|P1|COMPLETED|Overall Study||90
7952091|NCT00434967|19572719|P4|STARTED|Overall Study||492
7952092|NCT00434967|19572720|P3|STARTED|Overall Study||470
7952093|NCT00434967|19572721|P2|STARTED|Overall Study||465
7952094|NCT00434967|19572722|P1|STARTED|Overall Study||97
7952095|NCT00434954|19572742|P2|NOT COMPLETED|Overall Study||71
7952096|NCT00434954|19572743|P1|NOT COMPLETED|Overall Study||82
7952097|NCT00434954|19572742|P2|COMPLETED|Overall Study||175
7952098|NCT00434954|19572743|P1|COMPLETED|Overall Study||166
7952099|NCT00434954|19572742|P2|Completed - Previous Treatment MET + SU|Overall Study||38
7952100|NCT00434954|19572743|P1|Completed - Previous Treatment MET + SU|Overall Study||31
7952101|NCT00434954|19572742|P2|Completed - Previous Treatment MET Only|Overall Study||137
7952102|NCT00434954|19572743|P1|Completed - Previous Treatment MET Only|Overall Study||135
7952103|NCT00434954|19572742|P2|FAS - Previous Treatment MET + SU|Overall Study||60
7952104|NCT00434954|19572743|P1|FAS - Previous Treatment MET + SU|Overall Study||66
7952105|NCT00434954|19572742|P2|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173
7952106|NCT00434954|19572743|P1|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181
7952107|NCT00434954|19572742|P2|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233
7952108|NCT00434954|19572743|P1|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247
7952109|NCT00434954|19572742|P2|Started - Previous Treatment MET + SU|Overall Study||65
7952110|NCT00434954|19572743|P1|Started - Previous Treatment MET + SU|Overall Study||66
7952111|NCT00434954|19572742|P2|Started - Previous Treatment MET Only|Overall Study||181
7952112|NCT00434954|19572743|P1|Started - Previous Treatment MET Only|Overall Study||182
7952113|NCT00434954|19572742|P2|STARTED|Overall Study||246
7952114|NCT00434954|19572743|P1|STARTED|Overall Study||248
7952115|NCT00434876|19572773|P2|NOT COMPLETED|Overall Study||1
7952116|NCT00434876|19572774|P1|NOT COMPLETED|Overall Study||1
7952117|NCT00434876|19572773|P2|COMPLETED|Overall Study||10
7952118|NCT00434876|19572774|P1|COMPLETED|Overall Study||10
7952119|NCT00434876|19572773|P2|STARTED|Overall Study||11
7952120|NCT00434876|19572774|P1|STARTED|Overall Study||11
7952121|NCT00434759|19572788|P2|NOT COMPLETED|Overall Study||5
7952122|NCT00434759|19572789|P1|NOT COMPLETED|Overall Study||24
7952123|NCT00434759|19572788|P2|COMPLETED|Overall Study||38
7952124|NCT00434759|19572789|P1|COMPLETED|Overall Study||22
7952125|NCT00434759|19572788|P2|STARTED|Overall Study||43
7952126|NCT00434759|19572789|P1|STARTED|Overall Study||46
7952127|NCT00434642|19572805|P2|NOT COMPLETED|Open-label Treatment Phase||11
7952128|NCT00434642|19572806|P1|NOT COMPLETED|Open-label Treatment Phase||0
7952129|NCT00434642|19572805|P2|COMPLETED|Open-label Treatment Phase||1
7952130|NCT00434642|19572806|P1|COMPLETED|Open-label Treatment Phase||0
7952131|NCT00434642|19572805|P2|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12
7952132|NCT00434642|19572806|P1|STARTED|Open-label Treatment Phase||0
7952133|NCT00434642|19572805|P2|NOT COMPLETED|Blinded Treatment Phase||229
7952134|NCT00434642|19572806|P1|NOT COMPLETED|Blinded Treatment Phase||242
7952135|NCT00434642|19572805|P2|COMPLETED|Blinded Treatment Phase||13
7952136|NCT00434642|19572806|P1|COMPLETED|Blinded Treatment Phase||0
7952137|NCT00434642|19572805|P2|STARTED|Blinded Treatment Phase||242
7952138|NCT00434642|19572806|P1|STARTED|Blinded Treatment Phase||242
7952139|NCT00434590|19572824|P2|NOT COMPLETED|Overall Study||5
7952140|NCT00434590|19572825|P1|NOT COMPLETED|Overall Study||5
7952141|NCT00434590|19572824|P2|COMPLETED|Overall Study||0
7952142|NCT00434590|19572825|P1|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0
7952143|NCT00434590|19572824|P2|STARTED|Overall Study||5
7952144|NCT00434590|19572825|P1|STARTED|Overall Study||5
7952145|NCT00434577|19572836|P5|NOT COMPLETED|Month 36||0
7952146|NCT00434577|19572837|P4|NOT COMPLETED|Month 36||0
7952147|NCT00434577|19572838|P3|NOT COMPLETED|Month 36||0
7952148|NCT00434577|19572839|P2|NOT COMPLETED|Month 36||0
7952149|NCT00434577|19572840|P1|NOT COMPLETED|Month 36||0
7952150|NCT00434577|19572836|P5|COMPLETED|Month 36||47
7952151|NCT00434577|19572837|P4|COMPLETED|Month 36||155
7952152|NCT00434577|19572838|P3|COMPLETED|Month 36||150
7952153|NCT00434577|19572839|P2|COMPLETED|Month 36||147
7952154|NCT00434577|19572840|P1|COMPLETED|Month 36||147
7952155|NCT00434577|19572836|P5|STARTED|Month 36||47
7952156|NCT00434577|19572837|P4|STARTED|Month 36||155
7952157|NCT00434577|19572838|P3|STARTED|Month 36||150
7952158|NCT00434577|19572839|P2|STARTED|Month 36||147
7952159|NCT00434577|19572840|P1|STARTED|Month 36||147
7952160|NCT00434577|19572836|P5|NOT COMPLETED|Month 24||0
7952161|NCT00434577|19572837|P4|NOT COMPLETED|Month 24||0
7952162|NCT00434577|19572838|P3|NOT COMPLETED|Month 24||0
7952163|NCT00434577|19572839|P2|NOT COMPLETED|Month 24||0
7952164|NCT00434577|19572840|P1|NOT COMPLETED|Month 24||0
7952165|NCT00434577|19572836|P5|COMPLETED|Month 24||49
7952166|NCT00434577|19572837|P4|COMPLETED|Month 24||157
7952167|NCT00434577|19572838|P3|COMPLETED|Month 24||154
7952168|NCT00434577|19572839|P2|COMPLETED|Month 24||155
7952169|NCT00434577|19572840|P1|COMPLETED|Month 24||150
7952170|NCT00434577|19572836|P5|STARTED|Month 24||49
7952171|NCT00434577|19572837|P4|STARTED|Month 24||157
7952172|NCT00434577|19572838|P3|STARTED|Month 24||154
7952173|NCT00434577|19572839|P2|STARTED|Month 24||155
7952174|NCT00434577|19572840|P1|STARTED|Month 24||150
7952175|NCT00434577|19572836|P5|NOT COMPLETED|Month 12||0
7952176|NCT00434577|19572837|P4|NOT COMPLETED|Month 12||0
7952177|NCT00434577|19572838|P3|NOT COMPLETED|Month 12||0
7952178|NCT00434577|19572839|P2|NOT COMPLETED|Month 12||0
7952179|NCT00434577|19572840|P1|NOT COMPLETED|Month 12||0
7952180|NCT00434577|19572836|P5|COMPLETED|Month 12||50
7952181|NCT00434577|19572837|P4|COMPLETED|Month 12||161
7952182|NCT00434577|19572838|P3|COMPLETED|Month 12||159
7952183|NCT00434577|19572839|P2|COMPLETED|Month 12||159
7952184|NCT00434577|19572840|P1|COMPLETED|Month 12||156
7952185|NCT00434577|19572836|P5|STARTED|Month 12||50
7952186|NCT00434577|19572837|P4|STARTED|Month 12||161
7952187|NCT00434577|19572838|P3|STARTED|Month 12||159
7952188|NCT00434577|19572839|P2|STARTED|Month 12||159
7952189|NCT00434577|19572840|P1|STARTED|Month 12||156
7952190|NCT00434577|19572836|P5|NOT COMPLETED|Months 0-3||3
7952191|NCT00434577|19572837|P4|NOT COMPLETED|Months 0-3||1
7952192|NCT00434577|19572838|P3|NOT COMPLETED|Months 0-3||4
7952193|NCT00434577|19572839|P2|NOT COMPLETED|Months 0-3||2
7952194|NCT00434577|19572840|P1|NOT COMPLETED|Months 0-3||3
7952195|NCT00434577|19572836|P5|COMPLETED|Months 0-3||51
7952196|NCT00434577|19572837|P4|COMPLETED|Months 0-3||164
7952197|NCT00434577|19572838|P3|COMPLETED|Months 0-3||161
7952198|NCT00434577|19572839|P2|COMPLETED|Months 0-3||164
7952199|NCT00434577|19572840|P1|COMPLETED|Months 0-3||161
7952200|NCT00434577|19572836|P5|STARTED|Months 0-3||54
7952201|NCT00434577|19572837|P4|STARTED|Months 0-3||165
7952202|NCT00434577|19572838|P3|STARTED|Months 0-3||165
7952203|NCT00434577|19572839|P2|STARTED|Months 0-3||166
7952204|NCT00434577|19572840|P1|STARTED|Months 0-3||164
7952205|NCT00434512|19573018|P6|NOT COMPLETED|Overall Study||1
7952206|NCT00434512|19573019|P5|NOT COMPLETED|Overall Study||1
7952207|NCT00434512|19573020|P4|NOT COMPLETED|Overall Study||1
7952208|NCT00434512|19573021|P3|NOT COMPLETED|Overall Study||0
7952209|NCT00434512|19573022|P2|NOT COMPLETED|Overall Study||1
7952210|NCT00434512|19573023|P1|NOT COMPLETED|Overall Study||0
7952211|NCT00434512|19573018|P6|COMPLETED|Overall Study||49
7952212|NCT00434512|19573019|P5|COMPLETED|Overall Study||49
7952213|NCT00434512|19573020|P4|COMPLETED|Overall Study||49
7952214|NCT00434512|19573021|P3|COMPLETED|Overall Study||10
7952215|NCT00434512|19573022|P2|COMPLETED|Overall Study||9
7952216|NCT00434512|19573023|P1|COMPLETED|Overall Study||10
7952217|NCT00434512|19573018|P6|STARTED|Overall Study||50
7952218|NCT00434512|19573019|P5|STARTED|Overall Study||50
7952219|NCT00434512|19573020|P4|STARTED|Overall Study||50
7952220|NCT00434512|19573021|P3|STARTED|Overall Study||10
7952221|NCT00434512|19573022|P2|STARTED|Overall Study||10
7952222|NCT00434512|19573023|P1|STARTED|Overall Study||10
7952223|NCT00434434|19573124|P3|NOT COMPLETED|Overall Study||1
7952224|NCT00434434|19573125|P2|NOT COMPLETED|Overall Study||0
7952225|NCT00434434|19573126|P1|NOT COMPLETED|Overall Study||2
7952226|NCT00434434|19573124|P3|COMPLETED|Overall Study||13
7952227|NCT00434434|19573125|P2|COMPLETED|Overall Study||24
7952228|NCT00434434|19573126|P1|COMPLETED|Overall Study||21
7952229|NCT00434434|19573124|P3|STARTED|Overall Study||14
7952230|NCT00434434|19573125|P2|STARTED|Overall Study||24
7952231|NCT00434434|19573126|P1|STARTED|Overall Study||23
7952232|NCT00434421|19573137|P1|NOT COMPLETED|Overall Study||2
7952233|NCT00434421|19573137|P1|COMPLETED|Overall Study||26
7952234|NCT00434421|19573137|P1|STARTED|Overall Study||28
7952235|NCT00434356|19573143|P2|NOT COMPLETED|Overall Study||23
7952236|NCT00434356|19573144|P1|NOT COMPLETED|Overall Study||23
7952237|NCT00434356|19573143|P2|COMPLETED|Overall Study||0
7952238|NCT00434356|19573144|P1|COMPLETED|Overall Study||0
7952239|NCT00434356|19573143|P2|STARTED|Overall Study||23
7952240|NCT00434356|19573144|P1|STARTED|Overall Study||23
7952241|NCT00434330|19573165|P6|NOT COMPLETED|Overall Study||1
7952242|NCT00434330|19573166|P5|NOT COMPLETED|Overall Study||1
7952243|NCT00434330|19573167|P4|NOT COMPLETED|Overall Study||2
7952244|NCT00434330|19573168|P3|NOT COMPLETED|Overall Study||3
7952245|NCT00434330|19573169|P2|NOT COMPLETED|Overall Study||0
7952246|NCT00434330|19573170|P1|NOT COMPLETED|Overall Study||1
7952247|NCT00434330|19573165|P6|COMPLETED|Overall Study||14
7952248|NCT00434330|19573166|P5|COMPLETED|Overall Study||14
7952249|NCT00434330|19573167|P4|COMPLETED|Overall Study||13
7952250|NCT00434330|19573168|P3|COMPLETED|Overall Study||13
7952251|NCT00434330|19573169|P2|COMPLETED|Overall Study||15
7952252|NCT00434330|19573170|P1|COMPLETED|Overall Study||14
7952253|NCT00434330|19573165|P6|STARTED|Overall Study||15
7952254|NCT00434330|19573166|P5|STARTED|Overall Study||15
7952255|NCT00434330|19573167|P4|STARTED|Overall Study||15
7952256|NCT00434330|19573168|P3|STARTED|Overall Study||16
7952257|NCT00434330|19573169|P2|STARTED|Overall Study||15
7952258|NCT00434330|19573170|P1|STARTED|Overall Study||15
7952259|NCT00434304|19573202|P1|NOT COMPLETED|Overall Study||20
7952260|NCT00434304|19573202|P1|COMPLETED|Overall Study||42
7952261|NCT00434304|19573202|P1|STARTED|Overall Study||62
7952262|NCT00434278|19573240|P2|NOT COMPLETED|Overall Study||0
7952263|NCT00434278|19573241|P1|NOT COMPLETED|Overall Study||2
7952264|NCT00434278|19573240|P2|COMPLETED|Overall Study||13
7952265|NCT00434278|19573241|P1|COMPLETED|Overall Study||12
7952266|NCT00434278|19573240|P2|STARTED|Overall Study||13
7952267|NCT00434278|19573241|P1|STARTED|Overall Study||14
7952268|NCT00434252|19573251|P2|NOT COMPLETED|Overall Study||131
7952269|NCT00434252|19573252|P1|NOT COMPLETED|Overall Study||64
7952270|NCT00434252|19573251|P2|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12
7952271|NCT00434252|19573252|P1|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7
7952272|NCT00434252|19573251|P2|Treated|Overall Study||143
7952273|NCT00434252|19573252|P1|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69
7952274|NCT00434252|19573251|P2|STARTED|Overall Study||143
7952275|NCT00434252|19573252|P1|STARTED|Overall Study||71
7952276|NCT00434226|19573274|P2|NOT COMPLETED|Overall Study||26
7952277|NCT00434226|19573275|P1|NOT COMPLETED|Overall Study||30
7952278|NCT00434226|19573274|P2|COMPLETED|Overall Study||0
7952279|NCT00434226|19573275|P1|COMPLETED|Overall Study||0
7952280|NCT00434226|19573274|P2|STARTED|Overall Study||26
7952281|NCT00434226|19573275|P1|STARTED|Overall Study||30
7952282|NCT00434213|19573286|P1|NOT COMPLETED|Overall Study||49
7952283|NCT00434213|19573286|P1|COMPLETED|Overall Study||260
7952284|NCT00434213|19573286|P1|STARTED|Overall Study||309
7952285|NCT00434161|19573294|P3|NOT COMPLETED|Overall Study||11
7952286|NCT00434161|19573295|P2|NOT COMPLETED|Overall Study||3
7952287|NCT00434161|19573296|P1|NOT COMPLETED|Overall Study||10
7952288|NCT00434161|19573294|P3|COMPLETED|Overall Study||104
7952289|NCT00434161|19573295|P2|COMPLETED|Overall Study||54
7952290|NCT00434161|19573296|P1|COMPLETED|Overall Study||99
7952291|NCT00434161|19573294|P3|STARTED|Overall Study||115
7952292|NCT00434161|19573295|P2|STARTED|Overall Study||57
7952293|NCT00434161|19573296|P1|STARTED|Overall Study||109
7952294|NCT00434148|19573340|P2|NOT COMPLETED|Overall Study||73
7952295|NCT00434148|19573341|P1|NOT COMPLETED|Overall Study||69
7952296|NCT00434148|19573340|P2|COMPLETED|Overall Study||7
7952297|NCT00434148|19573341|P1|COMPLETED|Overall Study||13
7952298|NCT00434148|19573340|P2|Completed Month 12; Entered Extension|Overall Study||32
7952299|NCT00434148|19573341|P1|Completed Month 12; Entered Extension|Overall Study||26
7952300|NCT00434148|19573340|P2|Completed m. 12; Did Not Enter Extension|Overall Study||7
7952301|NCT00434148|19573341|P1|Completed m. 12; Did Not Enter Extension|Overall Study||13
7952302|NCT00434148|19573340|P2|Completed Month 12|Overall Study||39
7952303|NCT00434148|19573341|P1|Completed Month 12|Overall Study||39
7952304|NCT00434148|19573340|P2|STARTED|Overall Study||80
7952305|NCT00434148|19573341|P1|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82
7952306|NCT00434122|19573377|P2|NOT COMPLETED|Overall Study||7
7952307|NCT00434122|19573378|P1|NOT COMPLETED|Overall Study||6
7952308|NCT00434122|19573377|P2|COMPLETED|Overall Study||36
7952309|NCT00434122|19573378|P1|COMPLETED|Overall Study||36
7952310|NCT00434122|19573377|P2|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
7952311|NCT00434122|19573378|P1|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
7952312|NCT00434122|19573377|P2|STARTED|Overall Study|Randomised|43
7952313|NCT00434122|19573378|P1|STARTED|Overall Study|Randomised|42
7952314|NCT00434109|19573387|P1|NOT COMPLETED|Overall Study||18
7952315|NCT00434109|19573387|P1|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21
7952316|NCT00434109|19573387|P1|STARTED|Overall Study||39
7952317|NCT00434057|19573396|P1|NOT COMPLETED|Overall Study||1
7952318|NCT00434057|19573396|P1|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382
7952319|NCT00434057|19573396|P1|STARTED|Overall Study||1383
7952320|NCT00434018|19573402|P2|NOT COMPLETED|Overall Study||12
7952321|NCT00434018|19573403|P1|NOT COMPLETED|Overall Study||17
7952322|NCT00434018|19573402|P2|COMPLETED|Overall Study||57
7952323|NCT00434018|19573403|P1|COMPLETED|Overall Study||52
7952324|NCT00434018|19573402|P2|STARTED|Overall Study||69
7952325|NCT00434018|19573403|P1|STARTED|Overall Study||69
7952326|NCT00433992|19573421|P2|NOT COMPLETED|Overall Study||8
7952327|NCT00433992|19573422|P1|NOT COMPLETED|Overall Study||9
7952328|NCT00433992|19573421|P2|COMPLETED|Overall Study||20
7952329|NCT00433992|19573422|P1|COMPLETED|Overall Study||19
7952330|NCT00433992|19573421|P2|STARTED|Overall Study||28
7952331|NCT00433992|19573422|P1|STARTED|Overall Study||28
7952332|NCT00433966|19573434|P4|NOT COMPLETED|Stent Intervention/Randomization||62
7952333|NCT00433966|19573435|P3|NOT COMPLETED|Stent Intervention/Randomization||154
7952334|NCT00433966|19573436|P2|NOT COMPLETED|Stent Intervention/Randomization||0
7952335|NCT00433966|19573437|P1|NOT COMPLETED|Stent Intervention/Randomization||0
7952336|NCT00433966|19573434|P4|COMPLETED|Stent Intervention/Randomization||687
7952337|NCT00433966|19573435|P3|COMPLETED|Stent Intervention/Randomization||2103
7952338|NCT00433966|19573436|P2|COMPLETED|Stent Intervention/Randomization||0
7952339|NCT00433966|19573437|P1|COMPLETED|Stent Intervention/Randomization||0
7952340|NCT00433966|19573434|P4|3-Year Follow-up|Stent Intervention/Randomization||687
7952341|NCT00433966|19573435|P3|3-Year Follow-up|Stent Intervention/Randomization||2103
7952342|NCT00433966|19573436|P2|3-Year Follow-up|Stent Intervention/Randomization||0
7952343|NCT00433966|19573437|P1|3-Year Follow-up|Stent Intervention/Randomization||0
7952344|NCT00433966|19573434|P4|1-Year Follow-up|Stent Intervention/Randomization||715
7952345|NCT00433966|19573435|P3|1-Year Follow-up|Stent Intervention/Randomization||2186
7952346|NCT00433966|19573436|P2|1-Year Follow-up|Stent Intervention/Randomization||0
7952347|NCT00433966|19573437|P1|1-Year Follow-up|Stent Intervention/Randomization||0
7952348|NCT00433966|19573434|P4|STARTED|Stent Intervention/Randomization||749
7952349|NCT00433966|19573435|P3|STARTED|Stent Intervention/Randomization||2257
7952350|NCT00433966|19573436|P2|STARTED|Stent Intervention/Randomization||0
7952351|NCT00433966|19573437|P1|STARTED|Stent Intervention/Randomization||0
7952352|NCT00433966|19573434|P4|NOT COMPLETED|Pharmacology Intervention/Randomization||0
7952353|NCT00433966|19573435|P3|NOT COMPLETED|Pharmacology Intervention/Randomization||0
7952354|NCT00433966|19573436|P2|NOT COMPLETED|Pharmacology Intervention/Randomization||174
7952355|NCT00433966|19573437|P1|NOT COMPLETED|Pharmacology Intervention/Randomization||166
7952356|NCT00433966|19573434|P4|COMPLETED|Pharmacology Intervention/Randomization||0
7952357|NCT00433966|19573435|P3|COMPLETED|Pharmacology Intervention/Randomization||0
7952358|NCT00433966|19573436|P2|COMPLETED|Pharmacology Intervention/Randomization||1628
7952359|NCT00433966|19573437|P1|COMPLETED|Pharmacology Intervention/Randomization||1634
7952360|NCT00433966|19573434|P4|3-Year Follow-up|Pharmacology Intervention/Randomization||0
7952361|NCT00433966|19573435|P3|3-Year Follow-up|Pharmacology Intervention/Randomization||0
7952362|NCT00433966|19573436|P2|3-Year Follow-up|Pharmacology Intervention/Randomization||1628
7952363|NCT00433966|19573437|P1|3-Year Follow-up|Pharmacology Intervention/Randomization||1634
7952364|NCT00433966|19573434|P4|1-Year Follow-up|Pharmacology Intervention/Randomization||0
7952365|NCT00433966|19573435|P3|1-Year Follow-up|Pharmacology Intervention/Randomization||0
7952366|NCT00433966|19573436|P2|1-Year Follow-up|Pharmacology Intervention/Randomization||1702
7952367|NCT00433966|19573437|P1|1-Year Follow-up|Pharmacology Intervention/Randomization||1696
7952368|NCT00433966|19573434|P4|30-Day Follow-up|Pharmacology Intervention/Randomization||0
7952369|NCT00433966|19573435|P3|30-Day Follow-up|Pharmacology Intervention/Randomization||0
7952370|NCT00433966|19573436|P2|30-Day Follow-up|Pharmacology Intervention/Randomization||1791
7952371|NCT00433966|19573437|P1|30-Day Follow-up|Pharmacology Intervention/Randomization||1787
7952372|NCT00433966|19573434|P4|STARTED|Pharmacology Intervention/Randomization||0
7952373|NCT00433966|19573435|P3|STARTED|Pharmacology Intervention/Randomization||0
7952374|NCT00433966|19573436|P2|STARTED|Pharmacology Intervention/Randomization||1802
7952375|NCT00433966|19573437|P1|STARTED|Pharmacology Intervention/Randomization||1800
7952376|NCT00433914|19573459|P2|NOT COMPLETED|Overall Study||3
7952377|NCT00433914|19573460|P1|NOT COMPLETED|Overall Study||0
7952378|NCT00433914|19573459|P2|COMPLETED|Overall Study||27
7952379|NCT00433914|19573460|P1|COMPLETED|Overall Study||30
7952380|NCT00433914|19573459|P2|STARTED|Overall Study||30
7952381|NCT00433914|19573460|P1|STARTED|Overall Study||30
7952382|NCT00433836|19573480|P2|NOT COMPLETED|Overall Study||6
7952383|NCT00433836|19573481|P1|NOT COMPLETED|Overall Study||13
7952384|NCT00433836|19573480|P2|COMPLETED|Overall Study||143
7952385|NCT00433836|19573481|P1|COMPLETED|Overall Study||138
7952386|NCT00433836|19573480|P2|STARTED|Overall Study||149
7952387|NCT00433836|19573481|P1|STARTED|Overall Study||151
7952388|NCT00433771|19573493|P1|NOT COMPLETED|Overall Study||19
7952389|NCT00433771|19573493|P1|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55
7952390|NCT00433771|19573493|P1|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74
7952391|NCT00433745|19573509|P1|NOT COMPLETED|Overall Study||0
7952392|NCT00433745|19573509|P1|COMPLETED|Overall Study||4
7952393|NCT00433745|19573509|P1|STARTED|Overall Study||4
7952394|NCT00433654|19573516|P2|NOT COMPLETED|Overall Study||5
7952395|NCT00433654|19573517|P1|NOT COMPLETED|Overall Study||15
7952396|NCT00433654|19573516|P2|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201
7952397|NCT00433654|19573517|P1|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243
7952398|NCT00433654|19573516|P2|STARTED|Overall Study||206
7952399|NCT00433654|19573517|P1|STARTED|Overall Study||258
7952400|NCT00433550|19573551|P3|NOT COMPLETED|Overall Study||0
7952401|NCT00433550|19573552|P2|NOT COMPLETED|Overall Study||0
7952402|NCT00433550|19573553|P1|NOT COMPLETED|Overall Study||0
7952403|NCT00433550|19573551|P3|COMPLETED|Overall Study||6
7952404|NCT00433550|19573552|P2|COMPLETED|Overall Study||10
7952405|NCT00433550|19573553|P1|COMPLETED|Overall Study||17
7952406|NCT00433550|19573551|P3|STARTED|Overall Study||6
7952407|NCT00433550|19573552|P2|STARTED|Overall Study||10
7952408|NCT00433550|19573553|P1|STARTED|Overall Study||17
7952409|NCT00433537|19573563|P3|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
7952410|NCT00433537|19573564|P2|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
7952411|NCT00433537|19573565|P1|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16
7952412|NCT00433537|19573563|P3|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
7952413|NCT00433537|19573564|P2|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22
7952414|NCT00433537|19573565|P1|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29
7952415|NCT00433537|19573563|P3|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0
7952416|NCT00433537|19573564|P2|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22
7952417|NCT00433537|19573565|P1|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44
7952418|NCT00433537|19573563|P3|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0
7952419|NCT00433537|19573564|P2|STARTED|Step 2 - Maintenance Rituximab or ASCT||22
7952420|NCT00433537|19573565|P1|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45
7952421|NCT00433537|19573563|P3|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9
7952422|NCT00433537|19573564|P2|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0
7952423|NCT00433537|19573565|P1|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1
7952424|NCT00433537|19573563|P3|COMPLETED|Step 1 - VcR-CVAD Induction||1
7952425|NCT00433537|19573564|P2|COMPLETED|Step 1 - VcR-CVAD Induction||22
7952426|NCT00433537|19573565|P1|COMPLETED|Step 1 - VcR-CVAD Induction||44
7952427|NCT00433537|19573563|P3|Eligible and Treated|Step 1 - VcR-CVAD Induction||9
7952428|NCT00433537|19573564|P2|Eligible and Treated|Step 1 - VcR-CVAD Induction||22
7952429|NCT00433537|19573565|P1|Eligible and Treated|Step 1 - VcR-CVAD Induction||44
7952430|NCT00433537|19573563|P3|STARTED|Step 1 - VcR-CVAD Induction||10
7952431|NCT00433537|19573564|P2|STARTED|Step 1 - VcR-CVAD Induction||22
7952432|NCT00433537|19573565|P1|STARTED|Step 1 - VcR-CVAD Induction||45
7952433|NCT00433511|19573577|P3|NOT COMPLETED|Step 2 (Arm D)||491
7952434|NCT00433511|19573578|P2|NOT COMPLETED|Step 2 (Arm D)||0
7952435|NCT00433511|19573579|P1|NOT COMPLETED|Step 2 (Arm D)||0
7952436|NCT00433511|19573577|P3|COMPLETED|Step 2 (Arm D)||825
7952437|NCT00433511|19573578|P2|COMPLETED|Step 2 (Arm D)||0
7952438|NCT00433511|19573579|P1|COMPLETED|Step 2 (Arm D)||0
7952439|NCT00433511|19573577|P3|Patients Who Received Treatment|Step 2 (Arm D)||1168
7952440|NCT00433511|19573578|P2|Patients Who Received Treatment|Step 2 (Arm D)||0
7952441|NCT00433511|19573579|P1|Patients Who Received Treatment|Step 2 (Arm D)||0
7952442|NCT00433511|19573577|P3|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|1316
7952443|NCT00433511|19573578|P2|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
7952444|NCT00433511|19573579|P1|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
7952445|NCT00433511|19573577|P3|NOT COMPLETED|Step 1||390
7952446|NCT00433511|19573578|P2|NOT COMPLETED|Step 1||385
7952447|NCT00433511|19573579|P1|NOT COMPLETED|Step 1||136
7952448|NCT00433511|19573577|P3|COMPLETED|Step 1||1618
7952449|NCT00433511|19573578|P2|COMPLETED|Step 1||1601
7952450|NCT00433511|19573579|P1|COMPLETED|Step 1||864
7952451|NCT00433511|19573577|P3|Patients in Genetic Ancestry Analysis|Step 1||1158
7952452|NCT00433511|19573578|P2|Patients in Genetic Ancestry Analysis|Step 1||1126
7952453|NCT00433511|19573579|P1|Patients in Genetic Ancestry Analysis|Step 1||575
7952454|NCT00433511|19573577|P3|Patients Who Received Treatment|Step 1||1942
7952455|NCT00433511|19573578|P2|Patients Who Received Treatment|Step 1||1922
7952456|NCT00433511|19573579|P1|Patients Who Received Treatment|Step 1||972
7952457|NCT00433511|19573577|P3|STARTED|Step 1||2008
7952458|NCT00433511|19573578|P2|STARTED|Step 1||1986
7952459|NCT00433511|19573579|P1|STARTED|Step 1||1000
7952460|NCT00433446|19573593|P1|NOT COMPLETED|Overall Study||61
7952461|NCT00433446|19573593|P1|COMPLETED|Overall Study||1
7952462|NCT00433446|19573593|P1|Eligible and Began Protocol Therapy|Overall Study||53
7952463|NCT00433446|19573593|P1|Eligible|Overall Study||53
7952464|NCT00433446|19573593|P1|STARTED|Overall Study||62
7952465|NCT00433381|19573603|P2|NOT COMPLETED|Overall Study||3
7952466|NCT00433381|19573604|P1|NOT COMPLETED|Overall Study||3
7952467|NCT00433381|19573603|P2|COMPLETED|Overall Study||57
7952468|NCT00433381|19573604|P1|COMPLETED|Overall Study|Subjects contributing data to [the primary] analysis are considered to have completed the study.|60
7952469|NCT00433381|19573603|P2|STARTED|Overall Study||60
7952470|NCT00433381|19573604|P1|STARTED|Overall Study||63
7952471|NCT00433329|19573623|P1|NOT COMPLETED|Overall Study||21
7952472|NCT00433329|19573623|P1|COMPLETED|Overall Study||79
7952473|NCT00433329|19573623|P1|STARTED|Overall Study||100
7952474|NCT00433290|19573629|P2|NOT COMPLETED|Overall Study||17
7952475|NCT00433290|19573630|P1|NOT COMPLETED|Overall Study||35
7952476|NCT00433290|19573629|P2|COMPLETED|Overall Study||111
7952477|NCT00433290|19573630|P1|COMPLETED|Overall Study||93
7952478|NCT00433290|19573629|P2|STARTED|Overall Study||128
7952479|NCT00433290|19573630|P1|STARTED|Overall Study||128
7952480|NCT00433199|19573699|P2|NOT COMPLETED|Open-Label Period||34
7952481|NCT00433199|19573700|P1|NOT COMPLETED|Open-Label Period||0
7952482|NCT00433199|19573699|P2|COMPLETED|Open-Label Period||185
7952483|NCT00433199|19573700|P1|COMPLETED|Open-Label Period||0
7952484|NCT00433199|19573699|P2|STARTED|Open-Label Period||219
7952485|NCT00433199|19573700|P1|STARTED|Open-Label Period||0
7952486|NCT00433199|19573699|P2|NOT COMPLETED|Double-Blind Period||66
7952487|NCT00433199|19573700|P1|NOT COMPLETED|Double-Blind Period||12
7952488|NCT00433199|19573699|P2|COMPLETED|Double-Blind Period||168
7952489|NCT00433199|19573700|P1|COMPLETED|Double-Blind Period||28
7952490|NCT00433199|19573699|P2|STARTED|Double-Blind Period||234
7952491|NCT00433199|19573700|P1|STARTED|Double-Blind Period||40
7952492|NCT00433160|19573720|P2|NOT COMPLETED|104 Weeks, 28-Week OL Period||3
7952493|NCT00433160|19573721|P1|NOT COMPLETED|104 Weeks, 28-Week OL Period||10
7952494|NCT00433160|19573720|P2|COMPLETED|104 Weeks, 28-Week OL Period||47
7952495|NCT00433160|19573721|P1|COMPLETED|104 Weeks, 28-Week OL Period||92
7952496|NCT00433160|19573720|P2|Received Treatment|104 Weeks, 28-Week OL Period||50
7952497|NCT00433160|19573721|P1|Received Treatment|104 Weeks, 28-Week OL Period||102
7952498|NCT00433160|19573720|P2|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50
7952499|NCT00433160|19573721|P1|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102
7952500|NCT00433160|19573720|P2|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4
7952501|NCT00433160|19573721|P1|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6
7952502|NCT00433160|19573720|P2|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55
7952503|NCT00433160|19573721|P1|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113
7952504|NCT00433160|19573720|P2|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59
7952505|NCT00433160|19573721|P1|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119
7952506|NCT00433160|19573720|P2|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59
7952507|NCT00433160|19573721|P1|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119
7952508|NCT00433160|19573720|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||10
7952509|NCT00433160|19573721|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||17
7952510|NCT00433160|19573720|P2|COMPLETED|52-Week Double-Blind (DB) Period||60
7952511|NCT00433160|19573721|P1|COMPLETED|52-Week Double-Blind (DB) Period||120
7952512|NCT00433160|19573720|P2|Received Treatment|52-Week Double-Blind (DB) Period||68
7952513|NCT00433160|19573721|P1|Received Treatment|52-Week Double-Blind (DB) Period||136
7952514|NCT00433160|19573720|P2|STARTED|52-Week Double-Blind (DB) Period||70
7952515|NCT00433160|19573721|P1|STARTED|52-Week Double-Blind (DB) Period||137
7952516|NCT00433147|19573773|P4|NOT COMPLETED|Overall Study||0
7952517|NCT00433147|19573774|P3|NOT COMPLETED|Overall Study||0
7952518|NCT00433147|19573775|P2|NOT COMPLETED|Overall Study||1
7952519|NCT00433147|19573776|P1|NOT COMPLETED|Overall Study||0
7952520|NCT00433147|19573773|P4|COMPLETED|Overall Study||7
7952521|NCT00433147|19573774|P3|COMPLETED|Overall Study||9
7952522|NCT00433147|19573775|P2|COMPLETED|Overall Study||6
7952523|NCT00433147|19573776|P1|COMPLETED|Overall Study||7
7952524|NCT00433147|19573773|P4|Received at Least One Dose of Study Drug|Overall Study||7
7952525|NCT00433147|19573774|P3|Received at Least One Dose of Study Drug|Overall Study||9
7952526|NCT00433147|19573775|P2|Received at Least One Dose of Study Drug|Overall Study||7
7952527|NCT00433147|19573776|P1|Received at Least One Dose of Study Drug|Overall Study||7
7952528|NCT00433147|19573773|P4|PD Population|Overall Study||7
7952529|NCT00433147|19573774|P3|PD Population|Overall Study||9
7952530|NCT00433147|19573775|P2|PD Population|Overall Study||6
7952531|NCT00433147|19573776|P1|PD Population|Overall Study||7
7952532|NCT00433147|19573773|P4|Safety Population|Overall Study||7
7952533|NCT00433147|19573774|P3|Safety Population|Overall Study||9
7952534|NCT00433147|19573775|P2|Safety Population|Overall Study||7
7952535|NCT00433147|19573776|P1|Safety Population|Overall Study||7
7952536|NCT00433147|19573773|P4|STARTED|Overall Study||7
7952537|NCT00433147|19573774|P3|STARTED|Overall Study||9
7952538|NCT00433147|19573775|P2|STARTED|Overall Study||7
7952539|NCT00433147|19573776|P1|STARTED|Overall Study||7
7952540|NCT00433017|19573792|P2|NOT COMPLETED|Overall Study||101
7952541|NCT00433017|19573793|P1|NOT COMPLETED|Overall Study||96
7952542|NCT00433017|19573792|P2|COMPLETED|Overall Study||32
7952543|NCT00433017|19573793|P1|COMPLETED|Overall Study||26
7952544|NCT00433017|19573792|P2|Completed 12 Month Phase|Overall Study||126
7952545|NCT00433017|19573793|P1|Completed 12 Month Phase|Overall Study||114
7952546|NCT00433017|19573792|P2|STARTED|Overall Study||133
7952547|NCT00433017|19573793|P1|STARTED|Overall Study||122
7952548|NCT00433004|19573809|P2|NOT COMPLETED|Overall Study||7
7952549|NCT00433004|19573810|P1|NOT COMPLETED|Overall Study||5
7952550|NCT00433004|19573809|P2|COMPLETED|Overall Study||16
7952551|NCT00433004|19573810|P1|COMPLETED|Overall Study||22
7952552|NCT00433004|19573809|P2|STARTED|Overall Study||23
7952553|NCT00433004|19573810|P1|STARTED|Overall Study||27
7952554|NCT00432991|19573822|P2|NOT COMPLETED|Overall Study||12
7952555|NCT00432991|19573823|P1|NOT COMPLETED|Overall Study||7
7952556|NCT00432991|19573822|P2|COMPLETED|Overall Study||19
7952557|NCT00432991|19573823|P1|COMPLETED|Overall Study||15
7952558|NCT00432991|19573822|P2|STARTED|Overall Study||31
7952559|NCT00432991|19573823|P1|STARTED|Overall Study||22
7952560|NCT00432965|19573835|P2|NOT COMPLETED|Overall Study||86
7952561|NCT00432965|19573836|P1|NOT COMPLETED|Overall Study||94
7952562|NCT00432965|19573835|P2|COMPLETED|Overall Study||80
7952563|NCT00432965|19573836|P1|COMPLETED|Overall Study||75
7952564|NCT00432965|19573835|P2|STARTED|Overall Study||166
7952565|NCT00432965|19573836|P1|STARTED|Overall Study||169
7952566|NCT00432835|19573844|P2|NOT COMPLETED|Overall Study||7
7952567|NCT00432835|19573845|P1|NOT COMPLETED|Overall Study||6
7952568|NCT00432835|19573844|P2|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23
7952569|NCT00432835|19573845|P1|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22
7952570|NCT00432835|19573844|P2|Completed 2nd Intervention|Overall Study||23
7952571|NCT00432835|19573845|P1|Completed 2nd Intervention|Overall Study||22
7952572|NCT00432835|19573844|P2|Completed 1st Intervention|Overall Study||23
7952573|NCT00432835|19573845|P1|Completed 1st Intervention|Overall Study||22
7952574|NCT00432835|19573844|P2|STARTED|Overall Study||30
7952575|NCT00432835|19573845|P1|STARTED|Overall Study||28
7952576|NCT00432809|19573858|P3|NOT COMPLETED|2 Year Sub-study||1
7952577|NCT00432809|19573859|P2|NOT COMPLETED|2 Year Sub-study||2
7952578|NCT00432809|19573860|P1|NOT COMPLETED|2 Year Sub-study||3
7952579|NCT00432809|19573858|P3|COMPLETED|2 Year Sub-study||19
7952580|NCT00432809|19573859|P2|COMPLETED|2 Year Sub-study||18
7952581|NCT00432809|19573860|P1|COMPLETED|2 Year Sub-study||17
7952582|NCT00432809|19573858|P3|STARTED|2 Year Sub-study||20
7952583|NCT00432809|19573859|P2|STARTED|2 Year Sub-study||20
7952584|NCT00432809|19573860|P1|STARTED|2 Year Sub-study||20
7952585|NCT00432809|19573858|P3|NOT COMPLETED|1 Year Follow-up||1
7952586|NCT00432809|19573859|P2|NOT COMPLETED|1 Year Follow-up||0
7952587|NCT00432809|19573860|P1|NOT COMPLETED|1 Year Follow-up||9
7952588|NCT00432809|19573858|P3|COMPLETED|1 Year Follow-up||49
7952589|NCT00432809|19573859|P2|COMPLETED|1 Year Follow-up||50
7952590|NCT00432809|19573860|P1|COMPLETED|1 Year Follow-up||41
7952591|NCT00432809|19573858|P3|STARTED|1 Year Follow-up||50
7952592|NCT00432809|19573859|P2|STARTED|1 Year Follow-up||50
7952593|NCT00432809|19573860|P1|STARTED|1 Year Follow-up||50
7952594|NCT00432744|19573933|P2|NOT COMPLETED|Months 7 - 12||1
7952595|NCT00432744|19573934|P1|NOT COMPLETED|Months 7 - 12||1
7952596|NCT00432744|19573933|P2|COMPLETED|Months 7 - 12||7
7952597|NCT00432744|19573934|P1|COMPLETED|Months 7 - 12||6
7952598|NCT00432744|19573933|P2|STARTED|Months 7 - 12||8
7952599|NCT00432744|19573934|P1|STARTED|Months 7 - 12||7
7952600|NCT00432744|19573933|P2|NOT COMPLETED|Months 0-6||4
7952601|NCT00432744|19573934|P1|NOT COMPLETED|Months 0-6||5
7952602|NCT00432744|19573933|P2|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8
7952603|NCT00432744|19573934|P1|COMPLETED|Months 0-6||7
7952604|NCT00432744|19573933|P2|STARTED|Months 0-6||12
7952605|NCT00432744|19573934|P1|STARTED|Months 0-6||12
7952606|NCT00432679|19573946|P2|NOT COMPLETED|Overall Study||3
7952607|NCT00432679|19573947|P1|NOT COMPLETED|Overall Study||5
7952608|NCT00432679|19573946|P2|COMPLETED|Overall Study||72
7952609|NCT00432679|19573947|P1|COMPLETED|Overall Study||69
7952610|NCT00432679|19573946|P2|STARTED|Overall Study||75
7952611|NCT00432679|19573947|P1|STARTED|Overall Study||74
7952612|NCT00432666|19573971|P2|NOT COMPLETED|Open-Label Extension Period||0
7952613|NCT00432666|19573972|P1|NOT COMPLETED|Open-Label Extension Period||25
7952614|NCT00432666|19573971|P2|COMPLETED|Open-Label Extension Period||0
7952615|NCT00432666|19573972|P1|COMPLETED|Open-Label Extension Period||120
7952616|NCT00432666|19573971|P2|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0
7952617|NCT00432666|19573972|P1|STARTED|Open-Label Extension Period||145
7952618|NCT00432666|19573971|P2|NOT COMPLETED|Main Period||1
7952619|NCT00432666|19573972|P1|NOT COMPLETED|Main Period||2
7952620|NCT00432666|19573971|P2|COMPLETED|Main Period||74
7952621|NCT00432666|19573972|P1|COMPLETED|Main Period||71
7952622|NCT00432666|19573971|P2|STARTED|Main Period||75
7952623|NCT00432666|19573972|P1|STARTED|Main Period||73
7952624|NCT00432601|19574136|P2|NOT COMPLETED|Time 2 to Time 3||22
7952625|NCT00432601|19574137|P1|NOT COMPLETED|Time 2 to Time 3||19
7952626|NCT00432601|19574136|P2|COMPLETED|Time 2 to Time 3||122
7952627|NCT00432601|19574137|P1|COMPLETED|Time 2 to Time 3||122
7952628|NCT00432601|19574136|P2|STARTED|Time 2 to Time 3||144
7952629|NCT00432601|19574137|P1|STARTED|Time 2 to Time 3||141
7952630|NCT00432601|19574136|P2|NOT COMPLETED|Time 1 to Time 2||368
7952631|NCT00432601|19574137|P1|NOT COMPLETED|Time 1 to Time 2||369
7952632|NCT00432601|19574136|P2|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144
7952633|NCT00432601|19574137|P1|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141
7952634|NCT00432601|19574136|P2|STARTED|Time 1 to Time 2||512
7952635|NCT00432601|19574137|P1|STARTED|Time 1 to Time 2||510
7952636|NCT00432562|19574145|P2|NOT COMPLETED|Overall Study||0
7952637|NCT00432562|19574146|P1|NOT COMPLETED|Overall Study||3
7952638|NCT00432562|19574145|P2|COMPLETED|Overall Study||15
7952639|NCT00432562|19574146|P1|COMPLETED|Overall Study||13
7952640|NCT00432562|19574145|P2|STARTED|Overall Study||15
7952641|NCT00432562|19574146|P1|STARTED|Overall Study||16
7952642|NCT00432458|19574172|P2|NOT COMPLETED|Overall Study||1
7952643|NCT00432458|19574173|P1|NOT COMPLETED|Overall Study||5
7952644|NCT00432458|19574172|P2|COMPLETED|Overall Study||32
7952645|NCT00432458|19574173|P1|COMPLETED|Overall Study||30
7952646|NCT00432458|19574172|P2|STARTED|Overall Study||33
7952647|NCT00432458|19574173|P1|STARTED|Overall Study||35
7952648|NCT00432445|19574191|P1|NOT COMPLETED|Overall Study||0
7952649|NCT00432445|19574191|P1|COMPLETED|Overall Study||2
7952650|NCT00432445|19574191|P1|STARTED|Overall Study||2
7952651|NCT00432380|19574198|P3|NOT COMPLETED|Overall Study||1
7952652|NCT00432380|19574199|P2|NOT COMPLETED|Overall Study||4
7952653|NCT00432380|19574200|P1|NOT COMPLETED|Overall Study||4
7952654|NCT00432380|19574198|P3|COMPLETED|Overall Study||74
7952655|NCT00432380|19574199|P2|COMPLETED|Overall Study||146
7952656|NCT00432380|19574200|P1|COMPLETED|Overall Study||146
7952657|NCT00432380|19574198|P3|STARTED|Overall Study||75
7952658|NCT00432380|19574199|P2|STARTED|Overall Study||150
7952659|NCT00432380|19574200|P1|STARTED|Overall Study||150
7952660|NCT00432341|19574226|P2|NOT COMPLETED|Overall Study||0
7952661|NCT00432341|19574227|P1|NOT COMPLETED|Overall Study||0
7952662|NCT00432341|19574226|P2|COMPLETED|Overall Study||30
7952663|NCT00432341|19574227|P1|COMPLETED|Overall Study||24
7952664|NCT00432341|19574226|P2|STARTED|Overall Study||30
7952665|NCT00432341|19574227|P1|STARTED|Overall Study||24
7952666|NCT00432276|19574253|P2|NOT COMPLETED|Overall Study||156
7952667|NCT00432276|19574254|P1|NOT COMPLETED|Overall Study||121
7952668|NCT00432276|19574253|P2|COMPLETED|Overall Study||243
7952669|NCT00432276|19574254|P1|COMPLETED|Overall Study||283
7952670|NCT00432276|19574253|P2|Per Protocol Set|Overall Study||306
7952671|NCT00432276|19574254|P1|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303
7952672|NCT00432276|19574253|P2|STARTED|Overall Study||399
7952673|NCT00432276|19574254|P1|STARTED|Overall Study||404
7952674|NCT00432237|19574344|P4|NOT COMPLETED|Overall Study||124
7952675|NCT00432237|19574345|P3|NOT COMPLETED|Overall Study||109
7952676|NCT00432237|19574346|P2|NOT COMPLETED|Overall Study||101
7952677|NCT00432237|19574347|P1|NOT COMPLETED|Overall Study||67
7952678|NCT00432237|19574344|P4|COMPLETED|Overall Study||366
7952679|NCT00432237|19574345|P3|COMPLETED|Overall Study||375
7952680|NCT00432237|19574346|P2|COMPLETED|Overall Study||384
7952681|NCT00432237|19574347|P1|COMPLETED|Overall Study||177
7952682|NCT00432237|19574344|P4|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
7952683|NCT00432237|19574345|P3|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5
7952684|NCT00432237|19574346|P2|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3
7952685|NCT00432237|19574347|P1|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
7952686|NCT00432237|19574344|P4|Completed--With Data|Overall Study||365
7952687|NCT00432237|19574345|P3|Completed--With Data|Overall Study||370
7952688|NCT00432237|19574346|P2|Completed--With Data|Overall Study||381
7952689|NCT00432237|19574347|P1|Completed--With Data|Overall Study||176
7952690|NCT00432237|19574344|P4|STARTED|Overall Study||490
7952691|NCT00432237|19574345|P3|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484
7952692|NCT00432237|19574346|P2|STARTED|Overall Study||485
7952693|NCT00432237|19574347|P1|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244
7952694|NCT00432172|19574389|P4|NOT COMPLETED|Overall Study||7
7952695|NCT00432172|19574390|P3|NOT COMPLETED|Overall Study||11
7952696|NCT00432172|19574391|P2|NOT COMPLETED|Overall Study||7
7952697|NCT00432172|19574392|P1|NOT COMPLETED|Overall Study||6
7952698|NCT00432172|19574389|P4|COMPLETED|Overall Study||41
7952699|NCT00432172|19574390|P3|COMPLETED|Overall Study||35
7952700|NCT00432172|19574391|P2|COMPLETED|Overall Study||41
7952701|NCT00432172|19574392|P1|COMPLETED|Overall Study||41
7952702|NCT00432172|19574389|P4|STARTED|Overall Study||48
7952703|NCT00432172|19574390|P3|STARTED|Overall Study||46
7952704|NCT00432172|19574391|P2|STARTED|Overall Study||48
7952705|NCT00432172|19574392|P1|STARTED|Overall Study||47
7952706|NCT00432159|19574417|P5|NOT COMPLETED|Overall Study||10
7952707|NCT00432159|19574418|P4|NOT COMPLETED|Overall Study||5
7952708|NCT00432159|19574419|P3|NOT COMPLETED|Overall Study||4
7952709|NCT00432159|19574420|P2|NOT COMPLETED|Overall Study||30
7952710|NCT00432159|19574421|P1|NOT COMPLETED|Overall Study||22
7952711|NCT00432159|19574417|P5|COMPLETED|Overall Study|Actual (Complete efficacy)|79
7952712|NCT00432159|19574418|P4|COMPLETED|Overall Study|Actual (Complete efficacy)|15
7952713|NCT00432159|19574419|P3|COMPLETED|Overall Study|Actual (Complete efficacy)|35
7952714|NCT00432159|19574420|P2|COMPLETED|Overall Study|Actual (Complete efficacy)|137
7952715|NCT00432159|19574421|P1|COMPLETED|Overall Study|Actual (Complete efficacy)|163
7952716|NCT00432159|19574417|P5|STARTED|Overall Study||89
7952717|NCT00432159|19574418|P4|STARTED|Overall Study||20
7952718|NCT00432159|19574419|P3|STARTED|Overall Study||39
7952719|NCT00432159|19574420|P2|STARTED|Overall Study||167
7952720|NCT00432159|19574421|P1|STARTED|Overall Study||185
7952721|NCT00432042|19574528|P3|NOT COMPLETED|Overall Study||2
7952722|NCT00432042|19574529|P2|NOT COMPLETED|Overall Study||1
7952723|NCT00432042|19574530|P1|NOT COMPLETED|Overall Study||7
7952724|NCT00432042|19574528|P3|COMPLETED|Overall Study||239
7952725|NCT00432042|19574529|P2|COMPLETED|Overall Study||234
7952726|NCT00432042|19574530|P1|COMPLETED|Overall Study||472
7952727|NCT00432042|19574528|P3|Vaccinated|Overall Study||240
7952728|NCT00432042|19574529|P2|Vaccinated|Overall Study||235
7952729|NCT00432042|19574530|P1|Vaccinated|Overall Study||477
7952730|NCT00432042|19574528|P3|STARTED|Overall Study|Number randomized.|241
7952731|NCT00432042|19574529|P2|STARTED|Overall Study|Number randomized.|235
7952732|NCT00432042|19574530|P1|STARTED|Overall Study|Number randomized.|479
7952733|NCT00431964|19574543|P2|NOT COMPLETED|Overall Study||8
7952734|NCT00431964|19574544|P1|NOT COMPLETED|Overall Study||6
7952735|NCT00431964|19574543|P2|COMPLETED|Overall Study||124
7952736|NCT00431964|19574544|P1|COMPLETED|Overall Study||125
7952737|NCT00431964|19574543|P2|Withdrew From Study|Overall Study||5
7952738|NCT00431964|19574544|P1|Withdrew From Study|Overall Study||6
7952739|NCT00431964|19574543|P2|Did Not Receive Drug|Overall Study||3
7952740|NCT00431964|19574544|P1|Did Not Receive Drug|Overall Study||0
7952741|NCT00431964|19574543|P2|Randomized/Received Drug|Overall Study||129
7952742|NCT00431964|19574544|P1|Randomized/Received Drug|Overall Study||131
7952743|NCT00431964|19574543|P2|STARTED|Overall Study||132
7952744|NCT00431964|19574544|P1|STARTED|Overall Study||131
7952745|NCT00431951|19574554|P4|NOT COMPLETED|Overall Study||2
7952746|NCT00431951|19574555|P3|NOT COMPLETED|Overall Study||2
7952747|NCT00431951|19574556|P2|NOT COMPLETED|Overall Study||2
7952748|NCT00431951|19574557|P1|NOT COMPLETED|Overall Study||1
7952749|NCT00431951|19574554|P4|COMPLETED|Overall Study||4
7952750|NCT00431951|19574555|P3|COMPLETED|Overall Study||6
7952751|NCT00431951|19574556|P2|COMPLETED|Overall Study||6
7952752|NCT00431951|19574557|P1|COMPLETED|Overall Study||7
7952753|NCT00431951|19574554|P4|STARTED|Overall Study||6
7952754|NCT00431951|19574555|P3|STARTED|Overall Study||8
7952755|NCT00431951|19574556|P2|STARTED|Overall Study||8
7952756|NCT00431951|19574557|P1|STARTED|Overall Study||8
7952757|NCT00431847|19574619|P5|NOT COMPLETED|Overall Study||1
7952758|NCT00431847|19574620|P4|NOT COMPLETED|Overall Study||14
7952759|NCT00431847|19574621|P3|NOT COMPLETED|Overall Study||4
7952760|NCT00431847|19574622|P2|NOT COMPLETED|Overall Study||3
7952761|NCT00431847|19574623|P1|NOT COMPLETED|Overall Study||6
7952762|NCT00431847|19574619|P5|COMPLETED|Overall Study||0
7952763|NCT00431847|19574620|P4|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|170
7952764|NCT00431847|19574621|P3|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|20
7952765|NCT00431847|19574622|P2|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|42
7952766|NCT00431847|19574623|P1|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|126
7952767|NCT00431847|19574619|P5|STARTED|Overall Study||1
7952768|NCT00431847|19574620|P4|STARTED|Overall Study||184
7952769|NCT00431847|19574621|P3|STARTED|Overall Study||24
7952770|NCT00431847|19574622|P2|STARTED|Overall Study||45
7952771|NCT00431847|19574623|P1|STARTED|Overall Study||132
7952772|NCT00431834|19574697|P1|NOT COMPLETED|Overall Study||13
7952773|NCT00431834|19574697|P1|COMPLETED|Overall Study||62
7952774|NCT00431834|19574697|P1|STARTED|Overall Study||75
7952775|NCT00431626|19574706|P2|NOT COMPLETED|Overall Study||0
7952776|NCT00431626|19574707|P1|NOT COMPLETED|Overall Study||0
7952777|NCT00431626|19574706|P2|COMPLETED|Overall Study||0
7952778|NCT00431626|19574707|P1|COMPLETED|Overall Study||4
7952779|NCT00431626|19574706|P2|STARTED|Overall Study||0
7952780|NCT00431626|19574707|P1|STARTED|Overall Study||4
7952781|NCT00431496|19574713|P1|NOT COMPLETED|Overall Study||11
7952782|NCT00431496|19574713|P1|COMPLETED|Overall Study||60
7952783|NCT00431496|19574713|P1|STARTED|Overall Study||71
7952784|NCT00431444|19574724|P2|NOT COMPLETED|Overall Study||7
7952785|NCT00431444|19574725|P1|NOT COMPLETED|Overall Study||5
7952786|NCT00431444|19574724|P2|COMPLETED|Overall Study||46
7952787|NCT00431444|19574725|P1|COMPLETED|Overall Study||51
7952788|NCT00431444|19574724|P2|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53
7952789|NCT00431444|19574725|P1|STARTED|Overall Study||56
7952790|NCT00431184|19574751|P2|NOT COMPLETED|Second Intervention (Day 2)||0
7952791|NCT00431184|19574752|P1|NOT COMPLETED|Second Intervention (Day 2)||0
7952792|NCT00431184|19574751|P2|COMPLETED|Second Intervention (Day 2)||9
7952793|NCT00431184|19574752|P1|COMPLETED|Second Intervention (Day 2)||10
7952794|NCT00431184|19574751|P2|STARTED|Second Intervention (Day 2)||9
7952795|NCT00431184|19574752|P1|STARTED|Second Intervention (Day 2)||10
7952796|NCT00431184|19574751|P2|NOT COMPLETED|1st Intervention (Day 1)||0
7952797|NCT00431184|19574752|P1|NOT COMPLETED|1st Intervention (Day 1)||0
7952798|NCT00431184|19574751|P2|COMPLETED|1st Intervention (Day 1)||9
7952799|NCT00431184|19574752|P1|COMPLETED|1st Intervention (Day 1)||10
7952800|NCT00431184|19574751|P2|STARTED|1st Intervention (Day 1)||9
7952801|NCT00431184|19574752|P1|STARTED|1st Intervention (Day 1)||10
7952802|NCT00431132|19574760|P1|NOT COMPLETED|Overall Study||44
7952803|NCT00431132|19574760|P1|COMPLETED|Overall Study||292
7952804|NCT00431132|19574760|P1|STARTED|Overall Study||336
7952805|NCT00431067|19574765|P1|NOT COMPLETED|Overall Study||41
7952806|NCT00431067|19574765|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0
7952807|NCT00431067|19574765|P1|STARTED|Overall Study|52 patients screened, 41 treated|41
7952808|NCT00431041|19574775|P2|NOT COMPLETED|Overall Study||24
7952809|NCT00431041|19574776|P1|NOT COMPLETED|Overall Study||16
7952810|NCT00431041|19574775|P2|COMPLETED|Overall Study||40
7952811|NCT00431041|19574776|P1|COMPLETED|Overall Study||52
7952812|NCT00431041|19574775|P2|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64
7952813|NCT00431041|19574776|P1|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68
7952814|NCT00430989|19574790|P2|NOT COMPLETED|Overall Study||60
7952815|NCT00430989|19574791|P1|NOT COMPLETED|Overall Study||60
7952816|NCT00430989|19574790|P2|COMPLETED|Overall Study||3509
7952817|NCT00430989|19574791|P1|COMPLETED|Overall Study||3483
7952818|NCT00430989|19574790|P2|STARTED|Overall Study||3569
7952819|NCT00430989|19574791|P1|STARTED|Overall Study||3543
7952820|NCT00430950|19574811|P2|NOT COMPLETED|Overall Study||13
7952821|NCT00430950|19574812|P1|NOT COMPLETED|Overall Study||13
7952822|NCT00430950|19574811|P2|COMPLETED|Overall Study||495
7952823|NCT00430950|19574812|P1|COMPLETED|Overall Study||489
7952824|NCT00430950|19574811|P2|STARTED|Overall Study||508
7952825|NCT00430950|19574812|P1|STARTED|Overall Study||502
7952826|NCT00430937|19574826|P2|NOT COMPLETED|Overall Study||28
7952827|NCT00430937|19574827|P1|NOT COMPLETED|Overall Study||27
7952828|NCT00430937|19574826|P2|COMPLETED|Overall Study||64
7952829|NCT00430937|19574827|P1|COMPLETED|Overall Study||70
7952830|NCT00430937|19574826|P2|STARTED|Overall Study||92
7952831|NCT00430937|19574827|P1|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97
7952832|NCT00430781|19574838|P3|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20
7952833|NCT00430781|19574839|P2|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18
7952834|NCT00430781|19574840|P1|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24
7952835|NCT00430781|19574838|P3|COMPLETED|End-of-Study Analysis; 28 July 2011||54
7952836|NCT00430781|19574839|P2|COMPLETED|End-of-Study Analysis; 28 July 2011||59
7952837|NCT00430781|19574840|P1|COMPLETED|End-of-Study Analysis; 28 July 2011||53
7952838|NCT00430781|19574838|P3|STARTED|End-of-Study Analysis; 28 July 2011||74
7952839|NCT00430781|19574839|P2|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77
7952840|NCT00430781|19574840|P1|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77
7952841|NCT00430781|19574838|P3|NOT COMPLETED|Final Analysis; 31 July 2008||48
7952842|NCT00430781|19574839|P2|NOT COMPLETED|Final Analysis; 31 July 2008||39
7952843|NCT00430781|19574840|P1|NOT COMPLETED|Final Analysis; 31 July 2008||0
7952844|NCT00430781|19574838|P3|COMPLETED|Final Analysis; 31 July 2008||26
7952845|NCT00430781|19574839|P2|COMPLETED|Final Analysis; 31 July 2008||39
7952846|NCT00430781|19574840|P1|COMPLETED|Final Analysis; 31 July 2008||0
7952847|NCT00430781|19574838|P3|Ongoing|Final Analysis; 31 July 2008||32
7952848|NCT00430781|19574839|P2|Ongoing|Final Analysis; 31 July 2008||29
7952849|NCT00430781|19574840|P1|Ongoing|Final Analysis; 31 July 2008||0
7952850|NCT00430781|19574838|P3|STARTED|Final Analysis; 31 July 2008||74
7952851|NCT00430781|19574839|P2|STARTED|Final Analysis; 31 July 2008||78
7952852|NCT00430781|19574840|P1|STARTED|Final Analysis; 31 July 2008||0
7952853|NCT00430781|19574838|P3|NOT COMPLETED|Interim Analysis; 11 February 2008||60
7952854|NCT00430781|19574839|P2|NOT COMPLETED|Interim Analysis; 11 February 2008||58
7952855|NCT00430781|19574840|P1|NOT COMPLETED|Interim Analysis; 11 February 2008||59
7952856|NCT00430781|19574838|P3|COMPLETED|Interim Analysis; 11 February 2008||0
7952857|NCT00430781|19574839|P2|COMPLETED|Interim Analysis; 11 February 2008||0
7952858|NCT00430781|19574840|P1|COMPLETED|Interim Analysis; 11 February 2008||0
7952859|NCT00430781|19574838|P3|Ongoing|Interim Analysis; 11 February 2008||25
7952860|NCT00430781|19574839|P2|Ongoing|Interim Analysis; 11 February 2008||20
7952861|NCT00430781|19574840|P1|Ongoing|Interim Analysis; 11 February 2008||23
7952862|NCT00430781|19574838|P3|STARTED|Interim Analysis; 11 February 2008||60
7952863|NCT00430781|19574839|P2|STARTED|Interim Analysis; 11 February 2008||58
7952864|NCT00430781|19574840|P1|STARTED|Interim Analysis; 11 February 2008||59
7952865|NCT00430768|19574866|P3|NOT COMPLETED|Overall Study||0
7952866|NCT00430768|19574867|P2|NOT COMPLETED|Overall Study||0
7952867|NCT00430768|19574868|P1|NOT COMPLETED|Overall Study||0
7952868|NCT00430768|19574866|P3|COMPLETED|Overall Study||3
7952869|NCT00430768|19574867|P2|COMPLETED|Overall Study||3
7952870|NCT00430768|19574868|P1|COMPLETED|Overall Study||3
7952871|NCT00430768|19574866|P3|STARTED|Overall Study||3
7952872|NCT00430768|19574867|P2|STARTED|Overall Study||3
7952873|NCT00430768|19574868|P1|STARTED|Overall Study||3
7952874|NCT00430755|19574882|P1|NOT COMPLETED|Overall Study||53
7952875|NCT00430755|19574882|P1|COMPLETED|Overall Study||45
7952876|NCT00430755|19574882|P1|STARTED|Overall Study||98
7952877|NCT00430716|19574889|P3|NOT COMPLETED|Open Label Phase||7
7952878|NCT00430716|19574890|P2|NOT COMPLETED|Open Label Phase||7
7952879|NCT00430716|19574891|P1|NOT COMPLETED|Open Label Phase||9
7952880|NCT00430716|19574889|P3|COMPLETED|Open Label Phase||32
7952881|NCT00430716|19574890|P2|COMPLETED|Open Label Phase||31
7952882|NCT00430716|19574891|P1|COMPLETED|Open Label Phase||27
7952883|NCT00430716|19574889|P3|STARTED|Open Label Phase||39
7952884|NCT00430716|19574890|P2|STARTED|Open Label Phase||38
7952885|NCT00430716|19574891|P1|STARTED|Open Label Phase||36
7952886|NCT00430716|19574889|P3|NOT COMPLETED|Double Blind Phase||6
7952887|NCT00430716|19574890|P2|NOT COMPLETED|Double Blind Phase||5
7952888|NCT00430716|19574891|P1|NOT COMPLETED|Double Blind Phase||6
7952889|NCT00430716|19574889|P3|COMPLETED|Double Blind Phase||39
7952890|NCT00430716|19574890|P2|COMPLETED|Double Blind Phase||38
7952891|NCT00430716|19574891|P1|COMPLETED|Double Blind Phase||36
7952892|NCT00430716|19574889|P3|Treated|Double Blind Phase||45
7952893|NCT00430716|19574890|P2|Treated|Double Blind Phase||43
7952894|NCT00430716|19574891|P1|Treated|Double Blind Phase||41
7952895|NCT00430716|19574889|P3|STARTED|Double Blind Phase||45
7952896|NCT00430716|19574890|P2|STARTED|Double Blind Phase||43
7952897|NCT00430716|19574891|P1|STARTED|Double Blind Phase||42
7952898|NCT00430677|19574923|P3|NOT COMPLETED|Long-term Extension Period||63
7952899|NCT00430677|19574924|P2|NOT COMPLETED|Long-term Extension Period||58
7952900|NCT00430677|19574925|P1|NOT COMPLETED|Long-term Extension Period||60
7952901|NCT00430677|19574923|P3|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11
7952902|NCT00430677|19574924|P2|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9
7952903|NCT00430677|19574925|P1|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10
7952904|NCT00430677|19574923|P3|STARTED|Long-term Extension Period||74
7952905|NCT00430677|19574924|P2|STARTED|Long-term Extension Period||67
7952906|NCT00430677|19574925|P1|STARTED|Long-term Extension Period||70
7952907|NCT00430677|19574923|P3|NOT COMPLETED|Short-term Period||22
7952908|NCT00430677|19574924|P2|NOT COMPLETED|Short-term Period||25
7952909|NCT00430677|19574925|P1|NOT COMPLETED|Short-term Period||23
7952910|NCT00430677|19574923|P3|COMPLETED|Short-term Period|Completed the short-term period|78
7952911|NCT00430677|19574924|P2|COMPLETED|Short-term Period|Completed the short-term period|74
7952912|NCT00430677|19574925|P1|COMPLETED|Short-term Period|Completed the short-term period|76
7952913|NCT00430677|19574923|P3|STARTED|Short-term Period||100
7952914|NCT00430677|19574924|P2|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99
7952915|NCT00430677|19574925|P1|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99
7952916|NCT00430638|19575048|P2|NOT COMPLETED|Overall Study||48
7952917|NCT00430638|19575049|P1|NOT COMPLETED|Overall Study||78
7952918|NCT00430638|19575048|P2|COMPLETED|Overall Study||92
7952919|NCT00430638|19575049|P1|COMPLETED|Overall Study||60
7952920|NCT00430638|19575048|P2|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140
7952921|NCT00430638|19575049|P1|STARTED|Overall Study||138
7952922|NCT00430625|19575067|P2|NOT COMPLETED|Overall Study||0
7952923|NCT00430625|19575068|P1|NOT COMPLETED|Overall Study||0
7952924|NCT00430625|19575067|P2|COMPLETED|Overall Study||12
7952925|NCT00430625|19575068|P1|COMPLETED|Overall Study||13
7952926|NCT00430625|19575067|P2|STARTED|Overall Study||12
7952927|NCT00430625|19575068|P1|STARTED|Overall Study||13
7952928|NCT00430573|19575084|P1|NOT COMPLETED|Overall Study||5
7952929|NCT00430573|19575084|P1|COMPLETED|Overall Study|Only 5 took study drug on at least one occasion and 8 completed the baseline ASI.|5
7952930|NCT00430573|19575084|P1|STARTED|Overall Study||10
7952931|NCT00430521|19575097|P8|NOT COMPLETED|Overall Study||12
7952932|NCT00430521|19575098|P7|NOT COMPLETED|Overall Study||10
7952933|NCT00430521|19575099|P6|NOT COMPLETED|Overall Study||5
7952934|NCT00430521|19575100|P5|NOT COMPLETED|Overall Study||5
7952935|NCT00430521|19575101|P4|NOT COMPLETED|Overall Study||8
7952936|NCT00430521|19575102|P3|NOT COMPLETED|Overall Study||3
7952937|NCT00430521|19575103|P2|NOT COMPLETED|Overall Study||9
7952938|NCT00430521|19575104|P1|NOT COMPLETED|Overall Study||11
7952939|NCT00430521|19575097|P8|COMPLETED|Overall Study||51
7952940|NCT00430521|19575098|P7|COMPLETED|Overall Study||55
7952941|NCT00430521|19575099|P6|COMPLETED|Overall Study||59
7952942|NCT00430521|19575100|P5|COMPLETED|Overall Study||59
7952943|NCT00430521|19575101|P4|COMPLETED|Overall Study||55
7952944|NCT00430521|19575102|P3|COMPLETED|Overall Study||61
7952945|NCT00430521|19575103|P2|COMPLETED|Overall Study||57
7952946|NCT00430521|19575104|P1|COMPLETED|Overall Study||52
7952947|NCT00430521|19575097|P8|STARTED|Overall Study||63
7952948|NCT00430521|19575098|P7|STARTED|Overall Study||65
7952949|NCT00430521|19575099|P6|STARTED|Overall Study||64
7952950|NCT00430521|19575100|P5|STARTED|Overall Study||64
7952951|NCT00430521|19575101|P4|STARTED|Overall Study||63
7952952|NCT00430521|19575102|P3|STARTED|Overall Study||64
7952953|NCT00430521|19575103|P2|STARTED|Overall Study||66
7952954|NCT00430521|19575104|P1|STARTED|Overall Study||63
7952955|NCT00430508|19575346|P4|NOT COMPLETED|Overall Study||5
7952956|NCT00430508|19575347|P3|NOT COMPLETED|Overall Study||13
7952957|NCT00430508|19575348|P2|NOT COMPLETED|Overall Study||6
7952958|NCT00430508|19575349|P1|NOT COMPLETED|Overall Study||3
7952959|NCT00430508|19575346|P4|COMPLETED|Overall Study||269
7952960|NCT00430508|19575347|P3|COMPLETED|Overall Study||266
7952961|NCT00430508|19575348|P2|COMPLETED|Overall Study||272
7952962|NCT00430508|19575349|P1|COMPLETED|Overall Study||137
7952963|NCT00430508|19575346|P4|STARTED|Overall Study||274
7952964|NCT00430508|19575347|P3|STARTED|Overall Study||279
7952965|NCT00430508|19575348|P2|STARTED|Overall Study||278
7952966|NCT00430508|19575349|P1|STARTED|Overall Study||140
7952967|NCT00430495|19575387|P4|NOT COMPLETED|Overall Study||4
7952968|NCT00430495|19575388|P3|NOT COMPLETED|Overall Study||13
7952969|NCT00430495|19575389|P2|NOT COMPLETED|Overall Study||7
7952970|NCT00430495|19575390|P1|NOT COMPLETED|Overall Study||14
7952971|NCT00430495|19575387|P4|COMPLETED|Overall Study||60
7952972|NCT00430495|19575388|P3|COMPLETED|Overall Study||49
7952973|NCT00430495|19575389|P2|COMPLETED|Overall Study||59
7952974|NCT00430495|19575390|P1|COMPLETED|Overall Study||50
7952975|NCT00430495|19575387|P4|Treated|Overall Study||64
7952976|NCT00430495|19575388|P3|Treated|Overall Study||62
7952977|NCT00430495|19575389|P2|Treated|Overall Study||66
7952978|NCT00430495|19575390|P1|Treated|Overall Study||62
7952979|NCT00430495|19575387|P4|STARTED|Overall Study||64
7952980|NCT00430495|19575388|P3|STARTED|Overall Study||62
7952981|NCT00430495|19575389|P2|STARTED|Overall Study||66
7952982|NCT00430495|19575390|P1|STARTED|Overall Study||64
7952983|NCT00430482|19575430|P2|NOT COMPLETED|Completed 2 Follow-Up Visits||6
7952984|NCT00430482|19575431|P1|NOT COMPLETED|Completed 2 Follow-Up Visits||5
7952985|NCT00430482|19575430|P2|COMPLETED|Completed 2 Follow-Up Visits||20
7952986|NCT00430482|19575431|P1|COMPLETED|Completed 2 Follow-Up Visits||29
7952987|NCT00430482|19575430|P2|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||20
7952988|NCT00430482|19575431|P1|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||29
7952989|NCT00430482|19575430|P2|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||20
7952990|NCT00430482|19575431|P1|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||27
7952991|NCT00430482|19575430|P2|STARTED|Completed 2 Follow-Up Visits||26
7952992|NCT00430482|19575431|P1|STARTED|Completed 2 Follow-Up Visits||34
7952993|NCT00430482|19575430|P2|NOT COMPLETED|Completed Treatment||11
7952994|NCT00430482|19575431|P1|NOT COMPLETED|Completed Treatment||7
7952995|NCT00430482|19575430|P2|COMPLETED|Completed Treatment||26
7952996|NCT00430482|19575431|P1|COMPLETED|Completed Treatment||34
7952997|NCT00430482|19575430|P2|Completed ASI at Midpoint|Completed Treatment||29
7952998|NCT00430482|19575431|P1|Completed ASI at Midpoint|Completed Treatment||35
7952999|NCT00430482|19575430|P2|STARTED|Completed Treatment||37
7953000|NCT00430482|19575431|P1|STARTED|Completed Treatment||41
7953001|NCT00430352|19575439|P1|NOT COMPLETED|Overall Study||138
7953002|NCT00430352|19575439|P1|COMPLETED|Overall Study||407
7953003|NCT00430352|19575439|P1|STARTED|Overall Study||545
7953004|NCT00430300|19575457|P4|NOT COMPLETED|Overall Study||2
7953005|NCT00430300|19575458|P3|NOT COMPLETED|Overall Study||6
7953006|NCT00430300|19575459|P2|NOT COMPLETED|Overall Study||2
7953007|NCT00430300|19575460|P1|NOT COMPLETED|Overall Study||2
7953008|NCT00430300|19575457|P4|COMPLETED|Overall Study||15
7953009|NCT00430300|19575458|P3|COMPLETED|Overall Study||29
7953010|NCT00430300|19575459|P2|COMPLETED|Overall Study||16
7953011|NCT00430300|19575460|P1|COMPLETED|Overall Study||15
7953012|NCT00430300|19575457|P4|STARTED|Overall Study||17
7953013|NCT00430300|19575458|P3|STARTED|Overall Study||35
7953014|NCT00430300|19575459|P2|STARTED|Overall Study||18
7953015|NCT00430300|19575460|P1|STARTED|Overall Study||17
7953016|NCT00430248|19575565|P3|NOT COMPLETED|Overall Study||135
7953017|NCT00430248|19575566|P2|NOT COMPLETED|Overall Study||158
7953018|NCT00430248|19575567|P1|NOT COMPLETED|Overall Study||125
7953019|NCT00430248|19575565|P3|COMPLETED|Overall Study||621
7953020|NCT00430248|19575566|P2|COMPLETED|Overall Study||598
7953021|NCT00430248|19575567|P1|COMPLETED|Overall Study||632
7953022|NCT00430248|19575565|P3|STARTED|Overall Study||756
7953023|NCT00430248|19575566|P2|STARTED|Overall Study||756
7953024|NCT00430248|19575567|P1|STARTED|Overall Study||757
7953025|NCT00430183|19575625|P2|NOT COMPLETED|Overall Study||0
7953026|NCT00430183|19575626|P1|NOT COMPLETED|Overall Study||0
7953027|NCT00430183|19575625|P2|COMPLETED|Overall Study||397
7953028|NCT00430183|19575626|P1|COMPLETED|Overall Study||391
7953029|NCT00430183|19575625|P2|STARTED|Overall Study||397
7953030|NCT00430183|19575626|P1|STARTED|Overall Study||391
7953031|NCT00430092|19575635|P3|NOT COMPLETED|Overall Study||57
7953032|NCT00430092|19575636|P2|NOT COMPLETED|Overall Study||4
7953033|NCT00430092|19575637|P1|NOT COMPLETED|Overall Study||6
7953034|NCT00430092|19575635|P3|COMPLETED|Overall Study||56
7953035|NCT00430092|19575636|P2|COMPLETED|Overall Study||48
7953036|NCT00430092|19575637|P1|COMPLETED|Overall Study||48
7953037|NCT00430092|19575635|P3|STARTED|Overall Study||113
7953038|NCT00430092|19575636|P2|STARTED|Overall Study||52
7953039|NCT00430092|19575637|P1|STARTED|Overall Study||54
7953040|NCT00430027|19575642|P1|NOT COMPLETED|Overall Study||8
7953041|NCT00430027|19575642|P1|COMPLETED|Overall Study||0
7953042|NCT00430027|19575642|P1|STARTED|Overall Study||8
7953043|NCT00429949|19575646|P1|NOT COMPLETED|Overall Study||0
7953044|NCT00429949|19575646|P1|COMPLETED|Overall Study||21
7953045|NCT00429949|19575646|P1|STARTED|Overall Study||21
7953046|NCT00429923|19575659|P3|NOT COMPLETED|Overall Study||39
7953047|NCT00429923|19575660|P2|NOT COMPLETED|Overall Study||4
7953048|NCT00429923|19575661|P1|NOT COMPLETED|Overall Study||5
7953049|NCT00429923|19575659|P3|COMPLETED|Overall Study||68
7953050|NCT00429923|19575660|P2|COMPLETED|Overall Study||51
7953051|NCT00429923|19575661|P1|COMPLETED|Overall Study||52
7953052|NCT00429923|19575659|P3|STARTED|Overall Study||107
7953053|NCT00429923|19575660|P2|STARTED|Overall Study||55
7953054|NCT00429923|19575661|P1|STARTED|Overall Study||57
7953055|NCT00429858|19575666|P1|NOT COMPLETED|Overall Study||2
7953056|NCT00429858|19575666|P1|COMPLETED|Overall Study||19
7953057|NCT00429858|19575666|P1|STARTED|Overall Study||21
7953058|NCT00429793|19575677|P1|NOT COMPLETED|Overall Study||6
7953059|NCT00429793|19575677|P1|COMPLETED|Overall Study||54
7953060|NCT00429793|19575677|P1|STARTED|Overall Study||60
7953061|NCT00429702|19575693|P2|NOT COMPLETED|Overall Study||0
7953062|NCT00429702|19575694|P1|NOT COMPLETED|Overall Study||0
7953063|NCT00429702|19575693|P2|COMPLETED|Overall Study||4
7953064|NCT00429702|19575694|P1|COMPLETED|Overall Study||3
7953065|NCT00429702|19575693|P2|STARTED|Overall Study||4
7953066|NCT00429702|19575694|P1|STARTED|Overall Study||3
7953067|NCT00429663|19575704|P2|NOT COMPLETED|Overall Study||39
7953068|NCT00429663|19575705|P1|NOT COMPLETED|Overall Study||36
7953069|NCT00429663|19575704|P2|COMPLETED|Overall Study||41
7953070|NCT00429663|19575705|P1|COMPLETED|Overall Study||40
7953071|NCT00429663|19575704|P2|STARTED|Overall Study||80
7953072|NCT00429663|19575705|P1|STARTED|Overall Study||76
7953073|NCT00429572|19575719|P1|NOT COMPLETED|Overall Study||1
7953074|NCT00429572|19575719|P1|COMPLETED|Overall Study||18
7953075|NCT00429572|19575719|P1|STARTED|Overall Study||19
7953076|NCT00429507|19575727|P1|NOT COMPLETED|Overall Study||0
7953077|NCT00429507|19575727|P1|COMPLETED|Overall Study||12
7953078|NCT00429507|19575727|P1|STARTED|Overall Study||12
7953079|NCT00429494|19575731|P1|NOT COMPLETED|Overall Study||15
7953080|NCT00429494|19575731|P1|COMPLETED|Overall Study||44
7953081|NCT00429494|19575731|P1|STARTED|Overall Study||59
7953082|NCT00429416|19575735|P1|NOT COMPLETED|Overall Study||1
7953083|NCT00429416|19575735|P1|COMPLETED|Overall Study||13
7953084|NCT00429416|19575735|P1|STARTED|Overall Study||14
7953085|NCT00429403|19575745|P2|NOT COMPLETED|Overall Study||0
7953086|NCT00429403|19575746|P1|NOT COMPLETED|Overall Study||0
7953087|NCT00429403|19575745|P2|COMPLETED|Overall Study||0
7953088|NCT00429403|19575746|P1|COMPLETED|Overall Study||1
7953089|NCT00429403|19575745|P2|STARTED|Overall Study||0
7953090|NCT00429403|19575746|P1|STARTED|Overall Study||1
7953091|NCT00429364|19575754|P2|NOT COMPLETED|Overall Study||33
7953092|NCT00429364|19575755|P1|NOT COMPLETED|Overall Study||32
7953093|NCT00429364|19575754|P2|COMPLETED|Overall Study||272
7953094|NCT00429364|19575755|P1|COMPLETED|Overall Study||271
7953095|NCT00429364|19575754|P2|STARTED|Overall Study||305
7953096|NCT00429364|19575755|P1|STARTED|Overall Study||303
7953097|NCT00429299|19575814|P3|NOT COMPLETED|Overall Study||4
7953098|NCT00429299|19575815|P2|NOT COMPLETED|Overall Study||7
7953099|NCT00429299|19575816|P1|NOT COMPLETED|Overall Study||4
7953100|NCT00429299|19575814|P3|COMPLETED|Overall Study||42
7953101|NCT00429299|19575815|P2|COMPLETED|Overall Study||32
7953102|NCT00429299|19575816|P1|COMPLETED|Overall Study||32
7953103|NCT00429299|19575814|P3|STARTED|Overall Study||46
7953104|NCT00429299|19575815|P2|STARTED|Overall Study||39
7953105|NCT00429299|19575816|P1|STARTED|Overall Study||36
7953106|NCT00429273|19575848|P3|NOT COMPLETED|Overall Study||9
7953107|NCT00429273|19575849|P2|NOT COMPLETED|Overall Study||8
7953108|NCT00429273|19575850|P1|NOT COMPLETED|Overall Study||8
7953109|NCT00429273|19575848|P3|COMPLETED|Overall Study||61
7953110|NCT00429273|19575849|P2|COMPLETED|Overall Study||61
7953111|NCT00429273|19575850|P1|COMPLETED|Overall Study||60
7953112|NCT00429273|19575848|P3|STARTED|Overall Study||70
7953113|NCT00429273|19575849|P2|STARTED|Overall Study||69
7953114|NCT00429273|19575850|P1|STARTED|Overall Study||68
7953115|NCT00429182|19575858|P1|NOT COMPLETED|Overall Study||7
7953116|NCT00429182|19575858|P1|COMPLETED|Overall Study||25
7953117|NCT00429182|19575858|P1|STARTED|Overall Study||32
7953118|NCT00429169|19575865|P2|NOT COMPLETED|Overall Study||2
7953119|NCT00429169|19575866|P1|NOT COMPLETED|Overall Study||2
7953120|NCT00429169|19575865|P2|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38
7953121|NCT00429169|19575866|P1|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36
7953122|NCT00429169|19575865|P2|STARTED|Overall Study||40
7953123|NCT00429169|19575866|P1|STARTED|Overall Study||38
7953124|NCT00429143|19575878|P1|NOT COMPLETED|Overall Study||0
7953125|NCT00429143|19575878|P1|COMPLETED|Overall Study||27
7953126|NCT00429143|19575878|P1|STARTED|Overall Study||27
7953127|NCT00429104|19575886|P1|NOT COMPLETED|Overall Study||1
7953128|NCT00429104|19575886|P1|COMPLETED|Overall Study||17
7953129|NCT00429104|19575886|P1|STARTED|Overall Study||18
7953130|NCT00429026|19575891|P1|NOT COMPLETED|Overall Study||40
7953131|NCT00429026|19575891|P1|COMPLETED|Overall Study||0
7953132|NCT00429026|19575891|P1|STARTED|Overall Study||40
7953133|NCT00428974|19575899|P4|NOT COMPLETED|Overall Study||3
7953134|NCT00428974|19575900|P3|NOT COMPLETED|Overall Study||1
7953135|NCT00428974|19575901|P2|NOT COMPLETED|Overall Study||0
7953136|NCT00428974|19575902|P1|NOT COMPLETED|Overall Study||8
7953137|NCT00428974|19575899|P4|COMPLETED|Overall Study||16
7953138|NCT00428974|19575900|P3|COMPLETED|Overall Study||14
7953139|NCT00428974|19575901|P2|COMPLETED|Overall Study||17
7953140|NCT00428974|19575902|P1|COMPLETED|Overall Study||17
7953141|NCT00428974|19575899|P4|STARTED|Overall Study||19
7953142|NCT00428974|19575900|P3|STARTED|Overall Study||15
7953143|NCT00428974|19575901|P2|STARTED|Overall Study||17
7953144|NCT00428974|19575902|P1|STARTED|Overall Study|one patient was randomized but never received study treatment|25
7953145|NCT00428948|19575918|P2|NOT COMPLETED|Overall Study||67
7953146|NCT00428948|19575919|P1|NOT COMPLETED|Overall Study||221
7953147|NCT00428948|19575918|P2|COMPLETED|Overall Study||417
7953148|NCT00428948|19575919|P1|COMPLETED|Overall Study||740
7953149|NCT00428948|19575918|P2|Received Treatment|Overall Study||483
7953150|NCT00428948|19575919|P1|Received Treatment|Overall Study||961
7953151|NCT00428948|19575918|P2|STARTED|Overall Study||484
7953152|NCT00428948|19575919|P1|STARTED|Overall Study||961
7953153|NCT00428922|19575937|P1|NOT COMPLETED|Overall Study||0
7953154|NCT00428922|19575937|P1|COMPLETED|Overall Study||26
7953155|NCT00428922|19575937|P1|STARTED|Overall Study||26
7953156|NCT00428844|19575947|P3|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
7953157|NCT00428844|19575948|P2|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
7953158|NCT00428844|19575949|P1|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3
7953159|NCT00428844|19575947|P3|COMPLETED|Completed Test of Cure (TOC) Visit||17
7953160|NCT00428844|19575948|P2|COMPLETED|Completed Test of Cure (TOC) Visit||16
7953161|NCT00428844|19575949|P1|COMPLETED|Completed Test of Cure (TOC) Visit||20
7953162|NCT00428844|19575947|P3|STARTED|Completed Test of Cure (TOC) Visit||19
7953163|NCT00428844|19575948|P2|STARTED|Completed Test of Cure (TOC) Visit||18
7953164|NCT00428844|19575949|P1|STARTED|Completed Test of Cure (TOC) Visit||23
7953165|NCT00428844|19575947|P3|NOT COMPLETED|Completed Study Drug Treatment||7
7953166|NCT00428844|19575948|P2|NOT COMPLETED|Completed Study Drug Treatment||6
7953167|NCT00428844|19575949|P1|NOT COMPLETED|Completed Study Drug Treatment||2
7953168|NCT00428844|19575947|P3|COMPLETED|Completed Study Drug Treatment||19
7953169|NCT00428844|19575948|P2|COMPLETED|Completed Study Drug Treatment||18
7953170|NCT00428844|19575949|P1|COMPLETED|Completed Study Drug Treatment||23
7953171|NCT00428844|19575947|P3|Received First Dose|Completed Study Drug Treatment||25
7953172|NCT00428844|19575948|P2|Received First Dose|Completed Study Drug Treatment||24
7953173|NCT00428844|19575949|P1|Received First Dose|Completed Study Drug Treatment||25
7953174|NCT00428844|19575947|P3|STARTED|Completed Study Drug Treatment||26
7953175|NCT00428844|19575948|P2|STARTED|Completed Study Drug Treatment||24
7953176|NCT00428844|19575949|P1|STARTED|Completed Study Drug Treatment||25
7953177|NCT00428792|19575972|P2|NOT COMPLETED|Overall Study||4
7953178|NCT00428792|19575973|P1|NOT COMPLETED|Overall Study||1
7953179|NCT00428792|19575972|P2|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66
7953180|NCT00428792|19575973|P1|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79
7953181|NCT00428792|19575972|P2|STARTED|Overall Study||70
7953182|NCT00428792|19575973|P1|STARTED|Overall Study||80
7953183|NCT00428714|19575999|P2|NOT COMPLETED|Overall Study||42
7953184|NCT00428714|19576000|P1|NOT COMPLETED|Overall Study||31
7953185|NCT00428714|19575999|P2|COMPLETED|Overall Study||0
7953186|NCT00428714|19576000|P1|COMPLETED|Overall Study||0
7953187|NCT00428714|19575999|P2|Received at Least 1 Dose of Study Drug|Overall Study||42
7953188|NCT00428714|19576000|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
7953189|NCT00428714|19575999|P2|STARTED|Overall Study||42
7953190|NCT00428714|19576000|P1|STARTED|Overall Study||31
7953191|NCT00428610|19576019|P3|NOT COMPLETED|Overall Study||32
7953192|NCT00428610|19576020|P2|NOT COMPLETED|Overall Study||18
7953193|NCT00428610|19576021|P1|NOT COMPLETED|Overall Study||53
7953194|NCT00428610|19576019|P3|COMPLETED|Overall Study||0
7953195|NCT00428610|19576020|P2|COMPLETED|Overall Study||0
7953196|NCT00428610|19576021|P1|COMPLETED|Overall Study||0
7953197|NCT00428610|19576019|P3|Received at Least One Dose of Study Drug|Overall Study||32
7953198|NCT00428610|19576020|P2|Received at Least One Dose of Study Drug|Overall Study||18
7953199|NCT00428610|19576021|P1|Received at Least One Dose of Study Drug|Overall Study||53
7953200|NCT00428610|19576019|P3|STARTED|Overall Study||32
7953201|NCT00428610|19576020|P2|STARTED|Overall Study||18
7953202|NCT00428610|19576021|P1|STARTED|Overall Study||53
7953203|NCT00428597|19576055|P2|NOT COMPLETED|Overall Study||85
7953204|NCT00428597|19576056|P1|NOT COMPLETED|Overall Study||86
7953205|NCT00428597|19576055|P2|COMPLETED|Overall Study||0
7953206|NCT00428597|19576056|P1|COMPLETED|Overall Study||0
7953207|NCT00428597|19576055|P2|Received Treatment|Overall Study||82
7953208|NCT00428597|19576056|P1|Received Treatment|Overall Study||83
7953209|NCT00428597|19576055|P2|STARTED|Overall Study||85
7953210|NCT00428597|19576056|P1|STARTED|Overall Study||86
7953211|NCT00428584|19576098|P2|NOT COMPLETED|Extension Phase||29
7953212|NCT00428584|19576099|P1|NOT COMPLETED|Extension Phase||21
7953213|NCT00428584|19576098|P2|COMPLETED|Extension Phase||34
7953214|NCT00428584|19576099|P1|COMPLETED|Extension Phase||35
7953215|NCT00428584|19576098|P2|STARTED|Extension Phase||63
7953216|NCT00428584|19576099|P1|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56
7953217|NCT00428584|19576098|P2|NOT COMPLETED|Comparative Phase||1
7953218|NCT00428584|19576099|P1|NOT COMPLETED|Comparative Phase||9
7953219|NCT00428584|19576098|P2|COMPLETED|Comparative Phase||63
7953220|NCT00428584|19576099|P1|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56
7953221|NCT00428584|19576098|P2|STARTED|Comparative Phase||64
7953222|NCT00428584|19576099|P1|STARTED|Comparative Phase||65
7953223|NCT00428441|19576123|P1|NOT COMPLETED|Overall Study||1
7953224|NCT00428441|19576123|P1|COMPLETED|Overall Study||74
7953225|NCT00428441|19576123|P1|STARTED|Overall Study||75
7953226|NCT00428389|19576129|P2|NOT COMPLETED|Extension Phase||26
7953227|NCT00428389|19576130|P1|NOT COMPLETED|Extension Phase||32
7953228|NCT00428389|19576129|P2|COMPLETED|Extension Phase||91
7953229|NCT00428389|19576130|P1|COMPLETED|Extension Phase||85
7953230|NCT00428389|19576129|P2|STARTED|Extension Phase||117
7953231|NCT00428389|19576130|P1|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117
7953232|NCT00428389|19576129|P2|NOT COMPLETED|Core Phase||11
7953233|NCT00428389|19576130|P1|NOT COMPLETED|Core Phase||11
7953234|NCT00428389|19576129|P2|COMPLETED|Core Phase||120
7953235|NCT00428389|19576130|P1|COMPLETED|Core Phase||120
7953236|NCT00428389|19576129|P2|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130
7953237|NCT00428389|19576130|P1|Intent-to-treat Population|Core Phase||131
7953238|NCT00428389|19576129|P2|STARTED|Core Phase||131
7953239|NCT00428389|19576130|P1|STARTED|Core Phase||131
7953240|NCT00428298|19576150|P2|NOT COMPLETED|Overall Study||11
7953241|NCT00428298|19576151|P1|NOT COMPLETED|Overall Study||14
7953242|NCT00428298|19576150|P2|COMPLETED|Overall Study||19
7953243|NCT00428298|19576151|P1|COMPLETED|Overall Study||16
7953244|NCT00428298|19576150|P2|Second RBANS at Study Exit|Overall Study||3
7953245|NCT00428298|19576151|P1|Second RBANS at Study Exit|Overall Study||3
7953246|NCT00428298|19576150|P2|STARTED|Overall Study||30
7953247|NCT00428298|19576151|P1|STARTED|Overall Study||30
7953248|NCT00428246|19576164|P3|NOT COMPLETED|Overall Study||1
7953249|NCT00428246|19576165|P2|NOT COMPLETED|Overall Study||0
7953250|NCT00428246|19576166|P1|NOT COMPLETED|Overall Study||1
7953251|NCT00428246|19576164|P3|COMPLETED|Overall Study||7
7953252|NCT00428246|19576165|P2|COMPLETED|Overall Study||8
7953253|NCT00428246|19576166|P1|COMPLETED|Overall Study||7
7953254|NCT00428246|19576164|P3|STARTED|Overall Study||8
7953255|NCT00428246|19576165|P2|STARTED|Overall Study||8
7953256|NCT00428246|19576166|P1|STARTED|Overall Study||8
7953257|NCT00428220|19576174|P1|NOT COMPLETED|Overall Study||223
7953258|NCT00428220|19576174|P1|COMPLETED|Overall Study||0
7953259|NCT00428220|19576174|P1|STARTED|Overall Study||223
7953260|NCT00428207|19576190|P2|NOT COMPLETED|Overall Study||0
7953261|NCT00428207|19576191|P1|NOT COMPLETED|Overall Study||0
7953262|NCT00428207|19576190|P2|COMPLETED|Overall Study||2
7953263|NCT00428207|19576191|P1|COMPLETED|Overall Study||2
7953264|NCT00428207|19576190|P2|STARTED|Overall Study||2
7953265|NCT00428207|19576191|P1|STARTED|Overall Study||2
7953266|NCT00428116|19576199|P2|NOT COMPLETED|Overall Study||0
7953267|NCT00428116|19576200|P1|NOT COMPLETED|Overall Study||3
7953268|NCT00428116|19576199|P2|COMPLETED|Overall Study||21
7953269|NCT00428116|19576200|P1|COMPLETED|Overall Study||18
7953270|NCT00428116|19576199|P2|STARTED|Overall Study||21
7953271|NCT00428116|19576200|P1|STARTED|Overall Study||21
7953272|NCT00428090|19576212|P4|NOT COMPLETED|Overall Study||28
7953273|NCT00428090|19576213|P3|NOT COMPLETED|Overall Study||38
7953274|NCT00428090|19576214|P2|NOT COMPLETED|Overall Study||31
7953275|NCT00428090|19576215|P1|NOT COMPLETED|Overall Study||34
7953276|NCT00428090|19576212|P4|COMPLETED|Overall Study||55
7953277|NCT00428090|19576213|P3|COMPLETED|Overall Study||127
7953278|NCT00428090|19576214|P2|COMPLETED|Overall Study||135
7953279|NCT00428090|19576215|P1|COMPLETED|Overall Study||131
7953280|NCT00428090|19576212|P4|STARTED|Overall Study||83
7953281|NCT00428090|19576213|P3|STARTED|Overall Study||165
7953282|NCT00428090|19576214|P2|STARTED|Overall Study||166
7953283|NCT00428090|19576215|P1|STARTED|Overall Study||165
7953284|NCT00428077|19576329|P1|NOT COMPLETED|Overall Study||0
7953285|NCT00428077|19576329|P1|COMPLETED|Overall Study||4
7953286|NCT00428077|19576329|P1|STARTED|Overall Study||4
7953287|NCT00427999|19576333|P1|NOT COMPLETED|Overall Study||32
7953288|NCT00427999|19576333|P1|COMPLETED|Overall Study||33
7953289|NCT00427999|19576333|P1|Extension Follow-up|Overall Study||19
7953290|NCT00427999|19576333|P1|Intent to Treat (ITT)|Overall Study||61
7953291|NCT00427999|19576333|P1|STARTED|Overall Study||65
7953292|NCT00427973|19576342|P1|NOT COMPLETED|Overall Study||0
7953293|NCT00427973|19576342|P1|COMPLETED|Overall Study||17
7953294|NCT00427973|19576342|P1|STARTED|Overall Study||17
7953295|NCT00427960|19576351|P2|NOT COMPLETED|Overall Study||4
7953296|NCT00427960|19576352|P1|NOT COMPLETED|Overall Study||2
7953297|NCT00427960|19576351|P2|COMPLETED|Overall Study||21
7953298|NCT00427960|19576352|P1|COMPLETED|Overall Study||28
7953299|NCT00427960|19576351|P2|STARTED|Overall Study||25
7953300|NCT00427960|19576352|P1|STARTED|Overall Study||30
7953301|NCT00427934|19576390|P4|NOT COMPLETED|Overall Study||15
7953302|NCT00427934|19576391|P3|NOT COMPLETED|Overall Study||23
7953303|NCT00427934|19576392|P2|NOT COMPLETED|Overall Study||0
7953304|NCT00427934|19576393|P1|NOT COMPLETED|Overall Study||1
7953305|NCT00427934|19576390|P4|COMPLETED|Overall Study||19
7953306|NCT00427934|19576391|P3|COMPLETED|Overall Study||55
7953307|NCT00427934|19576392|P2|COMPLETED|Overall Study||8
7953308|NCT00427934|19576393|P1|COMPLETED|Overall Study||7
7953309|NCT00427934|19576390|P4|Treated|Overall Study||33
7953310|NCT00427934|19576391|P3|Treated|Overall Study||77
7953311|NCT00427934|19576392|P2|Treated|Overall Study||8
7953312|NCT00427934|19576393|P1|Treated|Overall Study||8
7953313|NCT00427934|19576390|P4|STARTED|Overall Study||34
7953314|NCT00427934|19576391|P3|STARTED|Overall Study||78
7953315|NCT00427934|19576392|P2|STARTED|Overall Study||8
7953316|NCT00427934|19576393|P1|STARTED|Overall Study||8
7953317|NCT00427921|19576461|P1|NOT COMPLETED|Overall Study||50
7953318|NCT00427921|19576461|P1|COMPLETED|Overall Study||254
7953319|NCT00427921|19576461|P1|STARTED|Overall Study||304
7953320|NCT00427908|19576484|P4|NOT COMPLETED|Persistence Phase Year 5||0
7953321|NCT00427908|19576485|P3|NOT COMPLETED|Persistence Phase Year 5||0
7953322|NCT00427908|19576486|P2|NOT COMPLETED|Persistence Phase Year 5||0
7953323|NCT00427908|19576487|P1|NOT COMPLETED|Persistence Phase Year 5||0
7953324|NCT00427908|19576484|P4|COMPLETED|Persistence Phase Year 5||13
7953325|NCT00427908|19576485|P3|COMPLETED|Persistence Phase Year 5||12
7953326|NCT00427908|19576486|P2|COMPLETED|Persistence Phase Year 5||99
7953327|NCT00427908|19576487|P1|COMPLETED|Persistence Phase Year 5||52
7953328|NCT00427908|19576484|P4|STARTED|Persistence Phase Year 5||13
7953329|NCT00427908|19576485|P3|STARTED|Persistence Phase Year 5||12
7953330|NCT00427908|19576486|P2|STARTED|Persistence Phase Year 5||99
7953331|NCT00427908|19576487|P1|STARTED|Persistence Phase Year 5||52
7953332|NCT00427908|19576484|P4|NOT COMPLETED|Persistence Phase Year 4||0
7953333|NCT00427908|19576485|P3|NOT COMPLETED|Persistence Phase Year 4||0
7953334|NCT00427908|19576486|P2|NOT COMPLETED|Persistence Phase Year 4||0
7953335|NCT00427908|19576487|P1|NOT COMPLETED|Persistence Phase Year 4||0
7953336|NCT00427908|19576484|P4|COMPLETED|Persistence Phase Year 4||32
7953337|NCT00427908|19576485|P3|COMPLETED|Persistence Phase Year 4||34
7953338|NCT00427908|19576486|P2|COMPLETED|Persistence Phase Year 4||192
7953339|NCT00427908|19576487|P1|COMPLETED|Persistence Phase Year 4||165
7953340|NCT00427908|19576484|P4|STARTED|Persistence Phase Year 4||32
7953341|NCT00427908|19576485|P3|STARTED|Persistence Phase Year 4||34
7953342|NCT00427908|19576486|P2|STARTED|Persistence Phase Year 4||192
7953343|NCT00427908|19576487|P1|STARTED|Persistence Phase Year 4||165
7953344|NCT00427908|19576484|P4|NOT COMPLETED|Persistence Phase Year 3||0
7953345|NCT00427908|19576485|P3|NOT COMPLETED|Persistence Phase Year 3||0
7953346|NCT00427908|19576486|P2|NOT COMPLETED|Persistence Phase Year 3||0
7953347|NCT00427908|19576487|P1|NOT COMPLETED|Persistence Phase Year 3||0
7953348|NCT00427908|19576484|P4|COMPLETED|Persistence Phase Year 3||38
7953349|NCT00427908|19576485|P3|COMPLETED|Persistence Phase Year 3||38
7953350|NCT00427908|19576486|P2|COMPLETED|Persistence Phase Year 3||201
7953351|NCT00427908|19576487|P1|COMPLETED|Persistence Phase Year 3||185
7953352|NCT00427908|19576484|P4|STARTED|Persistence Phase Year 3||38
7953353|NCT00427908|19576485|P3|STARTED|Persistence Phase Year 3||38
7953354|NCT00427908|19576486|P2|STARTED|Persistence Phase Year 3||201
7953355|NCT00427908|19576487|P1|STARTED|Persistence Phase Year 3||185
7953356|NCT00427908|19576484|P4|NOT COMPLETED|Persistence Phase Year 2||0
7953357|NCT00427908|19576485|P3|NOT COMPLETED|Persistence Phase Year 2||0
7953358|NCT00427908|19576486|P2|NOT COMPLETED|Persistence Phase Year 2||0
7953359|NCT00427908|19576487|P1|NOT COMPLETED|Persistence Phase Year 2||0
7953360|NCT00427908|19576484|P4|COMPLETED|Persistence Phase Year 2||61
7953361|NCT00427908|19576485|P3|COMPLETED|Persistence Phase Year 2||53
7953362|NCT00427908|19576486|P2|COMPLETED|Persistence Phase Year 2||215
7953363|NCT00427908|19576487|P1|COMPLETED|Persistence Phase Year 2||208
7953364|NCT00427908|19576484|P4|STARTED|Persistence Phase Year 2||61
7953365|NCT00427908|19576485|P3|STARTED|Persistence Phase Year 2||53
7953366|NCT00427908|19576486|P2|STARTED|Persistence Phase Year 2||215
7953367|NCT00427908|19576487|P1|STARTED|Persistence Phase Year 2||208
7953368|NCT00427908|19576484|P4|NOT COMPLETED|Persistence Phase Year 1||0
7953369|NCT00427908|19576485|P3|NOT COMPLETED|Persistence Phase Year 1||0
7953370|NCT00427908|19576486|P2|NOT COMPLETED|Persistence Phase Year 1||0
7953371|NCT00427908|19576487|P1|NOT COMPLETED|Persistence Phase Year 1||0
7953372|NCT00427908|19576484|P4|COMPLETED|Persistence Phase Year 1||78
7953373|NCT00427908|19576485|P3|COMPLETED|Persistence Phase Year 1||71
7953374|NCT00427908|19576486|P2|COMPLETED|Persistence Phase Year 1||221
7953375|NCT00427908|19576487|P1|COMPLETED|Persistence Phase Year 1||222
7953376|NCT00427908|19576484|P4|STARTED|Persistence Phase Year 1||78
7953377|NCT00427908|19576485|P3|STARTED|Persistence Phase Year 1||71
7953378|NCT00427908|19576486|P2|STARTED|Persistence Phase Year 1||221
7953379|NCT00427908|19576487|P1|STARTED|Persistence Phase Year 1||222
7953380|NCT00427908|19576484|P4|NOT COMPLETED|Primary Phase||0
7953381|NCT00427908|19576485|P3|NOT COMPLETED|Primary Phase||3
7953382|NCT00427908|19576486|P2|NOT COMPLETED|Primary Phase||3
7953383|NCT00427908|19576487|P1|NOT COMPLETED|Primary Phase||5
7953384|NCT00427908|19576484|P4|COMPLETED|Primary Phase||78
7953385|NCT00427908|19576485|P3|COMPLETED|Primary Phase||72
7953386|NCT00427908|19576486|P2|COMPLETED|Primary Phase||228
7953387|NCT00427908|19576487|P1|COMPLETED|Primary Phase||224
7953388|NCT00427908|19576484|P4|STARTED|Primary Phase||78
7953389|NCT00427908|19576485|P3|STARTED|Primary Phase||75
7953390|NCT00427908|19576486|P2|STARTED|Primary Phase||231
7953391|NCT00427908|19576487|P1|STARTED|Primary Phase||229
7953392|NCT00427895|19576687|P8|NOT COMPLETED|Vax 2/Year 3 to 4||2
7953393|NCT00427895|19576688|P7|NOT COMPLETED|Vax 2/Year 3 to 4||0
7953394|NCT00427895|19576689|P6|NOT COMPLETED|Vax 2/Year 3 to 4||0
7953395|NCT00427895|19576690|P5|NOT COMPLETED|Vax 2/Year 3 to 4||1
7953396|NCT00427895|19576691|P4|NOT COMPLETED|Vax 2/Year 3 to 4||0
7953397|NCT00427895|19576692|P3|NOT COMPLETED|Vax 2/Year 3 to 4||0
7953398|NCT00427895|19576693|P2|NOT COMPLETED|Vax 2/Year 3 to 4||0
7953399|NCT00427895|19576694|P1|NOT COMPLETED|Vax 2/Year 3 to 4||0
7953400|NCT00427895|19576687|P8|COMPLETED|Vax 2/Year 3 to 4||212
7953401|NCT00427895|19576688|P7|COMPLETED|Vax 2/Year 3 to 4||189
7953402|NCT00427895|19576689|P6|COMPLETED|Vax 2/Year 3 to 4||108
7953403|NCT00427895|19576690|P5|COMPLETED|Vax 2/Year 3 to 4||107
7953404|NCT00427895|19576691|P4|COMPLETED|Vax 2/Year 3 to 4||0
7953405|NCT00427895|19576692|P3|COMPLETED|Vax 2/Year 3 to 4||0
7953406|NCT00427895|19576693|P2|COMPLETED|Vax 2/Year 3 to 4||0
7953407|NCT00427895|19576694|P1|COMPLETED|Vax 2/Year 3 to 4||0
7953408|NCT00427895|19576687|P8|STARTED|Vax 2/Year 3 to 4||214
7953409|NCT00427895|19576688|P7|STARTED|Vax 2/Year 3 to 4||189
7953410|NCT00427895|19576689|P6|STARTED|Vax 2/Year 3 to 4||108
7953411|NCT00427895|19576690|P5|STARTED|Vax 2/Year 3 to 4||108
7953412|NCT00427895|19576691|P4|STARTED|Vax 2/Year 3 to 4||0
7953413|NCT00427895|19576692|P3|STARTED|Vax 2/Year 3 to 4||0
7953414|NCT00427895|19576693|P2|STARTED|Vax 2/Year 3 to 4||0
7953415|NCT00427895|19576694|P1|STARTED|Vax 2/Year 3 to 4||0
7953416|NCT00427895|19576687|P8|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
7953417|NCT00427895|19576688|P7|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
7953418|NCT00427895|19576689|P6|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
7953419|NCT00427895|19576690|P5|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
7953420|NCT00427895|19576691|P4|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469
7953421|NCT00427895|19576692|P3|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159
7953422|NCT00427895|19576693|P2|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207
7953423|NCT00427895|19576694|P1|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188
7953424|NCT00427895|19576687|P8|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
7953425|NCT00427895|19576688|P7|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
7953426|NCT00427895|19576689|P6|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
7953427|NCT00427895|19576690|P5|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
7953428|NCT00427895|19576691|P4|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
7953429|NCT00427895|19576692|P3|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214
7953430|NCT00427895|19576693|P2|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189
7953431|NCT00427895|19576694|P1|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216
7953432|NCT00427895|19576687|P8|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
7953433|NCT00427895|19576688|P7|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
7953434|NCT00427895|19576689|P6|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
7953435|NCT00427895|19576690|P5|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
7953436|NCT00427895|19576691|P4|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469
7953437|NCT00427895|19576692|P3|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373
7953438|NCT00427895|19576693|P2|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396
7953439|NCT00427895|19576694|P1|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404
7953440|NCT00427895|19576687|P8|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
7953441|NCT00427895|19576688|P7|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
7953442|NCT00427895|19576689|P6|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
7953443|NCT00427895|19576690|P5|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
7953444|NCT00427895|19576691|P4|NOT COMPLETED|Vax 1/Year 1 Follow-up||33
7953445|NCT00427895|19576692|P3|NOT COMPLETED|Vax 1/Year 1 Follow-up||19
7953446|NCT00427895|19576693|P2|NOT COMPLETED|Vax 1/Year 1 Follow-up||15
7953447|NCT00427895|19576694|P1|NOT COMPLETED|Vax 1/Year 1 Follow-up||7
7953448|NCT00427895|19576687|P8|COMPLETED|Vax 1/Year 1 Follow-up||0
7953449|NCT00427895|19576688|P7|COMPLETED|Vax 1/Year 1 Follow-up||0
7953450|NCT00427895|19576689|P6|COMPLETED|Vax 1/Year 1 Follow-up||0
7953451|NCT00427895|19576690|P5|COMPLETED|Vax 1/Year 1 Follow-up||0
7953452|NCT00427895|19576691|P4|COMPLETED|Vax 1/Year 1 Follow-up||469
7953453|NCT00427895|19576692|P3|COMPLETED|Vax 1/Year 1 Follow-up||373
7953454|NCT00427895|19576693|P2|COMPLETED|Vax 1/Year 1 Follow-up||396
7953455|NCT00427895|19576694|P1|COMPLETED|Vax 1/Year 1 Follow-up||404
7953456|NCT00427895|19576687|P8|STARTED|Vax 1/Year 1 Follow-up||0
7953457|NCT00427895|19576688|P7|STARTED|Vax 1/Year 1 Follow-up||0
7953458|NCT00427895|19576689|P6|STARTED|Vax 1/Year 1 Follow-up||0
7953459|NCT00427895|19576690|P5|STARTED|Vax 1/Year 1 Follow-up||0
7953460|NCT00427895|19576691|P4|STARTED|Vax 1/Year 1 Follow-up||502
7953461|NCT00427895|19576692|P3|STARTED|Vax 1/Year 1 Follow-up||392
7953462|NCT00427895|19576693|P2|STARTED|Vax 1/Year 1 Follow-up||411
7953463|NCT00427895|19576694|P1|STARTED|Vax 1/Year 1 Follow-up||411
7953464|NCT00427895|19576687|P8|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
7953465|NCT00427895|19576688|P7|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
7953466|NCT00427895|19576689|P6|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
7953467|NCT00427895|19576690|P5|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
7953468|NCT00427895|19576691|P4|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352
7953469|NCT00427895|19576692|P3|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
7953470|NCT00427895|19576693|P2|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
7953471|NCT00427895|19576694|P1|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
7953472|NCT00427895|19576687|P8|COMPLETED|Between 6-Month Follow-up - Year 1||0
7953473|NCT00427895|19576688|P7|COMPLETED|Between 6-Month Follow-up - Year 1||0
7953474|NCT00427895|19576689|P6|COMPLETED|Between 6-Month Follow-up - Year 1||0
7953475|NCT00427895|19576690|P5|COMPLETED|Between 6-Month Follow-up - Year 1||0
7953476|NCT00427895|19576691|P4|COMPLETED|Between 6-Month Follow-up - Year 1||502
7953477|NCT00427895|19576692|P3|COMPLETED|Between 6-Month Follow-up - Year 1||392
7953478|NCT00427895|19576693|P2|COMPLETED|Between 6-Month Follow-up - Year 1||411
7953479|NCT00427895|19576694|P1|COMPLETED|Between 6-Month Follow-up - Year 1||411
7953480|NCT00427895|19576687|P8|STARTED|Between 6-Month Follow-up - Year 1||0
7953481|NCT00427895|19576688|P7|STARTED|Between 6-Month Follow-up - Year 1||0
7953482|NCT00427895|19576689|P6|STARTED|Between 6-Month Follow-up - Year 1||0
7953483|NCT00427895|19576690|P5|STARTED|Between 6-Month Follow-up - Year 1||0
7953484|NCT00427895|19576691|P4|STARTED|Between 6-Month Follow-up - Year 1||854
7953485|NCT00427895|19576692|P3|STARTED|Between 6-Month Follow-up - Year 1||392
7953486|NCT00427895|19576693|P2|STARTED|Between 6-Month Follow-up - Year 1||411
7953487|NCT00427895|19576694|P1|STARTED|Between 6-Month Follow-up - Year 1||411
7953488|NCT00427895|19576687|P8|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
7953489|NCT00427895|19576688|P7|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
7953490|NCT00427895|19576689|P6|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
7953491|NCT00427895|19576690|P5|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
7953492|NCT00427895|19576691|P4|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46
7953493|NCT00427895|19576692|P3|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14
7953494|NCT00427895|19576693|P2|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6
7953495|NCT00427895|19576694|P1|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7
7953496|NCT00427895|19576687|P8|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
7953497|NCT00427895|19576688|P7|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
7953498|NCT00427895|19576689|P6|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
7953499|NCT00427895|19576690|P5|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
7953500|NCT00427895|19576691|P4|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854
7953501|NCT00427895|19576692|P3|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392
7953502|NCT00427895|19576693|P2|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
7953503|NCT00427895|19576694|P1|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
7953504|NCT00427895|19576687|P8|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
7953505|NCT00427895|19576688|P7|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
7953506|NCT00427895|19576689|P6|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
7953507|NCT00427895|19576690|P5|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
7953508|NCT00427895|19576691|P4|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899
7953509|NCT00427895|19576692|P3|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404
7953510|NCT00427895|19576693|P2|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414
7953511|NCT00427895|19576694|P1|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417
7953512|NCT00427895|19576687|P8|STARTED|Vax 1 Baseline/6-Month Follow-up||0
7953513|NCT00427895|19576688|P7|STARTED|Vax 1 Baseline/6-Month Follow-up||0
7953514|NCT00427895|19576689|P6|STARTED|Vax 1 Baseline/6-Month Follow-up||0
7953515|NCT00427895|19576690|P5|STARTED|Vax 1 Baseline/6-Month Follow-up||0
7953516|NCT00427895|19576691|P4|STARTED|Vax 1 Baseline/6-Month Follow-up||900
7953517|NCT00427895|19576692|P3|STARTED|Vax 1 Baseline/6-Month Follow-up||406
7953518|NCT00427895|19576693|P2|STARTED|Vax 1 Baseline/6-Month Follow-up||417
7953519|NCT00427895|19576694|P1|STARTED|Vax 1 Baseline/6-Month Follow-up||418
7953520|NCT00427804|19576751|P2|NOT COMPLETED|Overall Study||0
7953521|NCT00427804|19576752|P1|NOT COMPLETED|Overall Study||0
7953522|NCT00427804|19576751|P2|COMPLETED|Overall Study||5
7953523|NCT00427804|19576752|P1|COMPLETED|Overall Study||4
7953524|NCT00427804|19576751|P2|STARTED|Overall Study||5
7953525|NCT00427804|19576752|P1|STARTED|Overall Study||4
7953526|NCT00427791|19576760|P2|NOT COMPLETED|Overall Study||0
7953527|NCT00427791|19576761|P1|NOT COMPLETED|Overall Study||0
7953528|NCT00427791|19576760|P2|COMPLETED|Overall Study||13
7953529|NCT00427791|19576761|P1|COMPLETED|Overall Study||10
7953530|NCT00427791|19576760|P2|STARTED|Overall Study||13
7953531|NCT00427791|19576761|P1|STARTED|Overall Study||10
7953532|NCT00427778|19576769|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
7953533|NCT00427778|19576770|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
7953534|NCT00427778|19576769|P2|COMPLETED|Second Intervention (4 Weeks)||14
7953535|NCT00427778|19576770|P1|COMPLETED|Second Intervention (4 Weeks)||10
7953536|NCT00427778|19576769|P2|STARTED|Second Intervention (4 Weeks)||14
7953537|NCT00427778|19576770|P1|STARTED|Second Intervention (4 Weeks)||10
7953538|NCT00427778|19576769|P2|NOT COMPLETED|Wash Out (2 Weeks)||0
7953539|NCT00427778|19576770|P1|NOT COMPLETED|Wash Out (2 Weeks)||0
7953540|NCT00427778|19576769|P2|COMPLETED|Wash Out (2 Weeks)||14
7953541|NCT00427778|19576770|P1|COMPLETED|Wash Out (2 Weeks)||10
7953542|NCT00427778|19576769|P2|STARTED|Wash Out (2 Weeks)||14
7953543|NCT00427778|19576770|P1|STARTED|Wash Out (2 Weeks)||10
7953544|NCT00427778|19576769|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
7953545|NCT00427778|19576770|P1|NOT COMPLETED|First Intervention (4 Weeks)||4
7953546|NCT00427778|19576769|P2|COMPLETED|First Intervention (4 Weeks)||14
7953547|NCT00427778|19576770|P1|COMPLETED|First Intervention (4 Weeks)||10
7953548|NCT00427778|19576769|P2|STARTED|First Intervention (4 Weeks)||15
7953549|NCT00427778|19576770|P1|STARTED|First Intervention (4 Weeks)||14
7953550|NCT00427765|19576789|P1|NOT COMPLETED|Overall Study||0
7953551|NCT00427765|19576789|P1|COMPLETED|Overall Study||164
7953552|NCT00427765|19576789|P1|STARTED|Overall Study||164
7953553|NCT00427700|19576795|P2|NOT COMPLETED|Overall Study||11
7953554|NCT00427700|19576796|P1|NOT COMPLETED|Overall Study||3
7953555|NCT00427700|19576795|P2|COMPLETED|Overall Study||31
7953556|NCT00427700|19576796|P1|COMPLETED|Overall Study||37
7953557|NCT00427700|19576795|P2|STARTED|Overall Study||42
7953558|NCT00427700|19576796|P1|STARTED|Overall Study||40
7953559|NCT00427661|19576804|P1|NOT COMPLETED|Overall Study||0
7953560|NCT00427661|19576804|P1|COMPLETED|Overall Study||8
7953561|NCT00427661|19576804|P1|STARTED|Overall Study||8
7953562|NCT00427648|19576812|P2|NOT COMPLETED|Overall Study||3
7953563|NCT00427648|19576813|P1|NOT COMPLETED|Overall Study||1
7953564|NCT00427648|19576812|P2|COMPLETED|Overall Study||7
7953565|NCT00427648|19576813|P1|COMPLETED|Overall Study||11
7953566|NCT00427648|19576812|P2|STARTED|Overall Study||10
7953567|NCT00427648|19576813|P1|STARTED|Overall Study||12
7953568|NCT00427635|19576833|P2|NOT COMPLETED|Study Completion to Safety Follow-up||1
7953569|NCT00427635|19576834|P1|NOT COMPLETED|Study Completion to Safety Follow-up||0
7953570|NCT00427635|19576833|P2|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25
7953571|NCT00427635|19576834|P1|COMPLETED|Study Completion to Safety Follow-up||25
7953572|NCT00427635|19576833|P2|STARTED|Study Completion to Safety Follow-up||26
7953573|NCT00427635|19576834|P1|STARTED|Study Completion to Safety Follow-up||25
7953574|NCT00427635|19576833|P2|NOT COMPLETED|Treatment Phase||0
7953575|NCT00427635|19576834|P1|NOT COMPLETED|Treatment Phase||1
7953576|NCT00427635|19576833|P2|COMPLETED|Treatment Phase|ITT population|26
7953577|NCT00427635|19576834|P1|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25
7953578|NCT00427635|19576833|P2|STARTED|Treatment Phase|Randomised|26
7953579|NCT00427635|19576834|P1|STARTED|Treatment Phase|Randomised|26
7953580|NCT00427557|19576862|P1|NOT COMPLETED|Overall Study||0
7953581|NCT00427557|19576862|P1|COMPLETED|Overall Study||30
7953582|NCT00427557|19576862|P1|STARTED|Overall Study||30
7953583|NCT00427349|19576866|P1|NOT COMPLETED|Overall Study||46
7953584|NCT00427349|19576866|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0
7953585|NCT00427349|19576866|P1|Eligible and Treated|Overall Study||44
7953586|NCT00427349|19576866|P1|Treated|Overall Study||45
7953587|NCT00427349|19576866|P1|Eligible|Overall Study||45
7953588|NCT00427349|19576866|P1|STARTED|Overall Study||46
7953589|NCT00427336|19576872|P1|NOT COMPLETED|Overall Study||0
7953590|NCT00427336|19576872|P1|COMPLETED|Overall Study||9
7953591|NCT00427336|19576872|P1|STARTED|Overall Study||9
7953592|NCT00427297|19576878|P2|NOT COMPLETED|Overall Study||0
7953593|NCT00427297|19576879|P1|NOT COMPLETED|Overall Study||0
7953594|NCT00427297|19576878|P2|COMPLETED|Overall Study||17
7953595|NCT00427297|19576879|P1|COMPLETED|Overall Study||17
7953596|NCT00427297|19576878|P2|STARTED|Overall Study||17
7953597|NCT00427297|19576879|P1|STARTED|Overall Study||17
7953598|NCT00427193|19576893|P2|NOT COMPLETED|Overall Study||4
7953599|NCT00427193|19576894|P1|NOT COMPLETED|Overall Study||26
7953600|NCT00427193|19576893|P2|COMPLETED|Overall Study||71
7953601|NCT00427193|19576894|P1|COMPLETED|Overall Study||117
7953602|NCT00427193|19576893|P2|STARTED|Overall Study||75
7953603|NCT00427193|19576894|P1|STARTED|Overall Study||143
7953604|NCT00427037|19576914|P2|NOT COMPLETED|Overall Study||7
7953605|NCT00427037|19576915|P1|NOT COMPLETED|Overall Study||7
7953606|NCT00427037|19576914|P2|COMPLETED|Overall Study||10
7953607|NCT00427037|19576915|P1|COMPLETED|Overall Study||10
7953608|NCT00427037|19576914|P2|STARTED|Overall Study||17
7953609|NCT00427037|19576915|P1|STARTED|Overall Study||17
7953610|NCT00427011|19576923|P1|NOT COMPLETED|Overall Study||25
7953611|NCT00427011|19576923|P1|COMPLETED|Overall Study||0
7953612|NCT00427011|19576923|P1|STARTED|Overall Study||25
7953613|NCT00426855|19576934|P1|NOT COMPLETED|Overall Study||0
7953614|NCT00426855|19576934|P1|COMPLETED|Overall Study||12
7953615|NCT00426855|19576934|P1|STARTED|Overall Study||12
7953616|NCT00426842|19576938|P1|NOT COMPLETED|Overall Study||1
7953617|NCT00426842|19576938|P1|COMPLETED|Overall Study||10
7953618|NCT00426842|19576938|P1|STARTED|Overall Study||11
7953619|NCT00426764|19576944|P1|NOT COMPLETED|Overall Study||131
7953620|NCT00426764|19576944|P1|COMPLETED|Overall Study||0
7953621|NCT00426764|19576944|P1|Discontinued at End of or After Cycle 6|Overall Study||33
7953622|NCT00426764|19576944|P1|Discontinued Prior to or During Cycle 6|Overall Study||98
7953623|NCT00426764|19576944|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131
7953624|NCT00426751|19576961|P2|NOT COMPLETED|Overall Study||20
7953625|NCT00426751|19576962|P1|NOT COMPLETED|Overall Study||22
7953626|NCT00426751|19576961|P2|COMPLETED|Overall Study||183
7953627|NCT00426751|19576962|P1|COMPLETED|Overall Study||204
7953628|NCT00426751|19576961|P2|STARTED|Overall Study||203
7953629|NCT00426751|19576962|P1|STARTED|Overall Study||226
7953630|NCT00426660|19577006|P1|NOT COMPLETED|Overall Study||131
7953631|NCT00426660|19577006|P1|COMPLETED|Overall Study||916
7953632|NCT00426660|19577006|P1|Safety Analysis Set|Overall Study||1032
7953633|NCT00426660|19577006|P1|Treated|Overall Study||1032
7953634|NCT00426660|19577006|P1|STARTED|Overall Study||1047
7953635|NCT00426556|19577037|P4|NOT COMPLETED|Phase II - Extension Phase||23
7953636|NCT00426556|19577038|P3|NOT COMPLETED|Phase II - Extension Phase||0
7953637|NCT00426556|19577039|P2|NOT COMPLETED|Phase II - Extension Phase||0
7953638|NCT00426556|19577040|P1|NOT COMPLETED|Phase II - Extension Phase||0
7953639|NCT00426556|19577037|P4|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1
7953640|NCT00426556|19577038|P3|COMPLETED|Phase II - Extension Phase||0
7953641|NCT00426556|19577039|P2|COMPLETED|Phase II - Extension Phase||0
7953642|NCT00426556|19577040|P1|COMPLETED|Phase II - Extension Phase||0
7953643|NCT00426556|19577037|P4|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24
7953644|NCT00426556|19577038|P3|STARTED|Phase II - Extension Phase||0
7953645|NCT00426556|19577039|P2|STARTED|Phase II - Extension Phase||0
7953646|NCT00426556|19577040|P1|STARTED|Phase II - Extension Phase||0
7953647|NCT00426556|19577037|P4|NOT COMPLETED|Phase II - Core Phase||27
7953648|NCT00426556|19577038|P3|NOT COMPLETED|Phase II - Core Phase||0
7953649|NCT00426556|19577039|P2|NOT COMPLETED|Phase II - Core Phase||0
7953650|NCT00426556|19577040|P1|NOT COMPLETED|Phase II - Core Phase||0
7953651|NCT00426556|19577037|P4|COMPLETED|Phase II - Core Phase||28
7953652|NCT00426556|19577038|P3|COMPLETED|Phase II - Core Phase||0
7953653|NCT00426556|19577039|P2|COMPLETED|Phase II - Core Phase||0
7953654|NCT00426556|19577040|P1|COMPLETED|Phase II - Core Phase||0
7953655|NCT00426556|19577037|P4|STARTED|Phase II - Core Phase||55
7953656|NCT00426556|19577038|P3|STARTED|Phase II - Core Phase||0
7953657|NCT00426556|19577039|P2|STARTED|Phase II - Core Phase||0
7953658|NCT00426556|19577040|P1|STARTED|Phase II - Core Phase||0
7953659|NCT00426556|19577037|P4|NOT COMPLETED|Phase I - Extension Phase||0
7953660|NCT00426556|19577038|P3|NOT COMPLETED|Phase I - Extension Phase||7
7953661|NCT00426556|19577039|P2|NOT COMPLETED|Phase I - Extension Phase||6
7953662|NCT00426556|19577040|P1|NOT COMPLETED|Phase I - Extension Phase||5
7953663|NCT00426556|19577037|P4|COMPLETED|Phase I - Extension Phase||0
7953664|NCT00426556|19577038|P3|COMPLETED|Phase I - Extension Phase||0
7953665|NCT00426556|19577039|P2|COMPLETED|Phase I - Extension Phase||1
7953666|NCT00426556|19577040|P1|COMPLETED|Phase I - Extension Phase||0
7953667|NCT00426556|19577037|P4|STARTED|Phase I - Extension Phase||0
7953668|NCT00426556|19577038|P3|STARTED|Phase I - Extension Phase||7
7953669|NCT00426556|19577039|P2|STARTED|Phase I - Extension Phase||7
7953670|NCT00426556|19577040|P1|STARTED|Phase I - Extension Phase||5
7953671|NCT00426556|19577037|P4|NOT COMPLETED|Phase I - Core Phase||0
7953672|NCT00426556|19577038|P3|NOT COMPLETED|Phase I - Core Phase||3
7953673|NCT00426556|19577039|P2|NOT COMPLETED|Phase I - Core Phase||10
7953674|NCT00426556|19577040|P1|NOT COMPLETED|Phase I - Core Phase||1
7953675|NCT00426556|19577037|P4|COMPLETED|Phase I - Core Phase||0
7953676|NCT00426556|19577038|P3|COMPLETED|Phase I - Core Phase||7
7953677|NCT00426556|19577039|P2|COMPLETED|Phase I - Core Phase||7
7953678|NCT00426556|19577040|P1|COMPLETED|Phase I - Core Phase||5
7953679|NCT00426556|19577037|P4|STARTED|Phase I - Core Phase||0
7953680|NCT00426556|19577038|P3|STARTED|Phase I - Core Phase||10
7953681|NCT00426556|19577039|P2|STARTED|Phase I - Core Phase||17
7953682|NCT00426556|19577040|P1|STARTED|Phase I - Core Phase||6
7953683|NCT00426361|19577065|P3|NOT COMPLETED|Overall Study||5
7953684|NCT00426361|19577066|P2|NOT COMPLETED|Overall Study||5
7953685|NCT00426361|19577067|P1|NOT COMPLETED|Overall Study||4
7953686|NCT00426361|19577065|P3|COMPLETED|Overall Study||243
7953687|NCT00426361|19577066|P2|COMPLETED|Overall Study||250
7953688|NCT00426361|19577067|P1|COMPLETED|Overall Study||244
7953689|NCT00426361|19577065|P3|STARTED|Overall Study||248
7953690|NCT00426361|19577066|P2|STARTED|Overall Study||255
7953691|NCT00426361|19577067|P1|STARTED|Overall Study||248
7953692|NCT00426283|19577119|P2|NOT COMPLETED|Overall Study||1
7953693|NCT00426283|19577120|P1|NOT COMPLETED|Overall Study||5
7953694|NCT00426283|19577119|P2|COMPLETED|Overall Study||13
7953695|NCT00426283|19577120|P1|COMPLETED|Overall Study||23
7953696|NCT00426283|19577119|P2|STARTED|Overall Study||14
7953697|NCT00426283|19577120|P1|STARTED|Overall Study||28
7953698|NCT00426270|19577134|P1|NOT COMPLETED|Overall Study||6
7953699|NCT00426270|19577134|P1|COMPLETED|Overall Study||110
7953700|NCT00426270|19577134|P1|STARTED|Overall Study||116
7953701|NCT00426231|19577144|P2|NOT COMPLETED|Overall Study||12
7953702|NCT00426231|19577145|P1|NOT COMPLETED|Overall Study||9
7953703|NCT00426231|19577144|P2|COMPLETED|Overall Study|For the 6-month endpoint|25
7953704|NCT00426231|19577145|P1|COMPLETED|Overall Study|For the 6 month endpoint|27
7953705|NCT00426231|19577144|P2|STARTED|Overall Study||37
7953706|NCT00426231|19577145|P1|STARTED|Overall Study||36
7953707|NCT00426153|19577155|P2|NOT COMPLETED|Overall Study||0
7953708|NCT00426153|19577156|P1|NOT COMPLETED|Overall Study||0
7953709|NCT00426153|19577155|P2|COMPLETED|Overall Study||14
7953710|NCT00426153|19577156|P1|COMPLETED|Overall Study||28
7953711|NCT00426153|19577155|P2|STARTED|Overall Study||14
7953712|NCT00426153|19577156|P1|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28
7953713|NCT00426127|19577168|P1|NOT COMPLETED|Overall Study||2
7953714|NCT00426127|19577168|P1|COMPLETED|Overall Study||0
7953715|NCT00426127|19577168|P1|STARTED|Overall Study||2
7953716|NCT00425945|19577176|P2|NOT COMPLETED|Overall Study||5
7953717|NCT00425945|19577177|P1|NOT COMPLETED|Overall Study||4
7953718|NCT00425945|19577176|P2|COMPLETED|Overall Study||61
7953719|NCT00425945|19577177|P1|COMPLETED|Overall Study||60
7953720|NCT00425945|19577176|P2|STARTED|Overall Study||66
7953721|NCT00425945|19577177|P1|STARTED|Overall Study||64
7953722|NCT00425854|19577215|P2|NOT COMPLETED|Overall Study||21
7953723|NCT00425854|19577216|P1|NOT COMPLETED|Overall Study||29
7953724|NCT00425854|19577215|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
7953725|NCT00425854|19577216|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
7953726|NCT00425854|19577215|P2|STARTED|Overall Study|Treated|21
7953727|NCT00425854|19577216|P1|STARTED|Overall Study|Treated|29
7953728|NCT00425802|19577237|P1|NOT COMPLETED|Overall Study||0
7953729|NCT00425802|19577237|P1|COMPLETED|Overall Study||61
7953730|NCT00425802|19577237|P1|STARTED|Overall Study||61
7953731|NCT00425750|19577249|P1|NOT COMPLETED|Overall Study||25
7953732|NCT00425750|19577249|P1|COMPLETED|Overall Study||0
7953733|NCT00425750|19577249|P1|STARTED|Overall Study||25
7953734|NCT00425698|19577257|P2|NOT COMPLETED|Overall Study||2
7953735|NCT00425698|19577258|P1|NOT COMPLETED|Overall Study||3
7953736|NCT00425698|19577257|P2|COMPLETED|Overall Study||42
7953737|NCT00425698|19577258|P1|COMPLETED|Overall Study||41
7953738|NCT00425698|19577257|P2|STARTED|Overall Study||44
7953739|NCT00425698|19577258|P1|STARTED|Overall Study||44
7953740|NCT00425672|19577264|P1|NOT COMPLETED|Overall Study||1
7953741|NCT00425672|19577264|P1|COMPLETED|Overall Study||14
7953742|NCT00425672|19577264|P1|STARTED|Overall Study||15
7953743|NCT00425607|19577273|P1|NOT COMPLETED|Overall Study||2
7953744|NCT00425607|19577273|P1|COMPLETED|Overall Study||27
7953745|NCT00425607|19577273|P1|Received Treatment|Overall Study||28
7953746|NCT00425607|19577273|P1|STARTED|Overall Study||29
7953747|NCT00425503|19577277|P1|NOT COMPLETED|Overall Study||3
7953748|NCT00425503|19577277|P1|COMPLETED|Overall Study||37
7953749|NCT00425503|19577277|P1|STARTED|Overall Study||40
7953750|NCT00425477|19577281|P1|NOT COMPLETED|Overall Study||13
7953751|NCT00425477|19577281|P1|COMPLETED|Overall Study||13
7953752|NCT00425477|19577281|P1|STARTED|Overall Study||26
7953753|NCT00425438|19577289|P2|NOT COMPLETED|Overall Study||27
7953754|NCT00425438|19577290|P1|NOT COMPLETED|Overall Study||25
7953755|NCT00425438|19577289|P2|COMPLETED|Overall Study||0
7953756|NCT00425438|19577290|P1|COMPLETED|Overall Study||0
7953757|NCT00425438|19577289|P2|STARTED|Overall Study||27
7953758|NCT00425438|19577290|P1|STARTED|Overall Study||25
7953759|NCT00425386|19577306|P1|NOT COMPLETED|Overall Study||3
7953760|NCT00425386|19577306|P1|COMPLETED|Overall Study||43
7953761|NCT00425386|19577306|P1|STARTED|Overall Study||46
7953762|NCT00425373|19577324|P9|NOT COMPLETED|Overall Study||18
7953763|NCT00425373|19577325|P8|NOT COMPLETED|Overall Study||10
7953764|NCT00425373|19577326|P7|NOT COMPLETED|Overall Study||7
7953765|NCT00425373|19577327|P6|NOT COMPLETED|Overall Study||9
7953766|NCT00425373|19577328|P5|NOT COMPLETED|Overall Study||10
7953767|NCT00425373|19577329|P4|NOT COMPLETED|Overall Study||2
7953768|NCT00425373|19577330|P3|NOT COMPLETED|Overall Study||3
7953769|NCT00425373|19577331|P2|NOT COMPLETED|Overall Study||3
7953770|NCT00425373|19577332|P1|NOT COMPLETED|Overall Study||5
7953771|NCT00425373|19577324|P9|COMPLETED|Overall Study||148
7953772|NCT00425373|19577325|P8|COMPLETED|Overall Study||151
7953773|NCT00425373|19577326|P7|COMPLETED|Overall Study||154
7953774|NCT00425373|19577327|P6|COMPLETED|Overall Study||154
7953775|NCT00425373|19577328|P5|COMPLETED|Overall Study||159
7953776|NCT00425373|19577329|P4|COMPLETED|Overall Study||160
7953777|NCT00425373|19577330|P3|COMPLETED|Overall Study||157
7953778|NCT00425373|19577331|P2|COMPLETED|Overall Study||164
7953779|NCT00425373|19577332|P1|COMPLETED|Overall Study||154
7953780|NCT00425373|19577324|P9|STARTED|Overall Study||166
7953781|NCT00425373|19577325|P8|STARTED|Overall Study||161
7953782|NCT00425373|19577326|P7|STARTED|Overall Study||161
7953783|NCT00425373|19577327|P6|STARTED|Overall Study||163
7953784|NCT00425373|19577328|P5|STARTED|Overall Study||169
7953785|NCT00425373|19577329|P4|STARTED|Overall Study||162
7953786|NCT00425373|19577330|P3|STARTED|Overall Study||160
7953787|NCT00425373|19577331|P2|STARTED|Overall Study||167
7953788|NCT00425373|19577332|P1|STARTED|Overall Study||159
7953789|NCT00425308|19577390|P2|NOT COMPLETED|Overall Study||1
7953790|NCT00425308|19577391|P1|NOT COMPLETED|Overall Study||4
7953791|NCT00425308|19577390|P2|COMPLETED|Overall Study||14
7953792|NCT00425308|19577391|P1|COMPLETED|Overall Study||11
7953793|NCT00425308|19577390|P2|STARTED|Overall Study||15
7953794|NCT00425308|19577391|P1|STARTED|Overall Study||15
7953795|NCT00425269|19577421|P2|NOT COMPLETED|Overall Study||20
7953796|NCT00425269|19577422|P1|NOT COMPLETED|Overall Study||19
7953797|NCT00425269|19577421|P2|COMPLETED|Overall Study||77
7953798|NCT00425269|19577422|P1|COMPLETED|Overall Study||82
7953799|NCT00425269|19577421|P2|STARTED|Overall Study||97
7953800|NCT00425269|19577422|P1|STARTED|Overall Study||101
7953801|NCT00425113|19577500|P2|NOT COMPLETED|Overall Study||2
7953802|NCT00425113|19577501|P1|NOT COMPLETED|Overall Study||2
7953803|NCT00425113|19577500|P2|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16
7953804|NCT00425113|19577501|P1|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15
7953805|NCT00425113|19577500|P2|Exposed to Study Drug|Overall Study||17
7953806|NCT00425113|19577501|P1|Exposed to Study Drug|Overall Study||16
7953807|NCT00425113|19577500|P2|STARTED|Overall Study||18
7953808|NCT00425113|19577501|P1|STARTED|Overall Study||17
7953809|NCT00425100|19577509|P1|NOT COMPLETED|Overall Study||53
7953810|NCT00425100|19577509|P1|COMPLETED|Overall Study||463
7953811|NCT00425100|19577509|P1|STARTED|Overall Study||516
7953812|NCT00425061|19577553|P7|NOT COMPLETED|Overall Study||19
7953813|NCT00425061|19577554|P6|NOT COMPLETED|Overall Study||4
7953814|NCT00425061|19577555|P5|NOT COMPLETED|Overall Study||26
7953815|NCT00425061|19577556|P4|NOT COMPLETED|Overall Study||2
7953816|NCT00425061|19577557|P3|NOT COMPLETED|Overall Study||0
7953817|NCT00425061|19577558|P2|NOT COMPLETED|Overall Study||2
7953818|NCT00425061|19577559|P1|NOT COMPLETED|Overall Study||2
7953819|NCT00425061|19577553|P7|COMPLETED|Overall Study||26
7953820|NCT00425061|19577554|P6|COMPLETED|Overall Study||0
7953821|NCT00425061|19577555|P5|COMPLETED|Overall Study||19
7953822|NCT00425061|19577556|P4|COMPLETED|Overall Study||14
7953823|NCT00425061|19577557|P3|COMPLETED|Overall Study||16
7953824|NCT00425061|19577558|P2|COMPLETED|Overall Study||15
7953825|NCT00425061|19577559|P1|COMPLETED|Overall Study||14
7953826|NCT00425061|19577553|P7|STARTED|Overall Study||45
7953827|NCT00425061|19577554|P6|STARTED|Overall Study||4
7953828|NCT00425061|19577555|P5|STARTED|Overall Study||45
7953829|NCT00425061|19577556|P4|STARTED|Overall Study||16
7953830|NCT00425061|19577557|P3|STARTED|Overall Study||16
7953831|NCT00425061|19577558|P2|STARTED|Overall Study||17
7953832|NCT00425061|19577559|P1|STARTED|Overall Study||16
7953833|NCT00424840|19577675|P3|NOT COMPLETED|Overall Study||0
7953834|NCT00424840|19577676|P2|NOT COMPLETED|Overall Study||0
7953835|NCT00424840|19577677|P1|NOT COMPLETED|Overall Study||0
7953836|NCT00424840|19577675|P3|COMPLETED|Overall Study||5
7953837|NCT00424840|19577676|P2|COMPLETED|Overall Study||4
7953838|NCT00424840|19577677|P1|COMPLETED|Overall Study||3
7953839|NCT00424840|19577675|P3|STARTED|Overall Study||5
7953840|NCT00424840|19577676|P2|STARTED|Overall Study||4
7953841|NCT00424840|19577677|P1|STARTED|Overall Study||3
7953842|NCT00424827|19577683|P1|NOT COMPLETED|Overall Study||1
7953843|NCT00424827|19577683|P1|COMPLETED|Overall Study||10
7953844|NCT00424827|19577683|P1|STARTED|Overall Study||11
7953845|NCT00424775|19577691|P2|NOT COMPLETED|Overall Study||0
7953846|NCT00424775|19577692|P1|NOT COMPLETED|Overall Study||3
7953847|NCT00424775|19577691|P2|COMPLETED|Overall Study||0
7953848|NCT00424775|19577692|P1|COMPLETED|Overall Study||0
7953849|NCT00424775|19577691|P2|STARTED|Overall Study||0
7953850|NCT00424775|19577692|P1|STARTED|Overall Study||3
7953851|NCT00424762|19577702|P2|NOT COMPLETED|Overall Study||22
7953852|NCT00424762|19577703|P1|NOT COMPLETED|Overall Study||20
7953853|NCT00424762|19577702|P2|COMPLETED|Overall Study||54
7953854|NCT00424762|19577703|P1|COMPLETED|Overall Study||54
7953855|NCT00424762|19577702|P2|STARTED|Overall Study||76
7953856|NCT00424762|19577703|P1|STARTED|Overall Study||74
7953857|NCT00424749|19577713|P1|NOT COMPLETED|Overall Study||1
7953858|NCT00424749|19577713|P1|COMPLETED|Overall Study||3
7953859|NCT00424749|19577713|P1|STARTED|Overall Study||4
7953860|NCT00424645|19577720|P2|NOT COMPLETED|Overall Study||0
7953861|NCT00424645|19577721|P1|NOT COMPLETED|Overall Study||1
7953862|NCT00424645|19577720|P2|COMPLETED|Overall Study||0
7953863|NCT00424645|19577721|P1|COMPLETED|Overall Study||2
7953864|NCT00424645|19577720|P2|STARTED|Overall Study||0
7953865|NCT00424645|19577721|P1|STARTED|Overall Study||3
7953866|NCT00424632|19577729|P10|NOT COMPLETED|Overall Study||6
7953867|NCT00424632|19577730|P9|NOT COMPLETED|Overall Study||16
7953868|NCT00424632|19577731|P8|NOT COMPLETED|Overall Study||3
7953869|NCT00424632|19577732|P7|NOT COMPLETED|Overall Study||7
7953870|NCT00424632|19577733|P6|NOT COMPLETED|Overall Study||15
7953871|NCT00424632|19577734|P5|NOT COMPLETED|Overall Study||3
7953872|NCT00424632|19577735|P4|NOT COMPLETED|Overall Study||4
7953873|NCT00424632|19577736|P3|NOT COMPLETED|Overall Study||1
7953874|NCT00424632|19577737|P2|NOT COMPLETED|Overall Study||1
7953875|NCT00424632|19577738|P1|NOT COMPLETED|Overall Study||1
7953876|NCT00424632|19577729|P10|COMPLETED|Overall Study||0
7953877|NCT00424632|19577730|P9|COMPLETED|Overall Study||0
7953878|NCT00424632|19577731|P8|COMPLETED|Overall Study||0
7953879|NCT00424632|19577732|P7|COMPLETED|Overall Study||0
7953880|NCT00424632|19577733|P6|COMPLETED|Overall Study||0
7953881|NCT00424632|19577734|P5|COMPLETED|Overall Study||0
7953882|NCT00424632|19577735|P4|COMPLETED|Overall Study||0
7953883|NCT00424632|19577736|P3|COMPLETED|Overall Study||0
7953884|NCT00424632|19577737|P2|COMPLETED|Overall Study||0
7953885|NCT00424632|19577738|P1|COMPLETED|Overall Study||0
7953886|NCT00424632|19577729|P10|STARTED|Overall Study||6
7953887|NCT00424632|19577730|P9|STARTED|Overall Study||16
7953888|NCT00424632|19577731|P8|STARTED|Overall Study||3
7953889|NCT00424632|19577732|P7|STARTED|Overall Study||7
7953890|NCT00424632|19577733|P6|STARTED|Overall Study||15
7953891|NCT00424632|19577734|P5|STARTED|Overall Study||3
7953892|NCT00424632|19577735|P4|STARTED|Overall Study||4
7953893|NCT00424632|19577736|P3|STARTED|Overall Study||1
7953894|NCT00424632|19577737|P2|STARTED|Overall Study||1
7953895|NCT00424632|19577738|P1|STARTED|Overall Study||1
7953896|NCT00424619|19577872|P3|NOT COMPLETED|3 Month||0
7953897|NCT00424619|19577873|P2|NOT COMPLETED|3 Month||0
7953898|NCT00424619|19577874|P1|NOT COMPLETED|3 Month||0
7953899|NCT00424619|19577872|P3|COMPLETED|3 Month||17
7953900|NCT00424619|19577873|P2|COMPLETED|3 Month||18
7953901|NCT00424619|19577874|P1|COMPLETED|3 Month||12
7953902|NCT00424619|19577872|P3|STARTED|3 Month||17
7953903|NCT00424619|19577873|P2|STARTED|3 Month||18
7953904|NCT00424619|19577874|P1|STARTED|3 Month||12
7953905|NCT00424619|19577872|P3|NOT COMPLETED|4 Week||0
7953906|NCT00424619|19577873|P2|NOT COMPLETED|4 Week||0
7953907|NCT00424619|19577874|P1|NOT COMPLETED|4 Week||0
7953908|NCT00424619|19577872|P3|COMPLETED|4 Week||17
7953909|NCT00424619|19577873|P2|COMPLETED|4 Week||17
7953910|NCT00424619|19577874|P1|COMPLETED|4 Week||18
7953911|NCT00424619|19577872|P3|STARTED|4 Week||17
7953912|NCT00424619|19577873|P2|STARTED|4 Week||17
7953913|NCT00424619|19577874|P1|STARTED|4 Week||18
7953914|NCT00424619|19577872|P3|NOT COMPLETED|Baseline||1
7953915|NCT00424619|19577873|P2|NOT COMPLETED|Baseline||0
7953916|NCT00424619|19577874|P1|NOT COMPLETED|Baseline||0
7953917|NCT00424619|19577872|P3|COMPLETED|Baseline||20
7953918|NCT00424619|19577873|P2|COMPLETED|Baseline||22
7953919|NCT00424619|19577874|P1|COMPLETED|Baseline||22
7953920|NCT00424619|19577872|P3|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21
7953921|NCT00424619|19577873|P2|STARTED|Baseline||22
7953922|NCT00424619|19577874|P1|STARTED|Baseline||22
7953923|NCT00424593|19577908|P2|NOT COMPLETED|Dose-Blind Extension Period||0
7953924|NCT00424593|19577909|P1|NOT COMPLETED|Dose-Blind Extension Period||64
7953925|NCT00424593|19577908|P2|COMPLETED|Dose-Blind Extension Period||0
7953926|NCT00424593|19577909|P1|COMPLETED|Dose-Blind Extension Period||117
7953927|NCT00424593|19577908|P2|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0
7953928|NCT00424593|19577909|P1|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181
7953929|NCT00424593|19577908|P2|NOT COMPLETED|Acute Double-Blind Period||23
7953930|NCT00424593|19577909|P1|NOT COMPLETED|Acute Double-Blind Period||31
7953931|NCT00424593|19577908|P2|COMPLETED|Acute Double-Blind Period||98
7953932|NCT00424593|19577909|P1|COMPLETED|Acute Double-Blind Period||84
7953933|NCT00424593|19577908|P2|STARTED|Acute Double-Blind Period||121
7953934|NCT00424593|19577909|P1|STARTED|Acute Double-Blind Period||115
7953935|NCT00424554|19577955|P2|NOT COMPLETED|Overall Study||0
7953936|NCT00424554|19577956|P1|NOT COMPLETED|Overall Study||0
7953937|NCT00424554|19577955|P2|COMPLETED|Overall Study||6
7953938|NCT00424554|19577956|P1|COMPLETED|Overall Study||34
7953939|NCT00424554|19577955|P2|STARTED|Overall Study||6
7953940|NCT00424554|19577956|P1|STARTED|Overall Study||34
7953941|NCT00424528|19577973|P3|NOT COMPLETED|Overall Study||4
7953942|NCT00424528|19577974|P2|NOT COMPLETED|Overall Study||4
7953943|NCT00424528|19577975|P1|NOT COMPLETED|Overall Study||5
7953944|NCT00424528|19577973|P3|COMPLETED|Overall Study||74
7953945|NCT00424528|19577974|P2|COMPLETED|Overall Study||76
7953946|NCT00424528|19577975|P1|COMPLETED|Overall Study||71
7953947|NCT00424528|19577973|P3|STARTED|Overall Study||78
7953948|NCT00424528|19577974|P2|STARTED|Overall Study||80
7953949|NCT00424528|19577975|P1|STARTED|Overall Study||76
7953950|NCT00424515|19578030|P2|NOT COMPLETED|Overall Study||13
7953951|NCT00424515|19578031|P1|NOT COMPLETED|Overall Study||11
7953952|NCT00424515|19578030|P2|COMPLETED|Overall Study||0
7953953|NCT00424515|19578031|P1|COMPLETED|Overall Study||0
7953954|NCT00424515|19578030|P2|STARTED|Overall Study||13
7953955|NCT00424515|19578031|P1|STARTED|Overall Study||11
7953956|NCT00424502|19578041|P1|NOT COMPLETED|Overall Study||0
7953957|NCT00424502|19578041|P1|COMPLETED|Overall Study||20
7953958|NCT00424502|19578041|P1|STARTED|Overall Study||20
7953959|NCT00424489|19578050|P1|NOT COMPLETED|Overall Study||3
7953960|NCT00424489|19578050|P1|COMPLETED|Overall Study||6
7953961|NCT00424489|19578050|P1|STARTED|Overall Study||9
7953962|NCT00424476|19578057|P3|NOT COMPLETED|Overall Study||49
7953963|NCT00424476|19578058|P2|NOT COMPLETED|Overall Study||48
7953964|NCT00424476|19578059|P1|NOT COMPLETED|Overall Study||61
7953965|NCT00424476|19578057|P3|COMPLETED|Overall Study||241
7953966|NCT00424476|19578058|P2|COMPLETED|Overall Study||240
7953967|NCT00424476|19578059|P1|COMPLETED|Overall Study||226
7953968|NCT00424476|19578057|P3|STARTED|Overall Study||290
7953969|NCT00424476|19578058|P2|STARTED|Overall Study||288
7953970|NCT00424476|19578059|P1|STARTED|Overall Study||287
7953971|NCT00424463|19578085|P3|NOT COMPLETED|Overall Study||16
7953972|NCT00424463|19578086|P2|NOT COMPLETED|Overall Study||14
7953973|NCT00424463|19578087|P1|NOT COMPLETED|Overall Study||7
7953974|NCT00424463|19578085|P3|COMPLETED|Overall Study||72
7953975|NCT00424463|19578086|P2|COMPLETED|Overall Study||34
7953976|NCT00424463|19578087|P1|COMPLETED|Overall Study||38
7953977|NCT00424463|19578085|P3|STARTED|Overall Study||88
7953978|NCT00424463|19578086|P2|STARTED|Overall Study||48
7953979|NCT00424463|19578087|P1|STARTED|Overall Study||45
7953980|NCT00424398|19578116|P3|NOT COMPLETED|Overall Study||0
7953981|NCT00424398|19578117|P2|NOT COMPLETED|Overall Study||1
7953982|NCT00424398|19578118|P1|NOT COMPLETED|Overall Study||3
7953983|NCT00424398|19578116|P3|COMPLETED|Overall Study||36
7953984|NCT00424398|19578117|P2|COMPLETED|Overall Study||35
7953985|NCT00424398|19578118|P1|COMPLETED|Overall Study||32
7953986|NCT00424398|19578116|P3|STARTED|Overall Study||36
7953987|NCT00424398|19578117|P2|STARTED|Overall Study||36
7953988|NCT00424398|19578118|P1|STARTED|Overall Study||35
7953989|NCT00424385|19578162|P1|NOT COMPLETED|Cohort 1||1
7953990|NCT00424385|19578162|P1|COMPLETED|Cohort 1||4
7953991|NCT00424385|19578162|P1|STARTED|Cohort 1||5
7953992|NCT00424385|19578162|P1|NOT COMPLETED|Cohort 0||6
7953993|NCT00424385|19578162|P1|COMPLETED|Cohort 0||6
7953994|NCT00424385|19578162|P1|STARTED|Cohort 0||12
7953995|NCT00424372|19578169|P1|NOT COMPLETED|Overall Study||31
7953996|NCT00424372|19578169|P1|COMPLETED|Overall Study||95
7953997|NCT00424372|19578169|P1|STARTED|Overall Study||126
7953998|NCT00424346|19578181|P4|NOT COMPLETED|Extension Phase||55
7953999|NCT00424346|19578182|P3|NOT COMPLETED|Extension Phase||55
7954000|NCT00424346|19578183|P2|NOT COMPLETED|Extension Phase||102
7954001|NCT00424346|19578184|P1|NOT COMPLETED|Extension Phase||0
7954002|NCT00424346|19578181|P4|COMPLETED|Extension Phase||3
7954003|NCT00424346|19578182|P3|COMPLETED|Extension Phase||4
7954004|NCT00424346|19578183|P2|COMPLETED|Extension Phase||8
7954005|NCT00424346|19578184|P1|COMPLETED|Extension Phase||0
7954006|NCT00424346|19578181|P4|STARTED|Extension Phase||58
7954007|NCT00424346|19578182|P3|STARTED|Extension Phase||59
7954008|NCT00424346|19578183|P2|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110
7954009|NCT00424346|19578184|P1|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0
7954010|NCT00424346|19578181|P4|NOT COMPLETED|Core Study||7
7954011|NCT00424346|19578182|P3|NOT COMPLETED|Core Study||4
7954012|NCT00424346|19578183|P2|NOT COMPLETED|Core Study||8
7954013|NCT00424346|19578184|P1|NOT COMPLETED|Core Study||9
7954014|NCT00424346|19578181|P4|COMPLETED|Core Study||63
7954015|NCT00424346|19578182|P3|COMPLETED|Core Study||65
7954016|NCT00424346|19578183|P2|COMPLETED|Core Study||56
7954017|NCT00424346|19578184|P1|COMPLETED|Core Study||62
7954018|NCT00424346|19578181|P4|STARTED|Core Study||70
7954019|NCT00424346|19578182|P3|STARTED|Core Study||69
7954020|NCT00424346|19578183|P2|STARTED|Core Study||64
7954021|NCT00424346|19578184|P1|STARTED|Core Study||71
7954022|NCT00424294|19578299|P2|NOT COMPLETED|Overall Study||15
7954023|NCT00424294|19578300|P1|NOT COMPLETED|Overall Study||8
7954024|NCT00424294|19578299|P2|COMPLETED|Overall Study||19
7954025|NCT00424294|19578300|P1|COMPLETED|Overall Study||28
7954026|NCT00424294|19578299|P2|Treated|Overall Study||34
7954027|NCT00424294|19578300|P1|Treated|Overall Study||35
7954028|NCT00424294|19578299|P2|STARTED|Overall Study||34
7954029|NCT00424294|19578300|P1|STARTED|Overall Study||36
7954030|NCT00424268|19578350|P2|NOT COMPLETED|Overall Study||39
7954031|NCT00424268|19578351|P1|NOT COMPLETED|Overall Study||62
7954032|NCT00424268|19578350|P2|COMPLETED|Overall Study||333
7954033|NCT00424268|19578351|P1|COMPLETED|Overall Study||309
7954034|NCT00424268|19578350|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372
7954035|NCT00424268|19578351|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371
7954036|NCT00424255|19578367|P2|NOT COMPLETED|Overall Study||346
7954037|NCT00424255|19578368|P1|NOT COMPLETED|Overall Study||342
7954038|NCT00424255|19578367|P2|COMPLETED|Overall Study||0
7954039|NCT00424255|19578368|P1|COMPLETED|Overall Study||0
7954040|NCT00424255|19578367|P2|STARTED|Overall Study||346
7954041|NCT00424255|19578368|P1|STARTED|Overall Study||342
7954042|NCT00424190|19578416|P2|NOT COMPLETED|Overall Study||30
7954043|NCT00424190|19578417|P1|NOT COMPLETED|Overall Study||22
7954044|NCT00424190|19578416|P2|COMPLETED|Overall Study||317
7954045|NCT00424190|19578417|P1|COMPLETED|Overall Study||329
7954046|NCT00424190|19578416|P2|STARTED|Overall Study||347
7954047|NCT00424190|19578417|P1|STARTED|Overall Study||351
7954048|NCT00424177|19578423|P1|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3
7954049|NCT00424177|19578423|P1|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48
7954050|NCT00424177|19578423|P1|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51
7954051|NCT00424177|19578423|P1|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4
7954052|NCT00424177|19578423|P1|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51
7954053|NCT00424177|19578423|P1|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55
7954054|NCT00424177|19578423|P1|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11
7954055|NCT00424177|19578423|P1|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55
7954056|NCT00424177|19578423|P1|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66
7954057|NCT00424047|19578452|P2|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8
7954058|NCT00424047|19578453|P1|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21
7954059|NCT00424047|19578452|P2|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
7954060|NCT00424047|19578453|P1|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
7954061|NCT00424047|19578452|P2|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8
7954062|NCT00424047|19578453|P1|STARTED|Long Term Extension (Up to 25 Jun 2013)||21
7954063|NCT00424047|19578452|P2|NOT COMPLETED|On Study at Time of Unblinding||167
7954064|NCT00424047|19578453|P1|NOT COMPLETED|On Study at Time of Unblinding||155
7954065|NCT00424047|19578452|P2|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8
7954066|NCT00424047|19578453|P1|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21
7954067|NCT00424047|19578452|P2|STARTED|On Study at Time of Unblinding||175
7954068|NCT00424047|19578453|P1|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176
7954069|NCT00424047|19578452|P2|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156
7954070|NCT00424047|19578453|P1|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122
7954071|NCT00424047|19578452|P2|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19
7954072|NCT00424047|19578453|P1|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54
7954073|NCT00424047|19578452|P2|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171
7954074|NCT00424047|19578453|P1|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175
7954075|NCT00424047|19578452|P2|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175
7954076|NCT00424047|19578453|P1|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176
7954077|NCT00424047|19578452|P2|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175
7954078|NCT00424047|19578453|P1|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176
7954079|NCT00424021|19578485|P4|NOT COMPLETED|AMB-220-E Study Period||10
7954080|NCT00424021|19578486|P3|NOT COMPLETED|AMB-220-E Study Period||5
7954081|NCT00424021|19578487|P2|NOT COMPLETED|AMB-220-E Study Period||2
7954082|NCT00424021|19578488|P1|NOT COMPLETED|AMB-220-E Study Period||1
7954083|NCT00424021|19578485|P4|COMPLETED|AMB-220-E Study Period||16
7954084|NCT00424021|19578486|P3|COMPLETED|AMB-220-E Study Period||14
7954085|NCT00424021|19578487|P2|COMPLETED|AMB-220-E Study Period||5
7954086|NCT00424021|19578488|P1|COMPLETED|AMB-220-E Study Period||1
7954087|NCT00424021|19578485|P4|STARTED|AMB-220-E Study Period||26
7954088|NCT00424021|19578486|P3|STARTED|AMB-220-E Study Period||19
7954089|NCT00424021|19578487|P2|STARTED|AMB-220-E Study Period||7
7954090|NCT00424021|19578488|P1|STARTED|AMB-220-E Study Period||2
7954091|NCT00424021|19578485|P4|NOT COMPLETED|NCT00046319 Study Period||1
7954092|NCT00424021|19578486|P3|NOT COMPLETED|NCT00046319 Study Period||1
7954093|NCT00424021|19578487|P2|NOT COMPLETED|NCT00046319 Study Period||3
7954094|NCT00424021|19578488|P1|NOT COMPLETED|NCT00046319 Study Period||1
7954095|NCT00424021|19578485|P4|COMPLETED|NCT00046319 Study Period||12
7954096|NCT00424021|19578486|P3|COMPLETED|NCT00046319 Study Period||15
7954097|NCT00424021|19578487|P2|COMPLETED|NCT00046319 Study Period||16
7954098|NCT00424021|19578488|P1|COMPLETED|NCT00046319 Study Period||15
7954099|NCT00424021|19578485|P4|STARTED|NCT00046319 Study Period||13
7954100|NCT00424021|19578486|P3|STARTED|NCT00046319 Study Period||16
7954101|NCT00424021|19578487|P2|STARTED|NCT00046319 Study Period||19
7954102|NCT00424021|19578488|P1|STARTED|NCT00046319 Study Period||16
7954103|NCT00424008|19578531|P2|NOT COMPLETED|Overall Study||335
7954104|NCT00424008|19578532|P1|NOT COMPLETED|Overall Study||349
7954105|NCT00424008|19578531|P2|COMPLETED|Overall Study||16
7954106|NCT00424008|19578532|P1|COMPLETED|Overall Study||22
7954107|NCT00424008|19578531|P2|STARTED|Overall Study||351
7954108|NCT00424008|19578532|P1|STARTED|Overall Study||371
7954109|NCT00423943|19578547|P2|NOT COMPLETED|Overall Study||1
7954110|NCT00423943|19578548|P1|NOT COMPLETED|Overall Study||3
7954111|NCT00423943|19578547|P2|COMPLETED|Overall Study||13
7954112|NCT00423943|19578548|P1|COMPLETED|Overall Study||16
7954113|NCT00423943|19578547|P2|STARTED|Overall Study||14
7954114|NCT00423943|19578548|P1|STARTED|Overall Study||19
7954115|NCT00423930|19578562|P1|NOT COMPLETED|Overall Study||2
7954116|NCT00423930|19578562|P1|COMPLETED|Overall Study||42
7954117|NCT00423930|19578562|P1|STARTED|Overall Study||44
7954118|NCT00423917|19578567|P1|NOT COMPLETED|Overall Study||3
7954119|NCT00423917|19578567|P1|COMPLETED|Overall Study||33
7954120|NCT00423917|19578567|P1|STARTED|Overall Study||36
7954121|NCT00423891|19578580|P3|NOT COMPLETED|Post-Dosing Follow Up||2
7954122|NCT00423891|19578581|P2|NOT COMPLETED|Post-Dosing Follow Up||3
7954123|NCT00423891|19578582|P1|NOT COMPLETED|Post-Dosing Follow Up||2
7954124|NCT00423891|19578580|P3|COMPLETED|Post-Dosing Follow Up||3
7954125|NCT00423891|19578581|P2|COMPLETED|Post-Dosing Follow Up||15
7954126|NCT00423891|19578582|P1|COMPLETED|Post-Dosing Follow Up||20
7954127|NCT00423891|19578580|P3|STARTED|Post-Dosing Follow Up||5
7954128|NCT00423891|19578581|P2|STARTED|Post-Dosing Follow Up||18
7954129|NCT00423891|19578582|P1|STARTED|Post-Dosing Follow Up||22
7954130|NCT00423891|19578580|P3|NOT COMPLETED|Treatment||0
7954131|NCT00423891|19578581|P2|NOT COMPLETED|Treatment||0
7954132|NCT00423891|19578582|P1|NOT COMPLETED|Treatment||2
7954133|NCT00423891|19578580|P3|COMPLETED|Treatment||5
7954134|NCT00423891|19578581|P2|COMPLETED|Treatment||19
7954135|NCT00423891|19578582|P1|COMPLETED|Treatment||22
7954136|NCT00423891|19578580|P3|STARTED|Treatment||5
7954137|NCT00423891|19578581|P2|STARTED|Treatment||19
7954138|NCT00423891|19578582|P1|STARTED|Treatment||24
7954139|NCT00423891|19578580|P3|NOT COMPLETED|Enrolled||3
7954140|NCT00423891|19578581|P2|NOT COMPLETED|Enrolled||2
7954141|NCT00423891|19578582|P1|NOT COMPLETED|Enrolled||11
7954142|NCT00423891|19578580|P3|COMPLETED|Enrolled||5
7954143|NCT00423891|19578581|P2|COMPLETED|Enrolled||19
7954144|NCT00423891|19578582|P1|COMPLETED|Enrolled||24
7954145|NCT00423891|19578580|P3|STARTED|Enrolled||8
7954146|NCT00423891|19578581|P2|STARTED|Enrolled||21
7954147|NCT00423891|19578582|P1|STARTED|Enrolled||35
7954148|NCT00423878|19578651|P2|NOT COMPLETED|Overall Study||8
7954149|NCT00423878|19578652|P1|NOT COMPLETED|Overall Study||20
7954150|NCT00423878|19578651|P2|COMPLETED|Overall Study||98
7954151|NCT00423878|19578652|P1|COMPLETED|Overall Study||89
7954152|NCT00423878|19578651|P2|STARTED|Overall Study||106
7954153|NCT00423878|19578652|P1|STARTED|Overall Study||109
7954154|NCT00423852|19578660|P1|NOT COMPLETED|Overall Study||3
7954155|NCT00423852|19578660|P1|COMPLETED|Overall Study||23
7954156|NCT00423852|19578660|P1|STARTED|Overall Study||26
7954157|NCT00423813|19578668|P3|NOT COMPLETED|Overall Study||74
7954158|NCT00423813|19578669|P2|NOT COMPLETED|Overall Study||66
7954159|NCT00423813|19578670|P1|NOT COMPLETED|Overall Study||57
7954160|NCT00423813|19578668|P3|COMPLETED|Overall Study||116
7954161|NCT00423813|19578669|P2|COMPLETED|Overall Study||129
7954162|NCT00423813|19578670|P1|COMPLETED|Overall Study||131
7954163|NCT00423813|19578668|P3|Treated|Overall Study||189
7954164|NCT00423813|19578669|P2|Treated|Overall Study||194
7954165|NCT00423813|19578670|P1|Treated|Overall Study||188
7954166|NCT00423813|19578668|P3|STARTED|Overall Study||190
7954167|NCT00423813|19578669|P2|STARTED|Overall Study||195
7954168|NCT00423813|19578670|P1|STARTED|Overall Study||188
7954169|NCT00423800|19578680|P2|NOT COMPLETED|Overall Study||1
7954170|NCT00423800|19578681|P1|NOT COMPLETED|Overall Study||0
7954171|NCT00423800|19578680|P2|COMPLETED|Overall Study||1
7954172|NCT00423800|19578681|P1|COMPLETED|Overall Study||3
7954173|NCT00423800|19578680|P2|STARTED|Overall Study||2
7954174|NCT00423800|19578681|P1|STARTED|Overall Study||3
7954175|NCT00423735|19578693|P3|NOT COMPLETED|Overall Study||0
7954176|NCT00423735|19578694|P2|NOT COMPLETED|Overall Study||6
7954177|NCT00423735|19578695|P1|NOT COMPLETED|Overall Study||8
7954178|NCT00423735|19578693|P3|COMPLETED|Overall Study||0
7954179|NCT00423735|19578694|P2|COMPLETED|Overall Study||29
7954180|NCT00423735|19578695|P1|COMPLETED|Overall Study||21
7954181|NCT00423735|19578693|P3|STARTED|Overall Study||0
7954182|NCT00423735|19578694|P2|STARTED|Overall Study||35
7954183|NCT00423735|19578695|P1|STARTED|Overall Study||29
7954184|NCT00423722|19578718|P2|NOT COMPLETED|Overall Study||13
7954185|NCT00423722|19578719|P1|NOT COMPLETED|Overall Study||14
7954186|NCT00423722|19578718|P2|COMPLETED|Overall Study||53
7954187|NCT00423722|19578719|P1|COMPLETED|Overall Study||49
7954188|NCT00423722|19578718|P2|STARTED|Overall Study||66
7954189|NCT00423722|19578719|P1|STARTED|Overall Study||63
7954190|NCT00423683|19578741|P2|NOT COMPLETED|Overall Study||0
7954191|NCT00423683|19578742|P1|NOT COMPLETED|Overall Study||1
7954192|NCT00423683|19578741|P2|COMPLETED|Overall Study||33
7954193|NCT00423683|19578742|P1|COMPLETED|Overall Study||30
7954194|NCT00423683|19578741|P2|STARTED|Overall Study||33
7954195|NCT00423683|19578742|P1|STARTED|Overall Study||31
7954196|NCT00423670|19578761|P8|NOT COMPLETED|Follow-up Period||3
7954197|NCT00423670|19578762|P7|NOT COMPLETED|Follow-up Period||9
7954198|NCT00423670|19578763|P6|NOT COMPLETED|Follow-up Period||0
7954199|NCT00423670|19578764|P5|NOT COMPLETED|Follow-up Period||2
7954200|NCT00423670|19578765|P4|NOT COMPLETED|Follow-up Period||5
7954201|NCT00423670|19578766|P3|NOT COMPLETED|Follow-up Period||11
7954202|NCT00423670|19578767|P2|NOT COMPLETED|Follow-up Period||16
7954203|NCT00423670|19578768|P1|NOT COMPLETED|Follow-up Period||3
7954204|NCT00423670|19578761|P8|COMPLETED|Follow-up Period||32
7954205|NCT00423670|19578762|P7|COMPLETED|Follow-up Period||41
7954206|NCT00423670|19578763|P6|COMPLETED|Follow-up Period||14
7954207|NCT00423670|19578764|P5|COMPLETED|Follow-up Period||89
7954208|NCT00423670|19578765|P4|COMPLETED|Follow-up Period||91
7954209|NCT00423670|19578766|P3|COMPLETED|Follow-up Period||85
7954210|NCT00423670|19578767|P2|COMPLETED|Follow-up Period||84
7954211|NCT00423670|19578768|P1|COMPLETED|Follow-up Period||94
7954212|NCT00423670|19578761|P8|STARTED|Follow-up Period||35
7954213|NCT00423670|19578762|P7|STARTED|Follow-up Period||50
7954214|NCT00423670|19578763|P6|STARTED|Follow-up Period||14
7954215|NCT00423670|19578764|P5|STARTED|Follow-up Period||91
7954216|NCT00423670|19578765|P4|STARTED|Follow-up Period||96
7954217|NCT00423670|19578766|P3|STARTED|Follow-up Period||96
7954218|NCT00423670|19578767|P2|STARTED|Follow-up Period||100
7954219|NCT00423670|19578768|P1|STARTED|Follow-up Period||97
7954220|NCT00423670|19578761|P8|NOT COMPLETED|Treatment Period||21
7954221|NCT00423670|19578762|P7|NOT COMPLETED|Treatment Period||31
7954222|NCT00423670|19578763|P6|NOT COMPLETED|Treatment Period||8
7954223|NCT00423670|19578764|P5|NOT COMPLETED|Treatment Period||27
7954224|NCT00423670|19578765|P4|NOT COMPLETED|Treatment Period||40
7954225|NCT00423670|19578766|P3|NOT COMPLETED|Treatment Period||27
7954226|NCT00423670|19578767|P2|NOT COMPLETED|Treatment Period||30
7954227|NCT00423670|19578768|P1|NOT COMPLETED|Treatment Period||52
7954228|NCT00423670|19578761|P8|COMPLETED|Treatment Period||15
7954229|NCT00423670|19578762|P7|COMPLETED|Treatment Period||28
7954230|NCT00423670|19578763|P6|COMPLETED|Treatment Period||8
7954231|NCT00423670|19578764|P5|COMPLETED|Treatment Period||76
7954232|NCT00423670|19578765|P4|COMPLETED|Treatment Period||63
7954233|NCT00423670|19578766|P3|COMPLETED|Treatment Period||76
7954234|NCT00423670|19578767|P2|COMPLETED|Treatment Period||77
7954235|NCT00423670|19578768|P1|COMPLETED|Treatment Period||52
7954236|NCT00423670|19578761|P8|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36
7954237|NCT00423670|19578762|P7|STARTED|Treatment Period||59
7954238|NCT00423670|19578763|P6|STARTED|Treatment Period||16
7954239|NCT00423670|19578764|P5|STARTED|Treatment Period||103
7954240|NCT00423670|19578765|P4|STARTED|Treatment Period||103
7954241|NCT00423670|19578766|P3|STARTED|Treatment Period||103
7954242|NCT00423670|19578767|P2|STARTED|Treatment Period||107
7954243|NCT00423670|19578768|P1|STARTED|Treatment Period||104
7954244|NCT00423657|19578826|P2|NOT COMPLETED|Overall Study||25
7954245|NCT00423657|19578827|P1|NOT COMPLETED|Overall Study||26
7954246|NCT00423657|19578826|P2|COMPLETED|Overall Study||313
7954247|NCT00423657|19578827|P1|COMPLETED|Overall Study||316
7954248|NCT00423657|19578826|P2|STARTED|Overall Study||338
7954249|NCT00423657|19578827|P1|STARTED|Overall Study||342
7954250|NCT00423605|19578833|P1|NOT COMPLETED|Overall Study||241
7954251|NCT00423605|19578833|P1|COMPLETED|Overall Study||319
7954252|NCT00423605|19578833|P1|STARTED|Overall Study||560
7954253|NCT00423592|19578837|P1|NOT COMPLETED|Overall Study||7
7954254|NCT00423592|19578837|P1|COMPLETED|Overall Study|Completed study|29
7954255|NCT00423592|19578837|P1|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34
7954256|NCT00423592|19578837|P1|STARTED|Overall Study|Enrolled|36
7954257|NCT00423579|19578858|P2|NOT COMPLETED|Overall Study||4
7954258|NCT00423579|19578859|P1|NOT COMPLETED|Overall Study||4
7954259|NCT00423579|19578858|P2|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
7954260|NCT00423579|19578859|P1|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
7954261|NCT00423579|19578858|P2|STARTED|Overall Study||60
7954262|NCT00423579|19578859|P1|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60
7954263|NCT00423488|19578867|P2|NOT COMPLETED|Overall Study||1
7954264|NCT00423488|19578868|P1|NOT COMPLETED|Overall Study||5
7954265|NCT00423488|19578867|P2|COMPLETED|Overall Study||50
7954266|NCT00423488|19578868|P1|COMPLETED|Overall Study||37
7954267|NCT00423488|19578867|P2|STARTED|Overall Study||51
7954268|NCT00423488|19578868|P1|STARTED|Overall Study||42
7954269|NCT00423449|19578874|P5|NOT COMPLETED|Overall Study||7
7954270|NCT00423449|19578875|P4|NOT COMPLETED|Overall Study||22
7954271|NCT00423449|19578876|P3|NOT COMPLETED|Overall Study||15
7954272|NCT00423449|19578877|P2|NOT COMPLETED|Overall Study||4
7954273|NCT00423449|19578878|P1|NOT COMPLETED|Overall Study||3
7954274|NCT00423449|19578874|P5|COMPLETED|Overall Study||0
7954275|NCT00423449|19578875|P4|COMPLETED|Overall Study||5
7954276|NCT00423449|19578876|P3|COMPLETED|Overall Study||2
7954277|NCT00423449|19578877|P2|COMPLETED|Overall Study||2
7954278|NCT00423449|19578878|P1|COMPLETED|Overall Study||1
7954279|NCT00423449|19578874|P5|STARTED|Overall Study||7
7954280|NCT00423449|19578875|P4|STARTED|Overall Study||27
7954281|NCT00423449|19578876|P3|STARTED|Overall Study||17
7954282|NCT00423449|19578877|P2|STARTED|Overall Study||6
7954283|NCT00423449|19578878|P1|STARTED|Overall Study||4
7954284|NCT00423436|19578903|P2|NOT COMPLETED|Overall Study||0
7954285|NCT00423436|19578904|P1|NOT COMPLETED|Overall Study||0
7954286|NCT00423436|19578903|P2|COMPLETED|Overall Study||33
7954287|NCT00423436|19578904|P1|COMPLETED|Overall Study||35
7954288|NCT00423436|19578903|P2|STARTED|Overall Study||33
7954289|NCT00423436|19578904|P1|STARTED|Overall Study||35
7954290|NCT00423358|19578912|P2|NOT COMPLETED|Overall Study||0
7954291|NCT00423358|19578913|P1|NOT COMPLETED|Overall Study||0
7954292|NCT00423358|19578912|P2|COMPLETED|Overall Study||11
7954293|NCT00423358|19578913|P1|COMPLETED|Overall Study||11
7954294|NCT00423358|19578912|P2|STARTED|Overall Study||11
7954295|NCT00423358|19578913|P1|STARTED|Overall Study||11
7954296|NCT00423332|19578925|P2|NOT COMPLETED|Overall Study||7
7954297|NCT00423332|19578926|P1|NOT COMPLETED|Overall Study||9
7954298|NCT00423332|19578925|P2|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11
7954299|NCT00423332|19578926|P1|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44
7954300|NCT00423332|19578925|P2|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4
7954301|NCT00423332|19578926|P1|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22
7954302|NCT00423332|19578925|P2|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14
7954303|NCT00423332|19578926|P1|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44
7954304|NCT00423332|19578925|P2|STARTED|Overall Study|Number randomised|18
7954305|NCT00423332|19578926|P1|STARTED|Overall Study|Randomised|53
7954306|NCT00423319|19578945|P2|NOT COMPLETED|Overall Study||252
7954307|NCT00423319|19578946|P1|NOT COMPLETED|Overall Study||224
7954308|NCT00423319|19578945|P2|COMPLETED|Overall Study||2447
7954309|NCT00423319|19578946|P1|COMPLETED|Overall Study||2484
7954310|NCT00423319|19578945|P2|Participants Who Received Treatment|Overall Study||2659
7954311|NCT00423319|19578946|P1|Participants Who Received Treatment|Overall Study||2673
7954312|NCT00423319|19578945|P2|STARTED|Overall Study|Randomized|2699
7954313|NCT00423319|19578946|P1|STARTED|Overall Study|Randomized|2708
7954314|NCT00423293|19578978|P1|NOT COMPLETED|Overall Study||11
7954315|NCT00423293|19578978|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
7954316|NCT00423293|19578978|P1|STARTED|Overall Study||63
7954317|NCT00423267|19578995|P2|NOT COMPLETED|Period B||0
7954318|NCT00423267|19578996|P1|NOT COMPLETED|Period B||0
7954319|NCT00423267|19578995|P2|COMPLETED|Period B||0
7954320|NCT00423267|19578996|P1|COMPLETED|Period B||12
7954321|NCT00423267|19578995|P2|STARTED|Period B||0
7954322|NCT00423267|19578996|P1|STARTED|Period B||12
7954323|NCT00423267|19578995|P2|NOT COMPLETED|Period A||1
7954324|NCT00423267|19578996|P1|NOT COMPLETED|Period A||2
7954325|NCT00423267|19578995|P2|COMPLETED|Period A||6
7954326|NCT00423267|19578996|P1|COMPLETED|Period A||7
7954327|NCT00423267|19578995|P2|STARTED|Period A||7
7954328|NCT00423267|19578996|P1|STARTED|Period A||9
7954329|NCT00423189|19579016|P3|NOT COMPLETED|Overall Study||0
7954330|NCT00423189|19579017|P2|NOT COMPLETED|Overall Study||1
7954331|NCT00423189|19579018|P1|NOT COMPLETED|Overall Study||0
7954332|NCT00423189|19579016|P3|COMPLETED|Overall Study||2
7954333|NCT00423189|19579017|P2|COMPLETED|Overall Study||2
7954334|NCT00423189|19579018|P1|COMPLETED|Overall Study||2
7954335|NCT00423189|19579016|P3|STARTED|Overall Study||2
7954336|NCT00423189|19579017|P2|STARTED|Overall Study||3
7954337|NCT00423189|19579018|P1|STARTED|Overall Study||2
7954338|NCT00423176|19579040|P2|NOT COMPLETED|Overall Study||29
7954339|NCT00423176|19579041|P1|NOT COMPLETED|Overall Study||16
7954340|NCT00423176|19579040|P2|COMPLETED|Overall Study||94
7954341|NCT00423176|19579041|P1|COMPLETED|Overall Study||98
7954342|NCT00423176|19579040|P2|STARTED|Overall Study||123
7954343|NCT00423176|19579041|P1|STARTED|Overall Study||114
7954344|NCT00423150|19579049|P1|NOT COMPLETED|Overall Study||86
7954345|NCT00423150|19579049|P1|COMPLETED|Overall Study||0
7954346|NCT00423150|19579049|P1|STARTED|Overall Study||86
7954347|NCT00423098|19579055|P2|NOT COMPLETED|Overall Study||4
7954348|NCT00423098|19579056|P1|NOT COMPLETED|Overall Study||3
7954349|NCT00423098|19579055|P2|COMPLETED|Overall Study||35
7954350|NCT00423098|19579056|P1|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39
7954351|NCT00423098|19579055|P2|STARTED|Overall Study||39
7954352|NCT00423098|19579056|P1|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42
7954353|NCT00423085|19579083|P4|NOT COMPLETED|52-Week Open-Label Extension Phase||163
7954354|NCT00423085|19579084|P3|NOT COMPLETED|52-Week Open-Label Extension Phase||0
7954355|NCT00423085|19579085|P2|NOT COMPLETED|52-Week Open-Label Extension Phase||0
7954356|NCT00423085|19579086|P1|NOT COMPLETED|52-Week Open-Label Extension Phase||0
7954357|NCT00423085|19579083|P4|COMPLETED|52-Week Open-Label Extension Phase||474
7954358|NCT00423085|19579084|P3|COMPLETED|52-Week Open-Label Extension Phase||0
7954359|NCT00423085|19579085|P2|COMPLETED|52-Week Open-Label Extension Phase||0
7954360|NCT00423085|19579086|P1|COMPLETED|52-Week Open-Label Extension Phase||0
7954361|NCT00423085|19579083|P4|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637
7954362|NCT00423085|19579084|P3|STARTED|52-Week Open-Label Extension Phase||0
7954363|NCT00423085|19579085|P2|STARTED|52-Week Open-Label Extension Phase||0
7954364|NCT00423085|19579086|P1|STARTED|52-Week Open-Label Extension Phase||0
7954365|NCT00423085|19579083|P4|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0
7954366|NCT00423085|19579084|P3|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59
7954367|NCT00423085|19579085|P2|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64
7954368|NCT00423085|19579086|P1|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46
7954369|NCT00423085|19579083|P4|COMPLETED|24-Week Double-Blind Treatment Phase||0
7954370|NCT00423085|19579084|P3|COMPLETED|24-Week Double-Blind Treatment Phase||228
7954371|NCT00423085|19579085|P2|COMPLETED|24-Week Double-Blind Treatment Phase||220
7954372|NCT00423085|19579086|P1|COMPLETED|24-Week Double-Blind Treatment Phase||242
7954373|NCT00423085|19579083|P4|STARTED|24-Week Double-Blind Treatment Phase||0
7954374|NCT00423085|19579084|P3|STARTED|24-Week Double-Blind Treatment Phase||287
7954375|NCT00423085|19579085|P2|STARTED|24-Week Double-Blind Treatment Phase||284
7954376|NCT00423085|19579086|P1|STARTED|24-Week Double-Blind Treatment Phase||288
7954377|NCT00423046|19579115|P2|NOT COMPLETED|Overall Study||345
7954378|NCT00423046|19579116|P1|NOT COMPLETED|Overall Study||340
7954379|NCT00423046|19579115|P2|COMPLETED|Overall Study|Completed until Month 60|208
7954380|NCT00423046|19579116|P1|COMPLETED|Overall Study|Completed until Month 60|213
7954381|NCT00423046|19579115|P2|STARTED|Overall Study||553
7954382|NCT00423046|19579116|P1|STARTED|Overall Study||553
7954383|NCT00422942|19579182|P1|NOT COMPLETED|Overall Study||3
7954384|NCT00422942|19579182|P1|COMPLETED|Overall Study||0
7954385|NCT00422942|19579182|P1|STARTED|Overall Study||3
7954386|NCT00422903|19579201|P2|NOT COMPLETED|Overall Study||5
7954387|NCT00422903|19579202|P1|NOT COMPLETED|Overall Study||4
7954388|NCT00422903|19579201|P2|COMPLETED|Overall Study||38
7954389|NCT00422903|19579202|P1|COMPLETED|Overall Study||45
7954390|NCT00422903|19579201|P2|STARTED|Overall Study||43
7954391|NCT00422903|19579202|P1|STARTED|Overall Study||49
7954392|NCT00422812|19579230|P4|NOT COMPLETED|Overall Study||2
7954393|NCT00422812|19579231|P3|NOT COMPLETED|Overall Study||2
7954394|NCT00422812|19579232|P2|NOT COMPLETED|Overall Study||1
7954395|NCT00422812|19579233|P1|NOT COMPLETED|Overall Study||0
7954396|NCT00422812|19579230|P4|COMPLETED|Overall Study||103
7954397|NCT00422812|19579231|P3|COMPLETED|Overall Study||91
7954398|NCT00422812|19579232|P2|COMPLETED|Overall Study||103
7954399|NCT00422812|19579233|P1|COMPLETED|Overall Study||98
7954400|NCT00422812|19579230|P4|STARTED|Overall Study||105
7954401|NCT00422812|19579231|P3|STARTED|Overall Study||93
7954402|NCT00422812|19579232|P2|STARTED|Overall Study||104
7954403|NCT00422812|19579233|P1|STARTED|Overall Study||98
7954404|NCT00422799|19579251|P1|NOT COMPLETED|Overall Study||13
7954405|NCT00422799|19579251|P1|COMPLETED|Overall Study||50
7954406|NCT00422799|19579251|P1|STARTED|Overall Study||63
7954407|NCT00422734|19579260|P2|NOT COMPLETED|Overall Study||21
7954408|NCT00422734|19579261|P1|NOT COMPLETED|Overall Study||14
7954409|NCT00422734|19579260|P2|COMPLETED|Overall Study||243
7954410|NCT00422734|19579261|P1|COMPLETED|Overall Study||64
7954411|NCT00422734|19579260|P2|STARTED|Overall Study||264
7954412|NCT00422734|19579261|P1|STARTED|Overall Study||78
7954413|NCT00422695|19579295|P2|NOT COMPLETED|Overall Study||0
7954414|NCT00422695|19579296|P1|NOT COMPLETED|Overall Study||0
7954415|NCT00422695|19579295|P2|COMPLETED|Overall Study||38
7954416|NCT00422695|19579296|P1|COMPLETED|Overall Study||105
7954417|NCT00422695|19579295|P2|STARTED|Overall Study||38
7954418|NCT00422695|19579296|P1|STARTED|Overall Study||105
7954419|NCT00422669|19579307|P3|NOT COMPLETED|Overall Study||7
7954420|NCT00422669|19579308|P2|NOT COMPLETED|Overall Study||100
7954421|NCT00422669|19579309|P1|NOT COMPLETED|Overall Study||98
7954422|NCT00422669|19579307|P3|COMPLETED|Overall Study||0
7954423|NCT00422669|19579308|P2|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
7954424|NCT00422669|19579309|P1|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
7954425|NCT00422669|19579307|P3|STARTED|Overall Study||7
7954426|NCT00422669|19579308|P2|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100
7954427|NCT00422669|19579309|P1|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98
7954428|NCT00422656|19579330|P1|NOT COMPLETED|Overall Study||0
7954429|NCT00422656|19579330|P1|COMPLETED|Overall Study||37
7954430|NCT00422656|19579330|P1|STARTED|Overall Study||37
7954431|NCT00422591|19579337|P1|NOT COMPLETED|Overall Study||6
7954432|NCT00422591|19579337|P1|COMPLETED|Overall Study||169
7954433|NCT00422591|19579337|P1|STARTED|Overall Study||175
7954434|NCT00422513|19579345|P2|NOT COMPLETED|Overall Study||106
7954435|NCT00422513|19579346|P1|NOT COMPLETED|Overall Study||107
7954436|NCT00422513|19579345|P2|COMPLETED|Overall Study||24
7954437|NCT00422513|19579346|P1|COMPLETED|Overall Study||23
7954438|NCT00422513|19579345|P2|STARTED|Overall Study||130
7954439|NCT00422513|19579346|P1|STARTED|Overall Study||130
7954440|NCT00422448|19579358|P1|NOT COMPLETED|Overall Study||0
7954441|NCT00422448|19579358|P1|COMPLETED|Overall Study||43
7954442|NCT00422448|19579358|P1|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43
7954443|NCT00422422|19579363|P1|NOT COMPLETED|Overall Study||10
7954444|NCT00422422|19579363|P1|COMPLETED|Overall Study||90
7954445|NCT00422422|19579363|P1|STARTED|Overall Study||100
7954446|NCT00422383|19579380|P5|NOT COMPLETED|Overall Study||3
7954447|NCT00422383|19579381|P4|NOT COMPLETED|Overall Study||2
7954448|NCT00422383|19579382|P3|NOT COMPLETED|Overall Study||4
7954449|NCT00422383|19579383|P2|NOT COMPLETED|Overall Study||14
7954450|NCT00422383|19579384|P1|NOT COMPLETED|Overall Study||15
7954451|NCT00422383|19579380|P5|COMPLETED|Overall Study||22
7954452|NCT00422383|19579381|P4|COMPLETED|Overall Study||4
7954453|NCT00422383|19579382|P3|COMPLETED|Overall Study||89
7954454|NCT00422383|19579383|P2|COMPLETED|Overall Study||106
7954455|NCT00422383|19579384|P1|COMPLETED|Overall Study||119
7954456|NCT00422383|19579380|P5|STARTED|Overall Study||25
7954457|NCT00422383|19579381|P4|STARTED|Overall Study||6
7954458|NCT00422383|19579382|P3|STARTED|Overall Study||93
7954459|NCT00422383|19579383|P2|STARTED|Overall Study||120
7954460|NCT00422383|19579384|P1|STARTED|Overall Study||134
7954461|NCT00422292|19579527|P4|NOT COMPLETED|Overall Study||24
7954462|NCT00422292|19579528|P3|NOT COMPLETED|Overall Study||22
7954463|NCT00422292|19579529|P2|NOT COMPLETED|Overall Study||66
7954464|NCT00422292|19579530|P1|NOT COMPLETED|Overall Study||18
7954465|NCT00422292|19579527|P4|COMPLETED|Overall Study||452
7954466|NCT00422292|19579528|P3|COMPLETED|Overall Study||224
7954467|NCT00422292|19579529|P2|COMPLETED|Overall Study||598
7954468|NCT00422292|19579530|P1|COMPLETED|Overall Study||239
7954469|NCT00422292|19579527|P4|STARTED|Overall Study||476
7954470|NCT00422292|19579528|P3|STARTED|Overall Study||246
7954471|NCT00422292|19579529|P2|STARTED|Overall Study||664
7954472|NCT00422292|19579530|P1|STARTED|Overall Study||257
7954473|NCT00422279|19579558|P2|NOT COMPLETED|Overall Study||0
7954474|NCT00422279|19579559|P1|NOT COMPLETED|Overall Study||0
7954475|NCT00422279|19579558|P2|COMPLETED|Overall Study||2
7954476|NCT00422279|19579559|P1|COMPLETED|Overall Study||2
7954477|NCT00422279|19579558|P2|24 Month After Loading Period|Overall Study||2
7954478|NCT00422279|19579559|P1|24 Month After Loading Period|Overall Study||2
7954479|NCT00422279|19579558|P2|STARTED|Overall Study||2
7954480|NCT00422279|19579559|P1|STARTED|Overall Study||2
7954481|NCT00422227|19579569|P2|NOT COMPLETED|Overall Study||15
7954482|NCT00422227|19579570|P1|NOT COMPLETED|Overall Study||4
7954483|NCT00422227|19579569|P2|COMPLETED|Overall Study||88
7954484|NCT00422227|19579570|P1|COMPLETED|Overall Study||193
7954485|NCT00422227|19579569|P2|STARTED|Overall Study||103
7954486|NCT00422227|19579570|P1|STARTED|Overall Study||197
7954487|NCT00422201|19579594|P1|NOT COMPLETED|Overall Study||11
7954488|NCT00422201|19579594|P1|COMPLETED|Overall Study||7
7954489|NCT00422201|19579594|P1|STARTED|Overall Study||18
7954490|NCT00422162|19579601|P2|NOT COMPLETED|Overall Study||30
7954491|NCT00422162|19579602|P1|NOT COMPLETED|Overall Study||24
7954492|NCT00422162|19579601|P2|COMPLETED|Overall Study||142
7954493|NCT00422162|19579602|P1|COMPLETED|Overall Study||143
7954494|NCT00422162|19579601|P2|Received Treatment|Overall Study||171
7954495|NCT00422162|19579602|P1|Received Treatment|Overall Study||167
7954496|NCT00422162|19579601|P2|STARTED|Overall Study||172
7954497|NCT00422162|19579602|P1|STARTED|Overall Study||167
7954498|NCT00422097|19579662|P8|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
7954499|NCT00422097|19579663|P7|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
7954500|NCT00422097|19579664|P6|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
7954501|NCT00422097|19579665|P5|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
7954502|NCT00422097|19579666|P4|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
7954503|NCT00422097|19579667|P3|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
7954504|NCT00422097|19579668|P2|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
7954505|NCT00422097|19579669|P1|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
7954506|NCT00422097|19579662|P8|COMPLETED|Ixabepilone With Famotidine or Food||7
7954507|NCT00422097|19579663|P7|COMPLETED|Ixabepilone With Famotidine or Food||8
7954508|NCT00422097|19579664|P6|COMPLETED|Ixabepilone With Famotidine or Food||0
7954509|NCT00422097|19579665|P5|COMPLETED|Ixabepilone With Famotidine or Food||0
7954510|NCT00422097|19579666|P4|COMPLETED|Ixabepilone With Famotidine or Food||0
7954511|NCT00422097|19579667|P3|COMPLETED|Ixabepilone With Famotidine or Food||0
7954512|NCT00422097|19579668|P2|COMPLETED|Ixabepilone With Famotidine or Food||0
7954513|NCT00422097|19579669|P1|COMPLETED|Ixabepilone With Famotidine or Food||0
7954514|NCT00422097|19579662|P8|STARTED|Ixabepilone With Famotidine or Food||7
7954515|NCT00422097|19579663|P7|STARTED|Ixabepilone With Famotidine or Food||8
7954516|NCT00422097|19579664|P6|STARTED|Ixabepilone With Famotidine or Food||0
7954517|NCT00422097|19579665|P5|STARTED|Ixabepilone With Famotidine or Food||0
7954518|NCT00422097|19579666|P4|STARTED|Ixabepilone With Famotidine or Food||0
7954519|NCT00422097|19579667|P3|STARTED|Ixabepilone With Famotidine or Food||0
7954520|NCT00422097|19579668|P2|STARTED|Ixabepilone With Famotidine or Food||0
7954521|NCT00422097|19579669|P1|STARTED|Ixabepilone With Famotidine or Food||0
7954522|NCT00422097|19579662|P8|NOT COMPLETED|Dose Level 6||0
7954523|NCT00422097|19579663|P7|NOT COMPLETED|Dose Level 6||0
7954524|NCT00422097|19579664|P6|NOT COMPLETED|Dose Level 6||0
7954525|NCT00422097|19579665|P5|NOT COMPLETED|Dose Level 6||0
7954526|NCT00422097|19579666|P4|NOT COMPLETED|Dose Level 6||0
7954527|NCT00422097|19579667|P3|NOT COMPLETED|Dose Level 6||0
7954528|NCT00422097|19579668|P2|NOT COMPLETED|Dose Level 6||0
7954529|NCT00422097|19579669|P1|NOT COMPLETED|Dose Level 6||0
7954530|NCT00422097|19579662|P8|COMPLETED|Dose Level 6||0
7954531|NCT00422097|19579663|P7|COMPLETED|Dose Level 6||0
7954532|NCT00422097|19579664|P6|COMPLETED|Dose Level 6||6
7954533|NCT00422097|19579665|P5|COMPLETED|Dose Level 6||0
7954534|NCT00422097|19579666|P4|COMPLETED|Dose Level 6||0
7954535|NCT00422097|19579667|P3|COMPLETED|Dose Level 6||0
7954536|NCT00422097|19579668|P2|COMPLETED|Dose Level 6||0
7954537|NCT00422097|19579669|P1|COMPLETED|Dose Level 6||0
7954538|NCT00422097|19579662|P8|STARTED|Dose Level 6||0
7954539|NCT00422097|19579663|P7|STARTED|Dose Level 6||0
7954540|NCT00422097|19579664|P6|STARTED|Dose Level 6||6
7954541|NCT00422097|19579665|P5|STARTED|Dose Level 6||0
7954542|NCT00422097|19579666|P4|STARTED|Dose Level 6||0
7954543|NCT00422097|19579667|P3|STARTED|Dose Level 6||0
7954544|NCT00422097|19579668|P2|STARTED|Dose Level 6||0
7954545|NCT00422097|19579669|P1|STARTED|Dose Level 6||0
7954546|NCT00422097|19579662|P8|NOT COMPLETED|Dose Level 5||0
7954547|NCT00422097|19579663|P7|NOT COMPLETED|Dose Level 5||0
7954548|NCT00422097|19579664|P6|NOT COMPLETED|Dose Level 5||0
7954549|NCT00422097|19579665|P5|NOT COMPLETED|Dose Level 5||0
7954550|NCT00422097|19579666|P4|NOT COMPLETED|Dose Level 5||0
7954551|NCT00422097|19579667|P3|NOT COMPLETED|Dose Level 5||0
7954552|NCT00422097|19579668|P2|NOT COMPLETED|Dose Level 5||0
7954553|NCT00422097|19579669|P1|NOT COMPLETED|Dose Level 5||0
7954554|NCT00422097|19579662|P8|COMPLETED|Dose Level 5||0
7954555|NCT00422097|19579663|P7|COMPLETED|Dose Level 5||0
7954556|NCT00422097|19579664|P6|COMPLETED|Dose Level 5||0
7954557|NCT00422097|19579665|P5|COMPLETED|Dose Level 5||23
7954558|NCT00422097|19579666|P4|COMPLETED|Dose Level 5||0
7954559|NCT00422097|19579667|P3|COMPLETED|Dose Level 5||0
7954560|NCT00422097|19579668|P2|COMPLETED|Dose Level 5||0
7954561|NCT00422097|19579669|P1|COMPLETED|Dose Level 5||0
7954562|NCT00422097|19579662|P8|STARTED|Dose Level 5||0
7954563|NCT00422097|19579663|P7|STARTED|Dose Level 5||0
7954564|NCT00422097|19579664|P6|STARTED|Dose Level 5||0
7954565|NCT00422097|19579665|P5|STARTED|Dose Level 5||23
7954566|NCT00422097|19579666|P4|STARTED|Dose Level 5||0
7954567|NCT00422097|19579667|P3|STARTED|Dose Level 5||0
7954568|NCT00422097|19579668|P2|STARTED|Dose Level 5||0
7954569|NCT00422097|19579669|P1|STARTED|Dose Level 5||0
7954570|NCT00422097|19579662|P8|NOT COMPLETED|Dose Level 4||0
7954571|NCT00422097|19579663|P7|NOT COMPLETED|Dose Level 4||0
7954572|NCT00422097|19579664|P6|NOT COMPLETED|Dose Level 4||0
7954573|NCT00422097|19579665|P5|NOT COMPLETED|Dose Level 4||0
7954574|NCT00422097|19579666|P4|NOT COMPLETED|Dose Level 4||0
7954575|NCT00422097|19579667|P3|NOT COMPLETED|Dose Level 4||0
7954576|NCT00422097|19579668|P2|NOT COMPLETED|Dose Level 4||0
7954577|NCT00422097|19579669|P1|NOT COMPLETED|Dose Level 4||0
7954578|NCT00422097|19579662|P8|COMPLETED|Dose Level 4||0
7954579|NCT00422097|19579663|P7|COMPLETED|Dose Level 4||0
7954580|NCT00422097|19579664|P6|COMPLETED|Dose Level 4||0
7954581|NCT00422097|19579665|P5|COMPLETED|Dose Level 4||0
7954582|NCT00422097|19579666|P4|COMPLETED|Dose Level 4||3
7954583|NCT00422097|19579667|P3|COMPLETED|Dose Level 4||0
7954584|NCT00422097|19579668|P2|COMPLETED|Dose Level 4||0
7954585|NCT00422097|19579669|P1|COMPLETED|Dose Level 4||0
7954586|NCT00422097|19579662|P8|STARTED|Dose Level 4||0
7954587|NCT00422097|19579663|P7|STARTED|Dose Level 4||0
7954588|NCT00422097|19579664|P6|STARTED|Dose Level 4||0
7954589|NCT00422097|19579665|P5|STARTED|Dose Level 4||0
7954590|NCT00422097|19579666|P4|STARTED|Dose Level 4||3
7954591|NCT00422097|19579667|P3|STARTED|Dose Level 4||0
7954592|NCT00422097|19579668|P2|STARTED|Dose Level 4||0
7954593|NCT00422097|19579669|P1|STARTED|Dose Level 4||0
7954594|NCT00422097|19579662|P8|NOT COMPLETED|Dose Level 3||0
7954595|NCT00422097|19579663|P7|NOT COMPLETED|Dose Level 3||0
7954596|NCT00422097|19579664|P6|NOT COMPLETED|Dose Level 3||0
7954597|NCT00422097|19579665|P5|NOT COMPLETED|Dose Level 3||0
7954598|NCT00422097|19579666|P4|NOT COMPLETED|Dose Level 3||0
7954599|NCT00422097|19579667|P3|NOT COMPLETED|Dose Level 3||0
7954600|NCT00422097|19579668|P2|NOT COMPLETED|Dose Level 3||0
7954601|NCT00422097|19579669|P1|NOT COMPLETED|Dose Level 3||0
7954602|NCT00422097|19579662|P8|COMPLETED|Dose Level 3||0
7954603|NCT00422097|19579663|P7|COMPLETED|Dose Level 3||0
7954604|NCT00422097|19579664|P6|COMPLETED|Dose Level 3||0
7954605|NCT00422097|19579665|P5|COMPLETED|Dose Level 3||0
7954606|NCT00422097|19579666|P4|COMPLETED|Dose Level 3||0
7954607|NCT00422097|19579667|P3|COMPLETED|Dose Level 3||3
7954608|NCT00422097|19579668|P2|COMPLETED|Dose Level 3||0
7954609|NCT00422097|19579669|P1|COMPLETED|Dose Level 3||0
7954610|NCT00422097|19579662|P8|STARTED|Dose Level 3||0
7954611|NCT00422097|19579663|P7|STARTED|Dose Level 3||0
7954612|NCT00422097|19579664|P6|STARTED|Dose Level 3||0
7954613|NCT00422097|19579665|P5|STARTED|Dose Level 3||0
7954614|NCT00422097|19579666|P4|STARTED|Dose Level 3||0
7954615|NCT00422097|19579667|P3|STARTED|Dose Level 3||3
7954616|NCT00422097|19579668|P2|STARTED|Dose Level 3||0
7954617|NCT00422097|19579669|P1|STARTED|Dose Level 3||0
7954618|NCT00422097|19579662|P8|NOT COMPLETED|Dose Level 2||0
7954619|NCT00422097|19579663|P7|NOT COMPLETED|Dose Level 2||0
7954620|NCT00422097|19579664|P6|NOT COMPLETED|Dose Level 2||0
7954621|NCT00422097|19579665|P5|NOT COMPLETED|Dose Level 2||0
7954622|NCT00422097|19579666|P4|NOT COMPLETED|Dose Level 2||0
7954623|NCT00422097|19579667|P3|NOT COMPLETED|Dose Level 2||0
7954624|NCT00422097|19579668|P2|NOT COMPLETED|Dose Level 2||1
7954625|NCT00422097|19579669|P1|NOT COMPLETED|Dose Level 2||0
7954626|NCT00422097|19579662|P8|COMPLETED|Dose Level 2||0
7954627|NCT00422097|19579663|P7|COMPLETED|Dose Level 2||0
7954628|NCT00422097|19579664|P6|COMPLETED|Dose Level 2||0
7954629|NCT00422097|19579665|P5|COMPLETED|Dose Level 2||0
7954630|NCT00422097|19579666|P4|COMPLETED|Dose Level 2||0
7954631|NCT00422097|19579667|P3|COMPLETED|Dose Level 2||0
7954632|NCT00422097|19579668|P2|COMPLETED|Dose Level 2||5
7954633|NCT00422097|19579669|P1|COMPLETED|Dose Level 2||0
7954634|NCT00422097|19579662|P8|STARTED|Dose Level 2||0
7954635|NCT00422097|19579663|P7|STARTED|Dose Level 2||0
7954636|NCT00422097|19579664|P6|STARTED|Dose Level 2||0
7954637|NCT00422097|19579665|P5|STARTED|Dose Level 2||0
7954638|NCT00422097|19579666|P4|STARTED|Dose Level 2||0
7954639|NCT00422097|19579667|P3|STARTED|Dose Level 2||0
7954640|NCT00422097|19579668|P2|STARTED|Dose Level 2||6
7954641|NCT00422097|19579669|P1|STARTED|Dose Level 2||0
7954642|NCT00422097|19579662|P8|NOT COMPLETED|Dose Level 1||0
7954643|NCT00422097|19579663|P7|NOT COMPLETED|Dose Level 1||0
7954644|NCT00422097|19579664|P6|NOT COMPLETED|Dose Level 1||0
7954645|NCT00422097|19579665|P5|NOT COMPLETED|Dose Level 1||0
7954646|NCT00422097|19579666|P4|NOT COMPLETED|Dose Level 1||0
7954647|NCT00422097|19579667|P3|NOT COMPLETED|Dose Level 1||0
7954648|NCT00422097|19579668|P2|NOT COMPLETED|Dose Level 1||0
7954649|NCT00422097|19579669|P1|NOT COMPLETED|Dose Level 1||0
7954650|NCT00422097|19579662|P8|COMPLETED|Dose Level 1||0
7954651|NCT00422097|19579663|P7|COMPLETED|Dose Level 1||0
7954652|NCT00422097|19579664|P6|COMPLETED|Dose Level 1||0
7954653|NCT00422097|19579665|P5|COMPLETED|Dose Level 1||0
7954654|NCT00422097|19579666|P4|COMPLETED|Dose Level 1||0
7954655|NCT00422097|19579667|P3|COMPLETED|Dose Level 1||0
7954656|NCT00422097|19579668|P2|COMPLETED|Dose Level 1||0
7954657|NCT00422097|19579669|P1|COMPLETED|Dose Level 1||3
7954658|NCT00422097|19579662|P8|STARTED|Dose Level 1||0
7954659|NCT00422097|19579663|P7|STARTED|Dose Level 1||0
7954660|NCT00422097|19579664|P6|STARTED|Dose Level 1||0
7954661|NCT00422097|19579665|P5|STARTED|Dose Level 1||0
7954662|NCT00422097|19579666|P4|STARTED|Dose Level 1||0
7954663|NCT00422097|19579667|P3|STARTED|Dose Level 1||0
7954664|NCT00422097|19579668|P2|STARTED|Dose Level 1||0
7954665|NCT00422097|19579669|P1|STARTED|Dose Level 1||3
7954666|NCT00422058|19579734|P6|NOT COMPLETED|Open-Label Extension, Week 20-104||34
7954667|NCT00422058|19579735|P5|NOT COMPLETED|Open-Label Extension, Week 20-104||35
7954668|NCT00422058|19579736|P4|NOT COMPLETED|Open-Label Extension, Week 20-104||28
7954669|NCT00422058|19579737|P3|NOT COMPLETED|Open-Label Extension, Week 20-104||36
7954670|NCT00422058|19579738|P2|NOT COMPLETED|Open-Label Extension, Week 20-104||39
7954671|NCT00422058|19579739|P1|NOT COMPLETED|Open-Label Extension, Week 20-104||32
7954672|NCT00422058|19579734|P6|COMPLETED|Open-Label Extension, Week 20-104||45
7954673|NCT00422058|19579735|P5|COMPLETED|Open-Label Extension, Week 20-104||47
7954674|NCT00422058|19579736|P4|COMPLETED|Open-Label Extension, Week 20-104||45
7954675|NCT00422058|19579737|P3|COMPLETED|Open-Label Extension, Week 20-104||38
7954676|NCT00422058|19579738|P2|COMPLETED|Open-Label Extension, Week 20-104||46
7954677|NCT00422058|19579739|P1|COMPLETED|Open-Label Extension, Week 20-104||47
7954678|NCT00422058|19579734|P6|Enrolled in Extension|Open-Label Extension, Week 20-104||67
7954679|NCT00422058|19579735|P5|Enrolled in Extension|Open-Label Extension, Week 20-104||72
7954680|NCT00422058|19579736|P4|Enrolled in Extension|Open-Label Extension, Week 20-104||65
7954765|NCT00421733|19580010|P3|NOT COMPLETED|Overall Study||20
7954681|NCT00422058|19579737|P3|Enrolled in Extension|Open-Label Extension, Week 20-104||59
7954682|NCT00422058|19579738|P2|Enrolled in Extension|Open-Label Extension, Week 20-104||68
7954683|NCT00422058|19579739|P1|Enrolled in Extension|Open-Label Extension, Week 20-104||67
7954684|NCT00422058|19579734|P6|STARTED|Open-Label Extension, Week 20-104||79
7954685|NCT00422058|19579735|P5|STARTED|Open-Label Extension, Week 20-104||82
7954686|NCT00422058|19579736|P4|STARTED|Open-Label Extension, Week 20-104||73
7954687|NCT00422058|19579737|P3|STARTED|Open-Label Extension, Week 20-104||74
7954688|NCT00422058|19579738|P2|STARTED|Open-Label Extension, Week 20-104||85
7954689|NCT00422058|19579739|P1|STARTED|Open-Label Extension, Week 20-104||79
7954690|NCT00422058|19579734|P6|NOT COMPLETED|Double-Blind, Week 0-20||16
7954691|NCT00422058|19579735|P5|NOT COMPLETED|Double-Blind, Week 0-20||11
7954692|NCT00422058|19579736|P4|NOT COMPLETED|Double-Blind, Week 0-20||20
7954693|NCT00422058|19579737|P3|NOT COMPLETED|Double-Blind, Week 0-20||16
7954694|NCT00422058|19579738|P2|NOT COMPLETED|Double-Blind, Week 0-20||10
7954695|NCT00422058|19579739|P1|NOT COMPLETED|Double-Blind, Week 0-20||19
7954696|NCT00422058|19579734|P6|COMPLETED|Double-Blind, Week 0-20||79
7954697|NCT00422058|19579735|P5|COMPLETED|Double-Blind, Week 0-20||82
7954698|NCT00422058|19579736|P4|COMPLETED|Double-Blind, Week 0-20||73
7954699|NCT00422058|19579737|P3|COMPLETED|Double-Blind, Week 0-20||74
7954700|NCT00422058|19579738|P2|COMPLETED|Double-Blind, Week 0-20||85
7954701|NCT00422058|19579739|P1|COMPLETED|Double-Blind, Week 0-20||79
7954702|NCT00422058|19579734|P6|STARTED|Double-Blind, Week 0-20||95
7954703|NCT00422058|19579735|P5|STARTED|Double-Blind, Week 0-20||93
7954704|NCT00422058|19579736|P4|STARTED|Double-Blind, Week 0-20||93
7954705|NCT00422058|19579737|P3|STARTED|Double-Blind, Week 0-20||90
7954706|NCT00422058|19579738|P2|STARTED|Double-Blind, Week 0-20||95
7954707|NCT00422058|19579739|P1|STARTED|Double-Blind, Week 0-20||98
7954708|NCT00422032|19579869|P2|NOT COMPLETED|Overall Study||0
7954709|NCT00422032|19579870|P1|NOT COMPLETED|Overall Study||0
7954710|NCT00422032|19579869|P2|COMPLETED|Overall Study||21
7954711|NCT00422032|19579870|P1|COMPLETED|Overall Study||37
7954712|NCT00422032|19579869|P2|STARTED|Overall Study||21
7954713|NCT00422032|19579870|P1|STARTED|Overall Study||37
7954714|NCT00421993|19579880|P4|NOT COMPLETED|Overall Study||57
7954715|NCT00421993|19579881|P3|NOT COMPLETED|Overall Study||52
7954716|NCT00421993|19579882|P2|NOT COMPLETED|Overall Study||49
7954717|NCT00421993|19579883|P1|NOT COMPLETED|Overall Study||53
7954718|NCT00421993|19579880|P4|COMPLETED|Overall Study||361
7954719|NCT00421993|19579881|P3|COMPLETED|Overall Study||363
7954720|NCT00421993|19579882|P2|COMPLETED|Overall Study||369
7954721|NCT00421993|19579883|P1|COMPLETED|Overall Study||366
7954722|NCT00421993|19579880|P4|STARTED|Overall Study||418
7954723|NCT00421993|19579881|P3|STARTED|Overall Study||415
7954724|NCT00421993|19579882|P2|STARTED|Overall Study||418
7954725|NCT00421993|19579883|P1|STARTED|Overall Study||419
7954726|NCT00421954|19579913|P1|NOT COMPLETED|Overall Study||0
7954727|NCT00421954|19579913|P1|COMPLETED|Overall Study||0
7954728|NCT00421954|19579913|P1|STARTED|Overall Study||0
7954729|NCT00421928|19579920|P3|NOT COMPLETED|Overall Study||134
7954730|NCT00421928|19579921|P2|NOT COMPLETED|Overall Study||224
7954731|NCT00421928|19579922|P1|NOT COMPLETED|Overall Study||163
7954732|NCT00421928|19579920|P3|COMPLETED|Overall Study||203
7954733|NCT00421928|19579921|P2|COMPLETED|Overall Study||118
7954734|NCT00421928|19579922|P1|COMPLETED|Overall Study||181
7954735|NCT00421928|19579920|P3|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337
7954736|NCT00421928|19579921|P2|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342
7954737|NCT00421928|19579922|P1|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344
7954738|NCT00421889|19579957|P9|NOT COMPLETED|Overall Study||11
7954739|NCT00421889|19579958|P8|NOT COMPLETED|Overall Study||2
7954740|NCT00421889|19579959|P7|NOT COMPLETED|Overall Study||4
7954741|NCT00421889|19579960|P6|NOT COMPLETED|Overall Study||35
7954742|NCT00421889|19579961|P5|NOT COMPLETED|Overall Study||6
7954743|NCT00421889|19579962|P4|NOT COMPLETED|Overall Study||4
7954744|NCT00421889|19579963|P3|NOT COMPLETED|Overall Study||3
7954745|NCT00421889|19579964|P2|NOT COMPLETED|Overall Study||5
7954746|NCT00421889|19579965|P1|NOT COMPLETED|Overall Study||5
7954747|NCT00421889|19579957|P9|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4
7954748|NCT00421889|19579958|P8|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1
7954749|NCT00421889|19579959|P7|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0
7954750|NCT00421889|19579960|P6|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0
7954751|NCT00421889|19579961|P5|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0
7954752|NCT00421889|19579962|P4|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0
7954753|NCT00421889|19579963|P3|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0
7954754|NCT00421889|19579964|P2|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0
7954755|NCT00421889|19579965|P1|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0
7954756|NCT00421889|19579957|P9|STARTED|Overall Study||15
7954757|NCT00421889|19579958|P8|STARTED|Overall Study||3
7954758|NCT00421889|19579959|P7|STARTED|Overall Study||4
7954759|NCT00421889|19579960|P6|STARTED|Overall Study||35
7954760|NCT00421889|19579961|P5|STARTED|Overall Study||6
7954761|NCT00421889|19579962|P4|STARTED|Overall Study||4
7954762|NCT00421889|19579963|P3|STARTED|Overall Study||3
7954763|NCT00421889|19579964|P2|STARTED|Overall Study||5
7954764|NCT00421889|19579965|P1|STARTED|Overall Study||5
7954766|NCT00421733|19580011|P2|NOT COMPLETED|Overall Study||26
7954767|NCT00421733|19580012|P1|NOT COMPLETED|Overall Study||15
7954768|NCT00421733|19580010|P3|COMPLETED|Overall Study||73
7954769|NCT00421733|19580011|P2|COMPLETED|Overall Study||69
7954770|NCT00421733|19580012|P1|COMPLETED|Overall Study||78
7954771|NCT00421733|19580010|P3|STARTED|Overall Study||93
7954772|NCT00421733|19580011|P2|STARTED|Overall Study||95
7954773|NCT00421733|19580012|P1|STARTED|Overall Study||93
7954774|NCT00421707|19580032|P2|NOT COMPLETED|Period 3:Treatment Period 2||3
7954775|NCT00421707|19580033|P1|NOT COMPLETED|Period 3:Treatment Period 2||2
7954776|NCT00421707|19580032|P2|COMPLETED|Period 3:Treatment Period 2||49
7954777|NCT00421707|19580033|P1|COMPLETED|Period 3:Treatment Period 2||53
7954778|NCT00421707|19580032|P2|STARTED|Period 3:Treatment Period 2||52
7954779|NCT00421707|19580033|P1|STARTED|Period 3:Treatment Period 2||55
7954780|NCT00421707|19580032|P2|NOT COMPLETED|Period 2: Washout||4
7954781|NCT00421707|19580033|P1|NOT COMPLETED|Period 2: Washout||1
7954782|NCT00421707|19580032|P2|COMPLETED|Period 2: Washout||52
7954783|NCT00421707|19580033|P1|COMPLETED|Period 2: Washout||55
7954784|NCT00421707|19580032|P2|STARTED|Period 2: Washout||56
7954785|NCT00421707|19580033|P1|STARTED|Period 2: Washout||56
7954786|NCT00421707|19580032|P2|NOT COMPLETED|Period 1: Treatment Period 1||9
7954787|NCT00421707|19580033|P1|NOT COMPLETED|Period 1: Treatment Period 1||11
7954788|NCT00421707|19580032|P2|COMPLETED|Period 1: Treatment Period 1||56
7954789|NCT00421707|19580033|P1|COMPLETED|Period 1: Treatment Period 1||56
7954790|NCT00421707|19580032|P2|STARTED|Period 1: Treatment Period 1||65
7954791|NCT00421707|19580033|P1|STARTED|Period 1: Treatment Period 1||67
7954792|NCT00421603|19580075|P2|NOT COMPLETED|Overall Study||12
7954793|NCT00421603|19580076|P1|NOT COMPLETED|Overall Study||11
7954794|NCT00421603|19580075|P2|COMPLETED|Overall Study|Completed all 14 week sof trial|30
7954795|NCT00421603|19580076|P1|COMPLETED|Overall Study|Completed all 14 week sof trial|28
7954796|NCT00421603|19580075|P2|STARTED|Overall Study||42
7954797|NCT00421603|19580076|P1|STARTED|Overall Study||39
7954798|NCT00421408|19580084|P2|NOT COMPLETED|Overall Study||45
7954799|NCT00421408|19580085|P1|NOT COMPLETED|Overall Study||42
7954800|NCT00421408|19580084|P2|COMPLETED|Overall Study||61
7954801|NCT00421408|19580085|P1|COMPLETED|Overall Study||60
7954802|NCT00421408|19580084|P2|STARTED|Overall Study||106
7954803|NCT00421408|19580085|P1|STARTED|Overall Study||102
7954804|NCT00421343|19580103|P1|NOT COMPLETED|Overall Study||6
7954805|NCT00421343|19580103|P1|COMPLETED|Overall Study||23
7954806|NCT00421343|19580103|P1|STARTED|Overall Study||29
7954807|NCT00421174|19580109|P2|NOT COMPLETED|Overall Study||1
7954808|NCT00421174|19580110|P1|NOT COMPLETED|Overall Study||2
7954809|NCT00421174|19580109|P2|COMPLETED|Overall Study||18
7954810|NCT00421174|19580110|P1|COMPLETED|Overall Study||16
7954811|NCT00421174|19580109|P2|STARTED|Overall Study||19
7954812|NCT00421174|19580110|P1|STARTED|Overall Study||18
7954813|NCT00421148|19580158|P20|NOT COMPLETED|Overall Study||0
7954814|NCT00421148|19580159|P19|NOT COMPLETED|Overall Study||1
7954815|NCT00421148|19580160|P18|NOT COMPLETED|Overall Study||2
7954816|NCT00421148|19580161|P17|NOT COMPLETED|Overall Study||0
7954817|NCT00421148|19580162|P16|NOT COMPLETED|Overall Study||0
7954818|NCT00421148|19580163|P15|NOT COMPLETED|Overall Study||0
7954819|NCT00421148|19580164|P14|NOT COMPLETED|Overall Study||0
7954820|NCT00421148|19580165|P13|NOT COMPLETED|Overall Study||0
7954821|NCT00421148|19580166|P12|NOT COMPLETED|Overall Study||0
7954822|NCT00421148|19580167|P11|NOT COMPLETED|Overall Study||0
7954823|NCT00421148|19580168|P10|NOT COMPLETED|Overall Study||0
7954824|NCT00421148|19580169|P9|NOT COMPLETED|Overall Study||0
7954825|NCT00421148|19580170|P8|NOT COMPLETED|Overall Study||0
7954826|NCT00421148|19580171|P7|NOT COMPLETED|Overall Study||0
7954827|NCT00421148|19580172|P6|NOT COMPLETED|Overall Study||1
7954828|NCT00421148|19580173|P5|NOT COMPLETED|Overall Study||0
7954829|NCT00421148|19580174|P4|NOT COMPLETED|Overall Study||0
7954830|NCT00421148|19580175|P3|NOT COMPLETED|Overall Study||0
7954831|NCT00421148|19580176|P2|NOT COMPLETED|Overall Study||0
7954832|NCT00421148|19580177|P1|NOT COMPLETED|Overall Study||0
7954833|NCT00421148|19580158|P20|COMPLETED|Overall Study||6
7954834|NCT00421148|19580159|P19|COMPLETED|Overall Study||5
7954835|NCT00421148|19580160|P18|COMPLETED|Overall Study||4
7954836|NCT00421148|19580161|P17|COMPLETED|Overall Study||6
7954837|NCT00421148|19580162|P16|COMPLETED|Overall Study||6
7954838|NCT00421148|19580163|P15|COMPLETED|Overall Study||6
7954839|NCT00421148|19580164|P14|COMPLETED|Overall Study||6
7954840|NCT00421148|19580165|P13|COMPLETED|Overall Study||6
7954841|NCT00421148|19580166|P12|COMPLETED|Overall Study||6
7954842|NCT00421148|19580167|P11|COMPLETED|Overall Study||6
7954843|NCT00421148|19580168|P10|COMPLETED|Overall Study||5
7954844|NCT00421148|19580169|P9|COMPLETED|Overall Study||5
7954845|NCT00421148|19580170|P8|COMPLETED|Overall Study||5
7954846|NCT00421148|19580171|P7|COMPLETED|Overall Study||6
7954847|NCT00421148|19580172|P6|COMPLETED|Overall Study||4
7954848|NCT00421148|19580173|P5|COMPLETED|Overall Study||1
7954849|NCT00421148|19580174|P4|COMPLETED|Overall Study||1
7954850|NCT00421148|19580175|P3|COMPLETED|Overall Study||2
7954851|NCT00421148|19580176|P2|COMPLETED|Overall Study||2
7954852|NCT00421148|19580177|P1|COMPLETED|Overall Study||2
7954853|NCT00421148|19580158|P20|Treated|Overall Study||6
7954854|NCT00421148|19580159|P19|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
7954855|NCT00421148|19580160|P18|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
7954856|NCT00421148|19580161|P17|Treated|Overall Study||6
7954857|NCT00421148|19580162|P16|Treated|Overall Study||6
7954858|NCT00421148|19580163|P15|Treated|Overall Study||6
7954859|NCT00421148|19580164|P14|Treated|Overall Study||6
7954860|NCT00421148|19580165|P13|Treated|Overall Study||6
7954861|NCT00421148|19580166|P12|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but received 5 mg/kg sugammadex|6
7954862|NCT00421148|19580167|P11|Treated|Overall Study||6
7954863|NCT00421148|19580168|P10|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but was an adolescent|5
7954864|NCT00421148|19580169|P9|Treated|Overall Study||5
7954865|NCT00421148|19580170|P8|Treated|Overall Study||5
7954866|NCT00421148|19580171|P7|Treated|Overall Study||6
7954867|NCT00421148|19580172|P6|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|4
7954868|NCT00421148|19580173|P5|Treated|Overall Study||1
7954869|NCT00421148|19580174|P4|Treated|Overall Study||1
7954870|NCT00421148|19580175|P3|Treated|Overall Study||2
7954871|NCT00421148|19580176|P2|Treated|Overall Study||2
7954872|NCT00421148|19580177|P1|Treated|Overall Study||2
7954873|NCT00421148|19580158|P20|STARTED|Overall Study||6
7954874|NCT00421148|19580159|P19|STARTED|Overall Study||6
7954875|NCT00421148|19580160|P18|STARTED|Overall Study||6
7954876|NCT00421148|19580161|P17|STARTED|Overall Study||6
7954877|NCT00421148|19580162|P16|STARTED|Overall Study||6
7954878|NCT00421148|19580163|P15|STARTED|Overall Study||6
7954879|NCT00421148|19580164|P14|STARTED|Overall Study||6
7954880|NCT00421148|19580165|P13|STARTED|Overall Study||6
7954881|NCT00421148|19580166|P12|STARTED|Overall Study||6
7954882|NCT00421148|19580167|P11|STARTED|Overall Study||6
7954883|NCT00421148|19580168|P10|STARTED|Overall Study||5
7954884|NCT00421148|19580169|P9|STARTED|Overall Study||5
7954885|NCT00421148|19580170|P8|STARTED|Overall Study||5
7954886|NCT00421148|19580171|P7|STARTED|Overall Study||6
7954887|NCT00421148|19580172|P6|STARTED|Overall Study||5
7954888|NCT00421148|19580173|P5|STARTED|Overall Study||1
7954889|NCT00421148|19580174|P4|STARTED|Overall Study||1
7954890|NCT00421148|19580175|P3|STARTED|Overall Study||2
7954891|NCT00421148|19580176|P2|STARTED|Overall Study||2
7954892|NCT00421148|19580177|P1|STARTED|Overall Study||2
7954893|NCT00420992|19580261|P2|NOT COMPLETED|Maintenance Phase||75
7954894|NCT00420992|19580262|P1|NOT COMPLETED|Maintenance Phase||61
7954895|NCT00420992|19580261|P2|COMPLETED|Maintenance Phase||98
7954896|NCT00420992|19580262|P1|COMPLETED|Maintenance Phase||110
7954897|NCT00420992|19580261|P2|STARTED|Maintenance Phase||173
7954898|NCT00420992|19580262|P1|STARTED|Maintenance Phase||171
7954899|NCT00420992|19580261|P2|NOT COMPLETED|Titration Phase||0
7954900|NCT00420992|19580262|P1|NOT COMPLETED|Titration Phase||203
7954901|NCT00420992|19580261|P2|COMPLETED|Titration Phase||0
7954902|NCT00420992|19580262|P1|COMPLETED|Titration Phase||344
7954903|NCT00420992|19580261|P2|STARTED|Titration Phase||0
7954904|NCT00420992|19580262|P1|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547
7954905|NCT00420927|19580276|P7|NOT COMPLETED|Period 2||53
7954906|NCT00420927|19580277|P6|NOT COMPLETED|Period 2||15
7954907|NCT00420927|19580278|P5|NOT COMPLETED|Period 2||43
7954908|NCT00420927|19580279|P4|NOT COMPLETED|Period 2||10
7954909|NCT00420927|19580280|P3|NOT COMPLETED|Period 2||13
7954910|NCT00420927|19580281|P2|NOT COMPLETED|Period 2||0
7954911|NCT00420927|19580282|P1|NOT COMPLETED|Period 2||0
7954912|NCT00420927|19580276|P7|COMPLETED|Period 2||295
7954913|NCT00420927|19580277|P6|COMPLETED|Period 2||97
7954914|NCT00420927|19580278|P5|COMPLETED|Period 2||216
7954915|NCT00420927|19580279|P4|COMPLETED|Period 2||95
7954916|NCT00420927|19580280|P3|COMPLETED|Period 2||89
7954917|NCT00420927|19580281|P2|COMPLETED|Period 2||0
7954918|NCT00420927|19580282|P1|COMPLETED|Period 2||0
7954919|NCT00420927|19580276|P7|STARTED|Period 2||348
7954920|NCT00420927|19580277|P6|STARTED|Period 2||112
7954921|NCT00420927|19580278|P5|STARTED|Period 2||259
7954922|NCT00420927|19580279|P4|STARTED|Period 2||105
7954923|NCT00420927|19580280|P3|STARTED|Period 2||102
7954924|NCT00420927|19580281|P2|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
7954925|NCT00420927|19580282|P1|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
7954926|NCT00420927|19580276|P7|NOT COMPLETED|Period 1||0
7954927|NCT00420927|19580277|P6|NOT COMPLETED|Period 1||0
7954928|NCT00420927|19580278|P5|NOT COMPLETED|Period 1||0
7954929|NCT00420927|19580279|P4|NOT COMPLETED|Period 1||0
7954930|NCT00420927|19580280|P3|NOT COMPLETED|Period 1||0
7954931|NCT00420927|19580281|P2|NOT COMPLETED|Period 1||57
7954932|NCT00420927|19580282|P1|NOT COMPLETED|Period 1||49
7954933|NCT00420927|19580276|P7|COMPLETED|Period 1||0
7954934|NCT00420927|19580277|P6|COMPLETED|Period 1||0
7954935|NCT00420927|19580278|P5|COMPLETED|Period 1||0
7954936|NCT00420927|19580279|P4|COMPLETED|Period 1||0
7954937|NCT00420927|19580280|P3|COMPLETED|Period 1||0
7954938|NCT00420927|19580281|P2|COMPLETED|Period 1||460
7954939|NCT00420927|19580282|P1|COMPLETED|Period 1||466
7954940|NCT00420927|19580276|P7|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
7954941|NCT00420927|19580277|P6|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
7954942|NCT00420927|19580278|P5|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
7954943|NCT00420927|19580279|P4|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
7954944|NCT00420927|19580280|P3|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
7954945|NCT00420927|19580281|P2|STARTED|Period 1||517
7954946|NCT00420927|19580282|P1|STARTED|Period 1||515
7954947|NCT00420849|19580386|P1|NOT COMPLETED|Overall Study||331
7954948|NCT00420849|19580386|P1|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256
7954949|NCT00420849|19580386|P1|STARTED|Overall Study||587
7954950|NCT00420784|19580455|P4|NOT COMPLETED|Overall Study||78
7954951|NCT00420784|19580456|P3|NOT COMPLETED|Overall Study||53
7954952|NCT00420784|19580457|P2|NOT COMPLETED|Overall Study||58
7954953|NCT00420784|19580458|P1|NOT COMPLETED|Overall Study||29
7954954|NCT00420784|19580455|P4|COMPLETED|Overall Study||36
7954955|NCT00420784|19580456|P3|COMPLETED|Overall Study||58
7954956|NCT00420784|19580457|P2|COMPLETED|Overall Study||55
7954957|NCT00420784|19580458|P1|COMPLETED|Overall Study||86
7954958|NCT00420784|19580455|P4|STARTED|Overall Study||114
7954959|NCT00420784|19580456|P3|STARTED|Overall Study||111
7954960|NCT00420784|19580457|P2|STARTED|Overall Study||113
7954961|NCT00420784|19580458|P1|STARTED|Overall Study||115
7954962|NCT00420771|19580487|P2|NOT COMPLETED|Overall Study||4
7954963|NCT00420771|19580488|P1|NOT COMPLETED|Overall Study||3
7954964|NCT00420771|19580487|P2|COMPLETED|Overall Study||7
7954965|NCT00420771|19580488|P1|COMPLETED|Overall Study||5
7954966|NCT00420771|19580487|P2|STARTED|Overall Study||11
7954967|NCT00420771|19580488|P1|STARTED|Overall Study||8
7954968|NCT00420745|19580496|P2|NOT COMPLETED|Overall Study||6
7954969|NCT00420745|19580497|P1|NOT COMPLETED|Overall Study||15
7954970|NCT00420745|19580496|P2|COMPLETED|Overall Study||333
7954971|NCT00420745|19580497|P1|COMPLETED|Overall Study||655
7954972|NCT00420745|19580496|P2|STARTED|Overall Study||339
7954973|NCT00420745|19580497|P1|STARTED|Overall Study||670
7954974|NCT00420641|19580516|P3|NOT COMPLETED|Overall Study||44
7954975|NCT00420641|19580517|P2|NOT COMPLETED|Overall Study||72
7954976|NCT00420641|19580518|P1|NOT COMPLETED|Overall Study||45
7954977|NCT00420641|19580516|P3|COMPLETED|Overall Study||128
7954978|NCT00420641|19580517|P2|COMPLETED|Overall Study||100
7954979|NCT00420641|19580518|P1|COMPLETED|Overall Study||115
7954980|NCT00420641|19580516|P3|STARTED|Overall Study||172
7954981|NCT00420641|19580517|P2|STARTED|Overall Study||172
7954982|NCT00420641|19580518|P1|STARTED|Overall Study||160
7954983|NCT00420628|19580594|P2|NOT COMPLETED|Overall Study||4
7954984|NCT00420628|19580595|P1|NOT COMPLETED|Overall Study||9
7954985|NCT00420628|19580594|P2|COMPLETED|Overall Study||32
7954986|NCT00420628|19580595|P1|COMPLETED|Overall Study||63
7954987|NCT00420628|19580594|P2|STARTED|Overall Study||36
7954988|NCT00420628|19580595|P1|STARTED|Overall Study||72
7954989|NCT00420511|19580611|P2|NOT COMPLETED|Overall Study||1
7954990|NCT00420511|19580612|P1|NOT COMPLETED|Overall Study||2
7954991|NCT00420511|19580611|P2|COMPLETED|Overall Study||10
7954992|NCT00420511|19580612|P1|COMPLETED|Overall Study||8
7954993|NCT00420511|19580611|P2|STARTED|Overall Study||11
7954994|NCT00420511|19580612|P1|STARTED|Overall Study||10
7954995|NCT00420459|19580622|P1|NOT COMPLETED|Overall Study||0
7954996|NCT00420459|19580622|P1|COMPLETED|Overall Study||12
7954997|NCT00420459|19580622|P1|STARTED|Overall Study||12
7954998|NCT00420420|19580633|P2|NOT COMPLETED|Overall Study||4
7954999|NCT00420420|19580634|P1|NOT COMPLETED|Overall Study||8
7955000|NCT00420420|19580633|P2|COMPLETED|Overall Study||67
7955001|NCT00420420|19580634|P1|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65
7955002|NCT00420420|19580633|P2|STARTED|Overall Study|Number of patients randomized.|71
7955003|NCT00420420|19580634|P1|STARTED|Overall Study|Number of patients randomized.|73
7955004|NCT00420407|19580652|P2|NOT COMPLETED|Overall Study||6
7955005|NCT00420407|19580653|P1|NOT COMPLETED|Overall Study||4
7955006|NCT00420407|19580652|P2|COMPLETED|Overall Study||34
7955007|NCT00420407|19580653|P1|COMPLETED|Overall Study||37
7955008|NCT00420407|19580652|P2|STARTED|Overall Study||40
7955009|NCT00420407|19580653|P1|STARTED|Overall Study||41
7955010|NCT00420381|19580660|P1|NOT COMPLETED|Overall Study||1
7955011|NCT00420381|19580660|P1|COMPLETED|Overall Study||27
7955012|NCT00420381|19580660|P1|Received at Least One Dose of Study Drug|Overall Study||27
7955013|NCT00420381|19580660|P1|STARTED|Overall Study||28
7955014|NCT00420342|19580672|P3|NOT COMPLETED|Overall Study||1
7955015|NCT00420342|19580673|P2|NOT COMPLETED|Overall Study||2
7955016|NCT00420342|19580674|P1|NOT COMPLETED|Overall Study||1
7955017|NCT00420342|19580672|P3|COMPLETED|Overall Study||28
7955018|NCT00420342|19580673|P2|COMPLETED|Overall Study||31
7955019|NCT00420342|19580674|P1|COMPLETED|Overall Study||29
7955020|NCT00420342|19580672|P3|Received Treatment|Overall Study||29
7955021|NCT00420342|19580673|P2|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32
7955022|NCT00420342|19580674|P1|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29
7955023|NCT00420342|19580672|P3|STARTED|Overall Study||29
7955024|NCT00420342|19580673|P2|STARTED|Overall Study||33
7955025|NCT00420342|19580674|P1|STARTED|Overall Study||30
7955026|NCT00420316|19580717|P2|NOT COMPLETED|Overall Study||9
7955027|NCT00420316|19580718|P1|NOT COMPLETED|Overall Study||12
7955028|NCT00420316|19580717|P2|COMPLETED|Overall Study||522
7955029|NCT00420316|19580718|P1|COMPLETED|Overall Study||1070
7955030|NCT00420316|19580717|P2|STARTED|Overall Study||531
7955031|NCT00420316|19580718|P1|STARTED|Overall Study||1082
7955032|NCT00420303|19580742|P2|NOT COMPLETED|Overall Study||4
7955033|NCT00420303|19580743|P1|NOT COMPLETED|Overall Study||1
7955034|NCT00420303|19580742|P2|COMPLETED|Overall Study||8
7955035|NCT00420303|19580743|P1|COMPLETED|Overall Study||11
7955036|NCT00420303|19580742|P2|STARTED|Overall Study||12
7955037|NCT00420303|19580743|P1|STARTED|Overall Study||12
7955038|NCT00420290|19580755|P2|NOT COMPLETED|Overall Study||4
7955039|NCT00420290|19580756|P1|NOT COMPLETED|Overall Study||4
7955040|NCT00420290|19580755|P2|COMPLETED|Overall Study||7
7955041|NCT00420290|19580756|P1|COMPLETED|Overall Study||7
7955042|NCT00420290|19580755|P2|STARTED|Overall Study||11
7955043|NCT00420290|19580756|P1|STARTED|Overall Study||11
7955044|NCT00420238|19580772|P2|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1
7955045|NCT00420238|19580773|P1|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2
7955046|NCT00420238|19580772|P2|COMPLETED|12 Week Open-Label Treatment Period 2||38
7955047|NCT00420238|19580773|P1|COMPLETED|12 Week Open-Label Treatment Period 2||36
7955048|NCT00420238|19580772|P2|STARTED|12 Week Open-Label Treatment Period 2||39
7955049|NCT00420238|19580773|P1|STARTED|12 Week Open-Label Treatment Period 2||38
7955050|NCT00420238|19580772|P2|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4
7955051|NCT00420238|19580773|P1|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1
7955052|NCT00420238|19580772|P2|COMPLETED|12 Week Double-Blind Treatment Period 1||39
7955053|NCT00420238|19580773|P1|COMPLETED|12 Week Double-Blind Treatment Period 1||38
7955054|NCT00420238|19580772|P2|STARTED|12 Week Double-Blind Treatment Period 1||43
7955055|NCT00420238|19580773|P1|STARTED|12 Week Double-Blind Treatment Period 1||39
7955056|NCT00420212|19580912|P3|NOT COMPLETED|Overall Study||96
7955057|NCT00420212|19580913|P2|NOT COMPLETED|Overall Study||95
7955058|NCT00420212|19580914|P1|NOT COMPLETED|Overall Study||91
7955059|NCT00420212|19580912|P3|COMPLETED|Overall Study||320
7955060|NCT00420212|19580913|P2|COMPLETED|Overall Study||315
7955061|NCT00420212|19580914|P1|COMPLETED|Overall Study||317
7955062|NCT00420212|19580912|P3|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416
7955063|NCT00420212|19580913|P2|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410
7955064|NCT00420212|19580914|P1|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408
7955065|NCT00420199|19580940|P2|NOT COMPLETED|Overall Study||0
7955066|NCT00420199|19580941|P1|NOT COMPLETED|Overall Study||1
7955067|NCT00420199|19580940|P2|COMPLETED|Overall Study||23
7955068|NCT00420199|19580941|P1|COMPLETED|Overall Study||26
7955069|NCT00420199|19580940|P2|STARTED|Overall Study||23
7955070|NCT00420199|19580941|P1|STARTED|Overall Study||27
7955071|NCT00420147|19580996|P2|NOT COMPLETED|Overall Study||0
7955072|NCT00420147|19580997|P1|NOT COMPLETED|Overall Study||0
7955073|NCT00420147|19580996|P2|COMPLETED|Overall Study||19
7955074|NCT00420147|19580997|P1|COMPLETED|Overall Study||19
7955075|NCT00420147|19580996|P2|STARTED|Overall Study||19
7955076|NCT00420147|19580997|P1|STARTED|Overall Study||19
7955077|NCT00420095|19581007|P2|NOT COMPLETED|Overall Study||1
7955078|NCT00420095|19581008|P1|NOT COMPLETED|Overall Study||3
7955079|NCT00420095|19581007|P2|COMPLETED|Overall Study||59
7955080|NCT00420095|19581008|P1|COMPLETED|Overall Study||54
7955081|NCT00420095|19581007|P2|STARTED|Overall Study||60
7955082|NCT00420095|19581008|P1|STARTED|Overall Study||57
7955083|NCT00420056|19581026|P1|NOT COMPLETED|Overall Study||17
7955084|NCT00420056|19581026|P1|COMPLETED|Overall Study||0
7955085|NCT00420056|19581026|P1|STARTED|Overall Study||17
7955086|NCT00420017|19581050|P2|NOT COMPLETED|Overall Study||0
7955087|NCT00420017|19581051|P1|NOT COMPLETED|Overall Study||2
7955088|NCT00420017|19581050|P2|COMPLETED|Overall Study||40
7955089|NCT00420017|19581051|P1|COMPLETED|Overall Study|40 completed analysis|38
7955090|NCT00420017|19581050|P2|STARTED|Overall Study||40
7955091|NCT00420017|19581051|P1|STARTED|Overall Study||40
7955092|NCT00420004|19581066|P3|NOT COMPLETED|Overall Study||32
7955093|NCT00420004|19581067|P2|NOT COMPLETED|Overall Study||71
7955094|NCT00420004|19581068|P1|NOT COMPLETED|Overall Study||129
7955095|NCT00420004|19581066|P3|COMPLETED|Overall Study||30
7955096|NCT00420004|19581067|P2|COMPLETED|Overall Study||67
7955097|NCT00420004|19581068|P1|COMPLETED|Overall Study||140
7955098|NCT00420004|19581066|P3|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|54
7955099|NCT00420004|19581067|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|122
7955100|NCT00420004|19581068|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|249
7955101|NCT00420004|19581066|P3|STARTED|Overall Study||62
7955102|NCT00420004|19581067|P2|STARTED|Overall Study||138
7955103|NCT00420004|19581068|P1|STARTED|Overall Study||269
7955104|NCT00419952|19581133|P2|NOT COMPLETED|Overall Study||125
7955105|NCT00419952|19581134|P1|NOT COMPLETED|Overall Study||149
7955106|NCT00419952|19581133|P2|COMPLETED|Overall Study||240
7955107|NCT00419952|19581134|P1|COMPLETED|Overall Study||228
7955108|NCT00419952|19581133|P2|STARTED|Overall Study||365
7955109|NCT00419952|19581134|P1|STARTED|Overall Study||377
7955110|NCT00419926|19581168|P2|NOT COMPLETED|Overall Study||10
7955111|NCT00419926|19581169|P1|NOT COMPLETED|Overall Study||14
7955112|NCT00419926|19581168|P2|COMPLETED|Overall Study||148
7955113|NCT00419926|19581169|P1|COMPLETED|Overall Study||141
7955114|NCT00419926|19581168|P2|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158
7955115|NCT00419926|19581169|P1|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155
7955116|NCT00419770|19581185|P2|NOT COMPLETED|Overall Study||1
7955117|NCT00419770|19581186|P1|NOT COMPLETED|Overall Study||5
7955118|NCT00419770|19581185|P2|COMPLETED|Overall Study||8
7955119|NCT00419770|19581186|P1|COMPLETED|Overall Study||6
7955120|NCT00419770|19581185|P2|STARTED|Overall Study||9
7955121|NCT00419770|19581186|P1|STARTED|Overall Study||11
7955122|NCT00419757|19581194|P2|NOT COMPLETED|Overall Study||21
7955123|NCT00419757|19581195|P1|NOT COMPLETED|Overall Study||18
7955124|NCT00419757|19581194|P2|COMPLETED|Overall Study|Randomized patients|102
7955125|NCT00419757|19581195|P1|COMPLETED|Overall Study|Randomized patients|109
7955126|NCT00419757|19581194|P2|STARTED|Overall Study|Randomized patients|123
7955127|NCT00419757|19581195|P1|STARTED|Overall Study|Randomized patients|127
7955128|NCT00419744|19581234|P3|NOT COMPLETED|Overall Study||133
7955129|NCT00419744|19581235|P2|NOT COMPLETED|Overall Study||118
7955130|NCT00419744|19581236|P1|NOT COMPLETED|Overall Study||117
7955131|NCT00419744|19581234|P3|COMPLETED|Overall Study||271
7955132|NCT00419744|19581235|P2|COMPLETED|Overall Study||290
7955133|NCT00419744|19581236|P1|COMPLETED|Overall Study||290
7955134|NCT00419744|19581234|P3|STARTED|Overall Study||404
7955135|NCT00419744|19581235|P2|STARTED|Overall Study||408
7955136|NCT00419744|19581236|P1|STARTED|Overall Study||407
7955137|NCT00419666|19581265|P1|NOT COMPLETED|Overall Study||0
7955138|NCT00419666|19581265|P1|COMPLETED|Overall Study||25
7955139|NCT00419666|19581265|P1|STARTED|Overall Study||25
7955140|NCT00419562|19581279|P2|NOT COMPLETED|Overall Study||31
7955141|NCT00419562|19581280|P1|NOT COMPLETED|Overall Study||33
7955142|NCT00419562|19581279|P2|COMPLETED|Overall Study||246
7955143|NCT00419562|19581280|P1|COMPLETED|Overall Study||250
7955144|NCT00419562|19581279|P2|STARTED|Overall Study||277
7955145|NCT00419562|19581280|P1|STARTED|Overall Study||283
7955146|NCT00419445|19581293|P3|NOT COMPLETED|Overall Study||1
7955147|NCT00419445|19581294|P2|NOT COMPLETED|Overall Study||2
7955148|NCT00419445|19581295|P1|NOT COMPLETED|Overall Study||1
7955149|NCT00419445|19581293|P3|COMPLETED|Overall Study||7
7955150|NCT00419445|19581294|P2|COMPLETED|Overall Study||14
7955151|NCT00419445|19581295|P1|COMPLETED|Overall Study||7
7955152|NCT00419445|19581293|P3|STARTED|Overall Study||8
7955153|NCT00419445|19581294|P2|STARTED|Overall Study||16
7955154|NCT00419445|19581295|P1|STARTED|Overall Study||8
7955155|NCT00419393|19581303|P1|NOT COMPLETED|Overall Study||24
7955156|NCT00419393|19581303|P1|COMPLETED|Overall Study||166
7955157|NCT00419393|19581303|P1|STARTED|Overall Study|One subject did not receive medication|190
7955158|NCT00419380|19581313|P2|NOT COMPLETED|Overall Study||10
7955159|NCT00419380|19581314|P1|NOT COMPLETED|Overall Study||1
7955160|NCT00419380|19581313|P2|COMPLETED|Overall Study||12
7955161|NCT00419380|19581314|P1|COMPLETED|Overall Study||18
7955162|NCT00419380|19581313|P2|STARTED|Overall Study||22
7955163|NCT00419380|19581314|P1|STARTED|Overall Study||19
7955164|NCT00419341|19581322|P1|NOT COMPLETED|Efficacy Period||10
7955165|NCT00419341|19581322|P1|COMPLETED|Efficacy Period||28
7955166|NCT00419341|19581322|P1|STARTED|Efficacy Period||38
7955167|NCT00419341|19581322|P1|NOT COMPLETED|Wash in/Wash Out Period||11
7955168|NCT00419341|19581322|P1|COMPLETED|Wash in/Wash Out Period||38
7955169|NCT00419341|19581322|P1|STARTED|Wash in/Wash Out Period||49
7955170|NCT00419315|19581345|P2|NOT COMPLETED|Overall Study||0
7955171|NCT00419315|19581346|P1|NOT COMPLETED|Overall Study||0
7955172|NCT00419315|19581345|P2|COMPLETED|Overall Study||78
7955173|NCT00419315|19581346|P1|COMPLETED|Overall Study||85
7955174|NCT00419315|19581345|P2|STARTED|Overall Study||78
7955175|NCT00419315|19581346|P1|STARTED|Overall Study||85
7955176|NCT00419263|19581357|P3|NOT COMPLETED|Overall Study||3
7955177|NCT00419263|19581358|P2|NOT COMPLETED|Overall Study||2
7955178|NCT00419263|19581359|P1|NOT COMPLETED|Overall Study||3
7955179|NCT00419263|19581357|P3|COMPLETED|Overall Study||112
7955180|NCT00419263|19581358|P2|COMPLETED|Overall Study||112
7955181|NCT00419263|19581359|P1|COMPLETED|Overall Study||112
7955182|NCT00419263|19581357|P3|STARTED|Overall Study||115
7955183|NCT00419263|19581358|P2|STARTED|Overall Study||114
7955184|NCT00419263|19581359|P1|STARTED|Overall Study||115
7955185|NCT00419159|19581388|P2|NOT COMPLETED|Overall Study||100
7955186|NCT00419159|19581389|P1|NOT COMPLETED|Overall Study||99
7955187|NCT00419159|19581388|P2|COMPLETED|Overall Study||0
7955188|NCT00419159|19581389|P1|COMPLETED|Overall Study||0
7955189|NCT00419159|19581388|P2|STARTED|Overall Study||100
7955190|NCT00419159|19581389|P1|STARTED|Overall Study|Full Analysis Set|99
7955191|NCT00419120|19581419|P1|NOT COMPLETED|Long Term Follow up Period||10
7955192|NCT00419120|19581419|P1|COMPLETED|Long Term Follow up Period||0
7955193|NCT00419120|19581419|P1|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10
7955194|NCT00419120|19581419|P1|NOT COMPLETED|Primary Study Period||0
7955195|NCT00419120|19581419|P1|COMPLETED|Primary Study Period||10
7955196|NCT00419120|19581419|P1|STARTED|Primary Study Period||10
7955197|NCT00419094|19581426|P2|NOT COMPLETED|Overall Study||30
7955198|NCT00419094|19581427|P1|NOT COMPLETED|Overall Study||7
7955199|NCT00419094|19581426|P2|COMPLETED|Overall Study||141
7955200|NCT00419094|19581427|P1|COMPLETED|Overall Study||50
7955201|NCT00419094|19581426|P2|STARTED|Overall Study||171
7955202|NCT00419094|19581427|P1|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57
7955203|NCT00419003|19581441|P2|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0
7955204|NCT00419003|19581442|P1|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1
7955205|NCT00419003|19581441|P2|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8
7955206|NCT00419003|19581442|P1|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5
7955207|NCT00419003|19581441|P2|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|8
7955208|NCT00419003|19581442|P1|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|6
7955209|NCT00419003|19581441|P2|NOT COMPLETED|Phase I, Ketamine Infusion||6
7955210|NCT00419003|19581442|P1|NOT COMPLETED|Phase I, Ketamine Infusion||6
7955211|NCT00419003|19581441|P2|COMPLETED|Phase I, Ketamine Infusion||7
7955212|NCT00419003|19581442|P1|COMPLETED|Phase I, Ketamine Infusion||7
7955213|NCT00419003|19581441|P2|STARTED|Phase I, Ketamine Infusion||13
7955214|NCT00419003|19581442|P1|STARTED|Phase I, Ketamine Infusion||13
7955215|NCT00418977|19581453|P2|NOT COMPLETED|Overall Study||3
7955216|NCT00418977|19581454|P1|NOT COMPLETED|Overall Study||3
7955217|NCT00418977|19581453|P2|COMPLETED|Overall Study||13
7955218|NCT00418977|19581454|P1|COMPLETED|Overall Study||40
7955219|NCT00418977|19581453|P2|STARTED|Overall Study||16
7955220|NCT00418977|19581454|P1|STARTED|Overall Study||43
7955221|NCT00418964|19581471|P3|NOT COMPLETED|Overall Study||6
7955222|NCT00418964|19581472|P2|NOT COMPLETED|Overall Study||3
7955223|NCT00418964|19581473|P1|NOT COMPLETED|Overall Study||1
7955224|NCT00418964|19581471|P3|COMPLETED|Overall Study||14
7955225|NCT00418964|19581472|P2|COMPLETED|Overall Study||17
7955226|NCT00418964|19581473|P1|COMPLETED|Overall Study||21
7955227|NCT00418964|19581471|P3|STARTED|Overall Study||20
7955228|NCT00418964|19581472|P2|STARTED|Overall Study||20
7955229|NCT00418964|19581473|P1|STARTED|Overall Study||22
7955230|NCT00418951|19581484|P3|NOT COMPLETED|Overall Study||0
7955231|NCT00418951|19581485|P2|NOT COMPLETED|Overall Study||0
7955232|NCT00418951|19581486|P1|NOT COMPLETED|Overall Study||0
7955233|NCT00418951|19581484|P3|COMPLETED|Overall Study||40
7955234|NCT00418951|19581485|P2|COMPLETED|Overall Study||33
7955235|NCT00418951|19581486|P1|COMPLETED|Overall Study||39
7955236|NCT00418951|19581484|P3|STARTED|Overall Study||40
7955237|NCT00418951|19581485|P2|STARTED|Overall Study||33
7955238|NCT00418951|19581486|P1|STARTED|Overall Study||39
7955239|NCT00418938|19581496|P2|NOT COMPLETED|Overall Study||23
7955240|NCT00418938|19581497|P1|NOT COMPLETED|Overall Study||24
7955241|NCT00418938|19581496|P2|COMPLETED|Overall Study||108
7955242|NCT00418938|19581497|P1|COMPLETED|Overall Study||109
7955243|NCT00418938|19581496|P2|STARTED|Overall Study||131
7955244|NCT00418938|19581497|P1|STARTED|Overall Study||133
7955245|NCT00418886|19581517|P2|NOT COMPLETED|Overall Study||255
7955246|NCT00418886|19581518|P1|NOT COMPLETED|Overall Study||226
7955247|NCT00418886|19581517|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23
7955248|NCT00418886|19581518|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30
7955249|NCT00418886|19581517|P2|STARTED|Overall Study|randomised patients|278
7955250|NCT00418886|19581518|P1|STARTED|Overall Study|randomised patients|256
7955251|NCT00418834|19581544|P2|NOT COMPLETED|Overall Study||20
7955252|NCT00418834|19581545|P1|NOT COMPLETED|Overall Study||23
7955253|NCT00418834|19581544|P2|COMPLETED|Overall Study||507
7955254|NCT00418834|19581545|P1|COMPLETED|Overall Study||503
7955255|NCT00418834|19581544|P2|STARTED|Overall Study||527
7955256|NCT00418834|19581545|P1|STARTED|Overall Study||526
7955257|NCT00418717|19581605|P1|NOT COMPLETED|Treatment Period B - Weeks 5-12||2
7955258|NCT00418717|19581605|P1|COMPLETED|Treatment Period B - Weeks 5-12||39
7955259|NCT00418717|19581605|P1|STARTED|Treatment Period B - Weeks 5-12||41
7955260|NCT00418717|19581605|P1|NOT COMPLETED|Treatment Period A - Weeks 1-4||1
7955261|NCT00418717|19581605|P1|COMPLETED|Treatment Period A - Weeks 1-4||41
7955262|NCT00418717|19581605|P1|STARTED|Treatment Period A - Weeks 1-4||42
7955263|NCT00418691|19581613|P3|NOT COMPLETED|Overall Study||5
7955264|NCT00418691|19581614|P2|NOT COMPLETED|Overall Study||2
7955265|NCT00418691|19581615|P1|NOT COMPLETED|Overall Study||2
7955266|NCT00418691|19581613|P3|COMPLETED|Overall Study||5
7955267|NCT00418691|19581614|P2|COMPLETED|Overall Study||10
7955268|NCT00418691|19581615|P1|COMPLETED|Overall Study||9
7955269|NCT00418691|19581613|P3|STARTED|Overall Study||10
7955270|NCT00418691|19581614|P2|STARTED|Overall Study||12
7955271|NCT00418691|19581615|P1|STARTED|Overall Study||11
7955272|NCT00418665|19581626|P3|NOT COMPLETED|Treatment Extension||2
7955273|NCT00418665|19581627|P2|NOT COMPLETED|Treatment Extension||4
7955274|NCT00418665|19581628|P1|NOT COMPLETED|Treatment Extension||6
7955275|NCT00418665|19581626|P3|COMPLETED|Treatment Extension||7
7955276|NCT00418665|19581627|P2|COMPLETED|Treatment Extension||4
7955277|NCT00418665|19581628|P1|COMPLETED|Treatment Extension||1
7955278|NCT00418665|19581626|P3|STARTED|Treatment Extension||9
7955279|NCT00418665|19581627|P2|STARTED|Treatment Extension||8
7955280|NCT00418665|19581628|P1|STARTED|Treatment Extension||7
7955281|NCT00418665|19581626|P3|NOT COMPLETED|Treatment Period||4
7955282|NCT00418665|19581627|P2|NOT COMPLETED|Treatment Period||6
7955283|NCT00418665|19581628|P1|NOT COMPLETED|Treatment Period||5
7955284|NCT00418665|19581626|P3|COMPLETED|Treatment Period||9
7955285|NCT00418665|19581627|P2|COMPLETED|Treatment Period||8
7955286|NCT00418665|19581628|P1|COMPLETED|Treatment Period||7
7955287|NCT00418665|19581626|P3|Received Study Medication|Treatment Period||13
7955288|NCT00418665|19581627|P2|Received Study Medication|Treatment Period||13
7955289|NCT00418665|19581628|P1|Received Study Medication|Treatment Period||11
7955290|NCT00418665|19581626|P3|STARTED|Treatment Period||13
7955291|NCT00418665|19581627|P2|STARTED|Treatment Period||14
7955292|NCT00418665|19581628|P1|STARTED|Treatment Period||12
7955293|NCT00418574|19581647|P2|NOT COMPLETED|Overall Study||23
7955294|NCT00418574|19581648|P1|NOT COMPLETED|Overall Study||48
7955295|NCT00418574|19581647|P2|COMPLETED|Overall Study||272
7955296|NCT00418574|19581648|P1|COMPLETED|Overall Study||545
7955297|NCT00418574|19581647|P2|TREATED|Overall Study||294
7955298|NCT00418574|19581648|P1|TREATED|Overall Study||592
7955299|NCT00418574|19581647|P2|STARTED|Overall Study||295
7955300|NCT00418574|19581648|P1|STARTED|Overall Study||593
7955301|NCT00418561|19581662|P3|NOT COMPLETED|Overall Study||0
7955302|NCT00418561|19581663|P2|NOT COMPLETED|Overall Study||1
7955303|NCT00418561|19581664|P1|NOT COMPLETED|Overall Study||0
7955304|NCT00418561|19581662|P3|COMPLETED|Overall Study||4
7955305|NCT00418561|19581663|P2|COMPLETED|Overall Study||4
7955306|NCT00418561|19581664|P1|COMPLETED|Overall Study||4
7955307|NCT00418561|19581662|P3|STARTED|Overall Study||4
7955308|NCT00418561|19581663|P2|STARTED|Overall Study||5
7955309|NCT00418561|19581664|P1|STARTED|Overall Study||4
7955310|NCT00418522|19581734|P2|NOT COMPLETED|Overall Study||42
7955311|NCT00418522|19581735|P1|NOT COMPLETED|Overall Study||83
7955312|NCT00418522|19581734|P2|COMPLETED|Overall Study||152
7955313|NCT00418522|19581735|P1|COMPLETED|Overall Study||136
7955314|NCT00418522|19581734|P2|Received Treatment|Overall Study||190
7955315|NCT00418522|19581735|P1|Received Treatment|Overall Study||212
7955316|NCT00418522|19581734|P2|STARTED|Overall Study||194
7955317|NCT00418522|19581735|P1|STARTED|Overall Study||219
7955318|NCT00418457|19581781|P2|NOT COMPLETED|Overall Study||0
7955319|NCT00418457|19581782|P1|NOT COMPLETED|Overall Study||0
7955320|NCT00418457|19581781|P2|COMPLETED|Overall Study||1043
7955321|NCT00418457|19581782|P1|COMPLETED|Overall Study||1065
7955322|NCT00418457|19581781|P2|STARTED|Overall Study||1043
7955323|NCT00418457|19581782|P1|STARTED|Overall Study||1065
7955324|NCT00418379|19581799|P3|NOT COMPLETED|Year 5||3
7955325|NCT00418379|19581800|P2|NOT COMPLETED|Year 5||5
7955326|NCT00418379|19581801|P1|NOT COMPLETED|Year 5||2
7955327|NCT00418379|19581799|P3|COMPLETED|Year 5||131
7955328|NCT00418379|19581800|P2|COMPLETED|Year 5||115
7955329|NCT00418379|19581801|P1|COMPLETED|Year 5||126
7955330|NCT00418379|19581799|P3|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134
7955331|NCT00418379|19581800|P2|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120
7955332|NCT00418379|19581801|P1|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128
7955333|NCT00418379|19581799|P3|NOT COMPLETED|Year 4||2
7955334|NCT00418379|19581800|P2|NOT COMPLETED|Year 4||5
7955335|NCT00418379|19581801|P1|NOT COMPLETED|Year 4||3
7955336|NCT00418379|19581799|P3|COMPLETED|Year 4||154
7955337|NCT00418379|19581800|P2|COMPLETED|Year 4||136
7955338|NCT00418379|19581801|P1|COMPLETED|Year 4||142
7955339|NCT00418379|19581799|P3|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156
7955340|NCT00418379|19581800|P2|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141
7955341|NCT00418379|19581801|P1|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145
7955342|NCT00418379|19581799|P3|NOT COMPLETED|Year 3||3
7955343|NCT00418379|19581800|P2|NOT COMPLETED|Year 3||2
7955344|NCT00418379|19581801|P1|NOT COMPLETED|Year 3||3
7955345|NCT00418379|19581799|P3|COMPLETED|Year 3||163
7955346|NCT00418379|19581800|P2|COMPLETED|Year 3||146
7955347|NCT00418379|19581801|P1|COMPLETED|Year 3||148
7955348|NCT00418379|19581799|P3|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166
7955349|NCT00418379|19581800|P2|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148
7955350|NCT00418379|19581801|P1|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151
7955351|NCT00418379|19581799|P3|NOT COMPLETED|Year 2||10
7955352|NCT00418379|19581800|P2|NOT COMPLETED|Year 2||4
7955353|NCT00418379|19581801|P1|NOT COMPLETED|Year 2||8
7955354|NCT00418379|19581799|P3|COMPLETED|Year 2||172
7955355|NCT00418379|19581800|P2|COMPLETED|Year 2||155
7955356|NCT00418379|19581801|P1|COMPLETED|Year 2||159
7955357|NCT00418379|19581799|P3|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182
7955358|NCT00418379|19581800|P2|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159
7955359|NCT00418379|19581801|P1|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167
7955360|NCT00418379|19581799|P3|NOT COMPLETED|Year 1||15
7955361|NCT00418379|19581800|P2|NOT COMPLETED|Year 1||28
7955362|NCT00418379|19581801|P1|NOT COMPLETED|Year 1||18
7955363|NCT00418379|19581799|P3|COMPLETED|Year 1||204
7955364|NCT00418379|19581800|P2|COMPLETED|Year 1||179
7955365|NCT00418379|19581801|P1|COMPLETED|Year 1||189
7955366|NCT00418379|19581799|P3|STARTED|Year 1||219
7955367|NCT00418379|19581800|P2|STARTED|Year 1||207
7955368|NCT00418379|19581801|P1|STARTED|Year 1||207
7955369|NCT00418314|19581811|P2|NOT COMPLETED|Overall Study||2
7955370|NCT00418314|19581812|P1|NOT COMPLETED|Overall Study||1
7955371|NCT00418314|19581811|P2|COMPLETED|Overall Study||828
7955372|NCT00418314|19581812|P1|COMPLETED|Overall Study||816
7955373|NCT00418314|19581811|P2|STARTED|Overall Study||830
7955374|NCT00418314|19581812|P1|STARTED|Overall Study||817
7955375|NCT00418262|19581822|P1|NOT COMPLETED|Visits 8 Thru 10||5
7955376|NCT00418262|19581822|P1|COMPLETED|Visits 8 Thru 10||11
7955377|NCT00418262|19581822|P1|STARTED|Visits 8 Thru 10||16
7955378|NCT00418262|19581822|P1|NOT COMPLETED|Visits 5 Thru 8||9
7955379|NCT00418262|19581822|P1|COMPLETED|Visits 5 Thru 8||16
7955380|NCT00418262|19581822|P1|STARTED|Visits 5 Thru 8||25
7955381|NCT00418262|19581822|P1|NOT COMPLETED|Visits 1 (Baseline) Thru 5||2
7955382|NCT00418262|19581822|P1|COMPLETED|Visits 1 (Baseline) Thru 5||25
7955383|NCT00418262|19581822|P1|STARTED|Visits 1 (Baseline) Thru 5||27
7955384|NCT00418184|19581842|P2|NOT COMPLETED|Open-label Phase||5
7955385|NCT00418184|19581843|P1|NOT COMPLETED|Open-label Phase||5
7955386|NCT00418184|19581842|P2|COMPLETED|Open-label Phase|5 dropped out|43
7955387|NCT00418184|19581843|P1|COMPLETED|Open-label Phase|5 dropped out|97
7955388|NCT00418184|19581842|P2|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48
7955389|NCT00418184|19581843|P1|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102
7955390|NCT00418184|19581842|P2|NOT COMPLETED|Double-blind Phase||11
7955391|NCT00418184|19581843|P1|NOT COMPLETED|Double-blind Phase||27
7955392|NCT00418184|19581842|P2|COMPLETED|Double-blind Phase||52
7955393|NCT00418184|19581843|P1|COMPLETED|Double-blind Phase||110
7955394|NCT00418184|19581842|P2|STARTED|Double-blind Phase||63
7955395|NCT00418184|19581843|P1|STARTED|Double-blind Phase||137
7955396|NCT00418145|19581851|P1|NOT COMPLETED|Overall Study||6
7955397|NCT00418145|19581851|P1|COMPLETED|Overall Study||10
7955398|NCT00418145|19581851|P1|STARTED|Overall Study||16
7955399|NCT00418093|19581863|P1|NOT COMPLETED|Overall Study||0
7955400|NCT00418093|19581863|P1|COMPLETED|Overall Study||19
7955401|NCT00418093|19581863|P1|Completed Study|Overall Study||19
7955402|NCT00418093|19581863|P1|STARTED|Overall Study||19
7955403|NCT00418028|19581872|P2|NOT COMPLETED|Overall Study||1
7955404|NCT00418028|19581873|P1|NOT COMPLETED|Overall Study||2
7955405|NCT00418028|19581872|P2|COMPLETED|Overall Study||97
7955406|NCT00418028|19581873|P1|COMPLETED|Overall Study||95
7955407|NCT00418028|19581872|P2|STARTED|Overall Study||98
7955408|NCT00418028|19581873|P1|STARTED|Overall Study||97
7955409|NCT00418015|19581895|P4|NOT COMPLETED|Overall Study||0
7955410|NCT00418015|19581896|P3|NOT COMPLETED|Overall Study||0
7955411|NCT00418015|19581897|P2|NOT COMPLETED|Overall Study||0
7955412|NCT00418015|19581898|P1|NOT COMPLETED|Overall Study||0
7955413|NCT00418015|19581895|P4|COMPLETED|Overall Study||25
7955414|NCT00418015|19581896|P3|COMPLETED|Overall Study||78
7955415|NCT00418015|19581897|P2|COMPLETED|Overall Study||46
7955416|NCT00418015|19581898|P1|COMPLETED|Overall Study||144
7955417|NCT00418015|19581895|P4|STARTED|Overall Study||25
7955418|NCT00418015|19581896|P3|STARTED|Overall Study||78
7955419|NCT00418015|19581897|P2|STARTED|Overall Study||46
7955420|NCT00418015|19581898|P1|STARTED|Overall Study||144
7955421|NCT00417989|19581926|P2|NOT COMPLETED|Overall Study||22
7955422|NCT00417989|19581927|P1|NOT COMPLETED|Overall Study||20
7955423|NCT00417989|19581926|P2|COMPLETED|Overall Study||219
7955424|NCT00417989|19581927|P1|COMPLETED|Overall Study||224
7955425|NCT00417989|19581926|P2|STARTED|Overall Study||241
7955426|NCT00417989|19581927|P1|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244
7955427|NCT00417976|19581949|P1|NOT COMPLETED|Overall Study||3
7955428|NCT00417976|19581949|P1|COMPLETED|Overall Study||39
7955429|NCT00417976|19581949|P1|STARTED|Overall Study||42
7955430|NCT00417963|19581954|P1|NOT COMPLETED|Overall Study||41
7955431|NCT00417963|19581954|P1|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445
7955432|NCT00417963|19581954|P1|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486
7955433|NCT00417885|19581971|P1|NOT COMPLETED|Overall Study||6
7955434|NCT00417885|19581971|P1|COMPLETED|Overall Study||0
7955435|NCT00417885|19581971|P1|STARTED|Overall Study||6
7955436|NCT00417859|19581982|P2|NOT COMPLETED|Overall Study||1
7955437|NCT00417859|19581983|P1|NOT COMPLETED|Overall Study||0
7955438|NCT00417859|19581982|P2|COMPLETED|Overall Study||29
7955439|NCT00417859|19581983|P1|COMPLETED|Overall Study||26
7955440|NCT00417859|19581982|P2|STARTED|Overall Study||30
7955441|NCT00417859|19581983|P1|STARTED|Overall Study||26
7955442|NCT00417612|19581997|P2|NOT COMPLETED|Overall Study||3
7955443|NCT00417612|19581998|P1|NOT COMPLETED|Overall Study||3
7955444|NCT00417612|19581997|P2|COMPLETED|Overall Study||8
7955445|NCT00417612|19581998|P1|COMPLETED|Overall Study||19
7955446|NCT00417612|19581997|P2|STARTED|Overall Study||11
7955447|NCT00417612|19581998|P1|STARTED|Overall Study||22
7955448|NCT00417482|19582024|P3|NOT COMPLETED|Phase B 2nd 16 Weeks||3
7955449|NCT00417482|19582025|P2|NOT COMPLETED|Phase B 2nd 16 Weeks||13
7955450|NCT00417482|19582026|P1|NOT COMPLETED|Phase B 2nd 16 Weeks||3
7955451|NCT00417482|19582024|P3|COMPLETED|Phase B 2nd 16 Weeks||10
7955452|NCT00417482|19582025|P2|COMPLETED|Phase B 2nd 16 Weeks||14
7955453|NCT00417482|19582026|P1|COMPLETED|Phase B 2nd 16 Weeks||10
7955454|NCT00417482|19582024|P3|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13
7955455|NCT00417482|19582025|P2|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27
7955456|NCT00417482|19582026|P1|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13
7955457|NCT00417482|19582024|P3|NOT COMPLETED|Phase B 1st 16 Weeks||27
7955458|NCT00417482|19582025|P2|NOT COMPLETED|Phase B 1st 16 Weeks||11
7955459|NCT00417482|19582026|P1|NOT COMPLETED|Phase B 1st 16 Weeks||19
7955460|NCT00417482|19582024|P3|COMPLETED|Phase B 1st 16 Weeks||13
7955461|NCT00417482|19582025|P2|COMPLETED|Phase B 1st 16 Weeks||27
7955462|NCT00417482|19582026|P1|COMPLETED|Phase B 1st 16 Weeks||13
7955463|NCT00417482|19582024|P3|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40
7955464|NCT00417482|19582025|P2|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38
7955465|NCT00417482|19582026|P1|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32
7955466|NCT00417417|19582052|P2|NOT COMPLETED|Overall Study||0
7955467|NCT00417417|19582053|P1|NOT COMPLETED|Overall Study||0
7955468|NCT00417417|19582052|P2|COMPLETED|Overall Study||6
7955469|NCT00417417|19582053|P1|COMPLETED|Overall Study||4
7955470|NCT00417417|19582052|P2|STARTED|Overall Study||6
7955471|NCT00417417|19582053|P1|STARTED|Overall Study||4
7955472|NCT00417274|19582061|P1|NOT COMPLETED|Overall Study||0
7955473|NCT00417274|19582061|P1|COMPLETED|Overall Study||31
7955474|NCT00417274|19582061|P1|STARTED|Overall Study||31
7955475|NCT00417248|19582065|P1|NOT COMPLETED|Overall Study||8
7955476|NCT00417248|19582065|P1|COMPLETED|Overall Study||0
7955477|NCT00417248|19582065|P1|STARTED|Overall Study||8
7955478|NCT00417170|19582072|P2|NOT COMPLETED|Overall Study||3
7955479|NCT00417170|19582073|P1|NOT COMPLETED|Overall Study||2
7955480|NCT00417170|19582072|P2|COMPLETED|Overall Study||22
7955481|NCT00417170|19582073|P1|COMPLETED|Overall Study||21
7955482|NCT00417170|19582072|P2|Pharmacodynamics Population|Overall Study||23
7955483|NCT00417170|19582073|P1|Pharmacodynamics Population|Overall Study||21
7955484|NCT00417170|19582072|P2|STARTED|Overall Study||25
7955485|NCT00417170|19582073|P1|STARTED|Overall Study|"Started indicates Safety population."|23
7955486|NCT00417079|19582089|P2|NOT COMPLETED|Overall Study||273
7955487|NCT00417079|19582090|P1|NOT COMPLETED|Overall Study||331
7955488|NCT00417079|19582089|P2|COMPLETED|Overall Study|Randomized patients|105
7955489|NCT00417079|19582090|P1|COMPLETED|Overall Study|Randomized patients|46
7955490|NCT00417079|19582089|P2|STARTED|Overall Study|Randomized patients|378
7955491|NCT00417079|19582090|P1|STARTED|Overall Study|Randomized patients|377
7955492|NCT00417027|19582113|P3|NOT COMPLETED|Overall Study||5
7955493|NCT00417027|19582114|P2|NOT COMPLETED|Overall Study||5
7955494|NCT00417027|19582115|P1|NOT COMPLETED|Overall Study||0
7955495|NCT00417027|19582113|P3|COMPLETED|Overall Study||54
7955496|NCT00417027|19582114|P2|COMPLETED|Overall Study||60
7955497|NCT00417027|19582115|P1|COMPLETED|Overall Study||66
7955498|NCT00417027|19582113|P3|STARTED|Overall Study||59
7955499|NCT00417027|19582114|P2|STARTED|Overall Study||65
7955500|NCT00417027|19582115|P1|STARTED|Overall Study||66
7955501|NCT00416949|19582141|P1|NOT COMPLETED|Overall Study||5
7955502|NCT00416949|19582141|P1|COMPLETED|Overall Study||4
7955503|NCT00416949|19582141|P1|STARTED|Overall Study||9
7955504|NCT00416884|19582145|P1|NOT COMPLETED|Overall Study||1
7955505|NCT00416884|19582145|P1|COMPLETED|Overall Study||0
7955506|NCT00416884|19582145|P1|STARTED|Overall Study||1
7955507|NCT00416793|19582149|P1|NOT COMPLETED|Overall Study||0
7955508|NCT00416793|19582149|P1|COMPLETED|Overall Study||9
7955509|NCT00416793|19582149|P1|STARTED|Overall Study||9
7955510|NCT00416715|19582154|P1|NOT COMPLETED|Overall Study||15
7955511|NCT00416715|19582154|P1|COMPLETED|Overall Study||85
7955512|NCT00416715|19582154|P1|STARTED|Overall Study||100
7955513|NCT00416624|19582165|P4|NOT COMPLETED|Overall Study||17
7955514|NCT00416624|19582166|P3|NOT COMPLETED|Overall Study||18
7955515|NCT00416624|19582167|P2|NOT COMPLETED|Overall Study||27
7955516|NCT00416624|19582168|P1|NOT COMPLETED|Overall Study||22
7955517|NCT00416624|19582165|P4|COMPLETED|Overall Study||40
7955518|NCT00416624|19582166|P3|COMPLETED|Overall Study||40
7955519|NCT00416624|19582167|P2|COMPLETED|Overall Study||33
7955520|NCT00416624|19582168|P1|COMPLETED|Overall Study||39
7955521|NCT00416624|19582165|P4|STARTED|Overall Study||57
7955522|NCT00416624|19582166|P3|STARTED|Overall Study||58
7955523|NCT00416624|19582167|P2|STARTED|Overall Study||60
7955524|NCT00416624|19582168|P1|STARTED|Overall Study||61
7955525|NCT00416598|19582222|P1|NOT COMPLETED|Decitabine Maintenance||72
7955526|NCT00416598|19582222|P1|COMPLETED|Decitabine Maintenance||62
7955527|NCT00416598|19582222|P1|STARTED|Decitabine Maintenance||134
7955528|NCT00416598|19582222|P1|NOT COMPLETED|Induction & Intensification||412
7955529|NCT00416598|19582222|P1|COMPLETED|Induction & Intensification||134
7955530|NCT00416598|19582222|P1|STARTED|Induction & Intensification||546
7955531|NCT00416572|19582230|P3|NOT COMPLETED|Overall Study||8
7955532|NCT00416572|19582231|P2|NOT COMPLETED|Overall Study||7
7955533|NCT00416572|19582232|P1|NOT COMPLETED|Overall Study||13
7955534|NCT00416572|19582230|P3|COMPLETED|Overall Study||76
7955535|NCT00416572|19582231|P2|COMPLETED|Overall Study||78
7955536|NCT00416572|19582232|P1|COMPLETED|Overall Study||70
7955537|NCT00416572|19582230|P3|STARTED|Overall Study||84
7955538|NCT00416572|19582231|P2|STARTED|Overall Study||85
7955539|NCT00416572|19582232|P1|STARTED|Overall Study||83
7955540|NCT00416520|19582248|P4|NOT COMPLETED|Placebo-controlled Withdrawal Period||5
7955541|NCT00416520|19582249|P3|NOT COMPLETED|Placebo-controlled Withdrawal Period||1
7955542|NCT00416520|19582250|P2|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
7955543|NCT00416520|19582251|P1|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
7955544|NCT00416520|19582248|P4|COMPLETED|Placebo-controlled Withdrawal Period||49
7955545|NCT00416520|19582249|P3|COMPLETED|Placebo-controlled Withdrawal Period||49
7955546|NCT00416520|19582250|P2|COMPLETED|Placebo-controlled Withdrawal Period||0
7955547|NCT00416520|19582251|P1|COMPLETED|Placebo-controlled Withdrawal Period||0
7955548|NCT00416520|19582248|P4|STARTED|Placebo-controlled Withdrawal Period||54
7955549|NCT00416520|19582249|P3|STARTED|Placebo-controlled Withdrawal Period||50
7955550|NCT00416520|19582250|P2|STARTED|Placebo-controlled Withdrawal Period||0
7955551|NCT00416520|19582251|P1|STARTED|Placebo-controlled Withdrawal Period||0
7955552|NCT00416520|19582248|P4|NOT COMPLETED|Open-label Period||0
7955553|NCT00416520|19582249|P3|NOT COMPLETED|Open-label Period||0
7955554|NCT00416520|19582250|P2|NOT COMPLETED|Open-label Period||32
7955555|NCT00416520|19582251|P1|NOT COMPLETED|Open-label Period||60
7955556|NCT00416520|19582248|P4|COMPLETED|Open-label Period||0
7955557|NCT00416520|19582249|P3|COMPLETED|Open-label Period||0
7955558|NCT00416520|19582250|P2|COMPLETED|Open-label Period||139
7955559|NCT00416520|19582251|P1|COMPLETED|Open-label Period||105
7955560|NCT00416520|19582248|P4|STARTED|Open-label Period||0
7955561|NCT00416520|19582249|P3|STARTED|Open-label Period||0
7955562|NCT00416520|19582250|P2|STARTED|Open-label Period||171
7955563|NCT00416520|19582251|P1|STARTED|Open-label Period||165
7955564|NCT00416494|19582263|P2|NOT COMPLETED|Overall Study||0
7955565|NCT00416494|19582264|P1|NOT COMPLETED|Overall Study||0
7955566|NCT00416494|19582263|P2|COMPLETED|Overall Study||31
7955567|NCT00416494|19582264|P1|COMPLETED|Overall Study||19
7955568|NCT00416494|19582263|P2|STARTED|Overall Study||31
7955569|NCT00416494|19582264|P1|STARTED|Overall Study||19
7955570|NCT00416455|19582280|P2|NOT COMPLETED|Overall Study||8
7955571|NCT00416455|19582281|P1|NOT COMPLETED|Overall Study||16
7955572|NCT00416455|19582280|P2|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207
7955573|NCT00416455|19582281|P1|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153
7955574|NCT00416455|19582280|P2|STARTED|Overall Study|This is a diagnostic imaging study.|215
7955575|NCT00416455|19582281|P1|STARTED|Overall Study|This is a diagnostic imaging study.|169
7955576|NCT00416312|19582316|P1|NOT COMPLETED|Overall Study||2
7955577|NCT00416312|19582316|P1|COMPLETED|Overall Study||7
7955578|NCT00416312|19582316|P1|Patient-specific Dosimetry|Overall Study||9
7955579|NCT00416312|19582316|P1|Conventional Dosimetry|Overall Study||9
7955580|NCT00416312|19582316|P1|STARTED|Overall Study||9
7955581|NCT00416195|19582322|P2|NOT COMPLETED|Overall Study||4
7955582|NCT00416195|19582323|P1|NOT COMPLETED|Overall Study||2
7955583|NCT00416195|19582322|P2|COMPLETED|Overall Study||34
7955584|NCT00416195|19582323|P1|COMPLETED|Overall Study||8
7955585|NCT00416195|19582322|P2|STARTED|Overall Study||38
7955586|NCT00416195|19582323|P1|STARTED|Overall Study||10
7955587|NCT00416182|19582333|P2|NOT COMPLETED|Overall Study||2
7955588|NCT00416182|19582334|P1|NOT COMPLETED|Overall Study||3
7955589|NCT00416182|19582333|P2|COMPLETED|Overall Study||6
7955590|NCT00416182|19582334|P1|COMPLETED|Overall Study||5
7955591|NCT00416182|19582333|P2|STARTED|Overall Study||8
7955592|NCT00416182|19582334|P1|STARTED|Overall Study||8
7955593|NCT00416078|19582348|P2|NOT COMPLETED|Overall Study||8
7955594|NCT00416078|19582349|P1|NOT COMPLETED|Overall Study||11
7955595|NCT00416078|19582348|P2|COMPLETED|Overall Study||16
7955596|NCT00416078|19582349|P1|COMPLETED|Overall Study||18
7955597|NCT00416078|19582348|P2|STARTED|Overall Study||24
7955598|NCT00416078|19582349|P1|STARTED|Overall Study||29
7955599|NCT00415909|19582365|P1|NOT COMPLETED|Overall Study||3
7955600|NCT00415909|19582365|P1|COMPLETED|Overall Study||0
7955601|NCT00415909|19582365|P1|STARTED|Overall Study||3
7955602|NCT00415870|19582371|P2|NOT COMPLETED|Overall Study||7
7955603|NCT00415870|19582372|P1|NOT COMPLETED|Overall Study||6
7955604|NCT00415870|19582371|P2|COMPLETED|Overall Study||26
7955605|NCT00415870|19582372|P1|COMPLETED|Overall Study||26
7955606|NCT00415870|19582371|P2|STARTED|Overall Study||33
7955607|NCT00415870|19582372|P1|STARTED|Overall Study||32
7955608|NCT00415857|19582384|P2|NOT COMPLETED|Overall Study||0
7955609|NCT00415857|19582385|P1|NOT COMPLETED|Overall Study||0
7955610|NCT00415857|19582384|P2|COMPLETED|Overall Study||3
7955611|NCT00415857|19582385|P1|COMPLETED|Overall Study||2
7955612|NCT00415857|19582384|P2|STARTED|Overall Study||3
7955613|NCT00415857|19582385|P1|STARTED|Overall Study||2
7955614|NCT00415636|19582399|P6|NOT COMPLETED|Overall Study||2
7955615|NCT00415636|19582400|P5|NOT COMPLETED|Overall Study||2
7955616|NCT00415636|19582401|P4|NOT COMPLETED|Overall Study||6
7955617|NCT00415636|19582402|P3|NOT COMPLETED|Overall Study||1
7955618|NCT00415636|19582403|P2|NOT COMPLETED|Overall Study||0
7955619|NCT00415636|19582404|P1|NOT COMPLETED|Overall Study||1
7955620|NCT00415636|19582399|P6|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|1
7955621|NCT00415636|19582400|P5|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|4
7955622|NCT00415636|19582401|P4|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|7
7955623|NCT00415636|19582402|P3|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
7955624|NCT00415636|19582403|P2|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|3
7955625|NCT00415636|19582404|P1|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
7955626|NCT00415636|19582399|P6|STARTED|Overall Study||3
7955627|NCT00415636|19582400|P5|STARTED|Overall Study||6
7955628|NCT00415636|19582401|P4|STARTED|Overall Study||13
7955629|NCT00415636|19582402|P3|STARTED|Overall Study||3
7955630|NCT00415636|19582403|P2|STARTED|Overall Study||3
7955631|NCT00415636|19582404|P1|STARTED|Overall Study||3
7955632|NCT00415623|19582438|P2|NOT COMPLETED|Overall Study||5
7955633|NCT00415623|19582439|P1|NOT COMPLETED|Overall Study||5
7955634|NCT00415623|19582438|P2|COMPLETED|Overall Study||146
7955635|NCT00415623|19582439|P1|COMPLETED|Overall Study||149
7955636|NCT00415623|19582438|P2|STARTED|Overall Study||151
7955637|NCT00415623|19582439|P1|STARTED|Overall Study||154
7955638|NCT00415610|19582466|P3|NOT COMPLETED|Overall Study||5
7955639|NCT00415610|19582467|P2|NOT COMPLETED|Overall Study||2
7955640|NCT00415610|19582468|P1|NOT COMPLETED|Overall Study||3
7955641|NCT00415610|19582466|P3|COMPLETED|Overall Study||17
7955642|NCT00415610|19582467|P2|COMPLETED|Overall Study||18
7955643|NCT00415610|19582468|P1|COMPLETED|Overall Study||15
7955644|NCT00415610|19582466|P3|STARTED|Overall Study||22
7955645|NCT00415610|19582467|P2|STARTED|Overall Study||20
7955646|NCT00415610|19582468|P1|STARTED|Overall Study||18
7955647|NCT00415597|19582488|P1|NOT COMPLETED|Treatment||305
7955648|NCT00415597|19582488|P1|COMPLETED|Treatment||160
7955649|NCT00415597|19582488|P1|STARTED|Treatment||465
7955650|NCT00415597|19582488|P1|NOT COMPLETED|Enrollment||2
7955651|NCT00415597|19582488|P1|COMPLETED|Enrollment||465
7955652|NCT00415597|19582488|P1|STARTED|Enrollment||467
7955653|NCT00415532|19582496|P2|NOT COMPLETED|Safety Follow Up Period||12
7955654|NCT00415532|19582497|P1|NOT COMPLETED|Safety Follow Up Period||9
7955655|NCT00415532|19582496|P2|COMPLETED|Safety Follow Up Period||18
7955656|NCT00415532|19582497|P1|COMPLETED|Safety Follow Up Period||34
7955657|NCT00415532|19582496|P2|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30
7955658|NCT00415532|19582497|P1|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43
7955659|NCT00415532|19582496|P2|NOT COMPLETED|Treatment Period||15
7955660|NCT00415532|19582497|P1|NOT COMPLETED|Treatment Period||17
7955661|NCT00415532|19582496|P2|COMPLETED|Treatment Period||142
7955662|NCT00415532|19582497|P1|COMPLETED|Treatment Period||60
7955663|NCT00415532|19582496|P2|Switched to Romiplostim Group|Treatment Period||0
7955664|NCT00415532|19582497|P1|Switched to Romiplostim Group|Treatment Period||2
7955665|NCT00415532|19582496|P2|Received Treatment|Treatment Period||154
7955666|NCT00415532|19582497|P1|Received Treatment|Treatment Period||75
7955667|NCT00415532|19582496|P2|STARTED|Treatment Period||157
7955668|NCT00415532|19582497|P1|STARTED|Treatment Period||77
7955669|NCT00415519|19582519|P2|NOT COMPLETED|Overall Study||0
7955670|NCT00415519|19582520|P1|NOT COMPLETED|Overall Study||4
7955671|NCT00415519|19582519|P2|COMPLETED|Overall Study||12
7955672|NCT00415519|19582520|P1|COMPLETED|Overall Study||9
7955673|NCT00415519|19582519|P2|STARTED|Overall Study||12
7955674|NCT00415519|19582520|P1|STARTED|Overall Study||13
7955675|NCT00415506|19582540|P2|NOT COMPLETED|Overall Study||1
7955676|NCT00415506|19582541|P1|NOT COMPLETED|Overall Study||3
7955677|NCT00415506|19582540|P2|COMPLETED|Overall Study||9
7955678|NCT00415506|19582541|P1|COMPLETED|Overall Study||9
7955679|NCT00415506|19582540|P2|STARTED|Overall Study||10
7955680|NCT00415506|19582541|P1|STARTED|Overall Study||12
7955681|NCT00415493|19582551|P2|NOT COMPLETED|Overall Study||0
7955682|NCT00415493|19582552|P1|NOT COMPLETED|Overall Study||0
7955683|NCT00415493|19582551|P2|COMPLETED|Overall Study||12
7955684|NCT00415493|19582552|P1|COMPLETED|Overall Study||12
7955685|NCT00415493|19582551|P2|STARTED|Overall Study||12
7955686|NCT00415493|19582552|P1|STARTED|Overall Study||12
7955687|NCT00415363|19582560|P2|NOT COMPLETED|Overall Study||54
7955688|NCT00415363|19582561|P1|NOT COMPLETED|Overall Study||55
7955689|NCT00415363|19582560|P2|COMPLETED|Overall Study||0
7955690|NCT00415363|19582561|P1|COMPLETED|Overall Study||0
7955691|NCT00415363|19582560|P2|Safety Population|Overall Study||53
7955692|NCT00415363|19582561|P1|Safety Population|Overall Study||54
7955693|NCT00415363|19582560|P2|STARTED|Overall Study||54
7955694|NCT00415363|19582561|P1|STARTED|Overall Study||55
7955695|NCT00415194|19582591|P2|NOT COMPLETED|Overall Study||342
7955696|NCT00415194|19582592|P1|NOT COMPLETED|Overall Study||328
7955697|NCT00415194|19582591|P2|COMPLETED|Overall Study||55
7955698|NCT00415194|19582592|P1|COMPLETED|Overall Study||70
7955699|NCT00415194|19582591|P2|Received at Least 1 Dose of Study Drug|Overall Study||385
7955700|NCT00415194|19582592|P1|Received at Least 1 Dose of Study Drug|Overall Study||392
7955701|NCT00415194|19582591|P2|STARTED|Overall Study||397
7955702|NCT00415194|19582592|P1|STARTED|Overall Study||398
7955703|NCT00415168|19582608|P1|NOT COMPLETED|Overall Study||52
7955704|NCT00415168|19582608|P1|COMPLETED|Overall Study||1
7955705|NCT00415168|19582608|P1|Completed Treatment|Overall Study||15
7955706|NCT00415168|19582608|P1|STARTED|Overall Study||53
7955707|NCT00415051|19582618|P1|NOT COMPLETED|Overall Study||1
7955708|NCT00415051|19582618|P1|COMPLETED|Overall Study||19
7955709|NCT00415051|19582618|P1|STARTED|Overall Study||20
7955710|NCT00414973|19582629|P4|NOT COMPLETED|Overall Study||0
7955711|NCT00414973|19582630|P3|NOT COMPLETED|Overall Study||3
7955712|NCT00414973|19582631|P2|NOT COMPLETED|Overall Study||10
7955713|NCT00414973|19582632|P1|NOT COMPLETED|Overall Study||28
7955714|NCT00414973|19582629|P4|COMPLETED|Overall Study||11
7955715|NCT00414973|19582630|P3|COMPLETED|Overall Study||21
7955716|NCT00414973|19582631|P2|COMPLETED|Overall Study||99
7955717|NCT00414973|19582632|P1|COMPLETED|Overall Study||190
7955718|NCT00414973|19582629|P4|STARTED|Overall Study||11
7955719|NCT00414973|19582630|P3|STARTED|Overall Study||24
7955720|NCT00414973|19582631|P2|STARTED|Overall Study||109
7955721|NCT00414973|19582632|P1|STARTED|Overall Study||218
7955722|NCT00414960|19582652|P2|NOT COMPLETED|Overall Study||1
7955723|NCT00414960|19582653|P1|NOT COMPLETED|Overall Study||7
7955724|NCT00414960|19582652|P2|COMPLETED|Overall Study||14
7955725|NCT00414960|19582653|P1|COMPLETED|Overall Study||18
7955726|NCT00414960|19582652|P2|Received at Least One Dose of Study Drug|Overall Study||15
7955727|NCT00414960|19582653|P1|Received at Least One Dose of Study Drug|Overall Study||24
7955728|NCT00414960|19582652|P2|STARTED|Overall Study||15
7955729|NCT00414960|19582653|P1|STARTED|Overall Study||25
7955730|NCT00414908|19582663|P2|NOT COMPLETED|Overall Study||1
7955731|NCT00414908|19582664|P1|NOT COMPLETED|Overall Study||1
7955732|NCT00414908|19582663|P2|COMPLETED|Overall Study||28
7955733|NCT00414908|19582664|P1|COMPLETED|Overall Study||24
7955734|NCT00414908|19582663|P2|STARTED|Overall Study||29
7955735|NCT00414908|19582664|P1|STARTED|Overall Study||25
7955736|NCT00414817|19582688|P2|NOT COMPLETED|Overall Study||3016
7955737|NCT00414817|19582689|P1|NOT COMPLETED|Overall Study||3130
7955738|NCT00414817|19582688|P2|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015
7955739|NCT00414817|19582689|P1|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903
7955740|NCT00414817|19582688|P2|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184
7955741|NCT00414817|19582689|P1|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175
7955742|NCT00414817|19582688|P2|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123
7955743|NCT00414817|19582689|P1|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117
7955831|NCT00414466|19582844|P2|STARTED|Overall Study||42
7955744|NCT00414817|19582688|P2|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900
7955745|NCT00414817|19582689|P1|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922
7955746|NCT00414817|19582688|P2|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417
7955747|NCT00414817|19582689|P1|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451
7955748|NCT00414817|19582688|P2|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392
7955749|NCT00414817|19582689|P1|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465
7955750|NCT00414817|19582688|P2|STARTED|Overall Study||7031
7955751|NCT00414817|19582689|P1|STARTED|Overall Study||7033
7955752|NCT00414726|19582701|P2|NOT COMPLETED|Overall Study||1
7955753|NCT00414726|19582702|P1|NOT COMPLETED|Overall Study||0
7955754|NCT00414726|19582701|P2|COMPLETED|Overall Study||41
7955755|NCT00414726|19582702|P1|COMPLETED|Overall Study||43
7955756|NCT00414726|19582701|P2|STARTED|Overall Study||42
7955757|NCT00414726|19582702|P1|STARTED|Overall Study||43
7955758|NCT00414700|19582712|P2|NOT COMPLETED|Overall Study||3
7955759|NCT00414700|19582713|P1|NOT COMPLETED|Overall Study||6
7955760|NCT00414700|19582712|P2|COMPLETED|Overall Study||58
7955761|NCT00414700|19582713|P1|COMPLETED|Overall Study||51
7955762|NCT00414700|19582712|P2|STARTED|Overall Study||61
7955763|NCT00414700|19582713|P1|STARTED|Overall Study||57
7955764|NCT00414661|19582737|P4|NOT COMPLETED|Overall Study||3
7955765|NCT00414661|19582738|P3|NOT COMPLETED|Overall Study||2
7955766|NCT00414661|19582739|P2|NOT COMPLETED|Overall Study||14
7955767|NCT00414661|19582740|P1|NOT COMPLETED|Overall Study||14
7955768|NCT00414661|19582737|P4|COMPLETED|Overall Study||0
7955769|NCT00414661|19582738|P3|COMPLETED|Overall Study||20
7955770|NCT00414661|19582739|P2|COMPLETED|Overall Study||75
7955771|NCT00414661|19582740|P1|COMPLETED|Overall Study||34
7955772|NCT00414661|19582737|P4|STARTED|Overall Study||3
7955773|NCT00414661|19582738|P3|STARTED|Overall Study||22
7955774|NCT00414661|19582739|P2|STARTED|Overall Study||89
7955775|NCT00414661|19582740|P1|STARTED|Overall Study||48
7955776|NCT00414635|19582764|P2|NOT COMPLETED|Overall Study||2
7955777|NCT00414635|19582765|P1|NOT COMPLETED|Overall Study||5
7955778|NCT00414635|19582764|P2|COMPLETED|Overall Study||28
7955779|NCT00414635|19582765|P1|COMPLETED|Overall Study||25
7955780|NCT00414635|19582764|P2|STARTED|Overall Study||30
7955781|NCT00414635|19582765|P1|STARTED|Overall Study||30
7955782|NCT00414609|19582785|P3|NOT COMPLETED|Extension Study||57
7955783|NCT00414609|19582786|P2|NOT COMPLETED|Extension Study||0
7955784|NCT00414609|19582787|P1|NOT COMPLETED|Extension Study||0
7955785|NCT00414609|19582785|P3|COMPLETED|Extension Study||365
7955786|NCT00414609|19582786|P2|COMPLETED|Extension Study||0
7955787|NCT00414609|19582787|P1|COMPLETED|Extension Study||0
7955788|NCT00414609|19582785|P3|Echocardiogram (ECHO) Analysis Set|Extension Study||400
7955789|NCT00414609|19582786|P2|Echocardiogram (ECHO) Analysis Set|Extension Study||0
7955790|NCT00414609|19582787|P1|Echocardiogram (ECHO) Analysis Set|Extension Study||0
7955791|NCT00414609|19582785|P3|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422
7955792|NCT00414609|19582786|P2|STARTED|Extension Study||0
7955793|NCT00414609|19582787|P1|STARTED|Extension Study||0
7955794|NCT00414609|19582785|P3|NOT COMPLETED|Core Study||0
7955795|NCT00414609|19582786|P2|NOT COMPLETED|Core Study||45
7955796|NCT00414609|19582787|P1|NOT COMPLETED|Core Study||34
7955797|NCT00414609|19582785|P3|COMPLETED|Core Study||0
7955798|NCT00414609|19582786|P2|COMPLETED|Core Study||378
7955799|NCT00414609|19582787|P1|COMPLETED|Core Study||363
7955800|NCT00414609|19582785|P3|Echocardiogram Evaluable Set|Core Study||0
7955801|NCT00414609|19582786|P2|Echocardiogram Evaluable Set|Core Study||343
7955802|NCT00414609|19582787|P1|Echocardiogram Evaluable Set|Core Study||330
7955803|NCT00414609|19582785|P3|Received Study Drug|Core Study||0
7955804|NCT00414609|19582786|P2|Received Study Drug|Core Study||422
7955805|NCT00414609|19582787|P1|Received Study Drug|Core Study||397
7955806|NCT00414609|19582785|P3|STARTED|Core Study||0
7955807|NCT00414609|19582786|P2|STARTED|Core Study||423
7955808|NCT00414609|19582787|P1|STARTED|Core Study||397
7955809|NCT00414596|19582810|P1|NOT COMPLETED|Overall Study||2
7955810|NCT00414596|19582810|P1|COMPLETED|Overall Study|April 2007|18
7955811|NCT00414596|19582810|P1|STARTED|Overall Study|December 2006|20
7955812|NCT00414544|19582819|P1|NOT COMPLETED|Overall Study||14
7955813|NCT00414544|19582819|P1|COMPLETED|Overall Study||131
7955814|NCT00414544|19582819|P1|STARTED|Overall Study||145
7955815|NCT00414518|19582827|P2|NOT COMPLETED|Overall Study||0
7955816|NCT00414518|19582828|P1|NOT COMPLETED|Overall Study||0
7955817|NCT00414518|19582827|P2|COMPLETED|Overall Study||9
7955818|NCT00414518|19582828|P1|COMPLETED|Overall Study||7
7955819|NCT00414518|19582827|P2|STARTED|Overall Study||9
7955820|NCT00414518|19582828|P1|STARTED|Overall Study||7
7955821|NCT00414466|19582842|P4|NOT COMPLETED|Overall Study||1
7955822|NCT00414466|19582843|P3|NOT COMPLETED|Overall Study||1
7955823|NCT00414466|19582844|P2|NOT COMPLETED|Overall Study||0
7955824|NCT00414466|19582845|P1|NOT COMPLETED|Overall Study||2
7955825|NCT00414466|19582842|P4|COMPLETED|Overall Study||42
7955826|NCT00414466|19582843|P3|COMPLETED|Overall Study||40
7955827|NCT00414466|19582844|P2|COMPLETED|Overall Study||42
7955828|NCT00414466|19582845|P1|COMPLETED|Overall Study||42
7955829|NCT00414466|19582842|P4|STARTED|Overall Study||43
7955830|NCT00414466|19582843|P3|STARTED|Overall Study||41
7955832|NCT00414466|19582845|P1|STARTED|Overall Study||44
7955833|NCT00414453|19582863|P1|NOT COMPLETED|Overall Study||16
7955834|NCT00414453|19582863|P1|COMPLETED|Overall Study||3
7955835|NCT00414453|19582863|P1|STARTED|Overall Study||19
7955836|NCT00414440|19582911|P2|NOT COMPLETED|Extension Period||140
7955837|NCT00414440|19582912|P1|NOT COMPLETED|Extension Period||150
7955838|NCT00414440|19582911|P2|COMPLETED|Extension Period|Extension|77
7955839|NCT00414440|19582912|P1|COMPLETED|Extension Period|Extension|64
7955840|NCT00414440|19582911|P2|STARTED|Extension Period|Extension|217
7955841|NCT00414440|19582912|P1|STARTED|Extension Period|Extension|214
7955842|NCT00414440|19582911|P2|NOT COMPLETED|Core Period||32
7955843|NCT00414440|19582912|P1|NOT COMPLETED|Core Period||70
7955844|NCT00414440|19582911|P2|COMPLETED|Core Period|Core period|185
7955845|NCT00414440|19582912|P1|COMPLETED|Core Period|Core period|144
7955846|NCT00414440|19582911|P2|STARTED|Core Period|Core period|217
7955847|NCT00414440|19582912|P1|STARTED|Core Period|Core period|214
7955848|NCT00414388|19582926|P1|NOT COMPLETED|Overall Study||1
7955849|NCT00414388|19582926|P1|COMPLETED|Overall Study||21
7955850|NCT00414388|19582926|P1|STARTED|Overall Study||22
7955851|NCT00414310|19582934|P2|NOT COMPLETED|Overall Study||0
7955852|NCT00414310|19582935|P1|NOT COMPLETED|Overall Study||1
7955853|NCT00414310|19582934|P2|COMPLETED|Overall Study||79
7955854|NCT00414310|19582935|P1|COMPLETED|Overall Study||70
7955855|NCT00414310|19582934|P2|STARTED|Overall Study||79
7955856|NCT00414310|19582935|P1|STARTED|Overall Study||71
7955857|NCT00414271|19582945|P1|NOT COMPLETED|Overall Study||0
7955858|NCT00414271|19582945|P1|COMPLETED|Overall Study||18
7955859|NCT00414271|19582945|P1|STARTED|Overall Study||18
7955860|NCT00414206|19582956|P3|NOT COMPLETED|Overall Study||55
7955861|NCT00414206|19582957|P2|NOT COMPLETED|Overall Study||56
7955862|NCT00414206|19582958|P1|NOT COMPLETED|Overall Study||58
7955863|NCT00414206|19582956|P3|COMPLETED|Overall Study||59
7955864|NCT00414206|19582957|P2|COMPLETED|Overall Study||58
7955865|NCT00414206|19582958|P1|COMPLETED|Overall Study||57
7955866|NCT00414206|19582956|P3|STARTED|Overall Study||114
7955867|NCT00414206|19582957|P2|STARTED|Overall Study||114
7955868|NCT00414206|19582958|P1|STARTED|Overall Study||115
7955869|NCT00414167|19582968|P2|NOT COMPLETED|Overall Study||3
7955870|NCT00414167|19582969|P1|NOT COMPLETED|Overall Study||4
7955871|NCT00414167|19582968|P2|COMPLETED|Overall Study||27
7955872|NCT00414167|19582969|P1|COMPLETED|Overall Study||27
7955873|NCT00414167|19582968|P2|STARTED|Overall Study||30
7955874|NCT00414167|19582969|P1|STARTED|Overall Study||31
7955875|NCT00414076|19582979|P2|NOT COMPLETED|Overall Study||5
7955876|NCT00414076|19582980|P1|NOT COMPLETED|Overall Study||3
7955877|NCT00414076|19582979|P2|COMPLETED|Overall Study||0
7955878|NCT00414076|19582980|P1|COMPLETED|Overall Study||1
7955879|NCT00414076|19582979|P2|STARTED|Overall Study||5
7955880|NCT00414076|19582980|P1|STARTED|Overall Study||4
7955881|NCT00414050|19582990|P4|NOT COMPLETED|Overall Study||8
7955882|NCT00414050|19582991|P3|NOT COMPLETED|Overall Study||6
7955883|NCT00414050|19582992|P2|NOT COMPLETED|Overall Study||8
7955884|NCT00414050|19582993|P1|NOT COMPLETED|Overall Study||9
7955885|NCT00414050|19582990|P4|COMPLETED|Overall Study||423
7955886|NCT00414050|19582991|P3|COMPLETED|Overall Study||423
7955887|NCT00414050|19582992|P2|COMPLETED|Overall Study||419
7955888|NCT00414050|19582993|P1|COMPLETED|Overall Study||422
7955889|NCT00414050|19582990|P4|Received Vaccination 3|Overall Study||424
7955890|NCT00414050|19582991|P3|Received Vaccination 3|Overall Study||425
7955891|NCT00414050|19582992|P2|Received Vaccination 3|Overall Study||419
7955892|NCT00414050|19582993|P1|Received Vaccination 3|Overall Study||424
7955893|NCT00414050|19582990|P4|Received Vaccination 2|Overall Study||425
7955894|NCT00414050|19582991|P3|Received Vaccination 2|Overall Study||425
7955895|NCT00414050|19582992|P2|Received Vaccination 2|Overall Study||421
7955896|NCT00414050|19582993|P1|Received Vaccination 2|Overall Study||425
7955897|NCT00414050|19582990|P4|Received Vaccination 1|Overall Study||431
7955898|NCT00414050|19582991|P3|Received Vaccination 1|Overall Study||429
7955899|NCT00414050|19582992|P2|Received Vaccination 1|Overall Study||426
7955900|NCT00414050|19582993|P1|Received Vaccination 1|Overall Study||431
7955901|NCT00414050|19582990|P4|STARTED|Overall Study||431
7955902|NCT00414050|19582991|P3|STARTED|Overall Study||429
7955903|NCT00414050|19582992|P2|STARTED|Overall Study||427
7955904|NCT00414050|19582993|P1|STARTED|Overall Study||431
7955905|NCT00414011|19583007|P1|NOT COMPLETED|Overall Study||5
7955906|NCT00414011|19583007|P1|COMPLETED|Overall Study||35
7955907|NCT00414011|19583007|P1|STARTED|Overall Study||40
7955908|NCT00413972|19583016|P4|NOT COMPLETED|Overall Study||3
7955909|NCT00413972|19583017|P3|NOT COMPLETED|Overall Study||10
7955910|NCT00413972|19583018|P2|NOT COMPLETED|Overall Study||8
7955911|NCT00413972|19583019|P1|NOT COMPLETED|Overall Study||7
7955912|NCT00413972|19583016|P4|COMPLETED|Overall Study||95
7955913|NCT00413972|19583017|P3|COMPLETED|Overall Study||88
7955914|NCT00413972|19583018|P2|COMPLETED|Overall Study||90
7955915|NCT00413972|19583019|P1|COMPLETED|Overall Study||91
7955916|NCT00413972|19583016|P4|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
7955917|NCT00413972|19583017|P3|STARTED|Overall Study||98
7955918|NCT00413972|19583018|P2|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
7955919|NCT00413972|19583019|P1|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
7955920|NCT00413959|19583029|P1|NOT COMPLETED|Overall Study||1
7955921|NCT00413959|19583029|P1|COMPLETED|Overall Study||11
7955922|NCT00413959|19583029|P1|STARTED|Overall Study||12
7955923|NCT00413920|19583036|P2|NOT COMPLETED|Overall Study||28
7955924|NCT00413920|19583037|P1|NOT COMPLETED|Overall Study||28
7955925|NCT00413920|19583036|P2|COMPLETED|Overall Study||82
7955926|NCT00413920|19583037|P1|COMPLETED|Overall Study||84
7955927|NCT00413920|19583036|P2|STARTED|Overall Study||110
7955928|NCT00413920|19583037|P1|STARTED|Overall Study||112
7955929|NCT00413894|19583052|P1|NOT COMPLETED|Overall Study||80
7955930|NCT00413894|19583052|P1|COMPLETED|Overall Study||344
7955931|NCT00413894|19583052|P1|STARTED|Overall Study||424
7955932|NCT00413777|19583069|P2|NOT COMPLETED|Extension Period||0
7955933|NCT00413777|19583070|P1|NOT COMPLETED|Extension Period||0
7955934|NCT00413777|19583069|P2|COMPLETED|Extension Period||18
7955935|NCT00413777|19583070|P1|COMPLETED|Extension Period||17
7955936|NCT00413777|19583069|P2|STARTED|Extension Period||18
7955937|NCT00413777|19583070|P1|STARTED|Extension Period||17
7955938|NCT00413777|19583069|P2|NOT COMPLETED|Fixed-dose Period||3
7955939|NCT00413777|19583070|P1|NOT COMPLETED|Fixed-dose Period||4
7955940|NCT00413777|19583069|P2|COMPLETED|Fixed-dose Period||21
7955941|NCT00413777|19583070|P1|COMPLETED|Fixed-dose Period||18
7955942|NCT00413777|19583069|P2|STARTED|Fixed-dose Period||24
7955943|NCT00413777|19583070|P1|STARTED|Fixed-dose Period||22
7955944|NCT00413699|19583118|P3|NOT COMPLETED|Extension Period||5
7955945|NCT00413699|19583119|P2|NOT COMPLETED|Extension Period||0
7955946|NCT00413699|19583120|P1|NOT COMPLETED|Extension Period||0
7955947|NCT00413699|19583118|P3|COMPLETED|Extension Period||43
7955948|NCT00413699|19583119|P2|COMPLETED|Extension Period||0
7955949|NCT00413699|19583120|P1|COMPLETED|Extension Period||0
7955950|NCT00413699|19583118|P3|STARTED|Extension Period||48
7955951|NCT00413699|19583119|P2|STARTED|Extension Period||0
7955952|NCT00413699|19583120|P1|STARTED|Extension Period||0
7955953|NCT00413699|19583118|P3|NOT COMPLETED|Initial Period||0
7955954|NCT00413699|19583119|P2|NOT COMPLETED|Initial Period||1705
7955955|NCT00413699|19583120|P1|NOT COMPLETED|Initial Period||639
7955956|NCT00413699|19583118|P3|COMPLETED|Initial Period||0
7955957|NCT00413699|19583119|P2|COMPLETED|Initial Period||1653
7955958|NCT00413699|19583120|P1|COMPLETED|Initial Period||484
7955959|NCT00413699|19583118|P3|STARTED|Initial Period||0
7955960|NCT00413699|19583119|P2|STARTED|Initial Period||3358
7955961|NCT00413699|19583120|P1|STARTED|Initial Period||1123
7955962|NCT00413660|19583202|P11|NOT COMPLETED|Post Week 12||1
7955963|NCT00413660|19583203|P10|NOT COMPLETED|Post Week 12||1
7955964|NCT00413660|19583204|P9|NOT COMPLETED|Post Week 12||0
7955965|NCT00413660|19583205|P8|NOT COMPLETED|Post Week 12||0
7955966|NCT00413660|19583206|P7|NOT COMPLETED|Post Week 12||3
7955967|NCT00413660|19583207|P6|NOT COMPLETED|Post Week 12||3
7955968|NCT00413660|19583208|P5|NOT COMPLETED|Post Week 12||6
7955969|NCT00413660|19583209|P4|NOT COMPLETED|Post Week 12||1
7955970|NCT00413660|19583210|P3|NOT COMPLETED|Post Week 12||8
7955971|NCT00413660|19583211|P2|NOT COMPLETED|Post Week 12||4
7955972|NCT00413660|19583212|P1|NOT COMPLETED|Post Week 12||3
7955973|NCT00413660|19583202|P11|COMPLETED|Post Week 12||17
7955974|NCT00413660|19583203|P10|COMPLETED|Post Week 12||12
7955975|NCT00413660|19583204|P9|COMPLETED|Post Week 12||13
7955976|NCT00413660|19583205|P8|COMPLETED|Post Week 12||21
7955977|NCT00413660|19583206|P7|COMPLETED|Post Week 12||37
7955978|NCT00413660|19583207|P6|COMPLETED|Post Week 12||54
7955979|NCT00413660|19583208|P5|COMPLETED|Post Week 12||60
7955980|NCT00413660|19583209|P4|COMPLETED|Post Week 12||66
7955981|NCT00413660|19583210|P3|COMPLETED|Post Week 12||56
7955982|NCT00413660|19583211|P2|COMPLETED|Post Week 12||44
7955983|NCT00413660|19583212|P1|COMPLETED|Post Week 12||40
7955984|NCT00413660|19583202|P11|STARTED|Post Week 12||18
7955985|NCT00413660|19583203|P10|STARTED|Post Week 12||13
7955986|NCT00413660|19583204|P9|STARTED|Post Week 12||13
7955987|NCT00413660|19583205|P8|STARTED|Post Week 12||21
7955988|NCT00413660|19583206|P7|STARTED|Post Week 12||40
7955989|NCT00413660|19583207|P6|STARTED|Post Week 12||57
7955990|NCT00413660|19583208|P5|STARTED|Post Week 12||66
7955991|NCT00413660|19583209|P4|STARTED|Post Week 12||67
7955992|NCT00413660|19583210|P3|STARTED|Post Week 12||64
7955993|NCT00413660|19583211|P2|STARTED|Post Week 12||48
7955994|NCT00413660|19583212|P1|STARTED|Post Week 12||43
7955995|NCT00413660|19583202|P11|NOT COMPLETED|Up To Week 12||0
7955996|NCT00413660|19583203|P10|NOT COMPLETED|Up To Week 12||0
7955997|NCT00413660|19583204|P9|NOT COMPLETED|Up To Week 12||0
7955998|NCT00413660|19583205|P8|NOT COMPLETED|Up To Week 12||0
7955999|NCT00413660|19583206|P7|NOT COMPLETED|Up To Week 12||11
7956000|NCT00413660|19583207|P6|NOT COMPLETED|Up To Week 12||10
7956001|NCT00413660|19583208|P5|NOT COMPLETED|Up To Week 12||9
7956002|NCT00413660|19583209|P4|NOT COMPLETED|Up To Week 12||8
7956003|NCT00413660|19583210|P3|NOT COMPLETED|Up To Week 12||7
7956004|NCT00413660|19583211|P2|NOT COMPLETED|Up To Week 12||7
7956005|NCT00413660|19583212|P1|NOT COMPLETED|Up To Week 12||7
7956006|NCT00413660|19583202|P11|COMPLETED|Up To Week 12||0
7956007|NCT00413660|19583203|P10|COMPLETED|Up To Week 12||0
7956008|NCT00413660|19583204|P9|COMPLETED|Up To Week 12||0
7956009|NCT00413660|19583205|P8|COMPLETED|Up To Week 12||0
7956010|NCT00413660|19583206|P7|COMPLETED|Up To Week 12||58
7956011|NCT00413660|19583207|P6|COMPLETED|Up To Week 12||70
7956012|NCT00413660|19583208|P5|COMPLETED|Up To Week 12||66
7956013|NCT00413660|19583209|P4|COMPLETED|Up To Week 12||67
7956014|NCT00413660|19583210|P3|COMPLETED|Up To Week 12||64
7956015|NCT00413660|19583211|P2|COMPLETED|Up To Week 12||61
7956016|NCT00413660|19583212|P1|COMPLETED|Up To Week 12||64
7956017|NCT00413660|19583202|P11|Treated|Up To Week 12||0
7956018|NCT00413660|19583203|P10|Treated|Up To Week 12||0
7956019|NCT00413660|19583204|P9|Treated|Up To Week 12||0
7956020|NCT00413660|19583205|P8|Treated|Up To Week 12||0
7956021|NCT00413660|19583206|P7|Treated|Up To Week 12||69
7956022|NCT00413660|19583207|P6|Treated|Up To Week 12||80
7956023|NCT00413660|19583208|P5|Treated|Up To Week 12||75
7956024|NCT00413660|19583209|P4|Treated|Up To Week 12||74
7956025|NCT00413660|19583210|P3|Treated|Up To Week 12||71
7956026|NCT00413660|19583211|P2|Treated|Up To Week 12||68
7956027|NCT00413660|19583212|P1|Treated|Up To Week 12||70
7956028|NCT00413660|19583202|P11|STARTED|Up To Week 12||0
7956029|NCT00413660|19583203|P10|STARTED|Up To Week 12||0
7956030|NCT00413660|19583204|P9|STARTED|Up To Week 12||0
7956031|NCT00413660|19583205|P8|STARTED|Up To Week 12||0
7956032|NCT00413660|19583206|P7|STARTED|Up To Week 12||69
7956033|NCT00413660|19583207|P6|STARTED|Up To Week 12||80
7956034|NCT00413660|19583208|P5|STARTED|Up To Week 12||75
7956035|NCT00413660|19583209|P4|STARTED|Up To Week 12||75
7956036|NCT00413660|19583210|P3|STARTED|Up To Week 12||71
7956037|NCT00413660|19583211|P2|STARTED|Up To Week 12||68
7956038|NCT00413660|19583212|P1|STARTED|Up To Week 12||71
7956039|NCT00413634|19583560|P2|NOT COMPLETED|Overall Study||0
7956040|NCT00413634|19583561|P1|NOT COMPLETED|Overall Study||0
7956041|NCT00413634|19583560|P2|COMPLETED|Overall Study||12
7956042|NCT00413634|19583561|P1|COMPLETED|Overall Study||12
7956043|NCT00413634|19583560|P2|STARTED|Overall Study||12
7956044|NCT00413634|19583561|P1|STARTED|Overall Study||12
7956045|NCT00413582|19583599|P2|NOT COMPLETED|Overall Study||0
7956046|NCT00413582|19583600|P1|NOT COMPLETED|Overall Study||0
7956047|NCT00413582|19583599|P2|COMPLETED|Overall Study|all enrolled completed|55
7956048|NCT00413582|19583600|P1|COMPLETED|Overall Study|all enrolled completed|55
7956049|NCT00413582|19583599|P2|Completion of Study|Overall Study|all enrolled completed|55
7956050|NCT00413582|19583600|P1|Completion of Study|Overall Study|all enrolled completed|55
7956051|NCT00413582|19583599|P2|STARTED|Overall Study|all enrolled completed|55
7956052|NCT00413582|19583600|P1|STARTED|Overall Study|all enrolled completed|55
7956053|NCT00413478|19583608|P1|NOT COMPLETED|Overall Study||0
7956054|NCT00413478|19583608|P1|COMPLETED|Overall Study||9
7956055|NCT00413478|19583608|P1|STARTED|Overall Study||9
7956056|NCT00413413|19583615|P3|NOT COMPLETED|Double-Blind||18
7956057|NCT00413413|19583616|P2|NOT COMPLETED|Double-Blind||14
7956058|NCT00413413|19583617|P1|NOT COMPLETED|Double-Blind||15
7956059|NCT00413413|19583615|P3|COMPLETED|Double-Blind||285
7956060|NCT00413413|19583616|P2|COMPLETED|Double-Blind||293
7956061|NCT00413413|19583617|P1|COMPLETED|Double-Blind||293
7956062|NCT00413413|19583615|P3|STARTED|Double-Blind||303
7956063|NCT00413413|19583616|P2|STARTED|Double-Blind||307
7956064|NCT00413413|19583617|P1|STARTED|Double-Blind||308
7956065|NCT00413413|19583615|P3|NOT COMPLETED|Single-Blind||0
7956066|NCT00413413|19583616|P2|NOT COMPLETED|Single-Blind||216
7956067|NCT00413413|19583617|P1|NOT COMPLETED|Single-Blind||0
7956068|NCT00413413|19583615|P3|COMPLETED|Single-Blind||0
7956069|NCT00413413|19583616|P2|COMPLETED|Single-Blind||918
7956070|NCT00413413|19583617|P1|COMPLETED|Single-Blind||0
7956071|NCT00413413|19583615|P3|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
7956072|NCT00413413|19583616|P2|STARTED|Single-Blind||1134
7956073|NCT00413413|19583617|P1|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
7956074|NCT00413400|19583639|P2|NOT COMPLETED|Overall Study||4
7956075|NCT00413400|19583640|P1|NOT COMPLETED|Overall Study||2
7956076|NCT00413400|19583639|P2|COMPLETED|Overall Study||12
7956077|NCT00413400|19583640|P1|COMPLETED|Overall Study||22
7956078|NCT00413400|19583639|P2|3 Month Visit|Overall Study||12
7956079|NCT00413400|19583640|P1|3 Month Visit|Overall Study||22
7956080|NCT00413400|19583639|P2|STARTED|Overall Study||16
7956081|NCT00413400|19583640|P1|STARTED|Overall Study||24
7956082|NCT00413374|19583670|P2|NOT COMPLETED|Overall Study||0
7956083|NCT00413374|19583671|P1|NOT COMPLETED|Overall Study||6
7956084|NCT00413374|19583670|P2|COMPLETED|Overall Study||80
7956085|NCT00413374|19583671|P1|COMPLETED|Overall Study||34
7956086|NCT00413374|19583670|P2|STARTED|Overall Study||80
7956087|NCT00413374|19583671|P1|STARTED|Overall Study||40
7956088|NCT00413335|19583683|P2|NOT COMPLETED|Overall Study||0
7956089|NCT00413335|19583684|P1|NOT COMPLETED|Overall Study||0
7956090|NCT00413335|19583683|P2|COMPLETED|Overall Study||9
7956091|NCT00413335|19583684|P1|COMPLETED|Overall Study||12
7956092|NCT00413335|19583683|P2|STARTED|Overall Study||9
7956093|NCT00413335|19583684|P1|STARTED|Overall Study||12
7956094|NCT00413283|19583702|P4|NOT COMPLETED|Overall Study||4
7956095|NCT00413283|19583703|P3|NOT COMPLETED|Overall Study||2
7956096|NCT00413283|19583704|P2|NOT COMPLETED|Overall Study||3
7956097|NCT00413283|19583705|P1|NOT COMPLETED|Overall Study||1
7956098|NCT00413283|19583702|P4|COMPLETED|Overall Study||13
7956099|NCT00413283|19583703|P3|COMPLETED|Overall Study||16
7956100|NCT00413283|19583704|P2|COMPLETED|Overall Study||13
7956101|NCT00413283|19583705|P1|COMPLETED|Overall Study||11
7956102|NCT00413283|19583702|P4|Received Study Drug|Overall Study||16
7956103|NCT00413283|19583703|P3|Received Study Drug|Overall Study||18
7956104|NCT00413283|19583704|P2|Received Study Drug|Overall Study||16
7956105|NCT00413283|19583705|P1|Received Study Drug|Overall Study||12
7956106|NCT00413283|19583702|P4|STARTED|Overall Study||17
7956107|NCT00413283|19583703|P3|STARTED|Overall Study||18
7956108|NCT00413283|19583704|P2|STARTED|Overall Study||16
7956109|NCT00413283|19583705|P1|STARTED|Overall Study||12
7956110|NCT00413244|19583737|P2|NOT COMPLETED|Overall Study||1
7956111|NCT00413244|19583738|P1|NOT COMPLETED|Overall Study||10
7956112|NCT00413244|19583737|P2|COMPLETED|Overall Study||19
7956113|NCT00413244|19583738|P1|COMPLETED|Overall Study||21
7956114|NCT00413244|19583737|P2|STARTED|Overall Study||20
7956115|NCT00413244|19583738|P1|STARTED|Overall Study||31
7956116|NCT00413231|19583766|P1|NOT COMPLETED|365-day to 60-month Post Treatment||46
7956117|NCT00413231|19583766|P1|COMPLETED|365-day to 60-month Post Treatment||93
7956118|NCT00413231|19583766|P1|STARTED|365-day to 60-month Post Treatment||139
7956119|NCT00413231|19583766|P1|NOT COMPLETED|30-day to 365-day Post Treatment||13
7956120|NCT00413231|19583766|P1|COMPLETED|30-day to 365-day Post Treatment||139
7956121|NCT00413231|19583766|P1|STARTED|30-day to 365-day Post Treatment||152
7956122|NCT00413231|19583766|P1|NOT COMPLETED|0 to 30-day Post Treatment||8
7956123|NCT00413231|19583766|P1|COMPLETED|0 to 30-day Post Treatment||152
7956124|NCT00413231|19583766|P1|STARTED|0 to 30-day Post Treatment||160
7956125|NCT00413218|19583798|P2|NOT COMPLETED|Overall Study||96
7956126|NCT00413218|19583799|P1|NOT COMPLETED|Overall Study||103
7956127|NCT00413218|19583798|P2|COMPLETED|Overall Study||131
7956128|NCT00413218|19583799|P1|COMPLETED|Overall Study||120
7956129|NCT00413218|19583798|P2|Intent to Treat Population (ITT)|Overall Study||219
7956130|NCT00413218|19583799|P1|Intent to Treat Population (ITT)|Overall Study||221
7956131|NCT00413218|19583798|P2|STARTED|Overall Study||227
7956132|NCT00413218|19583799|P1|STARTED|Overall Study||223
7956133|NCT00413192|19583825|P4|NOT COMPLETED|Overall Study||32
7956134|NCT00413192|19583826|P3|NOT COMPLETED|Overall Study||19
7956135|NCT00413192|19583827|P2|NOT COMPLETED|Overall Study||40
7956136|NCT00413192|19583828|P1|NOT COMPLETED|Overall Study||37
7956137|NCT00413192|19583825|P4|COMPLETED|Overall Study||0
7956138|NCT00413192|19583826|P3|COMPLETED|Overall Study||0
7956139|NCT00413192|19583827|P2|COMPLETED|Overall Study||0
7956140|NCT00413192|19583828|P1|COMPLETED|Overall Study||0
7956141|NCT00413192|19583825|P4|STARTED|Overall Study||32
7956142|NCT00413192|19583826|P3|STARTED|Overall Study||19
7956143|NCT00413192|19583827|P2|STARTED|Overall Study||40
7956144|NCT00413192|19583828|P1|STARTED|Overall Study||37
7956145|NCT00413166|19583869|P3|NOT COMPLETED|Overall Study||0
7956146|NCT00413166|19583870|P2|NOT COMPLETED|Overall Study||0
7956147|NCT00413166|19583871|P1|NOT COMPLETED|Overall Study||0
7956148|NCT00413166|19583869|P3|COMPLETED|Overall Study||16
7956149|NCT00413166|19583870|P2|COMPLETED|Overall Study||5
7956150|NCT00413166|19583871|P1|COMPLETED|Overall Study||57
7956151|NCT00413166|19583869|P3|STARTED|Overall Study||16
7956152|NCT00413166|19583870|P2|STARTED|Overall Study||5
7956153|NCT00413166|19583871|P1|STARTED|Overall Study||57
7956154|NCT00413153|19583881|P2|NOT COMPLETED|Overall Study||1
7956155|NCT00413153|19583882|P1|NOT COMPLETED|Overall Study||2
7956156|NCT00413153|19583881|P2|COMPLETED|Overall Study||7
7956157|NCT00413153|19583882|P1|COMPLETED|Overall Study||5
7956158|NCT00413153|19583881|P2|STARTED|Overall Study||8
7956159|NCT00413153|19583882|P1|STARTED|Overall Study||7
7956160|NCT00413062|19583906|P2|NOT COMPLETED|Overall Study||210
7956161|NCT00413062|19583907|P1|NOT COMPLETED|Overall Study||678
7956162|NCT00413062|19583906|P2|COMPLETED|Overall Study||344
7956163|NCT00413062|19583907|P1|COMPLETED|Overall Study||988
7956164|NCT00413062|19583906|P2|STARTED|Overall Study||554
7956165|NCT00413062|19583907|P1|STARTED|Overall Study||1666
7956166|NCT00413049|19583933|P2|NOT COMPLETED|Overall Study||18
7956167|NCT00413049|19583934|P1|NOT COMPLETED|Overall Study||24
7956168|NCT00413049|19583933|P2|COMPLETED|Overall Study||331
7956169|NCT00413049|19583934|P1|COMPLETED|Overall Study||325
7956170|NCT00413049|19583933|P2|STARTED|Overall Study||349
7956171|NCT00413049|19583934|P1|STARTED|Overall Study||349
7956172|NCT00413036|19583950|P1|NOT COMPLETED|Overall Study||217
7956173|NCT00413036|19583950|P1|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0
7956174|NCT00413036|19583950|P1|STARTED|Overall Study||217
7956175|NCT00413010|19583960|P2|NOT COMPLETED|Overall Study||63
7956176|NCT00413010|19583961|P1|NOT COMPLETED|Overall Study||72
7956177|NCT00413010|19583960|P2|COMPLETED|Overall Study||113
7956178|NCT00413010|19583961|P1|COMPLETED|Overall Study||108
7956179|NCT00413010|19583960|P2|STARTED|Overall Study||176
7956180|NCT00413010|19583961|P1|STARTED|Overall Study||180
7956181|NCT00412984|19583983|P2|NOT COMPLETED|Overall Study||2493
7956182|NCT00412984|19583984|P1|NOT COMPLETED|Overall Study||2310
7956183|NCT00412984|19583983|P2|COMPLETED|Overall Study||6588
7956184|NCT00412984|19583984|P1|COMPLETED|Overall Study||6810
7956185|NCT00412984|19583983|P2|STARTED|Overall Study|Randomized participants|9081
7956186|NCT00412984|19583984|P1|STARTED|Overall Study|Randomized participants|9120
7956187|NCT00412971|19584028|P2|NOT COMPLETED|Overall Study||10
7956188|NCT00412971|19584029|P1|NOT COMPLETED|Overall Study||30
7956189|NCT00412971|19584028|P2|COMPLETED|Overall Study||108
7956190|NCT00412971|19584029|P1|COMPLETED|Overall Study||85
7956191|NCT00412971|19584028|P2|STARTED|Overall Study||118
7956192|NCT00412971|19584029|P1|STARTED|Overall Study||115
7956193|NCT00412958|19584042|P4|NOT COMPLETED|Overall Study||1
7956194|NCT00412958|19584043|P3|NOT COMPLETED|Overall Study||0
7956195|NCT00412958|19584044|P2|NOT COMPLETED|Overall Study||4
7956196|NCT00412958|19584045|P1|NOT COMPLETED|Overall Study||3
7956197|NCT00412958|19584042|P4|COMPLETED|Overall Study||30
7956198|NCT00412958|19584043|P3|COMPLETED|Overall Study||32
7956199|NCT00412958|19584044|P2|COMPLETED|Overall Study||29
7956200|NCT00412958|19584045|P1|COMPLETED|Overall Study||26
7956201|NCT00412958|19584042|P4|STARTED|Overall Study||31
7956202|NCT00412958|19584043|P3|STARTED|Overall Study||32
7956203|NCT00412958|19584044|P2|STARTED|Overall Study||33
7956204|NCT00412958|19584045|P1|STARTED|Overall Study||29
7956205|NCT00412932|19584055|P1|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2
7956206|NCT00412932|19584055|P1|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123
7956207|NCT00412932|19584055|P1|STARTED|Olm+ Hydrochlorothiazide 25 mg|153 -28 met their blood pressure goal (stayed on olmesartan 40/hydrochlorothiazide 12.5) = 125|125
7956208|NCT00412932|19584055|P1|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6
7956209|NCT00412932|19584055|P1|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153
7956210|NCT00412932|19584055|P1|STARTED|Olm+Hydrochlorothiazide 12.5 mg|161 -2 met blood pressure goal (stayed on olmesartan 40) = 159|159
7956211|NCT00412932|19584055|P1|NOT COMPLETED|Olmesartan 40 mg||8
7956212|NCT00412932|19584055|P1|COMPLETED|Olmesartan 40 mg||161
7956213|NCT00412932|19584055|P1|STARTED|Olmesartan 40 mg|171 -1 met blood pressure goal (stayed on olmesartan 20) -1 who erroneously skipped this step = 169.|169
7956214|NCT00412932|19584055|P1|NOT COMPLETED|Olmesartan (Olm) 20 mg||7
7956215|NCT00412932|19584055|P1|COMPLETED|Olmesartan (Olm) 20 mg||171
7956216|NCT00412932|19584055|P1|STARTED|Olmesartan (Olm) 20 mg||178
7956217|NCT00412893|19584066|P2|NOT COMPLETED|Overall Study||144
7956218|NCT00412893|19584067|P1|NOT COMPLETED|Overall Study||145
7956219|NCT00412893|19584066|P2|COMPLETED|Overall Study|Defined as completed treatment|120
7956220|NCT00412893|19584067|P1|COMPLETED|Overall Study|Defined as completed treatment|118
7956221|NCT00412893|19584066|P2|Received Treatment|Overall Study||258
7956222|NCT00412893|19584067|P1|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258
7956223|NCT00412893|19584066|P2|STARTED|Overall Study||264
7956224|NCT00412893|19584067|P1|STARTED|Overall Study||263
7956225|NCT00412867|19584093|P1|NOT COMPLETED|Overall Study||0
7956226|NCT00412867|19584093|P1|COMPLETED|Overall Study||58
7956227|NCT00412867|19584093|P1|STARTED|Overall Study||58
7956228|NCT00412854|19584105|P2|NOT COMPLETED|Overall Study||16
7956229|NCT00412854|19584106|P1|NOT COMPLETED|Overall Study||14
7956230|NCT00412854|19584105|P2|COMPLETED|Overall Study||314
7956231|NCT00412854|19584106|P1|COMPLETED|Overall Study||316
7956232|NCT00412854|19584105|P2|STARTED|Overall Study||330
7956233|NCT00412854|19584106|P1|STARTED|Overall Study||330
7956234|NCT00412841|19584134|P2|NOT COMPLETED|Overall Study||5
7956235|NCT00412841|19584135|P1|NOT COMPLETED|Overall Study||10
7956236|NCT00412841|19584134|P2|COMPLETED|Overall Study||16
7956237|NCT00412841|19584135|P1|COMPLETED|Overall Study||12
7956238|NCT00412841|19584134|P2|STARTED|Overall Study||21
7956239|NCT00412841|19584135|P1|STARTED|Overall Study||22
7956240|NCT00412750|19584150|P3|NOT COMPLETED|Overall Study||23
7956241|NCT00412750|19584151|P2|NOT COMPLETED|Overall Study||21
7956242|NCT00412750|19584152|P1|NOT COMPLETED|Overall Study||31
7956243|NCT00412750|19584150|P3|COMPLETED|Overall Study||31
7956244|NCT00412750|19584151|P2|COMPLETED|Overall Study||34
7956245|NCT00412750|19584152|P1|COMPLETED|Overall Study||19
7956246|NCT00412750|19584150|P3|STARTED|Overall Study||54
7956247|NCT00412750|19584151|P2|STARTED|Overall Study||55
7956248|NCT00412750|19584152|P1|STARTED|Overall Study||50
7956249|NCT00412737|19584177|P2|NOT COMPLETED|Overall Study||6
7956250|NCT00412737|19584178|P1|NOT COMPLETED|Overall Study||16
7956251|NCT00412737|19584177|P2|COMPLETED|Overall Study||232
7956252|NCT00412737|19584178|P1|COMPLETED|Overall Study||221
7956253|NCT00412737|19584177|P2|STARTED|Overall Study||238
7956254|NCT00412737|19584178|P1|STARTED|Overall Study||237
7956255|NCT00412607|19584196|P1|NOT COMPLETED|Overall Study||104
7956256|NCT00412607|19584196|P1|COMPLETED|Overall Study||145
7956257|NCT00412607|19584196|P1|Started Study Catheter|Overall Study||233
7956258|NCT00412607|19584196|P1|STARTED|Overall Study||249
7956259|NCT00412542|19584209|P2|NOT COMPLETED|Overall Study||3
7956260|NCT00412542|19584210|P1|NOT COMPLETED|Overall Study||0
7956261|NCT00412542|19584209|P2|COMPLETED|Overall Study||42
7956262|NCT00412542|19584210|P1|COMPLETED|Overall Study||33
7956263|NCT00412542|19584209|P2|STARTED|Overall Study||45
7956264|NCT00412542|19584210|P1|STARTED|Overall Study||33
7956265|NCT00412529|19584216|P2|NOT COMPLETED|Overall Study||0
7956266|NCT00412529|19584217|P1|NOT COMPLETED|Overall Study||0
7956267|NCT00412529|19584216|P2|COMPLETED|Overall Study||21
7956268|NCT00412529|19584217|P1|COMPLETED|Overall Study||23
7956269|NCT00412529|19584216|P2|STARTED|Overall Study||21
7956270|NCT00412529|19584217|P1|STARTED|Overall Study||23
7956271|NCT00412516|19584240|P3|NOT COMPLETED|Overall Study||0
7956272|NCT00412516|19584241|P2|NOT COMPLETED|Overall Study||0
7956273|NCT00412516|19584242|P1|NOT COMPLETED|Overall Study||0
7956274|NCT00412516|19584240|P3|COMPLETED|Overall Study||214
7956275|NCT00412516|19584241|P2|COMPLETED|Overall Study||212
7956276|NCT00412516|19584242|P1|COMPLETED|Overall Study||93
7956277|NCT00412516|19584240|P3|STARTED|Overall Study||214
7956278|NCT00412516|19584241|P2|STARTED|Overall Study||212
7956279|NCT00412516|19584242|P1|STARTED|Overall Study||93
7956280|NCT00412464|19584259|P1|NOT COMPLETED|Overall Study||0
7956281|NCT00412464|19584259|P1|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
7956282|NCT00412464|19584259|P1|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
7956283|NCT00412451|19584271|P4|NOT COMPLETED|Overall Study||2
7956284|NCT00412451|19584272|P3|NOT COMPLETED|Overall Study||1
7956285|NCT00412451|19584273|P2|NOT COMPLETED|Overall Study||0
7956286|NCT00412451|19584274|P1|NOT COMPLETED|Overall Study||0
7956287|NCT00412451|19584271|P4|COMPLETED|Overall Study||11
7956288|NCT00412451|19584272|P3|COMPLETED|Overall Study||14
7956289|NCT00412451|19584273|P2|COMPLETED|Overall Study||15
7956290|NCT00412451|19584274|P1|COMPLETED|Overall Study||8
7956291|NCT00412451|19584271|P4|STARTED|Overall Study||13
7956292|NCT00412451|19584272|P3|STARTED|Overall Study||15
7956293|NCT00412451|19584273|P2|STARTED|Overall Study||15
7956294|NCT00412451|19584274|P1|STARTED|Overall Study||8
7956295|NCT00412425|19584286|P2|NOT COMPLETED|Overall Study||0
7956296|NCT00412425|19584287|P1|NOT COMPLETED|Overall Study||0
7956297|NCT00412425|19584286|P2|COMPLETED|Overall Study||15
7956298|NCT00412425|19584287|P1|COMPLETED|Overall Study||15
7956299|NCT00412425|19584286|P2|STARTED|Overall Study||15
7956300|NCT00412425|19584287|P1|STARTED|Overall Study||15
7956301|NCT00412373|19584295|P2|NOT COMPLETED|Overall Study||77
7956302|NCT00412373|19584296|P1|NOT COMPLETED|Overall Study||41
7956303|NCT00412373|19584295|P2|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134
7956304|NCT00412373|19584296|P1|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52
7956305|NCT00412373|19584295|P2|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211
7956306|NCT00412373|19584296|P1|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93
7956307|NCT00412360|19584338|P2|NOT COMPLETED|Overall Study||3
7956308|NCT00412360|19584339|P1|NOT COMPLETED|Overall Study||1
7956309|NCT00412360|19584338|P2|COMPLETED|Overall Study||108
7956310|NCT00412360|19584339|P1|COMPLETED|Overall Study||112
7956311|NCT00412360|19584338|P2|STARTED|Overall Study||111
7956312|NCT00412360|19584339|P1|STARTED|Overall Study||113
7956313|NCT00412243|19584363|P1|NOT COMPLETED|Overall Study||0
7956314|NCT00412243|19584363|P1|COMPLETED|Overall Study||50
7956315|NCT00412243|19584363|P1|STARTED|Overall Study||50
7956316|NCT00412217|19584369|P2|NOT COMPLETED|Overall Study||48
7956317|NCT00412217|19584370|P1|NOT COMPLETED|Overall Study||46
7956318|NCT00412217|19584369|P2|COMPLETED|Overall Study||0
7956319|NCT00412217|19584370|P1|COMPLETED|Overall Study||0
7956320|NCT00412217|19584369|P2|STARTED|Overall Study||48
7956321|NCT00412217|19584370|P1|STARTED|Overall Study||46
7956322|NCT00412113|19584384|P2|NOT COMPLETED|Overall Study||15
7956323|NCT00412113|19584385|P1|NOT COMPLETED|Overall Study||12
7956324|NCT00412113|19584384|P2|COMPLETED|Overall Study|15-April-2008|107
7956325|NCT00412113|19584385|P1|COMPLETED|Overall Study|15-April-2008|111
7956326|NCT00412113|19584384|P2|Received Treatment|Overall Study||122
7956327|NCT00412113|19584385|P1|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122
7956328|NCT00412113|19584384|P2|STARTED|Overall Study|15-January-2007|122
7956329|NCT00412113|19584385|P1|STARTED|Overall Study|15-January-2007|123
7956330|NCT00412087|19584439|P2|NOT COMPLETED|Overall Study||65
7956331|NCT00412087|19584440|P1|NOT COMPLETED|Overall Study||62
7956332|NCT00412087|19584439|P2|COMPLETED|Overall Study||66
7956333|NCT00412087|19584440|P1|COMPLETED|Overall Study||72
7956334|NCT00412087|19584439|P2|STARTED|Overall Study||131
7956335|NCT00412087|19584440|P1|STARTED|Overall Study||134
7956336|NCT00412074|19584451|P3|NOT COMPLETED|Overall Study||67
7956337|NCT00412074|19584452|P2|NOT COMPLETED|Overall Study||22
7956338|NCT00412074|19584453|P1|NOT COMPLETED|Overall Study||77
7956339|NCT00412074|19584451|P3|COMPLETED|Overall Study||128
7956340|NCT00412074|19584452|P2|COMPLETED|Overall Study||44
7956341|NCT00412074|19584453|P1|COMPLETED|Overall Study||122
7956342|NCT00412074|19584451|P3|STARTED|Overall Study||195
7956343|NCT00412074|19584452|P2|STARTED|Overall Study||66
7956344|NCT00412074|19584453|P1|STARTED|Overall Study||199
7956345|NCT00412061|19584469|P2|NOT COMPLETED|Open Label Phase||170
7956346|NCT00412061|19584470|P1|NOT COMPLETED|Open Label Phase||0
7956347|NCT00412061|19584469|P2|COMPLETED|Open Label Phase||0
7956348|NCT00412061|19584470|P1|COMPLETED|Open Label Phase||0
7956349|NCT00412061|19584469|P2|STARTED|Open Label Phase||170
7956350|NCT00412061|19584470|P1|STARTED|Open Label Phase||0
7956351|NCT00412061|19584469|P2|NOT COMPLETED|Double Blind Phase||213
7956352|NCT00412061|19584470|P1|NOT COMPLETED|Double Blind Phase||216
7956353|NCT00412061|19584469|P2|COMPLETED|Double Blind Phase||0
7956354|NCT00412061|19584470|P1|COMPLETED|Double Blind Phase||0
7956355|NCT00412061|19584469|P2|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211
7956356|NCT00412061|19584470|P1|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215
7956357|NCT00412061|19584469|P2|STARTED|Double Blind Phase||213
7956358|NCT00412061|19584470|P1|STARTED|Double Blind Phase||216
7956359|NCT00411788|19584488|P1|NOT COMPLETED|Overall Study||2
7956360|NCT00411788|19584488|P1|COMPLETED|Overall Study||9
7956361|NCT00411788|19584488|P1|STARTED|Overall Study||11
7956362|NCT00411762|19584497|P1|NOT COMPLETED|Overall Study||5
7956363|NCT00411762|19584497|P1|COMPLETED|Overall Study||20
7956364|NCT00411762|19584497|P1|STARTED|Overall Study||25
7956365|NCT00411749|19584504|P2|NOT COMPLETED|Overall Study||0
7956366|NCT00411749|19584505|P1|NOT COMPLETED|Overall Study||0
7956367|NCT00411749|19584504|P2|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25
7956368|NCT00411749|19584505|P1|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82
7956369|NCT00411749|19584504|P2|Vaccinated|Overall Study||25
7956370|NCT00411749|19584505|P1|Vaccinated|Overall Study||82
7956371|NCT00411749|19584504|P2|STARTED|Overall Study||25
7956372|NCT00411749|19584505|P1|STARTED|Overall Study||82
7956373|NCT00411671|19584521|P1|NOT COMPLETED|Overall Study||20
7956374|NCT00411671|19584521|P1|COMPLETED|Overall Study||85
7956375|NCT00411671|19584521|P1|STARTED|Overall Study||105
7956376|NCT00411645|19584529|P2|NOT COMPLETED|Overall Study||164
7956377|NCT00411645|19584530|P1|NOT COMPLETED|Overall Study||81
7956378|NCT00411645|19584529|P2|COMPLETED|Overall Study||290
7956379|NCT00411645|19584530|P1|COMPLETED|Overall Study||146
7956380|NCT00411645|19584529|P2|STARTED|Overall Study||454
7956381|NCT00411645|19584530|P1|STARTED|Overall Study||227
7956382|NCT00411632|19584554|P1|NOT COMPLETED|Overall Study||1
7956383|NCT00411632|19584554|P1|COMPLETED|Overall Study||36
7956384|NCT00411632|19584554|P1|STARTED|Overall Study||37
7956385|NCT00411619|19584558|P1|NOT COMPLETED|Overall Study||6
7956386|NCT00411619|19584558|P1|COMPLETED|Overall Study||22
7956387|NCT00411619|19584558|P1|STARTED|Overall Study||28
7956388|NCT00411554|19584565|P2|NOT COMPLETED|Overall Study||9
7956389|NCT00411554|19584566|P1|NOT COMPLETED|Overall Study||8
7956390|NCT00411554|19584565|P2|COMPLETED|Overall Study||147
7956391|NCT00411554|19584566|P1|COMPLETED|Overall Study||155
7956392|NCT00411554|19584565|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156
7956393|NCT00411554|19584566|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163
7956394|NCT00411463|19584578|P2|NOT COMPLETED|Overall Study||3
7956395|NCT00411463|19584579|P1|NOT COMPLETED|Overall Study||3
7956396|NCT00411463|19584578|P2|COMPLETED|Overall Study||8
7956397|NCT00411463|19584579|P1|COMPLETED|Overall Study||11
7956398|NCT00411463|19584578|P2|STARTED|Overall Study||11
7956399|NCT00411463|19584579|P1|STARTED|Overall Study||14
7956400|NCT00411450|19584592|P1|NOT COMPLETED|Overall Study||3
7956401|NCT00411450|19584592|P1|COMPLETED|Overall Study|Ended second-line treatment|113
7956402|NCT00411450|19584592|P1|Received Treatment|Overall Study||115
7956403|NCT00411450|19584592|P1|STARTED|Overall Study||116
7956404|NCT00411411|19584620|P2|NOT COMPLETED|Overall Study||0
7956405|NCT00411411|19584621|P1|NOT COMPLETED|Overall Study||0
7956406|NCT00411411|19584620|P2|COMPLETED|Overall Study||25
7956407|NCT00411411|19584621|P1|COMPLETED|Overall Study||24
7956408|NCT00411411|19584620|P2|STARTED|Overall Study||25
7956409|NCT00411411|19584621|P1|STARTED|Overall Study||24
7956410|NCT00411398|19584629|P1|NOT COMPLETED|Overall Study||5
7956411|NCT00411398|19584629|P1|COMPLETED|Overall Study||10
7956412|NCT00411398|19584629|P1|STARTED|Overall Study||15
7956413|NCT00411216|19584635|P2|NOT COMPLETED|Overall Study||2
7956414|NCT00411216|19584636|P1|NOT COMPLETED|Overall Study||0
7956415|NCT00411216|19584635|P2|COMPLETED|Overall Study||8
7956416|NCT00411216|19584636|P1|COMPLETED|Overall Study||13
7956417|NCT00411216|19584635|P2|STARTED|Overall Study||10
7956418|NCT00411216|19584636|P1|STARTED|Overall Study||13
7956419|NCT00411151|19584642|P1|NOT COMPLETED|Overall Study||47
7956420|NCT00411151|19584642|P1|COMPLETED|Overall Study||5
7956421|NCT00411151|19584642|P1|STARTED|Overall Study||52
7956422|NCT00411086|19584652|P1|NOT COMPLETED|Overall Study||0
7956423|NCT00411086|19584652|P1|COMPLETED|Overall Study||52
7956424|NCT00411086|19584652|P1|STARTED|Overall Study||52
7956425|NCT00410904|19584660|P2|NOT COMPLETED|Overall Study||0
7956426|NCT00410904|19584661|P1|NOT COMPLETED|Overall Study||0
7956427|NCT00410904|19584660|P2|COMPLETED|Overall Study||20
7956428|NCT00410904|19584661|P1|COMPLETED|Overall Study||40
7956429|NCT00410904|19584660|P2|STARTED|Overall Study||20
7956430|NCT00410904|19584661|P1|STARTED|Overall Study||40
7956431|NCT00410891|19584669|P1|NOT COMPLETED|Overall Study||0
7956432|NCT00410891|19584669|P1|COMPLETED|Overall Study||129
7956433|NCT00410891|19584669|P1|STARTED|Overall Study||129
7956434|NCT00410826|19584675|P2|NOT COMPLETED|Overall Study||4
7956435|NCT00410826|19584676|P1|NOT COMPLETED|Overall Study||9
7956436|NCT00410826|19584675|P2|COMPLETED|Overall Study||95
7956437|NCT00410826|19584676|P1|COMPLETED|Overall Study||96
7956438|NCT00410826|19584675|P2|STARTED|Overall Study||99
7956439|NCT00410826|19584676|P1|STARTED|Overall Study||105
7956440|NCT00410813|19584686|P2|NOT COMPLETED|Overall Study||42
7956441|NCT00410813|19584687|P1|NOT COMPLETED|Overall Study||43
7956442|NCT00410813|19584686|P2|COMPLETED|Overall Study||0
7956443|NCT00410813|19584687|P1|COMPLETED|Overall Study|Patients treated until progression.|0
7956444|NCT00410813|19584686|P2|Eligible|Overall Study||38
7956445|NCT00410813|19584687|P1|Eligible|Overall Study||41
7956446|NCT00410813|19584686|P2|STARTED|Overall Study||42
7956447|NCT00410813|19584687|P1|STARTED|Overall Study||43
7956448|NCT00410761|19584724|P2|NOT COMPLETED|Overall Study||72
7956449|NCT00410761|19584725|P1|NOT COMPLETED|Overall Study||120
7956450|NCT00410761|19584724|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28
7956451|NCT00410761|19584725|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111
7956452|NCT00410761|19584724|P2|STARTED|Overall Study|randomised patients|100
7956453|NCT00410761|19584725|P1|STARTED|Overall Study|randomised patients|231
7956454|NCT00410605|19584745|P1|NOT COMPLETED|Overall Study||25
7956455|NCT00410605|19584745|P1|COMPLETED|Overall Study||14
7956456|NCT00410605|19584745|P1|STARTED|Overall Study||39
7956457|NCT00410514|19584757|P3|NOT COMPLETED|Overall Study||7
7956458|NCT00410514|19584758|P2|NOT COMPLETED|Overall Study||3
7956459|NCT00410514|19584759|P1|NOT COMPLETED|Overall Study||2
7956460|NCT00410514|19584757|P3|COMPLETED|Overall Study||58
7956461|NCT00410514|19584758|P2|COMPLETED|Overall Study||67
7956462|NCT00410514|19584759|P1|COMPLETED|Overall Study||63
7956463|NCT00410514|19584757|P3|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58
7956464|NCT00410514|19584758|P2|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64
7956465|NCT00410514|19584759|P1|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63
7956466|NCT00410514|19584757|P3|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
7956467|NCT00410514|19584758|P2|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70
7956468|NCT00410514|19584759|P1|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
7956469|NCT00410514|19584757|P3|STARTED|Overall Study||65
7956470|NCT00410514|19584758|P2|STARTED|Overall Study||70
7956471|NCT00410514|19584759|P1|STARTED|Overall Study||65
7956472|NCT00410488|19584820|P2|NOT COMPLETED|Overall Study||0
7956473|NCT00410488|19584821|P1|NOT COMPLETED|Overall Study||0
7956474|NCT00410488|19584820|P2|COMPLETED|Overall Study||34
7956475|NCT00410488|19584821|P1|COMPLETED|Overall Study||16
7956476|NCT00410488|19584820|P2|STARTED|Overall Study||34
7956477|NCT00410488|19584821|P1|STARTED|Overall Study||16
7956478|NCT00410423|19584826|P4|NOT COMPLETED|Phase 2||0
7956479|NCT00410423|19584827|P3|NOT COMPLETED|Phase 2||0
7956480|NCT00410423|19584828|P2|NOT COMPLETED|Phase 2||0
7956481|NCT00410423|19584829|P1|NOT COMPLETED|Phase 2||0
7956482|NCT00410423|19584826|P4|COMPLETED|Phase 2||44
7956483|NCT00410423|19584827|P3|COMPLETED|Phase 2||0
7956484|NCT00410423|19584828|P2|COMPLETED|Phase 2||0
7956485|NCT00410423|19584829|P1|COMPLETED|Phase 2||0
7956486|NCT00410423|19584826|P4|STARTED|Phase 2||44
7956487|NCT00410423|19584827|P3|STARTED|Phase 2||0
7956488|NCT00410423|19584828|P2|STARTED|Phase 2||0
7956489|NCT00410423|19584829|P1|STARTED|Phase 2||0
7956490|NCT00410423|19584826|P4|NOT COMPLETED|Phase 1 - Dose Level 3||0
7956491|NCT00410423|19584827|P3|NOT COMPLETED|Phase 1 - Dose Level 3||0
7956492|NCT00410423|19584828|P2|NOT COMPLETED|Phase 1 - Dose Level 3||0
7956493|NCT00410423|19584829|P1|NOT COMPLETED|Phase 1 - Dose Level 3||0
7956494|NCT00410423|19584826|P4|COMPLETED|Phase 1 - Dose Level 3||0
7956495|NCT00410423|19584827|P3|COMPLETED|Phase 1 - Dose Level 3||3
7956496|NCT00410423|19584828|P2|COMPLETED|Phase 1 - Dose Level 3||0
7956497|NCT00410423|19584829|P1|COMPLETED|Phase 1 - Dose Level 3||0
7956498|NCT00410423|19584826|P4|STARTED|Phase 1 - Dose Level 3||0
7956499|NCT00410423|19584827|P3|STARTED|Phase 1 - Dose Level 3||3
7956500|NCT00410423|19584828|P2|STARTED|Phase 1 - Dose Level 3||0
7956501|NCT00410423|19584829|P1|STARTED|Phase 1 - Dose Level 3||0
7956502|NCT00410423|19584826|P4|NOT COMPLETED|Phase 1 - Dose Level 2||0
7956503|NCT00410423|19584827|P3|NOT COMPLETED|Phase 1 - Dose Level 2||0
7956504|NCT00410423|19584828|P2|NOT COMPLETED|Phase 1 - Dose Level 2||0
7956505|NCT00410423|19584829|P1|NOT COMPLETED|Phase 1 - Dose Level 2||0
7956506|NCT00410423|19584826|P4|COMPLETED|Phase 1 - Dose Level 2||0
7956507|NCT00410423|19584827|P3|COMPLETED|Phase 1 - Dose Level 2||0
7956508|NCT00410423|19584828|P2|COMPLETED|Phase 1 - Dose Level 2||5
7956509|NCT00410423|19584829|P1|COMPLETED|Phase 1 - Dose Level 2||0
7956510|NCT00410423|19584826|P4|STARTED|Phase 1 - Dose Level 2||0
7956511|NCT00410423|19584827|P3|STARTED|Phase 1 - Dose Level 2||0
7956512|NCT00410423|19584828|P2|STARTED|Phase 1 - Dose Level 2||5
7956513|NCT00410423|19584829|P1|STARTED|Phase 1 - Dose Level 2||0
7956514|NCT00410423|19584826|P4|NOT COMPLETED|Phase 1 - Dose Level 1||0
7956515|NCT00410423|19584827|P3|NOT COMPLETED|Phase 1 - Dose Level 1||0
7956516|NCT00410423|19584828|P2|NOT COMPLETED|Phase 1 - Dose Level 1||0
7956517|NCT00410423|19584829|P1|NOT COMPLETED|Phase 1 - Dose Level 1||0
7956518|NCT00410423|19584826|P4|COMPLETED|Phase 1 - Dose Level 1||0
7956519|NCT00410423|19584827|P3|COMPLETED|Phase 1 - Dose Level 1||0
7956520|NCT00410423|19584828|P2|COMPLETED|Phase 1 - Dose Level 1||0
7956521|NCT00410423|19584829|P1|COMPLETED|Phase 1 - Dose Level 1||3
7956522|NCT00410423|19584826|P4|STARTED|Phase 1 - Dose Level 1||0
7956523|NCT00410423|19584827|P3|STARTED|Phase 1 - Dose Level 1||0
7956524|NCT00410423|19584828|P2|STARTED|Phase 1 - Dose Level 1||0
7956525|NCT00410423|19584829|P1|STARTED|Phase 1 - Dose Level 1||3
7956526|NCT00410410|19584842|P9|NOT COMPLETED|Open-Label Period (OL)||349
7956527|NCT00410410|19584843|P8|NOT COMPLETED|Open-Label Period (OL)||0
7956528|NCT00410410|19584844|P7|NOT COMPLETED|Open-Label Period (OL)||0
7956529|NCT00410410|19584845|P6|NOT COMPLETED|Open-Label Period (OL)||0
7956530|NCT00410410|19584846|P5|NOT COMPLETED|Open-Label Period (OL)||0
7956531|NCT00410410|19584847|P4|NOT COMPLETED|Open-Label Period (OL)||0
7956532|NCT00410410|19584848|P3|NOT COMPLETED|Open-Label Period (OL)||0
7956533|NCT00410410|19584849|P2|NOT COMPLETED|Open-Label Period (OL)||0
7956534|NCT00410410|19584850|P1|NOT COMPLETED|Open-Label Period (OL)||0
7956535|NCT00410410|19584842|P9|COMPLETED|Open-Label Period (OL)||0
7956536|NCT00410410|19584843|P8|COMPLETED|Open-Label Period (OL)||0
7956537|NCT00410410|19584844|P7|COMPLETED|Open-Label Period (OL)||0
7956538|NCT00410410|19584845|P6|COMPLETED|Open-Label Period (OL)||0
7956539|NCT00410410|19584846|P5|COMPLETED|Open-Label Period (OL)||0
7956540|NCT00410410|19584847|P4|COMPLETED|Open-Label Period (OL)||0
7956541|NCT00410410|19584848|P3|COMPLETED|Open-Label Period (OL)||0
7956542|NCT00410410|19584849|P2|COMPLETED|Open-Label Period (OL)||0
7956543|NCT00410410|19584850|P1|COMPLETED|Open-Label Period (OL)||0
7956544|NCT00410410|19584842|P9|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349
7956545|NCT00410410|19584843|P8|STARTED|Open-Label Period (OL)||0
7956546|NCT00410410|19584844|P7|STARTED|Open-Label Period (OL)||0
7956547|NCT00410410|19584845|P6|STARTED|Open-Label Period (OL)||0
7956548|NCT00410410|19584846|P5|STARTED|Open-Label Period (OL)||0
7956549|NCT00410410|19584847|P4|STARTED|Open-Label Period (OL)||0
7956550|NCT00410410|19584848|P3|STARTED|Open-Label Period (OL)||0
7956551|NCT00410410|19584849|P2|STARTED|Open-Label Period (OL)||0
7956552|NCT00410410|19584850|P1|STARTED|Open-Label Period (OL)||0
7956553|NCT00410410|19584842|P9|NOT COMPLETED|Maintenance Period (MP)||0
7956554|NCT00410410|19584843|P8|NOT COMPLETED|Maintenance Period (MP)||55
7956555|NCT00410410|19584844|P7|NOT COMPLETED|Maintenance Period (MP)||50
7956556|NCT00410410|19584845|P6|NOT COMPLETED|Maintenance Period (MP)||0
7956557|NCT00410410|19584846|P5|NOT COMPLETED|Maintenance Period (MP)||0
7956558|NCT00410410|19584847|P4|NOT COMPLETED|Maintenance Period (MP)||0
7956559|NCT00410410|19584848|P3|NOT COMPLETED|Maintenance Period (MP)||0
7956560|NCT00410410|19584849|P2|NOT COMPLETED|Maintenance Period (MP)||0
7956561|NCT00410410|19584850|P1|NOT COMPLETED|Maintenance Period (MP)||0
7956562|NCT00410410|19584842|P9|COMPLETED|Maintenance Period (MP)||0
7956563|NCT00410410|19584843|P8|COMPLETED|Maintenance Period (MP)||11
7956564|NCT00410410|19584844|P7|COMPLETED|Maintenance Period (MP)||15
7956565|NCT00410410|19584845|P6|COMPLETED|Maintenance Period (MP)||0
7956566|NCT00410410|19584846|P5|COMPLETED|Maintenance Period (MP)||0
7956567|NCT00410410|19584847|P4|COMPLETED|Maintenance Period (MP)||0
7956568|NCT00410410|19584848|P3|COMPLETED|Maintenance Period (MP)||0
7956569|NCT00410410|19584849|P2|COMPLETED|Maintenance Period (MP)||0
7956570|NCT00410410|19584850|P1|COMPLETED|Maintenance Period (MP)||0
7956571|NCT00410410|19584842|P9|STARTED|Maintenance Period (MP)||0
7956572|NCT00410410|19584843|P8|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66
7956573|NCT00410410|19584844|P7|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65
7956574|NCT00410410|19584845|P6|STARTED|Maintenance Period (MP)||0
7956575|NCT00410410|19584846|P5|STARTED|Maintenance Period (MP)||0
7956576|NCT00410410|19584847|P4|STARTED|Maintenance Period (MP)||0
7956577|NCT00410410|19584848|P3|STARTED|Maintenance Period (MP)||0
7956578|NCT00410410|19584849|P2|STARTED|Maintenance Period (MP)||0
7956579|NCT00410410|19584850|P1|STARTED|Maintenance Period (MP)||0
7956580|NCT00410410|19584842|P9|NOT COMPLETED|Induction Period (IP)||0
7956581|NCT00410410|19584843|P8|NOT COMPLETED|Induction Period (IP)||0
7956582|NCT00410410|19584844|P7|NOT COMPLETED|Induction Period (IP)||0
7956583|NCT00410410|19584845|P6|NOT COMPLETED|Induction Period (IP)||29
7956584|NCT00410410|19584846|P5|NOT COMPLETED|Induction Period (IP)||32
7956585|NCT00410410|19584847|P4|NOT COMPLETED|Induction Period (IP)||20
7956586|NCT00410410|19584848|P3|NOT COMPLETED|Induction Period (IP)||17
7956587|NCT00410410|19584849|P2|NOT COMPLETED|Induction Period (IP)||35
7956588|NCT00410410|19584850|P1|NOT COMPLETED|Induction Period (IP)||35
7956589|NCT00410410|19584842|P9|COMPLETED|Induction Period (IP)||0
7956590|NCT00410410|19584843|P8|COMPLETED|Induction Period (IP)||0
7956591|NCT00410410|19584844|P7|COMPLETED|Induction Period (IP)||0
7956592|NCT00410410|19584845|P6|COMPLETED|Induction Period (IP)||21
7956593|NCT00410410|19584846|P5|COMPLETED|Induction Period (IP)||19
7956594|NCT00410410|19584847|P4|COMPLETED|Induction Period (IP)||120
7956595|NCT00410410|19584848|P3|COMPLETED|Induction Period (IP)||53
7956596|NCT00410410|19584849|P2|COMPLETED|Induction Period (IP)||104
7956597|NCT00410410|19584850|P1|COMPLETED|Induction Period (IP)||106
7956598|NCT00410410|19584842|P9|STARTED|Induction Period (IP)||0
7956599|NCT00410410|19584843|P8|STARTED|Induction Period (IP)||0
7956600|NCT00410410|19584844|P7|STARTED|Induction Period (IP)||0
7956601|NCT00410410|19584845|P6|STARTED|Induction Period (IP)||50
7956602|NCT00410410|19584846|P5|STARTED|Induction Period (IP)||51
7956603|NCT00410410|19584847|P4|STARTED|Induction Period (IP)||140
7956604|NCT00410410|19584848|P3|STARTED|Induction Period (IP)||70
7956605|NCT00410410|19584849|P2|STARTED|Induction Period (IP)||139
7956606|NCT00410410|19584850|P1|STARTED|Induction Period (IP)||141
7956607|NCT00410384|19585011|P3|NOT COMPLETED|Overall Study||82
7956608|NCT00410384|19585012|P2|NOT COMPLETED|Overall Study||72
7956609|NCT00410384|19585013|P1|NOT COMPLETED|Overall Study||89
7956610|NCT00410384|19585011|P3|COMPLETED|Overall Study||191
7956611|NCT00410384|19585012|P2|COMPLETED|Overall Study||199
7956612|NCT00410384|19585013|P1|COMPLETED|Overall Study||186
7956613|NCT00410384|19585011|P3|STARTED|Overall Study||273
7956614|NCT00410384|19585012|P2|STARTED|Overall Study||271
7956615|NCT00410384|19585013|P1|STARTED|Overall Study||275
7956616|NCT00410280|19585041|P2|NOT COMPLETED|Overall Study||0
7956617|NCT00410280|19585042|P1|NOT COMPLETED|Overall Study||0
7956618|NCT00410280|19585041|P2|COMPLETED|Overall Study||13
7956619|NCT00410280|19585042|P1|COMPLETED|Overall Study||14
7956620|NCT00410280|19585041|P2|STARTED|Overall Study||13
7956621|NCT00410280|19585042|P1|STARTED|Overall Study||14
7956622|NCT00410202|19585086|P3|NOT COMPLETED|Off-treatment Follow up||12
7956623|NCT00410202|19585087|P2|NOT COMPLETED|Off-treatment Follow up||8
7956624|NCT00410202|19585088|P1|NOT COMPLETED|Off-treatment Follow up||14
7956625|NCT00410202|19585086|P3|COMPLETED|Off-treatment Follow up||2
7956626|NCT00410202|19585087|P2|COMPLETED|Off-treatment Follow up||0
7956627|NCT00410202|19585088|P1|COMPLETED|Off-treatment Follow up||1
7956628|NCT00410202|19585086|P3|STARTED|Off-treatment Follow up||14
7956629|NCT00410202|19585087|P2|STARTED|Off-treatment Follow up||8
7956630|NCT00410202|19585088|P1|STARTED|Off-treatment Follow up||15
7956631|NCT00410202|19585086|P3|NOT COMPLETED|On-Treatment||71
7956632|NCT00410202|19585087|P2|NOT COMPLETED|On-Treatment||79
7956633|NCT00410202|19585088|P1|NOT COMPLETED|On-Treatment||75
7956634|NCT00410202|19585086|P3|COMPLETED|On-Treatment|Completed the 100 week dosing|66
7956635|NCT00410202|19585087|P2|COMPLETED|On-Treatment|Completed the 100 week dosing|61
7956636|NCT00410202|19585088|P1|COMPLETED|On-Treatment|Completed the 100 week dosing|63
7956637|NCT00410202|19585086|P3|Discontinued at or After Week 48 Visit|On-Treatment||3
7956638|NCT00410202|19585087|P2|Discontinued at or After Week 48 Visit|On-Treatment||6
7956639|NCT00410202|19585088|P1|Discontinued at or After Week 48 Visit|On-Treatment||2
7956640|NCT00410202|19585086|P3|Discontinued Prior to Week 48 Visit|On-Treatment||2
7956641|NCT00410202|19585087|P2|Discontinued Prior to Week 48 Visit|On-Treatment||2
7956642|NCT00410202|19585088|P1|Discontinued Prior to Week 48 Visit|On-Treatment||4
7956643|NCT00410202|19585086|P3|STARTED|On-Treatment||137
7956644|NCT00410202|19585087|P2|STARTED|On-Treatment||140
7956645|NCT00410202|19585088|P1|STARTED|On-Treatment||138
7956646|NCT00410189|19585168|P1|NOT COMPLETED|Overall Study||0
7956647|NCT00410189|19585168|P1|COMPLETED|Overall Study||54
7956648|NCT00410189|19585168|P1|STARTED|Overall Study||54
7956649|NCT00410163|19585175|P2|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
7956650|NCT00410163|19585176|P1|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
7956651|NCT00410163|19585175|P2|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11
7956652|NCT00410163|19585176|P1|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
7956653|NCT00410163|19585175|P2|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21
7956654|NCT00410163|19585176|P1|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20
7956655|NCT00410163|19585175|P2|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11
7956656|NCT00410163|19585176|P1|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12
7956657|NCT00410163|19585175|P2|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
7956658|NCT00410163|19585176|P1|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
7956659|NCT00410163|19585175|P2|STARTED|Treatment and Follow-up Phase (2 Years)||30
7956660|NCT00410163|19585176|P1|STARTED|Treatment and Follow-up Phase (2 Years)||31
7956661|NCT00410150|19585220|P2|NOT COMPLETED|Overall Study||3
7956662|NCT00410150|19585221|P1|NOT COMPLETED|Overall Study||2
7956663|NCT00410150|19585220|P2|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17
7956664|NCT00410150|19585221|P1|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20
7956665|NCT00410150|19585220|P2|STARTED|Overall Study||20
7956666|NCT00410150|19585221|P1|STARTED|Overall Study||22
7956667|NCT00410124|19585229|P2|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111
7956668|NCT00410124|19585230|P1|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67
7956669|NCT00410124|19585229|P2|COMPLETED|Extension Phase - Open Label (45 Months)||0
7956670|NCT00410124|19585230|P1|COMPLETED|Extension Phase - Open Label (45 Months)||0
7956671|NCT00410124|19585229|P2|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111
7956672|NCT00410124|19585230|P1|STARTED|Extension Phase - Open Label (45 Months)||67
7956673|NCT00410124|19585229|P2|NOT COMPLETED|Core Phase Double Blind (15 Months)||133
7956674|NCT00410124|19585230|P1|NOT COMPLETED|Core Phase Double Blind (15 Months)||202
7956675|NCT00410124|19585229|P2|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6
7956676|NCT00410124|19585230|P1|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75
7956677|NCT00410124|19585229|P2|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2
7956678|NCT00410124|19585230|P1|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62
7956679|NCT00410124|19585229|P2|Ongoing|Core Phase Double Blind (15 Months)||4
7956680|NCT00410124|19585230|P1|Ongoing|Core Phase Double Blind (15 Months)||13
7956681|NCT00410124|19585229|P2|STARTED|Core Phase Double Blind (15 Months)||139
7956682|NCT00410124|19585230|P1|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277
7956683|NCT00410072|19585261|P2|NOT COMPLETED|After Week 48 to Week 96||11
7956684|NCT00410072|19585262|P1|NOT COMPLETED|After Week 48 to Week 96||6
7956685|NCT00410072|19585261|P2|COMPLETED|After Week 48 to Week 96||174
7956686|NCT00410072|19585262|P1|COMPLETED|After Week 48 to Week 96||170
7956687|NCT00410072|19585261|P2|STARTED|After Week 48 to Week 96||185
7956688|NCT00410072|19585262|P1|STARTED|After Week 48 to Week 96||176
7956689|NCT00410072|19585261|P2|NOT COMPLETED|Day 1 to Week 48||12
7956690|NCT00410072|19585262|P1|NOT COMPLETED|Day 1 to Week 48||6
7956691|NCT00410072|19585261|P2|COMPLETED|Day 1 to Week 48||185
7956692|NCT00410072|19585262|P1|COMPLETED|Day 1 to Week 48||176
7956693|NCT00410072|19585261|P2|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197
7956694|NCT00410072|19585262|P1|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182
7956695|NCT00410059|19585298|P1|NOT COMPLETED|Overall Study||0
7956696|NCT00410059|19585298|P1|COMPLETED|Overall Study||59
7956697|NCT00410059|19585298|P1|STARTED|Overall Study||59
7956698|NCT00410046|19585302|P1|NOT COMPLETED|Overall Study||5
7956699|NCT00410046|19585302|P1|COMPLETED|Overall Study||79
7956700|NCT00410046|19585302|P1|STARTED|Overall Study||84
7956701|NCT00409838|19585333|P2|NOT COMPLETED|Long-term Extension Period||0
7956702|NCT00409838|19585334|P1|NOT COMPLETED|Long-term Extension Period||18
7956703|NCT00409838|19585333|P2|COMPLETED|Long-term Extension Period||0
7956704|NCT00409838|19585334|P1|COMPLETED|Long-term Extension Period||87
7956705|NCT00409838|19585333|P2|STARTED|Long-term Extension Period||0
7956706|NCT00409838|19585334|P1|STARTED|Long-term Extension Period||105
7956707|NCT00409838|19585333|P2|NOT COMPLETED|Short-term Period||5
7956708|NCT00409838|19585334|P1|NOT COMPLETED|Short-term Period||3
7956709|NCT00409838|19585333|P2|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52
7956710|NCT00409838|19585334|P1|COMPLETED|Short-term Period||53
7956711|NCT00409838|19585333|P2|Treated (Baseline) Population|Short-term Period||57
7956712|NCT00409838|19585334|P1|Treated (Baseline) Population|Short-term Period||55
7956713|NCT00409838|19585333|P2|STARTED|Short-term Period|Randomized|57
7956714|NCT00409838|19585334|P1|STARTED|Short-term Period|Randomized|56
7956715|NCT00409825|19585395|P1|NOT COMPLETED|Overall Study||0
7956716|NCT00409825|19585395|P1|COMPLETED|Overall Study||61
7956717|NCT00409825|19585395|P1|STARTED|Overall Study||61
7956718|NCT00409786|19585399|P1|NOT COMPLETED|Overall Study||3
7956719|NCT00409786|19585399|P1|COMPLETED|Overall Study||47
7956720|NCT00409786|19585399|P1|STARTED|Overall Study||50
7956721|NCT00409773|19585408|P5|NOT COMPLETED|Overall Study||10
7956722|NCT00409773|19585409|P4|NOT COMPLETED|Overall Study||12
7956723|NCT00409773|19585410|P3|NOT COMPLETED|Overall Study||9
7956724|NCT00409773|19585411|P2|NOT COMPLETED|Overall Study||7
7956725|NCT00409773|19585412|P1|NOT COMPLETED|Overall Study||9
7956726|NCT00409773|19585408|P5|COMPLETED|Overall Study||218
7956727|NCT00409773|19585409|P4|COMPLETED|Overall Study||216
7956728|NCT00409773|19585410|P3|COMPLETED|Overall Study||220
7956729|NCT00409773|19585411|P2|COMPLETED|Overall Study||222
7956730|NCT00409773|19585412|P1|COMPLETED|Overall Study||220
7956731|NCT00409773|19585408|P5|STARTED|Overall Study||228
7956732|NCT00409773|19585409|P4|STARTED|Overall Study||228
7956733|NCT00409773|19585410|P3|STARTED|Overall Study||229
7956734|NCT00409773|19585411|P2|STARTED|Overall Study||229
7956735|NCT00409773|19585412|P1|STARTED|Overall Study||229
7956736|NCT00409747|19585494|P1|NOT COMPLETED|Overall Study||1
7956737|NCT00409747|19585494|P1|COMPLETED|Overall Study||10
7956738|NCT00409747|19585494|P1|STARTED|Overall Study||11
7956739|NCT00409708|19585501|P2|NOT COMPLETED|Washout||10
7956740|NCT00409708|19585502|P1|NOT COMPLETED|Washout||21
7956741|NCT00409708|19585501|P2|COMPLETED|Washout||29
7956742|NCT00409708|19585502|P1|COMPLETED|Washout||17
7956743|NCT00409708|19585501|P2|STARTED|Washout||39
7956744|NCT00409708|19585502|P1|STARTED|Washout||38
7956745|NCT00409708|19585501|P2|NOT COMPLETED|Treatment||17
7956746|NCT00409708|19585502|P1|NOT COMPLETED|Treatment||15
7956747|NCT00409708|19585501|P2|COMPLETED|Treatment||39
7956748|NCT00409708|19585502|P1|COMPLETED|Treatment||38
7956749|NCT00409708|19585501|P2|STARTED|Treatment||56
7956750|NCT00409708|19585502|P1|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53
7956751|NCT00409682|19585523|P3|NOT COMPLETED|EOW Double-blind Maintenance Period||27
7956752|NCT00409682|19585524|P2|NOT COMPLETED|EOW Double-blind Maintenance Period||37
7956753|NCT00409682|19585525|P1|NOT COMPLETED|EOW Double-blind Maintenance Period||0
7956754|NCT00409682|19585523|P3|COMPLETED|EOW Double-blind Maintenance Period||66
7956755|NCT00409682|19585524|P2|COMPLETED|EOW Double-blind Maintenance Period||58
7956756|NCT00409682|19585525|P1|COMPLETED|EOW Double-blind Maintenance Period||0
7956757|NCT00409682|19585523|P3|STARTED|EOW Double-blind Maintenance Period||93
7956758|NCT00409682|19585524|P2|STARTED|EOW Double-blind Maintenance Period||95
7956759|NCT00409682|19585525|P1|STARTED|EOW Double-blind Maintenance Period||0
7956760|NCT00409682|19585523|P3|NOT COMPLETED|Open-label Induction Period||0
7956761|NCT00409682|19585524|P2|NOT COMPLETED|Open-label Induction Period||0
7956762|NCT00409682|19585525|P1|NOT COMPLETED|Open-label Induction Period||4
7956763|NCT00409682|19585523|P3|COMPLETED|Open-label Induction Period||0
7956764|NCT00409682|19585524|P2|COMPLETED|Open-label Induction Period||0
7956765|NCT00409682|19585525|P1|COMPLETED|Open-label Induction Period||188
7956766|NCT00409682|19585523|P3|STARTED|Open-label Induction Period||0
7956767|NCT00409682|19585524|P2|STARTED|Open-label Induction Period||0
7956768|NCT00409682|19585525|P1|STARTED|Open-label Induction Period||192
7956769|NCT00409617|19585542|P1|NOT COMPLETED|Overall Study||160
7956770|NCT00409617|19585542|P1|COMPLETED|Overall Study||785
7956771|NCT00409617|19585542|P1|STARTED|Overall Study||945
7956772|NCT00409578|19585558|P4|NOT COMPLETED|Overall Study||67
7956773|NCT00409578|19585559|P3|NOT COMPLETED|Overall Study||54
7956774|NCT00409578|19585560|P2|NOT COMPLETED|Overall Study||70
7956775|NCT00409578|19585561|P1|NOT COMPLETED|Overall Study||52
7956776|NCT00409578|19585558|P4|COMPLETED|Overall Study||214
7956777|NCT00409578|19585559|P3|COMPLETED|Overall Study||215
7956778|NCT00409578|19585560|P2|COMPLETED|Overall Study||201
7956779|NCT00409578|19585561|P1|COMPLETED|Overall Study||228
7956780|NCT00409578|19585558|P4|STARTED|Overall Study||281
7956781|NCT00409578|19585559|P3|STARTED|Overall Study||269
7956782|NCT00409578|19585560|P2|STARTED|Overall Study||271
7956783|NCT00409578|19585561|P1|STARTED|Overall Study||280
7956784|NCT00409565|19585583|P1|NOT COMPLETED|Overall Study||1
7956785|NCT00409565|19585583|P1|COMPLETED|Overall Study||45
7956786|NCT00409565|19585583|P1|Overall Response Rate|Overall Study||7
7956787|NCT00409565|19585583|P1|STARTED|Overall Study||46
7956788|NCT00409539|19585596|P5|NOT COMPLETED|Overall Study||25
7956789|NCT00409539|19585597|P4|NOT COMPLETED|Overall Study||12
7956790|NCT00409539|19585598|P3|NOT COMPLETED|Overall Study||14
7956791|NCT00409539|19585599|P2|NOT COMPLETED|Overall Study||11
7956792|NCT00409539|19585600|P1|NOT COMPLETED|Overall Study||11
7956793|NCT00409539|19585596|P5|COMPLETED|Overall Study||85
7956794|NCT00409539|19585597|P4|COMPLETED|Overall Study||97
7956795|NCT00409539|19585598|P3|COMPLETED|Overall Study||95
7956796|NCT00409539|19585599|P2|COMPLETED|Overall Study||100
7956797|NCT00409539|19585600|P1|COMPLETED|Overall Study||100
7956798|NCT00409539|19585596|P5|STARTED|Overall Study||110
7956799|NCT00409539|19585597|P4|STARTED|Overall Study||109
7956800|NCT00409539|19585598|P3|STARTED|Overall Study||109
7956801|NCT00409539|19585599|P2|STARTED|Overall Study||111
7956802|NCT00409539|19585600|P1|STARTED|Overall Study||111
7956803|NCT00409409|19585619|P2|NOT COMPLETED|Overall Study||4
7956804|NCT00409409|19585620|P1|NOT COMPLETED|Overall Study||8
7956805|NCT00409409|19585619|P2|COMPLETED|Overall Study||135
7956806|NCT00409409|19585620|P1|COMPLETED|Overall Study||131
7956807|NCT00409409|19585619|P2|STARTED|Overall Study||139
7956808|NCT00409409|19585620|P1|STARTED|Overall Study||139
7956809|NCT00409344|19585628|P2|NOT COMPLETED|Overall Study||0
7956810|NCT00409344|19585629|P1|NOT COMPLETED|Overall Study||0
7956811|NCT00409344|19585628|P2|COMPLETED|Overall Study|No participants were enrolled to completion|0
7956812|NCT00409344|19585629|P1|COMPLETED|Overall Study|No participants were enrolled to completion|0
7956813|NCT00409344|19585628|P2|STARTED|Overall Study|No participants enrolled|0
7956814|NCT00409344|19585629|P1|STARTED|Overall Study|No participants enrolled|0
7956815|NCT00409331|19585647|P1|NOT COMPLETED|Overall Study||1
7956816|NCT00409331|19585647|P1|COMPLETED|Overall Study||0
7956817|NCT00409331|19585647|P1|STARTED|Overall Study||1
7956818|NCT00409292|19585651|P1|NOT COMPLETED|Overall Study||0
7956819|NCT00409292|19585651|P1|COMPLETED|Overall Study||33
7956820|NCT00409292|19585651|P1|STARTED|Overall Study||33
7956821|NCT00409240|19585660|P2|NOT COMPLETED|Overall Study||1
7956822|NCT00409240|19585661|P1|NOT COMPLETED|Overall Study||3
7956823|NCT00409240|19585660|P2|COMPLETED|Overall Study||49
7956824|NCT00409240|19585661|P1|COMPLETED|Overall Study||50
7956825|NCT00409240|19585660|P2|STARTED|Overall Study||50
7956826|NCT00409240|19585661|P1|STARTED|Overall Study||53
7956827|NCT00409188|19585669|P2|NOT COMPLETED|Overall Study||175
7956828|NCT00409188|19585670|P1|NOT COMPLETED|Overall Study||383
7956829|NCT00409188|19585669|P2|COMPLETED|Overall Study||332
7956830|NCT00409188|19585670|P1|COMPLETED|Overall Study||623
7956831|NCT00409188|19585669|P2|STARTED|Overall Study||507
7956832|NCT00409188|19585670|P1|STARTED|Overall Study||1006
7956833|NCT00409175|19585686|P2|NOT COMPLETED|Overall Study||19
7956834|NCT00409175|19585687|P1|NOT COMPLETED|Overall Study||18
7956835|NCT00409175|19585686|P2|COMPLETED|Overall Study||44
7956836|NCT00409175|19585687|P1|COMPLETED|Overall Study||47
7956837|NCT00409175|19585686|P2|STARTED|Overall Study||63
7956838|NCT00409175|19585687|P1|STARTED|Overall Study||65
7956839|NCT00409006|19585713|P2|NOT COMPLETED|Overall Study||12
7956840|NCT00409006|19585714|P1|NOT COMPLETED|Overall Study||20
7956841|NCT00409006|19585713|P2|COMPLETED|Overall Study||19
7956842|NCT00409006|19585714|P1|COMPLETED|Overall Study||19
7956843|NCT00409006|19585713|P2|STARTED|Overall Study||31
7956844|NCT00409006|19585714|P1|STARTED|Overall Study||39
7956845|NCT00408993|19585730|P2|NOT COMPLETED|Overall Study||17
7956846|NCT00408993|19585731|P1|NOT COMPLETED|Overall Study||19
7956847|NCT00408993|19585730|P2|COMPLETED|Overall Study||92
7956848|NCT00408993|19585731|P1|COMPLETED|Overall Study||87
7956849|NCT00408993|19585730|P2|STARTED|Overall Study||109
7956850|NCT00408993|19585731|P1|STARTED|Overall Study||106
7956851|NCT00408928|19585763|P1|NOT COMPLETED|Overall Study||3
7956852|NCT00408928|19585763|P1|COMPLETED|Overall Study||8
7956853|NCT00408928|19585763|P1|STARTED|Overall Study||11
7956854|NCT00408902|19585768|P1|NOT COMPLETED|Overall Study||10
7956855|NCT00408902|19585768|P1|COMPLETED|Overall Study||0
7956856|NCT00408902|19585768|P1|STARTED|Overall Study||10
7956857|NCT00408876|19585778|P4|NOT COMPLETED|Overall Study||35
7956858|NCT00408876|19585779|P3|NOT COMPLETED|Overall Study||50
7956859|NCT00408876|19585780|P2|NOT COMPLETED|Overall Study||36
7956860|NCT00408876|19585781|P1|NOT COMPLETED|Overall Study||16
7956861|NCT00408876|19585778|P4|COMPLETED|Overall Study||82
7956862|NCT00408876|19585779|P3|COMPLETED|Overall Study||62
7956863|NCT00408876|19585780|P2|COMPLETED|Overall Study||80
7956864|NCT00408876|19585781|P1|COMPLETED|Overall Study||43
7956865|NCT00408876|19585778|P4|STARTED|Overall Study||117
7956866|NCT00408876|19585779|P3|STARTED|Overall Study||112
7956867|NCT00408876|19585780|P2|STARTED|Overall Study||116
7956868|NCT00408876|19585781|P1|STARTED|Overall Study||59
7956869|NCT00408694|19586031|P1|NOT COMPLETED|Overall Study||2
7956870|NCT00408694|19586031|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
7956871|NCT00408694|19586031|P1|STARTED|Overall Study||46
7956872|NCT00408681|19586043|P1|NOT COMPLETED|Overall Study||9
7956873|NCT00408681|19586043|P1|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11
7956874|NCT00408681|19586043|P1|STARTED|Overall Study||20
7956875|NCT00408629|19586062|P2|NOT COMPLETED|Overall Study||125
7956876|NCT00408629|19586063|P1|NOT COMPLETED|Overall Study||97
7956877|NCT00408629|19586062|P2|COMPLETED|Overall Study||135
7956878|NCT00408629|19586063|P1|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161
7956879|NCT00408629|19586062|P2|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260
7956880|NCT00408629|19586063|P1|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258
7956881|NCT00408603|19586105|P3|NOT COMPLETED|Overall Study||40
7956882|NCT00408603|19586106|P2|NOT COMPLETED|Overall Study||2
7956883|NCT00408603|19586107|P1|NOT COMPLETED|Overall Study||4
7956884|NCT00408603|19586105|P3|COMPLETED|Overall Study||35
7956885|NCT00408603|19586106|P2|COMPLETED|Overall Study||37
7956886|NCT00408603|19586107|P1|COMPLETED|Overall Study||65
7956887|NCT00408603|19586105|P3|STARTED|Overall Study||75
7956888|NCT00408603|19586106|P2|STARTED|Overall Study||39
7956889|NCT00408603|19586107|P1|STARTED|Overall Study||69
7956890|NCT00408590|19586123|P9|NOT COMPLETED|Overall Study||0
7956891|NCT00408590|19586124|P8|NOT COMPLETED|Overall Study||0
7956892|NCT00408590|19586125|P7|NOT COMPLETED|Overall Study||0
7956893|NCT00408590|19586126|P6|NOT COMPLETED|Overall Study||0
7956894|NCT00408590|19586127|P5|NOT COMPLETED|Overall Study||0
7956895|NCT00408590|19586128|P4|NOT COMPLETED|Overall Study||0
7956896|NCT00408590|19586129|P3|NOT COMPLETED|Overall Study||0
7956897|NCT00408590|19586130|P2|NOT COMPLETED|Overall Study||0
7956898|NCT00408590|19586131|P1|NOT COMPLETED|Overall Study||0
7956899|NCT00408590|19586123|P9|COMPLETED|Overall Study||13
7956900|NCT00408590|19586124|P8|COMPLETED|Overall Study||3
7956901|NCT00408590|19586125|P7|COMPLETED|Overall Study||3
7956902|NCT00408590|19586126|P6|COMPLETED|Overall Study||3
7956903|NCT00408590|19586127|P5|COMPLETED|Overall Study||3
7956904|NCT00408590|19586128|P4|COMPLETED|Overall Study||3
7956905|NCT00408590|19586129|P3|COMPLETED|Overall Study||3
7956906|NCT00408590|19586130|P2|COMPLETED|Overall Study||3
7956907|NCT00408590|19586131|P1|COMPLETED|Overall Study||3
7956908|NCT00408590|19586123|P9|STARTED|Overall Study||13
7956909|NCT00408590|19586124|P8|STARTED|Overall Study||3
7956910|NCT00408590|19586125|P7|STARTED|Overall Study||3
7956911|NCT00408590|19586126|P6|STARTED|Overall Study||3
7956912|NCT00408590|19586127|P5|STARTED|Overall Study||3
7956913|NCT00408590|19586128|P4|STARTED|Overall Study||3
7956914|NCT00408590|19586129|P3|STARTED|Overall Study||3
7956915|NCT00408590|19586130|P2|STARTED|Overall Study||3
7956916|NCT00408590|19586131|P1|STARTED|Overall Study||3
7956917|NCT00408564|19586150|P1|NOT COMPLETED|Overall Study||0
7956918|NCT00408564|19586150|P1|COMPLETED|Overall Study||39
7956919|NCT00408564|19586150|P1|STARTED|Overall Study||39
7956920|NCT00408499|19586159|P5|NOT COMPLETED|Phase II- MTD Expansion||20
7956921|NCT00408499|19586160|P4|NOT COMPLETED|Phase II- MTD Expansion||0
7956922|NCT00408499|19586161|P3|NOT COMPLETED|Phase II- MTD Expansion||0
7956923|NCT00408499|19586162|P2|NOT COMPLETED|Phase II- MTD Expansion||0
7956924|NCT00408499|19586163|P1|NOT COMPLETED|Phase II- MTD Expansion||0
7956925|NCT00408499|19586159|P5|COMPLETED|Phase II- MTD Expansion||24
7956926|NCT00408499|19586160|P4|COMPLETED|Phase II- MTD Expansion||0
7956927|NCT00408499|19586161|P3|COMPLETED|Phase II- MTD Expansion||0
7956928|NCT00408499|19586162|P2|COMPLETED|Phase II- MTD Expansion||0
7956929|NCT00408499|19586163|P1|COMPLETED|Phase II- MTD Expansion||0
7956930|NCT00408499|19586159|P5|STARTED|Phase II- MTD Expansion||44
7956931|NCT00408499|19586160|P4|STARTED|Phase II- MTD Expansion||0
7956932|NCT00408499|19586161|P3|STARTED|Phase II- MTD Expansion||0
7956933|NCT00408499|19586162|P2|STARTED|Phase II- MTD Expansion||0
7956934|NCT00408499|19586163|P1|STARTED|Phase II- MTD Expansion||0
7956935|NCT00408499|19586159|P5|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
7956936|NCT00408499|19586160|P4|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
7956937|NCT00408499|19586161|P3|NOT COMPLETED|Phase 1: Dose Levels 1-4||1
7956938|NCT00408499|19586162|P2|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
7956939|NCT00408499|19586163|P1|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
7956940|NCT00408499|19586159|P5|COMPLETED|Phase 1: Dose Levels 1-4||0
7956941|NCT00408499|19586160|P4|COMPLETED|Phase 1: Dose Levels 1-4||6
7956942|NCT00408499|19586161|P3|COMPLETED|Phase 1: Dose Levels 1-4||2
7956943|NCT00408499|19586162|P2|COMPLETED|Phase 1: Dose Levels 1-4||5
7956944|NCT00408499|19586163|P1|COMPLETED|Phase 1: Dose Levels 1-4||2
7956945|NCT00408499|19586159|P5|STARTED|Phase 1: Dose Levels 1-4||0
7956946|NCT00408499|19586160|P4|STARTED|Phase 1: Dose Levels 1-4||6
7956947|NCT00408499|19586161|P3|STARTED|Phase 1: Dose Levels 1-4||3
7956948|NCT00408499|19586162|P2|STARTED|Phase 1: Dose Levels 1-4||7
7956949|NCT00408499|19586163|P1|STARTED|Phase 1: Dose Levels 1-4||4
7956950|NCT00408460|19586172|P1|NOT COMPLETED|Overall Study||0
7956951|NCT00408460|19586172|P1|COMPLETED|Overall Study||34
7956952|NCT00408460|19586172|P1|STARTED|Overall Study||34
7956953|NCT00408434|19586185|P7|NOT COMPLETED|Overall Study||4
7956954|NCT00408434|19586186|P6|NOT COMPLETED|Overall Study||3
7956955|NCT00408434|19586187|P5|NOT COMPLETED|Overall Study||6
7956956|NCT00408434|19586188|P4|NOT COMPLETED|Overall Study||3
7956957|NCT00408434|19586189|P3|NOT COMPLETED|Overall Study||6
7956958|NCT00408434|19586190|P2|NOT COMPLETED|Overall Study||3
7956959|NCT00408434|19586191|P1|NOT COMPLETED|Overall Study||6
7956960|NCT00408434|19586185|P7|COMPLETED|Overall Study||0
7956961|NCT00408434|19586186|P6|COMPLETED|Overall Study||0
7956962|NCT00408434|19586187|P5|COMPLETED|Overall Study||0
7956963|NCT00408434|19586188|P4|COMPLETED|Overall Study||0
7956964|NCT00408434|19586189|P3|COMPLETED|Overall Study||0
7956965|NCT00408434|19586190|P2|COMPLETED|Overall Study||0
7956966|NCT00408434|19586191|P1|COMPLETED|Overall Study||0
7956967|NCT00408434|19586185|P7|STARTED|Overall Study||4
7956968|NCT00408434|19586186|P6|STARTED|Overall Study||3
7956969|NCT00408434|19586187|P5|STARTED|Overall Study||6
7956970|NCT00408434|19586188|P4|STARTED|Overall Study||3
7956971|NCT00408434|19586189|P3|STARTED|Overall Study||6
7956972|NCT00408434|19586190|P2|STARTED|Overall Study||3
7956973|NCT00408434|19586191|P1|STARTED|Overall Study||6
7956974|NCT00408421|19586238|P3|NOT COMPLETED|Treatment Re-Randomization||5
7956975|NCT00408421|19586239|P2|NOT COMPLETED|Treatment Re-Randomization||7
7956976|NCT00408421|19586240|P1|NOT COMPLETED|Treatment Re-Randomization||7
7956977|NCT00408421|19586238|P3|COMPLETED|Treatment Re-Randomization||38
7956978|NCT00408421|19586239|P2|COMPLETED|Treatment Re-Randomization||39
7956979|NCT00408421|19586240|P1|COMPLETED|Treatment Re-Randomization||96
7956980|NCT00408421|19586238|P3|STARTED|Treatment Re-Randomization||43
7956981|NCT00408421|19586239|P2|STARTED|Treatment Re-Randomization||46
7956982|NCT00408421|19586240|P1|STARTED|Treatment Re-Randomization||103
7956983|NCT00408421|19586238|P3|NOT COMPLETED|Treatment Initial Randomization||0
7956984|NCT00408421|19586239|P2|NOT COMPLETED|Treatment Initial Randomization||22
7956985|NCT00408421|19586240|P1|NOT COMPLETED|Treatment Initial Randomization||17
7956986|NCT00408421|19586238|P3|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0
7956987|NCT00408421|19586239|P2|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89
7956988|NCT00408421|19586240|P1|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103
7956989|NCT00408421|19586238|P3|STARTED|Treatment Initial Randomization||0
7956990|NCT00408421|19586239|P2|STARTED|Treatment Initial Randomization||111
7956991|NCT00408421|19586240|P1|STARTED|Treatment Initial Randomization||120
7956992|NCT00408408|19586320|P6|NOT COMPLETED|Overall Study||3
7956993|NCT00408408|19586321|P5|NOT COMPLETED|Overall Study||5
7956994|NCT00408408|19586322|P4|NOT COMPLETED|Overall Study||7
7956995|NCT00408408|19586323|P3|NOT COMPLETED|Overall Study||0
7956996|NCT00408408|19586324|P2|NOT COMPLETED|Overall Study||3
7956997|NCT00408408|19586325|P1|NOT COMPLETED|Overall Study||2
7956998|NCT00408408|19586320|P6|COMPLETED|Overall Study||201
7956999|NCT00408408|19586321|P5|COMPLETED|Overall Study||192
7957000|NCT00408408|19586322|P4|COMPLETED|Overall Study||194
7957001|NCT00408408|19586323|P3|COMPLETED|Overall Study||204
7957002|NCT00408408|19586324|P2|COMPLETED|Overall Study||196
7957003|NCT00408408|19586325|P1|COMPLETED|Overall Study||199
7957004|NCT00408408|19586320|P6|STARTED|Overall Study||204
7957005|NCT00408408|19586321|P5|STARTED|Overall Study||197
7957006|NCT00408408|19586322|P4|STARTED|Overall Study||201
7957007|NCT00408408|19586323|P3|STARTED|Overall Study||204
7957008|NCT00408408|19586324|P2|STARTED|Overall Study||199
7957009|NCT00408408|19586325|P1|STARTED|Overall Study||201
7957010|NCT00408317|19586387|P2|NOT COMPLETED|Second Intervention Period||2
7957011|NCT00408317|19586388|P1|NOT COMPLETED|Second Intervention Period||2
7957012|NCT00408317|19586387|P2|COMPLETED|Second Intervention Period||14
7957013|NCT00408317|19586388|P1|COMPLETED|Second Intervention Period||12
7957014|NCT00408317|19586387|P2|STARTED|Second Intervention Period||16
7957015|NCT00408317|19586388|P1|STARTED|Second Intervention Period||14
7957016|NCT00408317|19586387|P2|NOT COMPLETED|First Intervention Period||1
7957017|NCT00408317|19586388|P1|NOT COMPLETED|First Intervention Period||0
7957018|NCT00408317|19586387|P2|COMPLETED|First Intervention Period||16
7957019|NCT00408317|19586388|P1|COMPLETED|First Intervention Period||14
7957020|NCT00408317|19586387|P2|STARTED|First Intervention Period||17
7957021|NCT00408317|19586388|P1|STARTED|First Intervention Period||14
7957022|NCT00408200|19586402|P2|NOT COMPLETED|Overall Study||0
7957023|NCT00408200|19586403|P1|NOT COMPLETED|Overall Study||0
7957024|NCT00408200|19586402|P2|COMPLETED|Overall Study||53
7957025|NCT00408200|19586403|P1|COMPLETED|Overall Study||57
7957026|NCT00408200|19586402|P2|STARTED|Overall Study||53
7957027|NCT00408200|19586403|P1|STARTED|Overall Study||57
7957028|NCT00408070|19586411|P1|NOT COMPLETED|Overall Study||0
7957029|NCT00408070|19586411|P1|COMPLETED|Overall Study||5
7957030|NCT00408070|19586411|P1|STARTED|Overall Study||5
7957031|NCT00408005|19586421|P8|NOT COMPLETED|Post Induction Therapy by Tx Assignment||14
7957032|NCT00408005|19586422|P7|NOT COMPLETED|Post Induction Therapy by Tx Assignment||28
7957033|NCT00408005|19586423|P6|NOT COMPLETED|Post Induction Therapy by Tx Assignment||101
7957034|NCT00408005|19586424|P5|NOT COMPLETED|Post Induction Therapy by Tx Assignment||132
7957035|NCT00408005|19586425|P4|NOT COMPLETED|Post Induction Therapy by Tx Assignment||44
7957036|NCT00408005|19586426|P3|NOT COMPLETED|Post Induction Therapy by Tx Assignment||85
7957037|NCT00408005|19586427|P2|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
7957038|NCT00408005|19586428|P1|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
7957039|NCT00408005|19586421|P8|COMPLETED|Post Induction Therapy by Tx Assignment||48
7957040|NCT00408005|19586422|P7|COMPLETED|Post Induction Therapy by Tx Assignment||115
7957041|NCT00408005|19586423|P6|COMPLETED|Post Induction Therapy by Tx Assignment||118
7957042|NCT00408005|19586424|P5|COMPLETED|Post Induction Therapy by Tx Assignment||319
7957043|NCT00408005|19586425|P4|COMPLETED|Post Induction Therapy by Tx Assignment||103
7957044|NCT00408005|19586426|P3|COMPLETED|Post Induction Therapy by Tx Assignment||287
7957045|NCT00408005|19586427|P2|COMPLETED|Post Induction Therapy by Tx Assignment||0
7957046|NCT00408005|19586428|P1|COMPLETED|Post Induction Therapy by Tx Assignment||0
7957047|NCT00408005|19586421|P8|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||2
7957048|NCT00408005|19586422|P7|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
7957049|NCT00408005|19586423|P6|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
7957050|NCT00408005|19586424|P5|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
7957051|NCT00408005|19586425|P4|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
7957052|NCT00408005|19586426|P3|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
7957053|NCT00408005|19586427|P2|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
7957054|NCT00408005|19586428|P1|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
7957055|NCT00408005|19586421|P8|T-LLy High Risk|Post Induction Therapy by Tx Assignment||60
7957056|NCT00408005|19586422|P7|T-LLy High Risk|Post Induction Therapy by Tx Assignment||61
7957057|NCT00408005|19586423|P6|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
7957058|NCT00408005|19586424|P5|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
7957059|NCT00408005|19586425|P4|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
7957060|NCT00408005|19586426|P3|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
7957061|NCT00408005|19586427|P2|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
7957062|NCT00408005|19586428|P1|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
7957063|NCT00408005|19586421|P8|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
7957064|NCT00408005|19586422|P7|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||82
7957065|NCT00408005|19586423|P6|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
7957066|NCT00408005|19586424|P5|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
7957067|NCT00408005|19586425|P4|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
7957068|NCT00408005|19586426|P3|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
7957069|NCT00408005|19586427|P2|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
7957070|NCT00408005|19586428|P1|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
7957071|NCT00408005|19586421|P8|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
7957072|NCT00408005|19586422|P7|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
7957073|NCT00408005|19586423|P6|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||43
7957074|NCT00408005|19586424|P5|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
7957075|NCT00408005|19586425|P4|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
7957076|NCT00408005|19586426|P3|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
7957077|NCT00408005|19586427|P2|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
7957078|NCT00408005|19586428|P1|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
7957079|NCT00408005|19586421|P8|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
7957080|NCT00408005|19586422|P7|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
7957081|NCT00408005|19586423|P6|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||31
7957082|NCT00408005|19586424|P5|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||84
7957083|NCT00408005|19586425|P4|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
7957084|NCT00408005|19586426|P3|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
7957085|NCT00408005|19586427|P2|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
7957086|NCT00408005|19586428|P1|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
7957087|NCT00408005|19586421|P8|High Risk|Post Induction Therapy by Tx Assignment||0
7957088|NCT00408005|19586422|P7|High Risk|Post Induction Therapy by Tx Assignment||0
7957089|NCT00408005|19586423|P6|High Risk|Post Induction Therapy by Tx Assignment||52
7957090|NCT00408005|19586424|P5|High Risk|Post Induction Therapy by Tx Assignment||55
7957091|NCT00408005|19586425|P4|High Risk|Post Induction Therapy by Tx Assignment||52
7957092|NCT00408005|19586426|P3|High Risk|Post Induction Therapy by Tx Assignment||56
7957093|NCT00408005|19586427|P2|High Risk|Post Induction Therapy by Tx Assignment||0
7957094|NCT00408005|19586428|P1|High Risk|Post Induction Therapy by Tx Assignment||0
7957095|NCT00408005|19586421|P8|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
7957096|NCT00408005|19586422|P7|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
7957097|NCT00408005|19586423|P6|Intermediate Risk|Post Induction Therapy by Tx Assignment||93
7957098|NCT00408005|19586424|P5|Intermediate Risk|Post Induction Therapy by Tx Assignment||257
7957099|NCT00408005|19586425|P4|Intermediate Risk|Post Induction Therapy by Tx Assignment||95
7957100|NCT00408005|19586426|P3|Intermediate Risk|Post Induction Therapy by Tx Assignment||99
7957101|NCT00408005|19586427|P2|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
7957102|NCT00408005|19586428|P1|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
7957103|NCT00408005|19586421|P8|Low Risk|Post Induction Therapy by Tx Assignment||0
7957104|NCT00408005|19586422|P7|Low Risk|Post Induction Therapy by Tx Assignment||0
7957105|NCT00408005|19586423|P6|Low Risk|Post Induction Therapy by Tx Assignment||0
7957106|NCT00408005|19586424|P5|Low Risk|Post Induction Therapy by Tx Assignment||55
7957107|NCT00408005|19586425|P4|Low Risk|Post Induction Therapy by Tx Assignment||0
7957108|NCT00408005|19586426|P3|Low Risk|Post Induction Therapy by Tx Assignment||217
7957109|NCT00408005|19586427|P2|Low Risk|Post Induction Therapy by Tx Assignment||0
7957110|NCT00408005|19586428|P1|Low Risk|Post Induction Therapy by Tx Assignment||0
7957111|NCT00408005|19586421|P8|STARTED|Post Induction Therapy by Tx Assignment||62
7957112|NCT00408005|19586422|P7|STARTED|Post Induction Therapy by Tx Assignment||143
7957113|NCT00408005|19586423|P6|STARTED|Post Induction Therapy by Tx Assignment||219
7957114|NCT00408005|19586424|P5|STARTED|Post Induction Therapy by Tx Assignment||451
7957115|NCT00408005|19586425|P4|STARTED|Post Induction Therapy by Tx Assignment||147
7957116|NCT00408005|19586426|P3|STARTED|Post Induction Therapy by Tx Assignment||372
7957117|NCT00408005|19586427|P2|STARTED|Post Induction Therapy by Tx Assignment||0
7957118|NCT00408005|19586428|P1|STARTED|Post Induction Therapy by Tx Assignment||0
7957119|NCT00408005|19586421|P8|NOT COMPLETED|Induction||0
7957120|NCT00408005|19586422|P7|NOT COMPLETED|Induction||0
7957121|NCT00408005|19586423|P6|NOT COMPLETED|Induction||0
7957122|NCT00408005|19586424|P5|NOT COMPLETED|Induction||0
7957123|NCT00408005|19586425|P4|NOT COMPLETED|Induction||0
7957124|NCT00408005|19586426|P3|NOT COMPLETED|Induction||0
7957125|NCT00408005|19586427|P2|NOT COMPLETED|Induction||94
7957126|NCT00408005|19586428|P1|NOT COMPLETED|Induction||407
7957127|NCT00408005|19586421|P8|COMPLETED|Induction||0
7957128|NCT00408005|19586422|P7|COMPLETED|Induction||0
7957129|NCT00408005|19586423|P6|COMPLETED|Induction||0
7957130|NCT00408005|19586424|P5|COMPLETED|Induction||0
7957131|NCT00408005|19586425|P4|COMPLETED|Induction||0
7957132|NCT00408005|19586426|P3|COMPLETED|Induction||0
7957133|NCT00408005|19586427|P2|COMPLETED|Induction||205
7957134|NCT00408005|19586428|P1|COMPLETED|Induction||1189
7957135|NCT00408005|19586421|P8|STARTED|Induction||0
7957136|NCT00408005|19586422|P7|STARTED|Induction||0
7957137|NCT00408005|19586423|P6|STARTED|Induction||0
7957138|NCT00408005|19586424|P5|STARTED|Induction||0
7957139|NCT00408005|19586425|P4|STARTED|Induction||0
7957140|NCT00408005|19586426|P3|STARTED|Induction||0
7957141|NCT00408005|19586427|P2|STARTED|Induction||299
7957142|NCT00408005|19586428|P1|STARTED|Induction||1596
7957143|NCT00407966|19586458|P1|NOT COMPLETED|Overall Study||0
7957144|NCT00407966|19586458|P1|COMPLETED|Overall Study||45
7957145|NCT00407966|19586458|P1|CR|Overall Study||30
7957146|NCT00407966|19586458|P1|STARTED|Overall Study||45
7957147|NCT00407888|19586462|P1|NOT COMPLETED|Overall Study||0
7957148|NCT00407888|19586462|P1|COMPLETED|Overall Study||60
7957149|NCT00407888|19586462|P1|STARTED|Overall Study||60
7957150|NCT00407797|19586470|P1|NOT COMPLETED|Overall Study||18
7957151|NCT00407797|19586470|P1|COMPLETED|Overall Study||118
7957152|NCT00407797|19586470|P1|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135
7957153|NCT00407797|19586470|P1|STARTED|Overall Study||136
7957154|NCT00407758|19586485|P1|NOT COMPLETED|Overall Study||1
7957155|NCT00407758|19586485|P1|COMPLETED|Overall Study||27
7957156|NCT00407758|19586485|P1|STARTED|Overall Study||28
7957157|NCT00407745|19586498|P2|NOT COMPLETED|Overall Study||17
7957158|NCT00407745|19586499|P1|NOT COMPLETED|Overall Study||19
7957159|NCT00407745|19586498|P2|COMPLETED|Overall Study||91
7957160|NCT00407745|19586499|P1|COMPLETED|Overall Study||93
7957161|NCT00407745|19586498|P2|Treated|Overall Study||107
7957162|NCT00407745|19586499|P1|Treated|Overall Study||112
7957163|NCT00407745|19586498|P2|STARTED|Overall Study||108
7957164|NCT00407745|19586499|P1|STARTED|Overall Study||112
7957165|NCT00407654|19586571|P1|NOT COMPLETED|Overall Study||0
7957166|NCT00407654|19586571|P1|COMPLETED|Overall Study||75
7957167|NCT00407654|19586571|P1|STARTED|Overall Study||75
7957168|NCT00407563|19586585|P1|NOT COMPLETED|Overall Study||1
7957169|NCT00407563|19586585|P1|COMPLETED|Overall Study|One patient remains on study treatment.|47
7957170|NCT00407563|19586585|P1|STARTED|Overall Study||48
7957171|NCT00407550|19586595|P2|NOT COMPLETED|Overall Study||4
7957172|NCT00407550|19586596|P1|NOT COMPLETED|Overall Study||3
7957173|NCT00407550|19586595|P2|COMPLETED|Overall Study||5
7957174|NCT00407550|19586596|P1|COMPLETED|Overall Study||7
7957175|NCT00407550|19586595|P2|STARTED|Overall Study||9
7957176|NCT00407550|19586596|P1|STARTED|Overall Study||10
7957177|NCT00407537|19586610|P2|NOT COMPLETED|Overall Study||44
7957178|NCT00407537|19586611|P1|NOT COMPLETED|Overall Study||93
7957179|NCT00407537|19586610|P2|COMPLETED|Overall Study||638
7957180|NCT00407537|19586611|P1|COMPLETED|Overall Study||686
7957181|NCT00407537|19586610|P2|Eligible for Efficacy Analysis|Overall Study||657
7957182|NCT00407537|19586611|P1|Eligible for Efficacy Analysis|Overall Study||760
7957183|NCT00407537|19586610|P2|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682
7957184|NCT00407537|19586611|P1|STARTED|Overall Study||779
7957185|NCT00407511|19586659|P1|NOT COMPLETED|Overall Study||22
7957186|NCT00407511|19586659|P1|COMPLETED|Overall Study||99
7957187|NCT00407511|19586659|P1|STARTED|Overall Study||121
7957188|NCT00407485|19586673|P1|NOT COMPLETED|Overall Study||0
7957189|NCT00407485|19586673|P1|COMPLETED|Overall Study||22
7957190|NCT00407485|19586673|P1|STARTED|Overall Study||22
7957191|NCT00407420|19586680|P2|NOT COMPLETED|Overall Study||6
7957192|NCT00407420|19586681|P1|NOT COMPLETED|Overall Study||9
7957193|NCT00407420|19586680|P2|COMPLETED|Overall Study||46
7957194|NCT00407420|19586681|P1|COMPLETED|Overall Study||45
7957195|NCT00407420|19586680|P2|STARTED|Overall Study||52
7957196|NCT00407420|19586681|P1|STARTED|Overall Study||54
7957197|NCT00407381|19586696|P3|NOT COMPLETED|Overall Study||2
7957198|NCT00407381|19586697|P2|NOT COMPLETED|Overall Study||4
7957199|NCT00407381|19586698|P1|NOT COMPLETED|Overall Study||3
7957200|NCT00407381|19586696|P3|COMPLETED|Overall Study||40
7957201|NCT00407381|19586697|P2|COMPLETED|Overall Study||38
7957202|NCT00407381|19586698|P1|COMPLETED|Overall Study||39
7957203|NCT00407381|19586696|P3|STARTED|Overall Study||42
7957204|NCT00407381|19586697|P2|STARTED|Overall Study||42
7957205|NCT00407381|19586698|P1|STARTED|Overall Study||42
7957206|NCT00407355|19586708|P2|NOT COMPLETED|Overall Study||11
7957207|NCT00407355|19586709|P1|NOT COMPLETED|Overall Study||10
7957208|NCT00407355|19586708|P2|COMPLETED|Overall Study||9
7957209|NCT00407355|19586709|P1|COMPLETED|Overall Study||10
7957210|NCT00407355|19586708|P2|STARTED|Overall Study||20
7957211|NCT00407355|19586709|P1|STARTED|Overall Study||20
7957212|NCT00407030|19586720|P3|NOT COMPLETED|Extension Period - up to 68 Weeks||0
7957213|NCT00407030|19586721|P2|NOT COMPLETED|Extension Period - up to 68 Weeks||29
7957214|NCT00407030|19586722|P1|NOT COMPLETED|Extension Period - up to 68 Weeks||27
7957215|NCT00407030|19586720|P3|COMPLETED|Extension Period - up to 68 Weeks||0
7957216|NCT00407030|19586721|P2|COMPLETED|Extension Period - up to 68 Weeks||74
7957217|NCT00407030|19586722|P1|COMPLETED|Extension Period - up to 68 Weeks||84
7957218|NCT00407030|19586720|P3|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0
7957219|NCT00407030|19586721|P2|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103
7957220|NCT00407030|19586722|P1|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111
7957221|NCT00407030|19586720|P3|NOT COMPLETED|Main Period - 8 to 20 Weeks||6
7957222|NCT00407030|19586721|P2|NOT COMPLETED|Main Period - 8 to 20 Weeks||3
7957223|NCT00407030|19586722|P1|NOT COMPLETED|Main Period - 8 to 20 Weeks||5
7957224|NCT00407030|19586720|P3|COMPLETED|Main Period - 8 to 20 Weeks||68
7957225|NCT00407030|19586721|P2|COMPLETED|Main Period - 8 to 20 Weeks||75
7957226|NCT00407030|19586722|P1|COMPLETED|Main Period - 8 to 20 Weeks||76
7957227|NCT00407030|19586720|P3|STARTED|Main Period - 8 to 20 Weeks||74
7957228|NCT00407030|19586721|P2|STARTED|Main Period - 8 to 20 Weeks||78
7957229|NCT00407030|19586722|P1|STARTED|Main Period - 8 to 20 Weeks||81
7957230|NCT00406848|19586750|P2|NOT COMPLETED|Overall Study||54
7957231|NCT00406848|19586751|P1|NOT COMPLETED|Overall Study||93
7957232|NCT00406848|19586750|P2|COMPLETED|Overall Study||67
7957233|NCT00406848|19586751|P1|COMPLETED|Overall Study||156
7957234|NCT00406848|19586750|P2|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121
7957235|NCT00406848|19586751|P1|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249
7957236|NCT00406783|19586815|P2|NOT COMPLETED|Overall Study||15
7957237|NCT00406783|19586816|P1|NOT COMPLETED|Overall Study||14
7957238|NCT00406783|19586815|P2|COMPLETED|Overall Study||256
7957239|NCT00406783|19586816|P1|COMPLETED|Overall Study||262
7957240|NCT00406783|19586815|P2|STARTED|Overall Study||271
7957241|NCT00406783|19586816|P1|STARTED|Overall Study||276
7957242|NCT00406718|19586831|P3|NOT COMPLETED|Overall Study||8
7957243|NCT00406718|19586832|P2|NOT COMPLETED|Overall Study||14
7957244|NCT00406718|19586833|P1|NOT COMPLETED|Overall Study||4
7957245|NCT00406718|19586831|P3|COMPLETED|Overall Study||39
7957246|NCT00406718|19586832|P2|COMPLETED|Overall Study||34
7957247|NCT00406718|19586833|P1|COMPLETED|Overall Study||43
7957248|NCT00406718|19586831|P3|STARTED|Overall Study||47
7957249|NCT00406718|19586832|P2|STARTED|Overall Study||48
7957250|NCT00406718|19586833|P1|STARTED|Overall Study||47
7957251|NCT00406692|19586847|P1|NOT COMPLETED|Overall Study||7
7957252|NCT00406692|19586847|P1|COMPLETED|Overall Study||9
7957253|NCT00406692|19586847|P1|STARTED|Overall Study||16
7957254|NCT00406653|19586857|P7|NOT COMPLETED|Open-Label Period||324
7957255|NCT00406653|19586858|P6|NOT COMPLETED|Open-Label Period||0
7957256|NCT00406653|19586859|P5|NOT COMPLETED|Open-Label Period||0
7957257|NCT00406653|19586860|P4|NOT COMPLETED|Open-Label Period||0
7957258|NCT00406653|19586861|P3|NOT COMPLETED|Open-Label Period||0
7957259|NCT00406653|19586862|P2|NOT COMPLETED|Open-Label Period||0
7957260|NCT00406653|19586863|P1|NOT COMPLETED|Open-Label Period||0
7957261|NCT00406653|19586857|P7|COMPLETED|Open-Label Period||0
7957262|NCT00406653|19586858|P6|COMPLETED|Open-Label Period||0
7957263|NCT00406653|19586859|P5|COMPLETED|Open-Label Period||0
7957264|NCT00406653|19586860|P4|COMPLETED|Open-Label Period||0
7957265|NCT00406653|19586861|P3|COMPLETED|Open-Label Period||0
7957266|NCT00406653|19586862|P2|COMPLETED|Open-Label Period||0
7957267|NCT00406653|19586863|P1|COMPLETED|Open-Label Period||0
7957268|NCT00406653|19586857|P7|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324
7957269|NCT00406653|19586858|P6|STARTED|Open-Label Period||0
7957270|NCT00406653|19586859|P5|STARTED|Open-Label Period||0
7957271|NCT00406653|19586860|P4|STARTED|Open-Label Period||0
7957272|NCT00406653|19586861|P3|STARTED|Open-Label Period||0
7957273|NCT00406653|19586862|P2|STARTED|Open-Label Period||0
7957274|NCT00406653|19586863|P1|STARTED|Open-Label Period||0
7957275|NCT00406653|19586857|P7|NOT COMPLETED|Maintenance Period||0
7957276|NCT00406653|19586858|P6|NOT COMPLETED|Maintenance Period||36
7957277|NCT00406653|19586859|P5|NOT COMPLETED|Maintenance Period||30
7957278|NCT00406653|19586860|P4|NOT COMPLETED|Maintenance Period||0
7957279|NCT00406653|19586861|P3|NOT COMPLETED|Maintenance Period||0
7957280|NCT00406653|19586862|P2|NOT COMPLETED|Maintenance Period||0
7957281|NCT00406653|19586863|P1|NOT COMPLETED|Maintenance Period||0
7957282|NCT00406653|19586857|P7|COMPLETED|Maintenance Period||0
7957283|NCT00406653|19586858|P6|COMPLETED|Maintenance Period||10
7957284|NCT00406653|19586859|P5|COMPLETED|Maintenance Period||14
7957285|NCT00406653|19586860|P4|COMPLETED|Maintenance Period||0
7957286|NCT00406653|19586861|P3|COMPLETED|Maintenance Period||0
7957287|NCT00406653|19586862|P2|COMPLETED|Maintenance Period||0
7957288|NCT00406653|19586863|P1|COMPLETED|Maintenance Period||0
7957289|NCT00406653|19586857|P7|STARTED|Maintenance Period||0
7957290|NCT00406653|19586858|P6|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46
7957291|NCT00406653|19586859|P5|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44
7957292|NCT00406653|19586860|P4|STARTED|Maintenance Period||0
7957293|NCT00406653|19586861|P3|STARTED|Maintenance Period||0
7957294|NCT00406653|19586862|P2|STARTED|Maintenance Period||0
7957295|NCT00406653|19586863|P1|STARTED|Maintenance Period||0
7957296|NCT00406653|19586857|P7|NOT COMPLETED|Induction Period||0
7957297|NCT00406653|19586858|P6|NOT COMPLETED|Induction Period||0
7957298|NCT00406653|19586859|P5|NOT COMPLETED|Induction Period||0
7957299|NCT00406653|19586860|P4|NOT COMPLETED|Induction Period||26
7957300|NCT00406653|19586861|P3|NOT COMPLETED|Induction Period||18
7957301|NCT00406653|19586862|P2|NOT COMPLETED|Induction Period||34
7957302|NCT00406653|19586863|P1|NOT COMPLETED|Induction Period||15
7957303|NCT00406653|19586857|P7|COMPLETED|Induction Period||0
7957304|NCT00406653|19586858|P6|COMPLETED|Induction Period||0
7957305|NCT00406653|19586859|P5|COMPLETED|Induction Period||0
7957306|NCT00406653|19586860|P4|COMPLETED|Induction Period||102
7957307|NCT00406653|19586861|P3|COMPLETED|Induction Period||112
7957308|NCT00406653|19586862|P2|COMPLETED|Induction Period||94
7957309|NCT00406653|19586863|P1|COMPLETED|Induction Period||50
7957310|NCT00406653|19586857|P7|STARTED|Induction Period||0
7957311|NCT00406653|19586858|P6|STARTED|Induction Period||0
7957312|NCT00406653|19586859|P5|STARTED|Induction Period||0
7957313|NCT00406653|19586860|P4|STARTED|Induction Period||128
7957314|NCT00406653|19586861|P3|STARTED|Induction Period||130
7957315|NCT00406653|19586862|P2|STARTED|Induction Period||128
7957316|NCT00406653|19586863|P1|STARTED|Induction Period||65
7957317|NCT00406640|19586944|P2|NOT COMPLETED|OL Extension Phase for Non-Responders||24
7957318|NCT00406640|19586945|P1|NOT COMPLETED|OL Extension Phase for Non-Responders||22
7957319|NCT00406640|19586944|P2|COMPLETED|OL Extension Phase for Non-Responders||36
7957320|NCT00406640|19586945|P1|COMPLETED|OL Extension Phase for Non-Responders||47
7957321|NCT00406640|19586944|P2|STARTED|OL Extension Phase for Non-Responders||60
7957322|NCT00406640|19586945|P1|STARTED|OL Extension Phase for Non-Responders||69
7957323|NCT00406640|19586944|P2|NOT COMPLETED|DB Continuation Phase for Responders||37
7957324|NCT00406640|19586945|P1|NOT COMPLETED|DB Continuation Phase for Responders||33
7957325|NCT00406640|19586944|P2|COMPLETED|DB Continuation Phase for Responders||151
7957326|NCT00406640|19586945|P1|COMPLETED|DB Continuation Phase for Responders||139
7957327|NCT00406640|19586944|P2|STARTED|DB Continuation Phase for Responders||188
7957328|NCT00406640|19586945|P1|STARTED|DB Continuation Phase for Responders||172
7957329|NCT00406640|19586944|P2|NOT COMPLETED|Acute Phase||43
7957330|NCT00406640|19586945|P1|NOT COMPLETED|Acute Phase||51
7957331|NCT00406640|19586944|P2|COMPLETED|Acute Phase||256
7957332|NCT00406640|19586945|P1|COMPLETED|Acute Phase||245
7957333|NCT00406640|19586944|P2|STARTED|Acute Phase||299
7957334|NCT00406640|19586945|P1|STARTED|Acute Phase||296
7957335|NCT00406419|19586978|P3|NOT COMPLETED|Overall Study||347
7957336|NCT00406419|19586979|P2|NOT COMPLETED|Overall Study||344
7957337|NCT00406419|19586980|P1|NOT COMPLETED|Overall Study||324
7957338|NCT00406419|19586978|P3|COMPLETED|Overall Study||0
7957339|NCT00406419|19586979|P2|COMPLETED|Overall Study||0
7957340|NCT00406419|19586980|P1|COMPLETED|Overall Study||0
7957341|NCT00406419|19586978|P3|STARTED|Overall Study||347
7957342|NCT00406419|19586979|P2|STARTED|Overall Study||344
7957343|NCT00406419|19586980|P1|STARTED|Overall Study||324
7957344|NCT00406393|19587065|P2|NOT COMPLETED|Overall Study||1
7957345|NCT00406393|19587066|P1|NOT COMPLETED|Overall Study||2
7957346|NCT00406393|19587065|P2|COMPLETED|Overall Study||152
7957347|NCT00406393|19587066|P1|COMPLETED|Overall Study||149
7957348|NCT00406393|19587065|P2|STARTED|Overall Study||153
7957349|NCT00406393|19587066|P1|STARTED|Overall Study||151
7957350|NCT00406367|19587096|P2|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
7957351|NCT00406367|19587097|P1|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20
7957352|NCT00406367|19587096|P2|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
7957353|NCT00406367|19587097|P1|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82
7957354|NCT00406367|19587096|P2|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0
7957355|NCT00406367|19587097|P1|STARTED|Open-Label Ext. Period - up to 68 Weeks||102
7957356|NCT00406367|19587096|P2|NOT COMPLETED|Main Period - 6 to 20 Weeks||2
7957357|NCT00406367|19587097|P1|NOT COMPLETED|Main Period - 6 to 20 Weeks||5
7957358|NCT00406367|19587096|P2|COMPLETED|Main Period - 6 to 20 Weeks||32
7957359|NCT00406367|19587097|P1|COMPLETED|Main Period - 6 to 20 Weeks||70
7957360|NCT00406367|19587096|P2|STARTED|Main Period - 6 to 20 Weeks||34
7957361|NCT00406367|19587097|P1|STARTED|Main Period - 6 to 20 Weeks||75
7957362|NCT00406354|19587112|P3|NOT COMPLETED|All Randomized and Treated Patients||22
7957363|NCT00406354|19587113|P2|NOT COMPLETED|All Randomized and Treated Patients||13
7957364|NCT00406354|19587114|P1|NOT COMPLETED|All Randomized and Treated Patients||16
7957365|NCT00406354|19587112|P3|COMPLETED|All Randomized and Treated Patients||37
7957366|NCT00406354|19587113|P2|COMPLETED|All Randomized and Treated Patients||48
7957367|NCT00406354|19587114|P1|COMPLETED|All Randomized and Treated Patients||44
7957368|NCT00406354|19587112|P3|STARTED|All Randomized and Treated Patients||59
7957369|NCT00406354|19587113|P2|STARTED|All Randomized and Treated Patients||61
7957370|NCT00406354|19587114|P1|STARTED|All Randomized and Treated Patients||60
7957371|NCT00406354|19587112|P3|NOT COMPLETED|All Randomized Patients||1
7957372|NCT00406354|19587113|P2|NOT COMPLETED|All Randomized Patients||0
7957373|NCT00406354|19587114|P1|NOT COMPLETED|All Randomized Patients||0
7957374|NCT00406354|19587112|P3|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59
7957375|NCT00406354|19587113|P2|COMPLETED|All Randomized Patients||61
7957376|NCT00406354|19587114|P1|COMPLETED|All Randomized Patients||60
7957377|NCT00406354|19587112|P3|STARTED|All Randomized Patients||60
7957378|NCT00406354|19587113|P2|STARTED|All Randomized Patients||61
7957379|NCT00406354|19587114|P1|STARTED|All Randomized Patients||60
7957380|NCT00406315|19587185|P1|NOT COMPLETED|Overall Study||141
7957381|NCT00406315|19587185|P1|COMPLETED|Overall Study||100
7957382|NCT00406315|19587185|P1|STARTED|Overall Study|Started = Treated|241
7957383|NCT00406276|19587203|P1|NOT COMPLETED|Overall Study||4
7957384|NCT00406276|19587203|P1|COMPLETED|Overall Study||24
7957385|NCT00406276|19587203|P1|STARTED|Overall Study||28
7957386|NCT00406133|19587212|P4|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
7957387|NCT00406133|19587213|P3|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
7957388|NCT00406133|19587214|P2|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3
7957389|NCT00406133|19587215|P1|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2
7957390|NCT00406133|19587212|P4|COMPLETED|Phase 2 (Second 26 Week Period)||60
7957391|NCT00406133|19587213|P3|COMPLETED|Phase 2 (Second 26 Week Period)||67
7957392|NCT00406133|19587214|P2|COMPLETED|Phase 2 (Second 26 Week Period)||152
7957393|NCT00406133|19587215|P1|COMPLETED|Phase 2 (Second 26 Week Period)||157
7957394|NCT00406133|19587212|P4|STARTED|Phase 2 (Second 26 Week Period)||60
7957395|NCT00406133|19587213|P3|STARTED|Phase 2 (Second 26 Week Period)||67
7957396|NCT00406133|19587214|P2|STARTED|Phase 2 (Second 26 Week Period)||155
7957397|NCT00406133|19587215|P1|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159
7957398|NCT00406133|19587212|P4|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
7957399|NCT00406133|19587213|P3|NOT COMPLETED|Phase 1 (First 26 Week Period)||0
7957400|NCT00406133|19587214|P2|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
7957401|NCT00406133|19587215|P1|NOT COMPLETED|Phase 1 (First 26 Week Period)||3
7957402|NCT00406133|19587212|P4|COMPLETED|Phase 1 (First 26 Week Period)||60
7957403|NCT00406133|19587213|P3|COMPLETED|Phase 1 (First 26 Week Period)||67
7957404|NCT00406133|19587214|P2|COMPLETED|Phase 1 (First 26 Week Period)||155
7957405|NCT00406133|19587215|P1|COMPLETED|Phase 1 (First 26 Week Period)||162
7957406|NCT00406133|19587212|P4|STARTED|Phase 1 (First 26 Week Period)||62
7957407|NCT00406133|19587213|P3|STARTED|Phase 1 (First 26 Week Period)||67
7957408|NCT00406133|19587214|P2|STARTED|Phase 1 (First 26 Week Period)||157
7957409|NCT00406133|19587215|P1|STARTED|Phase 1 (First 26 Week Period)||165
7957410|NCT00406107|19587279|P2|NOT COMPLETED|Overall Study||1
7957411|NCT00406107|19587280|P1|NOT COMPLETED|Overall Study||1
7957412|NCT00406107|19587279|P2|COMPLETED|Overall Study||4
7957413|NCT00406107|19587280|P1|COMPLETED|Overall Study||14
7957414|NCT00406107|19587279|P2|STARTED|Overall Study||5
7957415|NCT00406107|19587280|P1|STARTED|Overall Study||15
7957416|NCT00406029|19587295|P5|NOT COMPLETED|Overall Study||8
7957417|NCT00406029|19587296|P4|NOT COMPLETED|Overall Study||17
7957418|NCT00406029|19587297|P3|NOT COMPLETED|Overall Study||10
7957419|NCT00406029|19587298|P2|NOT COMPLETED|Overall Study||8
7957420|NCT00406029|19587299|P1|NOT COMPLETED|Overall Study||16
7957421|NCT00406029|19587295|P5|COMPLETED|Overall Study||41
7957422|NCT00406029|19587296|P4|COMPLETED|Overall Study||40
7957423|NCT00406029|19587297|P3|COMPLETED|Overall Study||39
7957424|NCT00406029|19587298|P2|COMPLETED|Overall Study||41
7957425|NCT00406029|19587299|P1|COMPLETED|Overall Study||33
7957426|NCT00406029|19587295|P5|Treated|Overall Study||47
7957427|NCT00406029|19587296|P4|Treated|Overall Study||54
7957428|NCT00406029|19587297|P3|Treated|Overall Study||47
7957429|NCT00406029|19587298|P2|Treated|Overall Study||49
7957430|NCT00406029|19587299|P1|Treated|Overall Study||49
7957431|NCT00406029|19587295|P5|STARTED|Overall Study||49
7957432|NCT00406029|19587296|P4|STARTED|Overall Study||57
7957433|NCT00406029|19587297|P3|STARTED|Overall Study||49
7957434|NCT00406029|19587298|P2|STARTED|Overall Study||49
7957435|NCT00406029|19587299|P1|STARTED|Overall Study||49
7957436|NCT00405964|19587403|P2|NOT COMPLETED|Overall Study||95
7957437|NCT00405964|19587404|P1|NOT COMPLETED|Overall Study||59
7957438|NCT00405964|19587403|P2|COMPLETED|Overall Study||261
7957439|NCT00405964|19587404|P1|COMPLETED|Overall Study||301
7957440|NCT00405964|19587403|P2|STARTED|Overall Study||356
7957441|NCT00405964|19587404|P1|STARTED|Overall Study||360
7957442|NCT00405938|19587416|P2|NOT COMPLETED|Overall Study||0
7957443|NCT00405938|19587417|P1|NOT COMPLETED|Overall Study||0
7957444|NCT00405938|19587416|P2|COMPLETED|Overall Study||41
7957445|NCT00405938|19587417|P1|COMPLETED|Overall Study||38
7957446|NCT00405938|19587416|P2|STARTED|Overall Study||41
7957447|NCT00405938|19587417|P1|STARTED|Overall Study||38
7957448|NCT00405912|19587426|P3|NOT COMPLETED|Overall Study||16
7957449|NCT00405912|19587427|P2|NOT COMPLETED|Overall Study||19
7957450|NCT00405912|19587428|P1|NOT COMPLETED|Overall Study||16
7957451|NCT00405912|19587426|P3|COMPLETED|Overall Study||23
7957452|NCT00405912|19587427|P2|COMPLETED|Overall Study||21
7957453|NCT00405912|19587428|P1|COMPLETED|Overall Study||23
7957454|NCT00405912|19587426|P3|STARTED|Overall Study||39
7957455|NCT00405912|19587427|P2|STARTED|Overall Study||40
7957456|NCT00405912|19587428|P1|STARTED|Overall Study||39
7957457|NCT00405821|19587441|P2|NOT COMPLETED|Overall Study||22
7957458|NCT00405821|19587442|P1|NOT COMPLETED|Overall Study||22
7957459|NCT00405821|19587441|P2|COMPLETED|Overall Study||198
7957460|NCT00405821|19587442|P1|COMPLETED|Overall Study||198
7957461|NCT00405821|19587441|P2|STARTED|Overall Study||220
7957462|NCT00405821|19587442|P1|STARTED|Overall Study||220
7957463|NCT00405756|19587455|P3|NOT COMPLETED|Follow-up||88
7957464|NCT00405756|19587456|P2|NOT COMPLETED|Follow-up||90
7957465|NCT00405756|19587457|P1|NOT COMPLETED|Follow-up||75
7957466|NCT00405756|19587455|P3|COMPLETED|Follow-up||0
7957467|NCT00405756|19587456|P2|COMPLETED|Follow-up||0
7957468|NCT00405756|19587457|P1|COMPLETED|Follow-up||0
7957469|NCT00405756|19587455|P3|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88
7957470|NCT00405756|19587456|P2|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90
7957471|NCT00405756|19587457|P1|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75
7957472|NCT00405756|19587455|P3|NOT COMPLETED|Open-label Extension||72
7957473|NCT00405756|19587456|P2|NOT COMPLETED|Open-label Extension||47
7957474|NCT00405756|19587457|P1|NOT COMPLETED|Open-label Extension||19
7957475|NCT00405756|19587455|P3|COMPLETED|Open-label Extension||0
7957476|NCT00405756|19587456|P2|COMPLETED|Open-label Extension||0
7957477|NCT00405756|19587457|P1|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0
7957478|NCT00405756|19587455|P3|STARTED|Open-label Extension||72
7957479|NCT00405756|19587456|P2|STARTED|Open-label Extension||47
7957480|NCT00405756|19587457|P1|STARTED|Open-label Extension||19
7957481|NCT00405756|19587455|P3|NOT COMPLETED|Double-blind Treatment||154
7957482|NCT00405756|19587456|P2|NOT COMPLETED|Double-blind Treatment||153
7957483|NCT00405756|19587457|P1|NOT COMPLETED|Double-blind Treatment||152
7957484|NCT00405756|19587455|P3|COMPLETED|Double-blind Treatment||0
7957485|NCT00405756|19587456|P2|COMPLETED|Double-blind Treatment||0
7957486|NCT00405756|19587457|P1|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0
7957487|NCT00405756|19587455|P3|Safety Population|Double-blind Treatment||153
7957488|NCT00405756|19587456|P2|Safety Population|Double-blind Treatment||152
7957489|NCT00405756|19587457|P1|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150
7957490|NCT00405756|19587455|P3|STARTED|Double-blind Treatment||154
7957491|NCT00405756|19587456|P2|STARTED|Double-blind Treatment||153
7957492|NCT00405756|19587457|P1|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152
7957493|NCT00405704|19587547|P2|NOT COMPLETED|Overall Study||46
7957494|NCT00405704|19587548|P1|NOT COMPLETED|Overall Study||41
7957495|NCT00405704|19587547|P2|COMPLETED|Overall Study||259
7957496|NCT00405704|19587548|P1|COMPLETED|Overall Study||261
7957497|NCT00405704|19587547|P2|Recurrent UTI With TMP-SMZ Panel|Overall Study||69
7957498|NCT00405704|19587548|P1|Recurrent UTI With TMP-SMZ Panel|Overall Study||38
7957499|NCT00405704|19587547|P2|Recurrent UTI With E. Coli|Overall Study||57
7957500|NCT00405704|19587548|P1|Recurrent UTI With E. Coli|Overall Study||30
7957501|NCT00405704|19587547|P2|Outcome Stool Assessed|Overall Study||210
7957502|NCT00405704|19587548|P1|Outcome Stool Assessed|Overall Study||203
7957503|NCT00405704|19587547|P2|Completed Assessments for New Scarring|Overall Study||227
7957504|NCT00405704|19587548|P1|Completed Assessments for New Scarring|Overall Study||220
7957505|NCT00405704|19587547|P2|Completed Outcome Renal Scan|Overall Study||235
7957506|NCT00405704|19587548|P1|Completed Outcome Renal Scan|Overall Study||227
7957507|NCT00405704|19587547|P2|STARTED|Overall Study||305
7957508|NCT00405704|19587548|P1|STARTED|Overall Study||302
7957509|NCT00405652|19587568|P1|NOT COMPLETED|Overall Study||4
7957510|NCT00405652|19587568|P1|COMPLETED|Overall Study||30
7957511|NCT00405652|19587568|P1|STARTED|Overall Study||34
7957512|NCT00405639|19587575|P2|NOT COMPLETED|Overall Study||0
7957513|NCT00405639|19587576|P1|NOT COMPLETED|Overall Study||3
7957514|NCT00405639|19587575|P2|COMPLETED|Overall Study||12
7957515|NCT00405639|19587576|P1|COMPLETED|Overall Study||22
7957516|NCT00405639|19587575|P2|STARTED|Overall Study||12
7957517|NCT00405639|19587576|P1|STARTED|Overall Study||25
7957518|NCT00405587|19587592|P4|NOT COMPLETED|Overall Study||20
7957519|NCT00405587|19587593|P3|NOT COMPLETED|Overall Study||22
7957520|NCT00405587|19587594|P2|NOT COMPLETED|Overall Study||28
7957521|NCT00405587|19587595|P1|NOT COMPLETED|Overall Study||26
7957522|NCT00405587|19587592|P4|COMPLETED|Overall Study||1
7957523|NCT00405587|19587593|P3|COMPLETED|Overall Study||10
7957524|NCT00405587|19587594|P2|COMPLETED|Overall Study||2
7957525|NCT00405587|19587595|P1|COMPLETED|Overall Study||0
7957526|NCT00405587|19587592|P4|STARTED|Overall Study||21
7957527|NCT00405587|19587593|P3|STARTED|Overall Study||32
7957528|NCT00405587|19587594|P2|STARTED|Overall Study||30
7957529|NCT00405587|19587595|P1|STARTED|Overall Study||26
7957530|NCT00405548|19587713|P2|NOT COMPLETED|Overall Study||1
7957531|NCT00405548|19587714|P1|NOT COMPLETED|Overall Study||4
7957532|NCT00405548|19587713|P2|COMPLETED|Overall Study||12
7957533|NCT00405548|19587714|P1|COMPLETED|Overall Study||24
7957534|NCT00405548|19587713|P2|STARTED|Overall Study||13
7957535|NCT00405548|19587714|P1|STARTED|Overall Study||28
7957536|NCT00405522|19587728|P2|NOT COMPLETED|Overall Study||0
7957537|NCT00405522|19587729|P1|NOT COMPLETED|Overall Study||0
7957538|NCT00405522|19587728|P2|COMPLETED|Overall Study||17
7957539|NCT00405522|19587729|P1|COMPLETED|Overall Study||17
7957540|NCT00405522|19587728|P2|STARTED|Overall Study||17
7957541|NCT00405522|19587729|P1|STARTED|Overall Study||17
7957542|NCT00405509|19587741|P2|NOT COMPLETED|Overall Study||0
7957543|NCT00405509|19587742|P1|NOT COMPLETED|Overall Study||0
7957544|NCT00405509|19587741|P2|COMPLETED|Overall Study||22
7957545|NCT00405509|19587742|P1|COMPLETED|Overall Study||11
7957546|NCT00405509|19587741|P2|STARTED|Overall Study||22
7957547|NCT00405509|19587742|P1|STARTED|Overall Study||11
7957548|NCT00405392|19587758|P2|NOT COMPLETED|Overall Study||27
7957549|NCT00405392|19587759|P1|NOT COMPLETED|Overall Study||30
7957550|NCT00405392|19587758|P2|COMPLETED|Overall Study||155
7957551|NCT00405392|19587759|P1|COMPLETED|Overall Study||153
7957552|NCT00405392|19587758|P2|STARTED|Overall Study||182
7957553|NCT00405392|19587759|P1|STARTED|Overall Study||183
7957554|NCT00405353|19587769|P1|NOT COMPLETED|Overall Study||0
7957555|NCT00405353|19587769|P1|COMPLETED|Overall Study||10
7957556|NCT00405353|19587769|P1|STARTED|Overall Study||10
7957557|NCT00405288|19587775|P2|NOT COMPLETED|Overall Study||0
7957558|NCT00405288|19587776|P1|NOT COMPLETED|Overall Study||0
7957559|NCT00405288|19587775|P2|COMPLETED|Overall Study||204
7957560|NCT00405288|19587776|P1|COMPLETED|Overall Study||204
7957561|NCT00405288|19587775|P2|STARTED|Overall Study||204
7957562|NCT00405288|19587776|P1|STARTED|Overall Study||204
7957563|NCT00405275|19587806|P2|NOT COMPLETED|Overall Study||19
7957564|NCT00405275|19587807|P1|NOT COMPLETED|Overall Study||23
7957565|NCT00405275|19587806|P2|COMPLETED|Overall Study||156
7957566|NCT00405275|19587807|P1|COMPLETED|Overall Study||155
7957567|NCT00405275|19587806|P2|24 Week (Switch)|Overall Study||44
7957568|NCT00405275|19587807|P1|24 Week (Switch)|Overall Study||44
7957569|NCT00405275|19587806|P2|24 Week (no Switch)|Overall Study||121
7957570|NCT00405275|19587807|P1|24 Week (no Switch)|Overall Study||119
7957571|NCT00405275|19587806|P2|24 Weeks (Total)|Overall Study||165
7957572|NCT00405275|19587807|P1|24 Weeks (Total)|Overall Study||163
7957573|NCT00405275|19587806|P2|STARTED|Overall Study||175
7957574|NCT00405275|19587807|P1|STARTED|Overall Study||178
7957575|NCT00405067|19587816|P3|NOT COMPLETED|Overall Study||5
7957576|NCT00405067|19587817|P2|NOT COMPLETED|Overall Study||9
7957577|NCT00405067|19587818|P1|NOT COMPLETED|Overall Study||4
7957578|NCT00405067|19587816|P3|COMPLETED|Overall Study||24
7957579|NCT00405067|19587817|P2|COMPLETED|Overall Study||19
7957580|NCT00405067|19587818|P1|COMPLETED|Overall Study||24
7957581|NCT00405067|19587816|P3|STARTED|Overall Study||29
7957582|NCT00405067|19587817|P2|STARTED|Overall Study||28
7957583|NCT00405067|19587818|P1|STARTED|Overall Study||28
7957584|NCT00404924|19587855|P2|NOT COMPLETED|Overall Study||306
7957585|NCT00404924|19587856|P1|NOT COMPLETED|Overall Study||603
7957586|NCT00404924|19587855|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1
7957587|NCT00404924|19587856|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
7957588|NCT00404924|19587855|P2|STARTED|Overall Study|randomised patients|307
7957589|NCT00404924|19587856|P1|STARTED|Overall Study|randomised patients|617
7957590|NCT00404820|19587874|P2|NOT COMPLETED|Overall Study||24
7957591|NCT00404820|19587875|P1|NOT COMPLETED|Overall Study||19
7957592|NCT00404820|19587874|P2|COMPLETED|Overall Study||172
7957593|NCT00404820|19587875|P1|COMPLETED|Overall Study||389
7957594|NCT00404820|19587874|P2|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194
7957595|NCT00404820|19587875|P1|Started Treatment|Overall Study||408
7957596|NCT00404820|19587874|P2|STARTED|Overall Study||196
7957597|NCT00404820|19587875|P1|STARTED|Overall Study||408
7957598|NCT00404768|19587897|P4|NOT COMPLETED|Part C||14
7957599|NCT00404768|19587898|P3|NOT COMPLETED|Part C||8
7957600|NCT00404768|19587899|P2|NOT COMPLETED|Part C||0
7957601|NCT00404768|19587900|P1|NOT COMPLETED|Part C||0
7957602|NCT00404768|19587897|P4|COMPLETED|Part C||20
7957603|NCT00404768|19587898|P3|COMPLETED|Part C||22
7957604|NCT00404768|19587899|P2|COMPLETED|Part C||0
7957605|NCT00404768|19587900|P1|COMPLETED|Part C||0
7957606|NCT00404768|19587897|P4|STARTED|Part C||34
7957607|NCT00404768|19587898|P3|STARTED|Part C||30
7957608|NCT00404768|19587899|P2|STARTED|Part C||0
7957609|NCT00404768|19587900|P1|STARTED|Part C||0
7957610|NCT00404768|19587897|P4|NOT COMPLETED|Part A and B||0
7957611|NCT00404768|19587898|P3|NOT COMPLETED|Part A and B||0
7957612|NCT00404768|19587899|P2|NOT COMPLETED|Part A and B||1
7957613|NCT00404768|19587900|P1|NOT COMPLETED|Part A and B||1
7957614|NCT00404768|19587897|P4|COMPLETED|Part A and B||0
7957615|NCT00404768|19587898|P3|COMPLETED|Part A and B||0
7957616|NCT00404768|19587899|P2|COMPLETED|Part A and B||8
7957617|NCT00404768|19587900|P1|COMPLETED|Part A and B||19
7957618|NCT00404768|19587897|P4|STARTED|Part A and B||0
7957619|NCT00404768|19587898|P3|STARTED|Part A and B||0
7957620|NCT00404768|19587899|P2|STARTED|Part A and B||9
7957621|NCT00404768|19587900|P1|STARTED|Part A and B||20
7957622|NCT00404755|19587961|P1|NOT COMPLETED|Phase III (Imipramine)||0
7957623|NCT00404755|19587961|P1|COMPLETED|Phase III (Imipramine)||3
7957624|NCT00404755|19587961|P1|STARTED|Phase III (Imipramine)||3
7957625|NCT00404755|19587961|P1|NOT COMPLETED|Phase II (Escitalopram)||2
7957626|NCT00404755|19587961|P1|COMPLETED|Phase II (Escitalopram)||9
7957627|NCT00404755|19587961|P1|STARTED|Phase II (Escitalopram)||11
7957628|NCT00404755|19587961|P1|NOT COMPLETED|Phase I (Bupropion)||4
7957629|NCT00404755|19587961|P1|COMPLETED|Phase I (Bupropion)||13
7957630|NCT00404755|19587961|P1|STARTED|Phase I (Bupropion)|3 went directly into Phase II (intolerant of bupropion), 1 withdrew consent and 4 did not return|17
7957631|NCT00404651|19587976|P4|NOT COMPLETED|Overall Study||21
7957632|NCT00404651|19587977|P3|NOT COMPLETED|Overall Study||45
7957633|NCT00404651|19587978|P2|NOT COMPLETED|Overall Study||28
7957634|NCT00404651|19587979|P1|NOT COMPLETED|Overall Study||39
7957635|NCT00404651|19587976|P4|COMPLETED|Overall Study||146
7957636|NCT00404651|19587977|P3|COMPLETED|Overall Study||294
7957637|NCT00404651|19587978|P2|COMPLETED|Overall Study||315
7957638|NCT00404651|19587979|P1|COMPLETED|Overall Study||301
7957639|NCT00404651|19587976|P4|STARTED|Overall Study||167
7957640|NCT00404651|19587977|P3|STARTED|Overall Study||339
7957641|NCT00404651|19587978|P2|STARTED|Overall Study||343
7957642|NCT00404651|19587979|P1|STARTED|Overall Study||340
7957643|NCT00404547|19588007|P2|NOT COMPLETED|Overall Study||25
7957644|NCT00404547|19588008|P1|NOT COMPLETED|Overall Study||90
7957645|NCT00404547|19588007|P2|COMPLETED|Overall Study||334
7957646|NCT00404547|19588008|P1|COMPLETED|Overall Study||672
7957647|NCT00404547|19588007|P2|STARTED|Overall Study||359
7957648|NCT00404547|19588008|P1|STARTED|Overall Study||762
7957649|NCT00404495|19588018|P2|NOT COMPLETED|Overall Study||11
7957650|NCT00404495|19588019|P1|NOT COMPLETED|Overall Study||44
7957651|NCT00404495|19588018|P2|COMPLETED|Overall Study||6
7957652|NCT00404495|19588019|P1|COMPLETED|Overall Study||22
7957653|NCT00404495|19588018|P2|STARTED|Overall Study||17
7957654|NCT00404495|19588019|P1|STARTED|Overall Study||66
7957655|NCT00404352|19588038|P9|NOT COMPLETED|Open Label Extension (up to 36 Months)||2
7957656|NCT00404352|19588039|P8|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
7957657|NCT00404352|19588040|P7|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
7957658|NCT00404352|19588041|P6|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
7957659|NCT00404352|19588042|P5|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
7957660|NCT00404352|19588043|P4|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
7957661|NCT00404352|19588044|P3|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
7957662|NCT00404352|19588045|P2|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
7957663|NCT00404352|19588046|P1|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
7957664|NCT00404352|19588038|P9|COMPLETED|Open Label Extension (up to 36 Months)||9
7957665|NCT00404352|19588039|P8|COMPLETED|Open Label Extension (up to 36 Months)||4
7957666|NCT00404352|19588040|P7|COMPLETED|Open Label Extension (up to 36 Months)||3
7957667|NCT00404352|19588041|P6|COMPLETED|Open Label Extension (up to 36 Months)||0
7957668|NCT00404352|19588042|P5|COMPLETED|Open Label Extension (up to 36 Months)||0
7957669|NCT00404352|19588043|P4|COMPLETED|Open Label Extension (up to 36 Months)||0
7957670|NCT00404352|19588044|P3|COMPLETED|Open Label Extension (up to 36 Months)||0
7957671|NCT00404352|19588045|P2|COMPLETED|Open Label Extension (up to 36 Months)||0
7957672|NCT00404352|19588046|P1|COMPLETED|Open Label Extension (up to 36 Months)||0
7957673|NCT00404352|19588038|P9|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11
7957674|NCT00404352|19588039|P8|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5
7957675|NCT00404352|19588040|P7|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4
7957676|NCT00404352|19588041|P6|STARTED|Open Label Extension (up to 36 Months)||0
7957677|NCT00404352|19588042|P5|STARTED|Open Label Extension (up to 36 Months)||0
7957678|NCT00404352|19588043|P4|STARTED|Open Label Extension (up to 36 Months)||0
7957679|NCT00404352|19588044|P3|STARTED|Open Label Extension (up to 36 Months)||0
7957680|NCT00404352|19588045|P2|STARTED|Open Label Extension (up to 36 Months)||0
7957681|NCT00404352|19588046|P1|STARTED|Open Label Extension (up to 36 Months)||0
7957682|NCT00404352|19588038|P9|NOT COMPLETED|Open Label (up to 24 Month)||0
7957683|NCT00404352|19588039|P8|NOT COMPLETED|Open Label (up to 24 Month)||0
7957684|NCT00404352|19588040|P7|NOT COMPLETED|Open Label (up to 24 Month)||0
7957685|NCT00404352|19588041|P6|NOT COMPLETED|Open Label (up to 24 Month)||7
7957686|NCT00404352|19588042|P5|NOT COMPLETED|Open Label (up to 24 Month)||2
7957687|NCT00404352|19588043|P4|NOT COMPLETED|Open Label (up to 24 Month)||3
7957688|NCT00404352|19588044|P3|NOT COMPLETED|Open Label (up to 24 Month)||0
7957689|NCT00404352|19588045|P2|NOT COMPLETED|Open Label (up to 24 Month)||0
7957690|NCT00404352|19588046|P1|NOT COMPLETED|Open Label (up to 24 Month)||0
7957691|NCT00404352|19588038|P9|COMPLETED|Open Label (up to 24 Month)||0
7957692|NCT00404352|19588039|P8|COMPLETED|Open Label (up to 24 Month)||0
7957693|NCT00404352|19588040|P7|COMPLETED|Open Label (up to 24 Month)||0
7957694|NCT00404352|19588041|P6|COMPLETED|Open Label (up to 24 Month)||52
7957695|NCT00404352|19588042|P5|COMPLETED|Open Label (up to 24 Month)||28
7957696|NCT00404352|19588043|P4|COMPLETED|Open Label (up to 24 Month)||28
7957697|NCT00404352|19588044|P3|COMPLETED|Open Label (up to 24 Month)||0
7957698|NCT00404352|19588045|P2|COMPLETED|Open Label (up to 24 Month)||0
7957699|NCT00404352|19588046|P1|COMPLETED|Open Label (up to 24 Month)||0
7957700|NCT00404352|19588038|P9|STARTED|Open Label (up to 24 Month)||0
7957701|NCT00404352|19588039|P8|STARTED|Open Label (up to 24 Month)||0
7957702|NCT00404352|19588040|P7|STARTED|Open Label (up to 24 Month)||0
7957703|NCT00404352|19588041|P6|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59
7957704|NCT00404352|19588042|P5|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30
7957705|NCT00404352|19588043|P4|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31
7957706|NCT00404352|19588044|P3|STARTED|Open Label (up to 24 Month)||0
7957707|NCT00404352|19588045|P2|STARTED|Open Label (up to 24 Month)||0
7957708|NCT00404352|19588046|P1|STARTED|Open Label (up to 24 Month)||0
7957709|NCT00404352|19588038|P9|NOT COMPLETED|Double Blind (up to 24 Month)||0
7957710|NCT00404352|19588039|P8|NOT COMPLETED|Double Blind (up to 24 Month)||0
7957711|NCT00404352|19588040|P7|NOT COMPLETED|Double Blind (up to 24 Month)||0
7957712|NCT00404352|19588041|P6|NOT COMPLETED|Double Blind (up to 24 Month)||0
7957713|NCT00404352|19588042|P5|NOT COMPLETED|Double Blind (up to 24 Month)||0
7957714|NCT00404352|19588043|P4|NOT COMPLETED|Double Blind (up to 24 Month)||0
7957715|NCT00404352|19588044|P3|NOT COMPLETED|Double Blind (up to 24 Month)||79
7957716|NCT00404352|19588045|P2|NOT COMPLETED|Double Blind (up to 24 Month)||47
7957717|NCT00404352|19588046|P1|NOT COMPLETED|Double Blind (up to 24 Month)||52
7957718|NCT00404352|19588038|P9|COMPLETED|Double Blind (up to 24 Month)||0
7957719|NCT00404352|19588039|P8|COMPLETED|Double Blind (up to 24 Month)||0
7957720|NCT00404352|19588040|P7|COMPLETED|Double Blind (up to 24 Month)||0
7957721|NCT00404352|19588041|P6|COMPLETED|Double Blind (up to 24 Month)||0
7957722|NCT00404352|19588042|P5|COMPLETED|Double Blind (up to 24 Month)||0
7957723|NCT00404352|19588043|P4|COMPLETED|Double Blind (up to 24 Month)||0
7957724|NCT00404352|19588044|P3|COMPLETED|Double Blind (up to 24 Month)||92
7957725|NCT00404352|19588045|P2|COMPLETED|Double Blind (up to 24 Month)||128
7957726|NCT00404352|19588046|P1|COMPLETED|Double Blind (up to 24 Month)||119
7957727|NCT00404352|19588038|P9|Treated|Double Blind (up to 24 Month)||0
7957728|NCT00404352|19588039|P8|Treated|Double Blind (up to 24 Month)||0
7957729|NCT00404352|19588040|P7|Treated|Double Blind (up to 24 Month)||0
7957730|NCT00404352|19588041|P6|Treated|Double Blind (up to 24 Month)||0
7957731|NCT00404352|19588042|P5|Treated|Double Blind (up to 24 Month)||0
7957732|NCT00404352|19588043|P4|Treated|Double Blind (up to 24 Month)||0
7957733|NCT00404352|19588044|P3|Treated|Double Blind (up to 24 Month)||171
7957734|NCT00404352|19588045|P2|Treated|Double Blind (up to 24 Month)||173
7957735|NCT00404352|19588046|P1|Treated|Double Blind (up to 24 Month)||171
7957736|NCT00404352|19588038|P9|STARTED|Double Blind (up to 24 Month)||0
7957737|NCT00404352|19588039|P8|STARTED|Double Blind (up to 24 Month)||0
7957738|NCT00404352|19588040|P7|STARTED|Double Blind (up to 24 Month)||0
7957739|NCT00404352|19588041|P6|STARTED|Double Blind (up to 24 Month)||0
7957740|NCT00404352|19588042|P5|STARTED|Double Blind (up to 24 Month)||0
7957741|NCT00404352|19588043|P4|STARTED|Double Blind (up to 24 Month)||0
7957742|NCT00404352|19588044|P3|STARTED|Double Blind (up to 24 Month)||171
7957743|NCT00404352|19588045|P2|STARTED|Double Blind (up to 24 Month)||175
7957744|NCT00404352|19588046|P1|STARTED|Double Blind (up to 24 Month)||171
7957745|NCT00404248|19588081|P9|NOT COMPLETED|Overall Study||0
7957746|NCT00404248|19588082|P8|NOT COMPLETED|Overall Study||0
7957747|NCT00404248|19588083|P7|NOT COMPLETED|Overall Study||0
7957748|NCT00404248|19588084|P6|NOT COMPLETED|Overall Study||0
7957749|NCT00404248|19588085|P5|NOT COMPLETED|Overall Study||0
7957750|NCT00404248|19588086|P4|NOT COMPLETED|Overall Study||0
7957751|NCT00404248|19588087|P3|NOT COMPLETED|Overall Study||0
7957752|NCT00404248|19588088|P2|NOT COMPLETED|Overall Study||1
7957753|NCT00404248|19588089|P1|NOT COMPLETED|Overall Study||0
7957754|NCT00404248|19588081|P9|COMPLETED|Overall Study||3
7957755|NCT00404248|19588082|P8|COMPLETED|Overall Study||6
7957756|NCT00404248|19588083|P7|COMPLETED|Overall Study||6
7957757|NCT00404248|19588084|P6|COMPLETED|Overall Study||3
7957758|NCT00404248|19588085|P5|COMPLETED|Overall Study||3
7957759|NCT00404248|19588086|P4|COMPLETED|Overall Study||2
7957760|NCT00404248|19588087|P3|COMPLETED|Overall Study||5
7957761|NCT00404248|19588088|P2|COMPLETED|Overall Study||3
7957762|NCT00404248|19588089|P1|COMPLETED|Overall Study||3
7957763|NCT00404248|19588081|P9|STARTED|Overall Study||3
7957764|NCT00404248|19588082|P8|STARTED|Overall Study||6
7957765|NCT00404248|19588083|P7|STARTED|Overall Study||6
7957766|NCT00404248|19588084|P6|STARTED|Overall Study||3
7957767|NCT00404248|19588085|P5|STARTED|Overall Study||3
7957768|NCT00404248|19588086|P4|STARTED|Overall Study||2
7957769|NCT00404248|19588087|P3|STARTED|Overall Study||5
7957770|NCT00404248|19588088|P2|STARTED|Overall Study||4
7957771|NCT00404248|19588089|P1|STARTED|Overall Study||3
7957772|NCT00404235|19588122|P2|NOT COMPLETED|Overall Study||2
7957773|NCT00404235|19588123|P1|NOT COMPLETED|Overall Study||1
7957774|NCT00404235|19588122|P2|COMPLETED|Overall Study||39
7957775|NCT00404235|19588123|P1|COMPLETED|Overall Study||34
7957776|NCT00404235|19588122|P2|STARTED|Overall Study||41
7957777|NCT00404235|19588123|P1|STARTED|Overall Study||35
7957778|NCT00404092|19588141|P4|NOT COMPLETED|Overall Study||0
7957779|NCT00404092|19588142|P3|NOT COMPLETED|Overall Study||1
7957780|NCT00404092|19588143|P2|NOT COMPLETED|Overall Study||0
7957781|NCT00404092|19588144|P1|NOT COMPLETED|Overall Study||1
7957782|NCT00404092|19588141|P4|COMPLETED|Overall Study||20
7957783|NCT00404092|19588142|P3|COMPLETED|Overall Study||8
7957784|NCT00404092|19588143|P2|COMPLETED|Overall Study||8
7957785|NCT00404092|19588144|P1|COMPLETED|Overall Study||8
7957786|NCT00404092|19588141|P4|STARTED|Overall Study||20
7957787|NCT00404092|19588142|P3|STARTED|Overall Study||9
7957788|NCT00404092|19588143|P2|STARTED|Overall Study||8
7957789|NCT00404092|19588144|P1|STARTED|Overall Study||9
7957790|NCT00404079|19588160|P2|NOT COMPLETED|Overall Study||20
7957791|NCT00404079|19588161|P1|NOT COMPLETED|Overall Study||22
7957792|NCT00404079|19588160|P2|COMPLETED|Overall Study||105
7957793|NCT00404079|19588161|P1|COMPLETED|Overall Study||103
7957794|NCT00404079|19588160|P2|STARTED|Overall Study||125
7957795|NCT00404079|19588161|P1|STARTED|Overall Study||125
7957796|NCT00404066|19588167|P1|NOT COMPLETED|Overall Study||3
7957797|NCT00404066|19588167|P1|COMPLETED|Overall Study||18
7957798|NCT00404066|19588167|P1|STARTED|Overall Study|1 subject started but withdrew after adriamycin+cytoxan, but before study drugs lapatinib+docetaxel.|21
7957799|NCT00403845|19588172|P4|NOT COMPLETED|Treatment Period 4||0
7957800|NCT00403845|19588173|P3|NOT COMPLETED|Treatment Period 4||0
7957801|NCT00403845|19588174|P2|NOT COMPLETED|Treatment Period 4||0
7957802|NCT00403845|19588175|P1|NOT COMPLETED|Treatment Period 4||0
7957803|NCT00403845|19588172|P4|COMPLETED|Treatment Period 4||11
7957804|NCT00403845|19588173|P3|COMPLETED|Treatment Period 4||11
7957805|NCT00403845|19588174|P2|COMPLETED|Treatment Period 4||13
7957806|NCT00403845|19588175|P1|COMPLETED|Treatment Period 4||10
7957807|NCT00403845|19588172|P4|STARTED|Treatment Period 4||11
7957808|NCT00403845|19588173|P3|STARTED|Treatment Period 4||11
7957809|NCT00403845|19588174|P2|STARTED|Treatment Period 4||13
7957810|NCT00403845|19588175|P1|STARTED|Treatment Period 4||10
7957811|NCT00403845|19588172|P4|NOT COMPLETED|Treatment Period 3||2
7957812|NCT00403845|19588173|P3|NOT COMPLETED|Treatment Period 3||0
7957813|NCT00403845|19588174|P2|NOT COMPLETED|Treatment Period 3||0
7957814|NCT00403845|19588175|P1|NOT COMPLETED|Treatment Period 3||0
7957815|NCT00403845|19588172|P4|COMPLETED|Treatment Period 3||11
7957816|NCT00403845|19588173|P3|COMPLETED|Treatment Period 3||11
7957817|NCT00403845|19588174|P2|COMPLETED|Treatment Period 3||13
7957818|NCT00403845|19588175|P1|COMPLETED|Treatment Period 3||10
7957819|NCT00403845|19588172|P4|STARTED|Treatment Period 3||13
7957820|NCT00403845|19588173|P3|STARTED|Treatment Period 3||11
7957821|NCT00403845|19588174|P2|STARTED|Treatment Period 3||13
7957822|NCT00403845|19588175|P1|STARTED|Treatment Period 3||10
7957823|NCT00403845|19588172|P4|NOT COMPLETED|Treatment Period 2||0
7957824|NCT00403845|19588173|P3|NOT COMPLETED|Treatment Period 2||0
7957825|NCT00403845|19588174|P2|NOT COMPLETED|Treatment Period 2||0
7957826|NCT00403845|19588175|P1|NOT COMPLETED|Treatment Period 2||1
7957827|NCT00403845|19588172|P4|COMPLETED|Treatment Period 2||13
7957828|NCT00403845|19588173|P3|COMPLETED|Treatment Period 2||11
7957829|NCT00403845|19588174|P2|COMPLETED|Treatment Period 2||13
7957830|NCT00403845|19588175|P1|COMPLETED|Treatment Period 2||10
7957831|NCT00403845|19588172|P4|STARTED|Treatment Period 2||13
7957832|NCT00403845|19588173|P3|STARTED|Treatment Period 2||11
7957833|NCT00403845|19588174|P2|STARTED|Treatment Period 2||13
7957834|NCT00403845|19588175|P1|STARTED|Treatment Period 2||11
7957835|NCT00403845|19588172|P4|NOT COMPLETED|Treatment Period 1||1
7957836|NCT00403845|19588173|P3|NOT COMPLETED|Treatment Period 1||0
7957837|NCT00403845|19588174|P2|NOT COMPLETED|Treatment Period 1||0
7957838|NCT00403845|19588175|P1|NOT COMPLETED|Treatment Period 1||1
7957839|NCT00403845|19588172|P4|COMPLETED|Treatment Period 1||13
7957840|NCT00403845|19588173|P3|COMPLETED|Treatment Period 1||11
7957841|NCT00403845|19588174|P2|COMPLETED|Treatment Period 1||13
7957842|NCT00403845|19588175|P1|COMPLETED|Treatment Period 1||11
7957843|NCT00403845|19588172|P4|STARTED|Treatment Period 1||14
7957844|NCT00403845|19588173|P3|STARTED|Treatment Period 1||11
7957845|NCT00403845|19588174|P2|STARTED|Treatment Period 1||13
7957846|NCT00403845|19588175|P1|STARTED|Treatment Period 1||12
7957847|NCT00403767|19588199|P2|NOT COMPLETED|Overall Study||2468
7957848|NCT00403767|19588200|P1|NOT COMPLETED|Overall Study||2520
7957849|NCT00403767|19588199|P2|COMPLETED|Overall Study||4657
7957850|NCT00403767|19588200|P1|COMPLETED|Overall Study||4591
7957851|NCT00403767|19588199|P2|STARTED|Overall Study||7125
7957852|NCT00403767|19588200|P1|STARTED|Overall Study||7111
7957853|NCT00403754|19588224|P4|NOT COMPLETED|Open Label: Salmeterol||0
7957854|NCT00403754|19588225|P3|NOT COMPLETED|Open Label: Salmeterol||0
7957855|NCT00403754|19588226|P2|NOT COMPLETED|Open Label: Salmeterol||0
7957856|NCT00403754|19588227|P1|NOT COMPLETED|Open Label: Salmeterol||0
7957857|NCT00403754|19588224|P4|COMPLETED|Open Label: Salmeterol||11
7957858|NCT00403754|19588225|P3|COMPLETED|Open Label: Salmeterol||8
7957859|NCT00403754|19588226|P2|COMPLETED|Open Label: Salmeterol||9
7957860|NCT00403754|19588227|P1|COMPLETED|Open Label: Salmeterol||11
7957861|NCT00403754|19588224|P4|STARTED|Open Label: Salmeterol||11
7957862|NCT00403754|19588225|P3|STARTED|Open Label: Salmeterol||8
7957863|NCT00403754|19588226|P2|STARTED|Open Label: Salmeterol||9
7957864|NCT00403754|19588227|P1|STARTED|Open Label: Salmeterol||11
7957865|NCT00403754|19588224|P4|NOT COMPLETED|Core Treatment Period 4||0
7957866|NCT00403754|19588225|P3|NOT COMPLETED|Core Treatment Period 4||0
7957867|NCT00403754|19588226|P2|NOT COMPLETED|Core Treatment Period 4||0
7957868|NCT00403754|19588227|P1|NOT COMPLETED|Core Treatment Period 4||0
7957869|NCT00403754|19588224|P4|COMPLETED|Core Treatment Period 4||11
7957870|NCT00403754|19588225|P3|COMPLETED|Core Treatment Period 4||8
7957871|NCT00403754|19588226|P2|COMPLETED|Core Treatment Period 4||9
7957872|NCT00403754|19588227|P1|COMPLETED|Core Treatment Period 4||11
7957873|NCT00403754|19588224|P4|STARTED|Core Treatment Period 4||11
7957874|NCT00403754|19588225|P3|STARTED|Core Treatment Period 4||8
7957875|NCT00403754|19588226|P2|STARTED|Core Treatment Period 4||9
7957876|NCT00403754|19588227|P1|STARTED|Core Treatment Period 4||11
7957877|NCT00403754|19588224|P4|NOT COMPLETED|Core Treatment Period 3||0
7957878|NCT00403754|19588225|P3|NOT COMPLETED|Core Treatment Period 3||0
7957879|NCT00403754|19588226|P2|NOT COMPLETED|Core Treatment Period 3||0
7957880|NCT00403754|19588227|P1|NOT COMPLETED|Core Treatment Period 3||0
7957881|NCT00403754|19588224|P4|COMPLETED|Core Treatment Period 3||11
7957882|NCT00403754|19588225|P3|COMPLETED|Core Treatment Period 3||8
7957883|NCT00403754|19588226|P2|COMPLETED|Core Treatment Period 3||9
7957884|NCT00403754|19588227|P1|COMPLETED|Core Treatment Period 3||11
7957885|NCT00403754|19588224|P4|STARTED|Core Treatment Period 3||11
7957886|NCT00403754|19588225|P3|STARTED|Core Treatment Period 3||8
7957887|NCT00403754|19588226|P2|STARTED|Core Treatment Period 3||9
7957888|NCT00403754|19588227|P1|STARTED|Core Treatment Period 3||11
7957889|NCT00403754|19588224|P4|NOT COMPLETED|Core Treatment Period 2||0
7957890|NCT00403754|19588225|P3|NOT COMPLETED|Core Treatment Period 2||1
7957891|NCT00403754|19588226|P2|NOT COMPLETED|Core Treatment Period 2||0
7957892|NCT00403754|19588227|P1|NOT COMPLETED|Core Treatment Period 2||0
7957893|NCT00403754|19588224|P4|COMPLETED|Core Treatment Period 2||11
7957894|NCT00403754|19588225|P3|COMPLETED|Core Treatment Period 2||8
7957895|NCT00403754|19588226|P2|COMPLETED|Core Treatment Period 2||9
7957896|NCT00403754|19588227|P1|COMPLETED|Core Treatment Period 2||11
7957897|NCT00403754|19588224|P4|STARTED|Core Treatment Period 2||11
7957898|NCT00403754|19588225|P3|STARTED|Core Treatment Period 2||9
7957899|NCT00403754|19588226|P2|STARTED|Core Treatment Period 2||9
7957900|NCT00403754|19588227|P1|STARTED|Core Treatment Period 2||11
7957901|NCT00403754|19588224|P4|NOT COMPLETED|Core Treatment Period 1||0
7957902|NCT00403754|19588225|P3|NOT COMPLETED|Core Treatment Period 1||0
7957903|NCT00403754|19588226|P2|NOT COMPLETED|Core Treatment Period 1||1
7957904|NCT00403754|19588227|P1|NOT COMPLETED|Core Treatment Period 1||0
7957905|NCT00403754|19588224|P4|COMPLETED|Core Treatment Period 1||11
7957906|NCT00403754|19588225|P3|COMPLETED|Core Treatment Period 1||9
7957907|NCT00403754|19588226|P2|COMPLETED|Core Treatment Period 1||9
7957908|NCT00403754|19588227|P1|COMPLETED|Core Treatment Period 1||11
7957909|NCT00403754|19588224|P4|STARTED|Core Treatment Period 1||11
7957910|NCT00403754|19588225|P3|STARTED|Core Treatment Period 1||9
7957911|NCT00403754|19588226|P2|STARTED|Core Treatment Period 1||10
7957912|NCT00403754|19588227|P1|STARTED|Core Treatment Period 1||11
7957913|NCT00403585|19588254|P1|NOT COMPLETED|Open-Label Phase; Extension Study||6
7957914|NCT00403585|19588254|P1|COMPLETED|Open-Label Phase; Extension Study||74
7957915|NCT00403585|19588254|P1|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80
7957916|NCT00403585|19588254|P1|NOT COMPLETED|Initial Treatment Phase||2
7957917|NCT00403585|19588254|P1|COMPLETED|Initial Treatment Phase||102
7957918|NCT00403585|19588254|P1|STARTED|Initial Treatment Phase||104
7957919|NCT00403546|19588265|P3|NOT COMPLETED|Randomized Trial||16
7957920|NCT00403546|19588266|P2|NOT COMPLETED|Randomized Trial||17
7957921|NCT00403546|19588267|P1|NOT COMPLETED|Randomized Trial||0
7957922|NCT00403546|19588265|P3|COMPLETED|Randomized Trial||21
7957923|NCT00403546|19588266|P2|COMPLETED|Randomized Trial||21
7957924|NCT00403546|19588267|P1|COMPLETED|Randomized Trial||0
7957925|NCT00403546|19588265|P3|STARTED|Randomized Trial||37
7957926|NCT00403546|19588266|P2|STARTED|Randomized Trial||38
7957927|NCT00403546|19588267|P1|STARTED|Randomized Trial|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|0
7957928|NCT00403546|19588265|P3|NOT COMPLETED|Screening Phase||0
7957929|NCT00403546|19588266|P2|NOT COMPLETED|Screening Phase||0
7957930|NCT00403546|19588267|P1|NOT COMPLETED|Screening Phase||28
7957931|NCT00403546|19588265|P3|COMPLETED|Screening Phase||0
7957932|NCT00403546|19588266|P2|COMPLETED|Screening Phase||0
7957933|NCT00403546|19588267|P1|COMPLETED|Screening Phase|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|75
7957934|NCT00403546|19588265|P3|STARTED|Screening Phase||0
7957935|NCT00403546|19588266|P2|STARTED|Screening Phase||0
7957936|NCT00403546|19588267|P1|STARTED|Screening Phase||103
7957937|NCT00403546|19588265|P3|NOT COMPLETED|Signed Informed Consent/Open-Label||0
7957938|NCT00403546|19588266|P2|NOT COMPLETED|Signed Informed Consent/Open-Label||0
7957939|NCT00403546|19588267|P1|NOT COMPLETED|Signed Informed Consent/Open-Label||28
7957940|NCT00403546|19588265|P3|COMPLETED|Signed Informed Consent/Open-Label||0
7957941|NCT00403546|19588266|P2|COMPLETED|Signed Informed Consent/Open-Label||0
7957942|NCT00403546|19588267|P1|COMPLETED|Signed Informed Consent/Open-Label||103
7957943|NCT00403546|19588265|P3|STARTED|Signed Informed Consent/Open-Label||0
7957944|NCT00403546|19588266|P2|STARTED|Signed Informed Consent/Open-Label||0
7957945|NCT00403546|19588267|P1|STARTED|Signed Informed Consent/Open-Label||131
7957946|NCT00403481|19588307|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2
7957947|NCT00403481|19588307|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142
7957948|NCT00403481|19588307|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144
7957949|NCT00403481|19588307|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5
7957950|NCT00403481|19588307|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168
7957951|NCT00403481|19588307|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173
7957952|NCT00403481|19588307|P1|NOT COMPLETED|Olm 40 mg||5
7957953|NCT00403481|19588307|P1|COMPLETED|Olm 40 mg||177
7957954|NCT00403481|19588307|P1|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182
7957955|NCT00403481|19588307|P1|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6
7957956|NCT00403481|19588307|P1|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186
7957957|NCT00403481|19588307|P1|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192
7957958|NCT00403455|19588322|P1|NOT COMPLETED|Overall Study||1
7957959|NCT00403455|19588322|P1|COMPLETED|Overall Study||37
7957960|NCT00403455|19588322|P1|STARTED|Overall Study||38
7957961|NCT00403403|19588328|P2|NOT COMPLETED|Overall Study||0
7957962|NCT00403403|19588329|P1|NOT COMPLETED|Overall Study||0
7957963|NCT00403403|19588328|P2|COMPLETED|Overall Study||52
7957964|NCT00403403|19588329|P1|COMPLETED|Overall Study||50
7957965|NCT00403403|19588328|P2|Safety-Evaluable Patients|Overall Study||51
7957966|NCT00403403|19588329|P1|Safety-Evaluable Patients|Overall Study||47
7957967|NCT00403403|19588328|P2|STARTED|Overall Study||52
7957968|NCT00403403|19588329|P1|STARTED|Overall Study||50
7957969|NCT00403390|19588345|P2|NOT COMPLETED|Overall Study||0
7957970|NCT00403390|19588346|P1|NOT COMPLETED|Overall Study||3
7957971|NCT00403390|19588345|P2|COMPLETED|Overall Study||18
7957972|NCT00403390|19588346|P1|COMPLETED|Overall Study||13
7957973|NCT00403390|19588345|P2|STARTED|Overall Study||18
7957974|NCT00403390|19588346|P1|STARTED|Overall Study||16
7957975|NCT00403273|19588354|P2|NOT COMPLETED|Overall Study||4
7957976|NCT00403273|19588355|P1|NOT COMPLETED|Overall Study||3
7957977|NCT00403273|19588354|P2|COMPLETED|Overall Study||25
7957978|NCT00403273|19588355|P1|COMPLETED|Overall Study||22
7957979|NCT00403273|19588354|P2|STARTED|Overall Study||29
7957980|NCT00403273|19588355|P1|STARTED|Overall Study||25
7957981|NCT00403234|19588397|P4|NOT COMPLETED|Overall Study||0
7957982|NCT00403234|19588398|P3|NOT COMPLETED|Overall Study||1
7957983|NCT00403234|19588399|P2|NOT COMPLETED|Overall Study||1
7957984|NCT00403234|19588400|P1|NOT COMPLETED|Overall Study||1
7957985|NCT00403234|19588397|P4|COMPLETED|Overall Study||2
7957986|NCT00403234|19588398|P3|COMPLETED|Overall Study||2
7957987|NCT00403234|19588399|P2|COMPLETED|Overall Study||2
7957988|NCT00403234|19588400|P1|COMPLETED|Overall Study||1
7957989|NCT00403234|19588397|P4|STARTED|Overall Study||2
7957990|NCT00403234|19588398|P3|STARTED|Overall Study||3
7957991|NCT00403234|19588399|P2|STARTED|Overall Study||3
7957992|NCT00403234|19588400|P1|STARTED|Overall Study||2
7957993|NCT00403130|19588410|P1|NOT COMPLETED|Survival Follow-up up to 6 Years||10
7957994|NCT00403130|19588410|P1|COMPLETED|Survival Follow-up up to 6 Years||16
7957995|NCT00403130|19588410|P1|STARTED|Survival Follow-up up to 6 Years||26
7957996|NCT00403130|19588410|P1|NOT COMPLETED|2 Years From Start of Treatment||5
7957997|NCT00403130|19588410|P1|COMPLETED|2 Years From Start of Treatment||26
7957998|NCT00403130|19588410|P1|STARTED|2 Years From Start of Treatment||31
7957999|NCT00403117|19588417|P1|NOT COMPLETED|Overall Study||20
7958000|NCT00403117|19588417|P1|COMPLETED|Overall Study||29
7958001|NCT00403117|19588417|P1|STARTED|Overall Study||49
7958002|NCT00402987|19588463|P4|NOT COMPLETED|Overall Study||0
7958003|NCT00402987|19588464|P3|NOT COMPLETED|Overall Study||1
7958004|NCT00402987|19588465|P2|NOT COMPLETED|Overall Study||0
7958005|NCT00402987|19588466|P1|NOT COMPLETED|Overall Study||0
7958006|NCT00402987|19588463|P4|COMPLETED|Overall Study||89
7958007|NCT00402987|19588464|P3|COMPLETED|Overall Study||44
7958008|NCT00402987|19588465|P2|COMPLETED|Overall Study||45
7958009|NCT00402987|19588466|P1|COMPLETED|Overall Study||90
7958010|NCT00402987|19588463|P4|STARTED|Overall Study||89
7958011|NCT00402987|19588464|P3|STARTED|Overall Study||45
7958012|NCT00402987|19588465|P2|STARTED|Overall Study||45
7958013|NCT00402987|19588466|P1|STARTED|Overall Study||90
7958014|NCT00402896|19588628|P1|NOT COMPLETED|Overall Study||0
7958015|NCT00402896|19588628|P1|COMPLETED|Overall Study||20
7958016|NCT00402896|19588628|P1|STARTED|Overall Study||20
7958017|NCT00402883|19588632|P1|NOT COMPLETED|Maintenance Therapy||0
7958018|NCT00402883|19588632|P1|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5
7958019|NCT00402883|19588632|P1|STARTED|Maintenance Therapy||5
7958020|NCT00402883|19588632|P1|NOT COMPLETED|Consolidation Therapy||0
7958021|NCT00402883|19588632|P1|COMPLETED|Consolidation Therapy||5
7958022|NCT00402883|19588632|P1|STARTED|Consolidation Therapy||5
7958023|NCT00402883|19588632|P1|NOT COMPLETED|Induction Therapy||0
7958024|NCT00402883|19588632|P1|COMPLETED|Induction Therapy||5
7958025|NCT00402883|19588632|P1|STARTED|Induction Therapy||5
7958026|NCT00402831|19588638|P2|NOT COMPLETED|Overall Study||3
7958027|NCT00402831|19588639|P1|NOT COMPLETED|Overall Study||1
7958028|NCT00402831|19588638|P2|COMPLETED|Overall Study||200
7958029|NCT00402831|19588639|P1|COMPLETED|Overall Study||201
7958030|NCT00402831|19588638|P2|ProQuad® Dose 1 (Day 30)|Overall Study||203
7958031|NCT00402831|19588639|P1|ProQuad® Dose 1 (Day 30)|Overall Study||202
7958032|NCT00402831|19588638|P2|ProQuad® Dose 1 (Day 1)|Overall Study||203
7958033|NCT00402831|19588639|P1|ProQuad® Dose 1 (Day 1)|Overall Study||202
7958034|NCT00402831|19588638|P2|STARTED|Overall Study||203
7958035|NCT00402831|19588639|P1|STARTED|Overall Study||202
7958036|NCT00402779|19588673|P2|NOT COMPLETED|Overall Study||76
7958037|NCT00402779|19588674|P1|NOT COMPLETED|Overall Study||77
7958038|NCT00402779|19588673|P2|COMPLETED|Overall Study||75
7958039|NCT00402779|19588674|P1|COMPLETED|Overall Study||75
7958040|NCT00402779|19588673|P2|STARTED|Overall Study||151
7958041|NCT00402779|19588674|P1|STARTED|Overall Study||152
7958042|NCT00402740|19588680|P1|NOT COMPLETED|Overall Study||80
7958043|NCT00402740|19588680|P1|COMPLETED|Overall Study||242
7958044|NCT00402740|19588680|P1|STARTED|Overall Study||322
7958045|NCT00402727|19588692|P2|NOT COMPLETED|Overall Study||34
7958046|NCT00402727|19588693|P1|NOT COMPLETED|Overall Study||42
7958047|NCT00402727|19588692|P2|COMPLETED|Overall Study||347
7958048|NCT00402727|19588693|P1|COMPLETED|Overall Study||390
7958049|NCT00402727|19588692|P2|Achieving Test Of Cure (TOC)|Overall Study||347
7958050|NCT00402727|19588693|P1|Achieving Test Of Cure (TOC)|Overall Study||390
7958051|NCT00402727|19588692|P2|Achieving End Of Treatment (EOT)|Overall Study||355
7958052|NCT00402727|19588693|P1|Achieving End Of Treatment (EOT)|Overall Study||408
7958053|NCT00402727|19588692|P2|STARTED|Overall Study||381
7958054|NCT00402727|19588693|P1|STARTED|Overall Study||432
7958055|NCT00402714|19588723|P2|NOT COMPLETED|Overall Study||0
7958056|NCT00402714|19588724|P1|NOT COMPLETED|Overall Study||0
7958057|NCT00402714|19588723|P2|COMPLETED|Overall Study||11
7958058|NCT00402714|19588724|P1|COMPLETED|Overall Study||3
7958059|NCT00402714|19588723|P2|STARTED|Overall Study||11
7958060|NCT00402714|19588724|P1|STARTED|Overall Study||3
7958061|NCT00402688|19588735|P3|NOT COMPLETED|Overall Study||15
7958062|NCT00402688|19588736|P2|NOT COMPLETED|Overall Study||16
7958063|NCT00402688|19588737|P1|NOT COMPLETED|Overall Study||21
7958064|NCT00402688|19588735|P3|COMPLETED|Overall Study||65
7958065|NCT00402688|19588736|P2|COMPLETED|Overall Study||65
7958066|NCT00402688|19588737|P1|COMPLETED|Overall Study||60
7958067|NCT00402688|19588735|P3|STARTED|Overall Study||80
7958068|NCT00402688|19588736|P2|STARTED|Overall Study||81
7958069|NCT00402688|19588737|P1|STARTED|Overall Study||81
7958070|NCT00402649|19588760|P1|NOT COMPLETED|Overall Study||2
7958071|NCT00402649|19588760|P1|COMPLETED|Overall Study||33
7958072|NCT00402649|19588760|P1|STARTED|Overall Study||35
7958073|NCT00402597|19588775|P5|NOT COMPLETED|Overall Study||124
7958074|NCT00402597|19588776|P4|NOT COMPLETED|Overall Study||74
7958075|NCT00402597|19588777|P3|NOT COMPLETED|Overall Study||212
7958076|NCT00402597|19588778|P2|NOT COMPLETED|Overall Study||46
7958077|NCT00402597|19588779|P1|NOT COMPLETED|Overall Study||191
7958078|NCT00402597|19588775|P5|COMPLETED|Overall Study||479
7958079|NCT00402597|19588776|P4|COMPLETED|Overall Study||279
7958080|NCT00402597|19588777|P3|COMPLETED|Overall Study||834
7958081|NCT00402597|19588778|P2|COMPLETED|Overall Study||261
7958082|NCT00402597|19588779|P1|COMPLETED|Overall Study||962
7958083|NCT00402597|19588775|P5|STARTED|Overall Study||603
7958084|NCT00402597|19588776|P4|STARTED|Overall Study||353
7958085|NCT00402597|19588777|P3|STARTED|Overall Study||1046
7958086|NCT00402597|19588778|P2|STARTED|Overall Study||307
7958087|NCT00402597|19588779|P1|STARTED|Overall Study||1153
7958088|NCT00402363|19588820|P4|NOT COMPLETED|Overall Study||10
7958089|NCT00402363|19588821|P3|NOT COMPLETED|Overall Study||6
7958090|NCT00402363|19588822|P2|NOT COMPLETED|Overall Study||30
7958091|NCT00402363|19588823|P1|NOT COMPLETED|Overall Study||33
7958092|NCT00402363|19588820|P4|COMPLETED|Overall Study||45
7958093|NCT00402363|19588821|P3|COMPLETED|Overall Study||60
7958094|NCT00402363|19588822|P2|COMPLETED|Overall Study||246
7958095|NCT00402363|19588823|P1|COMPLETED|Overall Study||233
7958096|NCT00402363|19588820|P4|STARTED|Overall Study||55
7958097|NCT00402363|19588821|P3|STARTED|Overall Study||66
7958098|NCT00402363|19588822|P2|STARTED|Overall Study||276
7958099|NCT00402363|19588823|P1|STARTED|Overall Study||266
7958100|NCT00402337|19588886|P5|NOT COMPLETED|Overall Study||8
7958101|NCT00402337|19588887|P4|NOT COMPLETED|Overall Study||12
7958102|NCT00402337|19588888|P3|NOT COMPLETED|Overall Study||4
7958103|NCT00402337|19588889|P2|NOT COMPLETED|Overall Study||6
7958104|NCT00402337|19588890|P1|NOT COMPLETED|Overall Study||5
7958105|NCT00402337|19588886|P5|COMPLETED|Overall Study||61
7958106|NCT00402337|19588887|P4|COMPLETED|Overall Study||51
7958107|NCT00402337|19588888|P3|COMPLETED|Overall Study||58
7958108|NCT00402337|19588889|P2|COMPLETED|Overall Study||51
7958109|NCT00402337|19588890|P1|COMPLETED|Overall Study||54
7958110|NCT00402337|19588886|P5|STARTED|Overall Study||69
7958111|NCT00402337|19588887|P4|STARTED|Overall Study||63
7958112|NCT00402337|19588888|P3|STARTED|Overall Study||62
7958113|NCT00402337|19588889|P2|STARTED|Overall Study||57
7958114|NCT00402337|19588890|P1|STARTED|Overall Study||59
7958115|NCT00402324|19588929|P2|NOT COMPLETED|Overall Study||41
7958116|NCT00402324|19588930|P1|NOT COMPLETED|Overall Study||43
7958117|NCT00402324|19588929|P2|COMPLETED|Overall Study||60
7958118|NCT00402324|19588930|P1|COMPLETED|Overall Study||58
7958119|NCT00402324|19588929|P2|STARTED|Overall Study||101
7958120|NCT00402324|19588930|P1|STARTED|Overall Study||101
7958121|NCT00402285|19588963|P3|NOT COMPLETED|Overall Study||2
7958122|NCT00402285|19588964|P2|NOT COMPLETED|Overall Study||6
7958123|NCT00402285|19588965|P1|NOT COMPLETED|Overall Study||7
7958124|NCT00402285|19588963|P3|COMPLETED|Overall Study||26
7958125|NCT00402285|19588964|P2|COMPLETED|Overall Study||21
7958126|NCT00402285|19588965|P1|COMPLETED|Overall Study||22
7958127|NCT00402285|19588963|P3|STARTED|Overall Study||28
7958128|NCT00402285|19588964|P2|STARTED|Overall Study||27
7958129|NCT00402285|19588965|P1|STARTED|Overall Study||29
7958130|NCT00402246|19588973|P2|NOT COMPLETED|Overall Study||234
7958131|NCT00402246|19588974|P1|NOT COMPLETED|Overall Study||220
7958132|NCT00402246|19588973|P2|COMPLETED|Overall Study||749
7958133|NCT00402246|19588974|P1|COMPLETED|Overall Study||794
7958134|NCT00402246|19588973|P2|STARTED|Overall Study||983
7958135|NCT00402246|19588974|P1|STARTED|Overall Study||1014
7958136|NCT00402233|19589008|P4|NOT COMPLETED|Overall Study||11
7958137|NCT00402233|19589009|P3|NOT COMPLETED|Overall Study||11
7958138|NCT00402233|19589010|P2|NOT COMPLETED|Overall Study||10
7958139|NCT00402233|19589011|P1|NOT COMPLETED|Overall Study||5
7958140|NCT00402233|19589008|P4|COMPLETED|Overall Study||62
7958141|NCT00402233|19589009|P3|COMPLETED|Overall Study||70
7958142|NCT00402233|19589010|P2|COMPLETED|Overall Study||70
7958143|NCT00402233|19589011|P1|COMPLETED|Overall Study||72
7958144|NCT00402233|19589008|P4|STARTED|Overall Study||73
7958145|NCT00402233|19589009|P3|STARTED|Overall Study||81
7958146|NCT00402233|19589010|P2|STARTED|Overall Study||80
7958147|NCT00402233|19589011|P1|STARTED|Overall Study||77
7958148|NCT00402194|19589035|P2|NOT COMPLETED|Overall Study||0
7958149|NCT00402194|19589036|P1|NOT COMPLETED|Overall Study||0
7958150|NCT00402194|19589035|P2|COMPLETED|Overall Study||8
7958151|NCT00402194|19589036|P1|COMPLETED|Overall Study||9
7958152|NCT00402194|19589035|P2|STARTED|Overall Study||8
7958153|NCT00402194|19589036|P1|STARTED|Overall Study||9
7958154|NCT00402168|19589046|P2|NOT COMPLETED|Switched From CNI to Belatacept in LT||0
7958155|NCT00402168|19589047|P1|NOT COMPLETED|Switched From CNI to Belatacept in LT||6
7958156|NCT00402168|19589046|P2|COMPLETED|Switched From CNI to Belatacept in LT||0
7958157|NCT00402168|19589047|P1|COMPLETED|Switched From CNI to Belatacept in LT||32
7958158|NCT00402168|19589046|P2|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0
7958159|NCT00402168|19589047|P1|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38
7958160|NCT00402168|19589046|P2|NOT COMPLETED|Long Term (LT)||17
7958161|NCT00402168|19589047|P1|NOT COMPLETED|Long Term (LT)||11
7958162|NCT00402168|19589046|P2|COMPLETED|Long Term (LT)||64
7958163|NCT00402168|19589047|P1|COMPLETED|Long Term (LT)||70
7958164|NCT00402168|19589046|P2|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81
7958165|NCT00402168|19589047|P1|STARTED|Long Term (LT)||81
7958166|NCT00402168|19589046|P2|NOT COMPLETED|Treatment (up to 12 Months)||2
7958167|NCT00402168|19589047|P1|NOT COMPLETED|Treatment (up to 12 Months)||2
7958168|NCT00402168|19589046|P2|COMPLETED|Treatment (up to 12 Months)||86
7958169|NCT00402168|19589047|P1|COMPLETED|Treatment (up to 12 Months)||81
7958170|NCT00402168|19589046|P2|STARTED|Treatment (up to 12 Months)||88
7958171|NCT00402168|19589047|P1|STARTED|Treatment (up to 12 Months)||83
7958172|NCT00402168|19589046|P2|NOT COMPLETED|Randomized||1
7958173|NCT00402168|19589047|P1|NOT COMPLETED|Randomized||1
7958174|NCT00402168|19589046|P2|COMPLETED|Randomized||88
7958175|NCT00402168|19589047|P1|COMPLETED|Randomized||83
7958176|NCT00402168|19589046|P2|STARTED|Randomized||89
7958177|NCT00402168|19589047|P1|STARTED|Randomized||84
7958178|NCT00402116|19589105|P3|NOT COMPLETED|Overall Study||55
7958179|NCT00402116|19589106|P2|NOT COMPLETED|Overall Study||6
7958180|NCT00402116|19589107|P1|NOT COMPLETED|Overall Study||3
7958181|NCT00402116|19589105|P3|COMPLETED|Overall Study||5
7958182|NCT00402116|19589106|P2|COMPLETED|Overall Study||0
7958183|NCT00402116|19589107|P1|COMPLETED|Overall Study||3
7958184|NCT00402116|19589105|P3|STARTED|Overall Study||60
7958185|NCT00402116|19589106|P2|STARTED|Overall Study||6
7958186|NCT00402116|19589107|P1|STARTED|Overall Study||6
7958187|NCT00402103|19589137|P2|NOT COMPLETED|Overall Study||13
7958188|NCT00402103|19589138|P1|NOT COMPLETED|Overall Study||91
7958189|NCT00402103|19589137|P2|COMPLETED|Overall Study||73
7958190|NCT00402103|19589138|P1|COMPLETED|Overall Study||379
7958191|NCT00402103|19589137|P2|STARTED|Overall Study||86
7958192|NCT00402103|19589138|P1|STARTED|Overall Study||470
7958193|NCT00402051|19589154|P2|NOT COMPLETED|Overall Study||35
7958194|NCT00402051|19589155|P1|NOT COMPLETED|Overall Study||38
7958195|NCT00402051|19589154|P2|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32
7958196|NCT00402051|19589155|P1|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28
7958197|NCT00402051|19589154|P2|Received Treatment|Overall Study||65
7958198|NCT00402051|19589155|P1|Received Treatment|Overall Study||65
7958199|NCT00402051|19589154|P2|STARTED|Overall Study||67
7958200|NCT00402051|19589155|P1|STARTED|Overall Study||66
7958201|NCT00402025|19589172|P3|NOT COMPLETED|Overall Study||10
7958202|NCT00402025|19589173|P2|NOT COMPLETED|Overall Study||3
7958203|NCT00402025|19589174|P1|NOT COMPLETED|Overall Study||2
7958204|NCT00402025|19589172|P3|COMPLETED|Overall Study||0
7958205|NCT00402025|19589173|P2|COMPLETED|Overall Study||1
7958206|NCT00402025|19589174|P1|COMPLETED|Overall Study||1
7958207|NCT00402025|19589172|P3|STARTED|Overall Study||10
7958208|NCT00402025|19589173|P2|STARTED|Overall Study||4
7958209|NCT00402025|19589174|P1|STARTED|Overall Study||3
7958210|NCT00401973|19589200|P3|NOT COMPLETED|Overall Study||23
7958211|NCT00401973|19589201|P2|NOT COMPLETED|Overall Study||26
7958212|NCT00401973|19589202|P1|NOT COMPLETED|Overall Study||11
7958213|NCT00401973|19589200|P3|COMPLETED|Overall Study||50
7958214|NCT00401973|19589201|P2|COMPLETED|Overall Study||50
7958215|NCT00401973|19589202|P1|COMPLETED|Overall Study||39
7958216|NCT00401973|19589200|P3|STARTED|Overall Study||73
7958217|NCT00401973|19589201|P2|STARTED|Overall Study||76
7958218|NCT00401973|19589202|P1|STARTED|Overall Study||50
7958219|NCT00401960|19589241|P2|NOT COMPLETED|Overall Study||0
7958220|NCT00401960|19589242|P1|NOT COMPLETED|Overall Study||5
7958221|NCT00401960|19589241|P2|COMPLETED|Overall Study||1
7958222|NCT00401960|19589242|P1|COMPLETED|Overall Study||0
7958223|NCT00401960|19589241|P2|STARTED|Overall Study||1
7958224|NCT00401960|19589242|P1|STARTED|Overall Study||5
7958225|NCT00401882|19589252|P2|NOT COMPLETED|Overall Study||0
7958226|NCT00401882|19589253|P1|NOT COMPLETED|Overall Study||0
7958227|NCT00401882|19589252|P2|COMPLETED|Overall Study||5
7958228|NCT00401882|19589253|P1|COMPLETED|Overall Study||2
7958229|NCT00401882|19589252|P2|STARTED|Overall Study||5
7958230|NCT00401882|19589253|P1|STARTED|Overall Study||2
7958231|NCT00401843|19589272|P3|NOT COMPLETED|Overall Study||142
7958232|NCT00401843|19589273|P2|NOT COMPLETED|Overall Study||144
7958233|NCT00401843|19589274|P1|NOT COMPLETED|Overall Study||21
7958234|NCT00401843|19589272|P3|COMPLETED|Overall Study||0
7958235|NCT00401843|19589273|P2|COMPLETED|Overall Study||0
7958236|NCT00401843|19589274|P1|COMPLETED|Overall Study||0
7958237|NCT00401843|19589272|P3|Treated|Overall Study||139
7958238|NCT00401843|19589273|P2|Treated|Overall Study||142
7958239|NCT00401843|19589274|P1|Treated|Overall Study||21
7958240|NCT00401843|19589272|P3|STARTED|Overall Study||142
7958241|NCT00401843|19589273|P2|STARTED|Overall Study||144
7958242|NCT00401843|19589274|P1|STARTED|Overall Study||21
7958243|NCT00401830|19589292|P2|NOT COMPLETED|Overall Study||32
7958244|NCT00401830|19589293|P1|NOT COMPLETED|Overall Study||31
7958245|NCT00401830|19589292|P2|COMPLETED|Overall Study||46
7958246|NCT00401830|19589293|P1|COMPLETED|Overall Study||50
7958247|NCT00401830|19589292|P2|STARTED|Overall Study||78
7958248|NCT00401830|19589293|P1|STARTED|Overall Study||81
7958249|NCT00401817|19589325|P1|NOT COMPLETED|Overall Study||0
7958250|NCT00401817|19589325|P1|COMPLETED|Overall Study||11
7958251|NCT00401817|19589325|P1|STARTED|Overall Study||11
7958252|NCT00401778|19589335|P3|NOT COMPLETED|Overall Study||1
7958253|NCT00401778|19589336|P2|NOT COMPLETED|Overall Study||1
7958254|NCT00401778|19589337|P1|NOT COMPLETED|Overall Study||1
7958255|NCT00401778|19589335|P3|COMPLETED|Overall Study||10
7958256|NCT00401778|19589336|P2|COMPLETED|Overall Study||11
7958257|NCT00401778|19589337|P1|COMPLETED|Overall Study||9
7958258|NCT00401778|19589335|P3|STARTED|Overall Study||11
7958259|NCT00401778|19589336|P2|STARTED|Overall Study||12
7958260|NCT00401778|19589337|P1|STARTED|Overall Study||10
7958261|NCT00401752|19589351|P2|NOT COMPLETED|Overall Study||18
7958262|NCT00401752|19589352|P1|NOT COMPLETED|Overall Study||10
7958263|NCT00401752|19589351|P2|COMPLETED|Overall Study||94
7958264|NCT00401752|19589352|P1|COMPLETED|Overall Study||97
7958265|NCT00401752|19589351|P2|Patients Included in Per-Protocol Popula|Overall Study||99
7958266|NCT00401752|19589352|P1|Patients Included in Per-Protocol Popula|Overall Study||100
7958267|NCT00401752|19589351|P2|Patients Included in Safety Population|Overall Study||110
7958268|NCT00401752|19589352|P1|Patients Included in Safety Population|Overall Study||107
7958269|NCT00401752|19589351|P2|Patients Included in ITT Population|Overall Study||111
7958270|NCT00401752|19589352|P1|Patients Included in ITT Population|Overall Study||106
7958271|NCT00401752|19589351|P2|Number of Patients Received Treatment|Overall Study||111
7958272|NCT00401752|19589352|P1|Number of Patients Received Treatment|Overall Study||107
7958273|NCT00401752|19589351|P2|STARTED|Overall Study||112
7958274|NCT00401752|19589352|P1|STARTED|Overall Study||107
7958275|NCT00401726|19589370|P2|NOT COMPLETED|Overall Study||112
7958276|NCT00401726|19589371|P1|NOT COMPLETED|Overall Study||97
7958277|NCT00401726|19589370|P2|COMPLETED|Overall Study||156
7958278|NCT00401726|19589371|P1|COMPLETED|Overall Study||172
7958279|NCT00401726|19589370|P2|STARTED|Overall Study||268
7958280|NCT00401726|19589371|P1|STARTED|Overall Study||269
7958281|NCT00401622|19589393|P2|NOT COMPLETED|Overall Study||43
7958282|NCT00401622|19589394|P1|NOT COMPLETED|Overall Study||34
7958283|NCT00401622|19589393|P2|COMPLETED|Overall Study||117
7958284|NCT00401622|19589394|P1|COMPLETED|Overall Study||126
7958285|NCT00401622|19589393|P2|STARTED|Overall Study||160
7958286|NCT00401622|19589394|P1|STARTED|Overall Study||160
7958287|NCT00401544|19589406|P4|NOT COMPLETED|Overall Study||16
7958288|NCT00401544|19589407|P3|NOT COMPLETED|Overall Study||12
7958289|NCT00401544|19589408|P2|NOT COMPLETED|Overall Study||18
7958290|NCT00401544|19589409|P1|NOT COMPLETED|Overall Study||18
7958291|NCT00401544|19589406|P4|COMPLETED|Overall Study||44
7958292|NCT00401544|19589407|P3|COMPLETED|Overall Study||48
7958293|NCT00401544|19589408|P2|COMPLETED|Overall Study||44
7958294|NCT00401544|19589409|P1|COMPLETED|Overall Study||38
7958295|NCT00401544|19589406|P4|STARTED|Overall Study|Randomized and treated|60
7958296|NCT00401544|19589407|P3|STARTED|Overall Study|Randomized and treated|60
7958297|NCT00401544|19589408|P2|STARTED|Overall Study|Randomized and treated|62
7958298|NCT00401544|19589409|P1|STARTED|Overall Study|Randomized and treated|56
7958299|NCT00401531|19589449|P2|NOT COMPLETED|Overall Study||10
7958300|NCT00401531|19589450|P1|NOT COMPLETED|Overall Study||9
7958301|NCT00401531|19589449|P2|COMPLETED|Overall Study||196
7958302|NCT00401531|19589450|P1|COMPLETED|Overall Study||197
7958303|NCT00401531|19589449|P2|STARTED|Overall Study||206
7958304|NCT00401531|19589450|P1|STARTED|Overall Study||206
7958305|NCT00401518|19589469|P3|NOT COMPLETED|Overall Study||23
7958306|NCT00401518|19589470|P2|NOT COMPLETED|Overall Study||37
7958307|NCT00401518|19589471|P1|NOT COMPLETED|Overall Study||6
7958308|NCT00401518|19589469|P3|COMPLETED|Overall Study||94
7958309|NCT00401518|19589470|P2|COMPLETED|Overall Study||190
7958310|NCT00401518|19589471|P1|COMPLETED|Overall Study||40
7958311|NCT00401518|19589469|P3|STARTED|Overall Study||117
7958312|NCT00401518|19589470|P2|STARTED|Overall Study||227
7958313|NCT00401518|19589471|P1|STARTED|Overall Study||46
7958314|NCT00401414|19589500|P3|NOT COMPLETED|Overall Study||0
7958315|NCT00401414|19589501|P2|NOT COMPLETED|Overall Study||0
7958316|NCT00401414|19589502|P1|NOT COMPLETED|Overall Study||0
7958317|NCT00401414|19589500|P3|COMPLETED|Overall Study||79
7958318|NCT00401414|19589501|P2|COMPLETED|Overall Study||147
7958319|NCT00401414|19589502|P1|COMPLETED|Overall Study||118
7958320|NCT00401414|19589500|P3|STARTED|Overall Study||79
7958321|NCT00401414|19589501|P2|STARTED|Overall Study||147
7958322|NCT00401414|19589502|P1|STARTED|Overall Study||118
7958323|NCT00401401|19589526|P4|NOT COMPLETED|Overall Study||3
7958324|NCT00401401|19589527|P3|NOT COMPLETED|Overall Study||1
7958325|NCT00401401|19589528|P2|NOT COMPLETED|Overall Study||0
7958326|NCT00401401|19589529|P1|NOT COMPLETED|Overall Study||0
7958327|NCT00401401|19589526|P4|COMPLETED|Overall Study||9
7958328|NCT00401401|19589527|P3|COMPLETED|Overall Study||5
7958329|NCT00401401|19589528|P2|COMPLETED|Overall Study||6
7958330|NCT00401401|19589529|P1|COMPLETED|Overall Study||6
7958331|NCT00401401|19589526|P4|STARTED|Overall Study||12
7958332|NCT00401401|19589527|P3|STARTED|Overall Study||6
7958333|NCT00401401|19589528|P2|STARTED|Overall Study||6
7958334|NCT00401401|19589529|P1|STARTED|Overall Study||6
7958335|NCT00401375|19589554|P3|NOT COMPLETED|Overall Study||25
7958336|NCT00401375|19589555|P2|NOT COMPLETED|Overall Study||25
7958337|NCT00401375|19589556|P1|NOT COMPLETED|Overall Study||22
7958338|NCT00401375|19589554|P3|COMPLETED|Overall Study||149
7958339|NCT00401375|19589555|P2|COMPLETED|Overall Study||151
7958340|NCT00401375|19589556|P1|COMPLETED|Overall Study||152
7958341|NCT00401375|19589554|P3|Received at Least 1 Dose of Study Drug|Overall Study||171
7958342|NCT00401375|19589555|P2|Received at Least 1 Dose of Study Drug|Overall Study||173
7958343|NCT00401375|19589556|P1|Received at Least 1 Dose of Study Drug|Overall Study||171
7958344|NCT00401375|19589554|P3|STARTED|Overall Study||174
7958345|NCT00401375|19589555|P2|STARTED|Overall Study||176
7958346|NCT00401375|19589556|P1|STARTED|Overall Study||174
7958347|NCT00401258|19589573|P1|NOT COMPLETED|Overall Study||7
7958348|NCT00401258|19589573|P1|COMPLETED|Overall Study||8
7958349|NCT00401258|19589573|P1|STARTED|Overall Study||15
7958350|NCT00401245|19589588|P8|NOT COMPLETED|Double Blind Tapering Phase||7
7958351|NCT00401245|19589589|P7|NOT COMPLETED|Double Blind Tapering Phase||7
7958352|NCT00401245|19589590|P6|NOT COMPLETED|Double Blind Tapering Phase||4
7958353|NCT00401245|19589591|P5|NOT COMPLETED|Double Blind Tapering Phase||4
7958354|NCT00401245|19589592|P4|NOT COMPLETED|Double Blind Tapering Phase||0
7958355|NCT00401245|19589593|P3|NOT COMPLETED|Double Blind Tapering Phase||0
7958356|NCT00401245|19589594|P2|NOT COMPLETED|Double Blind Tapering Phase||0
7958357|NCT00401245|19589595|P1|NOT COMPLETED|Double Blind Tapering Phase||0
7958358|NCT00401245|19589588|P8|COMPLETED|Double Blind Tapering Phase||95
7958359|NCT00401245|19589589|P7|COMPLETED|Double Blind Tapering Phase||80
7958360|NCT00401245|19589590|P6|COMPLETED|Double Blind Tapering Phase||90
7958361|NCT00401245|19589591|P5|COMPLETED|Double Blind Tapering Phase||97
7958362|NCT00401245|19589592|P4|COMPLETED|Double Blind Tapering Phase||0
7958363|NCT00401245|19589593|P3|COMPLETED|Double Blind Tapering Phase||0
7958364|NCT00401245|19589594|P2|COMPLETED|Double Blind Tapering Phase||0
7958365|NCT00401245|19589595|P1|COMPLETED|Double Blind Tapering Phase||0
7958366|NCT00401245|19589588|P8|STARTED|Double Blind Tapering Phase||102
7958367|NCT00401245|19589589|P7|STARTED|Double Blind Tapering Phase||87
7958368|NCT00401245|19589590|P6|STARTED|Double Blind Tapering Phase||94
7958369|NCT00401245|19589591|P5|STARTED|Double Blind Tapering Phase||101
7958370|NCT00401245|19589592|P4|STARTED|Double Blind Tapering Phase||0
7958371|NCT00401245|19589593|P3|STARTED|Double Blind Tapering Phase||0
7958372|NCT00401245|19589594|P2|STARTED|Double Blind Tapering Phase||0
7958373|NCT00401245|19589595|P1|STARTED|Double Blind Tapering Phase||0
7958374|NCT00401245|19589588|P8|NOT COMPLETED|Open Label Phase||0
7958375|NCT00401245|19589589|P7|NOT COMPLETED|Open Label Phase||0
7958376|NCT00401245|19589590|P6|NOT COMPLETED|Open Label Phase||0
7958377|NCT00401245|19589591|P5|NOT COMPLETED|Open Label Phase||0
7958378|NCT00401245|19589592|P4|NOT COMPLETED|Open Label Phase||21
7958379|NCT00401245|19589593|P3|NOT COMPLETED|Open Label Phase||23
7958380|NCT00401245|19589594|P2|NOT COMPLETED|Open Label Phase||35
7958381|NCT00401245|19589595|P1|NOT COMPLETED|Open Label Phase||21
7958382|NCT00401245|19589588|P8|COMPLETED|Open Label Phase||0
7958383|NCT00401245|19589589|P7|COMPLETED|Open Label Phase||0
7958384|NCT00401245|19589590|P6|COMPLETED|Open Label Phase||0
7958385|NCT00401245|19589591|P5|COMPLETED|Open Label Phase||0
7958386|NCT00401245|19589592|P4|COMPLETED|Open Label Phase||84
7958387|NCT00401245|19589593|P3|COMPLETED|Open Label Phase||95
7958388|NCT00401245|19589594|P2|COMPLETED|Open Label Phase||81
7958389|NCT00401245|19589595|P1|COMPLETED|Open Label Phase||101
7958390|NCT00401245|19589588|P8|STARTED|Open Label Phase||0
7958391|NCT00401245|19589589|P7|STARTED|Open Label Phase||0
7958392|NCT00401245|19589590|P6|STARTED|Open Label Phase||0
7958393|NCT00401245|19589591|P5|STARTED|Open Label Phase||0
7958394|NCT00401245|19589592|P4|STARTED|Open Label Phase||105
7958395|NCT00401245|19589593|P3|STARTED|Open Label Phase||118
7958396|NCT00401245|19589594|P2|STARTED|Open Label Phase||116
7958397|NCT00401245|19589595|P1|STARTED|Open Label Phase||122
7958398|NCT00401245|19589588|P8|NOT COMPLETED|Between Titration and Open Label Phase||0
7958399|NCT00401245|19589589|P7|NOT COMPLETED|Between Titration and Open Label Phase||0
7958400|NCT00401245|19589590|P6|NOT COMPLETED|Between Titration and Open Label Phase||0
7958401|NCT00401245|19589591|P5|NOT COMPLETED|Between Titration and Open Label Phase||0
7958402|NCT00401245|19589592|P4|NOT COMPLETED|Between Titration and Open Label Phase||2
7958403|NCT00401245|19589593|P3|NOT COMPLETED|Between Titration and Open Label Phase||0
7958404|NCT00401245|19589594|P2|NOT COMPLETED|Between Titration and Open Label Phase||2
7958405|NCT00401245|19589595|P1|NOT COMPLETED|Between Titration and Open Label Phase||0
7958406|NCT00401245|19589588|P8|COMPLETED|Between Titration and Open Label Phase||0
7958407|NCT00401245|19589589|P7|COMPLETED|Between Titration and Open Label Phase||0
7958408|NCT00401245|19589590|P6|COMPLETED|Between Titration and Open Label Phase||0
7958409|NCT00401245|19589591|P5|COMPLETED|Between Titration and Open Label Phase||0
7958410|NCT00401245|19589592|P4|COMPLETED|Between Titration and Open Label Phase||105
7958411|NCT00401245|19589593|P3|COMPLETED|Between Titration and Open Label Phase||118
7958412|NCT00401245|19589594|P2|COMPLETED|Between Titration and Open Label Phase||116
7958413|NCT00401245|19589595|P1|COMPLETED|Between Titration and Open Label Phase||122
7958414|NCT00401245|19589588|P8|STARTED|Between Titration and Open Label Phase||0
7958415|NCT00401245|19589589|P7|STARTED|Between Titration and Open Label Phase||0
7958416|NCT00401245|19589590|P6|STARTED|Between Titration and Open Label Phase||0
7958417|NCT00401245|19589591|P5|STARTED|Between Titration and Open Label Phase||0
7958418|NCT00401245|19589592|P4|STARTED|Between Titration and Open Label Phase||107
7958419|NCT00401245|19589593|P3|STARTED|Between Titration and Open Label Phase||118
7958420|NCT00401245|19589594|P2|STARTED|Between Titration and Open Label Phase||118
7958421|NCT00401245|19589595|P1|STARTED|Between Titration and Open Label Phase||122
7958422|NCT00401245|19589588|P8|NOT COMPLETED|Double Blind Titration Phase||0
7958423|NCT00401245|19589589|P7|NOT COMPLETED|Double Blind Titration Phase||0
7958424|NCT00401245|19589590|P6|NOT COMPLETED|Double Blind Titration Phase||0
7958425|NCT00401245|19589591|P5|NOT COMPLETED|Double Blind Titration Phase||0
7958426|NCT00401245|19589592|P4|NOT COMPLETED|Double Blind Titration Phase||15
7958427|NCT00401245|19589593|P3|NOT COMPLETED|Double Blind Titration Phase||6
7958428|NCT00401245|19589594|P2|NOT COMPLETED|Double Blind Titration Phase||3
7958429|NCT00401245|19589595|P1|NOT COMPLETED|Double Blind Titration Phase||4
7958430|NCT00401245|19589588|P8|COMPLETED|Double Blind Titration Phase||0
7958431|NCT00401245|19589589|P7|COMPLETED|Double Blind Titration Phase||0
7958432|NCT00401245|19589590|P6|COMPLETED|Double Blind Titration Phase||0
7958433|NCT00401245|19589591|P5|COMPLETED|Double Blind Titration Phase||0
7958434|NCT00401245|19589592|P4|COMPLETED|Double Blind Titration Phase||107
7958435|NCT00401245|19589593|P3|COMPLETED|Double Blind Titration Phase||118
7958436|NCT00401245|19589594|P2|COMPLETED|Double Blind Titration Phase||118
7958437|NCT00401245|19589595|P1|COMPLETED|Double Blind Titration Phase||122
7958438|NCT00401245|19589588|P8|STARTED|Double Blind Titration Phase||0
7958439|NCT00401245|19589589|P7|STARTED|Double Blind Titration Phase||0
7958440|NCT00401245|19589590|P6|STARTED|Double Blind Titration Phase||0
7958441|NCT00401245|19589591|P5|STARTED|Double Blind Titration Phase||0
7958442|NCT00401245|19589592|P4|STARTED|Double Blind Titration Phase||122
7958443|NCT00401245|19589593|P3|STARTED|Double Blind Titration Phase||124
7958444|NCT00401245|19589594|P2|STARTED|Double Blind Titration Phase||121
7958445|NCT00401245|19589595|P1|STARTED|Double Blind Titration Phase||126
7958446|NCT00401193|19589663|P3|NOT COMPLETED|Overall Study||6
7958447|NCT00401193|19589664|P2|NOT COMPLETED|Overall Study||11
7958448|NCT00401193|19589665|P1|NOT COMPLETED|Overall Study||15
7958449|NCT00401193|19589663|P3|COMPLETED|Overall Study||63
7958450|NCT00401193|19589664|P2|COMPLETED|Overall Study||106
7958451|NCT00401193|19589665|P1|COMPLETED|Overall Study||103
7958452|NCT00401193|19589663|P3|Modified Intent to Treat Population|Overall Study||67
7958453|NCT00401193|19589664|P2|Modified Intent to Treat Population|Overall Study||115
7958454|NCT00401193|19589665|P1|Modified Intent to Treat Population|Overall Study||112
7958455|NCT00401193|19589663|P3|Intent to Treat Population|Overall Study||67
7958456|NCT00401193|19589664|P2|Intent to Treat Population|Overall Study||115
7958457|NCT00401193|19589665|P1|Intent to Treat Population|Overall Study||115
7958458|NCT00401193|19589663|P3|STARTED|Overall Study||69
7958459|NCT00401193|19589664|P2|STARTED|Overall Study||117
7958460|NCT00401193|19589665|P1|STARTED|Overall Study||118
7958461|NCT00401102|19589679|P1|NOT COMPLETED|Overall Study||7
7958462|NCT00401102|19589679|P1|COMPLETED|Overall Study||5
7958463|NCT00401102|19589679|P1|STARTED|Overall Study||12
7958464|NCT00400985|19589683|P1|NOT COMPLETED|Overall Study||52
7958465|NCT00400985|19589683|P1|COMPLETED|Overall Study||449
7958466|NCT00400985|19589683|P1|STARTED|Overall Study||501
7958467|NCT00400946|19589692|P5|NOT COMPLETED|Overall Study||38
7958468|NCT00400946|19589693|P4|NOT COMPLETED|Overall Study||47
7958469|NCT00400946|19589694|P3|NOT COMPLETED|Overall Study||2
7958470|NCT00400946|19589695|P2|NOT COMPLETED|Overall Study||11
7958471|NCT00400946|19589696|P1|NOT COMPLETED|Overall Study||14
7958472|NCT00400946|19589692|P5|COMPLETED|Overall Study||206
7958473|NCT00400946|19589693|P4|COMPLETED|Overall Study||4
7958474|NCT00400946|19589694|P3|COMPLETED|Overall Study||40
7958475|NCT00400946|19589695|P2|COMPLETED|Overall Study||221
7958476|NCT00400946|19589696|P1|COMPLETED|Overall Study||217
7958477|NCT00400946|19589692|P5|Eligible and Treated|Overall Study||243
7958478|NCT00400946|19589693|P4|Eligible and Treated|Overall Study||46
7958479|NCT00400946|19589694|P3|Eligible and Treated|Overall Study||42
7958480|NCT00400946|19589695|P2|Eligible and Treated|Overall Study||232
7958481|NCT00400946|19589696|P1|Eligible and Treated|Overall Study||231
7958482|NCT00400946|19589692|P5|Evaluable for Day 32 MRD|Overall Study||168
7958483|NCT00400946|19589693|P4|Evaluable for Day 32 MRD|Overall Study||12
7958484|NCT00400946|19589694|P3|Evaluable for Day 32 MRD|Overall Study||33
7958485|NCT00400946|19589695|P2|Evaluable for Day 32 MRD|Overall Study||167
7958486|NCT00400946|19589696|P1|Evaluable for Day 32 MRD|Overall Study||166
7958487|NCT00400946|19589692|P5|Evaluable for Day 18 Marrow Morphology|Overall Study||152
7958488|NCT00400946|19589693|P4|Evaluable for Day 18 Marrow Morphology|Overall Study||13
7958489|NCT00400946|19589694|P3|Evaluable for Day 18 Marrow Morphology|Overall Study||19
7958490|NCT00400946|19589695|P2|Evaluable for Day 18 Marrow Morphology|Overall Study||161
7958491|NCT00400946|19589696|P1|Evaluable for Day 18 Marrow Morphology|Overall Study||158
7958492|NCT00400946|19589692|P5|Evaluable for CNS Directed-Treatment|Overall Study||227
7958493|NCT00400946|19589693|P4|Evaluable for CNS Directed-Treatment|Overall Study||21
7958494|NCT00400946|19589694|P3|Evaluable for CNS Directed-Treatment|Overall Study||42
7958495|NCT00400946|19589695|P2|Evaluable for CNS Directed-Treatment|Overall Study||232
7958496|NCT00400946|19589696|P1|Evaluable for CNS Directed-Treatment|Overall Study||231
7958497|NCT00400946|19589692|P5|STARTED|Overall Study||244
7958498|NCT00400946|19589693|P4|STARTED|Overall Study||51
7958499|NCT00400946|19589694|P3|STARTED|Overall Study||42
7958500|NCT00400946|19589695|P2|STARTED|Overall Study||232
7958501|NCT00400946|19589696|P1|STARTED|Overall Study||231
7958502|NCT00400881|19589724|P2|NOT COMPLETED|Overall Study||0
7958503|NCT00400881|19589725|P1|NOT COMPLETED|Overall Study||0
7958504|NCT00400881|19589724|P2|COMPLETED|Overall Study||60
7958505|NCT00400881|19589725|P1|COMPLETED|Overall Study||62
7958506|NCT00400881|19589724|P2|STARTED|Overall Study||60
7958507|NCT00400881|19589725|P1|STARTED|Overall Study||62
7958508|NCT00400829|19589733|P1|NOT COMPLETED|Overall Study||0
7958509|NCT00400829|19589733|P1|COMPLETED|Overall Study||66
7958510|NCT00400829|19589733|P1|STARTED|Overall Study||66
7958511|NCT00400803|19589739|P1|NOT COMPLETED|Overall Study||0
7958512|NCT00400803|19589739|P1|COMPLETED|Overall Study||35
7958513|NCT00400803|19589739|P1|STARTED|Overall Study||35
7958514|NCT00400764|19589755|P5|NOT COMPLETED|Phase II||11
7958515|NCT00400764|19589756|P4|NOT COMPLETED|Phase II||26
7958516|NCT00400764|19589757|P3|NOT COMPLETED|Phase II||23
7958517|NCT00400764|19589758|P2|NOT COMPLETED|Phase II||0
7958518|NCT00400764|19589759|P1|NOT COMPLETED|Phase II||0
7958519|NCT00400764|19589755|P5|COMPLETED|Phase II||0
7958520|NCT00400764|19589756|P4|COMPLETED|Phase II||0
7958521|NCT00400764|19589757|P3|COMPLETED|Phase II||0
7958522|NCT00400764|19589758|P2|COMPLETED|Phase II||0
7958523|NCT00400764|19589759|P1|COMPLETED|Phase II||0
7958524|NCT00400764|19589755|P5|Treated|Phase II||11
7958525|NCT00400764|19589756|P4|Treated|Phase II||26
7958526|NCT00400764|19589757|P3|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22
7958527|NCT00400764|19589758|P2|Treated|Phase II||0
7958528|NCT00400764|19589759|P1|Treated|Phase II||0
7958529|NCT00400764|19589755|P5|STARTED|Phase II||11
7958530|NCT00400764|19589756|P4|STARTED|Phase II||26
7958531|NCT00400764|19589757|P3|STARTED|Phase II||23
7958532|NCT00400764|19589758|P2|STARTED|Phase II||0
7958533|NCT00400764|19589759|P1|STARTED|Phase II||0
7958534|NCT00400764|19589755|P5|NOT COMPLETED|Phase Ib||0
7958535|NCT00400764|19589756|P4|NOT COMPLETED|Phase Ib||0
7958536|NCT00400764|19589757|P3|NOT COMPLETED|Phase Ib||0
7958537|NCT00400764|19589758|P2|NOT COMPLETED|Phase Ib||4
7958538|NCT00400764|19589759|P1|NOT COMPLETED|Phase Ib||6
7958539|NCT00400764|19589755|P5|COMPLETED|Phase Ib||0
7958540|NCT00400764|19589756|P4|COMPLETED|Phase Ib||0
7958541|NCT00400764|19589757|P3|COMPLETED|Phase Ib||0
7958542|NCT00400764|19589758|P2|COMPLETED|Phase Ib||2
7958543|NCT00400764|19589759|P1|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0
7958544|NCT00400764|19589755|P5|Treated|Phase Ib||0
7958545|NCT00400764|19589756|P4|Treated|Phase Ib||0
7958546|NCT00400764|19589757|P3|Treated|Phase Ib||0
7958547|NCT00400764|19589758|P2|Treated|Phase Ib||6
7958548|NCT00400764|19589759|P1|Treated|Phase Ib||6
7958549|NCT00400764|19589755|P5|STARTED|Phase Ib||0
7958550|NCT00400764|19589756|P4|STARTED|Phase Ib||0
7958551|NCT00400764|19589757|P3|STARTED|Phase Ib||0
7958552|NCT00400764|19589758|P2|STARTED|Phase Ib||6
7958553|NCT00400764|19589759|P1|STARTED|Phase Ib||6
7958554|NCT00400712|19589812|P2|NOT COMPLETED|Overall Study||16
7958555|NCT00400712|19589813|P1|NOT COMPLETED|Overall Study||17
7958556|NCT00400712|19589812|P2|COMPLETED|Overall Study||35
7958557|NCT00400712|19589813|P1|COMPLETED|Overall Study||35
7958558|NCT00400712|19589812|P2|STARTED|Overall Study||51
7958559|NCT00400712|19589813|P1|STARTED|Overall Study||52
7958560|NCT00400686|19589831|P1|NOT COMPLETED|Overall Study||0
7958561|NCT00400686|19589831|P1|COMPLETED|Overall Study||31
7958562|NCT00400686|19589831|P1|STARTED|Overall Study||31
7958563|NCT00400634|19589839|P2|NOT COMPLETED|Overall Study||1
7958564|NCT00400634|19589840|P1|NOT COMPLETED|Overall Study||4
7958565|NCT00400634|19589839|P2|COMPLETED|Overall Study||19
7958566|NCT00400634|19589840|P1|COMPLETED|Overall Study||34
7958567|NCT00400634|19589839|P2|STARTED|Overall Study||20
7958568|NCT00400634|19589840|P1|STARTED|Overall Study||38
7958569|NCT00400569|19589848|P1|NOT COMPLETED|Overall Study||1
7958570|NCT00400569|19589848|P1|COMPLETED|Overall Study||47
7958571|NCT00400569|19589848|P1|STARTED|Overall Study||48
7958572|NCT00400517|19589859|P1|NOT COMPLETED|Overall Study||2
7958573|NCT00400517|19589859|P1|COMPLETED|Overall Study||26
7958574|NCT00400517|19589859|P1|STARTED|Overall Study|1 pt w/d consent. 1 pt found to have unresectable dx at time of sx and is exc. in tissue analysis.|28
7958575|NCT00400439|19589868|P2|NOT COMPLETED|Overall Study||2
7958576|NCT00400439|19589869|P1|NOT COMPLETED|Overall Study||5
7958577|NCT00400439|19589868|P2|COMPLETED|Overall Study||23
7958578|NCT00400439|19589869|P1|COMPLETED|Overall Study||47
7958579|NCT00400439|19589868|P2|STARTED|Overall Study||25
7958580|NCT00400439|19589869|P1|STARTED|Overall Study||52
7958581|NCT00400400|19589879|P2|NOT COMPLETED|Overall Study||15
7958582|NCT00400400|19589880|P1|NOT COMPLETED|Overall Study||14
7958583|NCT00400400|19589879|P2|COMPLETED|Overall Study||185
7958584|NCT00400400|19589880|P1|COMPLETED|Overall Study||186
7958585|NCT00400400|19589879|P2|Intent-to-Treat Population|Overall Study||197
7958586|NCT00400400|19589880|P1|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199
7958587|NCT00400400|19589879|P2|STARTED|Overall Study||200
7958588|NCT00400400|19589880|P1|STARTED|Overall Study||200
7958589|NCT00400205|19589898|P1|NOT COMPLETED|Overall Study||5
7958590|NCT00400205|19589898|P1|COMPLETED|Overall Study||9
7958591|NCT00400205|19589898|P1|STARTED|Overall Study||14
7958592|NCT00400179|19589905|P2|NOT COMPLETED|Overall Study||18
7958593|NCT00400179|19589906|P1|NOT COMPLETED|Overall Study||6
7958594|NCT00400179|19589905|P2|COMPLETED|Overall Study||508
7958595|NCT00400179|19589906|P1|COMPLETED|Overall Study|Received Treatment|521
7958596|NCT00400179|19589905|P2|STARTED|Overall Study||526
7958597|NCT00400179|19589906|P1|STARTED|Overall Study|Signed informed consent form and randomized|527
7958598|NCT00400153|19589923|P3|NOT COMPLETED|Overall Study||61
7958599|NCT00400153|19589924|P2|NOT COMPLETED|Overall Study||55
7958600|NCT00400153|19589925|P1|NOT COMPLETED|Overall Study||48
7958601|NCT00400153|19589923|P3|COMPLETED|Overall Study||422
7958602|NCT00400153|19589924|P2|COMPLETED|Overall Study||436
7958603|NCT00400153|19589925|P1|COMPLETED|Overall Study||438
7958604|NCT00400153|19589923|P3|STARTED|Overall Study||483
7958605|NCT00400153|19589924|P2|STARTED|Overall Study||491
7958606|NCT00400153|19589925|P1|STARTED|Overall Study||486
7958607|NCT00399893|19590172|P2|NOT COMPLETED|Overall Study||0
7958608|NCT00399893|19590173|P1|NOT COMPLETED|Overall Study||1
7958609|NCT00399893|19590172|P2|COMPLETED|Overall Study||3
7958610|NCT00399893|19590173|P1|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1
7958611|NCT00399893|19590172|P2|STARTED|Overall Study||3
7958612|NCT00399893|19590173|P1|STARTED|Overall Study||2
7958613|NCT00399880|19590201|P2|NOT COMPLETED|Overall Study||0
7958614|NCT00399880|19590202|P1|NOT COMPLETED|Overall Study||0
7958615|NCT00399880|19590201|P2|COMPLETED|Overall Study||65
7958616|NCT00399880|19590202|P1|COMPLETED|Overall Study||65
7958617|NCT00399880|19590201|P2|STARTED|Overall Study||65
7958618|NCT00399880|19590202|P1|STARTED|Overall Study||65
7958619|NCT00399841|19590210|P3|NOT COMPLETED|Overall Study||0
7958620|NCT00399841|19590211|P2|NOT COMPLETED|Overall Study||0
7958621|NCT00399841|19590212|P1|NOT COMPLETED|Overall Study||12
7958622|NCT00399841|19590210|P3|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
7958623|NCT00399841|19590211|P2|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
7958624|NCT00399841|19590212|P1|COMPLETED|Overall Study||1
7958625|NCT00399841|19590210|P3|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
7958626|NCT00399841|19590211|P2|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
7958627|NCT00399841|19590212|P1|12-week|Overall Study||2
7958628|NCT00399841|19590210|P3|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
7958629|NCT00399841|19590211|P2|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
7958630|NCT00399841|19590212|P1|Permanent Implant|Overall Study||6
7958631|NCT00399841|19590210|P3|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
7958632|NCT00399841|19590211|P2|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
7958633|NCT00399841|19590212|P1|STARTED|Overall Study||13
7958634|NCT00399802|19590219|P2|NOT COMPLETED|Overall Study||3
7958635|NCT00399802|19590220|P1|NOT COMPLETED|Overall Study||0
7958636|NCT00399802|19590219|P2|COMPLETED|Overall Study||26
7958637|NCT00399802|19590220|P1|COMPLETED|Overall Study||14
7958638|NCT00399802|19590219|P2|STARTED|Overall Study||29
7958639|NCT00399802|19590220|P1|STARTED|Overall Study||14
7958640|NCT00399763|19590234|P2|NOT COMPLETED|Overall Study||3
7958641|NCT00399763|19590235|P1|NOT COMPLETED|Overall Study||2
7958642|NCT00399763|19590234|P2|COMPLETED|Overall Study||32
7958643|NCT00399763|19590235|P1|COMPLETED|Overall Study||33
7958644|NCT00399763|19590234|P2|STARTED|Overall Study||35
7958645|NCT00399763|19590235|P1|STARTED|Overall Study||35
7958646|NCT00399568|19590247|P2|NOT COMPLETED|Overall Study||9
7958647|NCT00399568|19590248|P1|NOT COMPLETED|Overall Study||12
7958648|NCT00399568|19590247|P2|COMPLETED|Overall Study||156
7958649|NCT00399568|19590248|P1|COMPLETED|Overall Study||154
7958650|NCT00399568|19590247|P2|STARTED|Overall Study||165
7958651|NCT00399568|19590248|P1|STARTED|Overall Study||166
7958652|NCT00399542|19590262|P2|NOT COMPLETED|Overall Study||43
7958653|NCT00399542|19590263|P1|NOT COMPLETED|Overall Study||84
7958654|NCT00399542|19590262|P2|COMPLETED|Overall Study||151
7958655|NCT00399542|19590263|P1|COMPLETED|Overall Study||303
7958656|NCT00399542|19590262|P2|STARTED|Overall Study||194
7958657|NCT00399542|19590263|P1|STARTED|Overall Study||387
7958658|NCT00399529|19590325|P1|NOT COMPLETED|Overall Study||2
7958659|NCT00399529|19590325|P1|COMPLETED|Overall Study||20
7958660|NCT00399529|19590325|P1|STARTED|Overall Study||22
7958661|NCT00399516|19590331|P1|NOT COMPLETED|Overall Study||2
7958662|NCT00399516|19590331|P1|COMPLETED|Overall Study||19
7958663|NCT00399516|19590331|P1|STARTED|Overall Study||21
7958664|NCT00399360|19590339|P4|NOT COMPLETED|Overall Study||6
7958665|NCT00399360|19590340|P3|NOT COMPLETED|Overall Study||3
7958666|NCT00399360|19590341|P2|NOT COMPLETED|Overall Study||3
7958667|NCT00399360|19590342|P1|NOT COMPLETED|Overall Study||2
7958668|NCT00399360|19590339|P4|COMPLETED|Overall Study||9
7958669|NCT00399360|19590340|P3|COMPLETED|Overall Study||10
7958670|NCT00399360|19590341|P2|COMPLETED|Overall Study||8
7958671|NCT00399360|19590342|P1|COMPLETED|Overall Study||9
7958672|NCT00399360|19590339|P4|STARTED|Overall Study||15
7958673|NCT00399360|19590340|P3|STARTED|Overall Study||13
7958674|NCT00399360|19590341|P2|STARTED|Overall Study||11
7958675|NCT00399360|19590342|P1|STARTED|Overall Study||11
7958676|NCT00399308|19590391|P3|NOT COMPLETED|Overall Study||1
7958677|NCT00399308|19590392|P2|NOT COMPLETED|Overall Study||0
7958678|NCT00399308|19590393|P1|NOT COMPLETED|Overall Study||0
7958679|NCT00399308|19590391|P3|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11
7958680|NCT00399308|19590392|P2|COMPLETED|Overall Study||15
7958681|NCT00399308|19590393|P1|COMPLETED|Overall Study||13
7958682|NCT00399308|19590391|P3|STARTED|Overall Study||12
7958683|NCT00399308|19590392|P2|STARTED|Overall Study||15
7958684|NCT00399308|19590393|P1|STARTED|Overall Study||13
7958685|NCT00399035|19590413|P3|NOT COMPLETED|Overall Study||252
7958686|NCT00399035|19590414|P2|NOT COMPLETED|Overall Study||158
7958687|NCT00399035|19590415|P1|NOT COMPLETED|Overall Study||313
7958688|NCT00399035|19590413|P3|COMPLETED|Overall Study||106
7958689|NCT00399035|19590414|P2|COMPLETED|Overall Study||58
7958690|NCT00399035|19590415|P1|COMPLETED|Overall Study||189
7958691|NCT00399035|19590413|P3|STARTED|Overall Study||358
7958692|NCT00399035|19590414|P2|STARTED|Overall Study||216
7958693|NCT00399035|19590415|P1|STARTED|Overall Study||502
7958694|NCT00398983|19590436|P2|NOT COMPLETED|Overall Study||0
7958695|NCT00398983|19590437|P1|NOT COMPLETED|Overall Study||0
7958696|NCT00398983|19590436|P2|COMPLETED|Overall Study||25
7958697|NCT00398983|19590437|P1|COMPLETED|Overall Study||20
7958698|NCT00398983|19590436|P2|STARTED|Overall Study||25
7958699|NCT00398983|19590437|P1|STARTED|Overall Study||20
7958700|NCT00398918|19590443|P1|NOT COMPLETED|Overall Study||0
7958701|NCT00398918|19590443|P1|COMPLETED|Overall Study||10
7958702|NCT00398918|19590443|P1|STARTED|Overall Study||10
7958703|NCT00398866|19590451|P3|NOT COMPLETED|Overall Study||8
7958704|NCT00398866|19590452|P2|NOT COMPLETED|Overall Study||8
7958705|NCT00398866|19590453|P1|NOT COMPLETED|Overall Study||14
7958706|NCT00398866|19590451|P3|COMPLETED|Overall Study||58
7958707|NCT00398866|19590452|P2|COMPLETED|Overall Study||60
7958708|NCT00398866|19590453|P1|COMPLETED|Overall Study||52
7958709|NCT00398866|19590451|P3|STARTED|Overall Study||66
7958710|NCT00398866|19590452|P2|STARTED|Overall Study||68
7958711|NCT00398866|19590453|P1|STARTED|Overall Study||66
7958712|NCT00398632|19590464|P1|NOT COMPLETED|Overall Study||2
7958713|NCT00398632|19590464|P1|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4
7958714|NCT00398632|19590464|P1|STARTED|Overall Study||6
7958715|NCT00398567|19590472|P3|NOT COMPLETED|Overall Study||34
7958716|NCT00398567|19590473|P2|NOT COMPLETED|Overall Study||4
7958717|NCT00398567|19590474|P1|NOT COMPLETED|Overall Study||4
7958718|NCT00398567|19590472|P3|COMPLETED|Overall Study||3
7958719|NCT00398567|19590473|P2|COMPLETED|Overall Study||0
7958720|NCT00398567|19590474|P1|COMPLETED|Overall Study||0
7958721|NCT00398567|19590472|P3|STARTED|Overall Study||37
7958722|NCT00398567|19590473|P2|STARTED|Overall Study||4
7958723|NCT00398567|19590474|P1|STARTED|Overall Study||4
7958724|NCT00398476|19590486|P2|NOT COMPLETED|Treatment Period 2||0
7958725|NCT00398476|19590487|P1|NOT COMPLETED|Treatment Period 2||0
7958726|NCT00398476|19590486|P2|COMPLETED|Treatment Period 2||64
7958727|NCT00398476|19590487|P1|COMPLETED|Treatment Period 2||63
7958728|NCT00398476|19590486|P2|STARTED|Treatment Period 2||64
7958729|NCT00398476|19590487|P1|STARTED|Treatment Period 2||63
7958730|NCT00398476|19590486|P2|NOT COMPLETED|Washout Period (20 Minutes)||0
7958731|NCT00398476|19590487|P1|NOT COMPLETED|Washout Period (20 Minutes)||0
7958732|NCT00398476|19590486|P2|COMPLETED|Washout Period (20 Minutes)||64
7958733|NCT00398476|19590487|P1|COMPLETED|Washout Period (20 Minutes)||63
7958734|NCT00398476|19590486|P2|STARTED|Washout Period (20 Minutes)||64
7958735|NCT00398476|19590487|P1|STARTED|Washout Period (20 Minutes)||63
7958736|NCT00398476|19590486|P2|NOT COMPLETED|Treatment Period 1||0
7958737|NCT00398476|19590487|P1|NOT COMPLETED|Treatment Period 1||0
7958738|NCT00398476|19590486|P2|COMPLETED|Treatment Period 1||64
7958739|NCT00398476|19590487|P1|COMPLETED|Treatment Period 1||63
7958740|NCT00398476|19590486|P2|STARTED|Treatment Period 1||64
7958741|NCT00398476|19590487|P1|STARTED|Treatment Period 1||63
7958742|NCT00398411|19590528|P2|NOT COMPLETED|Overall Study||1
7958743|NCT00398411|19590529|P1|NOT COMPLETED|Overall Study||0
7958744|NCT00398411|19590528|P2|COMPLETED|Overall Study||31
7958745|NCT00398411|19590529|P1|COMPLETED|Overall Study||34
7958746|NCT00398411|19590528|P2|STARTED|Overall Study||32
7958747|NCT00398411|19590529|P1|STARTED|Overall Study||34
7958748|NCT00398398|19590545|P1|NOT COMPLETED|Overall Study||0
7958749|NCT00398398|19590545|P1|COMPLETED|Overall Study||44
7958750|NCT00398398|19590545|P1|STARTED|Overall Study||44
7958751|NCT00398320|19590552|P1|NOT COMPLETED|Overall Study||6
7958752|NCT00398320|19590552|P1|COMPLETED|Overall Study||34
7958753|NCT00398320|19590552|P1|STARTED|Overall Study||40
7958754|NCT00398216|19590565|P5|NOT COMPLETED|Overall Study||15
7958755|NCT00398216|19590566|P4|NOT COMPLETED|Overall Study||22
7958756|NCT00398216|19590567|P3|NOT COMPLETED|Overall Study||21
7958757|NCT00398216|19590568|P2|NOT COMPLETED|Overall Study||19
7958758|NCT00398216|19590569|P1|NOT COMPLETED|Overall Study||11
7958759|NCT00398216|19590565|P5|COMPLETED|Overall Study||157
7958760|NCT00398216|19590566|P4|COMPLETED|Overall Study||155
7958761|NCT00398216|19590567|P3|COMPLETED|Overall Study||164
7958762|NCT00398216|19590568|P2|COMPLETED|Overall Study||151
7958763|NCT00398216|19590569|P1|COMPLETED|Overall Study||181
7958764|NCT00398216|19590565|P5|STARTED|Overall Study||172
7958765|NCT00398216|19590566|P4|STARTED|Overall Study||177
7958766|NCT00398216|19590567|P3|STARTED|Overall Study||185
7958767|NCT00398216|19590568|P2|STARTED|Overall Study||170
7958768|NCT00398216|19590569|P1|STARTED|Overall Study||192
7958769|NCT00398138|19590596|P1|NOT COMPLETED|Overall Study||2
7958770|NCT00398138|19590596|P1|COMPLETED|Overall Study||10
7958771|NCT00398138|19590596|P1|STARTED|Overall Study||12
7958772|NCT00398112|19590601|P1|NOT COMPLETED|Overall Study||18
7958773|NCT00398112|19590601|P1|COMPLETED|Overall Study||0
7958774|NCT00398112|19590601|P1|STARTED|Overall Study||18
7958775|NCT00398086|19590612|P3|NOT COMPLETED|Overall Study||2
7958776|NCT00398086|19590613|P2|NOT COMPLETED|Overall Study||23
7958777|NCT00398086|19590614|P1|NOT COMPLETED|Overall Study||9
7958778|NCT00398086|19590612|P3|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1
7958779|NCT00398086|19590613|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21
7958780|NCT00398086|19590614|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11
7958781|NCT00398086|19590612|P3|Phase 1, Dose Escalation Population|Overall Study||3
7958782|NCT00398086|19590613|P2|Phase 1, Dose Escalation Population|Overall Study||7
7958783|NCT00398086|19590614|P1|Phase 1, Dose Escalation Population|Overall Study||20
7958784|NCT00398086|19590612|P3|STARTED|Overall Study||3
7958785|NCT00398086|19590613|P2|STARTED|Overall Study||44
7958786|NCT00398086|19590614|P1|STARTED|Overall Study||20
7958787|NCT00398073|19590648|P2|NOT COMPLETED|Overall Study||0
7958788|NCT00398073|19590649|P1|NOT COMPLETED|Overall Study||1
7958789|NCT00398073|19590648|P2|COMPLETED|Overall Study||17
7958790|NCT00398073|19590649|P1|COMPLETED|Overall Study||17
7958791|NCT00398073|19590648|P2|STARTED|Overall Study||17
7958792|NCT00398073|19590649|P1|STARTED|Overall Study||18
7958793|NCT00398047|19590659|P1|NOT COMPLETED|Overall Study||3
7958794|NCT00398047|19590659|P1|COMPLETED|Overall Study|all three patients progressed before completing|0
7958795|NCT00398047|19590659|P1|STARTED|Overall Study||3
7958796|NCT00397982|19590669|P1|NOT COMPLETED|Overall Study||4
7958797|NCT00397982|19590669|P1|COMPLETED|Overall Study||13
7958798|NCT00397982|19590669|P1|STARTED|Overall Study||17
7958799|NCT00397943|19590683|P5|NOT COMPLETED|Overall Study||0
7958800|NCT00397943|19590684|P4|NOT COMPLETED|Overall Study||0
7958801|NCT00397943|19590685|P3|NOT COMPLETED|Overall Study||0
7958802|NCT00397943|19590686|P2|NOT COMPLETED|Overall Study||9
7958803|NCT00397943|19590687|P1|NOT COMPLETED|Overall Study||12
7958804|NCT00397943|19590683|P5|COMPLETED|Overall Study||10
7958805|NCT00397943|19590684|P4|COMPLETED|Overall Study||10
7958806|NCT00397943|19590685|P3|COMPLETED|Overall Study||10
7958807|NCT00397943|19590686|P2|COMPLETED|Overall Study||31
7958808|NCT00397943|19590687|P1|COMPLETED|Overall Study||28
7958809|NCT00397943|19590683|P5|STARTED|Overall Study||10
7958810|NCT00397943|19590684|P4|STARTED|Overall Study||10
7958811|NCT00397943|19590685|P3|STARTED|Overall Study||10
7958812|NCT00397943|19590686|P2|STARTED|Overall Study||40
7958813|NCT00397943|19590687|P1|STARTED|Overall Study||40
7958814|NCT00397930|19590843|P2|NOT COMPLETED|Overall Study||51
7958815|NCT00397930|19590844|P1|NOT COMPLETED|Overall Study||38
7958816|NCT00397930|19590843|P2|COMPLETED|Overall Study||153
7958817|NCT00397930|19590844|P1|COMPLETED|Overall Study||168
7958818|NCT00397930|19590843|P2|STARTED|Overall Study||204
7958819|NCT00397930|19590844|P1|STARTED|Overall Study||206
7958820|NCT00397904|19590850|P1|NOT COMPLETED|Overall Study||0
7958821|NCT00397904|19590850|P1|COMPLETED|Overall Study||16
7958822|NCT00397904|19590850|P1|STARTED|Overall Study||16
7958823|NCT00397891|19590859|P5|NOT COMPLETED|Overall Study||1
7958824|NCT00397891|19590860|P4|NOT COMPLETED|Overall Study||0
7958825|NCT00397891|19590861|P3|NOT COMPLETED|Overall Study||0
7958826|NCT00397891|19590862|P2|NOT COMPLETED|Overall Study||0
7958827|NCT00397891|19590863|P1|NOT COMPLETED|Overall Study||1
7958828|NCT00397891|19590859|P5|COMPLETED|Overall Study||7
7958829|NCT00397891|19590860|P4|COMPLETED|Overall Study||6
7958830|NCT00397891|19590861|P3|COMPLETED|Overall Study||6
7958831|NCT00397891|19590862|P2|COMPLETED|Overall Study||6
7958832|NCT00397891|19590863|P1|COMPLETED|Overall Study||5
7958833|NCT00397891|19590859|P5|STARTED|Overall Study||8
7958834|NCT00397891|19590860|P4|STARTED|Overall Study||6
7958835|NCT00397891|19590861|P3|STARTED|Overall Study||6
7958836|NCT00397891|19590862|P2|STARTED|Overall Study||6
7958837|NCT00397891|19590863|P1|STARTED|Overall Study||6
7958838|NCT00397878|19590961|P1|NOT COMPLETED|Overall Study||0
7958839|NCT00397878|19590961|P1|COMPLETED|Overall Study||10
7958840|NCT00397878|19590961|P1|STARTED|Overall Study||10
7958841|NCT00397839|19590970|P2|NOT COMPLETED|Overall Study||18
7958842|NCT00397839|19590971|P1|NOT COMPLETED|Overall Study||7
7958843|NCT00397839|19590970|P2|COMPLETED|Overall Study||69
7958844|NCT00397839|19590971|P1|COMPLETED|Overall Study||41
7958845|NCT00397839|19590970|P2|STARTED|Overall Study||87
7958846|NCT00397839|19590971|P1|STARTED|Overall Study||48
7958847|NCT00397813|19590991|P6|NOT COMPLETED|Overall Study||0
7958848|NCT00397813|19590992|P5|NOT COMPLETED|Overall Study||0
7958849|NCT00397813|19590993|P4|NOT COMPLETED|Overall Study||0
7958850|NCT00397813|19590994|P3|NOT COMPLETED|Overall Study||0
7958851|NCT00397813|19590995|P2|NOT COMPLETED|Overall Study||0
7958852|NCT00397813|19590996|P1|NOT COMPLETED|Overall Study||0
7958853|NCT00397813|19590991|P6|COMPLETED|Overall Study||24
7958854|NCT00397813|19590992|P5|COMPLETED|Overall Study||5
7958855|NCT00397813|19590993|P4|COMPLETED|Overall Study||12
7958856|NCT00397813|19590994|P3|COMPLETED|Overall Study||0
7958857|NCT00397813|19590995|P2|COMPLETED|Overall Study||0
7958858|NCT00397813|19590996|P1|COMPLETED|Overall Study||36
7958859|NCT00397813|19590991|P6|STARTED|Overall Study||24
7958860|NCT00397813|19590992|P5|STARTED|Overall Study||5
7958861|NCT00397813|19590993|P4|STARTED|Overall Study||12
7958862|NCT00397813|19590994|P3|STARTED|Overall Study||0
7958863|NCT00397813|19590995|P2|STARTED|Overall Study||0
7958864|NCT00397813|19590996|P1|STARTED|Overall Study||36
7958865|NCT00397631|19591036|P2|NOT COMPLETED|Overall Study||44
7958866|NCT00397631|19591037|P1|NOT COMPLETED|Overall Study||30
7958867|NCT00397631|19591036|P2|COMPLETED|Overall Study||215
7958868|NCT00397631|19591037|P1|COMPLETED|Overall Study||231
7958869|NCT00397631|19591036|P2|STARTED|Overall Study||259
7958870|NCT00397631|19591037|P1|STARTED|Overall Study|Randomization ratio was 1:1|261
7958871|NCT00397579|19591047|P1|NOT COMPLETED|Overall Study||0
7958872|NCT00397579|19591047|P1|COMPLETED|Overall Study||11
7958873|NCT00397579|19591047|P1|STARTED|Overall Study||11
7958874|NCT00397540|19591053|P2|NOT COMPLETED|Overall Study||0
7958875|NCT00397540|19591054|P1|NOT COMPLETED|Overall Study||1
7958876|NCT00397540|19591053|P2|COMPLETED|Overall Study||85
7958877|NCT00397540|19591054|P1|COMPLETED|Overall Study||59
7958878|NCT00397540|19591053|P2|STARTED|Overall Study||85
7958879|NCT00397540|19591054|P1|STARTED|Overall Study||60
7958880|NCT00397514|19591062|P1|NOT COMPLETED|Overall Study||9
7958881|NCT00397514|19591062|P1|COMPLETED|Overall Study||25
7958882|NCT00397514|19591062|P1|STARTED|Overall Study||34
7958883|NCT00397488|19591072|P1|NOT COMPLETED|Overall Study||7
7958884|NCT00397488|19591072|P1|COMPLETED|Overall Study||71
7958885|NCT00397488|19591072|P1|STARTED|Overall Study||78
7958886|NCT00397462|19591079|P3|NOT COMPLETED|Overall Study||0
7958887|NCT00397462|19591080|P2|NOT COMPLETED|Overall Study||0
7958888|NCT00397462|19591081|P1|NOT COMPLETED|Overall Study||0
7958889|NCT00397462|19591079|P3|COMPLETED|Overall Study||15
7958890|NCT00397462|19591080|P2|COMPLETED|Overall Study||13
7958891|NCT00397462|19591081|P1|COMPLETED|Overall Study||16
7958892|NCT00397462|19591079|P3|STARTED|Overall Study||15
7958893|NCT00397462|19591080|P2|STARTED|Overall Study||13
7958894|NCT00397462|19591081|P1|STARTED|Overall Study||16
7958895|NCT00397254|19591092|P2|NOT COMPLETED|Overall Study||2
7958896|NCT00397254|19591093|P1|NOT COMPLETED|Overall Study||2
7958897|NCT00397254|19591092|P2|COMPLETED|Overall Study||74
7958898|NCT00397254|19591093|P1|COMPLETED|Overall Study||77
7958899|NCT00397254|19591092|P2|STARTED|Overall Study||76
7958900|NCT00397254|19591093|P1|STARTED|Overall Study||79
7958901|NCT00397215|19591115|P4|NOT COMPLETED|Month 24 (Day 720)||0
7958902|NCT00397215|19591116|P3|NOT COMPLETED|Month 24 (Day 720)||0
7958903|NCT00397215|19591117|P2|NOT COMPLETED|Month 24 (Day 720)||0
7958904|NCT00397215|19591118|P1|NOT COMPLETED|Month 24 (Day 720)||0
7958905|NCT00397215|19591115|P4|COMPLETED|Month 24 (Day 720)||36
7958906|NCT00397215|19591116|P3|COMPLETED|Month 24 (Day 720)||117
7958907|NCT00397215|19591117|P2|COMPLETED|Month 24 (Day 720)||45
7958908|NCT00397215|19591118|P1|COMPLETED|Month 24 (Day 720)||122
7958909|NCT00397215|19591115|P4|STARTED|Month 24 (Day 720)||36
7958910|NCT00397215|19591116|P3|STARTED|Month 24 (Day 720)||117
7958911|NCT00397215|19591117|P2|STARTED|Month 24 (Day 720)||45
7958912|NCT00397215|19591118|P1|STARTED|Month 24 (Day 720)||122
7958913|NCT00397215|19591115|P4|NOT COMPLETED|Month 12 (Day 360)||0
7958914|NCT00397215|19591116|P3|NOT COMPLETED|Month 12 (Day 360)||0
7958915|NCT00397215|19591117|P2|NOT COMPLETED|Month 12 (Day 360)||0
7958916|NCT00397215|19591118|P1|NOT COMPLETED|Month 12 (Day 360)||0
7958917|NCT00397215|19591115|P4|COMPLETED|Month 12 (Day 360)||42
7958918|NCT00397215|19591116|P3|COMPLETED|Month 12 (Day 360)||125
7958919|NCT00397215|19591117|P2|COMPLETED|Month 12 (Day 360)||48
7958920|NCT00397215|19591118|P1|COMPLETED|Month 12 (Day 360)||130
7958921|NCT00397215|19591115|P4|STARTED|Month 12 (Day 360)||42
7958922|NCT00397215|19591116|P3|STARTED|Month 12 (Day 360)||125
7958923|NCT00397215|19591117|P2|STARTED|Month 12 (Day 360)||48
7958924|NCT00397215|19591118|P1|STARTED|Month 12 (Day 360)||130
7958925|NCT00397215|19591115|P4|NOT COMPLETED|Month 6 (Day 180)||0
7958926|NCT00397215|19591116|P3|NOT COMPLETED|Month 6 (Day 180)||5
7958927|NCT00397215|19591117|P2|NOT COMPLETED|Month 6 (Day 180)||3
7958928|NCT00397215|19591118|P1|NOT COMPLETED|Month 6 (Day 180)||2
7958929|NCT00397215|19591115|P4|COMPLETED|Month 6 (Day 180)||51
7958930|NCT00397215|19591116|P3|COMPLETED|Month 6 (Day 180)||153
7958931|NCT00397215|19591117|P2|COMPLETED|Month 6 (Day 180)||55
7958932|NCT00397215|19591118|P1|COMPLETED|Month 6 (Day 180)||162
7958933|NCT00397215|19591115|P4|STARTED|Month 6 (Day 180)||51
7958934|NCT00397215|19591116|P3|STARTED|Month 6 (Day 180)||158
7958935|NCT00397215|19591117|P2|STARTED|Month 6 (Day 180)||58
7958936|NCT00397215|19591118|P1|STARTED|Month 6 (Day 180)||164
7958937|NCT00397215|19591115|P4|NOT COMPLETED|Month 0 (Day 0)||4
7958938|NCT00397215|19591116|P3|NOT COMPLETED|Month 0 (Day 0)||6
7958939|NCT00397215|19591117|P2|NOT COMPLETED|Month 0 (Day 0)||5
7958940|NCT00397215|19591118|P1|NOT COMPLETED|Month 0 (Day 0)||7
7958941|NCT00397215|19591115|P4|COMPLETED|Month 0 (Day 0)||48
7958942|NCT00397215|19591116|P3|COMPLETED|Month 0 (Day 0)||153
7958943|NCT00397215|19591117|P2|COMPLETED|Month 0 (Day 0)||56
7958944|NCT00397215|19591118|P1|COMPLETED|Month 0 (Day 0)||158
7958945|NCT00397215|19591115|P4|STARTED|Month 0 (Day 0)||52
7958946|NCT00397215|19591116|P3|STARTED|Month 0 (Day 0)||159
7958947|NCT00397215|19591117|P2|STARTED|Month 0 (Day 0)||61
7958948|NCT00397215|19591118|P1|STARTED|Month 0 (Day 0)||165
7958949|NCT00397189|19591254|P2|NOT COMPLETED|Extension Period||43
7958950|NCT00397189|19591255|P1|NOT COMPLETED|Extension Period||113
7958951|NCT00397189|19591254|P2|COMPLETED|Extension Period||134
7958952|NCT00397189|19591255|P1|COMPLETED|Extension Period||421
7958953|NCT00397189|19591254|P2|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177
7958954|NCT00397189|19591255|P1|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534
7958955|NCT00397189|19591254|P2|NOT COMPLETED|3 Weeks Period||22
7958956|NCT00397189|19591255|P1|NOT COMPLETED|3 Weeks Period||21
7958957|NCT00397189|19591254|P2|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373
7958958|NCT00397189|19591255|P1|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373
7958959|NCT00397189|19591254|P2|STARTED|3 Weeks Period||395
7958960|NCT00397189|19591255|P1|STARTED|3 Weeks Period||394
7958961|NCT00397150|19591265|P2|NOT COMPLETED|Overall Study||145
7958962|NCT00397150|19591266|P1|NOT COMPLETED|Overall Study||135
7958963|NCT00397150|19591265|P2|COMPLETED|Overall Study||1111
7958964|NCT00397150|19591266|P1|COMPLETED|Overall Study||1188
7958965|NCT00397150|19591265|P2|STARTED|Overall Study||1256
7958966|NCT00397150|19591266|P1|STARTED|Overall Study||1323
7958967|NCT00397046|19591282|P4|NOT COMPLETED|Overall Study||5
7958968|NCT00397046|19591283|P3|NOT COMPLETED|Overall Study||10
7958969|NCT00397046|19591284|P2|NOT COMPLETED|Overall Study||3
7958970|NCT00397046|19591285|P1|NOT COMPLETED|Overall Study||3
7958971|NCT00397046|19591282|P4|COMPLETED|Overall Study||0
7958972|NCT00397046|19591283|P3|COMPLETED|Overall Study||0
7958973|NCT00397046|19591284|P2|COMPLETED|Overall Study||0
7958974|NCT00397046|19591285|P1|COMPLETED|Overall Study||0
7958975|NCT00397046|19591282|P4|STARTED|Overall Study||5
7958976|NCT00397046|19591283|P3|STARTED|Overall Study||10
7958977|NCT00397046|19591284|P2|STARTED|Overall Study||3
7958978|NCT00397046|19591285|P1|STARTED|Overall Study||3
7958979|NCT00397033|19591307|P3|NOT COMPLETED|Overall Study||23
7958980|NCT00397033|19591308|P2|NOT COMPLETED|Overall Study||37
7958981|NCT00397033|19591309|P1|NOT COMPLETED|Overall Study||44
7958982|NCT00397033|19591307|P3|COMPLETED|Overall Study||77
7958983|NCT00397033|19591308|P2|COMPLETED|Overall Study||72
7958984|NCT00397033|19591309|P1|COMPLETED|Overall Study||63
7958985|NCT00397033|19591307|P3|ITT Population|Overall Study||98
7958986|NCT00397033|19591308|P2|ITT Population|Overall Study||105
7958987|NCT00397033|19591309|P1|ITT Population|Overall Study||107
7958988|NCT00397033|19591307|P3|Safety Population: >= 1 Dose of Drug|Overall Study||98
7958989|NCT00397033|19591308|P2|Safety Population: >= 1 Dose of Drug|Overall Study||108
7958990|NCT00397033|19591309|P1|Safety Population: >= 1 Dose of Drug|Overall Study||107
7958991|NCT00397033|19591307|P3|STARTED|Overall Study||100
7958992|NCT00397033|19591308|P2|STARTED|Overall Study||109
7958993|NCT00397033|19591309|P1|STARTED|Overall Study||107
7958994|NCT00397020|19591370|P2|NOT COMPLETED|Overall Study||1
7958995|NCT00397020|19591371|P1|NOT COMPLETED|Overall Study||1
7958996|NCT00397020|19591370|P2|COMPLETED|Overall Study||15
7958997|NCT00397020|19591371|P1|COMPLETED|Overall Study||13
7958998|NCT00397020|19591370|P2|STARTED|Overall Study||16
7958999|NCT00397020|19591371|P1|STARTED|Overall Study||14
7959000|NCT00396981|19591379|P2|NOT COMPLETED|Overall Study||9
7959001|NCT00396981|19591380|P1|NOT COMPLETED|Overall Study||15
7959002|NCT00396981|19591379|P2|COMPLETED|Overall Study||306
7959003|NCT00396981|19591380|P1|COMPLETED|Overall Study||296
7959004|NCT00396981|19591379|P2|STARTED|Overall Study||315
7959005|NCT00396981|19591380|P1|STARTED|Overall Study||311
7959006|NCT00396877|19591400|P2|NOT COMPLETED|Overall Study||8
7959007|NCT00396877|19591401|P1|NOT COMPLETED|Overall Study||6
7959008|NCT00396877|19591400|P2|COMPLETED|Overall Study|Completed follow-up|459
7959009|NCT00396877|19591401|P1|COMPLETED|Overall Study|Completed follow-up|433
7959010|NCT00396877|19591400|P2|Completed Treatment|Overall Study||352
7959011|NCT00396877|19591401|P1|Completed Treatment|Overall Study||356
7959012|NCT00396877|19591400|P2|Treated|Overall Study||464
7959013|NCT00396877|19591401|P1|Treated|Overall Study||436
7959014|NCT00396877|19591400|P2|STARTED|Overall Study|Randomized|467
7959015|NCT00396877|19591401|P1|STARTED|Overall Study|Randomized|439
7959016|NCT00396812|19591411|P1|NOT COMPLETED|Overall Study||1
7959017|NCT00396812|19591411|P1|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3
7959018|NCT00396812|19591411|P1|STARTED|Overall Study||4
7959019|NCT00396656|19591423|P2|NOT COMPLETED|Second Treatment Period||1
7959020|NCT00396656|19591424|P1|NOT COMPLETED|Second Treatment Period||0
7959021|NCT00396656|19591423|P2|COMPLETED|Second Treatment Period||12
7959022|NCT00396656|19591424|P1|COMPLETED|Second Treatment Period||15
7959023|NCT00396656|19591423|P2|STARTED|Second Treatment Period||13
7959024|NCT00396656|19591424|P1|STARTED|Second Treatment Period||15
7959025|NCT00396656|19591423|P2|NOT COMPLETED|First Treatment Period||2
7959026|NCT00396656|19591424|P1|NOT COMPLETED|First Treatment Period||0
7959027|NCT00396656|19591423|P2|COMPLETED|First Treatment Period||13
7959028|NCT00396656|19591424|P1|COMPLETED|First Treatment Period||15
7959029|NCT00396656|19591423|P2|STARTED|First Treatment Period||15
7959030|NCT00396656|19591424|P1|STARTED|First Treatment Period||15
7959031|NCT00396630|19591442|P2|NOT COMPLETED|Overall Study||5
7959032|NCT00396630|19591443|P1|NOT COMPLETED|Overall Study||5
7959033|NCT00396630|19591442|P2|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
7959034|NCT00396630|19591443|P1|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
7959035|NCT00396630|19591442|P2|STARTED|Overall Study||100
7959036|NCT00396630|19591443|P1|STARTED|Overall Study||100
7959037|NCT00396591|19591463|P1|NOT COMPLETED|Overall Study||16
7959038|NCT00396591|19591463|P1|COMPLETED|Overall Study||0
7959039|NCT00396591|19591463|P1|STARTED|Overall Study||16
7959040|NCT00396565|19591476|P3|NOT COMPLETED|Overall Study||17
7959041|NCT00396565|19591477|P2|NOT COMPLETED|Overall Study||91
7959042|NCT00396565|19591478|P1|NOT COMPLETED|Overall Study||48
7959043|NCT00396565|19591476|P3|COMPLETED|Overall Study||30
7959044|NCT00396565|19591477|P2|COMPLETED|Overall Study||47
7959045|NCT00396565|19591478|P1|COMPLETED|Overall Study||88
7959046|NCT00396565|19591476|P3|STARTED|Overall Study||47
7959047|NCT00396565|19591477|P2|STARTED|Overall Study||138
7959048|NCT00396565|19591478|P1|STARTED|Overall Study||136
7959049|NCT00396409|19591503|P2|NOT COMPLETED|Period 2 - 2008||2
7959050|NCT00396409|19591504|P1|NOT COMPLETED|Period 2 - 2008||7
7959051|NCT00396409|19591503|P2|COMPLETED|Period 2 - 2008||53
7959052|NCT00396409|19591504|P1|COMPLETED|Period 2 - 2008||52
7959053|NCT00396409|19591503|P2|STARTED|Period 2 - 2008||55
7959054|NCT00396409|19591504|P1|STARTED|Period 2 - 2008||59
7959055|NCT00396409|19591503|P2|NOT COMPLETED|Between Period 1 and Period 2||2
7959056|NCT00396409|19591504|P1|NOT COMPLETED|Between Period 1 and Period 2||3
7959057|NCT00396409|19591503|P2|COMPLETED|Between Period 1 and Period 2||55
7959058|NCT00396409|19591504|P1|COMPLETED|Between Period 1 and Period 2||59
7959059|NCT00396409|19591503|P2|STARTED|Between Period 1 and Period 2||57
7959060|NCT00396409|19591504|P1|STARTED|Between Period 1 and Period 2||62
7959061|NCT00396409|19591503|P2|NOT COMPLETED|Period 1 - 2007||6
7959062|NCT00396409|19591504|P1|NOT COMPLETED|Period 1 - 2007||3
7959063|NCT00396409|19591503|P2|COMPLETED|Period 1 - 2007||57
7959064|NCT00396409|19591504|P1|COMPLETED|Period 1 - 2007||62
7959065|NCT00396409|19591503|P2|STARTED|Period 1 - 2007||63
7959066|NCT00396409|19591504|P1|STARTED|Period 1 - 2007||65
7959067|NCT00396383|19591534|P1|NOT COMPLETED|Overall Study||3
7959068|NCT00396383|19591534|P1|COMPLETED|Overall Study||6
7959069|NCT00396383|19591534|P1|STARTED|Overall Study||9
7959070|NCT00396331|19591547|P1|NOT COMPLETED|Overall Study||32
7959071|NCT00396331|19591547|P1|COMPLETED|Overall Study||68
7959072|NCT00396331|19591547|P1|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87
7959073|NCT00396331|19591547|P1|Number of Participants Treated|Overall Study||100
7959074|NCT00396331|19591547|P1|STARTED|Overall Study||100
7959075|NCT00396318|19591600|P1|NOT COMPLETED|7-Day Post-Treatment Contact||1
7959076|NCT00396318|19591600|P1|COMPLETED|7-Day Post-Treatment Contact||240
7959077|NCT00396318|19591600|P1|STARTED|7-Day Post-Treatment Contact||241
7959078|NCT00396318|19591600|P1|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5
7959079|NCT00396318|19591600|P1|COMPLETED|48- to 96-Hour Follow-Up Period||241
7959080|NCT00396318|19591600|P1|STARTED|48- to 96-Hour Follow-Up Period||246
7959081|NCT00396318|19591600|P1|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5
7959082|NCT00396318|19591600|P1|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241
7959083|NCT00396318|19591600|P1|STARTED|At Least One Dose of Tenecteplase (MITT)||246
7959084|NCT00396292|19591613|P2|NOT COMPLETED|Overall Study||16
7959085|NCT00396292|19591614|P1|NOT COMPLETED|Overall Study||9
7959086|NCT00396292|19591613|P2|COMPLETED|Overall Study||162
7959087|NCT00396292|19591614|P1|COMPLETED|Overall Study||165
7959088|NCT00396292|19591613|P2|STARTED|Overall Study||178
7959089|NCT00396292|19591614|P1|STARTED|Overall Study||174
7959090|NCT00396279|19591620|P1|NOT COMPLETED|Overall Study||30
7959091|NCT00396279|19591620|P1|COMPLETED|Overall Study|Defined as participants with a complete resection|7
7959092|NCT00396279|19591620|P1|STARTED|Overall Study||37
7959093|NCT00396266|19591631|P2|NOT COMPLETED|Overall Study||0
7959094|NCT00396266|19591632|P1|NOT COMPLETED|Overall Study||0
7959095|NCT00396266|19591631|P2|COMPLETED|Overall Study||14
7959096|NCT00396266|19591632|P1|COMPLETED|Overall Study||8
7959097|NCT00396266|19591631|P2|STARTED|Overall Study||14
7959098|NCT00396266|19591632|P1|STARTED|Overall Study||8
7959099|NCT00396253|19591653|P1|NOT COMPLETED|Overall Study||13
7959100|NCT00396253|19591653|P1|COMPLETED|Overall Study||210
7959101|NCT00396253|19591653|P1|STARTED|Overall Study||223
7959102|NCT00396201|19591665|P1|NOT COMPLETED|Follow-up Period||0
7959103|NCT00396201|19591665|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21
7959104|NCT00396201|19591665|P1|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21
7959105|NCT00396201|19591665|P1|NOT COMPLETED|Treatment Period||0
7959106|NCT00396201|19591665|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22
7959107|NCT00396201|19591665|P1|STARTED|Treatment Period||22
7959108|NCT00396162|19591684|P2|NOT COMPLETED|Overall Study||3
7959109|NCT00396162|19591685|P1|NOT COMPLETED|Overall Study||2
7959110|NCT00396162|19591684|P2|COMPLETED|Overall Study||35
7959111|NCT00396162|19591685|P1|COMPLETED|Overall Study||37
7959112|NCT00396162|19591684|P2|STARTED|Overall Study||38
7959113|NCT00396162|19591685|P1|STARTED|Overall Study||39
7959114|NCT00396136|19591697|P1|NOT COMPLETED|Overall Study||125
7959115|NCT00396136|19591697|P1|COMPLETED|Overall Study||96
7959116|NCT00396136|19591697|P1|STARTED|Overall Study||221
7959117|NCT00396097|19591704|P2|NOT COMPLETED|Overall Study||46
7959118|NCT00396097|19591705|P1|NOT COMPLETED|Overall Study||26
7959119|NCT00396097|19591704|P2|COMPLETED|Overall Study||156
7959120|NCT00396097|19591705|P1|COMPLETED|Overall Study||88
7959121|NCT00396097|19591704|P2|STARTED|Overall Study||202
7959122|NCT00396097|19591705|P1|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114
7959123|NCT00396084|19591733|P6|NOT COMPLETED|Overall Study||2
7959124|NCT00396084|19591734|P5|NOT COMPLETED|Overall Study||1
7959125|NCT00396084|19591735|P4|NOT COMPLETED|Overall Study||1
7959126|NCT00396084|19591736|P3|NOT COMPLETED|Overall Study||0
7959127|NCT00396084|19591737|P2|NOT COMPLETED|Overall Study||0
7959128|NCT00396084|19591738|P1|NOT COMPLETED|Overall Study||0
7959129|NCT00396084|19591733|P6|COMPLETED|Overall Study||18
7959130|NCT00396084|19591734|P5|COMPLETED|Overall Study||9
7959131|NCT00396084|19591735|P4|COMPLETED|Overall Study||9
7959132|NCT00396084|19591736|P3|COMPLETED|Overall Study||10
7959133|NCT00396084|19591737|P2|COMPLETED|Overall Study||10
7959134|NCT00396084|19591738|P1|COMPLETED|Overall Study||10
7959135|NCT00396084|19591733|P6|STARTED|Overall Study||20
7959136|NCT00396084|19591734|P5|STARTED|Overall Study||10
7959137|NCT00396084|19591735|P4|STARTED|Overall Study||10
7959138|NCT00396084|19591736|P3|STARTED|Overall Study||10
7959139|NCT00396084|19591737|P2|STARTED|Overall Study||10
7959140|NCT00396084|19591738|P1|STARTED|Overall Study||10
7959141|NCT00396032|19591813|P2|NOT COMPLETED|Overall Study||5
7959142|NCT00396032|19591814|P1|NOT COMPLETED|Overall Study||4
7959143|NCT00396032|19591813|P2|COMPLETED|Overall Study||71
7959144|NCT00396032|19591814|P1|COMPLETED|Overall Study||70
7959145|NCT00396032|19591813|P2|STARTED|Overall Study||76
7959146|NCT00396032|19591814|P1|STARTED|Overall Study||74
7959147|NCT00396019|19591831|P3|NOT COMPLETED|Overall Study||1
7959148|NCT00396019|19591832|P2|NOT COMPLETED|Overall Study||3
7959149|NCT00396019|19591833|P1|NOT COMPLETED|Overall Study||0
7959150|NCT00396019|19591831|P3|COMPLETED|Overall Study||29
7959151|NCT00396019|19591832|P2|COMPLETED|Overall Study||26
7959152|NCT00396019|19591833|P1|COMPLETED|Overall Study||27
7959153|NCT00396019|19591831|P3|STARTED|Overall Study||30
7959154|NCT00396019|19591832|P2|STARTED|Overall Study||29
7959155|NCT00396019|19591833|P1|STARTED|Overall Study||27
7959156|NCT00396006|19591843|P1|NOT COMPLETED|Overall Study||0
7959157|NCT00396006|19591843|P1|COMPLETED|Overall Study||13
7959158|NCT00396006|19591843|P1|STARTED|Overall Study||13
7959159|NCT00395993|19591860|P2|NOT COMPLETED|Overall Study||19
7959160|NCT00395993|19591861|P1|NOT COMPLETED|Overall Study||35
7959161|NCT00395993|19591860|P2|COMPLETED|Overall Study||212
7959162|NCT00395993|19591861|P1|COMPLETED|Overall Study||211
7959163|NCT00395993|19591860|P2|STARTED|Overall Study||231
7959164|NCT00395993|19591861|P1|STARTED|Overall Study||246
7959165|NCT00395967|19591867|P1|NOT COMPLETED|Follow-up Period||2
7959166|NCT00395967|19591867|P1|COMPLETED|Follow-up Period||3
7959167|NCT00395967|19591867|P1|STARTED|Follow-up Period|Participants who had transplants.|5
7959168|NCT00395967|19591867|P1|NOT COMPLETED|Treatment Period||1
7959169|NCT00395967|19591867|P1|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4
7959170|NCT00395967|19591867|P1|STARTED|Treatment Period||5
7959171|NCT00395876|19591878|P2|NOT COMPLETED|Overall Study||0
7959172|NCT00395876|19591879|P1|NOT COMPLETED|Overall Study||3
7959173|NCT00395876|19591878|P2|COMPLETED|Overall Study||50
7959174|NCT00395876|19591879|P1|COMPLETED|Overall Study||47
7959175|NCT00395876|19591878|P2|STARTED|Overall Study||50
7959176|NCT00395876|19591879|P1|STARTED|Overall Study||50
7959177|NCT00395863|19591907|P2|NOT COMPLETED|Overall Study||3
7959178|NCT00395863|19591908|P1|NOT COMPLETED|Overall Study||2
7959179|NCT00395863|19591907|P2|COMPLETED|Overall Study||20
7959180|NCT00395863|19591908|P1|COMPLETED|Overall Study||21
7959181|NCT00395863|19591907|P2|STARTED|Overall Study||23
7959182|NCT00395863|19591908|P1|STARTED|Overall Study||23
7959183|NCT00395850|19591943|P4|NOT COMPLETED|Disulfiram/Placebo Treatment||13
7959184|NCT00395850|19591944|P3|NOT COMPLETED|Disulfiram/Placebo Treatment||19
7959185|NCT00395850|19591945|P2|NOT COMPLETED|Disulfiram/Placebo Treatment||14
7959186|NCT00395850|19591946|P1|NOT COMPLETED|Disulfiram/Placebo Treatment||9
7959187|NCT00395850|19591943|P4|COMPLETED|Disulfiram/Placebo Treatment||8
7959188|NCT00395850|19591944|P3|COMPLETED|Disulfiram/Placebo Treatment||5
7959189|NCT00395850|19591945|P2|COMPLETED|Disulfiram/Placebo Treatment||9
7959190|NCT00395850|19591946|P1|COMPLETED|Disulfiram/Placebo Treatment||11
7959191|NCT00395850|19591943|P4|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21
7959192|NCT00395850|19591944|P3|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24
7959193|NCT00395850|19591945|P2|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23
7959194|NCT00395850|19591946|P1|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20
7959195|NCT00395850|19591943|P4|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4
7959196|NCT00395850|19591944|P3|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6
7959197|NCT00395850|19591945|P2|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2
7959198|NCT00395850|19591946|P1|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5
7959199|NCT00395850|19591943|P4|COMPLETED|Randomization to Disulfiram/ Pre-admin||21
7959200|NCT00395850|19591944|P3|COMPLETED|Randomization to Disulfiram/ Pre-admin||24
7959201|NCT00395850|19591945|P2|COMPLETED|Randomization to Disulfiram/ Pre-admin||23
7959202|NCT00395850|19591946|P1|COMPLETED|Randomization to Disulfiram/ Pre-admin||22
7959203|NCT00395850|19591943|P4|STARTED|Randomization to Disulfiram/ Pre-admin||25
7959204|NCT00395850|19591944|P3|STARTED|Randomization to Disulfiram/ Pre-admin||30
7959205|NCT00395850|19591945|P2|STARTED|Randomization to Disulfiram/ Pre-admin||25
7959206|NCT00395850|19591946|P1|STARTED|Randomization to Disulfiram/ Pre-admin||27
7959207|NCT00395850|19591943|P4|NOT COMPLETED|Pre-randomization Baseline/Induction||0
7959208|NCT00395850|19591944|P3|NOT COMPLETED|Pre-randomization Baseline/Induction||0
7959209|NCT00395850|19591945|P2|NOT COMPLETED|Pre-randomization Baseline/Induction||0
7959210|NCT00395850|19591946|P1|NOT COMPLETED|Pre-randomization Baseline/Induction||11
7959211|NCT00395850|19591943|P4|COMPLETED|Pre-randomization Baseline/Induction||0
7959212|NCT00395850|19591944|P3|COMPLETED|Pre-randomization Baseline/Induction||0
7959213|NCT00395850|19591945|P2|COMPLETED|Pre-randomization Baseline/Induction||0
7959214|NCT00395850|19591946|P1|COMPLETED|Pre-randomization Baseline/Induction||107
7959215|NCT00395850|19591943|P4|STARTED|Pre-randomization Baseline/Induction||0
7959216|NCT00395850|19591944|P3|STARTED|Pre-randomization Baseline/Induction||0
7959217|NCT00395850|19591945|P2|STARTED|Pre-randomization Baseline/Induction||0
7959218|NCT00395850|19591946|P1|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118
7959219|NCT00395746|19591963|P3|NOT COMPLETED|Overall Study||22
7959220|NCT00395746|19591964|P2|NOT COMPLETED|Overall Study||4
7959221|NCT00395746|19591965|P1|NOT COMPLETED|Overall Study||10
7959222|NCT00395746|19591963|P3|COMPLETED|Overall Study|Completed 52 weeks treatment|66
7959223|NCT00395746|19591964|P2|COMPLETED|Overall Study|Completed 52 weeks treatment|84
7959224|NCT00395746|19591965|P1|COMPLETED|Overall Study|Completed 52 weeks treatment|78
7959225|NCT00395746|19591963|P3|STARTED|Overall Study|Exposed to study drug|88
7959226|NCT00395746|19591964|P2|STARTED|Overall Study|Exposed to study drug|88
7959227|NCT00395746|19591965|P1|STARTED|Overall Study|Exposed to study drug|88
7959228|NCT00395733|19592011|P2|NOT COMPLETED|Period 2||5
7959229|NCT00395733|19592012|P1|NOT COMPLETED|Period 2||2
7959230|NCT00395733|19592011|P2|COMPLETED|Period 2||37
7959231|NCT00395733|19592012|P1|COMPLETED|Period 2||39
7959232|NCT00395733|19592011|P2|STARTED|Period 2||42
7959233|NCT00395733|19592012|P1|STARTED|Period 2||41
7959234|NCT00395733|19592011|P2|NOT COMPLETED|Period 1||0
7959235|NCT00395733|19592012|P1|NOT COMPLETED|Period 1||0
7959236|NCT00395733|19592011|P2|COMPLETED|Period 1||42
7959237|NCT00395733|19592012|P1|COMPLETED|Period 1||41
7959238|NCT00395733|19592011|P2|STARTED|Period 1||42
7959239|NCT00395733|19592012|P1|STARTED|Period 1||41
7959240|NCT00395694|19592036|P2|NOT COMPLETED|Continuation Phase||13
7959241|NCT00395694|19592037|P1|NOT COMPLETED|Continuation Phase||15
7959242|NCT00395694|19592036|P2|COMPLETED|Continuation Phase||35
7959243|NCT00395694|19592037|P1|COMPLETED|Continuation Phase||34
7959244|NCT00395694|19592036|P2|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48
7959245|NCT00395694|19592037|P1|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49
7959246|NCT00395694|19592036|P2|NOT COMPLETED|Escalation Phase + Maintenance Phase||2
7959247|NCT00395694|19592037|P1|NOT COMPLETED|Escalation Phase + Maintenance Phase||1
7959248|NCT00395694|19592036|P2|COMPLETED|Escalation Phase + Maintenance Phase||49
7959249|NCT00395694|19592037|P1|COMPLETED|Escalation Phase + Maintenance Phase||50
7959250|NCT00395694|19592036|P2|STARTED|Escalation Phase + Maintenance Phase||51
7959251|NCT00395694|19592037|P1|STARTED|Escalation Phase + Maintenance Phase||51
7959252|NCT00395642|19592068|P1|NOT COMPLETED|Overall Study||13
7959253|NCT00395642|19592068|P1|COMPLETED|Overall Study||53
7959254|NCT00395642|19592068|P1|STARTED|Overall Study||66
7959255|NCT00395629|19592075|P3|NOT COMPLETED|Extension Study||3
7959256|NCT00395629|19592076|P2|NOT COMPLETED|Extension Study||0
7959257|NCT00395629|19592077|P1|NOT COMPLETED|Extension Study||0
7959258|NCT00395629|19592075|P3|COMPLETED|Extension Study||8
7959259|NCT00395629|19592076|P2|COMPLETED|Extension Study||6
7959260|NCT00395629|19592077|P1|COMPLETED|Extension Study||9
7959261|NCT00395629|19592075|P3|STARTED|Extension Study||11
7959262|NCT00395629|19592076|P2|STARTED|Extension Study||6
7959263|NCT00395629|19592077|P1|STARTED|Extension Study||9
7959264|NCT00395629|19592075|P3|NOT COMPLETED|Core Study||7
7959265|NCT00395629|19592076|P2|NOT COMPLETED|Core Study||4
7959266|NCT00395629|19592077|P1|NOT COMPLETED|Core Study||1
7959267|NCT00395629|19592075|P3|COMPLETED|Core Study||16
7959268|NCT00395629|19592076|P2|COMPLETED|Core Study||11
7959269|NCT00395629|19592077|P1|COMPLETED|Core Study||10
7959270|NCT00395629|19592075|P3|STARTED|Core Study||23
7959271|NCT00395629|19592076|P2|STARTED|Core Study||15
7959272|NCT00395629|19592077|P1|STARTED|Core Study||11
7959273|NCT00395538|19592094|P3|NOT COMPLETED|Overall Study||23
7959274|NCT00395538|19592095|P2|NOT COMPLETED|Overall Study||13
7959275|NCT00395538|19592096|P1|NOT COMPLETED|Overall Study||3
7959276|NCT00395538|19592094|P3|COMPLETED|Overall Study||0
7959277|NCT00395538|19592095|P2|COMPLETED|Overall Study||2
7959278|NCT00395538|19592096|P1|COMPLETED|Overall Study||5
7959279|NCT00395538|19592094|P3|Completed Bone Biopsy Year 4|Overall Study||1
7959280|NCT00395538|19592095|P2|Completed Bone Biopsy Year 4|Overall Study||1
7959281|NCT00395538|19592096|P1|Completed Bone Biopsy Year 4|Overall Study||0
7959282|NCT00395538|19592094|P3|Completed Bone Biopsy Year 2|Overall Study||3
7959283|NCT00395538|19592095|P2|Completed Bone Biopsy Year 2|Overall Study||2
7959284|NCT00395538|19592096|P1|Completed Bone Biopsy Year 2|Overall Study||0
7959285|NCT00395538|19592094|P3|Completed Bone Biopsy Year 1|Overall Study||4
7959286|NCT00395538|19592095|P2|Completed Bone Biopsy Year 1|Overall Study||1
7959287|NCT00395538|19592096|P1|Completed Bone Biopsy Year 1|Overall Study||0
7959288|NCT00395538|19592094|P3|Randomized to Bone Biospy Year 4|Overall Study||8
7959289|NCT00395538|19592095|P2|Randomized to Bone Biospy Year 4|Overall Study||2
7959290|NCT00395538|19592096|P1|Randomized to Bone Biospy Year 4|Overall Study||0
7959291|NCT00395538|19592094|P3|Randomized to Bone Biopsy Year 2|Overall Study||6
7959292|NCT00395538|19592095|P2|Randomized to Bone Biopsy Year 2|Overall Study||2
7959293|NCT00395538|19592096|P1|Randomized to Bone Biopsy Year 2|Overall Study||0
7959294|NCT00395538|19592094|P3|Randomized to Bone Biopsy Year 1|Overall Study||5
7959295|NCT00395538|19592095|P2|Randomized to Bone Biopsy Year 1|Overall Study||1
7959296|NCT00395538|19592096|P1|Randomized to Bone Biopsy Year 1|Overall Study||0
7959297|NCT00395538|19592094|P3|Received HPTH on New Protocol|Overall Study||19
7959298|NCT00395538|19592095|P2|Received HPTH on New Protocol|Overall Study||5
7959299|NCT00395538|19592096|P1|Received HPTH on New Protocol|Overall Study||7
7959300|NCT00395538|19592094|P3|Signed Consent to the New Protocol|Overall Study||23
7959301|NCT00395538|19592095|P2|Signed Consent to the New Protocol|Overall Study||5
7959302|NCT00395538|19592096|P1|Signed Consent to the New Protocol|Overall Study||7
7959303|NCT00395538|19592094|P3|STARTED|Overall Study||23
7959304|NCT00395538|19592095|P2|STARTED|Overall Study||15
7959305|NCT00395538|19592096|P1|STARTED|Overall Study||8
7959306|NCT00395512|19592169|P4|NOT COMPLETED|Overall Study||38
7959307|NCT00395512|19592170|P3|NOT COMPLETED|Overall Study||28
7959308|NCT00395512|19592171|P2|NOT COMPLETED|Overall Study||37
7959309|NCT00395512|19592172|P1|NOT COMPLETED|Overall Study||38
7959310|NCT00395512|19592169|P4|COMPLETED|Overall Study||126
7959311|NCT00395512|19592170|P3|COMPLETED|Overall Study||136
7959312|NCT00395512|19592171|P2|COMPLETED|Overall Study||126
7959313|NCT00395512|19592172|P1|COMPLETED|Overall Study||126
7959314|NCT00395512|19592169|P4|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163
7959315|NCT00395512|19592170|P3|Safety Set|Overall Study||164
7959316|NCT00395512|19592171|P2|Safety Set|Overall Study||163
7959317|NCT00395512|19592172|P1|Safety Set|Overall Study||164
7959318|NCT00395512|19592169|P4|STARTED|Overall Study||164
7959319|NCT00395512|19592170|P3|STARTED|Overall Study||164
7959320|NCT00395512|19592171|P2|STARTED|Overall Study||163
7959321|NCT00395512|19592172|P1|STARTED|Overall Study||164
7959322|NCT00395486|19592344|P2|NOT COMPLETED|Overall Study||5
7959323|NCT00395486|19592345|P1|NOT COMPLETED|Overall Study||6
7959324|NCT00395486|19592344|P2|COMPLETED|Overall Study|Completed subjects|121
7959325|NCT00395486|19592345|P1|COMPLETED|Overall Study|Completed subjects|126
7959326|NCT00395486|19592344|P2|STARTED|Overall Study|Randomized subjects|126
7959327|NCT00395486|19592345|P1|STARTED|Overall Study|Randomized subjects|132
7959328|NCT00395460|19592375|P2|NOT COMPLETED|Overall Study||0
7959329|NCT00395460|19592376|P1|NOT COMPLETED|Overall Study||1
7959330|NCT00395460|19592375|P2|COMPLETED|Overall Study||75
7959331|NCT00395460|19592376|P1|COMPLETED|Overall Study||71
7959332|NCT00395460|19592375|P2|Received Treatment|Overall Study||75
7959333|NCT00395460|19592376|P1|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71
7959334|NCT00395460|19592375|P2|STARTED|Overall Study||75
7959335|NCT00395460|19592376|P1|STARTED|Overall Study||72
7959336|NCT00395447|19592400|P2|NOT COMPLETED|Overall Study||111
7959337|NCT00395447|19592401|P1|NOT COMPLETED|Overall Study||121
7959338|NCT00395447|19592400|P2|COMPLETED|Overall Study||602
7959339|NCT00395447|19592401|P1|COMPLETED|Overall Study||910
7959340|NCT00395447|19592400|P2|STARTED|Overall Study||713
7959341|NCT00395447|19592401|P1|STARTED|Overall Study||1031
7959342|NCT00395343|19592409|P2|NOT COMPLETED|Overall Study||36
7959343|NCT00395343|19592410|P1|NOT COMPLETED|Overall Study||41
7959344|NCT00395343|19592409|P2|COMPLETED|Overall Study||283
7959345|NCT00395343|19592410|P1|COMPLETED|Overall Study||281
7959346|NCT00395343|19592409|P2|STARTED|Overall Study||319
7959347|NCT00395343|19592410|P1|STARTED|Overall Study||322
7959348|NCT00395304|19592428|P6|NOT COMPLETED|Treatment Period 3||1
7959349|NCT00395304|19592429|P5|NOT COMPLETED|Treatment Period 3||0
7959350|NCT00395304|19592430|P4|NOT COMPLETED|Treatment Period 3||2
7959351|NCT00395304|19592431|P3|NOT COMPLETED|Treatment Period 3||0
7959352|NCT00395304|19592432|P2|NOT COMPLETED|Treatment Period 3||2
7959353|NCT00395304|19592433|P1|NOT COMPLETED|Treatment Period 3||1
7959354|NCT00395304|19592428|P6|COMPLETED|Treatment Period 3||27
7959355|NCT00395304|19592429|P5|COMPLETED|Treatment Period 3||27
7959356|NCT00395304|19592430|P4|COMPLETED|Treatment Period 3||25
7959357|NCT00395304|19592431|P3|COMPLETED|Treatment Period 3||29
7959358|NCT00395304|19592432|P2|COMPLETED|Treatment Period 3||20
7959359|NCT00395304|19592433|P1|COMPLETED|Treatment Period 3||29
7959360|NCT00395304|19592428|P6|STARTED|Treatment Period 3||28
7959361|NCT00395304|19592429|P5|STARTED|Treatment Period 3||27
7959362|NCT00395304|19592430|P4|STARTED|Treatment Period 3||27
7959363|NCT00395304|19592431|P3|STARTED|Treatment Period 3||29
7959364|NCT00395304|19592432|P2|STARTED|Treatment Period 3||22
7959365|NCT00395304|19592433|P1|STARTED|Treatment Period 3||30
7959366|NCT00395304|19592428|P6|NOT COMPLETED|Treatment Period 2||2
7959367|NCT00395304|19592429|P5|NOT COMPLETED|Treatment Period 2||0
7959368|NCT00395304|19592430|P4|NOT COMPLETED|Treatment Period 2||1
7959369|NCT00395304|19592431|P3|NOT COMPLETED|Treatment Period 2||1
7959370|NCT00395304|19592432|P2|NOT COMPLETED|Treatment Period 2||4
7959371|NCT00395304|19592433|P1|NOT COMPLETED|Treatment Period 2||0
7959372|NCT00395304|19592428|P6|COMPLETED|Treatment Period 2||28
7959373|NCT00395304|19592429|P5|COMPLETED|Treatment Period 2||27
7959374|NCT00395304|19592430|P4|COMPLETED|Treatment Period 2||27
7959375|NCT00395304|19592431|P3|COMPLETED|Treatment Period 2||29
7959376|NCT00395304|19592432|P2|COMPLETED|Treatment Period 2||22
7959377|NCT00395304|19592433|P1|COMPLETED|Treatment Period 2||30
7959378|NCT00395304|19592428|P6|STARTED|Treatment Period 2||30
7959379|NCT00395304|19592429|P5|STARTED|Treatment Period 2||27
7959380|NCT00395304|19592430|P4|STARTED|Treatment Period 2||28
7959381|NCT00395304|19592431|P3|STARTED|Treatment Period 2||30
7959382|NCT00395304|19592432|P2|STARTED|Treatment Period 2||26
7959383|NCT00395304|19592433|P1|STARTED|Treatment Period 2||30
7959384|NCT00395304|19592428|P6|NOT COMPLETED|Treatment Period 1||2
7959385|NCT00395304|19592429|P5|NOT COMPLETED|Treatment Period 1||1
7959386|NCT00395304|19592430|P4|NOT COMPLETED|Treatment Period 1||3
7959387|NCT00395304|19592431|P3|NOT COMPLETED|Treatment Period 1||0
7959388|NCT00395304|19592432|P2|NOT COMPLETED|Treatment Period 1||4
7959389|NCT00395304|19592433|P1|NOT COMPLETED|Treatment Period 1||1
7959390|NCT00395304|19592428|P6|COMPLETED|Treatment Period 1||30
7959391|NCT00395304|19592429|P5|COMPLETED|Treatment Period 1||27
7959392|NCT00395304|19592430|P4|COMPLETED|Treatment Period 1||28
7959393|NCT00395304|19592431|P3|COMPLETED|Treatment Period 1||30
7959394|NCT00395304|19592432|P2|COMPLETED|Treatment Period 1||26
7959395|NCT00395304|19592433|P1|COMPLETED|Treatment Period 1||30
7959396|NCT00395304|19592428|P6|STARTED|Treatment Period 1||32
7959397|NCT00395304|19592429|P5|STARTED|Treatment Period 1||28
7959398|NCT00395304|19592430|P4|STARTED|Treatment Period 1||31
7959399|NCT00395304|19592431|P3|STARTED|Treatment Period 1||30
7959400|NCT00395304|19592432|P2|STARTED|Treatment Period 1||30
7959401|NCT00395304|19592433|P1|STARTED|Treatment Period 1||31
7959402|NCT00395291|19592476|P2|NOT COMPLETED|Second Intervention||0
7959403|NCT00395291|19592477|P1|NOT COMPLETED|Second Intervention||0
7959404|NCT00395291|19592476|P2|COMPLETED|Second Intervention||9
7959405|NCT00395291|19592477|P1|COMPLETED|Second Intervention||13
7959406|NCT00395291|19592476|P2|STARTED|Second Intervention||9
7959407|NCT00395291|19592477|P1|STARTED|Second Intervention||13
7959408|NCT00395291|19592476|P2|NOT COMPLETED|Washout Period for 30 Days||0
7959409|NCT00395291|19592477|P1|NOT COMPLETED|Washout Period for 30 Days||2
7959410|NCT00395291|19592476|P2|COMPLETED|Washout Period for 30 Days||9
7959411|NCT00395291|19592477|P1|COMPLETED|Washout Period for 30 Days||13
7959412|NCT00395291|19592476|P2|STARTED|Washout Period for 30 Days||9
7959413|NCT00395291|19592477|P1|STARTED|Washout Period for 30 Days||15
7959414|NCT00395291|19592476|P2|NOT COMPLETED|First Intervention||0
7959415|NCT00395291|19592477|P1|NOT COMPLETED|First Intervention||2
7959416|NCT00395291|19592476|P2|COMPLETED|First Intervention||9
7959417|NCT00395291|19592477|P1|COMPLETED|First Intervention||15
7959418|NCT00395291|19592476|P2|STARTED|First Intervention||9
7959419|NCT00395291|19592477|P1|STARTED|First Intervention||17
7959420|NCT00395226|19592509|P2|NOT COMPLETED|Overall Study||5
7959421|NCT00395226|19592510|P1|NOT COMPLETED|Overall Study||4
7959422|NCT00395226|19592509|P2|COMPLETED|Overall Study||22
7959423|NCT00395226|19592510|P1|COMPLETED|Overall Study||22
7959424|NCT00395226|19592509|P2|STARTED|Overall Study||27
7959425|NCT00395226|19592510|P1|STARTED|Overall Study||26
7959426|NCT00395161|19592518|P2|NOT COMPLETED|Overall Study||0
7959427|NCT00395161|19592519|P1|NOT COMPLETED|Overall Study||0
7959428|NCT00395161|19592518|P2|COMPLETED|Overall Study||144
7959429|NCT00395161|19592519|P1|COMPLETED|Overall Study||149
7959430|NCT00395161|19592518|P2|STARTED|Overall Study||144
7959431|NCT00395161|19592519|P1|STARTED|Overall Study||149
7959432|NCT00395135|19592535|P5|NOT COMPLETED|Year 2||190
7959433|NCT00395135|19592536|P4|NOT COMPLETED|Year 2||88
7959434|NCT00395135|19592537|P3|NOT COMPLETED|Year 2||147
7959435|NCT00395135|19592538|P2|NOT COMPLETED|Year 2||0
7959436|NCT00395135|19592539|P1|NOT COMPLETED|Year 2||0
7959437|NCT00395135|19592535|P5|COMPLETED|Year 2||507
7959438|NCT00395135|19592536|P4|COMPLETED|Year 2||195
7959439|NCT00395135|19592537|P3|COMPLETED|Year 2||426
7959440|NCT00395135|19592538|P2|COMPLETED|Year 2||0
7959441|NCT00395135|19592539|P1|COMPLETED|Year 2||0
7959442|NCT00395135|19592535|P5|STARTED|Year 2||697
7959443|NCT00395135|19592536|P4|STARTED|Year 2||283
7959444|NCT00395135|19592537|P3|STARTED|Year 2||573
7959445|NCT00395135|19592538|P2|STARTED|Year 2||0
7959446|NCT00395135|19592539|P1|STARTED|Year 2||0
7959447|NCT00395135|19592535|P5|NOT COMPLETED|Year 1||0
7959448|NCT00395135|19592536|P4|NOT COMPLETED|Year 1||0
7959449|NCT00395135|19592537|P3|NOT COMPLETED|Year 1||0
7959450|NCT00395135|19592538|P2|NOT COMPLETED|Year 1||871
7959451|NCT00395135|19592539|P1|NOT COMPLETED|Year 1||712
7959452|NCT00395135|19592535|P5|COMPLETED|Year 1||0
7959453|NCT00395135|19592536|P4|COMPLETED|Year 1||0
7959454|NCT00395135|19592537|P3|COMPLETED|Year 1||0
7959455|NCT00395135|19592538|P2|COMPLETED|Year 1||716
7959456|NCT00395135|19592539|P1|COMPLETED|Year 1||883
7959457|NCT00395135|19592535|P5|STARTED|Year 1||0
7959458|NCT00395135|19592536|P4|STARTED|Year 1||0
7959459|NCT00395135|19592537|P3|STARTED|Year 1||0
7959460|NCT00395135|19592538|P2|STARTED|Year 1||1587
7959461|NCT00395135|19592539|P1|STARTED|Year 1||1595
7959462|NCT00395083|19592557|P2|NOT COMPLETED|Overall Study||8
7959463|NCT00395083|19592558|P1|NOT COMPLETED|Overall Study||10
7959464|NCT00395083|19592557|P2|COMPLETED|Overall Study||201
7959465|NCT00395083|19592558|P1|COMPLETED|Overall Study||207
7959466|NCT00395083|19592557|P2|STARTED|Overall Study||209
7959467|NCT00395083|19592558|P1|STARTED|Overall Study||217
7959468|NCT00395057|19592574|P4|NOT COMPLETED|Overall Study||33
7959469|NCT00395057|19592575|P3|NOT COMPLETED|Overall Study||33
7959470|NCT00395057|19592576|P2|NOT COMPLETED|Overall Study||34
7959471|NCT00395057|19592577|P1|NOT COMPLETED|Overall Study||32
7959472|NCT00395057|19592574|P4|COMPLETED|Overall Study||1
7959473|NCT00395057|19592575|P3|COMPLETED|Overall Study||2
7959474|NCT00395057|19592576|P2|COMPLETED|Overall Study||1
7959475|NCT00395057|19592577|P1|COMPLETED|Overall Study||2
7959476|NCT00395057|19592574|P4|STARTED|Overall Study||34
7959477|NCT00395057|19592575|P3|STARTED|Overall Study||35
7959478|NCT00395057|19592576|P2|STARTED|Overall Study||35
7959479|NCT00395057|19592577|P1|STARTED|Overall Study||34
7959480|NCT00395044|19592605|P2|NOT COMPLETED|Overall Study||14
7959481|NCT00395044|19592606|P1|NOT COMPLETED|Overall Study||18
7959482|NCT00395044|19592605|P2|COMPLETED|Overall Study||11
7959483|NCT00395044|19592606|P1|COMPLETED|Overall Study||7
7959484|NCT00395044|19592605|P2|STARTED|Overall Study||25
7959485|NCT00395044|19592606|P1|STARTED|Overall Study||25
7959486|NCT00395018|19592624|P1|NOT COMPLETED|Off-Treatment Follow-up||4
7959487|NCT00395018|19592624|P1|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1
7959488|NCT00395018|19592624|P1|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5
7959489|NCT00395018|19592624|P1|NOT COMPLETED|On-Treatment||10
7959490|NCT00395018|19592624|P1|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55
7959491|NCT00395018|19592624|P1|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0
7959492|NCT00395018|19592624|P1|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10
7959493|NCT00395018|19592624|P1|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65
7959494|NCT00394953|19592645|P2|NOT COMPLETED|Second Treatment Period||74
7959495|NCT00394953|19592646|P1|NOT COMPLETED|Second Treatment Period||29
7959496|NCT00394953|19592645|P2|COMPLETED|Second Treatment Period||148
7959497|NCT00394953|19592646|P1|COMPLETED|Second Treatment Period||187
7959498|NCT00394953|19592645|P2|STARTED|Second Treatment Period||222
7959499|NCT00394953|19592646|P1|STARTED|Second Treatment Period||216
7959500|NCT00394953|19592645|P2|NOT COMPLETED|First Treatment Period||22
7959501|NCT00394953|19592646|P1|NOT COMPLETED|First Treatment Period||29
7959502|NCT00394953|19592645|P2|COMPLETED|First Treatment Period||222
7959503|NCT00394953|19592646|P1|COMPLETED|First Treatment Period||216
7959504|NCT00394953|19592645|P2|STARTED|First Treatment Period||244
7959505|NCT00394953|19592646|P1|STARTED|First Treatment Period||245
7959506|NCT00394914|19592664|P3|NOT COMPLETED|Treatment Period||6
7959507|NCT00394914|19592665|P2|NOT COMPLETED|Treatment Period||10
7959508|NCT00394914|19592666|P1|NOT COMPLETED|Treatment Period||0
7959509|NCT00394914|19592664|P3|COMPLETED|Treatment Period||151
7959510|NCT00394914|19592665|P2|COMPLETED|Treatment Period||144
7959511|NCT00394914|19592666|P1|COMPLETED|Treatment Period||0
7959512|NCT00394914|19592664|P3|STARTED|Treatment Period||157
7959513|NCT00394914|19592665|P2|STARTED|Treatment Period||154
7959514|NCT00394914|19592666|P1|STARTED|Treatment Period||0
7959515|NCT00394914|19592664|P3|NOT COMPLETED|Pre-exposure Period||0
7959516|NCT00394914|19592665|P2|NOT COMPLETED|Pre-exposure Period||0
7959517|NCT00394914|19592666|P1|NOT COMPLETED|Pre-exposure Period||0
7959518|NCT00394914|19592664|P3|COMPLETED|Pre-exposure Period||0
7959519|NCT00394914|19592665|P2|COMPLETED|Pre-exposure Period||0
7959520|NCT00394914|19592666|P1|COMPLETED|Pre-exposure Period||311
7959521|NCT00394914|19592664|P3|STARTED|Pre-exposure Period||0
7959522|NCT00394914|19592665|P2|STARTED|Pre-exposure Period||0
7959523|NCT00394914|19592666|P1|STARTED|Pre-exposure Period||311
7959524|NCT00394914|19592664|P3|NOT COMPLETED|Screening Period||0
7959525|NCT00394914|19592665|P2|NOT COMPLETED|Screening Period||0
7959526|NCT00394914|19592666|P1|NOT COMPLETED|Screening Period||0
7959527|NCT00394914|19592664|P3|COMPLETED|Screening Period||0
7959528|NCT00394914|19592665|P2|COMPLETED|Screening Period||0
7959529|NCT00394914|19592666|P1|COMPLETED|Screening Period||311
7959530|NCT00394914|19592664|P3|STARTED|Screening Period||0
7959531|NCT00394914|19592665|P2|STARTED|Screening Period||0
7959532|NCT00394914|19592666|P1|STARTED|Screening Period||311
7959533|NCT00394901|19592694|P4|NOT COMPLETED|Double-blind Phase||27
7959534|NCT00394901|19592695|P3|NOT COMPLETED|Double-blind Phase||18
7959535|NCT00394901|19592696|P2|NOT COMPLETED|Double-blind Phase||14
7959536|NCT00394901|19592697|P1|NOT COMPLETED|Double-blind Phase||15
7959537|NCT00394901|19592694|P4|COMPLETED|Double-blind Phase||70
7959538|NCT00394901|19592695|P3|COMPLETED|Double-blind Phase||71
7959539|NCT00394901|19592696|P2|COMPLETED|Double-blind Phase||73
7959540|NCT00394901|19592697|P1|COMPLETED|Double-blind Phase||83
7959541|NCT00394901|19592694|P4|STARTED|Double-blind Phase|Subjects treated with the study drug.|97
7959542|NCT00394901|19592695|P3|STARTED|Double-blind Phase|Subjects treated with the study drug.|89
7959543|NCT00394901|19592696|P2|STARTED|Double-blind Phase|Subjects treated with the study drug.|87
7959544|NCT00394901|19592697|P1|STARTED|Double-blind Phase|Subjects treated with the study drug.|98
7959545|NCT00394901|19592694|P4|NOT COMPLETED|Baseline Phase||0
7959546|NCT00394901|19592695|P3|NOT COMPLETED|Baseline Phase||1
7959547|NCT00394901|19592696|P2|NOT COMPLETED|Baseline Phase||0
7959548|NCT00394901|19592697|P1|NOT COMPLETED|Baseline Phase||0
7959549|NCT00394901|19592694|P4|COMPLETED|Baseline Phase||97
7959550|NCT00394901|19592695|P3|COMPLETED|Baseline Phase||89
7959551|NCT00394901|19592696|P2|COMPLETED|Baseline Phase||87
7959552|NCT00394901|19592697|P1|COMPLETED|Baseline Phase||98
7959553|NCT00394901|19592694|P4|STARTED|Baseline Phase|Subjects randomized|97
7959554|NCT00394901|19592695|P3|STARTED|Baseline Phase|Subjects randomized|90
7959555|NCT00394901|19592696|P2|STARTED|Baseline Phase|Subjects randomized|87
7959556|NCT00394901|19592697|P1|STARTED|Baseline Phase|Subjects randomized|98
7959557|NCT00394888|19592925|P3|NOT COMPLETED|Overall Study||0
7959558|NCT00394888|19592926|P2|NOT COMPLETED|Overall Study||0
7959559|NCT00394888|19592927|P1|NOT COMPLETED|Overall Study||0
7959560|NCT00394888|19592925|P3|COMPLETED|Overall Study||201
7959561|NCT00394888|19592926|P2|COMPLETED|Overall Study||48
7959562|NCT00394888|19592927|P1|COMPLETED|Overall Study||108
7959563|NCT00394888|19592925|P3|STARTED|Overall Study||201
7959564|NCT00394888|19592926|P2|STARTED|Overall Study||48
7959565|NCT00394888|19592927|P1|STARTED|Overall Study||108
7959566|NCT00394836|19592940|P2|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53
7959567|NCT00394836|19592941|P1|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20
7959568|NCT00394836|19592940|P2|COMPLETED|Extended Follow-up Phase (2-5 Years)||5
7959569|NCT00394836|19592941|P1|COMPLETED|Extended Follow-up Phase (2-5 Years)||0
7959570|NCT00394836|19592940|P2|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58
7959571|NCT00394836|19592941|P1|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20
7959572|NCT00394836|19592940|P2|NOT COMPLETED|Teatment or Follow-up Phase||78
7959573|NCT00394836|19592941|P1|NOT COMPLETED|Teatment or Follow-up Phase||28
7959574|NCT00394836|19592940|P2|COMPLETED|Teatment or Follow-up Phase||8
7959575|NCT00394836|19592941|P1|COMPLETED|Teatment or Follow-up Phase||2
7959576|NCT00394836|19592940|P2|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8
7959577|NCT00394836|19592941|P1|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4
7959578|NCT00394836|19592940|P2|STARTED|Teatment or Follow-up Phase||86
7959579|NCT00394836|19592941|P1|STARTED|Teatment or Follow-up Phase||30
7959580|NCT00394771|19592987|P4|NOT COMPLETED|Overall Study||39
7959581|NCT00394771|19592988|P3|NOT COMPLETED|Overall Study||47
7959582|NCT00394771|19592989|P2|NOT COMPLETED|Overall Study||34
7959583|NCT00394771|19592990|P1|NOT COMPLETED|Overall Study||41
7959584|NCT00394771|19592987|P4|COMPLETED|Overall Study||109
7959585|NCT00394771|19592988|P3|COMPLETED|Overall Study||96
7959586|NCT00394771|19592989|P2|COMPLETED|Overall Study||102
7959587|NCT00394771|19592990|P1|COMPLETED|Overall Study||99
7959588|NCT00394771|19592987|P4|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120
7959589|NCT00394771|19592988|P3|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108
7959590|NCT00394771|19592989|P2|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
7959591|NCT00394771|19592990|P1|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
7959592|NCT00394771|19592987|P4|STARTED|Overall Study|Safety population of treated participants|148
7959593|NCT00394771|19592988|P3|STARTED|Overall Study|Safety population of treated participants|143
7959594|NCT00394771|19592989|P2|STARTED|Overall Study|Safety population of treated participants|136
7959595|NCT00394771|19592990|P1|STARTED|Overall Study|Safety population of treated participants|140
7959596|NCT00394706|19593060|P8|NOT COMPLETED|Overall Study||0
7959597|NCT00394706|19593061|P7|NOT COMPLETED|Overall Study||3
7959598|NCT00394706|19593062|P6|NOT COMPLETED|Overall Study||7
7959599|NCT00394706|19593063|P5|NOT COMPLETED|Overall Study||2
7959600|NCT00394706|19593064|P4|NOT COMPLETED|Overall Study||1
7959601|NCT00394706|19593065|P3|NOT COMPLETED|Overall Study||9
7959602|NCT00394706|19593066|P2|NOT COMPLETED|Overall Study||2
7959603|NCT00394706|19593067|P1|NOT COMPLETED|Overall Study||4
7959604|NCT00394706|19593060|P8|COMPLETED|Overall Study||851
7959605|NCT00394706|19593061|P7|COMPLETED|Overall Study||926
7959606|NCT00394706|19593062|P6|COMPLETED|Overall Study||1377
7959607|NCT00394706|19593063|P5|COMPLETED|Overall Study||1634
7959608|NCT00394706|19593064|P4|COMPLETED|Overall Study||1632
7959609|NCT00394706|19593065|P3|COMPLETED|Overall Study||1615
7959610|NCT00394706|19593066|P2|COMPLETED|Overall Study||1860
7959611|NCT00394706|19593067|P1|COMPLETED|Overall Study||1815
7959612|NCT00394706|19593060|P8|STARTED|Overall Study||851
7959613|NCT00394706|19593061|P7|STARTED|Overall Study||929
7959614|NCT00394706|19593062|P6|STARTED|Overall Study||1384
7959615|NCT00394706|19593063|P5|STARTED|Overall Study||1636
7959616|NCT00394706|19593064|P4|STARTED|Overall Study||1633
7959617|NCT00394706|19593065|P3|STARTED|Overall Study||1624
7959618|NCT00394706|19593066|P2|STARTED|Overall Study||1862
7959619|NCT00394706|19593067|P1|STARTED|Overall Study||1819
7959620|NCT00394654|19593099|P2|NOT COMPLETED|Overall Study||0
7959621|NCT00394654|19593100|P1|NOT COMPLETED|Overall Study||2
7959622|NCT00394654|19593099|P2|COMPLETED|Overall Study||15
7959623|NCT00394654|19593100|P1|COMPLETED|Overall Study||13
7959624|NCT00394654|19593099|P2|STARTED|Overall Study||15
7959625|NCT00394654|19593100|P1|STARTED|Overall Study||15
7959626|NCT00394589|19593165|P3|NOT COMPLETED|Overall Study||7
7959627|NCT00394589|19593166|P2|NOT COMPLETED|Overall Study||3
7959628|NCT00394589|19593167|P1|NOT COMPLETED|Overall Study||8
7959629|NCT00394589|19593165|P3|COMPLETED|Overall Study||11
7959630|NCT00394589|19593166|P2|COMPLETED|Overall Study||8
7959631|NCT00394589|19593167|P1|COMPLETED|Overall Study||6
7959632|NCT00394589|19593165|P3|STARTED|Overall Study||18
7959633|NCT00394589|19593166|P2|STARTED|Overall Study||11
7959634|NCT00394589|19593167|P1|STARTED|Overall Study||14
7959635|NCT00394524|19593177|P2|NOT COMPLETED|Overall Study||4
7959636|NCT00394524|19593178|P1|NOT COMPLETED|Overall Study||3
7959637|NCT00394524|19593177|P2|COMPLETED|Overall Study||76
7959638|NCT00394524|19593178|P1|COMPLETED|Overall Study||77
7959639|NCT00394524|19593177|P2|STARTED|Overall Study||80
7959640|NCT00394524|19593178|P1|STARTED|Overall Study||80
7959641|NCT00394472|19593192|P2|NOT COMPLETED|Overall Study||11
7959642|NCT00394472|19593193|P1|NOT COMPLETED|Overall Study||9
7959643|NCT00394472|19593192|P2|COMPLETED|Overall Study||111
7959644|NCT00394472|19593193|P1|COMPLETED|Overall Study||113
7959645|NCT00394472|19593192|P2|STARTED|Overall Study||122
7959646|NCT00394472|19593193|P1|STARTED|Overall Study||122
7959647|NCT00394433|19593201|P1|NOT COMPLETED|Overall Study||3
7959648|NCT00394433|19593201|P1|COMPLETED|Overall Study||35
7959649|NCT00394433|19593201|P1|Evaluable and Treated|Overall Study||35
7959650|NCT00394433|19593201|P1|STARTED|Overall Study||38
7959651|NCT00394355|19593212|P4|NOT COMPLETED|Overall Study||31
7959652|NCT00394355|19593213|P3|NOT COMPLETED|Overall Study||38
7959653|NCT00394355|19593214|P2|NOT COMPLETED|Overall Study||34
7959654|NCT00394355|19593215|P1|NOT COMPLETED|Overall Study||35
7959655|NCT00394355|19593212|P4|COMPLETED|Overall Study||111
7959656|NCT00394355|19593213|P3|COMPLETED|Overall Study||109
7959657|NCT00394355|19593214|P2|COMPLETED|Overall Study||103
7959658|NCT00394355|19593215|P1|COMPLETED|Overall Study||105
7959659|NCT00394355|19593212|P4|STARTED|Overall Study||142
7959660|NCT00394355|19593213|P3|STARTED|Overall Study||147
7959661|NCT00394355|19593214|P2|STARTED|Overall Study||137
7959662|NCT00394355|19593215|P1|STARTED|Overall Study||140
7959663|NCT00394329|19593241|P4|NOT COMPLETED|Overall Study||24
7959664|NCT00394329|19593242|P3|NOT COMPLETED|Overall Study||13
7959665|NCT00394329|19593243|P2|NOT COMPLETED|Overall Study||9
7959666|NCT00394329|19593244|P1|NOT COMPLETED|Overall Study||8
7959667|NCT00394329|19593241|P4|COMPLETED|Overall Study||50
7959668|NCT00394329|19593242|P3|COMPLETED|Overall Study||58
7959669|NCT00394329|19593243|P2|COMPLETED|Overall Study||63
7959670|NCT00394329|19593244|P1|COMPLETED|Overall Study||63
7959671|NCT00394329|19593241|P4|STARTED|Overall Study||74
7959672|NCT00394329|19593242|P3|STARTED|Overall Study||71
7959673|NCT00394329|19593243|P2|STARTED|Overall Study||72
7959674|NCT00394329|19593244|P1|STARTED|Overall Study||71
7959675|NCT00394277|19593294|P4|NOT COMPLETED|Overall Study||125
7959676|NCT00394277|19593295|P3|NOT COMPLETED|Overall Study||120
7959677|NCT00394277|19593296|P2|NOT COMPLETED|Overall Study||60
7959678|NCT00394277|19593297|P1|NOT COMPLETED|Overall Study||58
7959679|NCT00394277|19593294|P4|COMPLETED|Overall Study||266
7959680|NCT00394277|19593295|P3|COMPLETED|Overall Study||273
7959681|NCT00394277|19593296|P2|COMPLETED|Overall Study||136
7959682|NCT00394277|19593297|P1|COMPLETED|Overall Study||137
7959683|NCT00394277|19593294|P4|STARTED|Overall Study||391
7959684|NCT00394277|19593295|P3|STARTED|Overall Study||393
7959685|NCT00394277|19593296|P2|STARTED|Overall Study||196
7959686|NCT00394277|19593297|P1|STARTED|Overall Study||195
7959687|NCT00394251|19593321|P2|NOT COMPLETED|Overall Study||38
7959688|NCT00394251|19593322|P1|NOT COMPLETED|Overall Study||37
7959689|NCT00394251|19593321|P2|COMPLETED|Overall Study||61
7959690|NCT00394251|19593322|P1|COMPLETED|Overall Study||61
7959691|NCT00394251|19593321|P2|At Least One Dose of Taxane|Overall Study||93
7959692|NCT00394251|19593322|P1|At Least One Dose of Taxane|Overall Study||93
7959693|NCT00394251|19593321|P2|STARTED|Overall Study||99
7959694|NCT00394251|19593322|P1|STARTED|Overall Study||98
7959695|NCT00394212|19593350|P2|NOT COMPLETED|Overall Study||1
7959696|NCT00394212|19593351|P1|NOT COMPLETED|Overall Study||7
7959697|NCT00394212|19593350|P2|COMPLETED|Overall Study||26
7959698|NCT00394212|19593351|P1|COMPLETED|Overall Study||43
7959699|NCT00394212|19593350|P2|6 Month Follow-up|Overall Study||26
7959700|NCT00394212|19593351|P1|6 Month Follow-up|Overall Study||43
7959701|NCT00394212|19593350|P2|3 Month Follow-up|Overall Study||26
7959702|NCT00394212|19593351|P1|3 Month Follow-up|Overall Study||45
7959703|NCT00394212|19593350|P2|6 Week Follow-up|Overall Study||26
7959704|NCT00394212|19593351|P1|6 Week Follow-up|Overall Study||45
7959705|NCT00394212|19593350|P2|STARTED|Overall Study||27
7959706|NCT00394212|19593351|P1|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50
7959707|NCT00394095|19593365|P2|NOT COMPLETED|Overall Study||0
7959708|NCT00394095|19593366|P1|NOT COMPLETED|Overall Study||1
7959709|NCT00394095|19593365|P2|COMPLETED|Overall Study||14
7959710|NCT00394095|19593366|P1|COMPLETED|Overall Study||16
7959711|NCT00394095|19593365|P2|Screened|Overall Study||14
7959712|NCT00394095|19593366|P1|Screened|Overall Study||17
7959713|NCT00394095|19593365|P2|STARTED|Overall Study||14
7959714|NCT00394095|19593366|P1|STARTED|Overall Study||17
7959715|NCT00394082|19593374|P1|NOT COMPLETED|Overall Study||26
7959716|NCT00394082|19593374|P1|COMPLETED|Overall Study|Treatment completed upon disease progression|24
7959717|NCT00394082|19593374|P1|At Least One Response Assessment|Overall Study||43
7959718|NCT00394082|19593374|P1|STARTED|Overall Study||50
7959719|NCT00393978|19593385|P2|NOT COMPLETED|Overall Study||20
7959720|NCT00393978|19593386|P1|NOT COMPLETED|Overall Study||16
7959721|NCT00393978|19593385|P2|COMPLETED|Overall Study||18
7959722|NCT00393978|19593386|P1|COMPLETED|Overall Study||21
7959723|NCT00393978|19593385|P2|STARTED|Overall Study||38
7959724|NCT00393978|19593386|P1|STARTED|Overall Study||37
7959725|NCT00393939|19593396|P2|NOT COMPLETED|Overall Study||297
7959726|NCT00393939|19593397|P1|NOT COMPLETED|Overall Study||296
7959727|NCT00393939|19593396|P2|COMPLETED|Overall Study||0
7959728|NCT00393939|19593397|P1|COMPLETED|Overall Study||0
7959729|NCT00393939|19593396|P2|Treated|Overall Study||293
7959730|NCT00393939|19593397|P1|Treated|Overall Study||295
7959731|NCT00393939|19593396|P2|STARTED|Overall Study||297
7959732|NCT00393939|19593397|P1|STARTED|Overall Study||296
7959733|NCT00393913|19593415|P1|NOT COMPLETED|CPAP Withdrawal||0
7959734|NCT00393913|19593415|P1|COMPLETED|CPAP Withdrawal||42
7959735|NCT00393913|19593415|P1|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42
7959736|NCT00393913|19593415|P1|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42
7959737|NCT00393913|19593415|P1|NOT COMPLETED|CPAP||7
7959738|NCT00393913|19593415|P1|COMPLETED|CPAP||93
7959739|NCT00393913|19593415|P1|STARTED|CPAP|Excludes normal volunteers without OSA|100
7959740|NCT00393913|19593415|P1|NOT COMPLETED|Initial Assessment||37
7959741|NCT00393913|19593415|P1|COMPLETED|Initial Assessment||107
7959742|NCT00393913|19593415|P1|STARTED|Initial Assessment||144
7959743|NCT00393887|19593423|P2|NOT COMPLETED|Overall Study||9
7959744|NCT00393887|19593424|P1|NOT COMPLETED|Overall Study||16
7959745|NCT00393887|19593423|P2|COMPLETED|Overall Study||41
7959746|NCT00393887|19593424|P1|COMPLETED|Overall Study||34
7959747|NCT00393887|19593423|P2|1 Year|Overall Study||50
7959748|NCT00393887|19593424|P1|1 Year|Overall Study||45
7959749|NCT00393887|19593423|P2|STARTED|Overall Study||50
7959750|NCT00393887|19593424|P1|STARTED|Overall Study||50
7959751|NCT00393874|19593433|P3|NOT COMPLETED|Overall Study||2
7959752|NCT00393874|19593434|P2|NOT COMPLETED|Overall Study||4
7959753|NCT00393874|19593435|P1|NOT COMPLETED|Overall Study||3
7959754|NCT00393874|19593433|P3|COMPLETED|Overall Study||13
7959755|NCT00393874|19593434|P2|COMPLETED|Overall Study||13
7959756|NCT00393874|19593435|P1|COMPLETED|Overall Study||15
7959757|NCT00393874|19593433|P3|STARTED|Overall Study||15
7959758|NCT00393874|19593434|P2|STARTED|Overall Study||17
7959759|NCT00393874|19593435|P1|STARTED|Overall Study||18
7959760|NCT00393861|19593452|P1|NOT COMPLETED|Overall Study||26
7959761|NCT00393861|19593452|P1|COMPLETED|Overall Study||3
7959762|NCT00393861|19593452|P1|STARTED|Overall Study||29
7959763|NCT00393848|19593463|P4|NOT COMPLETED|Overall Study||1
7959764|NCT00393848|19593464|P3|NOT COMPLETED|Overall Study||2
7959765|NCT00393848|19593465|P2|NOT COMPLETED|Overall Study||0
7959766|NCT00393848|19593466|P1|NOT COMPLETED|Overall Study||0
7959767|NCT00393848|19593463|P4|COMPLETED|Overall Study||8
7959768|NCT00393848|19593464|P3|COMPLETED|Overall Study||4
7959769|NCT00393848|19593465|P2|COMPLETED|Overall Study||9
7959770|NCT00393848|19593466|P1|COMPLETED|Overall Study||16
7959771|NCT00393848|19593463|P4|STARTED|Overall Study||9
7959772|NCT00393848|19593464|P3|STARTED|Overall Study||6
7959773|NCT00393848|19593465|P2|STARTED|Overall Study||9
7959774|NCT00393848|19593466|P1|STARTED|Overall Study||16
7959775|NCT00393796|19593480|P2|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
7959776|NCT00393796|19593481|P1|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
7959777|NCT00393796|19593480|P2|COMPLETED|Open Label Period - Placebo to SUTENT||16
7959778|NCT00393796|19593481|P1|COMPLETED|Open Label Period - Placebo to SUTENT||0
7959779|NCT00393796|19593480|P2|STARTED|Open Label Period - Placebo to SUTENT||16
7959780|NCT00393796|19593481|P1|STARTED|Open Label Period - Placebo to SUTENT||0
7959781|NCT00393796|19593480|P2|NOT COMPLETED|Double Blind Period||0
7959782|NCT00393796|19593481|P1|NOT COMPLETED|Double Blind Period||0
7959783|NCT00393796|19593480|P2|COMPLETED|Double Blind Period||28
7959784|NCT00393796|19593481|P1|COMPLETED|Double Blind Period||26
7959785|NCT00393796|19593480|P2|STARTED|Double Blind Period||28
7959786|NCT00393796|19593481|P1|STARTED|Double Blind Period||26
7959787|NCT00393718|19593489|P2|NOT COMPLETED|Overall Study||22
7959788|NCT00393718|19593490|P1|NOT COMPLETED|Overall Study||43
7959789|NCT00393718|19593489|P2|COMPLETED|Overall Study||110
7959790|NCT00393718|19593490|P1|COMPLETED|Overall Study||225
7959791|NCT00393718|19593489|P2|STARTED|Overall Study||132
7959792|NCT00393718|19593490|P1|STARTED|Overall Study||268
7959793|NCT00393705|19593522|P2|NOT COMPLETED|Overall Study||23
7959794|NCT00393705|19593523|P1|NOT COMPLETED|Overall Study||23
7959795|NCT00393705|19593522|P2|COMPLETED|Overall Study||128
7959796|NCT00393705|19593523|P1|COMPLETED|Overall Study||128
7959797|NCT00393705|19593522|P2|Received at Least One Dose of Study Drug|Overall Study||139
7959798|NCT00393705|19593523|P1|Received at Least One Dose of Study Drug|Overall Study||139
7959799|NCT00393705|19593522|P2|STARTED|Overall Study||151
7959800|NCT00393705|19593523|P1|STARTED|Overall Study||151
7959801|NCT00393523|19593552|P5|NOT COMPLETED|Overall Study||1
7959802|NCT00393523|19593553|P4|NOT COMPLETED|Overall Study||6
7959803|NCT00393523|19593554|P3|NOT COMPLETED|Overall Study||4
7959804|NCT00393523|19593555|P2|NOT COMPLETED|Overall Study||9
7959805|NCT00393523|19593556|P1|NOT COMPLETED|Overall Study||12
7959806|NCT00393523|19593552|P5|COMPLETED|Overall Study||19
7959807|NCT00393523|19593553|P4|COMPLETED|Overall Study||348
7959808|NCT00393523|19593554|P3|COMPLETED|Overall Study||349
7959809|NCT00393523|19593555|P2|COMPLETED|Overall Study||366
7959810|NCT00393523|19593556|P1|COMPLETED|Overall Study||364
7959811|NCT00393523|19593552|P5|Vaccination Visit 1|Overall Study||20
7959812|NCT00393523|19593553|P4|Vaccination Visit 1|Overall Study||352
7959813|NCT00393523|19593554|P3|Vaccination Visit 1|Overall Study||349
7959814|NCT00393523|19593555|P2|Vaccination Visit 1|Overall Study||375
7959815|NCT00393523|19593556|P1|Vaccination Visit 1|Overall Study||374
7959816|NCT00393523|19593552|P5|STARTED|Overall Study||20
7959817|NCT00393523|19593553|P4|STARTED|Overall Study||354
7959818|NCT00393523|19593554|P3|STARTED|Overall Study||353
7959819|NCT00393523|19593555|P2|STARTED|Overall Study||375
7959820|NCT00393523|19593556|P1|STARTED|Overall Study||376
7959821|NCT00393510|19593573|P2|NOT COMPLETED|Overall Study||9
7959822|NCT00393510|19593574|P1|NOT COMPLETED|Overall Study||3
7959823|NCT00393510|19593573|P2|COMPLETED|Overall Study||31
7959824|NCT00393510|19593574|P1|COMPLETED|Overall Study||37
7959825|NCT00393510|19593573|P2|STARTED|Overall Study||40
7959826|NCT00393510|19593574|P1|STARTED|Overall Study||40
7959827|NCT00393484|19593586|P2|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23
7959828|NCT00393484|19593587|P1|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8
7959829|NCT00393484|19593586|P2|COMPLETED|Open-label Period (Weeks 96 to 240)||21
7959830|NCT00393484|19593587|P1|COMPLETED|Open-label Period (Weeks 96 to 240)||40
7959831|NCT00393484|19593586|P2|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2
7959832|NCT00393484|19593587|P1|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0
7959833|NCT00393484|19593586|P2|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
7959834|NCT00393484|19593587|P1|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
7959835|NCT00393484|19593586|P2|STARTED|Open-label Period (Weeks 96 to 240)||44
7959836|NCT00393484|19593587|P1|STARTED|Open-label Period (Weeks 96 to 240)||48
7959837|NCT00393484|19593586|P2|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12
7959838|NCT00393484|19593587|P1|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2
7959839|NCT00393484|19593586|P2|COMPLETED|Double-blind Period (Day 1 to Week 96)||52
7959840|NCT00393484|19593587|P1|COMPLETED|Double-blind Period (Day 1 to Week 96)||54
7959841|NCT00393484|19593586|P2|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
7959842|NCT00393484|19593587|P1|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
7959843|NCT00393484|19593586|P2|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64
7959844|NCT00393484|19593587|P1|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56
7959845|NCT00393458|19593623|P4|NOT COMPLETED|Overall Study||137
7959846|NCT00393458|19593624|P3|NOT COMPLETED|Overall Study||112
7959847|NCT00393458|19593625|P2|NOT COMPLETED|Overall Study||102
7959848|NCT00393458|19593626|P1|NOT COMPLETED|Overall Study||99
7959849|NCT00393458|19593623|P4|COMPLETED|Overall Study||295
7959850|NCT00393458|19593624|P3|COMPLETED|Overall Study||323
7959851|NCT00393458|19593625|P2|COMPLETED|Overall Study||326
7959852|NCT00393458|19593626|P1|COMPLETED|Overall Study||338
7959853|NCT00393458|19593623|P4|Exposed to Study Medication or Placebo|Overall Study||432
7959854|NCT00393458|19593624|P3|Exposed to Study Medication or Placebo|Overall Study||434
7959855|NCT00393458|19593625|P2|Exposed to Study Medication or Placebo|Overall Study||425
7959856|NCT00393458|19593626|P1|Exposed to Study Medication or Placebo|Overall Study||437
7959857|NCT00393458|19593623|P4|STARTED|Overall Study||432
7959858|NCT00393458|19593624|P3|STARTED|Overall Study||435
7959859|NCT00393458|19593625|P2|STARTED|Overall Study||428
7959860|NCT00393458|19593626|P1|STARTED|Overall Study||437
7959861|NCT00393380|19593640|P1|NOT COMPLETED|Overall Study||0
7959862|NCT00393380|19593640|P1|COMPLETED|Overall Study||13
7959863|NCT00393380|19593640|P1|STARTED|Overall Study||13
7959864|NCT00393367|19593653|P2|NOT COMPLETED|Overall Study||7
7959865|NCT00393367|19593654|P1|NOT COMPLETED|Overall Study||2
7959866|NCT00393367|19593653|P2|COMPLETED|Overall Study||81
7959867|NCT00393367|19593654|P1|COMPLETED|Overall Study||89
7959868|NCT00393367|19593653|P2|STARTED|Overall Study||88
7959869|NCT00393367|19593654|P1|STARTED|Overall Study||91
7959870|NCT00393094|19593682|P1|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1
7959871|NCT00393094|19593682|P1|COMPLETED|Disease Progression After Trtmt: Onstudy||29
7959872|NCT00393094|19593682|P1|STARTED|Disease Progression After Trtmt: Onstudy||30
7959873|NCT00393094|19593682|P1|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1
7959874|NCT00393094|19593682|P1|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30
7959875|NCT00393094|19593682|P1|STARTED|Period1Bevacizumab & Irinotecan Patients||31
7959876|NCT00393068|19593689|P1|NOT COMPLETED|Overall Study||18
7959877|NCT00393068|19593689|P1|COMPLETED|Overall Study||44
7959878|NCT00393068|19593689|P1|STARTED|Overall Study||62
7959879|NCT00393042|19593693|P2|NOT COMPLETED|Second Intervetion||8
7959880|NCT00393042|19593694|P1|NOT COMPLETED|Second Intervetion||2
7959881|NCT00393042|19593693|P2|COMPLETED|Second Intervetion||19
7959882|NCT00393042|19593694|P1|COMPLETED|Second Intervetion||24
7959883|NCT00393042|19593693|P2|Completed 25/30 mg Dosage|Second Intervetion||20
7959884|NCT00393042|19593694|P1|Completed 25/30 mg Dosage|Second Intervetion||24
7959885|NCT00393042|19593693|P2|Completed the 20mg Dosage|Second Intervetion||21
7959886|NCT00393042|19593694|P1|Completed the 20mg Dosage|Second Intervetion||24
7959887|NCT00393042|19593693|P2|Completed 10 mg Dosage|Second Intervetion||24
7959888|NCT00393042|19593694|P1|Completed 10 mg Dosage|Second Intervetion||26
7959889|NCT00393042|19593693|P2|Completed Placebo Dosage|Second Intervetion||21
7959890|NCT00393042|19593694|P1|Completed Placebo Dosage|Second Intervetion||25
7959891|NCT00393042|19593693|P2|STARTED|Second Intervetion||27
7959892|NCT00393042|19593694|P1|STARTED|Second Intervetion||26
7959893|NCT00393042|19593693|P2|NOT COMPLETED|First Intervention||6
7959894|NCT00393042|19593694|P1|NOT COMPLETED|First Intervention||5
7959895|NCT00393042|19593693|P2|COMPLETED|First Intervention||27
7959896|NCT00393042|19593694|P1|COMPLETED|First Intervention||26
7959897|NCT00393042|19593693|P2|Completed 25/30mg Dosage|First Intervention||27
7959898|NCT00393042|19593694|P1|Completed 25/30mg Dosage|First Intervention||27
7959899|NCT00393042|19593693|P2|Completed 20 mg Dosage|First Intervention||28
7959900|NCT00393042|19593694|P1|Completed 20 mg Dosage|First Intervention||26
7959901|NCT00393042|19593693|P2|Completed 10mg Dosage|First Intervention||29
7959902|NCT00393042|19593694|P1|Completed 10mg Dosage|First Intervention||29
7959903|NCT00393042|19593693|P2|Completed the Placebo Dosage|First Intervention||29
7959904|NCT00393042|19593694|P1|Completed the Placebo Dosage|First Intervention||27
7959905|NCT00393042|19593693|P2|STARTED|First Intervention||33
7959906|NCT00393042|19593694|P1|STARTED|First Intervention||31
7959907|NCT00393029|19593766|P2|NOT COMPLETED|Overall Study||1
7959908|NCT00393029|19593767|P1|NOT COMPLETED|Overall Study||0
7959909|NCT00393029|19593766|P2|COMPLETED|Overall Study||9
7959910|NCT00393029|19593767|P1|COMPLETED|Overall Study||2
7959911|NCT00393029|19593766|P2|STARTED|Overall Study||10
7959912|NCT00393029|19593767|P1|STARTED|Overall Study||2
7959913|NCT00392990|19593778|P2|NOT COMPLETED|Follow up for 2 Years||0
7959914|NCT00392990|19593779|P1|NOT COMPLETED|Follow up for 2 Years||4
7959915|NCT00392990|19593778|P2|COMPLETED|Follow up for 2 Years||5
7959916|NCT00392990|19593779|P1|COMPLETED|Follow up for 2 Years||16
7959917|NCT00392990|19593778|P2|STARTED|Follow up for 2 Years||5
7959918|NCT00392990|19593779|P1|STARTED|Follow up for 2 Years||20
7959919|NCT00392990|19593778|P2|NOT COMPLETED|Treatment on Study||1
7959920|NCT00392990|19593779|P1|NOT COMPLETED|Treatment on Study||3
7959921|NCT00392990|19593778|P2|COMPLETED|Treatment on Study||4
7959922|NCT00392990|19593779|P1|COMPLETED|Treatment on Study||17
7959923|NCT00392990|19593778|P2|STARTED|Treatment on Study||5
7959924|NCT00392990|19593779|P1|STARTED|Treatment on Study||20
7959925|NCT00392951|19593791|P1|NOT COMPLETED|Overall Study||0
7959926|NCT00392951|19593791|P1|COMPLETED|Overall Study||30
7959927|NCT00392951|19593791|P1|STARTED|Overall Study||30
7959928|NCT00392925|19593803|P4|NOT COMPLETED|Randomization to Treatment Group Period||18
7959929|NCT00392925|19593804|P3|NOT COMPLETED|Randomization to Treatment Group Period||19
7959930|NCT00392925|19593805|P2|NOT COMPLETED|Randomization to Treatment Group Period||8
7959931|NCT00392925|19593806|P1|NOT COMPLETED|Randomization to Treatment Group Period||0
7959932|NCT00392925|19593803|P4|COMPLETED|Randomization to Treatment Group Period|At Week 20|38
7959933|NCT00392925|19593804|P3|COMPLETED|Randomization to Treatment Group Period|At Week 20|37
7959934|NCT00392925|19593805|P2|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19
7959935|NCT00392925|19593806|P1|COMPLETED|Randomization to Treatment Group Period||0
7959936|NCT00392925|19593803|P4|STARTED|Randomization to Treatment Group Period||56
7959937|NCT00392925|19593804|P3|STARTED|Randomization to Treatment Group Period||56
7959938|NCT00392925|19593805|P2|STARTED|Randomization to Treatment Group Period||27
7959939|NCT00392925|19593806|P1|STARTED|Randomization to Treatment Group Period||0
7959940|NCT00392925|19593803|P4|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
7959941|NCT00392925|19593804|P3|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
7959942|NCT00392925|19593805|P2|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
7959943|NCT00392925|19593806|P1|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38
7959944|NCT00392925|19593803|P4|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
7959945|NCT00392925|19593804|P3|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
7959946|NCT00392925|19593805|P2|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
7959947|NCT00392925|19593806|P1|COMPLETED|4 Week Lead-In Period - Non-Randomized||139
7959948|NCT00392925|19593803|P4|STARTED|4 Week Lead-In Period - Non-Randomized||0
7959949|NCT00392925|19593804|P3|STARTED|4 Week Lead-In Period - Non-Randomized||0
7959950|NCT00392925|19593805|P2|STARTED|4 Week Lead-In Period - Non-Randomized||0
7959951|NCT00392925|19593806|P1|STARTED|4 Week Lead-In Period - Non-Randomized||177
7959952|NCT00392860|19593894|P3|NOT COMPLETED|Overall Study||0
7959953|NCT00392860|19593895|P2|NOT COMPLETED|Overall Study||0
7959954|NCT00392860|19593896|P1|NOT COMPLETED|Overall Study||0
7959955|NCT00392860|19593894|P3|COMPLETED|Overall Study||1
7959956|NCT00392860|19593895|P2|COMPLETED|Overall Study||0
7959957|NCT00392860|19593896|P1|COMPLETED|Overall Study||3
7959958|NCT00392860|19593894|P3|STARTED|Overall Study||1
7959959|NCT00392860|19593895|P2|STARTED|Overall Study||0
7959960|NCT00392860|19593896|P1|STARTED|Overall Study||3
7959961|NCT00392834|19593904|P2|NOT COMPLETED|Overall Study||0
7959962|NCT00392834|19593905|P1|NOT COMPLETED|Overall Study||0
7959963|NCT00392834|19593904|P2|COMPLETED|Overall Study||32
7959964|NCT00392834|19593905|P1|COMPLETED|Overall Study||2
7959965|NCT00392834|19593904|P2|STARTED|Overall Study||32
7959966|NCT00392834|19593905|P1|STARTED|Overall Study||2
7959967|NCT00392821|19593911|P1|NOT COMPLETED|Overall Study||19
7959968|NCT00392821|19593911|P1|COMPLETED|Overall Study||59
7959969|NCT00392821|19593911|P1|STARTED|Overall Study||78
7959970|NCT00392808|19593920|P4|NOT COMPLETED|Overall Study||4
7959971|NCT00392808|19593921|P3|NOT COMPLETED|Overall Study||2
7959972|NCT00392808|19593922|P2|NOT COMPLETED|Overall Study||3
7959973|NCT00392808|19593923|P1|NOT COMPLETED|Overall Study||6
7959974|NCT00392808|19593920|P4|COMPLETED|Overall Study||100
7959975|NCT00392808|19593921|P3|COMPLETED|Overall Study||107
7959976|NCT00392808|19593922|P2|COMPLETED|Overall Study||86
7959977|NCT00392808|19593923|P1|COMPLETED|Overall Study||81
7959978|NCT00392808|19593920|P4|STARTED|Overall Study||104
7959979|NCT00392808|19593921|P3|STARTED|Overall Study||109
7959980|NCT00392808|19593922|P2|STARTED|Overall Study||89
7959981|NCT00392808|19593923|P1|STARTED|Overall Study||87
7959982|NCT00392782|19593937|P1|NOT COMPLETED|Overall Study||0
7959983|NCT00392782|19593937|P1|COMPLETED|Overall Study||24
7959984|NCT00392782|19593937|P1|STARTED|Overall Study||24
7959985|NCT00392769|19593947|P1|NOT COMPLETED|Overall Study||10
7959986|NCT00392769|19593947|P1|COMPLETED|Overall Study||23
7959987|NCT00392769|19593947|P1|STARTED|Overall Study||33
7959988|NCT00392704|19593951|P1|NOT COMPLETED|Combined Modality Therapy||5
7959989|NCT00392704|19593951|P1|COMPLETED|Combined Modality Therapy||49
7959990|NCT00392704|19593951|P1|STARTED|Combined Modality Therapy||54
7959991|NCT00392704|19593951|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||6
7959992|NCT00392704|19593951|P1|COMPLETED|Neoadjuvant Chemotherapy||54
7959993|NCT00392704|19593951|P1|STARTED|Neoadjuvant Chemotherapy||60
7959994|NCT00392678|19593960|P4|NOT COMPLETED|Overall Study||1
7959995|NCT00392678|19593961|P3|NOT COMPLETED|Overall Study||2
7959996|NCT00392678|19593962|P2|NOT COMPLETED|Overall Study||1
7959997|NCT00392678|19593963|P1|NOT COMPLETED|Overall Study||0
7959998|NCT00392678|19593960|P4|COMPLETED|Overall Study||26
7959999|NCT00392678|19593961|P3|COMPLETED|Overall Study||25
7960000|NCT00392678|19593962|P2|COMPLETED|Overall Study||26
7960001|NCT00392678|19593963|P1|COMPLETED|Overall Study||27
7960002|NCT00392678|19593960|P4|STARTED|Overall Study||27
7960003|NCT00392678|19593961|P3|STARTED|Overall Study||27
7960004|NCT00392678|19593962|P2|STARTED|Overall Study||27
7960005|NCT00392678|19593963|P1|STARTED|Overall Study||27
7960006|NCT00392665|19593999|P2|NOT COMPLETED|Overall Study||15
7960007|NCT00392665|19594000|P1|NOT COMPLETED|Overall Study||17
7960008|NCT00392665|19593999|P2|COMPLETED|Overall Study||3
7960009|NCT00392665|19594000|P1|COMPLETED|Overall Study||1
7960010|NCT00392665|19593999|P2|STARTED|Overall Study||18
7960011|NCT00392665|19594000|P1|STARTED|Overall Study||18
7960012|NCT00392496|19594012|P1|NOT COMPLETED|Overall Study||0
7960013|NCT00392496|19594012|P1|COMPLETED|Overall Study||19
7960014|NCT00392496|19594012|P1|STARTED|Overall Study||19
7960015|NCT00392444|19594016|P1|NOT COMPLETED|Overall Study||0
7960016|NCT00392444|19594016|P1|COMPLETED|Overall Study||39
7960017|NCT00392444|19594016|P1|STARTED|Overall Study||39
7960018|NCT00392392|19594020|P1|NOT COMPLETED|Overall Study||20
7960019|NCT00392392|19594020|P1|COMPLETED|Overall Study||9
7960020|NCT00392392|19594020|P1|STARTED|Overall Study||29
7960021|NCT00392379|19594026|P2|NOT COMPLETED|Overall Study||38
7960022|NCT00392379|19594027|P1|NOT COMPLETED|Overall Study||22
7960023|NCT00392379|19594026|P2|COMPLETED|Overall Study|Medication period|96
7960024|NCT00392379|19594027|P1|COMPLETED|Overall Study|Medication period|114
7960025|NCT00392379|19594026|P2|STARTED|Overall Study|Medication period|134
7960026|NCT00392379|19594027|P1|STARTED|Overall Study|Medication period|136
7960027|NCT00392327|19594045|P8|NOT COMPLETED|Overall Study||11
7960028|NCT00392327|19594046|P7|NOT COMPLETED|Overall Study||9
7960029|NCT00392327|19594047|P6|NOT COMPLETED|Overall Study||5
7960030|NCT00392327|19594048|P5|NOT COMPLETED|Overall Study||3
7960031|NCT00392327|19594049|P4|NOT COMPLETED|Overall Study||16
7960032|NCT00392327|19594050|P3|NOT COMPLETED|Overall Study||20
7960033|NCT00392327|19594051|P2|NOT COMPLETED|Overall Study||19
7960034|NCT00392327|19594052|P1|NOT COMPLETED|Overall Study||15
7960035|NCT00392327|19594045|P8|COMPLETED|Overall Study||11
7960036|NCT00392327|19594046|P7|COMPLETED|Overall Study||12
7960037|NCT00392327|19594047|P6|COMPLETED|Overall Study||14
7960038|NCT00392327|19594048|P5|COMPLETED|Overall Study||20
7960039|NCT00392327|19594049|P4|COMPLETED|Overall Study||42
7960040|NCT00392327|19594050|P3|COMPLETED|Overall Study||36
7960041|NCT00392327|19594051|P2|COMPLETED|Overall Study||74
7960042|NCT00392327|19594052|P1|COMPLETED|Overall Study||72
7960043|NCT00392327|19594045|P8|STARTED|Overall Study||22
7960044|NCT00392327|19594046|P7|STARTED|Overall Study||21
7960045|NCT00392327|19594047|P6|STARTED|Overall Study||19
7960046|NCT00392327|19594048|P5|STARTED|Overall Study||23
7960047|NCT00392327|19594049|P4|STARTED|Overall Study||58
7960048|NCT00392327|19594050|P3|STARTED|Overall Study||56
7960049|NCT00392327|19594051|P2|STARTED|Overall Study||93
7960050|NCT00392327|19594052|P1|STARTED|Overall Study||87
7960051|NCT00392288|19594121|P3|NOT COMPLETED|Overall Study||17
7960052|NCT00392288|19594122|P2|NOT COMPLETED|Overall Study||22
7960053|NCT00392288|19594123|P1|NOT COMPLETED|Overall Study||32
7960054|NCT00392288|19594121|P3|COMPLETED|Overall Study|ITT set = 172 patients|159
7960055|NCT00392288|19594122|P2|COMPLETED|Overall Study|ITT set = 166 patients|155
7960056|NCT00392288|19594123|P1|COMPLETED|Overall Study|ITT set = 163 patients|143
7960057|NCT00392288|19594121|P3|Treatment Period|Overall Study||175
7960058|NCT00392288|19594122|P2|Treatment Period|Overall Study||174
7960059|NCT00392288|19594123|P1|Treatment Period|Overall Study||172
7960060|NCT00392288|19594121|P3|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176
7960061|NCT00392288|19594122|P2|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177
7960062|NCT00392288|19594123|P1|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175
7960063|NCT00392236|19594139|P2|NOT COMPLETED|Overall Study||6
7960064|NCT00392236|19594140|P1|NOT COMPLETED|Overall Study||12
7960065|NCT00392236|19594139|P2|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12
7960066|NCT00392236|19594140|P1|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8
7960067|NCT00392236|19594139|P2|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18
7960068|NCT00392236|19594140|P1|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20
7960069|NCT00392223|19594148|P2|NOT COMPLETED|Overall Study||13
7960070|NCT00392223|19594149|P1|NOT COMPLETED|Overall Study||9
7960071|NCT00392223|19594148|P2|COMPLETED|Overall Study||47
7960072|NCT00392223|19594149|P1|COMPLETED|Overall Study||49
7960073|NCT00392223|19594148|P2|STARTED|Overall Study||60
7960074|NCT00392223|19594149|P1|STARTED|Overall Study||58
7960075|NCT00392210|19594167|P2|NOT COMPLETED|Second Voiding Trial||0
7960076|NCT00392210|19594168|P1|NOT COMPLETED|Second Voiding Trial||0
7960077|NCT00392210|19594167|P2|COMPLETED|Second Voiding Trial||31
7960078|NCT00392210|19594168|P1|COMPLETED|Second Voiding Trial||34
7960079|NCT00392210|19594167|P2|STARTED|Second Voiding Trial||31
7960080|NCT00392210|19594168|P1|STARTED|Second Voiding Trial||34
7960081|NCT00392210|19594167|P2|NOT COMPLETED|First Voiding Trial||2
7960082|NCT00392210|19594168|P1|NOT COMPLETED|First Voiding Trial||2
7960083|NCT00392210|19594167|P2|COMPLETED|First Voiding Trial||31
7960084|NCT00392210|19594168|P1|COMPLETED|First Voiding Trial||34
7960085|NCT00392210|19594167|P2|STARTED|First Voiding Trial||33
7960086|NCT00392210|19594168|P1|STARTED|First Voiding Trial||36
7960087|NCT00392197|19594176|P2|NOT COMPLETED|Overall Study||30
7960088|NCT00392197|19594177|P1|NOT COMPLETED|Overall Study||21
7960089|NCT00392197|19594176|P2|COMPLETED|Overall Study||33
7960090|NCT00392197|19594177|P1|COMPLETED|Overall Study||27
7960091|NCT00392197|19594176|P2|STARTED|Overall Study||63
7960092|NCT00392197|19594177|P1|STARTED|Overall Study||48
7960093|NCT00392171|19594185|P1|NOT COMPLETED|Overall Study||105
7960094|NCT00392171|19594185|P1|COMPLETED|Overall Study||15
7960095|NCT00392171|19594185|P1|STARTED|Overall Study||120
7960096|NCT00392054|19594191|P2|NOT COMPLETED|Overall Study||0
7960097|NCT00392054|19594192|P1|NOT COMPLETED|Overall Study||0
7960098|NCT00392054|19594191|P2|COMPLETED|Overall Study||61
7960099|NCT00392054|19594192|P1|COMPLETED|Overall Study||66
7960100|NCT00392054|19594191|P2|Received Allocated Intervention|Overall Study||60
7960101|NCT00392054|19594192|P1|Received Allocated Intervention|Overall Study||65
7960102|NCT00392054|19594191|P2|STARTED|Overall Study|All participants randomized are included in final analysis|61
7960103|NCT00392054|19594192|P1|STARTED|Overall Study|All participants randomized are included in final analysis|66
7960104|NCT00391989|19594212|P1|NOT COMPLETED|Overall Study||2
7960105|NCT00391989|19594212|P1|COMPLETED|Overall Study||53
7960106|NCT00391989|19594212|P1|STARTED|Overall Study||55
7960107|NCT00391976|19594219|P3|NOT COMPLETED|Overall Study||35
7960108|NCT00391976|19594220|P2|NOT COMPLETED|Overall Study||25
7960109|NCT00391976|19594221|P1|NOT COMPLETED|Overall Study||27
7960110|NCT00391976|19594219|P3|COMPLETED|Overall Study||0
7960111|NCT00391976|19594220|P2|COMPLETED|Overall Study||18
7960112|NCT00391976|19594221|P1|COMPLETED|Overall Study||18
7960113|NCT00391976|19594219|P3|Safety Population|Overall Study||35
7960114|NCT00391976|19594220|P2|Safety Population|Overall Study||43
7960115|NCT00391976|19594221|P1|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44
7960116|NCT00391976|19594219|P3|Randomized|Overall Study||0
7960117|NCT00391976|19594220|P2|Randomized|Overall Study||43
7960118|NCT00391976|19594221|P1|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45
7960119|NCT00391976|19594219|P3|STARTED|Overall Study||35
7960120|NCT00391976|19594220|P2|STARTED|Overall Study||43
7960121|NCT00391976|19594221|P1|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45
7960122|NCT00391898|19594245|P2|NOT COMPLETED|Overall Study||10
7960123|NCT00391898|19594246|P1|NOT COMPLETED|Overall Study||11
7960124|NCT00391898|19594245|P2|COMPLETED|Overall Study||39
7960125|NCT00391898|19594246|P1|COMPLETED|Overall Study||35
7960126|NCT00391898|19594245|P2|STARTED|Overall Study||49
7960127|NCT00391898|19594246|P1|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46
7960128|NCT00391872|19594266|P2|NOT COMPLETED|Overall Study||255
7960129|NCT00391872|19594267|P1|NOT COMPLETED|Overall Study||307
7960130|NCT00391872|19594266|P2|COMPLETED|Overall Study||9036
7960131|NCT00391872|19594267|P1|COMPLETED|Overall Study||9026
7960132|NCT00391872|19594266|P2|STARTED|Overall Study||9291
7960133|NCT00391872|19594267|P1|STARTED|Overall Study||9333
7960134|NCT00391846|19594305|P2|NOT COMPLETED|Overall Study||7
7960135|NCT00391846|19594306|P1|NOT COMPLETED|Overall Study||8
7960136|NCT00391846|19594305|P2|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118
7960137|NCT00391846|19594306|P1|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119
7960138|NCT00391846|19594305|P2|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125
7960139|NCT00391846|19594306|P1|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127
7960140|NCT00391807|19594326|P1|NOT COMPLETED|Overall Study||715
7960141|NCT00391807|19594326|P1|COMPLETED|Overall Study||968
7960142|NCT00391807|19594326|P1|STARTED|Overall Study||1683
7960143|NCT00391768|19594353|P7|NOT COMPLETED|Overall Study||4
7960144|NCT00391768|19594354|P6|NOT COMPLETED|Overall Study||3
7960145|NCT00391768|19594355|P5|NOT COMPLETED|Overall Study||2
7960146|NCT00391768|19594356|P4|NOT COMPLETED|Overall Study||1
7960147|NCT00391768|19594357|P3|NOT COMPLETED|Overall Study||1
7960148|NCT00391768|19594358|P2|NOT COMPLETED|Overall Study||0
7960149|NCT00391768|19594359|P1|NOT COMPLETED|Overall Study||0
7960150|NCT00391768|19594353|P7|COMPLETED|Overall Study||19
7960151|NCT00391768|19594354|P6|COMPLETED|Overall Study||7
7960152|NCT00391768|19594355|P5|COMPLETED|Overall Study||22
7960153|NCT00391768|19594356|P4|COMPLETED|Overall Study||7
7960154|NCT00391768|19594357|P3|COMPLETED|Overall Study||6
7960155|NCT00391768|19594358|P2|COMPLETED|Overall Study||3
7960156|NCT00391768|19594359|P1|COMPLETED|Overall Study||12
7960157|NCT00391768|19594353|P7|STARTED|Overall Study||23
7960158|NCT00391768|19594354|P6|STARTED|Overall Study||10
7960159|NCT00391768|19594355|P5|STARTED|Overall Study||24
7960160|NCT00391768|19594356|P4|STARTED|Overall Study||8
7960161|NCT00391768|19594357|P3|STARTED|Overall Study||7
7960162|NCT00391768|19594358|P2|STARTED|Overall Study||3
7960163|NCT00391768|19594359|P1|STARTED|Overall Study||12
7960164|NCT00391716|19594427|P3|NOT COMPLETED|Overall Study||19
7960165|NCT00391716|19594428|P2|NOT COMPLETED|Overall Study||19
7960166|NCT00391716|19594429|P1|NOT COMPLETED|Overall Study||27
7960167|NCT00391716|19594427|P3|COMPLETED|Overall Study||30
7960168|NCT00391716|19594428|P2|COMPLETED|Overall Study||28
7960169|NCT00391716|19594429|P1|COMPLETED|Overall Study||27
7960170|NCT00391716|19594427|P3|STARTED|Overall Study||49
7960171|NCT00391716|19594428|P2|STARTED|Overall Study||47
7960172|NCT00391716|19594429|P1|STARTED|Overall Study||54
7960173|NCT00391625|19594446|P1|NOT COMPLETED|Month 84||0
7960174|NCT00391625|19594446|P1|COMPLETED|Month 84||8
7960175|NCT00391625|19594446|P1|STARTED|Month 84||8
7960176|NCT00391625|19594446|P1|NOT COMPLETED|Month 50||1
7960177|NCT00391625|19594446|P1|COMPLETED|Month 50||8
7960178|NCT00391625|19594446|P1|STARTED|Month 50||9
7960179|NCT00391625|19594446|P1|NOT COMPLETED|Month 14||1
7960180|NCT00391625|19594446|P1|COMPLETED|Month 14||9
7960181|NCT00391625|19594446|P1|STARTED|Month 14||10
7960182|NCT00391625|19594446|P1|NOT COMPLETED|Baseline||0
7960183|NCT00391625|19594446|P1|COMPLETED|Baseline||10
7960184|NCT00391625|19594446|P1|STARTED|Baseline||10
7960185|NCT00391599|19594488|P2|NOT COMPLETED|Overall Study||0
7960186|NCT00391599|19594489|P1|NOT COMPLETED|Overall Study||0
7960187|NCT00391599|19594488|P2|COMPLETED|Overall Study||65
7960188|NCT00391599|19594489|P1|COMPLETED|Overall Study||65
7960189|NCT00391599|19594488|P2|STARTED|Overall Study||65
7960190|NCT00391599|19594489|P1|STARTED|Overall Study||65
7960191|NCT00391586|19594499|P1|NOT COMPLETED|Overall Study||24
7960192|NCT00391586|19594499|P1|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21
7960193|NCT00391586|19594499|P1|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10
7960194|NCT00391586|19594499|P1|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43
7960195|NCT00391586|19594499|P1|STARTED|Overall Study||45
7960196|NCT00391469|19594508|P2|NOT COMPLETED|Overall Study||0
7960197|NCT00391469|19594509|P1|NOT COMPLETED|Overall Study||0
7960198|NCT00391469|19594508|P2|COMPLETED|Overall Study||671
7960199|NCT00391469|19594509|P1|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688
7960200|NCT00391469|19594508|P2|STARTED|Overall Study||671
7960201|NCT00391469|19594509|P1|STARTED|Overall Study||688
7960202|NCT00391443|19594523|P2|NOT COMPLETED|Overall Study||0
7960203|NCT00391443|19594524|P1|NOT COMPLETED|Overall Study||0
7960204|NCT00391443|19594523|P2|COMPLETED|Overall Study||407
7960205|NCT00391443|19594524|P1|COMPLETED|Overall Study||209
7960206|NCT00391443|19594523|P2|STARTED|Overall Study||407
7960207|NCT00391443|19594524|P1|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209
7960208|NCT00391391|19594536|P4|NOT COMPLETED|Overall Study||19
7960209|NCT00391391|19594537|P3|NOT COMPLETED|Overall Study||23
7960210|NCT00391391|19594538|P2|NOT COMPLETED|Overall Study||10
7960211|NCT00391391|19594539|P1|NOT COMPLETED|Overall Study||9
7960212|NCT00391391|19594536|P4|COMPLETED|Overall Study||145
7960213|NCT00391391|19594537|P3|COMPLETED|Overall Study||138
7960214|NCT00391391|19594538|P2|COMPLETED|Overall Study||87
7960215|NCT00391391|19594539|P1|COMPLETED|Overall Study||89
7960216|NCT00391391|19594536|P4|STARTED|Overall Study|1 participant was not vaccinated.|164
7960217|NCT00391391|19594537|P3|STARTED|Overall Study|1 participant was not vaccinated.|161
7960218|NCT00391391|19594538|P2|STARTED|Overall Study||97
7960219|NCT00391391|19594539|P1|STARTED|Overall Study|1 participant was not vaccinated.|98
7960220|NCT00391365|19594571|P2|NOT COMPLETED|Overall Study||19
7960221|NCT00391365|19594572|P1|NOT COMPLETED|Overall Study||25
7960222|NCT00391365|19594571|P2|COMPLETED|Overall Study||151
7960223|NCT00391365|19594572|P1|COMPLETED|Overall Study||78
7960224|NCT00391365|19594571|P2|STARTED|Overall Study||170
7960225|NCT00391365|19594572|P1|STARTED|Overall Study||103
7960226|NCT00391274|19594584|P2|NOT COMPLETED|Overall Study||57
7960227|NCT00391274|19594585|P1|NOT COMPLETED|Overall Study||61
7960228|NCT00391274|19594584|P2|COMPLETED|Overall Study||47
7960229|NCT00391274|19594585|P1|COMPLETED|Overall Study||46
7960230|NCT00391274|19594584|P2|Received at Least One Dose of Study Drug|Overall Study||102
7960231|NCT00391274|19594585|P1|Received at Least One Dose of Study Drug|Overall Study||106
7960232|NCT00391274|19594584|P2|STARTED|Overall Study||104
7960233|NCT00391274|19594585|P1|STARTED|Overall Study||107
7960234|NCT00391222|19594604|P4|NOT COMPLETED|Period III (Double-Blind Treatment)||0
7960235|NCT00391222|19594605|P3|NOT COMPLETED|Period III (Double-Blind Treatment)||23
7960236|NCT00391222|19594606|P2|NOT COMPLETED|Period III (Double-Blind Treatment)||22
7960237|NCT00391222|19594607|P1|NOT COMPLETED|Period III (Double-Blind Treatment)||28
7960238|NCT00391222|19594604|P4|COMPLETED|Period III (Double-Blind Treatment)||0
7960239|NCT00391222|19594605|P3|COMPLETED|Period III (Double-Blind Treatment)||108
7960240|NCT00391222|19594606|P2|COMPLETED|Period III (Double-Blind Treatment)||113
7960241|NCT00391222|19594607|P1|COMPLETED|Period III (Double-Blind Treatment)||104
7960242|NCT00391222|19594604|P4|STARTED|Period III (Double-Blind Treatment)||0
7960243|NCT00391222|19594605|P3|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131
7960244|NCT00391222|19594606|P2|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135
7960245|NCT00391222|19594607|P1|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132
7960246|NCT00391222|19594604|P4|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162
7960247|NCT00391222|19594605|P3|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
7960248|NCT00391222|19594606|P2|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
7960249|NCT00391222|19594607|P1|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
7960250|NCT00391222|19594604|P4|COMPLETED|Period II (Open-label Risperidone LAI)||398
7960251|NCT00391222|19594605|P3|COMPLETED|Period II (Open-label Risperidone LAI)||0
7960252|NCT00391222|19594606|P2|COMPLETED|Period II (Open-label Risperidone LAI)||0
7960253|NCT00391222|19594607|P1|COMPLETED|Period II (Open-label Risperidone LAI)||0
7960254|NCT00391222|19594604|P4|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560
7960255|NCT00391222|19594605|P3|STARTED|Period II (Open-label Risperidone LAI)||0
7960256|NCT00391222|19594606|P2|STARTED|Period II (Open-label Risperidone LAI)||0
7960257|NCT00391222|19594607|P1|STARTED|Period II (Open-label Risperidone LAI)||0
7960258|NCT00391118|19594634|P3|NOT COMPLETED|Overall Study||58
7960259|NCT00391118|19594635|P2|NOT COMPLETED|Overall Study||55
7960260|NCT00391118|19594636|P1|NOT COMPLETED|Overall Study||11
7960261|NCT00391118|19594634|P3|COMPLETED|Overall Study||15
7960262|NCT00391118|19594635|P2|COMPLETED|Overall Study||14
7960263|NCT00391118|19594636|P1|COMPLETED|Overall Study||0
7960264|NCT00391118|19594634|P3|Received ≥1 Dose of Assigned Study Drug|Overall Study||72
7960265|NCT00391118|19594635|P2|Received ≥1 Dose of Assigned Study Drug|Overall Study||67
7960266|NCT00391118|19594636|P1|Received ≥1 Dose of Assigned Study Drug|Overall Study||11
7960267|NCT00391118|19594634|P3|STARTED|Overall Study||73
7960268|NCT00391118|19594635|P2|STARTED|Overall Study||69
7960269|NCT00391118|19594636|P1|STARTED|Overall Study||11
7960270|NCT00391092|19594662|P2|NOT COMPLETED|Overall Study||216
7960271|NCT00391092|19594663|P1|NOT COMPLETED|Overall Study||208
7960272|NCT00391092|19594662|P2|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
7960273|NCT00391092|19594663|P1|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
7960274|NCT00391092|19594662|P2|Received Treatment|Overall Study||215
7960275|NCT00391092|19594663|P1|Received Treatment|Overall Study||206
7960276|NCT00391092|19594662|P2|STARTED|Overall Study||216
7960277|NCT00391092|19594663|P1|STARTED|Overall Study||208
7960278|NCT00391079|19594683|P2|NOT COMPLETED|Overall Study||16
7960279|NCT00391079|19594684|P1|NOT COMPLETED|Overall Study||26
7960280|NCT00391079|19594683|P2|COMPLETED|Overall Study||156
7960281|NCT00391079|19594684|P1|COMPLETED|Overall Study||141
7960282|NCT00391079|19594683|P2|STARTED|Overall Study||172
7960283|NCT00391079|19594684|P1|STARTED|Overall Study||167
7960284|NCT00391053|19594706|P4|NOT COMPLETED|Overall Study||10
7960285|NCT00391053|19594707|P3|NOT COMPLETED|Overall Study||2
7960286|NCT00391053|19594708|P2|NOT COMPLETED|Overall Study||1
7960287|NCT00391053|19594709|P1|NOT COMPLETED|Overall Study||9
7960288|NCT00391053|19594706|P4|COMPLETED|Overall Study||1252
7960289|NCT00391053|19594707|P3|COMPLETED|Overall Study||868
7960290|NCT00391053|19594708|P2|COMPLETED|Overall Study||847
7960291|NCT00391053|19594709|P1|COMPLETED|Overall Study||848
7960292|NCT00391053|19594706|P4|STARTED|Overall Study||1262
7960293|NCT00391053|19594707|P3|STARTED|Overall Study||870
7960294|NCT00391053|19594708|P2|STARTED|Overall Study||848
7960295|NCT00391053|19594709|P1|STARTED|Overall Study||857
7960296|NCT00391027|19594733|P2|NOT COMPLETED|Overall Study||12
7960297|NCT00391027|19594734|P1|NOT COMPLETED|Overall Study||25
7960298|NCT00391027|19594733|P2|COMPLETED|Overall Study||110
7960299|NCT00391027|19594734|P1|COMPLETED|Overall Study||110
7960300|NCT00391027|19594733|P2|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122
7960301|NCT00391027|19594734|P1|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135
7960302|NCT00390949|19594774|P2|NOT COMPLETED|Overall Study||2128
7960303|NCT00390949|19594775|P1|NOT COMPLETED|Overall Study||2098
7960304|NCT00390949|19594774|P2|COMPLETED|Overall Study||2664
7960305|NCT00390949|19594775|P1|COMPLETED|Overall Study||2564
7960306|NCT00390949|19594774|P2|STARTED|Overall Study||4792
7960307|NCT00390949|19594775|P1|STARTED|Overall Study||4662
7960308|NCT00390910|19594784|P3|NOT COMPLETED|Overall Study||10
7960309|NCT00390910|19594785|P2|NOT COMPLETED|Overall Study||4
7960310|NCT00390910|19594786|P1|NOT COMPLETED|Overall Study||2
7960311|NCT00390910|19594784|P3|COMPLETED|Overall Study||139
7960312|NCT00390910|19594785|P2|COMPLETED|Overall Study||83
7960313|NCT00390910|19594786|P1|COMPLETED|Overall Study||48
7960314|NCT00390910|19594784|P3|STARTED|Overall Study||149
7960315|NCT00390910|19594785|P2|STARTED|Overall Study||87
7960316|NCT00390910|19594786|P1|STARTED|Overall Study||50
7960317|NCT00390884|19594874|P2|NOT COMPLETED|Overall Study||2
7960318|NCT00390884|19594875|P1|NOT COMPLETED|Overall Study||2
7960319|NCT00390884|19594874|P2|COMPLETED|Overall Study||55
7960320|NCT00390884|19594875|P1|COMPLETED|Overall Study||114
7960321|NCT00390884|19594874|P2|STARTED|Overall Study||57
7960322|NCT00390884|19594875|P1|STARTED|Overall Study||116
7960323|NCT00390858|19594887|P2|NOT COMPLETED|Overall Study||7
7960324|NCT00390858|19594888|P1|NOT COMPLETED|Overall Study||9
7960325|NCT00390858|19594887|P2|COMPLETED|Overall Study|13 Participants completed the Extension Study|13
7960326|NCT00390858|19594888|P1|COMPLETED|Overall Study|11 participants Completed the Extension Study|11
7960327|NCT00390858|19594887|P2|Completed Core & Entered Extension Study|Overall Study||20
7960328|NCT00390858|19594888|P1|Completed Core & Entered Extension Study|Overall Study||19
7960329|NCT00390858|19594887|P2|STARTED|Overall Study|20 Participants started the Core Study|20
7960330|NCT00390858|19594888|P1|STARTED|Overall Study|20 participants started the Core Study|20
7960331|NCT00390806|19594902|P2|NOT COMPLETED|Overall Study||32
7960332|NCT00390806|19594903|P1|NOT COMPLETED|Overall Study||30
7960333|NCT00390806|19594902|P2|COMPLETED|Overall Study||204
7960334|NCT00390806|19594903|P1|COMPLETED|Overall Study||206
7960335|NCT00390806|19594902|P2|Ongoing|Overall Study||2
7960336|NCT00390806|19594903|P1|Ongoing|Overall Study||4
7960337|NCT00390806|19594902|P2|STARTED|Overall Study||236
7960338|NCT00390806|19594903|P1|STARTED|Overall Study||236
7960339|NCT00390780|19594971|P2|NOT COMPLETED|Overall Study||27
7960340|NCT00390780|19594972|P1|NOT COMPLETED|Overall Study||23
7960341|NCT00390780|19594971|P2|COMPLETED|Overall Study||260
7960342|NCT00390780|19594972|P1|COMPLETED|Overall Study||268
7960343|NCT00390780|19594971|P2|Treatment|Overall Study||287
7960344|NCT00390780|19594972|P1|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290
7960345|NCT00390780|19594971|P2|STARTED|Overall Study||287
7960346|NCT00390780|19594972|P1|STARTED|Overall Study||291
7960347|NCT00390689|19595005|P3|NOT COMPLETED|Overall Study||3
7960348|NCT00390689|19595006|P2|NOT COMPLETED|Overall Study||5
7960349|NCT00390689|19595007|P1|NOT COMPLETED|Overall Study||5
7960350|NCT00390689|19595005|P3|COMPLETED|Overall Study||50
7960351|NCT00390689|19595006|P2|COMPLETED|Overall Study||48
7960352|NCT00390689|19595007|P1|COMPLETED|Overall Study||43
7960353|NCT00390689|19595005|P3|STARTED|Overall Study||53
7960354|NCT00390689|19595006|P2|STARTED|Overall Study||53
7960355|NCT00390689|19595007|P1|STARTED|Overall Study||48
7960356|NCT00390611|19595067|P2|NOT COMPLETED|Maintenance Sorafenib to Month 12||0
7960357|NCT00390611|19595068|P1|NOT COMPLETED|Maintenance Sorafenib to Month 12||10
7960358|NCT00390611|19595067|P2|COMPLETED|Maintenance Sorafenib to Month 12||0
7960359|NCT00390611|19595068|P1|COMPLETED|Maintenance Sorafenib to Month 12||13
7960360|NCT00390611|19595067|P2|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0
7960361|NCT00390611|19595068|P1|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23
7960362|NCT00390611|19595067|P2|NOT COMPLETED|6 Cycles of Study Treatment||5
7960363|NCT00390611|19595068|P1|NOT COMPLETED|6 Cycles of Study Treatment||9
7960364|NCT00390611|19595067|P2|COMPLETED|6 Cycles of Study Treatment||37
7960365|NCT00390611|19595068|P1|COMPLETED|6 Cycles of Study Treatment||34
7960366|NCT00390611|19595067|P2|STARTED|6 Cycles of Study Treatment||42
7960367|NCT00390611|19595068|P1|STARTED|6 Cycles of Study Treatment||43
7960368|NCT00390572|19595082|P2|NOT COMPLETED|Overall Study||5
7960369|NCT00390572|19595083|P1|NOT COMPLETED|Overall Study||8
7960370|NCT00390572|19595082|P2|COMPLETED|Overall Study||64
7960371|NCT00390572|19595083|P1|COMPLETED|Overall Study||60
7960372|NCT00390572|19595082|P2|STARTED|Overall Study||69
7960373|NCT00390572|19595083|P1|STARTED|Overall Study||68
7960374|NCT00390559|19595097|P1|NOT COMPLETED|Overall Study||44
7960375|NCT00390559|19595097|P1|COMPLETED|Overall Study||80
7960376|NCT00390559|19595097|P1|ActiveP/PlaceboC|Overall Study||90
7960377|NCT00390559|19595097|P1|PlaceboP/PlaceboC|Overall Study||93
7960378|NCT00390559|19595097|P1|ActiveP/ActiveC|Overall Study||87
7960379|NCT00390559|19595097|P1|Received PlaceboP/Active C|Overall Study||93
7960380|NCT00390559|19595097|P1|STARTED|Overall Study||124
7960381|NCT00390546|19595109|P2|NOT COMPLETED|Overall Study||5
7960382|NCT00390546|19595110|P1|NOT COMPLETED|Overall Study||6
7960383|NCT00390546|19595109|P2|COMPLETED|Overall Study||34
7960384|NCT00390546|19595110|P1|COMPLETED|Overall Study||27
7960385|NCT00390546|19595109|P2|STARTED|Overall Study||39
7960386|NCT00390546|19595110|P1|STARTED|Overall Study||33
7960387|NCT00390468|19595120|P1|NOT COMPLETED|Overall Study||3
7960388|NCT00390468|19595120|P1|COMPLETED|Overall Study||15
7960389|NCT00390468|19595120|P1|STARTED|Overall Study||18
7960390|NCT00390455|19595126|P2|NOT COMPLETED|Overall Study||23
7960391|NCT00390455|19595127|P1|NOT COMPLETED|Overall Study||32
7960392|NCT00390455|19595126|P2|COMPLETED|Overall Study||124
7960393|NCT00390455|19595127|P1|COMPLETED|Overall Study||116
7960394|NCT00390455|19595126|P2|STARTED|Overall Study||147
7960395|NCT00390455|19595127|P1|STARTED|Overall Study||148
7960396|NCT00390429|19595148|P4|NOT COMPLETED|Overall Study||0
7960397|NCT00390429|19595149|P3|NOT COMPLETED|Overall Study||0
7960398|NCT00390429|19595150|P2|NOT COMPLETED|Overall Study||0
7960399|NCT00390429|19595151|P1|NOT COMPLETED|Overall Study||0
7960400|NCT00390429|19595148|P4|COMPLETED|Overall Study||39
7960401|NCT00390429|19595149|P3|COMPLETED|Overall Study||25
7960402|NCT00390429|19595150|P2|COMPLETED|Overall Study||12
7960403|NCT00390429|19595151|P1|COMPLETED|Overall Study||5
7960404|NCT00390429|19595148|P4|STARTED|Overall Study||39
7960405|NCT00390429|19595149|P3|STARTED|Overall Study||25
7960406|NCT00390429|19595150|P2|STARTED|Overall Study||12
7960407|NCT00390429|19595151|P1|STARTED|Overall Study||5
7960408|NCT00390416|19595172|P1|NOT COMPLETED|Overall Study||4
7960409|NCT00390416|19595172|P1|COMPLETED|Overall Study||44
7960410|NCT00390416|19595172|P1|STARTED|Overall Study||48
7960411|NCT00390364|19595178|P1|NOT COMPLETED|Overall Study||0
7960412|NCT00390364|19595178|P1|COMPLETED|Overall Study||1
7960413|NCT00390364|19595178|P1|STARTED|Overall Study||1
7960414|NCT00390325|19595184|P2|NOT COMPLETED|Overall Study||0
7960415|NCT00390325|19595185|P1|NOT COMPLETED|Overall Study||0
7960416|NCT00390325|19595184|P2|COMPLETED|Overall Study||16
7960417|NCT00390325|19595185|P1|COMPLETED|Overall Study||5
7960418|NCT00390325|19595184|P2|STARTED|Overall Study||16
7960419|NCT00390325|19595185|P1|STARTED|Overall Study||5
7960420|NCT00390299|19595210|P5|NOT COMPLETED|Overall Study||0
7960421|NCT00390299|19595211|P4|NOT COMPLETED|Overall Study||0
7960422|NCT00390299|19595212|P3|NOT COMPLETED|Overall Study||0
7960423|NCT00390299|19595213|P2|NOT COMPLETED|Overall Study||0
7960424|NCT00390299|19595214|P1|NOT COMPLETED|Overall Study||1
7960425|NCT00390299|19595210|P5|COMPLETED|Overall Study||10
7960426|NCT00390299|19595211|P4|COMPLETED|Overall Study||3
7960427|NCT00390299|19595212|P3|COMPLETED|Overall Study||3
7960428|NCT00390299|19595213|P2|COMPLETED|Overall Study||3
7960429|NCT00390299|19595214|P1|COMPLETED|Overall Study||3
7960430|NCT00390299|19595210|P5|STARTED|Overall Study||10
7960431|NCT00390299|19595211|P4|STARTED|Overall Study||3
7960432|NCT00390299|19595212|P3|STARTED|Overall Study||3
7960433|NCT00390299|19595213|P2|STARTED|Overall Study||3
7960434|NCT00390299|19595214|P1|STARTED|Overall Study||4
7960435|NCT00390234|19595234|P1|NOT COMPLETED|Overall Study||0
7960436|NCT00390234|19595234|P1|COMPLETED|Overall Study||63
7960437|NCT00390234|19595234|P1|STARTED|Overall Study||63
7960438|NCT00390221|19595245|P3|NOT COMPLETED|Overall Study||15
7960439|NCT00390221|19595246|P2|NOT COMPLETED|Overall Study||20
7960440|NCT00390221|19595247|P1|NOT COMPLETED|Overall Study||18
7960441|NCT00390221|19595245|P3|COMPLETED|Overall Study||194
7960442|NCT00390221|19595246|P2|COMPLETED|Overall Study||188
7960443|NCT00390221|19595247|P1|COMPLETED|Overall Study||186
7960444|NCT00390221|19595245|P3|STARTED|Overall Study||209
7960445|NCT00390221|19595246|P2|STARTED|Overall Study||208
7960446|NCT00390221|19595247|P1|STARTED|Overall Study||204
7960447|NCT00390182|19595268|P1|NOT COMPLETED|Overall Study||5
7960448|NCT00390182|19595268|P1|COMPLETED|Overall Study||33
7960449|NCT00390182|19595268|P1|STARTED|Overall Study||38
7960450|NCT00390013|19595277|P4|NOT COMPLETED|Phase 2 Second Treatment||0
7960451|NCT00390013|19595278|P3|NOT COMPLETED|Phase 2 Second Treatment||0
7960452|NCT00390013|19595279|P2|NOT COMPLETED|Phase 2 Second Treatment||0
7960453|NCT00390013|19595280|P1|NOT COMPLETED|Phase 2 Second Treatment||0
7960454|NCT00390013|19595277|P4|COMPLETED|Phase 2 Second Treatment||0
7960455|NCT00390013|19595278|P3|COMPLETED|Phase 2 Second Treatment||0
7960456|NCT00390013|19595279|P2|COMPLETED|Phase 2 Second Treatment||1
7960457|NCT00390013|19595280|P1|COMPLETED|Phase 2 Second Treatment||2
7960458|NCT00390013|19595277|P4|STARTED|Phase 2 Second Treatment||0
7960459|NCT00390013|19595278|P3|STARTED|Phase 2 Second Treatment||0
7960460|NCT00390013|19595279|P2|STARTED|Phase 2 Second Treatment||1
7960461|NCT00390013|19595280|P1|STARTED|Phase 2 Second Treatment||2
7960462|NCT00390013|19595277|P4|NOT COMPLETED|Phase 2 First Treatment||0
7960463|NCT00390013|19595278|P3|NOT COMPLETED|Phase 2 First Treatment||0
7960464|NCT00390013|19595279|P2|NOT COMPLETED|Phase 2 First Treatment||1
7960465|NCT00390013|19595280|P1|NOT COMPLETED|Phase 2 First Treatment||1
7960466|NCT00390013|19595277|P4|COMPLETED|Phase 2 First Treatment||0
7960467|NCT00390013|19595278|P3|COMPLETED|Phase 2 First Treatment||0
7960468|NCT00390013|19595279|P2|COMPLETED|Phase 2 First Treatment||1
7960469|NCT00390013|19595280|P1|COMPLETED|Phase 2 First Treatment||2
7960470|NCT00390013|19595277|P4|STARTED|Phase 2 First Treatment||0
7960471|NCT00390013|19595278|P3|STARTED|Phase 2 First Treatment||0
7960472|NCT00390013|19595279|P2|STARTED|Phase 2 First Treatment||2
7960473|NCT00390013|19595280|P1|STARTED|Phase 2 First Treatment||3
7960474|NCT00390013|19595277|P4|NOT COMPLETED|Phase 1||1
7960475|NCT00390013|19595278|P3|NOT COMPLETED|Phase 1||0
7960476|NCT00390013|19595279|P2|NOT COMPLETED|Phase 1||0
7960477|NCT00390013|19595280|P1|NOT COMPLETED|Phase 1||0
7960478|NCT00390013|19595277|P4|COMPLETED|Phase 1||1
7960479|NCT00390013|19595278|P3|COMPLETED|Phase 1||2
7960480|NCT00390013|19595279|P2|COMPLETED|Phase 1||0
7960481|NCT00390013|19595280|P1|COMPLETED|Phase 1||0
7960482|NCT00390013|19595277|P4|STARTED|Phase 1||2
7960483|NCT00390013|19595278|P3|STARTED|Phase 1||2
7960484|NCT00390013|19595279|P2|STARTED|Phase 1||0
7960485|NCT00390013|19595280|P1|STARTED|Phase 1||0
7960486|NCT00389974|19595286|P1|NOT COMPLETED|Overall Study||0
7960487|NCT00389974|19595286|P1|COMPLETED|Overall Study||19
7960488|NCT00389974|19595286|P1|STARTED|Overall Study||19
7960489|NCT00389857|19595292|P2|NOT COMPLETED|Overall Study||0
7960490|NCT00389857|19595293|P1|NOT COMPLETED|Overall Study||0
7960491|NCT00389857|19595292|P2|COMPLETED|Overall Study||17
7960492|NCT00389857|19595293|P1|COMPLETED|Overall Study||14
7960493|NCT00389857|19595292|P2|STARTED|Overall Study||17
7960494|NCT00389857|19595293|P1|STARTED|Overall Study||14
7960495|NCT00389831|19595305|P2|NOT COMPLETED|Overall Study||7
7960496|NCT00389831|19595306|P1|NOT COMPLETED|Overall Study||0
7960497|NCT00389831|19595305|P2|COMPLETED|Overall Study||27
7960498|NCT00389831|19595306|P1|COMPLETED|Overall Study||10
7960499|NCT00389831|19595305|P2|STARTED|Overall Study||34
7960500|NCT00389831|19595306|P1|STARTED|Overall Study||10
7960501|NCT00389818|19595332|P1|NOT COMPLETED|Overall Study||3
7960502|NCT00389818|19595332|P1|COMPLETED|Overall Study||40
7960503|NCT00389818|19595332|P1|STARTED|Overall Study||43
7960504|NCT00389805|19595338|P2|NOT COMPLETED|Phase II||0
7960505|NCT00389805|19595339|P1|NOT COMPLETED|Phase II||0
7960506|NCT00389805|19595338|P2|COMPLETED|Phase II||0
7960507|NCT00389805|19595339|P1|COMPLETED|Phase II||0
7960508|NCT00389805|19595338|P2|STARTED|Phase II|The Phase II study was not conducted.|0
7960509|NCT00389805|19595339|P1|STARTED|Phase II|The Phase II study was not conducted.|0
7960510|NCT00389805|19595338|P2|NOT COMPLETED|Phase I||0
7960511|NCT00389805|19595339|P1|NOT COMPLETED|Phase I||0
7960512|NCT00389805|19595338|P2|COMPLETED|Phase I||12
7960513|NCT00389805|19595339|P1|COMPLETED|Phase I||15
7960514|NCT00389805|19595338|P2|STARTED|Phase I||12
7960515|NCT00389805|19595339|P1|STARTED|Phase I||15
7960516|NCT00389597|19595369|P4|NOT COMPLETED|Overall Study||6
7960517|NCT00389597|19595370|P3|NOT COMPLETED|Overall Study||4
7960518|NCT00389597|19595371|P2|NOT COMPLETED|Overall Study||6
7960519|NCT00389597|19595372|P1|NOT COMPLETED|Overall Study||8
7960520|NCT00389597|19595369|P4|COMPLETED|Overall Study||99
7960521|NCT00389597|19595370|P3|COMPLETED|Overall Study||221
7960522|NCT00389597|19595371|P2|COMPLETED|Overall Study||75
7960523|NCT00389597|19595372|P1|COMPLETED|Overall Study||156
7960524|NCT00389597|19595369|P4|24 mo|Overall Study||99
7960525|NCT00389597|19595370|P3|24 mo|Overall Study||221
7960526|NCT00389597|19595371|P2|24 mo|Overall Study||75
7960527|NCT00389597|19595372|P1|24 mo|Overall Study||156
7960528|NCT00389597|19595369|P4|STARTED|Overall Study||105
7960529|NCT00389597|19595370|P3|STARTED|Overall Study||225
7960530|NCT00389597|19595371|P2|STARTED|Overall Study||81
7960531|NCT00389597|19595372|P1|STARTED|Overall Study||164
7960532|NCT00389532|19595384|P2|NOT COMPLETED|Overall Study||0
7960533|NCT00389532|19595385|P1|NOT COMPLETED|Overall Study||0
7960534|NCT00389532|19595384|P2|COMPLETED|Overall Study||56
7960535|NCT00389532|19595385|P1|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60
7960536|NCT00389532|19595384|P2|STARTED|Overall Study||56
7960537|NCT00389532|19595385|P1|STARTED|Overall Study||60
7960538|NCT00389519|19595397|P4|NOT COMPLETED|Treated||4
7960539|NCT00389519|19595398|P3|NOT COMPLETED|Treated||0
7960540|NCT00389519|19595399|P2|NOT COMPLETED|Treated||1
7960541|NCT00389519|19595400|P1|NOT COMPLETED|Treated||2
7960542|NCT00389519|19595397|P4|COMPLETED|Treated||76
7960543|NCT00389519|19595398|P3|COMPLETED|Treated||40
7960544|NCT00389519|19595399|P2|COMPLETED|Treated||40
7960545|NCT00389519|19595400|P1|COMPLETED|Treated||79
7960546|NCT00389519|19595397|P4|STARTED|Treated||80
7960547|NCT00389519|19595398|P3|STARTED|Treated||40
7960548|NCT00389519|19595399|P2|STARTED|Treated||41
7960549|NCT00389519|19595400|P1|STARTED|Treated||81
7960550|NCT00389519|19595397|P4|NOT COMPLETED|Randomized||0
7960551|NCT00389519|19595398|P3|NOT COMPLETED|Randomized||0
7960552|NCT00389519|19595399|P2|NOT COMPLETED|Randomized||0
7960553|NCT00389519|19595400|P1|NOT COMPLETED|Randomized||2
7960554|NCT00389519|19595397|P4|COMPLETED|Randomized||80
7960555|NCT00389519|19595398|P3|COMPLETED|Randomized||40
7960556|NCT00389519|19595399|P2|COMPLETED|Randomized||41
7960557|NCT00389519|19595400|P1|COMPLETED|Randomized||81
7960558|NCT00389519|19595397|P4|STARTED|Randomized||80
7960559|NCT00389519|19595398|P3|STARTED|Randomized||40
7960560|NCT00389519|19595399|P2|STARTED|Randomized||41
7960561|NCT00389519|19595400|P1|STARTED|Randomized||83
7960562|NCT00389519|19595397|P4|NOT COMPLETED|Placebo Run-In||0
7960563|NCT00389519|19595398|P3|NOT COMPLETED|Placebo Run-In||0
7960564|NCT00389519|19595399|P2|NOT COMPLETED|Placebo Run-In||0
7960565|NCT00389519|19595400|P1|NOT COMPLETED|Placebo Run-In||178
7960566|NCT00389519|19595397|P4|COMPLETED|Placebo Run-In||0
7960567|NCT00389519|19595398|P3|COMPLETED|Placebo Run-In||0
7960568|NCT00389519|19595399|P2|COMPLETED|Placebo Run-In||0
7960569|NCT00389519|19595400|P1|COMPLETED|Placebo Run-In||244
7960570|NCT00389519|19595397|P4|STARTED|Placebo Run-In||0
7960571|NCT00389519|19595398|P3|STARTED|Placebo Run-In||0
7960572|NCT00389519|19595399|P2|STARTED|Placebo Run-In||0
7960573|NCT00389519|19595400|P1|STARTED|Placebo Run-In||422
7960574|NCT00389493|19595429|P3|NOT COMPLETED|Overall Study||3
7960575|NCT00389493|19595430|P2|NOT COMPLETED|Overall Study||8
7960576|NCT00389493|19595431|P1|NOT COMPLETED|Overall Study||3
7960577|NCT00389493|19595429|P3|COMPLETED|Overall Study||17
7960578|NCT00389493|19595430|P2|COMPLETED|Overall Study||32
7960579|NCT00389493|19595431|P1|COMPLETED|Overall Study||37
7960580|NCT00389493|19595429|P3|STARTED|Overall Study||20
7960581|NCT00389493|19595430|P2|STARTED|Overall Study||40
7960582|NCT00389493|19595431|P1|STARTED|Overall Study||40
7960583|NCT00389467|19595455|P4|NOT COMPLETED|Overall Study||0
7960584|NCT00389467|19595456|P3|NOT COMPLETED|Overall Study||0
7960585|NCT00389467|19595457|P2|NOT COMPLETED|Overall Study||0
7960586|NCT00389467|19595458|P1|NOT COMPLETED|Overall Study||0
7960587|NCT00389467|19595455|P4|COMPLETED|Overall Study||20
7960588|NCT00389467|19595456|P3|COMPLETED|Overall Study||30
7960589|NCT00389467|19595457|P2|COMPLETED|Overall Study||34
7960590|NCT00389467|19595458|P1|COMPLETED|Overall Study||34
7960591|NCT00389467|19595455|P4|STARTED|Overall Study||20
7960592|NCT00389467|19595456|P3|STARTED|Overall Study||30
7960593|NCT00389467|19595457|P2|STARTED|Overall Study||34
7960594|NCT00389467|19595458|P1|STARTED|Overall Study||34
7960595|NCT00389441|19595477|P1|NOT COMPLETED|Overall Study||52
7960596|NCT00389441|19595477|P1|COMPLETED|Overall Study||0
7960597|NCT00389441|19595477|P1|STARTED|Overall Study||52
7960598|NCT00389324|19595486|P1|NOT COMPLETED|Subcutaneous Phase||7
7960599|NCT00389324|19595486|P1|COMPLETED|Subcutaneous Phase||25
7960600|NCT00389324|19595486|P1|STARTED|Subcutaneous Phase||32
7960601|NCT00389324|19595486|P1|NOT COMPLETED|Intravenous Phase||0
7960602|NCT00389324|19595486|P1|COMPLETED|Intravenous Phase||32
7960603|NCT00389324|19595486|P1|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32
7960604|NCT00389324|19595486|P1|NOT COMPLETED|Run-In Phase||3
7960605|NCT00389324|19595486|P1|COMPLETED|Run-In Phase||18
7960606|NCT00389324|19595486|P1|STARTED|Run-In Phase||21
7960607|NCT00389207|19595496|P3|NOT COMPLETED|Overall Study||41
7960608|NCT00389207|19595497|P2|NOT COMPLETED|Overall Study||72
7960609|NCT00389207|19595498|P1|NOT COMPLETED|Overall Study||63
7960610|NCT00389207|19595496|P3|COMPLETED|Overall Study||152
7960611|NCT00389207|19595497|P2|COMPLETED|Overall Study||116
7960612|NCT00389207|19595498|P1|COMPLETED|Overall Study||125
7960613|NCT00389207|19595496|P3|STARTED|Overall Study||193
7960614|NCT00389207|19595497|P2|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188
7960615|NCT00389207|19595498|P1|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188
7960616|NCT00389168|19595602|P2|NOT COMPLETED|Overall Study||5
7960617|NCT00389168|19595603|P1|NOT COMPLETED|Overall Study||9
7960618|NCT00389168|19595602|P2|COMPLETED|Overall Study||53
7960619|NCT00389168|19595603|P1|COMPLETED|Overall Study||47
7960620|NCT00389168|19595602|P2|STARTED|Overall Study||58
7960621|NCT00389168|19595603|P1|STARTED|Overall Study||56
7960622|NCT00389064|19595621|P2|NOT COMPLETED|Overall Study||59
7960623|NCT00389064|19595622|P1|NOT COMPLETED|Overall Study||45
7960624|NCT00389064|19595621|P2|COMPLETED|Overall Study||168
7960625|NCT00389064|19595622|P1|COMPLETED|Overall Study||178
7960626|NCT00389064|19595621|P2|STARTED|Overall Study||227
7960627|NCT00389064|19595622|P1|STARTED|Overall Study||223
7960628|NCT00388973|19595650|P2|NOT COMPLETED|Overall Study||58
7960629|NCT00388973|19595651|P1|NOT COMPLETED|Overall Study||56
7960630|NCT00388973|19595650|P2|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114
7960631|NCT00388973|19595651|P1|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110
7960632|NCT00388973|19595650|P2|Completed Study|Overall Study||114
7960633|NCT00388973|19595651|P1|Completed Study|Overall Study||110
7960634|NCT00388973|19595650|P2|STARTED|Overall Study|Randomized|172
7960635|NCT00388973|19595651|P1|STARTED|Overall Study|Randomized|166
7960636|NCT00388947|19595671|P1|NOT COMPLETED|Overall Study||47
7960637|NCT00388947|19595671|P1|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543
7960638|NCT00388947|19595671|P1|STARTED|Overall Study||1590
7960639|NCT00388804|19595678|P2|NOT COMPLETED|Overall Study||0
7960640|NCT00388804|19595679|P1|NOT COMPLETED|Overall Study||0
7960641|NCT00388804|19595678|P2|COMPLETED|Overall Study||21
7960642|NCT00388804|19595679|P1|COMPLETED|Overall Study||17
7960643|NCT00388804|19595678|P2|STARTED|Overall Study||21
7960644|NCT00388804|19595679|P1|STARTED|Overall Study||17
7960645|NCT00388726|19595687|P2|NOT COMPLETED|Overall Study||244
7960646|NCT00388726|19595688|P1|NOT COMPLETED|Overall Study||484
7960647|NCT00388726|19595687|P2|COMPLETED|Overall Study||10
7960648|NCT00388726|19595688|P1|COMPLETED|Overall Study||24
7960649|NCT00388726|19595687|P2|STARTED|Overall Study||254
7960650|NCT00388726|19595688|P1|STARTED|Overall Study||508
7960651|NCT00388674|19595704|P2|NOT COMPLETED|End of Study||2169
7960652|NCT00388674|19595705|P1|NOT COMPLETED|End of Study||1734
7960653|NCT00388674|19595704|P2|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|3993
7960654|NCT00388674|19595705|P1|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|4482
7960655|NCT00388674|19595704|P2|STARTED|End of Study||6162
7960656|NCT00388674|19595705|P1|STARTED|End of Study||6216
7960657|NCT00388674|19595704|P2|NOT COMPLETED|Initial Treatment||2586
7960658|NCT00388674|19595705|P1|NOT COMPLETED|Initial Treatment||1828
7960659|NCT00388674|19595704|P2|COMPLETED|Initial Treatment|"Completed=discontinued initial treatment reason of successful treatment or end of study"|3576
7960660|NCT00388674|19595705|P1|COMPLETED|Initial Treatment|Completed=Reason of 'successful treatment', 'other: successful treatment' or 'other: end of study'|4388
7960661|NCT00388674|19595704|P2|STARTED|Initial Treatment||6162
7960662|NCT00388674|19595705|P1|STARTED|Initial Treatment||6216
7960663|NCT00388583|19595723|P2|NOT COMPLETED|Overall Study||4
7960664|NCT00388583|19595724|P1|NOT COMPLETED|Overall Study||6
7960665|NCT00388583|19595723|P2|COMPLETED|Overall Study||406
7960666|NCT00388583|19595724|P1|COMPLETED|Overall Study||401
7960667|NCT00388583|19595723|P2|STARTED|Overall Study||410
7960668|NCT00388583|19595724|P1|STARTED|Overall Study||407
7960669|NCT00388505|19595738|P2|NOT COMPLETED|Overall Study||38
7960670|NCT00388505|19595739|P1|NOT COMPLETED|Overall Study||83
7960671|NCT00388505|19595738|P2|COMPLETED|Overall Study||171
7960672|NCT00388505|19595739|P1|COMPLETED|Overall Study||225
7960673|NCT00388505|19595738|P2|STARTED|Overall Study|Randomized patients who received any amount of study medication|209
7960674|NCT00388505|19595739|P1|STARTED|Overall Study|Randomized patients who received any amount of study medication|308
7960675|NCT00388453|19595764|P3|NOT COMPLETED|Overall Study||0
7960676|NCT00388453|19595765|P2|NOT COMPLETED|Overall Study||0
7960677|NCT00388453|19595766|P1|NOT COMPLETED|Overall Study||0
7960678|NCT00388453|19595764|P3|COMPLETED|Overall Study||10
7960679|NCT00388453|19595765|P2|COMPLETED|Overall Study||17
7960680|NCT00388453|19595766|P1|COMPLETED|Overall Study||20
7960681|NCT00388453|19595764|P3|STARTED|Overall Study||10
7960682|NCT00388453|19595765|P2|STARTED|Overall Study||17
7960683|NCT00388453|19595766|P1|STARTED|Overall Study||20
7960684|NCT00388414|19595785|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
7960685|NCT00388414|19595786|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
7960686|NCT00388414|19595785|P2|COMPLETED|Second Intervention (8 Weeks)||7
7960687|NCT00388414|19595786|P1|COMPLETED|Second Intervention (8 Weeks)||7
7960688|NCT00388414|19595785|P2|STARTED|Second Intervention (8 Weeks)||7
7960689|NCT00388414|19595786|P1|STARTED|Second Intervention (8 Weeks)||7
7960690|NCT00388414|19595785|P2|NOT COMPLETED|Washout (1 Week)||0
7960691|NCT00388414|19595786|P1|NOT COMPLETED|Washout (1 Week)||0
7960692|NCT00388414|19595785|P2|COMPLETED|Washout (1 Week)||7
7960693|NCT00388414|19595786|P1|COMPLETED|Washout (1 Week)||7
7960694|NCT00388414|19595785|P2|STARTED|Washout (1 Week)||7
7960695|NCT00388414|19595786|P1|STARTED|Washout (1 Week)||7
7960696|NCT00388414|19595785|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
7960697|NCT00388414|19595786|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
7960698|NCT00388414|19595785|P2|COMPLETED|First Intervention (8 Weeks)||7
7960699|NCT00388414|19595786|P1|COMPLETED|First Intervention (8 Weeks)||7
7960700|NCT00388414|19595785|P2|STARTED|First Intervention (8 Weeks)||7
7960701|NCT00388414|19595786|P1|STARTED|First Intervention (8 Weeks)||7
7960702|NCT00388362|19595794|P1|NOT COMPLETED|Remained on Study Median of 514 Days||2
7960703|NCT00388362|19595794|P1|COMPLETED|Remained on Study Median of 514 Days||21
7960704|NCT00388362|19595794|P1|STARTED|Remained on Study Median of 514 Days||23
7960705|NCT00388362|19595794|P1|NOT COMPLETED|Enrolled||13
7960706|NCT00388362|19595794|P1|COMPLETED|Enrolled||23
7960707|NCT00388362|19595794|P1|STARTED|Enrolled||36
7960708|NCT00388349|19595799|P2|NOT COMPLETED|Phase 2 Dose Expansion||0
7960709|NCT00388349|19595800|P1|NOT COMPLETED|Phase 2 Dose Expansion||0
7960710|NCT00388349|19595799|P2|COMPLETED|Phase 2 Dose Expansion||0
7960711|NCT00388349|19595800|P1|COMPLETED|Phase 2 Dose Expansion||139
7960712|NCT00388349|19595799|P2|STARTED|Phase 2 Dose Expansion|No participants were treated in Phase 2 at 1500 mg/m2 gemcitabine (MTD exceeded)|0
7960713|NCT00388349|19595800|P1|STARTED|Phase 2 Dose Expansion|Includes the three phase 1 participants who received 1250 mg/m2 gemcitabine (MTD)|139
7960714|NCT00388349|19595799|P2|NOT COMPLETED|Phase I Dose Escalation||3
7960715|NCT00388349|19595800|P1|NOT COMPLETED|Phase I Dose Escalation||0
7960716|NCT00388349|19595799|P2|COMPLETED|Phase I Dose Escalation||1
7960717|NCT00388349|19595800|P1|COMPLETED|Phase I Dose Escalation||3
7960718|NCT00388349|19595799|P2|STARTED|Phase I Dose Escalation||4
7960719|NCT00388349|19595800|P1|STARTED|Phase I Dose Escalation||3
7960720|NCT00388297|19595813|P4|NOT COMPLETED|Overall Study||8
7960721|NCT00388297|19595814|P3|NOT COMPLETED|Overall Study||11
7960722|NCT00388297|19595815|P2|NOT COMPLETED|Overall Study||12
7960723|NCT00388297|19595816|P1|NOT COMPLETED|Overall Study||16
7960724|NCT00388297|19595813|P4|COMPLETED|Overall Study||253
7960725|NCT00388297|19595814|P3|COMPLETED|Overall Study||254
7960726|NCT00388297|19595815|P2|COMPLETED|Overall Study||326
7960727|NCT00388297|19595816|P1|COMPLETED|Overall Study||323
7960728|NCT00388297|19595813|P4|STARTED|Overall Study||261
7960729|NCT00388297|19595814|P3|STARTED|Overall Study||265
7960730|NCT00388297|19595815|P2|STARTED|Overall Study||338
7960731|NCT00388297|19595816|P1|STARTED|Overall Study||339
7960732|NCT00388154|19595926|P1|NOT COMPLETED|Overall Study||1
7960733|NCT00388154|19595926|P1|COMPLETED|Overall Study||20
7960734|NCT00388154|19595926|P1|STARTED|Overall Study||21
7960735|NCT00388037|19595931|P1|NOT COMPLETED|Overall Study||1
7960736|NCT00388037|19595931|P1|COMPLETED|Overall Study||30
7960737|NCT00388037|19595931|P1|STARTED|Overall Study||31
7960738|NCT00387959|19595935|P1|NOT COMPLETED|Overall Study||1
7960739|NCT00387959|19595935|P1|COMPLETED|Overall Study||16
7960740|NCT00387959|19595935|P1|STARTED|Overall Study||17
7960741|NCT00387894|19595939|P1|NOT COMPLETED|Overall Study||1
7960742|NCT00387894|19595939|P1|COMPLETED|Overall Study||5
7960743|NCT00387894|19595939|P1|STARTED|Overall Study||6
7960744|NCT00387881|19595946|P2|NOT COMPLETED|Overall Study||102
7960745|NCT00387881|19595947|P1|NOT COMPLETED|Overall Study||89
7960746|NCT00387881|19595946|P2|COMPLETED|Overall Study||243
7960747|NCT00387881|19595947|P1|COMPLETED|Overall Study||245
7960748|NCT00387881|19595946|P2|STARTED|Overall Study||345
7960749|NCT00387881|19595947|P1|STARTED|Overall Study||334
7960750|NCT00387829|19595971|P2|NOT COMPLETED|Intent-to-treat Population||30
7960751|NCT00387829|19595972|P1|NOT COMPLETED|Intent-to-treat Population||38
7960752|NCT00387829|19595971|P2|COMPLETED|Intent-to-treat Population||136
7960753|NCT00387829|19595972|P1|COMPLETED|Intent-to-treat Population||139
7960754|NCT00387829|19595971|P2|STARTED|Intent-to-treat Population||166
7960755|NCT00387829|19595972|P1|STARTED|Intent-to-treat Population||177
7960756|NCT00387829|19595971|P2|NOT COMPLETED|Safety Population||33
7960757|NCT00387829|19595972|P1|NOT COMPLETED|Safety Population||39
7960758|NCT00387829|19595971|P2|COMPLETED|Safety Population||136
7960759|NCT00387829|19595972|P1|COMPLETED|Safety Population||139
7960760|NCT00387829|19595971|P2|STARTED|Safety Population||169
7960761|NCT00387829|19595972|P1|STARTED|Safety Population||178
7960762|NCT00387790|19595980|P1|NOT COMPLETED|Overall Study||14
7960763|NCT00387790|19595980|P1|COMPLETED|Overall Study||50
7960764|NCT00387790|19595980|P1|STARTED|Overall Study||64
7960765|NCT00387764|19595986|P1|NOT COMPLETED|Overall Study||31
7960766|NCT00387764|19595986|P1|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49
7960767|NCT00387764|19595986|P1|STARTED|Overall Study||80
7960768|NCT00387751|19596004|P1|NOT COMPLETED|Overall Study||0
7960769|NCT00387751|19596004|P1|COMPLETED|Overall Study||14
7960770|NCT00387751|19596004|P1|STARTED|Overall Study||14
7960771|NCT00387725|19596014|P4|NOT COMPLETED|Overall Study||2
7960772|NCT00387725|19596015|P3|NOT COMPLETED|Overall Study||2
7960773|NCT00387725|19596016|P2|NOT COMPLETED|Overall Study||1
7960774|NCT00387725|19596017|P1|NOT COMPLETED|Overall Study||1
7960775|NCT00387725|19596014|P4|COMPLETED|Overall Study||43
7960776|NCT00387725|19596015|P3|COMPLETED|Overall Study||43
7960777|NCT00387725|19596016|P2|COMPLETED|Overall Study||15
7960778|NCT00387725|19596017|P1|COMPLETED|Overall Study||20
7960779|NCT00387725|19596014|P4|STARTED|Overall Study||45
7960780|NCT00387725|19596015|P3|STARTED|Overall Study||45
7960781|NCT00387725|19596016|P2|STARTED|Overall Study||16
7960782|NCT00387725|19596017|P1|STARTED|Overall Study||21
7960783|NCT00387712|19596037|P2|NOT COMPLETED|Overall Study||36
7960784|NCT00387712|19596038|P1|NOT COMPLETED|Overall Study||29
7960785|NCT00387712|19596037|P2|COMPLETED|Overall Study||16
7960786|NCT00387712|19596038|P1|COMPLETED|Overall Study||18
7960787|NCT00387712|19596037|P2|STARTED|Overall Study||52
7960788|NCT00387712|19596038|P1|STARTED|Overall Study||47
7960789|NCT00387673|19596048|P3|NOT COMPLETED|Overall Study||0
7960790|NCT00387673|19596049|P2|NOT COMPLETED|Overall Study||0
7960791|NCT00387673|19596050|P1|NOT COMPLETED|Overall Study||0
7960792|NCT00387673|19596048|P3|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
7960793|NCT00387673|19596049|P2|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
7960794|NCT00387673|19596050|P1|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
7960795|NCT00387673|19596048|P3|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
7960796|NCT00387673|19596049|P2|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
7960797|NCT00387673|19596050|P1|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
7960798|NCT00387660|19596058|P2|NOT COMPLETED|Overall Study||0
7960799|NCT00387660|19596059|P1|NOT COMPLETED|Overall Study||0
7960800|NCT00387660|19596058|P2|COMPLETED|Overall Study||40
7960801|NCT00387660|19596059|P1|COMPLETED|Overall Study||40
7960802|NCT00387660|19596058|P2|STARTED|Overall Study||40
7960803|NCT00387660|19596059|P1|STARTED|Overall Study||40
7960804|NCT00387647|19596069|P1|NOT COMPLETED|Overall Study||18
7960805|NCT00387647|19596069|P1|COMPLETED|Overall Study||6
7960806|NCT00387647|19596069|P1|STARTED|Overall Study||24
7960807|NCT00387621|19596078|P2|NOT COMPLETED|Second Intervention||0
7960808|NCT00387621|19596079|P1|NOT COMPLETED|Second Intervention||0
7960809|NCT00387621|19596078|P2|COMPLETED|Second Intervention||29
7960810|NCT00387621|19596079|P1|COMPLETED|Second Intervention||29
7960811|NCT00387621|19596078|P2|STARTED|Second Intervention||29
7960812|NCT00387621|19596079|P1|STARTED|Second Intervention||29
7960813|NCT00387621|19596078|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
7960814|NCT00387621|19596079|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
7960815|NCT00387621|19596078|P2|COMPLETED|Washout Period of 2 Weeks||29
7960816|NCT00387621|19596079|P1|COMPLETED|Washout Period of 2 Weeks||29
7960817|NCT00387621|19596078|P2|STARTED|Washout Period of 2 Weeks||29
7960818|NCT00387621|19596079|P1|STARTED|Washout Period of 2 Weeks||29
7960819|NCT00387621|19596078|P2|NOT COMPLETED|First Intervention||0
7960820|NCT00387621|19596079|P1|NOT COMPLETED|First Intervention||0
7960821|NCT00387621|19596078|P2|COMPLETED|First Intervention||29
7960822|NCT00387621|19596079|P1|COMPLETED|First Intervention||29
7960823|NCT00387621|19596078|P2|STARTED|First Intervention||29
7960824|NCT00387621|19596079|P1|STARTED|First Intervention||29
7960825|NCT00387465|19596112|P3|NOT COMPLETED|Overall Study||0
7960826|NCT00387465|19596113|P2|NOT COMPLETED|Overall Study||1
7960827|NCT00387465|19596114|P1|NOT COMPLETED|Overall Study||0
7960828|NCT00387465|19596112|P3|COMPLETED|Overall Study||35
7960829|NCT00387465|19596113|P2|COMPLETED|Overall Study||6
7960830|NCT00387465|19596114|P1|COMPLETED|Overall Study||3
7960831|NCT00387465|19596112|P3|STARTED|Overall Study||35
7960832|NCT00387465|19596113|P2|STARTED|Overall Study||7
7960833|NCT00387465|19596114|P1|STARTED|Overall Study||3
7960834|NCT00387426|19596131|P1|NOT COMPLETED|Overall Study||14
7960835|NCT00387426|19596131|P1|COMPLETED|Overall Study||0
7960836|NCT00387426|19596131|P1|STARTED|Overall Study||14
7960837|NCT00387348|19596138|P3|NOT COMPLETED|Overall Study||4
7960838|NCT00387348|19596139|P2|NOT COMPLETED|Overall Study||3
7960839|NCT00387348|19596140|P1|NOT COMPLETED|Overall Study||3
7960840|NCT00387348|19596138|P3|COMPLETED|Overall Study||7
7960841|NCT00387348|19596139|P2|COMPLETED|Overall Study||2
7960842|NCT00387348|19596140|P1|COMPLETED|Overall Study||5
7960843|NCT00387348|19596138|P3|STARTED|Overall Study||11
7960844|NCT00387348|19596139|P2|STARTED|Overall Study||5
7960845|NCT00387348|19596140|P1|STARTED|Overall Study||8
7960846|NCT00387335|19596156|P2|NOT COMPLETED|Overall Study||0
7960847|NCT00387335|19596157|P1|NOT COMPLETED|Overall Study||0
7960848|NCT00387335|19596156|P2|COMPLETED|Overall Study||7
7960849|NCT00387335|19596157|P1|COMPLETED|Overall Study||15
7960850|NCT00387335|19596156|P2|STARTED|Overall Study||7
7960851|NCT00387335|19596157|P1|STARTED|Overall Study||15
7960852|NCT00387244|19596169|P1|NOT COMPLETED|Overall Study||7
7960853|NCT00387244|19596169|P1|COMPLETED|Overall Study||0
7960854|NCT00387244|19596169|P1|End of Trial|Overall Study||0
7960855|NCT00387244|19596169|P1|STARTED|Overall Study||7
7960856|NCT00387153|19596173|P1|NOT COMPLETED|Overall Study||8
7960857|NCT00387153|19596173|P1|COMPLETED|Overall Study||0
7960858|NCT00387153|19596173|P1|STARTED|Overall Study||8
7960859|NCT00387127|19596179|P2|NOT COMPLETED|Overall Study||34
7960860|NCT00387127|19596180|P1|NOT COMPLETED|Overall Study||33
7960861|NCT00387127|19596179|P2|COMPLETED|Overall Study||0
7960862|NCT00387127|19596180|P1|COMPLETED|Overall Study||0
7960863|NCT00387127|19596179|P2|STARTED|Overall Study||34
7960864|NCT00387127|19596180|P1|STARTED|Overall Study||33
7960865|NCT00387088|19596222|P2|NOT COMPLETED|Overall Study||373
7960866|NCT00387088|19596223|P1|NOT COMPLETED|Overall Study||318
7960867|NCT00387088|19596222|P2|COMPLETED|Overall Study||1629
7960868|NCT00387088|19596223|P1|COMPLETED|Overall Study||1671
7960869|NCT00387088|19596222|P2|STARTED|Overall Study||2002
7960870|NCT00387088|19596223|P1|STARTED|Overall Study||1989
7960871|NCT00387036|19596267|P2|NOT COMPLETED|2-Week Crossover Second Intervention||0
7960872|NCT00387036|19596268|P1|NOT COMPLETED|2-Week Crossover Second Intervention||0
7960873|NCT00387036|19596267|P2|COMPLETED|2-Week Crossover Second Intervention||6
7960874|NCT00387036|19596268|P1|COMPLETED|2-Week Crossover Second Intervention||6
7960875|NCT00387036|19596267|P2|STARTED|2-Week Crossover Second Intervention||6
7960876|NCT00387036|19596268|P1|STARTED|2-Week Crossover Second Intervention||6
7960877|NCT00387036|19596267|P2|NOT COMPLETED|2-Week Placebo Washout||0
7960878|NCT00387036|19596268|P1|NOT COMPLETED|2-Week Placebo Washout||0
7960879|NCT00387036|19596267|P2|COMPLETED|2-Week Placebo Washout||6
7960880|NCT00387036|19596268|P1|COMPLETED|2-Week Placebo Washout||6
7960881|NCT00387036|19596267|P2|STARTED|2-Week Placebo Washout||6
7960882|NCT00387036|19596268|P1|STARTED|2-Week Placebo Washout||6
7960883|NCT00387036|19596267|P2|NOT COMPLETED|2-Week First Intervention||0
7960884|NCT00387036|19596268|P1|NOT COMPLETED|2-Week First Intervention||0
7960885|NCT00387036|19596267|P2|COMPLETED|2-Week First Intervention||6
7960886|NCT00387036|19596268|P1|COMPLETED|2-Week First Intervention||6
7960887|NCT00387036|19596267|P2|STARTED|2-Week First Intervention||6
7960888|NCT00387036|19596268|P1|STARTED|2-Week First Intervention||6
7960889|NCT00387023|19596276|P1|NOT COMPLETED|Overall Study||0
7960890|NCT00387023|19596276|P1|COMPLETED|Overall Study||12
7960891|NCT00387023|19596276|P1|STARTED|Overall Study||12
7960892|NCT00387010|19596280|P1|NOT COMPLETED|Treatment Period||11
7960893|NCT00387010|19596280|P1|COMPLETED|Treatment Period||169
7960894|NCT00387010|19596280|P1|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175
7960895|NCT00387010|19596280|P1|STARTED|Treatment Period||180
7960896|NCT00387010|19596280|P1|NOT COMPLETED|Dose Titration Period||38
7960897|NCT00387010|19596280|P1|COMPLETED|Dose Titration Period||180
7960898|NCT00387010|19596280|P1|STARTED|Dose Titration Period||218
7960899|NCT00386880|19596301|P2|NOT COMPLETED|Overall Study||0
7960900|NCT00386880|19596302|P1|NOT COMPLETED|Overall Study||0
7960901|NCT00386880|19596301|P2|COMPLETED|Overall Study||8
7960902|NCT00386880|19596302|P1|COMPLETED|Overall Study||30
7960903|NCT00386880|19596301|P2|STARTED|Overall Study||8
7960904|NCT00386880|19596302|P1|STARTED|Overall Study||30
7960905|NCT00386776|19596307|P1|NOT COMPLETED|Overall Study||8
7960906|NCT00386776|19596307|P1|COMPLETED|Overall Study||32
7960907|NCT00386776|19596307|P1|STARTED|Overall Study||40
7960908|NCT00386724|19596317|P1|NOT COMPLETED|Overall Study||5
7960909|NCT00386724|19596317|P1|COMPLETED|Overall Study||3
7960910|NCT00386724|19596317|P1|3 Months Post-activation|Overall Study||4
7960911|NCT00386724|19596317|P1|STARTED|Overall Study||8
7960912|NCT00386607|19596321|P2|NOT COMPLETED|Extension||17
7960913|NCT00386607|19596322|P1|NOT COMPLETED|Extension||0
7960914|NCT00386607|19596321|P2|COMPLETED|Extension||145
7960915|NCT00386607|19596322|P1|COMPLETED|Extension||0
7960916|NCT00386607|19596321|P2|STARTED|Extension||162
7960917|NCT00386607|19596322|P1|STARTED|Extension||0
7960918|NCT00386607|19596321|P2|NOT COMPLETED|Core||0
7960919|NCT00386607|19596322|P1|NOT COMPLETED|Core||115
7960920|NCT00386607|19596321|P2|COMPLETED|Core||0
7960921|NCT00386607|19596322|P1|COMPLETED|Core||486
7960922|NCT00386607|19596321|P2|STARTED|Core||0
7960923|NCT00386607|19596322|P1|STARTED|Core||601
7960924|NCT00386477|19596340|P2|NOT COMPLETED|Overall Study||0
7960925|NCT00386477|19596341|P1|NOT COMPLETED|Overall Study||0
7960926|NCT00386477|19596340|P2|COMPLETED|Overall Study||145
7960927|NCT00386477|19596341|P1|COMPLETED|Overall Study||155
7960928|NCT00386477|19596340|P2|STARTED|Overall Study||145
7960929|NCT00386477|19596341|P1|STARTED|Overall Study||155
7960930|NCT00386425|19596350|P3|NOT COMPLETED|Overall Study||0
7960931|NCT00386425|19596351|P2|NOT COMPLETED|Overall Study||1
7960932|NCT00386425|19596352|P1|NOT COMPLETED|Overall Study||3
7960933|NCT00386425|19596350|P3|COMPLETED|Overall Study||53
7960934|NCT00386425|19596351|P2|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205
7960935|NCT00386425|19596352|P1|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224
7960936|NCT00386425|19596350|P3|Received Study Drug|Overall Study||53
7960937|NCT00386425|19596351|P2|Received Study Drug|Overall Study||206
7960938|NCT00386425|19596352|P1|Received Study Drug|Overall Study||227
7960939|NCT00386425|19596350|P3|STARTED|Overall Study||53
7960940|NCT00386425|19596351|P2|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206
7960941|NCT00386425|19596352|P1|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227
7960942|NCT00386360|19596378|P2|NOT COMPLETED|Overall Study||17
7960943|NCT00386360|19596379|P1|NOT COMPLETED|Overall Study||9
7960944|NCT00386360|19596378|P2|COMPLETED|Overall Study||95
7960945|NCT00386360|19596379|P1|COMPLETED|Overall Study||40
7960946|NCT00386360|19596378|P2|Primary Efficacy|Overall Study||77
7960947|NCT00386360|19596379|P1|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36
7960948|NCT00386360|19596378|P2|Intent to Treat Population (ITT)|Overall Study||110
7961038|NCT00385944|19596762|P2|COMPLETED|2nd Maintenance Dose Period||19
7960949|NCT00386360|19596379|P1|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49
7960950|NCT00386360|19596378|P2|STARTED|Overall Study||112
7960951|NCT00386360|19596379|P1|STARTED|Overall Study||49
7960952|NCT00386334|19596413|P2|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1
7960953|NCT00386334|19596414|P1|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3
7960954|NCT00386334|19596413|P2|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144
7960955|NCT00386334|19596414|P1|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143
7960956|NCT00386334|19596413|P2|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145
7960957|NCT00386334|19596414|P1|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146
7960958|NCT00386334|19596413|P2|NOT COMPLETED|Double Blind Period||47
7960959|NCT00386334|19596414|P1|NOT COMPLETED|Double Blind Period||46
7960960|NCT00386334|19596413|P2|COMPLETED|Double Blind Period||147
7960961|NCT00386334|19596414|P1|COMPLETED|Double Blind Period||148
7960962|NCT00386334|19596413|P2|STARTED|Double Blind Period||194
7960963|NCT00386334|19596414|P1|STARTED|Double Blind Period||194
7960964|NCT00386308|19596558|P2|NOT COMPLETED|Overall Study||19
7960965|NCT00386308|19596559|P1|NOT COMPLETED|Overall Study||29
7960966|NCT00386308|19596558|P2|COMPLETED|Overall Study||54
7960967|NCT00386308|19596559|P1|COMPLETED|Overall Study||94
7960968|NCT00386308|19596558|P2|Modified Intent to Treat Population|Overall Study||72
7960969|NCT00386308|19596559|P1|Modified Intent to Treat Population|Overall Study||115
7960970|NCT00386308|19596558|P2|Intent to Treat Population|Overall Study||72
7960971|NCT00386308|19596559|P1|Intent to Treat Population|Overall Study||117
7960972|NCT00386308|19596558|P2|STARTED|Overall Study||73
7960973|NCT00386308|19596559|P1|STARTED|Overall Study||123
7960974|NCT00386256|19596575|P4|NOT COMPLETED|Overall Study||0
7960975|NCT00386256|19596576|P3|NOT COMPLETED|Overall Study||0
7960976|NCT00386256|19596577|P2|NOT COMPLETED|Overall Study||0
7960977|NCT00386256|19596578|P1|NOT COMPLETED|Overall Study||0
7960978|NCT00386256|19596575|P4|COMPLETED|Overall Study||3
7960979|NCT00386256|19596576|P3|COMPLETED|Overall Study||4
7960980|NCT00386256|19596577|P2|COMPLETED|Overall Study||15
7960981|NCT00386256|19596578|P1|COMPLETED|Overall Study||16
7960982|NCT00386256|19596575|P4|STARTED|Overall Study||3
7960983|NCT00386256|19596576|P3|STARTED|Overall Study||4
7960984|NCT00386256|19596577|P2|STARTED|Overall Study||15
7960985|NCT00386256|19596578|P1|STARTED|Overall Study||16
7960986|NCT00386243|19596594|P2|NOT COMPLETED|Overall Study||13
7960987|NCT00386243|19596595|P1|NOT COMPLETED|Overall Study||7
7960988|NCT00386243|19596594|P2|COMPLETED|Overall Study||108
7960989|NCT00386243|19596595|P1|COMPLETED|Overall Study||114
7960990|NCT00386243|19596594|P2|STARTED|Overall Study||121
7960991|NCT00386243|19596595|P1|STARTED|Overall Study||121
7960992|NCT00386152|19596616|P3|NOT COMPLETED|Overall Study||33
7960993|NCT00386152|19596617|P2|NOT COMPLETED|Overall Study||40
7960994|NCT00386152|19596618|P1|NOT COMPLETED|Overall Study||44
7960995|NCT00386152|19596616|P3|COMPLETED|Overall Study||42
7960996|NCT00386152|19596617|P2|COMPLETED|Overall Study||37
7960997|NCT00386152|19596618|P1|COMPLETED|Overall Study||31
7960998|NCT00386152|19596616|P3|STARTED|Overall Study|number of subjects treated|75
7960999|NCT00386152|19596617|P2|STARTED|Overall Study|number of subjects treated|77
7961000|NCT00386152|19596618|P1|STARTED|Overall Study|number of subjects treated|75
7961001|NCT00386100|19596637|P2|NOT COMPLETED|Overall Study||131
7961002|NCT00386100|19596638|P1|NOT COMPLETED|Overall Study||154
7961003|NCT00386100|19596637|P2|COMPLETED|Overall Study||217
7961004|NCT00386100|19596638|P1|COMPLETED|Overall Study||186
7961005|NCT00386100|19596637|P2|STARTED|Overall Study||348
7961006|NCT00386100|19596638|P1|STARTED|Overall Study||340
7961007|NCT00386022|19596702|P2|NOT COMPLETED|Plus Estrogen||1
7961008|NCT00386022|19596703|P1|NOT COMPLETED|Plus Estrogen||2
7961009|NCT00386022|19596702|P2|COMPLETED|Plus Estrogen||8
7961010|NCT00386022|19596703|P1|COMPLETED|Plus Estrogen||8
7961011|NCT00386022|19596702|P2|All Doses GnRH|Plus Estrogen||8
7961012|NCT00386022|19596703|P1|All Doses GnRH|Plus Estrogen||8
7961013|NCT00386022|19596702|P2|Estrogen Patch|Plus Estrogen||9
7961014|NCT00386022|19596703|P1|Estrogen Patch|Plus Estrogen||8
7961015|NCT00386022|19596702|P2|STARTED|Plus Estrogen||9
7961016|NCT00386022|19596703|P1|STARTED|Plus Estrogen||10
7961017|NCT00386022|19596702|P2|NOT COMPLETED|Baseline||0
7961018|NCT00386022|19596703|P1|NOT COMPLETED|Baseline||0
7961019|NCT00386022|19596702|P2|COMPLETED|Baseline||9
7961020|NCT00386022|19596703|P1|COMPLETED|Baseline||10
7961021|NCT00386022|19596702|P2|All Doses of GnRH|Baseline||9
7961022|NCT00386022|19596703|P1|All Doses of GnRH|Baseline||10
7961023|NCT00386022|19596702|P2|STARTED|Baseline||9
7961024|NCT00386022|19596703|P1|STARTED|Baseline||10
7961025|NCT00386009|19596713|P2|NOT COMPLETED|Overall Study||10
7961026|NCT00386009|19596714|P1|NOT COMPLETED|Overall Study||9
7961027|NCT00386009|19596713|P2|COMPLETED|Overall Study||89
7961028|NCT00386009|19596714|P1|COMPLETED|Overall Study||92
7961029|NCT00386009|19596713|P2|STARTED|Overall Study||99
7961030|NCT00386009|19596714|P1|STARTED|Overall Study||101
7961031|NCT00385996|19596752|P1|NOT COMPLETED|Overall Study||0
7961032|NCT00385996|19596752|P1|COMPLETED|Overall Study||22
7961033|NCT00385996|19596752|P1|STARTED|Overall Study||22
7961034|NCT00385944|19596761|P3|NOT COMPLETED|2nd Maintenance Dose Period||0
7961035|NCT00385944|19596762|P2|NOT COMPLETED|2nd Maintenance Dose Period||3
7961036|NCT00385944|19596763|P1|NOT COMPLETED|2nd Maintenance Dose Period||2
7961037|NCT00385944|19596761|P3|COMPLETED|2nd Maintenance Dose Period||0
7961039|NCT00385944|19596763|P1|COMPLETED|2nd Maintenance Dose Period||22
7961040|NCT00385944|19596761|P3|STARTED|2nd Maintenance Dose Period||0
7961041|NCT00385944|19596762|P2|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22
7961042|NCT00385944|19596763|P1|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24
7961043|NCT00385944|19596761|P3|NOT COMPLETED|1st Maintenance Dose Period||0
7961044|NCT00385944|19596762|P2|NOT COMPLETED|1st Maintenance Dose Period||1
7961045|NCT00385944|19596763|P1|NOT COMPLETED|1st Maintenance Dose Period||4
7961046|NCT00385944|19596761|P3|COMPLETED|1st Maintenance Dose Period||0
7961047|NCT00385944|19596762|P2|COMPLETED|1st Maintenance Dose Period||24
7961048|NCT00385944|19596763|P1|COMPLETED|1st Maintenance Dose Period||25
7961049|NCT00385944|19596761|P3|STARTED|1st Maintenance Dose Period||0
7961050|NCT00385944|19596762|P2|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25
7961051|NCT00385944|19596763|P1|STARTED|1st Maintenance Dose Period||29
7961052|NCT00385944|19596761|P3|NOT COMPLETED|Loading Dose||0
7961053|NCT00385944|19596762|P2|NOT COMPLETED|Loading Dose||0
7961054|NCT00385944|19596763|P1|NOT COMPLETED|Loading Dose||0
7961055|NCT00385944|19596761|P3|COMPLETED|Loading Dose||56
7961056|NCT00385944|19596762|P2|COMPLETED|Loading Dose||0
7961057|NCT00385944|19596763|P1|COMPLETED|Loading Dose||0
7961058|NCT00385944|19596761|P3|STARTED|Loading Dose||56
7961059|NCT00385944|19596762|P2|STARTED|Loading Dose||0
7961060|NCT00385944|19596763|P1|STARTED|Loading Dose||0
7961061|NCT00385918|19596806|P3|NOT COMPLETED|Intervention Phase After Randomization||0
7961062|NCT00385918|19596807|P2|NOT COMPLETED|Intervention Phase After Randomization||0
7961063|NCT00385918|19596808|P1|NOT COMPLETED|Intervention Phase After Randomization||3
7961064|NCT00385918|19596806|P3|COMPLETED|Intervention Phase After Randomization||0
7961065|NCT00385918|19596807|P2|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6
7961066|NCT00385918|19596808|P1|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12
7961067|NCT00385918|19596806|P3|STARTED|Intervention Phase After Randomization||0
7961068|NCT00385918|19596807|P2|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6
7961069|NCT00385918|19596808|P1|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15
7961070|NCT00385918|19596806|P3|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14
7961071|NCT00385918|19596807|P2|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
7961072|NCT00385918|19596808|P1|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
7961073|NCT00385918|19596806|P3|COMPLETED|Feasibility & Baseline Measurement Phase||21
7961074|NCT00385918|19596807|P2|COMPLETED|Feasibility & Baseline Measurement Phase||0
7961075|NCT00385918|19596808|P1|COMPLETED|Feasibility & Baseline Measurement Phase||0
7961076|NCT00385918|19596806|P3|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21
7961077|NCT00385918|19596807|P2|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
7961078|NCT00385918|19596808|P1|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
7961079|NCT00385918|19596806|P3|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27
7961080|NCT00385918|19596807|P2|Number Eligible|Feasibility & Baseline Measurement Phase||0
7961081|NCT00385918|19596808|P1|Number Eligible|Feasibility & Baseline Measurement Phase||0
7961082|NCT00385918|19596806|P3|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35
7961083|NCT00385918|19596807|P2|STARTED|Feasibility & Baseline Measurement Phase||0
7961084|NCT00385918|19596808|P1|STARTED|Feasibility & Baseline Measurement Phase||0
7961085|NCT00385840|19596832|P2|NOT COMPLETED|Overall Study||14
7961086|NCT00385840|19596833|P1|NOT COMPLETED|Overall Study||4
7961087|NCT00385840|19596832|P2|COMPLETED|Overall Study||531
7961088|NCT00385840|19596833|P1|COMPLETED|Overall Study||129
7961089|NCT00385840|19596832|P2|STARTED|Overall Study||545
7961090|NCT00385840|19596833|P1|STARTED|Overall Study||133
7961091|NCT00385827|19596856|P3|NOT COMPLETED|Part 2||48
7961092|NCT00385827|19596857|P2|NOT COMPLETED|Part 2||33
7961093|NCT00385827|19596858|P1|NOT COMPLETED|Part 2||0
7961094|NCT00385827|19596856|P3|COMPLETED|Part 2||0
7961095|NCT00385827|19596857|P2|COMPLETED|Part 2||16
7961096|NCT00385827|19596858|P1|COMPLETED|Part 2||0
7961097|NCT00385827|19596856|P3|Treated|Part 2||46
7961098|NCT00385827|19596857|P2|Treated|Part 2||47
7961099|NCT00385827|19596858|P1|Treated|Part 2||0
7961100|NCT00385827|19596856|P3|STARTED|Part 2||48
7961101|NCT00385827|19596857|P2|STARTED|Part 2||49
7961102|NCT00385827|19596858|P1|STARTED|Part 2||0
7961103|NCT00385827|19596856|P3|NOT COMPLETED|Part 1||0
7961104|NCT00385827|19596857|P2|NOT COMPLETED|Part 1||0
7961105|NCT00385827|19596858|P1|NOT COMPLETED|Part 1||9
7961106|NCT00385827|19596856|P3|COMPLETED|Part 1||0
7961107|NCT00385827|19596857|P2|COMPLETED|Part 1||0
7961108|NCT00385827|19596858|P1|COMPLETED|Part 1||0
7961109|NCT00385827|19596856|P3|Treated|Part 1||0
7961110|NCT00385827|19596857|P2|Treated|Part 1||0
7961111|NCT00385827|19596858|P1|Treated|Part 1||9
7961112|NCT00385827|19596856|P3|STARTED|Part 1||0
7961113|NCT00385827|19596857|P2|STARTED|Part 1||0
7961114|NCT00385827|19596858|P1|STARTED|Part 1||9
7961115|NCT00385801|19596880|P2|NOT COMPLETED|Overall Study||8
7961116|NCT00385801|19596881|P1|NOT COMPLETED|Overall Study||9
7961117|NCT00385801|19596880|P2|COMPLETED|Overall Study||8
7961118|NCT00385801|19596881|P1|COMPLETED|Overall Study||6
7961119|NCT00385801|19596880|P2|STARTED|Overall Study||16
7961120|NCT00385801|19596881|P1|STARTED|Overall Study||15
7961121|NCT00385788|19596895|P2|NOT COMPLETED|Overall Study||0
7961122|NCT00385788|19596896|P1|NOT COMPLETED|Overall Study||0
7961123|NCT00385788|19596895|P2|COMPLETED|Overall Study||40
7961124|NCT00385788|19596896|P1|COMPLETED|Overall Study||12
7961125|NCT00385788|19596895|P2|STARTED|Overall Study||40
7961126|NCT00385788|19596896|P1|STARTED|Overall Study||12
7961127|NCT00385762|19596902|P1|NOT COMPLETED|Overall Study||2
7961128|NCT00385762|19596902|P1|COMPLETED|Overall Study||33
7961129|NCT00385762|19596902|P1|STARTED|Overall Study||35
7961130|NCT00385736|19596912|P3|NOT COMPLETED|Safety Analysis Set||80
7961131|NCT00385736|19596913|P2|NOT COMPLETED|Safety Analysis Set||44
7961132|NCT00385736|19596914|P1|NOT COMPLETED|Safety Analysis Set||70
7961133|NCT00385736|19596912|P3|COMPLETED|Safety Analysis Set||143
7961134|NCT00385736|19596913|P2|COMPLETED|Safety Analysis Set||86
7961135|NCT00385736|19596914|P1|COMPLETED|Safety Analysis Set||153
7961136|NCT00385736|19596912|P3|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
7961137|NCT00385736|19596913|P2|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130
7961138|NCT00385736|19596914|P1|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
7961139|NCT00385736|19596912|P3|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80
7961140|NCT00385736|19596913|P2|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44
7961141|NCT00385736|19596914|P1|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69
7961142|NCT00385736|19596912|P3|COMPLETED|Efficacy Analysis Set - Maintenance||143
7961143|NCT00385736|19596913|P2|COMPLETED|Efficacy Analysis Set - Maintenance||86
7961144|NCT00385736|19596914|P1|COMPLETED|Efficacy Analysis Set - Maintenance||153
7961145|NCT00385736|19596912|P3|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223
7961146|NCT00385736|19596913|P2|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130
7961147|NCT00385736|19596914|P1|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222
7961148|NCT00385736|19596912|P3|NOT COMPLETED|Efficacy Analysis Set - Induction||9
7961149|NCT00385736|19596913|P2|NOT COMPLETED|Efficacy Analysis Set - Induction||12
7961150|NCT00385736|19596914|P1|NOT COMPLETED|Efficacy Analysis Set - Induction||9
7961151|NCT00385736|19596912|P3|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
7961152|NCT00385736|19596913|P2|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118
7961153|NCT00385736|19596914|P1|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
7961154|NCT00385736|19596912|P3|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
7961155|NCT00385736|19596913|P2|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
7961156|NCT00385736|19596914|P1|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
7961157|NCT00385723|19596959|P3|NOT COMPLETED|Overall Study||2
7961158|NCT00385723|19596960|P2|NOT COMPLETED|Overall Study||1
7961159|NCT00385723|19596961|P1|NOT COMPLETED|Overall Study||2
7961160|NCT00385723|19596959|P3|COMPLETED|Overall Study||44
7961161|NCT00385723|19596960|P2|COMPLETED|Overall Study||45
7961162|NCT00385723|19596961|P1|COMPLETED|Overall Study||44
7961163|NCT00385723|19596959|P3|STARTED|Overall Study||46
7961164|NCT00385723|19596960|P2|STARTED|Overall Study||46
7961165|NCT00385723|19596961|P1|STARTED|Overall Study||46
7961166|NCT00385684|19596975|P2|NOT COMPLETED|PHASE B||0
7961167|NCT00385684|19596976|P1|NOT COMPLETED|PHASE B||0
7961168|NCT00385684|19596975|P2|COMPLETED|PHASE B||3
7961169|NCT00385684|19596976|P1|COMPLETED|PHASE B||5
7961170|NCT00385684|19596975|P2|STARTED|PHASE B||3
7961171|NCT00385684|19596976|P1|STARTED|PHASE B||5
7961172|NCT00385684|19596975|P2|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2
7961173|NCT00385684|19596976|P1|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0
7961174|NCT00385684|19596975|P2|COMPLETED|SECOND INTERVENTION OF PHASE A||3
7961175|NCT00385684|19596976|P1|COMPLETED|SECOND INTERVENTION OF PHASE A||5
7961176|NCT00385684|19596975|P2|STARTED|SECOND INTERVENTION OF PHASE A||5
7961177|NCT00385684|19596976|P1|STARTED|SECOND INTERVENTION OF PHASE A||5
7961178|NCT00385684|19596975|P2|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0
7961179|NCT00385684|19596976|P1|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1
7961180|NCT00385684|19596975|P2|COMPLETED|FIRST INTERVENTION OF PHASE A||5
7961181|NCT00385684|19596976|P1|COMPLETED|FIRST INTERVENTION OF PHASE A||5
7961182|NCT00385684|19596975|P2|STARTED|FIRST INTERVENTION OF PHASE A||5
7961183|NCT00385684|19596976|P1|STARTED|FIRST INTERVENTION OF PHASE A||6
7961184|NCT00385671|19596985|P3|NOT COMPLETED|Overall Study||36
7961185|NCT00385671|19596986|P2|NOT COMPLETED|Overall Study||51
7961186|NCT00385671|19596987|P1|NOT COMPLETED|Overall Study||38
7961187|NCT00385671|19596985|P3|COMPLETED|Overall Study||99
7961188|NCT00385671|19596986|P2|COMPLETED|Overall Study||87
7961189|NCT00385671|19596987|P1|COMPLETED|Overall Study||96
7961190|NCT00385671|19596985|P3|STARTED|Overall Study||135
7961191|NCT00385671|19596986|P2|STARTED|Overall Study||138
7961192|NCT00385671|19596987|P1|STARTED|Overall Study||134
7961193|NCT00385593|19597143|P2|NOT COMPLETED|Overall Study||37
7961194|NCT00385593|19597144|P1|NOT COMPLETED|Overall Study||58
7961195|NCT00385593|19597143|P2|COMPLETED|Overall Study||289
7961196|NCT00385593|19597144|P1|COMPLETED|Overall Study||270
7961197|NCT00385593|19597143|P2|STARTED|Overall Study||326
7961198|NCT00385593|19597144|P1|STARTED|Overall Study||328
7961199|NCT00385580|19597162|P2|NOT COMPLETED|Overall Study||0
7961200|NCT00385580|19597163|P1|NOT COMPLETED|Overall Study||0
7961201|NCT00385580|19597162|P2|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47
7961202|NCT00385580|19597163|P1|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48
7961203|NCT00385580|19597162|P2|STARTED|Overall Study|Number of participants treated.|47
7961204|NCT00385580|19597163|P1|STARTED|Overall Study|Number of participants treated.|48
7961205|NCT00385541|19597254|P2|NOT COMPLETED|Overall Study||1
7961206|NCT00385541|19597255|P1|NOT COMPLETED|Overall Study||0
7961207|NCT00385541|19597254|P2|COMPLETED|Overall Study||24
7961208|NCT00385541|19597255|P1|COMPLETED|Overall Study||25
7961209|NCT00385541|19597254|P2|STARTED|Overall Study||25
7961210|NCT00385541|19597255|P1|STARTED|Overall Study||25
7961211|NCT00385515|19597271|P2|NOT COMPLETED|Overall Study||3
7961212|NCT00385515|19597272|P1|NOT COMPLETED|Overall Study||4
7961213|NCT00385515|19597271|P2|COMPLETED|Overall Study||21
7961214|NCT00385515|19597272|P1|COMPLETED|Overall Study||53
7961215|NCT00385515|19597271|P2|STARTED|Overall Study||24
7961216|NCT00385515|19597272|P1|STARTED|Overall Study||57
7961217|NCT00385268|19597280|P2|NOT COMPLETED|Overall Study||8
7961218|NCT00385268|19597281|P1|NOT COMPLETED|Overall Study||16
7961219|NCT00385268|19597280|P2|COMPLETED|Overall Study||18
7961220|NCT00385268|19597281|P1|COMPLETED|Overall Study||18
7961221|NCT00385268|19597280|P2|STARTED|Overall Study||26
7961222|NCT00385268|19597281|P1|STARTED|Overall Study||34
7961223|NCT00385255|19597289|P2|NOT COMPLETED|Overall Study||73
7961224|NCT00385255|19597290|P1|NOT COMPLETED|Overall Study||21
7961225|NCT00385255|19597289|P2|COMPLETED|Overall Study||785
7961226|NCT00385255|19597290|P1|COMPLETED|Overall Study||839
7961227|NCT00385255|19597289|P2|19-64 Years of Age (YOA) Cohort|Overall Study||749
7961228|NCT00385255|19597290|P1|19-64 Years of Age (YOA) Cohort|Overall Study||748
7961229|NCT00385255|19597289|P2|≥ 65 Years of Age (YOA) Cohort|Overall Study||109
7961230|NCT00385255|19597290|P1|≥ 65 Years of Age (YOA) Cohort|Overall Study||112
7961231|NCT00385255|19597289|P2|STARTED|Overall Study||858
7961232|NCT00385255|19597290|P1|STARTED|Overall Study||860
7961233|NCT00385216|19597354|P2|NOT COMPLETED|Second Intervention||0
7961234|NCT00385216|19597355|P1|NOT COMPLETED|Second Intervention||0
7961235|NCT00385216|19597354|P2|COMPLETED|Second Intervention||9
7961236|NCT00385216|19597355|P1|COMPLETED|Second Intervention||11
7961237|NCT00385216|19597354|P2|STARTED|Second Intervention||9
7961238|NCT00385216|19597355|P1|STARTED|Second Intervention||11
7961239|NCT00385216|19597354|P2|NOT COMPLETED|First Intervention||0
7961240|NCT00385216|19597355|P1|NOT COMPLETED|First Intervention||0
7961241|NCT00385216|19597354|P2|COMPLETED|First Intervention||9
7961242|NCT00385216|19597355|P1|COMPLETED|First Intervention||11
7961243|NCT00385216|19597354|P2|STARTED|First Intervention||9
7961244|NCT00385216|19597355|P1|STARTED|First Intervention||11
7961245|NCT00385203|19597369|P2|NOT COMPLETED|Overall Study||7
7961246|NCT00385203|19597370|P1|NOT COMPLETED|Overall Study||26
7961247|NCT00385203|19597369|P2|COMPLETED|Overall Study||3
7961248|NCT00385203|19597370|P1|COMPLETED|Overall Study||0
7961249|NCT00385203|19597369|P2|STARTED|Overall Study||10
7961250|NCT00385203|19597370|P1|STARTED|Overall Study||26
7961251|NCT00385138|19597390|P2|NOT COMPLETED|Overall Study||28
7961252|NCT00385138|19597391|P1|NOT COMPLETED|Overall Study||30
7961253|NCT00385138|19597390|P2|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641
7961254|NCT00385138|19597391|P1|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665
7961255|NCT00385138|19597390|P2|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650
7961256|NCT00385138|19597391|P1|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662
7961257|NCT00385138|19597390|P2|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645
7961258|NCT00385138|19597391|P1|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656
7961259|NCT00385138|19597390|P2|Intent-to-treat (ITT)|Overall Study||2669
7961260|NCT00385138|19597391|P1|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693
7961261|NCT00385138|19597390|P2|STARTED|Overall Study||2669
7961262|NCT00385138|19597391|P1|STARTED|Overall Study||2695
7961263|NCT00385008|19597437|P2|NOT COMPLETED|Overall Study||0
7961264|NCT00385008|19597438|P1|NOT COMPLETED|Overall Study||0
7961265|NCT00385008|19597437|P2|COMPLETED|Overall Study||10
7961266|NCT00385008|19597438|P1|COMPLETED|Overall Study||10
7961267|NCT00385008|19597437|P2|In Presence of Migraine|Overall Study||5
7961268|NCT00385008|19597438|P1|In Presence of Migraine|Overall Study||5
7961269|NCT00385008|19597437|P2|In Absence of Migraine|Overall Study||10
7961270|NCT00385008|19597438|P1|In Absence of Migraine|Overall Study||10
7961271|NCT00385008|19597437|P2|STARTED|Overall Study||10
7961272|NCT00385008|19597438|P1|STARTED|Overall Study||10
7961273|NCT00384956|19597458|P1|NOT COMPLETED|Overall Study||3
7961274|NCT00384956|19597458|P1|COMPLETED|Overall Study||22
7961275|NCT00384956|19597458|P1|STARTED|Overall Study||25
7961276|NCT00384930|19597475|P5|NOT COMPLETED|Overall Study||47
7961277|NCT00384930|19597476|P4|NOT COMPLETED|Overall Study||41
7961278|NCT00384930|19597477|P3|NOT COMPLETED|Overall Study||30
7961279|NCT00384930|19597478|P2|NOT COMPLETED|Overall Study||27
7961280|NCT00384930|19597479|P1|NOT COMPLETED|Overall Study||27
7961281|NCT00384930|19597475|P5|COMPLETED|Overall Study||162
7961282|NCT00384930|19597476|P4|COMPLETED|Overall Study||175
7961283|NCT00384930|19597477|P3|COMPLETED|Overall Study||182
7961284|NCT00384930|19597478|P2|COMPLETED|Overall Study||182
7961285|NCT00384930|19597479|P1|COMPLETED|Overall Study||185
7961286|NCT00384930|19597475|P5|Received Double-Blind Study Drug|Overall Study||209
7961287|NCT00384930|19597476|P4|Received Double-Blind Study Drug|Overall Study||216
7961288|NCT00384930|19597477|P3|Received Double-Blind Study Drug|Overall Study||212
7961289|NCT00384930|19597478|P2|Received Double-Blind Study Drug|Overall Study||208
7961290|NCT00384930|19597479|P1|Received Double-Blind Study Drug|Overall Study||211
7961291|NCT00384930|19597475|P5|STARTED|Overall Study||209
7961292|NCT00384930|19597476|P4|STARTED|Overall Study||216
7961293|NCT00384930|19597477|P3|STARTED|Overall Study||212
7961294|NCT00384930|19597478|P2|STARTED|Overall Study||209
7961295|NCT00384930|19597479|P1|STARTED|Overall Study||212
7961296|NCT00384865|19597537|P4|NOT COMPLETED|Overall Study||0
7961297|NCT00384865|19597538|P3|NOT COMPLETED|Overall Study||0
7961298|NCT00384865|19597539|P2|NOT COMPLETED|Overall Study||0
7961299|NCT00384865|19597540|P1|NOT COMPLETED|Overall Study||0
7961300|NCT00384865|19597537|P4|COMPLETED|Overall Study||16
7961301|NCT00384865|19597538|P3|COMPLETED|Overall Study||16
7961302|NCT00384865|19597539|P2|COMPLETED|Overall Study||16
7961303|NCT00384865|19597540|P1|COMPLETED|Overall Study||16
7961304|NCT00384865|19597537|P4|Completed Six Month Assessment|Overall Study||11
7961305|NCT00384865|19597538|P3|Completed Six Month Assessment|Overall Study||15
7961306|NCT00384865|19597539|P2|Completed Six Month Assessment|Overall Study||12
7961307|NCT00384865|19597540|P1|Completed Six Month Assessment|Overall Study||11
7961308|NCT00384865|19597537|P4|STARTED|Overall Study||16
7961309|NCT00384865|19597538|P3|STARTED|Overall Study||16
7961310|NCT00384865|19597539|P2|STARTED|Overall Study||16
7961311|NCT00384865|19597540|P1|STARTED|Overall Study||16
7961312|NCT00384839|19597558|P1|NOT COMPLETED|Overall Study||8
7961313|NCT00384839|19597558|P1|COMPLETED|Overall Study||28
7961314|NCT00384839|19597558|P1|STARTED|Overall Study||36
7961315|NCT00384813|19597569|P2|NOT COMPLETED|Overall Study||0
7961316|NCT00384813|19597570|P1|NOT COMPLETED|Overall Study||2
7961317|NCT00384813|19597569|P2|COMPLETED|Overall Study||20
7961318|NCT00384813|19597570|P1|COMPLETED|Overall Study||21
7961319|NCT00384813|19597569|P2|STARTED|Overall Study||20
7961320|NCT00384813|19597570|P1|STARTED|Overall Study||23
7961321|NCT00384774|19597583|P7|NOT COMPLETED|Overall Study||0
7961322|NCT00384774|19597584|P6|NOT COMPLETED|Overall Study||0
7961323|NCT00384774|19597585|P5|NOT COMPLETED|Overall Study||0
7961324|NCT00384774|19597586|P4|NOT COMPLETED|Overall Study||0
7961325|NCT00384774|19597587|P3|NOT COMPLETED|Overall Study||0
7961326|NCT00384774|19597588|P2|NOT COMPLETED|Overall Study||0
7961327|NCT00384774|19597589|P1|NOT COMPLETED|Overall Study||0
7961328|NCT00384774|19597583|P7|COMPLETED|Overall Study||4
7961329|NCT00384774|19597584|P6|COMPLETED|Overall Study||16
7961330|NCT00384774|19597585|P5|COMPLETED|Overall Study||28
7961331|NCT00384774|19597586|P4|COMPLETED|Overall Study||24
7961332|NCT00384774|19597587|P3|COMPLETED|Overall Study||12
7961333|NCT00384774|19597588|P2|COMPLETED|Overall Study||4
7961334|NCT00384774|19597589|P1|COMPLETED|Overall Study||42
7961335|NCT00384774|19597583|P7|Received at Least 1 Dose of Study Drug|Overall Study||4
7961336|NCT00384774|19597584|P6|Received at Least 1 Dose of Study Drug|Overall Study||16
7961337|NCT00384774|19597585|P5|Received at Least 1 Dose of Study Drug|Overall Study||28
7961338|NCT00384774|19597586|P4|Received at Least 1 Dose of Study Drug|Overall Study||24
7961339|NCT00384774|19597587|P3|Received at Least 1 Dose of Study Drug|Overall Study||12
7961340|NCT00384774|19597588|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
7961341|NCT00384774|19597589|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
7961342|NCT00384774|19597583|P7|STARTED|Overall Study||4
7961343|NCT00384774|19597584|P6|STARTED|Overall Study||16
7961344|NCT00384774|19597585|P5|STARTED|Overall Study||28
7961345|NCT00384774|19597586|P4|STARTED|Overall Study||24
7961346|NCT00384774|19597587|P3|STARTED|Overall Study||12
7961347|NCT00384774|19597588|P2|STARTED|Overall Study||4
7961348|NCT00384774|19597589|P1|STARTED|Overall Study||42
7961349|NCT00384748|19597663|P2|NOT COMPLETED|Overall Study||0
7961350|NCT00384748|19597664|P1|NOT COMPLETED|Overall Study||0
7961351|NCT00384748|19597663|P2|COMPLETED|Overall Study||23
7961352|NCT00384748|19597664|P1|COMPLETED|Overall Study||25
7961353|NCT00384748|19597663|P2|STARTED|Overall Study||23
7961354|NCT00384748|19597664|P1|STARTED|Overall Study||25
7961355|NCT00384670|19597670|P1|NOT COMPLETED|Overall Study||0
7961356|NCT00384670|19597670|P1|COMPLETED|Overall Study||7
7961357|NCT00384670|19597670|P1|STARTED|Overall Study||7
7961358|NCT00384449|19597680|P1|NOT COMPLETED|Overall Study||0
7961359|NCT00384449|19597680|P1|COMPLETED|Overall Study||1
7961360|NCT00384449|19597680|P1|STARTED|Overall Study||1
7961361|NCT00384397|19597691|P3|NOT COMPLETED|Overall Study||33
7961362|NCT00384397|19597692|P2|NOT COMPLETED|Overall Study||46
7961363|NCT00384397|19597693|P1|NOT COMPLETED|Overall Study||32
7961364|NCT00384397|19597691|P3|COMPLETED|Overall Study||385
7961365|NCT00384397|19597692|P2|COMPLETED|Overall Study||247
7961366|NCT00384397|19597693|P1|COMPLETED|Overall Study||375
7961367|NCT00384397|19597691|P3|STARTED|Overall Study||418
7961368|NCT00384397|19597692|P2|STARTED|Overall Study||293
7961369|NCT00384397|19597693|P1|STARTED|Overall Study||407
7961370|NCT00384332|19597712|P2|NOT COMPLETED|Overall Study||0
7961371|NCT00384332|19597713|P1|NOT COMPLETED|Overall Study||4
7961372|NCT00384332|19597712|P2|COMPLETED|Overall Study||10
7961373|NCT00384332|19597713|P1|COMPLETED|Overall Study||9
7961374|NCT00384332|19597712|P2|STARTED|Overall Study||10
7961375|NCT00384332|19597713|P1|STARTED|Overall Study||13
7961376|NCT00384293|19597723|P3|NOT COMPLETED|Post-randomization Period||219
7961377|NCT00384293|19597724|P2|NOT COMPLETED|Post-randomization Period||214
7961378|NCT00384293|19597725|P1|NOT COMPLETED|Post-randomization Period||0
7961379|NCT00384293|19597723|P3|COMPLETED|Post-randomization Period||0
7961380|NCT00384293|19597724|P2|COMPLETED|Post-randomization Period||0
7961381|NCT00384293|19597725|P1|COMPLETED|Post-randomization Period||0
7961382|NCT00384293|19597723|P3|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218
7961383|NCT00384293|19597724|P2|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214
7961384|NCT00384293|19597725|P1|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0
7961385|NCT00384293|19597723|P3|STARTED|Post-randomization Period||219
7961386|NCT00384293|19597724|P2|STARTED|Post-randomization Period||214
7961387|NCT00384293|19597725|P1|STARTED|Post-randomization Period||0
7961388|NCT00384293|19597723|P3|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
7961389|NCT00384293|19597724|P2|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
7961390|NCT00384293|19597725|P1|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504
7961391|NCT00384293|19597723|P3|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
7961392|NCT00384293|19597724|P2|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
7961393|NCT00384293|19597725|P1|COMPLETED|MK0524A Active Run-In, Pre-randomization||433
7961394|NCT00384293|19597723|P3|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
7961395|NCT00384293|19597724|P2|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
7961396|NCT00384293|19597725|P1|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813
7961397|NCT00384293|19597723|P3|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
7961398|NCT00384293|19597724|P2|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
7961399|NCT00384293|19597725|P1|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937
7961400|NCT00384293|19597723|P3|STARTED|MK0524A Active Run-In, Pre-randomization||0
7961401|NCT00384293|19597724|P2|STARTED|MK0524A Active Run-In, Pre-randomization||0
7961402|NCT00384293|19597725|P1|STARTED|MK0524A Active Run-In, Pre-randomization||937
7961403|NCT00384241|19597738|P2|NOT COMPLETED|Overall Study||0
7961404|NCT00384241|19597739|P1|NOT COMPLETED|Overall Study||0
7961405|NCT00384241|19597738|P2|COMPLETED|Overall Study||599
7961406|NCT00384241|19597739|P1|COMPLETED|Overall Study||500
7961407|NCT00384241|19597738|P2|STARTED|Overall Study||599
7961408|NCT00384241|19597739|P1|STARTED|Overall Study||500
7961409|NCT00384189|19597749|P4|NOT COMPLETED|Overall Study||40
7961410|NCT00384189|19597750|P3|NOT COMPLETED|Overall Study||58
7961411|NCT00384189|19597751|P2|NOT COMPLETED|Overall Study||57
7961412|NCT00384189|19597752|P1|NOT COMPLETED|Overall Study||50
7961413|NCT00384189|19597749|P4|COMPLETED|Overall Study||110
7961414|NCT00384189|19597750|P3|COMPLETED|Overall Study||255
7961415|NCT00384189|19597751|P2|COMPLETED|Overall Study||255
7961416|NCT00384189|19597752|P1|COMPLETED|Overall Study||255
7961417|NCT00384189|19597749|P4|Actual Treatment Received|Overall Study||146
7961418|NCT00384189|19597750|P3|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310
7961419|NCT00384189|19597751|P2|Actual Treatment Received|Overall Study||312
7961420|NCT00384189|19597752|P1|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305
7961421|NCT00384189|19597749|P4|Randomized, Not Treated|Overall Study||4
7961422|NCT00384189|19597750|P3|Randomized, Not Treated|Overall Study||2
7961423|NCT00384189|19597751|P2|Randomized, Not Treated|Overall Study||0
7961424|NCT00384189|19597752|P1|Randomized, Not Treated|Overall Study||1
7961425|NCT00384189|19597749|P4|STARTED|Overall Study||150
7961426|NCT00384189|19597750|P3|STARTED|Overall Study||313
7961427|NCT00384189|19597751|P2|STARTED|Overall Study||312
7961428|NCT00384189|19597752|P1|STARTED|Overall Study||305
7961429|NCT00384176|19597813|P3|NOT COMPLETED|Overall Study||132
7961430|NCT00384176|19597814|P2|NOT COMPLETED|Overall Study||319
7961431|NCT00384176|19597815|P1|NOT COMPLETED|Overall Study||312
7961432|NCT00384176|19597813|P3|COMPLETED|Overall Study||60
7961433|NCT00384176|19597814|P2|COMPLETED|Overall Study||394
7961434|NCT00384176|19597815|P1|COMPLETED|Overall Study||397
7961435|NCT00384176|19597813|P3|STARTED|Overall Study||192
7961436|NCT00384176|19597814|P2|STARTED|Overall Study||713
7961437|NCT00384176|19597815|P1|STARTED|Overall Study||709
7961438|NCT00384085|19597841|P3|NOT COMPLETED|Overall Study||56
7961439|NCT00384085|19597842|P2|NOT COMPLETED|Overall Study||46
7961440|NCT00384085|19597843|P1|NOT COMPLETED|Overall Study||39
7961441|NCT00384085|19597841|P3|COMPLETED|Overall Study|Based on the entire ITT population|141
7961442|NCT00384085|19597842|P2|COMPLETED|Overall Study|Based on the entire ITT population|150
7961443|NCT00384085|19597843|P1|COMPLETED|Overall Study|Based on the entire ITT population|156
7961444|NCT00384085|19597841|P3|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189
7961445|NCT00384085|19597842|P2|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186
7961446|NCT00384085|19597843|P1|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187
7961447|NCT00384085|19597841|P3|Treated (Safety Population)|Overall Study||194
7961448|NCT00384085|19597842|P2|Treated (Safety Population)|Overall Study||194
7961449|NCT00384085|19597843|P1|Treated (Safety Population)|Overall Study||194
7961450|NCT00384085|19597841|P3|Intent-To-Treat (ITT)|Overall Study||197
7961451|NCT00384085|19597842|P2|Intent-To-Treat (ITT)|Overall Study||196
7961452|NCT00384085|19597843|P1|Intent-To-Treat (ITT)|Overall Study||195
7961453|NCT00384085|19597841|P3|STARTED|Overall Study|Randomized|197
7961454|NCT00384085|19597842|P2|STARTED|Overall Study|Randomized|196
7961455|NCT00384085|19597843|P1|STARTED|Overall Study|Randomized|195
7961456|NCT00384059|19597869|P2|NOT COMPLETED|Toddler Dose||2
7961457|NCT00384059|19597870|P1|NOT COMPLETED|Toddler Dose||1
7961458|NCT00384059|19597869|P2|COMPLETED|Toddler Dose||120
7961459|NCT00384059|19597870|P1|COMPLETED|Toddler Dose||130
7961460|NCT00384059|19597869|P2|STARTED|Toddler Dose||122
7961461|NCT00384059|19597870|P1|STARTED|Toddler Dose||131
7961462|NCT00384059|19597869|P2|NOT COMPLETED|After Infant Series||10
7961463|NCT00384059|19597870|P1|NOT COMPLETED|After Infant Series||4
7961464|NCT00384059|19597869|P2|COMPLETED|After Infant Series||122
7961465|NCT00384059|19597870|P1|COMPLETED|After Infant Series||131
7961466|NCT00384059|19597869|P2|STARTED|After Infant Series||132
7961467|NCT00384059|19597870|P1|STARTED|After Infant Series||135
7961468|NCT00384059|19597869|P2|NOT COMPLETED|Infant Series||13
7961469|NCT00384059|19597870|P1|NOT COMPLETED|Infant Series||6
7961470|NCT00384059|19597869|P2|COMPLETED|Infant Series||132
7961471|NCT00384059|19597870|P1|COMPLETED|Infant Series||135
7961472|NCT00384059|19597869|P2|Vaccinated Dose 2|Infant Series||135
7961473|NCT00384059|19597870|P1|Vaccinated Dose 2|Infant Series||136
7961474|NCT00384059|19597869|P2|Vaccinated Dose 1|Infant Series||139
7961475|NCT00384059|19597870|P1|Vaccinated Dose 1|Infant Series||139
7961476|NCT00384059|19597869|P2|STARTED|Infant Series||145
7961477|NCT00384059|19597870|P1|STARTED|Infant Series||141
7961478|NCT00384033|19597920|P4|NOT COMPLETED|Overall Study||40
7961479|NCT00384033|19597921|P3|NOT COMPLETED|Overall Study||43
7961480|NCT00384033|19597922|P2|NOT COMPLETED|Overall Study||35
7961481|NCT00384033|19597923|P1|NOT COMPLETED|Overall Study||41
7961482|NCT00384033|19597920|P4|COMPLETED|Overall Study||119
7961483|NCT00384033|19597921|P3|COMPLETED|Overall Study||117
7961484|NCT00384033|19597922|P2|COMPLETED|Overall Study||120
7961485|NCT00384033|19597923|P1|COMPLETED|Overall Study||123
7961486|NCT00384033|19597920|P4|Treated|Overall Study||157
7961487|NCT00384033|19597921|P3|Treated|Overall Study||150
7961488|NCT00384033|19597922|P2|Treated|Overall Study||148
7961489|NCT00384033|19597923|P1|Treated|Overall Study||161
7961490|NCT00384033|19597920|P4|STARTED|Overall Study||159
7961491|NCT00384033|19597921|P3|STARTED|Overall Study||160
7961492|NCT00384033|19597922|P2|STARTED|Overall Study||155
7961493|NCT00384033|19597923|P1|STARTED|Overall Study||164
7961494|NCT00383942|19597967|P2|NOT COMPLETED|Overall Study||0
7961495|NCT00383942|19597968|P1|NOT COMPLETED|Overall Study||0
7961496|NCT00383942|19597967|P2|COMPLETED|Overall Study||40
7961497|NCT00383942|19597968|P1|COMPLETED|Overall Study||40
7961498|NCT00383942|19597967|P2|STARTED|Overall Study||40
7961499|NCT00383942|19597968|P1|STARTED|Overall Study||40
7961500|NCT00383786|19597976|P2|NOT COMPLETED|Overall Study||12
7961501|NCT00383786|19597977|P1|NOT COMPLETED|Overall Study||4
7961502|NCT00383786|19597976|P2|COMPLETED|Overall Study||13
7961503|NCT00383786|19597977|P1|COMPLETED|Overall Study||18
7961504|NCT00383786|19597976|P2|STARTED|Overall Study||25
7961505|NCT00383786|19597977|P1|STARTED|Overall Study||22
7961506|NCT00383760|19597983|P1|NOT COMPLETED|Overall Study||0
7961507|NCT00383760|19597983|P1|COMPLETED|Overall Study||15
7961508|NCT00383760|19597983|P1|STARTED|Overall Study||15
7961509|NCT00383747|19597999|P4|NOT COMPLETED|Visit 2||0
7961510|NCT00383747|19598000|P3|NOT COMPLETED|Visit 2||0
7961511|NCT00383747|19598001|P2|NOT COMPLETED|Visit 2||0
7961512|NCT00383747|19598002|P1|NOT COMPLETED|Visit 2||0
7961513|NCT00383747|19597999|P4|COMPLETED|Visit 2||16
7961514|NCT00383747|19598000|P3|COMPLETED|Visit 2||16
7961515|NCT00383747|19598001|P2|COMPLETED|Visit 2||14
7961516|NCT00383747|19598002|P1|COMPLETED|Visit 2||14
7961517|NCT00383747|19597999|P4|STARTED|Visit 2||16
7961518|NCT00383747|19598000|P3|STARTED|Visit 2||16
7961519|NCT00383747|19598001|P2|STARTED|Visit 2||14
7961520|NCT00383747|19598002|P1|STARTED|Visit 2||14
7961521|NCT00383747|19597999|P4|NOT COMPLETED|Visit 1||0
7961522|NCT00383747|19598000|P3|NOT COMPLETED|Visit 1||0
7961523|NCT00383747|19598001|P2|NOT COMPLETED|Visit 1||0
7961524|NCT00383747|19598002|P1|NOT COMPLETED|Visit 1||0
7961525|NCT00383747|19597999|P4|COMPLETED|Visit 1||16
7961526|NCT00383747|19598000|P3|COMPLETED|Visit 1||16
7961527|NCT00383747|19598001|P2|COMPLETED|Visit 1||14
7961528|NCT00383747|19598002|P1|COMPLETED|Visit 1||14
7961529|NCT00383747|19597999|P4|STARTED|Visit 1||16
7961530|NCT00383747|19598000|P3|STARTED|Visit 1||16
7961531|NCT00383747|19598001|P2|STARTED|Visit 1||14
7961532|NCT00383747|19598002|P1|STARTED|Visit 1||14
7961533|NCT00383721|19598027|P5|NOT COMPLETED|26-Week Treatment Safety Extension||0
7961534|NCT00383721|19598028|P4|NOT COMPLETED|26-Week Treatment Safety Extension||17
7961535|NCT00383721|19598029|P3|NOT COMPLETED|26-Week Treatment Safety Extension||23
7961536|NCT00383721|19598030|P2|NOT COMPLETED|26-Week Treatment Safety Extension||17
7961537|NCT00383721|19598031|P1|NOT COMPLETED|26-Week Treatment Safety Extension||19
7961538|NCT00383721|19598027|P5|COMPLETED|26-Week Treatment Safety Extension||8
7961539|NCT00383721|19598028|P4|COMPLETED|26-Week Treatment Safety Extension||131
7961540|NCT00383721|19598029|P3|COMPLETED|26-Week Treatment Safety Extension||126
7961541|NCT00383721|19598030|P2|COMPLETED|26-Week Treatment Safety Extension||136
7961542|NCT00383721|19598031|P1|COMPLETED|26-Week Treatment Safety Extension||126
7961543|NCT00383721|19598027|P5|STARTED|26-Week Treatment Safety Extension||8
7961544|NCT00383721|19598028|P4|STARTED|26-Week Treatment Safety Extension||148
7961545|NCT00383721|19598029|P3|STARTED|26-Week Treatment Safety Extension||149
7961546|NCT00383721|19598030|P2|STARTED|26-Week Treatment Safety Extension||153
7961547|NCT00383721|19598031|P1|STARTED|26-Week Treatment Safety Extension||145
7961548|NCT00383721|19598027|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||67
7961549|NCT00383721|19598028|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||50
7961550|NCT00383721|19598029|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||51
7961551|NCT00383721|19598030|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
7961552|NCT00383721|19598031|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||35
7961553|NCT00383721|19598027|P5|COMPLETED|26-Week Double-Blind Treatment Period||169
7961554|NCT00383721|19598028|P4|COMPLETED|26-Week Double-Blind Treatment Period||193
7961555|NCT00383721|19598029|P3|COMPLETED|26-Week Double-Blind Treatment Period||202
7961556|NCT00383721|19598030|P2|COMPLETED|26-Week Double-Blind Treatment Period||202
7961557|NCT00383721|19598031|P1|COMPLETED|26-Week Double-Blind Treatment Period|"1 participant listed as ongoing since the participant status could not be formally confirmed."|190
7961558|NCT00383721|19598027|P5|STARTED|26-Week Double-Blind Treatment Period||236
7961559|NCT00383721|19598028|P4|STARTED|26-Week Double-Blind Treatment Period||243
7961560|NCT00383721|19598029|P3|STARTED|26-Week Double-Blind Treatment Period||253
7961561|NCT00383721|19598030|P2|STARTED|26-Week Double-Blind Treatment Period||239
7961562|NCT00383721|19598031|P1|STARTED|26-Week Double-Blind Treatment Period||225
7961563|NCT00383708|19598068|P1|NOT COMPLETED|Co-administration Period||5
7961564|NCT00383708|19598068|P1|COMPLETED|Co-administration Period||52
7961565|NCT00383708|19598068|P1|STARTED|Co-administration Period||57
7961566|NCT00383708|19598068|P1|NOT COMPLETED|Run-in Period||7
7961567|NCT00383708|19598068|P1|COMPLETED|Run-in Period||85
7961568|NCT00383708|19598068|P1|STARTED|Run-in Period||92
7961569|NCT00383708|19598068|P1|NOT COMPLETED|Enrolment Through Start Treatment||33
7961570|NCT00383708|19598068|P1|COMPLETED|Enrolment Through Start Treatment||92
7961571|NCT00383708|19598068|P1|STARTED|Enrolment Through Start Treatment||125
7961572|NCT00383643|19598105|P3|NOT COMPLETED|Overall Study||1
7961573|NCT00383643|19598106|P2|NOT COMPLETED|Overall Study||1
7961574|NCT00383643|19598107|P1|NOT COMPLETED|Overall Study||1
7961575|NCT00383643|19598105|P3|COMPLETED|Overall Study||13
7961576|NCT00383643|19598106|P2|COMPLETED|Overall Study||15
7961577|NCT00383643|19598107|P1|COMPLETED|Overall Study||17
7961578|NCT00383643|19598105|P3|STARTED|Overall Study||14
7961579|NCT00383643|19598106|P2|STARTED|Overall Study||16
7961580|NCT00383643|19598107|P1|STARTED|Overall Study||18
7961581|NCT00383630|19598127|P1|NOT COMPLETED|Overall Study||0
7961582|NCT00383630|19598127|P1|COMPLETED|Overall Study||1
7961583|NCT00383630|19598127|P1|STARTED|Overall Study||1
7961584|NCT00383565|19598133|P1|NOT COMPLETED|Overall Study||0
7961585|NCT00383565|19598133|P1|COMPLETED|Overall Study||9
7961586|NCT00383565|19598133|P1|STARTED|Overall Study||9
7961587|NCT00383552|19598143|P4|NOT COMPLETED|Overall Study||72
7961588|NCT00383552|19598144|P3|NOT COMPLETED|Overall Study||61
7961589|NCT00383552|19598145|P2|NOT COMPLETED|Overall Study||41
7961590|NCT00383552|19598146|P1|NOT COMPLETED|Overall Study||36
7961591|NCT00383552|19598143|P4|COMPLETED|Overall Study||116
7961592|NCT00383552|19598144|P3|COMPLETED|Overall Study||127
7961593|NCT00383552|19598145|P2|COMPLETED|Overall Study||147
7961594|NCT00383552|19598146|P1|COMPLETED|Overall Study||146
7961595|NCT00383552|19598143|P4|STARTED|Overall Study||188
7961596|NCT00383552|19598144|P3|STARTED|Overall Study||188
7961597|NCT00383552|19598145|P2|STARTED|Overall Study||188
7961598|NCT00383552|19598146|P1|STARTED|Overall Study||182
7961599|NCT00383500|19598188|P3|NOT COMPLETED|Overall Study||2
7961600|NCT00383500|19598189|P2|NOT COMPLETED|Overall Study||3
7961601|NCT00383500|19598190|P1|NOT COMPLETED|Overall Study||8
7961602|NCT00383500|19598188|P3|COMPLETED|Overall Study||22
7961603|NCT00383500|19598189|P2|COMPLETED|Overall Study||21
7961604|NCT00383500|19598190|P1|COMPLETED|Overall Study||19
7961605|NCT00383500|19598188|P3|STARTED|Overall Study||24
7961606|NCT00383500|19598189|P2|STARTED|Overall Study||24
7961607|NCT00383500|19598190|P1|STARTED|Overall Study||27
7961608|NCT00383448|19598201|P1|NOT COMPLETED|Overall Study||0
7961609|NCT00383448|19598201|P1|COMPLETED|Overall Study||38
7961610|NCT00383448|19598201|P1|STARTED|Overall Study||38
7961611|NCT00383435|19598214|P5|NOT COMPLETED|26-Week Treatment Safety Extension||3
7961612|NCT00383435|19598215|P4|NOT COMPLETED|26-Week Treatment Safety Extension||15
7961613|NCT00383435|19598216|P3|NOT COMPLETED|26-Week Treatment Safety Extension||16
7961614|NCT00383435|19598217|P2|NOT COMPLETED|26-Week Treatment Safety Extension||9
7961615|NCT00383435|19598218|P1|NOT COMPLETED|26-Week Treatment Safety Extension||14
7961616|NCT00383435|19598214|P5|COMPLETED|26-Week Treatment Safety Extension||10
7961617|NCT00383435|19598215|P4|COMPLETED|26-Week Treatment Safety Extension||116
7961618|NCT00383435|19598216|P3|COMPLETED|26-Week Treatment Safety Extension||108
7961619|NCT00383435|19598217|P2|COMPLETED|26-Week Treatment Safety Extension||121
7961620|NCT00383435|19598218|P1|COMPLETED|26-Week Treatment Safety Extension||117
7961621|NCT00383435|19598214|P5|STARTED|26-Week Treatment Safety Extension||13
7961622|NCT00383435|19598215|P4|STARTED|26-Week Treatment Safety Extension||131
7961623|NCT00383435|19598216|P3|STARTED|26-Week Treatment Safety Extension||124
7961624|NCT00383435|19598217|P2|STARTED|26-Week Treatment Safety Extension||130
7961625|NCT00383435|19598218|P1|STARTED|26-Week Treatment Safety Extension||131
7961626|NCT00383435|19598214|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||53
7961627|NCT00383435|19598215|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
7961628|NCT00383435|19598216|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||46
7961629|NCT00383435|19598217|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||38
7961630|NCT00383435|19598218|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||41
7961631|NCT00383435|19598214|P5|COMPLETED|26-Week Double-Blind Treatment Period||159
7961721|NCT00383019|19598490|P2|COMPLETED|Overall Study||143
7961632|NCT00383435|19598215|P4|COMPLETED|26-Week Double-Blind Treatment Period||172
7961633|NCT00383435|19598216|P3|COMPLETED|26-Week Double-Blind Treatment Period||164
7961634|NCT00383435|19598217|P2|COMPLETED|26-Week Double-Blind Treatment Period||169
7961635|NCT00383435|19598218|P1|COMPLETED|26-Week Double-Blind Treatment Period||176
7961636|NCT00383435|19598214|P5|STARTED|26-Week Double-Blind Treatment Period||212
7961637|NCT00383435|19598215|P4|STARTED|26-Week Double-Blind Treatment Period||209
7961638|NCT00383435|19598216|P3|STARTED|26-Week Double-Blind Treatment Period||210
7961639|NCT00383435|19598217|P2|STARTED|26-Week Double-Blind Treatment Period||207
7961640|NCT00383435|19598218|P1|STARTED|26-Week Double-Blind Treatment Period||217
7961641|NCT00383331|19598257|P2|NOT COMPLETED|Overall Study||1
7961642|NCT00383331|19598258|P1|NOT COMPLETED|Overall Study||0
7961643|NCT00383331|19598257|P2|COMPLETED|Overall Study||8
7961644|NCT00383331|19598258|P1|COMPLETED|Overall Study||10
7961645|NCT00383331|19598257|P2|STARTED|Overall Study||9
7961646|NCT00383331|19598258|P1|STARTED|Overall Study||10
7961647|NCT00383292|19598277|P3|NOT COMPLETED|Overall Study||8
7961648|NCT00383292|19598278|P2|NOT COMPLETED|Overall Study||6
7961649|NCT00383292|19598279|P1|NOT COMPLETED|Overall Study||15
7961650|NCT00383292|19598277|P3|COMPLETED|Overall Study||22
7961651|NCT00383292|19598278|P2|COMPLETED|Overall Study||26
7961652|NCT00383292|19598279|P1|COMPLETED|Overall Study||53
7961653|NCT00383292|19598277|P3|Received at Least One Dose of Study Drug|Overall Study||30
7961654|NCT00383292|19598278|P2|Received at Least One Dose of Study Drug|Overall Study||32
7961655|NCT00383292|19598279|P1|Received at Least One Dose of Study Drug|Overall Study||68
7961656|NCT00383292|19598277|P3|STARTED|Overall Study||30
7961657|NCT00383292|19598278|P2|STARTED|Overall Study||32
7961658|NCT00383292|19598279|P1|STARTED|Overall Study||68
7961659|NCT00383266|19598307|P1|NOT COMPLETED|Overall Study||0
7961660|NCT00383266|19598307|P1|COMPLETED|Overall Study||9
7961661|NCT00383266|19598307|P1|STARTED|Overall Study||9
7961662|NCT00383240|19598320|P4|NOT COMPLETED|Overall Study||77
7961663|NCT00383240|19598321|P3|NOT COMPLETED|Overall Study||85
7961664|NCT00383240|19598322|P2|NOT COMPLETED|Overall Study||33
7961665|NCT00383240|19598323|P1|NOT COMPLETED|Overall Study||35
7961666|NCT00383240|19598320|P4|COMPLETED|Overall Study||119
7961667|NCT00383240|19598321|P3|COMPLETED|Overall Study||117
7961668|NCT00383240|19598322|P2|COMPLETED|Overall Study||159
7961669|NCT00383240|19598323|P1|COMPLETED|Overall Study||156
7961670|NCT00383240|19598320|P4|STARTED|Overall Study||196
7961671|NCT00383240|19598321|P3|STARTED|Overall Study||202
7961672|NCT00383240|19598322|P2|STARTED|Overall Study||192
7961673|NCT00383240|19598323|P1|STARTED|Overall Study||191
7961674|NCT00383162|19598354|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||7
7961675|NCT00383162|19598355|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
7961676|NCT00383162|19598354|P2|COMPLETED|Migraine Attack 2 (Period 2)||66
7961677|NCT00383162|19598355|P1|COMPLETED|Migraine Attack 2 (Period 2)||65
7961678|NCT00383162|19598354|P2|STARTED|Migraine Attack 2 (Period 2)||73
7961679|NCT00383162|19598355|P1|STARTED|Migraine Attack 2 (Period 2)||67
7961680|NCT00383162|19598354|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||13
7961681|NCT00383162|19598355|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||20
7961682|NCT00383162|19598354|P2|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73
7961683|NCT00383162|19598355|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67
7961684|NCT00383162|19598354|P2|STARTED|Migraine Attack 1 (Period 1)||86
7961685|NCT00383162|19598355|P1|STARTED|Migraine Attack 1 (Period 1)||87
7961686|NCT00383149|19598397|P1|NOT COMPLETED|Overall Study||54
7961687|NCT00383149|19598397|P1|COMPLETED|Overall Study||0
7961688|NCT00383149|19598397|P1|STARTED|Overall Study||54
7961689|NCT00383123|19598416|P2|NOT COMPLETED|Overall Study||86
7961690|NCT00383123|19598417|P1|NOT COMPLETED|Overall Study||111
7961691|NCT00383123|19598416|P2|COMPLETED|Overall Study||1124
7961692|NCT00383123|19598417|P1|COMPLETED|Overall Study||2004
7961693|NCT00383123|19598416|P2|STARTED|Overall Study||1210
7961694|NCT00383123|19598417|P1|STARTED|Overall Study||2115
7961695|NCT00383110|19598439|P2|NOT COMPLETED|Overall Study||0
7961696|NCT00383110|19598440|P1|NOT COMPLETED|Overall Study||0
7961697|NCT00383110|19598439|P2|COMPLETED|Overall Study||150
7961698|NCT00383110|19598440|P1|COMPLETED|Overall Study||150
7961699|NCT00383110|19598439|P2|STARTED|Overall Study||150
7961700|NCT00383110|19598440|P1|STARTED|Overall Study||150
7961701|NCT00383084|19598458|P2|NOT COMPLETED|Overall Study||10
7961702|NCT00383084|19598459|P1|NOT COMPLETED|Overall Study||12
7961703|NCT00383084|19598458|P2|COMPLETED|Overall Study||28
7961704|NCT00383084|19598459|P1|COMPLETED|Overall Study||34
7961705|NCT00383084|19598458|P2|STARTED|Overall Study||38
7961706|NCT00383084|19598459|P1|STARTED|Overall Study||46
7961707|NCT00383071|19598475|P4|NOT COMPLETED|Overall Study||3
7961708|NCT00383071|19598476|P3|NOT COMPLETED|Overall Study||7
7961709|NCT00383071|19598477|P2|NOT COMPLETED|Overall Study||4
7961710|NCT00383071|19598478|P1|NOT COMPLETED|Overall Study||0
7961711|NCT00383071|19598475|P4|COMPLETED|Overall Study||22
7961712|NCT00383071|19598476|P3|COMPLETED|Overall Study||44
7961713|NCT00383071|19598477|P2|COMPLETED|Overall Study||21
7961714|NCT00383071|19598478|P1|COMPLETED|Overall Study||25
7961715|NCT00383071|19598475|P4|STARTED|Overall Study||25
7961716|NCT00383071|19598476|P3|STARTED|Overall Study||51
7961717|NCT00383071|19598477|P2|STARTED|Overall Study||25
7961718|NCT00383071|19598478|P1|STARTED|Overall Study||25
7961719|NCT00383019|19598490|P2|NOT COMPLETED|Overall Study||2
7961720|NCT00383019|19598491|P1|NOT COMPLETED|Overall Study||5
7961722|NCT00383019|19598491|P1|COMPLETED|Overall Study||139
7961723|NCT00383019|19598490|P2|STARTED|Overall Study||145
7961724|NCT00383019|19598491|P1|STARTED|Overall Study||144
7961725|NCT00382993|19598513|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||4
7961726|NCT00382993|19598514|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
7961727|NCT00382993|19598513|P2|COMPLETED|Migraine Attack 2 (Period 2)||63
7961728|NCT00382993|19598514|P1|COMPLETED|Migraine Attack 2 (Period 2)||68
7961729|NCT00382993|19598513|P2|STARTED|Migraine Attack 2 (Period 2)||67
7961730|NCT00382993|19598514|P1|STARTED|Migraine Attack 2 (Period 2)||70
7961731|NCT00382993|19598513|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||18
7961732|NCT00382993|19598514|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||14
7961733|NCT00382993|19598513|P2|COMPLETED|Migraine Attack 1 (Period 1)||67
7961734|NCT00382993|19598514|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70
7961735|NCT00382993|19598513|P2|STARTED|Migraine Attack 1 (Period 1)||85
7961736|NCT00382993|19598514|P1|STARTED|Migraine Attack 1 (Period 1)||84
7961737|NCT00382967|19598558|P2|NOT COMPLETED|Overall Study||1
7961738|NCT00382967|19598559|P1|NOT COMPLETED|Overall Study||1
7961739|NCT00382967|19598558|P2|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137
7961740|NCT00382967|19598559|P1|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121
7961741|NCT00382967|19598558|P2|STARTED|Overall Study||138
7961742|NCT00382967|19598559|P1|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122
7961743|NCT00382928|19598569|P2|NOT COMPLETED|Overall Study||0
7961744|NCT00382928|19598570|P1|NOT COMPLETED|Overall Study||0
7961745|NCT00382928|19598569|P2|COMPLETED|Overall Study||95
7961746|NCT00382928|19598570|P1|COMPLETED|Overall Study||97
7961747|NCT00382928|19598569|P2|STARTED|Overall Study||95
7961748|NCT00382928|19598570|P1|STARTED|Overall Study||97
7961749|NCT00382863|19598584|P2|NOT COMPLETED|Overall Study||36
7961750|NCT00382863|19598585|P1|NOT COMPLETED|Overall Study||15
7961751|NCT00382863|19598584|P2|COMPLETED|Overall Study||78
7961752|NCT00382863|19598585|P1|COMPLETED|Overall Study||81
7961753|NCT00382863|19598584|P2|STARTED|Overall Study||114
7961754|NCT00382863|19598585|P1|STARTED|Overall Study||96
7961755|NCT00382824|19598641|P2|NOT COMPLETED|Overall Study||13
7961756|NCT00382824|19598642|P1|NOT COMPLETED|Overall Study||12
7961757|NCT00382824|19598641|P2|COMPLETED|Overall Study||16
7961758|NCT00382824|19598642|P1|COMPLETED|Overall Study||20
7961759|NCT00382824|19598641|P2|STARTED|Overall Study||29
7961760|NCT00382824|19598642|P1|STARTED|Overall Study||32
7961761|NCT00382785|19598658|P2|NOT COMPLETED|Overall Study||0
7961762|NCT00382785|19598659|P1|NOT COMPLETED|Overall Study||0
7961763|NCT00382785|19598658|P2|COMPLETED|Overall Study||26
7961764|NCT00382785|19598659|P1|COMPLETED|Overall Study||25
7961765|NCT00382785|19598658|P2|STARTED|Overall Study||26
7961766|NCT00382785|19598659|P1|STARTED|Overall Study||25
7961767|NCT00382733|19598669|P5|NOT COMPLETED|Overall Study||0
7961768|NCT00382733|19598670|P4|NOT COMPLETED|Overall Study||0
7961769|NCT00382733|19598671|P3|NOT COMPLETED|Overall Study||0
7961770|NCT00382733|19598672|P2|NOT COMPLETED|Overall Study||1
7961771|NCT00382733|19598673|P1|NOT COMPLETED|Overall Study||0
7961772|NCT00382733|19598669|P5|COMPLETED|Overall Study||2
7961773|NCT00382733|19598670|P4|COMPLETED|Overall Study||14
7961774|NCT00382733|19598671|P3|COMPLETED|Overall Study||3
7961775|NCT00382733|19598672|P2|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3
7961776|NCT00382733|19598673|P1|COMPLETED|Overall Study||3
7961777|NCT00382733|19598669|P5|STARTED|Overall Study||2
7961778|NCT00382733|19598670|P4|STARTED|Overall Study||14
7961779|NCT00382733|19598671|P3|STARTED|Overall Study||3
7961780|NCT00382733|19598672|P2|STARTED|Overall Study||4
7961781|NCT00382733|19598673|P1|STARTED|Overall Study||3
7961782|NCT00382720|19598694|P3|NOT COMPLETED|Overall Study||86
7961783|NCT00382720|19598695|P2|NOT COMPLETED|Overall Study||89
7961784|NCT00382720|19598696|P1|NOT COMPLETED|Overall Study||79
7961785|NCT00382720|19598694|P3|COMPLETED|Overall Study||0
7961786|NCT00382720|19598695|P2|COMPLETED|Overall Study||0
7961787|NCT00382720|19598696|P1|COMPLETED|Overall Study||0
7961788|NCT00382720|19598694|P3|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82
7961789|NCT00382720|19598695|P2|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88
7961790|NCT00382720|19598696|P1|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78
7961791|NCT00382720|19598694|P3|Administered Optimal Dose (Parts I & II)|Overall Study||82
7961792|NCT00382720|19598695|P2|Administered Optimal Dose (Parts I & II)|Overall Study||88
7961793|NCT00382720|19598696|P1|Administered Optimal Dose (Parts I & II)|Overall Study||78
7961794|NCT00382720|19598694|P3|Administered Non-Optimal Dose (Part I)|Overall Study||0
7961795|NCT00382720|19598695|P2|Administered Non-Optimal Dose (Part I)|Overall Study||11
7961796|NCT00382720|19598696|P1|Administered Non-Optimal Dose (Part I)|Overall Study||10
7961797|NCT00382720|19598694|P3|STARTED|Overall Study||86
7961798|NCT00382720|19598695|P2|STARTED|Overall Study||89
7961799|NCT00382720|19598696|P1|STARTED|Overall Study||79
7961800|NCT00382590|19598712|P2|NOT COMPLETED|Overall Study||0
7961801|NCT00382590|19598713|P1|NOT COMPLETED|Overall Study||0
7961802|NCT00382590|19598712|P2|COMPLETED|Overall Study||6
7961803|NCT00382590|19598713|P1|COMPLETED|Overall Study||4
7961804|NCT00382590|19598712|P2|STARTED|Overall Study||6
7961805|NCT00382590|19598713|P1|STARTED|Overall Study||4
7961806|NCT00382408|19598721|P2|NOT COMPLETED|Overall Study||54
7961807|NCT00382408|19598722|P1|NOT COMPLETED|Overall Study||144
7961808|NCT00382408|19598721|P2|COMPLETED|Overall Study||955
7961809|NCT00382408|19598722|P1|COMPLETED|Overall Study||2887
7961810|NCT00382408|19598721|P2|STARTED|Overall Study||1009
7961811|NCT00382408|19598722|P1|STARTED|Overall Study||3031
7961812|NCT00382291|19598749|P3|NOT COMPLETED|Overall Study||8
7961813|NCT00382291|19598750|P2|NOT COMPLETED|Overall Study||7
7961814|NCT00382291|19598751|P1|NOT COMPLETED|Overall Study||4
7961815|NCT00382291|19598749|P3|COMPLETED|Overall Study||13
7961816|NCT00382291|19598750|P2|COMPLETED|Overall Study||10
7961817|NCT00382291|19598751|P1|COMPLETED|Overall Study||14
7961818|NCT00382291|19598749|P3|STARTED|Overall Study||21
7961819|NCT00382291|19598750|P2|STARTED|Overall Study||17
7961820|NCT00382291|19598751|P1|STARTED|Overall Study||18
7961821|NCT00382265|19598764|P2|NOT COMPLETED|Overall Study||6
7961822|NCT00382265|19598765|P1|NOT COMPLETED|Overall Study||9
7961823|NCT00382265|19598764|P2|COMPLETED|Overall Study||239
7961824|NCT00382265|19598765|P1|COMPLETED|Overall Study||258
7961825|NCT00382265|19598764|P2|STARTED|Overall Study||245
7961826|NCT00382265|19598765|P1|STARTED|Overall Study||267
7961827|NCT00382174|19598783|P3|NOT COMPLETED|Overall Study||21
7961828|NCT00382174|19598784|P2|NOT COMPLETED|Overall Study||17
7961829|NCT00382174|19598785|P1|NOT COMPLETED|Overall Study||4
7961830|NCT00382174|19598783|P3|COMPLETED|Overall Study||51
7961831|NCT00382174|19598784|P2|COMPLETED|Overall Study||37
7961832|NCT00382174|19598785|P1|COMPLETED|Overall Study||14
7961833|NCT00382174|19598783|P3|STARTED|Overall Study||72
7961834|NCT00382174|19598784|P2|STARTED|Overall Study||54
7961835|NCT00382174|19598785|P1|STARTED|Overall Study||18
7961836|NCT00382148|19598798|P2|NOT COMPLETED|Overall Study||0
7961837|NCT00382148|19598799|P1|NOT COMPLETED|Overall Study||1
7961838|NCT00382148|19598798|P2|COMPLETED|Overall Study||7
7961839|NCT00382148|19598799|P1|COMPLETED|Overall Study||3
7961840|NCT00382148|19598798|P2|STARTED|Overall Study||7
7961841|NCT00382148|19598799|P1|STARTED|Overall Study||4
7961842|NCT00382109|19598813|P2|NOT COMPLETED|Overall Study||4
7961843|NCT00382109|19598814|P1|NOT COMPLETED|Overall Study||12
7961844|NCT00382109|19598813|P2|COMPLETED|Overall Study||66
7961845|NCT00382109|19598814|P1|COMPLETED|Overall Study||64
7961846|NCT00382109|19598813|P2|STARTED|Overall Study||70
7961847|NCT00382109|19598814|P1|STARTED|Overall Study||76
7961848|NCT00382031|19598836|P2|NOT COMPLETED|Overall Study||0
7961849|NCT00382031|19598837|P1|NOT COMPLETED|Overall Study||0
7961850|NCT00382031|19598836|P2|COMPLETED|Overall Study||95
7961851|NCT00382031|19598837|P1|COMPLETED|Overall Study||191
7961852|NCT00382031|19598836|P2|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95
7961853|NCT00382031|19598837|P1|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191
7961854|NCT00382018|19598853|P4|NOT COMPLETED|Overall Study||59
7961855|NCT00382018|19598854|P3|NOT COMPLETED|Overall Study||64
7961856|NCT00382018|19598855|P2|NOT COMPLETED|Overall Study||165
7961857|NCT00382018|19598856|P1|NOT COMPLETED|Overall Study||0
7961858|NCT00382018|19598853|P4|COMPLETED|Overall Study||0
7961859|NCT00382018|19598854|P3|COMPLETED|Overall Study||0
7961860|NCT00382018|19598855|P2|COMPLETED|Overall Study||0
7961861|NCT00382018|19598856|P1|COMPLETED|Overall Study|This group of patients did not receive protocol treatment.|276
7961862|NCT00382018|19598853|P4|STARTED|Overall Study||59
7961863|NCT00382018|19598854|P3|STARTED|Overall Study||64
7961864|NCT00382018|19598855|P2|STARTED|Overall Study||165
7961865|NCT00382018|19598856|P1|STARTED|Overall Study||276
7961866|NCT00381966|19598874|P1|NOT COMPLETED|Overall Study||0
7961867|NCT00381966|19598874|P1|COMPLETED|Overall Study||5
7961868|NCT00381966|19598874|P1|STARTED|Overall Study||5
7961869|NCT00381940|19598879|P1|NOT COMPLETED|Overall Study||5
7961870|NCT00381940|19598879|P1|COMPLETED|Overall Study||21
7961871|NCT00381940|19598879|P1|STARTED|Overall Study||26
7961872|NCT00381888|19598883|P1|NOT COMPLETED|Overall Study||17
7961873|NCT00381888|19598883|P1|COMPLETED|Overall Study||27
7961874|NCT00381888|19598883|P1|STARTED|Overall Study||44
7961875|NCT00381862|19598888|P1|NOT COMPLETED|Overall Study||10
7961876|NCT00381862|19598888|P1|COMPLETED|Overall Study||44
7961877|NCT00381862|19598888|P1|STARTED|Overall Study||54
7961878|NCT00381849|19598894|P2|NOT COMPLETED|Open-label||0
7961879|NCT00381849|19598895|P1|NOT COMPLETED|Open-label||0
7961880|NCT00381849|19598894|P2|COMPLETED|Open-label||9
7961881|NCT00381849|19598895|P1|COMPLETED|Open-label||10
7961882|NCT00381849|19598894|P2|STARTED|Open-label||9
7961883|NCT00381849|19598895|P1|STARTED|Open-label||10
7961884|NCT00381849|19598894|P2|NOT COMPLETED|Second Intervention||0
7961885|NCT00381849|19598895|P1|NOT COMPLETED|Second Intervention||0
7961886|NCT00381849|19598894|P2|COMPLETED|Second Intervention||9
7961887|NCT00381849|19598895|P1|COMPLETED|Second Intervention||10
7961888|NCT00381849|19598894|P2|STARTED|Second Intervention||9
7961889|NCT00381849|19598895|P1|STARTED|Second Intervention||10
7961890|NCT00381849|19598894|P2|NOT COMPLETED|Wash Out||1
7961891|NCT00381849|19598895|P1|NOT COMPLETED|Wash Out||0
7961892|NCT00381849|19598894|P2|COMPLETED|Wash Out||9
7961893|NCT00381849|19598895|P1|COMPLETED|Wash Out||10
7961894|NCT00381849|19598894|P2|STARTED|Wash Out||10
7961895|NCT00381849|19598895|P1|STARTED|Wash Out||10
7961896|NCT00381849|19598894|P2|NOT COMPLETED|First Intervention||0
7961897|NCT00381849|19598895|P1|NOT COMPLETED|First Intervention||0
7961898|NCT00381849|19598894|P2|COMPLETED|First Intervention||10
7961899|NCT00381849|19598895|P1|COMPLETED|First Intervention||10
7961900|NCT00381849|19598894|P2|STARTED|First Intervention||10
7961901|NCT00381849|19598895|P1|STARTED|First Intervention||10
7961902|NCT00381810|19598913|P1|NOT COMPLETED|B Cell Follow-up||7
7961903|NCT00381810|19598913|P1|COMPLETED|B Cell Follow-up||0
7961904|NCT00381810|19598913|P1|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7
7961905|NCT00381810|19598913|P1|NOT COMPLETED|Treatment and Safety Follow-up||15
7961906|NCT00381810|19598913|P1|COMPLETED|Treatment and Safety Follow-up||16
7961907|NCT00381810|19598913|P1|STARTED|Treatment and Safety Follow-up||31
7961908|NCT00381797|19598922|P5|NOT COMPLETED|Overall Study||2
7961909|NCT00381797|19598923|P4|NOT COMPLETED|Overall Study||1
7961910|NCT00381797|19598924|P3|NOT COMPLETED|Overall Study||0
7961911|NCT00381797|19598925|P2|NOT COMPLETED|Overall Study||1
7961912|NCT00381797|19598926|P1|NOT COMPLETED|Overall Study||1
7961913|NCT00381797|19598922|P5|COMPLETED|Overall Study||35
7961914|NCT00381797|19598923|P4|COMPLETED|Overall Study||14
7961915|NCT00381797|19598924|P3|COMPLETED|Overall Study||10
7961916|NCT00381797|19598925|P2|COMPLETED|Overall Study||16
7961917|NCT00381797|19598926|P1|COMPLETED|Overall Study||17
7961918|NCT00381797|19598922|P5|STARTED|Overall Study||37
7961919|NCT00381797|19598923|P4|STARTED|Overall Study||15
7961920|NCT00381797|19598924|P3|STARTED|Overall Study||10
7961921|NCT00381797|19598925|P2|STARTED|Overall Study||17
7961922|NCT00381797|19598926|P1|STARTED|Overall Study||18
7961923|NCT00381706|19599001|P3|NOT COMPLETED|Overall Study||1
7961924|NCT00381706|19599002|P2|NOT COMPLETED|Overall Study||2
7961925|NCT00381706|19599003|P1|NOT COMPLETED|Overall Study||7
7961926|NCT00381706|19599001|P3|COMPLETED|Overall Study||79
7961927|NCT00381706|19599002|P2|COMPLETED|Overall Study||81
7961928|NCT00381706|19599003|P1|COMPLETED|Overall Study||75
7961929|NCT00381706|19599001|P3|STARTED|Overall Study||80
7961930|NCT00381706|19599002|P2|STARTED|Overall Study||83
7961931|NCT00381706|19599003|P1|STARTED|Overall Study||82
7961932|NCT00381693|19599026|P1|NOT COMPLETED|Overall Study||8
7961933|NCT00381693|19599026|P1|COMPLETED|Overall Study||2
7961934|NCT00381693|19599026|P1|STARTED|Overall Study||10
7961935|NCT00381680|19599035|P2|NOT COMPLETED|Overall Study||50
7961936|NCT00381680|19599036|P1|NOT COMPLETED|Overall Study||125
7961937|NCT00381680|19599035|P2|COMPLETED|Overall Study||19
7961938|NCT00381680|19599036|P1|COMPLETED|Overall Study||81
7961939|NCT00381680|19599035|P2|STARTED|Overall Study||69
7961940|NCT00381680|19599036|P1|STARTED|Overall Study||206
7961941|NCT00381641|19599053|P2|NOT COMPLETED|Overall Study||2
7961942|NCT00381641|19599054|P1|NOT COMPLETED|Overall Study||0
7961943|NCT00381641|19599053|P2|COMPLETED|Overall Study||23
7961944|NCT00381641|19599054|P1|COMPLETED|Overall Study||38
7961945|NCT00381641|19599053|P2|STARTED|Overall Study||25
7961946|NCT00381641|19599054|P1|STARTED|Overall Study||38
7961947|NCT00381628|19599070|P4|NOT COMPLETED|Overall Study||0
7961948|NCT00381628|19599071|P3|NOT COMPLETED|Overall Study||0
7961949|NCT00381628|19599072|P2|NOT COMPLETED|Overall Study||0
7961950|NCT00381628|19599073|P1|NOT COMPLETED|Overall Study||0
7961951|NCT00381628|19599070|P4|COMPLETED|Overall Study||14
7961952|NCT00381628|19599071|P3|COMPLETED|Overall Study||0
7961953|NCT00381628|19599072|P2|COMPLETED|Overall Study||27
7961954|NCT00381628|19599073|P1|COMPLETED|Overall Study||18
7961955|NCT00381628|19599070|P4|STARTED|Overall Study||14
7961956|NCT00381628|19599071|P3|STARTED|Overall Study||0
7961957|NCT00381628|19599072|P2|STARTED|Overall Study||27
7961958|NCT00381628|19599073|P1|STARTED|Overall Study||18
7961959|NCT00381615|19599087|P4|NOT COMPLETED|Overall Study||2
7961960|NCT00381615|19599088|P3|NOT COMPLETED|Overall Study||1
7961961|NCT00381615|19599089|P2|NOT COMPLETED|Overall Study||5
7961962|NCT00381615|19599090|P1|NOT COMPLETED|Overall Study||4
7961963|NCT00381615|19599087|P4|COMPLETED|Overall Study||22
7961964|NCT00381615|19599088|P3|COMPLETED|Overall Study||24
7961965|NCT00381615|19599089|P2|COMPLETED|Overall Study||45
7961966|NCT00381615|19599090|P1|COMPLETED|Overall Study||44
7961967|NCT00381615|19599087|P4|STARTED|Overall Study||24
7961968|NCT00381615|19599088|P3|STARTED|Overall Study||25
7961969|NCT00381615|19599089|P2|STARTED|Overall Study||50
7961970|NCT00381615|19599090|P1|STARTED|Overall Study||48
7961971|NCT00381563|19599142|P2|NOT COMPLETED|Overall Study||6
7961972|NCT00381563|19599143|P1|NOT COMPLETED|Overall Study||7
7961973|NCT00381563|19599142|P2|COMPLETED|Overall Study||33
7961974|NCT00381563|19599143|P1|COMPLETED|Overall Study||34
7961975|NCT00381563|19599142|P2|STARTED|Overall Study||39
7961976|NCT00381563|19599143|P1|STARTED|Overall Study||41
7961977|NCT00381550|19599150|P1|NOT COMPLETED|Overall Study||0
7961978|NCT00381550|19599150|P1|COMPLETED|Overall Study||35
7961979|NCT00381550|19599150|P1|STARTED|Overall Study||35
7961980|NCT00381485|19599158|P4|NOT COMPLETED|Double-Blind Treatment Period||33
7961981|NCT00381485|19599159|P3|NOT COMPLETED|Double-Blind Treatment Period||25
7961982|NCT00381485|19599160|P2|NOT COMPLETED|Double-Blind Treatment Period||27
7961983|NCT00381485|19599161|P1|NOT COMPLETED|Double-Blind Treatment Period||0
7961984|NCT00381485|19599158|P4|COMPLETED|Double-Blind Treatment Period||207
7961985|NCT00381485|19599159|P3|COMPLETED|Double-Blind Treatment Period||208
7961986|NCT00381485|19599160|P2|COMPLETED|Double-Blind Treatment Period||228
7961987|NCT00381485|19599161|P1|COMPLETED|Double-Blind Treatment Period||0
7961988|NCT00381485|19599158|P4|STARTED|Double-Blind Treatment Period||240
7961989|NCT00381485|19599159|P3|STARTED|Double-Blind Treatment Period||233
7961990|NCT00381485|19599160|P2|STARTED|Double-Blind Treatment Period||255
7961991|NCT00381485|19599161|P1|STARTED|Double-Blind Treatment Period||0
7961992|NCT00381485|19599158|P4|NOT COMPLETED|Open-Label Run-In Period||0
7961993|NCT00381485|19599159|P3|NOT COMPLETED|Open-Label Run-In Period||0
7961994|NCT00381485|19599160|P2|NOT COMPLETED|Open-Label Run-In Period||0
7961995|NCT00381485|19599161|P1|NOT COMPLETED|Open-Label Run-In Period||106
7961996|NCT00381485|19599158|P4|COMPLETED|Open-Label Run-In Period||0
7961997|NCT00381485|19599159|P3|COMPLETED|Open-Label Run-In Period||0
7961998|NCT00381485|19599160|P2|COMPLETED|Open-Label Run-In Period||0
7961999|NCT00381485|19599161|P1|COMPLETED|Open-Label Run-In Period||728
7962000|NCT00381485|19599158|P4|STARTED|Open-Label Run-In Period||0
7962001|NCT00381485|19599159|P3|STARTED|Open-Label Run-In Period||0
7962002|NCT00381485|19599160|P2|STARTED|Open-Label Run-In Period||0
7962003|NCT00381485|19599161|P1|STARTED|Open-Label Run-In Period||834
7962004|NCT00381381|19599179|P1|NOT COMPLETED|Overall Study||64
7962005|NCT00381381|19599179|P1|COMPLETED|Overall Study||135
7962006|NCT00381381|19599179|P1|STARTED|Overall Study||199
7962007|NCT00381303|19599188|P2|NOT COMPLETED|Overall Study||33
7962008|NCT00381303|19599189|P1|NOT COMPLETED|Overall Study||94
7962009|NCT00381303|19599188|P2|COMPLETED|Overall Study||109
7962010|NCT00381303|19599189|P1|COMPLETED|Overall Study||193
7962011|NCT00381303|19599188|P2|STARTED|Overall Study||142
7962012|NCT00381303|19599189|P1|STARTED|Overall Study||287
7962013|NCT00381238|19599249|P1|NOT COMPLETED|Overall Study||12
7962014|NCT00381238|19599249|P1|COMPLETED|Overall Study||21
7962015|NCT00381238|19599249|P1|STARTED|Overall Study||33
7962016|NCT00381095|19599265|P2|NOT COMPLETED|Overall Study||21
7962017|NCT00381095|19599266|P1|NOT COMPLETED|Overall Study||13
7962018|NCT00381095|19599265|P2|COMPLETED|Overall Study||59
7962019|NCT00381095|19599266|P1|COMPLETED|Overall Study||59
7962020|NCT00381095|19599265|P2|STARTED|Overall Study||80
7962021|NCT00381095|19599266|P1|STARTED|Overall Study||72
7962022|NCT00381043|19599298|P2|NOT COMPLETED|Overall Study||8
7962023|NCT00381043|19599299|P1|NOT COMPLETED|Overall Study||12
7962024|NCT00381043|19599298|P2|COMPLETED|Overall Study||41
7962025|NCT00381043|19599299|P1|COMPLETED|Overall Study||39
7962026|NCT00381043|19599298|P2|STARTED|Overall Study||49
7962027|NCT00381043|19599299|P1|STARTED|Overall Study||51
7962028|NCT00381004|19599317|P1|NOT COMPLETED|Overall Study||0
7962029|NCT00381004|19599317|P1|COMPLETED|Overall Study||60
7962030|NCT00381004|19599317|P1|STARTED|Overall Study||60
7962031|NCT00380978|19599325|P2|NOT COMPLETED|Overall Study||10
7962032|NCT00380978|19599326|P1|NOT COMPLETED|Overall Study||2
7962033|NCT00380978|19599325|P2|COMPLETED|Overall Study||400
7962034|NCT00380978|19599326|P1|COMPLETED|Overall Study||406
7962035|NCT00380978|19599325|P2|STARTED|Overall Study||410
7962036|NCT00380978|19599326|P1|STARTED|Overall Study||408
7962037|NCT00380874|19599348|P2|NOT COMPLETED|Overall Study||10
7962038|NCT00380874|19599349|P1|NOT COMPLETED|Overall Study||13
7962039|NCT00380874|19599348|P2|COMPLETED|Overall Study||19
7962040|NCT00380874|19599349|P1|COMPLETED|Overall Study||19
7962041|NCT00380874|19599348|P2|STARTED|Overall Study||29
7962042|NCT00380874|19599349|P1|STARTED|Overall Study||32
7962043|NCT00380861|19599367|P2|NOT COMPLETED|Overall Study||17
7962044|NCT00380861|19599368|P1|NOT COMPLETED|Overall Study||18
7962045|NCT00380861|19599367|P2|COMPLETED|Overall Study||74
7962046|NCT00380861|19599368|P1|COMPLETED|Overall Study||75
7962047|NCT00380861|19599367|P2|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91
7962048|NCT00380861|19599368|P1|STARTED|Overall Study||93
7962049|NCT00380744|19599381|P7|NOT COMPLETED|Overall Study||1
7962050|NCT00380744|19599382|P6|NOT COMPLETED|Overall Study||0
7962051|NCT00380744|19599383|P5|NOT COMPLETED|Overall Study||0
7962052|NCT00380744|19599384|P4|NOT COMPLETED|Overall Study||0
7962053|NCT00380744|19599385|P3|NOT COMPLETED|Overall Study||0
7962054|NCT00380744|19599386|P2|NOT COMPLETED|Overall Study||0
7962055|NCT00380744|19599387|P1|NOT COMPLETED|Overall Study||1
7962056|NCT00380744|19599381|P7|COMPLETED|Overall Study||24
7962057|NCT00380744|19599382|P6|COMPLETED|Overall Study||25
7962058|NCT00380744|19599383|P5|COMPLETED|Overall Study||23
7962059|NCT00380744|19599384|P4|COMPLETED|Overall Study||4
7962060|NCT00380744|19599385|P3|COMPLETED|Overall Study||20
7962061|NCT00380744|19599386|P2|COMPLETED|Overall Study||4
7962062|NCT00380744|19599387|P1|COMPLETED|Overall Study||19
7962063|NCT00380744|19599381|P7|Received at Least 1 Dose of Study Drug|Overall Study||25
7962064|NCT00380744|19599382|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
7962065|NCT00380744|19599383|P5|Received at Least 1 Dose of Study Drug|Overall Study||23
7962066|NCT00380744|19599384|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
7962067|NCT00380744|19599385|P3|Received at Least 1 Dose of Study Drug|Overall Study||20
7962068|NCT00380744|19599386|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
7962069|NCT00380744|19599387|P1|Received at Least 1 Dose of Study Drug|Overall Study||20
7962070|NCT00380744|19599381|P7|STARTED|Overall Study||25
7962071|NCT00380744|19599382|P6|STARTED|Overall Study||25
7962072|NCT00380744|19599383|P5|STARTED|Overall Study||23
7962073|NCT00380744|19599384|P4|STARTED|Overall Study||4
7962074|NCT00380744|19599385|P3|STARTED|Overall Study||20
7962075|NCT00380744|19599386|P2|STARTED|Overall Study||4
7962076|NCT00380744|19599387|P1|STARTED|Overall Study||20
7962077|NCT00380718|19599437|P1|NOT COMPLETED|Overall Study||18
7962078|NCT00380718|19599437|P1|COMPLETED|Overall Study||15
7962079|NCT00380718|19599437|P1|Received Escalated Dose in Cycle 2|Overall Study||25
7962080|NCT00380718|19599437|P1|Received at Least One Dose of Study Drug|Overall Study||33
7962081|NCT00380718|19599437|P1|STARTED|Overall Study||33
7962082|NCT00380692|19599449|P2|NOT COMPLETED|Study Period III - Open Label||12
7962083|NCT00380692|19599450|P1|NOT COMPLETED|Study Period III - Open Label||6
7962084|NCT00380692|19599449|P2|COMPLETED|Study Period III - Open Label||34
7962085|NCT00380692|19599450|P1|COMPLETED|Study Period III - Open Label||36
7962086|NCT00380692|19599449|P2|STARTED|Study Period III - Open Label||46
7962087|NCT00380692|19599450|P1|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42
7962088|NCT00380692|19599449|P2|NOT COMPLETED|Study Period II - Double Blind||3
7962089|NCT00380692|19599450|P1|NOT COMPLETED|Study Period II - Double Blind||5
7962090|NCT00380692|19599449|P2|COMPLETED|Study Period II - Double Blind||46
7962091|NCT00380692|19599450|P1|COMPLETED|Study Period II - Double Blind||43
7962092|NCT00380692|19599449|P2|STARTED|Study Period II - Double Blind||49
7962093|NCT00380692|19599450|P1|STARTED|Study Period II - Double Blind||48
7962094|NCT00380588|19599498|P2|NOT COMPLETED|Overall Study||40
7962095|NCT00380588|19599499|P1|NOT COMPLETED|Overall Study||39
7962096|NCT00380588|19599498|P2|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2
7962097|NCT00380588|19599499|P1|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3
7962098|NCT00380588|19599498|P2|Received at Least One Dose of Study Drug|Overall Study||42
7962099|NCT00380588|19599499|P1|Received at Least One Dose of Study Drug|Overall Study||41
7962100|NCT00380588|19599498|P2|STARTED|Overall Study||42
7962101|NCT00380588|19599499|P1|STARTED|Overall Study||42
7962102|NCT00380393|19599513|P2|NOT COMPLETED|Month 14||56
7962103|NCT00380393|19599514|P1|NOT COMPLETED|Month 14||57
7962104|NCT00380393|19599513|P2|COMPLETED|Month 14||391
7962105|NCT00380393|19599514|P1|COMPLETED|Month 14||390
7962106|NCT00380393|19599513|P2|STARTED|Month 14||447
7962107|NCT00380393|19599514|P1|STARTED|Month 14||447
7962108|NCT00380393|19599513|P2|NOT COMPLETED|Month 8 (Cross-sectional Visit)||40
7962109|NCT00380393|19599514|P1|NOT COMPLETED|Month 8 (Cross-sectional Visit)||49
7962110|NCT00380393|19599513|P2|COMPLETED|Month 8 (Cross-sectional Visit)||407
7962111|NCT00380393|19599514|P1|COMPLETED|Month 8 (Cross-sectional Visit)||398
7962112|NCT00380393|19599513|P2|STARTED|Month 8 (Cross-sectional Visit)||447
7962113|NCT00380393|19599514|P1|STARTED|Month 8 (Cross-sectional Visit)||447
7962114|NCT00380367|19599562|P1|NOT COMPLETED|Overall Study||2
7962115|NCT00380367|19599562|P1|COMPLETED|Overall Study||108
7962116|NCT00380367|19599562|P1|STARTED|Overall Study||110
7962117|NCT00380250|19599569|P2|NOT COMPLETED|Overall Study||55
7962118|NCT00380250|19599570|P1|NOT COMPLETED|Overall Study||99
7962119|NCT00380250|19599569|P2|COMPLETED|Overall Study||139
7962120|NCT00380250|19599570|P1|COMPLETED|Overall Study||297
7962121|NCT00380250|19599569|P2|STARTED|Overall Study||194
7962122|NCT00380250|19599570|P1|STARTED|Overall Study||396
7962123|NCT00380081|19599638|P6|NOT COMPLETED|Overall Study||1
7962124|NCT00380081|19599639|P5|NOT COMPLETED|Overall Study||1
7962125|NCT00380081|19599640|P4|NOT COMPLETED|Overall Study||0
7962126|NCT00380081|19599641|P3|NOT COMPLETED|Overall Study||0
7962127|NCT00380081|19599642|P2|NOT COMPLETED|Overall Study||0
7962128|NCT00380081|19599643|P1|NOT COMPLETED|Overall Study||0
7962129|NCT00380081|19599638|P6|COMPLETED|Overall Study||13
7962130|NCT00380081|19599639|P5|COMPLETED|Overall Study||12
7962131|NCT00380081|19599640|P4|COMPLETED|Overall Study||15
7962132|NCT00380081|19599641|P3|COMPLETED|Overall Study||13
7962133|NCT00380081|19599642|P2|COMPLETED|Overall Study||13
7962134|NCT00380081|19599643|P1|COMPLETED|Overall Study||14
7962135|NCT00380081|19599638|P6|STARTED|Overall Study||14
7962136|NCT00380081|19599639|P5|STARTED|Overall Study||13
7962137|NCT00380081|19599640|P4|STARTED|Overall Study||15
7962138|NCT00380081|19599641|P3|STARTED|Overall Study||13
7962139|NCT00380081|19599642|P2|STARTED|Overall Study||13
7962140|NCT00380081|19599643|P1|STARTED|Overall Study||14
7962141|NCT00380068|19599693|P1|NOT COMPLETED|Overall Study||69
7962142|NCT00380068|19599693|P1|COMPLETED|Overall Study||155
7962143|NCT00380068|19599693|P1|STARTED|Overall Study||224
7962144|NCT00380029|19599713|P1|NOT COMPLETED|Overall Study||0
7962145|NCT00380029|19599713|P1|COMPLETED|Overall Study||20
7962146|NCT00380029|19599713|P1|STARTED|Overall Study||20
7962147|NCT00379912|19599725|P2|NOT COMPLETED|Overall Study||0
7962148|NCT00379912|19599726|P1|NOT COMPLETED|Overall Study||1
7962149|NCT00379912|19599725|P2|COMPLETED|Overall Study||8
7962150|NCT00379912|19599726|P1|COMPLETED|Overall Study||6
7962151|NCT00379912|19599725|P2|STARTED|Overall Study||8
7962152|NCT00379912|19599726|P1|STARTED|Overall Study||7
7962153|NCT00379899|19599748|P2|NOT COMPLETED|Overall Study||40
7962154|NCT00379899|19599749|P1|NOT COMPLETED|Overall Study||40
7962155|NCT00379899|19599748|P2|COMPLETED|Overall Study||140
7962156|NCT00379899|19599749|P1|COMPLETED|Overall Study||140
7962157|NCT00379899|19599748|P2|STARTED|Overall Study||180
7962158|NCT00379899|19599749|P1|STARTED|Overall Study||180
7962159|NCT00379834|19599777|P1|NOT COMPLETED|Overall Study||2
7962160|NCT00379834|19599777|P1|COMPLETED|Overall Study||8
7962161|NCT00379834|19599777|P1|STARTED|Overall Study||10
7962162|NCT00379821|19599785|P4|NOT COMPLETED|Overall Study||79
7962163|NCT00379821|19599786|P3|NOT COMPLETED|Overall Study||67
7962164|NCT00379821|19599787|P2|NOT COMPLETED|Overall Study||89
7962165|NCT00379821|19599788|P1|NOT COMPLETED|Overall Study||73
7962166|NCT00379821|19599785|P4|COMPLETED|Overall Study||81
7962167|NCT00379821|19599786|P3|COMPLETED|Overall Study||93
7962168|NCT00379821|19599787|P2|COMPLETED|Overall Study||71
7962169|NCT00379821|19599788|P1|COMPLETED|Overall Study||87
7962170|NCT00379821|19599785|P4|STARTED|Overall Study||160
7962171|NCT00379821|19599786|P3|STARTED|Overall Study||160
7962172|NCT00379821|19599787|P2|STARTED|Overall Study||160
7962173|NCT00379821|19599788|P1|STARTED|Overall Study||160
7962174|NCT00379808|19599929|P2|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1
7962175|NCT00379808|19599930|P1|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0
7962176|NCT00379808|19599929|P2|COMPLETED|Intervention Period 2 (4 Weeks)||10
7962177|NCT00379808|19599930|P1|COMPLETED|Intervention Period 2 (4 Weeks)||11
7962178|NCT00379808|19599929|P2|STARTED|Intervention Period 2 (4 Weeks)||11
7962179|NCT00379808|19599930|P1|STARTED|Intervention Period 2 (4 Weeks)||11
7962180|NCT00379808|19599929|P2|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
7962181|NCT00379808|19599930|P1|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
7962182|NCT00379808|19599929|P2|COMPLETED|Intervention Period 1 (4 Weeks)||11
7962183|NCT00379808|19599930|P1|COMPLETED|Intervention Period 1 (4 Weeks)||11
7962184|NCT00379808|19599929|P2|STARTED|Intervention Period 1 (4 Weeks)||11
7962185|NCT00379808|19599930|P1|STARTED|Intervention Period 1 (4 Weeks)||11
7962186|NCT00379795|19599951|P5|NOT COMPLETED|Overall Study||49
7962187|NCT00379795|19599952|P4|NOT COMPLETED|Overall Study||68
7962188|NCT00379795|19599953|P3|NOT COMPLETED|Overall Study||93
7962189|NCT00379795|19599954|P2|NOT COMPLETED|Overall Study||51
7962190|NCT00379795|19599955|P1|NOT COMPLETED|Overall Study||476
7962191|NCT00379795|19599951|P5|COMPLETED|Overall Study||14
7962192|NCT00379795|19599952|P4|COMPLETED|Overall Study||6
7962193|NCT00379795|19599953|P3|COMPLETED|Overall Study||23
7962194|NCT00379795|19599954|P2|COMPLETED|Overall Study||23
7962195|NCT00379795|19599955|P1|COMPLETED|Overall Study||50
7962196|NCT00379795|19599951|P5|Received Ranibizumab in Extension Study|Overall Study||0
7962197|NCT00379795|19599952|P4|Received Ranibizumab in Extension Study|Overall Study||55
7962198|NCT00379795|19599953|P3|Received Ranibizumab in Extension Study|Overall Study||113
7962199|NCT00379795|19599954|P2|Received Ranibizumab in Extension Study|Overall Study||41
7962200|NCT00379795|19599955|P1|Received Ranibizumab in Extension Study|Overall Study||377
7962201|NCT00379795|19599951|P5|STARTED|Overall Study||63
7962202|NCT00379795|19599952|P4|STARTED|Overall Study||74
7962203|NCT00379795|19599953|P3|STARTED|Overall Study||116
7962204|NCT00379795|19599954|P2|STARTED|Overall Study||74
7962205|NCT00379795|19599955|P1|STARTED|Overall Study||526
7962206|NCT00379769|19599985|P6|NOT COMPLETED|Observational Follow-up||148
7962207|NCT00379769|19599986|P5|NOT COMPLETED|Observational Follow-up||149
7962208|NCT00379769|19599987|P4|NOT COMPLETED|Observational Follow-up||0
7962209|NCT00379769|19599988|P3|NOT COMPLETED|Observational Follow-up||0
7962210|NCT00379769|19599989|P2|NOT COMPLETED|Observational Follow-up||0
7962211|NCT00379769|19599990|P1|NOT COMPLETED|Observational Follow-up||0
7962212|NCT00379769|19599985|P6|COMPLETED|Observational Follow-up||1102
7962213|NCT00379769|19599986|P5|COMPLETED|Observational Follow-up||1131
7962214|NCT00379769|19599987|P4|COMPLETED|Observational Follow-up||0
7962215|NCT00379769|19599988|P3|COMPLETED|Observational Follow-up||0
7962216|NCT00379769|19599989|P2|COMPLETED|Observational Follow-up||0
7962217|NCT00379769|19599990|P1|COMPLETED|Observational Follow-up||0
7962218|NCT00379769|19599985|P6|STARTED|Observational Follow-up|"647 from SU in Addition to Background MET arm; 603 from MET in Addition to Background SU arm."|1250
7962219|NCT00379769|19599986|P5|STARTED|Observational Follow-up|"665 from RSG in Addition to Background MET arm; 615 from RGS in Addition to Background SU arm."|1280
7962220|NCT00379769|19599987|P4|STARTED|Observational Follow-up||0
7962221|NCT00379769|19599988|P3|STARTED|Observational Follow-up||0
7962222|NCT00379769|19599989|P2|STARTED|Observational Follow-up||0
7962223|NCT00379769|19599990|P1|STARTED|Observational Follow-up||0
7962224|NCT00379769|19599985|P6|NOT COMPLETED|Main Study||0
7962225|NCT00379769|19599986|P5|NOT COMPLETED|Main Study||0
7962226|NCT00379769|19599987|P4|NOT COMPLETED|Main Study||230
7962227|NCT00379769|19599988|P3|NOT COMPLETED|Main Study||207
7962228|NCT00379769|19599989|P2|NOT COMPLETED|Main Study||199
7962229|NCT00379769|19599990|P1|NOT COMPLETED|Main Study||178
7962230|NCT00379769|19599985|P6|COMPLETED|Main Study||0
7962231|NCT00379769|19599986|P5|COMPLETED|Main Study||0
7962232|NCT00379769|19599987|P4|COMPLETED|Main Study||892
7962233|NCT00379769|19599988|P3|COMPLETED|Main Study||896
7962234|NCT00379769|19599989|P2|COMPLETED|Main Study||906
7962235|NCT00379769|19599990|P1|COMPLETED|Main Study||939
7962236|NCT00379769|19599985|P6|STARTED|Main Study||0
7962237|NCT00379769|19599986|P5|STARTED|Main Study||0
7962238|NCT00379769|19599987|P4|STARTED|Main Study||1122
7962239|NCT00379769|19599988|P3|STARTED|Main Study||1103
7962240|NCT00379769|19599989|P2|STARTED|Main Study||1105
7962241|NCT00379769|19599990|P1|STARTED|Main Study||1117
7962242|NCT00379639|19600149|P5|NOT COMPLETED|Overall Study||6
7962243|NCT00379639|19600150|P4|NOT COMPLETED|Overall Study||6
7962244|NCT00379639|19600151|P3|NOT COMPLETED|Overall Study||9
7962245|NCT00379639|19600152|P2|NOT COMPLETED|Overall Study||5
7962246|NCT00379639|19600153|P1|NOT COMPLETED|Overall Study||3
7962247|NCT00379639|19600149|P5|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
7962248|NCT00379639|19600150|P4|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
7962249|NCT00379639|19600151|P3|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1
7962250|NCT00379639|19600152|P2|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2
7962251|NCT00379639|19600153|P1|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4
7962252|NCT00379639|19600149|P5|Completed 6 Cycles of Therapy|Overall Study||0
7962253|NCT00379639|19600150|P4|Completed 6 Cycles of Therapy|Overall Study||0
7962254|NCT00379639|19600151|P3|Completed 6 Cycles of Therapy|Overall Study||1
7962255|NCT00379639|19600152|P2|Completed 6 Cycles of Therapy|Overall Study||2
7962256|NCT00379639|19600153|P1|Completed 6 Cycles of Therapy|Overall Study||4
7962257|NCT00379639|19600149|P5|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3
7962258|NCT00379639|19600150|P4|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4
7962259|NCT00379639|19600151|P3|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
7962260|NCT00379639|19600152|P2|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
7962261|NCT00379639|19600153|P1|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6
7962262|NCT00379639|19600149|P5|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
7962263|NCT00379639|19600150|P4|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
7962264|NCT00379639|19600151|P3|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10
7962265|NCT00379639|19600152|P2|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
7962266|NCT00379639|19600153|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
7962267|NCT00379587|19600175|P1|NOT COMPLETED|Overall Study||2
7962268|NCT00379587|19600175|P1|COMPLETED|Overall Study||63
7962269|NCT00379587|19600175|P1|STARTED|Overall Study||65
7962270|NCT00379574|19600182|P1|NOT COMPLETED|Overall Study||0
7962271|NCT00379574|19600182|P1|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49
7962272|NCT00379574|19600182|P1|STARTED|Overall Study|Phase I (9) + Phase II (40)|49
7962273|NCT00379353|19600189|P2|NOT COMPLETED|Overall Study||6
7962274|NCT00379353|19600190|P1|NOT COMPLETED|Overall Study||11
7962275|NCT00379353|19600189|P2|COMPLETED|Overall Study||9
7962276|NCT00379353|19600190|P1|COMPLETED|Overall Study||5
7962277|NCT00379353|19600189|P2|STARTED|Overall Study||15
7962278|NCT00379353|19600190|P1|STARTED|Overall Study||16
7962279|NCT00379340|19600225|P5|NOT COMPLETED|Overall Study||14
7962280|NCT00379340|19600226|P4|NOT COMPLETED|Overall Study||13
7962281|NCT00379340|19600227|P3|NOT COMPLETED|Overall Study||2
7962282|NCT00379340|19600228|P2|NOT COMPLETED|Overall Study||3
7962283|NCT00379340|19600229|P1|NOT COMPLETED|Overall Study||13
7962284|NCT00379340|19600225|P5|COMPLETED|Overall Study||9
7962285|NCT00379340|19600226|P4|COMPLETED|Overall Study||37
7962286|NCT00379340|19600227|P3|COMPLETED|Overall Study||50
7962287|NCT00379340|19600228|P2|COMPLETED|Overall Study||132
7962288|NCT00379340|19600229|P1|COMPLETED|Overall Study||107
7962289|NCT00379340|19600225|P5|STARTED|Overall Study||23
7962290|NCT00379340|19600226|P4|STARTED|Overall Study||50
7962291|NCT00379340|19600227|P3|STARTED|Overall Study||52
7962292|NCT00379340|19600228|P2|STARTED|Overall Study||135
7962293|NCT00379340|19600229|P1|STARTED|Overall Study||120
7962294|NCT00379288|19600246|P4|NOT COMPLETED|Overall Study||8
7962295|NCT00379288|19600247|P3|NOT COMPLETED|Overall Study||10
7962296|NCT00379288|19600248|P2|NOT COMPLETED|Overall Study||22
7962297|NCT00379288|19600249|P1|NOT COMPLETED|Overall Study||19
7962298|NCT00379288|19600246|P4|COMPLETED|Overall Study||57
7962299|NCT00379288|19600247|P3|COMPLETED|Overall Study||58
7962300|NCT00379288|19600248|P2|COMPLETED|Overall Study||108
7962301|NCT00379288|19600249|P1|COMPLETED|Overall Study||122
7962302|NCT00379288|19600246|P4|STARTED|Overall Study||65
7962303|NCT00379288|19600247|P3|STARTED|Overall Study||68
7962304|NCT00379288|19600248|P2|STARTED|Overall Study||130
7962305|NCT00379288|19600249|P1|STARTED|Overall Study||141
7962306|NCT00379236|19600261|P3|NOT COMPLETED|Open-label Extension||55
7962307|NCT00379236|19600262|P2|NOT COMPLETED|Open-label Extension||0
7962308|NCT00379236|19600263|P1|NOT COMPLETED|Open-label Extension||0
7962309|NCT00379236|19600261|P3|COMPLETED|Open-label Extension||378
7962310|NCT00379236|19600262|P2|COMPLETED|Open-label Extension||0
7962311|NCT00379236|19600263|P1|COMPLETED|Open-label Extension||0
7962312|NCT00379236|19600261|P3|STARTED|Open-label Extension||433
7962313|NCT00379236|19600262|P2|STARTED|Open-label Extension||0
7962314|NCT00379236|19600263|P1|STARTED|Open-label Extension||0
7962315|NCT00379236|19600261|P3|NOT COMPLETED|Double-blind||0
7962316|NCT00379236|19600262|P2|NOT COMPLETED|Double-blind||36
7962317|NCT00379236|19600263|P1|NOT COMPLETED|Double-blind||36
7962318|NCT00379236|19600261|P3|COMPLETED|Double-blind||0
7962319|NCT00379236|19600262|P2|COMPLETED|Double-blind|Data could not be retrieved for two participants|259
7962320|NCT00379236|19600263|P1|COMPLETED|Double-blind|Data could not be retrieved for two participants|257
7962321|NCT00379236|19600261|P3|STARTED|Double-blind||0
7962322|NCT00379236|19600262|P2|STARTED|Double-blind||295
7962323|NCT00379236|19600263|P1|STARTED|Double-blind||293
7962324|NCT00379210|19600308|P2|NOT COMPLETED|Overall Study||7
7962325|NCT00379210|19600309|P1|NOT COMPLETED|Overall Study||10
7962326|NCT00379210|19600308|P2|COMPLETED|Overall Study||23
7962327|NCT00379210|19600309|P1|COMPLETED|Overall Study||20
7962328|NCT00379210|19600308|P2|STARTED|Overall Study||30
7962329|NCT00379210|19600309|P1|STARTED|Overall Study||30
7962330|NCT00379197|19600315|P1|NOT COMPLETED|Overall Study||5
7962331|NCT00379197|19600315|P1|COMPLETED|Overall Study||8
7962332|NCT00379197|19600315|P1|STARTED|Overall Study||13
7962333|NCT00379145|19600320|P1|NOT COMPLETED|Overall Study||0
7962334|NCT00379145|19600320|P1|COMPLETED|Overall Study||20
7962335|NCT00379145|19600320|P1|STARTED|Overall Study||20
7962336|NCT00379080|19600332|P3|NOT COMPLETED|Overall Study||0
7962337|NCT00379080|19600333|P2|NOT COMPLETED|Overall Study||4
7962338|NCT00379080|19600334|P1|NOT COMPLETED|Overall Study||0
7962339|NCT00379080|19600332|P3|COMPLETED|Overall Study||31
7962340|NCT00379080|19600333|P2|COMPLETED|Overall Study||15
7962341|NCT00379080|19600334|P1|COMPLETED|Overall Study||6
7962342|NCT00379080|19600332|P3|STARTED|Overall Study||31
7962343|NCT00379080|19600333|P2|STARTED|Overall Study||19
7962344|NCT00379080|19600334|P1|STARTED|Overall Study||6
7962345|NCT00378898|19600379|P2|NOT COMPLETED|Overall Study||6
7962346|NCT00378898|19600380|P1|NOT COMPLETED|Overall Study||11
7962347|NCT00378898|19600379|P2|COMPLETED|Overall Study||11
7962348|NCT00378898|19600380|P1|COMPLETED|Overall Study||11
7962349|NCT00378898|19600379|P2|STARTED|Overall Study||17
7962350|NCT00378898|19600380|P1|STARTED|Overall Study||22
7962351|NCT00378703|19600392|P4|NOT COMPLETED|Overall Study||91
7962352|NCT00378703|19600393|P3|NOT COMPLETED|Overall Study||90
7962353|NCT00378703|19600394|P2|NOT COMPLETED|Overall Study||91
7962354|NCT00378703|19600395|P1|NOT COMPLETED|Overall Study||89
7962355|NCT00378703|19600392|P4|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
7962356|NCT00378703|19600393|P3|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
7962357|NCT00378703|19600394|P2|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
7962358|NCT00378703|19600395|P1|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
7962359|NCT00378703|19600392|P4|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
7962360|NCT00378703|19600393|P3|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83
7962361|NCT00378703|19600394|P2|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80
7962362|NCT00378703|19600395|P1|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
7962363|NCT00378703|19600392|P4|Treated|Overall Study|Number of patients included in the toxicity analysis.|91
7962364|NCT00378703|19600393|P3|Treated|Overall Study|Number of patients included in the toxicity analysis.|90
7962365|NCT00378703|19600394|P2|Treated|Overall Study|Number of patients included in the toxicity analysis.|86
7962366|NCT00378703|19600395|P1|Treated|Overall Study|Number of patients included in the toxicity analysis.|88
7962367|NCT00378703|19600392|P4|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
7962368|NCT00378703|19600393|P3|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90
7962369|NCT00378703|19600394|P2|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
7962370|NCT00378703|19600395|P1|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89
7962371|NCT00378599|19600417|P1|NOT COMPLETED|Overall Study||52
7962372|NCT00378599|19600417|P1|COMPLETED|Overall Study||73
7962373|NCT00378599|19600417|P1|STARTED|Overall Study||125
7962374|NCT00378573|19600421|P1|NOT COMPLETED|Follow-up||14
7962375|NCT00378573|19600421|P1|COMPLETED|Follow-up||3
7962376|NCT00378573|19600421|P1|STARTED|Follow-up||17
7962377|NCT00378573|19600421|P1|NOT COMPLETED|Treatment Period||17
7962378|NCT00378573|19600421|P1|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0
7962379|NCT00378573|19600421|P1|STARTED|Treatment Period||17
7962380|NCT00378560|19600429|P2|NOT COMPLETED|Overall Study||58
7962381|NCT00378560|19600430|P1|NOT COMPLETED|Overall Study||56
7962382|NCT00378560|19600429|P2|COMPLETED|Overall Study||454
7962383|NCT00378560|19600430|P1|COMPLETED|Overall Study||453
7962384|NCT00378560|19600429|P2|Vaccinated|Overall Study||512
7962385|NCT00378560|19600430|P1|Vaccinated|Overall Study||509
7962386|NCT00378560|19600429|P2|STARTED|Overall Study||512
7962387|NCT00378560|19600430|P1|STARTED|Overall Study||509
7962388|NCT00378534|19600444|P1|NOT COMPLETED|Overall Study||60
7962389|NCT00378534|19600444|P1|COMPLETED|Overall Study|Transplantation Recipients|55
7962390|NCT00378534|19600444|P1|STARTED|Overall Study||115
7962391|NCT00378508|19600450|P2|NOT COMPLETED|Overall Study||3
7962392|NCT00378508|19600451|P1|NOT COMPLETED|Overall Study||2
7962393|NCT00378508|19600450|P2|COMPLETED|Overall Study||31
7962394|NCT00378508|19600451|P1|COMPLETED|Overall Study||27
7962395|NCT00378508|19600450|P2|Received Intervention/Placebo|Overall Study||31
7962396|NCT00378508|19600451|P1|Received Intervention/Placebo|Overall Study||28
7962397|NCT00378508|19600450|P2|Randomized|Overall Study||34
7962398|NCT00378508|19600451|P1|Randomized|Overall Study||29
7962399|NCT00378508|19600450|P2|STARTED|Overall Study||34
7962400|NCT00378508|19600451|P1|STARTED|Overall Study||29
7962401|NCT00378378|19600470|P3|NOT COMPLETED|Overall Study||2
7962402|NCT00378378|19600471|P2|NOT COMPLETED|Overall Study||1
7962403|NCT00378378|19600472|P1|NOT COMPLETED|Overall Study||0
7962404|NCT00378378|19600470|P3|COMPLETED|Overall Study||24
7962405|NCT00378378|19600471|P2|COMPLETED|Overall Study||49
7962406|NCT00378378|19600472|P1|COMPLETED|Overall Study||51
7962407|NCT00378378|19600470|P3|STARTED|Overall Study||26
7962408|NCT00378378|19600471|P2|STARTED|Overall Study||50
7962409|NCT00378378|19600472|P1|STARTED|Overall Study||51
7962410|NCT00378352|19600485|P6|NOT COMPLETED|Efficacy Phase||7
7962411|NCT00378352|19600486|P5|NOT COMPLETED|Efficacy Phase||11
7962412|NCT00378352|19600487|P4|NOT COMPLETED|Efficacy Phase||0
7962413|NCT00378352|19600488|P3|NOT COMPLETED|Efficacy Phase||0
7962414|NCT00378352|19600489|P2|NOT COMPLETED|Efficacy Phase||0
7962415|NCT00378352|19600490|P1|NOT COMPLETED|Efficacy Phase||0
7962416|NCT00378352|19600485|P6|COMPLETED|Efficacy Phase||59
7962417|NCT00378352|19600486|P5|COMPLETED|Efficacy Phase||54
7962418|NCT00378352|19600487|P4|COMPLETED|Efficacy Phase||0
7962419|NCT00378352|19600488|P3|COMPLETED|Efficacy Phase||0
7962420|NCT00378352|19600489|P2|COMPLETED|Efficacy Phase||0
7962421|NCT00378352|19600490|P1|COMPLETED|Efficacy Phase||0
7962422|NCT00378352|19600485|P6|Safety Analysis|Efficacy Phase||64
7962423|NCT00378352|19600486|P5|Safety Analysis|Efficacy Phase|Two participants randomized to placebo received 60,000 units Epoetin alfa|67
7962424|NCT00378352|19600487|P4|Safety Analysis|Efficacy Phase||0
7962425|NCT00378352|19600488|P3|Safety Analysis|Efficacy Phase||0
7962426|NCT00378352|19600489|P2|Safety Analysis|Efficacy Phase||0
7962427|NCT00378352|19600490|P1|Safety Analysis|Efficacy Phase||0
7962428|NCT00378352|19600485|P6|STARTED|Efficacy Phase||66
7962429|NCT00378352|19600486|P5|STARTED|Efficacy Phase||65
7962430|NCT00378352|19600487|P4|STARTED|Efficacy Phase||0
7962431|NCT00378352|19600488|P3|STARTED|Efficacy Phase||0
7962432|NCT00378352|19600489|P2|STARTED|Efficacy Phase||0
7962433|NCT00378352|19600490|P1|STARTED|Efficacy Phase||0
7962434|NCT00378352|19600485|P6|NOT COMPLETED|Dose Escalation 60,000 Units||0
7962435|NCT00378352|19600486|P5|NOT COMPLETED|Dose Escalation 60,000 Units||0
7962436|NCT00378352|19600487|P4|NOT COMPLETED|Dose Escalation 60,000 Units||1
7962437|NCT00378352|19600488|P3|NOT COMPLETED|Dose Escalation 60,000 Units||3
7962438|NCT00378352|19600489|P2|NOT COMPLETED|Dose Escalation 60,000 Units||0
7962439|NCT00378352|19600490|P1|NOT COMPLETED|Dose Escalation 60,000 Units||0
7962440|NCT00378352|19600485|P6|COMPLETED|Dose Escalation 60,000 Units||0
7962441|NCT00378352|19600486|P5|COMPLETED|Dose Escalation 60,000 Units||0
7962442|NCT00378352|19600487|P4|COMPLETED|Dose Escalation 60,000 Units||10
7962443|NCT00378352|19600488|P3|COMPLETED|Dose Escalation 60,000 Units||17
7962444|NCT00378352|19600489|P2|COMPLETED|Dose Escalation 60,000 Units||0
7962445|NCT00378352|19600490|P1|COMPLETED|Dose Escalation 60,000 Units||0
7962446|NCT00378352|19600485|P6|Safety Analysis|Dose Escalation 60,000 Units||0
7962447|NCT00378352|19600486|P5|Safety Analysis|Dose Escalation 60,000 Units||0
7962448|NCT00378352|19600487|P4|Safety Analysis|Dose Escalation 60,000 Units||11
7962449|NCT00378352|19600488|P3|Safety Analysis|Dose Escalation 60,000 Units||19
7962450|NCT00378352|19600489|P2|Safety Analysis|Dose Escalation 60,000 Units||0
7962451|NCT00378352|19600490|P1|Safety Analysis|Dose Escalation 60,000 Units||0
7962452|NCT00378352|19600485|P6|STARTED|Dose Escalation 60,000 Units||0
7962453|NCT00378352|19600486|P5|STARTED|Dose Escalation 60,000 Units||0
7962454|NCT00378352|19600487|P4|STARTED|Dose Escalation 60,000 Units||11
7962455|NCT00378352|19600488|P3|STARTED|Dose Escalation 60,000 Units||20
7962456|NCT00378352|19600489|P2|STARTED|Dose Escalation 60,000 Units||0
7962457|NCT00378352|19600490|P1|STARTED|Dose Escalation 60,000 Units||0
7962458|NCT00378352|19600485|P6|NOT COMPLETED|Dose Escalation 30,000 Units||0
7962459|NCT00378352|19600486|P5|NOT COMPLETED|Dose Escalation 30,000 Units||0
7962460|NCT00378352|19600487|P4|NOT COMPLETED|Dose Escalation 30,000 Units||2
7962461|NCT00378352|19600488|P3|NOT COMPLETED|Dose Escalation 30,000 Units||0
7962462|NCT00378352|19600489|P2|NOT COMPLETED|Dose Escalation 30,000 Units||3
7962463|NCT00378352|19600490|P1|NOT COMPLETED|Dose Escalation 30,000 Units||0
7962464|NCT00378352|19600485|P6|COMPLETED|Dose Escalation 30,000 Units||0
7962465|NCT00378352|19600486|P5|COMPLETED|Dose Escalation 30,000 Units||0
7962466|NCT00378352|19600487|P4|COMPLETED|Dose Escalation 30,000 Units||9
7962467|NCT00378352|19600488|P3|COMPLETED|Dose Escalation 30,000 Units||0
7962468|NCT00378352|19600489|P2|COMPLETED|Dose Escalation 30,000 Units||16
7962469|NCT00378352|19600490|P1|COMPLETED|Dose Escalation 30,000 Units||0
7962470|NCT00378352|19600485|P6|Safety Analysis|Dose Escalation 30,000 Units||0
7962471|NCT00378352|19600486|P5|Safety Analysis|Dose Escalation 30,000 Units||0
7962472|NCT00378352|19600487|P4|Safety Analysis|Dose Escalation 30,000 Units||11
7962473|NCT00378352|19600488|P3|Safety Analysis|Dose Escalation 30,000 Units||0
7962474|NCT00378352|19600489|P2|Safety Analysis|Dose Escalation 30,000 Units|One participant randomized to 60,000 units received 30,000 units|20
7962475|NCT00378352|19600490|P1|Safety Analysis|Dose Escalation 30,000 Units||0
7962476|NCT00378352|19600485|P6|STARTED|Dose Escalation 30,000 Units||0
7962477|NCT00378352|19600486|P5|STARTED|Dose Escalation 30,000 Units||0
7962478|NCT00378352|19600487|P4|STARTED|Dose Escalation 30,000 Units||11
7962479|NCT00378352|19600488|P3|STARTED|Dose Escalation 30,000 Units||0
7962480|NCT00378352|19600489|P2|STARTED|Dose Escalation 30,000 Units||19
7962481|NCT00378352|19600490|P1|STARTED|Dose Escalation 30,000 Units||0
7962482|NCT00378352|19600485|P6|NOT COMPLETED|Dose Escalation 15,000 Units||0
7962483|NCT00378352|19600486|P5|NOT COMPLETED|Dose Escalation 15,000 Units||0
7962484|NCT00378352|19600487|P4|NOT COMPLETED|Dose Escalation 15,000 Units||1
7962485|NCT00378352|19600488|P3|NOT COMPLETED|Dose Escalation 15,000 Units||0
7962486|NCT00378352|19600489|P2|NOT COMPLETED|Dose Escalation 15,000 Units||0
7962487|NCT00378352|19600490|P1|NOT COMPLETED|Dose Escalation 15,000 Units||5
7962488|NCT00378352|19600485|P6|COMPLETED|Dose Escalation 15,000 Units||0
7962489|NCT00378352|19600486|P5|COMPLETED|Dose Escalation 15,000 Units||0
7962490|NCT00378352|19600487|P4|COMPLETED|Dose Escalation 15,000 Units||10
7962491|NCT00378352|19600488|P3|COMPLETED|Dose Escalation 15,000 Units||0
7962492|NCT00378352|19600489|P2|COMPLETED|Dose Escalation 15,000 Units||0
7962493|NCT00378352|19600490|P1|COMPLETED|Dose Escalation 15,000 Units||15
7962494|NCT00378352|19600485|P6|Safety Analysis|Dose Escalation 15,000 Units||0
7962495|NCT00378352|19600486|P5|Safety Analysis|Dose Escalation 15,000 Units||0
7962496|NCT00378352|19600487|P4|Safety Analysis|Dose Escalation 15,000 Units||11
7962497|NCT00378352|19600488|P3|Safety Analysis|Dose Escalation 15,000 Units||0
7962498|NCT00378352|19600489|P2|Safety Analysis|Dose Escalation 15,000 Units||0
7962499|NCT00378352|19600490|P1|Safety Analysis|Dose Escalation 15,000 Units||19
7962500|NCT00378352|19600485|P6|STARTED|Dose Escalation 15,000 Units||0
7962501|NCT00378352|19600486|P5|STARTED|Dose Escalation 15,000 Units||0
7962502|NCT00378352|19600487|P4|STARTED|Dose Escalation 15,000 Units||11
7962503|NCT00378352|19600488|P3|STARTED|Dose Escalation 15,000 Units||0
7962504|NCT00378352|19600489|P2|STARTED|Dose Escalation 15,000 Units||0
7962505|NCT00378352|19600490|P1|STARTED|Dose Escalation 15,000 Units||20
7962506|NCT00378326|19600512|P1|NOT COMPLETED|Overall Study||0
7962507|NCT00378326|19600512|P1|COMPLETED|Overall Study||26
7962508|NCT00378326|19600512|P1|STARTED|Overall Study||26
7962509|NCT00378209|19600518|P1|NOT COMPLETED|Overall Study||22
7962510|NCT00378209|19600518|P1|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42
7962511|NCT00378209|19600518|P1|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64
7962512|NCT00378105|19600528|P2|NOT COMPLETED|Overall Study||30
7962513|NCT00378105|19600529|P1|NOT COMPLETED|Overall Study||20
7962514|NCT00378105|19600528|P2|COMPLETED|Overall Study||5
7962515|NCT00378105|19600529|P1|COMPLETED|Overall Study||11
7962516|NCT00378105|19600528|P2|STARTED|Overall Study||35
7962517|NCT00378105|19600529|P1|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31
7962518|NCT00378079|19600541|P3|NOT COMPLETED|Overall Study||0
7962519|NCT00378079|19600542|P2|NOT COMPLETED|Overall Study||1
7962520|NCT00378079|19600543|P1|NOT COMPLETED|Overall Study||6
7962521|NCT00378079|19600541|P3|COMPLETED|Overall Study||71
7962522|NCT00378079|19600542|P2|COMPLETED|Overall Study||69
7962523|NCT00378079|19600543|P1|COMPLETED|Overall Study||64
7962524|NCT00378079|19600541|P3|STARTED|Overall Study||71
7962525|NCT00378079|19600542|P2|STARTED|Overall Study||70
7962526|NCT00378079|19600543|P1|STARTED|Overall Study||70
7962527|NCT00378014|19600565|P2|NOT COMPLETED|Extension (Month 12 to Month 59)||14
7962528|NCT00378014|19600566|P1|NOT COMPLETED|Extension (Month 12 to Month 59)||14
7962529|NCT00378014|19600565|P2|COMPLETED|Extension (Month 12 to Month 59)||26
7962530|NCT00378014|19600566|P1|COMPLETED|Extension (Month 12 to Month 59)||27
7962531|NCT00378014|19600565|P2|STARTED|Extension (Month 12 to Month 59)||40
7962532|NCT00378014|19600566|P1|STARTED|Extension (Month 12 to Month 59)||41
7962533|NCT00378014|19600565|P2|NOT COMPLETED|Core (Randomization to Month 11)||12
7962534|NCT00378014|19600566|P1|NOT COMPLETED|Core (Randomization to Month 11)||14
7962535|NCT00378014|19600565|P2|COMPLETED|Core (Randomization to Month 11)||90
7962536|NCT00378014|19600566|P1|COMPLETED|Core (Randomization to Month 11)||87
7962537|NCT00378014|19600565|P2|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98
7962538|NCT00378014|19600566|P1|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96
7962539|NCT00378014|19600565|P2|STARTED|Core (Randomization to Month 11)||102
7962540|NCT00378014|19600566|P1|STARTED|Core (Randomization to Month 11)||101
7962541|NCT00377962|19600592|P2|NOT COMPLETED|Extension Study: 12-24 Months||4
7962542|NCT00377962|19600593|P1|NOT COMPLETED|Extension Study: 12-24 Months||10
7962543|NCT00377962|19600592|P2|COMPLETED|Extension Study: 12-24 Months||123
7962544|NCT00377962|19600593|P1|COMPLETED|Extension Study: 12-24 Months||98
7962545|NCT00377962|19600592|P2|STARTED|Extension Study: 12-24 Months||127
7962546|NCT00377962|19600593|P1|STARTED|Extension Study: 12-24 Months||108
7962547|NCT00377962|19600592|P2|NOT COMPLETED|Core Study: 0-12 Months||9
7962548|NCT00377962|19600593|P1|NOT COMPLETED|Core Study: 0-12 Months||28
7962549|NCT00377962|19600592|P2|COMPLETED|Core Study: 0-12 Months||133
7962550|NCT00377962|19600593|P1|COMPLETED|Core Study: 0-12 Months||112
7962551|NCT00377962|19600592|P2|STARTED|Core Study: 0-12 Months||142
7962552|NCT00377962|19600593|P1|STARTED|Core Study: 0-12 Months||140
7962553|NCT00377858|19600629|P2|NOT COMPLETED|Overall Study||27
7962554|NCT00377858|19600630|P1|NOT COMPLETED|Overall Study||31
7962555|NCT00377858|19600629|P2|COMPLETED|Overall Study||215
7962556|NCT00377858|19600630|P1|COMPLETED|Overall Study||211
7962557|NCT00377858|19600629|P2|Had at Least One Post-Baseline Value|Overall Study||240
7962558|NCT00377858|19600630|P1|Had at Least One Post-Baseline Value|Overall Study||239
7962559|NCT00377858|19600629|P2|STARTED|Overall Study||242
7962560|NCT00377858|19600630|P1|STARTED|Overall Study||242
7962561|NCT00377832|19600660|P2|NOT COMPLETED|Overall Study||0
7962562|NCT00377832|19600661|P1|NOT COMPLETED|Overall Study||0
7962563|NCT00377832|19600660|P2|COMPLETED|Overall Study||6
7962564|NCT00377832|19600661|P1|COMPLETED|Overall Study||7
7962565|NCT00377832|19600660|P2|STARTED|Overall Study||6
7962566|NCT00377832|19600661|P1|STARTED|Overall Study||7
7962567|NCT00377819|19600683|P2|NOT COMPLETED|Overall Study||10
7962568|NCT00377819|19600684|P1|NOT COMPLETED|Overall Study||13
7962569|NCT00377819|19600683|P2|COMPLETED|Overall Study||243
7962570|NCT00377819|19600684|P1|COMPLETED|Overall Study||238
7962571|NCT00377819|19600683|P2|Received Study Medication|Overall Study||253
7962572|NCT00377819|19600684|P1|Received Study Medication|Overall Study||249
7962573|NCT00377819|19600683|P2|STARTED|Overall Study||253
7962574|NCT00377819|19600684|P1|STARTED|Overall Study||251
7962575|NCT00377741|19600696|P2|NOT COMPLETED|Overall Study||0
7962576|NCT00377741|19600697|P1|NOT COMPLETED|Overall Study||0
7962577|NCT00377741|19600696|P2|COMPLETED|Overall Study||15
7962578|NCT00377741|19600697|P1|COMPLETED|Overall Study||16
7962579|NCT00377741|19600696|P2|STARTED|Overall Study||15
7962580|NCT00377741|19600697|P1|STARTED|Overall Study||16
7962581|NCT00377676|19600713|P2|NOT COMPLETED|Overall Study||322
7962582|NCT00377676|19600714|P1|NOT COMPLETED|Overall Study||961
7962583|NCT00377676|19600713|P2|COMPLETED|Overall Study||694
7962584|NCT00377676|19600714|P1|COMPLETED|Overall Study||1093
7962585|NCT00377676|19600713|P2|STARTED|Overall Study||1016
7962586|NCT00377676|19600714|P1|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054
7962587|NCT00377637|19600730|P4|NOT COMPLETED|Maintenance Phase||57
7962588|NCT00377637|19600731|P3|NOT COMPLETED|Maintenance Phase||43
7962589|NCT00377637|19600732|P2|NOT COMPLETED|Maintenance Phase||0
7962590|NCT00377637|19600733|P1|NOT COMPLETED|Maintenance Phase||0
7962591|NCT00377637|19600730|P4|COMPLETED|Maintenance Phase||54
7962592|NCT00377637|19600731|P3|COMPLETED|Maintenance Phase||73
7962593|NCT00377637|19600732|P2|COMPLETED|Maintenance Phase||0
7962594|NCT00377637|19600733|P1|COMPLETED|Maintenance Phase||0
7962595|NCT00377637|19600730|P4|STARTED|Maintenance Phase||111
7962596|NCT00377637|19600731|P3|STARTED|Maintenance Phase||116
7962597|NCT00377637|19600732|P2|STARTED|Maintenance Phase||0
7962598|NCT00377637|19600733|P1|STARTED|Maintenance Phase||0
7962599|NCT00377637|19600730|P4|NOT COMPLETED|Induction Phase||0
7962600|NCT00377637|19600731|P3|NOT COMPLETED|Induction Phase||0
7962601|NCT00377637|19600732|P2|NOT COMPLETED|Induction Phase||35
7962602|NCT00377637|19600733|P1|NOT COMPLETED|Induction Phase||29
7962603|NCT00377637|19600730|P4|COMPLETED|Induction Phase||0
7962604|NCT00377637|19600731|P3|COMPLETED|Induction Phase||0
7962605|NCT00377637|19600732|P2|COMPLETED|Induction Phase||150
7962606|NCT00377637|19600733|P1|COMPLETED|Induction Phase||156
7962607|NCT00377637|19600730|P4|Safety Population|Induction Phase||0
7962608|NCT00377637|19600731|P3|Safety Population|Induction Phase||0
7962609|NCT00377637|19600732|P2|Safety Population|Induction Phase||184
7962610|NCT00377637|19600733|P1|Safety Population|Induction Phase||180
7962611|NCT00377637|19600730|P4|STARTED|Induction Phase||0
7962612|NCT00377637|19600731|P3|STARTED|Induction Phase||0
7962613|NCT00377637|19600732|P2|STARTED|Induction Phase|Intent-To-Treat|185
7962614|NCT00377637|19600733|P1|STARTED|Induction Phase|Intent-To-Treat|185
7962615|NCT00377611|19600769|P2|NOT COMPLETED|Overall Study||33
7962616|NCT00377611|19600770|P1|NOT COMPLETED|Overall Study||22
7962617|NCT00377611|19600769|P2|COMPLETED|Overall Study||1974
7962618|NCT00377611|19600770|P1|COMPLETED|Overall Study||1025
7962619|NCT00377611|19600769|P2|STARTED|Overall Study||2007
7962620|NCT00377611|19600770|P1|STARTED|Overall Study||1047
7962621|NCT00377572|19600833|P2|NOT COMPLETED|Overall Study||54
7962622|NCT00377572|19600834|P1|NOT COMPLETED|Overall Study||53
7962623|NCT00377572|19600833|P2|COMPLETED|Overall Study||157
7962624|NCT00377572|19600834|P1|COMPLETED|Overall Study||155
7962625|NCT00377572|19600833|P2|STARTED|Overall Study||211
7962626|NCT00377572|19600834|P1|STARTED|Overall Study||208
7962627|NCT00377520|19600872|P1|NOT COMPLETED|Overall Study||1
7962628|NCT00377520|19600872|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26
7962629|NCT00377520|19600872|P1|STARTED|Overall Study||27
7962630|NCT00377455|19600877|P1|NOT COMPLETED|Overall Study||1
7962631|NCT00377455|19600877|P1|COMPLETED|Overall Study||4
7962632|NCT00377455|19600877|P1|STARTED|Overall Study||5
7962633|NCT00377429|19600885|P1|NOT COMPLETED|Overall Study||15
7962634|NCT00377429|19600885|P1|COMPLETED|Overall Study|Completed main study|32
7962635|NCT00377429|19600885|P1|STARTED|Overall Study|Treated|47
7962636|NCT00377403|19600896|P2|NOT COMPLETED|Overall Study||7
7962637|NCT00377403|19600897|P1|NOT COMPLETED|Overall Study||4
7962638|NCT00377403|19600896|P2|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74
7962639|NCT00377403|19600897|P1|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81
7962640|NCT00377403|19600896|P2|Day 28 Assessment|Overall Study||77
7962641|NCT00377403|19600897|P1|Day 28 Assessment|Overall Study||82
7962642|NCT00377403|19600896|P2|Day 10 Assessment|Overall Study||71
7962643|NCT00377403|19600897|P1|Day 10 Assessment|Overall Study||81
7962644|NCT00377403|19600896|P2|Day 7 Assessment|Overall Study||75
7962645|NCT00377403|19600897|P1|Day 7 Assessment|Overall Study||80
7962646|NCT00377403|19600896|P2|Day -3 Assessment|Overall Study||74
7962647|NCT00377403|19600897|P1|Day -3 Assessment|Overall Study||81
7962648|NCT00377403|19600896|P2|STARTED|Overall Study||81
7962649|NCT00377403|19600897|P1|STARTED|Overall Study||85
7962650|NCT00377364|19600905|P2|NOT COMPLETED|Overall Study||0
7962651|NCT00377364|19600906|P1|NOT COMPLETED|Overall Study||2
7962652|NCT00377364|19600905|P2|COMPLETED|Overall Study||14
7962653|NCT00377364|19600906|P1|COMPLETED|Overall Study||14
7962654|NCT00377364|19600905|P2|STARTED|Overall Study||14
7962655|NCT00377364|19600906|P1|STARTED|Overall Study||16
7962656|NCT00377312|19600932|P2|NOT COMPLETED|Overall Study||1
7962657|NCT00377312|19600933|P1|NOT COMPLETED|Overall Study||1
7962658|NCT00377312|19600932|P2|COMPLETED|Overall Study||4
7962659|NCT00377312|19600933|P1|COMPLETED|Overall Study||5
7962660|NCT00377312|19600932|P2|STARTED|Overall Study||5
7962661|NCT00377312|19600933|P1|STARTED|Overall Study||6
7962662|NCT00377299|19600965|P2|NOT COMPLETED|Overall Study||24
7962663|NCT00377299|19600966|P1|NOT COMPLETED|Overall Study||19
7962664|NCT00377299|19600965|P2|COMPLETED|Overall Study||4
7962665|NCT00377299|19600966|P1|COMPLETED|Overall Study||13
7962666|NCT00377299|19600965|P2|STARTED|Overall Study||28
7962667|NCT00377299|19600966|P1|STARTED|Overall Study||32
7962668|NCT00377260|19600982|P2|NOT COMPLETED|Overall Study||5
7962669|NCT00377260|19600983|P1|NOT COMPLETED|Overall Study||2
7962670|NCT00377260|19600982|P2|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
7962671|NCT00377260|19600983|P1|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
7962672|NCT00377260|19600982|P2|STARTED|Overall Study||147
7962673|NCT00377260|19600983|P1|STARTED|Overall Study||144
7962674|NCT00377234|19601037|P2|NOT COMPLETED|Overall Study||31
7962675|NCT00377234|19601038|P1|NOT COMPLETED|Overall Study||34
7962676|NCT00377234|19601037|P2|COMPLETED|Overall Study||145
7962677|NCT00377234|19601038|P1|COMPLETED|Overall Study||146
7962678|NCT00377234|19601037|P2|Safety Analysis Set: Risedronate|Overall Study||174
7962679|NCT00377234|19601038|P1|Safety Analysis Set: Risedronate|Overall Study||153
7962680|NCT00377234|19601037|P2|Safety Analysis Set: Ibandronate|Overall Study||150
7962681|NCT00377234|19601038|P1|Safety Analysis Set: Ibandronate|Overall Study||177
7962682|NCT00377234|19601037|P2|Safety Analysis Set: Period 2|Overall Study||150
7962683|NCT00377234|19601038|P1|Safety Analysis Set: Period 2|Overall Study||153
7962684|NCT00377234|19601037|P2|Safety Analysis Set: Period 1|Overall Study||174
7962685|NCT00377234|19601038|P1|Safety Analysis Set: Period 1|Overall Study||177
7962686|NCT00377234|19601037|P2|Received Treatment|Overall Study||174
7962687|NCT00377234|19601038|P1|Received Treatment|Overall Study||177
7962688|NCT00377234|19601037|P2|Did Not Receive Study Treatment|Overall Study||2
7962689|NCT00377234|19601038|P1|Did Not Receive Study Treatment|Overall Study||3
7962690|NCT00377234|19601037|P2|Randomized|Overall Study||176
7962691|NCT00377234|19601038|P1|Randomized|Overall Study||180
7962692|NCT00377234|19601037|P2|STARTED|Overall Study||176
7962693|NCT00377234|19601038|P1|STARTED|Overall Study||180
7962694|NCT00377156|19601056|P2|NOT COMPLETED|Overall Study||54
7962695|NCT00377156|19601057|P1|NOT COMPLETED|Overall Study||48
7962696|NCT00377156|19601056|P2|COMPLETED|Overall Study||48
7962697|NCT00377156|19601057|P1|COMPLETED|Overall Study||63
7962698|NCT00377156|19601056|P2|STARTED|Overall Study||102
7962699|NCT00377156|19601057|P1|STARTED|Overall Study||111
7962700|NCT00376961|19601071|P2|NOT COMPLETED|Maintenance||23
7962701|NCT00376961|19601072|P1|NOT COMPLETED|Maintenance||0
7962702|NCT00376961|19601071|P2|COMPLETED|Maintenance||27
7962703|NCT00376961|19601072|P1|COMPLETED|Maintenance||0
7962704|NCT00376961|19601071|P2|Eligible|Maintenance||47
7962705|NCT00376961|19601072|P1|Eligible|Maintenance||0
7962706|NCT00376961|19601071|P2|STARTED|Maintenance||50
7962707|NCT00376961|19601072|P1|STARTED|Maintenance||0
7962708|NCT00376961|19601071|P2|NOT COMPLETED|Initial Registration||0
7962709|NCT00376961|19601072|P1|NOT COMPLETED|Initial Registration||7
7962710|NCT00376961|19601071|P2|COMPLETED|Initial Registration||0
7962711|NCT00376961|19601072|P1|COMPLETED|Initial Registration||61
7962712|NCT00376961|19601071|P2|Eligible|Initial Registration||0
7962713|NCT00376961|19601072|P1|Eligible|Initial Registration||65
7962714|NCT00376961|19601071|P2|STARTED|Initial Registration||0
7962715|NCT00376961|19601072|P1|STARTED|Initial Registration||68
7962716|NCT00376948|19601081|P1|NOT COMPLETED|Overall Study||0
7962717|NCT00376948|19601081|P1|COMPLETED|Overall Study||20
7962718|NCT00376948|19601081|P1|STARTED|Overall Study||20
7962719|NCT00376935|19601090|P4|NOT COMPLETED|Overall Study||0
7962720|NCT00376935|19601091|P3|NOT COMPLETED|Overall Study||0
7962721|NCT00376935|19601092|P2|NOT COMPLETED|Overall Study||0
7962722|NCT00376935|19601093|P1|NOT COMPLETED|Overall Study||0
7962723|NCT00376935|19601090|P4|COMPLETED|Overall Study||24
7962724|NCT00376935|19601091|P3|COMPLETED|Overall Study||25
7962725|NCT00376935|19601092|P2|COMPLETED|Overall Study||25
7962726|NCT00376935|19601093|P1|COMPLETED|Overall Study||25
7962727|NCT00376935|19601090|P4|STARTED|Overall Study||24
7962728|NCT00376935|19601091|P3|STARTED|Overall Study||25
7962729|NCT00376935|19601092|P2|STARTED|Overall Study||25
7962730|NCT00376935|19601093|P1|STARTED|Overall Study||25
7962731|NCT00376805|19601131|P1|NOT COMPLETED|Overall Study||0
7962732|NCT00376805|19601131|P1|COMPLETED|Overall Study||6
7962733|NCT00376805|19601131|P1|STARTED|Overall Study||6
7962734|NCT00376688|19601138|P1|NOT COMPLETED|Overall Study||4
7962735|NCT00376688|19601138|P1|COMPLETED|Overall Study||27
7962736|NCT00376688|19601138|P1|STARTED|Overall Study||31
7962737|NCT00376675|19601144|P2|NOT COMPLETED|Overall Study||14
7962738|NCT00376675|19601145|P1|NOT COMPLETED|Overall Study||20
7962739|NCT00376675|19601144|P2|COMPLETED|Overall Study||56
7962740|NCT00376675|19601145|P1|COMPLETED|Overall Study||49
7962741|NCT00376675|19601144|P2|STARTED|Overall Study||70
7962742|NCT00376675|19601145|P1|STARTED|Overall Study||69
7962743|NCT00376597|19601169|P2|NOT COMPLETED|Overall Study||3
7962744|NCT00376597|19601170|P1|NOT COMPLETED|Overall Study||11
7962745|NCT00376597|19601169|P2|COMPLETED|Overall Study||312
7962746|NCT00376597|19601170|P1|COMPLETED|Overall Study||242
7962747|NCT00376597|19601169|P2|STARTED|Overall Study||315
7962748|NCT00376597|19601170|P1|STARTED|Overall Study||253
7962749|NCT00376558|19601184|P2|NOT COMPLETED|Overall Study||0
7962750|NCT00376558|19601185|P1|NOT COMPLETED|Overall Study||0
7962751|NCT00376558|19601184|P2|COMPLETED|Overall Study||25
7962752|NCT00376558|19601185|P1|COMPLETED|Overall Study||25
7962753|NCT00376558|19601184|P2|STARTED|Overall Study||25
7962754|NCT00376558|19601185|P1|STARTED|Overall Study||25
7962755|NCT00376532|19601194|P2|NOT COMPLETED|Overall Study||6
7962756|NCT00376532|19601195|P1|NOT COMPLETED|Overall Study||6
7962757|NCT00376532|19601194|P2|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26
7962758|NCT00376532|19601195|P1|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25
7962759|NCT00376532|19601194|P2|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32
7962760|NCT00376532|19601195|P1|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31
7962761|NCT00376506|19601205|P2|NOT COMPLETED|Overall Study||2
7962762|NCT00376506|19601206|P1|NOT COMPLETED|Overall Study||0
7962763|NCT00376506|19601205|P2|COMPLETED|Overall Study||4
7962764|NCT00376506|19601206|P1|COMPLETED|Overall Study||4
7962765|NCT00376506|19601205|P2|STARTED|Overall Study||6
7962766|NCT00376506|19601206|P1|STARTED|Overall Study||4
7962767|NCT00376363|19601224|P2|NOT COMPLETED|Overall Study||46
7962768|NCT00376363|19601225|P1|NOT COMPLETED|Overall Study||56
7962769|NCT00376363|19601224|P2|COMPLETED|Overall Study||87
7962770|NCT00376363|19601225|P1|COMPLETED|Overall Study||87
7962771|NCT00376363|19601224|P2|STARTED|Overall Study||133
7962772|NCT00376363|19601225|P1|STARTED|Overall Study||143
7962773|NCT00376259|19601237|P2|NOT COMPLETED|Overall Study||21
7962774|NCT00376259|19601238|P1|NOT COMPLETED|Overall Study||22
7962775|NCT00376259|19601237|P2|COMPLETED|Overall Study||0
7962776|NCT00376259|19601238|P1|COMPLETED|Overall Study||0
7962777|NCT00376259|19601237|P2|Received Study Drug|Overall Study||21
7962778|NCT00376259|19601238|P1|Received Study Drug|Overall Study||21
7962779|NCT00376259|19601237|P2|STARTED|Overall Study||21
7962780|NCT00376259|19601238|P1|STARTED|Overall Study||22
7962781|NCT00376246|19601250|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
7962782|NCT00376246|19601251|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
7962783|NCT00376246|19601250|P2|COMPLETED|Second Intervention (2 Weeks)||12
7962784|NCT00376246|19601251|P1|COMPLETED|Second Intervention (2 Weeks)||10
7962785|NCT00376246|19601250|P2|STARTED|Second Intervention (2 Weeks)||12
7962786|NCT00376246|19601251|P1|STARTED|Second Intervention (2 Weeks)||10
7962787|NCT00376246|19601250|P2|NOT COMPLETED|Washout (2 Weeks)||0
7962788|NCT00376246|19601251|P1|NOT COMPLETED|Washout (2 Weeks)||0
7962789|NCT00376246|19601250|P2|COMPLETED|Washout (2 Weeks)||12
7962790|NCT00376246|19601251|P1|COMPLETED|Washout (2 Weeks)||10
7962791|NCT00376246|19601250|P2|STARTED|Washout (2 Weeks)||12
7962792|NCT00376246|19601251|P1|STARTED|Washout (2 Weeks)||10
7962793|NCT00376246|19601250|P2|NOT COMPLETED|First Intervention (2 Weeks)||2
7962794|NCT00376246|19601251|P1|NOT COMPLETED|First Intervention (2 Weeks)||4
7962795|NCT00376246|19601250|P2|COMPLETED|First Intervention (2 Weeks)||12
7962796|NCT00376246|19601251|P1|COMPLETED|First Intervention (2 Weeks)||10
7962797|NCT00376246|19601250|P2|STARTED|First Intervention (2 Weeks)||14
7962798|NCT00376246|19601251|P1|STARTED|First Intervention (2 Weeks)||14
7962799|NCT00376220|19601261|P2|NOT COMPLETED|Overall Study||12
7962800|NCT00376220|19601262|P1|NOT COMPLETED|Overall Study||10
7962801|NCT00376220|19601261|P2|COMPLETED|Overall Study||35
7962802|NCT00376220|19601262|P1|COMPLETED|Overall Study||37
7962803|NCT00376220|19601261|P2|STARTED|Overall Study||47
7962804|NCT00376220|19601262|P1|STARTED|Overall Study||47
7962805|NCT00376168|19601270|P2|NOT COMPLETED|Overall Study||1
7962806|NCT00376168|19601271|P1|NOT COMPLETED|Overall Study||2
7962807|NCT00376168|19601270|P2|COMPLETED|Overall Study||15
7962808|NCT00376168|19601271|P1|COMPLETED|Overall Study||14
7962809|NCT00376168|19601270|P2|STARTED|Overall Study|One patient randomized but not treated|16
7962810|NCT00376168|19601271|P1|STARTED|Overall Study||16
7962811|NCT00375999|19601285|P1|NOT COMPLETED|Overall Study||2
7962812|NCT00375999|19601285|P1|COMPLETED|Overall Study||32
7962813|NCT00375999|19601285|P1|STARTED|Overall Study||34
7962814|NCT00375973|19601291|P2|NOT COMPLETED|Overall Study||2
7962815|NCT00375973|19601292|P1|NOT COMPLETED|Overall Study||10
7962816|NCT00375973|19601291|P2|COMPLETED|Overall Study||28
7962817|NCT00375973|19601292|P1|COMPLETED|Overall Study||20
7962818|NCT00375973|19601291|P2|STARTED|Overall Study||30
7962819|NCT00375973|19601292|P1|STARTED|Overall Study||30
7962820|NCT00375934|19601312|P2|NOT COMPLETED|Overall Study||6
7962821|NCT00375934|19601313|P1|NOT COMPLETED|Overall Study||3
7962822|NCT00375934|19601312|P2|COMPLETED|Overall Study||95
7962823|NCT00375934|19601313|P1|COMPLETED|Overall Study||96
7962824|NCT00375934|19601312|P2|STARTED|Overall Study||101
7962825|NCT00375934|19601313|P1|STARTED|Overall Study||99
7962826|NCT00375830|19601342|P3|NOT COMPLETED|Overall Study||0
7962827|NCT00375830|19601343|P2|NOT COMPLETED|Overall Study||0
7962828|NCT00375830|19601344|P1|NOT COMPLETED|Overall Study||0
7962829|NCT00375830|19601342|P3|COMPLETED|Overall Study||74
7962830|NCT00375830|19601343|P2|COMPLETED|Overall Study||30
7962831|NCT00375830|19601344|P1|COMPLETED|Overall Study||10
7962832|NCT00375830|19601342|P3|STARTED|Overall Study||74
7962833|NCT00375830|19601343|P2|STARTED|Overall Study||30
7962834|NCT00375830|19601344|P1|STARTED|Overall Study||10
7962835|NCT00375752|19601371|P2|NOT COMPLETED|Overall Study||15
7962836|NCT00375752|19601372|P1|NOT COMPLETED|Overall Study||12
7962837|NCT00375752|19601371|P2|COMPLETED|Overall Study||74
7962838|NCT00375752|19601372|P1|COMPLETED|Overall Study||67
7962839|NCT00375752|19601371|P2|STARTED|Overall Study||89
7962840|NCT00375752|19601372|P1|STARTED|Overall Study||79
7962841|NCT00375713|19601388|P2|NOT COMPLETED|Overall Study||23
7962842|NCT00375713|19601389|P1|NOT COMPLETED|Overall Study||20
7962843|NCT00375713|19601388|P2|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211
7962844|NCT00375713|19601389|P1|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212
7962845|NCT00375713|19601388|P2|STARTED|Overall Study|Randomized population (N=234).|234
7962846|NCT00375713|19601389|P1|STARTED|Overall Study|Randomized population (N=232).|232
7962847|NCT00375674|19601403|P2|NOT COMPLETED|Overall Study||141
7962848|NCT00375674|19601404|P1|NOT COMPLETED|Overall Study||144
7962849|NCT00375674|19601403|P2|COMPLETED|Overall Study||165
7962850|NCT00375674|19601404|P1|COMPLETED|Overall Study||165
7962851|NCT00375674|19601403|P2|As-Treated Population|Overall Study|2 were randomized but not treated: 1 was screening failure & 1 discontinued due to new liver lesions|304
7962852|NCT00375674|19601404|P1|As-Treated Population|Overall Study|3 were randomized but not treated: 2 refused treatment & 1 withdrew before receiving study drug|306
7962853|NCT00375674|19601403|P2|Intent-to-Treat Population|Overall Study||306
7962854|NCT00375674|19601404|P1|Intent-to-Treat Population|Overall Study||309
7962855|NCT00375674|19601403|P2|STARTED|Overall Study||306
7962856|NCT00375674|19601404|P1|STARTED|Overall Study||309
7962857|NCT00375609|19601433|P3|NOT COMPLETED|Overall Study||1
7962858|NCT00375609|19601434|P2|NOT COMPLETED|Overall Study||7
7962859|NCT00375609|19601435|P1|NOT COMPLETED|Overall Study||4
7962860|NCT00375609|19601433|P3|COMPLETED|Overall Study||42
7962861|NCT00375609|19601434|P2|COMPLETED|Overall Study||77
7962862|NCT00375609|19601435|P1|COMPLETED|Overall Study||84
7962863|NCT00375609|19601433|P3|STARTED|Overall Study||43
7962864|NCT00375609|19601434|P2|STARTED|Overall Study||84
7962865|NCT00375609|19601435|P1|STARTED|Overall Study||88
7962866|NCT00375518|19601451|P2|NOT COMPLETED|Overall Study||17
7962867|NCT00375518|19601452|P1|NOT COMPLETED|Overall Study||8
7962868|NCT00375518|19601451|P2|COMPLETED|Overall Study||65
7962869|NCT00375518|19601452|P1|COMPLETED|Overall Study||72
7962870|NCT00375518|19601451|P2|STARTED|Overall Study||82
7962871|NCT00375518|19601452|P1|STARTED|Overall Study||80
7962872|NCT00375505|19601460|P2|NOT COMPLETED|Overall Study||2
7962873|NCT00375505|19601461|P1|NOT COMPLETED|Overall Study||1
7962874|NCT00375505|19601460|P2|COMPLETED|Overall Study||32
7962875|NCT00375505|19601461|P1|COMPLETED|Overall Study||35
7962876|NCT00375505|19601460|P2|STARTED|Overall Study||34
7962877|NCT00375505|19601461|P1|STARTED|Overall Study||36
7962878|NCT00375492|19601505|P2|NOT COMPLETED|Overall Study||26
7962879|NCT00375492|19601506|P1|NOT COMPLETED|Overall Study||26
7962880|NCT00375492|19601505|P2|COMPLETED|Overall Study||72
7962881|NCT00375492|19601506|P1|COMPLETED|Overall Study||70
7962882|NCT00375492|19601505|P2|STARTED|Overall Study||98
7962883|NCT00375492|19601506|P1|STARTED|Overall Study||96
7962884|NCT00375427|19601536|P2|NOT COMPLETED|Overall Study||74
7962885|NCT00375427|19601537|P1|NOT COMPLETED|Overall Study||60
7962886|NCT00375427|19601536|P2|COMPLETED|Overall Study||142
7962887|NCT00375427|19601537|P1|COMPLETED|Overall Study||149
7962888|NCT00375427|19601536|P2|STARTED|Overall Study||216
7962889|NCT00375427|19601537|P1|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209
7962890|NCT00375219|19601562|P3|NOT COMPLETED|Overall Study||21
7962891|NCT00375219|19601563|P2|NOT COMPLETED|Overall Study||20
7962892|NCT00375219|19601564|P1|NOT COMPLETED|Overall Study||59
7962893|NCT00375219|19601562|P3|COMPLETED|Overall Study||0
7962894|NCT00375219|19601563|P2|COMPLETED|Overall Study||0
7962895|NCT00375219|19601564|P1|COMPLETED|Overall Study||3
7962896|NCT00375219|19601562|P3|STARTED|Overall Study||21
7962897|NCT00375219|19601563|P2|STARTED|Overall Study||20
7962898|NCT00375219|19601564|P1|STARTED|Overall Study||62
7962899|NCT00375167|19601632|P2|NOT COMPLETED|Overall Study||0
7962900|NCT00375167|19601633|P1|NOT COMPLETED|Overall Study||0
7962901|NCT00375167|19601632|P2|COMPLETED|Overall Study||17
7962902|NCT00375167|19601633|P1|COMPLETED|Overall Study||16
7962903|NCT00375167|19601632|P2|STARTED|Overall Study|Participants were already clients of ACT and continued receiving services following this period|17
7962904|NCT00375167|19601633|P1|STARTED|Overall Study|Clients were already receiving ACT services and this continued after study completion|16
7962905|NCT00374907|19601647|P2|NOT COMPLETED|116-Week Short-term + Long-term Period||14
7962906|NCT00374907|19601648|P1|NOT COMPLETED|116-Week Short-term + Long-term Period||13
7962907|NCT00374907|19601647|P2|COMPLETED|116-Week Short-term + Long-term Period||2
7962908|NCT00374907|19601648|P1|COMPLETED|116-Week Short-term + Long-term Period||7
7962909|NCT00374907|19601647|P2|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15
7962910|NCT00374907|19601648|P1|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17
7962911|NCT00374907|19601647|P2|STARTED|116-Week Short-term + Long-term Period||16
7962912|NCT00374907|19601648|P1|STARTED|116-Week Short-term + Long-term Period||20
7962913|NCT00374907|19601647|P2|NOT COMPLETED|12-Week Short-term Period||1
7962914|NCT00374907|19601648|P1|NOT COMPLETED|12-Week Short-term Period||3
7962915|NCT00374907|19601647|P2|COMPLETED|12-Week Short-term Period||15
7962916|NCT00374907|19601648|P1|COMPLETED|12-Week Short-term Period||17
7962917|NCT00374907|19601647|P2|STARTED|12-Week Short-term Period||16
7962918|NCT00374907|19601648|P1|STARTED|12-Week Short-term Period||20
7962919|NCT00374868|19601660|P1|NOT COMPLETED|Overall Study||36
7962920|NCT00374868|19601660|P1|COMPLETED|Overall Study||2
7962921|NCT00374868|19601660|P1|STARTED|Overall Study||38
7962922|NCT00374842|19601674|P3|NOT COMPLETED|Overall Study||0
7962923|NCT00374842|19601675|P2|NOT COMPLETED|Overall Study||0
7962924|NCT00374842|19601676|P1|NOT COMPLETED|Overall Study||0
7962925|NCT00374842|19601674|P3|COMPLETED|Overall Study||100
7962926|NCT00374842|19601675|P2|COMPLETED|Overall Study||100
7962927|NCT00374842|19601676|P1|COMPLETED|Overall Study||100
7962928|NCT00374842|19601674|P3|STARTED|Overall Study||100
7962929|NCT00374842|19601675|P2|STARTED|Overall Study||100
7962930|NCT00374842|19601676|P1|STARTED|Overall Study||100
7962931|NCT00374803|19601707|P2|NOT COMPLETED|Overall Study||0
7962932|NCT00374803|19601708|P1|NOT COMPLETED|Overall Study||0
7962933|NCT00374803|19601707|P2|COMPLETED|Overall Study||23
7962934|NCT00374803|19601708|P1|COMPLETED|Overall Study||22
7962935|NCT00374803|19601707|P2|STARTED|Overall Study||23
7962936|NCT00374803|19601708|P1|STARTED|Overall Study||22
7962937|NCT00374556|19601724|P2|NOT COMPLETED|Overall Study||1
7962938|NCT00374556|19601725|P1|NOT COMPLETED|Overall Study||1
7962939|NCT00374556|19601724|P2|COMPLETED|Overall Study||15
7962940|NCT00374556|19601725|P1|COMPLETED|Overall Study||13
7962941|NCT00374556|19601724|P2|STARTED|Overall Study||16
7962942|NCT00374556|19601725|P1|STARTED|Overall Study||14
7962943|NCT00374543|19601777|P2|NOT COMPLETED|Overall Study||0
7962944|NCT00374543|19601778|P1|NOT COMPLETED|Overall Study||0
7962945|NCT00374543|19601777|P2|COMPLETED|Overall Study||1
7962946|NCT00374543|19601778|P1|COMPLETED|Overall Study||2
7962947|NCT00374543|19601777|P2|STARTED|Overall Study||1
7962948|NCT00374543|19601778|P1|STARTED|Overall Study||2
7962949|NCT00374452|19601786|P2|NOT COMPLETED|Overall Study||5
7962950|NCT00374452|19601787|P1|NOT COMPLETED|Overall Study||5
7962951|NCT00374452|19601786|P2|COMPLETED|Overall Study||43
7962952|NCT00374452|19601787|P1|COMPLETED|Overall Study||29
7962953|NCT00374452|19601786|P2|Intervention Started|Overall Study||46
7962954|NCT00374452|19601787|P1|Intervention Started|Overall Study||30
7962955|NCT00374452|19601786|P2|STARTED|Overall Study||48
7962956|NCT00374452|19601787|P1|STARTED|Overall Study||34
7962957|NCT00374335|19601793|P1|NOT COMPLETED|Overall Study||0
7962958|NCT00374335|19601793|P1|COMPLETED|Overall Study||261
7962959|NCT00374335|19601793|P1|STARTED|Overall Study||261
7962960|NCT00374322|19601800|P2|NOT COMPLETED|Overall Study||1304
7962961|NCT00374322|19601801|P1|NOT COMPLETED|Overall Study||1257
7962962|NCT00374322|19601800|P2|COMPLETED|Overall Study||278
7962963|NCT00374322|19601801|P1|COMPLETED|Overall Study||322
7962964|NCT00374322|19601800|P2|Received >=1 Dose of Study Treatment|Overall Study||1576
7962965|NCT00374322|19601801|P1|Received >=1 Dose of Study Treatment|Overall Study||1571
7962966|NCT00374322|19601800|P2|STARTED|Overall Study||1582
7962967|NCT00374322|19601801|P1|STARTED|Overall Study||1579
7962968|NCT00374244|19601839|P2|NOT COMPLETED|Overall Study||0
7962969|NCT00374244|19601840|P1|NOT COMPLETED|Overall Study||0
7962970|NCT00374244|19601839|P2|COMPLETED|Overall Study||14
7962971|NCT00374244|19601840|P1|COMPLETED|Overall Study||14
7962972|NCT00374244|19601839|P2|STARTED|Overall Study||14
7962973|NCT00374244|19601840|P1|STARTED|Overall Study||14
7962974|NCT00374231|19601886|P1|NOT COMPLETED|Overall Study||0
7962975|NCT00374231|19601886|P1|COMPLETED|Overall Study||40
7962976|NCT00374231|19601886|P1|STARTED|Overall Study||40
7962977|NCT00374140|19601892|P1|NOT COMPLETED|Overall Study||2
7962978|NCT00374140|19601892|P1|COMPLETED|Overall Study||38
7962979|NCT00374140|19601892|P1|STARTED|Overall Study||40
7962980|NCT00374127|19601899|P1|NOT COMPLETED|Overall Study||11
7962981|NCT00374127|19601899|P1|COMPLETED|Overall Study||24
7962982|NCT00374127|19601899|P1|STARTED|Overall Study||35
7962983|NCT00374088|19601935|P2|NOT COMPLETED|Overall Study||1
7962984|NCT00374088|19601936|P1|NOT COMPLETED|Overall Study||1
7962985|NCT00374088|19601935|P2|COMPLETED|Overall Study||10
7962986|NCT00374088|19601936|P1|COMPLETED|Overall Study||9
7962987|NCT00374088|19601935|P2|STARTED|Overall Study||11
7962988|NCT00374088|19601936|P1|STARTED|Overall Study||10
7962989|NCT00373958|19601948|P2|NOT COMPLETED|Toddler Dose||38
7962990|NCT00373958|19601949|P1|NOT COMPLETED|Toddler Dose||30
7962991|NCT00373958|19601948|P2|COMPLETED|Toddler Dose||252
7962992|NCT00373958|19601949|P1|COMPLETED|Toddler Dose||264
7962993|NCT00373958|19601948|P2|Vaccinated Toddler Dose|Toddler Dose||265
7962994|NCT00373958|19601949|P1|Vaccinated Toddler Dose|Toddler Dose||272
7962995|NCT00373958|19601948|P2|Withdrawn After Infant Series|Toddler Dose||25
7962996|NCT00373958|19601949|P1|Withdrawn After Infant Series|Toddler Dose||22
7962997|NCT00373958|19601948|P2|STARTED|Toddler Dose||290
7962998|NCT00373958|19601949|P1|STARTED|Toddler Dose||294
7962999|NCT00373958|19601948|P2|NOT COMPLETED|Infant Series||42
7963000|NCT00373958|19601949|P1|NOT COMPLETED|Infant Series||40
7963001|NCT00373958|19601948|P2|COMPLETED|Infant Series||290
7963002|NCT00373958|19601949|P1|COMPLETED|Infant Series||294
7963003|NCT00373958|19601948|P2|Vaccinated Dose 3|Infant Series||300
7963004|NCT00373958|19601949|P1|Vaccinated Dose 3|Infant Series||298
7963005|NCT00373958|19601948|P2|Vaccinated Dose 2|Infant Series||305
7963006|NCT00373958|19601949|P1|Vaccinated Dose 2|Infant Series||309
7963007|NCT00373958|19601948|P2|Vaccinated Dose 1|Infant Series||331
7963008|NCT00373958|19601949|P1|Vaccinated Dose 1|Infant Series||332
7963009|NCT00373958|19601948|P2|STARTED|Infant Series||332
7963010|NCT00373958|19601949|P1|STARTED|Infant Series|One participant was prerandomized but not consented.|334
7963011|NCT00373880|19601997|P1|NOT COMPLETED|Overall Study||18
7963012|NCT00373880|19601997|P1|COMPLETED|Overall Study||8
7963013|NCT00373880|19601997|P1|STARTED|Overall Study||26
7963014|NCT00373698|19602027|P2|NOT COMPLETED|Overall Study||0
7963015|NCT00373698|19602028|P1|NOT COMPLETED|Overall Study||11
7963016|NCT00373698|19602027|P2|COMPLETED|Overall Study||99
7963017|NCT00373698|19602028|P1|COMPLETED|Overall Study||85
7963018|NCT00373698|19602027|P2|STARTED|Overall Study||99
7963019|NCT00373698|19602028|P1|STARTED|Overall Study||96
7963020|NCT00373685|19602042|P2|NOT COMPLETED|Overall Study||1421
7963021|NCT00373685|19602043|P1|NOT COMPLETED|Overall Study||1439
7963022|NCT00373685|19602042|P2|COMPLETED|Overall Study||2611
7963023|NCT00373685|19602043|P1|COMPLETED|Overall Study||2596
7963024|NCT00373685|19602042|P2|Treated|Overall Study||3955
7963025|NCT00373685|19602043|P1|Treated|Overall Study||3984
7963026|NCT00373685|19602042|P2|STARTED|Overall Study||4032
7963027|NCT00373685|19602043|P1|STARTED|Overall Study||4035
7963028|NCT00373529|19602077|P1|NOT COMPLETED|Overall Study||108
7963029|NCT00373529|19602077|P1|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8
7963030|NCT00373529|19602077|P1|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112
7963031|NCT00373529|19602077|P1|STARTED|Overall Study||116
7963032|NCT00373490|19602089|P2|NOT COMPLETED|Overall Study||6
7963033|NCT00373490|19602090|P1|NOT COMPLETED|Overall Study||9
7963034|NCT00373490|19602089|P2|COMPLETED|Overall Study||0
7963035|NCT00373490|19602090|P1|COMPLETED|Overall Study||1
7963036|NCT00373490|19602089|P2|STARTED|Overall Study||6
7963037|NCT00373490|19602090|P1|STARTED|Overall Study||10
7963038|NCT00373425|19602113|P5|NOT COMPLETED|Overall Study||72
7963039|NCT00373425|19602114|P4|NOT COMPLETED|Overall Study||11
7963040|NCT00373425|19602115|P3|NOT COMPLETED|Overall Study||134
7963041|NCT00373425|19602116|P2|NOT COMPLETED|Overall Study||153
7963042|NCT00373425|19602117|P1|NOT COMPLETED|Overall Study||370
7963043|NCT00373425|19602113|P5|COMPLETED|Overall Study|Completed 2 years of study treatment|60
7963044|NCT00373425|19602114|P4|COMPLETED|Overall Study|Completed 2 years of study treatment|0
7963045|NCT00373425|19602115|P3|COMPLETED|Overall Study|Completed 2 years of study treatment|0
7963046|NCT00373425|19602116|P2|COMPLETED|Overall Study|Completed 2 years of study treatment|197
7963047|NCT00373425|19602117|P1|COMPLETED|Overall Study|Completed 2 years of study treatment|253
7963048|NCT00373425|19602113|P5|Received Treatment|Overall Study||132
7963049|NCT00373425|19602114|P4|Received Treatment|Overall Study||7
7963050|NCT00373425|19602115|P3|Received Treatment|Overall Study||134
7963051|NCT00373425|19602116|P2|Received Treatment|Overall Study||342
7963052|NCT00373425|19602117|P1|Received Treatment|Overall Study||612
7963053|NCT00373425|19602113|P5|STARTED|Overall Study||132
7963054|NCT00373425|19602114|P4|STARTED|Overall Study||11
7963055|NCT00373425|19602115|P3|STARTED|Overall Study||134
7963056|NCT00373425|19602116|P2|STARTED|Overall Study||350
7963057|NCT00373425|19602117|P1|STARTED|Overall Study||623
7963058|NCT00373399|19602142|P6|NOT COMPLETED|Overall Study||0
7963059|NCT00373399|19602143|P5|NOT COMPLETED|Overall Study||0
7963060|NCT00373399|19602144|P4|NOT COMPLETED|Overall Study||0
7963061|NCT00373399|19602145|P3|NOT COMPLETED|Overall Study||0
7963062|NCT00373399|19602146|P2|NOT COMPLETED|Overall Study||0
7963063|NCT00373399|19602147|P1|NOT COMPLETED|Overall Study||0
7963064|NCT00373399|19602142|P6|COMPLETED|Overall Study||7
7963065|NCT00373399|19602143|P5|COMPLETED|Overall Study||7
7963066|NCT00373399|19602144|P4|COMPLETED|Overall Study||6
7963067|NCT00373399|19602145|P3|COMPLETED|Overall Study||4
7963068|NCT00373399|19602146|P2|COMPLETED|Overall Study||7
7963069|NCT00373399|19602147|P1|COMPLETED|Overall Study||5
7963070|NCT00373399|19602142|P6|STARTED|Overall Study||7
7963071|NCT00373399|19602143|P5|STARTED|Overall Study||7
7963072|NCT00373399|19602144|P4|STARTED|Overall Study||6
7963073|NCT00373399|19602145|P3|STARTED|Overall Study||4
7963074|NCT00373399|19602146|P2|STARTED|Overall Study||7
7963075|NCT00373399|19602147|P1|STARTED|Overall Study||5
7963076|NCT00373386|19602155|P1|NOT COMPLETED|Overall Study||0
7963077|NCT00373386|19602155|P1|COMPLETED|Overall Study||9
7963078|NCT00373386|19602155|P1|STARTED|Overall Study||9
7963079|NCT00373360|19602165|P1|NOT COMPLETED|Overall Study||0
7963080|NCT00373360|19602165|P1|COMPLETED|Overall Study||10
7963081|NCT00373360|19602165|P1|STARTED|Overall Study||10
7963082|NCT00373334|19602196|P3|NOT COMPLETED|Overall Study||13
7963083|NCT00373334|19602197|P2|NOT COMPLETED|Overall Study||18
7963084|NCT00373334|19602198|P1|NOT COMPLETED|Overall Study||10
7963085|NCT00373334|19602196|P3|COMPLETED|Overall Study||32
7963086|NCT00373334|19602197|P2|COMPLETED|Overall Study||32
7963087|NCT00373334|19602198|P1|COMPLETED|Overall Study||33
7963088|NCT00373334|19602196|P3|STARTED|Overall Study||45
7963089|NCT00373334|19602197|P2|STARTED|Overall Study||50
7963090|NCT00373334|19602198|P1|STARTED|Overall Study||43
7963091|NCT00373295|19602212|P6|NOT COMPLETED|Intervention 3 (8 Days)||0
7963092|NCT00373295|19602213|P5|NOT COMPLETED|Intervention 3 (8 Days)||0
7963093|NCT00373295|19602214|P4|NOT COMPLETED|Intervention 3 (8 Days)||0
7963094|NCT00373295|19602215|P3|NOT COMPLETED|Intervention 3 (8 Days)||0
7963095|NCT00373295|19602216|P2|NOT COMPLETED|Intervention 3 (8 Days)||0
7963096|NCT00373295|19602217|P1|NOT COMPLETED|Intervention 3 (8 Days)||0
7963097|NCT00373295|19602212|P6|COMPLETED|Intervention 3 (8 Days)||2
7963098|NCT00373295|19602213|P5|COMPLETED|Intervention 3 (8 Days)||2
7963099|NCT00373295|19602214|P4|COMPLETED|Intervention 3 (8 Days)||2
7963100|NCT00373295|19602215|P3|COMPLETED|Intervention 3 (8 Days)||1
7963101|NCT00373295|19602216|P2|COMPLETED|Intervention 3 (8 Days)||1
7963102|NCT00373295|19602217|P1|COMPLETED|Intervention 3 (8 Days)||2
7963103|NCT00373295|19602212|P6|STARTED|Intervention 3 (8 Days)||2
7963104|NCT00373295|19602213|P5|STARTED|Intervention 3 (8 Days)||2
7963105|NCT00373295|19602214|P4|STARTED|Intervention 3 (8 Days)||2
7963106|NCT00373295|19602215|P3|STARTED|Intervention 3 (8 Days)||1
7963107|NCT00373295|19602216|P2|STARTED|Intervention 3 (8 Days)||1
7963108|NCT00373295|19602217|P1|STARTED|Intervention 3 (8 Days)||2
7963109|NCT00373295|19602212|P6|NOT COMPLETED|Intervention 2 (8 Days)||0
7963110|NCT00373295|19602213|P5|NOT COMPLETED|Intervention 2 (8 Days)||0
7963111|NCT00373295|19602214|P4|NOT COMPLETED|Intervention 2 (8 Days)||0
7963112|NCT00373295|19602215|P3|NOT COMPLETED|Intervention 2 (8 Days)||0
7963113|NCT00373295|19602216|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
7963114|NCT00373295|19602217|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
7963115|NCT00373295|19602212|P6|COMPLETED|Intervention 2 (8 Days)||2
7963116|NCT00373295|19602213|P5|COMPLETED|Intervention 2 (8 Days)||2
7963117|NCT00373295|19602214|P4|COMPLETED|Intervention 2 (8 Days)||2
7963118|NCT00373295|19602215|P3|COMPLETED|Intervention 2 (8 Days)||1
7963119|NCT00373295|19602216|P2|COMPLETED|Intervention 2 (8 Days)||1
7963120|NCT00373295|19602217|P1|COMPLETED|Intervention 2 (8 Days)||2
7963121|NCT00373295|19602212|P6|STARTED|Intervention 2 (8 Days)||2
7963122|NCT00373295|19602213|P5|STARTED|Intervention 2 (8 Days)||2
7963123|NCT00373295|19602214|P4|STARTED|Intervention 2 (8 Days)||2
7963124|NCT00373295|19602215|P3|STARTED|Intervention 2 (8 Days)||1
7963125|NCT00373295|19602216|P2|STARTED|Intervention 2 (8 Days)||1
7963126|NCT00373295|19602217|P1|STARTED|Intervention 2 (8 Days)||2
7963127|NCT00373295|19602212|P6|NOT COMPLETED|Intervention 1 (8 Days)||0
7963128|NCT00373295|19602213|P5|NOT COMPLETED|Intervention 1 (8 Days)||1
7963129|NCT00373295|19602214|P4|NOT COMPLETED|Intervention 1 (8 Days)||0
7963130|NCT00373295|19602215|P3|NOT COMPLETED|Intervention 1 (8 Days)||0
7963131|NCT00373295|19602216|P2|NOT COMPLETED|Intervention 1 (8 Days)||2
7963132|NCT00373295|19602217|P1|NOT COMPLETED|Intervention 1 (8 Days)||0
7963133|NCT00373295|19602212|P6|COMPLETED|Intervention 1 (8 Days)||2
7963134|NCT00373295|19602213|P5|COMPLETED|Intervention 1 (8 Days)||2
7963135|NCT00373295|19602214|P4|COMPLETED|Intervention 1 (8 Days)||2
7963136|NCT00373295|19602215|P3|COMPLETED|Intervention 1 (8 Days)||1
7963137|NCT00373295|19602216|P2|COMPLETED|Intervention 1 (8 Days)||1
7963138|NCT00373295|19602217|P1|COMPLETED|Intervention 1 (8 Days)||2
7963139|NCT00373295|19602212|P6|STARTED|Intervention 1 (8 Days)||2
7963140|NCT00373295|19602213|P5|STARTED|Intervention 1 (8 Days)||3
7963141|NCT00373295|19602214|P4|STARTED|Intervention 1 (8 Days)||2
7963142|NCT00373295|19602215|P3|STARTED|Intervention 1 (8 Days)||1
7963143|NCT00373295|19602216|P2|STARTED|Intervention 1 (8 Days)||3
7963144|NCT00373295|19602217|P1|STARTED|Intervention 1 (8 Days)||2
7963145|NCT00373269|19602227|P2|NOT COMPLETED|Overall Study||0
7963146|NCT00373269|19602228|P1|NOT COMPLETED|Overall Study||0
7963147|NCT00373269|19602227|P2|COMPLETED|Overall Study||10
7963148|NCT00373269|19602228|P1|COMPLETED|Overall Study||11
7963149|NCT00373269|19602227|P2|STARTED|Overall Study||10
7963150|NCT00373269|19602228|P1|STARTED|Overall Study||11
7963151|NCT00373256|19602238|P2|NOT COMPLETED|Overall Study||247
7963152|NCT00373256|19602239|P1|NOT COMPLETED|Overall Study||241
7963153|NCT00373256|19602238|P2|COMPLETED|Overall Study||0
7963154|NCT00373256|19602239|P1|COMPLETED|Overall Study||0
7963155|NCT00373256|19602238|P2|Treated|Overall Study||236
7963156|NCT00373256|19602239|P1|Treated|Overall Study||235
7963157|NCT00373256|19602238|P2|STARTED|Overall Study||247
7963158|NCT00373256|19602239|P1|STARTED|Overall Study||241
7963159|NCT00373113|19602265|P2|NOT COMPLETED|Overall Study||244
7963160|NCT00373113|19602266|P1|NOT COMPLETED|Overall Study||238
7963161|NCT00373113|19602265|P2|COMPLETED|Overall Study||0
7963162|NCT00373113|19602266|P1|COMPLETED|Overall Study||0
7963163|NCT00373113|19602265|P2|Received Treatment|Overall Study||240
7963164|NCT00373113|19602266|P1|Received Treatment|Overall Study||238
7963165|NCT00373113|19602265|P2|STARTED|Overall Study||244
7963166|NCT00373113|19602266|P1|STARTED|Overall Study||238
7963167|NCT00372996|19602288|P4|NOT COMPLETED|Overall Study||20
7963168|NCT00372996|19602289|P3|NOT COMPLETED|Overall Study||28
7963169|NCT00372996|19602290|P2|NOT COMPLETED|Overall Study||14
7963170|NCT00372996|19602291|P1|NOT COMPLETED|Overall Study||37
7963171|NCT00372996|19602288|P4|COMPLETED|Overall Study||23
7963172|NCT00372996|19602289|P3|COMPLETED|Overall Study||33
7963173|NCT00372996|19602290|P2|COMPLETED|Overall Study||22
7963174|NCT00372996|19602291|P1|COMPLETED|Overall Study||42
7963175|NCT00372996|19602288|P4|STARTED|Overall Study||43
7963176|NCT00372996|19602289|P3|STARTED|Overall Study||61
7963177|NCT00372996|19602290|P2|STARTED|Overall Study||36
7963178|NCT00372996|19602291|P1|STARTED|Overall Study||79
7963179|NCT00372970|19602317|P2|NOT COMPLETED|Overall Study||0
7963180|NCT00372970|19602318|P1|NOT COMPLETED|Overall Study||0
7963181|NCT00372970|19602317|P2|COMPLETED|Overall Study||16
7963182|NCT00372970|19602318|P1|COMPLETED|Overall Study||16
7963183|NCT00372970|19602317|P2|STARTED|Overall Study||16
7963184|NCT00372970|19602318|P1|STARTED|Overall Study||16
7963185|NCT00372957|19602327|P3|NOT COMPLETED|Overall Study||0
7963186|NCT00372957|19602328|P2|NOT COMPLETED|Overall Study||0
7963187|NCT00372957|19602329|P1|NOT COMPLETED|Overall Study||0
7963188|NCT00372957|19602327|P3|COMPLETED|Overall Study||10
7963189|NCT00372957|19602328|P2|COMPLETED|Overall Study||10
7963190|NCT00372957|19602329|P1|COMPLETED|Overall Study||10
7963191|NCT00372957|19602327|P3|STARTED|Overall Study||10
7963192|NCT00372957|19602328|P2|STARTED|Overall Study||10
7963193|NCT00372957|19602329|P1|STARTED|Overall Study||10
7963194|NCT00372905|19602376|P4|NOT COMPLETED|Follow up Until Relapse or Progression||3
7963195|NCT00372905|19602377|P3|NOT COMPLETED|Follow up Until Relapse or Progression||0
7963196|NCT00372905|19602378|P2|NOT COMPLETED|Follow up Until Relapse or Progression||1
7963197|NCT00372905|19602379|P1|NOT COMPLETED|Follow up Until Relapse or Progression||0
7963198|NCT00372905|19602376|P4|COMPLETED|Follow up Until Relapse or Progression||5
7963199|NCT00372905|19602377|P3|COMPLETED|Follow up Until Relapse or Progression||3
7963200|NCT00372905|19602378|P2|COMPLETED|Follow up Until Relapse or Progression||2
7963201|NCT00372905|19602379|P1|COMPLETED|Follow up Until Relapse or Progression||3
7963202|NCT00372905|19602376|P4|STARTED|Follow up Until Relapse or Progression||8
7963203|NCT00372905|19602377|P3|STARTED|Follow up Until Relapse or Progression||3
7963204|NCT00372905|19602378|P2|STARTED|Follow up Until Relapse or Progression||3
7963205|NCT00372905|19602379|P1|STARTED|Follow up Until Relapse or Progression|All patients that are treated on study move into the follow up phase at the completion of therapy.|3
7963206|NCT00372905|19602376|P4|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||2
7963207|NCT00372905|19602377|P3|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
7963208|NCT00372905|19602378|P2|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
7963209|NCT00372905|19602379|P1|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
7963210|NCT00372905|19602376|P4|COMPLETED|Expansion Phase at Dose 1.3mg/m2||6
7963211|NCT00372905|19602377|P3|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
7963212|NCT00372905|19602378|P2|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
7963213|NCT00372905|19602379|P1|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
7963214|NCT00372905|19602376|P4|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||6
7963215|NCT00372905|19602377|P3|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
7963216|NCT00372905|19602378|P2|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
7963217|NCT00372905|19602379|P1|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
7963218|NCT00372905|19602376|P4|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||8
7963219|NCT00372905|19602377|P3|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
7963220|NCT00372905|19602378|P2|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
7963221|NCT00372905|19602379|P1|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
7963222|NCT00372905|19602376|P4|Registration|Expansion Phase at Dose 1.3mg/m2||8
7963223|NCT00372905|19602377|P3|Registration|Expansion Phase at Dose 1.3mg/m2||0
7963224|NCT00372905|19602378|P2|Registration|Expansion Phase at Dose 1.3mg/m2||0
7963225|NCT00372905|19602379|P1|Registration|Expansion Phase at Dose 1.3mg/m2||0
7963226|NCT00372905|19602376|P4|STARTED|Expansion Phase at Dose 1.3mg/m2||8
7963227|NCT00372905|19602377|P3|STARTED|Expansion Phase at Dose 1.3mg/m2||0
7963228|NCT00372905|19602378|P2|STARTED|Expansion Phase at Dose 1.3mg/m2||0
7963229|NCT00372905|19602379|P1|STARTED|Expansion Phase at Dose 1.3mg/m2||0
7963230|NCT00372905|19602376|P4|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
7963231|NCT00372905|19602377|P3|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||3
7963232|NCT00372905|19602378|P2|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
7963233|NCT00372905|19602379|P1|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
7963234|NCT00372905|19602376|P4|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
7963235|NCT00372905|19602377|P3|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||1
7963236|NCT00372905|19602378|P2|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
7963237|NCT00372905|19602379|P1|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
7963238|NCT00372905|19602376|P4|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
7963239|NCT00372905|19602377|P3|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||1
7963240|NCT00372905|19602378|P2|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
7963241|NCT00372905|19602379|P1|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
7963242|NCT00372905|19602376|P4|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
7963243|NCT00372905|19602377|P3|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||3
7963244|NCT00372905|19602378|P2|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
7963245|NCT00372905|19602379|P1|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
7963246|NCT00372905|19602376|P4|Registered|Cohort 3: Dose Level 1.6mg/m2||0
7963247|NCT00372905|19602377|P3|Registered|Cohort 3: Dose Level 1.6mg/m2||4
7963248|NCT00372905|19602378|P2|Registered|Cohort 3: Dose Level 1.6mg/m2||0
7963249|NCT00372905|19602379|P1|Registered|Cohort 3: Dose Level 1.6mg/m2||0
7963250|NCT00372905|19602376|P4|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
7963251|NCT00372905|19602377|P3|STARTED|Cohort 3: Dose Level 1.6mg/m2||4
7963252|NCT00372905|19602378|P2|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
7963253|NCT00372905|19602379|P1|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
7963254|NCT00372905|19602376|P4|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
7963255|NCT00372905|19602377|P3|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
7963256|NCT00372905|19602378|P2|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
7963257|NCT00372905|19602379|P1|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
7963258|NCT00372905|19602376|P4|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
7963259|NCT00372905|19602377|P3|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
7963260|NCT00372905|19602378|P2|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||3
7963261|NCT00372905|19602379|P1|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
7963262|NCT00372905|19602376|P4|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
7963263|NCT00372905|19602377|P3|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
7963264|NCT00372905|19602378|P2|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||3
7963265|NCT00372905|19602379|P1|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
7963266|NCT00372905|19602376|P4|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
7963267|NCT00372905|19602377|P3|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
7963268|NCT00372905|19602378|P2|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||3
7963269|NCT00372905|19602379|P1|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
7963270|NCT00372905|19602376|P4|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
7963271|NCT00372905|19602377|P3|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
7963272|NCT00372905|19602378|P2|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||3
7963273|NCT00372905|19602379|P1|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
7963274|NCT00372905|19602376|P4|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
7963275|NCT00372905|19602377|P3|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
7963276|NCT00372905|19602378|P2|STARTED|Cohort 2: Dose Level 1.3mg/m2||3
7963277|NCT00372905|19602379|P1|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
7963278|NCT00372905|19602376|P4|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
7963279|NCT00372905|19602377|P3|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
7963280|NCT00372905|19602378|P2|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
7963281|NCT00372905|19602379|P1|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||2
7963282|NCT00372905|19602376|P4|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
7963283|NCT00372905|19602377|P3|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
7963284|NCT00372905|19602378|P2|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
7963285|NCT00372905|19602379|P1|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||1
7963286|NCT00372905|19602376|P4|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
7963287|NCT00372905|19602377|P3|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
7963288|NCT00372905|19602378|P2|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
7963289|NCT00372905|19602379|P1|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||1
7963290|NCT00372905|19602376|P4|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
7963291|NCT00372905|19602377|P3|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
7963292|NCT00372905|19602378|P2|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
7963293|NCT00372905|19602379|P1|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||3
7963294|NCT00372905|19602376|P4|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
7963295|NCT00372905|19602377|P3|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
7963296|NCT00372905|19602378|P2|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
7963297|NCT00372905|19602379|P1|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||3
7963298|NCT00372905|19602376|P4|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
7963299|NCT00372905|19602377|P3|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
7963300|NCT00372905|19602378|P2|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
7963301|NCT00372905|19602379|P1|STARTED|Cohort 1: Dose Level 1.0mg/m2||3
7963302|NCT00372775|19602391|P1|NOT COMPLETED|Overall Study||63
7963303|NCT00372775|19602391|P1|COMPLETED|Overall Study||3
7963304|NCT00372775|19602391|P1|Received Treatment|Overall Study||64
7963305|NCT00372775|19602391|P1|STARTED|Overall Study||66
7963306|NCT00372697|19602413|P2|NOT COMPLETED|Overall Study||1
7963307|NCT00372697|19602414|P1|NOT COMPLETED|Overall Study||1
7963308|NCT00372697|19602413|P2|COMPLETED|Overall Study||11
7963309|NCT00372697|19602414|P1|COMPLETED|Overall Study||15
7963310|NCT00372697|19602413|P2|STARTED|Overall Study||12
7963311|NCT00372697|19602414|P1|STARTED|Overall Study||16
7963312|NCT00372619|19602439|P7|NOT COMPLETED|Overall Study||0
7963313|NCT00372619|19602440|P6|NOT COMPLETED|Overall Study||3
7963314|NCT00372619|19602441|P5|NOT COMPLETED|Overall Study||0
7963315|NCT00372619|19602442|P4|NOT COMPLETED|Overall Study||0
7963316|NCT00372619|19602443|P3|NOT COMPLETED|Overall Study||0
7963317|NCT00372619|19602444|P2|NOT COMPLETED|Overall Study||0
7963318|NCT00372619|19602445|P1|NOT COMPLETED|Overall Study||0
7963319|NCT00372619|19602439|P7|COMPLETED|Overall Study||2
7963320|NCT00372619|19602440|P6|COMPLETED|Overall Study||39
7963321|NCT00372619|19602441|P5|COMPLETED|Overall Study||7
7963322|NCT00372619|19602442|P4|COMPLETED|Overall Study||10
7963323|NCT00372619|19602443|P3|COMPLETED|Overall Study||3
7963324|NCT00372619|19602444|P2|COMPLETED|Overall Study||2
7963325|NCT00372619|19602445|P1|COMPLETED|Overall Study||8
7963326|NCT00372619|19602439|P7|STARTED|Overall Study||2
7963327|NCT00372619|19602440|P6|STARTED|Overall Study||42
7963328|NCT00372619|19602441|P5|STARTED|Overall Study||7
7963329|NCT00372619|19602442|P4|STARTED|Overall Study||10
7963330|NCT00372619|19602443|P3|STARTED|Overall Study||3
7963331|NCT00372619|19602444|P2|STARTED|Overall Study||2
7963332|NCT00372619|19602445|P1|STARTED|Overall Study||8
7963333|NCT00372593|19602478|P3|NOT COMPLETED|Overall Study||4
7963334|NCT00372593|19602479|P2|NOT COMPLETED|Overall Study||198
7963335|NCT00372593|19602480|P1|NOT COMPLETED|Overall Study||204
7963336|NCT00372593|19602478|P3|COMPLETED|Overall Study||3
7963337|NCT00372593|19602479|P2|COMPLETED|Overall Study||334
7963338|NCT00372593|19602480|P1|COMPLETED|Overall Study||327
7963339|NCT00372593|19602478|P3|STARTED|Overall Study||7
7963340|NCT00372593|19602479|P2|STARTED|Overall Study||532
7963341|NCT00372593|19602480|P1|STARTED|Overall Study||531
7963342|NCT00372567|19602509|P3|NOT COMPLETED|Phase 3 Study||12
7963343|NCT00372567|19602510|P2|NOT COMPLETED|Phase 3 Study||26
7963344|NCT00372567|19602511|P1|NOT COMPLETED|Phase 3 Study||31
7963345|NCT00372567|19602509|P3|COMPLETED|Phase 3 Study||0
7963346|NCT00372567|19602510|P2|COMPLETED|Phase 3 Study||0
7963347|NCT00372567|19602511|P1|COMPLETED|Phase 3 Study||0
7963348|NCT00372567|19602509|P3|Received Treatment|Phase 3 Study||12
7963349|NCT00372567|19602510|P2|Received Treatment|Phase 3 Study||25
7963350|NCT00372567|19602511|P1|Received Treatment|Phase 3 Study||31
7963351|NCT00372567|19602509|P3|STARTED|Phase 3 Study||12
7963352|NCT00372567|19602510|P2|STARTED|Phase 3 Study||26
7963353|NCT00372567|19602511|P1|STARTED|Phase 3 Study||31
7963354|NCT00372567|19602509|P3|NOT COMPLETED|Phase 1 Sub-study||0
7963355|NCT00372567|19602510|P2|NOT COMPLETED|Phase 1 Sub-study||0
7963356|NCT00372567|19602511|P1|NOT COMPLETED|Phase 1 Sub-study||0
7963357|NCT00372567|19602509|P3|COMPLETED|Phase 1 Sub-study||12
7963358|NCT00372567|19602510|P2|COMPLETED|Phase 1 Sub-study||0
7963359|NCT00372567|19602511|P1|COMPLETED|Phase 1 Sub-study||0
7963360|NCT00372567|19602509|P3|STARTED|Phase 1 Sub-study||12
7963361|NCT00372567|19602510|P2|STARTED|Phase 1 Sub-study||0
7963362|NCT00372567|19602511|P1|STARTED|Phase 1 Sub-study||0
7963363|NCT00372528|19602539|P1|NOT COMPLETED|Overall Study||21
7963364|NCT00372528|19602539|P1|COMPLETED|Overall Study||0
7963365|NCT00372528|19602539|P1|STARTED|Overall Study||21
7963366|NCT00372489|19602544|P1|NOT COMPLETED|Overall Study||79
7963367|NCT00372489|19602544|P1|COMPLETED|Overall Study||2
7963368|NCT00372489|19602544|P1|STARTED|Overall Study||81
7963369|NCT00372424|19602548|P1|NOT COMPLETED|Overall Study||26
7963370|NCT00372424|19602548|P1|COMPLETED|Overall Study||0
7963371|NCT00372424|19602548|P1|Treated|Overall Study||25
7963372|NCT00372424|19602548|P1|STARTED|Overall Study||26
7963373|NCT00372411|19602562|P3|NOT COMPLETED|Overall Study||3
7963374|NCT00372411|19602563|P2|NOT COMPLETED|Overall Study||8
7963375|NCT00372411|19602564|P1|NOT COMPLETED|Overall Study||5
7963376|NCT00372411|19602562|P3|COMPLETED|Overall Study||25
7963377|NCT00372411|19602563|P2|COMPLETED|Overall Study||42
7963378|NCT00372411|19602564|P1|COMPLETED|Overall Study||44
7963379|NCT00372411|19602562|P3|STARTED|Overall Study||28
7963380|NCT00372411|19602563|P2|STARTED|Overall Study||50
7963381|NCT00372411|19602564|P1|STARTED|Overall Study||49
7963382|NCT00372385|19602588|P4|NOT COMPLETED|Overall Study||8
7963383|NCT00372385|19602589|P3|NOT COMPLETED|Overall Study||10
7963384|NCT00372385|19602590|P2|NOT COMPLETED|Overall Study||20
7963385|NCT00372385|19602591|P1|NOT COMPLETED|Overall Study||33
7963386|NCT00372385|19602588|P4|COMPLETED|Overall Study||70
7963387|NCT00372385|19602589|P3|COMPLETED|Overall Study||72
7963388|NCT00372385|19602590|P2|COMPLETED|Overall Study||61
7963389|NCT00372385|19602591|P1|COMPLETED|Overall Study||49
7963390|NCT00372385|19602588|P4|STARTED|Overall Study||78
7963391|NCT00372385|19602589|P3|STARTED|Overall Study||82
7963392|NCT00372385|19602590|P2|STARTED|Overall Study||81
7963393|NCT00372385|19602591|P1|STARTED|Overall Study||82
7963394|NCT00372255|19602620|P2|NOT COMPLETED|Overall Study||1
7963395|NCT00372255|19602621|P1|NOT COMPLETED|Overall Study||2
7963396|NCT00372255|19602620|P2|COMPLETED|Overall Study||113
7963397|NCT00372255|19602621|P1|COMPLETED|Overall Study||108
7963398|NCT00372255|19602620|P2|STARTED|Overall Study||114
7963399|NCT00372255|19602621|P1|STARTED|Overall Study||110
7963400|NCT00372229|19602643|P2|NOT COMPLETED|Follow-Up Phase||52
7963401|NCT00372229|19602644|P1|NOT COMPLETED|Follow-Up Phase||46
7963402|NCT00372229|19602643|P2|COMPLETED|Follow-Up Phase||70
7963403|NCT00372229|19602644|P1|COMPLETED|Follow-Up Phase||71
7963404|NCT00372229|19602643|P2|STARTED|Follow-Up Phase||122
7963405|NCT00372229|19602644|P1|STARTED|Follow-Up Phase||117
7963406|NCT00372229|19602643|P2|NOT COMPLETED|Study Phase||29
7963407|NCT00372229|19602644|P1|NOT COMPLETED|Study Phase||31
7963408|NCT00372229|19602643|P2|COMPLETED|Study Phase||122
7963409|NCT00372229|19602644|P1|COMPLETED|Study Phase||117
7963410|NCT00372229|19602643|P2|STARTED|Study Phase||151
7963411|NCT00372229|19602644|P1|STARTED|Study Phase||148
7963412|NCT00372190|19602734|P2|NOT COMPLETED|Overall Study||1
7963413|NCT00372190|19602735|P1|NOT COMPLETED|Overall Study||3
7963414|NCT00372190|19602734|P2|COMPLETED|Overall Study||96
7963415|NCT00372190|19602735|P1|COMPLETED|Overall Study||90
7963416|NCT00372190|19602734|P2|STARTED|Overall Study|99 were allocated to conventional arm, however 2 never underwent any surgery|97
7963417|NCT00372190|19602735|P1|STARTED|Overall Study|95 were allocated to mesh group, however 2 never underwent any surgery|93
7963418|NCT00372112|19602751|P4|NOT COMPLETED|Overall Study||4
7963419|NCT00372112|19602752|P3|NOT COMPLETED|Overall Study||4
7963420|NCT00372112|19602753|P2|NOT COMPLETED|Overall Study||1
7963421|NCT00372112|19602754|P1|NOT COMPLETED|Overall Study||1
7963422|NCT00372112|19602751|P4|COMPLETED|Overall Study||14
7963423|NCT00372112|19602752|P3|COMPLETED|Overall Study||13
7963424|NCT00372112|19602753|P2|COMPLETED|Overall Study||15
7963425|NCT00372112|19602754|P1|COMPLETED|Overall Study||16
7963426|NCT00372112|19602751|P4|STARTED|Overall Study||18
7963427|NCT00372112|19602752|P3|STARTED|Overall Study||17
7963428|NCT00372112|19602753|P2|STARTED|Overall Study||16
7963429|NCT00372112|19602754|P1|STARTED|Overall Study||17
7963430|NCT00372060|19602885|P2|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8
7963431|NCT00372060|19602886|P1|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14
7963432|NCT00372060|19602885|P2|COMPLETED|Period II - Open-label (Weeks 12-52)||59
7963433|NCT00372060|19602886|P1|COMPLETED|Period II - Open-label (Weeks 12-52)||49
7963434|NCT00372060|19602885|P2|STARTED|Period II - Open-label (Weeks 12-52)||67
7963435|NCT00372060|19602886|P1|STARTED|Period II - Open-label (Weeks 12-52)||63
7963436|NCT00372060|19602885|P2|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1
7963437|NCT00372060|19602886|P1|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3
7963438|NCT00372060|19602885|P2|COMPLETED|Period I - Double-blind (Weeks 0-12)||67
7963439|NCT00372060|19602886|P1|COMPLETED|Period I - Double-blind (Weeks 0-12)||63
7963440|NCT00372060|19602885|P2|STARTED|Period I - Double-blind (Weeks 0-12)||68
7963441|NCT00372060|19602886|P1|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66
7963442|NCT00371865|19602901|P2|NOT COMPLETED|Overall Study||14
7963443|NCT00371865|19602902|P1|NOT COMPLETED|Overall Study||15
7963444|NCT00371865|19602901|P2|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43
7963445|NCT00371865|19602902|P1|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42
7963446|NCT00371865|19602901|P2|STARTED|Overall Study||57
7963447|NCT00371865|19602902|P1|STARTED|Overall Study||57
7963448|NCT00371839|19602919|P3|NOT COMPLETED|Overall Study||2
7963449|NCT00371839|19602920|P2|NOT COMPLETED|Overall Study||7
7963450|NCT00371839|19602921|P1|NOT COMPLETED|Overall Study||17
7963451|NCT00371839|19602919|P3|COMPLETED|Overall Study||7
7963452|NCT00371839|19602920|P2|COMPLETED|Overall Study||13
7963453|NCT00371839|19602921|P1|COMPLETED|Overall Study||32
7963454|NCT00371839|19602919|P3|STARTED|Overall Study||9
7963455|NCT00371839|19602920|P2|STARTED|Overall Study||20
7963456|NCT00371839|19602921|P1|STARTED|Overall Study||49
7963457|NCT00371826|19602930|P3|NOT COMPLETED|Extension Phase (24 Months)||2
7963458|NCT00371826|19602931|P2|NOT COMPLETED|Extension Phase (24 Months)||10
7963459|NCT00371826|19602932|P1|NOT COMPLETED|Extension Phase (24 Months)||5
7963460|NCT00371826|19602930|P3|COMPLETED|Extension Phase (24 Months)||3
7963461|NCT00371826|19602931|P2|COMPLETED|Extension Phase (24 Months)||29
7963462|NCT00371826|19602932|P1|COMPLETED|Extension Phase (24 Months)||18
7963463|NCT00371826|19602930|P3|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5
7963464|NCT00371826|19602931|P2|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40
7963545|NCT00371462|19603236|P1|NOT COMPLETED|Overall Study||8
7963465|NCT00371826|19602932|P1|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22
7963466|NCT00371826|19602930|P3|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4
7963467|NCT00371826|19602931|P2|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39
7963468|NCT00371826|19602932|P1|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23
7963469|NCT00371826|19602930|P3|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5
7963470|NCT00371826|19602931|P2|STARTED|Extension Phase (24 Months)||39
7963471|NCT00371826|19602932|P1|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23
7963472|NCT00371826|19602930|P3|NOT COMPLETED|Core Phase (12 Months)||24
7963473|NCT00371826|19602931|P2|NOT COMPLETED|Core Phase (12 Months)||8
7963474|NCT00371826|19602932|P1|NOT COMPLETED|Core Phase (12 Months)||24
7963475|NCT00371826|19602930|P3|COMPLETED|Core Phase (12 Months)||6
7963476|NCT00371826|19602931|P2|COMPLETED|Core Phase (12 Months)||39
7963477|NCT00371826|19602932|P1|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25
7963478|NCT00371826|19602930|P3|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6
7963479|NCT00371826|19602931|P2|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39
7963480|NCT00371826|19602932|P1|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27
7963481|NCT00371826|19602930|P3|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20
7963482|NCT00371826|19602931|P2|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44
7963483|NCT00371826|19602932|P1|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46
7963484|NCT00371826|19602930|P3|STARTED|Core Phase (12 Months)||30
7963485|NCT00371826|19602931|P2|STARTED|Core Phase (12 Months)||47
7963486|NCT00371826|19602932|P1|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49
7963487|NCT00371787|19603056|P2|NOT COMPLETED|Overall Study||1
7963488|NCT00371787|19603057|P1|NOT COMPLETED|Overall Study||3
7963489|NCT00371787|19603056|P2|COMPLETED|Overall Study||11
7963490|NCT00371787|19603057|P1|COMPLETED|Overall Study||23
7963491|NCT00371787|19603056|P2|STARTED|Overall Study||12
7963492|NCT00371787|19603057|P1|STARTED|Overall Study||26
7963493|NCT00371761|19603071|P2|NOT COMPLETED|Overall Study||10
7963494|NCT00371761|19603072|P1|NOT COMPLETED|Overall Study||8
7963495|NCT00371761|19603071|P2|COMPLETED|Overall Study||2
7963496|NCT00371761|19603072|P1|COMPLETED|Overall Study||5
7963497|NCT00371761|19603071|P2|STARTED|Overall Study||12
7963498|NCT00371761|19603072|P1|STARTED|Overall Study||13
7963499|NCT00371683|19603080|P2|NOT COMPLETED|Follow-Up Period - Randomized Patients||72
7963500|NCT00371683|19603081|P1|NOT COMPLETED|Follow-Up Period - Randomized Patients||61
7963501|NCT00371683|19603080|P2|COMPLETED|Follow-Up Period - Randomized Patients||1461
7963502|NCT00371683|19603081|P1|COMPLETED|Follow-Up Period - Randomized Patients||1492
7963503|NCT00371683|19603080|P2|STARTED|Follow-Up Period - Randomized Patients||1533
7963504|NCT00371683|19603081|P1|STARTED|Follow-Up Period - Randomized Patients||1553
7963505|NCT00371683|19603080|P2|NOT COMPLETED|DB Treatment Period-Randomized Patients||107
7963506|NCT00371683|19603081|P1|NOT COMPLETED|DB Treatment Period-Randomized Patients||90
7963507|NCT00371683|19603080|P2|COMPLETED|DB Treatment Period-Randomized Patients||1489
7963508|NCT00371683|19603081|P1|COMPLETED|DB Treatment Period-Randomized Patients||1509
7963509|NCT00371683|19603080|P2|STARTED|DB Treatment Period-Randomized Patients||1596
7963510|NCT00371683|19603081|P1|STARTED|DB Treatment Period-Randomized Patients||1599
7963511|NCT00371644|19603135|P2|NOT COMPLETED|Overall Study||13
7963512|NCT00371644|19603136|P1|NOT COMPLETED|Overall Study||28
7963513|NCT00371644|19603135|P2|COMPLETED|Overall Study||44
7963514|NCT00371644|19603136|P1|COMPLETED|Overall Study||44
7963515|NCT00371644|19603135|P2|STARTED|Overall Study||57
7963516|NCT00371644|19603136|P1|STARTED|Overall Study||72
7963517|NCT00371631|19603142|P1|NOT COMPLETED|Overall Study||0
7963518|NCT00371631|19603142|P1|COMPLETED|Overall Study||13
7963519|NCT00371631|19603142|P1|STARTED|Overall Study||13
7963520|NCT00371566|19603149|P2|NOT COMPLETED|Follow Up Phase||7
7963521|NCT00371566|19603150|P1|NOT COMPLETED|Follow Up Phase||3
7963522|NCT00371566|19603149|P2|COMPLETED|Follow Up Phase||58
7963523|NCT00371566|19603150|P1|COMPLETED|Follow Up Phase||28
7963524|NCT00371566|19603149|P2|STARTED|Follow Up Phase||65
7963525|NCT00371566|19603150|P1|STARTED|Follow Up Phase||31
7963526|NCT00371566|19603149|P2|NOT COMPLETED|Chemoradiation Phase||3
7963527|NCT00371566|19603150|P1|NOT COMPLETED|Chemoradiation Phase||5
7963528|NCT00371566|19603149|P2|COMPLETED|Chemoradiation Phase||65
7963529|NCT00371566|19603150|P1|COMPLETED|Chemoradiation Phase||31
7963530|NCT00371566|19603149|P2|STARTED|Chemoradiation Phase||68
7963531|NCT00371566|19603150|P1|STARTED|Chemoradiation Phase||36
7963532|NCT00371566|19603149|P2|NOT COMPLETED|Treatment Phase||3
7963533|NCT00371566|19603150|P1|NOT COMPLETED|Treatment Phase||0
7963534|NCT00371566|19603149|P2|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68
7963535|NCT00371566|19603150|P1|COMPLETED|Treatment Phase||36
7963536|NCT00371566|19603149|P2|STARTED|Treatment Phase||71
7963537|NCT00371566|19603150|P1|STARTED|Treatment Phase||36
7963538|NCT00371540|19603222|P2|NOT COMPLETED|Overall Study||9
7963539|NCT00371540|19603223|P1|NOT COMPLETED|Overall Study||10
7963540|NCT00371540|19603222|P2|COMPLETED|Overall Study||87
7963541|NCT00371540|19603223|P1|COMPLETED|Overall Study||102
7963542|NCT00371540|19603222|P2|STARTED|Overall Study||96
7963543|NCT00371540|19603223|P1|STARTED|Overall Study||112
7963544|NCT00371462|19603235|P2|NOT COMPLETED|Overall Study||8
7963546|NCT00371462|19603235|P2|COMPLETED|Overall Study||27
7963547|NCT00371462|19603236|P1|COMPLETED|Overall Study||27
7963548|NCT00371462|19603235|P2|STARTED|Overall Study||35
7963549|NCT00371462|19603236|P1|STARTED|Overall Study||35
7963550|NCT00371449|19603242|P1|NOT COMPLETED|Overall Study||0
7963551|NCT00371449|19603242|P1|COMPLETED|Overall Study||120
7963552|NCT00371449|19603242|P1|STARTED|Overall Study||120
7963553|NCT00371436|19603253|P2|NOT COMPLETED|Overall Study||21
7963554|NCT00371436|19603254|P1|NOT COMPLETED|Overall Study||34
7963555|NCT00371436|19603253|P2|COMPLETED|Overall Study||68
7963556|NCT00371436|19603254|P1|COMPLETED|Overall Study||58
7963557|NCT00371436|19603253|P2|STARTED|Overall Study||89
7963558|NCT00371436|19603254|P1|STARTED|Overall Study||92
7963559|NCT00371397|19603260|P12|NOT COMPLETED|Session 3||0
7963560|NCT00371397|19603261|P11|NOT COMPLETED|Session 3||0
7963561|NCT00371397|19603262|P10|NOT COMPLETED|Session 3||0
7963562|NCT00371397|19603263|P9|NOT COMPLETED|Session 3||0
7963563|NCT00371397|19603264|P8|NOT COMPLETED|Session 3||0
7963564|NCT00371397|19603265|P7|NOT COMPLETED|Session 3||0
7963565|NCT00371397|19603266|P6|NOT COMPLETED|Session 3||0
7963566|NCT00371397|19603267|P5|NOT COMPLETED|Session 3||0
7963567|NCT00371397|19603268|P4|NOT COMPLETED|Session 3||0
7963568|NCT00371397|19603269|P3|NOT COMPLETED|Session 3||0
7963569|NCT00371397|19603270|P2|NOT COMPLETED|Session 3||0
7963570|NCT00371397|19603271|P1|NOT COMPLETED|Session 3||0
7963571|NCT00371397|19603260|P12|COMPLETED|Session 3||2
7963572|NCT00371397|19603261|P11|COMPLETED|Session 3||4
7963573|NCT00371397|19603262|P10|COMPLETED|Session 3||5
7963574|NCT00371397|19603263|P9|COMPLETED|Session 3||6
7963575|NCT00371397|19603264|P8|COMPLETED|Session 3||4
7963576|NCT00371397|19603265|P7|COMPLETED|Session 3||4
7963577|NCT00371397|19603266|P6|COMPLETED|Session 3||4
7963578|NCT00371397|19603267|P5|COMPLETED|Session 3||3
7963579|NCT00371397|19603268|P4|COMPLETED|Session 3||2
7963580|NCT00371397|19603269|P3|COMPLETED|Session 3||5
7963581|NCT00371397|19603270|P2|COMPLETED|Session 3||7
7963582|NCT00371397|19603271|P1|COMPLETED|Session 3||4
7963583|NCT00371397|19603260|P12|STARTED|Session 3||2
7963584|NCT00371397|19603261|P11|STARTED|Session 3||4
7963585|NCT00371397|19603262|P10|STARTED|Session 3||5
7963586|NCT00371397|19603263|P9|STARTED|Session 3||6
7963587|NCT00371397|19603264|P8|STARTED|Session 3||4
7963588|NCT00371397|19603265|P7|STARTED|Session 3||4
7963589|NCT00371397|19603266|P6|STARTED|Session 3||4
7963590|NCT00371397|19603267|P5|STARTED|Session 3||3
7963591|NCT00371397|19603268|P4|STARTED|Session 3||2
7963592|NCT00371397|19603269|P3|STARTED|Session 3||5
7963593|NCT00371397|19603270|P2|STARTED|Session 3||7
7963594|NCT00371397|19603271|P1|STARTED|Session 3||4
7963595|NCT00371397|19603260|P12|NOT COMPLETED|Session 2||0
7963596|NCT00371397|19603261|P11|NOT COMPLETED|Session 2||0
7963597|NCT00371397|19603262|P10|NOT COMPLETED|Session 2||0
7963598|NCT00371397|19603263|P9|NOT COMPLETED|Session 2||0
7963599|NCT00371397|19603264|P8|NOT COMPLETED|Session 2||0
7963600|NCT00371397|19603265|P7|NOT COMPLETED|Session 2||0
7963601|NCT00371397|19603266|P6|NOT COMPLETED|Session 2||0
7963602|NCT00371397|19603267|P5|NOT COMPLETED|Session 2||0
7963603|NCT00371397|19603268|P4|NOT COMPLETED|Session 2||0
7963604|NCT00371397|19603269|P3|NOT COMPLETED|Session 2||0
7963605|NCT00371397|19603270|P2|NOT COMPLETED|Session 2||0
7963606|NCT00371397|19603271|P1|NOT COMPLETED|Session 2||0
7963607|NCT00371397|19603260|P12|COMPLETED|Session 2||2
7963608|NCT00371397|19603261|P11|COMPLETED|Session 2||4
7963609|NCT00371397|19603262|P10|COMPLETED|Session 2||5
7963610|NCT00371397|19603263|P9|COMPLETED|Session 2||6
7963611|NCT00371397|19603264|P8|COMPLETED|Session 2||4
7963612|NCT00371397|19603265|P7|COMPLETED|Session 2||4
7963613|NCT00371397|19603266|P6|COMPLETED|Session 2||4
7963614|NCT00371397|19603267|P5|COMPLETED|Session 2||3
7963615|NCT00371397|19603268|P4|COMPLETED|Session 2||2
7963616|NCT00371397|19603269|P3|COMPLETED|Session 2||5
7963617|NCT00371397|19603270|P2|COMPLETED|Session 2||7
7963618|NCT00371397|19603271|P1|COMPLETED|Session 2||4
7963619|NCT00371397|19603260|P12|STARTED|Session 2||2
7963620|NCT00371397|19603261|P11|STARTED|Session 2||4
7963621|NCT00371397|19603262|P10|STARTED|Session 2||5
7963622|NCT00371397|19603263|P9|STARTED|Session 2||6
7963623|NCT00371397|19603264|P8|STARTED|Session 2||4
7963624|NCT00371397|19603265|P7|STARTED|Session 2||4
7963625|NCT00371397|19603266|P6|STARTED|Session 2||4
7963626|NCT00371397|19603267|P5|STARTED|Session 2||3
7963627|NCT00371397|19603268|P4|STARTED|Session 2||2
7963628|NCT00371397|19603269|P3|STARTED|Session 2||5
7963629|NCT00371397|19603270|P2|STARTED|Session 2||7
7963630|NCT00371397|19603271|P1|STARTED|Session 2||4
7963631|NCT00371397|19603260|P12|NOT COMPLETED|Session 1||0
7963632|NCT00371397|19603261|P11|NOT COMPLETED|Session 1||0
7963633|NCT00371397|19603262|P10|NOT COMPLETED|Session 1||0
7963634|NCT00371397|19603263|P9|NOT COMPLETED|Session 1||0
7963635|NCT00371397|19603264|P8|NOT COMPLETED|Session 1||1
7963636|NCT00371397|19603265|P7|NOT COMPLETED|Session 1||0
7963637|NCT00371397|19603266|P6|NOT COMPLETED|Session 1||0
7963638|NCT00371397|19603267|P5|NOT COMPLETED|Session 1||0
7963639|NCT00371397|19603268|P4|NOT COMPLETED|Session 1||0
7963640|NCT00371397|19603269|P3|NOT COMPLETED|Session 1||0
7963641|NCT00371397|19603270|P2|NOT COMPLETED|Session 1||0
7963642|NCT00371397|19603271|P1|NOT COMPLETED|Session 1||1
7963643|NCT00371397|19603260|P12|COMPLETED|Session 1||2
7963644|NCT00371397|19603261|P11|COMPLETED|Session 1||4
7963645|NCT00371397|19603262|P10|COMPLETED|Session 1||5
7963646|NCT00371397|19603263|P9|COMPLETED|Session 1||6
7963647|NCT00371397|19603264|P8|COMPLETED|Session 1||4
7963648|NCT00371397|19603265|P7|COMPLETED|Session 1||4
7963649|NCT00371397|19603266|P6|COMPLETED|Session 1||4
7963650|NCT00371397|19603267|P5|COMPLETED|Session 1||3
7963651|NCT00371397|19603268|P4|COMPLETED|Session 1||2
7963652|NCT00371397|19603269|P3|COMPLETED|Session 1||5
7963653|NCT00371397|19603270|P2|COMPLETED|Session 1||7
7963654|NCT00371397|19603271|P1|COMPLETED|Session 1||4
7963655|NCT00371397|19603260|P12|STARTED|Session 1||2
7963656|NCT00371397|19603261|P11|STARTED|Session 1||4
7963657|NCT00371397|19603262|P10|STARTED|Session 1||5
7963658|NCT00371397|19603263|P9|STARTED|Session 1||6
7963659|NCT00371397|19603264|P8|STARTED|Session 1||5
7963660|NCT00371397|19603265|P7|STARTED|Session 1||4
7963661|NCT00371397|19603266|P6|STARTED|Session 1||4
7963662|NCT00371397|19603267|P5|STARTED|Session 1||3
7963663|NCT00371397|19603268|P4|STARTED|Session 1||2
7963664|NCT00371397|19603269|P3|STARTED|Session 1||5
7963665|NCT00371397|19603270|P2|STARTED|Session 1||7
7963666|NCT00371397|19603271|P1|STARTED|Session 1||5
7963667|NCT00371345|19603279|P2|NOT COMPLETED|Overall Study||46
7963668|NCT00371345|19603280|P1|NOT COMPLETED|Overall Study||24
7963669|NCT00371345|19603279|P2|COMPLETED|Overall Study||0
7963670|NCT00371345|19603280|P1|COMPLETED|Overall Study||0
7963671|NCT00371345|19603279|P2|STARTED|Overall Study||46
7963672|NCT00371345|19603280|P1|STARTED|Overall Study||24
7963673|NCT00371293|19603340|P3|NOT COMPLETED|Overall Study||16
7963674|NCT00371293|19603341|P2|NOT COMPLETED|Overall Study||19
7963675|NCT00371293|19603342|P1|NOT COMPLETED|Overall Study||10
7963676|NCT00371293|19603340|P3|COMPLETED|Overall Study||46
7963677|NCT00371293|19603341|P2|COMPLETED|Overall Study||42
7963678|NCT00371293|19603342|P1|COMPLETED|Overall Study||48
7963679|NCT00371293|19603340|P3|STARTED|Overall Study||62
7963680|NCT00371293|19603341|P2|STARTED|Overall Study||61
7963681|NCT00371293|19603342|P1|STARTED|Overall Study||58
7963682|NCT00371267|19603364|P2|NOT COMPLETED|Overall Study||18
7963683|NCT00371267|19603365|P1|NOT COMPLETED|Overall Study||9
7963684|NCT00371267|19603364|P2|COMPLETED|Overall Study||32
7963685|NCT00371267|19603365|P1|COMPLETED|Overall Study||39
7963686|NCT00371267|19603364|P2|STARTED|Overall Study||50
7963687|NCT00371267|19603365|P1|STARTED|Overall Study||48
7963688|NCT00371254|19603381|P2|NOT COMPLETED|Overall Study||21
7963689|NCT00371254|19603382|P1|NOT COMPLETED|Overall Study||23
7963690|NCT00371254|19603381|P2|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
7963691|NCT00371254|19603382|P1|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
7963692|NCT00371254|19603381|P2|STARTED|Overall Study|Number of participants treated|21
7963693|NCT00371254|19603382|P1|STARTED|Overall Study|Number of participants treated|23
7963694|NCT00371176|19603434|P2|NOT COMPLETED|Overall Study||8
7963695|NCT00371176|19603435|P1|NOT COMPLETED|Overall Study||5
7963696|NCT00371176|19603434|P2|COMPLETED|Overall Study||5
7963697|NCT00371176|19603435|P1|COMPLETED|Overall Study||8
7963698|NCT00371176|19603434|P2|Completed Treatment|Overall Study||9
7963699|NCT00371176|19603435|P1|Completed Treatment|Overall Study||10
7963700|NCT00371176|19603434|P2|STARTED|Overall Study||13
7963701|NCT00371176|19603435|P1|STARTED|Overall Study||13
7963702|NCT00371150|19603465|P2|NOT COMPLETED|Overall Study||2
7963703|NCT00371150|19603466|P1|NOT COMPLETED|Overall Study||3
7963704|NCT00371150|19603465|P2|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|4
7963705|NCT00371150|19603466|P1|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|37
7963706|NCT00371150|19603465|P2|Discontinued at or After Week 48 Visit|Overall Study||1
7963707|NCT00371150|19603466|P1|Discontinued at or After Week 48 Visit|Overall Study||2
7963708|NCT00371150|19603465|P2|Discontinued Prior to Week 48 Visit|Overall Study||1
7963709|NCT00371150|19603466|P1|Discontinued Prior to Week 48 Visit|Overall Study||1
7963710|NCT00371150|19603465|P2|STARTED|Overall Study||6
7963711|NCT00371150|19603466|P1|STARTED|Overall Study||40
7963712|NCT00371137|19603501|P3|NOT COMPLETED|Overall Study||79
7963713|NCT00371137|19603502|P2|NOT COMPLETED|Overall Study||63
7963714|NCT00371137|19603503|P1|NOT COMPLETED|Overall Study||72
7963715|NCT00371137|19603501|P3|COMPLETED|Overall Study||104
7963716|NCT00371137|19603502|P2|COMPLETED|Overall Study||119
7963717|NCT00371137|19603503|P1|COMPLETED|Overall Study||111
7963718|NCT00371137|19603501|P3|Treated|Overall Study||182
7963719|NCT00371137|19603502|P2|Treated|Overall Study||182
7963720|NCT00371137|19603503|P1|Treated|Overall Study||183
7963721|NCT00371137|19603501|P3|STARTED|Overall Study||183
7963722|NCT00371137|19603502|P2|STARTED|Overall Study||182
7963723|NCT00371137|19603503|P1|STARTED|Overall Study||183
7963724|NCT00370994|19603513|P2|NOT COMPLETED|Overall Study||0
7963725|NCT00370994|19603514|P1|NOT COMPLETED|Overall Study||0
7963726|NCT00370994|19603513|P2|COMPLETED|Overall Study||60
7963727|NCT00370994|19603514|P1|COMPLETED|Overall Study||60
7963728|NCT00370994|19603513|P2|STARTED|Overall Study||60
7963729|NCT00370994|19603514|P1|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60
7963730|NCT00370838|19603524|P2|NOT COMPLETED|Taper||0
7963731|NCT00370838|19603525|P1|NOT COMPLETED|Taper||0
7963732|NCT00370838|19603524|P2|COMPLETED|Taper||3
7963733|NCT00370838|19603525|P1|COMPLETED|Taper||7
7963734|NCT00370838|19603524|P2|STARTED|Taper||3
7963735|NCT00370838|19603525|P1|STARTED|Taper||7
7963736|NCT00370838|19603524|P2|NOT COMPLETED|Period 2 (Days 65-107)||0
7963737|NCT00370838|19603525|P1|NOT COMPLETED|Period 2 (Days 65-107)||0
7963738|NCT00370838|19603524|P2|COMPLETED|Period 2 (Days 65-107)||3
7963739|NCT00370838|19603525|P1|COMPLETED|Period 2 (Days 65-107)||7
7963740|NCT00370838|19603524|P2|STARTED|Period 2 (Days 65-107)||3
7963741|NCT00370838|19603525|P1|STARTED|Period 2 (Days 65-107)||7
7963742|NCT00370838|19603524|P2|NOT COMPLETED|Washout (Days 51-64)||0
7963743|NCT00370838|19603525|P1|NOT COMPLETED|Washout (Days 51-64)||0
7963744|NCT00370838|19603524|P2|COMPLETED|Washout (Days 51-64)||3
7963745|NCT00370838|19603525|P1|COMPLETED|Washout (Days 51-64)||7
7963746|NCT00370838|19603524|P2|STARTED|Washout (Days 51-64)||3
7963747|NCT00370838|19603525|P1|STARTED|Washout (Days 51-64)||7
7963748|NCT00370838|19603524|P2|NOT COMPLETED|Period 1 (Days 8-50)||0
7963749|NCT00370838|19603525|P1|NOT COMPLETED|Period 1 (Days 8-50)||0
7963750|NCT00370838|19603524|P2|COMPLETED|Period 1 (Days 8-50)||3
7963751|NCT00370838|19603525|P1|COMPLETED|Period 1 (Days 8-50)||7
7963752|NCT00370838|19603524|P2|STARTED|Period 1 (Days 8-50)||3
7963753|NCT00370838|19603525|P1|STARTED|Period 1 (Days 8-50)||7
7963754|NCT00370695|19603543|P1|NOT COMPLETED|Overall Study||15
7963755|NCT00370695|19603543|P1|COMPLETED|Overall Study||0
7963756|NCT00370695|19603543|P1|12 Weeks Post-activation|Overall Study||2
7963757|NCT00370695|19603543|P1|STARTED|Overall Study||15
7963758|NCT00370682|19603550|P3|NOT COMPLETED|Overall Study||1
7963759|NCT00370682|19603551|P2|NOT COMPLETED|Overall Study||3
7963760|NCT00370682|19603552|P1|NOT COMPLETED|Overall Study||0
7963761|NCT00370682|19603550|P3|COMPLETED|Overall Study||39
7963762|NCT00370682|19603551|P2|COMPLETED|Overall Study||37
7963763|NCT00370682|19603552|P1|COMPLETED|Overall Study||40
7963764|NCT00370682|19603550|P3|STARTED|Overall Study||40
7963765|NCT00370682|19603551|P2|STARTED|Overall Study||40
7963766|NCT00370682|19603552|P1|STARTED|Overall Study||40
7963767|NCT00370552|19603594|P3|NOT COMPLETED|Overall Study||32
7963768|NCT00370552|19603595|P2|NOT COMPLETED|Overall Study||45
7963769|NCT00370552|19603596|P1|NOT COMPLETED|Overall Study||46
7963770|NCT00370552|19603594|P3|COMPLETED|Overall Study||0
7963771|NCT00370552|19603595|P2|COMPLETED|Overall Study||0
7963772|NCT00370552|19603596|P1|COMPLETED|Overall Study||0
7963773|NCT00370552|19603594|P3|STARTED|Overall Study|Randomized|32
7963774|NCT00370552|19603595|P2|STARTED|Overall Study|Randomized|45
7963775|NCT00370552|19603596|P1|STARTED|Overall Study|Randomized|46
7963776|NCT00370396|19603637|P3|NOT COMPLETED|Overall Study||1
7963777|NCT00370396|19603638|P2|NOT COMPLETED|Overall Study||1
7963778|NCT00370396|19603639|P1|NOT COMPLETED|Overall Study||11
7963779|NCT00370396|19603637|P3|COMPLETED|Overall Study||282
7963780|NCT00370396|19603638|P2|COMPLETED|Overall Study||91
7963781|NCT00370396|19603639|P1|COMPLETED|Overall Study||726
7963782|NCT00370396|19603637|P3|STARTED|Overall Study||283
7963783|NCT00370396|19603638|P2|STARTED|Overall Study||92
7963784|NCT00370396|19603639|P1|STARTED|Overall Study||737
7963785|NCT00370331|19603693|P2|NOT COMPLETED|Overall Study||23
7963786|NCT00370331|19603694|P1|NOT COMPLETED|Overall Study||7
7963787|NCT00370331|19603693|P2|COMPLETED|Overall Study||112
7963788|NCT00370331|19603694|P1|COMPLETED|Overall Study||55
7963789|NCT00370331|19603693|P2|STARTED|Overall Study||135
7963790|NCT00370331|19603694|P1|STARTED|Overall Study||62
7963791|NCT00370292|19603720|P1|NOT COMPLETED|Overall Study||13
7963792|NCT00370292|19603720|P1|COMPLETED|Overall Study||6
7963793|NCT00370292|19603720|P1|STARTED|Overall Study||19
7963794|NCT00370149|19603733|P2|NOT COMPLETED|Overall Study||19
7963795|NCT00370149|19603734|P1|NOT COMPLETED|Overall Study||19
7963796|NCT00370149|19603733|P2|COMPLETED|Overall Study||142
7963797|NCT00370149|19603734|P1|COMPLETED|Overall Study||146
7963798|NCT00370149|19603733|P2|STARTED|Overall Study||161
7963799|NCT00370149|19603734|P1|STARTED|Overall Study||165
7963800|NCT00370071|19603744|P1|NOT COMPLETED|Overall Study||2
7963801|NCT00370071|19603744|P1|COMPLETED|Overall Study||37
7963802|NCT00370071|19603744|P1|STARTED|Overall Study||39
7963803|NCT00370032|19603761|P2|NOT COMPLETED|Follow-up Period||0
7963804|NCT00370032|19603762|P1|NOT COMPLETED|Follow-up Period||1
7963805|NCT00370032|19603761|P2|COMPLETED|Follow-up Period||22
7963806|NCT00370032|19603762|P1|COMPLETED|Follow-up Period||22
7963807|NCT00370032|19603761|P2|STARTED|Follow-up Period||22
7963808|NCT00370032|19603762|P1|STARTED|Follow-up Period||23
7963809|NCT00370032|19603761|P2|NOT COMPLETED|Treatment Period 2||0
7963810|NCT00370032|19603762|P1|NOT COMPLETED|Treatment Period 2||0
7963811|NCT00370032|19603761|P2|COMPLETED|Treatment Period 2||22
7963812|NCT00370032|19603762|P1|COMPLETED|Treatment Period 2||23
7963813|NCT00370032|19603761|P2|STARTED|Treatment Period 2||22
7963814|NCT00370032|19603762|P1|STARTED|Treatment Period 2||23
7963815|NCT00370032|19603761|P2|NOT COMPLETED|Washout Period||2
7963816|NCT00370032|19603762|P1|NOT COMPLETED|Washout Period||1
7963817|NCT00370032|19603761|P2|COMPLETED|Washout Period||22
7963818|NCT00370032|19603762|P1|COMPLETED|Washout Period||23
7963819|NCT00370032|19603761|P2|STARTED|Washout Period||24
7963820|NCT00370032|19603762|P1|STARTED|Washout Period||24
7963821|NCT00370032|19603761|P2|NOT COMPLETED|Treatment Period 1||1
7963822|NCT00370032|19603762|P1|NOT COMPLETED|Treatment Period 1||0
7963823|NCT00370032|19603761|P2|COMPLETED|Treatment Period 1||24
7963824|NCT00370032|19603762|P1|COMPLETED|Treatment Period 1||24
7963825|NCT00370032|19603761|P2|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25
7963826|NCT00370032|19603762|P1|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24
7963827|NCT00369967|19603782|P2|NOT COMPLETED|Overall Study||12
7963828|NCT00369967|19603783|P1|NOT COMPLETED|Overall Study||23
7963829|NCT00369967|19603782|P2|COMPLETED|Overall Study||5
7963830|NCT00369967|19603783|P1|COMPLETED|Overall Study||8
7963831|NCT00369967|19603782|P2|STARTED|Overall Study||17
7963832|NCT00369967|19603783|P1|STARTED|Overall Study||31
7963833|NCT00369941|19603801|P2|NOT COMPLETED|Overall Study||100
7963834|NCT00369941|19603802|P1|NOT COMPLETED|Overall Study||72
7963835|NCT00369941|19603801|P2|COMPLETED|Overall Study||184
7963836|NCT00369941|19603802|P1|COMPLETED|Overall Study||210
7963837|NCT00369941|19603801|P2|Treated|Overall Study||282
7963838|NCT00369941|19603802|P1|Treated|Overall Study||281
7963839|NCT00369941|19603801|P2|STARTED|Overall Study||284
7963840|NCT00369941|19603802|P1|STARTED|Overall Study||282
7963841|NCT00369928|19603955|P3|NOT COMPLETED|Overall Study||20
7963842|NCT00369928|19603956|P2|NOT COMPLETED|Overall Study||16
7963843|NCT00369928|19603957|P1|NOT COMPLETED|Overall Study||8
7963844|NCT00369928|19603955|P3|COMPLETED|Overall Study||66
7963845|NCT00369928|19603956|P2|COMPLETED|Overall Study||69
7963846|NCT00369928|19603957|P1|COMPLETED|Overall Study||77
7963847|NCT00369928|19603955|P3|STARTED|Overall Study||86
7963848|NCT00369928|19603956|P2|STARTED|Overall Study||85
7963849|NCT00369928|19603957|P1|STARTED|Overall Study||85
7963850|NCT00369915|19603967|P2|NOT COMPLETED|Overall Study||3
7963851|NCT00369915|19603968|P1|NOT COMPLETED|Overall Study||6
7963852|NCT00369915|19603967|P2|COMPLETED|Overall Study||4
7963853|NCT00369915|19603968|P1|COMPLETED|Overall Study||4
7963854|NCT00369915|19603967|P2|STARTED|Overall Study||7
7963855|NCT00369915|19603968|P1|STARTED|Overall Study||10
7963856|NCT00369824|19603982|P6|NOT COMPLETED|Overall Study||11
7963857|NCT00369824|19603983|P5|NOT COMPLETED|Overall Study||18
7963858|NCT00369824|19603984|P4|NOT COMPLETED|Overall Study||15
7963859|NCT00369824|19603985|P3|NOT COMPLETED|Overall Study||12
7963860|NCT00369824|19603986|P2|NOT COMPLETED|Overall Study||19
7963861|NCT00369824|19603987|P1|NOT COMPLETED|Overall Study||15
7963862|NCT00369824|19603982|P6|COMPLETED|Overall Study||204
7963863|NCT00369824|19603983|P5|COMPLETED|Overall Study||196
7963864|NCT00369824|19603984|P4|COMPLETED|Overall Study||199
7963865|NCT00369824|19603985|P3|COMPLETED|Overall Study||202
7963866|NCT00369824|19603986|P2|COMPLETED|Overall Study||195
7963867|NCT00369824|19603987|P1|COMPLETED|Overall Study||197
7963868|NCT00369824|19603982|P6|STARTED|Overall Study||215
7963869|NCT00369824|19603983|P5|STARTED|Overall Study||214
7963870|NCT00369824|19603984|P4|STARTED|Overall Study||214
7963871|NCT00369824|19603985|P3|STARTED|Overall Study||214
7963872|NCT00369824|19603986|P2|STARTED|Overall Study||214
7963873|NCT00369824|19603987|P1|STARTED|Overall Study||212
7963874|NCT00369785|19604087|P2|NOT COMPLETED|Overall Study||25
7963875|NCT00369785|19604088|P1|NOT COMPLETED|Overall Study||27
7963876|NCT00369785|19604087|P2|COMPLETED|Overall Study||74
7963877|NCT00369785|19604088|P1|COMPLETED|Overall Study||72
7963878|NCT00369785|19604087|P2|STARTED|Overall Study||99
7963879|NCT00369785|19604088|P1|STARTED|Overall Study||99
7963880|NCT00369746|19604098|P2|NOT COMPLETED|Overall Study||0
7963881|NCT00369746|19604099|P1|NOT COMPLETED|Overall Study||0
7963882|NCT00369746|19604098|P2|COMPLETED|Overall Study||536
7963883|NCT00369746|19604099|P1|COMPLETED|Overall Study||138
7963884|NCT00369746|19604098|P2|STARTED|Overall Study||536
7963885|NCT00369746|19604099|P1|STARTED|Overall Study||138
7963886|NCT00369707|19604109|P1|NOT COMPLETED|Follow up for 2 Years After Treatment||3
7963887|NCT00369707|19604109|P1|COMPLETED|Follow up for 2 Years After Treatment||38
7963888|NCT00369707|19604109|P1|STARTED|Follow up for 2 Years After Treatment||41
7963889|NCT00369707|19604109|P1|NOT COMPLETED|Maintenance Period (up to 4 Cycles)||8
7963890|NCT00369707|19604109|P1|COMPLETED|Maintenance Period (up to 4 Cycles)||27
7963891|NCT00369707|19604109|P1|STARTED|Maintenance Period (up to 4 Cycles)||35
7963892|NCT00369707|19604109|P1|NOT COMPLETED|Induction Part B (2 Cycles)||7
7963893|NCT00369707|19604109|P1|COMPLETED|Induction Part B (2 Cycles)||35
7963894|NCT00369707|19604109|P1|STARTED|Induction Part B (2 Cycles)||42
7963895|NCT00369707|19604109|P1|NOT COMPLETED|Induction Part A (1 Cycle -35 Days)||0
7963896|NCT00369707|19604109|P1|COMPLETED|Induction Part A (1 Cycle -35 Days)||42
7963897|NCT00369707|19604109|P1|STARTED|Induction Part A (1 Cycle -35 Days)||42
7963898|NCT00369681|19604122|P1|NOT COMPLETED|Overall Study||1
7963899|NCT00369681|19604122|P1|COMPLETED|Overall Study||49
7963900|NCT00369681|19604122|P1|STARTED|Overall Study||50
7963901|NCT00369668|19604132|P3|NOT COMPLETED|Overall Study||7
7963902|NCT00369668|19604133|P2|NOT COMPLETED|Overall Study||5
7963903|NCT00369668|19604134|P1|NOT COMPLETED|Overall Study||4
7963904|NCT00369668|19604132|P3|COMPLETED|Overall Study||3
7963905|NCT00369668|19604133|P2|COMPLETED|Overall Study||5
7963906|NCT00369668|19604134|P1|COMPLETED|Overall Study||6
7963907|NCT00369668|19604132|P3|STARTED|Overall Study||10
7963908|NCT00369668|19604133|P2|STARTED|Overall Study||10
7963909|NCT00369668|19604134|P1|STARTED|Overall Study|Original number of participants to be recruited for each group.|10
7963910|NCT00369655|19604148|P1|NOT COMPLETED|Overall Study||2
7963911|NCT00369655|19604148|P1|COMPLETED|Overall Study||19
7963912|NCT00369655|19604148|P1|STARTED|Overall Study||21
7963913|NCT00369629|19604157|P4|NOT COMPLETED|Follow up for 1 Year||0
7963914|NCT00369629|19604158|P3|NOT COMPLETED|Follow up for 1 Year||3
7963915|NCT00369629|19604159|P2|NOT COMPLETED|Follow up for 1 Year||2
7963916|NCT00369629|19604160|P1|NOT COMPLETED|Follow up for 1 Year||2
7963917|NCT00369629|19604157|P4|COMPLETED|Follow up for 1 Year||0
7963918|NCT00369629|19604158|P3|COMPLETED|Follow up for 1 Year||2
7963919|NCT00369629|19604159|P2|COMPLETED|Follow up for 1 Year||1
7963920|NCT00369629|19604160|P1|COMPLETED|Follow up for 1 Year||4
7963921|NCT00369629|19604157|P4|STARTED|Follow up for 1 Year||0
7963922|NCT00369629|19604158|P3|STARTED|Follow up for 1 Year||5
7963923|NCT00369629|19604159|P2|STARTED|Follow up for 1 Year||3
7963924|NCT00369629|19604160|P1|STARTED|Follow up for 1 Year|All patients treated on study go into the follow up period|6
7963925|NCT00369629|19604157|P4|NOT COMPLETED|Completed 4 More Cycles||0
7963926|NCT00369629|19604158|P3|NOT COMPLETED|Completed 4 More Cycles||2
7963927|NCT00369629|19604159|P2|NOT COMPLETED|Completed 4 More Cycles||2
7963928|NCT00369629|19604160|P1|NOT COMPLETED|Completed 4 More Cycles||4
7963929|NCT00369629|19604157|P4|COMPLETED|Completed 4 More Cycles||0
7963930|NCT00369629|19604158|P3|COMPLETED|Completed 4 More Cycles||0
7963931|NCT00369629|19604159|P2|COMPLETED|Completed 4 More Cycles||0
7963932|NCT00369629|19604160|P1|COMPLETED|Completed 4 More Cycles||0
7963933|NCT00369629|19604157|P4|STARTED|Completed 4 More Cycles||0
7963934|NCT00369629|19604158|P3|STARTED|Completed 4 More Cycles||2
7963935|NCT00369629|19604159|P2|STARTED|Completed 4 More Cycles||2
7963936|NCT00369629|19604160|P1|STARTED|Completed 4 More Cycles||4
7963937|NCT00369629|19604157|P4|NOT COMPLETED|Moved on to 4 More Cycles||0
7963938|NCT00369629|19604158|P3|NOT COMPLETED|Moved on to 4 More Cycles||1
7963939|NCT00369629|19604159|P2|NOT COMPLETED|Moved on to 4 More Cycles||0
7963940|NCT00369629|19604160|P1|NOT COMPLETED|Moved on to 4 More Cycles||0
7963941|NCT00369629|19604157|P4|COMPLETED|Moved on to 4 More Cycles||0
7963942|NCT00369629|19604158|P3|COMPLETED|Moved on to 4 More Cycles||2
7963943|NCT00369629|19604159|P2|COMPLETED|Moved on to 4 More Cycles||2
7963944|NCT00369629|19604160|P1|COMPLETED|Moved on to 4 More Cycles||4
7963945|NCT00369629|19604157|P4|STARTED|Moved on to 4 More Cycles||0
7963946|NCT00369629|19604158|P3|STARTED|Moved on to 4 More Cycles||3
7963947|NCT00369629|19604159|P2|STARTED|Moved on to 4 More Cycles||2
7963948|NCT00369629|19604160|P1|STARTED|Moved on to 4 More Cycles||4
7963949|NCT00369629|19604157|P4|NOT COMPLETED|Treated 2 Cycles/Reached First Response||0
7963950|NCT00369629|19604158|P3|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
7963951|NCT00369629|19604159|P2|NOT COMPLETED|Treated 2 Cycles/Reached First Response||1
7963952|NCT00369629|19604160|P1|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
7963953|NCT00369629|19604157|P4|COMPLETED|Treated 2 Cycles/Reached First Response||0
7963954|NCT00369629|19604158|P3|COMPLETED|Treated 2 Cycles/Reached First Response||3
7963955|NCT00369629|19604159|P2|COMPLETED|Treated 2 Cycles/Reached First Response||2
7963956|NCT00369629|19604160|P1|COMPLETED|Treated 2 Cycles/Reached First Response||4
7963957|NCT00369629|19604157|P4|STARTED|Treated 2 Cycles/Reached First Response|No patients were enrolled at this dose level as the study closed early due to lack of funding.|0
7963958|NCT00369629|19604158|P3|STARTED|Treated 2 Cycles/Reached First Response||5
7963959|NCT00369629|19604159|P2|STARTED|Treated 2 Cycles/Reached First Response||3
7963960|NCT00369629|19604160|P1|STARTED|Treated 2 Cycles/Reached First Response||6
7963961|NCT00369590|19604172|P2|NOT COMPLETED|Overall Study||0
7963962|NCT00369590|19604173|P1|NOT COMPLETED|Overall Study||0
7963963|NCT00369590|19604172|P2|COMPLETED|Overall Study||42
7963964|NCT00369590|19604173|P1|COMPLETED|Overall Study||16
7963965|NCT00369590|19604172|P2|STARTED|Overall Study||42
7963966|NCT00369590|19604173|P1|STARTED|Overall Study||16
7963967|NCT00369577|19604191|P3|NOT COMPLETED|Overall Study||1
7963968|NCT00369577|19604192|P2|NOT COMPLETED|Overall Study||0
7963969|NCT00369577|19604193|P1|NOT COMPLETED|Overall Study||0
7963970|NCT00369577|19604191|P3|COMPLETED|Overall Study||40
7963971|NCT00369577|19604192|P2|COMPLETED|Overall Study||45
7963972|NCT00369577|19604193|P1|COMPLETED|Overall Study||43
7963973|NCT00369577|19604191|P3|STARTED|Overall Study||41
7963974|NCT00369577|19604192|P2|STARTED|Overall Study||45
7963975|NCT00369577|19604193|P1|STARTED|Overall Study||43
7963976|NCT00369564|19604212|P2|NOT COMPLETED|Overall Study||23
7963977|NCT00369564|19604213|P1|NOT COMPLETED|Overall Study||43
7963978|NCT00369564|19604212|P2|COMPLETED|Overall Study||100
7963979|NCT00369564|19604213|P1|COMPLETED|Overall Study||84
7963980|NCT00369564|19604212|P2|STARTED|Overall Study||123
7963981|NCT00369564|19604213|P1|STARTED|Overall Study||127
7963982|NCT00369512|19604219|P1|NOT COMPLETED|Overall Study||0
7963983|NCT00369512|19604219|P1|COMPLETED|Overall Study||15
7963984|NCT00369512|19604219|P1|STARTED|Overall Study||15
7963985|NCT00369486|19604230|P5|NOT COMPLETED|34-Week Visit||3
7963986|NCT00369486|19604231|P4|NOT COMPLETED|34-Week Visit||3
7963987|NCT00369486|19604232|P3|NOT COMPLETED|34-Week Visit||1
7963988|NCT00369486|19604233|P2|NOT COMPLETED|34-Week Visit||1
7963989|NCT00369486|19604234|P1|NOT COMPLETED|34-Week Visit||0
7963990|NCT00369486|19604230|P5|COMPLETED|34-Week Visit|Number of eyes|22
7963991|NCT00369486|19604231|P4|COMPLETED|34-Week Visit|Number of eyes|19
7963992|NCT00369486|19604232|P3|COMPLETED|34-Week Visit|Number of eyes|22
7963993|NCT00369486|19604233|P2|COMPLETED|34-Week Visit|Number of eyes|20
7963994|NCT00369486|19604234|P1|COMPLETED|34-Week Visit|Number of eyes|38
7963995|NCT00369486|19604230|P5|STARTED|34-Week Visit|Number of eyes that|25
7963996|NCT00369486|19604231|P4|STARTED|34-Week Visit|Number of eyes|22
7963997|NCT00369486|19604232|P3|STARTED|34-Week Visit|Number of eyes|23
7963998|NCT00369486|19604233|P2|STARTED|34-Week Visit|Number of eyes|21
7963999|NCT00369486|19604234|P1|STARTED|34-Week Visit|Number of eyes|38
7964000|NCT00369486|19604230|P5|NOT COMPLETED|17-Week Visit||1
7964001|NCT00369486|19604231|P4|NOT COMPLETED|17-Week Visit||1
7964002|NCT00369486|19604232|P3|NOT COMPLETED|17-Week Visit||1
7964003|NCT00369486|19604233|P2|NOT COMPLETED|17-Week Visit||0
7964004|NCT00369486|19604234|P1|NOT COMPLETED|17-Week Visit||0
7964005|NCT00369486|19604230|P5|COMPLETED|17-Week Visit|Number of eyes|24
7964006|NCT00369486|19604231|P4|COMPLETED|17-Week Visit|Number of eyes|21
7964007|NCT00369486|19604232|P3|COMPLETED|17-Week Visit|Number of eyes|22
7964008|NCT00369486|19604233|P2|COMPLETED|17-Week Visit|Number of eyes|21
7964009|NCT00369486|19604234|P1|COMPLETED|17-Week Visit|Number of eyes|38
7964010|NCT00369486|19604230|P5|STARTED|17-Week Visit|Number of eyes|25
7964011|NCT00369486|19604231|P4|STARTED|17-Week Visit|Number of eyes|22
7964012|NCT00369486|19604232|P3|STARTED|17-Week Visit|Number of eyes|23
7964013|NCT00369486|19604233|P2|STARTED|17-Week Visit|Number of eyes|21
7964014|NCT00369486|19604234|P1|STARTED|17-Week Visit|Number of eyes|38
7964015|NCT00369486|19604230|P5|NOT COMPLETED|8-Week Visit||1
7964016|NCT00369486|19604231|P4|NOT COMPLETED|8-Week Visit||1
7964017|NCT00369486|19604232|P3|NOT COMPLETED|8-Week Visit||0
7964018|NCT00369486|19604233|P2|NOT COMPLETED|8-Week Visit||1
7964019|NCT00369486|19604234|P1|NOT COMPLETED|8-Week Visit||0
7964020|NCT00369486|19604230|P5|COMPLETED|8-Week Visit|Number of eyes|24
7964021|NCT00369486|19604231|P4|COMPLETED|8-Week Visit|Number of eyes|21
7964022|NCT00369486|19604232|P3|COMPLETED|8-Week Visit|Number of eyes|22
7964023|NCT00369486|19604233|P2|COMPLETED|8-Week Visit|Number of eyes|20
7964024|NCT00369486|19604234|P1|COMPLETED|8-Week Visit|Number of eyes|38
7964025|NCT00369486|19604230|P5|STARTED|8-Week Visit|Number of eyes|25
7964026|NCT00369486|19604231|P4|STARTED|8-Week Visit|Number of eyes|22
7964027|NCT00369486|19604232|P3|STARTED|8-Week Visit|Number of eyes|22
7964028|NCT00369486|19604233|P2|STARTED|8-Week Visit|Number of eyes|21
7964029|NCT00369486|19604234|P1|STARTED|8-Week Visit|Number of eyes|38
7964030|NCT00369486|19604230|P5|NOT COMPLETED|4-Week Visit||1
7964031|NCT00369486|19604231|P4|NOT COMPLETED|4-Week Visit||2
7964032|NCT00369486|19604232|P3|NOT COMPLETED|4-Week Visit||1
7964033|NCT00369486|19604233|P2|NOT COMPLETED|4-Week Visit||2
7964034|NCT00369486|19604234|P1|NOT COMPLETED|4-Week Visit||2
7964035|NCT00369486|19604230|P5|COMPLETED|4-Week Visit|Number of eyes|24
7964036|NCT00369486|19604231|P4|COMPLETED|4-Week Visit|Number of eyes|20
7964037|NCT00369486|19604232|P3|COMPLETED|4-Week Visit|Number of eyes|22
7964038|NCT00369486|19604233|P2|COMPLETED|4-Week Visit|Number of eyes;|19
7964039|NCT00369486|19604234|P1|COMPLETED|4-Week Visit|Number of eyes|36
7964040|NCT00369486|19604230|P5|STARTED|4-Week Visit|Number of eyes|25
7964041|NCT00369486|19604231|P4|STARTED|4-Week Visit|Number of eyes|22
7964042|NCT00369486|19604232|P3|STARTED|4-Week Visit|Number of eyes|23
7964043|NCT00369486|19604233|P2|STARTED|4-Week Visit|Number of eyes|21
7964044|NCT00369486|19604234|P1|STARTED|4-Week Visit|Number of eyes|38
7964045|NCT00369382|19604273|P2|NOT COMPLETED|Overall Study||3
7964046|NCT00369382|19604274|P1|NOT COMPLETED|Overall Study||10
7964047|NCT00369382|19604273|P2|COMPLETED|Overall Study||54
7964048|NCT00369382|19604274|P1|COMPLETED|Overall Study||49
7964049|NCT00369382|19604273|P2|Completed Assigned Treatment Regimen|Overall Study||33
7964050|NCT00369382|19604274|P1|Completed Assigned Treatment Regimen|Overall Study||48
7964051|NCT00369382|19604273|P2|Received Treatment|Overall Study||57
7964052|NCT00369382|19604274|P1|Received Treatment|Overall Study||57
7964053|NCT00369382|19604273|P2|STARTED|Overall Study||57
7964054|NCT00369382|19604274|P1|STARTED|Overall Study||59
7964055|NCT00369343|19604307|P2|NOT COMPLETED|Open-label Phase||30
7964056|NCT00369343|19604308|P1|NOT COMPLETED|Open-label Phase||57
7964057|NCT00369343|19604307|P2|COMPLETED|Open-label Phase||79
7964058|NCT00369343|19604308|P1|COMPLETED|Open-label Phase||155
7964059|NCT00369343|19604307|P2|STARTED|Open-label Phase||109
7964060|NCT00369343|19604308|P1|STARTED|Open-label Phase||212
7964061|NCT00369343|19604307|P2|NOT COMPLETED|Double-blind Phase||16
7964062|NCT00369343|19604308|P1|NOT COMPLETED|Double-blind Phase||44
7964063|NCT00369343|19604307|P2|COMPLETED|Double-blind Phase||109
7964064|NCT00369343|19604308|P1|COMPLETED|Double-blind Phase||212
7964065|NCT00369343|19604307|P2|STARTED|Double-blind Phase||125
7964066|NCT00369343|19604308|P1|STARTED|Double-blind Phase||256
7964067|NCT00369317|19604341|P1|NOT COMPLETED|Overall Study||20
7964068|NCT00369317|19604341|P1|COMPLETED|Overall Study||185
7964069|NCT00369317|19604341|P1|STARTED|Overall Study||205
7964070|NCT00369278|19604357|P2|NOT COMPLETED|Overall Study||21
7964071|NCT00369278|19604358|P1|NOT COMPLETED|Overall Study||24
7964072|NCT00369278|19604357|P2|COMPLETED|Overall Study||44
7964073|NCT00369278|19604358|P1|COMPLETED|Overall Study||39
7964074|NCT00369278|19604357|P2|STARTED|Overall Study||65
7964075|NCT00369278|19604358|P1|STARTED|Overall Study||63
7964076|NCT00369265|19604374|P2|NOT COMPLETED|Overall Study||7
7964077|NCT00369265|19604375|P1|NOT COMPLETED|Overall Study||4
7964078|NCT00369265|19604374|P2|COMPLETED|Overall Study||0
7964079|NCT00369265|19604375|P1|COMPLETED|Overall Study||0
7964080|NCT00369265|19604374|P2|STARTED|Overall Study||7
7964081|NCT00369265|19604375|P1|STARTED|Overall Study||4
7964082|NCT00369226|19604383|P2|NOT COMPLETED|Phase II (45 Days)||0
7964083|NCT00369226|19604384|P1|NOT COMPLETED|Phase II (45 Days)||0
7964084|NCT00369226|19604383|P2|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32
7964085|NCT00369226|19604384|P1|COMPLETED|Phase II (45 Days)||0
7964086|NCT00369226|19604383|P2|STARTED|Phase II (45 Days)||32
7964087|NCT00369226|19604384|P1|STARTED|Phase II (45 Days)||0
7964088|NCT00369226|19604383|P2|NOT COMPLETED|Phase I (45 Days)||0
7964089|NCT00369226|19604384|P1|NOT COMPLETED|Phase I (45 Days)||0
7964090|NCT00369226|19604383|P2|COMPLETED|Phase I (45 Days)||0
7964091|NCT00369226|19604384|P1|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13
7964092|NCT00369226|19604383|P2|STARTED|Phase I (45 Days)||0
7964093|NCT00369226|19604384|P1|STARTED|Phase I (45 Days)||13
7964094|NCT00369161|19604396|P2|NOT COMPLETED|Overall Study||24
7964095|NCT00369161|19604397|P1|NOT COMPLETED|Overall Study||27
7964096|NCT00369161|19604396|P2|COMPLETED|Overall Study||95
7964097|NCT00369161|19604397|P1|COMPLETED|Overall Study||82
7964098|NCT00369161|19604396|P2|Intention to Treat (ITT)|Overall Study||117
7964099|NCT00369161|19604397|P1|Intention to Treat (ITT)|Overall Study||107
7964100|NCT00369161|19604396|P2|STARTED|Overall Study||119
7964101|NCT00369161|19604397|P1|STARTED|Overall Study|"Started indicates randomized and safety population."|109
7964102|NCT00369122|19604407|P1|NOT COMPLETED|Overall Study||11
7964103|NCT00369122|19604407|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49
7964104|NCT00369122|19604407|P1|STARTED|Overall Study||60
7964105|NCT00368992|19604414|P1|NOT COMPLETED|Overall Study||110
7964106|NCT00368992|19604414|P1|COMPLETED|Overall Study||0
7964107|NCT00368992|19604414|P1|STARTED|Overall Study||110
7964108|NCT00368979|19604423|P2|NOT COMPLETED|Overall Study||30
7964109|NCT00368979|19604424|P1|NOT COMPLETED|Overall Study||25
7964110|NCT00368979|19604423|P2|COMPLETED|Overall Study||163
7964111|NCT00368979|19604424|P1|COMPLETED|Overall Study||160
7964112|NCT00368979|19604423|P2|STARTED|Overall Study||193
7964113|NCT00368979|19604424|P1|STARTED|Overall Study||185
7964114|NCT00368966|19604440|P2|NOT COMPLETED|Toddler Dose||3
7964115|NCT00368966|19604441|P1|NOT COMPLETED|Toddler Dose||1
7964116|NCT00368966|19604440|P2|COMPLETED|Toddler Dose||286
7964117|NCT00368966|19604441|P1|COMPLETED|Toddler Dose||292
7964118|NCT00368966|19604440|P2|STARTED|Toddler Dose||289
7964119|NCT00368966|19604441|P1|STARTED|Toddler Dose||293
7964120|NCT00368966|19604440|P2|NOT COMPLETED|After Infant||5
7964121|NCT00368966|19604441|P1|NOT COMPLETED|After Infant||6
7964122|NCT00368966|19604440|P2|COMPLETED|After Infant||289
7964123|NCT00368966|19604441|P1|COMPLETED|After Infant||293
7964124|NCT00368966|19604440|P2|STARTED|After Infant||294
7964125|NCT00368966|19604441|P1|STARTED|After Infant||299
7964126|NCT00368966|19604440|P2|NOT COMPLETED|Infant Series||10
7964127|NCT00368966|19604441|P1|NOT COMPLETED|Infant Series||16
7964128|NCT00368966|19604440|P2|COMPLETED|Infant Series||294
7964129|NCT00368966|19604441|P1|COMPLETED|Infant Series||299
7964130|NCT00368966|19604440|P2|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296
7964131|NCT00368966|19604441|P1|Vaccinated Dose 3|Infant Series||301
7964132|NCT00368966|19604440|P2|Vaccinated Dose 2|Infant Series||298
7964133|NCT00368966|19604441|P1|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307
7964134|NCT00368966|19604440|P2|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302
7964135|NCT00368966|19604441|P1|Vaccinated Dose 1|Infant Series||314
7964136|NCT00368966|19604440|P2|STARTED|Infant Series||304
7964137|NCT00368966|19604441|P1|STARTED|Infant Series||315
7964138|NCT00368940|19604497|P2|NOT COMPLETED|Completed 12-wk Treatment||5
7964139|NCT00368940|19604498|P1|NOT COMPLETED|Completed 12-wk Treatment||6
7964140|NCT00368940|19604497|P2|COMPLETED|Completed 12-wk Treatment||32
7964141|NCT00368940|19604498|P1|COMPLETED|Completed 12-wk Treatment||31
7964142|NCT00368940|19604497|P2|STARTED|Completed 12-wk Treatment||37
7964143|NCT00368940|19604498|P1|STARTED|Completed 12-wk Treatment||37
7964144|NCT00368940|19604497|P2|NOT COMPLETED|Intention-to-Treat||0
7964145|NCT00368940|19604498|P1|NOT COMPLETED|Intention-to-Treat||0
7964146|NCT00368940|19604497|P2|COMPLETED|Intention-to-Treat||37
7964147|NCT00368940|19604498|P1|COMPLETED|Intention-to-Treat||37
7964148|NCT00368940|19604497|P2|STARTED|Intention-to-Treat||37
7964149|NCT00368940|19604498|P1|STARTED|Intention-to-Treat||37
7964150|NCT00368927|19604512|P2|NOT COMPLETED|Overall Study||3
7964151|NCT00368927|19604513|P1|NOT COMPLETED|Overall Study||5
7964152|NCT00368927|19604512|P2|COMPLETED|Overall Study||27
7964153|NCT00368927|19604513|P1|COMPLETED|Overall Study||26
7964154|NCT00368927|19604512|P2|STARTED|Overall Study||30
7964155|NCT00368927|19604513|P1|STARTED|Overall Study||31
7964156|NCT00368875|19604521|P2|NOT COMPLETED|Overall Study||48
7964157|NCT00368875|19604522|P1|NOT COMPLETED|Overall Study||6
7964158|NCT00368875|19604521|P2|COMPLETED|Overall Study||0
7964159|NCT00368875|19604522|P1|COMPLETED|Overall Study||0
7964160|NCT00368875|19604521|P2|STARTED|Overall Study||48
7964161|NCT00368875|19604522|P1|STARTED|Overall Study||6
7964162|NCT00368849|19604530|P2|NOT COMPLETED|Overall Study||2
7964163|NCT00368849|19604531|P1|NOT COMPLETED|Overall Study||0
7964164|NCT00368849|19604530|P2|COMPLETED|Overall Study||8
7964165|NCT00368849|19604531|P1|COMPLETED|Overall Study||10
7964166|NCT00368849|19604530|P2|STARTED|Overall Study||10
7964167|NCT00368849|19604531|P1|STARTED|Overall Study||10
7964168|NCT00368745|19604547|P2|NOT COMPLETED|Double-blind Treatment Period||31
7964169|NCT00368745|19604548|P1|NOT COMPLETED|Double-blind Treatment Period||26
7964170|NCT00368745|19604547|P2|COMPLETED|Double-blind Treatment Period||19
7964171|NCT00368745|19604548|P1|COMPLETED|Double-blind Treatment Period||30
7964172|NCT00368745|19604547|P2|STARTED|Double-blind Treatment Period||50
7964173|NCT00368745|19604548|P1|STARTED|Double-blind Treatment Period||56
7964174|NCT00368745|19604547|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
7964175|NCT00368745|19604548|P1|NOT COMPLETED|Randomized to Double-blind Treatment||1
7964176|NCT00368745|19604547|P2|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50
7964177|NCT00368745|19604548|P1|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56
7964178|NCT00368745|19604547|P2|STARTED|Randomized to Double-blind Treatment||51
7964179|NCT00368745|19604548|P1|STARTED|Randomized to Double-blind Treatment||57
7964180|NCT00368654|19604582|P4|NOT COMPLETED|Overall Study||3
7964181|NCT00368654|19604583|P3|NOT COMPLETED|Overall Study||3
7964182|NCT00368654|19604584|P2|NOT COMPLETED|Overall Study||3
7964183|NCT00368654|19604585|P1|NOT COMPLETED|Overall Study||3
7964184|NCT00368654|19604582|P4|COMPLETED|Overall Study||0
7964185|NCT00368654|19604583|P3|COMPLETED|Overall Study||0
7964186|NCT00368654|19604584|P2|COMPLETED|Overall Study||0
7964187|NCT00368654|19604585|P1|COMPLETED|Overall Study||0
7964188|NCT00368654|19604582|P4|STARTED|Overall Study||3
7964189|NCT00368654|19604583|P3|STARTED|Overall Study||3
7964190|NCT00368654|19604584|P2|STARTED|Overall Study||3
7964191|NCT00368654|19604585|P1|STARTED|Overall Study||3
7964192|NCT00368641|19604601|P2|NOT COMPLETED|Overall Study||6
7964193|NCT00368641|19604602|P1|NOT COMPLETED|Overall Study||6
7964194|NCT00368641|19604601|P2|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
7964195|NCT00368641|19604602|P1|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
7964196|NCT00368641|19604601|P2|STARTED|Overall Study||6
7964197|NCT00368641|19604602|P1|STARTED|Overall Study||6
7964198|NCT00368550|19604610|P2|NOT COMPLETED|Overall Study||23
7964199|NCT00368550|19604611|P1|NOT COMPLETED|Overall Study||28
7964200|NCT00368550|19604610|P2|COMPLETED|Overall Study||48
7964201|NCT00368550|19604611|P1|COMPLETED|Overall Study||35
7964202|NCT00368550|19604610|P2|STARTED|Overall Study||71
7964203|NCT00368550|19604611|P1|STARTED|Overall Study||63
7964204|NCT00368537|19604623|P2|NOT COMPLETED|Baseline Participants||24
7964205|NCT00368537|19604624|P1|NOT COMPLETED|Baseline Participants||24
7964206|NCT00368537|19604623|P2|COMPLETED|Baseline Participants||239
7964207|NCT00368537|19604624|P1|COMPLETED|Baseline Participants||244
7964208|NCT00368537|19604623|P2|STARTED|Baseline Participants||263
7964209|NCT00368537|19604624|P1|STARTED|Baseline Participants||268
7964210|NCT00368537|19604623|P2|NOT COMPLETED|Randomization||6
7964211|NCT00368537|19604624|P1|NOT COMPLETED|Randomization||13
7964212|NCT00368537|19604623|P2|COMPLETED|Randomization||263
7964213|NCT00368537|19604624|P1|COMPLETED|Randomization||268
7964214|NCT00368537|19604623|P2|STARTED|Randomization||269
7964215|NCT00368537|19604624|P1|STARTED|Randomization||281
7964216|NCT00368472|19604638|P1|NOT COMPLETED|Overall Study||105
7964217|NCT00368472|19604638|P1|COMPLETED|Overall Study||33
7964218|NCT00368472|19604638|P1|STARTED|Overall Study||138
7964219|NCT00368459|19604646|P2|NOT COMPLETED|Overall Study||1
7964220|NCT00368459|19604647|P1|NOT COMPLETED|Overall Study||2
7964221|NCT00368459|19604646|P2|COMPLETED|Overall Study||20
7964222|NCT00368459|19604647|P1|COMPLETED|Overall Study||19
7964223|NCT00368459|19604646|P2|STARTED|Overall Study||21
7964224|NCT00368459|19604647|P1|STARTED|Overall Study||21
7964225|NCT00368355|19604673|P2|NOT COMPLETED|Overall Study||17
7964226|NCT00368355|19604674|P1|NOT COMPLETED|Overall Study||11
7964227|NCT00368355|19604673|P2|COMPLETED|Overall Study||11
7964228|NCT00368355|19604674|P1|COMPLETED|Overall Study||7
7964229|NCT00368355|19604673|P2|STARTED|Overall Study||28
7964230|NCT00368355|19604674|P1|STARTED|Overall Study||18
7964231|NCT00368316|19604690|P2|NOT COMPLETED|Overall Study||46
7964232|NCT00368316|19604691|P1|NOT COMPLETED|Overall Study||42
7964233|NCT00368316|19604690|P2|COMPLETED|Overall Study||1319
7964234|NCT00368316|19604691|P1|COMPLETED|Overall Study||1392
7964235|NCT00368316|19604690|P2|STARTED|Overall Study||1365
7964236|NCT00368316|19604691|P1|STARTED|Overall Study||1434
7964237|NCT00368290|19604703|P2|NOT COMPLETED|Overall Study||10
7964238|NCT00368290|19604704|P1|NOT COMPLETED|Overall Study||13
7964239|NCT00368290|19604703|P2|COMPLETED|Overall Study||37
7964240|NCT00368290|19604704|P1|COMPLETED|Overall Study||34
7964241|NCT00368290|19604703|P2|STARTED|Overall Study||47
7964242|NCT00368290|19604704|P1|STARTED|Overall Study||47
7964243|NCT00368277|19604714|P2|NOT COMPLETED|Overall Study||108
7964244|NCT00368277|19604715|P1|NOT COMPLETED|Overall Study||113
7964245|NCT00368277|19604714|P2|COMPLETED|Overall Study||336
7964246|NCT00368277|19604715|P1|COMPLETED|Overall Study||344
7964247|NCT00368277|19604714|P2|STARTED|Overall Study||444
7964248|NCT00368277|19604715|P1|STARTED|Overall Study||457
7964249|NCT00368251|19604730|P3|NOT COMPLETED|Overall Study||1
7964250|NCT00368251|19604731|P2|NOT COMPLETED|Overall Study||0
7964251|NCT00368251|19604732|P1|NOT COMPLETED|Overall Study||1
7964252|NCT00368251|19604730|P3|COMPLETED|Overall Study||17
7964253|NCT00368251|19604731|P2|COMPLETED|Overall Study||20
7964254|NCT00368251|19604732|P1|COMPLETED|Overall Study||17
7964255|NCT00368251|19604730|P3|STARTED|Overall Study||18
7964256|NCT00368251|19604731|P2|STARTED|Overall Study||20
7964257|NCT00368251|19604732|P1|STARTED|Overall Study||18
7964258|NCT00368108|19604755|P3|NOT COMPLETED|Overall Study||68
7964259|NCT00368108|19604756|P2|NOT COMPLETED|Overall Study||53
7964260|NCT00368108|19604757|P1|NOT COMPLETED|Overall Study||64
7964261|NCT00368108|19604755|P3|COMPLETED|Overall Study||182
7964262|NCT00368108|19604756|P2|COMPLETED|Overall Study||198
7964263|NCT00368108|19604757|P1|COMPLETED|Overall Study||187
7964264|NCT00368108|19604755|P3|STARTED|Overall Study||250
7964265|NCT00368108|19604756|P2|STARTED|Overall Study||251
7964266|NCT00368108|19604757|P1|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251
7964267|NCT00368069|19604776|P2|NOT COMPLETED|Overall Study||7
7964268|NCT00368069|19604777|P1|NOT COMPLETED|Overall Study||8
7964269|NCT00368069|19604776|P2|COMPLETED|Overall Study||72
7964270|NCT00368069|19604777|P1|COMPLETED|Overall Study||71
7964271|NCT00368069|19604776|P2|STARTED|Overall Study||79
7964272|NCT00368069|19604777|P1|STARTED|Overall Study||79
7964273|NCT00367991|19604795|P2|NOT COMPLETED|Overall Study||2
7964274|NCT00367991|19604796|P1|NOT COMPLETED|Overall Study||2
7964275|NCT00367991|19604795|P2|COMPLETED|Overall Study||13
7964276|NCT00367991|19604796|P1|COMPLETED|Overall Study||27
7964277|NCT00367991|19604795|P2|STARTED|Overall Study||15
7964278|NCT00367991|19604796|P1|STARTED|Overall Study||29
7964279|NCT00367835|19604814|P2|NOT COMPLETED|Overall Study||31
7964280|NCT00367835|19604815|P1|NOT COMPLETED|Overall Study||29
7964281|NCT00367835|19604814|P2|COMPLETED|Overall Study||48
7964282|NCT00367835|19604815|P1|COMPLETED|Overall Study||109
7964283|NCT00367835|19604814|P2|STARTED|Overall Study||79
7964284|NCT00367835|19604815|P1|STARTED|Overall Study||138
7964285|NCT00367770|19604841|P1|NOT COMPLETED|Overall Study||2
7964286|NCT00367770|19604841|P1|COMPLETED|Overall Study||35
7964287|NCT00367770|19604841|P1|STARTED|Overall Study||37
7964288|NCT00367744|19604849|P2|NOT COMPLETED|Overall Study||5
7964289|NCT00367744|19604850|P1|NOT COMPLETED|Overall Study||4
7964290|NCT00367744|19604849|P2|COMPLETED|Overall Study||32
7964291|NCT00367744|19604850|P1|COMPLETED|Overall Study||30
7964292|NCT00367744|19604849|P2|STARTED|Overall Study||37
7964293|NCT00367744|19604850|P1|STARTED|Overall Study||34
7964294|NCT00367679|19604858|P1|NOT COMPLETED|Overall Study||0
7964295|NCT00367679|19604858|P1|COMPLETED|Overall Study||35
7964296|NCT00367679|19604858|P1|STARTED|Overall Study||35
7964297|NCT00367640|19604879|P4|NOT COMPLETED|Overall Study||10
7964298|NCT00367640|19604880|P3|NOT COMPLETED|Overall Study||19
7964299|NCT00367640|19604881|P2|NOT COMPLETED|Overall Study||22
7964300|NCT00367640|19604882|P1|NOT COMPLETED|Overall Study||18
7964301|NCT00367640|19604879|P4|COMPLETED|Overall Study||146
7964302|NCT00367640|19604880|P3|COMPLETED|Overall Study||141
7964303|NCT00367640|19604881|P2|COMPLETED|Overall Study||133
7964304|NCT00367640|19604882|P1|COMPLETED|Overall Study||139
7964305|NCT00367640|19604879|P4|STARTED|Overall Study||156
7964306|NCT00367640|19604880|P3|STARTED|Overall Study||160
7964307|NCT00367640|19604881|P2|STARTED|Overall Study||155
7964308|NCT00367640|19604882|P1|STARTED|Overall Study||157
7964309|NCT00367601|19604892|P1|NOT COMPLETED|Overall Study||0
7964310|NCT00367601|19604892|P1|COMPLETED|Overall Study||25
7964311|NCT00367601|19604892|P1|STARTED|Overall Study||25
7964312|NCT00367484|19604898|P1|NOT COMPLETED|Overall Study||17
7964313|NCT00367484|19604898|P1|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443
7964314|NCT00367484|19604898|P1|STARTED|Overall Study||460
7964315|NCT00367458|19604904|P2|NOT COMPLETED|Second Intervention - 8 Weeks||0
7964316|NCT00367458|19604905|P1|NOT COMPLETED|Second Intervention - 8 Weeks||0
7964317|NCT00367458|19604904|P2|COMPLETED|Second Intervention - 8 Weeks||12
7964318|NCT00367458|19604905|P1|COMPLETED|Second Intervention - 8 Weeks||10
7964319|NCT00367458|19604904|P2|STARTED|Second Intervention - 8 Weeks||12
7964320|NCT00367458|19604905|P1|STARTED|Second Intervention - 8 Weeks||10
7964321|NCT00367458|19604904|P2|NOT COMPLETED|Washout Period - 4-6 Weeks||0
7964322|NCT00367458|19604905|P1|NOT COMPLETED|Washout Period - 4-6 Weeks||0
7964323|NCT00367458|19604904|P2|COMPLETED|Washout Period - 4-6 Weeks||12
7964324|NCT00367458|19604905|P1|COMPLETED|Washout Period - 4-6 Weeks||10
7964325|NCT00367458|19604904|P2|STARTED|Washout Period - 4-6 Weeks||12
7964326|NCT00367458|19604905|P1|STARTED|Washout Period - 4-6 Weeks||10
7964327|NCT00367458|19604904|P2|NOT COMPLETED|First Intervention - 8 Weeks||0
7964328|NCT00367458|19604905|P1|NOT COMPLETED|First Intervention - 8 Weeks||2
7964329|NCT00367458|19604904|P2|COMPLETED|First Intervention - 8 Weeks||12
7964330|NCT00367458|19604905|P1|COMPLETED|First Intervention - 8 Weeks||10
7964331|NCT00367458|19604904|P2|STARTED|First Intervention - 8 Weeks||12
7964332|NCT00367458|19604905|P1|STARTED|First Intervention - 8 Weeks||12
7964333|NCT00367432|19604919|P2|NOT COMPLETED|Second Period (up to 54 Months)||16
7964334|NCT00367432|19604920|P1|NOT COMPLETED|Second Period (up to 54 Months)||87
7964335|NCT00367432|19604919|P2|COMPLETED|Second Period (up to 54 Months)||69
7964336|NCT00367432|19604920|P1|COMPLETED|Second Period (up to 54 Months)||188
7964337|NCT00367432|19604919|P2|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85
7964338|NCT00367432|19604920|P1|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275
7964339|NCT00367432|19604919|P2|NOT COMPLETED|First Period (16 Weeks)||0
7964340|NCT00367432|19604920|P1|NOT COMPLETED|First Period (16 Weeks)||38
7964341|NCT00367432|19604919|P2|COMPLETED|First Period (16 Weeks)||0
7964342|NCT00367432|19604920|P1|COMPLETED|First Period (16 Weeks)||275
7964343|NCT00367432|19604919|P2|STARTED|First Period (16 Weeks)||0
7964344|NCT00367432|19604920|P1|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313
7964345|NCT00367380|19604935|P3|NOT COMPLETED|Overall Study||0
7964346|NCT00367380|19604936|P2|NOT COMPLETED|Overall Study||0
7964347|NCT00367380|19604937|P1|NOT COMPLETED|Overall Study||0
7964348|NCT00367380|19604935|P3|COMPLETED|Overall Study||6
7964349|NCT00367380|19604936|P2|COMPLETED|Overall Study||6
7964350|NCT00367380|19604937|P1|COMPLETED|Overall Study||6
7964351|NCT00367380|19604935|P3|STARTED|Overall Study||6
7964352|NCT00367380|19604936|P2|STARTED|Overall Study||6
7964353|NCT00367380|19604937|P1|STARTED|Overall Study||6
7964354|NCT00367341|19604947|P2|NOT COMPLETED|Overall Study||0
7964355|NCT00367341|19604948|P1|NOT COMPLETED|Overall Study||2
7964356|NCT00367341|19604947|P2|COMPLETED|Overall Study||40
7964357|NCT00367341|19604948|P1|COMPLETED|Overall Study||40
7964358|NCT00367341|19604947|P2|STARTED|Overall Study||40
7964359|NCT00367341|19604948|P1|STARTED|Overall Study||42
7964360|NCT00367237|19604958|P2|NOT COMPLETED|Overall Study||11
7964361|NCT00367237|19604959|P1|NOT COMPLETED|Overall Study||10
7964362|NCT00367237|19604958|P2|COMPLETED|Overall Study||47
7964363|NCT00367237|19604959|P1|COMPLETED|Overall Study||47
7964364|NCT00367237|19604958|P2|STARTED|Overall Study|Number of subjects randomized|58
7964365|NCT00367237|19604959|P1|STARTED|Overall Study|Number of subjects randomized|57
7964366|NCT00367133|19604968|P3|NOT COMPLETED|3 Years||18
7964367|NCT00367133|19604969|P2|NOT COMPLETED|3 Years||23
7964368|NCT00367133|19604970|P1|NOT COMPLETED|3 Years||28
7964369|NCT00367133|19604968|P3|COMPLETED|3 Years||98
7964370|NCT00367133|19604969|P2|COMPLETED|3 Years||93
7964371|NCT00367133|19604970|P1|COMPLETED|3 Years||115
7964372|NCT00367133|19604968|P3|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
7964373|NCT00367133|19604969|P2|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
7964374|NCT00367133|19604970|P1|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143
7964375|NCT00367133|19604968|P3|NOT COMPLETED|2 Years||49
7964376|NCT00367133|19604969|P2|NOT COMPLETED|2 Years||36
7964377|NCT00367133|19604970|P1|NOT COMPLETED|2 Years||58
7964378|NCT00367133|19604968|P3|COMPLETED|2 Years||205
7964379|NCT00367133|19604969|P2|COMPLETED|2 Years||220
7964380|NCT00367133|19604970|P1|COMPLETED|2 Years||272
7964381|NCT00367133|19604968|P3|STARTED|2 Years|Number of Eyes|254
7964382|NCT00367133|19604969|P2|STARTED|2 Years|Number of Eyes|256
7964383|NCT00367133|19604970|P1|STARTED|2 Years|Number of Eyes|330
7964384|NCT00367055|19605022|P2|NOT COMPLETED|Overall Study||11
7964385|NCT00367055|19605023|P1|NOT COMPLETED|Overall Study||11
7964386|NCT00367055|19605022|P2|COMPLETED|Overall Study||30
7964387|NCT00367055|19605023|P1|COMPLETED|Overall Study||32
7964388|NCT00367055|19605022|P2|STARTED|Overall Study||41
7964389|NCT00367055|19605023|P1|STARTED|Overall Study||43
7964390|NCT00367003|19605037|P1|NOT COMPLETED|Overall Study||9
7964391|NCT00367003|19605037|P1|COMPLETED|Overall Study||28
7964392|NCT00367003|19605037|P1|STARTED|Overall Study||37
7964393|NCT00366899|19605043|P2|NOT COMPLETED|Toddler Dose||1
7964394|NCT00366899|19605044|P1|NOT COMPLETED|Toddler Dose||2
7964395|NCT00366899|19605043|P2|COMPLETED|Toddler Dose||281
7964396|NCT00366899|19605044|P1|COMPLETED|Toddler Dose||285
7964397|NCT00366899|19605043|P2|STARTED|Toddler Dose||282
7964398|NCT00366899|19605044|P1|STARTED|Toddler Dose||287
7964399|NCT00366899|19605043|P2|NOT COMPLETED|After Infant Series||9
7964400|NCT00366899|19605044|P1|NOT COMPLETED|After Infant Series||7
7964401|NCT00366899|19605043|P2|COMPLETED|After Infant Series||282
7964402|NCT00366899|19605044|P1|COMPLETED|After Infant Series||287
7964403|NCT00366899|19605043|P2|STARTED|After Infant Series||291
7964404|NCT00366899|19605044|P1|STARTED|After Infant Series||294
7964405|NCT00366899|19605043|P2|NOT COMPLETED|Infant Series||12
7964406|NCT00366899|19605044|P1|NOT COMPLETED|Infant Series||9
7964407|NCT00366899|19605043|P2|COMPLETED|Infant Series||291
7964408|NCT00366899|19605044|P1|COMPLETED|Infant Series||294
7964409|NCT00366899|19605043|P2|Vaccinated Dose 2|Infant Series||293
7964410|NCT00366899|19605044|P1|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296
7964411|NCT00366899|19605043|P2|Vaccinated Dose 1|Infant Series||302
7964412|NCT00366899|19605044|P1|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302
7964413|NCT00366899|19605043|P2|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303
7964414|NCT00366899|19605044|P1|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303
7964415|NCT00366678|19605104|P3|NOT COMPLETED|Toddler Dose||0
7964416|NCT00366678|19605105|P2|NOT COMPLETED|Toddler Dose||1
7964417|NCT00366678|19605106|P1|NOT COMPLETED|Toddler Dose||5
7964418|NCT00366678|19605104|P3|COMPLETED|Toddler Dose||137
7964419|NCT00366678|19605105|P2|COMPLETED|Toddler Dose||151
7964420|NCT00366678|19605106|P1|COMPLETED|Toddler Dose||268
7964421|NCT00366678|19605104|P3|STARTED|Toddler Dose||137
7964422|NCT00366678|19605105|P2|STARTED|Toddler Dose||152
7964423|NCT00366678|19605106|P1|STARTED|Toddler Dose||273
7964424|NCT00366678|19605104|P3|NOT COMPLETED|After Infant||0
7964425|NCT00366678|19605105|P2|NOT COMPLETED|After Infant||10
7964426|NCT00366678|19605106|P1|NOT COMPLETED|After Infant||17
7964427|NCT00366678|19605104|P3|COMPLETED|After Infant||0
7964428|NCT00366678|19605105|P2|COMPLETED|After Infant||289
7964429|NCT00366678|19605106|P1|COMPLETED|After Infant||273
7964430|NCT00366678|19605104|P3|STARTED|After Infant||0
7964431|NCT00366678|19605105|P2|STARTED|After Infant||299
7964432|NCT00366678|19605106|P1|STARTED|After Infant||290
7964433|NCT00366678|19605104|P3|NOT COMPLETED|Infant Series||0
7964434|NCT00366678|19605105|P2|NOT COMPLETED|Infant Series||10
7964435|NCT00366678|19605106|P1|NOT COMPLETED|Infant Series||14
7964436|NCT00366678|19605104|P3|COMPLETED|Infant Series||0
7964437|NCT00366678|19605105|P2|COMPLETED|Infant Series||299
7964438|NCT00366678|19605106|P1|COMPLETED|Infant Series||290
7964439|NCT00366678|19605104|P3|Vaccinated Dose 3|Infant Series||0
7964440|NCT00366678|19605105|P2|Vaccinated Dose 3|Infant Series||302
7964441|NCT00366678|19605106|P1|Vaccinated Dose 3|Infant Series||291
7964442|NCT00366678|19605104|P3|Vaccinated Dose 2|Infant Series||0
7964443|NCT00366678|19605105|P2|Vaccinated Dose 2|Infant Series||304
7964444|NCT00366678|19605106|P1|Vaccinated Dose 2|Infant Series||295
7964445|NCT00366678|19605104|P3|Vaccinated Dose 1|Infant Series||0
7964446|NCT00366678|19605105|P2|Vaccinated Dose 1|Infant Series||309
7964447|NCT00366678|19605106|P1|Vaccinated Dose 1|Infant Series||302
7964448|NCT00366678|19605104|P3|STARTED|Infant Series||0
7964449|NCT00366678|19605105|P2|STARTED|Infant Series||309
7964450|NCT00366678|19605106|P1|STARTED|Infant Series||304
7964451|NCT00366626|19605173|P2|NOT COMPLETED|Overall Study||0
7964452|NCT00366626|19605174|P1|NOT COMPLETED|Overall Study||0
7964453|NCT00366626|19605173|P2|COMPLETED|Overall Study||45
7964454|NCT00366626|19605174|P1|COMPLETED|Overall Study||38
7964455|NCT00366626|19605173|P2|STARTED|Overall Study||45
7964456|NCT00366626|19605174|P1|STARTED|Overall Study||38
7964457|NCT00366548|19605188|P2|NOT COMPLETED|Toddler Dose||0
7964458|NCT00366548|19605189|P1|NOT COMPLETED|Toddler Dose||0
7964459|NCT00366548|19605188|P2|COMPLETED|Toddler Dose||244
7964460|NCT00366548|19605189|P1|COMPLETED|Toddler Dose||240
7964461|NCT00366548|19605188|P2|STARTED|Toddler Dose||244
7964462|NCT00366548|19605189|P1|STARTED|Toddler Dose||240
7964463|NCT00366548|19605188|P2|NOT COMPLETED|After Infant Series||1
7964464|NCT00366548|19605189|P1|NOT COMPLETED|After Infant Series||6
7964465|NCT00366548|19605188|P2|COMPLETED|After Infant Series||244
7964466|NCT00366548|19605189|P1|COMPLETED|After Infant Series||240
7964467|NCT00366548|19605188|P2|STARTED|After Infant Series||245
7964468|NCT00366548|19605189|P1|STARTED|After Infant Series||246
7964469|NCT00366548|19605188|P2|NOT COMPLETED|Infant Series||5
7964470|NCT00366548|19605189|P1|NOT COMPLETED|Infant Series||4
7964471|NCT00366548|19605188|P2|COMPLETED|Infant Series||245
7964472|NCT00366548|19605189|P1|COMPLETED|Infant Series||246
7964473|NCT00366548|19605188|P2|Vaccinated Dose 3|Infant Series||247
7964474|NCT00366548|19605189|P1|Vaccinated Dose 3|Infant Series||246
7964475|NCT00366548|19605188|P2|Vaccinated Dose 2|Infant Series||249
7964476|NCT00366548|19605189|P1|Vaccinated Dose 2|Infant Series||246
7964477|NCT00366548|19605188|P2|Vaccinated Dose 1|Infant Series||250
7964478|NCT00366548|19605189|P1|Vaccinated Dose 1|Infant Series||250
7964479|NCT00366548|19605188|P2|STARTED|Infant Series||250
7964480|NCT00366548|19605189|P1|STARTED|Infant Series||250
7964481|NCT00366535|19605225|P2|NOT COMPLETED|Second Phase: 12 Weeks||3
7964482|NCT00366535|19605226|P1|NOT COMPLETED|Second Phase: 12 Weeks||3
7964483|NCT00366535|19605225|P2|COMPLETED|Second Phase: 12 Weeks||18
7964484|NCT00366535|19605226|P1|COMPLETED|Second Phase: 12 Weeks||21
7964485|NCT00366535|19605225|P2|STARTED|Second Phase: 12 Weeks||21
7964486|NCT00366535|19605226|P1|STARTED|Second Phase: 12 Weeks||24
7964487|NCT00366535|19605225|P2|NOT COMPLETED|Washout Period (at Least a Week)||0
7964488|NCT00366535|19605226|P1|NOT COMPLETED|Washout Period (at Least a Week)||0
7964489|NCT00366535|19605225|P2|COMPLETED|Washout Period (at Least a Week)||21
7964490|NCT00366535|19605226|P1|COMPLETED|Washout Period (at Least a Week)||24
7964491|NCT00366535|19605225|P2|STARTED|Washout Period (at Least a Week)||21
7964492|NCT00366535|19605226|P1|STARTED|Washout Period (at Least a Week)||24
7964493|NCT00366535|19605225|P2|NOT COMPLETED|First Phase: 12 Weeks||8
7964494|NCT00366535|19605226|P1|NOT COMPLETED|First Phase: 12 Weeks||3
7964495|NCT00366535|19605225|P2|COMPLETED|First Phase: 12 Weeks||21
7964496|NCT00366535|19605226|P1|COMPLETED|First Phase: 12 Weeks||24
7964497|NCT00366535|19605225|P2|STARTED|First Phase: 12 Weeks||29
7964498|NCT00366535|19605226|P1|STARTED|First Phase: 12 Weeks||27
7964499|NCT00366457|19605240|P1|NOT COMPLETED|Overall Study||2
7964500|NCT00366457|19605240|P1|COMPLETED|Overall Study||30
7964501|NCT00366457|19605240|P1|STARTED|Overall Study||32
7964502|NCT00366444|19605249|P2|NOT COMPLETED|Overall Study||2
7964503|NCT00366444|19605250|P1|NOT COMPLETED|Overall Study||1
7964504|NCT00366444|19605249|P2|COMPLETED|Overall Study||97
7964505|NCT00366444|19605250|P1|COMPLETED|Overall Study||101
7964506|NCT00366444|19605249|P2|STARTED|Overall Study||99
7964507|NCT00366444|19605250|P1|STARTED|Overall Study||102
7964508|NCT00366340|19605278|P2|NOT COMPLETED|Toddler Dose||1
7964509|NCT00366340|19605279|P1|NOT COMPLETED|Toddler Dose||1
7964510|NCT00366340|19605278|P2|COMPLETED|Toddler Dose||286
7964511|NCT00366340|19605279|P1|COMPLETED|Toddler Dose||289
7964512|NCT00366340|19605278|P2|STARTED|Toddler Dose||287
7964513|NCT00366340|19605279|P1|STARTED|Toddler Dose||290
7964514|NCT00366340|19605278|P2|NOT COMPLETED|After the Infant Series||6
7964515|NCT00366340|19605279|P1|NOT COMPLETED|After the Infant Series||3
7964516|NCT00366340|19605278|P2|COMPLETED|After the Infant Series||287
7964517|NCT00366340|19605279|P1|COMPLETED|After the Infant Series||290
7964518|NCT00366340|19605278|P2|STARTED|After the Infant Series||293
7964519|NCT00366340|19605279|P1|STARTED|After the Infant Series||293
7964520|NCT00366340|19605278|P2|NOT COMPLETED|Infant Series||10
7964521|NCT00366340|19605279|P1|NOT COMPLETED|Infant Series||8
7964522|NCT00366340|19605278|P2|COMPLETED|Infant Series||293
7964523|NCT00366340|19605279|P1|COMPLETED|Infant Series||293
7964524|NCT00366340|19605278|P2|Vaccinated Dose 3|Infant Series||293
7964525|NCT00366340|19605279|P1|Vaccinated Dose 3|Infant Series||294
7964526|NCT00366340|19605278|P2|Vaccinated Dose 2|Infant Series||297
7964527|NCT00366340|19605279|P1|Vaccinated Dose 2|Infant Series||296
7964528|NCT00366340|19605278|P2|Vaccinated Dose 1|Infant Series||303
7964529|NCT00366340|19605279|P1|Vaccinated Dose 1|Infant Series||300
7964530|NCT00366340|19605278|P2|STARTED|Infant Series||303
7964531|NCT00366340|19605279|P1|STARTED|Infant Series||301
7964532|NCT00366301|19605337|P4|NOT COMPLETED|Overall Study||8
7964533|NCT00366301|19605338|P3|NOT COMPLETED|Overall Study||4
7964534|NCT00366301|19605339|P2|NOT COMPLETED|Overall Study||6
7964535|NCT00366301|19605340|P1|NOT COMPLETED|Overall Study||8
7964536|NCT00366301|19605337|P4|COMPLETED|Overall Study||116
7964537|NCT00366301|19605338|P3|COMPLETED|Overall Study||122
7964538|NCT00366301|19605339|P2|COMPLETED|Overall Study||120
7964539|NCT00366301|19605340|P1|COMPLETED|Overall Study||116
7964540|NCT00366301|19605337|P4|Either 6W or 14W CRP Obtained|Overall Study||119
7964541|NCT00366301|19605338|P3|Either 6W or 14W CRP Obtained|Overall Study||124
7964542|NCT00366301|19605339|P2|Either 6W or 14W CRP Obtained|Overall Study||124
7964543|NCT00366301|19605340|P1|Either 6W or 14W CRP Obtained|Overall Study||120
7964544|NCT00366301|19605337|P4|STARTED|Overall Study||124
7964545|NCT00366301|19605338|P3|STARTED|Overall Study||126
7964546|NCT00366301|19605339|P2|STARTED|Overall Study||126
7964547|NCT00366301|19605340|P1|STARTED|Overall Study||124
7964548|NCT00366275|19605350|P1|NOT COMPLETED|Overall Study||6
7964549|NCT00366275|19605350|P1|COMPLETED|Overall Study||58
7964550|NCT00366275|19605350|P1|STARTED|Overall Study||64
7964551|NCT00366249|19605356|P2|NOT COMPLETED|Overall Study||78
7964552|NCT00366249|19605357|P1|NOT COMPLETED|Overall Study||131
7964553|NCT00366249|19605356|P2|COMPLETED|Overall Study||430
7964554|NCT00366249|19605357|P1|COMPLETED|Overall Study||422
7964555|NCT00366249|19605356|P2|STARTED|Overall Study||508
7964556|NCT00366249|19605357|P1|STARTED|Overall Study||553
7964557|NCT00366106|19605371|P1|NOT COMPLETED|Overall Study||0
7964558|NCT00366106|19605371|P1|COMPLETED|Overall Study||32
7964559|NCT00366106|19605371|P1|STARTED|Overall Study||32
7964560|NCT00366028|19605380|P2|NOT COMPLETED|Overall Study||0
7964561|NCT00366028|19605381|P1|NOT COMPLETED|Overall Study||0
7964562|NCT00366028|19605380|P2|COMPLETED|Overall Study||735
7964563|NCT00366028|19605381|P1|COMPLETED|Overall Study||889
7964564|NCT00366028|19605380|P2|STARTED|Overall Study||735
7964565|NCT00366028|19605381|P1|STARTED|Overall Study||889
7964566|NCT00365989|19605389|P1|NOT COMPLETED|Overall Study||2
7964567|NCT00365989|19605389|P1|COMPLETED|Overall Study||48
7964568|NCT00365989|19605389|P1|STARTED|Overall Study||50
7964569|NCT00365976|19605397|P2|NOT COMPLETED|Overall Study||5
7964570|NCT00365976|19605398|P1|NOT COMPLETED|Overall Study||1
7964571|NCT00365976|19605397|P2|COMPLETED|Overall Study||20
7964572|NCT00365976|19605398|P1|COMPLETED|Overall Study||32
7964573|NCT00365976|19605397|P2|STARTED|Overall Study||25
7964574|NCT00365976|19605398|P1|STARTED|Overall Study||33
7964575|NCT00365872|19605429|P3|NOT COMPLETED|Overall Study||0
7964576|NCT00365872|19605430|P2|NOT COMPLETED|Overall Study||0
7964577|NCT00365872|19605431|P1|NOT COMPLETED|Overall Study||0
7964578|NCT00365872|19605429|P3|COMPLETED|Overall Study||6
7964579|NCT00365872|19605430|P2|COMPLETED|Overall Study||6
7964580|NCT00365872|19605431|P1|COMPLETED|Overall Study||5
7964581|NCT00365872|19605429|P3|STARTED|Overall Study||6
7964582|NCT00365872|19605430|P2|STARTED|Overall Study||6
7964583|NCT00365872|19605431|P1|STARTED|Overall Study||5
7964584|NCT00365859|19605444|P4|NOT COMPLETED|Overall Study||131
7964585|NCT00365859|19605445|P3|NOT COMPLETED|Overall Study||67
7964586|NCT00365859|19605446|P2|NOT COMPLETED|Overall Study||33
7964587|NCT00365859|19605447|P1|NOT COMPLETED|Overall Study||31
7964588|NCT00365859|19605444|P4|COMPLETED|Overall Study||199
7964589|NCT00365859|19605445|P3|COMPLETED|Overall Study||107
7964590|NCT00365859|19605446|P2|COMPLETED|Overall Study||37
7964591|NCT00365859|19605447|P1|COMPLETED|Overall Study||55
7964592|NCT00365859|19605444|P4|Efficacy Population|Overall Study||322
7964593|NCT00365859|19605445|P3|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169
7964594|NCT00365859|19605446|P2|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69
7964595|NCT00365859|19605447|P1|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84
7964596|NCT00365859|19605444|P4|Safety Population|Overall Study||330
7964597|NCT00365859|19605445|P3|Safety Population|Overall Study||174
7964598|NCT00365859|19605446|P2|Safety Population|Overall Study||70
7964599|NCT00365859|19605447|P1|Safety Population|Overall Study||86
7964600|NCT00365859|19605444|P4|STARTED|Overall Study||330
7964601|NCT00365859|19605445|P3|STARTED|Overall Study||174
7964602|NCT00365859|19605446|P2|STARTED|Overall Study||70
7964603|NCT00365859|19605447|P1|STARTED|Overall Study||86
7964604|NCT00365846|19605536|P1|NOT COMPLETED|Overall Study||1
7964605|NCT00365846|19605536|P1|COMPLETED|Overall Study||28
7964606|NCT00365846|19605536|P1|STARTED|Overall Study||29
7964607|NCT00365794|19605545|P1|NOT COMPLETED|Overall Study||2
7964608|NCT00365794|19605545|P1|COMPLETED|Overall Study||20
7964609|NCT00365794|19605545|P1|STARTED|Overall Study|22 subjects were enrolled since only 20 completed all post treatment measures.|22
7964610|NCT00365768|19605560|P2|NOT COMPLETED|Overall Study||0
7964611|NCT00365768|19605561|P1|NOT COMPLETED|Overall Study||0
7964612|NCT00365768|19605560|P2|COMPLETED|Overall Study||25
7964613|NCT00365768|19605561|P1|COMPLETED|Overall Study||24
7964614|NCT00365768|19605560|P2|STARTED|Overall Study||25
7964615|NCT00365768|19605561|P1|STARTED|Overall Study||24
7964616|NCT00365716|19605574|P7|NOT COMPLETED|Extension 2||10
7964617|NCT00365716|19605575|P6|NOT COMPLETED|Extension 2||0
7964618|NCT00365716|19605576|P5|NOT COMPLETED|Extension 2||0
7964619|NCT00365716|19605577|P4|NOT COMPLETED|Extension 2||0
7964620|NCT00365716|19605578|P3|NOT COMPLETED|Extension 2||0
7964621|NCT00365716|19605579|P2|NOT COMPLETED|Extension 2||0
7964622|NCT00365716|19605580|P1|NOT COMPLETED|Extension 2||0
7964623|NCT00365716|19605574|P7|COMPLETED|Extension 2||7
7964624|NCT00365716|19605575|P6|COMPLETED|Extension 2||0
7964625|NCT00365716|19605576|P5|COMPLETED|Extension 2||0
7964626|NCT00365716|19605577|P4|COMPLETED|Extension 2||0
7964627|NCT00365716|19605578|P3|COMPLETED|Extension 2||0
7964628|NCT00365716|19605579|P2|COMPLETED|Extension 2||0
7964629|NCT00365716|19605580|P1|COMPLETED|Extension 2||0
7964630|NCT00365716|19605574|P7|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17
7964631|NCT00365716|19605575|P6|STARTED|Extension 2||0
7964632|NCT00365716|19605576|P5|STARTED|Extension 2||0
7964633|NCT00365716|19605577|P4|STARTED|Extension 2||0
7964634|NCT00365716|19605578|P3|STARTED|Extension 2||0
7964635|NCT00365716|19605579|P2|STARTED|Extension 2||0
7964636|NCT00365716|19605580|P1|STARTED|Extension 2||0
7964637|NCT00365716|19605574|P7|NOT COMPLETED|Extension 1||0
7964638|NCT00365716|19605575|P6|NOT COMPLETED|Extension 1||22
7964639|NCT00365716|19605576|P5|NOT COMPLETED|Extension 1||0
7964640|NCT00365716|19605577|P4|NOT COMPLETED|Extension 1||0
7964641|NCT00365716|19605578|P3|NOT COMPLETED|Extension 1||0
7964642|NCT00365716|19605579|P2|NOT COMPLETED|Extension 1||0
7964643|NCT00365716|19605580|P1|NOT COMPLETED|Extension 1||0
7964644|NCT00365716|19605574|P7|COMPLETED|Extension 1||0
7964645|NCT00365716|19605575|P6|COMPLETED|Extension 1||219
7964646|NCT00365716|19605576|P5|COMPLETED|Extension 1||0
7964647|NCT00365716|19605577|P4|COMPLETED|Extension 1||0
7964648|NCT00365716|19605578|P3|COMPLETED|Extension 1||0
7964649|NCT00365716|19605579|P2|COMPLETED|Extension 1||0
7964650|NCT00365716|19605580|P1|COMPLETED|Extension 1||0
7964651|NCT00365716|19605574|P7|STARTED|Extension 1||0
7964652|NCT00365716|19605575|P6|STARTED|Extension 1||241
7964653|NCT00365716|19605576|P5|STARTED|Extension 1||0
7964654|NCT00365716|19605577|P4|STARTED|Extension 1||0
7964655|NCT00365716|19605578|P3|STARTED|Extension 1||0
7964656|NCT00365716|19605579|P2|STARTED|Extension 1||0
7964657|NCT00365716|19605580|P1|STARTED|Extension 1||0
7964658|NCT00365716|19605574|P7|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
7964659|NCT00365716|19605575|P6|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
7964660|NCT00365716|19605576|P5|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82
7964661|NCT00365716|19605577|P4|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79
7964662|NCT00365716|19605578|P3|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20
7964663|NCT00365716|19605579|P2|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15
7964664|NCT00365716|19605580|P1|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132
7964665|NCT00365716|19605574|P7|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
7964666|NCT00365716|19605575|P6|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
7964667|NCT00365716|19605576|P5|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
7964668|NCT00365716|19605577|P4|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
7964669|NCT00365716|19605578|P3|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251
7964670|NCT00365716|19605579|P2|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245
7964671|NCT00365716|19605580|P1|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137
7964672|NCT00365716|19605574|P7|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
7964673|NCT00365716|19605575|P6|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
7964674|NCT00365716|19605576|P5|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139
7964675|NCT00365716|19605577|P4|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136
7964676|NCT00365716|19605578|P3|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271
7964677|NCT00365716|19605579|P2|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260
7964678|NCT00365716|19605580|P1|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269
7964679|NCT00365716|19605574|P7|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
7964680|NCT00365716|19605575|P6|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
7964681|NCT00365716|19605576|P5|NOT COMPLETED|Base Study (Day 1 to Month 7)||7
7964682|NCT00365716|19605577|P4|NOT COMPLETED|Base Study (Day 1 to Month 7)||10
7964683|NCT00365716|19605578|P3|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
7964684|NCT00365716|19605579|P2|NOT COMPLETED|Base Study (Day 1 to Month 7)||24
7964685|NCT00365716|19605580|P1|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
7964686|NCT00365716|19605574|P7|COMPLETED|Base Study (Day 1 to Month 7)||0
7964687|NCT00365716|19605575|P6|COMPLETED|Base Study (Day 1 to Month 7)||0
7964688|NCT00365716|19605576|P5|COMPLETED|Base Study (Day 1 to Month 7)||139
7964689|NCT00365716|19605577|P4|COMPLETED|Base Study (Day 1 to Month 7)||136
7964690|NCT00365716|19605578|P3|COMPLETED|Base Study (Day 1 to Month 7)||271
7964691|NCT00365716|19605579|P2|COMPLETED|Base Study (Day 1 to Month 7)||260
7964692|NCT00365716|19605580|P1|COMPLETED|Base Study (Day 1 to Month 7)||269
7964693|NCT00365716|19605574|P7|STARTED|Base Study (Day 1 to Month 7)||0
7964694|NCT00365716|19605575|P6|STARTED|Base Study (Day 1 to Month 7)||0
7964695|NCT00365716|19605576|P5|STARTED|Base Study (Day 1 to Month 7)||146
7964696|NCT00365716|19605577|P4|STARTED|Base Study (Day 1 to Month 7)||146
7964697|NCT00365716|19605578|P3|STARTED|Base Study (Day 1 to Month 7)||292
7964698|NCT00365716|19605579|P2|STARTED|Base Study (Day 1 to Month 7)||284
7964699|NCT00365716|19605580|P1|STARTED|Base Study (Day 1 to Month 7)||290
7964700|NCT00365599|19605595|P1|NOT COMPLETED|Overall Study||0
7964701|NCT00365599|19605595|P1|COMPLETED|Overall Study||43
7964702|NCT00365599|19605595|P1|STARTED|Overall Study||43
7964703|NCT00365547|19605601|P1|NOT COMPLETED|Overall Study||3
7964704|NCT00365547|19605601|P1|COMPLETED|Overall Study||43
7964705|NCT00365547|19605601|P1|STARTED|Overall Study||46
7964706|NCT00365508|19605611|P2|NOT COMPLETED|Overall Study||154
7964707|NCT00365508|19605612|P1|NOT COMPLETED|Overall Study||139
7964708|NCT00365508|19605611|P2|COMPLETED|Overall Study||167
7964709|NCT00365508|19605612|P1|COMPLETED|Overall Study||182
7964710|NCT00365508|19605611|P2|STARTED|Overall Study||321
7964711|NCT00365508|19605612|P1|STARTED|Overall Study||321
7964712|NCT00365456|19605620|P2|NOT COMPLETED|Trial Period III (12 Months)||5
7964713|NCT00365456|19605621|P1|NOT COMPLETED|Trial Period III (12 Months)||18
7964714|NCT00365456|19605620|P2|COMPLETED|Trial Period III (12 Months)||127
7964715|NCT00365456|19605621|P1|COMPLETED|Trial Period III (12 Months)||118
7964716|NCT00365456|19605620|P2|STARTED|Trial Period III (12 Months)||132
7964717|NCT00365456|19605621|P1|STARTED|Trial Period III (12 Months)||136
7964718|NCT00365456|19605620|P2|NOT COMPLETED|Trial Period II (12 Months)||14
7964719|NCT00365456|19605621|P1|NOT COMPLETED|Trial Period II (12 Months)||0
7964720|NCT00365456|19605620|P2|COMPLETED|Trial Period II (12 Months)||268
7964721|NCT00365456|19605621|P1|COMPLETED|Trial Period II (12 Months)||0
7964722|NCT00365456|19605620|P2|STARTED|Trial Period II (12 Months)||282
7964723|NCT00365456|19605621|P1|STARTED|Trial Period II (12 Months)||0
7964724|NCT00365456|19605620|P2|NOT COMPLETED|Trial Period I (12 Months)||0
7964725|NCT00365456|19605621|P1|NOT COMPLETED|Trial Period I (12 Months)||125
7964726|NCT00365456|19605620|P2|COMPLETED|Trial Period I (12 Months)||0
7964727|NCT00365456|19605621|P1|COMPLETED|Trial Period I (12 Months)||282
7964728|NCT00365456|19605620|P2|STARTED|Trial Period I (12 Months)||0
7964729|NCT00365456|19605621|P1|STARTED|Trial Period I (12 Months)||407
7964730|NCT00365417|19605627|P1|NOT COMPLETED|Overall Study||0
7964731|NCT00365417|19605627|P1|COMPLETED|Overall Study||45
7964732|NCT00365417|19605627|P1|STARTED|Overall Study||45
7964733|NCT00365391|19605638|P1|NOT COMPLETED|Overall Study||0
7964734|NCT00365391|19605638|P1|COMPLETED|Overall Study||27
7964735|NCT00365391|19605638|P1|STARTED|Overall Study||27
7964736|NCT00365378|19605648|P3|NOT COMPLETED|Extension||197
7964737|NCT00365378|19605649|P2|NOT COMPLETED|Extension||0
7964738|NCT00365378|19605650|P1|NOT COMPLETED|Extension||0
7964739|NCT00365378|19605648|P3|COMPLETED|Extension||203
7964740|NCT00365378|19605649|P2|COMPLETED|Extension||0
7964741|NCT00365378|19605650|P1|COMPLETED|Extension||0
7964742|NCT00365378|19605648|P3|STARTED|Extension||400
7964743|NCT00365378|19605649|P2|STARTED|Extension||0
7964744|NCT00365378|19605650|P1|STARTED|Extension||0
7964745|NCT00365378|19605648|P3|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0
7964746|NCT00365378|19605649|P2|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202
7964747|NCT00365378|19605650|P1|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158
7964748|NCT00365378|19605648|P3|COMPLETED|Follow-up (Month 7 Though Month 48)||0
7964749|NCT00365378|19605649|P2|COMPLETED|Follow-up (Month 7 Though Month 48)||836
7964750|NCT00365378|19605650|P1|COMPLETED|Follow-up (Month 7 Though Month 48)||835
7964751|NCT00365378|19605648|P3|STARTED|Follow-up (Month 7 Though Month 48)||0
7964752|NCT00365378|19605649|P2|STARTED|Follow-up (Month 7 Though Month 48)||1038
7964753|NCT00365378|19605650|P1|STARTED|Follow-up (Month 7 Though Month 48)||993
7964754|NCT00365378|19605648|P3|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0
7964755|NCT00365378|19605649|P2|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167
7964756|NCT00365378|19605650|P1|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211
7964757|NCT00365378|19605648|P3|COMPLETED|Vaccination (Day 1 to Month 7)||0
7964758|NCT00365378|19605649|P2|COMPLETED|Vaccination (Day 1 to Month 7)||1038
7964759|NCT00365378|19605650|P1|COMPLETED|Vaccination (Day 1 to Month 7)||993
7964760|NCT00365378|19605648|P3|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0
7964761|NCT00365378|19605649|P2|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198
7964762|NCT00365378|19605650|P1|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193
7964763|NCT00365378|19605648|P3|STARTED|Vaccination (Day 1 to Month 7)||0
7964764|NCT00365378|19605649|P2|STARTED|Vaccination (Day 1 to Month 7)||1205
7964765|NCT00365378|19605650|P1|STARTED|Vaccination (Day 1 to Month 7)||1204
7964766|NCT00365365|19605664|P3|NOT COMPLETED|Overall Study||15
7964767|NCT00365365|19605665|P2|NOT COMPLETED|Overall Study||36
7964768|NCT00365365|19605666|P1|NOT COMPLETED|Overall Study||34
7964769|NCT00365365|19605664|P3|COMPLETED|Overall Study||44
7964770|NCT00365365|19605665|P2|COMPLETED|Overall Study||41
7964771|NCT00365365|19605666|P1|COMPLETED|Overall Study||44
7964772|NCT00365365|19605664|P3|COMPLETED TREATMENT|Overall Study||45
7964773|NCT00365365|19605665|P2|COMPLETED TREATMENT|Overall Study||36
7964774|NCT00365365|19605666|P1|COMPLETED TREATMENT|Overall Study||38
7964775|NCT00365365|19605664|P3|TREATED (SAFETY POPULATION)|Overall Study||59
7964776|NCT00365365|19605665|P2|TREATED (SAFETY POPULATION)|Overall Study||75
7964777|NCT00365365|19605666|P1|TREATED (SAFETY POPULATION)|Overall Study||78
7964778|NCT00365365|19605664|P3|STARTED|Overall Study||59
7964779|NCT00365365|19605665|P2|STARTED|Overall Study||77
7964780|NCT00365365|19605666|P1|STARTED|Overall Study||78
7964781|NCT00365352|19605683|P3|NOT COMPLETED|Overall Study||15
7964782|NCT00365352|19605684|P2|NOT COMPLETED|Overall Study||11
7964783|NCT00365352|19605685|P1|NOT COMPLETED|Overall Study||20
7964784|NCT00365352|19605683|P3|COMPLETED|Overall Study||98
7964785|NCT00365352|19605684|P2|COMPLETED|Overall Study||104
7964786|NCT00365352|19605685|P1|COMPLETED|Overall Study||77
7964787|NCT00365352|19605683|P3|Modified Intent-to-Treat Population|Overall Study||111
7964788|NCT00365352|19605684|P2|Modified Intent-to-Treat Population|Overall Study||114
7964789|NCT00365352|19605685|P1|Modified Intent-to-Treat Population|Overall Study||96
7964790|NCT00365352|19605683|P3|Safety Population|Overall Study||111
7964791|NCT00365352|19605684|P2|Safety Population|Overall Study||115
7964792|NCT00365352|19605685|P1|Safety Population|Overall Study||96
7964793|NCT00365352|19605683|P3|STARTED|Overall Study||113
7964794|NCT00365352|19605684|P2|STARTED|Overall Study||115
7964795|NCT00365352|19605685|P1|STARTED|Overall Study||97
7964796|NCT00365300|19605769|P2|NOT COMPLETED|Double-blind Phase||9
7964797|NCT00365300|19605770|P1|NOT COMPLETED|Double-blind Phase||11
7964798|NCT00365300|19605769|P2|COMPLETED|Double-blind Phase||45
7964799|NCT00365300|19605770|P1|COMPLETED|Double-blind Phase||43
7964800|NCT00365300|19605769|P2|STARTED|Double-blind Phase||54
7964801|NCT00365300|19605770|P1|STARTED|Double-blind Phase||54
7964802|NCT00365300|19605769|P2|NOT COMPLETED|Open-label Phase||0
7964803|NCT00365300|19605770|P1|NOT COMPLETED|Open-label Phase||22
7964804|NCT00365300|19605769|P2|COMPLETED|Open-label Phase||0
7964805|NCT00365300|19605770|P1|COMPLETED|Open-label Phase||107
7964806|NCT00365300|19605769|P2|STARTED|Open-label Phase||0
7964807|NCT00365300|19605770|P1|STARTED|Open-label Phase||129
7964808|NCT00365274|19605779|P1|NOT COMPLETED|Overall Study||0
7964809|NCT00365274|19605779|P1|COMPLETED|Overall Study||6
7964810|NCT00365274|19605779|P1|STARTED|Overall Study||6
7964811|NCT00365261|19605785|P2|NOT COMPLETED|Overall Study||3
7964812|NCT00365261|19605786|P1|NOT COMPLETED|Overall Study||3
7964813|NCT00365261|19605785|P2|COMPLETED|Overall Study||19
7964814|NCT00365261|19605786|P1|COMPLETED|Overall Study||20
7964815|NCT00365261|19605785|P2|STARTED|Overall Study||22
7964816|NCT00365261|19605786|P1|STARTED|Overall Study||23
7964817|NCT00365209|19605796|P1|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2
7964818|NCT00365209|19605796|P1|COMPLETED|Stage 2: Receiving 4g Curcumin||19
7964819|NCT00365209|19605796|P1|STARTED|Stage 2: Receiving 4g Curcumin||21
7964820|NCT00365209|19605796|P1|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2
7964821|NCT00365209|19605796|P1|COMPLETED|Stage 1: Receiving 2g Curcumin||21
7964822|NCT00365209|19605796|P1|STARTED|Stage 1: Receiving 2g Curcumin||23
7964823|NCT00365144|19605825|P1|NOT COMPLETED|Overall Study||0
7964824|NCT00365144|19605825|P1|COMPLETED|Overall Study||36
7964825|NCT00365144|19605825|P1|STARTED|Overall Study||36
7964826|NCT00365105|19605835|P2|NOT COMPLETED|Overall Study||8
7964827|NCT00365105|19605836|P1|NOT COMPLETED|Overall Study||5
7964828|NCT00365105|19605835|P2|COMPLETED|Overall Study||124
7964829|NCT00365105|19605836|P1|COMPLETED|Overall Study||124
7964830|NCT00365105|19605835|P2|Eligible With Adverse Event Data|Overall Study||124
7964831|NCT00365105|19605836|P1|Eligible With Adverse Event Data|Overall Study||123
7964832|NCT00365105|19605835|P2|Eligible|Overall Study||124
7964833|NCT00365105|19605836|P1|Eligible|Overall Study||124
7964834|NCT00365105|19605835|P2|STARTED|Overall Study||132
7964835|NCT00365105|19605836|P1|STARTED|Overall Study||129
7964836|NCT00365053|19605852|P1|NOT COMPLETED|Overall Study||0
7964837|NCT00365053|19605852|P1|COMPLETED|Overall Study||13
7964838|NCT00365053|19605852|P1|STARTED|Overall Study||13
7964839|NCT00364949|19605863|P2|NOT COMPLETED|Overall Study||0
7964840|NCT00364949|19605864|P1|NOT COMPLETED|Overall Study||0
7964841|NCT00364949|19605863|P2|COMPLETED|Overall Study||39
7964842|NCT00364949|19605864|P1|COMPLETED|Overall Study||31
7964843|NCT00364949|19605863|P2|STARTED|Overall Study||39
7964844|NCT00364949|19605864|P1|STARTED|Overall Study||31
7964845|NCT00364923|19605882|P1|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24
7964846|NCT00364923|19605882|P1|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83
7964847|NCT00364923|19605882|P1|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107
7964848|NCT00364923|19605882|P1|NOT COMPLETED|Treatment With Pralatrexate||4
7964849|NCT00364923|19605882|P1|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107
7964850|NCT00364923|19605882|P1|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111
7964851|NCT00364858|19605891|P2|NOT COMPLETED|Overall Study||22
7964852|NCT00364858|19605892|P1|NOT COMPLETED|Overall Study||7
7964853|NCT00364858|19605891|P2|COMPLETED|Overall Study||40
7964854|NCT00364858|19605892|P1|COMPLETED|Overall Study||26
7964855|NCT00364858|19605891|P2|STARTED|Overall Study||62
7964856|NCT00364858|19605892|P1|STARTED|Overall Study||33
7964857|NCT00364845|19605907|P2|NOT COMPLETED|Overall Study||11
7964858|NCT00364845|19605908|P1|NOT COMPLETED|Overall Study||11
7964859|NCT00364845|19605907|P2|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12
7964860|NCT00364845|19605908|P1|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17
7964861|NCT00364845|19605907|P2|STARTED|Overall Study||23
7964862|NCT00364845|19605908|P1|STARTED|Overall Study||28
7964863|NCT00364832|19605929|P12|NOT COMPLETED|Extension Year 2||3
7964864|NCT00364832|19605930|P11|NOT COMPLETED|Extension Year 2||5
7964865|NCT00364832|19605931|P10|NOT COMPLETED|Extension Year 2||5
7964866|NCT00364832|19605932|P9|NOT COMPLETED|Extension Year 2||0
7964867|NCT00364832|19605933|P8|NOT COMPLETED|Extension Year 2||0
7964868|NCT00364832|19605934|P7|NOT COMPLETED|Extension Year 2||0
7964869|NCT00364832|19605935|P6|NOT COMPLETED|Extension Year 2||0
7964870|NCT00364832|19605936|P5|NOT COMPLETED|Extension Year 2||0
7964871|NCT00364832|19605937|P4|NOT COMPLETED|Extension Year 2||0
7964872|NCT00364832|19605938|P3|NOT COMPLETED|Extension Year 2||0
7964873|NCT00364832|19605939|P2|NOT COMPLETED|Extension Year 2||0
7964874|NCT00364832|19605940|P1|NOT COMPLETED|Extension Year 2||0
7964875|NCT00364832|19605929|P12|COMPLETED|Extension Year 2||11
7964876|NCT00364832|19605930|P11|COMPLETED|Extension Year 2||9
7964877|NCT00364832|19605931|P10|COMPLETED|Extension Year 2||9
7964878|NCT00364832|19605932|P9|COMPLETED|Extension Year 2||0
7964879|NCT00364832|19605933|P8|COMPLETED|Extension Year 2||0
7964880|NCT00364832|19605934|P7|COMPLETED|Extension Year 2||0
7964881|NCT00364832|19605935|P6|COMPLETED|Extension Year 2||0
7964882|NCT00364832|19605936|P5|COMPLETED|Extension Year 2||0
7964883|NCT00364832|19605937|P4|COMPLETED|Extension Year 2||0
7964884|NCT00364832|19605938|P3|COMPLETED|Extension Year 2||0
7964885|NCT00364832|19605939|P2|COMPLETED|Extension Year 2||0
7964886|NCT00364832|19605940|P1|COMPLETED|Extension Year 2||0
7964887|NCT00364832|19605929|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
7964888|NCT00364832|19605930|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
7964889|NCT00364832|19605931|P10|STARTED|Extension Year 2||14
7964890|NCT00364832|19605932|P9|STARTED|Extension Year 2||0
7964891|NCT00364832|19605933|P8|STARTED|Extension Year 2||0
7964892|NCT00364832|19605934|P7|STARTED|Extension Year 2||0
7964893|NCT00364832|19605935|P6|STARTED|Extension Year 2||0
7964894|NCT00364832|19605936|P5|STARTED|Extension Year 2||0
7964895|NCT00364832|19605937|P4|STARTED|Extension Year 2||0
7964896|NCT00364832|19605938|P3|STARTED|Extension Year 2||0
7964897|NCT00364832|19605939|P2|STARTED|Extension Year 2||0
7964898|NCT00364832|19605940|P1|STARTED|Extension Year 2||0
7964899|NCT00364832|19605929|P12|NOT COMPLETED|Extension Year 1||10
7964900|NCT00364832|19605930|P11|NOT COMPLETED|Extension Year 1||2
7964901|NCT00364832|19605931|P10|NOT COMPLETED|Extension Year 1||4
7964902|NCT00364832|19605932|P9|NOT COMPLETED|Extension Year 1||0
7964903|NCT00364832|19605933|P8|NOT COMPLETED|Extension Year 1||0
7964904|NCT00364832|19605934|P7|NOT COMPLETED|Extension Year 1||0
7964905|NCT00364832|19605935|P6|NOT COMPLETED|Extension Year 1||0
7964906|NCT00364832|19605936|P5|NOT COMPLETED|Extension Year 1||0
7964907|NCT00364832|19605937|P4|NOT COMPLETED|Extension Year 1||0
7964908|NCT00364832|19605938|P3|NOT COMPLETED|Extension Year 1||0
7964909|NCT00364832|19605939|P2|NOT COMPLETED|Extension Year 1||0
7964910|NCT00364832|19605940|P1|NOT COMPLETED|Extension Year 1||0
7964911|NCT00364832|19605929|P12|COMPLETED|Extension Year 1||17
7964912|NCT00364832|19605930|P11|COMPLETED|Extension Year 1||15
7964913|NCT00364832|19605931|P10|COMPLETED|Extension Year 1||14
7964914|NCT00364832|19605932|P9|COMPLETED|Extension Year 1||0
7964915|NCT00364832|19605933|P8|COMPLETED|Extension Year 1||0
7964916|NCT00364832|19605934|P7|COMPLETED|Extension Year 1||0
7964917|NCT00364832|19605935|P6|COMPLETED|Extension Year 1||0
7964918|NCT00364832|19605936|P5|COMPLETED|Extension Year 1||0
7964919|NCT00364832|19605937|P4|COMPLETED|Extension Year 1||0
7964920|NCT00364832|19605938|P3|COMPLETED|Extension Year 1||0
7964921|NCT00364832|19605939|P2|COMPLETED|Extension Year 1||0
7964922|NCT00364832|19605940|P1|COMPLETED|Extension Year 1||0
7964923|NCT00364832|19605929|P12|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27
7964924|NCT00364832|19605930|P11|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17
7964925|NCT00364832|19605931|P10|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18
7964926|NCT00364832|19605932|P9|STARTED|Extension Year 1||0
7964927|NCT00364832|19605933|P8|STARTED|Extension Year 1||0
7964928|NCT00364832|19605934|P7|STARTED|Extension Year 1||0
7964929|NCT00364832|19605935|P6|STARTED|Extension Year 1||0
7964930|NCT00364832|19605936|P5|STARTED|Extension Year 1||0
7964931|NCT00364832|19605937|P4|STARTED|Extension Year 1||0
7964932|NCT00364832|19605938|P3|STARTED|Extension Year 1||0
7964933|NCT00364832|19605939|P2|STARTED|Extension Year 1||0
7964934|NCT00364832|19605940|P1|STARTED|Extension Year 1||0
7964935|NCT00364832|19605929|P12|NOT COMPLETED|Core Period||0
7964936|NCT00364832|19605930|P11|NOT COMPLETED|Core Period||0
7964937|NCT00364832|19605931|P10|NOT COMPLETED|Core Period||0
7964938|NCT00364832|19605932|P9|NOT COMPLETED|Core Period||0
7964939|NCT00364832|19605933|P8|NOT COMPLETED|Core Period||1
7964940|NCT00364832|19605934|P7|NOT COMPLETED|Core Period||4
7964941|NCT00364832|19605935|P6|NOT COMPLETED|Core Period||0
7964942|NCT00364832|19605936|P5|NOT COMPLETED|Core Period||0
7964943|NCT00364832|19605937|P4|NOT COMPLETED|Core Period||1
7964944|NCT00364832|19605938|P3|NOT COMPLETED|Core Period||1
7964945|NCT00364832|19605939|P2|NOT COMPLETED|Core Period||2
7964946|NCT00364832|19605940|P1|NOT COMPLETED|Core Period||2
7964947|NCT00364832|19605929|P12|COMPLETED|Core Period||0
7964948|NCT00364832|19605930|P11|COMPLETED|Core Period||0
7964949|NCT00364832|19605931|P10|COMPLETED|Core Period||0
7964950|NCT00364832|19605932|P9|COMPLETED|Core Period||16
7964951|NCT00364832|19605933|P8|COMPLETED|Core Period||14
7964952|NCT00364832|19605934|P7|COMPLETED|Core Period||12
7964953|NCT00364832|19605935|P6|COMPLETED|Core Period||12
7964954|NCT00364832|19605936|P5|COMPLETED|Core Period||16
7964955|NCT00364832|19605937|P4|COMPLETED|Core Period||15
7964956|NCT00364832|19605938|P3|COMPLETED|Core Period||14
7964957|NCT00364832|19605939|P2|COMPLETED|Core Period||13
7964958|NCT00364832|19605940|P1|COMPLETED|Core Period||14
7964959|NCT00364832|19605929|P12|STARTED|Core Period||0
7964960|NCT00364832|19605930|P11|STARTED|Core Period||0
7964961|NCT00364832|19605931|P10|STARTED|Core Period||0
7964962|NCT00364832|19605932|P9|STARTED|Core Period||16
7964963|NCT00364832|19605933|P8|STARTED|Core Period||15
7964964|NCT00364832|19605934|P7|STARTED|Core Period||16
7964965|NCT00364832|19605935|P6|STARTED|Core Period||12
7964966|NCT00364832|19605936|P5|STARTED|Core Period||16
7964967|NCT00364832|19605937|P4|STARTED|Core Period||16
7964968|NCT00364832|19605938|P3|STARTED|Core Period||15
7964969|NCT00364832|19605939|P2|STARTED|Core Period||15
7964970|NCT00364832|19605940|P1|STARTED|Core Period||16
7964971|NCT00364819|19605993|P1|NOT COMPLETED|Overall Study||0
7964972|NCT00364819|19605993|P1|COMPLETED|Overall Study||6
7964973|NCT00364819|19605993|P1|STARTED|Overall Study||6
7964974|NCT00364793|19606005|P4|NOT COMPLETED|Overall Study||3
7964975|NCT00364793|19606006|P3|NOT COMPLETED|Overall Study||4
7964976|NCT00364793|19606007|P2|NOT COMPLETED|Overall Study||5
7964977|NCT00364793|19606008|P1|NOT COMPLETED|Overall Study||8
7964978|NCT00364793|19606005|P4|COMPLETED|Overall Study||5
7964979|NCT00364793|19606006|P3|COMPLETED|Overall Study||0
7964980|NCT00364793|19606007|P2|COMPLETED|Overall Study||5
7964981|NCT00364793|19606008|P1|COMPLETED|Overall Study||7
7964982|NCT00364793|19606005|P4|STARTED|Overall Study||8
7964983|NCT00364793|19606006|P3|STARTED|Overall Study||4
7964984|NCT00364793|19606007|P2|STARTED|Overall Study||10
7964985|NCT00364793|19606008|P1|STARTED|Overall Study||15
7964986|NCT00364689|19606145|P1|NOT COMPLETED|Overall Study||1
7964987|NCT00364689|19606145|P1|COMPLETED|Overall Study||12
7964988|NCT00364689|19606145|P1|STARTED|Overall Study||13
7964989|NCT00364611|19606165|P2|NOT COMPLETED|Overall Study||21
7964990|NCT00364611|19606166|P1|NOT COMPLETED|Overall Study||51
7964991|NCT00364611|19606165|P2|COMPLETED|Overall Study||0
7964992|NCT00364611|19606166|P1|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1
7964993|NCT00364611|19606165|P2|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20
7964994|NCT00364611|19606166|P1|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52
7964995|NCT00364611|19606165|P2|STARTED|Overall Study||21
7964996|NCT00364611|19606166|P1|STARTED|Overall Study||52
7964997|NCT00364533|19606189|P5|NOT COMPLETED|Overall Study||51
7964998|NCT00364533|19606190|P4|NOT COMPLETED|Overall Study||31
7964999|NCT00364533|19606191|P3|NOT COMPLETED|Overall Study||45
7965000|NCT00364533|19606192|P2|NOT COMPLETED|Overall Study||40
7965001|NCT00364533|19606193|P1|NOT COMPLETED|Overall Study||42
7965002|NCT00364533|19606189|P5|COMPLETED|Overall Study||24
7965003|NCT00364533|19606190|P4|COMPLETED|Overall Study||36
7965004|NCT00364533|19606191|P3|COMPLETED|Overall Study||30
7965005|NCT00364533|19606192|P2|COMPLETED|Overall Study||31
7965006|NCT00364533|19606193|P1|COMPLETED|Overall Study||35
7965007|NCT00364533|19606189|P5|STARTED|Overall Study||75
7965008|NCT00364533|19606190|P4|STARTED|Overall Study||67
7965009|NCT00364533|19606191|P3|STARTED|Overall Study||75
7965010|NCT00364533|19606192|P2|STARTED|Overall Study||71
7965011|NCT00364533|19606193|P1|STARTED|Overall Study||77
7965012|NCT00364377|19606217|P2|NOT COMPLETED|Overall Study||0
7965013|NCT00364377|19606218|P1|NOT COMPLETED|Overall Study||0
7965014|NCT00364377|19606217|P2|COMPLETED|Overall Study||11
7965015|NCT00364377|19606218|P1|COMPLETED|Overall Study||11
7965016|NCT00364377|19606217|P2|STARTED|Overall Study||11
7965017|NCT00364377|19606218|P1|STARTED|Overall Study||11
7965018|NCT00364351|19606226|P2|NOT COMPLETED|Overall Study||583
7965019|NCT00364351|19606227|P1|NOT COMPLETED|Overall Study||592
7965020|NCT00364351|19606226|P2|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|34
7965021|NCT00364351|19606227|P1|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|31
7965022|NCT00364351|19606226|P2|STARTED|Overall Study|randomised patients|617
7965023|NCT00364351|19606227|P1|STARTED|Overall Study|randomised patients|623
7965024|NCT00364286|19606245|P1|NOT COMPLETED|Overall Study||3
7965025|NCT00364286|19606245|P1|COMPLETED|Overall Study||14
7965026|NCT00364286|19606245|P1|STARTED|Overall Study||17
7965027|NCT00364182|19606252|P3|NOT COMPLETED|Fourth Intervention||0
7965028|NCT00364182|19606253|P2|NOT COMPLETED|Fourth Intervention||0
7965029|NCT00364182|19606254|P1|NOT COMPLETED|Fourth Intervention||0
7965030|NCT00364182|19606252|P3|COMPLETED|Fourth Intervention||22
7965031|NCT00364182|19606253|P2|COMPLETED|Fourth Intervention||19
7965032|NCT00364182|19606254|P1|COMPLETED|Fourth Intervention||0
7965033|NCT00364182|19606252|P3|STARTED|Fourth Intervention||22
7965034|NCT00364182|19606253|P2|STARTED|Fourth Intervention||19
7965035|NCT00364182|19606254|P1|STARTED|Fourth Intervention||0
7965036|NCT00364182|19606252|P3|NOT COMPLETED|Third Intervention||1
7965037|NCT00364182|19606253|P2|NOT COMPLETED|Third Intervention||1
7965038|NCT00364182|19606254|P1|NOT COMPLETED|Third Intervention||0
7965039|NCT00364182|19606252|P3|COMPLETED|Third Intervention||22
7965040|NCT00364182|19606253|P2|COMPLETED|Third Intervention||19
7965041|NCT00364182|19606254|P1|COMPLETED|Third Intervention||0
7965042|NCT00364182|19606252|P3|STARTED|Third Intervention||23
7965043|NCT00364182|19606253|P2|STARTED|Third Intervention||20
7965044|NCT00364182|19606254|P1|STARTED|Third Intervention||0
7965045|NCT00364182|19606252|P3|NOT COMPLETED|Second Intervention||2
7965046|NCT00364182|19606253|P2|NOT COMPLETED|Second Intervention||2
7965047|NCT00364182|19606254|P1|NOT COMPLETED|Second Intervention||0
7965048|NCT00364182|19606252|P3|COMPLETED|Second Intervention||23
7965049|NCT00364182|19606253|P2|COMPLETED|Second Intervention||20
7965050|NCT00364182|19606254|P1|COMPLETED|Second Intervention||0
7965051|NCT00364182|19606252|P3|Randomized|Second Intervention||25
7965052|NCT00364182|19606253|P2|Randomized|Second Intervention||22
7965053|NCT00364182|19606254|P1|Randomized|Second Intervention||0
7965054|NCT00364182|19606252|P3|STARTED|Second Intervention||25
7965055|NCT00364182|19606253|P2|STARTED|Second Intervention||22
7965056|NCT00364182|19606254|P1|STARTED|Second Intervention||0
7965057|NCT00364182|19606252|P3|NOT COMPLETED|First Intervention||0
7965058|NCT00364182|19606253|P2|NOT COMPLETED|First Intervention||0
7965059|NCT00364182|19606254|P1|NOT COMPLETED|First Intervention||3
7965060|NCT00364182|19606252|P3|COMPLETED|First Intervention||25
7965061|NCT00364182|19606253|P2|COMPLETED|First Intervention||22
7965062|NCT00364182|19606254|P1|COMPLETED|First Intervention||0
7965063|NCT00364182|19606252|P3|STARTED|First Intervention||25
7965064|NCT00364182|19606253|P2|STARTED|First Intervention||22
7965065|NCT00364182|19606254|P1|STARTED|First Intervention||3
7965066|NCT00364156|19606288|P2|NOT COMPLETED|Overall Study||81
7965067|NCT00364156|19606289|P1|NOT COMPLETED|Overall Study||79
7965068|NCT00364156|19606288|P2|COMPLETED|Overall Study||205
7965069|NCT00364156|19606289|P1|COMPLETED|Overall Study||203
7965070|NCT00364156|19606288|P2|STARTED|Overall Study||286
7965071|NCT00364156|19606289|P1|STARTED|Overall Study||282
7965072|NCT00364130|19606297|P2|NOT COMPLETED|Post Intervention Follow-up Period||11
7965073|NCT00364130|19606298|P1|NOT COMPLETED|Post Intervention Follow-up Period||5
7965074|NCT00364130|19606297|P2|COMPLETED|Post Intervention Follow-up Period||50
7965075|NCT00364130|19606298|P1|COMPLETED|Post Intervention Follow-up Period||55
7965076|NCT00364130|19606297|P2|STARTED|Post Intervention Follow-up Period||61
7965077|NCT00364130|19606298|P1|STARTED|Post Intervention Follow-up Period||60
7965078|NCT00364130|19606297|P2|NOT COMPLETED|Intervention Period||8
7965079|NCT00364130|19606298|P1|NOT COMPLETED|Intervention Period||9
7965080|NCT00364130|19606297|P2|COMPLETED|Intervention Period||61
7965081|NCT00364130|19606298|P1|COMPLETED|Intervention Period||60
7965082|NCT00364130|19606297|P2|STARTED|Intervention Period||69
7965083|NCT00364130|19606298|P1|STARTED|Intervention Period||69
7965084|NCT00364013|19606320|P2|NOT COMPLETED|Overall Study||95
7965085|NCT00364013|19606321|P1|NOT COMPLETED|Overall Study||101
7965086|NCT00364013|19606320|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495
7965087|NCT00364013|19606321|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492
7965088|NCT00364013|19606320|P2|Received Study Drug|Overall Study||583
7965089|NCT00364013|19606321|P1|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586
7965090|NCT00364013|19606320|P2|STARTED|Overall Study||590
7965091|NCT00364013|19606321|P1|STARTED|Overall Study||593
7965092|NCT00363896|19606349|P2|NOT COMPLETED|Overall Study||47
7965093|NCT00363896|19606350|P1|NOT COMPLETED|Overall Study||89
7965094|NCT00363896|19606349|P2|COMPLETED|Overall Study||169
7965095|NCT00363896|19606350|P1|COMPLETED|Overall Study||538
7965096|NCT00363896|19606349|P2|STARTED|Overall Study||216
7965097|NCT00363896|19606350|P1|STARTED|Overall Study||627
7965098|NCT00363883|19606362|P1|NOT COMPLETED|Overall Study||0
7965099|NCT00363883|19606362|P1|COMPLETED|Overall Study||14
7965100|NCT00363883|19606362|P1|STARTED|Overall Study||14
7965101|NCT00363805|19606371|P3|NOT COMPLETED|Overall Study||3
7965102|NCT00363805|19606372|P2|NOT COMPLETED|Overall Study||6
7965103|NCT00363805|19606373|P1|NOT COMPLETED|Overall Study||4
7965104|NCT00363805|19606371|P3|COMPLETED|Overall Study||70
7965105|NCT00363805|19606372|P2|COMPLETED|Overall Study||57
7965106|NCT00363805|19606373|P1|COMPLETED|Overall Study||38
7965107|NCT00363805|19606371|P3|STARTED|Overall Study||73
7965108|NCT00363805|19606372|P2|STARTED|Overall Study||63
7965109|NCT00363805|19606373|P1|STARTED|Overall Study||42
7965110|NCT00363779|19606384|P1|NOT COMPLETED|Overall Study||0
7965111|NCT00363779|19606384|P1|COMPLETED|Overall Study||5
7965112|NCT00363779|19606384|P1|STARTED|Overall Study||5
7965113|NCT00363766|19606391|P2|NOT COMPLETED|Overall Study||20
7965114|NCT00363766|19606392|P1|NOT COMPLETED|Overall Study||32
7965115|NCT00363766|19606391|P2|COMPLETED|Overall Study||0
7965116|NCT00363766|19606392|P1|COMPLETED|Overall Study||0
7965117|NCT00363766|19606391|P2|STARTED|Overall Study||20
7965118|NCT00363766|19606392|P1|STARTED|Overall Study||32
7965119|NCT00363675|19606412|P1|NOT COMPLETED|Overall Study||0
7965120|NCT00363675|19606412|P1|COMPLETED|Overall Study||3
7965121|NCT00363675|19606412|P1|Completed Testing|Overall Study||3
7965122|NCT00363675|19606412|P1|STARTED|Overall Study||3
7965123|NCT00363649|19606421|P2|NOT COMPLETED|Overall Study||1
7965124|NCT00363649|19606422|P1|NOT COMPLETED|Overall Study||7
7965125|NCT00363649|19606421|P2|COMPLETED|Overall Study||15
7965126|NCT00363649|19606422|P1|COMPLETED|Overall Study||11
7965127|NCT00363649|19606421|P2|Did Not Cross Over|Overall Study||3
7965128|NCT00363649|19606422|P1|Did Not Cross Over|Overall Study||2
7965129|NCT00363649|19606421|P2|Crossed Over to Arm A|Overall Study||12
7965130|NCT00363649|19606422|P1|Crossed Over to Arm A|Overall Study||0
7965131|NCT00363649|19606421|P2|Crossed Over to Arm B|Overall Study||0
7965132|NCT00363649|19606422|P1|Crossed Over to Arm B|Overall Study||9
7965133|NCT00363649|19606421|P2|STARTED|Overall Study||16
7965134|NCT00363649|19606422|P1|STARTED|Overall Study||18
7965135|NCT00363545|19606438|P2|NOT COMPLETED|Overall Study||57
7965136|NCT00363545|19606439|P1|NOT COMPLETED|Overall Study||44
7965137|NCT00363545|19606438|P2|COMPLETED|Overall Study||581
7965138|NCT00363545|19606439|P1|COMPLETED|Overall Study||592
7965139|NCT00363545|19606438|P2|STARTED|Overall Study||638
7965140|NCT00363545|19606439|P1|STARTED|Overall Study||636
7965141|NCT00363480|19606457|P1|NOT COMPLETED|Overall Study||17
7965142|NCT00363480|19606457|P1|COMPLETED|Overall Study||204
7965143|NCT00363480|19606457|P1|STARTED|Overall Study||221
7965144|NCT00363467|19606477|P1|NOT COMPLETED|Overall Study||1
7965145|NCT00363467|19606477|P1|COMPLETED|Overall Study||2
7965146|NCT00363467|19606477|P1|STARTED|Overall Study||3
7965147|NCT00363415|19606487|P2|NOT COMPLETED|Overall Study||249
7965148|NCT00363415|19606488|P1|NOT COMPLETED|Overall Study||361
7965149|NCT00363415|19606487|P2|COMPLETED|Overall Study||206
7965150|NCT00363415|19606488|P1|COMPLETED|Overall Study||92
7965151|NCT00363415|19606487|P2|Received at Least One Dose of Study Drug|Overall Study||447
7965152|NCT00363415|19606488|P1|Received at Least One Dose of Study Drug|Overall Study||433
7965153|NCT00363415|19606487|P2|STARTED|Overall Study||455
7965154|NCT00363415|19606488|P1|STARTED|Overall Study||453
7965155|NCT00363311|19606506|P2|NOT COMPLETED|Overall Study||45
7965156|NCT00363311|19606507|P1|NOT COMPLETED|Overall Study||76
7965157|NCT00363311|19606506|P2|COMPLETED|Overall Study||102
7965158|NCT00363311|19606507|P1|COMPLETED|Overall Study||79
7965159|NCT00363311|19606506|P2|STARTED|Overall Study||147
7965160|NCT00363311|19606507|P1|STARTED|Overall Study||155
7965161|NCT00363298|19606573|P2|NOT COMPLETED|4-week Study Continuation Phase||0
7965162|NCT00363298|19606574|P1|NOT COMPLETED|4-week Study Continuation Phase||1
7965163|NCT00363298|19606573|P2|COMPLETED|4-week Study Continuation Phase||7
7965164|NCT00363298|19606574|P1|COMPLETED|4-week Study Continuation Phase||5
7965165|NCT00363298|19606573|P2|STARTED|4-week Study Continuation Phase||7
7965166|NCT00363298|19606574|P1|STARTED|4-week Study Continuation Phase||6
7965167|NCT00363298|19606573|P2|NOT COMPLETED|First Study Week||5
7965168|NCT00363298|19606574|P1|NOT COMPLETED|First Study Week||6
7965169|NCT00363298|19606573|P2|COMPLETED|First Study Week|At end of week 1, 7/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|7
7965170|NCT00363298|19606574|P1|COMPLETED|First Study Week|At end of week 1, 6/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|6
7965171|NCT00363298|19606573|P2|STARTED|First Study Week||12
7965172|NCT00363298|19606574|P1|STARTED|First Study Week||12
7965173|NCT00363246|19606582|P1|NOT COMPLETED|Overall Study||97
7965174|NCT00363246|19606582|P1|COMPLETED|Overall Study||669
7965175|NCT00363246|19606582|P1|STARTED|Overall Study||766
7965176|NCT00363168|19606589|P2|NOT COMPLETED|Overall Study||0
7965177|NCT00363168|19606590|P1|NOT COMPLETED|Overall Study||0
7965178|NCT00363168|19606589|P2|COMPLETED|Overall Study||2
7965179|NCT00363168|19606590|P1|COMPLETED|Overall Study||5
7965180|NCT00363168|19606589|P2|STARTED|Overall Study||2
7965181|NCT00363168|19606590|P1|STARTED|Overall Study||5
7965182|NCT00363142|19606600|P2|NOT COMPLETED|Overall Study||3
7965183|NCT00363142|19606601|P1|NOT COMPLETED|Overall Study||7
7965184|NCT00363142|19606600|P2|COMPLETED|Overall Study||66
7965185|NCT00363142|19606601|P1|COMPLETED|Overall Study||133
7965186|NCT00363142|19606600|P2|STARTED|Overall Study||69
7965187|NCT00363142|19606601|P1|STARTED|Overall Study||140
7965188|NCT00363129|19606630|P2|NOT COMPLETED|Overall Study||33
7965189|NCT00363129|19606631|P1|NOT COMPLETED|Overall Study||29
7965190|NCT00363129|19606630|P2|COMPLETED|Overall Study||60
7965191|NCT00363129|19606631|P1|COMPLETED|Overall Study||67
7965192|NCT00363129|19606630|P2|STARTED|Overall Study||93
7965193|NCT00363129|19606631|P1|STARTED|Overall Study||96
7965194|NCT00363077|19606647|P2|NOT COMPLETED|Overall Study||0
7965195|NCT00363077|19606648|P1|NOT COMPLETED|Overall Study||0
7965196|NCT00363077|19606647|P2|COMPLETED|Overall Study||75
7965197|NCT00363077|19606648|P1|COMPLETED|Overall Study||75
7965198|NCT00363077|19606647|P2|STARTED|Overall Study||75
7965199|NCT00363077|19606648|P1|STARTED|Overall Study||75
7965200|NCT00363051|19606674|P2|NOT COMPLETED|Overall Study||22
7965201|NCT00363051|19606675|P1|NOT COMPLETED|Overall Study||38
7965202|NCT00363051|19606674|P2|COMPLETED|Overall Study||23
7965203|NCT00363051|19606675|P1|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77
7965204|NCT00363051|19606674|P2|STARTED|Overall Study||45
7965205|NCT00363051|19606675|P1|STARTED|Overall Study||115
7965206|NCT00363038|19606692|P1|NOT COMPLETED|Overall Study||0
7965207|NCT00363038|19606692|P1|COMPLETED|Overall Study||16
7965208|NCT00363038|19606692|P1|STARTED|Overall Study||16
7965209|NCT00362882|19606698|P2|NOT COMPLETED|Overall Study||0
7965210|NCT00362882|19606699|P1|NOT COMPLETED|Overall Study||0
7965211|NCT00362882|19606698|P2|COMPLETED|Overall Study||41
7965212|NCT00362882|19606699|P1|COMPLETED|Overall Study||40
7965213|NCT00362882|19606698|P2|STARTED|Overall Study||41
7965214|NCT00362882|19606699|P1|STARTED|Overall Study||40
7965215|NCT00362817|19606711|P1|NOT COMPLETED|Overall Study||0
7965216|NCT00362817|19606711|P1|COMPLETED|Overall Study||17
7965217|NCT00362817|19606711|P1|STARTED|Overall Study||17
7965218|NCT00362648|19606724|P4|NOT COMPLETED|Overall Study||11
7965219|NCT00362648|19606725|P3|NOT COMPLETED|Overall Study||9
7965220|NCT00362648|19606726|P2|NOT COMPLETED|Overall Study||134
7965221|NCT00362648|19606727|P1|NOT COMPLETED|Overall Study||126
7965222|NCT00362648|19606724|P4|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007
7965223|NCT00362648|19606725|P3|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009
7965224|NCT00362648|19606726|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601
7965225|NCT00362648|19606727|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607
7965226|NCT00362648|19606724|P4|Vaccinated at Visit 3|Overall Study||1007
7965227|NCT00362648|19606725|P3|Vaccinated at Visit 3|Overall Study||1009
7965228|NCT00362648|19606726|P2|Vaccinated at Visit 3|Overall Study||2612
7965229|NCT00362648|19606727|P1|Vaccinated at Visit 3|Overall Study||2613
7965230|NCT00362648|19606724|P4|Vaccinated at Visit 2|Overall Study||1009
7965231|NCT00362648|19606725|P3|Vaccinated at Visit 2|Overall Study||1013
7965232|NCT00362648|19606726|P2|Vaccinated at Visit 2|Overall Study||2666
7965233|NCT00362648|19606727|P1|Vaccinated at Visit 2|Overall Study||2657
7965234|NCT00362648|19606724|P4|Vaccinated at Visit 1|Overall Study||1018
7965235|NCT00362648|19606725|P3|Vaccinated at Visit 1|Overall Study||1018
7965236|NCT00362648|19606726|P2|Vaccinated at Visit 1|Overall Study||2735
7965237|NCT00362648|19606727|P1|Vaccinated at Visit 1|Overall Study||2733
7965238|NCT00362648|19606724|P4|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
7965239|NCT00362648|19606725|P3|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
7965240|NCT00362648|19606726|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735
7965241|NCT00362648|19606727|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733
7965242|NCT00362609|19606745|P2|NOT COMPLETED|Overall Study||2
7965243|NCT00362609|19606746|P1|NOT COMPLETED|Overall Study||0
7965244|NCT00362609|19606745|P2|COMPLETED|Overall Study||38
7965245|NCT00362609|19606746|P1|COMPLETED|Overall Study||19
7965246|NCT00362609|19606745|P2|STARTED|Overall Study||40
7965247|NCT00362609|19606746|P1|STARTED|Overall Study||19
7965248|NCT00362466|19606760|P2|NOT COMPLETED|Overall Study||0
7965249|NCT00362466|19606761|P1|NOT COMPLETED|Overall Study||0
7965250|NCT00362466|19606760|P2|COMPLETED|Overall Study||1
7965251|NCT00362466|19606761|P1|COMPLETED|Overall Study||2
7965252|NCT00362466|19606760|P2|STARTED|Overall Study||1
7965253|NCT00362466|19606761|P1|STARTED|Overall Study||2
7965254|NCT00362453|19606783|P2|NOT COMPLETED|Overall Study||0
7965255|NCT00362453|19606784|P1|NOT COMPLETED|Overall Study||0
7965256|NCT00362453|19606783|P2|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
7965257|NCT00362453|19606784|P1|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
7965258|NCT00362453|19606783|P2|STARTED|Overall Study||20
7965259|NCT00362453|19606784|P1|STARTED|Overall Study||20
7965260|NCT00362440|19606816|P2|NOT COMPLETED|Overall Study||1
7965261|NCT00362440|19606817|P1|NOT COMPLETED|Overall Study||2
7965262|NCT00362440|19606816|P2|COMPLETED|Overall Study||3
7965263|NCT00362440|19606817|P1|COMPLETED|Overall Study||3
7965264|NCT00362440|19606816|P2|STARTED|Overall Study||4
7965265|NCT00362440|19606817|P1|STARTED|Overall Study||5
7965266|NCT00362414|19606827|P1|NOT COMPLETED|Overall Study||3
7965267|NCT00362414|19606827|P1|COMPLETED|Overall Study||12
7965268|NCT00362414|19606827|P1|STARTED|Overall Study||15
7965269|NCT00362401|19606847|P3|NOT COMPLETED|Overall Study||0
7965270|NCT00362401|19606848|P2|NOT COMPLETED|Overall Study||0
7965271|NCT00362401|19606849|P1|NOT COMPLETED|Overall Study||0
7965272|NCT00362401|19606847|P3|COMPLETED|Overall Study||40
7965273|NCT00362401|19606848|P2|COMPLETED|Overall Study||29
7965274|NCT00362401|19606849|P1|COMPLETED|Overall Study||15
7965275|NCT00362401|19606847|P3|STARTED|Overall Study||40
7965276|NCT00362401|19606848|P2|STARTED|Overall Study||29
7965277|NCT00362401|19606849|P1|STARTED|Overall Study||15
7965278|NCT00362375|19606856|P2|NOT COMPLETED|Overall Study||35
7965279|NCT00362375|19606857|P1|NOT COMPLETED|Overall Study||40
7965280|NCT00362375|19606856|P2|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117
7965281|NCT00362375|19606857|P1|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121
7965282|NCT00362375|19606856|P2|STARTED|Overall Study|Number eligible and randomized|152
7965283|NCT00362375|19606857|P1|STARTED|Overall Study|Number eligible and randomized|161
7965284|NCT00362336|19606874|P3|NOT COMPLETED|Overall Study||3
7965285|NCT00362336|19606875|P2|NOT COMPLETED|Overall Study||7
7965286|NCT00362336|19606876|P1|NOT COMPLETED|Overall Study||10
7965287|NCT00362336|19606874|P3|COMPLETED|Overall Study||134
7965288|NCT00362336|19606875|P2|COMPLETED|Overall Study||235
7965289|NCT00362336|19606876|P1|COMPLETED|Overall Study||233
7965290|NCT00362336|19606874|P3|STARTED|Overall Study||137
7965291|NCT00362336|19606875|P2|STARTED|Overall Study||242
7965292|NCT00362336|19606876|P1|STARTED|Overall Study||243
7965293|NCT00362297|19606904|P2|NOT COMPLETED|Treatment 2||0
7965294|NCT00362297|19606905|P1|NOT COMPLETED|Treatment 2||0
7965295|NCT00362297|19606904|P2|COMPLETED|Treatment 2||11
7965296|NCT00362297|19606905|P1|COMPLETED|Treatment 2||16
7965297|NCT00362297|19606904|P2|STARTED|Treatment 2||11
7965298|NCT00362297|19606905|P1|STARTED|Treatment 2||16
7965299|NCT00362297|19606904|P2|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||4
7965300|NCT00362297|19606905|P1|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||0
7965301|NCT00362297|19606904|P2|COMPLETED|Treatment 1 (Initial Drug Assignment)||11
7965302|NCT00362297|19606905|P1|COMPLETED|Treatment 1 (Initial Drug Assignment)||16
7965303|NCT00362297|19606904|P2|STARTED|Treatment 1 (Initial Drug Assignment)||15
7965304|NCT00362297|19606905|P1|STARTED|Treatment 1 (Initial Drug Assignment)||16
7965305|NCT00362232|19606913|P2|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39
7965306|NCT00362232|19606914|P1|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38
7965307|NCT00362232|19606913|P2|COMPLETED|Follow-up (30 (+ 5) Days)||1416
7965308|NCT00362232|19606914|P1|COMPLETED|Follow-up (30 (+ 5) Days)||1433
7965309|NCT00362232|19606913|P2|STARTED|Follow-up (30 (+ 5) Days)||1455
7965310|NCT00362232|19606914|P1|STARTED|Follow-up (30 (+ 5) Days)||1471
7965311|NCT00362232|19606913|P2|NOT COMPLETED|Treatment (12 +/- 2 Days)||151
7965312|NCT00362232|19606914|P1|NOT COMPLETED|Treatment (12 +/- 2 Days)||159
7965313|NCT00362232|19606913|P2|COMPLETED|Treatment (12 +/- 2 Days)||1413
7965314|NCT00362232|19606914|P1|COMPLETED|Treatment (12 +/- 2 Days)||1425
7965315|NCT00362232|19606913|P2|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508
7965316|NCT00362232|19606914|P1|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526
7965317|NCT00362232|19606913|P2|STARTED|Treatment (12 +/- 2 Days)||1564
7965318|NCT00362232|19606914|P1|STARTED|Treatment (12 +/- 2 Days)||1584
7965319|NCT00362180|19606959|P9|NOT COMPLETED|20 Week Safety Follow-up||0
7965320|NCT00362180|19606960|P8|NOT COMPLETED|20 Week Safety Follow-up||0
7965321|NCT00362180|19606961|P7|NOT COMPLETED|20 Week Safety Follow-up||0
7965322|NCT00362180|19606962|P6|NOT COMPLETED|20 Week Safety Follow-up||0
7965323|NCT00362180|19606963|P5|NOT COMPLETED|20 Week Safety Follow-up||0
7965324|NCT00362180|19606964|P4|NOT COMPLETED|20 Week Safety Follow-up||0
7965325|NCT00362180|19606965|P3|NOT COMPLETED|20 Week Safety Follow-up||0
7965326|NCT00362180|19606966|P2|NOT COMPLETED|20 Week Safety Follow-up||0
7965327|NCT00362180|19606967|P1|NOT COMPLETED|20 Week Safety Follow-up||0
7965328|NCT00362180|19606959|P9|COMPLETED|20 Week Safety Follow-up||1
7965329|NCT00362180|19606960|P8|COMPLETED|20 Week Safety Follow-up||3
7965330|NCT00362180|19606961|P7|COMPLETED|20 Week Safety Follow-up||0
7965331|NCT00362180|19606962|P6|COMPLETED|20 Week Safety Follow-up||9
7965332|NCT00362180|19606963|P5|COMPLETED|20 Week Safety Follow-up||11
7965333|NCT00362180|19606964|P4|COMPLETED|20 Week Safety Follow-up||0
7965334|NCT00362180|19606965|P3|COMPLETED|20 Week Safety Follow-up||1
7965335|NCT00362180|19606966|P2|COMPLETED|20 Week Safety Follow-up||2
7965336|NCT00362180|19606967|P1|COMPLETED|20 Week Safety Follow-up||3
7965337|NCT00362180|19606959|P9|STARTED|20 Week Safety Follow-up||1
7965338|NCT00362180|19606960|P8|STARTED|20 Week Safety Follow-up||3
7965339|NCT00362180|19606961|P7|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0
7965340|NCT00362180|19606962|P6|STARTED|20 Week Safety Follow-up||9
7965341|NCT00362180|19606963|P5|STARTED|20 Week Safety Follow-up||11
7965342|NCT00362180|19606964|P4|STARTED|20 Week Safety Follow-up||0
7965343|NCT00362180|19606965|P3|STARTED|20 Week Safety Follow-up||1
7965344|NCT00362180|19606966|P2|STARTED|20 Week Safety Follow-up||2
7965345|NCT00362180|19606967|P1|STARTED|20 Week Safety Follow-up||3
7965346|NCT00362180|19606959|P9|NOT COMPLETED|Treated Period||0
7965347|NCT00362180|19606960|P8|NOT COMPLETED|Treated Period||1
7965348|NCT00362180|19606961|P7|NOT COMPLETED|Treated Period||0
7965349|NCT00362180|19606962|P6|NOT COMPLETED|Treated Period||1
7965350|NCT00362180|19606963|P5|NOT COMPLETED|Treated Period||0
7965351|NCT00362180|19606964|P4|NOT COMPLETED|Treated Period||0
7965352|NCT00362180|19606965|P3|NOT COMPLETED|Treated Period||0
7965353|NCT00362180|19606966|P2|NOT COMPLETED|Treated Period||0
7965354|NCT00362180|19606967|P1|NOT COMPLETED|Treated Period||1
7965355|NCT00362180|19606959|P9|COMPLETED|Treated Period||1
7965356|NCT00362180|19606960|P8|COMPLETED|Treated Period||2
7965357|NCT00362180|19606961|P7|COMPLETED|Treated Period||6
7965358|NCT00362180|19606962|P6|COMPLETED|Treated Period||9
7965359|NCT00362180|19606963|P5|COMPLETED|Treated Period||11
7965360|NCT00362180|19606964|P4|COMPLETED|Treated Period||0
7965361|NCT00362180|19606965|P3|COMPLETED|Treated Period||1
7965362|NCT00362180|19606966|P2|COMPLETED|Treated Period||2
7965363|NCT00362180|19606967|P1|COMPLETED|Treated Period||3
7965364|NCT00362180|19606959|P9|STARTED|Treated Period||1
7965365|NCT00362180|19606960|P8|STARTED|Treated Period||3
7965366|NCT00362180|19606961|P7|STARTED|Treated Period||6
7965367|NCT00362180|19606962|P6|STARTED|Treated Period||10
7965368|NCT00362180|19606963|P5|STARTED|Treated Period||11
7965369|NCT00362180|19606964|P4|STARTED|Treated Period||0
7965370|NCT00362180|19606965|P3|STARTED|Treated Period||1
7965371|NCT00362180|19606966|P2|STARTED|Treated Period||2
7965372|NCT00362180|19606967|P1|STARTED|Treated Period||4
7965373|NCT00362128|19607028|P1|NOT COMPLETED|Overall Study||0
7965374|NCT00362128|19607028|P1|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072
7965375|NCT00362128|19607028|P1|STARTED|Overall Study|Enrollment was initiated in 2007.|2072
7965376|NCT00362115|19607039|P7|NOT COMPLETED|Overall Study||12
7965377|NCT00362115|19607040|P6|NOT COMPLETED|Overall Study||7
7965378|NCT00362115|19607041|P5|NOT COMPLETED|Overall Study||7
7965379|NCT00362115|19607042|P4|NOT COMPLETED|Overall Study||4
7965380|NCT00362115|19607043|P3|NOT COMPLETED|Overall Study||7
7965381|NCT00362115|19607044|P2|NOT COMPLETED|Overall Study||6
7965382|NCT00362115|19607045|P1|NOT COMPLETED|Overall Study||2
7965383|NCT00362115|19607039|P7|COMPLETED|Overall Study||52
7965384|NCT00362115|19607040|P6|COMPLETED|Overall Study||57
7965385|NCT00362115|19607041|P5|COMPLETED|Overall Study||57
7965386|NCT00362115|19607042|P4|COMPLETED|Overall Study||59
7965387|NCT00362115|19607043|P3|COMPLETED|Overall Study||57
7965388|NCT00362115|19607044|P2|COMPLETED|Overall Study||59
7965389|NCT00362115|19607045|P1|COMPLETED|Overall Study||63
7965390|NCT00362115|19607039|P7|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
7965391|NCT00362115|19607040|P6|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
7965392|NCT00362115|19607041|P5|STARTED|Overall Study||64
7965393|NCT00362115|19607042|P4|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63
7965394|NCT00362115|19607043|P3|STARTED|Overall Study||64
7965395|NCT00362115|19607044|P2|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65
7965396|NCT00362115|19607045|P1|STARTED|Overall Study||65
7965397|NCT00361972|19607196|P2|NOT COMPLETED|Overall Study||0
7965398|NCT00361972|19607197|P1|NOT COMPLETED|Overall Study||0
7965399|NCT00361972|19607196|P2|COMPLETED|Overall Study||9
7965400|NCT00361972|19607197|P1|COMPLETED|Overall Study||8
7965401|NCT00361972|19607196|P2|STARTED|Overall Study||9
7965402|NCT00361972|19607197|P1|STARTED|Overall Study||8
7965403|NCT00361712|19607207|P2|NOT COMPLETED|Overall Study||0
7965404|NCT00361712|19607208|P1|NOT COMPLETED|Overall Study||0
7965405|NCT00361712|19607207|P2|COMPLETED|Overall Study||21
7965406|NCT00361712|19607208|P1|COMPLETED|Overall Study||20
7965407|NCT00361712|19607207|P2|STARTED|Overall Study||21
7965408|NCT00361712|19607208|P1|STARTED|Overall Study||20
7965409|NCT00361634|19607218|P1|NOT COMPLETED|Overall Study||2
7965410|NCT00361634|19607218|P1|COMPLETED|Overall Study||12
7965411|NCT00361634|19607218|P1|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13
7965412|NCT00361634|19607218|P1|STARTED|Overall Study||14
7965413|NCT00361595|19607236|P1|NOT COMPLETED|Overall Study||0
7965414|NCT00361595|19607236|P1|COMPLETED|Overall Study||35
7965415|NCT00361595|19607236|P1|STARTED|Overall Study||35
7965416|NCT00361569|19607247|P4|NOT COMPLETED|Overall Study||21
7965417|NCT00361569|19607248|P3|NOT COMPLETED|Overall Study||18
7965418|NCT00361569|19607249|P2|NOT COMPLETED|Overall Study||11
7965419|NCT00361569|19607250|P1|NOT COMPLETED|Overall Study||12
7965420|NCT00361569|19607247|P4|COMPLETED|Overall Study||135
7965421|NCT00361569|19607248|P3|COMPLETED|Overall Study||137
7965422|NCT00361569|19607249|P2|COMPLETED|Overall Study||150
7965423|NCT00361569|19607250|P1|COMPLETED|Overall Study||138
7965424|NCT00361569|19607247|P4|STARTED|Overall Study||156
7965425|NCT00361569|19607248|P3|STARTED|Overall Study||155
7965426|NCT00361569|19607249|P2|STARTED|Overall Study||161
7965427|NCT00361569|19607250|P1|STARTED|Overall Study||150
7965428|NCT00361504|19607274|P2|NOT COMPLETED|Overall Study||145
7965429|NCT00361504|19607275|P1|NOT COMPLETED|Overall Study||481
7965430|NCT00361504|19607274|P2|COMPLETED|Overall Study||78
7965431|NCT00361504|19607275|P1|COMPLETED|Overall Study||413
7965432|NCT00361504|19607274|P2|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223
7965433|NCT00361504|19607275|P1|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894
7965434|NCT00361439|19607285|P2|NOT COMPLETED|Overall Study||0
7965435|NCT00361439|19607286|P1|NOT COMPLETED|Overall Study||0
7965436|NCT00361439|19607285|P2|COMPLETED|Overall Study||9
7965437|NCT00361439|19607286|P1|COMPLETED|Overall Study||8
7965438|NCT00361439|19607285|P2|STARTED|Overall Study||9
7965439|NCT00361439|19607286|P1|STARTED|Overall Study||8
7965440|NCT00361374|19607301|P3|NOT COMPLETED|Overall Study||12
7965441|NCT00361374|19607302|P2|NOT COMPLETED|Overall Study||15
7965442|NCT00361374|19607303|P1|NOT COMPLETED|Overall Study||15
7965443|NCT00361374|19607301|P3|COMPLETED|Overall Study||53
7965444|NCT00361374|19607302|P2|COMPLETED|Overall Study||50
7965445|NCT00361374|19607303|P1|COMPLETED|Overall Study||51
7965446|NCT00361374|19607301|P3|STARTED|Overall Study||65
7965447|NCT00361374|19607302|P2|STARTED|Overall Study||65
7965448|NCT00361374|19607303|P1|STARTED|Overall Study||66
7965449|NCT00361335|19607316|P7|NOT COMPLETED|SC Period: Week E0 to Week E24||9
7965450|NCT00361335|19607317|P6|NOT COMPLETED|SC Period: Week E0 to Week E24||1
7965451|NCT00361335|19607318|P5|NOT COMPLETED|SC Period: Week E0 to Week E24||0
7965452|NCT00361335|19607319|P4|NOT COMPLETED|SC Period: Week E0 to Week E24||4
7965453|NCT00361335|19607320|P3|NOT COMPLETED|SC Period: Week E0 to Week E24||5
7965454|NCT00361335|19607321|P2|NOT COMPLETED|SC Period: Week E0 to Week E24||3
7965455|NCT00361335|19607322|P1|NOT COMPLETED|SC Period: Week E0 to Week E24||2
7965456|NCT00361335|19607316|P7|COMPLETED|SC Period: Week E0 to Week E24||164
7965457|NCT00361335|19607317|P6|COMPLETED|SC Period: Week E0 to Week E24||23
7965458|NCT00361335|19607318|P5|COMPLETED|SC Period: Week E0 to Week E24||3
7965459|NCT00361335|19607319|P4|COMPLETED|SC Period: Week E0 to Week E24||59
7965460|NCT00361335|19607320|P3|COMPLETED|SC Period: Week E0 to Week E24||99
7965461|NCT00361335|19607321|P2|COMPLETED|SC Period: Week E0 to Week E24||56
7965462|NCT00361335|19607322|P1|COMPLETED|SC Period: Week E0 to Week E24||80
7965463|NCT00361335|19607316|P7|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173
7965464|NCT00361335|19607317|P6|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24
7965465|NCT00361335|19607318|P5|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3
7965466|NCT00361335|19607319|P4|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63
7965467|NCT00361335|19607320|P3|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104
7965468|NCT00361335|19607321|P2|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59
7965469|NCT00361335|19607322|P1|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82
7965470|NCT00361335|19607316|P7|NOT COMPLETED|IV Period: Baseline to E0||0
7965471|NCT00361335|19607317|P6|NOT COMPLETED|IV Period: Baseline to E0||0
7965472|NCT00361335|19607318|P5|NOT COMPLETED|IV Period: Baseline to E0||24
7965473|NCT00361335|19607319|P4|NOT COMPLETED|IV Period: Baseline to E0||27
7965474|NCT00361335|19607320|P3|NOT COMPLETED|IV Period: Baseline to E0||21
7965475|NCT00361335|19607321|P2|NOT COMPLETED|IV Period: Baseline to E0||29
7965476|NCT00361335|19607322|P1|NOT COMPLETED|IV Period: Baseline to E0||20
7965477|NCT00361335|19607316|P7|COMPLETED|IV Period: Baseline to E0||0
7965478|NCT00361335|19607317|P6|COMPLETED|IV Period: Baseline to E0||0
7965479|NCT00361335|19607318|P5|COMPLETED|IV Period: Baseline to E0||105
7965480|NCT00361335|19607319|P4|COMPLETED|IV Period: Baseline to E0||102
7965481|NCT00361335|19607320|P3|COMPLETED|IV Period: Baseline to E0||107
7965482|NCT00361335|19607321|P2|COMPLETED|IV Period: Baseline to E0||99
7965483|NCT00361335|19607322|P1|COMPLETED|IV Period: Baseline to E0||109
7965484|NCT00361335|19607316|P7|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
7965485|NCT00361335|19607317|P6|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
7965486|NCT00361335|19607318|P5|STARTED|IV Period: Baseline to E0||129
7965487|NCT00361335|19607319|P4|STARTED|IV Period: Baseline to E0||129
7965488|NCT00361335|19607320|P3|STARTED|IV Period: Baseline to E0||128
7965489|NCT00361335|19607321|P2|STARTED|IV Period: Baseline to E0||128
7965490|NCT00361335|19607322|P1|STARTED|IV Period: Baseline to E0||129
7965491|NCT00361296|19607366|P1|NOT COMPLETED|Overall Study||3
7965492|NCT00361296|19607366|P1|COMPLETED|Overall Study||2
7965493|NCT00361296|19607366|P1|STARTED|Overall Study||5
7965494|NCT00361283|19607373|P1|NOT COMPLETED|Overall Study||27
7965495|NCT00361283|19607373|P1|COMPLETED|Overall Study||81
7965496|NCT00361283|19607373|P1|STARTED|Overall Study||108
7965497|NCT00361270|19607381|P4|NOT COMPLETED|Overall Study||13
7965498|NCT00361270|19607382|P3|NOT COMPLETED|Overall Study||10
7965499|NCT00361270|19607383|P2|NOT COMPLETED|Overall Study||14
7965500|NCT00361270|19607384|P1|NOT COMPLETED|Overall Study||24
7965501|NCT00361270|19607381|P4|COMPLETED|Overall Study||25
7965502|NCT00361270|19607382|P3|COMPLETED|Overall Study||25
7965503|NCT00361270|19607383|P2|COMPLETED|Overall Study||25
7965504|NCT00361270|19607384|P1|COMPLETED|Overall Study||25
7965505|NCT00361270|19607381|P4|STARTED|Overall Study||38
7965506|NCT00361270|19607382|P3|STARTED|Overall Study||35
7965507|NCT00361270|19607383|P2|STARTED|Overall Study||39
7965508|NCT00361270|19607384|P1|STARTED|Overall Study||49
7965509|NCT00361257|19607404|P2|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
7965510|NCT00361257|19607405|P1|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
7965511|NCT00361257|19607404|P2|COMPLETED|Step 2: Minocycline(Open Label) for All||19
7965512|NCT00361257|19607405|P1|COMPLETED|Step 2: Minocycline(Open Label) for All||13
7965513|NCT00361257|19607404|P2|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34
7965514|NCT00361257|19607405|P1|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28
7965515|NCT00361257|19607404|P2|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
7965516|NCT00361257|19607405|P1|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
7965517|NCT00361257|19607404|P2|COMPLETED|Step 1: Minocycline vs. Placebo||43
7965518|NCT00361257|19607405|P1|COMPLETED|Step 1: Minocycline vs. Placebo||40
7965519|NCT00361257|19607404|P2|STARTED|Step 1: Minocycline vs. Placebo||55
7965520|NCT00361257|19607405|P1|STARTED|Step 1: Minocycline vs. Placebo||52
7965521|NCT00361231|19607457|P1|NOT COMPLETED|Overall Study||34
7965522|NCT00361231|19607457|P1|COMPLETED|Overall Study||1
7965523|NCT00361231|19607457|P1|STARTED|Overall Study||35
7965524|NCT00361218|19607462|P1|NOT COMPLETED|Overall Study||23
7965525|NCT00361218|19607462|P1|COMPLETED|Overall Study||30
7965526|NCT00361218|19607462|P1|Completed Baseline Assessment|Overall Study||47
7965527|NCT00361218|19607462|P1|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53
7965528|NCT00361140|19607470|P3|NOT COMPLETED|Overall Study||0
7965529|NCT00361140|19607471|P2|NOT COMPLETED|Overall Study||0
7965530|NCT00361140|19607472|P1|NOT COMPLETED|Overall Study||0
7965531|NCT00361140|19607470|P3|COMPLETED|Overall Study||3
7965532|NCT00361140|19607471|P2|COMPLETED|Overall Study||29
7965533|NCT00361140|19607472|P1|COMPLETED|Overall Study||40
7965534|NCT00361140|19607470|P3|STARTED|Overall Study||3
7965535|NCT00361140|19607471|P2|STARTED|Overall Study||29
7965536|NCT00361140|19607472|P1|STARTED|Overall Study||40
7965537|NCT00360971|19607485|P2|NOT COMPLETED|Overall Study||0
7965538|NCT00360971|19607486|P1|NOT COMPLETED|Overall Study||0
7965539|NCT00360971|19607485|P2|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11
7965540|NCT00360971|19607486|P1|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10
7965541|NCT00360971|19607485|P2|STARTED|Overall Study||11
7965542|NCT00360971|19607486|P1|STARTED|Overall Study||10
7965543|NCT00360828|19607502|P1|NOT COMPLETED|Overall Study||1
7965544|NCT00360828|19607502|P1|COMPLETED|Overall Study||9
7965545|NCT00360828|19607502|P1|STARTED|Overall Study||10
7965546|NCT00360724|19607512|P2|NOT COMPLETED|Overall Study||4
7965547|NCT00360724|19607513|P1|NOT COMPLETED|Overall Study||4
7965548|NCT00360724|19607512|P2|COMPLETED|Overall Study||28
7965549|NCT00360724|19607513|P1|COMPLETED|Overall Study||29
7965550|NCT00360724|19607512|P2|STARTED|Overall Study||32
7965551|NCT00360724|19607513|P1|STARTED|Overall Study||33
7965552|NCT00360698|19607541|P2|NOT COMPLETED|Treatment Period||1
7965553|NCT00360698|19607542|P1|NOT COMPLETED|Treatment Period||1
7965554|NCT00360698|19607541|P2|COMPLETED|Treatment Period||56
7965555|NCT00360698|19607542|P1|COMPLETED|Treatment Period||48
7965556|NCT00360698|19607541|P2|STARTED|Treatment Period||57
7965557|NCT00360698|19607542|P1|STARTED|Treatment Period||49
7965558|NCT00360698|19607541|P2|NOT COMPLETED|Run-In||10
7965559|NCT00360698|19607542|P1|NOT COMPLETED|Run-In||0
7965560|NCT00360698|19607541|P2|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125
7965561|NCT00360698|19607542|P1|COMPLETED|Run-In||0
7965562|NCT00360698|19607541|P2|STARTED|Run-In||135
7965563|NCT00360698|19607542|P1|STARTED|Run-In||0
7965564|NCT00360685|19607570|P2|NOT COMPLETED|Overall Study||0
7965565|NCT00360685|19607571|P1|NOT COMPLETED|Overall Study||0
7965566|NCT00360685|19607570|P2|COMPLETED|Overall Study||42
7965567|NCT00360685|19607571|P1|COMPLETED|Overall Study||47
7965568|NCT00360685|19607570|P2|STARTED|Overall Study||42
7965569|NCT00360685|19607571|P1|STARTED|Overall Study||47
7965570|NCT00360672|19607581|P1|NOT COMPLETED|Overall Study||0
7965571|NCT00360672|19607581|P1|COMPLETED|Overall Study||27
7965572|NCT00360672|19607581|P1|STARTED|Overall Study||27
7965573|NCT00360568|19607587|P2|NOT COMPLETED|Overall Study||5
7965574|NCT00360568|19607588|P1|NOT COMPLETED|Overall Study||2
7965575|NCT00360568|19607587|P2|COMPLETED|Overall Study||24
7965576|NCT00360568|19607588|P1|COMPLETED|Overall Study||31
7965577|NCT00360568|19607587|P2|STARTED|Overall Study||29
7965578|NCT00360568|19607588|P1|STARTED|Overall Study||33
7965579|NCT00360555|19607699|P4|NOT COMPLETED|Overall Study||112
7965580|NCT00360555|19607700|P3|NOT COMPLETED|Overall Study||145
7965581|NCT00360555|19607701|P2|NOT COMPLETED|Overall Study||134
7965582|NCT00360555|19607702|P1|NOT COMPLETED|Overall Study||122
7965583|NCT00360555|19607699|P4|COMPLETED|Overall Study||287
7965584|NCT00360555|19607700|P3|COMPLETED|Overall Study||251
7965585|NCT00360555|19607701|P2|COMPLETED|Overall Study||259
7965586|NCT00360555|19607702|P1|COMPLETED|Overall Study||274
7965587|NCT00360555|19607699|P4|STARTED|Overall Study||399
7965588|NCT00360555|19607700|P3|STARTED|Overall Study||396
7965589|NCT00360555|19607701|P2|STARTED|Overall Study||393
7965590|NCT00360555|19607702|P1|STARTED|Overall Study||396
7965591|NCT00360529|19607719|P3|NOT COMPLETED|Overall Study||91
7965592|NCT00360529|19607720|P2|NOT COMPLETED|Overall Study||65
7965593|NCT00360529|19607721|P1|NOT COMPLETED|Overall Study||61
7965594|NCT00360529|19607719|P3|COMPLETED|Overall Study||199
7965595|NCT00360529|19607720|P2|COMPLETED|Overall Study||230
7965596|NCT00360529|19607721|P1|COMPLETED|Overall Study||234
7965597|NCT00360529|19607719|P3|STARTED|Overall Study||290
7965598|NCT00360529|19607720|P2|STARTED|Overall Study||295
7965599|NCT00360529|19607721|P1|STARTED|Overall Study||295
7965600|NCT00360490|19607749|P2|NOT COMPLETED|Overall Study||11
7965601|NCT00360490|19607750|P1|NOT COMPLETED|Overall Study||9
7965602|NCT00360490|19607749|P2|COMPLETED|Overall Study||72
7965603|NCT00360490|19607750|P1|COMPLETED|Overall Study||73
7965604|NCT00360490|19607749|P2|STARTED|Overall Study||83
7965605|NCT00360490|19607750|P1|STARTED|Overall Study||82
7965606|NCT00360412|19607785|P2|NOT COMPLETED|Overall Study||662
7965607|NCT00360412|19607786|P1|NOT COMPLETED|Overall Study||333
7965608|NCT00360412|19607785|P2|COMPLETED|Overall Study||2
7965609|NCT00360412|19607786|P1|COMPLETED|Overall Study||0
7965610|NCT00360412|19607785|P2|STARTED|Overall Study||664
7965611|NCT00360412|19607786|P1|STARTED|Overall Study||333
7965612|NCT00360399|19607801|P3|NOT COMPLETED|Overall Study||46
7965613|NCT00360399|19607802|P2|NOT COMPLETED|Overall Study||36
7965614|NCT00360399|19607803|P1|NOT COMPLETED|Overall Study||28
7965615|NCT00360399|19607801|P3|COMPLETED|Overall Study||69
7965616|NCT00360399|19607802|P2|COMPLETED|Overall Study||79
7965617|NCT00360399|19607803|P1|COMPLETED|Overall Study||86
7965618|NCT00360399|19607801|P3|Had Post-randomization Assessment|Overall Study||105
7965619|NCT00360399|19607802|P2|Had Post-randomization Assessment|Overall Study||106
7965620|NCT00360399|19607803|P1|Had Post-randomization Assessment|Overall Study||105
7965621|NCT00360399|19607801|P3|STARTED|Overall Study||115
7965622|NCT00360399|19607802|P2|STARTED|Overall Study||115
7965623|NCT00360399|19607803|P1|STARTED|Overall Study||114
7965624|NCT00360360|19607826|P1|NOT COMPLETED|Overall Study||6
7965625|NCT00360360|19607826|P1|COMPLETED|Overall Study||54
7965626|NCT00360360|19607826|P1|STARTED|Overall Study||60
7965627|NCT00360334|19607833|P2|NOT COMPLETED|Overall Study||13
7965628|NCT00360334|19607834|P1|NOT COMPLETED|Overall Study||19
7965629|NCT00360334|19607833|P2|COMPLETED|Overall Study||104
7965630|NCT00360334|19607834|P1|COMPLETED|Overall Study||99
7965631|NCT00360334|19607833|P2|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116
7965632|NCT00360334|19607834|P1|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118
7965633|NCT00360334|19607833|P2|STARTED|Overall Study||117
7965634|NCT00360334|19607834|P1|STARTED|Overall Study||118
7965635|NCT00360308|19607897|P3|NOT COMPLETED|Overall Study||88
7965636|NCT00360308|19607898|P2|NOT COMPLETED|Overall Study||79
7965637|NCT00360308|19607899|P1|NOT COMPLETED|Overall Study||76
7965638|NCT00360308|19607897|P3|COMPLETED|Overall Study||154
7965639|NCT00360308|19607898|P2|COMPLETED|Overall Study||155
7965640|NCT00360308|19607899|P1|COMPLETED|Overall Study||171
7965641|NCT00360308|19607897|P3|STARTED|Overall Study||242
7965642|NCT00360308|19607898|P2|STARTED|Overall Study||234
7965643|NCT00360308|19607899|P1|STARTED|Overall Study||247
7965644|NCT00360282|19607916|P4|NOT COMPLETED|Second Intervention||0
7965645|NCT00360282|19607917|P3|NOT COMPLETED|Second Intervention||0
7965646|NCT00360282|19607918|P2|NOT COMPLETED|Second Intervention||1
7965647|NCT00360282|19607919|P1|NOT COMPLETED|Second Intervention||0
7965648|NCT00360282|19607916|P4|COMPLETED|Second Intervention||6
7965649|NCT00360282|19607917|P3|COMPLETED|Second Intervention||6
7965650|NCT00360282|19607918|P2|COMPLETED|Second Intervention||7
7965651|NCT00360282|19607919|P1|COMPLETED|Second Intervention||6
7965652|NCT00360282|19607916|P4|STARTED|Second Intervention||6
7965653|NCT00360282|19607917|P3|STARTED|Second Intervention||6
7965654|NCT00360282|19607918|P2|STARTED|Second Intervention||8
7965655|NCT00360282|19607919|P1|STARTED|Second Intervention||6
7965656|NCT00360282|19607916|P4|NOT COMPLETED|Washout 1-3 Weeks||0
7965657|NCT00360282|19607917|P3|NOT COMPLETED|Washout 1-3 Weeks||1
7965658|NCT00360282|19607918|P2|NOT COMPLETED|Washout 1-3 Weeks||0
7965659|NCT00360282|19607919|P1|NOT COMPLETED|Washout 1-3 Weeks||0
7965660|NCT00360282|19607916|P4|COMPLETED|Washout 1-3 Weeks||6
7965661|NCT00360282|19607917|P3|COMPLETED|Washout 1-3 Weeks||6
7965662|NCT00360282|19607918|P2|COMPLETED|Washout 1-3 Weeks||8
7965663|NCT00360282|19607919|P1|COMPLETED|Washout 1-3 Weeks||6
7965664|NCT00360282|19607916|P4|STARTED|Washout 1-3 Weeks||6
7965665|NCT00360282|19607917|P3|STARTED|Washout 1-3 Weeks||7
7965666|NCT00360282|19607918|P2|STARTED|Washout 1-3 Weeks||8
7965667|NCT00360282|19607919|P1|STARTED|Washout 1-3 Weeks||6
7965668|NCT00360282|19607916|P4|NOT COMPLETED|First Intervention||0
7965669|NCT00360282|19607917|P3|NOT COMPLETED|First Intervention||0
7965670|NCT00360282|19607918|P2|NOT COMPLETED|First Intervention||0
7965671|NCT00360282|19607919|P1|NOT COMPLETED|First Intervention||0
7965672|NCT00360282|19607916|P4|COMPLETED|First Intervention||6
7965673|NCT00360282|19607917|P3|COMPLETED|First Intervention||7
7965674|NCT00360282|19607918|P2|COMPLETED|First Intervention||8
7965675|NCT00360282|19607919|P1|COMPLETED|First Intervention||6
7965676|NCT00360282|19607916|P4|STARTED|First Intervention||6
7965677|NCT00360282|19607917|P3|STARTED|First Intervention||7
7965678|NCT00360282|19607918|P2|STARTED|First Intervention||8
7965679|NCT00360282|19607919|P1|STARTED|First Intervention||6
7965680|NCT00360269|19607931|P2|NOT COMPLETED|Overall Study||12
7965681|NCT00360269|19607932|P1|NOT COMPLETED|Overall Study||10
7965682|NCT00360269|19607931|P2|COMPLETED|Overall Study||7
7965683|NCT00360269|19607932|P1|COMPLETED|Overall Study||9
7965684|NCT00360269|19607931|P2|STARTED|Overall Study||19
7965685|NCT00360269|19607932|P1|STARTED|Overall Study||19
7965686|NCT00360243|19607950|P4|NOT COMPLETED|Overall Study||125
7965687|NCT00360243|19607951|P3|NOT COMPLETED|Overall Study||156
7965688|NCT00360243|19607952|P2|NOT COMPLETED|Overall Study||120
7965689|NCT00360243|19607953|P1|NOT COMPLETED|Overall Study||102
7965690|NCT00360243|19607950|P4|COMPLETED|Overall Study||224
7965691|NCT00360243|19607951|P3|COMPLETED|Overall Study||180
7965692|NCT00360243|19607952|P2|COMPLETED|Overall Study||243
7965693|NCT00360243|19607953|P1|COMPLETED|Overall Study||235
7965694|NCT00360243|19607950|P4|STARTED|Overall Study||349
7965695|NCT00360243|19607951|P3|STARTED|Overall Study||336
7965696|NCT00360243|19607952|P2|STARTED|Overall Study||363
7965697|NCT00360243|19607953|P1|STARTED|Overall Study||337
7965698|NCT00360230|19607974|P7|NOT COMPLETED|Overall Study||2
7965699|NCT00360230|19607975|P6|NOT COMPLETED|Overall Study||4
7965700|NCT00360230|19607976|P5|NOT COMPLETED|Overall Study||5
7965701|NCT00360230|19607977|P4|NOT COMPLETED|Overall Study||2
7965702|NCT00360230|19607978|P3|NOT COMPLETED|Overall Study||3
7965703|NCT00360230|19607979|P2|NOT COMPLETED|Overall Study||3
7965704|NCT00360230|19607980|P1|NOT COMPLETED|Overall Study||6
7965705|NCT00360230|19607974|P7|COMPLETED|Overall Study||43
7965706|NCT00360230|19607975|P6|COMPLETED|Overall Study||86
7965707|NCT00360230|19607976|P5|COMPLETED|Overall Study||85
7965708|NCT00360230|19607977|P4|COMPLETED|Overall Study||88
7965709|NCT00360230|19607978|P3|COMPLETED|Overall Study||42
7965710|NCT00360230|19607979|P2|COMPLETED|Overall Study||87
7965711|NCT00360230|19607980|P1|COMPLETED|Overall Study||84
7965712|NCT00360230|19607974|P7|STARTED|Overall Study||45
7965713|NCT00360230|19607975|P6|STARTED|Overall Study||90
7965714|NCT00360230|19607976|P5|STARTED|Overall Study||90
7965715|NCT00360230|19607977|P4|STARTED|Overall Study||90
7965716|NCT00360230|19607978|P3|STARTED|Overall Study||45
7965717|NCT00360230|19607979|P2|STARTED|Overall Study||90
7965718|NCT00360230|19607980|P1|STARTED|Overall Study||90
7965719|NCT00360126|19608031|P1|NOT COMPLETED|Overall Study||0
7965720|NCT00360126|19608031|P1|COMPLETED|Overall Study||11
7965721|NCT00360126|19608031|P1|STARTED|Overall Study||11
7965722|NCT00360009|19608038|P3|NOT COMPLETED|Overall Study||3
7965723|NCT00360009|19608039|P2|NOT COMPLETED|Overall Study||4
7965724|NCT00360009|19608040|P1|NOT COMPLETED|Overall Study||0
7965725|NCT00360009|19608038|P3|COMPLETED|Overall Study||23
7965726|NCT00360009|19608039|P2|COMPLETED|Overall Study||22
7965727|NCT00360009|19608040|P1|COMPLETED|Overall Study||10
7965728|NCT00360009|19608038|P3|STARTED|Overall Study||26
7965729|NCT00360009|19608039|P2|STARTED|Overall Study||26
7965730|NCT00360009|19608040|P1|STARTED|Overall Study||10
7965731|NCT00359983|19608081|P3|NOT COMPLETED|Year 5 Persistence Follow-up||0
7965732|NCT00359983|19608082|P2|NOT COMPLETED|Year 5 Persistence Follow-up||0
7965733|NCT00359983|19608083|P1|NOT COMPLETED|Year 5 Persistence Follow-up||0
7965734|NCT00359983|19608081|P3|COMPLETED|Year 5 Persistence Follow-up||42
7965735|NCT00359983|19608082|P2|COMPLETED|Year 5 Persistence Follow-up||44
7965736|NCT00359983|19608083|P1|COMPLETED|Year 5 Persistence Follow-up||95
7965737|NCT00359983|19608081|P3|STARTED|Year 5 Persistence Follow-up||42
7965738|NCT00359983|19608082|P2|STARTED|Year 5 Persistence Follow-up||44
7965739|NCT00359983|19608083|P1|STARTED|Year 5 Persistence Follow-up||95
7965740|NCT00359983|19608081|P3|NOT COMPLETED|Year 3 Persistence Follow-up||0
7965741|NCT00359983|19608082|P2|NOT COMPLETED|Year 3 Persistence Follow-up||0
7965742|NCT00359983|19608083|P1|NOT COMPLETED|Year 3 Persistence Follow-up||0
7965743|NCT00359983|19608081|P3|COMPLETED|Year 3 Persistence Follow-up||51
7965744|NCT00359983|19608082|P2|COMPLETED|Year 3 Persistence Follow-up||47
7965745|NCT00359983|19608083|P1|COMPLETED|Year 3 Persistence Follow-up||103
7965746|NCT00359983|19608081|P3|STARTED|Year 3 Persistence Follow-up||51
7965747|NCT00359983|19608082|P2|STARTED|Year 3 Persistence Follow-up||47
7965748|NCT00359983|19608083|P1|STARTED|Year 3 Persistence Follow-up||103
7965749|NCT00359983|19608081|P3|NOT COMPLETED|Year 1 Persistence Follow-up||0
7965750|NCT00359983|19608082|P2|NOT COMPLETED|Year 1 Persistence Follow-up||0
7965751|NCT00359983|19608083|P1|NOT COMPLETED|Year 1 Persistence Follow-up||0
7965752|NCT00359983|19608081|P3|COMPLETED|Year 1 Persistence Follow-up||62
7965753|NCT00359983|19608082|P2|COMPLETED|Year 1 Persistence Follow-up||70
7965754|NCT00359983|19608083|P1|COMPLETED|Year 1 Persistence Follow-up||138
7965755|NCT00359983|19608081|P3|STARTED|Year 1 Persistence Follow-up||62
7965756|NCT00359983|19608082|P2|STARTED|Year 1 Persistence Follow-up||70
7965757|NCT00359983|19608083|P1|STARTED|Year 1 Persistence Follow-up||138
7965758|NCT00359944|19608118|P3|NOT COMPLETED|Overall Study||19
7965759|NCT00359944|19608119|P2|NOT COMPLETED|Overall Study||19
7965760|NCT00359944|19608120|P1|NOT COMPLETED|Overall Study||16
7965761|NCT00359944|19608118|P3|COMPLETED|Overall Study||38
7965762|NCT00359944|19608119|P2|COMPLETED|Overall Study||28
7965763|NCT00359944|19608120|P1|COMPLETED|Overall Study||34
7965764|NCT00359944|19608118|P3|STARTED|Overall Study||57
7965765|NCT00359944|19608119|P2|STARTED|Overall Study||47
7965766|NCT00359944|19608120|P1|STARTED|Overall Study||50
7965767|NCT00359801|19608136|P2|NOT COMPLETED|Overall Study||220
7965768|NCT00359801|19608137|P1|NOT COMPLETED|Overall Study||305
7965769|NCT00359801|19608136|P2|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769
7965770|NCT00359801|19608137|P1|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682
7965771|NCT00359801|19608136|P2|STARTED|Overall Study||989
7965772|NCT00359801|19608137|P1|STARTED|Overall Study||987
7965773|NCT00359788|19608171|P2|NOT COMPLETED|Overall Study||17
7965774|NCT00359788|19608172|P1|NOT COMPLETED|Overall Study||23
7965775|NCT00359788|19608171|P2|COMPLETED|Overall Study||159
7965776|NCT00359788|19608172|P1|COMPLETED|Overall Study||150
7965777|NCT00359788|19608171|P2|STARTED|Overall Study||176
7965778|NCT00359788|19608172|P1|STARTED|Overall Study||173
7965779|NCT00359762|19608406|P5|NOT COMPLETED|Period I||0
7965780|NCT00359762|19608407|P4|NOT COMPLETED|Period I||0
7965781|NCT00359762|19608408|P3|NOT COMPLETED|Period I||0
7965782|NCT00359762|19608409|P2|NOT COMPLETED|Period I||0
7965783|NCT00359762|19608410|P1|NOT COMPLETED|Period I||0
7965784|NCT00359762|19608406|P5|COMPLETED|Period I||0
7965785|NCT00359762|19608407|P4|COMPLETED|Period I||0
7965786|NCT00359762|19608408|P3|COMPLETED|Period I||0
7965787|NCT00359762|19608409|P2|COMPLETED|Period I||0
7965788|NCT00359762|19608410|P1|COMPLETED|Period I||0
7965789|NCT00359762|19608406|P5|STARTED|Period I||0
7965790|NCT00359762|19608407|P4|STARTED|Period I||0
7965791|NCT00359762|19608408|P3|STARTED|Period I||0
7965792|NCT00359762|19608409|P2|STARTED|Period I||0
7965793|NCT00359762|19608410|P1|STARTED|Period I||0
7965794|NCT00359762|19608406|P5|NOT COMPLETED|Period III||0
7965795|NCT00359762|19608407|P4|NOT COMPLETED|Period III||65
7965796|NCT00359762|19608408|P3|NOT COMPLETED|Period III||30
7965797|NCT00359762|19608409|P2|NOT COMPLETED|Period III||29
7965798|NCT00359762|19608410|P1|NOT COMPLETED|Period III||0
7965799|NCT00359762|19608406|P5|COMPLETED|Period III||0
7965800|NCT00359762|19608407|P4|COMPLETED|Period III||101
7965801|NCT00359762|19608408|P3|COMPLETED|Period III||47
7965802|NCT00359762|19608409|P2|COMPLETED|Period III||48
7965803|NCT00359762|19608410|P1|COMPLETED|Period III||0
7965804|NCT00359762|19608406|P5|Extension ITT Efficacy Population|Period III||0
7965805|NCT00359762|19608407|P4|Extension ITT Efficacy Population|Period III||164
7965806|NCT00359762|19608408|P3|Extension ITT Efficacy Population|Period III||75
7965807|NCT00359762|19608409|P2|Extension ITT Efficacy Population|Period III||73
7965808|NCT00359762|19608410|P1|Extension ITT Efficacy Population|Period III||0
7965809|NCT00359762|19608406|P5|Extension ITT Safety Population|Period III||0
7965810|NCT00359762|19608407|P4|Extension ITT Safety Population|Period III||166
7965811|NCT00359762|19608408|P3|Extension ITT Safety Population|Period III||76
7965812|NCT00359762|19608409|P2|Extension ITT Safety Population|Period III||74
7965813|NCT00359762|19608410|P1|Extension ITT Safety Population|Period III||0
7965814|NCT00359762|19608406|P5|STARTED|Period III||0
7965815|NCT00359762|19608407|P4|STARTED|Period III||166
7965816|NCT00359762|19608408|P3|STARTED|Period III||77
7965817|NCT00359762|19608409|P2|STARTED|Period III||77
7965818|NCT00359762|19608410|P1|STARTED|Period III||0
7965819|NCT00359762|19608406|P5|NOT COMPLETED|Period II||174
7965820|NCT00359762|19608407|P4|NOT COMPLETED|Period II||0
7965821|NCT00359762|19608408|P3|NOT COMPLETED|Period II||0
7965822|NCT00359762|19608409|P2|NOT COMPLETED|Period II||0
7965823|NCT00359762|19608410|P1|NOT COMPLETED|Period II||128
7965824|NCT00359762|19608406|P5|COMPLETED|Period II||341
7965825|NCT00359762|19608407|P4|COMPLETED|Period II||0
7965826|NCT00359762|19608408|P3|COMPLETED|Period II||0
7965827|NCT00359762|19608409|P2|COMPLETED|Period II||0
7965828|NCT00359762|19608410|P1|COMPLETED|Period II||386
7965829|NCT00359762|19608406|P5|Without Treatment Failure|Period II||138
7965830|NCT00359762|19608407|P4|Without Treatment Failure|Period II||0
7965831|NCT00359762|19608408|P3|Without Treatment Failure|Period II||0
7965832|NCT00359762|19608409|P2|Without Treatment Failure|Period II||0
7965833|NCT00359762|19608410|P1|Without Treatment Failure|Period II||124
7965834|NCT00359762|19608406|P5|Met Primary Endpoint|Period II||203
7965835|NCT00359762|19608407|P4|Met Primary Endpoint|Period II||0
7965836|NCT00359762|19608408|P3|Met Primary Endpoint|Period II||0
7965837|NCT00359762|19608409|P2|Met Primary Endpoint|Period II||0
7965838|NCT00359762|19608410|P1|Met Primary Endpoint|Period II||262
7965839|NCT00359762|19608406|P5|ITT Efficacy Population|Period II||490
7965840|NCT00359762|19608407|P4|ITT Efficacy Population|Period II||0
7965841|NCT00359762|19608408|P3|ITT Efficacy Population|Period II||0
7965842|NCT00359762|19608409|P2|ITT Efficacy Population|Period II||0
7965843|NCT00359762|19608410|P1|ITT Efficacy Population|Period II||487
7965844|NCT00359762|19608406|P5|Intent to Treat (ITT) Safety Population|Period II||511
7965845|NCT00359762|19608407|P4|Intent to Treat (ITT) Safety Population|Period II||0
7965846|NCT00359762|19608408|P3|Intent to Treat (ITT) Safety Population|Period II||0
7965847|NCT00359762|19608409|P2|Intent to Treat (ITT) Safety Population|Period II||0
7965848|NCT00359762|19608410|P1|Intent to Treat (ITT) Safety Population|Period II||508
7965849|NCT00359762|19608406|P5|STARTED|Period II||515
7965850|NCT00359762|19608407|P4|STARTED|Period II||0
7965851|NCT00359762|19608408|P3|STARTED|Period II||0
7965852|NCT00359762|19608409|P2|STARTED|Period II||0
7965853|NCT00359762|19608410|P1|STARTED|Period II||514
7965854|NCT00359736|19608473|P2|NOT COMPLETED|Overall Study||0
7965855|NCT00359736|19608474|P1|NOT COMPLETED|Overall Study||0
7965856|NCT00359736|19608473|P2|COMPLETED|Overall Study||15
7965857|NCT00359736|19608474|P1|COMPLETED|Overall Study||14
7965858|NCT00359736|19608473|P2|STARTED|Overall Study||15
7965859|NCT00359736|19608474|P1|STARTED|Overall Study||14
7965860|NCT00359632|19608484|P2|NOT COMPLETED|Overall Study||0
7965861|NCT00359632|19608485|P1|NOT COMPLETED|Overall Study||4
7965862|NCT00359632|19608484|P2|COMPLETED|Overall Study||9
7965863|NCT00359632|19608485|P1|COMPLETED|Overall Study||20
7965864|NCT00359632|19608484|P2|STARTED|Overall Study||9
7965865|NCT00359632|19608485|P1|STARTED|Overall Study||24
7965866|NCT00359619|19608499|P7|NOT COMPLETED|Overall Study||4
7965867|NCT00359619|19608500|P6|NOT COMPLETED|Overall Study||5
7965868|NCT00359619|19608501|P5|NOT COMPLETED|Overall Study||3
7965869|NCT00359619|19608502|P4|NOT COMPLETED|Overall Study||3
7965870|NCT00359619|19608503|P3|NOT COMPLETED|Overall Study||7
7965871|NCT00359619|19608504|P2|NOT COMPLETED|Overall Study||5
7965872|NCT00359619|19608505|P1|NOT COMPLETED|Overall Study||8
7965873|NCT00359619|19608499|P7|COMPLETED|Overall Study||46
7965874|NCT00359619|19608500|P6|COMPLETED|Overall Study||45
7965875|NCT00359619|19608501|P5|COMPLETED|Overall Study||45
7965876|NCT00359619|19608502|P4|COMPLETED|Overall Study||45
7965877|NCT00359619|19608503|P3|COMPLETED|Overall Study||42
7965878|NCT00359619|19608504|P2|COMPLETED|Overall Study||45
7965879|NCT00359619|19608505|P1|COMPLETED|Overall Study||80
7965880|NCT00359619|19608499|P7|STARTED|Overall Study||50
7965881|NCT00359619|19608500|P6|STARTED|Overall Study||50
7965882|NCT00359619|19608501|P5|STARTED|Overall Study||48
7965883|NCT00359619|19608502|P4|STARTED|Overall Study||48
7965884|NCT00359619|19608503|P3|STARTED|Overall Study||49
7965885|NCT00359619|19608504|P2|STARTED|Overall Study||50
7965886|NCT00359619|19608505|P1|STARTED|Overall Study||88
7965887|NCT00359424|19608635|P2|NOT COMPLETED|Overall Study||67
7965888|NCT00359424|19608636|P1|NOT COMPLETED|Overall Study||130
7965889|NCT00359424|19608635|P2|COMPLETED|Overall Study||155
7965890|NCT00359424|19608636|P1|COMPLETED|Overall Study||304
7965891|NCT00359424|19608635|P2|270 Day Follow up|Overall Study||159
7965892|NCT00359424|19608636|P1|270 Day Follow up|Overall Study||313
7965893|NCT00359424|19608635|P2|180 Day Follow up|Overall Study||167
7965894|NCT00359424|19608636|P1|180 Day Follow up|Overall Study||325
7965895|NCT00359424|19608635|P2|90 Day Follow up|Overall Study||172
7965896|NCT00359424|19608636|P1|90 Day Follow up|Overall Study||343
7965897|NCT00359424|19608635|P2|STARTED|Overall Study||222
7965898|NCT00359424|19608636|P1|STARTED|Overall Study||434
7965899|NCT00359281|19608675|P9|NOT COMPLETED|Overall Study||0
7965900|NCT00359281|19608676|P8|NOT COMPLETED|Overall Study||0
7965901|NCT00359281|19608677|P7|NOT COMPLETED|Overall Study||2
7965902|NCT00359281|19608678|P6|NOT COMPLETED|Overall Study||0
7965903|NCT00359281|19608679|P5|NOT COMPLETED|Overall Study||0
7965904|NCT00359281|19608680|P4|NOT COMPLETED|Overall Study||0
7965905|NCT00359281|19608681|P3|NOT COMPLETED|Overall Study||0
7965906|NCT00359281|19608682|P2|NOT COMPLETED|Overall Study||0
7965907|NCT00359281|19608683|P1|NOT COMPLETED|Overall Study||1
7965908|NCT00359281|19608675|P9|COMPLETED|Overall Study||20
7965909|NCT00359281|19608676|P8|COMPLETED|Overall Study||15
7965910|NCT00359281|19608677|P7|COMPLETED|Overall Study||16
7965911|NCT00359281|19608678|P6|COMPLETED|Overall Study||15
7965912|NCT00359281|19608679|P5|COMPLETED|Overall Study||10
7965913|NCT00359281|19608680|P4|COMPLETED|Overall Study||10
7965914|NCT00359281|19608681|P3|COMPLETED|Overall Study||10
7965915|NCT00359281|19608682|P2|COMPLETED|Overall Study||15
7965916|NCT00359281|19608683|P1|COMPLETED|Overall Study||15
7965917|NCT00359281|19608675|P9|STARTED|Overall Study||20
7965918|NCT00359281|19608676|P8|STARTED|Overall Study||15
7965919|NCT00359281|19608677|P7|STARTED|Overall Study||18
7965920|NCT00359281|19608678|P6|STARTED|Overall Study||15
7965921|NCT00359281|19608679|P5|STARTED|Overall Study||10
7965922|NCT00359281|19608680|P4|STARTED|Overall Study||10
7965923|NCT00359281|19608681|P3|STARTED|Overall Study||10
7965924|NCT00359281|19608682|P2|STARTED|Overall Study||15
7965925|NCT00359281|19608683|P1|STARTED|Overall Study||16
7965926|NCT00359216|19608715|P2|NOT COMPLETED|Overall Study||1
7965927|NCT00359216|19608716|P1|NOT COMPLETED|Overall Study||0
7965928|NCT00359216|19608715|P2|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9
7965929|NCT00359216|19608716|P1|COMPLETED|Overall Study||20
7965930|NCT00359216|19608715|P2|STARTED|Overall Study||10
7965931|NCT00359216|19608716|P1|STARTED|Overall Study||20
7965932|NCT00359203|19608724|P2|NOT COMPLETED|Overall Study||0
7965933|NCT00359203|19608725|P1|NOT COMPLETED|Overall Study||0
7965934|NCT00359203|19608724|P2|COMPLETED|Overall Study||38
7965935|NCT00359203|19608725|P1|COMPLETED|Overall Study||39
7965936|NCT00359203|19608724|P2|STARTED|Overall Study||38
7965937|NCT00359203|19608725|P1|STARTED|Overall Study||39
7965938|NCT00359138|19608734|P3|NOT COMPLETED|Overall Study||0
7965939|NCT00359138|19608735|P2|NOT COMPLETED|Overall Study||0
7965940|NCT00359138|19608736|P1|NOT COMPLETED|Overall Study||0
7965941|NCT00359138|19608734|P3|COMPLETED|Overall Study||12
7965942|NCT00359138|19608735|P2|COMPLETED|Overall Study||12
7965943|NCT00359138|19608736|P1|COMPLETED|Overall Study||12
7965944|NCT00359138|19608734|P3|STARTED|Overall Study||12
7965945|NCT00359138|19608735|P2|STARTED|Overall Study||12
7965946|NCT00359138|19608736|P1|STARTED|Overall Study||12
7965947|NCT00359073|19608746|P2|NOT COMPLETED|Overall Study||2
7965948|NCT00359073|19608747|P1|NOT COMPLETED|Overall Study||4
7965949|NCT00359073|19608746|P2|COMPLETED|Overall Study||11
7965950|NCT00359073|19608747|P1|COMPLETED|Overall Study||8
7965951|NCT00359073|19608746|P2|STARTED|Overall Study||13
7965952|NCT00359073|19608747|P1|STARTED|Overall Study||12
7965953|NCT00359021|19608759|P2|NOT COMPLETED|Overall Study||52
7965954|NCT00359021|19608760|P1|NOT COMPLETED|Overall Study||81
7965955|NCT00359021|19608759|P2|COMPLETED|Overall Study||195
7965956|NCT00359021|19608760|P1|COMPLETED|Overall Study||175
7965957|NCT00359021|19608759|P2|STARTED|Overall Study||247
7965958|NCT00359021|19608760|P1|STARTED|Overall Study||256
7965959|NCT00358956|19608772|P1|NOT COMPLETED|Overall Study||8
7965960|NCT00358956|19608772|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11
7965961|NCT00358956|19608772|P1|STARTED|Overall Study||19
7965962|NCT00358917|19608784|P2|NOT COMPLETED|Overall Study||69
7965963|NCT00358917|19608785|P1|NOT COMPLETED|Overall Study||66
7965964|NCT00358917|19608784|P2|COMPLETED|Overall Study||230
7965965|NCT00358917|19608785|P1|COMPLETED|Overall Study||234
7965966|NCT00358917|19608784|P2|STARTED|Overall Study||299
7965967|NCT00358917|19608785|P1|STARTED|Overall Study||300
7965968|NCT00358826|19608803|P8|NOT COMPLETED|MDCT Substudy||0
7965969|NCT00358826|19608804|P7|NOT COMPLETED|MDCT Substudy||0
7965970|NCT00358826|19608805|P6|NOT COMPLETED|MDCT Substudy||2
7965971|NCT00358826|19608806|P5|NOT COMPLETED|MDCT Substudy||1
7965972|NCT00358826|19608807|P4|NOT COMPLETED|MDCT Substudy||0
7965973|NCT00358826|19608808|P3|NOT COMPLETED|MDCT Substudy||0
7965974|NCT00358826|19608809|P2|NOT COMPLETED|MDCT Substudy||0
7965975|NCT00358826|19608810|P1|NOT COMPLETED|MDCT Substudy||0
7965976|NCT00358826|19608803|P8|COMPLETED|MDCT Substudy||27
7965977|NCT00358826|19608804|P7|COMPLETED|MDCT Substudy||19
7965978|NCT00358826|19608805|P6|COMPLETED|MDCT Substudy||20
7965979|NCT00358826|19608806|P5|COMPLETED|MDCT Substudy||24
7965980|NCT00358826|19608807|P4|COMPLETED|MDCT Substudy||0
7965981|NCT00358826|19608808|P3|COMPLETED|MDCT Substudy||0
7965982|NCT00358826|19608809|P2|COMPLETED|MDCT Substudy||0
7965983|NCT00358826|19608810|P1|COMPLETED|MDCT Substudy||0
7965984|NCT00358826|19608803|P8|STARTED|MDCT Substudy||27
7965985|NCT00358826|19608804|P7|STARTED|MDCT Substudy||19
7965986|NCT00358826|19608805|P6|STARTED|MDCT Substudy||22
7965987|NCT00358826|19608806|P5|STARTED|MDCT Substudy||25
7965988|NCT00358826|19608807|P4|STARTED|MDCT Substudy||0
7965989|NCT00358826|19608808|P3|STARTED|MDCT Substudy||0
7965990|NCT00358826|19608809|P2|STARTED|MDCT Substudy||0
7965991|NCT00358826|19608810|P1|STARTED|MDCT Substudy||0
7965992|NCT00358826|19608803|P8|NOT COMPLETED|Core Study||0
7965993|NCT00358826|19608804|P7|NOT COMPLETED|Core Study||0
7965994|NCT00358826|19608805|P6|NOT COMPLETED|Core Study||0
7965995|NCT00358826|19608806|P5|NOT COMPLETED|Core Study||0
7965996|NCT00358826|19608807|P4|NOT COMPLETED|Core Study||2
7965997|NCT00358826|19608808|P3|NOT COMPLETED|Core Study||2
7965998|NCT00358826|19608809|P2|NOT COMPLETED|Core Study||5
7965999|NCT00358826|19608810|P1|NOT COMPLETED|Core Study||3
7966000|NCT00358826|19608803|P8|COMPLETED|Core Study||0
7966001|NCT00358826|19608804|P7|COMPLETED|Core Study||0
7966002|NCT00358826|19608805|P6|COMPLETED|Core Study||0
7966003|NCT00358826|19608806|P5|COMPLETED|Core Study||0
7966004|NCT00358826|19608807|P4|COMPLETED|Core Study||50
7966005|NCT00358826|19608808|P3|COMPLETED|Core Study||42
7966006|NCT00358826|19608809|P2|COMPLETED|Core Study||41
7966007|NCT00358826|19608810|P1|COMPLETED|Core Study||46
7966008|NCT00358826|19608803|P8|STARTED|Core Study||0
7966009|NCT00358826|19608804|P7|STARTED|Core Study||0
7966010|NCT00358826|19608805|P6|STARTED|Core Study||0
7966011|NCT00358826|19608806|P5|STARTED|Core Study||0
7966012|NCT00358826|19608807|P4|STARTED|Core Study||52
7966013|NCT00358826|19608808|P3|STARTED|Core Study||44
7966014|NCT00358826|19608809|P2|STARTED|Core Study||46
7966015|NCT00358826|19608810|P1|STARTED|Core Study||49
7966016|NCT00358735|19608846|P2|NOT COMPLETED|Overall Study||17
7966017|NCT00358735|19608847|P1|NOT COMPLETED|Overall Study||8
7966018|NCT00358735|19608846|P2|COMPLETED|Overall Study|Efficacy|190
7966019|NCT00358735|19608847|P1|COMPLETED|Overall Study|Efficacy|196
7966020|NCT00358735|19608846|P2|Not Completed Safety|Overall Study||13
7966021|NCT00358735|19608847|P1|Not Completed Safety|Overall Study||6
7966022|NCT00358735|19608846|P2|Completed Safety|Overall Study||194
7966023|NCT00358735|19608847|P1|Completed Safety|Overall Study||198
7966024|NCT00358735|19608846|P2|STARTED|Overall Study||207
7966025|NCT00358735|19608847|P1|STARTED|Overall Study||204
7966026|NCT00358670|19608877|P2|NOT COMPLETED|Overall Study||219
7966027|NCT00358670|19608878|P1|NOT COMPLETED|Overall Study||222
7966028|NCT00358670|19608877|P2|COMPLETED|Overall Study||0
7966029|NCT00358670|19608878|P1|COMPLETED|Overall Study||0
7966030|NCT00358670|19608877|P2|STARTED|Overall Study||219
7966031|NCT00358670|19608878|P1|STARTED|Overall Study||222
7966032|NCT00358644|19608892|P1|NOT COMPLETED|Overall Study||50
7966033|NCT00358644|19608892|P1|COMPLETED|Overall Study||5
7966034|NCT00358644|19608892|P1|STARTED|Overall Study||55
7966035|NCT00358579|19608898|P2|NOT COMPLETED|Overall Study||0
7966036|NCT00358579|19608899|P1|NOT COMPLETED|Overall Study||0
7966037|NCT00358579|19608898|P2|COMPLETED|Overall Study||374
7966038|NCT00358579|19608899|P1|COMPLETED|Overall Study||353
7966039|NCT00358579|19608898|P2|STARTED|Overall Study||374
7966040|NCT00358579|19608899|P1|STARTED|Overall Study||353
7966041|NCT00358527|19608915|P2|NOT COMPLETED|Overall Study||3
7966042|NCT00358527|19608916|P1|NOT COMPLETED|Overall Study||13
7966043|NCT00358527|19608915|P2|COMPLETED|Overall Study||131
7966044|NCT00358527|19608916|P1|COMPLETED|Overall Study||254
7966045|NCT00358527|19608915|P2|STARTED|Overall Study||134
7966046|NCT00358527|19608916|P1|STARTED|Overall Study||267
7966047|NCT00358501|19608926|P2|NOT COMPLETED|Overall Study||0
7966048|NCT00358501|19608927|P1|NOT COMPLETED|Overall Study||0
7966049|NCT00358501|19608926|P2|COMPLETED|Overall Study||32
7966050|NCT00358501|19608927|P1|COMPLETED|Overall Study||102
7966051|NCT00358501|19608926|P2|STARTED|Overall Study||32
7966052|NCT00358501|19608927|P1|STARTED|Overall Study||102
7966053|NCT00358462|19608942|P2|NOT COMPLETED|Overall Study||64
7966054|NCT00358462|19608943|P1|NOT COMPLETED|Overall Study||59
7966055|NCT00358462|19608942|P2|COMPLETED|Overall Study||238
7966056|NCT00358462|19608943|P1|COMPLETED|Overall Study||245
7966057|NCT00358462|19608942|P2|STARTED|Overall Study||302
7966058|NCT00358462|19608943|P1|STARTED|Overall Study||304
7966059|NCT00358449|19608966|P3|NOT COMPLETED|Overall Study||2
7966060|NCT00358449|19608967|P2|NOT COMPLETED|Overall Study||1
7966061|NCT00358449|19608968|P1|NOT COMPLETED|Overall Study||4
7966062|NCT00358449|19608966|P3|COMPLETED|Overall Study||18
7966063|NCT00358449|19608967|P2|COMPLETED|Overall Study||19
7966064|NCT00358449|19608968|P1|COMPLETED|Overall Study||15
7966065|NCT00358449|19608966|P3|STARTED|Overall Study||20
7966066|NCT00358449|19608967|P2|STARTED|Overall Study||20
7966067|NCT00358449|19608968|P1|STARTED|Overall Study||19
7966068|NCT00358436|19609071|P2|NOT COMPLETED|Overall Study||86
7966069|NCT00358436|19609072|P1|NOT COMPLETED|Overall Study||154
7966070|NCT00358436|19609071|P2|COMPLETED|Overall Study||118
7966071|NCT00358436|19609072|P1|COMPLETED|Overall Study||446
7966072|NCT00358436|19609071|P2|STARTED|Overall Study||204
7966073|NCT00358436|19609072|P1|STARTED|Overall Study||600
7966074|NCT00358332|19609088|P4|NOT COMPLETED|Overall Study||0
7966075|NCT00358332|19609089|P3|NOT COMPLETED|Overall Study||1
7966076|NCT00358332|19609090|P2|NOT COMPLETED|Overall Study||3
7966077|NCT00358332|19609091|P1|NOT COMPLETED|Overall Study||0
7966078|NCT00358332|19609088|P4|COMPLETED|Overall Study||25
7966079|NCT00358332|19609089|P3|COMPLETED|Overall Study||29
7966080|NCT00358332|19609090|P2|COMPLETED|Overall Study||27
7966081|NCT00358332|19609091|P1|COMPLETED|Overall Study||15
7966082|NCT00358332|19609088|P4|STARTED|Overall Study||25
7966083|NCT00358332|19609089|P3|STARTED|Overall Study||30
7966084|NCT00358332|19609090|P2|STARTED|Overall Study||30
7966085|NCT00358332|19609091|P1|STARTED|Overall Study||15
7966086|NCT00358215|19609143|P2|NOT COMPLETED|Overall Study||652
7966087|NCT00358215|19609144|P1|NOT COMPLETED|Overall Study||679
7966088|NCT00358215|19609143|P2|COMPLETED|Overall Study|Participants who completed investigational product|484
7966089|NCT00358215|19609144|P1|COMPLETED|Overall Study|Participants who completed investigational product|463
7966090|NCT00358215|19609143|P2|Received Investigational Product|Overall Study||1133
7966091|NCT00358215|19609144|P1|Received Investigational Product|Overall Study||1140
7966092|NCT00358215|19609143|P2|STARTED|Overall Study||1136
7966093|NCT00358215|19609144|P1|STARTED|Overall Study||1142
7966094|NCT00358150|19609158|P1|NOT COMPLETED|Overall Study||7
7966095|NCT00358150|19609158|P1|COMPLETED|Overall Study||19
7966096|NCT00358150|19609158|P1|STARTED|Overall Study||26
7966097|NCT00358007|19609180|P1|NOT COMPLETED|Overall Study||2
7966098|NCT00358007|19609180|P1|COMPLETED|Overall Study||28
7966099|NCT00358007|19609180|P1|STARTED|Overall Study||30
7966100|NCT00357994|19609187|P2|NOT COMPLETED|Overall Study||3
7966101|NCT00357994|19609188|P1|NOT COMPLETED|Overall Study||2
7966102|NCT00357994|19609187|P2|COMPLETED|Overall Study||31
7966103|NCT00357994|19609188|P1|COMPLETED|Overall Study||35
7966104|NCT00357994|19609187|P2|STARTED|Overall Study||34
7966105|NCT00357994|19609188|P1|STARTED|Overall Study||37
7966106|NCT00357968|19609242|P2|NOT COMPLETED|Crossover Maintenance Dose Phase||0
7966107|NCT00357968|19609243|P1|NOT COMPLETED|Crossover Maintenance Dose Phase||0
7966108|NCT00357968|19609242|P2|COMPLETED|Crossover Maintenance Dose Phase||55
7966109|NCT00357968|19609243|P1|COMPLETED|Crossover Maintenance Dose Phase||54
7966110|NCT00357968|19609242|P2|STARTED|Crossover Maintenance Dose Phase||55
7966111|NCT00357968|19609243|P1|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54
7966112|NCT00357968|19609242|P2|NOT COMPLETED|First Maintenance Dose Phase||44
7966113|NCT00357968|19609243|P1|NOT COMPLETED|First Maintenance Dose Phase||48
7966114|NCT00357968|19609242|P2|COMPLETED|First Maintenance Dose Phase||55
7966115|NCT00357968|19609243|P1|COMPLETED|First Maintenance Dose Phase||54
7966116|NCT00357968|19609242|P2|Started Maintenance Dose|First Maintenance Dose Phase||55
7966117|NCT00357968|19609243|P1|Started Maintenance Dose|First Maintenance Dose Phase||55
7966118|NCT00357968|19609242|P2|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57
7966119|NCT00357968|19609243|P1|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55
7966120|NCT00357968|19609242|P2|Received Loading Dose|First Maintenance Dose Phase||99
7966121|NCT00357968|19609243|P1|Received Loading Dose|First Maintenance Dose Phase||102
7966122|NCT00357968|19609242|P2|STARTED|First Maintenance Dose Phase||99
7966123|NCT00357968|19609243|P1|STARTED|First Maintenance Dose Phase||102
7966124|NCT00357955|19609287|P2|NOT COMPLETED|Overall Study||3
7966125|NCT00357955|19609288|P1|NOT COMPLETED|Overall Study||6
7966126|NCT00357955|19609287|P2|COMPLETED|Overall Study||51
7966127|NCT00357955|19609288|P1|COMPLETED|Overall Study||58
7966128|NCT00357955|19609287|P2|STARTED|Overall Study||54
7966129|NCT00357955|19609288|P1|STARTED|Overall Study||64
7966130|NCT00357903|19609296|P2|NOT COMPLETED|Overall Study||43
7966131|NCT00357903|19609297|P1|NOT COMPLETED|Overall Study||363
7966132|NCT00357903|19609296|P2|COMPLETED|Overall Study||15
7966133|NCT00357903|19609297|P1|COMPLETED|Overall Study||218
7966134|NCT00357903|19609296|P2|STARTED|Overall Study||58
7966135|NCT00357903|19609297|P1|STARTED|Overall Study||581
7966136|NCT00357877|19609337|P2|NOT COMPLETED|Overall Study||30
7966137|NCT00357877|19609338|P1|NOT COMPLETED|Overall Study||26
7966138|NCT00357877|19609337|P2|COMPLETED|Overall Study||460
7966139|NCT00357877|19609338|P1|COMPLETED|Overall Study||467
7966140|NCT00357877|19609337|P2|STARTED|Overall Study||490
7966141|NCT00357877|19609338|P1|STARTED|Overall Study||493
7966142|NCT00357760|19609352|P2|NOT COMPLETED|Overall Study||35
7966143|NCT00357760|19609353|P1|NOT COMPLETED|Overall Study||59
7966144|NCT00357760|19609352|P2|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
7966145|NCT00357760|19609353|P1|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
7966146|NCT00357760|19609352|P2|Patients Who Undergo Dose Escalation|Overall Study||16
7966147|NCT00357760|19609353|P1|Patients Who Undergo Dose Escalation|Overall Study|Only patients who progressed on the low dose (Arm B) had the opportunity to undergo dose escalation.|0
7966148|NCT00357760|19609352|P2|Eligible and Treated Patients|Overall Study||32
7966149|NCT00357760|19609353|P1|Eligible and Treated Patients|Overall Study||57
7966150|NCT00357760|19609352|P2|Patients Who Started Treatment|Overall Study||34
7966151|NCT00357760|19609353|P1|Patients Who Started Treatment|Overall Study||57
7966152|NCT00357760|19609352|P2|STARTED|Overall Study||35
7966153|NCT00357760|19609353|P1|STARTED|Overall Study||59
7966154|NCT00357734|19609363|P1|NOT COMPLETED|Overall Study||4
7966155|NCT00357734|19609363|P1|COMPLETED|Overall Study||10
7966156|NCT00357734|19609363|P1|Patient Received 500 mg of ZD1839|Overall Study||1
7966157|NCT00357734|19609363|P1|Patients Received 250 mg of ZD1839|Overall Study||13
7966158|NCT00357734|19609363|P1|STARTED|Overall Study||14
7966159|NCT00357656|19609374|P2|NOT COMPLETED|Overall Study||3
7966160|NCT00357656|19609375|P1|NOT COMPLETED|Overall Study||0
7966161|NCT00357656|19609374|P2|COMPLETED|Overall Study||29
7966162|NCT00357656|19609375|P1|COMPLETED|Overall Study||31
7966163|NCT00357656|19609374|P2|STARTED|Overall Study||32
7966164|NCT00357656|19609375|P1|STARTED|Overall Study||31
7966165|NCT00357552|19609426|P1|NOT COMPLETED|Weeks 24 to 104||5
7966166|NCT00357552|19609426|P1|COMPLETED|Weeks 24 to 104||117
7966167|NCT00357552|19609426|P1|STARTED|Weeks 24 to 104||122
7966168|NCT00357552|19609426|P1|NOT COMPLETED|Weeks 0 to 24||1
7966169|NCT00357552|19609426|P1|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122
7966170|NCT00357552|19609426|P1|STARTED|Weeks 0 to 24||123
7966171|NCT00357552|19609426|P1|NOT COMPLETED|Screening||84
7966172|NCT00357552|19609426|P1|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123
7966173|NCT00357552|19609426|P1|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207
7966174|NCT00357500|19609441|P1|NOT COMPLETED|Overall Study||77
7966175|NCT00357500|19609441|P1|COMPLETED|Overall Study||24
7966176|NCT00357500|19609441|P1|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97
7966177|NCT00357500|19609441|P1|STARTED|Overall Study||101
7966178|NCT00357396|19609450|P2|NOT COMPLETED|Overall Study||0
7966179|NCT00357396|19609451|P1|NOT COMPLETED|Overall Study||1
7966180|NCT00357396|19609450|P2|COMPLETED|Overall Study||4
7966181|NCT00357396|19609451|P1|COMPLETED|Overall Study||5
7966182|NCT00357396|19609450|P2|STARTED|Overall Study||4
7966183|NCT00357396|19609451|P1|STARTED|Overall Study||6
7966184|NCT00357370|19609459|P3|NOT COMPLETED|Cohort 2||2
7966185|NCT00357370|19609460|P2|NOT COMPLETED|Cohort 2||7
7966186|NCT00357370|19609461|P1|NOT COMPLETED|Cohort 2||2
7966187|NCT00357370|19609459|P3|COMPLETED|Cohort 2||22
7966188|NCT00357370|19609460|P2|COMPLETED|Cohort 2||16
7966189|NCT00357370|19609461|P1|COMPLETED|Cohort 2||22
7966190|NCT00357370|19609459|P3|STARTED|Cohort 2||24
7966191|NCT00357370|19609460|P2|STARTED|Cohort 2||23
7966192|NCT00357370|19609461|P1|STARTED|Cohort 2||24
7966193|NCT00357370|19609459|P3|NOT COMPLETED|Cohort 1||0
7966194|NCT00357370|19609460|P2|NOT COMPLETED|Cohort 1||0
7966195|NCT00357370|19609461|P1|NOT COMPLETED|Cohort 1||0
7966196|NCT00357370|19609459|P3|COMPLETED|Cohort 1||0
7966197|NCT00357370|19609460|P2|COMPLETED|Cohort 1||0
7966198|NCT00357370|19609461|P1|COMPLETED|Cohort 1||4
7966199|NCT00357370|19609459|P3|STARTED|Cohort 1||0
7966200|NCT00357370|19609460|P2|STARTED|Cohort 1||0
7966201|NCT00357370|19609461|P1|STARTED|Cohort 1||4
7966202|NCT00357331|19609486|P2|NOT COMPLETED|Overall Study||0
7966203|NCT00357331|19609487|P1|NOT COMPLETED|Overall Study||0
7966204|NCT00357331|19609486|P2|COMPLETED|Overall Study||41
7966205|NCT00357331|19609487|P1|COMPLETED|Overall Study||42
7966206|NCT00357331|19609486|P2|STARTED|Overall Study||41
7966207|NCT00357331|19609487|P1|STARTED|Overall Study||42
7966208|NCT00357214|19609501|P4|NOT COMPLETED|Overall Study||1
7966209|NCT00357214|19609502|P3|NOT COMPLETED|Overall Study||0
7966210|NCT00357214|19609503|P2|NOT COMPLETED|Overall Study||4
7966211|NCT00357214|19609504|P1|NOT COMPLETED|Overall Study||4
7966212|NCT00357214|19609501|P4|COMPLETED|Overall Study||42
7966213|NCT00357214|19609502|P3|COMPLETED|Overall Study||42
7966214|NCT00357214|19609503|P2|COMPLETED|Overall Study||39
7966215|NCT00357214|19609504|P1|COMPLETED|Overall Study||39
7966216|NCT00357214|19609501|P4|STARTED|Overall Study||43
7966217|NCT00357214|19609502|P3|STARTED|Overall Study||42
7966218|NCT00357214|19609503|P2|STARTED|Overall Study||43
7966219|NCT00357214|19609504|P1|STARTED|Overall Study||43
7966220|NCT00357162|19609514|P1|NOT COMPLETED|Overall Study||0
7966221|NCT00357162|19609514|P1|COMPLETED|Overall Study||21
7966222|NCT00357162|19609514|P1|STARTED|Overall Study||21
7966223|NCT00357110|19609524|P2|NOT COMPLETED|Overall Study||5
7966224|NCT00357110|19609525|P1|NOT COMPLETED|Overall Study||5
7966225|NCT00357110|19609524|P2|COMPLETED|Overall Study||2
7966226|NCT00357110|19609525|P1|COMPLETED|Overall Study||1
7966227|NCT00357110|19609524|P2|STARTED|Overall Study||7
7966228|NCT00357110|19609525|P1|STARTED|Overall Study||6
7966229|NCT00357097|19609533|P2|NOT COMPLETED|Overall Study||29
7966230|NCT00357097|19609534|P1|NOT COMPLETED|Overall Study||54
7966231|NCT00357097|19609533|P2|COMPLETED|Overall Study||38
7966232|NCT00357097|19609534|P1|COMPLETED|Overall Study||145
7966233|NCT00357097|19609533|P2|STARTED|Overall Study||67
7966234|NCT00357097|19609534|P1|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199
7966235|NCT00357032|19609578|P1|NOT COMPLETED|Overall Study||0
7966236|NCT00357032|19609578|P1|COMPLETED|Overall Study||12
7966237|NCT00357032|19609578|P1|STARTED|Overall Study||12
7966238|NCT00357006|19609588|P3|NOT COMPLETED|Overall Study||3
7966239|NCT00357006|19609589|P2|NOT COMPLETED|Overall Study||5
7966240|NCT00357006|19609590|P1|NOT COMPLETED|Overall Study||2
7966241|NCT00357006|19609588|P3|COMPLETED|Overall Study||59
7966242|NCT00357006|19609589|P2|COMPLETED|Overall Study||51
7966243|NCT00357006|19609590|P1|COMPLETED|Overall Study||60
7966244|NCT00357006|19609588|P3|STARTED|Overall Study||62
7966245|NCT00357006|19609589|P2|STARTED|Overall Study||56
7966246|NCT00357006|19609590|P1|STARTED|Overall Study||62
7966247|NCT00356993|19609598|P1|NOT COMPLETED|Overall Study||3921
7966248|NCT00356993|19609598|P1|COMPLETED|Overall Study||2088
7966249|NCT00356993|19609598|P1|STARTED|Overall Study||6009
7966250|NCT00356915|19609605|P3|NOT COMPLETED|Overall Study||42
7966251|NCT00356915|19609606|P2|NOT COMPLETED|Overall Study||94
7966252|NCT00356915|19609607|P1|NOT COMPLETED|Overall Study||76
7966253|NCT00356915|19609605|P3|COMPLETED|Overall Study||156
7966254|NCT00356915|19609606|P2|COMPLETED|Overall Study||496
7966255|NCT00356915|19609607|P1|COMPLETED|Overall Study||517
7966256|NCT00356915|19609605|P3|STARTED|Overall Study||198
7966257|NCT00356915|19609606|P2|STARTED|Overall Study||590
7966258|NCT00356915|19609607|P1|STARTED|Overall Study||593
7966259|NCT00356889|19609624|P1|NOT COMPLETED|Overall Study||3
7966260|NCT00356889|19609624|P1|COMPLETED|Overall Study||53
7966261|NCT00356889|19609624|P1|STARTED|Overall Study||56
7966262|NCT00356863|19609633|P2|NOT COMPLETED|Overall Study||75
7966263|NCT00356863|19609634|P1|NOT COMPLETED|Overall Study||92
7966264|NCT00356863|19609633|P2|COMPLETED|Overall Study||445
7966265|NCT00356863|19609634|P1|COMPLETED|Overall Study||412
7966266|NCT00356863|19609633|P2|STARTED|Overall Study||520
7966267|NCT00356863|19609634|P1|STARTED|Overall Study||504
7966268|NCT00356811|19609660|P1|NOT COMPLETED|Overall Study||49
7966269|NCT00356811|19609660|P1|COMPLETED|Overall Study||8
7966270|NCT00356811|19609660|P1|STARTED|Overall Study||57
7966271|NCT00356759|19609675|P2|NOT COMPLETED|Overall Study||10
7966272|NCT00356759|19609676|P1|NOT COMPLETED|Overall Study||14
7966273|NCT00356759|19609675|P2|COMPLETED|Overall Study||114
7966274|NCT00356759|19609676|P1|COMPLETED|Overall Study||112
7966275|NCT00356759|19609675|P2|STARTED|Overall Study||124
7966276|NCT00356759|19609676|P1|STARTED|Overall Study||126
7966277|NCT00356603|19609694|P2|NOT COMPLETED|Overall Study||3
7966278|NCT00356603|19609695|P1|NOT COMPLETED|Overall Study||6
7966279|NCT00356603|19609694|P2|COMPLETED|Overall Study||33
7966280|NCT00356603|19609695|P1|COMPLETED|Overall Study||33
7966281|NCT00356603|19609694|P2|STARTED|Overall Study||36
7966282|NCT00356603|19609695|P1|STARTED|Overall Study||39
7966283|NCT00356590|19609709|P1|NOT COMPLETED|Overall Study||274
7966284|NCT00356590|19609709|P1|COMPLETED|Overall Study||194
7966285|NCT00356590|19609709|P1|STARTED|Overall Study||468
7966286|NCT00356525|19609745|P4|NOT COMPLETED|Overall Study||9
7966287|NCT00356525|19609746|P3|NOT COMPLETED|Overall Study||7
7966288|NCT00356525|19609747|P2|NOT COMPLETED|Overall Study||11
7966289|NCT00356525|19609748|P1|NOT COMPLETED|Overall Study||14
7966290|NCT00356525|19609745|P4|COMPLETED|Overall Study||0
7966291|NCT00356525|19609746|P3|COMPLETED|Overall Study||0
7966292|NCT00356525|19609747|P2|COMPLETED|Overall Study||0
7966293|NCT00356525|19609748|P1|COMPLETED|Overall Study||0
7966294|NCT00356525|19609745|P4|STARTED|Overall Study||9
7966295|NCT00356525|19609746|P3|STARTED|Overall Study||7
7966296|NCT00356525|19609747|P2|STARTED|Overall Study||11
7966297|NCT00356525|19609748|P1|STARTED|Overall Study||14
7966298|NCT00356434|19609776|P2|NOT COMPLETED|Overall Study||0
7966299|NCT00356434|19609777|P1|NOT COMPLETED|Overall Study||0
7966300|NCT00356434|19609776|P2|COMPLETED|Overall Study||7
7966301|NCT00356434|19609777|P1|COMPLETED|Overall Study||4
7966302|NCT00356434|19609776|P2|STARTED|Overall Study||7
7966303|NCT00356434|19609777|P1|STARTED|Overall Study||4
7966304|NCT00356421|19609789|P2|NOT COMPLETED|Overall Study||17
7966305|NCT00356421|19609790|P1|NOT COMPLETED|Overall Study||32
7966306|NCT00356421|19609789|P2|COMPLETED|Overall Study||3
7966307|NCT00356421|19609790|P1|COMPLETED|Overall Study||6
7966308|NCT00356421|19609789|P2|STARTED|Overall Study||20
7966309|NCT00356421|19609790|P1|STARTED|Overall Study||38
7966310|NCT00356408|19609830|P1|NOT COMPLETED|Overall Study||60
7966311|NCT00356408|19609830|P1|COMPLETED|Overall Study||43
7966312|NCT00356408|19609830|P1|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103
7966313|NCT00356369|19609847|P2|NOT COMPLETED|Year 5||0
7966314|NCT00356369|19609848|P1|NOT COMPLETED|Year 5||0
7966315|NCT00356369|19609847|P2|COMPLETED|Year 5||105
7966316|NCT00356369|19609848|P1|COMPLETED|Year 5||299
7966317|NCT00356369|19609847|P2|STARTED|Year 5||105
7966318|NCT00356369|19609848|P1|STARTED|Year 5||299
7966319|NCT00356369|19609847|P2|NOT COMPLETED|Year 4||0
7966320|NCT00356369|19609848|P1|NOT COMPLETED|Year 4||0
7966321|NCT00356369|19609847|P2|COMPLETED|Year 4||109
7966322|NCT00356369|19609848|P1|COMPLETED|Year 4||317
7966323|NCT00356369|19609847|P2|STARTED|Year 4||109
7966324|NCT00356369|19609848|P1|STARTED|Year 4||317
7966325|NCT00356369|19609847|P2|NOT COMPLETED|Year 3||0
7966326|NCT00356369|19609848|P1|NOT COMPLETED|Year 3||0
7966327|NCT00356369|19609847|P2|COMPLETED|Year 3||116
7966328|NCT00356369|19609848|P1|COMPLETED|Year 3||344
7966329|NCT00356369|19609847|P2|STARTED|Year 3||116
7966330|NCT00356369|19609848|P1|STARTED|Year 3||344
7966331|NCT00356369|19609847|P2|NOT COMPLETED|Year 2||0
7966332|NCT00356369|19609848|P1|NOT COMPLETED|Year 2||0
7966333|NCT00356369|19609847|P2|COMPLETED|Year 2||117
7966334|NCT00356369|19609848|P1|COMPLETED|Year 2||354
7966335|NCT00356369|19609847|P2|STARTED|Year 2||117
7966336|NCT00356369|19609848|P1|STARTED|Year 2||354
7966337|NCT00356369|19609847|P2|NOT COMPLETED|Year 1||0
7966338|NCT00356369|19609848|P1|NOT COMPLETED|Year 1||0
7966339|NCT00356369|19609847|P2|COMPLETED|Year 1||121
7966340|NCT00356369|19609848|P1|COMPLETED|Year 1||364
7966341|NCT00356369|19609847|P2|STARTED|Year 1||121
7966342|NCT00356369|19609848|P1|STARTED|Year 1||364
7966343|NCT00356369|19609847|P2|NOT COMPLETED|Active Phase||1
7966344|NCT00356369|19609848|P1|NOT COMPLETED|Active Phase||2
7966345|NCT00356369|19609847|P2|COMPLETED|Active Phase||125
7966346|NCT00356369|19609848|P1|COMPLETED|Active Phase||372
7966347|NCT00356369|19609847|P2|STARTED|Active Phase||126
7966348|NCT00356369|19609848|P1|STARTED|Active Phase||374
7966349|NCT00356304|19609918|P2|NOT COMPLETED|Overall Study||4
7966350|NCT00356304|19609919|P1|NOT COMPLETED|Overall Study||2
7966351|NCT00356304|19609918|P2|COMPLETED|Overall Study||20
7966352|NCT00356304|19609919|P1|COMPLETED|Overall Study||24
7966353|NCT00356304|19609918|P2|STARTED|Overall Study||24
7966354|NCT00356304|19609919|P1|STARTED|Overall Study||26
7966355|NCT00356278|19609930|P3|NOT COMPLETED|Overall Study||19
7966356|NCT00356278|19609931|P2|NOT COMPLETED|Overall Study||15
7966357|NCT00356278|19609932|P1|NOT COMPLETED|Overall Study||25
7966358|NCT00356278|19609930|P3|COMPLETED|Overall Study||34
7966359|NCT00356278|19609931|P2|COMPLETED|Overall Study||35
7966360|NCT00356278|19609932|P1|COMPLETED|Overall Study||28
7966361|NCT00356278|19609930|P3|STARTED|Overall Study||53
7966362|NCT00356278|19609931|P2|STARTED|Overall Study||50
7966363|NCT00356278|19609932|P1|STARTED|Overall Study||53
7966364|NCT00356265|19609970|P3|NOT COMPLETED|Overall Study||1
7966365|NCT00356265|19609971|P2|NOT COMPLETED|Overall Study||0
7966366|NCT00356265|19609972|P1|NOT COMPLETED|Overall Study||0
7966367|NCT00356265|19609970|P3|COMPLETED|Overall Study||5
7966368|NCT00356265|19609971|P2|COMPLETED|Overall Study||2
7966369|NCT00356265|19609972|P1|COMPLETED|Overall Study||7
7966370|NCT00356265|19609970|P3|STARTED|Overall Study||6
7966371|NCT00356265|19609971|P2|STARTED|Overall Study||2
7966372|NCT00356265|19609972|P1|STARTED|Overall Study||7
7966373|NCT00356200|19609984|P2|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2
7966374|NCT00356200|19609985|P1|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
7966375|NCT00356200|19609984|P2|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3
7966376|NCT00356200|19609985|P1|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
7966377|NCT00356200|19609984|P2|STARTED|Cohort 2: 100 ug/ml (New Patients)||5
7966378|NCT00356200|19609985|P1|STARTED|Cohort 2: 100 ug/ml (New Patients)||0
7966379|NCT00356200|19609984|P2|NOT COMPLETED|Cohort 1: 10 ug/ml||0
7966380|NCT00356200|19609985|P1|NOT COMPLETED|Cohort 1: 10 ug/ml||1
7966381|NCT00356200|19609984|P2|COMPLETED|Cohort 1: 10 ug/ml||0
7966382|NCT00356200|19609985|P1|COMPLETED|Cohort 1: 10 ug/ml||4
7966383|NCT00356200|19609984|P2|STARTED|Cohort 1: 10 ug/ml||0
7966384|NCT00356200|19609985|P1|STARTED|Cohort 1: 10 ug/ml||5
7966385|NCT00356187|19609999|P2|NOT COMPLETED|Overall Study||0
7966386|NCT00356187|19610000|P1|NOT COMPLETED|Overall Study||0
7966387|NCT00356187|19609999|P2|COMPLETED|Overall Study||0
7966388|NCT00356187|19610000|P1|COMPLETED|Overall Study||0
7966389|NCT00356187|19609999|P2|STARTED|Overall Study||0
7966390|NCT00356187|19610000|P1|STARTED|Overall Study||0
7966391|NCT00356148|19610014|P2|NOT COMPLETED|Overall Study||1
7966392|NCT00356148|19610015|P1|NOT COMPLETED|Overall Study||2
7966393|NCT00356148|19610014|P2|COMPLETED|Overall Study||182
7966394|NCT00356148|19610015|P1|COMPLETED|Overall Study||187
7966395|NCT00356148|19610014|P2|STARTED|Overall Study||183
7966396|NCT00356148|19610015|P1|STARTED|Overall Study||189
7966397|NCT00356135|19610026|P3|NOT COMPLETED|Overall Study||5
7966398|NCT00356135|19610027|P2|NOT COMPLETED|Overall Study||2
7966399|NCT00356135|19610028|P1|NOT COMPLETED|Overall Study||4
7966400|NCT00356135|19610026|P3|COMPLETED|Overall Study||39
7966401|NCT00356135|19610027|P2|COMPLETED|Overall Study||46
7966402|NCT00356135|19610028|P1|COMPLETED|Overall Study||43
7966403|NCT00356135|19610026|P3|STARTED|Overall Study||44
7966404|NCT00356135|19610027|P2|STARTED|Overall Study||48
7966405|NCT00356135|19610028|P1|STARTED|Overall Study||47
7966406|NCT00356122|19610050|P1|NOT COMPLETED|FOLLOW-UP||41
7966407|NCT00356122|19610050|P1|COMPLETED|FOLLOW-UP||12
7966408|NCT00356122|19610050|P1|STARTED|FOLLOW-UP||53
7966409|NCT00356122|19610050|P1|NOT COMPLETED|TREATMENT||45
7966410|NCT00356122|19610050|P1|COMPLETED|TREATMENT||8
7966411|NCT00356122|19610050|P1|STARTED|TREATMENT||53
7966412|NCT00356057|19610061|P3|NOT COMPLETED|Overall Study||12
7966413|NCT00356057|19610062|P2|NOT COMPLETED|Overall Study||14
7966414|NCT00356057|19610063|P1|NOT COMPLETED|Overall Study||13
7966415|NCT00356057|19610061|P3|COMPLETED|Overall Study||22
7966416|NCT00356057|19610062|P2|COMPLETED|Overall Study||47
7966417|NCT00356057|19610063|P1|COMPLETED|Overall Study||45
7966418|NCT00356057|19610061|P3|IMPLANTED|Overall Study||25
7966419|NCT00356057|19610062|P2|IMPLANTED|Overall Study||52
7966420|NCT00356057|19610063|P1|IMPLANTED|Overall Study||49
7966421|NCT00356057|19610061|P3|STARTED|Overall Study||34
7966422|NCT00356057|19610062|P2|STARTED|Overall Study||61
7966423|NCT00356057|19610063|P1|STARTED|Overall Study||58
7966424|NCT00356031|19610101|P1|NOT COMPLETED|Overall Study||0
7966425|NCT00356031|19610101|P1|COMPLETED|Overall Study||20
7966426|NCT00356031|19610101|P1|STARTED|Overall Study||20
7966427|NCT00355914|19610112|P2|NOT COMPLETED|Overall Study||0
7966428|NCT00355914|19610113|P1|NOT COMPLETED|Overall Study||0
7966429|NCT00355914|19610112|P2|COMPLETED|Overall Study||60
7966430|NCT00355914|19610113|P1|COMPLETED|Overall Study||60
7966431|NCT00355914|19610112|P2|STARTED|Overall Study||60
7966432|NCT00355914|19610113|P1|STARTED|Overall Study||60
7966433|NCT00355797|19610124|P3|NOT COMPLETED|Overall Study||142
7966434|NCT00355797|19610125|P2|NOT COMPLETED|Overall Study||148
7966435|NCT00355797|19610126|P1|NOT COMPLETED|Overall Study||240
7966436|NCT00355797|19610124|P3|COMPLETED|Overall Study||239
7966437|NCT00355797|19610125|P2|COMPLETED|Overall Study||221
7966438|NCT00355797|19610126|P1|COMPLETED|Overall Study||501
7966439|NCT00355797|19610124|P3|STARTED|Overall Study||381
7966440|NCT00355797|19610125|P2|STARTED|Overall Study||369
7966441|NCT00355797|19610126|P1|STARTED|Overall Study||741
7966442|NCT00355784|19610158|P3|NOT COMPLETED|Overall Study||2
7966443|NCT00355784|19610159|P2|NOT COMPLETED|Overall Study||0
7966444|NCT00355784|19610160|P1|NOT COMPLETED|Overall Study||0
7966445|NCT00355784|19610158|P3|COMPLETED|Overall Study||5
7966446|NCT00355784|19610159|P2|COMPLETED|Overall Study||8
7966447|NCT00355784|19610160|P1|COMPLETED|Overall Study||9
7966448|NCT00355784|19610158|P3|STARTED|Overall Study||7
7966449|NCT00355784|19610159|P2|STARTED|Overall Study||8
7966450|NCT00355784|19610160|P1|STARTED|Overall Study||9
7966451|NCT00355706|19610194|P2|NOT COMPLETED|Overall Study||0
7966452|NCT00355706|19610195|P1|NOT COMPLETED|Overall Study||0
7966453|NCT00355706|19610194|P2|COMPLETED|Overall Study||50
7966454|NCT00355706|19610195|P1|COMPLETED|Overall Study||50
7966455|NCT00355706|19610194|P2|STARTED|Overall Study||50
7966456|NCT00355706|19610195|P1|STARTED|Overall Study||50
7966457|NCT00355615|19610209|P5|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9
7966458|NCT00355615|19610210|P4|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
7966459|NCT00355615|19610211|P3|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
7966460|NCT00355615|19610212|P2|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
7966461|NCT00355615|19610213|P1|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
7966462|NCT00355615|19610209|P5|COMPLETED|40-week Rosuvastatin Open Label Period||164
7966463|NCT00355615|19610210|P4|COMPLETED|40-week Rosuvastatin Open Label Period||0
7966464|NCT00355615|19610211|P3|COMPLETED|40-week Rosuvastatin Open Label Period||0
7966465|NCT00355615|19610212|P2|COMPLETED|40-week Rosuvastatin Open Label Period||0
7966466|NCT00355615|19610213|P1|COMPLETED|40-week Rosuvastatin Open Label Period||0
7966467|NCT00355615|19610209|P5|STARTED|40-week Rosuvastatin Open Label Period||173
7966468|NCT00355615|19610210|P4|STARTED|40-week Rosuvastatin Open Label Period||0
7966469|NCT00355615|19610211|P3|STARTED|40-week Rosuvastatin Open Label Period||0
7966470|NCT00355615|19610212|P2|STARTED|40-week Rosuvastatin Open Label Period||0
7966471|NCT00355615|19610213|P1|STARTED|40-week Rosuvastatin Open Label Period||0
7966472|NCT00355615|19610209|P5|NOT COMPLETED|Randomized Double Blind Period||0
7966473|NCT00355615|19610210|P4|NOT COMPLETED|Randomized Double Blind Period||1
7966474|NCT00355615|19610211|P3|NOT COMPLETED|Randomized Double Blind Period||1
7966475|NCT00355615|19610212|P2|NOT COMPLETED|Randomized Double Blind Period||0
7966476|NCT00355615|19610213|P1|NOT COMPLETED|Randomized Double Blind Period||1
7966477|NCT00355615|19610209|P5|COMPLETED|Randomized Double Blind Period||0
7966478|NCT00355615|19610210|P4|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45
7966479|NCT00355615|19610211|P3|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44
7966480|NCT00355615|19610212|P2|COMPLETED|Randomized Double Blind Period||44
7966481|NCT00355615|19610213|P1|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41
7966482|NCT00355615|19610209|P5|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0
7966483|NCT00355615|19610210|P4|STARTED|Randomized Double Blind Period||46
7966484|NCT00355615|19610211|P3|STARTED|Randomized Double Blind Period||45
7966485|NCT00355615|19610212|P2|STARTED|Randomized Double Blind Period||44
7966486|NCT00355615|19610213|P1|STARTED|Randomized Double Blind Period||42
7966487|NCT00355472|19610272|P1|NOT COMPLETED|Overall Study||1
7966488|NCT00355472|19610272|P1|COMPLETED|Overall Study||15
7966489|NCT00355472|19610272|P1|STARTED|Overall Study||16
7966490|NCT00355394|19610299|P2|NOT COMPLETED|Overall Study||0
7966491|NCT00355394|19610300|P1|NOT COMPLETED|Overall Study||0
7966492|NCT00355394|19610299|P2|COMPLETED|Overall Study||16
7966493|NCT00355394|19610300|P1|COMPLETED|Overall Study||15
7966494|NCT00355394|19610299|P2|STARTED|Overall Study||16
7966495|NCT00355394|19610300|P1|STARTED|Overall Study||15
7966496|NCT00355368|19610318|P2|NOT COMPLETED|Overall Study||9
7966497|NCT00355368|19610319|P1|NOT COMPLETED|Overall Study||10
7966498|NCT00355368|19610318|P2|COMPLETED|Overall Study||201
7966499|NCT00355368|19610319|P1|COMPLETED|Overall Study||200
7966500|NCT00355368|19610318|P2|STARTED|Overall Study||210
7966501|NCT00355368|19610319|P1|STARTED|Overall Study||210
7966502|NCT00355342|19610333|P2|NOT COMPLETED|Overall Study||36
7966503|NCT00355342|19610334|P1|NOT COMPLETED|Overall Study||39
7966504|NCT00355342|19610333|P2|COMPLETED|Overall Study||56
7966505|NCT00355342|19610334|P1|COMPLETED|Overall Study||55
7966506|NCT00355342|19610333|P2|STARTED|Overall Study||92
7966507|NCT00355342|19610334|P1|STARTED|Overall Study||94
7966508|NCT00355264|19610342|P1|NOT COMPLETED|Extension (Variable Duration)||2
7966509|NCT00355264|19610342|P1|COMPLETED|Extension (Variable Duration)||10
7966510|NCT00355264|19610342|P1|STARTED|Extension (Variable Duration)||12
7966511|NCT00355264|19610342|P1|NOT COMPLETED|Part 3 (7 Weeks of Extension)||0
7966512|NCT00355264|19610342|P1|COMPLETED|Part 3 (7 Weeks of Extension)||2
7966513|NCT00355264|19610342|P1|STARTED|Part 3 (7 Weeks of Extension)||2
7966514|NCT00355264|19610342|P1|NOT COMPLETED|Part 2 (8 Weeks)||0
7966515|NCT00355264|19610342|P1|COMPLETED|Part 2 (8 Weeks)||12
7966516|NCT00355264|19610342|P1|STARTED|Part 2 (8 Weeks)||12
7966517|NCT00355264|19610342|P1|NOT COMPLETED|Part 1 (2 Weeks)||0
7966518|NCT00355264|19610342|P1|COMPLETED|Part 1 (2 Weeks)||12
7966519|NCT00355264|19610342|P1|STARTED|Part 1 (2 Weeks)||12
7966520|NCT00355199|19610353|P2|NOT COMPLETED|Overall Study||4
7966521|NCT00355199|19610354|P1|NOT COMPLETED|Overall Study||7
7966522|NCT00355199|19610353|P2|COMPLETED|Overall Study||122
7966523|NCT00355199|19610354|P1|COMPLETED|Overall Study||113
7966524|NCT00355199|19610353|P2|STARTED|Overall Study||126
7966525|NCT00355199|19610354|P1|STARTED|Overall Study||120
7966526|NCT00355147|19610370|P2|NOT COMPLETED|Overall Study||20
7966527|NCT00355147|19610371|P1|NOT COMPLETED|Overall Study||18
7966528|NCT00355147|19610370|P2|COMPLETED|Overall Study||67
7966529|NCT00355147|19610371|P1|COMPLETED|Overall Study||69
7966530|NCT00355147|19610370|P2|STARTED|Overall Study||87
7966531|NCT00355147|19610371|P1|STARTED|Overall Study||87
7966532|NCT00355134|19610390|P5|NOT COMPLETED|Extension Phase||19
7966533|NCT00355134|19610391|P4|NOT COMPLETED|Extension Phase||16
7966534|NCT00355134|19610392|P3|NOT COMPLETED|Extension Phase||0
7966535|NCT00355134|19610393|P2|NOT COMPLETED|Extension Phase||37
7966536|NCT00355134|19610394|P1|NOT COMPLETED|Extension Phase||31
7966537|NCT00355134|19610390|P5|COMPLETED|Extension Phase||88
7966538|NCT00355134|19610391|P4|COMPLETED|Extension Phase||89
7966539|NCT00355134|19610392|P3|COMPLETED|Extension Phase||0
7966540|NCT00355134|19610393|P2|COMPLETED|Extension Phase||180
7966541|NCT00355134|19610394|P1|COMPLETED|Extension Phase||172
7966542|NCT00355134|19610390|P5|STARTED|Extension Phase||107
7966543|NCT00355134|19610391|P4|STARTED|Extension Phase||105
7966544|NCT00355134|19610392|P3|STARTED|Extension Phase||0
7966545|NCT00355134|19610393|P2|STARTED|Extension Phase||217
7966546|NCT00355134|19610394|P1|STARTED|Extension Phase||203
7966547|NCT00355134|19610390|P5|NOT COMPLETED|Core Phase||0
7966548|NCT00355134|19610391|P4|NOT COMPLETED|Core Phase||0
7966549|NCT00355134|19610392|P3|NOT COMPLETED|Core Phase||100
7966550|NCT00355134|19610393|P2|NOT COMPLETED|Core Phase||86
7966551|NCT00355134|19610394|P1|NOT COMPLETED|Core Phase||119
7966552|NCT00355134|19610390|P5|COMPLETED|Core Phase||0
7966553|NCT00355134|19610391|P4|COMPLETED|Core Phase||0
7966554|NCT00355134|19610392|P3|COMPLETED|Core Phase||255
7966555|NCT00355134|19610393|P2|COMPLETED|Core Phase||272
7966556|NCT00355134|19610394|P1|COMPLETED|Core Phase||251
7966557|NCT00355134|19610390|P5|STARTED|Core Phase||0
7966558|NCT00355134|19610391|P4|STARTED|Core Phase||0
7966559|NCT00355134|19610392|P3|STARTED|Core Phase||355
7966560|NCT00355134|19610393|P2|STARTED|Core Phase||358
7966561|NCT00355134|19610394|P1|STARTED|Core Phase||370
7966562|NCT00355121|19610437|P3|NOT COMPLETED|Overall Study||5
7966563|NCT00355121|19610438|P2|NOT COMPLETED|Overall Study||29
7966564|NCT00355121|19610439|P1|NOT COMPLETED|Overall Study||21
7966565|NCT00355121|19610437|P3|COMPLETED|Overall Study||170
7966566|NCT00355121|19610438|P2|COMPLETED|Overall Study||324
7966567|NCT00355121|19610439|P1|COMPLETED|Overall Study||332
7966568|NCT00355121|19610437|P3|STARTED|Overall Study||175
7966569|NCT00355121|19610438|P2|STARTED|Overall Study||353
7966570|NCT00355121|19610439|P1|STARTED|Overall Study||353
7966571|NCT00355082|19610470|P3|NOT COMPLETED|Continuation Phase||3
7966572|NCT00355082|19610471|P2|NOT COMPLETED|Continuation Phase||0
7966573|NCT00355082|19610472|P1|NOT COMPLETED|Continuation Phase||24
7966574|NCT00355082|19610470|P3|COMPLETED|Continuation Phase||8
7966575|NCT00355082|19610471|P2|COMPLETED|Continuation Phase||0
7966576|NCT00355082|19610472|P1|COMPLETED|Continuation Phase||160
7966577|NCT00355082|19610470|P3|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11
7966578|NCT00355082|19610471|P2|STARTED|Continuation Phase||0
7966579|NCT00355082|19610472|P1|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184
7966580|NCT00355082|19610470|P3|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0
7966581|NCT00355082|19610471|P2|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34
7966582|NCT00355082|19610472|P1|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19
7966583|NCT00355082|19610470|P3|COMPLETED|Double-Blind (DB) Treatment Phase||0
7966584|NCT00355082|19610471|P2|COMPLETED|Double-Blind (DB) Treatment Phase||79
7966585|NCT00355082|19610472|P1|COMPLETED|Double-Blind (DB) Treatment Phase||94
7966586|NCT00355082|19610470|P3|STARTED|Double-Blind (DB) Treatment Phase||0
7966587|NCT00355082|19610471|P2|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113
7966588|NCT00355082|19610472|P1|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113
7966589|NCT00355056|19610494|P2|NOT COMPLETED|Optional Patent Foramen Ovale Closure||3
7966590|NCT00355056|19610495|P1|NOT COMPLETED|Optional Patent Foramen Ovale Closure||0
7966591|NCT00355056|19610494|P2|COMPLETED|Optional Patent Foramen Ovale Closure||84
7966592|NCT00355056|19610495|P1|COMPLETED|Optional Patent Foramen Ovale Closure||0
7966593|NCT00355056|19610494|P2|STARTED|Optional Patent Foramen Ovale Closure|Participants who completed Sham Procedure randomization Arm were eligible. 87/103 consented.|87
7966594|NCT00355056|19610495|P1|STARTED|Optional Patent Foramen Ovale Closure|A sham procedure was not part of this period.|0
7966595|NCT00355056|19610494|P2|NOT COMPLETED|Randomization Period||6
7966596|NCT00355056|19610495|P1|NOT COMPLETED|Randomization Period||4
7966597|NCT00355056|19610494|P2|COMPLETED|Randomization Period||117
7966598|NCT00355056|19610495|P1|COMPLETED|Randomization Period||103
7966599|NCT00355056|19610494|P2|STARTED|Randomization Period||123
7966600|NCT00355056|19610495|P1|STARTED|Randomization Period||107
7966601|NCT00355030|19610525|P2|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2
7966602|NCT00355030|19610526|P1|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1
7966603|NCT00355030|19610525|P2|COMPLETED|Study Period 2 Long Term Follow-Up||17
7966604|NCT00355030|19610526|P1|COMPLETED|Study Period 2 Long Term Follow-Up||19
7966605|NCT00355030|19610525|P2|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19
7966606|NCT00355030|19610526|P1|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20
7966607|NCT00355030|19610525|P2|NOT COMPLETED|Study Period 1 Treatment||44
7966608|NCT00355030|19610526|P1|NOT COMPLETED|Study Period 1 Treatment||45
7966609|NCT00355030|19610525|P2|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
7966610|NCT00355030|19610526|P1|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
7966611|NCT00355030|19610525|P2|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43
7966612|NCT00355030|19610526|P1|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45
7966613|NCT00355030|19610525|P2|STARTED|Study Period 1 Treatment||45
7966614|NCT00355030|19610526|P1|STARTED|Study Period 1 Treatment||46
7966615|NCT00354978|19610548|P1|NOT COMPLETED|Overall Study||0
7966616|NCT00354978|19610548|P1|COMPLETED|Overall Study||43
7966617|NCT00354978|19610548|P1|STARTED|Overall Study||43
7966618|NCT00354913|19610552|P1|NOT COMPLETED|Overall Study||0
7966619|NCT00354913|19610552|P1|COMPLETED|Overall Study||21
7966620|NCT00354913|19610552|P1|STARTED|Overall Study||21
7966621|NCT00354887|19610559|P1|NOT COMPLETED|Overall Study||1
7966622|NCT00354887|19610559|P1|COMPLETED|Overall Study||29
7966623|NCT00354887|19610559|P1|STARTED|Overall Study||30
7966624|NCT00354835|19610565|P2|NOT COMPLETED|Overall Study||61
7966625|NCT00354835|19610566|P1|NOT COMPLETED|Overall Study||52
7966626|NCT00354835|19610565|P2|COMPLETED|Overall Study||181
7966627|NCT00354835|19610566|P1|COMPLETED|Overall Study||187
7966628|NCT00354835|19610565|P2|STARTED|Overall Study||242
7966629|NCT00354835|19610566|P1|STARTED|Overall Study||239
7966630|NCT00354770|19610598|P2|NOT COMPLETED|Overall Study||3
7966631|NCT00354770|19610599|P1|NOT COMPLETED|Overall Study||3
7966632|NCT00354770|19610598|P2|COMPLETED|Overall Study||22
7966633|NCT00354770|19610599|P1|COMPLETED|Overall Study||22
7966634|NCT00354770|19610598|P2|STARTED|Overall Study||25
7966635|NCT00354770|19610599|P1|STARTED|Overall Study||25
7966636|NCT00354744|19610605|P1|NOT COMPLETED|Overall Study||42
7966637|NCT00354744|19610605|P1|COMPLETED|Overall Study||67
7966638|NCT00354744|19610605|P1|STARTED|Overall Study||109
7966639|NCT00354679|19610611|P1|NOT COMPLETED|Overall Study||1
7966640|NCT00354679|19610611|P1|COMPLETED|Overall Study||33
7966641|NCT00354679|19610611|P1|STARTED|Overall Study||34
7966642|NCT00354640|19610615|P1|NOT COMPLETED|Overall Study||0
7966643|NCT00354640|19610615|P1|COMPLETED|Overall Study||11
7966644|NCT00354640|19610615|P1|STARTED|Overall Study||11
7966645|NCT00354614|19610620|P1|NOT COMPLETED|Overall Study||28
7966646|NCT00354614|19610620|P1|COMPLETED|Overall Study||53
7966647|NCT00354614|19610620|P1|STARTED|Overall Study||81
7966648|NCT00354601|19610624|P1|NOT COMPLETED|Overall Study||2
7966649|NCT00354601|19610624|P1|COMPLETED|Overall Study||0
7966650|NCT00354601|19610624|P1|STARTED|Overall Study||2
7966651|NCT00354484|19610633|P2|NOT COMPLETED|Overall Study||3
7966652|NCT00354484|19610634|P1|NOT COMPLETED|Overall Study||4
7966653|NCT00354484|19610633|P2|COMPLETED|Overall Study||144
7966654|NCT00354484|19610634|P1|COMPLETED|Overall Study||138
7966655|NCT00354484|19610633|P2|STARTED|Overall Study||147
7966656|NCT00354484|19610634|P1|STARTED|Overall Study||142
7966657|NCT00354432|19610644|P4|NOT COMPLETED|Overall Study||10
7966658|NCT00354432|19610645|P3|NOT COMPLETED|Overall Study||10
7966659|NCT00354432|19610646|P2|NOT COMPLETED|Overall Study||8
7966660|NCT00354432|19610647|P1|NOT COMPLETED|Overall Study||6
7966661|NCT00354432|19610644|P4|COMPLETED|Overall Study||20
7966662|NCT00354432|19610645|P3|COMPLETED|Overall Study||20
7966663|NCT00354432|19610646|P2|COMPLETED|Overall Study||22
7966664|NCT00354432|19610647|P1|COMPLETED|Overall Study||24
7966665|NCT00354432|19610644|P4|STARTED|Overall Study||30
7966666|NCT00354432|19610645|P3|STARTED|Overall Study||30
7966667|NCT00354432|19610646|P2|STARTED|Overall Study||30
7966668|NCT00354432|19610647|P1|STARTED|Overall Study||30
7966669|NCT00354341|19610663|P2|NOT COMPLETED|Overall Study||7
7966670|NCT00354341|19610664|P1|NOT COMPLETED|Overall Study||3
7966671|NCT00354341|19610663|P2|COMPLETED|Overall Study||75
7966672|NCT00354341|19610664|P1|COMPLETED|Overall Study||85
7966673|NCT00354341|19610663|P2|STARTED|Overall Study||82
7966674|NCT00354341|19610664|P1|STARTED|Overall Study||88
7966675|NCT00354224|19610680|P1|NOT COMPLETED|Overall Study||0
7966676|NCT00354224|19610680|P1|COMPLETED|Overall Study||10
7966677|NCT00354224|19610680|P1|STARTED|Overall Study||10
7966678|NCT00354172|19610686|P1|NOT COMPLETED|Overall Study||1
7966679|NCT00354172|19610686|P1|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15
7966680|NCT00354172|19610686|P1|STARTED|Overall Study||16
7966681|NCT00354159|19610706|P2|NOT COMPLETED|Long-term Follow-up||176
7966682|NCT00354159|19610707|P1|NOT COMPLETED|Long-term Follow-up||180
7966683|NCT00354159|19610706|P2|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
7966684|NCT00354159|19610707|P1|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
7966685|NCT00354159|19610706|P2|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176
7966686|NCT00354159|19610707|P1|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180
7966687|NCT00354159|19610706|P2|NOT COMPLETED|Randomized Study Period||22
7966688|NCT00354159|19610707|P1|NOT COMPLETED|Randomized Study Period||22
7966689|NCT00354159|19610706|P2|COMPLETED|Randomized Study Period||176
7966690|NCT00354159|19610707|P1|COMPLETED|Randomized Study Period||180
7966691|NCT00354159|19610706|P2|STARTED|Randomized Study Period||198
7966692|NCT00354159|19610707|P1|STARTED|Randomized Study Period||202
7966693|NCT00354107|19610750|P1|NOT COMPLETED|Overall Study||5
7966694|NCT00354107|19610750|P1|COMPLETED|Overall Study||0
7966695|NCT00354107|19610750|P1|STARTED|Overall Study||5
7966696|NCT00354029|19610760|P2|NOT COMPLETED|Overall Study||2
7966697|NCT00354029|19610761|P1|NOT COMPLETED|Overall Study||4
7966698|NCT00354029|19610760|P2|COMPLETED|Overall Study||38
7966699|NCT00354029|19610761|P1|COMPLETED|Overall Study||39
7966700|NCT00354029|19610760|P2|STARTED|Overall Study||40
7966701|NCT00354029|19610761|P1|STARTED|Overall Study||43
7966702|NCT00353977|19610767|P1|NOT COMPLETED|Overall Study||0
7966703|NCT00353977|19610767|P1|COMPLETED|Overall Study||38
7966704|NCT00353977|19610767|P1|STARTED|Overall Study||38
7966705|NCT00353873|19610773|P2|NOT COMPLETED|Overall Study||3
7966706|NCT00353873|19610774|P1|NOT COMPLETED|Overall Study||6
7966707|NCT00353873|19610773|P2|COMPLETED|Overall Study||147
7966708|NCT00353873|19610774|P1|COMPLETED|Overall Study||147
7966709|NCT00353873|19610773|P2|STARTED|Overall Study||150
7966710|NCT00353873|19610774|P1|STARTED|Overall Study||153
7966711|NCT00353834|19610788|P2|NOT COMPLETED|Overall Study||0
7966712|NCT00353834|19610789|P1|NOT COMPLETED|Overall Study||0
7966713|NCT00353834|19610788|P2|COMPLETED|Overall Study||27
7966714|NCT00353834|19610789|P1|COMPLETED|Overall Study||26
7966715|NCT00353834|19610788|P2|STARTED|Overall Study||27
7966716|NCT00353834|19610789|P1|STARTED|Overall Study||26
7966717|NCT00353795|19610797|P1|NOT COMPLETED|Overall Study||0
7966718|NCT00353795|19610797|P1|COMPLETED|Overall Study||179
7966719|NCT00353795|19610797|P1|STARTED|Overall Study||179
7966720|NCT00353704|19610803|P2|NOT COMPLETED|Overall Study||1
7966721|NCT00353704|19610804|P1|NOT COMPLETED|Overall Study||3
7966722|NCT00353704|19610803|P2|COMPLETED|Overall Study||24
7966723|NCT00353704|19610804|P1|COMPLETED|Overall Study||22
7966724|NCT00353704|19610803|P2|STARTED|Overall Study||25
7966725|NCT00353704|19610804|P1|STARTED|Overall Study||25
7966726|NCT00353652|19610814|P8|NOT COMPLETED|Third Intervention - 3 Months||0
7966727|NCT00353652|19610815|P7|NOT COMPLETED|Third Intervention - 3 Months||0
7966728|NCT00353652|19610816|P6|NOT COMPLETED|Third Intervention - 3 Months||0
7966729|NCT00353652|19610817|P5|NOT COMPLETED|Third Intervention - 3 Months||0
7966730|NCT00353652|19610818|P4|NOT COMPLETED|Third Intervention - 3 Months||1
7966731|NCT00353652|19610819|P3|NOT COMPLETED|Third Intervention - 3 Months||0
7966732|NCT00353652|19610820|P2|NOT COMPLETED|Third Intervention - 3 Months||0
7966733|NCT00353652|19610821|P1|NOT COMPLETED|Third Intervention - 3 Months||0
7966734|NCT00353652|19610814|P8|COMPLETED|Third Intervention - 3 Months||0
7966735|NCT00353652|19610815|P7|COMPLETED|Third Intervention - 3 Months||1
7966736|NCT00353652|19610816|P6|COMPLETED|Third Intervention - 3 Months||0
7966737|NCT00353652|19610817|P5|COMPLETED|Third Intervention - 3 Months||3
7966738|NCT00353652|19610818|P4|COMPLETED|Third Intervention - 3 Months||6
7966739|NCT00353652|19610819|P3|COMPLETED|Third Intervention - 3 Months||6
7966740|NCT00353652|19610820|P2|COMPLETED|Third Intervention - 3 Months||0
7966741|NCT00353652|19610821|P1|COMPLETED|Third Intervention - 3 Months||0
7966742|NCT00353652|19610814|P8|STARTED|Third Intervention - 3 Months||0
7966743|NCT00353652|19610815|P7|STARTED|Third Intervention - 3 Months||1
7966744|NCT00353652|19610816|P6|STARTED|Third Intervention - 3 Months||0
7966745|NCT00353652|19610817|P5|STARTED|Third Intervention - 3 Months||3
7966746|NCT00353652|19610818|P4|STARTED|Third Intervention - 3 Months||7
7966747|NCT00353652|19610819|P3|STARTED|Third Intervention - 3 Months||6
7966748|NCT00353652|19610820|P2|STARTED|Third Intervention - 3 Months||0
7966749|NCT00353652|19610821|P1|STARTED|Third Intervention - 3 Months||0
7966750|NCT00353652|19610814|P8|NOT COMPLETED|Second Intervention - 3 Months||0
7966751|NCT00353652|19610815|P7|NOT COMPLETED|Second Intervention - 3 Months||0
7966752|NCT00353652|19610816|P6|NOT COMPLETED|Second Intervention - 3 Months||0
7966753|NCT00353652|19610817|P5|NOT COMPLETED|Second Intervention - 3 Months||0
7966754|NCT00353652|19610818|P4|NOT COMPLETED|Second Intervention - 3 Months||0
7966755|NCT00353652|19610819|P3|NOT COMPLETED|Second Intervention - 3 Months||0
7966756|NCT00353652|19610820|P2|NOT COMPLETED|Second Intervention - 3 Months||0
7966757|NCT00353652|19610821|P1|NOT COMPLETED|Second Intervention - 3 Months||0
7966758|NCT00353652|19610814|P8|COMPLETED|Second Intervention - 3 Months||0
7966759|NCT00353652|19610815|P7|COMPLETED|Second Intervention - 3 Months||1
7966760|NCT00353652|19610816|P6|COMPLETED|Second Intervention - 3 Months||0
7966761|NCT00353652|19610817|P5|COMPLETED|Second Intervention - 3 Months||3
7966762|NCT00353652|19610818|P4|COMPLETED|Second Intervention - 3 Months||7
7966763|NCT00353652|19610819|P3|COMPLETED|Second Intervention - 3 Months||6
7966764|NCT00353652|19610820|P2|COMPLETED|Second Intervention - 3 Months||11
7966765|NCT00353652|19610821|P1|COMPLETED|Second Intervention - 3 Months||12
7966766|NCT00353652|19610814|P8|STARTED|Second Intervention - 3 Months||0
7966767|NCT00353652|19610815|P7|STARTED|Second Intervention - 3 Months||1
7966768|NCT00353652|19610816|P6|STARTED|Second Intervention - 3 Months||0
7966769|NCT00353652|19610817|P5|STARTED|Second Intervention - 3 Months||3
7966770|NCT00353652|19610818|P4|STARTED|Second Intervention - 3 Months||7
7966771|NCT00353652|19610819|P3|STARTED|Second Intervention - 3 Months||6
7966772|NCT00353652|19610820|P2|STARTED|Second Intervention - 3 Months||11
7966773|NCT00353652|19610821|P1|STARTED|Second Intervention - 3 Months||12
7966774|NCT00353652|19610814|P8|NOT COMPLETED|First Intervention - 3 Months||0
7966775|NCT00353652|19610815|P7|NOT COMPLETED|First Intervention - 3 Months||0
7966776|NCT00353652|19610816|P6|NOT COMPLETED|First Intervention - 3 Months||0
7966777|NCT00353652|19610817|P5|NOT COMPLETED|First Intervention - 3 Months||0
7966778|NCT00353652|19610818|P4|NOT COMPLETED|First Intervention - 3 Months||0
7966779|NCT00353652|19610819|P3|NOT COMPLETED|First Intervention - 3 Months||0
7966780|NCT00353652|19610820|P2|NOT COMPLETED|First Intervention - 3 Months||4
7966781|NCT00353652|19610821|P1|NOT COMPLETED|First Intervention - 3 Months||3
7966782|NCT00353652|19610814|P8|COMPLETED|First Intervention - 3 Months||0
7966783|NCT00353652|19610815|P7|COMPLETED|First Intervention - 3 Months||1
7966784|NCT00353652|19610816|P6|COMPLETED|First Intervention - 3 Months||0
7966785|NCT00353652|19610817|P5|COMPLETED|First Intervention - 3 Months||3
7966786|NCT00353652|19610818|P4|COMPLETED|First Intervention - 3 Months||7
7966787|NCT00353652|19610819|P3|COMPLETED|First Intervention - 3 Months||6
7966788|NCT00353652|19610820|P2|COMPLETED|First Intervention - 3 Months||11
7966789|NCT00353652|19610821|P1|COMPLETED|First Intervention - 3 Months||12
7966790|NCT00353652|19610814|P8|STARTED|First Intervention - 3 Months||0
7966791|NCT00353652|19610815|P7|STARTED|First Intervention - 3 Months||1
7966792|NCT00353652|19610816|P6|STARTED|First Intervention - 3 Months||0
7966793|NCT00353652|19610817|P5|STARTED|First Intervention - 3 Months||3
7966794|NCT00353652|19610818|P4|STARTED|First Intervention - 3 Months||7
7966795|NCT00353652|19610819|P3|STARTED|First Intervention - 3 Months||6
7966796|NCT00353652|19610820|P2|STARTED|First Intervention - 3 Months||15
7966797|NCT00353652|19610821|P1|STARTED|First Intervention - 3 Months||15
7966798|NCT00353522|19610855|P2|NOT COMPLETED|Overall Study||9
7966799|NCT00353522|19610856|P1|NOT COMPLETED|Overall Study||15
7966800|NCT00353522|19610855|P2|COMPLETED|Overall Study||37
7966801|NCT00353522|19610856|P1|COMPLETED|Overall Study||74
7966802|NCT00353522|19610855|P2|STARTED|Overall Study||46
7966803|NCT00353522|19610856|P1|STARTED|Overall Study||89
7966804|NCT00353496|19610874|P2|NOT COMPLETED|Overall Study||17
7966805|NCT00353496|19610875|P1|NOT COMPLETED|Overall Study||16
7966806|NCT00353496|19610874|P2|COMPLETED|Overall Study||86
7966807|NCT00353496|19610875|P1|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85
7966808|NCT00353496|19610874|P2|STARTED|Overall Study||103
7966809|NCT00353496|19610875|P1|STARTED|Overall Study||101
7966810|NCT00353431|19610892|P2|NOT COMPLETED|Overall Study||0
7966811|NCT00353431|19610893|P1|NOT COMPLETED|Overall Study||0
7966812|NCT00353431|19610892|P2|COMPLETED|Overall Study||67
7966813|NCT00353431|19610893|P1|COMPLETED|Overall Study||63
7966814|NCT00353431|19610892|P2|STARTED|Overall Study||67
7966815|NCT00353431|19610893|P1|STARTED|Overall Study||63
7966816|NCT00353418|19610909|P2|NOT COMPLETED|Overall Study||158
7966817|NCT00353418|19610910|P1|NOT COMPLETED|Overall Study||83
7966818|NCT00353418|19610909|P2|COMPLETED|Overall Study||119
7966819|NCT00353418|19610910|P1|COMPLETED|Overall Study||55
7966820|NCT00353418|19610909|P2|STARTED|Overall Study||277
7966821|NCT00353418|19610910|P1|STARTED|Overall Study||138
7966822|NCT00353366|19610928|P1|NOT COMPLETED|Overall Study||143
7966823|NCT00353366|19610928|P1|COMPLETED|Overall Study||1289
7966824|NCT00353366|19610928|P1|STARTED|Overall Study||1432
7966825|NCT00353301|19610935|P1|NOT COMPLETED|Overall Study||0
7966826|NCT00353301|19610935|P1|COMPLETED|Overall Study||25
7966827|NCT00353301|19610935|P1|STARTED|Overall Study||25
7966828|NCT00353275|19610942|P2|NOT COMPLETED|Overall Study||0
7966829|NCT00353275|19610943|P1|NOT COMPLETED|Overall Study||0
7966830|NCT00353275|19610942|P2|COMPLETED|Overall Study||3
7966831|NCT00353275|19610943|P1|COMPLETED|Overall Study||2
7966832|NCT00353275|19610942|P2|STARTED|Overall Study||3
7966833|NCT00353275|19610943|P1|STARTED|Overall Study||2
7966834|NCT00353262|19610955|P1|NOT COMPLETED|Overall Study||29
7966835|NCT00353262|19610955|P1|COMPLETED|Overall Study||7
7966836|NCT00353262|19610955|P1|STARTED|Overall Study||36
7966837|NCT00353119|19610974|P2|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
7966838|NCT00353119|19610975|P1|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
7966839|NCT00353119|19610974|P2|COMPLETED|Second Intervention Week 12 to Week 28||10
7966840|NCT00353119|19610975|P1|COMPLETED|Second Intervention Week 12 to Week 28||5
7966841|NCT00353119|19610974|P2|STARTED|Second Intervention Week 12 to Week 28||10
7966842|NCT00353119|19610975|P1|STARTED|Second Intervention Week 12 to Week 28||5
7966843|NCT00353119|19610974|P2|NOT COMPLETED|First Intervention Day 0 to Week 12||0
7966844|NCT00353119|19610975|P1|NOT COMPLETED|First Intervention Day 0 to Week 12||0
7966845|NCT00353119|19610974|P2|COMPLETED|First Intervention Day 0 to Week 12||10
7966846|NCT00353119|19610975|P1|COMPLETED|First Intervention Day 0 to Week 12||5
7966847|NCT00353119|19610974|P2|STARTED|First Intervention Day 0 to Week 12||10
7966848|NCT00353119|19610975|P1|STARTED|First Intervention Day 0 to Week 12||5
7966849|NCT00352911|19610987|P2|NOT COMPLETED|300mg Twice Daily (14 Days)||0
7966850|NCT00352911|19610988|P1|NOT COMPLETED|300mg Twice Daily (14 Days)||1
7966851|NCT00352911|19610987|P2|COMPLETED|300mg Twice Daily (14 Days)||3
7966852|NCT00352911|19610988|P1|COMPLETED|300mg Twice Daily (14 Days)||15
7966853|NCT00352911|19610987|P2|STARTED|300mg Twice Daily (14 Days)||3
7966854|NCT00352911|19610988|P1|STARTED|300mg Twice Daily (14 Days)||16
7966855|NCT00352911|19610987|P2|NOT COMPLETED|150mg Twice Daily (14 Days)||0
7966856|NCT00352911|19610988|P1|NOT COMPLETED|150mg Twice Daily (14 Days)||0
7966857|NCT00352911|19610987|P2|COMPLETED|150mg Twice Daily (14 Days)||3
7966858|NCT00352911|19610988|P1|COMPLETED|150mg Twice Daily (14 Days)||16
7966859|NCT00352911|19610987|P2|STARTED|150mg Twice Daily (14 Days)||3
7966860|NCT00352911|19610988|P1|STARTED|150mg Twice Daily (14 Days)||16
7966861|NCT00352885|19610996|P2|NOT COMPLETED|Overall Study||7
7966862|NCT00352885|19610997|P1|NOT COMPLETED|Overall Study||6
7966863|NCT00352885|19610996|P2|COMPLETED|Overall Study||4
7966864|NCT00352885|19610997|P1|COMPLETED|Overall Study||3
7966865|NCT00352885|19610996|P2|Completed Cycle 3 of IL-2 Treatment|Overall Study||7
7966866|NCT00352885|19610997|P1|Completed Cycle 3 of IL-2 Treatment|Overall Study||4
7966867|NCT00352885|19610996|P2|Completed Cycle 2 of IL-2 Treatment|Overall Study||9
7966868|NCT00352885|19610997|P1|Completed Cycle 2 of IL-2 Treatment|Overall Study||8
7966869|NCT00352885|19610996|P2|Completed Cycle 1 of IL-2 Treatment|Overall Study||11
7966870|NCT00352885|19610997|P1|Completed Cycle 1 of IL-2 Treatment|Overall Study||9
7966871|NCT00352885|19610996|P2|STARTED|Overall Study||11
7966872|NCT00352885|19610997|P1|STARTED|Overall Study||9
7966873|NCT00352846|19611015|P2|NOT COMPLETED|Overall Study||13
7966874|NCT00352846|19611016|P1|NOT COMPLETED|Overall Study||8
7966875|NCT00352846|19611015|P2|COMPLETED|Overall Study||24
7966876|NCT00352846|19611016|P1|COMPLETED|Overall Study||29
7966877|NCT00352846|19611015|P2|STARTED|Overall Study||37
7966878|NCT00352846|19611016|P1|STARTED|Overall Study||37
7966879|NCT00352794|19611022|P1|NOT COMPLETED|Overall Study||0
7966880|NCT00352794|19611022|P1|COMPLETED|Overall Study||40
7966881|NCT00352794|19611022|P1|STARTED|Overall Study||40
7966882|NCT00352781|19611026|P1|NOT COMPLETED|Overall Study||883
7966883|NCT00352781|19611026|P1|COMPLETED|Overall Study||884
7966884|NCT00352781|19611026|P1|STARTED|Overall Study||1767
7966885|NCT00352755|19611031|P1|NOT COMPLETED|Overall Study||2
7966886|NCT00352755|19611031|P1|COMPLETED|Overall Study||16
7966887|NCT00352755|19611031|P1|STARTED|Overall Study||18
7966888|NCT00352690|19611041|P2|NOT COMPLETED|Overall Study||0
7966889|NCT00352690|19611042|P1|NOT COMPLETED|Overall Study||2
7966890|NCT00352690|19611041|P2|COMPLETED|Overall Study||0
7966891|NCT00352690|19611042|P1|COMPLETED|Overall Study||8
7966892|NCT00352690|19611041|P2|STARTED|Overall Study||0
7966893|NCT00352690|19611042|P1|STARTED|Overall Study||10
7966894|NCT00352664|19611062|P2|NOT COMPLETED|Overall Study||0
7966895|NCT00352664|19611063|P1|NOT COMPLETED|Overall Study||7
7966896|NCT00352664|19611062|P2|COMPLETED|Overall Study||0
7966897|NCT00352664|19611063|P1|COMPLETED|Overall Study||20
7966898|NCT00352664|19611062|P2|STARTED|Overall Study||0
7966899|NCT00352664|19611063|P1|STARTED|Overall Study||27
7966900|NCT00352612|19611071|P2|NOT COMPLETED|Overall Study||0
7966901|NCT00352612|19611072|P1|NOT COMPLETED|Overall Study||0
7966902|NCT00352612|19611071|P2|COMPLETED|Overall Study||100
7966903|NCT00352612|19611072|P1|COMPLETED|Overall Study||100
7966904|NCT00352612|19611071|P2|STARTED|Overall Study||100
7966905|NCT00352612|19611072|P1|STARTED|Overall Study||100
7966906|NCT00352534|19611080|P7|NOT COMPLETED|Final Risk Group Assignment||39
7966907|NCT00352534|19611081|P6|NOT COMPLETED|Final Risk Group Assignment||45
7966908|NCT00352534|19611082|P5|NOT COMPLETED|Final Risk Group Assignment||1
7966909|NCT00352534|19611083|P4|NOT COMPLETED|Final Risk Group Assignment||3
7966910|NCT00352534|19611084|P3|NOT COMPLETED|Final Risk Group Assignment||3
7966911|NCT00352534|19611085|P2|NOT COMPLETED|Final Risk Group Assignment||0
7966912|NCT00352534|19611086|P1|NOT COMPLETED|Final Risk Group Assignment||0
7966913|NCT00352534|19611080|P7|COMPLETED|Final Risk Group Assignment||1
7966914|NCT00352534|19611081|P6|COMPLETED|Final Risk Group Assignment||503
7966915|NCT00352534|19611082|P5|COMPLETED|Final Risk Group Assignment||31
7966916|NCT00352534|19611083|P4|COMPLETED|Final Risk Group Assignment||49
7966917|NCT00352534|19611084|P3|COMPLETED|Final Risk Group Assignment||116
7966918|NCT00352534|19611085|P2|COMPLETED|Final Risk Group Assignment||0
7966919|NCT00352534|19611086|P1|COMPLETED|Final Risk Group Assignment||0
7966920|NCT00352534|19611080|P7|STARTED|Final Risk Group Assignment||40
7966921|NCT00352534|19611081|P6|STARTED|Final Risk Group Assignment||548
7966922|NCT00352534|19611082|P5|STARTED|Final Risk Group Assignment||32
7966923|NCT00352534|19611083|P4|STARTED|Final Risk Group Assignment||52
7966924|NCT00352534|19611084|P3|STARTED|Final Risk Group Assignment||119
7966925|NCT00352534|19611085|P2|STARTED|Final Risk Group Assignment||0
7966926|NCT00352534|19611086|P1|STARTED|Final Risk Group Assignment||0
7966927|NCT00352534|19611080|P7|NOT COMPLETED|Initial Staging||0
7966928|NCT00352534|19611081|P6|NOT COMPLETED|Initial Staging||0
7966929|NCT00352534|19611082|P5|NOT COMPLETED|Initial Staging||0
7966930|NCT00352534|19611083|P4|NOT COMPLETED|Initial Staging||0
7966931|NCT00352534|19611084|P3|NOT COMPLETED|Initial Staging||0
7966932|NCT00352534|19611085|P2|NOT COMPLETED|Initial Staging||9
7966933|NCT00352534|19611086|P1|NOT COMPLETED|Initial Staging||8
7966934|NCT00352534|19611080|P7|COMPLETED|Initial Staging||0
7966935|NCT00352534|19611081|P6|COMPLETED|Initial Staging||0
7966936|NCT00352534|19611082|P5|COMPLETED|Initial Staging||0
7966937|NCT00352534|19611083|P4|COMPLETED|Initial Staging||0
7966938|NCT00352534|19611084|P3|COMPLETED|Initial Staging||0
7966939|NCT00352534|19611085|P2|COMPLETED|Initial Staging||588
7966940|NCT00352534|19611086|P1|COMPLETED|Initial Staging||203
7966941|NCT00352534|19611080|P7|STARTED|Initial Staging||0
7966942|NCT00352534|19611081|P6|STARTED|Initial Staging||0
7966943|NCT00352534|19611082|P5|STARTED|Initial Staging||0
7966944|NCT00352534|19611083|P4|STARTED|Initial Staging||0
7966945|NCT00352534|19611084|P3|STARTED|Initial Staging||0
7966946|NCT00352534|19611085|P2|STARTED|Initial Staging||597
7966947|NCT00352534|19611086|P1|STARTED|Initial Staging||211
7966948|NCT00352417|19611103|P2|NOT COMPLETED|Overall Study||5
7966949|NCT00352417|19611104|P1|NOT COMPLETED|Overall Study||5
7966950|NCT00352417|19611103|P2|COMPLETED|Overall Study||21
7966951|NCT00352417|19611104|P1|COMPLETED|Overall Study||19
7966952|NCT00352417|19611103|P2|STARTED|Overall Study||26
7966953|NCT00352417|19611104|P1|STARTED|Overall Study||24
7966954|NCT00352365|19611118|P1|NOT COMPLETED|Maintenance Therapy||12
7966955|NCT00352365|19611118|P1|COMPLETED|Maintenance Therapy||0
7966956|NCT00352365|19611118|P1|Eligible and Began Protocol Therapy|Maintenance Therapy||8
7966957|NCT00352365|19611118|P1|STARTED|Maintenance Therapy||12
7966958|NCT00352365|19611118|P1|NOT COMPLETED|Induction Therapy||27
7966959|NCT00352365|19611118|P1|COMPLETED|Induction Therapy||14
7966960|NCT00352365|19611118|P1|Eligible and Began Protocol Therapy|Induction Therapy||37
7966961|NCT00352365|19611118|P1|Eligible|Induction Therapy||38
7966962|NCT00352365|19611118|P1|STARTED|Induction Therapy||41
7966963|NCT00352118|19611128|P1|NOT COMPLETED|Overall Study||4
7966964|NCT00352118|19611128|P1|COMPLETED|Overall Study||0
7966965|NCT00352118|19611128|P1|STARTED|Overall Study||4
7966966|NCT00352105|19611138|P1|NOT COMPLETED|Overall Study||40
7966967|NCT00352105|19611138|P1|COMPLETED|Overall Study||20
7966968|NCT00352105|19611138|P1|STARTED|Overall Study||60
7966969|NCT00352053|19611149|P2|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2
7966970|NCT00352053|19611150|P1|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1
7966971|NCT00352053|19611149|P2|COMPLETED|Third Extension Phase (Weeks 240-294)||2
7966972|NCT00352053|19611150|P1|COMPLETED|Third Extension Phase (Weeks 240-294)||0
7966973|NCT00352053|19611149|P2|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4
7966974|NCT00352053|19611150|P1|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1
7966975|NCT00352053|19611149|P2|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
7966976|NCT00352053|19611150|P1|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
7966977|NCT00352053|19611149|P2|COMPLETED|Second Extension Phase (Weeks 144-240)||9
7966978|NCT00352053|19611150|P1|COMPLETED|Second Extension Phase (Weeks 144-240)||4
7966979|NCT00352053|19611149|P2|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14
7966980|NCT00352053|19611150|P1|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9
7966981|NCT00352053|19611149|P2|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17
7966982|NCT00352053|19611150|P1|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12
7966983|NCT00352053|19611149|P2|COMPLETED|First Extension Phase (Weeks 48-144)||19
7966984|NCT00352053|19611150|P1|COMPLETED|First Extension Phase (Weeks 48-144)||12
7966985|NCT00352053|19611149|P2|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36
7966986|NCT00352053|19611150|P1|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24
7966987|NCT00352053|19611149|P2|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13
7966988|NCT00352053|19611150|P1|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18
7966989|NCT00352053|19611149|P2|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29
7966990|NCT00352053|19611150|P1|COMPLETED|Double-Blind Phase (Through Week 48)||27
7966991|NCT00352053|19611149|P2|STARTED|Double-Blind Phase (Through Week 48)||42
7966992|NCT00352053|19611150|P1|STARTED|Double-Blind Phase (Through Week 48)||45
7966993|NCT00352027|19611317|P1|NOT COMPLETED|Overall Study||3
7966994|NCT00352027|19611317|P1|COMPLETED|Overall Study||77
7966995|NCT00352027|19611317|P1|STARTED|Overall Study||80
7966996|NCT00352001|19611586|P1|NOT COMPLETED|Overall Study||0
7966997|NCT00352001|19611586|P1|COMPLETED|Overall Study||37
7966998|NCT00352001|19611586|P1|Azacitidine 75mg/Lenalidomide 10mg-14day|Overall Study||3
7966999|NCT00352001|19611586|P1|Azacitidine 75mg/Lenalidomide 5mg-21 Day|Overall Study||3
7967000|NCT00352001|19611586|P1|Azacitidine 75mg/Lenalidomide 5mg-14 Day|Overall Study||3
7967001|NCT00352001|19611586|P1|STARTED|Overall Study||37
7967002|NCT00351936|19611597|P1|NOT COMPLETED|Overall Study||0
7967003|NCT00351936|19611597|P1|COMPLETED|Overall Study||15
7967004|NCT00351936|19611597|P1|STARTED|Overall Study||15
7967005|NCT00351819|19611616|P2|NOT COMPLETED|Overall Study||12
7967006|NCT00351819|19611617|P1|NOT COMPLETED|Overall Study||7
7967007|NCT00351819|19611616|P2|COMPLETED|Overall Study||29
7967008|NCT00351819|19611617|P1|COMPLETED|Overall Study||36
7967009|NCT00351819|19611616|P2|STARTED|Overall Study||41
7967010|NCT00351819|19611617|P1|STARTED|Overall Study||43
7967011|NCT00351741|19611667|P2|NOT COMPLETED|Overall Study||0
7967012|NCT00351741|19611668|P1|NOT COMPLETED|Overall Study||0
7967013|NCT00351741|19611667|P2|COMPLETED|Overall Study||31
7967014|NCT00351741|19611668|P1|COMPLETED|Overall Study||31
7967015|NCT00351741|19611667|P2|STARTED|Overall Study||31
7967016|NCT00351741|19611668|P1|STARTED|Overall Study||31
7967017|NCT00351533|19611688|P2|NOT COMPLETED|Overall Study||5
7967018|NCT00351533|19611689|P1|NOT COMPLETED|Overall Study||2
7967019|NCT00351533|19611688|P2|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44
7967020|NCT00351533|19611689|P1|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39
7967021|NCT00351533|19611688|P2|STARTED|Overall Study||49
7967022|NCT00351533|19611689|P1|STARTED|Overall Study||41
7967023|NCT00351468|19611749|P1|NOT COMPLETED|Overall Study||167
7967024|NCT00351468|19611749|P1|COMPLETED|Overall Study||135
7967025|NCT00351468|19611749|P1|Unknown - Not From Previous Trial|Overall Study|Mistakenly enrolled (not in any of the 3 trials) On 50 mg/d eltrombopag for 18 days and withdrawn|1
7967026|NCT00351468|19611749|P1|Subjects From TRA108057 Repeat|Overall Study||43
7967027|NCT00351468|19611749|P1|Subjects From TRA102537 Raise|Overall Study||146
7967028|NCT00351468|19611749|P1|Subjects From TRA100773B|Overall Study||61
7967029|NCT00351468|19611749|P1|Subjects From TRA100773A|Overall Study||51
7967030|NCT00351468|19611749|P1|STARTED|Overall Study||302
7967031|NCT00351416|19611766|P2|NOT COMPLETED|Overall Study||0
7967032|NCT00351416|19611767|P1|NOT COMPLETED|Overall Study||0
7967033|NCT00351416|19611766|P2|COMPLETED|Overall Study||9
7967034|NCT00351416|19611767|P1|COMPLETED|Overall Study||6
7967035|NCT00351416|19611766|P2|STARTED|Overall Study||9
7967036|NCT00351416|19611767|P1|STARTED|Overall Study||6
7967037|NCT00351377|19611773|P1|NOT COMPLETED|Overall Study||7
7967038|NCT00351377|19611773|P1|COMPLETED|Overall Study||104
7967039|NCT00351377|19611773|P1|STARTED|Overall Study||111
7967040|NCT00351351|19611787|P2|NOT COMPLETED|Overall Study||4
7967041|NCT00351351|19611788|P1|NOT COMPLETED|Overall Study||9
7967042|NCT00351351|19611787|P2|COMPLETED|Overall Study||32
7967043|NCT00351351|19611788|P1|COMPLETED|Overall Study||25
7967044|NCT00351351|19611787|P2|STARTED|Overall Study||36
7967045|NCT00351351|19611788|P1|STARTED|Overall Study||34
7967046|NCT00351299|19611796|P2|NOT COMPLETED|Overall Study||0
7967047|NCT00351299|19611797|P1|NOT COMPLETED|Overall Study||0
7967048|NCT00351299|19611796|P2|COMPLETED|Overall Study||28
7967049|NCT00351299|19611797|P1|COMPLETED|Overall Study||25
7967050|NCT00351299|19611796|P2|STARTED|Overall Study||28
7967051|NCT00351299|19611797|P1|STARTED|Overall Study||25
7967052|NCT00351273|19611814|P3|NOT COMPLETED|Overall Study||5
7967053|NCT00351273|19611815|P2|NOT COMPLETED|Overall Study||2
7967054|NCT00351273|19611816|P1|NOT COMPLETED|Overall Study||1
7967055|NCT00351273|19611814|P3|COMPLETED|Overall Study||10
7967056|NCT00351273|19611815|P2|COMPLETED|Overall Study||10
7967057|NCT00351273|19611816|P1|COMPLETED|Overall Study||14
7967058|NCT00351273|19611814|P3|STARTED|Overall Study||15
7967059|NCT00351273|19611815|P2|STARTED|Overall Study||12
7967060|NCT00351273|19611816|P1|STARTED|Overall Study||15
7967061|NCT00351039|19611839|P1|NOT COMPLETED|Overall Study||0
7967062|NCT00351039|19611839|P1|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8
7967063|NCT00351039|19611839|P1|STARTED|Overall Study||8
7967064|NCT00351000|19611848|P1|NOT COMPLETED|Overall Study||3
7967065|NCT00351000|19611848|P1|COMPLETED|Overall Study||21
7967066|NCT00351000|19611848|P1|STARTED|Overall Study||24
7967067|NCT00350870|19611859|P4|NOT COMPLETED|Overall Study||15
7967068|NCT00350870|19611860|P3|NOT COMPLETED|Overall Study||16
7967069|NCT00350870|19611861|P2|NOT COMPLETED|Overall Study||17
7967070|NCT00350870|19611862|P1|NOT COMPLETED|Overall Study||22
7967071|NCT00350870|19611859|P4|COMPLETED|Overall Study||7
7967072|NCT00350870|19611860|P3|COMPLETED|Overall Study||6
7967073|NCT00350870|19611861|P2|COMPLETED|Overall Study||11
7967074|NCT00350870|19611862|P1|COMPLETED|Overall Study||5
7967075|NCT00350870|19611859|P4|Had at Least 1 Day of Med|Overall Study||19
7967076|NCT00350870|19611860|P3|Had at Least 1 Day of Med|Overall Study||18
7967077|NCT00350870|19611861|P2|Had at Least 1 Day of Med|Overall Study||24
7967078|NCT00350870|19611862|P1|Had at Least 1 Day of Med|Overall Study||19
7967079|NCT00350870|19611859|P4|STARTED|Overall Study||22
7967080|NCT00350870|19611860|P3|STARTED|Overall Study||22
7967081|NCT00350870|19611861|P2|STARTED|Overall Study||28
7967082|NCT00350870|19611862|P1|STARTED|Overall Study||27
7967083|NCT00350844|19611876|P1|NOT COMPLETED|Overall Study||1
7967084|NCT00350844|19611876|P1|COMPLETED|Overall Study||5
7967085|NCT00350844|19611876|P1|STARTED|Overall Study||6
7967086|NCT00350792|19611880|P1|NOT COMPLETED|Overall Study||33
7967087|NCT00350792|19611880|P1|COMPLETED|Overall Study||29
7967088|NCT00350792|19611880|P1|STARTED|Overall Study||62
7967089|NCT00350779|19611890|P2|NOT COMPLETED|Overall Study||21
7967090|NCT00350779|19611891|P1|NOT COMPLETED|Overall Study||22
7967091|NCT00350779|19611890|P2|COMPLETED|Overall Study||71
7967092|NCT00350779|19611891|P1|COMPLETED|Overall Study||148
7967093|NCT00350779|19611890|P2|STARTED|Overall Study||92
7967094|NCT00350779|19611891|P1|STARTED|Overall Study||170
7967095|NCT00350727|19611912|P3|NOT COMPLETED|Phase II||22
7967096|NCT00350727|19611913|P2|NOT COMPLETED|Phase II||19
7967097|NCT00350727|19611914|P1|NOT COMPLETED|Phase II||0
7967098|NCT00350727|19611912|P3|COMPLETED|Phase II||0
7967099|NCT00350727|19611913|P2|COMPLETED|Phase II||0
7967100|NCT00350727|19611914|P1|COMPLETED|Phase II||0
7967101|NCT00350727|19611912|P3|STARTED|Phase II||22
7967102|NCT00350727|19611913|P2|STARTED|Phase II||19
7967103|NCT00350727|19611914|P1|STARTED|Phase II||0
7967104|NCT00350727|19611912|P3|NOT COMPLETED|Phase I: Dose Escalation||0
7967105|NCT00350727|19611913|P2|NOT COMPLETED|Phase I: Dose Escalation||0
7967106|NCT00350727|19611914|P1|NOT COMPLETED|Phase I: Dose Escalation||34
7967107|NCT00350727|19611912|P3|COMPLETED|Phase I: Dose Escalation||0
7967108|NCT00350727|19611913|P2|COMPLETED|Phase I: Dose Escalation||0
7967109|NCT00350727|19611914|P1|COMPLETED|Phase I: Dose Escalation||0
7967110|NCT00350727|19611912|P3|STARTED|Phase I: Dose Escalation||0
7967111|NCT00350727|19611913|P2|STARTED|Phase I: Dose Escalation||0
7967112|NCT00350727|19611914|P1|STARTED|Phase I: Dose Escalation||34
7967113|NCT00350636|19612058|P2|NOT COMPLETED|Overall Study||45
7967114|NCT00350636|19612059|P1|NOT COMPLETED|Overall Study||43
7967115|NCT00350636|19612058|P2|COMPLETED|Overall Study||355
7967116|NCT00350636|19612059|P1|COMPLETED|Overall Study||346
7967117|NCT00350636|19612058|P2|STARTED|Overall Study||400
7967118|NCT00350636|19612059|P1|STARTED|Overall Study||389
7967119|NCT00350623|19612078|P3|NOT COMPLETED|Overall Study||6
7967120|NCT00350623|19612079|P2|NOT COMPLETED|Overall Study||4
7967121|NCT00350623|19612080|P1|NOT COMPLETED|Overall Study||8
7967122|NCT00350623|19612078|P3|COMPLETED|Overall Study||62
7967123|NCT00350623|19612079|P2|COMPLETED|Overall Study||67
7967124|NCT00350623|19612080|P1|COMPLETED|Overall Study||63
7967125|NCT00350623|19612078|P3|STARTED|Overall Study||68
7967126|NCT00350623|19612079|P2|STARTED|Overall Study||71
7967127|NCT00350623|19612080|P1|STARTED|Overall Study||71
7967128|NCT00350545|19612088|P1|NOT COMPLETED|Overall Study||2
7967129|NCT00350545|19612088|P1|COMPLETED|Overall Study||35
7967130|NCT00350545|19612088|P1|STARTED|Overall Study||37
7967131|NCT00350532|19612098|P2|NOT COMPLETED|Overall Study||0
7967132|NCT00350532|19612099|P1|NOT COMPLETED|Overall Study||0
7967133|NCT00350532|19612098|P2|COMPLETED|Overall Study||19
7967134|NCT00350532|19612099|P1|COMPLETED|Overall Study||24
7967135|NCT00350532|19612098|P2|STARTED|Overall Study||19
7967136|NCT00350532|19612099|P1|STARTED|Overall Study||24
7967137|NCT00350519|19612107|P2|NOT COMPLETED|Overall Study||6
7967138|NCT00350519|19612108|P1|NOT COMPLETED|Overall Study||4
7967139|NCT00350519|19612107|P2|COMPLETED|Overall Study||13
7967140|NCT00350519|19612108|P1|COMPLETED|Overall Study||14
7967141|NCT00350519|19612107|P2|STARTED|Overall Study||19
7967142|NCT00350519|19612108|P1|STARTED|Overall Study||18
7967143|NCT00350402|19612122|P2|NOT COMPLETED|Overall Study||1
7967144|NCT00350402|19612123|P1|NOT COMPLETED|Overall Study||1
7967145|NCT00350402|19612122|P2|COMPLETED|Overall Study||20
7967146|NCT00350402|19612123|P1|COMPLETED|Overall Study||20
7967147|NCT00350402|19612122|P2|STARTED|Overall Study||21
7967148|NCT00350402|19612123|P1|STARTED|Overall Study||21
7967149|NCT00350363|19612135|P1|NOT COMPLETED|Overall Study||0
7967150|NCT00350363|19612135|P1|COMPLETED|Overall Study||60
7967151|NCT00350363|19612135|P1|STARTED|Overall Study||60
7967152|NCT00350337|19612143|P4|NOT COMPLETED|Overall Study||0
7967153|NCT00350337|19612144|P3|NOT COMPLETED|Overall Study||3
7967154|NCT00350337|19612145|P2|NOT COMPLETED|Overall Study||3
7967155|NCT00350337|19612146|P1|NOT COMPLETED|Overall Study||5
7967156|NCT00350337|19612143|P4|COMPLETED|Overall Study||21
7967157|NCT00350337|19612144|P3|COMPLETED|Overall Study||18
7967158|NCT00350337|19612145|P2|COMPLETED|Overall Study||19
7967159|NCT00350337|19612146|P1|COMPLETED|Overall Study||17
7967160|NCT00350337|19612143|P4|STARTED|Overall Study||21
7967161|NCT00350337|19612144|P3|STARTED|Overall Study||21
7967162|NCT00350337|19612145|P2|STARTED|Overall Study||22
7967163|NCT00350337|19612146|P1|STARTED|Overall Study||22
7967164|NCT00350272|19612196|P2|NOT COMPLETED|Open-Label 84 Week Treatment||8
7967165|NCT00350272|19612197|P1|NOT COMPLETED|Open-Label 84 Week Treatment||9
7967166|NCT00350272|19612196|P2|COMPLETED|Open-Label 84 Week Treatment||27
7967167|NCT00350272|19612197|P1|COMPLETED|Open-Label 84 Week Treatment||21
7967168|NCT00350272|19612196|P2|STARTED|Open-Label 84 Week Treatment||35
7967169|NCT00350272|19612197|P1|STARTED|Open-Label 84 Week Treatment||30
7967170|NCT00350272|19612196|P2|NOT COMPLETED|Blinded 12 Week Treatment||2
7967171|NCT00350272|19612197|P1|NOT COMPLETED|Blinded 12 Week Treatment||9
7967172|NCT00350272|19612196|P2|COMPLETED|Blinded 12 Week Treatment||35
7967173|NCT00350272|19612197|P1|COMPLETED|Blinded 12 Week Treatment||30
7967174|NCT00350272|19612196|P2|STARTED|Blinded 12 Week Treatment||37
7967175|NCT00350272|19612197|P1|STARTED|Blinded 12 Week Treatment||39
7967176|NCT00350220|19612207|P2|NOT COMPLETED|Overall Study||0
7967177|NCT00350220|19612208|P1|NOT COMPLETED|Overall Study||0
7967178|NCT00350220|19612207|P2|COMPLETED|Overall Study||30
7967179|NCT00350220|19612208|P1|COMPLETED|Overall Study||30
7967180|NCT00350220|19612207|P2|STARTED|Overall Study||30
7967181|NCT00350220|19612208|P1|STARTED|Overall Study||30
7967182|NCT00350207|19612219|P3|NOT COMPLETED|Overall Study||7
7967183|NCT00350207|19612220|P2|NOT COMPLETED|Overall Study||6
7967184|NCT00350207|19612221|P1|NOT COMPLETED|Overall Study||8
7967185|NCT00350207|19612219|P3|COMPLETED|Overall Study||119
7967186|NCT00350207|19612220|P2|COMPLETED|Overall Study||128
7967187|NCT00350207|19612221|P1|COMPLETED|Overall Study||120
7967188|NCT00350207|19612219|P3|STARTED|Overall Study||126
7967189|NCT00350207|19612220|P2|STARTED|Overall Study||134
7967190|NCT00350207|19612221|P1|STARTED|Overall Study||128
7967191|NCT00350142|19612415|P1|NOT COMPLETED|Overall Study||0
7967192|NCT00350142|19612415|P1|COMPLETED|Overall Study||20
7967193|NCT00350142|19612415|P1|STARTED|Overall Study||20
7967194|NCT00350025|19612422|P2|NOT COMPLETED|Overall Study||2
7967195|NCT00350025|19612423|P1|NOT COMPLETED|Overall Study||0
7967196|NCT00350025|19612422|P2|COMPLETED|Overall Study||28
7967197|NCT00350025|19612423|P1|COMPLETED|Overall Study||11
7967198|NCT00350025|19612422|P2|STARTED|Overall Study||30
7967199|NCT00350025|19612423|P1|STARTED|Overall Study||11
7967200|NCT00349973|19612433|P2|NOT COMPLETED|Overall Study||3
7967201|NCT00349973|19612434|P1|NOT COMPLETED|Overall Study||4
7967202|NCT00349973|19612433|P2|COMPLETED|Overall Study||5
7967203|NCT00349973|19612434|P1|COMPLETED|Overall Study||8
7967204|NCT00349973|19612433|P2|STARTED|Overall Study||8
7967205|NCT00349973|19612434|P1|STARTED|Overall Study||12
7967206|NCT00349921|19612448|P4|NOT COMPLETED|Second Spinal Injection||0
7967207|NCT00349921|19612449|P3|NOT COMPLETED|Second Spinal Injection||0
7967208|NCT00349921|19612450|P2|NOT COMPLETED|Second Spinal Injection||0
7967209|NCT00349921|19612451|P1|NOT COMPLETED|Second Spinal Injection||0
7967210|NCT00349921|19612448|P4|COMPLETED|Second Spinal Injection||1
7967211|NCT00349921|19612449|P3|COMPLETED|Second Spinal Injection||0
7967212|NCT00349921|19612450|P2|COMPLETED|Second Spinal Injection||10
7967213|NCT00349921|19612451|P1|COMPLETED|Second Spinal Injection||9
7967214|NCT00349921|19612448|P4|STARTED|Second Spinal Injection||1
7967215|NCT00349921|19612449|P3|STARTED|Second Spinal Injection||0
7967216|NCT00349921|19612450|P2|STARTED|Second Spinal Injection||10
7967217|NCT00349921|19612451|P1|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9
7967218|NCT00349921|19612448|P4|NOT COMPLETED|First Spinal Injection||0
7967219|NCT00349921|19612449|P3|NOT COMPLETED|First Spinal Injection||1
7967220|NCT00349921|19612450|P2|NOT COMPLETED|First Spinal Injection||0
7967221|NCT00349921|19612451|P1|NOT COMPLETED|First Spinal Injection||1
7967222|NCT00349921|19612448|P4|COMPLETED|First Spinal Injection||1
7967223|NCT00349921|19612449|P3|COMPLETED|First Spinal Injection||0
7967224|NCT00349921|19612450|P2|COMPLETED|First Spinal Injection||10
7967225|NCT00349921|19612451|P1|COMPLETED|First Spinal Injection||9
7967226|NCT00349921|19612448|P4|STARTED|First Spinal Injection||1
7967227|NCT00349921|19612449|P3|STARTED|First Spinal Injection||1
7967228|NCT00349921|19612450|P2|STARTED|First Spinal Injection||10
7967229|NCT00349921|19612451|P1|STARTED|First Spinal Injection||10
7967230|NCT00349908|19612462|P2|NOT COMPLETED|Overall Study||4
7967231|NCT00349908|19612463|P1|NOT COMPLETED|Overall Study||0
7967232|NCT00349908|19612462|P2|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6
7967233|NCT00349908|19612463|P1|COMPLETED|Overall Study||10
7967234|NCT00349908|19612462|P2|STARTED|Overall Study||10
7967235|NCT00349908|19612463|P1|STARTED|Overall Study||10
7967236|NCT00349778|19612481|P1|NOT COMPLETED|Overall Study||0
7967237|NCT00349778|19612481|P1|COMPLETED|Overall Study||102
7967238|NCT00349778|19612481|P1|STARTED|Overall Study||102
7967239|NCT00349752|19612489|P2|NOT COMPLETED|Overall Study||64
7967240|NCT00349752|19612490|P1|NOT COMPLETED|Overall Study||59
7967241|NCT00349752|19612489|P2|COMPLETED|Overall Study||23
7967242|NCT00349752|19612490|P1|COMPLETED|Overall Study||28
7967243|NCT00349752|19612489|P2|STARTED|Overall Study||87
7967244|NCT00349752|19612490|P1|STARTED|Overall Study||87
7967245|NCT00349713|19612519|P3|NOT COMPLETED|Overall Study||0
7967246|NCT00349713|19612520|P2|NOT COMPLETED|Overall Study||0
7967247|NCT00349713|19612521|P1|NOT COMPLETED|Overall Study||0
7967248|NCT00349713|19612519|P3|COMPLETED|Overall Study||20
7967249|NCT00349713|19612520|P2|COMPLETED|Overall Study||20
7967250|NCT00349713|19612521|P1|COMPLETED|Overall Study||20
7967251|NCT00349713|19612519|P3|STARTED|Overall Study||20
7967252|NCT00349713|19612520|P2|STARTED|Overall Study||20
7967253|NCT00349713|19612521|P1|STARTED|Overall Study||20
7967254|NCT00349622|19612543|P2|NOT COMPLETED|Overall Study||96
7967255|NCT00349622|19612544|P1|NOT COMPLETED|Overall Study||178
7967256|NCT00349622|19612543|P2|COMPLETED|Overall Study||77
7967257|NCT00349622|19612544|P1|COMPLETED|Overall Study||162
7967258|NCT00349622|19612543|P2|STARTED|Overall Study||173
7967259|NCT00349622|19612544|P1|STARTED|Overall Study||340
7967260|NCT00349466|19612562|P2|NOT COMPLETED|Overall Study||3
7967261|NCT00349466|19612563|P1|NOT COMPLETED|Overall Study||9
7967262|NCT00349466|19612562|P2|COMPLETED|Overall Study||35
7967263|NCT00349466|19612563|P1|COMPLETED|Overall Study||33
7967264|NCT00349466|19612562|P2|STARTED|Overall Study||38
7967265|NCT00349466|19612563|P1|STARTED|Overall Study||42
7967266|NCT00349388|19612571|P2|NOT COMPLETED|Overall Study||0
7967267|NCT00349388|19612572|P1|NOT COMPLETED|Overall Study||0
7967268|NCT00349388|19612571|P2|COMPLETED|Overall Study||1
7967269|NCT00349388|19612572|P1|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0
7967270|NCT00349388|19612571|P2|STARTED|Overall Study||1
7967271|NCT00349388|19612572|P1|STARTED|Overall Study|no patients enrolled|0
7967272|NCT00349349|19612583|P3|NOT COMPLETED|Overall Study||6
7967273|NCT00349349|19612584|P2|NOT COMPLETED|Overall Study||62
7967274|NCT00349349|19612585|P1|NOT COMPLETED|Overall Study||53
7967275|NCT00349349|19612583|P3|COMPLETED|Overall Study||10
7967276|NCT00349349|19612584|P2|COMPLETED|Overall Study||50
7967277|NCT00349349|19612585|P1|COMPLETED|Overall Study||42
7967278|NCT00349349|19612583|P3|STARTED|Overall Study||16
7967279|NCT00349349|19612584|P2|STARTED|Overall Study||112
7967280|NCT00349349|19612585|P1|STARTED|Overall Study||95
7967281|NCT00349336|19612651|P2|NOT COMPLETED|Overall Study||14
7967282|NCT00349336|19612652|P1|NOT COMPLETED|Overall Study||13
7967283|NCT00349336|19612651|P2|COMPLETED|Overall Study||18
7967284|NCT00349336|19612652|P1|COMPLETED|Overall Study||19
7967285|NCT00349336|19612651|P2|STARTED|Overall Study||32
7967286|NCT00349336|19612652|P1|STARTED|Overall Study||32
7967287|NCT00348933|19612674|P1|NOT COMPLETED|Overall Study||25
7967288|NCT00348933|19612674|P1|COMPLETED|Overall Study||65
7967289|NCT00348933|19612674|P1|STARTED|Overall Study||90
7967290|NCT00348881|19612682|P2|NOT COMPLETED|Overall Study||12
7967291|NCT00348881|19612683|P1|NOT COMPLETED|Overall Study||17
7967292|NCT00348881|19612682|P2|COMPLETED|Overall Study||697
7967293|NCT00348881|19612683|P1|COMPLETED|Overall Study||1407
7967294|NCT00348881|19612682|P2|STARTED|Overall Study||709
7967295|NCT00348881|19612683|P1|STARTED|Overall Study||1424
7967296|NCT00348816|19612695|P1|NOT COMPLETED|Overall Study||1
7967297|NCT00348816|19612695|P1|COMPLETED|Overall Study||19
7967298|NCT00348816|19612695|P1|STARTED|Overall Study||20
7967299|NCT00348790|19612702|P1|NOT COMPLETED|Completed Treatment||25
7967300|NCT00348790|19612702|P1|COMPLETED|Completed Treatment||0
7967301|NCT00348790|19612702|P1|STARTED|Completed Treatment||25
7967302|NCT00348790|19612702|P1|NOT COMPLETED|Began Treatment||0
7967303|NCT00348790|19612702|P1|COMPLETED|Began Treatment||25
7967304|NCT00348790|19612702|P1|STARTED|Began Treatment||25
7967305|NCT00348686|19612714|P1|NOT COMPLETED|Overall Study||66
7967306|NCT00348686|19612714|P1|COMPLETED|Overall Study||249
7967307|NCT00348686|19612714|P1|STARTED|Overall Study||315
7967308|NCT00348673|19612731|P9|NOT COMPLETED|Stage 2||0
7967309|NCT00348673|19612732|P8|NOT COMPLETED|Stage 2||0
7967310|NCT00348673|19612733|P7|NOT COMPLETED|Stage 2||0
7967311|NCT00348673|19612734|P6|NOT COMPLETED|Stage 2||0
7967312|NCT00348673|19612735|P5|NOT COMPLETED|Stage 2||0
7967313|NCT00348673|19612736|P4|NOT COMPLETED|Stage 2||0
7967314|NCT00348673|19612737|P3|NOT COMPLETED|Stage 2||0
7967315|NCT00348673|19612738|P2|NOT COMPLETED|Stage 2||0
7967316|NCT00348673|19612739|P1|NOT COMPLETED|Stage 2||0
7967317|NCT00348673|19612731|P9|COMPLETED|Stage 2||2
7967318|NCT00348673|19612732|P8|COMPLETED|Stage 2||6
7967319|NCT00348673|19612733|P7|COMPLETED|Stage 2||6
7967320|NCT00348673|19612734|P6|COMPLETED|Stage 2||6
7967321|NCT00348673|19612735|P5|COMPLETED|Stage 2||0
7967322|NCT00348673|19612736|P4|COMPLETED|Stage 2||0
7967323|NCT00348673|19612737|P3|COMPLETED|Stage 2||0
7967324|NCT00348673|19612738|P2|COMPLETED|Stage 2||0
7967325|NCT00348673|19612739|P1|COMPLETED|Stage 2||0
7967326|NCT00348673|19612731|P9|STARTED|Stage 2||2
7967327|NCT00348673|19612732|P8|STARTED|Stage 2||6
7967328|NCT00348673|19612733|P7|STARTED|Stage 2||6
7967329|NCT00348673|19612734|P6|STARTED|Stage 2||6
7967330|NCT00348673|19612735|P5|STARTED|Stage 2||0
7967331|NCT00348673|19612736|P4|STARTED|Stage 2||0
7967332|NCT00348673|19612737|P3|STARTED|Stage 2||0
7967333|NCT00348673|19612738|P2|STARTED|Stage 2||0
7967334|NCT00348673|19612739|P1|STARTED|Stage 2||0
7967335|NCT00348673|19612731|P9|NOT COMPLETED|Stage 1||0
7967336|NCT00348673|19612732|P8|NOT COMPLETED|Stage 1||0
7967337|NCT00348673|19612733|P7|NOT COMPLETED|Stage 1||0
7967338|NCT00348673|19612734|P6|NOT COMPLETED|Stage 1||0
7967339|NCT00348673|19612735|P5|NOT COMPLETED|Stage 1||0
7967340|NCT00348673|19612736|P4|NOT COMPLETED|Stage 1||0
7967341|NCT00348673|19612737|P3|NOT COMPLETED|Stage 1||1
7967342|NCT00348673|19612738|P2|NOT COMPLETED|Stage 1||0
7967343|NCT00348673|19612739|P1|NOT COMPLETED|Stage 1||0
7967344|NCT00348673|19612731|P9|COMPLETED|Stage 1||0
7967345|NCT00348673|19612732|P8|COMPLETED|Stage 1||0
7967346|NCT00348673|19612733|P7|COMPLETED|Stage 1||0
7967347|NCT00348673|19612734|P6|COMPLETED|Stage 1||0
7967348|NCT00348673|19612735|P5|COMPLETED|Stage 1||4
7967349|NCT00348673|19612736|P4|COMPLETED|Stage 1||6
7967350|NCT00348673|19612737|P3|COMPLETED|Stage 1||6
7967351|NCT00348673|19612738|P2|COMPLETED|Stage 1||6
7967352|NCT00348673|19612739|P1|COMPLETED|Stage 1||6
7967353|NCT00348673|19612731|P9|Treated|Stage 1||0
7967354|NCT00348673|19612732|P8|Treated|Stage 1||0
7967355|NCT00348673|19612733|P7|Treated|Stage 1||0
7967356|NCT00348673|19612734|P6|Treated|Stage 1||0
7967357|NCT00348673|19612735|P5|Treated|Stage 1||4
7967358|NCT00348673|19612736|P4|Treated|Stage 1||6
7967359|NCT00348673|19612737|P3|Treated|Stage 1||6
7967360|NCT00348673|19612738|P2|Treated|Stage 1||6
7967361|NCT00348673|19612739|P1|Treated|Stage 1||6
7967362|NCT00348673|19612731|P9|STARTED|Stage 1||0
7967363|NCT00348673|19612732|P8|STARTED|Stage 1||0
7967364|NCT00348673|19612733|P7|STARTED|Stage 1||0
7967365|NCT00348673|19612734|P6|STARTED|Stage 1||0
7967366|NCT00348673|19612735|P5|STARTED|Stage 1||4
7967367|NCT00348673|19612736|P4|STARTED|Stage 1||6
7967368|NCT00348673|19612737|P3|STARTED|Stage 1||7
7967369|NCT00348673|19612738|P2|STARTED|Stage 1||6
7967370|NCT00348673|19612739|P1|STARTED|Stage 1||6
7967371|NCT00348595|19612788|P2|NOT COMPLETED|Overall Study||8
7967372|NCT00348595|19612789|P1|NOT COMPLETED|Overall Study||5
7967373|NCT00348595|19612788|P2|COMPLETED|Overall Study||26
7967374|NCT00348595|19612789|P1|COMPLETED|Overall Study||21
7967375|NCT00348595|19612788|P2|STARTED|Overall Study||34
7967376|NCT00348595|19612789|P1|STARTED|Overall Study||26
7967377|NCT00348556|19612801|P1|NOT COMPLETED|Overall Study||1
7967378|NCT00348556|19612801|P1|COMPLETED|Overall Study||3
7967379|NCT00348556|19612801|P1|STARTED|Overall Study||4
7967380|NCT00348374|19612808|P2|NOT COMPLETED|Overall Study||32
7967381|NCT00348374|19612809|P1|NOT COMPLETED|Overall Study||19
7967382|NCT00348374|19612808|P2|COMPLETED|Overall Study||71
7967383|NCT00348374|19612809|P1|COMPLETED|Overall Study||69
7967384|NCT00348374|19612808|P2|Received Study Treatment|Overall Study||96
7967385|NCT00348374|19612809|P1|Received Study Treatment|Overall Study||88
7967386|NCT00348374|19612808|P2|STARTED|Overall Study||103
7967387|NCT00348374|19612809|P1|STARTED|Overall Study||88
7967388|NCT00348348|19612856|P2|NOT COMPLETED|Overall Study||27
7967389|NCT00348348|19612857|P1|NOT COMPLETED|Overall Study||25
7967390|NCT00348348|19612856|P2|COMPLETED|Overall Study||555
7967391|NCT00348348|19612857|P1|COMPLETED|Overall Study||554
7967392|NCT00348348|19612856|P2|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582
7967393|NCT00348348|19612857|P1|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579
7967394|NCT00348309|19612872|P3|NOT COMPLETED|Overall Study||143
7967395|NCT00348309|19612873|P2|NOT COMPLETED|Overall Study||98
7967396|NCT00348309|19612874|P1|NOT COMPLETED|Overall Study||134
7967397|NCT00348309|19612872|P3|COMPLETED|Overall Study||346
7967398|NCT00348309|19612873|P2|COMPLETED|Overall Study||396
7967399|NCT00348309|19612874|P1|COMPLETED|Overall Study||362
7967400|NCT00348309|19612872|P3|STARTED|Overall Study||489
7967401|NCT00348309|19612873|P2|STARTED|Overall Study||494
7967402|NCT00348309|19612874|P1|STARTED|Overall Study||496
7967403|NCT00348283|19612947|P2|NOT COMPLETED|Open Label||34
7967404|NCT00348283|19612948|P1|NOT COMPLETED|Open Label||0
7967405|NCT00348283|19612947|P2|COMPLETED|Open Label||66
7967406|NCT00348283|19612948|P1|COMPLETED|Open Label||0
7967488|NCT00347360|19613170|P8|NOT COMPLETED|Overall Study||3
7967407|NCT00348283|19612947|P2|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100
7967408|NCT00348283|19612948|P1|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0
7967409|NCT00348283|19612947|P2|NOT COMPLETED|Double Blind||10
7967410|NCT00348283|19612948|P1|NOT COMPLETED|Double Blind||5
7967411|NCT00348283|19612947|P2|COMPLETED|Double Blind||54
7967412|NCT00348283|19612948|P1|COMPLETED|Double Blind||60
7967413|NCT00348283|19612947|P2|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64
7967414|NCT00348283|19612948|P1|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65
7967415|NCT00348283|19612947|P2|NOT COMPLETED|Induction||6
7967416|NCT00348283|19612948|P1|NOT COMPLETED|Induction||0
7967417|NCT00348283|19612947|P2|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129
7967418|NCT00348283|19612948|P1|COMPLETED|Induction||0
7967419|NCT00348283|19612947|P2|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135
7967420|NCT00348283|19612948|P1|STARTED|Induction||0
7967421|NCT00348205|19612964|P1|NOT COMPLETED|Overall Study||2
7967422|NCT00348205|19612964|P1|COMPLETED|Overall Study||78
7967423|NCT00348205|19612964|P1|STARTED|Overall Study||80
7967424|NCT00348140|19612977|P3|NOT COMPLETED|Overall Study||163
7967425|NCT00348140|19612978|P2|NOT COMPLETED|Overall Study||139
7967426|NCT00348140|19612979|P1|NOT COMPLETED|Overall Study||126
7967427|NCT00348140|19612977|P3|COMPLETED|Overall Study||328
7967428|NCT00348140|19612978|P2|COMPLETED|Overall Study||351
7967429|NCT00348140|19612979|P1|COMPLETED|Overall Study||361
7967430|NCT00348140|19612977|P3|STARTED|Overall Study||491
7967431|NCT00348140|19612978|P2|STARTED|Overall Study||490
7967432|NCT00348140|19612979|P1|STARTED|Overall Study||487
7967433|NCT00347958|19613077|P1|NOT COMPLETED|Overall Study||4
7967434|NCT00347958|19613077|P1|COMPLETED|Overall Study||540
7967435|NCT00347958|19613077|P1|STARTED|Overall Study||544
7967436|NCT00347932|19613086|P2|NOT COMPLETED|Overall Study||52
7967437|NCT00347932|19613087|P1|NOT COMPLETED|Overall Study||31
7967438|NCT00347932|19613086|P2|COMPLETED|Overall Study||430
7967439|NCT00347932|19613087|P1|COMPLETED|Overall Study||444
7967440|NCT00347932|19613086|P2|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482
7967441|NCT00347932|19613087|P1|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475
7967442|NCT00347919|19613102|P3|NOT COMPLETED|Overall Study||38
7967443|NCT00347919|19613103|P2|NOT COMPLETED|Overall Study||76
7967444|NCT00347919|19613104|P1|NOT COMPLETED|Overall Study||71
7967445|NCT00347919|19613102|P3|COMPLETED|Overall Study||2
7967446|NCT00347919|19613103|P2|COMPLETED|Overall Study||0
7967447|NCT00347919|19613104|P1|COMPLETED|Overall Study||2
7967448|NCT00347919|19613102|P3|STARTED|Overall Study|Safety Population|40
7967449|NCT00347919|19613103|P2|STARTED|Overall Study|Safety Population|76
7967450|NCT00347919|19613104|P1|STARTED|Overall Study|Safety Population|73
7967451|NCT00347776|19613127|P3|NOT COMPLETED|12 Month Follow-up||19
7967452|NCT00347776|19613128|P2|NOT COMPLETED|12 Month Follow-up||16
7967453|NCT00347776|19613129|P1|NOT COMPLETED|12 Month Follow-up||23
7967454|NCT00347776|19613127|P3|COMPLETED|12 Month Follow-up||436
7967455|NCT00347776|19613128|P2|COMPLETED|12 Month Follow-up||446
7967456|NCT00347776|19613129|P1|COMPLETED|12 Month Follow-up||425
7967457|NCT00347776|19613127|P3|STARTED|12 Month Follow-up||455
7967458|NCT00347776|19613128|P2|STARTED|12 Month Follow-up||462
7967459|NCT00347776|19613129|P1|STARTED|12 Month Follow-up||448
7967460|NCT00347776|19613127|P3|NOT COMPLETED|6 Month Follow-up||18
7967461|NCT00347776|19613128|P2|NOT COMPLETED|6 Month Follow-up||13
7967462|NCT00347776|19613129|P1|NOT COMPLETED|6 Month Follow-up||22
7967463|NCT00347776|19613127|P3|COMPLETED|6 Month Follow-up|452 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|455
7967464|NCT00347776|19613128|P2|COMPLETED|6 Month Follow-up|459 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|462
7967465|NCT00347776|19613129|P1|COMPLETED|6 Month Follow-up|440 had no recurrence.8 were lost to follow-up but were still eligible for follow-up at next visits|448
7967466|NCT00347776|19613127|P3|STARTED|6 Month Follow-up||473
7967467|NCT00347776|19613128|P2|STARTED|6 Month Follow-up||475
7967468|NCT00347776|19613129|P1|STARTED|6 Month Follow-up||470
7967469|NCT00347776|19613127|P3|NOT COMPLETED|1.5 Month Follow-up||12
7967470|NCT00347776|19613128|P2|NOT COMPLETED|1.5 Month Follow-up||8
7967471|NCT00347776|19613129|P1|NOT COMPLETED|1.5 Month Follow-up||14
7967472|NCT00347776|19613127|P3|COMPLETED|1.5 Month Follow-up|472 had no recurrence.1 was lost to follow-up but was still eligible for follow-up at next visits|473
7967473|NCT00347776|19613128|P2|COMPLETED|1.5 Month Follow-up|473 had no recurrence.2 were lost to follow-up but were still eligible for follow-up at next visits|475
7967474|NCT00347776|19613129|P1|COMPLETED|1.5 Month Follow-up||470
7967475|NCT00347776|19613127|P3|STARTED|1.5 Month Follow-up||485
7967476|NCT00347776|19613128|P2|STARTED|1.5 Month Follow-up||483
7967477|NCT00347776|19613129|P1|STARTED|1.5 Month Follow-up||484
7967478|NCT00347438|19613141|P1|NOT COMPLETED|Overall Study||2
7967479|NCT00347438|19613141|P1|COMPLETED|Overall Study||16
7967480|NCT00347438|19613141|P1|STARTED|Overall Study||18
7967481|NCT00347360|19613163|P15|NOT COMPLETED|Overall Study||4
7967482|NCT00347360|19613164|P14|NOT COMPLETED|Overall Study||8
7967483|NCT00347360|19613165|P13|NOT COMPLETED|Overall Study||10
7967484|NCT00347360|19613166|P12|NOT COMPLETED|Overall Study||6
7967485|NCT00347360|19613167|P11|NOT COMPLETED|Overall Study||5
7967486|NCT00347360|19613168|P10|NOT COMPLETED|Overall Study||9
7967487|NCT00347360|19613169|P9|NOT COMPLETED|Overall Study||6
7967489|NCT00347360|19613171|P7|NOT COMPLETED|Overall Study||7
7967490|NCT00347360|19613172|P6|NOT COMPLETED|Overall Study||8
7967491|NCT00347360|19613173|P5|NOT COMPLETED|Overall Study||5
7967492|NCT00347360|19613174|P4|NOT COMPLETED|Overall Study||13
7967493|NCT00347360|19613175|P3|NOT COMPLETED|Overall Study||6
7967494|NCT00347360|19613176|P2|NOT COMPLETED|Overall Study||8
7967495|NCT00347360|19613177|P1|NOT COMPLETED|Overall Study||5
7967496|NCT00347360|19613163|P15|COMPLETED|Overall Study||39
7967497|NCT00347360|19613164|P14|COMPLETED|Overall Study||36
7967498|NCT00347360|19613165|P13|COMPLETED|Overall Study||34
7967499|NCT00347360|19613166|P12|COMPLETED|Overall Study||37
7967500|NCT00347360|19613167|P11|COMPLETED|Overall Study||39
7967501|NCT00347360|19613168|P10|COMPLETED|Overall Study||35
7967502|NCT00347360|19613169|P9|COMPLETED|Overall Study||38
7967503|NCT00347360|19613170|P8|COMPLETED|Overall Study||40
7967504|NCT00347360|19613171|P7|COMPLETED|Overall Study||37
7967505|NCT00347360|19613172|P6|COMPLETED|Overall Study||36
7967506|NCT00347360|19613173|P5|COMPLETED|Overall Study||39
7967507|NCT00347360|19613174|P4|COMPLETED|Overall Study||30
7967508|NCT00347360|19613175|P3|COMPLETED|Overall Study||37
7967509|NCT00347360|19613176|P2|COMPLETED|Overall Study||35
7967510|NCT00347360|19613177|P1|COMPLETED|Overall Study||39
7967511|NCT00347360|19613163|P15|STARTED|Overall Study||43
7967512|NCT00347360|19613164|P14|STARTED|Overall Study||44
7967513|NCT00347360|19613165|P13|STARTED|Overall Study||44
7967514|NCT00347360|19613166|P12|STARTED|Overall Study||43
7967515|NCT00347360|19613167|P11|STARTED|Overall Study||44
7967516|NCT00347360|19613168|P10|STARTED|Overall Study||44
7967517|NCT00347360|19613169|P9|STARTED|Overall Study||44
7967518|NCT00347360|19613170|P8|STARTED|Overall Study||43
7967519|NCT00347360|19613171|P7|STARTED|Overall Study||44
7967520|NCT00347360|19613172|P6|STARTED|Overall Study||44
7967521|NCT00347360|19613173|P5|STARTED|Overall Study||44
7967522|NCT00347360|19613174|P4|STARTED|Overall Study||43
7967523|NCT00347360|19613175|P3|STARTED|Overall Study||43
7967524|NCT00347360|19613176|P2|STARTED|Overall Study||43
7967525|NCT00347360|19613177|P1|STARTED|Overall Study||44
7967526|NCT00347308|19613359|P1|NOT COMPLETED|Overall Study||0
7967527|NCT00347308|19613359|P1|COMPLETED|Overall Study||40
7967528|NCT00347308|19613359|P1|STARTED|Overall Study||40
7967529|NCT00347269|19613365|P2|NOT COMPLETED|Overall Study||106
7967530|NCT00347269|19613366|P1|NOT COMPLETED|Overall Study||94
7967531|NCT00347269|19613365|P2|COMPLETED|Overall Study||395
7967532|NCT00347269|19613366|P1|COMPLETED|Overall Study||409
7967533|NCT00347269|19613365|P2|STARTED|Overall Study||501
7967534|NCT00347269|19613366|P1|STARTED|Overall Study||503
7967535|NCT00347022|19613374|P2|NOT COMPLETED|Overall Study||5
7967536|NCT00347022|19613375|P1|NOT COMPLETED|Overall Study||12
7967537|NCT00347022|19613374|P2|COMPLETED|Overall Study||66
7967538|NCT00347022|19613375|P1|COMPLETED|Overall Study||62
7967539|NCT00347022|19613374|P2|STARTED|Overall Study||71
7967540|NCT00347022|19613375|P1|STARTED|Overall Study||74
7967541|NCT00347009|19613381|P1|NOT COMPLETED|Overall Study||27
7967542|NCT00347009|19613381|P1|COMPLETED|Overall Study||128
7967543|NCT00347009|19613381|P1|STARTED|Overall Study||155
7967544|NCT00346905|19613398|P1|NOT COMPLETED|Overall Study||4
7967545|NCT00346905|19613398|P1|COMPLETED|Overall Study||12
7967546|NCT00346905|19613398|P1|STARTED|Overall Study||16
7967547|NCT00346775|19613402|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
7967548|NCT00346775|19613403|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
7967549|NCT00346775|19613402|P2|COMPLETED|Period 3: Intervention Period 2||45
7967550|NCT00346775|19613403|P1|COMPLETED|Period 3: Intervention Period 2||44
7967551|NCT00346775|19613402|P2|STARTED|Period 3: Intervention Period 2||45
7967552|NCT00346775|19613403|P1|STARTED|Period 3: Intervention Period 2||44
7967553|NCT00346775|19613402|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
7967554|NCT00346775|19613403|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
7967555|NCT00346775|19613402|P2|COMPLETED|Period 2: Washout Period (7 Days)||45
7967556|NCT00346775|19613403|P1|COMPLETED|Period 2: Washout Period (7 Days)||44
7967557|NCT00346775|19613402|P2|STARTED|Period 2: Washout Period (7 Days)||45
7967558|NCT00346775|19613403|P1|STARTED|Period 2: Washout Period (7 Days)||44
7967559|NCT00346775|19613402|P2|NOT COMPLETED|Period 1: Intervention Period 1||3
7967560|NCT00346775|19613403|P1|NOT COMPLETED|Period 1: Intervention Period 1||5
7967561|NCT00346775|19613402|P2|COMPLETED|Period 1: Intervention Period 1||45
7967562|NCT00346775|19613403|P1|COMPLETED|Period 1: Intervention Period 1||44
7967563|NCT00346775|19613402|P2|STARTED|Period 1: Intervention Period 1||48
7967564|NCT00346775|19613403|P1|STARTED|Period 1: Intervention Period 1||49
7967565|NCT00346697|19613415|P2|NOT COMPLETED|Overall Study||1
7967566|NCT00346697|19613416|P1|NOT COMPLETED|Overall Study||0
7967567|NCT00346697|19613415|P2|COMPLETED|Overall Study||23
7967568|NCT00346697|19613416|P1|COMPLETED|Overall Study||24
7967569|NCT00346697|19613415|P2|STARTED|Overall Study||24
7967570|NCT00346697|19613416|P1|STARTED|Overall Study||24
7967571|NCT00346632|19613452|P10|NOT COMPLETED|Overall Study||3
7967572|NCT00346632|19613453|P9|NOT COMPLETED|Overall Study||4
7967573|NCT00346632|19613454|P8|NOT COMPLETED|Overall Study||4
7967574|NCT00346632|19613455|P7|NOT COMPLETED|Overall Study||5
7967575|NCT00346632|19613456|P6|NOT COMPLETED|Overall Study||2
7967576|NCT00346632|19613457|P5|NOT COMPLETED|Overall Study||4
7967577|NCT00346632|19613458|P4|NOT COMPLETED|Overall Study||3
7967578|NCT00346632|19613459|P3|NOT COMPLETED|Overall Study||6
7967579|NCT00346632|19613460|P2|NOT COMPLETED|Overall Study||3
7967580|NCT00346632|19613461|P1|NOT COMPLETED|Overall Study||3
7967581|NCT00346632|19613452|P10|COMPLETED|Overall Study||0
7967582|NCT00346632|19613453|P9|COMPLETED|Overall Study||0
7967583|NCT00346632|19613454|P8|COMPLETED|Overall Study||0
7967584|NCT00346632|19613455|P7|COMPLETED|Overall Study||0
7967585|NCT00346632|19613456|P6|COMPLETED|Overall Study||0
7967586|NCT00346632|19613457|P5|COMPLETED|Overall Study||0
7967587|NCT00346632|19613458|P4|COMPLETED|Overall Study||0
7967588|NCT00346632|19613459|P3|COMPLETED|Overall Study||0
7967589|NCT00346632|19613460|P2|COMPLETED|Overall Study||0
7967590|NCT00346632|19613461|P1|COMPLETED|Overall Study||0
7967591|NCT00346632|19613452|P10|STARTED|Overall Study||3
7967592|NCT00346632|19613453|P9|STARTED|Overall Study||4
7967593|NCT00346632|19613454|P8|STARTED|Overall Study||4
7967594|NCT00346632|19613455|P7|STARTED|Overall Study||5
7967595|NCT00346632|19613456|P6|STARTED|Overall Study||2
7967596|NCT00346632|19613457|P5|STARTED|Overall Study||4
7967597|NCT00346632|19613458|P4|STARTED|Overall Study||3
7967598|NCT00346632|19613459|P3|STARTED|Overall Study||6
7967599|NCT00346632|19613460|P2|STARTED|Overall Study||3
7967600|NCT00346632|19613461|P1|STARTED|Overall Study||3
7967601|NCT00346476|19613604|P1|NOT COMPLETED|Overall Study||0
7967602|NCT00346476|19613604|P1|COMPLETED|Overall Study||1250
7967603|NCT00346476|19613604|P1|STARTED|Overall Study||1250
7967604|NCT00346398|19613611|P2|NOT COMPLETED|Overall Study||2
7967605|NCT00346398|19613612|P1|NOT COMPLETED|Overall Study||3
7967606|NCT00346398|19613611|P2|COMPLETED|Overall Study||24
7967607|NCT00346398|19613612|P1|COMPLETED|Overall Study||22
7967608|NCT00346398|19613611|P2|STARTED|Overall Study||26
7967609|NCT00346398|19613612|P1|STARTED|Overall Study||25
7967610|NCT00346333|19613624|P2|NOT COMPLETED|Overall Study||8
7967611|NCT00346333|19613625|P1|NOT COMPLETED|Overall Study||5
7967612|NCT00346333|19613624|P2|COMPLETED|Overall Study||111
7967613|NCT00346333|19613625|P1|COMPLETED|Overall Study||116
7967614|NCT00346333|19613624|P2|STARTED|Overall Study||119
7967615|NCT00346333|19613625|P1|STARTED|Overall Study||121
7967616|NCT00346268|19613641|P2|NOT COMPLETED|Overall Study||3
7967617|NCT00346268|19613642|P1|NOT COMPLETED|Overall Study||2
7967618|NCT00346268|19613641|P2|COMPLETED|Overall Study||50
7967619|NCT00346268|19613642|P1|COMPLETED|Overall Study||50
7967620|NCT00346268|19613641|P2|STARTED|Overall Study||53
7967621|NCT00346268|19613642|P1|STARTED|Overall Study||52
7967622|NCT00346216|19613677|P3|NOT COMPLETED|Overall Study||2348
7967623|NCT00346216|19613678|P2|NOT COMPLETED|Overall Study||2460
7967624|NCT00346216|19613679|P1|NOT COMPLETED|Overall Study||2408
7967625|NCT00346216|19613677|P3|COMPLETED|Overall Study||5621
7967626|NCT00346216|19613678|P2|COMPLETED|Overall Study||5580
7967627|NCT00346216|19613679|P1|COMPLETED|Overall Study||5664
7967628|NCT00346216|19613677|P3|STARTED|Overall Study||7969
7967629|NCT00346216|19613678|P2|STARTED|Overall Study||8040
7967630|NCT00346216|19613679|P1|STARTED|Overall Study||8072
7967631|NCT00346164|19613700|P4|NOT COMPLETED|Overall Study||106
7967632|NCT00346164|19613701|P3|NOT COMPLETED|Overall Study||26
7967633|NCT00346164|19613702|P2|NOT COMPLETED|Overall Study||7
7967634|NCT00346164|19613703|P1|NOT COMPLETED|Overall Study||17
7967635|NCT00346164|19613700|P4|COMPLETED|Overall Study||117
7967636|NCT00346164|19613701|P3|COMPLETED|Overall Study||96
7967637|NCT00346164|19613702|P2|COMPLETED|Overall Study||14
7967638|NCT00346164|19613703|P1|COMPLETED|Overall Study||205
7967639|NCT00346164|19613700|P4|STARTED|Overall Study||223
7967640|NCT00346164|19613701|P3|STARTED|Overall Study||122
7967641|NCT00346164|19613702|P2|STARTED|Overall Study||21
7967642|NCT00346164|19613703|P1|STARTED|Overall Study||222
7967643|NCT00346151|19613738|P1|NOT COMPLETED|Overall Study||3
7967644|NCT00346151|19613738|P1|COMPLETED|Overall Study||2
7967645|NCT00346151|19613738|P1|STARTED|Overall Study||5
7967646|NCT00346073|19613758|P2|NOT COMPLETED|Overall Study||24
7967647|NCT00346073|19613759|P1|NOT COMPLETED|Overall Study||41
7967648|NCT00346073|19613758|P2|COMPLETED|Overall Study||738
7967649|NCT00346073|19613759|P1|COMPLETED|Overall Study||1481
7967650|NCT00346073|19613758|P2|STARTED|Overall Study||762
7967651|NCT00346073|19613759|P1|STARTED|Overall Study||1522
7967652|NCT00346034|19613793|P1|NOT COMPLETED|Overall Study||57
7967653|NCT00346034|19613793|P1|COMPLETED|Overall Study||300
7967654|NCT00346034|19613793|P1|STARTED|Overall Study||357
7967655|NCT00345969|19613800|P2|NOT COMPLETED|Overall Study||2
7967656|NCT00345969|19613801|P1|NOT COMPLETED|Overall Study||1
7967657|NCT00345969|19613800|P2|COMPLETED|Overall Study||11
7967658|NCT00345969|19613801|P1|COMPLETED|Overall Study||11
7967659|NCT00345969|19613800|P2|STARTED|Overall Study||13
7967660|NCT00345969|19613801|P1|STARTED|Overall Study||12
7967661|NCT00345878|19613833|P2|NOT COMPLETED|Overall Study||1
7967662|NCT00345878|19613834|P1|NOT COMPLETED|Overall Study||4
7967663|NCT00345878|19613833|P2|COMPLETED|Overall Study||135
7967664|NCT00345878|19613834|P1|COMPLETED|Overall Study||131
7967665|NCT00345878|19613833|P2|STARTED|Overall Study||136
7967666|NCT00345878|19613834|P1|STARTED|Overall Study||135
7967667|NCT00345865|19613855|P5|NOT COMPLETED|Overall Study||0
7967668|NCT00345865|19613856|P4|NOT COMPLETED|Overall Study||0
7967669|NCT00345865|19613857|P3|NOT COMPLETED|Overall Study||0
7967670|NCT00345865|19613858|P2|NOT COMPLETED|Overall Study||0
7967671|NCT00345865|19613859|P1|NOT COMPLETED|Overall Study||0
7967672|NCT00345865|19613855|P5|COMPLETED|Overall Study||146
7967673|NCT00345865|19613856|P4|COMPLETED|Overall Study||5
7967674|NCT00345865|19613857|P3|COMPLETED|Overall Study||2
7967675|NCT00345865|19613858|P2|COMPLETED|Overall Study||149
7967676|NCT00345865|19613859|P1|COMPLETED|Overall Study||171
7967677|NCT00345865|19613855|P5|STARTED|Overall Study||146
7967678|NCT00345865|19613856|P4|STARTED|Overall Study||5
7967679|NCT00345865|19613857|P3|STARTED|Overall Study||2
7967680|NCT00345865|19613858|P2|STARTED|Overall Study||149
7967681|NCT00345865|19613859|P1|STARTED|Overall Study||171
7967682|NCT00345839|19613893|P2|NOT COMPLETED|Overall Study||159
7967683|NCT00345839|19613894|P1|NOT COMPLETED|Overall Study||149
7967684|NCT00345839|19613893|P2|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776
7967685|NCT00345839|19613894|P1|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799
7967686|NCT00345839|19613893|P2|STARTED|Overall Study|Randomized to placebo|1935
7967687|NCT00345839|19613894|P1|STARTED|Overall Study|Randomized to cinacalcet|1948
7967688|NCT00345683|19613920|P2|NOT COMPLETED|Overall Study||9
7967689|NCT00345683|19613921|P1|NOT COMPLETED|Overall Study||25
7967690|NCT00345683|19613920|P2|COMPLETED|Overall Study||1001
7967691|NCT00345683|19613921|P1|COMPLETED|Overall Study||2985
7967692|NCT00345683|19613920|P2|STARTED|Overall Study||1010
7967693|NCT00345683|19613921|P1|STARTED|Overall Study||3010
7967694|NCT00345631|19613944|P3|NOT COMPLETED|Overall Study||6
7967695|NCT00345631|19613945|P2|NOT COMPLETED|Overall Study||8
7967696|NCT00345631|19613946|P1|NOT COMPLETED|Overall Study||4
7967697|NCT00345631|19613944|P3|COMPLETED|Overall Study||128
7967698|NCT00345631|19613945|P2|COMPLETED|Overall Study||259
7967699|NCT00345631|19613946|P1|COMPLETED|Overall Study||83
7967700|NCT00345631|19613944|P3|STARTED|Overall Study||134
7967701|NCT00345631|19613945|P2|STARTED|Overall Study||267
7967702|NCT00345631|19613946|P1|STARTED|Overall Study||87
7967703|NCT00345605|19613978|P2|NOT COMPLETED|Arm 2, Opposite Treatment||0
7967704|NCT00345605|19613979|P1|NOT COMPLETED|Arm 2, Opposite Treatment||1
7967705|NCT00345605|19613978|P2|COMPLETED|Arm 2, Opposite Treatment||6
7967706|NCT00345605|19613979|P1|COMPLETED|Arm 2, Opposite Treatment||5
7967707|NCT00345605|19613978|P2|STARTED|Arm 2, Opposite Treatment||6
7967708|NCT00345605|19613979|P1|STARTED|Arm 2, Opposite Treatment||6
7967709|NCT00345605|19613978|P2|NOT COMPLETED|Crossover Wash-out||0
7967710|NCT00345605|19613979|P1|NOT COMPLETED|Crossover Wash-out||0
7967711|NCT00345605|19613978|P2|COMPLETED|Crossover Wash-out||6
7967712|NCT00345605|19613979|P1|COMPLETED|Crossover Wash-out||6
7967713|NCT00345605|19613978|P2|STARTED|Crossover Wash-out||6
7967714|NCT00345605|19613979|P1|STARTED|Crossover Wash-out||6
7967715|NCT00345605|19613978|P2|NOT COMPLETED|Interval||0
7967716|NCT00345605|19613979|P1|NOT COMPLETED|Interval||0
7967717|NCT00345605|19613978|P2|COMPLETED|Interval||6
7967718|NCT00345605|19613979|P1|COMPLETED|Interval||6
7967719|NCT00345605|19613978|P2|STARTED|Interval||6
7967720|NCT00345605|19613979|P1|STARTED|Interval||6
7967721|NCT00345605|19613978|P2|NOT COMPLETED|Arm 1||1
7967722|NCT00345605|19613979|P1|NOT COMPLETED|Arm 1||0
7967723|NCT00345605|19613978|P2|COMPLETED|Arm 1||5
7967724|NCT00345605|19613979|P1|COMPLETED|Arm 1||6
7967725|NCT00345605|19613978|P2|STARTED|Arm 1||6
7967726|NCT00345605|19613979|P1|STARTED|Arm 1||6
7967727|NCT00345605|19613978|P2|NOT COMPLETED|Initial Washout||0
7967728|NCT00345605|19613979|P1|NOT COMPLETED|Initial Washout||0
7967729|NCT00345605|19613978|P2|COMPLETED|Initial Washout||6
7967730|NCT00345605|19613979|P1|COMPLETED|Initial Washout||6
7967731|NCT00345605|19613978|P2|STARTED|Initial Washout||6
7967732|NCT00345605|19613979|P1|STARTED|Initial Washout||6
7967733|NCT00345592|19613999|P2|NOT COMPLETED|Overall Study||24
7967734|NCT00345592|19614000|P1|NOT COMPLETED|Overall Study||25
7967735|NCT00345592|19613999|P2|COMPLETED|Overall Study||173
7967736|NCT00345592|19614000|P1|COMPLETED|Overall Study||174
7967737|NCT00345592|19613999|P2|STARTED|Overall Study||197
7967738|NCT00345592|19614000|P1|STARTED|Overall Study||199
7967739|NCT00345579|19614008|P2|NOT COMPLETED|Overall Study||65
7967740|NCT00345579|19614009|P1|NOT COMPLETED|Overall Study||164
7967741|NCT00345579|19614008|P2|COMPLETED|Overall Study||1048
7967742|NCT00345579|19614009|P1|COMPLETED|Overall Study||3114
7967743|NCT00345579|19614008|P2|STARTED|Overall Study||1113
7967744|NCT00345579|19614009|P1|STARTED|Overall Study||3278
7967745|NCT00345540|19614029|P1|NOT COMPLETED|Overall Study||1
7967746|NCT00345540|19614029|P1|COMPLETED|Overall Study||15
7967747|NCT00345540|19614029|P1|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16
7967748|NCT00345397|19614035|P1|NOT COMPLETED|Overall Study||1
7967749|NCT00345397|19614035|P1|COMPLETED|Overall Study||6
7967750|NCT00345397|19614035|P1|STARTED|Overall Study||7
7967751|NCT00345384|19614042|P2|NOT COMPLETED|Overall Study||0
7967752|NCT00345384|19614043|P1|NOT COMPLETED|Overall Study||0
7967753|NCT00345384|19614042|P2|COMPLETED|Overall Study||19
7967754|NCT00345384|19614043|P1|COMPLETED|Overall Study||19
7967755|NCT00345384|19614042|P2|STARTED|Overall Study||19
7967756|NCT00345384|19614043|P1|STARTED|Overall Study||19
7967757|NCT00345371|19614053|P2|NOT COMPLETED|Overall Study||33
7967758|NCT00345371|19614054|P1|NOT COMPLETED|Overall Study||30
7967759|NCT00345371|19614053|P2|COMPLETED|Overall Study||38
7967760|NCT00345371|19614054|P1|COMPLETED|Overall Study||39
7967761|NCT00345371|19614053|P2|STARTED|Overall Study||71
7967762|NCT00345371|19614054|P1|STARTED|Overall Study||69
7967763|NCT00345358|19614066|P4|NOT COMPLETED|Booster Vaccination Phase||0
7967764|NCT00345358|19614067|P3|NOT COMPLETED|Booster Vaccination Phase||0
7967765|NCT00345358|19614068|P2|NOT COMPLETED|Booster Vaccination Phase||0
7967766|NCT00345358|19614069|P1|NOT COMPLETED|Booster Vaccination Phase||4
7967767|NCT00345358|19614066|P4|COMPLETED|Booster Vaccination Phase||0
7967768|NCT00345358|19614067|P3|COMPLETED|Booster Vaccination Phase||0
7967769|NCT00345358|19614068|P2|COMPLETED|Booster Vaccination Phase||145
7967770|NCT00345358|19614069|P1|COMPLETED|Booster Vaccination Phase||141
7967771|NCT00345358|19614066|P4|STARTED|Booster Vaccination Phase||0
7967772|NCT00345358|19614067|P3|STARTED|Booster Vaccination Phase||0
7967773|NCT00345358|19614068|P2|STARTED|Booster Vaccination Phase||145
7967774|NCT00345358|19614069|P1|STARTED|Booster Vaccination Phase||145
7967775|NCT00345358|19614066|P4|NOT COMPLETED|Primary Vaccination Phase||2
7967776|NCT00345358|19614067|P3|NOT COMPLETED|Primary Vaccination Phase||8
7967777|NCT00345358|19614068|P2|NOT COMPLETED|Primary Vaccination Phase||4
7967778|NCT00345358|19614069|P1|NOT COMPLETED|Primary Vaccination Phase||5
7967779|NCT00345358|19614066|P4|COMPLETED|Primary Vaccination Phase||148
7967780|NCT00345358|19614067|P3|COMPLETED|Primary Vaccination Phase||142
7967781|NCT00345358|19614068|P2|COMPLETED|Primary Vaccination Phase||146
7967782|NCT00345358|19614069|P1|COMPLETED|Primary Vaccination Phase||145
7967783|NCT00345358|19614066|P4|STARTED|Primary Vaccination Phase||150
7967784|NCT00345358|19614067|P3|STARTED|Primary Vaccination Phase||150
7967785|NCT00345358|19614068|P2|STARTED|Primary Vaccination Phase||150
7967786|NCT00345358|19614069|P1|STARTED|Primary Vaccination Phase||150
7967787|NCT00345345|19614144|P1|NOT COMPLETED|Overall Study||2
7967788|NCT00345345|19614144|P1|COMPLETED|Overall Study||27
7967789|NCT00345345|19614144|P1|STARTED|Overall Study||29
7967790|NCT00345332|19614150|P2|NOT COMPLETED|Overall Study||0
7967791|NCT00345332|19614151|P1|NOT COMPLETED|Overall Study||0
7967792|NCT00345332|19614150|P2|COMPLETED|Overall Study||20
7967793|NCT00345332|19614151|P1|COMPLETED|Overall Study||11
7967794|NCT00345332|19614150|P2|STARTED|Overall Study||20
7967795|NCT00345332|19614151|P1|STARTED|Overall Study||11
7967796|NCT00345293|19614159|P2|NOT COMPLETED|Overall Study||0
7967797|NCT00345293|19614160|P1|NOT COMPLETED|Overall Study||2
7967798|NCT00345293|19614159|P2|COMPLETED|Overall Study||3
7967799|NCT00345293|19614160|P1|COMPLETED|Overall Study||8
7967800|NCT00345293|19614159|P2|STARTED|Overall Study||3
7967801|NCT00345293|19614160|P1|STARTED|Overall Study||10
7967802|NCT00345254|19614169|P2|NOT COMPLETED|Overall Study||0
7967803|NCT00345254|19614170|P1|NOT COMPLETED|Overall Study||0
7967804|NCT00345254|19614169|P2|COMPLETED|Overall Study||30
7967805|NCT00345254|19614170|P1|COMPLETED|Overall Study||30
7967806|NCT00345254|19614169|P2|STARTED|Overall Study||30
7967807|NCT00345254|19614170|P1|STARTED|Overall Study||30
7967808|NCT00345176|19614180|P4|NOT COMPLETED|Overall Study||10
7967809|NCT00345176|19614181|P3|NOT COMPLETED|Overall Study||6
7967810|NCT00345176|19614182|P2|NOT COMPLETED|Overall Study||6
7967811|NCT00345176|19614183|P1|NOT COMPLETED|Overall Study||5
7967812|NCT00345176|19614180|P4|COMPLETED|Overall Study||1069
7967813|NCT00345176|19614181|P3|COMPLETED|Overall Study||1062
7967814|NCT00345176|19614182|P2|COMPLETED|Overall Study||1038
7967815|NCT00345176|19614183|P1|COMPLETED|Overall Study||1007
7967816|NCT00345176|19614180|P4|STARTED|Overall Study||1079
7967817|NCT00345176|19614181|P3|STARTED|Overall Study||1068
7967818|NCT00345176|19614182|P2|STARTED|Overall Study||1044
7967819|NCT00345176|19614183|P1|STARTED|Overall Study||1012
7967820|NCT00345046|19614206|P3|NOT COMPLETED|Overall Study||2
7967821|NCT00345046|19614207|P2|NOT COMPLETED|Overall Study||1
7967822|NCT00345046|19614208|P1|NOT COMPLETED|Overall Study||1
7967823|NCT00345046|19614206|P3|COMPLETED|Overall Study||14
7967824|NCT00345046|19614207|P2|COMPLETED|Overall Study||21
7967825|NCT00345046|19614208|P1|COMPLETED|Overall Study||17
7967826|NCT00345046|19614206|P3|STARTED|Overall Study||16
7967827|NCT00345046|19614207|P2|STARTED|Overall Study||22
7967828|NCT00345046|19614208|P1|STARTED|Overall Study||18
7967829|NCT00345033|19614218|P2|NOT COMPLETED|Overall Study||4
7967830|NCT00345033|19614219|P1|NOT COMPLETED|Overall Study||4
7967831|NCT00345033|19614218|P2|COMPLETED|Overall Study||14
7967832|NCT00345033|19614219|P1|COMPLETED|Overall Study||16
7967833|NCT00345033|19614218|P2|STARTED|Overall Study||18
7967834|NCT00345033|19614219|P1|STARTED|Overall Study||20
7967835|NCT00344968|19614238|P3|NOT COMPLETED|Overall Study||116
7967836|NCT00344968|19614239|P2|NOT COMPLETED|Overall Study||102
7967837|NCT00344968|19614240|P1|NOT COMPLETED|Overall Study||59
7967838|NCT00344968|19614238|P3|COMPLETED|Overall Study||279
7967839|NCT00344968|19614239|P2|COMPLETED|Overall Study||274
7967840|NCT00344968|19614240|P1|COMPLETED|Overall Study||126
7967841|NCT00344968|19614238|P3|STARTED|Overall Study||395
7967842|NCT00344968|19614239|P2|STARTED|Overall Study||376
7967843|NCT00344968|19614240|P1|STARTED|Overall Study||185
7967844|NCT00344773|19614251|P1|NOT COMPLETED|Overall Study||21
7967845|NCT00344773|19614251|P1|COMPLETED|Overall Study||25
7967846|NCT00344773|19614251|P1|STARTED|Overall Study||46
7967847|NCT00344682|19614259|P2|NOT COMPLETED|Overall Study||1
7967848|NCT00344682|19614260|P1|NOT COMPLETED|Overall Study||4
7967849|NCT00344682|19614259|P2|COMPLETED|Overall Study||14
7967850|NCT00344682|19614260|P1|COMPLETED|Overall Study||12
7967851|NCT00344682|19614259|P2|STARTED|Overall Study||15
7967852|NCT00344682|19614260|P1|STARTED|Overall Study||16
7967853|NCT00344500|19614274|P3|NOT COMPLETED|Overall Study||2
7967854|NCT00344500|19614275|P2|NOT COMPLETED|Overall Study||35
7967855|NCT00344500|19614276|P1|NOT COMPLETED|Overall Study||23
7967856|NCT00344500|19614274|P3|COMPLETED|Overall Study||12
7967857|NCT00344500|19614275|P2|COMPLETED|Overall Study||25
7967858|NCT00344500|19614276|P1|COMPLETED|Overall Study||25
7967859|NCT00344500|19614274|P3|STARTED|Overall Study||14
7967860|NCT00344500|19614275|P2|STARTED|Overall Study||60
7967861|NCT00344500|19614276|P1|STARTED|Overall Study||48
7967862|NCT00344487|19614287|P1|NOT COMPLETED|Overall Study||1
7967863|NCT00344487|19614287|P1|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2
7967864|NCT00344487|19614287|P1|STARTED|Overall Study||3
7967865|NCT00344461|19614291|P1|NOT COMPLETED|Overall Study||21
7967866|NCT00344461|19614291|P1|COMPLETED|Overall Study||33
7967867|NCT00344461|19614291|P1|STARTED|Overall Study||54
7967868|NCT00344448|19614302|P2|NOT COMPLETED|Open Label||1
7967869|NCT00344448|19614303|P1|NOT COMPLETED|Open Label||2
7967870|NCT00344448|19614302|P2|COMPLETED|Open Label||2
7967871|NCT00344448|19614303|P1|COMPLETED|Open Label||2
7967872|NCT00344448|19614302|P2|STARTED|Open Label||3
7967873|NCT00344448|19614303|P1|STARTED|Open Label||4
7967874|NCT00344448|19614302|P2|NOT COMPLETED|Double Blind, Placebo Controlled||0
7967875|NCT00344448|19614303|P1|NOT COMPLETED|Double Blind, Placebo Controlled||2
7967876|NCT00344448|19614302|P2|COMPLETED|Double Blind, Placebo Controlled||3
7967877|NCT00344448|19614303|P1|COMPLETED|Double Blind, Placebo Controlled||4
7967878|NCT00344448|19614302|P2|STARTED|Double Blind, Placebo Controlled||3
7967879|NCT00344448|19614303|P1|STARTED|Double Blind, Placebo Controlled||6
7967880|NCT00344448|19614302|P2|NOT COMPLETED|Screening||1
7967881|NCT00344448|19614303|P1|NOT COMPLETED|Screening||0
7967882|NCT00344448|19614302|P2|COMPLETED|Screening||3
7967883|NCT00344448|19614303|P1|COMPLETED|Screening||6
7967884|NCT00344448|19614302|P2|STARTED|Screening||4
7967885|NCT00344448|19614303|P1|STARTED|Screening|No randomization during the screening phase|6
7967886|NCT00344370|19614311|P2|NOT COMPLETED|Overall Study||3
7967887|NCT00344370|19614312|P1|NOT COMPLETED|Overall Study||15
7967888|NCT00344370|19614311|P2|COMPLETED|Overall Study||68
7967889|NCT00344370|19614312|P1|COMPLETED|Overall Study||128
7967890|NCT00344370|19614311|P2|STARTED|Overall Study||71
7967891|NCT00344370|19614312|P1|STARTED|Overall Study||143
7967892|NCT00344318|19614324|P4|NOT COMPLETED|Overall Study||3
7967893|NCT00344318|19614325|P3|NOT COMPLETED|Overall Study||1
7967894|NCT00344318|19614326|P2|NOT COMPLETED|Overall Study||5
7967895|NCT00344318|19614327|P1|NOT COMPLETED|Overall Study||4
7967896|NCT00344318|19614324|P4|COMPLETED|Overall Study||100
7967897|NCT00344318|19614325|P3|COMPLETED|Overall Study||99
7967898|NCT00344318|19614326|P2|COMPLETED|Overall Study||298
7967899|NCT00344318|19614327|P1|COMPLETED|Overall Study||296
7967900|NCT00344318|19614324|P4|STARTED|Overall Study||103
7967901|NCT00344318|19614325|P3|STARTED|Overall Study||100
7967902|NCT00344318|19614326|P2|STARTED|Overall Study||303
7967903|NCT00344318|19614327|P1|STARTED|Overall Study||300
7967904|NCT00344305|19614449|P2|NOT COMPLETED|Overall Study||1
7967905|NCT00344305|19614450|P1|NOT COMPLETED|Overall Study||2
7967906|NCT00344305|19614449|P2|COMPLETED|Overall Study||99
7967907|NCT00344305|19614450|P1|COMPLETED|Overall Study||98
7967908|NCT00344305|19614449|P2|STARTED|Overall Study||100
7967909|NCT00344305|19614450|P1|STARTED|Overall Study||100
7967910|NCT00344175|19614487|P2|NOT COMPLETED|Overall Study||10
7967911|NCT00344175|19614488|P1|NOT COMPLETED|Overall Study||12
7967912|NCT00344175|19614487|P2|COMPLETED|Overall Study||47
7967913|NCT00344175|19614488|P1|COMPLETED|Overall Study||109
7967914|NCT00344175|19614487|P2|STARTED|Overall Study||57
7967915|NCT00344175|19614488|P1|STARTED|Overall Study||121
7967916|NCT00344032|19614500|P2|NOT COMPLETED|Overall Study||10
7967917|NCT00344032|19614501|P1|NOT COMPLETED|Overall Study||14
7967918|NCT00344032|19614500|P2|COMPLETED|Overall Study||168
7967919|NCT00344032|19614501|P1|COMPLETED|Overall Study||162
7967920|NCT00344032|19614500|P2|STARTED|Overall Study||178
7967921|NCT00344032|19614501|P1|STARTED|Overall Study||176
7967922|NCT00344019|19614520|P3|NOT COMPLETED|Overall Study||74
7967923|NCT00344019|19614521|P2|NOT COMPLETED|Overall Study||0
7967924|NCT00344019|19614522|P1|NOT COMPLETED|Overall Study||0
7967925|NCT00344019|19614520|P3|COMPLETED|Overall Study||0
7967926|NCT00344019|19614521|P2|COMPLETED|Overall Study||11
7967927|NCT00344019|19614522|P1|COMPLETED|Overall Study||12
7967928|NCT00344019|19614520|P3|STARTED|Overall Study||74
7967929|NCT00344019|19614521|P2|STARTED|Overall Study||11
7967930|NCT00344019|19614522|P1|STARTED|Overall Study||12
7967931|NCT00343915|19614540|P2|NOT COMPLETED|Month 66 Follow-up||0
7967932|NCT00343915|19614541|P1|NOT COMPLETED|Month 66 Follow-up||0
7967933|NCT00343915|19614540|P2|COMPLETED|Month 66 Follow-up||76
7967934|NCT00343915|19614541|P1|COMPLETED|Month 66 Follow-up||158
7967935|NCT00343915|19614540|P2|STARTED|Month 66 Follow-up||76
7967936|NCT00343915|19614541|P1|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158
7967937|NCT00343915|19614540|P2|NOT COMPLETED|Month 54 Follow-up||0
7967938|NCT00343915|19614541|P1|NOT COMPLETED|Month 54 Follow-up||0
7967939|NCT00343915|19614540|P2|COMPLETED|Month 54 Follow-up||79
7967940|NCT00343915|19614541|P1|COMPLETED|Month 54 Follow-up||166
7967941|NCT00343915|19614540|P2|STARTED|Month 54 Follow-up||79
7967942|NCT00343915|19614541|P1|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166
7967943|NCT00343915|19614540|P2|NOT COMPLETED|Month 42 Follow-up||0
7967944|NCT00343915|19614541|P1|NOT COMPLETED|Month 42 Follow-up||0
7967945|NCT00343915|19614540|P2|COMPLETED|Month 42 Follow-up||84
7967946|NCT00343915|19614541|P1|COMPLETED|Month 42 Follow-up||174
7967947|NCT00343915|19614540|P2|STARTED|Month 42 Follow-up||84
7967948|NCT00343915|19614541|P1|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174
7967949|NCT00343915|19614540|P2|NOT COMPLETED|Month 30 Follow-up||0
7967950|NCT00343915|19614541|P1|NOT COMPLETED|Month 30 Follow-up||0
7967951|NCT00343915|19614540|P2|COMPLETED|Month 30 Follow-up||88
7967952|NCT00343915|19614541|P1|COMPLETED|Month 30 Follow-up||179
7967953|NCT00343915|19614540|P2|STARTED|Month 30 Follow-up||88
7967954|NCT00343915|19614541|P1|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179
7967955|NCT00343915|19614540|P2|NOT COMPLETED|Primary Study||3
7967956|NCT00343915|19614541|P1|NOT COMPLETED|Primary Study||4
7967957|NCT00343915|19614540|P2|COMPLETED|Primary Study||123
7967958|NCT00343915|19614541|P1|COMPLETED|Primary Study||254
7967959|NCT00343915|19614540|P2|STARTED|Primary Study||126
7967960|NCT00343915|19614541|P1|STARTED|Primary Study||258
7967961|NCT00343889|19614567|P2|NOT COMPLETED|Overall Study||1
7967962|NCT00343889|19614568|P1|NOT COMPLETED|Overall Study||3
7967963|NCT00343889|19614567|P2|COMPLETED|Overall Study||188
7967964|NCT00343889|19614568|P1|COMPLETED|Overall Study||187
7967965|NCT00343889|19614567|P2|STARTED|Overall Study||189
7967966|NCT00343889|19614568|P1|STARTED|Overall Study||190
7967967|NCT00343863|19614586|P2|NOT COMPLETED|Overall Study||0
7967968|NCT00343863|19614587|P1|NOT COMPLETED|Overall Study||0
7967969|NCT00343863|19614586|P2|COMPLETED|Overall Study||34
7967970|NCT00343863|19614587|P1|COMPLETED|Overall Study||7
7967971|NCT00343863|19614586|P2|STARTED|Overall Study||34
7967972|NCT00343863|19614587|P1|STARTED|Overall Study||7
7967973|NCT00343785|19614609|P1|NOT COMPLETED|Overall Study||0
7967974|NCT00343785|19614609|P1|COMPLETED|Overall Study||21
7967975|NCT00343785|19614609|P1|STARTED|Overall Study||21
7967976|NCT00343564|19614626|P11|NOT COMPLETED|Overall Study||0
7967977|NCT00343564|19614627|P10|NOT COMPLETED|Overall Study||0
7967978|NCT00343564|19614628|P9|NOT COMPLETED|Overall Study||0
7967979|NCT00343564|19614629|P8|NOT COMPLETED|Overall Study||0
7967980|NCT00343564|19614630|P7|NOT COMPLETED|Overall Study||0
7967981|NCT00343564|19614631|P6|NOT COMPLETED|Overall Study||0
7967982|NCT00343564|19614632|P5|NOT COMPLETED|Overall Study||0
7967983|NCT00343564|19614633|P4|NOT COMPLETED|Overall Study||0
7967984|NCT00343564|19614634|P3|NOT COMPLETED|Overall Study||0
7967985|NCT00343564|19614635|P2|NOT COMPLETED|Overall Study||0
7967986|NCT00343564|19614636|P1|NOT COMPLETED|Overall Study||0
7967987|NCT00343564|19614626|P11|COMPLETED|Overall Study||8
7967988|NCT00343564|19614627|P10|COMPLETED|Overall Study||8
7967989|NCT00343564|19614628|P9|COMPLETED|Overall Study||3
7967990|NCT00343564|19614629|P8|COMPLETED|Overall Study||3
7967991|NCT00343564|19614630|P7|COMPLETED|Overall Study||4
7967992|NCT00343564|19614631|P6|COMPLETED|Overall Study||9
7967993|NCT00343564|19614632|P5|COMPLETED|Overall Study||10
7967994|NCT00343564|19614633|P4|COMPLETED|Overall Study||7
7967995|NCT00343564|19614634|P3|COMPLETED|Overall Study||3
7967996|NCT00343564|19614635|P2|COMPLETED|Overall Study||7
7967997|NCT00343564|19614636|P1|COMPLETED|Overall Study||6
7967998|NCT00343564|19614626|P11|STARTED|Overall Study||8
7967999|NCT00343564|19614627|P10|STARTED|Overall Study||8
7968000|NCT00343564|19614628|P9|STARTED|Overall Study||3
7968001|NCT00343564|19614629|P8|STARTED|Overall Study||3
7968002|NCT00343564|19614630|P7|STARTED|Overall Study||4
7968003|NCT00343564|19614631|P6|STARTED|Overall Study||9
7968004|NCT00343564|19614632|P5|STARTED|Overall Study||10
7968005|NCT00343564|19614633|P4|STARTED|Overall Study||7
7968006|NCT00343564|19614634|P3|STARTED|Overall Study||3
7968007|NCT00343564|19614635|P2|STARTED|Overall Study||7
7968008|NCT00343564|19614636|P1|STARTED|Overall Study||6
7968009|NCT00343512|19614732|P1|NOT COMPLETED|Overall Study||2
7968010|NCT00343512|19614732|P1|COMPLETED|Overall Study||32
7968011|NCT00343512|19614732|P1|STARTED|Overall Study||34
7968012|NCT00343460|19614744|P3|NOT COMPLETED|Cycle 2 - 4||0
7968013|NCT00343460|19614745|P2|NOT COMPLETED|Cycle 2 - 4||50
7968014|NCT00343460|19614746|P1|NOT COMPLETED|Cycle 2 - 4||56
7968015|NCT00343460|19614744|P3|COMPLETED|Cycle 2 - 4||0
7968016|NCT00343460|19614745|P2|COMPLETED|Cycle 2 - 4||515
7968017|NCT00343460|19614746|P1|COMPLETED|Cycle 2 - 4||528
7968018|NCT00343460|19614744|P3|STARTED|Cycle 2 - 4||0
7968019|NCT00343460|19614745|P2|STARTED|Cycle 2 - 4||565
7968020|NCT00343460|19614746|P1|STARTED|Cycle 2 - 4||584
7968021|NCT00343460|19614744|P3|NOT COMPLETED|Cycle 1||18
7968022|NCT00343460|19614745|P2|NOT COMPLETED|Cycle 1||22
7968023|NCT00343460|19614746|P1|NOT COMPLETED|Cycle 1||22
7968024|NCT00343460|19614744|P3|COMPLETED|Cycle 1||454
7968025|NCT00343460|19614745|P2|COMPLETED|Cycle 1||459
7968026|NCT00343460|19614746|P1|COMPLETED|Cycle 1||453
7968027|NCT00343460|19614744|P3|STARTED|Cycle 1||472
7968028|NCT00343460|19614745|P2|STARTED|Cycle 1||481
7968029|NCT00343460|19614746|P1|STARTED|Cycle 1||475
7968030|NCT00343382|19614820|P3|NOT COMPLETED|Overall Study||17
7968031|NCT00343382|19614821|P2|NOT COMPLETED|Overall Study||14
7968032|NCT00343382|19614822|P1|NOT COMPLETED|Overall Study||4
7968033|NCT00343382|19614820|P3|COMPLETED|Overall Study||49
7968034|NCT00343382|19614821|P2|COMPLETED|Overall Study||51
7968035|NCT00343382|19614822|P1|COMPLETED|Overall Study||60
7968036|NCT00343382|19614820|P3|STARTED|Overall Study||66
7968037|NCT00343382|19614821|P2|STARTED|Overall Study||65
7968038|NCT00343382|19614822|P1|STARTED|Overall Study||64
7968039|NCT00343291|19614841|P2|NOT COMPLETED|Overall Study||56
7968040|NCT00343291|19614842|P1|NOT COMPLETED|Overall Study||57
7968041|NCT00343291|19614841|P2|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5
7968042|NCT00343291|19614842|P1|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3
7968043|NCT00343291|19614841|P2|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
7968044|NCT00343291|19614842|P1|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
7968045|NCT00343291|19614841|P2|STARTED|Overall Study||61
7968046|NCT00343291|19614842|P1|STARTED|Overall Study||60
7968047|NCT00343252|19614858|P2|NOT COMPLETED|18 Months (All Treated Participants)||81
7968048|NCT00343252|19614859|P1|NOT COMPLETED|18 Months (All Treated Participants)||101
7968049|NCT00343252|19614858|P2|COMPLETED|18 Months (All Treated Participants)||269
7968050|NCT00343252|19614859|P1|COMPLETED|18 Months (All Treated Participants)||259
7968051|NCT00343252|19614858|P2|STARTED|18 Months (All Treated Participants)||350
7968052|NCT00343252|19614859|P1|STARTED|18 Months (All Treated Participants)||360
7968053|NCT00343252|19614858|P2|NOT COMPLETED|12 Months (All Treated Participants)||69
7968054|NCT00343252|19614859|P1|NOT COMPLETED|12 Months (All Treated Participants)||86
7968055|NCT00343252|19614858|P2|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281
7968056|NCT00343252|19614859|P1|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274
7968057|NCT00343252|19614858|P2|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
7968058|NCT00343252|19614859|P1|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
7968059|NCT00343252|19614858|P2|NOT COMPLETED|6 Months (All Treated Participants)||44
7968060|NCT00343252|19614859|P1|NOT COMPLETED|6 Months (All Treated Participants)||56
7968061|NCT00343252|19614858|P2|COMPLETED|6 Months (All Treated Participants)||306
7968062|NCT00343252|19614859|P1|COMPLETED|6 Months (All Treated Participants)||304
7968063|NCT00343252|19614858|P2|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
7968064|NCT00343252|19614859|P1|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
7968065|NCT00343252|19614858|P2|NOT COMPLETED|All Randomized Participants||82
7968066|NCT00343252|19614859|P1|NOT COMPLETED|All Randomized Participants||102
7968067|NCT00343252|19614858|P2|COMPLETED|All Randomized Participants||269
7968068|NCT00343252|19614859|P1|COMPLETED|All Randomized Participants||259
7968069|NCT00343252|19614858|P2|STARTED|All Randomized Participants||351
7968070|NCT00343252|19614859|P1|STARTED|All Randomized Participants||361
7968071|NCT00343083|19614905|P1|NOT COMPLETED|Overall Study||21
7968072|NCT00343083|19614905|P1|COMPLETED|Overall Study||22
7968073|NCT00343083|19614905|P1|STARTED|Overall Study||43
7968074|NCT00343044|19614914|P1|NOT COMPLETED|Overall Study||0
7968075|NCT00343044|19614914|P1|COMPLETED|Overall Study||40
7968076|NCT00343044|19614914|P1|STARTED|Overall Study||40
7968077|NCT00342628|19614924|P3|NOT COMPLETED|Overall Study||19
7968078|NCT00342628|19614925|P2|NOT COMPLETED|Overall Study||21
7968079|NCT00342628|19614926|P1|NOT COMPLETED|Overall Study||20
7968080|NCT00342628|19614924|P3|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81
7968081|NCT00342628|19614925|P2|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80
7968082|NCT00342628|19614926|P1|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80
7968083|NCT00342628|19614924|P3|STARTED|Overall Study||100
7968084|NCT00342628|19614925|P2|STARTED|Overall Study||101
7968085|NCT00342628|19614926|P1|STARTED|Overall Study||100
7968086|NCT00342563|19614947|P4|NOT COMPLETED|Overall Study||6
7968087|NCT00342563|19614948|P3|NOT COMPLETED|Overall Study||14
7968088|NCT00342563|19614949|P2|NOT COMPLETED|Overall Study||8
7968089|NCT00342563|19614950|P1|NOT COMPLETED|Overall Study||6
7968090|NCT00342563|19614947|P4|COMPLETED|Overall Study||22
7968091|NCT00342563|19614948|P3|COMPLETED|Overall Study||26
7968092|NCT00342563|19614949|P2|COMPLETED|Overall Study||19
7968093|NCT00342563|19614950|P1|COMPLETED|Overall Study||35
7968094|NCT00342563|19614947|P4|STARTED|Overall Study||28
7968095|NCT00342563|19614948|P3|STARTED|Overall Study||40
7968096|NCT00342563|19614949|P2|STARTED|Overall Study||27
7968097|NCT00342563|19614950|P1|STARTED|Overall Study||41
7968098|NCT00342355|19614970|P4|NOT COMPLETED|Overall Study||0
7968099|NCT00342355|19614971|P3|NOT COMPLETED|Overall Study||0
7968100|NCT00342355|19614972|P2|NOT COMPLETED|Overall Study||0
7968101|NCT00342355|19614973|P1|NOT COMPLETED|Overall Study||0
7968102|NCT00342355|19614970|P4|COMPLETED|Overall Study||443
7968103|NCT00342355|19614971|P3|COMPLETED|Overall Study||444
7968104|NCT00342355|19614972|P2|COMPLETED|Overall Study||440
7968105|NCT00342355|19614973|P1|COMPLETED|Overall Study||444
7968106|NCT00342355|19614970|P4|STARTED|Overall Study||443
7968107|NCT00342355|19614971|P3|STARTED|Overall Study||444
7968108|NCT00342355|19614972|P2|STARTED|Overall Study||440
7968109|NCT00342355|19614973|P1|STARTED|Overall Study||444
7968110|NCT00340834|19614992|P5|NOT COMPLETED|Extension Phase of Study||44
7968111|NCT00340834|19614993|P4|NOT COMPLETED|Extension Phase of Study||53
7968112|NCT00340834|19614994|P3|NOT COMPLETED|Extension Phase of Study||0
7968113|NCT00340834|19614995|P2|NOT COMPLETED|Extension Phase of Study||76
7968114|NCT00340834|19614996|P1|NOT COMPLETED|Extension Phase of Study||85
7968115|NCT00340834|19614992|P5|COMPLETED|Extension Phase of Study||123
7968116|NCT00340834|19614993|P4|COMPLETED|Extension Phase of Study||123
7968117|NCT00340834|19614994|P3|COMPLETED|Extension Phase of Study||0
7968118|NCT00340834|19614995|P2|COMPLETED|Extension Phase of Study||281
7968119|NCT00340834|19614996|P1|COMPLETED|Extension Phase of Study||245
7968120|NCT00340834|19614992|P5|Received Study Drug|Extension Phase of Study||167
7968121|NCT00340834|19614993|P4|Received Study Drug|Extension Phase of Study||174
7968122|NCT00340834|19614994|P3|Received Study Drug|Extension Phase of Study||0
7968123|NCT00340834|19614995|P2|Received Study Drug|Extension Phase of Study||356
7968124|NCT00340834|19614996|P1|Received Study Drug|Extension Phase of Study||330
7968125|NCT00340834|19614992|P5|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167
7968126|NCT00340834|19614993|P4|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176
7968127|NCT00340834|19614994|P3|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0
7968128|NCT00340834|19614995|P2|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357
7968129|NCT00340834|19614996|P1|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330
7968130|NCT00340834|19614992|P5|NOT COMPLETED|Core Phase of Study||0
7968131|NCT00340834|19614993|P4|NOT COMPLETED|Core Phase of Study||0
7968132|NCT00340834|19614994|P3|NOT COMPLETED|Core Phase of Study||49
7968133|NCT00340834|19614995|P2|NOT COMPLETED|Core Phase of Study||33
7968134|NCT00340834|19614996|P1|NOT COMPLETED|Core Phase of Study||57
7968135|NCT00340834|19614992|P5|COMPLETED|Core Phase of Study||0
7968136|NCT00340834|19614993|P4|COMPLETED|Core Phase of Study||0
7968137|NCT00340834|19614994|P3|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386
7968138|NCT00340834|19614995|P2|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398
7968139|NCT00340834|19614996|P1|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369
7968140|NCT00340834|19614992|P5|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
7968141|NCT00340834|19614993|P4|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
7968142|NCT00340834|19614994|P3|STARTED|Core Phase of Study||435
7968143|NCT00340834|19614995|P2|STARTED|Core Phase of Study||431
7968144|NCT00340834|19614996|P1|STARTED|Core Phase of Study||426
7968145|NCT00340704|19615030|P9|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29
7968146|NCT00340704|19615031|P8|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12
7968147|NCT00340704|19615032|P7|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53
7968148|NCT00340704|19615033|P6|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7
7968149|NCT00340704|19615034|P5|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5
7968150|NCT00340704|19615035|P4|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2
7968151|NCT00340704|19615036|P3|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
7968152|NCT00340704|19615037|P2|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
7968153|NCT00340704|19615038|P1|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
7968154|NCT00340704|19615030|P9|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
7968155|NCT00340704|19615031|P8|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
7968156|NCT00340704|19615032|P7|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
7968157|NCT00340704|19615033|P6|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30
7968158|NCT00340704|19615034|P5|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16
7968159|NCT00340704|19615035|P4|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27
7968160|NCT00340704|19615036|P3|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
7968161|NCT00340704|19615037|P2|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
7968162|NCT00340704|19615038|P1|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
7968163|NCT00340704|19615030|P9|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
7968164|NCT00340704|19615031|P8|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
7968165|NCT00340704|19615032|P7|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
7968166|NCT00340704|19615033|P6|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18
7968167|NCT00340704|19615034|P5|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5
7968168|NCT00340704|19615035|P4|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7
7968169|NCT00340704|19615036|P3|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
7968170|NCT00340704|19615037|P2|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
7968171|NCT00340704|19615038|P1|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
7968172|NCT00340704|19615030|P9|STARTED|Group D- Denovo & 527.51 Rollover Study||29
7968173|NCT00340704|19615031|P8|STARTED|Group D- Denovo & 527.51 Rollover Study||13
7968174|NCT00340704|19615032|P7|STARTED|Group D- Denovo & 527.51 Rollover Study||54
7968175|NCT00340704|19615033|P6|STARTED|Group D- Denovo & 527.51 Rollover Study||37
7968176|NCT00340704|19615034|P5|STARTED|Group D- Denovo & 527.51 Rollover Study||21
7968177|NCT00340704|19615035|P4|STARTED|Group D- Denovo & 527.51 Rollover Study||29
7968178|NCT00340704|19615036|P3|STARTED|Group D- Denovo & 527.51 Rollover Study||0
7968179|NCT00340704|19615037|P2|STARTED|Group D- Denovo & 527.51 Rollover Study||0
7968180|NCT00340704|19615038|P1|STARTED|Group D- Denovo & 527.51 Rollover Study||0
7968181|NCT00340704|19615030|P9|NOT COMPLETED|PK Study||0
7968182|NCT00340704|19615031|P8|NOT COMPLETED|PK Study||0
7968183|NCT00340704|19615032|P7|NOT COMPLETED|PK Study||0
7968184|NCT00340704|19615033|P6|NOT COMPLETED|PK Study||0
7968185|NCT00340704|19615034|P5|NOT COMPLETED|PK Study||0
7968186|NCT00340704|19615035|P4|NOT COMPLETED|PK Study||0
7968187|NCT00340704|19615036|P3|NOT COMPLETED|PK Study||1
7968188|NCT00340704|19615037|P2|NOT COMPLETED|PK Study||1
7968189|NCT00340704|19615038|P1|NOT COMPLETED|PK Study||0
7968190|NCT00340704|19615030|P9|COMPLETED|PK Study||0
7968191|NCT00340704|19615031|P8|COMPLETED|PK Study||0
7968192|NCT00340704|19615032|P7|COMPLETED|PK Study||0
7968193|NCT00340704|19615033|P6|COMPLETED|PK Study||0
7968194|NCT00340704|19615034|P5|COMPLETED|PK Study||0
7968195|NCT00340704|19615035|P4|COMPLETED|PK Study||0
7968196|NCT00340704|19615036|P3|COMPLETED|PK Study||10
7968197|NCT00340704|19615037|P2|COMPLETED|PK Study||9
7968198|NCT00340704|19615038|P1|COMPLETED|PK Study||10
7968199|NCT00340704|19615030|P9|STARTED|PK Study||0
7968200|NCT00340704|19615031|P8|STARTED|PK Study||0
7968201|NCT00340704|19615032|P7|STARTED|PK Study||0
7968202|NCT00340704|19615033|P6|STARTED|PK Study||0
7968203|NCT00340704|19615034|P5|STARTED|PK Study||0
7968204|NCT00340704|19615035|P4|STARTED|PK Study||0
7968205|NCT00340704|19615036|P3|STARTED|PK Study||11
7968206|NCT00340704|19615037|P2|STARTED|PK Study||10
7968207|NCT00340704|19615038|P1|STARTED|PK Study||10
7968208|NCT00340678|19615144|P4|NOT COMPLETED|Overall Study||0
7968209|NCT00340678|19615145|P3|NOT COMPLETED|Overall Study||0
7968210|NCT00340678|19615146|P2|NOT COMPLETED|Overall Study||0
7968211|NCT00340678|19615147|P1|NOT COMPLETED|Overall Study||1
7968212|NCT00340678|19615144|P4|COMPLETED|Overall Study||39
7968213|NCT00340678|19615145|P3|COMPLETED|Overall Study||39
7968214|NCT00340678|19615146|P2|COMPLETED|Overall Study||46
7968215|NCT00340678|19615147|P1|COMPLETED|Overall Study||45
7968216|NCT00340678|19615144|P4|STARTED|Overall Study||39
7968217|NCT00340678|19615145|P3|STARTED|Overall Study||39
7968218|NCT00340678|19615146|P2|STARTED|Overall Study||46
7968219|NCT00340678|19615147|P1|STARTED|Overall Study||46
7968220|NCT00340379|19615161|P2|NOT COMPLETED|Overall Study||9
7968221|NCT00340379|19615162|P1|NOT COMPLETED|Overall Study||8
7968222|NCT00340379|19615161|P2|COMPLETED|Overall Study||28
7968223|NCT00340379|19615162|P1|COMPLETED|Overall Study||27
7968224|NCT00340379|19615161|P2|STARTED|Overall Study||37
7968225|NCT00340379|19615162|P1|STARTED|Overall Study||35
7968226|NCT00339833|19615174|P2|NOT COMPLETED|Overall Study||8
7968227|NCT00339833|19615175|P1|NOT COMPLETED|Overall Study||6
7968228|NCT00339833|19615174|P2|COMPLETED|Overall Study||18
7968229|NCT00339833|19615175|P1|COMPLETED|Overall Study||22
7968230|NCT00339833|19615174|P2|STARTED|Overall Study||26
7968231|NCT00339833|19615175|P1|STARTED|Overall Study||28
7968232|NCT00339183|19615185|P2|NOT COMPLETED|Overall Study||105
7968233|NCT00339183|19615186|P1|NOT COMPLETED|Overall Study||121
7968234|NCT00339183|19615185|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490
7968235|NCT00339183|19615186|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470
7968236|NCT00339183|19615185|P2|Received Study Drug|Overall Study||593
7968237|NCT00339183|19615186|P1|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588
7968238|NCT00339183|19615185|P2|STARTED|Overall Study||595
7968239|NCT00339183|19615186|P1|STARTED|Overall Study||591
7968240|NCT00339144|19615215|P3|NOT COMPLETED|Overall Study||4
7968241|NCT00339144|19615216|P2|NOT COMPLETED|Overall Study||3
7968242|NCT00339144|19615217|P1|NOT COMPLETED|Overall Study||9
7968243|NCT00339144|19615215|P3|COMPLETED|Overall Study||0
7968244|NCT00339144|19615216|P2|COMPLETED|Overall Study||0
7968245|NCT00339144|19615217|P1|COMPLETED|Overall Study||0
7968246|NCT00339144|19615215|P3|STARTED|Overall Study|Number of participants enrolled and treated|4
7968247|NCT00339144|19615216|P2|STARTED|Overall Study|Number of participants enrolled and treated|3
7968248|NCT00339144|19615217|P1|STARTED|Overall Study|Number of participants enrolled and treated|9
7968249|NCT00339079|19615303|P4|NOT COMPLETED|Overall Study||24
7968250|NCT00339079|19615304|P3|NOT COMPLETED|Overall Study||18
7968251|NCT00339079|19615305|P2|NOT COMPLETED|Overall Study||23
7968252|NCT00339079|19615306|P1|NOT COMPLETED|Overall Study||33
7968253|NCT00339079|19615303|P4|COMPLETED|Overall Study||29
7968254|NCT00339079|19615304|P3|COMPLETED|Overall Study||27
7968255|NCT00339079|19615305|P2|COMPLETED|Overall Study||21
7968256|NCT00339079|19615306|P1|COMPLETED|Overall Study||20
7968257|NCT00339079|19615303|P4|STARTED|Overall Study||53
7968258|NCT00339079|19615304|P3|STARTED|Overall Study||45
7968259|NCT00339079|19615305|P2|STARTED|Overall Study||44
7968260|NCT00339079|19615306|P1|STARTED|Overall Study||53
7968261|NCT00339040|19615322|P2|NOT COMPLETED|Stage II||2
7968262|NCT00339040|19615323|P1|NOT COMPLETED|Stage II||10
7968263|NCT00339040|19615322|P2|COMPLETED|Stage II||27
7968264|NCT00339040|19615323|P1|COMPLETED|Stage II||84
7968265|NCT00339040|19615322|P2|Vaccination 6 at Week 120|Stage II||27
7968266|NCT00339040|19615323|P1|Vaccination 6 at Week 120|Stage II||0
7968267|NCT00339040|19615322|P2|Vaccination 5 at Week 104|Stage II||28
7968268|NCT00339040|19615323|P1|Vaccination 5 at Week 104|Stage II||0
7968269|NCT00339040|19615322|P2|Vaccination 4 at Week 96|Stage II||29
7968270|NCT00339040|19615323|P1|Vaccination 4 at Week 96|Stage II||84
7968271|NCT00339040|19615322|P2|STARTED|Stage II||29
7968272|NCT00339040|19615323|P1|STARTED|Stage II||94
7968273|NCT00339040|19615322|P2|NOT COMPLETED|Stage I||1
7968274|NCT00339040|19615323|P1|NOT COMPLETED|Stage I||2
7968275|NCT00339040|19615322|P2|COMPLETED|Stage I||29
7968276|NCT00339040|19615323|P1|COMPLETED|Stage I||94
7968277|NCT00339040|19615322|P2|Vaccination 3 at Week 24|Stage I||30
7968278|NCT00339040|19615323|P1|Vaccination 3 at Week 24|Stage I||94
7968279|NCT00339040|19615322|P2|Vaccination 2 at Week 8|Stage I||30
7968280|NCT00339040|19615323|P1|Vaccination 2 at Week 8|Stage I||95
7968281|NCT00339040|19615322|P2|Vaccination 1 at Week 0|Stage I||30
7968282|NCT00339040|19615323|P1|Vaccination 1 at Week 0|Stage I||96
7968283|NCT00339040|19615322|P2|STARTED|Stage I||30
7968284|NCT00339040|19615323|P1|STARTED|Stage I||96
7968285|NCT00338988|19615341|P1|NOT COMPLETED|Overall Study||1
7968286|NCT00338988|19615341|P1|COMPLETED|Overall Study||43
7968287|NCT00338988|19615341|P1|STARTED|Overall Study||44
7968288|NCT00338962|19615350|P4|NOT COMPLETED|Overall Study||3
7968289|NCT00338962|19615351|P3|NOT COMPLETED|Overall Study||6
7968290|NCT00338962|19615352|P2|NOT COMPLETED|Overall Study||4
7968291|NCT00338962|19615353|P1|NOT COMPLETED|Overall Study||8
7968292|NCT00338962|19615350|P4|COMPLETED|Overall Study||21
7968293|NCT00338962|19615351|P3|COMPLETED|Overall Study||16
7968294|NCT00338962|19615352|P2|COMPLETED|Overall Study||16
7968295|NCT00338962|19615353|P1|COMPLETED|Overall Study||14
7968296|NCT00338962|19615350|P4|STARTED|Overall Study||24
7968297|NCT00338962|19615351|P3|STARTED|Overall Study||22
7968298|NCT00338962|19615352|P2|STARTED|Overall Study||20
7968299|NCT00338962|19615353|P1|STARTED|Overall Study||22
7968300|NCT00338949|19615377|P2|NOT COMPLETED|Randomization||5
7968301|NCT00338949|19615378|P1|NOT COMPLETED|Randomization||1
7968302|NCT00338949|19615377|P2|COMPLETED|Randomization|"Reasons for drop out:
~2- insomnia 2- symptom exacerbation
~1- akathisia"|25
7968303|NCT00338949|19615378|P1|COMPLETED|Randomization|1 subject withdrew after relapse and hospitalization|24
7968304|NCT00338949|19615377|P2|STARTED|Randomization||30
7968305|NCT00338949|19615378|P1|STARTED|Randomization||25
7968306|NCT00338949|19615377|P2|NOT COMPLETED|Subject Screening||11
7968307|NCT00338949|19615378|P1|NOT COMPLETED|Subject Screening||11
7968308|NCT00338949|19615377|P2|COMPLETED|Subject Screening||30
7968309|NCT00338949|19615378|P1|COMPLETED|Subject Screening||25
7968310|NCT00338949|19615377|P2|STARTED|Subject Screening||41
7968311|NCT00338949|19615378|P1|STARTED|Subject Screening||36
7968312|NCT00338884|19615386|P1|NOT COMPLETED|Overall Study||78
7968313|NCT00338884|19615386|P1|COMPLETED|Overall Study||42
7968314|NCT00338884|19615386|P1|Received Treatment|Overall Study||119
7968315|NCT00338884|19615386|P1|STARTED|Overall Study||120
7968316|NCT00338806|19615420|P2|NOT COMPLETED|Follow-up||3
7968317|NCT00338806|19615421|P1|NOT COMPLETED|Follow-up||1
7968318|NCT00338806|19615420|P2|COMPLETED|Follow-up||1
7968319|NCT00338806|19615421|P1|COMPLETED|Follow-up||1
7968320|NCT00338806|19615420|P2|STARTED|Follow-up||4
7968321|NCT00338806|19615421|P1|STARTED|Follow-up||2
7968322|NCT00338806|19615420|P2|NOT COMPLETED|Acute Phase||1
7968323|NCT00338806|19615421|P1|NOT COMPLETED|Acute Phase||0
7968324|NCT00338806|19615420|P2|COMPLETED|Acute Phase||4
7968325|NCT00338806|19615421|P1|COMPLETED|Acute Phase||2
7968326|NCT00338806|19615420|P2|STARTED|Acute Phase||5
7968327|NCT00338806|19615421|P1|STARTED|Acute Phase||2
7968328|NCT00338741|19615483|P2|NOT COMPLETED|Overall Study||0
7968329|NCT00338741|19615484|P1|NOT COMPLETED|Overall Study||2
7968330|NCT00338741|19615483|P2|COMPLETED|Overall Study||2
7968331|NCT00338741|19615484|P1|COMPLETED|Overall Study||32
7968332|NCT00338741|19615483|P2|STARTED|Overall Study||2
7968333|NCT00338741|19615484|P1|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34
7968334|NCT00338728|19615492|P1|NOT COMPLETED|Overall Study||14
7968335|NCT00338728|19615492|P1|COMPLETED|Overall Study||45
7968336|NCT00338728|19615492|P1|STARTED|Overall Study||59
7968337|NCT00338598|19615499|P2|NOT COMPLETED|Overall Study||2
7968338|NCT00338598|19615500|P1|NOT COMPLETED|Overall Study||0
7968339|NCT00338598|19615499|P2|COMPLETED|Overall Study||8
7968340|NCT00338598|19615500|P1|COMPLETED|Overall Study||10
7968341|NCT00338598|19615499|P2|STARTED|Overall Study||10
7968342|NCT00338598|19615500|P1|STARTED|Overall Study||10
7968343|NCT00338455|19615520|P2|NOT COMPLETED|Overall Study||1
7968344|NCT00338455|19615521|P1|NOT COMPLETED|Overall Study||3
7968345|NCT00338455|19615520|P2|COMPLETED|Overall Study||6
7968346|NCT00338455|19615521|P1|COMPLETED|Overall Study||6
7968347|NCT00338455|19615520|P2|Administered Study Drug|Overall Study||7
7968348|NCT00338455|19615521|P1|Administered Study Drug|Overall Study||8
7968349|NCT00338455|19615520|P2|STARTED|Overall Study||7
7968350|NCT00338455|19615521|P1|STARTED|Overall Study||9
7968351|NCT00338286|19615535|P2|NOT COMPLETED|Overall Study||213
7968352|NCT00338286|19615536|P1|NOT COMPLETED|Overall Study||233
7968353|NCT00338286|19615535|P2|COMPLETED|Overall Study||837
7968354|NCT00338286|19615536|P1|COMPLETED|Overall Study||815
7968355|NCT00338286|19615535|P2|STARTED|Overall Study||1050
7968356|NCT00338286|19615536|P1|STARTED|Overall Study||1048
7968357|NCT00338104|19615553|P3|NOT COMPLETED|Overall Study||3
7968358|NCT00338104|19615554|P2|NOT COMPLETED|Overall Study||1
7968359|NCT00338104|19615555|P1|NOT COMPLETED|Overall Study||2
7968360|NCT00338104|19615553|P3|COMPLETED|Overall Study||22
7968361|NCT00338104|19615554|P2|COMPLETED|Overall Study||24
7968362|NCT00338104|19615555|P1|COMPLETED|Overall Study||23
7968363|NCT00338104|19615553|P3|STARTED|Overall Study||25
7968364|NCT00338104|19615554|P2|STARTED|Overall Study||25
7968365|NCT00338104|19615555|P1|STARTED|Overall Study||25
7968366|NCT00338039|19615566|P1|NOT COMPLETED|Overall Study||0
7968367|NCT00338039|19615566|P1|COMPLETED|Overall Study||69
7968368|NCT00338039|19615566|P1|STARTED|Overall Study||69
7968369|NCT00337987|19615571|P1|NOT COMPLETED|Overall Study||0
7968370|NCT00337987|19615571|P1|COMPLETED|Overall Study||49
7968371|NCT00337987|19615571|P1|STARTED|Overall Study||49
7968372|NCT00337935|19615578|P2|NOT COMPLETED|Overall Study||27
7968373|NCT00337935|19615579|P1|NOT COMPLETED|Overall Study||10
7968374|NCT00337935|19615578|P2|COMPLETED|Overall Study||91
7968375|NCT00337935|19615579|P1|COMPLETED|Overall Study||29
7968376|NCT00337935|19615578|P2|STARTED|Overall Study||118
7968377|NCT00337935|19615579|P1|STARTED|Overall Study||39
7968378|NCT00337818|19615592|P3|NOT COMPLETED|Overall Study||107
7968379|NCT00337818|19615593|P2|NOT COMPLETED|Overall Study||91
7968380|NCT00337818|19615594|P1|NOT COMPLETED|Overall Study||289
7968381|NCT00337818|19615592|P3|COMPLETED|Overall Study||51
7968382|NCT00337818|19615593|P2|COMPLETED|Overall Study||63
7968383|NCT00337818|19615594|P1|COMPLETED|Overall Study||169
7968384|NCT00337818|19615592|P3|STARTED|Overall Study||158
7968385|NCT00337818|19615593|P2|STARTED|Overall Study||154
7968386|NCT00337818|19615594|P1|STARTED|Overall Study||458
7968387|NCT00337779|19615616|P2|NOT COMPLETED|Overall Study||79
7968388|NCT00337779|19615617|P1|NOT COMPLETED|Overall Study||52
7968389|NCT00337779|19615616|P2|COMPLETED|Overall Study||490
7968390|NCT00337779|19615617|P1|COMPLETED|Overall Study||534
7968391|NCT00337779|19615616|P2|STARTED|Overall Study||569
7968392|NCT00337779|19615617|P1|STARTED|Overall Study||586
7968393|NCT00337727|19615629|P2|NOT COMPLETED|Overall Study||12
7968394|NCT00337727|19615630|P1|NOT COMPLETED|Overall Study||18
7968395|NCT00337727|19615629|P2|COMPLETED|Overall Study||406
7968396|NCT00337727|19615630|P1|COMPLETED|Overall Study||412
7968397|NCT00337727|19615629|P2|STARTED|Overall Study||418
7968398|NCT00337727|19615630|P1|STARTED|Overall Study||430
7968399|NCT00337675|19615641|P3|NOT COMPLETED|Overall Study||99
7968400|NCT00337675|19615642|P2|NOT COMPLETED|Overall Study||103
7968401|NCT00337675|19615643|P1|NOT COMPLETED|Overall Study||97
7968402|NCT00337675|19615641|P3|COMPLETED|Overall Study||492
7968403|NCT00337675|19615642|P2|COMPLETED|Overall Study||488
7968404|NCT00337675|19615643|P1|COMPLETED|Overall Study||492
7968405|NCT00337675|19615641|P3|STARTED|Overall Study||591
7968406|NCT00337675|19615642|P2|STARTED|Overall Study||591
7968407|NCT00337675|19615643|P1|STARTED|Overall Study||589
7968408|NCT00337662|19615660|P4|NOT COMPLETED|Study Period III||0
7968409|NCT00337662|19615661|P3|NOT COMPLETED|Study Period III||44
7968410|NCT00337662|19615662|P2|NOT COMPLETED|Study Period III||58
7968411|NCT00337662|19615663|P1|NOT COMPLETED|Study Period III||60
7968412|NCT00337662|19615660|P4|COMPLETED|Study Period III||0
7968413|NCT00337662|19615661|P3|COMPLETED|Study Period III||100
7968414|NCT00337662|19615662|P2|COMPLETED|Study Period III||134
7968415|NCT00337662|19615663|P1|COMPLETED|Study Period III||126
7968416|NCT00337662|19615660|P4|STARTED|Study Period III||0
7968417|NCT00337662|19615661|P3|STARTED|Study Period III||144
7968418|NCT00337662|19615662|P2|STARTED|Study Period III||192
7968419|NCT00337662|19615663|P1|STARTED|Study Period III||186
7968420|NCT00337662|19615660|P4|NOT COMPLETED|Study Period II||106
7968421|NCT00337662|19615661|P3|NOT COMPLETED|Study Period II||0
7968422|NCT00337662|19615662|P2|NOT COMPLETED|Study Period II||0
7968423|NCT00337662|19615663|P1|NOT COMPLETED|Study Period II||0
7968424|NCT00337662|19615660|P4|COMPLETED|Study Period II||522
7968425|NCT00337662|19615661|P3|COMPLETED|Study Period II||0
7968426|NCT00337662|19615662|P2|COMPLETED|Study Period II||0
7968427|NCT00337662|19615663|P1|COMPLETED|Study Period II||0
7968428|NCT00337662|19615660|P4|STARTED|Study Period II||628
7968429|NCT00337662|19615661|P3|STARTED|Study Period II||0
7968430|NCT00337662|19615662|P2|STARTED|Study Period II||0
7968431|NCT00337662|19615663|P1|STARTED|Study Period II||0
7968432|NCT00337610|19615717|P2|NOT COMPLETED|Overall Study||14
7968433|NCT00337610|19615718|P1|NOT COMPLETED|Overall Study||17
7968434|NCT00337610|19615717|P2|COMPLETED|Overall Study||80
7968435|NCT00337610|19615718|P1|COMPLETED|Overall Study||79
7968436|NCT00337610|19615717|P2|Completed Week 18|Overall Study||82
7968437|NCT00337610|19615718|P1|Completed Week 18|Overall Study||89
7968438|NCT00337610|19615717|P2|STARTED|Overall Study||94
7968439|NCT00337610|19615718|P1|STARTED|Overall Study||96
7968440|NCT00337571|19615734|P4|NOT COMPLETED|Overall Study||7
7968441|NCT00337571|19615735|P3|NOT COMPLETED|Overall Study||10
7968442|NCT00337571|19615736|P2|NOT COMPLETED|Overall Study||9
7968443|NCT00337571|19615737|P1|NOT COMPLETED|Overall Study||14
7968444|NCT00337571|19615734|P4|COMPLETED|Overall Study||47
7968445|NCT00337571|19615735|P3|COMPLETED|Overall Study||49
7968446|NCT00337571|19615736|P2|COMPLETED|Overall Study||44
7968447|NCT00337571|19615737|P1|COMPLETED|Overall Study||38
7968448|NCT00337571|19615734|P4|STARTED|Overall Study||54
7968449|NCT00337571|19615735|P3|STARTED|Overall Study||59
7968450|NCT00337571|19615736|P2|STARTED|Overall Study||53
7968451|NCT00337571|19615737|P1|STARTED|Overall Study||52
7968452|NCT00337467|19615775|P1|NOT COMPLETED|Overall Study||10
7968453|NCT00337467|19615775|P1|COMPLETED|Overall Study||51
7968454|NCT00337467|19615775|P1|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10
7968455|NCT00337467|19615775|P1|STARTED|Overall Study||61
7968456|NCT00337428|19615794|P2|NOT COMPLETED|Overall Study||3
7968457|NCT00337428|19615795|P1|NOT COMPLETED|Overall Study||4
7968458|NCT00337428|19615794|P2|COMPLETED|Overall Study||421
7968459|NCT00337428|19615795|P1|COMPLETED|Overall Study||415
7968460|NCT00337428|19615794|P2|STARTED|Overall Study||424
7968461|NCT00337428|19615795|P1|STARTED|Overall Study||419
7968462|NCT00337350|19615835|P2|NOT COMPLETED|Overall Study||1
7968463|NCT00337350|19615836|P1|NOT COMPLETED|Overall Study||1
7968464|NCT00337350|19615835|P2|COMPLETED|Overall Study||10
7968465|NCT00337350|19615836|P1|COMPLETED|Overall Study||8
7968466|NCT00337350|19615835|P2|STARTED|Overall Study||11
7968467|NCT00337350|19615836|P1|STARTED|Overall Study||9
7968468|NCT00337285|19615846|P1|NOT COMPLETED|Overall Study||158
7968469|NCT00337285|19615846|P1|COMPLETED|Overall Study||191
7968470|NCT00337285|19615846|P1|STARTED|Overall Study||349
7968471|NCT00337272|19615854|P2|NOT COMPLETED|Withdrawal Period||1
7968472|NCT00337272|19615855|P1|NOT COMPLETED|Withdrawal Period||0
7968473|NCT00337272|19615854|P2|COMPLETED|Withdrawal Period||6
7968474|NCT00337272|19615855|P1|COMPLETED|Withdrawal Period||6
7968475|NCT00337272|19615854|P2|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7
7968476|NCT00337272|19615855|P1|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6
7968477|NCT00337272|19615854|P2|NOT COMPLETED|Treatment Period||2
7968478|NCT00337272|19615855|P1|NOT COMPLETED|Treatment Period||1
7968479|NCT00337272|19615854|P2|COMPLETED|Treatment Period||7
7968480|NCT00337272|19615855|P1|COMPLETED|Treatment Period||6
7968481|NCT00337272|19615854|P2|Randomization|Treatment Period||9
7968482|NCT00337272|19615855|P1|Randomization|Treatment Period||7
7968483|NCT00337272|19615854|P2|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9
7968484|NCT00337272|19615855|P1|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7
7968485|NCT00337272|19615854|P2|NOT COMPLETED|Screening Period (Pre-randomization)||0
7968486|NCT00337272|19615855|P1|NOT COMPLETED|Screening Period (Pre-randomization)||6
7968487|NCT00337272|19615854|P2|COMPLETED|Screening Period (Pre-randomization)||0
7968488|NCT00337272|19615855|P1|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16
7968489|NCT00337272|19615854|P2|STARTED|Screening Period (Pre-randomization)||0
7968490|NCT00337272|19615855|P1|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22
7968491|NCT00337207|19615875|P1|NOT COMPLETED|Overall Study||3
7968492|NCT00337207|19615875|P1|COMPLETED|Overall Study||52
7968493|NCT00337207|19615875|P1|STARTED|Overall Study||55
7968494|NCT00337194|19615883|P2|NOT COMPLETED|Overall Study||4
7968495|NCT00337194|19615884|P1|NOT COMPLETED|Overall Study||12
7968496|NCT00337194|19615883|P2|COMPLETED|Overall Study||3
7968497|NCT00337194|19615884|P1|COMPLETED|Overall Study||11
7968498|NCT00337194|19615883|P2|STARTED|Overall Study||7
7968499|NCT00337194|19615884|P1|STARTED|Overall Study||23
7968500|NCT00337181|19615901|P2|NOT COMPLETED|Overall Study||0
7968501|NCT00337181|19615902|P1|NOT COMPLETED|Overall Study||0
7968502|NCT00337181|19615901|P2|COMPLETED|Overall Study||65
7968503|NCT00337181|19615902|P1|COMPLETED|Overall Study||49
7968504|NCT00337181|19615901|P2|STARTED|Overall Study||65
7968505|NCT00337181|19615902|P1|STARTED|Overall Study||49
7968506|NCT00337168|19615908|P1|NOT COMPLETED|Overall Study||8
7968507|NCT00337168|19615908|P1|COMPLETED|Overall Study||29
7968508|NCT00337168|19615908|P1|Eligible and Treated|Overall Study||36
7968509|NCT00337168|19615908|P1|Eligible|Overall Study||37
7968510|NCT00337168|19615908|P1|STARTED|Overall Study||37
7968511|NCT00337129|19615915|P1|NOT COMPLETED|Overall Study||40
7968512|NCT00337129|19615915|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0
7968513|NCT00337129|19615915|P1|STARTED|Overall Study||40
7968514|NCT00337103|19615924|P2|NOT COMPLETED|Overall Study||548
7968515|NCT00337103|19615925|P1|NOT COMPLETED|Overall Study||554
7968516|NCT00337103|19615924|P2|COMPLETED|Overall Study||0
7968517|NCT00337103|19615925|P1|COMPLETED|Overall Study||0
7968518|NCT00337103|19615924|P2|Treated (Safety Population)|Overall Study||546
7968519|NCT00337103|19615925|P1|Treated (Safety Population)|Overall Study||544
7968520|NCT00337103|19615924|P2|STARTED|Overall Study||548
7968521|NCT00337103|19615925|P1|STARTED|Overall Study||554
7968522|NCT00337077|19615959|P3|NOT COMPLETED|Overall Study||25
7968523|NCT00337077|19615960|P2|NOT COMPLETED|Overall Study||53
7968524|NCT00337077|19615961|P1|NOT COMPLETED|Overall Study||43
7968525|NCT00337077|19615959|P3|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
7968526|NCT00337077|19615960|P2|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
7968527|NCT00337077|19615961|P1|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
7968528|NCT00337077|19615959|P3|Patients With Measurable Disease|Overall Study||13
7968529|NCT00337077|19615960|P2|Patients With Measurable Disease|Overall Study||38
7968530|NCT00337077|19615961|P1|Patients With Measurable Disease|Overall Study||26
7968531|NCT00337077|19615959|P3|Eligible and Treated|Overall Study||24
7968532|NCT00337077|19615960|P2|Eligible and Treated|Overall Study||51
7968533|NCT00337077|19615961|P1|Eligible and Treated|Overall Study||41
7968534|NCT00337077|19615959|P3|Toxicity Assessed|Overall Study||25
7968535|NCT00337077|19615960|P2|Toxicity Assessed|Overall Study||51
7968536|NCT00337077|19615961|P1|Toxicity Assessed|Overall Study||42
7968537|NCT00337077|19615959|P3|Treated|Overall Study||25
7968538|NCT00337077|19615960|P2|Treated|Overall Study||52
7968539|NCT00337077|19615961|P1|Treated|Overall Study||42
7968540|NCT00337077|19615959|P3|STARTED|Overall Study||25
7968541|NCT00337077|19615960|P2|STARTED|Overall Study||53
7968542|NCT00337077|19615961|P1|STARTED|Overall Study||43
7968543|NCT00336973|19615970|P1|NOT COMPLETED|Overall Study||33
7968544|NCT00336973|19615970|P1|COMPLETED|Overall Study||33
7968545|NCT00336973|19615970|P1|STARTED|Overall Study||66
7968546|NCT00336895|19615976|P1|NOT COMPLETED|Overall Study||4
7968547|NCT00336895|19615976|P1|COMPLETED|Overall Study||26
7968548|NCT00336895|19615976|P1|STARTED|Overall Study||30
7968549|NCT00336856|19615982|P1|NOT COMPLETED|Overall Study||4
7968550|NCT00336856|19615982|P1|COMPLETED|Overall Study||31
7968551|NCT00336856|19615982|P1|STARTED|Overall Study|Number of patients consented and registered for the study|35
7968552|NCT00336817|19615990|P2|NOT COMPLETED|Overall Study||2
7968553|NCT00336817|19615991|P1|NOT COMPLETED|Overall Study||1
7968554|NCT00336817|19615990|P2|COMPLETED|Overall Study||13
7968555|NCT00336817|19615991|P1|COMPLETED|Overall Study||14
7968556|NCT00336817|19615990|P2|STARTED|Overall Study||15
7968557|NCT00336817|19615991|P1|STARTED|Overall Study||15
7968558|NCT00336700|19616021|P1|NOT COMPLETED|Overall Study||0
7968559|NCT00336700|19616021|P1|COMPLETED|Overall Study||25
7968560|NCT00336700|19616021|P1|STARTED|Overall Study||25
7968561|NCT00336583|19616030|P1|NOT COMPLETED|Overall Study||2
7968562|NCT00336583|19616030|P1|COMPLETED|Overall Study||25
7968563|NCT00336583|19616030|P1|STARTED|Overall Study||27
7968564|NCT00336544|19616037|P2|NOT COMPLETED|Overall Study||22
7968565|NCT00336544|19616038|P1|NOT COMPLETED|Overall Study||19
7968566|NCT00336544|19616037|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238
7968567|NCT00336544|19616038|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242
7968568|NCT00336544|19616037|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|260
7968569|NCT00336544|19616038|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|261
7968570|NCT00336505|19616052|P2|NOT COMPLETED|Overall Study||27
7968571|NCT00336505|19616053|P1|NOT COMPLETED|Overall Study||37
7968572|NCT00336505|19616052|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264
7968573|NCT00336505|19616053|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254
7968574|NCT00336505|19616052|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|291
7968575|NCT00336505|19616053|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|291
7968576|NCT00336492|19616068|P3|NOT COMPLETED|Overall Study||11
7968577|NCT00336492|19616069|P2|NOT COMPLETED|Overall Study||4
7968578|NCT00336492|19616070|P1|NOT COMPLETED|Overall Study||15
7968579|NCT00336492|19616068|P3|COMPLETED|Overall Study||12
7968580|NCT00336492|19616069|P2|COMPLETED|Overall Study||18
7968581|NCT00336492|19616070|P1|COMPLETED|Overall Study||0
7968582|NCT00336492|19616068|P3|STARTED|Overall Study||23
7968583|NCT00336492|19616069|P2|STARTED|Overall Study||22
7968584|NCT00336492|19616070|P1|STARTED|Overall Study||15
7968585|NCT00336479|19616082|P4|NOT COMPLETED|Overall Study||4
7968586|NCT00336479|19616083|P3|NOT COMPLETED|Overall Study||26
7968587|NCT00336479|19616084|P2|NOT COMPLETED|Overall Study||25
7968588|NCT00336479|19616085|P1|NOT COMPLETED|Overall Study||37
7968589|NCT00336479|19616082|P4|COMPLETED|Overall Study||13
7968590|NCT00336479|19616083|P3|COMPLETED|Overall Study||53
7968591|NCT00336479|19616084|P2|COMPLETED|Overall Study||54
7968592|NCT00336479|19616085|P1|COMPLETED|Overall Study||38
7968593|NCT00336479|19616082|P4|STARTED|Overall Study||17
7968594|NCT00336479|19616083|P3|STARTED|Overall Study||79
7968595|NCT00336479|19616084|P2|STARTED|Overall Study||79
7968596|NCT00336479|19616085|P1|STARTED|Overall Study||75
7968597|NCT00336323|19616113|P5|NOT COMPLETED|Overall Study||3
7968598|NCT00336323|19616114|P4|NOT COMPLETED|Overall Study||0
7968599|NCT00336323|19616115|P3|NOT COMPLETED|Overall Study||1
7968600|NCT00336323|19616116|P2|NOT COMPLETED|Overall Study||1
7968601|NCT00336323|19616117|P1|NOT COMPLETED|Overall Study||0
7968602|NCT00336323|19616113|P5|COMPLETED|Overall Study||19
7968603|NCT00336323|19616114|P4|COMPLETED|Overall Study||22
7968604|NCT00336323|19616115|P3|COMPLETED|Overall Study||23
7968605|NCT00336323|19616116|P2|COMPLETED|Overall Study||21
7968606|NCT00336323|19616117|P1|COMPLETED|Overall Study||19
7968607|NCT00336323|19616113|P5|24 Week Visit|Overall Study||19
7968608|NCT00336323|19616114|P4|24 Week Visit|Overall Study||22
7968609|NCT00336323|19616115|P3|24 Week Visit|Overall Study|1 patient was dropped from the study|22
7968610|NCT00336323|19616116|P2|24 Week Visit|Overall Study|1 patient was dropped from the study|20
7968611|NCT00336323|19616117|P1|24 Week Visit|Overall Study||18
7968612|NCT00336323|19616113|P5|18 Week Visit|Overall Study|1 patient was dropped from the study|18
7968613|NCT00336323|19616114|P4|18 Week Visit|Overall Study||21
7968614|NCT00336323|19616115|P3|18 Week Visit|Overall Study||23
7968615|NCT00336323|19616116|P2|18 Week Visit|Overall Study||22
7968616|NCT00336323|19616117|P1|18 Week Visit|Overall Study||19
7968617|NCT00336323|19616113|P5|12 Week Visit|Overall Study|1 patient was dropped from study|20
7968618|NCT00336323|19616114|P4|12 Week Visit|Overall Study||22
7968619|NCT00336323|19616115|P3|12 Week Visit|Overall Study||24
7968620|NCT00336323|19616116|P2|12 Week Visit|Overall Study||21
7968621|NCT00336323|19616117|P1|12 Week Visit|Overall Study||19
7968622|NCT00336323|19616113|P5|9 Week Visit|Overall Study||19
7968623|NCT00336323|19616114|P4|9 Week Visit|Overall Study||21
7968624|NCT00336323|19616115|P3|9 Week Visit|Overall Study||23
7968625|NCT00336323|19616116|P2|9 Week Visit|Overall Study||21
7968626|NCT00336323|19616117|P1|9 Week Visit|Overall Study||18
7968627|NCT00336323|19616113|P5|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20
7968628|NCT00336323|19616114|P4|6 Week Visit|Overall Study||22
7968629|NCT00336323|19616115|P3|6 Week Visit|Overall Study||24
7968630|NCT00336323|19616116|P2|6 Week Visit|Overall Study||22
7968631|NCT00336323|19616117|P1|6 Week Visit|Overall Study||18
7968632|NCT00336323|19616113|P5|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20
7968633|NCT00336323|19616114|P4|3 Week Visit|Overall Study||22
7968634|NCT00336323|19616115|P3|3 Week Visit|Overall Study||24
7968635|NCT00336323|19616116|P2|3 Week Visit|Overall Study||21
7968636|NCT00336323|19616117|P1|3 Week Visit|Overall Study||18
7968637|NCT00336323|19616113|P5|STARTED|Overall Study||22
7968638|NCT00336323|19616114|P4|STARTED|Overall Study||22
7968639|NCT00336323|19616115|P3|STARTED|Overall Study||24
7968640|NCT00336323|19616116|P2|STARTED|Overall Study||22
7968641|NCT00336323|19616117|P1|STARTED|Overall Study||19
7968642|NCT00336284|19616174|P2|NOT COMPLETED|Overall Study||151
7968643|NCT00336284|19616175|P1|NOT COMPLETED|Overall Study||236
7968644|NCT00336284|19616174|P2|COMPLETED|Overall Study||322
7968645|NCT00336284|19616175|P1|COMPLETED|Overall Study||741
7968646|NCT00336284|19616174|P2|STARTED|Overall Study||473
7968647|NCT00336284|19616175|P1|STARTED|Overall Study||977
7968648|NCT00336232|19616187|P1|NOT COMPLETED|High Vitamin K (500mcg Daily)||0
7968649|NCT00336232|19616187|P1|COMPLETED|High Vitamin K (500mcg Daily)||42
7968650|NCT00336232|19616187|P1|STARTED|High Vitamin K (500mcg Daily)||42
7968651|NCT00336232|19616187|P1|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0
7968652|NCT00336232|19616187|P1|COMPLETED|Low Vitamin K (10mcg Daily)||42
7968653|NCT00336232|19616187|P1|STARTED|Low Vitamin K (10mcg Daily)||42
7968654|NCT00336232|19616187|P1|NOT COMPLETED|Baseline (200mcg Daily)||17
7968655|NCT00336232|19616187|P1|COMPLETED|Baseline (200mcg Daily)||42
7968656|NCT00336232|19616187|P1|STARTED|Baseline (200mcg Daily)||59
7968657|NCT00336024|19616193|P2|NOT COMPLETED|Overall Study||19
7968658|NCT00336024|19616194|P1|NOT COMPLETED|Overall Study||20
7968659|NCT00336024|19616193|P2|COMPLETED|Overall Study||26
7968660|NCT00336024|19616194|P1|COMPLETED|Overall Study||26
7968661|NCT00336024|19616193|P2|STARTED|Overall Study||45
7968662|NCT00336024|19616194|P1|STARTED|Overall Study||46
7968663|NCT00335972|19616230|P2|NOT COMPLETED|Overall Study||3
7968664|NCT00335972|19616231|P1|NOT COMPLETED|Overall Study||0
7968665|NCT00335972|19616230|P2|COMPLETED|Overall Study||68
7968666|NCT00335972|19616231|P1|COMPLETED|Overall Study||71
7968667|NCT00335972|19616230|P2|STARTED|Overall Study||71
7968668|NCT00335972|19616231|P1|STARTED|Overall Study||71
7968669|NCT00335959|19616241|P1|NOT COMPLETED|Overall Study||3
7968670|NCT00335959|19616241|P1|COMPLETED|Overall Study||4
7968671|NCT00335959|19616241|P1|Eligible and Began Protocol Therapy|Overall Study||6
7968672|NCT00335959|19616241|P1|Eligible|Overall Study||6
7968673|NCT00335959|19616241|P1|STARTED|Overall Study||7
7968674|NCT00335829|19616246|P1|NOT COMPLETED|Overall Study||3
7968675|NCT00335829|19616246|P1|COMPLETED|Overall Study||23
7968676|NCT00335829|19616246|P1|Received First TACE|Overall Study|1 patient left after receiving bevacizumab but prior to first TACE|25
7968677|NCT00335829|19616246|P1|Received Bevacizumab|Overall Study||26
7968678|NCT00335829|19616246|P1|STARTED|Overall Study||26
7968679|NCT00335777|19616260|P1|NOT COMPLETED|Treated 2 Headaches Per Protocol||13
7968680|NCT00335777|19616260|P1|COMPLETED|Treated 2 Headaches Per Protocol||22
7968681|NCT00335777|19616260|P1|STARTED|Treated 2 Headaches Per Protocol||35
7968682|NCT00335777|19616260|P1|NOT COMPLETED|Enrolled and Dispensed Study Medication||29
7968683|NCT00335777|19616260|P1|COMPLETED|Enrolled and Dispensed Study Medication||35
7968684|NCT00335777|19616260|P1|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64
7968685|NCT00335764|19616270|P5|NOT COMPLETED|Overall Study||1
7968686|NCT00335764|19616271|P4|NOT COMPLETED|Overall Study||0
7968687|NCT00335764|19616272|P3|NOT COMPLETED|Overall Study||0
7968688|NCT00335764|19616273|P2|NOT COMPLETED|Overall Study||0
7968689|NCT00335764|19616274|P1|NOT COMPLETED|Overall Study||1
7968690|NCT00335764|19616270|P5|COMPLETED|Overall Study||18
7968691|NCT00335764|19616271|P4|COMPLETED|Overall Study||19
7968692|NCT00335764|19616272|P3|COMPLETED|Overall Study||24
7968693|NCT00335764|19616273|P2|COMPLETED|Overall Study||13
7968694|NCT00335764|19616274|P1|COMPLETED|Overall Study||16
7968695|NCT00335764|19616270|P5|STARTED|Overall Study||19
7968696|NCT00335764|19616271|P4|STARTED|Overall Study||19
7968697|NCT00335764|19616272|P3|STARTED|Overall Study||24
7968698|NCT00335764|19616273|P2|STARTED|Overall Study||13
7968699|NCT00335764|19616274|P1|STARTED|Overall Study||17
7968700|NCT00335738|19616323|P2|NOT COMPLETED|Overall Study||4
7968701|NCT00335738|19616324|P1|NOT COMPLETED|Overall Study||11
7968702|NCT00335738|19616323|P2|COMPLETED|Overall Study||219
7968703|NCT00335738|19616324|P1|COMPLETED|Overall Study||97
7968704|NCT00335738|19616323|P2|STARTED|Overall Study||223
7968705|NCT00335738|19616324|P1|STARTED|Overall Study||108
7968706|NCT00335725|19616341|P2|NOT COMPLETED|Overall Study||5
7968707|NCT00335725|19616342|P1|NOT COMPLETED|Overall Study||4
7968708|NCT00335725|19616341|P2|COMPLETED|Overall Study||71
7968709|NCT00335725|19616342|P1|COMPLETED|Overall Study||71
7968710|NCT00335725|19616341|P2|STARTED|Overall Study||76
7968711|NCT00335725|19616342|P1|STARTED|Overall Study||75
7968712|NCT00335556|19616356|P6|NOT COMPLETED|Overall Study||1
7968713|NCT00335556|19616357|P5|NOT COMPLETED|Overall Study||1
7968714|NCT00335556|19616358|P4|NOT COMPLETED|Overall Study||5
7968715|NCT00335556|19616359|P3|NOT COMPLETED|Overall Study||5
7968716|NCT00335556|19616360|P2|NOT COMPLETED|Overall Study||34
7968717|NCT00335556|19616361|P1|NOT COMPLETED|Overall Study||2
7968718|NCT00335556|19616356|P6|COMPLETED|Overall Study||29
7968719|NCT00335556|19616357|P5|COMPLETED|Overall Study||77
7968720|NCT00335556|19616358|P4|COMPLETED|Overall Study||5
7968721|NCT00335556|19616359|P3|COMPLETED|Overall Study||2
7968722|NCT00335556|19616360|P2|COMPLETED|Overall Study||64
7968723|NCT00335556|19616361|P1|COMPLETED|Overall Study||66
7968724|NCT00335556|19616356|P6|STARTED|Overall Study||30
7968725|NCT00335556|19616357|P5|STARTED|Overall Study||78
7968726|NCT00335556|19616358|P4|STARTED|Overall Study||10
7968727|NCT00335556|19616359|P3|STARTED|Overall Study||7
7968728|NCT00335556|19616360|P2|STARTED|Overall Study||98
7968729|NCT00335556|19616361|P1|STARTED|Overall Study||68
7968730|NCT00335517|19616382|P1|NOT COMPLETED|Overall Study||2
7968731|NCT00335517|19616382|P1|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98
7968732|NCT00335517|19616382|P1|STARTED|Overall Study||100
7968733|NCT00335504|19616390|P4|NOT COMPLETED|Overall Study||0
7968734|NCT00335504|19616391|P3|NOT COMPLETED|Overall Study||0
7968735|NCT00335504|19616392|P2|NOT COMPLETED|Overall Study||0
7968736|NCT00335504|19616393|P1|NOT COMPLETED|Overall Study||0
7968737|NCT00335504|19616390|P4|COMPLETED|Overall Study||22
7968738|NCT00335504|19616391|P3|COMPLETED|Overall Study||20
7968739|NCT00335504|19616392|P2|COMPLETED|Overall Study||21
7968740|NCT00335504|19616393|P1|COMPLETED|Overall Study||22
7968741|NCT00335504|19616390|P4|STARTED|Overall Study||22
7968742|NCT00335504|19616391|P3|STARTED|Overall Study||20
7968743|NCT00335504|19616392|P2|STARTED|Overall Study||21
7968744|NCT00335504|19616393|P1|STARTED|Overall Study||22
7968745|NCT00335478|19616415|P1|NOT COMPLETED|Overall Study||24
7968746|NCT00335478|19616415|P1|COMPLETED|Overall Study||30
7968747|NCT00335478|19616415|P1|STARTED|Overall Study||54
7968748|NCT00335452|19616423|P4|NOT COMPLETED|Overall Study||131
7968749|NCT00335452|19616424|P3|NOT COMPLETED|Overall Study||159
7968750|NCT00335452|19616425|P2|NOT COMPLETED|Overall Study||147
7968751|NCT00335452|19616426|P1|NOT COMPLETED|Overall Study||158
7968752|NCT00335452|19616423|P4|COMPLETED|Overall Study|Completed 30 days follow-up period|6122
7968753|NCT00335452|19616424|P3|COMPLETED|Overall Study|Completed 30 days follow-up period|6108
7968754|NCT00335452|19616425|P2|COMPLETED|Overall Study|Completed 30 days follow-up period|6107
7968755|NCT00335452|19616426|P1|COMPLETED|Overall Study|Completed 30 days follow-up period|6154
7968756|NCT00335452|19616423|P4|TREATED WITH ASA|Overall Study||6247
7968757|NCT00335452|19616424|P3|TREATED WITH ASA|Overall Study||6261
7968758|NCT00335452|19616425|P2|TREATED WITH ASA|Overall Study||6251
7968759|NCT00335452|19616426|P1|TREATED WITH ASA|Overall Study||6302
7968760|NCT00335452|19616423|P4|TREATED WITH CLOPIDOGREL|Overall Study||6217
7968761|NCT00335452|19616424|P3|TREATED WITH CLOPIDOGREL|Overall Study||6228
7968762|NCT00335452|19616425|P2|TREATED WITH CLOPIDOGREL|Overall Study||6218
7968763|NCT00335452|19616426|P1|TREATED WITH CLOPIDOGREL|Overall Study||6271
7968764|NCT00335452|19616423|P4|STARTED|Overall Study|Randomized|6253
7968765|NCT00335452|19616424|P3|STARTED|Overall Study|Randomized|6267
7968766|NCT00335452|19616425|P2|STARTED|Overall Study|Randomized|6254
7968767|NCT00335452|19616426|P1|STARTED|Overall Study|Randomized|6312
7968768|NCT00335322|19616451|P3|NOT COMPLETED|Overall Study||2
7968769|NCT00335322|19616452|P2|NOT COMPLETED|Overall Study||2
7968770|NCT00335322|19616453|P1|NOT COMPLETED|Overall Study||1
7968771|NCT00335322|19616451|P3|COMPLETED|Overall Study||103
7968772|NCT00335322|19616452|P2|COMPLETED|Overall Study||105
7968773|NCT00335322|19616453|P1|COMPLETED|Overall Study||114
7968774|NCT00335322|19616451|P3|STARTED|Overall Study||105
7968775|NCT00335322|19616452|P2|STARTED|Overall Study||107
7968776|NCT00335322|19616453|P1|STARTED|Overall Study||115
7968777|NCT00335283|19616466|P2|NOT COMPLETED|Overall Study||5
7968778|NCT00335283|19616467|P1|NOT COMPLETED|Overall Study||6
7968779|NCT00335283|19616466|P2|COMPLETED|Overall Study||34
7968780|NCT00335283|19616467|P1|COMPLETED|Overall Study||30
7968781|NCT00335283|19616466|P2|STARTED|Overall Study||39
7968782|NCT00335283|19616467|P1|STARTED|Overall Study||36
7968783|NCT00335257|19616482|P3|NOT COMPLETED|Overall Study||0
7968784|NCT00335257|19616483|P2|NOT COMPLETED|Overall Study||0
7968785|NCT00335257|19616484|P1|NOT COMPLETED|Overall Study||0
7968786|NCT00335257|19616482|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190
7968787|NCT00335257|19616483|P2|COMPLETED|Overall Study||9377
7968788|NCT00335257|19616484|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542
7968789|NCT00335257|19616482|P3|STARTED|Overall Study||60190
7968790|NCT00335257|19616483|P2|STARTED|Overall Study||9377
7968791|NCT00335257|19616484|P1|STARTED|Overall Study||15542
7968792|NCT00335153|19616501|P1|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52
7968793|NCT00335153|19616501|P1|COMPLETED|Post-PEG-J Long-Term Treatment Period||272
7968794|NCT00335153|19616501|P1|STARTED|Post-PEG-J Long-Term Treatment Period||324
7968795|NCT00335153|19616501|P1|NOT COMPLETED|Nasojejunal (NJ) Test Period||30
7968796|NCT00335153|19616501|P1|COMPLETED|Nasojejunal (NJ) Test Period||324
7968797|NCT00335153|19616501|P1|STARTED|Nasojejunal (NJ) Test Period||354
7968798|NCT00335140|19616538|P1|NOT COMPLETED|Overall Study||1
7968799|NCT00335140|19616538|P1|COMPLETED|Overall Study||25
7968800|NCT00335140|19616538|P1|Treated|Overall Study||25
7968801|NCT00335140|19616538|P1|Eligible|Overall Study||25
7968802|NCT00335140|19616538|P1|STARTED|Overall Study||26
7968803|NCT00334958|19616544|P2|NOT COMPLETED|Overall Study||24
7968804|NCT00334958|19616545|P1|NOT COMPLETED|Overall Study||37
7968805|NCT00334958|19616544|P2|COMPLETED|Overall Study||156
7968806|NCT00334958|19616545|P1|COMPLETED|Overall Study||139
7968807|NCT00334958|19616544|P2|STARTED|Overall Study|1 subject withdrawn prior to study drug dosing due to not obtaining labs|180
7968808|NCT00334958|19616545|P1|STARTED|Overall Study||176
7968809|NCT00334893|19616559|P2|NOT COMPLETED|Overall Study||0
7968810|NCT00334893|19616560|P1|NOT COMPLETED|Overall Study||1
7968811|NCT00334893|19616559|P2|COMPLETED|Overall Study||37
7968812|NCT00334893|19616560|P1|COMPLETED|Overall Study||36
7968813|NCT00334893|19616559|P2|STARTED|Overall Study||37
7968814|NCT00334893|19616560|P1|STARTED|Overall Study||37
7968815|NCT00334815|19616570|P2|NOT COMPLETED|Overall Study||10
7968816|NCT00334815|19616571|P1|NOT COMPLETED|Overall Study||7
7968817|NCT00334815|19616570|P2|COMPLETED|Overall Study||3
7968818|NCT00334815|19616571|P1|COMPLETED|Overall Study||9
7968819|NCT00334815|19616570|P2|STARTED|Overall Study||13
7968820|NCT00334815|19616571|P1|STARTED|Overall Study||16
7968821|NCT00334802|19616585|P2|NOT COMPLETED|Overall Study||40
7968822|NCT00334802|19616586|P1|NOT COMPLETED|Overall Study||6
7968823|NCT00334802|19616585|P2|COMPLETED|Overall Study||16
7968824|NCT00334802|19616586|P1|COMPLETED|Overall Study||0
7968825|NCT00334802|19616585|P2|STARTED|Overall Study||56
7968826|NCT00334802|19616586|P1|STARTED|Overall Study||6
7968827|NCT00334737|19616606|P3|NOT COMPLETED|Follow up Phase||6
7968828|NCT00334737|19616607|P2|NOT COMPLETED|Follow up Phase||3
7968829|NCT00334737|19616608|P1|NOT COMPLETED|Follow up Phase||5
7968830|NCT00334737|19616606|P3|COMPLETED|Follow up Phase||24
7968831|NCT00334737|19616607|P2|COMPLETED|Follow up Phase||29
7968832|NCT00334737|19616608|P1|COMPLETED|Follow up Phase||27
7968833|NCT00334737|19616606|P3|STARTED|Follow up Phase||30
7968834|NCT00334737|19616607|P2|STARTED|Follow up Phase||32
7968835|NCT00334737|19616608|P1|STARTED|Follow up Phase||32
7968836|NCT00334737|19616606|P3|NOT COMPLETED|Hospital Phase||4
7968837|NCT00334737|19616607|P2|NOT COMPLETED|Hospital Phase||2
7968838|NCT00334737|19616608|P1|NOT COMPLETED|Hospital Phase||2
7968839|NCT00334737|19616606|P3|COMPLETED|Hospital Phase||30
7968840|NCT00334737|19616607|P2|COMPLETED|Hospital Phase||32
7968841|NCT00334737|19616608|P1|COMPLETED|Hospital Phase||32
7968842|NCT00334737|19616606|P3|STARTED|Hospital Phase||34
7968843|NCT00334737|19616607|P2|STARTED|Hospital Phase||34
7968844|NCT00334737|19616608|P1|STARTED|Hospital Phase||34
7968845|NCT00334633|19616643|P3|NOT COMPLETED|Overall Study||82
7968846|NCT00334633|19616644|P2|NOT COMPLETED|Overall Study||82
7968847|NCT00334633|19616645|P1|NOT COMPLETED|Overall Study||80
7968848|NCT00334633|19616643|P3|COMPLETED|Overall Study||114
7968849|NCT00334633|19616644|P2|COMPLETED|Overall Study||118
7968850|NCT00334633|19616645|P1|COMPLETED|Overall Study||117
7968851|NCT00334633|19616643|P3|STARTED|Overall Study||196
7968852|NCT00334633|19616644|P2|STARTED|Overall Study||200
7968853|NCT00334633|19616645|P1|STARTED|Overall Study||197
7968854|NCT00334542|19616656|P1|NOT COMPLETED|Overall Study||5
7968855|NCT00334542|19616656|P1|COMPLETED|Overall Study||45
7968856|NCT00334542|19616656|P1|STARTED|Overall Study||50
7968857|NCT00334295|19616663|P1|NOT COMPLETED|Overall Study||5
7968858|NCT00334295|19616663|P1|COMPLETED|Overall Study||30
7968859|NCT00334295|19616663|P1|STARTED|Overall Study||35
7968860|NCT00334282|19616673|P2|NOT COMPLETED|Overall Study||108
7968861|NCT00334282|19616674|P1|NOT COMPLETED|Overall Study||222
7968862|NCT00334282|19616673|P2|COMPLETED|Overall Study||37
7968863|NCT00334282|19616674|P1|COMPLETED|Overall Study||68
7968864|NCT00334282|19616673|P2|STARTED|Overall Study||145
7968865|NCT00334282|19616674|P1|STARTED|Overall Study||290
7968866|NCT00334204|19616697|P1|NOT COMPLETED|Overall Study||2
7968867|NCT00334204|19616697|P1|COMPLETED|Overall Study||56
7968868|NCT00334204|19616697|P1|STARTED|Overall Study||58
7968869|NCT00334113|19616705|P2|NOT COMPLETED|Overall Study||3
7968870|NCT00334113|19616706|P1|NOT COMPLETED|Overall Study||2
7968871|NCT00334113|19616705|P2|COMPLETED|Overall Study||31
7968872|NCT00334113|19616706|P1|COMPLETED|Overall Study||30
7968873|NCT00334113|19616705|P2|STARTED|Overall Study||34
7968874|NCT00334113|19616706|P1|STARTED|Overall Study||32
7968875|NCT00334074|19616712|P1|NOT COMPLETED|Overall Study||0
7968876|NCT00334074|19616712|P1|COMPLETED|Overall Study||30
7968877|NCT00334074|19616712|P1|STARTED|Overall Study||30
7968878|NCT00334061|19616717|P1|NOT COMPLETED|Overall Study||0
7968879|NCT00334061|19616717|P1|COMPLETED|Overall Study|November 2007|125
7968880|NCT00334061|19616717|P1|STARTED|Overall Study|June 2006|125
7968881|NCT00333983|19616729|P3|NOT COMPLETED|Overall Study||2
7968882|NCT00333983|19616730|P2|NOT COMPLETED|Overall Study||5
7968883|NCT00333983|19616731|P1|NOT COMPLETED|Overall Study||3
7968884|NCT00333983|19616729|P3|COMPLETED|Overall Study||19
7968885|NCT00333983|19616730|P2|COMPLETED|Overall Study||16
7968886|NCT00333983|19616731|P1|COMPLETED|Overall Study||17
7968887|NCT00333983|19616729|P3|STARTED|Overall Study||21
7968888|NCT00333983|19616730|P2|STARTED|Overall Study||21
7968889|NCT00333983|19616731|P1|STARTED|Overall Study||20
7968890|NCT00333970|19616741|P2|NOT COMPLETED|Overall Study||7
7968891|NCT00333970|19616742|P1|NOT COMPLETED|Overall Study||13
7968892|NCT00333970|19616741|P2|COMPLETED|Overall Study||18
7968893|NCT00333970|19616742|P1|COMPLETED|Overall Study||37
7968894|NCT00333970|19616741|P2|STARTED|Overall Study||25
7968895|NCT00333970|19616742|P1|STARTED|Overall Study||50
7968896|NCT00333879|19616748|P1|NOT COMPLETED|Overall Study||0
7968897|NCT00333879|19616748|P1|COMPLETED|Overall Study||4
7968898|NCT00333879|19616748|P1|STARTED|Overall Study||4
7968899|NCT00333866|19616757|P4|NOT COMPLETED|Overall Study||66
7968900|NCT00333866|19616758|P3|NOT COMPLETED|Overall Study||51
7968901|NCT00333866|19616759|P2|NOT COMPLETED|Overall Study||64
7968902|NCT00333866|19616760|P1|NOT COMPLETED|Overall Study||48
7968903|NCT00333866|19616757|P4|COMPLETED|Overall Study||121
7968904|NCT00333866|19616758|P3|COMPLETED|Overall Study||133
7968905|NCT00333866|19616759|P2|COMPLETED|Overall Study||123
7968906|NCT00333866|19616760|P1|COMPLETED|Overall Study||141
7968907|NCT00333866|19616757|P4|TREATED|Overall Study||186
7968908|NCT00333866|19616758|P3|TREATED|Overall Study||182
7968909|NCT00333866|19616759|P2|TREATED|Overall Study||184
7968910|NCT00333866|19616760|P1|TREATED|Overall Study||184
7968911|NCT00333866|19616757|P4|STARTED|Overall Study||187
7968912|NCT00333866|19616758|P3|STARTED|Overall Study||184
7968913|NCT00333866|19616759|P2|STARTED|Overall Study||187
7968914|NCT00333866|19616760|P1|STARTED|Overall Study||189
7968915|NCT00333840|19616820|P4|NOT COMPLETED|Second-line Treatment Period||188
7968916|NCT00333840|19616821|P3|NOT COMPLETED|Second-line Treatment Period||14
7968917|NCT00333840|19616822|P2|NOT COMPLETED|Second-line Treatment Period||0
7968918|NCT00333840|19616823|P1|NOT COMPLETED|Second-line Treatment Period||0
7968919|NCT00333840|19616820|P4|COMPLETED|Second-line Treatment Period||175
7968920|NCT00333840|19616821|P3|COMPLETED|Second-line Treatment Period||0
7968921|NCT00333840|19616822|P2|COMPLETED|Second-line Treatment Period||0
7968922|NCT00333840|19616823|P1|COMPLETED|Second-line Treatment Period||0
7968923|NCT00333840|19616820|P4|STARTED|Second-line Treatment Period||363
7968924|NCT00333840|19616821|P3|STARTED|Second-line Treatment Period||14
7968925|NCT00333840|19616822|P2|STARTED|Second-line Treatment Period||0
7968926|NCT00333840|19616823|P1|STARTED|Second-line Treatment Period||0
7968927|NCT00333840|19616820|P4|NOT COMPLETED|First-line Treatment Period||0
7968928|NCT00333840|19616821|P3|NOT COMPLETED|First-line Treatment Period||0
7968929|NCT00333840|19616822|P2|NOT COMPLETED|First-line Treatment Period||546
7968930|NCT00333840|19616823|P1|NOT COMPLETED|First-line Treatment Period||286
7968931|NCT00333840|19616820|P4|COMPLETED|First-line Treatment Period||0
7968932|NCT00333840|19616821|P3|COMPLETED|First-line Treatment Period||0
7968933|NCT00333840|19616822|P2|COMPLETED|First-line Treatment Period||7
7968934|NCT00333840|19616823|P1|COMPLETED|First-line Treatment Period||267
7968935|NCT00333840|19616820|P4|Safety Population; Received Study Drug|First-line Treatment Period||0
7968936|NCT00333840|19616821|P3|Safety Population; Received Study Drug|First-line Treatment Period||0
7968937|NCT00333840|19616822|P2|Safety Population; Received Study Drug|First-line Treatment Period||533
7968938|NCT00333840|19616823|P1|Safety Population; Received Study Drug|First-line Treatment Period||551
7968939|NCT00333840|19616820|P4|STARTED|First-line Treatment Period||0
7968940|NCT00333840|19616821|P3|STARTED|First-line Treatment Period||0
7968941|NCT00333840|19616822|P2|STARTED|First-line Treatment Period||553
7968942|NCT00333840|19616823|P1|STARTED|First-line Treatment Period||553
7968943|NCT00333814|19616851|P3|NOT COMPLETED|Overall Study||5
7968944|NCT00333814|19616852|P2|NOT COMPLETED|Overall Study||4
7968945|NCT00333814|19616853|P1|NOT COMPLETED|Overall Study||3
7968946|NCT00333814|19616851|P3|COMPLETED|Overall Study||71
7968947|NCT00333814|19616852|P2|COMPLETED|Overall Study||73
7968948|NCT00333814|19616853|P1|COMPLETED|Overall Study||73
7968949|NCT00333814|19616851|P3|STARTED|Overall Study||76
7968950|NCT00333814|19616852|P2|STARTED|Overall Study||77
7968951|NCT00333814|19616853|P1|STARTED|Overall Study||76
7968952|NCT00333801|19616869|P2|NOT COMPLETED|Overall Study||6
7968953|NCT00333801|19616870|P1|NOT COMPLETED|Overall Study||8
7968954|NCT00333801|19616869|P2|COMPLETED|Overall Study||36
7968955|NCT00333801|19616870|P1|COMPLETED|Overall Study||35
7968956|NCT00333801|19616869|P2|STARTED|Overall Study||42
7968957|NCT00333801|19616870|P1|STARTED|Overall Study||43
7968958|NCT00333788|19616888|P1|NOT COMPLETED|Overall Study||162
7968959|NCT00333788|19616888|P1|COMPLETED|Overall Study||71
7968960|NCT00333788|19616888|P1|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233
7968961|NCT00333775|19616918|P3|NOT COMPLETED|Overall Study||247
7968962|NCT00333775|19616919|P2|NOT COMPLETED|Overall Study||248
7968963|NCT00333775|19616920|P1|NOT COMPLETED|Overall Study||241
7968964|NCT00333775|19616918|P3|COMPLETED|Overall Study||0
7968965|NCT00333775|19616919|P2|COMPLETED|Overall Study||0
7968966|NCT00333775|19616920|P1|COMPLETED|Overall Study||0
7968967|NCT00333775|19616918|P3|Received Treatment|Overall Study||245
7968968|NCT00333775|19616919|P2|Received Treatment|Overall Study||247
7968969|NCT00333775|19616920|P1|Received Treatment|Overall Study||238
7968970|NCT00333775|19616918|P3|STARTED|Overall Study||247
7968971|NCT00333775|19616919|P2|STARTED|Overall Study||248
7968972|NCT00333775|19616920|P1|STARTED|Overall Study||241
7968973|NCT00333762|19616940|P1|NOT COMPLETED|Overall Study||4
7968974|NCT00333762|19616940|P1|COMPLETED|Overall Study||0
7968975|NCT00333762|19616940|P1|STARTED|Overall Study||4
7968976|NCT00333710|19616947|P3|NOT COMPLETED|Overall Study||1
7968977|NCT00333710|19616948|P2|NOT COMPLETED|Overall Study||4
7968978|NCT00333710|19616949|P1|NOT COMPLETED|Overall Study||11
7968979|NCT00333710|19616947|P3|COMPLETED|Overall Study||15
7968980|NCT00333710|19616948|P2|COMPLETED|Overall Study||14
7968981|NCT00333710|19616949|P1|COMPLETED|Overall Study||8
7968982|NCT00333710|19616947|P3|STARTED|Overall Study||16
7968983|NCT00333710|19616948|P2|STARTED|Overall Study||18
7968984|NCT00333710|19616949|P1|STARTED|Overall Study||19
7968985|NCT00333619|19616959|P2|NOT COMPLETED|Overall Study||10
7968986|NCT00333619|19616960|P1|NOT COMPLETED|Overall Study||21
7968987|NCT00333619|19616959|P2|COMPLETED|Overall Study||99
7968988|NCT00333619|19616960|P1|COMPLETED|Overall Study||89
7968989|NCT00333619|19616959|P2|3-month Follow-up|Overall Study||105
7968990|NCT00333619|19616960|P1|3-month Follow-up|Overall Study||101
7968991|NCT00333619|19616959|P2|Post-treatment|Overall Study||109
7968992|NCT00333619|19616960|P1|Post-treatment|Overall Study||109
7968993|NCT00333619|19616959|P2|STARTED|Overall Study||109
7968994|NCT00333619|19616960|P1|STARTED|Overall Study||110
7968995|NCT00333606|19616970|P2|NOT COMPLETED|Overall Study||0
7968996|NCT00333606|19616971|P1|NOT COMPLETED|Overall Study||0
7968997|NCT00333606|19616970|P2|COMPLETED|Overall Study||30
7968998|NCT00333606|19616971|P1|COMPLETED|Overall Study||30
7968999|NCT00333606|19616970|P2|STARTED|Overall Study||30
7969000|NCT00333606|19616971|P1|STARTED|Overall Study||30
7969001|NCT00333437|19616979|P1|NOT COMPLETED|Overall Study||0
7969002|NCT00333437|19616979|P1|COMPLETED|Overall Study||7
7969003|NCT00333437|19616979|P1|STARTED|Overall Study||7
7969004|NCT00333359|19616989|P2|NOT COMPLETED|Overall Study||122
7969005|NCT00333359|19616990|P1|NOT COMPLETED|Overall Study||73
7969006|NCT00333359|19616989|P2|COMPLETED|Overall Study||260
7969007|NCT00333359|19616990|P1|COMPLETED|Overall Study||126
7969008|NCT00333359|19616989|P2|STARTED|Overall Study||382
7969009|NCT00333359|19616990|P1|STARTED|Overall Study||199
7969010|NCT00333229|19617033|P2|NOT COMPLETED|Overall Study||1
7969011|NCT00333229|19617034|P1|NOT COMPLETED|Overall Study||0
7969012|NCT00333229|19617033|P2|COMPLETED|Overall Study||4
7969013|NCT00333229|19617034|P1|COMPLETED|Overall Study||6
7969014|NCT00333229|19617033|P2|STARTED|Overall Study||5
7969015|NCT00333229|19617034|P1|STARTED|Overall Study||6
7969016|NCT00333177|19617052|P4|NOT COMPLETED|Overall Study||2
7969017|NCT00333177|19617053|P3|NOT COMPLETED|Overall Study||1
7969018|NCT00333177|19617054|P2|NOT COMPLETED|Overall Study||1
7969019|NCT00333177|19617055|P1|NOT COMPLETED|Overall Study||0
7969020|NCT00333177|19617052|P4|COMPLETED|Overall Study||12
7969021|NCT00333177|19617053|P3|COMPLETED|Overall Study||16
7969022|NCT00333177|19617054|P2|COMPLETED|Overall Study||16
7969023|NCT00333177|19617055|P1|COMPLETED|Overall Study||12
7969024|NCT00333177|19617052|P4|Received Intervention|Overall Study||12
7969025|NCT00333177|19617053|P3|Received Intervention|Overall Study||16
7969026|NCT00333177|19617054|P2|Received Intervention|Overall Study||16
7969027|NCT00333177|19617055|P1|Received Intervention|Overall Study||12
7969028|NCT00333177|19617052|P4|STARTED|Overall Study||14
7969029|NCT00333177|19617053|P3|STARTED|Overall Study||17
7969030|NCT00333177|19617054|P2|STARTED|Overall Study||17
7969031|NCT00333177|19617055|P1|STARTED|Overall Study||12
7969032|NCT00333138|19617104|P3|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
7969033|NCT00333138|19617105|P2|NOT COMPLETED|Extension Study (Month6 to End of Study)||42
7969034|NCT00333138|19617106|P1|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
7969035|NCT00333138|19617104|P3|COMPLETED|Extension Study (Month6 to End of Study)||37
7969036|NCT00333138|19617105|P2|COMPLETED|Extension Study (Month6 to End of Study)||45
7969037|NCT00333138|19617106|P1|COMPLETED|Extension Study (Month6 to End of Study)||40
7969038|NCT00333138|19617104|P3|STARTED|Extension Study (Month6 to End of Study)||80
7969039|NCT00333138|19617105|P2|STARTED|Extension Study (Month6 to End of Study)||87
7969040|NCT00333138|19617106|P1|STARTED|Extension Study (Month6 to End of Study)||83
7969041|NCT00333138|19617104|P3|NOT COMPLETED|Core Study (6 Months)||12
7969042|NCT00333138|19617105|P2|NOT COMPLETED|Core Study (6 Months)||6
7969043|NCT00333138|19617106|P1|NOT COMPLETED|Core Study (6 Months)||7
7969044|NCT00333138|19617104|P3|COMPLETED|Core Study (6 Months)||82
7969045|NCT00333138|19617105|P2|COMPLETED|Core Study (6 Months)||88
7969046|NCT00333138|19617106|P1|COMPLETED|Core Study (6 Months)||86
7969047|NCT00333138|19617104|P3|STARTED|Core Study (6 Months)||94
7969048|NCT00333138|19617105|P2|STARTED|Core Study (6 Months)||94
7969049|NCT00333138|19617106|P1|STARTED|Core Study (6 Months)||93
7969050|NCT00332839|19617145|P2|NOT COMPLETED|Follow-up (Months 12 - 60)||3
7969051|NCT00332839|19617146|P1|NOT COMPLETED|Follow-up (Months 12 - 60)||4
7969052|NCT00332839|19617145|P2|COMPLETED|Follow-up (Months 12 - 60)||31
7969053|NCT00332839|19617146|P1|COMPLETED|Follow-up (Months 12 - 60)||29
7969054|NCT00332839|19617145|P2|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34
7969055|NCT00332839|19617146|P1|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33
7969056|NCT00332839|19617145|P2|NOT COMPLETED|Core (Months 0 - 12)||18
7969057|NCT00332839|19617146|P1|NOT COMPLETED|Core (Months 0 - 12)||10
7969058|NCT00332839|19617145|P2|COMPLETED|Core (Months 0 - 12)||28
7969059|NCT00332839|19617146|P1|COMPLETED|Core (Months 0 - 12)||37
7969060|NCT00332839|19617145|P2|Safety Set|Core (Months 0 - 12)||46
7969061|NCT00332839|19617146|P1|Safety Set|Core (Months 0 - 12)||47
7969062|NCT00332839|19617145|P2|STARTED|Core (Months 0 - 12)||46
7969063|NCT00332839|19617146|P1|STARTED|Core (Months 0 - 12)||47
7969064|NCT00332722|19617166|P2|NOT COMPLETED|Overall Study||0
7969065|NCT00332722|19617167|P1|NOT COMPLETED|Overall Study||0
7969066|NCT00332722|19617166|P2|COMPLETED|Overall Study||60
7969067|NCT00332722|19617167|P1|COMPLETED|Overall Study||60
7969068|NCT00332722|19617166|P2|STARTED|Overall Study||60
7969069|NCT00332722|19617167|P1|STARTED|Overall Study||60
7969070|NCT00332709|19617177|P2|NOT COMPLETED|Overall Study||20
7969071|NCT00332709|19617178|P1|NOT COMPLETED|Overall Study||16
7969072|NCT00332709|19617177|P2|COMPLETED|Overall Study||21
7969073|NCT00332709|19617178|P1|COMPLETED|Overall Study||24
7969074|NCT00332709|19617177|P2|STARTED|Overall Study||41
7969075|NCT00332709|19617178|P1|STARTED|Overall Study||40
7969076|NCT00332696|19617202|P2|NOT COMPLETED|Overall Study||30
7969077|NCT00332696|19617203|P1|NOT COMPLETED|Overall Study||30
7969078|NCT00332696|19617202|P2|COMPLETED|Overall Study||2
7969079|NCT00332696|19617203|P1|COMPLETED|Overall Study|Completed Month 3 Visit|2
7969080|NCT00332696|19617202|P2|Completed Day 14 Visit|Overall Study||15
7969081|NCT00332696|19617203|P1|Completed Day 14 Visit|Overall Study|Primary Endpoint|21
7969082|NCT00332696|19617202|P2|STARTED|Overall Study||32
7969083|NCT00332696|19617203|P1|STARTED|Overall Study||32
7969084|NCT00332644|19617235|P6|NOT COMPLETED|Overall Study||15
7969085|NCT00332644|19617236|P5|NOT COMPLETED|Overall Study||12
7969086|NCT00332644|19617237|P4|NOT COMPLETED|Overall Study||20
7969087|NCT00332644|19617238|P3|NOT COMPLETED|Overall Study||9
7969088|NCT00332644|19617239|P2|NOT COMPLETED|Overall Study||22
7969089|NCT00332644|19617240|P1|NOT COMPLETED|Overall Study||12
7969090|NCT00332644|19617235|P6|COMPLETED|Overall Study||174
7969091|NCT00332644|19617236|P5|COMPLETED|Overall Study||250
7969092|NCT00332644|19617237|P4|COMPLETED|Overall Study||244
7969093|NCT00332644|19617238|P3|COMPLETED|Overall Study||258
7969094|NCT00332644|19617239|P2|COMPLETED|Overall Study||238
7969095|NCT00332644|19617240|P1|COMPLETED|Overall Study||250
7969096|NCT00332644|19617235|P6|STARTED|Overall Study||189
7969097|NCT00332644|19617236|P5|STARTED|Overall Study||262
7969098|NCT00332644|19617237|P4|STARTED|Overall Study||264
7969099|NCT00332644|19617238|P3|STARTED|Overall Study||267
7969100|NCT00332644|19617239|P2|STARTED|Overall Study||260
7969101|NCT00332644|19617240|P1|STARTED|Overall Study||262
7969102|NCT00332605|19617257|P3|NOT COMPLETED|Overall Study||8
7969103|NCT00332605|19617258|P2|NOT COMPLETED|Overall Study||2
7969104|NCT00332605|19617259|P1|NOT COMPLETED|Overall Study||2
7969105|NCT00332605|19617257|P3|COMPLETED|Overall Study||9
7969106|NCT00332605|19617258|P2|COMPLETED|Overall Study||12
7969107|NCT00332605|19617259|P1|COMPLETED|Overall Study||12
7969108|NCT00332605|19617257|P3|STARTED|Overall Study||17
7969109|NCT00332605|19617258|P2|STARTED|Overall Study||14
7969110|NCT00332605|19617259|P1|STARTED|Overall Study||14
7969111|NCT00332579|19617269|P2|NOT COMPLETED|Overall Study||1
7969112|NCT00332579|19617270|P1|NOT COMPLETED|Overall Study||1
7969113|NCT00332579|19617269|P2|COMPLETED|Overall Study||12
7969114|NCT00332579|19617270|P1|COMPLETED|Overall Study||11
7969115|NCT00332579|19617269|P2|STARTED|Overall Study||13
7969116|NCT00332579|19617270|P1|STARTED|Overall Study||12
7969117|NCT00332488|19617279|P3|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||21
7969118|NCT00332488|19617280|P2|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
7969119|NCT00332488|19617281|P1|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
7969120|NCT00332488|19617279|P3|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||233
7969121|NCT00332488|19617280|P2|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||70
7969122|NCT00332488|19617281|P1|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||27
7969123|NCT00332488|19617279|P3|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254
7969124|NCT00332488|19617280|P2|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72
7969125|NCT00332488|19617281|P1|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29
7969126|NCT00332488|19617279|P3|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56
7969127|NCT00332488|19617280|P2|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18
7969128|NCT00332488|19617281|P1|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50
7969129|NCT00332488|19617279|P3|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119
7969130|NCT00332488|19617280|P2|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152
7969131|NCT00332488|19617281|P1|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133
7969132|NCT00332488|19617279|P3|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175
7969133|NCT00332488|19617280|P2|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170
7969134|NCT00332488|19617281|P1|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183
7969135|NCT00332462|19617293|P1|NOT COMPLETED|Overall Study||16
7969136|NCT00332462|19617293|P1|COMPLETED|Overall Study||18
7969137|NCT00332462|19617293|P1|Patients Treated With Sandimmun® Optoral|Overall Study||29
7969138|NCT00332462|19617293|P1|Patients Treated With Sandimmun® i.v.|Overall Study||34
7969139|NCT00332462|19617293|P1|STARTED|Overall Study|Safety and Intention to treat population.|34
7969140|NCT00332332|19617300|P1|NOT COMPLETED|Overall Study||68
7969141|NCT00332332|19617300|P1|COMPLETED|Overall Study||178
7969142|NCT00332332|19617300|P1|Received Study Medication|Overall Study||230
7969143|NCT00332332|19617300|P1|STARTED|Overall Study||246
7969144|NCT00332241|19617309|P2|NOT COMPLETED|Overall Study||8
7969145|NCT00332241|19617310|P1|NOT COMPLETED|Overall Study||15
7969146|NCT00332241|19617309|P2|COMPLETED|Overall Study||39
7969147|NCT00332241|19617310|P1|COMPLETED|Overall Study||36
7969148|NCT00332241|19617309|P2|STARTED|Overall Study||47
7969149|NCT00332241|19617310|P1|STARTED|Overall Study||51
7969150|NCT00332202|19617332|P2|NOT COMPLETED|Overall Study||125
7969151|NCT00332202|19617333|P1|NOT COMPLETED|Overall Study||241
7969152|NCT00332202|19617332|P2|COMPLETED|Overall Study||129
7969153|NCT00332202|19617333|P1|COMPLETED|Overall Study||263
7969154|NCT00332202|19617332|P2|Received At Least One Dose of Study Drug|Overall Study||249
7969155|NCT00332202|19617333|P1|Received At Least One Dose of Study Drug|Overall Study||493
7969156|NCT00332202|19617332|P2|STARTED|Overall Study||254
7969157|NCT00332202|19617333|P1|STARTED|Overall Study||504
7969158|NCT00332189|19617362|P1|NOT COMPLETED|Overall Study||21
7969159|NCT00332189|19617362|P1|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90
7969160|NCT00332189|19617362|P1|STARTED|Overall Study||111
7969161|NCT00332163|19617369|P2|NOT COMPLETED|Overall Study||0
7969162|NCT00332163|19617370|P1|NOT COMPLETED|Overall Study||0
7969163|NCT00332163|19617369|P2|COMPLETED|Overall Study||47
7969164|NCT00332163|19617370|P1|COMPLETED|Overall Study||48
7969165|NCT00332163|19617369|P2|Received Treatment|Overall Study||47
7969166|NCT00332163|19617370|P1|Received Treatment|Overall Study||48
7969167|NCT00332163|19617369|P2|STARTED|Overall Study||47
7969168|NCT00332163|19617370|P1|STARTED|Overall Study||48
7969169|NCT00331864|19617404|P2|NOT COMPLETED|Overall Study||4
7969170|NCT00331864|19617405|P1|NOT COMPLETED|Overall Study||58
7969171|NCT00331864|19617404|P2|COMPLETED|Overall Study||14
7969172|NCT00331864|19617405|P1|COMPLETED|Overall Study||455
7969173|NCT00331864|19617404|P2|STARTED|Overall Study||18
7969174|NCT00331864|19617405|P1|STARTED|Overall Study||513
7969175|NCT00331799|19617424|P1|NOT COMPLETED|Overall Study||3
7969176|NCT00331799|19617424|P1|COMPLETED|Overall Study||15
7969177|NCT00331799|19617424|P1|STARTED|Overall Study||18
7969178|NCT00331773|19617430|P2|NOT COMPLETED|Overall Study||7
7969179|NCT00331773|19617431|P1|NOT COMPLETED|Overall Study||16
7969180|NCT00331773|19617430|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|550
7969181|NCT00331773|19617431|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|542
7969182|NCT00331773|19617430|P2|STARTED|Overall Study||557
7969183|NCT00331773|19617431|P1|STARTED|Overall Study||558
7969184|NCT00331760|19617461|P2|NOT COMPLETED|Overall Study||8
7969185|NCT00331760|19617462|P1|NOT COMPLETED|Overall Study||15
7969186|NCT00331760|19617461|P2|COMPLETED|Overall Study||40
7969187|NCT00331760|19617462|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
7969188|NCT00331760|19617461|P2|STARTED|Overall Study||48
7969189|NCT00331760|19617462|P1|STARTED|Overall Study||58
7969190|NCT00331682|19617483|P1|NOT COMPLETED|Overall Study||1
7969191|NCT00331682|19617483|P1|COMPLETED|Overall Study||9
7969192|NCT00331682|19617483|P1|STARTED|Overall Study||10
7969193|NCT00331630|19617489|P1|NOT COMPLETED|Follow up for 5 Years||29
7969194|NCT00331630|19617489|P1|COMPLETED|Follow up for 5 Years||0
7969195|NCT00331630|19617489|P1|STARTED|Follow up for 5 Years|One patient did not enter follow up as was lost to follow up|29
7969196|NCT00331630|19617489|P1|NOT COMPLETED|Evaluated for and Completed SOC Surgery||2
7969197|NCT00331630|19617489|P1|COMPLETED|Evaluated for and Completed SOC Surgery||28
7969198|NCT00331630|19617489|P1|STARTED|Evaluated for and Completed SOC Surgery||30
7969199|NCT00331630|19617489|P1|NOT COMPLETED|Treatment on Study||0
7969200|NCT00331630|19617489|P1|COMPLETED|Treatment on Study||30
7969201|NCT00331630|19617489|P1|Completed 4 Cycles|Treatment on Study||30
7969202|NCT00331630|19617489|P1|Completed 1st Cycle|Treatment on Study||30
7969203|NCT00331630|19617489|P1|STARTED|Treatment on Study||30
7969204|NCT00331552|19617501|P2|NOT COMPLETED|Period 3: Phase II||0
7969205|NCT00331552|19617502|P1|NOT COMPLETED|Period 3: Phase II||2
7969206|NCT00331552|19617501|P2|COMPLETED|Period 3: Phase II||0
7969207|NCT00331552|19617502|P1|COMPLETED|Period 3: Phase II||22
7969208|NCT00331552|19617501|P2|STARTED|Period 3: Phase II||0
7969209|NCT00331552|19617502|P1|STARTED|Period 3: Phase II||24
7969210|NCT00331552|19617501|P2|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
7969211|NCT00331552|19617502|P1|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
7969212|NCT00331552|19617501|P2|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
7969213|NCT00331552|19617502|P1|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
7969214|NCT00331552|19617501|P2|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
7969215|NCT00331552|19617502|P1|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
7969216|NCT00331552|19617501|P2|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
7969217|NCT00331552|19617502|P1|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
7969218|NCT00331552|19617501|P2|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
7969219|NCT00331552|19617502|P1|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
7969220|NCT00331552|19617501|P2|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
7969221|NCT00331552|19617502|P1|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
7969222|NCT00331422|19617516|P1|NOT COMPLETED|Overall Study||5
7969223|NCT00331422|19617516|P1|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2
7969224|NCT00331422|19617516|P1|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7
7969225|NCT00331409|19617525|P1|NOT COMPLETED|Overall Study||4
7969226|NCT00331409|19617525|P1|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15
7969227|NCT00331409|19617525|P1|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19
7969228|NCT00331344|19617533|P9|NOT COMPLETED|Phase II||4
7969229|NCT00331344|19617534|P8|NOT COMPLETED|Phase II||0
7969230|NCT00331344|19617535|P7|NOT COMPLETED|Phase II||0
7969231|NCT00331344|19617536|P6|NOT COMPLETED|Phase II||0
7969232|NCT00331344|19617537|P5|NOT COMPLETED|Phase II||0
7969233|NCT00331344|19617538|P4|NOT COMPLETED|Phase II||0
7969234|NCT00331344|19617539|P3|NOT COMPLETED|Phase II||0
7969235|NCT00331344|19617540|P2|NOT COMPLETED|Phase II||0
7969236|NCT00331344|19617541|P1|NOT COMPLETED|Phase II||0
7969237|NCT00331344|19617533|P9|COMPLETED|Phase II||48
7969238|NCT00331344|19617534|P8|COMPLETED|Phase II||6
7969239|NCT00331344|19617535|P7|COMPLETED|Phase II||0
7969240|NCT00331344|19617536|P6|COMPLETED|Phase II||0
7969241|NCT00331344|19617537|P5|COMPLETED|Phase II||0
7969242|NCT00331344|19617538|P4|COMPLETED|Phase II||0
7969243|NCT00331344|19617539|P3|COMPLETED|Phase II||0
7969244|NCT00331344|19617540|P2|COMPLETED|Phase II||0
7969245|NCT00331344|19617541|P1|COMPLETED|Phase II||0
7969246|NCT00331344|19617533|P9|STARTED|Phase II|Protocol enrollment (63) minus 11 ineligible prior to receiving treatment.|52
7969247|NCT00331344|19617534|P8|STARTED|Phase II|6 patients in Phase I Group VIa continued to the Phase II period.|6
7969248|NCT00331344|19617535|P7|STARTED|Phase II||0
7969249|NCT00331344|19617536|P6|STARTED|Phase II||0
7969250|NCT00331344|19617537|P5|STARTED|Phase II||0
7969251|NCT00331344|19617538|P4|STARTED|Phase II||0
7969252|NCT00331344|19617539|P3|STARTED|Phase II||0
7969253|NCT00331344|19617540|P2|STARTED|Phase II||0
7969254|NCT00331344|19617541|P1|STARTED|Phase II||0
7969255|NCT00331344|19617533|P9|NOT COMPLETED|Phase I||0
7969256|NCT00331344|19617534|P8|NOT COMPLETED|Phase I||1
7969257|NCT00331344|19617535|P7|NOT COMPLETED|Phase I||0
7969258|NCT00331344|19617536|P6|NOT COMPLETED|Phase I||2
7969259|NCT00331344|19617537|P5|NOT COMPLETED|Phase I||2
7969260|NCT00331344|19617538|P4|NOT COMPLETED|Phase I||1
7969261|NCT00331344|19617539|P3|NOT COMPLETED|Phase I||0
7969262|NCT00331344|19617540|P2|NOT COMPLETED|Phase I||0
7969263|NCT00331344|19617541|P1|NOT COMPLETED|Phase I||0
7969264|NCT00331344|19617533|P9|COMPLETED|Phase I||0
7969265|NCT00331344|19617534|P8|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
7969266|NCT00331344|19617535|P7|COMPLETED|Phase I||4
7969267|NCT00331344|19617536|P6|COMPLETED|Phase I|2 participants reached dose limiting toxicity|3
7969268|NCT00331344|19617537|P5|COMPLETED|Phase I|2 participants reached dose limiting toxicity|4
7969269|NCT00331344|19617538|P4|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
7969270|NCT00331344|19617539|P3|COMPLETED|Phase I||3
7969271|NCT00331344|19617540|P2|COMPLETED|Phase I||3
7969272|NCT00331344|19617541|P1|COMPLETED|Phase I||3
7969273|NCT00331344|19617533|P9|STARTED|Phase I||0
7969274|NCT00331344|19617534|P8|STARTED|Phase I|1 participant who was enrolled died prior to initiating protocol therapy.|6
7969275|NCT00331344|19617535|P7|STARTED|Phase I||4
7969276|NCT00331344|19617536|P6|STARTED|Phase I||5
7969277|NCT00331344|19617537|P5|STARTED|Phase I||6
7969278|NCT00331344|19617538|P4|STARTED|Phase I||6
7969279|NCT00331344|19617539|P3|STARTED|Phase I||3
7969280|NCT00331344|19617540|P2|STARTED|Phase I||3
7969281|NCT00331344|19617541|P1|STARTED|Phase I||3
7969282|NCT00331162|19617557|P2|NOT COMPLETED|Overall Study||0
7969283|NCT00331162|19617558|P1|NOT COMPLETED|Overall Study||0
7969284|NCT00331162|19617557|P2|COMPLETED|Overall Study||109
7969285|NCT00331162|19617558|P1|COMPLETED|Overall Study||113
7969286|NCT00331162|19617557|P2|STARTED|Overall Study||109
7969287|NCT00331162|19617558|P1|STARTED|Overall Study||113
7969288|NCT00331006|19617578|P1|NOT COMPLETED|Follow-Up Phase II||3
7969289|NCT00331006|19617578|P1|COMPLETED|Follow-Up Phase II||11
7969290|NCT00331006|19617578|P1|STARTED|Follow-Up Phase II||14
7969291|NCT00331006|19617578|P1|NOT COMPLETED|Follow-Up Phase I||1
7969292|NCT00331006|19617578|P1|COMPLETED|Follow-Up Phase I||14
7969293|NCT00331006|19617578|P1|STARTED|Follow-Up Phase I||15
7969294|NCT00331006|19617578|P1|NOT COMPLETED|Treatment Phase||1
7969295|NCT00331006|19617578|P1|COMPLETED|Treatment Phase||15
7969296|NCT00331006|19617578|P1|STARTED|Treatment Phase||16
7969297|NCT00331006|19617578|P1|NOT COMPLETED|Screening Phase||7
7969298|NCT00331006|19617578|P1|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16
7969299|NCT00331006|19617578|P1|STARTED|Screening Phase||23
7969300|NCT00330967|19617591|P2|NOT COMPLETED|Overall Study||14
7969301|NCT00330967|19617592|P1|NOT COMPLETED|Overall Study||0
7969302|NCT00330967|19617591|P2|COMPLETED|Overall Study||11
7969303|NCT00330967|19617592|P1|COMPLETED|Overall Study||0
7969304|NCT00330967|19617591|P2|STARTED|Overall Study||25
7969305|NCT00330967|19617592|P1|STARTED|Overall Study||0
7969306|NCT00330928|19617603|P1|NOT COMPLETED|Overall Study||17
7969307|NCT00330928|19617603|P1|COMPLETED|Overall Study||89
7969308|NCT00330928|19617603|P1|1 Year Phone Contact|Overall Study||89
7969309|NCT00330928|19617603|P1|7 Day Phone Contact|Overall Study||99
7969310|NCT00330928|19617603|P1|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106
7969311|NCT00330915|19617608|P1|NOT COMPLETED|Overall Study||0
7969312|NCT00330915|19617608|P1|COMPLETED|Overall Study||37
7969313|NCT00330915|19617608|P1|STARTED|Overall Study||37
7969314|NCT00330876|19617615|P2|NOT COMPLETED|Overall Study||13
7969315|NCT00330876|19617616|P1|NOT COMPLETED|Overall Study||71
7969316|NCT00330876|19617615|P2|COMPLETED|Overall Study||77
7969317|NCT00330876|19617616|P1|COMPLETED|Overall Study||378
7969318|NCT00330876|19617615|P2|STARTED|Overall Study||90
7969319|NCT00330876|19617616|P1|STARTED|Overall Study||449
7969320|NCT00330863|19617626|P2|NOT COMPLETED|Overall Study||80
7969321|NCT00330863|19617627|P1|NOT COMPLETED|Overall Study||81
7969322|NCT00330863|19617626|P2|COMPLETED|Overall Study||72
7969323|NCT00330863|19617627|P1|COMPLETED|Overall Study||72
7969324|NCT00330863|19617626|P2|STARTED|Overall Study||152
7969325|NCT00330863|19617627|P1|STARTED|Overall Study||153
7969326|NCT00330759|19617645|P2|NOT COMPLETED|Overall Study||706
7969327|NCT00330759|19617646|P1|NOT COMPLETED|Overall Study||712
7969328|NCT00330759|19617645|P2|COMPLETED|Overall Study||180
7969329|NCT00330759|19617646|P1|COMPLETED|Overall Study||178
7969330|NCT00330759|19617645|P2|Received Investigational Product|Overall Study||878
7969331|NCT00330759|19617646|P1|Received Investigational Product|Overall Study||878
7969332|NCT00330759|19617645|P2|STARTED|Overall Study||886
7969333|NCT00330759|19617646|P1|STARTED|Overall Study||890
7969334|NCT00330733|19617658|P2|NOT COMPLETED|Overall Study||5
7969335|NCT00330733|19617659|P1|NOT COMPLETED|Overall Study||7
7969336|NCT00330733|19617658|P2|COMPLETED|Overall Study||29
7969337|NCT00330733|19617659|P1|COMPLETED|Overall Study||30
7969338|NCT00330733|19617658|P2|Received Study Medication|Overall Study||34
7969339|NCT00330733|19617659|P1|Received Study Medication|Overall Study||36
7969340|NCT00330733|19617658|P2|STARTED|Overall Study||34
7969341|NCT00330733|19617659|P1|STARTED|Overall Study||37
7969342|NCT00330681|19617679|P2|NOT COMPLETED|Overall Study||14
7969343|NCT00330681|19617680|P1|NOT COMPLETED|Overall Study||9
7969344|NCT00330681|19617679|P2|COMPLETED|Overall Study||90
7969345|NCT00330681|19617680|P1|COMPLETED|Overall Study||93
7969346|NCT00330681|19617679|P2|STARTED|Overall Study||104
7969347|NCT00330681|19617680|P1|STARTED|Overall Study||102
7969348|NCT00330668|19617702|P1|NOT COMPLETED|QD Dosing Period||78
7969349|NCT00330668|19617702|P1|COMPLETED|QD Dosing Period||0
7969350|NCT00330668|19617702|P1|STARTED|QD Dosing Period||78
7969351|NCT00330668|19617702|P1|NOT COMPLETED|BID Dosing Period||36
7969352|NCT00330668|19617702|P1|COMPLETED|BID Dosing Period||78
7969353|NCT00330668|19617702|P1|STARTED|BID Dosing Period||114
7969354|NCT00330616|19617710|P1|NOT COMPLETED|Overall Study||21
7969355|NCT00330616|19617710|P1|COMPLETED|Overall Study||14
7969356|NCT00330616|19617710|P1|STARTED|Overall Study||35
7969357|NCT00330564|19617729|P1|NOT COMPLETED|Overall Study||0
7969358|NCT00330564|19617729|P1|COMPLETED|Overall Study||15
7969359|NCT00330564|19617729|P1|STARTED|Overall Study||15
7969360|NCT00330551|19617736|P2|NOT COMPLETED|Overall Study||16
7969361|NCT00330551|19617737|P1|NOT COMPLETED|Overall Study||10
7969362|NCT00330551|19617736|P2|COMPLETED|Overall Study||27
7969363|NCT00330551|19617737|P1|COMPLETED|Overall Study||30
7969364|NCT00330551|19617736|P2|STARTED|Overall Study||43
7969365|NCT00330551|19617737|P1|STARTED|Overall Study||40
7969366|NCT00330460|19617761|P2|NOT COMPLETED|Overall Study||33
7969367|NCT00330460|19617762|P1|NOT COMPLETED|Overall Study||42
7969368|NCT00330460|19617761|P2|COMPLETED|Overall Study||561
7969369|NCT00330460|19617762|P1|COMPLETED|Overall Study||553
7969370|NCT00330460|19617761|P2|STARTED|Overall Study||594
7969371|NCT00330460|19617762|P1|STARTED|Overall Study||595
7969372|NCT00330421|19617776|P2|NOT COMPLETED|Overall Study||0
7969373|NCT00330421|19617777|P1|NOT COMPLETED|Overall Study||0
7969374|NCT00330421|19617776|P2|COMPLETED|Overall Study||0
7969375|NCT00330421|19617777|P1|COMPLETED|Overall Study||15
7969376|NCT00330421|19617776|P2|STARTED|Overall Study||0
7969377|NCT00330421|19617777|P1|STARTED|Overall Study||15
7969378|NCT00330382|19617783|P2|NOT COMPLETED|Overall Study||17
7969379|NCT00330382|19617784|P1|NOT COMPLETED|Overall Study||24
7969380|NCT00330382|19617783|P2|COMPLETED|Overall Study||48
7969381|NCT00330382|19617784|P1|COMPLETED|Overall Study||43
7969382|NCT00330382|19617783|P2|STARTED|Overall Study||65
7969383|NCT00330382|19617784|P1|STARTED|Overall Study||67
7969384|NCT00330343|19617805|P1|NOT COMPLETED|Overall Study||5
7969385|NCT00330343|19617805|P1|COMPLETED|Overall Study||59
7969386|NCT00330343|19617805|P1|STARTED|Overall Study||64
7969387|NCT00330187|19617813|P4|NOT COMPLETED|Overall Study||14
7969388|NCT00330187|19617814|P3|NOT COMPLETED|Overall Study||18
7969389|NCT00330187|19617815|P2|NOT COMPLETED|Overall Study||18
7969390|NCT00330187|19617816|P1|NOT COMPLETED|Overall Study||20
7969391|NCT00330187|19617813|P4|COMPLETED|Overall Study||18
7969392|NCT00330187|19617814|P3|COMPLETED|Overall Study||11
7969393|NCT00330187|19617815|P2|COMPLETED|Overall Study||18
7969394|NCT00330187|19617816|P1|COMPLETED|Overall Study||17
7969395|NCT00330187|19617813|P4|STARTED|Overall Study||32
7969396|NCT00330187|19617814|P3|STARTED|Overall Study||29
7969397|NCT00330187|19617815|P2|STARTED|Overall Study||36
7969398|NCT00330187|19617816|P1|STARTED|Overall Study||37
7969399|NCT00330174|19617828|P2|NOT COMPLETED|Overall Study||19
7969400|NCT00330174|19617829|P1|NOT COMPLETED|Overall Study||22
7969401|NCT00330174|19617828|P2|COMPLETED|Overall Study||26
7969402|NCT00330174|19617829|P1|COMPLETED|Overall Study||23
7969403|NCT00330174|19617828|P2|STARTED|Overall Study||45
7969404|NCT00330174|19617829|P1|STARTED|Overall Study||45
7969405|NCT00330161|19617841|P1|NOT COMPLETED|Overall Study||0
7969406|NCT00330161|19617841|P1|COMPLETED|Overall Study||29
7969407|NCT00330161|19617841|P1|STARTED|Overall Study||29
7969408|NCT00329901|19617853|P3|NOT COMPLETED|Overall Study||4
7969409|NCT00329901|19617854|P2|NOT COMPLETED|Overall Study||5
7969410|NCT00329901|19617855|P1|NOT COMPLETED|Overall Study||9
7969411|NCT00329901|19617853|P3|COMPLETED|Overall Study||353
7969412|NCT00329901|19617854|P2|COMPLETED|Overall Study||349
7969413|NCT00329901|19617855|P1|COMPLETED|Overall Study||352
7969414|NCT00329901|19617853|P3|STARTED|Overall Study||357
7969415|NCT00329901|19617854|P2|STARTED|Overall Study||354
7969416|NCT00329901|19617855|P1|STARTED|Overall Study||361
7969417|NCT00329849|19617885|P2|NOT COMPLETED|Overall Study||4
7969418|NCT00329849|19617886|P1|NOT COMPLETED|Overall Study||6
7969419|NCT00329849|19617885|P2|COMPLETED|Overall Study||546
7969420|NCT00329849|19617886|P1|COMPLETED|Overall Study||944
7969421|NCT00329849|19617885|P2|STARTED|Overall Study||550
7969422|NCT00329849|19617886|P1|STARTED|Overall Study||950
7969423|NCT00329836|19617906|P1|NOT COMPLETED|Overall Study||0
7969424|NCT00329836|19617906|P1|COMPLETED|Overall Study||41
7969425|NCT00329836|19617906|P1|STARTED|Overall Study||41
7969426|NCT00329797|19617912|P2|NOT COMPLETED|Overall Study||6
7969427|NCT00329797|19617913|P1|NOT COMPLETED|Overall Study||7
7969428|NCT00329797|19617912|P2|COMPLETED|Overall Study||46
7969429|NCT00329797|19617913|P1|COMPLETED|Overall Study||50
7969430|NCT00329797|19617912|P2|STARTED|Overall Study||52
7969431|NCT00329797|19617913|P1|STARTED|Overall Study||57
7969432|NCT00329784|19617929|P4|NOT COMPLETED|Overall Study||0
7969433|NCT00329784|19617930|P3|NOT COMPLETED|Overall Study||0
7969434|NCT00329784|19617931|P2|NOT COMPLETED|Overall Study||5
7969435|NCT00329784|19617932|P1|NOT COMPLETED|Overall Study||5
7969436|NCT00329784|19617929|P4|COMPLETED|Overall Study||47
7969437|NCT00329784|19617930|P3|COMPLETED|Overall Study||51
7969438|NCT00329784|19617931|P2|COMPLETED|Overall Study||267
7969439|NCT00329784|19617932|P1|COMPLETED|Overall Study||265
7969440|NCT00329784|19617929|P4|STARTED|Overall Study||47
7969441|NCT00329784|19617930|P3|STARTED|Overall Study||51
7969442|NCT00329784|19617931|P2|STARTED|Overall Study||272
7969443|NCT00329784|19617932|P1|STARTED|Overall Study||270
7969444|NCT00329771|19617954|P1|NOT COMPLETED|Overall Study||3
7969445|NCT00329771|19617954|P1|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25
7969446|NCT00329771|19617954|P1|STARTED|Overall Study||28
7969447|NCT00329745|19617960|P2|NOT COMPLETED|Overall Study||102
7969448|NCT00329745|19617961|P1|NOT COMPLETED|Overall Study||87
7969449|NCT00329745|19617960|P2|COMPLETED|Overall Study||4226
7969450|NCT00329745|19617961|P1|COMPLETED|Overall Study||4272
7969451|NCT00329745|19617960|P2|STARTED|Overall Study||4328
7969452|NCT00329745|19617961|P1|STARTED|Overall Study||4359
7969453|NCT00329732|19617971|P2|NOT COMPLETED|Overall Study||0
7969454|NCT00329732|19617972|P1|NOT COMPLETED|Overall Study||0
7969455|NCT00329732|19617971|P2|COMPLETED|Overall Study||0
7969456|NCT00329732|19617972|P1|COMPLETED|Overall Study||2
7969457|NCT00329732|19617971|P2|STARTED|Overall Study||0
7969458|NCT00329732|19617972|P1|STARTED|Overall Study||2
7969459|NCT00329719|19617981|P4|NOT COMPLETED|Overall Study||1
7969460|NCT00329719|19617982|P3|NOT COMPLETED|Overall Study||0
7969461|NCT00329719|19617983|P2|NOT COMPLETED|Overall Study||0
7969462|NCT00329719|19617984|P1|NOT COMPLETED|Overall Study||0
7969463|NCT00329719|19617981|P4|COMPLETED|Overall Study||44
7969464|NCT00329719|19617982|P3|COMPLETED|Overall Study||9
7969465|NCT00329719|19617983|P2|COMPLETED|Overall Study||49
7969466|NCT00329719|19617984|P1|COMPLETED|Overall Study||12
7969467|NCT00329719|19617981|P4|STARTED|Overall Study||45
7969468|NCT00329719|19617982|P3|STARTED|Overall Study||9
7969469|NCT00329719|19617983|P2|STARTED|Overall Study||49
7969470|NCT00329719|19617984|P1|STARTED|Overall Study||12
7969471|NCT00329641|19618006|P1|NOT COMPLETED|Overall Study||6
7969472|NCT00329641|19618006|P1|COMPLETED|Overall Study||19
7969473|NCT00329641|19618006|P1|Eligible and Received Treatment|Overall Study||24
7969474|NCT00329641|19618006|P1|Eligible|Overall Study||25
7969475|NCT00329641|19618006|P1|STARTED|Overall Study||25
7969476|NCT00329602|19618015|P3|NOT COMPLETED|40-Week Open-Label Treatment Phase||36
7969477|NCT00329602|19618016|P2|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
7969478|NCT00329602|19618017|P1|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
7969479|NCT00329602|19618015|P3|COMPLETED|40-Week Open-Label Treatment Phase||233
7969480|NCT00329602|19618016|P2|COMPLETED|40-Week Open-Label Treatment Phase||0
7969481|NCT00329602|19618017|P1|COMPLETED|40-Week Open-Label Treatment Phase||0
7969482|NCT00329602|19618015|P3|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269
7969483|NCT00329602|19618016|P2|STARTED|40-Week Open-Label Treatment Phase||0
7969484|NCT00329602|19618017|P1|STARTED|40-Week Open-Label Treatment Phase||0
7969485|NCT00329602|19618015|P3|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0
7969486|NCT00329602|19618016|P2|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99
7969487|NCT00329602|19618017|P1|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119
7969488|NCT00329602|19618015|P3|COMPLETED|26-Week Double-Blind Treatment Phase||0
7969489|NCT00329602|19618016|P2|COMPLETED|26-Week Double-Blind Treatment Phase||98
7969490|NCT00329602|19618017|P1|COMPLETED|26-Week Double-Blind Treatment Phase||88
7969491|NCT00329602|19618015|P3|STARTED|26-Week Double-Blind Treatment Phase||0
7969492|NCT00329602|19618016|P2|STARTED|26-Week Double-Blind Treatment Phase||197
7969493|NCT00329602|19618017|P1|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207
7969494|NCT00329550|19618055|P3|NOT COMPLETED|Overall Study||4
7969495|NCT00329550|19618056|P2|NOT COMPLETED|Overall Study||4
7969496|NCT00329550|19618057|P1|NOT COMPLETED|Overall Study||4
7969497|NCT00329550|19618055|P3|COMPLETED|Overall Study||12
7969498|NCT00329550|19618056|P2|COMPLETED|Overall Study||11
7969499|NCT00329550|19618057|P1|COMPLETED|Overall Study||5
7969500|NCT00329550|19618055|P3|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16
7969501|NCT00329550|19618056|P2|STARTED|Overall Study||15
7969502|NCT00329550|19618057|P1|STARTED|Overall Study||9
7969503|NCT00329524|19618304|P1|NOT COMPLETED|Overall Study||0
7969504|NCT00329524|19618304|P1|COMPLETED|Overall Study||5
7969505|NCT00329524|19618304|P1|STARTED|Overall Study||5
7969506|NCT00329433|19618312|P2|NOT COMPLETED|Overall Study||0
7969507|NCT00329433|19618313|P1|NOT COMPLETED|Overall Study||0
7969508|NCT00329433|19618312|P2|COMPLETED|Overall Study||59
7969509|NCT00329433|19618313|P1|COMPLETED|Overall Study||61
7969510|NCT00329433|19618312|P2|STARTED|Overall Study||59
7969511|NCT00329433|19618313|P1|STARTED|Overall Study||61
7969512|NCT00329420|19618326|P3|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1
7969513|NCT00329420|19618327|P2|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2
7969514|NCT00329420|19618328|P1|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4
7969515|NCT00329420|19618326|P3|COMPLETED|4-weekly Dosing Phase (Responders Only)||6
7969516|NCT00329420|19618327|P2|COMPLETED|4-weekly Dosing Phase (Responders Only)||5
7969517|NCT00329420|19618328|P1|COMPLETED|4-weekly Dosing Phase (Responders Only)||8
7969518|NCT00329420|19618326|P3|STARTED|4-weekly Dosing Phase (Responders Only)||7
7969519|NCT00329420|19618327|P2|STARTED|4-weekly Dosing Phase (Responders Only)||7
7969520|NCT00329420|19618328|P1|STARTED|4-weekly Dosing Phase (Responders Only)||12
7969521|NCT00329420|19618326|P3|NOT COMPLETED|Re-induction Phase||8
7969522|NCT00329420|19618327|P2|NOT COMPLETED|Re-induction Phase||6
7969523|NCT00329420|19618328|P1|NOT COMPLETED|Re-induction Phase||6
7969524|NCT00329420|19618326|P3|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
7969525|NCT00329420|19618327|P2|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
7969526|NCT00329420|19618328|P1|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12
7969527|NCT00329420|19618326|P3|STARTED|Re-induction Phase||15
7969528|NCT00329420|19618327|P2|STARTED|Re-induction Phase||13
7969529|NCT00329420|19618328|P1|STARTED|Re-induction Phase||18
7969530|NCT00329407|19618707|P1|NOT COMPLETED|Overall Study||1
7969531|NCT00329407|19618707|P1|COMPLETED|Overall Study||9
7969532|NCT00329407|19618707|P1|STARTED|Overall Study||10
7969533|NCT00329303|19618714|P2|NOT COMPLETED|Overall Study||2
7969534|NCT00329303|19618715|P1|NOT COMPLETED|Overall Study||2
7969535|NCT00329303|19618714|P2|COMPLETED|Overall Study||35
7969536|NCT00329303|19618715|P1|COMPLETED|Overall Study||32
7969537|NCT00329303|19618714|P2|STARTED|Overall Study||37
7969538|NCT00329303|19618715|P1|STARTED|Overall Study||34
7969539|NCT00329238|19618877|P2|NOT COMPLETED|Overall Study||281
7969540|NCT00329238|19618878|P1|NOT COMPLETED|Overall Study||276
7969541|NCT00329238|19618877|P2|COMPLETED|Overall Study||1145
7969542|NCT00329238|19618878|P1|COMPLETED|Overall Study||1154
7969543|NCT00329238|19618877|P2|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426
7969544|NCT00329238|19618878|P1|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430
7969545|NCT00329160|19618914|P1|NOT COMPLETED|Overall Study||88
7969546|NCT00329160|19618914|P1|COMPLETED|Overall Study||126
7969547|NCT00329160|19618914|P1|Treatment Period|Overall Study||214
7969548|NCT00329160|19618914|P1|Observation Period|Overall Study||214
7969549|NCT00329160|19618914|P1|STARTED|Overall Study||214
7969550|NCT00329108|19618923|P2|NOT COMPLETED|Overall Study||12
7969551|NCT00329108|19618924|P1|NOT COMPLETED|Overall Study||10
7969552|NCT00329108|19618923|P2|COMPLETED|Overall Study||2
7969553|NCT00329108|19618924|P1|COMPLETED|Overall Study||5
7969554|NCT00329108|19618923|P2|STARTED|Overall Study|study terminated due to poor recruitment|14
7969555|NCT00329108|19618924|P1|STARTED|Overall Study|study terminated due to poor recruitment|15
7969556|NCT00329030|19618932|P2|NOT COMPLETED|Overall Study||6
7969557|NCT00329030|19618933|P1|NOT COMPLETED|Overall Study||8
7969558|NCT00329030|19618932|P2|COMPLETED|Overall Study||107
7969559|NCT00329030|19618933|P1|COMPLETED|Overall Study||103
7969560|NCT00329030|19618932|P2|STARTED|Overall Study||113
7969561|NCT00329030|19618933|P1|STARTED|Overall Study||111
7969562|NCT00328926|19618964|P3|NOT COMPLETED|Overall Study||2
7969563|NCT00328926|19618965|P2|NOT COMPLETED|Overall Study||3
7969564|NCT00328926|19618966|P1|NOT COMPLETED|Overall Study||2
7969565|NCT00328926|19618964|P3|COMPLETED|Overall Study||1
7969566|NCT00328926|19618965|P2|COMPLETED|Overall Study||0
7969567|NCT00328926|19618966|P1|COMPLETED|Overall Study||3
7969568|NCT00328926|19618964|P3|STARTED|Overall Study||3
7969569|NCT00328926|19618965|P2|STARTED|Overall Study||3
7969570|NCT00328926|19618966|P1|STARTED|Overall Study||5
7969571|NCT00328861|19618982|P2|NOT COMPLETED|Overall Study||0
7969572|NCT00328861|19618983|P1|NOT COMPLETED|Overall Study||0
7969573|NCT00328861|19618982|P2|COMPLETED|Overall Study||1
7969574|NCT00328861|19618983|P1|COMPLETED|Overall Study||7
7969575|NCT00328861|19618982|P2|STARTED|Overall Study||1
7969576|NCT00328861|19618983|P1|STARTED|Overall Study||7
7969577|NCT00328783|19618991|P1|NOT COMPLETED|Overall Study||26
7969578|NCT00328783|19618991|P1|COMPLETED|Overall Study||86
7969579|NCT00328783|19618991|P1|STARTED|Overall Study||112
7969580|NCT00328770|19618999|P1|NOT COMPLETED|Overall Study||0
7969581|NCT00328770|19618999|P1|COMPLETED|Overall Study||70
7969582|NCT00328770|19618999|P1|STARTED|Overall Study||70
7969583|NCT00328627|19619017|P12|NOT COMPLETED|Overall Study||16
7969584|NCT00328627|19619018|P11|NOT COMPLETED|Overall Study||18
7969585|NCT00328627|19619019|P10|NOT COMPLETED|Overall Study||32
7969586|NCT00328627|19619020|P9|NOT COMPLETED|Overall Study||17
7969587|NCT00328627|19619021|P8|NOT COMPLETED|Overall Study||14
7969588|NCT00328627|19619022|P7|NOT COMPLETED|Overall Study||35
7969589|NCT00328627|19619023|P6|NOT COMPLETED|Overall Study||20
7969590|NCT00328627|19619024|P5|NOT COMPLETED|Overall Study||15
7969591|NCT00328627|19619025|P4|NOT COMPLETED|Overall Study||37
7969592|NCT00328627|19619026|P3|NOT COMPLETED|Overall Study||28
7969593|NCT00328627|19619027|P2|NOT COMPLETED|Overall Study||31
7969594|NCT00328627|19619028|P1|NOT COMPLETED|Overall Study||59
7969595|NCT00328627|19619017|P12|COMPLETED|Overall Study||114
7969596|NCT00328627|19619018|P11|COMPLETED|Overall Study||112
7969597|NCT00328627|19619019|P10|COMPLETED|Overall Study||97
7969598|NCT00328627|19619020|P9|COMPLETED|Overall Study||113
7969599|NCT00328627|19619021|P8|COMPLETED|Overall Study||116
7969600|NCT00328627|19619022|P7|COMPLETED|Overall Study||94
7969601|NCT00328627|19619023|P6|COMPLETED|Overall Study||110
7969602|NCT00328627|19619024|P5|COMPLETED|Overall Study||115
7969603|NCT00328627|19619025|P4|COMPLETED|Overall Study||93
7969604|NCT00328627|19619026|P3|COMPLETED|Overall Study||101
7969605|NCT00328627|19619027|P2|COMPLETED|Overall Study||97
7969606|NCT00328627|19619028|P1|COMPLETED|Overall Study||70
7969607|NCT00328627|19619017|P12|Safety Set|Overall Study||130
7969608|NCT00328627|19619018|P11|Safety Set|Overall Study||130
7969609|NCT00328627|19619019|P10|Safety Set|Overall Study||129
7969610|NCT00328627|19619020|P9|Safety Set|Overall Study||130
7969611|NCT00328627|19619021|P8|Safety Set|Overall Study||130
7969612|NCT00328627|19619022|P7|Safety Set|Overall Study||129
7969613|NCT00328627|19619023|P6|Safety Set|Overall Study||130
7969614|NCT00328627|19619024|P5|Safety Set|Overall Study||130
7969615|NCT00328627|19619025|P4|Safety Set|Overall Study||129
7969616|NCT00328627|19619026|P3|Safety Set|Overall Study||129
7969617|NCT00328627|19619027|P2|Safety Set|Overall Study||128
7969618|NCT00328627|19619028|P1|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129
7969619|NCT00328627|19619017|P12|STARTED|Overall Study||130
7969620|NCT00328627|19619018|P11|STARTED|Overall Study||130
7969621|NCT00328627|19619019|P10|STARTED|Overall Study||129
7969622|NCT00328627|19619020|P9|STARTED|Overall Study||130
7969623|NCT00328627|19619021|P8|STARTED|Overall Study||130
7969624|NCT00328627|19619022|P7|STARTED|Overall Study||129
7969625|NCT00328627|19619023|P6|STARTED|Overall Study||130
7969626|NCT00328627|19619024|P5|STARTED|Overall Study||130
7969627|NCT00328627|19619025|P4|STARTED|Overall Study||130
7969628|NCT00328627|19619026|P3|STARTED|Overall Study||129
7969629|NCT00328627|19619027|P2|STARTED|Overall Study||128
7969630|NCT00328627|19619028|P1|STARTED|Overall Study||129
7969631|NCT00328614|19620551|P6|NOT COMPLETED|Overall Study||1
7969632|NCT00328614|19620552|P5|NOT COMPLETED|Overall Study||1
7969633|NCT00328614|19620553|P4|NOT COMPLETED|Overall Study||1
7969634|NCT00328614|19620554|P3|NOT COMPLETED|Overall Study||0
7969635|NCT00328614|19620555|P2|NOT COMPLETED|Overall Study||0
7969636|NCT00328614|19620556|P1|NOT COMPLETED|Overall Study||0
7969637|NCT00328614|19620551|P6|COMPLETED|Overall Study||5
7969638|NCT00328614|19620552|P5|COMPLETED|Overall Study||5
7969639|NCT00328614|19620553|P4|COMPLETED|Overall Study||5
7969640|NCT00328614|19620554|P3|COMPLETED|Overall Study||6
7969641|NCT00328614|19620555|P2|COMPLETED|Overall Study||4
7969642|NCT00328614|19620556|P1|COMPLETED|Overall Study||4
7969643|NCT00328614|19620551|P6|STARTED|Overall Study||6
7969644|NCT00328614|19620552|P5|STARTED|Overall Study||6
7969645|NCT00328614|19620553|P4|STARTED|Overall Study||6
7969646|NCT00328614|19620554|P3|STARTED|Overall Study||6
7969647|NCT00328614|19620555|P2|STARTED|Overall Study||4
7969648|NCT00328614|19620556|P1|STARTED|Overall Study||4
7969649|NCT00328562|19620565|P1|NOT COMPLETED|Overall Study||1
7969650|NCT00328562|19620565|P1|COMPLETED|Overall Study||12
7969651|NCT00328562|19620565|P1|STARTED|Overall Study||13
7969652|NCT00328510|19620574|P2|NOT COMPLETED|Overall Study||4
7969653|NCT00328510|19620575|P1|NOT COMPLETED|Overall Study||10
7969654|NCT00328510|19620574|P2|COMPLETED|Overall Study||37
7969655|NCT00328510|19620575|P1|COMPLETED|Overall Study||32
7969656|NCT00328510|19620574|P2|STARTED|Overall Study||41
7969657|NCT00328510|19620575|P1|STARTED|Overall Study||42
7969658|NCT00328263|19620583|P2|NOT COMPLETED|Overall Study||4
7969659|NCT00328263|19620584|P1|NOT COMPLETED|Overall Study||3
7969660|NCT00328263|19620583|P2|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217
7969661|NCT00328263|19620584|P1|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213
7969662|NCT00328263|19620583|P2|STARTED|Overall Study||221
7969663|NCT00328263|19620584|P1|STARTED|Overall Study||216
7969664|NCT00328198|19620590|P1|NOT COMPLETED|Follow-up||35
7969665|NCT00328198|19620590|P1|COMPLETED|Follow-up||43
7969666|NCT00328198|19620590|P1|STARTED|Follow-up|Eight participants did not enter Follow-up|78
7969667|NCT00328198|19620590|P1|NOT COMPLETED|Treatment||38
7969668|NCT00328198|19620590|P1|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48
7969669|NCT00328198|19620590|P1|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86
7969670|NCT00328172|19620605|P5|NOT COMPLETED|Overall Study||5
7969671|NCT00328172|19620606|P4|NOT COMPLETED|Overall Study||13
7969672|NCT00328172|19620607|P3|NOT COMPLETED|Overall Study||10
7969673|NCT00328172|19620608|P2|NOT COMPLETED|Overall Study||14
7969674|NCT00328172|19620609|P1|NOT COMPLETED|Overall Study||22
7969675|NCT00328172|19620605|P5|COMPLETED|Overall Study||60
7969676|NCT00328172|19620606|P4|COMPLETED|Overall Study||42
7969677|NCT00328172|19620607|P3|COMPLETED|Overall Study||47
7969678|NCT00328172|19620608|P2|COMPLETED|Overall Study||44
7969679|NCT00328172|19620609|P1|COMPLETED|Overall Study||45
7969680|NCT00328172|19620605|P5|STARTED|Overall Study||65
7969681|NCT00328172|19620606|P4|STARTED|Overall Study||55
7969682|NCT00328172|19620607|P3|STARTED|Overall Study||57
7969683|NCT00328172|19620608|P2|STARTED|Overall Study||58
7969684|NCT00328172|19620609|P1|STARTED|Overall Study||67
7969685|NCT00328094|19620633|P2|NOT COMPLETED|Overall Study||3
7969686|NCT00328094|19620634|P1|NOT COMPLETED|Overall Study||3
7969687|NCT00328094|19620633|P2|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122
7969688|NCT00328094|19620634|P1|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114
7969689|NCT00328094|19620633|P2|STARTED|Overall Study||125
7969690|NCT00328094|19620634|P1|STARTED|Overall Study||117
7969691|NCT00328042|19620644|P2|NOT COMPLETED|Overall Study||2
7969692|NCT00328042|19620645|P1|NOT COMPLETED|Overall Study||0
7969693|NCT00328042|19620644|P2|COMPLETED|Overall Study||63
7969694|NCT00328042|19620645|P1|COMPLETED|Overall Study||69
7969695|NCT00328042|19620644|P2|STARTED|Overall Study||65
7969696|NCT00328042|19620645|P1|STARTED|Overall Study||69
7969697|NCT00328016|19620655|P2|NOT COMPLETED|Overall Study||0
7969698|NCT00328016|19620656|P1|NOT COMPLETED|Overall Study||0
7969699|NCT00328016|19620655|P2|COMPLETED|Overall Study||21
7969700|NCT00328016|19620656|P1|COMPLETED|Overall Study||23
7969701|NCT00328016|19620655|P2|STARTED|Overall Study||21
7969702|NCT00328016|19620656|P1|STARTED|Overall Study||23
7969703|NCT00327717|19620668|P2|NOT COMPLETED|Overall Study||14
7969704|NCT00327717|19620669|P1|NOT COMPLETED|Overall Study||9
7969705|NCT00327717|19620668|P2|COMPLETED|Overall Study||106
7969706|NCT00327717|19620669|P1|COMPLETED|Overall Study||111
7969707|NCT00327717|19620668|P2|STARTED|Overall Study||120
7969708|NCT00327717|19620669|P1|STARTED|Overall Study||120
7969709|NCT00327470|19620695|P2|NOT COMPLETED|Overall Study||63
7969710|NCT00327470|19620696|P1|NOT COMPLETED|Overall Study||29
7969711|NCT00327470|19620695|P2|COMPLETED|Overall Study||118
7969712|NCT00327470|19620696|P1|COMPLETED|Overall Study||78
7969713|NCT00327470|19620695|P2|Treated|Overall Study||179
7969714|NCT00327470|19620696|P1|Treated|Overall Study||107
7969715|NCT00327470|19620695|P2|STARTED|Overall Study||181
7969716|NCT00327470|19620696|P1|STARTED|Overall Study||107
7969717|NCT00327444|19620716|P2|NOT COMPLETED|Open Label Treatment (OL) Period||10
7969718|NCT00327444|19620717|P1|NOT COMPLETED|Open Label Treatment (OL) Period||11
7969719|NCT00327444|19620716|P2|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
7969720|NCT00327444|19620717|P1|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
7969721|NCT00327444|19620716|P2|ONGOING TREATMENT|Open Label Treatment (OL) Period||0
7969722|NCT00327444|19620717|P1|ONGOING TREATMENT|Open Label Treatment (OL) Period||1
7969723|NCT00327444|19620716|P2|STARTED|Open Label Treatment (OL) Period||10
7969724|NCT00327444|19620717|P1|STARTED|Open Label Treatment (OL) Period||11
7969725|NCT00327444|19620716|P2|NOT COMPLETED|Double Blind Treatment (DB) Period||29
7969726|NCT00327444|19620717|P1|NOT COMPLETED|Double Blind Treatment (DB) Period||26
7969727|NCT00327444|19620716|P2|COMPLETED|Double Blind Treatment (DB) Period||0
7969728|NCT00327444|19620717|P1|COMPLETED|Double Blind Treatment (DB) Period||0
7969729|NCT00327444|19620716|P2|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30
7969730|NCT00327444|19620717|P1|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25
7969731|NCT00327444|19620716|P2|STARTED|Double Blind Treatment (DB) Period||29
7969732|NCT00327444|19620717|P1|STARTED|Double Blind Treatment (DB) Period||26
7969733|NCT00327392|19620729|P1|NOT COMPLETED|Overall Study||0
7969734|NCT00327392|19620729|P1|COMPLETED|Overall Study||123
7969735|NCT00327392|19620729|P1|STARTED|Overall Study||123
7969736|NCT00327340|19620735|P2|NOT COMPLETED|Overall Study||30
7969737|NCT00327340|19620736|P1|NOT COMPLETED|Overall Study||15
7969738|NCT00327340|19620735|P2|COMPLETED|Overall Study||16
7969739|NCT00327340|19620736|P1|COMPLETED|Overall Study||8
7969740|NCT00327340|19620735|P2|STARTED|Overall Study||46
7969741|NCT00327340|19620736|P1|STARTED|Overall Study||23
7969742|NCT00327171|19620750|P2|NOT COMPLETED|Overall Study||109
7969743|NCT00327171|19620751|P1|NOT COMPLETED|Overall Study||108
7969744|NCT00327171|19620750|P2|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0
7969745|NCT00327171|19620751|P1|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1
7969746|NCT00327171|19620750|P2|STARTED|Overall Study||109
7969747|NCT00327171|19620751|P1|STARTED|Overall Study||109
7969748|NCT00327015|19620783|P4|NOT COMPLETED|Overall Study||109
7969749|NCT00327015|19620784|P3|NOT COMPLETED|Overall Study||126
7969750|NCT00327015|19620785|P2|NOT COMPLETED|Overall Study||92
7969751|NCT00327015|19620786|P1|NOT COMPLETED|Overall Study||91
7969752|NCT00327015|19620783|P4|COMPLETED|Overall Study||219
7969753|NCT00327015|19620784|P3|COMPLETED|Overall Study||209
7969754|NCT00327015|19620785|P2|COMPLETED|Overall Study||231
7969755|NCT00327015|19620786|P1|COMPLETED|Overall Study||229
7969756|NCT00327015|19620783|P4|Completed Study Without Being Rescued|Overall Study||144
7969757|NCT00327015|19620784|P3|Completed Study Without Being Rescued|Overall Study||113
7969758|NCT00327015|19620785|P2|Completed Study Without Being Rescued|Overall Study||177
7969759|NCT00327015|19620786|P1|Completed Study Without Being Rescued|Overall Study||179
7969760|NCT00327015|19620783|P4|STARTED|Overall Study||328
7969761|NCT00327015|19620784|P3|STARTED|Overall Study||335
7969762|NCT00327015|19620785|P2|STARTED|Overall Study||323
7969763|NCT00327015|19620786|P1|STARTED|Overall Study||320
7969764|NCT00326963|19620828|P1|NOT COMPLETED|Overall Study||33
7969765|NCT00326963|19620828|P1|COMPLETED|Overall Study||107
7969766|NCT00326963|19620828|P1|STARTED|Overall Study||140
7969767|NCT00326950|19620848|P1|NOT COMPLETED|Overall Study||1
7969768|NCT00326950|19620848|P1|COMPLETED|Overall Study||14
7969769|NCT00326950|19620848|P1|STARTED|Overall Study||15
7969770|NCT00326924|19620855|P2|NOT COMPLETED|Overall Study||1
7969771|NCT00326924|19620856|P1|NOT COMPLETED|Overall Study||1
7969772|NCT00326924|19620855|P2|COMPLETED|Overall Study||188
7969773|NCT00326924|19620856|P1|COMPLETED|Overall Study||187
7969774|NCT00326924|19620855|P2|STARTED|Overall Study||189
7969775|NCT00326924|19620856|P1|STARTED|Overall Study||188
7969776|NCT00326911|19620870|P2|NOT COMPLETED|Overall Study||2
7969777|NCT00326911|19620871|P1|NOT COMPLETED|Overall Study||1
7969778|NCT00326911|19620870|P2|COMPLETED|Overall Study|This number reflects all treated patients.|29
7969779|NCT00326911|19620871|P1|COMPLETED|Overall Study|This number reflects all treated patients.|29
7969780|NCT00326911|19620870|P2|STARTED|Overall Study|This number reflects all randomized patients.|31
7969781|NCT00326911|19620871|P1|STARTED|Overall Study|This number reflects all randomized patients.|30
7969782|NCT00326898|19620924|P3|NOT COMPLETED|Overall Study||203
7969783|NCT00326898|19620925|P2|NOT COMPLETED|Overall Study||343
7969784|NCT00326898|19620926|P1|NOT COMPLETED|Overall Study||351
7969785|NCT00326898|19620924|P3|COMPLETED|Overall Study||444
7969786|NCT00326898|19620925|P2|COMPLETED|Overall Study||306
7969787|NCT00326898|19620926|P1|COMPLETED|Overall Study||296
7969788|NCT00326898|19620924|P3|Patients With >=1 Follow-up MUGA Scan|Overall Study||580
7969789|NCT00326898|19620925|P2|Patients With >=1 Follow-up MUGA Scan|Overall Study||510
7969790|NCT00326898|19620926|P1|Patients With >=1 Follow-up MUGA Scan|Overall Study||513
7969791|NCT00326898|19620924|P3|Patients With Clear Cell Histology|Overall Study||540
7969792|NCT00326898|19620925|P2|Patients With Clear Cell Histology|Overall Study||540
7969793|NCT00326898|19620926|P1|Patients With Clear Cell Histology|Overall Study||542
7969794|NCT00326898|19620924|P3|Patients With Toxicity Data|Overall Study||626
7969795|NCT00326898|19620925|P2|Patients With Toxicity Data|Overall Study||628
7969796|NCT00326898|19620926|P1|Patients With Toxicity Data|Overall Study||625
7969797|NCT00326898|19620924|P3|STARTED|Overall Study||647
7969798|NCT00326898|19620925|P2|STARTED|Overall Study||649
7969799|NCT00326898|19620926|P1|STARTED|Overall Study||647
7969800|NCT00326885|19620943|P1|NOT COMPLETED|Overall Study||7
7969801|NCT00326885|19620943|P1|COMPLETED|Overall Study||25
7969802|NCT00326885|19620943|P1|STARTED|Overall Study||32
7969803|NCT00326872|19620952|P1|NOT COMPLETED|Overall Study||0
7969804|NCT00326872|19620952|P1|COMPLETED|Overall Study||26
7969805|NCT00326872|19620952|P1|STARTED|Overall Study||26
7969806|NCT00326781|19620963|P2|NOT COMPLETED|Overall Study||32
7969807|NCT00326781|19620964|P1|NOT COMPLETED|Overall Study||42
7969808|NCT00326781|19620963|P2|COMPLETED|Overall Study||298
7969809|NCT00326781|19620964|P1|COMPLETED|Overall Study||302
7969810|NCT00326781|19620963|P2|STARTED|Overall Study||330
7969811|NCT00326781|19620964|P1|STARTED|Overall Study||344
7969812|NCT00326716|19620974|P4|NOT COMPLETED|Infants||0
7969813|NCT00326716|19620975|P3|NOT COMPLETED|Infants||0
7969814|NCT00326716|19620976|P2|NOT COMPLETED|Infants||0
7969815|NCT00326716|19620977|P1|NOT COMPLETED|Infants||0
7969816|NCT00326716|19620974|P4|COMPLETED|Infants||20
7969817|NCT00326716|19620975|P3|COMPLETED|Infants||20
7969818|NCT00326716|19620976|P2|COMPLETED|Infants||0
7969819|NCT00326716|19620977|P1|COMPLETED|Infants||0
7969820|NCT00326716|19620974|P4|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20
7969821|NCT00326716|19620975|P3|STARTED|Infants|All infants were followed.|20
7969822|NCT00326716|19620976|P2|STARTED|Infants||0
7969823|NCT00326716|19620977|P1|STARTED|Infants||0
7969824|NCT00326716|19620974|P4|NOT COMPLETED|Pre-Natal Mothers||0
7969825|NCT00326716|19620975|P3|NOT COMPLETED|Pre-Natal Mothers||0
7969826|NCT00326716|19620976|P2|NOT COMPLETED|Pre-Natal Mothers||2
7969827|NCT00326716|19620977|P1|NOT COMPLETED|Pre-Natal Mothers||1
7969828|NCT00326716|19620974|P4|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
7969829|NCT00326716|19620975|P3|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
7969830|NCT00326716|19620976|P2|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
7969831|NCT00326716|19620977|P1|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
7969832|NCT00326716|19620974|P4|STARTED|Pre-Natal Mothers||0
7969833|NCT00326716|19620975|P3|STARTED|Pre-Natal Mothers||0
7969834|NCT00326716|19620976|P2|STARTED|Pre-Natal Mothers||21
7969835|NCT00326716|19620977|P1|STARTED|Pre-Natal Mothers||20
7969836|NCT00326612|19621049|P2|NOT COMPLETED|Overall Study||137
7969837|NCT00326612|19621050|P1|NOT COMPLETED|Overall Study||129
7969838|NCT00326612|19621049|P2|COMPLETED|Overall Study||42
7969839|NCT00326612|19621050|P1|COMPLETED|Overall Study||50
7969840|NCT00326612|19621049|P2|STARTED|Overall Study||179
7969841|NCT00326612|19621050|P1|STARTED|Overall Study||179
7969842|NCT00326599|19621072|P4|NOT COMPLETED|Overall Study||19
7969843|NCT00326599|19621073|P3|NOT COMPLETED|Overall Study||53
7969844|NCT00326599|19621074|P2|NOT COMPLETED|Overall Study||1
7969845|NCT00326599|19621075|P1|NOT COMPLETED|Overall Study||6
7969846|NCT00326599|19621072|P4|COMPLETED|Overall Study||10
7969847|NCT00326599|19621073|P3|COMPLETED|Overall Study||5
7969848|NCT00326599|19621074|P2|COMPLETED|Overall Study||2
7969849|NCT00326599|19621075|P1|COMPLETED|Overall Study||0
7969850|NCT00326599|19621072|P4|STARTED|Overall Study||29
7969851|NCT00326599|19621073|P3|STARTED|Overall Study||58
7969852|NCT00326599|19621074|P2|STARTED|Overall Study||3
7969853|NCT00326599|19621075|P1|STARTED|Overall Study||6
7969854|NCT00326495|19621094|P1|NOT COMPLETED|Overall Study||5
7969855|NCT00326495|19621094|P1|COMPLETED|Overall Study||46
7969856|NCT00326495|19621094|P1|STARTED|Overall Study||51
7969857|NCT00326417|19621101|P4|NOT COMPLETED|Overall Study||3
7969858|NCT00326417|19621102|P3|NOT COMPLETED|Overall Study||1
7969859|NCT00326417|19621103|P2|NOT COMPLETED|Overall Study||0
7969860|NCT00326417|19621104|P1|NOT COMPLETED|Overall Study||14
7969861|NCT00326417|19621101|P4|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0
7969862|NCT00326417|19621102|P3|COMPLETED|Overall Study||38
7969863|NCT00326417|19621103|P2|COMPLETED|Overall Study||41
7969864|NCT00326417|19621104|P1|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0
7969865|NCT00326417|19621101|P4|Phase II|Overall Study||0
7969866|NCT00326417|19621102|P3|Phase II|Overall Study||33
7969867|NCT00326417|19621103|P2|Phase II|Overall Study||35
7969868|NCT00326417|19621104|P1|Phase II|Overall Study||8
7969869|NCT00326417|19621101|P4|Phase I|Overall Study||3
7969870|NCT00326417|19621102|P3|Phase I|Overall Study||6
7969871|NCT00326417|19621103|P2|Phase I|Overall Study||6
7969872|NCT00326417|19621104|P1|Phase I|Overall Study||6
7969873|NCT00326417|19621101|P4|STARTED|Overall Study||3
7969874|NCT00326417|19621102|P3|STARTED|Overall Study||39
7969875|NCT00326417|19621103|P2|STARTED|Overall Study||41
7969876|NCT00326417|19621104|P1|STARTED|Overall Study||14
7969877|NCT00326209|19621120|P1|NOT COMPLETED|Overall Study||282
7969878|NCT00326209|19621120|P1|COMPLETED|Overall Study||111
7969879|NCT00326209|19621120|P1|Safety Population|Overall Study||388
7969880|NCT00326209|19621120|P1|STARTED|Overall Study||393
7969881|NCT00326196|19621129|P2|NOT COMPLETED|Overall Study||0
7969882|NCT00326196|19621130|P1|NOT COMPLETED|Overall Study||0
7969883|NCT00326196|19621129|P2|COMPLETED|Overall Study||97
7969884|NCT00326196|19621130|P1|COMPLETED|Overall Study||101
7969885|NCT00326196|19621129|P2|STARTED|Overall Study||97
7969886|NCT00326196|19621130|P1|STARTED|Overall Study||101
7969887|NCT00326183|19621138|P2|NOT COMPLETED|Overall Study||83
7969888|NCT00326183|19621139|P1|NOT COMPLETED|Overall Study||200
7969889|NCT00326183|19621138|P2|COMPLETED|Overall Study||264
7969890|NCT00326183|19621139|P1|COMPLETED|Overall Study||1253
7969891|NCT00326183|19621138|P2|Postvaccination 2 Post-safety Follow-up|Overall Study||271
7969892|NCT00326183|19621139|P1|Postvaccination 2 Post-safety Follow-up|Overall Study||1265
7969893|NCT00326183|19621138|P2|Vaccination 2 + Safety Follow-up|Overall Study||292
7969894|NCT00326183|19621139|P1|Vaccination 2 + Safety Follow-up|Overall Study||1301
7969895|NCT00326183|19621138|P2|Postvaccination 1 Post-safety Follow-up|Overall Study||325
7969896|NCT00326183|19621139|P1|Postvaccination 1 Post-safety Follow-up|Overall Study||1393
7969897|NCT00326183|19621138|P2|Vaccination 1 + Safety Follow-up|Overall Study||347
7969898|NCT00326183|19621139|P1|Vaccination 1 + Safety Follow-up|Overall Study||1453
7969899|NCT00326183|19621138|P2|STARTED|Overall Study||347
7969900|NCT00326183|19621139|P1|STARTED|Overall Study||1453
7969901|NCT00326170|19621165|P1|NOT COMPLETED|Overall Study||0
7969902|NCT00326170|19621165|P1|COMPLETED|Overall Study||34
7969903|NCT00326170|19621165|P1|STARTED|Overall Study||34
7969904|NCT00326118|19621171|P2|NOT COMPLETED|Year 5 Follow up||0
7969905|NCT00326118|19621172|P1|NOT COMPLETED|Year 5 Follow up||0
7969906|NCT00326118|19621171|P2|COMPLETED|Year 5 Follow up||78
7969907|NCT00326118|19621172|P1|COMPLETED|Year 5 Follow up||217
7969908|NCT00326118|19621171|P2|STARTED|Year 5 Follow up||78
7969909|NCT00326118|19621172|P1|STARTED|Year 5 Follow up||217
7969910|NCT00326118|19621171|P2|NOT COMPLETED|Year 4 Follow-up||0
7969911|NCT00326118|19621172|P1|NOT COMPLETED|Year 4 Follow-up||0
7969912|NCT00326118|19621171|P2|COMPLETED|Year 4 Follow-up||80
7969913|NCT00326118|19621172|P1|COMPLETED|Year 4 Follow-up||228
7969914|NCT00326118|19621171|P2|STARTED|Year 4 Follow-up||80
7969915|NCT00326118|19621172|P1|STARTED|Year 4 Follow-up||228
7969916|NCT00326118|19621171|P2|NOT COMPLETED|Year 3 Follow-up||0
7969917|NCT00326118|19621172|P1|NOT COMPLETED|Year 3 Follow-up||0
7969918|NCT00326118|19621171|P2|COMPLETED|Year 3 Follow-up||89
7969919|NCT00326118|19621172|P1|COMPLETED|Year 3 Follow-up||256
7969920|NCT00326118|19621171|P2|STARTED|Year 3 Follow-up||89
7969921|NCT00326118|19621172|P1|STARTED|Year 3 Follow-up||256
7969922|NCT00326118|19621171|P2|NOT COMPLETED|Year 2 Follow-up||0
7969923|NCT00326118|19621172|P1|NOT COMPLETED|Year 2 Follow-up||0
7969924|NCT00326118|19621171|P2|COMPLETED|Year 2 Follow-up||92
7969925|NCT00326118|19621172|P1|COMPLETED|Year 2 Follow-up||270
7969926|NCT00326118|19621171|P2|STARTED|Year 2 Follow-up||92
7969927|NCT00326118|19621172|P1|STARTED|Year 2 Follow-up||270
7969928|NCT00326118|19621171|P2|NOT COMPLETED|Year 1 Follow-up||0
7969929|NCT00326118|19621172|P1|NOT COMPLETED|Year 1 Follow-up||0
7969930|NCT00326118|19621171|P2|COMPLETED|Year 1 Follow-up||100
7969931|NCT00326118|19621172|P1|COMPLETED|Year 1 Follow-up||295
7969932|NCT00326118|19621171|P2|STARTED|Year 1 Follow-up||100
7969933|NCT00326118|19621172|P1|STARTED|Year 1 Follow-up||295
7969934|NCT00326118|19621171|P2|NOT COMPLETED|Active Phase||1
7969935|NCT00326118|19621172|P1|NOT COMPLETED|Active Phase||4
7969936|NCT00326118|19621171|P2|COMPLETED|Active Phase||108
7969937|NCT00326118|19621172|P1|COMPLETED|Active Phase||320
7969938|NCT00326118|19621171|P2|STARTED|Active Phase||109
7969939|NCT00326118|19621172|P1|STARTED|Active Phase||324
7969940|NCT00326001|19621208|P2|NOT COMPLETED|Overall Study||8
7969941|NCT00326001|19621209|P1|NOT COMPLETED|Overall Study||7
7969942|NCT00326001|19621208|P2|COMPLETED|Overall Study||219
7969943|NCT00326001|19621209|P1|COMPLETED|Overall Study||229
7969944|NCT00326001|19621208|P2|STARTED|Overall Study||227
7969945|NCT00326001|19621209|P1|STARTED|Overall Study||236
7969946|NCT00325897|19621223|P2|NOT COMPLETED|Overall Study||13
7969947|NCT00325897|19621224|P1|NOT COMPLETED|Overall Study||12
7969948|NCT00325897|19621223|P2|COMPLETED|Overall Study||559
7969949|NCT00325897|19621224|P1|COMPLETED|Overall Study||558
7969950|NCT00325897|19621223|P2|STARTED|Overall Study||572
7969951|NCT00325897|19621224|P1|STARTED|Overall Study||570
7969952|NCT00325819|19621244|P2|NOT COMPLETED|Overall Study||13
7969953|NCT00325819|19621245|P1|NOT COMPLETED|Overall Study||9
7969954|NCT00325819|19621244|P2|COMPLETED|Overall Study||176
7969955|NCT00325819|19621245|P1|COMPLETED|Overall Study||176
7969956|NCT00325819|19621244|P2|STARTED|Overall Study||189
7969957|NCT00325819|19621245|P1|STARTED|Overall Study||185
7969958|NCT00325780|19621265|P1|NOT COMPLETED|Overall Study||155
7969959|NCT00325780|19621265|P1|COMPLETED|Overall Study||1200
7969960|NCT00325780|19621265|P1|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353
7969961|NCT00325780|19621265|P1|STARTED|Overall Study||1355
7969962|NCT00325754|19621272|P2|NOT COMPLETED|Overall Study||1
7969963|NCT00325754|19621273|P1|NOT COMPLETED|Overall Study||4
7969964|NCT00325754|19621272|P2|COMPLETED|Overall Study||10
7969965|NCT00325754|19621273|P1|COMPLETED|Overall Study||7
7969966|NCT00325754|19621272|P2|STARTED|Overall Study||11
7969967|NCT00325754|19621273|P1|STARTED|Overall Study||11
7969968|NCT00325598|19621289|P2|NOT COMPLETED|Overall Study||0
7969969|NCT00325598|19621290|P1|NOT COMPLETED|Overall Study||0
7969970|NCT00325598|19621289|P2|COMPLETED|Overall Study||50
7969971|NCT00325598|19621290|P1|COMPLETED|Overall Study||50
7969972|NCT00325598|19621289|P2|STARTED|Overall Study||50
7969973|NCT00325598|19621290|P1|STARTED|Overall Study||50
7969974|NCT00325572|19621316|P2|NOT COMPLETED|PHASE ii||0
7969975|NCT00325572|19621317|P1|NOT COMPLETED|PHASE ii||0
7969976|NCT00325572|19621316|P2|COMPLETED|PHASE ii||0
7969977|NCT00325572|19621317|P1|COMPLETED|PHASE ii||0
7969978|NCT00325572|19621316|P2|STARTED|PHASE ii||0
7969979|NCT00325572|19621317|P1|STARTED|PHASE ii||0
7969980|NCT00325572|19621316|P2|NOT COMPLETED|PHASE I||0
7969981|NCT00325572|19621317|P1|NOT COMPLETED|PHASE I||0
7969982|NCT00325572|19621316|P2|COMPLETED|PHASE I||44
7969983|NCT00325572|19621317|P1|COMPLETED|PHASE I||45
7969984|NCT00325572|19621316|P2|STARTED|PHASE I||44
7969985|NCT00325572|19621317|P1|STARTED|PHASE I||45
7969986|NCT00325468|19621328|P5|NOT COMPLETED|Overall Study||8
7969987|NCT00325468|19621329|P4|NOT COMPLETED|Overall Study||34
7969988|NCT00325468|19621330|P3|NOT COMPLETED|Overall Study||4
7969989|NCT00325468|19621331|P2|NOT COMPLETED|Overall Study||5
7969990|NCT00325468|19621332|P1|NOT COMPLETED|Overall Study||11
7969991|NCT00325468|19621328|P5|COMPLETED|Overall Study||14
7969992|NCT00325468|19621329|P4|COMPLETED|Overall Study||90
7969993|NCT00325468|19621330|P3|COMPLETED|Overall Study||10
7969994|NCT00325468|19621331|P2|COMPLETED|Overall Study||12
7969995|NCT00325468|19621332|P1|COMPLETED|Overall Study||12
7969996|NCT00325468|19621328|P5|STARTED|Overall Study||22
7969997|NCT00325468|19621329|P4|STARTED|Overall Study||124
7969998|NCT00325468|19621330|P3|STARTED|Overall Study||14
7969999|NCT00325468|19621331|P2|STARTED|Overall Study||17
7970000|NCT00325468|19621332|P1|STARTED|Overall Study||23
7970001|NCT00325442|19621367|P2|NOT COMPLETED|Overall Study||21
7970002|NCT00325442|19621368|P1|NOT COMPLETED|Overall Study||9
7970003|NCT00325442|19621367|P2|COMPLETED|Overall Study||153
7970004|NCT00325442|19621368|P1|COMPLETED|Overall Study||167
7970005|NCT00325442|19621367|P2|STARTED|Overall Study||174
7970006|NCT00325442|19621368|P1|STARTED|Overall Study||176
7970007|NCT00325416|19621415|P2|NOT COMPLETED|Phase II: Treatment at MTD||2
7970008|NCT00325416|19621416|P1|NOT COMPLETED|Phase II: Treatment at MTD||0
7970009|NCT00325416|19621415|P2|COMPLETED|Phase II: Treatment at MTD||40
7970010|NCT00325416|19621416|P1|COMPLETED|Phase II: Treatment at MTD||78
7970011|NCT00325416|19621415|P2|Enrolled During Phase II|Phase II: Treatment at MTD||8
7970012|NCT00325416|19621416|P1|Enrolled During Phase II|Phase II: Treatment at MTD||40
7970013|NCT00325416|19621415|P2|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34
7970014|NCT00325416|19621416|P1|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38
7970015|NCT00325416|19621415|P2|STARTED|Phase II: Treatment at MTD||42
7970016|NCT00325416|19621416|P1|STARTED|Phase II: Treatment at MTD||78
7970017|NCT00325416|19621415|P2|NOT COMPLETED|Phase I: Dose Escalation||16
7970018|NCT00325416|19621416|P1|NOT COMPLETED|Phase I: Dose Escalation||22
7970019|NCT00325416|19621415|P2|COMPLETED|Phase I: Dose Escalation||44
7970020|NCT00325416|19621416|P1|COMPLETED|Phase I: Dose Escalation||48
7970021|NCT00325416|19621415|P2|STARTED|Phase I: Dose Escalation||60
7970022|NCT00325416|19621416|P1|STARTED|Phase I: Dose Escalation||70
7970023|NCT00325403|19621430|P2|NOT COMPLETED|Overall Study||51
7970024|NCT00325403|19621431|P1|NOT COMPLETED|Overall Study||18
7970025|NCT00325403|19621430|P2|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182
7970026|NCT00325403|19621431|P1|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98
7970027|NCT00325403|19621430|P2|STARTED|Overall Study||233
7970028|NCT00325403|19621431|P1|STARTED|Overall Study||116
7970029|NCT00325234|19621469|P2|NOT COMPLETED|Overall Study||66
7970030|NCT00325234|19621470|P1|NOT COMPLETED|Overall Study||69
7970031|NCT00325234|19621469|P2|COMPLETED|Overall Study||0
7970032|NCT00325234|19621470|P1|COMPLETED|Overall Study||0
7970033|NCT00325234|19621469|P2|Received At Least 1 Dose of Study Drug|Overall Study||66
7970034|NCT00325234|19621470|P1|Received At Least 1 Dose of Study Drug|Overall Study||65
7970035|NCT00325234|19621469|P2|STARTED|Overall Study||66
7970036|NCT00325234|19621470|P1|STARTED|Overall Study||69
7970037|NCT00325195|19621489|P3|NOT COMPLETED|Received Intervention: ITT Population||4
7970038|NCT00325195|19621490|P2|NOT COMPLETED|Received Intervention: ITT Population||25
7970039|NCT00325195|19621491|P1|NOT COMPLETED|Received Intervention: ITT Population||26
7970040|NCT00325195|19621489|P3|COMPLETED|Received Intervention: ITT Population||39
7970041|NCT00325195|19621490|P2|COMPLETED|Received Intervention: ITT Population||59
7970042|NCT00325195|19621491|P1|COMPLETED|Received Intervention: ITT Population||59
7970043|NCT00325195|19621489|P3|STARTED|Received Intervention: ITT Population||43
7970044|NCT00325195|19621490|P2|STARTED|Received Intervention: ITT Population||84
7970045|NCT00325195|19621491|P1|STARTED|Received Intervention: ITT Population||85
7970046|NCT00325195|19621489|P3|NOT COMPLETED|Randomized||3
7970047|NCT00325195|19621490|P2|NOT COMPLETED|Randomized||5
7970048|NCT00325195|19621491|P1|NOT COMPLETED|Randomized||5
7970049|NCT00325195|19621489|P3|COMPLETED|Randomized||43
7970050|NCT00325195|19621490|P2|COMPLETED|Randomized||84
7970051|NCT00325195|19621491|P1|COMPLETED|Randomized||85
7970052|NCT00325195|19621489|P3|STARTED|Randomized||46
7970053|NCT00325195|19621490|P2|STARTED|Randomized||89
7970054|NCT00325195|19621491|P1|STARTED|Randomized||90
7970055|NCT00325156|19621514|P1|NOT COMPLETED|Overall Study||112
7970056|NCT00325156|19621514|P1|COMPLETED|Overall Study||2478
7970057|NCT00325156|19621514|P1|STARTED|Overall Study||2590
7970058|NCT00325143|19621521|P1|NOT COMPLETED|Overall Study||26
7970059|NCT00325143|19621521|P1|COMPLETED|Overall Study||676
7970060|NCT00325143|19621521|P1|STARTED|Overall Study||702
7970061|NCT00325130|19621531|P2|NOT COMPLETED|Overall Study||30
7970062|NCT00325130|19621532|P1|NOT COMPLETED|Overall Study||19
7970063|NCT00325130|19621531|P2|COMPLETED|Overall Study||494
7970064|NCT00325130|19621532|P1|COMPLETED|Overall Study||499
7970065|NCT00325130|19621531|P2|STARTED|Overall Study||524
7970066|NCT00325130|19621532|P1|STARTED|Overall Study||518
7970067|NCT00325078|19621575|P3|NOT COMPLETED|Overall Study||2
7970068|NCT00325078|19621576|P2|NOT COMPLETED|Overall Study||5
7970069|NCT00325078|19621577|P1|NOT COMPLETED|Overall Study||5
7970070|NCT00325078|19621575|P3|COMPLETED|Overall Study||23
7970071|NCT00325078|19621576|P2|COMPLETED|Overall Study||2
7970072|NCT00325078|19621577|P1|COMPLETED|Overall Study||3
7970073|NCT00325078|19621575|P3|STARTED|Overall Study||25
7970074|NCT00325078|19621576|P2|STARTED|Overall Study||7
7970075|NCT00325078|19621577|P1|STARTED|Overall Study||8
7970076|NCT00325039|19621589|P2|NOT COMPLETED|Overall Study||14
7970077|NCT00325039|19621590|P1|NOT COMPLETED|Overall Study||18
7970078|NCT00325039|19621589|P2|COMPLETED|Overall Study||285
7970079|NCT00325039|19621590|P1|COMPLETED|Overall Study||280
7970080|NCT00325039|19621589|P2|STARTED|Overall Study||299
7970081|NCT00325039|19621590|P1|STARTED|Overall Study||298
7970082|NCT00324987|19621606|P2|NOT COMPLETED|Overall Study||6
7970083|NCT00324987|19621607|P1|NOT COMPLETED|Overall Study||6
7970178|NCT00324272|19621802|P2|STARTED|Overall Study||20
7970084|NCT00324987|19621606|P2|COMPLETED|Overall Study|Patients were to be treated until progression|0
7970085|NCT00324987|19621607|P1|COMPLETED|Overall Study|Patients were to be treated until progression|0
7970086|NCT00324987|19621606|P2|STARTED|Overall Study||6
7970087|NCT00324987|19621607|P1|STARTED|Overall Study||6
7970088|NCT00324961|19621621|P1|NOT COMPLETED|Overall Study||43
7970089|NCT00324961|19621621|P1|COMPLETED|Overall Study||490
7970090|NCT00324961|19621621|P1|STARTED|Overall Study||533
7970091|NCT00324896|19621636|P2|NOT COMPLETED|Overall Study||8
7970092|NCT00324896|19621637|P1|NOT COMPLETED|Overall Study||3
7970093|NCT00324896|19621636|P2|COMPLETED|Overall Study||7
7970094|NCT00324896|19621637|P1|COMPLETED|Overall Study||12
7970095|NCT00324896|19621636|P2|STARTED|Overall Study||15
7970096|NCT00324896|19621637|P1|STARTED|Overall Study||15
7970097|NCT00324870|19621645|P1|NOT COMPLETED|Overall Study||0
7970098|NCT00324870|19621645|P1|COMPLETED|Overall Study||37
7970099|NCT00324870|19621645|P1|STARTED|Overall Study||37
7970100|NCT00324857|19621653|P4|NOT COMPLETED|Overall Study||5
7970101|NCT00324857|19621654|P3|NOT COMPLETED|Overall Study||7
7970102|NCT00324857|19621655|P2|NOT COMPLETED|Overall Study||6
7970103|NCT00324857|19621656|P1|NOT COMPLETED|Overall Study||6
7970104|NCT00324857|19621653|P4|COMPLETED|Overall Study||158
7970105|NCT00324857|19621654|P3|COMPLETED|Overall Study||158
7970106|NCT00324857|19621655|P2|COMPLETED|Overall Study||162
7970107|NCT00324857|19621656|P1|COMPLETED|Overall Study||161
7970108|NCT00324857|19621653|P4|STARTED|Overall Study||163
7970109|NCT00324857|19621654|P3|STARTED|Overall Study||165
7970110|NCT00324857|19621655|P2|STARTED|Overall Study||168
7970111|NCT00324857|19621656|P1|STARTED|Overall Study||167
7970112|NCT00324805|19621672|P2|NOT COMPLETED|Overall Study||483
7970113|NCT00324805|19621673|P1|NOT COMPLETED|Overall Study||150
7970114|NCT00324805|19621672|P2|COMPLETED|Overall Study||269
7970115|NCT00324805|19621673|P1|COMPLETED|Overall Study||599
7970116|NCT00324805|19621672|P2|Started Assigned Therapy|Overall Study||735
7970117|NCT00324805|19621673|P1|Started Assigned Therapy|Overall Study||737
7970118|NCT00324805|19621672|P2|STARTED|Overall Study||752
7970119|NCT00324805|19621673|P1|STARTED|Overall Study||749
7970120|NCT00324753|19621687|P2|NOT COMPLETED|Overall Study||0
7970121|NCT00324753|19621688|P1|NOT COMPLETED|Overall Study||0
7970122|NCT00324753|19621687|P2|COMPLETED|Overall Study||264
7970123|NCT00324753|19621688|P1|COMPLETED|Overall Study||190
7970124|NCT00324753|19621687|P2|STARTED|Overall Study||264
7970125|NCT00324753|19621688|P1|STARTED|Overall Study||190
7970126|NCT00324740|19621698|P3|NOT COMPLETED|Overall Study||1
7970127|NCT00324740|19621699|P2|NOT COMPLETED|Overall Study||0
7970128|NCT00324740|19621700|P1|NOT COMPLETED|Overall Study||1
7970129|NCT00324740|19621698|P3|COMPLETED|Overall Study||3
7970130|NCT00324740|19621699|P2|COMPLETED|Overall Study||3
7970131|NCT00324740|19621700|P1|COMPLETED|Overall Study||6
7970132|NCT00324740|19621698|P3|STARTED|Overall Study||4
7970133|NCT00324740|19621699|P2|STARTED|Overall Study||3
7970134|NCT00324740|19621700|P1|STARTED|Overall Study||7
7970135|NCT00324701|19621709|P2|NOT COMPLETED|Overall Study||17
7970136|NCT00324701|19621710|P1|NOT COMPLETED|Overall Study||20
7970137|NCT00324701|19621709|P2|COMPLETED|Overall Study||104
7970138|NCT00324701|19621710|P1|COMPLETED|Overall Study||100
7970139|NCT00324701|19621709|P2|Week 8 Assessment|Overall Study||107
7970140|NCT00324701|19621710|P1|Week 8 Assessment|Overall Study||108
7970141|NCT00324701|19621709|P2|STARTED|Overall Study||121
7970142|NCT00324701|19621710|P1|STARTED|Overall Study||120
7970143|NCT00324675|19621720|P2|NOT COMPLETED|Overall Study||0
7970144|NCT00324675|19621721|P1|NOT COMPLETED|Overall Study||1
7970145|NCT00324675|19621720|P2|COMPLETED|Overall Study||14
7970146|NCT00324675|19621721|P1|COMPLETED|Overall Study||13
7970147|NCT00324675|19621720|P2|STARTED|Overall Study||14
7970148|NCT00324675|19621721|P1|STARTED|Overall Study||14
7970149|NCT00324649|19621729|P2|NOT COMPLETED|Overall Study||5
7970150|NCT00324649|19621730|P1|NOT COMPLETED|Overall Study||2
7970151|NCT00324649|19621729|P2|COMPLETED|Overall Study||36
7970152|NCT00324649|19621730|P1|COMPLETED|Overall Study||37
7970153|NCT00324649|19621729|P2|STARTED|Overall Study||41
7970154|NCT00324649|19621730|P1|STARTED|Overall Study||39
7970155|NCT00324415|19621770|P1|NOT COMPLETED|Overall Study||0
7970156|NCT00324415|19621770|P1|COMPLETED|Overall Study||45
7970157|NCT00324415|19621770|P1|STARTED|Overall Study||45
7970158|NCT00324350|19621785|P2|NOT COMPLETED|Overall Study||0
7970159|NCT00324350|19621786|P1|NOT COMPLETED|Overall Study||0
7970160|NCT00324350|19621785|P2|COMPLETED|Overall Study||3632
7970161|NCT00324350|19621786|P1|COMPLETED|Overall Study||3655
7970162|NCT00324350|19621785|P2|Falls Follow-Up|Overall Study||3418
7970163|NCT00324350|19621786|P1|Falls Follow-Up|Overall Study||3364
7970164|NCT00324350|19621785|P2|Non-Vertebral Fracture Follow-Up|Overall Study||3632
7970165|NCT00324350|19621786|P1|Non-Vertebral Fracture Follow-Up|Overall Study||3655
7970166|NCT00324350|19621785|P2|STARTED|Overall Study||3632
7970167|NCT00324350|19621786|P1|STARTED|Overall Study||3655
7970168|NCT00324272|19621800|P4|NOT COMPLETED|Overall Study||0
7970169|NCT00324272|19621801|P3|NOT COMPLETED|Overall Study||0
7970170|NCT00324272|19621802|P2|NOT COMPLETED|Overall Study||0
7970171|NCT00324272|19621803|P1|NOT COMPLETED|Overall Study||0
7970172|NCT00324272|19621800|P4|COMPLETED|Overall Study||18
7970173|NCT00324272|19621801|P3|COMPLETED|Overall Study||18
7970174|NCT00324272|19621802|P2|COMPLETED|Overall Study||20
7970175|NCT00324272|19621803|P1|COMPLETED|Overall Study||18
7970176|NCT00324272|19621800|P4|STARTED|Overall Study||18
7970177|NCT00324272|19621801|P3|STARTED|Overall Study||18
7970179|NCT00324272|19621803|P1|STARTED|Overall Study||18
7970180|NCT00324259|19621839|P2|NOT COMPLETED|Overall Study||0
7970181|NCT00324259|19621840|P1|NOT COMPLETED|Overall Study||0
7970182|NCT00324259|19621839|P2|COMPLETED|Overall Study||32
7970183|NCT00324259|19621840|P1|COMPLETED|Overall Study||34
7970184|NCT00324259|19621839|P2|STARTED|Overall Study||32
7970185|NCT00324259|19621840|P1|STARTED|Overall Study||34
7970186|NCT00324233|19621861|P2|NOT COMPLETED|Second Period||7
7970187|NCT00324233|19621862|P1|NOT COMPLETED|Second Period||5
7970188|NCT00324233|19621861|P2|COMPLETED|Second Period||11
7970189|NCT00324233|19621862|P1|COMPLETED|Second Period||12
7970190|NCT00324233|19621861|P2|STARTED|Second Period||18
7970191|NCT00324233|19621862|P1|STARTED|Second Period||17
7970192|NCT00324233|19621861|P2|NOT COMPLETED|First Period||0
7970193|NCT00324233|19621862|P1|NOT COMPLETED|First Period||1
7970194|NCT00324233|19621861|P2|COMPLETED|First Period||18
7970195|NCT00324233|19621862|P1|COMPLETED|First Period||17
7970196|NCT00324233|19621861|P2|STARTED|First Period||18
7970197|NCT00324233|19621862|P1|STARTED|First Period||18
7970198|NCT00324168|19621870|P2|NOT COMPLETED|Overall Study||30
7970199|NCT00324168|19621871|P1|NOT COMPLETED|Overall Study||28
7970200|NCT00324168|19621870|P2|COMPLETED|Overall Study||220
7970201|NCT00324168|19621871|P1|COMPLETED|Overall Study||222
7970202|NCT00324168|19621870|P2|STARTED|Overall Study||250
7970203|NCT00324168|19621871|P1|STARTED|Overall Study||250
7970204|NCT00324155|19621899|P2|NOT COMPLETED|Follow-up Phase||6
7970205|NCT00324155|19621900|P1|NOT COMPLETED|Follow-up Phase||11
7970206|NCT00324155|19621899|P2|COMPLETED|Follow-up Phase||245
7970207|NCT00324155|19621900|P1|COMPLETED|Follow-up Phase||236
7970208|NCT00324155|19621899|P2|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251
7970209|NCT00324155|19621900|P1|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247
7970210|NCT00324155|19621899|P2|NOT COMPLETED|Received Treatment in Maintenance Phase||47
7970211|NCT00324155|19621900|P1|NOT COMPLETED|Received Treatment in Maintenance Phase||32
7970212|NCT00324155|19621899|P2|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6
7970213|NCT00324155|19621900|P1|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11
7970214|NCT00324155|19621899|P2|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53
7970215|NCT00324155|19621900|P1|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43
7970216|NCT00324155|19621899|P2|NOT COMPLETED|Received Treatment in Induction Phase||197
7970217|NCT00324155|19621900|P1|NOT COMPLETED|Received Treatment in Induction Phase||202
7970218|NCT00324155|19621899|P2|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54
7970219|NCT00324155|19621900|P1|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45
7970220|NCT00324155|19621899|P2|STARTED|Received Treatment in Induction Phase||251
7970221|NCT00324155|19621900|P1|STARTED|Received Treatment in Induction Phase||247
7970222|NCT00324155|19621899|P2|NOT COMPLETED|Enrolled and Randomized||1
7970223|NCT00324155|19621900|P1|NOT COMPLETED|Enrolled and Randomized||3
7970224|NCT00324155|19621899|P2|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251
7970225|NCT00324155|19621900|P1|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247
7970226|NCT00324155|19621899|P2|STARTED|Enrolled and Randomized||252
7970227|NCT00324155|19621900|P1|STARTED|Enrolled and Randomized||250
7970228|NCT00324116|19621930|P1|NOT COMPLETED|Overall Study||32
7970229|NCT00324116|19621930|P1|COMPLETED|Overall Study||49
7970230|NCT00324116|19621930|P1|STARTED|Overall Study|subjects received treatment|81
7970231|NCT00324038|19621942|P2|NOT COMPLETED|Overall Study||51
7970232|NCT00324038|19621943|P1|NOT COMPLETED|Overall Study||49
7970233|NCT00324038|19621942|P2|COMPLETED|Overall Study||58
7970234|NCT00324038|19621943|P1|COMPLETED|Overall Study||61
7970235|NCT00324038|19621942|P2|STARTED|Overall Study||109
7970236|NCT00324038|19621943|P1|STARTED|Overall Study||110
7970237|NCT00323882|19621954|P5|NOT COMPLETED|Overall Study||32
7970238|NCT00323882|19621955|P4|NOT COMPLETED|Overall Study||7
7970239|NCT00323882|19621956|P3|NOT COMPLETED|Overall Study||13
7970240|NCT00323882|19621957|P2|NOT COMPLETED|Overall Study||6
7970241|NCT00323882|19621958|P1|NOT COMPLETED|Overall Study||8
7970242|NCT00323882|19621954|P5|COMPLETED|Overall Study||2
7970243|NCT00323882|19621955|P4|COMPLETED|Overall Study||0
7970244|NCT00323882|19621956|P3|COMPLETED|Overall Study||3
7970245|NCT00323882|19621957|P2|COMPLETED|Overall Study||0
7970246|NCT00323882|19621958|P1|COMPLETED|Overall Study||0
7970247|NCT00323882|19621954|P5|STARTED|Overall Study||34
7970248|NCT00323882|19621955|P4|STARTED|Overall Study||7
7970249|NCT00323882|19621956|P3|STARTED|Overall Study||16
7970250|NCT00323882|19621957|P2|STARTED|Overall Study||6
7970251|NCT00323882|19621958|P1|STARTED|Overall Study||8
7970252|NCT00323869|19622029|P1|NOT COMPLETED|Overall Study||1
7970253|NCT00323869|19622029|P1|COMPLETED|Overall Study||47
7970254|NCT00323869|19622029|P1|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47
7970255|NCT00323869|19622029|P1|STARTED|Overall Study|Enrollment|48
7970256|NCT00323739|19622041|P1|NOT COMPLETED|Overall Study||0
7970257|NCT00323739|19622041|P1|COMPLETED|Overall Study||80
7970258|NCT00323739|19622041|P1|STARTED|Overall Study||80
7970259|NCT00323635|19622048|P2|NOT COMPLETED|Overall Study||0
7970260|NCT00323635|19622049|P1|NOT COMPLETED|Overall Study||0
7970261|NCT00323635|19622048|P2|COMPLETED|Overall Study||9
7970262|NCT00323635|19622049|P1|COMPLETED|Overall Study||10
7970263|NCT00323635|19622048|P2|STARTED|Overall Study||9
7970264|NCT00323635|19622049|P1|STARTED|Overall Study||10
7970265|NCT00323622|19622085|P8|NOT COMPLETED|Overall Study||15
7970266|NCT00323622|19622086|P7|NOT COMPLETED|Overall Study||5
7970267|NCT00323622|19622087|P6|NOT COMPLETED|Overall Study||74
7970268|NCT00323622|19622088|P5|NOT COMPLETED|Overall Study||39
7970269|NCT00323622|19622089|P4|NOT COMPLETED|Overall Study||12
7970270|NCT00323622|19622090|P3|NOT COMPLETED|Overall Study||4
7970271|NCT00323622|19622091|P2|NOT COMPLETED|Overall Study||92
7970272|NCT00323622|19622092|P1|NOT COMPLETED|Overall Study||31
7970273|NCT00323622|19622085|P8|COMPLETED|Overall Study||125
7970274|NCT00323622|19622086|P7|COMPLETED|Overall Study||38
7970275|NCT00323622|19622087|P6|COMPLETED|Overall Study||454
7970276|NCT00323622|19622088|P5|COMPLETED|Overall Study||120
7970277|NCT00323622|19622089|P4|COMPLETED|Overall Study||122
7970278|NCT00323622|19622090|P3|COMPLETED|Overall Study||38
7970279|NCT00323622|19622091|P2|COMPLETED|Overall Study||423
7970280|NCT00323622|19622092|P1|COMPLETED|Overall Study||145
7970281|NCT00323622|19622085|P8|STARTED|Overall Study||140
7970282|NCT00323622|19622086|P7|STARTED|Overall Study||43
7970283|NCT00323622|19622087|P6|STARTED|Overall Study||528
7970284|NCT00323622|19622088|P5|STARTED|Overall Study||159
7970285|NCT00323622|19622089|P4|STARTED|Overall Study||134
7970286|NCT00323622|19622090|P3|STARTED|Overall Study||42
7970287|NCT00323622|19622091|P2|STARTED|Overall Study||515
7970288|NCT00323622|19622092|P1|STARTED|Overall Study||176
7970289|NCT00323609|19622134|P4|NOT COMPLETED|Overall Study||15
7970290|NCT00323609|19622135|P3|NOT COMPLETED|Overall Study||8
7970291|NCT00323609|19622136|P2|NOT COMPLETED|Overall Study||99
7970292|NCT00323609|19622137|P1|NOT COMPLETED|Overall Study||91
7970293|NCT00323609|19622134|P4|COMPLETED|Overall Study||0
7970294|NCT00323609|19622135|P3|COMPLETED|Overall Study||0
7970295|NCT00323609|19622136|P2|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91
7970296|NCT00323609|19622137|P1|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100
7970297|NCT00323609|19622134|P4|STARTED|Overall Study||15
7970298|NCT00323609|19622135|P3|STARTED|Overall Study||8
7970299|NCT00323609|19622136|P2|STARTED|Overall Study||190
7970300|NCT00323609|19622137|P1|STARTED|Overall Study||191
7970301|NCT00323557|19622173|P2|NOT COMPLETED|Overall Study||0
7970302|NCT00323557|19622174|P1|NOT COMPLETED|Overall Study||1
7970303|NCT00323557|19622173|P2|COMPLETED|Overall Study||7
7970304|NCT00323557|19622174|P1|COMPLETED|Overall Study||24
7970305|NCT00323557|19622173|P2|STARTED|Overall Study||7
7970306|NCT00323557|19622174|P1|STARTED|Overall Study|GM-CSF pre and post vaccine.|25
7970307|NCT00323492|19622183|P3|NOT COMPLETED|Study Phase 2||1
7970308|NCT00323492|19622184|P2|NOT COMPLETED|Study Phase 2||1
7970309|NCT00323492|19622185|P1|NOT COMPLETED|Study Phase 2||4
7970310|NCT00323492|19622183|P3|COMPLETED|Study Phase 2||24
7970311|NCT00323492|19622184|P2|COMPLETED|Study Phase 2||17
7970312|NCT00323492|19622185|P1|COMPLETED|Study Phase 2||40
7970313|NCT00323492|19622183|P3|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25
7970314|NCT00323492|19622184|P2|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18
7970315|NCT00323492|19622185|P1|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44
7970316|NCT00323492|19622183|P3|NOT COMPLETED|Study Phase 1||0
7970317|NCT00323492|19622184|P2|NOT COMPLETED|Study Phase 1||0
7970318|NCT00323492|19622185|P1|NOT COMPLETED|Study Phase 1||2
7970319|NCT00323492|19622183|P3|COMPLETED|Study Phase 1||0
7970320|NCT00323492|19622184|P2|COMPLETED|Study Phase 1||45
7970321|NCT00323492|19622185|P1|COMPLETED|Study Phase 1||45
7970322|NCT00323492|19622183|P3|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0
7970323|NCT00323492|19622184|P2|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45
7970324|NCT00323492|19622185|P1|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46
7970325|NCT00323492|19622183|P3|STARTED|Study Phase 1|Not applicable to Phase 1.|0
7970326|NCT00323492|19622184|P2|STARTED|Study Phase 1||45
7970327|NCT00323492|19622185|P1|STARTED|Study Phase 1||47
7970328|NCT00323479|19622216|P1|NOT COMPLETED|Overall Study||8
7970329|NCT00323479|19622216|P1|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106
7970330|NCT00323479|19622216|P1|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110
7970331|NCT00323479|19622216|P1|STARTED|Overall Study||114
7970332|NCT00323453|19622227|P2|NOT COMPLETED|Overall Study||0
7970333|NCT00323453|19622228|P1|NOT COMPLETED|Overall Study||0
7970334|NCT00323453|19622227|P2|COMPLETED|Overall Study||48
7970335|NCT00323453|19622228|P1|COMPLETED|Overall Study||61
7970336|NCT00323453|19622227|P2|STARTED|Overall Study||48
7970337|NCT00323453|19622228|P1|STARTED|Overall Study||61
7970338|NCT00323427|19622236|P2|NOT COMPLETED|Overall Study||23
7970339|NCT00323427|19622237|P1|NOT COMPLETED|Overall Study||31
7970340|NCT00323427|19622236|P2|COMPLETED|Overall Study||43
7970341|NCT00323427|19622237|P1|COMPLETED|Overall Study||38
7970342|NCT00323427|19622236|P2|STARTED|Overall Study||66
7970343|NCT00323427|19622237|P1|STARTED|Overall Study||69
7970344|NCT00323414|19622249|P2|NOT COMPLETED|Overall Study||1
7970345|NCT00323414|19622250|P1|NOT COMPLETED|Overall Study||0
7970346|NCT00323414|19622249|P2|COMPLETED|Overall Study||18
7970347|NCT00323414|19622250|P1|COMPLETED|Overall Study||18
7970348|NCT00323414|19622249|P2|STARTED|Overall Study||19
7970349|NCT00323414|19622250|P1|STARTED|Overall Study||18
7970350|NCT00323362|19622266|P1|NOT COMPLETED|Overall Study||0
7970351|NCT00323362|19622266|P1|COMPLETED|Overall Study||17
7970352|NCT00323362|19622266|P1|STARTED|Overall Study||17
7970353|NCT00323310|19622272|P1|NOT COMPLETED|Overall Study||3
7970354|NCT00323310|19622272|P1|COMPLETED|Overall Study||89
7970355|NCT00323310|19622272|P1|STARTED|Overall Study||92
7970356|NCT00323297|19622287|P2|NOT COMPLETED|Part B (Open-label)||12
7970357|NCT00323297|19622288|P1|NOT COMPLETED|Part B (Open-label)||9
7970358|NCT00323297|19622287|P2|COMPLETED|Part B (Open-label)||31
7970359|NCT00323297|19622288|P1|COMPLETED|Part B (Open-label)||39
7970360|NCT00323297|19622287|P2|STARTED|Part B (Open-label)||43
7970361|NCT00323297|19622288|P1|STARTED|Part B (Open-label)||48
7970362|NCT00323297|19622287|P2|NOT COMPLETED|Part A (Double Blind Randomized)||7
7970363|NCT00323297|19622288|P1|NOT COMPLETED|Part A (Double Blind Randomized)||5
7970364|NCT00323297|19622287|P2|COMPLETED|Part A (Double Blind Randomized)||43
7970365|NCT00323297|19622288|P1|COMPLETED|Part A (Double Blind Randomized)||48
7970366|NCT00323297|19622287|P2|STARTED|Part A (Double Blind Randomized)||50
7970367|NCT00323297|19622288|P1|STARTED|Part A (Double Blind Randomized)||53
7970368|NCT00323284|19622306|P2|NOT COMPLETED|24 Months Follow-up||22
7970369|NCT00323284|19622307|P1|NOT COMPLETED|24 Months Follow-up||18
7970370|NCT00323284|19622306|P2|COMPLETED|24 Months Follow-up||101
7970371|NCT00323284|19622307|P1|COMPLETED|24 Months Follow-up||98
7970372|NCT00323284|19622306|P2|STARTED|24 Months Follow-up||123
7970373|NCT00323284|19622307|P1|STARTED|24 Months Follow-up||116
7970374|NCT00323284|19622306|P2|NOT COMPLETED|12 Months Follow-up||9
7970375|NCT00323284|19622307|P1|NOT COMPLETED|12 Months Follow-up||5
7970376|NCT00323284|19622306|P2|COMPLETED|12 Months Follow-up||114
7970377|NCT00323284|19622307|P1|COMPLETED|12 Months Follow-up||111
7970378|NCT00323284|19622306|P2|STARTED|12 Months Follow-up||123
7970379|NCT00323284|19622307|P1|STARTED|12 Months Follow-up||116
7970380|NCT00323271|19622317|P2|NOT COMPLETED|Overall Study||3
7970381|NCT00323271|19622318|P1|NOT COMPLETED|Overall Study||2
7970382|NCT00323271|19622317|P2|COMPLETED|Overall Study||9
7970383|NCT00323271|19622318|P1|COMPLETED|Overall Study||11
7970384|NCT00323271|19622317|P2|STARTED|Overall Study||12
7970385|NCT00323271|19622318|P1|STARTED|Overall Study||13
7970386|NCT00323258|19622328|P2|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
7970387|NCT00323258|19622329|P1|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
7970388|NCT00323258|19622328|P2|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58
7970389|NCT00323258|19622329|P1|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57
7970390|NCT00323258|19622328|P2|STARTED|Secondary Outcome (6 Mon Refill Records)||72
7970391|NCT00323258|19622329|P1|STARTED|Secondary Outcome (6 Mon Refill Records)||71
7970392|NCT00323258|19622328|P2|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19
7970393|NCT00323258|19622329|P1|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16
7970394|NCT00323258|19622328|P2|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53
7970395|NCT00323258|19622329|P1|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55
7970396|NCT00323258|19622328|P2|STARTED|Primary Outcome (Phone Call at 6 Months)||72
7970397|NCT00323258|19622329|P1|STARTED|Primary Outcome (Phone Call at 6 Months)||71
7970398|NCT00323193|19622345|P2|NOT COMPLETED|Overall Study||15
7970399|NCT00323193|19622346|P1|NOT COMPLETED|Overall Study||23
7970400|NCT00323193|19622345|P2|COMPLETED|Overall Study||41
7970401|NCT00323193|19622346|P1|COMPLETED|Overall Study||30
7970402|NCT00323193|19622345|P2|STARTED|Overall Study||56
7970403|NCT00323193|19622346|P1|STARTED|Overall Study||53
7970404|NCT00323115|19622354|P1|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8
7970405|NCT00323115|19622354|P1|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2
7970406|NCT00323115|19622354|P1|STARTED|Adjuvant Therapy & Survival Follow-Up||10
7970407|NCT00323115|19622354|P1|NOT COMPLETED|Vaccine Administration||1
7970408|NCT00323115|19622354|P1|COMPLETED|Vaccine Administration||10
7970409|NCT00323115|19622354|P1|STARTED|Vaccine Administration||11
7970410|NCT00323063|19622381|P2|NOT COMPLETED|Overall Study||0
7970411|NCT00323063|19622382|P1|NOT COMPLETED|Overall Study||2
7970412|NCT00323063|19622381|P2|COMPLETED|Overall Study||23
7970413|NCT00323063|19622382|P1|COMPLETED|Overall Study||24
7970414|NCT00323063|19622381|P2|STARTED|Overall Study||23
7970415|NCT00323063|19622382|P1|STARTED|Overall Study||26
7970416|NCT00323037|19622394|P2|NOT COMPLETED|Overall Study||27
7970417|NCT00323037|19622395|P1|NOT COMPLETED|Overall Study||33
7970418|NCT00323037|19622394|P2|COMPLETED|Overall Study||126
7970419|NCT00323037|19622395|P1|COMPLETED|Overall Study||132
7970420|NCT00323037|19622394|P2|STARTED|Overall Study|Number randomized|153
7970421|NCT00323037|19622395|P1|STARTED|Overall Study|Number randomized|165
7970422|NCT00322881|19622399|P1|NOT COMPLETED|Overall Study||5
7970423|NCT00322881|19622399|P1|COMPLETED|Overall Study||7
7970424|NCT00322881|19622399|P1|STARTED|Overall Study||12
7970425|NCT00322868|19622403|P1|NOT COMPLETED|Overall Study||1
7970426|NCT00322868|19622403|P1|COMPLETED|Overall Study||20
7970427|NCT00322868|19622403|P1|STARTED|Overall Study||21
7970428|NCT00322855|19622422|P1|NOT COMPLETED|Overall Study||0
7970429|NCT00322855|19622422|P1|COMPLETED|Overall Study||1
7970430|NCT00322855|19622422|P1|STARTED|Overall Study||1
7970431|NCT00322842|19622428|P2|NOT COMPLETED|Overall Study||2
7970432|NCT00322842|19622429|P1|NOT COMPLETED|Overall Study||2
7970433|NCT00322842|19622428|P2|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29
7970434|NCT00322842|19622429|P1|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2
7970435|NCT00322842|19622428|P2|STARTED|Overall Study||31
7970436|NCT00322842|19622429|P1|STARTED|Overall Study||4
7970437|NCT00322777|19622456|P2|NOT COMPLETED|Overall Study||0
7970438|NCT00322777|19622457|P1|NOT COMPLETED|Overall Study||0
7970439|NCT00322777|19622456|P2|COMPLETED|Overall Study||45
7970440|NCT00322777|19622457|P1|COMPLETED|Overall Study||39
7970441|NCT00322777|19622456|P2|Data Collection at Week 24|Overall Study||45
7970442|NCT00322777|19622457|P1|Data Collection at Week 24|Overall Study||39
7970443|NCT00322777|19622456|P2|Data Collection at Week 16|Overall Study||45
7970444|NCT00322777|19622457|P1|Data Collection at Week 16|Overall Study||39
7970445|NCT00322777|19622456|P2|Data Collection at Week 8|Overall Study||45
7970446|NCT00322777|19622457|P1|Data Collection at Week 8|Overall Study||39
7970447|NCT00322777|19622456|P2|"Data Collection at BASELINE|"|Overall Study||45
7970448|NCT00322777|19622457|P1|"Data Collection at BASELINE|"|Overall Study||39
7970449|NCT00322777|19622456|P2|STARTED|Overall Study||45
7970450|NCT00322777|19622457|P1|STARTED|Overall Study||39
7970451|NCT00322712|19622467|P1|NOT COMPLETED|Overall Study||1
7970452|NCT00322712|19622467|P1|COMPLETED|Overall Study||11
7970453|NCT00322712|19622467|P1|STARTED|Overall Study||12
7970454|NCT00322621|19622471|P3|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36
7970455|NCT00322621|19622472|P2|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29
7970456|NCT00322621|19622473|P1|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0
7970457|NCT00322621|19622471|P3|COMPLETED|Period III - Maintenance / Rescue Phase||33
7970458|NCT00322621|19622472|P2|COMPLETED|Period III - Maintenance / Rescue Phase||86
7970459|NCT00322621|19622473|P1|COMPLETED|Period III - Maintenance / Rescue Phase||0
7970460|NCT00322621|19622471|P3|STARTED|Period III - Maintenance / Rescue Phase||69
7970461|NCT00322621|19622472|P2|STARTED|Period III - Maintenance / Rescue Phase||115
7970462|NCT00322621|19622473|P1|STARTED|Period III - Maintenance / Rescue Phase||0
7970463|NCT00322621|19622471|P3|NOT COMPLETED|Period II - Acute Therapy Phase||0
7970464|NCT00322621|19622472|P2|NOT COMPLETED|Period II - Acute Therapy Phase||0
7970465|NCT00322621|19622473|P1|NOT COMPLETED|Period II - Acute Therapy Phase||32
7970466|NCT00322621|19622471|P3|COMPLETED|Period II - Acute Therapy Phase||0
7970467|NCT00322621|19622472|P2|COMPLETED|Period II - Acute Therapy Phase||0
7970468|NCT00322621|19622473|P1|COMPLETED|Period II - Acute Therapy Phase||184
7970469|NCT00322621|19622471|P3|STARTED|Period II - Acute Therapy Phase||0
7970470|NCT00322621|19622472|P2|STARTED|Period II - Acute Therapy Phase||0
7970471|NCT00322621|19622473|P1|STARTED|Period II - Acute Therapy Phase||216
7970472|NCT00322556|19622525|P1|NOT COMPLETED|Overall Study||12
7970473|NCT00322556|19622525|P1|COMPLETED|Overall Study||43
7970474|NCT00322556|19622525|P1|STARTED|Overall Study||55
7970475|NCT00322491|19622541|P2|NOT COMPLETED|Overall Study||2
7970476|NCT00322491|19622542|P1|NOT COMPLETED|Overall Study||2
7970477|NCT00322491|19622541|P2|COMPLETED|Overall Study||24
7970478|NCT00322491|19622542|P1|COMPLETED|Overall Study||21
7970479|NCT00322491|19622541|P2|STARTED|Overall Study||26
7970480|NCT00322491|19622542|P1|STARTED|Overall Study||23
7970481|NCT00322465|19622568|P4|NOT COMPLETED|Overall Study||26
7970482|NCT00322465|19622569|P3|NOT COMPLETED|Overall Study||26
7970483|NCT00322465|19622570|P2|NOT COMPLETED|Overall Study||24
7970484|NCT00322465|19622571|P1|NOT COMPLETED|Overall Study||20
7970485|NCT00322465|19622568|P4|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53
7970486|NCT00322465|19622569|P3|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51
7970487|NCT00322465|19622570|P2|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49
7970488|NCT00322465|19622571|P1|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56
7970489|NCT00322465|19622568|P4|STARTED|Overall Study|Randomized|79
7970490|NCT00322465|19622569|P3|STARTED|Overall Study|Randomized|77
7970491|NCT00322465|19622570|P2|STARTED|Overall Study|Randomized|73
7970492|NCT00322465|19622571|P1|STARTED|Overall Study|Randomized|76
7970493|NCT00322452|19622632|P2|NOT COMPLETED|Overall Study||276
7970494|NCT00322452|19622633|P1|NOT COMPLETED|Overall Study||247
7970495|NCT00322452|19622632|P2|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332
7970496|NCT00322452|19622633|P1|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362
7970497|NCT00322452|19622632|P2|STARTED|Overall Study|Number of patients randomized|608
7970498|NCT00322452|19622633|P1|STARTED|Overall Study|Number of patients randomized|609
7970499|NCT00322439|19622669|P1|NOT COMPLETED|Overall Study||1056
7970500|NCT00322439|19622669|P1|COMPLETED|Overall Study||1455
7970501|NCT00322439|19622669|P1|Received at Least 1 Dose of Etanercept|Overall Study||2510
7970502|NCT00322439|19622669|P1|STARTED|Overall Study||2511
7970503|NCT00322387|19622684|P2|NOT COMPLETED|Follow-up Period||3
7970504|NCT00322387|19622685|P1|NOT COMPLETED|Follow-up Period||2
7970505|NCT00322387|19622684|P2|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23
7970506|NCT00322387|19622685|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12
7970507|NCT00322387|19622684|P2|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26
7970508|NCT00322387|19622685|P1|STARTED|Follow-up Period|Participants who had transplants|14
7970509|NCT00322387|19622684|P2|NOT COMPLETED|Treatment Period||1
7970510|NCT00322387|19622685|P1|NOT COMPLETED|Treatment Period||0
7970511|NCT00322387|19622684|P2|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25
7970512|NCT00322387|19622685|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14
7970598|NCT00322335|19622792|P3|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
7970513|NCT00322387|19622684|P2|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26
7970514|NCT00322387|19622685|P1|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14
7970515|NCT00322374|19622719|P4|NOT COMPLETED|Second Escalation||0
7970516|NCT00322374|19622720|P3|NOT COMPLETED|Second Escalation||6
7970517|NCT00322374|19622721|P2|NOT COMPLETED|Second Escalation||0
7970518|NCT00322374|19622722|P1|NOT COMPLETED|Second Escalation||0
7970519|NCT00322374|19622719|P4|COMPLETED|Second Escalation||0
7970520|NCT00322374|19622720|P3|COMPLETED|Second Escalation||0
7970521|NCT00322374|19622721|P2|COMPLETED|Second Escalation||0
7970522|NCT00322374|19622722|P1|COMPLETED|Second Escalation||0
7970523|NCT00322374|19622719|P4|STARTED|Second Escalation||0
7970524|NCT00322374|19622720|P3|STARTED|Second Escalation||6
7970525|NCT00322374|19622721|P2|STARTED|Second Escalation||0
7970526|NCT00322374|19622722|P1|STARTED|Second Escalation||0
7970527|NCT00322374|19622719|P4|NOT COMPLETED|First Escalation||0
7970528|NCT00322374|19622720|P3|NOT COMPLETED|First Escalation||0
7970529|NCT00322374|19622721|P2|NOT COMPLETED|First Escalation||30
7970530|NCT00322374|19622722|P1|NOT COMPLETED|First Escalation||0
7970531|NCT00322374|19622719|P4|COMPLETED|First Escalation||0
7970532|NCT00322374|19622720|P3|COMPLETED|First Escalation||0
7970533|NCT00322374|19622721|P2|COMPLETED|First Escalation||0
7970534|NCT00322374|19622722|P1|COMPLETED|First Escalation||0
7970535|NCT00322374|19622719|P4|STARTED|First Escalation||0
7970536|NCT00322374|19622720|P3|STARTED|First Escalation||0
7970537|NCT00322374|19622721|P2|STARTED|First Escalation||30
7970538|NCT00322374|19622722|P1|STARTED|First Escalation||0
7970539|NCT00322374|19622719|P4|NOT COMPLETED|Starting Dose||0
7970540|NCT00322374|19622720|P3|NOT COMPLETED|Starting Dose||0
7970541|NCT00322374|19622721|P2|NOT COMPLETED|Starting Dose||0
7970542|NCT00322374|19622722|P1|NOT COMPLETED|Starting Dose||6
7970543|NCT00322374|19622719|P4|COMPLETED|Starting Dose||0
7970544|NCT00322374|19622720|P3|COMPLETED|Starting Dose||0
7970545|NCT00322374|19622721|P2|COMPLETED|Starting Dose||0
7970546|NCT00322374|19622722|P1|COMPLETED|Starting Dose||0
7970547|NCT00322374|19622719|P4|STARTED|Starting Dose||0
7970548|NCT00322374|19622720|P3|STARTED|Starting Dose||0
7970549|NCT00322374|19622721|P2|STARTED|Starting Dose||0
7970550|NCT00322374|19622722|P1|STARTED|Starting Dose||6
7970551|NCT00322374|19622719|P4|NOT COMPLETED|Enrollment||0
7970552|NCT00322374|19622720|P3|NOT COMPLETED|Enrollment||0
7970553|NCT00322374|19622721|P2|NOT COMPLETED|Enrollment||0
7970554|NCT00322374|19622722|P1|NOT COMPLETED|Enrollment||0
7970555|NCT00322374|19622719|P4|COMPLETED|Enrollment||42
7970556|NCT00322374|19622720|P3|COMPLETED|Enrollment||0
7970557|NCT00322374|19622721|P2|COMPLETED|Enrollment||0
7970558|NCT00322374|19622722|P1|COMPLETED|Enrollment||0
7970559|NCT00322374|19622719|P4|STARTED|Enrollment||42
7970560|NCT00322374|19622720|P3|STARTED|Enrollment||0
7970561|NCT00322374|19622721|P2|STARTED|Enrollment||0
7970562|NCT00322374|19622722|P1|STARTED|Enrollment||0
7970563|NCT00322348|19622772|P2|NOT COMPLETED|Overall Study||33
7970564|NCT00322348|19622773|P1|NOT COMPLETED|Overall Study||37
7970565|NCT00322348|19622772|P2|COMPLETED|Overall Study|Number of participants completed up to Week 96|16
7970566|NCT00322348|19622773|P1|COMPLETED|Overall Study|Number of participants completed up to Week 96|12
7970567|NCT00322348|19622772|P2|Received Study Treatment|Overall Study||48
7970568|NCT00322348|19622773|P1|Received Study Treatment|Overall Study||50
7970569|NCT00322348|19622772|P2|STARTED|Overall Study||49
7970570|NCT00322348|19622773|P1|STARTED|Overall Study||49
7970571|NCT00322335|19622792|P3|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
7970572|NCT00322335|19622793|P2|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
7970573|NCT00322335|19622794|P1|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
7970574|NCT00322335|19622792|P3|COMPLETED|Subjects 66 Months After Booster Dose||53
7970575|NCT00322335|19622793|P2|COMPLETED|Subjects 66 Months After Booster Dose||104
7970576|NCT00322335|19622794|P1|COMPLETED|Subjects 66 Months After Booster Dose||48
7970577|NCT00322335|19622792|P3|STARTED|Subjects 66 Months After Booster Dose||53
7970578|NCT00322335|19622793|P2|STARTED|Subjects 66 Months After Booster Dose||104
7970579|NCT00322335|19622794|P1|STARTED|Subjects 66 Months After Booster Dose||48
7970580|NCT00322335|19622792|P3|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
7970581|NCT00322335|19622793|P2|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
7970582|NCT00322335|19622794|P1|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
7970583|NCT00322335|19622792|P3|COMPLETED|Subjects 54 Months After Booster Dose||56
7970584|NCT00322335|19622793|P2|COMPLETED|Subjects 54 Months After Booster Dose||108
7970585|NCT00322335|19622794|P1|COMPLETED|Subjects 54 Months After Booster Dose||50
7970586|NCT00322335|19622792|P3|STARTED|Subjects 54 Months After Booster Dose||56
7970587|NCT00322335|19622793|P2|STARTED|Subjects 54 Months After Booster Dose||108
7970588|NCT00322335|19622794|P1|STARTED|Subjects 54 Months After Booster Dose||50
7970589|NCT00322335|19622792|P3|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
7970590|NCT00322335|19622793|P2|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
7970591|NCT00322335|19622794|P1|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
7970592|NCT00322335|19622792|P3|COMPLETED|Subjects 42 Months After Booster Dose||56
7970593|NCT00322335|19622793|P2|COMPLETED|Subjects 42 Months After Booster Dose||113
7970594|NCT00322335|19622794|P1|COMPLETED|Subjects 42 Months After Booster Dose||51
7970595|NCT00322335|19622792|P3|STARTED|Subjects 42 Months After Booster Dose||56
7970596|NCT00322335|19622793|P2|STARTED|Subjects 42 Months After Booster Dose||113
7970597|NCT00322335|19622794|P1|STARTED|Subjects 42 Months After Booster Dose||51
7970599|NCT00322335|19622793|P2|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
7970600|NCT00322335|19622794|P1|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
7970601|NCT00322335|19622792|P3|COMPLETED|Subjects 30 Months After Booster Dose||57
7970602|NCT00322335|19622793|P2|COMPLETED|Subjects 30 Months After Booster Dose||119
7970603|NCT00322335|19622794|P1|COMPLETED|Subjects 30 Months After Booster Dose||54
7970604|NCT00322335|19622792|P3|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57
7970605|NCT00322335|19622793|P2|STARTED|Subjects 30 Months After Booster Dose||119
7970606|NCT00322335|19622794|P1|STARTED|Subjects 30 Months After Booster Dose||54
7970607|NCT00322335|19622792|P3|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
7970608|NCT00322335|19622793|P2|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
7970609|NCT00322335|19622794|P1|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
7970610|NCT00322335|19622792|P3|COMPLETED|Subjects 18 Months After Booster Dose||3
7970611|NCT00322335|19622793|P2|COMPLETED|Subjects 18 Months After Booster Dose||123
7970612|NCT00322335|19622794|P1|COMPLETED|Subjects 18 Months After Booster Dose||58
7970613|NCT00322335|19622792|P3|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3
7970614|NCT00322335|19622793|P2|STARTED|Subjects 18 Months After Booster Dose||123
7970615|NCT00322335|19622794|P1|STARTED|Subjects 18 Months After Booster Dose||58
7970616|NCT00322309|19622834|P2|NOT COMPLETED|Overall Study||4
7970617|NCT00322309|19622835|P1|NOT COMPLETED|Overall Study||2
7970618|NCT00322309|19622834|P2|COMPLETED|Overall Study||9
7970619|NCT00322309|19622835|P1|COMPLETED|Overall Study||9
7970620|NCT00322309|19622834|P2|STARTED|Overall Study||13
7970621|NCT00322309|19622835|P1|STARTED|Overall Study||11
7970622|NCT00322231|19622851|P2|NOT COMPLETED|Period 2||0
7970623|NCT00322231|19622852|P1|NOT COMPLETED|Period 2||0
7970624|NCT00322231|19622851|P2|COMPLETED|Period 2||49
7970625|NCT00322231|19622852|P1|COMPLETED|Period 2||51
7970626|NCT00322231|19622851|P2|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49
7970627|NCT00322231|19622852|P1|STARTED|Period 2||51
7970628|NCT00322231|19622851|P2|NOT COMPLETED|Period 1||0
7970629|NCT00322231|19622852|P1|NOT COMPLETED|Period 1||0
7970630|NCT00322231|19622851|P2|COMPLETED|Period 1||50
7970631|NCT00322231|19622852|P1|COMPLETED|Period 1||51
7970632|NCT00322231|19622851|P2|STARTED|Period 1||50
7970633|NCT00322231|19622852|P1|STARTED|Period 1||51
7970634|NCT00322153|19622864|P2|NOT COMPLETED|Overall Study||69
7970635|NCT00322153|19622865|P1|NOT COMPLETED|Overall Study||63
7970636|NCT00322153|19622864|P2|COMPLETED|Overall Study||273
7970637|NCT00322153|19622865|P1|COMPLETED|Overall Study||272
7970638|NCT00322153|19622864|P2|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341
7970639|NCT00322153|19622865|P1|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335
7970640|NCT00322153|19622864|P2|STARTED|Overall Study|Randomized to Memantine ER|342
7970641|NCT00322153|19622865|P1|STARTED|Overall Study|Randomized to placebo|335
7970642|NCT00322101|19622877|P2|NOT COMPLETED|Overall Study||0
7970643|NCT00322101|19622878|P1|NOT COMPLETED|Overall Study||0
7970644|NCT00322101|19622877|P2|COMPLETED|Overall Study||11
7970645|NCT00322101|19622878|P1|COMPLETED|Overall Study||14
7970646|NCT00322101|19622877|P2|STARTED|Overall Study||11
7970647|NCT00322101|19622878|P1|STARTED|Overall Study||14
7970648|NCT00322049|19622898|P4|NOT COMPLETED|Overall Study||1
7970649|NCT00322049|19622899|P3|NOT COMPLETED|Overall Study||0
7970650|NCT00322049|19622900|P2|NOT COMPLETED|Overall Study||1
7970651|NCT00322049|19622901|P1|NOT COMPLETED|Overall Study||0
7970652|NCT00322049|19622898|P4|COMPLETED|Overall Study||16
7970653|NCT00322049|19622899|P3|COMPLETED|Overall Study||20
7970654|NCT00322049|19622900|P2|COMPLETED|Overall Study||9
7970655|NCT00322049|19622901|P1|COMPLETED|Overall Study||4
7970656|NCT00322049|19622898|P4|STARTED|Overall Study||17
7970657|NCT00322049|19622899|P3|STARTED|Overall Study||20
7970658|NCT00322049|19622900|P2|STARTED|Overall Study||10
7970659|NCT00322049|19622901|P1|STARTED|Overall Study||4
7970660|NCT00322023|19622934|P3|NOT COMPLETED|Overall Study||6
7970661|NCT00322023|19622935|P2|NOT COMPLETED|Overall Study||2
7970662|NCT00322023|19622936|P1|NOT COMPLETED|Overall Study||0
7970663|NCT00322023|19622934|P3|COMPLETED|Overall Study||16
7970664|NCT00322023|19622935|P2|COMPLETED|Overall Study||19
7970665|NCT00322023|19622936|P1|COMPLETED|Overall Study||12
7970666|NCT00322023|19622934|P3|STARTED|Overall Study||22
7970667|NCT00322023|19622935|P2|STARTED|Overall Study||21
7970668|NCT00322023|19622936|P1|STARTED|Overall Study||12
7970669|NCT00321984|19622953|P3|NOT COMPLETED|Overall Study||26
7970670|NCT00321984|19622954|P2|NOT COMPLETED|Overall Study||21
7970671|NCT00321984|19622955|P1|NOT COMPLETED|Overall Study||27
7970672|NCT00321984|19622953|P3|COMPLETED|Overall Study||289
7970673|NCT00321984|19622954|P2|COMPLETED|Overall Study||294
7970674|NCT00321984|19622955|P1|COMPLETED|Overall Study||290
7970675|NCT00321984|19622953|P3|STARTED|Overall Study||315
7970676|NCT00321984|19622954|P2|STARTED|Overall Study||315
7970677|NCT00321984|19622955|P1|STARTED|Overall Study||317
7970678|NCT00321971|19622974|P2|NOT COMPLETED|Overall Study||11
7970679|NCT00321971|19622975|P1|NOT COMPLETED|Overall Study||8
7970680|NCT00321971|19622974|P2|COMPLETED|Overall Study||26
7970681|NCT00321971|19622975|P1|COMPLETED|Overall Study||28
7970682|NCT00321971|19622974|P2|STARTED|Overall Study||37
7970683|NCT00321971|19622975|P1|STARTED|Overall Study|Subject recruitment began in February 2007 and ended in December 2011|36
7970684|NCT00321932|19622983|P2|NOT COMPLETED|Overall Study||21
7970685|NCT00321932|19622984|P1|NOT COMPLETED|Overall Study||10
7970686|NCT00321932|19622983|P2|COMPLETED|Overall Study||11
7970687|NCT00321932|19622984|P1|COMPLETED|Overall Study||19
7970688|NCT00321932|19622983|P2|STARTED|Overall Study||32
7970689|NCT00321932|19622984|P1|STARTED|Overall Study||29
7970690|NCT00321919|19623008|P2|NOT COMPLETED|Overall Study||52
7970691|NCT00321919|19623009|P1|NOT COMPLETED|Overall Study||75
7970692|NCT00321919|19623008|P2|COMPLETED|Overall Study||250
7970693|NCT00321919|19623009|P1|COMPLETED|Overall Study||226
7970694|NCT00321919|19623008|P2|STARTED|Overall Study||302
7970695|NCT00321919|19623009|P1|STARTED|Overall Study||301
7970696|NCT00321906|19623051|P2|NOT COMPLETED|Overall Study||56
7970697|NCT00321906|19623052|P1|NOT COMPLETED|Overall Study||46
7970698|NCT00321906|19623051|P2|COMPLETED|Overall Study||31
7970699|NCT00321906|19623052|P1|COMPLETED|Overall Study||48
7970700|NCT00321906|19623051|P2|STARTED|Overall Study||87
7970701|NCT00321906|19623052|P1|STARTED|Overall Study||94
7970702|NCT00321893|19623074|P2|NOT COMPLETED|Overall Study||14
7970703|NCT00321893|19623075|P1|NOT COMPLETED|Overall Study||24
7970704|NCT00321893|19623074|P2|COMPLETED|Overall Study||87
7970705|NCT00321893|19623075|P1|COMPLETED|Overall Study||77
7970706|NCT00321893|19623074|P2|STARTED|Overall Study||101
7970707|NCT00321893|19623075|P1|STARTED|Overall Study||101
7970708|NCT00321854|19623089|P2|NOT COMPLETED|Overall Study||82
7970709|NCT00321854|19623090|P1|NOT COMPLETED|Overall Study||63
7970710|NCT00321854|19623089|P2|COMPLETED|Overall Study||192
7970711|NCT00321854|19623090|P1|COMPLETED|Overall Study||198
7970712|NCT00321854|19623089|P2|STARTED|Overall Study||274
7970713|NCT00321854|19623090|P1|STARTED|Overall Study||261
7970714|NCT00321828|19623208|P1|NOT COMPLETED|Overall Study||4
7970715|NCT00321828|19623208|P1|COMPLETED|Overall Study||86
7970716|NCT00321828|19623208|P1|STARTED|Overall Study||90
7970717|NCT00321789|19623214|P2|NOT COMPLETED|Overall Study||16
7970718|NCT00321789|19623215|P1|NOT COMPLETED|Overall Study||15
7970719|NCT00321789|19623214|P2|COMPLETED|Overall Study||112
7970720|NCT00321789|19623215|P1|COMPLETED|Overall Study||112
7970721|NCT00321789|19623214|P2|STARTED|Overall Study||128
7970722|NCT00321789|19623215|P1|STARTED|Overall Study||127
7970723|NCT00321763|19623247|P4|NOT COMPLETED|Overall Study||5
7970724|NCT00321763|19623248|P3|NOT COMPLETED|Overall Study||6
7970725|NCT00321763|19623249|P2|NOT COMPLETED|Overall Study||2
7970726|NCT00321763|19623250|P1|NOT COMPLETED|Overall Study||6
7970727|NCT00321763|19623247|P4|COMPLETED|Overall Study||565
7970728|NCT00321763|19623248|P3|COMPLETED|Overall Study||848
7970729|NCT00321763|19623249|P2|COMPLETED|Overall Study||848
7970730|NCT00321763|19623250|P1|COMPLETED|Overall Study||844
7970731|NCT00321763|19623247|P4|STARTED|Overall Study||570
7970732|NCT00321763|19623248|P3|STARTED|Overall Study||854
7970733|NCT00321763|19623249|P2|STARTED|Overall Study||850
7970734|NCT00321763|19623250|P1|STARTED|Overall Study||850
7970735|NCT00321737|19623310|P3|NOT COMPLETED|Overall Study||54
7970736|NCT00321737|19623311|P2|NOT COMPLETED|Overall Study||48
7970737|NCT00321737|19623312|P1|NOT COMPLETED|Overall Study||122
7970738|NCT00321737|19623310|P3|COMPLETED|Overall Study||104
7970739|NCT00321737|19623311|P2|COMPLETED|Overall Study||92
7970740|NCT00321737|19623312|P1|COMPLETED|Overall Study||25
7970741|NCT00321737|19623310|P3|STARTED|Overall Study||158
7970742|NCT00321737|19623311|P2|STARTED|Overall Study||140
7970743|NCT00321737|19623312|P1|STARTED|Overall Study||147
7970744|NCT00321711|19623340|P5|NOT COMPLETED|Part B||5
7970745|NCT00321711|19623341|P4|NOT COMPLETED|Part B||6
7970746|NCT00321711|19623342|P3|NOT COMPLETED|Part B||0
7970747|NCT00321711|19623343|P2|NOT COMPLETED|Part B||0
7970748|NCT00321711|19623344|P1|NOT COMPLETED|Part B||0
7970749|NCT00321711|19623340|P5|COMPLETED|Part B||10
7970750|NCT00321711|19623341|P4|COMPLETED|Part B||8
7970751|NCT00321711|19623342|P3|COMPLETED|Part B||0
7970752|NCT00321711|19623343|P2|COMPLETED|Part B||0
7970753|NCT00321711|19623344|P1|COMPLETED|Part B||0
7970754|NCT00321711|19623340|P5|STARTED|Part B||15
7970755|NCT00321711|19623341|P4|STARTED|Part B||14
7970756|NCT00321711|19623342|P3|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
7970757|NCT00321711|19623343|P2|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
7970758|NCT00321711|19623344|P1|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
7970759|NCT00321711|19623340|P5|NOT COMPLETED|Part A||0
7970760|NCT00321711|19623341|P4|NOT COMPLETED|Part A||0
7970761|NCT00321711|19623342|P3|NOT COMPLETED|Part A||11
7970762|NCT00321711|19623343|P2|NOT COMPLETED|Part A||10
7970763|NCT00321711|19623344|P1|NOT COMPLETED|Part A||5
7970764|NCT00321711|19623340|P5|COMPLETED|Part A||0
7970765|NCT00321711|19623341|P4|COMPLETED|Part A||0
7970766|NCT00321711|19623342|P3|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
7970767|NCT00321711|19623343|P2|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
7970768|NCT00321711|19623344|P1|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8
7970769|NCT00321711|19623340|P5|STARTED|Part A||0
7970770|NCT00321711|19623341|P4|STARTED|Part A||0
7970771|NCT00321711|19623342|P3|STARTED|Part A||14
7970772|NCT00321711|19623343|P2|STARTED|Part A||13
7970773|NCT00321711|19623344|P1|STARTED|Part A||13
7970774|NCT00321698|19623376|P5|NOT COMPLETED|Phase II, MTD Dose||0
7970775|NCT00321698|19623377|P4|NOT COMPLETED|Phase II, MTD Dose||0
7970776|NCT00321698|19623378|P3|NOT COMPLETED|Phase II, MTD Dose||0
7970777|NCT00321698|19623379|P2|NOT COMPLETED|Phase II, MTD Dose||0
7970778|NCT00321698|19623380|P1|NOT COMPLETED|Phase II, MTD Dose||0
7970779|NCT00321698|19623376|P5|COMPLETED|Phase II, MTD Dose||13
7970780|NCT00321698|19623377|P4|COMPLETED|Phase II, MTD Dose||0
7970781|NCT00321698|19623378|P3|COMPLETED|Phase II, MTD Dose||0
7970782|NCT00321698|19623379|P2|COMPLETED|Phase II, MTD Dose||0
7970783|NCT00321698|19623380|P1|COMPLETED|Phase II, MTD Dose||0
7970784|NCT00321698|19623376|P5|STARTED|Phase II, MTD Dose|+1 screen failure|13
7970785|NCT00321698|19623377|P4|STARTED|Phase II, MTD Dose||0
7970786|NCT00321698|19623378|P3|STARTED|Phase II, MTD Dose||0
7970787|NCT00321698|19623379|P2|STARTED|Phase II, MTD Dose||0
7970788|NCT00321698|19623380|P1|STARTED|Phase II, MTD Dose||0
7970789|NCT00321698|19623376|P5|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
7970790|NCT00321698|19623377|P4|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
7970791|NCT00321698|19623378|P3|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
7970792|NCT00321698|19623379|P2|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
7970793|NCT00321698|19623380|P1|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
7970794|NCT00321698|19623376|P5|COMPLETED|Phase I, Rad Only & Dose 1-3||0
7970795|NCT00321698|19623377|P4|COMPLETED|Phase I, Rad Only & Dose 1-3||3
7970796|NCT00321698|19623378|P3|COMPLETED|Phase I, Rad Only & Dose 1-3||3
7970797|NCT00321698|19623379|P2|COMPLETED|Phase I, Rad Only & Dose 1-3||3
7970798|NCT00321698|19623380|P1|COMPLETED|Phase I, Rad Only & Dose 1-3||3
7970799|NCT00321698|19623376|P5|STARTED|Phase I, Rad Only & Dose 1-3||0
7970800|NCT00321698|19623377|P4|STARTED|Phase I, Rad Only & Dose 1-3||3
7970801|NCT00321698|19623378|P3|STARTED|Phase I, Rad Only & Dose 1-3||3
7970802|NCT00321698|19623379|P2|STARTED|Phase I, Rad Only & Dose 1-3||3
7970803|NCT00321698|19623380|P1|STARTED|Phase I, Rad Only & Dose 1-3||3
7970804|NCT00321685|19623394|P1|NOT COMPLETED|Overall Study||39
7970805|NCT00321685|19623394|P1|COMPLETED|Overall Study||18
7970806|NCT00321685|19623394|P1|Eligible and Treated|Overall Study||53
7970807|NCT00321685|19623394|P1|Started Protocol Therapy|Overall Study||55
7970808|NCT00321685|19623394|P1|Eligible|Overall Study||55
7970809|NCT00321685|19623394|P1|STARTED|Overall Study||57
7970810|NCT00321672|19623406|P4|NOT COMPLETED|Overall Study||2
7970811|NCT00321672|19623407|P3|NOT COMPLETED|Overall Study||11
7970812|NCT00321672|19623408|P2|NOT COMPLETED|Overall Study||8
7970813|NCT00321672|19623409|P1|NOT COMPLETED|Overall Study||12
7970814|NCT00321672|19623406|P4|COMPLETED|Overall Study||71
7970815|NCT00321672|19623407|P3|COMPLETED|Overall Study||156
7970816|NCT00321672|19623408|P2|COMPLETED|Overall Study||81
7970817|NCT00321672|19623409|P1|COMPLETED|Overall Study||153
7970818|NCT00321672|19623406|P4|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73
7970819|NCT00321672|19623407|P3|STARTED|Overall Study||167
7970820|NCT00321672|19623408|P2|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89
7970821|NCT00321672|19623409|P1|STARTED|Overall Study||165
7970822|NCT00321646|19623435|P1|NOT COMPLETED|Prostatectomy||0
7970823|NCT00321646|19623435|P1|COMPLETED|Prostatectomy||37
7970824|NCT00321646|19623435|P1|STARTED|Prostatectomy||37
7970825|NCT00321646|19623435|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||4
7970826|NCT00321646|19623435|P1|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38
7970827|NCT00321646|19623435|P1|STARTED|Neoadjuvant Chemotherapy||42
7970828|NCT00321620|19623442|P2|NOT COMPLETED|Overall Study||722
7970829|NCT00321620|19623443|P1|NOT COMPLETED|Overall Study||743
7970830|NCT00321620|19623442|P2|COMPLETED|Overall Study||228
7970831|NCT00321620|19623443|P1|COMPLETED|Overall Study||208
7970832|NCT00321620|19623442|P2|Received Investigational Product|Overall Study||942
7970833|NCT00321620|19623443|P1|Received Investigational Product|Overall Study||946
7970834|NCT00321620|19623442|P2|STARTED|Overall Study||950
7970835|NCT00321620|19623443|P1|STARTED|Overall Study||951
7970836|NCT00321594|19623455|P5|NOT COMPLETED|Phase II, MTD Dose||0
7970837|NCT00321594|19623456|P4|NOT COMPLETED|Phase II, MTD Dose||0
7970838|NCT00321594|19623457|P3|NOT COMPLETED|Phase II, MTD Dose||0
7970839|NCT00321594|19623458|P2|NOT COMPLETED|Phase II, MTD Dose||0
7970840|NCT00321594|19623459|P1|NOT COMPLETED|Phase II, MTD Dose||0
7970841|NCT00321594|19623455|P5|COMPLETED|Phase II, MTD Dose||36
7970842|NCT00321594|19623456|P4|COMPLETED|Phase II, MTD Dose||6
7970843|NCT00321594|19623457|P3|COMPLETED|Phase II, MTD Dose||0
7970844|NCT00321594|19623458|P2|COMPLETED|Phase II, MTD Dose||0
7970845|NCT00321594|19623459|P1|COMPLETED|Phase II, MTD Dose||0
7970846|NCT00321594|19623455|P5|STARTED|Phase II, MTD Dose|last six patients in Phase I, Level 4 include in Phase II MTD Dose total number = 6 + 36 = 42|36
7970847|NCT00321594|19623456|P4|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|6
7970848|NCT00321594|19623457|P3|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
7970849|NCT00321594|19623458|P2|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
7970850|NCT00321594|19623459|P1|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
7970851|NCT00321594|19623455|P5|NOT COMPLETED|Phase I, Level 1-4||0
7970852|NCT00321594|19623456|P4|NOT COMPLETED|Phase I, Level 1-4||0
7970853|NCT00321594|19623457|P3|NOT COMPLETED|Phase I, Level 1-4||0
7970854|NCT00321594|19623458|P2|NOT COMPLETED|Phase I, Level 1-4||0
7970855|NCT00321594|19623459|P1|NOT COMPLETED|Phase I, Level 1-4||0
7970856|NCT00321594|19623455|P5|COMPLETED|Phase I, Level 1-4||0
7970857|NCT00321594|19623456|P4|COMPLETED|Phase I, Level 1-4||6
7970858|NCT00321594|19623457|P3|COMPLETED|Phase I, Level 1-4||6
7970859|NCT00321594|19623458|P2|COMPLETED|Phase I, Level 1-4||3
7970860|NCT00321594|19623459|P1|COMPLETED|Phase I, Level 1-4||3
7970861|NCT00321594|19623455|P5|STARTED|Phase I, Level 1-4||0
7970862|NCT00321594|19623456|P4|STARTED|Phase I, Level 1-4||6
7970863|NCT00321594|19623457|P3|STARTED|Phase I, Level 1-4||6
7970864|NCT00321594|19623458|P2|STARTED|Phase I, Level 1-4||3
7970865|NCT00321594|19623459|P1|STARTED|Phase I, Level 1-4||3
7970866|NCT00321555|19623471|P1|NOT COMPLETED|Overall Study||6
7970867|NCT00321555|19623471|P1|COMPLETED|Overall Study||9
7970868|NCT00321555|19623471|P1|STARTED|Overall Study||15
7970869|NCT00321464|19623479|P2|NOT COMPLETED|Overall Study||558
7970870|NCT00321464|19623480|P1|NOT COMPLETED|Overall Study||559
7970871|NCT00321464|19623479|P2|COMPLETED|Overall Study||468
7970872|NCT00321464|19623480|P1|COMPLETED|Overall Study||461
7970873|NCT00321464|19623479|P2|Received Investigational Product|Overall Study||1019
7970874|NCT00321464|19623480|P1|Received Investigational Product|Overall Study||1014
7970875|NCT00321464|19623479|P2|STARTED|Overall Study||1026
7970876|NCT00321464|19623480|P1|STARTED|Overall Study||1020
7970877|NCT00321373|19623493|P3|NOT COMPLETED|Overall Study||3
7970878|NCT00321373|19623494|P2|NOT COMPLETED|Overall Study||0
7970879|NCT00321373|19623495|P1|NOT COMPLETED|Overall Study||2
7970880|NCT00321373|19623493|P3|COMPLETED|Overall Study||404
7970881|NCT00321373|19623494|P2|COMPLETED|Overall Study||406
7970882|NCT00321373|19623495|P1|COMPLETED|Overall Study||405
7970883|NCT00321373|19623493|P3|STARTED|Overall Study||407
7970884|NCT00321373|19623494|P2|STARTED|Overall Study||406
7970885|NCT00321373|19623495|P1|STARTED|Overall Study||407
7970886|NCT00321321|19623518|P1|NOT COMPLETED|Overall Study||0
7970887|NCT00321321|19623518|P1|COMPLETED|Overall Study||12
7970888|NCT00321321|19623518|P1|STARTED|Overall Study||12
7970889|NCT00321269|19623524|P2|NOT COMPLETED|Overall Study||6
7970890|NCT00321269|19623525|P1|NOT COMPLETED|Overall Study||8
7970891|NCT00321269|19623524|P2|COMPLETED|Overall Study||68
7970892|NCT00321269|19623525|P1|COMPLETED|Overall Study||66
7970893|NCT00321269|19623524|P2|STARTED|Overall Study||74
7970894|NCT00321269|19623525|P1|STARTED|Overall Study||74
7970895|NCT00321048|19623535|P2|NOT COMPLETED|Overall Study||8
7970896|NCT00321048|19623536|P1|NOT COMPLETED|Overall Study||6
7970897|NCT00321048|19623535|P2|COMPLETED|Overall Study||21
7970898|NCT00321048|19623536|P1|COMPLETED|Overall Study||22
7970899|NCT00321048|19623535|P2|STARTED|Overall Study||29
7970900|NCT00321048|19623536|P1|STARTED|Overall Study||28
7970901|NCT00320801|19623544|P4|NOT COMPLETED|Extension Phase||48
7970902|NCT00320801|19623545|P3|NOT COMPLETED|Extension Phase||0
7970903|NCT00320801|19623546|P2|NOT COMPLETED|Extension Phase||0
7970904|NCT00320801|19623547|P1|NOT COMPLETED|Extension Phase||0
7970905|NCT00320801|19623544|P4|COMPLETED|Extension Phase||7
7970906|NCT00320801|19623545|P3|COMPLETED|Extension Phase||0
7970907|NCT00320801|19623546|P2|COMPLETED|Extension Phase||0
7970908|NCT00320801|19623547|P1|COMPLETED|Extension Phase||0
7970909|NCT00320801|19623544|P4|STARTED|Extension Phase||55
7970910|NCT00320801|19623545|P3|STARTED|Extension Phase||0
7970911|NCT00320801|19623546|P2|STARTED|Extension Phase||0
7970912|NCT00320801|19623547|P1|STARTED|Extension Phase||0
7970913|NCT00320801|19623544|P4|NOT COMPLETED|Double-blind Phase||0
7970914|NCT00320801|19623545|P3|NOT COMPLETED|Double-blind Phase||14
7970915|NCT00320801|19623546|P2|NOT COMPLETED|Double-blind Phase||11
7970916|NCT00320801|19623547|P1|NOT COMPLETED|Double-blind Phase||0
7970917|NCT00320801|19623544|P4|COMPLETED|Double-blind Phase||0
7970918|NCT00320801|19623545|P3|COMPLETED|Double-blind Phase||35
7970919|NCT00320801|19623546|P2|COMPLETED|Double-blind Phase||36
7970920|NCT00320801|19623547|P1|COMPLETED|Double-blind Phase||0
7970921|NCT00320801|19623544|P4|STARTED|Double-blind Phase||0
7970922|NCT00320801|19623545|P3|STARTED|Double-blind Phase||49
7970923|NCT00320801|19623546|P2|STARTED|Double-blind Phase||47
7970924|NCT00320801|19623547|P1|STARTED|Double-blind Phase||0
7970925|NCT00320801|19623544|P4|NOT COMPLETED|Open-label Run-in Period||0
7970926|NCT00320801|19623545|P3|NOT COMPLETED|Open-label Run-in Period||0
7970927|NCT00320801|19623546|P2|NOT COMPLETED|Open-label Run-in Period||0
7970928|NCT00320801|19623547|P1|NOT COMPLETED|Open-label Run-in Period||92
7970929|NCT00320801|19623544|P4|COMPLETED|Open-label Run-in Period||0
7970930|NCT00320801|19623545|P3|COMPLETED|Open-label Run-in Period||0
7970931|NCT00320801|19623546|P2|COMPLETED|Open-label Run-in Period||0
7970932|NCT00320801|19623547|P1|COMPLETED|Open-label Run-in Period||96
7970933|NCT00320801|19623544|P4|STARTED|Open-label Run-in Period||0
7970934|NCT00320801|19623545|P3|STARTED|Open-label Run-in Period||0
7970935|NCT00320801|19623546|P2|STARTED|Open-label Run-in Period||0
7970936|NCT00320801|19623547|P1|STARTED|Open-label Run-in Period||188
7970937|NCT00320788|19623562|P5|NOT COMPLETED|Overall Study||5
7970938|NCT00320788|19623563|P4|NOT COMPLETED|Overall Study||5
7970939|NCT00320788|19623564|P3|NOT COMPLETED|Overall Study||3
7970940|NCT00320788|19623565|P2|NOT COMPLETED|Overall Study||6
7970941|NCT00320788|19623566|P1|NOT COMPLETED|Overall Study||6
7970942|NCT00320788|19623562|P5|COMPLETED|Overall Study||26
7970943|NCT00320788|19623563|P4|COMPLETED|Overall Study||27
7970944|NCT00320788|19623564|P3|COMPLETED|Overall Study||29
7970945|NCT00320788|19623565|P2|COMPLETED|Overall Study||26
7970946|NCT00320788|19623566|P1|COMPLETED|Overall Study||26
7970947|NCT00320788|19623562|P5|Participants Received Treatment (SAF)|Overall Study||31
7970948|NCT00320788|19623563|P4|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
7970949|NCT00320788|19623564|P3|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
7970950|NCT00320788|19623565|P2|Participants Received Treatment (SAF)|Overall Study||32
7970951|NCT00320788|19623566|P1|Participants Received Treatment (SAF)|Overall Study||32
7970952|NCT00320788|19623562|P5|STARTED|Overall Study||31
7970953|NCT00320788|19623563|P4|STARTED|Overall Study|Participants Randomized|32
7970954|NCT00320788|19623564|P3|STARTED|Overall Study||32
7970955|NCT00320788|19623565|P2|STARTED|Overall Study||32
7970956|NCT00320788|19623566|P1|STARTED|Overall Study||32
7970957|NCT00320749|19623609|P3|NOT COMPLETED|Overall Study||9
7970958|NCT00320749|19623610|P2|NOT COMPLETED|Overall Study||2
7970959|NCT00320749|19623611|P1|NOT COMPLETED|Overall Study||0
7970960|NCT00320749|19623609|P3|COMPLETED|Overall Study||1
7970961|NCT00320749|19623610|P2|COMPLETED|Overall Study||6
7970962|NCT00320749|19623611|P1|COMPLETED|Overall Study||3
7970963|NCT00320749|19623609|P3|STARTED|Overall Study||10
7970964|NCT00320749|19623610|P2|STARTED|Overall Study||8
7970965|NCT00320749|19623611|P1|STARTED|Overall Study||3
7970966|NCT00320710|19623620|P3|NOT COMPLETED|Overall Study||5
7970967|NCT00320710|19623621|P2|NOT COMPLETED|Overall Study||76
7970968|NCT00320710|19623622|P1|NOT COMPLETED|Overall Study||94
7970969|NCT00320710|19623620|P3|COMPLETED|Overall Study||8
7970970|NCT00320710|19623621|P2|COMPLETED|Overall Study||127
7970971|NCT00320710|19623622|P1|COMPLETED|Overall Study||106
7970972|NCT00320710|19623620|P3|Treated (Safety Set)|Overall Study||13
7970973|NCT00320710|19623621|P2|Treated (Safety Set)|Overall Study||202
7970974|NCT00320710|19623622|P1|Treated (Safety Set)|Overall Study||198
7970975|NCT00320710|19623620|P3|STARTED|Overall Study||13
7970976|NCT00320710|19623621|P2|STARTED|Overall Study||203
7970977|NCT00320710|19623622|P1|STARTED|Overall Study||200
7970978|NCT00320671|19623645|P2|NOT COMPLETED|Overall Study||38
7970979|NCT00320671|19623646|P1|NOT COMPLETED|Overall Study||33
7970980|NCT00320671|19623645|P2|COMPLETED|Overall Study||58
7970981|NCT00320671|19623646|P1|COMPLETED|Overall Study||69
7970982|NCT00320671|19623645|P2|STARTED|Overall Study||96
7970983|NCT00320671|19623646|P1|STARTED|Overall Study||102
7970984|NCT00320606|19623652|P1|NOT COMPLETED|Overall Study||3
7970985|NCT00320606|19623652|P1|COMPLETED|Overall Study||17
7970986|NCT00320606|19623652|P1|STARTED|Overall Study||20
7970987|NCT00320593|19623668|P2|NOT COMPLETED|Overall Study||1
7970988|NCT00320593|19623669|P1|NOT COMPLETED|Overall Study||7
7970989|NCT00320593|19623668|P2|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58
7970990|NCT00320593|19623669|P1|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52
7970991|NCT00320593|19623668|P2|STARTED|Overall Study||59
7970992|NCT00320593|19623669|P1|STARTED|Overall Study||59
7970993|NCT00320541|19623693|P2|NOT COMPLETED|Overall Study||57
7970994|NCT00320541|19623694|P1|NOT COMPLETED|Overall Study||50
7970995|NCT00320541|19623693|P2|COMPLETED|Overall Study||36
7970996|NCT00320541|19623694|P1|COMPLETED|Overall Study||44
7970997|NCT00320541|19623693|P2|STARTED|Overall Study||93
7970998|NCT00320541|19623694|P1|STARTED|Overall Study||94
7970999|NCT00320528|19623721|P3|NOT COMPLETED|Study Period III||106
7971000|NCT00320528|19623722|P2|NOT COMPLETED|Study Period III||31
7971001|NCT00320528|19623723|P1|NOT COMPLETED|Study Period III||87
7971002|NCT00320528|19623721|P3|COMPLETED|Study Period III||2
7971003|NCT00320528|19623722|P2|COMPLETED|Study Period III||0
7971004|NCT00320528|19623723|P1|COMPLETED|Study Period III||0
7971005|NCT00320528|19623721|P3|STARTED|Study Period III||108
7971006|NCT00320528|19623722|P2|STARTED|Study Period III||31
7971007|NCT00320528|19623723|P1|STARTED|Study Period III||87
7971008|NCT00320528|19623721|P3|NOT COMPLETED|Study Period II||22
7971009|NCT00320528|19623722|P2|NOT COMPLETED|Study Period II||10
7971010|NCT00320528|19623723|P1|NOT COMPLETED|Study Period II||11
7971011|NCT00320528|19623721|P3|COMPLETED|Study Period II||108
7971012|NCT00320528|19623722|P2|COMPLETED|Study Period II||31
7971013|NCT00320528|19623723|P1|COMPLETED|Study Period II||87
7971014|NCT00320528|19623721|P3|Received at Least One Dose of Study Drug|Study Period II||128
7971015|NCT00320528|19623722|P2|Received at Least One Dose of Study Drug|Study Period II||38
7971016|NCT00320528|19623723|P1|Received at Least One Dose of Study Drug|Study Period II||97
7971017|NCT00320528|19623721|P3|STARTED|Study Period II||130
7971018|NCT00320528|19623722|P2|STARTED|Study Period II||41
7971019|NCT00320528|19623723|P1|STARTED|Study Period II||98
7971020|NCT00320515|19623758|P1|NOT COMPLETED|Overall Study||49
7971021|NCT00320515|19623758|P1|COMPLETED|Overall Study||20
7971022|NCT00320515|19623758|P1|STARTED|Overall Study||69
7971023|NCT00320489|19623767|P2|NOT COMPLETED|Overall Study||136
7971024|NCT00320489|19623768|P1|NOT COMPLETED|Overall Study||145
7971025|NCT00320489|19623767|P2|COMPLETED|Overall Study||124
7971026|NCT00320489|19623768|P1|COMPLETED|Overall Study||119
7971027|NCT00320489|19623767|P2|STARTED|Overall Study||260
7971028|NCT00320489|19623768|P1|STARTED|Overall Study||264
7971029|NCT00320424|19623824|P1|NOT COMPLETED|Overall Study||6
7971030|NCT00320424|19623824|P1|COMPLETED|Overall Study||42
7971031|NCT00320424|19623824|P1|STARTED|Overall Study||48
7971032|NCT00320411|19623838|P1|NOT COMPLETED|Overall Study||4
7971033|NCT00320411|19623838|P1|COMPLETED|Overall Study||58
7971034|NCT00320411|19623838|P1|STARTED|Overall Study||62
7971035|NCT00320398|19623861|P2|NOT COMPLETED|Overall Study||4
7971036|NCT00320398|19623862|P1|NOT COMPLETED|Overall Study||2
7971037|NCT00320398|19623861|P2|COMPLETED|Overall Study||52
7971038|NCT00320398|19623862|P1|COMPLETED|Overall Study||56
7971039|NCT00320398|19623861|P2|STARTED|Overall Study||56
7971040|NCT00320398|19623862|P1|STARTED|Overall Study||58
7971041|NCT00320385|19623890|P2|NOT COMPLETED|Overall Study||22
7971042|NCT00320385|19623891|P1|NOT COMPLETED|Overall Study||18
7971043|NCT00320385|19623890|P2|COMPLETED|Overall Study||126
7971044|NCT00320385|19623891|P1|COMPLETED|Overall Study||130
7971045|NCT00320385|19623890|P2|STARTED|Overall Study||148
7971046|NCT00320385|19623891|P1|STARTED|Overall Study||148
7971047|NCT00320372|19623914|P2|NOT COMPLETED|Overall Study||163
7971048|NCT00320372|19623915|P1|NOT COMPLETED|Overall Study||195
7971049|NCT00320372|19623914|P2|COMPLETED|Overall Study||138
7971050|NCT00320372|19623915|P1|COMPLETED|Overall Study||299
7971051|NCT00320372|19623914|P2|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0
7971052|NCT00320372|19623915|P1|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159
7971053|NCT00320372|19623914|P2|VNS Therapy D-23 Original|Overall Study||0
7971054|NCT00320372|19623915|P1|VNS Therapy D-23 Original|Overall Study||335
7971055|NCT00320372|19623914|P2|STARTED|Overall Study||301
7971056|NCT00320372|19623915|P1|STARTED|Overall Study||494
7971057|NCT00320281|19623942|P2|NOT COMPLETED|Overall Study||0
7971058|NCT00320281|19623943|P1|NOT COMPLETED|Overall Study||0
7971059|NCT00320281|19623942|P2|COMPLETED|Overall Study||9
7971060|NCT00320281|19623943|P1|COMPLETED|Overall Study||10
7971061|NCT00320281|19623942|P2|STARTED|Overall Study||9
7971062|NCT00320281|19623943|P1|STARTED|Overall Study||10
7971063|NCT00320255|19623957|P6|NOT COMPLETED|Overall Study||0
7971064|NCT00320255|19623958|P5|NOT COMPLETED|Overall Study||0
7971065|NCT00320255|19623959|P4|NOT COMPLETED|Overall Study||8
7971066|NCT00320255|19623960|P3|NOT COMPLETED|Overall Study||6
7971067|NCT00320255|19623961|P2|NOT COMPLETED|Overall Study||7
7971068|NCT00320255|19623962|P1|NOT COMPLETED|Overall Study||11
7971069|NCT00320255|19623957|P6|COMPLETED|Overall Study||3
7971070|NCT00320255|19623958|P5|COMPLETED|Overall Study||2
7971071|NCT00320255|19623959|P4|COMPLETED|Overall Study||25
7971072|NCT00320255|19623960|P3|COMPLETED|Overall Study||24
7971073|NCT00320255|19623961|P2|COMPLETED|Overall Study||25
7971074|NCT00320255|19623962|P1|COMPLETED|Overall Study||19
7971075|NCT00320255|19623957|P6|Received Treatment|Overall Study||3
7971076|NCT00320255|19623958|P5|Received Treatment|Overall Study||2
7971077|NCT00320255|19623959|P4|Received Treatment|Overall Study||32
7971078|NCT00320255|19623960|P3|Received Treatment|Overall Study||29
7971079|NCT00320255|19623961|P2|Received Treatment|Overall Study||32
7971080|NCT00320255|19623962|P1|Received Treatment|Overall Study||29
7971081|NCT00320255|19623957|P6|STARTED|Overall Study||3
7971082|NCT00320255|19623958|P5|STARTED|Overall Study||2
7971083|NCT00320255|19623959|P4|STARTED|Overall Study||33
7971084|NCT00320255|19623960|P3|STARTED|Overall Study||30
7971085|NCT00320255|19623961|P2|STARTED|Overall Study||32
7971086|NCT00320255|19623962|P1|STARTED|Overall Study||30
7971087|NCT00320242|19624042|P2|NOT COMPLETED|Overall Study||4
7971088|NCT00320242|19624043|P1|NOT COMPLETED|Overall Study||2
7971089|NCT00320242|19624042|P2|COMPLETED|Overall Study||12
7971090|NCT00320242|19624043|P1|COMPLETED|Overall Study||14
7971091|NCT00320242|19624042|P2|STARTED|Overall Study||16
7971092|NCT00320242|19624043|P1|STARTED|Overall Study||16
7971093|NCT00320216|19624055|P5|NOT COMPLETED|Overall Study||6
7971094|NCT00320216|19624056|P4|NOT COMPLETED|Overall Study||3
7971095|NCT00320216|19624057|P3|NOT COMPLETED|Overall Study||6
7971096|NCT00320216|19624058|P2|NOT COMPLETED|Overall Study||10
7971097|NCT00320216|19624059|P1|NOT COMPLETED|Overall Study||16
7971098|NCT00320216|19624055|P5|COMPLETED|Overall Study||58
7971099|NCT00320216|19624056|P4|COMPLETED|Overall Study||61
7971100|NCT00320216|19624057|P3|COMPLETED|Overall Study||58
7971101|NCT00320216|19624058|P2|COMPLETED|Overall Study||54
7971102|NCT00320216|19624059|P1|COMPLETED|Overall Study||48
7971103|NCT00320216|19624055|P5|STARTED|Overall Study||64
7971104|NCT00320216|19624056|P4|STARTED|Overall Study||64
7971105|NCT00320216|19624057|P3|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
7971106|NCT00320216|19624058|P2|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
7971107|NCT00320216|19624059|P1|STARTED|Overall Study||64
7971108|NCT00320190|19624093|P2|NOT COMPLETED|Long-term (12-month) Extension||2
7971109|NCT00320190|19624094|P1|NOT COMPLETED|Long-term (12-month) Extension||9
7971110|NCT00320190|19624093|P2|COMPLETED|Long-term (12-month) Extension||1
7971111|NCT00320190|19624094|P1|COMPLETED|Long-term (12-month) Extension||2
7971112|NCT00320190|19624093|P2|STARTED|Long-term (12-month) Extension||3
7971113|NCT00320190|19624094|P1|STARTED|Long-term (12-month) Extension||11
7971114|NCT00320190|19624093|P2|NOT COMPLETED|First 12 Months||10
7971115|NCT00320190|19624094|P1|NOT COMPLETED|First 12 Months||8
7971116|NCT00320190|19624093|P2|COMPLETED|First 12 Months||3
7971117|NCT00320190|19624094|P1|COMPLETED|First 12 Months||11
7971118|NCT00320190|19624093|P2|STARTED|First 12 Months||13
7971119|NCT00320190|19624094|P1|STARTED|First 12 Months||19
7971120|NCT00320112|19624114|P2|NOT COMPLETED|Overall Study||5
7971121|NCT00320112|19624115|P1|NOT COMPLETED|Overall Study||8
7971122|NCT00320112|19624114|P2|COMPLETED|Overall Study||114
7971123|NCT00320112|19624115|P1|COMPLETED|Overall Study||117
7971124|NCT00320112|19624114|P2|STARTED|Overall Study||119
7971125|NCT00320112|19624115|P1|STARTED|Overall Study||125
7971126|NCT00319982|19624129|P2|NOT COMPLETED|Overall Study||0
7971127|NCT00319982|19624130|P1|NOT COMPLETED|Overall Study||1
7971128|NCT00319982|19624129|P2|COMPLETED|Overall Study||20
7971129|NCT00319982|19624130|P1|COMPLETED|Overall Study||18
7971130|NCT00319982|19624129|P2|STARTED|Overall Study||20
7971131|NCT00319982|19624130|P1|STARTED|Overall Study||19
7971132|NCT00319956|19624150|P2|NOT COMPLETED|Overall Study||24
7971133|NCT00319956|19624151|P1|NOT COMPLETED|Overall Study||20
7971134|NCT00319956|19624150|P2|COMPLETED|Overall Study||85
7971135|NCT00319956|19624151|P1|COMPLETED|Overall Study||91
7971136|NCT00319956|19624150|P2|STARTED|Overall Study||109
7971137|NCT00319956|19624151|P1|STARTED|Overall Study||111
7971138|NCT00319839|19624163|P1|NOT COMPLETED|Overall Study||6
7971139|NCT00319839|19624163|P1|COMPLETED|Overall Study||1
7971140|NCT00319839|19624163|P1|STARTED|Overall Study||7
7971141|NCT00319748|19624169|P1|NOT COMPLETED|Overall Study||0
7971142|NCT00319748|19624169|P1|COMPLETED|Overall Study||13
7971143|NCT00319748|19624169|P1|STARTED|Overall Study||13
7971144|NCT00319735|19624179|P1|NOT COMPLETED|Overall Study||2
7971145|NCT00319735|19624179|P1|COMPLETED|Overall Study||39
7971146|NCT00319735|19624179|P1|STARTED|Overall Study||41
7971147|NCT00319696|19624192|P1|NOT COMPLETED|Overall Study||60
7971148|NCT00319696|19624192|P1|COMPLETED|Overall Study||56
7971149|NCT00319696|19624192|P1|STARTED|Overall Study||116
7971150|NCT00319644|19624218|P2|NOT COMPLETED|Overall Study||0
7971151|NCT00319644|19624219|P1|NOT COMPLETED|Overall Study||0
7971152|NCT00319644|19624218|P2|COMPLETED|Overall Study||16
7971153|NCT00319644|19624219|P1|COMPLETED|Overall Study||21
7971154|NCT00319644|19624218|P2|STARTED|Overall Study||16
7971155|NCT00319644|19624219|P1|STARTED|Overall Study||21
7971156|NCT00319592|19624229|P2|NOT COMPLETED|Overall Study||1
7971157|NCT00319592|19624230|P1|NOT COMPLETED|Overall Study||1
7971158|NCT00319592|19624229|P2|COMPLETED|Overall Study||29
7971159|NCT00319592|19624230|P1|COMPLETED|Overall Study||29
7971160|NCT00319592|19624229|P2|STARTED|Overall Study||30
7971161|NCT00319592|19624230|P1|STARTED|Overall Study||30
7971162|NCT00319553|19624246|P2|NOT COMPLETED|Overall Study||4
7971163|NCT00319553|19624247|P1|NOT COMPLETED|Overall Study||4
7971164|NCT00319553|19624246|P2|COMPLETED|Overall Study||317
7971165|NCT00319553|19624247|P1|COMPLETED|Overall Study||319
7971166|NCT00319553|19624246|P2|STARTED|Overall Study||321
7971167|NCT00319553|19624247|P1|STARTED|Overall Study||323
7971168|NCT00319501|19624261|P2|NOT COMPLETED|Open-label Extension Period||0
7971169|NCT00319501|19624262|P1|NOT COMPLETED|Open-label Extension Period||51
7971170|NCT00319501|19624261|P2|COMPLETED|Open-label Extension Period||0
7971171|NCT00319501|19624262|P1|COMPLETED|Open-label Extension Period||0
7971172|NCT00319501|19624261|P2|Received Treatment|Open-label Extension Period||0
7971173|NCT00319501|19624262|P1|Received Treatment|Open-label Extension Period||33
7971174|NCT00319501|19624261|P2|STARTED|Open-label Extension Period||0
7971175|NCT00319501|19624262|P1|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51
7971176|NCT00319501|19624261|P2|NOT COMPLETED|Open-label Period||0
7971177|NCT00319501|19624262|P1|NOT COMPLETED|Open-label Period||116
7971178|NCT00319501|19624261|P2|COMPLETED|Open-label Period||0
7971179|NCT00319501|19624262|P1|COMPLETED|Open-label Period|Competed=continuing treatment|45
7971180|NCT00319501|19624261|P2|Received Treatment|Open-label Period||0
7971181|NCT00319501|19624262|P1|Received Treatment|Open-label Period||128
7971182|NCT00319501|19624261|P2|STARTED|Open-label Period||0
7971183|NCT00319501|19624262|P1|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161
7971184|NCT00319501|19624261|P2|NOT COMPLETED|Double-blind Period||32
7971185|NCT00319501|19624262|P1|NOT COMPLETED|Double-blind Period||43
7971186|NCT00319501|19624261|P2|COMPLETED|Double-blind Period||78
7971187|NCT00319501|19624262|P1|COMPLETED|Double-blind Period||81
7971188|NCT00319501|19624261|P2|Received Treatment|Double-blind Period||81
7971189|NCT00319501|19624262|P1|Received Treatment|Double-blind Period||82
7971190|NCT00319501|19624261|P2|STARTED|Double-blind Period|Randomized participants|110
7971191|NCT00319501|19624262|P1|STARTED|Double-blind Period|Randomized participants|124
7971192|NCT00319449|19624288|P2|NOT COMPLETED|Overall Study||0
7971193|NCT00319449|19624289|P1|NOT COMPLETED|Overall Study||2
7971194|NCT00319449|19624288|P2|COMPLETED|Overall Study||12
7971195|NCT00319449|19624289|P1|COMPLETED|Overall Study||8
7971196|NCT00319449|19624288|P2|STARTED|Overall Study||12
7971197|NCT00319449|19624289|P1|STARTED|Overall Study||10
7971198|NCT00319436|19624301|P2|NOT COMPLETED|Overall Study||7
7971199|NCT00319436|19624302|P1|NOT COMPLETED|Overall Study||6
7971200|NCT00319436|19624301|P2|COMPLETED|Overall Study||17
7971201|NCT00319436|19624302|P1|COMPLETED|Overall Study||17
7971202|NCT00319436|19624301|P2|STARTED|Overall Study||24
7971203|NCT00319436|19624302|P1|STARTED|Overall Study||23
7971204|NCT00319254|19624320|P1|NOT COMPLETED|Overall Study||54
7971205|NCT00319254|19624320|P1|COMPLETED|Overall Study||21
7971206|NCT00319254|19624320|P1|Treated|Overall Study||73
7971207|NCT00319254|19624320|P1|STARTED|Overall Study||75
7971208|NCT00319111|19624333|P1|NOT COMPLETED|Overall Study||47
7971209|NCT00319111|19624333|P1|COMPLETED|Overall Study||104
7971210|NCT00319111|19624333|P1|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151
7971211|NCT00319098|19624347|P2|NOT COMPLETED|Overall Study||32
7971212|NCT00319098|19624348|P1|NOT COMPLETED|Overall Study||135
7971213|NCT00319098|19624347|P2|COMPLETED|Overall Study||1237
7971214|NCT00319098|19624348|P1|COMPLETED|Overall Study||3667
7971215|NCT00319098|19624347|P2|STARTED|Overall Study||1269
7971216|NCT00319098|19624348|P1|STARTED|Overall Study||3802
7971217|NCT00319046|19624406|P1|NOT COMPLETED|Overall Study||8
7971218|NCT00319046|19624406|P1|COMPLETED|Overall Study||34
7971219|NCT00319046|19624406|P1|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42
7971220|NCT00319020|19624415|P2|NOT COMPLETED|Overall Study||13
7971221|NCT00319020|19624416|P1|NOT COMPLETED|Overall Study||7
7971222|NCT00319020|19624415|P2|COMPLETED|Overall Study||8
7971223|NCT00319020|19624416|P1|COMPLETED|Overall Study||8
7971224|NCT00319020|19624415|P2|Enrollment in FUTURE 2 (F-2)|Overall Study||20
7971225|NCT00319020|19624416|P1|Enrollment in FUTURE 2 (F-2)|Overall Study||13
7971226|NCT00319020|19624415|P2|STARTED|Overall Study||21
7971227|NCT00319020|19624416|P1|STARTED|Overall Study||15
7971228|NCT00318929|19624445|P1|NOT COMPLETED|Overall Study||0
7971229|NCT00318929|19624445|P1|COMPLETED|Overall Study||14
7971230|NCT00318929|19624445|P1|STARTED|Overall Study||14
7971231|NCT00318812|19624454|P2|NOT COMPLETED|Overall Study||0
7971232|NCT00318812|19624455|P1|NOT COMPLETED|Overall Study||0
7971233|NCT00318812|19624454|P2|COMPLETED|Overall Study||22
7971234|NCT00318812|19624455|P1|COMPLETED|Overall Study||18
7971235|NCT00318812|19624454|P2|STARTED|Overall Study||22
7971236|NCT00318812|19624455|P1|STARTED|Overall Study||18
7971237|NCT00318708|19624467|P2|NOT COMPLETED|Overall Study||5
7971238|NCT00318708|19624468|P1|NOT COMPLETED|Overall Study||8
7971239|NCT00318708|19624467|P2|COMPLETED|Overall Study||40
7971240|NCT00318708|19624468|P1|COMPLETED|Overall Study||39
7971241|NCT00318708|19624467|P2|8-week Milestone|Overall Study||42
7971242|NCT00318708|19624468|P1|8-week Milestone|Overall Study||42
7971243|NCT00318708|19624467|P2|STARTED|Overall Study||45
7971244|NCT00318708|19624468|P1|STARTED|Overall Study||47
7971245|NCT00318656|19624488|P2|NOT COMPLETED|Overall Study||2
7971246|NCT00318656|19624489|P1|NOT COMPLETED|Overall Study||0
7971247|NCT00318656|19624488|P2|COMPLETED|Overall Study|1 patient received by error avandamet treatment and 1 patient did not receive any treatment.|9
7971248|NCT00318656|19624489|P1|COMPLETED|Overall Study||12
7971249|NCT00318656|19624488|P2|STARTED|Overall Study||11
7971250|NCT00318656|19624489|P1|STARTED|Overall Study||12
7971251|NCT00318591|19624527|P2|NOT COMPLETED|Overall Study||45
7971252|NCT00318591|19624528|P1|NOT COMPLETED|Overall Study||60
7971253|NCT00318591|19624527|P2|COMPLETED|Overall Study||69
7971254|NCT00318591|19624528|P1|COMPLETED|Overall Study||45
7971255|NCT00318591|19624527|P2|STARTED|Overall Study||114
7971256|NCT00318591|19624528|P1|STARTED|Overall Study||105
7971257|NCT00318565|19624546|P1|NOT COMPLETED|Overall Study||24
7971258|NCT00318565|19624546|P1|COMPLETED|Overall Study||267
7971259|NCT00318565|19624546|P1|STARTED|Overall Study||291
7971260|NCT00318474|19624553|P2|NOT COMPLETED|Overall Study||17
7971261|NCT00318474|19624554|P1|NOT COMPLETED|Overall Study||18
7971262|NCT00318474|19624553|P2|COMPLETED|Overall Study||10
7971263|NCT00318474|19624554|P1|COMPLETED|Overall Study||7
7971264|NCT00318474|19624553|P2|STARTED|Overall Study||27
7971265|NCT00318474|19624554|P1|STARTED|Overall Study||25
7971266|NCT00318461|19624565|P5|NOT COMPLETED|Open-Label Extension, 18 Months||97
7971267|NCT00318461|19624566|P4|NOT COMPLETED|Open-Label Extension, 18 Months||43
7971268|NCT00318461|19624567|P3|NOT COMPLETED|Open-Label Extension, 18 Months||73
7971269|NCT00318461|19624568|P2|NOT COMPLETED|Open-Label Extension, 18 Months||60
7971270|NCT00318461|19624569|P1|NOT COMPLETED|Open-Label Extension, 18 Months||78
7971271|NCT00318461|19624565|P5|COMPLETED|Open-Label Extension, 18 Months||113
7971272|NCT00318461|19624566|P4|COMPLETED|Open-Label Extension, 18 Months||31
7971273|NCT00318461|19624567|P3|COMPLETED|Open-Label Extension, 18 Months||118
7971274|NCT00318461|19624568|P2|COMPLETED|Open-Label Extension, 18 Months||137
7971275|NCT00318461|19624569|P1|COMPLETED|Open-Label Extension, 18 Months||130
7971276|NCT00318461|19624565|P5|STARTED|Open-Label Extension, 18 Months||210
7971277|NCT00318461|19624566|P4|STARTED|Open-Label Extension, 18 Months||74
7971278|NCT00318461|19624567|P3|STARTED|Open-Label Extension, 18 Months||191
7971279|NCT00318461|19624568|P2|STARTED|Open-Label Extension, 18 Months||197
7971280|NCT00318461|19624569|P1|STARTED|Open-Label Extension, 18 Months||208
7971281|NCT00318461|19624565|P5|NOT COMPLETED|Double-Blind, 6 Months||34
7971282|NCT00318461|19624566|P4|NOT COMPLETED|Double-Blind, 6 Months||48
7971283|NCT00318461|19624567|P3|NOT COMPLETED|Double-Blind, 6 Months||51
7971284|NCT00318461|19624568|P2|NOT COMPLETED|Double-Blind, 6 Months||44
7971285|NCT00318461|19624569|P1|NOT COMPLETED|Double-Blind, 6 Months||34
7971286|NCT00318461|19624565|P5|COMPLETED|Double-Blind, 6 Months||210
7971287|NCT00318461|19624566|P4|COMPLETED|Double-Blind, 6 Months||74
7971288|NCT00318461|19624567|P3|COMPLETED|Double-Blind, 6 Months||191
7971289|NCT00318461|19624568|P2|COMPLETED|Double-Blind, 6 Months||197
7971290|NCT00318461|19624569|P1|COMPLETED|Double-Blind, 6 Months||208
7971291|NCT00318461|19624565|P5|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242
7971292|NCT00318461|19624566|P4|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121
7971293|NCT00318461|19624567|P3|Exposed to Study Drug|Double-Blind, 6 Months||242
7971294|NCT00318461|19624568|P2|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240
7971295|NCT00318461|19624569|P1|Exposed to Study Drug|Double-Blind, 6 Months||242
7971296|NCT00318461|19624565|P5|STARTED|Double-Blind, 6 Months|Randomised|244
7971297|NCT00318461|19624566|P4|STARTED|Double-Blind, 6 Months|Randomised|122
7971298|NCT00318461|19624567|P3|STARTED|Double-Blind, 6 Months|Randomised|242
7971299|NCT00318461|19624568|P2|STARTED|Double-Blind, 6 Months|Randomised|241
7971300|NCT00318461|19624569|P1|STARTED|Double-Blind, 6 Months|Randomised|242
7971301|NCT00318409|19624648|P2|NOT COMPLETED|Overall Study||1
7971302|NCT00318409|19624649|P1|NOT COMPLETED|Overall Study||2
7971303|NCT00318409|19624648|P2|COMPLETED|Overall Study||9
7971304|NCT00318409|19624649|P1|COMPLETED|Overall Study||18
7971305|NCT00318409|19624648|P2|STARTED|Overall Study||10
7971306|NCT00318409|19624649|P1|STARTED|Overall Study||20
7971307|NCT00318370|19624668|P3|NOT COMPLETED|Period 3||33
7971308|NCT00318370|19624669|P2|NOT COMPLETED|Period 3||0
7971309|NCT00318370|19624670|P1|NOT COMPLETED|Period 3||0
7971310|NCT00318370|19624668|P3|COMPLETED|Period 3||3
7971311|NCT00318370|19624669|P2|COMPLETED|Period 3||0
7971312|NCT00318370|19624670|P1|COMPLETED|Period 3||0
7971313|NCT00318370|19624668|P3|STARTED|Period 3||36
7971314|NCT00318370|19624669|P2|STARTED|Period 3||0
7971315|NCT00318370|19624670|P1|STARTED|Period 3||0
7971316|NCT00318370|19624668|P3|NOT COMPLETED|Period 2||0
7971317|NCT00318370|19624669|P2|NOT COMPLETED|Period 2||11
7971318|NCT00318370|19624670|P1|NOT COMPLETED|Period 2||0
7971319|NCT00318370|19624668|P3|COMPLETED|Period 2||0
7971320|NCT00318370|19624669|P2|COMPLETED|Period 2||36
7971321|NCT00318370|19624670|P1|COMPLETED|Period 2||0
7971322|NCT00318370|19624668|P3|STARTED|Period 2||0
7971323|NCT00318370|19624669|P2|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47
7971324|NCT00318370|19624670|P1|STARTED|Period 2||0
7971325|NCT00318370|19624668|P3|NOT COMPLETED|Period 1||0
7971326|NCT00318370|19624669|P2|NOT COMPLETED|Period 1||0
7971327|NCT00318370|19624670|P1|NOT COMPLETED|Period 1||7
7971328|NCT00318370|19624668|P3|COMPLETED|Period 1||0
7971329|NCT00318370|19624669|P2|COMPLETED|Period 1||0
7971330|NCT00318370|19624670|P1|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21
7971331|NCT00318370|19624668|P3|STARTED|Period 1||0
7971332|NCT00318370|19624669|P2|STARTED|Period 1||0
7971333|NCT00318370|19624670|P1|STARTED|Period 1||28
7971334|NCT00318357|19624682|P2|NOT COMPLETED|Overall Study||32
7971335|NCT00318357|19624683|P1|NOT COMPLETED|Overall Study||39
7971336|NCT00318357|19624682|P2|COMPLETED|Overall Study||104
7971337|NCT00318357|19624683|P1|COMPLETED|Overall Study||134
7971338|NCT00318357|19624682|P2|STARTED|Overall Study||136
7971339|NCT00318357|19624683|P1|STARTED|Overall Study||173
7971340|NCT00318292|19624691|P2|NOT COMPLETED|Overall Study||0
7971341|NCT00318292|19624692|P1|NOT COMPLETED|Overall Study||0
7971342|NCT00318292|19624691|P2|COMPLETED|Overall Study||45
7971343|NCT00318292|19624692|P1|COMPLETED|Overall Study||45
7971344|NCT00318292|19624691|P2|STARTED|Overall Study||45
7971345|NCT00318292|19624692|P1|STARTED|Overall Study||45
7971346|NCT00318149|19624704|P6|NOT COMPLETED|Overall Study||2
7971347|NCT00318149|19624705|P5|NOT COMPLETED|Overall Study||0
7971348|NCT00318149|19624706|P4|NOT COMPLETED|Overall Study||0
7971349|NCT00318149|19624707|P3|NOT COMPLETED|Overall Study||0
7971350|NCT00318149|19624708|P2|NOT COMPLETED|Overall Study||0
7971351|NCT00318149|19624709|P1|NOT COMPLETED|Overall Study||0
7971352|NCT00318149|19624704|P6|COMPLETED|Overall Study||73
7971353|NCT00318149|19624705|P5|COMPLETED|Overall Study||75
7971354|NCT00318149|19624706|P4|COMPLETED|Overall Study||75
7971355|NCT00318149|19624707|P3|COMPLETED|Overall Study||75
7971356|NCT00318149|19624708|P2|COMPLETED|Overall Study||50
7971357|NCT00318149|19624709|P1|COMPLETED|Overall Study||75
7971358|NCT00318149|19624704|P6|STARTED|Overall Study||75
7971359|NCT00318149|19624705|P5|STARTED|Overall Study||75
7971360|NCT00318149|19624706|P4|STARTED|Overall Study||75
7971361|NCT00318149|19624707|P3|STARTED|Overall Study||75
7971362|NCT00318149|19624708|P2|STARTED|Overall Study||50
7971363|NCT00318149|19624709|P1|STARTED|Overall Study||75
7971364|NCT00318136|19624795|P1|NOT COMPLETED|Overall Study||45
7971365|NCT00318136|19624795|P1|COMPLETED|Overall Study||2
7971366|NCT00318136|19624795|P1|STARTED|Overall Study||47
7971367|NCT00317941|19624804|P3|NOT COMPLETED|Overall Study||8
7971368|NCT00317941|19624805|P2|NOT COMPLETED|Overall Study||5
7971369|NCT00317941|19624806|P1|NOT COMPLETED|Overall Study||7
7971370|NCT00317941|19624804|P3|COMPLETED|Overall Study||60
7971371|NCT00317941|19624805|P2|COMPLETED|Overall Study||74
7971372|NCT00317941|19624806|P1|COMPLETED|Overall Study||66
7971373|NCT00317941|19624804|P3|Fulfilled Requirements PP Population|Overall Study||63
7971374|NCT00317941|19624805|P2|Fulfilled Requirements PP Population|Overall Study||76
7971375|NCT00317941|19624806|P1|Fulfilled Requirements PP Population|Overall Study||66
7971376|NCT00317941|19624804|P3|Fulfilled Requirement Safety Population|Overall Study||65
7971377|NCT00317941|19624805|P2|Fulfilled Requirement Safety Population|Overall Study||77
7971378|NCT00317941|19624806|P1|Fulfilled Requirement Safety Population|Overall Study||73
7971379|NCT00317941|19624804|P3|Participants Received Treatment|Overall Study||68
7971380|NCT00317941|19624805|P2|Participants Received Treatment|Overall Study||79
7971381|NCT00317941|19624806|P1|Participants Received Treatment|Overall Study||73
7971382|NCT00317941|19624804|P3|STARTED|Overall Study||68
7971383|NCT00317941|19624805|P2|STARTED|Overall Study||79
7971384|NCT00317941|19624806|P1|STARTED|Overall Study||73
7971385|NCT00317720|19624847|P2|NOT COMPLETED|Overall Study||0
7971386|NCT00317720|19624848|P1|NOT COMPLETED|Overall Study||0
7971387|NCT00317720|19624847|P2|COMPLETED|Overall Study||7
7971388|NCT00317720|19624848|P1|COMPLETED|Overall Study||40
7971389|NCT00317720|19624847|P2|STARTED|Overall Study||7
7971390|NCT00317720|19624848|P1|STARTED|Overall Study||40
7971391|NCT00317642|19624855|P2|NOT COMPLETED|Overall Study||135
7971392|NCT00317642|19624856|P1|NOT COMPLETED|Overall Study||122
7971393|NCT00317642|19624855|P2|COMPLETED|Overall Study|achieved remission and completed consolidation|28
7971394|NCT00317642|19624856|P1|COMPLETED|Overall Study|achieved remission and completed consolidation|41
7971395|NCT00317642|19624855|P2|Received >= 1 Study Drug (Safety Set)|Overall Study||155
7971396|NCT00317642|19624856|P1|Received >= 1 Study Drug (Safety Set)|Overall Study||161
7971397|NCT00317642|19624855|P2|Full Analysis Set|Overall Study|AML Centrally Confirmed|158
7971398|NCT00317642|19624856|P1|Full Analysis Set|Overall Study|AML Centrally Confirmed|162
7971399|NCT00317642|19624855|P2|STARTED|Overall Study||163
7971400|NCT00317642|19624856|P1|STARTED|Overall Study||163
7971401|NCT00317473|19624935|P6|NOT COMPLETED|Overall Study||3
7971402|NCT00317473|19624936|P5|NOT COMPLETED|Overall Study||8
7971403|NCT00317473|19624937|P4|NOT COMPLETED|Overall Study||2
7971404|NCT00317473|19624938|P3|NOT COMPLETED|Overall Study||3
7971405|NCT00317473|19624939|P2|NOT COMPLETED|Overall Study||3
7971406|NCT00317473|19624940|P1|NOT COMPLETED|Overall Study||4
7971407|NCT00317473|19624935|P6|COMPLETED|Overall Study||12
7971408|NCT00317473|19624936|P5|COMPLETED|Overall Study||22
7971409|NCT00317473|19624937|P4|COMPLETED|Overall Study||13
7971410|NCT00317473|19624938|P3|COMPLETED|Overall Study||27
7971411|NCT00317473|19624939|P2|COMPLETED|Overall Study||12
7971412|NCT00317473|19624940|P1|COMPLETED|Overall Study||26
7971413|NCT00317473|19624935|P6|STARTED|Overall Study||15
7971414|NCT00317473|19624936|P5|STARTED|Overall Study||30
7971415|NCT00317473|19624937|P4|STARTED|Overall Study||15
7971416|NCT00317473|19624938|P3|STARTED|Overall Study||30
7971417|NCT00317473|19624939|P2|STARTED|Overall Study||15
7971418|NCT00317473|19624940|P1|STARTED|Overall Study||30
7971419|NCT00317239|19624966|P2|NOT COMPLETED|Overall Study||19
7971420|NCT00317239|19624967|P1|NOT COMPLETED|Overall Study||13
7971421|NCT00317239|19624966|P2|COMPLETED|Overall Study||84
7971422|NCT00317239|19624967|P1|COMPLETED|Overall Study||134
7971423|NCT00317239|19624966|P2|STARTED|Overall Study||103
7971424|NCT00317239|19624967|P1|STARTED|Overall Study||147
7971425|NCT00317226|19624973|P1|NOT COMPLETED|Overall Study||23
7971426|NCT00317226|19624973|P1|COMPLETED|Overall Study||104
7971427|NCT00317226|19624973|P1|STARTED|Overall Study||127
7971428|NCT00317109|19624979|P2|NOT COMPLETED|Overall Study||0
7971429|NCT00317109|19624980|P1|NOT COMPLETED|Overall Study||3
7971430|NCT00317109|19624979|P2|COMPLETED|Overall Study||84
7971431|NCT00317109|19624980|P1|COMPLETED|Overall Study||81
7971432|NCT00317109|19624979|P2|STARTED|Overall Study||84
7971433|NCT00317109|19624980|P1|STARTED|Overall Study||84
7971434|NCT00317044|19625017|P3|NOT COMPLETED|Overall Study||45
7971435|NCT00317044|19625018|P2|NOT COMPLETED|Overall Study||40
7971436|NCT00317044|19625019|P1|NOT COMPLETED|Overall Study||48
7971437|NCT00317044|19625017|P3|COMPLETED|Overall Study||283
7971438|NCT00317044|19625018|P2|COMPLETED|Overall Study||273
7971439|NCT00317044|19625019|P1|COMPLETED|Overall Study||272
7971440|NCT00317044|19625017|P3|STARTED|Overall Study||328
7971441|NCT00317044|19625018|P2|STARTED|Overall Study||313
7971442|NCT00317044|19625019|P1|STARTED|Overall Study||320
7971443|NCT00316914|19625065|P2|NOT COMPLETED|Overall Study||36
7971444|NCT00316914|19625066|P1|NOT COMPLETED|Overall Study||33
7971445|NCT00316914|19625065|P2|COMPLETED|Overall Study||16
7971446|NCT00316914|19625066|P1|COMPLETED|Overall Study||17
7971447|NCT00316914|19625065|P2|STARTED|Overall Study||52
7971448|NCT00316914|19625066|P1|STARTED|Overall Study||50
7971449|NCT00316888|19625096|P2|NOT COMPLETED|Overall Study||8
7971450|NCT00316888|19625097|P1|NOT COMPLETED|Overall Study||6
7971451|NCT00316888|19625096|P2|COMPLETED|Overall Study||27
7971452|NCT00316888|19625097|P1|COMPLETED|Overall Study||22
7971453|NCT00316888|19625096|P2|Started Chemo+Radiation+Cetuximab|Overall Study||34
7971454|NCT00316888|19625097|P1|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27
7971455|NCT00316888|19625096|P2|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0
7971456|NCT00316888|19625097|P1|Started Induction Chemotherapy|Overall Study||28
7971457|NCT00316888|19625096|P2|Treated|Overall Study||34
7971458|NCT00316888|19625097|P1|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28
7971459|NCT00316888|19625096|P2|Eligible|Overall Study||35
7971460|NCT00316888|19625097|P1|Eligible|Overall Study||28
7971461|NCT00316888|19625096|P2|STARTED|Overall Study||35
7971462|NCT00316888|19625097|P1|STARTED|Overall Study||28
7971463|NCT00316862|19625111|P1|NOT COMPLETED|Overall Study||0
7971464|NCT00316862|19625111|P1|COMPLETED|Overall Study||82
7971465|NCT00316862|19625111|P1|STARTED|Overall Study||82
7971466|NCT00316719|19625119|P2|NOT COMPLETED|Overall Study||6
7971467|NCT00316719|19625120|P1|NOT COMPLETED|Overall Study||2
7971468|NCT00316719|19625119|P2|COMPLETED|Overall Study||47
7971469|NCT00316719|19625120|P1|COMPLETED|Overall Study||50
7971470|NCT00316719|19625119|P2|STARTED|Overall Study||53
7971471|NCT00316719|19625120|P1|STARTED|Overall Study||52
7971472|NCT00316706|19625146|P2|NOT COMPLETED|Overall Study||48
7971473|NCT00316706|19625147|P1|NOT COMPLETED|Overall Study||38
7971474|NCT00316706|19625146|P2|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571
7971475|NCT00316706|19625147|P1|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588
7971476|NCT00316706|19625146|P2|STARTED|Overall Study||619
7971477|NCT00316706|19625147|P1|STARTED|Overall Study||626
7971478|NCT00316693|19625163|P2|NOT COMPLETED|Overall Study||85
7971479|NCT00316693|19625164|P1|NOT COMPLETED|Overall Study||77
7971480|NCT00316693|19625163|P2|COMPLETED|Overall Study||436
7971481|NCT00316693|19625164|P1|COMPLETED|Overall Study||442
7971482|NCT00316693|19625163|P2|STARTED|Overall Study||521
7971483|NCT00316693|19625164|P1|STARTED|Overall Study||519
7971484|NCT00316602|19625206|P2|NOT COMPLETED|Overall Study||25
7971485|NCT00316602|19625207|P1|NOT COMPLETED|Overall Study||10
7971486|NCT00316602|19625206|P2|COMPLETED|Overall Study||325
7971487|NCT00316602|19625207|P1|COMPLETED|Overall Study||272
7971488|NCT00316602|19625206|P2|STARTED|Overall Study||350
7971489|NCT00316602|19625207|P1|STARTED|Overall Study||282
7971490|NCT00316589|19625239|P4|NOT COMPLETED|Overall Study||5
7971491|NCT00316589|19625240|P3|NOT COMPLETED|Overall Study||1
7971492|NCT00316589|19625241|P2|NOT COMPLETED|Overall Study||24
7971493|NCT00316589|19625242|P1|NOT COMPLETED|Overall Study||1
7971494|NCT00316589|19625239|P4|COMPLETED|Overall Study||127
7971495|NCT00316589|19625240|P3|COMPLETED|Overall Study||8
7971496|NCT00316589|19625241|P2|COMPLETED|Overall Study||328
7971497|NCT00316589|19625242|P1|COMPLETED|Overall Study||87
7971498|NCT00316589|19625239|P4|STARTED|Overall Study||132
7971499|NCT00316589|19625240|P3|STARTED|Overall Study||9
7971500|NCT00316589|19625241|P2|STARTED|Overall Study||352
7971501|NCT00316589|19625242|P1|STARTED|Overall Study||88
7971502|NCT00316524|19625310|P4|NOT COMPLETED|Overall Study||0
7971503|NCT00316524|19625311|P3|NOT COMPLETED|Overall Study||6
7971504|NCT00316524|19625312|P2|NOT COMPLETED|Overall Study||8
7971505|NCT00316524|19625313|P1|NOT COMPLETED|Overall Study||8
7971506|NCT00316524|19625310|P4|COMPLETED|Overall Study||200
7971507|NCT00316524|19625311|P3|COMPLETED|Overall Study||175
7971508|NCT00316524|19625312|P2|COMPLETED|Overall Study||173
7971509|NCT00316524|19625313|P1|COMPLETED|Overall Study||175
7971510|NCT00316524|19625310|P4|STARTED|Overall Study||200
7971511|NCT00316524|19625311|P3|STARTED|Overall Study||181
7971512|NCT00316524|19625312|P2|STARTED|Overall Study||181
7971513|NCT00316524|19625313|P1|STARTED|Overall Study||183
7971514|NCT00316355|19625365|P2|NOT COMPLETED|Overall Study||7
7971515|NCT00316355|19625366|P1|NOT COMPLETED|Overall Study||5
7971516|NCT00316355|19625365|P2|COMPLETED|Overall Study||12
7971517|NCT00316355|19625366|P1|COMPLETED|Overall Study||10
7971518|NCT00316355|19625365|P2|Started Treatment|Overall Study||18
7971519|NCT00316355|19625366|P1|Started Treatment|Overall Study||12
7971520|NCT00316355|19625365|P2|STARTED|Overall Study||19
7971521|NCT00316355|19625366|P1|STARTED|Overall Study||15
7971522|NCT00316303|19625376|P2|NOT COMPLETED|Overall Study||16
7971523|NCT00316303|19625377|P1|NOT COMPLETED|Overall Study||11
7971524|NCT00316303|19625376|P2|COMPLETED|Overall Study||102
7971525|NCT00316303|19625377|P1|COMPLETED|Overall Study||107
7971526|NCT00316303|19625376|P2|STARTED|Overall Study||118
7971527|NCT00316303|19625377|P1|STARTED|Overall Study||118
7971528|NCT00316277|19625393|P2|NOT COMPLETED|Phase 2 (24 Weeks)||19
7971529|NCT00316277|19625394|P1|NOT COMPLETED|Phase 2 (24 Weeks)||19
7971530|NCT00316277|19625393|P2|COMPLETED|Phase 2 (24 Weeks)||161
7971531|NCT00316277|19625394|P1|COMPLETED|Phase 2 (24 Weeks)||161
7971532|NCT00316277|19625393|P2|STARTED|Phase 2 (24 Weeks)||180
7971533|NCT00316277|19625394|P1|STARTED|Phase 2 (24 Weeks)||180
7971534|NCT00316277|19625393|P2|NOT COMPLETED|Phase 1 (12 Weeks)||300
7971535|NCT00316277|19625394|P1|NOT COMPLETED|Phase 1 (12 Weeks)||310
7971536|NCT00316277|19625393|P2|COMPLETED|Phase 1 (12 Weeks)||24
7971537|NCT00316277|19625394|P1|COMPLETED|Phase 1 (12 Weeks)||19
7971538|NCT00316277|19625393|P2|STARTED|Phase 1 (12 Weeks)||324
7971539|NCT00316277|19625394|P1|STARTED|Phase 1 (12 Weeks)||329
7971540|NCT00316264|19625415|P3|NOT COMPLETED|Overall Study||6
7971541|NCT00316264|19625416|P2|NOT COMPLETED|Overall Study||7
7971542|NCT00316264|19625417|P1|NOT COMPLETED|Overall Study||6
7971543|NCT00316264|19625415|P3|COMPLETED|Overall Study||87
7971544|NCT00316264|19625416|P2|COMPLETED|Overall Study||77
7971545|NCT00316264|19625417|P1|COMPLETED|Overall Study||77
7971546|NCT00316264|19625415|P3|STARTED|Overall Study||93
7971547|NCT00316264|19625416|P2|STARTED|Overall Study||84
7971548|NCT00316264|19625417|P1|STARTED|Overall Study||83
7971549|NCT00316225|19625485|P1|NOT COMPLETED|Overall Study||25
7971550|NCT00316225|19625485|P1|COMPLETED|Overall Study||6
7971551|NCT00316225|19625485|P1|STARTED|Overall Study||31
7971552|NCT00316199|19625494|P1|NOT COMPLETED|Overall Study||12
7971553|NCT00316199|19625494|P1|COMPLETED|Overall Study||48
7971554|NCT00316199|19625494|P1|STARTED|Overall Study||60
7971555|NCT00316186|19625502|P1|NOT COMPLETED|Overall Study||12
7971556|NCT00316186|19625502|P1|COMPLETED|Overall Study||21
7971557|NCT00316186|19625502|P1|STARTED|Overall Study||33
7971558|NCT00316173|19625516|P2|NOT COMPLETED|Treatment Phase||42
7971559|NCT00316173|19625517|P1|NOT COMPLETED|Treatment Phase||0
7971560|NCT00316173|19625516|P2|COMPLETED|Treatment Phase||13
7971561|NCT00316173|19625517|P1|COMPLETED|Treatment Phase||0
7971562|NCT00316173|19625516|P2|STARTED|Treatment Phase||55
7971563|NCT00316173|19625517|P1|STARTED|Treatment Phase||0
7971564|NCT00316173|19625516|P2|NOT COMPLETED|Run-in Phase||0
7971565|NCT00316173|19625517|P1|NOT COMPLETED|Run-in Phase||7
7971566|NCT00316173|19625516|P2|COMPLETED|Run-in Phase||0
7971567|NCT00316173|19625517|P1|COMPLETED|Run-in Phase||15
7971568|NCT00316173|19625516|P2|STARTED|Run-in Phase||0
7971569|NCT00316173|19625517|P1|STARTED|Run-in Phase||22
7971570|NCT00316121|19625530|P2|NOT COMPLETED|Overall Study||9
7971571|NCT00316121|19625531|P1|NOT COMPLETED|Overall Study||22
7971572|NCT00316121|19625530|P2|COMPLETED|Overall Study||37
7971573|NCT00316121|19625531|P1|COMPLETED|Overall Study||70
7971574|NCT00316121|19625530|P2|STARTED|Overall Study||46
7971575|NCT00316121|19625531|P1|STARTED|Overall Study||92
7971576|NCT00316082|19625542|P5|NOT COMPLETED|Overall Study||26
7971577|NCT00316082|19625543|P4|NOT COMPLETED|Overall Study||26
7971578|NCT00316082|19625544|P3|NOT COMPLETED|Overall Study||27
7971579|NCT00316082|19625545|P2|NOT COMPLETED|Overall Study||22
7971580|NCT00316082|19625546|P1|NOT COMPLETED|Overall Study||33
7971581|NCT00316082|19625542|P5|COMPLETED|Overall Study||48
7971582|NCT00316082|19625543|P4|COMPLETED|Overall Study||46
7971583|NCT00316082|19625544|P3|COMPLETED|Overall Study||44
7971584|NCT00316082|19625545|P2|COMPLETED|Overall Study||52
7971585|NCT00316082|19625546|P1|COMPLETED|Overall Study||41
7971586|NCT00316082|19625542|P5|Completed Study Without Being Rescued|Overall Study||31
7971587|NCT00316082|19625543|P4|Completed Study Without Being Rescued|Overall Study||27
7971588|NCT00316082|19625544|P3|Completed Study Without Being Rescued|Overall Study||29
7971589|NCT00316082|19625545|P2|Completed Study Without Being Rescued|Overall Study||35
7971590|NCT00316082|19625546|P1|Completed Study Without Being Rescued|Overall Study||25
7971591|NCT00316082|19625542|P5|STARTED|Overall Study||74
7971592|NCT00316082|19625543|P4|STARTED|Overall Study||72
7971593|NCT00316082|19625544|P3|STARTED|Overall Study||71
7971594|NCT00316082|19625545|P2|STARTED|Overall Study||74
7971595|NCT00316082|19625546|P1|STARTED|Overall Study||74
7971596|NCT00316017|19625577|P3|NOT COMPLETED|Overall Study||19
7971597|NCT00316017|19625578|P2|NOT COMPLETED|Overall Study||13
7971598|NCT00316017|19625579|P1|NOT COMPLETED|Overall Study||11
7971599|NCT00316017|19625577|P3|COMPLETED|Overall Study||376
7971600|NCT00316017|19625578|P2|COMPLETED|Overall Study||256
7971601|NCT00316017|19625579|P1|COMPLETED|Overall Study||220
7971602|NCT00316017|19625577|P3|STARTED|Overall Study|19 of 19 not complete due to BONG|395
7971603|NCT00316017|19625578|P2|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269
7971604|NCT00316017|19625579|P1|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231
7971605|NCT00316004|19625653|P3|NOT COMPLETED|Overall Study||21
7971606|NCT00316004|19625654|P2|NOT COMPLETED|Overall Study||14
7971607|NCT00316004|19625655|P1|NOT COMPLETED|Overall Study||14
7971608|NCT00316004|19625653|P3|COMPLETED|Overall Study||582
7971609|NCT00316004|19625654|P2|COMPLETED|Overall Study||341
7971610|NCT00316004|19625655|P1|COMPLETED|Overall Study||359
7971611|NCT00316004|19625653|P3|STARTED|Overall Study||603
7971612|NCT00316004|19625654|P2|STARTED|Overall Study||355
7971613|NCT00316004|19625655|P1|STARTED|Overall Study||373
7971614|NCT00315939|19625710|P2|NOT COMPLETED|Admission 3 (3 Months)||2
7971615|NCT00315939|19625711|P1|NOT COMPLETED|Admission 3 (3 Months)||4
7971616|NCT00315939|19625710|P2|COMPLETED|Admission 3 (3 Months)||49
7971617|NCT00315939|19625711|P1|COMPLETED|Admission 3 (3 Months)||48
7971618|NCT00315939|19625710|P2|STARTED|Admission 3 (3 Months)||51
7971619|NCT00315939|19625711|P1|STARTED|Admission 3 (3 Months)||52
7971620|NCT00315939|19625710|P2|NOT COMPLETED|Admission 2 (3 Months)||4
7971621|NCT00315939|19625711|P1|NOT COMPLETED|Admission 2 (3 Months)||4
7971622|NCT00315939|19625710|P2|COMPLETED|Admission 2 (3 Months)||51
7971623|NCT00315939|19625711|P1|COMPLETED|Admission 2 (3 Months)||52
7971624|NCT00315939|19625710|P2|STARTED|Admission 2 (3 Months)||55
7971625|NCT00315939|19625711|P1|STARTED|Admission 2 (3 Months)||56
7971626|NCT00315939|19625710|P2|NOT COMPLETED|Admission 1 (3 Months)||6
7971627|NCT00315939|19625711|P1|NOT COMPLETED|Admission 1 (3 Months)||3
7971628|NCT00315939|19625710|P2|COMPLETED|Admission 1 (3 Months)||55
7971629|NCT00315939|19625711|P1|COMPLETED|Admission 1 (3 Months)||56
7971630|NCT00315939|19625710|P2|STARTED|Admission 1 (3 Months)||61
7971631|NCT00315939|19625711|P1|STARTED|Admission 1 (3 Months)||59
7971632|NCT00315822|19625719|P2|NOT COMPLETED|Overall Study||0
7971633|NCT00315822|19625720|P1|NOT COMPLETED|Overall Study||0
7971634|NCT00315822|19625719|P2|COMPLETED|Overall Study||202
7971635|NCT00315822|19625720|P1|COMPLETED|Overall Study||198
7971636|NCT00315822|19625719|P2|STARTED|Overall Study||202
7971637|NCT00315822|19625720|P1|STARTED|Overall Study||198
7971638|NCT00315731|19625726|P1|NOT COMPLETED|Overall Study||6
7971639|NCT00315731|19625726|P1|COMPLETED|Overall Study||9
7971640|NCT00315731|19625726|P1|STARTED|Overall Study||15
7971641|NCT00315705|19625754|P1|NOT COMPLETED|Phase 2||25
7971642|NCT00315705|19625754|P1|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
7971643|NCT00315705|19625754|P1|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25
7971644|NCT00315705|19625754|P1|NOT COMPLETED|Phase 1||25
7971645|NCT00315705|19625754|P1|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
7971646|NCT00315705|19625754|P1|STARTED|Phase 1||25
7971647|NCT00315627|19625791|P1|NOT COMPLETED|Overall Study||0
7971648|NCT00315627|19625791|P1|COMPLETED|Overall Study||3
7971649|NCT00315627|19625791|P1|STARTED|Overall Study||3
7971650|NCT00315614|19625799|P1|NOT COMPLETED|Overall Study||0
7971651|NCT00315614|19625799|P1|COMPLETED|Overall Study||3
7971652|NCT00315614|19625799|P1|STARTED|Overall Study||3
7971653|NCT00315588|19625806|P1|NOT COMPLETED|Overall Study||0
7971654|NCT00315588|19625806|P1|COMPLETED|Overall Study||7
7971655|NCT00315588|19625806|P1|STARTED|Overall Study||7
7971656|NCT00315458|19625815|P4|NOT COMPLETED|Overall Study||29
7971657|NCT00315458|19625816|P3|NOT COMPLETED|Overall Study||52
7971658|NCT00315458|19625817|P2|NOT COMPLETED|Overall Study||12
7971659|NCT00315458|19625818|P1|NOT COMPLETED|Overall Study||3
7971660|NCT00315458|19625815|P4|COMPLETED|Overall Study||10
7971661|NCT00315458|19625816|P3|COMPLETED|Overall Study||107
7971662|NCT00315458|19625817|P2|COMPLETED|Overall Study||44
7971663|NCT00315458|19625818|P1|COMPLETED|Overall Study||48
7971664|NCT00315458|19625815|P4|STARTED|Overall Study||39
7971665|NCT00315458|19625816|P3|STARTED|Overall Study||159
7971666|NCT00315458|19625817|P2|STARTED|Overall Study||56
7971667|NCT00315458|19625818|P1|STARTED|Overall Study||51
7971668|NCT00315445|19625831|P3|NOT COMPLETED|Overall Study||24
7971669|NCT00315445|19625832|P2|NOT COMPLETED|Overall Study||16
7971670|NCT00315445|19625833|P1|NOT COMPLETED|Overall Study||27
7971671|NCT00315445|19625831|P3|COMPLETED|Overall Study||22
7971672|NCT00315445|19625832|P2|COMPLETED|Overall Study||27
7971673|NCT00315445|19625833|P1|COMPLETED|Overall Study||18
7971674|NCT00315445|19625831|P3|STARTED|Overall Study||46
7971675|NCT00315445|19625832|P2|STARTED|Overall Study||43
7971676|NCT00315445|19625833|P1|STARTED|Overall Study||45
7971677|NCT00315341|19625906|P2|NOT COMPLETED|Overall Study||138
7971678|NCT00315341|19625907|P1|NOT COMPLETED|Overall Study||400
7971679|NCT00315341|19625906|P2|COMPLETED|Overall Study||391
7971680|NCT00315341|19625907|P1|COMPLETED|Overall Study||340
7971681|NCT00315341|19625906|P2|STARTED|Overall Study||529
7971682|NCT00315341|19625907|P1|STARTED|Overall Study||740
7971683|NCT00315328|19625917|P4|NOT COMPLETED|Overall Study||2
7971684|NCT00315328|19625918|P3|NOT COMPLETED|Overall Study||5
7971685|NCT00315328|19625919|P2|NOT COMPLETED|Overall Study||7
7971686|NCT00315328|19625920|P1|NOT COMPLETED|Overall Study||14
7971687|NCT00315328|19625917|P4|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20
7971688|NCT00315328|19625918|P3|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13
7971689|NCT00315328|19625919|P2|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88
7971690|NCT00315328|19625920|P1|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84
7971691|NCT00315328|19625917|P4|5 Week Visit|Overall Study||19
7971692|NCT00315328|19625918|P3|5 Week Visit|Overall Study||17
7971693|NCT00315328|19625919|P2|5 Week Visit|Overall Study||89
7971694|NCT00315328|19625920|P1|5 Week Visit|Overall Study||91
7971695|NCT00315328|19625917|P4|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22
7971696|NCT00315328|19625918|P3|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18
7971697|NCT00315328|19625919|P2|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95
7971698|NCT00315328|19625920|P1|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98
7971699|NCT00315302|19625990|P4|NOT COMPLETED|Overall Study||3
7971700|NCT00315302|19625991|P3|NOT COMPLETED|Overall Study||2
7971701|NCT00315302|19625992|P2|NOT COMPLETED|Overall Study||2
7971702|NCT00315302|19625993|P1|NOT COMPLETED|Overall Study||6
7971703|NCT00315302|19625990|P4|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31
7971704|NCT00315302|19625991|P3|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24
7971705|NCT00315302|19625992|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88
7971706|NCT00315302|19625993|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84
7971707|NCT00315302|19625990|P4|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11
7971708|NCT00315302|19625991|P3|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9
7971709|NCT00315302|19625992|P2|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13
7971710|NCT00315302|19625993|P1|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16
7971711|NCT00315302|19625990|P4|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31
7971712|NCT00315302|19625991|P3|18 Week Primary Outcome Visit|Overall Study||24
7971713|NCT00315302|19625992|P2|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88
7971714|NCT00315302|19625993|P1|18 Week Primary Outcome Visit|Overall Study||84
7971715|NCT00315302|19625990|P4|10 Week Visit|Overall Study||29
7971716|NCT00315302|19625991|P3|10 Week Visit|Overall Study||24
7971717|NCT00315302|19625992|P2|10 Week Visit|Overall Study||85
7971718|NCT00315302|19625993|P1|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86
7971719|NCT00315302|19625990|P4|5 Week Visit|Overall Study||30
7971720|NCT00315302|19625991|P3|5 Week Visit|Overall Study||26
7971721|NCT00315302|19625992|P2|5 Week Visit|Overall Study||86
7971722|NCT00315302|19625993|P1|5 Week Visit|Overall Study||85
7971723|NCT00315302|19625990|P4|STARTED|Overall Study||34
7971724|NCT00315302|19625991|P3|STARTED|Overall Study||26
7971725|NCT00315302|19625992|P2|STARTED|Overall Study||90
7971726|NCT00315302|19625993|P1|STARTED|Overall Study||90
7971727|NCT00315146|19626039|P4|NOT COMPLETED|Overall Study||0
7971728|NCT00315146|19626040|P3|NOT COMPLETED|Overall Study||2
7971729|NCT00315146|19626041|P2|NOT COMPLETED|Overall Study||3
7971730|NCT00315146|19626042|P1|NOT COMPLETED|Overall Study||2
7971731|NCT00315146|19626039|P4|COMPLETED|Overall Study||22
7971732|NCT00315146|19626040|P3|COMPLETED|Overall Study||20
7971733|NCT00315146|19626041|P2|COMPLETED|Overall Study||19
7971734|NCT00315146|19626042|P1|COMPLETED|Overall Study||20
7971735|NCT00315146|19626039|P4|STARTED|Overall Study||22
7971736|NCT00315146|19626040|P3|STARTED|Overall Study||22
7971737|NCT00315146|19626041|P2|STARTED|Overall Study||22
7971738|NCT00315146|19626042|P1|STARTED|Overall Study||22
7971739|NCT00315120|19626060|P4|NOT COMPLETED|Overall Study||0
7971740|NCT00315120|19626061|P3|NOT COMPLETED|Overall Study||0
7971741|NCT00315120|19626062|P2|NOT COMPLETED|Overall Study||0
7971742|NCT00315120|19626063|P1|NOT COMPLETED|Overall Study||0
7971743|NCT00315120|19626060|P4|COMPLETED|Overall Study||107
7971744|NCT00315120|19626061|P3|COMPLETED|Overall Study||115
7971745|NCT00315120|19626062|P2|COMPLETED|Overall Study||118
7971746|NCT00315120|19626063|P1|COMPLETED|Overall Study||115
7971747|NCT00315120|19626060|P4|STARTED|Overall Study||107
7971748|NCT00315120|19626061|P3|STARTED|Overall Study||115
7971749|NCT00315120|19626062|P2|STARTED|Overall Study||118
7971750|NCT00315120|19626063|P1|STARTED|Overall Study||115
7971751|NCT00315055|19626123|P2|NOT COMPLETED|Overall Study||5
7971752|NCT00315055|19626124|P1|NOT COMPLETED|Overall Study||3
7971753|NCT00315055|19626123|P2|COMPLETED|Overall Study||150
7971754|NCT00315055|19626124|P1|COMPLETED|Overall Study||152
7971755|NCT00315055|19626123|P2|STARTED|Overall Study||155
7971756|NCT00315055|19626124|P1|STARTED|Overall Study||155
7971757|NCT00314951|19626142|P2|NOT COMPLETED|Follow-up||34
7971758|NCT00314951|19626143|P1|NOT COMPLETED|Follow-up||44
7971759|NCT00314951|19626142|P2|COMPLETED|Follow-up||255
7971760|NCT00314951|19626143|P1|COMPLETED|Follow-up||263
7971761|NCT00314951|19626142|P2|STARTED|Follow-up||289
7971762|NCT00314951|19626143|P1|STARTED|Follow-up||307
7971763|NCT00314951|19626142|P2|NOT COMPLETED|Treatment||11
7971764|NCT00314951|19626143|P1|NOT COMPLETED|Treatment||16
7971765|NCT00314951|19626142|P2|COMPLETED|Treatment||289
7971766|NCT00314951|19626143|P1|COMPLETED|Treatment||307
7971767|NCT00314951|19626142|P2|STARTED|Treatment||300
7971768|NCT00314951|19626143|P1|STARTED|Treatment||323
7971769|NCT00314951|19626142|P2|NOT COMPLETED|Enrollment||6
7971770|NCT00314951|19626143|P1|NOT COMPLETED|Enrollment||0
7971771|NCT00314951|19626142|P2|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300
7971772|NCT00314951|19626143|P1|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323
7971773|NCT00314951|19626142|P2|STARTED|Enrollment||306
7971774|NCT00314951|19626143|P1|STARTED|Enrollment||323
7971775|NCT00314808|19626153|P1|NOT COMPLETED|Overall Study||8
7971776|NCT00314808|19626153|P1|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25
7971777|NCT00314808|19626153|P1|STARTED|Overall Study||33
7971778|NCT00314795|19626161|P1|NOT COMPLETED|Overall Study||20
7971779|NCT00314795|19626161|P1|COMPLETED|Overall Study||2
7971780|NCT00314795|19626161|P1|STARTED|Overall Study||22
7971781|NCT00314574|19626171|P2|NOT COMPLETED|Overall Study||83
7971782|NCT00314574|19626172|P1|NOT COMPLETED|Overall Study||94
7971783|NCT00314574|19626171|P2|COMPLETED|Overall Study||344
7971784|NCT00314574|19626172|P1|COMPLETED|Overall Study||329
7971785|NCT00314574|19626171|P2|Safety Population|Overall Study||428
7971786|NCT00314574|19626172|P1|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420
7971787|NCT00314574|19626171|P2|Received at Least One Dose of Study Drug|Overall Study||427
7971788|NCT00314574|19626172|P1|Received at Least One Dose of Study Drug|Overall Study||421
7971789|NCT00314574|19626171|P2|STARTED|Overall Study||427
7971790|NCT00314574|19626172|P1|STARTED|Overall Study||423
7971791|NCT00314366|19626188|P2|NOT COMPLETED|Overall Study||0
7971792|NCT00314366|19626189|P1|NOT COMPLETED|Overall Study||1
7971793|NCT00314366|19626188|P2|COMPLETED|Overall Study||10
7971794|NCT00314366|19626189|P1|COMPLETED|Overall Study||10
7971795|NCT00314366|19626188|P2|STARTED|Overall Study||10
7971796|NCT00314366|19626189|P1|STARTED|Overall Study||11
7971797|NCT00314353|19626219|P2|NOT COMPLETED|Follow-up||0
7971798|NCT00314353|19626220|P1|NOT COMPLETED|Follow-up||0
7971799|NCT00314353|19626219|P2|COMPLETED|Follow-up||0
7971800|NCT00314353|19626220|P1|COMPLETED|Follow-up||3
7971801|NCT00314353|19626219|P2|STARTED|Follow-up||0
7971802|NCT00314353|19626220|P1|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3
7971803|NCT00314353|19626219|P2|NOT COMPLETED|Protocol Therapy (8 Cycles)||3
7971804|NCT00314353|19626220|P1|NOT COMPLETED|Protocol Therapy (8 Cycles)||2
7971805|NCT00314353|19626219|P2|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0
7971806|NCT00314353|19626220|P1|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2
7971807|NCT00314353|19626219|P2|STARTED|Protocol Therapy (8 Cycles)||3
7971808|NCT00314353|19626220|P1|STARTED|Protocol Therapy (8 Cycles)||4
7971809|NCT00314340|19626234|P1|NOT COMPLETED|Overall Study||1
7971810|NCT00314340|19626234|P1|COMPLETED|Overall Study||11
7971811|NCT00314340|19626234|P1|Placebo|Overall Study||12
7971812|NCT00314340|19626234|P1|Hydrocodone Plus APAP|Overall Study||12
7971813|NCT00314340|19626234|P1|ER Morphine|Overall Study||11
7971814|NCT00314340|19626234|P1|STARTED|Overall Study||12
7971815|NCT00314327|19626240|P1|NOT COMPLETED|Overall Study||1
7971816|NCT00314327|19626240|P1|COMPLETED|Overall Study||0
7971817|NCT00314327|19626240|P1|STARTED|Overall Study||1
7971818|NCT00314262|19626245|P1|NOT COMPLETED|Overall Study||5
7971819|NCT00314262|19626245|P1|COMPLETED|Overall Study||7
7971820|NCT00314262|19626245|P1|STARTED|Overall Study||12
7971821|NCT00314249|19626253|P2|NOT COMPLETED|Overall Study||163
7971822|NCT00314249|19626254|P1|NOT COMPLETED|Overall Study||152
7971823|NCT00314249|19626253|P2|COMPLETED|Overall Study||353
7971824|NCT00314249|19626254|P1|COMPLETED|Overall Study||357
7971825|NCT00314249|19626253|P2|STARTED|Overall Study||516
7971826|NCT00314249|19626254|P1|STARTED|Overall Study||509
7971827|NCT00314236|19626272|P2|NOT COMPLETED|Overall Study||2
7971828|NCT00314236|19626273|P1|NOT COMPLETED|Overall Study||0
7971829|NCT00314236|19626272|P2|COMPLETED|Overall Study||37
7971830|NCT00314236|19626273|P1|COMPLETED|Overall Study||41
7971831|NCT00314236|19626272|P2|STARTED|Overall Study||39
7971832|NCT00314236|19626273|P1|STARTED|Overall Study||41
7971833|NCT00314145|19626287|P2|NOT COMPLETED|Overall Study||29
7971834|NCT00314145|19626288|P1|NOT COMPLETED|Overall Study||21
7971835|NCT00314145|19626287|P2|COMPLETED|Overall Study||381
7971836|NCT00314145|19626288|P1|COMPLETED|Overall Study||389
7971837|NCT00314145|19626287|P2|STARTED|Overall Study||410
7971838|NCT00314145|19626288|P1|STARTED|Overall Study||410
7971839|NCT00314132|19626302|P2|NOT COMPLETED|Overall Study||18
7971840|NCT00314132|19626303|P1|NOT COMPLETED|Overall Study||8
7971841|NCT00314132|19626302|P2|COMPLETED|Overall Study||1583
7971842|NCT00314132|19626303|P1|COMPLETED|Overall Study||395
7971843|NCT00314132|19626302|P2|STARTED|Overall Study||1601
7971844|NCT00314132|19626303|P1|STARTED|Overall Study||403
7971845|NCT00314106|19626313|P2|NOT COMPLETED|Overall Study||0
7971846|NCT00314106|19626314|P1|NOT COMPLETED|Overall Study||0
7971847|NCT00314106|19626313|P2|COMPLETED|Overall Study||8
7971848|NCT00314106|19626314|P1|COMPLETED|Overall Study||18
7971849|NCT00314106|19626313|P2|STARTED|Overall Study||8
7971850|NCT00314106|19626314|P1|STARTED|Overall Study||18
7971851|NCT00314093|19626322|P1|NOT COMPLETED|Overall Study||0
7971852|NCT00314093|19626322|P1|COMPLETED|Overall Study||0
7971853|NCT00314093|19626322|P1|STARTED|Overall Study||0
7971854|NCT00313911|19626330|P2|NOT COMPLETED|Overall Study||41
7971855|NCT00313911|19626331|P1|NOT COMPLETED|Overall Study||94
7971856|NCT00313911|19626330|P2|COMPLETED|Overall Study||670
7971857|NCT00313911|19626331|P1|COMPLETED|Overall Study||1328
7971858|NCT00313911|19626330|P2|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711
7971859|NCT00313911|19626331|P1|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422
7971860|NCT00313846|19626345|P2|NOT COMPLETED|Overall Study||11
7971861|NCT00313846|19626346|P1|NOT COMPLETED|Overall Study||5
7971862|NCT00313846|19626345|P2|COMPLETED|Overall Study||153
7971863|NCT00313846|19626346|P1|COMPLETED|Overall Study||157
7971864|NCT00313846|19626345|P2|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164
7971865|NCT00313846|19626346|P1|STARTED|Overall Study||162
7971866|NCT00313820|19626357|P2|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19
7971867|NCT00313820|19626358|P1|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17
7971868|NCT00313820|19626357|P2|COMPLETED|Pregabalin or Placebo Treatment Period||90
7971869|NCT00313820|19626358|P1|COMPLETED|Pregabalin or Placebo Treatment Period||93
7971870|NCT00313820|19626357|P2|STARTED|Pregabalin or Placebo Treatment Period||109
7971871|NCT00313820|19626358|P1|STARTED|Pregabalin or Placebo Treatment Period||110
7971872|NCT00313820|19626357|P2|NOT COMPLETED|Assigned to Treatment||0
7971873|NCT00313820|19626358|P1|NOT COMPLETED|Assigned to Treatment||1
7971874|NCT00313820|19626357|P2|COMPLETED|Assigned to Treatment||109
7971875|NCT00313820|19626358|P1|COMPLETED|Assigned to Treatment||110
7971876|NCT00313820|19626357|P2|STARTED|Assigned to Treatment||109
7971877|NCT00313820|19626358|P1|STARTED|Assigned to Treatment||111
7971878|NCT00313781|19626396|P3|NOT COMPLETED|After Crossover||27
7971879|NCT00313781|19626397|P2|NOT COMPLETED|After Crossover||0
7971880|NCT00313781|19626398|P1|NOT COMPLETED|After Crossover||0
7971881|NCT00313781|19626396|P3|COMPLETED|After Crossover||10
7971882|NCT00313781|19626397|P2|COMPLETED|After Crossover||0
7971883|NCT00313781|19626398|P1|COMPLETED|After Crossover||0
7971884|NCT00313781|19626396|P3|STARTED|After Crossover||37
7971885|NCT00313781|19626397|P2|STARTED|After Crossover||0
7971886|NCT00313781|19626398|P1|STARTED|After Crossover||0
7971887|NCT00313781|19626396|P3|NOT COMPLETED|Before Crossover||0
7971888|NCT00313781|19626397|P2|NOT COMPLETED|Before Crossover||79
7971889|NCT00313781|19626398|P1|NOT COMPLETED|Before Crossover||75
7971890|NCT00313781|19626396|P3|COMPLETED|Before Crossover||0
7971891|NCT00313781|19626397|P2|COMPLETED|Before Crossover||23
7971892|NCT00313781|19626398|P1|COMPLETED|Before Crossover||27
7971893|NCT00313781|19626396|P3|Treated|Before Crossover||0
7971894|NCT00313781|19626397|P2|Treated|Before Crossover||102
7971895|NCT00313781|19626398|P1|Treated|Before Crossover||97
7971896|NCT00313781|19626396|P3|STARTED|Before Crossover||0
7971897|NCT00313781|19626397|P2|STARTED|Before Crossover||102
7971898|NCT00313781|19626398|P1|STARTED|Before Crossover||102
7971899|NCT00313729|19626432|P1|NOT COMPLETED|Overall Study||0
7971900|NCT00313729|19626432|P1|COMPLETED|Overall Study||120
7971901|NCT00313729|19626432|P1|STARTED|Overall Study||120
7971902|NCT00313716|19626444|P6|NOT COMPLETED|Overall Study||13
7971903|NCT00313716|19626445|P5|NOT COMPLETED|Overall Study||6
7971904|NCT00313716|19626446|P4|NOT COMPLETED|Overall Study||4
7971905|NCT00313716|19626447|P3|NOT COMPLETED|Overall Study||12
7971906|NCT00313716|19626448|P2|NOT COMPLETED|Overall Study||8
7971907|NCT00313716|19626449|P1|NOT COMPLETED|Overall Study||5
7971908|NCT00313716|19626444|P6|COMPLETED|Overall Study||35
7971909|NCT00313716|19626445|P5|COMPLETED|Overall Study||27
7971910|NCT00313716|19626446|P4|COMPLETED|Overall Study||16
7971911|NCT00313716|19626447|P3|COMPLETED|Overall Study||38
7971912|NCT00313716|19626448|P2|COMPLETED|Overall Study||23
7971913|NCT00313716|19626449|P1|COMPLETED|Overall Study||13
7971914|NCT00313716|19626444|P6|STARTED|Overall Study||48
7971915|NCT00313716|19626445|P5|STARTED|Overall Study||33
7971916|NCT00313716|19626446|P4|STARTED|Overall Study||20
7971917|NCT00313716|19626447|P3|STARTED|Overall Study||50
7971918|NCT00313716|19626448|P2|STARTED|Overall Study||31
7971919|NCT00313716|19626449|P1|STARTED|Overall Study||18
7971920|NCT00313703|19626476|P4|NOT COMPLETED|Overall Study||12
7971921|NCT00313703|19626477|P3|NOT COMPLETED|Overall Study||5
7971922|NCT00313703|19626478|P2|NOT COMPLETED|Overall Study||2
7971923|NCT00313703|19626479|P1|NOT COMPLETED|Overall Study||11
7971924|NCT00313703|19626476|P4|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0
7971925|NCT00313703|19626477|P3|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72
7971926|NCT00313703|19626478|P2|COMPLETED|Overall Study|Some subjects lost-to follow-up|32
7971927|NCT00313703|19626479|P1|COMPLETED|Overall Study|Some subjects lost to follow-up|175
7971928|NCT00313703|19626476|P4|STARTED|Overall Study||12
7971929|NCT00313703|19626477|P3|STARTED|Overall Study||77
7971930|NCT00313703|19626478|P2|STARTED|Overall Study||34
7971931|NCT00313703|19626479|P1|STARTED|Overall Study||186
7971932|NCT00313612|19626495|P2|NOT COMPLETED|Overall Study||1
7971933|NCT00313612|19626496|P1|NOT COMPLETED|Overall Study||0
7971934|NCT00313612|19626495|P2|COMPLETED|Overall Study||19
7971935|NCT00313612|19626496|P1|COMPLETED|Overall Study||19
7971936|NCT00313612|19626495|P2|STARTED|Overall Study||20
7971937|NCT00313612|19626496|P1|STARTED|Overall Study||19
7971938|NCT00313586|19626508|P4|NOT COMPLETED|Overall Study||23
7971939|NCT00313586|19626509|P3|NOT COMPLETED|Overall Study||24
7971940|NCT00313586|19626510|P2|NOT COMPLETED|Overall Study||70
7971941|NCT00313586|19626511|P1|NOT COMPLETED|Overall Study||70
7971942|NCT00313586|19626508|P4|COMPLETED|Overall Study||0
7971943|NCT00313586|19626509|P3|COMPLETED|Overall Study||0
7971944|NCT00313586|19626510|P2|COMPLETED|Overall Study||5
7971945|NCT00313586|19626511|P1|COMPLETED|Overall Study||5
7971946|NCT00313586|19626508|P4|Treated|Overall Study||23
7971947|NCT00313586|19626509|P3|Treated|Overall Study||24
7971948|NCT00313586|19626510|P2|Treated|Overall Study||75
7971949|NCT00313586|19626511|P1|Treated|Overall Study||74
7971950|NCT00313586|19626508|P4|STARTED|Overall Study||23
7971951|NCT00313586|19626509|P3|STARTED|Overall Study||24
7971952|NCT00313586|19626510|P2|STARTED|Overall Study||75
7971953|NCT00313586|19626511|P1|STARTED|Overall Study||75
7971954|NCT00313560|19626519|P1|NOT COMPLETED|Overall Study||0
7971955|NCT00313560|19626519|P1|COMPLETED|Overall Study||48
7971956|NCT00313560|19626519|P1|STARTED|Overall Study||48
7971957|NCT00313443|19626528|P1|NOT COMPLETED|Overall Study||0
7971958|NCT00313443|19626528|P1|COMPLETED|Overall Study||30
7971959|NCT00313443|19626528|P1|STARTED|Overall Study||30
7971960|NCT00313313|19626539|P3|NOT COMPLETED|Overall Study||82
7971961|NCT00313313|19626540|P2|NOT COMPLETED|Overall Study||66
7971962|NCT00313313|19626541|P1|NOT COMPLETED|Overall Study||63
7971963|NCT00313313|19626539|P3|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185
7971964|NCT00313313|19626540|P2|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187
7971965|NCT00313313|19626541|P1|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185
7971966|NCT00313313|19626539|P3|STARTED|Overall Study||267
7971967|NCT00313313|19626540|P2|STARTED|Overall Study||253
7971968|NCT00313313|19626541|P1|STARTED|Overall Study||248
7971969|NCT00313300|19626563|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
7971970|NCT00313300|19626564|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5
7971971|NCT00313300|19626565|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
7971972|NCT00313300|19626566|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0
7971973|NCT00313300|19626567|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3
7971974|NCT00313300|19626563|P5|COMPLETED|Follow-Up(30days)-Randomized Phase B||199
7971975|NCT00313300|19626564|P4|COMPLETED|Follow-Up(30days)-Randomized Phase B||217
7971976|NCT00313300|19626565|P3|COMPLETED|Follow-Up(30days)-Randomized Phase B||117
7971977|NCT00313300|19626566|P2|COMPLETED|Follow-Up(30days)-Randomized Phase B||123
7971978|NCT00313300|19626567|P1|COMPLETED|Follow-Up(30days)-Randomized Phase B||380
7971979|NCT00313300|19626563|P5|STARTED|Follow-Up(30days)-Randomized Phase B||201
7971980|NCT00313300|19626564|P4|STARTED|Follow-Up(30days)-Randomized Phase B||222
7971981|NCT00313300|19626565|P3|STARTED|Follow-Up(30days)-Randomized Phase B||119
7971982|NCT00313300|19626566|P2|STARTED|Follow-Up(30days)-Randomized Phase B||123
7971983|NCT00313300|19626567|P1|STARTED|Follow-Up(30days)-Randomized Phase B||383
7971984|NCT00313300|19626563|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
7971985|NCT00313300|19626564|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
7971986|NCT00313300|19626565|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2
7971987|NCT00313300|19626566|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6
7971988|NCT00313300|19626567|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5
7971989|NCT00313300|19626563|P5|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
7971990|NCT00313300|19626564|P4|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
7971991|NCT00313300|19626565|P3|COMPLETED|Follow-Up(30days)-Randomized Phase A||172
7971992|NCT00313300|19626566|P2|COMPLETED|Follow-Up(30days)-Randomized Phase A||156
7971993|NCT00313300|19626567|P1|COMPLETED|Follow-Up(30days)-Randomized Phase A||158
7971994|NCT00313300|19626563|P5|STARTED|Follow-Up(30days)-Randomized Phase A||0
7971995|NCT00313300|19626564|P4|STARTED|Follow-Up(30days)-Randomized Phase A||0
7971996|NCT00313300|19626565|P3|STARTED|Follow-Up(30days)-Randomized Phase A||174
7971997|NCT00313300|19626566|P2|STARTED|Follow-Up(30days)-Randomized Phase A||162
7971998|NCT00313300|19626567|P1|STARTED|Follow-Up(30days)-Randomized Phase A||163
7971999|NCT00313300|19626563|P5|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208
7972000|NCT00313300|19626564|P4|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233
7972001|NCT00313300|19626565|P3|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40
7972002|NCT00313300|19626566|P2|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33
7972003|NCT00313300|19626567|P1|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94
7972004|NCT00313300|19626563|P5|COMPLETED|Randomized in Phase B (26 Weeks)||13
7972005|NCT00313300|19626564|P4|COMPLETED|Randomized in Phase B (26 Weeks)||15
7972006|NCT00313300|19626565|P3|COMPLETED|Randomized in Phase B (26 Weeks)||94
7972007|NCT00313300|19626566|P2|COMPLETED|Randomized in Phase B (26 Weeks)||105
7972008|NCT00313300|19626567|P1|COMPLETED|Randomized in Phase B (26 Weeks)||333
7972009|NCT00313300|19626563|P5|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221
7972010|NCT00313300|19626564|P4|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248
7972011|NCT00313300|19626565|P3|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110
7972012|NCT00313300|19626566|P2|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120
7972013|NCT00313300|19626567|P1|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368
7972014|NCT00313300|19626563|P5|STARTED|Randomized in Phase B (26 Weeks)||221
7972015|NCT00313300|19626564|P4|STARTED|Randomized in Phase B (26 Weeks)||248
7972016|NCT00313300|19626565|P3|STARTED|Randomized in Phase B (26 Weeks)||134
7972017|NCT00313300|19626566|P2|STARTED|Randomized in Phase B (26 Weeks)||138
7972018|NCT00313300|19626567|P1|STARTED|Randomized in Phase B (26 Weeks)||427
7972019|NCT00313300|19626563|P5|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
7972020|NCT00313300|19626564|P4|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
7972021|NCT00313300|19626565|P3|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35
7972022|NCT00313300|19626566|P2|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39
7972023|NCT00313300|19626567|P1|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54
7972024|NCT00313300|19626563|P5|COMPLETED|Randomized in Phase A (26 Weeks)||0
7972025|NCT00313300|19626564|P4|COMPLETED|Randomized in Phase A (26 Weeks)||0
7972026|NCT00313300|19626565|P3|COMPLETED|Randomized in Phase A (26 Weeks)||149
7972027|NCT00313300|19626566|P2|COMPLETED|Randomized in Phase A (26 Weeks)||140
7972028|NCT00313300|19626567|P1|COMPLETED|Randomized in Phase A (26 Weeks)||130
7972029|NCT00313300|19626563|P5|STARTED|Randomized in Phase A (26 Weeks)||0
7972030|NCT00313300|19626564|P4|STARTED|Randomized in Phase A (26 Weeks)||0
7972031|NCT00313300|19626565|P3|STARTED|Randomized in Phase A (26 Weeks)||184
7972032|NCT00313300|19626566|P2|STARTED|Randomized in Phase A (26 Weeks)||179
7972033|NCT00313300|19626567|P1|STARTED|Randomized in Phase A (26 Weeks)||184
7972034|NCT00313209|19626619|P2|NOT COMPLETED|Overall Study||82
7972035|NCT00313209|19626620|P1|NOT COMPLETED|Overall Study||107
7972036|NCT00313209|19626619|P2|COMPLETED|Overall Study||385
7972037|NCT00313209|19626620|P1|COMPLETED|Overall Study||359
7972038|NCT00313209|19626619|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467
7972039|NCT00313209|19626620|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466
7972040|NCT00313170|19626637|P3|NOT COMPLETED|Overall Study||32
7972041|NCT00313170|19626638|P2|NOT COMPLETED|Overall Study||34
7972042|NCT00313170|19626639|P1|NOT COMPLETED|Overall Study||36
7972043|NCT00313170|19626637|P3|COMPLETED|Overall Study||14
7972044|NCT00313170|19626638|P2|COMPLETED|Overall Study||17
7972045|NCT00313170|19626639|P1|COMPLETED|Overall Study||11
7972046|NCT00313170|19626637|P3|STARTED|Overall Study||46
7972047|NCT00313170|19626638|P2|STARTED|Overall Study||51
7972048|NCT00313170|19626639|P1|STARTED|Overall Study||47
7972049|NCT00313144|19626658|P1|NOT COMPLETED|Overall Study||110
7972050|NCT00313144|19626658|P1|COMPLETED|Overall Study||17
7972051|NCT00313144|19626658|P1|STARTED|Overall Study||127
7972052|NCT00313014|19626745|P3|NOT COMPLETED|Overall Study||61
7972053|NCT00313014|19626746|P2|NOT COMPLETED|Overall Study||73
7972054|NCT00313014|19626747|P1|NOT COMPLETED|Overall Study||93
7972055|NCT00313014|19626745|P3|COMPLETED|Overall Study||159
7972056|NCT00313014|19626746|P2|COMPLETED|Overall Study||146
7972057|NCT00313014|19626747|P1|COMPLETED|Overall Study||128
7972058|NCT00313014|19626745|P3|STARTED|Overall Study||220
7972059|NCT00313014|19626746|P2|STARTED|Overall Study||219
7972060|NCT00313014|19626747|P1|STARTED|Overall Study||221
7972061|NCT00312923|19626767|P2|NOT COMPLETED|Overall Study||6
7972062|NCT00312923|19626768|P1|NOT COMPLETED|Overall Study||9
7972063|NCT00312923|19626767|P2|COMPLETED|Overall Study||20
7972064|NCT00312923|19626768|P1|COMPLETED|Overall Study||19
7972065|NCT00312923|19626767|P2|STARTED|Overall Study||26
7972066|NCT00312923|19626768|P1|STARTED|Overall Study||28
7972067|NCT00312897|19626778|P2|NOT COMPLETED|Overall Study||6
7972068|NCT00312897|19626779|P1|NOT COMPLETED|Overall Study||6
7972069|NCT00312897|19626778|P2|COMPLETED|Overall Study||18
7972070|NCT00312897|19626779|P1|COMPLETED|Overall Study||21
7972071|NCT00312897|19626778|P2|STARTED|Overall Study||24
7972072|NCT00312897|19626779|P1|STARTED|Overall Study||27
7972073|NCT00312884|19626789|P2|NOT COMPLETED|Overall Study||12
7972074|NCT00312884|19626790|P1|NOT COMPLETED|Overall Study||17
7972075|NCT00312884|19626789|P2|COMPLETED|Overall Study||79
7972076|NCT00312884|19626790|P1|COMPLETED|Overall Study||74
7972077|NCT00312884|19626789|P2|STARTED|Overall Study||91
7972078|NCT00312884|19626790|P1|STARTED|Overall Study||91
7972079|NCT00312858|19626804|P2|NOT COMPLETED|Overall Study||93
7972080|NCT00312858|19626805|P1|NOT COMPLETED|Overall Study||68
7972081|NCT00312858|19626804|P2|COMPLETED|Overall Study||230
7972082|NCT00312858|19626805|P1|COMPLETED|Overall Study||262
7972083|NCT00312858|19626804|P2|Visit 4|Overall Study||240
7972084|NCT00312858|19626805|P1|Visit 4|Overall Study||262
7972085|NCT00312858|19626804|P2|Visit 3|Overall Study||261
7972086|NCT00312858|19626805|P1|Visit 3|Overall Study||273
7972087|NCT00312858|19626804|P2|Visit 2|Overall Study||294
7972088|NCT00312858|19626805|P1|Visit 2|Overall Study||305
7972089|NCT00312858|19626804|P2|Visit 1|Overall Study||323
7972090|NCT00312858|19626805|P1|Visit 1|Overall Study||330
7972091|NCT00312858|19626804|P2|STARTED|Overall Study||323
7972092|NCT00312858|19626805|P1|STARTED|Overall Study||330
7972093|NCT00312845|19626859|P2|NOT COMPLETED|Overall Study||95
7972094|NCT00312845|19626860|P1|NOT COMPLETED|Overall Study||99
7972095|NCT00312845|19626859|P2|COMPLETED|Overall Study||245
7972096|NCT00312845|19626860|P1|COMPLETED|Overall Study||237
7972097|NCT00312845|19626859|P2|STARTED|Overall Study||340
7972098|NCT00312845|19626860|P1|STARTED|Overall Study||336
7972099|NCT00312728|19626868|P1|NOT COMPLETED|Overall Study||110
7972100|NCT00312728|19626868|P1|COMPLETED|Overall Study||5
7972101|NCT00312728|19626868|P1|STARTED|Overall Study||115
7972102|NCT00312702|19626880|P3|NOT COMPLETED|Challenge Phase||0
7972103|NCT00312702|19626881|P2|NOT COMPLETED|Challenge Phase||0
7972104|NCT00312702|19626882|P1|NOT COMPLETED|Challenge Phase||0
7972105|NCT00312702|19626880|P3|COMPLETED|Challenge Phase||1
7972106|NCT00312702|19626881|P2|COMPLETED|Challenge Phase||12
7972107|NCT00312702|19626882|P1|COMPLETED|Challenge Phase||0
7972108|NCT00312702|19626880|P3|STARTED|Challenge Phase|1 non-immunized subjects participated in the challenge phase.|1
7972109|NCT00312702|19626881|P2|STARTED|Challenge Phase|12 subjects from the high dose group participated in the challenge phase|12
7972110|NCT00312702|19626882|P1|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
7972111|NCT00312702|19626880|P3|NOT COMPLETED|Immunization Phase||0
7972112|NCT00312702|19626881|P2|NOT COMPLETED|Immunization Phase||1
7972113|NCT00312702|19626882|P1|NOT COMPLETED|Immunization Phase||0
7972114|NCT00312702|19626880|P3|COMPLETED|Immunization Phase||0
7972115|NCT00312702|19626881|P2|COMPLETED|Immunization Phase||12
7972116|NCT00312702|19626882|P1|COMPLETED|Immunization Phase||5
7972117|NCT00312702|19626880|P3|STARTED|Immunization Phase||0
7972118|NCT00312702|19626881|P2|STARTED|Immunization Phase||13
7972119|NCT00312702|19626882|P1|STARTED|Immunization Phase||5
7972120|NCT00312663|19626895|P3|NOT COMPLETED|Challenge Phase||0
7972121|NCT00312663|19626896|P2|NOT COMPLETED|Challenge Phase||0
7972122|NCT00312663|19626897|P1|NOT COMPLETED|Challenge Phase||0
7972123|NCT00312663|19626895|P3|COMPLETED|Challenge Phase||6
7972124|NCT00312663|19626896|P2|COMPLETED|Challenge Phase||10
7972125|NCT00312663|19626897|P1|COMPLETED|Challenge Phase||0
7972126|NCT00312663|19626895|P3|STARTED|Challenge Phase|6 non-immunized subjects participated in the challenge phase|6
7972127|NCT00312663|19626896|P2|STARTED|Challenge Phase|10 subjects from the high dose group participated in the challenge phase|10
7972128|NCT00312663|19626897|P1|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
7972129|NCT00312663|19626895|P3|NOT COMPLETED|Immunization Phase||0
7972130|NCT00312663|19626896|P2|NOT COMPLETED|Immunization Phase||1
7972131|NCT00312663|19626897|P1|NOT COMPLETED|Immunization Phase||0
7972132|NCT00312663|19626895|P3|COMPLETED|Immunization Phase||0
7972133|NCT00312663|19626896|P2|COMPLETED|Immunization Phase||12
7972134|NCT00312663|19626897|P1|COMPLETED|Immunization Phase||5
7972135|NCT00312663|19626895|P3|STARTED|Immunization Phase||0
7972136|NCT00312663|19626896|P2|STARTED|Immunization Phase||13
7972137|NCT00312663|19626897|P1|STARTED|Immunization Phase||5
7972138|NCT00312572|19626910|P2|NOT COMPLETED|Overall Study||21
7972139|NCT00312572|19626911|P1|NOT COMPLETED|Overall Study||16
7972140|NCT00312572|19626910|P2|COMPLETED|Overall Study||82
7972141|NCT00312572|19626911|P1|COMPLETED|Overall Study||85
7972142|NCT00312572|19626910|P2|STARTED|Overall Study||103
7972143|NCT00312572|19626911|P1|STARTED|Overall Study||101
7972144|NCT00312494|19626922|P3|NOT COMPLETED|Overall Study||43
7972145|NCT00312494|19626923|P2|NOT COMPLETED|Overall Study||58
7972146|NCT00312494|19626924|P1|NOT COMPLETED|Overall Study||71
7972147|NCT00312494|19626922|P3|COMPLETED|Overall Study||179
7972148|NCT00312494|19626923|P2|COMPLETED|Overall Study||168
7972149|NCT00312494|19626924|P1|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161
7972150|NCT00312494|19626922|P3|Received Study Treatment|Overall Study||217
7972151|NCT00312494|19626923|P2|Received Study Treatment|Overall Study||216
7972152|NCT00312494|19626924|P1|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223
7972153|NCT00312494|19626922|P3|STARTED|Overall Study||222
7972154|NCT00312494|19626923|P2|STARTED|Overall Study||226
7972155|NCT00312494|19626924|P1|STARTED|Overall Study||232
7972156|NCT00312377|19626958|P2|NOT COMPLETED|Overall Study||668
7972157|NCT00312377|19626959|P1|NOT COMPLETED|Overall Study||644
7972158|NCT00312377|19626958|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29
7972159|NCT00312377|19626959|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50
7972160|NCT00312377|19626958|P2|STARTED|Overall Study|randomised patients|697
7972161|NCT00312377|19626959|P1|STARTED|Overall Study|randomised patients|694
7972162|NCT00312338|19626983|P2|NOT COMPLETED|Overall Study||3
7972163|NCT00312338|19626984|P1|NOT COMPLETED|Overall Study||22
7972164|NCT00312338|19626983|P2|COMPLETED|Overall Study||54
7972165|NCT00312338|19626984|P1|COMPLETED|Overall Study||83
7972166|NCT00312338|19626983|P2|STARTED|Overall Study||57
7972167|NCT00312338|19626984|P1|STARTED|Overall Study||105
7972168|NCT00312221|19626997|P4|NOT COMPLETED|Double-blind Phase||70
7972169|NCT00312221|19626998|P3|NOT COMPLETED|Double-blind Phase||72
7972170|NCT00312221|19626999|P2|NOT COMPLETED|Double-blind Phase||59
7972171|NCT00312221|19627000|P1|NOT COMPLETED|Double-blind Phase||0
7972172|NCT00312221|19626997|P4|COMPLETED|Double-blind Phase||63
7972173|NCT00312221|19626998|P3|COMPLETED|Double-blind Phase||77
7972174|NCT00312221|19626999|P2|COMPLETED|Double-blind Phase||77
7972175|NCT00312221|19627000|P1|COMPLETED|Double-blind Phase||0
7972176|NCT00312221|19626997|P4|STARTED|Double-blind Phase||133
7972177|NCT00312221|19626998|P3|STARTED|Double-blind Phase||149
7972178|NCT00312221|19626999|P2|STARTED|Double-blind Phase||136
7972179|NCT00312221|19627000|P1|STARTED|Double-blind Phase||0
7972180|NCT00312221|19626997|P4|NOT COMPLETED|Open-label Run-in Period||0
7972181|NCT00312221|19626998|P3|NOT COMPLETED|Open-label Run-in Period||0
7972182|NCT00312221|19626999|P2|NOT COMPLETED|Open-label Run-in Period||0
7972183|NCT00312221|19627000|P1|NOT COMPLETED|Open-label Run-in Period||234
7972184|NCT00312221|19626997|P4|COMPLETED|Open-label Run-in Period||0
7972185|NCT00312221|19626998|P3|COMPLETED|Open-label Run-in Period||0
7972186|NCT00312221|19626999|P2|COMPLETED|Open-label Run-in Period||0
7972187|NCT00312221|19627000|P1|COMPLETED|Open-label Run-in Period||418
7972188|NCT00312221|19626997|P4|STARTED|Open-label Run-in Period||0
7972189|NCT00312221|19626998|P3|STARTED|Open-label Run-in Period||0
7972190|NCT00312221|19626999|P2|STARTED|Open-label Run-in Period||0
7972191|NCT00312221|19627000|P1|STARTED|Open-label Run-in Period||652
7972192|NCT00312208|19627020|P2|NOT COMPLETED|Overall Study||123
7972193|NCT00312208|19627021|P1|NOT COMPLETED|Overall Study||172
7972194|NCT00312208|19627020|P2|COMPLETED|Overall Study||1526
7972195|NCT00312208|19627021|P1|COMPLETED|Overall Study||1477
7972196|NCT00312208|19627020|P2|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649
7972197|NCT00312208|19627021|P1|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649
7972198|NCT00312195|19627031|P2|NOT COMPLETED|Overall Study||6
7972199|NCT00312195|19627032|P1|NOT COMPLETED|Overall Study||6
7972200|NCT00312195|19627031|P2|COMPLETED|Overall Study||123
7972201|NCT00312195|19627032|P1|COMPLETED|Overall Study||132
7972202|NCT00312195|19627031|P2|STARTED|Overall Study||129
7972203|NCT00312195|19627032|P1|STARTED|Overall Study||138
7972204|NCT00311766|19627048|P2|NOT COMPLETED|Overall Study||5
7972205|NCT00311766|19627049|P1|NOT COMPLETED|Overall Study||0
7972206|NCT00311766|19627048|P2|COMPLETED|Overall Study||17
7972207|NCT00311766|19627049|P1|COMPLETED|Overall Study||8
7972208|NCT00311766|19627048|P2|STARTED|Overall Study||22
7972209|NCT00311766|19627049|P1|STARTED|Overall Study||8
7972210|NCT00311623|19627060|P3|NOT COMPLETED|Overall Study||2
7972211|NCT00311623|19627061|P2|NOT COMPLETED|Overall Study||0
7972212|NCT00311623|19627062|P1|NOT COMPLETED|Overall Study||0
7972213|NCT00311623|19627060|P3|COMPLETED|Overall Study||0
7972214|NCT00311623|19627061|P2|COMPLETED|Overall Study||20
7972215|NCT00311623|19627062|P1|COMPLETED|Overall Study||10
7972216|NCT00311623|19627060|P3|STARTED|Overall Study||2
7972217|NCT00311623|19627061|P2|STARTED|Overall Study||20
7972218|NCT00311623|19627062|P1|STARTED|Overall Study||10
7972219|NCT00311584|19627104|P2|NOT COMPLETED|Overall Study||23
7972220|NCT00311584|19627105|P1|NOT COMPLETED|Overall Study||20
7972221|NCT00311584|19627104|P2|COMPLETED|Overall Study||7
7972222|NCT00311584|19627105|P1|COMPLETED|Overall Study||9
7972223|NCT00311584|19627104|P2|STARTED|Overall Study||30
7972224|NCT00311584|19627105|P1|STARTED|Overall Study||29
7972225|NCT00311402|19627113|P2|NOT COMPLETED|Overall Study||177
7972226|NCT00311402|19627114|P1|NOT COMPLETED|Overall Study||210
7972227|NCT00311402|19627113|P2|COMPLETED|Overall Study||462
7972228|NCT00311402|19627114|P1|COMPLETED|Overall Study||445
7972229|NCT00311402|19627113|P2|STARTED|Overall Study||639
7972230|NCT00311402|19627114|P1|STARTED|Overall Study||655
7972231|NCT00311376|19627141|P3|NOT COMPLETED|Treatment Cycle 2||0
7972232|NCT00311376|19627142|P2|NOT COMPLETED|Treatment Cycle 2||13
7972233|NCT00311376|19627143|P1|NOT COMPLETED|Treatment Cycle 2||9
7972234|NCT00311376|19627141|P3|COMPLETED|Treatment Cycle 2||0
7972235|NCT00311376|19627142|P2|COMPLETED|Treatment Cycle 2||112
7972236|NCT00311376|19627143|P1|COMPLETED|Treatment Cycle 2||106
7972237|NCT00311376|19627141|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0
7972238|NCT00311376|19627142|P2|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125
7972239|NCT00311376|19627143|P1|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115
7972240|NCT00311376|19627141|P3|NOT COMPLETED|Treatment Cycle 1||17
7972241|NCT00311376|19627142|P2|NOT COMPLETED|Treatment Cycle 1||17
7972242|NCT00311376|19627143|P1|NOT COMPLETED|Treatment Cycle 1||27
7972243|NCT00311376|19627141|P3|COMPLETED|Treatment Cycle 1||132
7972244|NCT00311376|19627142|P2|COMPLETED|Treatment Cycle 1||118
7972245|NCT00311376|19627143|P1|COMPLETED|Treatment Cycle 1||105
7972246|NCT00311376|19627141|P3|STARTED|Treatment Cycle 1||149
7972247|NCT00311376|19627142|P2|STARTED|Treatment Cycle 1||135
7972248|NCT00311376|19627143|P1|STARTED|Treatment Cycle 1||132
7972249|NCT00311363|19627163|P3|NOT COMPLETED|12-Week Double-Blind Treatment Period||12
7972250|NCT00311363|19627164|P2|NOT COMPLETED|12-Week Double-Blind Treatment Period||14
7972251|NCT00311363|19627165|P1|NOT COMPLETED|12-Week Double-Blind Treatment Period||0
7972252|NCT00311363|19627163|P3|COMPLETED|12-Week Double-Blind Treatment Period||84
7972253|NCT00311363|19627164|P2|COMPLETED|12-Week Double-Blind Treatment Period||84
7972254|NCT00311363|19627165|P1|COMPLETED|12-Week Double-Blind Treatment Period||0
7972255|NCT00311363|19627163|P3|STARTED|12-Week Double-Blind Treatment Period||96
7972256|NCT00311363|19627164|P2|STARTED|12-Week Double-Blind Treatment Period||98
7972257|NCT00311363|19627165|P1|STARTED|12-Week Double-Blind Treatment Period||0
7972258|NCT00311363|19627163|P3|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
7972259|NCT00311363|19627164|P2|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
7972260|NCT00311363|19627165|P1|NOT COMPLETED|24-Week Single-Blind Treatment Period||106
7972261|NCT00311363|19627163|P3|COMPLETED|24-Week Single-Blind Treatment Period||0
7972262|NCT00311363|19627164|P2|COMPLETED|24-Week Single-Blind Treatment Period||0
7972263|NCT00311363|19627165|P1|COMPLETED|24-Week Single-Blind Treatment Period||221
7972264|NCT00311363|19627163|P3|STARTED|24-Week Single-Blind Treatment Period||0
7972265|NCT00311363|19627164|P2|STARTED|24-Week Single-Blind Treatment Period||0
7972266|NCT00311363|19627165|P1|STARTED|24-Week Single-Blind Treatment Period||327
7972267|NCT00311311|19627225|P2|NOT COMPLETED|Overall Study||9
7972268|NCT00311311|19627226|P1|NOT COMPLETED|Overall Study||8
7972269|NCT00311311|19627225|P2|COMPLETED|Overall Study||26
7972270|NCT00311311|19627226|P1|COMPLETED|Overall Study||29
7972271|NCT00311311|19627225|P2|STARTED|Overall Study||35
7972272|NCT00311311|19627226|P1|STARTED|Overall Study||37
7972273|NCT00311246|19627276|P1|NOT COMPLETED|Overall Study||0
7972274|NCT00311246|19627276|P1|COMPLETED|Overall Study||11
7972275|NCT00311246|19627276|P1|STARTED|Overall Study||11
7972276|NCT00311181|19627284|P1|NOT COMPLETED|Overall Study||96
7972277|NCT00311181|19627284|P1|COMPLETED|Overall Study||121
7972278|NCT00311181|19627284|P1|STARTED|Overall Study||217
7972279|NCT00311155|19627290|P1|NOT COMPLETED|Overall Study||93
7972280|NCT00311155|19627290|P1|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601
7972281|NCT00311155|19627290|P1|STARTED|Overall Study||694
7972282|NCT00310856|19627302|P3|NOT COMPLETED|Overall Study||8
7972283|NCT00310856|19627303|P2|NOT COMPLETED|Overall Study||5
7972284|NCT00310856|19627304|P1|NOT COMPLETED|Overall Study||5
7972285|NCT00310856|19627302|P3|COMPLETED|Overall Study||42
7972286|NCT00310856|19627303|P2|COMPLETED|Overall Study||56
7972287|NCT00310856|19627304|P1|COMPLETED|Overall Study||59
7972288|NCT00310856|19627302|P3|STARTED|Overall Study||50
7972289|NCT00310856|19627303|P2|STARTED|Overall Study||61
7972290|NCT00310856|19627304|P1|STARTED|Overall Study||64
7972291|NCT00310817|19627328|P4|NOT COMPLETED|Overall Study||8
7972292|NCT00310817|19627329|P3|NOT COMPLETED|Overall Study||8
7972293|NCT00310817|19627330|P2|NOT COMPLETED|Overall Study||8
7972294|NCT00310817|19627331|P1|NOT COMPLETED|Overall Study||11
7972295|NCT00310817|19627328|P4|COMPLETED|Overall Study||74
7972296|NCT00310817|19627329|P3|COMPLETED|Overall Study||120
7972297|NCT00310817|19627330|P2|COMPLETED|Overall Study||198
7972298|NCT00310817|19627331|P1|COMPLETED|Overall Study||196
7972299|NCT00310817|19627328|P4|STARTED|Overall Study||82
7972300|NCT00310817|19627329|P3|STARTED|Overall Study||128
7972301|NCT00310817|19627330|P2|STARTED|Overall Study||206
7972302|NCT00310817|19627331|P1|STARTED|Overall Study||207
7972303|NCT00310804|19627419|P2|NOT COMPLETED|Overall Study||0
7972304|NCT00310804|19627420|P1|NOT COMPLETED|Overall Study||5
7972305|NCT00310804|19627419|P2|COMPLETED|Overall Study||171
7972306|NCT00310804|19627420|P1|COMPLETED|Overall Study||1024
7972307|NCT00310804|19627419|P2|STARTED|Overall Study||171
7972308|NCT00310804|19627420|P1|STARTED|Overall Study||1029
7972309|NCT00310791|19627455|P2|NOT COMPLETED|Overall Study||10
7972310|NCT00310791|19627456|P1|NOT COMPLETED|Overall Study||10
7972311|NCT00310791|19627455|P2|COMPLETED|Overall Study||30
7972312|NCT00310791|19627456|P1|COMPLETED|Overall Study||30
7972313|NCT00310791|19627455|P2|STARTED|Overall Study||40
7972314|NCT00310791|19627456|P1|STARTED|Overall Study||40
7972315|NCT00310466|19627464|P2|NOT COMPLETED|Overall Study||12
7972316|NCT00310466|19627465|P1|NOT COMPLETED|Overall Study||18
7972317|NCT00310466|19627464|P2|COMPLETED|Overall Study||101
7972318|NCT00310466|19627465|P1|COMPLETED|Overall Study||95
7972319|NCT00310466|19627464|P2|STARTED|Overall Study||113
7972320|NCT00310466|19627465|P1|STARTED|Overall Study||113
7972321|NCT00310440|19627479|P2|NOT COMPLETED|Overall Study||13
7972322|NCT00310440|19627480|P1|NOT COMPLETED|Overall Study||26
7972323|NCT00310440|19627479|P2|COMPLETED|Overall Study||141
7972324|NCT00310440|19627480|P1|COMPLETED|Overall Study||139
7972325|NCT00310440|19627479|P2|STARTED|Overall Study||154
7972326|NCT00310440|19627480|P1|STARTED|Overall Study||165
7972327|NCT00310427|19627506|P2|NOT COMPLETED|Overall Study||1
7972328|NCT00310427|19627507|P1|NOT COMPLETED|Overall Study||2
7972329|NCT00310427|19627506|P2|COMPLETED|Overall Study||25
7972330|NCT00310427|19627507|P1|COMPLETED|Overall Study||25
7972331|NCT00310427|19627506|P2|STARTED|Overall Study||26
7972332|NCT00310427|19627507|P1|STARTED|Overall Study||27
7972333|NCT00310401|19627529|P2|NOT COMPLETED|Overall Study||0
7972334|NCT00310401|19627530|P1|NOT COMPLETED|Overall Study||0
7972335|NCT00310401|19627529|P2|COMPLETED|Overall Study||246
7972336|NCT00310401|19627530|P1|COMPLETED|Overall Study||260
7972337|NCT00310401|19627529|P2|STARTED|Overall Study||246
7972338|NCT00310401|19627530|P1|STARTED|Overall Study||260
7972339|NCT00310388|19627544|P2|NOT COMPLETED|Safety Follow-up Continuation Phase||13
7972340|NCT00310388|19627545|P1|NOT COMPLETED|Safety Follow-up Continuation Phase||0
7972341|NCT00310388|19627544|P2|COMPLETED|Safety Follow-up Continuation Phase||13
7972342|NCT00310388|19627545|P1|COMPLETED|Safety Follow-up Continuation Phase||0
7972343|NCT00310388|19627544|P2|STARTED|Safety Follow-up Continuation Phase||26
7972344|NCT00310388|19627545|P1|STARTED|Safety Follow-up Continuation Phase||0
7972345|NCT00310388|19627544|P2|NOT COMPLETED|Primary Reporting Phase||0
7972346|NCT00310388|19627545|P1|NOT COMPLETED|Primary Reporting Phase||346
7972347|NCT00310388|19627544|P2|COMPLETED|Primary Reporting Phase||0
7972348|NCT00310388|19627545|P1|COMPLETED|Primary Reporting Phase||30
7972349|NCT00310388|19627544|P2|STARTED|Primary Reporting Phase||0
7972350|NCT00310388|19627545|P1|STARTED|Primary Reporting Phase||376
7972351|NCT00310375|19627587|P3|NOT COMPLETED|Safety Follow-up Continuation Phase||1
7972352|NCT00310375|19627588|P2|NOT COMPLETED|Safety Follow-up Continuation Phase||0
7972353|NCT00310375|19627589|P1|NOT COMPLETED|Safety Follow-up Continuation Phase||0
7972354|NCT00310375|19627587|P3|COMPLETED|Safety Follow-up Continuation Phase|Met the protocol defined stopping criteria|18
7972355|NCT00310375|19627588|P2|COMPLETED|Safety Follow-up Continuation Phase||0
7972356|NCT00310375|19627589|P1|COMPLETED|Safety Follow-up Continuation Phase||0
7972357|NCT00310375|19627587|P3|STARTED|Safety Follow-up Continuation Phase||19
7972358|NCT00310375|19627588|P2|STARTED|Safety Follow-up Continuation Phase||0
7972359|NCT00310375|19627589|P1|STARTED|Safety Follow-up Continuation Phase||0
7972360|NCT00310375|19627587|P3|NOT COMPLETED|Primary Reporting Phase||0
7972361|NCT00310375|19627588|P2|NOT COMPLETED|Primary Reporting Phase||68
7972362|NCT00310375|19627589|P1|NOT COMPLETED|Primary Reporting Phase||91
7972363|NCT00310375|19627587|P3|COMPLETED|Primary Reporting Phase||0
7972364|NCT00310375|19627588|P2|COMPLETED|Primary Reporting Phase||11
7972365|NCT00310375|19627589|P1|COMPLETED|Primary Reporting Phase||11
7972366|NCT00310375|19627587|P3|STARTED|Primary Reporting Phase||0
7972367|NCT00310375|19627588|P2|STARTED|Primary Reporting Phase||79
7972368|NCT00310375|19627589|P1|STARTED|Primary Reporting Phase||102
7972369|NCT00310362|19627634|P3|NOT COMPLETED|Overall Study||0
7972370|NCT00310362|19627635|P2|NOT COMPLETED|Overall Study||0
7972371|NCT00310362|19627636|P1|NOT COMPLETED|Overall Study||0
7972372|NCT00310362|19627634|P3|COMPLETED|Overall Study||1206
7972373|NCT00310362|19627635|P2|COMPLETED|Overall Study||1205
7972374|NCT00310362|19627636|P1|COMPLETED|Overall Study||1199
7972375|NCT00310362|19627634|P3|STARTED|Overall Study||1206
7972376|NCT00310362|19627635|P2|STARTED|Overall Study||1205
7972377|NCT00310362|19627636|P1|STARTED|Overall Study||1199
7972378|NCT00310310|19627655|P2|NOT COMPLETED|Overall Study||20
7972379|NCT00310310|19627656|P1|NOT COMPLETED|Overall Study||30
7972380|NCT00310310|19627655|P2|COMPLETED|Overall Study||100
7972381|NCT00310310|19627656|P1|COMPLETED|Overall Study||90
7972382|NCT00310310|19627655|P2|STARTED|Overall Study||120
7972383|NCT00310310|19627656|P1|STARTED|Overall Study||120
7972384|NCT00310180|19627684|P4|NOT COMPLETED|Overall Study||348
7972385|NCT00310180|19627685|P3|NOT COMPLETED|Overall Study||137
7972386|NCT00310180|19627686|P2|NOT COMPLETED|Overall Study||59
7972387|NCT00310180|19627687|P1|NOT COMPLETED|Overall Study||10
7972388|NCT00310180|19627684|P4|COMPLETED|Overall Study||1389
7972389|NCT00310180|19627685|P3|COMPLETED|Overall Study||3312
7972390|NCT00310180|19627686|P2|COMPLETED|Overall Study||3399
7972391|NCT00310180|19627687|P1|COMPLETED|Overall Study||1619
7972392|NCT00310180|19627684|P4|No Follow-up Data|Overall Study||245
7972393|NCT00310180|19627685|P3|No Follow-up Data|Overall Study||131
7972394|NCT00310180|19627686|P2|No Follow-up Data|Overall Study||55
7972395|NCT00310180|19627687|P1|No Follow-up Data|Overall Study||7
7972396|NCT00310180|19627684|P4|Ineligible|Overall Study||7
7972397|NCT00310180|19627685|P3|Ineligible|Overall Study||6
7972398|NCT00310180|19627686|P2|Ineligible|Overall Study||4
7972399|NCT00310180|19627687|P1|Ineligible|Overall Study||3
7972400|NCT00310180|19627684|P4|No On-study Data|Overall Study||172
7972401|NCT00310180|19627685|P3|No On-study Data|Overall Study||10
7972402|NCT00310180|19627686|P2|No On-study Data|Overall Study||2
7972403|NCT00310180|19627687|P1|No On-study Data|Overall Study||0
7972404|NCT00310180|19627684|P4|STARTED|Overall Study||1737
7972405|NCT00310180|19627685|P3|STARTED|Overall Study||3449
7972406|NCT00310180|19627686|P2|STARTED|Overall Study||3458
7972407|NCT00310180|19627687|P1|STARTED|Overall Study||1629
7972408|NCT00310076|19627717|P1|NOT COMPLETED|Overall Study||3
7972409|NCT00310076|19627717|P1|COMPLETED|Overall Study||26
7972410|NCT00310076|19627717|P1|STARTED|Overall Study||29
7972411|NCT00310050|19627723|P1|NOT COMPLETED|Overall Study||1
7972412|NCT00310050|19627723|P1|COMPLETED|Overall Study||3
7972413|NCT00310050|19627723|P1|STARTED|Overall Study||4
7972414|NCT00310037|19627734|P2|NOT COMPLETED|Overall Study||17
7972415|NCT00310037|19627735|P1|NOT COMPLETED|Overall Study||18
7972416|NCT00310037|19627734|P2|COMPLETED|Overall Study||33
7972417|NCT00310037|19627735|P1|COMPLETED|Overall Study||34
7972418|NCT00310037|19627734|P2|STARTED|Overall Study||50
7972419|NCT00310037|19627735|P1|STARTED|Overall Study||52
7972420|NCT00309985|19627749|P2|NOT COMPLETED|Overall Study||1
7972421|NCT00309985|19627750|P1|NOT COMPLETED|Overall Study||62
7972422|NCT00309985|19627749|P2|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392
7972423|NCT00309985|19627750|P1|COMPLETED|Overall Study||335
7972424|NCT00309985|19627749|P2|Both Baseline and 3-month FACT-P Evals|Overall Study||299
7972425|NCT00309985|19627750|P1|Both Baseline and 3-month FACT-P Evals|Overall Study||334
7972426|NCT00309985|19627749|P2|Toxicity Analysis|Overall Study||392
7972427|NCT00309985|19627750|P1|Toxicity Analysis|Overall Study||390
7972428|NCT00309985|19627749|P2|STARTED|Overall Study||393
7972429|NCT00309985|19627750|P1|STARTED|Overall Study||397
7972430|NCT00309959|19627766|P1|NOT COMPLETED|Overall Study||2
7972431|NCT00309959|19627766|P1|COMPLETED|Overall Study||35
7972432|NCT00309959|19627766|P1|STARTED|Overall Study||37
7972433|NCT00309946|19627775|P1|NOT COMPLETED|Overall Study||1
7972434|NCT00309946|19627775|P1|COMPLETED|Overall Study||50
7972435|NCT00309946|19627775|P1|STARTED|Overall Study||51
7972436|NCT00309907|19627781|P1|NOT COMPLETED|Overall Study||20
7972437|NCT00309907|19627781|P1|COMPLETED|Overall Study||19
7972438|NCT00309907|19627781|P1|STARTED|Overall Study||39
7972439|NCT00309842|19627790|P1|NOT COMPLETED|Overall Study||1
7972440|NCT00309842|19627790|P1|COMPLETED|Overall Study||212
7972441|NCT00309842|19627790|P1|STARTED|Overall Study||213
7972442|NCT00309777|19627808|P4|NOT COMPLETED|Overall Study||4
7972443|NCT00309777|19627809|P3|NOT COMPLETED|Overall Study||19
7972444|NCT00309777|19627810|P2|NOT COMPLETED|Overall Study||9
7972445|NCT00309777|19627811|P1|NOT COMPLETED|Overall Study||23
7972446|NCT00309777|19627808|P4|COMPLETED|Overall Study||107
7972447|NCT00309777|19627809|P3|COMPLETED|Overall Study||304
7972448|NCT00309777|19627810|P2|COMPLETED|Overall Study||99
7972449|NCT00309777|19627811|P1|COMPLETED|Overall Study||292
7972450|NCT00309777|19627808|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110
7972451|NCT00309777|19627809|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320
7972452|NCT00309777|19627810|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107
7972453|NCT00309777|19627811|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311
7972454|NCT00309777|19627808|P4|STARTED|Overall Study||111
7972455|NCT00309777|19627809|P3|STARTED|Overall Study||323
7972456|NCT00309777|19627810|P2|STARTED|Overall Study||108
7972457|NCT00309777|19627811|P1|STARTED|Overall Study||315
7972458|NCT00309751|19627827|P2|NOT COMPLETED|Overall Study||15
7972459|NCT00309751|19627828|P1|NOT COMPLETED|Overall Study||31
7972460|NCT00309751|19627827|P2|COMPLETED|Overall Study||124
7972461|NCT00309751|19627828|P1|COMPLETED|Overall Study||248
7972462|NCT00309751|19627827|P2|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137
7972463|NCT00309751|19627828|P1|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275
7972464|NCT00309751|19627827|P2|STARTED|Overall Study||139
7972465|NCT00309751|19627828|P1|STARTED|Overall Study||279
7972466|NCT00309738|19627838|P2|NOT COMPLETED|Overall Study||12
7972467|NCT00309738|19627839|P1|NOT COMPLETED|Overall Study||13
7972468|NCT00309738|19627838|P2|COMPLETED|Overall Study||107
7972469|NCT00309738|19627839|P1|COMPLETED|Overall Study||223
7972470|NCT00309738|19627838|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119
7972471|NCT00309738|19627839|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233
7972472|NCT00309738|19627838|P2|STARTED|Overall Study||119
7972473|NCT00309738|19627839|P1|STARTED|Overall Study||236
7972474|NCT00309608|19627852|P5|NOT COMPLETED|Overall Study||4
7972475|NCT00309608|19627853|P4|NOT COMPLETED|Overall Study||6
7972476|NCT00309608|19627854|P3|NOT COMPLETED|Overall Study||10
7972477|NCT00309608|19627855|P2|NOT COMPLETED|Overall Study||13
7972478|NCT00309608|19627856|P1|NOT COMPLETED|Overall Study||14
7972479|NCT00309608|19627852|P5|COMPLETED|Overall Study||61
7972480|NCT00309608|19627853|P4|COMPLETED|Overall Study||60
7972481|NCT00309608|19627854|P3|COMPLETED|Overall Study||56
7972482|NCT00309608|19627855|P2|COMPLETED|Overall Study||52
7972483|NCT00309608|19627856|P1|COMPLETED|Overall Study||57
7972484|NCT00309608|19627852|P5|STARTED|Overall Study||65
7972485|NCT00309608|19627853|P4|STARTED|Overall Study||66
7972486|NCT00309608|19627854|P3|STARTED|Overall Study||66
7972487|NCT00309608|19627855|P2|STARTED|Overall Study||65
7972488|NCT00309608|19627856|P1|STARTED|Overall Study||71
7972489|NCT00309465|19627883|P6|NOT COMPLETED|Overall Study||0
7972490|NCT00309465|19627884|P5|NOT COMPLETED|Overall Study||0
7972491|NCT00309465|19627885|P4|NOT COMPLETED|Overall Study||1
7972492|NCT00309465|19627886|P3|NOT COMPLETED|Overall Study||0
7972493|NCT00309465|19627887|P2|NOT COMPLETED|Overall Study||0
7972494|NCT00309465|19627888|P1|NOT COMPLETED|Overall Study||0
7972495|NCT00309465|19627883|P6|COMPLETED|Overall Study||76
7972496|NCT00309465|19627884|P5|COMPLETED|Overall Study||76
7972497|NCT00309465|19627885|P4|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75
7972498|NCT00309465|19627886|P3|COMPLETED|Overall Study||58
7972499|NCT00309465|19627887|P2|COMPLETED|Overall Study||58
7972500|NCT00309465|19627888|P1|COMPLETED|Overall Study||58
7972501|NCT00309465|19627883|P6|STARTED|Overall Study||76
7972502|NCT00309465|19627884|P5|STARTED|Overall Study||76
7972503|NCT00309465|19627885|P4|STARTED|Overall Study||76
7972504|NCT00309465|19627886|P3|STARTED|Overall Study||58
7972505|NCT00309465|19627887|P2|STARTED|Overall Study||58
7972506|NCT00309465|19627888|P1|STARTED|Overall Study||58
7972507|NCT00309452|19627904|P2|NOT COMPLETED|Overall Study||0
7972508|NCT00309452|19627905|P1|NOT COMPLETED|Overall Study||3
7972509|NCT00309452|19627904|P2|COMPLETED|Overall Study||60
7972510|NCT00309452|19627905|P1|COMPLETED|Overall Study||57
7972511|NCT00309452|19627904|P2|STARTED|Overall Study||60
7972512|NCT00309452|19627905|P1|STARTED|Overall Study||60
7972513|NCT00309387|19627933|P2|NOT COMPLETED|Overall Study||159
7972514|NCT00309387|19627934|P1|NOT COMPLETED|Overall Study||142
7972515|NCT00309387|19627933|P2|COMPLETED|Overall Study||351
7972516|NCT00309387|19627934|P1|COMPLETED|Overall Study||368
7972517|NCT00309387|19627933|P2|STARTED|Overall Study||510
7972518|NCT00309387|19627934|P1|STARTED|Overall Study||510
7972519|NCT00309244|19627952|P2|NOT COMPLETED|Overall Study||97
7972520|NCT00309244|19627953|P1|NOT COMPLETED|Overall Study||118
7972521|NCT00309244|19627952|P2|COMPLETED|Overall Study||246
7972522|NCT00309244|19627953|P1|COMPLETED|Overall Study||216
7972523|NCT00309244|19627952|P2|STARTED|Overall Study||343
7972524|NCT00309244|19627953|P1|STARTED|Overall Study||334
7972525|NCT00309166|19627975|P2|NOT COMPLETED|Overall Study||3
7972526|NCT00309166|19627976|P1|NOT COMPLETED|Overall Study||5
7972527|NCT00309166|19627975|P2|COMPLETED|Overall Study||86
7972528|NCT00309166|19627976|P1|COMPLETED|Overall Study||176
7972529|NCT00309166|19627975|P2|STARTED|Overall Study||89
7972530|NCT00309166|19627976|P1|STARTED|Overall Study||181
7972531|NCT00309140|19628002|P1|NOT COMPLETED|Overall Study||0
7972532|NCT00309140|19628002|P1|COMPLETED|Overall Study||23
7972533|NCT00309140|19628002|P1|Received at Least 1 Dose of Study Drug|Overall Study||23
7972534|NCT00309140|19628002|P1|STARTED|Overall Study||23
7972535|NCT00308997|19628010|P2|NOT COMPLETED|Overall Study||1
7972536|NCT00308997|19628011|P1|NOT COMPLETED|Overall Study||1
7972537|NCT00308997|19628010|P2|COMPLETED|Overall Study||28
7972538|NCT00308997|19628011|P1|COMPLETED|Overall Study||55
7972539|NCT00308997|19628010|P2|STARTED|Overall Study||29
7972540|NCT00308997|19628011|P1|STARTED|Overall Study||56
7972541|NCT00308737|19628030|P3|NOT COMPLETED|Overall Study||37
7972542|NCT00308737|19628031|P2|NOT COMPLETED|Overall Study||289
7972543|NCT00308737|19628032|P1|NOT COMPLETED|Overall Study||463
7972544|NCT00308737|19628030|P3|COMPLETED|Overall Study||127
7972545|NCT00308737|19628031|P2|COMPLETED|Overall Study||662
7972546|NCT00308737|19628032|P1|COMPLETED|Overall Study||475
7972547|NCT00308737|19628030|P3|STARTED|Overall Study||164
7972548|NCT00308737|19628031|P2|STARTED|Overall Study||951
7972549|NCT00308737|19628032|P1|STARTED|Overall Study||938
7972550|NCT00308711|19628072|P3|NOT COMPLETED|Overall Study||5
7972551|NCT00308711|19628073|P2|NOT COMPLETED|Overall Study||4
7972552|NCT00308711|19628074|P1|NOT COMPLETED|Overall Study||2
7972553|NCT00308711|19628072|P3|COMPLETED|Overall Study||431
7972554|NCT00308711|19628073|P2|COMPLETED|Overall Study||440
7972555|NCT00308711|19628074|P1|COMPLETED|Overall Study||426
7972556|NCT00308711|19628072|P3|STARTED|Overall Study||436
7972557|NCT00308711|19628073|P2|STARTED|Overall Study||444
7972558|NCT00308711|19628074|P1|STARTED|Overall Study||428
7972559|NCT00308620|19628109|P3|NOT COMPLETED|Overall Study||1
7972560|NCT00308620|19628110|P2|NOT COMPLETED|Overall Study||1
7972561|NCT00308620|19628111|P1|NOT COMPLETED|Overall Study||1
7972562|NCT00308620|19628109|P3|COMPLETED|Overall Study||5
7972563|NCT00308620|19628110|P2|COMPLETED|Overall Study||3
7972564|NCT00308620|19628111|P1|COMPLETED|Overall Study||2
7972565|NCT00308620|19628109|P3|STARTED|Overall Study||6
7972566|NCT00308620|19628110|P2|STARTED|Overall Study||4
7972567|NCT00308620|19628111|P1|STARTED|Overall Study||3
7972568|NCT00308581|19628120|P3|NOT COMPLETED|Randomized Maintenance Phase||0
7972569|NCT00308581|19628121|P2|NOT COMPLETED|Randomized Maintenance Phase||103
7972570|NCT00308581|19628122|P1|NOT COMPLETED|Randomized Maintenance Phase||105
7972571|NCT00308581|19628120|P3|COMPLETED|Randomized Maintenance Phase||0
7972572|NCT00308581|19628121|P2|COMPLETED|Randomized Maintenance Phase||83
7972573|NCT00308581|19628122|P1|COMPLETED|Randomized Maintenance Phase||82
7972574|NCT00308581|19628120|P3|STARTED|Randomized Maintenance Phase||0
7972575|NCT00308581|19628121|P2|STARTED|Randomized Maintenance Phase||186
7972576|NCT00308581|19628122|P1|STARTED|Randomized Maintenance Phase||187
7972577|NCT00308581|19628120|P3|NOT COMPLETED|Induction Phase||166
7972578|NCT00308581|19628121|P2|NOT COMPLETED|Induction Phase||0
7972579|NCT00308581|19628122|P1|NOT COMPLETED|Induction Phase||0
7972580|NCT00308581|19628120|P3|COMPLETED|Induction Phase||373
7972581|NCT00308581|19628121|P2|COMPLETED|Induction Phase|Not applicable in this period|0
7972582|NCT00308581|19628122|P1|COMPLETED|Induction Phase|Not applicable in this period|0
7972583|NCT00308581|19628120|P3|STARTED|Induction Phase||539
7972584|NCT00308581|19628121|P2|STARTED|Induction Phase|Not applicable in this period|0
7972585|NCT00308581|19628122|P1|STARTED|Induction Phase|Not applicable in this period|0
7972586|NCT00308555|19628248|P2|NOT COMPLETED|Overall Study||0
7972587|NCT00308555|19628249|P1|NOT COMPLETED|Overall Study||3
7972588|NCT00308555|19628248|P2|COMPLETED|Overall Study||11
7972589|NCT00308555|19628249|P1|COMPLETED|Overall Study||10
7972590|NCT00308555|19628248|P2|STARTED|Overall Study||11
7972591|NCT00308555|19628249|P1|STARTED|Overall Study||13
7972592|NCT00308516|19628257|P2|NOT COMPLETED|Overall Study||21
7972593|NCT00308516|19628258|P1|NOT COMPLETED|Overall Study||29
7972594|NCT00308516|19628257|P2|COMPLETED|Overall Study||10
7972595|NCT00308516|19628258|P1|COMPLETED|Overall Study||6
7972596|NCT00308516|19628257|P2|STARTED|Overall Study||31
7972597|NCT00308516|19628258|P1|STARTED|Overall Study||35
7972598|NCT00308308|19628266|P2|NOT COMPLETED|Overall Study||68
7972599|NCT00308308|19628267|P1|NOT COMPLETED|Overall Study||103
7972600|NCT00308308|19628266|P2|COMPLETED|Overall Study||220
7972601|NCT00308308|19628267|P1|COMPLETED|Overall Study||198
7972602|NCT00308308|19628266|P2|STARTED|Overall Study||288
7972603|NCT00308308|19628267|P1|STARTED|Overall Study||301
7972604|NCT00308282|19628291|P4|NOT COMPLETED|Overall Study||2
7972605|NCT00308282|19628292|P3|NOT COMPLETED|Overall Study||1
7972606|NCT00308282|19628293|P2|NOT COMPLETED|Overall Study||4
7972607|NCT00308282|19628294|P1|NOT COMPLETED|Overall Study||3
7972608|NCT00308282|19628291|P4|COMPLETED|Overall Study||32
7972609|NCT00308282|19628292|P3|COMPLETED|Overall Study||33
7972610|NCT00308282|19628293|P2|COMPLETED|Overall Study||30
7972611|NCT00308282|19628294|P1|COMPLETED|Overall Study||31
7972612|NCT00308282|19628291|P4|Received at Least One Dose of Study Drug|Overall Study||34
7972613|NCT00308282|19628292|P3|Received at Least One Dose of Study Drug|Overall Study||34
7972614|NCT00308282|19628293|P2|Received at Least One Dose of Study Drug|Overall Study||34
7972615|NCT00308282|19628294|P1|Received at Least One Dose of Study Drug|Overall Study||34
7972616|NCT00308282|19628291|P4|STARTED|Overall Study||34
7972617|NCT00308282|19628292|P3|STARTED|Overall Study||34
7972618|NCT00308282|19628293|P2|STARTED|Overall Study||34
7972619|NCT00308282|19628294|P1|STARTED|Overall Study||34
7972620|NCT00308230|19628334|P3|NOT COMPLETED|Overall Study||0
7972621|NCT00308230|19628335|P2|NOT COMPLETED|Overall Study||0
7972622|NCT00308230|19628336|P1|NOT COMPLETED|Overall Study||0
7972623|NCT00308230|19628334|P3|COMPLETED|Overall Study||20
7972624|NCT00308230|19628335|P2|COMPLETED|Overall Study||8
7972625|NCT00308230|19628336|P1|COMPLETED|Overall Study||6
7972626|NCT00308230|19628334|P3|STARTED|Overall Study||20
7972627|NCT00308230|19628335|P2|STARTED|Overall Study||8
7972628|NCT00308230|19628336|P1|STARTED|Overall Study||6
7972629|NCT00308139|19628346|P2|NOT COMPLETED|Overall Study||87
7972630|NCT00308139|19628347|P1|NOT COMPLETED|Overall Study||94
7972631|NCT00308139|19628346|P2|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64
7972632|NCT00308139|19628347|P1|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58
7972633|NCT00308139|19628346|P2|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130
7972634|NCT00308139|19628347|P1|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128
7972635|NCT00308139|19628346|P2|Evaluable Meal Tolerance Cohort|Overall Study||24
7972636|NCT00308139|19628347|P1|Evaluable Meal Tolerance Cohort|Overall Study||27
7972637|NCT00308139|19628346|P2|Pharmacokinetics Population|Overall Study||0
7972638|NCT00308139|19628347|P1|Pharmacokinetics Population|Overall Study||129
7972639|NCT00308139|19628346|P2|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145
7972640|NCT00308139|19628347|P1|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148
7972641|NCT00308139|19628346|P2|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147
7972642|NCT00308139|19628347|P1|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148
7972643|NCT00308139|19628346|P2|STARTED|Overall Study||151
7972644|NCT00308139|19628347|P1|STARTED|Overall Study||152
7972645|NCT00308113|19628421|P4|NOT COMPLETED|Overall Study||1
7972646|NCT00308113|19628422|P3|NOT COMPLETED|Overall Study||0
7972647|NCT00308113|19628423|P2|NOT COMPLETED|Overall Study||0
7972648|NCT00308113|19628424|P1|NOT COMPLETED|Overall Study||0
7972649|NCT00308113|19628421|P4|COMPLETED|Overall Study||1
7972650|NCT00308113|19628422|P3|COMPLETED|Overall Study||1
7972651|NCT00308113|19628423|P2|COMPLETED|Overall Study||0
7972652|NCT00308113|19628424|P1|COMPLETED|Overall Study||0
7972653|NCT00308113|19628421|P4|STARTED|Overall Study||2
7972654|NCT00308113|19628422|P3|STARTED|Overall Study||1
7972655|NCT00308113|19628423|P2|STARTED|Overall Study||0
7972656|NCT00308113|19628424|P1|STARTED|Overall Study||0
7972657|NCT00308087|19628444|P2|NOT COMPLETED|Overall Study||37
7972658|NCT00308087|19628445|P1|NOT COMPLETED|Overall Study||36
7972659|NCT00308087|19628444|P2|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
7972660|NCT00308087|19628445|P1|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
7972661|NCT00308087|19628444|P2|STARTED|Overall Study||38
7972662|NCT00308087|19628445|P1|STARTED|Overall Study||37
7972663|NCT00308074|19628461|P1|NOT COMPLETED|Overall Study||1
7972664|NCT00308074|19628461|P1|COMPLETED|Overall Study||13
7972665|NCT00308074|19628461|P1|STARTED|Overall Study||14
7972666|NCT00308061|19628470|P2|NOT COMPLETED|Overall Study||0
7972667|NCT00308061|19628471|P1|NOT COMPLETED|Overall Study||0
7972668|NCT00308061|19628470|P2|COMPLETED|Overall Study||20
7972669|NCT00308061|19628471|P1|COMPLETED|Overall Study||20
7972670|NCT00308061|19628470|P2|STARTED|Overall Study||20
7972671|NCT00308061|19628471|P1|STARTED|Overall Study||20
7972672|NCT00307931|19628478|P1|NOT COMPLETED|Overall Study||1
7972673|NCT00307931|19628478|P1|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15
7972674|NCT00307931|19628478|P1|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16
7972675|NCT00307801|19628495|P2|NOT COMPLETED|Overall Study||17
7972676|NCT00307801|19628496|P1|NOT COMPLETED|Overall Study||32
7972677|NCT00307801|19628495|P2|COMPLETED|Overall Study||65
7972678|NCT00307801|19628496|P1|COMPLETED|Overall Study||117
7972679|NCT00307801|19628495|P2|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77
7972680|NCT00307801|19628496|P1|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141
7972681|NCT00307801|19628495|P2|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71
7972682|NCT00307801|19628496|P1|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130
7972683|NCT00307801|19628495|P2|Cycle 1, Visit 5, Baseline|Overall Study||81
7972684|NCT00307801|19628496|P1|Cycle 1, Visit 5, Baseline|Overall Study||145
7972685|NCT00307801|19628495|P2|Subjects Received Treatment|Overall Study||81
7972686|NCT00307801|19628496|P1|Subjects Received Treatment|Overall Study||145
7972687|NCT00307801|19628495|P2|STARTED|Overall Study||82
7972688|NCT00307801|19628496|P1|STARTED|Overall Study||149
7972689|NCT00307736|19628608|P4|NOT COMPLETED|Overall Study||3
7972690|NCT00307736|19628609|P3|NOT COMPLETED|Overall Study||3
7972691|NCT00307736|19628610|P2|NOT COMPLETED|Overall Study||0
7972692|NCT00307736|19628611|P1|NOT COMPLETED|Overall Study||0
7972693|NCT00307736|19628608|P4|COMPLETED|Overall Study||20
7972694|NCT00307736|19628609|P3|COMPLETED|Overall Study||0
7972695|NCT00307736|19628610|P2|COMPLETED|Overall Study||3
7972696|NCT00307736|19628611|P1|COMPLETED|Overall Study||3
7972697|NCT00307736|19628608|P4|STARTED|Overall Study||23
7972698|NCT00307736|19628609|P3|STARTED|Overall Study||3
7972699|NCT00307736|19628610|P2|STARTED|Overall Study||3
7972700|NCT00307736|19628611|P1|STARTED|Overall Study||3
7972701|NCT00307684|19628622|P3|NOT COMPLETED|Double Blind Phase||0
7972702|NCT00307684|19628623|P2|NOT COMPLETED|Double Blind Phase||5
7972703|NCT00307684|19628624|P1|NOT COMPLETED|Double Blind Phase||2
7972704|NCT00307684|19628622|P3|COMPLETED|Double Blind Phase||0
7972705|NCT00307684|19628623|P2|COMPLETED|Double Blind Phase||17
7972706|NCT00307684|19628624|P1|COMPLETED|Double Blind Phase||21
7972707|NCT00307684|19628622|P3|STARTED|Double Blind Phase||0
7972708|NCT00307684|19628623|P2|STARTED|Double Blind Phase||22
7972709|NCT00307684|19628624|P1|STARTED|Double Blind Phase||23
7972710|NCT00307684|19628622|P3|NOT COMPLETED|Open Label Phase||56
7972711|NCT00307684|19628623|P2|NOT COMPLETED|Open Label Phase||0
7972712|NCT00307684|19628624|P1|NOT COMPLETED|Open Label Phase||0
7972713|NCT00307684|19628622|P3|COMPLETED|Open Label Phase||99
7972714|NCT00307684|19628623|P2|COMPLETED|Open Label Phase||0
7972715|NCT00307684|19628624|P1|COMPLETED|Open Label Phase||0
7972716|NCT00307684|19628622|P3|STARTED|Open Label Phase|1 screening failure|155
7972717|NCT00307684|19628623|P2|STARTED|Open Label Phase||0
7972718|NCT00307684|19628624|P1|STARTED|Open Label Phase||0
7972719|NCT00307489|19628652|P2|NOT COMPLETED|Week 48 Through Week 168||6
7972720|NCT00307489|19628653|P1|NOT COMPLETED|Week 48 Through Week 168||6
7972721|NCT00307489|19628652|P2|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44
7972722|NCT00307489|19628653|P1|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46
7972723|NCT00307489|19628652|P2|STARTED|Week 48 Through Week 168||50
7972724|NCT00307489|19628653|P1|STARTED|Week 48 Through Week 168||52
7972725|NCT00307489|19628652|P2|NOT COMPLETED|Baseline Through Week 48||2
7972726|NCT00307489|19628653|P1|NOT COMPLETED|Baseline Through Week 48||1
7972727|NCT00307489|19628652|P2|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50
7972728|NCT00307489|19628653|P1|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52
7972729|NCT00307489|19628652|P2|STARTED|Baseline Through Week 48||52
7972730|NCT00307489|19628653|P1|STARTED|Baseline Through Week 48||53
7972731|NCT00307437|19628698|P7|NOT COMPLETED|After Controlled Period||113
7972732|NCT00307437|19628699|P6|NOT COMPLETED|After Controlled Period||122
7972733|NCT00307437|19628700|P5|NOT COMPLETED|After Controlled Period||55
7972734|NCT00307437|19628701|P4|NOT COMPLETED|After Controlled Period||58
7972735|NCT00307437|19628702|P3|NOT COMPLETED|After Controlled Period||0
7972736|NCT00307437|19628703|P2|NOT COMPLETED|After Controlled Period||0
7972737|NCT00307437|19628704|P1|NOT COMPLETED|After Controlled Period||0
7972738|NCT00307437|19628698|P7|COMPLETED|After Controlled Period||289
7972739|NCT00307437|19628699|P6|COMPLETED|After Controlled Period||281
7972740|NCT00307437|19628700|P5|COMPLETED|After Controlled Period||140
7972741|NCT00307437|19628701|P4|COMPLETED|After Controlled Period||139
7972742|NCT00307437|19628702|P3|COMPLETED|After Controlled Period||0
7972743|NCT00307437|19628703|P2|COMPLETED|After Controlled Period||0
7972744|NCT00307437|19628704|P1|COMPLETED|After Controlled Period||0
7972745|NCT00307437|19628698|P7|STARTED|After Controlled Period||402
7972746|NCT00307437|19628699|P6|STARTED|After Controlled Period||403
7972747|NCT00307437|19628700|P5|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195
7972748|NCT00307437|19628701|P4|STARTED|After Controlled Period||197
7972749|NCT00307437|19628702|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
7972750|NCT00307437|19628703|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
7972751|NCT00307437|19628704|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
7972752|NCT00307437|19628698|P7|NOT COMPLETED|Controlled Period||0
7972753|NCT00307437|19628699|P6|NOT COMPLETED|Controlled Period||0
7972754|NCT00307437|19628700|P5|NOT COMPLETED|Controlled Period||0
7972755|NCT00307437|19628701|P4|NOT COMPLETED|Controlled Period||0
7972756|NCT00307437|19628702|P3|NOT COMPLETED|Controlled Period||9
7972757|NCT00307437|19628703|P2|NOT COMPLETED|Controlled Period||6
7972758|NCT00307437|19628704|P1|NOT COMPLETED|Controlled Period||16
7972759|NCT00307437|19628698|P7|COMPLETED|Controlled Period||0
7972760|NCT00307437|19628699|P6|COMPLETED|Controlled Period||0
7972761|NCT00307437|19628700|P5|COMPLETED|Controlled Period||0
7972762|NCT00307437|19628701|P4|COMPLETED|Controlled Period||0
7972763|NCT00307437|19628702|P3|COMPLETED|Controlled Period||402
7972764|NCT00307437|19628703|P2|COMPLETED|Controlled Period||403
7972765|NCT00307437|19628704|P1|COMPLETED|Controlled Period||394
7972766|NCT00307437|19628698|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
7972767|NCT00307437|19628699|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
7972768|NCT00307437|19628700|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
7972769|NCT00307437|19628701|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
7972770|NCT00307437|19628702|P3|STARTED|Controlled Period||411
7972771|NCT00307437|19628703|P2|STARTED|Controlled Period||409
7972772|NCT00307437|19628704|P1|STARTED|Controlled Period||410
7972773|NCT00307333|19628730|P2|NOT COMPLETED|Overall Study||3
7972774|NCT00307333|19628731|P1|NOT COMPLETED|Overall Study||11
7972775|NCT00307333|19628730|P2|COMPLETED|Overall Study||1489
7972776|NCT00307333|19628731|P1|COMPLETED|Overall Study||1500
7972777|NCT00307333|19628730|P2|STARTED|Overall Study||1492
7972778|NCT00307333|19628731|P1|STARTED|Overall Study||1511
7972779|NCT00307294|19628743|P1|NOT COMPLETED|Overall Study||1
7972780|NCT00307294|19628743|P1|COMPLETED|Overall Study||39
7972781|NCT00307294|19628743|P1|STARTED|Overall Study||40
7972782|NCT00307164|19628752|P2|NOT COMPLETED|Overall Study||14
7972783|NCT00307164|19628753|P1|NOT COMPLETED|Overall Study||15
7972784|NCT00307164|19628752|P2|COMPLETED|Overall Study||68
7972785|NCT00307164|19628753|P1|COMPLETED|Overall Study||68
7972786|NCT00307164|19628752|P2|STARTED|Overall Study||82
7972787|NCT00307164|19628753|P1|STARTED|Overall Study||83
7972788|NCT00307151|19628793|P4|NOT COMPLETED|Overall Study||11
7972789|NCT00307151|19628794|P3|NOT COMPLETED|Overall Study||20
7972790|NCT00307151|19628795|P2|NOT COMPLETED|Overall Study||7
7972791|NCT00307151|19628796|P1|NOT COMPLETED|Overall Study||11
7972792|NCT00307151|19628793|P4|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129
7972793|NCT00307151|19628794|P3|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127
7972794|NCT00307151|19628795|P2|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75
7972795|NCT00307151|19628796|P1|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71
7972796|NCT00307151|19628793|P4|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140
7972797|NCT00307151|19628794|P3|STARTED|Overall Study||147
7972798|NCT00307151|19628795|P2|STARTED|Overall Study||82
7972799|NCT00307151|19628796|P1|STARTED|Overall Study||82
7972800|NCT00307125|19628840|P3|NOT COMPLETED|Pilot Phase||1
7972801|NCT00307125|19628841|P2|NOT COMPLETED|Pilot Phase||2
7972802|NCT00307125|19628842|P1|NOT COMPLETED|Pilot Phase||0
7972803|NCT00307125|19628840|P3|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6
7972804|NCT00307125|19628841|P2|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13
7972805|NCT00307125|19628842|P1|COMPLETED|Pilot Phase||0
7972806|NCT00307125|19628840|P3|STARTED|Pilot Phase||7
7972807|NCT00307125|19628841|P2|STARTED|Pilot Phase||15
7972808|NCT00307125|19628842|P1|STARTED|Pilot Phase||0
7972809|NCT00307125|19628840|P3|NOT COMPLETED|Screening Phase||0
7972810|NCT00307125|19628841|P2|NOT COMPLETED|Screening Phase||0
7972811|NCT00307125|19628842|P1|NOT COMPLETED|Screening Phase||454
7972812|NCT00307125|19628840|P3|COMPLETED|Screening Phase||0
7972813|NCT00307125|19628841|P2|COMPLETED|Screening Phase||0
7972814|NCT00307125|19628842|P1|COMPLETED|Screening Phase||303
7972815|NCT00307125|19628840|P3|STARTED|Screening Phase||0
7972816|NCT00307125|19628841|P2|STARTED|Screening Phase||0
7972817|NCT00307125|19628842|P1|STARTED|Screening Phase||757
7972818|NCT00307086|19628864|P1|NOT COMPLETED|Overall Study||5
7972819|NCT00307086|19628864|P1|COMPLETED|Overall Study||25
7972820|NCT00307086|19628864|P1|STARTED|Overall Study||30
7972821|NCT00307047|19628870|P2|NOT COMPLETED|Overall Study||49
7972822|NCT00307047|19628871|P1|NOT COMPLETED|Overall Study||69
7972823|NCT00307047|19628870|P2|COMPLETED|Overall Study||1180
7972824|NCT00307047|19628871|P1|COMPLETED|Overall Study||2389
7972825|NCT00307047|19628870|P2|STARTED|Overall Study||1229
7972826|NCT00307047|19628871|P1|STARTED|Overall Study||2458
7972827|NCT00307034|19629009|P2|NOT COMPLETED|Overall Study||7
7972828|NCT00307034|19629010|P1|NOT COMPLETED|Overall Study||2
7972829|NCT00307034|19629009|P2|COMPLETED|Overall Study||169
7972830|NCT00307034|19629010|P1|COMPLETED|Overall Study||173
7972831|NCT00307034|19629009|P2|STARTED|Overall Study||176
7972832|NCT00307034|19629010|P1|STARTED|Overall Study||175
7972833|NCT00306995|19629055|P7|NOT COMPLETED|Study Part II for Subset 2||0
7972834|NCT00306995|19629056|P6|NOT COMPLETED|Study Part II for Subset 2||0
7972835|NCT00306995|19629057|P5|NOT COMPLETED|Study Part II for Subset 2||0
7972836|NCT00306995|19629058|P4|NOT COMPLETED|Study Part II for Subset 2||0
7972837|NCT00306995|19629059|P3|NOT COMPLETED|Study Part II for Subset 2||0
7972838|NCT00306995|19629060|P2|NOT COMPLETED|Study Part II for Subset 2||1
7972839|NCT00306995|19629061|P1|NOT COMPLETED|Study Part II for Subset 2||0
7972840|NCT00306995|19629055|P7|COMPLETED|Study Part II for Subset 2||24
7972841|NCT00306995|19629056|P6|COMPLETED|Study Part II for Subset 2||26
7972842|NCT00306995|19629057|P5|COMPLETED|Study Part II for Subset 2||23
7972843|NCT00306995|19629058|P4|COMPLETED|Study Part II for Subset 2||22
7972844|NCT00306995|19629059|P3|COMPLETED|Study Part II for Subset 2||23
7972845|NCT00306995|19629060|P2|COMPLETED|Study Part II for Subset 2||23
7972846|NCT00306995|19629061|P1|COMPLETED|Study Part II for Subset 2||23
7972847|NCT00306995|19629055|P7|STARTED|Study Part II for Subset 2||24
7972848|NCT00306995|19629056|P6|STARTED|Study Part II for Subset 2||26
7972849|NCT00306995|19629057|P5|STARTED|Study Part II for Subset 2||23
7972850|NCT00306995|19629058|P4|STARTED|Study Part II for Subset 2||22
7972851|NCT00306995|19629059|P3|STARTED|Study Part II for Subset 2||23
7972852|NCT00306995|19629060|P2|STARTED|Study Part II for Subset 2||24
7972853|NCT00306995|19629061|P1|STARTED|Study Part II for Subset 2||23
7972854|NCT00306995|19629055|P7|NOT COMPLETED|Study Part II for Subset 1||0
7972855|NCT00306995|19629056|P6|NOT COMPLETED|Study Part II for Subset 1||0
7972856|NCT00306995|19629057|P5|NOT COMPLETED|Study Part II for Subset 1||0
7972857|NCT00306995|19629058|P4|NOT COMPLETED|Study Part II for Subset 1||0
7972858|NCT00306995|19629059|P3|NOT COMPLETED|Study Part II for Subset 1||0
7972859|NCT00306995|19629060|P2|NOT COMPLETED|Study Part II for Subset 1||0
7972860|NCT00306995|19629061|P1|NOT COMPLETED|Study Part II for Subset 1||0
7972861|NCT00306995|19629055|P7|COMPLETED|Study Part II for Subset 1||23
7972862|NCT00306995|19629056|P6|COMPLETED|Study Part II for Subset 1||26
7972863|NCT00306995|19629057|P5|COMPLETED|Study Part II for Subset 1||27
7972864|NCT00306995|19629058|P4|COMPLETED|Study Part II for Subset 1||27
7972865|NCT00306995|19629059|P3|COMPLETED|Study Part II for Subset 1||27
7972866|NCT00306995|19629060|P2|COMPLETED|Study Part II for Subset 1||26
7972867|NCT00306995|19629061|P1|COMPLETED|Study Part II for Subset 1||27
7972868|NCT00306995|19629055|P7|STARTED|Study Part II for Subset 1||23
7972869|NCT00306995|19629056|P6|STARTED|Study Part II for Subset 1||26
7972870|NCT00306995|19629057|P5|STARTED|Study Part II for Subset 1||27
7972871|NCT00306995|19629058|P4|STARTED|Study Part II for Subset 1||27
7972872|NCT00306995|19629059|P3|STARTED|Study Part II for Subset 1||27
7972873|NCT00306995|19629060|P2|STARTED|Study Part II for Subset 1||26
7972874|NCT00306995|19629061|P1|STARTED|Study Part II for Subset 1||27
7972875|NCT00306995|19629055|P7|NOT COMPLETED|Study Part I||1
7972876|NCT00306995|19629056|P6|NOT COMPLETED|Study Part I||0
7972877|NCT00306995|19629057|P5|NOT COMPLETED|Study Part I||0
7972878|NCT00306995|19629058|P4|NOT COMPLETED|Study Part I||0
7972879|NCT00306995|19629059|P3|NOT COMPLETED|Study Part I||0
7972880|NCT00306995|19629060|P2|NOT COMPLETED|Study Part I||0
7972881|NCT00306995|19629061|P1|NOT COMPLETED|Study Part I||0
7972882|NCT00306995|19629055|P7|COMPLETED|Study Part I||54
7972883|NCT00306995|19629056|P6|COMPLETED|Study Part I||55
7972884|NCT00306995|19629057|P5|COMPLETED|Study Part I||55
7972885|NCT00306995|19629058|P4|COMPLETED|Study Part I||55
7972886|NCT00306995|19629059|P3|COMPLETED|Study Part I||55
7972887|NCT00306995|19629060|P2|COMPLETED|Study Part I||55
7972888|NCT00306995|19629061|P1|COMPLETED|Study Part I||55
7972889|NCT00306995|19629055|P7|STARTED|Study Part I||55
7972890|NCT00306995|19629056|P6|STARTED|Study Part I||55
7972891|NCT00306995|19629057|P5|STARTED|Study Part I||55
7972892|NCT00306995|19629058|P4|STARTED|Study Part I||55
7972893|NCT00306995|19629059|P3|STARTED|Study Part I||55
7972894|NCT00306995|19629060|P2|STARTED|Study Part I||55
7972895|NCT00306995|19629061|P1|STARTED|Study Part I||55
7972896|NCT00306917|19629443|P2|NOT COMPLETED|Overall Study||109
7972897|NCT00306917|19629444|P1|NOT COMPLETED|Overall Study||108
7972898|NCT00306917|19629443|P2|COMPLETED|Overall Study||15
7972899|NCT00306917|19629444|P1|COMPLETED|Overall Study||13
7972900|NCT00306917|19629443|P2|60 Month Follow up|Overall Study||15
7972901|NCT00306917|19629444|P1|60 Month Follow up|Overall Study||13
7972902|NCT00306917|19629443|P2|48 Month Follow up|Overall Study||22
7972903|NCT00306917|19629444|P1|48 Month Follow up|Overall Study||29
7972904|NCT00306917|19629443|P2|36 Month Follow up|Overall Study||42
7972905|NCT00306917|19629444|P1|36 Month Follow up|Overall Study||56
7972906|NCT00306917|19629443|P2|24 Month Follow up|Overall Study||71
7972907|NCT00306917|19629444|P1|24 Month Follow up|Overall Study||60
7972908|NCT00306917|19629443|P2|12 Month Follow|Overall Study||94
7972909|NCT00306917|19629444|P1|12 Month Follow|Overall Study||86
7972910|NCT00306917|19629443|P2|Postoperative to 6 Month Follow up|Overall Study||100
7972911|NCT00306917|19629444|P1|Postoperative to 6 Month Follow up|Overall Study||93
7972912|NCT00306917|19629443|P2|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124
7972913|NCT00306917|19629444|P1|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121
7972914|NCT00306891|19629454|P4|NOT COMPLETED|Part B||17
7972915|NCT00306891|19629455|P3|NOT COMPLETED|Part B||11
7972916|NCT00306891|19629456|P2|NOT COMPLETED|Part B||0
7972917|NCT00306891|19629457|P1|NOT COMPLETED|Part B||0
7972918|NCT00306891|19629454|P4|COMPLETED|Part B||14
7972919|NCT00306891|19629455|P3|COMPLETED|Part B||5
7972920|NCT00306891|19629456|P2|COMPLETED|Part B||0
7972921|NCT00306891|19629457|P1|COMPLETED|Part B||0
7972922|NCT00306891|19629454|P4|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31
7972923|NCT00306891|19629455|P3|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16
7972924|NCT00306891|19629456|P2|STARTED|Part B||0
7972925|NCT00306891|19629457|P1|STARTED|Part B||0
7972926|NCT00306891|19629454|P4|NOT COMPLETED|Part A||0
7972927|NCT00306891|19629455|P3|NOT COMPLETED|Part A||0
7972928|NCT00306891|19629456|P2|NOT COMPLETED|Part A||6
7972929|NCT00306891|19629457|P1|NOT COMPLETED|Part A||5
7972930|NCT00306891|19629454|P4|COMPLETED|Part A||0
7972931|NCT00306891|19629455|P3|COMPLETED|Part A||0
7972932|NCT00306891|19629456|P2|COMPLETED|Part A||16
7972933|NCT00306891|19629457|P1|COMPLETED|Part A||18
7972934|NCT00306891|19629454|P4|STARTED|Part A||0
7972935|NCT00306891|19629455|P3|STARTED|Part A||0
7972936|NCT00306891|19629456|P2|STARTED|Part A||22
7972937|NCT00306891|19629457|P1|STARTED|Part A||23
7972938|NCT00306852|19629480|P2|NOT COMPLETED|Overall Study||38
7972939|NCT00306852|19629481|P1|NOT COMPLETED|Overall Study||29
7972940|NCT00306852|19629480|P2|COMPLETED|Overall Study||69
7972941|NCT00306852|19629481|P1|COMPLETED|Overall Study||76
7972942|NCT00306852|19629480|P2|STARTED|Overall Study||107
7972943|NCT00306852|19629481|P1|STARTED|Overall Study||105
7972944|NCT00306787|19629499|P2|NOT COMPLETED|Overall Study||241
7972945|NCT00306787|19629500|P1|NOT COMPLETED|Overall Study||234
7972946|NCT00306787|19629499|P2|COMPLETED|Overall Study||359
7972947|NCT00306787|19629500|P1|COMPLETED|Overall Study||345
7972948|NCT00306787|19629499|P2|Intent to Treat (ITT) Population|Overall Study||381
7972949|NCT00306787|19629500|P1|Intent to Treat (ITT) Population|Overall Study||370
7972950|NCT00306787|19629499|P2|Received Study Drug (Safety Population)|Overall Study||385
7972951|NCT00306787|19629500|P1|Received Study Drug (Safety Population)|Overall Study||371
7972952|NCT00306787|19629499|P2|STARTED|Overall Study||600
7972953|NCT00306787|19629500|P1|STARTED|Overall Study||579
7972954|NCT00306670|19629518|P2|NOT COMPLETED|Overall Study||2
7972955|NCT00306670|19629519|P1|NOT COMPLETED|Overall Study||0
7972956|NCT00306670|19629518|P2|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0
7972957|NCT00306670|19629519|P1|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
7972958|NCT00306670|19629518|P2|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2
7972959|NCT00306670|19629519|P1|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
7972960|NCT00306592|19629525|P2|NOT COMPLETED|Overall Study||58
7972961|NCT00306592|19629526|P1|NOT COMPLETED|Overall Study||31
7972962|NCT00306592|19629525|P2|COMPLETED|Overall Study||632
7972963|NCT00306592|19629526|P1|COMPLETED|Overall Study||373
7972964|NCT00306592|19629525|P2|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0
7972965|NCT00306592|19629526|P1|Entered 101-MS-321 Extension Study|Overall Study||22
7972966|NCT00306592|19629525|P2|Completed at 48 Weeks|Overall Study||632
7972967|NCT00306592|19629526|P1|Completed at 48 Weeks|Overall Study||81
7972968|NCT00306592|19629525|P2|Completed Between 24 and 48 Weeks|Overall Study||0
7972969|NCT00306592|19629526|P1|Completed Between 24 and 48 Weeks|Overall Study||85
7972970|NCT00306592|19629525|P2|Completed at 24 Weeks|Overall Study||0
7972971|NCT00306592|19629526|P1|Completed at 24 Weeks|Overall Study||207
7972972|NCT00306592|19629525|P2|STARTED|Overall Study||690
7972973|NCT00306592|19629526|P1|STARTED|Overall Study||404
7972974|NCT00306527|19629536|P4|NOT COMPLETED|Overall Study||6
7972975|NCT00306527|19629537|P3|NOT COMPLETED|Overall Study||5
7972976|NCT00306527|19629538|P2|NOT COMPLETED|Overall Study||7
7972977|NCT00306527|19629539|P1|NOT COMPLETED|Overall Study||6
7972978|NCT00306527|19629536|P4|COMPLETED|Overall Study||590
7972979|NCT00306527|19629537|P3|COMPLETED|Overall Study|3 of 4 deaths in the elderly subjects resulted in premature discontinuation. Refer to OM2 .|567
7972980|NCT00306527|19629538|P2|COMPLETED|Overall Study||527
7972981|NCT00306527|19629539|P1|COMPLETED|Overall Study||527
7972982|NCT00306527|19629536|P4|STARTED|Overall Study||596
7972983|NCT00306527|19629537|P3|STARTED|Overall Study||572
7972984|NCT00306527|19629538|P2|STARTED|Overall Study||534
7972985|NCT00306527|19629539|P1|STARTED|Overall Study||533
7972986|NCT00306488|19629593|P1|NOT COMPLETED|Overall Study||1
7972987|NCT00306488|19629593|P1|COMPLETED|Overall Study||10
7972988|NCT00306488|19629593|P1|STARTED|Overall Study||11
7972989|NCT00306384|19629611|P3|NOT COMPLETED|Overall Study||277
7972990|NCT00306384|19629612|P2|NOT COMPLETED|Overall Study||508
7972991|NCT00306384|19629613|P1|NOT COMPLETED|Overall Study||542
7972992|NCT00306384|19629611|P3|COMPLETED|Overall Study||251
7972993|NCT00306384|19629612|P2|COMPLETED|Overall Study||891
7972994|NCT00306384|19629613|P1|COMPLETED|Overall Study||854
7972995|NCT00306384|19629611|P3|Safety Set|Overall Study|Patients who received at least one dose of study drug|527
7972996|NCT00306384|19629612|P2|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398
7972997|NCT00306384|19629613|P1|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395
7972998|NCT00306384|19629611|P3|STARTED|Overall Study||528
7972999|NCT00306384|19629612|P2|STARTED|Overall Study||1399
7973000|NCT00306384|19629613|P1|STARTED|Overall Study||1396
7973001|NCT00306293|19629645|P2|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||1
7973002|NCT00306293|19629646|P1|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||3
7973003|NCT00306293|19629645|P2|COMPLETED|Period 2 (Day 67 to Day 126 )||26
7973004|NCT00306293|19629646|P1|COMPLETED|Period 2 (Day 67 to Day 126 )||24
7973005|NCT00306293|19629645|P2|STARTED|Period 2 (Day 67 to Day 126 )||27
7973006|NCT00306293|19629646|P1|STARTED|Period 2 (Day 67 to Day 126 )||27
7973007|NCT00306293|19629645|P2|NOT COMPLETED|Washout (Day 61 to Day 66)||0
7973008|NCT00306293|19629646|P1|NOT COMPLETED|Washout (Day 61 to Day 66)||0
7973009|NCT00306293|19629645|P2|COMPLETED|Washout (Day 61 to Day 66)||27
7973010|NCT00306293|19629646|P1|COMPLETED|Washout (Day 61 to Day 66)||27
7973011|NCT00306293|19629645|P2|STARTED|Washout (Day 61 to Day 66)||27
7973012|NCT00306293|19629646|P1|STARTED|Washout (Day 61 to Day 66)||27
7973013|NCT00306293|19629645|P2|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
7973014|NCT00306293|19629646|P1|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
7973015|NCT00306293|19629645|P2|COMPLETED|Period 1 (Day 1 to Day 60)||27
7973016|NCT00306293|19629646|P1|COMPLETED|Period 1 (Day 1 to Day 60)||27
7973017|NCT00306293|19629645|P2|STARTED|Period 1 (Day 1 to Day 60)||35
7973018|NCT00306293|19629646|P1|STARTED|Period 1 (Day 1 to Day 60)||35
7973019|NCT00306202|19629667|P3|NOT COMPLETED|Overall Study||0
7973020|NCT00306202|19629668|P2|NOT COMPLETED|Overall Study||0
7973021|NCT00306202|19629669|P1|NOT COMPLETED|Overall Study||0
7973022|NCT00306202|19629667|P3|COMPLETED|Overall Study|Completed = Off-treatment|24
7973023|NCT00306202|19629668|P2|COMPLETED|Overall Study|Completed = Off-treatment|17
7973024|NCT00306202|19629669|P1|COMPLETED|Overall Study|Completed = Off-treatment|17
7973025|NCT00306202|19629667|P3|STARTED|Overall Study|Started = Treated. 25 were enrolled; 1 no longer met study criteria and was never treated|24
7973026|NCT00306202|19629668|P2|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17
7973027|NCT00306202|19629669|P1|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17
7973028|NCT00306189|19629829|P4|NOT COMPLETED|Overall Study||5
7973029|NCT00306189|19629830|P3|NOT COMPLETED|Overall Study||11
7973030|NCT00306189|19629831|P2|NOT COMPLETED|Overall Study||6
7973031|NCT00306189|19629832|P1|NOT COMPLETED|Overall Study||9
7973032|NCT00306189|19629829|P4|COMPLETED|Overall Study||52
7973033|NCT00306189|19629830|P3|COMPLETED|Overall Study||45
7973034|NCT00306189|19629831|P2|COMPLETED|Overall Study||50
7973035|NCT00306189|19629832|P1|COMPLETED|Overall Study||48
7973036|NCT00306189|19629829|P4|STARTED|Overall Study||57
7973037|NCT00306189|19629830|P3|STARTED|Overall Study||56
7973038|NCT00306189|19629831|P2|STARTED|Overall Study||56
7973039|NCT00306189|19629832|P1|STARTED|Overall Study||57
7973040|NCT00306163|19629844|P2|NOT COMPLETED|Overall Study||0
7973041|NCT00306163|19629845|P1|NOT COMPLETED|Overall Study||0
7973042|NCT00306163|19629844|P2|COMPLETED|Overall Study||18
7973043|NCT00306163|19629845|P1|COMPLETED|Overall Study||19
7973044|NCT00306163|19629844|P2|STARTED|Overall Study||18
7973045|NCT00306163|19629845|P1|STARTED|Overall Study||19
7973046|NCT00305942|19629851|P1|NOT COMPLETED|Overall Study||38
7973047|NCT00305942|19629851|P1|COMPLETED|Overall Study||23
7973048|NCT00305942|19629851|P1|STARTED|Overall Study||61
7973049|NCT00305877|19629859|P2|NOT COMPLETED|Overall Study||34
7973050|NCT00305877|19629860|P1|NOT COMPLETED|Overall Study||24
7973051|NCT00305877|19629859|P2|COMPLETED|Overall Study||34
7973052|NCT00305877|19629860|P1|COMPLETED|Overall Study||45
7973053|NCT00305877|19629859|P2|Included in Efficacy Analysis|Overall Study||62
7973054|NCT00305877|19629860|P1|Included in Efficacy Analysis|Overall Study||65
7973055|NCT00305877|19629859|P2|Eligible|Overall Study||66
7973056|NCT00305877|19629860|P1|Eligible|Overall Study||66
7973057|NCT00305877|19629859|P2|Treated|Overall Study||63
7973058|NCT00305877|19629860|P1|Treated|Overall Study||67
7973059|NCT00305877|19629859|P2|STARTED|Overall Study||68
7973060|NCT00305877|19629860|P1|STARTED|Overall Study||69
7973061|NCT00305864|19629874|P4|NOT COMPLETED|Overall Study||13
7973062|NCT00305864|19629875|P3|NOT COMPLETED|Overall Study||1
7973063|NCT00305864|19629876|P2|NOT COMPLETED|Overall Study||1
7973064|NCT00305864|19629877|P1|NOT COMPLETED|Overall Study||0
7973065|NCT00305864|19629874|P4|COMPLETED|Overall Study||81
7973066|NCT00305864|19629875|P3|COMPLETED|Overall Study||6
7973067|NCT00305864|19629876|P2|COMPLETED|Overall Study||9
7973068|NCT00305864|19629877|P1|COMPLETED|Overall Study||7
7973069|NCT00305864|19629874|P4|STARTED|Overall Study||94
7973070|NCT00305864|19629875|P3|STARTED|Overall Study||7
7973071|NCT00305864|19629876|P2|STARTED|Overall Study||10
7973072|NCT00305864|19629877|P1|STARTED|Overall Study||7
7973073|NCT00305773|19629890|P2|NOT COMPLETED|Overall Study||18
7973074|NCT00305773|19629891|P1|NOT COMPLETED|Overall Study||14
7973075|NCT00305773|19629890|P2|COMPLETED|Overall Study||4
7973076|NCT00305773|19629891|P1|COMPLETED|Overall Study||1
7973077|NCT00305773|19629890|P2|STARTED|Overall Study||22
7973078|NCT00305773|19629891|P1|STARTED|Overall Study||15
7973079|NCT00305760|19629905|P1|NOT COMPLETED|Overall Study||47
7973080|NCT00305760|19629905|P1|COMPLETED|Overall Study||13
7973081|NCT00305760|19629905|P1|STARTED|Overall Study||60
7973082|NCT00305695|19629911|P2|NOT COMPLETED|Overall Study||27
7973083|NCT00305695|19629912|P1|NOT COMPLETED|Overall Study||41
7973084|NCT00305695|19629911|P2|COMPLETED|Overall Study||52
7973085|NCT00305695|19629912|P1|COMPLETED|Overall Study||40
7973086|NCT00305695|19629911|P2|STARTED|Overall Study||79
7973087|NCT00305695|19629912|P1|STARTED|Overall Study||81
7973088|NCT00305682|19629930|P6|NOT COMPLETED|Overall Study||0
7973089|NCT00305682|19629931|P5|NOT COMPLETED|Overall Study||0
7973090|NCT00305682|19629932|P4|NOT COMPLETED|Overall Study||0
7973091|NCT00305682|19629933|P3|NOT COMPLETED|Overall Study||0
7973092|NCT00305682|19629934|P2|NOT COMPLETED|Overall Study||0
7973093|NCT00305682|19629935|P1|NOT COMPLETED|Overall Study||0
7973094|NCT00305682|19629930|P6|COMPLETED|Overall Study||35
7973095|NCT00305682|19629931|P5|COMPLETED|Overall Study||39
7973096|NCT00305682|19629932|P4|COMPLETED|Overall Study||34
7973097|NCT00305682|19629933|P3|COMPLETED|Overall Study||7
7973098|NCT00305682|19629934|P2|COMPLETED|Overall Study||71
7973099|NCT00305682|19629935|P1|COMPLETED|Overall Study||98
7973100|NCT00305682|19629930|P6|STARTED|Overall Study||35
7973101|NCT00305682|19629931|P5|STARTED|Overall Study||39
7973102|NCT00305682|19629932|P4|STARTED|Overall Study||34
7973103|NCT00305682|19629933|P3|STARTED|Overall Study||7
7973104|NCT00305682|19629934|P2|STARTED|Overall Study||71
7973105|NCT00305682|19629935|P1|STARTED|Overall Study||98
7973106|NCT00305643|19630035|P2|NOT COMPLETED|Overall Study||0
7973107|NCT00305643|19630036|P1|NOT COMPLETED|Overall Study||0
7973108|NCT00305643|19630035|P2|COMPLETED|Overall Study||5
7973109|NCT00305643|19630036|P1|COMPLETED|Overall Study||6
7973110|NCT00305643|19630035|P2|STARTED|Overall Study||5
7973111|NCT00305643|19630036|P1|STARTED|Overall Study||6
7973112|NCT00305604|19630046|P2|NOT COMPLETED|Overall Study||47
7973113|NCT00305604|19630047|P1|NOT COMPLETED|Overall Study||32
7973114|NCT00305604|19630046|P2|COMPLETED|Overall Study||57
7973115|NCT00305604|19630047|P1|COMPLETED|Overall Study||70
7973116|NCT00305604|19630046|P2|STARTED|Overall Study||104
7973117|NCT00305604|19630047|P1|STARTED|Overall Study||102
7973118|NCT00305578|19630061|P2|NOT COMPLETED|Overall Study||2
7973119|NCT00305578|19630062|P1|NOT COMPLETED|Overall Study||3
7973120|NCT00305578|19630061|P2|COMPLETED|Overall Study||12
7973121|NCT00305578|19630062|P1|COMPLETED|Overall Study||12
7973122|NCT00305578|19630061|P2|STARTED|Overall Study||14
7973123|NCT00305578|19630062|P1|STARTED|Overall Study||15
7973124|NCT00305565|19630071|P3|NOT COMPLETED|Overall Study (ITT Population)||5
7973125|NCT00305565|19630072|P2|NOT COMPLETED|Overall Study (ITT Population)||11
7973126|NCT00305565|19630073|P1|NOT COMPLETED|Overall Study (ITT Population)||13
7973127|NCT00305565|19630071|P3|COMPLETED|Overall Study (ITT Population)||102
7973128|NCT00305565|19630072|P2|COMPLETED|Overall Study (ITT Population)||90
7973129|NCT00305565|19630073|P1|COMPLETED|Overall Study (ITT Population)||89
7973130|NCT00305565|19630071|P3|STARTED|Overall Study (ITT Population)||107
7973131|NCT00305565|19630072|P2|STARTED|Overall Study (ITT Population)||101
7973132|NCT00305565|19630073|P1|STARTED|Overall Study (ITT Population)||102
7973133|NCT00305565|19630071|P3|NOT COMPLETED|Overall Study (Safety Population)||7
7973134|NCT00305565|19630072|P2|NOT COMPLETED|Overall Study (Safety Population)||12
7973135|NCT00305565|19630073|P1|NOT COMPLETED|Overall Study (Safety Population)||14
7973136|NCT00305565|19630071|P3|COMPLETED|Overall Study (Safety Population)||106
7973137|NCT00305565|19630072|P2|COMPLETED|Overall Study (Safety Population)||95
7973138|NCT00305565|19630073|P1|COMPLETED|Overall Study (Safety Population)||97
7973139|NCT00305565|19630071|P3|STARTED|Overall Study (Safety Population)||113
7973140|NCT00305565|19630072|P2|STARTED|Overall Study (Safety Population)||107
7973141|NCT00305565|19630073|P1|STARTED|Overall Study (Safety Population)||111
7973142|NCT00305448|19630191|P3|NOT COMPLETED|Overall Study||33
7973143|NCT00305448|19630192|P2|NOT COMPLETED|Overall Study||34
7973144|NCT00305448|19630193|P1|NOT COMPLETED|Overall Study||31
7973145|NCT00305448|19630191|P3|COMPLETED|Overall Study||14
7973146|NCT00305448|19630192|P2|COMPLETED|Overall Study||17
7973147|NCT00305448|19630193|P1|COMPLETED|Overall Study||14
7973148|NCT00305448|19630191|P3|STARTED|Overall Study||47
7973149|NCT00305448|19630192|P2|STARTED|Overall Study||51
7973150|NCT00305448|19630193|P1|STARTED|Overall Study||45
7973151|NCT00305344|19630209|P1|NOT COMPLETED|Overall Study||0
7973152|NCT00305344|19630209|P1|COMPLETED|Overall Study||23
7973153|NCT00305344|19630209|P1|STARTED|Overall Study||23
7973154|NCT00305253|19630215|P2|NOT COMPLETED|Overall Study||1
7973155|NCT00305253|19630216|P1|NOT COMPLETED|Overall Study||0
7973156|NCT00305253|19630215|P2|COMPLETED|Overall Study||558
7973157|NCT00305253|19630216|P1|COMPLETED|Overall Study||432
7973158|NCT00305253|19630215|P2|STARTED|Overall Study||559
7973159|NCT00305253|19630216|P1|STARTED|Overall Study||432
7973160|NCT00305227|19630228|P2|NOT COMPLETED|Overall Study||6
7973161|NCT00305227|19630229|P1|NOT COMPLETED|Overall Study||7
7973162|NCT00305227|19630228|P2|COMPLETED|Overall Study|with at least 8 weeks of observation|44
7973163|NCT00305227|19630229|P1|COMPLETED|Overall Study|with at least 8 weeks of observation|43
7973164|NCT00305227|19630228|P2|STARTED|Overall Study||50
7973165|NCT00305227|19630229|P1|STARTED|Overall Study||50
7973166|NCT00305162|19630237|P2|NOT COMPLETED|1 Year Follow-up Period||65
7973167|NCT00305162|19630238|P1|NOT COMPLETED|1 Year Follow-up Period||55
7973168|NCT00305162|19630237|P2|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382
7973169|NCT00305162|19630238|P1|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380
7973170|NCT00305162|19630237|P2|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444
7973171|NCT00305162|19630238|P1|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446
7973172|NCT00305162|19630237|P2|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818
7973173|NCT00305162|19630238|P1|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851
7973174|NCT00305162|19630237|P2|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504
7973175|NCT00305162|19630238|P1|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480
7973176|NCT00305162|19630237|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878
7973177|NCT00305162|19630238|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900
7973178|NCT00305162|19630237|P2|STARTED|1 Year Follow-up Period||4447
7973179|NCT00305162|19630238|P1|STARTED|1 Year Follow-up Period||4435
7973180|NCT00305162|19630237|P2|NOT COMPLETED|30-day Follow-up Period||63
7973181|NCT00305162|19630238|P1|NOT COMPLETED|30-day Follow-up Period||62
7973182|NCT00305162|19630237|P2|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384
7973183|NCT00305162|19630238|P1|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373
7973184|NCT00305162|19630237|P2|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444
7973185|NCT00305162|19630238|P1|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438
7973186|NCT00305162|19630237|P2|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827
7973187|NCT00305162|19630238|P1|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860
7973188|NCT00305162|19630237|P2|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501
7973189|NCT00305162|19630238|P1|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471
7973190|NCT00305162|19630237|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883
7973191|NCT00305162|19630238|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902
7973192|NCT00305162|19630237|P2|STARTED|30-day Follow-up Period||4447
7973193|NCT00305162|19630238|P1|STARTED|30-day Follow-up Period||4435
7973194|NCT00305162|19630237|P2|NOT COMPLETED|48 Hour Follow-up Period||16
7973195|NCT00305162|19630238|P1|NOT COMPLETED|48 Hour Follow-up Period||20
7973196|NCT00305162|19630237|P2|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431
7973197|NCT00305162|19630238|P1|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415
7973198|NCT00305162|19630237|P2|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365
7973199|NCT00305162|19630238|P1|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374
7973200|NCT00305162|19630237|P2|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447
7973201|NCT00305162|19630238|P1|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446
7973202|NCT00305162|19630237|P2|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865
7973203|NCT00305162|19630238|P1|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889
7973204|NCT00305162|19630237|P2|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507
7973205|NCT00305162|19630238|P1|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482
7973206|NCT00305162|19630237|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924
7973207|NCT00305162|19630238|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933
7973208|NCT00305162|19630237|P2|STARTED|48 Hour Follow-up Period||4447
7973209|NCT00305162|19630238|P1|STARTED|48 Hour Follow-up Period||4435
7973210|NCT00305110|19630276|P1|NOT COMPLETED|Overall Study||29
7973211|NCT00305110|19630276|P1|COMPLETED|Overall Study||269
7973212|NCT00305110|19630276|P1|All Necessary Data Collected|Overall Study||269
7973213|NCT00305110|19630276|P1|STARTED|Overall Study||298
7973214|NCT00305084|19630290|P5|NOT COMPLETED|Overall Study||0
7973215|NCT00305084|19630291|P4|NOT COMPLETED|Overall Study||0
7973216|NCT00305084|19630292|P3|NOT COMPLETED|Overall Study||0
7973217|NCT00305084|19630293|P2|NOT COMPLETED|Overall Study||0
7973218|NCT00305084|19630294|P1|NOT COMPLETED|Overall Study||0
7973219|NCT00305084|19630290|P5|COMPLETED|Overall Study||3
7973220|NCT00305084|19630291|P4|COMPLETED|Overall Study||3
7973221|NCT00305084|19630292|P3|COMPLETED|Overall Study||3
7973222|NCT00305084|19630293|P2|COMPLETED|Overall Study||3
7973223|NCT00305084|19630294|P1|COMPLETED|Overall Study||3
7973224|NCT00305084|19630290|P5|STARTED|Overall Study||3
7973225|NCT00305084|19630291|P4|STARTED|Overall Study||3
7973226|NCT00305084|19630292|P3|STARTED|Overall Study||3
7973227|NCT00305084|19630293|P2|STARTED|Overall Study||3
7973228|NCT00305084|19630294|P1|STARTED|Overall Study||3
7973229|NCT00305058|19630349|P2|NOT COMPLETED|Overall Study||4
7973230|NCT00305058|19630350|P1|NOT COMPLETED|Overall Study||7
7973231|NCT00305058|19630349|P2|COMPLETED|Overall Study||93
7973232|NCT00305058|19630350|P1|COMPLETED|Overall Study||90
7973233|NCT00305058|19630349|P2|Data Collection Forms Filed for Analysis|Overall Study||93
7973234|NCT00305058|19630350|P1|Data Collection Forms Filed for Analysis|Overall Study||90
7973235|NCT00305058|19630349|P2|All Outcome Data Collected|Overall Study||95
7973236|NCT00305058|19630350|P1|All Outcome Data Collected|Overall Study||93
7973237|NCT00305058|19630349|P2|Inclusion/Exclusion Verification|Overall Study||97
7973238|NCT00305058|19630350|P1|Inclusion/Exclusion Verification|Overall Study||96
7973239|NCT00305058|19630349|P2|STARTED|Overall Study||97
7973240|NCT00305058|19630350|P1|STARTED|Overall Study||97
7973241|NCT00304954|19630366|P4|NOT COMPLETED|Overall Study||0
7973242|NCT00304954|19630367|P3|NOT COMPLETED|Overall Study||1
7973243|NCT00304954|19630368|P2|NOT COMPLETED|Overall Study||0
7973244|NCT00304954|19630369|P1|NOT COMPLETED|Overall Study||1
7973245|NCT00304954|19630366|P4|COMPLETED|Overall Study||3
7973246|NCT00304954|19630367|P3|COMPLETED|Overall Study||2
7973247|NCT00304954|19630368|P2|COMPLETED|Overall Study||3
7973248|NCT00304954|19630369|P1|COMPLETED|Overall Study||3
7973249|NCT00304954|19630366|P4|STARTED|Overall Study||3
7973250|NCT00304954|19630367|P3|STARTED|Overall Study||3
7973251|NCT00304954|19630368|P2|STARTED|Overall Study||3
7973252|NCT00304954|19630369|P1|STARTED|Overall Study||4
7973253|NCT00304915|19630389|P2|NOT COMPLETED|Overall Study||16
7973254|NCT00304915|19630390|P1|NOT COMPLETED|Overall Study||18
7973255|NCT00304915|19630389|P2|COMPLETED|Overall Study||110
7973256|NCT00304915|19630390|P1|COMPLETED|Overall Study||105
7973257|NCT00304915|19630389|P2|STARTED|Overall Study||126
7973258|NCT00304915|19630390|P1|STARTED|Overall Study||123
7973259|NCT00304746|19630398|P2|NOT COMPLETED|Overall Study||0
7973260|NCT00304746|19630399|P1|NOT COMPLETED|Overall Study||0
7973261|NCT00304746|19630398|P2|COMPLETED|Overall Study||50
7973262|NCT00304746|19630399|P1|COMPLETED|Overall Study||50
7973263|NCT00304746|19630398|P2|STARTED|Overall Study||50
7973264|NCT00304746|19630399|P1|STARTED|Overall Study||50
7973265|NCT00304707|19630409|P2|NOT COMPLETED|Overall Study||6
7973266|NCT00304707|19630410|P1|NOT COMPLETED|Overall Study||7
7973267|NCT00304707|19630409|P2|COMPLETED|Overall Study||64
7973268|NCT00304707|19630410|P1|COMPLETED|Overall Study||66
7973269|NCT00304707|19630409|P2|STARTED|Overall Study||70
7973270|NCT00304707|19630410|P1|STARTED|Overall Study||73
7973271|NCT00304512|19630419|P3|NOT COMPLETED|Extension Period||0
7973272|NCT00304512|19630420|P2|NOT COMPLETED|Extension Period||0
7973273|NCT00304512|19630421|P1|NOT COMPLETED|Extension Period||0
7973274|NCT00304512|19630419|P3|COMPLETED|Extension Period||3
7973275|NCT00304512|19630420|P2|COMPLETED|Extension Period||4
7973276|NCT00304512|19630421|P1|COMPLETED|Extension Period||2
7973277|NCT00304512|19630419|P3|STARTED|Extension Period||3
7973278|NCT00304512|19630420|P2|STARTED|Extension Period||4
7973279|NCT00304512|19630421|P1|STARTED|Extension Period||2
7973280|NCT00304512|19630419|P3|NOT COMPLETED|Treatment Period||0
7973281|NCT00304512|19630420|P2|NOT COMPLETED|Treatment Period||0
7973282|NCT00304512|19630421|P1|NOT COMPLETED|Treatment Period||0
7973283|NCT00304512|19630419|P3|COMPLETED|Treatment Period||3
7973284|NCT00304512|19630420|P2|COMPLETED|Treatment Period||4
7973285|NCT00304512|19630421|P1|COMPLETED|Treatment Period||2
7973286|NCT00304512|19630419|P3|Pharmacodynamic (PD) Population|Treatment Period||3
7973287|NCT00304512|19630420|P2|Pharmacodynamic (PD) Population|Treatment Period||4
7973288|NCT00304512|19630421|P1|Pharmacodynamic (PD) Population|Treatment Period||2
7973289|NCT00304512|19630419|P3|Pharmacokinetic (PK) Population|Treatment Period||3
7973290|NCT00304512|19630420|P2|Pharmacokinetic (PK) Population|Treatment Period||4
7973291|NCT00304512|19630421|P1|Pharmacokinetic (PK) Population|Treatment Period||2
7973292|NCT00304512|19630419|P3|Safety Population|Treatment Period||3
7973293|NCT00304512|19630420|P2|Safety Population|Treatment Period||4
7973294|NCT00304512|19630421|P1|Safety Population|Treatment Period||2
7973295|NCT00304512|19630419|P3|STARTED|Treatment Period||3
7973296|NCT00304512|19630420|P2|STARTED|Treatment Period||4
7973297|NCT00304512|19630421|P1|STARTED|Treatment Period||2
7973298|NCT00304356|19630435|P1|NOT COMPLETED|Nitazoxanide||5
7973299|NCT00304356|19630435|P1|COMPLETED|Nitazoxanide||22
7973300|NCT00304356|19630435|P1|STARTED|Nitazoxanide||27
7973301|NCT00304356|19630435|P1|NOT COMPLETED|Nitazoxanide||5
7973302|NCT00304356|19630435|P1|COMPLETED|Nitazoxanide||22
7973303|NCT00304356|19630435|P1|STARTED|Nitazoxanide||27
7973304|NCT00304278|19630439|P1|NOT COMPLETED|Overall Study||2
7973305|NCT00304278|19630439|P1|COMPLETED|Overall Study||19
7973306|NCT00304278|19630439|P1|STARTED|Overall Study||21
7973307|NCT00304265|19630446|P2|NOT COMPLETED|Overall Study||0
7973308|NCT00304265|19630447|P1|NOT COMPLETED|Overall Study||0
7973309|NCT00304265|19630446|P2|COMPLETED|Overall Study||98
7973310|NCT00304265|19630447|P1|COMPLETED|Overall Study||117
7973311|NCT00304265|19630446|P2|STARTED|Overall Study||98
7973312|NCT00304265|19630447|P1|STARTED|Overall Study||117
7973313|NCT00304187|19630455|P2|NOT COMPLETED|Overall Study||1
7973314|NCT00304187|19630456|P1|NOT COMPLETED|Overall Study||2
7973315|NCT00304187|19630455|P2|COMPLETED|Overall Study||13
7973316|NCT00304187|19630456|P1|COMPLETED|Overall Study||13
7973317|NCT00304187|19630455|P2|STARTED|Overall Study||14
7973318|NCT00304187|19630456|P1|STARTED|Overall Study||15
7973319|NCT00304161|19630466|P2|NOT COMPLETED|Overall Study||6
7973320|NCT00304161|19630467|P1|NOT COMPLETED|Overall Study||6
7973321|NCT00304161|19630466|P2|COMPLETED|Overall Study||21
7973322|NCT00304161|19630467|P1|COMPLETED|Overall Study||22
7973323|NCT00304161|19630466|P2|STARTED|Overall Study||27
7973324|NCT00304161|19630467|P1|STARTED|Overall Study||28
7973325|NCT00304096|19630477|P2|NOT COMPLETED|Overall Study||0
7973326|NCT00304096|19630478|P1|NOT COMPLETED|Overall Study||0
7973327|NCT00304096|19630477|P2|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5
7973328|NCT00304096|19630478|P1|COMPLETED|Overall Study||6
7973329|NCT00304096|19630477|P2|STARTED|Overall Study||5
7973330|NCT00304096|19630478|P1|STARTED|Overall Study||6
7973331|NCT00304083|19630488|P2|NOT COMPLETED|Overall Study||8
7973332|NCT00304083|19630489|P1|NOT COMPLETED|Overall Study||22
7973333|NCT00304083|19630488|P2|COMPLETED|Overall Study||6
7973334|NCT00304083|19630489|P1|COMPLETED|Overall Study||12
7973335|NCT00304083|19630488|P2|Patients Had Neither RT or Surgery|Overall Study||1
7973336|NCT00304083|19630489|P1|Patients Had Neither RT or Surgery|Overall Study||6
7973337|NCT00304083|19630488|P2|Patients Treated With RT Only|Overall Study||2
7973338|NCT00304083|19630489|P1|Patients Treated With RT Only|Overall Study||4
7973339|NCT00304083|19630488|P2|Patients Treated With Surgery and RT|Overall Study||1
7973340|NCT00304083|19630489|P1|Patients Treated With Surgery and RT|Overall Study||5
7973341|NCT00304083|19630488|P2|Patients Treated With Surgery|Overall Study||3
7973342|NCT00304083|19630489|P1|Patients Treated With Surgery|Overall Study||7
7973343|NCT00304083|19630488|P2|Completed 4 Cycles|Overall Study||7
7973344|NCT00304083|19630489|P1|Completed 4 Cycles|Overall Study||22
7973345|NCT00304083|19630488|P2|STARTED|Overall Study||14
7973346|NCT00304083|19630489|P1|STARTED|Overall Study||34
7973347|NCT00304070|19630508|P3|NOT COMPLETED|Overall Study||12
7973348|NCT00304070|19630509|P2|NOT COMPLETED|Overall Study||7
7973349|NCT00304070|19630510|P1|NOT COMPLETED|Overall Study||3
7973350|NCT00304070|19630508|P3|COMPLETED|Overall Study||27
7973351|NCT00304070|19630509|P2|COMPLETED|Overall Study||8
7973352|NCT00304070|19630510|P1|COMPLETED|Overall Study||21
7973353|NCT00304070|19630508|P3|STARTED|Overall Study||39
7973354|NCT00304070|19630509|P2|STARTED|Overall Study||15
7973355|NCT00304070|19630510|P1|STARTED|Overall Study||24
7973356|NCT00304031|19630525|P3|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2
7973357|NCT00304031|19630526|P2|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
7973358|NCT00304031|19630527|P1|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
7973359|NCT00304031|19630525|P3|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|420
7973360|NCT00304031|19630526|P2|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|411
7973361|NCT00304031|19630527|P1|COMPLETED|Randomization to Adjuvant TMZ Arm||0
7973362|NCT00304031|19630525|P3|Quality of Life Population|Randomization to Adjuvant TMZ Arm||95
7973363|NCT00304031|19630526|P2|Quality of Life Population|Randomization to Adjuvant TMZ Arm||96
7973364|NCT00304031|19630527|P1|Quality of Life Population|Randomization to Adjuvant TMZ Arm||0
7973365|NCT00304031|19630525|P3|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
7973366|NCT00304031|19630526|P2|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
7973367|NCT00304031|19630527|P1|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
7973368|NCT00304031|19630525|P3|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||262
7973369|NCT00304031|19630526|P2|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||254
7973370|NCT00304031|19630527|P1|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
7973371|NCT00304031|19630525|P3|Eligible Population|Randomization to Adjuvant TMZ Arm||420
7973372|NCT00304031|19630526|P2|Eligible Population|Randomization to Adjuvant TMZ Arm||411
7973373|NCT00304031|19630527|P1|Eligible Population|Randomization to Adjuvant TMZ Arm||0
7973374|NCT00304031|19630525|P3|STARTED|Randomization to Adjuvant TMZ Arm||422
7973375|NCT00304031|19630526|P2|STARTED|Randomization to Adjuvant TMZ Arm||411
7973376|NCT00304031|19630527|P1|STARTED|Randomization to Adjuvant TMZ Arm||0
7973377|NCT00304031|19630525|P3|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
7973378|NCT00304031|19630526|P2|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
7973379|NCT00304031|19630527|P1|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||292
7973380|NCT00304031|19630525|P3|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
7973381|NCT00304031|19630526|P2|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
7973382|NCT00304031|19630527|P1|COMPLETED|Concomitant RT+TMZ (Pre-randomization)|These participants completed concomitant treatment and met requirements for randomization.|833
7973383|NCT00304031|19630525|P3|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
7973384|NCT00304031|19630526|P2|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
7973385|NCT00304031|19630527|P1|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||1120
7973386|NCT00304031|19630525|P3|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
7973387|NCT00304031|19630526|P2|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
7973388|NCT00304031|19630527|P1|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||1125
7973389|NCT00304031|19630525|P3|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
7973390|NCT00304031|19630526|P2|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
7973391|NCT00304031|19630527|P1|STARTED|Concomitant RT+TMZ (Pre-randomization)|All participants registered to concomitant treatment; randomized after completing this treatment.|1125
7973392|NCT00303979|19630580|P3|NOT COMPLETED|Overall Study||0
7973393|NCT00303979|19630581|P2|NOT COMPLETED|Overall Study||0
7973394|NCT00303979|19630582|P1|NOT COMPLETED|Overall Study||7572
7973395|NCT00303979|19630580|P3|COMPLETED|Overall Study|at 18 months|9641
7973396|NCT00303979|19630581|P2|COMPLETED|Overall Study|at 6 months|9992
7973397|NCT00303979|19630582|P1|COMPLETED|Overall Study|at 24 Months|7605
7973398|NCT00303979|19630580|P3|STARTED|Overall Study|at 18 months|9641
7973399|NCT00303979|19630581|P2|STARTED|Overall Study|at 6 months|9992
7973400|NCT00303979|19630582|P1|STARTED|Overall Study|at baseline|15177
7973401|NCT00303966|19630600|P1|NOT COMPLETED|Overall Study||0
7973402|NCT00303966|19630600|P1|COMPLETED|Overall Study||5
7973403|NCT00303966|19630600|P1|STARTED|Overall Study||5
7973404|NCT00303953|19630609|P1|NOT COMPLETED|Overall Study||19
7973405|NCT00303953|19630609|P1|COMPLETED|Overall Study||3
7973406|NCT00303953|19630609|P1|Eligible and Treated|Overall Study||20
7973407|NCT00303953|19630609|P1|Eligible|Overall Study||21
7973408|NCT00303953|19630609|P1|STARTED|Overall Study||22
7973409|NCT00303901|19630615|P1|NOT COMPLETED|Overall Study||0
7973410|NCT00303901|19630615|P1|COMPLETED|Overall Study||40
7973411|NCT00303901|19630615|P1|STARTED|Overall Study||40
7973412|NCT00303862|19630621|P1|NOT COMPLETED|Overall Study||0
7973413|NCT00303862|19630621|P1|COMPLETED|Overall Study||10
7973414|NCT00303862|19630621|P1|STARTED|Overall Study||10
7973415|NCT00303823|19630630|P2|NOT COMPLETED|Overall Study||10
7973416|NCT00303823|19630631|P1|NOT COMPLETED|Overall Study||15
7973417|NCT00303823|19630630|P2|COMPLETED|Overall Study||38
7973418|NCT00303823|19630631|P1|COMPLETED|Overall Study||35
7973419|NCT00303823|19630630|P2|STARTED|Overall Study||48
7973420|NCT00303823|19630631|P1|STARTED|Overall Study||50
7973421|NCT00303719|19630645|P2|NOT COMPLETED|Overall Study||37
7973422|NCT00303719|19630646|P1|NOT COMPLETED|Overall Study||0
7973423|NCT00303719|19630645|P2|COMPLETED|Overall Study||292
7973424|NCT00303719|19630646|P1|COMPLETED|Overall Study||13
7973425|NCT00303719|19630645|P2|STARTED|Overall Study||329
7973426|NCT00303719|19630646|P1|STARTED|Overall Study||13
7973427|NCT00303667|19630662|P2|NOT COMPLETED|Overall Study||4
7973428|NCT00303667|19630663|P1|NOT COMPLETED|Overall Study||0
7973429|NCT00303667|19630662|P2|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35
7973430|NCT00303667|19630663|P1|COMPLETED|Overall Study||8
7973431|NCT00303667|19630662|P2|STARTED|Overall Study||39
7973432|NCT00303667|19630663|P1|STARTED|Overall Study||8
7973433|NCT00303628|19630687|P2|NOT COMPLETED|Overall Study||73
7973434|NCT00303628|19630688|P1|NOT COMPLETED|Overall Study||50
7973435|NCT00303628|19630687|P2|COMPLETED|Overall Study||106
7973436|NCT00303628|19630688|P1|COMPLETED|Overall Study||126
7973437|NCT00303628|19630687|P2|Treated|Overall Study||174
7973438|NCT00303628|19630688|P1|Treated|Overall Study||173
7973439|NCT00303628|19630687|P2|Eligible|Overall Study||177
7973440|NCT00303628|19630688|P1|Eligible|Overall Study||171
7973441|NCT00303628|19630687|P2|STARTED|Overall Study||179
7973442|NCT00303628|19630688|P1|STARTED|Overall Study||176
7973443|NCT00303602|19630706|P2|NOT COMPLETED|Overall Study||15
7973444|NCT00303602|19630707|P1|NOT COMPLETED|Overall Study||19
7973445|NCT00303602|19630706|P2|COMPLETED|Overall Study||50
7973446|NCT00303602|19630707|P1|COMPLETED|Overall Study||65
7973447|NCT00303602|19630706|P2|STARTED|Overall Study||65
7973448|NCT00303602|19630707|P1|STARTED|Overall Study||84
7973449|NCT00303511|19630747|P1|NOT COMPLETED|Overall Study||0
7973450|NCT00303511|19630747|P1|COMPLETED|Overall Study||10
7973451|NCT00303511|19630747|P1|STARTED|Overall Study||10
7973452|NCT00303485|19630753|P2|NOT COMPLETED|Overall Study||2
7973453|NCT00303485|19630754|P1|NOT COMPLETED|Overall Study||1
7973454|NCT00303485|19630753|P2|COMPLETED|Overall Study||15
7973455|NCT00303485|19630754|P1|COMPLETED|Overall Study||48
7973456|NCT00303485|19630753|P2|STARTED|Overall Study||17
7973457|NCT00303485|19630754|P1|STARTED|Overall Study||49
7973458|NCT00303472|19630785|P7|NOT COMPLETED|Treatment Extension (Optional)||0
7973459|NCT00303472|19630786|P6|NOT COMPLETED|Treatment Extension (Optional)||1
7973460|NCT00303472|19630787|P5|NOT COMPLETED|Treatment Extension (Optional)||4
7973461|NCT00303472|19630788|P4|NOT COMPLETED|Treatment Extension (Optional)||8
7973462|NCT00303472|19630789|P3|NOT COMPLETED|Treatment Extension (Optional)||9
7973463|NCT00303472|19630790|P2|NOT COMPLETED|Treatment Extension (Optional)||6
7973464|NCT00303472|19630791|P1|NOT COMPLETED|Treatment Extension (Optional)||5
7973465|NCT00303472|19630785|P7|COMPLETED|Treatment Extension (Optional)||1
7973466|NCT00303472|19630786|P6|COMPLETED|Treatment Extension (Optional)||4
7973467|NCT00303472|19630787|P5|COMPLETED|Treatment Extension (Optional)||1
7973468|NCT00303472|19630788|P4|COMPLETED|Treatment Extension (Optional)||5
7973469|NCT00303472|19630789|P3|COMPLETED|Treatment Extension (Optional)||2
7973470|NCT00303472|19630790|P2|COMPLETED|Treatment Extension (Optional)||5
7973471|NCT00303472|19630791|P1|COMPLETED|Treatment Extension (Optional)||1
7973472|NCT00303472|19630785|P7|STARTED|Treatment Extension (Optional)||1
7973473|NCT00303472|19630786|P6|STARTED|Treatment Extension (Optional)||5
7973474|NCT00303472|19630787|P5|STARTED|Treatment Extension (Optional)||5
7973475|NCT00303472|19630788|P4|STARTED|Treatment Extension (Optional)||13
7973476|NCT00303472|19630789|P3|STARTED|Treatment Extension (Optional)||11
7973477|NCT00303472|19630790|P2|STARTED|Treatment Extension (Optional)||11
7973478|NCT00303472|19630791|P1|STARTED|Treatment Extension (Optional)||6
7973479|NCT00303472|19630785|P7|NOT COMPLETED|Treatment Period||2
7973480|NCT00303472|19630786|P6|NOT COMPLETED|Treatment Period||1
7973481|NCT00303472|19630787|P5|NOT COMPLETED|Treatment Period||3
7973482|NCT00303472|19630788|P4|NOT COMPLETED|Treatment Period||2
7973483|NCT00303472|19630789|P3|NOT COMPLETED|Treatment Period||0
7973484|NCT00303472|19630790|P2|NOT COMPLETED|Treatment Period||0
7973485|NCT00303472|19630791|P1|NOT COMPLETED|Treatment Period||0
7973486|NCT00303472|19630785|P7|COMPLETED|Treatment Period||3
7973487|NCT00303472|19630786|P6|COMPLETED|Treatment Period||11
7973488|NCT00303472|19630787|P5|COMPLETED|Treatment Period||8
7973489|NCT00303472|19630788|P4|COMPLETED|Treatment Period||14
7973490|NCT00303472|19630789|P3|COMPLETED|Treatment Period||11
7973491|NCT00303472|19630790|P2|COMPLETED|Treatment Period||11
7973492|NCT00303472|19630791|P1|COMPLETED|Treatment Period||6
7973493|NCT00303472|19630785|P7|STARTED|Treatment Period||5
7973494|NCT00303472|19630786|P6|STARTED|Treatment Period||12
7973495|NCT00303472|19630787|P5|STARTED|Treatment Period||11
7973496|NCT00303472|19630788|P4|STARTED|Treatment Period||16
7973497|NCT00303472|19630789|P3|STARTED|Treatment Period||11
7973498|NCT00303472|19630790|P2|STARTED|Treatment Period||11
7973499|NCT00303472|19630791|P1|STARTED|Treatment Period||6
7973500|NCT00303459|19630851|P2|NOT COMPLETED|Overall Study||89
7973501|NCT00303459|19630852|P1|NOT COMPLETED|Overall Study||83
7973502|NCT00303459|19630851|P2|COMPLETED|Overall Study||86
7973503|NCT00303459|19630852|P1|COMPLETED|Overall Study||76
7973504|NCT00303459|19630851|P2|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175
7973505|NCT00303459|19630852|P1|STARTED|Overall Study||159
7973506|NCT00303446|19630878|P2|NOT COMPLETED|Overall Study||4
7973507|NCT00303446|19630879|P1|NOT COMPLETED|Overall Study||2
7973508|NCT00303446|19630878|P2|COMPLETED|Overall Study||21
7973509|NCT00303446|19630879|P1|COMPLETED|Overall Study||23
7973510|NCT00303446|19630878|P2|STARTED|Overall Study||25
7973511|NCT00303446|19630879|P1|STARTED|Overall Study||25
7973512|NCT00303329|19630915|P2|NOT COMPLETED|Overall Study||62
7973513|NCT00303329|19630916|P1|NOT COMPLETED|Overall Study||35
7973514|NCT00303329|19630915|P2|COMPLETED|Overall Study||37
7973515|NCT00303329|19630916|P1|COMPLETED|Overall Study||50
7973516|NCT00303329|19630915|P2|STARTED|Overall Study||99
7973517|NCT00303329|19630916|P1|STARTED|Overall Study||85
7973518|NCT00303316|19630930|P2|NOT COMPLETED|Overall Study||3
7973519|NCT00303316|19630931|P1|NOT COMPLETED|Overall Study||2
7973520|NCT00303316|19630930|P2|COMPLETED|Overall Study||223
7973521|NCT00303316|19630931|P1|COMPLETED|Overall Study||230
7973522|NCT00303316|19630930|P2|STARTED|Overall Study||226
7973523|NCT00303316|19630931|P1|STARTED|Overall Study||232
7973524|NCT00303186|19630943|P1|NOT COMPLETED|Overall Study||52
7973525|NCT00303186|19630943|P1|COMPLETED|Overall Study||55
7973526|NCT00303186|19630943|P1|STARTED|Overall Study||107
7973527|NCT00303108|19630977|P3|NOT COMPLETED|Overall Study||16
7973528|NCT00303108|19630978|P2|NOT COMPLETED|Overall Study||9
7973529|NCT00303108|19630979|P1|NOT COMPLETED|Overall Study||12
7973530|NCT00303108|19630977|P3|COMPLETED|Overall Study||31
7973531|NCT00303108|19630978|P2|COMPLETED|Overall Study||37
7973532|NCT00303108|19630979|P1|COMPLETED|Overall Study||31
7973533|NCT00303108|19630977|P3|STARTED|Overall Study||47
7973534|NCT00303108|19630978|P2|STARTED|Overall Study||46
7973535|NCT00303108|19630979|P1|STARTED|Overall Study||43
7973536|NCT00303069|19630999|P4|NOT COMPLETED|Overall Study||2
7973537|NCT00303069|19631000|P3|NOT COMPLETED|Overall Study||1
7973538|NCT00303069|19631001|P2|NOT COMPLETED|Overall Study||0
7973539|NCT00303069|19631002|P1|NOT COMPLETED|Overall Study||2
7973540|NCT00303069|19630999|P4|COMPLETED|Overall Study||29
7973541|NCT00303069|19631000|P3|COMPLETED|Overall Study||33
7973542|NCT00303069|19631001|P2|COMPLETED|Overall Study||28
7973543|NCT00303069|19631002|P1|COMPLETED|Overall Study||29
7973544|NCT00303069|19630999|P4|STARTED|Overall Study||31
7973545|NCT00303069|19631000|P3|STARTED|Overall Study||34
7973546|NCT00303069|19631001|P2|STARTED|Overall Study||28
7973547|NCT00303069|19631002|P1|STARTED|Overall Study||31
7973548|NCT00302952|19631022|P2|NOT COMPLETED|Overall Study||5
7973549|NCT00302952|19631023|P1|NOT COMPLETED|Overall Study||3
7973550|NCT00302952|19631022|P2|COMPLETED|Overall Study||25
7973551|NCT00302952|19631023|P1|COMPLETED|Overall Study||31
7973552|NCT00302952|19631022|P2|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29
7973553|NCT00302952|19631023|P1|Completed Intent-to-Treat (ITT)|Overall Study||34
7973554|NCT00302952|19631022|P2|Started Intent-to-Treat (ITT)|Overall Study||30
7973555|NCT00302952|19631023|P1|Started Intent-to-Treat (ITT)|Overall Study||34
7973556|NCT00302952|19631022|P2|STARTED|Overall Study||30
7973557|NCT00302952|19631023|P1|STARTED|Overall Study||34
7973558|NCT00302848|19631060|P3|NOT COMPLETED|Overall Study||579
7973559|NCT00302848|19631061|P2|NOT COMPLETED|Overall Study||419
7973560|NCT00302848|19631062|P1|NOT COMPLETED|Overall Study||401
7973561|NCT00302848|19631060|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762
7973562|NCT00302848|19631061|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009
7973563|NCT00302848|19631062|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133
7973564|NCT00302848|19631060|P3|STARTED|Overall Study||26341
7973565|NCT00302848|19631061|P2|STARTED|Overall Study||15428
7973566|NCT00302848|19631062|P1|STARTED|Overall Study||16534
7973567|NCT00302731|19631073|P4|NOT COMPLETED|Overall Study||0
7973568|NCT00302731|19631074|P3|NOT COMPLETED|Overall Study||3
7973569|NCT00302731|19631075|P2|NOT COMPLETED|Overall Study||5
7973570|NCT00302731|19631076|P1|NOT COMPLETED|Overall Study||4
7973571|NCT00302731|19631073|P4|COMPLETED|Overall Study||4
7973572|NCT00302731|19631074|P3|COMPLETED|Overall Study||2
7973573|NCT00302731|19631075|P2|COMPLETED|Overall Study||1
7973574|NCT00302731|19631076|P1|COMPLETED|Overall Study||2
7973575|NCT00302731|19631073|P4|STARTED|Overall Study||4
7973576|NCT00302731|19631074|P3|STARTED|Overall Study||5
7973577|NCT00302731|19631075|P2|STARTED|Overall Study||6
7973578|NCT00302731|19631076|P1|STARTED|Overall Study||6
7973579|NCT00302718|19631102|P4|NOT COMPLETED|Overall Study||2
7973580|NCT00302718|19631103|P3|NOT COMPLETED|Overall Study||2
7973581|NCT00302718|19631104|P2|NOT COMPLETED|Overall Study||1
7973582|NCT00302718|19631105|P1|NOT COMPLETED|Overall Study||1
7973583|NCT00302718|19631102|P4|COMPLETED|Overall Study||19
7973584|NCT00302718|19631103|P3|COMPLETED|Overall Study||19
7973585|NCT00302718|19631104|P2|COMPLETED|Overall Study||20
7973586|NCT00302718|19631105|P1|COMPLETED|Overall Study||19
7973587|NCT00302718|19631102|P4|STARTED|Overall Study||21
7973588|NCT00302718|19631103|P3|STARTED|Overall Study||21
7973589|NCT00302718|19631104|P2|STARTED|Overall Study||21
7973590|NCT00302718|19631105|P1|STARTED|Overall Study||20
7973591|NCT00302458|19631171|P1|NOT COMPLETED|Overall Study||3
7973592|NCT00302458|19631171|P1|COMPLETED|Overall Study||26
7973593|NCT00302458|19631171|P1|STARTED|Overall Study||29
7973594|NCT00302328|19631182|P3|NOT COMPLETED|Overall Study||0
7973595|NCT00302328|19631183|P2|NOT COMPLETED|Overall Study||1
7973596|NCT00302328|19631184|P1|NOT COMPLETED|Overall Study||0
7973597|NCT00302328|19631182|P3|COMPLETED|Overall Study||18
7973598|NCT00302328|19631183|P2|COMPLETED|Overall Study|developed cancer during the study|34
7973599|NCT00302328|19631184|P1|COMPLETED|Overall Study||25
7973600|NCT00302328|19631182|P3|STARTED|Overall Study||18
7973601|NCT00302328|19631183|P2|STARTED|Overall Study||35
7973602|NCT00302328|19631184|P1|STARTED|Overall Study||25
7973603|NCT00302211|19631201|P5|NOT COMPLETED|Open Label-Patients From Double-Blind||8
7973604|NCT00302211|19631202|P4|NOT COMPLETED|Open Label-Patients From Double-Blind||8
7973605|NCT00302211|19631203|P3|NOT COMPLETED|Open Label-Patients From Double-Blind||0
7973606|NCT00302211|19631204|P2|NOT COMPLETED|Open Label-Patients From Double-Blind||0
7973607|NCT00302211|19631205|P1|NOT COMPLETED|Open Label-Patients From Double-Blind||0
7973608|NCT00302211|19631201|P5|COMPLETED|Open Label-Patients From Double-Blind||24
7973609|NCT00302211|19631202|P4|COMPLETED|Open Label-Patients From Double-Blind||18
7973610|NCT00302211|19631203|P3|COMPLETED|Open Label-Patients From Double-Blind||0
7973611|NCT00302211|19631204|P2|COMPLETED|Open Label-Patients From Double-Blind||0
7973612|NCT00302211|19631205|P1|COMPLETED|Open Label-Patients From Double-Blind||0
7973613|NCT00302211|19631201|P5|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32
7973614|NCT00302211|19631202|P4|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26
7973615|NCT00302211|19631203|P3|STARTED|Open Label-Patients From Double-Blind||0
7973616|NCT00302211|19631204|P2|STARTED|Open Label-Patients From Double-Blind||0
7973617|NCT00302211|19631205|P1|STARTED|Open Label-Patients From Double-Blind||0
7973618|NCT00302211|19631201|P5|NOT COMPLETED|Double Blind Period (New Patients)||0
7973619|NCT00302211|19631202|P4|NOT COMPLETED|Double Blind Period (New Patients)||0
7973620|NCT00302211|19631203|P3|NOT COMPLETED|Double Blind Period (New Patients)||4
7973621|NCT00302211|19631204|P2|NOT COMPLETED|Double Blind Period (New Patients)||2
7973622|NCT00302211|19631205|P1|NOT COMPLETED|Double Blind Period (New Patients)||3
7973623|NCT00302211|19631201|P5|COMPLETED|Double Blind Period (New Patients)||0
7973624|NCT00302211|19631202|P4|COMPLETED|Double Blind Period (New Patients)||0
7973625|NCT00302211|19631203|P3|COMPLETED|Double Blind Period (New Patients)||10
7973626|NCT00302211|19631204|P2|COMPLETED|Double Blind Period (New Patients)||25
7973627|NCT00302211|19631205|P1|COMPLETED|Double Blind Period (New Patients)||23
7973628|NCT00302211|19631201|P5|STARTED|Double Blind Period (New Patients)||0
7973629|NCT00302211|19631202|P4|STARTED|Double Blind Period (New Patients)||0
7973630|NCT00302211|19631203|P3|STARTED|Double Blind Period (New Patients)|These subjects could receive either iloprost 4x/day or 6x/day in the OL period|14
7973631|NCT00302211|19631204|P2|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|27
7973632|NCT00302211|19631205|P1|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|26
7973633|NCT00302159|19631231|P1|NOT COMPLETED|Overall Study||2
7973634|NCT00302159|19631231|P1|COMPLETED|Overall Study||41
7973635|NCT00302159|19631231|P1|STARTED|Overall Study||43
7973636|NCT00302133|19631242|P2|NOT COMPLETED|Overall Study||4
7973637|NCT00302133|19631243|P1|NOT COMPLETED|Overall Study||4
7973638|NCT00302133|19631242|P2|COMPLETED|Overall Study||5
7973639|NCT00302133|19631243|P1|COMPLETED|Overall Study||5
7973640|NCT00302133|19631242|P2|STARTED|Overall Study||9
7973641|NCT00302133|19631243|P1|STARTED|Overall Study||9
7973642|NCT00302107|19631253|P2|NOT COMPLETED|Overall Study||9
7973643|NCT00302107|19631254|P1|NOT COMPLETED|Overall Study||8
7973644|NCT00302107|19631253|P2|COMPLETED|Overall Study||30
7973645|NCT00302107|19631254|P1|COMPLETED|Overall Study||31
7973646|NCT00302107|19631253|P2|STARTED|Overall Study||39
7973647|NCT00302107|19631254|P1|STARTED|Overall Study||39
7973648|NCT00302081|19631263|P3|NOT COMPLETED|Overall Study||52
7973649|NCT00302081|19631264|P2|NOT COMPLETED|Overall Study||43
7973650|NCT00302081|19631265|P1|NOT COMPLETED|Overall Study||56
7973651|NCT00302081|19631263|P3|COMPLETED|Overall Study||178
7973652|NCT00302081|19631264|P2|COMPLETED|Overall Study||186
7973653|NCT00302081|19631265|P1|COMPLETED|Overall Study||181
7973654|NCT00302081|19631263|P3|STARTED|Overall Study||230
7973655|NCT00302081|19631264|P2|STARTED|Overall Study||229
7973656|NCT00302081|19631265|P1|STARTED|Overall Study||237
7973657|NCT00302068|19631276|P3|NOT COMPLETED|Overall Study||1
7973658|NCT00302068|19631277|P2|NOT COMPLETED|Overall Study||4
7973659|NCT00302068|19631278|P1|NOT COMPLETED|Overall Study||1
7973660|NCT00302068|19631276|P3|COMPLETED|Overall Study||23
7973661|NCT00302068|19631277|P2|COMPLETED|Overall Study||36
7973662|NCT00302068|19631278|P1|COMPLETED|Overall Study||36
7973663|NCT00302068|19631276|P3|STARTED|Overall Study||24
7973664|NCT00302068|19631277|P2|STARTED|Overall Study||40
7973665|NCT00302068|19631278|P1|STARTED|Overall Study||37
7973666|NCT00302055|19631306|P2|NOT COMPLETED|Overall Study||13
7973667|NCT00302055|19631307|P1|NOT COMPLETED|Overall Study||9
7973668|NCT00302055|19631306|P2|COMPLETED|Overall Study||36
7973669|NCT00302055|19631307|P1|COMPLETED|Overall Study||14
7973670|NCT00302055|19631306|P2|STARTED|Overall Study||49
7973671|NCT00302055|19631307|P1|STARTED|Overall Study||23
7973672|NCT00302042|19631315|P2|NOT COMPLETED|Overall Study||8
7973673|NCT00302042|19631316|P1|NOT COMPLETED|Overall Study||7
7973674|NCT00302042|19631315|P2|COMPLETED|Overall Study||38
7973675|NCT00302042|19631316|P1|COMPLETED|Overall Study||39
7973676|NCT00302042|19631315|P2|STARTED|Overall Study||46
7973677|NCT00302042|19631316|P1|STARTED|Overall Study||46
7973678|NCT00302003|19631322|P1|NOT COMPLETED|Overall Study||80
7973679|NCT00302003|19631322|P1|COMPLETED|Overall Study||207
7973680|NCT00302003|19631322|P1|STARTED|Overall Study||287
7973681|NCT00301964|19631329|P1|NOT COMPLETED|Overall Study||4
7973682|NCT00301964|19631329|P1|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52
7973683|NCT00301964|19631329|P1|STARTED|Overall Study||56
7973684|NCT00301873|19631344|P1|NOT COMPLETED|Overall Study||0
7973685|NCT00301873|19631344|P1|COMPLETED|Overall Study||59
7973686|NCT00301873|19631344|P1|STARTED|Overall Study||59
7973687|NCT00301834|19631350|P1|NOT COMPLETED|Overall Study||1
7973688|NCT00301834|19631350|P1|COMPLETED|Overall Study||34
7973689|NCT00301834|19631350|P1|STARTED|Overall Study||35
7973690|NCT00301821|19631359|P1|NOT COMPLETED|Overall Study||26
7973691|NCT00301821|19631359|P1|COMPLETED|Overall Study||81
7973692|NCT00301821|19631359|P1|STARTED|Overall Study||107
7973693|NCT00301808|19631366|P1|NOT COMPLETED|Overall Study||12
7973694|NCT00301808|19631366|P1|COMPLETED|Overall Study||17
7973695|NCT00301808|19631366|P1|STARTED|Overall Study||29
7973696|NCT00301756|19631373|P1|NOT COMPLETED|Overall Study||0
7973697|NCT00301756|19631373|P1|COMPLETED|Overall Study||32
7973698|NCT00301756|19631373|P1|STARTED|Overall Study||32
7973699|NCT00301418|19631385|P1|NOT COMPLETED|Overall Study||0
7973700|NCT00301418|19631385|P1|COMPLETED|Overall Study||11
7973701|NCT00301418|19631385|P1|STARTED|Overall Study||11
7973702|NCT00301366|19631391|P1|NOT COMPLETED|Overall Study||1
7973703|NCT00301366|19631391|P1|COMPLETED|Overall Study||37
7973704|NCT00301366|19631391|P1|STARTED|Overall Study||38
7973705|NCT00301262|19631397|P2|NOT COMPLETED|Open Label Phase (OL)||2
7973706|NCT00301262|19631398|P1|NOT COMPLETED|Open Label Phase (OL)||4
7973707|NCT00301262|19631397|P2|COMPLETED|Open Label Phase (OL)||67
7973708|NCT00301262|19631398|P1|COMPLETED|Open Label Phase (OL)||79
7973709|NCT00301262|19631397|P2|STARTED|Open Label Phase (OL)||69
7973710|NCT00301262|19631398|P1|STARTED|Open Label Phase (OL)||83
7973711|NCT00301262|19631397|P2|NOT COMPLETED|Double Blind Phase (DB)||13
7973712|NCT00301262|19631398|P1|NOT COMPLETED|Double Blind Phase (DB)||10
7973713|NCT00301262|19631397|P2|COMPLETED|Double Blind Phase (DB)||69
7973714|NCT00301262|19631398|P1|COMPLETED|Double Blind Phase (DB)||84
7973715|NCT00301262|19631397|P2|STARTED|Double Blind Phase (DB)||82
7973716|NCT00301262|19631398|P1|STARTED|Double Blind Phase (DB)||94
7973717|NCT00301080|19631556|P5|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
7973718|NCT00301080|19631557|P4|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
7973719|NCT00301080|19631558|P3|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
7973720|NCT00301080|19631559|P2|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
7973721|NCT00301080|19631560|P1|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
7973722|NCT00301080|19631556|P5|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
7973723|NCT00301080|19631557|P4|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
7973724|NCT00301080|19631558|P3|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
7973725|NCT00301080|19631559|P2|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
7973726|NCT00301080|19631560|P1|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
7973727|NCT00301080|19631556|P5|STARTED|Revised Version (3 Arms & 12 Weeks)||0
7973728|NCT00301080|19631557|P4|STARTED|Revised Version (3 Arms & 12 Weeks)||0
7973729|NCT00301080|19631558|P3|STARTED|Revised Version (3 Arms & 12 Weeks)||0
7973730|NCT00301080|19631559|P2|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
7973731|NCT00301080|19631560|P1|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
7973732|NCT00301080|19631556|P5|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
7973733|NCT00301080|19631557|P4|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
7973734|NCT00301080|19631558|P3|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
7973735|NCT00301080|19631559|P2|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
7973736|NCT00301080|19631560|P1|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1
7973737|NCT00301080|19631556|P5|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
7973738|NCT00301080|19631557|P4|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
7973739|NCT00301080|19631558|P3|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
7973740|NCT00301080|19631559|P2|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
7973741|NCT00301080|19631560|P1|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
7973742|NCT00301080|19631556|P5|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
7973743|NCT00301080|19631557|P4|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
7973744|NCT00301080|19631558|P3|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
7973745|NCT00301080|19631559|P2|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
7973746|NCT00301080|19631560|P1|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
7973747|NCT00301080|19631556|P5|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
7973748|NCT00301080|19631557|P4|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
7973749|NCT00301080|19631558|P3|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
7973750|NCT00301080|19631559|P2|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
7973751|NCT00301080|19631560|P1|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
7973752|NCT00301080|19631556|P5|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
7973753|NCT00301080|19631557|P4|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
7973754|NCT00301080|19631558|P3|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
7973755|NCT00301080|19631559|P2|STARTED|Original Version (2 Arms & 4 Weeks)||3
7973756|NCT00301080|19631560|P1|STARTED|Original Version (2 Arms & 4 Weeks)||4
7973757|NCT00301067|19631589|P4|NOT COMPLETED|Follow up Until Death||1
7973758|NCT00301067|19631590|P3|NOT COMPLETED|Follow up Until Death||0
7973759|NCT00301067|19631591|P2|NOT COMPLETED|Follow up Until Death||0
7973760|NCT00301067|19631592|P1|NOT COMPLETED|Follow up Until Death||1
7973761|NCT00301067|19631589|P4|COMPLETED|Follow up Until Death||2
7973762|NCT00301067|19631590|P3|COMPLETED|Follow up Until Death||3
7973763|NCT00301067|19631591|P2|COMPLETED|Follow up Until Death||3
7973764|NCT00301067|19631592|P1|COMPLETED|Follow up Until Death||3
7973765|NCT00301067|19631589|P4|STARTED|Follow up Until Death||3
7973766|NCT00301067|19631590|P3|STARTED|Follow up Until Death||3
7973767|NCT00301067|19631591|P2|STARTED|Follow up Until Death||3
7973768|NCT00301067|19631592|P1|STARTED|Follow up Until Death||4
7973769|NCT00301067|19631589|P4|NOT COMPLETED|Completed 12 Cycles of Treatment||2
7973770|NCT00301067|19631590|P3|NOT COMPLETED|Completed 12 Cycles of Treatment||0
7973771|NCT00301067|19631591|P2|NOT COMPLETED|Completed 12 Cycles of Treatment||1
7973772|NCT00301067|19631592|P1|NOT COMPLETED|Completed 12 Cycles of Treatment||0
7973773|NCT00301067|19631589|P4|COMPLETED|Completed 12 Cycles of Treatment||0
7973774|NCT00301067|19631590|P3|COMPLETED|Completed 12 Cycles of Treatment||0
7973775|NCT00301067|19631591|P2|COMPLETED|Completed 12 Cycles of Treatment||0
7973776|NCT00301067|19631592|P1|COMPLETED|Completed 12 Cycles of Treatment||0
7973777|NCT00301067|19631589|P4|STARTED|Completed 12 Cycles of Treatment||2
7973778|NCT00301067|19631590|P3|STARTED|Completed 12 Cycles of Treatment||0
7973779|NCT00301067|19631591|P2|STARTED|Completed 12 Cycles of Treatment||1
7973780|NCT00301067|19631592|P1|STARTED|Completed 12 Cycles of Treatment||0
7973781|NCT00301067|19631589|P4|NOT COMPLETED|Completed 4 Cycles of Treatment||5
7973782|NCT00301067|19631590|P3|NOT COMPLETED|Completed 4 Cycles of Treatment||2
7973783|NCT00301067|19631591|P2|NOT COMPLETED|Completed 4 Cycles of Treatment||1
7973784|NCT00301067|19631592|P1|NOT COMPLETED|Completed 4 Cycles of Treatment||1
7973785|NCT00301067|19631589|P4|COMPLETED|Completed 4 Cycles of Treatment||2
7973786|NCT00301067|19631590|P3|COMPLETED|Completed 4 Cycles of Treatment||0
7973787|NCT00301067|19631591|P2|COMPLETED|Completed 4 Cycles of Treatment||1
7973788|NCT00301067|19631592|P1|COMPLETED|Completed 4 Cycles of Treatment||0
7973789|NCT00301067|19631589|P4|STARTED|Completed 4 Cycles of Treatment||7
7973790|NCT00301067|19631590|P3|STARTED|Completed 4 Cycles of Treatment||2
7973791|NCT00301067|19631591|P2|STARTED|Completed 4 Cycles of Treatment||2
7973792|NCT00301067|19631592|P1|STARTED|Completed 4 Cycles of Treatment||1
7973793|NCT00301067|19631589|P4|NOT COMPLETED|Reached 1st Response/2 Cycles||2
7973794|NCT00301067|19631590|P3|NOT COMPLETED|Reached 1st Response/2 Cycles||1
7973795|NCT00301067|19631591|P2|NOT COMPLETED|Reached 1st Response/2 Cycles||1
7973796|NCT00301067|19631592|P1|NOT COMPLETED|Reached 1st Response/2 Cycles||2
7973797|NCT00301067|19631589|P4|COMPLETED|Reached 1st Response/2 Cycles||7
7973798|NCT00301067|19631590|P3|COMPLETED|Reached 1st Response/2 Cycles||2
7973799|NCT00301067|19631591|P2|COMPLETED|Reached 1st Response/2 Cycles||2
7973800|NCT00301067|19631592|P1|COMPLETED|Reached 1st Response/2 Cycles||1
7973801|NCT00301067|19631589|P4|STARTED|Reached 1st Response/2 Cycles||9
7973802|NCT00301067|19631590|P3|STARTED|Reached 1st Response/2 Cycles||3
7973803|NCT00301067|19631591|P2|STARTED|Reached 1st Response/2 Cycles||3
7973804|NCT00301067|19631592|P1|STARTED|Reached 1st Response/2 Cycles||3
7973805|NCT00301067|19631589|P4|NOT COMPLETED|Completed DLT Period/1st Cycle||1
7973806|NCT00301067|19631590|P3|NOT COMPLETED|Completed DLT Period/1st Cycle||0
7973807|NCT00301067|19631591|P2|NOT COMPLETED|Completed DLT Period/1st Cycle||0
7973808|NCT00301067|19631592|P1|NOT COMPLETED|Completed DLT Period/1st Cycle||1
7973809|NCT00301067|19631589|P4|COMPLETED|Completed DLT Period/1st Cycle||9
7973810|NCT00301067|19631590|P3|COMPLETED|Completed DLT Period/1st Cycle||3
7973811|NCT00301067|19631591|P2|COMPLETED|Completed DLT Period/1st Cycle||3
7973812|NCT00301067|19631592|P1|COMPLETED|Completed DLT Period/1st Cycle||3
7973813|NCT00301067|19631589|P4|STARTED|Completed DLT Period/1st Cycle|Patients did not participate in the DLT portion of the trial, they completed 1st cycle of treatment.|10
7973814|NCT00301067|19631590|P3|STARTED|Completed DLT Period/1st Cycle||3
7973815|NCT00301067|19631591|P2|STARTED|Completed DLT Period/1st Cycle||3
7973816|NCT00301067|19631592|P1|STARTED|Completed DLT Period/1st Cycle||4
7973817|NCT00301028|19631611|P1|NOT COMPLETED|Overall Study||0
7973818|NCT00301028|19631611|P1|COMPLETED|Overall Study||47
7973819|NCT00301028|19631611|P1|STARTED|Overall Study||47
7973820|NCT00300885|19631617|P2|NOT COMPLETED|Follow-up||195
7973821|NCT00300885|19631618|P1|NOT COMPLETED|Follow-up||178
7973822|NCT00300885|19631617|P2|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174
7973823|NCT00300885|19631618|P1|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176
7973824|NCT00300885|19631617|P2|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369
7973825|NCT00300885|19631618|P1|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354
7973826|NCT00300885|19631617|P2|NOT COMPLETED|Treatment||374
7973827|NCT00300885|19631618|P1|NOT COMPLETED|Treatment||373
7973828|NCT00300885|19631617|P2|COMPLETED|Treatment||88
7973829|NCT00300885|19631618|P1|COMPLETED|Treatment||91
7973830|NCT00300885|19631617|P2|Received Treatment|Treatment||459
7973831|NCT00300885|19631618|P1|Received Treatment|Treatment||463
7973832|NCT00300885|19631617|P2|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462
7973833|NCT00300885|19631618|P1|STARTED|Treatment||464
7973834|NCT00300781|19631636|P2|NOT COMPLETED|Overall Study||62
7973835|NCT00300781|19631637|P1|NOT COMPLETED|Overall Study||63
7973836|NCT00300781|19631636|P2|COMPLETED|Overall Study||8
7973837|NCT00300781|19631637|P1|COMPLETED|Overall Study||3
7973838|NCT00300781|19631636|P2|STARTED|Overall Study||70
7973839|NCT00300781|19631637|P1|STARTED|Overall Study||66
7973840|NCT00300755|19631652|P3|NOT COMPLETED|Overall Study||2
7973841|NCT00300755|19631653|P2|NOT COMPLETED|Overall Study||4
7973842|NCT00300755|19631654|P1|NOT COMPLETED|Overall Study||1
7973843|NCT00300755|19631652|P3|COMPLETED|Overall Study||19
7973844|NCT00300755|19631653|P2|COMPLETED|Overall Study||17
7973845|NCT00300755|19631654|P1|COMPLETED|Overall Study||17
7973846|NCT00300755|19631652|P3|STARTED|Overall Study||21
7973847|NCT00300755|19631653|P2|STARTED|Overall Study||21
7973848|NCT00300755|19631654|P1|STARTED|Overall Study||18
7973849|NCT00300742|19631671|P1|NOT COMPLETED|Overall Study||2
7973850|NCT00300742|19631671|P1|COMPLETED|Overall Study||3
7973851|NCT00300742|19631671|P1|STARTED|Overall Study||5
7973852|NCT00300677|19631679|P1|NOT COMPLETED|Overall Study||0
7973853|NCT00300677|19631679|P1|COMPLETED|Overall Study||12
7973854|NCT00300677|19631679|P1|STARTED|Overall Study||12
7973855|NCT00300495|19631688|P2|NOT COMPLETED|Overall Study||1
7973856|NCT00300495|19631689|P1|NOT COMPLETED|Overall Study||4
7973857|NCT00300495|19631688|P2|COMPLETED|Overall Study||8
7973858|NCT00300495|19631689|P1|COMPLETED|Overall Study||6
7973859|NCT00300495|19631688|P2|STARTED|Overall Study||9
7973860|NCT00300495|19631689|P1|STARTED|Overall Study||10
7973861|NCT00300482|19631703|P6|NOT COMPLETED|Overall Study||16
7973862|NCT00300482|19631704|P5|NOT COMPLETED|Overall Study||23
7973863|NCT00300482|19631705|P4|NOT COMPLETED|Overall Study||24
7973864|NCT00300482|19631706|P3|NOT COMPLETED|Overall Study||51
7973865|NCT00300482|19631707|P2|NOT COMPLETED|Overall Study||41
7973866|NCT00300482|19631708|P1|NOT COMPLETED|Overall Study||41
7973867|NCT00300482|19631703|P6|COMPLETED|Overall Study||115
7973868|NCT00300482|19631704|P5|COMPLETED|Overall Study||243
7973869|NCT00300482|19631705|P4|COMPLETED|Overall Study||237
7973870|NCT00300482|19631706|P3|COMPLETED|Overall Study||208
7973871|NCT00300482|19631707|P2|COMPLETED|Overall Study||220
7973872|NCT00300482|19631708|P1|COMPLETED|Overall Study||220
7973873|NCT00300482|19631703|P6|STARTED|Overall Study||131
7973874|NCT00300482|19631704|P5|STARTED|Overall Study||266
7973875|NCT00300482|19631705|P4|STARTED|Overall Study||261
7973876|NCT00300482|19631706|P3|STARTED|Overall Study||259
7973877|NCT00300482|19631707|P2|STARTED|Overall Study||261
7973878|NCT00300482|19631708|P1|STARTED|Overall Study|"For all arms, started means treated."|261
7973879|NCT00300469|19631770|P6|NOT COMPLETED|Overall Study||9
7973880|NCT00300469|19631771|P5|NOT COMPLETED|Overall Study||14
7973881|NCT00300469|19631772|P4|NOT COMPLETED|Overall Study||9
7973882|NCT00300469|19631773|P3|NOT COMPLETED|Overall Study||17
7973883|NCT00300469|19631774|P2|NOT COMPLETED|Overall Study||21
7973884|NCT00300469|19631775|P1|NOT COMPLETED|Overall Study||21
7973885|NCT00300469|19631770|P6|COMPLETED|Overall Study||46
7973886|NCT00300469|19631771|P5|COMPLETED|Overall Study||95
7973887|NCT00300469|19631772|P4|COMPLETED|Overall Study||104
7973888|NCT00300469|19631773|P3|COMPLETED|Overall Study||95
7973889|NCT00300469|19631774|P2|COMPLETED|Overall Study||89
7973890|NCT00300469|19631775|P1|COMPLETED|Overall Study||89
7973891|NCT00300469|19631770|P6|STARTED|Overall Study||55
7973892|NCT00300469|19631771|P5|STARTED|Overall Study||109
7973893|NCT00300469|19631772|P4|STARTED|Overall Study||113
7973894|NCT00300469|19631773|P3|STARTED|Overall Study||112
7973895|NCT00300469|19631774|P2|STARTED|Overall Study||110
7973896|NCT00300469|19631775|P1|STARTED|Overall Study|"For all arms, started means treated."|110
7973897|NCT00300456|19631837|P6|NOT COMPLETED|Overall Study||11
7973898|NCT00300456|19631838|P5|NOT COMPLETED|Overall Study||17
7973899|NCT00300456|19631839|P4|NOT COMPLETED|Overall Study||14
7973900|NCT00300456|19631840|P3|NOT COMPLETED|Overall Study||21
7973901|NCT00300456|19631841|P2|NOT COMPLETED|Overall Study||16
7973902|NCT00300456|19631842|P1|NOT COMPLETED|Overall Study||16
7973903|NCT00300456|19631837|P6|COMPLETED|Overall Study||48
7973904|NCT00300456|19631838|P5|COMPLETED|Overall Study||99
7973905|NCT00300456|19631839|P4|COMPLETED|Overall Study||105
7973906|NCT00300456|19631840|P3|COMPLETED|Overall Study||98
7973907|NCT00300456|19631841|P2|COMPLETED|Overall Study||102
7973908|NCT00300456|19631842|P1|COMPLETED|Overall Study||103
7973909|NCT00300456|19631837|P6|STARTED|Overall Study||59
7973910|NCT00300456|19631838|P5|STARTED|Overall Study||116
7973911|NCT00300456|19631839|P4|STARTED|Overall Study||119
7973912|NCT00300456|19631840|P3|STARTED|Overall Study||119
7973913|NCT00300456|19631841|P2|STARTED|Overall Study||118
7973914|NCT00300456|19631842|P1|STARTED|Overall Study|"For all arms, started means treated."|119
7973915|NCT00300430|19631901|P3|NOT COMPLETED|Overall Study||151
7973916|NCT00300430|19631902|P2|NOT COMPLETED|Overall Study||169
7973917|NCT00300430|19631903|P1|NOT COMPLETED|Overall Study||367
7973918|NCT00300430|19631901|P3|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350
7973919|NCT00300430|19631902|P2|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345
7973920|NCT00300430|19631903|P1|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819
7973921|NCT00300430|19631901|P3|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501
7973922|NCT00300430|19631902|P2|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514
7973923|NCT00300430|19631903|P1|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186
7973924|NCT00300391|19631937|P2|NOT COMPLETED|Overall Study||0
7973925|NCT00300391|19631938|P1|NOT COMPLETED|Overall Study||0
7973926|NCT00300391|19631937|P2|COMPLETED|Overall Study||14
7973927|NCT00300391|19631938|P1|COMPLETED|Overall Study||16
7973928|NCT00300391|19631937|P2|STARTED|Overall Study||14
7973929|NCT00300391|19631938|P1|STARTED|Overall Study||16
7973930|NCT00300365|19631956|P2|NOT COMPLETED|Overall Study||2
7973931|NCT00300365|19631957|P1|NOT COMPLETED|Overall Study||4
7973932|NCT00300365|19631956|P2|COMPLETED|Overall Study||38
7973933|NCT00300365|19631957|P1|COMPLETED|Overall Study||34
7973934|NCT00300365|19631956|P2|STARTED|Overall Study||40
7973935|NCT00300365|19631957|P1|STARTED|Overall Study||38
7973936|NCT00300274|19631966|P3|NOT COMPLETED|Overall Study||45
7973937|NCT00300274|19631967|P2|NOT COMPLETED|Overall Study||27
7973938|NCT00300274|19631968|P1|NOT COMPLETED|Overall Study||46
7973939|NCT00300274|19631966|P3|COMPLETED|Overall Study||226
7973940|NCT00300274|19631967|P2|COMPLETED|Overall Study||141
7973941|NCT00300274|19631968|P1|COMPLETED|Overall Study||236
7973942|NCT00300274|19631966|P3|Completed 12 Month|Overall Study||248
7973943|NCT00300274|19631967|P2|Completed 12 Month|Overall Study||149
7973944|NCT00300274|19631968|P1|Completed 12 Month|Overall Study||250
7973945|NCT00300274|19631966|P3|STARTED|Overall Study||271
7973946|NCT00300274|19631967|P2|STARTED|Overall Study||168
7973947|NCT00300274|19631968|P1|STARTED|Overall Study||282
7973948|NCT00300235|19632008|P5|NOT COMPLETED|Overall Study||0
7973949|NCT00300235|19632009|P4|NOT COMPLETED|Overall Study||0
7973950|NCT00300235|19632010|P3|NOT COMPLETED|Overall Study||0
7973951|NCT00300235|19632011|P2|NOT COMPLETED|Overall Study||0
7973952|NCT00300235|19632012|P1|NOT COMPLETED|Overall Study||0
7973953|NCT00300235|19632008|P5|COMPLETED|Overall Study||251
7973954|NCT00300235|19632009|P4|COMPLETED|Overall Study||362
7973955|NCT00300235|19632010|P3|COMPLETED|Overall Study||398
7973956|NCT00300235|19632011|P2|COMPLETED|Overall Study||240
7973957|NCT00300235|19632012|P1|COMPLETED|Overall Study||208
7973958|NCT00300235|19632008|P5|STARTED|Overall Study||251
7973959|NCT00300235|19632009|P4|STARTED|Overall Study||362
7973960|NCT00300235|19632010|P3|STARTED|Overall Study||398
7973961|NCT00300235|19632011|P2|STARTED|Overall Study||240
7973962|NCT00300235|19632012|P1|STARTED|Overall Study||208
7973963|NCT00299988|19632026|P2|NOT COMPLETED|Overall Study||0
7973964|NCT00299988|19632027|P1|NOT COMPLETED|Overall Study||0
7973965|NCT00299988|19632026|P2|COMPLETED|Overall Study||8
7973966|NCT00299988|19632027|P1|COMPLETED|Overall Study||16
7973967|NCT00299988|19632026|P2|STARTED|Overall Study||8
7973968|NCT00299988|19632027|P1|STARTED|Overall Study||16
7973969|NCT00299975|19632038|P3|NOT COMPLETED|Overall Study||8
7973970|NCT00299975|19632039|P2|NOT COMPLETED|Overall Study||1
7973971|NCT00299975|19632040|P1|NOT COMPLETED|Overall Study||3
7973972|NCT00299975|19632038|P3|COMPLETED|Overall Study||25
7973973|NCT00299975|19632039|P2|COMPLETED|Overall Study||31
7973974|NCT00299975|19632040|P1|COMPLETED|Overall Study||29
7973975|NCT00299975|19632038|P3|Received Allocated Intervention|Overall Study||32
7973976|NCT00299975|19632039|P2|Received Allocated Intervention|Overall Study||32
7973977|NCT00299975|19632040|P1|Received Allocated Intervention|Overall Study||32
7973978|NCT00299975|19632038|P3|STARTED|Overall Study||33
7973979|NCT00299975|19632039|P2|STARTED|Overall Study||32
7973980|NCT00299975|19632040|P1|STARTED|Overall Study||32
7973981|NCT00299741|19632090|P1|NOT COMPLETED|Overall Study||0
7973982|NCT00299741|19632090|P1|COMPLETED|Overall Study||36
7973983|NCT00299741|19632090|P1|STARTED|Overall Study||36
7973984|NCT00299702|19632097|P2|NOT COMPLETED|Overall Study||50
7973985|NCT00299702|19632098|P1|NOT COMPLETED|Overall Study||53
7973986|NCT00299702|19632097|P2|COMPLETED|Overall Study||126
7973987|NCT00299702|19632098|P1|COMPLETED|Overall Study||126
7973988|NCT00299702|19632097|P2|STARTED|Overall Study||176
7973989|NCT00299702|19632098|P1|STARTED|Overall Study||179
7973990|NCT00299689|19632106|P1|NOT COMPLETED|Overall Study||0
7973991|NCT00299689|19632106|P1|COMPLETED|Overall Study||69
7973992|NCT00299689|19632106|P1|STARTED|Overall Study||69
7973993|NCT00299546|19632113|P3|NOT COMPLETED|Overall Study||86
7973994|NCT00299546|19632114|P2|NOT COMPLETED|Overall Study||92
7973995|NCT00299546|19632115|P1|NOT COMPLETED|Overall Study||100
7973996|NCT00299546|19632113|P3|COMPLETED|Overall Study||67
7973997|NCT00299546|19632114|P2|COMPLETED|Overall Study||61
7973998|NCT00299546|19632115|P1|COMPLETED|Overall Study||55
7973999|NCT00299546|19632113|P3|STARTED|Overall Study||153
7974000|NCT00299546|19632114|P2|STARTED|Overall Study||153
7974001|NCT00299546|19632115|P1|STARTED|Overall Study||155
7974002|NCT00299494|19632146|P6|NOT COMPLETED|Overall Study||26
7974003|NCT00299494|19632147|P5|NOT COMPLETED|Overall Study||27
7974004|NCT00299494|19632148|P4|NOT COMPLETED|Overall Study||10
7974005|NCT00299494|19632149|P3|NOT COMPLETED|Overall Study||4
7974006|NCT00299494|19632150|P2|NOT COMPLETED|Overall Study||1
7974007|NCT00299494|19632151|P1|NOT COMPLETED|Overall Study||3
7974008|NCT00299494|19632146|P6|COMPLETED|Overall Study||4
7974009|NCT00299494|19632147|P5|COMPLETED|Overall Study||13
7974010|NCT00299494|19632148|P4|COMPLETED|Overall Study||24
7974011|NCT00299494|19632149|P3|COMPLETED|Overall Study||3
7974012|NCT00299494|19632150|P2|COMPLETED|Overall Study||2
7974013|NCT00299494|19632151|P1|COMPLETED|Overall Study||2
7974014|NCT00299494|19632146|P6|STARTED|Overall Study||30
7974015|NCT00299494|19632147|P5|STARTED|Overall Study|1 participant received rituximab only, and did not receive inotuzumab ozogamicin|40
7974016|NCT00299494|19632148|P4|STARTED|Overall Study||34
7974017|NCT00299494|19632149|P3|STARTED|Overall Study||7
7974018|NCT00299494|19632150|P2|STARTED|Overall Study||3
7974019|NCT00299494|19632151|P1|STARTED|Overall Study||5
7974020|NCT00299416|19632254|P1|NOT COMPLETED|Overall Study||0
7974021|NCT00299416|19632254|P1|COMPLETED|Overall Study||30
7974022|NCT00299416|19632254|P1|STARTED|Overall Study||30
7974023|NCT00299221|19632262|P2|NOT COMPLETED|Overall Study||0
7974024|NCT00299221|19632263|P1|NOT COMPLETED|Overall Study||0
7974025|NCT00299221|19632262|P2|COMPLETED|Overall Study||71
7974026|NCT00299221|19632263|P1|COMPLETED|Overall Study||79
7974027|NCT00299221|19632262|P2|STARTED|Overall Study||71
7974028|NCT00299221|19632263|P1|STARTED|Overall Study||79
7974029|NCT00299195|19632279|P2|NOT COMPLETED|Overall Study||0
7974030|NCT00299195|19632280|P1|NOT COMPLETED|Overall Study||0
7974031|NCT00299195|19632279|P2|COMPLETED|Overall Study||33
7974032|NCT00299195|19632280|P1|COMPLETED|Overall Study||30
7974033|NCT00299195|19632279|P2|STARTED|Overall Study||33
7974034|NCT00299195|19632280|P1|STARTED|Overall Study||30
7974035|NCT00299156|19632297|P3|NOT COMPLETED|Period 2 (Randomized)||0
7974036|NCT00299156|19632298|P2|NOT COMPLETED|Period 2 (Randomized)||1
7974037|NCT00299156|19632299|P1|NOT COMPLETED|Period 2 (Randomized)||0
7974038|NCT00299156|19632297|P3|COMPLETED|Period 2 (Randomized)||16
7974039|NCT00299156|19632298|P2|COMPLETED|Period 2 (Randomized)||16
7974040|NCT00299156|19632299|P1|COMPLETED|Period 2 (Randomized)||0
7974041|NCT00299156|19632297|P3|STARTED|Period 2 (Randomized)||16
7974042|NCT00299156|19632298|P2|STARTED|Period 2 (Randomized)||17
7974043|NCT00299156|19632299|P1|STARTED|Period 2 (Randomized)||0
7974044|NCT00299156|19632297|P3|NOT COMPLETED|Period 1 (Non-Randomized)||0
7974045|NCT00299156|19632298|P2|NOT COMPLETED|Period 1 (Non-Randomized)||0
7974046|NCT00299156|19632299|P1|NOT COMPLETED|Period 1 (Non-Randomized)||0
7974047|NCT00299156|19632297|P3|COMPLETED|Period 1 (Non-Randomized)||0
7974048|NCT00299156|19632298|P2|COMPLETED|Period 1 (Non-Randomized)||0
7974049|NCT00299156|19632299|P1|COMPLETED|Period 1 (Non-Randomized)||32
7974050|NCT00299156|19632297|P3|STARTED|Period 1 (Non-Randomized)||0
7974051|NCT00299156|19632298|P2|STARTED|Period 1 (Non-Randomized)||0
7974052|NCT00299156|19632299|P1|STARTED|Period 1 (Non-Randomized)||32
7974053|NCT00299130|19632310|P3|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6
7974054|NCT00299130|19632311|P2|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8
7974055|NCT00299130|19632312|P1|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
7974056|NCT00299130|19632310|P3|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38
7974057|NCT00299130|19632311|P2|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74
7974058|NCT00299130|19632312|P1|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
7974059|NCT00299130|19632310|P3|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44
7974060|NCT00299130|19632311|P2|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82
7974061|NCT00299130|19632312|P1|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0
7974062|NCT00299130|19632310|P3|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
7974063|NCT00299130|19632311|P2|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
7974064|NCT00299130|19632312|P1|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
7974065|NCT00299130|19632310|P3|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123
7974066|NCT00299130|19632311|P2|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120
7974067|NCT00299130|19632312|P1|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122
7974068|NCT00299130|19632310|P3|STARTED|Safety Follow-up (SFU) (48 Weeks)||168
7974069|NCT00299130|19632311|P2|STARTED|Safety Follow-up (SFU) (48 Weeks)||165
7974070|NCT00299130|19632312|P1|STARTED|Safety Follow-up (SFU) (48 Weeks)||167
7974071|NCT00299130|19632310|P3|NOT COMPLETED|Treatment Period (up to 5 Years)||50
7974072|NCT00299130|19632311|P2|NOT COMPLETED|Treatment Period (up to 5 Years)||43
7974073|NCT00299130|19632312|P1|NOT COMPLETED|Treatment Period (up to 5 Years)||53
7974074|NCT00299130|19632310|P3|COMPLETED|Treatment Period (up to 5 Years)||121
7974075|NCT00299130|19632311|P2|COMPLETED|Treatment Period (up to 5 Years)||125
7974076|NCT00299130|19632312|P1|COMPLETED|Treatment Period (up to 5 Years)||119
7974077|NCT00299130|19632310|P3|Completed 144 Weeks|Treatment Period (up to 5 Years)||132
7974078|NCT00299130|19632311|P2|Completed 144 Weeks|Treatment Period (up to 5 Years)||138
7974079|NCT00299130|19632312|P1|Completed 144 Weeks|Treatment Period (up to 5 Years)||133
7974080|NCT00299130|19632310|P3|Completed 48 Weeks|Treatment Period (up to 5 Years)||158
7974081|NCT00299130|19632311|P2|Completed 48 Weeks|Treatment Period (up to 5 Years)||157
7974082|NCT00299130|19632312|P1|Completed 48 Weeks|Treatment Period (up to 5 Years)||155
7974083|NCT00299130|19632310|P3|Completed 24 Weeks|Treatment Period (up to 5 Years)||166
7974084|NCT00299130|19632311|P2|Completed 24 Weeks|Treatment Period (up to 5 Years)||162
7974085|NCT00299130|19632312|P1|Completed 24 Weeks|Treatment Period (up to 5 Years)||159
7974086|NCT00299130|19632310|P3|Treated|Treatment Period (up to 5 Years)||170
7974087|NCT00299130|19632311|P2|Treated|Treatment Period (up to 5 Years)||167
7974088|NCT00299130|19632312|P1|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172
7974089|NCT00299130|19632310|P3|STARTED|Treatment Period (up to 5 Years)||171
7974090|NCT00299130|19632311|P2|STARTED|Treatment Period (up to 5 Years)||168
7974091|NCT00299130|19632312|P1|STARTED|Treatment Period (up to 5 Years)||172
7974092|NCT00299104|19632417|P3|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12
7974093|NCT00299104|19632418|P2|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9
7974094|NCT00299104|19632419|P1|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5
7974095|NCT00299104|19632417|P3|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39
7974096|NCT00299104|19632418|P2|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31
7974097|NCT00299104|19632419|P1|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29
7974098|NCT00299104|19632417|P3|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51
7974099|NCT00299104|19632418|P2|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40
7974100|NCT00299104|19632419|P1|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34
7974101|NCT00299104|19632417|P3|NOT COMPLETED|Safety Follow-Up (SFU) Period||37
7974102|NCT00299104|19632418|P2|NOT COMPLETED|Safety Follow-Up (SFU) Period||41
7974103|NCT00299104|19632419|P1|NOT COMPLETED|Safety Follow-Up (SFU) Period||55
7974104|NCT00299104|19632417|P3|COMPLETED|Safety Follow-Up (SFU) Period||176
7974105|NCT00299104|19632418|P2|COMPLETED|Safety Follow-Up (SFU) Period||171
7974106|NCT00299104|19632419|P1|COMPLETED|Safety Follow-Up (SFU) Period||129
7974107|NCT00299104|19632417|P3|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213
7974108|NCT00299104|19632418|P2|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212
7974109|NCT00299104|19632419|P1|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184
7974110|NCT00299104|19632417|P3|NOT COMPLETED|Treatment Period||172
7974111|NCT00299104|19632418|P2|NOT COMPLETED|Treatment Period||175
7974112|NCT00299104|19632419|P1|NOT COMPLETED|Treatment Period||189
7974113|NCT00299104|19632417|P3|COMPLETED|Treatment Period||80
7974114|NCT00299104|19632418|P2|COMPLETED|Treatment Period||77
7974115|NCT00299104|19632419|P1|COMPLETED|Treatment Period|Completed Week 152|62
7974116|NCT00299104|19632417|P3|Completed Week 104|Treatment Period||216
7974117|NCT00299104|19632418|P2|Completed Week 104|Treatment Period||213
7974118|NCT00299104|19632419|P1|Completed Week 104|Treatment Period||178
7974119|NCT00299104|19632417|P3|Completed Week 52|Treatment Period||232
7974120|NCT00299104|19632418|P2|Completed Week 52|Treatment Period||227
7974121|NCT00299104|19632419|P1|Completed Week 52|Treatment Period||213
7974122|NCT00299104|19632417|P3|Completed Week 24|Treatment Period||241
7974123|NCT00299104|19632418|P2|Completed Week 24|Treatment Period||240
7974124|NCT00299104|19632419|P1|Completed Week 24|Treatment Period||227
7974125|NCT00299104|19632417|P3|Safety/ITT: Received Study Drug|Treatment Period||250
7974126|NCT00299104|19632418|P2|Safety/ITT: Received Study Drug|Treatment Period||249
7974127|NCT00299104|19632419|P1|Safety/ITT: Received Study Drug|Treatment Period||249
7974128|NCT00299104|19632417|P3|STARTED|Treatment Period||252
7974129|NCT00299104|19632418|P2|STARTED|Treatment Period||252
7974130|NCT00299104|19632419|P1|STARTED|Treatment Period||251
7974131|NCT00299000|19632516|P2|NOT COMPLETED|Overall Study||0
7974132|NCT00299000|19632517|P1|NOT COMPLETED|Overall Study||0
7974133|NCT00299000|19632516|P2|COMPLETED|Overall Study||2
7974134|NCT00299000|19632517|P1|COMPLETED|Overall Study||2
7974135|NCT00299000|19632516|P2|STARTED|Overall Study||2
7974136|NCT00299000|19632517|P1|STARTED|Overall Study||2
7974137|NCT00298896|19632529|P1|NOT COMPLETED|Overall Study||50
7974138|NCT00298896|19632529|P1|COMPLETED|Overall Study||5
7974139|NCT00298896|19632529|P1|STARTED|Overall Study||55
7974140|NCT00298831|19632534|P1|NOT COMPLETED|Overall Study||32
7974141|NCT00298831|19632534|P1|COMPLETED|Overall Study||192
7974142|NCT00298831|19632534|P1|Treated|Overall Study||197
7974143|NCT00298831|19632534|P1|STARTED|Overall Study||224
7974144|NCT00298766|19632543|P1|NOT COMPLETED|Overall Study||46
7974145|NCT00298766|19632543|P1|COMPLETED|Overall Study||24
7974146|NCT00298766|19632543|P1|STARTED|Overall Study||70
7974147|NCT00298740|19632552|P1|NOT COMPLETED|Overall Study||9
7974148|NCT00298740|19632552|P1|COMPLETED|Overall Study||3
7974149|NCT00298740|19632552|P1|STARTED|Overall Study||12
7974150|NCT00298610|19632556|P1|NOT COMPLETED|Overall Study||0
7974151|NCT00298610|19632556|P1|COMPLETED|Overall Study||30
7974152|NCT00298610|19632556|P1|STARTED|Overall Study||30
7974153|NCT00298558|19632570|P4|NOT COMPLETED|10th Annual (A10)||163
7974154|NCT00298558|19632571|P3|NOT COMPLETED|10th Annual (A10)||171
7974155|NCT00298558|19632572|P2|NOT COMPLETED|10th Annual (A10)||153
7974156|NCT00298558|19632573|P1|NOT COMPLETED|10th Annual (A10)||172
7974157|NCT00298558|19632570|P4|COMPLETED|10th Annual (A10)||285
7974158|NCT00298558|19632571|P3|COMPLETED|10th Annual (A10)||319
7974159|NCT00298558|19632572|P2|COMPLETED|10th Annual (A10)||316
7974160|NCT00298558|19632573|P1|COMPLETED|10th Annual (A10)||300
7974161|NCT00298558|19632570|P4|STARTED|10th Annual (A10)||448
7974162|NCT00298558|19632571|P3|STARTED|10th Annual (A10)||490
7974163|NCT00298558|19632572|P2|STARTED|10th Annual (A10)||469
7974164|NCT00298558|19632573|P1|STARTED|10th Annual (A10)||472
7974165|NCT00298558|19632570|P4|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104
7974166|NCT00298558|19632571|P3|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84
7974167|NCT00298558|19632572|P2|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86
7974168|NCT00298558|19632573|P1|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91
7974169|NCT00298558|19632570|P4|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448
7974170|NCT00298558|19632571|P3|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490
7974171|NCT00298558|19632572|P2|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469
7974172|NCT00298558|19632573|P1|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472
7974173|NCT00298558|19632570|P4|STARTED|3rd Annual (A3) and 5th Annual (A5)||552
7974174|NCT00298558|19632571|P3|STARTED|3rd Annual (A3) and 5th Annual (A5)||574
7974175|NCT00298558|19632572|P2|STARTED|3rd Annual (A3) and 5th Annual (A5)||555
7974176|NCT00298558|19632573|P1|STARTED|3rd Annual (A3) and 5th Annual (A5)||563
7974177|NCT00298558|19632570|P4|NOT COMPLETED|3rd Annual Booster||0
7974178|NCT00298558|19632571|P3|NOT COMPLETED|3rd Annual Booster||140
7974179|NCT00298558|19632572|P2|NOT COMPLETED|3rd Annual Booster||128
7974180|NCT00298558|19632573|P1|NOT COMPLETED|3rd Annual Booster||122
7974181|NCT00298558|19632570|P4|COMPLETED|3rd Annual Booster||0
7974182|NCT00298558|19632571|P3|COMPLETED|3rd Annual Booster||230
7974183|NCT00298558|19632572|P2|COMPLETED|3rd Annual Booster||243
7974184|NCT00298558|19632573|P1|COMPLETED|3rd Annual Booster||250
7974185|NCT00298558|19632570|P4|STARTED|3rd Annual Booster||0
7974186|NCT00298558|19632571|P3|STARTED|3rd Annual Booster||370
7974187|NCT00298558|19632572|P2|STARTED|3rd Annual Booster||371
7974188|NCT00298558|19632573|P1|STARTED|3rd Annual Booster||372
7974189|NCT00298558|19632570|P4|NOT COMPLETED|2nd Annual (A2)||32
7974190|NCT00298558|19632571|P3|NOT COMPLETED|2nd Annual (A2)||27
7974191|NCT00298558|19632572|P2|NOT COMPLETED|2nd Annual (A2)||11
7974192|NCT00298558|19632573|P1|NOT COMPLETED|2nd Annual (A2)||22
7974193|NCT00298558|19632570|P4|COMPLETED|2nd Annual (A2)||552
7974194|NCT00298558|19632571|P3|COMPLETED|2nd Annual (A2)||574
7974195|NCT00298558|19632572|P2|COMPLETED|2nd Annual (A2)||555
7974196|NCT00298558|19632573|P1|COMPLETED|2nd Annual (A2)||563
7974197|NCT00298558|19632570|P4|STARTED|2nd Annual (A2)||584
7974198|NCT00298558|19632571|P3|STARTED|2nd Annual (A2)||601
7974199|NCT00298558|19632572|P2|STARTED|2nd Annual (A2)||566
7974200|NCT00298558|19632573|P1|STARTED|2nd Annual (A2)||585
7974201|NCT00298558|19632570|P4|NOT COMPLETED|1st Annual (A1)||55
7974202|NCT00298558|19632571|P3|NOT COMPLETED|1st Annual (A1)||52
7974203|NCT00298558|19632572|P2|NOT COMPLETED|1st Annual (A1)||63
7974204|NCT00298558|19632573|P1|NOT COMPLETED|1st Annual (A1)||55
7974205|NCT00298558|19632570|P4|COMPLETED|1st Annual (A1)||584
7974206|NCT00298558|19632571|P3|COMPLETED|1st Annual (A1)||601
7974207|NCT00298558|19632572|P2|COMPLETED|1st Annual (A1)||566
7974208|NCT00298558|19632573|P1|COMPLETED|1st Annual (A1)||585
7974209|NCT00298558|19632570|P4|STARTED|1st Annual (A1)||639
7974210|NCT00298558|19632571|P3|STARTED|1st Annual (A1)||653
7974211|NCT00298558|19632572|P2|STARTED|1st Annual (A1)||629
7974212|NCT00298558|19632573|P1|STARTED|1st Annual (A1)||640
7974213|NCT00298558|19632570|P4|NOT COMPLETED|Booster||0
7974214|NCT00298558|19632571|P3|NOT COMPLETED|Booster||75
7974215|NCT00298558|19632572|P2|NOT COMPLETED|Booster||70
7974216|NCT00298558|19632573|P1|NOT COMPLETED|Booster||89
7974217|NCT00298558|19632570|P4|COMPLETED|Booster||0
7974218|NCT00298558|19632571|P3|COMPLETED|Booster||295
7974219|NCT00298558|19632572|P2|COMPLETED|Booster||301
7974220|NCT00298558|19632573|P1|COMPLETED|Booster||283
7974221|NCT00298558|19632570|P4|STARTED|Booster||0
7974222|NCT00298558|19632571|P3|STARTED|Booster||370
7974223|NCT00298558|19632572|P2|STARTED|Booster||371
7974224|NCT00298558|19632573|P1|STARTED|Booster||372
7974225|NCT00298558|19632570|P4|NOT COMPLETED|Immediate Post Test||65
7974226|NCT00298558|19632571|P3|NOT COMPLETED|Immediate Post Test||59
7974227|NCT00298558|19632572|P2|NOT COMPLETED|Immediate Post Test||76
7974228|NCT00298558|19632573|P1|NOT COMPLETED|Immediate Post Test||71
7974229|NCT00298558|19632570|P4|COMPLETED|Immediate Post Test||639
7974230|NCT00298558|19632571|P3|COMPLETED|Immediate Post Test||653
7974231|NCT00298558|19632572|P2|COMPLETED|Immediate Post Test||629
7974232|NCT00298558|19632573|P1|COMPLETED|Immediate Post Test||640
7974233|NCT00298558|19632570|P4|STARTED|Immediate Post Test||704
7974234|NCT00298558|19632571|P3|STARTED|Immediate Post Test||712
7974235|NCT00298558|19632572|P2|STARTED|Immediate Post Test||705
7974236|NCT00298558|19632573|P1|STARTED|Immediate Post Test||711
7974237|NCT00298558|19632570|P4|NOT COMPLETED|Intervention||419
7974238|NCT00298558|19632571|P3|NOT COMPLETED|Intervention||75
7974239|NCT00298558|19632572|P2|NOT COMPLETED|Intervention||78
7974240|NCT00298558|19632573|P1|NOT COMPLETED|Intervention||91
7974241|NCT00298558|19632570|P4|COMPLETED|Intervention||285
7974242|NCT00298558|19632571|P3|COMPLETED|Intervention||637
7974243|NCT00298558|19632572|P2|COMPLETED|Intervention||627
7974244|NCT00298558|19632573|P1|COMPLETED|Intervention||620
7974245|NCT00298558|19632570|P4|STARTED|Intervention||704
7974246|NCT00298558|19632571|P3|STARTED|Intervention||712
7974247|NCT00298558|19632572|P2|STARTED|Intervention||705
7974248|NCT00298558|19632573|P1|STARTED|Intervention||711
7974249|NCT00298558|19632570|P4|NOT COMPLETED|Baseline||0
7974250|NCT00298558|19632571|P3|NOT COMPLETED|Baseline||0
7974251|NCT00298558|19632572|P2|NOT COMPLETED|Baseline||0
7974252|NCT00298558|19632573|P1|NOT COMPLETED|Baseline||0
7974253|NCT00298558|19632570|P4|COMPLETED|Baseline||704
7974254|NCT00298558|19632571|P3|COMPLETED|Baseline||712
7974255|NCT00298558|19632572|P2|COMPLETED|Baseline||705
7974256|NCT00298558|19632573|P1|COMPLETED|Baseline||711
7974257|NCT00298558|19632570|P4|STARTED|Baseline||704
7974258|NCT00298558|19632571|P3|STARTED|Baseline||712
7974259|NCT00298558|19632572|P2|STARTED|Baseline||705
7974260|NCT00298558|19632573|P1|STARTED|Baseline||711
7974261|NCT00298389|19632606|P3|NOT COMPLETED|Overall Study||0
7974262|NCT00298389|19632607|P2|NOT COMPLETED|Overall Study||0
7974263|NCT00298389|19632608|P1|NOT COMPLETED|Overall Study||0
7974264|NCT00298389|19632606|P3|COMPLETED|Overall Study||19
7974265|NCT00298389|19632607|P2|COMPLETED|Overall Study||17
7974266|NCT00298389|19632608|P1|COMPLETED|Overall Study||20
7974267|NCT00298389|19632606|P3|STARTED|Overall Study||19
7974268|NCT00298389|19632607|P2|STARTED|Overall Study||17
7974269|NCT00298389|19632608|P1|STARTED|Overall Study||20
7974270|NCT00298363|19632622|P3|NOT COMPLETED|Overall Study||6
7974271|NCT00298363|19632623|P2|NOT COMPLETED|Overall Study||8
7974272|NCT00298363|19632624|P1|NOT COMPLETED|Overall Study||17
7974273|NCT00298363|19632622|P3|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16
7974274|NCT00298363|19632623|P2|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37
7974275|NCT00298363|19632624|P1|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28
7974276|NCT00298363|19632622|P3|STARTED|Overall Study||22
7974277|NCT00298363|19632623|P2|STARTED|Overall Study||45
7974278|NCT00298363|19632624|P1|STARTED|Overall Study||45
7974279|NCT00298272|19632782|P2|NOT COMPLETED|Safety Follow-up Phase||4
7974280|NCT00298272|19632783|P1|NOT COMPLETED|Safety Follow-up Phase||4
7974281|NCT00298272|19632782|P2|COMPLETED|Safety Follow-up Phase||13
7974282|NCT00298272|19632783|P1|COMPLETED|Safety Follow-up Phase||18
7974283|NCT00298272|19632782|P2|STARTED|Safety Follow-up Phase||17
7974284|NCT00298272|19632783|P1|STARTED|Safety Follow-up Phase||22
7974285|NCT00298272|19632782|P2|NOT COMPLETED|Open Label Retreatment Phase||4
7974286|NCT00298272|19632783|P1|NOT COMPLETED|Open Label Retreatment Phase||9
7974287|NCT00298272|19632782|P2|COMPLETED|Open Label Retreatment Phase||12
7974288|NCT00298272|19632783|P1|COMPLETED|Open Label Retreatment Phase||13
7974289|NCT00298272|19632782|P2|Completed to Week 56|Open Label Retreatment Phase||12
7974290|NCT00298272|19632783|P1|Completed to Week 56|Open Label Retreatment Phase||13
7974291|NCT00298272|19632782|P2|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15
7974292|NCT00298272|19632783|P1|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22
7974293|NCT00298272|19632782|P2|STARTED|Open Label Retreatment Phase||16
7974294|NCT00298272|19632783|P1|STARTED|Open Label Retreatment Phase||22
7974295|NCT00298272|19632782|P2|NOT COMPLETED|Double-blind Phase||0
7974296|NCT00298272|19632783|P1|NOT COMPLETED|Double-blind Phase||8
7974297|NCT00298272|19632782|P2|COMPLETED|Double-blind Phase||18
7974298|NCT00298272|19632783|P1|COMPLETED|Double-blind Phase||28
7974299|NCT00298272|19632782|P2|Completed to Week 56|Double-blind Phase||3
7974300|NCT00298272|19632783|P1|Completed to Week 56|Double-blind Phase||8
7974301|NCT00298272|19632782|P2|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18
7974302|NCT00298272|19632783|P1|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31
7974303|NCT00298272|19632782|P2|Safety Population|Double-blind Phase||18
7974304|NCT00298272|19632783|P1|Safety Population|Double-blind Phase|received treatment|33
7974305|NCT00298272|19632782|P2|STARTED|Double-blind Phase||18
7974306|NCT00298272|19632783|P1|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36
7974307|NCT00298233|19632806|P4|NOT COMPLETED|Overall Study||0
7974308|NCT00298233|19632807|P3|NOT COMPLETED|Overall Study||0
7974309|NCT00298233|19632808|P2|NOT COMPLETED|Overall Study||0
7974310|NCT00298233|19632809|P1|NOT COMPLETED|Overall Study||0
7974311|NCT00298233|19632806|P4|COMPLETED|Overall Study||124
7974312|NCT00298233|19632807|P3|COMPLETED|Overall Study||122
7974313|NCT00298233|19632808|P2|COMPLETED|Overall Study||41
7974314|NCT00298233|19632809|P1|COMPLETED|Overall Study||39
7974315|NCT00298233|19632806|P4|STARTED|Overall Study||124
7974316|NCT00298233|19632807|P3|STARTED|Overall Study||122
7974317|NCT00298233|19632808|P2|STARTED|Overall Study||41
7974318|NCT00298233|19632809|P1|STARTED|Overall Study||39
7974319|NCT00298155|19632828|P3|NOT COMPLETED|Overall Study||0
7974320|NCT00298155|19632829|P2|NOT COMPLETED|Overall Study||0
7974321|NCT00298155|19632830|P1|NOT COMPLETED|Overall Study||0
7974322|NCT00298155|19632828|P3|COMPLETED|Overall Study||13
7974323|NCT00298155|19632829|P2|COMPLETED|Overall Study||10
7974324|NCT00298155|19632830|P1|COMPLETED|Overall Study||12
7974325|NCT00298155|19632828|P3|STARTED|Overall Study||13
7974326|NCT00298155|19632829|P2|STARTED|Overall Study||10
7974327|NCT00298155|19632830|P1|STARTED|Overall Study||12
7974328|NCT00298090|19632841|P1|NOT COMPLETED|Overall Study||18
7974329|NCT00298090|19632841|P1|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29
7974330|NCT00298090|19632841|P1|STARTED|Overall Study||47
7974331|NCT00298038|19632847|P2|NOT COMPLETED|Overall Study||93
7974332|NCT00298038|19632848|P1|NOT COMPLETED|Overall Study||52
7974333|NCT00298038|19632847|P2|COMPLETED|Overall Study||66
7974334|NCT00298038|19632848|P1|COMPLETED|Overall Study||88
7974335|NCT00298038|19632847|P2|Received At Least 1 Dose Of Study Drug|Overall Study||159
7974336|NCT00298038|19632848|P1|Received At Least 1 Dose Of Study Drug|Overall Study||140
7974337|NCT00298038|19632847|P2|STARTED|Overall Study||159
7974338|NCT00298038|19632848|P1|STARTED|Overall Study||140
7974339|NCT00297830|19632867|P3|NOT COMPLETED|12 Month Visit||0
7974340|NCT00297830|19632868|P2|NOT COMPLETED|12 Month Visit||6
7974341|NCT00297830|19632869|P1|NOT COMPLETED|12 Month Visit||1
7974342|NCT00297830|19632867|P3|COMPLETED|12 Month Visit||24
7974343|NCT00297830|19632868|P2|COMPLETED|12 Month Visit||35
7974344|NCT00297830|19632869|P1|COMPLETED|12 Month Visit||37
7974345|NCT00297830|19632867|P3|STARTED|12 Month Visit||24
7974346|NCT00297830|19632868|P2|STARTED|12 Month Visit||41
7974347|NCT00297830|19632869|P1|STARTED|12 Month Visit||38
7974348|NCT00297830|19632867|P3|NOT COMPLETED|6 Month Visit||3
7974349|NCT00297830|19632868|P2|NOT COMPLETED|6 Month Visit||2
7974350|NCT00297830|19632869|P1|NOT COMPLETED|6 Month Visit||3
7974351|NCT00297830|19632867|P3|COMPLETED|6 Month Visit||24
7974352|NCT00297830|19632868|P2|COMPLETED|6 Month Visit||41
7974353|NCT00297830|19632869|P1|COMPLETED|6 Month Visit||38
7974354|NCT00297830|19632867|P3|STARTED|6 Month Visit||27
7974355|NCT00297830|19632868|P2|STARTED|6 Month Visit||43
7974356|NCT00297830|19632869|P1|STARTED|6 Month Visit||41
7974357|NCT00297830|19632867|P3|NOT COMPLETED|Baseline||0
7974358|NCT00297830|19632868|P2|NOT COMPLETED|Baseline||0
7974359|NCT00297830|19632869|P1|NOT COMPLETED|Baseline||0
7974360|NCT00297830|19632867|P3|COMPLETED|Baseline||27
7974361|NCT00297830|19632868|P2|COMPLETED|Baseline||43
7974362|NCT00297830|19632869|P1|COMPLETED|Baseline||41
7974363|NCT00297830|19632867|P3|STARTED|Baseline||27
7974364|NCT00297830|19632868|P2|STARTED|Baseline||43
7974365|NCT00297830|19632869|P1|STARTED|Baseline||41
7974366|NCT00297778|19632888|P2|NOT COMPLETED|Overall Study||20
7974367|NCT00297778|19632889|P1|NOT COMPLETED|Overall Study||19
7974368|NCT00297778|19632888|P2|COMPLETED|Overall Study||124
7974369|NCT00297778|19632889|P1|COMPLETED|Overall Study||133
7974370|NCT00297778|19632888|P2|STARTED|Overall Study||144
7974371|NCT00297778|19632889|P1|STARTED|Overall Study||152
7974372|NCT00297648|19632923|P1|NOT COMPLETED|Overall Study||36
7974373|NCT00297648|19632923|P1|COMPLETED|Overall Study||53
7974374|NCT00297648|19632923|P1|STARTED|Overall Study||89
7974375|NCT00297596|19632962|P1|NOT COMPLETED|Overall Study||0
7974376|NCT00297596|19632962|P1|COMPLETED|Overall Study||25
7974377|NCT00297596|19632962|P1|STARTED|Overall Study||25
7974378|NCT00297492|19632969|P3|NOT COMPLETED|6 Month Follow-up||27
7974379|NCT00297492|19632970|P2|NOT COMPLETED|6 Month Follow-up||49
7974380|NCT00297492|19632971|P1|NOT COMPLETED|6 Month Follow-up||63
7974381|NCT00297492|19632969|P3|COMPLETED|6 Month Follow-up||118
7974382|NCT00297492|19632970|P2|COMPLETED|6 Month Follow-up||237
7974383|NCT00297492|19632971|P1|COMPLETED|6 Month Follow-up||227
7974384|NCT00297492|19632969|P3|STARTED|6 Month Follow-up||145
7974385|NCT00297492|19632970|P2|STARTED|6 Month Follow-up||286
7974386|NCT00297492|19632971|P1|STARTED|6 Month Follow-up||290
7974387|NCT00297492|19632969|P3|NOT COMPLETED|Set Quit Date||5
7974388|NCT00297492|19632970|P2|NOT COMPLETED|Set Quit Date||13
7974389|NCT00297492|19632971|P1|NOT COMPLETED|Set Quit Date||7
7974390|NCT00297492|19632969|P3|COMPLETED|Set Quit Date||145
7974391|NCT00297492|19632970|P2|COMPLETED|Set Quit Date||286
7974392|NCT00297492|19632971|P1|COMPLETED|Set Quit Date||290
7974393|NCT00297492|19632969|P3|STARTED|Set Quit Date||150
7974394|NCT00297492|19632970|P2|STARTED|Set Quit Date||299
7974395|NCT00297492|19632971|P1|STARTED|Set Quit Date||297
7974396|NCT00297479|19632982|P3|NOT COMPLETED|Overall Study||51
7974397|NCT00297479|19632983|P2|NOT COMPLETED|Overall Study||54
7974398|NCT00297479|19632984|P1|NOT COMPLETED|Overall Study||37
7974399|NCT00297479|19632982|P3|COMPLETED|Overall Study||103
7974400|NCT00297479|19632983|P2|COMPLETED|Overall Study||101
7974401|NCT00297479|19632984|P1|COMPLETED|Overall Study||66
7974402|NCT00297479|19632982|P3|26- Week Follow Up|Overall Study||103
7974403|NCT00297479|19632983|P2|26- Week Follow Up|Overall Study||101
7974404|NCT00297479|19632984|P1|26- Week Follow Up|Overall Study||66
7974405|NCT00297479|19632982|P3|4-Week Follow Up|Overall Study||128
7974406|NCT00297479|19632983|P2|4-Week Follow Up|Overall Study||132
7974407|NCT00297479|19632984|P1|4-Week Follow Up|Overall Study||78
7974408|NCT00297479|19632982|P3|STARTED|Overall Study||154
7974409|NCT00297479|19632983|P2|STARTED|Overall Study||155
7974410|NCT00297479|19632984|P1|STARTED|Overall Study||103
7974411|NCT00297427|19633003|P2|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0
7974412|NCT00297427|19633004|P1|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34
7974413|NCT00297427|19633003|P2|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
7974414|NCT00297427|19633004|P1|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60
7974415|NCT00297427|19633003|P2|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
7974416|NCT00297427|19633004|P1|STARTED|Phase 3: Follow-up Post-True Acupuncture||94
7974417|NCT00297427|19633003|P2|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0
7974418|NCT00297427|19633004|P1|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16
7974419|NCT00297427|19633003|P2|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
7974420|NCT00297427|19633004|P1|COMPLETED|Phase 2: Optional Crossover for Sham||38
7974421|NCT00297427|19633003|P2|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
7974422|NCT00297427|19633004|P1|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42
7974423|NCT00297427|19633003|P2|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
7974424|NCT00297427|19633004|P1|STARTED|Phase 2: Optional Crossover for Sham||54
7974425|NCT00297427|19633003|P2|NOT COMPLETED|Phase 1: Initial Intervention||9
7974426|NCT00297427|19633004|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
7974427|NCT00297427|19633003|P2|COMPLETED|Phase 1: Initial Intervention||54
7974428|NCT00297427|19633004|P1|COMPLETED|Phase 1: Initial Intervention||56
7974429|NCT00297427|19633003|P2|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63
7974430|NCT00297427|19633004|P1|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64
7974431|NCT00297258|19633045|P1|NOT COMPLETED|Overall Study||142
7974432|NCT00297258|19633045|P1|COMPLETED|Overall Study||0
7974433|NCT00297258|19633045|P1|STARTED|Overall Study||142
7974434|NCT00297232|19633064|P1|NOT COMPLETED|Overall Study||605
7974435|NCT00297232|19633064|P1|COMPLETED|Overall Study||489
7974436|NCT00297232|19633064|P1|STARTED|Overall Study||1094
7974437|NCT00297167|19633070|P3|NOT COMPLETED|Open-label Dose Normalization Period 2||0
7974438|NCT00297167|19633071|P2|NOT COMPLETED|Open-label Dose Normalization Period 2||0
7974439|NCT00297167|19633072|P1|NOT COMPLETED|Open-label Dose Normalization Period 2||0
7974440|NCT00297167|19633070|P3|COMPLETED|Open-label Dose Normalization Period 2||31
7974441|NCT00297167|19633071|P2|COMPLETED|Open-label Dose Normalization Period 2||0
7974442|NCT00297167|19633072|P1|COMPLETED|Open-label Dose Normalization Period 2||0
7974443|NCT00297167|19633070|P3|STARTED|Open-label Dose Normalization Period 2||31
7974444|NCT00297167|19633071|P2|STARTED|Open-label Dose Normalization Period 2||0
7974445|NCT00297167|19633072|P1|STARTED|Open-label Dose Normalization Period 2||0
7974446|NCT00297167|19633070|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
7974447|NCT00297167|19633071|P2|NOT COMPLETED|Second Double-blind Intervention Period||0
7974448|NCT00297167|19633072|P1|NOT COMPLETED|Second Double-blind Intervention Period||1
7974449|NCT00297167|19633070|P3|COMPLETED|Second Double-blind Intervention Period||0
7974450|NCT00297167|19633071|P2|COMPLETED|Second Double-blind Intervention Period||15
7974451|NCT00297167|19633072|P1|COMPLETED|Second Double-blind Intervention Period||16
7974452|NCT00297167|19633070|P3|STARTED|Second Double-blind Intervention Period||0
7974453|NCT00297167|19633071|P2|STARTED|Second Double-blind Intervention Period||15
7974454|NCT00297167|19633072|P1|STARTED|Second Double-blind Intervention Period||17
7974455|NCT00297167|19633070|P3|NOT COMPLETED|Open-label Dose Normalization Period 1||1
7974456|NCT00297167|19633071|P2|NOT COMPLETED|Open-label Dose Normalization Period 1||0
7974457|NCT00297167|19633072|P1|NOT COMPLETED|Open-label Dose Normalization Period 1||0
7974458|NCT00297167|19633070|P3|COMPLETED|Open-label Dose Normalization Period 1||32
7974459|NCT00297167|19633071|P2|COMPLETED|Open-label Dose Normalization Period 1||0
7974460|NCT00297167|19633072|P1|COMPLETED|Open-label Dose Normalization Period 1||0
7974461|NCT00297167|19633070|P3|STARTED|Open-label Dose Normalization Period 1||33
7974462|NCT00297167|19633071|P2|STARTED|Open-label Dose Normalization Period 1||0
7974463|NCT00297167|19633072|P1|STARTED|Open-label Dose Normalization Period 1||0
7974464|NCT00297167|19633070|P3|NOT COMPLETED|First Double-blind Intervention Period||0
7974465|NCT00297167|19633071|P2|NOT COMPLETED|First Double-blind Intervention Period||0
7974466|NCT00297167|19633072|P1|NOT COMPLETED|First Double-blind Intervention Period||0
7974467|NCT00297167|19633070|P3|COMPLETED|First Double-blind Intervention Period||0
7974468|NCT00297167|19633071|P2|COMPLETED|First Double-blind Intervention Period||16
7974469|NCT00297167|19633072|P1|COMPLETED|First Double-blind Intervention Period||17
7974470|NCT00297167|19633070|P3|STARTED|First Double-blind Intervention Period||0
7974471|NCT00297167|19633071|P2|STARTED|First Double-blind Intervention Period||16
7974472|NCT00297167|19633072|P1|STARTED|First Double-blind Intervention Period||17
7974473|NCT00297115|19633098|P2|NOT COMPLETED|Overall Study||246
7974474|NCT00297115|19633099|P1|NOT COMPLETED|Overall Study||245
7974475|NCT00297115|19633098|P2|COMPLETED|Overall Study||550
7974476|NCT00297115|19633099|P1|COMPLETED|Overall Study||527
7974477|NCT00297115|19633098|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796
7974478|NCT00297115|19633099|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772
7974479|NCT00297102|19633117|P2|NOT COMPLETED|Overall Study||233
7974480|NCT00297102|19633118|P1|NOT COMPLETED|Overall Study||263
7974481|NCT00297102|19633117|P2|COMPLETED|Overall Study||525
7974482|NCT00297102|19633118|P1|COMPLETED|Overall Study||502
7974483|NCT00297102|19633117|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758
7974484|NCT00297102|19633118|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765
7974485|NCT00297037|19633136|P2|NOT COMPLETED|Overall Study||0
7974486|NCT00297037|19633137|P1|NOT COMPLETED|Overall Study||2
7974487|NCT00297037|19633136|P2|COMPLETED|Overall Study||11
7974488|NCT00297037|19633137|P1|COMPLETED|Overall Study||8
7974489|NCT00297037|19633136|P2|STARTED|Overall Study||11
7974490|NCT00297037|19633137|P1|STARTED|Overall Study||10
7974491|NCT00296816|19633149|P1|NOT COMPLETED|Overall Study||74
7974492|NCT00296816|19633149|P1|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58
7974493|NCT00296816|19633149|P1|STARTED|Overall Study||132
7974494|NCT00296725|19633161|P1|NOT COMPLETED|Phase 2: Imipramine (1-6 Weeks)||1
7974495|NCT00296725|19633161|P1|COMPLETED|Phase 2: Imipramine (1-6 Weeks)||7
7974496|NCT00296725|19633161|P1|STARTED|Phase 2: Imipramine (1-6 Weeks)||8
7974497|NCT00296725|19633161|P1|NOT COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||5
7974498|NCT00296725|19633161|P1|COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||12
7974499|NCT00296725|19633161|P1|STARTED|Phase 1: Fluoxetine (1-12 Weeks)||17
7974500|NCT00296647|19633174|P5|NOT COMPLETED|Overall Study||20
7974501|NCT00296647|19633175|P4|NOT COMPLETED|Overall Study||17
7974502|NCT00296647|19633176|P3|NOT COMPLETED|Overall Study||34
7974503|NCT00296647|19633177|P2|NOT COMPLETED|Overall Study||28
7974504|NCT00296647|19633178|P1|NOT COMPLETED|Overall Study||32
7974505|NCT00296647|19633174|P5|COMPLETED|Overall Study||248
7974506|NCT00296647|19633175|P4|COMPLETED|Overall Study||262
7974507|NCT00296647|19633176|P3|COMPLETED|Overall Study||222
7974508|NCT00296647|19633177|P2|COMPLETED|Overall Study||233
7974509|NCT00296647|19633178|P1|COMPLETED|Overall Study||250
7974510|NCT00296647|19633174|P5|STARTED|Overall Study||268
7974511|NCT00296647|19633175|P4|STARTED|Overall Study||279
7974512|NCT00296647|19633176|P3|STARTED|Overall Study||256
7974513|NCT00296647|19633177|P2|STARTED|Overall Study||261
7974514|NCT00296647|19633178|P1|STARTED|Overall Study||282
7974515|NCT00296517|19633192|P2|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62
7974516|NCT00296517|19633193|P1|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45
7974517|NCT00296517|19633192|P2|COMPLETED|Dose Level 3 - Weeks 3-12||99
7974518|NCT00296517|19633193|P1|COMPLETED|Dose Level 3 - Weeks 3-12||112
7974519|NCT00296517|19633192|P2|STARTED|Dose Level 3 - Weeks 3-12||161
7974520|NCT00296517|19633193|P1|STARTED|Dose Level 3 - Weeks 3-12||157
7974521|NCT00296517|19633192|P2|NOT COMPLETED|Dose Level 2 - Week 2||5
7974522|NCT00296517|19633193|P1|NOT COMPLETED|Dose Level 2 - Week 2||2
7974523|NCT00296517|19633192|P2|COMPLETED|Dose Level 2 - Week 2||161
7974524|NCT00296517|19633193|P1|COMPLETED|Dose Level 2 - Week 2||157
7974525|NCT00296517|19633192|P2|STARTED|Dose Level 2 - Week 2||166
7974526|NCT00296517|19633193|P1|STARTED|Dose Level 2 - Week 2||159
7974527|NCT00296517|19633192|P2|NOT COMPLETED|Dose Level 1 - Week 1||0
7974528|NCT00296517|19633193|P1|NOT COMPLETED|Dose Level 1 - Week 1||0
7974529|NCT00296517|19633192|P2|COMPLETED|Dose Level 1 - Week 1||166
7974530|NCT00296517|19633193|P1|COMPLETED|Dose Level 1 - Week 1||159
7974531|NCT00296517|19633192|P2|STARTED|Dose Level 1 - Week 1||166
7974532|NCT00296517|19633193|P1|STARTED|Dose Level 1 - Week 1||159
7974533|NCT00296504|19633229|P9|NOT COMPLETED|Final Analysis||21
7974534|NCT00296504|19633230|P8|NOT COMPLETED|Final Analysis||0
7974535|NCT00296504|19633231|P7|NOT COMPLETED|Final Analysis||0
7974536|NCT00296504|19633232|P6|NOT COMPLETED|Final Analysis||0
7974537|NCT00296504|19633233|P5|NOT COMPLETED|Final Analysis||0
7974538|NCT00296504|19633234|P4|NOT COMPLETED|Final Analysis||0
7974539|NCT00296504|19633235|P3|NOT COMPLETED|Final Analysis||0
7974540|NCT00296504|19633236|P2|NOT COMPLETED|Final Analysis||0
7974541|NCT00296504|19633237|P1|NOT COMPLETED|Final Analysis||0
7974542|NCT00296504|19633229|P9|COMPLETED|Final Analysis||90
7974543|NCT00296504|19633230|P8|COMPLETED|Final Analysis||0
7974544|NCT00296504|19633231|P7|COMPLETED|Final Analysis||0
7974545|NCT00296504|19633232|P6|COMPLETED|Final Analysis||0
7974546|NCT00296504|19633233|P5|COMPLETED|Final Analysis||0
7974547|NCT00296504|19633234|P4|COMPLETED|Final Analysis||0
7974548|NCT00296504|19633235|P3|COMPLETED|Final Analysis||0
7974549|NCT00296504|19633236|P2|COMPLETED|Final Analysis||0
7974550|NCT00296504|19633237|P1|COMPLETED|Final Analysis||0
7974551|NCT00296504|19633229|P9|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111
7974552|NCT00296504|19633230|P8|STARTED|Final Analysis||0
7974553|NCT00296504|19633231|P7|STARTED|Final Analysis||0
7974554|NCT00296504|19633232|P6|STARTED|Final Analysis||0
7974555|NCT00296504|19633233|P5|STARTED|Final Analysis||0
7974556|NCT00296504|19633234|P4|STARTED|Final Analysis||0
7974557|NCT00296504|19633235|P3|STARTED|Final Analysis||0
7974558|NCT00296504|19633236|P2|STARTED|Final Analysis||0
7974559|NCT00296504|19633237|P1|STARTED|Final Analysis||0
7974560|NCT00296504|19633229|P9|NOT COMPLETED|Interim Analysis||0
7974561|NCT00296504|19633230|P8|NOT COMPLETED|Interim Analysis||49
7974562|NCT00296504|19633231|P7|NOT COMPLETED|Interim Analysis||74
7974563|NCT00296504|19633232|P6|NOT COMPLETED|Interim Analysis||37
7974564|NCT00296504|19633233|P5|NOT COMPLETED|Interim Analysis||37
7974565|NCT00296504|19633234|P4|NOT COMPLETED|Interim Analysis||43
7974566|NCT00296504|19633235|P3|NOT COMPLETED|Interim Analysis||105
7974567|NCT00296504|19633236|P2|NOT COMPLETED|Interim Analysis||18
7974568|NCT00296504|19633237|P1|NOT COMPLETED|Interim Analysis||76
7974569|NCT00296504|19633229|P9|COMPLETED|Interim Analysis||0
7974570|NCT00296504|19633230|P8|COMPLETED|Interim Analysis||37
7974571|NCT00296504|19633231|P7|COMPLETED|Interim Analysis||30
7974572|NCT00296504|19633232|P6|COMPLETED|Interim Analysis||41
7974573|NCT00296504|19633233|P5|COMPLETED|Interim Analysis||36
7974574|NCT00296504|19633234|P4|COMPLETED|Interim Analysis||11
7974575|NCT00296504|19633235|P3|COMPLETED|Interim Analysis||116
7974576|NCT00296504|19633236|P2|COMPLETED|Interim Analysis||0
7974577|NCT00296504|19633237|P1|COMPLETED|Interim Analysis||43
7974578|NCT00296504|19633229|P9|Ongoing|Interim Analysis||0
7974579|NCT00296504|19633230|P8|Ongoing|Interim Analysis||1
7974580|NCT00296504|19633231|P7|Ongoing|Interim Analysis||30
7974581|NCT00296504|19633232|P6|Ongoing|Interim Analysis||0
7974582|NCT00296504|19633233|P5|Ongoing|Interim Analysis||0
7974583|NCT00296504|19633234|P4|Ongoing|Interim Analysis||22
7974584|NCT00296504|19633235|P3|Ongoing|Interim Analysis||16
7974585|NCT00296504|19633236|P2|Ongoing|Interim Analysis||12
7974586|NCT00296504|19633237|P1|Ongoing|Interim Analysis||32
7974587|NCT00296504|19633229|P9|STARTED|Interim Analysis||0
7974588|NCT00296504|19633230|P8|STARTED|Interim Analysis||86
7974589|NCT00296504|19633231|P7|STARTED|Interim Analysis||104
7974590|NCT00296504|19633232|P6|STARTED|Interim Analysis||78
7974591|NCT00296504|19633233|P5|STARTED|Interim Analysis||73
7974592|NCT00296504|19633234|P4|STARTED|Interim Analysis||54
7974593|NCT00296504|19633235|P3|STARTED|Interim Analysis||221
7974594|NCT00296504|19633236|P2|STARTED|Interim Analysis||18
7974595|NCT00296504|19633237|P1|STARTED|Interim Analysis||119
7974596|NCT00296491|19633330|P4|NOT COMPLETED|Overall Study||43
7974597|NCT00296491|19633331|P3|NOT COMPLETED|Overall Study||43
7974598|NCT00296491|19633332|P2|NOT COMPLETED|Overall Study||53
7974599|NCT00296491|19633333|P1|NOT COMPLETED|Overall Study||42
7974600|NCT00296491|19633330|P4|COMPLETED|Overall Study||138
7974601|NCT00296491|19633331|P3|COMPLETED|Overall Study||137
7974602|NCT00296491|19633332|P2|COMPLETED|Overall Study||129
7974603|NCT00296491|19633333|P1|COMPLETED|Overall Study||140
7974604|NCT00296491|19633330|P4|STARTED|Overall Study||181
7974605|NCT00296491|19633331|P3|STARTED|Overall Study||180
7974606|NCT00296491|19633332|P2|STARTED|Overall Study||182
7974607|NCT00296491|19633333|P1|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182
7974608|NCT00296400|19633362|P3|NOT COMPLETED|Overall Study||13
7974609|NCT00296400|19633363|P2|NOT COMPLETED|Overall Study||18
7974610|NCT00296400|19633364|P1|NOT COMPLETED|Overall Study||17
7974611|NCT00296400|19633362|P3|COMPLETED|Overall Study||67
7974612|NCT00296400|19633363|P2|COMPLETED|Overall Study||69
7974613|NCT00296400|19633364|P1|COMPLETED|Overall Study||53
7974614|NCT00296400|19633362|P3|STARTED|Overall Study||80
7974615|NCT00296400|19633363|P2|STARTED|Overall Study||87
7974616|NCT00296400|19633364|P1|STARTED|Overall Study||70
7974617|NCT00296374|19633588|P3|NOT COMPLETED|Overall Study||29
7974618|NCT00296374|19633589|P2|NOT COMPLETED|Overall Study||23
7974619|NCT00296374|19633590|P1|NOT COMPLETED|Overall Study||25
7974620|NCT00296374|19633588|P3|COMPLETED|Overall Study||82
7974621|NCT00296374|19633589|P2|COMPLETED|Overall Study||101
7974622|NCT00296374|19633590|P1|COMPLETED|Overall Study||93
7974623|NCT00296374|19633588|P3|STARTED|Overall Study||111
7974624|NCT00296374|19633589|P2|STARTED|Overall Study||124
7974625|NCT00296374|19633590|P1|STARTED|Overall Study||118
7974626|NCT00296335|19633813|P2|NOT COMPLETED|Overall Study||122
7974627|NCT00296335|19633814|P1|NOT COMPLETED|Overall Study||30
7974628|NCT00296335|19633813|P2|COMPLETED|Overall Study||309
7974629|NCT00296335|19633814|P1|COMPLETED|Overall Study||394
7974630|NCT00296335|19633813|P2|STARTED|Overall Study||431
7974631|NCT00296335|19633814|P1|STARTED|Overall Study||424
7974632|NCT00296322|19633826|P2|NOT COMPLETED|Overall Study||79
7974633|NCT00296322|19633827|P1|NOT COMPLETED|Overall Study||21
7974634|NCT00296322|19633826|P2|COMPLETED|Overall Study||184
7974635|NCT00296322|19633827|P1|COMPLETED|Overall Study||237
7974636|NCT00296322|19633826|P2|STARTED|Overall Study||263
7974637|NCT00296322|19633827|P1|STARTED|Overall Study||258
7974638|NCT00296296|19633839|P2|NOT COMPLETED|Overall Study||13
7974639|NCT00296296|19633840|P1|NOT COMPLETED|Overall Study||2
7974640|NCT00296296|19633839|P2|COMPLETED|Overall Study||5
7974641|NCT00296296|19633840|P1|COMPLETED|Overall Study||9
7974642|NCT00296296|19633839|P2|STARTED|Overall Study||18
7974643|NCT00296296|19633840|P1|STARTED|Overall Study||11
7974644|NCT00296244|19633854|P2|NOT COMPLETED|Overall Study||1
7974645|NCT00296244|19633855|P1|NOT COMPLETED|Overall Study||0
7974646|NCT00296244|19633854|P2|COMPLETED|Overall Study||19
7974647|NCT00296244|19633855|P1|COMPLETED|Overall Study||20
7974648|NCT00296244|19633854|P2|STARTED|Overall Study||20
7974649|NCT00296244|19633855|P1|STARTED|Overall Study||20
7974650|NCT00296231|19633871|P1|NOT COMPLETED|Overall Study||0
7974651|NCT00296231|19633871|P1|COMPLETED|Overall Study||14
7974652|NCT00296231|19633871|P1|STARTED|Overall Study||14
7974653|NCT00296192|19633881|P5|NOT COMPLETED|Overall Study||0
7974654|NCT00296192|19633882|P4|NOT COMPLETED|Overall Study||0
7974655|NCT00296192|19633883|P3|NOT COMPLETED|Overall Study||0
7974656|NCT00296192|19633884|P2|NOT COMPLETED|Overall Study||0
7974657|NCT00296192|19633885|P1|NOT COMPLETED|Overall Study||0
7974658|NCT00296192|19633881|P5|COMPLETED|Overall Study||16
7974659|NCT00296192|19633882|P4|COMPLETED|Overall Study||17
7974660|NCT00296192|19633883|P3|COMPLETED|Overall Study||16
7974661|NCT00296192|19633884|P2|COMPLETED|Overall Study||16
7974662|NCT00296192|19633885|P1|COMPLETED|Overall Study||17
7974663|NCT00296192|19633881|P5|STARTED|Overall Study||16
7974664|NCT00296192|19633882|P4|STARTED|Overall Study||17
7974665|NCT00296192|19633883|P3|STARTED|Overall Study||16
7974666|NCT00296192|19633884|P2|STARTED|Overall Study||16
7974667|NCT00296192|19633885|P1|STARTED|Overall Study||17
7974668|NCT00296140|19633919|P2|NOT COMPLETED|Overall Study||0
7974669|NCT00296140|19633920|P1|NOT COMPLETED|Overall Study||3
7974670|NCT00296140|19633919|P2|COMPLETED|Overall Study||33
7974671|NCT00296140|19633920|P1|COMPLETED|Overall Study||30
7974672|NCT00296140|19633919|P2|STARTED|Overall Study||33
7974673|NCT00296140|19633920|P1|STARTED|Overall Study||33
7974674|NCT00296036|19633932|P6|NOT COMPLETED|Overall Study||4
7974675|NCT00296036|19633933|P5|NOT COMPLETED|Overall Study||2
7974676|NCT00296036|19633934|P4|NOT COMPLETED|Overall Study||1
7974677|NCT00296036|19633935|P3|NOT COMPLETED|Overall Study||2
7974678|NCT00296036|19633936|P2|NOT COMPLETED|Overall Study||0
7974679|NCT00296036|19633937|P1|NOT COMPLETED|Overall Study||1
7974680|NCT00296036|19633932|P6|COMPLETED|Overall Study||28
7974681|NCT00296036|19633933|P5|COMPLETED|Overall Study||31
7974682|NCT00296036|19633934|P4|COMPLETED|Overall Study||16
7974683|NCT00296036|19633935|P3|COMPLETED|Overall Study||16
7974684|NCT00296036|19633936|P2|COMPLETED|Overall Study||18
7974685|NCT00296036|19633937|P1|COMPLETED|Overall Study||18
7974686|NCT00296036|19633932|P6|STARTED|Overall Study||32
7974687|NCT00296036|19633933|P5|STARTED|Overall Study||33
7974688|NCT00296036|19633934|P4|STARTED|Overall Study||17
7974689|NCT00296036|19633935|P3|STARTED|Overall Study||18
7974690|NCT00296036|19633936|P2|STARTED|Overall Study||18
7974691|NCT00296036|19633937|P1|STARTED|Overall Study||19
7974692|NCT00295932|19633974|P11|NOT COMPLETED|Overall Study||1
7974693|NCT00295932|19633975|P10|NOT COMPLETED|Overall Study||0
7974694|NCT00295932|19633976|P9|NOT COMPLETED|Overall Study||0
7974695|NCT00295932|19633977|P8|NOT COMPLETED|Overall Study||0
7974696|NCT00295932|19633978|P7|NOT COMPLETED|Overall Study||0
7974697|NCT00295932|19633979|P6|NOT COMPLETED|Overall Study||0
7974698|NCT00295932|19633980|P5|NOT COMPLETED|Overall Study||0
7974699|NCT00295932|19633981|P4|NOT COMPLETED|Overall Study||0
7974700|NCT00295932|19633982|P3|NOT COMPLETED|Overall Study||0
7974701|NCT00295932|19633983|P2|NOT COMPLETED|Overall Study||0
7974702|NCT00295932|19633984|P1|NOT COMPLETED|Overall Study||0
7974703|NCT00295932|19633974|P11|COMPLETED|Overall Study||12
7974704|NCT00295932|19633975|P10|COMPLETED|Overall Study||12
7974705|NCT00295932|19633976|P9|COMPLETED|Overall Study||10
7974706|NCT00295932|19633977|P8|COMPLETED|Overall Study||4
7974707|NCT00295932|19633978|P7|COMPLETED|Overall Study||3
7974708|NCT00295932|19633979|P6|COMPLETED|Overall Study||18
7974709|NCT00295932|19633980|P5|COMPLETED|Overall Study||2
7974710|NCT00295932|19633981|P4|COMPLETED|Overall Study||4
7974711|NCT00295932|19633982|P3|COMPLETED|Overall Study||3
7974712|NCT00295932|19633983|P2|COMPLETED|Overall Study||6
7974713|NCT00295932|19633984|P1|COMPLETED|Overall Study||4
7974714|NCT00295932|19633974|P11|STARTED|Overall Study||13
7974715|NCT00295932|19633975|P10|STARTED|Overall Study||12
7974716|NCT00295932|19633976|P9|STARTED|Overall Study||10
7974717|NCT00295932|19633977|P8|STARTED|Overall Study||4
7974718|NCT00295932|19633978|P7|STARTED|Overall Study||3
7974719|NCT00295932|19633979|P6|STARTED|Overall Study||18
7974720|NCT00295932|19633980|P5|STARTED|Overall Study||2
7974721|NCT00295932|19633981|P4|STARTED|Overall Study||4
7974722|NCT00295932|19633982|P3|STARTED|Overall Study||3
7974723|NCT00295932|19633983|P2|STARTED|Overall Study||6
7974724|NCT00295932|19633984|P1|STARTED|Overall Study||4
7974725|NCT00295880|19634018|P1|NOT COMPLETED|Overall Study||2
7974726|NCT00295880|19634018|P1|COMPLETED|Overall Study||10
7974727|NCT00295880|19634018|P1|STARTED|Overall Study||12
7974728|NCT00295867|19634029|P1|NOT COMPLETED|Overall Study||11
7974729|NCT00295867|19634029|P1|COMPLETED|Overall Study||34
7974730|NCT00295867|19634029|P1|STARTED|Overall Study||45
7974731|NCT00295854|19634038|P3|NOT COMPLETED|Overall Study||15
7974732|NCT00295854|19634039|P2|NOT COMPLETED|Overall Study||21
7974733|NCT00295854|19634040|P1|NOT COMPLETED|Overall Study||18
7974734|NCT00295854|19634038|P3|COMPLETED|Overall Study||87
7974735|NCT00295854|19634039|P2|COMPLETED|Overall Study||87
7974736|NCT00295854|19634040|P1|COMPLETED|Overall Study||77
7974737|NCT00295854|19634038|P3|ITT Population (N=296)|Overall Study||99
7974738|NCT00295854|19634039|P2|ITT Population (N=296)|Overall Study||105
7974739|NCT00295854|19634040|P1|ITT Population (N=296)|Overall Study||92
7974740|NCT00295854|19634038|P3|Safety Population (N=304)|Overall Study||101
7974741|NCT00295854|19634039|P2|Safety Population (N=304)|Overall Study||108
7974742|NCT00295854|19634040|P1|Safety Population (N=304)|Overall Study||95
7974743|NCT00295854|19634038|P3|STARTED|Overall Study||102
7974744|NCT00295854|19634039|P2|STARTED|Overall Study||108
7974745|NCT00295854|19634040|P1|STARTED|Overall Study||95
7974746|NCT00295750|19634054|P3|NOT COMPLETED|Overall Study||32
7974747|NCT00295750|19634055|P2|NOT COMPLETED|Overall Study||41
7974748|NCT00295750|19634056|P1|NOT COMPLETED|Overall Study||43
7974749|NCT00295750|19634054|P3|COMPLETED|Overall Study||172
7974750|NCT00295750|19634055|P2|COMPLETED|Overall Study||169
7974751|NCT00295750|19634056|P1|COMPLETED|Overall Study||163
7974752|NCT00295750|19634054|P3|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201
7974753|NCT00295750|19634055|P2|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207
7974754|NCT00295750|19634056|P1|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202
7974755|NCT00295750|19634054|P3|STARTED|Overall Study|randomized|204
7974756|NCT00295750|19634055|P2|STARTED|Overall Study|randomized|210
7974757|NCT00295750|19634056|P1|STARTED|Overall Study|randomized|206
7974758|NCT00295633|19634091|P3|NOT COMPLETED|Overall Study||76
7974759|NCT00295633|19634092|P2|NOT COMPLETED|Overall Study||67
7974760|NCT00295633|19634093|P1|NOT COMPLETED|Overall Study||62
7974761|NCT00295633|19634091|P3|COMPLETED|Overall Study||108
7974762|NCT00295633|19634092|P2|COMPLETED|Overall Study||119
7974763|NCT00295633|19634093|P1|COMPLETED|Overall Study||133
7974764|NCT00295633|19634091|P3|Completed Study Without Being Rescued|Overall Study||51
7974765|NCT00295633|19634092|P2|Completed Study Without Being Rescued|Overall Study||82
7974766|NCT00295633|19634093|P1|Completed Study Without Being Rescued|Overall Study||88
7974767|NCT00295633|19634091|P3|STARTED|Overall Study||184
7974768|NCT00295633|19634092|P2|STARTED|Overall Study||186
7974769|NCT00295633|19634093|P1|STARTED|Overall Study||195
7974770|NCT00295620|19634112|P2|NOT COMPLETED|Overall Study||896
7974771|NCT00295620|19634113|P1|NOT COMPLETED|Overall Study||872
7974772|NCT00295620|19634112|P2|COMPLETED|Overall Study||842
7974773|NCT00295620|19634113|P1|COMPLETED|Overall Study||860
7974774|NCT00295620|19634112|P2|Safety Analysis Set|Overall Study||1710
7974775|NCT00295620|19634113|P1|Safety Analysis Set|Overall Study||1705
7974776|NCT00295620|19634112|P2|STARTED|Overall Study||1738
7974777|NCT00295620|19634113|P1|STARTED|Overall Study||1732
7974778|NCT00295503|19634127|P1|NOT COMPLETED|Overall Study||0
7974779|NCT00295503|19634127|P1|COMPLETED|Overall Study||53
7974780|NCT00295503|19634127|P1|STARTED|Overall Study||53
7974781|NCT00295490|19634137|P4|NOT COMPLETED|Overall Study||5
7974782|NCT00295490|19634138|P3|NOT COMPLETED|Overall Study||4
7974783|NCT00295490|19634139|P2|NOT COMPLETED|Overall Study||4
7974784|NCT00295490|19634140|P1|NOT COMPLETED|Overall Study||1
7974785|NCT00295490|19634137|P4|COMPLETED|Overall Study||12
7974786|NCT00295490|19634138|P3|COMPLETED|Overall Study||12
7974787|NCT00295490|19634139|P2|COMPLETED|Overall Study||15
7974788|NCT00295490|19634140|P1|COMPLETED|Overall Study||14
7974789|NCT00295490|19634137|P4|STARTED|Overall Study||17
7974790|NCT00295490|19634138|P3|STARTED|Overall Study||16
7974791|NCT00295490|19634139|P2|STARTED|Overall Study||19
7974792|NCT00295490|19634140|P1|STARTED|Overall Study||15
7974793|NCT00295061|19634180|P2|NOT COMPLETED|Overall Study||0
7974794|NCT00295061|19634181|P1|NOT COMPLETED|Overall Study||0
7974795|NCT00295061|19634180|P2|COMPLETED|Overall Study||12
7974796|NCT00295061|19634181|P1|COMPLETED|Overall Study||12
7974797|NCT00295061|19634180|P2|STARTED|Overall Study||12
7974798|NCT00295061|19634181|P1|STARTED|Overall Study||12
7974799|NCT00295022|19634190|P3|NOT COMPLETED|Overall Study||5
7974800|NCT00295022|19634191|P2|NOT COMPLETED|Overall Study||1
7974801|NCT00295022|19634192|P1|NOT COMPLETED|Overall Study||1
7974802|NCT00295022|19634190|P3|COMPLETED|Overall Study||151
7974803|NCT00295022|19634191|P2|COMPLETED|Overall Study||156
7974804|NCT00295022|19634192|P1|COMPLETED|Overall Study||104
7974805|NCT00295022|19634190|P3|STARTED|Overall Study||156
7974806|NCT00295022|19634191|P2|STARTED|Overall Study||157
7974807|NCT00295022|19634192|P1|STARTED|Overall Study||105
7974808|NCT00295009|19634281|P6|NOT COMPLETED|Overall Study||269
7974809|NCT00295009|19634282|P5|NOT COMPLETED|Overall Study||58
7974810|NCT00295009|19634283|P4|NOT COMPLETED|Overall Study||25
7974811|NCT00295009|19634284|P3|NOT COMPLETED|Overall Study||12
7974812|NCT00295009|19634285|P2|NOT COMPLETED|Overall Study||49
7974813|NCT00295009|19634286|P1|NOT COMPLETED|Overall Study||41
7974814|NCT00295009|19634281|P6|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0
7974815|NCT00295009|19634282|P5|COMPLETED|Overall Study|Completed 60 month visit|116
7974816|NCT00295009|19634283|P4|COMPLETED|Overall Study|Completed 60 month visit|57
7974817|NCT00295009|19634284|P3|COMPLETED|Overall Study|Completed 60 month visit|39
7974818|NCT00295009|19634285|P2|COMPLETED|Overall Study|Completed 60 month visit|134
7974819|NCT00295009|19634286|P1|COMPLETED|Overall Study|Completed 60 month visit|52
7974820|NCT00295009|19634281|P6|Completed 24 Month Analysis|Overall Study||198
7974821|NCT00295009|19634282|P5|Completed 24 Month Analysis|Overall Study||133
7974822|NCT00295009|19634283|P4|Completed 24 Month Analysis|Overall Study||60
7974823|NCT00295009|19634284|P3|Completed 24 Month Analysis|Overall Study||45
7974824|NCT00295009|19634285|P2|Completed 24 Month Analysis|Overall Study||148
7974825|NCT00295009|19634286|P1|Completed 24 Month Analysis|Overall Study||71
7974826|NCT00295009|19634281|P6|Treated|Overall Study||259
7974827|NCT00295009|19634282|P5|Treated|Overall Study||165
7974828|NCT00295009|19634283|P4|Treated|Overall Study||72
7974829|NCT00295009|19634284|P3|Treated|Overall Study||50
7974830|NCT00295009|19634285|P2|Treated|Overall Study||162
7974831|NCT00295009|19634286|P1|Treated|Overall Study||80
7974832|NCT00295009|19634281|P6|STARTED|Overall Study||269
7974833|NCT00295009|19634282|P5|STARTED|Overall Study||174
7974834|NCT00295009|19634283|P4|STARTED|Overall Study||82
7974835|NCT00295009|19634284|P3|STARTED|Overall Study||51
7974836|NCT00295009|19634285|P2|STARTED|Overall Study||183
7974837|NCT00295009|19634286|P1|STARTED|Overall Study||93
7974838|NCT00294762|19634308|P2|NOT COMPLETED|Overall Study||3
7974839|NCT00294762|19634309|P1|NOT COMPLETED|Overall Study||3
7974840|NCT00294762|19634308|P2|COMPLETED|Overall Study||68
7974841|NCT00294762|19634309|P1|COMPLETED|Overall Study||69
7974842|NCT00294762|19634308|P2|STARTED|Overall Study||71
7974843|NCT00294762|19634309|P1|STARTED|Overall Study||72
7974844|NCT00294723|19634328|P3|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20
7974845|NCT00294723|19634329|P2|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21
7974846|NCT00294723|19634330|P1|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28
7974847|NCT00294723|19634328|P3|COMPLETED|Additional Open-Label Extension 91 Weeks||8
7974848|NCT00294723|19634329|P2|COMPLETED|Additional Open-Label Extension 91 Weeks||32
7974849|NCT00294723|19634330|P1|COMPLETED|Additional Open-Label Extension 91 Weeks||34
7974850|NCT00294723|19634328|P3|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28
7974851|NCT00294723|19634329|P2|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53
7974852|NCT00294723|19634330|P1|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62
7974853|NCT00294723|19634328|P3|NOT COMPLETED|Open-Label Extension 52 Weeks||40
7974854|NCT00294723|19634329|P2|NOT COMPLETED|Open-Label Extension 52 Weeks||39
7974855|NCT00294723|19634330|P1|NOT COMPLETED|Open-Label Extension 52 Weeks||40
7974856|NCT00294723|19634328|P3|COMPLETED|Open-Label Extension 52 Weeks||97
7974857|NCT00294723|19634329|P2|COMPLETED|Open-Label Extension 52 Weeks||110
7974858|NCT00294723|19634330|P1|COMPLETED|Open-Label Extension 52 Weeks||114
7974859|NCT00294723|19634328|P3|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137
7974860|NCT00294723|19634329|P2|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149
7974861|NCT00294723|19634330|P1|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154
7974862|NCT00294723|19634328|P3|NOT COMPLETED|Double-Blind Period 52 Weeks||96
7974863|NCT00294723|19634329|P2|NOT COMPLETED|Double-Blind Period 52 Weeks||89
7974864|NCT00294723|19634330|P1|NOT COMPLETED|Double-Blind Period 52 Weeks||74
7974865|NCT00294723|19634328|P3|COMPLETED|Double-Blind Period 52 Weeks||152
7974866|NCT00294723|19634329|P2|COMPLETED|Double-Blind Period 52 Weeks||162
7974867|NCT00294723|19634330|P1|COMPLETED|Double-Blind Period 52 Weeks||173
7974868|NCT00294723|19634328|P3|Exposed to Study Drug|Double-Blind Period 52 Weeks||248
7974869|NCT00294723|19634329|P2|Exposed to Study Drug|Double-Blind Period 52 Weeks||251
7974870|NCT00294723|19634330|P1|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246
7974871|NCT00294723|19634328|P3|STARTED|Double-Blind Period 52 Weeks|Randomised|248
7974872|NCT00294723|19634329|P2|STARTED|Double-Blind Period 52 Weeks|Randomised|251
7974873|NCT00294723|19634330|P1|STARTED|Double-Blind Period 52 Weeks|Randomised|247
7974874|NCT00294684|19634391|P2|NOT COMPLETED|Overall Study||8
7974875|NCT00294684|19634392|P1|NOT COMPLETED|Overall Study||5
7974876|NCT00294684|19634391|P2|COMPLETED|Overall Study||62
7974877|NCT00294684|19634392|P1|COMPLETED|Overall Study||65
7974878|NCT00294684|19634391|P2|STARTED|Overall Study||70
7974879|NCT00294684|19634392|P1|STARTED|Overall Study||70
7974880|NCT00294671|19634432|P2|NOT COMPLETED|Overall Study||40
7974881|NCT00294671|19634433|P1|NOT COMPLETED|Overall Study||27
7974882|NCT00294671|19634432|P2|COMPLETED|Overall Study||26
7974883|NCT00294671|19634433|P1|COMPLETED|Overall Study||37
7974884|NCT00294671|19634432|P2|STARTED|Overall Study||66
7974885|NCT00294671|19634433|P1|STARTED|Overall Study||64
7974886|NCT00294658|19634449|P2|NOT COMPLETED|Overall Study||9
7974887|NCT00294658|19634450|P1|NOT COMPLETED|Overall Study||6
7974888|NCT00294658|19634449|P2|COMPLETED|Overall Study||51
7974889|NCT00294658|19634450|P1|COMPLETED|Overall Study||60
7974890|NCT00294658|19634449|P2|STARTED|Overall Study||60
7974891|NCT00294658|19634450|P1|STARTED|Overall Study||66
7974892|NCT00294645|19634514|P2|NOT COMPLETED|Overall Study||92
7974893|NCT00294645|19634515|P1|NOT COMPLETED|Overall Study||48
7974894|NCT00294645|19634514|P2|COMPLETED|Overall Study||510
7974895|NCT00294645|19634515|P1|COMPLETED|Overall Study||247
7974896|NCT00294645|19634514|P2|STARTED|Overall Study||602
7974897|NCT00294645|19634515|P1|STARTED|Overall Study||295
7974898|NCT00294632|19634549|P2|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
7974899|NCT00294632|19634550|P1|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
7974900|NCT00294632|19634549|P2|COMPLETED|Phase II: 20 mg Lenalidomide||38
7974901|NCT00294632|19634550|P1|COMPLETED|Phase II: 20 mg Lenalidomide||6
7974902|NCT00294632|19634549|P2|STARTED|Phase II: 20 mg Lenalidomide||38
7974903|NCT00294632|19634550|P1|STARTED|Phase II: 20 mg Lenalidomide||6
7974904|NCT00294632|19634549|P2|NOT COMPLETED|Phase I Dose Escalation Period||0
7974905|NCT00294632|19634550|P1|NOT COMPLETED|Phase I Dose Escalation Period||0
7974906|NCT00294632|19634549|P2|COMPLETED|Phase I Dose Escalation Period||0
7974907|NCT00294632|19634550|P1|COMPLETED|Phase I Dose Escalation Period||14
7974908|NCT00294632|19634549|P2|Cohort 4: 25 mg|Phase I Dose Escalation Period||0
7974909|NCT00294632|19634550|P1|Cohort 4: 25 mg|Phase I Dose Escalation Period||2
7974910|NCT00294632|19634549|P2|Cohort 3: 20 mg|Phase I Dose Escalation Period||0
7974911|NCT00294632|19634550|P1|Cohort 3: 20 mg|Phase I Dose Escalation Period||6
7974912|NCT00294632|19634549|P2|Cohort 2: 15 mg|Phase I Dose Escalation Period||0
7974913|NCT00294632|19634550|P1|Cohort 2: 15 mg|Phase I Dose Escalation Period||3
7974914|NCT00294632|19634549|P2|Cohort 1: 10 mg|Phase I Dose Escalation Period||0
7974915|NCT00294632|19634550|P1|Cohort 1: 10 mg|Phase I Dose Escalation Period||3
7974916|NCT00294632|19634549|P2|STARTED|Phase I Dose Escalation Period||0
7974917|NCT00294632|19634550|P1|STARTED|Phase I Dose Escalation Period||14
7974918|NCT00294554|19634559|P2|NOT COMPLETED|Overall Study||2
7974919|NCT00294554|19634560|P1|NOT COMPLETED|Overall Study||0
7974920|NCT00294554|19634559|P2|COMPLETED|Overall Study|"1 S withdrew @ 20 wks for lack perceived benefit
~1 S withdrawn @ 13 wks b/o extreme agitation"|8
7974921|NCT00294554|19634560|P1|COMPLETED|Overall Study||10
7974922|NCT00294554|19634559|P2|STARTED|Overall Study||10
7974923|NCT00294554|19634560|P1|STARTED|Overall Study||10
7974924|NCT00294515|19634570|P2|NOT COMPLETED|Overall Study||28
7974925|NCT00294515|19634571|P1|NOT COMPLETED|Overall Study||34
7974926|NCT00294515|19634570|P2|COMPLETED|Overall Study||132
7974927|NCT00294515|19634571|P1|COMPLETED|Overall Study||132
7974928|NCT00294515|19634570|P2|STARTED|Overall Study|Randomized|160
7974929|NCT00294515|19634571|P1|STARTED|Overall Study|Randomized|166
7974930|NCT00294398|19634587|P2|NOT COMPLETED|Overall Study||26
7974931|NCT00294398|19634588|P1|NOT COMPLETED|Overall Study||21
7974932|NCT00294398|19634587|P2|COMPLETED|Overall Study||48
7974933|NCT00294398|19634588|P1|COMPLETED|Overall Study||57
7974934|NCT00294398|19634587|P2|STARTED|Overall Study||74
7974935|NCT00294398|19634588|P1|STARTED|Overall Study||78
7974936|NCT00294060|19634596|P1|NOT COMPLETED|Overall Study||1173
7974937|NCT00294060|19634596|P1|COMPLETED|Overall Study||840
7974938|NCT00294060|19634596|P1|STARTED|Overall Study||2013
7974939|NCT00294047|19634604|P2|NOT COMPLETED|Month 84||989
7974940|NCT00294047|19634605|P1|NOT COMPLETED|Month 84||973
7974941|NCT00294047|19634604|P2|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881
7974942|NCT00294047|19634605|P1|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904
7974943|NCT00294047|19634604|P2|STARTED|Month 84||2870
7974944|NCT00294047|19634605|P1|STARTED|Month 84||2877
7974945|NCT00294047|19634604|P2|NOT COMPLETED|Month 48||433
7974946|NCT00294047|19634605|P1|NOT COMPLETED|Month 48||425
7974947|NCT00294047|19634604|P2|COMPLETED|Month 48||2438
7974948|NCT00294047|19634605|P1|COMPLETED|Month 48||2456
7974949|NCT00294047|19634604|P2|Participated up to Month 48|Month 48||2281
7974950|NCT00294047|19634605|P1|Participated up to Month 48|Month 48||2305
7974951|NCT00294047|19634604|P2|STARTED|Month 48||2871
7974952|NCT00294047|19634605|P1|STARTED|Month 48||2881
7974953|NCT00293813|19634710|P3|NOT COMPLETED|Overall Study||8
7974954|NCT00293813|19634711|P2|NOT COMPLETED|Overall Study||9
7974955|NCT00293813|19634712|P1|NOT COMPLETED|Overall Study||13
7974956|NCT00293813|19634710|P3|COMPLETED|Overall Study||74
7974957|NCT00293813|19634711|P2|COMPLETED|Overall Study||74
7974958|NCT00293813|19634712|P1|COMPLETED|Overall Study||69
7974959|NCT00293813|19634710|P3|STARTED|Overall Study||82
7974960|NCT00293813|19634711|P2|STARTED|Overall Study||83
7974961|NCT00293813|19634712|P1|STARTED|Overall Study||82
7974962|NCT00293722|19634723|P1|NOT COMPLETED|Overall Study||427
7974963|NCT00293722|19634723|P1|COMPLETED|Overall Study||864
7974964|NCT00293722|19634723|P1|STARTED|Overall Study||1291
7974965|NCT00293709|19634737|P1|NOT COMPLETED|Overall Study||47
7974966|NCT00293709|19634737|P1|COMPLETED|Overall Study||102
7974967|NCT00293709|19634737|P1|STARTED|Overall Study||149
7974968|NCT00293579|19634751|P1|NOT COMPLETED|Overall Study||1
7974969|NCT00293579|19634751|P1|COMPLETED|Overall Study||4
7974970|NCT00293579|19634751|P1|STARTED|Overall Study||5
7974971|NCT00293540|19634760|P2|NOT COMPLETED|Overall Study||8
7974972|NCT00293540|19634761|P1|NOT COMPLETED|Overall Study||7
7974973|NCT00293540|19634760|P2|COMPLETED|Overall Study||119
7974974|NCT00293540|19634761|P1|COMPLETED|Overall Study||115
7974975|NCT00293540|19634760|P2|STARTED|Overall Study||127
7974976|NCT00293540|19634761|P1|STARTED|Overall Study||122
7974977|NCT00293462|19634770|P3|NOT COMPLETED|Overall Study||10
7974978|NCT00293462|19634771|P2|NOT COMPLETED|Overall Study||8
7974979|NCT00293462|19634772|P1|NOT COMPLETED|Overall Study||7
7974980|NCT00293462|19634770|P3|COMPLETED|Overall Study||21
7974981|NCT00293462|19634771|P2|COMPLETED|Overall Study||21
7974982|NCT00293462|19634772|P1|COMPLETED|Overall Study||24
7974983|NCT00293462|19634770|P3|STARTED|Overall Study||31
7974984|NCT00293462|19634771|P2|STARTED|Overall Study||29
7974985|NCT00293462|19634772|P1|STARTED|Overall Study||31
7974986|NCT00293397|19634791|P1|NOT COMPLETED|Overall Study||2
7974987|NCT00293397|19634791|P1|COMPLETED|Overall Study|1 patient death within 30 days post-TACE - not attributed to TACE procedure|18
7974988|NCT00293397|19634791|P1|Received First DEB-TACE|Overall Study|1 patient death after baseline inclusion screening and before first treatment|19
7974989|NCT00293397|19634791|P1|STARTED|Overall Study||20
7974990|NCT00293384|19634801|P1|NOT COMPLETED|Overall Study||5
7974991|NCT00293384|19634801|P1|COMPLETED|Overall Study||35
7974992|NCT00293384|19634801|P1|STARTED|Overall Study||40
7974993|NCT00293293|19634810|P2|NOT COMPLETED|Overall Study||2
7974994|NCT00293293|19634811|P1|NOT COMPLETED|Overall Study||2
7974995|NCT00293293|19634810|P2|COMPLETED|Overall Study||21
7974996|NCT00293293|19634811|P1|COMPLETED|Overall Study||18
7974997|NCT00293293|19634810|P2|STARTED|Overall Study||23
7974998|NCT00293293|19634811|P1|STARTED|Overall Study||20
7974999|NCT00293267|19634839|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37
7975000|NCT00293267|19634840|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33
7975001|NCT00293267|19634839|P2|COMPLETED|Open-Label Post Virologic Failure Phase||29
7975002|NCT00293267|19634840|P1|COMPLETED|Open-Label Post Virologic Failure Phase||15
7975003|NCT00293267|19634839|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66
7975004|NCT00293267|19634840|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48
7975005|NCT00293267|19634839|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||2
7975006|NCT00293267|19634840|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||20
7975007|NCT00293267|19634839|P2|COMPLETED|Extension - Open-Label Week 157-240||26
7975008|NCT00293267|19634840|P1|COMPLETED|Extension - Open-Label Week 157-240||111
7975009|NCT00293267|19634839|P2|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28
7975010|NCT00293267|19634840|P1|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131
7975011|NCT00293267|19634839|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||15
7975012|NCT00293267|19634840|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||52
7975013|NCT00293267|19634839|P2|COMPLETED|Extension - Double-Blind Week 49-156||35
7975014|NCT00293267|19634840|P1|COMPLETED|Extension - Double-Blind Week 49-156||139
7975015|NCT00293267|19634839|P2|STARTED|Extension - Double-Blind Week 49-156||50
7975016|NCT00293267|19634840|P1|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191
7975017|NCT00293267|19634839|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68
7975018|NCT00293267|19634840|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41
7975019|NCT00293267|19634839|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||50
7975020|NCT00293267|19634840|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||193
7975094|NCT00292942|19635221|P3|NOT COMPLETED|Overall Study||1
7975021|NCT00293267|19634839|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50
7975022|NCT00293267|19634840|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193
7975023|NCT00293267|19634839|P2|Treated|Primary Study - Double-Blind Week 0-48||118
7975024|NCT00293267|19634840|P1|Treated|Primary Study - Double-Blind Week 0-48||232
7975025|NCT00293267|19634839|P2|STARTED|Primary Study - Double-Blind Week 0-48||118
7975026|NCT00293267|19634840|P1|STARTED|Primary Study - Double-Blind Week 0-48||234
7975027|NCT00293254|19634880|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27
7975028|NCT00293254|19634881|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31
7975029|NCT00293254|19634880|P2|COMPLETED|Open-Label Post Virologic Failure Phase||37
7975030|NCT00293254|19634881|P1|COMPLETED|Open-Label Post Virologic Failure Phase||19
7975031|NCT00293254|19634880|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64
7975032|NCT00293254|19634881|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50
7975033|NCT00293254|19634880|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||1
7975034|NCT00293254|19634881|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||10
7975035|NCT00293254|19634880|P2|COMPLETED|Extension - Open-Label Week 157-240||18
7975036|NCT00293254|19634881|P1|COMPLETED|Extension - Open-Label Week 157-240||110
7975037|NCT00293254|19634880|P2|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19
7975038|NCT00293254|19634881|P1|STARTED|Extension - Open-Label Week 157-240||120
7975039|NCT00293254|19634880|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||29
7975040|NCT00293254|19634881|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||57
7975041|NCT00293254|19634880|P2|COMPLETED|Extension - Double-Blind Week 49-156||25
7975042|NCT00293254|19634881|P1|COMPLETED|Extension - Double-Blind Week 49-156||120
7975043|NCT00293254|19634880|P2|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54
7975044|NCT00293254|19634881|P1|STARTED|Extension - Double-Blind Week 49-156||177
7975045|NCT00293254|19634880|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64
7975046|NCT00293254|19634881|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55
7975047|NCT00293254|19634880|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||55
7975048|NCT00293254|19634881|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||177
7975049|NCT00293254|19634880|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55
7975050|NCT00293254|19634881|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177
7975051|NCT00293254|19634880|P2|Treated|Primary Study - Double-Blind Week 0-48||119
7975052|NCT00293254|19634881|P1|Treated|Primary Study - Double-Blind Week 0-48||230
7975053|NCT00293254|19634880|P2|STARTED|Primary Study - Double-Blind Week 0-48||119
7975054|NCT00293254|19634881|P1|STARTED|Primary Study - Double-Blind Week 0-48||232
7975055|NCT00293241|19634921|P2|NOT COMPLETED|Overall Study||41
7975056|NCT00293241|19634922|P1|NOT COMPLETED|Overall Study||36
7975057|NCT00293241|19634921|P2|COMPLETED|Overall Study||265
7975058|NCT00293241|19634922|P1|COMPLETED|Overall Study||263
7975059|NCT00293241|19634921|P2|STARTED|Overall Study||306
7975060|NCT00293241|19634922|P1|STARTED|Overall Study||299
7975061|NCT00293215|19634966|P2|NOT COMPLETED|Overall Study||3
7975062|NCT00293215|19634967|P1|NOT COMPLETED|Overall Study||5
7975063|NCT00293215|19634966|P2|COMPLETED|Overall Study||0
7975064|NCT00293215|19634967|P1|COMPLETED|Overall Study||1
7975065|NCT00293215|19634966|P2|STARTED|Overall Study||3
7975066|NCT00293215|19634967|P1|STARTED|Overall Study||6
7975067|NCT00293059|19634989|P2|NOT COMPLETED|Overall Study||19
7975068|NCT00293059|19634990|P1|NOT COMPLETED|Overall Study||35
7975069|NCT00293059|19634989|P2|COMPLETED|Overall Study||51
7975070|NCT00293059|19634990|P1|COMPLETED|Overall Study||85
7975071|NCT00293059|19634989|P2|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62
7975072|NCT00293059|19634990|P1|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113
7975073|NCT00293059|19634989|P2|Cycle 3/Treatment Day 84|Overall Study||55
7975074|NCT00293059|19634990|P1|Cycle 3/Treatment Day 84|Overall Study||100
7975075|NCT00293059|19634989|P2|Cycle 1/Treatment Day 28|Overall Study||64
7975076|NCT00293059|19634990|P1|Cycle 1/Treatment Day 28|Overall Study||115
7975077|NCT00293059|19634989|P2|Subjects Received Treatment|Overall Study||66
7975078|NCT00293059|19634990|P1|Subjects Received Treatment|Overall Study||119
7975079|NCT00293059|19634989|P2|STARTED|Overall Study||70
7975080|NCT00293059|19634990|P1|STARTED|Overall Study||120
7975081|NCT00293033|19635102|P1|NOT COMPLETED|Double-blind Treatment Period||12
7975082|NCT00293033|19635102|P1|COMPLETED|Double-blind Treatment Period||70
7975083|NCT00293033|19635102|P1|STARTED|Double-blind Treatment Period|82 randomized; 1 didn't take double-blind drug; 1 didn't report a pain assessment within 30 minutes|82
7975084|NCT00293033|19635102|P1|NOT COMPLETED|Open-label Titration Period||69
7975085|NCT00293033|19635102|P1|COMPLETED|Open-label Titration Period||82
7975086|NCT00293033|19635102|P1|STARTED|Open-label Titration Period|152 subjects enrolled; 151 subjects received at least one dose of study drug|151
7975087|NCT00293020|19635205|P1|NOT COMPLETED|Overall Study||162
7975088|NCT00293020|19635205|P1|COMPLETED|Overall Study||82
7975089|NCT00293020|19635205|P1|STARTED|Overall Study||244
7975090|NCT00292981|19635209|P1|NOT COMPLETED|Overall Study||39
7975091|NCT00292981|19635209|P1|COMPLETED|Overall Study||18
7975092|NCT00292981|19635209|P1|STARTED|Overall Study||57
7975093|NCT00292942|19635220|P4|NOT COMPLETED|Overall Study||1
7975095|NCT00292942|19635222|P2|NOT COMPLETED|Overall Study||0
7975096|NCT00292942|19635223|P1|NOT COMPLETED|Overall Study||0
7975097|NCT00292942|19635220|P4|COMPLETED|Overall Study||6
7975098|NCT00292942|19635221|P3|COMPLETED|Overall Study||6
7975099|NCT00292942|19635222|P2|COMPLETED|Overall Study||6
7975100|NCT00292942|19635223|P1|COMPLETED|Overall Study||6
7975101|NCT00292942|19635220|P4|STARTED|Overall Study||7
7975102|NCT00292942|19635221|P3|STARTED|Overall Study||7
7975103|NCT00292942|19635222|P2|STARTED|Overall Study||6
7975104|NCT00292942|19635223|P1|STARTED|Overall Study||6
7975105|NCT00292591|19635257|P3|NOT COMPLETED|Overall Study||58
7975106|NCT00292591|19635258|P2|NOT COMPLETED|Overall Study||56
7975107|NCT00292591|19635259|P1|NOT COMPLETED|Overall Study||64
7975108|NCT00292591|19635257|P3|COMPLETED|Overall Study||110
7975109|NCT00292591|19635258|P2|COMPLETED|Overall Study||111
7975110|NCT00292591|19635259|P1|COMPLETED|Overall Study||102
7975111|NCT00292591|19635257|P3|STARTED|Overall Study||168
7975112|NCT00292591|19635258|P2|STARTED|Overall Study||167
7975113|NCT00292591|19635259|P1|STARTED|Overall Study||166
7975114|NCT00292461|19635269|P2|NOT COMPLETED|Overall Study||6
7975115|NCT00292461|19635270|P1|NOT COMPLETED|Overall Study||10
7975116|NCT00292461|19635269|P2|COMPLETED|Overall Study||24
7975117|NCT00292461|19635270|P1|COMPLETED|Overall Study||24
7975118|NCT00292461|19635269|P2|STARTED|Overall Study||30
7975119|NCT00292461|19635270|P1|STARTED|Overall Study||34
7975120|NCT00292370|19635285|P3|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7
7975121|NCT00292370|19635286|P2|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4
7975122|NCT00292370|19635287|P1|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
7975123|NCT00292370|19635285|P3|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18
7975124|NCT00292370|19635286|P2|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21
7975125|NCT00292370|19635287|P1|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
7975126|NCT00292370|19635285|P3|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
7975127|NCT00292370|19635286|P2|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
7975128|NCT00292370|19635287|P1|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I
~28 Excluded Ph II:
~20 responded
~7 declined
~1 medical
~50 to Arm 2 & 3"|0
7975129|NCT00292370|19635285|P3|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
7975130|NCT00292370|19635286|P2|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
7975131|NCT00292370|19635287|P1|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46
7975132|NCT00292370|19635285|P3|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
7975133|NCT00292370|19635286|P2|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
7975134|NCT00292370|19635287|P1|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78
7975135|NCT00292370|19635285|P3|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
7975136|NCT00292370|19635286|P2|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
7975137|NCT00292370|19635287|P1|STARTED|Phase I - Open-Label Paroxetine (OLP)||124
7975138|NCT00292318|19635312|P2|NOT COMPLETED|Overall Study||1
7975139|NCT00292318|19635313|P1|NOT COMPLETED|Overall Study||2
7975140|NCT00292318|19635312|P2|COMPLETED|Overall Study||2
7975141|NCT00292318|19635313|P1|COMPLETED|Overall Study||2
7975142|NCT00292318|19635312|P2|STARTED|Overall Study||3
7975143|NCT00292318|19635313|P1|STARTED|Overall Study||4
7975144|NCT00292227|19635323|P3|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
7975145|NCT00292227|19635324|P2|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
7975146|NCT00292227|19635325|P1|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
7975147|NCT00292227|19635323|P3|COMPLETED|Cross-over Period 2 (Day 39)||30
7975148|NCT00292227|19635324|P2|COMPLETED|Cross-over Period 2 (Day 39)||31
7975149|NCT00292227|19635325|P1|COMPLETED|Cross-over Period 2 (Day 39)||65
7975150|NCT00292227|19635323|P3|STARTED|Cross-over Period 2 (Day 39)||30
7975151|NCT00292227|19635324|P2|STARTED|Cross-over Period 2 (Day 39)||31
7975152|NCT00292227|19635325|P1|STARTED|Cross-over Period 2 (Day 39)||65
7975153|NCT00292227|19635323|P3|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
7975154|NCT00292227|19635324|P2|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
7975155|NCT00292227|19635325|P1|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
7975156|NCT00292227|19635323|P3|COMPLETED|Cross-over Period 1 (Day 32)||30
7975157|NCT00292227|19635324|P2|COMPLETED|Cross-over Period 1 (Day 32)||31
7975158|NCT00292227|19635325|P1|COMPLETED|Cross-over Period 1 (Day 32)||65
7975159|NCT00292227|19635323|P3|STARTED|Cross-over Period 1 (Day 32)||30
7975160|NCT00292227|19635324|P2|STARTED|Cross-over Period 1 (Day 32)||31
7975161|NCT00292227|19635325|P1|STARTED|Cross-over Period 1 (Day 32)||65
7975162|NCT00292227|19635323|P3|NOT COMPLETED|Patch Period||3
7975163|NCT00292227|19635324|P2|NOT COMPLETED|Patch Period||0
7975164|NCT00292227|19635325|P1|NOT COMPLETED|Patch Period||1
7975165|NCT00292227|19635323|P3|COMPLETED|Patch Period||30
7975166|NCT00292227|19635324|P2|COMPLETED|Patch Period||31
7975167|NCT00292227|19635325|P1|COMPLETED|Patch Period||65
7975168|NCT00292227|19635323|P3|STARTED|Patch Period||33
7975169|NCT00292227|19635324|P2|STARTED|Patch Period||31
7975170|NCT00292227|19635325|P1|STARTED|Patch Period||66
7975171|NCT00292188|19635407|P3|NOT COMPLETED|Double-Blind||29
7975172|NCT00292188|19635408|P2|NOT COMPLETED|Double-Blind||31
7975173|NCT00292188|19635409|P1|NOT COMPLETED|Double-Blind||0
7975174|NCT00292188|19635407|P3|COMPLETED|Double-Blind||98
7975175|NCT00292188|19635408|P2|COMPLETED|Double-Blind||96
7975176|NCT00292188|19635409|P1|COMPLETED|Double-Blind||0
7975177|NCT00292188|19635407|P3|STARTED|Double-Blind||127
7975178|NCT00292188|19635408|P2|STARTED|Double-Blind||127
7975179|NCT00292188|19635409|P1|STARTED|Double-Blind||0
7975180|NCT00292188|19635407|P3|NOT COMPLETED|Single-Blind||0
7975181|NCT00292188|19635408|P2|NOT COMPLETED|Single-Blind||0
7975182|NCT00292188|19635409|P1|NOT COMPLETED|Single-Blind||114
7975183|NCT00292188|19635407|P3|COMPLETED|Single-Blind||0
7975184|NCT00292188|19635408|P2|COMPLETED|Single-Blind||0
7975185|NCT00292188|19635409|P1|COMPLETED|Single-Blind||254
7975186|NCT00292188|19635407|P3|Received Treatment|Single-Blind||0
7975187|NCT00292188|19635408|P2|Received Treatment|Single-Blind||0
7975188|NCT00292188|19635409|P1|Received Treatment|Single-Blind||367
7975189|NCT00292188|19635407|P3|STARTED|Single-Blind||0
7975190|NCT00292188|19635408|P2|STARTED|Single-Blind||0
7975191|NCT00292188|19635409|P1|STARTED|Single-Blind||368
7975192|NCT00292162|19635470|P2|NOT COMPLETED|Overall Study||2
7975193|NCT00292162|19635471|P1|NOT COMPLETED|Overall Study||1
7975194|NCT00292162|19635470|P2|COMPLETED|Overall Study||20
7975195|NCT00292162|19635471|P1|COMPLETED|Overall Study||18
7975196|NCT00292162|19635470|P2|STARTED|Overall Study||22
7975197|NCT00292162|19635471|P1|STARTED|Overall Study||19
7975198|NCT00291876|19635487|P1|NOT COMPLETED|Month 246||0
7975199|NCT00291876|19635487|P1|COMPLETED|Month 246||116
7975200|NCT00291876|19635487|P1|STARTED|Month 246||116
7975201|NCT00291876|19635487|P1|NOT COMPLETED|Month 234||0
7975202|NCT00291876|19635487|P1|COMPLETED|Month 234||110
7975203|NCT00291876|19635487|P1|STARTED|Month 234||110
7975204|NCT00291876|19635487|P1|NOT COMPLETED|Month 222||0
7975205|NCT00291876|19635487|P1|COMPLETED|Month 222||114
7975206|NCT00291876|19635487|P1|STARTED|Month 222||114
7975207|NCT00291876|19635487|P1|NOT COMPLETED|Month 210||0
7975208|NCT00291876|19635487|P1|COMPLETED|Month 210||124
7975209|NCT00291876|19635487|P1|STARTED|Month 210||124
7975210|NCT00291876|19635487|P1|NOT COMPLETED|Month 198||0
7975211|NCT00291876|19635487|P1|COMPLETED|Month 198||135
7975212|NCT00291876|19635487|P1|STARTED|Month 198||135
7975213|NCT00291876|19635487|P1|NOT COMPLETED|Month 186||0
7975214|NCT00291876|19635487|P1|COMPLETED|Month 186||129
7975215|NCT00291876|19635487|P1|STARTED|Month 186||129
7975216|NCT00291876|19635487|P1|NOT COMPLETED|Month 174||0
7975217|NCT00291876|19635487|P1|COMPLETED|Month 174||127
7975218|NCT00291876|19635487|P1|STARTED|Month 174||127
7975219|NCT00291876|19635487|P1|NOT COMPLETED|Month 162||0
7975220|NCT00291876|19635487|P1|COMPLETED|Month 162||127
7975221|NCT00291876|19635487|P1|STARTED|Month 162||127
7975222|NCT00291876|19635487|P1|NOT COMPLETED|Month 150||0
7975223|NCT00291876|19635487|P1|COMPLETED|Month 150||117
7975224|NCT00291876|19635487|P1|STARTED|Month 150||117
7975225|NCT00291876|19635487|P1|NOT COMPLETED|Month 138||0
7975226|NCT00291876|19635487|P1|COMPLETED|Month 138||107
7975227|NCT00291876|19635487|P1|STARTED|Month 138||107
7975228|NCT00291694|19635501|P2|NOT COMPLETED|Overall Study||5
7975229|NCT00291694|19635502|P1|NOT COMPLETED|Overall Study||3
7975230|NCT00291694|19635501|P2|COMPLETED|Overall Study||43
7975231|NCT00291694|19635502|P1|COMPLETED|Overall Study||21
7975232|NCT00291694|19635501|P2|STARTED|Overall Study||48
7975233|NCT00291694|19635502|P1|STARTED|Overall Study||24
7975234|NCT00291668|19635519|P3|NOT COMPLETED|Overall Study||1
7975235|NCT00291668|19635520|P2|NOT COMPLETED|Overall Study||1
7975236|NCT00291668|19635521|P1|NOT COMPLETED|Overall Study||4
7975237|NCT00291668|19635519|P3|COMPLETED|Overall Study||31
7975238|NCT00291668|19635520|P2|COMPLETED|Overall Study||29
7975239|NCT00291668|19635521|P1|COMPLETED|Overall Study||28
7975240|NCT00291668|19635519|P3|STARTED|Overall Study||32
7975241|NCT00291668|19635520|P2|STARTED|Overall Study||30
7975242|NCT00291668|19635521|P1|STARTED|Overall Study||32
7975243|NCT00291655|19635607|P1|NOT COMPLETED|Overall Study||15
7975244|NCT00291655|19635607|P1|COMPLETED|Overall Study||115
7975245|NCT00291655|19635607|P1|STARTED|Overall Study||130
7975246|NCT00291642|19635617|P5|NOT COMPLETED|Overall Study||1
7975247|NCT00291642|19635618|P4|NOT COMPLETED|Overall Study||0
7975248|NCT00291642|19635619|P3|NOT COMPLETED|Overall Study||2
7975249|NCT00291642|19635620|P2|NOT COMPLETED|Overall Study||0
7975250|NCT00291642|19635621|P1|NOT COMPLETED|Overall Study||2
7975251|NCT00291642|19635617|P5|COMPLETED|Overall Study||118
7975252|NCT00291642|19635618|P4|COMPLETED|Overall Study||119
7975253|NCT00291642|19635619|P3|COMPLETED|Overall Study||117
7975254|NCT00291642|19635620|P2|COMPLETED|Overall Study||116
7975255|NCT00291642|19635621|P1|COMPLETED|Overall Study||76
7975256|NCT00291642|19635617|P5|STARTED|Overall Study||119
7975257|NCT00291642|19635618|P4|STARTED|Overall Study||119
7975258|NCT00291642|19635619|P3|STARTED|Overall Study||119
7975259|NCT00291642|19635620|P2|STARTED|Overall Study||116
7975260|NCT00291642|19635621|P1|STARTED|Overall Study||78
7975261|NCT00291577|19635673|P1|NOT COMPLETED|Overall Study||21
7975262|NCT00291577|19635673|P1|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1
7975263|NCT00291577|19635673|P1|STARTED|Overall Study||22
7975264|NCT00291551|19635692|P1|NOT COMPLETED|Overall Study||13
7975265|NCT00291551|19635692|P1|COMPLETED|Overall Study||26
7975266|NCT00291551|19635692|P1|STARTED|Overall Study||39
7975267|NCT00291343|19635709|P2|NOT COMPLETED|Overall Study||0
7975268|NCT00291343|19635710|P1|NOT COMPLETED|Overall Study||0
7975269|NCT00291343|19635709|P2|COMPLETED|Overall Study||93
7975270|NCT00291343|19635710|P1|COMPLETED|Overall Study||203
7975271|NCT00291343|19635709|P2|STARTED|Overall Study||93
7975272|NCT00291343|19635710|P1|STARTED|Overall Study||203
7975273|NCT00291330|19635740|P2|NOT COMPLETED|Overall Study||97
7975274|NCT00291330|19635741|P1|NOT COMPLETED|Overall Study||101
7975275|NCT00291330|19635740|P2|COMPLETED|Overall Study|Completed planned observation time|1169
7975276|NCT00291330|19635741|P1|COMPLETED|Overall Study|Completed planned observation time|1172
7975277|NCT00291330|19635740|P2|STARTED|Overall Study|Started Treatment|1266
7975278|NCT00291330|19635741|P1|STARTED|Overall Study|Started Treatment|1273
7975279|NCT00291317|19635763|P1|NOT COMPLETED|Overall Study||0
7975280|NCT00291317|19635763|P1|COMPLETED|Overall Study||6
7975281|NCT00291317|19635763|P1|STARTED|Overall Study||6
7975282|NCT00291226|19635770|P2|NOT COMPLETED|Overall Study||1
7975283|NCT00291226|19635771|P1|NOT COMPLETED|Overall Study||1
7975284|NCT00291226|19635770|P2|COMPLETED|Overall Study||3
7975285|NCT00291226|19635771|P1|COMPLETED|Overall Study||3
7975286|NCT00291226|19635770|P2|STARTED|Overall Study||4
7975287|NCT00291226|19635771|P1|STARTED|Overall Study||4
7975288|NCT00291187|19635783|P4|NOT COMPLETED|Overall Study||0
7975289|NCT00291187|19635784|P3|NOT COMPLETED|Overall Study||1
7975290|NCT00291187|19635785|P2|NOT COMPLETED|Overall Study||0
7975291|NCT00291187|19635786|P1|NOT COMPLETED|Overall Study||0
7975292|NCT00291187|19635783|P4|COMPLETED|Overall Study||106
7975293|NCT00291187|19635784|P3|COMPLETED|Overall Study||102
7975294|NCT00291187|19635785|P2|COMPLETED|Overall Study||100
7975295|NCT00291187|19635786|P1|COMPLETED|Overall Study||103
7975296|NCT00291187|19635783|P4|STARTED|Overall Study||106
7975297|NCT00291187|19635784|P3|STARTED|Overall Study||103
7975298|NCT00291187|19635785|P2|STARTED|Overall Study||100
7975299|NCT00291187|19635786|P1|STARTED|Overall Study||103
7975300|NCT00291161|19635812|P4|NOT COMPLETED|Overall Study||65
7975301|NCT00291161|19635813|P3|NOT COMPLETED|Overall Study||93
7975302|NCT00291161|19635814|P2|NOT COMPLETED|Overall Study||58
7975303|NCT00291161|19635815|P1|NOT COMPLETED|Overall Study||81
7975304|NCT00291161|19635812|P4|COMPLETED|Overall Study||122
7975305|NCT00291161|19635813|P3|COMPLETED|Overall Study||206
7975306|NCT00291161|19635814|P2|COMPLETED|Overall Study||134
7975307|NCT00291161|19635815|P1|COMPLETED|Overall Study||235
7975308|NCT00291161|19635812|P4|STARTED|Overall Study||187
7975309|NCT00291161|19635813|P3|STARTED|Overall Study||299
7975310|NCT00291161|19635814|P2|STARTED|Overall Study||192
7975311|NCT00291161|19635815|P1|STARTED|Overall Study||316
7975312|NCT00291135|19635823|P1|NOT COMPLETED|Overall Study||0
7975313|NCT00291135|19635823|P1|COMPLETED|Overall Study||42
7975314|NCT00291135|19635823|P1|STARTED|Overall Study||42
7975315|NCT00291018|19635830|P3|NOT COMPLETED|Overall Study||43
7975316|NCT00291018|19635831|P2|NOT COMPLETED|Overall Study||42
7975317|NCT00291018|19635832|P1|NOT COMPLETED|Overall Study||25
7975318|NCT00291018|19635830|P3|COMPLETED|Overall Study|Evaluated at 84 Months|93
7975319|NCT00291018|19635831|P2|COMPLETED|Overall Study|Evaluated at 84 Months|64
7975320|NCT00291018|19635832|P1|COMPLETED|Overall Study|Evaluated at 84 Months|78
7975321|NCT00291018|19635830|P3|Evaluated at 24 Months|Overall Study||105
7975322|NCT00291018|19635831|P2|Evaluated at 24 Months|Overall Study||92
7975323|NCT00291018|19635832|P1|Evaluated at 24 Months|Overall Study||99
7975324|NCT00291018|19635830|P3|STARTED|Overall Study|Enrolled and Treated. 140 PDC-CA subjects were Enrolled but only 136 were Treated.|136
7975325|NCT00291018|19635831|P2|STARTED|Overall Study|Enrolled and Treated. 117 ACDF subjects were Enrolled but only 106 were Treated.|106
7975326|NCT00291018|19635832|P1|STARTED|Overall Study|Enrolled and Treated. 111 PDC subjects were Enrolled but only 103 were Treated.|103
7975327|NCT00290888|19635872|P2|NOT COMPLETED|Overall Study||1
7975328|NCT00290888|19635873|P1|NOT COMPLETED|Overall Study||3
7975329|NCT00290888|19635872|P2|COMPLETED|Overall Study||44
7975330|NCT00290888|19635873|P1|COMPLETED|Overall Study||38
7975331|NCT00290888|19635872|P2|STARTED|Overall Study||45
7975332|NCT00290888|19635873|P1|STARTED|Overall Study||41
7975333|NCT00290810|19635881|P1|NOT COMPLETED|Overall Study||0
7975334|NCT00290810|19635881|P1|COMPLETED|Overall Study||12
7975335|NCT00290810|19635881|P1|STARTED|Overall Study||12
7975336|NCT00290771|19635890|P2|NOT COMPLETED|Overall Study||97
7975337|NCT00290771|19635891|P1|NOT COMPLETED|Overall Study||127
7975338|NCT00290771|19635890|P2|COMPLETED|Overall Study||3
7975339|NCT00290771|19635891|P1|COMPLETED|Overall Study||4
7975340|NCT00290771|19635890|P2|STARTED|Overall Study||100
7975341|NCT00290771|19635891|P1|STARTED|Overall Study||131
7975342|NCT00290758|19635915|P2|NOT COMPLETED|Post Intervention rFNA||5
7975343|NCT00290758|19635916|P1|NOT COMPLETED|Post Intervention rFNA||6
7975344|NCT00290758|19635915|P2|COMPLETED|Post Intervention rFNA||49
7975345|NCT00290758|19635916|P1|COMPLETED|Post Intervention rFNA||49
7975346|NCT00290758|19635915|P2|STARTED|Post Intervention rFNA||54
7975347|NCT00290758|19635916|P1|STARTED|Post Intervention rFNA||55
7975348|NCT00290758|19635915|P2|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10
7975349|NCT00290758|19635916|P1|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7
7975350|NCT00290758|19635915|P2|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54
7975351|NCT00290758|19635916|P1|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55
7975352|NCT00290758|19635915|P2|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54
7975353|NCT00290758|19635916|P1|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55
7975354|NCT00290758|19635915|P2|Treatment|Pre-Intervention rFNA Through Follow-Up||64
7975355|NCT00290758|19635916|P1|Treatment|Pre-Intervention rFNA Through Follow-Up||61
7975356|NCT00290758|19635915|P2|Randomization|Pre-Intervention rFNA Through Follow-Up||62
7975357|NCT00290758|19635916|P1|Randomization|Pre-Intervention rFNA Through Follow-Up||62
7975358|NCT00290758|19635915|P2|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64
7975359|NCT00290758|19635916|P1|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62
7975360|NCT00290758|19635915|P2|STARTED|Pre-Intervention rFNA Through Follow-Up||64
7975361|NCT00290758|19635916|P1|STARTED|Pre-Intervention rFNA Through Follow-Up||62
7975362|NCT00290745|19635936|P1|NOT COMPLETED|Overall Study||12
7975363|NCT00290745|19635936|P1|COMPLETED|Overall Study||67
7975364|NCT00290745|19635936|P1|STARTED|Overall Study||79
7975365|NCT00290732|19635950|P5|NOT COMPLETED|Overall Study||0
7975366|NCT00290732|19635951|P4|NOT COMPLETED|Overall Study||0
7975367|NCT00290732|19635952|P3|NOT COMPLETED|Overall Study||1
7975368|NCT00290732|19635953|P2|NOT COMPLETED|Overall Study||1
7975369|NCT00290732|19635954|P1|NOT COMPLETED|Overall Study||0
7975370|NCT00290732|19635950|P5|COMPLETED|Overall Study||3
7975371|NCT00290732|19635951|P4|COMPLETED|Overall Study||6
7975372|NCT00290732|19635952|P3|COMPLETED|Overall Study||3
7975373|NCT00290732|19635953|P2|COMPLETED|Overall Study||3
7975374|NCT00290732|19635954|P1|COMPLETED|Overall Study||3
7975375|NCT00290732|19635950|P5|STARTED|Overall Study||3
7975376|NCT00290732|19635951|P4|STARTED|Overall Study||6
7975377|NCT00290732|19635952|P3|STARTED|Overall Study||4
7975378|NCT00290732|19635953|P2|STARTED|Overall Study||4
7975379|NCT00290732|19635954|P1|STARTED|Overall Study||3
7975380|NCT00290706|19635976|P4|NOT COMPLETED|Overall Study||12
7975381|NCT00290706|19635977|P3|NOT COMPLETED|Overall Study||6
7975382|NCT00290706|19635978|P2|NOT COMPLETED|Overall Study||6
7975383|NCT00290706|19635979|P1|NOT COMPLETED|Overall Study||5
7975384|NCT00290706|19635976|P4|COMPLETED|Overall Study||2
7975385|NCT00290706|19635977|P3|COMPLETED|Overall Study||1
7975386|NCT00290706|19635978|P2|COMPLETED|Overall Study||0
7975387|NCT00290706|19635979|P1|COMPLETED|Overall Study||0
7975388|NCT00290706|19635976|P4|Reached 1st Response/Cycle 3|Overall Study||2
7975389|NCT00290706|19635977|P3|Reached 1st Response/Cycle 3|Overall Study||1
7975390|NCT00290706|19635978|P2|Reached 1st Response/Cycle 3|Overall Study||0
7975391|NCT00290706|19635979|P1|Reached 1st Response/Cycle 3|Overall Study||0
7975392|NCT00290706|19635976|P4|Attempted1st Cycle|Overall Study||14
7975393|NCT00290706|19635977|P3|Attempted1st Cycle|Overall Study||7
7975394|NCT00290706|19635978|P2|Attempted1st Cycle|Overall Study||6
7975395|NCT00290706|19635979|P1|Attempted1st Cycle|Overall Study||5
7975396|NCT00290706|19635976|P4|STARTED|Overall Study||14
7975397|NCT00290706|19635977|P3|STARTED|Overall Study||7
7975398|NCT00290706|19635978|P2|STARTED|Overall Study||6
7975399|NCT00290706|19635979|P1|STARTED|Overall Study||5
7975400|NCT00290693|19635998|P1|NOT COMPLETED|Overall Study||2
7975401|NCT00290693|19635998|P1|COMPLETED|Overall Study||43
7975402|NCT00290693|19635998|P1|STARTED|Overall Study||45
7975403|NCT00290654|19636006|P1|NOT COMPLETED|Overall Study||0
7975404|NCT00290654|19636006|P1|COMPLETED|Overall Study||41
7975405|NCT00290654|19636006|P1|STARTED|Overall Study||41
7975406|NCT00290615|19636017|P1|NOT COMPLETED|Overall Study||0
7975407|NCT00290615|19636017|P1|COMPLETED|Overall Study||30
7975408|NCT00290615|19636017|P1|STARTED|Overall Study||30
7975409|NCT00290589|19636026|P2|NOT COMPLETED|Overall Study||2
7975410|NCT00290589|19636027|P1|NOT COMPLETED|Overall Study||2
7975411|NCT00290589|19636026|P2|COMPLETED|Overall Study||41
7975412|NCT00290589|19636027|P1|COMPLETED|Overall Study||37
7975413|NCT00290589|19636026|P2|STARTED|Overall Study||43
7975414|NCT00290589|19636027|P1|STARTED|Overall Study||39
7975415|NCT00290537|19636037|P2|NOT COMPLETED|Overall Study||0
7975416|NCT00290537|19636038|P1|NOT COMPLETED|Overall Study||0
7975417|NCT00290537|19636037|P2|COMPLETED|Overall Study||0
7975418|NCT00290537|19636038|P1|COMPLETED|Overall Study||4
7975419|NCT00290537|19636037|P2|STARTED|Overall Study||0
7975420|NCT00290537|19636038|P1|STARTED|Overall Study||4
7975421|NCT00290498|19636045|P2|NOT COMPLETED|Overall Study||0
7975422|NCT00290498|19636046|P1|NOT COMPLETED|Overall Study||8
7975423|NCT00290498|19636045|P2|COMPLETED|Overall Study||10
7975424|NCT00290498|19636046|P1|COMPLETED|Overall Study||41
7975425|NCT00290498|19636045|P2|STARTED|Overall Study||10
7975426|NCT00290498|19636046|P1|STARTED|Overall Study||49
7975427|NCT00290472|19636057|P3|NOT COMPLETED|Overall Study||0
7975428|NCT00290472|19636058|P2|NOT COMPLETED|Overall Study||0
7975429|NCT00290472|19636059|P1|NOT COMPLETED|Overall Study||0
7975430|NCT00290472|19636057|P3|COMPLETED|Overall Study||18
7975431|NCT00290472|19636058|P2|COMPLETED|Overall Study||39
7975432|NCT00290472|19636059|P1|COMPLETED|Overall Study||32
7975433|NCT00290472|19636057|P3|STARTED|Overall Study||18
7975434|NCT00290472|19636058|P2|STARTED|Overall Study||39
7975435|NCT00290472|19636059|P1|STARTED|Overall Study||32
7975436|NCT00290433|19636071|P1|NOT COMPLETED|Overall Study||36
7975437|NCT00290433|19636071|P1|COMPLETED|Overall Study||17
7975438|NCT00290433|19636071|P1|STARTED|Overall Study||53
7975439|NCT00290407|19636075|P1|NOT COMPLETED|Overall Study||2
7975440|NCT00290407|19636075|P1|COMPLETED|Overall Study||0
7975441|NCT00290407|19636075|P1|STARTED|Overall Study||2
7975442|NCT00290355|19636082|P2|NOT COMPLETED|Overall Study||5
7975443|NCT00290355|19636083|P1|NOT COMPLETED|Overall Study||17
7975444|NCT00290355|19636082|P2|COMPLETED|Overall Study||55
7975445|NCT00290355|19636083|P1|COMPLETED|Overall Study||105
7975446|NCT00290355|19636082|P2|STARTED|Overall Study||60
7975447|NCT00290355|19636083|P1|STARTED|Overall Study||122
7975448|NCT00290342|19636127|P2|NOT COMPLETED|Overall Study||5
7975449|NCT00290342|19636128|P1|NOT COMPLETED|Overall Study||7
7975450|NCT00290342|19636127|P2|COMPLETED|Overall Study||223
7975451|NCT00290342|19636128|P1|COMPLETED|Overall Study||217
7975452|NCT00290342|19636127|P2|STARTED|Overall Study||228
7975453|NCT00290342|19636128|P1|STARTED|Overall Study||224
7975454|NCT00290329|19636159|P3|NOT COMPLETED|Overall Study||0
7975455|NCT00290329|19636160|P2|NOT COMPLETED|Overall Study||0
7975456|NCT00290329|19636161|P1|NOT COMPLETED|Overall Study||0
7975457|NCT00290329|19636159|P3|COMPLETED|Overall Study||61
7975458|NCT00290329|19636160|P2|COMPLETED|Overall Study||86
7975459|NCT00290329|19636161|P1|COMPLETED|Overall Study||102
7975460|NCT00290329|19636159|P3|STARTED|Overall Study||61
7975461|NCT00290329|19636160|P2|STARTED|Overall Study||86
7975462|NCT00290329|19636161|P1|STARTED|Overall Study||102
7975463|NCT00290290|19636183|P2|NOT COMPLETED|Overall Study||18
7975464|NCT00290290|19636184|P1|NOT COMPLETED|Overall Study||18
7975465|NCT00290290|19636183|P2|COMPLETED|Overall Study||391
7975466|NCT00290290|19636184|P1|COMPLETED|Overall Study||422
7975467|NCT00290290|19636183|P2|STARTED|Overall Study||409
7975468|NCT00290290|19636184|P1|STARTED|Overall Study||440
7975469|NCT00290251|19636190|P3|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
7975470|NCT00290251|19636191|P2|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
7975471|NCT00290251|19636192|P1|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
7975472|NCT00290251|19636190|P3|COMPLETED|Elective Extension (to 12 Months no Rx)||5
7975473|NCT00290251|19636191|P2|COMPLETED|Elective Extension (to 12 Months no Rx)||3
7975474|NCT00290251|19636192|P1|COMPLETED|Elective Extension (to 12 Months no Rx)||5
7975475|NCT00290251|19636190|P3|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
7975476|NCT00290251|19636191|P2|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|3
7975477|NCT00290251|19636192|P1|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
7975478|NCT00290251|19636190|P3|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
7975479|NCT00290251|19636191|P2|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
7975480|NCT00290251|19636192|P1|NOT COMPLETED|Treatment 2 (Months 4 - 6)||2
7975481|NCT00290251|19636190|P3|COMPLETED|Treatment 2 (Months 4 - 6)||0
7975482|NCT00290251|19636191|P2|COMPLETED|Treatment 2 (Months 4 - 6)||5
7975483|NCT00290251|19636192|P1|COMPLETED|Treatment 2 (Months 4 - 6)||6
7975484|NCT00290251|19636190|P3|STARTED|Treatment 2 (Months 4 - 6)|Women were randomized from PLC to ulipristal acetate or continued same dose ulipristal acetate|0
7975485|NCT00290251|19636191|P2|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 10 grp did not continue|5
7975486|NCT00290251|19636192|P1|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 20 did not continue|8
7975487|NCT00290251|19636190|P3|NOT COMPLETED|Treatment 1 (Months 1 - 3)||2
7975488|NCT00290251|19636191|P2|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
7975489|NCT00290251|19636192|P1|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
7975490|NCT00290251|19636190|P3|COMPLETED|Treatment 1 (Months 1 - 3)||12
7975491|NCT00290251|19636191|P2|COMPLETED|Treatment 1 (Months 1 - 3)||13
7975492|NCT00290251|19636192|P1|COMPLETED|Treatment 1 (Months 1 - 3)||13
7975493|NCT00290251|19636190|P3|STARTED|Treatment 1 (Months 1 - 3)||14
7975494|NCT00290251|19636191|P2|STARTED|Treatment 1 (Months 1 - 3)||14
7975495|NCT00290251|19636192|P1|STARTED|Treatment 1 (Months 1 - 3)||14
7975496|NCT00290238|19636204|P2|NOT COMPLETED|Overall Study||41
7975497|NCT00290238|19636205|P1|NOT COMPLETED|Overall Study||42
7975498|NCT00290238|19636204|P2|COMPLETED|Overall Study||24
7975499|NCT00290238|19636205|P1|COMPLETED|Overall Study||15
7975500|NCT00290238|19636204|P2|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65
7975501|NCT00290238|19636205|P1|STARTED|Overall Study||57
7975502|NCT00290199|19636215|P2|NOT COMPLETED|Overall Study||0
7975503|NCT00290199|19636216|P1|NOT COMPLETED|Overall Study||0
7975504|NCT00290199|19636215|P2|COMPLETED|Overall Study||82
7975505|NCT00290199|19636216|P1|COMPLETED|Overall Study||87
7975506|NCT00290199|19636215|P2|STARTED|Overall Study||82
7975507|NCT00290199|19636216|P1|STARTED|Overall Study||87
7975508|NCT00290186|19636230|P2|NOT COMPLETED|Overall Study||5
7975509|NCT00290186|19636231|P1|NOT COMPLETED|Overall Study||5
7975510|NCT00290186|19636230|P2|COMPLETED|Overall Study||19
7975511|NCT00290186|19636231|P1|COMPLETED|Overall Study||20
7975512|NCT00290186|19636230|P2|Completed 6-month Followup Assessments|Overall Study||19
7975513|NCT00290186|19636231|P1|Completed 6-month Followup Assessments|Overall Study||20
7975514|NCT00290186|19636230|P2|Completed 3-month Followup Assessments|Overall Study||21
7975515|NCT00290186|19636231|P1|Completed 3-month Followup Assessments|Overall Study||20
7975516|NCT00290186|19636230|P2|Completed Post-treatment Assessments|Overall Study||22
7975517|NCT00290186|19636231|P1|Completed Post-treatment Assessments|Overall Study||24
7975518|NCT00290186|19636230|P2|Completed 8 Weeks of Treatment|Overall Study||22
7975519|NCT00290186|19636231|P1|Completed 8 Weeks of Treatment|Overall Study||24
7975520|NCT00290186|19636230|P2|Completed Baseline Assessments|Overall Study||24
7975521|NCT00290186|19636231|P1|Completed Baseline Assessments|Overall Study||25
7975522|NCT00290186|19636230|P2|STARTED|Overall Study||24
7975523|NCT00290186|19636231|P1|STARTED|Overall Study||25
7975524|NCT00290147|19636271|P2|NOT COMPLETED|Overall Study||0
7975525|NCT00290147|19636272|P1|NOT COMPLETED|Overall Study||0
7975526|NCT00290147|19636271|P2|COMPLETED|Overall Study||12
7975527|NCT00290147|19636272|P1|COMPLETED|Overall Study||10
7975528|NCT00290147|19636271|P2|STARTED|Overall Study||12
7975529|NCT00290147|19636272|P1|STARTED|Overall Study||10
7975530|NCT00289991|19636282|P2|NOT COMPLETED|Overall Study||80
7975531|NCT00289991|19636283|P1|NOT COMPLETED|Overall Study||58
7975532|NCT00289991|19636282|P2|COMPLETED|Overall Study||175
7975533|NCT00289991|19636283|P1|COMPLETED|Overall Study||176
7975534|NCT00289991|19636282|P2|STARTED|Overall Study||255
7975535|NCT00289991|19636283|P1|STARTED|Overall Study||234
7975536|NCT00289978|19636308|P3|NOT COMPLETED|Overall Study||86
7975537|NCT00289978|19636309|P2|NOT COMPLETED|Overall Study||56
7975538|NCT00289978|19636310|P1|NOT COMPLETED|Overall Study||97
7975539|NCT00289978|19636308|P3|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332
7975540|NCT00289978|19636309|P2|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369
7975541|NCT00289978|19636310|P1|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332
7975542|NCT00289978|19636308|P3|STARTED|Overall Study||418
7975543|NCT00289978|19636309|P2|STARTED|Overall Study||425
7975544|NCT00289978|19636310|P1|STARTED|Overall Study||429
7975545|NCT00289913|19636329|P5|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
7975546|NCT00289913|19636330|P4|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
7975547|NCT00289913|19636331|P3|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
7975548|NCT00289913|19636332|P2|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
7975549|NCT00289913|19636333|P1|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
7975550|NCT00289913|19636329|P5|COMPLETED|Visit 4 (Stage I and Stage II)||597
7975551|NCT00289913|19636330|P4|COMPLETED|Visit 4 (Stage I and Stage II)||131
7975552|NCT00289913|19636331|P3|COMPLETED|Visit 4 (Stage I and Stage II)||138
7975553|NCT00289913|19636332|P2|COMPLETED|Visit 4 (Stage I and Stage II)||106
7975554|NCT00289913|19636333|P1|COMPLETED|Visit 4 (Stage I and Stage II)||122
7975555|NCT00289913|19636329|P5|STARTED|Visit 4 (Stage I and Stage II)||597
7975556|NCT00289913|19636330|P4|STARTED|Visit 4 (Stage I and Stage II)||131
7975557|NCT00289913|19636331|P3|STARTED|Visit 4 (Stage I and Stage II)||138
7975558|NCT00289913|19636332|P2|STARTED|Visit 4 (Stage I and Stage II)||106
7975559|NCT00289913|19636333|P1|STARTED|Visit 4 (Stage I and Stage II)||122
7975560|NCT00289913|19636329|P5|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
7975561|NCT00289913|19636330|P4|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4
7975562|NCT00289913|19636331|P3|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2
7975563|NCT00289913|19636332|P2|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
7975564|NCT00289913|19636333|P1|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9
7975565|NCT00289913|19636329|P5|COMPLETED|Visit 3 (Stage I and Stage II)||597
7975566|NCT00289913|19636330|P4|COMPLETED|Visit 3 (Stage I and Stage II)||131
7975567|NCT00289913|19636331|P3|COMPLETED|Visit 3 (Stage I and Stage II)||138
7975568|NCT00289913|19636332|P2|COMPLETED|Visit 3 (Stage I and Stage II)||106
7975569|NCT00289913|19636333|P1|COMPLETED|Visit 3 (Stage I and Stage II)||122
7975570|NCT00289913|19636329|P5|STARTED|Visit 3 (Stage I and Stage II)||605
7975571|NCT00289913|19636330|P4|STARTED|Visit 3 (Stage I and Stage II)||135
7975572|NCT00289913|19636331|P3|STARTED|Visit 3 (Stage I and Stage II)||140
7975573|NCT00289913|19636332|P2|STARTED|Visit 3 (Stage I and Stage II)||114
7975574|NCT00289913|19636333|P1|STARTED|Visit 3 (Stage I and Stage II)||131
7975575|NCT00289913|19636329|P5|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40
7975576|NCT00289913|19636330|P4|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6
7975577|NCT00289913|19636331|P3|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10
7975578|NCT00289913|19636332|P2|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21
7975579|NCT00289913|19636333|P1|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15
7975580|NCT00289913|19636329|P5|COMPLETED|Visit 2 (Stage I and Stage II)||605
7975581|NCT00289913|19636330|P4|COMPLETED|Visit 2 (Stage I and Stage II)||135
7975582|NCT00289913|19636331|P3|COMPLETED|Visit 2 (Stage I and Stage II)||140
7975583|NCT00289913|19636332|P2|COMPLETED|Visit 2 (Stage I and Stage II)||114
7975584|NCT00289913|19636333|P1|COMPLETED|Visit 2 (Stage I and Stage II)||131
7975585|NCT00289913|19636329|P5|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645
7975586|NCT00289913|19636330|P4|STARTED|Visit 2 (Stage I and Stage II)||141
7975587|NCT00289913|19636331|P3|STARTED|Visit 2 (Stage I and Stage II)||150
7975588|NCT00289913|19636332|P2|STARTED|Visit 2 (Stage I and Stage II)||135
7975589|NCT00289913|19636333|P1|STARTED|Visit 2 (Stage I and Stage II)||146
7975590|NCT00289913|19636329|P5|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
7975591|NCT00289913|19636330|P4|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11
7975592|NCT00289913|19636331|P3|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
7975593|NCT00289913|19636332|P2|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16
7975594|NCT00289913|19636333|P1|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
7975595|NCT00289913|19636329|P5|COMPLETED|Visit 1 (Stage I and Stage II)||645
7975596|NCT00289913|19636330|P4|COMPLETED|Visit 1 (Stage I and Stage II)||141
7975597|NCT00289913|19636331|P3|COMPLETED|Visit 1 (Stage I and Stage II)||150
7975598|NCT00289913|19636332|P2|COMPLETED|Visit 1 (Stage I and Stage II)||135
7975599|NCT00289913|19636333|P1|COMPLETED|Visit 1 (Stage I and Stage II)||146
7975600|NCT00289913|19636329|P5|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654
7975601|NCT00289913|19636330|P4|STARTED|Visit 1 (Stage I and Stage II)||152
7975602|NCT00289913|19636331|P3|STARTED|Visit 1 (Stage I and Stage II)||159
7975603|NCT00289913|19636332|P2|STARTED|Visit 1 (Stage I and Stage II)||151
7975604|NCT00289913|19636333|P1|STARTED|Visit 1 (Stage I and Stage II)||155
7975605|NCT00289900|19636364|P6|NOT COMPLETED|Overall Study||61
7975606|NCT00289900|19636365|P5|NOT COMPLETED|Overall Study||45
7975607|NCT00289900|19636366|P4|NOT COMPLETED|Overall Study||59
7975608|NCT00289900|19636367|P3|NOT COMPLETED|Overall Study||33
7975609|NCT00289900|19636368|P2|NOT COMPLETED|Overall Study||120
7975610|NCT00289900|19636369|P1|NOT COMPLETED|Overall Study||68
7975611|NCT00289900|19636364|P6|COMPLETED|Overall Study||372
7975612|NCT00289900|19636365|P5|COMPLETED|Overall Study||392
7975613|NCT00289900|19636366|P4|COMPLETED|Overall Study||380
7975614|NCT00289900|19636367|P3|COMPLETED|Overall Study||265
7975615|NCT00289900|19636368|P2|COMPLETED|Overall Study||316
7975616|NCT00289900|19636369|P1|COMPLETED|Overall Study||229
7975617|NCT00289900|19636364|P6|Treated|Overall Study||433
7975618|NCT00289900|19636365|P5|Treated|Overall Study||437
7975619|NCT00289900|19636366|P4|Treated|Overall Study||439
7975620|NCT00289900|19636367|P3|Treated|Overall Study||298
7975621|NCT00289900|19636368|P2|Treated|Overall Study||435
7975622|NCT00289900|19636369|P1|Treated|Overall Study||297
7975623|NCT00289900|19636364|P6|STARTED|Overall Study||433
7975624|NCT00289900|19636365|P5|STARTED|Overall Study||437
7975625|NCT00289900|19636366|P4|STARTED|Overall Study||439
7975626|NCT00289900|19636367|P3|STARTED|Overall Study||298
7975627|NCT00289900|19636368|P2|STARTED|Overall Study||436
7975628|NCT00289900|19636369|P1|STARTED|Overall Study||297
7975629|NCT00289887|19636473|P2|NOT COMPLETED|Overall Study||29
7975630|NCT00289887|19636474|P1|NOT COMPLETED|Overall Study||22
7975631|NCT00289887|19636473|P2|COMPLETED|Overall Study||105
7975632|NCT00289887|19636474|P1|COMPLETED|Overall Study||105
7975633|NCT00289887|19636473|P2|STARTED|Overall Study||134
7975634|NCT00289887|19636474|P1|STARTED|Overall Study||127
7975635|NCT00289874|19636492|P2|NOT COMPLETED|Overall Study||8
7975636|NCT00289874|19636493|P1|NOT COMPLETED|Overall Study||6
7975637|NCT00289874|19636492|P2|COMPLETED|Overall Study||210
7975638|NCT00289874|19636493|P1|COMPLETED|Overall Study||197
7975639|NCT00289874|19636492|P2|STARTED|Overall Study||218
7975640|NCT00289874|19636493|P1|STARTED|Overall Study||203
7975641|NCT00289848|19636503|P2|NOT COMPLETED|Overall Study||45
7975642|NCT00289848|19636504|P1|NOT COMPLETED|Overall Study||46
7975643|NCT00289848|19636503|P2|COMPLETED|Overall Study||133
7975644|NCT00289848|19636504|P1|COMPLETED|Overall Study||306
7975645|NCT00289848|19636503|P2|STARTED|Overall Study||178
7975646|NCT00289848|19636504|P1|STARTED|Overall Study||352
7975647|NCT00289783|19636516|P2|NOT COMPLETED|Fourth Dose Phase||24
7975648|NCT00289783|19636517|P1|NOT COMPLETED|Fourth Dose Phase||87
7975649|NCT00289783|19636516|P2|COMPLETED|Fourth Dose Phase||899
7975650|NCT00289783|19636517|P1|COMPLETED|Fourth Dose Phase||2682
7975651|NCT00289783|19636516|P2|STARTED|Fourth Dose Phase||923
7975652|NCT00289783|19636517|P1|STARTED|Fourth Dose Phase||2769
7975653|NCT00289783|19636516|P2|NOT COMPLETED|Primary Phase||83
7975654|NCT00289783|19636517|P1|NOT COMPLETED|Primary Phase||248
7975655|NCT00289783|19636516|P2|COMPLETED|Primary Phase||961
7975656|NCT00289783|19636517|P1|COMPLETED|Primary Phase||2888
7975657|NCT00289783|19636516|P2|STARTED|Primary Phase||1044
7975658|NCT00289783|19636517|P1|STARTED|Primary Phase||3136
7975659|NCT00289770|19636695|P1|NOT COMPLETED|Year 15||1
7975660|NCT00289770|19636695|P1|COMPLETED|Year 15||49
7975661|NCT00289770|19636695|P1|STARTED|Year 15||50
7975662|NCT00289770|19636695|P1|NOT COMPLETED|Year 14||0
7975663|NCT00289770|19636695|P1|COMPLETED|Year 14||43
7975664|NCT00289770|19636695|P1|STARTED|Year 14||43
7975665|NCT00289770|19636695|P1|NOT COMPLETED|Year 13||0
7975666|NCT00289770|19636695|P1|COMPLETED|Year 13||37
7975667|NCT00289770|19636695|P1|STARTED|Year 13||37
7975668|NCT00289770|19636695|P1|NOT COMPLETED|Year 12||0
7975669|NCT00289770|19636695|P1|COMPLETED|Year 12||40
7975670|NCT00289770|19636695|P1|STARTED|Year 12||40
7975671|NCT00289770|19636695|P1|NOT COMPLETED|Year 11||0
7975672|NCT00289770|19636695|P1|COMPLETED|Year 11||37
7975673|NCT00289770|19636695|P1|STARTED|Year 11||37
7975674|NCT00289757|19636707|P1|NOT COMPLETED|Overall Study||0
7975675|NCT00289757|19636707|P1|COMPLETED|Overall Study||78
7975676|NCT00289757|19636707|P1|STARTED|Overall Study||78
7975677|NCT00289744|19636718|P3|NOT COMPLETED|Additional Dose Phase||0
7975678|NCT00289744|19636719|P2|NOT COMPLETED|Additional Dose Phase||0
7975679|NCT00289744|19636720|P1|NOT COMPLETED|Additional Dose Phase||0
7975680|NCT00289744|19636718|P3|COMPLETED|Additional Dose Phase||6
7975681|NCT00289744|19636719|P2|COMPLETED|Additional Dose Phase||19
7975682|NCT00289744|19636720|P1|COMPLETED|Additional Dose Phase||0
7975683|NCT00289744|19636718|P3|STARTED|Additional Dose Phase||6
7975684|NCT00289744|19636719|P2|STARTED|Additional Dose Phase||19
7975685|NCT00289744|19636720|P1|STARTED|Additional Dose Phase||0
7975686|NCT00289744|19636718|P3|NOT COMPLETED|Year 10 Long-term Follow-up||0
7975687|NCT00289744|19636719|P2|NOT COMPLETED|Year 10 Long-term Follow-up||0
7975688|NCT00289744|19636720|P1|NOT COMPLETED|Year 10 Long-term Follow-up||0
7975689|NCT00289744|19636718|P3|COMPLETED|Year 10 Long-term Follow-up||0
7975690|NCT00289744|19636719|P2|COMPLETED|Year 10 Long-term Follow-up||0
7975691|NCT00289744|19636720|P1|COMPLETED|Year 10 Long-term Follow-up||171
7975692|NCT00289744|19636718|P3|STARTED|Year 10 Long-term Follow-up||0
7975693|NCT00289744|19636719|P2|STARTED|Year 10 Long-term Follow-up||0
7975694|NCT00289744|19636720|P1|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171
7975695|NCT00289744|19636718|P3|NOT COMPLETED|Year 9 Long-term Follow-up||0
7975696|NCT00289744|19636719|P2|NOT COMPLETED|Year 9 Long-term Follow-up||0
7975697|NCT00289744|19636720|P1|NOT COMPLETED|Year 9 Long-term Follow-up||0
7975698|NCT00289744|19636718|P3|COMPLETED|Year 9 Long-term Follow-up||0
7975699|NCT00289744|19636719|P2|COMPLETED|Year 9 Long-term Follow-up||0
7975700|NCT00289744|19636720|P1|COMPLETED|Year 9 Long-term Follow-up||173
7975701|NCT00289744|19636718|P3|STARTED|Year 9 Long-term Follow-up||0
7975702|NCT00289744|19636719|P2|STARTED|Year 9 Long-term Follow-up||0
7975703|NCT00289744|19636720|P1|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173
7975704|NCT00289744|19636718|P3|NOT COMPLETED|Year 8 Long-term Follow-up||0
7975705|NCT00289744|19636719|P2|NOT COMPLETED|Year 8 Long-term Follow-up||0
7975706|NCT00289744|19636720|P1|NOT COMPLETED|Year 8 Long-term Follow-up||0
7975707|NCT00289744|19636718|P3|COMPLETED|Year 8 Long-term Follow-up||0
7975708|NCT00289744|19636719|P2|COMPLETED|Year 8 Long-term Follow-up||0
7975709|NCT00289744|19636720|P1|COMPLETED|Year 8 Long-term Follow-up||174
7975710|NCT00289744|19636718|P3|STARTED|Year 8 Long-term Follow-up||0
7975711|NCT00289744|19636719|P2|STARTED|Year 8 Long-term Follow-up||0
7975712|NCT00289744|19636720|P1|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174
7975713|NCT00289744|19636718|P3|NOT COMPLETED|Year 7 Long-term Follow-up||0
7975714|NCT00289744|19636719|P2|NOT COMPLETED|Year 7 Long-term Follow-up||0
7975715|NCT00289744|19636720|P1|NOT COMPLETED|Year 7 Long-term Follow-up||0
7975716|NCT00289744|19636718|P3|COMPLETED|Year 7 Long-term Follow-up||0
7975717|NCT00289744|19636719|P2|COMPLETED|Year 7 Long-term Follow-up||0
7975718|NCT00289744|19636720|P1|COMPLETED|Year 7 Long-term Follow-up||175
7975719|NCT00289744|19636718|P3|STARTED|Year 7 Long-term Follow-up||0
7975720|NCT00289744|19636719|P2|STARTED|Year 7 Long-term Follow-up||0
7975721|NCT00289744|19636720|P1|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175
7975722|NCT00289744|19636718|P3|NOT COMPLETED|Year 6 Long-term Follow-up||0
7975723|NCT00289744|19636719|P2|NOT COMPLETED|Year 6 Long-term Follow-up||0
7975724|NCT00289744|19636720|P1|NOT COMPLETED|Year 6 Long-term Follow-up||0
7975725|NCT00289744|19636718|P3|COMPLETED|Year 6 Long-term Follow-up||0
7975726|NCT00289744|19636719|P2|COMPLETED|Year 6 Long-term Follow-up||0
7975727|NCT00289744|19636720|P1|COMPLETED|Year 6 Long-term Follow-up||178
7975728|NCT00289744|19636718|P3|STARTED|Year 6 Long-term Follow-up||0
7975729|NCT00289744|19636719|P2|STARTED|Year 6 Long-term Follow-up||0
7975730|NCT00289744|19636720|P1|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178
7975731|NCT00289731|19636741|P3|NOT COMPLETED|Overall Study||2
7975732|NCT00289731|19636742|P2|NOT COMPLETED|Overall Study||2
7975733|NCT00289731|19636743|P1|NOT COMPLETED|Overall Study||2
7975734|NCT00289731|19636741|P3|COMPLETED|Overall Study||195
7975735|NCT00289731|19636742|P2|COMPLETED|Overall Study||198
7975736|NCT00289731|19636743|P1|COMPLETED|Overall Study||197
7975737|NCT00289731|19636741|P3|STARTED|Overall Study||197
7975738|NCT00289731|19636742|P2|STARTED|Overall Study||200
7975739|NCT00289731|19636743|P1|STARTED|Overall Study||199
7975740|NCT00289718|19636835|P1|NOT COMPLETED|Overall Study||0
7975741|NCT00289718|19636835|P1|COMPLETED|Overall Study||51
7975742|NCT00289718|19636835|P1|STARTED|Overall Study||51
7975743|NCT00289653|19636850|P1|NOT COMPLETED|Overall Study||11
7975744|NCT00289653|19636850|P1|COMPLETED|Overall Study||12
7975745|NCT00289653|19636850|P1|STARTED|Overall Study||23
7975746|NCT00289536|19636855|P3|NOT COMPLETED|Period 3||1
7975747|NCT00289536|19636856|P2|NOT COMPLETED|Period 3||0
7975748|NCT00289536|19636857|P1|NOT COMPLETED|Period 3||0
7975749|NCT00289536|19636855|P3|COMPLETED|Period 3||9
7975750|NCT00289536|19636856|P2|COMPLETED|Period 3||9
7975751|NCT00289536|19636857|P1|COMPLETED|Period 3||7
7975752|NCT00289536|19636855|P3|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10
7975753|NCT00289536|19636856|P2|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9
7975754|NCT00289536|19636857|P1|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7
7975755|NCT00289536|19636855|P3|NOT COMPLETED|Period 2||0
7975756|NCT00289536|19636856|P2|NOT COMPLETED|Period 2||0
7975757|NCT00289536|19636857|P1|NOT COMPLETED|Period 2||0
7975758|NCT00289536|19636855|P3|COMPLETED|Period 2||7
7975759|NCT00289536|19636856|P2|COMPLETED|Period 2||9
7975760|NCT00289536|19636857|P1|COMPLETED|Period 2||10
7975761|NCT00289536|19636855|P3|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7
7975762|NCT00289536|19636856|P2|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9
7975763|NCT00289536|19636857|P1|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10
7975764|NCT00289536|19636855|P3|NOT COMPLETED|Period 1||0
7975765|NCT00289536|19636856|P2|NOT COMPLETED|Period 1||0
7975766|NCT00289536|19636857|P1|NOT COMPLETED|Period 1||0
7975767|NCT00289536|19636855|P3|COMPLETED|Period 1||9
7975768|NCT00289536|19636856|P2|COMPLETED|Period 1||8
7975769|NCT00289536|19636857|P1|COMPLETED|Period 1||9
7975770|NCT00289536|19636855|P3|STARTED|Period 1||9
7975771|NCT00289536|19636856|P2|STARTED|Period 1||8
7975772|NCT00289536|19636857|P1|STARTED|Period 1||9
7975773|NCT00289471|19636896|P1|NOT COMPLETED|Overall Study||0
7975774|NCT00289471|19636896|P1|COMPLETED|Overall Study||630
7975775|NCT00289471|19636896|P1|STARTED|Overall Study||630
7975776|NCT00289458|19636903|P3|NOT COMPLETED|Overall Study||6
7975777|NCT00289458|19636904|P2|NOT COMPLETED|Overall Study||6
7975778|NCT00289458|19636905|P1|NOT COMPLETED|Overall Study||6
7975779|NCT00289458|19636903|P3|COMPLETED|Overall Study||22
7975780|NCT00289458|19636904|P2|COMPLETED|Overall Study||20
7975781|NCT00289458|19636905|P1|COMPLETED|Overall Study||19
7975782|NCT00289458|19636903|P3|STARTED|Overall Study||28
7975783|NCT00289458|19636904|P2|STARTED|Overall Study||26
7975784|NCT00289458|19636905|P1|STARTED|Overall Study||25
7975785|NCT00289341|19636930|P2|NOT COMPLETED|Overall Study||0
7975786|NCT00289341|19636931|P1|NOT COMPLETED|Overall Study||0
7975787|NCT00289341|19636930|P2|COMPLETED|Overall Study||12
7975788|NCT00289341|19636931|P1|COMPLETED|Overall Study||12
7975789|NCT00289341|19636930|P2|STARTED|Overall Study||12
7975790|NCT00289341|19636931|P1|STARTED|Overall Study||12
7975791|NCT00289315|19636944|P3|NOT COMPLETED|Overall Study||140
7975792|NCT00289315|19636945|P2|NOT COMPLETED|Overall Study||122
7975793|NCT00289315|19636946|P1|NOT COMPLETED|Overall Study||101
7975794|NCT00289315|19636944|P3|COMPLETED|Overall Study||447
7975795|NCT00289315|19636945|P2|COMPLETED|Overall Study||638
7975796|NCT00289315|19636946|P1|COMPLETED|Overall Study||612
7975797|NCT00289315|19636944|P3|STARTED|Overall Study||587
7975798|NCT00289315|19636945|P2|STARTED|Overall Study||760
7975799|NCT00289315|19636946|P1|STARTED|Overall Study||713
7975800|NCT00289289|19636966|P3|NOT COMPLETED|Overall Study||49
7975801|NCT00289289|19636967|P2|NOT COMPLETED|Overall Study||10
7975802|NCT00289289|19636968|P1|NOT COMPLETED|Overall Study||19
7975803|NCT00289289|19636966|P3|COMPLETED|Overall Study||95
7975804|NCT00289289|19636967|P2|COMPLETED|Overall Study||114
7975805|NCT00289289|19636968|P1|COMPLETED|Overall Study||113
7975806|NCT00289289|19636966|P3|STARTED|Overall Study||144
7975807|NCT00289289|19636967|P2|STARTED|Overall Study||124
7975808|NCT00289289|19636968|P1|STARTED|Overall Study||132
7975809|NCT00289276|19636983|P2|NOT COMPLETED|Second Part of FAST Study (Expansion)||3
7975810|NCT00289276|19636984|P1|NOT COMPLETED|Second Part of FAST Study (Expansion)||0
7975811|NCT00289276|19636983|P2|COMPLETED|Second Part of FAST Study (Expansion)||106
7975812|NCT00289276|19636984|P1|COMPLETED|Second Part of FAST Study (Expansion)||0
7975813|NCT00289276|19636983|P2|STARTED|Second Part of FAST Study (Expansion)||109
7975814|NCT00289276|19636984|P1|STARTED|Second Part of FAST Study (Expansion)||0
7975815|NCT00289276|19636983|P2|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
7975816|NCT00289276|19636984|P1|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
7975817|NCT00289276|19636983|P2|COMPLETED|First Part of FAST Study (Pivotal)||0
7975818|NCT00289276|19636984|P1|COMPLETED|First Part of FAST Study (Pivotal)||47
7975819|NCT00289276|19636983|P2|STARTED|First Part of FAST Study (Pivotal)||0
7975820|NCT00289276|19636984|P1|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47
7975821|NCT00289211|19636999|P3|NOT COMPLETED|Overall Study||10
7975822|NCT00289211|19637000|P2|NOT COMPLETED|Overall Study||1
7975823|NCT00289211|19637001|P1|NOT COMPLETED|Overall Study||0
7975824|NCT00289211|19636999|P3|COMPLETED|Overall Study||2
7975825|NCT00289211|19637000|P2|COMPLETED|Overall Study||34
7975826|NCT00289211|19637001|P1|COMPLETED|Overall Study||36
7975827|NCT00289211|19636999|P3|STARTED|Overall Study||12
7975828|NCT00289211|19637000|P2|STARTED|Overall Study||35
7975829|NCT00289211|19637001|P1|STARTED|Overall Study||36
7975830|NCT00289198|19637019|P2|NOT COMPLETED|Overall Study||30
7975831|NCT00289198|19637020|P1|NOT COMPLETED|Overall Study||31
7975832|NCT00289198|19637019|P2|COMPLETED|Overall Study||121
7975833|NCT00289198|19637020|P1|COMPLETED|Overall Study||120
7975834|NCT00289198|19637019|P2|STARTED|Overall Study||151
7975835|NCT00289198|19637020|P1|STARTED|Overall Study||151
7975836|NCT00289185|19637070|P2|NOT COMPLETED|Overall Study||26
7975837|NCT00289185|19637071|P1|NOT COMPLETED|Overall Study||28
7975838|NCT00289185|19637070|P2|COMPLETED|Overall Study||144
7975839|NCT00289185|19637071|P1|COMPLETED|Overall Study||142
7975840|NCT00289185|19637070|P2|STARTED|Overall Study||170
7975841|NCT00289185|19637071|P1|STARTED|Overall Study||170
7975842|NCT00289133|19637118|P2|NOT COMPLETED|Overall Study||298
7975843|NCT00289133|19637119|P1|NOT COMPLETED|Overall Study||272
7975844|NCT00289133|19637118|P2|COMPLETED|Overall Study||179
7975845|NCT00289133|19637119|P1|COMPLETED|Overall Study||189
7975846|NCT00289133|19637118|P2|STARTED|Overall Study||477
7975847|NCT00289133|19637119|P1|STARTED|Overall Study||461
7975848|NCT00289120|19637141|P1|NOT COMPLETED|Overall Study||0
7975849|NCT00289120|19637141|P1|COMPLETED|Overall Study||13
7975850|NCT00289120|19637141|P1|STARTED|Overall Study||13
7975851|NCT00289107|19637159|P2|NOT COMPLETED|Overall Study||44
7975852|NCT00289107|19637160|P1|NOT COMPLETED|Overall Study||53
7975853|NCT00289107|19637159|P2|COMPLETED|Overall Study||28
7975854|NCT00289107|19637160|P1|COMPLETED|Overall Study||24
7975855|NCT00289107|19637159|P2|STARTED|Overall Study||72
7975856|NCT00289107|19637160|P1|STARTED|Overall Study||77
7975857|NCT00289094|19637168|P2|NOT COMPLETED|Overall Study||47
7975858|NCT00289094|19637169|P1|NOT COMPLETED|Overall Study||47
7975859|NCT00289094|19637168|P2|COMPLETED|Overall Study||2
7975860|NCT00289094|19637169|P1|COMPLETED|Overall Study||3
7975861|NCT00289094|19637168|P2|STARTED|Overall Study||49
7975862|NCT00289094|19637169|P1|STARTED|Overall Study||50
7975863|NCT00289016|19637175|P1|NOT COMPLETED|Overall Study||37
7975864|NCT00289016|19637175|P1|COMPLETED|Overall Study||13
7975865|NCT00289016|19637175|P1|STARTED|Overall Study||50
7975866|NCT00288912|19637187|P3|NOT COMPLETED|Overall Study||28
7975867|NCT00288912|19637188|P2|NOT COMPLETED|Overall Study||17
7975868|NCT00288912|19637189|P1|NOT COMPLETED|Overall Study||17
7975869|NCT00288912|19637187|P3|COMPLETED|Overall Study||146
7975870|NCT00288912|19637188|P2|COMPLETED|Overall Study||157
7975871|NCT00288912|19637189|P1|COMPLETED|Overall Study||158
7975872|NCT00288912|19637187|P3|STARTED|Overall Study||174
7975873|NCT00288912|19637188|P2|STARTED|Overall Study||174
7975874|NCT00288912|19637189|P1|STARTED|Overall Study||175
7975875|NCT00288886|19637208|P2|NOT COMPLETED|Overall Study||11
7975876|NCT00288886|19637209|P1|NOT COMPLETED|Overall Study||11
7975877|NCT00288886|19637208|P2|COMPLETED|Overall Study||81
7975878|NCT00288886|19637209|P1|COMPLETED|Overall Study||80
7975879|NCT00288886|19637208|P2|12-month Follow Up|Overall Study||81
7975880|NCT00288886|19637209|P1|12-month Follow Up|Overall Study||80
7975881|NCT00288886|19637208|P2|6-month Follow Up|Overall Study||84
7975882|NCT00288886|19637209|P1|6-month Follow Up|Overall Study||85
7975883|NCT00288886|19637208|P2|3-month Follow Up|Overall Study||85
7975884|NCT00288886|19637209|P1|3-month Follow Up|Overall Study||82
7975885|NCT00288886|19637208|P2|STARTED|Overall Study||92
7975886|NCT00288886|19637209|P1|STARTED|Overall Study||91
7975887|NCT00288860|19637229|P2|NOT COMPLETED|Overall Study||97
7975888|NCT00288860|19637230|P1|NOT COMPLETED|Overall Study||102
7975889|NCT00288860|19637229|P2|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328
7975890|NCT00288860|19637230|P1|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310
7975891|NCT00288860|19637229|P2|Completed 12 Month fu Survey|Overall Study||281
7975892|NCT00288860|19637230|P1|Completed 12 Month fu Survey|Overall Study||257
7975893|NCT00288860|19637229|P2|Completed 4 Month fu Survey|Overall Study||299
7975894|NCT00288860|19637230|P1|Completed 4 Month fu Survey|Overall Study||275
7975895|NCT00288860|19637229|P2|Completed Intake Survey|Overall Study||417
7975896|NCT00288860|19637230|P1|Completed Intake Survey|Overall Study||408
7975897|NCT00288860|19637229|P2|STARTED|Overall Study||425
7975898|NCT00288860|19637230|P1|STARTED|Overall Study||412
7975899|NCT00288704|19637243|P3|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20
7975900|NCT00288704|19637244|P2|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
7975901|NCT00288704|19637245|P1|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
7975902|NCT00288704|19637243|P3|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81
7975903|NCT00288704|19637244|P2|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
7975904|NCT00288704|19637245|P1|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
7975905|NCT00288704|19637243|P3|STARTED|Open-Label Extension (OLE) Weeks 24-117||101
7975906|NCT00288704|19637244|P2|STARTED|Open-Label Extension (OLE) Weeks 24-117||0
7975907|NCT00288704|19637245|P1|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0
7975908|NCT00288704|19637243|P3|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
7975909|NCT00288704|19637244|P2|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1
7975910|NCT00288704|19637245|P1|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
7975911|NCT00288704|19637243|P3|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
7975912|NCT00288704|19637244|P2|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21
7975913|NCT00288704|19637245|P1|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23
7975914|NCT00288704|19637243|P3|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0
7975915|NCT00288704|19637244|P2|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22
7975916|NCT00288704|19637245|P1|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23
7975917|NCT00288704|19637243|P3|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
7975918|NCT00288704|19637244|P2|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1
7975919|NCT00288704|19637245|P1|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
7975920|NCT00288704|19637243|P3|COMPLETED|Part A, Double Blind, Weeks 1-6||0
7975921|NCT00288704|19637244|P2|COMPLETED|Part A, Double Blind, Weeks 1-6||22
7975922|NCT00288704|19637245|P1|COMPLETED|Part A, Double Blind, Weeks 1-6||24
7975923|NCT00288704|19637243|P3|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0
7975924|NCT00288704|19637244|P2|STARTED|Part A, Double Blind, Weeks 1-6||23
7975925|NCT00288704|19637245|P1|STARTED|Part A, Double Blind, Weeks 1-6||24
7975926|NCT00288639|19637272|P1|NOT COMPLETED|Overall Study||12
7975927|NCT00288639|19637272|P1|COMPLETED|Overall Study||86
7975928|NCT00288639|19637272|P1|STARTED|Overall Study||98
7975929|NCT00288626|19637289|P1|NOT COMPLETED|Overall Study||7
7975930|NCT00288626|19637289|P1|COMPLETED|Overall Study||17
7975931|NCT00288626|19637289|P1|STARTED|Overall Study||24
7975932|NCT00288600|19637314|P2|NOT COMPLETED|Overall Study||0
7975933|NCT00288600|19637315|P1|NOT COMPLETED|Overall Study||0
7975934|NCT00288600|19637314|P2|COMPLETED|Overall Study||46
7975935|NCT00288600|19637315|P1|COMPLETED|Overall Study||46
7975936|NCT00288600|19637314|P2|STARTED|Overall Study||46
7975937|NCT00288600|19637315|P1|STARTED|Overall Study||46
7975938|NCT00288587|19637323|P2|NOT COMPLETED|Overall Study||10
7975939|NCT00288587|19637324|P1|NOT COMPLETED|Overall Study||5
7975940|NCT00288587|19637323|P2|COMPLETED|Overall Study||7
7975941|NCT00288587|19637324|P1|COMPLETED|Overall Study||14
7975942|NCT00288587|19637323|P2|STARTED|Overall Study||17
7975943|NCT00288587|19637324|P1|STARTED|Overall Study||19
7975944|NCT00288574|19637340|P2|NOT COMPLETED|Overall Study||0
7975945|NCT00288574|19637341|P1|NOT COMPLETED|Overall Study||0
7975946|NCT00288574|19637340|P2|COMPLETED|Overall Study||44
7975947|NCT00288574|19637341|P1|COMPLETED|Overall Study||49
7975948|NCT00288574|19637340|P2|STARTED|Overall Study||44
7975949|NCT00288574|19637341|P1|STARTED|Overall Study||49
7975950|NCT00288509|19637367|P1|NOT COMPLETED|Treatment Cycle 4||8
7975951|NCT00288509|19637367|P1|COMPLETED|Treatment Cycle 4||80
7975952|NCT00288509|19637367|P1|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88
7975953|NCT00288509|19637367|P1|NOT COMPLETED|Treatment Cycle 3||5
7975954|NCT00288509|19637367|P1|COMPLETED|Treatment Cycle 3||91
7975955|NCT00288509|19637367|P1|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96
7975956|NCT00288509|19637367|P1|NOT COMPLETED|Treatment Cycle 2||3
7975957|NCT00288509|19637367|P1|COMPLETED|Treatment Cycle 2||97
7975958|NCT00288509|19637367|P1|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100
7975959|NCT00288509|19637367|P1|NOT COMPLETED|Treatment Cycle 1||6
7975960|NCT00288509|19637367|P1|COMPLETED|Treatment Cycle 1||102
7975961|NCT00288509|19637367|P1|STARTED|Treatment Cycle 1||108
7975962|NCT00288366|19637376|P2|NOT COMPLETED|Overall Study||0
7975963|NCT00288366|19637377|P1|NOT COMPLETED|Overall Study||0
7975964|NCT00288366|19637376|P2|COMPLETED|Overall Study||26
7975965|NCT00288366|19637377|P1|COMPLETED|Overall Study||23
7975966|NCT00288366|19637376|P2|STARTED|Overall Study||26
7975967|NCT00288366|19637377|P1|STARTED|Overall Study||23
7975968|NCT00288080|19637385|P2|NOT COMPLETED|Overall Study||23
7975969|NCT00288080|19637386|P1|NOT COMPLETED|Overall Study||26
7975970|NCT00288080|19637385|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282
7975971|NCT00288080|19637386|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281
7975972|NCT00288080|19637385|P2|STARTED|Overall Study||305
7975973|NCT00288080|19637386|P1|STARTED|Overall Study||307
7975974|NCT00288067|19637402|P1|NOT COMPLETED|Overall Study||0
7975975|NCT00288067|19637402|P1|COMPLETED|Overall Study||32
7975976|NCT00288067|19637402|P1|STARTED|Overall Study||32
7975977|NCT00288054|19637408|P1|NOT COMPLETED|Overall Study||24
7975978|NCT00288054|19637408|P1|COMPLETED|Overall Study||0
7975979|NCT00288054|19637408|P1|STARTED|Overall Study||24
7975980|NCT00288015|19637416|P1|NOT COMPLETED|Follow up for Survival x 2 Years||26
7975981|NCT00288015|19637416|P1|COMPLETED|Follow up for Survival x 2 Years||3
7975982|NCT00288015|19637416|P1|STARTED|Follow up for Survival x 2 Years||29
7975983|NCT00288015|19637416|P1|NOT COMPLETED|Continued Bevacizumab Cycle 3+||7
7975984|NCT00288015|19637416|P1|COMPLETED|Continued Bevacizumab Cycle 3+||19
7975985|NCT00288015|19637416|P1|STARTED|Continued Bevacizumab Cycle 3+||26
7975986|NCT00288015|19637416|P1|NOT COMPLETED|First Response Assessment||4
7975987|NCT00288015|19637416|P1|COMPLETED|First Response Assessment||26
7975988|NCT00288015|19637416|P1|STARTED|First Response Assessment||30
7975989|NCT00288015|19637416|P1|NOT COMPLETED|Bevacizumab Treatment Cycles 1-2||2
7975990|NCT00288015|19637416|P1|COMPLETED|Bevacizumab Treatment Cycles 1-2||30
7975991|NCT00288015|19637416|P1|STARTED|Bevacizumab Treatment Cycles 1-2||32
7975992|NCT00288015|19637416|P1|NOT COMPLETED|Registered to Study||0
7975993|NCT00288015|19637416|P1|COMPLETED|Registered to Study||32
7975994|NCT00288015|19637416|P1|STARTED|Registered to Study||32
7975995|NCT00287989|19637428|P3|NOT COMPLETED|Overall Study||0
7975996|NCT00287989|19637429|P2|NOT COMPLETED|Overall Study||0
7975997|NCT00287989|19637430|P1|NOT COMPLETED|Overall Study||0
7975998|NCT00287989|19637428|P3|COMPLETED|Overall Study||29
7975999|NCT00287989|19637429|P2|COMPLETED|Overall Study||29
7976000|NCT00287989|19637430|P1|COMPLETED|Overall Study||28
7976001|NCT00287989|19637428|P3|STARTED|Overall Study||29
7976002|NCT00287989|19637429|P2|STARTED|Overall Study||29
7976003|NCT00287989|19637430|P1|STARTED|Overall Study||28
7976004|NCT00287872|19637441|P1|NOT COMPLETED|Overall Study||0
7976005|NCT00287872|19637441|P1|COMPLETED|Overall Study||30
7976006|NCT00287872|19637441|P1|STARTED|Overall Study||30
7976007|NCT00287729|19637451|P2|NOT COMPLETED|Overall Study||31
7976008|NCT00287729|19637452|P1|NOT COMPLETED|Overall Study||34
7976009|NCT00287729|19637451|P2|COMPLETED|Overall Study||142
7976010|NCT00287729|19637452|P1|COMPLETED|Overall Study||137
7976011|NCT00287729|19637451|P2|STARTED|Overall Study||173
7976012|NCT00287729|19637452|P1|STARTED|Overall Study||171
7976013|NCT00287716|19637475|P3|NOT COMPLETED|Overall Study||31
7976014|NCT00287716|19637476|P2|NOT COMPLETED|Overall Study||17
7976015|NCT00287716|19637477|P1|NOT COMPLETED|Overall Study||38
7976016|NCT00287716|19637475|P3|COMPLETED|Overall Study||143
7976017|NCT00287716|19637476|P2|COMPLETED|Overall Study||70
7976018|NCT00287716|19637477|P1|COMPLETED|Overall Study||136
7976019|NCT00287716|19637475|P3|STARTED|Overall Study||174
7976020|NCT00287716|19637476|P2|STARTED|Overall Study||87
7976021|NCT00287716|19637477|P1|STARTED|Overall Study||174
7976022|NCT00287690|19637508|P2|NOT COMPLETED|Overall Study||26
7976023|NCT00287690|19637509|P1|NOT COMPLETED|Overall Study||20
7976024|NCT00287690|19637508|P2|COMPLETED|Overall Study||12
7976025|NCT00287690|19637509|P1|COMPLETED|Overall Study||13
7976026|NCT00287690|19637508|P2|STARTED|Overall Study||38
7976027|NCT00287690|19637509|P1|STARTED|Overall Study||33
7976028|NCT00287586|19637521|P2|NOT COMPLETED|Overall Study||52
7976029|NCT00287586|19637522|P1|NOT COMPLETED|Overall Study||45
7976030|NCT00287586|19637521|P2|COMPLETED|Overall Study||100
7976031|NCT00287586|19637522|P1|COMPLETED|Overall Study||111
7976032|NCT00287586|19637521|P2|Intent-to-treat: Received Study Drug|Overall Study||151
7976033|NCT00287586|19637522|P1|Intent-to-treat: Received Study Drug|Overall Study||155
7976034|NCT00287586|19637521|P2|STARTED|Overall Study||152
7976035|NCT00287586|19637522|P1|STARTED|Overall Study||156
7976036|NCT00287469|19637560|P2|NOT COMPLETED|Overall Study||214
7976037|NCT00287469|19637561|P1|NOT COMPLETED|Overall Study||220
7976038|NCT00287469|19637560|P2|COMPLETED|Overall Study||786
7976039|NCT00287469|19637561|P1|COMPLETED|Overall Study||780
7976040|NCT00287469|19637560|P2|STARTED|Overall Study||1000
7976041|NCT00287469|19637561|P1|STARTED|Overall Study||1000
7976042|NCT00287365|19637571|P1|NOT COMPLETED|Overall Study||13
7976043|NCT00287365|19637571|P1|COMPLETED|Overall Study||12
7976044|NCT00287365|19637571|P1|STARTED|Overall Study||25
7976045|NCT00287339|19637582|P2|NOT COMPLETED|Overall Study||0
7976046|NCT00287339|19637583|P1|NOT COMPLETED|Overall Study||0
7976047|NCT00287339|19637582|P2|COMPLETED|Overall Study||18
7976048|NCT00287339|19637583|P1|COMPLETED|Overall Study||22
7976049|NCT00287339|19637582|P2|STARTED|Overall Study||18
7976050|NCT00287339|19637583|P1|STARTED|Overall Study||22
7976051|NCT00287287|19637589|P1|NOT COMPLETED|Overall Study||0
7976052|NCT00287287|19637589|P1|COMPLETED|Overall Study||25
7976053|NCT00287287|19637589|P1|STARTED|Overall Study||25
7976054|NCT00287222|19637593|P1|NOT COMPLETED|Overall Study||0
7976055|NCT00287222|19637593|P1|COMPLETED|Overall Study||21
7976056|NCT00287222|19637593|P1|STARTED|Overall Study||21
7976057|NCT00287118|19637597|P1|NOT COMPLETED|Overall Study||52
7976058|NCT00287118|19637597|P1|COMPLETED|Overall Study||137
7976059|NCT00287118|19637597|P1|STARTED|Overall Study||189
7976060|NCT00287079|19637603|P2|NOT COMPLETED|Overall Study||1
7976061|NCT00287079|19637604|P1|NOT COMPLETED|Overall Study||22
7976062|NCT00287079|19637603|P2|COMPLETED|Overall Study||2
7976063|NCT00287079|19637604|P1|COMPLETED|Overall Study||10
7976064|NCT00287079|19637603|P2|STARTED|Overall Study||3
7976065|NCT00287079|19637604|P1|STARTED|Overall Study||32
7976066|NCT00287053|19637616|P2|NOT COMPLETED|Overall Study||1
7976067|NCT00287053|19637617|P1|NOT COMPLETED|Overall Study||4
7976068|NCT00287053|19637616|P2|COMPLETED|Overall Study||26
7976069|NCT00287053|19637617|P1|COMPLETED|Overall Study||26
7976070|NCT00287053|19637616|P2|STARTED|Overall Study||27
7976071|NCT00287053|19637617|P1|STARTED|Overall Study||30
7976072|NCT00286949|19637623|P1|NOT COMPLETED|Overall Study||0
7976073|NCT00286949|19637623|P1|COMPLETED|Overall Study||12
7976074|NCT00286949|19637623|P1|STARTED|Overall Study||12
7976075|NCT00286754|19637632|P3|NOT COMPLETED|Overall Study||10
7976076|NCT00286754|19637633|P2|NOT COMPLETED|Overall Study||18
7976077|NCT00286754|19637634|P1|NOT COMPLETED|Overall Study||20
7976078|NCT00286754|19637632|P3|COMPLETED|Overall Study||170
7976079|NCT00286754|19637633|P2|COMPLETED|Overall Study||159
7976080|NCT00286754|19637634|P1|COMPLETED|Overall Study||156
7976081|NCT00286754|19637632|P3|STARTED|Overall Study||180
7976082|NCT00286754|19637633|P2|STARTED|Overall Study||177
7976083|NCT00286754|19637634|P1|STARTED|Overall Study||176
7976084|NCT00286741|19637668|P2|NOT COMPLETED|Overall Study||17
7976085|NCT00286741|19637669|P1|NOT COMPLETED|Overall Study||11
7976086|NCT00286741|19637668|P2|COMPLETED|Overall Study||89
7976087|NCT00286741|19637669|P1|COMPLETED|Overall Study||122
7976088|NCT00286741|19637668|P2|STARTED|Overall Study||106
7976089|NCT00286741|19637669|P1|STARTED|Overall Study||133
7976090|NCT00286728|19637681|P2|NOT COMPLETED|Overall Study||29
7976091|NCT00286728|19637682|P1|NOT COMPLETED|Overall Study||36
7976092|NCT00286728|19637681|P2|COMPLETED|Overall Study||116
7976093|NCT00286728|19637682|P1|COMPLETED|Overall Study||106
7976094|NCT00286728|19637681|P2|STARTED|Overall Study||145
7976095|NCT00286728|19637682|P1|STARTED|Overall Study||142
7976096|NCT00286494|19637693|P3|NOT COMPLETED|Overall Study||39
7976097|NCT00286494|19637694|P2|NOT COMPLETED|Overall Study||44
7976098|NCT00286494|19637695|P1|NOT COMPLETED|Overall Study||26
7976099|NCT00286494|19637693|P3|COMPLETED|Overall Study||160
7976100|NCT00286494|19637694|P2|COMPLETED|Overall Study||153
7976101|NCT00286494|19637695|P1|COMPLETED|Overall Study||71
7976102|NCT00286494|19637693|P3|STARTED|Overall Study||199
7976103|NCT00286494|19637694|P2|STARTED|Overall Study||197
7976104|NCT00286494|19637695|P1|STARTED|Overall Study||97
7976105|NCT00286468|19637856|P3|NOT COMPLETED|Overall Study||50
7976106|NCT00286468|19637857|P2|NOT COMPLETED|Overall Study||50
7976107|NCT00286468|19637858|P1|NOT COMPLETED|Overall Study||37
7976108|NCT00286468|19637856|P3|COMPLETED|Overall Study||148
7976109|NCT00286468|19637857|P2|COMPLETED|Overall Study||153
7976110|NCT00286468|19637858|P1|COMPLETED|Overall Study||62
7976111|NCT00286468|19637856|P3|STARTED|Overall Study||198
7976112|NCT00286468|19637857|P2|STARTED|Overall Study||203
7976113|NCT00286468|19637858|P1|STARTED|Overall Study||99
7976114|NCT00286455|19638019|P3|NOT COMPLETED|Overall Study||24
7976115|NCT00286455|19638020|P2|NOT COMPLETED|Overall Study||28
7976116|NCT00286455|19638021|P1|NOT COMPLETED|Overall Study||25
7976117|NCT00286455|19638019|P3|COMPLETED|Overall Study||107
7976118|NCT00286455|19638020|P2|COMPLETED|Overall Study||105
7976119|NCT00286455|19638021|P1|COMPLETED|Overall Study||40
7976120|NCT00286455|19638019|P3|STARTED|Overall Study||131
7976121|NCT00286455|19638020|P2|STARTED|Overall Study||133
7976122|NCT00286455|19638021|P1|STARTED|Overall Study||65
7976123|NCT00286442|19638200|P3|NOT COMPLETED|Overall Study||32
7976124|NCT00286442|19638201|P2|NOT COMPLETED|Overall Study||45
7976125|NCT00286442|19638202|P1|NOT COMPLETED|Overall Study||37
7976126|NCT00286442|19638200|P3|COMPLETED|Overall Study||72
7976127|NCT00286442|19638201|P2|COMPLETED|Overall Study||165
7976128|NCT00286442|19638202|P1|COMPLETED|Overall Study||176
7976129|NCT00286442|19638200|P3|STARTED|Overall Study||104
7976130|NCT00286442|19638201|P2|STARTED|Overall Study||210
7976131|NCT00286442|19638202|P1|STARTED|Overall Study||213
7976132|NCT00286429|19638363|P3|NOT COMPLETED|Overall Study||52
7976133|NCT00286429|19638364|P2|NOT COMPLETED|Overall Study||48
7976134|NCT00286429|19638365|P1|NOT COMPLETED|Overall Study||75
7976135|NCT00286429|19638363|P3|COMPLETED|Overall Study||77
7976136|NCT00286429|19638364|P2|COMPLETED|Overall Study||83
7976137|NCT00286429|19638365|P1|COMPLETED|Overall Study||55
7976138|NCT00286429|19638363|P3|STARTED|Overall Study||129
7976139|NCT00286429|19638364|P2|STARTED|Overall Study||131
7976140|NCT00286429|19638365|P1|STARTED|Overall Study||130
7976141|NCT00286325|19638469|P1|NOT COMPLETED|Overall Study||0
7976142|NCT00286325|19638469|P1|COMPLETED|Overall Study||8
7976143|NCT00286325|19638469|P1|STARTED|Overall Study||8
7976144|NCT00286221|19638481|P4|NOT COMPLETED|Overall Study||6
7976145|NCT00286221|19638482|P3|NOT COMPLETED|Overall Study||9
7976146|NCT00286221|19638483|P2|NOT COMPLETED|Overall Study||5
7976147|NCT00286221|19638484|P1|NOT COMPLETED|Overall Study||10
7976148|NCT00286221|19638481|P4|COMPLETED|Overall Study||34
7976149|NCT00286221|19638482|P3|COMPLETED|Overall Study||31
7976150|NCT00286221|19638483|P2|COMPLETED|Overall Study||35
7976151|NCT00286221|19638484|P1|COMPLETED|Overall Study||29
7976152|NCT00286221|19638481|P4|STARTED|Overall Study||40
7976153|NCT00286221|19638482|P3|STARTED|Overall Study||40
7976154|NCT00286221|19638483|P2|STARTED|Overall Study||40
7976155|NCT00286221|19638484|P1|STARTED|Overall Study||39
7976156|NCT00286182|19638500|P2|NOT COMPLETED|Overall Study||3
7976157|NCT00286182|19638501|P1|NOT COMPLETED|Overall Study||5
7976158|NCT00286182|19638500|P2|COMPLETED|Overall Study||25
7976159|NCT00286182|19638501|P1|COMPLETED|Overall Study||23
7976160|NCT00286182|19638500|P2|STARTED|Overall Study||28
7976161|NCT00286182|19638501|P1|STARTED|Overall Study||28
7976162|NCT00286156|19638510|P3|NOT COMPLETED|Overall Study||1
7976163|NCT00286156|19638511|P2|NOT COMPLETED|Overall Study||1
7976164|NCT00286156|19638512|P1|NOT COMPLETED|Overall Study||2
7976165|NCT00286156|19638510|P3|COMPLETED|Overall Study||9
7976166|NCT00286156|19638511|P2|COMPLETED|Overall Study||9
7976167|NCT00286156|19638512|P1|COMPLETED|Overall Study||8
7976168|NCT00286156|19638510|P3|STARTED|Overall Study||10
7976169|NCT00286156|19638511|P2|STARTED|Overall Study||10
7976170|NCT00286156|19638512|P1|STARTED|Overall Study||10
7976171|NCT00286091|19638525|P2|NOT COMPLETED|Open-label Treatment Phase||71
7976172|NCT00286091|19638526|P1|NOT COMPLETED|Open-label Treatment Phase||77
7976173|NCT00286091|19638525|P2|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
7976174|NCT00286091|19638526|P1|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
7976175|NCT00286091|19638525|P2|Received Treatment|Open-label Treatment Phase||101
7976176|NCT00286091|19638526|P1|Received Treatment|Open-label Treatment Phase||109
7976177|NCT00286091|19638525|P2|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104
7976178|NCT00286091|19638526|P1|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110
7976179|NCT00286091|19638525|P2|NOT COMPLETED|Double-blind Treatment Phase||593
7976180|NCT00286091|19638526|P1|NOT COMPLETED|Double-blind Treatment Phase||584
7976181|NCT00286091|19638525|P2|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123
7976182|NCT00286091|19638526|P1|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132
7976183|NCT00286091|19638525|P2|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174
7976184|NCT00286091|19638526|P1|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164
7976185|NCT00286091|19638525|P2|Received Treatment|Double-blind Treatment Phase||716
7976186|NCT00286091|19638526|P1|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709
7976187|NCT00286091|19638525|P2|STARTED|Double-blind Treatment Phase||716
7976188|NCT00286091|19638526|P1|STARTED|Double-blind Treatment Phase||716
7976189|NCT00286078|19638540|P2|NOT COMPLETED|Overall Study||34
7976190|NCT00286078|19638541|P1|NOT COMPLETED|Overall Study||32
7976191|NCT00286078|19638540|P2|COMPLETED|Overall Study||34
7976192|NCT00286078|19638541|P1|COMPLETED|Overall Study||40
7976193|NCT00286078|19638540|P2|12 Weeks|Overall Study||62
7976194|NCT00286078|19638541|P1|12 Weeks|Overall Study||63
7976195|NCT00286078|19638540|P2|STARTED|Overall Study||68
7976196|NCT00286078|19638541|P1|STARTED|Overall Study||72
7976197|NCT00285857|19638549|P1|NOT COMPLETED|Overall Study||4
7976198|NCT00285857|19638549|P1|COMPLETED|Overall Study||26
7976199|NCT00285857|19638549|P1|STARTED|Overall Study||30
7976200|NCT00285818|19638562|P2|NOT COMPLETED|Overall Study||2
7976201|NCT00285818|19638563|P1|NOT COMPLETED|Overall Study||4
7976202|NCT00285818|19638562|P2|COMPLETED|Overall Study||3
7976203|NCT00285818|19638563|P1|COMPLETED|Overall Study||2
7976204|NCT00285818|19638562|P2|STARTED|Overall Study||5
7976205|NCT00285818|19638563|P1|STARTED|Overall Study||6
7976206|NCT00285779|19638571|P2|NOT COMPLETED|Follow-up Period (wk 24-32)||0
7976207|NCT00285779|19638572|P1|NOT COMPLETED|Follow-up Period (wk 24-32)||1
7976208|NCT00285779|19638571|P2|COMPLETED|Follow-up Period (wk 24-32)||10
7976209|NCT00285779|19638572|P1|COMPLETED|Follow-up Period (wk 24-32)||8
7976210|NCT00285779|19638571|P2|STARTED|Follow-up Period (wk 24-32)||10
7976211|NCT00285779|19638572|P1|STARTED|Follow-up Period (wk 24-32)||9
7976212|NCT00285779|19638571|P2|NOT COMPLETED|Open Label Period (wk 12-24)||2
7976213|NCT00285779|19638572|P1|NOT COMPLETED|Open Label Period (wk 12-24)||2
7976214|NCT00285779|19638571|P2|COMPLETED|Open Label Period (wk 12-24)||10
7976215|NCT00285779|19638572|P1|COMPLETED|Open Label Period (wk 12-24)||9
7976216|NCT00285779|19638571|P2|STARTED|Open Label Period (wk 12-24)||12
7976217|NCT00285779|19638572|P1|STARTED|Open Label Period (wk 12-24)||11
7976218|NCT00285779|19638571|P2|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1
7976219|NCT00285779|19638572|P1|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3
7976220|NCT00285779|19638571|P2|COMPLETED|Placebo-controlled Period (wk 1-12)||12
7976221|NCT00285779|19638572|P1|COMPLETED|Placebo-controlled Period (wk 1-12)||11
7976222|NCT00285779|19638571|P2|STARTED|Placebo-controlled Period (wk 1-12)||13
7976223|NCT00285779|19638572|P1|STARTED|Placebo-controlled Period (wk 1-12)||14
7976224|NCT00285649|19638608|P3|NOT COMPLETED|Overall Study||6
7976225|NCT00285649|19638609|P2|NOT COMPLETED|Overall Study||6
7976226|NCT00285649|19638610|P1|NOT COMPLETED|Overall Study||9
7976227|NCT00285649|19638608|P3|COMPLETED|Overall Study||42
7976228|NCT00285649|19638609|P2|COMPLETED|Overall Study||66
7976229|NCT00285649|19638610|P1|COMPLETED|Overall Study||63
7976230|NCT00285649|19638608|P3|STARTED|Overall Study||48
7976231|NCT00285649|19638609|P2|STARTED|Overall Study||72
7976232|NCT00285649|19638610|P1|STARTED|Overall Study||72
7976233|NCT00285584|19638620|P2|NOT COMPLETED|Month 9||3
7976234|NCT00285584|19638621|P1|NOT COMPLETED|Month 9||1
7976235|NCT00285584|19638620|P2|COMPLETED|Month 9||14
7976236|NCT00285584|19638621|P1|COMPLETED|Month 9||15
7976237|NCT00285584|19638620|P2|STARTED|Month 9||17
7976238|NCT00285584|19638621|P1|STARTED|Month 9||16
7976239|NCT00285584|19638620|P2|NOT COMPLETED|Month 6||1
7976240|NCT00285584|19638621|P1|NOT COMPLETED|Month 6||0
7976241|NCT00285584|19638620|P2|COMPLETED|Month 6||17
7976242|NCT00285584|19638621|P1|COMPLETED|Month 6||16
7976243|NCT00285584|19638620|P2|STARTED|Month 6||18
7976244|NCT00285584|19638621|P1|STARTED|Month 6||16
7976245|NCT00285584|19638620|P2|NOT COMPLETED|Month 3||3
7976246|NCT00285584|19638621|P1|NOT COMPLETED|Month 3||4
7976247|NCT00285584|19638620|P2|COMPLETED|Month 3||18
7976248|NCT00285584|19638621|P1|COMPLETED|Month 3||16
7976249|NCT00285584|19638620|P2|STARTED|Month 3||21
7976250|NCT00285584|19638621|P1|STARTED|Month 3||20
7976251|NCT00285584|19638620|P2|NOT COMPLETED|Enrollment (Month 0)||0
7976252|NCT00285584|19638621|P1|NOT COMPLETED|Enrollment (Month 0)||0
7976253|NCT00285584|19638620|P2|COMPLETED|Enrollment (Month 0)||21
7976254|NCT00285584|19638621|P1|COMPLETED|Enrollment (Month 0)||20
7976255|NCT00285584|19638620|P2|STARTED|Enrollment (Month 0)||21
7976256|NCT00285584|19638621|P1|STARTED|Enrollment (Month 0)||20
7976257|NCT00285467|19638635|P2|NOT COMPLETED|Overall Study||0
7976258|NCT00285467|19638636|P1|NOT COMPLETED|Overall Study||0
7976259|NCT00285467|19638635|P2|COMPLETED|Overall Study||22
7976260|NCT00285467|19638636|P1|COMPLETED|Overall Study||25
7976261|NCT00285467|19638635|P2|STARTED|Overall Study||22
7976262|NCT00285467|19638636|P1|STARTED|Overall Study||25
7976263|NCT00285246|19638644|P1|NOT COMPLETED|Overall Study||48
7976264|NCT00285246|19638644|P1|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790
7976265|NCT00285246|19638644|P1|STARTED|Overall Study||838
7976266|NCT00285207|19638653|P2|NOT COMPLETED|Overall Study||6
7976267|NCT00285207|19638654|P1|NOT COMPLETED|Overall Study||9
7976268|NCT00285207|19638653|P2|COMPLETED|Overall Study||71
7976269|NCT00285207|19638654|P1|COMPLETED|Overall Study||61
7976270|NCT00285207|19638653|P2|Treated|Overall Study||75
7976271|NCT00285207|19638654|P1|Treated|Overall Study||63
7976272|NCT00285207|19638653|P2|STARTED|Overall Study||77
7976273|NCT00285207|19638654|P1|STARTED|Overall Study||70
7976274|NCT00285012|19638662|P2|NOT COMPLETED|Received Study Tx||94
7976275|NCT00285012|19638663|P1|NOT COMPLETED|Received Study Tx||72
7976276|NCT00285012|19638662|P2|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157
7976277|NCT00285012|19638663|P1|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176
7976278|NCT00285012|19638662|P2|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58
7976279|NCT00285012|19638663|P1|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41
7976280|NCT00285012|19638662|P2|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193
7976281|NCT00285012|19638663|P1|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207
7976282|NCT00285012|19638662|P2|STARTED|Received Study Tx||251
7976283|NCT00285012|19638663|P1|STARTED|Received Study Tx||248
7976284|NCT00285012|19638662|P2|NOT COMPLETED|Assigned to Study Treatment (Tx)||3
7976285|NCT00285012|19638663|P1|NOT COMPLETED|Assigned to Study Treatment (Tx)||2
7976286|NCT00285012|19638662|P2|COMPLETED|Assigned to Study Treatment (Tx)||251
7976287|NCT00285012|19638663|P1|COMPLETED|Assigned to Study Treatment (Tx)||248
7976288|NCT00285012|19638662|P2|STARTED|Assigned to Study Treatment (Tx)||254
7976289|NCT00285012|19638663|P1|STARTED|Assigned to Study Treatment (Tx)||250
7976290|NCT00284934|19638689|P2|NOT COMPLETED|Overall Study||3
7976291|NCT00284934|19638690|P1|NOT COMPLETED|Overall Study||4
7976292|NCT00284934|19638689|P2|COMPLETED|Overall Study||43
7976293|NCT00284934|19638690|P1|COMPLETED|Overall Study||44
7976294|NCT00284934|19638689|P2|Intent-to-treat Population (ITT)|Overall Study||45
7976295|NCT00284934|19638690|P1|Intent-to-treat Population (ITT)|Overall Study||47
7976296|NCT00284934|19638689|P2|STARTED|Overall Study||46
7976297|NCT00284934|19638690|P1|STARTED|Overall Study||48
7976298|NCT00284856|19638705|P3|NOT COMPLETED|Overall Study||60
7976299|NCT00284856|19638706|P2|NOT COMPLETED|Overall Study||50
7976300|NCT00284856|19638707|P1|NOT COMPLETED|Overall Study||51
7976301|NCT00284856|19638705|P3|COMPLETED|Overall Study||276
7976302|NCT00284856|19638706|P2|COMPLETED|Overall Study||286
7976303|NCT00284856|19638707|P1|COMPLETED|Overall Study||296
7976304|NCT00284856|19638705|P3|STARTED|Overall Study||336
7976305|NCT00284856|19638706|P2|STARTED|Overall Study||336
7976306|NCT00284856|19638707|P1|STARTED|Overall Study||347
7976307|NCT00284739|19638723|P2|NOT COMPLETED|Overall Study||0
7976308|NCT00284739|19638724|P1|NOT COMPLETED|Overall Study||0
7976309|NCT00284739|19638723|P2|COMPLETED|Overall Study||9
7976310|NCT00284739|19638724|P1|COMPLETED|Overall Study||11
7976311|NCT00284739|19638723|P2|STARTED|Overall Study||9
7976312|NCT00284739|19638724|P1|STARTED|Overall Study||11
7976313|NCT00284557|19638736|P2|NOT COMPLETED|Overall Study||13
7976314|NCT00284557|19638737|P1|NOT COMPLETED|Overall Study||9
7976315|NCT00284557|19638736|P2|COMPLETED|Overall Study||50
7976316|NCT00284557|19638737|P1|COMPLETED|Overall Study||58
7976317|NCT00284557|19638736|P2|STARTED|Overall Study||63
7976318|NCT00284557|19638737|P1|STARTED|Overall Study||67
7976319|NCT00284518|19638749|P4|NOT COMPLETED|Overall Study||33
7976320|NCT00284518|19638750|P3|NOT COMPLETED|Overall Study||28
7976321|NCT00284518|19638751|P2|NOT COMPLETED|Overall Study||28
7976322|NCT00284518|19638752|P1|NOT COMPLETED|Overall Study||26
7976323|NCT00284518|19638749|P4|COMPLETED|Overall Study||61
7976324|NCT00284518|19638750|P3|COMPLETED|Overall Study||67
7976325|NCT00284518|19638751|P2|COMPLETED|Overall Study||66
7976326|NCT00284518|19638752|P1|COMPLETED|Overall Study||71
7976327|NCT00284518|19638749|P4|STARTED|Overall Study||94
7976328|NCT00284518|19638750|P3|STARTED|Overall Study||95
7976329|NCT00284518|19638751|P2|STARTED|Overall Study||94
7976330|NCT00284518|19638752|P1|STARTED|Overall Study||97
7976331|NCT00284180|19638792|P2|NOT COMPLETED|Overall Study||4
7976332|NCT00284180|19638793|P1|NOT COMPLETED|Overall Study||0
7976333|NCT00284180|19638792|P2|COMPLETED|Overall Study||17
7976334|NCT00284180|19638793|P1|COMPLETED|Overall Study||11
7976335|NCT00284180|19638792|P2|STARTED|Overall Study||21
7976336|NCT00284180|19638793|P1|STARTED|Overall Study||11
7976337|NCT00284154|19638799|P1|NOT COMPLETED|Overall Study||42
7976338|NCT00284154|19638799|P1|COMPLETED|Overall Study||9
7976339|NCT00284154|19638799|P1|STARTED|Overall Study||51
7976340|NCT00284141|19638806|P1|NOT COMPLETED|Overall Study||98
7976341|NCT00284141|19638806|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0
7976342|NCT00284141|19638806|P1|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2
7976343|NCT00284141|19638806|P1|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96
7976344|NCT00284141|19638806|P1|STARTED|Overall Study||98
7976345|NCT00284089|19638829|P4|NOT COMPLETED|Extension Phase||12
7976346|NCT00284089|19638830|P3|NOT COMPLETED|Extension Phase||6
7976347|NCT00284089|19638831|P2|NOT COMPLETED|Extension Phase||0
7976348|NCT00284089|19638832|P1|NOT COMPLETED|Extension Phase||2
7976349|NCT00284089|19638829|P4|COMPLETED|Extension Phase||21
7976350|NCT00284089|19638830|P3|COMPLETED|Extension Phase||22
7976351|NCT00284089|19638831|P2|COMPLETED|Extension Phase||6
7976352|NCT00284089|19638832|P1|COMPLETED|Extension Phase||1
7976353|NCT00284089|19638829|P4|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33
7976354|NCT00284089|19638830|P3|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28
7976355|NCT00284089|19638831|P2|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6
7976356|NCT00284089|19638832|P1|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3
7976357|NCT00284089|19638829|P4|NOT COMPLETED|Multiple Dose Phase||4
7976358|NCT00284089|19638830|P3|NOT COMPLETED|Multiple Dose Phase||4
7976359|NCT00284089|19638831|P2|NOT COMPLETED|Multiple Dose Phase||0
7976360|NCT00284089|19638832|P1|NOT COMPLETED|Multiple Dose Phase||1
7976361|NCT00284089|19638829|P4|COMPLETED|Multiple Dose Phase||37
7976362|NCT00284089|19638830|P3|COMPLETED|Multiple Dose Phase||31
7976363|NCT00284089|19638831|P2|COMPLETED|Multiple Dose Phase||6
7976364|NCT00284089|19638832|P1|COMPLETED|Multiple Dose Phase||4
7976365|NCT00284089|19638829|P4|STARTED|Multiple Dose Phase||41
7976366|NCT00284089|19638830|P3|STARTED|Multiple Dose Phase||35
7976367|NCT00284089|19638831|P2|STARTED|Multiple Dose Phase||6
7976368|NCT00284089|19638832|P1|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5
7976369|NCT00284089|19638829|P4|NOT COMPLETED|Single Dose Phase||0
7976370|NCT00284089|19638830|P3|NOT COMPLETED|Single Dose Phase||0
7976371|NCT00284089|19638831|P2|NOT COMPLETED|Single Dose Phase||0
7976372|NCT00284089|19638832|P1|NOT COMPLETED|Single Dose Phase||0
7976373|NCT00284089|19638829|P4|COMPLETED|Single Dose Phase||0
7976374|NCT00284089|19638830|P3|COMPLETED|Single Dose Phase||0
7976375|NCT00284089|19638831|P2|COMPLETED|Single Dose Phase||6
7976376|NCT00284089|19638832|P1|COMPLETED|Single Dose Phase||6
7976377|NCT00284089|19638829|P4|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
7976378|NCT00284089|19638830|P3|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
7976379|NCT00284089|19638831|P2|STARTED|Single Dose Phase||6
7976380|NCT00284089|19638832|P1|STARTED|Single Dose Phase||6
7976381|NCT00284050|19638861|P3|NOT COMPLETED|Overall Study||9
7976382|NCT00284050|19638862|P2|NOT COMPLETED|Overall Study||5
7976383|NCT00284050|19638863|P1|NOT COMPLETED|Overall Study||5
7976384|NCT00284050|19638861|P3|COMPLETED|Overall Study||40
7976385|NCT00284050|19638862|P2|COMPLETED|Overall Study||46
7976386|NCT00284050|19638863|P1|COMPLETED|Overall Study||46
7976387|NCT00284050|19638861|P3|STARTED|Overall Study||49
7976388|NCT00284050|19638862|P2|STARTED|Overall Study||51
7976389|NCT00284050|19638863|P1|STARTED|Overall Study||51
7976390|NCT00283959|19638877|P1|NOT COMPLETED|Extension Period||1
7976391|NCT00283959|19638877|P1|COMPLETED|Extension Period||3
7976392|NCT00283959|19638877|P1|STARTED|Extension Period||4
7976393|NCT00283959|19638877|P1|NOT COMPLETED|Treatment Period||0
7976394|NCT00283959|19638877|P1|COMPLETED|Treatment Period||4
7976395|NCT00283959|19638877|P1|Pharmacodynamics (PD) Population|Treatment Period||4
7976396|NCT00283959|19638877|P1|Safety Population|Treatment Period||4
7976397|NCT00283959|19638877|P1|STARTED|Treatment Period||4
7976398|NCT00283933|19638882|P1|NOT COMPLETED|Extension Period||0
7976399|NCT00283933|19638882|P1|COMPLETED|Extension Period||5
7976400|NCT00283933|19638882|P1|STARTED|Extension Period||5
7976401|NCT00283933|19638882|P1|NOT COMPLETED|Treatment Period||0
7976402|NCT00283933|19638882|P1|COMPLETED|Treatment Period||5
7976403|NCT00283933|19638882|P1|Pharmacodynamic (PD) Population|Treatment Period||5
7976404|NCT00283933|19638882|P1|Safety Population|Treatment Period||5
7976405|NCT00283933|19638882|P1|STARTED|Treatment Period||5
7976406|NCT00283868|19638889|P2|NOT COMPLETED|Overall Study||8
7976407|NCT00283868|19638890|P1|NOT COMPLETED|Overall Study||7
7976408|NCT00283868|19638889|P2|COMPLETED|Overall Study||103
7976409|NCT00283868|19638890|P1|COMPLETED|Overall Study||104
7976410|NCT00283868|19638889|P2|STARTED|Overall Study||111
7976411|NCT00283868|19638890|P1|STARTED|Overall Study||111
7976412|NCT00283842|19638907|P5|NOT COMPLETED|Overall Study||15
7976413|NCT00283842|19638908|P4|NOT COMPLETED|Overall Study||27
7976414|NCT00283842|19638909|P3|NOT COMPLETED|Overall Study||31
7976415|NCT00283842|19638910|P2|NOT COMPLETED|Overall Study||18
7976416|NCT00283842|19638911|P1|NOT COMPLETED|Overall Study||12
7976417|NCT00283842|19638907|P5|COMPLETED|Overall Study||75
7976418|NCT00283842|19638908|P4|COMPLETED|Overall Study||42
7976419|NCT00283842|19638909|P3|COMPLETED|Overall Study||68
7976420|NCT00283842|19638910|P2|COMPLETED|Overall Study||69
7976421|NCT00283842|19638911|P1|COMPLETED|Overall Study||51
7976422|NCT00283842|19638907|P5|STARTED|Overall Study||90
7976423|NCT00283842|19638908|P4|STARTED|Overall Study||69
7976424|NCT00283842|19638909|P3|STARTED|Overall Study||99
7976425|NCT00283842|19638910|P2|STARTED|Overall Study||87
7976426|NCT00283842|19638911|P1|STARTED|Overall Study||63
7976427|NCT00283816|19638930|P2|NOT COMPLETED|Overall Study||2
7976428|NCT00283816|19638931|P1|NOT COMPLETED|Overall Study||2
7976429|NCT00283816|19638930|P2|COMPLETED|Overall Study||16
7976430|NCT00283816|19638931|P1|COMPLETED|Overall Study||16
7976431|NCT00283816|19638930|P2|STARTED|Overall Study||18
7976432|NCT00283816|19638931|P1|STARTED|Overall Study||18
7976433|NCT00283803|19638943|P1|NOT COMPLETED|Overall Study||13
7976434|NCT00283803|19638943|P1|COMPLETED|Overall Study||19
7976435|NCT00283803|19638943|P1|STARTED|Overall Study||32
7976436|NCT00283712|19638951|P2|NOT COMPLETED|Overall Study||1
7976437|NCT00283712|19638952|P1|NOT COMPLETED|Overall Study||0
7976438|NCT00283712|19638951|P2|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9
7976439|NCT00283712|19638952|P1|COMPLETED|Overall Study||10
7976440|NCT00283712|19638951|P2|Per-Protocol Sample|Overall Study||7
7976441|NCT00283712|19638952|P1|Per-Protocol Sample|Overall Study||6
7976442|NCT00283712|19638951|P2|Safety Sample|Overall Study||10
7976443|NCT00283712|19638952|P1|Safety Sample|Overall Study||10
7976444|NCT00283712|19638951|P2|Intent-to-treat Sample|Overall Study||10
7976445|NCT00283712|19638952|P1|Intent-to-treat Sample|Overall Study||10
7976446|NCT00283712|19638951|P2|STARTED|Overall Study||10
7976447|NCT00283712|19638952|P1|STARTED|Overall Study||10
7976448|NCT00283686|19638990|P4|NOT COMPLETED|Overall Study||32
7976449|NCT00283686|19638991|P3|NOT COMPLETED|Overall Study||33
7976450|NCT00283686|19638992|P2|NOT COMPLETED|Overall Study||41
7976451|NCT00283686|19638993|P1|NOT COMPLETED|Overall Study||29
7976452|NCT00283686|19638990|P4|COMPLETED|Overall Study||109
7976453|NCT00283686|19638991|P3|COMPLETED|Overall Study||111
7976454|NCT00283686|19638992|P2|COMPLETED|Overall Study||92
7976455|NCT00283686|19638993|P1|COMPLETED|Overall Study||111
7976456|NCT00283686|19638990|P4|STARTED|Overall Study||141
7976457|NCT00283686|19638991|P3|STARTED|Overall Study||144
7976458|NCT00283686|19638992|P2|STARTED|Overall Study||133
7976459|NCT00283686|19638993|P1|STARTED|Overall Study||140
7976460|NCT00283595|19639037|P2|NOT COMPLETED|Overall Study||2
7976461|NCT00283595|19639038|P1|NOT COMPLETED|Overall Study||1
7976462|NCT00283595|19639037|P2|COMPLETED|Overall Study||9
7976463|NCT00283595|19639038|P1|COMPLETED|Overall Study||9
7976464|NCT00283595|19639037|P2|STARTED|Overall Study||11
7976465|NCT00283595|19639038|P1|STARTED|Overall Study||10
7976466|NCT00283504|19639048|P2|NOT COMPLETED|Overall Study||0
7976467|NCT00283504|19639049|P1|NOT COMPLETED|Overall Study||0
7976468|NCT00283504|19639048|P2|COMPLETED|Overall Study||6
7976469|NCT00283504|19639049|P1|COMPLETED|Overall Study||7
7976470|NCT00283504|19639048|P2|STARTED|Overall Study||6
7976471|NCT00283504|19639049|P1|STARTED|Overall Study||7
7976472|NCT00283439|19639063|P4|NOT COMPLETED|Overall Study||9
7976473|NCT00283439|19639064|P3|NOT COMPLETED|Overall Study||11
7976474|NCT00283439|19639065|P2|NOT COMPLETED|Overall Study||11
7976475|NCT00283439|19639066|P1|NOT COMPLETED|Overall Study||8
7976476|NCT00283439|19639063|P4|COMPLETED|Overall Study||0
7976477|NCT00283439|19639064|P3|COMPLETED|Overall Study||0
7976478|NCT00283439|19639065|P2|COMPLETED|Overall Study||0
7976479|NCT00283439|19639066|P1|COMPLETED|Overall Study||0
7976480|NCT00283439|19639063|P4|STARTED|Overall Study||9
7976481|NCT00283439|19639064|P3|STARTED|Overall Study||11
7976482|NCT00283439|19639065|P2|STARTED|Overall Study||11
7976483|NCT00283439|19639066|P1|STARTED|Overall Study||8
7976484|NCT00283400|19639092|P4|NOT COMPLETED|Overall Study||0
7976485|NCT00283400|19639093|P3|NOT COMPLETED|Overall Study||1
7976486|NCT00283400|19639094|P2|NOT COMPLETED|Overall Study||1
7976487|NCT00283400|19639095|P1|NOT COMPLETED|Overall Study||2
7976488|NCT00283400|19639092|P4|COMPLETED|Overall Study||0
7976489|NCT00283400|19639093|P3|COMPLETED|Overall Study||6
7976490|NCT00283400|19639094|P2|COMPLETED|Overall Study||19
7976491|NCT00283400|19639095|P1|COMPLETED|Overall Study||18
7976492|NCT00283400|19639092|P4|STARTED|Overall Study||0
7976493|NCT00283400|19639093|P3|STARTED|Overall Study||7
7976494|NCT00283400|19639094|P2|STARTED|Overall Study||20
7976495|NCT00283400|19639095|P1|STARTED|Overall Study||20
7976496|NCT00283387|19639113|P2|NOT COMPLETED|Second Intervention||0
7976497|NCT00283387|19639114|P1|NOT COMPLETED|Second Intervention||0
7976498|NCT00283387|19639113|P2|COMPLETED|Second Intervention||5
7976499|NCT00283387|19639114|P1|COMPLETED|Second Intervention||5
7976500|NCT00283387|19639113|P2|STARTED|Second Intervention||5
7976501|NCT00283387|19639114|P1|STARTED|Second Intervention||5
7976502|NCT00283387|19639113|P2|NOT COMPLETED|Washout Period of 2 Months||0
7976503|NCT00283387|19639114|P1|NOT COMPLETED|Washout Period of 2 Months||0
7976504|NCT00283387|19639113|P2|COMPLETED|Washout Period of 2 Months||5
7976505|NCT00283387|19639114|P1|COMPLETED|Washout Period of 2 Months||5
7976506|NCT00283387|19639113|P2|STARTED|Washout Period of 2 Months||5
7976507|NCT00283387|19639114|P1|STARTED|Washout Period of 2 Months||5
7976508|NCT00283387|19639113|P2|NOT COMPLETED|First Intervention||2
7976509|NCT00283387|19639114|P1|NOT COMPLETED|First Intervention||1
7976510|NCT00283387|19639113|P2|COMPLETED|First Intervention||5
7976511|NCT00283387|19639114|P1|COMPLETED|First Intervention||5
7976512|NCT00283387|19639113|P2|STARTED|First Intervention||7
7976513|NCT00283387|19639114|P1|STARTED|First Intervention||6
7976514|NCT00283296|19639120|P1|NOT COMPLETED|Overall Study||5
7976515|NCT00283296|19639120|P1|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9
7976516|NCT00283296|19639120|P1|STARTED|Overall Study||14
7976517|NCT00283283|19639130|P4|NOT COMPLETED|Overall Study||0
7976518|NCT00283283|19639131|P3|NOT COMPLETED|Overall Study||0
7976519|NCT00283283|19639132|P2|NOT COMPLETED|Overall Study||0
7976520|NCT00283283|19639133|P1|NOT COMPLETED|Overall Study||0
7976521|NCT00283283|19639130|P4|COMPLETED|Overall Study||276
7976522|NCT00283283|19639131|P3|COMPLETED|Overall Study||280
7976523|NCT00283283|19639132|P2|COMPLETED|Overall Study||284
7976524|NCT00283283|19639133|P1|COMPLETED|Overall Study||274
7976525|NCT00283283|19639130|P4|STARTED|Overall Study||276
7976526|NCT00283283|19639131|P3|STARTED|Overall Study||280
7976527|NCT00283283|19639132|P2|STARTED|Overall Study||284
7976528|NCT00283283|19639133|P1|STARTED|Overall Study||274
7976529|NCT00283244|19639151|P3|NOT COMPLETED|Overall Study||51
7976530|NCT00283244|19639152|P2|NOT COMPLETED|Overall Study||51
7976531|NCT00283244|19639153|P1|NOT COMPLETED|Overall Study||18
7976532|NCT00283244|19639151|P3|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 9 patients received 2nd line therapy|0
7976533|NCT00283244|19639152|P2|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 12 patients received 2nd line therapy|0
7976534|NCT00283244|19639153|P1|COMPLETED|Overall Study|19 patients went on to receive second line Erlotinib|26
7976535|NCT00283244|19639151|P3|STARTED|Overall Study||51
7976536|NCT00283244|19639152|P2|STARTED|Overall Study||51
7976537|NCT00283244|19639153|P1|STARTED|Overall Study||44
7976538|NCT00283075|19639173|P2|NOT COMPLETED|Overall Study||0
7976539|NCT00283075|19639174|P1|NOT COMPLETED|Overall Study||0
7976540|NCT00283075|19639173|P2|COMPLETED|Overall Study||6
7976541|NCT00283075|19639174|P1|COMPLETED|Overall Study||25
7976542|NCT00283075|19639173|P2|STARTED|Overall Study||6
7976543|NCT00283075|19639174|P1|STARTED|Overall Study||25
7976544|NCT00283062|19639189|P4|NOT COMPLETED|Overall Study||49
7976545|NCT00283062|19639190|P3|NOT COMPLETED|Overall Study||41
7976546|NCT00283062|19639191|P2|NOT COMPLETED|Overall Study||7
7976547|NCT00283062|19639192|P1|NOT COMPLETED|Overall Study||12
7976548|NCT00283062|19639189|P4|COMPLETED|Overall Study||13
7976549|NCT00283062|19639190|P3|COMPLETED|Overall Study||15
7976550|NCT00283062|19639191|P2|COMPLETED|Overall Study||48
7976551|NCT00283062|19639192|P1|COMPLETED|Overall Study||43
7976552|NCT00283062|19639189|P4|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
7976553|NCT00283062|19639190|P3|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15
7976554|NCT00283062|19639191|P2|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
7976555|NCT00283062|19639192|P1|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43
7976556|NCT00283062|19639189|P4|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13
7976557|NCT00283062|19639190|P3|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15
7976558|NCT00283062|19639191|P2|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48
7976559|NCT00283062|19639192|P1|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44
7976560|NCT00283062|19639189|P4|ADMINISTERED STUDY TREATMENT|Overall Study||17
7976561|NCT00283062|19639190|P3|ADMINISTERED STUDY TREATMENT|Overall Study||20
7976562|NCT00283062|19639191|P2|ADMINISTERED STUDY TREATMENT|Overall Study||51
7976563|NCT00283062|19639192|P1|ADMINISTERED STUDY TREATMENT|Overall Study||50
7976564|NCT00283062|19639189|P4|STARTED|Overall Study||62
7976565|NCT00283062|19639190|P3|STARTED|Overall Study||56
7976566|NCT00283062|19639191|P2|STARTED|Overall Study||55
7976567|NCT00283062|19639192|P1|STARTED|Overall Study||55
7976568|NCT00283049|19639225|P3|NOT COMPLETED|Overall Study||54
7976569|NCT00283049|19639226|P2|NOT COMPLETED|Overall Study||45
7976570|NCT00283049|19639227|P1|NOT COMPLETED|Overall Study||58
7976571|NCT00283049|19639225|P3|COMPLETED|Overall Study||76
7976572|NCT00283049|19639226|P2|COMPLETED|Overall Study||83
7976573|NCT00283049|19639227|P1|COMPLETED|Overall Study||70
7976574|NCT00283049|19639225|P3|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130
7976575|NCT00283049|19639226|P2|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128
7976576|NCT00283049|19639227|P1|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128
7976577|NCT00282984|19639255|P2|NOT COMPLETED|Overall Study||61
7976578|NCT00282984|19639256|P1|NOT COMPLETED|Overall Study||51
7976579|NCT00282984|19639255|P2|COMPLETED|Overall Study||289
7976580|NCT00282984|19639256|P1|COMPLETED|Overall Study||302
7976581|NCT00282984|19639255|P2|STARTED|Overall Study||350
7976582|NCT00282984|19639256|P1|STARTED|Overall Study||353
7976583|NCT00282971|19639282|P2|NOT COMPLETED|Overall Study||22
7976584|NCT00282971|19639283|P1|NOT COMPLETED|Overall Study||34
7976585|NCT00282971|19639282|P2|COMPLETED|Overall Study||149
7976586|NCT00282971|19639283|P1|COMPLETED|Overall Study||146
7976587|NCT00282971|19639282|P2|STARTED|Overall Study||171
7976588|NCT00282971|19639283|P1|STARTED|Overall Study||180
7976589|NCT00282919|19639293|P1|NOT COMPLETED|Overall Study||7
7976590|NCT00282919|19639293|P1|COMPLETED|Overall Study||103
7976591|NCT00282919|19639293|P1|STARTED|Overall Study||110
7976592|NCT00282867|19639308|P3|NOT COMPLETED|Overall Study||0
7976593|NCT00282867|19639309|P2|NOT COMPLETED|Overall Study||1
7976594|NCT00282867|19639310|P1|NOT COMPLETED|Overall Study||1
7976595|NCT00282867|19639308|P3|COMPLETED|Overall Study||25
7976596|NCT00282867|19639309|P2|COMPLETED|Overall Study||24
7976597|NCT00282867|19639310|P1|COMPLETED|Overall Study||23
7976598|NCT00282867|19639308|P3|STARTED|Overall Study||25
7976599|NCT00282867|19639309|P2|STARTED|Overall Study||25
7976600|NCT00282867|19639310|P1|STARTED|Overall Study||24
7976601|NCT00282841|19639324|P1|NOT COMPLETED|Overall Study||0
7976602|NCT00282841|19639324|P1|COMPLETED|Overall Study||61
7976603|NCT00282841|19639324|P1|STARTED|Overall Study|Anticipated recruitment 400; stopped due to funding and poor recruitment.|61
7976604|NCT00282828|19639332|P3|NOT COMPLETED|Overall Study||9
7976605|NCT00282828|19639333|P2|NOT COMPLETED|Overall Study||12
7976606|NCT00282828|19639334|P1|NOT COMPLETED|Overall Study||6
7976607|NCT00282828|19639332|P3|COMPLETED|Overall Study||50
7976608|NCT00282828|19639333|P2|COMPLETED|Overall Study||47
7976609|NCT00282828|19639334|P1|COMPLETED|Overall Study||57
7976610|NCT00282828|19639332|P3|STARTED|Overall Study||59
7976611|NCT00282828|19639333|P2|STARTED|Overall Study||59
7976612|NCT00282828|19639334|P1|STARTED|Overall Study||63
7976613|NCT00282815|19639347|P2|NOT COMPLETED|Overall Study||6
7976614|NCT00282815|19639348|P1|NOT COMPLETED|Overall Study||7
7976615|NCT00282815|19639347|P2|COMPLETED|Overall Study||11
7976616|NCT00282815|19639348|P1|COMPLETED|Overall Study||8
7976617|NCT00282815|19639347|P2|STARTED|Overall Study||17
7976618|NCT00282815|19639348|P1|STARTED|Overall Study||15
7976619|NCT00282672|19639361|P4|NOT COMPLETED|5 Year: Follow up||5
7976620|NCT00282672|19639362|P3|NOT COMPLETED|5 Year: Follow up||0
7976621|NCT00282672|19639363|P2|NOT COMPLETED|5 Year: Follow up||5
7976622|NCT00282672|19639364|P1|NOT COMPLETED|5 Year: Follow up||1
7976623|NCT00282672|19639361|P4|COMPLETED|5 Year: Follow up||20
7976624|NCT00282672|19639362|P3|COMPLETED|5 Year: Follow up||12
7976625|NCT00282672|19639363|P2|COMPLETED|5 Year: Follow up||27
7976626|NCT00282672|19639364|P1|COMPLETED|5 Year: Follow up||14
7976627|NCT00282672|19639361|P4|STARTED|5 Year: Follow up|11 withdrew|25
7976628|NCT00282672|19639362|P3|STARTED|5 Year: Follow up|3 withdrew|12
7976629|NCT00282672|19639363|P2|STARTED|5 Year: Follow up|7 withdrew|32
7976630|NCT00282672|19639364|P1|STARTED|5 Year: Follow up|1 withdrew|15
7976631|NCT00282672|19639361|P4|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2
7976632|NCT00282672|19639362|P3|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
7976633|NCT00282672|19639363|P2|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
7976634|NCT00282672|19639364|P1|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3
7976635|NCT00282672|19639361|P4|COMPLETED|2 Year: Sham Crossed Over to RFA||36
7976636|NCT00282672|19639362|P3|COMPLETED|2 Year: Sham Crossed Over to RFA||15
7976637|NCT00282672|19639363|P2|COMPLETED|2 Year: Sham Crossed Over to RFA||39
7976638|NCT00282672|19639364|P1|COMPLETED|2 Year: Sham Crossed Over to RFA||16
7976639|NCT00282672|19639361|P4|STARTED|2 Year: Sham Crossed Over to RFA||38
7976640|NCT00282672|19639362|P3|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16
7976641|NCT00282672|19639363|P2|STARTED|2 Year: Sham Crossed Over to RFA||40
7976642|NCT00282672|19639364|P1|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19
7976643|NCT00282672|19639361|P4|NOT COMPLETED|1 Year||4
7976644|NCT00282672|19639362|P3|NOT COMPLETED|1 Year||1
7976645|NCT00282672|19639363|P2|NOT COMPLETED|1 Year||2
7976646|NCT00282672|19639364|P1|NOT COMPLETED|1 Year||3
7976647|NCT00282672|19639361|P4|COMPLETED|1 Year||38
7976648|NCT00282672|19639362|P3|COMPLETED|1 Year||20
7976649|NCT00282672|19639363|P2|COMPLETED|1 Year||40
7976650|NCT00282672|19639364|P1|COMPLETED|1 Year||19
7976651|NCT00282672|19639361|P4|STARTED|1 Year||42
7976652|NCT00282672|19639362|P3|STARTED|1 Year||21
7976653|NCT00282672|19639363|P2|STARTED|1 Year||42
7976654|NCT00282672|19639364|P1|STARTED|1 Year||22
7976655|NCT00282568|19639412|P1|NOT COMPLETED|Extended Treatment Period||24
7976656|NCT00282568|19639412|P1|COMPLETED|Extended Treatment Period||42
7976657|NCT00282568|19639412|P1|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66
7976658|NCT00282568|19639412|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||3
7976659|NCT00282568|19639412|P1|COMPLETED|Pharmacokinetic Treatment Period||67
7976660|NCT00282568|19639412|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67
7976661|NCT00282568|19639412|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||68
7976662|NCT00282568|19639412|P1|STARTED|Pharmacokinetic Treatment Period||70
7976663|NCT00282464|19639438|P2|NOT COMPLETED|Overall Study||62
7976664|NCT00282464|19639439|P1|NOT COMPLETED|Overall Study||73
7976665|NCT00282464|19639438|P2|COMPLETED|Overall Study||134
7976666|NCT00282464|19639439|P1|COMPLETED|Overall Study||112
7976667|NCT00282464|19639438|P2|STARTED|Overall Study||196
7976668|NCT00282464|19639439|P1|STARTED|Overall Study||185
7976669|NCT00282438|19639489|P2|NOT COMPLETED|Overall Study||1
7976670|NCT00282438|19639490|P1|NOT COMPLETED|Overall Study||1
7976671|NCT00282438|19639489|P2|COMPLETED|Overall Study||0
7976672|NCT00282438|19639490|P1|COMPLETED|Overall Study||0
7976673|NCT00282438|19639489|P2|STARTED|Overall Study||1
7976674|NCT00282438|19639490|P1|STARTED|Overall Study||1
7976675|NCT00282412|19639500|P1|NOT COMPLETED|Overall Study||2
7976676|NCT00282412|19639500|P1|COMPLETED|Overall Study|Two late deaths non-treatment related. One from pulmonary embolism and one from late leukemia.|2
7976677|NCT00282412|19639500|P1|STARTED|Overall Study||4
7976678|NCT00282347|19639506|P2|NOT COMPLETED|B Cell Follow-up Period||0
7976679|NCT00282347|19639507|P1|NOT COMPLETED|B Cell Follow-up Period||5
7976680|NCT00282347|19639506|P2|COMPLETED|B Cell Follow-up Period||4
7976681|NCT00282347|19639507|P1|COMPLETED|B Cell Follow-up Period||15
7976682|NCT00282347|19639506|P2|STARTED|B Cell Follow-up Period||4
7976683|NCT00282347|19639507|P1|STARTED|B Cell Follow-up Period||20
7976684|NCT00282347|19639506|P2|NOT COMPLETED|Safety Follow-up Period||6
7976685|NCT00282347|19639507|P1|NOT COMPLETED|Safety Follow-up Period||3
7976686|NCT00282347|19639506|P2|COMPLETED|Safety Follow-up Period||57
7976687|NCT00282347|19639507|P1|COMPLETED|Safety Follow-up Period||64
7976688|NCT00282347|19639506|P2|STARTED|Safety Follow-up Period||63
7976689|NCT00282347|19639507|P1|STARTED|Safety Follow-up Period||67
7976690|NCT00282347|19639506|P2|NOT COMPLETED|Treatment Period||9
7976691|NCT00282347|19639507|P1|NOT COMPLETED|Treatment Period||5
7976692|NCT00282347|19639506|P2|COMPLETED|Treatment Period||63
7976693|NCT00282347|19639507|P1|COMPLETED|Treatment Period||67
7976694|NCT00282347|19639506|P2|STARTED|Treatment Period||72
7976695|NCT00282347|19639507|P1|STARTED|Treatment Period||72
7976696|NCT00282334|19639533|P2|NOT COMPLETED|Overall Study||5
7976697|NCT00282334|19639534|P1|NOT COMPLETED|Overall Study||8
7976698|NCT00282334|19639533|P2|COMPLETED|Overall Study||118
7976699|NCT00282334|19639534|P1|COMPLETED|Overall Study||105
7976700|NCT00282334|19639533|P2|STARTED|Overall Study||123
7976701|NCT00282334|19639534|P1|STARTED|Overall Study||113
7976702|NCT00282308|19639542|P3|NOT COMPLETED|Safety Follow-up Period||19
7976703|NCT00282308|19639543|P2|NOT COMPLETED|Safety Follow-up Period||0
7976704|NCT00282308|19639544|P1|NOT COMPLETED|Safety Follow-up Period||0
7976705|NCT00282308|19639542|P3|COMPLETED|Safety Follow-up Period||81
7976706|NCT00282308|19639543|P2|COMPLETED|Safety Follow-up Period||0
7976707|NCT00282308|19639544|P1|COMPLETED|Safety Follow-up Period||0
7976708|NCT00282308|19639542|P3|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100
7976709|NCT00282308|19639543|P2|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
7976710|NCT00282308|19639544|P1|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
7976711|NCT00282308|19639542|P3|NOT COMPLETED|Optional Extension Re-treatment Period||6
7976712|NCT00282308|19639543|P2|NOT COMPLETED|Optional Extension Re-treatment Period||0
7976713|NCT00282308|19639544|P1|NOT COMPLETED|Optional Extension Re-treatment Period||0
7976714|NCT00282308|19639542|P3|COMPLETED|Optional Extension Re-treatment Period||72
7976715|NCT00282308|19639543|P2|COMPLETED|Optional Extension Re-treatment Period||0
7976716|NCT00282308|19639544|P1|COMPLETED|Optional Extension Re-treatment Period||0
7976717|NCT00282308|19639542|P3|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78
7976718|NCT00282308|19639543|P2|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
7976719|NCT00282308|19639544|P1|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
7976720|NCT00282308|19639542|P3|NOT COMPLETED|Treatment Period||0
7976721|NCT00282308|19639543|P2|NOT COMPLETED|Treatment Period||6
7976722|NCT00282308|19639544|P1|NOT COMPLETED|Treatment Period||4
7976723|NCT00282308|19639542|P3|COMPLETED|Treatment Period||0
7976724|NCT00282308|19639543|P2|COMPLETED|Treatment Period||28
7976725|NCT00282308|19639544|P1|COMPLETED|Treatment Period||65
7976726|NCT00282308|19639542|P3|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0
7976727|NCT00282308|19639543|P2|STARTED|Treatment Period||34
7976728|NCT00282308|19639544|P1|STARTED|Treatment Period||69
7976729|NCT00282295|19639574|P3|NOT COMPLETED|Overall Study||8
7976730|NCT00282295|19639575|P2|NOT COMPLETED|Overall Study||17
7976731|NCT00282295|19639576|P1|NOT COMPLETED|Overall Study||3
7976732|NCT00282295|19639574|P3|COMPLETED|Overall Study||441
7976733|NCT00282295|19639575|P2|COMPLETED|Overall Study||429
7976734|NCT00282295|19639576|P1|COMPLETED|Overall Study||443
7976735|NCT00282295|19639574|P3|STARTED|Overall Study||449
7976736|NCT00282295|19639575|P2|STARTED|Overall Study||446
7976737|NCT00282295|19639576|P1|STARTED|Overall Study||446
7976738|NCT00282282|19639625|P1|NOT COMPLETED|Overall Study||0
7976739|NCT00282282|19639625|P1|COMPLETED|Overall Study||29
7976740|NCT00282282|19639625|P1|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29
7976741|NCT00282256|19639631|P1|NOT COMPLETED|Extension Treatment Period||2
7976742|NCT00282256|19639631|P1|COMPLETED|Extension Treatment Period||16
7976743|NCT00282256|19639631|P1|STARTED|Extension Treatment Period||18
7976744|NCT00282256|19639631|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||1
7976745|NCT00282256|19639631|P1|COMPLETED|Pharmacokinetic Treatment Period||18
7976746|NCT00282256|19639631|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18
7976747|NCT00282256|19639631|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||19
7976748|NCT00282256|19639631|P1|STARTED|Pharmacokinetic Treatment Period||19
7976749|NCT00282243|19639652|P1|NOT COMPLETED|Extension Treatment Period||22
7976750|NCT00282243|19639652|P1|COMPLETED|Extension Treatment Period||43
7976751|NCT00282243|19639652|P1|STARTED|Extension Treatment Period||65
7976752|NCT00282243|19639652|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||5
7976753|NCT00282243|19639652|P1|COMPLETED|Pharmacokinetic Treatment Period||65
7976754|NCT00282243|19639652|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69
7976755|NCT00282243|19639652|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||70
7976756|NCT00282243|19639652|P1|STARTED|Pharmacokinetic Treatment Period||70
7976757|NCT00282152|19639678|P2|NOT COMPLETED|Overall Study||0
7976758|NCT00282152|19639679|P1|NOT COMPLETED|Overall Study||1
7976759|NCT00282152|19639678|P2|COMPLETED|Overall Study||15
7976760|NCT00282152|19639679|P1|COMPLETED|Overall Study||14
7976761|NCT00282152|19639678|P2|STARTED|Overall Study||15
7976762|NCT00282152|19639679|P1|STARTED|Overall Study||15
7976763|NCT00282113|19639700|P3|NOT COMPLETED|Overall Study||0
7976764|NCT00282113|19639701|P2|NOT COMPLETED|Overall Study||0
7976765|NCT00282113|19639702|P1|NOT COMPLETED|Overall Study||1
7976766|NCT00282113|19639700|P3|COMPLETED|Overall Study||29
7976767|NCT00282113|19639701|P2|COMPLETED|Overall Study||30
7976768|NCT00282113|19639702|P1|COMPLETED|Overall Study||30
7976769|NCT00282113|19639700|P3|STARTED|Overall Study||29
7976770|NCT00282113|19639701|P2|STARTED|Overall Study||30
7976771|NCT00282113|19639702|P1|STARTED|Overall Study||31
7976772|NCT00282087|19639716|P1|NOT COMPLETED|Overall Study||1
7976773|NCT00282087|19639716|P1|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46
7976774|NCT00282087|19639716|P1|STARTED|Overall Study||47
7976775|NCT00282048|19639729|P1|NOT COMPLETED|Overall Study||62
7976776|NCT00282048|19639729|P1|COMPLETED|Overall Study||0
7976777|NCT00282048|19639729|P1|STARTED|Overall Study||62
7976778|NCT00281957|19639743|P2|NOT COMPLETED|Overall Study||42
7976779|NCT00281957|19639744|P1|NOT COMPLETED|Overall Study||67
7976780|NCT00281957|19639743|P2|COMPLETED|Overall Study||0
7976781|NCT00281957|19639744|P1|COMPLETED|Overall Study||0
7976782|NCT00281957|19639743|P2|Eligible and Received Treatment|Overall Study||39
7976783|NCT00281957|19639744|P1|Eligible and Received Treatment|Overall Study||63
7976784|NCT00281957|19639743|P2|Eligible|Overall Study||40
7976785|NCT00281957|19639744|P1|Eligible|Overall Study||66
7976786|NCT00281957|19639743|P2|STARTED|Overall Study||42
7976787|NCT00281957|19639744|P1|STARTED|Overall Study||67
7976788|NCT00281918|19639758|P2|NOT COMPLETED|Overall Study||108
7976789|NCT00281918|19639759|P1|NOT COMPLETED|Overall Study||142
7976790|NCT00281918|19639758|P2|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300
7976791|NCT00281918|19639759|P1|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267
7976792|NCT00281918|19639758|P2|Safety Population; Received Study Drug|Overall Study||402
7976793|NCT00281918|19639759|P1|Safety Population; Received Study Drug|Overall Study||398
7976794|NCT00281918|19639758|P2|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408
7976795|NCT00281918|19639759|P1|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409
7976796|NCT00281879|19639793|P8|NOT COMPLETED|Overall Study||1
7976797|NCT00281879|19639794|P7|NOT COMPLETED|Overall Study||0
7976798|NCT00281879|19639795|P6|NOT COMPLETED|Overall Study||9
7976799|NCT00281879|19639796|P5|NOT COMPLETED|Overall Study||6
7976800|NCT00281879|19639797|P4|NOT COMPLETED|Overall Study||0
7976801|NCT00281879|19639798|P3|NOT COMPLETED|Overall Study||20
7976802|NCT00281879|19639799|P2|NOT COMPLETED|Overall Study||36
7976803|NCT00281879|19639800|P1|NOT COMPLETED|Overall Study||128
7976804|NCT00281879|19639793|P8|COMPLETED|Overall Study||0
7976805|NCT00281879|19639794|P7|COMPLETED|Overall Study||0
7976806|NCT00281879|19639795|P6|COMPLETED|Overall Study||0
7976807|NCT00281879|19639796|P5|COMPLETED|Overall Study||0
7976808|NCT00281879|19639797|P4|COMPLETED|Overall Study||0
7976809|NCT00281879|19639798|P3|COMPLETED|Overall Study||0
7976810|NCT00281879|19639799|P2|COMPLETED|Overall Study||0
7976811|NCT00281879|19639800|P1|COMPLETED|Overall Study||0
7976812|NCT00281879|19639793|P8|STARTED|Overall Study||1
7976813|NCT00281879|19639794|P7|STARTED|Overall Study||0
7976814|NCT00281879|19639795|P6|STARTED|Overall Study||9
7976815|NCT00281879|19639796|P5|STARTED|Overall Study||6
7976816|NCT00281879|19639797|P4|STARTED|Overall Study||0
7976817|NCT00281879|19639798|P3|STARTED|Overall Study||20
7976818|NCT00281879|19639799|P2|STARTED|Overall Study||36
7976819|NCT00281879|19639800|P1|STARTED|Overall Study||128
7976820|NCT00281840|19639818|P1|NOT COMPLETED|Overall Study||25
7976821|NCT00281840|19639818|P1|COMPLETED|Overall Study||5
7976822|NCT00281840|19639818|P1|STARTED|Overall Study||30
7976823|NCT00281827|19639823|P1|NOT COMPLETED|Overall Study||0
7976824|NCT00281827|19639823|P1|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22
7976825|NCT00281827|19639823|P1|STARTED|Overall Study||22
7976826|NCT00281697|19639834|P2|NOT COMPLETED|Overall Study||197
7976827|NCT00281697|19639835|P1|NOT COMPLETED|Overall Study||401
7976828|NCT00281697|19639834|P2|COMPLETED|Overall Study||28
7976829|NCT00281697|19639835|P1|COMPLETED|Overall Study||58
7976830|NCT00281697|19639834|P2|STARTED|Overall Study||225
7976831|NCT00281697|19639835|P1|STARTED|Overall Study||459
7976832|NCT00281684|19639855|P4|NOT COMPLETED|Overall Study||0
7976833|NCT00281684|19639856|P3|NOT COMPLETED|Overall Study||1
7976834|NCT00281684|19639857|P2|NOT COMPLETED|Overall Study||0
7976835|NCT00281684|19639858|P1|NOT COMPLETED|Overall Study||1
7976836|NCT00281684|19639855|P4|COMPLETED|Overall Study||38
7976837|NCT00281684|19639856|P3|COMPLETED|Overall Study||33
7976838|NCT00281684|19639857|P2|COMPLETED|Overall Study||36
7976839|NCT00281684|19639858|P1|COMPLETED|Overall Study||36
7976840|NCT00281684|19639855|P4|STARTED|Overall Study||38
7976841|NCT00281684|19639856|P3|STARTED|Overall Study||34
7976842|NCT00281684|19639857|P2|STARTED|Overall Study||36
7976843|NCT00281684|19639858|P1|STARTED|Overall Study||37
7976844|NCT00281671|19639930|P2|NOT COMPLETED|Overall Study||0
7976845|NCT00281671|19639931|P1|NOT COMPLETED|Overall Study||0
7976846|NCT00281671|19639930|P2|COMPLETED|Overall Study||4
7976847|NCT00281671|19639931|P1|COMPLETED|Overall Study||5
7976848|NCT00281671|19639930|P2|STARTED|Overall Study||4
7976849|NCT00281671|19639931|P1|STARTED|Overall Study||5
7976850|NCT00281658|19639945|P3|NOT COMPLETED|Open-label Monotherapy Extension Phase||101
7976851|NCT00281658|19639946|P2|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
7976852|NCT00281658|19639947|P1|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
7976853|NCT00281658|19639945|P3|COMPLETED|Open-label Monotherapy Extension Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|48
7976854|NCT00281658|19639946|P2|COMPLETED|Open-label Monotherapy Extension Phase||0
7976855|NCT00281658|19639947|P1|COMPLETED|Open-label Monotherapy Extension Phase||0
7976856|NCT00281658|19639945|P3|STARTED|Open-label Monotherapy Extension Phase||149
7976857|NCT00281658|19639946|P2|STARTED|Open-label Monotherapy Extension Phase||0
7976858|NCT00281658|19639947|P1|STARTED|Open-label Monotherapy Extension Phase||0
7976859|NCT00281658|19639945|P3|NOT COMPLETED|Double-blind, Randomized Phase||0
7976860|NCT00281658|19639946|P2|NOT COMPLETED|Double-blind, Randomized Phase||54
7976861|NCT00281658|19639947|P1|NOT COMPLETED|Double-blind, Randomized Phase||137
7976862|NCT00281658|19639945|P3|COMPLETED|Double-blind, Randomized Phase||0
7976863|NCT00281658|19639946|P2|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|168
7976864|NCT00281658|19639947|P1|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|85
7976865|NCT00281658|19639945|P3|STARTED|Double-blind, Randomized Phase||0
7976866|NCT00281658|19639946|P2|STARTED|Double-blind, Randomized Phase|Of these participants, 149 entered the open-label extension phase.|222
7976867|NCT00281658|19639947|P1|STARTED|Double-blind, Randomized Phase||222
7976868|NCT00281632|19639964|P1|NOT COMPLETED|Overall Study||36
7976869|NCT00281632|19639964|P1|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0
7976870|NCT00281632|19639964|P1|STARTED|Overall Study||36
7976871|NCT00281580|19640006|P16|NOT COMPLETED|Overall Study||13
7976872|NCT00281580|19640007|P15|NOT COMPLETED|Overall Study||7
7976873|NCT00281580|19640008|P14|NOT COMPLETED|Overall Study||7
7976874|NCT00281580|19640009|P13|NOT COMPLETED|Overall Study||13
7976875|NCT00281580|19640010|P12|NOT COMPLETED|Overall Study||10
7976876|NCT00281580|19640011|P11|NOT COMPLETED|Overall Study||4
7976877|NCT00281580|19640012|P10|NOT COMPLETED|Overall Study||12
7976878|NCT00281580|19640013|P9|NOT COMPLETED|Overall Study||8
7976879|NCT00281580|19640014|P8|NOT COMPLETED|Overall Study||1
7976880|NCT00281580|19640015|P7|NOT COMPLETED|Overall Study||5
7976881|NCT00281580|19640016|P6|NOT COMPLETED|Overall Study||3
7976882|NCT00281580|19640017|P5|NOT COMPLETED|Overall Study||4
7976883|NCT00281580|19640018|P4|NOT COMPLETED|Overall Study||17
7976884|NCT00281580|19640019|P3|NOT COMPLETED|Overall Study||5
7976885|NCT00281580|19640020|P2|NOT COMPLETED|Overall Study||1
7976886|NCT00281580|19640021|P1|NOT COMPLETED|Overall Study||7
7976887|NCT00281580|19640006|P16|COMPLETED|Overall Study||116
7976888|NCT00281580|19640007|P15|COMPLETED|Overall Study||133
7976889|NCT00281580|19640008|P14|COMPLETED|Overall Study||43
7976890|NCT00281580|19640009|P13|COMPLETED|Overall Study||129
7976891|NCT00281580|19640010|P12|COMPLETED|Overall Study||136
7976892|NCT00281580|19640011|P11|COMPLETED|Overall Study||44
7976893|NCT00281580|19640012|P10|COMPLETED|Overall Study||117
7976894|NCT00281580|19640013|P9|COMPLETED|Overall Study||135
7976895|NCT00281580|19640014|P8|COMPLETED|Overall Study||46
7976896|NCT00281580|19640015|P7|COMPLETED|Overall Study||39
7976897|NCT00281580|19640016|P6|COMPLETED|Overall Study||43
7976898|NCT00281580|19640017|P5|COMPLETED|Overall Study||40
7976899|NCT00281580|19640018|P4|COMPLETED|Overall Study||118
7976900|NCT00281580|19640019|P3|COMPLETED|Overall Study||125
7976901|NCT00281580|19640020|P2|COMPLETED|Overall Study||41
7976902|NCT00281580|19640021|P1|COMPLETED|Overall Study||39
7976903|NCT00281580|19640006|P16|STARTED|Overall Study||129
7976904|NCT00281580|19640007|P15|STARTED|Overall Study||140
7976905|NCT00281580|19640008|P14|STARTED|Overall Study||50
7976906|NCT00281580|19640009|P13|STARTED|Overall Study||142
7976907|NCT00281580|19640010|P12|STARTED|Overall Study||146
7976908|NCT00281580|19640011|P11|STARTED|Overall Study||48
7976909|NCT00281580|19640012|P10|STARTED|Overall Study||129
7976910|NCT00281580|19640013|P9|STARTED|Overall Study||143
7976911|NCT00281580|19640014|P8|STARTED|Overall Study||47
7976912|NCT00281580|19640015|P7|STARTED|Overall Study||44
7976913|NCT00281580|19640016|P6|STARTED|Overall Study||46
7976914|NCT00281580|19640017|P5|STARTED|Overall Study||44
7976915|NCT00281580|19640018|P4|STARTED|Overall Study||135
7976916|NCT00281580|19640019|P3|STARTED|Overall Study||130
7976917|NCT00281580|19640020|P2|STARTED|Overall Study||42
7976918|NCT00281580|19640021|P1|STARTED|Overall Study||46
7976919|NCT00281528|19640368|P3|NOT COMPLETED|Overall Study||79
7976920|NCT00281528|19640369|P2|NOT COMPLETED|Overall Study||54
7976921|NCT00281528|19640370|P1|NOT COMPLETED|Overall Study||75
7976922|NCT00281528|19640368|P3|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
7976923|NCT00281528|19640369|P2|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
7976924|NCT00281528|19640370|P1|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
7976925|NCT00281528|19640368|P3|STARTED|Overall Study||79
7976926|NCT00281528|19640369|P2|STARTED|Overall Study||54
7976927|NCT00281528|19640370|P1|STARTED|Overall Study||75
7976928|NCT00281463|19640414|P1|NOT COMPLETED|Overall Study||0
7976929|NCT00281463|19640414|P1|COMPLETED|Overall Study||45
7976930|NCT00281463|19640414|P1|STARTED|Overall Study||45
7976931|NCT00281320|19640421|P2|NOT COMPLETED|Overall Study||21
7976932|NCT00281320|19640422|P1|NOT COMPLETED|Overall Study||25
7976933|NCT00281320|19640421|P2|COMPLETED|Overall Study||40
7976934|NCT00281320|19640422|P1|COMPLETED|Overall Study||36
7976935|NCT00281320|19640421|P2|STARTED|Overall Study||61
7976936|NCT00281320|19640422|P1|STARTED|Overall Study||61
7976937|NCT00281099|19640444|P2|NOT COMPLETED|Overall Study||222
7976938|NCT00281099|19640445|P1|NOT COMPLETED|Overall Study||205
7976939|NCT00281099|19640444|P2|COMPLETED|Overall Study||296
7976940|NCT00281099|19640445|P1|COMPLETED|Overall Study||308
7976941|NCT00281099|19640444|P2|STARTED|Overall Study||518
7976942|NCT00281099|19640445|P1|STARTED|Overall Study||513
7976943|NCT00281021|19640486|P1|NOT COMPLETED|Overall Study||2
7976944|NCT00281021|19640486|P1|COMPLETED|Overall Study||24
7976945|NCT00281021|19640486|P1|STARTED|Overall Study||26
7976946|NCT00280917|19640494|P4|NOT COMPLETED|Overall Study||2
7976947|NCT00280917|19640495|P3|NOT COMPLETED|Overall Study||6
7976948|NCT00280917|19640496|P2|NOT COMPLETED|Overall Study||6
7976949|NCT00280917|19640497|P1|NOT COMPLETED|Overall Study||2
7976950|NCT00280917|19640494|P4|COMPLETED|Overall Study||61
7976951|NCT00280917|19640495|P3|COMPLETED|Overall Study||57
7976952|NCT00280917|19640496|P2|COMPLETED|Overall Study||57
7976953|NCT00280917|19640497|P1|COMPLETED|Overall Study||63
7976954|NCT00280917|19640494|P4|STARTED|Overall Study||63
7976955|NCT00280917|19640495|P3|STARTED|Overall Study||63
7976956|NCT00280917|19640496|P2|STARTED|Overall Study||63
7976957|NCT00280917|19640497|P1|STARTED|Overall Study||65
7976958|NCT00280904|19640507|P1|NOT COMPLETED|Overall Study||0
7976959|NCT00280904|19640507|P1|COMPLETED|Overall Study||433
7976960|NCT00280904|19640507|P1|STARTED|Overall Study||433
7976961|NCT00280826|19640512|P1|NOT COMPLETED|Overall Study||0
7976962|NCT00280826|19640512|P1|COMPLETED|Overall Study||6
7976963|NCT00280826|19640512|P1|STARTED|Overall Study||6
7976964|NCT00280748|19640520|P1|NOT COMPLETED|Overall Study||4
7976965|NCT00280748|19640520|P1|COMPLETED|Overall Study||6
7976966|NCT00280748|19640520|P1|STARTED|Overall Study||10
7976967|NCT00280735|19640530|P1|NOT COMPLETED|Overall Study||18
7976968|NCT00280735|19640530|P1|COMPLETED|Overall Study||57
7976969|NCT00280735|19640530|P1|Received Adequate Exposure|Overall Study||57
7976970|NCT00280735|19640530|P1|Received Treatment|Overall Study||72
7976971|NCT00280735|19640530|P1|STARTED|Overall Study||75
7976972|NCT00280683|19640542|P2|NOT COMPLETED|Overall Study||3
7976973|NCT00280683|19640543|P1|NOT COMPLETED|Overall Study||2
7976974|NCT00280683|19640542|P2|COMPLETED|Overall Study||7
7976975|NCT00280683|19640543|P1|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8
7976976|NCT00280683|19640542|P2|STARTED|Overall Study||10
7976977|NCT00280683|19640543|P1|STARTED|Overall Study||10
7976978|NCT00280566|19640553|P3|NOT COMPLETED|Period 2 Double Blind||57
7976979|NCT00280566|19640554|P2|NOT COMPLETED|Period 2 Double Blind||43
7976980|NCT00280566|19640555|P1|NOT COMPLETED|Period 2 Double Blind||0
7976981|NCT00280566|19640553|P3|COMPLETED|Period 2 Double Blind||54
7976982|NCT00280566|19640554|P2|COMPLETED|Period 2 Double Blind||84
7976983|NCT00280566|19640555|P1|COMPLETED|Period 2 Double Blind||0
7976984|NCT00280566|19640553|P3|STARTED|Period 2 Double Blind||111
7976985|NCT00280566|19640554|P2|STARTED|Period 2 Double Blind||127
7976986|NCT00280566|19640555|P1|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0
7976987|NCT00280566|19640553|P3|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
7976988|NCT00280566|19640554|P2|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
7976989|NCT00280566|19640555|P1|NOT COMPLETED|Period 1 Open Label Ziprasidone||343
7976990|NCT00280566|19640553|P3|COMPLETED|Period 1 Open Label Ziprasidone||0
7976991|NCT00280566|19640554|P2|COMPLETED|Period 1 Open Label Ziprasidone||0
7976992|NCT00280566|19640555|P1|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241
7976993|NCT00280566|19640553|P3|STARTED|Period 1 Open Label Ziprasidone||0
7976994|NCT00280566|19640554|P2|STARTED|Period 1 Open Label Ziprasidone||0
7976995|NCT00280566|19640555|P1|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584
7976996|NCT00280397|19640580|P1|NOT COMPLETED|Overall Study||1
7976997|NCT00280397|19640580|P1|COMPLETED|Overall Study||26
7976998|NCT00280397|19640580|P1|STARTED|Overall Study||27
7976999|NCT00280384|19640595|P8|NOT COMPLETED|Overall Study||0
7977000|NCT00280384|19640596|P7|NOT COMPLETED|Overall Study||0
7977001|NCT00280384|19640597|P6|NOT COMPLETED|Overall Study||0
7977002|NCT00280384|19640598|P5|NOT COMPLETED|Overall Study||0
7977003|NCT00280384|19640599|P4|NOT COMPLETED|Overall Study||0
7977004|NCT00280384|19640600|P3|NOT COMPLETED|Overall Study||0
7977005|NCT00280384|19640601|P2|NOT COMPLETED|Overall Study||0
7977006|NCT00280384|19640602|P1|NOT COMPLETED|Overall Study||0
7977007|NCT00280384|19640595|P8|COMPLETED|Overall Study||6
7977008|NCT00280384|19640596|P7|COMPLETED|Overall Study||6
7977009|NCT00280384|19640597|P6|COMPLETED|Overall Study||6
7977010|NCT00280384|19640598|P5|COMPLETED|Overall Study||6
7977011|NCT00280384|19640599|P4|COMPLETED|Overall Study||6
7977012|NCT00280384|19640600|P3|COMPLETED|Overall Study||6
7977013|NCT00280384|19640601|P2|COMPLETED|Overall Study||6
7977014|NCT00280384|19640602|P1|COMPLETED|Overall Study||6
7977015|NCT00280384|19640595|P8|STARTED|Overall Study||6
7977016|NCT00280384|19640596|P7|STARTED|Overall Study||6
7977017|NCT00280384|19640597|P6|STARTED|Overall Study||6
7977018|NCT00280384|19640598|P5|STARTED|Overall Study||6
7977019|NCT00280384|19640599|P4|STARTED|Overall Study||6
7977020|NCT00280384|19640600|P3|STARTED|Overall Study||6
7977021|NCT00280384|19640601|P2|STARTED|Overall Study||6
7977022|NCT00280384|19640602|P1|STARTED|Overall Study||6
7977023|NCT00280293|19640646|P2|NOT COMPLETED|Overall Study||23
7977024|NCT00280293|19640647|P1|NOT COMPLETED|Overall Study||26
7977025|NCT00280293|19640646|P2|COMPLETED|Overall Study||34
7977026|NCT00280293|19640647|P1|COMPLETED|Overall Study||29
7977027|NCT00280293|19640646|P2|STARTED|Overall Study||57
7977028|NCT00280293|19640647|P1|STARTED|Overall Study||55
7977029|NCT00280241|19640659|P1|NOT COMPLETED|Overall Study||10
7977030|NCT00280241|19640659|P1|COMPLETED|Overall Study||55
7977031|NCT00280241|19640659|P1|STARTED|Overall Study||65
7977032|NCT00280150|19640670|P4|NOT COMPLETED|Overall Study||10
7977033|NCT00280150|19640671|P3|NOT COMPLETED|Overall Study||5
7977034|NCT00280150|19640672|P2|NOT COMPLETED|Overall Study||1
7977035|NCT00280150|19640673|P1|NOT COMPLETED|Overall Study||3
7977036|NCT00280150|19640670|P4|COMPLETED|Overall Study||20
7977037|NCT00280150|19640671|P3|COMPLETED|Overall Study||1
7977038|NCT00280150|19640672|P2|COMPLETED|Overall Study||4
7977039|NCT00280150|19640673|P1|COMPLETED|Overall Study||2
7977040|NCT00280150|19640670|P4|Consolidation Therapy|Overall Study|Phase II participants did not receive consolidation therapy.|0
7977041|NCT00280150|19640671|P3|Consolidation Therapy|Overall Study||3
7977042|NCT00280150|19640672|P2|Consolidation Therapy|Overall Study||5
7977043|NCT00280150|19640673|P1|Consolidation Therapy|Overall Study||2
7977044|NCT00280150|19640670|P4|Cohort Induction|Overall Study||30
7977045|NCT00280150|19640671|P3|Cohort Induction|Overall Study||6
7977046|NCT00280150|19640672|P2|Cohort Induction|Overall Study||5
7977047|NCT00280150|19640673|P1|Cohort Induction|Overall Study||5
7977048|NCT00280150|19640670|P4|STARTED|Overall Study||30
7977049|NCT00280150|19640671|P3|STARTED|Overall Study||6
7977050|NCT00280150|19640672|P2|STARTED|Overall Study||5
7977051|NCT00280150|19640673|P1|STARTED|Overall Study||5
7977052|NCT00280059|19640688|P2|NOT COMPLETED|Extension Phase||38
7977053|NCT00280059|19640689|P1|NOT COMPLETED|Extension Phase||49
7977054|NCT00280059|19640688|P2|COMPLETED|Extension Phase||177
7977055|NCT00280059|19640689|P1|COMPLETED|Extension Phase||145
7977056|NCT00280059|19640688|P2|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215
7977057|NCT00280059|19640689|P1|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194
7977058|NCT00280059|19640688|P2|NOT COMPLETED|Efficacy Assessment Phase||80
7977059|NCT00280059|19640689|P1|NOT COMPLETED|Efficacy Assessment Phase||94
7977060|NCT00280059|19640688|P2|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250
7977061|NCT00280059|19640689|P1|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236
7977062|NCT00280059|19640688|P2|STARTED|Efficacy Assessment Phase||330
7977063|NCT00280059|19640689|P1|STARTED|Efficacy Assessment Phase||330
7977064|NCT00279955|19640738|P3|NOT COMPLETED|Overall Study||0
7977065|NCT00279955|19640739|P2|NOT COMPLETED|Overall Study||0
7977066|NCT00279955|19640740|P1|NOT COMPLETED|Overall Study||0
7977067|NCT00279955|19640738|P3|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358
7977068|NCT00279955|19640739|P2|COMPLETED|Overall Study||486
7977069|NCT00279955|19640740|P1|COMPLETED|Overall Study||157
7977070|NCT00279955|19640738|P3|STARTED|Overall Study||358
7977071|NCT00279955|19640739|P2|STARTED|Overall Study||486
7977072|NCT00279955|19640740|P1|STARTED|Overall Study||157
7977073|NCT00279916|19640753|P2|NOT COMPLETED|Overall Study||5
7977074|NCT00279916|19640754|P1|NOT COMPLETED|Overall Study||7
7977075|NCT00279916|19640753|P2|COMPLETED|Overall Study||41
7977076|NCT00279916|19640754|P1|COMPLETED|Overall Study||38
7977077|NCT00279916|19640753|P2|STARTED|Overall Study||46
7977078|NCT00279916|19640754|P1|STARTED|Overall Study||45
7977079|NCT00279812|19640780|P6|NOT COMPLETED|Overall Study||1
7977080|NCT00279812|19640781|P5|NOT COMPLETED|Overall Study||3
7977081|NCT00279812|19640782|P4|NOT COMPLETED|Overall Study||0
7977082|NCT00279812|19640783|P3|NOT COMPLETED|Overall Study||3
7977083|NCT00279812|19640784|P2|NOT COMPLETED|Overall Study||6
7977084|NCT00279812|19640785|P1|NOT COMPLETED|Overall Study||1
7977085|NCT00279812|19640780|P6|COMPLETED|Overall Study||18
7977086|NCT00279812|19640781|P5|COMPLETED|Overall Study||17
7977087|NCT00279812|19640782|P4|COMPLETED|Overall Study||23
7977088|NCT00279812|19640783|P3|COMPLETED|Overall Study||21
7977089|NCT00279812|19640784|P2|COMPLETED|Overall Study||20
7977090|NCT00279812|19640785|P1|COMPLETED|Overall Study||20
7977091|NCT00279812|19640780|P6|STARTED|Overall Study||19
7977092|NCT00279812|19640781|P5|STARTED|Overall Study||20
7977093|NCT00279812|19640782|P4|STARTED|Overall Study||23
7977094|NCT00279812|19640783|P3|STARTED|Overall Study||24
7977095|NCT00279812|19640784|P2|STARTED|Overall Study||26
7977096|NCT00279812|19640785|P1|STARTED|Overall Study||21
7977097|NCT00279708|19640813|P2|NOT COMPLETED|Overall Study||4
7977098|NCT00279708|19640814|P1|NOT COMPLETED|Overall Study||3
7977099|NCT00279708|19640813|P2|COMPLETED|Overall Study||24
7977100|NCT00279708|19640814|P1|COMPLETED|Overall Study||24
7977101|NCT00279708|19640813|P2|STARTED|Overall Study||28
7977102|NCT00279708|19640814|P1|STARTED|Overall Study|"Started meaning randomized"|27
7977103|NCT00279591|19640822|P2|NOT COMPLETED|Overall Study||0
7977104|NCT00279591|19640823|P1|NOT COMPLETED|Overall Study||0
7977105|NCT00279591|19640822|P2|COMPLETED|Overall Study||46
7977106|NCT00279591|19640823|P1|COMPLETED|Overall Study||48
7977107|NCT00279591|19640822|P2|STARTED|Overall Study||46
7977108|NCT00279591|19640823|P1|STARTED|Overall Study||48
7977109|NCT00279500|19640837|P1|NOT COMPLETED|Overall Study||0
7977110|NCT00279500|19640837|P1|COMPLETED|Overall Study|6 patients treated|6
7977111|NCT00279500|19640837|P1|STARTED|Overall Study|6 patients treated|6
7977112|NCT00279409|19640843|P2|NOT COMPLETED|Overall Study||0
7977113|NCT00279409|19640844|P1|NOT COMPLETED|Overall Study||0
7977114|NCT00279409|19640843|P2|COMPLETED|Overall Study||0
7977115|NCT00279409|19640844|P1|COMPLETED|Overall Study||0
7977116|NCT00279409|19640843|P2|STARTED|Overall Study||0
7977117|NCT00279409|19640844|P1|STARTED|Overall Study||0
7977118|NCT00279305|19640852|P2|NOT COMPLETED|Overall Study||1
7977119|NCT00279305|19640853|P1|NOT COMPLETED|Overall Study||8
7977120|NCT00279305|19640852|P2|COMPLETED|Overall Study||29
7977121|NCT00279305|19640853|P1|COMPLETED|Overall Study||49
7977122|NCT00279305|19640852|P2|STARTED|Overall Study||30
7977123|NCT00279305|19640853|P1|STARTED|Overall Study||57
7977124|NCT00279214|19640861|P2|NOT COMPLETED|Overall Study||2
7977125|NCT00279214|19640862|P1|NOT COMPLETED|Overall Study||3
7977126|NCT00279214|19640861|P2|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
7977127|NCT00279214|19640862|P1|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
7977128|NCT00279214|19640861|P2|STARTED|Overall Study||21
7977129|NCT00279214|19640862|P1|STARTED|Overall Study||22
7977130|NCT00279201|19640892|P6|NOT COMPLETED|Intensification Addendum||37
7977131|NCT00279201|19640893|P5|NOT COMPLETED|Intensification Addendum||29
7977132|NCT00279201|19640894|P4|NOT COMPLETED|Intensification Addendum||28
7977133|NCT00279201|19640895|P3|NOT COMPLETED|Intensification Addendum||23
7977134|NCT00279201|19640896|P2|NOT COMPLETED|Intensification Addendum||0
7977135|NCT00279201|19640897|P1|NOT COMPLETED|Intensification Addendum||0
7977136|NCT00279201|19640892|P6|COMPLETED|Intensification Addendum||162
7977137|NCT00279201|19640893|P5|COMPLETED|Intensification Addendum||142
7977138|NCT00279201|19640894|P4|COMPLETED|Intensification Addendum||172
7977139|NCT00279201|19640895|P3|COMPLETED|Intensification Addendum||151
7977140|NCT00279201|19640896|P2|COMPLETED|Intensification Addendum||0
7977141|NCT00279201|19640897|P1|COMPLETED|Intensification Addendum||0
7977142|NCT00279201|19640892|P6|STARTED|Intensification Addendum||199
7977143|NCT00279201|19640893|P5|STARTED|Intensification Addendum||171
7977144|NCT00279201|19640894|P4|STARTED|Intensification Addendum||200
7977145|NCT00279201|19640895|P3|STARTED|Intensification Addendum||174
7977146|NCT00279201|19640896|P2|STARTED|Intensification Addendum||0
7977147|NCT00279201|19640897|P1|STARTED|Intensification Addendum||0
7977148|NCT00279201|19640892|P6|NOT COMPLETED|Maintenance||0
7977149|NCT00279201|19640893|P5|NOT COMPLETED|Maintenance||0
7977150|NCT00279201|19640894|P4|NOT COMPLETED|Maintenance||0
7977151|NCT00279201|19640895|P3|NOT COMPLETED|Maintenance||0
7977152|NCT00279201|19640896|P2|NOT COMPLETED|Maintenance||234
7977153|NCT00279201|19640897|P1|NOT COMPLETED|Maintenance||231
7977154|NCT00279201|19640892|P6|COMPLETED|Maintenance||0
7977155|NCT00279201|19640893|P5|COMPLETED|Maintenance||0
7977156|NCT00279201|19640894|P4|COMPLETED|Maintenance||0
7977157|NCT00279201|19640895|P3|COMPLETED|Maintenance||0
7977158|NCT00279201|19640896|P2|COMPLETED|Maintenance||239
7977159|NCT00279201|19640897|P1|COMPLETED|Maintenance||188
7977160|NCT00279201|19640892|P6|STARTED|Maintenance||0
7977161|NCT00279201|19640893|P5|STARTED|Maintenance||0
7977162|NCT00279201|19640894|P4|STARTED|Maintenance||0
7977163|NCT00279201|19640895|P3|STARTED|Maintenance||0
7977164|NCT00279201|19640896|P2|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473
7977165|NCT00279201|19640897|P1|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419
7977166|NCT00279201|19640892|P6|NOT COMPLETED|Initiation||0
7977167|NCT00279201|19640893|P5|NOT COMPLETED|Initiation||0
7977168|NCT00279201|19640894|P4|NOT COMPLETED|Initiation||0
7977169|NCT00279201|19640895|P3|NOT COMPLETED|Initiation||0
7977170|NCT00279201|19640896|P2|NOT COMPLETED|Initiation||145
7977171|NCT00279201|19640897|P1|NOT COMPLETED|Initiation||128
7977172|NCT00279201|19640892|P6|COMPLETED|Initiation||0
7977173|NCT00279201|19640893|P5|COMPLETED|Initiation||0
7977174|NCT00279201|19640894|P4|COMPLETED|Initiation||0
7977175|NCT00279201|19640895|P3|COMPLETED|Initiation||0
7977176|NCT00279201|19640896|P2|COMPLETED|Initiation||900
7977177|NCT00279201|19640897|P1|COMPLETED|Initiation||918
7977178|NCT00279201|19640892|P6|STARTED|Initiation||0
7977179|NCT00279201|19640893|P5|STARTED|Initiation||0
7977180|NCT00279201|19640894|P4|STARTED|Initiation||0
7977181|NCT00279201|19640895|P3|STARTED|Initiation||0
7977182|NCT00279201|19640896|P2|STARTED|Initiation||1045
7977183|NCT00279201|19640897|P1|STARTED|Initiation||1046
7977184|NCT00278993|19641041|P1|NOT COMPLETED|Overall Study||107
7977185|NCT00278993|19641041|P1|COMPLETED|Overall Study||1
7977186|NCT00278993|19641041|P1|STARTED|Overall Study||108
7977187|NCT00278954|19641049|P1|NOT COMPLETED|Overall Study||5
7977188|NCT00278954|19641049|P1|COMPLETED|Overall Study||45
7977189|NCT00278954|19641049|P1|STARTED|Overall Study||50
7977190|NCT00278915|19641057|P1|NOT COMPLETED|Overall Study||1
7977191|NCT00278915|19641057|P1|COMPLETED|Overall Study||29
7977192|NCT00278915|19641057|P1|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30
7977193|NCT00278889|19641093|P3|NOT COMPLETED|Overall Study||20
7977194|NCT00278889|19641094|P2|NOT COMPLETED|Overall Study||27
7977195|NCT00278889|19641095|P1|NOT COMPLETED|Overall Study||25
7977196|NCT00278889|19641093|P3|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
7977197|NCT00278889|19641094|P2|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47
7977198|NCT00278889|19641095|P1|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
7977199|NCT00278889|19641093|P3|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19
7977200|NCT00278889|19641094|P2|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20
7977201|NCT00278889|19641095|P1|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16
7977202|NCT00278889|19641093|P3|STARTED|Overall Study|Randomised|68
7977203|NCT00278889|19641094|P2|STARTED|Overall Study|Randomised|74
7977204|NCT00278889|19641095|P1|STARTED|Overall Study|Randomised|73
7977205|NCT00278876|19641121|P1|NOT COMPLETED|Overall Study||9
7977206|NCT00278876|19641121|P1|COMPLETED|Overall Study||38
7977207|NCT00278876|19641121|P1|STARTED|Overall Study||47
7977208|NCT00278863|19641129|P2|NOT COMPLETED|Overall Study||2
7977209|NCT00278863|19641130|P1|NOT COMPLETED|Overall Study||5
7977210|NCT00278863|19641129|P2|COMPLETED|Overall Study||45
7977211|NCT00278863|19641130|P1|COMPLETED|Overall Study||44
7977212|NCT00278863|19641129|P2|STARTED|Overall Study||47
7977213|NCT00278863|19641130|P1|STARTED|Overall Study||49
7977214|NCT00278655|19641138|P1|NOT COMPLETED|Overall Study||0
7977215|NCT00278655|19641138|P1|COMPLETED|Overall Study||21
7977216|NCT00278655|19641138|P1|STARTED|Overall Study||21
7977217|NCT00278629|19641143|P1|NOT COMPLETED|Overall Study||14
7977218|NCT00278629|19641143|P1|COMPLETED|Overall Study||66
7977219|NCT00278629|19641143|P1|STARTED|Overall Study||80
7977220|NCT00278564|19641150|P1|NOT COMPLETED|Overall Study||4
7977221|NCT00278564|19641150|P1|COMPLETED|Overall Study||3
7977222|NCT00278564|19641150|P1|STARTED|Overall Study||7
7977223|NCT00278538|19641154|P1|NOT COMPLETED|Overall Study||2
7977224|NCT00278538|19641154|P1|COMPLETED|Overall Study||30
7977225|NCT00278538|19641154|P1|STARTED|Overall Study||32
7977226|NCT00278525|19641160|P2|NOT COMPLETED|Overall Study||0
7977227|NCT00278525|19641161|P1|NOT COMPLETED|Overall Study||0
7977228|NCT00278525|19641160|P2|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10
7977229|NCT00278525|19641161|P1|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9
7977230|NCT00278525|19641160|P2|STARTED|Overall Study||10
7977231|NCT00278525|19641161|P1|STARTED|Overall Study||9
7977232|NCT00278512|19641171|P2|NOT COMPLETED|Overall Study||0
7977233|NCT00278512|19641172|P1|NOT COMPLETED|Overall Study||1
7977234|NCT00278512|19641171|P2|COMPLETED|Overall Study||0
7977235|NCT00278512|19641172|P1|COMPLETED|Overall Study||6
7977236|NCT00278512|19641171|P2|STARTED|Overall Study||0
7977237|NCT00278512|19641172|P1|STARTED|Overall Study||7
7977238|NCT00278473|19641180|P2|NOT COMPLETED|Overall Study||3
7977239|NCT00278473|19641181|P1|NOT COMPLETED|Overall Study||4
7977240|NCT00278473|19641180|P2|COMPLETED|Overall Study||40
7977241|NCT00278473|19641181|P1|COMPLETED|Overall Study||41
7977242|NCT00278473|19641180|P2|STARTED|Overall Study||43
7977243|NCT00278473|19641181|P1|STARTED|Overall Study||45
7977244|NCT00278395|19641197|P1|NOT COMPLETED|Overall Study||3
7977245|NCT00278395|19641197|P1|COMPLETED|Overall Study||11
7977246|NCT00278395|19641197|P1|STARTED|Overall Study||14
7977247|NCT00278343|19641204|P1|NOT COMPLETED|Overall Study||0
7977248|NCT00278343|19641204|P1|COMPLETED|Overall Study||74
7977249|NCT00278343|19641204|P1|STARTED|Overall Study||74
7977250|NCT00278200|19641215|P2|NOT COMPLETED|Overall Study||4
7977251|NCT00278200|19641216|P1|NOT COMPLETED|Overall Study||1
7977252|NCT00278200|19641215|P2|COMPLETED|Overall Study||8
7977253|NCT00278200|19641216|P1|COMPLETED|Overall Study||1
7977254|NCT00278200|19641215|P2|STARTED|Overall Study||12
7977255|NCT00278200|19641216|P1|STARTED|Overall Study||2
7977256|NCT00278161|19641225|P1|NOT COMPLETED|Overall Study||11
7977257|NCT00278161|19641225|P1|COMPLETED|Overall Study||70
7977258|NCT00278161|19641225|P1|STARTED|Overall Study||81
7977259|NCT00278148|19641231|P3|NOT COMPLETED|Phase II - Expansion Phase||6
7977260|NCT00278148|19641232|P2|NOT COMPLETED|Phase II - Expansion Phase||0
7977261|NCT00278148|19641233|P1|NOT COMPLETED|Phase II - Expansion Phase||0
7977262|NCT00278148|19641231|P3|COMPLETED|Phase II - Expansion Phase||20
7977263|NCT00278148|19641232|P2|COMPLETED|Phase II - Expansion Phase||0
7977264|NCT00278148|19641233|P1|COMPLETED|Phase II - Expansion Phase||0
7977265|NCT00278148|19641231|P3|STARTED|Phase II - Expansion Phase|Includes the 3 participants from phase I|26
7977266|NCT00278148|19641232|P2|STARTED|Phase II - Expansion Phase||0
7977267|NCT00278148|19641233|P1|STARTED|Phase II - Expansion Phase||0
7977268|NCT00278148|19641231|P3|NOT COMPLETED|Phase I - Dose Escalation||0
7977269|NCT00278148|19641232|P2|NOT COMPLETED|Phase I - Dose Escalation||0
7977270|NCT00278148|19641233|P1|NOT COMPLETED|Phase I - Dose Escalation||0
7977271|NCT00278148|19641231|P3|COMPLETED|Phase I - Dose Escalation||3
7977272|NCT00278148|19641232|P2|COMPLETED|Phase I - Dose Escalation||2
7977273|NCT00278148|19641233|P1|COMPLETED|Phase I - Dose Escalation||4
7977274|NCT00278148|19641231|P3|STARTED|Phase I - Dose Escalation||3
7977275|NCT00278148|19641232|P2|STARTED|Phase I - Dose Escalation||2
7977276|NCT00278148|19641233|P1|STARTED|Phase I - Dose Escalation||4
7977277|NCT00278109|19641245|P1|NOT COMPLETED|Overall Study||4
7977278|NCT00278109|19641245|P1|COMPLETED|Overall Study||21
7977279|NCT00278109|19641245|P1|Completed 3 Cycles of Chemotherapy|Overall Study||25
7977280|NCT00278109|19641245|P1|STARTED|Overall Study||25
7977281|NCT00277524|19641249|P4|NOT COMPLETED|Overall Study||0
7977282|NCT00277524|19641250|P3|NOT COMPLETED|Overall Study||0
7977283|NCT00277524|19641251|P2|NOT COMPLETED|Overall Study||0
7977284|NCT00277524|19641252|P1|NOT COMPLETED|Overall Study||0
7977285|NCT00277524|19641249|P4|COMPLETED|Overall Study||850
7977286|NCT00277524|19641250|P3|COMPLETED|Overall Study||1088
7977287|NCT00277524|19641251|P2|COMPLETED|Overall Study||324
7977288|NCT00277524|19641252|P1|COMPLETED|Overall Study||621
7977289|NCT00277524|19641249|P4|STARTED|Overall Study||850
7977290|NCT00277524|19641250|P3|STARTED|Overall Study||1088
7977291|NCT00277524|19641251|P2|STARTED|Overall Study||324
7977292|NCT00277524|19641252|P1|STARTED|Overall Study||621
7977293|NCT00277446|19641270|P1|NOT COMPLETED|Overall Study||0
7977294|NCT00277446|19641270|P1|COMPLETED|Overall Study||13
7977295|NCT00277446|19641270|P1|STARTED|Overall Study||13
7977296|NCT00277394|19641278|P2|NOT COMPLETED|Overall Study||24
7977297|NCT00277394|19641279|P1|NOT COMPLETED|Overall Study||37
7977298|NCT00277394|19641278|P2|COMPLETED|Overall Study||246
7977299|NCT00277394|19641279|P1|COMPLETED|Overall Study||232
7977300|NCT00277394|19641278|P2|STARTED|Overall Study||270
7977301|NCT00277394|19641279|P1|STARTED|Overall Study||269
7977302|NCT00277355|19641291|P2|NOT COMPLETED|Overall Study||5
7977303|NCT00277355|19641292|P1|NOT COMPLETED|Overall Study||14
7977304|NCT00277355|19641291|P2|COMPLETED|Overall Study||22
7977305|NCT00277355|19641292|P1|COMPLETED|Overall Study||73
7977306|NCT00277355|19641291|P2|STARTED|Overall Study||27
7977307|NCT00277355|19641292|P1|STARTED|Overall Study||87
7977308|NCT00277212|19641300|P3|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113
7977309|NCT00277212|19641301|P2|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120
7977310|NCT00277212|19641302|P1|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0
7977311|NCT00277212|19641300|P3|COMPLETED|Phase 2 - Double-Blind Treatment||65
7977312|NCT00277212|19641301|P2|COMPLETED|Phase 2 - Double-Blind Treatment||53
7977313|NCT00277212|19641302|P1|COMPLETED|Phase 2 - Double-Blind Treatment||0
7977314|NCT00277212|19641300|P3|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174
7977315|NCT00277212|19641301|P2|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164
7977316|NCT00277212|19641302|P1|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0
7977317|NCT00277212|19641300|P3|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176
7977318|NCT00277212|19641301|P2|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165
7977319|NCT00277212|19641302|P1|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0
7977320|NCT00277212|19641300|P3|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178
7977321|NCT00277212|19641301|P2|STARTED|Phase 2 - Double-Blind Treatment||173
7977322|NCT00277212|19641302|P1|STARTED|Phase 2 - Double-Blind Treatment||0
7977323|NCT00277212|19641300|P3|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
7977324|NCT00277212|19641301|P2|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
7977325|NCT00277212|19641302|P1|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435
7977326|NCT00277212|19641300|P3|COMPLETED|Phase 1 - Single-Blind Treatment||0
7977327|NCT00277212|19641301|P2|COMPLETED|Phase 1 - Single-Blind Treatment||0
7977328|NCT00277212|19641302|P1|COMPLETED|Phase 1 - Single-Blind Treatment||352
7977329|NCT00277212|19641300|P3|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
7977330|NCT00277212|19641301|P2|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
7977331|NCT00277212|19641302|P1|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756
7977332|NCT00277212|19641300|P3|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
7977333|NCT00277212|19641301|P2|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
7977334|NCT00277212|19641302|P1|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787
7977335|NCT00277212|19641300|P3|STARTED|Phase 1 - Single-Blind Treatment||0
7977336|NCT00277212|19641301|P2|STARTED|Phase 1 - Single-Blind Treatment||0
7977337|NCT00277212|19641302|P1|STARTED|Phase 1 - Single-Blind Treatment||787
7977338|NCT00277095|19641340|P1|NOT COMPLETED|Overall Study||21
7977339|NCT00277095|19641340|P1|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103
7977340|NCT00277095|19641340|P1|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124
7977341|NCT00276861|19641344|P1|NOT COMPLETED|Overall Study||0
7977342|NCT00276861|19641344|P1|COMPLETED|Overall Study||10
7977343|NCT00276861|19641344|P1|STARTED|Overall Study||10
7977344|NCT00276744|19641349|P1|NOT COMPLETED|PART B||0
7977345|NCT00276744|19641349|P1|COMPLETED|PART B||0
7977346|NCT00276744|19641349|P1|STARTED|PART B|This study was terminated before participants could reach this stage of the study.|0
7977347|NCT00276744|19641349|P1|NOT COMPLETED|PART A||98
7977348|NCT00276744|19641349|P1|COMPLETED|PART A||142
7977349|NCT00276744|19641349|P1|STARTED|PART A||240
7977350|NCT00276614|19641353|P1|NOT COMPLETED|Overall Study||3
7977351|NCT00276614|19641353|P1|COMPLETED|Overall Study||1
7977352|NCT00276614|19641353|P1|STARTED|Overall Study||4
7977353|NCT00276549|19641357|P1|NOT COMPLETED|Overall Study||0
7977354|NCT00276549|19641357|P1|COMPLETED|Overall Study||35
7977355|NCT00276549|19641357|P1|STARTED|Overall Study||35
7977356|NCT00276484|19641364|P2|NOT COMPLETED|Overall Study||13
7977357|NCT00276484|19641365|P1|NOT COMPLETED|Overall Study||9
7977358|NCT00276484|19641364|P2|COMPLETED|Overall Study||278
7977359|NCT00276484|19641365|P1|COMPLETED|Overall Study||279
7977360|NCT00276484|19641364|P2|STARTED|Overall Study||291
7977361|NCT00276484|19641365|P1|STARTED|Overall Study||288
7977362|NCT00276458|19641397|P2|NOT COMPLETED|Overall Study||7
7977363|NCT00276458|19641398|P1|NOT COMPLETED|Overall Study||6
7977364|NCT00276458|19641397|P2|COMPLETED|Overall Study||91
7977365|NCT00276458|19641398|P1|COMPLETED|Overall Study||92
7977366|NCT00276458|19641397|P2|STARTED|Overall Study||98
7977367|NCT00276458|19641398|P1|STARTED|Overall Study||98
7977368|NCT00276419|19641432|P2|NOT COMPLETED|Second Intervention||0
7977369|NCT00276419|19641433|P1|NOT COMPLETED|Second Intervention||0
7977370|NCT00276419|19641432|P2|COMPLETED|Second Intervention||8
7977371|NCT00276419|19641433|P1|COMPLETED|Second Intervention||7
7977372|NCT00276419|19641432|P2|STARTED|Second Intervention||8
7977373|NCT00276419|19641433|P1|STARTED|Second Intervention||7
7977374|NCT00276419|19641432|P2|NOT COMPLETED|Wash-out Phase||0
7977375|NCT00276419|19641433|P1|NOT COMPLETED|Wash-out Phase||0
7977376|NCT00276419|19641432|P2|COMPLETED|Wash-out Phase||8
7977377|NCT00276419|19641433|P1|COMPLETED|Wash-out Phase||7
7977378|NCT00276419|19641432|P2|STARTED|Wash-out Phase||8
7977379|NCT00276419|19641433|P1|STARTED|Wash-out Phase||7
7977380|NCT00276419|19641432|P2|NOT COMPLETED|First Intervention||2
7977381|NCT00276419|19641433|P1|NOT COMPLETED|First Intervention||1
7977382|NCT00276419|19641432|P2|COMPLETED|First Intervention||8
7977383|NCT00276419|19641433|P1|COMPLETED|First Intervention||7
7977384|NCT00276419|19641432|P2|STARTED|First Intervention||10
7977385|NCT00276419|19641433|P1|STARTED|First Intervention||8
7977386|NCT00276406|19641445|P2|NOT COMPLETED|Overall Study||0
7977387|NCT00276406|19641446|P1|NOT COMPLETED|Overall Study||0
7977388|NCT00276406|19641445|P2|COMPLETED|Overall Study||14
7977389|NCT00276406|19641446|P1|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16
7977390|NCT00276406|19641445|P2|STARTED|Overall Study||14
7977391|NCT00276406|19641446|P1|STARTED|Overall Study||16
7977392|NCT00276380|19641476|P2|NOT COMPLETED|Overall Study||14
7977393|NCT00276380|19641477|P1|NOT COMPLETED|Overall Study||14
7977394|NCT00276380|19641476|P2|COMPLETED|Overall Study||88
7977395|NCT00276380|19641477|P1|COMPLETED|Overall Study||88
7977396|NCT00276380|19641476|P2|STARTED|Overall Study||102
7977397|NCT00276380|19641477|P1|STARTED|Overall Study||102
7977398|NCT00276250|19641498|P3|NOT COMPLETED|Overall Study||0
7977399|NCT00276250|19641499|P2|NOT COMPLETED|Overall Study||0
7977400|NCT00276250|19641500|P1|NOT COMPLETED|Overall Study||0
7977401|NCT00276250|19641498|P3|COMPLETED|Overall Study||0
7977402|NCT00276250|19641499|P2|COMPLETED|Overall Study||1
7977403|NCT00276250|19641500|P1|COMPLETED|Overall Study||4
7977404|NCT00276250|19641498|P3|STARTED|Overall Study||0
7977405|NCT00276250|19641499|P2|STARTED|Overall Study||1
7977406|NCT00276250|19641500|P1|STARTED|Overall Study||4
7977407|NCT00276159|19641532|P1|NOT COMPLETED|Overall Study||6
7977408|NCT00276159|19641532|P1|COMPLETED|Overall Study||0
7977409|NCT00276159|19641532|P1|STARTED|Overall Study||6
7977410|NCT00276094|19641542|P3|NOT COMPLETED|Overall Study||38
7977411|NCT00276094|19641543|P2|NOT COMPLETED|Overall Study||42
7977412|NCT00276094|19641544|P1|NOT COMPLETED|Overall Study||57
7977413|NCT00276094|19641542|P3|COMPLETED|Overall Study||230
7977414|NCT00276094|19641543|P2|COMPLETED|Overall Study||234
7977415|NCT00276094|19641544|P1|COMPLETED|Overall Study||225
7977416|NCT00276094|19641542|P3|STARTED|Overall Study||268
7977417|NCT00276094|19641543|P2|STARTED|Overall Study||276
7977418|NCT00276094|19641544|P1|STARTED|Overall Study||282
7977419|NCT00276016|19641597|P6|NOT COMPLETED|Intervention 3||0
7977420|NCT00276016|19641598|P5|NOT COMPLETED|Intervention 3||0
7977421|NCT00276016|19641599|P4|NOT COMPLETED|Intervention 3||0
7977422|NCT00276016|19641600|P3|NOT COMPLETED|Intervention 3||0
7977423|NCT00276016|19641601|P2|NOT COMPLETED|Intervention 3||0
7977424|NCT00276016|19641602|P1|NOT COMPLETED|Intervention 3||0
7977425|NCT00276016|19641597|P6|COMPLETED|Intervention 3||6
7977426|NCT00276016|19641598|P5|COMPLETED|Intervention 3||6
7977427|NCT00276016|19641599|P4|COMPLETED|Intervention 3||6
7977428|NCT00276016|19641600|P3|COMPLETED|Intervention 3||7
7977429|NCT00276016|19641601|P2|COMPLETED|Intervention 3||6
7977430|NCT00276016|19641602|P1|COMPLETED|Intervention 3||7
7977431|NCT00276016|19641597|P6|STARTED|Intervention 3||6
7977432|NCT00276016|19641598|P5|STARTED|Intervention 3||6
7977433|NCT00276016|19641599|P4|STARTED|Intervention 3||6
7977434|NCT00276016|19641600|P3|STARTED|Intervention 3||7
7977435|NCT00276016|19641601|P2|STARTED|Intervention 3||6
7977436|NCT00276016|19641602|P1|STARTED|Intervention 3||7
7977437|NCT00276016|19641597|P6|NOT COMPLETED|Wash Out 2||0
7977438|NCT00276016|19641598|P5|NOT COMPLETED|Wash Out 2||0
7977439|NCT00276016|19641599|P4|NOT COMPLETED|Wash Out 2||0
7977440|NCT00276016|19641600|P3|NOT COMPLETED|Wash Out 2||0
7977441|NCT00276016|19641601|P2|NOT COMPLETED|Wash Out 2||0
7977442|NCT00276016|19641602|P1|NOT COMPLETED|Wash Out 2||0
7977443|NCT00276016|19641597|P6|COMPLETED|Wash Out 2||6
7977444|NCT00276016|19641598|P5|COMPLETED|Wash Out 2||6
7977445|NCT00276016|19641599|P4|COMPLETED|Wash Out 2||6
7977446|NCT00276016|19641600|P3|COMPLETED|Wash Out 2||7
7977447|NCT00276016|19641601|P2|COMPLETED|Wash Out 2||6
7977448|NCT00276016|19641602|P1|COMPLETED|Wash Out 2||7
7977449|NCT00276016|19641597|P6|STARTED|Wash Out 2||6
7977450|NCT00276016|19641598|P5|STARTED|Wash Out 2||6
7977451|NCT00276016|19641599|P4|STARTED|Wash Out 2||6
7977452|NCT00276016|19641600|P3|STARTED|Wash Out 2||7
7977453|NCT00276016|19641601|P2|STARTED|Wash Out 2||6
7977454|NCT00276016|19641602|P1|STARTED|Wash Out 2||7
7977455|NCT00276016|19641597|P6|NOT COMPLETED|Intervention 2||0
7977456|NCT00276016|19641598|P5|NOT COMPLETED|Intervention 2||0
7977457|NCT00276016|19641599|P4|NOT COMPLETED|Intervention 2||0
7977458|NCT00276016|19641600|P3|NOT COMPLETED|Intervention 2||0
7977459|NCT00276016|19641601|P2|NOT COMPLETED|Intervention 2||0
7977460|NCT00276016|19641602|P1|NOT COMPLETED|Intervention 2||0
7977461|NCT00276016|19641597|P6|COMPLETED|Intervention 2||6
7977462|NCT00276016|19641598|P5|COMPLETED|Intervention 2||6
7977463|NCT00276016|19641599|P4|COMPLETED|Intervention 2||6
7977464|NCT00276016|19641600|P3|COMPLETED|Intervention 2||7
7977465|NCT00276016|19641601|P2|COMPLETED|Intervention 2||6
7977466|NCT00276016|19641602|P1|COMPLETED|Intervention 2||7
7977467|NCT00276016|19641597|P6|STARTED|Intervention 2||6
7977468|NCT00276016|19641598|P5|STARTED|Intervention 2||6
7977469|NCT00276016|19641599|P4|STARTED|Intervention 2||6
7977470|NCT00276016|19641600|P3|STARTED|Intervention 2||7
7977471|NCT00276016|19641601|P2|STARTED|Intervention 2||6
7977472|NCT00276016|19641602|P1|STARTED|Intervention 2||7
7977473|NCT00276016|19641597|P6|NOT COMPLETED|Wash Out 1||0
7977474|NCT00276016|19641598|P5|NOT COMPLETED|Wash Out 1||0
7977475|NCT00276016|19641599|P4|NOT COMPLETED|Wash Out 1||0
7977476|NCT00276016|19641600|P3|NOT COMPLETED|Wash Out 1||0
7977477|NCT00276016|19641601|P2|NOT COMPLETED|Wash Out 1||0
7977478|NCT00276016|19641602|P1|NOT COMPLETED|Wash Out 1||0
7977479|NCT00276016|19641597|P6|COMPLETED|Wash Out 1||6
7977480|NCT00276016|19641598|P5|COMPLETED|Wash Out 1||6
7977481|NCT00276016|19641599|P4|COMPLETED|Wash Out 1||6
7977482|NCT00276016|19641600|P3|COMPLETED|Wash Out 1||7
7977483|NCT00276016|19641601|P2|COMPLETED|Wash Out 1||6
7977484|NCT00276016|19641602|P1|COMPLETED|Wash Out 1||7
7977485|NCT00276016|19641597|P6|STARTED|Wash Out 1||6
7977486|NCT00276016|19641598|P5|STARTED|Wash Out 1||6
7977487|NCT00276016|19641599|P4|STARTED|Wash Out 1||6
7977488|NCT00276016|19641600|P3|STARTED|Wash Out 1||7
7977489|NCT00276016|19641601|P2|STARTED|Wash Out 1||6
7977490|NCT00276016|19641602|P1|STARTED|Wash Out 1||7
7977491|NCT00276016|19641597|P6|NOT COMPLETED|Intervention 1||0
7977492|NCT00276016|19641598|P5|NOT COMPLETED|Intervention 1||0
7977493|NCT00276016|19641599|P4|NOT COMPLETED|Intervention 1||0
7977494|NCT00276016|19641600|P3|NOT COMPLETED|Intervention 1||0
7977495|NCT00276016|19641601|P2|NOT COMPLETED|Intervention 1||1
7977496|NCT00276016|19641602|P1|NOT COMPLETED|Intervention 1||0
7977497|NCT00276016|19641597|P6|COMPLETED|Intervention 1||6
7977498|NCT00276016|19641598|P5|COMPLETED|Intervention 1||6
7977499|NCT00276016|19641599|P4|COMPLETED|Intervention 1||6
7977500|NCT00276016|19641600|P3|COMPLETED|Intervention 1||7
7977501|NCT00276016|19641601|P2|COMPLETED|Intervention 1||6
7977502|NCT00276016|19641602|P1|COMPLETED|Intervention 1||7
7977503|NCT00276016|19641597|P6|STARTED|Intervention 1||6
7977504|NCT00276016|19641598|P5|STARTED|Intervention 1||6
7977505|NCT00276016|19641599|P4|STARTED|Intervention 1||6
7977506|NCT00276016|19641600|P3|STARTED|Intervention 1||7
7977507|NCT00276016|19641601|P2|STARTED|Intervention 1||7
7977508|NCT00276016|19641602|P1|STARTED|Intervention 1||7
7977509|NCT00275834|19641614|P3|NOT COMPLETED|Overall Study||1
7977510|NCT00275834|19641615|P2|NOT COMPLETED|Overall Study||3
7977511|NCT00275834|19641616|P1|NOT COMPLETED|Overall Study||3
7977512|NCT00275834|19641614|P3|COMPLETED|Overall Study||74
7977513|NCT00275834|19641615|P2|COMPLETED|Overall Study||73
7977514|NCT00275834|19641616|P1|COMPLETED|Overall Study||71
7977515|NCT00275834|19641614|P3|Completed Study While on Study Drug|Overall Study||62
7977516|NCT00275834|19641615|P2|Completed Study While on Study Drug|Overall Study||51
7977517|NCT00275834|19641616|P1|Completed Study While on Study Drug|Overall Study||54
7977518|NCT00275834|19641614|P3|STARTED|Overall Study||75
7977519|NCT00275834|19641615|P2|STARTED|Overall Study||76
7977520|NCT00275834|19641616|P1|STARTED|Overall Study||74
7977521|NCT00275821|19641648|P3|NOT COMPLETED|Overall Study||12
7977522|NCT00275821|19641649|P2|NOT COMPLETED|Overall Study||23
7977523|NCT00275821|19641650|P1|NOT COMPLETED|Overall Study||14
7977524|NCT00275821|19641648|P3|COMPLETED|Overall Study||103
7977525|NCT00275821|19641649|P2|COMPLETED|Overall Study||95
7977526|NCT00275821|19641650|P1|COMPLETED|Overall Study||106
7977527|NCT00275821|19641648|P3|STARTED|Overall Study||115
7977528|NCT00275821|19641649|P2|STARTED|Overall Study||118
7977529|NCT00275821|19641650|P1|STARTED|Overall Study||120
7977530|NCT00275561|19641669|P2|NOT COMPLETED|Overall Study||6
7977531|NCT00275561|19641670|P1|NOT COMPLETED|Overall Study||2
7977532|NCT00275561|19641669|P2|COMPLETED|Overall Study||15
7977533|NCT00275561|19641670|P1|COMPLETED|Overall Study||19
7977534|NCT00275561|19641669|P2|STARTED|Overall Study||21
7977535|NCT00275561|19641670|P1|STARTED|Overall Study||21
7977536|NCT00275509|19641682|P2|NOT COMPLETED|Overall Study||1
7977537|NCT00275509|19641683|P1|NOT COMPLETED|Overall Study||0
7977538|NCT00275509|19641682|P2|COMPLETED|Overall Study||25
7977539|NCT00275509|19641683|P1|COMPLETED|Overall Study||30
7977540|NCT00275509|19641682|P2|STARTED|Overall Study||26
7977541|NCT00275509|19641683|P1|STARTED|Overall Study||30
7977542|NCT00275392|19641695|P2|NOT COMPLETED|Overall Study||2
7977543|NCT00275392|19641696|P1|NOT COMPLETED|Overall Study||0
7977544|NCT00275392|19641695|P2|COMPLETED|Overall Study||17
7977545|NCT00275392|19641696|P1|COMPLETED|Overall Study||20
7977546|NCT00275392|19641695|P2|STARTED|Overall Study||19
7977547|NCT00275392|19641696|P1|STARTED|Overall Study||20
7977548|NCT00275340|19641706|P2|NOT COMPLETED|Overall Study||4
7977549|NCT00275340|19641707|P1|NOT COMPLETED|Overall Study||2
7977550|NCT00275340|19641706|P2|COMPLETED|Overall Study||45
7977551|NCT00275340|19641707|P1|COMPLETED|Overall Study||50
7977552|NCT00275340|19641706|P2|STARTED|Overall Study||49
7977553|NCT00275340|19641707|P1|STARTED|Overall Study||52
7977554|NCT00275301|19641711|P1|NOT COMPLETED|Overall Study||5
7977555|NCT00275301|19641711|P1|COMPLETED|Overall Study||14
7977556|NCT00275301|19641711|P1|STARTED|Overall Study||19
7977557|NCT00275275|19641718|P3|NOT COMPLETED|Overall Study||6
7977558|NCT00275275|19641719|P2|NOT COMPLETED|Overall Study||2
7977559|NCT00275275|19641720|P1|NOT COMPLETED|Overall Study||6
7977560|NCT00275275|19641718|P3|COMPLETED|Overall Study||15
7977561|NCT00275275|19641719|P2|COMPLETED|Overall Study||18
7977562|NCT00275275|19641720|P1|COMPLETED|Overall Study||14
7977563|NCT00275275|19641718|P3|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21
7977564|NCT00275275|19641719|P2|STARTED|Overall Study||20
7977565|NCT00275275|19641720|P1|STARTED|Overall Study||20
7977566|NCT00275262|19641730|P2|NOT COMPLETED|Overall Study||9
7977567|NCT00275262|19641731|P1|NOT COMPLETED|Overall Study||6
7977568|NCT00275262|19641730|P2|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4
7977569|NCT00275262|19641731|P1|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6
7977570|NCT00275262|19641730|P2|STARTED|Overall Study||13
7977571|NCT00275262|19641731|P1|STARTED|Overall Study||12
7977572|NCT00275028|19641745|P1|NOT COMPLETED|Overall Study||47
7977573|NCT00275028|19641745|P1|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0
7977574|NCT00275028|19641745|P1|STARTED|Overall Study||47
7977575|NCT00275002|19641752|P2|NOT COMPLETED|Overall Study||16
7977576|NCT00275002|19641753|P1|NOT COMPLETED|Overall Study||22
7977577|NCT00275002|19641752|P2|COMPLETED|Overall Study||0
7977578|NCT00275002|19641753|P1|COMPLETED|Overall Study||3
7977579|NCT00275002|19641752|P2|STARTED|Overall Study||16
7977580|NCT00275002|19641753|P1|STARTED|Overall Study||25
7977581|NCT00274937|19641761|P1|NOT COMPLETED|Overall Study||20
7977582|NCT00274937|19641761|P1|COMPLETED|Overall Study||91
7977583|NCT00274937|19641761|P1|STARTED|Overall Study||111
7977584|NCT00274924|19641773|P3|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
7977585|NCT00274924|19641774|P2|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18
7977586|NCT00274924|19641775|P1|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7
7977587|NCT00274924|19641773|P3|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
7977588|NCT00274924|19641774|P2|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58
7977589|NCT00274924|19641775|P1|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10
7977590|NCT00274924|19641773|P3|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0
7977591|NCT00274924|19641774|P2|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61
7977592|NCT00274924|19641775|P1|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13
7977593|NCT00274924|19641773|P3|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0
7977594|NCT00274924|19641774|P2|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76
7977595|NCT00274924|19641775|P1|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17
7977596|NCT00274924|19641773|P3|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6
7977597|NCT00274924|19641774|P2|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14
7977598|NCT00274924|19641775|P1|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4
7977599|NCT00274924|19641773|P3|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0
7977600|NCT00274924|19641774|P2|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63
7977601|NCT00274924|19641775|P1|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13
7977602|NCT00274924|19641773|P3|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4
7977603|NCT00274924|19641774|P2|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63
7977604|NCT00274924|19641775|P1|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13
7977605|NCT00274924|19641773|P3|Treated|Step 1 (R-CHOP X 3 Cycles)||5
7977606|NCT00274924|19641774|P2|Treated|Step 1 (R-CHOP X 3 Cycles)||77
7977607|NCT00274924|19641775|P1|Treated|Step 1 (R-CHOP X 3 Cycles)||17
7977608|NCT00274924|19641773|P3|STARTED|Step 1 (R-CHOP X 3 Cycles)||6
7977609|NCT00274924|19641774|P2|STARTED|Step 1 (R-CHOP X 3 Cycles)||77
7977610|NCT00274924|19641775|P1|STARTED|Step 1 (R-CHOP X 3 Cycles)||17
7977611|NCT00274846|19641784|P1|NOT COMPLETED|Overall Study||1
7977612|NCT00274846|19641784|P1|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20
7977613|NCT00274846|19641784|P1|STARTED|Overall Study||21
7977614|NCT00274781|19641792|P1|NOT COMPLETED|Overall Study||0
7977615|NCT00274781|19641792|P1|COMPLETED|Overall Study||30
7977616|NCT00274781|19641792|P1|STARTED|Overall Study||30
7977617|NCT00274768|19641798|P1|NOT COMPLETED|Overall Study||0
7977618|NCT00274768|19641798|P1|COMPLETED|Overall Study||26
7977619|NCT00274768|19641798|P1|STARTED|Overall Study||26
7977620|NCT00274742|19641813|P6|NOT COMPLETED|Overall Study||3
7977621|NCT00274742|19641814|P5|NOT COMPLETED|Overall Study||16
7977622|NCT00274742|19641815|P4|NOT COMPLETED|Overall Study||5
7977623|NCT00274742|19641816|P3|NOT COMPLETED|Overall Study||2
7977624|NCT00274742|19641817|P2|NOT COMPLETED|Overall Study||8
7977625|NCT00274742|19641818|P1|NOT COMPLETED|Overall Study||0
7977626|NCT00274742|19641813|P6|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1
7977627|NCT00274742|19641814|P5|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16
7977628|NCT00274742|19641815|P4|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
7977629|NCT00274742|19641816|P3|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
7977630|NCT00274742|19641817|P2|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5
7977631|NCT00274742|19641818|P1|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12
7977632|NCT00274742|19641813|P6|STARTED|Overall Study||4
7977633|NCT00274742|19641814|P5|STARTED|Overall Study||32
7977634|NCT00274742|19641815|P4|STARTED|Overall Study||9
7977635|NCT00274742|19641816|P3|STARTED|Overall Study||6
7977636|NCT00274742|19641817|P2|STARTED|Overall Study||13
7977637|NCT00274742|19641818|P1|STARTED|Overall Study||12
7977638|NCT00274716|19641856|P6|NOT COMPLETED|Phase B||1
7977639|NCT00274716|19641857|P5|NOT COMPLETED|Phase B||0
7977640|NCT00274716|19641858|P4|NOT COMPLETED|Phase B||1
7977641|NCT00274716|19641859|P3|NOT COMPLETED|Phase B||3
7977642|NCT00274716|19641860|P2|NOT COMPLETED|Phase B||4
7977643|NCT00274716|19641861|P1|NOT COMPLETED|Phase B||1
7977644|NCT00274716|19641856|P6|COMPLETED|Phase B||14
7977645|NCT00274716|19641857|P5|COMPLETED|Phase B||16
7977646|NCT00274716|19641858|P4|COMPLETED|Phase B||41
7977647|NCT00274716|19641859|P3|COMPLETED|Phase B||41
7977648|NCT00274716|19641860|P2|COMPLETED|Phase B||40
7977649|NCT00274716|19641861|P1|COMPLETED|Phase B||42
7977650|NCT00274716|19641856|P6|STARTED|Phase B||15
7977651|NCT00274716|19641857|P5|STARTED|Phase B||16
7977652|NCT00274716|19641858|P4|STARTED|Phase B||42
7977653|NCT00274716|19641859|P3|STARTED|Phase B||44
7977654|NCT00274716|19641860|P2|STARTED|Phase B||44
7977655|NCT00274716|19641861|P1|STARTED|Phase B||43
7977656|NCT00274716|19641856|P6|NOT COMPLETED|Phase A||4
7977657|NCT00274716|19641857|P5|NOT COMPLETED|Phase A||3
7977658|NCT00274716|19641858|P4|NOT COMPLETED|Phase A||9
7977659|NCT00274716|19641859|P3|NOT COMPLETED|Phase A||8
7977660|NCT00274716|19641860|P2|NOT COMPLETED|Phase A||10
7977661|NCT00274716|19641861|P1|NOT COMPLETED|Phase A||11
7977662|NCT00274716|19641856|P6|COMPLETED|Phase A||15
7977663|NCT00274716|19641857|P5|COMPLETED|Phase A||16
7977664|NCT00274716|19641858|P4|COMPLETED|Phase A||42
7977665|NCT00274716|19641859|P3|COMPLETED|Phase A||44
7977666|NCT00274716|19641860|P2|COMPLETED|Phase A||44
7977667|NCT00274716|19641861|P1|COMPLETED|Phase A||43
7977668|NCT00274716|19641856|P6|STARTED|Phase A||19
7977669|NCT00274716|19641857|P5|STARTED|Phase A||19
7977670|NCT00274716|19641858|P4|STARTED|Phase A||51
7977671|NCT00274716|19641859|P3|STARTED|Phase A||52
7977672|NCT00274716|19641860|P2|STARTED|Phase A||54
7977673|NCT00274716|19641861|P1|STARTED|Phase A||54
7977674|NCT00274651|19641923|P2|NOT COMPLETED|Overall Study||20
7977675|NCT00274651|19641924|P1|NOT COMPLETED|Overall Study||28
7977676|NCT00274651|19641923|P2|COMPLETED|Overall Study||4
7977677|NCT00274651|19641924|P1|COMPLETED|Overall Study||1
7977678|NCT00274651|19641923|P2|STARTED|Overall Study||24
7977679|NCT00274651|19641924|P1|STARTED|Overall Study||29
7977680|NCT00274625|19641939|P2|NOT COMPLETED|Overall Study||62
7977681|NCT00274625|19641940|P1|NOT COMPLETED|Overall Study||60
7977682|NCT00274625|19641939|P2|COMPLETED|Overall Study||141
7977683|NCT00274625|19641940|P1|COMPLETED|Overall Study||139
7977684|NCT00274625|19641939|P2|STARTED|Overall Study||203
7977685|NCT00274625|19641940|P1|STARTED|Overall Study||199
7977686|NCT00274469|19641948|P2|NOT COMPLETED|Overall Study||93
7977687|NCT00274469|19641949|P1|NOT COMPLETED|Overall Study||79
7977688|NCT00274469|19641948|P2|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|10
7977689|NCT00274469|19641949|P1|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|23
7977690|NCT00274469|19641948|P2|STARTED|Overall Study|Number of patients randomized|103
7977691|NCT00274469|19641949|P1|STARTED|Overall Study|Number of patients randomized|102
7977692|NCT00274456|19641969|P4|NOT COMPLETED|Overall Study||45
7977693|NCT00274456|19641970|P3|NOT COMPLETED|Overall Study||35
7977694|NCT00274456|19641971|P2|NOT COMPLETED|Overall Study||27
7977695|NCT00274456|19641972|P1|NOT COMPLETED|Overall Study||37
7977696|NCT00274456|19641969|P4|COMPLETED|Overall Study|Treatment completed upon progressive disease|29
7977697|NCT00274456|19641970|P3|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
7977698|NCT00274456|19641971|P2|COMPLETED|Overall Study|Treatment completed upon progressive disease|49
7977699|NCT00274456|19641972|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
7977700|NCT00274456|19641969|P4|At Least One Response Assessment|Overall Study||70
7977701|NCT00274456|19641970|P3|At Least One Response Assessment|Overall Study||73
7977702|NCT00274456|19641971|P2|At Least One Response Assessment|Overall Study||76
7977703|NCT00274456|19641972|P1|At Least One Response Assessment|Overall Study||73
7977704|NCT00274456|19641969|P4|STARTED|Overall Study||74
7977705|NCT00274456|19641970|P3|STARTED|Overall Study||74
7977706|NCT00274456|19641971|P2|STARTED|Overall Study||76
7977707|NCT00274456|19641972|P1|STARTED|Overall Study||76
7977708|NCT00274287|19642014|P1|NOT COMPLETED|Overall Study||2
7977709|NCT00274287|19642014|P1|COMPLETED|Overall Study||13
7977710|NCT00274287|19642014|P1|STARTED|Overall Study||15
7977711|NCT00274261|19642024|P2|NOT COMPLETED|Overall Study||337
7977712|NCT00274261|19642025|P1|NOT COMPLETED|Overall Study||489
7977713|NCT00274261|19642024|P2|COMPLETED|Overall Study||296
7977714|NCT00274261|19642025|P1|COMPLETED|Overall Study||443
7977715|NCT00274261|19642024|P2|STARTED|Overall Study||633
7977716|NCT00274261|19642025|P1|STARTED|Overall Study||932
7977717|NCT00273910|19642039|P6|NOT COMPLETED|Overall Study||0
7977718|NCT00273910|19642040|P5|NOT COMPLETED|Overall Study||0
7977719|NCT00273910|19642041|P4|NOT COMPLETED|Overall Study||0
7977720|NCT00273910|19642042|P3|NOT COMPLETED|Overall Study||0
7977721|NCT00273910|19642043|P2|NOT COMPLETED|Overall Study||0
7977722|NCT00273910|19642044|P1|NOT COMPLETED|Overall Study||0
7977723|NCT00273910|19642039|P6|COMPLETED|Overall Study||14
7977724|NCT00273910|19642040|P5|COMPLETED|Overall Study||15
7977725|NCT00273910|19642041|P4|COMPLETED|Overall Study||19
7977726|NCT00273910|19642042|P3|COMPLETED|Overall Study||18
7977727|NCT00273910|19642043|P2|COMPLETED|Overall Study||19
7977728|NCT00273910|19642044|P1|COMPLETED|Overall Study||19
7977729|NCT00273910|19642039|P6|STARTED|Overall Study||14
7977730|NCT00273910|19642040|P5|STARTED|Overall Study||15
7977731|NCT00273910|19642041|P4|STARTED|Overall Study||19
7977732|NCT00273910|19642042|P3|STARTED|Overall Study||18
7977733|NCT00273910|19642043|P2|STARTED|Overall Study||19
7977734|NCT00273910|19642044|P1|STARTED|Overall Study||19
7977735|NCT00273858|19642064|P1|NOT COMPLETED|Overall Study||537
7977736|NCT00273858|19642064|P1|COMPLETED|Overall Study||343
7977737|NCT00273858|19642064|P1|STARTED|Overall Study||880
7977738|NCT00273793|19642079|P6|NOT COMPLETED|Overall Study||0
7977739|NCT00273793|19642080|P5|NOT COMPLETED|Overall Study||0
7977740|NCT00273793|19642081|P4|NOT COMPLETED|Overall Study||0
7977741|NCT00273793|19642082|P3|NOT COMPLETED|Overall Study||0
7977742|NCT00273793|19642083|P2|NOT COMPLETED|Overall Study||0
7977743|NCT00273793|19642084|P1|NOT COMPLETED|Overall Study||0
7977744|NCT00273793|19642079|P6|COMPLETED|Overall Study||29
7977745|NCT00273793|19642080|P5|COMPLETED|Overall Study||58
7977746|NCT00273793|19642081|P4|COMPLETED|Overall Study||60
7977747|NCT00273793|19642082|P3|COMPLETED|Overall Study||18
7977748|NCT00273793|19642083|P2|COMPLETED|Overall Study||38
7977749|NCT00273793|19642084|P1|COMPLETED|Overall Study||36
7977750|NCT00273793|19642079|P6|STARTED|Overall Study||29
7977751|NCT00273793|19642080|P5|STARTED|Overall Study||58
7977752|NCT00273793|19642081|P4|STARTED|Overall Study||60
7977753|NCT00273793|19642082|P3|STARTED|Overall Study||18
7977754|NCT00273793|19642083|P2|STARTED|Overall Study||38
7977755|NCT00273793|19642084|P1|STARTED|Overall Study||36
7977756|NCT00273754|19642106|P2|NOT COMPLETED|Overall Study||0
7977757|NCT00273754|19642107|P1|NOT COMPLETED|Overall Study||0
7977758|NCT00273754|19642106|P2|COMPLETED|Overall Study||36
7977759|NCT00273754|19642107|P1|COMPLETED|Overall Study||36
7977760|NCT00273754|19642106|P2|STARTED|Overall Study||36
7977761|NCT00273754|19642107|P1|STARTED|Overall Study||36
7977762|NCT00273364|19642125|P2|NOT COMPLETED|Overall Study||0
7977763|NCT00273364|19642126|P1|NOT COMPLETED|Overall Study||0
7977764|NCT00273364|19642125|P2|COMPLETED|Overall Study||55
7977765|NCT00273364|19642126|P1|COMPLETED|Overall Study||55
7977766|NCT00273364|19642125|P2|STARTED|Overall Study||55
7977767|NCT00273364|19642126|P1|STARTED|Overall Study||55
7977768|NCT00273182|19642132|P1|NOT COMPLETED|Overall Study||985
7977769|NCT00273182|19642132|P1|COMPLETED|Overall Study||1014
7977770|NCT00273182|19642132|P1|STARTED|Overall Study||1999
7977771|NCT00273052|19642142|P2|NOT COMPLETED|Overall Study||88
7977772|NCT00273052|19642143|P1|NOT COMPLETED|Overall Study||69
7977773|NCT00273052|19642142|P2|COMPLETED|Overall Study||190
7977774|NCT00273052|19642143|P1|COMPLETED|Overall Study||221
7977775|NCT00273052|19642142|P2|STARTED|Overall Study||278
7977776|NCT00273052|19642143|P1|STARTED|Overall Study||290
7977777|NCT00272987|19642178|P3|NOT COMPLETED|Overall Study||11
7977778|NCT00272987|19642179|P2|NOT COMPLETED|Overall Study||4
7977779|NCT00272987|19642180|P1|NOT COMPLETED|Overall Study||9
7977780|NCT00272987|19642178|P3|COMPLETED|Overall Study||9
7977781|NCT00272987|19642179|P2|COMPLETED|Overall Study||10
7977782|NCT00272987|19642180|P1|COMPLETED|Overall Study||20
7977783|NCT00272987|19642178|P3|STARTED|Overall Study||20
7977784|NCT00272987|19642179|P2|STARTED|Overall Study||14
7977785|NCT00272987|19642180|P1|STARTED|Overall Study||29
7977786|NCT00272961|19642250|P5|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
7977787|NCT00272961|19642251|P4|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3
7977788|NCT00272961|19642252|P3|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
7977789|NCT00272961|19642253|P2|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
7977790|NCT00272961|19642254|P1|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2
7977791|NCT00272961|19642250|P5|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6
7977792|NCT00272961|19642251|P4|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
7977793|NCT00272961|19642252|P3|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
7977794|NCT00272961|19642253|P2|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
7977795|NCT00272961|19642254|P1|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8
7977796|NCT00272961|19642250|P5|STARTED|Treatment Phase: Week 3 Up to Week 12||10
7977797|NCT00272961|19642251|P4|STARTED|Treatment Phase: Week 3 Up to Week 12||10
7977798|NCT00272961|19642252|P3|STARTED|Treatment Phase: Week 3 Up to Week 12||11
7977799|NCT00272961|19642253|P2|STARTED|Treatment Phase: Week 3 Up to Week 12||8
7977800|NCT00272961|19642254|P1|STARTED|Treatment Phase: Week 3 Up to Week 12||10
7977801|NCT00272961|19642250|P5|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
7977802|NCT00272961|19642251|P4|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
7977803|NCT00272961|19642252|P3|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
7977804|NCT00272961|19642253|P2|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
7977805|NCT00272961|19642254|P1|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11
7977806|NCT00272961|19642250|P5|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
7977807|NCT00272961|19642251|P4|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
7977808|NCT00272961|19642252|P3|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
7977809|NCT00272961|19642253|P2|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
7977810|NCT00272961|19642254|P1|COMPLETED|Placebo Run-in Phase: Up to Week 2||49
7977811|NCT00272961|19642250|P5|STARTED|Placebo Run-in Phase: Up to Week 2||0
7977812|NCT00272961|19642251|P4|STARTED|Placebo Run-in Phase: Up to Week 2||0
7977813|NCT00272961|19642252|P3|STARTED|Placebo Run-in Phase: Up to Week 2||0
7977814|NCT00272961|19642253|P2|STARTED|Placebo Run-in Phase: Up to Week 2||0
7977815|NCT00272961|19642254|P1|STARTED|Placebo Run-in Phase: Up to Week 2||60
7977816|NCT00272844|19642311|P1|NOT COMPLETED|Overall Study||5
7977817|NCT00272844|19642311|P1|COMPLETED|Overall Study||18
7977818|NCT00272844|19642311|P1|STARTED|Overall Study||23
7977819|NCT00272792|19642319|P2|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3
7977820|NCT00272792|19642320|P1|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1
7977821|NCT00272792|19642319|P2|COMPLETED|Part 2: Blinded, Placebo Control Period||9
7977822|NCT00272792|19642320|P1|COMPLETED|Part 2: Blinded, Placebo Control Period||32
7977823|NCT00272792|19642319|P2|STARTED|Part 2: Blinded, Placebo Control Period||12
7977824|NCT00272792|19642320|P1|STARTED|Part 2: Blinded, Placebo Control Period||33
7977825|NCT00272792|19642319|P2|NOT COMPLETED|Part 1: Responsiveness||0
7977826|NCT00272792|19642320|P1|NOT COMPLETED|Part 1: Responsiveness||1
7977827|NCT00272792|19642319|P2|COMPLETED|Part 1: Responsiveness||0
7977828|NCT00272792|19642320|P1|COMPLETED|Part 1: Responsiveness||89
7977829|NCT00272792|19642319|P2|STARTED|Part 1: Responsiveness||0
7977830|NCT00272792|19642320|P1|STARTED|Part 1: Responsiveness||90
7977831|NCT00272779|19642330|P2|NOT COMPLETED|Baseline Through Week 96||136
7977832|NCT00272779|19642331|P1|NOT COMPLETED|Baseline Through Week 96||139
7977833|NCT00272779|19642330|P2|COMPLETED|Baseline Through Week 96||307
7977834|NCT00272779|19642331|P1|COMPLETED|Baseline Through Week 96||301
7977835|NCT00272779|19642330|P2|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437
7977836|NCT00272779|19642331|P1|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441
7977837|NCT00272779|19642330|P2|STARTED|Baseline Through Week 96|Number randomized to LPV|443
7977838|NCT00272779|19642331|P1|STARTED|Baseline Through Week 96|Number randomized to ATV|440
7977839|NCT00272779|19642330|P2|NOT COMPLETED|Baseline Through Week 48||443
7977840|NCT00272779|19642331|P1|NOT COMPLETED|Baseline Through Week 48||440
7977841|NCT00272779|19642330|P2|COMPLETED|Baseline Through Week 48||0
7977842|NCT00272779|19642331|P1|COMPLETED|Baseline Through Week 48||0
7977843|NCT00272779|19642330|P2|STILL ON TREATMENT|Baseline Through Week 48||368
7977844|NCT00272779|19642331|P1|STILL ON TREATMENT|Baseline Through Week 48||385
7977845|NCT00272779|19642330|P2|Discontinued on or After Week 48|Baseline Through Week 48||14
7977846|NCT00272779|19642331|P1|Discontinued on or After Week 48|Baseline Through Week 48||14
7977847|NCT00272779|19642330|P2|Discontinued Before Week 48|Baseline Through Week 48||58
7977848|NCT00272779|19642331|P1|Discontinued Before Week 48|Baseline Through Week 48||39
7977849|NCT00272779|19642330|P2|TREATED AS RANDOMIZED|Baseline Through Week 48||440
7977850|NCT00272779|19642331|P1|TREATED AS RANDOMIZED|Baseline Through Week 48||438
7977851|NCT00272779|19642330|P2|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437
7977852|NCT00272779|19642331|P1|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441
7977853|NCT00272779|19642330|P2|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443
7977854|NCT00272779|19642331|P1|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440
7977855|NCT00272337|19642515|P5|NOT COMPLETED|Overall Study||0
7977856|NCT00272337|19642516|P4|NOT COMPLETED|Overall Study||0
7977857|NCT00272337|19642517|P3|NOT COMPLETED|Overall Study||0
7977858|NCT00272337|19642518|P2|NOT COMPLETED|Overall Study||0
7977859|NCT00272337|19642519|P1|NOT COMPLETED|Overall Study||0
7977860|NCT00272337|19642515|P5|COMPLETED|Overall Study||8
7977861|NCT00272337|19642516|P4|COMPLETED|Overall Study||7
7977862|NCT00272337|19642517|P3|COMPLETED|Overall Study||7
7977863|NCT00272337|19642518|P2|COMPLETED|Overall Study||7
7977864|NCT00272337|19642519|P1|COMPLETED|Overall Study||8
7977865|NCT00272337|19642515|P5|STARTED|Overall Study||8
7977866|NCT00272337|19642516|P4|STARTED|Overall Study||7
7977867|NCT00272337|19642517|P3|STARTED|Overall Study||7
7977868|NCT00272337|19642518|P2|STARTED|Overall Study||7
7977869|NCT00272337|19642519|P1|STARTED|Overall Study||8
7977870|NCT00272311|19642546|P5|NOT COMPLETED|Overall Study||0
7977871|NCT00272311|19642547|P4|NOT COMPLETED|Overall Study||0
7977872|NCT00272311|19642548|P3|NOT COMPLETED|Overall Study||0
7977873|NCT00272311|19642549|P2|NOT COMPLETED|Overall Study||0
7977874|NCT00272311|19642550|P1|NOT COMPLETED|Overall Study||0
7977875|NCT00272311|19642546|P5|COMPLETED|Overall Study||14
7977876|NCT00272311|19642547|P4|COMPLETED|Overall Study||14
7977877|NCT00272311|19642548|P3|COMPLETED|Overall Study||14
7977878|NCT00272311|19642549|P2|COMPLETED|Overall Study||14
7977879|NCT00272311|19642550|P1|COMPLETED|Overall Study||14
7977880|NCT00272311|19642546|P5|STARTED|Overall Study||14
7977881|NCT00272311|19642547|P4|STARTED|Overall Study||14
7977882|NCT00272311|19642548|P3|STARTED|Overall Study||14
7977883|NCT00272311|19642549|P2|STARTED|Overall Study||14
7977884|NCT00272311|19642550|P1|STARTED|Overall Study||14
7977885|NCT00272168|19642574|P2|NOT COMPLETED|Overall Study||10
7977886|NCT00272168|19642575|P1|NOT COMPLETED|Overall Study||10
7977887|NCT00272168|19642574|P2|COMPLETED|Overall Study||31
7977888|NCT00272168|19642575|P1|COMPLETED|Overall Study||37
7977889|NCT00272168|19642574|P2|STARTED|Overall Study||41
7977890|NCT00272168|19642575|P1|STARTED|Overall Study||47
7977891|NCT00272038|19642591|P1|NOT COMPLETED|Overall Study||7
7977892|NCT00272038|19642591|P1|COMPLETED|Overall Study||22
7977893|NCT00272038|19642591|P1|STARTED|Overall Study||29
7977894|NCT00271947|19642597|P1|NOT COMPLETED|Overall Study||1
7977895|NCT00271947|19642597|P1|COMPLETED|Overall Study||0
7977896|NCT00271947|19642597|P1|STARTED|Overall Study||1
7977897|NCT00271856|19642603|P2|NOT COMPLETED|Overall Study||18
7977898|NCT00271856|19642604|P1|NOT COMPLETED|Overall Study||11
7977899|NCT00271856|19642603|P2|COMPLETED|Overall Study||70
7977900|NCT00271856|19642604|P1|COMPLETED|Overall Study||78
7977901|NCT00271856|19642603|P2|STARTED|Overall Study||88
7977902|NCT00271856|19642604|P1|STARTED|Overall Study||89
7977903|NCT00271817|19642623|P3|NOT COMPLETED|Part 2||84
7977904|NCT00271817|19642624|P2|NOT COMPLETED|Part 2||32
7977905|NCT00271817|19642625|P1|NOT COMPLETED|Part 2||0
7977906|NCT00271817|19642623|P3|COMPLETED|Part 2||401
7977907|NCT00271817|19642624|P2|COMPLETED|Part 2||234
7977908|NCT00271817|19642625|P1|COMPLETED|Part 2||0
7977909|NCT00271817|19642623|P3|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485
7977910|NCT00271817|19642624|P2|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266
7977911|NCT00271817|19642625|P1|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0
7977912|NCT00271817|19642623|P3|NOT COMPLETED|Part 1||285
7977913|NCT00271817|19642624|P2|NOT COMPLETED|Part 1||59
7977914|NCT00271817|19642625|P1|NOT COMPLETED|Part 1||106
7977915|NCT00271817|19642623|P3|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391
7977916|NCT00271817|19642624|P2|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213
7977917|NCT00271817|19642625|P1|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166
7977918|NCT00271817|19642623|P3|STARTED|Part 1||676
7977919|NCT00271817|19642624|P2|STARTED|Part 1||272
7977920|NCT00271817|19642625|P1|STARTED|Part 1||272
7977921|NCT00271739|19642654|P2|NOT COMPLETED|Overall Study||105
7977922|NCT00271739|19642655|P1|NOT COMPLETED|Overall Study||115
7977923|NCT00271739|19642654|P2|COMPLETED|Overall Study||716
7977924|NCT00271739|19642655|P1|COMPLETED|Overall Study||729
7977925|NCT00271739|19642654|P2|STARTED|Overall Study||821
7977926|NCT00271739|19642655|P1|STARTED|Overall Study||844
7977927|NCT00271609|19642667|P2|NOT COMPLETED|Overall Study||3
7977928|NCT00271609|19642668|P1|NOT COMPLETED|Overall Study||13
7977929|NCT00271609|19642667|P2|COMPLETED|Overall Study||29
7977930|NCT00271609|19642668|P1|COMPLETED|Overall Study||43
7977931|NCT00271609|19642667|P2|STARTED|Overall Study||32
7977932|NCT00271609|19642668|P1|STARTED|Overall Study||56
7977933|NCT00271596|19642678|P2|NOT COMPLETED|Overall Study||1
7977934|NCT00271596|19642679|P1|NOT COMPLETED|Overall Study||1
7977935|NCT00271596|19642678|P2|COMPLETED|Overall Study||15
7977936|NCT00271596|19642679|P1|COMPLETED|Overall Study||16
7977937|NCT00271596|19642678|P2|STARTED|Overall Study||16
7977938|NCT00271596|19642679|P1|STARTED|Overall Study||17
7977939|NCT00271570|19642705|P2|NOT COMPLETED|Overall Study||0
7977940|NCT00271570|19642706|P1|NOT COMPLETED|Overall Study||0
7977941|NCT00271570|19642705|P2|COMPLETED|Overall Study||12
7977942|NCT00271570|19642706|P1|COMPLETED|Overall Study||12
7977943|NCT00271570|19642705|P2|STARTED|Overall Study||12
7977944|NCT00271570|19642706|P1|STARTED|Overall Study||12
7977945|NCT00271544|19642714|P1|NOT COMPLETED|Overall Study||20
7977946|NCT00271544|19642714|P1|COMPLETED|Overall Study|Total number subjects successfully implanted 4196 lead.|170
7977947|NCT00271544|19642714|P1|Model 4196 Lead Attempted|Overall Study|Total number of subjects attempted Model 4196 lead.|177
7977948|NCT00271544|19642714|P1|Implant Attempted|Overall Study|Total number of subjects completed baseline and underwent system implant attempt.|186
7977949|NCT00271544|19642714|P1|STARTED|Overall Study|Total number of subjects enrolled.|190
7977950|NCT00271505|19642735|P1|NOT COMPLETED|Overall Study||5
7977951|NCT00271505|19642735|P1|COMPLETED|Overall Study||38
7977952|NCT00271505|19642735|P1|STARTED|Overall Study||43
7977953|NCT00271375|19642744|P3|NOT COMPLETED|Overall Study||0
7977954|NCT00271375|19642745|P2|NOT COMPLETED|Overall Study||0
7977955|NCT00271375|19642746|P1|NOT COMPLETED|Overall Study||0
7977956|NCT00271375|19642744|P3|COMPLETED|Overall Study||57
7977957|NCT00271375|19642745|P2|COMPLETED|Overall Study||83
7977958|NCT00271375|19642746|P1|COMPLETED|Overall Study||114
7977959|NCT00271375|19642744|P3|STARTED|Overall Study||57
7977960|NCT00271375|19642745|P2|STARTED|Overall Study||83
7977961|NCT00271375|19642746|P1|STARTED|Overall Study||114
7977962|NCT00271219|19642784|P2|NOT COMPLETED|Overall Study||28
7977963|NCT00271219|19642785|P1|NOT COMPLETED|Overall Study||16
7977964|NCT00271219|19642784|P2|COMPLETED|Overall Study||58
7977965|NCT00271219|19642785|P1|COMPLETED|Overall Study||73
7977966|NCT00271219|19642784|P2|STARTED|Overall Study||86
7977967|NCT00271219|19642785|P1|STARTED|Overall Study||89
7977968|NCT00271154|19642811|P2|NOT COMPLETED|Overall Study||0
7977969|NCT00271154|19642812|P1|NOT COMPLETED|Overall Study||0
7977970|NCT00271154|19642811|P2|COMPLETED|Overall Study||419
7977971|NCT00271154|19642812|P1|COMPLETED|Overall Study||191
7977972|NCT00271154|19642811|P2|STARTED|Overall Study||419
7977973|NCT00271154|19642812|P1|STARTED|Overall Study||191
7977974|NCT00271102|19642823|P2|NOT COMPLETED|Overall Study||5
7977975|NCT00271102|19642824|P1|NOT COMPLETED|Overall Study||5
7977976|NCT00271102|19642823|P2|COMPLETED|Overall Study||30
7977977|NCT00271102|19642824|P1|COMPLETED|Overall Study||30
7977978|NCT00271102|19642823|P2|STARTED|Overall Study||35
7977979|NCT00271102|19642824|P1|STARTED|Overall Study||35
7977980|NCT00271024|19642834|P4|NOT COMPLETED|Overall Study||24
7977981|NCT00271024|19642835|P3|NOT COMPLETED|Overall Study||23
7977982|NCT00271024|19642836|P2|NOT COMPLETED|Overall Study||26
7977983|NCT00271024|19642837|P1|NOT COMPLETED|Overall Study||22
7977984|NCT00271024|19642834|P4|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64
7977985|NCT00271024|19642835|P3|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65
7977986|NCT00271024|19642836|P2|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51
7977987|NCT00271024|19642837|P1|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58
7978077|NCT00270231|19643086|P2|COMPLETED|Second Intervention||30
7977988|NCT00271024|19642834|P4|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83
7977989|NCT00271024|19642835|P3|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85
7977990|NCT00271024|19642836|P2|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71
7977991|NCT00271024|19642837|P1|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76
7977992|NCT00271024|19642834|P4|STARTED|Overall Study||88
7977993|NCT00271024|19642835|P3|STARTED|Overall Study||88
7977994|NCT00271024|19642836|P2|STARTED|Overall Study||77
7977995|NCT00271024|19642837|P1|STARTED|Overall Study||80
7977996|NCT00271011|19642879|P1|NOT COMPLETED|Overall Study||0
7977997|NCT00271011|19642879|P1|COMPLETED|Overall Study||13
7977998|NCT00271011|19642879|P1|STARTED|Overall Study||13
7977999|NCT00270998|19642887|P3|NOT COMPLETED|12 Month Follow-up||21
7978000|NCT00270998|19642888|P2|NOT COMPLETED|12 Month Follow-up||25
7978001|NCT00270998|19642889|P1|NOT COMPLETED|12 Month Follow-up||14
7978002|NCT00270998|19642887|P3|COMPLETED|12 Month Follow-up||111
7978003|NCT00270998|19642888|P2|COMPLETED|12 Month Follow-up||99
7978004|NCT00270998|19642889|P1|COMPLETED|12 Month Follow-up||96
7978005|NCT00270998|19642887|P3|STARTED|12 Month Follow-up||132
7978006|NCT00270998|19642888|P2|STARTED|12 Month Follow-up||124
7978007|NCT00270998|19642889|P1|STARTED|12 Month Follow-up||110
7978008|NCT00270998|19642887|P3|NOT COMPLETED|3 Month Follow-up||18
7978009|NCT00270998|19642888|P2|NOT COMPLETED|3 Month Follow-up||22
7978010|NCT00270998|19642889|P1|NOT COMPLETED|3 Month Follow-up||39
7978011|NCT00270998|19642887|P3|COMPLETED|3 Month Follow-up||132
7978012|NCT00270998|19642888|P2|COMPLETED|3 Month Follow-up||124
7978013|NCT00270998|19642889|P1|COMPLETED|3 Month Follow-up||110
7978014|NCT00270998|19642887|P3|STARTED|3 Month Follow-up|1 participant randomized to combined found ineligible at first treatment visit, removed from study.|150
7978015|NCT00270998|19642888|P2|STARTED|3 Month Follow-up||146
7978016|NCT00270998|19642889|P1|STARTED|3 Month Follow-up||149
7978017|NCT00270894|19642918|P1|NOT COMPLETED|Overall Study||2
7978018|NCT00270894|19642918|P1|COMPLETED|Overall Study||28
7978019|NCT00270894|19642918|P1|STARTED|Overall Study||30
7978020|NCT00270855|19642930|P2|NOT COMPLETED|Overall Study||8
7978021|NCT00270855|19642931|P1|NOT COMPLETED|Overall Study||8
7978022|NCT00270855|19642930|P2|COMPLETED|Overall Study||6
7978023|NCT00270855|19642931|P1|COMPLETED|Overall Study||7
7978024|NCT00270855|19642930|P2|STARTED|Overall Study||14
7978025|NCT00270855|19642931|P1|STARTED|Overall Study||15
7978026|NCT00270842|19642990|P3|NOT COMPLETED|Overall Study||16
7978027|NCT00270842|19642991|P2|NOT COMPLETED|Overall Study||16
7978028|NCT00270842|19642992|P1|NOT COMPLETED|Overall Study||15
7978029|NCT00270842|19642990|P3|COMPLETED|Overall Study||18
7978030|NCT00270842|19642991|P2|COMPLETED|Overall Study||18
7978031|NCT00270842|19642992|P1|COMPLETED|Overall Study||18
7978032|NCT00270842|19642990|P3|STARTED|Overall Study||34
7978033|NCT00270842|19642991|P2|STARTED|Overall Study||34
7978034|NCT00270842|19642992|P1|STARTED|Overall Study||33
7978035|NCT00270790|19643003|P1|NOT COMPLETED|Overall Study||5
7978036|NCT00270790|19643003|P1|COMPLETED|Overall Study||16
7978037|NCT00270790|19643003|P1|STARTED|Overall Study||21
7978038|NCT00270634|19643012|P4|NOT COMPLETED|Overall Study||5
7978039|NCT00270634|19643013|P3|NOT COMPLETED|Overall Study||22
7978040|NCT00270634|19643014|P2|NOT COMPLETED|Overall Study||13
7978041|NCT00270634|19643015|P1|NOT COMPLETED|Overall Study||17
7978042|NCT00270634|19643012|P4|COMPLETED|Overall Study||81
7978043|NCT00270634|19643013|P3|COMPLETED|Overall Study||62
7978044|NCT00270634|19643014|P2|COMPLETED|Overall Study||64
7978045|NCT00270634|19643015|P1|COMPLETED|Overall Study||70
7978046|NCT00270634|19643012|P4|STARTED|Overall Study||86
7978047|NCT00270634|19643013|P3|STARTED|Overall Study||84
7978048|NCT00270634|19643014|P2|STARTED|Overall Study||77
7978049|NCT00270634|19643015|P1|STARTED|Overall Study||87
7978050|NCT00270296|19643052|P3|NOT COMPLETED|Overall Study||61
7978051|NCT00270296|19643053|P2|NOT COMPLETED|Overall Study||90
7978052|NCT00270296|19643054|P1|NOT COMPLETED|Overall Study||99
7978053|NCT00270296|19643052|P3|COMPLETED|Overall Study||109
7978054|NCT00270296|19643053|P2|COMPLETED|Overall Study||185
7978055|NCT00270296|19643054|P1|COMPLETED|Overall Study||186
7978056|NCT00270296|19643052|P3|STARTED|Overall Study||170
7978057|NCT00270296|19643053|P2|STARTED|Overall Study||275
7978058|NCT00270296|19643054|P1|STARTED|Overall Study||285
7978059|NCT00270257|19643067|P2|NOT COMPLETED|Overall Study||424
7978060|NCT00270257|19643068|P1|NOT COMPLETED|Overall Study||412
7978061|NCT00270257|19643067|P2|COMPLETED|Overall Study||204
7978062|NCT00270257|19643068|P1|COMPLETED|Overall Study||211
7978063|NCT00270257|19643067|P2|Visit 104|Overall Study||204
7978064|NCT00270257|19643068|P1|Visit 104|Overall Study||211
7978065|NCT00270257|19643067|P2|Week 78|Overall Study||285
7978066|NCT00270257|19643068|P1|Week 78|Overall Study||283
7978067|NCT00270257|19643067|P2|Week 52|Overall Study||340
7978068|NCT00270257|19643068|P1|Week 52|Overall Study||362
7978069|NCT00270257|19643067|P2|Week 26|Overall Study||440
7978070|NCT00270257|19643068|P1|Week 26|Overall Study||460
7978071|NCT00270257|19643067|P2|Week 8|Overall Study||443
7978072|NCT00270257|19643068|P1|Week 8|Overall Study||510
7978073|NCT00270257|19643067|P2|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628
7978074|NCT00270257|19643068|P1|STARTED|Overall Study||623
7978075|NCT00270231|19643086|P2|NOT COMPLETED|Second Intervention||1
7978076|NCT00270231|19643087|P1|NOT COMPLETED|Second Intervention||0
7978078|NCT00270231|19643087|P1|COMPLETED|Second Intervention||30
7978079|NCT00270231|19643086|P2|STARTED|Second Intervention||31
7978080|NCT00270231|19643087|P1|STARTED|Second Intervention||30
7978081|NCT00270231|19643086|P2|NOT COMPLETED|Washout Period||0
7978082|NCT00270231|19643087|P1|NOT COMPLETED|Washout Period||1
7978083|NCT00270231|19643086|P2|COMPLETED|Washout Period||31
7978084|NCT00270231|19643087|P1|COMPLETED|Washout Period||30
7978085|NCT00270231|19643086|P2|STARTED|Washout Period||31
7978086|NCT00270231|19643087|P1|STARTED|Washout Period||31
7978087|NCT00270231|19643086|P2|NOT COMPLETED|First Intervention||1
7978088|NCT00270231|19643087|P1|NOT COMPLETED|First Intervention||1
7978089|NCT00270231|19643086|P2|COMPLETED|First Intervention||31
7978090|NCT00270231|19643087|P1|COMPLETED|First Intervention||31
7978091|NCT00270231|19643086|P2|STARTED|First Intervention||32
7978092|NCT00270231|19643087|P1|STARTED|First Intervention||32
7978093|NCT00270205|19643097|P4|NOT COMPLETED|Overall Study||1
7978094|NCT00270205|19643098|P3|NOT COMPLETED|Overall Study||0
7978095|NCT00270205|19643099|P2|NOT COMPLETED|Overall Study||0
7978096|NCT00270205|19643100|P1|NOT COMPLETED|Overall Study||1
7978097|NCT00270205|19643097|P4|COMPLETED|Overall Study||6
7978098|NCT00270205|19643098|P3|COMPLETED|Overall Study||6
7978099|NCT00270205|19643099|P2|COMPLETED|Overall Study||6
7978100|NCT00270205|19643100|P1|COMPLETED|Overall Study||5
7978101|NCT00270205|19643097|P4|STARTED|Overall Study||7
7978102|NCT00270205|19643098|P3|STARTED|Overall Study||6
7978103|NCT00270205|19643099|P2|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6
7978104|NCT00270205|19643100|P1|STARTED|Overall Study||6
7978105|NCT00269919|19643218|P1|NOT COMPLETED|Overall Study||27
7978106|NCT00269919|19643218|P1|COMPLETED|Overall Study||13
7978107|NCT00269919|19643218|P1|Treated|Overall Study||39
7978108|NCT00269919|19643218|P1|STARTED|Overall Study||40
7978109|NCT00269633|19643237|P2|NOT COMPLETED|Overall Study||0
7978110|NCT00269633|19643238|P1|NOT COMPLETED|Overall Study||1
7978111|NCT00269633|19643237|P2|COMPLETED|Overall Study||5
7978112|NCT00269633|19643238|P1|COMPLETED|Overall Study||3
7978113|NCT00269633|19643237|P2|STARTED|Overall Study||5
7978114|NCT00269633|19643238|P1|STARTED|Overall Study||4
7978115|NCT00269477|19643248|P4|NOT COMPLETED|Overall Study||0
7978116|NCT00269477|19643249|P3|NOT COMPLETED|Overall Study||1
7978117|NCT00269477|19643250|P2|NOT COMPLETED|Overall Study||6
7978118|NCT00269477|19643251|P1|NOT COMPLETED|Overall Study||5
7978119|NCT00269477|19643248|P4|COMPLETED|Overall Study||60
7978120|NCT00269477|19643249|P3|COMPLETED|Overall Study||57
7978121|NCT00269477|19643250|P2|COMPLETED|Overall Study||12
7978122|NCT00269477|19643251|P1|COMPLETED|Overall Study||4
7978123|NCT00269477|19643248|P4|STARTED|Overall Study||60
7978124|NCT00269477|19643249|P3|STARTED|Overall Study||58
7978125|NCT00269477|19643250|P2|STARTED|Overall Study||18
7978126|NCT00269477|19643251|P1|STARTED|Overall Study||9
7978127|NCT00269399|19643267|P2|NOT COMPLETED|Overall Study||27
7978128|NCT00269399|19643268|P1|NOT COMPLETED|Overall Study||41
7978129|NCT00269399|19643267|P2|COMPLETED|Overall Study||91
7978130|NCT00269399|19643268|P1|COMPLETED|Overall Study||78
7978131|NCT00269399|19643267|P2|STARTED|Overall Study||118
7978132|NCT00269399|19643268|P1|STARTED|Overall Study||119
7978133|NCT00269152|19643278|P2|NOT COMPLETED|Overall Study||10
7978134|NCT00269152|19643279|P1|NOT COMPLETED|Overall Study||18
7978135|NCT00269152|19643278|P2|COMPLETED|Overall Study||49
7978136|NCT00269152|19643279|P1|COMPLETED|Overall Study||45
7978137|NCT00269152|19643278|P2|STARTED|Overall Study|4 were randomized without receiving any study drug.|59
7978138|NCT00269152|19643279|P1|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63
7978139|NCT00269113|19643295|P2|NOT COMPLETED|Overall Study||37
7978140|NCT00269113|19643296|P1|NOT COMPLETED|Overall Study||74
7978141|NCT00269113|19643295|P2|COMPLETED|Overall Study||146
7978142|NCT00269113|19643296|P1|COMPLETED|Overall Study||103
7978143|NCT00269113|19643295|P2|STARTED|Overall Study||183
7978144|NCT00269113|19643296|P1|STARTED|Overall Study||177
7978145|NCT00269087|19643314|P1|NOT COMPLETED|Overall Study||34
7978146|NCT00269087|19643314|P1|COMPLETED|Overall Study||88
7978147|NCT00269087|19643314|P1|STARTED|Overall Study||122
7978148|NCT00268996|19643344|P2|NOT COMPLETED|Overall Study||20
7978149|NCT00268996|19643345|P1|NOT COMPLETED|Overall Study||21
7978150|NCT00268996|19643344|P2|COMPLETED|Overall Study||152
7978151|NCT00268996|19643345|P1|COMPLETED|Overall Study||130
7978152|NCT00268996|19643344|P2|STARTED|Overall Study||172
7978153|NCT00268996|19643345|P1|STARTED|Overall Study||151
7978154|NCT00268983|19643389|P2|NOT COMPLETED|Overall Study||0
7978155|NCT00268983|19643390|P1|NOT COMPLETED|Overall Study||3
7978156|NCT00268983|19643389|P2|COMPLETED|Overall Study||8
7978157|NCT00268983|19643390|P1|COMPLETED|Overall Study||3
7978158|NCT00268983|19643389|P2|STARTED|Overall Study||8
7978159|NCT00268983|19643390|P1|STARTED|Overall Study||6
7978160|NCT00268905|19643433|P3|NOT COMPLETED|Overall Study||12
7978161|NCT00268905|19643434|P2|NOT COMPLETED|Overall Study||9
7978162|NCT00268905|19643435|P1|NOT COMPLETED|Overall Study||43
7978163|NCT00268905|19643433|P3|COMPLETED|Overall Study||0
7978164|NCT00268905|19643434|P2|COMPLETED|Overall Study||0
7978165|NCT00268905|19643435|P1|COMPLETED|Overall Study||0
7978166|NCT00268905|19643433|P3|STARTED|Overall Study||12
7978167|NCT00268905|19643434|P2|STARTED|Overall Study||9
7978168|NCT00268905|19643435|P1|STARTED|Overall Study||43
7978169|NCT00268892|19643452|P3|NOT COMPLETED|Overall Study||39
7978170|NCT00268892|19643453|P2|NOT COMPLETED|Overall Study||42
7978171|NCT00268892|19643454|P1|NOT COMPLETED|Overall Study||39
7978172|NCT00268892|19643452|P3|COMPLETED|Overall Study||54
7978173|NCT00268892|19643453|P2|COMPLETED|Overall Study||53
7978174|NCT00268892|19643454|P1|COMPLETED|Overall Study||51
7978175|NCT00268892|19643452|P3|Switched to Higher Dose|Overall Study||76
7978176|NCT00268892|19643453|P2|Switched to Higher Dose|Overall Study||68
7978177|NCT00268892|19643454|P1|Switched to Higher Dose|Overall Study||59
7978178|NCT00268892|19643452|P3|STARTED|Overall Study||93
7978179|NCT00268892|19643453|P2|STARTED|Overall Study||95
7978180|NCT00268892|19643454|P1|STARTED|Overall Study||90
7978181|NCT00268762|19643465|P1|NOT COMPLETED|Overall Study||0
7978182|NCT00268762|19643465|P1|COMPLETED|Overall Study||65
7978183|NCT00268762|19643465|P1|STARTED|Overall Study||65
7978184|NCT00268463|19643473|P2|NOT COMPLETED|Overall Study||12
7978185|NCT00268463|19643474|P1|NOT COMPLETED|Overall Study||10
7978186|NCT00268463|19643473|P2|COMPLETED|Overall Study||0
7978187|NCT00268463|19643474|P1|COMPLETED|Overall Study||0
7978188|NCT00268463|19643473|P2|STARTED|Overall Study||12
7978189|NCT00268463|19643474|P1|STARTED|Overall Study||10
7978190|NCT00268450|19643480|P1|NOT COMPLETED|Overall Study||0
7978191|NCT00268450|19643480|P1|COMPLETED|Overall Study||21
7978192|NCT00268450|19643480|P1|STARTED|Overall Study||21
7978193|NCT00268437|19643490|P1|NOT COMPLETED|Overall Study||1
7978194|NCT00268437|19643490|P1|COMPLETED|Overall Study||26
7978195|NCT00268437|19643490|P1|STARTED|Overall Study||27
7978196|NCT00268346|19643497|P2|NOT COMPLETED|Overall Study||3
7978197|NCT00268346|19643498|P1|NOT COMPLETED|Overall Study||0
7978198|NCT00268346|19643497|P2|COMPLETED|Overall Study||37
7978199|NCT00268346|19643498|P1|COMPLETED|Overall Study||18
7978200|NCT00268346|19643497|P2|Started Treatment|Overall Study||40
7978201|NCT00268346|19643498|P1|Started Treatment|Overall Study||18
7978202|NCT00268346|19643497|P2|STARTED|Overall Study||40
7978203|NCT00268346|19643498|P1|STARTED|Overall Study||18
7978204|NCT00268242|19643504|P1|NOT COMPLETED|Overall Study||1
7978205|NCT00268242|19643504|P1|COMPLETED|Overall Study||23
7978206|NCT00268242|19643504|P1|STARTED|Overall Study||24
7978207|NCT00268203|19643513|P1|NOT COMPLETED|Overall Study||647
7978208|NCT00268203|19643513|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118
7978209|NCT00268203|19643513|P1|Completed 2 Years of Follow-up|Overall Study||62
7978210|NCT00268203|19643513|P1|STARTED|Overall Study||765
7978211|NCT00267969|19643527|P7|NOT COMPLETED|After Controlled Period||72
7978212|NCT00267969|19643528|P6|NOT COMPLETED|After Controlled Period||82
7978213|NCT00267969|19643529|P5|NOT COMPLETED|After Controlled Period||35
7978214|NCT00267969|19643530|P4|NOT COMPLETED|After Controlled Period||36
7978215|NCT00267969|19643531|P3|NOT COMPLETED|After Controlled Period||0
7978216|NCT00267969|19643532|P2|NOT COMPLETED|After Controlled Period||0
7978217|NCT00267969|19643533|P1|NOT COMPLETED|After Controlled Period||0
7978218|NCT00267969|19643527|P7|COMPLETED|After Controlled Period||173
7978219|NCT00267969|19643528|P6|COMPLETED|After Controlled Period||172
7978220|NCT00267969|19643529|P5|COMPLETED|After Controlled Period||85
7978221|NCT00267969|19643530|P4|COMPLETED|After Controlled Period||87
7978222|NCT00267969|19643531|P3|COMPLETED|After Controlled Period||0
7978223|NCT00267969|19643532|P2|COMPLETED|After Controlled Period||0
7978224|NCT00267969|19643533|P1|COMPLETED|After Controlled Period||0
7978225|NCT00267969|19643527|P7|STARTED|After Controlled Period||245
7978226|NCT00267969|19643528|P6|STARTED|After Controlled Period||254
7978227|NCT00267969|19643529|P5|STARTED|After Controlled Period||120
7978228|NCT00267969|19643530|P4|STARTED|After Controlled Period||123
7978229|NCT00267969|19643531|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
7978230|NCT00267969|19643532|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
7978231|NCT00267969|19643533|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
7978232|NCT00267969|19643527|P7|NOT COMPLETED|Controlled Period||0
7978233|NCT00267969|19643528|P6|NOT COMPLETED|Controlled Period||0
7978234|NCT00267969|19643529|P5|NOT COMPLETED|Controlled Period||0
7978235|NCT00267969|19643530|P4|NOT COMPLETED|Controlled Period||0
7978236|NCT00267969|19643531|P3|NOT COMPLETED|Controlled Period||11
7978237|NCT00267969|19643532|P2|NOT COMPLETED|Controlled Period||1
7978238|NCT00267969|19643533|P1|NOT COMPLETED|Controlled Period||12
7978239|NCT00267969|19643527|P7|COMPLETED|Controlled Period||0
7978240|NCT00267969|19643528|P6|COMPLETED|Controlled Period||0
7978241|NCT00267969|19643529|P5|COMPLETED|Controlled Period||0
7978242|NCT00267969|19643530|P4|COMPLETED|Controlled Period||0
7978243|NCT00267969|19643531|P3|COMPLETED|Controlled Period||245
7978244|NCT00267969|19643532|P2|COMPLETED|Controlled Period||254
7978245|NCT00267969|19643533|P1|COMPLETED|Controlled Period||243
7978246|NCT00267969|19643527|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
7978247|NCT00267969|19643528|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
7978248|NCT00267969|19643529|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
7978249|NCT00267969|19643530|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
7978250|NCT00267969|19643531|P3|STARTED|Controlled Period|Number of patients randomized|256
7978251|NCT00267969|19643532|P2|STARTED|Controlled Period|Number of patients randomized|255
7978252|NCT00267969|19643533|P1|STARTED|Controlled Period|Number of patients randomized|255
7978253|NCT00267956|19643559|P4|NOT COMPLETED|After Controlled Period||2
7978254|NCT00267956|19643560|P3|NOT COMPLETED|After Controlled Period||5
7978255|NCT00267956|19643561|P2|NOT COMPLETED|After Controlled Period||0
7978256|NCT00267956|19643562|P1|NOT COMPLETED|After Controlled Period||0
7978257|NCT00267956|19643559|P4|COMPLETED|After Controlled Period||70
7978258|NCT00267956|19643560|P3|COMPLETED|After Controlled Period||52
7978259|NCT00267956|19643561|P2|COMPLETED|After Controlled Period||0
7978260|NCT00267956|19643562|P1|COMPLETED|After Controlled Period||0
7978261|NCT00267956|19643559|P4|STARTED|After Controlled Period||72
7978262|NCT00267956|19643560|P3|STARTED|After Controlled Period||57
7978263|NCT00267956|19643561|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
7978264|NCT00267956|19643562|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
7978265|NCT00267956|19643559|P4|NOT COMPLETED|Controlled Period||0
7978266|NCT00267956|19643560|P3|NOT COMPLETED|Controlled Period||0
7978267|NCT00267956|19643561|P2|NOT COMPLETED|Controlled Period||4
7978268|NCT00267956|19643562|P1|NOT COMPLETED|Controlled Period||13
7978269|NCT00267956|19643559|P4|COMPLETED|Controlled Period||0
7978270|NCT00267956|19643560|P3|COMPLETED|Controlled Period||0
7978271|NCT00267956|19643561|P2|COMPLETED|Controlled Period||72
7978272|NCT00267956|19643562|P1|COMPLETED|Controlled Period||57
7978273|NCT00267956|19643559|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
7978274|NCT00267956|19643560|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
7978275|NCT00267956|19643561|P2|STARTED|Controlled Period||76
7978276|NCT00267956|19643562|P1|STARTED|Controlled Period||70
7978277|NCT00267865|19643580|P1|NOT COMPLETED|Consolidation Treatment||0
7978278|NCT00267865|19643580|P1|COMPLETED|Consolidation Treatment||5
7978279|NCT00267865|19643580|P1|STARTED|Consolidation Treatment||5
7978280|NCT00267865|19643580|P1|NOT COMPLETED|Induction Treatment||3
7978281|NCT00267865|19643580|P1|COMPLETED|Induction Treatment||9
7978282|NCT00267865|19643580|P1|STARTED|Induction Treatment||12
7978283|NCT00267774|19643591|P2|NOT COMPLETED|Overall Study||0
7978284|NCT00267774|19643592|P1|NOT COMPLETED|Overall Study||0
7978285|NCT00267774|19643591|P2|COMPLETED|Overall Study||496
7978286|NCT00267774|19643592|P1|COMPLETED|Overall Study||509
7978287|NCT00267774|19643591|P2|STARTED|Overall Study||496
7978288|NCT00267774|19643592|P1|STARTED|Overall Study||509
7978289|NCT00267748|19643603|P3|NOT COMPLETED|Randomized Period||132
7978290|NCT00267748|19643604|P2|NOT COMPLETED|Randomized Period||127
7978291|NCT00267748|19643605|P1|NOT COMPLETED|Randomized Period||0
7978292|NCT00267748|19643603|P3|COMPLETED|Randomized Period||14
7978293|NCT00267748|19643604|P2|COMPLETED|Randomized Period||19
7978294|NCT00267748|19643605|P1|COMPLETED|Randomized Period||0
7978295|NCT00267748|19643603|P3|Treated|Randomized Period||143
7978296|NCT00267748|19643604|P2|Treated|Randomized Period||146
7978297|NCT00267748|19643605|P1|Treated|Randomized Period||0
7978298|NCT00267748|19643603|P3|STARTED|Randomized Period||146
7978299|NCT00267748|19643604|P2|STARTED|Randomized Period||146
7978300|NCT00267748|19643605|P1|STARTED|Randomized Period||0
7978301|NCT00267748|19643603|P3|NOT COMPLETED|Non-randomized Period||0
7978302|NCT00267748|19643604|P2|NOT COMPLETED|Non-randomized Period||0
7978303|NCT00267748|19643605|P1|NOT COMPLETED|Non-randomized Period||23
7978304|NCT00267748|19643603|P3|COMPLETED|Non-randomized Period||0
7978305|NCT00267748|19643604|P2|COMPLETED|Non-randomized Period||0
7978306|NCT00267748|19643605|P1|COMPLETED|Non-randomized Period||2
7978307|NCT00267748|19643603|P3|STARTED|Non-randomized Period||0
7978308|NCT00267748|19643604|P2|STARTED|Non-randomized Period||0
7978309|NCT00267748|19643605|P1|STARTED|Non-randomized Period||25
7978310|NCT00267696|19643622|P1|NOT COMPLETED|Overall Study||0
7978311|NCT00267696|19643622|P1|COMPLETED|Overall Study||45
7978312|NCT00267696|19643622|P1|STARTED|Overall Study||45
7978313|NCT00267670|19643629|P2|NOT COMPLETED|Overall Study||0
7978314|NCT00267670|19643630|P1|NOT COMPLETED|Overall Study||4
7978315|NCT00267670|19643629|P2|COMPLETED|Overall Study||7
7978316|NCT00267670|19643630|P1|COMPLETED|Overall Study||15
7978317|NCT00267670|19643629|P2|STARTED|Overall Study||7
7978318|NCT00267670|19643630|P1|STARTED|Overall Study||19
7978319|NCT00267644|19643644|P2|NOT COMPLETED|Overall Study||0
7978320|NCT00267644|19643645|P1|NOT COMPLETED|Overall Study||0
7978321|NCT00267644|19643644|P2|COMPLETED|Overall Study||63
7978322|NCT00267644|19643645|P1|COMPLETED|Overall Study||13
7978323|NCT00267644|19643644|P2|STARTED|Overall Study||63
7978324|NCT00267644|19643645|P1|STARTED|Overall Study||13
7978325|NCT00267631|19643655|P2|NOT COMPLETED|Overall Study||0
7978326|NCT00267631|19643656|P1|NOT COMPLETED|Overall Study||0
7978327|NCT00267631|19643655|P2|COMPLETED|Overall Study||3031
7978328|NCT00267631|19643656|P1|COMPLETED|Overall Study||2361
7978329|NCT00267631|19643655|P2|STARTED|Overall Study||3031
7978330|NCT00267631|19643656|P1|STARTED|Overall Study||2361
7978331|NCT00267488|19643662|P1|NOT COMPLETED|Overall Study||11
7978332|NCT00267488|19643662|P1|COMPLETED|Overall Study||26
7978333|NCT00267488|19643662|P1|STARTED|Overall Study||37
7978334|NCT00267293|19643674|P3|NOT COMPLETED|Overall Study||0
7978335|NCT00267293|19643675|P2|NOT COMPLETED|Overall Study||0
7978336|NCT00267293|19643676|P1|NOT COMPLETED|Overall Study||0
7978337|NCT00267293|19643674|P3|COMPLETED|Overall Study||20
7978338|NCT00267293|19643675|P2|COMPLETED|Overall Study||20
7978339|NCT00267293|19643676|P1|COMPLETED|Overall Study||20
7978340|NCT00267293|19643674|P3|STARTED|Overall Study||20
7978341|NCT00267293|19643675|P2|STARTED|Overall Study||20
7978342|NCT00267293|19643676|P1|STARTED|Overall Study||20
7978343|NCT00267202|19643686|P2|NOT COMPLETED|Overall Study||34
7978344|NCT00267202|19643687|P1|NOT COMPLETED|Overall Study||53
7978345|NCT00267202|19643686|P2|COMPLETED|Overall Study||105
7978346|NCT00267202|19643687|P1|COMPLETED|Overall Study||83
7978347|NCT00267202|19643686|P2|STARTED|Overall Study||139
7978348|NCT00267202|19643687|P1|STARTED|Overall Study||136
7978349|NCT00267189|19643708|P2|NOT COMPLETED|Overall Study||1
7978350|NCT00267189|19643709|P1|NOT COMPLETED|Overall Study||5
7978351|NCT00267189|19643708|P2|COMPLETED|Overall Study||72
7978352|NCT00267189|19643709|P1|COMPLETED|Overall Study|"Completed indicates completed study."|67
7978353|NCT00267189|19643708|P2|Completed Study Medication|Overall Study||72
7978354|NCT00267189|19643709|P1|Completed Study Medication|Overall Study||54
7978355|NCT00267189|19643708|P2|STARTED|Overall Study||73
7978356|NCT00267189|19643709|P1|STARTED|Overall Study|Intention to treat (ITT) population.|72
7978357|NCT00267150|19643719|P1|NOT COMPLETED|Overall Study||1
7978358|NCT00267150|19643719|P1|COMPLETED|Overall Study||30
7978359|NCT00267150|19643719|P1|STARTED|Overall Study||31
7978360|NCT00267111|19643726|P2|NOT COMPLETED|Overall Study||0
7978361|NCT00267111|19643727|P1|NOT COMPLETED|Overall Study||0
7978362|NCT00267111|19643726|P2|COMPLETED|Overall Study||55
7978363|NCT00267111|19643727|P1|COMPLETED|Overall Study||55
7978364|NCT00267111|19643726|P2|STARTED|Overall Study||55
7978365|NCT00267111|19643727|P1|STARTED|Overall Study||55
7978366|NCT00267098|19643743|P8|NOT COMPLETED|Overall Study||15
7978367|NCT00267098|19643744|P7|NOT COMPLETED|Overall Study||46
7978368|NCT00267098|19643745|P6|NOT COMPLETED|Overall Study||40
7978369|NCT00267098|19643746|P5|NOT COMPLETED|Overall Study||37
7978370|NCT00267098|19643747|P4|NOT COMPLETED|Overall Study||106
7978371|NCT00267098|19643748|P3|NOT COMPLETED|Overall Study||94
7978372|NCT00267098|19643749|P2|NOT COMPLETED|Overall Study||51
7978373|NCT00267098|19643750|P1|NOT COMPLETED|Overall Study||109
7978374|NCT00267098|19643743|P8|COMPLETED|Overall Study||5
7978375|NCT00267098|19643744|P7|COMPLETED|Overall Study||55
7978376|NCT00267098|19643745|P6|COMPLETED|Overall Study||66
7978377|NCT00267098|19643746|P5|COMPLETED|Overall Study||10
7978378|NCT00267098|19643747|P4|COMPLETED|Overall Study||135
7978379|NCT00267098|19643748|P3|COMPLETED|Overall Study||149
7978380|NCT00267098|19643749|P2|COMPLETED|Overall Study||0
7978381|NCT00267098|19643750|P1|COMPLETED|Overall Study||0
7978382|NCT00267098|19643743|P8|STARTED|Overall Study||20
7978383|NCT00267098|19643744|P7|STARTED|Overall Study||101
7978384|NCT00267098|19643745|P6|STARTED|Overall Study||106
7978385|NCT00267098|19643746|P5|STARTED|Overall Study||47
7978386|NCT00267098|19643747|P4|STARTED|Overall Study||241
7978387|NCT00267098|19643748|P3|STARTED|Overall Study||243
7978388|NCT00267098|19643749|P2|STARTED|Overall Study||51
7978389|NCT00267098|19643750|P1|STARTED|Overall Study||109
7978390|NCT00267085|19643883|P1|NOT COMPLETED|Overall Study||0
7978391|NCT00267085|19643883|P1|COMPLETED|Overall Study||10
7978392|NCT00267085|19643883|P1|STARTED|Overall Study||10
7978393|NCT00267059|19643887|P1|NOT COMPLETED|Overall Study||0
7978394|NCT00267059|19643887|P1|COMPLETED|Overall Study||44
7978395|NCT00267059|19643887|P1|STARTED|Overall Study||44
7978396|NCT00267046|19643893|P2|NOT COMPLETED|Overall Study||11
7978397|NCT00267046|19643894|P1|NOT COMPLETED|Overall Study||12
7978398|NCT00267046|19643893|P2|COMPLETED|Overall Study||5
7978399|NCT00267046|19643894|P1|COMPLETED|Overall Study||20
7978400|NCT00267046|19643893|P2|STARTED|Overall Study||16
7978401|NCT00267046|19643894|P1|STARTED|Overall Study||32
7978402|NCT00267020|19643904|P2|NOT COMPLETED|Overall Study||43
7978403|NCT00267020|19643905|P1|NOT COMPLETED|Overall Study||86
7978404|NCT00267020|19643904|P2|COMPLETED|Overall Study||1
7978405|NCT00267020|19643905|P1|COMPLETED|Overall Study||0
7978406|NCT00267020|19643904|P2|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|38
7978407|NCT00267020|19643905|P1|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|81
7978408|NCT00267020|19643904|P2|Received at Least 1 Dose|Overall Study||39
7978409|NCT00267020|19643905|P1|Received at Least 1 Dose|Overall Study||82
7978410|NCT00267020|19643904|P2|STARTED|Overall Study||44
7978411|NCT00267020|19643905|P1|STARTED|Overall Study||86
7978412|NCT00267007|19643927|P2|NOT COMPLETED|Overall Study||1
7978413|NCT00267007|19643928|P1|NOT COMPLETED|Overall Study||8
7978414|NCT00267007|19643927|P2|COMPLETED|Overall Study||10
7978415|NCT00267007|19643928|P1|COMPLETED|Overall Study||11
7978416|NCT00267007|19643927|P2|STARTED|Overall Study||11
7978417|NCT00267007|19643928|P1|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19
7978418|NCT00266877|19643939|P3|NOT COMPLETED|Overall Study||28
7978419|NCT00266877|19643940|P2|NOT COMPLETED|Overall Study||48
7978420|NCT00266877|19643941|P1|NOT COMPLETED|Overall Study||91
7978421|NCT00266877|19643939|P3|COMPLETED|Overall Study||0
7978422|NCT00266877|19643940|P2|COMPLETED|Overall Study||0
7978423|NCT00266877|19643941|P1|COMPLETED|Overall Study||0
7978424|NCT00266877|19643939|P3|STARTED|Overall Study||28
7978425|NCT00266877|19643940|P2|STARTED|Overall Study||48
7978426|NCT00266877|19643941|P1|STARTED|Overall Study||91
7978427|NCT00266864|19643960|P2|NOT COMPLETED|Overall Study||2
7978428|NCT00266864|19643961|P1|NOT COMPLETED|Overall Study||5
7978429|NCT00266864|19643960|P2|COMPLETED|Overall Study||11
7978430|NCT00266864|19643961|P1|COMPLETED|Overall Study||13
7978431|NCT00266864|19643960|P2|STARTED|Overall Study||13
7978432|NCT00266864|19643961|P1|STARTED|Overall Study||18
7978433|NCT00266851|19643971|P3|NOT COMPLETED|Overall Study||0
7978434|NCT00266851|19643972|P2|NOT COMPLETED|Overall Study||0
7978435|NCT00266851|19643973|P1|NOT COMPLETED|Overall Study||0
7978436|NCT00266851|19643971|P3|COMPLETED|Overall Study||22
7978437|NCT00266851|19643972|P2|COMPLETED|Overall Study||38
7978438|NCT00266851|19643973|P1|COMPLETED|Overall Study||37
7978439|NCT00266851|19643971|P3|Completed 12 Month Follow up|Overall Study||13
7978440|NCT00266851|19643972|P2|Completed 12 Month Follow up|Overall Study||19
7978441|NCT00266851|19643973|P1|Completed 12 Month Follow up|Overall Study||25
7978442|NCT00266851|19643971|P3|Completed 9 Month Follow up|Overall Study||15
7978443|NCT00266851|19643972|P2|Completed 9 Month Follow up|Overall Study||23
7978444|NCT00266851|19643973|P1|Completed 9 Month Follow up|Overall Study||22
7978445|NCT00266851|19643971|P3|Completed 6 Month Follow up|Overall Study||17
7978446|NCT00266851|19643972|P2|Completed 6 Month Follow up|Overall Study||22
7978447|NCT00266851|19643973|P1|Completed 6 Month Follow up|Overall Study||27
7978448|NCT00266851|19643971|P3|Completed 3 Month Follow up|Overall Study||15
7978449|NCT00266851|19643972|P2|Completed 3 Month Follow up|Overall Study||22
7978450|NCT00266851|19643973|P1|Completed 3 Month Follow up|Overall Study||26
7978451|NCT00266851|19643971|P3|STARTED|Overall Study||22
7978452|NCT00266851|19643972|P2|STARTED|Overall Study||38
7978453|NCT00266851|19643973|P1|STARTED|Overall Study||37
7978454|NCT00266825|19643992|P2|NOT COMPLETED|Completed Follow-Up||24
7978455|NCT00266825|19643993|P1|NOT COMPLETED|Completed Follow-Up||25
7978456|NCT00266825|19643992|P2|COMPLETED|Completed Follow-Up||154
7978457|NCT00266825|19643993|P1|COMPLETED|Completed Follow-Up||147
7978458|NCT00266825|19643992|P2|STARTED|Completed Follow-Up||178
7978459|NCT00266825|19643993|P1|STARTED|Completed Follow-Up||172
7978460|NCT00266825|19643992|P2|NOT COMPLETED|Enrolled and Allocated Intervention||0
7978461|NCT00266825|19643993|P1|NOT COMPLETED|Enrolled and Allocated Intervention||0
7978462|NCT00266825|19643992|P2|COMPLETED|Enrolled and Allocated Intervention||178
7978463|NCT00266825|19643993|P1|COMPLETED|Enrolled and Allocated Intervention||172
7978464|NCT00266825|19643992|P2|STARTED|Enrolled and Allocated Intervention||178
7978465|NCT00266825|19643993|P1|STARTED|Enrolled and Allocated Intervention||172
7978466|NCT00266812|19644019|P2|NOT COMPLETED|Overall Study||11
7978467|NCT00266812|19644020|P1|NOT COMPLETED|Overall Study||21
7978468|NCT00266812|19644019|P2|COMPLETED|Overall Study||2
7978469|NCT00266812|19644020|P1|COMPLETED|Overall Study||1
7978470|NCT00266812|19644019|P2|STARTED|Overall Study||13
7978471|NCT00266812|19644020|P1|STARTED|Overall Study||22
7978472|NCT00266799|19644028|P2|NOT COMPLETED|Overall Study||34
7978473|NCT00266799|19644029|P1|NOT COMPLETED|Overall Study||36
7978474|NCT00266799|19644028|P2|COMPLETED|Overall Study||68
7978475|NCT00266799|19644029|P1|COMPLETED|Overall Study||62
7978476|NCT00266799|19644028|P2|STARTED|Overall Study||102
7978477|NCT00266799|19644029|P1|STARTED|Overall Study||98
7978478|NCT00266708|19644045|P2|NOT COMPLETED|Overall Study||9
7978479|NCT00266708|19644046|P1|NOT COMPLETED|Overall Study||4
7978480|NCT00266708|19644045|P2|COMPLETED|Overall Study||13
7978481|NCT00266708|19644046|P1|COMPLETED|Overall Study||16
7978482|NCT00266708|19644045|P2|STARTED|Overall Study||22
7978483|NCT00266708|19644046|P1|STARTED|Overall Study||20
7978484|NCT00266695|19644086|P1|NOT COMPLETED|Overall Study||29
7978485|NCT00266695|19644086|P1|COMPLETED|Overall Study||174
7978486|NCT00266695|19644086|P1|STARTED|Overall Study||203
7978487|NCT00266656|19644098|P2|NOT COMPLETED|Overall Study||13
7978488|NCT00266656|19644099|P1|NOT COMPLETED|Overall Study||14
7978489|NCT00266656|19644098|P2|COMPLETED|Overall Study||20
7978490|NCT00266656|19644099|P1|COMPLETED|Overall Study||22
7978491|NCT00266656|19644098|P2|STARTED|Overall Study||33
7978492|NCT00266656|19644099|P1|STARTED|Overall Study||36
7978493|NCT00266630|19644123|P2|NOT COMPLETED|Overall Study||28
7978494|NCT00266630|19644124|P1|NOT COMPLETED|Overall Study||42
7978495|NCT00266630|19644123|P2|COMPLETED|Overall Study||11
7978496|NCT00266630|19644124|P1|COMPLETED|Overall Study||58
7978497|NCT00266630|19644123|P2|STARTED|Overall Study||39
7978498|NCT00266630|19644124|P1|STARTED|Overall Study||100
7978499|NCT00266409|19644166|P4|NOT COMPLETED|Overall Study||22
7978500|NCT00266409|19644167|P3|NOT COMPLETED|Overall Study||17
7978501|NCT00266409|19644168|P2|NOT COMPLETED|Overall Study||46
7978502|NCT00266409|19644169|P1|NOT COMPLETED|Overall Study||45
7978503|NCT00266409|19644166|P4|COMPLETED|Overall Study||49
7978504|NCT00266409|19644167|P3|COMPLETED|Overall Study||55
7978505|NCT00266409|19644168|P2|COMPLETED|Overall Study||92
7978506|NCT00266409|19644169|P1|COMPLETED|Overall Study||92
7978507|NCT00266409|19644166|P4|STARTED|Overall Study||71
7978508|NCT00266409|19644167|P3|STARTED|Overall Study||72
7978509|NCT00266409|19644168|P2|STARTED|Overall Study||138
7978510|NCT00266409|19644169|P1|STARTED|Overall Study||137
7978511|NCT00266279|19644451|P1|NOT COMPLETED|Overall Study||2
7978512|NCT00266279|19644451|P1|COMPLETED|Overall Study||15
7978513|NCT00266279|19644451|P1|STARTED|Overall Study||17
7978514|NCT00266227|19644458|P3|NOT COMPLETED|Retreatment: Week 48 to Week 72||0
7978515|NCT00266227|19644459|P2|NOT COMPLETED|Retreatment: Week 48 to Week 72||42
7978516|NCT00266227|19644460|P1|NOT COMPLETED|Retreatment: Week 48 to Week 72||64
7978517|NCT00266227|19644458|P3|COMPLETED|Retreatment: Week 48 to Week 72||0
7978518|NCT00266227|19644459|P2|COMPLETED|Retreatment: Week 48 to Week 72||92
7978519|NCT00266227|19644460|P1|COMPLETED|Retreatment: Week 48 to Week 72||227
7978520|NCT00266227|19644458|P3|STARTED|Retreatment: Week 48 to Week 72||0
7978521|NCT00266227|19644459|P2|STARTED|Retreatment: Week 48 to Week 72||134
7978522|NCT00266227|19644460|P1|STARTED|Retreatment: Week 48 to Week 72||291
7978523|NCT00266227|19644458|P3|NOT COMPLETED|Retreatment: Up to Week 48||0
7978524|NCT00266227|19644459|P2|NOT COMPLETED|Retreatment: Up to Week 48||23
7978525|NCT00266227|19644460|P1|NOT COMPLETED|Retreatment: Up to Week 48||27
7978526|NCT00266227|19644458|P3|COMPLETED|Retreatment: Up to Week 48||0
7978527|NCT00266227|19644459|P2|COMPLETED|Retreatment: Up to Week 48||134
7978528|NCT00266227|19644460|P1|COMPLETED|Retreatment: Up to Week 48||291
7978529|NCT00266227|19644458|P3|STARTED|Retreatment: Up to Week 48||0
7978530|NCT00266227|19644459|P2|STARTED|Retreatment: Up to Week 48||157
7978531|NCT00266227|19644460|P1|STARTED|Retreatment: Up to Week 48||318
7978532|NCT00266227|19644458|P3|NOT COMPLETED|Initial Treatment||77
7978533|NCT00266227|19644459|P2|NOT COMPLETED|Initial Treatment||0
7978534|NCT00266227|19644460|P1|NOT COMPLETED|Initial Treatment||0
7978535|NCT00266227|19644458|P3|COMPLETED|Initial Treatment||482
7978536|NCT00266227|19644459|P2|COMPLETED|Initial Treatment||0
7978537|NCT00266227|19644460|P1|COMPLETED|Initial Treatment||0
7978538|NCT00266227|19644458|P3|STARTED|Initial Treatment||559
7978539|NCT00266227|19644459|P2|STARTED|Initial Treatment||0
7978540|NCT00266227|19644460|P1|STARTED|Initial Treatment||0
7978541|NCT00266110|19644505|P1|NOT COMPLETED|Overall Study||7
7978542|NCT00266110|19644505|P1|COMPLETED|Overall Study||10
7978543|NCT00266110|19644505|P1|STARTED|Overall Study||17
7978544|NCT00266032|19644514|P3|NOT COMPLETED|Open-label Safety Extension||25
7978545|NCT00266032|19644515|P2|NOT COMPLETED|Open-label Safety Extension||14
7978546|NCT00266032|19644516|P1|NOT COMPLETED|Open-label Safety Extension||41
7978547|NCT00266032|19644514|P3|COMPLETED|Open-label Safety Extension||140
7978548|NCT00266032|19644515|P2|COMPLETED|Open-label Safety Extension||115
7978549|NCT00266032|19644516|P1|COMPLETED|Open-label Safety Extension||448
7978550|NCT00266032|19644514|P3|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165
7978551|NCT00266032|19644515|P2|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129
7978552|NCT00266032|19644516|P1|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489
7978553|NCT00266032|19644514|P3|NOT COMPLETED|Treatment||47
7978554|NCT00266032|19644515|P2|NOT COMPLETED|Treatment||64
7978555|NCT00266032|19644516|P1|NOT COMPLETED|Treatment||111
7978556|NCT00266032|19644514|P3|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192
7978557|NCT00266032|19644515|P2|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172
7978558|NCT00266032|19644516|P1|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580
7978559|NCT00266032|19644514|P3|Patients Treated and in FAS|Treatment|FAS|216
7978560|NCT00266032|19644515|P2|Patients Treated and in FAS|Treatment|FAS|209
7978561|NCT00266032|19644516|P1|Patients Treated and in FAS|Treatment|FAS|642
7978562|NCT00266032|19644514|P3|Patients Treated|Treatment||229
7978563|NCT00266032|19644515|P2|Patients Treated|Treatment||221
7978564|NCT00266032|19644516|P1|Patients Treated|Treatment||684
7978565|NCT00266032|19644514|P3|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239
7978566|NCT00266032|19644515|P2|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236
7978567|NCT00266032|19644516|P1|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691
7978568|NCT00265980|19644544|P1|NOT COMPLETED|Overall Study||0
7978569|NCT00265980|19644544|P1|COMPLETED|Overall Study||22
7978570|NCT00265980|19644544|P1|Weight -10% Leptin|Overall Study||22
7978571|NCT00265980|19644544|P1|Weight -10% Placebo|Overall Study||22
7978572|NCT00265980|19644544|P1|Weight Initial|Overall Study||22
7978573|NCT00265980|19644544|P1|STARTED|Overall Study||22
7978574|NCT00265941|19644551|P2|NOT COMPLETED|Overall Study||26
7978575|NCT00265941|19644552|P1|NOT COMPLETED|Overall Study||23
7978576|NCT00265941|19644551|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|444
7978577|NCT00265941|19644552|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|447
7978578|NCT00265941|19644551|P2|STARTED|Overall Study||470
7978579|NCT00265941|19644552|P1|STARTED|Overall Study||470
7978580|NCT00265889|19644584|P1|NOT COMPLETED|Overall Study||5
7978581|NCT00265889|19644584|P1|COMPLETED|Overall Study||37
7978582|NCT00265889|19644584|P1|Cycle 2: 2nd Regimen/Transplant|Overall Study||37
7978583|NCT00265889|19644584|P1|Cycle 1: 1st Regimen/Transplant|Overall Study||37
7978584|NCT00265889|19644584|P1|STARTED|Overall Study||42
7978585|NCT00265850|19644593|P3|NOT COMPLETED|Overall Study||0
7978586|NCT00265850|19644594|P2|NOT COMPLETED|Overall Study||0
7978587|NCT00265850|19644595|P1|NOT COMPLETED|Overall Study||0
7978588|NCT00265850|19644593|P3|COMPLETED|Overall Study||533
7978589|NCT00265850|19644594|P2|COMPLETED|Overall Study||902
7978590|NCT00265850|19644595|P1|COMPLETED|Overall Study||899
7978591|NCT00265850|19644593|P3|STARTED|Overall Study||533
7978592|NCT00265850|19644594|P2|STARTED|Overall Study||902
7978593|NCT00265850|19644595|P1|STARTED|Overall Study||899
7978594|NCT00265798|19644605|P1|NOT COMPLETED|Overall Study||0
7978595|NCT00265798|19644605|P1|COMPLETED|Overall Study||38
7978596|NCT00265798|19644605|P1|STARTED|Overall Study||38
7978597|NCT00265785|19644611|P1|NOT COMPLETED|Overall Study||27
7978598|NCT00265785|19644611|P1|COMPLETED|Overall Study||0
7978599|NCT00265785|19644611|P1|Eligible and Began Protocol Treatment|Overall Study||24
7978600|NCT00265785|19644611|P1|Eligible|Overall Study||26
7978601|NCT00265785|19644611|P1|STARTED|Overall Study||27
7978602|NCT00265759|19644624|P4|NOT COMPLETED|Overall Study||9
7978603|NCT00265759|19644625|P3|NOT COMPLETED|Overall Study||2
7978604|NCT00265759|19644626|P2|NOT COMPLETED|Overall Study||1
7978605|NCT00265759|19644627|P1|NOT COMPLETED|Overall Study||0
7978606|NCT00265759|19644624|P4|COMPLETED|Overall Study||236
7978607|NCT00265759|19644625|P3|COMPLETED|Overall Study||123
7978608|NCT00265759|19644626|P2|COMPLETED|Overall Study||127
7978609|NCT00265759|19644627|P1|COMPLETED|Overall Study||124
7978610|NCT00265759|19644624|P4|STARTED|Overall Study||245
7978611|NCT00265759|19644625|P3|STARTED|Overall Study||125
7978612|NCT00265759|19644626|P2|STARTED|Overall Study||128
7978613|NCT00265759|19644627|P1|STARTED|Overall Study||124
7978614|NCT00265616|19644658|P2|NOT COMPLETED|Overall Study||0
7978615|NCT00265616|19644659|P1|NOT COMPLETED|Overall Study||0
7978616|NCT00265616|19644658|P2|COMPLETED|Overall Study||9
7978617|NCT00265616|19644659|P1|COMPLETED|Overall Study||14
7978618|NCT00265616|19644658|P2|STARTED|Overall Study||9
7978619|NCT00265616|19644659|P1|STARTED|Overall Study||14
7978620|NCT00265564|19644677|P2|NOT COMPLETED|Overall Study||9
7978621|NCT00265564|19644678|P1|NOT COMPLETED|Overall Study||10
7978622|NCT00265564|19644677|P2|COMPLETED|Overall Study||49
7978623|NCT00265564|19644678|P1|COMPLETED|Overall Study||49
7978624|NCT00265564|19644677|P2|STARTED|Overall Study||58
7978625|NCT00265564|19644678|P1|STARTED|Overall Study||59
7978626|NCT00265538|19644690|P4|NOT COMPLETED|Overall Study||19
7978627|NCT00265538|19644691|P3|NOT COMPLETED|Overall Study||11
7978628|NCT00265538|19644692|P2|NOT COMPLETED|Overall Study||9
7978629|NCT00265538|19644693|P1|NOT COMPLETED|Overall Study||10
7978630|NCT00265538|19644690|P4|COMPLETED|Overall Study||267
7978631|NCT00265538|19644691|P3|COMPLETED|Overall Study||171
7978632|NCT00265538|19644692|P2|COMPLETED|Overall Study||161
7978633|NCT00265538|19644693|P1|COMPLETED|Overall Study||186
7978634|NCT00265538|19644690|P4|STARTED|Overall Study||286
7978635|NCT00265538|19644691|P3|STARTED|Overall Study||182
7978636|NCT00265538|19644692|P2|STARTED|Overall Study||170
7978637|NCT00265538|19644693|P1|STARTED|Overall Study||196
7978638|NCT00265512|19644707|P2|NOT COMPLETED|Overall Study||95
7978639|NCT00265512|19644708|P1|NOT COMPLETED|Overall Study||45
7978640|NCT00265512|19644707|P2|COMPLETED|Overall Study||359
7978641|NCT00265512|19644708|P1|COMPLETED|Overall Study||168
7978642|NCT00265512|19644707|P2|STARTED|Overall Study||454
7978643|NCT00265512|19644708|P1|STARTED|Overall Study||213
7978644|NCT00265473|19644718|P1|NOT COMPLETED|Overall Study||0
7978645|NCT00265473|19644718|P1|COMPLETED|Overall Study||5
7978646|NCT00265473|19644718|P1|STARTED|Overall Study||5
7978647|NCT00265395|19644728|P2|NOT COMPLETED|Overall Study||17
7978648|NCT00265395|19644729|P1|NOT COMPLETED|Overall Study||8
7978649|NCT00265395|19644728|P2|COMPLETED|Overall Study||56
7978650|NCT00265395|19644729|P1|COMPLETED|Overall Study||78
7978651|NCT00265395|19644728|P2|STARTED|Overall Study||73
7978652|NCT00265395|19644729|P1|STARTED|Overall Study||86
7978653|NCT00265382|19644734|P1|NOT COMPLETED|Overall Study||145
7978654|NCT00265382|19644734|P1|COMPLETED|Overall Study||76
7978655|NCT00265382|19644734|P1|STARTED|Overall Study||221
7978656|NCT00265343|19644754|P2|NOT COMPLETED|Overall Study||19
7978657|NCT00265343|19644755|P1|NOT COMPLETED|Overall Study||21
7978658|NCT00265343|19644754|P2|COMPLETED|Overall Study||153
7978659|NCT00265343|19644755|P1|COMPLETED|Overall Study||113
7978660|NCT00265343|19644754|P2|STARTED|Overall Study||172
7978661|NCT00265343|19644755|P1|STARTED|Overall Study||134
7978662|NCT00265330|19644763|P1|NOT COMPLETED|Overall Study||95
7978663|NCT00265330|19644763|P1|COMPLETED|Overall Study||67
7978664|NCT00265330|19644763|P1|STARTED|Overall Study||162
7978665|NCT00265317|19644789|P4|NOT COMPLETED|Phase 2||65
7978666|NCT00265317|19644790|P3|NOT COMPLETED|Phase 2||64
7978667|NCT00265317|19644791|P2|NOT COMPLETED|Phase 2||0
7978668|NCT00265317|19644792|P1|NOT COMPLETED|Phase 2||0
7978669|NCT00265317|19644789|P4|COMPLETED|Phase 2||2
7978670|NCT00265317|19644790|P3|COMPLETED|Phase 2||1
7978671|NCT00265317|19644791|P2|COMPLETED|Phase 2||0
7978672|NCT00265317|19644792|P1|COMPLETED|Phase 2||0
7978673|NCT00265317|19644789|P4|STARTED|Phase 2||67
7978674|NCT00265317|19644790|P3|STARTED|Phase 2||65
7978675|NCT00265317|19644791|P2|STARTED|Phase 2||0
7978676|NCT00265317|19644792|P1|STARTED|Phase 2||0
7978677|NCT00265317|19644789|P4|NOT COMPLETED|Lead-In||0
7978678|NCT00265317|19644790|P3|NOT COMPLETED|Lead-In||0
7978679|NCT00265317|19644791|P2|NOT COMPLETED|Lead-In||17
7978680|NCT00265317|19644792|P1|NOT COMPLETED|Lead-In||12
7978681|NCT00265317|19644789|P4|COMPLETED|Lead-In||0
7978682|NCT00265317|19644790|P3|COMPLETED|Lead-In||0
7978683|NCT00265317|19644791|P2|COMPLETED|Lead-In||0
7978684|NCT00265317|19644792|P1|COMPLETED|Lead-In||1
7978685|NCT00265317|19644789|P4|STARTED|Lead-In||0
7978686|NCT00265317|19644790|P3|STARTED|Lead-In||0
7978687|NCT00265317|19644791|P2|STARTED|Lead-In||17
7978688|NCT00265317|19644792|P1|STARTED|Lead-In||13
7978689|NCT00265239|19644907|P2|NOT COMPLETED|Overall Study||1
7978690|NCT00265239|19644908|P1|NOT COMPLETED|Overall Study||2
7978691|NCT00265239|19644907|P2|COMPLETED|Overall Study||51
7978692|NCT00265239|19644908|P1|COMPLETED|Overall Study||50
7978693|NCT00265239|19644907|P2|STARTED|Overall Study||52
7978694|NCT00265239|19644908|P1|STARTED|Overall Study||52
7978695|NCT00265200|19644920|P1|NOT COMPLETED|Overall Study||4
7978696|NCT00265200|19644920|P1|COMPLETED|Overall Study||24
7978697|NCT00265200|19644920|P1|STARTED|Overall Study||28
7978698|NCT00265148|19644926|P2|NOT COMPLETED|Overall Study||9
7978699|NCT00265148|19644927|P1|NOT COMPLETED|Overall Study||9
7978700|NCT00265148|19644926|P2|COMPLETED|Overall Study||31
7978701|NCT00265148|19644927|P1|COMPLETED|Overall Study||31
7978702|NCT00265148|19644926|P2|STARTED|Overall Study||40
7978703|NCT00265148|19644927|P1|STARTED|Overall Study||40
7978704|NCT00265122|19644991|P6|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
7978705|NCT00265122|19644992|P5|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5
7978706|NCT00265122|19644993|P4|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
7978707|NCT00265122|19644994|P3|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
7978708|NCT00265122|19644995|P2|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
7978709|NCT00265122|19644996|P1|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7
7978710|NCT00265122|19644991|P6|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12
7978711|NCT00265122|19644992|P5|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8
7978712|NCT00265122|19644993|P4|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20
7978713|NCT00265122|19644994|P3|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18
7978714|NCT00265122|19644995|P2|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22
7978715|NCT00265122|19644996|P1|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17
7978716|NCT00265122|19644991|P6|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
7978717|NCT00265122|19644992|P5|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
7978718|NCT00265122|19644993|P4|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
7978719|NCT00265122|19644994|P3|STARTED|Intervention Period 2 (Weeks 8 to 28):||22
7978720|NCT00265122|19644995|P2|STARTED|Intervention Period 2 (Weeks 8 to 28):||23
7978721|NCT00265122|19644996|P1|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
7978722|NCT00265122|19644991|P6|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0
7978723|NCT00265122|19644992|P5|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1
7978724|NCT00265122|19644993|P4|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
7978725|NCT00265122|19644994|P3|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5
7978726|NCT00265122|19644995|P2|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
7978727|NCT00265122|19644996|P1|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
7978728|NCT00265122|19644991|P6|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
7978729|NCT00265122|19644992|P5|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
7978730|NCT00265122|19644993|P4|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
7978731|NCT00265122|19644994|P3|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22
7978732|NCT00265122|19644995|P2|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23
7978733|NCT00265122|19644996|P1|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
7978734|NCT00265122|19644991|P6|STARTED|Intervention Period 1 (Weeks 0 to 8):||13
7978735|NCT00265122|19644992|P5|STARTED|Intervention Period 1 (Weeks 0 to 8):||14
7978736|NCT00265122|19644993|P4|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
7978737|NCT00265122|19644994|P3|STARTED|Intervention Period 1 (Weeks 0 to 8):||27
7978738|NCT00265122|19644995|P2|STARTED|Intervention Period 1 (Weeks 0 to 8):||25
7978739|NCT00265122|19644996|P1|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
7978740|NCT00265109|19645018|P1|NOT COMPLETED|Overall Study||6
7978741|NCT00265109|19645018|P1|COMPLETED|Overall Study||11
7978742|NCT00265109|19645018|P1|STARTED|Overall Study||17
7978743|NCT00265096|19645037|P3|NOT COMPLETED|Overall Study||39
7978744|NCT00265096|19645038|P2|NOT COMPLETED|Overall Study||51
7978745|NCT00265096|19645039|P1|NOT COMPLETED|Overall Study||36
7978746|NCT00265096|19645037|P3|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107
7978747|NCT00265096|19645038|P2|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95
7978748|NCT00265096|19645039|P1|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77
7978749|NCT00265096|19645037|P3|STARTED|Overall Study||146
7978750|NCT00265096|19645038|P2|STARTED|Overall Study||146
7978751|NCT00265096|19645039|P1|STARTED|Overall Study||113
7978752|NCT00265083|19645071|P3|NOT COMPLETED|Overall Study||42
7978753|NCT00265083|19645072|P2|NOT COMPLETED|Overall Study||42
7978754|NCT00265083|19645073|P1|NOT COMPLETED|Overall Study||17
7978755|NCT00265083|19645071|P3|COMPLETED|Overall Study||98
7978756|NCT00265083|19645072|P2|COMPLETED|Overall Study|One patient did not receive study agent.|96
7978757|NCT00265083|19645073|P1|COMPLETED|Overall Study||61
7978758|NCT00265083|19645071|P3|STARTED|Overall Study||140
7978759|NCT00265083|19645072|P2|STARTED|Overall Study|One patient did not receive study agent.|138
7978760|NCT00265083|19645073|P1|STARTED|Overall Study||78
7978761|NCT00264875|19645094|P1|NOT COMPLETED|Overall Study||30
7978762|NCT00264875|19645094|P1|COMPLETED|Overall Study||190
7978763|NCT00264875|19645094|P1|STARTED|Overall Study||220
7978764|NCT00264849|19645100|P2|NOT COMPLETED|Overall Study||25
7978765|NCT00264849|19645101|P1|NOT COMPLETED|Overall Study||22
7978766|NCT00264849|19645100|P2|COMPLETED|Overall Study||106
7978767|NCT00264849|19645101|P1|COMPLETED|Overall Study||253
7978768|NCT00264849|19645100|P2|STARTED|Overall Study||131
7978769|NCT00264849|19645101|P1|STARTED|Overall Study||275
7978770|NCT00264810|19645135|P2|NOT COMPLETED|Open Label Evaluation Period||6
7978771|NCT00264810|19645136|P1|NOT COMPLETED|Open Label Evaluation Period||6
7978772|NCT00264810|19645135|P2|COMPLETED|Open Label Evaluation Period||86
7978773|NCT00264810|19645136|P1|COMPLETED|Open Label Evaluation Period||89
7978774|NCT00264810|19645135|P2|1-year Post-implant|Open Label Evaluation Period||90
7978775|NCT00264810|19645136|P1|1-year Post-implant|Open Label Evaluation Period||92
7978776|NCT00264810|19645135|P2|STARTED|Open Label Evaluation Period||92
7978777|NCT00264810|19645136|P1|STARTED|Open Label Evaluation Period||95
7978778|NCT00264810|19645135|P2|NOT COMPLETED|Blinded Evaluation Period||1
7978779|NCT00264810|19645136|P1|NOT COMPLETED|Blinded Evaluation Period||1
7978780|NCT00264810|19645135|P2|COMPLETED|Blinded Evaluation Period||92
7978781|NCT00264810|19645136|P1|COMPLETED|Blinded Evaluation Period||95
7978782|NCT00264810|19645135|P2|STARTED|Blinded Evaluation Period||93
7978783|NCT00264810|19645136|P1|STARTED|Blinded Evaluation Period||96
7978784|NCT00264810|19645135|P2|NOT COMPLETED|Stimulation Optimization Period||1
7978785|NCT00264810|19645136|P1|NOT COMPLETED|Stimulation Optimization Period||1
7978786|NCT00264810|19645135|P2|COMPLETED|Stimulation Optimization Period||93
7978787|NCT00264810|19645136|P1|COMPLETED|Stimulation Optimization Period||96
7978788|NCT00264810|19645135|P2|STARTED|Stimulation Optimization Period||94
7978789|NCT00264810|19645136|P1|STARTED|Stimulation Optimization Period||97
7978790|NCT00264810|19645135|P2|NOT COMPLETED|Post-Operative Stabilization Period||0
7978791|NCT00264810|19645136|P1|NOT COMPLETED|Post-Operative Stabilization Period||0
7978792|NCT00264810|19645135|P2|COMPLETED|Post-Operative Stabilization Period||94
7978793|NCT00264810|19645136|P1|COMPLETED|Post-Operative Stabilization Period||97
7978794|NCT00264810|19645135|P2|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
7978795|NCT00264810|19645136|P1|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
7978796|NCT00264810|19645135|P2|NOT COMPLETED|Baseline||26
7978797|NCT00264810|19645136|P1|NOT COMPLETED|Baseline||23
7978798|NCT00264810|19645135|P2|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
7978799|NCT00264810|19645136|P1|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
7978800|NCT00264810|19645135|P2|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
7978801|NCT00264810|19645136|P1|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
7978802|NCT00264797|19645146|P2|NOT COMPLETED|Overall Study||43
7978803|NCT00264797|19645147|P1|NOT COMPLETED|Overall Study||33
7978804|NCT00264797|19645146|P2|COMPLETED|Overall Study||109
7978805|NCT00264797|19645147|P1|COMPLETED|Overall Study||118
7978806|NCT00264797|19645146|P2|STARTED|Overall Study||152
7978807|NCT00264797|19645147|P1|STARTED|Overall Study||151
7978808|NCT00264641|19645161|P2|NOT COMPLETED|Overall Study||0
7978809|NCT00264641|19645162|P1|NOT COMPLETED|Overall Study||0
7978810|NCT00264641|19645161|P2|COMPLETED|Overall Study||10
7978811|NCT00264641|19645162|P1|COMPLETED|Overall Study||10
7978812|NCT00264641|19645161|P2|Initiation of the Study|Overall Study||10
7978813|NCT00264641|19645162|P1|Initiation of the Study|Overall Study||10
7978814|NCT00264641|19645161|P2|STARTED|Overall Study||10
7978815|NCT00264641|19645162|P1|STARTED|Overall Study||10
7978816|NCT00264576|19645169|P2|NOT COMPLETED|Overall Study||1
7978817|NCT00264576|19645170|P1|NOT COMPLETED|Overall Study||1
7978818|NCT00264576|19645169|P2|COMPLETED|Overall Study||304
7978819|NCT00264576|19645170|P1|COMPLETED|Overall Study||307
7978820|NCT00264576|19645169|P2|STARTED|Overall Study||305
7978821|NCT00264576|19645170|P1|STARTED|Overall Study||308
7978822|NCT00264550|19645194|P4|NOT COMPLETED|Overall Study||30
7978823|NCT00264550|19645195|P3|NOT COMPLETED|Overall Study||17
7978824|NCT00264550|19645196|P2|NOT COMPLETED|Overall Study||41
7978825|NCT00264550|19645197|P1|NOT COMPLETED|Overall Study||43
7978826|NCT00264550|19645194|P4|COMPLETED|Overall Study||59
7978827|NCT00264550|19645195|P3|COMPLETED|Overall Study||72
7978828|NCT00264550|19645196|P2|COMPLETED|Overall Study||92
7978829|NCT00264550|19645197|P1|COMPLETED|Overall Study||90
7978830|NCT00264550|19645194|P4|STARTED|Overall Study||89
7978831|NCT00264550|19645195|P3|STARTED|Overall Study||89
7978832|NCT00264550|19645196|P2|STARTED|Overall Study||133
7978833|NCT00264550|19645197|P1|STARTED|Overall Study||133
7978834|NCT00264537|19645236|P4|NOT COMPLETED|Overall Study||60
7978835|NCT00264537|19645237|P3|NOT COMPLETED|Overall Study||50
7978836|NCT00264537|19645238|P2|NOT COMPLETED|Overall Study||58
7978837|NCT00264537|19645239|P1|NOT COMPLETED|Overall Study||50
7978838|NCT00264537|19645236|P4|COMPLETED|Overall Study||99
7978839|NCT00264537|19645237|P3|COMPLETED|Overall Study||109
7978840|NCT00264537|19645238|P2|COMPLETED|Overall Study||101
7978841|NCT00264537|19645239|P1|COMPLETED|Overall Study||110
7978842|NCT00264537|19645236|P4|STARTED|Overall Study||159
7978843|NCT00264537|19645237|P3|STARTED|Overall Study||159
7978844|NCT00264537|19645238|P2|STARTED|Overall Study||159
7978845|NCT00264537|19645239|P1|STARTED|Overall Study||160
7978846|NCT00264498|19645271|P2|NOT COMPLETED|Crossover Treatment||9
7978847|NCT00264498|19645272|P1|NOT COMPLETED|Crossover Treatment||6
7978848|NCT00264498|19645271|P2|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
7978849|NCT00264498|19645272|P1|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
7978850|NCT00264498|19645271|P2|STARTED|Crossover Treatment||9
7978851|NCT00264498|19645272|P1|STARTED|Crossover Treatment||6
7978852|NCT00264498|19645271|P2|NOT COMPLETED|Randomized Treatment||18
7978853|NCT00264498|19645272|P1|NOT COMPLETED|Randomized Treatment||17
7978854|NCT00264498|19645271|P2|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
7978855|NCT00264498|19645272|P1|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
7978856|NCT00264498|19645271|P2|STARTED|Randomized Treatment||18
7978857|NCT00264498|19645272|P1|STARTED|Randomized Treatment||17
7978858|NCT00264381|19645280|P2|NOT COMPLETED|Overall Study||0
7978859|NCT00264381|19645281|P1|NOT COMPLETED|Overall Study||0
7978860|NCT00264381|19645280|P2|COMPLETED|Overall Study||37
7978861|NCT00264381|19645281|P1|COMPLETED|Overall Study||35
7978862|NCT00264381|19645280|P2|STARTED|Overall Study||37
7978863|NCT00264381|19645281|P1|STARTED|Overall Study||35
7978864|NCT00264303|19645295|P2|NOT COMPLETED|Overall Study||29
7978865|NCT00264303|19645296|P1|NOT COMPLETED|Overall Study||25
7978866|NCT00264303|19645295|P2|COMPLETED|Overall Study||419
7978867|NCT00264303|19645296|P1|COMPLETED|Overall Study||413
7978868|NCT00264303|19645295|P2|STARTED|Overall Study||448
7978869|NCT00264303|19645296|P1|STARTED|Overall Study||438
7978870|NCT00264290|19645314|P2|NOT COMPLETED|Observation (4 Weeks)||0
7978871|NCT00264290|19645315|P1|NOT COMPLETED|Observation (4 Weeks)||0
7978872|NCT00264290|19645314|P2|COMPLETED|Observation (4 Weeks)||14
7978873|NCT00264290|19645315|P1|COMPLETED|Observation (4 Weeks)||15
7978874|NCT00264290|19645314|P2|STARTED|Observation (4 Weeks)||14
7978875|NCT00264290|19645315|P1|STARTED|Observation (4 Weeks)||15
7978876|NCT00264290|19645314|P2|NOT COMPLETED|Intervention (8 Weeks)||0
7978877|NCT00264290|19645315|P1|NOT COMPLETED|Intervention (8 Weeks)||1
7978878|NCT00264290|19645314|P2|COMPLETED|Intervention (8 Weeks)||14
7978879|NCT00264290|19645315|P1|COMPLETED|Intervention (8 Weeks)||15
7978880|NCT00264290|19645314|P2|STARTED|Intervention (8 Weeks)||14
7978881|NCT00264290|19645315|P1|STARTED|Intervention (8 Weeks)||16
7978882|NCT00264238|19645331|P1|NOT COMPLETED|Overall Study||1
7978883|NCT00264238|19645331|P1|COMPLETED|Overall Study||14
7978884|NCT00264238|19645331|P1|STARTED|Overall Study||15
7978885|NCT00264147|19645343|P6|NOT COMPLETED|Treatment II Period||33
7978886|NCT00264147|19645344|P5|NOT COMPLETED|Treatment II Period||33
7978887|NCT00264147|19645345|P4|NOT COMPLETED|Treatment II Period||0
7978888|NCT00264147|19645346|P3|NOT COMPLETED|Treatment II Period||0
7978889|NCT00264147|19645347|P2|NOT COMPLETED|Treatment II Period||0
7978890|NCT00264147|19645348|P1|NOT COMPLETED|Treatment II Period||0
7978891|NCT00264147|19645343|P6|COMPLETED|Treatment II Period||116
7978892|NCT00264147|19645344|P5|COMPLETED|Treatment II Period||147
7978893|NCT00264147|19645345|P4|COMPLETED|Treatment II Period||0
7978894|NCT00264147|19645346|P3|COMPLETED|Treatment II Period||0
7978895|NCT00264147|19645347|P2|COMPLETED|Treatment II Period||0
7978896|NCT00264147|19645348|P1|COMPLETED|Treatment II Period||0
7978897|NCT00264147|19645343|P6|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149
7978898|NCT00264147|19645344|P5|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180
7978899|NCT00264147|19645345|P4|STARTED|Treatment II Period||0
7978900|NCT00264147|19645346|P3|STARTED|Treatment II Period||0
7978901|NCT00264147|19645347|P2|STARTED|Treatment II Period||0
7978902|NCT00264147|19645348|P1|STARTED|Treatment II Period||0
7978903|NCT00264147|19645343|P6|NOT COMPLETED|Treatment I Period||0
7978904|NCT00264147|19645344|P5|NOT COMPLETED|Treatment I Period||56
7978905|NCT00264147|19645345|P4|NOT COMPLETED|Treatment I Period||72
7978906|NCT00264147|19645346|P3|NOT COMPLETED|Treatment I Period||77
7978907|NCT00264147|19645347|P2|NOT COMPLETED|Treatment I Period||83
7978908|NCT00264147|19645348|P1|NOT COMPLETED|Treatment I Period||98
7978909|NCT00264147|19645343|P6|COMPLETED|Treatment I Period||0
7978910|NCT00264147|19645344|P5|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99
7978911|NCT00264147|19645345|P4|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68
7978912|NCT00264147|19645346|P3|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74
7978913|NCT00264147|19645347|P2|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71
7978914|NCT00264147|19645348|P1|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63
7978915|NCT00264147|19645343|P6|STARTED|Treatment I Period||0
7978916|NCT00264147|19645344|P5|STARTED|Treatment I Period||155
7978917|NCT00264147|19645345|P4|STARTED|Treatment I Period||140
7978918|NCT00264147|19645346|P3|STARTED|Treatment I Period||151
7978919|NCT00264147|19645347|P2|STARTED|Treatment I Period||154
7978920|NCT00264147|19645348|P1|STARTED|Treatment I Period||161
7978921|NCT00264004|19645391|P4|NOT COMPLETED|Overall Study||15
7978922|NCT00264004|19645392|P3|NOT COMPLETED|Overall Study||14
7978923|NCT00264004|19645393|P2|NOT COMPLETED|Overall Study||11
7978924|NCT00264004|19645394|P1|NOT COMPLETED|Overall Study||17
7978925|NCT00264004|19645391|P4|COMPLETED|Overall Study|Completed 12 weeks treatment|19
7978926|NCT00264004|19645392|P3|COMPLETED|Overall Study|Completed 12 weeks treatment|16
7978927|NCT00264004|19645393|P2|COMPLETED|Overall Study|Completed 12 weeks treatment|21
7978928|NCT00264004|19645394|P1|COMPLETED|Overall Study|Completed 12 weeks treatment|13
7978929|NCT00264004|19645391|P4|STARTED|Overall Study|Randomised|34
7978930|NCT00264004|19645392|P3|STARTED|Overall Study|Randomised|30
7978931|NCT00264004|19645393|P2|STARTED|Overall Study|Randomised|32
7978932|NCT00264004|19645394|P1|STARTED|Overall Study|Randomised|30
7978933|NCT00263887|19645422|P2|NOT COMPLETED|Overall Study||7
7978934|NCT00263887|19645423|P1|NOT COMPLETED|Overall Study||3
7978935|NCT00263887|19645422|P2|COMPLETED|Overall Study||32
7978936|NCT00263887|19645423|P1|COMPLETED|Overall Study||35
7978937|NCT00263887|19645422|P2|STARTED|Overall Study||39
7978938|NCT00263887|19645423|P1|STARTED|Overall Study||38
7978939|NCT00263757|19645431|P2|NOT COMPLETED|Overall Study||8
7978940|NCT00263757|19645432|P1|NOT COMPLETED|Overall Study||8
7978941|NCT00263757|19645431|P2|COMPLETED|Overall Study||5
7978942|NCT00263757|19645432|P1|COMPLETED|Overall Study||4
7978943|NCT00263757|19645431|P2|STARTED|Overall Study||13
7978944|NCT00263757|19645432|P1|STARTED|Overall Study||12
7978945|NCT00263666|19645444|P2|NOT COMPLETED|Overall Study||11
7978946|NCT00263666|19645445|P1|NOT COMPLETED|Overall Study||7
7978947|NCT00263666|19645444|P2|COMPLETED|Overall Study||39
7978948|NCT00263666|19645445|P1|COMPLETED|Overall Study||43
7978949|NCT00263666|19645444|P2|STARTED|Overall Study||50
7978950|NCT00263666|19645445|P1|STARTED|Overall Study||50
7978951|NCT00263588|19645498|P2|NOT COMPLETED|Overall Study||132
7978952|NCT00263588|19645499|P1|NOT COMPLETED|Overall Study||81
7978953|NCT00263588|19645498|P2|COMPLETED|Overall Study||15
7978954|NCT00263588|19645499|P1|COMPLETED|Overall Study||14
7978955|NCT00263588|19645498|P2|STARTED|Overall Study||147
7978956|NCT00263588|19645499|P1|STARTED|Overall Study||95
7978957|NCT00263575|19645522|P1|NOT COMPLETED|Maintence Period||77
7978958|NCT00263575|19645522|P1|COMPLETED|Maintence Period||19
7978959|NCT00263575|19645522|P1|STARTED|Maintence Period||96
7978960|NCT00263575|19645522|P1|NOT COMPLETED|Titration Period||43
7978961|NCT00263575|19645522|P1|COMPLETED|Titration Period||96
7978962|NCT00263575|19645522|P1|STARTED|Titration Period||139
7978963|NCT00263562|19645530|P2|NOT COMPLETED|Overall Study||0
7978964|NCT00263562|19645531|P1|NOT COMPLETED|Overall Study||3
7978965|NCT00263562|19645530|P2|COMPLETED|Overall Study||9
7978966|NCT00263562|19645531|P1|COMPLETED|Overall Study||6
7978967|NCT00263562|19645530|P2|STARTED|Overall Study||9
7978968|NCT00263562|19645531|P1|STARTED|Overall Study||9
7978969|NCT00263328|19645548|P3|NOT COMPLETED|Overall Study||7
7978970|NCT00263328|19645549|P2|NOT COMPLETED|Overall Study||2
7978971|NCT00263328|19645550|P1|NOT COMPLETED|Overall Study||8
7978972|NCT00263328|19645548|P3|COMPLETED|Overall Study||6
7978973|NCT00263328|19645549|P2|COMPLETED|Overall Study||12
7978974|NCT00263328|19645550|P1|COMPLETED|Overall Study||10
7978975|NCT00263328|19645548|P3|STARTED|Overall Study||13
7978976|NCT00263328|19645549|P2|STARTED|Overall Study||14
7978977|NCT00263328|19645550|P1|STARTED|Overall Study||18
7978978|NCT00263211|19645708|P2|NOT COMPLETED|Overall Study||1
7978979|NCT00263211|19645709|P1|NOT COMPLETED|Overall Study||5
7978980|NCT00263211|19645708|P2|COMPLETED|Overall Study||23
7978981|NCT00263211|19645709|P1|COMPLETED|Overall Study||19
7978982|NCT00263211|19645708|P2|STARTED|Overall Study||24
7978983|NCT00263211|19645709|P1|STARTED|Overall Study||24
7978984|NCT00262964|19645727|P4|NOT COMPLETED|Overall Study||0
7978985|NCT00262964|19645728|P3|NOT COMPLETED|Overall Study||0
7978986|NCT00262964|19645729|P2|NOT COMPLETED|Overall Study||0
7978987|NCT00262964|19645730|P1|NOT COMPLETED|Overall Study||0
7978988|NCT00262964|19645727|P4|COMPLETED|Overall Study||12
7978989|NCT00262964|19645728|P3|COMPLETED|Overall Study||17
7978990|NCT00262964|19645729|P2|COMPLETED|Overall Study||11
7978991|NCT00262964|19645730|P1|COMPLETED|Overall Study||11
7978992|NCT00262964|19645727|P4|STARTED|Overall Study||12
7978993|NCT00262964|19645728|P3|STARTED|Overall Study||17
7978994|NCT00262964|19645729|P2|STARTED|Overall Study||11
7978995|NCT00262964|19645730|P1|STARTED|Overall Study||11
7978996|NCT00262951|19645760|P1|NOT COMPLETED|Overall Study||16
7978997|NCT00262951|19645760|P1|COMPLETED|Overall Study||7
7978998|NCT00262951|19645760|P1|STARTED|Overall Study||23
7978999|NCT00262925|19645765|P1|NOT COMPLETED|Overall Study||11
7979000|NCT00262925|19645765|P1|COMPLETED|Overall Study||1
7979001|NCT00262925|19645765|P1|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12
7979002|NCT00262873|19645771|P1|NOT COMPLETED|Overall Study||8
7979003|NCT00262873|19645771|P1|COMPLETED|Overall Study||0
7979004|NCT00262873|19645771|P1|STARTED|Overall Study||8
7979005|NCT00262860|19645782|P1|NOT COMPLETED|Overall Study||2
7979006|NCT00262860|19645782|P1|COMPLETED|Overall Study||16
7979007|NCT00262860|19645782|P1|STARTED|Overall Study||18
7979008|NCT00262847|19645791|P3|NOT COMPLETED|Overall Study||396
7979009|NCT00262847|19645792|P2|NOT COMPLETED|Overall Study||513
7979010|NCT00262847|19645793|P1|NOT COMPLETED|Overall Study||518
7979011|NCT00262847|19645791|P3|COMPLETED|Overall Study||227
7979012|NCT00262847|19645792|P2|COMPLETED|Overall Study||112
7979013|NCT00262847|19645793|P1|COMPLETED|Overall Study||107
7979014|NCT00262847|19645791|P3|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623
7979015|NCT00262847|19645792|P2|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
7979016|NCT00262847|19645793|P1|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
7979017|NCT00262834|19645812|P2|NOT COMPLETED|Overall Study||4
7979018|NCT00262834|19645813|P1|NOT COMPLETED|Overall Study||1
7979019|NCT00262834|19645812|P2|COMPLETED|Overall Study||25
7979020|NCT00262834|19645813|P1|COMPLETED|Overall Study||24
7979021|NCT00262834|19645812|P2|STARTED|Overall Study||29
7979022|NCT00262834|19645813|P1|STARTED|Overall Study||25
7979023|NCT00262821|19645826|P2|NOT COMPLETED|Overall Study||19
7979024|NCT00262821|19645827|P1|NOT COMPLETED|Overall Study||4
7979025|NCT00262821|19645826|P2|COMPLETED|Overall Study||185
7979026|NCT00262821|19645827|P1|COMPLETED|Overall Study||194
7979027|NCT00262821|19645826|P2|STARTED|Overall Study||204
7979028|NCT00262821|19645827|P1|STARTED|Overall Study||198
7979029|NCT00262743|19645839|P2|NOT COMPLETED|Overall Study||12
7979030|NCT00262743|19645840|P1|NOT COMPLETED|Overall Study||0
7979031|NCT00262743|19645839|P2|COMPLETED|Overall Study||30
7979032|NCT00262743|19645840|P1|COMPLETED|Overall Study||27
7979033|NCT00262743|19645839|P2|STARTED|Overall Study||42
7979034|NCT00262743|19645840|P1|STARTED|Overall Study||27
7979035|NCT00262730|19645847|P1|NOT COMPLETED|Overall Study||0
7979036|NCT00262730|19645847|P1|COMPLETED|Overall Study||97
7979037|NCT00262730|19645847|P1|STARTED|Overall Study||97
7979038|NCT00262639|19645855|P4|NOT COMPLETED|Overall Study||0
7979039|NCT00262639|19645856|P3|NOT COMPLETED|Overall Study||0
7979040|NCT00262639|19645857|P2|NOT COMPLETED|Overall Study||0
7979041|NCT00262639|19645858|P1|NOT COMPLETED|Overall Study||0
7979042|NCT00262639|19645855|P4|COMPLETED|Overall Study||7
7979043|NCT00262639|19645856|P3|COMPLETED|Overall Study||9
7979044|NCT00262639|19645857|P2|COMPLETED|Overall Study||26
7979045|NCT00262639|19645858|P1|COMPLETED|Overall Study||18
7979046|NCT00262639|19645855|P4|STARTED|Overall Study||7
7979047|NCT00262639|19645856|P3|STARTED|Overall Study||9
7979048|NCT00262639|19645857|P2|STARTED|Overall Study||26
7979049|NCT00262639|19645858|P1|STARTED|Overall Study||18
7979050|NCT00262600|19645875|P3|NOT COMPLETED|Overall Study||266
7979051|NCT00262600|19645876|P2|NOT COMPLETED|Overall Study||252
7979052|NCT00262600|19645877|P1|NOT COMPLETED|Overall Study||235
7979053|NCT00262600|19645875|P3|COMPLETED|Overall Study||5756
7979054|NCT00262600|19645876|P2|COMPLETED|Overall Study||5824
7979055|NCT00262600|19645877|P1|COMPLETED|Overall Study||5780
7979056|NCT00262600|19645875|P3|STARTED|Overall Study||6022
7979057|NCT00262600|19645876|P2|STARTED|Overall Study||6076
7979058|NCT00262600|19645877|P1|STARTED|Overall Study||6015
7979059|NCT00262522|19645904|P4|NOT COMPLETED|Study Start Through 96 Weeks||0
7979060|NCT00262522|19645905|P3|NOT COMPLETED|Study Start Through 96 Weeks||77
7979061|NCT00262522|19645906|P2|NOT COMPLETED|Study Start Through 96 Weeks||0
7979062|NCT00262522|19645907|P1|NOT COMPLETED|Study Start Through 96 Weeks||77
7979063|NCT00262522|19645904|P4|COMPLETED|Study Start Through 96 Weeks||0
7979064|NCT00262522|19645905|P3|COMPLETED|Study Start Through 96 Weeks||254
7979065|NCT00262522|19645906|P2|COMPLETED|Study Start Through 96 Weeks||0
7979066|NCT00262522|19645907|P1|COMPLETED|Study Start Through 96 Weeks||256
7979067|NCT00262522|19645904|P4|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
7979068|NCT00262522|19645905|P3|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331
7979069|NCT00262522|19645906|P2|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
7979070|NCT00262522|19645907|P1|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333
7979071|NCT00262522|19645904|P4|NOT COMPLETED|Study Start Through 48 Weeks||0
7979072|NCT00262522|19645905|P3|NOT COMPLETED|Study Start Through 48 Weeks||55
7979073|NCT00262522|19645906|P2|NOT COMPLETED|Study Start Through 48 Weeks||0
7979074|NCT00262522|19645907|P1|NOT COMPLETED|Study Start Through 48 Weeks||49
7979075|NCT00262522|19645904|P4|COMPLETED|Study Start Through 48 Weeks||0
7979076|NCT00262522|19645905|P3|COMPLETED|Study Start Through 48 Weeks||276
7979077|NCT00262522|19645906|P2|COMPLETED|Study Start Through 48 Weeks||0
7979078|NCT00262522|19645907|P1|COMPLETED|Study Start Through 48 Weeks||284
7979079|NCT00262522|19645904|P4|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
7979080|NCT00262522|19645905|P3|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331
7979081|NCT00262522|19645906|P2|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
7979082|NCT00262522|19645907|P1|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333
7979083|NCT00262522|19645904|P4|NOT COMPLETED|Study Start Through 8 Weeks||5
7979084|NCT00262522|19645905|P3|NOT COMPLETED|Study Start Through 8 Weeks||11
7979085|NCT00262522|19645906|P2|NOT COMPLETED|Study Start Through 8 Weeks||5
7979086|NCT00262522|19645907|P1|NOT COMPLETED|Study Start Through 8 Weeks||4
7979087|NCT00262522|19645904|P4|COMPLETED|Study Start Through 8 Weeks||160
7979088|NCT00262522|19645905|P3|COMPLETED|Study Start Through 8 Weeks||155
7979089|NCT00262522|19645906|P2|COMPLETED|Study Start Through 8 Weeks||161
7979090|NCT00262522|19645907|P1|COMPLETED|Study Start Through 8 Weeks||163
7979091|NCT00262522|19645904|P4|STARTED|Study Start Through 8 Weeks||165
7979092|NCT00262522|19645905|P3|STARTED|Study Start Through 8 Weeks||166
7979093|NCT00262522|19645906|P2|STARTED|Study Start Through 8 Weeks||166
7979094|NCT00262522|19645907|P1|STARTED|Study Start Through 8 Weeks||167
7979095|NCT00262509|19645929|P2|NOT COMPLETED|Overall Study||0
7979096|NCT00262509|19645930|P1|NOT COMPLETED|Overall Study||0
7979097|NCT00262509|19645929|P2|COMPLETED|Overall Study||9
7979098|NCT00262509|19645930|P1|COMPLETED|Overall Study||8
7979099|NCT00262509|19645929|P2|STARTED|Overall Study||9
7979100|NCT00262509|19645930|P1|STARTED|Overall Study||8
7979101|NCT00262314|19645936|P1|NOT COMPLETED|Overall Study||337
7979102|NCT00262314|19645936|P1|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172
7979103|NCT00262314|19645936|P1|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509
7979104|NCT00262301|19645954|P3|NOT COMPLETED|Open-label Phase||0
7979105|NCT00262301|19645955|P2|NOT COMPLETED|Open-label Phase||0
7979106|NCT00262301|19645956|P1|NOT COMPLETED|Open-label Phase||0
7979107|NCT00262301|19645954|P3|COMPLETED|Open-label Phase||57
7979108|NCT00262301|19645955|P2|COMPLETED|Open-label Phase||0
7979109|NCT00262301|19645956|P1|COMPLETED|Open-label Phase||0
7979110|NCT00262301|19645954|P3|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57
7979111|NCT00262301|19645955|P2|STARTED|Open-label Phase||0
7979112|NCT00262301|19645956|P1|STARTED|Open-label Phase||0
7979113|NCT00262301|19645954|P3|NOT COMPLETED|Double-blind Phase||0
7979114|NCT00262301|19645955|P2|NOT COMPLETED|Double-blind Phase||1
7979115|NCT00262301|19645956|P1|NOT COMPLETED|Double-blind Phase||1
7979116|NCT00262301|19645954|P3|COMPLETED|Double-blind Phase||0
7979117|NCT00262301|19645955|P2|COMPLETED|Double-blind Phase||15
7979118|NCT00262301|19645956|P1|COMPLETED|Double-blind Phase||15
7979119|NCT00262301|19645954|P3|STARTED|Double-blind Phase||0
7979120|NCT00262301|19645955|P2|STARTED|Double-blind Phase||16
7979121|NCT00262301|19645956|P1|STARTED|Double-blind Phase||16
7979122|NCT00262223|19645969|P2|NOT COMPLETED|12-month Post-treatment Follow-up||7
7979123|NCT00262223|19645970|P1|NOT COMPLETED|12-month Post-treatment Follow-up||7
7979124|NCT00262223|19645969|P2|COMPLETED|12-month Post-treatment Follow-up||22
7979125|NCT00262223|19645970|P1|COMPLETED|12-month Post-treatment Follow-up||21
7979126|NCT00262223|19645969|P2|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
7979127|NCT00262223|19645970|P1|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
7979128|NCT00262223|19645969|P2|NOT COMPLETED|6-month Post-treatment Follow-up||1
7979129|NCT00262223|19645970|P1|NOT COMPLETED|6-month Post-treatment Follow-up||6
7979130|NCT00262223|19645969|P2|COMPLETED|6-month Post-treatment Follow-up||28
7979131|NCT00262223|19645970|P1|COMPLETED|6-month Post-treatment Follow-up||22
7979132|NCT00262223|19645969|P2|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
7979133|NCT00262223|19645970|P1|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
7979134|NCT00262223|19645969|P2|NOT COMPLETED|1-week Post-treatment Follow-up||4
7979135|NCT00262223|19645970|P1|NOT COMPLETED|1-week Post-treatment Follow-up||4
7979136|NCT00262223|19645969|P2|COMPLETED|1-week Post-treatment Follow-up||25
7979137|NCT00262223|19645970|P1|COMPLETED|1-week Post-treatment Follow-up||24
7979138|NCT00262223|19645969|P2|STARTED|1-week Post-treatment Follow-up||29
7979139|NCT00262223|19645970|P1|STARTED|1-week Post-treatment Follow-up||28
7979140|NCT00262223|19645969|P2|NOT COMPLETED|Treatment Phase||8
7979141|NCT00262223|19645970|P1|NOT COMPLETED|Treatment Phase||4
7979142|NCT00262223|19645969|P2|COMPLETED|Treatment Phase||29
7979143|NCT00262223|19645970|P1|COMPLETED|Treatment Phase||28
7979144|NCT00262223|19645969|P2|STARTED|Treatment Phase||37
7979145|NCT00262223|19645970|P1|STARTED|Treatment Phase||32
7979146|NCT00262119|19645981|P3|NOT COMPLETED|Overall Study||58
7979147|NCT00262119|19645982|P2|NOT COMPLETED|Overall Study||70
7979148|NCT00262119|19645983|P1|NOT COMPLETED|Overall Study||58
7979149|NCT00262119|19645981|P3|COMPLETED|Overall Study||325
7979150|NCT00262119|19645982|P2|COMPLETED|Overall Study||328
7979151|NCT00262119|19645983|P1|COMPLETED|Overall Study||327
7979152|NCT00262119|19645981|P3|STARTED|Overall Study||383
7979153|NCT00262119|19645982|P2|STARTED|Overall Study||398
7979154|NCT00262119|19645983|P1|STARTED|Overall Study||385
7979155|NCT00262080|19646003|P3|NOT COMPLETED|Repeat Dose Treatment Period||5
7979156|NCT00262080|19646004|P2|NOT COMPLETED|Repeat Dose Treatment Period||1
7979157|NCT00262080|19646005|P1|NOT COMPLETED|Repeat Dose Treatment Period||4
7979158|NCT00262080|19646003|P3|COMPLETED|Repeat Dose Treatment Period||14
7979159|NCT00262080|19646004|P2|COMPLETED|Repeat Dose Treatment Period||25
7979160|NCT00262080|19646005|P1|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18
7979161|NCT00262080|19646003|P3|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19
7979162|NCT00262080|19646004|P2|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26
7979163|NCT00262080|19646005|P1|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22
7979164|NCT00262080|19646003|P3|NOT COMPLETED|Double Blind Treatment Period||0
7979165|NCT00262080|19646004|P2|NOT COMPLETED|Double Blind Treatment Period||0
7979166|NCT00262080|19646005|P1|NOT COMPLETED|Double Blind Treatment Period||1
7979167|NCT00262080|19646003|P3|COMPLETED|Double Blind Treatment Period||0
7979168|NCT00262080|19646004|P2|COMPLETED|Double Blind Treatment Period||36
7979169|NCT00262080|19646005|P1|COMPLETED|Double Blind Treatment Period||35
7979170|NCT00262080|19646003|P3|STARTED|Double Blind Treatment Period||0
7979171|NCT00262080|19646004|P2|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36
7979172|NCT00262080|19646005|P1|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36
7979173|NCT00262067|19646025|P4|NOT COMPLETED|Overall Study||113
7979174|NCT00262067|19646026|P3|NOT COMPLETED|Overall Study||216
7979175|NCT00262067|19646027|P2|NOT COMPLETED|Overall Study||100
7979176|NCT00262067|19646028|P1|NOT COMPLETED|Overall Study||219
7979177|NCT00262067|19646025|P4|COMPLETED|Overall Study||93
7979178|NCT00262067|19646026|P3|COMPLETED|Overall Study||193
7979179|NCT00262067|19646027|P2|COMPLETED|Overall Study||107
7979180|NCT00262067|19646028|P1|COMPLETED|Overall Study||196
7979181|NCT00262067|19646025|P4|STARTED|Overall Study||206
7979182|NCT00262067|19646026|P3|STARTED|Overall Study||409
7979183|NCT00262067|19646027|P2|STARTED|Overall Study||207
7979184|NCT00262067|19646028|P1|STARTED|Overall Study||415
7979185|NCT00262041|19646062|P3|NOT COMPLETED|Overall Study||6
7979186|NCT00262041|19646063|P2|NOT COMPLETED|Overall Study||4
7979187|NCT00262041|19646064|P1|NOT COMPLETED|Overall Study||2
7979188|NCT00262041|19646062|P3|COMPLETED|Overall Study||203
7979189|NCT00262041|19646063|P2|COMPLETED|Overall Study||147
7979190|NCT00262041|19646064|P1|COMPLETED|Overall Study||162
7979191|NCT00262041|19646062|P3|STARTED|Overall Study||209
7979192|NCT00262041|19646063|P2|STARTED|Overall Study||151
7979193|NCT00262041|19646064|P1|STARTED|Overall Study||164
7979194|NCT00262028|19646093|P9|NOT COMPLETED|Overall Study||19
7979195|NCT00262028|19646094|P8|NOT COMPLETED|Overall Study||18
7979196|NCT00262028|19646095|P7|NOT COMPLETED|Overall Study||12
7979197|NCT00262028|19646096|P6|NOT COMPLETED|Overall Study||13
7979198|NCT00262028|19646097|P5|NOT COMPLETED|Overall Study||12
7979199|NCT00262028|19646098|P4|NOT COMPLETED|Overall Study||23
7979200|NCT00262028|19646099|P3|NOT COMPLETED|Overall Study||20
7979201|NCT00262028|19646100|P2|NOT COMPLETED|Overall Study||27
7979202|NCT00262028|19646101|P1|NOT COMPLETED|Overall Study||24
7979203|NCT00262028|19646093|P9|COMPLETED|Overall Study||81
7979204|NCT00262028|19646094|P8|COMPLETED|Overall Study||55
7979205|NCT00262028|19646095|P7|COMPLETED|Overall Study||59
7979206|NCT00262028|19646096|P6|COMPLETED|Overall Study||60
7979207|NCT00262028|19646097|P5|COMPLETED|Overall Study||62
7979208|NCT00262028|19646098|P4|COMPLETED|Overall Study||134
7979209|NCT00262028|19646099|P3|COMPLETED|Overall Study||137
7979210|NCT00262028|19646100|P2|COMPLETED|Overall Study||126
7979211|NCT00262028|19646101|P1|COMPLETED|Overall Study||128
7979212|NCT00262028|19646093|P9|STARTED|Overall Study||100
7979213|NCT00262028|19646094|P8|STARTED|Overall Study||73
7979214|NCT00262028|19646095|P7|STARTED|Overall Study||71
7979215|NCT00262028|19646096|P6|STARTED|Overall Study||73
7979216|NCT00262028|19646097|P5|STARTED|Overall Study||74
7979217|NCT00262028|19646098|P4|STARTED|Overall Study||157
7979218|NCT00262028|19646099|P3|STARTED|Overall Study||157
7979219|NCT00262028|19646100|P2|STARTED|Overall Study||153
7979220|NCT00262028|19646101|P1|STARTED|Overall Study||152
7979221|NCT00262002|19646163|P7|NOT COMPLETED|Overall Study||6
7979222|NCT00262002|19646164|P6|NOT COMPLETED|Overall Study||7
7979223|NCT00262002|19646165|P5|NOT COMPLETED|Overall Study||7
7979224|NCT00262002|19646166|P4|NOT COMPLETED|Overall Study||5
7979225|NCT00262002|19646167|P3|NOT COMPLETED|Overall Study||0
7979226|NCT00262002|19646168|P2|NOT COMPLETED|Overall Study||6
7979227|NCT00262002|19646169|P1|NOT COMPLETED|Overall Study||11
7979228|NCT00262002|19646163|P7|COMPLETED|Overall Study||84
7979229|NCT00262002|19646164|P6|COMPLETED|Overall Study||83
7979230|NCT00262002|19646165|P5|COMPLETED|Overall Study||91
7979231|NCT00262002|19646166|P4|COMPLETED|Overall Study||93
7979232|NCT00262002|19646167|P3|COMPLETED|Overall Study||45
7979233|NCT00262002|19646168|P2|COMPLETED|Overall Study||84
7979234|NCT00262002|19646169|P1|COMPLETED|Overall Study||79
7979235|NCT00262002|19646163|P7|STARTED|Overall Study||90
7979236|NCT00262002|19646164|P6|STARTED|Overall Study||90
7979237|NCT00262002|19646165|P5|STARTED|Overall Study||98
7979238|NCT00262002|19646166|P4|STARTED|Overall Study||98
7979239|NCT00262002|19646167|P3|STARTED|Overall Study||45
7979240|NCT00262002|19646168|P2|STARTED|Overall Study||90
7979241|NCT00262002|19646169|P1|STARTED|Overall Study||90
7979242|NCT00261950|19646262|P1|NOT COMPLETED|Overall Study||26
7979243|NCT00261950|19646262|P1|COMPLETED|Overall Study||84
7979244|NCT00261950|19646262|P1|STARTED|Overall Study||110
7979245|NCT00261846|19646287|P12|NOT COMPLETED|Period 2: Part 2 (Efficacy)||23
7979246|NCT00261846|19646288|P11|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
7979247|NCT00261846|19646289|P10|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
7979248|NCT00261846|19646290|P9|NOT COMPLETED|Period 2: Part 2 (Efficacy)||14
7979249|NCT00261846|19646291|P8|NOT COMPLETED|Period 2: Part 2 (Efficacy)||29
7979250|NCT00261846|19646292|P7|NOT COMPLETED|Period 2: Part 2 (Efficacy)||22
7979251|NCT00261846|19646293|P6|NOT COMPLETED|Period 2: Part 2 (Efficacy)||2
7979252|NCT00261846|19646294|P5|NOT COMPLETED|Period 2: Part 2 (Efficacy)||50
7979253|NCT00261846|19646295|P4|NOT COMPLETED|Period 2: Part 2 (Efficacy)||135
7979254|NCT00261846|19646296|P3|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
7979255|NCT00261846|19646297|P2|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
7979256|NCT00261846|19646298|P1|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
7979257|NCT00261846|19646287|P12|COMPLETED|Period 2: Part 2 (Efficacy)||1
7979258|NCT00261846|19646288|P11|COMPLETED|Period 2: Part 2 (Efficacy)||15
7979259|NCT00261846|19646289|P10|COMPLETED|Period 2: Part 2 (Efficacy)||30
7979260|NCT00261846|19646290|P9|COMPLETED|Period 2: Part 2 (Efficacy)||12
7979261|NCT00261846|19646291|P8|COMPLETED|Period 2: Part 2 (Efficacy)||21
7979262|NCT00261846|19646292|P7|COMPLETED|Period 2: Part 2 (Efficacy)||16
7979263|NCT00261846|19646293|P6|COMPLETED|Period 2: Part 2 (Efficacy)||3
7979264|NCT00261846|19646294|P5|COMPLETED|Period 2: Part 2 (Efficacy)||39
7979265|NCT00261846|19646295|P4|COMPLETED|Period 2: Part 2 (Efficacy)||60
7979266|NCT00261846|19646296|P3|COMPLETED|Period 2: Part 2 (Efficacy)||0
7979267|NCT00261846|19646297|P2|COMPLETED|Period 2: Part 2 (Efficacy)||0
7979268|NCT00261846|19646298|P1|COMPLETED|Period 2: Part 2 (Efficacy)||0
7979269|NCT00261846|19646287|P12|STARTED|Period 2: Part 2 (Efficacy)||24
7979270|NCT00261846|19646288|P11|STARTED|Period 2: Part 2 (Efficacy)||64
7979271|NCT00261846|19646289|P10|STARTED|Period 2: Part 2 (Efficacy)|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|79
7979272|NCT00261846|19646290|P9|STARTED|Period 2: Part 2 (Efficacy)||26
7979273|NCT00261846|19646291|P8|STARTED|Period 2: Part 2 (Efficacy)||50
7979274|NCT00261846|19646292|P7|STARTED|Period 2: Part 2 (Efficacy)||38
7979275|NCT00261846|19646293|P6|STARTED|Period 2: Part 2 (Efficacy)||5
7979276|NCT00261846|19646294|P5|STARTED|Period 2: Part 2 (Efficacy)||89
7979277|NCT00261846|19646295|P4|STARTED|Period 2: Part 2 (Efficacy)|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|195
7979278|NCT00261846|19646296|P3|STARTED|Period 2: Part 2 (Efficacy)||0
7979279|NCT00261846|19646297|P2|STARTED|Period 2: Part 2 (Efficacy)||0
7979280|NCT00261846|19646298|P1|STARTED|Period 2: Part 2 (Efficacy)||0
7979281|NCT00261846|19646287|P12|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
7979282|NCT00261846|19646288|P11|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
7979283|NCT00261846|19646289|P10|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
7979284|NCT00261846|19646290|P9|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
7979285|NCT00261846|19646291|P8|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
7979286|NCT00261846|19646292|P7|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
7979287|NCT00261846|19646293|P6|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
7979288|NCT00261846|19646294|P5|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
7979289|NCT00261846|19646295|P4|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
7979290|NCT00261846|19646296|P3|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||12
7979291|NCT00261846|19646297|P2|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
7979292|NCT00261846|19646298|P1|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
7979293|NCT00261846|19646287|P12|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
7979294|NCT00261846|19646288|P11|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
7979295|NCT00261846|19646289|P10|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
7979296|NCT00261846|19646290|P9|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
7979297|NCT00261846|19646291|P8|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
7979298|NCT00261846|19646292|P7|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
7979299|NCT00261846|19646293|P6|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
7979300|NCT00261846|19646294|P5|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
7979301|NCT00261846|19646295|P4|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
7979302|NCT00261846|19646296|P3|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
7979303|NCT00261846|19646297|P2|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
7979304|NCT00261846|19646298|P1|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
7979305|NCT00261846|19646287|P12|STARTED|Period 1: Part 1 (Dose Escalation)||0
7979306|NCT00261846|19646288|P11|STARTED|Period 1: Part 1 (Dose Escalation)||0
7979307|NCT00261846|19646289|P10|STARTED|Period 1: Part 1 (Dose Escalation)||0
7979308|NCT00261846|19646290|P9|STARTED|Period 1: Part 1 (Dose Escalation)||0
7979309|NCT00261846|19646291|P8|STARTED|Period 1: Part 1 (Dose Escalation)||0
7979310|NCT00261846|19646292|P7|STARTED|Period 1: Part 1 (Dose Escalation)||0
7979311|NCT00261846|19646293|P6|STARTED|Period 1: Part 1 (Dose Escalation)||0
7979312|NCT00261846|19646294|P5|STARTED|Period 1: Part 1 (Dose Escalation)||0
7979313|NCT00261846|19646295|P4|STARTED|Period 1: Part 1 (Dose Escalation)||0
7979314|NCT00261846|19646296|P3|STARTED|Period 1: Part 1 (Dose Escalation)||12
7979315|NCT00261846|19646297|P2|STARTED|Period 1: Part 1 (Dose Escalation)||3
7979316|NCT00261846|19646298|P1|STARTED|Period 1: Part 1 (Dose Escalation)||3
7979317|NCT00261833|19646557|P2|NOT COMPLETED|Overall Study||18
7979318|NCT00261833|19646558|P1|NOT COMPLETED|Overall Study||9
7979319|NCT00261833|19646557|P2|COMPLETED|Overall Study||69
7979320|NCT00261833|19646558|P1|COMPLETED|Overall Study||84
7979321|NCT00261833|19646557|P2|STARTED|Overall Study||87
7979322|NCT00261833|19646558|P1|STARTED|Overall Study||93
7979323|NCT00261716|19646592|P2|NOT COMPLETED|Overall Study||10
7979324|NCT00261716|19646593|P1|NOT COMPLETED|Overall Study||6
7979325|NCT00261716|19646592|P2|COMPLETED|Overall Study||11
7979326|NCT00261716|19646593|P1|COMPLETED|Overall Study||11
7979327|NCT00261716|19646592|P2|STARTED|Overall Study||21
7979328|NCT00261716|19646593|P1|STARTED|Overall Study||17
7979329|NCT00261495|19646613|P2|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
7979330|NCT00261495|19646614|P1|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10
7979331|NCT00261495|19646613|P2|COMPLETED|Extension Phase (Weeks 24 to 52)||47
7979332|NCT00261495|19646614|P1|COMPLETED|Extension Phase (Weeks 24 to 52)||50
7979333|NCT00261495|19646613|P2|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52
7979334|NCT00261495|19646614|P1|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60
7979335|NCT00261495|19646613|P2|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48
7979336|NCT00261495|19646614|P1|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66
7979337|NCT00261495|19646613|P2|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137
7979338|NCT00261495|19646614|P1|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140
7979339|NCT00261495|19646613|P2|STARTED|Maintenance Phase (Weeks 4 to 24)||185
7979340|NCT00261495|19646614|P1|STARTED|Maintenance Phase (Weeks 4 to 24)||206
7979341|NCT00261495|19646613|P2|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65
7979342|NCT00261495|19646614|P1|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48
7979343|NCT00261495|19646613|P2|COMPLETED|Titration Phase (Weeks 0 to 4)||185
7979344|NCT00261495|19646614|P1|COMPLETED|Titration Phase (Weeks 0 to 4)||206
7979345|NCT00261495|19646613|P2|STARTED|Titration Phase (Weeks 0 to 4)||250
7979346|NCT00261495|19646614|P1|STARTED|Titration Phase (Weeks 0 to 4)||254
7979347|NCT00261443|19646778|P3|NOT COMPLETED|4: Extension Phase||2
7979348|NCT00261443|19646779|P2|NOT COMPLETED|4: Extension Phase||3
7979349|NCT00261443|19646780|P1|NOT COMPLETED|4: Extension Phase||0
7979350|NCT00261443|19646778|P3|COMPLETED|4: Extension Phase||21
7979351|NCT00261443|19646779|P2|COMPLETED|4: Extension Phase||16
7979352|NCT00261443|19646780|P1|COMPLETED|4: Extension Phase||0
7979353|NCT00261443|19646778|P3|STARTED|4: Extension Phase||23
7979354|NCT00261443|19646779|P2|STARTED|4: Extension Phase||19
7979355|NCT00261443|19646780|P1|STARTED|4: Extension Phase||0
7979356|NCT00261443|19646778|P3|NOT COMPLETED|3: Assessment of Relapse||65
7979357|NCT00261443|19646779|P2|NOT COMPLETED|3: Assessment of Relapse||80
7979358|NCT00261443|19646780|P1|NOT COMPLETED|3: Assessment of Relapse||0
7979359|NCT00261443|19646778|P3|COMPLETED|3: Assessment of Relapse||103
7979360|NCT00261443|19646779|P2|COMPLETED|3: Assessment of Relapse||89
7979361|NCT00261443|19646780|P1|COMPLETED|3: Assessment of Relapse||0
7979362|NCT00261443|19646778|P3|STARTED|3: Assessment of Relapse||168
7979363|NCT00261443|19646779|P2|STARTED|3: Assessment of Relapse||169
7979364|NCT00261443|19646780|P1|STARTED|3: Assessment of Relapse||0
7979365|NCT00261443|19646778|P3|NOT COMPLETED|2: Stability & Maintenance of Stability||0
7979366|NCT00261443|19646779|P2|NOT COMPLETED|2: Stability & Maintenance of Stability||0
7979367|NCT00261443|19646780|P1|NOT COMPLETED|2: Stability & Maintenance of Stability||340
7979368|NCT00261443|19646778|P3|COMPLETED|2: Stability & Maintenance of Stability||0
7979369|NCT00261443|19646779|P2|COMPLETED|2: Stability & Maintenance of Stability||0
7979370|NCT00261443|19646780|P1|COMPLETED|2: Stability & Maintenance of Stability||346
7979371|NCT00261443|19646778|P3|STARTED|2: Stability & Maintenance of Stability||0
7979372|NCT00261443|19646779|P2|STARTED|2: Stability & Maintenance of Stability||0
7979373|NCT00261443|19646780|P1|STARTED|2: Stability & Maintenance of Stability||686
7979374|NCT00261443|19646778|P3|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
7979375|NCT00261443|19646779|P2|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
7979376|NCT00261443|19646780|P1|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584
7979377|NCT00261443|19646778|P3|COMPLETED|1: Confirmation of Partial Nonresponse||0
7979378|NCT00261443|19646779|P2|COMPLETED|1: Confirmation of Partial Nonresponse||0
7979379|NCT00261443|19646780|P1|COMPLETED|1: Confirmation of Partial Nonresponse||686
7979380|NCT00261443|19646778|P3|STARTED|1: Confirmation of Partial Nonresponse||0
7979381|NCT00261443|19646779|P2|STARTED|1: Confirmation of Partial Nonresponse||0
7979382|NCT00261443|19646780|P1|STARTED|1: Confirmation of Partial Nonresponse||1270
7979383|NCT00261040|19647037|P2|NOT COMPLETED|Overall Study||0
7979384|NCT00261040|19647038|P1|NOT COMPLETED|Overall Study||1
7979385|NCT00261040|19647037|P2|COMPLETED|Overall Study||20
7979386|NCT00261040|19647038|P1|COMPLETED|Overall Study||19
7979387|NCT00261040|19647037|P2|STARTED|Overall Study||20
7979388|NCT00261040|19647038|P1|STARTED|Overall Study||20
7979389|NCT00260962|19647054|P2|NOT COMPLETED|Overall Study||2
7979390|NCT00260962|19647055|P1|NOT COMPLETED|Overall Study||4
7979391|NCT00260962|19647054|P2|COMPLETED|Overall Study||14
7979392|NCT00260962|19647055|P1|COMPLETED|Overall Study||14
7979393|NCT00260962|19647054|P2|STARTED|Overall Study||16
7979394|NCT00260962|19647055|P1|STARTED|Overall Study||18
7979395|NCT00260832|19647065|P2|NOT COMPLETED|Overall Study||211
7979396|NCT00260832|19647066|P1|NOT COMPLETED|Overall Study||228
7979397|NCT00260832|19647065|P2|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31
7979398|NCT00260832|19647066|P1|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15
7979399|NCT00260832|19647065|P2|STARTED|Overall Study||242
7979400|NCT00260832|19647066|P1|STARTED|Overall Study||243
7979401|NCT00260689|19647077|P3|NOT COMPLETED|Overall Study||15
7979402|NCT00260689|19647078|P2|NOT COMPLETED|Overall Study||49
7979403|NCT00260689|19647079|P1|NOT COMPLETED|Overall Study||41
7979404|NCT00260689|19647077|P3|COMPLETED|Overall Study||1
7979405|NCT00260689|19647078|P2|COMPLETED|Overall Study||11
7979406|NCT00260689|19647079|P1|COMPLETED|Overall Study||19
7979407|NCT00260689|19647077|P3|STARTED|Overall Study||16
7979408|NCT00260689|19647078|P2|STARTED|Overall Study||60
7979409|NCT00260689|19647079|P1|STARTED|Overall Study||60
7979410|NCT00260533|19647095|P2|NOT COMPLETED|Overall Study||3
7979411|NCT00260533|19647096|P1|NOT COMPLETED|Overall Study||3
7979412|NCT00260533|19647095|P2|COMPLETED|Overall Study||10
7979413|NCT00260533|19647096|P1|COMPLETED|Overall Study||11
7979414|NCT00260533|19647095|P2|STARTED|Overall Study||13
7979415|NCT00260533|19647096|P1|STARTED|Overall Study||14
7979416|NCT00260429|19647104|P2|NOT COMPLETED|Overall Study||0
7979417|NCT00260429|19647105|P1|NOT COMPLETED|Overall Study||2
7979418|NCT00260429|19647104|P2|COMPLETED|Overall Study||12
7979419|NCT00260429|19647105|P1|COMPLETED|Overall Study||21
7979420|NCT00260429|19647104|P2|STARTED|Overall Study||12
7979421|NCT00260429|19647105|P1|STARTED|Overall Study||23
7979422|NCT00260208|19647113|P2|NOT COMPLETED|Overall Study||34
7979423|NCT00260208|19647114|P1|NOT COMPLETED|Overall Study||47
7979424|NCT00260208|19647113|P2|COMPLETED|Overall Study||138
7979425|NCT00260208|19647114|P1|COMPLETED|Overall Study||137
7979426|NCT00260208|19647113|P2|Modified ITT|Overall Study||96
7979427|NCT00260208|19647114|P1|Modified ITT|Overall Study||101
7979428|NCT00260208|19647113|P2|Intent to Treat (ITT) Population|Overall Study||169
7979429|NCT00260208|19647114|P1|Intent to Treat (ITT) Population|Overall Study||182
7979430|NCT00260208|19647113|P2|STARTED|Overall Study||172
7979431|NCT00260208|19647114|P1|STARTED|Overall Study|"Started indicates safety population."|184
7979432|NCT00260195|19647144|P2|NOT COMPLETED|Overall Study||0
7979433|NCT00260195|19647145|P1|NOT COMPLETED|Overall Study||0
7979434|NCT00260195|19647144|P2|COMPLETED|Overall Study||37
7979435|NCT00260195|19647145|P1|COMPLETED|Overall Study||39
7979436|NCT00260195|19647144|P2|STARTED|Overall Study||37
7979437|NCT00260195|19647145|P1|STARTED|Overall Study||39
7979438|NCT00260065|19647157|P1|NOT COMPLETED|Overall Study||93
7979439|NCT00260065|19647157|P1|COMPLETED|Overall Study||6
7979440|NCT00260065|19647157|P1|STARTED|Overall Study||99
7979441|NCT00259857|19647164|P2|NOT COMPLETED|24 Months Treatment||3
7979442|NCT00259857|19647165|P1|NOT COMPLETED|24 Months Treatment||0
7979443|NCT00259857|19647164|P2|COMPLETED|24 Months Treatment||6
7979444|NCT00259857|19647165|P1|COMPLETED|24 Months Treatment||10
7979445|NCT00259857|19647164|P2|STARTED|24 Months Treatment||9
7979446|NCT00259857|19647165|P1|STARTED|24 Months Treatment||10
7979447|NCT00259857|19647164|P2|NOT COMPLETED|12 Months Treatment||2
7979448|NCT00259857|19647165|P1|NOT COMPLETED|12 Months Treatment||1
7979449|NCT00259857|19647164|P2|COMPLETED|12 Months Treatment||9
7979450|NCT00259857|19647165|P1|COMPLETED|12 Months Treatment||10
7979451|NCT00259857|19647164|P2|STARTED|12 Months Treatment||11
7979452|NCT00259857|19647165|P1|STARTED|12 Months Treatment||11
7979453|NCT00259740|19647183|P2|NOT COMPLETED|Overall Study||53
7979454|NCT00259740|19647184|P1|NOT COMPLETED|Overall Study||43
7979455|NCT00259740|19647183|P2|COMPLETED|Overall Study||0
7979456|NCT00259740|19647184|P1|COMPLETED|Overall Study||0
7979457|NCT00259740|19647183|P2|Received Study Medication|Overall Study||53
7979458|NCT00259740|19647184|P1|Received Study Medication|Overall Study||42
7979459|NCT00259740|19647183|P2|STARTED|Overall Study||53
7979460|NCT00259740|19647184|P1|STARTED|Overall Study||43
7979461|NCT00259649|19647194|P1|NOT COMPLETED|Overall Study||10
7979462|NCT00259649|19647194|P1|COMPLETED|Overall Study||61
7979463|NCT00259649|19647194|P1|STARTED|Overall Study||71
7979464|NCT00259610|19647202|P4|NOT COMPLETED|Overall Study||43
7979465|NCT00259610|19647203|P3|NOT COMPLETED|Overall Study||73
7979466|NCT00259610|19647204|P2|NOT COMPLETED|Overall Study||46
7979467|NCT00259610|19647205|P1|NOT COMPLETED|Overall Study||76
7979468|NCT00259610|19647202|P4|COMPLETED|Overall Study||81
7979469|NCT00259610|19647203|P3|COMPLETED|Overall Study||182
7979470|NCT00259610|19647204|P2|COMPLETED|Overall Study||86
7979471|NCT00259610|19647205|P1|COMPLETED|Overall Study||168
7979472|NCT00259610|19647202|P4|STARTED|Overall Study||124
7979473|NCT00259610|19647203|P3|STARTED|Overall Study||255
7979474|NCT00259610|19647204|P2|STARTED|Overall Study||132
7979475|NCT00259610|19647205|P1|STARTED|Overall Study||244
7979476|NCT00259298|19647219|P1|NOT COMPLETED|Overall Study||3
7979477|NCT00259298|19647219|P1|COMPLETED|Overall Study||9
7979478|NCT00259298|19647219|P1|Received at Least 1 Dose of Study Drug|Overall Study||10
7979479|NCT00259298|19647219|P1|STARTED|Overall Study||12
7979480|NCT00259285|19647227|P1|NOT COMPLETED|Overall Study||0
7979481|NCT00259285|19647227|P1|COMPLETED|Overall Study||10
7979482|NCT00259285|19647227|P1|STARTED|Overall Study||10
7979483|NCT00259272|19647237|P4|NOT COMPLETED|Overall Study||21
7979484|NCT00259272|19647238|P3|NOT COMPLETED|Overall Study||5
7979485|NCT00259272|19647239|P2|NOT COMPLETED|Overall Study||7
7979486|NCT00259272|19647240|P1|NOT COMPLETED|Overall Study||15
7979487|NCT00259272|19647237|P4|COMPLETED|Overall Study||27
7979488|NCT00259272|19647238|P3|COMPLETED|Overall Study||21
7979489|NCT00259272|19647239|P2|COMPLETED|Overall Study||24
7979490|NCT00259272|19647240|P1|COMPLETED|Overall Study||21
7979491|NCT00259272|19647237|P4|STARTED|Overall Study||48
7979492|NCT00259272|19647238|P3|STARTED|Overall Study||26
7979493|NCT00259272|19647239|P2|STARTED|Overall Study||31
7979494|NCT00259272|19647240|P1|STARTED|Overall Study||36
7979495|NCT00259090|19647318|P3|NOT COMPLETED|Overall Study||0
7979496|NCT00259090|19647319|P2|NOT COMPLETED|Overall Study||0
7979497|NCT00259090|19647320|P1|NOT COMPLETED|Overall Study||0
7979498|NCT00259090|19647318|P3|COMPLETED|Overall Study||37
7979499|NCT00259090|19647319|P2|COMPLETED|Overall Study||31
7979500|NCT00259090|19647320|P1|COMPLETED|Overall Study||35
7979501|NCT00259090|19647318|P3|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37
7979502|NCT00259090|19647319|P2|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31
7979503|NCT00259090|19647320|P1|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35
7979504|NCT00259012|19647336|P2|NOT COMPLETED|Overall Study||4
7979505|NCT00259012|19647337|P1|NOT COMPLETED|Overall Study||2
7979506|NCT00259012|19647336|P2|COMPLETED|Overall Study||30
7979507|NCT00259012|19647337|P1|COMPLETED|Overall Study||31
7979508|NCT00259012|19647336|P2|STARTED|Overall Study||34
7979509|NCT00259012|19647337|P1|STARTED|Overall Study||33
7979510|NCT00258960|19647369|P1|NOT COMPLETED|Overall Study||17
7979511|NCT00258960|19647369|P1|COMPLETED|Overall Study||32
7979512|NCT00258960|19647369|P1|STARTED|Overall Study|49 patients included but 1 is not considered due to not receive any treatment and died before start|49
7979513|NCT00258908|19647377|P1|NOT COMPLETED|Overall Study||0
7979514|NCT00258908|19647377|P1|COMPLETED|Overall Study||112
7979515|NCT00258908|19647377|P1|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112
7979516|NCT00258895|19647385|P2|NOT COMPLETED|Overall Study||3
7979517|NCT00258895|19647386|P1|NOT COMPLETED|Overall Study||10
7979518|NCT00258895|19647385|P2|COMPLETED|Overall Study||159
7979519|NCT00258895|19647386|P1|COMPLETED|Overall Study||477
7979520|NCT00258895|19647385|P2|STARTED|Overall Study||162
7979521|NCT00258895|19647386|P1|STARTED|Overall Study||487
7979522|NCT00258882|19647402|P2|NOT COMPLETED|Pregnancy Surveillance||0
7979523|NCT00258882|19647403|P1|NOT COMPLETED|Pregnancy Surveillance||0
7979524|NCT00258882|19647402|P2|COMPLETED|Pregnancy Surveillance||675
7979525|NCT00258882|19647403|P1|COMPLETED|Pregnancy Surveillance||225
7979526|NCT00258882|19647402|P2|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675
7979527|NCT00258882|19647403|P1|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225
7979528|NCT00258882|19647402|P2|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
7979529|NCT00258882|19647403|P1|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
7979530|NCT00258882|19647402|P2|COMPLETED|Adacel Recipients-Risk Interval Method||0
7979531|NCT00258882|19647403|P1|COMPLETED|Adacel Recipients-Risk Interval Method||124139
7979532|NCT00258882|19647402|P2|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0
7979533|NCT00258882|19647403|P1|STARTED|Adacel Recipients-Risk Interval Method||124139
7979534|NCT00258882|19647402|P2|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
7979535|NCT00258882|19647403|P1|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
7979536|NCT00258882|19647402|P2|COMPLETED|Adacel Recipients Historic Cohort Method||203154
7979537|NCT00258882|19647403|P1|COMPLETED|Adacel Recipients Historic Cohort Method||124139
7979538|NCT00258882|19647402|P2|STARTED|Adacel Recipients Historic Cohort Method||203154
7979539|NCT00258882|19647403|P1|STARTED|Adacel Recipients Historic Cohort Method||124139
7979540|NCT00258856|19647422|P4|NOT COMPLETED|Overall Study||1
7979541|NCT00258856|19647423|P3|NOT COMPLETED|Overall Study||2
7979542|NCT00258856|19647424|P2|NOT COMPLETED|Overall Study||0
7979543|NCT00258856|19647425|P1|NOT COMPLETED|Overall Study||3
7979544|NCT00258856|19647422|P4|COMPLETED|Overall Study||58
7979545|NCT00258856|19647423|P3|COMPLETED|Overall Study||56
7979546|NCT00258856|19647424|P2|COMPLETED|Overall Study||58
7979547|NCT00258856|19647425|P1|COMPLETED|Overall Study||56
7979548|NCT00258856|19647422|P4|STARTED|Overall Study||59
7979549|NCT00258856|19647423|P3|STARTED|Overall Study||58
7979550|NCT00258856|19647424|P2|STARTED|Overall Study||58
7979551|NCT00258856|19647425|P1|STARTED|Overall Study||59
7979552|NCT00258830|19647437|P2|NOT COMPLETED|Overall Study||0
7979553|NCT00258830|19647438|P1|NOT COMPLETED|Overall Study||0
7979554|NCT00258830|19647437|P2|COMPLETED|Overall Study||60
7979555|NCT00258830|19647438|P1|COMPLETED|Overall Study||60
7979556|NCT00258830|19647437|P2|STARTED|Overall Study||60
7979557|NCT00258830|19647438|P1|STARTED|Overall Study||60
7979558|NCT00258817|19647452|P2|NOT COMPLETED|Overall Study||0
7979559|NCT00258817|19647453|P1|NOT COMPLETED|Overall Study||0
7979560|NCT00258817|19647452|P2|COMPLETED|Overall Study||15
7979561|NCT00258817|19647453|P1|COMPLETED|Overall Study||15
7979562|NCT00258817|19647452|P2|STARTED|Overall Study||15
7979563|NCT00258817|19647453|P1|STARTED|Overall Study||15
7979564|NCT00258674|19647466|P3|NOT COMPLETED|Overall Study||34
7979565|NCT00258674|19647467|P2|NOT COMPLETED|Overall Study||53
7979566|NCT00258674|19647468|P1|NOT COMPLETED|Overall Study||32
7979567|NCT00258674|19647466|P3|COMPLETED|Overall Study||568
7979568|NCT00258674|19647467|P2|COMPLETED|Overall Study||758
7979569|NCT00258674|19647468|P1|COMPLETED|Overall Study||565
7979570|NCT00258674|19647466|P3|STARTED|Overall Study||602
7979571|NCT00258674|19647467|P2|STARTED|Overall Study||811
7979572|NCT00258674|19647468|P1|STARTED|Overall Study||597
7979573|NCT00258440|19647527|P3|NOT COMPLETED|Overall Study||1
7979574|NCT00258440|19647528|P2|NOT COMPLETED|Overall Study||0
7979575|NCT00258440|19647529|P1|NOT COMPLETED|Overall Study||0
7979576|NCT00258440|19647527|P3|COMPLETED|Overall Study||5
7979577|NCT00258440|19647528|P2|COMPLETED|Overall Study||0
7979578|NCT00258440|19647529|P1|COMPLETED|Overall Study||1
7979579|NCT00258440|19647527|P3|STARTED|Overall Study||6
7979580|NCT00258440|19647528|P2|STARTED|Overall Study||0
7979581|NCT00258440|19647529|P1|STARTED|Overall Study||1
7979582|NCT00258362|19647540|P1|NOT COMPLETED|Overall Study||0
7979583|NCT00258362|19647540|P1|COMPLETED|Overall Study||41
7979584|NCT00258362|19647540|P1|STARTED|Overall Study||41
7979585|NCT00258349|19647545|P1|NOT COMPLETED|Overall Study||0
7979586|NCT00258349|19647545|P1|COMPLETED|Overall Study||16
7979587|NCT00258349|19647545|P1|HER2-positive by Central Review|Overall Study||10
7979588|NCT00258349|19647545|P1|STARTED|Overall Study||16
7979589|NCT00258310|19647552|P1|NOT COMPLETED|Overall Study||0
7979590|NCT00258310|19647552|P1|COMPLETED|Overall Study||35
7979591|NCT00258310|19647552|P1|STARTED|Overall Study||35
7979592|NCT00258206|19647556|P1|NOT COMPLETED|Overall Study||0
7979593|NCT00258206|19647556|P1|COMPLETED|Overall Study||21
7979594|NCT00258206|19647556|P1|STARTED|Overall Study||21
7979595|NCT00258180|19647560|P1|NOT COMPLETED|Overall Study||0
7979596|NCT00258180|19647560|P1|COMPLETED|Overall Study||2
7979597|NCT00258180|19647560|P1|STARTED|Overall Study||2
7979598|NCT00258154|19647567|P2|NOT COMPLETED|Overall Study||7
7979599|NCT00258154|19647568|P1|NOT COMPLETED|Overall Study||9
7979600|NCT00258154|19647567|P2|COMPLETED|Overall Study|Subjects who completed the study.|195
7979601|NCT00258154|19647568|P1|COMPLETED|Overall Study|Subjects who completed the study.|192
7979602|NCT00258154|19647567|P2|Vaccinated at Visit 3|Overall Study||197
7979603|NCT00258154|19647568|P1|Vaccinated at Visit 3|Overall Study||195
7979604|NCT00258154|19647567|P2|Vaccinated at Visit 2|Overall Study||198
7979605|NCT00258154|19647568|P1|Vaccinated at Visit 2|Overall Study||198
7979606|NCT00258154|19647567|P2|Vaccinated at Visit 1|Overall Study||202
7979607|NCT00258154|19647568|P1|Vaccinated at Visit 1|Overall Study||201
7979608|NCT00258154|19647567|P2|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202
7979609|NCT00258154|19647568|P1|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201
7979610|NCT00258128|19647638|P2|NOT COMPLETED|Overall Study||0
7979611|NCT00258128|19647639|P1|NOT COMPLETED|Overall Study||0
7979612|NCT00258128|19647638|P2|COMPLETED|Overall Study||9
7979613|NCT00258128|19647639|P1|COMPLETED|Overall Study||8
7979614|NCT00258128|19647638|P2|STARTED|Overall Study||9
7979615|NCT00258128|19647639|P1|STARTED|Overall Study||8
7979616|NCT00258011|19647647|P1|NOT COMPLETED|Overall Study||0
7979617|NCT00258011|19647647|P1|COMPLETED|Overall Study||3
7979618|NCT00258011|19647647|P1|STARTED|Overall Study||3
7979619|NCT00257933|19647654|P2|NOT COMPLETED|Overall Study||0
7979620|NCT00257933|19647655|P1|NOT COMPLETED|Overall Study||0
7979621|NCT00257933|19647654|P2|COMPLETED|Overall Study||78
7979622|NCT00257933|19647655|P1|COMPLETED|Overall Study||74
7979623|NCT00257933|19647654|P2|STARTED|Overall Study||78
7979624|NCT00257933|19647655|P1|STARTED|Overall Study||74
7979625|NCT00257920|19647663|P2|NOT COMPLETED|Period: Second Intervention||1
7979626|NCT00257920|19647664|P1|NOT COMPLETED|Period: Second Intervention||2
7979627|NCT00257920|19647663|P2|COMPLETED|Period: Second Intervention||18
7979628|NCT00257920|19647664|P1|COMPLETED|Period: Second Intervention||19
7979629|NCT00257920|19647663|P2|STARTED|Period: Second Intervention||19
7979630|NCT00257920|19647664|P1|STARTED|Period: Second Intervention||21
7979631|NCT00257920|19647663|P2|NOT COMPLETED|Period: Washout Period of Two Weeks||1
7979632|NCT00257920|19647664|P1|NOT COMPLETED|Period: Washout Period of Two Weeks||0
7979633|NCT00257920|19647663|P2|COMPLETED|Period: Washout Period of Two Weeks||19
7979634|NCT00257920|19647664|P1|COMPLETED|Period: Washout Period of Two Weeks||21
7979635|NCT00257920|19647663|P2|STARTED|Period: Washout Period of Two Weeks||20
7979636|NCT00257920|19647664|P1|STARTED|Period: Washout Period of Two Weeks||21
7979637|NCT00257920|19647663|P2|NOT COMPLETED|Period: First Intervention||0
7979638|NCT00257920|19647664|P1|NOT COMPLETED|Period: First Intervention||0
7979639|NCT00257920|19647663|P2|COMPLETED|Period: First Intervention||20
7979640|NCT00257920|19647664|P1|COMPLETED|Period: First Intervention||21
7979641|NCT00257920|19647663|P2|STARTED|Period: First Intervention||20
7979642|NCT00257920|19647664|P1|STARTED|Period: First Intervention||21
7979643|NCT00257894|19647674|P2|NOT COMPLETED|Overall Study||5
7979644|NCT00257894|19647675|P1|NOT COMPLETED|Overall Study||4
7979645|NCT00257894|19647674|P2|COMPLETED|Overall Study||15
7979646|NCT00257894|19647675|P1|COMPLETED|Overall Study||17
7979647|NCT00257894|19647674|P2|STARTED|Overall Study||20
7979648|NCT00257894|19647675|P1|STARTED|Overall Study||21
7979649|NCT00257725|19647687|P1|NOT COMPLETED|Overall Study||3
7979650|NCT00257725|19647687|P1|COMPLETED|Overall Study||8
7979651|NCT00257725|19647687|P1|STARTED|Overall Study||11
7979652|NCT00257686|19647699|P6|NOT COMPLETED|Overall Study||9
7979653|NCT00257686|19647700|P5|NOT COMPLETED|Overall Study||22
7979654|NCT00257686|19647701|P4|NOT COMPLETED|Overall Study||11
7979655|NCT00257686|19647702|P3|NOT COMPLETED|Overall Study||18
7979656|NCT00257686|19647703|P2|NOT COMPLETED|Overall Study||19
7979657|NCT00257686|19647704|P1|NOT COMPLETED|Overall Study||21
7979658|NCT00257686|19647699|P6|COMPLETED|Overall Study||95
7979659|NCT00257686|19647700|P5|COMPLETED|Overall Study||194
7979660|NCT00257686|19647701|P4|COMPLETED|Overall Study||88
7979661|NCT00257686|19647702|P3|COMPLETED|Overall Study||208
7979662|NCT00257686|19647703|P2|COMPLETED|Overall Study||89
7979663|NCT00257686|19647704|P1|COMPLETED|Overall Study||188
7979664|NCT00257686|19647699|P6|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102
7979665|NCT00257686|19647700|P5|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210
7979666|NCT00257686|19647701|P4|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96
7979667|NCT00257686|19647702|P3|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224
7979668|NCT00257686|19647703|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103
7979669|NCT00257686|19647704|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207
7979670|NCT00257686|19647699|P6|STARTED|Overall Study||104
7979671|NCT00257686|19647700|P5|STARTED|Overall Study||216
7979672|NCT00257686|19647701|P4|STARTED|Overall Study||99
7979673|NCT00257686|19647702|P3|STARTED|Overall Study||226
7979674|NCT00257686|19647703|P2|STARTED|Overall Study||108
7979675|NCT00257686|19647704|P1|STARTED|Overall Study||209
7979676|NCT00257660|19647726|P2|NOT COMPLETED|Overall Study||23
7979677|NCT00257660|19647727|P1|NOT COMPLETED|Overall Study||10
7979678|NCT00257660|19647726|P2|COMPLETED|Overall Study||38
7979679|NCT00257660|19647727|P1|COMPLETED|Overall Study||45
7979680|NCT00257660|19647726|P2|STARTED|Overall Study||61
7979681|NCT00257660|19647727|P1|STARTED|Overall Study||55
7979682|NCT00257608|19647757|P3|NOT COMPLETED|Post Chemotherapy Phase||244
7979683|NCT00257608|19647758|P2|NOT COMPLETED|Post Chemotherapy Phase||264
7979684|NCT00257608|19647759|P1|NOT COMPLETED|Post Chemotherapy Phase||0
7979685|NCT00257608|19647757|P3|COMPLETED|Post Chemotherapy Phase||126
7979686|NCT00257608|19647758|P2|COMPLETED|Post Chemotherapy Phase||109
7979687|NCT00257608|19647759|P1|COMPLETED|Post Chemotherapy Phase||0
7979688|NCT00257608|19647757|P3|STARTED|Post Chemotherapy Phase||370
7979689|NCT00257608|19647758|P2|STARTED|Post Chemotherapy Phase||373
7979690|NCT00257608|19647759|P1|STARTED|Post Chemotherapy Phase||0
7979691|NCT00257608|19647757|P3|NOT COMPLETED|Chemotherapy Phase||0
7979692|NCT00257608|19647758|P2|NOT COMPLETED|Chemotherapy Phase||0
7979693|NCT00257608|19647759|P1|NOT COMPLETED|Chemotherapy Phase||376
7979694|NCT00257608|19647757|P3|COMPLETED|Chemotherapy Phase||0
7979695|NCT00257608|19647758|P2|COMPLETED|Chemotherapy Phase||0
7979696|NCT00257608|19647759|P1|COMPLETED|Chemotherapy Phase||769
7979697|NCT00257608|19647757|P3|STARTED|Chemotherapy Phase||0
7979698|NCT00257608|19647758|P2|STARTED|Chemotherapy Phase||0
7979699|NCT00257608|19647759|P1|STARTED|Chemotherapy Phase||1145
7979700|NCT00257556|19647785|P2|NOT COMPLETED|Overall Study||10
7979701|NCT00257556|19647786|P1|NOT COMPLETED|Overall Study||14
7979702|NCT00257556|19647785|P2|COMPLETED|Overall Study||32
7979703|NCT00257556|19647786|P1|COMPLETED|Overall Study||24
7979704|NCT00257556|19647785|P2|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39
7979705|NCT00257556|19647786|P1|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37
7979706|NCT00257556|19647785|P2|STARTED|Overall Study||42
7979707|NCT00257556|19647786|P1|STARTED|Overall Study||38
7979708|NCT00257322|19647812|P1|NOT COMPLETED|Overall Study||4
7979709|NCT00257322|19647812|P1|COMPLETED|Overall Study|4 subjects withdrew from this study.|16
7979710|NCT00257322|19647812|P1|STARTED|Overall Study|20 subjects accrued.|20
7979711|NCT00257309|19647819|P2|NOT COMPLETED|Overall Study||2
7979712|NCT00257309|19647820|P1|NOT COMPLETED|Overall Study||2
7979713|NCT00257309|19647819|P2|COMPLETED|Overall Study||130
7979714|NCT00257309|19647820|P1|COMPLETED|Overall Study||132
7979715|NCT00257309|19647819|P2|STARTED|Overall Study||132
7979716|NCT00257309|19647820|P1|STARTED|Overall Study||134
7979717|NCT00257192|19647830|P2|NOT COMPLETED|Overall Study||39
7979718|NCT00257192|19647831|P1|NOT COMPLETED|Overall Study||58
7979719|NCT00257192|19647830|P2|COMPLETED|Overall Study||52
7979720|NCT00257192|19647831|P1|COMPLETED|Overall Study||135
7979721|NCT00257192|19647830|P2|Received Study Treatment|Overall Study||90
7979722|NCT00257192|19647831|P1|Received Study Treatment|Overall Study||193
7979723|NCT00257192|19647830|P2|STARTED|Overall Study|Includes 1 subject randomized but not treated|91
7979724|NCT00257192|19647831|P1|STARTED|Overall Study||193
7979725|NCT00257166|19647875|P2|NOT COMPLETED|Overall Study||37
7979726|NCT00257166|19647876|P1|NOT COMPLETED|Overall Study||53
7979727|NCT00257166|19647875|P2|COMPLETED|Overall Study||51
7979728|NCT00257166|19647876|P1|COMPLETED|Overall Study||97
7979729|NCT00257166|19647875|P2|Treated|Overall Study||88
7979730|NCT00257166|19647876|P1|Treated|Overall Study||149
7979731|NCT00257166|19647875|P2|STARTED|Overall Study||88
7979732|NCT00257166|19647876|P1|STARTED|Overall Study||150
7979733|NCT00257010|19647888|P1|NOT COMPLETED|Overall Study||128
7979734|NCT00257010|19647888|P1|COMPLETED|Overall Study||319
7979735|NCT00257010|19647888|P1|STARTED|Overall Study||447
7979736|NCT00256997|19647899|P2|NOT COMPLETED|Overall Study||55
7979737|NCT00256997|19647900|P1|NOT COMPLETED|Overall Study||48
7979738|NCT00256997|19647899|P2|COMPLETED|Overall Study||31
7979739|NCT00256997|19647900|P1|COMPLETED|Overall Study||33
7979740|NCT00256997|19647899|P2|Treated|Overall Study||86
7979741|NCT00256997|19647900|P1|Treated|Overall Study||79
7979742|NCT00256997|19647899|P2|STARTED|Overall Study||86
7979743|NCT00256997|19647900|P1|STARTED|Overall Study||81
7979744|NCT00256984|19647924|P1|NOT COMPLETED|Overall Study||16
7979745|NCT00256984|19647924|P1|COMPLETED|Overall Study||59
7979746|NCT00256984|19647924|P1|STARTED|Overall Study||75
7979747|NCT00256867|19647942|P8|NOT COMPLETED|Overall Study||11
7979748|NCT00256867|19647943|P7|NOT COMPLETED|Overall Study||5
7979749|NCT00256867|19647944|P6|NOT COMPLETED|Overall Study||6
7979750|NCT00256867|19647945|P5|NOT COMPLETED|Overall Study||7
7979751|NCT00256867|19647946|P4|NOT COMPLETED|Overall Study||6
7979752|NCT00256867|19647947|P3|NOT COMPLETED|Overall Study||5
7979753|NCT00256867|19647948|P2|NOT COMPLETED|Overall Study||5
7979754|NCT00256867|19647949|P1|NOT COMPLETED|Overall Study||2
7979755|NCT00256867|19647942|P8|COMPLETED|Overall Study||36
7979756|NCT00256867|19647943|P7|COMPLETED|Overall Study||41
7979757|NCT00256867|19647944|P6|COMPLETED|Overall Study||40
7979758|NCT00256867|19647945|P5|COMPLETED|Overall Study||41
7979759|NCT00256867|19647946|P4|COMPLETED|Overall Study||40
7979760|NCT00256867|19647947|P3|COMPLETED|Overall Study||40
7979761|NCT00256867|19647948|P2|COMPLETED|Overall Study||39
7979762|NCT00256867|19647949|P1|COMPLETED|Overall Study||45
7979763|NCT00256867|19647942|P8|STARTED|Overall Study||47
7979764|NCT00256867|19647943|P7|STARTED|Overall Study||46
7979765|NCT00256867|19647944|P6|STARTED|Overall Study||46
7979766|NCT00256867|19647945|P5|STARTED|Overall Study||48
7979767|NCT00256867|19647946|P4|STARTED|Overall Study||46
7979768|NCT00256867|19647947|P3|STARTED|Overall Study||45
7979769|NCT00256867|19647948|P2|STARTED|Overall Study||44
7979770|NCT00256867|19647949|P1|STARTED|Overall Study||47
7979771|NCT00256854|19648039|P6|NOT COMPLETED|Overall Study||1
7979772|NCT00256854|19648040|P5|NOT COMPLETED|Overall Study||1
7979773|NCT00256854|19648041|P4|NOT COMPLETED|Overall Study||3
7979774|NCT00256854|19648042|P3|NOT COMPLETED|Overall Study||3
7979775|NCT00256854|19648043|P2|NOT COMPLETED|Overall Study||4
7979776|NCT00256854|19648044|P1|NOT COMPLETED|Overall Study||3
7979777|NCT00256854|19648039|P6|COMPLETED|Overall Study||13
7979778|NCT00256854|19648040|P5|COMPLETED|Overall Study||15
7979779|NCT00256854|19648041|P4|COMPLETED|Overall Study||24
7979780|NCT00256854|19648042|P3|COMPLETED|Overall Study||23
7979781|NCT00256854|19648043|P2|COMPLETED|Overall Study||22
7979782|NCT00256854|19648044|P1|COMPLETED|Overall Study||23
7979783|NCT00256854|19648039|P6|STARTED|Overall Study||14
7979784|NCT00256854|19648040|P5|STARTED|Overall Study||16
7979785|NCT00256854|19648041|P4|STARTED|Overall Study||27
7979786|NCT00256854|19648042|P3|STARTED|Overall Study||26
7979787|NCT00256854|19648043|P2|STARTED|Overall Study||26
7979788|NCT00256854|19648044|P1|STARTED|Overall Study||26
7979789|NCT00256750|19648103|P3|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28
7979790|NCT00256750|19648104|P2|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30
7979791|NCT00256750|19648105|P1|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47
7979792|NCT00256750|19648103|P3|COMPLETED|Long Term Extension (LTE; 84 Months)||127
7979793|NCT00256750|19648104|P2|COMPLETED|Long Term Extension (LTE; 84 Months)||136
7979794|NCT00256750|19648105|P1|COMPLETED|Long Term Extension (LTE; 84 Months)||89
7979795|NCT00256750|19648103|P3|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155
7979796|NCT00256750|19648104|P2|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166
7979797|NCT00256750|19648105|P1|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136
7979798|NCT00256750|19648103|P3|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
7979799|NCT00256750|19648104|P2|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
7979800|NCT00256750|19648105|P1|NOT COMPLETED|Post-Transplant Treated (36 Months)||10
7979801|NCT00256750|19648103|P3|COMPLETED|Post-Transplant Treated (36 Months)||158
7979802|NCT00256750|19648104|P2|COMPLETED|Post-Transplant Treated (36 Months)||170
7979803|NCT00256750|19648105|P1|COMPLETED|Post-Transplant Treated (36 Months)||143
7979804|NCT00256750|19648103|P3|STARTED|Post-Transplant Treated (36 Months)||164
7979805|NCT00256750|19648104|P2|STARTED|Post-Transplant Treated (36 Months)||176
7979806|NCT00256750|19648105|P1|STARTED|Post-Transplant Treated (36 Months)||153
7979807|NCT00256750|19648103|P3|NOT COMPLETED|Post-Transplant Treated (24 Months)||9
7979808|NCT00256750|19648104|P2|NOT COMPLETED|Post-Transplant Treated (24 Months)||7
7979809|NCT00256750|19648105|P1|NOT COMPLETED|Post-Transplant Treated (24 Months)||21
7979810|NCT00256750|19648103|P3|COMPLETED|Post-Transplant Treated (24 Months)||164
7979811|NCT00256750|19648104|P2|COMPLETED|Post-Transplant Treated (24 Months)||176
7979812|NCT00256750|19648105|P1|COMPLETED|Post-Transplant Treated (24 Months)||153
7979813|NCT00256750|19648103|P3|STARTED|Post-Transplant Treated (24 Months)||173
7979814|NCT00256750|19648104|P2|STARTED|Post-Transplant Treated (24 Months)||183
7979815|NCT00256750|19648105|P1|STARTED|Post-Transplant Treated (24 Months)||174
7979816|NCT00256750|19648103|P3|NOT COMPLETED|Post-Transplant Treated (12 Months)||46
7979817|NCT00256750|19648104|P2|NOT COMPLETED|Post-Transplant Treated (12 Months)||43
7979818|NCT00256750|19648105|P1|NOT COMPLETED|Post-Transplant Treated (12 Months)||41
7979819|NCT00256750|19648103|P3|COMPLETED|Post-Transplant Treated (12 Months)||173
7979820|NCT00256750|19648104|P2|COMPLETED|Post-Transplant Treated (12 Months)||183
7979821|NCT00256750|19648105|P1|COMPLETED|Post-Transplant Treated (12 Months)||174
7979822|NCT00256750|19648103|P3|STARTED|Post-Transplant Treated (12 Months)||219
7979823|NCT00256750|19648104|P2|STARTED|Post-Transplant Treated (12 Months)||226
7979824|NCT00256750|19648105|P1|STARTED|Post-Transplant Treated (12 Months)||215
7979825|NCT00256750|19648103|P3|NOT COMPLETED|Transplanted Pre-Treatment||0
7979826|NCT00256750|19648104|P2|NOT COMPLETED|Transplanted Pre-Treatment||0
7979827|NCT00256750|19648105|P1|NOT COMPLETED|Transplanted Pre-Treatment||6
7979828|NCT00256750|19648103|P3|COMPLETED|Transplanted Pre-Treatment||219
7979829|NCT00256750|19648104|P2|COMPLETED|Transplanted Pre-Treatment||226
7979830|NCT00256750|19648105|P1|COMPLETED|Transplanted Pre-Treatment||215
7979831|NCT00256750|19648103|P3|STARTED|Transplanted Pre-Treatment||219
7979832|NCT00256750|19648104|P2|STARTED|Transplanted Pre-Treatment||226
7979833|NCT00256750|19648105|P1|STARTED|Transplanted Pre-Treatment||221
7979834|NCT00256724|19648241|P2|NOT COMPLETED|Overall Study||8
7979835|NCT00256724|19648242|P1|NOT COMPLETED|Overall Study||5
7979836|NCT00256724|19648241|P2|COMPLETED|Overall Study||16
7979837|NCT00256724|19648242|P1|COMPLETED|Overall Study||18
7979838|NCT00256724|19648241|P2|STARTED|Overall Study||24
7979839|NCT00256724|19648242|P1|STARTED|Overall Study||23
7979840|NCT00256698|19648252|P2|NOT COMPLETED|Overall Study||172
7979841|NCT00256698|19648253|P1|NOT COMPLETED|Overall Study||167
7979842|NCT00256698|19648252|P2|COMPLETED|Overall Study||84
7979843|NCT00256698|19648253|P1|COMPLETED|Overall Study||91
7979844|NCT00256698|19648252|P2|STARTED|Overall Study||256
7979845|NCT00256698|19648253|P1|STARTED|Overall Study||258
7979846|NCT00256451|19648271|P4|NOT COMPLETED|Session4||0
7979847|NCT00256451|19648272|P3|NOT COMPLETED|Session4||0
7979848|NCT00256451|19648273|P2|NOT COMPLETED|Session4||0
7979849|NCT00256451|19648274|P1|NOT COMPLETED|Session4||0
7979850|NCT00256451|19648271|P4|COMPLETED|Session4||8
7979851|NCT00256451|19648272|P3|COMPLETED|Session4||10
7979852|NCT00256451|19648273|P2|COMPLETED|Session4||8
7979853|NCT00256451|19648274|P1|COMPLETED|Session4||9
7979854|NCT00256451|19648271|P4|STARTED|Session4||8
7979855|NCT00256451|19648272|P3|STARTED|Session4||10
7979856|NCT00256451|19648273|P2|STARTED|Session4||8
7979857|NCT00256451|19648274|P1|STARTED|Session4||9
7979858|NCT00256451|19648271|P4|NOT COMPLETED|Session3||0
7979859|NCT00256451|19648272|P3|NOT COMPLETED|Session3||0
7979860|NCT00256451|19648273|P2|NOT COMPLETED|Session3||0
7979861|NCT00256451|19648274|P1|NOT COMPLETED|Session3||0
7979862|NCT00256451|19648271|P4|COMPLETED|Session3||9
7979863|NCT00256451|19648272|P3|COMPLETED|Session3||10
7979864|NCT00256451|19648273|P2|COMPLETED|Session3||9
7979865|NCT00256451|19648274|P1|COMPLETED|Session3||9
7979866|NCT00256451|19648271|P4|STARTED|Session3||9
7979867|NCT00256451|19648272|P3|STARTED|Session3||10
7979868|NCT00256451|19648273|P2|STARTED|Session3||9
7979869|NCT00256451|19648274|P1|STARTED|Session3||9
7979870|NCT00256451|19648271|P4|NOT COMPLETED|Session2||0
7979871|NCT00256451|19648272|P3|NOT COMPLETED|Session2||0
7979872|NCT00256451|19648273|P2|NOT COMPLETED|Session2||0
7979873|NCT00256451|19648274|P1|NOT COMPLETED|Session2||0
7979874|NCT00256451|19648271|P4|COMPLETED|Session2||10
7979875|NCT00256451|19648272|P3|COMPLETED|Session2||10
7979876|NCT00256451|19648273|P2|COMPLETED|Session2||11
7979877|NCT00256451|19648274|P1|COMPLETED|Session2||9
7979878|NCT00256451|19648271|P4|STARTED|Session2||10
7979879|NCT00256451|19648272|P3|STARTED|Session2||10
7979880|NCT00256451|19648273|P2|STARTED|Session2||11
7979881|NCT00256451|19648274|P1|STARTED|Session2||9
7979882|NCT00256451|19648271|P4|NOT COMPLETED|Session1||0
7979883|NCT00256451|19648272|P3|NOT COMPLETED|Session1||0
7979884|NCT00256451|19648273|P2|NOT COMPLETED|Session1||0
7979885|NCT00256451|19648274|P1|NOT COMPLETED|Session1||0
7979886|NCT00256451|19648271|P4|COMPLETED|Session1||11
7979887|NCT00256451|19648272|P3|COMPLETED|Session1||11
7979888|NCT00256451|19648273|P2|COMPLETED|Session1||11
7979889|NCT00256451|19648274|P1|COMPLETED|Session1||10
7979890|NCT00256451|19648271|P4|STARTED|Session1||11
7979891|NCT00256451|19648272|P3|STARTED|Session1||11
7979892|NCT00256451|19648273|P2|STARTED|Session1||11
7979893|NCT00256451|19648274|P1|STARTED|Session1||10
7979894|NCT00256308|19648300|P1|NOT COMPLETED|Overall Study||2
7979895|NCT00256308|19648300|P1|COMPLETED|Overall Study||4
7979896|NCT00256308|19648300|P1|STARTED|Overall Study||6
7979897|NCT00256295|19648308|P1|NOT COMPLETED|Overall Study||4
7979898|NCT00256295|19648308|P1|COMPLETED|Overall Study||3
7979899|NCT00256295|19648308|P1|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7
7979900|NCT00256282|19648314|P1|NOT COMPLETED|Overall Study||16
7979901|NCT00256282|19648314|P1|COMPLETED|Overall Study||36
7979902|NCT00256282|19648314|P1|STARTED|Overall Study||52
7979903|NCT00256243|19648319|P1|NOT COMPLETED|Overall Study||10
7979904|NCT00256243|19648319|P1|COMPLETED|Overall Study||38
7979905|NCT00256243|19648319|P1|STARTED|Overall Study||48
7979906|NCT00256204|19648328|P4|NOT COMPLETED|Overall Study||49
7979907|NCT00256204|19648329|P3|NOT COMPLETED|Overall Study||54
7979908|NCT00256204|19648330|P2|NOT COMPLETED|Overall Study||50
7979909|NCT00256204|19648331|P1|NOT COMPLETED|Overall Study||67
7979910|NCT00256204|19648328|P4|COMPLETED|Overall Study||244
7979911|NCT00256204|19648329|P3|COMPLETED|Overall Study||241
7979912|NCT00256204|19648330|P2|COMPLETED|Overall Study||238
7979913|NCT00256204|19648331|P1|COMPLETED|Overall Study||231
7979914|NCT00256204|19648328|P4|STARTED|Overall Study||293
7979915|NCT00256204|19648329|P3|STARTED|Overall Study||295
7979916|NCT00256204|19648330|P2|STARTED|Overall Study||288
7979917|NCT00256204|19648331|P1|STARTED|Overall Study||298
7979918|NCT00256126|19648346|P2|NOT COMPLETED|Overall Study||2
7979919|NCT00256126|19648347|P1|NOT COMPLETED|Overall Study||2
7979920|NCT00256126|19648346|P2|COMPLETED|Overall Study||167
7979921|NCT00256126|19648347|P1|COMPLETED|Overall Study||147
7979922|NCT00256126|19648346|P2|STARTED|Overall Study||169
7979923|NCT00256126|19648347|P1|STARTED|Overall Study||149
7979924|NCT00255970|19648365|P2|NOT COMPLETED|Overall Study||0
7979925|NCT00255970|19648366|P1|NOT COMPLETED|Overall Study||0
7979926|NCT00255970|19648365|P2|COMPLETED|Overall Study||19
7979927|NCT00255970|19648366|P1|COMPLETED|Overall Study||21
7979928|NCT00255970|19648365|P2|Final Visit Week 24|Overall Study||19
7979929|NCT00255970|19648366|P1|Final Visit Week 24|Overall Study||21
7979930|NCT00255970|19648365|P2|Screening Visit|Overall Study||19
7979931|NCT00255970|19648366|P1|Screening Visit|Overall Study||21
7979932|NCT00255970|19648365|P2|STARTED|Overall Study||19
7979933|NCT00255970|19648366|P1|STARTED|Overall Study||21
7979934|NCT00255944|19648386|P2|NOT COMPLETED|Overall Study||834
7979935|NCT00255944|19648387|P1|NOT COMPLETED|Overall Study||797
7979936|NCT00255944|19648386|P2|COMPLETED|Overall Study||477
7979937|NCT00255944|19648387|P1|COMPLETED|Overall Study||514
7979938|NCT00255944|19648386|P2|STARTED|Overall Study||1311
7979939|NCT00255944|19648387|P1|STARTED|Overall Study||1311
7979940|NCT00255840|19648395|P2|NOT COMPLETED|Overall Study||70
7979941|NCT00255840|19648396|P1|NOT COMPLETED|Overall Study||63
7979942|NCT00255840|19648395|P2|COMPLETED|Overall Study||334
7979943|NCT00255840|19648396|P1|COMPLETED|Overall Study||345
7979944|NCT00255840|19648395|P2|STARTED|Overall Study||404
7979945|NCT00255840|19648396|P1|STARTED|Overall Study||408
7979946|NCT00255801|19648402|P1|NOT COMPLETED|Overall Study||0
7979947|NCT00255801|19648402|P1|COMPLETED|Overall Study||37
7979948|NCT00255801|19648402|P1|STARTED|Overall Study||37
7979949|NCT00255723|19648409|P2|NOT COMPLETED|Overall Study||2
7979950|NCT00255723|19648410|P1|NOT COMPLETED|Overall Study||2
7979951|NCT00255723|19648409|P2|COMPLETED|Overall Study||39
7979952|NCT00255723|19648410|P1|COMPLETED|Overall Study||54
7979953|NCT00255723|19648409|P2|STARTED|Overall Study||41
7979954|NCT00255723|19648410|P1|STARTED|Overall Study||56
7979955|NCT00255684|19648416|P1|NOT COMPLETED|Overall Study||0
7979956|NCT00255684|19648416|P1|COMPLETED|Overall Study||16
7979957|NCT00255684|19648416|P1|STARTED|Overall Study||16
7979958|NCT00255346|19648426|P5|NOT COMPLETED|Overall Study||0
7979959|NCT00255346|19648427|P4|NOT COMPLETED|Overall Study||0
7979960|NCT00255346|19648428|P3|NOT COMPLETED|Overall Study||0
7979961|NCT00255346|19648429|P2|NOT COMPLETED|Overall Study||0
7979962|NCT00255346|19648430|P1|NOT COMPLETED|Overall Study||1
7979963|NCT00255346|19648426|P5|COMPLETED|Overall Study||33
7979964|NCT00255346|19648427|P4|COMPLETED|Overall Study||11
7979965|NCT00255346|19648428|P3|COMPLETED|Overall Study||8
7979966|NCT00255346|19648429|P2|COMPLETED|Overall Study||6
7979967|NCT00255346|19648430|P1|COMPLETED|Overall Study||9
7979968|NCT00255346|19648426|P5|STARTED|Overall Study||33
7979969|NCT00255346|19648427|P4|STARTED|Overall Study||11
7979970|NCT00255346|19648428|P3|STARTED|Overall Study||8
7979971|NCT00255346|19648429|P2|STARTED|Overall Study||6
7979972|NCT00255346|19648430|P1|STARTED|Overall Study||10
7979973|NCT00255190|19648445|P2|NOT COMPLETED|Overall Study||157
7979974|NCT00255190|19648446|P1|NOT COMPLETED|Overall Study||50
7979975|NCT00255190|19648445|P2|COMPLETED|Overall Study||281
7979976|NCT00255190|19648446|P1|COMPLETED|Overall Study||103
7979977|NCT00255190|19648445|P2|STARTED|Overall Study||438
7979978|NCT00255190|19648446|P1|STARTED|Overall Study||153
7979979|NCT00255177|19648514|P4|NOT COMPLETED|Overall Study||2
7979980|NCT00255177|19648515|P3|NOT COMPLETED|Overall Study||1
7979981|NCT00255177|19648516|P2|NOT COMPLETED|Overall Study||1
7979982|NCT00255177|19648517|P1|NOT COMPLETED|Overall Study||2
7979983|NCT00255177|19648514|P4|COMPLETED|Overall Study||4
7979984|NCT00255177|19648515|P3|COMPLETED|Overall Study||12
7979985|NCT00255177|19648516|P2|COMPLETED|Overall Study||13
7979986|NCT00255177|19648517|P1|COMPLETED|Overall Study||9
7979987|NCT00255177|19648514|P4|STARTED|Overall Study||6
7979988|NCT00255177|19648515|P3|STARTED|Overall Study||13
7979989|NCT00255177|19648516|P2|STARTED|Overall Study||14
7979990|NCT00255177|19648517|P1|STARTED|Overall Study||11
7979991|NCT00255164|19648530|P3|NOT COMPLETED|Overall Study||49
7979992|NCT00255164|19648531|P2|NOT COMPLETED|Overall Study||49
7979993|NCT00255164|19648532|P1|NOT COMPLETED|Overall Study||123
7979994|NCT00255164|19648530|P3|COMPLETED|Overall Study||103
7979995|NCT00255164|19648531|P2|COMPLETED|Overall Study||110
7979996|NCT00255164|19648532|P1|COMPLETED|Overall Study||17
7979997|NCT00255164|19648530|P3|STARTED|Overall Study||152
7979998|NCT00255164|19648531|P2|STARTED|Overall Study||159
7979999|NCT00255164|19648532|P1|STARTED|Overall Study||140
7980000|NCT00255151|19648558|P3|NOT COMPLETED|Overall Study||49
7980001|NCT00255151|19648559|P2|NOT COMPLETED|Overall Study||49
7980002|NCT00255151|19648560|P1|NOT COMPLETED|Overall Study||123
7980003|NCT00255151|19648558|P3|COMPLETED|Overall Study||103
7980004|NCT00255151|19648559|P2|COMPLETED|Overall Study||110
7980005|NCT00255151|19648560|P1|COMPLETED|Overall Study||17
7980006|NCT00255151|19648558|P3|STARTED|Overall Study||152
7980007|NCT00255151|19648559|P2|STARTED|Overall Study||159
7980008|NCT00255151|19648560|P1|STARTED|Overall Study||140
7980009|NCT00255125|19648585|P2|NOT COMPLETED|Overall Study||0
7980010|NCT00255125|19648586|P1|NOT COMPLETED|Overall Study||0
7980011|NCT00255125|19648585|P2|COMPLETED|Overall Study||44
7980012|NCT00255125|19648586|P1|COMPLETED|Overall Study||42
7980013|NCT00255125|19648585|P2|STARTED|Overall Study||44
7980014|NCT00255125|19648586|P1|STARTED|Overall Study||42
7980015|NCT00255086|19648598|P2|NOT COMPLETED|Overall Study||2
7980016|NCT00255086|19648599|P1|NOT COMPLETED|Overall Study||2
7980017|NCT00255086|19648598|P2|COMPLETED|Overall Study||6
7980018|NCT00255086|19648599|P1|COMPLETED|Overall Study||7
7980019|NCT00255086|19648598|P2|STARTED|Overall Study||8
7980020|NCT00255086|19648599|P1|STARTED|Overall Study||9
7980021|NCT00255047|19648611|P4|NOT COMPLETED|Overall Study||46
7980022|NCT00255047|19648612|P3|NOT COMPLETED|Overall Study||50
7980023|NCT00255047|19648613|P2|NOT COMPLETED|Overall Study||48
7980024|NCT00255047|19648614|P1|NOT COMPLETED|Overall Study||48
7980025|NCT00255047|19648611|P4|COMPLETED|Overall Study||502
7980026|NCT00255047|19648612|P3|COMPLETED|Overall Study||496
7980027|NCT00255047|19648613|P2|COMPLETED|Overall Study||487
7980028|NCT00255047|19648614|P1|COMPLETED|Overall Study||490
7980029|NCT00255047|19648611|P4|STARTED|Overall Study||548
7980030|NCT00255047|19648612|P3|STARTED|Overall Study||546
7980031|NCT00255047|19648613|P2|STARTED|Overall Study||535
7980032|NCT00255047|19648614|P1|STARTED|Overall Study||538
7980033|NCT00255034|19648638|P2|NOT COMPLETED|Overall Study||38
7980034|NCT00255034|19648639|P1|NOT COMPLETED|Overall Study||15
7980035|NCT00255034|19648638|P2|COMPLETED|Overall Study||26
7980036|NCT00255034|19648639|P1|COMPLETED|Overall Study||64
7980037|NCT00255034|19648638|P2|STARTED|Overall Study||64
7980038|NCT00255034|19648639|P1|STARTED|Overall Study||79
7980039|NCT00255008|19648649|P4|NOT COMPLETED|Overall Study||22
7980040|NCT00255008|19648650|P3|NOT COMPLETED|Overall Study||16
7980041|NCT00255008|19648651|P2|NOT COMPLETED|Overall Study||9
7980042|NCT00255008|19648652|P1|NOT COMPLETED|Overall Study||32
7980043|NCT00255008|19648649|P4|COMPLETED|Overall Study||12
7980044|NCT00255008|19648650|P3|COMPLETED|Overall Study||17
7980045|NCT00255008|19648651|P2|COMPLETED|Overall Study||0
7980046|NCT00255008|19648652|P1|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13
7980047|NCT00255008|19648649|P4|STARTED|Overall Study||34
7980048|NCT00255008|19648650|P3|STARTED|Overall Study||33
7980049|NCT00255008|19648651|P2|STARTED|Overall Study||9
7980050|NCT00255008|19648652|P1|STARTED|Overall Study||45
7980051|NCT00254995|19648664|P2|NOT COMPLETED|Overall Study||0
7980052|NCT00254995|19648665|P1|NOT COMPLETED|Overall Study||0
7980053|NCT00254995|19648664|P2|COMPLETED|Overall Study||31065
7980054|NCT00254995|19648665|P1|COMPLETED|Overall Study||31561
7980055|NCT00254995|19648664|P2|STARTED|Overall Study||31065
7980056|NCT00254995|19648665|P1|STARTED|Overall Study||31561
7980057|NCT00254982|19648688|P2|NOT COMPLETED|Overall Study||31
7980058|NCT00254982|19648689|P1|NOT COMPLETED|Overall Study||36
7980059|NCT00254982|19648688|P2|COMPLETED|Overall Study||265
7980060|NCT00254982|19648689|P1|COMPLETED|Overall Study||261
7980061|NCT00254982|19648688|P2|STARTED|Overall Study||296
7980062|NCT00254982|19648689|P1|STARTED|Overall Study||297
7980063|NCT00254592|19648695|P1|NOT COMPLETED|Overall Study||2
7980064|NCT00254592|19648695|P1|COMPLETED|Overall Study||41
7980065|NCT00254592|19648695|P1|STARTED|Overall Study||43
7980066|NCT00254566|19648701|P2|NOT COMPLETED|Overall Study||26
7980067|NCT00254566|19648702|P1|NOT COMPLETED|Overall Study||31
7980068|NCT00254566|19648701|P2|COMPLETED|Overall Study||172
7980069|NCT00254566|19648702|P1|COMPLETED|Overall Study||167
7980070|NCT00254566|19648701|P2|STARTED|Overall Study||198
7980071|NCT00254566|19648702|P1|STARTED|Overall Study||198
7980072|NCT00254540|19648726|P2|NOT COMPLETED|Overall Study||22
7980073|NCT00254540|19648727|P1|NOT COMPLETED|Overall Study||19
7980074|NCT00254540|19648726|P2|COMPLETED|Overall Study||4
7980075|NCT00254540|19648727|P1|COMPLETED|Overall Study||6
7980076|NCT00254540|19648726|P2|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26
7980077|NCT00254540|19648727|P1|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25
7980078|NCT00254501|19648756|P2|NOT COMPLETED|Overall Study||1
7980079|NCT00254501|19648757|P1|NOT COMPLETED|Overall Study||1
7980080|NCT00254501|19648756|P2|COMPLETED|Overall Study||36
7980081|NCT00254501|19648757|P1|COMPLETED|Overall Study||31
7980082|NCT00254501|19648756|P2|STARTED|Overall Study||37
7980083|NCT00254501|19648757|P1|STARTED|Overall Study||32
7980084|NCT00254488|19648771|P2|NOT COMPLETED|Overall Study||49
7980085|NCT00254488|19648772|P1|NOT COMPLETED|Overall Study||57
7980086|NCT00254488|19648771|P2|COMPLETED|Overall Study||63
7980087|NCT00254488|19648772|P1|COMPLETED|Overall Study||55
7980088|NCT00254488|19648771|P2|STARTED|Overall Study||112
7980089|NCT00254488|19648772|P1|STARTED|Overall Study||112
7980090|NCT00254462|19648782|P2|NOT COMPLETED|Overall Study||10
7980091|NCT00254462|19648783|P1|NOT COMPLETED|Overall Study||8
7980092|NCT00254462|19648782|P2|COMPLETED|Overall Study||39
7980093|NCT00254462|19648783|P1|COMPLETED|Overall Study||36
7980094|NCT00254462|19648782|P2|STARTED|Overall Study||49
7980095|NCT00254462|19648783|P1|STARTED|Overall Study||44
7980096|NCT00254410|19648791|P1|NOT COMPLETED|Overall Study||0
7980097|NCT00254410|19648791|P1|COMPLETED|Overall Study||30
7980098|NCT00254410|19648791|P1|STARTED|Overall Study||30
7980099|NCT00254397|19648802|P4|NOT COMPLETED|Overall Study||25
7980100|NCT00254397|19648803|P3|NOT COMPLETED|Overall Study||19
7980101|NCT00254397|19648804|P2|NOT COMPLETED|Overall Study||1
7980102|NCT00254397|19648805|P1|NOT COMPLETED|Overall Study||6
7980103|NCT00254397|19648802|P4|COMPLETED|Overall Study||20
7980104|NCT00254397|19648803|P3|COMPLETED|Overall Study||18
7980105|NCT00254397|19648804|P2|COMPLETED|Overall Study||5
7980106|NCT00254397|19648805|P1|COMPLETED|Overall Study||4
7980107|NCT00254397|19648802|P4|STARTED|Overall Study||45
7980108|NCT00254397|19648803|P3|STARTED|Overall Study||37
7980109|NCT00254397|19648804|P2|STARTED|Overall Study||6
7980110|NCT00254397|19648805|P1|STARTED|Overall Study||10
7980111|NCT00254293|19648829|P7|NOT COMPLETED|LTE Open Label Fixed Dosing||13
7980112|NCT00254293|19648830|P6|NOT COMPLETED|LTE Open Label Fixed Dosing||0
7980113|NCT00254293|19648831|P5|NOT COMPLETED|LTE Open Label Fixed Dosing||0
7980114|NCT00254293|19648832|P4|NOT COMPLETED|LTE Open Label Fixed Dosing||0
7980115|NCT00254293|19648833|P3|NOT COMPLETED|LTE Open Label Fixed Dosing||0
7980116|NCT00254293|19648834|P2|NOT COMPLETED|LTE Open Label Fixed Dosing||0
7980117|NCT00254293|19648835|P1|NOT COMPLETED|LTE Open Label Fixed Dosing||0
7980118|NCT00254293|19648829|P7|COMPLETED|LTE Open Label Fixed Dosing||35
7980119|NCT00254293|19648830|P6|COMPLETED|LTE Open Label Fixed Dosing||0
7980120|NCT00254293|19648831|P5|COMPLETED|LTE Open Label Fixed Dosing||0
7980121|NCT00254293|19648832|P4|COMPLETED|LTE Open Label Fixed Dosing||0
7980122|NCT00254293|19648833|P3|COMPLETED|LTE Open Label Fixed Dosing||0
7980123|NCT00254293|19648834|P2|COMPLETED|LTE Open Label Fixed Dosing||0
7980124|NCT00254293|19648835|P1|COMPLETED|LTE Open Label Fixed Dosing||0
7980125|NCT00254293|19648829|P7|STARTED|LTE Open Label Fixed Dosing||48
7980126|NCT00254293|19648830|P6|STARTED|LTE Open Label Fixed Dosing||0
7980127|NCT00254293|19648831|P5|STARTED|LTE Open Label Fixed Dosing||0
7980128|NCT00254293|19648832|P4|STARTED|LTE Open Label Fixed Dosing||0
7980129|NCT00254293|19648833|P3|STARTED|LTE Open Label Fixed Dosing||0
7980130|NCT00254293|19648834|P2|STARTED|LTE Open Label Fixed Dosing||0
7980131|NCT00254293|19648835|P1|STARTED|LTE Open Label Fixed Dosing||0
7980132|NCT00254293|19648829|P7|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
7980133|NCT00254293|19648830|P6|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
7980134|NCT00254293|19648831|P5|NOT COMPLETED|LTE Open Label Variable SC Dosing||2
7980135|NCT00254293|19648832|P4|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
7980136|NCT00254293|19648833|P3|NOT COMPLETED|LTE Open Label Variable SC Dosing||10
7980137|NCT00254293|19648834|P2|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
7980138|NCT00254293|19648835|P1|NOT COMPLETED|LTE Open Label Variable SC Dosing||3
7980139|NCT00254293|19648829|P7|COMPLETED|LTE Open Label Variable SC Dosing||0
7980140|NCT00254293|19648830|P6|COMPLETED|LTE Open Label Variable SC Dosing||0
7980141|NCT00254293|19648831|P5|COMPLETED|LTE Open Label Variable SC Dosing||8
7980142|NCT00254293|19648832|P4|COMPLETED|LTE Open Label Variable SC Dosing||0
7980143|NCT00254293|19648833|P3|COMPLETED|LTE Open Label Variable SC Dosing||32
7980144|NCT00254293|19648834|P2|COMPLETED|LTE Open Label Variable SC Dosing||0
7980145|NCT00254293|19648835|P1|COMPLETED|LTE Open Label Variable SC Dosing||8
7980146|NCT00254293|19648829|P7|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0
7980147|NCT00254293|19648830|P6|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0
7980148|NCT00254293|19648831|P5|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10
7980149|NCT00254293|19648832|P4|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
7980150|NCT00254293|19648833|P3|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42
7980151|NCT00254293|19648834|P2|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
7980152|NCT00254293|19648835|P1|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11
7980153|NCT00254293|19648829|P7|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
7980154|NCT00254293|19648830|P6|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
7980155|NCT00254293|19648831|P5|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
7980156|NCT00254293|19648832|P4|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
7980157|NCT00254293|19648833|P3|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3
7980158|NCT00254293|19648834|P2|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
7980159|NCT00254293|19648835|P1|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
7980160|NCT00254293|19648829|P7|COMPLETED|Short Term (12 Week) Randomized Dosing||0
7980161|NCT00254293|19648830|P6|COMPLETED|Short Term (12 Week) Randomized Dosing||17
7980162|NCT00254293|19648831|P5|COMPLETED|Short Term (12 Week) Randomized Dosing||5
7980163|NCT00254293|19648832|P4|COMPLETED|Short Term (12 Week) Randomized Dosing||5
7980164|NCT00254293|19648833|P3|COMPLETED|Short Term (12 Week) Randomized Dosing||26
7980165|NCT00254293|19648834|P2|COMPLETED|Short Term (12 Week) Randomized Dosing||3
7980166|NCT00254293|19648835|P1|COMPLETED|Short Term (12 Week) Randomized Dosing||7
7980167|NCT00254293|19648829|P7|STARTED|Short Term (12 Week) Randomized Dosing||0
7980168|NCT00254293|19648830|P6|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17
7980169|NCT00254293|19648831|P5|STARTED|Short Term (12 Week) Randomized Dosing||5
7980170|NCT00254293|19648832|P4|STARTED|Short Term (12 Week) Randomized Dosing||6
7980171|NCT00254293|19648833|P3|STARTED|Short Term (12 Week) Randomized Dosing||29
7980172|NCT00254293|19648834|P2|STARTED|Short Term (12 Week) Randomized Dosing||4
7980173|NCT00254293|19648835|P1|STARTED|Short Term (12 Week) Randomized Dosing||7
7980174|NCT00254163|19648918|P2|NOT COMPLETED|Overall Study||46
7980175|NCT00254163|19648919|P1|NOT COMPLETED|Overall Study||45
7980176|NCT00254163|19648918|P2|COMPLETED|Overall Study||46
7980177|NCT00254163|19648919|P1|COMPLETED|Overall Study||47
7980178|NCT00254163|19648918|P2|STARTED|Overall Study||92
7980179|NCT00254163|19648919|P1|STARTED|Overall Study||92
7980180|NCT00254072|19648943|P2|NOT COMPLETED|Overall Study||0
7980181|NCT00254072|19648944|P1|NOT COMPLETED|Overall Study||0
7980182|NCT00254072|19648943|P2|COMPLETED|Overall Study||175
7980183|NCT00254072|19648944|P1|COMPLETED|Overall Study||180
7980184|NCT00254072|19648943|P2|STARTED|Overall Study||175
7980185|NCT00254072|19648944|P1|STARTED|Overall Study||180
7980186|NCT00253981|19648952|P2|NOT COMPLETED|Overall Study||0
7980187|NCT00253981|19648953|P1|NOT COMPLETED|Overall Study||0
7980188|NCT00253981|19648952|P2|COMPLETED|Overall Study||14
7980189|NCT00253981|19648953|P1|COMPLETED|Overall Study||16
7980190|NCT00253981|19648952|P2|STARTED|Overall Study||14
7980191|NCT00253981|19648953|P1|STARTED|Overall Study||16
7980192|NCT00253890|19648961|P2|NOT COMPLETED|Overall Study||7
7980193|NCT00253890|19648962|P1|NOT COMPLETED|Overall Study||7
7980194|NCT00253890|19648961|P2|COMPLETED|Overall Study||61
7980195|NCT00253890|19648962|P1|COMPLETED|Overall Study||62
7980196|NCT00253890|19648961|P2|STARTED|Overall Study||68
7980197|NCT00253890|19648962|P1|STARTED|Overall Study||69
7980198|NCT00253747|19648970|P2|NOT COMPLETED|Overall Study||27
7980199|NCT00253747|19648971|P1|NOT COMPLETED|Overall Study||24
7980200|NCT00253747|19648970|P2|COMPLETED|Overall Study||101
7980201|NCT00253747|19648971|P1|COMPLETED|Overall Study||103
7980202|NCT00253747|19648970|P2|STARTED|Overall Study||128
7980203|NCT00253747|19648971|P1|STARTED|Overall Study||127
7980204|NCT00253708|19648992|P3|NOT COMPLETED|Overall Study||1
7980205|NCT00253708|19648993|P2|NOT COMPLETED|Overall Study||0
7980206|NCT00253708|19648994|P1|NOT COMPLETED|Overall Study||0
7980207|NCT00253708|19648992|P3|COMPLETED|Overall Study||8
7980208|NCT00253708|19648993|P2|COMPLETED|Overall Study||10
7980209|NCT00253708|19648994|P1|COMPLETED|Overall Study||20
7980210|NCT00253708|19648992|P3|STARTED|Overall Study||9
7980211|NCT00253708|19648993|P2|STARTED|Overall Study||10
7980212|NCT00253708|19648994|P1|STARTED|Overall Study||20
7980213|NCT00253643|19649024|P4|NOT COMPLETED|Overall Study||3
7980214|NCT00253643|19649025|P3|NOT COMPLETED|Overall Study||1
7980215|NCT00253643|19649026|P2|NOT COMPLETED|Overall Study||0
7980216|NCT00253643|19649027|P1|NOT COMPLETED|Overall Study||0
7980217|NCT00253643|19649024|P4|COMPLETED|Overall Study||28
7980218|NCT00253643|19649025|P3|COMPLETED|Overall Study||28
7980219|NCT00253643|19649026|P2|COMPLETED|Overall Study||15
7980220|NCT00253643|19649027|P1|COMPLETED|Overall Study||14
7980221|NCT00253643|19649024|P4|STARTED|Overall Study||31
7980222|NCT00253643|19649025|P3|STARTED|Overall Study||29
7980223|NCT00253643|19649026|P2|STARTED|Overall Study||15
7980224|NCT00253643|19649027|P1|STARTED|Overall Study||14
7980225|NCT00253630|19649041|P1|NOT COMPLETED|Overall Study||2
7980226|NCT00253630|19649041|P1|COMPLETED|Overall Study||35
7980227|NCT00253630|19649041|P1|STARTED|Overall Study||37
7980228|NCT00253513|19649050|P1|NOT COMPLETED|Overall Study||0
7980229|NCT00253513|19649050|P1|COMPLETED|Overall Study||60
7980230|NCT00253513|19649050|P1|STARTED|Overall Study||60
7980231|NCT00253448|19649057|P1|NOT COMPLETED|Overall Study||1
7980232|NCT00253448|19649057|P1|COMPLETED|Overall Study||34
7980233|NCT00253448|19649057|P1|STARTED|Overall Study||35
7980234|NCT00253435|19649063|P2|NOT COMPLETED|Overall Study||0
7980235|NCT00253435|19649064|P1|NOT COMPLETED|Overall Study||0
7980236|NCT00253435|19649063|P2|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8
7980237|NCT00253435|19649064|P1|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42
7980238|NCT00253435|19649063|P2|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
7980239|NCT00253435|19649064|P1|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10
7980240|NCT00253435|19649063|P2|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
7980241|NCT00253435|19649064|P1|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10
7980242|NCT00253435|19649063|P2|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8
7980243|NCT00253435|19649064|P1|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15
7980244|NCT00253435|19649063|P2|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8
7980245|NCT00253435|19649064|P1|STARTED|Overall Study|Total number is 42|42
7980246|NCT00253370|19649076|P1|NOT COMPLETED|Overall Study||43
7980247|NCT00253370|19649076|P1|COMPLETED|Overall Study||1
7980248|NCT00253370|19649076|P1|STARTED|Overall Study||44
7980249|NCT00253019|19649085|P3|NOT COMPLETED|Overall Study||18
7980250|NCT00253019|19649086|P2|NOT COMPLETED|Overall Study||31
7980251|NCT00253019|19649087|P1|NOT COMPLETED|Overall Study||29
7980252|NCT00253019|19649085|P3|COMPLETED|Overall Study||83
7980253|NCT00253019|19649086|P2|COMPLETED|Overall Study||78
7980254|NCT00253019|19649087|P1|COMPLETED|Overall Study||82
7980255|NCT00253019|19649085|P3|STARTED|Overall Study||101
7980256|NCT00253019|19649086|P2|STARTED|Overall Study||109
7980257|NCT00253019|19649087|P1|STARTED|Overall Study||111
7980258|NCT00252967|19649097|P2|NOT COMPLETED|Overall Study||0
7980259|NCT00252967|19649098|P1|NOT COMPLETED|Overall Study||0
7980260|NCT00252967|19649097|P2|COMPLETED|Overall Study||33
7980261|NCT00252967|19649098|P1|COMPLETED|Overall Study||31
7980262|NCT00252967|19649097|P2|STARTED|Overall Study||33
7980263|NCT00252967|19649098|P1|STARTED|Overall Study||31
7980264|NCT00252733|19649122|P2|NOT COMPLETED|Overall Study||92
7980265|NCT00252733|19649123|P1|NOT COMPLETED|Overall Study||106
7980266|NCT00252733|19649122|P2|COMPLETED|Overall Study||618
7980267|NCT00252733|19649123|P1|COMPLETED|Overall Study||605
7980268|NCT00252733|19649122|P2|STARTED|Overall Study||710
7980269|NCT00252733|19649123|P1|STARTED|Overall Study||711
7980270|NCT00252720|19649133|P2|NOT COMPLETED|Overall Study||165
7980271|NCT00252720|19649134|P1|NOT COMPLETED|Overall Study||132
7980272|NCT00252720|19649133|P2|COMPLETED|Overall Study||789
7980273|NCT00252720|19649134|P1|COMPLETED|Overall Study||819
7980274|NCT00252720|19649133|P2|STARTED|Overall Study||954
7980275|NCT00252720|19649134|P1|STARTED|Overall Study||951
7980276|NCT00252694|19649148|P2|NOT COMPLETED|Overall Study||154
7980277|NCT00252694|19649149|P1|NOT COMPLETED|Overall Study||144
7980278|NCT00252694|19649148|P2|COMPLETED|Overall Study||800
7980279|NCT00252694|19649149|P1|COMPLETED|Overall Study||807
7980280|NCT00252694|19649148|P2|STARTED|Overall Study||954
7980281|NCT00252694|19649149|P1|STARTED|Overall Study||951
7980282|NCT00252629|19649164|P3|NOT COMPLETED|Overall Study||0
7980283|NCT00252629|19649165|P2|NOT COMPLETED|Overall Study||0
7980284|NCT00252629|19649166|P1|NOT COMPLETED|Overall Study||1
7980285|NCT00252629|19649164|P3|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
7980286|NCT00252629|19649165|P2|COMPLETED|Overall Study||9
7980287|NCT00252629|19649166|P1|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8
7980288|NCT00252629|19649164|P3|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
7980289|NCT00252629|19649165|P2|STARTED|Overall Study||9
7980290|NCT00252629|19649166|P1|STARTED|Overall Study||9
7980291|NCT00252590|19649182|P3|NOT COMPLETED|Overall Study||3
7980292|NCT00252590|19649183|P2|NOT COMPLETED|Overall Study||2
7980293|NCT00252590|19649184|P1|NOT COMPLETED|Overall Study||2
7980294|NCT00252590|19649182|P3|COMPLETED|Overall Study||31
7980295|NCT00252590|19649183|P2|COMPLETED|Overall Study||28
7980296|NCT00252590|19649184|P1|COMPLETED|Overall Study||33
7980297|NCT00252590|19649182|P3|STARTED|Overall Study||34
7980298|NCT00252590|19649183|P2|STARTED|Overall Study||30
7980299|NCT00252590|19649184|P1|STARTED|Overall Study||35
7980300|NCT00252577|19649195|P1|NOT COMPLETED|Overall Study||20
7980301|NCT00252577|19649195|P1|COMPLETED|Overall Study||110
7980302|NCT00252577|19649195|P1|STARTED|Overall Study||130
7980303|NCT00252564|19649201|P2|NOT COMPLETED|Overall Study||44
7980304|NCT00252564|19649202|P1|NOT COMPLETED|Overall Study||39
7980305|NCT00252564|19649201|P2|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79
7980306|NCT00252564|19649202|P1|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85
7980307|NCT00252564|19649201|P2|STARTED|Overall Study|From randomization|123
7980308|NCT00252564|19649202|P1|STARTED|Overall Study|From randomization|124
7980309|NCT00252538|19649214|P2|NOT COMPLETED|Overall Study||0
7980310|NCT00252538|19649215|P1|NOT COMPLETED|Overall Study||0
7980311|NCT00252538|19649214|P2|COMPLETED|Overall Study||114
7980312|NCT00252538|19649215|P1|COMPLETED|Overall Study||19
7980313|NCT00252538|19649214|P2|STARTED|Overall Study||114
7980314|NCT00252538|19649215|P1|STARTED|Overall Study||19
7980315|NCT00252512|19649222|P2|NOT COMPLETED|12 Month Follow up||1
7980316|NCT00252512|19649223|P1|NOT COMPLETED|12 Month Follow up||9
7980317|NCT00252512|19649222|P2|COMPLETED|12 Month Follow up||121
7980318|NCT00252512|19649223|P1|COMPLETED|12 Month Follow up||123
7980319|NCT00252512|19649222|P2|STARTED|12 Month Follow up||122
7980320|NCT00252512|19649223|P1|STARTED|12 Month Follow up||132
7980321|NCT00252512|19649222|P2|NOT COMPLETED|Six Month Follow up||12
7980322|NCT00252512|19649223|P1|NOT COMPLETED|Six Month Follow up||4
7980323|NCT00252512|19649222|P2|COMPLETED|Six Month Follow up||122
7980324|NCT00252512|19649223|P1|COMPLETED|Six Month Follow up||132
7980325|NCT00252512|19649222|P2|STARTED|Six Month Follow up||134
7980326|NCT00252512|19649223|P1|STARTED|Six Month Follow up||136
7980327|NCT00252512|19649222|P2|NOT COMPLETED|Intervention||31
7980328|NCT00252512|19649223|P1|NOT COMPLETED|Intervention||29
7980329|NCT00252512|19649222|P2|COMPLETED|Intervention||134
7980330|NCT00252512|19649223|P1|COMPLETED|Intervention||136
7980331|NCT00252512|19649222|P2|STARTED|Intervention||165
7980332|NCT00252512|19649223|P1|STARTED|Intervention||165
7980333|NCT00252499|19649242|P3|NOT COMPLETED|Overall Study||0
7980334|NCT00252499|19649243|P2|NOT COMPLETED|Overall Study||0
7980335|NCT00252499|19649244|P1|NOT COMPLETED|Overall Study||1
7980336|NCT00252499|19649242|P3|COMPLETED|Overall Study||6
7980337|NCT00252499|19649243|P2|COMPLETED|Overall Study||2
7980338|NCT00252499|19649244|P1|COMPLETED|Overall Study||4
7980339|NCT00252499|19649242|P3|STARTED|Overall Study||6
7980340|NCT00252499|19649243|P2|STARTED|Overall Study||2
7980341|NCT00252499|19649244|P1|STARTED|Overall Study||5
7980342|NCT00252382|19649267|P1|NOT COMPLETED|Overall Study||26
7980343|NCT00252382|19649267|P1|COMPLETED|Overall Study||5
7980344|NCT00252382|19649267|P1|STARTED|Overall Study||31
7980345|NCT00252239|19649276|P4|NOT COMPLETED|Overall Study||1
7980346|NCT00252239|19649277|P3|NOT COMPLETED|Overall Study||2
7980347|NCT00252239|19649278|P2|NOT COMPLETED|Overall Study||0
7980348|NCT00252239|19649279|P1|NOT COMPLETED|Overall Study||1
7980349|NCT00252239|19649276|P4|COMPLETED|Overall Study||30
7980350|NCT00252239|19649277|P3|COMPLETED|Overall Study||17
7980351|NCT00252239|19649278|P2|COMPLETED|Overall Study||31
7980352|NCT00252239|19649279|P1|COMPLETED|Overall Study||30
7980353|NCT00252239|19649276|P4|STARTED|Overall Study||31
7980354|NCT00252239|19649277|P3|STARTED|Overall Study||19
7980355|NCT00252239|19649278|P2|STARTED|Overall Study||31
7980356|NCT00252239|19649279|P1|STARTED|Overall Study||31
7980357|NCT00252187|19649291|P2|NOT COMPLETED|Overall Study||1
7980358|NCT00252187|19649292|P1|NOT COMPLETED|Overall Study||4
7980359|NCT00252187|19649291|P2|COMPLETED|Overall Study||20
7980360|NCT00252187|19649292|P1|COMPLETED|Overall Study||20
7980361|NCT00252187|19649291|P2|STARTED|Overall Study||21
7980362|NCT00252187|19649292|P1|STARTED|Overall Study||24
7980363|NCT00252174|19649315|P3|NOT COMPLETED|Overall Study||0
7980364|NCT00252174|19649316|P2|NOT COMPLETED|Overall Study||1
7980365|NCT00252174|19649317|P1|NOT COMPLETED|Overall Study||0
7980366|NCT00252174|19649315|P3|COMPLETED|Overall Study||0
7980367|NCT00252174|19649316|P2|COMPLETED|Overall Study||1
7980368|NCT00252174|19649317|P1|COMPLETED|Overall Study||0
7980369|NCT00252174|19649315|P3|STARTED|Overall Study|No subjects entered Stage 2|0
7980370|NCT00252174|19649316|P2|STARTED|Overall Study|2 subjects entered the control arm in total|2
7980371|NCT00252174|19649317|P1|STARTED|Overall Study|No subjects were randomized into Active Arm as only 2 subjects were randomized into the Control Arm.|0
7980372|NCT00252057|19649357|P2|NOT COMPLETED|Overall Study||8
7980373|NCT00252057|19649358|P1|NOT COMPLETED|Overall Study||3
7980374|NCT00252057|19649357|P2|COMPLETED|Overall Study||368
7980375|NCT00252057|19649358|P1|COMPLETED|Overall Study||370
7980376|NCT00252057|19649357|P2|STARTED|Overall Study||376
7980377|NCT00252057|19649358|P1|STARTED|Overall Study||373
7980378|NCT00251979|19649366|P2|NOT COMPLETED|Overall Study||40
7980379|NCT00251979|19649367|P1|NOT COMPLETED|Overall Study||38
7980380|NCT00251979|19649366|P2|COMPLETED|Overall Study||349
7980381|NCT00251979|19649367|P1|COMPLETED|Overall Study||337
7980382|NCT00251979|19649366|P2|STARTED|Overall Study|ITT population|389
7980383|NCT00251979|19649367|P1|STARTED|Overall Study|ITT population|375
7980384|NCT00251927|19649399|P2|NOT COMPLETED|Overall Study||74
7980385|NCT00251927|19649400|P1|NOT COMPLETED|Overall Study||108
7980386|NCT00251927|19649399|P2|COMPLETED|Overall Study|Completed 5 year visit|192
7980387|NCT00251927|19649400|P1|COMPLETED|Overall Study|Completed 5 year visit|180
7980388|NCT00251927|19649399|P2|STARTED|Overall Study|Randomised|266
7980389|NCT00251927|19649400|P1|STARTED|Overall Study|Randomised|288
7980390|NCT00251862|19649430|P3|NOT COMPLETED|Overall Study||0
7980391|NCT00251862|19649431|P2|NOT COMPLETED|Overall Study||0
7980392|NCT00251862|19649432|P1|NOT COMPLETED|Overall Study||0
7980393|NCT00251862|19649430|P3|COMPLETED|Overall Study||276
7980394|NCT00251862|19649431|P2|COMPLETED|Overall Study||269
7980395|NCT00251862|19649432|P1|COMPLETED|Overall Study||280
7980396|NCT00251862|19649430|P3|STARTED|Overall Study||276
7980397|NCT00251862|19649431|P2|STARTED|Overall Study||269
7980398|NCT00251862|19649432|P1|STARTED|Overall Study||280
7980399|NCT00251758|19649452|P3|NOT COMPLETED|Overall Study||27
7980400|NCT00251758|19649453|P2|NOT COMPLETED|Overall Study||27
7980401|NCT00251758|19649454|P1|NOT COMPLETED|Overall Study||28
7980402|NCT00251758|19649452|P3|COMPLETED|Overall Study||277
7980403|NCT00251758|19649453|P2|COMPLETED|Overall Study||285
7980404|NCT00251758|19649454|P1|COMPLETED|Overall Study||264
7980405|NCT00251758|19649452|P3|STARTED|Overall Study||304
7980406|NCT00251758|19649453|P2|STARTED|Overall Study||312
7980407|NCT00251758|19649454|P1|STARTED|Overall Study||292
7980408|NCT00251745|19649474|P3|NOT COMPLETED|Overall Study||27
7980409|NCT00251745|19649475|P2|NOT COMPLETED|Overall Study||27
7980410|NCT00251745|19649476|P1|NOT COMPLETED|Overall Study||28
7980411|NCT00251745|19649474|P3|COMPLETED|Overall Study||277
7980412|NCT00251745|19649475|P2|COMPLETED|Overall Study||285
7980413|NCT00251745|19649476|P1|COMPLETED|Overall Study||264
7980414|NCT00251745|19649474|P3|STARTED|Overall Study||304
7980415|NCT00251745|19649475|P2|STARTED|Overall Study||312
7980416|NCT00251745|19649476|P1|STARTED|Overall Study||292
7980417|NCT00251719|19649496|P3|NOT COMPLETED|Overall Study||30
7980418|NCT00251719|19649497|P2|NOT COMPLETED|Overall Study||45
7980419|NCT00251719|19649498|P1|NOT COMPLETED|Overall Study||53
7980420|NCT00251719|19649496|P3|COMPLETED|Overall Study||643
7980421|NCT00251719|19649497|P2|COMPLETED|Overall Study||642
7980422|NCT00251719|19649498|P1|COMPLETED|Overall Study||641
7980423|NCT00251719|19649496|P3|STARTED|Overall Study||673
7980424|NCT00251719|19649497|P2|STARTED|Overall Study||687
7980425|NCT00251719|19649498|P1|STARTED|Overall Study||694
7980426|NCT00251693|19649524|P3|NOT COMPLETED|Overall Study||46
7980427|NCT00251693|19649525|P2|NOT COMPLETED|Overall Study||44
7980428|NCT00251693|19649526|P1|NOT COMPLETED|Overall Study||51
7980429|NCT00251693|19649524|P3|COMPLETED|Overall Study||644
7980430|NCT00251693|19649525|P2|COMPLETED|Overall Study||624
7980431|NCT00251693|19649526|P1|COMPLETED|Overall Study||629
7980432|NCT00251693|19649524|P3|STARTED|Overall Study||690
7980433|NCT00251693|19649525|P2|STARTED|Overall Study||668
7980434|NCT00251693|19649526|P1|STARTED|Overall Study||680
7980435|NCT00251641|19649551|P2|NOT COMPLETED|Overall Study||88
7980436|NCT00251641|19649552|P1|NOT COMPLETED|Overall Study||112
7980437|NCT00251641|19649551|P2|COMPLETED|Overall Study||127
7980438|NCT00251641|19649552|P1|COMPLETED|Overall Study||541
7980439|NCT00251641|19649551|P2|STARTED|Overall Study||215
7980440|NCT00251641|19649552|P1|STARTED|Overall Study||653
7980441|NCT00251589|19649570|P4|NOT COMPLETED|Overall Study||2
7980442|NCT00251589|19649571|P3|NOT COMPLETED|Overall Study||2
7980443|NCT00251589|19649572|P2|NOT COMPLETED|Overall Study||3
7980444|NCT00251589|19649573|P1|NOT COMPLETED|Overall Study||15
7980445|NCT00251589|19649570|P4|COMPLETED|Overall Study||0
7980446|NCT00251589|19649571|P3|COMPLETED|Overall Study||0
7980447|NCT00251589|19649572|P2|COMPLETED|Overall Study||0
7980448|NCT00251589|19649573|P1|COMPLETED|Overall Study||1
7980449|NCT00251589|19649570|P4|STARTED|Overall Study||2
7980450|NCT00251589|19649571|P3|STARTED|Overall Study||2
7980451|NCT00251589|19649572|P2|STARTED|Overall Study||3
7980452|NCT00251589|19649573|P1|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16
7980453|NCT00251316|19649610|P2|NOT COMPLETED|Overall Study||3
7980454|NCT00251316|19649611|P1|NOT COMPLETED|Overall Study||2
7980455|NCT00251316|19649610|P2|COMPLETED|Overall Study||14
7980456|NCT00251316|19649611|P1|COMPLETED|Overall Study||15
7980457|NCT00251316|19649610|P2|STARTED|Overall Study||17
7980458|NCT00251316|19649611|P1|STARTED|Overall Study||17
7980459|NCT00251303|19649619|P2|NOT COMPLETED|Overall Study||1
7980460|NCT00251303|19649620|P1|NOT COMPLETED|Overall Study||8
7980461|NCT00251303|19649619|P2|COMPLETED|Overall Study||29
7980462|NCT00251303|19649620|P1|COMPLETED|Overall Study||22
7980463|NCT00251303|19649619|P2|STARTED|Overall Study||30
7980464|NCT00251303|19649620|P1|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30
7980465|NCT00251238|19649630|P2|NOT COMPLETED|Overall Study||0
7980466|NCT00251238|19649631|P1|NOT COMPLETED|Overall Study||0
7980467|NCT00251238|19649630|P2|COMPLETED|Overall Study||20
7980468|NCT00251238|19649631|P1|COMPLETED|Overall Study||21
7980469|NCT00251238|19649630|P2|STARTED|Overall Study||20
7980470|NCT00251238|19649631|P1|STARTED|Overall Study||21
7980471|NCT00251225|19649641|P1|NOT COMPLETED|Overall Study||0
7980472|NCT00251225|19649641|P1|COMPLETED|Overall Study||49
7980473|NCT00251225|19649641|P1|STARTED|Overall Study||49
7980474|NCT00251004|19649650|P3|NOT COMPLETED|Overall Study||31
7980475|NCT00251004|19649651|P2|NOT COMPLETED|Overall Study||41
7980476|NCT00251004|19649652|P1|NOT COMPLETED|Overall Study||45
7980477|NCT00251004|19649650|P3|COMPLETED|Overall Study||246
7980478|NCT00251004|19649651|P2|COMPLETED|Overall Study||238
7980479|NCT00251004|19649652|P1|COMPLETED|Overall Study||232
7980480|NCT00251004|19649650|P3|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246
7980481|NCT00251004|19649651|P2|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238
7980482|NCT00251004|19649652|P1|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232
7980483|NCT00251004|19649650|P3|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253
7980484|NCT00251004|19649651|P2|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249
7980485|NCT00251004|19649652|P1|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241
7980486|NCT00251004|19649650|P3|STARTED|Overall Study||277
7980487|NCT00251004|19649651|P2|STARTED|Overall Study||279
7980488|NCT00251004|19649652|P1|STARTED|Overall Study||277
7980489|NCT00250926|19649669|P1|NOT COMPLETED|Overall Study||0
7980490|NCT00250926|19649669|P1|COMPLETED|Overall Study||23
7980491|NCT00250926|19649669|P1|STARTED|Overall Study||23
7980492|NCT00250835|19649676|P1|NOT COMPLETED|Overall Study||1
7980493|NCT00250835|19649676|P1|COMPLETED|Overall Study||37
7980494|NCT00250835|19649676|P1|STARTED|Overall Study||38
7980495|NCT00250718|19649685|P1|NOT COMPLETED|Overall Study||3
7980496|NCT00250718|19649685|P1|COMPLETED|Overall Study||14
7980497|NCT00250718|19649685|P1|Received Treatment|Overall Study||16
7980498|NCT00250718|19649685|P1|STARTED|Overall Study||17
7980499|NCT00250705|19649690|P1|NOT COMPLETED|Overall Study||2
7980500|NCT00250705|19649690|P1|COMPLETED|Overall Study||10
7980501|NCT00250705|19649690|P1|STARTED|Overall Study||12
7980502|NCT00250679|19649701|P3|NOT COMPLETED|Overall Study||44
7980503|NCT00250679|19649702|P2|NOT COMPLETED|Overall Study||49
7980504|NCT00250679|19649703|P1|NOT COMPLETED|Overall Study||39
7980505|NCT00250679|19649701|P3|COMPLETED|Overall Study||103
7980506|NCT00250679|19649702|P2|COMPLETED|Overall Study||100
7980507|NCT00250679|19649703|P1|COMPLETED|Overall Study||108
7980508|NCT00250679|19649701|P3|STARTED|Overall Study||147
7980509|NCT00250679|19649702|P2|STARTED|Overall Study||149
7980510|NCT00250679|19649703|P1|STARTED|Overall Study||147
7980511|NCT00250588|19649804|P3|NOT COMPLETED|Overall Study||13
7980512|NCT00250588|19649805|P2|NOT COMPLETED|Overall Study||19
7980513|NCT00250588|19649806|P1|NOT COMPLETED|Overall Study||9
7980514|NCT00250588|19649804|P3|COMPLETED|Overall Study||74
7980515|NCT00250588|19649805|P2|COMPLETED|Overall Study||65
7980516|NCT00250588|19649806|P1|COMPLETED|Overall Study||72
7980517|NCT00250588|19649804|P3|STARTED|Overall Study||87
7980518|NCT00250588|19649805|P2|STARTED|Overall Study||84
7980519|NCT00250588|19649806|P1|STARTED|Overall Study||81
7980520|NCT00250497|19649822|P2|NOT COMPLETED|Overall Study||15
7980521|NCT00250497|19649823|P1|NOT COMPLETED|Overall Study||5
7980522|NCT00250497|19649822|P2|COMPLETED|Overall Study||159
7980523|NCT00250497|19649823|P1|COMPLETED|Overall Study||177
7980524|NCT00250497|19649822|P2|STARTED|Overall Study||174
7980525|NCT00250497|19649823|P1|STARTED|Overall Study||182
7980526|NCT00250484|19649841|P2|NOT COMPLETED|Overall Study||0
7980527|NCT00250484|19649842|P1|NOT COMPLETED|Overall Study||0
7980528|NCT00250484|19649841|P2|COMPLETED|Overall Study||8
7980529|NCT00250484|19649842|P1|COMPLETED|Overall Study||9
7980530|NCT00250484|19649841|P2|STARTED|Overall Study||8
7980531|NCT00250484|19649842|P1|STARTED|Overall Study||9
7980532|NCT00250458|19649854|P2|NOT COMPLETED|Overall Study||17
7980533|NCT00250458|19649855|P1|NOT COMPLETED|Overall Study||32
7980534|NCT00250458|19649854|P2|COMPLETED|Overall Study||97
7980535|NCT00250458|19649855|P1|COMPLETED|Overall Study||200
7980536|NCT00250458|19649854|P2|STARTED|Overall Study||114
7980537|NCT00250458|19649855|P1|STARTED|Overall Study||232
7980538|NCT00250432|19649865|P2|NOT COMPLETED|Overall Study||47
7980539|NCT00250432|19649866|P1|NOT COMPLETED|Overall Study||45
7980540|NCT00250432|19649865|P2|COMPLETED|Overall Study||53
7980541|NCT00250432|19649866|P1|COMPLETED|Overall Study||59
7980542|NCT00250432|19649865|P2|STARTED|Overall Study||100
7980543|NCT00250432|19649866|P1|STARTED|Overall Study||104
7980544|NCT00250276|19649878|P4|NOT COMPLETED|Overall Study||19
7980545|NCT00250276|19649879|P3|NOT COMPLETED|Overall Study||19
7980546|NCT00250276|19649880|P2|NOT COMPLETED|Overall Study||21
7980547|NCT00250276|19649881|P1|NOT COMPLETED|Overall Study||17
7980548|NCT00250276|19649878|P4|COMPLETED|Overall Study||181
7980549|NCT00250276|19649879|P3|COMPLETED|Overall Study||182
7980550|NCT00250276|19649880|P2|COMPLETED|Overall Study||177
7980551|NCT00250276|19649881|P1|COMPLETED|Overall Study||182
7980552|NCT00250276|19649878|P4|STARTED|Overall Study||200
7980553|NCT00250276|19649879|P3|STARTED|Overall Study||201
7980554|NCT00250276|19649880|P2|STARTED|Overall Study||198
7980555|NCT00250276|19649881|P1|STARTED|Overall Study||199
7980556|NCT00249873|19649961|P2|NOT COMPLETED|Overall Study||1254
7980557|NCT00249873|19649962|P1|NOT COMPLETED|Overall Study||1330
7980558|NCT00249873|19649961|P2|COMPLETED|Overall Study|started and completed study drug|2528
7980559|NCT00249873|19649962|P1|COMPLETED|Overall Study|started and completed study drug|2442
7980560|NCT00249873|19649961|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782
7980561|NCT00249873|19649962|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772
7980562|NCT00249834|19649982|P8|NOT COMPLETED|Overall Study||0
7980563|NCT00249834|19649983|P7|NOT COMPLETED|Overall Study||1
7980564|NCT00249834|19649984|P6|NOT COMPLETED|Overall Study||2
7980565|NCT00249834|19649985|P5|NOT COMPLETED|Overall Study||5
7980566|NCT00249834|19649986|P4|NOT COMPLETED|Overall Study||8
7980567|NCT00249834|19649987|P3|NOT COMPLETED|Overall Study||14
7980568|NCT00249834|19649988|P2|NOT COMPLETED|Overall Study||19
7980569|NCT00249834|19649989|P1|NOT COMPLETED|Overall Study||1
7980570|NCT00249834|19649982|P8|COMPLETED|Overall Study||2
7980571|NCT00249834|19649983|P7|COMPLETED|Overall Study||1
7980572|NCT00249834|19649984|P6|COMPLETED|Overall Study||8
7980573|NCT00249834|19649985|P5|COMPLETED|Overall Study||19
7980574|NCT00249834|19649986|P4|COMPLETED|Overall Study||26
7980575|NCT00249834|19649987|P3|COMPLETED|Overall Study||31
7980576|NCT00249834|19649988|P2|COMPLETED|Overall Study||29
7980577|NCT00249834|19649989|P1|COMPLETED|Overall Study||0
7980578|NCT00249834|19649982|P8|STARTED|Overall Study||2
7980579|NCT00249834|19649983|P7|STARTED|Overall Study||2
7980580|NCT00249834|19649984|P6|STARTED|Overall Study||10
7980581|NCT00249834|19649985|P5|STARTED|Overall Study||24
7980582|NCT00249834|19649986|P4|STARTED|Overall Study||34
7980583|NCT00249834|19649987|P3|STARTED|Overall Study||45
7980584|NCT00249834|19649988|P2|STARTED|Overall Study||48
7980585|NCT00249834|19649989|P1|STARTED|Overall Study||1
7980586|NCT00249821|19650038|P2|NOT COMPLETED|Overall Study||1
7980587|NCT00249821|19650039|P1|NOT COMPLETED|Overall Study||0
7980588|NCT00249821|19650038|P2|COMPLETED|Overall Study||11
7980589|NCT00249821|19650039|P1|COMPLETED|Overall Study||10
7980590|NCT00249821|19650038|P2|STARTED|Overall Study||12
7980591|NCT00249821|19650039|P1|STARTED|Overall Study||10
7980592|NCT00249808|19650059|P1|NOT COMPLETED|Overall Study||182
7980593|NCT00249808|19650059|P1|COMPLETED|Overall Study||1084
7980594|NCT00249808|19650059|P1|STARTED|Overall Study||1266
7980595|NCT00249795|19650067|P2|NOT COMPLETED|Overall Study||1390
7980596|NCT00249795|19650068|P1|NOT COMPLETED|Overall Study||1394
7980597|NCT00249795|19650067|P2|COMPLETED|Overall Study|started and completed study drug|3108
7980598|NCT00249795|19650068|P1|COMPLETED|Overall Study|started and completed study drug|3124
7980599|NCT00249795|19650067|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498
7980600|NCT00249795|19650068|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518
7980601|NCT00249769|19650089|P3|NOT COMPLETED|Overall Study||28
7980602|NCT00249769|19650090|P2|NOT COMPLETED|Overall Study||15
7980603|NCT00249769|19650091|P1|NOT COMPLETED|Overall Study||2
7980604|NCT00249769|19650089|P3|COMPLETED|Overall Study||222
7980605|NCT00249769|19650090|P2|COMPLETED|Overall Study||235
7980606|NCT00249769|19650091|P1|COMPLETED|Overall Study||98
7980607|NCT00249769|19650089|P3|Received Measles Vaccine|Overall Study||235
7980608|NCT00249769|19650090|P2|Received Measles Vaccine|Overall Study||236
7980609|NCT00249769|19650091|P1|Received Measles Vaccine|Overall Study||97
7980610|NCT00249769|19650089|P3|Received LJEV|Overall Study||224
7980611|NCT00249769|19650090|P2|Received LJEV|Overall Study||236
7980612|NCT00249769|19650091|P1|Received LJEV|Overall Study||100
7980613|NCT00249769|19650089|P3|STARTED|Overall Study||250
7980614|NCT00249769|19650090|P2|STARTED|Overall Study||250
7980615|NCT00249769|19650091|P1|STARTED|Overall Study||100
7980616|NCT00249613|19650119|P2|NOT COMPLETED|12 Month Follow-up||15
7980617|NCT00249613|19650120|P1|NOT COMPLETED|12 Month Follow-up||17
7980618|NCT00249613|19650119|P2|COMPLETED|12 Month Follow-up||124
7980619|NCT00249613|19650120|P1|COMPLETED|12 Month Follow-up||135
7980620|NCT00249613|19650119|P2|STARTED|12 Month Follow-up||139
7980621|NCT00249613|19650120|P1|STARTED|12 Month Follow-up||152
7980622|NCT00249613|19650119|P2|NOT COMPLETED|Baseline||0
7980623|NCT00249613|19650120|P1|NOT COMPLETED|Baseline||0
7980624|NCT00249613|19650119|P2|COMPLETED|Baseline||139
7980625|NCT00249613|19650120|P1|COMPLETED|Baseline||152
7980626|NCT00249613|19650119|P2|STARTED|Baseline||139
7980627|NCT00249613|19650120|P1|STARTED|Baseline||152
7980628|NCT00249496|19650131|P2|NOT COMPLETED|Overall Study||1
7980629|NCT00249496|19650132|P1|NOT COMPLETED|Overall Study||0
7980630|NCT00249496|19650131|P2|COMPLETED|Overall Study||26
7980631|NCT00249496|19650132|P1|COMPLETED|Overall Study||24
7980632|NCT00249496|19650131|P2|STARTED|Overall Study||27
7980633|NCT00249496|19650132|P1|STARTED|Overall Study||24
7980634|NCT00249470|19650148|P2|NOT COMPLETED|Overall Study||0
7980635|NCT00249470|19650149|P1|NOT COMPLETED|Overall Study||0
7980636|NCT00249470|19650148|P2|COMPLETED|Overall Study||28
7980637|NCT00249470|19650149|P1|COMPLETED|Overall Study||28
7980638|NCT00249470|19650148|P2|STARTED|Overall Study||28
7980639|NCT00249470|19650149|P1|STARTED|Overall Study||28
7980640|NCT00249444|19650161|P2|NOT COMPLETED|Overall Study||15
7980641|NCT00249444|19650162|P1|NOT COMPLETED|Overall Study||12
7980642|NCT00249444|19650161|P2|COMPLETED|Overall Study||29
7980643|NCT00249444|19650162|P1|COMPLETED|Overall Study||30
7980644|NCT00249444|19650161|P2|STARTED|Overall Study||44
7980645|NCT00249444|19650162|P1|STARTED|Overall Study||42
7980646|NCT00249379|19650172|P2|NOT COMPLETED|Overall Study||8
7980647|NCT00249379|19650173|P1|NOT COMPLETED|Overall Study||8
7980648|NCT00249379|19650172|P2|COMPLETED|Overall Study||4
7980649|NCT00249379|19650173|P1|COMPLETED|Overall Study||6
7980650|NCT00249379|19650172|P2|STARTED|Overall Study||12
7980651|NCT00249379|19650173|P1|STARTED|Overall Study||14
7980652|NCT00249288|19650187|P2|NOT COMPLETED|Overall Study||5
7980653|NCT00249288|19650188|P1|NOT COMPLETED|Overall Study||5
7980654|NCT00249288|19650187|P2|COMPLETED|Overall Study||14
7980655|NCT00249288|19650188|P1|COMPLETED|Overall Study||14
7980656|NCT00249288|19650187|P2|Initiated Treatment|Overall Study||15
7980657|NCT00249288|19650188|P1|Initiated Treatment|Overall Study||17
7980658|NCT00249288|19650187|P2|STARTED|Overall Study||19
7980659|NCT00249288|19650188|P1|STARTED|Overall Study||19
7980660|NCT00249249|19650223|P4|NOT COMPLETED|Overall Study||3
7980661|NCT00249249|19650224|P3|NOT COMPLETED|Overall Study||15
7980662|NCT00249249|19650225|P2|NOT COMPLETED|Overall Study||5
7980663|NCT00249249|19650226|P1|NOT COMPLETED|Overall Study||20
7980664|NCT00249249|19650223|P4|COMPLETED|Overall Study||100
7980665|NCT00249249|19650224|P3|COMPLETED|Overall Study||288
7980666|NCT00249249|19650225|P2|COMPLETED|Overall Study||98
7980667|NCT00249249|19650226|P1|COMPLETED|Overall Study||301
7980668|NCT00249249|19650223|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103
7980669|NCT00249249|19650224|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300
7980670|NCT00249249|19650225|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102
7980671|NCT00249249|19650226|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316
7980672|NCT00249249|19650223|P4|STARTED|Overall Study||103
7980673|NCT00249249|19650224|P3|STARTED|Overall Study||303
7980674|NCT00249249|19650225|P2|STARTED|Overall Study||103
7980675|NCT00249249|19650226|P1|STARTED|Overall Study||321
7980676|NCT00249002|19650280|P1|NOT COMPLETED|Overall Study||7
7980677|NCT00249002|19650280|P1|COMPLETED|Overall Study||2
7980678|NCT00249002|19650280|P1|STARTED|Overall Study||9
7980679|NCT00248833|19650299|P3|NOT COMPLETED|Overall Study||2
7980680|NCT00248833|19650300|P2|NOT COMPLETED|Overall Study||3
7980681|NCT00248833|19650301|P1|NOT COMPLETED|Overall Study||3
7980682|NCT00248833|19650299|P3|COMPLETED|Overall Study||9
7980683|NCT00248833|19650300|P2|COMPLETED|Overall Study||8
7980684|NCT00248833|19650301|P1|COMPLETED|Overall Study||9
7980685|NCT00248833|19650299|P3|STARTED|Overall Study||11
7980686|NCT00248833|19650300|P2|STARTED|Overall Study||11
7980687|NCT00248833|19650301|P1|STARTED|Overall Study||12
7980688|NCT00248807|19650319|P2|NOT COMPLETED|Overall Study||0
7980689|NCT00248807|19650320|P1|NOT COMPLETED|Overall Study||0
7980690|NCT00248807|19650319|P2|COMPLETED|Overall Study||11
7980691|NCT00248807|19650320|P1|COMPLETED|Overall Study||19
7980692|NCT00248807|19650319|P2|STARTED|Overall Study||11
7980693|NCT00248807|19650320|P1|STARTED|Overall Study||19
7980694|NCT00248794|19650337|P3|NOT COMPLETED|Overall Study||3
7980695|NCT00248794|19650338|P2|NOT COMPLETED|Overall Study||8
7980696|NCT00248794|19650339|P1|NOT COMPLETED|Overall Study||6
7980697|NCT00248794|19650337|P3|COMPLETED|Overall Study||7
7980698|NCT00248794|19650338|P2|COMPLETED|Overall Study||16
7980699|NCT00248794|19650339|P1|COMPLETED|Overall Study||19
7980700|NCT00248794|19650337|P3|STARTED|Overall Study||10
7980701|NCT00248794|19650338|P2|STARTED|Overall Study||24
7980702|NCT00248794|19650339|P1|STARTED|Overall Study||25
7980703|NCT00248781|19650361|P2|NOT COMPLETED|Overall Study||4
7980704|NCT00248781|19650362|P1|NOT COMPLETED|Overall Study||10
7980705|NCT00248781|19650361|P2|COMPLETED|Overall Study||47
7980706|NCT00248781|19650362|P1|COMPLETED|Overall Study||42
7980707|NCT00248781|19650361|P2|STARTED|Overall Study||51
7980708|NCT00248781|19650362|P1|STARTED|Overall Study||52
7980709|NCT00248651|19650389|P3|NOT COMPLETED|Overall Study||32
7980710|NCT00248651|19650390|P2|NOT COMPLETED|Overall Study||40
7980711|NCT00248651|19650391|P1|NOT COMPLETED|Overall Study||28
7980712|NCT00248651|19650389|P3|COMPLETED|Overall Study||65
7980713|NCT00248651|19650390|P2|COMPLETED|Overall Study||58
7980714|NCT00248651|19650391|P1|COMPLETED|Overall Study||69
7980715|NCT00248651|19650389|P3|Completed 12 Weeks of Treatment|Overall Study||75
7980716|NCT00248651|19650390|P2|Completed 12 Weeks of Treatment|Overall Study||66
7980717|NCT00248651|19650391|P1|Completed 12 Weeks of Treatment|Overall Study||78
7980718|NCT00248651|19650389|P3|STARTED|Overall Study||97
7980719|NCT00248651|19650390|P2|STARTED|Overall Study||98
7980720|NCT00248651|19650391|P1|STARTED|Overall Study||97
7980721|NCT00248638|19650410|P2|NOT COMPLETED|Overall Study||0
7980722|NCT00248638|19650411|P1|NOT COMPLETED|Overall Study||0
7980723|NCT00248638|19650410|P2|COMPLETED|Overall Study||75
7980724|NCT00248638|19650411|P1|COMPLETED|Overall Study||75
7980725|NCT00248638|19650410|P2|STARTED|Overall Study||75
7980726|NCT00248638|19650411|P1|STARTED|Overall Study||75
7980727|NCT00248625|19650427|P2|NOT COMPLETED|Overall Study||2
7980728|NCT00248625|19650428|P1|NOT COMPLETED|Overall Study||0
7980729|NCT00248625|19650427|P2|COMPLETED|Overall Study||90
7980730|NCT00248625|19650428|P1|COMPLETED|Overall Study||92
7980731|NCT00248625|19650427|P2|STARTED|Overall Study||92
7980732|NCT00248625|19650428|P1|STARTED|Overall Study||92
7980733|NCT00248612|19650452|P4|NOT COMPLETED|Overall Study||0
7980734|NCT00248612|19650453|P3|NOT COMPLETED|Overall Study||0
7980735|NCT00248612|19650454|P2|NOT COMPLETED|Overall Study||0
7980736|NCT00248612|19650455|P1|NOT COMPLETED|Overall Study||0
7980737|NCT00248612|19650452|P4|COMPLETED|Overall Study||22
7980738|NCT00248612|19650453|P3|COMPLETED|Overall Study||14
7980739|NCT00248612|19650454|P2|COMPLETED|Overall Study||21
7980740|NCT00248612|19650455|P1|COMPLETED|Overall Study||24
7980741|NCT00248612|19650452|P4|STARTED|Overall Study||22
7980742|NCT00248612|19650453|P3|STARTED|Overall Study||14
7980743|NCT00248612|19650454|P2|STARTED|Overall Study||21
7980744|NCT00248612|19650455|P1|STARTED|Overall Study||24
7980745|NCT00248560|19650497|P1|NOT COMPLETED|Overall Study||0
7980746|NCT00248560|19650497|P1|COMPLETED|Overall Study||36
7980747|NCT00248560|19650497|P1|STARTED|Overall Study||36
7980748|NCT00248547|19650506|P2|NOT COMPLETED|Overall Study||0
7980749|NCT00248547|19650507|P1|NOT COMPLETED|Overall Study||0
7980750|NCT00248547|19650506|P2|COMPLETED|Overall Study||20
7980751|NCT00248547|19650507|P1|COMPLETED|Overall Study||20
7980752|NCT00248547|19650506|P2|STARTED|Overall Study||20
7980753|NCT00248547|19650507|P1|STARTED|Overall Study||20
7980754|NCT00248534|19650513|P1|NOT COMPLETED|Overall Study||0
7980755|NCT00248534|19650513|P1|COMPLETED|Overall Study||16
7980756|NCT00248534|19650513|P1|STARTED|Overall Study||16
7980757|NCT00248495|19650520|P1|NOT COMPLETED|Overall Study||1
7980758|NCT00248495|19650520|P1|COMPLETED|Overall Study||37
7980759|NCT00248495|19650520|P1|STARTED|Overall Study||38
7980760|NCT00248287|19650531|P2|NOT COMPLETED|Overall Study||19
7980761|NCT00248287|19650532|P1|NOT COMPLETED|Overall Study||24
7980762|NCT00248287|19650531|P2|COMPLETED|Overall Study||60
7980763|NCT00248287|19650532|P1|COMPLETED|Overall Study||51
7980764|NCT00248287|19650531|P2|STARTED|Overall Study||79
7980765|NCT00248287|19650532|P1|STARTED|Overall Study||75
7980766|NCT00248170|19650546|P2|NOT COMPLETED|Overall Study||808
7980767|NCT00248170|19650547|P1|NOT COMPLETED|Overall Study||761
7980768|NCT00248170|19650546|P2|COMPLETED|Overall Study||1286
7980769|NCT00248170|19650547|P1|COMPLETED|Overall Study||1317
7980770|NCT00248170|19650546|P2|Safety Set|Overall Study||2062
7980771|NCT00248170|19650547|P1|Safety Set|Overall Study||2049
7980772|NCT00248170|19650546|P2|Intent-to-treat (ITT)|Overall Study||2075
7980773|NCT00248170|19650547|P1|Intent-to-treat (ITT)|Overall Study||2061
7980774|NCT00248170|19650546|P2|STARTED|Overall Study||2094
7980775|NCT00248170|19650547|P1|STARTED|Overall Study||2078
7980776|NCT00248040|19650570|P3|NOT COMPLETED|Overall Study||4
7980777|NCT00248040|19650571|P2|NOT COMPLETED|Overall Study||1
7980778|NCT00248040|19650572|P1|NOT COMPLETED|Overall Study||3
7980779|NCT00248040|19650570|P3|COMPLETED|Overall Study||22
7980780|NCT00248040|19650571|P2|COMPLETED|Overall Study||22
7980781|NCT00248040|19650572|P1|COMPLETED|Overall Study||22
7980782|NCT00248040|19650570|P3|STARTED|Overall Study||26
7980783|NCT00248040|19650571|P2|STARTED|Overall Study||23
7980784|NCT00248040|19650572|P1|STARTED|Overall Study||25
7980785|NCT00247962|19650621|P2|NOT COMPLETED|Overall Study||19
7980786|NCT00247962|19650622|P1|NOT COMPLETED|Overall Study||26
7980787|NCT00247962|19650621|P2|COMPLETED|Overall Study||168
7980788|NCT00247962|19650622|P1|COMPLETED|Overall Study||353
7980789|NCT00247962|19650621|P2|STARTED|Overall Study||187
7980790|NCT00247962|19650622|P1|STARTED|Overall Study||379
7980791|NCT00247728|19650633|P3|NOT COMPLETED|Overall Study||14
7980792|NCT00247728|19650634|P2|NOT COMPLETED|Overall Study||6
7980793|NCT00247728|19650635|P1|NOT COMPLETED|Overall Study||3
7980794|NCT00247728|19650633|P3|COMPLETED|Overall Study||43
7980795|NCT00247728|19650634|P2|COMPLETED|Overall Study||51
7980796|NCT00247728|19650635|P1|COMPLETED|Overall Study||55
7980797|NCT00247728|19650633|P3|STARTED|Overall Study||57
7980798|NCT00247728|19650634|P2|STARTED|Overall Study||57
7980799|NCT00247728|19650635|P1|STARTED|Overall Study||58
7980800|NCT00247676|19650649|P1|NOT COMPLETED|Overall Study||36
7980801|NCT00247676|19650649|P1|COMPLETED|Overall Study||1
7980802|NCT00247676|19650649|P1|STARTED|Overall Study||37
7980803|NCT00247624|19650679|P2|NOT COMPLETED|Overall Study||4
7980804|NCT00247624|19650680|P1|NOT COMPLETED|Overall Study||5
7980805|NCT00247624|19650679|P2|COMPLETED|Overall Study||26
7980806|NCT00247624|19650680|P1|COMPLETED|Overall Study||25
7980807|NCT00247624|19650679|P2|STARTED|Overall Study||30
7980808|NCT00247624|19650680|P1|STARTED|Overall Study||30
7980809|NCT00247611|19650694|P2|NOT COMPLETED|On Protocol Sample||125
7980810|NCT00247611|19650695|P1|NOT COMPLETED|On Protocol Sample||111
7980811|NCT00247611|19650694|P2|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152
7980812|NCT00247611|19650695|P1|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176
7980813|NCT00247611|19650694|P2|STARTED|On Protocol Sample|ITT sample participants|277
7980814|NCT00247611|19650695|P1|STARTED|On Protocol Sample|ITT sample participants|287
7980815|NCT00247611|19650694|P2|NOT COMPLETED|Intention to Treat Sample||13
7980816|NCT00247611|19650695|P1|NOT COMPLETED|Intention to Treat Sample||17
7980817|NCT00247611|19650694|P2|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277
7980818|NCT00247611|19650695|P1|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287
7980819|NCT00247611|19650694|P2|STARTED|Intention to Treat Sample|Participants randomized|290
7980820|NCT00247611|19650695|P1|STARTED|Intention to Treat Sample|Participants randomized|304
7980821|NCT00247611|19650694|P2|NOT COMPLETED|Baselined||13
7980822|NCT00247611|19650695|P1|NOT COMPLETED|Baselined||17
7980823|NCT00247611|19650694|P2|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277
7980824|NCT00247611|19650695|P1|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287
7980825|NCT00247611|19650694|P2|STARTED|Baselined|Participants randomized|290
7980826|NCT00247611|19650695|P1|STARTED|Baselined|Participants randomized|304
7980827|NCT00247416|19650713|P2|NOT COMPLETED|Overall Study||2
7980828|NCT00247416|19650714|P1|NOT COMPLETED|Overall Study||1
7980829|NCT00247416|19650713|P2|COMPLETED|Overall Study||31
7980830|NCT00247416|19650714|P1|COMPLETED|Overall Study||25
7980831|NCT00247416|19650713|P2|STARTED|Overall Study||33
7980832|NCT00247416|19650714|P1|STARTED|Overall Study||26
7980833|NCT00247377|19650728|P2|NOT COMPLETED|Overall Study||0
7980834|NCT00247377|19650729|P1|NOT COMPLETED|Overall Study||0
7980835|NCT00247377|19650728|P2|COMPLETED|Overall Study||86
7980836|NCT00247377|19650729|P1|COMPLETED|Overall Study||111
7980837|NCT00247377|19650728|P2|STARTED|Overall Study||86
7980838|NCT00247377|19650729|P1|STARTED|Overall Study||111
7980839|NCT00247273|19650755|P2|NOT COMPLETED|Overall Study||137
7980840|NCT00247273|19650756|P1|NOT COMPLETED|Overall Study||146
7980841|NCT00247273|19650755|P2|COMPLETED|Overall Study||513
7980842|NCT00247273|19650756|P1|COMPLETED|Overall Study||498
7980843|NCT00247273|19650755|P2|Intent to Treat Population|Overall Study||650
7980844|NCT00247273|19650756|P1|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642
7980845|NCT00247273|19650755|P2|STARTED|Overall Study||650
7980846|NCT00247273|19650756|P1|STARTED|Overall Study||644
7980847|NCT00246805|19650802|P2|NOT COMPLETED|Phase 2||0
7980848|NCT00246805|19650803|P1|NOT COMPLETED|Phase 2||0
7980849|NCT00246805|19650802|P2|COMPLETED|Phase 2||33
7980850|NCT00246805|19650803|P1|COMPLETED|Phase 2||33
7980851|NCT00246805|19650802|P2|STARTED|Phase 2||33
7980852|NCT00246805|19650803|P1|STARTED|Phase 2||33
7980853|NCT00246805|19650802|P2|NOT COMPLETED|Phase 1||0
7980854|NCT00246805|19650803|P1|NOT COMPLETED|Phase 1||1
7980855|NCT00246805|19650802|P2|COMPLETED|Phase 1||33
7980856|NCT00246805|19650803|P1|COMPLETED|Phase 1||33
7980857|NCT00246805|19650802|P2|STARTED|Phase 1||33
7980858|NCT00246805|19650803|P1|STARTED|Phase 1||34
7980859|NCT00246753|19650809|P1|NOT COMPLETED|Overall Study||8
7980860|NCT00246753|19650809|P1|COMPLETED|Overall Study||21
7980861|NCT00246753|19650809|P1|STARTED|Overall Study||29
7980862|NCT00246740|19650817|P2|NOT COMPLETED|Experimental Phase||0
7980863|NCT00246740|19650818|P1|NOT COMPLETED|Experimental Phase||0
7980864|NCT00246740|19650817|P2|COMPLETED|Experimental Phase||20
7980865|NCT00246740|19650818|P1|COMPLETED|Experimental Phase||22
7980866|NCT00246740|19650817|P2|STARTED|Experimental Phase||20
7980867|NCT00246740|19650818|P1|STARTED|Experimental Phase||22
7980868|NCT00246740|19650817|P2|NOT COMPLETED|Initial Enrollment||8
7980869|NCT00246740|19650818|P1|NOT COMPLETED|Initial Enrollment||6
7980870|NCT00246740|19650817|P2|COMPLETED|Initial Enrollment||20
7980871|NCT00246740|19650818|P1|COMPLETED|Initial Enrollment||22
7980872|NCT00246740|19650817|P2|STARTED|Initial Enrollment||28
7980873|NCT00246740|19650818|P1|STARTED|Initial Enrollment||28
7980874|NCT00246571|19650842|P2|NOT COMPLETED|Overall Study||104
7980875|NCT00246571|19650843|P1|NOT COMPLETED|Overall Study||113
7980876|NCT00246571|19650842|P2|COMPLETED|Overall Study||0
7980877|NCT00246571|19650843|P1|COMPLETED|Overall Study||0
7980878|NCT00246571|19650842|P2|Randomized But Not Treated|Overall Study||1
7980879|NCT00246571|19650843|P1|Randomized But Not Treated|Overall Study||3
7980880|NCT00246571|19650842|P2|STARTED|Overall Study||104
7980881|NCT00246571|19650843|P1|STARTED|Overall Study||113
7980882|NCT00246519|19650883|P2|NOT COMPLETED|Overall Study||64
7980883|NCT00246519|19650884|P1|NOT COMPLETED|Overall Study||56
7980884|NCT00246519|19650883|P2|COMPLETED|Overall Study||382
7980885|NCT00246519|19650884|P1|COMPLETED|Overall Study||386
7980886|NCT00246519|19650883|P2|STARTED|Overall Study||446
7980887|NCT00246519|19650884|P1|STARTED|Overall Study||442
7980888|NCT00246441|19650892|P2|NOT COMPLETED|Overall Study||0
7980889|NCT00246441|19650893|P1|NOT COMPLETED|Overall Study||1
7980890|NCT00246441|19650892|P2|COMPLETED|Overall Study||22
7980891|NCT00246441|19650893|P1|COMPLETED|Overall Study||19
7980892|NCT00246441|19650892|P2|STARTED|Overall Study||22
7980893|NCT00246441|19650893|P1|STARTED|Overall Study||20
7980894|NCT00246376|19650908|P5|NOT COMPLETED|Overall Study||17
7980895|NCT00246376|19650909|P4|NOT COMPLETED|Overall Study||26
7980896|NCT00246376|19650910|P3|NOT COMPLETED|Overall Study||16
7980897|NCT00246376|19650911|P2|NOT COMPLETED|Overall Study||19
7980898|NCT00246376|19650912|P1|NOT COMPLETED|Overall Study||15
7980899|NCT00246376|19650908|P5|COMPLETED|Overall Study||28
7980900|NCT00246376|19650909|P4|COMPLETED|Overall Study||21
7980901|NCT00246376|19650910|P3|COMPLETED|Overall Study||29
7980902|NCT00246376|19650911|P2|COMPLETED|Overall Study||24
7980903|NCT00246376|19650912|P1|COMPLETED|Overall Study||26
7980904|NCT00246376|19650908|P5|After Dietary run-in at Two Weeks|Overall Study||42
7980905|NCT00246376|19650909|P4|After Dietary run-in at Two Weeks|Overall Study||40
7980906|NCT00246376|19650910|P3|After Dietary run-in at Two Weeks|Overall Study||41
7980907|NCT00246376|19650911|P2|After Dietary run-in at Two Weeks|Overall Study||38
7980908|NCT00246376|19650912|P1|After Dietary run-in at Two Weeks|Overall Study||30
7980909|NCT00246376|19650908|P5|STARTED|Overall Study||45
7980910|NCT00246376|19650909|P4|STARTED|Overall Study||47
7980911|NCT00246376|19650910|P3|STARTED|Overall Study||45
7980912|NCT00246376|19650911|P2|STARTED|Overall Study||43
7980913|NCT00246376|19650912|P1|STARTED|Overall Study||41
7980914|NCT00246337|19650963|P9|NOT COMPLETED|Overall Study||11
7980915|NCT00246337|19650964|P8|NOT COMPLETED|Overall Study||13
7980916|NCT00246337|19650965|P7|NOT COMPLETED|Overall Study||9
7980917|NCT00246337|19650966|P6|NOT COMPLETED|Overall Study||15
7980918|NCT00246337|19650967|P5|NOT COMPLETED|Overall Study||4
7980919|NCT00246337|19650968|P4|NOT COMPLETED|Overall Study||1
7980920|NCT00246337|19650969|P3|NOT COMPLETED|Overall Study||3
7980921|NCT00246337|19650970|P2|NOT COMPLETED|Overall Study||2
7980922|NCT00246337|19650971|P1|NOT COMPLETED|Overall Study||32
7980923|NCT00246337|19650963|P9|COMPLETED|Overall Study||34
7980924|NCT00246337|19650964|P8|COMPLETED|Overall Study||40
7980925|NCT00246337|19650965|P7|COMPLETED|Overall Study||45
7980926|NCT00246337|19650966|P6|COMPLETED|Overall Study||39
7980927|NCT00246337|19650967|P5|COMPLETED|Overall Study||12
7980928|NCT00246337|19650968|P4|COMPLETED|Overall Study||16
7980929|NCT00246337|19650969|P3|COMPLETED|Overall Study||15
7980930|NCT00246337|19650970|P2|COMPLETED|Overall Study||14
7980931|NCT00246337|19650971|P1|COMPLETED|Overall Study||115
7980932|NCT00246337|19650963|P9|Completed Period (Both Doses)|Overall Study||15
7980933|NCT00246337|19650964|P8|Completed Period (Both Doses)|Overall Study||13
7980934|NCT00246337|19650965|P7|Completed Period (Both Doses)|Overall Study||16
7980935|NCT00246337|19650966|P6|Completed Period (Both Doses)|Overall Study||10
7980936|NCT00246337|19650967|P5|Completed Period (Both Doses)|Overall Study||4
7980937|NCT00246337|19650968|P4|Completed Period (Both Doses)|Overall Study||11
7980938|NCT00246337|19650969|P3|Completed Period (Both Doses)|Overall Study||6
7980939|NCT00246337|19650970|P2|Completed Period (Both Doses)|Overall Study||10
7980940|NCT00246337|19650971|P1|Completed Period (Both Doses)|Overall Study||69
7980941|NCT00246337|19650963|P9|Completed Period (Initial Dose)|Overall Study||19
7980942|NCT00246337|19650964|P8|Completed Period (Initial Dose)|Overall Study||27
7980943|NCT00246337|19650965|P7|Completed Period (Initial Dose)|Overall Study||29
7980944|NCT00246337|19650966|P6|Completed Period (Initial Dose)|Overall Study||29
7980945|NCT00246337|19650967|P5|Completed Period (Initial Dose)|Overall Study||8
7980946|NCT00246337|19650968|P4|Completed Period (Initial Dose)|Overall Study||5
7980947|NCT00246337|19650969|P3|Completed Period (Initial Dose)|Overall Study||9
7980948|NCT00246337|19650970|P2|Completed Period (Initial Dose)|Overall Study||4
7980949|NCT00246337|19650971|P1|Completed Period (Initial Dose)|Overall Study||46
7980950|NCT00246337|19650963|P9|STARTED|Overall Study||45
7980951|NCT00246337|19650964|P8|STARTED|Overall Study||53
7980952|NCT00246337|19650965|P7|STARTED|Overall Study||54
7980953|NCT00246337|19650966|P6|STARTED|Overall Study||54
7980954|NCT00246337|19650967|P5|STARTED|Overall Study||16
7980955|NCT00246337|19650968|P4|STARTED|Overall Study||17
7980956|NCT00246337|19650969|P3|STARTED|Overall Study||18
7980957|NCT00246337|19650970|P2|STARTED|Overall Study||16
7980958|NCT00246337|19650971|P1|STARTED|Overall Study||147
7980959|NCT00246324|19651018|P1|NOT COMPLETED|Overall Study||1
7980960|NCT00246324|19651018|P1|COMPLETED|Overall Study||15
7980961|NCT00246324|19651018|P1|STARTED|Overall Study||16
7980962|NCT00246259|19651025|P2|NOT COMPLETED|Overall Study||26
7980963|NCT00246259|19651026|P1|NOT COMPLETED|Overall Study||28
7980964|NCT00246259|19651025|P2|COMPLETED|Overall Study||15
7980965|NCT00246259|19651026|P1|COMPLETED|Overall Study||16
7980966|NCT00246259|19651025|P2|Eligible for Intent-to-treat (ITT)|Overall Study||35
7980967|NCT00246259|19651026|P1|Eligible for Intent-to-treat (ITT)|Overall Study||42
7980968|NCT00246259|19651025|P2|STARTED|Overall Study||41
7980969|NCT00246259|19651026|P1|STARTED|Overall Study||44
7980970|NCT00246090|19651060|P1|NOT COMPLETED|Overall Study||295
7980971|NCT00246090|19651060|P1|COMPLETED|Overall Study||3
7980972|NCT00246090|19651060|P1|STARTED|Overall Study||298
7980973|NCT00246025|19651069|P4|NOT COMPLETED|Overall Study||13
7980974|NCT00246025|19651070|P3|NOT COMPLETED|Overall Study||10
7980975|NCT00246025|19651071|P2|NOT COMPLETED|Overall Study||9
7980976|NCT00246025|19651072|P1|NOT COMPLETED|Overall Study||10
7980977|NCT00246025|19651069|P4|COMPLETED|Overall Study||116
7980978|NCT00246025|19651070|P3|COMPLETED|Overall Study||116
7980979|NCT00246025|19651071|P2|COMPLETED|Overall Study||124
7980980|NCT00246025|19651072|P1|COMPLETED|Overall Study||114
7980981|NCT00246025|19651069|P4|STARTED|Overall Study||129
7980982|NCT00246025|19651070|P3|STARTED|Overall Study||126
7980983|NCT00246025|19651071|P2|STARTED|Overall Study||133
7980984|NCT00246025|19651072|P1|STARTED|Overall Study||124
7980985|NCT00246012|19651131|P9|NOT COMPLETED|Overall Study||28
7980986|NCT00246012|19651132|P8|NOT COMPLETED|Overall Study||28
7980987|NCT00246012|19651133|P7|NOT COMPLETED|Overall Study||31
7980988|NCT00246012|19651134|P6|NOT COMPLETED|Overall Study||28
7980989|NCT00246012|19651135|P5|NOT COMPLETED|Overall Study||3
7980990|NCT00246012|19651136|P4|NOT COMPLETED|Overall Study||3
7980991|NCT00246012|19651137|P3|NOT COMPLETED|Overall Study||2
7980992|NCT00246012|19651138|P2|NOT COMPLETED|Overall Study||1
7980993|NCT00246012|19651139|P1|NOT COMPLETED|Overall Study||3
7980994|NCT00246012|19651131|P9|COMPLETED|Overall Study||4
7980995|NCT00246012|19651132|P8|COMPLETED|Overall Study||5
7980996|NCT00246012|19651133|P7|COMPLETED|Overall Study||1
7980997|NCT00246012|19651134|P6|COMPLETED|Overall Study||4
7980998|NCT00246012|19651135|P5|COMPLETED|Overall Study||0
7980999|NCT00246012|19651136|P4|COMPLETED|Overall Study||0
7981000|NCT00246012|19651137|P3|COMPLETED|Overall Study||1
7981001|NCT00246012|19651138|P2|COMPLETED|Overall Study||2
7981002|NCT00246012|19651139|P1|COMPLETED|Overall Study||0
7981003|NCT00246012|19651131|P9|Treated|Overall Study||32
7981004|NCT00246012|19651132|P8|Treated|Overall Study||33
7981005|NCT00246012|19651133|P7|Treated|Overall Study||31
7981006|NCT00246012|19651134|P6|Treated|Overall Study||31
7981007|NCT00246012|19651135|P5|Treated|Overall Study||3
7981008|NCT00246012|19651136|P4|Treated|Overall Study||3
7981009|NCT00246012|19651137|P3|Treated|Overall Study||3
7981010|NCT00246012|19651138|P2|Treated|Overall Study||3
7981011|NCT00246012|19651139|P1|Treated|Overall Study||3
7981012|NCT00246012|19651131|P9|STARTED|Overall Study||32
7981013|NCT00246012|19651132|P8|STARTED|Overall Study||33
7981014|NCT00246012|19651133|P7|STARTED|Overall Study||32
7981015|NCT00246012|19651134|P6|STARTED|Overall Study||32
7981016|NCT00246012|19651135|P5|STARTED|Overall Study||3
7981017|NCT00246012|19651136|P4|STARTED|Overall Study||3
7981018|NCT00246012|19651137|P3|STARTED|Overall Study||3
7981019|NCT00246012|19651138|P2|STARTED|Overall Study||3
7981020|NCT00246012|19651139|P1|STARTED|Overall Study||3
7981021|NCT00245960|19651234|P2|NOT COMPLETED|Overall Study||28
7981022|NCT00245960|19651235|P1|NOT COMPLETED|Overall Study||29
7981023|NCT00245960|19651234|P2|COMPLETED|Overall Study||345
7981024|NCT00245960|19651235|P1|COMPLETED|Overall Study||350
7981025|NCT00245960|19651234|P2|STARTED|Overall Study||373
7981026|NCT00245960|19651235|P1|STARTED|Overall Study||379
7981027|NCT00245856|19651243|P2|NOT COMPLETED|Period Two||1
7981028|NCT00245856|19651244|P1|NOT COMPLETED|Period Two||0
7981029|NCT00245856|19651243|P2|COMPLETED|Period Two||38
7981030|NCT00245856|19651244|P1|COMPLETED|Period Two||0
7981031|NCT00245856|19651243|P2|STARTED|Period Two||39
7981032|NCT00245856|19651244|P1|STARTED|Period Two||0
7981033|NCT00245856|19651243|P2|NOT COMPLETED|Period One||0
7981034|NCT00245856|19651244|P1|NOT COMPLETED|Period One||0
7981035|NCT00245856|19651243|P2|COMPLETED|Period One||0
7981036|NCT00245856|19651244|P1|COMPLETED|Period One||28
7981037|NCT00245856|19651243|P2|STARTED|Period One||0
7981038|NCT00245856|19651244|P1|STARTED|Period One||28
7981039|NCT00245765|19651254|P3|NOT COMPLETED|Overall Study||8
7981040|NCT00245765|19651255|P2|NOT COMPLETED|Overall Study||14
7981041|NCT00245765|19651256|P1|NOT COMPLETED|Overall Study||32
7981042|NCT00245765|19651254|P3|COMPLETED|Overall Study||50
7981043|NCT00245765|19651255|P2|COMPLETED|Overall Study||45
7981044|NCT00245765|19651256|P1|COMPLETED|Overall Study||27
7981045|NCT00245765|19651254|P3|Safety Population|Overall Study|One subject in the 400 mg group was randomized by mistake but did not receive study medication.|57
7981046|NCT00245765|19651255|P2|Safety Population|Overall Study|For safety analysis, the PBO group subj. who received CDP870 was considered to be in the 200mg group|60
7981047|NCT00245765|19651256|P1|Safety Population|Overall Study|One subject in the Placebo (PBO) group received one injection of CDP870 200 mg on one occasion.|58
7981048|NCT00245765|19651254|P3|STARTED|Overall Study||58
7981049|NCT00245765|19651255|P2|STARTED|Overall Study||59
7981050|NCT00245765|19651256|P1|STARTED|Overall Study||59
7981051|NCT00245635|19651296|P2|NOT COMPLETED|Overall Study||0
7981052|NCT00245635|19651297|P1|NOT COMPLETED|Overall Study||0
7981053|NCT00245635|19651296|P2|COMPLETED|Overall Study||18
7981054|NCT00245635|19651297|P1|COMPLETED|Overall Study||25
7981055|NCT00245635|19651296|P2|STARTED|Overall Study||18
7981056|NCT00245635|19651297|P1|STARTED|Overall Study||25
7981057|NCT00245583|19651305|P2|NOT COMPLETED|Overall Study||9
7981058|NCT00245583|19651306|P1|NOT COMPLETED|Overall Study||6
7981059|NCT00245583|19651305|P2|COMPLETED|Overall Study||13
7981060|NCT00245583|19651306|P1|COMPLETED|Overall Study||14
7981061|NCT00245583|19651305|P2|STARTED|Overall Study||22
7981062|NCT00245583|19651306|P1|STARTED|Overall Study||20
7981063|NCT00245570|19651326|P6|NOT COMPLETED|Treatment Period IV||0
7981064|NCT00245570|19651327|P5|NOT COMPLETED|Treatment Period IV||0
7981065|NCT00245570|19651328|P4|NOT COMPLETED|Treatment Period IV||0
7981066|NCT00245570|19651329|P3|NOT COMPLETED|Treatment Period IV||0
7981067|NCT00245570|19651330|P2|NOT COMPLETED|Treatment Period IV||0
7981068|NCT00245570|19651331|P1|NOT COMPLETED|Treatment Period IV||0
7981069|NCT00245570|19651326|P6|COMPLETED|Treatment Period IV||8
7981070|NCT00245570|19651327|P5|COMPLETED|Treatment Period IV||8
7981071|NCT00245570|19651328|P4|COMPLETED|Treatment Period IV||8
7981072|NCT00245570|19651329|P3|COMPLETED|Treatment Period IV||8
7981073|NCT00245570|19651330|P2|COMPLETED|Treatment Period IV||7
7981074|NCT00245570|19651331|P1|COMPLETED|Treatment Period IV||7
7981075|NCT00245570|19651326|P6|STARTED|Treatment Period IV||8
7981076|NCT00245570|19651327|P5|STARTED|Treatment Period IV||8
7981077|NCT00245570|19651328|P4|STARTED|Treatment Period IV||8
7981078|NCT00245570|19651329|P3|STARTED|Treatment Period IV||8
7981079|NCT00245570|19651330|P2|STARTED|Treatment Period IV||7
7981080|NCT00245570|19651331|P1|STARTED|Treatment Period IV||7
7981081|NCT00245570|19651326|P6|NOT COMPLETED|Washout Between Periods III and IV||0
7981082|NCT00245570|19651327|P5|NOT COMPLETED|Washout Between Periods III and IV||0
7981083|NCT00245570|19651328|P4|NOT COMPLETED|Washout Between Periods III and IV||0
7981084|NCT00245570|19651329|P3|NOT COMPLETED|Washout Between Periods III and IV||0
7981085|NCT00245570|19651330|P2|NOT COMPLETED|Washout Between Periods III and IV||1
7981086|NCT00245570|19651331|P1|NOT COMPLETED|Washout Between Periods III and IV||0
7981087|NCT00245570|19651326|P6|COMPLETED|Washout Between Periods III and IV||8
7981088|NCT00245570|19651327|P5|COMPLETED|Washout Between Periods III and IV||8
7981089|NCT00245570|19651328|P4|COMPLETED|Washout Between Periods III and IV||8
7981090|NCT00245570|19651329|P3|COMPLETED|Washout Between Periods III and IV||8
7981091|NCT00245570|19651330|P2|COMPLETED|Washout Between Periods III and IV||7
7981092|NCT00245570|19651331|P1|COMPLETED|Washout Between Periods III and IV||7
7981093|NCT00245570|19651326|P6|STARTED|Washout Between Periods III and IV||8
7981094|NCT00245570|19651327|P5|STARTED|Washout Between Periods III and IV||8
7981095|NCT00245570|19651328|P4|STARTED|Washout Between Periods III and IV||8
7981096|NCT00245570|19651329|P3|STARTED|Washout Between Periods III and IV||8
7981097|NCT00245570|19651330|P2|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8
7981098|NCT00245570|19651331|P1|STARTED|Washout Between Periods III and IV||7
7981099|NCT00245570|19651326|P6|NOT COMPLETED|Treatment Period III||0
7981100|NCT00245570|19651327|P5|NOT COMPLETED|Treatment Period III||0
7981101|NCT00245570|19651328|P4|NOT COMPLETED|Treatment Period III||0
7981102|NCT00245570|19651329|P3|NOT COMPLETED|Treatment Period III||0
7981103|NCT00245570|19651330|P2|NOT COMPLETED|Treatment Period III||0
7981104|NCT00245570|19651331|P1|NOT COMPLETED|Treatment Period III||0
7981105|NCT00245570|19651326|P6|COMPLETED|Treatment Period III||8
7981106|NCT00245570|19651327|P5|COMPLETED|Treatment Period III||8
7981107|NCT00245570|19651328|P4|COMPLETED|Treatment Period III||8
7981108|NCT00245570|19651329|P3|COMPLETED|Treatment Period III||8
7981109|NCT00245570|19651330|P2|COMPLETED|Treatment Period III||8
7981110|NCT00245570|19651331|P1|COMPLETED|Treatment Period III||7
7981111|NCT00245570|19651326|P6|STARTED|Treatment Period III||8
7981112|NCT00245570|19651327|P5|STARTED|Treatment Period III||8
7981113|NCT00245570|19651328|P4|STARTED|Treatment Period III||8
7981114|NCT00245570|19651329|P3|STARTED|Treatment Period III||8
7981115|NCT00245570|19651330|P2|STARTED|Treatment Period III||8
7981116|NCT00245570|19651331|P1|STARTED|Treatment Period III||7
7981117|NCT00245570|19651326|P6|NOT COMPLETED|Washout Between Periods II and III||0
7981118|NCT00245570|19651327|P5|NOT COMPLETED|Washout Between Periods II and III||0
7981119|NCT00245570|19651328|P4|NOT COMPLETED|Washout Between Periods II and III||0
7981120|NCT00245570|19651329|P3|NOT COMPLETED|Washout Between Periods II and III||0
7981121|NCT00245570|19651330|P2|NOT COMPLETED|Washout Between Periods II and III||0
7981122|NCT00245570|19651331|P1|NOT COMPLETED|Washout Between Periods II and III||0
7981123|NCT00245570|19651326|P6|COMPLETED|Washout Between Periods II and III||8
7981124|NCT00245570|19651327|P5|COMPLETED|Washout Between Periods II and III||8
7981125|NCT00245570|19651328|P4|COMPLETED|Washout Between Periods II and III||8
7981126|NCT00245570|19651329|P3|COMPLETED|Washout Between Periods II and III||8
7981127|NCT00245570|19651330|P2|COMPLETED|Washout Between Periods II and III||8
7981128|NCT00245570|19651331|P1|COMPLETED|Washout Between Periods II and III||7
7981129|NCT00245570|19651326|P6|STARTED|Washout Between Periods II and III||8
7981130|NCT00245570|19651327|P5|STARTED|Washout Between Periods II and III||8
7981131|NCT00245570|19651328|P4|STARTED|Washout Between Periods II and III||8
7981132|NCT00245570|19651329|P3|STARTED|Washout Between Periods II and III||8
7981133|NCT00245570|19651330|P2|STARTED|Washout Between Periods II and III||8
7981134|NCT00245570|19651331|P1|STARTED|Washout Between Periods II and III||7
7981135|NCT00245570|19651326|P6|NOT COMPLETED|Treatment Period II||0
7981136|NCT00245570|19651327|P5|NOT COMPLETED|Treatment Period II||0
7981137|NCT00245570|19651328|P4|NOT COMPLETED|Treatment Period II||0
7981138|NCT00245570|19651329|P3|NOT COMPLETED|Treatment Period II||0
7981139|NCT00245570|19651330|P2|NOT COMPLETED|Treatment Period II||0
7981140|NCT00245570|19651331|P1|NOT COMPLETED|Treatment Period II||0
7981141|NCT00245570|19651326|P6|COMPLETED|Treatment Period II||8
7981142|NCT00245570|19651327|P5|COMPLETED|Treatment Period II||8
7981143|NCT00245570|19651328|P4|COMPLETED|Treatment Period II||8
7981144|NCT00245570|19651329|P3|COMPLETED|Treatment Period II||8
7981145|NCT00245570|19651330|P2|COMPLETED|Treatment Period II||8
7981146|NCT00245570|19651331|P1|COMPLETED|Treatment Period II||7
7981147|NCT00245570|19651326|P6|STARTED|Treatment Period II||8
7981148|NCT00245570|19651327|P5|STARTED|Treatment Period II||8
7981149|NCT00245570|19651328|P4|STARTED|Treatment Period II||8
7981150|NCT00245570|19651329|P3|STARTED|Treatment Period II||8
7981151|NCT00245570|19651330|P2|STARTED|Treatment Period II||8
7981152|NCT00245570|19651331|P1|STARTED|Treatment Period II||7
7981153|NCT00245557|19651377|P2|NOT COMPLETED|Overall Study||16
7981154|NCT00245557|19651378|P1|NOT COMPLETED|Overall Study||6
7981155|NCT00245557|19651377|P2|COMPLETED|Overall Study||10
7981156|NCT00245557|19651378|P1|COMPLETED|Overall Study||11
7981157|NCT00245557|19651377|P2|STARTED|Overall Study||26
7981158|NCT00245557|19651378|P1|STARTED|Overall Study||17
7981159|NCT00245518|19651391|P2|NOT COMPLETED|Overall Study||0
7981160|NCT00245518|19651392|P1|NOT COMPLETED|Overall Study||0
7981161|NCT00245518|19651391|P2|COMPLETED|Overall Study||16
7981162|NCT00245518|19651392|P1|COMPLETED|Overall Study||17
7981163|NCT00245518|19651391|P2|STARTED|Overall Study||16
7981164|NCT00245518|19651392|P1|STARTED|Overall Study||17
7981165|NCT00245466|19651465|P3|NOT COMPLETED|Overall Study||37
7981166|NCT00245466|19651466|P2|NOT COMPLETED|Overall Study||44
7981167|NCT00245466|19651467|P1|NOT COMPLETED|Overall Study||36
7981168|NCT00245466|19651465|P3|COMPLETED|Overall Study||3
7981169|NCT00245466|19651466|P2|COMPLETED|Overall Study||2
7981170|NCT00245466|19651467|P1|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7
7981171|NCT00245466|19651465|P3|Started FE200486 CS02A|Overall Study||26
7981172|NCT00245466|19651466|P2|Started FE200486 CS02A|Overall Study||30
7981173|NCT00245466|19651467|P1|Started FE200486 CS02A|Overall Study||32
7981174|NCT00245466|19651465|P3|STARTED|Overall Study||40
7981175|NCT00245466|19651466|P2|STARTED|Overall Study||46
7981176|NCT00245466|19651467|P1|STARTED|Overall Study||43
7981177|NCT00245219|19651484|P3|NOT COMPLETED|Overall Study||2
7981178|NCT00245219|19651485|P2|NOT COMPLETED|Overall Study||6
7981179|NCT00245219|19651486|P1|NOT COMPLETED|Overall Study||6
7981180|NCT00245219|19651484|P3|COMPLETED|Overall Study||58
7981181|NCT00245219|19651485|P2|COMPLETED|Overall Study||88
7981182|NCT00245219|19651486|P1|COMPLETED|Overall Study||85
7981183|NCT00245219|19651484|P3|STARTED|Overall Study||60
7981184|NCT00245219|19651485|P2|STARTED|Overall Study||94
7981185|NCT00245219|19651486|P1|STARTED|Overall Study||91
7981186|NCT00245128|19651500|P1|NOT COMPLETED|Overall Study||10
7981187|NCT00245128|19651500|P1|COMPLETED|Overall Study||0
7981188|NCT00245128|19651500|P1|STARTED|Overall Study||10
7981189|NCT00245102|19651510|P6|NOT COMPLETED|Overall Study||4
7981190|NCT00245102|19651511|P5|NOT COMPLETED|Overall Study||0
7981191|NCT00245102|19651512|P4|NOT COMPLETED|Overall Study||3
7981192|NCT00245102|19651513|P3|NOT COMPLETED|Overall Study||7
7981193|NCT00245102|19651514|P2|NOT COMPLETED|Overall Study||4
7981194|NCT00245102|19651515|P1|NOT COMPLETED|Overall Study||7
7981195|NCT00245102|19651510|P6|COMPLETED|Overall Study||19
7981196|NCT00245102|19651511|P5|COMPLETED|Overall Study||5
7981197|NCT00245102|19651512|P4|COMPLETED|Overall Study||10
7981198|NCT00245102|19651513|P3|COMPLETED|Overall Study||39
7981199|NCT00245102|19651514|P2|COMPLETED|Overall Study||12
7981200|NCT00245102|19651515|P1|COMPLETED|Overall Study||37
7981201|NCT00245102|19651510|P6|STARTED|Overall Study||23
7981202|NCT00245102|19651511|P5|STARTED|Overall Study||5
7981203|NCT00245102|19651512|P4|STARTED|Overall Study||13
7981204|NCT00245102|19651513|P3|STARTED|Overall Study||46
7981205|NCT00245102|19651514|P2|STARTED|Overall Study||16
7981206|NCT00245102|19651515|P1|STARTED|Overall Study||44
7981207|NCT00245063|19651531|P2|NOT COMPLETED|Overall Study||5
7981208|NCT00245063|19651532|P1|NOT COMPLETED|Overall Study||7
7981209|NCT00245063|19651531|P2|COMPLETED|Overall Study||8
7981210|NCT00245063|19651532|P1|COMPLETED|Overall Study||5
7981211|NCT00245063|19651531|P2|STARTED|Overall Study||13
7981212|NCT00245063|19651532|P1|STARTED|Overall Study||12
7981213|NCT00245050|19651540|P2|NOT COMPLETED|Overall Study||2
7981214|NCT00245050|19651541|P1|NOT COMPLETED|Overall Study||3
7981215|NCT00245050|19651540|P2|COMPLETED|Overall Study||14
7981216|NCT00245050|19651541|P1|COMPLETED|Overall Study||15
7981217|NCT00245050|19651540|P2|STARTED|Overall Study||16
7981218|NCT00245050|19651541|P1|STARTED|Overall Study||18
7981219|NCT00245037|19651549|P1|NOT COMPLETED|Overall Study||17
7981220|NCT00245037|19651549|P1|COMPLETED|Overall Study|17 participants died from infectious complications.|130
7981221|NCT00245037|19651549|P1|STARTED|Overall Study||147
7981222|NCT00245011|19651559|P1|NOT COMPLETED|Overall Study||1
7981223|NCT00245011|19651559|P1|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10
7981224|NCT00245011|19651559|P1|STARTED|Overall Study||11
7981225|NCT00244985|19651568|P1|NOT COMPLETED|Overall Study||0
7981226|NCT00244985|19651568|P1|COMPLETED|Overall Study||42
7981227|NCT00244985|19651568|P1|STARTED|Overall Study||42
7981228|NCT00244933|19651576|P1|NOT COMPLETED|Overall Study||2
7981229|NCT00244933|19651576|P1|COMPLETED|Overall Study||17
7981230|NCT00244933|19651576|P1|STARTED|Overall Study||19
7981231|NCT00244881|19651580|P1|NOT COMPLETED|Overall Study||3
7981232|NCT00244881|19651580|P1|COMPLETED|Overall Study||23
7981233|NCT00244881|19651580|P1|STARTED|Overall Study||26
7981234|NCT00244855|19651588|P2|NOT COMPLETED|Overall Study||1
7981235|NCT00244855|19651589|P1|NOT COMPLETED|Overall Study||0
7981236|NCT00244855|19651588|P2|COMPLETED|Overall Study||24
7981237|NCT00244855|19651589|P1|COMPLETED|Overall Study||7
7981238|NCT00244855|19651588|P2|STARTED|Overall Study||25
7981239|NCT00244855|19651589|P1|STARTED|Overall Study||7
7981240|NCT00244764|19651597|P1|NOT COMPLETED|Overall Study||96
7981241|NCT00244764|19651597|P1|COMPLETED|Overall Study||129
7981242|NCT00244764|19651597|P1|STARTED|Overall Study||225
7981243|NCT00244751|19651607|P3|NOT COMPLETED|Overall Study||10
7981244|NCT00244751|19651608|P2|NOT COMPLETED|Overall Study||15
7981245|NCT00244751|19651609|P1|NOT COMPLETED|Overall Study||16
7981246|NCT00244751|19651607|P3|COMPLETED|Overall Study||78
7981247|NCT00244751|19651608|P2|COMPLETED|Overall Study||74
7981248|NCT00244751|19651609|P1|COMPLETED|Overall Study||72
7981249|NCT00244751|19651607|P3|STARTED|Overall Study||88
7981250|NCT00244751|19651608|P2|STARTED|Overall Study||89
7981251|NCT00244751|19651609|P1|STARTED|Overall Study||88
7981252|NCT00244725|19651710|P4|NOT COMPLETED|Overall Study||21
7981253|NCT00244725|19651711|P3|NOT COMPLETED|Overall Study||24
7981254|NCT00244725|19651712|P2|NOT COMPLETED|Overall Study||19
7981255|NCT00244725|19651713|P1|NOT COMPLETED|Overall Study||23
7981256|NCT00244725|19651710|P4|COMPLETED|Overall Study||216
7981257|NCT00244725|19651711|P3|COMPLETED|Overall Study||215
7981258|NCT00244725|19651712|P2|COMPLETED|Overall Study||226
7981259|NCT00244725|19651713|P1|COMPLETED|Overall Study||214
7981260|NCT00244725|19651710|P4|STARTED|Overall Study||237
7981261|NCT00244725|19651711|P3|STARTED|Overall Study||239
7981262|NCT00244725|19651712|P2|STARTED|Overall Study||245
7981263|NCT00244725|19651713|P1|STARTED|Overall Study||237
7981264|NCT00244712|19651769|P2|NOT COMPLETED|Overall Study||124
7981265|NCT00244712|19651770|P1|NOT COMPLETED|Overall Study||109
7981266|NCT00244712|19651769|P2|COMPLETED|Overall Study||221
7981267|NCT00244712|19651770|P1|COMPLETED|Overall Study||234
7981268|NCT00244712|19651769|P2|STARTED|Overall Study||345
7981269|NCT00244712|19651770|P1|STARTED|Overall Study||343
7981270|NCT00244621|19651805|P3|NOT COMPLETED|Open-label Treatment Period||2
7981271|NCT00244621|19651806|P2|NOT COMPLETED|Open-label Treatment Period||1
7981272|NCT00244621|19651807|P1|NOT COMPLETED|Open-label Treatment Period||1
7981273|NCT00244621|19651805|P3|COMPLETED|Open-label Treatment Period||28
7981274|NCT00244621|19651806|P2|COMPLETED|Open-label Treatment Period||28
7981275|NCT00244621|19651807|P1|COMPLETED|Open-label Treatment Period||25
7981276|NCT00244621|19651805|P3|STARTED|Open-label Treatment Period||30
7981277|NCT00244621|19651806|P2|STARTED|Open-label Treatment Period||29
7981278|NCT00244621|19651807|P1|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26
7981279|NCT00244621|19651805|P3|NOT COMPLETED|Double-blind Treatment Period||2
7981280|NCT00244621|19651806|P2|NOT COMPLETED|Double-blind Treatment Period||3
7981281|NCT00244621|19651807|P1|NOT COMPLETED|Double-blind Treatment Period||2
7981282|NCT00244621|19651805|P3|COMPLETED|Double-blind Treatment Period||30
7981283|NCT00244621|19651806|P2|COMPLETED|Double-blind Treatment Period||29
7981284|NCT00244621|19651807|P1|COMPLETED|Double-blind Treatment Period||27
7981285|NCT00244621|19651805|P3|STARTED|Double-blind Treatment Period||32
7981286|NCT00244621|19651806|P2|STARTED|Double-blind Treatment Period||32
7981287|NCT00244621|19651807|P1|STARTED|Double-blind Treatment Period||29
7981288|NCT00244374|19651824|P5|NOT COMPLETED|Vaccine Adherence Cohort||0
7981289|NCT00244374|19651825|P4|NOT COMPLETED|Vaccine Adherence Cohort||0
7981290|NCT00244374|19651826|P3|NOT COMPLETED|Vaccine Adherence Cohort||0
7981291|NCT00244374|19651827|P2|NOT COMPLETED|Vaccine Adherence Cohort||0
7981292|NCT00244374|19651828|P1|NOT COMPLETED|Vaccine Adherence Cohort||0
7981293|NCT00244374|19651824|P5|COMPLETED|Vaccine Adherence Cohort||41
7981294|NCT00244374|19651825|P4|COMPLETED|Vaccine Adherence Cohort||36
7981295|NCT00244374|19651826|P3|COMPLETED|Vaccine Adherence Cohort||43
7981296|NCT00244374|19651827|P2|COMPLETED|Vaccine Adherence Cohort||47
7981297|NCT00244374|19651828|P1|COMPLETED|Vaccine Adherence Cohort||0
7981298|NCT00244374|19651824|P5|STARTED|Vaccine Adherence Cohort||41
7981299|NCT00244374|19651825|P4|STARTED|Vaccine Adherence Cohort||36
7981300|NCT00244374|19651826|P3|STARTED|Vaccine Adherence Cohort||43
7981301|NCT00244374|19651827|P2|STARTED|Vaccine Adherence Cohort||47
7981302|NCT00244374|19651828|P1|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0
7981303|NCT00244374|19651824|P5|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
7981304|NCT00244374|19651825|P4|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
7981305|NCT00244374|19651826|P3|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
7981306|NCT00244374|19651827|P2|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
7981307|NCT00244374|19651828|P1|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273
7981308|NCT00244374|19651824|P5|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
7981309|NCT00244374|19651825|P4|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
7981310|NCT00244374|19651826|P3|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
7981311|NCT00244374|19651827|P2|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
7981312|NCT00244374|19651828|P1|COMPLETED|Evaluation for Vaccine Adherence Cohort||167
7981313|NCT00244374|19651824|P5|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
7981314|NCT00244374|19651825|P4|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
7981315|NCT00244374|19651826|P3|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
7981316|NCT00244374|19651827|P2|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
7981317|NCT00244374|19651828|P1|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217
7981318|NCT00244374|19651824|P5|STARTED|Evaluation for Vaccine Adherence Cohort||0
7981319|NCT00244374|19651825|P4|STARTED|Evaluation for Vaccine Adherence Cohort||0
7981320|NCT00244374|19651826|P3|STARTED|Evaluation for Vaccine Adherence Cohort||0
7981321|NCT00244374|19651827|P2|STARTED|Evaluation for Vaccine Adherence Cohort||0
7981322|NCT00244374|19651828|P1|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440
7981323|NCT00244374|19651824|P5|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
7981324|NCT00244374|19651825|P4|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
7981325|NCT00244374|19651826|P3|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
7981326|NCT00244374|19651827|P2|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
7981327|NCT00244374|19651828|P1|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137
7981328|NCT00244374|19651824|P5|COMPLETED|Pre-Randomization Cross-sectional Study||0
7981329|NCT00244374|19651825|P4|COMPLETED|Pre-Randomization Cross-sectional Study||0
7981330|NCT00244374|19651826|P3|COMPLETED|Pre-Randomization Cross-sectional Study||0
7981331|NCT00244374|19651827|P2|COMPLETED|Pre-Randomization Cross-sectional Study||0
7981332|NCT00244374|19651828|P1|COMPLETED|Pre-Randomization Cross-sectional Study||409
7981333|NCT00244374|19651824|P5|STARTED|Pre-Randomization Cross-sectional Study||0
7981334|NCT00244374|19651825|P4|STARTED|Pre-Randomization Cross-sectional Study||0
7981335|NCT00244374|19651826|P3|STARTED|Pre-Randomization Cross-sectional Study||0
7981336|NCT00244374|19651827|P2|STARTED|Pre-Randomization Cross-sectional Study||0
7981337|NCT00244374|19651828|P1|STARTED|Pre-Randomization Cross-sectional Study||546
7981338|NCT00244140|19651846|P2|NOT COMPLETED|Overall Study||0
7981339|NCT00244140|19651847|P1|NOT COMPLETED|Overall Study||0
7981340|NCT00244140|19651846|P2|COMPLETED|Overall Study||22
7981341|NCT00244140|19651847|P1|COMPLETED|Overall Study||412
7981342|NCT00244140|19651846|P2|STARTED|Overall Study||22
7981343|NCT00244140|19651847|P1|STARTED|Overall Study||412
7981344|NCT00244101|19651862|P3|NOT COMPLETED|Overall Study||0
7981345|NCT00244101|19651863|P2|NOT COMPLETED|Overall Study||0
7981346|NCT00244101|19651864|P1|NOT COMPLETED|Overall Study||0
7981347|NCT00244101|19651862|P3|COMPLETED|Overall Study||216
7981348|NCT00244101|19651863|P2|COMPLETED|Overall Study||223
7981349|NCT00244101|19651864|P1|COMPLETED|Overall Study||209
7981350|NCT00244101|19651862|P3|STARTED|Overall Study||216
7981351|NCT00244101|19651863|P2|STARTED|Overall Study||223
7981352|NCT00244101|19651864|P1|STARTED|Overall Study||209
7981353|NCT00244010|19651874|P2|NOT COMPLETED|Overall Study||0
7981354|NCT00244010|19651875|P1|NOT COMPLETED|Overall Study||0
7981355|NCT00244010|19651874|P2|COMPLETED|Overall Study||2
7981356|NCT00244010|19651875|P1|COMPLETED|Overall Study||2
7981357|NCT00244010|19651874|P2|STARTED|Overall Study||2
7981358|NCT00244010|19651875|P1|STARTED|Overall Study||2
7981359|NCT00243932|19651884|P3|NOT COMPLETED|Stage 2: Efficacy||0
7981360|NCT00243932|19651885|P2|NOT COMPLETED|Stage 2: Efficacy||0
7981361|NCT00243932|19651886|P1|NOT COMPLETED|Stage 2: Efficacy||0
7981362|NCT00243932|19651884|P3|COMPLETED|Stage 2: Efficacy||0
7981363|NCT00243932|19651885|P2|COMPLETED|Stage 2: Efficacy||40
7981364|NCT00243932|19651886|P1|COMPLETED|Stage 2: Efficacy||40
7981365|NCT00243932|19651884|P3|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0
7981366|NCT00243932|19651885|P2|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
7981367|NCT00243932|19651886|P1|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
7981368|NCT00243932|19651884|P3|NOT COMPLETED|Stage 1: Dose Selection||0
7981369|NCT00243932|19651885|P2|NOT COMPLETED|Stage 1: Dose Selection||0
7981370|NCT00243932|19651886|P1|NOT COMPLETED|Stage 1: Dose Selection||2
7981371|NCT00243932|19651884|P3|COMPLETED|Stage 1: Dose Selection||35
7981372|NCT00243932|19651885|P2|COMPLETED|Stage 1: Dose Selection||35
7981373|NCT00243932|19651886|P1|COMPLETED|Stage 1: Dose Selection||33
7981374|NCT00243932|19651884|P3|STARTED|Stage 1: Dose Selection||35
7981375|NCT00243932|19651885|P2|STARTED|Stage 1: Dose Selection||35
7981376|NCT00243932|19651886|P1|STARTED|Stage 1: Dose Selection||35
7981377|NCT00243919|19651897|P3|NOT COMPLETED|Overall Study||11
7981378|NCT00243919|19651898|P2|NOT COMPLETED|Overall Study||18
7981379|NCT00243919|19651899|P1|NOT COMPLETED|Overall Study||17
7981380|NCT00243919|19651897|P3|COMPLETED|Overall Study||115
7981381|NCT00243919|19651898|P2|COMPLETED|Overall Study||125
7981382|NCT00243919|19651899|P1|COMPLETED|Overall Study||122
7981383|NCT00243919|19651897|P3|STARTED|Overall Study||126
7981384|NCT00243919|19651898|P2|STARTED|Overall Study||143
7981385|NCT00243919|19651899|P1|STARTED|Overall Study||139
7981386|NCT00243841|19651943|P6|NOT COMPLETED|Overall Study||2
7981387|NCT00243841|19651944|P5|NOT COMPLETED|Overall Study||0
7981388|NCT00243841|19651945|P4|NOT COMPLETED|Overall Study||0
7981389|NCT00243841|19651946|P3|NOT COMPLETED|Overall Study||1
7981390|NCT00243841|19651947|P2|NOT COMPLETED|Overall Study||0
7981391|NCT00243841|19651948|P1|NOT COMPLETED|Overall Study||0
7981392|NCT00243841|19651943|P6|COMPLETED|Overall Study||19
7981393|NCT00243841|19651944|P5|COMPLETED|Overall Study||39
7981394|NCT00243841|19651945|P4|COMPLETED|Overall Study||3
7981395|NCT00243841|19651946|P3|COMPLETED|Overall Study||4
7981396|NCT00243841|19651947|P2|COMPLETED|Overall Study||6
7981397|NCT00243841|19651948|P1|COMPLETED|Overall Study||3
7981398|NCT00243841|19651943|P6|STARTED|Overall Study||21
7981399|NCT00243841|19651944|P5|STARTED|Overall Study||39
7981400|NCT00243841|19651945|P4|STARTED|Overall Study||3
7981401|NCT00243841|19651946|P3|STARTED|Overall Study||5
7981402|NCT00243841|19651947|P2|STARTED|Overall Study||6
7981403|NCT00243841|19651948|P1|STARTED|Overall Study||3
7981404|NCT00243659|19651970|P2|NOT COMPLETED|Overall Study||3
7981405|NCT00243659|19651971|P1|NOT COMPLETED|Overall Study||2
7981406|NCT00243659|19651970|P2|COMPLETED|Overall Study||5
7981407|NCT00243659|19651971|P1|COMPLETED|Overall Study||20
7981408|NCT00243659|19651970|P2|STARTED|Overall Study||8
7981409|NCT00243659|19651971|P1|STARTED|Overall Study||22
7981410|NCT00243503|19651979|P1|NOT COMPLETED|Overall Study||58
7981411|NCT00243503|19651979|P1|COMPLETED|Overall Study||2
7981412|NCT00243503|19651979|P1|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60
7981413|NCT00243412|19651996|P2|NOT COMPLETED|Overall Study||11
7981414|NCT00243412|19651997|P1|NOT COMPLETED|Overall Study||10
7981415|NCT00243412|19651996|P2|COMPLETED|Overall Study|Completed Week 104|10
7981416|NCT00243412|19651997|P1|COMPLETED|Overall Study|Completed Week 104|11
7981417|NCT00243412|19651996|P2|Safety Evaluable|Overall Study||20
7981418|NCT00243412|19651997|P1|Safety Evaluable|Overall Study||21
7981419|NCT00243412|19651996|P2|STARTED|Overall Study|Intent to treat|21
7981420|NCT00243412|19651997|P1|STARTED|Overall Study|Intent to treat|21
7981421|NCT00243386|19652023|P3|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
7981422|NCT00243386|19652024|P2|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3
7981423|NCT00243386|19652025|P1|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
7981424|NCT00243386|19652023|P3|COMPLETED|PK-Driven or Standard Prophylaxis||32
7981425|NCT00243386|19652024|P2|COMPLETED|PK-Driven or Standard Prophylaxis||31
7981426|NCT00243386|19652025|P1|COMPLETED|PK-Driven or Standard Prophylaxis||0
7981427|NCT00243386|19652023|P3|STARTED|PK-Driven or Standard Prophylaxis||32
7981428|NCT00243386|19652024|P2|STARTED|PK-Driven or Standard Prophylaxis||34
7981429|NCT00243386|19652025|P1|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
7981430|NCT00243386|19652023|P3|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
7981431|NCT00243386|19652024|P2|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
7981432|NCT00243386|19652025|P1|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3
7981433|NCT00243386|19652023|P3|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
7981434|NCT00243386|19652024|P2|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
7981435|NCT00243386|19652025|P1|COMPLETED|End of Part 1, But Prior to Prophylaxis||66
7981436|NCT00243386|19652023|P3|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
7981437|NCT00243386|19652024|P2|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
7981438|NCT00243386|19652025|P1|STARTED|End of Part 1, But Prior to Prophylaxis||69
7981439|NCT00243386|19652023|P3|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
7981440|NCT00243386|19652024|P2|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
7981441|NCT00243386|19652025|P1|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4
7981442|NCT00243386|19652023|P3|COMPLETED|On-Demand Regimen (Study Part 1)||0
7981443|NCT00243386|19652024|P2|COMPLETED|On-Demand Regimen (Study Part 1)||0
7981444|NCT00243386|19652025|P1|COMPLETED|On-Demand Regimen (Study Part 1)||69
7981445|NCT00243386|19652023|P3|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
7981446|NCT00243386|19652024|P2|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
7981447|NCT00243386|19652025|P1|STARTED|On-Demand Regimen (Study Part 1)||73
7981448|NCT00243347|19652090|P1|NOT COMPLETED|Overall Study||19
7981449|NCT00243347|19652090|P1|COMPLETED|Overall Study|Completed study|0
7981450|NCT00243347|19652090|P1|STARTED|Overall Study|Treated|19
7981451|NCT00243269|19652099|P4|NOT COMPLETED|Overall Study||4
7981452|NCT00243269|19652100|P3|NOT COMPLETED|Overall Study||1
7981453|NCT00243269|19652101|P2|NOT COMPLETED|Overall Study||1
7981454|NCT00243269|19652102|P1|NOT COMPLETED|Overall Study||3
7981455|NCT00243269|19652099|P4|COMPLETED|Overall Study||25
7981456|NCT00243269|19652100|P3|COMPLETED|Overall Study||11
7981457|NCT00243269|19652101|P2|COMPLETED|Overall Study||10
7981458|NCT00243269|19652102|P1|COMPLETED|Overall Study||28
7981459|NCT00243269|19652099|P4|STARTED|Overall Study||29
7981460|NCT00243269|19652100|P3|STARTED|Overall Study||12
7981461|NCT00243269|19652101|P2|STARTED|Overall Study||11
7981462|NCT00243269|19652102|P1|STARTED|Overall Study||31
7981463|NCT00243243|19652118|P2|NOT COMPLETED|Overall Study||0
7981464|NCT00243243|19652119|P1|NOT COMPLETED|Overall Study||0
7981465|NCT00243243|19652118|P2|COMPLETED|Overall Study||10
7981466|NCT00243243|19652119|P1|COMPLETED|Overall Study||10
7981467|NCT00243243|19652118|P2|STARTED|Overall Study||10
7981468|NCT00243243|19652119|P1|STARTED|Overall Study||10
7981469|NCT00243191|19652125|P1|NOT COMPLETED|Overall Study||0
7981470|NCT00243191|19652125|P1|COMPLETED|Overall Study||18
7981471|NCT00243191|19652125|P1|STARTED|Overall Study||18
7981472|NCT00243152|19652129|P2|NOT COMPLETED|Overall Study||0
7981473|NCT00243152|19652130|P1|NOT COMPLETED|Overall Study||0
7981474|NCT00243152|19652129|P2|COMPLETED|Overall Study||3
7981475|NCT00243152|19652130|P1|COMPLETED|Overall Study||3
7981476|NCT00243152|19652129|P2|Scan 2: Placebo or Drug|Overall Study||3
7981477|NCT00243152|19652130|P1|Scan 2: Placebo or Drug|Overall Study||3
7981478|NCT00243152|19652129|P2|Scan 1: Drug or Placebo|Overall Study||3
7981479|NCT00243152|19652130|P1|Scan 1: Drug or Placebo|Overall Study||3
7981480|NCT00243152|19652129|P2|STARTED|Overall Study||3
7981481|NCT00243152|19652130|P1|STARTED|Overall Study||3
7981482|NCT00243074|19652137|P1|NOT COMPLETED|Overall Study||54
7981483|NCT00243074|19652137|P1|COMPLETED|Overall Study||0
7981484|NCT00243074|19652137|P1|STARTED|Overall Study||54
7981485|NCT00243061|19652147|P1|NOT COMPLETED|Overall Study||0
7981486|NCT00243061|19652147|P1|COMPLETED|Overall Study||24
7981487|NCT00243061|19652147|P1|STARTED|Overall Study||24
7981488|NCT00243022|19652163|P2|NOT COMPLETED|Overall Study||1
7981489|NCT00243022|19652164|P1|NOT COMPLETED|Overall Study||2
7981490|NCT00243022|19652163|P2|COMPLETED|Overall Study||4
7981491|NCT00243022|19652164|P1|COMPLETED|Overall Study||5
7981492|NCT00243022|19652163|P2|STARTED|Overall Study||5
7981493|NCT00243022|19652164|P1|STARTED|Overall Study||7
7981494|NCT00242710|19652188|P4|NOT COMPLETED|Study Extension (up to Year 2)||10
7981495|NCT00242710|19652189|P3|NOT COMPLETED|Study Extension (up to Year 2)||15
7981496|NCT00242710|19652190|P2|NOT COMPLETED|Study Extension (up to Year 2)||29
7981497|NCT00242710|19652191|P1|NOT COMPLETED|Study Extension (up to Year 2)||27
7981498|NCT00242710|19652188|P4|COMPLETED|Study Extension (up to Year 2)||84
7981499|NCT00242710|19652189|P3|COMPLETED|Study Extension (up to Year 2)||69
7981500|NCT00242710|19652190|P2|COMPLETED|Study Extension (up to Year 2)||148
7981501|NCT00242710|19652191|P1|COMPLETED|Study Extension (up to Year 2)||141
7981502|NCT00242710|19652188|P4|STARTED|Study Extension (up to Year 2)||94
7981503|NCT00242710|19652189|P3|STARTED|Study Extension (up to Year 2)||84
7981504|NCT00242710|19652190|P2|STARTED|Study Extension (up to Year 2)||177
7981505|NCT00242710|19652191|P1|STARTED|Study Extension (up to Year 2)||168
7981506|NCT00242710|19652188|P4|NOT COMPLETED|Period Between Core Study and Extension||49
7981507|NCT00242710|19652189|P3|NOT COMPLETED|Period Between Core Study and Extension||48
7981508|NCT00242710|19652190|P2|NOT COMPLETED|Period Between Core Study and Extension||112
7981509|NCT00242710|19652191|P1|NOT COMPLETED|Period Between Core Study and Extension||119
7981510|NCT00242710|19652188|P4|COMPLETED|Period Between Core Study and Extension||94
7981511|NCT00242710|19652189|P3|COMPLETED|Period Between Core Study and Extension||84
7981512|NCT00242710|19652190|P2|COMPLETED|Period Between Core Study and Extension||177
7981513|NCT00242710|19652191|P1|COMPLETED|Period Between Core Study and Extension||168
7981514|NCT00242710|19652188|P4|STARTED|Period Between Core Study and Extension||143
7981515|NCT00242710|19652189|P3|STARTED|Period Between Core Study and Extension||132
7981516|NCT00242710|19652190|P2|STARTED|Period Between Core Study and Extension||289
7981517|NCT00242710|19652191|P1|STARTED|Period Between Core Study and Extension||287
7981518|NCT00242710|19652188|P4|NOT COMPLETED|Core Study (up to Year 1)||31
7981519|NCT00242710|19652189|P3|NOT COMPLETED|Core Study (up to Year 1)||51
7981520|NCT00242710|19652190|P2|NOT COMPLETED|Core Study (up to Year 1)||64
7981521|NCT00242710|19652191|P1|NOT COMPLETED|Core Study (up to Year 1)||86
7981522|NCT00242710|19652188|P4|COMPLETED|Core Study (up to Year 1)||143
7981523|NCT00242710|19652189|P3|COMPLETED|Core Study (up to Year 1)||132
7981524|NCT00242710|19652190|P2|COMPLETED|Core Study (up to Year 1)||289
7981525|NCT00242710|19652191|P1|COMPLETED|Core Study (up to Year 1)||287
7981526|NCT00242710|19652188|P4|Treated|Core Study (up to Year 1)||172
7981527|NCT00242710|19652189|P3|Treated|Core Study (up to Year 1)||179
7981528|NCT00242710|19652190|P2|Treated|Core Study (up to Year 1)||349
7981529|NCT00242710|19652191|P1|Treated|Core Study (up to Year 1)||361
7981530|NCT00242710|19652188|P4|STARTED|Core Study (up to Year 1)||174
7981531|NCT00242710|19652189|P3|STARTED|Core Study (up to Year 1)||183
7981532|NCT00242710|19652190|P2|STARTED|Core Study (up to Year 1)||353
7981533|NCT00242710|19652191|P1|STARTED|Core Study (up to Year 1)||373
7981534|NCT00242684|19652241|P1|NOT COMPLETED|Overall Study||0
7981535|NCT00242684|19652241|P1|COMPLETED|Overall Study||446
7981536|NCT00242684|19652241|P1|STARTED|Overall Study||446
7981537|NCT00242658|19652248|P2|NOT COMPLETED|Overall Study||19
7981538|NCT00242658|19652249|P1|NOT COMPLETED|Overall Study||22
7981539|NCT00242658|19652248|P2|COMPLETED|Overall Study||188
7981540|NCT00242658|19652249|P1|COMPLETED|Overall Study||165
7981541|NCT00242658|19652248|P2|STARTED|Overall Study||207
7981542|NCT00242658|19652249|P1|STARTED|Overall Study||187
7981543|NCT00242632|19652259|P2|NOT COMPLETED|Overall Study||0
7981544|NCT00242632|19652260|P1|NOT COMPLETED|Overall Study||0
7981545|NCT00242632|19652259|P2|COMPLETED|Overall Study||11
7981546|NCT00242632|19652260|P1|COMPLETED|Overall Study||11
7981547|NCT00242632|19652259|P2|STARTED|Overall Study||11
7981548|NCT00242632|19652260|P1|STARTED|Overall Study||11
7981549|NCT00242619|19652268|P2|NOT COMPLETED|Overall Study||0
7981550|NCT00242619|19652269|P1|NOT COMPLETED|Overall Study||0
7981551|NCT00242619|19652268|P2|COMPLETED|Overall Study||4
7981552|NCT00242619|19652269|P1|COMPLETED|Overall Study||8
7981553|NCT00242619|19652268|P2|STARTED|Overall Study||4
7981554|NCT00242619|19652269|P1|STARTED|Overall Study||8
7981555|NCT00242580|19652280|P3|NOT COMPLETED|Overall Study||14
7981556|NCT00242580|19652281|P2|NOT COMPLETED|Overall Study||12
7981557|NCT00242580|19652282|P1|NOT COMPLETED|Overall Study||10
7981558|NCT00242580|19652280|P3|COMPLETED|Overall Study||24
7981559|NCT00242580|19652281|P2|COMPLETED|Overall Study||29
7981560|NCT00242580|19652282|P1|COMPLETED|Overall Study|"Completed indicates 12 month data."|22
7981561|NCT00242580|19652280|P3|STARTED|Overall Study||38
7981562|NCT00242580|19652281|P2|STARTED|Overall Study||41
7981563|NCT00242580|19652282|P1|STARTED|Overall Study||32
7981564|NCT00242567|19652307|P2|NOT COMPLETED|Overall Study||140
7981565|NCT00242567|19652308|P1|NOT COMPLETED|Overall Study||166
7981566|NCT00242567|19652307|P2|COMPLETED|Overall Study||123
7981567|NCT00242567|19652308|P1|COMPLETED|Overall Study||93
7981568|NCT00242567|19652307|P2|Never Received Study Drug|Overall Study||191
7981569|NCT00242567|19652308|P1|Never Received Study Drug|Overall Study||0
7981570|NCT00242567|19652307|P2|Received at Least 1 Dose of Study Drug|Overall Study||72
7981571|NCT00242567|19652308|P1|Received at Least 1 Dose of Study Drug|Overall Study||259
7981572|NCT00242567|19652307|P2|STARTED|Overall Study||263
7981573|NCT00242567|19652308|P1|STARTED|Overall Study||259
7981574|NCT00242502|19652324|P1|NOT COMPLETED|Overall Study||0
7981575|NCT00242502|19652324|P1|COMPLETED|Overall Study||59
7981576|NCT00242502|19652324|P1|STARTED|Overall Study||59
7981577|NCT00242385|19652328|P2|NOT COMPLETED|Period 2||0
7981578|NCT00242385|19652329|P1|NOT COMPLETED|Period 2||0
7981579|NCT00242385|19652328|P2|COMPLETED|Period 2||11
7981580|NCT00242385|19652329|P1|COMPLETED|Period 2||14
7981581|NCT00242385|19652328|P2|STARTED|Period 2||11
7981582|NCT00242385|19652329|P1|STARTED|Period 2||14
7981583|NCT00242385|19652328|P2|NOT COMPLETED|Period 1||0
7981584|NCT00242385|19652329|P1|NOT COMPLETED|Period 1||0
7981585|NCT00242385|19652328|P2|COMPLETED|Period 1||11
7981586|NCT00242385|19652329|P1|COMPLETED|Period 1||14
7981587|NCT00242385|19652328|P2|STARTED|Period 1||11
7981588|NCT00242385|19652329|P1|STARTED|Period 1||14
7981589|NCT00242216|19652355|P2|NOT COMPLETED|Overall Study||22
7981590|NCT00242216|19652356|P1|NOT COMPLETED|Overall Study||18
7981591|NCT00242216|19652355|P2|COMPLETED|Overall Study||15
7981592|NCT00242216|19652356|P1|COMPLETED|Overall Study||21
7981593|NCT00242216|19652355|P2|STARTED|Overall Study||37
7981594|NCT00242216|19652356|P1|STARTED|Overall Study||39
7981595|NCT00241969|19652366|P2|NOT COMPLETED|Overall Study||0
7981596|NCT00241969|19652367|P1|NOT COMPLETED|Overall Study||0
7981597|NCT00241969|19652366|P2|COMPLETED|Overall Study||42
7981598|NCT00241969|19652367|P1|COMPLETED|Overall Study||36
7981599|NCT00241969|19652366|P2|STARTED|Overall Study||42
7981600|NCT00241969|19652367|P1|STARTED|Overall Study||36
7981601|NCT00241904|19652379|P2|NOT COMPLETED|Overall Study||24
7981602|NCT00241904|19652380|P1|NOT COMPLETED|Overall Study||34
7981603|NCT00241904|19652379|P2|COMPLETED|Overall Study||240
7981604|NCT00241904|19652380|P1|COMPLETED|Overall Study||227
7981605|NCT00241904|19652379|P2|STARTED|Overall Study||264
7981606|NCT00241904|19652380|P1|STARTED|Overall Study||261
7981607|NCT00241839|19652394|P2|NOT COMPLETED|Overall Study||18
7981608|NCT00241839|19652395|P1|NOT COMPLETED|Overall Study||19
7981609|NCT00241839|19652394|P2|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53
7981610|NCT00241839|19652395|P1|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52
7981611|NCT00241839|19652394|P2|STARTED|Overall Study||71
7981612|NCT00241839|19652395|P1|STARTED|Overall Study||71
7981613|NCT00241644|19652411|P4|NOT COMPLETED|Second Efficacy Period (Year 2)||118
7981614|NCT00241644|19652412|P3|NOT COMPLETED|Second Efficacy Period (Year 2)||64
7981615|NCT00241644|19652413|P2|NOT COMPLETED|Second Efficacy Period (Year 2)||57
7981616|NCT00241644|19652414|P1|NOT COMPLETED|Second Efficacy Period (Year 2)||61
7981617|NCT00241644|19652411|P4|COMPLETED|Second Efficacy Period (Year 2)||1407
7981618|NCT00241644|19652412|P3|COMPLETED|Second Efficacy Period (Year 2)||682
7981619|NCT00241644|19652413|P2|COMPLETED|Second Efficacy Period (Year 2)||697
7981620|NCT00241644|19652414|P1|COMPLETED|Second Efficacy Period (Year 2)||710
7981621|NCT00241644|19652411|P4|STARTED|Second Efficacy Period (Year 2)||1525
7981622|NCT00241644|19652412|P3|STARTED|Second Efficacy Period (Year 2)||746
7981623|NCT00241644|19652413|P2|STARTED|Second Efficacy Period (Year 2)||754
7981624|NCT00241644|19652414|P1|STARTED|Second Efficacy Period (Year 2)||771
7981625|NCT00241644|19652411|P4|NOT COMPLETED|First Efficacy Period (Year 1)||495
7981626|NCT00241644|19652412|P3|NOT COMPLETED|First Efficacy Period (Year 1)||249
7981627|NCT00241644|19652413|P2|NOT COMPLETED|First Efficacy Period (Year 1)||268
7981628|NCT00241644|19652414|P1|NOT COMPLETED|First Efficacy Period (Year 1)||227
7981629|NCT00241644|19652411|P4|COMPLETED|First Efficacy Period (Year 1)||2803
7981630|NCT00241644|19652412|P3|COMPLETED|First Efficacy Period (Year 1)||1392
7981631|NCT00241644|19652413|P2|COMPLETED|First Efficacy Period (Year 1)||1383
7981632|NCT00241644|19652414|P1|COMPLETED|First Efficacy Period (Year 1)||1420
7981633|NCT00241644|19652411|P4|STARTED|First Efficacy Period (Year 1)||3298
7981634|NCT00241644|19652412|P3|STARTED|First Efficacy Period (Year 1)||1641
7981635|NCT00241644|19652413|P2|STARTED|First Efficacy Period (Year 1)||1651
7981636|NCT00241644|19652414|P1|STARTED|First Efficacy Period (Year 1)||1647
7981637|NCT00241631|19652498|P2|NOT COMPLETED|Phase 2 (4 Weeks)||0
7981638|NCT00241631|19652499|P1|NOT COMPLETED|Phase 2 (4 Weeks)||0
7981639|NCT00241631|19652498|P2|COMPLETED|Phase 2 (4 Weeks)||16
7981640|NCT00241631|19652499|P1|COMPLETED|Phase 2 (4 Weeks)||14
7981641|NCT00241631|19652498|P2|STARTED|Phase 2 (4 Weeks)||16
7981642|NCT00241631|19652499|P1|STARTED|Phase 2 (4 Weeks)||14
7981643|NCT00241631|19652498|P2|NOT COMPLETED|Wash Out (2 Weeks)||0
7981644|NCT00241631|19652499|P1|NOT COMPLETED|Wash Out (2 Weeks)||0
7981645|NCT00241631|19652498|P2|COMPLETED|Wash Out (2 Weeks)||16
7981646|NCT00241631|19652499|P1|COMPLETED|Wash Out (2 Weeks)||14
7981647|NCT00241631|19652498|P2|STARTED|Wash Out (2 Weeks)||16
7981648|NCT00241631|19652499|P1|STARTED|Wash Out (2 Weeks)||14
7981649|NCT00241631|19652498|P2|NOT COMPLETED|Phase 1 (4 Weeks)||5
7981650|NCT00241631|19652499|P1|NOT COMPLETED|Phase 1 (4 Weeks)||8
7981651|NCT00241631|19652498|P2|COMPLETED|Phase 1 (4 Weeks)||16
7981652|NCT00241631|19652499|P1|COMPLETED|Phase 1 (4 Weeks)||14
7981653|NCT00241631|19652498|P2|STARTED|Phase 1 (4 Weeks)||21
7981654|NCT00241631|19652499|P1|STARTED|Phase 1 (4 Weeks)||22
7981655|NCT00241631|19652498|P2|NOT COMPLETED|Run in (2 Weeks)||3
7981656|NCT00241631|19652499|P1|NOT COMPLETED|Run in (2 Weeks)||3
7981657|NCT00241631|19652498|P2|COMPLETED|Run in (2 Weeks)||21
7981658|NCT00241631|19652499|P1|COMPLETED|Run in (2 Weeks)||22
7981659|NCT00241631|19652498|P2|STARTED|Run in (2 Weeks)||24
7981660|NCT00241631|19652499|P1|STARTED|Run in (2 Weeks)||25
7981661|NCT00241358|19652512|P3|NOT COMPLETED|Overall Study||1
7981662|NCT00241358|19652513|P2|NOT COMPLETED|Overall Study||1
7981663|NCT00241358|19652514|P1|NOT COMPLETED|Overall Study||0
7981664|NCT00241358|19652512|P3|COMPLETED|Overall Study||20
7981665|NCT00241358|19652513|P2|COMPLETED|Overall Study||45
7981666|NCT00241358|19652514|P1|COMPLETED|Overall Study||25
7981667|NCT00241358|19652512|P3|STARTED|Overall Study||21
7981668|NCT00241358|19652513|P2|STARTED|Overall Study||46
7981669|NCT00241358|19652514|P1|STARTED|Overall Study||25
7981670|NCT00241280|19652547|P2|NOT COMPLETED|Overall Study||68
7981671|NCT00241280|19652548|P1|NOT COMPLETED|Overall Study||48
7981672|NCT00241280|19652547|P2|COMPLETED|Overall Study||186
7981673|NCT00241280|19652548|P1|COMPLETED|Overall Study||199
7981674|NCT00241280|19652547|P2|STARTED|Overall Study||254
7981675|NCT00241280|19652548|P1|STARTED|Overall Study||247
7981676|NCT00241176|19652556|P1|NOT COMPLETED|Overall Study||0
7981677|NCT00241176|19652556|P1|COMPLETED|Overall Study||11
7981678|NCT00241176|19652556|P1|STARTED|Overall Study||11
7981679|NCT00240994|19652563|P1|NOT COMPLETED|Overall Study||3
7981680|NCT00240994|19652563|P1|COMPLETED|Overall Study||32
7981681|NCT00240994|19652563|P1|STARTED|Overall Study||35
7981682|NCT00240981|19652569|P2|NOT COMPLETED|Overall Study||33
7981683|NCT00240981|19652570|P1|NOT COMPLETED|Overall Study||38
7981684|NCT00240981|19652569|P2|COMPLETED|Overall Study||70
7981685|NCT00240981|19652570|P1|COMPLETED|Overall Study||68
7981686|NCT00240981|19652569|P2|Intent to Treat Sample|Overall Study||83
7981687|NCT00240981|19652570|P1|Intent to Treat Sample|Overall Study||82
7981688|NCT00240981|19652569|P2|STARTED|Overall Study||103
7981689|NCT00240981|19652570|P1|STARTED|Overall Study||106
7981690|NCT00240539|19652598|P4|NOT COMPLETED|Overall Study||0
7981691|NCT00240539|19652599|P3|NOT COMPLETED|Overall Study||0
7981692|NCT00240539|19652600|P2|NOT COMPLETED|Overall Study||0
7981693|NCT00240539|19652601|P1|NOT COMPLETED|Overall Study||0
7981694|NCT00240539|19652598|P4|COMPLETED|Overall Study||1
7981695|NCT00240539|19652599|P3|COMPLETED|Overall Study||31
7981696|NCT00240539|19652600|P2|COMPLETED|Overall Study||2
7981697|NCT00240539|19652601|P1|COMPLETED|Overall Study||2
7981698|NCT00240539|19652598|P4|STARTED|Overall Study||1
7981699|NCT00240539|19652599|P3|STARTED|Overall Study||31
7981700|NCT00240539|19652600|P2|STARTED|Overall Study||2
7981701|NCT00240539|19652601|P1|STARTED|Overall Study||2
7981702|NCT00240526|19652623|P4|NOT COMPLETED|Year 20||0
7981703|NCT00240526|19652624|P3|NOT COMPLETED|Year 20||0
7981704|NCT00240526|19652625|P2|NOT COMPLETED|Year 20||0
7981705|NCT00240526|19652626|P1|NOT COMPLETED|Year 20||0
7981706|NCT00240526|19652623|P4|COMPLETED|Year 20||20
7981707|NCT00240526|19652624|P3|COMPLETED|Year 20||13
7981708|NCT00240526|19652625|P2|COMPLETED|Year 20||17
7981709|NCT00240526|19652626|P1|COMPLETED|Year 20||19
7981710|NCT00240526|19652623|P4|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20
7981711|NCT00240526|19652624|P3|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13
7981712|NCT00240526|19652625|P2|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17
7981713|NCT00240526|19652626|P1|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19
7981714|NCT00240526|19652623|P4|NOT COMPLETED|Year 19||0
7981715|NCT00240526|19652624|P3|NOT COMPLETED|Year 19||0
7981716|NCT00240526|19652625|P2|NOT COMPLETED|Year 19||0
7981717|NCT00240526|19652626|P1|NOT COMPLETED|Year 19||0
7981718|NCT00240526|19652623|P4|COMPLETED|Year 19||18
7981719|NCT00240526|19652624|P3|COMPLETED|Year 19||12
7981720|NCT00240526|19652625|P2|COMPLETED|Year 19||16
7981721|NCT00240526|19652626|P1|COMPLETED|Year 19||17
7981722|NCT00240526|19652623|P4|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18
7981723|NCT00240526|19652624|P3|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12
7981724|NCT00240526|19652625|P2|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16
7981725|NCT00240526|19652626|P1|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17
7981726|NCT00240526|19652623|P4|NOT COMPLETED|Year 18||0
7981727|NCT00240526|19652624|P3|NOT COMPLETED|Year 18||0
7981728|NCT00240526|19652625|P2|NOT COMPLETED|Year 18||0
7981729|NCT00240526|19652626|P1|NOT COMPLETED|Year 18||0
7981730|NCT00240526|19652623|P4|COMPLETED|Year 18||20
7981731|NCT00240526|19652624|P3|COMPLETED|Year 18||14
7981732|NCT00240526|19652625|P2|COMPLETED|Year 18||17
7981733|NCT00240526|19652626|P1|COMPLETED|Year 18||16
7981734|NCT00240526|19652623|P4|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20
7981735|NCT00240526|19652624|P3|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14
7981736|NCT00240526|19652625|P2|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17
7981737|NCT00240526|19652626|P1|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16
7981738|NCT00240526|19652623|P4|NOT COMPLETED|Year 17||0
7981739|NCT00240526|19652624|P3|NOT COMPLETED|Year 17||0
7981740|NCT00240526|19652625|P2|NOT COMPLETED|Year 17||0
7981741|NCT00240526|19652626|P1|NOT COMPLETED|Year 17||0
7981742|NCT00240526|19652623|P4|COMPLETED|Year 17||20
7981743|NCT00240526|19652624|P3|COMPLETED|Year 17||13
7981744|NCT00240526|19652625|P2|COMPLETED|Year 17||17
7981745|NCT00240526|19652626|P1|COMPLETED|Year 17||19
7981746|NCT00240526|19652623|P4|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20
7981747|NCT00240526|19652624|P3|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13
7981748|NCT00240526|19652625|P2|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17
7981749|NCT00240526|19652626|P1|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19
7981750|NCT00240526|19652623|P4|NOT COMPLETED|Year 16||0
7981751|NCT00240526|19652624|P3|NOT COMPLETED|Year 16||0
7981752|NCT00240526|19652625|P2|NOT COMPLETED|Year 16||0
7981753|NCT00240526|19652626|P1|NOT COMPLETED|Year 16||0
7981754|NCT00240526|19652623|P4|COMPLETED|Year 16||22
7981755|NCT00240526|19652624|P3|COMPLETED|Year 16||16
7981756|NCT00240526|19652625|P2|COMPLETED|Year 16||19
7981757|NCT00240526|19652626|P1|COMPLETED|Year 16||17
7981758|NCT00240526|19652623|P4|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22
7981846|NCT00239681|19652816|P1|NOT COMPLETED|Overall Study||693
7981759|NCT00240526|19652624|P3|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16
7981760|NCT00240526|19652625|P2|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19
7981761|NCT00240526|19652626|P1|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17
7981762|NCT00240526|19652623|P4|NOT COMPLETED|Year 15||0
7981763|NCT00240526|19652624|P3|NOT COMPLETED|Year 15||0
7981764|NCT00240526|19652625|P2|NOT COMPLETED|Year 15||0
7981765|NCT00240526|19652626|P1|NOT COMPLETED|Year 15||0
7981766|NCT00240526|19652623|P4|COMPLETED|Year 15||21
7981767|NCT00240526|19652624|P3|COMPLETED|Year 15||14
7981768|NCT00240526|19652625|P2|COMPLETED|Year 15||19
7981769|NCT00240526|19652626|P1|COMPLETED|Year 15||19
7981770|NCT00240526|19652623|P4|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21
7981771|NCT00240526|19652624|P3|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14
7981772|NCT00240526|19652625|P2|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
7981773|NCT00240526|19652626|P1|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
7981774|NCT00240500|19652662|P6|NOT COMPLETED|Overall Study||1
7981775|NCT00240500|19652663|P5|NOT COMPLETED|Overall Study||3
7981776|NCT00240500|19652664|P4|NOT COMPLETED|Overall Study||4
7981777|NCT00240500|19652665|P3|NOT COMPLETED|Overall Study||3
7981778|NCT00240500|19652666|P2|NOT COMPLETED|Overall Study||3
7981779|NCT00240500|19652667|P1|NOT COMPLETED|Overall Study||1
7981780|NCT00240500|19652662|P6|COMPLETED|Overall Study||2
7981781|NCT00240500|19652663|P5|COMPLETED|Overall Study||26
7981782|NCT00240500|19652664|P4|COMPLETED|Overall Study||19
7981783|NCT00240500|19652665|P3|COMPLETED|Overall Study||14
7981784|NCT00240500|19652666|P2|COMPLETED|Overall Study||17
7981785|NCT00240500|19652667|P1|COMPLETED|Overall Study||16
7981786|NCT00240500|19652662|P6|STARTED|Overall Study||3
7981787|NCT00240500|19652663|P5|STARTED|Overall Study||29
7981788|NCT00240500|19652664|P4|STARTED|Overall Study||23
7981789|NCT00240500|19652665|P3|STARTED|Overall Study||17
7981790|NCT00240500|19652666|P2|STARTED|Overall Study||20
7981791|NCT00240500|19652667|P1|STARTED|Overall Study||17
7981792|NCT00240487|19652689|P2|NOT COMPLETED|Overall Study||0
7981793|NCT00240487|19652690|P1|NOT COMPLETED|Overall Study||0
7981794|NCT00240487|19652689|P2|COMPLETED|Overall Study||28
7981795|NCT00240487|19652690|P1|COMPLETED|Overall Study||24
7981796|NCT00240487|19652689|P2|STARTED|Overall Study||28
7981797|NCT00240487|19652690|P1|STARTED|Overall Study||24
7981798|NCT00240331|19652698|P2|NOT COMPLETED|Overall Study||134
7981799|NCT00240331|19652699|P1|NOT COMPLETED|Overall Study||126
7981800|NCT00240331|19652698|P2|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250
7981801|NCT00240331|19652699|P1|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263
7981802|NCT00240331|19652698|P2|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384
7981803|NCT00240331|19652699|P1|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389
7981804|NCT00240227|19652717|P1|NOT COMPLETED|Overall Study||0
7981805|NCT00240227|19652717|P1|COMPLETED|Overall Study||8
7981806|NCT00240227|19652717|P1|STARTED|Overall Study||8
7981807|NCT00240162|19652733|P1|NOT COMPLETED|Overall Study||0
7981808|NCT00240162|19652733|P1|COMPLETED|Overall Study||21
7981809|NCT00240162|19652733|P1|STARTED|Overall Study||21
7981810|NCT00240110|19652742|P2|NOT COMPLETED|Overall Study||7
7981811|NCT00240110|19652743|P1|NOT COMPLETED|Overall Study||6
7981812|NCT00240110|19652742|P2|COMPLETED|Overall Study||6
7981813|NCT00240110|19652743|P1|COMPLETED|Overall Study||7
7981814|NCT00240110|19652742|P2|STARTED|Overall Study||13
7981815|NCT00240110|19652743|P1|STARTED|Overall Study||13
7981816|NCT00240097|19652751|P1|NOT COMPLETED|Part II||23
7981817|NCT00240097|19652751|P1|COMPLETED|Part II||3
7981818|NCT00240097|19652751|P1|STARTED|Part II||26
7981819|NCT00240097|19652751|P1|NOT COMPLETED|Part I||4
7981820|NCT00240097|19652751|P1|COMPLETED|Part I||26
7981821|NCT00240097|19652751|P1|STARTED|Part I||30
7981822|NCT00240071|19652761|P1|NOT COMPLETED|Overall Study||3
7981823|NCT00240071|19652761|P1|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27
7981824|NCT00240071|19652761|P1|STARTED|Overall Study||30
7981825|NCT00239928|19652766|P1|NOT COMPLETED|Overall Study||10
7981826|NCT00239928|19652766|P1|COMPLETED|Overall Study||51
7981827|NCT00239928|19652766|P1|STARTED|Overall Study||61
7981828|NCT00239837|19652778|P2|NOT COMPLETED|Overall Study||7
7981829|NCT00239837|19652779|P1|NOT COMPLETED|Overall Study||3
7981830|NCT00239837|19652778|P2|COMPLETED|Overall Study|3-year follow-up|45
7981831|NCT00239837|19652779|P1|COMPLETED|Overall Study|3-year follow-up|45
7981832|NCT00239837|19652778|P2|6 Months|Overall Study||50
7981833|NCT00239837|19652779|P1|6 Months|Overall Study||48
7981834|NCT00239837|19652778|P2|STARTED|Overall Study||52
7981835|NCT00239837|19652779|P1|STARTED|Overall Study||48
7981836|NCT00239733|19652799|P1|NOT COMPLETED|Overall Study||0
7981837|NCT00239733|19652799|P1|COMPLETED|Overall Study||6
7981838|NCT00239733|19652799|P1|STARTED|Overall Study||6
7981839|NCT00239720|19652806|P2|NOT COMPLETED|Overall Study||1
7981840|NCT00239720|19652807|P1|NOT COMPLETED|Overall Study||1
7981841|NCT00239720|19652806|P2|COMPLETED|Overall Study|One participant lost to follow-up|0
7981842|NCT00239720|19652807|P1|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2
7981843|NCT00239720|19652806|P2|STARTED|Overall Study||1
7981844|NCT00239720|19652807|P1|STARTED|Overall Study||3
7981845|NCT00239681|19652815|P2|NOT COMPLETED|Overall Study||715
7981847|NCT00239681|19652815|P2|COMPLETED|Overall Study||8186
7981848|NCT00239681|19652816|P1|COMPLETED|Overall Study||8208
7981849|NCT00239681|19652815|P2|Randomized and Treated (Safety Pop)|Overall Study||8864
7981850|NCT00239681|19652816|P1|Randomized and Treated (Safety Pop)|Overall Study||8869
7981851|NCT00239681|19652815|P2|STARTED|Overall Study||8901
7981852|NCT00239681|19652816|P1|STARTED|Overall Study||8901
7981853|NCT00239642|19652835|P3|NOT COMPLETED|Overall Study||2
7981854|NCT00239642|19652836|P2|NOT COMPLETED|Overall Study||0
7981855|NCT00239642|19652837|P1|NOT COMPLETED|Overall Study||2
7981856|NCT00239642|19652835|P3|COMPLETED|Overall Study||47
7981857|NCT00239642|19652836|P2|COMPLETED|Overall Study||47
7981858|NCT00239642|19652837|P1|COMPLETED|Overall Study||47
7981859|NCT00239642|19652835|P3|STARTED|Overall Study||49
7981860|NCT00239642|19652836|P2|STARTED|Overall Study||47
7981861|NCT00239642|19652837|P1|STARTED|Overall Study||49
7981862|NCT00239590|19652869|P2|NOT COMPLETED|Completed Study Protocol||2
7981863|NCT00239590|19652870|P1|NOT COMPLETED|Completed Study Protocol||1
7981864|NCT00239590|19652869|P2|COMPLETED|Completed Study Protocol||10
7981865|NCT00239590|19652870|P1|COMPLETED|Completed Study Protocol||13
7981866|NCT00239590|19652869|P2|STARTED|Completed Study Protocol||12
7981867|NCT00239590|19652870|P1|STARTED|Completed Study Protocol||14
7981868|NCT00239590|19652869|P2|NOT COMPLETED|Started Intervention After Randomization||0
7981869|NCT00239590|19652870|P1|NOT COMPLETED|Started Intervention After Randomization||0
7981870|NCT00239590|19652869|P2|COMPLETED|Started Intervention After Randomization||12
7981871|NCT00239590|19652870|P1|COMPLETED|Started Intervention After Randomization||14
7981872|NCT00239590|19652869|P2|STARTED|Started Intervention After Randomization||12
7981873|NCT00239590|19652870|P1|STARTED|Started Intervention After Randomization||14
7981874|NCT00239590|19652869|P2|NOT COMPLETED|Randomized||2
7981875|NCT00239590|19652870|P1|NOT COMPLETED|Randomized||0
7981876|NCT00239590|19652869|P2|COMPLETED|Randomized||12
7981877|NCT00239590|19652870|P1|COMPLETED|Randomized||14
7981878|NCT00239590|19652869|P2|STARTED|Randomized||14
7981879|NCT00239590|19652870|P1|STARTED|Randomized||14
7981880|NCT00239577|19652882|P4|NOT COMPLETED|Booster Phase||0
7981881|NCT00239577|19652883|P3|NOT COMPLETED|Booster Phase||0
7981882|NCT00239577|19652884|P2|NOT COMPLETED|Booster Phase||0
7981883|NCT00239577|19652885|P1|NOT COMPLETED|Booster Phase||0
7981884|NCT00239577|19652882|P4|COMPLETED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
7981885|NCT00239577|19652883|P3|COMPLETED|Booster Phase||12
7981886|NCT00239577|19652884|P2|COMPLETED|Booster Phase||9
7981887|NCT00239577|19652885|P1|COMPLETED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
7981888|NCT00239577|19652882|P4|STARTED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
7981889|NCT00239577|19652883|P3|STARTED|Booster Phase||12
7981890|NCT00239577|19652884|P2|STARTED|Booster Phase||9
7981891|NCT00239577|19652885|P1|STARTED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
7981892|NCT00239577|19652882|P4|NOT COMPLETED|Primary Phase||0
7981893|NCT00239577|19652883|P3|NOT COMPLETED|Primary Phase||3
7981894|NCT00239577|19652884|P2|NOT COMPLETED|Primary Phase||3
7981895|NCT00239577|19652885|P1|NOT COMPLETED|Primary Phase||5
7981896|NCT00239577|19652882|P4|COMPLETED|Primary Phase||21
7981897|NCT00239577|19652883|P3|COMPLETED|Primary Phase||18
7981898|NCT00239577|19652884|P2|COMPLETED|Primary Phase||19
7981899|NCT00239577|19652885|P1|COMPLETED|Primary Phase||17
7981900|NCT00239577|19652882|P4|STARTED|Primary Phase||21
7981901|NCT00239577|19652883|P3|STARTED|Primary Phase||21
7981902|NCT00239577|19652884|P2|STARTED|Primary Phase||22
7981903|NCT00239577|19652885|P1|STARTED|Primary Phase||22
7981904|NCT00239356|19652989|P2|NOT COMPLETED|Overall Study||9
7981905|NCT00239356|19652990|P1|NOT COMPLETED|Overall Study||39
7981906|NCT00239356|19652989|P2|COMPLETED|Overall Study||11
7981907|NCT00239356|19652990|P1|COMPLETED|Overall Study||58
7981908|NCT00239356|19652989|P2|STARTED|Overall Study||20
7981909|NCT00239356|19652990|P1|STARTED|Overall Study||97
7981910|NCT00239226|19653012|P4|NOT COMPLETED|Overall Study||3
7981911|NCT00239226|19653013|P3|NOT COMPLETED|Overall Study||1
7981912|NCT00239226|19653014|P2|NOT COMPLETED|Overall Study||0
7981913|NCT00239226|19653015|P1|NOT COMPLETED|Overall Study||1
7981914|NCT00239226|19653012|P4|COMPLETED|Overall Study||14
7981915|NCT00239226|19653013|P3|COMPLETED|Overall Study||36
7981916|NCT00239226|19653014|P2|COMPLETED|Overall Study||18
7981917|NCT00239226|19653015|P1|COMPLETED|Overall Study||29
7981918|NCT00239226|19653012|P4|STARTED|Overall Study||17
7981919|NCT00239226|19653013|P3|STARTED|Overall Study||37
7981920|NCT00239226|19653014|P2|STARTED|Overall Study||18
7981921|NCT00239226|19653015|P1|STARTED|Overall Study||30
7981922|NCT00239005|19653027|P2|NOT COMPLETED|Overall Study||12
7981923|NCT00239005|19653028|P1|NOT COMPLETED|Overall Study||12
7981924|NCT00239005|19653027|P2|COMPLETED|Overall Study||53
7981925|NCT00239005|19653028|P1|COMPLETED|Overall Study||57
7981926|NCT00239005|19653027|P2|Intention-to-treat Population (ITT)|Overall Study||61
7981927|NCT00239005|19653028|P1|Intention-to-treat Population (ITT)|Overall Study||68
7981928|NCT00239005|19653027|P2|STARTED|Overall Study||65
7981929|NCT00239005|19653028|P1|STARTED|Overall Study||69
7981930|NCT00238615|19653038|P1|NOT COMPLETED|Overall Study||0
7981931|NCT00238615|19653038|P1|COMPLETED|Overall Study||13
7981932|NCT00238615|19653038|P1|STARTED|Overall Study||13
7981933|NCT00238433|19653044|P1|NOT COMPLETED|Overall Study||3
7981934|NCT00238433|19653044|P1|COMPLETED|Overall Study||34
7981935|NCT00238433|19653044|P1|STARTED|Overall Study||37
7981936|NCT00238420|19653051|P2|NOT COMPLETED|Overall Study||1
7981937|NCT00238420|19653052|P1|NOT COMPLETED|Overall Study||1
7981938|NCT00238420|19653051|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
7981939|NCT00238420|19653052|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21
7981940|NCT00238420|19653051|P2|STARTED|Overall Study||48
7981941|NCT00238420|19653052|P1|STARTED|Overall Study||22
7981942|NCT00238355|19653062|P1|NOT COMPLETED|Overall Study||3
7981943|NCT00238355|19653062|P1|COMPLETED|Overall Study||10
7981944|NCT00238355|19653062|P1|STARTED|Overall Study||13
7981945|NCT00238303|19653069|P3|NOT COMPLETED|Overall Study||9
7981946|NCT00238303|19653070|P2|NOT COMPLETED|Overall Study||2
7981947|NCT00238303|19653071|P1|NOT COMPLETED|Overall Study||15
7981948|NCT00238303|19653069|P3|COMPLETED|Overall Study||11
7981949|NCT00238303|19653070|P2|COMPLETED|Overall Study||13
7981950|NCT00238303|19653071|P1|COMPLETED|Overall Study||53
7981951|NCT00238303|19653069|P3|STARTED|Overall Study||20
7981952|NCT00238303|19653070|P2|STARTED|Overall Study||15
7981953|NCT00238303|19653071|P1|STARTED|Overall Study||68
7981954|NCT00238264|19653088|P1|NOT COMPLETED|Overall Study||36
7981955|NCT00238264|19653088|P1|COMPLETED|Overall Study||56
7981956|NCT00238264|19653088|P1|STARTED|Overall Study||92
7981957|NCT00238238|19653101|P3|NOT COMPLETED|Overall Study||0
7981958|NCT00238238|19653102|P2|NOT COMPLETED|Overall Study||3
7981959|NCT00238238|19653103|P1|NOT COMPLETED|Overall Study||0
7981960|NCT00238238|19653101|P3|COMPLETED|Overall Study||46
7981961|NCT00238238|19653102|P2|COMPLETED|Overall Study||45
7981962|NCT00238238|19653103|P1|COMPLETED|Overall Study||3
7981963|NCT00238238|19653101|P3|STARTED|Overall Study||46
7981964|NCT00238238|19653102|P2|STARTED|Overall Study||48
7981965|NCT00238238|19653103|P1|STARTED|Overall Study||3
7981966|NCT00238121|19653116|P2|NOT COMPLETED|Overall Study||2
7981967|NCT00238121|19653117|P1|NOT COMPLETED|Overall Study||3
7981968|NCT00238121|19653116|P2|COMPLETED|Overall Study||14
7981969|NCT00238121|19653117|P1|COMPLETED|Overall Study||37
7981970|NCT00238121|19653116|P2|STARTED|Overall Study||16
7981971|NCT00238121|19653117|P1|STARTED|Overall Study||40
7981972|NCT00238108|19653130|P2|NOT COMPLETED|Overall Study||0
7981973|NCT00238108|19653131|P1|NOT COMPLETED|Overall Study||0
7981974|NCT00238108|19653130|P2|COMPLETED|Overall Study||8
7981975|NCT00238108|19653131|P1|COMPLETED|Overall Study||8
7981976|NCT00238108|19653130|P2|STARTED|Overall Study||8
7981977|NCT00238108|19653131|P1|STARTED|Overall Study||8
7981978|NCT00237809|19653143|P4|NOT COMPLETED|Overall Study||9
7981979|NCT00237809|19653144|P3|NOT COMPLETED|Overall Study||9
7981980|NCT00237809|19653145|P2|NOT COMPLETED|Overall Study||10
7981981|NCT00237809|19653146|P1|NOT COMPLETED|Overall Study||11
7981982|NCT00237809|19653143|P4|COMPLETED|Overall Study||17
7981983|NCT00237809|19653144|P3|COMPLETED|Overall Study||15
7981984|NCT00237809|19653145|P2|COMPLETED|Overall Study||17
7981985|NCT00237809|19653146|P1|COMPLETED|Overall Study||16
7981986|NCT00237809|19653143|P4|STARTED|Overall Study||26
7981987|NCT00237809|19653144|P3|STARTED|Overall Study||24
7981988|NCT00237809|19653145|P2|STARTED|Overall Study||27
7981989|NCT00237809|19653146|P1|STARTED|Overall Study||27
7981990|NCT00237796|19653182|P2|NOT COMPLETED|Overall Study||5
7981991|NCT00237796|19653183|P1|NOT COMPLETED|Overall Study||10
7981992|NCT00237796|19653182|P2|COMPLETED|Overall Study||33
7981993|NCT00237796|19653183|P1|COMPLETED|Overall Study||31
7981994|NCT00237796|19653182|P2|STARTED|Overall Study||38
7981995|NCT00237796|19653183|P1|STARTED|Overall Study||41
7981996|NCT00237770|19653203|P2|NOT COMPLETED|Overall Study||0
7981997|NCT00237770|19653204|P1|NOT COMPLETED|Overall Study||0
7981998|NCT00237770|19653203|P2|COMPLETED|Overall Study||7
7981999|NCT00237770|19653204|P1|COMPLETED|Overall Study||9
7982000|NCT00237770|19653203|P2|STARTED|Overall Study||7
7982001|NCT00237770|19653204|P1|STARTED|Overall Study||9
7982002|NCT00237744|19653217|P3|NOT COMPLETED|Overall Study||0
7982003|NCT00237744|19653218|P2|NOT COMPLETED|Overall Study||1
7982004|NCT00237744|19653219|P1|NOT COMPLETED|Overall Study||3
7982005|NCT00237744|19653217|P3|COMPLETED|Overall Study||18
7982006|NCT00237744|19653218|P2|COMPLETED|Overall Study||10
7982007|NCT00237744|19653219|P1|COMPLETED|Overall Study||8
7982008|NCT00237744|19653217|P3|STARTED|Overall Study||18
7982009|NCT00237744|19653218|P2|STARTED|Overall Study||11
7982010|NCT00237744|19653219|P1|STARTED|Overall Study||11
7982011|NCT00237718|19653232|P2|NOT COMPLETED|Overall Study||41
7982012|NCT00237718|19653233|P1|NOT COMPLETED|Overall Study||46
7982013|NCT00237718|19653232|P2|COMPLETED|Overall Study||124
7982014|NCT00237718|19653233|P1|COMPLETED|Overall Study||114
7982015|NCT00237718|19653232|P2|STARTED|Overall Study||165
7982016|NCT00237718|19653233|P1|STARTED|Overall Study||160
7982017|NCT00237692|19653245|P4|NOT COMPLETED|Overall Study||19
7982018|NCT00237692|19653246|P3|NOT COMPLETED|Overall Study||22
7982019|NCT00237692|19653247|P2|NOT COMPLETED|Overall Study||14
7982020|NCT00237692|19653248|P1|NOT COMPLETED|Overall Study||18
7982021|NCT00237692|19653245|P4|COMPLETED|Overall Study||128
7982022|NCT00237692|19653246|P3|COMPLETED|Overall Study||127
7982023|NCT00237692|19653247|P2|COMPLETED|Overall Study||134
7982024|NCT00237692|19653248|P1|COMPLETED|Overall Study||129
7982025|NCT00237692|19653245|P4|18 Month f/u|Overall Study||122
7982026|NCT00237692|19653246|P3|18 Month f/u|Overall Study||126
7982027|NCT00237692|19653247|P2|18 Month f/u|Overall Study||131
7982028|NCT00237692|19653248|P1|18 Month f/u|Overall Study||124
7982029|NCT00237692|19653245|P4|12 Month f/u|Overall Study||127
7982030|NCT00237692|19653246|P3|12 Month f/u|Overall Study||132
7982031|NCT00237692|19653247|P2|12 Month f/u|Overall Study||127
7982032|NCT00237692|19653248|P1|12 Month f/u|Overall Study||137
7982033|NCT00237692|19653245|P4|6 Month f/u|Overall Study||134
7982034|NCT00237692|19653246|P3|6 Month f/u|Overall Study||135
7982035|NCT00237692|19653247|P2|6 Month f/u|Overall Study||134
7982036|NCT00237692|19653248|P1|6 Month f/u|Overall Study||132
7982037|NCT00237692|19653245|P4|STARTED|Overall Study||147
7982038|NCT00237692|19653246|P3|STARTED|Overall Study||149
7982039|NCT00237692|19653247|P2|STARTED|Overall Study||148
7982040|NCT00237692|19653248|P1|STARTED|Overall Study||147
7982041|NCT00237666|19653278|P1|NOT COMPLETED|Overall Study||6
7982042|NCT00237666|19653278|P1|COMPLETED|Overall Study||24
7982043|NCT00237666|19653278|P1|STARTED|Overall Study||30
7982044|NCT00237458|19653288|P1|NOT COMPLETED|Overall Study||3
7982045|NCT00237458|19653288|P1|COMPLETED|Overall Study||4
7982046|NCT00237458|19653288|P1|STARTED|Overall Study||7
7982047|NCT00237185|19653306|P2|NOT COMPLETED|Extension||19
7982048|NCT00237185|19653307|P1|NOT COMPLETED|Extension||16
7982049|NCT00237185|19653306|P2|COMPLETED|Extension||13
7982050|NCT00237185|19653307|P1|COMPLETED|Extension||8
7982051|NCT00237185|19653306|P2|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32
7982052|NCT00237185|19653307|P1|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24
7982053|NCT00237185|19653306|P2|NOT COMPLETED|Core||37
7982054|NCT00237185|19653307|P1|NOT COMPLETED|Core||44
7982055|NCT00237185|19653306|P2|COMPLETED|Core||37
7982056|NCT00237185|19653307|P1|COMPLETED|Core||30
7982057|NCT00237185|19653306|P2|Treated Participants|Core||74
7982058|NCT00237185|19653307|P1|Treated Participants|Core||73
7982059|NCT00237185|19653306|P2|STARTED|Core||74
7982060|NCT00237185|19653307|P1|STARTED|Core||74
7982061|NCT00237042|19653338|P3|NOT COMPLETED|Long Term (12 Month) Follow up||9
7982062|NCT00237042|19653339|P2|NOT COMPLETED|Long Term (12 Month) Follow up||9
7982063|NCT00237042|19653340|P1|NOT COMPLETED|Long Term (12 Month) Follow up||11
7982064|NCT00237042|19653338|P3|COMPLETED|Long Term (12 Month) Follow up||48
7982065|NCT00237042|19653339|P2|COMPLETED|Long Term (12 Month) Follow up||46
7982066|NCT00237042|19653340|P1|COMPLETED|Long Term (12 Month) Follow up||48
7982067|NCT00237042|19653338|P3|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
7982068|NCT00237042|19653339|P2|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
7982069|NCT00237042|19653340|P1|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
7982070|NCT00237042|19653338|P3|NOT COMPLETED|Short Term (6 Month) Follow up||11
7982071|NCT00237042|19653339|P2|NOT COMPLETED|Short Term (6 Month) Follow up||8
7982072|NCT00237042|19653340|P1|NOT COMPLETED|Short Term (6 Month) Follow up||9
7982073|NCT00237042|19653338|P3|COMPLETED|Short Term (6 Month) Follow up||46
7982074|NCT00237042|19653339|P2|COMPLETED|Short Term (6 Month) Follow up||47
7982075|NCT00237042|19653340|P1|COMPLETED|Short Term (6 Month) Follow up||50
7982076|NCT00237042|19653338|P3|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
7982077|NCT00237042|19653339|P2|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
7982078|NCT00237042|19653340|P1|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
7982079|NCT00237042|19653338|P3|NOT COMPLETED|Treatment||38
7982080|NCT00237042|19653339|P2|NOT COMPLETED|Treatment||7
7982081|NCT00237042|19653340|P1|NOT COMPLETED|Treatment||6
7982082|NCT00237042|19653338|P3|COMPLETED|Treatment||36
7982083|NCT00237042|19653339|P2|COMPLETED|Treatment||50
7982084|NCT00237042|19653340|P1|COMPLETED|Treatment||54
7982085|NCT00237042|19653338|P3|STARTED|Treatment||74
7982086|NCT00237042|19653339|P2|STARTED|Treatment||57
7982087|NCT00237042|19653340|P1|STARTED|Treatment||60
7982088|NCT00236977|19653359|P2|NOT COMPLETED|Overall Study||19
7982089|NCT00236977|19653360|P1|NOT COMPLETED|Overall Study||21
7982090|NCT00236977|19653359|P2|COMPLETED|Overall Study||72
7982091|NCT00236977|19653360|P1|COMPLETED|Overall Study||70
7982092|NCT00236977|19653359|P2|STARTED|Overall Study||91
7982093|NCT00236977|19653360|P1|STARTED|Overall Study||91
7982094|NCT00236951|19653382|P4|NOT COMPLETED|Overall Study||31
7982095|NCT00236951|19653383|P3|NOT COMPLETED|Overall Study||19
7982096|NCT00236951|19653384|P2|NOT COMPLETED|Overall Study||31
7982097|NCT00236951|19653385|P1|NOT COMPLETED|Overall Study||26
7982098|NCT00236951|19653382|P4|COMPLETED|Overall Study||17
7982099|NCT00236951|19653383|P3|COMPLETED|Overall Study||21
7982100|NCT00236951|19653384|P2|COMPLETED|Overall Study||46
7982101|NCT00236951|19653385|P1|COMPLETED|Overall Study||33
7982102|NCT00236951|19653382|P4|STARTED|Overall Study||48
7982103|NCT00236951|19653383|P3|STARTED|Overall Study||40
7982104|NCT00236951|19653384|P2|STARTED|Overall Study||77
7982105|NCT00236951|19653385|P1|STARTED|Overall Study||59
7982106|NCT00236938|19653397|P2|NOT COMPLETED|Overall Study||20
7982107|NCT00236938|19653398|P1|NOT COMPLETED|Overall Study||13
7982108|NCT00236938|19653397|P2|COMPLETED|Overall Study||26
7982109|NCT00236938|19653398|P1|COMPLETED|Overall Study||62
7982110|NCT00236938|19653397|P2|STARTED|Overall Study||46
7982111|NCT00236938|19653398|P1|STARTED|Overall Study||75
7982112|NCT00236899|19653414|P4|NOT COMPLETED|Overall Study||40
7982113|NCT00236899|19653415|P3|NOT COMPLETED|Overall Study||44
7982114|NCT00236899|19653416|P2|NOT COMPLETED|Overall Study||40
7982115|NCT00236899|19653417|P1|NOT COMPLETED|Overall Study||42
7982116|NCT00236899|19653414|P4|COMPLETED|Overall Study||19
7982117|NCT00236899|19653415|P3|COMPLETED|Overall Study||14
7982118|NCT00236899|19653416|P2|COMPLETED|Overall Study||24
7982119|NCT00236899|19653417|P1|COMPLETED|Overall Study||18
7982120|NCT00236899|19653414|P4|STARTED|Overall Study||59
7982121|NCT00236899|19653415|P3|STARTED|Overall Study||58
7982122|NCT00236899|19653416|P2|STARTED|Overall Study||64
7982123|NCT00236899|19653417|P1|STARTED|Overall Study||60
7982124|NCT00236197|19653449|P2|NOT COMPLETED|Overall Study||14
7982125|NCT00236197|19653450|P1|NOT COMPLETED|Overall Study||5
7982126|NCT00236197|19653449|P2|COMPLETED|Overall Study||293
7982127|NCT00236197|19653450|P1|COMPLETED|Overall Study||307
7982128|NCT00236197|19653449|P2|STARTED|Overall Study||307
7982129|NCT00236197|19653450|P1|STARTED|Overall Study||312
7982130|NCT00236184|19653458|P2|NOT COMPLETED|Overall Study||11
7982131|NCT00236184|19653459|P1|NOT COMPLETED|Overall Study||18
7982132|NCT00236184|19653458|P2|COMPLETED|Overall Study||308
7982133|NCT00236184|19653459|P1|COMPLETED|Overall Study||292
7982134|NCT00236184|19653458|P2|STARTED|Overall Study||319
7982135|NCT00236184|19653459|P1|STARTED|Overall Study||310
7982136|NCT00236080|19653470|P5|NOT COMPLETED|Overall Study||1
7982137|NCT00236080|19653471|P4|NOT COMPLETED|Overall Study||2
7982138|NCT00236080|19653472|P3|NOT COMPLETED|Overall Study||5
7982139|NCT00236080|19653473|P2|NOT COMPLETED|Overall Study||1
7982140|NCT00236080|19653474|P1|NOT COMPLETED|Overall Study||2
7982141|NCT00236080|19653470|P5|COMPLETED|Overall Study||26
7982142|NCT00236080|19653471|P4|COMPLETED|Overall Study||23
7982143|NCT00236080|19653472|P3|COMPLETED|Overall Study||22
7982144|NCT00236080|19653473|P2|COMPLETED|Overall Study||27
7982145|NCT00236080|19653474|P1|COMPLETED|Overall Study||27
7982146|NCT00236080|19653470|P5|STARTED|Overall Study||27
7982147|NCT00236080|19653471|P4|STARTED|Overall Study||25
7982148|NCT00236080|19653472|P3|STARTED|Overall Study||27
7982149|NCT00236080|19653473|P2|STARTED|Overall Study||28
7982150|NCT00236080|19653474|P1|STARTED|Overall Study||29
7982151|NCT00235989|19653495|P6|NOT COMPLETED|Extension Treatment Period (ET)||0
7982152|NCT00235989|19653496|P5|NOT COMPLETED|Extension Treatment Period (ET)||0
7982153|NCT00235989|19653497|P4|NOT COMPLETED|Extension Treatment Period (ET)||6
7982154|NCT00235989|19653498|P3|NOT COMPLETED|Extension Treatment Period (ET)||5
7982155|NCT00235989|19653499|P2|NOT COMPLETED|Extension Treatment Period (ET)||4
7982156|NCT00235989|19653500|P1|NOT COMPLETED|Extension Treatment Period (ET)||8
7982157|NCT00235989|19653495|P6|COMPLETED|Extension Treatment Period (ET)||0
7982158|NCT00235989|19653496|P5|COMPLETED|Extension Treatment Period (ET)||0
7982159|NCT00235989|19653497|P4|COMPLETED|Extension Treatment Period (ET)||14
7982160|NCT00235989|19653498|P3|COMPLETED|Extension Treatment Period (ET)||14
7982161|NCT00235989|19653499|P2|COMPLETED|Extension Treatment Period (ET)||2
7982162|NCT00235989|19653500|P1|COMPLETED|Extension Treatment Period (ET)||8
7982163|NCT00235989|19653495|P6|STARTED|Extension Treatment Period (ET)||0
7982164|NCT00235989|19653496|P5|STARTED|Extension Treatment Period (ET)||0
7982165|NCT00235989|19653497|P4|STARTED|Extension Treatment Period (ET)||20
7982166|NCT00235989|19653498|P3|STARTED|Extension Treatment Period (ET)||19
7982167|NCT00235989|19653499|P2|STARTED|Extension Treatment Period (ET)||6
7982168|NCT00235989|19653500|P1|STARTED|Extension Treatment Period (ET)||16
7982169|NCT00235989|19653495|P6|NOT COMPLETED|Core Treatment Period (CT)||2
7982170|NCT00235989|19653496|P5|NOT COMPLETED|Core Treatment Period (CT)||0
7982171|NCT00235989|19653497|P4|NOT COMPLETED|Core Treatment Period (CT)||0
7982172|NCT00235989|19653498|P3|NOT COMPLETED|Core Treatment Period (CT)||0
7982173|NCT00235989|19653499|P2|NOT COMPLETED|Core Treatment Period (CT)||0
7982174|NCT00235989|19653500|P1|NOT COMPLETED|Core Treatment Period (CT)||0
7982175|NCT00235989|19653495|P6|COMPLETED|Core Treatment Period (CT)||25
7982176|NCT00235989|19653496|P5|COMPLETED|Core Treatment Period (CT)||36
7982177|NCT00235989|19653497|P4|COMPLETED|Core Treatment Period (CT)||0
7982178|NCT00235989|19653498|P3|COMPLETED|Core Treatment Period (CT)||0
7982179|NCT00235989|19653499|P2|COMPLETED|Core Treatment Period (CT)||0
7982180|NCT00235989|19653500|P1|COMPLETED|Core Treatment Period (CT)||0
7982181|NCT00235989|19653495|P6|STARTED|Core Treatment Period (CT)||27
7982182|NCT00235989|19653496|P5|STARTED|Core Treatment Period (CT)||36
7982183|NCT00235989|19653497|P4|STARTED|Core Treatment Period (CT)||0
7982184|NCT00235989|19653498|P3|STARTED|Core Treatment Period (CT)||0
7982185|NCT00235989|19653499|P2|STARTED|Core Treatment Period (CT)||0
7982186|NCT00235989|19653500|P1|STARTED|Core Treatment Period (CT)||0
7982187|NCT00235872|19653514|P1|NOT COMPLETED|Overall Study||147
7982188|NCT00235872|19653514|P1|COMPLETED|Overall Study||162
7982189|NCT00235872|19653514|P1|STARTED|Overall Study||309
7982190|NCT00235833|19653529|P1|NOT COMPLETED|Overall Study||16
7982191|NCT00235833|19653529|P1|COMPLETED|Overall Study||9
7982192|NCT00235833|19653529|P1|STARTED|Overall Study||25
7982193|NCT00235755|19653545|P3|NOT COMPLETED|12-Week Maintenance Phase||31
7982194|NCT00235755|19653546|P2|NOT COMPLETED|12-Week Maintenance Phase||27
7982195|NCT00235755|19653547|P1|NOT COMPLETED|12-Week Maintenance Phase||16
7982196|NCT00235755|19653545|P3|COMPLETED|12-Week Maintenance Phase||122
7982197|NCT00235755|19653546|P2|COMPLETED|12-Week Maintenance Phase||135
7982198|NCT00235755|19653547|P1|COMPLETED|12-Week Maintenance Phase||152
7982199|NCT00235755|19653545|P3|STARTED|12-Week Maintenance Phase||153
7982200|NCT00235755|19653546|P2|STARTED|12-Week Maintenance Phase||162
7982201|NCT00235755|19653547|P1|STARTED|12-Week Maintenance Phase||168
7982202|NCT00235755|19653545|P3|NOT COMPLETED|4-Week Titration Phase||26
7982203|NCT00235755|19653546|P2|NOT COMPLETED|4-Week Titration Phase||19
7982204|NCT00235755|19653547|P1|NOT COMPLETED|4-Week Titration Phase||11
7982205|NCT00235755|19653545|P3|COMPLETED|4-Week Titration Phase||153
7982206|NCT00235755|19653546|P2|COMPLETED|4-Week Titration Phase||162
7982207|NCT00235755|19653547|P1|COMPLETED|4-Week Titration Phase||168
7982208|NCT00235755|19653545|P3|STARTED|4-Week Titration Phase||179
7982209|NCT00235755|19653546|P2|STARTED|4-Week Titration Phase||181
7982210|NCT00235755|19653547|P1|STARTED|4-Week Titration Phase||179
7982211|NCT00235716|19653625|P4|NOT COMPLETED|Overall Study||62
7982212|NCT00235716|19653626|P3|NOT COMPLETED|Overall Study||65
7982213|NCT00235716|19653627|P2|NOT COMPLETED|Overall Study||67
7982214|NCT00235716|19653628|P1|NOT COMPLETED|Overall Study||62
7982215|NCT00235716|19653625|P4|COMPLETED|Overall Study||90
7982216|NCT00235716|19653626|P3|COMPLETED|Overall Study||89
7982217|NCT00235716|19653627|P2|COMPLETED|Overall Study||88
7982218|NCT00235716|19653628|P1|COMPLETED|Overall Study||90
7982219|NCT00235716|19653625|P4|STARTED|Overall Study||152
7982220|NCT00235716|19653626|P3|STARTED|Overall Study||154
7982221|NCT00235716|19653627|P2|STARTED|Overall Study||155
7982222|NCT00235716|19653628|P1|STARTED|Overall Study||152
7982223|NCT00235573|19653662|P1|NOT COMPLETED|Overall Study||0
7982224|NCT00235573|19653662|P1|COMPLETED|Overall Study||21
7982225|NCT00235573|19653662|P1|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21
7982226|NCT00235547|19653668|P2|NOT COMPLETED|6 Month Follow-up Survey||68
7982227|NCT00235547|19653669|P1|NOT COMPLETED|6 Month Follow-up Survey||71
7982228|NCT00235547|19653668|P2|COMPLETED|6 Month Follow-up Survey||76
7982229|NCT00235547|19653669|P1|COMPLETED|6 Month Follow-up Survey||83
7982230|NCT00235547|19653668|P2|STARTED|6 Month Follow-up Survey||144
7982231|NCT00235547|19653669|P1|STARTED|6 Month Follow-up Survey||154
7982232|NCT00235547|19653668|P2|NOT COMPLETED|2 Month Follow-up Survey||40
7982233|NCT00235547|19653669|P1|NOT COMPLETED|2 Month Follow-up Survey||46
7982234|NCT00235547|19653668|P2|COMPLETED|2 Month Follow-up Survey||104
7982235|NCT00235547|19653669|P1|COMPLETED|2 Month Follow-up Survey||108
7982236|NCT00235547|19653668|P2|STARTED|2 Month Follow-up Survey||144
7982237|NCT00235547|19653669|P1|STARTED|2 Month Follow-up Survey||154
7982238|NCT00235495|19653679|P2|NOT COMPLETED|Overall Study||68
7982239|NCT00235495|19653680|P1|NOT COMPLETED|Overall Study||68
7982240|NCT00235495|19653679|P2|COMPLETED|Overall Study||351
7982241|NCT00235495|19653680|P1|COMPLETED|Overall Study||354
7982242|NCT00235495|19653679|P2|STARTED|Overall Study||419
7982243|NCT00235495|19653680|P1|STARTED|Overall Study||422
7982244|NCT00235456|19653730|P2|NOT COMPLETED|Overall Study||7
7982245|NCT00235456|19653731|P1|NOT COMPLETED|Overall Study||2
7982246|NCT00235456|19653730|P2|COMPLETED|Overall Study||143
7982247|NCT00235456|19653731|P1|COMPLETED|Overall Study||148
7982248|NCT00235456|19653730|P2|STARTED|Overall Study||150
7982249|NCT00235456|19653731|P1|STARTED|Overall Study||150
7982250|NCT00235443|19653753|P6|NOT COMPLETED|Overall Study||45
7982251|NCT00235443|19653754|P5|NOT COMPLETED|Overall Study||30
7982252|NCT00235443|19653755|P4|NOT COMPLETED|Overall Study||97
7982253|NCT00235443|19653756|P3|NOT COMPLETED|Overall Study||62
7982254|NCT00235443|19653757|P2|NOT COMPLETED|Overall Study||38
7982255|NCT00235443|19653758|P1|NOT COMPLETED|Overall Study||8
7982256|NCT00235443|19653753|P6|COMPLETED|Overall Study||9
7982257|NCT00235443|19653754|P5|COMPLETED|Overall Study||9
7982258|NCT00235443|19653755|P4|COMPLETED|Overall Study||108
7982259|NCT00235443|19653756|P3|COMPLETED|Overall Study||23
7982260|NCT00235443|19653757|P2|COMPLETED|Overall Study||19
7982261|NCT00235443|19653758|P1|COMPLETED|Overall Study||3
7982262|NCT00235443|19653753|P6|STARTED|Overall Study||54
7982263|NCT00235443|19653754|P5|STARTED|Overall Study||39
7982264|NCT00235443|19653755|P4|STARTED|Overall Study||205
7982265|NCT00235443|19653756|P3|STARTED|Overall Study||85
7982266|NCT00235443|19653757|P2|STARTED|Overall Study||57
7982267|NCT00235443|19653758|P1|STARTED|Overall Study||11
7982268|NCT00235391|19653899|P6|NOT COMPLETED|Overall Study||4
7982269|NCT00235391|19653900|P5|NOT COMPLETED|Overall Study||12
7982270|NCT00235391|19653901|P4|NOT COMPLETED|Overall Study||220
7982271|NCT00235391|19653902|P3|NOT COMPLETED|Overall Study||24
7982272|NCT00235391|19653903|P2|NOT COMPLETED|Overall Study||18
7982273|NCT00235391|19653904|P1|NOT COMPLETED|Overall Study||12
7982274|NCT00235391|19653899|P6|COMPLETED|Overall Study||3
7982275|NCT00235391|19653900|P5|COMPLETED|Overall Study||31
7982276|NCT00235391|19653901|P4|COMPLETED|Overall Study||944
7982277|NCT00235391|19653902|P3|COMPLETED|Overall Study||148
7982278|NCT00235391|19653903|P2|COMPLETED|Overall Study||182
7982279|NCT00235391|19653904|P1|COMPLETED|Overall Study||85
7982280|NCT00235391|19653899|P6|Deferasirox Treatment|Overall Study||7
7982281|NCT00235391|19653900|P5|Deferasirox Treatment|Overall Study||43
7982282|NCT00235391|19653901|P4|Deferasirox Treatment|Overall Study||1164
7982283|NCT00235391|19653902|P3|Deferasirox Treatment|Overall Study||172
7982284|NCT00235391|19653903|P2|Deferasirox Treatment|Overall Study||200
7982285|NCT00235391|19653904|P1|Deferasirox Treatment|Overall Study||97
7982286|NCT00235391|19653899|P6|STARTED|Overall Study||7
7982287|NCT00235391|19653900|P5|STARTED|Overall Study||43
7982288|NCT00235391|19653901|P4|STARTED|Overall Study||1164
7982289|NCT00235391|19653902|P3|STARTED|Overall Study||172
7982290|NCT00235391|19653903|P2|STARTED|Overall Study||200
7982291|NCT00235391|19653904|P1|STARTED|Overall Study||97
7982292|NCT00235326|19653921|P2|NOT COMPLETED|Overall Study||1400
7982293|NCT00235326|19653922|P1|NOT COMPLETED|Overall Study||746
7982294|NCT00235326|19653921|P2|COMPLETED|Overall Study||1586
7982295|NCT00235326|19653922|P1|COMPLETED|Overall Study||829
7982296|NCT00235326|19653921|P2|STARTED|Overall Study||2986
7982297|NCT00235326|19653922|P1|STARTED|Overall Study||1575
7982298|NCT00234884|19653926|P1|NOT COMPLETED|Overall Study||1630
7982299|NCT00234884|19653926|P1|COMPLETED|Overall Study||1805
7982300|NCT00234884|19653926|P1|STARTED|Overall Study||3435
7982301|NCT00234832|19653936|P2|NOT COMPLETED|Overall Study||996
7982302|NCT00234832|19653937|P1|NOT COMPLETED|Overall Study||1016
7982303|NCT00234832|19653936|P2|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902
7982304|NCT00234832|19653937|P1|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890
7982305|NCT00234832|19653936|P2|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898
7982306|NCT00234832|19653937|P1|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906
7982307|NCT00234533|19653962|P1|NOT COMPLETED|Overall Study||11
7982308|NCT00234533|19653962|P1|COMPLETED|Overall Study||240
7982309|NCT00234533|19653962|P1|STARTED|Overall Study||251
7982310|NCT00234494|19653981|P1|NOT COMPLETED|Overall Study||2
7982311|NCT00234494|19653981|P1|COMPLETED|Overall Study||43
7982312|NCT00234494|19653981|P1|STARTED|Overall Study||45
7982313|NCT00234286|19653988|P1|NOT COMPLETED|Overall Study||0
7982314|NCT00234286|19653988|P1|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
7982315|NCT00234286|19653988|P1|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
7982316|NCT00234104|19654027|P4|NOT COMPLETED|Overall Study||8
7982317|NCT00234104|19654028|P3|NOT COMPLETED|Overall Study||5
7982318|NCT00234104|19654029|P2|NOT COMPLETED|Overall Study||1
7982319|NCT00234104|19654030|P1|NOT COMPLETED|Overall Study||4
7982320|NCT00234104|19654027|P4|COMPLETED|Overall Study||21
7982321|NCT00234104|19654028|P3|COMPLETED|Overall Study||29
7982322|NCT00234104|19654029|P2|COMPLETED|Overall Study||28
7982323|NCT00234104|19654030|P1|COMPLETED|Overall Study||26
7982324|NCT00234104|19654027|P4|STARTED|Overall Study||29
7982325|NCT00234104|19654028|P3|STARTED|Overall Study||34
7982326|NCT00234104|19654029|P2|STARTED|Overall Study||29
7982327|NCT00234104|19654030|P1|STARTED|Overall Study||30
7982328|NCT00234078|19654044|P4|NOT COMPLETED|Overall Study||4
7982329|NCT00234078|19654045|P3|NOT COMPLETED|Overall Study||10
7982330|NCT00234078|19654046|P2|NOT COMPLETED|Overall Study||9
7982331|NCT00234078|19654047|P1|NOT COMPLETED|Overall Study||6
7982332|NCT00234078|19654044|P4|COMPLETED|Overall Study||68
7982333|NCT00234078|19654045|P3|COMPLETED|Overall Study||64
7982334|NCT00234078|19654046|P2|COMPLETED|Overall Study||63
7982335|NCT00234078|19654047|P1|COMPLETED|Overall Study||66
7982336|NCT00234078|19654044|P4|STARTED|Overall Study||72
7982337|NCT00234078|19654045|P3|STARTED|Overall Study||74
7982338|NCT00234078|19654046|P2|STARTED|Overall Study||72
7982339|NCT00234078|19654047|P1|STARTED|Overall Study||72
7982340|NCT00234065|19654071|P2|NOT COMPLETED|Overall Study||356
7982341|NCT00234065|19654072|P1|NOT COMPLETED|Overall Study||475
7982342|NCT00234065|19654071|P2|COMPLETED|Overall Study||1004
7982343|NCT00234065|19654072|P1|COMPLETED|Overall Study||881
7982344|NCT00234065|19654071|P2|STARTED|Overall Study||1360
7982345|NCT00234065|19654072|P1|STARTED|Overall Study||1356
7982346|NCT00234052|19654088|P1|NOT COMPLETED|Follow-up for 5 Years||49
7982347|NCT00234052|19654088|P1|COMPLETED|Follow-up for 5 Years||1
7982348|NCT00234052|19654088|P1|STARTED|Follow-up for 5 Years|All patients that are treated on study go into the follow up period.|50
7982349|NCT00234052|19654088|P1|NOT COMPLETED|Treatment||21
7982350|NCT00234052|19654088|P1|COMPLETED|Treatment||30
7982351|NCT00234052|19654088|P1|Went Into Maintenance Phase|Treatment||30
7982352|NCT00234052|19654088|P1|Completed 6 Cycles|Treatment||33
7982353|NCT00234052|19654088|P1|Started Treatment|Treatment||50
7982354|NCT00234052|19654088|P1|STARTED|Treatment||51
7982355|NCT00234039|19654098|P1|NOT COMPLETED|Overall Study||50
7982356|NCT00234039|19654098|P1|COMPLETED|Overall Study||8
7982357|NCT00234039|19654098|P1|Eligible and Began Protocol Therapy|Overall Study||47
7982358|NCT00234039|19654098|P1|Eligible|Overall Study||49
7982359|NCT00234039|19654098|P1|STARTED|Overall Study||58
7982360|NCT00233987|19654105|P1|NOT COMPLETED|Overall Study||15
7982361|NCT00233987|19654105|P1|COMPLETED|Overall Study||83
7982362|NCT00233987|19654105|P1|Eligible and Treated|Overall Study||92
7982363|NCT00233987|19654105|P1|Eligible|Overall Study||94
7982364|NCT00233987|19654105|P1|STARTED|Overall Study||98
7982365|NCT00233948|19654114|P6|NOT COMPLETED|Overall Study||0
7982366|NCT00233948|19654115|P5|NOT COMPLETED|Overall Study||0
7982367|NCT00233948|19654116|P4|NOT COMPLETED|Overall Study||0
7982368|NCT00233948|19654117|P3|NOT COMPLETED|Overall Study||0
7982369|NCT00233948|19654118|P2|NOT COMPLETED|Overall Study||0
7982370|NCT00233948|19654119|P1|NOT COMPLETED|Overall Study||1
7982371|NCT00233948|19654114|P6|COMPLETED|Overall Study||12
7982372|NCT00233948|19654115|P5|COMPLETED|Overall Study||4
7982373|NCT00233948|19654116|P4|COMPLETED|Overall Study||3
7982374|NCT00233948|19654117|P3|COMPLETED|Overall Study||3
7982375|NCT00233948|19654118|P2|COMPLETED|Overall Study||3
7982376|NCT00233948|19654119|P1|COMPLETED|Overall Study||3
7982377|NCT00233948|19654114|P6|STARTED|Overall Study||12
7982378|NCT00233948|19654115|P5|STARTED|Overall Study||4
7982379|NCT00233948|19654116|P4|STARTED|Overall Study||3
7982380|NCT00233948|19654117|P3|STARTED|Overall Study||3
7982381|NCT00233948|19654118|P2|STARTED|Overall Study||3
7982382|NCT00233948|19654119|P1|STARTED|Overall Study||4
7982383|NCT00233519|19654136|P2|NOT COMPLETED|Overall Study||1
7982384|NCT00233519|19654137|P1|NOT COMPLETED|Overall Study||1
7982385|NCT00233519|19654136|P2|COMPLETED|Overall Study||9
7982386|NCT00233519|19654137|P1|COMPLETED|Overall Study||6
7982387|NCT00233519|19654136|P2|STARTED|Overall Study||10
7982388|NCT00233519|19654137|P1|STARTED|Overall Study||7
7982389|NCT00233480|19654145|P2|NOT COMPLETED|Overall Study||1
7982390|NCT00233480|19654146|P1|NOT COMPLETED|Overall Study||0
7982391|NCT00233480|19654145|P2|COMPLETED|Overall Study||12
7982392|NCT00233480|19654146|P1|COMPLETED|Overall Study||14
7982393|NCT00233480|19654145|P2|STARTED|Overall Study||13
7982394|NCT00233480|19654146|P1|STARTED|Overall Study||14
7982395|NCT00233454|19654162|P1|NOT COMPLETED|Overall Study||6
7982396|NCT00233454|19654162|P1|COMPLETED|Overall Study||20
7982397|NCT00233454|19654162|P1|2 Months (for Response Rate)|Overall Study||26
7982398|NCT00233454|19654162|P1|STARTED|Overall Study||26
7982399|NCT00233402|19654170|P2|NOT COMPLETED|Overall Study||124
7982400|NCT00233402|19654171|P1|NOT COMPLETED|Overall Study||104
7982401|NCT00233402|19654170|P2|COMPLETED|Overall Study||271
7982402|NCT00233402|19654171|P1|COMPLETED|Overall Study||280
7982403|NCT00233402|19654170|P2|STARTED|Overall Study||395
7982404|NCT00233402|19654171|P1|STARTED|Overall Study||384
7982405|NCT00233324|19654186|P4|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11
7982406|NCT00233324|19654187|P3|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18
7982407|NCT00233324|19654188|P2|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14
7982408|NCT00233324|19654189|P1|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13
7982409|NCT00233324|19654186|P4|COMPLETED|Follow up at 18-22 Months Corrected Age||269
7982410|NCT00233324|19654187|P3|COMPLETED|Follow up at 18-22 Months Corrected Age||256
7982411|NCT00233324|19654188|P2|COMPLETED|Follow up at 18-22 Months Corrected Age||261
7982412|NCT00233324|19654189|P1|COMPLETED|Follow up at 18-22 Months Corrected Age||237
7982413|NCT00233324|19654186|P4|STARTED|Follow up at 18-22 Months Corrected Age||280
7982414|NCT00233324|19654187|P3|STARTED|Follow up at 18-22 Months Corrected Age||274
7982415|NCT00233324|19654188|P2|STARTED|Follow up at 18-22 Months Corrected Age||275
7982416|NCT00233324|19654189|P1|STARTED|Follow up at 18-22 Months Corrected Age||250
7982417|NCT00233324|19654186|P4|NOT COMPLETED|Main Study||47
7982418|NCT00233324|19654187|P3|NOT COMPLETED|Main Study||62
7982419|NCT00233324|19654188|P2|NOT COMPLETED|Main Study||60
7982420|NCT00233324|19654189|P1|NOT COMPLETED|Main Study||68
7982421|NCT00233324|19654186|P4|COMPLETED|Main Study||280
7982422|NCT00233324|19654187|P3|COMPLETED|Main Study||274
7982423|NCT00233324|19654188|P2|COMPLETED|Main Study||275
7982424|NCT00233324|19654189|P1|COMPLETED|Main Study||250
7982425|NCT00233324|19654186|P4|STARTED|Main Study||327
7982426|NCT00233324|19654187|P3|STARTED|Main Study||336
7982427|NCT00233324|19654188|P2|STARTED|Main Study||335
7982428|NCT00233324|19654189|P1|STARTED|Main Study||318
7982429|NCT00233103|19654273|P2|NOT COMPLETED|Overall Study||6
7982430|NCT00233103|19654274|P1|NOT COMPLETED|Overall Study||5
7982431|NCT00233103|19654273|P2|COMPLETED|Overall Study||19
7982432|NCT00233103|19654274|P1|COMPLETED|Overall Study||22
7982433|NCT00233103|19654273|P2|STARTED|Overall Study||25
7982434|NCT00233103|19654274|P1|STARTED|Overall Study||27
7982435|NCT00233090|19654288|P2|NOT COMPLETED|Overall Study||0
7982436|NCT00233090|19654289|P1|NOT COMPLETED|Overall Study||0
7982437|NCT00233090|19654288|P2|COMPLETED|Overall Study||9
7982438|NCT00233090|19654289|P1|COMPLETED|Overall Study||12
7982439|NCT00233090|19654288|P2|STARTED|Overall Study||9
7982440|NCT00233090|19654289|P1|STARTED|Overall Study||12
7982441|NCT00233064|19654311|P2|NOT COMPLETED|Overall Study||12
7982442|NCT00233064|19654312|P1|NOT COMPLETED|Overall Study||14
7982443|NCT00233064|19654311|P2|COMPLETED|Overall Study||190
7982444|NCT00233064|19654312|P1|COMPLETED|Overall Study||197
7982445|NCT00233064|19654311|P2|STARTED|Overall Study||202
7982446|NCT00233064|19654312|P1|STARTED|Overall Study||211
7982447|NCT00232739|19654319|P1|NOT COMPLETED|Overall Study||9
7982448|NCT00232739|19654319|P1|COMPLETED|Overall Study||91
7982449|NCT00232739|19654319|P1|STARTED|Overall Study||100
7982450|NCT00232596|19654338|P2|NOT COMPLETED|12-Week Maintenance Phase||28
7982451|NCT00232596|19654339|P1|NOT COMPLETED|12-Week Maintenance Phase||12
7982452|NCT00232596|19654338|P2|COMPLETED|12-Week Maintenance Phase||97
7982453|NCT00232596|19654339|P1|COMPLETED|12-Week Maintenance Phase|"One participant withdrew after being considered a completer and is listed as an early withdraw."|126
7982454|NCT00232596|19654338|P2|STARTED|12-Week Maintenance Phase||125
7982455|NCT00232596|19654339|P1|STARTED|12-Week Maintenance Phase||138
7982456|NCT00232596|19654338|P2|NOT COMPLETED|6-Week Titration Phase||29
7982457|NCT00232596|19654339|P1|NOT COMPLETED|6-Week Titration Phase||14
7982458|NCT00232596|19654338|P2|COMPLETED|6-Week Titration Phase||125
7982459|NCT00232596|19654339|P1|COMPLETED|6-Week Titration Phase||138
7982460|NCT00232596|19654338|P2|STARTED|6-Week Titration Phase||154
7982461|NCT00232596|19654339|P1|STARTED|6-Week Titration Phase||152
7982462|NCT00232583|19654391|P2|NOT COMPLETED|Overall Study||13
7982463|NCT00232583|19654392|P1|NOT COMPLETED|Overall Study||10
7982464|NCT00232583|19654391|P2|COMPLETED|Overall Study||16
7982465|NCT00232583|19654392|P1|COMPLETED|Overall Study||19
7982466|NCT00232583|19654391|P2|STARTED|Overall Study||29
7982467|NCT00232583|19654392|P1|STARTED|Overall Study||29
7982468|NCT00232557|19654430|P2|NOT COMPLETED|Overall Study||5
7982469|NCT00232557|19654431|P1|NOT COMPLETED|Overall Study||3
7982470|NCT00232557|19654430|P2|COMPLETED|Overall Study||60
7982471|NCT00232557|19654431|P1|COMPLETED|Overall Study||68
7982472|NCT00232557|19654430|P2|STARTED|Overall Study||65
7982473|NCT00232557|19654431|P1|STARTED|Overall Study||71
7982474|NCT00232544|19654441|P2|NOT COMPLETED|Overall Study||15
7982475|NCT00232544|19654442|P1|NOT COMPLETED|Overall Study||20
7982476|NCT00232544|19654441|P2|COMPLETED|Overall Study||111
7982477|NCT00232544|19654442|P1|COMPLETED|Overall Study||104
7982478|NCT00232544|19654441|P2|STARTED|Overall Study||126
7982479|NCT00232544|19654442|P1|STARTED|Overall Study||124
7982480|NCT00232505|19654452|P2|NOT COMPLETED|Overall Study||11
7982481|NCT00232505|19654453|P1|NOT COMPLETED|Overall Study||5
7982482|NCT00232505|19654452|P2|COMPLETED|Overall Study||60
7982483|NCT00232505|19654453|P1|COMPLETED|Overall Study||26
7982484|NCT00232505|19654452|P2|Off Protocol|Overall Study||0
7982485|NCT00232505|19654453|P1|Off Protocol|Overall Study||5
7982486|NCT00232505|19654452|P2|Early Progressors|Overall Study||5
7982487|NCT00232505|19654453|P1|Early Progressors|Overall Study||2
7982488|NCT00232505|19654452|P2|Not Evaluable|Overall Study||6
7982489|NCT00232505|19654453|P1|Not Evaluable|Overall Study||0
7982490|NCT00232505|19654452|P2|STARTED|Overall Study||71
7982491|NCT00232505|19654453|P1|STARTED|Overall Study||31
7982492|NCT00232479|19654466|P1|NOT COMPLETED|Overall Study||0
7982493|NCT00232479|19654466|P1|COMPLETED|Overall Study||44
7982494|NCT00232479|19654466|P1|STARTED|Overall Study||44
7982495|NCT00232180|19654473|P3|NOT COMPLETED|Open Label Phase||148
7982496|NCT00232180|19654474|P2|NOT COMPLETED|Open Label Phase||0
7982497|NCT00232180|19654475|P1|NOT COMPLETED|Open Label Phase||0
7982498|NCT00232180|19654473|P3|COMPLETED|Open Label Phase||1098
7982499|NCT00232180|19654474|P2|COMPLETED|Open Label Phase||0
7982500|NCT00232180|19654475|P1|COMPLETED|Open Label Phase||0
7982501|NCT00232180|19654473|P3|Treated|Open Label Phase||1245
7982502|NCT00232180|19654474|P2|Treated|Open Label Phase||0
7982503|NCT00232180|19654475|P1|Treated|Open Label Phase||0
7982504|NCT00232180|19654473|P3|STARTED|Open Label Phase||1246
7982505|NCT00232180|19654474|P2|STARTED|Open Label Phase||0
7982506|NCT00232180|19654475|P1|STARTED|Open Label Phase||0
7982507|NCT00232180|19654473|P3|NOT COMPLETED|Double-blind (DB) Phase||0
7982508|NCT00232180|19654474|P2|NOT COMPLETED|Double-blind (DB) Phase||605
7982509|NCT00232180|19654475|P1|NOT COMPLETED|Double-blind (DB) Phase||541
7982510|NCT00232180|19654473|P3|COMPLETED|Double-blind (DB) Phase||0
7982511|NCT00232180|19654474|P2|COMPLETED|Double-blind (DB) Phase||771
7982512|NCT00232180|19654475|P1|COMPLETED|Double-blind (DB) Phase||826
7982513|NCT00232180|19654473|P3|Treated|Double-blind (DB) Phase||0
7982514|NCT00232180|19654474|P2|Treated|Double-blind (DB) Phase||1372
7982515|NCT00232180|19654475|P1|Treated|Double-blind (DB) Phase||1364
7982516|NCT00232180|19654473|P3|STARTED|Double-blind (DB) Phase||0
7982517|NCT00232180|19654474|P2|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376
7982518|NCT00232180|19654475|P1|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367
7982519|NCT00232141|19654520|P2|NOT COMPLETED|Overall Study||26
7982520|NCT00232141|19654521|P1|NOT COMPLETED|Overall Study||31
7982521|NCT00232141|19654520|P2|COMPLETED|Overall Study||125
7982522|NCT00232141|19654521|P1|COMPLETED|Overall Study||120
7982523|NCT00232141|19654520|P2|STARTED|Overall Study||151
7982524|NCT00232141|19654521|P1|STARTED|Overall Study||151
7982525|NCT00231894|19654591|P2|NOT COMPLETED|Overall Study||1
7982526|NCT00231894|19654592|P1|NOT COMPLETED|Overall Study||1
7982527|NCT00231894|19654591|P2|COMPLETED|Overall Study||24
7982528|NCT00231894|19654592|P1|COMPLETED|Overall Study||30
7982529|NCT00231894|19654591|P2|STARTED|Overall Study||25
7982530|NCT00231894|19654592|P1|STARTED|Overall Study||31
7982531|NCT00231868|19654614|P1|NOT COMPLETED|Overall Study||16
7982532|NCT00231868|19654614|P1|COMPLETED|Overall Study||65
7982533|NCT00231868|19654614|P1|STARTED|Overall Study||81
7982534|NCT00231842|19654618|P1|NOT COMPLETED|Overall Study||11
7982535|NCT00231842|19654618|P1|COMPLETED|Overall Study||19
7982536|NCT00231842|19654618|P1|Completed Full Prescribed Therapy|Overall Study||19
7982537|NCT00231842|19654618|P1|Completed Prescribed RT|Overall Study||27
7982538|NCT00231842|19654618|P1|Completed First 3 Cycles|Overall Study||27
7982539|NCT00231842|19654618|P1|Initiated Therapy|Overall Study||27
7982540|NCT00231842|19654618|P1|STARTED|Overall Study||30
7982541|NCT00231816|19654625|P2|NOT COMPLETED|Overall Study||12
7982542|NCT00231816|19654626|P1|NOT COMPLETED|Overall Study||16
7982543|NCT00231816|19654625|P2|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369
7982544|NCT00231816|19654626|P1|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366
7982545|NCT00231816|19654625|P2|Vaccinated at Visit 2|Overall Study||371
7982546|NCT00231816|19654626|P1|Vaccinated at Visit 2|Overall Study||369
7982547|NCT00231816|19654625|P2|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380
7982548|NCT00231816|19654626|P1|Vaccinated at Visit 1|Overall Study||382
7982549|NCT00231816|19654625|P2|STARTED|Overall Study||381
7982550|NCT00231816|19654626|P1|STARTED|Overall Study||382
7982551|NCT00231777|19654641|P2|NOT COMPLETED|Overall Study||2
7982552|NCT00231777|19654642|P1|NOT COMPLETED|Overall Study||6
7982553|NCT00231777|19654641|P2|COMPLETED|Overall Study||44
7982554|NCT00231777|19654642|P1|COMPLETED|Overall Study||164
7982555|NCT00231777|19654641|P2|STARTED|Overall Study||46
7982556|NCT00231777|19654642|P1|STARTED|Overall Study||170
7982557|NCT00231478|19654656|P2|NOT COMPLETED|Overall Study||6
7982558|NCT00231478|19654657|P1|NOT COMPLETED|Overall Study||8
7982559|NCT00231478|19654656|P2|COMPLETED|Overall Study||78
7982560|NCT00231478|19654657|P1|COMPLETED|Overall Study||79
7982561|NCT00231478|19654656|P2|STARTED|Overall Study||84
7982562|NCT00231478|19654657|P1|STARTED|Overall Study||87
7982563|NCT00231465|19654669|P1|NOT COMPLETED|Overall Study||2
7982564|NCT00231465|19654669|P1|COMPLETED|Overall Study||42
7982565|NCT00231465|19654669|P1|STARTED|Overall Study||44
7982566|NCT00231413|19654682|P7|NOT COMPLETED|Overall Study||4
7982567|NCT00231413|19654683|P6|NOT COMPLETED|Overall Study||5
7982568|NCT00231413|19654684|P5|NOT COMPLETED|Overall Study||3
7982569|NCT00231413|19654685|P4|NOT COMPLETED|Overall Study||3
7982570|NCT00231413|19654686|P3|NOT COMPLETED|Overall Study||7
7982571|NCT00231413|19654687|P2|NOT COMPLETED|Overall Study||5
7982572|NCT00231413|19654688|P1|NOT COMPLETED|Overall Study||8
7982573|NCT00231413|19654682|P7|COMPLETED|Overall Study||46
7982574|NCT00231413|19654683|P6|COMPLETED|Overall Study||45
7982575|NCT00231413|19654684|P5|COMPLETED|Overall Study||45
7982576|NCT00231413|19654685|P4|COMPLETED|Overall Study||45
7982577|NCT00231413|19654686|P3|COMPLETED|Overall Study||42
7982578|NCT00231413|19654687|P2|COMPLETED|Overall Study||45
7982579|NCT00231413|19654688|P1|COMPLETED|Overall Study||80
7982580|NCT00231413|19654682|P7|STARTED|Overall Study||50
7982581|NCT00231413|19654683|P6|STARTED|Overall Study||50
7982582|NCT00231413|19654684|P5|STARTED|Overall Study||48
7982583|NCT00231413|19654685|P4|STARTED|Overall Study||48
7982584|NCT00231413|19654686|P3|STARTED|Overall Study||49
7982585|NCT00231413|19654687|P2|STARTED|Overall Study||50
7982586|NCT00231413|19654688|P1|STARTED|Overall Study||88
7982587|NCT00231309|19654844|P1|NOT COMPLETED|Overall Study||0
7982588|NCT00231309|19654844|P1|COMPLETED|Overall Study||10
7982589|NCT00231309|19654844|P1|STARTED|Overall Study||10
7982590|NCT00231283|19654849|P1|NOT COMPLETED|Overall Study||5
7982591|NCT00231283|19654849|P1|COMPLETED|Overall Study||95
7982592|NCT00231283|19654849|P1|STARTED|Overall Study||100
7982593|NCT00231179|19654858|P2|NOT COMPLETED|Overall Study||24
7982594|NCT00231179|19654859|P1|NOT COMPLETED|Overall Study||24
7982595|NCT00231179|19654858|P2|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126
7982596|NCT00231179|19654859|P1|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128
7982597|NCT00231179|19654858|P2|STARTED|Overall Study||150
7982598|NCT00231179|19654859|P1|STARTED|Overall Study||152
7982599|NCT00231153|19654875|P2|NOT COMPLETED|Overall Study||188
7982600|NCT00231153|19654876|P1|NOT COMPLETED|Overall Study||217
7982601|NCT00231153|19654875|P2|COMPLETED|Overall Study||720
7982602|NCT00231153|19654876|P1|COMPLETED|Overall Study||690
7982603|NCT00231153|19654875|P2|STARTED|Overall Study|Subjects randomized to povidone-iodine who received at least one dose of study treatment.|908
7982604|NCT00231153|19654876|P1|STARTED|Overall Study|Subjects randomized to omiganan 1% gel who received at least one dose of study treatment.|907
7982605|NCT00231114|19654886|P2|NOT COMPLETED|Post-Treatment Period||1
7982606|NCT00231114|19654887|P1|NOT COMPLETED|Post-Treatment Period||8
7982607|NCT00231114|19654886|P2|COMPLETED|Post-Treatment Period||97
7982608|NCT00231114|19654887|P1|COMPLETED|Post-Treatment Period||181
7982609|NCT00231114|19654886|P2|STARTED|Post-Treatment Period||98
7982610|NCT00231114|19654887|P1|STARTED|Post-Treatment Period||189
7982611|NCT00231114|19654886|P2|NOT COMPLETED|Treatment Period||0
7982612|NCT00231114|19654887|P1|NOT COMPLETED|Treatment Period||1
7982613|NCT00231114|19654886|P2|COMPLETED|Treatment Period||98
7982614|NCT00231114|19654887|P1|COMPLETED|Treatment Period||189
7982615|NCT00231114|19654886|P2|STARTED|Treatment Period||98
7982616|NCT00231114|19654887|P1|STARTED|Treatment Period||190
7982617|NCT00231114|19654886|P2|NOT COMPLETED|Randomized||3
7982618|NCT00231114|19654887|P1|NOT COMPLETED|Randomized||6
7982619|NCT00231114|19654886|P2|COMPLETED|Randomized||98
7982620|NCT00231114|19654887|P1|COMPLETED|Randomized||190
7982621|NCT00231114|19654886|P2|STARTED|Randomized||101
7982622|NCT00231114|19654887|P1|STARTED|Randomized||196
7982623|NCT00231062|19654923|P1|NOT COMPLETED|Overall Study||6
7982624|NCT00231062|19654923|P1|COMPLETED|Overall Study||109
7982625|NCT00231062|19654923|P1|STARTED|Overall Study||115
7982626|NCT00230971|19654931|P2|NOT COMPLETED|Baseline Participants||19
7982627|NCT00230971|19654932|P1|NOT COMPLETED|Baseline Participants||22
7982628|NCT00230971|19654931|P2|COMPLETED|Baseline Participants||216
7982629|NCT00230971|19654932|P1|COMPLETED|Baseline Participants||210
7982630|NCT00230971|19654931|P2|STARTED|Baseline Participants||235
7982631|NCT00230971|19654932|P1|STARTED|Baseline Participants||232
7982632|NCT00230971|19654931|P2|NOT COMPLETED|Randomization||3
7982633|NCT00230971|19654932|P1|NOT COMPLETED|Randomization||3
7982634|NCT00230971|19654931|P2|COMPLETED|Randomization||235
7982635|NCT00230971|19654932|P1|COMPLETED|Randomization||232
7982636|NCT00230971|19654931|P2|STARTED|Randomization||238
7982637|NCT00230971|19654932|P1|STARTED|Randomization||235
7982638|NCT00230802|19654946|P2|NOT COMPLETED|Overall Study||0
7982639|NCT00230802|19654947|P1|NOT COMPLETED|Overall Study||0
7982640|NCT00230802|19654946|P2|COMPLETED|Overall Study||23
7982641|NCT00230802|19654947|P1|COMPLETED|Overall Study||25
7982642|NCT00230802|19654946|P2|STARTED|Overall Study||23
7982643|NCT00230802|19654947|P1|STARTED|Overall Study||25
7982644|NCT00230737|19654960|P3|NOT COMPLETED|Overall Study||0
7982645|NCT00230737|19654961|P2|NOT COMPLETED|Overall Study||0
7982646|NCT00230737|19654962|P1|NOT COMPLETED|Overall Study||0
7982647|NCT00230737|19654960|P3|COMPLETED|Overall Study||8
7982648|NCT00230737|19654961|P2|COMPLETED|Overall Study||10
7982649|NCT00230737|19654962|P1|COMPLETED|Overall Study||9
7982650|NCT00230737|19654960|P3|STARTED|Overall Study||8
7982651|NCT00230737|19654961|P2|STARTED|Overall Study||10
7982652|NCT00230737|19654962|P1|STARTED|Overall Study||9
7982653|NCT00230282|19654970|P1|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0
7982654|NCT00230282|19654970|P1|COMPLETED|Maintanence Therapy With Alemtuzumab||17
7982655|NCT00230282|19654970|P1|STARTED|Maintanence Therapy With Alemtuzumab||17
7982656|NCT00230282|19654970|P1|NOT COMPLETED|Fludarabine + Cyclophosphamide||8
7982657|NCT00230282|19654970|P1|COMPLETED|Fludarabine + Cyclophosphamide||17
7982658|NCT00230282|19654970|P1|STARTED|Fludarabine + Cyclophosphamide||25
7982659|NCT00230178|19654978|P3|NOT COMPLETED|Overall Study||7
7982660|NCT00230178|19654979|P2|NOT COMPLETED|Overall Study||7
7982661|NCT00230178|19654980|P1|NOT COMPLETED|Overall Study||4
7982662|NCT00230178|19654978|P3|COMPLETED|Overall Study||86
7982663|NCT00230178|19654979|P2|COMPLETED|Overall Study||86
7982664|NCT00230178|19654980|P1|COMPLETED|Overall Study||90
7982665|NCT00230178|19654978|P3|Treated|Overall Study||91
7982666|NCT00230178|19654979|P2|Treated|Overall Study||92
7982667|NCT00230178|19654980|P1|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92
7982668|NCT00230178|19654978|P3|STARTED|Overall Study||93
7982669|NCT00230178|19654979|P2|STARTED|Overall Study||93
7982670|NCT00230178|19654980|P1|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94
7982671|NCT00230126|19654996|P2|NOT COMPLETED|Overall Study||1
7982672|NCT00230126|19654997|P1|NOT COMPLETED|Overall Study||2
7982673|NCT00230126|19654996|P2|COMPLETED|Overall Study||27
7982674|NCT00230126|19654997|P1|COMPLETED|Overall Study||28
7982675|NCT00230126|19654996|P2|STARTED|Overall Study||28
7982676|NCT00230126|19654997|P1|STARTED|Overall Study||30
7982677|NCT00230100|19655009|P2|NOT COMPLETED|Overall Study||0
7982678|NCT00230100|19655010|P1|NOT COMPLETED|Overall Study||0
7982679|NCT00230100|19655009|P2|COMPLETED|Overall Study||17
7982680|NCT00230100|19655010|P1|COMPLETED|Overall Study||29
7982681|NCT00230100|19655009|P2|STARTED|Overall Study||17
7982682|NCT00230100|19655010|P1|STARTED|Overall Study||29
7982683|NCT00230048|19655032|P2|NOT COMPLETED|Overall Study||18
7982684|NCT00230048|19655033|P1|NOT COMPLETED|Overall Study||13
7982685|NCT00230048|19655032|P2|COMPLETED|Overall Study||37
7982686|NCT00230048|19655033|P1|COMPLETED|Overall Study||39
7982687|NCT00230048|19655032|P2|Completed Intervention/Control Session|Overall Study||55
7982688|NCT00230048|19655033|P1|Completed Intervention/Control Session|Overall Study||52
7982689|NCT00230048|19655032|P2|STARTED|Overall Study||55
7982690|NCT00230048|19655033|P1|STARTED|Overall Study||52
7982691|NCT00230022|19655043|P2|NOT COMPLETED|Overall Study||0
7982692|NCT00230022|19655044|P1|NOT COMPLETED|Overall Study||0
7982693|NCT00230022|19655043|P2|COMPLETED|Overall Study||15
7982694|NCT00230022|19655044|P1|COMPLETED|Overall Study||15
7982695|NCT00230022|19655043|P2|STARTED|Overall Study||15
7982696|NCT00230022|19655044|P1|STARTED|Overall Study||15
7982697|NCT00230009|19655052|P2|NOT COMPLETED|Follow-up||26
7982698|NCT00230009|19655053|P1|NOT COMPLETED|Follow-up||31
7982699|NCT00230009|19655052|P2|COMPLETED|Follow-up||24
7982700|NCT00230009|19655053|P1|COMPLETED|Follow-up||19
7982701|NCT00230009|19655052|P2|STARTED|Follow-up||50
7982702|NCT00230009|19655053|P1|STARTED|Follow-up||50
7982703|NCT00230009|19655052|P2|NOT COMPLETED|Single Session Intervention/Control||0
7982704|NCT00230009|19655053|P1|NOT COMPLETED|Single Session Intervention/Control||0
7982705|NCT00230009|19655052|P2|COMPLETED|Single Session Intervention/Control||50
7982706|NCT00230009|19655053|P1|COMPLETED|Single Session Intervention/Control||50
7982707|NCT00230009|19655052|P2|STARTED|Single Session Intervention/Control||50
7982708|NCT00230009|19655053|P1|STARTED|Single Session Intervention/Control||50
7982709|NCT00229970|19655070|P3|NOT COMPLETED|Overall Study||0
7982710|NCT00229970|19655071|P2|NOT COMPLETED|Overall Study||0
7982711|NCT00229970|19655072|P1|NOT COMPLETED|Overall Study||0
7982712|NCT00229970|19655070|P3|COMPLETED|Overall Study||75
7982713|NCT00229970|19655071|P2|COMPLETED|Overall Study||72
7982714|NCT00229970|19655072|P1|COMPLETED|Overall Study||78
7982715|NCT00229970|19655070|P3|STARTED|Overall Study||75
7982716|NCT00229970|19655071|P2|STARTED|Overall Study||72
7982717|NCT00229970|19655072|P1|STARTED|Overall Study||78
7982718|NCT00229957|19655082|P2|NOT COMPLETED|Overall Study||12
7982719|NCT00229957|19655083|P1|NOT COMPLETED|Overall Study||20
7982720|NCT00229957|19655082|P2|COMPLETED|Overall Study||139
7982721|NCT00229957|19655083|P1|COMPLETED|Overall Study||132
7982722|NCT00229957|19655082|P2|STARTED|Overall Study||151
7982723|NCT00229957|19655083|P1|STARTED|Overall Study||152
7982724|NCT00229931|19655091|P2|NOT COMPLETED|Overall Study||2
7982725|NCT00229931|19655092|P1|NOT COMPLETED|Overall Study||4
7982726|NCT00229931|19655091|P2|COMPLETED|Overall Study||3
7982727|NCT00229931|19655092|P1|COMPLETED|Overall Study||2
7982728|NCT00229931|19655091|P2|STARTED|Overall Study||5
7982729|NCT00229931|19655092|P1|STARTED|Overall Study||6
7982730|NCT00229723|19655107|P7|NOT COMPLETED|Maintenance Phase||10
7982731|NCT00229723|19655108|P6|NOT COMPLETED|Maintenance Phase||19
7982732|NCT00229723|19655109|P5|NOT COMPLETED|Maintenance Phase||15
7982733|NCT00229723|19655110|P4|NOT COMPLETED|Maintenance Phase||17
7982734|NCT00229723|19655111|P3|NOT COMPLETED|Maintenance Phase||9
7982735|NCT00229723|19655112|P2|NOT COMPLETED|Maintenance Phase||14
7982736|NCT00229723|19655113|P1|NOT COMPLETED|Maintenance Phase||25
7982737|NCT00229723|19655107|P7|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
7982738|NCT00229723|19655108|P6|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12
7982739|NCT00229723|19655109|P5|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7
7982740|NCT00229723|19655110|P4|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
7982741|NCT00229723|19655111|P3|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16
7982742|NCT00229723|19655112|P2|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5
7982743|NCT00229723|19655113|P1|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25
7982744|NCT00229723|19655107|P7|STARTED|Maintenance Phase||19
7982745|NCT00229723|19655108|P6|STARTED|Maintenance Phase||31
7982746|NCT00229723|19655109|P5|STARTED|Maintenance Phase||22
7982747|NCT00229723|19655110|P4|STARTED|Maintenance Phase||26
7982748|NCT00229723|19655111|P3|STARTED|Maintenance Phase||25
7982749|NCT00229723|19655112|P2|STARTED|Maintenance Phase||19
7982750|NCT00229723|19655113|P1|STARTED|Maintenance Phase||50
7982751|NCT00229723|19655107|P7|NOT COMPLETED|Concomitant Phase||3
7982752|NCT00229723|19655108|P6|NOT COMPLETED|Concomitant Phase||3
7982753|NCT00229723|19655109|P5|NOT COMPLETED|Concomitant Phase||2
7982754|NCT00229723|19655110|P4|NOT COMPLETED|Concomitant Phase||5
7982755|NCT00229723|19655111|P3|NOT COMPLETED|Concomitant Phase||6
7982756|NCT00229723|19655112|P2|NOT COMPLETED|Concomitant Phase||5
7982757|NCT00229723|19655113|P1|NOT COMPLETED|Concomitant Phase||10
7982758|NCT00229723|19655107|P7|COMPLETED|Concomitant Phase||19
7982759|NCT00229723|19655108|P6|COMPLETED|Concomitant Phase||31
7982760|NCT00229723|19655109|P5|COMPLETED|Concomitant Phase||22
7982761|NCT00229723|19655110|P4|COMPLETED|Concomitant Phase||26
7982762|NCT00229723|19655111|P3|COMPLETED|Concomitant Phase||25
7982763|NCT00229723|19655112|P2|COMPLETED|Concomitant Phase||19
7982764|NCT00229723|19655113|P1|COMPLETED|Concomitant Phase||50
7982765|NCT00229723|19655107|P7|STARTED|Concomitant Phase|Received randomized treatment|22
7982766|NCT00229723|19655108|P6|STARTED|Concomitant Phase|Received randomized treatment|34
7982767|NCT00229723|19655109|P5|STARTED|Concomitant Phase|Received randomized treatment|24
7982768|NCT00229723|19655110|P4|STARTED|Concomitant Phase|Received randomized treatment|31
7982769|NCT00229723|19655111|P3|STARTED|Concomitant Phase|Received randomized treatment|31
7982770|NCT00229723|19655112|P2|STARTED|Concomitant Phase|Received randomized treatment|24
7982771|NCT00229723|19655113|P1|STARTED|Concomitant Phase|Received randomized treatment|60
7982772|NCT00229658|19655166|P2|NOT COMPLETED|Overall Study||167
7982773|NCT00229658|19655167|P1|NOT COMPLETED|Overall Study||225
7982774|NCT00229658|19655166|P2|COMPLETED|Overall Study||364
7982775|NCT00229658|19655167|P1|COMPLETED|Overall Study||541
7982776|NCT00229658|19655166|P2|STARTED|Overall Study||531
7982777|NCT00229658|19655167|P1|STARTED|Overall Study||766
7982778|NCT00229619|19655195|P1|NOT COMPLETED|Overall Study||0
7982779|NCT00229619|19655195|P1|COMPLETED|Overall Study||11
7982780|NCT00229619|19655195|P1|STARTED|Overall Study||11
7982781|NCT00229203|19655203|P2|NOT COMPLETED|Overall Study||19
7982782|NCT00229203|19655204|P1|NOT COMPLETED|Overall Study||32
7982783|NCT00229203|19655203|P2|COMPLETED|Overall Study||0
7982784|NCT00229203|19655204|P1|COMPLETED|Overall Study||0
7982785|NCT00229203|19655203|P2|STARTED|Overall Study||19
7982786|NCT00229203|19655204|P1|STARTED|Overall Study||32
7982787|NCT00228943|19655216|P1|NOT COMPLETED|Week 2||1
7982788|NCT00228943|19655216|P1|COMPLETED|Week 2||27
7982789|NCT00228943|19655216|P1|STARTED|Week 2||28
7982790|NCT00228943|19655216|P1|NOT COMPLETED|Week 1||0
7982791|NCT00228943|19655216|P1|COMPLETED|Week 1||28
7982792|NCT00228943|19655216|P1|STARTED|Week 1||28
7982793|NCT00228917|19655232|P8|NOT COMPLETED|Overall Study||0
7982794|NCT00228917|19655233|P7|NOT COMPLETED|Overall Study||0
7982795|NCT00228917|19655234|P6|NOT COMPLETED|Overall Study||2
7982796|NCT00228917|19655235|P5|NOT COMPLETED|Overall Study||0
7982797|NCT00228917|19655236|P4|NOT COMPLETED|Overall Study||0
7982798|NCT00228917|19655237|P3|NOT COMPLETED|Overall Study||0
7982799|NCT00228917|19655238|P2|NOT COMPLETED|Overall Study||0
7982800|NCT00228917|19655239|P1|NOT COMPLETED|Overall Study||0
7982801|NCT00228917|19655232|P8|COMPLETED|Overall Study||33
7982802|NCT00228917|19655233|P7|COMPLETED|Overall Study||69
7982803|NCT00228917|19655234|P6|COMPLETED|Overall Study||102
7982804|NCT00228917|19655235|P5|COMPLETED|Overall Study||205
7982805|NCT00228917|19655236|P4|COMPLETED|Overall Study||33
7982806|NCT00228917|19655237|P3|COMPLETED|Overall Study||65
7982807|NCT00228917|19655238|P2|COMPLETED|Overall Study||96
7982808|NCT00228917|19655239|P1|COMPLETED|Overall Study||193
7982809|NCT00228917|19655232|P8|STARTED|Overall Study||33
7982810|NCT00228917|19655233|P7|STARTED|Overall Study||69
7982811|NCT00228917|19655234|P6|STARTED|Overall Study||104
7982812|NCT00228917|19655235|P5|STARTED|Overall Study||205
7982813|NCT00228917|19655236|P4|STARTED|Overall Study||33
7982814|NCT00228917|19655237|P3|STARTED|Overall Study||65
7982815|NCT00228917|19655238|P2|STARTED|Overall Study||96
7982816|NCT00228917|19655239|P1|STARTED|Overall Study||193
7982817|NCT00228813|19655285|P1|NOT COMPLETED|Overall Study||4
7982818|NCT00228813|19655285|P1|COMPLETED|Overall Study||4
7982819|NCT00228813|19655285|P1|STARTED|Overall Study||8
7982820|NCT00228566|19655291|P1|NOT COMPLETED|Overall Study||71
7982821|NCT00228566|19655291|P1|COMPLETED|Overall Study||176
7982822|NCT00228566|19655291|P1|STARTED|Overall Study||247
7982823|NCT00228553|19655295|P1|NOT COMPLETED|Overall Study||430
7982824|NCT00228553|19655295|P1|COMPLETED|Overall Study||313
7982825|NCT00228553|19655295|P1|STARTED|Overall Study||743
7982826|NCT00228384|19655301|P2|NOT COMPLETED|Overall Study||29
7982827|NCT00228384|19655302|P1|NOT COMPLETED|Overall Study||29
7982828|NCT00228384|19655301|P2|COMPLETED|Overall Study||47
7982829|NCT00228384|19655302|P1|COMPLETED|Overall Study||43
7982830|NCT00228384|19655301|P2|Three Year Follow-up (Final)|Overall Study||47
7982831|NCT00228384|19655302|P1|Three Year Follow-up (Final)|Overall Study||43
7982832|NCT00228384|19655301|P2|30-Day Follow-up (Safety Outcome)|Overall Study||72
7982833|NCT00228384|19655302|P1|30-Day Follow-up (Safety Outcome)|Overall Study||69
7982834|NCT00228384|19655301|P2|Baseline|Overall Study||76
7982835|NCT00228384|19655302|P1|Baseline|Overall Study||72
7982836|NCT00228384|19655301|P2|STARTED|Overall Study||76
7982837|NCT00228384|19655302|P1|STARTED|Overall Study||72
7982838|NCT00227994|19655342|P2|NOT COMPLETED|Overall Study||7
7982839|NCT00227994|19655343|P1|NOT COMPLETED|Overall Study||7
7982840|NCT00227994|19655342|P2|COMPLETED|Overall Study||13
7982841|NCT00227994|19655343|P1|COMPLETED|Overall Study||13
7982842|NCT00227994|19655342|P2|STARTED|Overall Study||20
7982843|NCT00227994|19655343|P1|STARTED|Overall Study||20
7982844|NCT00227903|19655353|P2|NOT COMPLETED|Overall Study||10
7982845|NCT00227903|19655354|P1|NOT COMPLETED|Overall Study||5
7982846|NCT00227903|19655353|P2|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82
7982847|NCT00227903|19655354|P1|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86
7982848|NCT00227903|19655353|P2|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82
7982849|NCT00227903|19655354|P1|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86
7982850|NCT00227903|19655353|P2|STARTED|Overall Study||92
7982851|NCT00227903|19655354|P1|STARTED|Overall Study||91
7982852|NCT00227877|19655418|P4|NOT COMPLETED|12-months Follow-up||26
7982853|NCT00227877|19655419|P3|NOT COMPLETED|12-months Follow-up||31
7982854|NCT00227877|19655420|P2|NOT COMPLETED|12-months Follow-up||263
7982855|NCT00227877|19655421|P1|NOT COMPLETED|12-months Follow-up||310
7982856|NCT00227877|19655418|P4|COMPLETED|12-months Follow-up||266
7982857|NCT00227877|19655419|P3|COMPLETED|12-months Follow-up||266
7982858|NCT00227877|19655420|P2|COMPLETED|12-months Follow-up||765
7982859|NCT00227877|19655421|P1|COMPLETED|12-months Follow-up||758
7982860|NCT00227877|19655418|P4|STARTED|12-months Follow-up||292
7982861|NCT00227877|19655419|P3|STARTED|12-months Follow-up||297
7982862|NCT00227877|19655420|P2|STARTED|12-months Follow-up||1028
7982863|NCT00227877|19655421|P1|STARTED|12-months Follow-up||1068
7982864|NCT00227877|19655418|P4|NOT COMPLETED|3-months Follow-up||21
7982865|NCT00227877|19655419|P3|NOT COMPLETED|3-months Follow-up||52
7982866|NCT00227877|19655420|P2|NOT COMPLETED|3-months Follow-up||267
7982867|NCT00227877|19655421|P1|NOT COMPLETED|3-months Follow-up||313
7982868|NCT00227877|19655418|P4|COMPLETED|3-months Follow-up||271
7982869|NCT00227877|19655419|P3|COMPLETED|3-months Follow-up||245
7982870|NCT00227877|19655420|P2|COMPLETED|3-months Follow-up||761
7982871|NCT00227877|19655421|P1|COMPLETED|3-months Follow-up||755
7982872|NCT00227877|19655418|P4|STARTED|3-months Follow-up||292
7982873|NCT00227877|19655419|P3|STARTED|3-months Follow-up||297
7982874|NCT00227877|19655420|P2|STARTED|3-months Follow-up||1028
7982875|NCT00227877|19655421|P1|STARTED|3-months Follow-up||1068
7982876|NCT00227877|19655418|P4|NOT COMPLETED|Post-visit Checklist||0
7982877|NCT00227877|19655419|P3|NOT COMPLETED|Post-visit Checklist||1
7982878|NCT00227877|19655420|P2|NOT COMPLETED|Post-visit Checklist||13
7982879|NCT00227877|19655421|P1|NOT COMPLETED|Post-visit Checklist||24
7982880|NCT00227877|19655418|P4|COMPLETED|Post-visit Checklist||292
7982881|NCT00227877|19655419|P3|COMPLETED|Post-visit Checklist||296
7982882|NCT00227877|19655420|P2|COMPLETED|Post-visit Checklist||1015
7982883|NCT00227877|19655421|P1|COMPLETED|Post-visit Checklist||1044
7982884|NCT00227877|19655418|P4|STARTED|Post-visit Checklist||292
7982885|NCT00227877|19655419|P3|STARTED|Post-visit Checklist||297
7982886|NCT00227877|19655420|P2|STARTED|Post-visit Checklist||1028
7982887|NCT00227877|19655421|P1|STARTED|Post-visit Checklist||1068
7982888|NCT00227877|19655418|P4|NOT COMPLETED|Pre-visit Assessment||0
7982889|NCT00227877|19655419|P3|NOT COMPLETED|Pre-visit Assessment||0
7982890|NCT00227877|19655420|P2|NOT COMPLETED|Pre-visit Assessment||3
7982891|NCT00227877|19655421|P1|NOT COMPLETED|Pre-visit Assessment||7
7982892|NCT00227877|19655418|P4|COMPLETED|Pre-visit Assessment|Final analysis sample|292
7982893|NCT00227877|19655419|P3|COMPLETED|Pre-visit Assessment|Final analysis sample|297
7982894|NCT00227877|19655420|P2|COMPLETED|Pre-visit Assessment|Final analysis sample|1028
7982895|NCT00227877|19655421|P1|COMPLETED|Pre-visit Assessment|Final analysis sample|1068
7982896|NCT00227877|19655418|P4|STARTED|Pre-visit Assessment||292
7982897|NCT00227877|19655419|P3|STARTED|Pre-visit Assessment||297
7982898|NCT00227877|19655420|P2|STARTED|Pre-visit Assessment||1031
7982899|NCT00227877|19655421|P1|STARTED|Pre-visit Assessment||1075
7982900|NCT00227760|19655451|P1|NOT COMPLETED|Overall Study||0
7982901|NCT00227760|19655451|P1|COMPLETED|Overall Study||44
7982902|NCT00227760|19655451|P1|STARTED|Overall Study||44
7982903|NCT00227721|19655457|P1|NOT COMPLETED|Overall Study||1
7982904|NCT00227721|19655457|P1|COMPLETED|Overall Study||29
7982905|NCT00227721|19655457|P1|STARTED|Overall Study||30
7982906|NCT00227617|19655462|P3|NOT COMPLETED|Stage 2||0
7982907|NCT00227617|19655463|P2|NOT COMPLETED|Stage 2||0
7982908|NCT00227617|19655464|P1|NOT COMPLETED|Stage 2||0
7982909|NCT00227617|19655462|P3|COMPLETED|Stage 2||0
7982910|NCT00227617|19655463|P2|COMPLETED|Stage 2||0
7982911|NCT00227617|19655464|P1|COMPLETED|Stage 2||0
7982912|NCT00227617|19655462|P3|STARTED|Stage 2||0
7982913|NCT00227617|19655463|P2|STARTED|Stage 2||0
7982914|NCT00227617|19655464|P1|STARTED|Stage 2||0
7982915|NCT00227617|19655462|P3|NOT COMPLETED|Stage 1||0
7982916|NCT00227617|19655463|P2|NOT COMPLETED|Stage 1||0
7982917|NCT00227617|19655464|P1|NOT COMPLETED|Stage 1||0
7982918|NCT00227617|19655462|P3|COMPLETED|Stage 1||2
7982919|NCT00227617|19655463|P2|COMPLETED|Stage 1||12
7982920|NCT00227617|19655464|P1|COMPLETED|Stage 1||22
7982921|NCT00227617|19655462|P3|STARTED|Stage 1||2
7982922|NCT00227617|19655463|P2|STARTED|Stage 1||12
7982923|NCT00227617|19655464|P1|STARTED|Stage 1||22
7982924|NCT00227591|19655480|P1|NOT COMPLETED|Overall Study||1
7982925|NCT00227591|19655480|P1|COMPLETED|Overall Study||47
7982926|NCT00227591|19655480|P1|Began Treatment|Overall Study||47
7982927|NCT00227591|19655480|P1|STARTED|Overall Study|48 pts registered to the study|48
7982928|NCT00227539|19655484|P1|NOT COMPLETED|Overall Study||1
7982929|NCT00227539|19655484|P1|COMPLETED|Overall Study||24
7982930|NCT00227539|19655484|P1|STARTED|Overall Study||25
7982931|NCT00227370|19655492|P2|NOT COMPLETED|Overall Study||24
7982932|NCT00227370|19655493|P1|NOT COMPLETED|Overall Study||21
7982933|NCT00227370|19655492|P2|COMPLETED|Overall Study||46
7982934|NCT00227370|19655493|P1|COMPLETED|Overall Study||45
7982935|NCT00227370|19655492|P2|STARTED|Overall Study|Treatment Group|70
7982936|NCT00227370|19655493|P1|STARTED|Overall Study|Placebo Group|66
7982937|NCT00227344|19655513|P2|NOT COMPLETED|Overall Study||5
7982938|NCT00227344|19655514|P1|NOT COMPLETED|Overall Study||12
7982939|NCT00227344|19655513|P2|COMPLETED|Overall Study||37
7982940|NCT00227344|19655514|P1|COMPLETED|Overall Study||75
7982941|NCT00227344|19655513|P2|STARTED|Overall Study||42
7982942|NCT00227344|19655514|P1|STARTED|Overall Study||87
7982943|NCT00227305|19655534|P1|NOT COMPLETED|Overall Study||144
7982944|NCT00227305|19655534|P1|COMPLETED|Overall Study|Completed 26 weeks|237
7982945|NCT00227305|19655534|P1|Drug Received|Overall Study|safety population|380
7982946|NCT00227305|19655534|P1|STARTED|Overall Study|enrolled|381
7982947|NCT00227266|19655551|P3|NOT COMPLETED|Overall Study||4
7982948|NCT00227266|19655552|P2|NOT COMPLETED|Overall Study||0
7982949|NCT00227266|19655553|P1|NOT COMPLETED|Overall Study||1
7982950|NCT00227266|19655551|P3|COMPLETED|Overall Study||29
7982951|NCT00227266|19655552|P2|COMPLETED|Overall Study||30
7982952|NCT00227266|19655553|P1|COMPLETED|Overall Study||30
7982953|NCT00227266|19655551|P3|STARTED|Overall Study||33
7982954|NCT00227266|19655552|P2|STARTED|Overall Study||30
7982955|NCT00227266|19655553|P1|STARTED|Overall Study||31
7982956|NCT00227019|19655573|P1|NOT COMPLETED|Overall Study||0
7982957|NCT00227019|19655573|P1|COMPLETED|Overall Study||16
7982958|NCT00227019|19655573|P1|STARTED|Overall Study||16
7982959|NCT00226941|19655583|P4|NOT COMPLETED|Overall Study||2
7982960|NCT00226941|19655584|P3|NOT COMPLETED|Overall Study||0
7982961|NCT00226941|19655585|P2|NOT COMPLETED|Overall Study||0
7982962|NCT00226941|19655586|P1|NOT COMPLETED|Overall Study||0
7982963|NCT00226941|19655583|P4|COMPLETED|Overall Study||5
7982964|NCT00226941|19655584|P3|COMPLETED|Overall Study||4
7982965|NCT00226941|19655585|P2|COMPLETED|Overall Study||6
7982966|NCT00226941|19655586|P1|COMPLETED|Overall Study||6
7982967|NCT00226941|19655583|P4|STARTED|Overall Study||7
7982968|NCT00226941|19655584|P3|STARTED|Overall Study||4
7982969|NCT00226941|19655585|P2|STARTED|Overall Study||6
7982970|NCT00226941|19655586|P1|STARTED|Overall Study||6
7982971|NCT00226811|19655620|P1|NOT COMPLETED|Overall Study||76
7982972|NCT00226811|19655620|P1|COMPLETED|Overall Study||2
7982973|NCT00226811|19655620|P1|STARTED|Overall Study||78
7982974|NCT00226655|19655630|P1|NOT COMPLETED|Overall Study||79
7982975|NCT00226655|19655630|P1|COMPLETED|Overall Study||33
7982976|NCT00226655|19655630|P1|STARTED|Overall Study||112
7982977|NCT00226590|19655634|P1|NOT COMPLETED|Overall Study||0
7982978|NCT00226590|19655634|P1|COMPLETED|Overall Study||39
7982979|NCT00226590|19655634|P1|STARTED|Overall Study||39
7982980|NCT00226577|19655641|P1|NOT COMPLETED|Overall Study||0
7982981|NCT00226577|19655641|P1|COMPLETED|Overall Study||52
7982982|NCT00226577|19655641|P1|STARTED|Overall Study||52
7982983|NCT00226499|19655652|P3|NOT COMPLETED|Overall Study||359
7982984|NCT00226499|19655653|P2|NOT COMPLETED|Overall Study||1072
7982985|NCT00226499|19655654|P1|NOT COMPLETED|Overall Study||1074
7982986|NCT00226499|19655652|P3|COMPLETED|Overall Study||468
7982987|NCT00226499|19655653|P2|COMPLETED|Overall Study||1415
7982988|NCT00226499|19655654|P1|COMPLETED|Overall Study||1415
7982989|NCT00226499|19655652|P3|STARTED|Overall Study||827
7982990|NCT00226499|19655653|P2|STARTED|Overall Study||2487
7982991|NCT00226499|19655654|P1|STARTED|Overall Study||2489
7982992|NCT00226239|19655769|P1|NOT COMPLETED|Maintenance Cetuximab||14
7982993|NCT00226239|19655769|P1|COMPLETED|Maintenance Cetuximab||17
7982994|NCT00226239|19655769|P1|STARTED|Maintenance Cetuximab||31
7982995|NCT00226239|19655769|P1|NOT COMPLETED|XPE, Definitive Therapy||4
7982996|NCT00226239|19655769|P1|COMPLETED|XPE, Definitive Therapy||33
7982997|NCT00226239|19655769|P1|STARTED|XPE, Definitive Therapy||37
7982998|NCT00226239|19655769|P1|NOT COMPLETED|TPE, Induction Therapy||2
7982999|NCT00226239|19655769|P1|COMPLETED|TPE, Induction Therapy||37
7983000|NCT00226239|19655769|P1|STARTED|TPE, Induction Therapy||39
7983001|NCT00225784|19655778|P1|NOT COMPLETED|Overall Study||4
7983002|NCT00225784|19655778|P1|COMPLETED|Overall Study||33
7983003|NCT00225784|19655778|P1|STARTED|Overall Study||37
7983004|NCT00225758|19655789|P1|NOT COMPLETED|Overall Study||4
7983005|NCT00225758|19655789|P1|COMPLETED|Overall Study||23
7983006|NCT00225758|19655789|P1|STARTED|Overall Study||27
7983007|NCT00225732|19655799|P2|NOT COMPLETED|Overall Study||0
7983008|NCT00225732|19655800|P1|NOT COMPLETED|Overall Study||0
7983009|NCT00225732|19655799|P2|COMPLETED|Overall Study||166
7983010|NCT00225732|19655800|P1|COMPLETED|Overall Study||153
7983011|NCT00225732|19655799|P2|STARTED|Overall Study||166
7983012|NCT00225732|19655800|P1|STARTED|Overall Study||153
7983013|NCT00225498|19655806|P1|NOT COMPLETED|Overall Study||0
7983014|NCT00225498|19655806|P1|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10
7983015|NCT00225498|19655806|P1|STARTED|Overall Study||10
7983016|NCT00225420|19655810|P3|NOT COMPLETED|Overall Study||0
7983017|NCT00225420|19655811|P2|NOT COMPLETED|Overall Study||0
7983018|NCT00225420|19655812|P1|NOT COMPLETED|Overall Study||0
7983019|NCT00225420|19655810|P3|COMPLETED|Overall Study||3
7983020|NCT00225420|19655811|P2|COMPLETED|Overall Study||6
7983021|NCT00225420|19655812|P1|COMPLETED|Overall Study||9
7983022|NCT00225420|19655810|P3|STARTED|Overall Study||3
7983023|NCT00225420|19655811|P2|STARTED|Overall Study||6
7983024|NCT00225420|19655812|P1|STARTED|Overall Study||9
7983025|NCT00225277|19655821|P2|NOT COMPLETED|Overall Study||95
7983026|NCT00225277|19655822|P1|NOT COMPLETED|Overall Study||97
7983027|NCT00225277|19655821|P2|COMPLETED|Overall Study||178
7983028|NCT00225277|19655822|P1|COMPLETED|Overall Study||177
7983029|NCT00225277|19655821|P2|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273
7983030|NCT00225277|19655822|P1|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274
7983031|NCT00225251|19655840|P2|NOT COMPLETED|Overall Study||1
7983032|NCT00225251|19655841|P1|NOT COMPLETED|Overall Study||1
7983033|NCT00225251|19655840|P2|COMPLETED|Overall Study||6
7983034|NCT00225251|19655841|P1|COMPLETED|Overall Study||10
7983035|NCT00225251|19655840|P2|STARTED|Overall Study||7
7983036|NCT00225251|19655841|P1|STARTED|Overall Study||11
7983037|NCT00225212|19655855|P1|NOT COMPLETED|Overall Study||6
7983038|NCT00225212|19655855|P1|COMPLETED|Overall Study||29
7983039|NCT00225212|19655855|P1|STARTED|Overall Study||35
7983040|NCT00225147|19655864|P4|NOT COMPLETED|Open-label Phase||10
7983041|NCT00225147|19655865|P3|NOT COMPLETED|Open-label Phase||0
7983042|NCT00225147|19655866|P2|NOT COMPLETED|Open-label Phase||0
7983043|NCT00225147|19655867|P1|NOT COMPLETED|Open-label Phase||0
7983044|NCT00225147|19655864|P4|COMPLETED|Open-label Phase||52
7983045|NCT00225147|19655865|P3|COMPLETED|Open-label Phase||0
7983046|NCT00225147|19655866|P2|COMPLETED|Open-label Phase||0
7983047|NCT00225147|19655867|P1|COMPLETED|Open-label Phase||0
7983048|NCT00225147|19655864|P4|STARTED|Open-label Phase||62
7983049|NCT00225147|19655865|P3|STARTED|Open-label Phase||0
7983050|NCT00225147|19655866|P2|STARTED|Open-label Phase||0
7983051|NCT00225147|19655867|P1|STARTED|Open-label Phase||0
7983052|NCT00225147|19655864|P4|NOT COMPLETED|Double-blind Phase||0
7983053|NCT00225147|19655865|P3|NOT COMPLETED|Double-blind Phase||0
7983054|NCT00225147|19655866|P2|NOT COMPLETED|Double-blind Phase||0
7983055|NCT00225147|19655867|P1|NOT COMPLETED|Double-blind Phase||0
7983056|NCT00225147|19655864|P4|COMPLETED|Double-blind Phase||0
7983057|NCT00225147|19655865|P3|COMPLETED|Double-blind Phase||13
7983058|NCT00225147|19655866|P2|COMPLETED|Double-blind Phase||12
7983059|NCT00225147|19655867|P1|COMPLETED|Double-blind Phase||13
7983060|NCT00225147|19655864|P4|STARTED|Double-blind Phase||0
7983061|NCT00225147|19655865|P3|STARTED|Double-blind Phase||13
7983062|NCT00225147|19655866|P2|STARTED|Double-blind Phase||12
7983063|NCT00225147|19655867|P1|STARTED|Double-blind Phase||13
7983064|NCT00225017|19655883|P2|NOT COMPLETED|Overall Study||1
7983065|NCT00225017|19655884|P1|NOT COMPLETED|Overall Study||0
7983066|NCT00225017|19655883|P2|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23
7983067|NCT00225017|19655884|P1|COMPLETED|Overall Study||26
7983068|NCT00225017|19655883|P2|STARTED|Overall Study||24
7983069|NCT00225017|19655884|P1|STARTED|Overall Study||26
7983070|NCT00224952|19655897|P3|NOT COMPLETED|Overall Study||0
7983071|NCT00224952|19655898|P2|NOT COMPLETED|Overall Study||0
7983072|NCT00224952|19655899|P1|NOT COMPLETED|Overall Study||0
7983073|NCT00224952|19655897|P3|COMPLETED|Overall Study||134
7983074|NCT00224952|19655898|P2|COMPLETED|Overall Study||87
7983075|NCT00224952|19655899|P1|COMPLETED|Overall Study||53
7983076|NCT00224952|19655897|P3|STARTED|Overall Study||134
7983077|NCT00224952|19655898|P2|STARTED|Overall Study||87
7983078|NCT00224952|19655899|P1|STARTED|Overall Study||53
7983079|NCT00224874|19655914|P4|NOT COMPLETED|Overall Study||0
7983080|NCT00224874|19655915|P3|NOT COMPLETED|Overall Study||1
7983081|NCT00224874|19655916|P2|NOT COMPLETED|Overall Study||0
7983082|NCT00224874|19655917|P1|NOT COMPLETED|Overall Study||0
7983083|NCT00224874|19655914|P4|COMPLETED|Overall Study||42
7983084|NCT00224874|19655915|P3|COMPLETED|Overall Study||46
7983085|NCT00224874|19655916|P2|COMPLETED|Overall Study||45
7983086|NCT00224874|19655917|P1|COMPLETED|Overall Study||46
7983087|NCT00224874|19655914|P4|STARTED|Overall Study||42
7983088|NCT00224874|19655915|P3|STARTED|Overall Study||47
7983089|NCT00224874|19655916|P2|STARTED|Overall Study||45
7983090|NCT00224874|19655917|P1|STARTED|Overall Study||46
7983091|NCT00224770|19655962|P3|NOT COMPLETED|Overall Study||0
7983092|NCT00224770|19655963|P2|NOT COMPLETED|Overall Study||2
7983093|NCT00224770|19655964|P1|NOT COMPLETED|Overall Study||4
7983094|NCT00224770|19655962|P3|COMPLETED|Overall Study||14
7983095|NCT00224770|19655963|P2|COMPLETED|Overall Study||52
7983096|NCT00224770|19655964|P1|COMPLETED|Overall Study||38
7983097|NCT00224770|19655962|P3|STARTED|Overall Study||14
7983098|NCT00224770|19655963|P2|STARTED|Overall Study||54
7983099|NCT00224770|19655964|P1|STARTED|Overall Study||42
7983100|NCT00224484|19655999|P3|NOT COMPLETED|Overall Study||62
7983101|NCT00224484|19656000|P2|NOT COMPLETED|Overall Study||65
7983102|NCT00224484|19656001|P1|NOT COMPLETED|Overall Study||146
7983103|NCT00224484|19655999|P3|COMPLETED|Overall Study||1425
7983104|NCT00224484|19656000|P2|COMPLETED|Overall Study||1426
7983105|NCT00224484|19656001|P1|COMPLETED|Overall Study||2831
7983106|NCT00224484|19655999|P3|STARTED|Overall Study||1487
7983107|NCT00224484|19656000|P2|STARTED|Overall Study||1491
7983108|NCT00224484|19656001|P1|STARTED|Overall Study||2977
7983109|NCT00224289|19656060|P1|NOT COMPLETED|Overall Study||0
7983110|NCT00224289|19656060|P1|COMPLETED|Overall Study||17
7983111|NCT00224289|19656060|P1|STARTED|Overall Study||17
7983112|NCT00224133|19656065|P1|NOT COMPLETED|Overall Study||226
7983113|NCT00224133|19656065|P1|COMPLETED|Overall Study||435
7983114|NCT00224133|19656065|P1|STARTED|Overall Study||661
7983115|NCT00224120|19656071|P2|NOT COMPLETED|Overall Study||24
7983116|NCT00224120|19656072|P1|NOT COMPLETED|Overall Study||22
7983117|NCT00224120|19656071|P2|COMPLETED|Overall Study||205
7983118|NCT00224120|19656072|P1|COMPLETED|Overall Study||211
7983119|NCT00224120|19656071|P2|STARTED|Overall Study||229
7983120|NCT00224120|19656072|P1|STARTED|Overall Study||233
7983121|NCT00224107|19656082|P2|NOT COMPLETED|Overall Study||14
7983122|NCT00224107|19656083|P1|NOT COMPLETED|Overall Study||31
7983123|NCT00224107|19656082|P2|COMPLETED|Overall Study||214
7983124|NCT00224107|19656083|P1|COMPLETED|Overall Study||202
7983125|NCT00224107|19656082|P2|STARTED|Overall Study||228
7983126|NCT00224107|19656083|P1|STARTED|Overall Study||233
7983127|NCT00224055|19656093|P2|NOT COMPLETED|Overall Study||14
7983128|NCT00224055|19656094|P1|NOT COMPLETED|Overall Study||15
7983129|NCT00224055|19656093|P2|COMPLETED|Overall Study||31
7983130|NCT00224055|19656094|P1|COMPLETED|Overall Study||29
7983131|NCT00224055|19656093|P2|STARTED|Overall Study||45
7983132|NCT00224055|19656094|P1|STARTED|Overall Study||44
7983133|NCT00224042|19656104|P2|NOT COMPLETED|Overall Study||6
7983134|NCT00224042|19656105|P1|NOT COMPLETED|Overall Study||6
7983135|NCT00224042|19656104|P2|COMPLETED|Overall Study||20
7983136|NCT00224042|19656105|P1|COMPLETED|Overall Study||20
7983137|NCT00224042|19656104|P2|STARTED|Overall Study||26
7983138|NCT00224042|19656105|P1|STARTED|Overall Study||26
7983139|NCT00224029|19656117|P1|NOT COMPLETED|Overall Study||6
7983140|NCT00224029|19656117|P1|COMPLETED|Overall Study||18
7983141|NCT00224029|19656117|P1|STARTED|Overall Study||24
7983142|NCT00224016|19656123|P2|NOT COMPLETED|Follow-Up Period||0
7983143|NCT00224016|19656124|P1|NOT COMPLETED|Follow-Up Period||0
7983144|NCT00224016|19656123|P2|COMPLETED|Follow-Up Period||0
7983145|NCT00224016|19656124|P1|COMPLETED|Follow-Up Period||35
7983146|NCT00224016|19656123|P2|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0
7983147|NCT00224016|19656124|P1|STARTED|Follow-Up Period||35
7983148|NCT00224016|19656123|P2|NOT COMPLETED|Maintenance Period||1
7983149|NCT00224016|19656124|P1|NOT COMPLETED|Maintenance Period||2
7983150|NCT00224016|19656123|P2|COMPLETED|Maintenance Period||14
7983151|NCT00224016|19656124|P1|COMPLETED|Maintenance Period||36
7983152|NCT00224016|19656123|P2|STARTED|Maintenance Period||15
7983153|NCT00224016|19656124|P1|STARTED|Maintenance Period||38
7983154|NCT00224016|19656123|P2|NOT COMPLETED|Titration Period||1
7983155|NCT00224016|19656124|P1|NOT COMPLETED|Titration Period||1
7983156|NCT00224016|19656123|P2|COMPLETED|Titration Period||15
7983157|NCT00224016|19656124|P1|COMPLETED|Titration Period||38
7983158|NCT00224016|19656123|P2|STARTED|Titration Period||16
7983159|NCT00224016|19656124|P1|STARTED|Titration Period||39
7983160|NCT00224003|19656132|P1|NOT COMPLETED|Overall Study||7
7983161|NCT00224003|19656132|P1|COMPLETED|Overall Study|Last patient out: March 31, 2004|16
7983162|NCT00224003|19656132|P1|STARTED|Overall Study|First patient in: April 2, 2003|23
7983163|NCT00223990|19656138|P2|NOT COMPLETED|Overall Study||9
7983164|NCT00223990|19656139|P1|NOT COMPLETED|Overall Study||7
7983165|NCT00223990|19656138|P2|COMPLETED|Overall Study||191
7983166|NCT00223990|19656139|P1|COMPLETED|Overall Study||193
7983167|NCT00223990|19656138|P2|STARTED|Overall Study||200
7983168|NCT00223990|19656139|P1|STARTED|Overall Study||200
7983169|NCT00223977|19656164|P3|NOT COMPLETED|Overall Study||3
7983170|NCT00223977|19656165|P2|NOT COMPLETED|Overall Study||11
7983171|NCT00223977|19656166|P1|NOT COMPLETED|Overall Study||9
7983172|NCT00223977|19656164|P3|COMPLETED|Overall Study||39
7983173|NCT00223977|19656165|P2|COMPLETED|Overall Study||47
7983174|NCT00223977|19656166|P1|COMPLETED|Overall Study||37
7983175|NCT00223977|19656164|P3|STARTED|Overall Study||42
7983176|NCT00223977|19656165|P2|STARTED|Overall Study||58
7983177|NCT00223977|19656166|P1|STARTED|Overall Study||46
7983178|NCT00223821|19656188|P2|NOT COMPLETED|Overall Study||10
7983179|NCT00223821|19656189|P1|NOT COMPLETED|Overall Study||4
7983180|NCT00223821|19656188|P2|COMPLETED|Overall Study||22
7983181|NCT00223821|19656189|P1|COMPLETED|Overall Study||28
7983182|NCT00223821|19656188|P2|Completed 6-month Follow-up|Overall Study||25
7983183|NCT00223821|19656189|P1|Completed 6-month Follow-up|Overall Study||28
7983184|NCT00223821|19656188|P2|Completed Post-treatment Assessment|Overall Study||27
7983185|NCT00223821|19656189|P1|Completed Post-treatment Assessment|Overall Study||31
7983186|NCT00223821|19656188|P2|Completed Therapy|Overall Study||28
7983187|NCT00223821|19656189|P1|Completed Therapy|Overall Study||31
7983188|NCT00223821|19656188|P2|STARTED|Overall Study||32
7983189|NCT00223821|19656189|P1|STARTED|Overall Study||32
7983190|NCT00223808|19656200|P3|NOT COMPLETED|Overall Study||5
7983191|NCT00223808|19656201|P2|NOT COMPLETED|Overall Study||5
7983192|NCT00223808|19656202|P1|NOT COMPLETED|Overall Study||3
7983193|NCT00223808|19656200|P3|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18
7983194|NCT00223808|19656201|P2|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17
7983195|NCT00223808|19656202|P1|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19
7983196|NCT00223808|19656200|P3|STARTED|Overall Study||23
7983197|NCT00223808|19656201|P2|STARTED|Overall Study||22
7983198|NCT00223808|19656202|P1|STARTED|Overall Study||22
7983199|NCT00223795|19656219|P2|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
7983200|NCT00223795|19656220|P1|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
7983201|NCT00223795|19656219|P2|COMPLETED|Second Intervention - All Use Canes 4 mo||17
7983202|NCT00223795|19656220|P1|COMPLETED|Second Intervention - All Use Canes 4 mo||18
7983203|NCT00223795|19656219|P2|STARTED|Second Intervention - All Use Canes 4 mo||18
7983204|NCT00223795|19656220|P1|STARTED|Second Intervention - All Use Canes 4 mo||19
7983205|NCT00223795|19656219|P2|NOT COMPLETED|First Intervention - Eight Weeks||9
7983206|NCT00223795|19656220|P1|NOT COMPLETED|First Intervention - Eight Weeks||7
7983207|NCT00223795|19656219|P2|COMPLETED|First Intervention - Eight Weeks||18
7983208|NCT00223795|19656220|P1|COMPLETED|First Intervention - Eight Weeks||19
7983209|NCT00223795|19656219|P2|STARTED|First Intervention - Eight Weeks||27
7983210|NCT00223795|19656220|P1|STARTED|First Intervention - Eight Weeks||26
7983211|NCT00223704|19656230|P3|NOT COMPLETED|Overall Study||0
7983212|NCT00223704|19656231|P2|NOT COMPLETED|Overall Study||0
7983213|NCT00223704|19656232|P1|NOT COMPLETED|Overall Study||0
7983214|NCT00223704|19656230|P3|COMPLETED|Overall Study||40
7983215|NCT00223704|19656231|P2|COMPLETED|Overall Study||37
7983216|NCT00223704|19656232|P1|COMPLETED|Overall Study||38
7983217|NCT00223704|19656230|P3|STARTED|Overall Study||40
7983218|NCT00223704|19656231|P2|STARTED|Overall Study||37
7983219|NCT00223704|19656232|P1|STARTED|Overall Study||38
7983220|NCT00223678|19656254|P2|NOT COMPLETED|Overall Study||0
7983221|NCT00223678|19656255|P1|NOT COMPLETED|Overall Study||0
7983222|NCT00223678|19656254|P2|COMPLETED|Overall Study||7
7983223|NCT00223678|19656255|P1|COMPLETED|Overall Study||13
7983224|NCT00223678|19656254|P2|STARTED|Overall Study||7
7983225|NCT00223678|19656255|P1|STARTED|Overall Study||13
7983226|NCT00223665|19656261|P1|NOT COMPLETED|Overall Study||0
7983227|NCT00223665|19656261|P1|COMPLETED|Overall Study||102
7983228|NCT00223665|19656261|P1|STARTED|Overall Study||102
7983229|NCT00223652|19656281|P2|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4
7983230|NCT00223652|19656282|P1|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1
7983231|NCT00223652|19656281|P2|COMPLETED|T-CBT and TAU 6 Month Follow-up||37
7983232|NCT00223652|19656282|P1|COMPLETED|T-CBT and TAU 6 Month Follow-up||39
7983233|NCT00223652|19656281|P2|STARTED|T-CBT and TAU 6 Month Follow-up||41
7983234|NCT00223652|19656282|P1|STARTED|T-CBT and TAU 6 Month Follow-up||40
7983235|NCT00223652|19656281|P2|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
7983236|NCT00223652|19656282|P1|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
7983237|NCT00223652|19656281|P2|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41
7983238|NCT00223652|19656282|P1|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40
7983239|NCT00223652|19656281|P2|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41
7983240|NCT00223652|19656282|P1|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40
7983241|NCT00223652|19656281|P2|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3
7983242|NCT00223652|19656282|P1|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1
7983243|NCT00223652|19656281|P2|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41
7983244|NCT00223652|19656282|P1|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40
7983245|NCT00223652|19656281|P2|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44
7983246|NCT00223652|19656282|P1|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41
7983247|NCT00223496|19656298|P1|NOT COMPLETED|Overall Study||22
7983248|NCT00223496|19656298|P1|COMPLETED|Overall Study||10
7983249|NCT00223496|19656298|P1|STARTED|Overall Study|32 people consented, 19 were baselined|32
7983250|NCT00223262|19656304|P2|NOT COMPLETED|Overall Study||1
7983251|NCT00223262|19656305|P1|NOT COMPLETED|Overall Study||8
7983252|NCT00223262|19656304|P2|COMPLETED|Overall Study||11
7983253|NCT00223262|19656305|P1|COMPLETED|Overall Study||8
7983254|NCT00223262|19656304|P2|STARTED|Overall Study||12
7983255|NCT00223262|19656305|P1|STARTED|Overall Study||16
7983256|NCT00223236|19656313|P2|NOT COMPLETED|Overall Study||14
7983257|NCT00223236|19656314|P1|NOT COMPLETED|Overall Study||7
7983258|NCT00223236|19656313|P2|COMPLETED|Overall Study|4 completed 12 week trial.|4
7983259|NCT00223236|19656314|P1|COMPLETED|Overall Study|9 completed 12 week trial.|9
7983260|NCT00223236|19656313|P2|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18
7983261|NCT00223236|19656314|P1|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16
7983262|NCT00223080|19656328|P2|NOT COMPLETED|Overall Study||797
7983263|NCT00223080|19656329|P1|NOT COMPLETED|Overall Study||796
7983264|NCT00223080|19656328|P2|COMPLETED|Overall Study||7401
7983265|NCT00223080|19656329|P1|COMPLETED|Overall Study||7401
7983266|NCT00223080|19656328|P2|STARTED|Overall Study||8198
7983267|NCT00223080|19656329|P1|STARTED|Overall Study||8197
7983268|NCT00222729|19656347|P1|NOT COMPLETED|Overall Study||3
7983269|NCT00222729|19656347|P1|COMPLETED|Overall Study||37
7983270|NCT00222729|19656347|P1|STARTED|Overall Study||40
7983271|NCT00222131|19656356|P2|NOT COMPLETED|Overall Study||0
7983272|NCT00222131|19656357|P1|NOT COMPLETED|Overall Study||0
7983273|NCT00222131|19656356|P2|COMPLETED|Overall Study||35
7983274|NCT00222131|19656357|P1|COMPLETED|Overall Study||38
7983275|NCT00222131|19656356|P2|STARTED|Overall Study||35
7983276|NCT00222131|19656357|P1|STARTED|Overall Study||38
7983277|NCT00222105|19656365|P1|NOT COMPLETED|Overall Study||14
7983278|NCT00222105|19656365|P1|COMPLETED|Overall Study||11
7983279|NCT00222105|19656365|P1|STARTED|Overall Study||25
7983280|NCT00221403|19656373|P3|NOT COMPLETED|Overall Study||0
7983281|NCT00221403|19656374|P2|NOT COMPLETED|Overall Study||5
7983282|NCT00221403|19656375|P1|NOT COMPLETED|Overall Study||2
7983283|NCT00221403|19656373|P3|COMPLETED|Overall Study||7
7983284|NCT00221403|19656374|P2|COMPLETED|Overall Study||16
7983285|NCT00221403|19656375|P1|COMPLETED|Overall Study||16
7983286|NCT00221403|19656373|P3|STARTED|Overall Study||7
7983287|NCT00221403|19656374|P2|STARTED|Overall Study||21
7983288|NCT00221403|19656375|P1|STARTED|Overall Study||18
7983289|NCT00221338|19656385|P2|NOT COMPLETED|Overall Study||29
7983290|NCT00221338|19656386|P1|NOT COMPLETED|Overall Study||24
7983291|NCT00221338|19656385|P2|COMPLETED|Overall Study||347
7983292|NCT00221338|19656386|P1|COMPLETED|Overall Study||350
7983293|NCT00221338|19656385|P2|STARTED|Overall Study||376
7983294|NCT00221338|19656386|P1|STARTED|Overall Study||374
7983295|NCT00221299|19656405|P4|NOT COMPLETED|Overall Study||1
7983296|NCT00221299|19656406|P3|NOT COMPLETED|Overall Study||0
7983297|NCT00221299|19656407|P2|NOT COMPLETED|Overall Study||2
7983298|NCT00221299|19656408|P1|NOT COMPLETED|Overall Study||1
7983299|NCT00221299|19656405|P4|COMPLETED|Overall Study||10
7983300|NCT00221299|19656406|P3|COMPLETED|Overall Study||14
7983301|NCT00221299|19656407|P2|COMPLETED|Overall Study||11
7983302|NCT00221299|19656408|P1|COMPLETED|Overall Study||10
7983303|NCT00221299|19656405|P4|STARTED|Overall Study||11
7983304|NCT00221299|19656406|P3|STARTED|Overall Study||14
7983305|NCT00221299|19656407|P2|STARTED|Overall Study||13
7983306|NCT00221299|19656408|P1|STARTED|Overall Study||11
7983307|NCT00221195|19656418|P2|NOT COMPLETED|Therapy 2 (Months 10-15)||0
7983308|NCT00221195|19656419|P1|NOT COMPLETED|Therapy 2 (Months 10-15)||2
7983309|NCT00221195|19656418|P2|COMPLETED|Therapy 2 (Months 10-15)||14
7983310|NCT00221195|19656419|P1|COMPLETED|Therapy 2 (Months 10-15)||12
7983311|NCT00221195|19656418|P2|STARTED|Therapy 2 (Months 10-15)||14
7983312|NCT00221195|19656419|P1|STARTED|Therapy 2 (Months 10-15)||14
7983313|NCT00221195|19656418|P2|NOT COMPLETED|Washout Period (Months 7-9)||1
7983314|NCT00221195|19656419|P1|NOT COMPLETED|Washout Period (Months 7-9)||0
7983315|NCT00221195|19656418|P2|COMPLETED|Washout Period (Months 7-9)||14
7983316|NCT00221195|19656419|P1|COMPLETED|Washout Period (Months 7-9)||14
7983317|NCT00221195|19656418|P2|STARTED|Washout Period (Months 7-9)||15
7983318|NCT00221195|19656419|P1|STARTED|Washout Period (Months 7-9)||14
7983319|NCT00221195|19656418|P2|NOT COMPLETED|Therapy 1 (Months 1-6)||2
7983320|NCT00221195|19656419|P1|NOT COMPLETED|Therapy 1 (Months 1-6)||3
7983321|NCT00221195|19656418|P2|COMPLETED|Therapy 1 (Months 1-6)||15
7983322|NCT00221195|19656419|P1|COMPLETED|Therapy 1 (Months 1-6)||14
7983323|NCT00221195|19656418|P2|STARTED|Therapy 1 (Months 1-6)||17
7983324|NCT00221195|19656419|P1|STARTED|Therapy 1 (Months 1-6)||17
7983325|NCT00221117|19656428|P2|NOT COMPLETED|Overall Study||0
7983326|NCT00221117|19656429|P1|NOT COMPLETED|Overall Study||0
7983327|NCT00221117|19656428|P2|COMPLETED|Overall Study||9
7983328|NCT00221117|19656429|P1|COMPLETED|Overall Study||12
7983329|NCT00221117|19656428|P2|STARTED|Overall Study|One participant dropped out of the study after signing consent but prior to baseline assessments.|9
7983330|NCT00221117|19656429|P1|STARTED|Overall Study||12
7983331|NCT00221104|19656441|P2|NOT COMPLETED|Overall Study||76
7983332|NCT00221104|19656442|P1|NOT COMPLETED|Overall Study||83
7983333|NCT00221104|19656441|P2|COMPLETED|Overall Study||709
7983334|NCT00221104|19656442|P1|COMPLETED|Overall Study||710
7983335|NCT00221104|19656441|P2|STARTED|Overall Study||785
7983336|NCT00221104|19656442|P1|STARTED|Overall Study||793
7983337|NCT00220961|19656458|P2|NOT COMPLETED|Overall Study||90
7983338|NCT00220961|19656459|P1|NOT COMPLETED|Overall Study||71
7983339|NCT00220961|19656458|P2|COMPLETED|Overall Study||213
7983340|NCT00220961|19656459|P1|COMPLETED|Overall Study||228
7983341|NCT00220961|19656458|P2|STARTED|Overall Study||303
7983342|NCT00220961|19656459|P1|STARTED|Overall Study||299
7983343|NCT00220805|19656475|P2|NOT COMPLETED|Overall Study||11
7983344|NCT00220805|19656476|P1|NOT COMPLETED|Overall Study||8
7983345|NCT00220805|19656475|P2|COMPLETED|Overall Study||16
7983346|NCT00220805|19656476|P1|COMPLETED|Overall Study||22
7983347|NCT00220805|19656475|P2|STARTED|Overall Study||27
7983348|NCT00220805|19656476|P1|STARTED|Overall Study||30
7983349|NCT00220779|19656497|P3|NOT COMPLETED|Overall Study||4
7983350|NCT00220779|19656498|P2|NOT COMPLETED|Overall Study||4
7983351|NCT00220779|19656499|P1|NOT COMPLETED|Overall Study||7
7983352|NCT00220779|19656497|P3|COMPLETED|Overall Study||37
7983353|NCT00220779|19656498|P2|COMPLETED|Overall Study||38
7983354|NCT00220779|19656499|P1|COMPLETED|Overall Study||38
7983355|NCT00220779|19656497|P3|STARTED|Overall Study||41
7983356|NCT00220779|19656498|P2|STARTED|Overall Study||42
7983357|NCT00220779|19656499|P1|STARTED|Overall Study||45
7983358|NCT00220740|19656509|P2|NOT COMPLETED|Withdrawal Period||15
7983359|NCT00220740|19656510|P1|NOT COMPLETED|Withdrawal Period||6
7983360|NCT00220740|19656509|P2|COMPLETED|Withdrawal Period||16
7983361|NCT00220740|19656510|P1|COMPLETED|Withdrawal Period||37
7983362|NCT00220740|19656509|P2|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31
7983363|NCT00220740|19656510|P1|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43
7983364|NCT00220740|19656509|P2|NOT COMPLETED|Rescue Treatment||18
7983365|NCT00220740|19656510|P1|NOT COMPLETED|Rescue Treatment||19
7983366|NCT00220740|19656509|P2|COMPLETED|Rescue Treatment||5
7983367|NCT00220740|19656510|P1|COMPLETED|Rescue Treatment||26
7983368|NCT00220740|19656509|P2|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23
7983369|NCT00220740|19656510|P1|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45
7983370|NCT00220740|19656509|P2|NOT COMPLETED|Efficacy Period||46
7983371|NCT00220740|19656510|P1|NOT COMPLETED|Efficacy Period||26
7983372|NCT00220740|19656509|P2|COMPLETED|Efficacy Period||12
7983373|NCT00220740|19656510|P1|COMPLETED|Efficacy Period||33
7983374|NCT00220740|19656509|P2|STARTED|Efficacy Period||58
7983375|NCT00220740|19656510|P1|STARTED|Efficacy Period||59
7983376|NCT00220727|19656524|P2|NOT COMPLETED|Second Infusion (Week <6)||0
7983377|NCT00220727|19656525|P1|NOT COMPLETED|Second Infusion (Week <6)||1
7983378|NCT00220727|19656524|P2|COMPLETED|Second Infusion (Week <6)||4
7983379|NCT00220727|19656525|P1|COMPLETED|Second Infusion (Week <6)||3
7983380|NCT00220727|19656524|P2|STARTED|Second Infusion (Week <6)||4
7983381|NCT00220727|19656525|P1|STARTED|Second Infusion (Week <6)||4
7983382|NCT00220727|19656524|P2|NOT COMPLETED|First Infusion (Week 0)||0
7983383|NCT00220727|19656525|P1|NOT COMPLETED|First Infusion (Week 0)||0
7983384|NCT00220727|19656524|P2|COMPLETED|First Infusion (Week 0)||4
7983385|NCT00220727|19656525|P1|COMPLETED|First Infusion (Week 0)||4
7983386|NCT00220727|19656524|P2|STARTED|First Infusion (Week 0)||4
7983387|NCT00220727|19656525|P1|STARTED|First Infusion (Week 0)||4
7983388|NCT00220701|19656541|P2|NOT COMPLETED|Overall Study||4
7983389|NCT00220701|19656542|P1|NOT COMPLETED|Overall Study||5
7983390|NCT00220701|19656541|P2|COMPLETED|Overall Study||13
7983391|NCT00220701|19656542|P1|COMPLETED|Overall Study||12
7983392|NCT00220701|19656541|P2|STARTED|Overall Study||17
7983393|NCT00220701|19656542|P1|STARTED|Overall Study||17
7983394|NCT00220636|19656558|P1|NOT COMPLETED|Overall Study||4
7983395|NCT00220636|19656558|P1|COMPLETED|Overall Study||11
7983396|NCT00220636|19656558|P1|STARTED|Overall Study||15
7983397|NCT00219557|19656568|P3|NOT COMPLETED|Phase 2||33
7983398|NCT00219557|19656569|P2|NOT COMPLETED|Phase 2||69
7983399|NCT00219557|19656570|P1|NOT COMPLETED|Phase 2||0
7983400|NCT00219557|19656568|P3|COMPLETED|Phase 2||1
7983401|NCT00219557|19656569|P2|COMPLETED|Phase 2||0
7983402|NCT00219557|19656570|P1|COMPLETED|Phase 2||0
7983403|NCT00219557|19656568|P3|Treated|Phase 2||31
7983404|NCT00219557|19656569|P2|Treated|Phase 2||68
7983405|NCT00219557|19656570|P1|Treated|Phase 2||0
7983406|NCT00219557|19656568|P3|STARTED|Phase 2||34
7983407|NCT00219557|19656569|P2|STARTED|Phase 2||69
7983408|NCT00219557|19656570|P1|STARTED|Phase 2||0
7983409|NCT00219557|19656568|P3|NOT COMPLETED|Phase 1||0
7983410|NCT00219557|19656569|P2|NOT COMPLETED|Phase 1||0
7983411|NCT00219557|19656570|P1|NOT COMPLETED|Phase 1||7
7983412|NCT00219557|19656568|P3|COMPLETED|Phase 1||0
7983413|NCT00219557|19656569|P2|COMPLETED|Phase 1||0
7983414|NCT00219557|19656570|P1|COMPLETED|Phase 1||1
7983415|NCT00219557|19656568|P3|STARTED|Phase 1||0
7983416|NCT00219557|19656569|P2|STARTED|Phase 1||0
7983417|NCT00219557|19656570|P1|STARTED|Phase 1||8
7983418|NCT00219544|19656598|P2|NOT COMPLETED|Double Blind Treatment Period||0
7983419|NCT00219544|19656599|P1|NOT COMPLETED|Double Blind Treatment Period||0
7983420|NCT00219544|19656598|P2|COMPLETED|Double Blind Treatment Period||77
7983421|NCT00219544|19656599|P1|COMPLETED|Double Blind Treatment Period||80
7983422|NCT00219544|19656598|P2|STARTED|Double Blind Treatment Period||77
7983423|NCT00219544|19656599|P1|STARTED|Double Blind Treatment Period||80
7983424|NCT00219544|19656598|P2|NOT COMPLETED|Single Blind Treatment Period||0
7983425|NCT00219544|19656599|P1|NOT COMPLETED|Single Blind Treatment Period||22
7983426|NCT00219544|19656598|P2|COMPLETED|Single Blind Treatment Period||0
7983427|NCT00219544|19656599|P1|COMPLETED|Single Blind Treatment Period||234
7983428|NCT00219544|19656598|P2|STARTED|Single Blind Treatment Period||0
7983429|NCT00219544|19656599|P1|STARTED|Single Blind Treatment Period||256
7983430|NCT00219349|19656637|P1|NOT COMPLETED|Escitalopram Phase||3
7983431|NCT00219349|19656637|P1|COMPLETED|Escitalopram Phase||4
7983432|NCT00219349|19656637|P1|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|7
7983433|NCT00219349|19656637|P1|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10
7983434|NCT00219349|19656637|P1|COMPLETED|Cognitive Behavioral Therapy Phase||15
7983435|NCT00219349|19656637|P1|STARTED|Cognitive Behavioral Therapy Phase||25
7983436|NCT00219284|19656650|P2|NOT COMPLETED|Extension Phase - 8 Weeks||7
7983437|NCT00219284|19656651|P1|NOT COMPLETED|Extension Phase - 8 Weeks||2
7983438|NCT00219284|19656650|P2|COMPLETED|Extension Phase - 8 Weeks||99
7983439|NCT00219284|19656651|P1|COMPLETED|Extension Phase - 8 Weeks||112
7983440|NCT00219284|19656650|P2|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106
7983441|NCT00219284|19656651|P1|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114
7983442|NCT00219284|19656650|P2|NOT COMPLETED|Treatment Phase - 16 Weeks||51
7983443|NCT00219284|19656651|P1|NOT COMPLETED|Treatment Phase - 16 Weeks||44
7983444|NCT00219284|19656650|P2|COMPLETED|Treatment Phase - 16 Weeks||128
7983445|NCT00219284|19656651|P1|COMPLETED|Treatment Phase - 16 Weeks||136
7983446|NCT00219284|19656650|P2|STARTED|Treatment Phase - 16 Weeks||179
7983447|NCT00219284|19656651|P1|STARTED|Treatment Phase - 16 Weeks||180
7983448|NCT00219141|19656676|P3|NOT COMPLETED|Overall Study||12
7983449|NCT00219141|19656677|P2|NOT COMPLETED|Overall Study||21
7983450|NCT00219141|19656678|P1|NOT COMPLETED|Overall Study||14
7983451|NCT00219141|19656676|P3|COMPLETED|Overall Study||142
7983452|NCT00219141|19656677|P2|COMPLETED|Overall Study||131
7983453|NCT00219141|19656678|P1|COMPLETED|Overall Study||140
7983454|NCT00219141|19656676|P3|STARTED|Overall Study||154
7983455|NCT00219141|19656677|P2|STARTED|Overall Study||152
7983456|NCT00219141|19656678|P1|STARTED|Overall Study||154
7983457|NCT00218634|19656724|P2|NOT COMPLETED|Overall Study||15
7983458|NCT00218634|19656725|P1|NOT COMPLETED|Overall Study||8
7983459|NCT00218634|19656724|P2|COMPLETED|Overall Study||30
7983460|NCT00218634|19656725|P1|COMPLETED|Overall Study||36
7983461|NCT00218634|19656724|P2|STARTED|Overall Study||45
7983462|NCT00218634|19656725|P1|STARTED|Overall Study||44
7983463|NCT00218543|19656745|P1|NOT COMPLETED|Overall Study||15
7983464|NCT00218543|19656745|P1|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5
7983465|NCT00218543|19656745|P1|STARTED|Overall Study||20
7983466|NCT00218491|19656753|P3|NOT COMPLETED|Overall Study||0
7983467|NCT00218491|19656754|P2|NOT COMPLETED|Overall Study||0
7983468|NCT00218491|19656755|P1|NOT COMPLETED|Overall Study||0
7983469|NCT00218491|19656753|P3|COMPLETED|Overall Study||38
7983470|NCT00218491|19656754|P2|COMPLETED|Overall Study||33
7983471|NCT00218491|19656755|P1|COMPLETED|Overall Study||40
7983472|NCT00218491|19656753|P3|STARTED|Overall Study||38
7983473|NCT00218491|19656754|P2|STARTED|Overall Study||33
7983474|NCT00218491|19656755|P1|STARTED|Overall Study||40
7983475|NCT00218465|19656765|P2|NOT COMPLETED|Overall Study||18
7983476|NCT00218465|19656766|P1|NOT COMPLETED|Overall Study||17
7983477|NCT00218465|19656765|P2|COMPLETED|Overall Study||30
7983478|NCT00218465|19656766|P1|COMPLETED|Overall Study||33
7983479|NCT00218465|19656765|P2|STARTED|Overall Study||48
7983480|NCT00218465|19656766|P1|STARTED|Overall Study||50
7983481|NCT00218439|19656778|P2|NOT COMPLETED|Second Intervention (4 Weeks)||5
7983482|NCT00218439|19656779|P1|NOT COMPLETED|Second Intervention (4 Weeks)||7
7983483|NCT00218439|19656778|P2|COMPLETED|Second Intervention (4 Weeks)||30
7983484|NCT00218439|19656779|P1|COMPLETED|Second Intervention (4 Weeks)||33
7983485|NCT00218439|19656778|P2|STARTED|Second Intervention (4 Weeks)||35
7983486|NCT00218439|19656779|P1|STARTED|Second Intervention (4 Weeks)||40
7983487|NCT00218439|19656778|P2|NOT COMPLETED|First Intervention (4 Weeks)||12
7983488|NCT00218439|19656779|P1|NOT COMPLETED|First Intervention (4 Weeks)||18
7983489|NCT00218439|19656778|P2|COMPLETED|First Intervention (4 Weeks)||35
7983490|NCT00218439|19656779|P1|COMPLETED|First Intervention (4 Weeks)||40
7983491|NCT00218439|19656778|P2|STARTED|First Intervention (4 Weeks)||47
7983492|NCT00218439|19656779|P1|STARTED|First Intervention (4 Weeks)||58
7983493|NCT00218426|19656796|P3|NOT COMPLETED|Overall Study||91
7983494|NCT00218426|19656797|P2|NOT COMPLETED|Overall Study||86
7983495|NCT00218426|19656798|P1|NOT COMPLETED|Overall Study||48
7983496|NCT00218426|19656796|P3|COMPLETED|Overall Study||11
7983497|NCT00218426|19656797|P2|COMPLETED|Overall Study||16
7983498|NCT00218426|19656798|P1|COMPLETED|Overall Study||54
7983499|NCT00218426|19656796|P3|STARTED|Overall Study||102
7983500|NCT00218426|19656797|P2|STARTED|Overall Study||102
7983501|NCT00218426|19656798|P1|STARTED|Overall Study||102
7983502|NCT00218387|19656839|P3|NOT COMPLETED|Overall Study||23
7983503|NCT00218387|19656840|P2|NOT COMPLETED|Overall Study||18
7983504|NCT00218387|19656841|P1|NOT COMPLETED|Overall Study||15
7983505|NCT00218387|19656839|P3|COMPLETED|Overall Study||17
7983506|NCT00218387|19656840|P2|COMPLETED|Overall Study||25
7983507|NCT00218387|19656841|P1|COMPLETED|Overall Study||25
7983508|NCT00218387|19656839|P3|STARTED|Overall Study||40
7983509|NCT00218387|19656840|P2|STARTED|Overall Study||43
7983510|NCT00218387|19656841|P1|STARTED|Overall Study||40
7983511|NCT00218335|19656856|P4|NOT COMPLETED|Overall Study||36
7983512|NCT00218335|19656857|P3|NOT COMPLETED|Overall Study||54
7983513|NCT00218335|19656858|P2|NOT COMPLETED|Overall Study||3
7983514|NCT00218335|19656859|P1|NOT COMPLETED|Overall Study||6
7983515|NCT00218335|19656856|P4|COMPLETED|Overall Study||388
7983516|NCT00218335|19656857|P3|COMPLETED|Overall Study||319
7983517|NCT00218335|19656858|P2|COMPLETED|Overall Study||110
7983518|NCT00218335|19656859|P1|COMPLETED|Overall Study||108
7983519|NCT00218335|19656856|P4|18 Month Follow-up|Overall Study||368
7983520|NCT00218335|19656857|P3|18 Month Follow-up|Overall Study||296
7983521|NCT00218335|19656858|P2|18 Month Follow-up|Overall Study||108
7983522|NCT00218335|19656859|P1|18 Month Follow-up|Overall Study||101
7983523|NCT00218335|19656856|P4|12 Month Follow-up|Overall Study||303
7983524|NCT00218335|19656857|P3|12 Month Follow-up|Overall Study||244
7983525|NCT00218335|19656858|P2|12 Month Follow-up|Overall Study||102
7983526|NCT00218335|19656859|P1|12 Month Follow-up|Overall Study||95
7983527|NCT00218335|19656856|P4|6 Month Follow-up|Overall Study||301
7983528|NCT00218335|19656857|P3|6 Month Follow-up|Overall Study||219
7983529|NCT00218335|19656858|P2|6 Month Follow-up|Overall Study||99
7983530|NCT00218335|19656859|P1|6 Month Follow-up|Overall Study||103
7983531|NCT00218335|19656856|P4|STARTED|Overall Study||424
7983532|NCT00218335|19656857|P3|STARTED|Overall Study||373
7983533|NCT00218335|19656858|P2|STARTED|Overall Study||113
7983534|NCT00218335|19656859|P1|STARTED|Overall Study||114
7983535|NCT00218296|19656923|P2|NOT COMPLETED|Overall Study||121
7983536|NCT00218296|19656924|P1|NOT COMPLETED|Overall Study||111
7983537|NCT00218296|19656923|P2|COMPLETED|Overall Study||48
7983538|NCT00218296|19656924|P1|COMPLETED|Overall Study||52
7983539|NCT00218296|19656923|P2|Attended Visti|Overall Study||102
7983540|NCT00218296|19656924|P1|Attended Visti|Overall Study||97
7983541|NCT00218296|19656923|P2|STARTED|Overall Study||169
7983542|NCT00218296|19656924|P1|STARTED|Overall Study||163
7983543|NCT00218257|19656940|P2|NOT COMPLETED|Intervention 2||0
7983544|NCT00218257|19656941|P1|NOT COMPLETED|Intervention 2||0
7983545|NCT00218257|19656940|P2|COMPLETED|Intervention 2||19
7983546|NCT00218257|19656941|P1|COMPLETED|Intervention 2||19
7983547|NCT00218257|19656940|P2|STARTED|Intervention 2||19
7983548|NCT00218257|19656941|P1|STARTED|Intervention 2||19
7983549|NCT00218257|19656940|P2|NOT COMPLETED|Period Between Visit 1 and 2||3
7983550|NCT00218257|19656941|P1|NOT COMPLETED|Period Between Visit 1 and 2||4
7983551|NCT00218257|19656940|P2|COMPLETED|Period Between Visit 1 and 2||19
7983552|NCT00218257|19656941|P1|COMPLETED|Period Between Visit 1 and 2||19
7983553|NCT00218257|19656940|P2|STARTED|Period Between Visit 1 and 2||22
7983554|NCT00218257|19656941|P1|STARTED|Period Between Visit 1 and 2||23
7983555|NCT00218257|19656940|P2|NOT COMPLETED|Intervention 1||0
7983556|NCT00218257|19656941|P1|NOT COMPLETED|Intervention 1||0
7983557|NCT00218257|19656940|P2|COMPLETED|Intervention 1||22
7983558|NCT00218257|19656941|P1|COMPLETED|Intervention 1||23
7983559|NCT00218257|19656940|P2|STARTED|Intervention 1||22
7983560|NCT00218257|19656941|P1|STARTED|Intervention 1||23
7983561|NCT00218062|19656959|P4|NOT COMPLETED|Overall Study||13
7983562|NCT00218062|19656960|P3|NOT COMPLETED|Overall Study||12
7983563|NCT00218062|19656961|P2|NOT COMPLETED|Overall Study||16
7983564|NCT00218062|19656962|P1|NOT COMPLETED|Overall Study||15
7983565|NCT00218062|19656959|P4|COMPLETED|Overall Study||3
7983566|NCT00218062|19656960|P3|COMPLETED|Overall Study||3
7983567|NCT00218062|19656961|P2|COMPLETED|Overall Study||4
7983568|NCT00218062|19656962|P1|COMPLETED|Overall Study||7
7983569|NCT00218062|19656959|P4|Received First Dose of Study Medication|Overall Study||12
7983570|NCT00218062|19656960|P3|Received First Dose of Study Medication|Overall Study||10
7983571|NCT00218062|19656961|P2|Received First Dose of Study Medication|Overall Study||11
7983572|NCT00218062|19656962|P1|Received First Dose of Study Medication|Overall Study||16
7983573|NCT00218062|19656959|P4|STARTED|Overall Study||16
7983574|NCT00218062|19656960|P3|STARTED|Overall Study||15
7983575|NCT00218062|19656961|P2|STARTED|Overall Study||20
7983576|NCT00218062|19656962|P1|STARTED|Overall Study||22
7983577|NCT00218036|19656993|P5|NOT COMPLETED|Overall Study||6
7983578|NCT00218036|19656994|P4|NOT COMPLETED|Overall Study||6
7983579|NCT00218036|19656995|P3|NOT COMPLETED|Overall Study||8
7983580|NCT00218036|19656996|P2|NOT COMPLETED|Overall Study||3
7983581|NCT00218036|19656997|P1|NOT COMPLETED|Overall Study||5
7983582|NCT00218036|19656993|P5|COMPLETED|Overall Study||3
7983583|NCT00218036|19656994|P4|COMPLETED|Overall Study||6
7983584|NCT00218036|19656995|P3|COMPLETED|Overall Study||5
7983585|NCT00218036|19656996|P2|COMPLETED|Overall Study||3
7983586|NCT00218036|19656997|P1|COMPLETED|Overall Study||6
7983587|NCT00218036|19656993|P5|STARTED|Overall Study||9
7983588|NCT00218036|19656994|P4|STARTED|Overall Study||12
7983589|NCT00218036|19656995|P3|STARTED|Overall Study||13
7983590|NCT00218036|19656996|P2|STARTED|Overall Study||6
7983591|NCT00218036|19656997|P1|STARTED|Overall Study||11
7983592|NCT00218023|19657023|P4|NOT COMPLETED|Overall Study||7
7983593|NCT00218023|19657024|P3|NOT COMPLETED|Overall Study||10
7983594|NCT00218023|19657025|P2|NOT COMPLETED|Overall Study||15
7983595|NCT00218023|19657026|P1|NOT COMPLETED|Overall Study||13
7983596|NCT00218023|19657023|P4|COMPLETED|Overall Study||11
7983597|NCT00218023|19657024|P3|COMPLETED|Overall Study||6
7983598|NCT00218023|19657025|P2|COMPLETED|Overall Study||10
7983599|NCT00218023|19657026|P1|COMPLETED|Overall Study||9
7983600|NCT00218023|19657023|P4|Received Drug or Placebo in Phase II|Overall Study||18
7983601|NCT00218023|19657024|P3|Received Drug or Placebo in Phase II|Overall Study||15
7983602|NCT00218023|19657025|P2|Received Drug or Placebo in Phase II|Overall Study||24
7983603|NCT00218023|19657026|P1|Received Drug or Placebo in Phase II|Overall Study||18
7983604|NCT00218023|19657023|P4|STARTED|Overall Study||18
7983605|NCT00218023|19657024|P3|STARTED|Overall Study||16
7983606|NCT00218023|19657025|P2|STARTED|Overall Study||25
7983607|NCT00218023|19657026|P1|STARTED|Overall Study||22
7983608|NCT00217971|19657042|P2|NOT COMPLETED|Overall Study||33
7983609|NCT00217971|19657043|P1|NOT COMPLETED|Overall Study||24
7983610|NCT00217971|19657042|P2|COMPLETED|Overall Study||44
7983611|NCT00217971|19657043|P1|COMPLETED|Overall Study||55
7983612|NCT00217971|19657042|P2|STARTED|Overall Study||77
7983613|NCT00217971|19657043|P1|STARTED|Overall Study||79
7983614|NCT00217724|19657049|P2|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0
7983615|NCT00217724|19657050|P1|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1
7983616|NCT00217724|19657049|P2|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5
7983617|NCT00217724|19657050|P1|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8
7983618|NCT00217724|19657049|P2|STARTED|Course 2, (Glutamine/Placebo Crossover)||5
7983619|NCT00217724|19657050|P1|STARTED|Course 2, (Glutamine/Placebo Crossover)||9
7983620|NCT00217724|19657049|P2|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1
7983621|NCT00217724|19657050|P1|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3
7983622|NCT00217724|19657049|P2|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9
7983623|NCT00217724|19657050|P1|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5
7983624|NCT00217724|19657049|P2|STARTED|Course 1, (Glutamine/Placebo Arms)||10
7983625|NCT00217724|19657050|P1|STARTED|Course 1, (Glutamine/Placebo Arms)||8
7983626|NCT00217672|19657058|P2|NOT COMPLETED|Follow-up||0
7983627|NCT00217672|19657059|P1|NOT COMPLETED|Follow-up||5
7983628|NCT00217672|19657058|P2|COMPLETED|Follow-up||0
7983629|NCT00217672|19657059|P1|COMPLETED|Follow-up||69
7983630|NCT00217672|19657058|P2|STARTED|Follow-up||0
7983631|NCT00217672|19657059|P1|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74
7983632|NCT00217672|19657058|P2|NOT COMPLETED|Treatment||7
7983633|NCT00217672|19657059|P1|NOT COMPLETED|Treatment||67
7983634|NCT00217672|19657058|P2|COMPLETED|Treatment||0
7983635|NCT00217672|19657059|P1|COMPLETED|Treatment||0
7983636|NCT00217672|19657058|P2|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
7983637|NCT00217672|19657059|P1|STARTED|Treatment||67
7983638|NCT00217672|19657058|P2|NOT COMPLETED|Allocation||0
7983639|NCT00217672|19657059|P1|NOT COMPLETED|Allocation||2
7983640|NCT00217672|19657058|P2|COMPLETED|Allocation||7
7983641|NCT00217672|19657059|P1|COMPLETED|Allocation||67
7983642|NCT00217672|19657058|P2|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
7983643|NCT00217672|19657059|P1|STARTED|Allocation||69
7983644|NCT00217620|19657065|P1|NOT COMPLETED|Overall Study||51
7983645|NCT00217620|19657065|P1|COMPLETED|Overall Study||0
7983646|NCT00217620|19657065|P1|Eligible and Began Protocol Therapy|Overall Study||37
7983647|NCT00217620|19657065|P1|Eligible|Overall Study||38
7983648|NCT00217620|19657065|P1|STARTED|Overall Study||51
7983649|NCT00217594|19657076|P1|NOT COMPLETED|Overall Study||0
7983650|NCT00217594|19657076|P1|COMPLETED|Overall Study||31
7983651|NCT00217594|19657076|P1|STARTED|Overall Study||31
7983652|NCT00217581|19657080|P1|NOT COMPLETED|Overall Study||1
7983653|NCT00217581|19657080|P1|COMPLETED|Overall Study||38
7983654|NCT00217581|19657080|P1|STARTED|Overall Study||39
7983655|NCT00217490|19657092|P4|NOT COMPLETED|Overall Study||23
7983656|NCT00217490|19657093|P3|NOT COMPLETED|Overall Study||24
7983657|NCT00217490|19657094|P2|NOT COMPLETED|Overall Study||25
7983658|NCT00217490|19657095|P1|NOT COMPLETED|Overall Study||17
7983659|NCT00217490|19657092|P4|COMPLETED|Overall Study||130
7983660|NCT00217490|19657093|P3|COMPLETED|Overall Study||131
7983661|NCT00217490|19657094|P2|COMPLETED|Overall Study||128
7983662|NCT00217490|19657095|P1|COMPLETED|Overall Study||137
7983663|NCT00217490|19657092|P4|STARTED|Overall Study||153
7983664|NCT00217490|19657093|P3|STARTED|Overall Study||155
7983665|NCT00217490|19657094|P2|STARTED|Overall Study||153
7983666|NCT00217490|19657095|P1|STARTED|Overall Study||154
7983667|NCT00217464|19657109|P1|NOT COMPLETED|Overall Study||17
7983668|NCT00217464|19657109|P1|COMPLETED|Overall Study||0
7983669|NCT00217464|19657109|P1|STARTED|Overall Study||17
7983670|NCT00217438|19657116|P2|NOT COMPLETED|Overall Study||1
7983671|NCT00217438|19657117|P1|NOT COMPLETED|Overall Study||0
7983672|NCT00217438|19657116|P2|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63
7983673|NCT00217438|19657117|P1|COMPLETED|Overall Study||66
7983674|NCT00217438|19657116|P2|STARTED|Overall Study||64
7983675|NCT00217438|19657117|P1|STARTED|Overall Study||66
7983676|NCT00217425|19657125|P1|NOT COMPLETED|Overall Study||37
7983677|NCT00217425|19657125|P1|COMPLETED|Overall Study||9
7983678|NCT00217425|19657125|P1|Eligible and Treated|Overall Study||39
7983679|NCT00217425|19657125|P1|Treated|Overall Study||44
7983680|NCT00217425|19657125|P1|STARTED|Overall Study||46
7983681|NCT00217399|19657131|P1|NOT COMPLETED|Overall Study||0
7983682|NCT00217399|19657131|P1|COMPLETED|Overall Study||35
7983683|NCT00217399|19657131|P1|STARTED|Overall Study||35
7983684|NCT00217087|19657139|P2|NOT COMPLETED|Overall Study||20
7983685|NCT00217087|19657140|P1|NOT COMPLETED|Overall Study||11
7983686|NCT00217087|19657139|P2|COMPLETED|Overall Study||17
7983687|NCT00217087|19657140|P1|COMPLETED|Overall Study||25
7983688|NCT00217087|19657139|P2|STARTED|Overall Study||37
7983689|NCT00217087|19657140|P1|STARTED|Overall Study||36
7983690|NCT00217022|19657154|P2|NOT COMPLETED|Overall Study||1
7983691|NCT00217022|19657155|P1|NOT COMPLETED|Overall Study||1
7983692|NCT00217022|19657154|P2|COMPLETED|Overall Study||3
7983693|NCT00217022|19657155|P1|COMPLETED|Overall Study||11
7983694|NCT00217022|19657154|P2|STARTED|Overall Study||4
7983695|NCT00217022|19657155|P1|STARTED|Overall Study||12
7983696|NCT00216736|19657165|P2|NOT COMPLETED|Overall Study||1
7983697|NCT00216736|19657166|P1|NOT COMPLETED|Overall Study||1
7983698|NCT00216736|19657165|P2|COMPLETED|Overall Study||30
7983699|NCT00216736|19657166|P1|COMPLETED|Overall Study||31
7983700|NCT00216736|19657165|P2|STARTED|Overall Study||31
7983701|NCT00216736|19657166|P1|STARTED|Overall Study||32
7983702|NCT00216671|19657180|P2|NOT COMPLETED|Overall Study||50
7983703|NCT00216671|19657181|P1|NOT COMPLETED|Overall Study||35
7983704|NCT00216671|19657180|P2|COMPLETED|Overall Study||60
7983705|NCT00216671|19657181|P1|COMPLETED|Overall Study||75
7983706|NCT00216671|19657180|P2|STARTED|Overall Study||110
7983707|NCT00216671|19657181|P1|STARTED|Overall Study||110
7983708|NCT00216476|19657199|P3|NOT COMPLETED|Overall Study||17
7983709|NCT00216476|19657200|P2|NOT COMPLETED|Overall Study||107
7983710|NCT00216476|19657201|P1|NOT COMPLETED|Overall Study||105
7983711|NCT00216476|19657199|P3|COMPLETED|Overall Study||28
7983712|NCT00216476|19657200|P2|COMPLETED|Overall Study||230
7983713|NCT00216476|19657201|P1|COMPLETED|Overall Study||224
7983714|NCT00216476|19657199|P3|STARTED|Overall Study||45
7983715|NCT00216476|19657200|P2|STARTED|Overall Study||337
7983716|NCT00216476|19657201|P1|STARTED|Overall Study||329
7983717|NCT00216320|19657221|P3|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1
7983718|NCT00216320|19657222|P2|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4
7983719|NCT00216320|19657223|P1|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5
7983720|NCT00216320|19657221|P3|COMPLETED|Phase 2 (Weeks 6 -12)||24
7983721|NCT00216320|19657222|P2|COMPLETED|Phase 2 (Weeks 6 -12)||31
7983722|NCT00216320|19657223|P1|COMPLETED|Phase 2 (Weeks 6 -12)||38
7983723|NCT00216320|19657221|P3|STARTED|Phase 2 (Weeks 6 -12)||25
7983724|NCT00216320|19657222|P2|STARTED|Phase 2 (Weeks 6 -12)||35
7983725|NCT00216320|19657223|P1|STARTED|Phase 2 (Weeks 6 -12)||43
7983726|NCT00216320|19657221|P3|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5
7983727|NCT00216320|19657222|P2|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4
7983728|NCT00216320|19657223|P1|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0
7983729|NCT00216320|19657221|P3|COMPLETED|Phase 1 (Weeks 0 - 6)||25
7983730|NCT00216320|19657222|P2|COMPLETED|Phase 1 (Weeks 0 - 6)||35
7983731|NCT00216320|19657223|P1|COMPLETED|Phase 1 (Weeks 0 - 6)||43
7983732|NCT00216320|19657221|P3|STARTED|Phase 1 (Weeks 0 - 6)||30
7983733|NCT00216320|19657222|P2|STARTED|Phase 1 (Weeks 0 - 6)||39
7983734|NCT00216320|19657223|P1|STARTED|Phase 1 (Weeks 0 - 6)||43
7983735|NCT00216203|19657238|P1|NOT COMPLETED|Overall Study||2
7983736|NCT00216203|19657238|P1|COMPLETED|Overall Study||34
7983737|NCT00216203|19657238|P1|STARTED|Overall Study||36
7983738|NCT00216125|19657246|P3|NOT COMPLETED|Randomization Phase||8
7983739|NCT00216125|19657247|P2|NOT COMPLETED|Randomization Phase||11
7983740|NCT00216125|19657248|P1|NOT COMPLETED|Randomization Phase||0
7983741|NCT00216125|19657246|P3|COMPLETED|Randomization Phase||74
7983742|NCT00216125|19657247|P2|COMPLETED|Randomization Phase||73
7983743|NCT00216125|19657248|P1|COMPLETED|Randomization Phase||0
7983744|NCT00216125|19657246|P3|DSMB Cohort for Futility|Randomization Phase||74
7983745|NCT00216125|19657247|P2|DSMB Cohort for Futility|Randomization Phase||73
7983746|NCT00216125|19657248|P1|DSMB Cohort for Futility|Randomization Phase||0
7983747|NCT00216125|19657246|P3|STARTED|Randomization Phase||82
7983748|NCT00216125|19657247|P2|STARTED|Randomization Phase||84
7983749|NCT00216125|19657248|P1|STARTED|Randomization Phase||0
7983750|NCT00216125|19657246|P3|NOT COMPLETED|Pre-Randomization Phase||0
7983751|NCT00216125|19657247|P2|NOT COMPLETED|Pre-Randomization Phase||0
7983752|NCT00216125|19657248|P1|NOT COMPLETED|Pre-Randomization Phase||77
7983753|NCT00216125|19657246|P3|COMPLETED|Pre-Randomization Phase||0
7983754|NCT00216125|19657247|P2|COMPLETED|Pre-Randomization Phase||0
7983755|NCT00216125|19657248|P1|COMPLETED|Pre-Randomization Phase||166
7983756|NCT00216125|19657246|P3|DSMB Cohort for Futility|Pre-Randomization Phase||0
7983757|NCT00216125|19657247|P2|DSMB Cohort for Futility|Pre-Randomization Phase||0
7983758|NCT00216125|19657248|P1|DSMB Cohort for Futility|Pre-Randomization Phase||203
7983759|NCT00216125|19657246|P3|STARTED|Pre-Randomization Phase||0
7983760|NCT00216125|19657247|P2|STARTED|Pre-Randomization Phase||0
7983761|NCT00216125|19657248|P1|STARTED|Pre-Randomization Phase||243
7983762|NCT00216099|19657257|P1|NOT COMPLETED|Overall Study||1
7983763|NCT00216099|19657257|P1|COMPLETED|Overall Study||48
7983764|NCT00216099|19657257|P1|Response Analysis|Overall Study||48
7983765|NCT00216099|19657257|P1|Toxicity Analysis|Overall Study||49
7983766|NCT00216099|19657257|P1|STARTED|Overall Study||49
7983767|NCT00216086|19657268|P1|NOT COMPLETED|Overall Study||4
7983768|NCT00216086|19657268|P1|COMPLETED|Overall Study||18
7983769|NCT00216086|19657268|P1|STARTED|Overall Study||22
7983770|NCT00216060|19657277|P2|NOT COMPLETED|Overall Study||0
7983771|NCT00216060|19657278|P1|NOT COMPLETED|Overall Study||0
7983772|NCT00216060|19657277|P2|COMPLETED|Overall Study||31
7983773|NCT00216060|19657278|P1|COMPLETED|Overall Study||32
7983774|NCT00216060|19657277|P2|STARTED|Overall Study||31
7983775|NCT00216060|19657278|P1|STARTED|Overall Study||32
7983776|NCT00215943|19657300|P2|NOT COMPLETED|Overall Study||14
7983777|NCT00215943|19657301|P1|NOT COMPLETED|Overall Study||9
7983778|NCT00215943|19657300|P2|COMPLETED|Overall Study||23
7983779|NCT00215943|19657301|P1|COMPLETED|Overall Study||27
7983780|NCT00215943|19657300|P2|STARTED|Overall Study||37
7983781|NCT00215943|19657301|P1|STARTED|Overall Study||36
7983782|NCT00215930|19657313|P1|NOT COMPLETED|Overall Study||0
7983783|NCT00215930|19657313|P1|COMPLETED|Overall Study||53
7983784|NCT00215930|19657313|P1|STARTED|Overall Study||53
7983785|NCT00215787|19657319|P1|NOT COMPLETED|Overall Study||0
7983786|NCT00215787|19657319|P1|COMPLETED|Overall Study||20
7983787|NCT00215787|19657319|P1|STARTED|Overall Study||20
7983788|NCT00215683|19657326|P3|NOT COMPLETED|Overall Study||32
7983789|NCT00215683|19657327|P2|NOT COMPLETED|Overall Study||26
7983790|NCT00215683|19657328|P1|NOT COMPLETED|Overall Study||29
7983791|NCT00215683|19657326|P3|COMPLETED|Overall Study||12
7983792|NCT00215683|19657327|P2|COMPLETED|Overall Study||22
7983793|NCT00215683|19657328|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16
7983794|NCT00215683|19657326|P3|Switched to 160 mg|Overall Study||36
7983795|NCT00215683|19657327|P2|Switched to 160 mg|Overall Study||41
7983796|NCT00215683|19657328|P1|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32
7983797|NCT00215683|19657326|P3|STARTED|Overall Study||44
7983798|NCT00215683|19657327|P2|STARTED|Overall Study||48
7983799|NCT00215683|19657328|P1|STARTED|Overall Study|Safety analysis set|45
7983800|NCT00215657|19657347|P8|NOT COMPLETED|Overall Study||16
7983801|NCT00215657|19657348|P7|NOT COMPLETED|Overall Study||23
7983802|NCT00215657|19657349|P6|NOT COMPLETED|Overall Study||20
7983803|NCT00215657|19657350|P5|NOT COMPLETED|Overall Study||23
7983804|NCT00215657|19657351|P4|NOT COMPLETED|Overall Study||18
7983805|NCT00215657|19657352|P3|NOT COMPLETED|Overall Study||11
7983806|NCT00215657|19657353|P2|NOT COMPLETED|Overall Study||11
7983807|NCT00215657|19657354|P1|NOT COMPLETED|Overall Study||22
7983808|NCT00215657|19657347|P8|COMPLETED|Overall Study||11
7983809|NCT00215657|19657348|P7|COMPLETED|Overall Study||4
7983810|NCT00215657|19657349|P6|COMPLETED|Overall Study||4
7983811|NCT00215657|19657350|P5|COMPLETED|Overall Study||4
7983812|NCT00215657|19657351|P4|COMPLETED|Overall Study||6
7983813|NCT00215657|19657352|P3|COMPLETED|Overall Study||2
7983814|NCT00215657|19657353|P2|COMPLETED|Overall Study||1
7983815|NCT00215657|19657354|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4
7983816|NCT00215657|19657347|P8|Started FE200486 CS07A|Overall Study||23
7983817|NCT00215657|19657348|P7|Started FE200486 CS07A|Overall Study||14
7983818|NCT00215657|19657349|P6|Started FE200486 CS07A|Overall Study||20
7983819|NCT00215657|19657350|P5|Started FE200486 CS07A|Overall Study||17
7983820|NCT00215657|19657351|P4|Started FE200486 CS07A|Overall Study||24
7983821|NCT00215657|19657352|P3|Started FE200486 CS07A|Overall Study||7
7983822|NCT00215657|19657353|P2|Started FE200486 CS07A|Overall Study||6
7983823|NCT00215657|19657354|P1|Started FE200486 CS07A|Overall Study||20
7983824|NCT00215657|19657347|P8|Intention-to-treat Population|Overall Study||27
7983825|NCT00215657|19657348|P7|Intention-to-treat Population|Overall Study||24
7983826|NCT00215657|19657349|P6|Intention-to-treat Population|Overall Study||24
7983827|NCT00215657|19657350|P5|Intention-to-treat Population|Overall Study||24
7983828|NCT00215657|19657351|P4|Intention-to-treat Population|Overall Study||24
7983829|NCT00215657|19657352|P3|Intention-to-treat Population|Overall Study||12
7983830|NCT00215657|19657353|P2|Intention-to-treat Population|Overall Study||12
7983831|NCT00215657|19657354|P1|Intention-to-treat Population|Overall Study||25
7983832|NCT00215657|19657347|P8|STARTED|Overall Study||27
7983833|NCT00215657|19657348|P7|STARTED|Overall Study||27
7983834|NCT00215657|19657349|P6|STARTED|Overall Study||24
7983835|NCT00215657|19657350|P5|STARTED|Overall Study||27
7983836|NCT00215657|19657351|P4|STARTED|Overall Study||24
7983837|NCT00215657|19657352|P3|STARTED|Overall Study||13
7983838|NCT00215657|19657353|P2|STARTED|Overall Study||12
7983839|NCT00215657|19657354|P1|STARTED|Overall Study||26
7983840|NCT00215644|19657382|P2|NOT COMPLETED|Overall Study||36
7983841|NCT00215644|19657383|P1|NOT COMPLETED|Overall Study||36
7983842|NCT00215644|19657382|P2|COMPLETED|Overall Study||0
7983843|NCT00215644|19657383|P1|COMPLETED|Overall Study||0
7983844|NCT00215644|19657382|P2|Treated|Overall Study||36
7983845|NCT00215644|19657383|P1|Treated|Overall Study||35
7983846|NCT00215644|19657382|P2|STARTED|Overall Study||36
7983847|NCT00215644|19657383|P1|STARTED|Overall Study||36
7983848|NCT00215553|19657410|P7|NOT COMPLETED|Overall Study||0
7983849|NCT00215553|19657411|P6|NOT COMPLETED|Overall Study||6
7983850|NCT00215553|19657412|P5|NOT COMPLETED|Overall Study||2
7983851|NCT00215553|19657413|P4|NOT COMPLETED|Overall Study||1
7983852|NCT00215553|19657414|P3|NOT COMPLETED|Overall Study||2
7983853|NCT00215553|19657415|P2|NOT COMPLETED|Overall Study||1
7983854|NCT00215553|19657416|P1|NOT COMPLETED|Overall Study||0
7983855|NCT00215553|19657410|P7|COMPLETED|Overall Study||36
7983856|NCT00215553|19657411|P6|COMPLETED|Overall Study||32
7983857|NCT00215553|19657412|P5|COMPLETED|Overall Study||26
7983858|NCT00215553|19657413|P4|COMPLETED|Overall Study||4
7983859|NCT00215553|19657414|P3|COMPLETED|Overall Study||4
7983860|NCT00215553|19657415|P2|COMPLETED|Overall Study||5
7983861|NCT00215553|19657416|P1|COMPLETED|Overall Study||5
7983862|NCT00215553|19657410|P7|STARTED|Overall Study||36
7983863|NCT00215553|19657411|P6|STARTED|Overall Study||38
7983864|NCT00215553|19657412|P5|STARTED|Overall Study||28
7983865|NCT00215553|19657413|P4|STARTED|Overall Study||5
7983866|NCT00215553|19657414|P3|STARTED|Overall Study||6
7983867|NCT00215553|19657415|P2|STARTED|Overall Study||6
7983868|NCT00215553|19657416|P1|STARTED|Overall Study||5
7983869|NCT00215540|19657449|P3|NOT COMPLETED|Overall Study||0
7983870|NCT00215540|19657450|P2|NOT COMPLETED|Overall Study||0
7983871|NCT00215540|19657451|P1|NOT COMPLETED|Overall Study||1
7983872|NCT00215540|19657449|P3|COMPLETED|Overall Study||44
7983873|NCT00215540|19657450|P2|COMPLETED|Overall Study||47
7983874|NCT00215540|19657451|P1|COMPLETED|Overall Study||44
7983875|NCT00215540|19657449|P3|STARTED|Overall Study||44
7983876|NCT00215540|19657450|P2|STARTED|Overall Study||47
7983877|NCT00215540|19657451|P1|STARTED|Overall Study||45
7983878|NCT00215150|19657486|P1|NOT COMPLETED|Randomization Phase Placebo||1
7983879|NCT00215150|19657486|P1|COMPLETED|Randomization Phase Placebo||10
7983880|NCT00215150|19657486|P1|STARTED|Randomization Phase Placebo||11
7983881|NCT00215150|19657486|P1|NOT COMPLETED|Randomization Phase Ziprasidone||3
7983882|NCT00215150|19657486|P1|COMPLETED|Randomization Phase Ziprasidone||7
7983883|NCT00215150|19657486|P1|STARTED|Randomization Phase Ziprasidone||10
7983884|NCT00215150|19657486|P1|NOT COMPLETED|Open Label Phase||30
7983885|NCT00215150|19657486|P1|COMPLETED|Open Label Phase||21
7983886|NCT00215150|19657486|P1|STARTED|Open Label Phase|Number of subjects consented|51
7983887|NCT00215137|19657494|P3|NOT COMPLETED|Randomization Period||0
7983888|NCT00215137|19657495|P2|NOT COMPLETED|Randomization Period||2
7983889|NCT00215137|19657496|P1|NOT COMPLETED|Randomization Period||0
7983890|NCT00215137|19657494|P3|COMPLETED|Randomization Period||5
7983891|NCT00215137|19657495|P2|COMPLETED|Randomization Period||5
7983892|NCT00215137|19657496|P1|COMPLETED|Randomization Period||0
7983893|NCT00215137|19657494|P3|STARTED|Randomization Period||5
7983894|NCT00215137|19657495|P2|STARTED|Randomization Period||7
7983895|NCT00215137|19657496|P1|STARTED|Randomization Period||0
7983896|NCT00215137|19657494|P3|NOT COMPLETED|Open Label Escitalopram||0
7983897|NCT00215137|19657495|P2|NOT COMPLETED|Open Label Escitalopram||0
7983898|NCT00215137|19657496|P1|NOT COMPLETED|Open Label Escitalopram||1
7983899|NCT00215137|19657494|P3|COMPLETED|Open Label Escitalopram||0
7983900|NCT00215137|19657495|P2|COMPLETED|Open Label Escitalopram||0
7983901|NCT00215137|19657496|P1|COMPLETED|Open Label Escitalopram||13
7983902|NCT00215137|19657494|P3|STARTED|Open Label Escitalopram||0
7983903|NCT00215137|19657495|P2|STARTED|Open Label Escitalopram||0
7983904|NCT00215137|19657496|P1|STARTED|Open Label Escitalopram||14
7983905|NCT00214903|19657508|P4|NOT COMPLETED|Overall Study||0
7983906|NCT00214903|19657509|P3|NOT COMPLETED|Overall Study||0
7983907|NCT00214903|19657510|P2|NOT COMPLETED|Overall Study||0
7983908|NCT00214903|19657511|P1|NOT COMPLETED|Overall Study||0
7983909|NCT00214903|19657508|P4|COMPLETED|Overall Study||3057
7983910|NCT00214903|19657509|P3|COMPLETED|Overall Study||4113
7983911|NCT00214903|19657510|P2|COMPLETED|Overall Study||13384
7983912|NCT00214903|19657511|P1|COMPLETED|Overall Study||10043
7983913|NCT00214903|19657508|P4|STARTED|Overall Study||3057
7983914|NCT00214903|19657509|P3|STARTED|Overall Study||4113
7983915|NCT00214903|19657510|P2|STARTED|Overall Study||13384
7983916|NCT00214903|19657511|P1|STARTED|Overall Study||10043
7983917|NCT00214786|19657525|P1|NOT COMPLETED|Overall Study||3
7983918|NCT00214786|19657525|P1|COMPLETED|Overall Study||1
7983919|NCT00214786|19657525|P1|STARTED|Overall Study||4
7983920|NCT00214539|19657540|P2|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
7983921|NCT00214539|19657541|P1|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
7983922|NCT00214539|19657540|P2|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17
7983923|NCT00214539|19657541|P1|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15
7983924|NCT00214539|19657540|P2|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17
7983925|NCT00214539|19657541|P1|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15
7983926|NCT00214539|19657540|P2|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
7983927|NCT00214539|19657541|P1|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
7983928|NCT00214539|19657540|P2|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17
7983929|NCT00214539|19657541|P1|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15
7983930|NCT00214539|19657540|P2|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17
7983931|NCT00214539|19657541|P1|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15
7983932|NCT00214539|19657540|P2|NOT COMPLETED|Treatment Period||0
7983933|NCT00214539|19657541|P1|NOT COMPLETED|Treatment Period||0
7983934|NCT00214539|19657540|P2|COMPLETED|Treatment Period||17
7983935|NCT00214539|19657541|P1|COMPLETED|Treatment Period||15
7983936|NCT00214539|19657540|P2|STARTED|Treatment Period||17
7983937|NCT00214539|19657541|P1|STARTED|Treatment Period||15
7983938|NCT00214539|19657540|P2|NOT COMPLETED|Randomized||0
7983939|NCT00214539|19657541|P1|NOT COMPLETED|Randomized||2
7983940|NCT00214539|19657540|P2|COMPLETED|Randomized||17
7983941|NCT00214539|19657541|P1|COMPLETED|Randomized||15
7983942|NCT00214539|19657540|P2|STARTED|Randomized||17
7983943|NCT00214539|19657541|P1|STARTED|Randomized||17
7983944|NCT00214526|19657567|P2|NOT COMPLETED|Post-Treatment Period||0
7983945|NCT00214526|19657568|P1|NOT COMPLETED|Post-Treatment Period||1
7983946|NCT00214526|19657567|P2|COMPLETED|Post-Treatment Period||49
7983947|NCT00214526|19657568|P1|COMPLETED|Post-Treatment Period||52
7983948|NCT00214526|19657567|P2|STARTED|Post-Treatment Period||49
7983949|NCT00214526|19657568|P1|STARTED|Post-Treatment Period||53
7983950|NCT00214526|19657567|P2|NOT COMPLETED|Treatment Period||5
7983951|NCT00214526|19657568|P1|NOT COMPLETED|Treatment Period||2
7983952|NCT00214526|19657567|P2|COMPLETED|Treatment Period||49
7983953|NCT00214526|19657568|P1|COMPLETED|Treatment Period||53
7983954|NCT00214526|19657567|P2|STARTED|Treatment Period||54
7983955|NCT00214526|19657568|P1|STARTED|Treatment Period||55
7983956|NCT00214526|19657567|P2|NOT COMPLETED|Randomized||2
7983957|NCT00214526|19657568|P1|NOT COMPLETED|Randomized||1
7983958|NCT00214526|19657567|P2|COMPLETED|Randomized||54
7983959|NCT00214526|19657568|P1|COMPLETED|Randomized||55
7983960|NCT00214526|19657567|P2|STARTED|Randomized||56
7983961|NCT00214526|19657568|P1|STARTED|Randomized||56
7983962|NCT00214500|19657594|P1|NOT COMPLETED|Extension Period||2
7983963|NCT00214500|19657594|P1|COMPLETED|Extension Period||6
7983964|NCT00214500|19657594|P1|STARTED|Extension Period||8
7983965|NCT00214500|19657594|P1|NOT COMPLETED|Treatment Period||1
7983966|NCT00214500|19657594|P1|COMPLETED|Treatment Period||8
7983967|NCT00214500|19657594|P1|Pharmacodynamic (PD) Population|Treatment Period||9
7983968|NCT00214500|19657594|P1|Pharmacokinetic (PK) Population|Treatment Period||9
7983969|NCT00214500|19657594|P1|Safety Population|Treatment Period||9
7983970|NCT00214500|19657594|P1|STARTED|Treatment Period|All eligible-enrolled participants who received at least 1 dose of study drug|9
7983971|NCT00214487|19657604|P2|NOT COMPLETED|Overall Study||3
7983972|NCT00214487|19657605|P1|NOT COMPLETED|Overall Study||5
7983973|NCT00214487|19657604|P2|COMPLETED|Overall Study||40
7983974|NCT00214487|19657605|P1|COMPLETED|Overall Study||38
7983975|NCT00214487|19657604|P2|STARTED|Overall Study||43
7983976|NCT00214487|19657605|P1|STARTED|Overall Study||43
7983977|NCT00214461|19657615|P4|NOT COMPLETED|Overall Study||1
7983978|NCT00214461|19657616|P3|NOT COMPLETED|Overall Study||2
7983979|NCT00214461|19657617|P2|NOT COMPLETED|Overall Study||0
7983980|NCT00214461|19657618|P1|NOT COMPLETED|Overall Study||0
7983981|NCT00214461|19657615|P4|COMPLETED|Overall Study||11
7983982|NCT00214461|19657616|P3|COMPLETED|Overall Study||10
7983983|NCT00214461|19657617|P2|COMPLETED|Overall Study||12
7983984|NCT00214461|19657618|P1|COMPLETED|Overall Study||12
7983985|NCT00214461|19657615|P4|STARTED|Overall Study||12
7983986|NCT00214461|19657616|P3|STARTED|Overall Study||12
7983987|NCT00214461|19657617|P2|STARTED|Overall Study||12
7983988|NCT00214461|19657618|P1|STARTED|Overall Study||12
7983989|NCT00214422|19657635|P3|NOT COMPLETED|Overall Study||1
7983990|NCT00214422|19657636|P2|NOT COMPLETED|Overall Study||1
7983991|NCT00214422|19657637|P1|NOT COMPLETED|Overall Study||5
7983992|NCT00214422|19657635|P3|COMPLETED|Overall Study||3
7983993|NCT00214422|19657636|P2|COMPLETED|Overall Study||2
7983994|NCT00214422|19657637|P1|COMPLETED|Overall Study||7
7983995|NCT00214422|19657635|P3|STARTED|Overall Study||4
7983996|NCT00214422|19657636|P2|STARTED|Overall Study||3
7983997|NCT00214422|19657637|P1|STARTED|Overall Study||12
7983998|NCT00214383|19657660|P2|NOT COMPLETED|Overall Study||26
7983999|NCT00214383|19657661|P1|NOT COMPLETED|Overall Study||16
7984000|NCT00214383|19657660|P2|COMPLETED|Overall Study||127
7984001|NCT00214383|19657661|P1|COMPLETED|Overall Study||132
7984002|NCT00214383|19657660|P2|STARTED|Overall Study||153
7984003|NCT00214383|19657661|P1|STARTED|Overall Study||148
7984004|NCT00214201|19657673|P2|NOT COMPLETED|Overall Study||2
7984005|NCT00214201|19657674|P1|NOT COMPLETED|Overall Study||2
7984006|NCT00214201|19657673|P2|COMPLETED|Overall Study||18
7984007|NCT00214201|19657674|P1|COMPLETED|Overall Study||18
7984008|NCT00214201|19657673|P2|STARTED|Overall Study||20
7984009|NCT00214201|19657674|P1|STARTED|Overall Study||20
7984010|NCT00214149|19657684|P1|NOT COMPLETED|Overall Study||127
7984103|NCT00213135|19657804|P1|STARTED|Overall Study||456
7984011|NCT00214149|19657684|P1|COMPLETED|Overall Study|No data are available; study was terminated and PI has left the institution.|0
7984012|NCT00214149|19657684|P1|STARTED|Overall Study||127
7984013|NCT00214136|19657689|P1|NOT COMPLETED|Overall Study||5
7984014|NCT00214136|19657689|P1|COMPLETED|Overall Study||25
7984015|NCT00214136|19657689|P1|STARTED|Overall Study||30
7984016|NCT00214097|19657697|P3|NOT COMPLETED|Overall Study||0
7984017|NCT00214097|19657698|P2|NOT COMPLETED|Overall Study||0
7984018|NCT00214097|19657699|P1|NOT COMPLETED|Overall Study||0
7984019|NCT00214097|19657697|P3|COMPLETED|Overall Study||135
7984020|NCT00214097|19657698|P2|COMPLETED|Overall Study||111
7984021|NCT00214097|19657699|P1|COMPLETED|Overall Study||101
7984022|NCT00214097|19657697|P3|STARTED|Overall Study||135
7984023|NCT00214097|19657698|P2|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|111
7984024|NCT00214097|19657699|P1|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|101
7984025|NCT00214045|19657727|P2|NOT COMPLETED|Overall Study||0
7984026|NCT00214045|19657728|P1|NOT COMPLETED|Overall Study||0
7984027|NCT00214045|19657727|P2|COMPLETED|Overall Study||18
7984028|NCT00214045|19657728|P1|COMPLETED|Overall Study||18
7984029|NCT00214045|19657727|P2|STARTED|Overall Study||18
7984030|NCT00214045|19657728|P1|STARTED|Overall Study||18
7984031|NCT00214019|19657734|P1|NOT COMPLETED|Overall Study||30
7984032|NCT00214019|19657734|P1|COMPLETED|Overall Study||6
7984033|NCT00214019|19657734|P1|Fluticason/Salmeterol Arm|Overall Study||6
7984034|NCT00214019|19657734|P1|Fluticasone/Placebo Arm|Overall Study||6
7984035|NCT00214019|19657734|P1|Placebo/Salmeterol Arm|Overall Study||6
7984036|NCT00214019|19657734|P1|Placebo/Placebo Arm|Overall Study||6
7984037|NCT00214019|19657734|P1|STARTED|Overall Study||36
7984038|NCT00213980|19657743|P2|NOT COMPLETED|Overall Study||7
7984039|NCT00213980|19657744|P1|NOT COMPLETED|Overall Study||6
7984040|NCT00213980|19657743|P2|COMPLETED|Overall Study||29
7984041|NCT00213980|19657744|P1|COMPLETED|Overall Study||26
7984042|NCT00213980|19657743|P2|STARTED|Overall Study||36
7984043|NCT00213980|19657744|P1|STARTED|Overall Study||32
7984044|NCT00213239|19657758|P2|NOT COMPLETED|Overall Study||0
7984045|NCT00213239|19657759|P1|NOT COMPLETED|Overall Study||0
7984046|NCT00213239|19657758|P2|COMPLETED|Overall Study||32
7984047|NCT00213239|19657759|P1|COMPLETED|Overall Study||32
7984048|NCT00213239|19657758|P2|STARTED|Overall Study||32
7984049|NCT00213239|19657759|P1|STARTED|Overall Study||32
7984050|NCT00213148|19657771|P5|NOT COMPLETED|Cycle 3 (1 Month)||1
7984051|NCT00213148|19657772|P4|NOT COMPLETED|Cycle 3 (1 Month)||1
7984052|NCT00213148|19657773|P3|NOT COMPLETED|Cycle 3 (1 Month)||1
7984053|NCT00213148|19657774|P2|NOT COMPLETED|Cycle 3 (1 Month)||2
7984054|NCT00213148|19657775|P1|NOT COMPLETED|Cycle 3 (1 Month)||0
7984055|NCT00213148|19657771|P5|COMPLETED|Cycle 3 (1 Month)||21
7984056|NCT00213148|19657772|P4|COMPLETED|Cycle 3 (1 Month)||23
7984057|NCT00213148|19657773|P3|COMPLETED|Cycle 3 (1 Month)||25
7984058|NCT00213148|19657774|P2|COMPLETED|Cycle 3 (1 Month)||8
7984059|NCT00213148|19657775|P1|COMPLETED|Cycle 3 (1 Month)||23
7984060|NCT00213148|19657771|P5|STARTED|Cycle 3 (1 Month)||22
7984061|NCT00213148|19657772|P4|STARTED|Cycle 3 (1 Month)||24
7984062|NCT00213148|19657773|P3|STARTED|Cycle 3 (1 Month)||26
7984063|NCT00213148|19657774|P2|STARTED|Cycle 3 (1 Month)||10
7984064|NCT00213148|19657775|P1|STARTED|Cycle 3 (1 Month)||23
7984065|NCT00213148|19657771|P5|NOT COMPLETED|Cycle 2 (1 Month)||30
7984066|NCT00213148|19657772|P4|NOT COMPLETED|Cycle 2 (1 Month)||19
7984067|NCT00213148|19657773|P3|NOT COMPLETED|Cycle 2 (1 Month)||14
7984068|NCT00213148|19657774|P2|NOT COMPLETED|Cycle 2 (1 Month)||6
7984069|NCT00213148|19657775|P1|NOT COMPLETED|Cycle 2 (1 Month)||14
7984070|NCT00213148|19657771|P5|COMPLETED|Cycle 2 (1 Month)||11
7984071|NCT00213148|19657772|P4|COMPLETED|Cycle 2 (1 Month)||33
7984072|NCT00213148|19657773|P3|COMPLETED|Cycle 2 (1 Month)||28
7984073|NCT00213148|19657774|P2|COMPLETED|Cycle 2 (1 Month)||4
7984074|NCT00213148|19657775|P1|COMPLETED|Cycle 2 (1 Month)||29
7984075|NCT00213148|19657771|P5|STARTED|Cycle 2 (1 Month)||41
7984076|NCT00213148|19657772|P4|STARTED|Cycle 2 (1 Month)||52
7984077|NCT00213148|19657773|P3|STARTED|Cycle 2 (1 Month)||42
7984078|NCT00213148|19657774|P2|STARTED|Cycle 2 (1 Month)||10
7984079|NCT00213148|19657775|P1|STARTED|Cycle 2 (1 Month)||43
7984080|NCT00213148|19657771|P5|NOT COMPLETED|Cycle 1 (1 Month)||22
7984081|NCT00213148|19657772|P4|NOT COMPLETED|Cycle 1 (1 Month)||18
7984082|NCT00213148|19657773|P3|NOT COMPLETED|Cycle 1 (1 Month)||19
7984083|NCT00213148|19657774|P2|NOT COMPLETED|Cycle 1 (1 Month)||0
7984084|NCT00213148|19657775|P1|NOT COMPLETED|Cycle 1 (1 Month)||24
7984085|NCT00213148|19657771|P5|COMPLETED|Cycle 1 (1 Month)||17
7984086|NCT00213148|19657772|P4|COMPLETED|Cycle 1 (1 Month)||58
7984087|NCT00213148|19657773|P3|COMPLETED|Cycle 1 (1 Month)||60
7984088|NCT00213148|19657774|P2|COMPLETED|Cycle 1 (1 Month)||0
7984089|NCT00213148|19657775|P1|COMPLETED|Cycle 1 (1 Month)||53
7984090|NCT00213148|19657771|P5|STARTED|Cycle 1 (1 Month)||39
7984091|NCT00213148|19657772|P4|STARTED|Cycle 1 (1 Month)||76
7984092|NCT00213148|19657773|P3|STARTED|Cycle 1 (1 Month)||79
7984093|NCT00213148|19657774|P2|STARTED|Cycle 1 (1 Month)||0
7984094|NCT00213148|19657775|P1|STARTED|Cycle 1 (1 Month)||77
7984095|NCT00213135|19657802|P3|NOT COMPLETED|Overall Study||57
7984096|NCT00213135|19657803|P2|NOT COMPLETED|Overall Study||35
7984097|NCT00213135|19657804|P1|NOT COMPLETED|Overall Study||50
7984098|NCT00213135|19657802|P3|COMPLETED|Overall Study||380
7984099|NCT00213135|19657803|P2|COMPLETED|Overall Study||398
7984100|NCT00213135|19657804|P1|COMPLETED|Overall Study||406
7984101|NCT00213135|19657802|P3|STARTED|Overall Study||437
7984102|NCT00213135|19657803|P2|STARTED|Overall Study||433
7984104|NCT00212888|19657824|P3|NOT COMPLETED|Overall Study||1
7984105|NCT00212888|19657825|P2|NOT COMPLETED|Overall Study||0
7984106|NCT00212888|19657826|P1|NOT COMPLETED|Overall Study||3
7984107|NCT00212888|19657824|P3|COMPLETED|Overall Study||14
7984108|NCT00212888|19657825|P2|COMPLETED|Overall Study||18
7984109|NCT00212888|19657826|P1|COMPLETED|Overall Study||16
7984110|NCT00212888|19657824|P3|STARTED|Overall Study||15
7984111|NCT00212888|19657825|P2|STARTED|Overall Study||18
7984112|NCT00212888|19657826|P1|STARTED|Overall Study||19
7984113|NCT00212758|19657847|P2|NOT COMPLETED|Standard Therapy of GH (12 Months)||1
7984114|NCT00212758|19657848|P1|NOT COMPLETED|Standard Therapy of GH (12 Months)||2
7984115|NCT00212758|19657847|P2|COMPLETED|Standard Therapy of GH (12 Months)||8
7984116|NCT00212758|19657848|P1|COMPLETED|Standard Therapy of GH (12 Months)||6
7984117|NCT00212758|19657847|P2|STARTED|Standard Therapy of GH (12 Months)||9
7984118|NCT00212758|19657848|P1|STARTED|Standard Therapy of GH (12 Months)||8
7984119|NCT00212758|19657847|P2|NOT COMPLETED|Second Intervention (7 Days)||0
7984120|NCT00212758|19657848|P1|NOT COMPLETED|Second Intervention (7 Days)||0
7984121|NCT00212758|19657847|P2|COMPLETED|Second Intervention (7 Days)||9
7984122|NCT00212758|19657848|P1|COMPLETED|Second Intervention (7 Days)||8
7984123|NCT00212758|19657847|P2|STARTED|Second Intervention (7 Days)||9
7984124|NCT00212758|19657848|P1|STARTED|Second Intervention (7 Days)||8
7984125|NCT00212758|19657847|P2|NOT COMPLETED|Wash Out Period (2 Weeks)||0
7984126|NCT00212758|19657848|P1|NOT COMPLETED|Wash Out Period (2 Weeks)||0
7984127|NCT00212758|19657847|P2|COMPLETED|Wash Out Period (2 Weeks)||9
7984128|NCT00212758|19657848|P1|COMPLETED|Wash Out Period (2 Weeks)||8
7984129|NCT00212758|19657847|P2|STARTED|Wash Out Period (2 Weeks)||9
7984130|NCT00212758|19657848|P1|STARTED|Wash Out Period (2 Weeks)||8
7984131|NCT00212758|19657847|P2|NOT COMPLETED|First Intervention (7 Days)||0
7984132|NCT00212758|19657848|P1|NOT COMPLETED|First Intervention (7 Days)||0
7984133|NCT00212758|19657847|P2|COMPLETED|First Intervention (7 Days)||9
7984134|NCT00212758|19657848|P1|COMPLETED|First Intervention (7 Days)||8
7984135|NCT00212758|19657847|P2|STARTED|First Intervention (7 Days)||9
7984136|NCT00212758|19657848|P1|STARTED|First Intervention (7 Days)||8
7984137|NCT00212446|19657854|P1|NOT COMPLETED|Overall Study||0
7984138|NCT00212446|19657854|P1|COMPLETED|Overall Study||8
7984139|NCT00212446|19657854|P1|STARTED|Overall Study||8
7984140|NCT00212355|19657864|P1|NOT COMPLETED|Overall Study||3
7984141|NCT00212355|19657864|P1|COMPLETED|Overall Study||34
7984142|NCT00212355|19657864|P1|STARTED|Overall Study||37
7984143|NCT00212264|19657871|P3|NOT COMPLETED|Overall Study||4
7984144|NCT00212264|19657872|P2|NOT COMPLETED|Overall Study||16
7984145|NCT00212264|19657873|P1|NOT COMPLETED|Overall Study||12
7984146|NCT00212264|19657871|P3|COMPLETED|Overall Study||64
7984147|NCT00212264|19657872|P2|COMPLETED|Overall Study||54
7984148|NCT00212264|19657873|P1|COMPLETED|Overall Study||58
7984149|NCT00212264|19657871|P3|STARTED|Overall Study||68
7984150|NCT00212264|19657872|P2|STARTED|Overall Study||70
7984151|NCT00212264|19657873|P1|STARTED|Overall Study||70
7984152|NCT00212134|19657885|P2|NOT COMPLETED|Phase 3 (Age 10 Years)||21
7984153|NCT00212134|19657886|P1|NOT COMPLETED|Phase 3 (Age 10 Years)||21
7984154|NCT00212134|19657885|P2|COMPLETED|Phase 3 (Age 10 Years)||35
7984155|NCT00212134|19657886|P1|COMPLETED|Phase 3 (Age 10 Years)||36
7984156|NCT00212134|19657885|P2|STARTED|Phase 3 (Age 10 Years)||56
7984157|NCT00212134|19657886|P1|STARTED|Phase 3 (Age 10 Years)||57
7984158|NCT00212134|19657885|P2|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1
7984159|NCT00212134|19657886|P1|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0
7984160|NCT00212134|19657885|P2|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56
7984161|NCT00212134|19657886|P1|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57
7984162|NCT00212134|19657885|P2|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
7984163|NCT00212134|19657886|P1|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
7984164|NCT00212134|19657885|P2|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
7984165|NCT00212134|19657886|P1|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
7984166|NCT00212134|19657885|P2|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
7984167|NCT00212134|19657886|P1|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
7984168|NCT00212134|19657885|P2|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
7984169|NCT00212134|19657886|P1|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
7984170|NCT00212134|19657885|P2|STARTED|Phase 1 (to Age 1 Year)||57
7984171|NCT00212134|19657886|P1|STARTED|Phase 1 (to Age 1 Year)||57
7984172|NCT00211887|19657907|P3|NOT COMPLETED|Overall Study||36
7984173|NCT00211887|19657908|P2|NOT COMPLETED|Overall Study||56
7984174|NCT00211887|19657909|P1|NOT COMPLETED|Overall Study||102
7984175|NCT00211887|19657907|P3|COMPLETED|Overall Study||223
7984176|NCT00211887|19657908|P2|COMPLETED|Overall Study||194
7984177|NCT00211887|19657909|P1|COMPLETED|Overall Study||397
7984178|NCT00211887|19657907|P3|STARTED|Overall Study||259
7984179|NCT00211887|19657908|P2|STARTED|Overall Study||250
7984180|NCT00211887|19657909|P1|STARTED|Overall Study||499
7984181|NCT00211809|19657926|P1|NOT COMPLETED|Overall Study||6
7984182|NCT00211809|19657926|P1|COMPLETED|Overall Study||11
7984183|NCT00211809|19657926|P1|STARTED|Overall Study||17
7984184|NCT00211757|19657942|P2|NOT COMPLETED|Overall Study||2
7984185|NCT00211757|19657943|P1|NOT COMPLETED|Overall Study||1
7984186|NCT00211757|19657942|P2|COMPLETED|Overall Study||14
7984187|NCT00211757|19657943|P1|COMPLETED|Overall Study||10
7984188|NCT00211757|19657942|P2|STARTED|Overall Study||16
7984189|NCT00211757|19657943|P1|STARTED|Overall Study||11
7984190|NCT00211692|19657953|P2|NOT COMPLETED|Overall Study||0
7984191|NCT00211692|19657954|P1|NOT COMPLETED|Overall Study||0
7984192|NCT00211692|19657953|P2|COMPLETED|Overall Study||31
7984193|NCT00211692|19657954|P1|COMPLETED|Overall Study||33
7984194|NCT00211692|19657953|P2|STARTED|Overall Study||31
7984195|NCT00211692|19657954|P1|STARTED|Overall Study||33
7984196|NCT00211536|19657964|P2|NOT COMPLETED|Overall Study||7
7984197|NCT00211536|19657965|P1|NOT COMPLETED|Overall Study||4
7984198|NCT00211536|19657964|P2|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47
7984199|NCT00211536|19657965|P1|COMPLETED|Overall Study||49
7984200|NCT00211536|19657964|P2|As Treated Data Analysis Set|Overall Study||48
7984201|NCT00211536|19657965|P1|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52
7984202|NCT00211536|19657964|P2|STARTED|Overall Study||54
7984203|NCT00211536|19657965|P1|STARTED|Overall Study||53
7984204|NCT00211510|19657981|P2|NOT COMPLETED|Overall Study||2
7984205|NCT00211510|19657982|P1|NOT COMPLETED|Overall Study||6
7984206|NCT00211510|19657981|P2|COMPLETED|Overall Study||72
7984207|NCT00211510|19657982|P1|COMPLETED|Overall Study||66
7984208|NCT00211510|19657981|P2|STARTED|Overall Study||74
7984209|NCT00211510|19657982|P1|STARTED|Overall Study||72
7984210|NCT00211237|19658000|P3|NOT COMPLETED|12 Months||6
7984211|NCT00211237|19658001|P2|NOT COMPLETED|12 Months||2
7984212|NCT00211237|19658002|P1|NOT COMPLETED|12 Months||9
7984213|NCT00211237|19658000|P3|COMPLETED|12 Months||28
7984214|NCT00211237|19658001|P2|COMPLETED|12 Months||6
7984215|NCT00211237|19658002|P1|COMPLETED|12 Months||40
7984216|NCT00211237|19658000|P3|STARTED|12 Months||34
7984217|NCT00211237|19658001|P2|STARTED|12 Months|1 patient crossed over Balloon Kyphoplasty|8
7984218|NCT00211237|19658002|P1|STARTED|12 Months||49
7984219|NCT00211237|19658000|P3|NOT COMPLETED|6 Months||3
7984220|NCT00211237|19658001|P2|NOT COMPLETED|6 Months||2
7984221|NCT00211237|19658002|P1|NOT COMPLETED|6 Months||8
7984222|NCT00211237|19658000|P3|COMPLETED|6 Months||33
7984223|NCT00211237|19658001|P2|COMPLETED|6 Months||9
7984224|NCT00211237|19658002|P1|COMPLETED|6 Months||49
7984225|NCT00211237|19658000|P3|STARTED|6 Months||36
7984226|NCT00211237|19658001|P2|STARTED|6 Months|3 patients crossed over Balloon Kyphoplasty|11
7984227|NCT00211237|19658002|P1|STARTED|6 Months||57
7984228|NCT00211237|19658000|P3|NOT COMPLETED|3 Months||1
7984229|NCT00211237|19658001|P2|NOT COMPLETED|3 Months||4
7984230|NCT00211237|19658002|P1|NOT COMPLETED|3 Months||8
7984231|NCT00211237|19658000|P3|COMPLETED|3 Months||33
7984232|NCT00211237|19658001|P2|COMPLETED|3 Months||14
7984233|NCT00211237|19658002|P1|COMPLETED|3 Months||57
7984234|NCT00211237|19658000|P3|STARTED|3 Months||34
7984235|NCT00211237|19658001|P2|STARTED|3 Months|34 patients crossed over to Balloon Kyphoplasty.|18
7984236|NCT00211237|19658002|P1|STARTED|3 Months||65
7984237|NCT00211237|19658000|P3|NOT COMPLETED|1 Month||0
7984238|NCT00211237|19658001|P2|NOT COMPLETED|1 Month||9
7984239|NCT00211237|19658002|P1|NOT COMPLETED|1 Month||3
7984240|NCT00211237|19658000|P3|COMPLETED|1 Month||0
7984241|NCT00211237|19658001|P2|COMPLETED|1 Month||52
7984242|NCT00211237|19658002|P1|COMPLETED|1 Month||65
7984243|NCT00211237|19658000|P3|STARTED|1 Month||0
7984244|NCT00211237|19658001|P2|STARTED|1 Month||61
7984245|NCT00211237|19658002|P1|STARTED|1 Month||68
7984246|NCT00211237|19658000|P3|NOT COMPLETED|Baseline||0
7984247|NCT00211237|19658001|P2|NOT COMPLETED|Baseline||3
7984248|NCT00211237|19658002|P1|NOT COMPLETED|Baseline||2
7984249|NCT00211237|19658000|P3|COMPLETED|Baseline||0
7984250|NCT00211237|19658001|P2|COMPLETED|Baseline||61
7984251|NCT00211237|19658002|P1|COMPLETED|Baseline||68
7984252|NCT00211237|19658000|P3|STARTED|Baseline||0
7984253|NCT00211237|19658001|P2|STARTED|Baseline||64
7984254|NCT00211237|19658002|P1|STARTED|Baseline||70
7984255|NCT00211185|19658092|P1|NOT COMPLETED|Overall Study||20
7984256|NCT00211185|19658092|P1|COMPLETED|Overall Study||29
7984257|NCT00211185|19658092|P1|STARTED|Overall Study||49
7984258|NCT00211172|19658106|P2|NOT COMPLETED|Overall Study||32
7984259|NCT00211172|19658107|P1|NOT COMPLETED|Overall Study||39
7984260|NCT00211172|19658106|P2|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426
7984261|NCT00211172|19658107|P1|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410
7984262|NCT00211172|19658106|P2|STARTED|Overall Study||458
7984263|NCT00211172|19658107|P1|STARTED|Overall Study||449
7984264|NCT00211081|19658113|P1|NOT COMPLETED|Overall Study||2
7984265|NCT00211081|19658113|P1|COMPLETED|Overall Study||10
7984266|NCT00211081|19658113|P1|STARTED|Overall Study||12
7984267|NCT00210639|19658125|P2|NOT COMPLETED|Overall Study||42
7984268|NCT00210639|19658126|P1|NOT COMPLETED|Overall Study||63
7984269|NCT00210639|19658125|P2|COMPLETED|Overall Study||41
7984270|NCT00210639|19658126|P1|COMPLETED|Overall Study||61
7984271|NCT00210639|19658125|P2|STARTED|Overall Study||83
7984272|NCT00210639|19658126|P1|STARTED|Overall Study||124
7984273|NCT00210626|19658134|P2|NOT COMPLETED|Overall Study||45
7984274|NCT00210626|19658135|P1|NOT COMPLETED|Overall Study||48
7984275|NCT00210626|19658134|P2|COMPLETED|Overall Study||50
7984276|NCT00210626|19658135|P1|COMPLETED|Overall Study||49
7984277|NCT00210626|19658134|P2|STARTED|Overall Study||95
7984278|NCT00210626|19658135|P1|STARTED|Overall Study||97
7984279|NCT00210470|19658143|P1|NOT COMPLETED|Overall Study||0
7984280|NCT00210470|19658143|P1|COMPLETED|Overall Study||27
7984281|NCT00210470|19658143|P1|STARTED|Overall Study||27
7984282|NCT00210353|19658158|P3|NOT COMPLETED|Overall Study||26
7984283|NCT00210353|19658159|P2|NOT COMPLETED|Overall Study||45
7984284|NCT00210353|19658160|P1|NOT COMPLETED|Overall Study||38
7984285|NCT00210353|19658158|P3|COMPLETED|Overall Study||125
7984286|NCT00210353|19658159|P2|COMPLETED|Overall Study||107
7984287|NCT00210353|19658160|P1|COMPLETED|Overall Study||113
7984288|NCT00210353|19658158|P3|STARTED|Overall Study||151
7984289|NCT00210353|19658159|P2|STARTED|Overall Study||152
7984290|NCT00210353|19658160|P1|STARTED|Overall Study||151
7984291|NCT00209560|19658182|P2|NOT COMPLETED|Overall Study||0
7984292|NCT00209560|19658183|P1|NOT COMPLETED|Overall Study||1
7984293|NCT00209560|19658182|P2|COMPLETED|Overall Study||42
7984294|NCT00209560|19658183|P1|COMPLETED|Overall Study||120
7984295|NCT00209560|19658182|P2|STARTED|Overall Study||42
7984296|NCT00209560|19658183|P1|STARTED|Overall Study||121
7984297|NCT00209417|19658193|P2|NOT COMPLETED|Overall Study||0
7984298|NCT00209417|19658194|P1|NOT COMPLETED|Overall Study||0
7984299|NCT00209417|19658193|P2|COMPLETED|Overall Study||327
7984300|NCT00209417|19658194|P1|COMPLETED|Overall Study||321
7984301|NCT00209417|19658193|P2|STARTED|Overall Study||327
7984302|NCT00209417|19658194|P1|STARTED|Overall Study||321
7984303|NCT00209339|19658202|P1|NOT COMPLETED|At 5 Years Follow-up||8
7984304|NCT00209339|19658202|P1|COMPLETED|At 5 Years Follow-up||15
7984305|NCT00209339|19658202|P1|STARTED|At 5 Years Follow-up||23
7984306|NCT00209339|19658202|P1|NOT COMPLETED|At 4 Years Follow-up||5
7984307|NCT00209339|19658202|P1|COMPLETED|At 4 Years Follow-up||23
7984308|NCT00209339|19658202|P1|STARTED|At 4 Years Follow-up||28
7984309|NCT00209339|19658202|P1|NOT COMPLETED|At 3 Years Follow-up||1
7984310|NCT00209339|19658202|P1|COMPLETED|At 3 Years Follow-up||28
7984311|NCT00209339|19658202|P1|STARTED|At 3 Years Follow-up||29
7984312|NCT00209339|19658202|P1|NOT COMPLETED|At 24 Months Follow-up||11
7984313|NCT00209339|19658202|P1|COMPLETED|At 24 Months Follow-up||29
7984314|NCT00209339|19658202|P1|STARTED|At 24 Months Follow-up||40
7984315|NCT00209339|19658202|P1|NOT COMPLETED|At 12 Months Follow-up||15
7984316|NCT00209339|19658202|P1|COMPLETED|At 12 Months Follow-up||40
7984317|NCT00209339|19658202|P1|STARTED|At 12 Months Follow-up||55
7984318|NCT00209274|19658286|P2|NOT COMPLETED|Overall Study||47
7984319|NCT00209274|19658287|P1|NOT COMPLETED|Overall Study||71
7984320|NCT00209274|19658286|P2|COMPLETED|Overall Study||48
7984321|NCT00209274|19658287|P1|COMPLETED|Overall Study||113
7984322|NCT00209274|19658286|P2|STARTED|Overall Study||95
7984323|NCT00209274|19658287|P1|STARTED|Overall Study||184
7984324|NCT00209170|19658607|P2|NOT COMPLETED|Overall Study||3
7984325|NCT00209170|19658608|P1|NOT COMPLETED|Overall Study||2
7984326|NCT00209170|19658607|P2|COMPLETED|Overall Study||4
7984327|NCT00209170|19658608|P1|COMPLETED|Overall Study||5
7984328|NCT00209170|19658607|P2|STARTED|Overall Study||7
7984329|NCT00209170|19658608|P1|STARTED|Overall Study||7
7984330|NCT00209131|19658616|P2|NOT COMPLETED|Overall Study||11
7984331|NCT00209131|19658617|P1|NOT COMPLETED|Overall Study||15
7984332|NCT00209131|19658616|P2|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
7984333|NCT00209131|19658617|P1|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
7984334|NCT00209131|19658616|P2|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11
7984335|NCT00209131|19658617|P1|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15
7984336|NCT00209092|19658627|P2|NOT COMPLETED|Overall Study||2
7984337|NCT00209092|19658628|P1|NOT COMPLETED|Overall Study||8
7984338|NCT00209092|19658627|P2|COMPLETED|Overall Study||24
7984339|NCT00209092|19658628|P1|COMPLETED|Overall Study||17
7984340|NCT00209092|19658627|P2|STARTED|Overall Study||26
7984341|NCT00209092|19658628|P1|STARTED|Overall Study||25
7984342|NCT00209027|19658638|P2|NOT COMPLETED|Overall Study||0
7984343|NCT00209027|19658639|P1|NOT COMPLETED|Overall Study||10
7984344|NCT00209027|19658638|P2|COMPLETED|Overall Study||10
7984345|NCT00209027|19658639|P1|COMPLETED|Overall Study||0
7984346|NCT00209027|19658638|P2|STARTED|Overall Study||10
7984347|NCT00209027|19658639|P1|STARTED|Overall Study||10
7984348|NCT00208975|19658645|P1|NOT COMPLETED|Overall Study||0
7984349|NCT00208975|19658645|P1|COMPLETED|Overall Study||15
7984350|NCT00208975|19658645|P1|STARTED|Overall Study||15
7984351|NCT00208949|19658652|P2|NOT COMPLETED|Overall Study||0
7984352|NCT00208949|19658653|P1|NOT COMPLETED|Overall Study||0
7984353|NCT00208949|19658652|P2|COMPLETED|Overall Study||25
7984354|NCT00208949|19658653|P1|COMPLETED|Overall Study||25
7984355|NCT00208949|19658652|P2|STARTED|Overall Study||25
7984356|NCT00208949|19658653|P1|STARTED|Overall Study||25
7984357|NCT00208767|19658663|P2|NOT COMPLETED|Overall Study||7
7984358|NCT00208767|19658664|P1|NOT COMPLETED|Overall Study||27
7984359|NCT00208767|19658663|P2|COMPLETED|Overall Study||33
7984360|NCT00208767|19658664|P1|COMPLETED|Overall Study||53
7984361|NCT00208767|19658663|P2|STARTED|Overall Study||40
7984362|NCT00208767|19658664|P1|STARTED|Overall Study||80
7984363|NCT00208507|19658672|P2|NOT COMPLETED|Overall Study||8
7984364|NCT00208507|19658673|P1|NOT COMPLETED|Overall Study||14
7984365|NCT00208507|19658672|P2|COMPLETED|Overall Study||79
7984366|NCT00208507|19658673|P1|COMPLETED|Overall Study||163
7984367|NCT00208507|19658672|P2|STARTED|Overall Study||87
7984368|NCT00208507|19658673|P1|STARTED|Overall Study||177
7984369|NCT00208494|19658681|P2|NOT COMPLETED|Overall Study||34
7984370|NCT00208494|19658682|P1|NOT COMPLETED|Overall Study||30
7984371|NCT00208494|19658681|P2|COMPLETED|Overall Study||162
7984372|NCT00208494|19658682|P1|COMPLETED|Overall Study||164
7984373|NCT00208494|19658681|P2|STARTED|Overall Study||196
7984374|NCT00208494|19658682|P1|STARTED|Overall Study||194
7984375|NCT00208325|19658692|P4|NOT COMPLETED|Overall Study||14
7984376|NCT00208325|19658693|P3|NOT COMPLETED|Overall Study||14
7984377|NCT00208325|19658694|P2|NOT COMPLETED|Overall Study||54
7984378|NCT00208325|19658695|P1|NOT COMPLETED|Overall Study||51
7984379|NCT00208325|19658692|P4|COMPLETED|Overall Study||147
7984380|NCT00208325|19658693|P3|COMPLETED|Overall Study||156
7984381|NCT00208325|19658694|P2|COMPLETED|Overall Study||142
7984382|NCT00208325|19658695|P1|COMPLETED|Overall Study||142
7984383|NCT00208325|19658692|P4|STARTED|Overall Study||161
7984384|NCT00208325|19658693|P3|STARTED|Overall Study||170
7984385|NCT00208325|19658694|P2|STARTED|Overall Study||196
7984386|NCT00208325|19658695|P1|STARTED|Overall Study||193
7984387|NCT00208091|19658803|P1|NOT COMPLETED|Overall Study||0
7984388|NCT00208091|19658803|P1|COMPLETED|Overall Study||16
7984389|NCT00208091|19658803|P1|STARTED|Overall Study||16
7984390|NCT00208026|19658811|P1|NOT COMPLETED|Overall Study||0
7984391|NCT00208026|19658811|P1|COMPLETED|Overall Study||3
7984392|NCT00208026|19658811|P1|STARTED|Overall Study||3
7984393|NCT00207883|19658819|P2|NOT COMPLETED|Overall Study||0
7984394|NCT00207883|19658820|P1|NOT COMPLETED|Overall Study||0
7984395|NCT00207883|19658819|P2|COMPLETED|Overall Study||119
7984396|NCT00207883|19658820|P1|COMPLETED|Overall Study||93
7984397|NCT00207883|19658819|P2|STARTED|Overall Study||119
7984398|NCT00207883|19658820|P1|STARTED|Overall Study||93
7984399|NCT00207740|19658832|P4|NOT COMPLETED|Overall Study||43
7984400|NCT00207740|19658833|P3|NOT COMPLETED|Overall Study||40
7984401|NCT00207740|19658834|P2|NOT COMPLETED|Overall Study||41
7984402|NCT00207740|19658835|P1|NOT COMPLETED|Overall Study||29
7984403|NCT00207740|19658832|P4|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35
7984404|NCT00207740|19658833|P3|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
7984405|NCT00207740|19658834|P2|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
7984406|NCT00207740|19658835|P1|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49
7984407|NCT00207740|19658832|P4|STARTED|Overall Study||78
7984408|NCT00207740|19658833|P3|STARTED|Overall Study||76
7984409|NCT00207740|19658834|P2|STARTED|Overall Study||77
7984410|NCT00207740|19658835|P1|STARTED|Overall Study||78
7984411|NCT00207727|19658881|P5|NOT COMPLETED|Overall Study||34
7984412|NCT00207727|19658882|P4|NOT COMPLETED|Overall Study||37
7984413|NCT00207727|19658883|P3|NOT COMPLETED|Overall Study||41
7984414|NCT00207727|19658884|P2|NOT COMPLETED|Overall Study||42
7984415|NCT00207727|19658885|P1|NOT COMPLETED|Overall Study||38
7984416|NCT00207727|19658881|P5|COMPLETED|Overall Study||16
7984417|NCT00207727|19658882|P4|COMPLETED|Overall Study||13
7984418|NCT00207727|19658883|P3|COMPLETED|Overall Study||9
7984419|NCT00207727|19658884|P2|COMPLETED|Overall Study||8
7984420|NCT00207727|19658885|P1|COMPLETED|Overall Study||11
7984421|NCT00207727|19658881|P5|STARTED|Overall Study||50
7984422|NCT00207727|19658882|P4|STARTED|Overall Study||50
7984423|NCT00207727|19658883|P3|STARTED|Overall Study||50
7984424|NCT00207727|19658884|P2|STARTED|Overall Study||50
7984425|NCT00207727|19658885|P1|STARTED|Overall Study||49
7984426|NCT00207714|19658912|P5|NOT COMPLETED|Overall Study||5
7984427|NCT00207714|19658913|P4|NOT COMPLETED|Overall Study||8
7984428|NCT00207714|19658914|P3|NOT COMPLETED|Overall Study||10
7984429|NCT00207714|19658915|P2|NOT COMPLETED|Overall Study||7
7984430|NCT00207714|19658916|P1|NOT COMPLETED|Overall Study||14
7984431|NCT00207714|19658912|P5|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29
7984432|NCT00207714|19658913|P4|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26
7984433|NCT00207714|19658914|P3|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24
7984434|NCT00207714|19658915|P2|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28
7984435|NCT00207714|19658916|P1|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21
7984436|NCT00207714|19658912|P5|STARTED|Overall Study||34
7984437|NCT00207714|19658913|P4|STARTED|Overall Study||34
7984438|NCT00207714|19658914|P3|STARTED|Overall Study||34
7984439|NCT00207714|19658915|P2|STARTED|Overall Study||35
7984440|NCT00207714|19658916|P1|STARTED|Overall Study||35
7984441|NCT00207142|19658938|P4|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
7984442|NCT00207142|19658939|P3|NOT COMPLETED|Maintenance Phase/Rescue Phase||13
7984443|NCT00207142|19658940|P2|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
7984444|NCT00207142|19658941|P1|NOT COMPLETED|Maintenance Phase/Rescue Phase||0
7984445|NCT00207142|19658938|P4|COMPLETED|Maintenance Phase/Rescue Phase||41
7984446|NCT00207142|19658939|P3|COMPLETED|Maintenance Phase/Rescue Phase||72
7984447|NCT00207142|19658940|P2|COMPLETED|Maintenance Phase/Rescue Phase||78
7984448|NCT00207142|19658941|P1|COMPLETED|Maintenance Phase/Rescue Phase||0
7984449|NCT00207142|19658938|P4|STARTED|Maintenance Phase/Rescue Phase||50
7984450|NCT00207142|19658939|P3|STARTED|Maintenance Phase/Rescue Phase||85
7984451|NCT00207142|19658940|P2|STARTED|Maintenance Phase/Rescue Phase||87
7984452|NCT00207142|19658941|P1|STARTED|Maintenance Phase/Rescue Phase||0
7984453|NCT00207142|19658938|P4|NOT COMPLETED|Induction Phase||0
7984454|NCT00207142|19658939|P3|NOT COMPLETED|Induction Phase||0
7984455|NCT00207142|19658940|P2|NOT COMPLETED|Induction Phase||0
7984456|NCT00207142|19658941|P1|NOT COMPLETED|Induction Phase||30
7984457|NCT00207142|19658938|P4|COMPLETED|Induction Phase||0
7984458|NCT00207142|19658939|P3|COMPLETED|Induction Phase||0
7984459|NCT00207142|19658940|P2|COMPLETED|Induction Phase||0
7984550|NCT00205777|19659194|P4|NOT COMPLETED|Study Extension II||149
7984460|NCT00207142|19658941|P1|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222
7984461|NCT00207142|19658938|P4|STARTED|Induction Phase||0
7984462|NCT00207142|19658939|P3|STARTED|Induction Phase||0
7984463|NCT00207142|19658940|P2|STARTED|Induction Phase||0
7984464|NCT00207142|19658941|P1|STARTED|Induction Phase||252
7984465|NCT00207090|19658978|P1|NOT COMPLETED|Overall Study||7
7984466|NCT00207090|19658978|P1|COMPLETED|Overall Study||8
7984467|NCT00207090|19658978|P1|STARTED|Overall Study|Number of participants treated|15
7984468|NCT00206726|19659007|P1|NOT COMPLETED|Overall Study||51
7984469|NCT00206726|19659007|P1|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9
7984470|NCT00206726|19659007|P1|4 Cycles Completed|Overall Study|per protocol population|41
7984471|NCT00206726|19659007|P1|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57
7984472|NCT00206726|19659007|P1|STARTED|Overall Study||60
7984473|NCT00206518|19659018|P2|NOT COMPLETED|Overall Study||6
7984474|NCT00206518|19659019|P1|NOT COMPLETED|Overall Study||10
7984475|NCT00206518|19659018|P2|COMPLETED|Overall Study||78
7984476|NCT00206518|19659019|P1|COMPLETED|Overall Study||73
7984477|NCT00206518|19659018|P2|STARTED|Overall Study||84
7984478|NCT00206518|19659019|P1|STARTED|Overall Study||83
7984479|NCT00206440|19659031|P2|NOT COMPLETED|Overall Study||4
7984480|NCT00206440|19659032|P1|NOT COMPLETED|Overall Study||5
7984481|NCT00206440|19659031|P2|COMPLETED|Overall Study||18
7984482|NCT00206440|19659032|P1|COMPLETED|Overall Study||16
7984483|NCT00206440|19659031|P2|STARTED|Overall Study||22
7984484|NCT00206440|19659032|P1|STARTED|Overall Study||21
7984485|NCT00206427|19659038|P1|NOT COMPLETED|Overall Study||2
7984486|NCT00206427|19659038|P1|COMPLETED|Overall Study|Complete 6-week therapy|47
7984487|NCT00206427|19659038|P1|STARTED|Overall Study|Received First Dose|49
7984488|NCT00206375|19659045|P3|NOT COMPLETED|Overall Study||4
7984489|NCT00206375|19659046|P2|NOT COMPLETED|Overall Study||2
7984490|NCT00206375|19659047|P1|NOT COMPLETED|Overall Study||3
7984491|NCT00206375|19659045|P3|COMPLETED|Overall Study||3
7984492|NCT00206375|19659046|P2|COMPLETED|Overall Study||1
7984493|NCT00206375|19659047|P1|COMPLETED|Overall Study||3
7984494|NCT00206375|19659045|P3|STARTED|Overall Study||7
7984495|NCT00206375|19659046|P2|STARTED|Overall Study||3
7984496|NCT00206375|19659047|P1|STARTED|Overall Study||6
7984497|NCT00206336|19659061|P1|NOT COMPLETED|Overall Study||0
7984498|NCT00206336|19659061|P1|COMPLETED|Overall Study||20
7984499|NCT00206336|19659061|P1|STARTED|Overall Study||20
7984500|NCT00206323|19659067|P2|NOT COMPLETED|Overall Study||3
7984501|NCT00206323|19659068|P1|NOT COMPLETED|Overall Study||6
7984502|NCT00206323|19659067|P2|COMPLETED|Overall Study||12
7984503|NCT00206323|19659068|P1|COMPLETED|Overall Study||8
7984504|NCT00206323|19659067|P2|STARTED|Overall Study||15
7984505|NCT00206323|19659068|P1|STARTED|Overall Study||14
7984506|NCT00206102|19659076|P2|NOT COMPLETED|Overall Study||315
7984507|NCT00206102|19659077|P1|NOT COMPLETED|Overall Study||408
7984508|NCT00206102|19659076|P2|COMPLETED|Overall Study||187
7984509|NCT00206102|19659077|P1|COMPLETED|Overall Study||188
7984510|NCT00206102|19659076|P2|STARTED|Overall Study||502
7984511|NCT00206102|19659077|P1|STARTED|Overall Study||596
7984512|NCT00206076|19659113|P2|NOT COMPLETED|Overall Study||1
7984513|NCT00206076|19659114|P1|NOT COMPLETED|Overall Study||3
7984514|NCT00206076|19659113|P2|COMPLETED|Overall Study||9
7984515|NCT00206076|19659114|P1|COMPLETED|Overall Study||6
7984516|NCT00206076|19659113|P2|STARTED|Overall Study||10
7984517|NCT00206076|19659114|P1|STARTED|Overall Study||9
7984518|NCT00205881|19659124|P1|NOT COMPLETED|Overall Study||16
7984519|NCT00205881|19659124|P1|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16
7984520|NCT00205881|19659124|P1|STARTED|Overall Study||32
7984521|NCT00205855|19659129|P1|NOT COMPLETED|Overall Study||21
7984522|NCT00205855|19659129|P1|COMPLETED|Overall Study||44
7984523|NCT00205855|19659129|P1|STARTED|Overall Study||65
7984524|NCT00205803|19659135|P2|NOT COMPLETED|Toddler Dose||3
7984525|NCT00205803|19659136|P1|NOT COMPLETED|Toddler Dose||2
7984526|NCT00205803|19659135|P2|COMPLETED|Toddler Dose||100
7984527|NCT00205803|19659136|P1|COMPLETED|Toddler Dose||84
7984528|NCT00205803|19659135|P2|STARTED|Toddler Dose||103
7984529|NCT00205803|19659136|P1|STARTED|Toddler Dose||86
7984530|NCT00205803|19659135|P2|NOT COMPLETED|After Infant Series||13
7984531|NCT00205803|19659136|P1|NOT COMPLETED|After Infant Series||18
7984532|NCT00205803|19659135|P2|COMPLETED|After Infant Series||103
7984533|NCT00205803|19659136|P1|COMPLETED|After Infant Series||86
7984534|NCT00205803|19659135|P2|STARTED|After Infant Series||116
7984535|NCT00205803|19659136|P1|STARTED|After Infant Series||104
7984536|NCT00205803|19659135|P2|NOT COMPLETED|Infant Series||11
7984537|NCT00205803|19659136|P1|NOT COMPLETED|Infant Series||18
7984538|NCT00205803|19659135|P2|COMPLETED|Infant Series||116
7984539|NCT00205803|19659136|P1|COMPLETED|Infant Series||104
7984540|NCT00205803|19659135|P2|Vaccinated Dose 3|Infant Series||118
7984541|NCT00205803|19659136|P1|Vaccinated Dose 3|Infant Series||110
7984542|NCT00205803|19659135|P2|Vaccinated Dose 2|Infant Series||122
7984543|NCT00205803|19659136|P1|Vaccinated Dose 2|Infant Series||115
7984544|NCT00205803|19659135|P2|Vaccinated Dose 1|Infant Series||126
7984545|NCT00205803|19659136|P1|Vaccinated Dose 1|Infant Series||121
7984546|NCT00205803|19659135|P2|STARTED|Infant Series||127
7984547|NCT00205803|19659136|P1|STARTED|Infant Series||122
7984548|NCT00205777|19659192|P6|NOT COMPLETED|Study Extension II||282
7984549|NCT00205777|19659193|P5|NOT COMPLETED|Study Extension II||0
7984551|NCT00205777|19659195|P3|NOT COMPLETED|Study Extension II||0
7984552|NCT00205777|19659196|P2|NOT COMPLETED|Study Extension II||0
7984553|NCT00205777|19659197|P1|NOT COMPLETED|Study Extension II||0
7984554|NCT00205777|19659192|P6|COMPLETED|Study Extension II||860
7984555|NCT00205777|19659193|P5|COMPLETED|Study Extension II||0
7984556|NCT00205777|19659194|P4|COMPLETED|Study Extension II||441
7984557|NCT00205777|19659195|P3|COMPLETED|Study Extension II||0
7984558|NCT00205777|19659196|P2|COMPLETED|Study Extension II||0
7984559|NCT00205777|19659197|P1|COMPLETED|Study Extension II||0
7984560|NCT00205777|19659192|P6|TREATED|Study Extension II||1011
7984561|NCT00205777|19659193|P5|TREATED|Study Extension II||0
7984562|NCT00205777|19659194|P4|TREATED|Study Extension II||519
7984563|NCT00205777|19659195|P3|TREATED|Study Extension II||0
7984564|NCT00205777|19659196|P2|TREATED|Study Extension II||0
7984565|NCT00205777|19659197|P1|TREATED|Study Extension II||0
7984566|NCT00205777|19659192|P6|STARTED|Study Extension II||1142
7984567|NCT00205777|19659193|P5|STARTED|Study Extension II||0
7984568|NCT00205777|19659194|P4|STARTED|Study Extension II||590
7984569|NCT00205777|19659195|P3|STARTED|Study Extension II||0
7984570|NCT00205777|19659196|P2|STARTED|Study Extension II||0
7984571|NCT00205777|19659197|P1|STARTED|Study Extension II||0
7984572|NCT00205777|19659192|P6|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
7984573|NCT00205777|19659193|P5|NOT COMPLETED|Completed SE I, Entered Extension SE II||258
7984574|NCT00205777|19659194|P4|NOT COMPLETED|Completed SE I, Entered Extension SE II||240
7984575|NCT00205777|19659195|P3|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
7984576|NCT00205777|19659196|P2|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
7984577|NCT00205777|19659197|P1|NOT COMPLETED|Completed SE I, Entered Extension SE II||273
7984578|NCT00205777|19659192|P6|COMPLETED|Completed SE I, Entered Extension SE II||0
7984579|NCT00205777|19659193|P5|COMPLETED|Completed SE I, Entered Extension SE II||582
7984580|NCT00205777|19659194|P4|COMPLETED|Completed SE I, Entered Extension SE II||590
7984581|NCT00205777|19659195|P3|COMPLETED|Completed SE I, Entered Extension SE II||0
7984582|NCT00205777|19659196|P2|COMPLETED|Completed SE I, Entered Extension SE II||0
7984583|NCT00205777|19659197|P1|COMPLETED|Completed SE I, Entered Extension SE II||560
7984584|NCT00205777|19659192|P6|STARTED|Completed SE I, Entered Extension SE II||0
7984585|NCT00205777|19659193|P5|STARTED|Completed SE I, Entered Extension SE II||840
7984586|NCT00205777|19659194|P4|STARTED|Completed SE I, Entered Extension SE II||830
7984587|NCT00205777|19659195|P3|STARTED|Completed SE I, Entered Extension SE II||0
7984588|NCT00205777|19659196|P2|STARTED|Completed SE I, Entered Extension SE II||0
7984589|NCT00205777|19659197|P1|STARTED|Completed SE I, Entered Extension SE II||833
7984590|NCT00205777|19659192|P6|NOT COMPLETED|Study Extension I||0
7984591|NCT00205777|19659193|P5|NOT COMPLETED|Study Extension I||201
7984592|NCT00205777|19659194|P4|NOT COMPLETED|Study Extension I||228
7984593|NCT00205777|19659195|P3|NOT COMPLETED|Study Extension I||1070
7984594|NCT00205777|19659196|P2|NOT COMPLETED|Study Extension I||0
7984595|NCT00205777|19659197|P1|NOT COMPLETED|Study Extension I||214
7984596|NCT00205777|19659192|P6|COMPLETED|Study Extension I||0
7984597|NCT00205777|19659193|P5|COMPLETED|Study Extension I||840
7984598|NCT00205777|19659194|P4|COMPLETED|Study Extension I||830
7984599|NCT00205777|19659195|P3|COMPLETED|Study Extension I||0
7984600|NCT00205777|19659196|P2|COMPLETED|Study Extension I||0
7984601|NCT00205777|19659197|P1|COMPLETED|Study Extension I||833
7984602|NCT00205777|19659192|P6|STARTED|Study Extension I||0
7984603|NCT00205777|19659193|P5|STARTED|Study Extension I||1041
7984604|NCT00205777|19659194|P4|STARTED|Study Extension I||1058
7984605|NCT00205777|19659195|P3|STARTED|Study Extension I||1070
7984606|NCT00205777|19659196|P2|STARTED|Study Extension I||0
7984607|NCT00205777|19659197|P1|STARTED|Study Extension I||1047
7984608|NCT00205777|19659192|P6|NOT COMPLETED|Completed Core Study, Entered SE I||0
7984609|NCT00205777|19659193|P5|NOT COMPLETED|Completed Core Study, Entered SE I||0
7984610|NCT00205777|19659194|P4|NOT COMPLETED|Completed Core Study, Entered SE I||224
7984611|NCT00205777|19659195|P3|NOT COMPLETED|Completed Core Study, Entered SE I||207
7984612|NCT00205777|19659196|P2|NOT COMPLETED|Completed Core Study, Entered SE I||204
7984613|NCT00205777|19659197|P1|NOT COMPLETED|Completed Core Study, Entered SE I||232
7984614|NCT00205777|19659192|P6|COMPLETED|Completed Core Study, Entered SE I||0
7984615|NCT00205777|19659193|P5|COMPLETED|Completed Core Study, Entered SE I||0
7984616|NCT00205777|19659194|P4|COMPLETED|Completed Core Study, Entered SE I||1058
7984617|NCT00205777|19659195|P3|COMPLETED|Completed Core Study, Entered SE I||1070
7984618|NCT00205777|19659196|P2|COMPLETED|Completed Core Study, Entered SE I||1041
7984619|NCT00205777|19659197|P1|COMPLETED|Completed Core Study, Entered SE I||1047
7984620|NCT00205777|19659192|P6|STARTED|Completed Core Study, Entered SE I||0
7984621|NCT00205777|19659193|P5|STARTED|Completed Core Study, Entered SE I||0
7984622|NCT00205777|19659194|P4|STARTED|Completed Core Study, Entered SE I||1282
7984623|NCT00205777|19659195|P3|STARTED|Completed Core Study, Entered SE I||1277
7984624|NCT00205777|19659196|P2|STARTED|Completed Core Study, Entered SE I||1245
7984625|NCT00205777|19659197|P1|STARTED|Completed Core Study, Entered SE I||1279
7984626|NCT00205777|19659192|P6|NOT COMPLETED|Core Study (Up to 3 Years)||0
7984627|NCT00205777|19659193|P5|NOT COMPLETED|Core Study (Up to 3 Years)||0
7984628|NCT00205777|19659194|P4|NOT COMPLETED|Core Study (Up to 3 Years)||632
7984629|NCT00205777|19659195|P3|NOT COMPLETED|Core Study (Up to 3 Years)||607
7984630|NCT00205777|19659196|P2|NOT COMPLETED|Core Study (Up to 3 Years)||659
7984631|NCT00205777|19659197|P1|NOT COMPLETED|Core Study (Up to 3 Years)||628
7984632|NCT00205777|19659192|P6|COMPLETED|Core Study (Up to 3 Years)||0
7984633|NCT00205777|19659193|P5|COMPLETED|Core Study (Up to 3 Years)||0
7984634|NCT00205777|19659194|P4|COMPLETED|Core Study (Up to 3 Years)||1282
7984635|NCT00205777|19659195|P3|COMPLETED|Core Study (Up to 3 Years)||1277
7984636|NCT00205777|19659196|P2|COMPLETED|Core Study (Up to 3 Years)||1245
7984637|NCT00205777|19659197|P1|COMPLETED|Core Study (Up to 3 Years)||1279
7984638|NCT00205777|19659192|P6|TREATED|Core Study (Up to 3 Years)||0
7984639|NCT00205777|19659193|P5|TREATED|Core Study (Up to 3 Years)||0
7984640|NCT00205777|19659194|P4|TREATED|Core Study (Up to 3 Years)||1885
7984641|NCT00205777|19659195|P3|TREATED|Core Study (Up to 3 Years)||1849
7984642|NCT00205777|19659196|P2|TREATED|Core Study (Up to 3 Years)||1872
7984643|NCT00205777|19659197|P1|TREATED|Core Study (Up to 3 Years)||1886
7984644|NCT00205777|19659192|P6|STARTED|Core Study (Up to 3 Years)||0
7984645|NCT00205777|19659193|P5|STARTED|Core Study (Up to 3 Years)||0
7984646|NCT00205777|19659194|P4|STARTED|Core Study (Up to 3 Years)||1914
7984647|NCT00205777|19659195|P3|STARTED|Core Study (Up to 3 Years)||1884
7984648|NCT00205777|19659196|P2|STARTED|Core Study (Up to 3 Years)||1904
7984649|NCT00205777|19659197|P1|STARTED|Core Study (Up to 3 Years)||1907
7984650|NCT00205712|19659406|P2|NOT COMPLETED|Overall Study||1
7984651|NCT00205712|19659407|P1|NOT COMPLETED|Overall Study||0
7984652|NCT00205712|19659406|P2|COMPLETED|Overall Study||19
7984653|NCT00205712|19659407|P1|COMPLETED|Overall Study||20
7984654|NCT00205712|19659406|P2|STARTED|Overall Study||20
7984655|NCT00205712|19659407|P1|STARTED|Overall Study||20
7984656|NCT00205699|19659420|P3|NOT COMPLETED|Overall Study||6
7984657|NCT00205699|19659421|P2|NOT COMPLETED|Overall Study||6
7984658|NCT00205699|19659422|P1|NOT COMPLETED|Overall Study||3
7984659|NCT00205699|19659420|P3|COMPLETED|Overall Study||43
7984660|NCT00205699|19659421|P2|COMPLETED|Overall Study||40
7984661|NCT00205699|19659422|P1|COMPLETED|Overall Study||46
7984662|NCT00205699|19659420|P3|STARTED|Overall Study||49
7984663|NCT00205699|19659421|P2|STARTED|Overall Study||46
7984664|NCT00205699|19659422|P1|STARTED|Overall Study||49
7984665|NCT00205660|19659447|P2|NOT COMPLETED|Overall Study||2
7984666|NCT00205660|19659448|P1|NOT COMPLETED|Overall Study||2
7984667|NCT00205660|19659447|P2|COMPLETED|Overall Study||35
7984668|NCT00205660|19659448|P1|COMPLETED|Overall Study||12
7984669|NCT00205660|19659447|P2|STARTED|Overall Study||37
7984670|NCT00205660|19659448|P1|STARTED|Overall Study||14
7984671|NCT00205504|19659460|P2|NOT COMPLETED|Overall Study||0
7984672|NCT00205504|19659461|P1|NOT COMPLETED|Overall Study||7
7984673|NCT00205504|19659460|P2|COMPLETED|Overall Study||15
7984674|NCT00205504|19659461|P1|COMPLETED|Overall Study||14
7984675|NCT00205504|19659460|P2|STARTED|Overall Study||15
7984676|NCT00205504|19659461|P1|STARTED|Overall Study||21
7984677|NCT00205374|19659487|P2|NOT COMPLETED|Overall Study||0
7984678|NCT00205374|19659488|P1|NOT COMPLETED|Overall Study||0
7984679|NCT00205374|19659487|P2|COMPLETED|Overall Study||9
7984680|NCT00205374|19659488|P1|COMPLETED|Overall Study||10
7984681|NCT00205374|19659487|P2|STARTED|Overall Study||9
7984682|NCT00205374|19659488|P1|STARTED|Overall Study||10
7984683|NCT00205348|19659496|P1|NOT COMPLETED|Overall Study||30
7984684|NCT00205348|19659496|P1|COMPLETED|Overall Study||116
7984685|NCT00205348|19659496|P1|STARTED|Overall Study||146
7984686|NCT00205179|19659502|P2|NOT COMPLETED|Overall Study||4
7984687|NCT00205179|19659503|P1|NOT COMPLETED|Overall Study||2
7984688|NCT00205179|19659502|P2|COMPLETED|Overall Study||29
7984689|NCT00205179|19659503|P1|COMPLETED|Overall Study||30
7984690|NCT00205179|19659502|P2|STARTED|Overall Study||33
7984691|NCT00205179|19659503|P1|STARTED|Overall Study||32
7984692|NCT00205049|19659567|P2|NOT COMPLETED|Overall Study||0
7984693|NCT00205049|19659568|P1|NOT COMPLETED|Overall Study||0
7984694|NCT00205049|19659567|P2|COMPLETED|Overall Study||0
7984695|NCT00205049|19659568|P1|COMPLETED|Overall Study||0
7984696|NCT00205049|19659567|P2|STARTED|Overall Study||0
7984697|NCT00205049|19659568|P1|STARTED|Overall Study||0
7984698|NCT00204932|19659576|P2|NOT COMPLETED|Overall Study||6
7984699|NCT00204932|19659577|P1|NOT COMPLETED|Overall Study||2
7984700|NCT00204932|19659576|P2|COMPLETED|Overall Study||18
7984701|NCT00204932|19659577|P1|COMPLETED|Overall Study||22
7984702|NCT00204932|19659576|P2|STARTED|Overall Study||24
7984703|NCT00204932|19659577|P1|STARTED|Overall Study||24
7984704|NCT00204737|19659585|P2|NOT COMPLETED|Overall Study||0
7984705|NCT00204737|19659586|P1|NOT COMPLETED|Overall Study||0
7984706|NCT00204737|19659585|P2|COMPLETED|Overall Study||6
7984707|NCT00204737|19659586|P1|COMPLETED|Overall Study||6
7984708|NCT00204737|19659585|P2|STARTED|Overall Study||6
7984709|NCT00204737|19659586|P1|STARTED|Overall Study||6
7984710|NCT00204373|19659610|P1|NOT COMPLETED|Overall Study||0
7984711|NCT00204373|19659610|P1|COMPLETED|Overall Study||72
7984712|NCT00204373|19659610|P1|STARTED|Overall Study||72
7984713|NCT00203996|19659621|P10|NOT COMPLETED|Overall Study||1
7984714|NCT00203996|19659622|P9|NOT COMPLETED|Overall Study||0
7984715|NCT00203996|19659623|P8|NOT COMPLETED|Overall Study||2
7984716|NCT00203996|19659624|P7|NOT COMPLETED|Overall Study||0
7984717|NCT00203996|19659625|P6|NOT COMPLETED|Overall Study||0
7984718|NCT00203996|19659626|P5|NOT COMPLETED|Overall Study||1
7984719|NCT00203996|19659627|P4|NOT COMPLETED|Overall Study||10
7984720|NCT00203996|19659628|P3|NOT COMPLETED|Overall Study||0
7984721|NCT00203996|19659629|P2|NOT COMPLETED|Overall Study||0
7984722|NCT00203996|19659630|P1|NOT COMPLETED|Overall Study||0
7984723|NCT00203996|19659621|P10|COMPLETED|Overall Study||2
7984724|NCT00203996|19659622|P9|COMPLETED|Overall Study||2
7984725|NCT00203996|19659623|P8|COMPLETED|Overall Study||2
7984726|NCT00203996|19659624|P7|COMPLETED|Overall Study||2
7984727|NCT00203996|19659625|P6|COMPLETED|Overall Study||3
7984728|NCT00203996|19659626|P5|COMPLETED|Overall Study||3
7984729|NCT00203996|19659627|P4|COMPLETED|Overall Study||9
7984730|NCT00203996|19659628|P3|COMPLETED|Overall Study||0
7984731|NCT00203996|19659629|P2|COMPLETED|Overall Study||0
7984732|NCT00203996|19659630|P1|COMPLETED|Overall Study||0
7984733|NCT00203996|19659621|P10|Aim 3 Only: Third Intervention|Overall Study||2
7984734|NCT00203996|19659622|P9|Aim 3 Only: Third Intervention|Overall Study||2
7984735|NCT00203996|19659623|P8|Aim 3 Only: Third Intervention|Overall Study||2
7984736|NCT00203996|19659624|P7|Aim 3 Only: Third Intervention|Overall Study||2
7984737|NCT00203996|19659625|P6|Aim 3 Only: Third Intervention|Overall Study||3
7984738|NCT00203996|19659626|P5|Aim 3 Only: Third Intervention|Overall Study||0
7984739|NCT00203996|19659627|P4|Aim 3 Only: Third Intervention|Overall Study||0
7984740|NCT00203996|19659628|P3|Aim 3 Only: Third Intervention|Overall Study||0
7984741|NCT00203996|19659629|P2|Aim 3 Only: Third Intervention|Overall Study||0
7984742|NCT00203996|19659630|P1|Aim 3 Only: Third Intervention|Overall Study||0
7984743|NCT00203996|19659621|P10|Aim 3 Only: Second Washout|Overall Study||2
7984744|NCT00203996|19659622|P9|Aim 3 Only: Second Washout|Overall Study||2
7984745|NCT00203996|19659623|P8|Aim 3 Only: Second Washout|Overall Study||2
7984746|NCT00203996|19659624|P7|Aim 3 Only: Second Washout|Overall Study||2
7984747|NCT00203996|19659625|P6|Aim 3 Only: Second Washout|Overall Study||3
7984748|NCT00203996|19659626|P5|Aim 3 Only: Second Washout|Overall Study||0
7984749|NCT00203996|19659627|P4|Aim 3 Only: Second Washout|Overall Study||0
7984750|NCT00203996|19659628|P3|Aim 3 Only: Second Washout|Overall Study||0
7984751|NCT00203996|19659629|P2|Aim 3 Only: Second Washout|Overall Study||0
7984752|NCT00203996|19659630|P1|Aim 3 Only: Second Washout|Overall Study||0
7984753|NCT00203996|19659621|P10|Aim 3 Only: Second Intervention|Overall Study||2
7984754|NCT00203996|19659622|P9|Aim 3 Only: Second Intervention|Overall Study||2
7984755|NCT00203996|19659623|P8|Aim 3 Only: Second Intervention|Overall Study||2
7984756|NCT00203996|19659624|P7|Aim 3 Only: Second Intervention|Overall Study||2
7984757|NCT00203996|19659625|P6|Aim 3 Only: Second Intervention|Overall Study||3
7984758|NCT00203996|19659626|P5|Aim 3 Only: Second Intervention|Overall Study||0
7984759|NCT00203996|19659627|P4|Aim 3 Only: Second Intervention|Overall Study||0
7984760|NCT00203996|19659628|P3|Aim 3 Only: Second Intervention|Overall Study||0
7984761|NCT00203996|19659629|P2|Aim 3 Only: Second Intervention|Overall Study||0
7984762|NCT00203996|19659630|P1|Aim 3 Only: Second Intervention|Overall Study||0
7984763|NCT00203996|19659621|P10|Aim 3 Only: Washout|Overall Study||2
7984764|NCT00203996|19659622|P9|Aim 3 Only: Washout|Overall Study||2
7984765|NCT00203996|19659623|P8|Aim 3 Only: Washout|Overall Study||2
7984766|NCT00203996|19659624|P7|Aim 3 Only: Washout|Overall Study||2
7984767|NCT00203996|19659625|P6|Aim 3 Only: Washout|Overall Study||3
7984768|NCT00203996|19659626|P5|Aim 3 Only: Washout|Overall Study||0
7984769|NCT00203996|19659627|P4|Aim 3 Only: Washout|Overall Study||0
7984770|NCT00203996|19659628|P3|Aim 3 Only: Washout|Overall Study||0
7984771|NCT00203996|19659629|P2|Aim 3 Only: Washout|Overall Study||0
7984772|NCT00203996|19659630|P1|Aim 3 Only: Washout|Overall Study||0
7984773|NCT00203996|19659621|P10|Aim 3 Only: First Intervention|Overall Study||3
7984774|NCT00203996|19659622|P9|Aim 3 Only: First Intervention|Overall Study||2
7984775|NCT00203996|19659623|P8|Aim 3 Only: First Intervention|Overall Study||4
7984776|NCT00203996|19659624|P7|Aim 3 Only: First Intervention|Overall Study||2
7984777|NCT00203996|19659625|P6|Aim 3 Only: First Intervention|Overall Study||3
7984778|NCT00203996|19659626|P5|Aim 3 Only: First Intervention|Overall Study||0
7984779|NCT00203996|19659627|P4|Aim 3 Only: First Intervention|Overall Study||0
7984780|NCT00203996|19659628|P3|Aim 3 Only: First Intervention|Overall Study||0
7984781|NCT00203996|19659629|P2|Aim 3 Only: First Intervention|Overall Study||0
7984782|NCT00203996|19659630|P1|Aim 3 Only: First Intervention|Overall Study||0
7984783|NCT00203996|19659621|P10|STARTED|Overall Study||3
7984784|NCT00203996|19659622|P9|STARTED|Overall Study||2
7984785|NCT00203996|19659623|P8|STARTED|Overall Study||4
7984786|NCT00203996|19659624|P7|STARTED|Overall Study||2
7984787|NCT00203996|19659625|P6|STARTED|Overall Study||3
7984788|NCT00203996|19659626|P5|STARTED|Overall Study||4
7984789|NCT00203996|19659627|P4|STARTED|Overall Study||19
7984790|NCT00203996|19659628|P3|STARTED|Overall Study||0
7984791|NCT00203996|19659629|P2|STARTED|Overall Study||0
7984792|NCT00203996|19659630|P1|STARTED|Overall Study||0
7984793|NCT00203931|19659679|P2|NOT COMPLETED|Overall Study||5
7984794|NCT00203931|19659680|P1|NOT COMPLETED|Overall Study||7
7984795|NCT00203931|19659679|P2|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23
7984796|NCT00203931|19659680|P1|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20
7984797|NCT00203931|19659679|P2|STARTED|Overall Study||28
7984798|NCT00203931|19659680|P1|STARTED|Overall Study||27
7984799|NCT00203892|19659697|P3|NOT COMPLETED|Overall Study||0
7984800|NCT00203892|19659698|P2|NOT COMPLETED|Overall Study||2
7984801|NCT00203892|19659699|P1|NOT COMPLETED|Overall Study||2
7984802|NCT00203892|19659697|P3|COMPLETED|Overall Study||6
7984803|NCT00203892|19659698|P2|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8
7984804|NCT00203892|19659699|P1|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5
7984805|NCT00203892|19659697|P3|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4
7984806|NCT00203892|19659698|P2|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
7984807|NCT00203892|19659699|P1|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
7984808|NCT00203892|19659697|P3|STARTED|Overall Study||6
7984809|NCT00203892|19659698|P2|STARTED|Overall Study||10
7984810|NCT00203892|19659699|P1|STARTED|Overall Study||7
7984811|NCT00203502|19659710|P1|NOT COMPLETED|Overall Study||1
7984812|NCT00203502|19659710|P1|COMPLETED|Overall Study||39
7984813|NCT00203502|19659710|P1|STARTED|Overall Study||40
7984814|NCT00203476|19659721|P3|NOT COMPLETED|Overall Study||0
7984815|NCT00203476|19659722|P2|NOT COMPLETED|Overall Study||1
7984816|NCT00203476|19659723|P1|NOT COMPLETED|Overall Study||1
7984817|NCT00203476|19659721|P3|COMPLETED|Overall Study||10
7984818|NCT00203476|19659722|P2|COMPLETED|Overall Study||9
7984819|NCT00203476|19659723|P1|COMPLETED|Overall Study||9
7984820|NCT00203476|19659721|P3|STARTED|Overall Study||10
7984821|NCT00203476|19659722|P2|STARTED|Overall Study||10
7984822|NCT00203476|19659723|P1|STARTED|Overall Study||10
7984823|NCT00203424|19659740|P1|NOT COMPLETED|Follow-up Period||6
7984824|NCT00203424|19659740|P1|COMPLETED|Follow-up Period||10
7984825|NCT00203424|19659740|P1|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16
7984826|NCT00203424|19659740|P1|NOT COMPLETED|Treatment Period||11
7984827|NCT00203424|19659740|P1|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11
7984828|NCT00203424|19659740|P1|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22
7984829|NCT00203411|19659747|P1|NOT COMPLETED|Follow-up||4
7984830|NCT00203411|19659747|P1|COMPLETED|Follow-up||41
7984831|NCT00203411|19659747|P1|STARTED|Follow-up||45
7984832|NCT00203411|19659747|P1|NOT COMPLETED|Treatment Period||0
7984833|NCT00203411|19659747|P1|COMPLETED|Treatment Period||45
7984834|NCT00203411|19659747|P1|STARTED|Treatment Period||45
7984835|NCT00203307|19659756|P2|NOT COMPLETED|Second Intervention||0
7984836|NCT00203307|19659757|P1|NOT COMPLETED|Second Intervention||0
7984837|NCT00203307|19659756|P2|COMPLETED|Second Intervention||0
7984838|NCT00203307|19659757|P1|COMPLETED|Second Intervention||1
7984839|NCT00203307|19659756|P2|STARTED|Second Intervention||0
7984840|NCT00203307|19659757|P1|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1
7984841|NCT00203307|19659756|P2|NOT COMPLETED|First Intervention||0
7984842|NCT00203307|19659757|P1|NOT COMPLETED|First Intervention||2
7984843|NCT00203307|19659756|P2|COMPLETED|First Intervention||0
7984844|NCT00203307|19659757|P1|COMPLETED|First Intervention||1
7984845|NCT00203307|19659756|P2|STARTED|First Intervention||0
7984846|NCT00203307|19659757|P1|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3
7984847|NCT00203294|19659765|P2|NOT COMPLETED|Overall Study||13
7984848|NCT00203294|19659766|P1|NOT COMPLETED|Overall Study||8
7984849|NCT00203294|19659765|P2|COMPLETED|Overall Study||10
7984850|NCT00203294|19659766|P1|COMPLETED|Overall Study||14
7984851|NCT00203294|19659765|P2|STARTED|Overall Study||23
7984852|NCT00203294|19659766|P1|STARTED|Overall Study||22
7984853|NCT00203268|19659772|P1|NOT COMPLETED|Late Treatment||0
7984854|NCT00203268|19659772|P1|COMPLETED|Late Treatment||9
7984855|NCT00203268|19659772|P1|STARTED|Late Treatment||9
7984856|NCT00203268|19659772|P1|NOT COMPLETED|Early Treatment||4
7984857|NCT00203268|19659772|P1|COMPLETED|Early Treatment||9
7984858|NCT00203268|19659772|P1|STARTED|Early Treatment||13
7984859|NCT00203242|19659778|P1|NOT COMPLETED|Overall Study||1
7984860|NCT00203242|19659778|P1|COMPLETED|Overall Study||14
7984861|NCT00203242|19659778|P1|STARTED|Overall Study||15
7984862|NCT00203229|19659784|P2|NOT COMPLETED|Overall Study||3
7984863|NCT00203229|19659785|P1|NOT COMPLETED|Overall Study||3
7984864|NCT00203229|19659784|P2|COMPLETED|Overall Study||7
7984865|NCT00203229|19659785|P1|COMPLETED|Overall Study||7
7984866|NCT00203229|19659784|P2|STARTED|Overall Study||10
7984867|NCT00203229|19659785|P1|STARTED|Overall Study||10
7984868|NCT00203216|19659791|P1|NOT COMPLETED|Overall Study||4
7984869|NCT00203216|19659791|P1|COMPLETED|Overall Study||27
7984870|NCT00203216|19659791|P1|STARTED|Overall Study||31
7984871|NCT00203203|19659797|P2|NOT COMPLETED|Overall Study||0
7984872|NCT00203203|19659798|P1|NOT COMPLETED|Overall Study||1
7984873|NCT00203203|19659797|P2|COMPLETED|Overall Study||20
7984874|NCT00203203|19659798|P1|COMPLETED|Overall Study||9
7984875|NCT00203203|19659797|P2|STARTED|Overall Study||20
7984876|NCT00203203|19659798|P1|STARTED|Overall Study||10
7984877|NCT00203047|19659830|P2|NOT COMPLETED|Overall Study||203
7984878|NCT00203047|19659831|P1|NOT COMPLETED|Overall Study||191
7984879|NCT00203047|19659830|P2|COMPLETED|Overall Study||7
7984880|NCT00203047|19659831|P1|COMPLETED|Overall Study||13
7984881|NCT00203047|19659830|P2|In Database as of January 29, 2009|Overall Study||209
7984882|NCT00203047|19659831|P1|In Database as of January 29, 2009|Overall Study||199
7984883|NCT00203047|19659830|P2|STARTED|Overall Study||210
7984884|NCT00203047|19659831|P1|STARTED|Overall Study||204
7984885|NCT00203021|19659845|P2|NOT COMPLETED|Overall Study||77
7984886|NCT00203021|19659846|P1|NOT COMPLETED|Overall Study||79
7984887|NCT00203021|19659845|P2|COMPLETED|Overall Study||24
7984888|NCT00203021|19659846|P1|COMPLETED|Overall Study||28
7984889|NCT00203021|19659845|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
7984890|NCT00203021|19659846|P1|Received at Least 1 Dose of Study Drug|Overall Study||107
7984891|NCT00203021|19659845|P2|STARTED|Overall Study||101
7984892|NCT00203021|19659846|P1|STARTED|Overall Study||107
7984893|NCT00202878|19659856|P2|NOT COMPLETED|Overall Study||2217
7984894|NCT00202878|19659857|P1|NOT COMPLETED|Overall Study||2199
7984895|NCT00202878|19659856|P2|COMPLETED|Overall Study||6860
7984896|NCT00202878|19659857|P1|COMPLETED|Overall Study||6868
7984897|NCT00202878|19659856|P2|STARTED|Overall Study||9077
7984898|NCT00202878|19659857|P1|STARTED|Overall Study||9067
7984899|NCT00202839|19659871|P2|NOT COMPLETED|Overall Study||10
7984900|NCT00202839|19659872|P1|NOT COMPLETED|Overall Study||24
7984901|NCT00202839|19659871|P2|COMPLETED|Overall Study||72
7984902|NCT00202839|19659872|P1|COMPLETED|Overall Study||54
7984903|NCT00202839|19659871|P2|STARTED|Overall Study||82
7984904|NCT00202839|19659872|P1|STARTED|Overall Study||78
7984905|NCT00202722|19659880|P1|NOT COMPLETED|Overall Study||0
7984906|NCT00202722|19659880|P1|COMPLETED|Overall Study||41
7984907|NCT00202722|19659880|P1|STARTED|Overall Study||41
7984908|NCT00202644|19659887|P2|NOT COMPLETED|Overall Study||27
7984909|NCT00202644|19659888|P1|NOT COMPLETED|Overall Study||35
7984910|NCT00202644|19659887|P2|COMPLETED|Overall Study||43
7984911|NCT00202644|19659888|P1|COMPLETED|Overall Study||41
7984912|NCT00202644|19659887|P2|STARTED|Overall Study||70
7984913|NCT00202644|19659888|P1|STARTED|Overall Study|One participant not randomized but treated.|76
7984914|NCT00202449|19659915|P3|NOT COMPLETED|Overall Study||12
7984915|NCT00202449|19659916|P2|NOT COMPLETED|Overall Study||11
7984916|NCT00202449|19659917|P1|NOT COMPLETED|Overall Study||11
7984917|NCT00202449|19659915|P3|COMPLETED|Overall Study||9
7984918|NCT00202449|19659916|P2|COMPLETED|Overall Study||9
7984919|NCT00202449|19659917|P1|COMPLETED|Overall Study||7
7984920|NCT00202449|19659915|P3|STARTED|Overall Study||21
7984921|NCT00202449|19659916|P2|STARTED|Overall Study||20
7984922|NCT00202449|19659917|P1|STARTED|Overall Study||18
7984923|NCT00201877|19659931|P1|NOT COMPLETED|Overall Study||0
7984924|NCT00201877|19659931|P1|COMPLETED|Overall Study||25
7984925|NCT00201877|19659931|P1|STARTED|Overall Study||25
7984926|NCT00201864|19659938|P1|NOT COMPLETED|Overall Study||0
7984927|NCT00201864|19659938|P1|COMPLETED|Overall Study||40
7984928|NCT00201864|19659938|P1|STARTED|Overall Study||40
7984929|NCT00201851|19659949|P3|NOT COMPLETED|Overall Study||1
7984930|NCT00201851|19659950|P2|NOT COMPLETED|Overall Study||2
7984931|NCT00201851|19659951|P1|NOT COMPLETED|Overall Study||8
7984932|NCT00201851|19659949|P3|COMPLETED|Overall Study||230
7984933|NCT00201851|19659950|P2|COMPLETED|Overall Study||255
7984934|NCT00201851|19659951|P1|COMPLETED|Overall Study||244
7984935|NCT00201851|19659949|P3|STARTED|Overall Study||231
7984936|NCT00201851|19659950|P2|STARTED|Overall Study||257
7984937|NCT00201851|19659951|P1|STARTED|Overall Study||252
7984938|NCT00201838|19659961|P2|NOT COMPLETED|Overall Study||0
7984939|NCT00201838|19659962|P1|NOT COMPLETED|Overall Study||0
7984940|NCT00201838|19659961|P2|COMPLETED|Overall Study||8
7984941|NCT00201838|19659962|P1|COMPLETED|Overall Study||30
7984942|NCT00201838|19659961|P2|Treatment Cohort|Overall Study||8
7984943|NCT00201838|19659962|P1|Treatment Cohort|Overall Study||30
7984944|NCT00201838|19659961|P2|STARTED|Overall Study||8
7984945|NCT00201838|19659962|P1|STARTED|Overall Study||30
7984946|NCT00201825|19659976|P1|NOT COMPLETED|Overall Study||0
7984947|NCT00201825|19659976|P1|COMPLETED|Overall Study||29
7984948|NCT00201825|19659976|P1|STARTED|Overall Study||29
7984949|NCT00201773|19659983|P1|NOT COMPLETED|Overall Study||6
7984950|NCT00201773|19659983|P1|COMPLETED|Overall Study||16
7984951|NCT00201773|19659983|P1|Stopped Exemestane After 4 Weeks|Overall Study||1
7984952|NCT00201773|19659983|P1|Received All Exemestane Therapy|Overall Study||5
7984953|NCT00201773|19659983|P1|Completed 8 Weeks of Planned Therapy|Overall Study||16
7984954|NCT00201773|19659983|P1|STARTED|Overall Study||22
7984955|NCT00201760|19659992|P2|NOT COMPLETED|Overall Study||0
7984956|NCT00201760|19659993|P1|NOT COMPLETED|Overall Study||0
7984957|NCT00201760|19659992|P2|COMPLETED|Overall Study||5
7984958|NCT00201760|19659993|P1|COMPLETED|Overall Study||5
7984959|NCT00201760|19659992|P2|STARTED|Overall Study||5
7984960|NCT00201760|19659993|P1|STARTED|Overall Study||5
7984961|NCT00201734|19660005|P2|NOT COMPLETED|Overall Study||0
7984962|NCT00201734|19660006|P1|NOT COMPLETED|Overall Study||3
7984963|NCT00201734|19660005|P2|COMPLETED|Overall Study||25
7984964|NCT00201734|19660006|P1|COMPLETED|Overall Study||29
7984965|NCT00201734|19660005|P2|Patients Not Evaluable|Overall Study||0
7984966|NCT00201734|19660006|P1|Patients Not Evaluable|Overall Study||3
7984967|NCT00201734|19660005|P2|STARTED|Overall Study||25
7984968|NCT00201734|19660006|P1|STARTED|Overall Study||32
7984969|NCT00201643|19660023|P2|NOT COMPLETED|Overall Study||4
7984970|NCT00201643|19660024|P1|NOT COMPLETED|Overall Study||5
7984971|NCT00201643|19660023|P2|COMPLETED|Overall Study||210
7984972|NCT00201643|19660024|P1|COMPLETED|Overall Study||218
7984973|NCT00201643|19660023|P2|STARTED|Overall Study||214
7984974|NCT00201643|19660024|P1|STARTED|Overall Study||223
7984975|NCT00201448|19660048|P2|NOT COMPLETED|Overall Study||0
7984976|NCT00201448|19660049|P1|NOT COMPLETED|Overall Study||0
7984977|NCT00201448|19660048|P2|COMPLETED|Overall Study||40
7984978|NCT00201448|19660049|P1|COMPLETED|Overall Study||42
7984979|NCT00201448|19660048|P2|STARTED|Overall Study||40
7984980|NCT00201448|19660049|P1|STARTED|Overall Study||42
7984981|NCT00201409|19660059|P2|NOT COMPLETED|Overall Study||1
7984982|NCT00201409|19660060|P1|NOT COMPLETED|Overall Study||1
7984983|NCT00201409|19660059|P2|COMPLETED|Overall Study||66
7984984|NCT00201409|19660060|P1|COMPLETED|Overall Study||64
7984985|NCT00201409|19660059|P2|STARTED|Overall Study||67
7984986|NCT00201409|19660060|P1|STARTED|Overall Study||65
7984987|NCT00201240|19660070|P1|NOT COMPLETED|Overall Study||3
7984988|NCT00201240|19660070|P1|COMPLETED|Overall Study||44
7984989|NCT00201240|19660070|P1|STARTED|Overall Study||47
7984990|NCT00201201|19660088|P2|NOT COMPLETED|Overall Study||7
7984991|NCT00201201|19660089|P1|NOT COMPLETED|Overall Study||5
7984992|NCT00201201|19660088|P2|COMPLETED|Overall Study||66
7984993|NCT00201201|19660089|P1|COMPLETED|Overall Study||82
7984994|NCT00201201|19660088|P2|STARTED|Overall Study||73
7984995|NCT00201201|19660089|P1|STARTED|Overall Study||87
7984996|NCT00201123|19660108|P3|NOT COMPLETED|Overall Study||9
7984997|NCT00201123|19660109|P2|NOT COMPLETED|Overall Study||4
7984998|NCT00201123|19660110|P1|NOT COMPLETED|Overall Study||6
7984999|NCT00201123|19660108|P3|COMPLETED|Overall Study||23
7985000|NCT00201123|19660109|P2|COMPLETED|Overall Study||28
7985001|NCT00201123|19660110|P1|COMPLETED|Overall Study||26
7985002|NCT00201123|19660108|P3|Did Not Meet Continuation Criteria|Overall Study||5
7985003|NCT00201123|19660109|P2|Did Not Meet Continuation Criteria|Overall Study||0
7985004|NCT00201123|19660110|P1|Did Not Meet Continuation Criteria|Overall Study||2
7985005|NCT00201123|19660108|P3|STARTED|Overall Study||32
7985006|NCT00201123|19660109|P2|STARTED|Overall Study||32
7985007|NCT00201123|19660110|P1|STARTED|Overall Study||32
7985008|NCT00201006|19660127|P3|NOT COMPLETED|Overall Study||4
7985009|NCT00201006|19660128|P2|NOT COMPLETED|Overall Study||2
7985010|NCT00201006|19660129|P1|NOT COMPLETED|Overall Study||8
7985011|NCT00201006|19660127|P3|COMPLETED|Overall Study||75
7985012|NCT00201006|19660128|P2|COMPLETED|Overall Study||70
7985013|NCT00201006|19660129|P1|COMPLETED|Overall Study||75
7985014|NCT00201006|19660127|P3|STARTED|Overall Study||79
7985015|NCT00201006|19660128|P2|STARTED|Overall Study||72
7985016|NCT00201006|19660129|P1|STARTED|Overall Study||83
7985017|NCT00200967|19660139|P2|NOT COMPLETED|Run-out Period||0
7985018|NCT00200967|19660140|P1|NOT COMPLETED|Run-out Period||1
7985019|NCT00200967|19660139|P2|COMPLETED|Run-out Period||41
7985020|NCT00200967|19660140|P1|COMPLETED|Run-out Period||34
7985021|NCT00200967|19660139|P2|STARTED|Run-out Period||41
7985022|NCT00200967|19660140|P1|STARTED|Run-out Period||35
7985023|NCT00200967|19660139|P2|NOT COMPLETED|Second Treatment Period||2
7985024|NCT00200967|19660140|P1|NOT COMPLETED|Second Treatment Period||1
7985025|NCT00200967|19660139|P2|COMPLETED|Second Treatment Period||41
7985026|NCT00200967|19660140|P1|COMPLETED|Second Treatment Period||35
7985027|NCT00200967|19660139|P2|STARTED|Second Treatment Period||43
7985028|NCT00200967|19660140|P1|STARTED|Second Treatment Period||36
7985029|NCT00200967|19660139|P2|NOT COMPLETED|Wash-out Period||1
7985030|NCT00200967|19660140|P1|NOT COMPLETED|Wash-out Period||0
7985031|NCT00200967|19660139|P2|COMPLETED|Wash-out Period||43
7985032|NCT00200967|19660140|P1|COMPLETED|Wash-out Period||36
7985033|NCT00200967|19660139|P2|STARTED|Wash-out Period||44
7985034|NCT00200967|19660140|P1|STARTED|Wash-out Period||36
7985035|NCT00200967|19660139|P2|NOT COMPLETED|First Treatment Period||1
7985036|NCT00200967|19660140|P1|NOT COMPLETED|First Treatment Period||6
7985037|NCT00200967|19660139|P2|COMPLETED|First Treatment Period||44
7985038|NCT00200967|19660140|P1|COMPLETED|First Treatment Period||36
7985039|NCT00200967|19660139|P2|First Treatment Period|First Treatment Period||45
7985040|NCT00200967|19660140|P1|First Treatment Period|First Treatment Period||42
7985041|NCT00200967|19660139|P2|STARTED|First Treatment Period||45
7985042|NCT00200967|19660140|P1|STARTED|First Treatment Period||42
7985043|NCT00200902|19660171|P3|NOT COMPLETED|Overall Study||8
7985044|NCT00200902|19660172|P2|NOT COMPLETED|Overall Study||3
7985045|NCT00200902|19660173|P1|NOT COMPLETED|Overall Study||10
7985046|NCT00200902|19660171|P3|COMPLETED|Overall Study||12
7985047|NCT00200902|19660172|P2|COMPLETED|Overall Study||26
7985048|NCT00200902|19660173|P1|COMPLETED|Overall Study||29
7985049|NCT00200902|19660171|P3|STARTED|Overall Study||20
7985050|NCT00200902|19660172|P2|STARTED|Overall Study||29
7985051|NCT00200902|19660173|P1|STARTED|Overall Study||39
7985052|NCT00200850|19660190|P3|NOT COMPLETED|Overall Study||6
7985053|NCT00200850|19660191|P2|NOT COMPLETED|Overall Study||1
7985054|NCT00200850|19660192|P1|NOT COMPLETED|Overall Study||3
7985055|NCT00200850|19660190|P3|COMPLETED|Overall Study||5
7985056|NCT00200850|19660191|P2|COMPLETED|Overall Study||9
7985057|NCT00200850|19660192|P1|COMPLETED|Overall Study||7
7985058|NCT00200850|19660190|P3|STARTED|Overall Study||11
7985059|NCT00200850|19660191|P2|STARTED|Overall Study||10
7985060|NCT00200850|19660192|P1|STARTED|Overall Study||10
7985061|NCT00200785|19660202|P2|NOT COMPLETED|Second Intervention||0
7985062|NCT00200785|19660203|P1|NOT COMPLETED|Second Intervention||0
7985063|NCT00200785|19660202|P2|COMPLETED|Second Intervention||6
7985064|NCT00200785|19660203|P1|COMPLETED|Second Intervention||9
7985065|NCT00200785|19660202|P2|STARTED|Second Intervention||6
7985066|NCT00200785|19660203|P1|STARTED|Second Intervention||9
7985067|NCT00200785|19660202|P2|NOT COMPLETED|Washout Period of 1 Week||0
7985068|NCT00200785|19660203|P1|NOT COMPLETED|Washout Period of 1 Week||0
7985069|NCT00200785|19660202|P2|COMPLETED|Washout Period of 1 Week||6
7985070|NCT00200785|19660203|P1|COMPLETED|Washout Period of 1 Week||9
7985071|NCT00200785|19660202|P2|STARTED|Washout Period of 1 Week||6
7985072|NCT00200785|19660203|P1|STARTED|Washout Period of 1 Week||9
7985073|NCT00200785|19660202|P2|NOT COMPLETED|First Intervention||0
7985074|NCT00200785|19660203|P1|NOT COMPLETED|First Intervention||0
7985075|NCT00200785|19660202|P2|COMPLETED|First Intervention||6
7985076|NCT00200785|19660203|P1|COMPLETED|First Intervention||9
7985077|NCT00200785|19660202|P2|STARTED|First Intervention||6
7985078|NCT00200785|19660203|P1|STARTED|First Intervention||9
7985079|NCT00200356|19660213|P2|NOT COMPLETED|Overall Study||7
7985080|NCT00200356|19660214|P1|NOT COMPLETED|Overall Study||8
7985081|NCT00200356|19660213|P2|COMPLETED|Overall Study||195
7985082|NCT00200356|19660214|P1|COMPLETED|Overall Study||191
7985083|NCT00200356|19660213|P2|Safety Analysis Set|Overall Study||198
7985084|NCT00200356|19660214|P1|Safety Analysis Set|Overall Study||194
7985085|NCT00200356|19660213|P2|STARTED|Overall Study||202
7985086|NCT00200356|19660214|P1|STARTED|Overall Study||199
7985087|NCT00200343|19660241|P3|NOT COMPLETED|Overall Study||13
7985088|NCT00200343|19660242|P2|NOT COMPLETED|Overall Study||8
7985089|NCT00200343|19660243|P1|NOT COMPLETED|Overall Study||16
7985090|NCT00200343|19660241|P3|COMPLETED|Overall Study||184
7985091|NCT00200343|19660242|P2|COMPLETED|Overall Study||192
7985092|NCT00200343|19660243|P1|COMPLETED|Overall Study||183
7985093|NCT00200343|19660241|P3|STARTED|Overall Study||197
7985094|NCT00200343|19660242|P2|STARTED|Overall Study||200
7985095|NCT00200343|19660243|P1|STARTED|Overall Study||199
7985096|NCT00200161|19660268|P2|NOT COMPLETED|Overall Study||0
7985097|NCT00200161|19660269|P1|NOT COMPLETED|Overall Study||0
7985098|NCT00200161|19660268|P2|COMPLETED|Overall Study||42
7985099|NCT00200161|19660269|P1|COMPLETED|Overall Study||43
7985100|NCT00200161|19660268|P2|STARTED|Overall Study||42
7985101|NCT00200161|19660269|P1|STARTED|Overall Study||43
7985102|NCT00200057|19660281|P1|NOT COMPLETED|Overall Study||9
7985103|NCT00200057|19660281|P1|COMPLETED|Overall Study||111
7985104|NCT00200057|19660281|P1|12 Month Follow-up|Overall Study||111
7985105|NCT00200057|19660281|P1|6 Month Follow-up|Overall Study||114
7985106|NCT00200057|19660281|P1|3 Month Follow-up|Overall Study||116
7985107|NCT00200057|19660281|P1|1 Month Follow-up|Overall Study||117
7985108|NCT00200057|19660281|P1|STARTED|Overall Study||120
7985109|NCT00199914|19660293|P2|NOT COMPLETED|Overall Study||6
7985110|NCT00199914|19660294|P1|NOT COMPLETED|Overall Study||3
7985111|NCT00199914|19660293|P2|COMPLETED|Overall Study||54
7985112|NCT00199914|19660294|P1|COMPLETED|Overall Study||50
7985113|NCT00199914|19660293|P2|STARTED|Overall Study||60
7985114|NCT00199914|19660294|P1|STARTED|Overall Study||53
7985115|NCT00199875|19660305|P5|NOT COMPLETED|Overall Study||1
7985116|NCT00199875|19660306|P4|NOT COMPLETED|Overall Study||0
7985117|NCT00199875|19660307|P3|NOT COMPLETED|Overall Study||0
7985118|NCT00199875|19660308|P2|NOT COMPLETED|Overall Study||0
7985119|NCT00199875|19660309|P1|NOT COMPLETED|Overall Study||0
7985120|NCT00199875|19660305|P5|COMPLETED|Overall Study||2
7985121|NCT00199875|19660306|P4|COMPLETED|Overall Study||3
7985122|NCT00199875|19660307|P3|COMPLETED|Overall Study||6
7985123|NCT00199875|19660308|P2|COMPLETED|Overall Study||3
7985124|NCT00199875|19660309|P1|COMPLETED|Overall Study||3
7985125|NCT00199875|19660305|P5|STARTED|Overall Study||3
7985126|NCT00199875|19660306|P4|STARTED|Overall Study||3
7985127|NCT00199875|19660307|P3|STARTED|Overall Study||6
7985128|NCT00199875|19660308|P2|STARTED|Overall Study||3
7985129|NCT00199875|19660309|P1|STARTED|Overall Study||3
7985130|NCT00199381|19660331|P1|NOT COMPLETED|Overall Study||504
7985131|NCT00199381|19660331|P1|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0
7985132|NCT00199381|19660331|P1|STARTED|Overall Study||504
7985133|NCT00198822|19660338|P3|NOT COMPLETED|Overall Study||21
7985134|NCT00198822|19660339|P2|NOT COMPLETED|Overall Study||20
7985135|NCT00198822|19660340|P1|NOT COMPLETED|Overall Study||14
7985136|NCT00198822|19660338|P3|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998
7985137|NCT00198822|19660339|P2|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806
7985138|NCT00198822|19660340|P1|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862
7985139|NCT00198822|19660338|P3|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019
7985140|NCT00198822|19660339|P2|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826
7985141|NCT00198822|19660340|P1|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876
7985142|NCT00198133|19660359|P2|NOT COMPLETED|Overall Study||8
7985143|NCT00198133|19660360|P1|NOT COMPLETED|Overall Study||5
7985144|NCT00198133|19660359|P2|COMPLETED|Overall Study||3
7985145|NCT00198133|19660360|P1|COMPLETED|Overall Study||11
7985146|NCT00198133|19660359|P2|STARTED|Overall Study||11
7985147|NCT00198133|19660360|P1|STARTED|Overall Study||16
7985148|NCT00198107|19660372|P3|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||2
7985149|NCT00198107|19660373|P2|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
7985150|NCT00198107|19660374|P1|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
7985151|NCT00198107|19660372|P3|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||8
7985152|NCT00198107|19660373|P2|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
7985153|NCT00198107|19660374|P1|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
7985154|NCT00198107|19660372|P3|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||10
7985155|NCT00198107|19660373|P2|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
7985156|NCT00198107|19660374|P1|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
7985157|NCT00198107|19660372|P3|NOT COMPLETED|Double-Blind Period||0
7985158|NCT00198107|19660373|P2|NOT COMPLETED|Double-Blind Period||3
7985159|NCT00198107|19660374|P1|NOT COMPLETED|Double-Blind Period||6
7985160|NCT00198107|19660372|P3|COMPLETED|Double-Blind Period||0
7985161|NCT00198107|19660373|P2|COMPLETED|Double-Blind Period||37
7985162|NCT00198107|19660374|P1|COMPLETED|Double-Blind Period||35
7985163|NCT00198107|19660372|P3|1 or More Follow-up Visits|Double-Blind Period||0
7985164|NCT00198107|19660373|P2|1 or More Follow-up Visits|Double-Blind Period||38
7985165|NCT00198107|19660374|P1|1 or More Follow-up Visits|Double-Blind Period||40
7985166|NCT00198107|19660372|P3|STARTED|Double-Blind Period||0
7985167|NCT00198107|19660373|P2|STARTED|Double-Blind Period||40
7985168|NCT00198107|19660374|P1|STARTED|Double-Blind Period||41
7985169|NCT00198081|19660411|P2|NOT COMPLETED|Overall Study||0
7985170|NCT00198081|19660412|P1|NOT COMPLETED|Overall Study||1
7985171|NCT00198081|19660411|P2|COMPLETED|Overall Study|No enrollment on this arm.|0
7985172|NCT00198081|19660412|P1|COMPLETED|Overall Study||4
7985173|NCT00198081|19660411|P2|STARTED|Overall Study|No enrollment on this arm.|0
7985174|NCT00198081|19660412|P1|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5
7985175|NCT00198042|19660438|P1|NOT COMPLETED|Overall Study||0
7985176|NCT00198042|19660438|P1|COMPLETED|Overall Study||18
7985177|NCT00198042|19660438|P1|STARTED|Overall Study||18
7985178|NCT00198029|19660442|P1|NOT COMPLETED|Overall Study||4
7985179|NCT00198029|19660442|P1|COMPLETED|Overall Study||28
7985180|NCT00198029|19660442|P1|STARTED|Overall Study||32
7985181|NCT00197496|19660449|P2|NOT COMPLETED|Follow-up||1
7985182|NCT00197496|19660450|P1|NOT COMPLETED|Follow-up||2
7985183|NCT00197496|19660449|P2|COMPLETED|Follow-up||4
7985184|NCT00197496|19660450|P1|COMPLETED|Follow-up||10
7985185|NCT00197496|19660449|P2|STARTED|Follow-up||5
7985186|NCT00197496|19660450|P1|STARTED|Follow-up||12
7985187|NCT00197496|19660449|P2|NOT COMPLETED|Baseline to Discharge||2
7985188|NCT00197496|19660450|P1|NOT COMPLETED|Baseline to Discharge||2
7985189|NCT00197496|19660449|P2|COMPLETED|Baseline to Discharge||5
7985190|NCT00197496|19660450|P1|COMPLETED|Baseline to Discharge||12
7985191|NCT00197496|19660449|P2|STARTED|Baseline to Discharge||7
7985192|NCT00197496|19660450|P1|STARTED|Baseline to Discharge||14
7985193|NCT00197392|19660465|P2|NOT COMPLETED|Overall Study||86
7985194|NCT00197392|19660466|P1|NOT COMPLETED|Overall Study||88
7985195|NCT00197392|19660465|P2|COMPLETED|Overall Study||134
7985196|NCT00197392|19660466|P1|COMPLETED|Overall Study||126
7985197|NCT00197392|19660465|P2|Per Protocol|Overall Study||134
7985198|NCT00197392|19660466|P1|Per Protocol|Overall Study||126
7985199|NCT00197392|19660465|P2|Evaluable|Overall Study||181
7985200|NCT00197392|19660466|P1|Evaluable|Overall Study||176
7985201|NCT00197392|19660465|P2|Modified Intent to Treat|Overall Study||210
7985202|NCT00197392|19660466|P1|Modified Intent to Treat|Overall Study||209
7985203|NCT00197392|19660465|P2|Safety Population|Overall Study||220
7985204|NCT00197392|19660466|P1|Safety Population|Overall Study||214
7985205|NCT00197392|19660465|P2|STARTED|Overall Study||220
7985206|NCT00197392|19660466|P1|STARTED|Overall Study||214
7985207|NCT00197236|19660498|P3|NOT COMPLETED|Overall Study||23
7985208|NCT00197236|19660499|P2|NOT COMPLETED|Overall Study||17
7985209|NCT00197236|19660500|P1|NOT COMPLETED|Overall Study||14
7985210|NCT00197236|19660498|P3|COMPLETED|Overall Study||109
7985211|NCT00197236|19660499|P2|COMPLETED|Overall Study||110
7985212|NCT00197236|19660500|P1|COMPLETED|Overall Study||121
7985213|NCT00197236|19660498|P3|STARTED|Overall Study||132
7985214|NCT00197236|19660499|P2|STARTED|Overall Study||127
7985215|NCT00197236|19660500|P1|STARTED|Overall Study||135
7985216|NCT00197184|19660549|P2|NOT COMPLETED|Overall Study||0
7985217|NCT00197184|19660550|P1|NOT COMPLETED|Overall Study||0
7985218|NCT00197184|19660549|P2|COMPLETED|Overall Study||137
7985219|NCT00197184|19660550|P1|COMPLETED|Overall Study||139
7985220|NCT00197184|19660549|P2|STARTED|Overall Study||137
7985221|NCT00197184|19660550|P1|STARTED|Overall Study||139
7985222|NCT00197145|19660574|P2|NOT COMPLETED|Period 2 : Open Label Phase||0
7985223|NCT00197145|19660575|P1|NOT COMPLETED|Period 2 : Open Label Phase||10
7985224|NCT00197145|19660574|P2|COMPLETED|Period 2 : Open Label Phase||0
7985225|NCT00197145|19660575|P1|COMPLETED|Period 2 : Open Label Phase||0
7985226|NCT00197145|19660574|P2|STARTED|Period 2 : Open Label Phase||0
7985227|NCT00197145|19660575|P1|STARTED|Period 2 : Open Label Phase||10
7985228|NCT00197145|19660574|P2|NOT COMPLETED|Period 1: Randomized Treatment Phase||11
7985229|NCT00197145|19660575|P1|NOT COMPLETED|Period 1: Randomized Treatment Phase||13
7985230|NCT00197145|19660574|P2|COMPLETED|Period 1: Randomized Treatment Phase||0
7985231|NCT00197145|19660575|P1|COMPLETED|Period 1: Randomized Treatment Phase||0
7985232|NCT00197145|19660574|P2|STARTED|Period 1: Randomized Treatment Phase||11
7985233|NCT00197145|19660575|P1|STARTED|Period 1: Randomized Treatment Phase||13
7985234|NCT00197119|19660633|P2|NOT COMPLETED|Year 10||0
7985235|NCT00197119|19660634|P1|NOT COMPLETED|Year 10||0
7985236|NCT00197119|19660633|P2|COMPLETED|Year 10||108
7985237|NCT00197119|19660634|P1|COMPLETED|Year 10||120
7985238|NCT00197119|19660633|P2|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108
7985239|NCT00197119|19660634|P1|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120
7985240|NCT00197119|19660633|P2|NOT COMPLETED|Year 9||0
7985241|NCT00197119|19660634|P1|NOT COMPLETED|Year 9||0
7985242|NCT00197119|19660633|P2|COMPLETED|Year 9||114
7985243|NCT00197119|19660634|P1|COMPLETED|Year 9||121
7985244|NCT00197119|19660633|P2|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114
7985245|NCT00197119|19660634|P1|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121
7985246|NCT00197119|19660633|P2|NOT COMPLETED|Year 8||0
7985247|NCT00197119|19660634|P1|NOT COMPLETED|Year 8||0
7985248|NCT00197119|19660633|P2|COMPLETED|Year 8||115
7985249|NCT00197119|19660634|P1|COMPLETED|Year 8||122
7985250|NCT00197119|19660633|P2|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115
7985251|NCT00197119|19660634|P1|STARTED|Year 8||122
7985252|NCT00197119|19660633|P2|NOT COMPLETED|Year 7||0
7985253|NCT00197119|19660634|P1|NOT COMPLETED|Year 7||0
7985254|NCT00197119|19660633|P2|COMPLETED|Year 7||114
7985255|NCT00197119|19660634|P1|COMPLETED|Year 7||122
7985349|NCT00196976|19660961|P8|STARTED|Booster Study||0
7985350|NCT00196976|19660962|P7|STARTED|Booster Study||0
7985256|NCT00197119|19660633|P2|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114
7985257|NCT00197119|19660634|P1|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122
7985258|NCT00197119|19660633|P2|NOT COMPLETED|Year 6||0
7985259|NCT00197119|19660634|P1|NOT COMPLETED|Year 6||0
7985260|NCT00197119|19660633|P2|COMPLETED|Year 6||118
7985261|NCT00197119|19660634|P1|COMPLETED|Year 6||126
7985262|NCT00197119|19660633|P2|STARTED|Year 6||118
7985263|NCT00197119|19660634|P1|STARTED|Year 6||126
7985264|NCT00197106|19660646|P3|NOT COMPLETED|Overall Treatment Period||6
7985265|NCT00197106|19660647|P2|NOT COMPLETED|Overall Treatment Period||1
7985266|NCT00197106|19660648|P1|NOT COMPLETED|Overall Treatment Period||0
7985267|NCT00197106|19660646|P3|COMPLETED|Overall Treatment Period||74
7985268|NCT00197106|19660647|P2|COMPLETED|Overall Treatment Period||77
7985269|NCT00197106|19660648|P1|COMPLETED|Overall Treatment Period||0
7985270|NCT00197106|19660646|P3|STARTED|Overall Treatment Period||80
7985271|NCT00197106|19660647|P2|STARTED|Overall Treatment Period||78
7985272|NCT00197106|19660648|P1|STARTED|Overall Treatment Period||0
7985273|NCT00197106|19660646|P3|NOT COMPLETED|4-Week Run-In Period||0
7985274|NCT00197106|19660647|P2|NOT COMPLETED|4-Week Run-In Period||0
7985275|NCT00197106|19660648|P1|NOT COMPLETED|4-Week Run-In Period||99
7985276|NCT00197106|19660646|P3|COMPLETED|4-Week Run-In Period||0
7985277|NCT00197106|19660647|P2|COMPLETED|4-Week Run-In Period||0
7985278|NCT00197106|19660648|P1|COMPLETED|4-Week Run-In Period||158
7985279|NCT00197106|19660646|P3|STARTED|4-Week Run-In Period||0
7985280|NCT00197106|19660647|P2|STARTED|4-Week Run-In Period||0
7985281|NCT00197106|19660648|P1|STARTED|4-Week Run-In Period||257
7985282|NCT00197054|19660685|P3|NOT COMPLETED|Overall Study||12
7985283|NCT00197054|19660686|P2|NOT COMPLETED|Overall Study||21
7985284|NCT00197054|19660687|P1|NOT COMPLETED|Overall Study||17
7985285|NCT00197054|19660685|P3|COMPLETED|Overall Study||73
7985286|NCT00197054|19660686|P2|COMPLETED|Overall Study||64
7985287|NCT00197054|19660687|P1|COMPLETED|Overall Study||68
7985288|NCT00197054|19660685|P3|STARTED|Overall Study||85
7985289|NCT00197054|19660686|P2|STARTED|Overall Study||85
7985290|NCT00197054|19660687|P1|STARTED|Overall Study||85
7985291|NCT00197028|19660797|P2|NOT COMPLETED|Overall Study||21
7985292|NCT00197028|19660798|P1|NOT COMPLETED|Overall Study||16
7985293|NCT00197028|19660797|P2|COMPLETED|Overall Study||86
7985294|NCT00197028|19660798|P1|COMPLETED|Overall Study||91
7985295|NCT00197028|19660797|P2|STARTED|Overall Study||107
7985296|NCT00197028|19660798|P1|STARTED|Overall Study||107
7985297|NCT00197015|19660841|P3|NOT COMPLETED|Overall Study||77
7985298|NCT00197015|19660842|P2|NOT COMPLETED|Overall Study||89
7985299|NCT00197015|19660843|P1|NOT COMPLETED|Overall Study||50
7985300|NCT00197015|19660841|P3|COMPLETED|Overall Study||385
7985301|NCT00197015|19660842|P2|COMPLETED|Overall Study||366
7985302|NCT00197015|19660843|P1|COMPLETED|Overall Study||274
7985303|NCT00197015|19660841|P3|STARTED|Overall Study||462
7985304|NCT00197015|19660842|P2|STARTED|Overall Study||455
7985305|NCT00197015|19660843|P1|STARTED|Overall Study||324
7985306|NCT00197002|19660902|P3|NOT COMPLETED|Overall Study||17
7985307|NCT00197002|19660903|P2|NOT COMPLETED|Overall Study||18
7985308|NCT00197002|19660904|P1|NOT COMPLETED|Overall Study||22
7985309|NCT00197002|19660902|P3|COMPLETED|Overall Study||132
7985310|NCT00197002|19660903|P2|COMPLETED|Overall Study||119
7985311|NCT00197002|19660904|P1|COMPLETED|Overall Study||125
7985312|NCT00197002|19660902|P3|STARTED|Overall Study||149
7985313|NCT00197002|19660903|P2|STARTED|Overall Study||137
7985314|NCT00197002|19660904|P1|STARTED|Overall Study||147
7985315|NCT00196976|19660955|P14|NOT COMPLETED|Booster Study||0
7985316|NCT00196976|19660956|P13|NOT COMPLETED|Booster Study||0
7985317|NCT00196976|19660957|P12|NOT COMPLETED|Booster Study||2
7985318|NCT00196976|19660958|P11|NOT COMPLETED|Booster Study||2
7985319|NCT00196976|19660959|P10|NOT COMPLETED|Booster Study||0
7985320|NCT00196976|19660960|P9|NOT COMPLETED|Booster Study||0
7985321|NCT00196976|19660961|P8|NOT COMPLETED|Booster Study||0
7985322|NCT00196976|19660962|P7|NOT COMPLETED|Booster Study||0
7985323|NCT00196976|19660963|P6|NOT COMPLETED|Booster Study||0
7985324|NCT00196976|19660964|P5|NOT COMPLETED|Booster Study||0
7985325|NCT00196976|19660965|P4|NOT COMPLETED|Booster Study||0
7985326|NCT00196976|19660966|P3|NOT COMPLETED|Booster Study||0
7985327|NCT00196976|19660967|P2|NOT COMPLETED|Booster Study||0
7985328|NCT00196976|19660968|P1|NOT COMPLETED|Booster Study||0
7985329|NCT00196976|19660955|P14|COMPLETED|Booster Study||43
7985330|NCT00196976|19660956|P13|COMPLETED|Booster Study||45
7985331|NCT00196976|19660957|P12|COMPLETED|Booster Study||30
7985332|NCT00196976|19660958|P11|COMPLETED|Booster Study||31
7985333|NCT00196976|19660959|P10|COMPLETED|Booster Study||0
7985334|NCT00196976|19660960|P9|COMPLETED|Booster Study||0
7985335|NCT00196976|19660961|P8|COMPLETED|Booster Study||0
7985336|NCT00196976|19660962|P7|COMPLETED|Booster Study||0
7985337|NCT00196976|19660963|P6|COMPLETED|Booster Study||0
7985338|NCT00196976|19660964|P5|COMPLETED|Booster Study||0
7985339|NCT00196976|19660965|P4|COMPLETED|Booster Study||0
7985340|NCT00196976|19660966|P3|COMPLETED|Booster Study||0
7985341|NCT00196976|19660967|P2|COMPLETED|Booster Study||0
7985342|NCT00196976|19660968|P1|COMPLETED|Booster Study||0
7985343|NCT00196976|19660955|P14|STARTED|Booster Study||43
7985344|NCT00196976|19660956|P13|STARTED|Booster Study||45
7985345|NCT00196976|19660957|P12|STARTED|Booster Study||32
7985346|NCT00196976|19660958|P11|STARTED|Booster Study||33
7985347|NCT00196976|19660959|P10|STARTED|Booster Study||0
7985348|NCT00196976|19660960|P9|STARTED|Booster Study||0
7985351|NCT00196976|19660963|P6|STARTED|Booster Study||0
7985352|NCT00196976|19660964|P5|STARTED|Booster Study||0
7985353|NCT00196976|19660965|P4|STARTED|Booster Study||0
7985354|NCT00196976|19660966|P3|STARTED|Booster Study||0
7985355|NCT00196976|19660967|P2|STARTED|Booster Study||0
7985356|NCT00196976|19660968|P1|STARTED|Booster Study||0
7985357|NCT00196976|19660955|P14|NOT COMPLETED|Primary Study||0
7985358|NCT00196976|19660956|P13|NOT COMPLETED|Primary Study||0
7985359|NCT00196976|19660957|P12|NOT COMPLETED|Primary Study||0
7985360|NCT00196976|19660958|P11|NOT COMPLETED|Primary Study||0
7985361|NCT00196976|19660959|P10|NOT COMPLETED|Primary Study||1
7985362|NCT00196976|19660960|P9|NOT COMPLETED|Primary Study||0
7985363|NCT00196976|19660961|P8|NOT COMPLETED|Primary Study||3
7985364|NCT00196976|19660962|P7|NOT COMPLETED|Primary Study||0
7985365|NCT00196976|19660963|P6|NOT COMPLETED|Primary Study||2
7985366|NCT00196976|19660964|P5|NOT COMPLETED|Primary Study||3
7985367|NCT00196976|19660965|P4|NOT COMPLETED|Primary Study||1
7985368|NCT00196976|19660966|P3|NOT COMPLETED|Primary Study||4
7985369|NCT00196976|19660967|P2|NOT COMPLETED|Primary Study||1
7985370|NCT00196976|19660968|P1|NOT COMPLETED|Primary Study||1
7985371|NCT00196976|19660955|P14|COMPLETED|Primary Study||0
7985372|NCT00196976|19660956|P13|COMPLETED|Primary Study||0
7985373|NCT00196976|19660957|P12|COMPLETED|Primary Study||0
7985374|NCT00196976|19660958|P11|COMPLETED|Primary Study||0
7985375|NCT00196976|19660959|P10|COMPLETED|Primary Study||51
7985376|NCT00196976|19660960|P9|COMPLETED|Primary Study||52
7985377|NCT00196976|19660961|P8|COMPLETED|Primary Study||49
7985378|NCT00196976|19660962|P7|COMPLETED|Primary Study||50
7985379|NCT00196976|19660963|P6|COMPLETED|Primary Study||52
7985380|NCT00196976|19660964|P5|COMPLETED|Primary Study||37
7985381|NCT00196976|19660965|P4|COMPLETED|Primary Study||39
7985382|NCT00196976|19660966|P3|COMPLETED|Primary Study||37
7985383|NCT00196976|19660967|P2|COMPLETED|Primary Study||40
7985384|NCT00196976|19660968|P1|COMPLETED|Primary Study||38
7985385|NCT00196976|19660955|P14|STARTED|Primary Study||0
7985386|NCT00196976|19660956|P13|STARTED|Primary Study||0
7985387|NCT00196976|19660957|P12|STARTED|Primary Study||0
7985388|NCT00196976|19660958|P11|STARTED|Primary Study||0
7985389|NCT00196976|19660959|P10|STARTED|Primary Study||52
7985390|NCT00196976|19660960|P9|STARTED|Primary Study||52
7985391|NCT00196976|19660961|P8|STARTED|Primary Study||52
7985392|NCT00196976|19660962|P7|STARTED|Primary Study||50
7985393|NCT00196976|19660963|P6|STARTED|Primary Study||54
7985394|NCT00196976|19660964|P5|STARTED|Primary Study||40
7985395|NCT00196976|19660965|P4|STARTED|Primary Study||40
7985396|NCT00196976|19660966|P3|STARTED|Primary Study||41
7985397|NCT00196976|19660967|P2|STARTED|Primary Study||41
7985398|NCT00196976|19660968|P1|STARTED|Primary Study||39
7985399|NCT00196937|19661164|P3|NOT COMPLETED|Overall Study||7
7985400|NCT00196937|19661165|P2|NOT COMPLETED|Overall Study||5
7985401|NCT00196937|19661166|P1|NOT COMPLETED|Overall Study||9
7985402|NCT00196937|19661164|P3|COMPLETED|Overall Study||204
7985403|NCT00196937|19661165|P2|COMPLETED|Overall Study||221
7985404|NCT00196937|19661166|P1|COMPLETED|Overall Study||220
7985405|NCT00196937|19661164|P3|STARTED|Overall Study||211
7985406|NCT00196937|19661165|P2|STARTED|Overall Study||226
7985407|NCT00196937|19661166|P1|STARTED|Overall Study||229
7985408|NCT00196716|19661210|P1|NOT COMPLETED|0.3 mg/kg Period||0
7985409|NCT00196716|19661210|P1|COMPLETED|0.3 mg/kg Period||21
7985410|NCT00196716|19661210|P1|STARTED|0.3 mg/kg Period||21
7985411|NCT00196716|19661210|P1|NOT COMPLETED|1.0 mg/kg Period||0
7985412|NCT00196716|19661210|P1|COMPLETED|1.0 mg/kg Period||21
7985413|NCT00196716|19661210|P1|STARTED|1.0 mg/kg Period||21
7985414|NCT00196326|19661220|P1|NOT COMPLETED|Overall Study||986
7985415|NCT00196326|19661220|P1|COMPLETED|Overall Study||1249
7985416|NCT00196326|19661220|P1|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735
7985417|NCT00196326|19661220|P1|Safety Population|Overall Study|Treated participants|2185
7985418|NCT00196326|19661220|P1|STARTED|Overall Study|Took at least one dose of study medication|2235
7985419|NCT00196313|19661228|P2|NOT COMPLETED|Overall Study||8
7985420|NCT00196313|19661229|P1|NOT COMPLETED|Overall Study||11
7985421|NCT00196313|19661228|P2|COMPLETED|Overall Study||40
7985422|NCT00196313|19661229|P1|COMPLETED|Overall Study||36
7985423|NCT00196313|19661228|P2|STARTED|Overall Study||48
7985424|NCT00196313|19661229|P1|STARTED|Overall Study||47
7985425|NCT00196196|19661243|P1|NOT COMPLETED|Overall Study||7
7985426|NCT00196196|19661243|P1|COMPLETED|Overall Study||267
7985427|NCT00196196|19661243|P1|STARTED|Overall Study||274
7985428|NCT00196105|19661251|P3|NOT COMPLETED|Overall Study||7
7985429|NCT00196105|19661252|P2|NOT COMPLETED|Overall Study||5
7985430|NCT00196105|19661253|P1|NOT COMPLETED|Overall Study||4
7985431|NCT00196105|19661251|P3|COMPLETED|Overall Study||82
7985432|NCT00196105|19661252|P2|COMPLETED|Overall Study||83
7985433|NCT00196105|19661253|P1|COMPLETED|Overall Study||60
7985434|NCT00196105|19661251|P3|STARTED|Overall Study||89
7985435|NCT00196105|19661252|P2|STARTED|Overall Study||88
7985436|NCT00196105|19661253|P1|STARTED|Overall Study||64
7985437|NCT00195819|19661273|P2|NOT COMPLETED|Open-label||20
7985438|NCT00195819|19661274|P1|NOT COMPLETED|Open-label||0
7985439|NCT00195819|19661273|P2|COMPLETED|Open-label||62
7985440|NCT00195819|19661274|P1|COMPLETED|Open-label||0
7985441|NCT00195819|19661273|P2|STARTED|Open-label||82
7985442|NCT00195819|19661274|P1|STARTED|Open-label||0
7985443|NCT00195819|19661273|P2|NOT COMPLETED|Double-Blind||0
7985444|NCT00195819|19661274|P1|NOT COMPLETED|Double-Blind||2
7985445|NCT00195819|19661273|P2|COMPLETED|Double-Blind||38
7985446|NCT00195819|19661274|P1|COMPLETED|Double-Blind||42
7985447|NCT00195819|19661273|P2|STARTED|Double-Blind||38
7985448|NCT00195819|19661274|P1|STARTED|Double-Blind||44
7985449|NCT00195715|19661324|P1|NOT COMPLETED|Overall Study||377
7985450|NCT00195715|19661324|P1|COMPLETED|Overall Study||400
7985451|NCT00195715|19661324|P1|STARTED|Overall Study||777
7985452|NCT00195702|19661355|P6|NOT COMPLETED|Open-label Extension Phase||78
7985453|NCT00195702|19661356|P5|NOT COMPLETED|Open-label Extension Phase||78
7985454|NCT00195702|19661357|P4|NOT COMPLETED|Open-label Extension Phase||99
7985455|NCT00195702|19661358|P3|NOT COMPLETED|Open-label Extension Phase||0
7985456|NCT00195702|19661359|P2|NOT COMPLETED|Open-label Extension Phase||0
7985457|NCT00195702|19661360|P1|NOT COMPLETED|Open-label Extension Phase||0
7985458|NCT00195702|19661355|P6|COMPLETED|Open-label Extension Phase||56
7985459|NCT00195702|19661356|P5|COMPLETED|Open-label Extension Phase||80
7985460|NCT00195702|19661357|P4|COMPLETED|Open-label Extension Phase||66
7985461|NCT00195702|19661358|P3|COMPLETED|Open-label Extension Phase||0
7985462|NCT00195702|19661359|P2|COMPLETED|Open-label Extension Phase||0
7985463|NCT00195702|19661360|P1|COMPLETED|Open-label Extension Phase||0
7985464|NCT00195702|19661355|P6|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134
7985465|NCT00195702|19661356|P5|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158
7985466|NCT00195702|19661357|P4|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165
7985467|NCT00195702|19661358|P3|STARTED|Open-label Extension Phase||0
7985468|NCT00195702|19661359|P2|STARTED|Open-label Extension Phase||0
7985469|NCT00195702|19661360|P1|STARTED|Open-label Extension Phase||0
7985470|NCT00195702|19661355|P6|NOT COMPLETED|Double-blind Phase||0
7985471|NCT00195702|19661356|P5|NOT COMPLETED|Double-blind Phase||0
7985472|NCT00195702|19661357|P4|NOT COMPLETED|Double-blind Phase||0
7985473|NCT00195702|19661358|P3|NOT COMPLETED|Double-blind Phase||60
7985474|NCT00195702|19661359|P2|NOT COMPLETED|Double-blind Phase||48
7985475|NCT00195702|19661360|P1|NOT COMPLETED|Double-blind Phase||44
7985476|NCT00195702|19661355|P6|COMPLETED|Double-blind Phase||0
7985477|NCT00195702|19661356|P5|COMPLETED|Double-blind Phase||0
7985478|NCT00195702|19661357|P4|COMPLETED|Double-blind Phase||0
7985479|NCT00195702|19661358|P3|COMPLETED|Double-blind Phase||140
7985480|NCT00195702|19661359|P2|COMPLETED|Double-blind Phase||159
7985481|NCT00195702|19661360|P1|COMPLETED|Double-blind Phase||168
7985482|NCT00195702|19661355|P6|STARTED|Double-blind Phase||0
7985483|NCT00195702|19661356|P5|STARTED|Double-blind Phase||0
7985484|NCT00195702|19661357|P4|STARTED|Double-blind Phase||0
7985485|NCT00195702|19661358|P3|STARTED|Double-blind Phase||200
7985486|NCT00195702|19661359|P2|STARTED|Double-blind Phase||207
7985487|NCT00195702|19661360|P1|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212
7985488|NCT00195676|19661424|P1|NOT COMPLETED|Period R - Retreatment 16 Weeks||35
7985489|NCT00195676|19661424|P1|COMPLETED|Period R - Retreatment 16 Weeks||490
7985490|NCT00195676|19661424|P1|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525
7985491|NCT00195676|19661424|P1|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608
7985492|NCT00195676|19661424|P1|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0
7985493|NCT00195676|19661424|P1|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608
7985494|NCT00195676|19661424|P1|NOT COMPLETED|Period O - Open-label Treatment||606
7985495|NCT00195676|19661424|P1|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862
7985496|NCT00195676|19661424|P1|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468
7985497|NCT00195663|19661438|P3|NOT COMPLETED|Open-Label Extension Period||97
7985498|NCT00195663|19661439|P2|NOT COMPLETED|Open-Label Extension Period||74
7985499|NCT00195663|19661440|P1|NOT COMPLETED|Open-Label Extension Period||76
7985500|NCT00195663|19661438|P3|COMPLETED|Open-Label Extension Period||86
7985501|NCT00195663|19661439|P2|COMPLETED|Open-Label Extension Period||85
7985502|NCT00195663|19661440|P1|COMPLETED|Open-Label Extension Period||79
7985503|NCT00195663|19661438|P3|STARTED|Open-Label Extension Period||183
7985504|NCT00195663|19661439|P2|STARTED|Open-Label Extension Period||159
7985505|NCT00195663|19661440|P1|STARTED|Open-Label Extension Period||155
7985506|NCT00195663|19661438|P3|NOT COMPLETED|2-year Double-blind Treatment Period||72
7985507|NCT00195663|19661439|P2|NOT COMPLETED|2-year Double-blind Treatment Period||108
7985508|NCT00195663|19661440|P1|NOT COMPLETED|2-year Double-blind Treatment Period||93
7985509|NCT00195663|19661438|P3|COMPLETED|2-year Double-blind Treatment Period||196
7985510|NCT00195663|19661439|P2|COMPLETED|2-year Double-blind Treatment Period||166
7985511|NCT00195663|19661440|P1|COMPLETED|2-year Double-blind Treatment Period||164
7985512|NCT00195663|19661438|P3|STARTED|2-year Double-blind Treatment Period||268
7985513|NCT00195663|19661439|P2|STARTED|2-year Double-blind Treatment Period||274
7985514|NCT00195663|19661440|P1|STARTED|2-year Double-blind Treatment Period||257
7985515|NCT00195650|19661534|P1|NOT COMPLETED|Overall Study||525
7985516|NCT00195650|19661534|P1|COMPLETED|Overall Study||321
7985517|NCT00195650|19661534|P1|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846
7985518|NCT00195624|19661550|P2|NOT COMPLETED|Overall Study||0
7985519|NCT00195624|19661551|P1|NOT COMPLETED|Overall Study||0
7985520|NCT00195624|19661550|P2|COMPLETED|Overall Study||42
7985521|NCT00195624|19661551|P1|COMPLETED|Overall Study||5
7985522|NCT00195624|19661550|P2|STARTED|Overall Study||42
7985523|NCT00195624|19661551|P1|STARTED|Overall Study||5
7985524|NCT00195507|19661559|P2|NOT COMPLETED|Overall Study||118
7985525|NCT00195507|19661560|P1|NOT COMPLETED|Overall Study||99
7985526|NCT00195507|19661559|P2|COMPLETED|Overall Study||245
7985527|NCT00195507|19661560|P1|COMPLETED|Overall Study||258
7985528|NCT00195507|19661559|P2|STARTED|Overall Study||363
7985529|NCT00195507|19661560|P1|STARTED|Overall Study||357
7985530|NCT00195494|19661574|P6|NOT COMPLETED|Year 2||0
7985531|NCT00195494|19661575|P5|NOT COMPLETED|Year 2||0
7985532|NCT00195494|19661576|P4|NOT COMPLETED|Year 2||23
7985533|NCT00195494|19661577|P3|NOT COMPLETED|Year 2||18
7985534|NCT00195494|19661578|P2|NOT COMPLETED|Year 2||16
7985535|NCT00195494|19661579|P1|NOT COMPLETED|Year 2||7
7985536|NCT00195494|19661574|P6|COMPLETED|Year 2||0
7985537|NCT00195494|19661575|P5|COMPLETED|Year 2||0
7985538|NCT00195494|19661576|P4|COMPLETED|Year 2||76
7985539|NCT00195494|19661577|P3|COMPLETED|Year 2||93
7985540|NCT00195494|19661578|P2|COMPLETED|Year 2||74
7985541|NCT00195494|19661579|P1|COMPLETED|Year 2||104
7985542|NCT00195494|19661574|P6|STARTED|Year 2||0
7985543|NCT00195494|19661575|P5|STARTED|Year 2||0
7985544|NCT00195494|19661576|P4|STARTED|Year 2||99
7985545|NCT00195494|19661577|P3|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
7985546|NCT00195494|19661578|P2|STARTED|Year 2||90
7985547|NCT00195494|19661579|P1|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
7985548|NCT00195494|19661574|P6|NOT COMPLETED|Year 1||53
7985549|NCT00195494|19661575|P5|NOT COMPLETED|Year 1||79
7985550|NCT00195494|19661576|P4|NOT COMPLETED|Year 1||0
7985551|NCT00195494|19661577|P3|NOT COMPLETED|Year 1||0
7985552|NCT00195494|19661578|P2|NOT COMPLETED|Year 1||0
7985553|NCT00195494|19661579|P1|NOT COMPLETED|Year 1||0
7985554|NCT00195494|19661574|P6|COMPLETED|Year 1||221
7985555|NCT00195494|19661575|P5|COMPLETED|Year 1||189
7985556|NCT00195494|19661576|P4|COMPLETED|Year 1||0
7985557|NCT00195494|19661577|P3|COMPLETED|Year 1||0
7985558|NCT00195494|19661578|P2|COMPLETED|Year 1||0
7985559|NCT00195494|19661579|P1|COMPLETED|Year 1||0
7985560|NCT00195494|19661574|P6|STARTED|Year 1||274
7985561|NCT00195494|19661575|P5|STARTED|Year 1||268
7985562|NCT00195494|19661576|P4|STARTED|Year 1||0
7985563|NCT00195494|19661577|P3|STARTED|Year 1||0
7985564|NCT00195494|19661578|P2|STARTED|Year 1||0
7985565|NCT00195494|19661579|P1|STARTED|Year 1||0
7985566|NCT00195442|19661597|P1|NOT COMPLETED|Overall Study||136
7985567|NCT00195442|19661597|P1|COMPLETED|Overall Study||152
7985568|NCT00195442|19661597|P1|STARTED|Overall Study||288
7985569|NCT00195429|19661616|P2|NOT COMPLETED|Overall Study||5
7985570|NCT00195429|19661617|P1|NOT COMPLETED|Overall Study||5
7985571|NCT00195429|19661616|P2|COMPLETED|Overall Study||18
7985572|NCT00195429|19661617|P1|COMPLETED|Overall Study||19
7985573|NCT00195429|19661616|P2|STARTED|Overall Study||23
7985574|NCT00195429|19661617|P1|STARTED|Overall Study||24
7985575|NCT00195403|19661625|P1|NOT COMPLETED|Overall Study||0
7985576|NCT00195403|19661625|P1|COMPLETED|Overall Study||1014
7985577|NCT00195403|19661625|P1|STARTED|Overall Study||1014
7985578|NCT00195351|19661633|P2|NOT COMPLETED|Overall Study||16
7985579|NCT00195351|19661634|P1|NOT COMPLETED|Overall Study||21
7985580|NCT00195351|19661633|P2|COMPLETED|Overall Study||215
7985581|NCT00195351|19661634|P1|COMPLETED|Overall Study||215
7985582|NCT00195351|19661633|P2|STARTED|Overall Study||231
7985583|NCT00195351|19661634|P1|STARTED|Overall Study||236
7985584|NCT00195338|19661644|P1|NOT COMPLETED|Overall Study||12
7985585|NCT00195338|19661644|P1|COMPLETED|Overall Study||13
7985586|NCT00195338|19661644|P1|STARTED|Overall Study||25
7985587|NCT00195273|19661654|P2|NOT COMPLETED|Overall Study||14
7985588|NCT00195273|19661655|P1|NOT COMPLETED|Overall Study||21
7985589|NCT00195273|19661654|P2|COMPLETED|Overall Study||16
7985590|NCT00195273|19661655|P1|COMPLETED|Overall Study||10
7985591|NCT00195273|19661654|P2|STARTED|Overall Study||30
7985592|NCT00195273|19661655|P1|STARTED|Overall Study||31
7985593|NCT00195260|19661669|P11|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23
7985594|NCT00195260|19661670|P10|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38
7985595|NCT00195260|19661671|P9|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33
7985596|NCT00195260|19661672|P8|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985597|NCT00195260|19661673|P7|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985598|NCT00195260|19661674|P6|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985599|NCT00195260|19661675|P5|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985600|NCT00195260|19661676|P4|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985601|NCT00195260|19661677|P3|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985602|NCT00195260|19661678|P2|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985603|NCT00195260|19661679|P1|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985604|NCT00195260|19661669|P11|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2
7985605|NCT00195260|19661670|P10|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985606|NCT00195260|19661671|P9|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4
7985607|NCT00195260|19661672|P8|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985608|NCT00195260|19661673|P7|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985609|NCT00195260|19661674|P6|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985610|NCT00195260|19661675|P5|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985611|NCT00195260|19661676|P4|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985612|NCT00195260|19661677|P3|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985613|NCT00195260|19661678|P2|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985614|NCT00195260|19661679|P1|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985615|NCT00195260|19661669|P11|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25
7985616|NCT00195260|19661670|P10|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38
7985617|NCT00195260|19661671|P9|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37
7985618|NCT00195260|19661672|P8|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985619|NCT00195260|19661673|P7|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985620|NCT00195260|19661674|P6|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985621|NCT00195260|19661675|P5|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985622|NCT00195260|19661676|P4|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985623|NCT00195260|19661677|P3|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985624|NCT00195260|19661678|P2|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985625|NCT00195260|19661679|P1|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
7985626|NCT00195260|19661669|P11|NOT COMPLETED|Part 1: Dose Escalation||0
7985627|NCT00195260|19661670|P10|NOT COMPLETED|Part 1: Dose Escalation||0
7985628|NCT00195260|19661671|P9|NOT COMPLETED|Part 1: Dose Escalation||0
7985629|NCT00195260|19661672|P8|NOT COMPLETED|Part 1: Dose Escalation||6
7985630|NCT00195260|19661673|P7|NOT COMPLETED|Part 1: Dose Escalation||10
7985631|NCT00195260|19661674|P6|NOT COMPLETED|Part 1: Dose Escalation||7
7985632|NCT00195260|19661675|P5|NOT COMPLETED|Part 1: Dose Escalation||7
7985633|NCT00195260|19661676|P4|NOT COMPLETED|Part 1: Dose Escalation||7
7985634|NCT00195260|19661677|P3|NOT COMPLETED|Part 1: Dose Escalation||6
7985635|NCT00195260|19661678|P2|NOT COMPLETED|Part 1: Dose Escalation||4
7985636|NCT00195260|19661679|P1|NOT COMPLETED|Part 1: Dose Escalation||4
7985637|NCT00195260|19661669|P11|COMPLETED|Part 1: Dose Escalation||0
7985638|NCT00195260|19661670|P10|COMPLETED|Part 1: Dose Escalation||0
7985639|NCT00195260|19661671|P9|COMPLETED|Part 1: Dose Escalation||0
7985640|NCT00195260|19661672|P8|COMPLETED|Part 1: Dose Escalation||0
7985641|NCT00195260|19661673|P7|COMPLETED|Part 1: Dose Escalation||0
7985642|NCT00195260|19661674|P6|COMPLETED|Part 1: Dose Escalation||0
7985643|NCT00195260|19661675|P5|COMPLETED|Part 1: Dose Escalation||0
7985644|NCT00195260|19661676|P4|COMPLETED|Part 1: Dose Escalation||0
7985645|NCT00195260|19661677|P3|COMPLETED|Part 1: Dose Escalation||0
7985646|NCT00195260|19661678|P2|COMPLETED|Part 1: Dose Escalation||0
7985647|NCT00195260|19661679|P1|COMPLETED|Part 1: Dose Escalation||0
7985648|NCT00195260|19661669|P11|STARTED|Part 1: Dose Escalation||0
7985649|NCT00195260|19661670|P10|STARTED|Part 1: Dose Escalation||0
7985650|NCT00195260|19661671|P9|STARTED|Part 1: Dose Escalation||0
7985651|NCT00195260|19661672|P8|STARTED|Part 1: Dose Escalation||6
7985652|NCT00195260|19661673|P7|STARTED|Part 1: Dose Escalation||10
7985653|NCT00195260|19661674|P6|STARTED|Part 1: Dose Escalation||7
7985654|NCT00195260|19661675|P5|STARTED|Part 1: Dose Escalation||7
7985655|NCT00195260|19661676|P4|STARTED|Part 1: Dose Escalation||7
7985656|NCT00195260|19661677|P3|STARTED|Part 1: Dose Escalation||6
7985657|NCT00195260|19661678|P2|STARTED|Part 1: Dose Escalation||4
7985658|NCT00195260|19661679|P1|STARTED|Part 1: Dose Escalation||4
7985659|NCT00195039|19661825|P1|NOT COMPLETED|Overall Study||0
7985660|NCT00195039|19661825|P1|COMPLETED|Overall Study||47
7985661|NCT00195039|19661825|P1|STARTED|Overall Study||47
7985662|NCT00195013|19661838|P2|NOT COMPLETED|Overall Study||1
7985663|NCT00195013|19661839|P1|NOT COMPLETED|Overall Study||2
7985664|NCT00195013|19661838|P2|COMPLETED|Overall Study||15
7985665|NCT00195013|19661839|P1|COMPLETED|Overall Study||12
7985666|NCT00195013|19661838|P2|STARTED|Overall Study||16
7985667|NCT00195013|19661839|P1|STARTED|Overall Study||14
7985668|NCT00194987|19661847|P2|NOT COMPLETED|Overall Study||3
7985669|NCT00194987|19661848|P1|NOT COMPLETED|Overall Study||0
7985670|NCT00194987|19661847|P2|COMPLETED|Overall Study|"3 women chose to withdraw because they felt the study was too inconvenient."|48
7985671|NCT00194987|19661848|P1|COMPLETED|Overall Study||51
7985672|NCT00194987|19661847|P2|STARTED|Overall Study||51
7985673|NCT00194987|19661848|P1|STARTED|Overall Study||51
7985674|NCT00194896|19661864|P4|NOT COMPLETED|Overall Study||12
7985675|NCT00194896|19661865|P3|NOT COMPLETED|Overall Study||6
7985676|NCT00194896|19661866|P2|NOT COMPLETED|Overall Study||5
7985677|NCT00194896|19661867|P1|NOT COMPLETED|Overall Study||11
7985678|NCT00194896|19661864|P4|COMPLETED|Overall Study||9
7985679|NCT00194896|19661865|P3|COMPLETED|Overall Study||7
7985680|NCT00194896|19661866|P2|COMPLETED|Overall Study||10
7985681|NCT00194896|19661867|P1|COMPLETED|Overall Study||4
7985682|NCT00194896|19661864|P4|STARTED|Overall Study||21
7985683|NCT00194896|19661865|P3|STARTED|Overall Study||13
7985684|NCT00194896|19661866|P2|STARTED|Overall Study||15
7985685|NCT00194896|19661867|P1|STARTED|Overall Study||15
7985686|NCT00194792|19661881|P1|NOT COMPLETED|Overall Study||1
7985687|NCT00194792|19661881|P1|COMPLETED|Overall Study||27
7985688|NCT00194792|19661881|P1|STARTED|Overall Study||28
7985689|NCT00194779|19661891|P1|NOT COMPLETED|Overall Study||0
7985690|NCT00194779|19661891|P1|COMPLETED|Overall Study||50
7985691|NCT00194779|19661891|P1|STARTED|Overall Study||50
7985692|NCT00194675|19661905|P2|NOT COMPLETED|Overall Study||2
7985693|NCT00194675|19661906|P1|NOT COMPLETED|Overall Study||5
7985694|NCT00194675|19661905|P2|COMPLETED|Overall Study||24
7985695|NCT00194675|19661906|P1|COMPLETED|Overall Study||22
7985696|NCT00194675|19661905|P2|STARTED|Overall Study||26
7985697|NCT00194675|19661906|P1|STARTED|Overall Study||27
7985698|NCT00194610|19661924|P2|NOT COMPLETED|Overall Study||0
7985699|NCT00194610|19661925|P1|NOT COMPLETED|Overall Study||0
7985700|NCT00194610|19661924|P2|COMPLETED|Overall Study||9
7985701|NCT00194610|19661925|P1|COMPLETED|Overall Study||11
7985702|NCT00194610|19661924|P2|STARTED|Overall Study||9
7985703|NCT00194610|19661925|P1|STARTED|Overall Study||11
7985704|NCT00194532|19661933|P2|NOT COMPLETED|Overall Study||0
7985705|NCT00194532|19661934|P1|NOT COMPLETED|Overall Study||0
7985706|NCT00194532|19661933|P2|COMPLETED|Overall Study||150
7985707|NCT00194532|19661934|P1|COMPLETED|Overall Study||150
7985708|NCT00194532|19661933|P2|STARTED|Overall Study||150
7985709|NCT00194532|19661934|P1|STARTED|Overall Study||150
7985710|NCT00194129|19661944|P2|NOT COMPLETED|Overall Study||13
7985711|NCT00194129|19661945|P1|NOT COMPLETED|Overall Study||10
7985712|NCT00194129|19661944|P2|COMPLETED|Overall Study||3
7985713|NCT00194129|19661945|P1|COMPLETED|Overall Study||5
7985714|NCT00194129|19661944|P2|STARTED|Overall Study||16
7985715|NCT00194129|19661945|P1|STARTED|Overall Study||15
7985716|NCT00194116|19661960|P2|NOT COMPLETED|Overall Study||15
7985717|NCT00194116|19661961|P1|NOT COMPLETED|Overall Study||13
7985718|NCT00194116|19661960|P2|COMPLETED|Overall Study||13
7985719|NCT00194116|19661961|P1|COMPLETED|Overall Study||13
7985720|NCT00194116|19661960|P2|STARTED|Overall Study||28
7985721|NCT00194116|19661961|P1|STARTED|Overall Study||26
7985722|NCT00194077|19661981|P2|NOT COMPLETED|Overall Study||30
7985723|NCT00194077|19661982|P1|NOT COMPLETED|Overall Study||24
7985724|NCT00194077|19661981|P2|COMPLETED|Overall Study|"Lack of efficacy:
~hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0
7985725|NCT00194077|19661982|P1|COMPLETED|Overall Study|"Lack of efficacy:
~Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6
7985726|NCT00194077|19661981|P2|STARTED|Overall Study||30
7985727|NCT00194077|19661982|P1|STARTED|Overall Study||30
7985728|NCT00194025|19661988|P1|NOT COMPLETED|Overall Study||5
7985729|NCT00194025|19661988|P1|COMPLETED|Overall Study|5 participants withdrew prematurely|15
7985730|NCT00194025|19661988|P1|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20
7985731|NCT00194012|19662003|P2|NOT COMPLETED|Open Label Extension (OLE)||6
7985732|NCT00194012|19662004|P1|NOT COMPLETED|Open Label Extension (OLE)||5
7985733|NCT00194012|19662003|P2|COMPLETED|Open Label Extension (OLE)||15
7985734|NCT00194012|19662004|P1|COMPLETED|Open Label Extension (OLE)||17
7985735|NCT00194012|19662003|P2|STARTED|Open Label Extension (OLE)|Participants from placebo group started OLE (eligible even if randomized period not completed).|21
7985736|NCT00194012|19662004|P1|STARTED|Open Label Extension (OLE)|Participants from aripiprazole group started OLE (eligible even if randomized period not completed).|22
7985737|NCT00194012|19662003|P2|NOT COMPLETED|Randomized Phase||25
7985738|NCT00194012|19662004|P1|NOT COMPLETED|Randomized Phase||16
7985739|NCT00194012|19662003|P2|COMPLETED|Randomized Phase||6
7985740|NCT00194012|19662004|P1|COMPLETED|Randomized Phase||15
7985741|NCT00194012|19662003|P2|Received More Than One Dose|Randomized Phase||29
7985742|NCT00194012|19662004|P1|Received More Than One Dose|Randomized Phase||30
7985743|NCT00194012|19662003|P2|STARTED|Randomized Phase||31
7985744|NCT00194012|19662004|P1|STARTED|Randomized Phase||31
7985745|NCT00193609|19662040|P1|NOT COMPLETED|Overall Study||4
7985746|NCT00193609|19662040|P1|COMPLETED|Overall Study||44
7985747|NCT00193609|19662040|P1|STARTED|Overall Study||48
7985748|NCT00193596|19662047|P2|NOT COMPLETED|Overall Study||66
7985749|NCT00193596|19662048|P1|NOT COMPLETED|Overall Study||56
7985750|NCT00193596|19662047|P2|COMPLETED|Overall Study||39
7985751|NCT00193596|19662048|P1|COMPLETED|Overall Study||37
7985752|NCT00193596|19662047|P2|STARTED|Overall Study||105
7985753|NCT00193596|19662048|P1|STARTED|Overall Study||93
7985754|NCT00193492|19662058|P2|NOT COMPLETED|Overall Study||15
7985755|NCT00193492|19662059|P1|NOT COMPLETED|Overall Study||17
7985756|NCT00193492|19662058|P2|COMPLETED|Overall Study||14
7985757|NCT00193492|19662059|P1|COMPLETED|Overall Study||14
7985758|NCT00193492|19662058|P2|STARTED|Overall Study||29
7985759|NCT00193492|19662059|P1|STARTED|Overall Study||31
7985760|NCT00193479|19662067|P1|NOT COMPLETED|Maintenance Rituximab||0
7985761|NCT00193479|19662067|P1|COMPLETED|Maintenance Rituximab||44
7985762|NCT00193479|19662067|P1|STARTED|Maintenance Rituximab||44
7985763|NCT00193479|19662067|P1|NOT COMPLETED|Induction Chemotherapy||3
7985764|NCT00193479|19662067|P1|COMPLETED|Induction Chemotherapy||48
7985765|NCT00193479|19662067|P1|STARTED|Induction Chemotherapy||51
7985766|NCT00193453|19662071|P1|NOT COMPLETED|Overall Study||48
7985767|NCT00193453|19662071|P1|COMPLETED|Overall Study||21
7985768|NCT00193453|19662071|P1|STARTED|Overall Study||69
7985769|NCT00193427|19662077|P1|NOT COMPLETED|Overall Study||49
7985770|NCT00193427|19662077|P1|COMPLETED|Overall Study||26
7985771|NCT00193427|19662077|P1|STARTED|Overall Study||75
7985772|NCT00193414|19662084|P1|NOT COMPLETED|Overall Study||58
7985773|NCT00193414|19662084|P1|COMPLETED|Overall Study||14
7985774|NCT00193414|19662084|P1|STARTED|Overall Study||72
7985775|NCT00193375|19662090|P1|NOT COMPLETED|Overall Study||19
7985776|NCT00193375|19662090|P1|COMPLETED|Overall Study||41
7985777|NCT00193375|19662090|P1|STARTED|Overall Study||60
7985778|NCT00193258|19662096|P1|NOT COMPLETED|Overall Study||0
7985779|NCT00193258|19662096|P1|COMPLETED|Overall Study||94
7985780|NCT00193258|19662096|P1|STARTED|Overall Study||94
7985781|NCT00193219|19662102|P1|NOT COMPLETED|Overall Study||30
7985782|NCT00193219|19662102|P1|COMPLETED|Overall Study||6
7985783|NCT00193219|19662102|P1|STARTED|Overall Study||36
7985784|NCT00193206|19662108|P1|NOT COMPLETED|Postoperative Therapy||14
7985785|NCT00193206|19662108|P1|COMPLETED|Postoperative Therapy||102
7985786|NCT00193206|19662108|P1|STARTED|Postoperative Therapy||116
7985787|NCT00193206|19662108|P1|NOT COMPLETED|Surgery||0
7985788|NCT00193206|19662108|P1|COMPLETED|Surgery||116
7985789|NCT00193206|19662108|P1|STARTED|Surgery||116
7985790|NCT00193206|19662108|P1|NOT COMPLETED|Preoperative Therapy||7
7985791|NCT00193206|19662108|P1|COMPLETED|Preoperative Therapy||116
7985792|NCT00193206|19662108|P1|STARTED|Preoperative Therapy||123
7985793|NCT00193180|19662112|P1|NOT COMPLETED|Overall Study||10
7985794|NCT00193180|19662112|P1|COMPLETED|Overall Study||27
7985795|NCT00193180|19662112|P1|STARTED|Overall Study||37
7985796|NCT00193128|19662120|P2|NOT COMPLETED|Overall Study||10
7985797|NCT00193128|19662121|P1|NOT COMPLETED|Overall Study||0
7985798|NCT00193128|19662120|P2|COMPLETED|Overall Study||39
7985799|NCT00193128|19662121|P1|COMPLETED|Overall Study||10
7985800|NCT00193128|19662120|P2|STARTED|Overall Study||49
7985801|NCT00193128|19662121|P1|STARTED|Overall Study||10
7985802|NCT00193063|19662127|P1|NOT COMPLETED|Overall Study||4
7985803|NCT00193063|19662127|P1|COMPLETED|Overall Study||37
7985804|NCT00193063|19662127|P1|STARTED|Overall Study||41
7985805|NCT00193050|19662133|P1|NOT COMPLETED|Adjuvant||10
7985806|NCT00193050|19662133|P1|COMPLETED|Adjuvant||77
7985807|NCT00193050|19662133|P1|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87
7985808|NCT00193050|19662133|P1|NOT COMPLETED|Surgery||0
7985809|NCT00193050|19662133|P1|COMPLETED|Surgery||103
7985810|NCT00193050|19662133|P1|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103
7985811|NCT00193050|19662133|P1|NOT COMPLETED|Neoadjuvant Treatment||9
7985812|NCT00193050|19662133|P1|COMPLETED|Neoadjuvant Treatment||101
7985813|NCT00193050|19662133|P1|STARTED|Neoadjuvant Treatment||110
7985814|NCT00193037|19662139|P2|NOT COMPLETED|Crossover Treatment||0
7985815|NCT00193037|19662140|P1|NOT COMPLETED|Crossover Treatment||0
7985816|NCT00193037|19662139|P2|COMPLETED|Crossover Treatment||24
7985817|NCT00193037|19662140|P1|COMPLETED|Crossover Treatment||32
7985818|NCT00193037|19662139|P2|STARTED|Crossover Treatment||24
7985819|NCT00193037|19662140|P1|STARTED|Crossover Treatment||32
7985820|NCT00193037|19662139|P2|NOT COMPLETED|Randomized Treatment||28
7985821|NCT00193037|19662140|P1|NOT COMPLETED|Randomized Treatment||18
7985822|NCT00193037|19662139|P2|COMPLETED|Randomized Treatment||24
7985823|NCT00193037|19662140|P1|COMPLETED|Randomized Treatment||32
7985824|NCT00193037|19662139|P2|STARTED|Randomized Treatment||52
7985825|NCT00193037|19662140|P1|STARTED|Randomized Treatment||50
7985826|NCT00192647|19662150|P2|NOT COMPLETED|Overall Study||146
7985827|NCT00192647|19662151|P1|NOT COMPLETED|Overall Study||128
7985828|NCT00192647|19662150|P2|COMPLETED|Overall Study||302
7985829|NCT00192647|19662151|P1|COMPLETED|Overall Study||320
7985830|NCT00192647|19662150|P2|Treated|Overall Study||438
7985831|NCT00192647|19662151|P1|Treated|Overall Study||433
7985832|NCT00192647|19662150|P2|STARTED|Overall Study||448
7985833|NCT00192647|19662151|P1|STARTED|Overall Study||448
7985834|NCT00192296|19662171|P4|NOT COMPLETED|Overall Study||0
7985835|NCT00192296|19662172|P3|NOT COMPLETED|Overall Study||0
7985836|NCT00192296|19662173|P2|NOT COMPLETED|Overall Study||1
7985837|NCT00192296|19662174|P1|NOT COMPLETED|Overall Study||0
7985838|NCT00192296|19662171|P4|COMPLETED|Overall Study||6
7985839|NCT00192296|19662172|P3|COMPLETED|Overall Study||6
7985840|NCT00192296|19662173|P2|COMPLETED|Overall Study||5
7985841|NCT00192296|19662174|P1|COMPLETED|Overall Study||6
7985842|NCT00192296|19662171|P4|STARTED|Overall Study||6
7985843|NCT00192296|19662172|P3|STARTED|Overall Study||6
7985844|NCT00192296|19662173|P2|STARTED|Overall Study||6
7985845|NCT00192296|19662174|P1|STARTED|Overall Study||6
7985846|NCT00192114|19662228|P1|NOT COMPLETED|Overall Study||24
7985847|NCT00192114|19662228|P1|COMPLETED|Overall Study||4
7985848|NCT00192114|19662228|P1|Received at Least 1 Dose of Study Drug|Overall Study||28
7985849|NCT00192114|19662228|P1|STARTED|Overall Study||28
7985850|NCT00192075|19662245|P2|NOT COMPLETED|Overall Study||19
7985851|NCT00192075|19662246|P1|NOT COMPLETED|Overall Study||39
7985852|NCT00192075|19662245|P2|COMPLETED|Overall Study||23
7985853|NCT00192075|19662246|P1|COMPLETED|Overall Study||3
7985854|NCT00192075|19662245|P2|STARTED|Overall Study||42
7985855|NCT00192075|19662246|P1|STARTED|Overall Study||42
7985856|NCT00192036|19662271|P1|NOT COMPLETED|Overall Study||21
7985857|NCT00192036|19662271|P1|COMPLETED|Overall Study||28
7985858|NCT00192036|19662271|P1|STARTED|Overall Study||49
7985859|NCT00192023|19662281|P2|NOT COMPLETED|Period IV - Optional Open-Label||0
7985860|NCT00192023|19662282|P1|NOT COMPLETED|Period IV - Optional Open-Label||75
7985861|NCT00192023|19662281|P2|COMPLETED|Period IV - Optional Open-Label||0
7985862|NCT00192023|19662282|P1|COMPLETED|Period IV - Optional Open-Label||49
7985863|NCT00192023|19662281|P2|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0
7985864|NCT00192023|19662282|P1|STARTED|Period IV - Optional Open-Label||124
7985865|NCT00192023|19662281|P2|NOT COMPLETED|Period III - Double-Blind||0
7985866|NCT00192023|19662282|P1|NOT COMPLETED|Period III - Double-Blind||7
7985867|NCT00192023|19662281|P2|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32
7985868|NCT00192023|19662282|P1|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100
7985869|NCT00192023|19662281|P2|STARTED|Period III - Double-Blind||32
7985870|NCT00192023|19662282|P1|STARTED|Period III - Double-Blind||107
7985871|NCT00191984|19662304|P1|NOT COMPLETED|Overall Study||39
7985872|NCT00191984|19662304|P1|COMPLETED|Overall Study||7
7985873|NCT00191984|19662304|P1|STARTED|Overall Study||46
7985874|NCT00191945|19662314|P2|NOT COMPLETED|Open-Label Treatment Extension||0
7985875|NCT00191945|19662315|P1|NOT COMPLETED|Open-Label Treatment Extension||0
7985876|NCT00191945|19662314|P2|COMPLETED|Open-Label Treatment Extension||48
7985877|NCT00191945|19662315|P1|COMPLETED|Open-Label Treatment Extension||94
7985878|NCT00191945|19662314|P2|STARTED|Open-Label Treatment Extension||48
7985879|NCT00191945|19662315|P1|STARTED|Open-Label Treatment Extension||94
7985880|NCT00191945|19662314|P2|NOT COMPLETED|Double-Blind Acute Treatment||3
7985881|NCT00191945|19662315|P1|NOT COMPLETED|Double-Blind Acute Treatment||6
7985882|NCT00191945|19662314|P2|COMPLETED|Double-Blind Acute Treatment||48
7985883|NCT00191945|19662315|P1|COMPLETED|Double-Blind Acute Treatment||94
7985884|NCT00191945|19662314|P2|STARTED|Double-Blind Acute Treatment||51
7985885|NCT00191945|19662315|P1|STARTED|Double-Blind Acute Treatment||100
7985886|NCT00191906|19662351|P4|NOT COMPLETED|Study Period III||0
7985887|NCT00191906|19662352|P3|NOT COMPLETED|Study Period III||0
7985888|NCT00191906|19662353|P2|NOT COMPLETED|Study Period III||4
7985889|NCT00191906|19662354|P1|NOT COMPLETED|Study Period III||5
7985890|NCT00191906|19662351|P4|COMPLETED|Study Period III||0
7985891|NCT00191906|19662352|P3|COMPLETED|Study Period III||0
7985892|NCT00191906|19662353|P2|COMPLETED|Study Period III||7
7985893|NCT00191906|19662354|P1|COMPLETED|Study Period III||9
7985894|NCT00191906|19662351|P4|STARTED|Study Period III||0
7985895|NCT00191906|19662352|P3|STARTED|Study Period III||0
7985896|NCT00191906|19662353|P2|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11
7985897|NCT00191906|19662354|P1|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14
7985898|NCT00191906|19662351|P4|NOT COMPLETED|Study Period II||0
7985899|NCT00191906|19662352|P3|NOT COMPLETED|Study Period II||1
7985900|NCT00191906|19662353|P2|NOT COMPLETED|Study Period II||5
7985901|NCT00191906|19662354|P1|NOT COMPLETED|Study Period II||0
7985902|NCT00191906|19662351|P4|COMPLETED|Study Period II||18
7985903|NCT00191906|19662352|P3|COMPLETED|Study Period II||26
7985904|NCT00191906|19662353|P2|COMPLETED|Study Period II||32
7985905|NCT00191906|19662354|P1|COMPLETED|Study Period II||39
7985906|NCT00191906|19662351|P4|STARTED|Study Period II||18
7985907|NCT00191906|19662352|P3|STARTED|Study Period II||27
7985908|NCT00191906|19662353|P2|STARTED|Study Period II||37
7985909|NCT00191906|19662354|P1|STARTED|Study Period II||39
7985910|NCT00191854|19662397|P3|NOT COMPLETED|Overall Study||39
7985911|NCT00191854|19662398|P2|NOT COMPLETED|Overall Study||30
7985912|NCT00191854|19662399|P1|NOT COMPLETED|Overall Study||37
7985913|NCT00191854|19662397|P3|COMPLETED|Overall Study||12
7985914|NCT00191854|19662398|P2|COMPLETED|Overall Study||17
7985915|NCT00191854|19662399|P1|COMPLETED|Overall Study||12
7985916|NCT00191854|19662397|P3|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50
7985917|NCT00191854|19662398|P2|Received at Least One Dose of Study Drug|Overall Study||47
7985918|NCT00191854|19662399|P1|Received at Least One Dose of Study Drug|Overall Study||49
7985919|NCT00191854|19662397|P3|STARTED|Overall Study||51
7985920|NCT00191854|19662398|P2|STARTED|Overall Study||47
7985921|NCT00191854|19662399|P1|STARTED|Overall Study||49
7985922|NCT00191815|19662419|P1|NOT COMPLETED|Overall Study||40
7985923|NCT00191815|19662419|P1|COMPLETED|Overall Study||30
7985924|NCT00191815|19662419|P1|Treated|Overall Study||67
7985925|NCT00191815|19662419|P1|STARTED|Overall Study||70
7985926|NCT00191789|19662431|P1|NOT COMPLETED|Overall Study||25
7985927|NCT00191789|19662431|P1|COMPLETED|Overall Study||40
7985928|NCT00191789|19662431|P1|STARTED|Overall Study||65
7985929|NCT00191724|19662448|P5|NOT COMPLETED|Overall Study||3
7985930|NCT00191724|19662449|P4|NOT COMPLETED|Overall Study||3
7985931|NCT00191724|19662450|P3|NOT COMPLETED|Overall Study||1
7985932|NCT00191724|19662451|P2|NOT COMPLETED|Overall Study||1
7985933|NCT00191724|19662452|P1|NOT COMPLETED|Overall Study||1
7985934|NCT00191724|19662448|P5|COMPLETED|Overall Study||12
7985935|NCT00191724|19662449|P4|COMPLETED|Overall Study||5
7985936|NCT00191724|19662450|P3|COMPLETED|Overall Study||8
7985937|NCT00191724|19662451|P2|COMPLETED|Overall Study||8
7985938|NCT00191724|19662452|P1|COMPLETED|Overall Study||5
7985939|NCT00191724|19662448|P5|STARTED|Overall Study||15
7985940|NCT00191724|19662449|P4|STARTED|Overall Study||8
7985941|NCT00191724|19662450|P3|STARTED|Overall Study||9
7985942|NCT00191724|19662451|P2|STARTED|Overall Study||9
7985943|NCT00191724|19662452|P1|STARTED|Overall Study||6
7985944|NCT00191646|19662481|P2|NOT COMPLETED|Overall Study||153
7985945|NCT00191646|19662482|P1|NOT COMPLETED|Overall Study||171
7985946|NCT00191646|19662481|P2|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261
7985947|NCT00191646|19662482|P1|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246
7985948|NCT00191646|19662481|P2|Received Crossover Therapy|Overall Study||78
7985949|NCT00191646|19662482|P1|Received Crossover Therapy|Overall Study||77
7985950|NCT00191646|19662481|P2|Received Consolidation Therapy|Overall Study||183
7985951|NCT00191646|19662482|P1|Received Consolidation Therapy|Overall Study||169
7985952|NCT00191646|19662481|P2|Received Induction Therapy|Overall Study||409
7985953|NCT00191646|19662482|P1|Received Induction Therapy|Overall Study||411
7985954|NCT00191646|19662481|P2|STARTED|Overall Study||414
7985955|NCT00191646|19662482|P1|STARTED|Overall Study||417
7985956|NCT00191477|19662502|P2|NOT COMPLETED|Overall Study||129
7985957|NCT00191477|19662503|P1|NOT COMPLETED|Overall Study||138
7985958|NCT00191477|19662502|P2|COMPLETED|Overall Study||47
7985959|NCT00191477|19662503|P1|COMPLETED|Overall Study||41
7985960|NCT00191477|19662502|P2|Received Study Drug|Overall Study||162
7985961|NCT00191477|19662503|P1|Received Study Drug|Overall Study||166
7985962|NCT00191477|19662502|P2|STARTED|Overall Study||176
7985963|NCT00191477|19662503|P1|STARTED|Overall Study||179
7985964|NCT00191451|19662522|P3|NOT COMPLETED|Overall Study||14
7985965|NCT00191451|19662523|P2|NOT COMPLETED|Overall Study||14
7985966|NCT00191451|19662524|P1|NOT COMPLETED|Overall Study||7
7985967|NCT00191451|19662522|P3|COMPLETED|Overall Study||35
7985968|NCT00191451|19662523|P2|COMPLETED|Overall Study||37
7985969|NCT00191451|19662524|P1|COMPLETED|Overall Study||43
7985970|NCT00191451|19662522|P3|Received at Least One Dose of Study Drug|Overall Study||47
7985971|NCT00191451|19662523|P2|Received at Least One Dose of Study Drug|Overall Study||48
7985972|NCT00191451|19662524|P1|Received at Least One Dose of Study Drug|Overall Study||50
7985973|NCT00191451|19662522|P3|STARTED|Overall Study||49
7985974|NCT00191451|19662523|P2|STARTED|Overall Study||51
7985975|NCT00191451|19662524|P1|STARTED|Overall Study||50
7985976|NCT00191386|19662544|P1|NOT COMPLETED|Overall Study||160
7985977|NCT00191386|19662544|P1|COMPLETED|Overall Study||68
7985978|NCT00191386|19662544|P1|3 Years|Overall Study||65
7985979|NCT00191386|19662544|P1|2 Years|Overall Study||105
7985980|NCT00191386|19662544|P1|12 Months|Overall Study||149
7985981|NCT00191386|19662544|P1|6 Months|Overall Study||183
7985982|NCT00191386|19662544|P1|STARTED|Overall Study||228
7985983|NCT00191334|19662551|P1|NOT COMPLETED|Overall Study||17
7985984|NCT00191334|19662551|P1|COMPLETED|Overall Study||33
7985985|NCT00191334|19662551|P1|STARTED|Overall Study||50
7985986|NCT00191308|19662559|P1|NOT COMPLETED|Overall Study||1
7985987|NCT00191308|19662559|P1|COMPLETED|Overall Study||29
7985988|NCT00191308|19662559|P1|STARTED|Overall Study||30
7985989|NCT00191282|19662569|P2|NOT COMPLETED|Overall Study||212
7985990|NCT00191282|19662570|P1|NOT COMPLETED|Overall Study||220
7985991|NCT00191282|19662569|P2|COMPLETED|Overall Study||346
7985992|NCT00191282|19662570|P1|COMPLETED|Overall Study||338
7985993|NCT00191282|19662569|P2|STARTED|Overall Study||558
7985994|NCT00191282|19662570|P1|STARTED|Overall Study||558
7985995|NCT00191269|19662630|P2|NOT COMPLETED|Overall Study||58
7985996|NCT00191269|19662631|P1|NOT COMPLETED|Overall Study||6
7985997|NCT00191269|19662630|P2|COMPLETED|Overall Study||4
7985998|NCT00191269|19662631|P1|COMPLETED|Overall Study||0
7985999|NCT00191269|19662630|P2|STARTED|Overall Study||62
7986000|NCT00191269|19662631|P1|STARTED|Overall Study||6
7986001|NCT00191191|19662647|P2|NOT COMPLETED|Overall Study||112
7986002|NCT00191191|19662648|P1|NOT COMPLETED|Overall Study||114
7986003|NCT00191191|19662647|P2|COMPLETED|Overall Study||0
7986004|NCT00191191|19662648|P1|COMPLETED|Overall Study||0
7986005|NCT00191191|19662647|P2|Full Analysis Set Population|Overall Study||108
7986006|NCT00191191|19662648|P1|Full Analysis Set Population|Overall Study||108
7986007|NCT00191191|19662647|P2|Safety Analysis Population|Overall Study||111
7986008|NCT00191191|19662648|P1|Safety Analysis Population|Overall Study||114
7986009|NCT00191191|19662647|P2|STARTED|Overall Study||112
7986010|NCT00191191|19662648|P1|STARTED|Overall Study||114
7986011|NCT00191165|19662664|P2|NOT COMPLETED|Overall Study||2
7986012|NCT00191165|19662665|P1|NOT COMPLETED|Overall Study||2
7986013|NCT00191165|19662664|P2|COMPLETED|Overall Study||11
7986014|NCT00191165|19662665|P1|COMPLETED|Overall Study||12
7986015|NCT00191165|19662664|P2|STARTED|Overall Study||13
7986016|NCT00191165|19662665|P1|STARTED|Overall Study||14
7986017|NCT00191152|19662677|P2|NOT COMPLETED|Crossover Treatment||28
7986018|NCT00191152|19662678|P1|NOT COMPLETED|Crossover Treatment||27
7986019|NCT00191152|19662677|P2|COMPLETED|Crossover Treatment||53
7986020|NCT00191152|19662678|P1|COMPLETED|Crossover Treatment||50
7986021|NCT00191152|19662677|P2|Received Treatment|Crossover Treatment||80
7986022|NCT00191152|19662678|P1|Received Treatment|Crossover Treatment||76
7986023|NCT00191152|19662677|P2|STARTED|Crossover Treatment||81
7986024|NCT00191152|19662678|P1|STARTED|Crossover Treatment||77
7986025|NCT00191152|19662677|P2|NOT COMPLETED|Initial Treatment||153
7986026|NCT00191152|19662678|P1|NOT COMPLETED|Initial Treatment||141
7986027|NCT00191152|19662677|P2|COMPLETED|Initial Treatment||83
7986028|NCT00191152|19662678|P1|COMPLETED|Initial Treatment||98
7986029|NCT00191152|19662677|P2|Received Initial Treatment|Initial Treatment||227
7986030|NCT00191152|19662678|P1|Received Initial Treatment|Initial Treatment||236
7986031|NCT00191152|19662677|P2|STARTED|Initial Treatment||236
7986032|NCT00191152|19662678|P1|STARTED|Initial Treatment||239
7986033|NCT00191139|19662710|P2|NOT COMPLETED|Overall Study||12
7986034|NCT00191139|19662711|P1|NOT COMPLETED|Overall Study||5
7986035|NCT00191139|19662710|P2|COMPLETED|Overall Study||20
7986036|NCT00191139|19662711|P1|COMPLETED|Overall Study||27
7986037|NCT00191139|19662710|P2|STARTED|Overall Study||32
7986038|NCT00191139|19662711|P1|STARTED|Overall Study||32
7986039|NCT00191113|19662727|P2|NOT COMPLETED|Addendum 3||0
7986040|NCT00191113|19662728|P1|NOT COMPLETED|Addendum 3||0
7986041|NCT00191113|19662727|P2|COMPLETED|Addendum 3||37
7986042|NCT00191113|19662728|P1|COMPLETED|Addendum 3||20
7986043|NCT00191113|19662727|P2|STARTED|Addendum 3||37
7986044|NCT00191113|19662728|P1|STARTED|Addendum 3||20
7986045|NCT00191113|19662727|P2|NOT COMPLETED|Addendum 2||17
7986046|NCT00191113|19662728|P1|NOT COMPLETED|Addendum 2||10
7986047|NCT00191113|19662727|P2|COMPLETED|Addendum 2||31
7986048|NCT00191113|19662728|P1|COMPLETED|Addendum 2||18
7986049|NCT00191113|19662727|P2|STARTED|Addendum 2||48
7986050|NCT00191113|19662728|P1|STARTED|Addendum 2||28
7986051|NCT00191113|19662727|P2|NOT COMPLETED|Addendum 1||0
7986052|NCT00191113|19662728|P1|NOT COMPLETED|Addendum 1||0
7986053|NCT00191113|19662727|P2|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
7986054|NCT00191113|19662728|P1|COMPLETED|Addendum 1||2
7986055|NCT00191113|19662727|P2|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
7986056|NCT00191113|19662728|P1|STARTED|Addendum 1||2
7986057|NCT00191113|19662727|P2|NOT COMPLETED|Core Study||15
7986058|NCT00191113|19662728|P1|NOT COMPLETED|Core Study||35
7986059|NCT00191113|19662727|P2|COMPLETED|Core Study||61
7986060|NCT00191113|19662728|P1|COMPLETED|Core Study||43
7986061|NCT00191113|19662727|P2|STARTED|Core Study||76
7986062|NCT00191113|19662728|P1|STARTED|Core Study||78
7986063|NCT00191100|19662770|P2|NOT COMPLETED|Overall Study||12
7986064|NCT00191100|19662771|P1|NOT COMPLETED|Overall Study||42
7986065|NCT00191100|19662770|P2|COMPLETED|Overall Study||244
7986066|NCT00191100|19662771|P1|COMPLETED|Overall Study||217
7986067|NCT00191100|19662770|P2|STARTED|Overall Study||256
7986068|NCT00191100|19662771|P1|STARTED|Overall Study||259
7986069|NCT00190983|19662787|P1|NOT COMPLETED|Overall Study||2
7986070|NCT00190983|19662787|P1|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27
7986071|NCT00190983|19662787|P1|STARTED|Overall Study||29
7986072|NCT00190775|19662796|P2|NOT COMPLETED|Overall Study||100
7986073|NCT00190775|19662797|P1|NOT COMPLETED|Overall Study||149
7986074|NCT00190775|19662796|P2|COMPLETED|Overall Study||134
7986075|NCT00190775|19662797|P1|COMPLETED|Overall Study||119
7986076|NCT00190775|19662796|P2|Received Study Drug|Overall Study||234
7986077|NCT00190775|19662797|P1|Received Study Drug|Overall Study||266
7986078|NCT00190775|19662796|P2|STARTED|Overall Study||234
7986079|NCT00190775|19662797|P1|STARTED|Overall Study||268
7986080|NCT00190749|19662868|P2|NOT COMPLETED|Overall Study||31
7986081|NCT00190749|19662869|P1|NOT COMPLETED|Overall Study||26
7986082|NCT00190749|19662868|P2|COMPLETED|Overall Study||31
7986083|NCT00190749|19662869|P1|COMPLETED|Overall Study||42
7986084|NCT00190749|19662868|P2|STARTED|Overall Study||62
7986085|NCT00190749|19662869|P1|STARTED|Overall Study||68
7986086|NCT00190684|19662933|P1|NOT COMPLETED|Overall Study||1489
7986087|NCT00190684|19662933|P1|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64
7986088|NCT00190684|19662933|P1|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551
7986089|NCT00190684|19662933|P1|STARTED|Overall Study||1553
7986090|NCT00190671|19662954|P2|NOT COMPLETED|Overall Study||42
7986091|NCT00190671|19662955|P1|NOT COMPLETED|Overall Study||27
7986092|NCT00190671|19662954|P2|COMPLETED|Overall Study||19
7986093|NCT00190671|19662955|P1|COMPLETED|Overall Study||15
7986094|NCT00190671|19662954|P2|STARTED|Overall Study||61
7986095|NCT00190671|19662955|P1|STARTED|Overall Study||42
7986096|NCT00189540|19662975|P2|NOT COMPLETED|Overall Study||1
7986097|NCT00189540|19662976|P1|NOT COMPLETED|Overall Study||7
7986098|NCT00189540|19662975|P2|COMPLETED|Overall Study||5
7986099|NCT00189540|19662976|P1|COMPLETED|Overall Study||14
7986100|NCT00189540|19662975|P2|STARTED|Overall Study||6
7986101|NCT00189540|19662976|P1|STARTED|Overall Study||21
7986102|NCT00189488|19662994|P2|NOT COMPLETED|Overall Study||22
7986103|NCT00189488|19662995|P1|NOT COMPLETED|Overall Study||15
7986104|NCT00189488|19662994|P2|COMPLETED|Overall Study||55
7986105|NCT00189488|19662995|P1|COMPLETED|Overall Study||63
7986106|NCT00189488|19662994|P2|Received Palifermin/Placebo|Overall Study||76
7986107|NCT00189488|19662995|P1|Received Palifermin/Placebo|Overall Study||75
7986108|NCT00189488|19662994|P2|STARTED|Overall Study||77
7986109|NCT00189488|19662995|P1|STARTED|Overall Study||78
7986110|NCT00189475|19663017|P2|NOT COMPLETED|Overall Study||0
7986111|NCT00189475|19663018|P1|NOT COMPLETED|Overall Study||0
7986112|NCT00189475|19663017|P2|COMPLETED|Overall Study||42
7986113|NCT00189475|19663018|P1|COMPLETED|Overall Study||42
7986114|NCT00189475|19663017|P2|STARTED|Overall Study||42
7986115|NCT00189475|19663018|P1|STARTED|Overall Study||42
7986116|NCT00189462|19663026|P2|NOT COMPLETED|Overall Study||21
7986117|NCT00189462|19663027|P1|NOT COMPLETED|Overall Study||23
7986118|NCT00189462|19663026|P2|COMPLETED|Overall Study||28
7986119|NCT00189462|19663027|P1|COMPLETED|Overall Study||27
7986120|NCT00189462|19663026|P2|STARTED|Overall Study||49
7986121|NCT00189462|19663027|P1|STARTED|Overall Study||50
7986122|NCT00189436|19663035|P2|NOT COMPLETED|Overall Study||5
7986123|NCT00189436|19663036|P1|NOT COMPLETED|Overall Study||8
7986124|NCT00189436|19663035|P2|COMPLETED|Overall Study||25
7986125|NCT00189436|19663036|P1|COMPLETED|Overall Study||23
7986126|NCT00189436|19663035|P2|STARTED|Overall Study||30
7986127|NCT00189436|19663036|P1|STARTED|Overall Study||31
7986128|NCT00189423|19663044|P2|NOT COMPLETED|Overall Study||766
7986129|NCT00189423|19663045|P1|NOT COMPLETED|Overall Study||765
7986130|NCT00189423|19663044|P2|COMPLETED|Overall Study||74
7986131|NCT00189423|19663045|P1|COMPLETED|Overall Study||48
7986132|NCT00189423|19663044|P2|STARTED|Overall Study||840
7986133|NCT00189423|19663045|P1|STARTED|Overall Study||813
7986134|NCT00189306|19663067|P1|NOT COMPLETED|Long-Term Follow-up||38
7986135|NCT00189306|19663067|P1|COMPLETED|Long-Term Follow-up||119
7986136|NCT00189306|19663067|P1|STARTED|Long-Term Follow-up||157
7986137|NCT00189306|19663067|P1|NOT COMPLETED|Posttreatment Period||12
7986138|NCT00189306|19663067|P1|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157
7986139|NCT00189306|19663067|P1|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169
7986140|NCT00189306|19663067|P1|NOT COMPLETED|Treatment Period||5
7986141|NCT00189306|19663067|P1|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164
7986142|NCT00189306|19663067|P1|STARTED|Treatment Period||169
7986143|NCT00189228|19663072|P1|NOT COMPLETED|Overall Study||0
7986144|NCT00189228|19663072|P1|COMPLETED|Overall Study||18
7986145|NCT00189228|19663072|P1|STARTED|Overall Study||18
7986146|NCT00189202|19663076|P1|NOT COMPLETED|Overall Study||5
7986147|NCT00189202|19663076|P1|COMPLETED|Overall Study||44
7986148|NCT00189202|19663076|P1|STARTED|Overall Study||49
7986149|NCT00189137|19663087|P2|NOT COMPLETED|Overall Study||0
7986150|NCT00189137|19663088|P1|NOT COMPLETED|Overall Study||0
7986151|NCT00189137|19663087|P2|COMPLETED|Overall Study||43
7986152|NCT00189137|19663088|P1|COMPLETED|Overall Study||37
7986153|NCT00189137|19663087|P2|STARTED|Overall Study||43
7986154|NCT00189137|19663088|P1|STARTED|Overall Study||37
7986155|NCT00189098|19663098|P2|NOT COMPLETED|Overall Study||6
7986156|NCT00189098|19663099|P1|NOT COMPLETED|Overall Study||5
7986157|NCT00189098|19663098|P2|COMPLETED|Overall Study||44
7986158|NCT00189098|19663099|P1|COMPLETED|Overall Study||46
7986159|NCT00189098|19663098|P2|STARTED|Overall Study||50
7986160|NCT00189098|19663099|P1|STARTED|Overall Study||51
7986161|NCT00187889|19663117|P2|NOT COMPLETED|Overall Study||4
7986162|NCT00187889|19663118|P1|NOT COMPLETED|Overall Study||6
7986163|NCT00187889|19663117|P2|COMPLETED|Overall Study||22
7986164|NCT00187889|19663118|P1|COMPLETED|Overall Study||19
7986165|NCT00187889|19663117|P2|STARTED|Overall Study||26
7986166|NCT00187889|19663118|P1|STARTED|Overall Study||25
7986167|NCT00187876|19663128|P2|NOT COMPLETED|Overall Study||0
7986168|NCT00187876|19663129|P1|NOT COMPLETED|Overall Study||0
7986169|NCT00187876|19663128|P2|COMPLETED|Overall Study||43
7986170|NCT00187876|19663129|P1|COMPLETED|Overall Study||24
7986171|NCT00187876|19663128|P2|STARTED|Overall Study||43
7986172|NCT00187876|19663129|P1|STARTED|Overall Study||24
7986173|NCT00187720|19663137|P2|NOT COMPLETED|Overall Study||0
7986174|NCT00187720|19663138|P1|NOT COMPLETED|Overall Study||0
7986175|NCT00187720|19663137|P2|COMPLETED|Overall Study||14
7986176|NCT00187720|19663138|P1|COMPLETED|Overall Study||9
7986177|NCT00187720|19663137|P2|STARTED|Overall Study||14
7986178|NCT00187720|19663138|P1|STARTED|Overall Study||9
7986179|NCT00187681|19663146|P2|NOT COMPLETED|Overall Study||0
7986180|NCT00187681|19663147|P1|NOT COMPLETED|Overall Study||0
7986181|NCT00187681|19663146|P2|COMPLETED|Overall Study||8
7986182|NCT00187681|19663147|P1|COMPLETED|Overall Study||12
7986183|NCT00187681|19663146|P2|STARTED|Overall Study||8
7986184|NCT00187681|19663147|P1|STARTED|Overall Study||12
7986185|NCT00187655|19663155|P1|NOT COMPLETED|Overall Study||0
7986186|NCT00187655|19663155|P1|COMPLETED|Overall Study||24
7986187|NCT00187655|19663155|P1|STARTED|Overall Study||24
7986188|NCT00187486|19663160|P1|NOT COMPLETED|Overall Study||1
7986189|NCT00187486|19663160|P1|COMPLETED|Overall Study||65
7986190|NCT00187486|19663160|P1|STARTED|Overall Study||66
7986191|NCT00187369|19663167|P2|NOT COMPLETED|Fetuses or Infants||30
7986192|NCT00187369|19663168|P1|NOT COMPLETED|Fetuses or Infants||12
7986193|NCT00187369|19663167|P2|COMPLETED|Fetuses or Infants||2782
7986194|NCT00187369|19663168|P1|COMPLETED|Fetuses or Infants||2783
7986195|NCT00187369|19663167|P2|Included in the Study|Fetuses or Infants||2786
7986196|NCT00187369|19663168|P1|Included in the Study|Fetuses or Infants||2785
7986197|NCT00187369|19663167|P2|STARTED|Fetuses or Infants||2812
7986198|NCT00187369|19663168|P1|STARTED|Fetuses or Infants||2795
7986199|NCT00187369|19663167|P2|NOT COMPLETED|Mothers||14
7986200|NCT00187369|19663168|P1|NOT COMPLETED|Mothers||6
7986201|NCT00187369|19663167|P2|COMPLETED|Mothers||1392
7986202|NCT00187369|19663168|P1|COMPLETED|Mothers||1392
7986203|NCT00187369|19663167|P2|Included in the Study|Mothers||1393
7986204|NCT00187369|19663168|P1|Included in the Study|Mothers||1393
7986205|NCT00187369|19663167|P2|STARTED|Mothers||1406
7986206|NCT00187369|19663168|P1|STARTED|Mothers||1398
7986207|NCT00187226|19663200|P6|NOT COMPLETED|Overall Study||0
7986208|NCT00187226|19663201|P5|NOT COMPLETED|Overall Study||0
7986209|NCT00187226|19663202|P4|NOT COMPLETED|Overall Study||0
7986210|NCT00187226|19663203|P3|NOT COMPLETED|Overall Study||0
7986211|NCT00187226|19663204|P2|NOT COMPLETED|Overall Study||0
7986212|NCT00187226|19663205|P1|NOT COMPLETED|Overall Study||0
7986213|NCT00187226|19663200|P6|COMPLETED|Overall Study||1
7986214|NCT00187226|19663201|P5|COMPLETED|Overall Study||34
7986215|NCT00187226|19663202|P4|COMPLETED|Overall Study||2
7986216|NCT00187226|19663203|P3|COMPLETED|Overall Study||28
7986217|NCT00187226|19663204|P2|COMPLETED|Overall Study||49
7986218|NCT00187226|19663205|P1|COMPLETED|Overall Study||88
7986219|NCT00187226|19663200|P6|STARTED|Overall Study||1
7986220|NCT00187226|19663201|P5|STARTED|Overall Study||34
7986221|NCT00187226|19663202|P4|STARTED|Overall Study||2
7986222|NCT00187226|19663203|P3|STARTED|Overall Study||28
7986223|NCT00187226|19663204|P2|STARTED|Overall Study||49
7986224|NCT00187226|19663205|P1|STARTED|Overall Study||88
7986225|NCT00187200|19663221|P2|NOT COMPLETED|Overall Study||18
7986226|NCT00187200|19663222|P1|NOT COMPLETED|Overall Study||18
7986227|NCT00187200|19663221|P2|COMPLETED|Overall Study||26
7986228|NCT00187200|19663222|P1|COMPLETED|Overall Study||31
7986229|NCT00187200|19663221|P2|STARTED|Overall Study||44
7986230|NCT00187200|19663222|P1|STARTED|Overall Study||49
7986231|NCT00187135|19663240|P6|NOT COMPLETED|Visit Three||6
7986232|NCT00187135|19663241|P5|NOT COMPLETED|Visit Three||8
7986233|NCT00187135|19663242|P4|NOT COMPLETED|Visit Three||9
7986234|NCT00187135|19663243|P3|NOT COMPLETED|Visit Three||9
7986235|NCT00187135|19663244|P2|NOT COMPLETED|Visit Three||7
7986236|NCT00187135|19663245|P1|NOT COMPLETED|Visit Three||7
7986237|NCT00187135|19663240|P6|COMPLETED|Visit Three||12
7986238|NCT00187135|19663241|P5|COMPLETED|Visit Three||11
7986239|NCT00187135|19663242|P4|COMPLETED|Visit Three||9
7986240|NCT00187135|19663243|P3|COMPLETED|Visit Three||14
7986241|NCT00187135|19663244|P2|COMPLETED|Visit Three||17
7986242|NCT00187135|19663245|P1|COMPLETED|Visit Three||14
7986243|NCT00187135|19663240|P6|STARTED|Visit Three||18
7986244|NCT00187135|19663241|P5|STARTED|Visit Three||19
7986245|NCT00187135|19663242|P4|STARTED|Visit Three||18
7986246|NCT00187135|19663243|P3|STARTED|Visit Three||23
7986247|NCT00187135|19663244|P2|STARTED|Visit Three||24
7986248|NCT00187135|19663245|P1|STARTED|Visit Three||21
7986249|NCT00187135|19663240|P6|NOT COMPLETED|Visit Two||8
7986250|NCT00187135|19663241|P5|NOT COMPLETED|Visit Two||6
7986251|NCT00187135|19663242|P4|NOT COMPLETED|Visit Two||8
7986252|NCT00187135|19663243|P3|NOT COMPLETED|Visit Two||2
7986253|NCT00187135|19663244|P2|NOT COMPLETED|Visit Two||3
7986254|NCT00187135|19663245|P1|NOT COMPLETED|Visit Two||5
7986255|NCT00187135|19663240|P6|COMPLETED|Visit Two||18
7986256|NCT00187135|19663241|P5|COMPLETED|Visit Two||19
7986257|NCT00187135|19663242|P4|COMPLETED|Visit Two||18
7986258|NCT00187135|19663243|P3|COMPLETED|Visit Two||23
7986259|NCT00187135|19663244|P2|COMPLETED|Visit Two||24
7986260|NCT00187135|19663245|P1|COMPLETED|Visit Two||21
7986261|NCT00187135|19663240|P6|STARTED|Visit Two||26
7986262|NCT00187135|19663241|P5|STARTED|Visit Two||25
7986263|NCT00187135|19663242|P4|STARTED|Visit Two||26
7986264|NCT00187135|19663243|P3|STARTED|Visit Two||25
7986265|NCT00187135|19663244|P2|STARTED|Visit Two||27
7986266|NCT00187135|19663245|P1|STARTED|Visit Two||26
7986267|NCT00187135|19663240|P6|NOT COMPLETED|Visit One||2
7986268|NCT00187135|19663241|P5|NOT COMPLETED|Visit One||0
7986269|NCT00187135|19663242|P4|NOT COMPLETED|Visit One||0
7986270|NCT00187135|19663243|P3|NOT COMPLETED|Visit One||0
7986271|NCT00187135|19663244|P2|NOT COMPLETED|Visit One||1
7986272|NCT00187135|19663245|P1|NOT COMPLETED|Visit One||4
7986273|NCT00187135|19663240|P6|COMPLETED|Visit One||26
7986274|NCT00187135|19663241|P5|COMPLETED|Visit One||25
7986275|NCT00187135|19663242|P4|COMPLETED|Visit One||26
7986276|NCT00187135|19663243|P3|COMPLETED|Visit One||25
7986277|NCT00187135|19663244|P2|COMPLETED|Visit One||27
7986278|NCT00187135|19663245|P1|COMPLETED|Visit One||26
7986279|NCT00187135|19663240|P6|STARTED|Visit One||28
7986280|NCT00187135|19663241|P5|STARTED|Visit One||25
7986281|NCT00187135|19663242|P4|STARTED|Visit One||26
7986282|NCT00187135|19663243|P3|STARTED|Visit One||25
7986283|NCT00187135|19663244|P2|STARTED|Visit One||28
7986284|NCT00187135|19663245|P1|STARTED|Visit One||30
7986285|NCT00187096|19663268|P3|NOT COMPLETED|Overall Study||1
7986286|NCT00187096|19663269|P2|NOT COMPLETED|Overall Study||0
7986287|NCT00187096|19663270|P1|NOT COMPLETED|Overall Study||0
7986288|NCT00187096|19663268|P3|COMPLETED|Overall Study||11
7986289|NCT00187096|19663269|P2|COMPLETED|Overall Study||3
7986290|NCT00187096|19663270|P1|COMPLETED|Overall Study||10
7986291|NCT00187096|19663268|P3|STARTED|Overall Study||12
7986292|NCT00187096|19663269|P2|STARTED|Overall Study||3
7986293|NCT00187096|19663270|P1|STARTED|Overall Study||10
7986294|NCT00186901|19663308|P3|NOT COMPLETED|Overall Study||149
7986295|NCT00186901|19663309|P2|NOT COMPLETED|Overall Study||45
7986296|NCT00186901|19663310|P1|NOT COMPLETED|Overall Study||49
7986297|NCT00186901|19663308|P3|COMPLETED|Overall Study||0
7986298|NCT00186901|19663309|P2|COMPLETED|Overall Study||96
7986299|NCT00186901|19663310|P1|COMPLETED|Overall Study||85
7986300|NCT00186901|19663308|P3|24 Month Follow-up|Overall Study||0
7986301|NCT00186901|19663309|P2|24 Month Follow-up|Overall Study||107
7986302|NCT00186901|19663310|P1|24 Month Follow-up|Overall Study||106
7986303|NCT00186901|19663308|P3|12 Month Follow-up|Overall Study||0
7986304|NCT00186901|19663309|P2|12 Month Follow-up|Overall Study||122
7986305|NCT00186901|19663310|P1|12 Month Follow-up|Overall Study||117
7986306|NCT00186901|19663308|P3|Baseline|Overall Study||0
7986307|NCT00186901|19663309|P2|Baseline|Overall Study||141
7986308|NCT00186901|19663310|P1|Baseline|Overall Study||134
7986309|NCT00186901|19663308|P3|STARTED|Overall Study||149
7986310|NCT00186901|19663309|P2|STARTED|Overall Study||141
7986311|NCT00186901|19663310|P1|STARTED|Overall Study||134
7986312|NCT00186888|19663350|P3|NOT COMPLETED|Overall Study||0
7986313|NCT00186888|19663351|P2|NOT COMPLETED|Overall Study||3
7986314|NCT00186888|19663352|P1|NOT COMPLETED|Overall Study||4
7986315|NCT00186888|19663350|P3|COMPLETED|Overall Study||55
7986316|NCT00186888|19663351|P2|COMPLETED|Overall Study||24
7986317|NCT00186888|19663352|P1|COMPLETED|Overall Study||19
7986318|NCT00186888|19663350|P3|Window Therapy|Overall Study||0
7986319|NCT00186888|19663351|P2|Window Therapy|Overall Study||27
7986320|NCT00186888|19663352|P1|Window Therapy|Overall Study||0
7986321|NCT00186888|19663350|P3|STARTED|Overall Study||55
7986322|NCT00186888|19663351|P2|STARTED|Overall Study||27
7986323|NCT00186888|19663352|P1|STARTED|Overall Study||23
7986324|NCT00186875|19663429|P2|NOT COMPLETED|Overall Study||0
7986325|NCT00186875|19663430|P1|NOT COMPLETED|Overall Study||0
7986326|NCT00186875|19663429|P2|COMPLETED|Overall Study||14
7986327|NCT00186875|19663430|P1|COMPLETED|Overall Study||26
7986328|NCT00186875|19663429|P2|STARTED|Overall Study||14
7986329|NCT00186875|19663430|P1|STARTED|Overall Study||26
7986330|NCT00186628|19663444|P1|NOT COMPLETED|Overall Study||3
7986331|NCT00186628|19663444|P1|COMPLETED|Overall Study||33
7986332|NCT00186628|19663444|P1|STARTED|Overall Study||36
7986333|NCT00186537|19663455|P3|NOT COMPLETED|Overall Study||3
7986334|NCT00186537|19663456|P2|NOT COMPLETED|Overall Study||0
7986335|NCT00186537|19663457|P1|NOT COMPLETED|Overall Study||7
7986336|NCT00186537|19663455|P3|COMPLETED|Overall Study||13
7986337|NCT00186537|19663456|P2|COMPLETED|Overall Study||12
7986338|NCT00186537|19663457|P1|COMPLETED|Overall Study||12
7986339|NCT00186537|19663455|P3|STARTED|Overall Study||16
7986340|NCT00186537|19663456|P2|STARTED|Overall Study||12
7986341|NCT00186537|19663457|P1|STARTED|Overall Study||19
7986342|NCT00186498|19663473|P2|NOT COMPLETED|Overall Study||2
7986343|NCT00186498|19663474|P1|NOT COMPLETED|Overall Study||2
7986344|NCT00186498|19663473|P2|COMPLETED|Overall Study||3
7986345|NCT00186498|19663474|P1|COMPLETED|Overall Study||4
7986346|NCT00186498|19663473|P2|STARTED|Overall Study||5
7986347|NCT00186498|19663474|P1|STARTED|Overall Study||6
7986348|NCT00186485|19663480|P1|NOT COMPLETED|Overall Study||3
7986349|NCT00186485|19663480|P1|COMPLETED|Overall Study||25
7986350|NCT00186485|19663480|P1|STARTED|Overall Study||28
7986351|NCT00186446|19663486|P1|NOT COMPLETED|Overall Study||9
7986352|NCT00186446|19663486|P1|COMPLETED|Overall Study||11
7986353|NCT00186446|19663486|P1|STARTED|Overall Study||20
7986354|NCT00186186|19663492|P1|NOT COMPLETED|Overall Study||8
7986355|NCT00186186|19663492|P1|COMPLETED|Overall Study||20
7986356|NCT00186186|19663492|P1|STARTED|Overall Study||28
7986357|NCT00186121|19663497|P1|NOT COMPLETED|Overall Study||3
7986358|NCT00186121|19663497|P1|COMPLETED|Overall Study||32
7986359|NCT00186121|19663497|P1|STARTED|Overall Study||35
7986360|NCT00186069|19663509|P2|NOT COMPLETED|Overall Study||0
7986361|NCT00186069|19663510|P1|NOT COMPLETED|Overall Study||0
7986362|NCT00186069|19663509|P2|COMPLETED|Overall Study||15
7986363|NCT00186069|19663510|P1|COMPLETED|Overall Study||15
7986364|NCT00186069|19663509|P2|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
7986365|NCT00186069|19663510|P1|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
7986366|NCT00186056|19663522|P2|NOT COMPLETED|Overall Study||1
7986367|NCT00186056|19663523|P1|NOT COMPLETED|Overall Study||2
7986368|NCT00186056|19663522|P2|COMPLETED|Overall Study||16
7986369|NCT00186056|19663523|P1|COMPLETED|Overall Study||12
7986370|NCT00186056|19663522|P2|STARTED|Overall Study||17
7986371|NCT00186056|19663523|P1|STARTED|Overall Study||14
7986372|NCT00186043|19663531|P2|NOT COMPLETED|Overall Study||13
7986373|NCT00186043|19663532|P1|NOT COMPLETED|Overall Study||15
7986374|NCT00186043|19663531|P2|COMPLETED|Overall Study||12
7986375|NCT00186043|19663532|P1|COMPLETED|Overall Study||15
7986376|NCT00186043|19663531|P2|STARTED|Overall Study||25
7986377|NCT00186043|19663532|P1|STARTED|Overall Study||30
7986378|NCT00186017|19663544|P2|NOT COMPLETED|Overall Study||3
7986379|NCT00186017|19663545|P1|NOT COMPLETED|Overall Study||2
7986380|NCT00186017|19663544|P2|COMPLETED|Overall Study||22
7986381|NCT00186017|19663545|P1|COMPLETED|Overall Study||23
7986382|NCT00186017|19663544|P2|STARTED|Overall Study||25
7986383|NCT00186017|19663545|P1|STARTED|Overall Study||25
7986384|NCT00185965|19663559|P2|NOT COMPLETED|Overall Study||1
7986385|NCT00185965|19663560|P1|NOT COMPLETED|Overall Study||0
7986386|NCT00185965|19663559|P2|COMPLETED|Overall Study||14
7986387|NCT00185965|19663560|P1|COMPLETED|Overall Study||15
7986388|NCT00185965|19663559|P2|STARTED|Overall Study||15
7986389|NCT00185965|19663560|P1|STARTED|Overall Study||15
7986390|NCT00185900|19663568|P2|NOT COMPLETED|Overall Study||0
7986391|NCT00185900|19663569|P1|NOT COMPLETED|Overall Study||0
7986392|NCT00185900|19663568|P2|COMPLETED|Overall Study||100
7986393|NCT00185900|19663569|P1|COMPLETED|Overall Study||92
7986394|NCT00185900|19663568|P2|STARTED|Overall Study||100
7986395|NCT00185900|19663569|P1|STARTED|Overall Study||92
7986396|NCT00185731|19663585|P1|NOT COMPLETED|Overall Study||2
7986397|NCT00185731|19663585|P1|COMPLETED|Overall Study||23
7986398|NCT00185731|19663585|P1|STARTED|Overall Study||25
7986399|NCT00185692|19663591|P1|NOT COMPLETED|Overall Study||16
7986400|NCT00185692|19663591|P1|COMPLETED|Overall Study||0
7986401|NCT00185692|19663591|P1|STARTED|Overall Study||16
7986402|NCT00185679|19663596|P1|NOT COMPLETED|Overall Study||0
7986403|NCT00185679|19663596|P1|COMPLETED|Overall Study||13
7986404|NCT00185679|19663596|P1|STARTED|Overall Study||13
7986405|NCT00185640|19663602|P1|NOT COMPLETED|Overall Study||145
7986406|NCT00185640|19663602|P1|COMPLETED|Overall Study||158
7986407|NCT00185640|19663602|P1|90 Days Post-transplant|Overall Study||161
7986408|NCT00185640|19663602|P1|Transplanted|Overall Study||296
7986409|NCT00185640|19663602|P1|STARTED|Overall Study||303
7986410|NCT00185614|19663611|P1|NOT COMPLETED|Allogenic HCT (Allo-HCT)||0
7986411|NCT00185614|19663611|P1|COMPLETED|Allogenic HCT (Allo-HCT)||59
7986412|NCT00185614|19663611|P1|STARTED|Allogenic HCT (Allo-HCT)||59
7986413|NCT00185614|19663611|P1|NOT COMPLETED|Inter-treatment Period||4
7986414|NCT00185614|19663611|P1|COMPLETED|Inter-treatment Period||59
7986415|NCT00185614|19663611|P1|STARTED|Inter-treatment Period|Not all participants who received autologous transplant continued to receive allogeneic transplant.|63
7986416|NCT00185614|19663611|P1|NOT COMPLETED|Autologous HCT (Auto-HCT)||0
7986417|NCT00185614|19663611|P1|COMPLETED|Autologous HCT (Auto-HCT)||63
7986418|NCT00185614|19663611|P1|STARTED|Autologous HCT (Auto-HCT)||63
7986419|NCT00185588|19663623|P4|NOT COMPLETED|Overall Study||4
7986420|NCT00185588|19663624|P3|NOT COMPLETED|Overall Study||6
7986421|NCT00185588|19663625|P2|NOT COMPLETED|Overall Study||2
7986422|NCT00185588|19663626|P1|NOT COMPLETED|Overall Study||3
7986423|NCT00185588|19663623|P4|COMPLETED|Overall Study||13
7986424|NCT00185588|19663624|P3|COMPLETED|Overall Study||0
7986425|NCT00185588|19663625|P2|COMPLETED|Overall Study||2
7986426|NCT00185588|19663626|P1|COMPLETED|Overall Study||3
7986427|NCT00185588|19663623|P4|STARTED|Overall Study||17
7986428|NCT00185588|19663624|P3|STARTED|Overall Study||6
7986429|NCT00185588|19663625|P2|STARTED|Overall Study||4
7986430|NCT00185588|19663626|P1|STARTED|Overall Study||6
7986431|NCT00185458|19663640|P1|NOT COMPLETED|HRT Phase||27
7986432|NCT00185458|19663640|P1|COMPLETED|HRT Phase||141
7986433|NCT00185458|19663640|P1|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168
7986434|NCT00185458|19663640|P1|NOT COMPLETED|Contraception Phase||58
7986435|NCT00185458|19663640|P1|COMPLETED|Contraception Phase||336
7986436|NCT00185458|19663640|P1|STARTED|Contraception Phase||394
7986437|NCT00185380|19663703|P3|NOT COMPLETED|Overall Study||74
7986438|NCT00185380|19663704|P2|NOT COMPLETED|Overall Study||72
7986439|NCT00185380|19663705|P1|NOT COMPLETED|Overall Study||66
7986440|NCT00185380|19663703|P3|COMPLETED|Overall Study||182
7986441|NCT00185380|19663704|P2|COMPLETED|Overall Study||174
7986442|NCT00185380|19663705|P1|COMPLETED|Overall Study||174
7986443|NCT00185380|19663703|P3|Subjects Received Treatment|Overall Study||254
7986444|NCT00185380|19663704|P2|Subjects Received Treatment|Overall Study||245
7986445|NCT00185380|19663705|P1|Subjects Received Treatment|Overall Study||239
7986446|NCT00185380|19663703|P3|STARTED|Overall Study||256
7986447|NCT00185380|19663704|P2|STARTED|Overall Study||246
7986448|NCT00185380|19663705|P1|STARTED|Overall Study||240
7986449|NCT00185211|19663733|P2|NOT COMPLETED|Follow-up Study (91031 - This Study)||34
7986450|NCT00185211|19663734|P1|NOT COMPLETED|Follow-up Study (91031 - This Study)||26
7986451|NCT00185211|19663733|P2|COMPLETED|Follow-up Study (91031 - This Study)||123
7986452|NCT00185211|19663734|P1|COMPLETED|Follow-up Study (91031 - This Study)||235
7986453|NCT00185211|19663733|P2|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157
7986454|NCT00185211|19663734|P1|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261
7986455|NCT00185211|19663733|P2|NOT COMPLETED|Placebo-controlled Study (92012)||10
7986456|NCT00185211|19663734|P1|NOT COMPLETED|Placebo-controlled Study (92012)||21
7986457|NCT00185211|19663733|P2|COMPLETED|Placebo-controlled Study (92012)||166
7986458|NCT00185211|19663734|P1|COMPLETED|Placebo-controlled Study (92012)||271
7986459|NCT00185211|19663733|P2|STARTED|Placebo-controlled Study (92012)||176
7986460|NCT00185211|19663734|P1|STARTED|Placebo-controlled Study (92012)||292
7986461|NCT00184717|19663762|P5|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5
7986462|NCT00184717|19663763|P4|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3
7986463|NCT00184717|19663764|P3|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0
7986464|NCT00184717|19663765|P2|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6
7986465|NCT00184717|19663766|P1|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10
7986466|NCT00184717|19663762|P5|COMPLETED|Extension Period (GHLIQUID-1517)||5
7986467|NCT00184717|19663763|P4|COMPLETED|Extension Period (GHLIQUID-1517)||7
7986468|NCT00184717|19663764|P3|COMPLETED|Extension Period (GHLIQUID-1517)||0
7986469|NCT00184717|19663765|P2|COMPLETED|Extension Period (GHLIQUID-1517)||27
7986470|NCT00184717|19663766|P1|COMPLETED|Extension Period (GHLIQUID-1517)||23
7986471|NCT00184717|19663762|P5|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
7986472|NCT00184717|19663763|P4|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
7986473|NCT00184717|19663764|P3|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0
7986474|NCT00184717|19663765|P2|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
7986475|NCT00184717|19663766|P1|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
7986476|NCT00184717|19663762|P5|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
7986477|NCT00184717|19663763|P4|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
7986478|NCT00184717|19663764|P3|NOT COMPLETED|Main Period (GHLIQUID-1516)||1
7986479|NCT00184717|19663765|P2|NOT COMPLETED|Main Period (GHLIQUID-1516)||2
7986480|NCT00184717|19663766|P1|NOT COMPLETED|Main Period (GHLIQUID-1516)||3
7986481|NCT00184717|19663762|P5|COMPLETED|Main Period (GHLIQUID-1516)||0
7986482|NCT00184717|19663763|P4|COMPLETED|Main Period (GHLIQUID-1516)||0
7986483|NCT00184717|19663764|P3|COMPLETED|Main Period (GHLIQUID-1516)||20
7986484|NCT00184717|19663765|P2|COMPLETED|Main Period (GHLIQUID-1516)||36
7986485|NCT00184717|19663766|P1|COMPLETED|Main Period (GHLIQUID-1516)||36
7986486|NCT00184717|19663762|P5|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
7986487|NCT00184717|19663763|P4|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
7986488|NCT00184717|19663764|P3|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21
7986489|NCT00184717|19663765|P2|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
7986490|NCT00184717|19663766|P1|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
7986491|NCT00184717|19663762|P5|STARTED|Main Period (GHLIQUID-1516)||0
7986492|NCT00184717|19663763|P4|STARTED|Main Period (GHLIQUID-1516)||0
7986493|NCT00184717|19663764|P3|STARTED|Main Period (GHLIQUID-1516)||21
7986494|NCT00184717|19663765|P2|STARTED|Main Period (GHLIQUID-1516)||38
7986495|NCT00184717|19663766|P1|STARTED|Main Period (GHLIQUID-1516)||39
7986496|NCT00184600|19663807|P3|NOT COMPLETED|Overall Study||34
7986497|NCT00184600|19663808|P2|NOT COMPLETED|Overall Study||51
7986498|NCT00184600|19663809|P1|NOT COMPLETED|Overall Study||45
7986499|NCT00184600|19663807|P3|COMPLETED|Overall Study||201
7986500|NCT00184600|19663808|P2|COMPLETED|Overall Study||188
7986501|NCT00184600|19663809|P1|COMPLETED|Overall Study||189
7986502|NCT00184600|19663807|P3|STARTED|Overall Study||235
7986503|NCT00184600|19663808|P2|STARTED|Overall Study||239
7986504|NCT00184600|19663809|P1|STARTED|Overall Study||234
7986505|NCT00184548|19663863|P4|NOT COMPLETED|Overall Study||7
7986506|NCT00184548|19663864|P3|NOT COMPLETED|Overall Study||3
7986507|NCT00184548|19663865|P2|NOT COMPLETED|Overall Study||13
7986508|NCT00184548|19663866|P1|NOT COMPLETED|Overall Study||8
7986509|NCT00184548|19663863|P4|COMPLETED|Overall Study||38
7986510|NCT00184548|19663864|P3|COMPLETED|Overall Study||44
7986511|NCT00184548|19663865|P2|COMPLETED|Overall Study||242
7986512|NCT00184548|19663866|P1|COMPLETED|Overall Study||218
7986513|NCT00184548|19663863|P4|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40
7986514|NCT00184548|19663864|P3|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46
7986515|NCT00184548|19663865|P2|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250
7986516|NCT00184548|19663866|P1|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224
7986517|NCT00184548|19663863|P4|STARTED|Overall Study||45
7986518|NCT00184548|19663864|P3|STARTED|Overall Study||47
7986519|NCT00184548|19663865|P2|STARTED|Overall Study||255
7986520|NCT00184548|19663866|P1|STARTED|Overall Study||226
7986521|NCT00184093|19663900|P1|NOT COMPLETED|Overall Study||9
7986522|NCT00184093|19663900|P1|COMPLETED|Overall Study||26
7986523|NCT00184093|19663900|P1|STARTED|Overall Study|Phase 1 participants = 6 Phase 2 participants = 29|35
7986524|NCT00184054|19663905|P1|NOT COMPLETED|Overall Study||1
7986525|NCT00184054|19663905|P1|COMPLETED|Overall Study||10
7986526|NCT00184054|19663905|P1|STARTED|Overall Study||11
7986527|NCT00184028|19663910|P1|NOT COMPLETED|Overall Study||10
7986528|NCT00184028|19663910|P1|COMPLETED|Overall Study||2
7986529|NCT00184028|19663910|P1|STARTED|Overall Study||12
7986530|NCT00184002|19663915|P1|NOT COMPLETED|Overall Study||17
7986531|NCT00184002|19663915|P1|COMPLETED|Overall Study||51
7986532|NCT00184002|19663915|P1|STARTED|Overall Study||68
7986533|NCT00183963|19663924|P4|NOT COMPLETED|Overall Study||1
7986534|NCT00183963|19663925|P3|NOT COMPLETED|Overall Study||1
7986535|NCT00183963|19663926|P2|NOT COMPLETED|Overall Study||1
7986536|NCT00183963|19663927|P1|NOT COMPLETED|Overall Study||1
7986537|NCT00183963|19663924|P4|COMPLETED|Overall Study||0
7986538|NCT00183963|19663925|P3|COMPLETED|Overall Study||0
7986539|NCT00183963|19663926|P2|COMPLETED|Overall Study||0
7986540|NCT00183963|19663927|P1|COMPLETED|Overall Study||0
7986541|NCT00183963|19663924|P4|STARTED|Overall Study||1
7986542|NCT00183963|19663925|P3|STARTED|Overall Study||1
7986543|NCT00183963|19663926|P2|STARTED|Overall Study||1
7986544|NCT00183963|19663927|P1|STARTED|Overall Study||1
7986545|NCT00183872|19663941|P1|NOT COMPLETED|Overall Study||16
7986546|NCT00183872|19663941|P1|COMPLETED|Overall Study||24
7986547|NCT00183872|19663941|P1|STARTED|Overall Study||40
7986548|NCT00183794|19663946|P1|NOT COMPLETED|Overall Study||0
7986549|NCT00183794|19663946|P1|COMPLETED|Overall Study||20
7986550|NCT00183794|19663946|P1|STARTED|Overall Study||20
7986551|NCT00183729|19663953|P2|NOT COMPLETED|Overall Study||5
7986552|NCT00183729|19663954|P1|NOT COMPLETED|Overall Study||3
7986553|NCT00183729|19663953|P2|COMPLETED|Overall Study||13
7986554|NCT00183729|19663954|P1|COMPLETED|Overall Study||14
7986555|NCT00183729|19663953|P2|STARTED|Overall Study||18
7986556|NCT00183729|19663954|P1|STARTED|Overall Study||17
7986557|NCT00183677|19663964|P1|NOT COMPLETED|Overall Study||44
7986558|NCT00183677|19663964|P1|COMPLETED|Overall Study||53
7986559|NCT00183677|19663964|P1|STARTED|Overall Study||97
7986560|NCT00183625|19663970|P4|NOT COMPLETED|Overall Study||14
7986561|NCT00183625|19663971|P3|NOT COMPLETED|Overall Study||19
7986562|NCT00183625|19663972|P2|NOT COMPLETED|Overall Study||18
7986563|NCT00183625|19663973|P1|NOT COMPLETED|Overall Study||18
7986564|NCT00183625|19663970|P4|COMPLETED|Overall Study||10
7986565|NCT00183625|19663971|P3|COMPLETED|Overall Study||9
7986566|NCT00183625|19663972|P2|COMPLETED|Overall Study||10
7986567|NCT00183625|19663973|P1|COMPLETED|Overall Study||9
7986568|NCT00183625|19663970|P4|Obtained Employment|Overall Study||14
7986569|NCT00183625|19663971|P3|Obtained Employment|Overall Study||14
7986570|NCT00183625|19663972|P2|Obtained Employment|Overall Study||18
7986571|NCT00183625|19663973|P1|Obtained Employment|Overall Study||21
7986572|NCT00183625|19663970|P4|STARTED|Overall Study||24
7986573|NCT00183625|19663971|P3|STARTED|Overall Study||28
7986574|NCT00183625|19663972|P2|STARTED|Overall Study||28
7986575|NCT00183625|19663973|P1|STARTED|Overall Study||27
7986576|NCT00183469|19663983|P2|NOT COMPLETED|Overall Study||29
7986577|NCT00183469|19663984|P1|NOT COMPLETED|Overall Study||28
7986578|NCT00183469|19663983|P2|COMPLETED|Overall Study||16
7986579|NCT00183469|19663984|P1|COMPLETED|Overall Study||13
7986580|NCT00183469|19663983|P2|STARTED|Overall Study||45
7986581|NCT00183469|19663984|P1|STARTED|Overall Study||41
7986582|NCT00183456|19663994|P4|NOT COMPLETED|Overall Study||28
7986583|NCT00183456|19663995|P3|NOT COMPLETED|Overall Study||16
7986584|NCT00183456|19663996|P2|NOT COMPLETED|Overall Study||1
7986585|NCT00183456|19663997|P1|NOT COMPLETED|Overall Study||3
7986586|NCT00183456|19663994|P4|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220
7986587|NCT00183456|19663995|P3|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313
7986588|NCT00183456|19663996|P2|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83
7986589|NCT00183456|19663997|P1|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82
7986590|NCT00183456|19663994|P4|18 Month Follow-up|Overall Study||207
7986591|NCT00183456|19663995|P3|18 Month Follow-up|Overall Study||303
7986592|NCT00183456|19663996|P2|18 Month Follow-up|Overall Study||81
7986593|NCT00183456|19663997|P1|18 Month Follow-up|Overall Study||80
7986594|NCT00183456|19663994|P4|12 Month Follow-up|Overall Study||186
7986595|NCT00183456|19663995|P3|12 Month Follow-up|Overall Study||267
7986596|NCT00183456|19663996|P2|12 Month Follow-up|Overall Study||74
7986597|NCT00183456|19663997|P1|12 Month Follow-up|Overall Study||76
7986598|NCT00183456|19663994|P4|6 Month Follow-up|Overall Study||175
7986599|NCT00183456|19663995|P3|6 Month Follow-up|Overall Study||278
7986600|NCT00183456|19663996|P2|6 Month Follow-up|Overall Study||77
7986601|NCT00183456|19663997|P1|6 Month Follow-up|Overall Study||74
7986602|NCT00183456|19663994|P4|STARTED|Overall Study||248
7986603|NCT00183456|19663995|P3|STARTED|Overall Study||329
7986604|NCT00183456|19663996|P2|STARTED|Overall Study||84
7986605|NCT00183456|19663997|P1|STARTED|Overall Study||85
7986606|NCT00183443|19664046|P3|NOT COMPLETED|Overall Study||0
7986607|NCT00183443|19664047|P2|NOT COMPLETED|Overall Study||0
7986608|NCT00183443|19664048|P1|NOT COMPLETED|Overall Study||0
7986609|NCT00183443|19664046|P3|COMPLETED|Overall Study|4 eligible participants were offered enrollment in the continuation phase|25
7986610|NCT00183443|19664047|P2|COMPLETED|Overall Study|8 eligible participants were offered enrollment in the continuation phase|26
7986611|NCT00183443|19664048|P1|COMPLETED|Overall Study|13 eligible participants were offered enrollment in the continuation phase|24
7986612|NCT00183443|19664046|P3|STARTED|Overall Study||25
7986613|NCT00183443|19664047|P2|STARTED|Overall Study||26
7986614|NCT00183443|19664048|P1|STARTED|Overall Study||24
7986615|NCT00183430|19664070|P2|NOT COMPLETED|Overall Study||0
7986616|NCT00183430|19664071|P1|NOT COMPLETED|Overall Study||6
7986617|NCT00183430|19664070|P2|COMPLETED|Overall Study||11
7986618|NCT00183430|19664071|P1|COMPLETED|Overall Study||3
7986619|NCT00183430|19664070|P2|STARTED|Overall Study||11
7986620|NCT00183430|19664071|P1|STARTED|Overall Study||9
7986621|NCT00183391|19664083|P2|NOT COMPLETED|Block 2 - 5 Weeks||2
7986622|NCT00183391|19664084|P1|NOT COMPLETED|Block 2 - 5 Weeks||4
7986623|NCT00183391|19664083|P2|COMPLETED|Block 2 - 5 Weeks||108
7986624|NCT00183391|19664084|P1|COMPLETED|Block 2 - 5 Weeks||91
7986625|NCT00183391|19664083|P2|STARTED|Block 2 - 5 Weeks||110
7986626|NCT00183391|19664084|P1|STARTED|Block 2 - 5 Weeks||95
7986627|NCT00183391|19664083|P2|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
7986628|NCT00183391|19664084|P1|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
7986629|NCT00183391|19664083|P2|COMPLETED|Crossover Placebo - 2 Weeks||110
7986630|NCT00183391|19664084|P1|COMPLETED|Crossover Placebo - 2 Weeks||95
7986631|NCT00183391|19664083|P2|STARTED|Crossover Placebo - 2 Weeks||110
7986632|NCT00183391|19664084|P1|STARTED|Crossover Placebo - 2 Weeks||95
7986633|NCT00183391|19664083|P2|NOT COMPLETED|Block 1 - 5 Weeks||14
7986634|NCT00183391|19664084|P1|NOT COMPLETED|Block 1 - 5 Weeks||13
7986635|NCT00183391|19664083|P2|COMPLETED|Block 1 - 5 Weeks||110
7986636|NCT00183391|19664084|P1|COMPLETED|Block 1 - 5 Weeks||95
7986637|NCT00183391|19664083|P2|STARTED|Block 1 - 5 Weeks||124
7986638|NCT00183391|19664084|P1|STARTED|Block 1 - 5 Weeks||108
7986639|NCT00183339|19664144|P2|NOT COMPLETED|Overall Study||4
7986640|NCT00183339|19664145|P1|NOT COMPLETED|Overall Study||6
7986641|NCT00183339|19664144|P2|COMPLETED|Overall Study||4
7986642|NCT00183339|19664145|P1|COMPLETED|Overall Study||4
7986643|NCT00183339|19664144|P2|STARTED|Overall Study||8
7986644|NCT00183339|19664145|P1|STARTED|Overall Study||10
7986645|NCT00183274|19664157|P6|NOT COMPLETED|Phase 3: Double-Blind||4
7986646|NCT00183274|19664158|P5|NOT COMPLETED|Phase 3: Double-Blind||20
7986647|NCT00183274|19664159|P4|NOT COMPLETED|Phase 3: Double-Blind||2
7986648|NCT00183274|19664160|P3|NOT COMPLETED|Phase 3: Double-Blind||0
7986649|NCT00183274|19664161|P2|NOT COMPLETED|Phase 3: Double-Blind||0
7986650|NCT00183274|19664162|P1|NOT COMPLETED|Phase 3: Double-Blind||0
7986651|NCT00183274|19664157|P6|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6
7986652|NCT00183274|19664158|P5|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14
7986653|NCT00183274|19664159|P4|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13
7986654|NCT00183274|19664160|P3|COMPLETED|Phase 3: Double-Blind||0
7986655|NCT00183274|19664161|P2|COMPLETED|Phase 3: Double-Blind||0
7986656|NCT00183274|19664162|P1|COMPLETED|Phase 3: Double-Blind||0
7986657|NCT00183274|19664157|P6|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10
7986658|NCT00183274|19664158|P5|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34
7986659|NCT00183274|19664159|P4|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15
7986660|NCT00183274|19664160|P3|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
7986661|NCT00183274|19664161|P2|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
7986662|NCT00183274|19664162|P1|STARTED|Phase 3: Double-Blind||0
7986663|NCT00183274|19664157|P6|NOT COMPLETED|Phase 2: Double-Blind||0
7986664|NCT00183274|19664158|P5|NOT COMPLETED|Phase 2: Double-Blind||0
7986665|NCT00183274|19664159|P4|NOT COMPLETED|Phase 2: Double-Blind||0
7986666|NCT00183274|19664160|P3|NOT COMPLETED|Phase 2: Double-Blind||43
7986667|NCT00183274|19664161|P2|NOT COMPLETED|Phase 2: Double-Blind||26
7986668|NCT00183274|19664162|P1|NOT COMPLETED|Phase 2: Double-Blind||0
7986669|NCT00183274|19664157|P6|COMPLETED|Phase 2: Double-Blind||0
7986670|NCT00183274|19664158|P5|COMPLETED|Phase 2: Double-Blind||0
7986671|NCT00183274|19664159|P4|COMPLETED|Phase 2: Double-Blind||0
7986672|NCT00183274|19664160|P3|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11
7986673|NCT00183274|19664161|P2|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56
7986674|NCT00183274|19664162|P1|COMPLETED|Phase 2: Double-Blind||0
7986675|NCT00183274|19664157|P6|STARTED|Phase 2: Double-Blind||0
7986676|NCT00183274|19664158|P5|STARTED|Phase 2: Double-Blind||0
7986677|NCT00183274|19664159|P4|STARTED|Phase 2: Double-Blind||0
7986678|NCT00183274|19664160|P3|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54
7986679|NCT00183274|19664161|P2|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82
7986680|NCT00183274|19664162|P1|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0
7986681|NCT00183274|19664157|P6|NOT COMPLETED|Phase 1: Open-Label||0
7986682|NCT00183274|19664158|P5|NOT COMPLETED|Phase 1: Open-Label||0
7986683|NCT00183274|19664159|P4|NOT COMPLETED|Phase 1: Open-Label||0
7986684|NCT00183274|19664160|P3|NOT COMPLETED|Phase 1: Open-Label||0
7986685|NCT00183274|19664161|P2|NOT COMPLETED|Phase 1: Open-Label||0
7986686|NCT00183274|19664162|P1|NOT COMPLETED|Phase 1: Open-Label||110
7986687|NCT00183274|19664157|P6|COMPLETED|Phase 1: Open-Label||0
7986688|NCT00183274|19664158|P5|COMPLETED|Phase 1: Open-Label||0
7986689|NCT00183274|19664159|P4|COMPLETED|Phase 1: Open-Label||0
7986690|NCT00183274|19664160|P3|COMPLETED|Phase 1: Open-Label||0
7986691|NCT00183274|19664161|P2|COMPLETED|Phase 1: Open-Label||0
7986692|NCT00183274|19664162|P1|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158
7986693|NCT00183274|19664157|P6|STARTED|Phase 1: Open-Label||0
7986694|NCT00183274|19664158|P5|STARTED|Phase 1: Open-Label||0
7986695|NCT00183274|19664159|P4|STARTED|Phase 1: Open-Label||0
7986696|NCT00183274|19664160|P3|STARTED|Phase 1: Open-Label||0
7986697|NCT00183274|19664161|P2|STARTED|Phase 1: Open-Label||0
7986698|NCT00183274|19664162|P1|STARTED|Phase 1: Open-Label||268
7986699|NCT00183248|19664179|P2|NOT COMPLETED|Overall Study||1
7986700|NCT00183248|19664180|P1|NOT COMPLETED|Overall Study||1
7986701|NCT00183248|19664179|P2|COMPLETED|Overall Study||4
7986702|NCT00183248|19664180|P1|COMPLETED|Overall Study||3
7986703|NCT00183248|19664179|P2|STARTED|Overall Study||5
7986704|NCT00183248|19664180|P1|STARTED|Overall Study||4
7986705|NCT00183196|19664201|P3|NOT COMPLETED|Overall Study||18
7986706|NCT00183196|19664202|P2|NOT COMPLETED|Overall Study||15
7986707|NCT00183196|19664203|P1|NOT COMPLETED|Overall Study||20
7986708|NCT00183196|19664201|P3|COMPLETED|Overall Study||32
7986709|NCT00183196|19664202|P2|COMPLETED|Overall Study||35
7986710|NCT00183196|19664203|P1|COMPLETED|Overall Study||30
7986711|NCT00183196|19664201|P3|STARTED|Overall Study|1 subject had no post-randomization data|50
7986712|NCT00183196|19664202|P2|STARTED|Overall Study|1 subject had no post-randomization data|50
7986713|NCT00183196|19664203|P1|STARTED|Overall Study|2 subjects had no post-randomization data|50
7986714|NCT00183170|19664213|P2|NOT COMPLETED|Second Intervention||2
7986715|NCT00183170|19664214|P1|NOT COMPLETED|Second Intervention||1
7986716|NCT00183170|19664213|P2|COMPLETED|Second Intervention||99
7986717|NCT00183170|19664214|P1|COMPLETED|Second Intervention||94
7986718|NCT00183170|19664213|P2|STARTED|Second Intervention||101
7986719|NCT00183170|19664214|P1|STARTED|Second Intervention||95
7986720|NCT00183170|19664213|P2|NOT COMPLETED|Washout 1 Week||8
7986721|NCT00183170|19664214|P1|NOT COMPLETED|Washout 1 Week||6
7986722|NCT00183170|19664213|P2|COMPLETED|Washout 1 Week||101
7986723|NCT00183170|19664214|P1|COMPLETED|Washout 1 Week||95
7986724|NCT00183170|19664213|P2|STARTED|Washout 1 Week||109
7986725|NCT00183170|19664214|P1|STARTED|Washout 1 Week||101
7986726|NCT00183170|19664213|P2|NOT COMPLETED|First Intervention||0
7986727|NCT00183170|19664214|P1|NOT COMPLETED|First Intervention||2
7986728|NCT00183170|19664213|P2|COMPLETED|First Intervention||109
7986729|NCT00183170|19664214|P1|COMPLETED|First Intervention||101
7986730|NCT00183170|19664213|P2|STARTED|First Intervention||109
7986731|NCT00183170|19664214|P1|STARTED|First Intervention||103
7986732|NCT00183092|19664230|P4|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
7986733|NCT00183092|19664231|P3|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
7986734|NCT00183092|19664232|P2|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14
7986735|NCT00183092|19664233|P1|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10
7986736|NCT00183092|19664230|P4|COMPLETED|Open-label Period (Month 2 Until Death)||0
7986737|NCT00183092|19664231|P3|COMPLETED|Open-label Period (Month 2 Until Death)||0
7986738|NCT00183092|19664232|P2|COMPLETED|Open-label Period (Month 2 Until Death)||0
7986739|NCT00183092|19664233|P1|COMPLETED|Open-label Period (Month 2 Until Death)||0
7986740|NCT00183092|19664230|P4|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1
7986741|NCT00183092|19664231|P3|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1
7986742|NCT00183092|19664232|P2|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14
7986743|NCT00183092|19664233|P1|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10
7986744|NCT00183092|19664230|P4|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
7986745|NCT00183092|19664231|P3|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
7986746|NCT00183092|19664232|P2|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
7986747|NCT00183092|19664233|P1|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
7986748|NCT00183092|19664230|P4|COMPLETED|Double-blind (Baseline - Month 2)||0
7986749|NCT00183092|19664231|P3|COMPLETED|Double-blind (Baseline - Month 2)||0
7986750|NCT00183092|19664232|P2|COMPLETED|Double-blind (Baseline - Month 2)||16
7986751|NCT00183092|19664233|P1|COMPLETED|Double-blind (Baseline - Month 2)||11
7986752|NCT00183092|19664230|P4|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
7986753|NCT00183092|19664231|P3|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
7986754|NCT00183092|19664232|P2|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16
7986755|NCT00183092|19664233|P1|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10
7986756|NCT00183092|19664230|P4|Alive at Month 2|Double-blind (Baseline - Month 2)||0
7986757|NCT00183092|19664231|P3|Alive at Month 2|Double-blind (Baseline - Month 2)||0
7986758|NCT00183092|19664232|P2|Alive at Month 2|Double-blind (Baseline - Month 2)||19
7986759|NCT00183092|19664233|P1|Alive at Month 2|Double-blind (Baseline - Month 2)||13
7986760|NCT00183092|19664230|P4|STARTED|Double-blind (Baseline - Month 2)||0
7986761|NCT00183092|19664231|P3|STARTED|Double-blind (Baseline - Month 2)||0
7986762|NCT00183092|19664232|P2|STARTED|Double-blind (Baseline - Month 2)||28
7986763|NCT00183092|19664233|P1|STARTED|Double-blind (Baseline - Month 2)||23
7986764|NCT00182793|19664254|P1|NOT COMPLETED|Overall Study||0
7986765|NCT00182793|19664254|P1|COMPLETED|Overall Study||32
7986766|NCT00182793|19664254|P1|STARTED|Overall Study||32
7986767|NCT00182767|19664259|P5|NOT COMPLETED|Overall Study||0
7986768|NCT00182767|19664260|P4|NOT COMPLETED|Overall Study||0
7986769|NCT00182767|19664261|P3|NOT COMPLETED|Overall Study||0
7986770|NCT00182767|19664262|P2|NOT COMPLETED|Overall Study||0
7986771|NCT00182767|19664263|P1|NOT COMPLETED|Overall Study||0
7986772|NCT00182767|19664259|P5|COMPLETED|Overall Study||24
7986773|NCT00182767|19664260|P4|COMPLETED|Overall Study||3
7986774|NCT00182767|19664261|P3|COMPLETED|Overall Study||6
7986775|NCT00182767|19664262|P2|COMPLETED|Overall Study||6
7986776|NCT00182767|19664263|P1|COMPLETED|Overall Study||6
7986777|NCT00182767|19664259|P5|STARTED|Overall Study||24
7986778|NCT00182767|19664260|P4|STARTED|Overall Study||3
7986779|NCT00182767|19664261|P3|STARTED|Overall Study||6
7986780|NCT00182767|19664262|P2|STARTED|Overall Study||6
7986781|NCT00182767|19664263|P1|STARTED|Overall Study||6
7986782|NCT00182754|19664280|P2|NOT COMPLETED|Overall Study||0
7986783|NCT00182754|19664281|P1|NOT COMPLETED|Overall Study||0
7986784|NCT00182754|19664280|P2|COMPLETED|Overall Study||17
7986785|NCT00182754|19664281|P1|COMPLETED|Overall Study||16
7986786|NCT00182754|19664280|P2|STARTED|Overall Study||17
7986787|NCT00182754|19664281|P1|STARTED|Overall Study||16
7986788|NCT00182728|19664291|P1|NOT COMPLETED|Overall Study||0
7986789|NCT00182728|19664291|P1|COMPLETED|Overall Study||71
7986790|NCT00182728|19664291|P1|STARTED|Overall Study||71
7986791|NCT00182689|19664303|P2|NOT COMPLETED|Overall Study||49
7986792|NCT00182689|19664304|P1|NOT COMPLETED|Overall Study||40
7986793|NCT00182689|19664303|P2|COMPLETED|Overall Study||0
7986794|NCT00182689|19664304|P1|COMPLETED|Overall Study||0
7986795|NCT00182689|19664303|P2|Eligible and Began Protocol Therapy|Overall Study||45
7986796|NCT00182689|19664304|P1|Eligible and Began Protocol Therapy|Overall Study||38
7986797|NCT00182689|19664303|P2|Eligible|Overall Study||45
7986798|NCT00182689|19664304|P1|Eligible|Overall Study||39
7986799|NCT00182689|19664303|P2|STARTED|Overall Study||49
7986800|NCT00182689|19664304|P1|STARTED|Overall Study||40
7986801|NCT00182637|19664314|P1|NOT COMPLETED|Overall Study||3
7986802|NCT00182637|19664314|P1|COMPLETED|Overall Study|off study date|2
7986803|NCT00182637|19664314|P1|STARTED|Overall Study|active/on treatment date|5
7986804|NCT00182325|19664322|P2|NOT COMPLETED|Overall Study||53
7986805|NCT00182325|19664323|P1|NOT COMPLETED|Overall Study||34
7986806|NCT00182325|19664322|P2|COMPLETED|Overall Study|43 completed survey, 89 included in intention-to-treat analysis|43
7986807|NCT00182325|19664323|P1|COMPLETED|Overall Study|63 completed survey, 85 included in intention-to-treat analysis|63
7986808|NCT00182325|19664322|P2|STARTED|Overall Study||96
7986809|NCT00182325|19664323|P1|STARTED|Overall Study||97
7986810|NCT00182091|19664351|P4|NOT COMPLETED|Overall Study||0
7986811|NCT00182091|19664352|P3|NOT COMPLETED|Overall Study||0
7986812|NCT00182091|19664353|P2|NOT COMPLETED|Overall Study||0
7986813|NCT00182091|19664354|P1|NOT COMPLETED|Overall Study||1
7986814|NCT00182091|19664351|P4|COMPLETED|Overall Study||20
7986815|NCT00182091|19664352|P3|COMPLETED|Overall Study||25
7986816|NCT00182091|19664353|P2|COMPLETED|Overall Study||15
7986817|NCT00182091|19664354|P1|COMPLETED|Overall Study||14
7986818|NCT00182091|19664351|P4|STARTED|Overall Study||20
7986819|NCT00182091|19664352|P3|STARTED|Overall Study||25
7986820|NCT00182091|19664353|P2|STARTED|Overall Study||15
7986821|NCT00182091|19664354|P1|STARTED|Overall Study||15
7986822|NCT00182078|19664370|P2|NOT COMPLETED|Overall Study||0
7986823|NCT00182078|19664371|P1|NOT COMPLETED|Overall Study||1
7986824|NCT00182078|19664370|P2|COMPLETED|Overall Study||17
7986825|NCT00182078|19664371|P1|COMPLETED|Overall Study||8
7986826|NCT00182078|19664370|P2|STARTED|Overall Study||17
7986827|NCT00182078|19664371|P1|STARTED|Overall Study||9
7986828|NCT00182000|19664383|P2|NOT COMPLETED|Overall Study||2
7986829|NCT00182000|19664384|P1|NOT COMPLETED|Overall Study||5
7986830|NCT00182000|19664383|P2|COMPLETED|Overall Study||13
7986831|NCT00182000|19664384|P1|COMPLETED|Overall Study||9
7986832|NCT00182000|19664383|P2|STARTED|Overall Study||15
7986833|NCT00182000|19664384|P1|STARTED|Overall Study||14
7986834|NCT00181961|19664392|P2|NOT COMPLETED|Overall Study||5
7986835|NCT00181961|19664393|P1|NOT COMPLETED|Overall Study||1
7986836|NCT00181961|19664392|P2|COMPLETED|Overall Study||4
7986837|NCT00181961|19664393|P1|COMPLETED|Overall Study||6
7986838|NCT00181961|19664392|P2|STARTED|Overall Study||9
7986839|NCT00181961|19664393|P1|STARTED|Overall Study||7
7986840|NCT00181883|19664399|P1|NOT COMPLETED|Overall Study||10
7986841|NCT00181883|19664399|P1|COMPLETED|Overall Study||20
7986842|NCT00181883|19664399|P1|STARTED|Overall Study||30
7986843|NCT00181844|19664403|P1|NOT COMPLETED|Exposed to Study Medication||17
7986844|NCT00181844|19664403|P1|COMPLETED|Exposed to Study Medication||22
7986845|NCT00181844|19664403|P1|STARTED|Exposed to Study Medication||39
7986846|NCT00181844|19664403|P1|NOT COMPLETED|Signed Consent||12
7986847|NCT00181844|19664403|P1|COMPLETED|Signed Consent||39
7986848|NCT00181844|19664403|P1|STARTED|Signed Consent||51
7986849|NCT00181766|19664407|P1|NOT COMPLETED|Overall Study||12
7986850|NCT00181766|19664407|P1|COMPLETED|Overall Study|Completed the trial.|33
7986851|NCT00181766|19664407|P1|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45
7986852|NCT00181714|19664412|P1|NOT COMPLETED|Began Treatment With OROS-MPH||124
7986853|NCT00181714|19664412|P1|COMPLETED|Began Treatment With OROS-MPH||30
7986854|NCT00181714|19664412|P1|STARTED|Began Treatment With OROS-MPH||154
7986855|NCT00181714|19664412|P1|NOT COMPLETED|Signed Consent/Enrolled||49
7986856|NCT00181714|19664412|P1|COMPLETED|Signed Consent/Enrolled||154
7986857|NCT00181714|19664412|P1|STARTED|Signed Consent/Enrolled||203
7986858|NCT00181623|19664416|P1|NOT COMPLETED|Overall Study||1
7986859|NCT00181623|19664416|P1|COMPLETED|Overall Study||5
7986860|NCT00181623|19664416|P1|STARTED|Overall Study||6
7986861|NCT00181610|19664424|P3|NOT COMPLETED|Overall Study||0
7986862|NCT00181610|19664425|P2|NOT COMPLETED|Overall Study||1
7986863|NCT00181610|19664426|P1|NOT COMPLETED|Overall Study||0
7986864|NCT00181610|19664424|P3|COMPLETED|Overall Study||3
7986865|NCT00181610|19664425|P2|COMPLETED|Overall Study||3
7986866|NCT00181610|19664426|P1|COMPLETED|Overall Study||4
7986867|NCT00181610|19664424|P3|STARTED|Overall Study||3
7986868|NCT00181610|19664425|P2|STARTED|Overall Study||4
7986869|NCT00181610|19664426|P1|STARTED|Overall Study||4
7986870|NCT00181363|19664437|P1|NOT COMPLETED|Overall Study||0
7986871|NCT00181363|19664437|P1|COMPLETED|Overall Study||10
7986872|NCT00181363|19664437|P1|STARTED|Overall Study|10|10
7986873|NCT00181285|19664452|P2|NOT COMPLETED|Overall Study||0
7986874|NCT00181285|19664453|P1|NOT COMPLETED|Overall Study||0
7986875|NCT00181285|19664452|P2|COMPLETED|Overall Study||25
7986876|NCT00181285|19664453|P1|COMPLETED|Overall Study||27
7986877|NCT00181285|19664452|P2|STARTED|Overall Study||25
7986878|NCT00181285|19664453|P1|STARTED|Overall Study||27
7986879|NCT00181207|19664463|P2|NOT COMPLETED|Overall Study||0
7986880|NCT00181207|19664464|P1|NOT COMPLETED|Overall Study||0
7986881|NCT00181207|19664463|P2|COMPLETED|Overall Study||26
7986882|NCT00181207|19664464|P1|COMPLETED|Overall Study||24
7986883|NCT00181207|19664463|P2|STARTED|Overall Study||26
7986884|NCT00181207|19664464|P1|STARTED|Overall Study||24
7986885|NCT00181168|19664474|P2|NOT COMPLETED|Overall Study||0
7986886|NCT00181168|19664475|P1|NOT COMPLETED|Overall Study||0
7986887|NCT00181168|19664474|P2|COMPLETED|Overall Study||33
7986888|NCT00181168|19664475|P1|COMPLETED|Overall Study||30
7986889|NCT00181168|19664474|P2|STARTED|Overall Study||33
7986890|NCT00181168|19664475|P1|STARTED|Overall Study||30
7986891|NCT00181155|19664481|P2|NOT COMPLETED|Overall Study||0
7986892|NCT00181155|19664482|P1|NOT COMPLETED|Overall Study||2
7986893|NCT00181155|19664481|P2|COMPLETED|Overall Study||3
7986894|NCT00181155|19664482|P1|COMPLETED|Overall Study||13
7986895|NCT00181155|19664481|P2|STARTED|Overall Study||3
7986896|NCT00181155|19664482|P1|STARTED|Overall Study||15
7986897|NCT00180713|19664492|P2|NOT COMPLETED|Overall Study||3
7986898|NCT00180713|19664493|P1|NOT COMPLETED|Overall Study||5
7986899|NCT00180713|19664492|P2|COMPLETED|Overall Study||16
7986900|NCT00180713|19664493|P1|COMPLETED|Overall Study||18
7986901|NCT00180713|19664492|P2|STARTED|Overall Study||19
7986902|NCT00180713|19664493|P1|STARTED|Overall Study||23
7986903|NCT00180687|19664511|P4|NOT COMPLETED|Overall Study||0
7986904|NCT00180687|19664512|P3|NOT COMPLETED|Overall Study||0
7986905|NCT00180687|19664513|P2|NOT COMPLETED|Overall Study||0
7986906|NCT00180687|19664514|P1|NOT COMPLETED|Overall Study||0
7986907|NCT00180687|19664511|P4|COMPLETED|Overall Study||20
7986908|NCT00180687|19664512|P3|COMPLETED|Overall Study||20
7986909|NCT00180687|19664513|P2|COMPLETED|Overall Study||20
7986910|NCT00180687|19664514|P1|COMPLETED|Overall Study||20
7986911|NCT00180687|19664511|P4|STARTED|Overall Study||20
7986912|NCT00180687|19664512|P3|STARTED|Overall Study||20
7986913|NCT00180687|19664513|P2|STARTED|Overall Study||20
7986914|NCT00180687|19664514|P1|STARTED|Overall Study||20
7986915|NCT00180674|19664536|P1|NOT COMPLETED|Phase 2, Warfarin Treatment Period||1
7986916|NCT00180674|19664536|P1|COMPLETED|Phase 2, Warfarin Treatment Period||9
7986917|NCT00180674|19664536|P1|STARTED|Phase 2, Warfarin Treatment Period||10
7986918|NCT00180674|19664536|P1|NOT COMPLETED|Phase 1, Observation Period||4
7986919|NCT00180674|19664536|P1|COMPLETED|Phase 1, Observation Period||10
7986920|NCT00180674|19664536|P1|STARTED|Phase 1, Observation Period||14
7986921|NCT00180661|19664546|P2|NOT COMPLETED|Overall Study||0
7986922|NCT00180661|19664547|P1|NOT COMPLETED|Overall Study||0
7986923|NCT00180661|19664546|P2|COMPLETED|Overall Study||20
7986924|NCT00180661|19664547|P1|COMPLETED|Overall Study||19
7986925|NCT00180661|19664546|P2|STARTED|Overall Study||20
7986926|NCT00180661|19664547|P1|STARTED|Overall Study||19
7986927|NCT00180479|19664565|P2|NOT COMPLETED|Overall Study||13
7986928|NCT00180479|19664566|P1|NOT COMPLETED|Overall Study||16
7986929|NCT00180479|19664565|P2|COMPLETED|Overall Study||320
7986930|NCT00180479|19664566|P1|COMPLETED|Overall Study||653
7986931|NCT00180479|19664565|P2|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333
7986932|NCT00180479|19664566|P1|STARTED|Overall Study||669
7986933|NCT00180323|19664658|P1|NOT COMPLETED|Overall Study||0
7986934|NCT00180323|19664658|P1|COMPLETED|Overall Study||43
7986935|NCT00180323|19664658|P1|STARTED|Overall Study||43
7986936|NCT00180271|19664667|P2|NOT COMPLETED|Overall Study||0
7986937|NCT00180271|19664668|P1|NOT COMPLETED|Overall Study||0
7986938|NCT00180271|19664667|P2|COMPLETED|Overall Study||731
7986939|NCT00180271|19664668|P1|COMPLETED|Overall Study||1089
7986940|NCT00180271|19664667|P2|STARTED|Overall Study||731
7986941|NCT00180271|19664668|P1|STARTED|Overall Study||1089
7986942|NCT00179998|19664678|P2|NOT COMPLETED|Crossover Period - 6 Months||2
7986943|NCT00179998|19664679|P1|NOT COMPLETED|Crossover Period - 6 Months||0
7986944|NCT00179998|19664678|P2|COMPLETED|Crossover Period - 6 Months||10
7986945|NCT00179998|19664679|P1|COMPLETED|Crossover Period - 6 Months||12
7986946|NCT00179998|19664678|P2|STARTED|Crossover Period - 6 Months||12
7986947|NCT00179998|19664679|P1|STARTED|Crossover Period - 6 Months||12
7986948|NCT00179998|19664678|P2|NOT COMPLETED|Initial Period - 6 Months||0
7986949|NCT00179998|19664679|P1|NOT COMPLETED|Initial Period - 6 Months||0
7986950|NCT00179998|19664678|P2|COMPLETED|Initial Period - 6 Months||12
7986951|NCT00179998|19664679|P1|COMPLETED|Initial Period - 6 Months||12
7986952|NCT00179998|19664678|P2|STARTED|Initial Period - 6 Months||12
7986953|NCT00179998|19664679|P1|STARTED|Initial Period - 6 Months||12
7986954|NCT00179959|19664691|P2|NOT COMPLETED|Overall Study||3
7986955|NCT00179959|19664692|P1|NOT COMPLETED|Overall Study||6
7986956|NCT00179959|19664691|P2|COMPLETED|Overall Study||13
7986957|NCT00179959|19664692|P1|COMPLETED|Overall Study||9
7986958|NCT00179959|19664691|P2|STARTED|Overall Study||16
7986959|NCT00179959|19664692|P1|STARTED|Overall Study||15
7986960|NCT00179673|19664698|P1|NOT COMPLETED|Overall Study||43
7986961|NCT00179673|19664698|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
7986962|NCT00179673|19664698|P1|Received Study Drug|Overall Study||43
7986963|NCT00179673|19664698|P1|STARTED|Overall Study||43
7986964|NCT00179660|19664706|P1|NOT COMPLETED|Overall Study||50
7986965|NCT00179660|19664706|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
7986966|NCT00179660|19664706|P1|Completed 12 Cycles of Treatment|Overall Study||12
7986967|NCT00179660|19664706|P1|Received Study Drug|Overall Study||49
7986968|NCT00179660|19664706|P1|STARTED|Overall Study||50
7986969|NCT00179647|19664715|P1|NOT COMPLETED|Overall Study||1913
7986970|NCT00179647|19664715|P1|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0
7986971|NCT00179647|19664715|P1|STARTED|Overall Study||1913
7986972|NCT00179621|19664722|P4|NOT COMPLETED|Open-Label Period||43
7986973|NCT00179621|19664723|P3|NOT COMPLETED|Open-Label Period||28
7986974|NCT00179621|19664724|P2|NOT COMPLETED|Open-Label Period||28
7986975|NCT00179621|19664725|P1|NOT COMPLETED|Open-Label Period||0
7986976|NCT00179621|19664722|P4|COMPLETED|Open-Label Period||13
7986977|NCT00179621|19664723|P3|COMPLETED|Open-Label Period||19
7986978|NCT00179621|19664724|P2|COMPLETED|Open-Label Period||14
7986979|NCT00179621|19664725|P1|COMPLETED|Open-Label Period||0
7986980|NCT00179621|19664722|P4|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56
7986981|NCT00179621|19664723|P3|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47
7986982|NCT00179621|19664724|P2|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42
7986983|NCT00179621|19664725|P1|STARTED|Open-Label Period||0
7986984|NCT00179621|19664722|P4|NOT COMPLETED|Double-Blind Period||0
7986985|NCT00179621|19664723|P3|NOT COMPLETED|Double-Blind Period||30
7986986|NCT00179621|19664724|P2|NOT COMPLETED|Double-Blind Period||46
7986987|NCT00179621|19664725|P1|NOT COMPLETED|Double-Blind Period||64
7986988|NCT00179621|19664722|P4|COMPLETED|Double-Blind Period||0
7986989|NCT00179621|19664723|P3|COMPLETED|Double-Blind Period||39
7986990|NCT00179621|19664724|P2|COMPLETED|Double-Blind Period||23
7986991|NCT00179621|19664725|P1|COMPLETED|Double-Blind Period||3
7986992|NCT00179621|19664722|P4|STARTED|Double-Blind Period||0
7986993|NCT00179621|19664723|P3|STARTED|Double-Blind Period||69
7986994|NCT00179621|19664724|P2|STARTED|Double-Blind Period||69
7986995|NCT00179621|19664725|P1|STARTED|Double-Blind Period||67
7986996|NCT00179517|19664778|P2|NOT COMPLETED|Overall Study||1
7986997|NCT00179517|19664779|P1|NOT COMPLETED|Overall Study||2
7986998|NCT00179517|19664778|P2|COMPLETED|Overall Study||19
7986999|NCT00179517|19664779|P1|COMPLETED|Overall Study||18
7987000|NCT00179517|19664778|P2|STARTED|Overall Study||20
7987001|NCT00179517|19664779|P1|STARTED|Overall Study||20
7987002|NCT00179478|19664803|P2|NOT COMPLETED|Overall Study||15
7987003|NCT00179478|19664804|P1|NOT COMPLETED|Overall Study||13
7987004|NCT00179478|19664803|P2|COMPLETED|Overall Study||59
7987005|NCT00179478|19664804|P1|COMPLETED|Overall Study||68
7987006|NCT00179478|19664803|P2|STARTED|Overall Study||74
7987007|NCT00179478|19664804|P1|STARTED|Overall Study||81
7987008|NCT00179413|19664817|P2|NOT COMPLETED|Overall Study||115
7987009|NCT00179413|19664818|P1|NOT COMPLETED|Overall Study||125
7987010|NCT00179413|19664817|P2|COMPLETED|Overall Study||152
7987011|NCT00179413|19664818|P1|COMPLETED|Overall Study||157
7987012|NCT00179413|19664817|P2|STARTED|Overall Study||267
7987013|NCT00179413|19664818|P1|STARTED|Overall Study||282
7987014|NCT00179309|19664830|P2|NOT COMPLETED|Crossover||0
7987015|NCT00179309|19664831|P1|NOT COMPLETED|Crossover||0
7987016|NCT00179309|19664830|P2|COMPLETED|Crossover||3
7987017|NCT00179309|19664831|P1|COMPLETED|Crossover||0
7987018|NCT00179309|19664830|P2|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3
7987019|NCT00179309|19664831|P1|STARTED|Crossover||0
7987020|NCT00179309|19664830|P2|NOT COMPLETED|Treatment||5
7987021|NCT00179309|19664831|P1|NOT COMPLETED|Treatment||4
7987022|NCT00179309|19664830|P2|COMPLETED|Treatment||18
7987023|NCT00179309|19664831|P1|COMPLETED|Treatment||21
7987024|NCT00179309|19664830|P2|STARTED|Treatment||23
7987025|NCT00179309|19664831|P1|STARTED|Treatment||25
7987026|NCT00179127|19664841|P2|NOT COMPLETED|Overall Study||0
7987027|NCT00179127|19664842|P1|NOT COMPLETED|Overall Study||0
7987028|NCT00179127|19664841|P2|COMPLETED|Overall Study||0
7987029|NCT00179127|19664842|P1|COMPLETED|Overall Study||0
7987030|NCT00179127|19664841|P2|STARTED|Overall Study||0
7987031|NCT00179127|19664842|P1|STARTED|Overall Study||0
7987032|NCT00179010|19664854|P2|NOT COMPLETED|Overall Study||2
7987033|NCT00179010|19664855|P1|NOT COMPLETED|Overall Study||1
7987034|NCT00179010|19664854|P2|COMPLETED|Overall Study||5
7987035|NCT00179010|19664855|P1|COMPLETED|Overall Study||5
7987036|NCT00179010|19664854|P2|STARTED|Overall Study||7
7987037|NCT00179010|19664855|P1|STARTED|Overall Study||6
7987038|NCT00178919|19664865|P2|NOT COMPLETED|Overall Study||25
7987039|NCT00178919|19664866|P1|NOT COMPLETED|Overall Study||0
7987040|NCT00178919|19664865|P2|COMPLETED|Overall Study||68
7987041|NCT00178919|19664866|P1|COMPLETED|Overall Study||19
7987042|NCT00178919|19664865|P2|STARTED|Overall Study||93
7987043|NCT00178919|19664866|P1|STARTED|Overall Study||19
7987044|NCT00178841|19664874|P1|NOT COMPLETED|Overall Study||0
7987045|NCT00178841|19664874|P1|COMPLETED|Overall Study||4
7987046|NCT00178841|19664874|P1|STARTED|Overall Study||4
7987047|NCT00178711|19664882|P2|NOT COMPLETED|Overall Study||0
7987048|NCT00178711|19664883|P1|NOT COMPLETED|Overall Study||0
7987049|NCT00178711|19664882|P2|COMPLETED|Overall Study||45
7987050|NCT00178711|19664883|P1|COMPLETED|Overall Study||52
7987051|NCT00178711|19664882|P2|STARTED|Overall Study||45
7987052|NCT00178711|19664883|P1|STARTED|Overall Study||52
7987053|NCT00178685|19664894|P3|NOT COMPLETED|Overall Study||196
7987054|NCT00178685|19664895|P2|NOT COMPLETED|Overall Study||204
7987055|NCT00178685|19664896|P1|NOT COMPLETED|Overall Study||111
7987056|NCT00178685|19664894|P3|COMPLETED|Overall Study||128
7987057|NCT00178685|19664895|P2|COMPLETED|Overall Study||120
7987058|NCT00178685|19664896|P1|COMPLETED|Overall Study||61
7987059|NCT00178685|19664894|P3|STARTED|Overall Study||324
7987060|NCT00178685|19664895|P2|STARTED|Overall Study||324
7987061|NCT00178685|19664896|P1|STARTED|Overall Study||172
7987062|NCT00178633|19664907|P1|NOT COMPLETED|Overall Study||6
7987063|NCT00178633|19664907|P1|COMPLETED|Overall Study||37
7987064|NCT00178633|19664907|P1|STARTED|Overall Study||43
7987065|NCT00178503|19664915|P1|NOT COMPLETED|MPH Trial: High Dose||0
7987066|NCT00178503|19664915|P1|COMPLETED|MPH Trial: High Dose||24
7987067|NCT00178503|19664915|P1|STARTED|MPH Trial: High Dose||24
7987068|NCT00178503|19664915|P1|NOT COMPLETED|MPH Trial: Med Dose||0
7987069|NCT00178503|19664915|P1|COMPLETED|MPH Trial: Med Dose||24
7987070|NCT00178503|19664915|P1|STARTED|MPH Trial: Med Dose||24
7987071|NCT00178503|19664915|P1|NOT COMPLETED|MPH Trial: Low Dose||0
7987072|NCT00178503|19664915|P1|COMPLETED|MPH Trial: Low Dose||24
7987073|NCT00178503|19664915|P1|STARTED|MPH Trial: Low Dose||24
7987074|NCT00178503|19664915|P1|NOT COMPLETED|MPH Trial: Placebo||0
7987075|NCT00178503|19664915|P1|COMPLETED|MPH Trial: Placebo||24
7987076|NCT00178503|19664915|P1|STARTED|MPH Trial: Placebo||24
7987077|NCT00178477|19664933|P1|NOT COMPLETED|Overall Study||5
7987078|NCT00178477|19664933|P1|COMPLETED|Overall Study||5
7987079|NCT00178477|19664933|P1|STARTED|Overall Study||10
7987080|NCT00178464|19664937|P1|NOT COMPLETED|Overall Study||2
7987081|NCT00178464|19664937|P1|COMPLETED|Overall Study||9
7987082|NCT00178464|19664937|P1|STARTED|Overall Study||11
7987083|NCT00178399|19664942|P1|NOT COMPLETED|Overall Study||13
7987084|NCT00178399|19664942|P1|COMPLETED|Overall Study||115
7987085|NCT00178399|19664942|P1|STARTED|Overall Study||128
7987086|NCT00178256|19664949|P4|NOT COMPLETED|Overall Study||2
7987087|NCT00178256|19664950|P3|NOT COMPLETED|Overall Study||0
7987088|NCT00178256|19664951|P2|NOT COMPLETED|Overall Study||1
7987089|NCT00178256|19664952|P1|NOT COMPLETED|Overall Study||4
7987090|NCT00178256|19664949|P4|COMPLETED|Overall Study||16
7987091|NCT00178256|19664950|P3|COMPLETED|Overall Study||6
7987092|NCT00178256|19664951|P2|COMPLETED|Overall Study||6
7987093|NCT00178256|19664952|P1|COMPLETED|Overall Study||6
7987094|NCT00178256|19664949|P4|STARTED|Overall Study||18
7987095|NCT00178256|19664950|P3|STARTED|Overall Study||6
7987096|NCT00178256|19664951|P2|STARTED|Overall Study||7
7987097|NCT00178256|19664952|P1|STARTED|Overall Study||10
7987098|NCT00178191|19664962|P3|NOT COMPLETED|Overall Study||0
7987099|NCT00178191|19664963|P2|NOT COMPLETED|Overall Study||0
7987100|NCT00178191|19664964|P1|NOT COMPLETED|Overall Study||0
7987101|NCT00178191|19664962|P3|COMPLETED|Overall Study||7
7987102|NCT00178191|19664963|P2|COMPLETED|Overall Study||10
7987103|NCT00178191|19664964|P1|COMPLETED|Overall Study||11
7987104|NCT00178191|19664962|P3|STARTED|Overall Study||7
7987105|NCT00178191|19664963|P2|STARTED|Overall Study||10
7987106|NCT00178191|19664964|P1|STARTED|Overall Study||11
7987107|NCT00178178|19664976|P4|NOT COMPLETED|Overall Study||0
7987108|NCT00178178|19664977|P3|NOT COMPLETED|Overall Study||0
7987109|NCT00178178|19664978|P2|NOT COMPLETED|Overall Study||0
7987110|NCT00178178|19664979|P1|NOT COMPLETED|Overall Study||0
7987111|NCT00178178|19664976|P4|COMPLETED|Overall Study||24
7987112|NCT00178178|19664977|P3|COMPLETED|Overall Study||24
7987113|NCT00178178|19664978|P2|COMPLETED|Overall Study||24
7987114|NCT00178178|19664979|P1|COMPLETED|Overall Study||24
7987115|NCT00178178|19664976|P4|STARTED|Overall Study||24
7987116|NCT00178178|19664977|P3|STARTED|Overall Study||24
7987117|NCT00178178|19664978|P2|STARTED|Overall Study||24
7987118|NCT00178178|19664979|P1|STARTED|Overall Study||24
7987119|NCT00178126|19664991|P2|NOT COMPLETED|Overall Study||27
7987120|NCT00178126|19664992|P1|NOT COMPLETED|Overall Study||25
7987121|NCT00178126|19664991|P2|COMPLETED|Overall Study||86
7987122|NCT00178126|19664992|P1|COMPLETED|Overall Study||94
7987123|NCT00178126|19664991|P2|STARTED|Overall Study||113
7987124|NCT00178126|19664992|P1|STARTED|Overall Study||119
7987125|NCT00177970|19665000|P2|NOT COMPLETED|Overall Study||0
7987126|NCT00177970|19665001|P1|NOT COMPLETED|Overall Study||0
7987127|NCT00177970|19665000|P2|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
7987128|NCT00177970|19665001|P1|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
7987129|NCT00177970|19665000|P2|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
7987130|NCT00177970|19665001|P1|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
7987131|NCT00177866|19665023|P2|NOT COMPLETED|Overall Study||0
7987132|NCT00177866|19665024|P1|NOT COMPLETED|Overall Study||0
7987133|NCT00177866|19665023|P2|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
7987134|NCT00177866|19665024|P1|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
7987135|NCT00177866|19665023|P2|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
7987136|NCT00177866|19665024|P1|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
7987137|NCT00177671|19665034|P2|NOT COMPLETED|Overall Study||14
7987138|NCT00177671|19665035|P1|NOT COMPLETED|Overall Study||25
7987139|NCT00177671|19665034|P2|COMPLETED|Overall Study||49
7987140|NCT00177671|19665035|P1|COMPLETED|Overall Study||42
7987141|NCT00177671|19665034|P2|Month 24|Overall Study||49
7987142|NCT00177671|19665035|P1|Month 24|Overall Study||42
7987143|NCT00177671|19665034|P2|Month 12|Overall Study||57
7987144|NCT00177671|19665035|P1|Month 12|Overall Study||45
7987145|NCT00177671|19665034|P2|STARTED|Overall Study||63
7987146|NCT00177671|19665035|P1|STARTED|Overall Study||67
7987147|NCT00177307|19665047|P1|NOT COMPLETED|Overall Study||1
7987148|NCT00177307|19665047|P1|COMPLETED|Overall Study||39
7987149|NCT00177307|19665047|P1|STARTED|Overall Study||40
7987150|NCT00177294|19665056|P2|NOT COMPLETED|Overall Study||5
7987151|NCT00177294|19665057|P1|NOT COMPLETED|Overall Study||7
7987152|NCT00177294|19665056|P2|COMPLETED|Overall Study||59
7987153|NCT00177294|19665057|P1|COMPLETED|Overall Study||53
7987154|NCT00177294|19665056|P2|STARTED|Overall Study||64
7987155|NCT00177294|19665057|P1|STARTED|Overall Study||60
7987156|NCT00177255|19665063|P1|NOT COMPLETED|Overall Study||0
7987157|NCT00177255|19665063|P1|COMPLETED|Overall Study||39
7987158|NCT00177255|19665063|P1|STARTED|Overall Study||39
7987159|NCT00177216|19665071|P3|NOT COMPLETED|Overall Study||1
7987160|NCT00177216|19665072|P2|NOT COMPLETED|Overall Study||3
7987161|NCT00177216|19665073|P1|NOT COMPLETED|Overall Study||6
7987162|NCT00177216|19665071|P3|COMPLETED|Overall Study||19
7987163|NCT00177216|19665072|P2|COMPLETED|Overall Study||20
7987164|NCT00177216|19665073|P1|COMPLETED|Overall Study||20
7987165|NCT00177216|19665071|P3|STARTED|Overall Study||20
7987166|NCT00177216|19665072|P2|STARTED|Overall Study||23
7987167|NCT00177216|19665073|P1|STARTED|Overall Study||26
7987168|NCT00177164|19665089|P2|NOT COMPLETED|Overall Study||16
7987169|NCT00177164|19665090|P1|NOT COMPLETED|Overall Study||9
7987170|NCT00177164|19665089|P2|COMPLETED|Overall Study||9
7987171|NCT00177164|19665090|P1|COMPLETED|Overall Study||14
7987172|NCT00177164|19665089|P2|STARTED|Overall Study||25
7987173|NCT00177164|19665090|P1|STARTED|Overall Study||23
7987174|NCT00176917|19665102|P1|NOT COMPLETED|Overall Study||0
7987175|NCT00176917|19665102|P1|COMPLETED|Overall Study||41
7987176|NCT00176917|19665102|P1|STARTED|Overall Study||41
7987177|NCT00176904|19665109|P1|NOT COMPLETED|Overall Study||0
7987178|NCT00176904|19665109|P1|COMPLETED|Overall Study||135
7987179|NCT00176904|19665109|P1|STARTED|Overall Study||135
7987180|NCT00176891|19665117|P1|NOT COMPLETED|Overall Study||3
7987181|NCT00176891|19665117|P1|COMPLETED|Overall Study||22
7987182|NCT00176891|19665117|P1|STARTED|Overall Study||25
7987183|NCT00176878|19665128|P1|NOT COMPLETED|Overall Study||0
7987184|NCT00176878|19665128|P1|COMPLETED|Overall Study||10
7987185|NCT00176878|19665128|P1|STARTED|Overall Study||10
7987186|NCT00176865|19665140|P3|NOT COMPLETED|Overall Study||0
7987187|NCT00176865|19665141|P2|NOT COMPLETED|Overall Study||0
7987188|NCT00176865|19665142|P1|NOT COMPLETED|Overall Study||0
7987189|NCT00176865|19665140|P3|COMPLETED|Overall Study||6
7987190|NCT00176865|19665141|P2|COMPLETED|Overall Study||10
7987191|NCT00176865|19665142|P1|COMPLETED|Overall Study||3
7987192|NCT00176865|19665140|P3|STARTED|Overall Study||6
7987193|NCT00176865|19665141|P2|STARTED|Overall Study||10
7987194|NCT00176865|19665142|P1|STARTED|Overall Study||3
7987195|NCT00176852|19665180|P3|NOT COMPLETED|Overall Study||0
7987196|NCT00176852|19665181|P2|NOT COMPLETED|Overall Study||0
7987197|NCT00176852|19665182|P1|NOT COMPLETED|Overall Study||0
7987198|NCT00176852|19665180|P3|COMPLETED|Overall Study||14
7987199|NCT00176852|19665181|P2|COMPLETED|Overall Study||5
7987200|NCT00176852|19665182|P1|COMPLETED|Overall Study||3
7987201|NCT00176852|19665180|P3|STARTED|Overall Study||14
7987202|NCT00176852|19665181|P2|STARTED|Overall Study||5
7987203|NCT00176852|19665182|P1|STARTED|Overall Study||3
7987204|NCT00176839|19665238|P1|NOT COMPLETED|Overall Study||0
7987205|NCT00176839|19665238|P1|COMPLETED|Overall Study||11
7987206|NCT00176839|19665238|P1|STARTED|Overall Study||11
7987207|NCT00176826|19665247|P1|NOT COMPLETED|Overall Study||0
7987208|NCT00176826|19665247|P1|COMPLETED|Overall Study||22
7987209|NCT00176826|19665247|P1|STARTED|Overall Study||22
7987210|NCT00176800|19665257|P1|NOT COMPLETED|Overall Study||0
7987211|NCT00176800|19665257|P1|COMPLETED|Overall Study||69
7987212|NCT00176800|19665257|P1|STARTED|Overall Study||69
7987213|NCT00176644|19665263|P1|NOT COMPLETED|Overall Study||1
7987214|NCT00176644|19665263|P1|COMPLETED|Overall Study||22
7987215|NCT00176644|19665263|P1|STARTED|Overall Study||23
7987216|NCT00176631|19665271|P1|NOT COMPLETED|Overall Study||0
7987217|NCT00176631|19665271|P1|COMPLETED|Overall Study||10
7987218|NCT00176631|19665271|P1|STARTED|Overall Study||10
7987219|NCT00176605|19665276|P1|NOT COMPLETED|Overall Study||2
7987220|NCT00176605|19665276|P1|COMPLETED|Overall Study||13
7987221|NCT00176605|19665276|P1|STARTED|Overall Study||15
7987222|NCT00176501|19665281|P1|NOT COMPLETED|Overall Study||0
7987223|NCT00176501|19665281|P1|COMPLETED|Overall Study||3
7987224|NCT00176501|19665281|P1|STARTED|Overall Study||3
7987225|NCT00176488|19665287|P1|NOT COMPLETED|Overall Study||1
7987226|NCT00176488|19665287|P1|COMPLETED|Overall Study||30
7987227|NCT00176488|19665287|P1|STARTED|Overall Study||31
7987228|NCT00176462|19665295|P2|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
7987229|NCT00176462|19665296|P1|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
7987230|NCT00176462|19665295|P2|COMPLETED|Continuation -up to 30mos Post Remission||26
7987231|NCT00176462|19665296|P1|COMPLETED|Continuation -up to 30mos Post Remission||19
7987232|NCT00176462|19665295|P2|STARTED|Continuation -up to 30mos Post Remission||26
7987233|NCT00176462|19665296|P1|STARTED|Continuation -up to 30mos Post Remission||19
7987234|NCT00176462|19665295|P2|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3
7987235|NCT00176462|19665296|P1|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1
7987236|NCT00176462|19665295|P2|COMPLETED|Intensive Continuation (8X8-week Cycles)||26
7987237|NCT00176462|19665296|P1|COMPLETED|Intensive Continuation (8X8-week Cycles)||19
7987238|NCT00176462|19665295|P2|STARTED|Intensive Continuation (8X8-week Cycles)||29
7987239|NCT00176462|19665296|P1|STARTED|Intensive Continuation (8X8-week Cycles)||20
7987240|NCT00176462|19665295|P2|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
7987241|NCT00176462|19665296|P1|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
7987242|NCT00176462|19665295|P2|COMPLETED|Delayed Intensification (8 Weeks)||29
7987243|NCT00176462|19665296|P1|COMPLETED|Delayed Intensification (8 Weeks)||20
7987244|NCT00176462|19665295|P2|STARTED|Delayed Intensification (8 Weeks)||29
7987245|NCT00176462|19665296|P1|STARTED|Delayed Intensification (8 Weeks)||20
7987246|NCT00176462|19665295|P2|NOT COMPLETED|Consolidation (12 Weeks)||5
7987247|NCT00176462|19665296|P1|NOT COMPLETED|Consolidation (12 Weeks)||0
7987248|NCT00176462|19665295|P2|COMPLETED|Consolidation (12 Weeks)||29
7987249|NCT00176462|19665296|P1|COMPLETED|Consolidation (12 Weeks)||20
7987250|NCT00176462|19665295|P2|STARTED|Consolidation (12 Weeks)||34
7987251|NCT00176462|19665296|P1|STARTED|Consolidation (12 Weeks)||20
7987252|NCT00176462|19665295|P2|NOT COMPLETED|Induction (4 Weeks)||5
7987253|NCT00176462|19665296|P1|NOT COMPLETED|Induction (4 Weeks)||1
7987254|NCT00176462|19665295|P2|COMPLETED|Induction (4 Weeks)||34
7987255|NCT00176462|19665296|P1|COMPLETED|Induction (4 Weeks)||20
7987256|NCT00176462|19665295|P2|STARTED|Induction (4 Weeks)||39
7987257|NCT00176462|19665296|P1|STARTED|Induction (4 Weeks)||21
7987258|NCT00176436|19665305|P2|NOT COMPLETED|Overall Study||5
7987259|NCT00176436|19665306|P1|NOT COMPLETED|Overall Study||6
7987260|NCT00176436|19665305|P2|COMPLETED|Overall Study||12
7987261|NCT00176436|19665306|P1|COMPLETED|Overall Study||14
7987262|NCT00176436|19665305|P2|STARTED|Overall Study||17
7987263|NCT00176436|19665306|P1|STARTED|Overall Study||20
7987264|NCT00176423|19665314|P2|NOT COMPLETED|Overall Study||6
7987265|NCT00176423|19665315|P1|NOT COMPLETED|Overall Study||7
7987266|NCT00176423|19665314|P2|COMPLETED|Overall Study||38
7987267|NCT00176423|19665315|P1|COMPLETED|Overall Study||35
7987268|NCT00176423|19665314|P2|STARTED|Overall Study||44
7987269|NCT00176423|19665315|P1|STARTED|Overall Study||42
7987270|NCT00176306|19665327|P1|NOT COMPLETED|Overall Study||0
7987271|NCT00176306|19665327|P1|COMPLETED|Overall Study||15
7987272|NCT00176306|19665327|P1|STARTED|Overall Study||15
7987273|NCT00176254|19665331|P1|NOT COMPLETED|Overall Study||1
7987274|NCT00176254|19665331|P1|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39
7987275|NCT00176254|19665331|P1|STARTED|Overall Study||40
7987276|NCT00176228|19665339|P1|NOT COMPLETED|Overall Study||2
7987277|NCT00176228|19665339|P1|COMPLETED|Overall Study|Study ended|46
7987278|NCT00176228|19665339|P1|STARTED|Overall Study|When study began|48
7987279|NCT00176202|19665346|P2|NOT COMPLETED|Overall Study||16
7987280|NCT00176202|19665347|P1|NOT COMPLETED|Overall Study||5
7987281|NCT00176202|19665346|P2|COMPLETED|Overall Study||17
7987282|NCT00176202|19665347|P1|COMPLETED|Overall Study||27
7987283|NCT00176202|19665346|P2|STARTED|Overall Study||33
7987284|NCT00176202|19665347|P1|STARTED|Overall Study||32
7987285|NCT00175916|19665359|P1|NOT COMPLETED|Overall Study||619
7987286|NCT00175916|19665359|P1|COMPLETED|Overall Study||234
7987287|NCT00175916|19665359|P1|STARTED|Overall Study||853
7987288|NCT00175877|19665368|P1|NOT COMPLETED|Overall Study||349
7987289|NCT00175877|19665368|P1|COMPLETED|Overall Study||497
7987290|NCT00175877|19665368|P1|STARTED|Overall Study||846
7987291|NCT00175825|19665403|P4|NOT COMPLETED|Overall Study||1
7987292|NCT00175825|19665404|P3|NOT COMPLETED|Overall Study||1
7987293|NCT00175825|19665405|P2|NOT COMPLETED|Overall Study||4
7987294|NCT00175825|19665406|P1|NOT COMPLETED|Overall Study||5
7987295|NCT00175825|19665403|P4|COMPLETED|Overall Study||51
7987296|NCT00175825|19665404|P3|COMPLETED|Overall Study||51
7987297|NCT00175825|19665405|P2|COMPLETED|Overall Study||46
7987298|NCT00175825|19665406|P1|COMPLETED|Overall Study||49
7987299|NCT00175825|19665403|P4|STARTED|Overall Study||52
7987300|NCT00175825|19665404|P3|STARTED|Overall Study||52
7987301|NCT00175825|19665405|P2|STARTED|Overall Study||50
7987302|NCT00175825|19665406|P1|STARTED|Overall Study||54
7987303|NCT00175019|19665459|P3|NOT COMPLETED|Overall Study||57
7987304|NCT00175019|19665460|P2|NOT COMPLETED|Overall Study||171
7987305|NCT00175019|19665461|P1|NOT COMPLETED|Overall Study||194
7987306|NCT00175019|19665459|P3|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35
7987307|NCT00175019|19665460|P2|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217
7987308|NCT00175019|19665461|P1|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412
7987309|NCT00175019|19665459|P3|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92
7987310|NCT00175019|19665460|P2|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388
7987311|NCT00175019|19665461|P1|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606
7987312|NCT00175006|19665505|P1|NOT COMPLETED|Overall Study||0
7987313|NCT00175006|19665505|P1|COMPLETED|Overall Study||13
7987314|NCT00175006|19665505|P1|STARTED|Overall Study||13
7987315|NCT00174967|19665514|P4|NOT COMPLETED|Overall Study||2
7987316|NCT00174967|19665515|P3|NOT COMPLETED|Overall Study||2
7987317|NCT00174967|19665516|P2|NOT COMPLETED|Overall Study||3
7987318|NCT00174967|19665517|P1|NOT COMPLETED|Overall Study||1
7987319|NCT00174967|19665514|P4|COMPLETED|Overall Study||36
7987320|NCT00174967|19665515|P3|COMPLETED|Overall Study||36
7987321|NCT00174967|19665516|P2|COMPLETED|Overall Study||37
7987322|NCT00174967|19665517|P1|COMPLETED|Overall Study||36
7987323|NCT00174967|19665514|P4|STARTED|Overall Study||38
7987324|NCT00174967|19665515|P3|STARTED|Overall Study||38
7987325|NCT00174967|19665516|P2|STARTED|Overall Study||40
7987326|NCT00174967|19665517|P1|STARTED|Overall Study||37
7987327|NCT00174954|19665563|P1|NOT COMPLETED|Overall Study||4
7987328|NCT00174954|19665563|P1|COMPLETED|Overall Study||28
7987329|NCT00174954|19665563|P1|STARTED|Overall Study||32
7987330|NCT00174941|19665571|P4|NOT COMPLETED|Overall Study||58
7987331|NCT00174941|19665572|P3|NOT COMPLETED|Overall Study||18
7987332|NCT00174941|19665573|P2|NOT COMPLETED|Overall Study||38
7987333|NCT00174941|19665574|P1|NOT COMPLETED|Overall Study||2
7987334|NCT00174941|19665571|P4|COMPLETED|Overall Study||58
7987335|NCT00174941|19665572|P3|COMPLETED|Overall Study||11
7987336|NCT00174941|19665573|P2|COMPLETED|Overall Study||41
7987337|NCT00174941|19665574|P1|COMPLETED|Overall Study||6
7987338|NCT00174941|19665571|P4|STARTED|Overall Study||116
7987339|NCT00174941|19665572|P3|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29
7987340|NCT00174941|19665573|P2|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79
7987341|NCT00174941|19665574|P1|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8
7987342|NCT00174915|19665649|P5|NOT COMPLETED|Overall Study||33
7987343|NCT00174915|19665650|P4|NOT COMPLETED|Overall Study||57
7987344|NCT00174915|19665651|P3|NOT COMPLETED|Overall Study||48
7987345|NCT00174915|19665652|P2|NOT COMPLETED|Overall Study||69
7987346|NCT00174915|19665653|P1|NOT COMPLETED|Overall Study||93
7987347|NCT00174915|19665649|P5|COMPLETED|Overall Study||101
7987348|NCT00174915|19665650|P4|COMPLETED|Overall Study||211
7987349|NCT00174915|19665651|P3|COMPLETED|Overall Study||86
7987350|NCT00174915|19665652|P2|COMPLETED|Overall Study||200
7987351|NCT00174915|19665653|P1|COMPLETED|Overall Study||174
7987352|NCT00174915|19665649|P5|STARTED|Overall Study||134
7987353|NCT00174915|19665650|P4|STARTED|Overall Study||268
7987354|NCT00174915|19665651|P3|STARTED|Overall Study||134
7987355|NCT00174915|19665652|P2|STARTED|Overall Study||269
7987356|NCT00174915|19665653|P1|STARTED|Overall Study||267
7987357|NCT00174785|19665712|P2|NOT COMPLETED|Overall Study||716
7987358|NCT00174785|19665713|P1|NOT COMPLETED|Overall Study||696
7987359|NCT00174785|19665712|P2|COMPLETED|Overall Study|completed study drug|1611
7987360|NCT00174785|19665713|P1|COMPLETED|Overall Study|completed study drug|1605
7987361|NCT00174785|19665712|P2|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327
7987362|NCT00174785|19665713|P1|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301
7987363|NCT00174460|19665729|P2|NOT COMPLETED|Overall Study||1
7987364|NCT00174460|19665730|P1|NOT COMPLETED|Overall Study||0
7987365|NCT00174460|19665729|P2|COMPLETED|Overall Study||14
7987366|NCT00174460|19665730|P1|COMPLETED|Overall Study||18
7987367|NCT00174460|19665729|P2|Received Study Treatment|Overall Study||14
7987368|NCT00174460|19665730|P1|Received Study Treatment|Overall Study||18
7987369|NCT00174460|19665729|P2|STARTED|Overall Study||15
7987370|NCT00174460|19665730|P1|STARTED|Overall Study||18
7987371|NCT00174447|19665776|P1|NOT COMPLETED|Overall Study||38
7987372|NCT00174447|19665776|P1|COMPLETED|Overall Study||5
7987373|NCT00174447|19665776|P1|STARTED|Overall Study||43
7987374|NCT00174382|19665785|P1|NOT COMPLETED|Overall Study||33
7987375|NCT00174382|19665785|P1|COMPLETED|Overall Study||116
7987376|NCT00174382|19665785|P1|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149
7987377|NCT00174291|19665804|P2|NOT COMPLETED|Overall Study||6
7987378|NCT00174291|19665805|P1|NOT COMPLETED|Overall Study||5
7987379|NCT00174291|19665804|P2|COMPLETED|Overall Study||4
7987380|NCT00174291|19665805|P1|COMPLETED|Overall Study||6
7987381|NCT00174291|19665804|P2|STARTED|Overall Study||10
7987382|NCT00174291|19665805|P1|STARTED|Overall Study||11
7987383|NCT00174265|19665835|P2|NOT COMPLETED|Overall Study||21
7987384|NCT00174265|19665836|P1|NOT COMPLETED|Overall Study||29
7987385|NCT00174265|19665835|P2|COMPLETED|Overall Study||89
7987386|NCT00174265|19665836|P1|COMPLETED|Overall Study||57
7987387|NCT00174265|19665835|P2|STARTED|Overall Study||110
7987388|NCT00174265|19665836|P1|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86
7987389|NCT00174252|19665844|P1|NOT COMPLETED|Overall Study||2
7987390|NCT00174252|19665844|P1|COMPLETED|Overall Study||55
7987391|NCT00174252|19665844|P1|STARTED|Overall Study||57
7987392|NCT00174187|19665879|P3|NOT COMPLETED|Period 2 (After 3 Years)||8
7987393|NCT00174187|19665880|P2|NOT COMPLETED|Period 2 (After 3 Years)||0
7987394|NCT00174187|19665881|P1|NOT COMPLETED|Period 2 (After 3 Years)||0
7987395|NCT00174187|19665879|P3|COMPLETED|Period 2 (After 3 Years)||13
7987396|NCT00174187|19665880|P2|COMPLETED|Period 2 (After 3 Years)||0
7987397|NCT00174187|19665881|P1|COMPLETED|Period 2 (After 3 Years)||0
7987398|NCT00174187|19665879|P3|STARTED|Period 2 (After 3 Years)||21
7987399|NCT00174187|19665880|P2|STARTED|Period 2 (After 3 Years)||0
7987400|NCT00174187|19665881|P1|STARTED|Period 2 (After 3 Years)||0
7987401|NCT00174187|19665879|P3|NOT COMPLETED|Between Period 1 and Period 2||5
7987402|NCT00174187|19665880|P2|NOT COMPLETED|Between Period 1 and Period 2||0
7987403|NCT00174187|19665881|P1|NOT COMPLETED|Between Period 1 and Period 2||0
7987404|NCT00174187|19665879|P3|COMPLETED|Between Period 1 and Period 2||21
7987405|NCT00174187|19665880|P2|COMPLETED|Between Period 1 and Period 2||0
7987406|NCT00174187|19665881|P1|COMPLETED|Between Period 1 and Period 2||0
7987407|NCT00174187|19665879|P3|Consented|Between Period 1 and Period 2||24
7987408|NCT00174187|19665880|P2|Consented|Between Period 1 and Period 2||0
7987409|NCT00174187|19665881|P1|Consented|Between Period 1 and Period 2||0
7987410|NCT00174187|19665879|P3|STARTED|Between Period 1 and Period 2||26
7987411|NCT00174187|19665880|P2|STARTED|Between Period 1 and Period 2||0
7987412|NCT00174187|19665881|P1|STARTED|Between Period 1 and Period 2||0
7987413|NCT00174187|19665879|P3|NOT COMPLETED|Period 1 (up to 3 Years)||0
7987414|NCT00174187|19665880|P2|NOT COMPLETED|Period 1 (up to 3 Years)||4
7987415|NCT00174187|19665881|P1|NOT COMPLETED|Period 1 (up to 3 Years)||0
7987416|NCT00174187|19665879|P3|COMPLETED|Period 1 (up to 3 Years)||0
7987417|NCT00174187|19665880|P2|COMPLETED|Period 1 (up to 3 Years)||11
7987418|NCT00174187|19665881|P1|COMPLETED|Period 1 (up to 3 Years)||15
7987419|NCT00174187|19665879|P3|STARTED|Period 1 (up to 3 Years)||0
7987420|NCT00174187|19665880|P2|STARTED|Period 1 (up to 3 Years)||15
7987421|NCT00174187|19665881|P1|STARTED|Period 1 (up to 3 Years)||15
7987422|NCT00172185|19665946|P4|NOT COMPLETED|Overall Study||4
7987423|NCT00172185|19665947|P3|NOT COMPLETED|Overall Study||5
7987424|NCT00172185|19665948|P2|NOT COMPLETED|Overall Study||2
7987425|NCT00172185|19665949|P1|NOT COMPLETED|Overall Study||0
7987426|NCT00172185|19665946|P4|COMPLETED|Overall Study||23
7987427|NCT00172185|19665947|P3|COMPLETED|Overall Study||20
7987428|NCT00172185|19665948|P2|COMPLETED|Overall Study||5
7987429|NCT00172185|19665949|P1|COMPLETED|Overall Study||6
7987430|NCT00172185|19665946|P4|STARTED|Overall Study||27
7987431|NCT00172185|19665947|P3|STARTED|Overall Study||25
7987432|NCT00172185|19665948|P2|STARTED|Overall Study||7
7987433|NCT00172185|19665949|P1|STARTED|Overall Study||6
7987434|NCT00172042|19665965|P2|NOT COMPLETED|Overall Study||125
7987435|NCT00172042|19665966|P1|NOT COMPLETED|Overall Study||158
7987436|NCT00172042|19665965|P2|COMPLETED|Overall Study||86
7987437|NCT00172042|19665966|P1|COMPLETED|Overall Study||68
7987438|NCT00172042|19665965|P2|STARTED|Overall Study||211
7987439|NCT00172042|19665966|P1|STARTED|Overall Study||226
7987440|NCT00171925|19665988|P2|NOT COMPLETED|Overall Study||31
7987441|NCT00171925|19665989|P1|NOT COMPLETED|Overall Study||30
7987442|NCT00171925|19665988|P2|COMPLETED|Overall Study||40
7987443|NCT00171925|19665989|P1|COMPLETED|Overall Study||42
7987444|NCT00171925|19665988|P2|STARTED|Overall Study||71
7987445|NCT00171925|19665989|P1|STARTED|Overall Study||72
7987446|NCT00171873|19666001|P2|NOT COMPLETED|Overall Study||3
7987447|NCT00171873|19666002|P1|NOT COMPLETED|Overall Study||9
7987448|NCT00171873|19666001|P2|COMPLETED|Overall Study||40
7987449|NCT00171873|19666002|P1|COMPLETED|Overall Study||33
7987450|NCT00171873|19666001|P2|STARTED|Overall Study||43
7987451|NCT00171873|19666002|P1|STARTED|Overall Study||42
7987452|NCT00171834|19666015|P7|NOT COMPLETED|Overall Study||4
7987453|NCT00171834|19666016|P6|NOT COMPLETED|Overall Study||35
7987454|NCT00171834|19666017|P5|NOT COMPLETED|Overall Study||8
7987455|NCT00171834|19666018|P4|NOT COMPLETED|Overall Study||12
7987456|NCT00171834|19666019|P3|NOT COMPLETED|Overall Study||12
7987457|NCT00171834|19666020|P2|NOT COMPLETED|Overall Study||12
7987458|NCT00171834|19666021|P1|NOT COMPLETED|Overall Study||6
7987459|NCT00171834|19666015|P7|COMPLETED|Overall Study||0
7987460|NCT00171834|19666016|P6|COMPLETED|Overall Study||0
7987461|NCT00171834|19666017|P5|COMPLETED|Overall Study||0
7987462|NCT00171834|19666018|P4|COMPLETED|Overall Study||0
7987463|NCT00171834|19666019|P3|COMPLETED|Overall Study||0
7987464|NCT00171834|19666020|P2|COMPLETED|Overall Study||0
7987465|NCT00171834|19666021|P1|COMPLETED|Overall Study||0
7987466|NCT00171834|19666015|P7|Completed 6 Cycles of Treatment|Overall Study||0
7987467|NCT00171834|19666016|P6|Completed 6 Cycles of Treatment|Overall Study||1
7987468|NCT00171834|19666017|P5|Completed 6 Cycles of Treatment|Overall Study||2
7987469|NCT00171834|19666018|P4|Completed 6 Cycles of Treatment|Overall Study||0
7987470|NCT00171834|19666019|P3|Completed 6 Cycles of Treatment|Overall Study||1
7987471|NCT00171834|19666020|P2|Completed 6 Cycles of Treatment|Overall Study||0
7987472|NCT00171834|19666021|P1|Completed 6 Cycles of Treatment|Overall Study||0
7987473|NCT00171834|19666015|P7|STARTED|Overall Study||4
7987474|NCT00171834|19666016|P6|STARTED|Overall Study||35
7987475|NCT00171834|19666017|P5|STARTED|Overall Study||8
7987476|NCT00171834|19666018|P4|STARTED|Overall Study||12
7987477|NCT00171834|19666019|P3|STARTED|Overall Study||12
7987478|NCT00171834|19666020|P2|STARTED|Overall Study||12
7987479|NCT00171834|19666021|P1|STARTED|Overall Study||6
7987480|NCT00171704|19666061|P2|NOT COMPLETED|Overall Study||49
7987481|NCT00171704|19666062|P1|NOT COMPLETED|Overall Study||44
7987482|NCT00171704|19666061|P2|COMPLETED|Overall Study||81
7987483|NCT00171704|19666062|P1|COMPLETED|Overall Study||89
7987484|NCT00171704|19666061|P2|STARTED|Overall Study||130
7987485|NCT00171704|19666062|P1|STARTED|Overall Study||133
7987486|NCT00171340|19666084|P2|NOT COMPLETED|Overall Study||135
7987487|NCT00171340|19666085|P1|NOT COMPLETED|Overall Study||124
7987488|NCT00171340|19666084|P2|COMPLETED|Overall Study||398
7987489|NCT00171340|19666085|P1|COMPLETED|Overall Study||408
7987490|NCT00171340|19666084|P2|STARTED|Overall Study||533
7987491|NCT00171340|19666085|P1|STARTED|Overall Study||532
7987492|NCT00171314|19666101|P2|NOT COMPLETED|Overall Study||78
7987493|NCT00171314|19666102|P1|NOT COMPLETED|Overall Study||91
7987494|NCT00171314|19666101|P2|COMPLETED|Overall Study||186
7987495|NCT00171314|19666102|P1|COMPLETED|Overall Study||172
7987496|NCT00171314|19666101|P2|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269
7987497|NCT00171314|19666102|P1|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254
7987498|NCT00171314|19666101|P2|STARTED|Overall Study||264
7987499|NCT00171314|19666102|P1|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263
7987500|NCT00171301|19666118|P2|NOT COMPLETED|Overall Study||9
7987501|NCT00171301|19666119|P1|NOT COMPLETED|Overall Study||8
7987502|NCT00171301|19666118|P2|COMPLETED|Overall Study||62
7987503|NCT00171301|19666119|P1|COMPLETED|Overall Study||154
7987504|NCT00171301|19666118|P2|Received Deferasirox|Overall Study||69
7987505|NCT00171301|19666119|P1|Received Deferasirox|Overall Study||162
7987506|NCT00171301|19666118|P2|STARTED|Overall Study|2 participants in this group never received deferasirox.|71
7987507|NCT00171301|19666119|P1|STARTED|Overall Study||162
7987508|NCT00171210|19666132|P2|NOT COMPLETED|Overall Study||115
7987509|NCT00171210|19666133|P1|NOT COMPLETED|Overall Study||69
7987510|NCT00171210|19666132|P2|COMPLETED|Overall Study||181
7987511|NCT00171210|19666133|P1|COMPLETED|Overall Study||190
7987512|NCT00171210|19666132|P2|STARTED EXTENSION STUDY|Overall Study||247
7987513|NCT00171210|19666133|P1|STARTED EXTENSION STUDY|Overall Study||259
7987514|NCT00171210|19666132|P2|STARTED|Overall Study||296
7987515|NCT00171210|19666133|P1|STARTED|Overall Study||259
7987516|NCT00171054|19666163|P2|NOT COMPLETED|Overall Study||12
7987517|NCT00171054|19666164|P1|NOT COMPLETED|Overall Study||10
7987518|NCT00171054|19666163|P2|COMPLETED|Overall Study||50
7987519|NCT00171054|19666164|P1|COMPLETED|Overall Study||53
7987520|NCT00171054|19666163|P2|STARTED|Overall Study||62
7987521|NCT00171054|19666164|P1|STARTED|Overall Study||63
7987522|NCT00170950|19666196|P2|NOT COMPLETED|Overall Study||910
7987523|NCT00170950|19666197|P1|NOT COMPLETED|Overall Study||885
7987524|NCT00170950|19666196|P2|COMPLETED|Overall Study||4852
7987525|NCT00170950|19666197|P1|COMPLETED|Overall Study||4859
7987526|NCT00170950|19666196|P2|STARTED|Overall Study||5762
7987527|NCT00170950|19666197|P1|STARTED|Overall Study||5744
7987528|NCT00170846|19666210|P3|NOT COMPLETED|Overall Study||13
7987529|NCT00170846|19666211|P2|NOT COMPLETED|Overall Study||19
7987530|NCT00170846|19666212|P1|NOT COMPLETED|Overall Study||11
7987531|NCT00170846|19666210|P3|COMPLETED|Overall Study||131
7987532|NCT00170846|19666211|P2|COMPLETED|Overall Study||108
7987533|NCT00170846|19666212|P1|COMPLETED|Overall Study||112
7987534|NCT00170846|19666210|P3|STARTED|Overall Study||144
7987535|NCT00170846|19666211|P2|STARTED|Overall Study||127
7987536|NCT00170846|19666212|P1|STARTED|Overall Study||123
7987537|NCT00170625|19666226|P1|NOT COMPLETED|Overall Study||0
7987538|NCT00170625|19666226|P1|COMPLETED|Overall Study||26
7987539|NCT00170625|19666226|P1|STARTED|Overall Study||26
7987540|NCT00170157|19666231|P2|NOT COMPLETED|Treatment Period 2 Crossover||0
7987541|NCT00170157|19666232|P1|NOT COMPLETED|Treatment Period 2 Crossover||0
7987542|NCT00170157|19666231|P2|COMPLETED|Treatment Period 2 Crossover||41
7987543|NCT00170157|19666232|P1|COMPLETED|Treatment Period 2 Crossover||0
7987544|NCT00170157|19666231|P2|STARTED|Treatment Period 2 Crossover||41
7987545|NCT00170157|19666232|P1|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0
7987546|NCT00170157|19666231|P2|NOT COMPLETED|Washout Period of 14 Days||17
7987547|NCT00170157|19666232|P1|NOT COMPLETED|Washout Period of 14 Days||0
7987548|NCT00170157|19666231|P2|COMPLETED|Washout Period of 14 Days||41
7987549|NCT00170157|19666232|P1|COMPLETED|Washout Period of 14 Days||0
7987550|NCT00170157|19666231|P2|STARTED|Washout Period of 14 Days||58
7987551|NCT00170157|19666232|P1|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0
7987552|NCT00170157|19666231|P2|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
7987553|NCT00170157|19666232|P1|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
7987554|NCT00170157|19666231|P2|COMPLETED|Treatment Period 1 Initial Randomization||58
7987555|NCT00170157|19666232|P1|COMPLETED|Treatment Period 1 Initial Randomization||54
7987556|NCT00170157|19666231|P2|STARTED|Treatment Period 1 Initial Randomization||58
7987557|NCT00170157|19666232|P1|STARTED|Treatment Period 1 Initial Randomization||54
7987558|NCT00169442|19666244|P6|NOT COMPLETED|Overall Study||2
7987559|NCT00169442|19666245|P5|NOT COMPLETED|Overall Study||1
7987560|NCT00169442|19666246|P4|NOT COMPLETED|Overall Study||0
7987561|NCT00169442|19666247|P3|NOT COMPLETED|Overall Study||1
7987562|NCT00169442|19666248|P2|NOT COMPLETED|Overall Study||1
7987563|NCT00169442|19666249|P1|NOT COMPLETED|Overall Study||0
7987564|NCT00169442|19666244|P6|COMPLETED|Overall Study||41
7987565|NCT00169442|19666245|P5|COMPLETED|Overall Study||41
7987566|NCT00169442|19666246|P4|COMPLETED|Overall Study||250
7987567|NCT00169442|19666247|P3|COMPLETED|Overall Study||166
7987568|NCT00169442|19666248|P2|COMPLETED|Overall Study||123
7987569|NCT00169442|19666249|P1|COMPLETED|Overall Study||119
7987570|NCT00169442|19666244|P6|STARTED|Overall Study||43
7987571|NCT00169442|19666245|P5|STARTED|Overall Study||42
7987572|NCT00169442|19666246|P4|STARTED|Overall Study||250
7987573|NCT00169442|19666247|P3|STARTED|Overall Study||167
7987574|NCT00169442|19666248|P2|STARTED|Overall Study||124
7987575|NCT00169442|19666249|P1|STARTED|Overall Study||119
7987576|NCT00169104|19666358|P2|NOT COMPLETED|Overall Study||2
7987577|NCT00169104|19666359|P1|NOT COMPLETED|Overall Study||2
7987578|NCT00169104|19666358|P2|COMPLETED|Overall Study||8
7987579|NCT00169104|19666359|P1|COMPLETED|Overall Study||11
7987580|NCT00169104|19666358|P2|STARTED|Overall Study||10
7987581|NCT00169104|19666359|P1|STARTED|Overall Study||13
7987582|NCT00168844|19666373|P3|NOT COMPLETED|Overall Study||91
7987583|NCT00168844|19666374|P2|NOT COMPLETED|Overall Study||55
7987584|NCT00168844|19666375|P1|NOT COMPLETED|Overall Study||55
7987585|NCT00168844|19666373|P3|COMPLETED|Overall Study||228
7987586|NCT00168844|19666374|P2|COMPLETED|Overall Study||277
7987587|NCT00168844|19666375|P1|COMPLETED|Overall Study||277
7987588|NCT00168844|19666373|P3|STARTED|Overall Study||319
7987589|NCT00168844|19666374|P2|STARTED|Overall Study||332
7987590|NCT00168844|19666375|P1|STARTED|Overall Study||332
7987591|NCT00168831|19666557|P3|NOT COMPLETED|Overall Study||114
7987592|NCT00168831|19666558|P2|NOT COMPLETED|Overall Study||81
7987593|NCT00168831|19666559|P1|NOT COMPLETED|Overall Study||60
7987594|NCT00168831|19666557|P3|COMPLETED|Overall Study||220
7987595|NCT00168831|19666558|P2|COMPLETED|Overall Study||254
7987596|NCT00168831|19666559|P1|COMPLETED|Overall Study||278
7987597|NCT00168831|19666557|P3|STARTED|Overall Study||334
7987598|NCT00168831|19666558|P2|STARTED|Overall Study||335
7987599|NCT00168831|19666559|P1|STARTED|Overall Study||338
7987600|NCT00168818|19666741|P3|NOT COMPLETED|Treatment||133
7987601|NCT00168818|19666742|P2|NOT COMPLETED|Treatment||151
7987602|NCT00168818|19666743|P1|NOT COMPLETED|Treatment||133
7987603|NCT00168818|19666741|P3|COMPLETED|Treatment||1021
7987604|NCT00168818|19666742|P2|COMPLETED|Treatment||1012
7987605|NCT00168818|19666743|P1|COMPLETED|Treatment||1013
7987606|NCT00168818|19666741|P3|STARTED|Treatment||1154
7987607|NCT00168818|19666742|P2|STARTED|Treatment||1163
7987608|NCT00168818|19666743|P1|STARTED|Treatment||1146
7987609|NCT00168818|19666741|P3|NOT COMPLETED|Overall Study||124
7987610|NCT00168818|19666742|P2|NOT COMPLETED|Overall Study||109
7987611|NCT00168818|19666743|P1|NOT COMPLETED|Overall Study||117
7987612|NCT00168818|19666741|P3|COMPLETED|Overall Study||1030
7987613|NCT00168818|19666742|P2|COMPLETED|Overall Study||1054
7987614|NCT00168818|19666743|P1|COMPLETED|Overall Study||1029
7987615|NCT00168818|19666741|P3|STARTED|Overall Study||1154
7987616|NCT00168818|19666742|P2|STARTED|Overall Study||1163
7987617|NCT00168818|19666743|P1|STARTED|Overall Study||1146
7987618|NCT00168805|19666787|P3|NOT COMPLETED|Treatment||62
7987619|NCT00168805|19666788|P2|NOT COMPLETED|Treatment||56
7987620|NCT00168805|19666789|P1|NOT COMPLETED|Treatment||49
7987621|NCT00168805|19666787|P3|COMPLETED|Treatment||632
7987622|NCT00168805|19666788|P2|COMPLETED|Treatment||647
7987623|NCT00168805|19666789|P1|COMPLETED|Treatment||630
7987624|NCT00168805|19666787|P3|STARTED|Treatment||694
7987625|NCT00168805|19666788|P2|STARTED|Treatment||703
7987626|NCT00168805|19666789|P1|STARTED|Treatment||679
7987627|NCT00168805|19666787|P3|NOT COMPLETED|Overall Study||78
7987628|NCT00168805|19666788|P2|NOT COMPLETED|Overall Study||78
7987629|NCT00168805|19666789|P1|NOT COMPLETED|Overall Study||71
7987630|NCT00168805|19666787|P3|COMPLETED|Overall Study||616
7987631|NCT00168805|19666788|P2|COMPLETED|Overall Study||625
7987632|NCT00168805|19666789|P1|COMPLETED|Overall Study||608
7987633|NCT00168805|19666787|P3|STARTED|Overall Study||694
7987634|NCT00168805|19666788|P2|STARTED|Overall Study||703
7987635|NCT00168805|19666789|P1|STARTED|Overall Study||679
7987636|NCT00168454|19666836|P6|NOT COMPLETED|Overall Study||6
7987637|NCT00168454|19666837|P5|NOT COMPLETED|Overall Study||6
7987638|NCT00168454|19666838|P4|NOT COMPLETED|Overall Study||9
7987639|NCT00168454|19666839|P3|NOT COMPLETED|Overall Study||6
7987640|NCT00168454|19666840|P2|NOT COMPLETED|Overall Study||7
7987641|NCT00168454|19666841|P1|NOT COMPLETED|Overall Study||7
7987642|NCT00168454|19666836|P6|COMPLETED|Overall Study||50
7987643|NCT00168454|19666837|P5|COMPLETED|Overall Study||47
7987644|NCT00168454|19666838|P4|COMPLETED|Overall Study||40
7987645|NCT00168454|19666839|P3|COMPLETED|Overall Study||48
7987646|NCT00168454|19666840|P2|COMPLETED|Overall Study||50
7987647|NCT00168454|19666841|P1|COMPLETED|Overall Study||37
7987648|NCT00168454|19666836|P6|STARTED|Overall Study||56
7987649|NCT00168454|19666837|P5|STARTED|Overall Study||53
7987650|NCT00168454|19666838|P4|STARTED|Overall Study||49
7987651|NCT00168454|19666839|P3|STARTED|Overall Study||54
7987652|NCT00168454|19666840|P2|STARTED|Overall Study||57
7987653|NCT00168454|19666841|P1|STARTED|Overall Study||44
7987654|NCT00168428|19666887|P2|NOT COMPLETED|Open-Label Phase (OL)||68
7987655|NCT00168428|19666888|P1|NOT COMPLETED|Open-Label Phase (OL)||44
7987656|NCT00168428|19666887|P2|COMPLETED|Open-Label Phase (OL)||261
7987657|NCT00168428|19666888|P1|COMPLETED|Open-Label Phase (OL)||261
7987658|NCT00168428|19666887|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329
7987659|NCT00168428|19666888|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305
7987660|NCT00168428|19666887|P2|NOT COMPLETED|Double-Blind Phase (DB)||24
7987661|NCT00168428|19666888|P1|NOT COMPLETED|Double-Blind Phase (DB)||36
7987662|NCT00168428|19666887|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334
7987663|NCT00168428|19666888|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311
7987664|NCT00168428|19666887|P2|STARTED|Double-Blind Phase (DB)||358
7987665|NCT00168428|19666888|P1|STARTED|Double-Blind Phase (DB)||347
7987666|NCT00168389|19666907|P3|NOT COMPLETED|Overall Study||95
7987667|NCT00168389|19666908|P2|NOT COMPLETED|Overall Study||48
7987668|NCT00168389|19666909|P1|NOT COMPLETED|Overall Study||56
7987669|NCT00168389|19666907|P3|COMPLETED|Overall Study||70
7987670|NCT00168389|19666908|P2|COMPLETED|Overall Study||118
7987671|NCT00168389|19666909|P1|COMPLETED|Overall Study||107
7987672|NCT00168389|19666907|P3|STARTED|Overall Study||165
7987673|NCT00168389|19666908|P2|STARTED|Overall Study||166
7987674|NCT00168389|19666909|P1|STARTED|Overall Study||163
7987675|NCT00168337|19666938|P3|NOT COMPLETED|Overall Study||103
7987676|NCT00168337|19666939|P2|NOT COMPLETED|Overall Study||69
7987677|NCT00168337|19666940|P1|NOT COMPLETED|Overall Study||70
7987678|NCT00168337|19666938|P3|COMPLETED|Overall Study||82
7987679|NCT00168337|19666939|P2|COMPLETED|Overall Study||112
7987680|NCT00168337|19666940|P1|COMPLETED|Overall Study||118
7987681|NCT00168337|19666938|P3|STARTED|Overall Study||185
7987682|NCT00168337|19666939|P2|STARTED|Overall Study||181
7987683|NCT00168337|19666940|P1|STARTED|Overall Study||188
7987684|NCT00168324|19666969|P3|NOT COMPLETED|Open-Label Period||6
7987685|NCT00168324|19666970|P2|NOT COMPLETED|Open-Label Period||8
7987686|NCT00168324|19666971|P1|NOT COMPLETED|Open-Label Period||4
7987687|NCT00168324|19666969|P3|COMPLETED|Open-Label Period||152
7987688|NCT00168324|19666970|P2|COMPLETED|Open-Label Period||147
7987689|NCT00168324|19666971|P1|COMPLETED|Open-Label Period||160
7987690|NCT00168324|19666969|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158
7987691|NCT00168324|19666970|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155
7987692|NCT00168324|19666971|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164
7987693|NCT00168324|19666969|P3|NOT COMPLETED|Double-Blind Period||13
7987694|NCT00168324|19666970|P2|NOT COMPLETED|Double-Blind Period||7
7987695|NCT00168324|19666971|P1|NOT COMPLETED|Double-Blind Period||12
7987696|NCT00168324|19666969|P3|COMPLETED|Double-Blind Period||189
7987697|NCT00168324|19666970|P2|COMPLETED|Double-Blind Period||189
7987698|NCT00168324|19666971|P1|COMPLETED|Double-Blind Period||189
7987699|NCT00168324|19666969|P3|STARTED|Double-Blind Period||202
7987700|NCT00168324|19666970|P2|STARTED|Double-Blind Period||196
7987701|NCT00168324|19666971|P1|STARTED|Double-Blind Period||201
7987702|NCT00168311|19666993|P2|NOT COMPLETED|Overall Study||2
7987703|NCT00168311|19666994|P1|NOT COMPLETED|Overall Study||0
7987704|NCT00168311|19666993|P2|COMPLETED|Overall Study||8
7987705|NCT00168311|19666994|P1|COMPLETED|Overall Study||12
7987706|NCT00168311|19666993|P2|STARTED|Overall Study||10
7987707|NCT00168311|19666994|P1|STARTED|Overall Study||12
7987708|NCT00168298|19667003|P3|NOT COMPLETED|Open-Label Period||8
7987709|NCT00168298|19667004|P2|NOT COMPLETED|Open-Label Period||5
7987710|NCT00168298|19667005|P1|NOT COMPLETED|Open-Label Period||7
7987711|NCT00168298|19667003|P3|COMPLETED|Open-Label Period||160
7987712|NCT00168298|19667004|P2|COMPLETED|Open-Label Period||168
7987713|NCT00168298|19667005|P1|COMPLETED|Open-Label Period||172
7987714|NCT00168298|19667003|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168
7987715|NCT00168298|19667004|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173
7987716|NCT00168298|19667005|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179
7987717|NCT00168298|19667003|P3|NOT COMPLETED|Double-Blind Period||15
7987718|NCT00168298|19667004|P2|NOT COMPLETED|Double-Blind Period||12
7987719|NCT00168298|19667005|P1|NOT COMPLETED|Double-Blind Period||12
7987720|NCT00168298|19667003|P3|COMPLETED|Double-Blind Period||209
7987721|NCT00168298|19667004|P2|COMPLETED|Double-Blind Period||206
7987722|NCT00168298|19667005|P1|COMPLETED|Double-Blind Period||214
7987723|NCT00168298|19667003|P3|STARTED|Double-Blind Period||224
7987724|NCT00168298|19667004|P2|STARTED|Double-Blind Period||218
7987725|NCT00168298|19667005|P1|STARTED|Double-Blind Period||226
7987726|NCT00168103|19667025|P4|NOT COMPLETED|Overall Study||0
7987727|NCT00168103|19667026|P3|NOT COMPLETED|Overall Study||1
7987728|NCT00168103|19667027|P2|NOT COMPLETED|Overall Study||5
7987729|NCT00168103|19667028|P1|NOT COMPLETED|Overall Study||2
7987730|NCT00168103|19667025|P4|COMPLETED|Overall Study||1
7987731|NCT00168103|19667026|P3|COMPLETED|Overall Study||41
7987732|NCT00168103|19667027|P2|COMPLETED|Overall Study||38
7987733|NCT00168103|19667028|P1|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38
7987734|NCT00168103|19667025|P4|STARTED|Overall Study||1
7987735|NCT00168103|19667026|P3|STARTED|Overall Study||42
7987736|NCT00168103|19667027|P2|STARTED|Overall Study||43
7987737|NCT00168103|19667028|P1|STARTED|Overall Study||40
7987738|NCT00168064|19667050|P2|NOT COMPLETED|Overall Study||44
7987739|NCT00168064|19667051|P1|NOT COMPLETED|Overall Study||49
7987740|NCT00168064|19667050|P2|COMPLETED|Overall Study||86
7987741|NCT00168064|19667051|P1|COMPLETED|Overall Study||81
7987742|NCT00168064|19667050|P2|STARTED|Overall Study|127 participants received AP formulation|130
7987743|NCT00168064|19667051|P1|STARTED|Overall Study|128 participants received PG formulation|130
7987744|NCT00168038|19667059|P1|NOT COMPLETED|Overall Study||2
7987745|NCT00168038|19667059|P1|COMPLETED|Overall Study||55
7987746|NCT00168038|19667059|P1|STARTED|Overall Study||57
7987747|NCT00167934|19667073|P2|NOT COMPLETED|Overall Study||0
7987748|NCT00167934|19667074|P1|NOT COMPLETED|Overall Study||0
7987749|NCT00167934|19667073|P2|COMPLETED|Overall Study||82
7987750|NCT00167934|19667074|P1|COMPLETED|Overall Study||82
7987751|NCT00167934|19667073|P2|STARTED|Overall Study||82
7987752|NCT00167934|19667074|P1|STARTED|Overall Study||82
7987753|NCT00167778|19667082|P1|NOT COMPLETED|Overall Study||1
7987754|NCT00167778|19667082|P1|COMPLETED|Overall Study||10
7987755|NCT00167778|19667082|P1|STARTED|Overall Study||11
7987756|NCT00167661|19667131|P1|NOT COMPLETED|Overall Study||0
7987757|NCT00167661|19667131|P1|COMPLETED|Overall Study||33
7987758|NCT00167661|19667131|P1|STARTED|Overall Study||33
7987759|NCT00167544|19667146|P2|NOT COMPLETED|Overall Study||0
7987760|NCT00167544|19667147|P1|NOT COMPLETED|Overall Study||1
7987761|NCT00167544|19667146|P2|COMPLETED|Overall Study||33
7987762|NCT00167544|19667147|P1|COMPLETED|Overall Study||30
7987763|NCT00167544|19667146|P2|STARTED|Overall Study||33
7987764|NCT00167544|19667147|P1|STARTED|Overall Study||31
7987765|NCT00167414|19667161|P1|NOT COMPLETED|Overall Study||10
7987766|NCT00167414|19667161|P1|COMPLETED|Overall Study||39
7987767|NCT00167414|19667161|P1|STARTED|Overall Study||49
7987768|NCT00167388|19667173|P4|NOT COMPLETED|Overall Study||0
7987769|NCT00167388|19667174|P3|NOT COMPLETED|Overall Study||0
7987770|NCT00167388|19667175|P2|NOT COMPLETED|Overall Study||0
7987771|NCT00167388|19667176|P1|NOT COMPLETED|Overall Study||0
7987772|NCT00167388|19667173|P4|COMPLETED|Overall Study||6
7987773|NCT00167388|19667174|P3|COMPLETED|Overall Study||6
7987774|NCT00167388|19667175|P2|COMPLETED|Overall Study||5
7987775|NCT00167388|19667176|P1|COMPLETED|Overall Study||5
7987776|NCT00167388|19667173|P4|Completed Doppler Study|Overall Study||6
7987777|NCT00167388|19667174|P3|Completed Doppler Study|Overall Study||6
7987778|NCT00167388|19667175|P2|Completed Doppler Study|Overall Study||5
7987779|NCT00167388|19667176|P1|Completed Doppler Study|Overall Study||5
7987780|NCT00167388|19667173|P4|STARTED|Overall Study||6
7987781|NCT00167388|19667174|P3|STARTED|Overall Study||6
7987782|NCT00167388|19667175|P2|STARTED|Overall Study||5
7987783|NCT00167388|19667176|P1|STARTED|Overall Study||5
7987784|NCT00167310|19667186|P2|NOT COMPLETED|Overall Study||10
7987785|NCT00167310|19667187|P1|NOT COMPLETED|Overall Study||8
7987786|NCT00167310|19667186|P2|COMPLETED|Overall Study||18
7987787|NCT00167310|19667187|P1|COMPLETED|Overall Study||21
7987788|NCT00167310|19667186|P2|STARTED|Overall Study||28
7987789|NCT00167310|19667187|P1|STARTED|Overall Study||29
7987790|NCT00167245|19667197|P2|NOT COMPLETED|Overall Study||41
7987791|NCT00167245|19667198|P1|NOT COMPLETED|Overall Study||29
7987792|NCT00167245|19667197|P2|COMPLETED|Overall Study||46
7987793|NCT00167245|19667198|P1|COMPLETED|Overall Study||54
7987794|NCT00167245|19667197|P2|STARTED|Overall Study||87
7987795|NCT00167245|19667198|P1|STARTED|Overall Study||83
7987796|NCT00167206|19667210|P1|NOT COMPLETED|Overall Study||0
7987797|NCT00167206|19667210|P1|COMPLETED|Overall Study||16
7987798|NCT00167206|19667210|P1|STARTED|Overall Study||16
7987799|NCT00167180|19667224|P2|NOT COMPLETED|Overall Study||0
7987800|NCT00167180|19667225|P1|NOT COMPLETED|Overall Study||0
7987801|NCT00167180|19667224|P2|COMPLETED|Overall Study||57
7987802|NCT00167180|19667225|P1|COMPLETED|Overall Study||0
7987803|NCT00167180|19667224|P2|STARTED|Overall Study||57
7987804|NCT00167180|19667225|P1|STARTED|Overall Study||0
7987805|NCT00167102|19667241|P2|NOT COMPLETED|Overall Study||0
7987806|NCT00167102|19667242|P1|NOT COMPLETED|Overall Study||0
7987807|NCT00167102|19667241|P2|COMPLETED|Overall Study||22
7987808|NCT00167102|19667242|P1|COMPLETED|Overall Study||23
7987809|NCT00167102|19667241|P2|STARTED|Overall Study||22
7987810|NCT00167102|19667242|P1|STARTED|Overall Study||23
7987811|NCT00166712|19667252|P2|NOT COMPLETED|Overall Study||5
7987812|NCT00166712|19667253|P1|NOT COMPLETED|Overall Study||2
7987813|NCT00166712|19667252|P2|COMPLETED|Overall Study|Completed study participation.|11
7987814|NCT00166712|19667253|P1|COMPLETED|Overall Study|Completed study participation.|22
7987815|NCT00166712|19667252|P2|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0
7987816|NCT00166712|19667253|P1|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0
7987817|NCT00166712|19667252|P2|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0
7987818|NCT00166712|19667253|P1|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3
7987819|NCT00166712|19667252|P2|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12
7987820|NCT00166712|19667253|P1|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19
7987821|NCT00166712|19667252|P2|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12
7987822|NCT00166712|19667253|P1|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22
7987823|NCT00166712|19667252|P2|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16
7987824|NCT00166712|19667253|P1|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24
7987825|NCT00166517|19667270|P2|NOT COMPLETED|Overall Study||2
7987826|NCT00166517|19667271|P1|NOT COMPLETED|Overall Study||5
7987827|NCT00166517|19667270|P2|COMPLETED|Overall Study||61
7987828|NCT00166517|19667271|P1|COMPLETED|Overall Study||110
7987829|NCT00166517|19667270|P2|Vaccinated at Visit 3|Overall Study||61
7987830|NCT00166517|19667271|P1|Vaccinated at Visit 3|Overall Study||110
7987831|NCT00166517|19667270|P2|Vaccinated at Visit 2|Overall Study||61
7987832|NCT00166517|19667271|P1|Vaccinated at Visit 2|Overall Study||112
7987833|NCT00166517|19667270|P2|Vaccinated at Visit 1|Overall Study||63
7987834|NCT00166517|19667271|P1|Vaccinated at Visit 1|Overall Study||115
7987835|NCT00166517|19667270|P2|STARTED|Overall Study||63
7987836|NCT00166517|19667271|P1|STARTED|Overall Study||115
7987837|NCT00166504|19667281|P2|NOT COMPLETED|Overall Study||4
7987838|NCT00166504|19667282|P1|NOT COMPLETED|Overall Study||5
7987839|NCT00166504|19667281|P2|COMPLETED|Overall Study||91
7987840|NCT00166504|19667282|P1|COMPLETED|Overall Study||103
7987841|NCT00166504|19667281|P2|STARTED|Overall Study||95
7987842|NCT00166504|19667282|P1|STARTED|Overall Study||108
7987843|NCT00166439|19667288|P1|NOT COMPLETED|Overall Study||5
7987844|NCT00166439|19667288|P1|COMPLETED|Overall Study||45
7987845|NCT00166439|19667288|P1|STARTED|Overall Study||50
7987846|NCT00166361|19667296|P2|NOT COMPLETED|Overall Study||0
7987847|NCT00166361|19667297|P1|NOT COMPLETED|Overall Study||0
7987848|NCT00166361|19667296|P2|COMPLETED|Overall Study||10
7987849|NCT00166361|19667297|P1|COMPLETED|Overall Study||14
7987850|NCT00166361|19667296|P2|STARTED|Overall Study||10
7987851|NCT00166361|19667297|P1|STARTED|Overall Study||14
7987852|NCT00166296|19667305|P2|NOT COMPLETED|Overall Study||9
7987853|NCT00166296|19667306|P1|NOT COMPLETED|Overall Study||7
7987854|NCT00166296|19667305|P2|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57
7987855|NCT00166296|19667306|P1|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60
7987856|NCT00166296|19667305|P2|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63
7987857|NCT00166296|19667306|P1|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66
7987858|NCT00166296|19667305|P2|STARTED|Overall Study|Randomized patients|66
7987859|NCT00166296|19667306|P1|STARTED|Overall Study|Randomized patients|67
7987860|NCT00166205|19667318|P1|NOT COMPLETED|Overall Study||48
7987861|NCT00166205|19667318|P1|COMPLETED|Overall Study||228
7987862|NCT00166205|19667318|P1|Intervention - SAGB Surgery|Overall Study||276
7987863|NCT00166205|19667318|P1|STARTED|Overall Study||276
7987864|NCT00166166|19667334|P2|NOT COMPLETED|Overall Study||0
7987865|NCT00166166|19667335|P1|NOT COMPLETED|Overall Study||0
7987866|NCT00166166|19667334|P2|COMPLETED|Overall Study||71
7987867|NCT00166166|19667335|P1|COMPLETED|Overall Study||103
7987868|NCT00166166|19667334|P2|STARTED|Overall Study||71
7987869|NCT00166166|19667335|P1|STARTED|Overall Study||103
7987870|NCT00166114|19667358|P2|NOT COMPLETED|Overall Study||6
7987871|NCT00166114|19667359|P1|NOT COMPLETED|Overall Study||14
7987872|NCT00166114|19667358|P2|COMPLETED|Overall Study||13
7987873|NCT00166114|19667359|P1|COMPLETED|Overall Study||7
7987874|NCT00166114|19667358|P2|STARTED|Overall Study||19
7987875|NCT00166114|19667359|P1|STARTED|Overall Study||21
7987876|NCT00166036|19667367|P2|NOT COMPLETED|Overall Study||0
7987877|NCT00166036|19667368|P1|NOT COMPLETED|Overall Study||0
7987878|NCT00166036|19667367|P2|COMPLETED|Overall Study||19
7987879|NCT00166036|19667368|P1|COMPLETED|Overall Study||17
7987880|NCT00166036|19667367|P2|STARTED|Overall Study||19
7987881|NCT00166036|19667368|P1|STARTED|Overall Study||17
7987882|NCT00165984|19667376|P1|NOT COMPLETED|Overall Study||15
7987883|NCT00165984|19667376|P1|COMPLETED|Overall Study||150
7987884|NCT00165984|19667376|P1|STARTED|Overall Study||165
7987885|NCT00165958|19667385|P2|NOT COMPLETED|Overall Study||2
7987886|NCT00165958|19667386|P1|NOT COMPLETED|Overall Study||1
7987887|NCT00165958|19667385|P2|COMPLETED|Overall Study||19
7987888|NCT00165958|19667386|P1|COMPLETED|Overall Study||18
7987889|NCT00165958|19667385|P2|STARTED|Overall Study||21
7987890|NCT00165958|19667386|P1|STARTED|Overall Study||19
7987891|NCT00165841|19667394|P2|NOT COMPLETED|Overall Study||62
7987892|NCT00165841|19667395|P1|NOT COMPLETED|Overall Study||30
7987893|NCT00165841|19667394|P2|COMPLETED|Overall Study||35
7987894|NCT00165841|19667395|P1|COMPLETED|Overall Study||73
7987895|NCT00165841|19667394|P2|STARTED|Overall Study||97
7987896|NCT00165841|19667395|P1|STARTED|Overall Study||103
7987897|NCT00165789|19667405|P4|NOT COMPLETED|Overall Study||14
7987898|NCT00165789|19667406|P3|NOT COMPLETED|Overall Study||1
7987899|NCT00165789|19667407|P2|NOT COMPLETED|Overall Study||4
7987900|NCT00165789|19667408|P1|NOT COMPLETED|Overall Study||0
7987901|NCT00165789|19667405|P4|COMPLETED|Overall Study||21
7987902|NCT00165789|19667406|P3|COMPLETED|Overall Study||11
7987903|NCT00165789|19667407|P2|COMPLETED|Overall Study||16
7987904|NCT00165789|19667408|P1|COMPLETED|Overall Study||8
7987905|NCT00165789|19667405|P4|STARTED|Overall Study||35
7987906|NCT00165789|19667406|P3|STARTED|Overall Study||12
7987907|NCT00165789|19667407|P2|STARTED|Overall Study||20
7987908|NCT00165789|19667408|P1|STARTED|Overall Study||8
7987909|NCT00165776|19667462|P4|NOT COMPLETED|Overall Study||2
7987910|NCT00165776|19667463|P3|NOT COMPLETED|Overall Study||2
7987911|NCT00165776|19667464|P2|NOT COMPLETED|Overall Study||1
7987912|NCT00165776|19667465|P1|NOT COMPLETED|Overall Study||4
7987913|NCT00165776|19667462|P4|COMPLETED|Overall Study||29
7987914|NCT00165776|19667463|P3|COMPLETED|Overall Study||31
7987915|NCT00165776|19667464|P2|COMPLETED|Overall Study||33
7987916|NCT00165776|19667465|P1|COMPLETED|Overall Study||31
7987917|NCT00165776|19667462|P4|STARTED|Overall Study||31
7987918|NCT00165776|19667463|P3|STARTED|Overall Study||33
7987919|NCT00165776|19667464|P2|STARTED|Overall Study||34
7987920|NCT00165776|19667465|P1|STARTED|Overall Study||35
7987921|NCT00165698|19667501|P2|NOT COMPLETED|Overall Study||15
7987922|NCT00165698|19667502|P1|NOT COMPLETED|Overall Study||8
7987923|NCT00165698|19667501|P2|COMPLETED|Overall Study||105
7987924|NCT00165698|19667502|P1|COMPLETED|Overall Study||112
7987925|NCT00165698|19667501|P2|STARTED|Overall Study||120
7987926|NCT00165698|19667502|P1|STARTED|Overall Study||120
7987927|NCT00165672|19667528|P2|NOT COMPLETED|Overall Study||1
7987928|NCT00165672|19667529|P1|NOT COMPLETED|Overall Study||0
7987929|NCT00165672|19667528|P2|COMPLETED|Overall Study||12
7987930|NCT00165672|19667529|P1|COMPLETED|Overall Study||13
7987931|NCT00165672|19667528|P2|STARTED|Overall Study||13
7987932|NCT00165672|19667529|P1|STARTED|Overall Study||13
7987933|NCT00165646|19667538|P3|NOT COMPLETED|Overall Study||4
7987934|NCT00165646|19667539|P2|NOT COMPLETED|Overall Study||5
7987935|NCT00165646|19667540|P1|NOT COMPLETED|Overall Study||5
7987936|NCT00165646|19667538|P3|COMPLETED|Overall Study||98
7987937|NCT00165646|19667539|P2|COMPLETED|Overall Study||88
7987938|NCT00165646|19667540|P1|COMPLETED|Overall Study||88
7987939|NCT00165646|19667538|P3|STARTED|Overall Study||102
7987940|NCT00165646|19667539|P2|STARTED|Overall Study||93
7987941|NCT00165646|19667540|P1|STARTED|Overall Study||93
7987942|NCT00165503|19667548|P1|NOT COMPLETED|Overall Study||16
7987943|NCT00165503|19667548|P1|COMPLETED|Overall Study||0
7987944|NCT00165503|19667548|P1|STARTED|Overall Study||16
7987945|NCT00163657|19667555|P3|NOT COMPLETED|Overall Study||37
7987946|NCT00163657|19667556|P2|NOT COMPLETED|Overall Study||23
7987947|NCT00163657|19667557|P1|NOT COMPLETED|Overall Study||20
7987948|NCT00163657|19667555|P3|COMPLETED|Overall Study||116
7987949|NCT00163657|19667556|P2|COMPLETED|Overall Study||56
7987950|NCT00163657|19667557|P1|COMPLETED|Overall Study||60
7987951|NCT00163657|19667555|P3|STARTED|Overall Study||153
7987952|NCT00163657|19667556|P2|STARTED|Overall Study||79
7987953|NCT00163657|19667557|P1|STARTED|Overall Study||80
7987954|NCT00163293|19667571|P3|NOT COMPLETED|Overall Study||19
7987955|NCT00163293|19667572|P2|NOT COMPLETED|Overall Study||7
7987956|NCT00163293|19667573|P1|NOT COMPLETED|Overall Study||13
7987957|NCT00163293|19667571|P3|COMPLETED|Overall Study||66
7987958|NCT00163293|19667572|P2|COMPLETED|Overall Study||69
7987959|NCT00163293|19667573|P1|COMPLETED|Overall Study||66
7987960|NCT00163293|19667571|P3|STARTED|Overall Study||85
7987961|NCT00163293|19667572|P2|STARTED|Overall Study||76
7987962|NCT00163293|19667573|P1|STARTED|Overall Study||79
7987963|NCT00163215|19667647|P1|NOT COMPLETED|Overall Study||15
7987964|NCT00163215|19667647|P1|COMPLETED|Overall Study||31
7987965|NCT00163215|19667647|P1|STARTED|Overall Study||46
7987966|NCT00163189|19667667|P1|NOT COMPLETED|Overall Study||63
7987967|NCT00163189|19667667|P1|COMPLETED|Overall Study||35
7987968|NCT00163189|19667667|P1|STARTED|Overall Study||98
7987969|NCT00163020|19667691|P2|NOT COMPLETED|Overall Study||2
7987970|NCT00163020|19667692|P1|NOT COMPLETED|Overall Study||0
7987971|NCT00163020|19667691|P2|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103
7987972|NCT00163020|19667692|P1|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216
7987973|NCT00163020|19667691|P2|STARTED|Overall Study|Twins = 80 Triplets = 25|105
7987974|NCT00163020|19667692|P1|STARTED|Overall Study|Twins = 160 Triplets = 56|216
7987975|NCT00162981|19667732|P2|NOT COMPLETED|Overall Study||6
7987976|NCT00162981|19667733|P1|NOT COMPLETED|Overall Study||4
7987977|NCT00162981|19667732|P2|COMPLETED|Overall Study||30
7987978|NCT00162981|19667733|P1|COMPLETED|Overall Study||28
7987979|NCT00162981|19667732|P2|STARTED|Overall Study||36
7987980|NCT00162981|19667733|P1|STARTED|Overall Study||32
7987981|NCT00162942|19667749|P2|NOT COMPLETED|Overall Study||52
7987982|NCT00162942|19667750|P1|NOT COMPLETED|Overall Study||106
7987983|NCT00162942|19667749|P2|COMPLETED|Overall Study||26
7987984|NCT00162942|19667750|P1|COMPLETED|Overall Study||51
7987985|NCT00162942|19667749|P2|Week 12|Overall Study||61
7987986|NCT00162942|19667750|P1|Week 12|Overall Study||127
7987987|NCT00162942|19667749|P2|STARTED|Overall Study||78
7987988|NCT00162942|19667750|P1|STARTED|Overall Study||157
7987989|NCT00162773|19667798|P1|NOT COMPLETED|Overall Study||22
7987990|NCT00162773|19667798|P1|COMPLETED|Overall Study||7
7987991|NCT00162773|19667798|P1|STARTED|Overall Study||29
7987992|NCT00162370|19667802|P1|NOT COMPLETED|Efficacy Population||51
7987993|NCT00162370|19667802|P1|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315
7987994|NCT00162370|19667802|P1|STARTED|Efficacy Population||366
7987995|NCT00162370|19667802|P1|NOT COMPLETED|Completed Echocardiography Imaging||0
7987996|NCT00162370|19667802|P1|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366
7987997|NCT00162370|19667802|P1|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366
7987998|NCT00162266|19667810|P4|NOT COMPLETED|Open-Label Period||137
7987999|NCT00162266|19667811|P3|NOT COMPLETED|Open-Label Period||0
7988000|NCT00162266|19667812|P2|NOT COMPLETED|Open-Label Period||0
7988001|NCT00162266|19667813|P1|NOT COMPLETED|Open-Label Period||0
7988002|NCT00162266|19667810|P4|COMPLETED|Open-Label Period||82
7988003|NCT00162266|19667811|P3|COMPLETED|Open-Label Period||0
7988004|NCT00162266|19667812|P2|COMPLETED|Open-Label Period||0
7988005|NCT00162266|19667813|P1|COMPLETED|Open-Label Period||0
7988006|NCT00162266|19667810|P4|STARTED|Open-Label Period||219
7988007|NCT00162266|19667811|P3|STARTED|Open-Label Period||0
7988008|NCT00162266|19667812|P2|STARTED|Open-Label Period||0
7988009|NCT00162266|19667813|P1|STARTED|Open-Label Period||0
7988010|NCT00162266|19667810|P4|NOT COMPLETED|Double-Blind Period||0
7988011|NCT00162266|19667811|P3|NOT COMPLETED|Double-Blind Period||48
7988012|NCT00162266|19667812|P2|NOT COMPLETED|Double-Blind Period||31
7988013|NCT00162266|19667813|P1|NOT COMPLETED|Double-Blind Period||25
7988014|NCT00162266|19667810|P4|COMPLETED|Double-Blind Period||0
7988015|NCT00162266|19667811|P3|COMPLETED|Double-Blind Period||71
7988016|NCT00162266|19667812|P2|COMPLETED|Double-Blind Period||74
7988017|NCT00162266|19667813|P1|COMPLETED|Double-Blind Period||90
7988018|NCT00162266|19667810|P4|Completed Day 1 to Day 181|Double-Blind Period||0
7988019|NCT00162266|19667811|P3|Completed Day 1 to Day 181|Double-Blind Period||78
7988020|NCT00162266|19667812|P2|Completed Day 1 to Day 181|Double-Blind Period||80
7988021|NCT00162266|19667813|P1|Completed Day 1 to Day 181|Double-Blind Period||98
7988022|NCT00162266|19667810|P4|STARTED|Double-Blind Period||0
7988023|NCT00162266|19667811|P3|STARTED|Double-Blind Period||119
7988024|NCT00162266|19667812|P2|STARTED|Double-Blind Period||105
7988025|NCT00162266|19667813|P1|STARTED|Double-Blind Period||115
7988026|NCT00162136|19668014|P1|NOT COMPLETED|Overall Study||35
7988027|NCT00162136|19668014|P1|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0
7988028|NCT00162136|19668014|P1|STARTED|Overall Study||35
7988029|NCT00162123|19668046|P8|NOT COMPLETED|Overall Study||58
7988030|NCT00162123|19668047|P7|NOT COMPLETED|Overall Study||4
7988031|NCT00162123|19668048|P6|NOT COMPLETED|Overall Study||9
7988032|NCT00162123|19668049|P5|NOT COMPLETED|Overall Study||31
7988033|NCT00162123|19668050|P4|NOT COMPLETED|Overall Study||8
7988034|NCT00162123|19668051|P3|NOT COMPLETED|Overall Study||21
7988035|NCT00162123|19668052|P2|NOT COMPLETED|Overall Study||29
7988036|NCT00162123|19668053|P1|NOT COMPLETED|Overall Study||44
7988037|NCT00162123|19668046|P8|COMPLETED|Overall Study|Still on treatment|0
7988038|NCT00162123|19668047|P7|COMPLETED|Overall Study|Still on treatment|0
7988039|NCT00162123|19668048|P6|COMPLETED|Overall Study|Still on treatment|4
7988040|NCT00162123|19668049|P5|COMPLETED|Overall Study|Still on treatment|14
7988041|NCT00162123|19668050|P4|COMPLETED|Overall Study|Still on treatment|3
7988042|NCT00162123|19668051|P3|COMPLETED|Overall Study|Still on treatment|3
7988043|NCT00162123|19668052|P2|COMPLETED|Overall Study|Still on treatment|5
7988044|NCT00162123|19668053|P1|COMPLETED|Overall Study|Still on treatment|9
7988045|NCT00162123|19668046|P8|Received Treatment|Overall Study||0
7988046|NCT00162123|19668047|P7|Received Treatment|Overall Study||4
7988047|NCT00162123|19668048|P6|Received Treatment|Overall Study||12
7988048|NCT00162123|19668049|P5|Received Treatment|Overall Study||33
7988049|NCT00162123|19668050|P4|Received Treatment|Overall Study||11
7988050|NCT00162123|19668051|P3|Received Treatment|Overall Study||24
7988051|NCT00162123|19668052|P2|Received Treatment|Overall Study||34
7988052|NCT00162123|19668053|P1|Received Treatment|Overall Study||53
7988053|NCT00162123|19668046|P8|STARTED|Overall Study|Enrolled|58
7988054|NCT00162123|19668047|P7|STARTED|Overall Study|Enrolled|4
7988055|NCT00162123|19668048|P6|STARTED|Overall Study|Enrolled|13
7988056|NCT00162123|19668049|P5|STARTED|Overall Study|Enrolled|45
7988057|NCT00162123|19668050|P4|STARTED|Overall Study|Enrolled|11
7988058|NCT00162123|19668051|P3|STARTED|Overall Study|Enrolled|24
7988059|NCT00162123|19668052|P2|STARTED|Overall Study|Enrolled|34
7988060|NCT00162123|19668053|P1|STARTED|Overall Study|Enrolled|53
7988061|NCT00162097|19668086|P4|NOT COMPLETED|Overall Study||1
7988062|NCT00162097|19668087|P3|NOT COMPLETED|Overall Study||0
7988063|NCT00162097|19668088|P2|NOT COMPLETED|Overall Study||0
7988064|NCT00162097|19668089|P1|NOT COMPLETED|Overall Study||0
7988065|NCT00162097|19668086|P4|COMPLETED|Overall Study||6
7988066|NCT00162097|19668087|P3|COMPLETED|Overall Study||1
7988067|NCT00162097|19668088|P2|COMPLETED|Overall Study||2
7988068|NCT00162097|19668089|P1|COMPLETED|Overall Study||6
7988069|NCT00162097|19668086|P4|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7
7988070|NCT00162097|19668087|P3|STARTED|Overall Study|Treated on Day 1|1
7988071|NCT00162097|19668088|P2|STARTED|Overall Study|Treated on Day 1|2
7988072|NCT00162097|19668089|P1|STARTED|Overall Study|Treated on Day 1|6
7988073|NCT00162032|19668151|P2|NOT COMPLETED|Overall Study||2
7988074|NCT00162032|19668152|P1|NOT COMPLETED|Overall Study||5
7988075|NCT00162032|19668151|P2|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114
7988076|NCT00162032|19668152|P1|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324
7988077|NCT00162032|19668151|P2|STARTED|Overall Study||116
7988078|NCT00162032|19668152|P1|STARTED|Overall Study||329
7988079|NCT00161616|19668173|P2|NOT COMPLETED|Overall Study||19
7988080|NCT00161616|19668174|P1|NOT COMPLETED|Overall Study||26
7988081|NCT00161616|19668173|P2|COMPLETED|Overall Study||119
7988082|NCT00161616|19668174|P1|COMPLETED|Overall Study||113
7988083|NCT00161616|19668173|P2|STARTED|Overall Study||138
7988084|NCT00161616|19668174|P1|STARTED|Overall Study||139
7988085|NCT00161473|19668184|P2|NOT COMPLETED|Overall Study||6
7988086|NCT00161473|19668185|P1|NOT COMPLETED|Overall Study||5
7988087|NCT00161473|19668184|P2|COMPLETED|Overall Study||6
7988088|NCT00161473|19668185|P1|COMPLETED|Overall Study||7
7988089|NCT00161473|19668184|P2|STARTED|Overall Study||12
7988090|NCT00161473|19668185|P1|STARTED|Overall Study||12
7988091|NCT00161382|19668199|P2|NOT COMPLETED|Overall Study||289
7988092|NCT00161382|19668200|P1|NOT COMPLETED|Overall Study||249
7988093|NCT00161382|19668199|P2|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558
7988094|NCT00161382|19668200|P1|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349
7988095|NCT00161382|19668199|P2|STARTED|Overall Study|Number of students allocated to comparison group|847
7988096|NCT00161382|19668200|P1|STARTED|Overall Study|Number of students allocated to intervention group|598
7988097|NCT00161213|19668206|P1|NOT COMPLETED|Overall Study||2
7988098|NCT00161213|19668206|P1|COMPLETED|Overall Study||42
7988099|NCT00161213|19668206|P1|STARTED|Overall Study||44
7988100|NCT00160706|19668213|P1|NOT COMPLETED|Overall Study||286
7988101|NCT00160706|19668213|P1|COMPLETED|Overall Study||24
7988102|NCT00160706|19668213|P1|STARTED|Overall Study||310
7988103|NCT00160693|19668225|P1|NOT COMPLETED|Overall Study||235
7988104|NCT00160693|19668225|P1|COMPLETED|Overall Study||167
7988105|NCT00160693|19668225|P1|STARTED|Overall Study||402
7988106|NCT00160680|19668244|P2|NOT COMPLETED|Overall Study||13
7988107|NCT00160680|19668245|P1|NOT COMPLETED|Overall Study||9
7988108|NCT00160680|19668244|P2|COMPLETED|Overall Study||18
7988109|NCT00160680|19668245|P1|COMPLETED|Overall Study||22
7988110|NCT00160680|19668244|P2|STARTED|Overall Study||31
7988111|NCT00160680|19668245|P1|STARTED|Overall Study||31
7988112|NCT00160667|19668280|P3|NOT COMPLETED|Overall Study||6
7988113|NCT00160667|19668281|P2|NOT COMPLETED|Overall Study||3
7988114|NCT00160667|19668282|P1|NOT COMPLETED|Overall Study||5
7988115|NCT00160667|19668280|P3|COMPLETED|Overall Study||45
7988116|NCT00160667|19668281|P2|COMPLETED|Overall Study||48
7988117|NCT00160667|19668282|P1|COMPLETED|Overall Study||45
7988118|NCT00160667|19668280|P3|STARTED|Overall Study||51
7988119|NCT00160667|19668281|P2|STARTED|Overall Study||51
7988120|NCT00160667|19668282|P1|STARTED|Overall Study||50
7988121|NCT00160654|19668329|P1|NOT COMPLETED|Overall Study||33
7988122|NCT00160654|19668329|P1|COMPLETED|Overall Study||218
7988123|NCT00160654|19668329|P1|STARTED|Overall Study||251
7988124|NCT00160641|19668339|P1|NOT COMPLETED|Overall Study||221
7988125|NCT00160641|19668339|P1|COMPLETED|Overall Study||346
7988126|NCT00160641|19668339|P1|STARTED|Overall Study||567
7988127|NCT00160615|19668372|P2|NOT COMPLETED|Overall Study||45
7988128|NCT00160615|19668373|P1|NOT COMPLETED|Overall Study||18
7988129|NCT00160615|19668372|P2|COMPLETED|Overall Study||56
7988130|NCT00160615|19668373|P1|COMPLETED|Overall Study||32
7988131|NCT00160615|19668372|P2|STARTED|Overall Study||101
7988132|NCT00160615|19668373|P1|STARTED|Overall Study||50
7988133|NCT00160563|19668396|P3|NOT COMPLETED|Overall Study||90
7988134|NCT00160563|19668397|P2|NOT COMPLETED|Overall Study||45
7988135|NCT00160563|19668398|P1|NOT COMPLETED|Overall Study||51
7988136|NCT00160563|19668396|P3|COMPLETED|Overall Study||11
7988137|NCT00160563|19668397|P2|COMPLETED|Overall Study||2
7988138|NCT00160563|19668398|P1|COMPLETED|Overall Study||8
7988139|NCT00160563|19668396|P3|STARTED|Overall Study||101
7988140|NCT00160563|19668397|P2|STARTED|Overall Study||47
7988141|NCT00160563|19668398|P1|STARTED|Overall Study||59
7988142|NCT00160524|19668410|P1|NOT COMPLETED|Overall Study||478
7988143|NCT00160524|19668410|P1|COMPLETED|Overall Study||117
7988144|NCT00160524|19668410|P1|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595
7988145|NCT00160251|19668427|P8|NOT COMPLETED|Post-amendment 2||55
7988146|NCT00160251|19668428|P7|NOT COMPLETED|Post-amendment 2||0
7988147|NCT00160251|19668429|P6|NOT COMPLETED|Post-amendment 2||0
7988148|NCT00160251|19668430|P5|NOT COMPLETED|Post-amendment 2||0
7988149|NCT00160251|19668431|P4|NOT COMPLETED|Post-amendment 2||0
7988150|NCT00160251|19668432|P3|NOT COMPLETED|Post-amendment 2||0
7988151|NCT00160251|19668433|P2|NOT COMPLETED|Post-amendment 2||0
7988152|NCT00160251|19668434|P1|NOT COMPLETED|Post-amendment 2||0
7988153|NCT00160251|19668427|P8|COMPLETED|Post-amendment 2||88
7988154|NCT00160251|19668428|P7|COMPLETED|Post-amendment 2||0
7988155|NCT00160251|19668429|P6|COMPLETED|Post-amendment 2||0
7988156|NCT00160251|19668430|P5|COMPLETED|Post-amendment 2||0
7988157|NCT00160251|19668431|P4|COMPLETED|Post-amendment 2||0
7988158|NCT00160251|19668432|P3|COMPLETED|Post-amendment 2||0
7988159|NCT00160251|19668433|P2|COMPLETED|Post-amendment 2||0
7988160|NCT00160251|19668434|P1|COMPLETED|Post-amendment 2||0
7988161|NCT00160251|19668427|P8|STARTED|Post-amendment 2||143
7988162|NCT00160251|19668428|P7|STARTED|Post-amendment 2||0
7988163|NCT00160251|19668429|P6|STARTED|Post-amendment 2||0
7988164|NCT00160251|19668430|P5|STARTED|Post-amendment 2||0
7988165|NCT00160251|19668431|P4|STARTED|Post-amendment 2||0
7988166|NCT00160251|19668432|P3|STARTED|Post-amendment 2||0
7988167|NCT00160251|19668433|P2|STARTED|Post-amendment 2||0
7988168|NCT00160251|19668434|P1|STARTED|Post-amendment 2||0
7988169|NCT00160251|19668427|P8|NOT COMPLETED|Prior to Amendment 2||0
7988170|NCT00160251|19668428|P7|NOT COMPLETED|Prior to Amendment 2||4
7988171|NCT00160251|19668429|P6|NOT COMPLETED|Prior to Amendment 2||83
7988172|NCT00160251|19668430|P5|NOT COMPLETED|Prior to Amendment 2||28
7988173|NCT00160251|19668431|P4|NOT COMPLETED|Prior to Amendment 2||40
7988174|NCT00160251|19668432|P3|NOT COMPLETED|Prior to Amendment 2||44
7988175|NCT00160251|19668433|P2|NOT COMPLETED|Prior to Amendment 2||6
7988176|NCT00160251|19668434|P1|NOT COMPLETED|Prior to Amendment 2||9
7988177|NCT00160251|19668427|P8|COMPLETED|Prior to Amendment 2||0
7988178|NCT00160251|19668428|P7|COMPLETED|Prior to Amendment 2||61
7988179|NCT00160251|19668429|P6|COMPLETED|Prior to Amendment 2||14
7988180|NCT00160251|19668430|P5|COMPLETED|Prior to Amendment 2||21
7988181|NCT00160251|19668431|P4|COMPLETED|Prior to Amendment 2||9
7988182|NCT00160251|19668432|P3|COMPLETED|Prior to Amendment 2||4
7988183|NCT00160251|19668433|P2|COMPLETED|Prior to Amendment 2||28
7988184|NCT00160251|19668434|P1|COMPLETED|Prior to Amendment 2||6
7988185|NCT00160251|19668427|P8|STARTED|Prior to Amendment 2||0
7988186|NCT00160251|19668428|P7|STARTED|Prior to Amendment 2||65
7988187|NCT00160251|19668429|P6|STARTED|Prior to Amendment 2||97
7988188|NCT00160251|19668430|P5|STARTED|Prior to Amendment 2||49
7988189|NCT00160251|19668431|P4|STARTED|Prior to Amendment 2||49
7988190|NCT00160251|19668432|P3|STARTED|Prior to Amendment 2||48
7988191|NCT00160251|19668433|P2|STARTED|Prior to Amendment 2||34
7988192|NCT00160251|19668434|P1|STARTED|Prior to Amendment 2||15
7988193|NCT00160199|19668510|P2|NOT COMPLETED|Overall Study||37
7988194|NCT00160199|19668511|P1|NOT COMPLETED|Overall Study||24
7988195|NCT00160199|19668510|P2|COMPLETED|Overall Study||81
7988196|NCT00160199|19668511|P1|COMPLETED|Overall Study||98
7988197|NCT00160199|19668510|P2|STARTED|Overall Study||118
7988198|NCT00160199|19668511|P1|STARTED|Overall Study||122
7988199|NCT00159965|19668531|P2|NOT COMPLETED|Overall Study||5
7988200|NCT00159965|19668532|P1|NOT COMPLETED|Overall Study||7
7988201|NCT00159965|19668531|P2|COMPLETED|Overall Study||14
7988202|NCT00159965|19668532|P1|COMPLETED|Overall Study||12
7988203|NCT00159965|19668531|P2|STARTED|Overall Study||19
7988204|NCT00159965|19668532|P1|STARTED|Overall Study||19
7988205|NCT00159913|19668568|P4|NOT COMPLETED|Overall Study||2
7988206|NCT00159913|19668569|P3|NOT COMPLETED|Overall Study||2
7988207|NCT00159913|19668570|P2|NOT COMPLETED|Overall Study||0
7988208|NCT00159913|19668571|P1|NOT COMPLETED|Overall Study||2
7988209|NCT00159913|19668568|P4|COMPLETED|Overall Study||58
7988210|NCT00159913|19668569|P3|COMPLETED|Overall Study||75
7988211|NCT00159913|19668570|P2|COMPLETED|Overall Study||55
7988212|NCT00159913|19668571|P1|COMPLETED|Overall Study||40
7988213|NCT00159913|19668568|P4|STARTED|Overall Study||60
7988214|NCT00159913|19668569|P3|STARTED|Overall Study||77
7988215|NCT00159913|19668570|P2|STARTED|Overall Study||55
7988216|NCT00159913|19668571|P1|STARTED|Overall Study||42
7988217|NCT00159874|19668645|P7|NOT COMPLETED|Overall Study||5
7988218|NCT00159874|19668646|P6|NOT COMPLETED|Overall Study||12
7988219|NCT00159874|19668647|P5|NOT COMPLETED|Overall Study||8
7988220|NCT00159874|19668648|P4|NOT COMPLETED|Overall Study||6
7988221|NCT00159874|19668649|P3|NOT COMPLETED|Overall Study||43
7988222|NCT00159874|19668650|P2|NOT COMPLETED|Overall Study||30
7988223|NCT00159874|19668651|P1|NOT COMPLETED|Overall Study||20
7988224|NCT00159874|19668645|P7|COMPLETED|Overall Study||0
7988225|NCT00159874|19668646|P6|COMPLETED|Overall Study||11
7988226|NCT00159874|19668647|P5|COMPLETED|Overall Study||11
7988227|NCT00159874|19668648|P4|COMPLETED|Overall Study||7
7988228|NCT00159874|19668649|P3|COMPLETED|Overall Study||34
7988229|NCT00159874|19668650|P2|COMPLETED|Overall Study||25
7988230|NCT00159874|19668651|P1|COMPLETED|Overall Study||22
7988231|NCT00159874|19668645|P7|Treated|Overall Study||5
7988232|NCT00159874|19668646|P6|Treated|Overall Study||23
7988233|NCT00159874|19668647|P5|Treated|Overall Study||19
7988234|NCT00159874|19668648|P4|Treated|Overall Study||13
7988235|NCT00159874|19668649|P3|Treated|Overall Study||77
7988236|NCT00159874|19668650|P2|Treated|Overall Study||55
7988237|NCT00159874|19668651|P1|Treated|Overall Study||42
7988238|NCT00159874|19668645|P7|STARTED|Overall Study||5
7988239|NCT00159874|19668646|P6|STARTED|Overall Study||23
7988240|NCT00159874|19668647|P5|STARTED|Overall Study||19
7988241|NCT00159874|19668648|P4|STARTED|Overall Study||13
7988242|NCT00159874|19668649|P3|STARTED|Overall Study||77
7988243|NCT00159874|19668650|P2|STARTED|Overall Study||55
7988244|NCT00159874|19668651|P1|STARTED|Overall Study||42
7988245|NCT00159861|19668821|P2|NOT COMPLETED|Extension Study - up to 3 Years||71
7988246|NCT00159861|19668822|P1|NOT COMPLETED|Extension Study - up to 3 Years||62
7988247|NCT00159861|19668821|P2|COMPLETED|Extension Study - up to 3 Years||56
7988248|NCT00159861|19668822|P1|COMPLETED|Extension Study - up to 3 Years||53
7988249|NCT00159861|19668821|P2|Treated|Extension Study - up to 3 Years||127
7988250|NCT00159861|19668822|P1|Treated|Extension Study - up to 3 Years||115
7988251|NCT00159861|19668821|P2|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127
7988252|NCT00159861|19668822|P1|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115
7988253|NCT00159861|19668821|P2|NOT COMPLETED|Core Study - 16 Weeks||12
7988254|NCT00159861|19668822|P1|NOT COMPLETED|Core Study - 16 Weeks||25
7988255|NCT00159861|19668821|P2|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122
7988256|NCT00159861|19668822|P1|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108
7988257|NCT00159861|19668821|P2|Treated|Core Study - 16 Weeks||134
7988258|NCT00159861|19668822|P1|Treated|Core Study - 16 Weeks||131
7988259|NCT00159861|19668821|P2|STARTED|Core Study - 16 Weeks||134
7988260|NCT00159861|19668822|P1|STARTED|Core Study - 16 Weeks||133
7988261|NCT00159822|19668843|P1|NOT COMPLETED|Post-treatment Follow-up Period||3
7988262|NCT00159822|19668843|P1|COMPLETED|Post-treatment Follow-up Period||23
7988263|NCT00159822|19668843|P1|STARTED|Post-treatment Follow-up Period||26
7988264|NCT00159822|19668843|P1|NOT COMPLETED|Voriconazole Treatment Period||22
7988265|NCT00159822|19668843|P1|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26
7988266|NCT00159822|19668843|P1|STARTED|Voriconazole Treatment Period||48
7988267|NCT00159783|19668861|P3|NOT COMPLETED|Overall Study||39
7988268|NCT00159783|19668862|P2|NOT COMPLETED|Overall Study||27
7988269|NCT00159783|19668863|P1|NOT COMPLETED|Overall Study||19
7988270|NCT00159783|19668861|P3|COMPLETED|Overall Study||68
7988271|NCT00159783|19668862|P2|COMPLETED|Overall Study||52
7988272|NCT00159783|19668863|P1|COMPLETED|Overall Study||13
7988273|NCT00159783|19668861|P3|STARTED|Overall Study||107
7988274|NCT00159783|19668862|P2|STARTED|Overall Study||79
7988275|NCT00159783|19668863|P1|STARTED|Overall Study||32
7988276|NCT00159432|19668893|P1|NOT COMPLETED|Overall Study||10
7988277|NCT00159432|19668893|P1|COMPLETED|Overall Study||53
7988278|NCT00159432|19668893|P1|STARTED|Overall Study||63
7988279|NCT00159419|19668900|P2|NOT COMPLETED|Overall Study||0
7988280|NCT00159419|19668901|P1|NOT COMPLETED|Overall Study||0
7988281|NCT00159419|19668900|P2|COMPLETED|Overall Study||9
7988282|NCT00159419|19668901|P1|COMPLETED|Overall Study||9
7988283|NCT00159419|19668900|P2|STARTED|Overall Study||9
7988284|NCT00159419|19668901|P1|STARTED|Overall Study||9
7988285|NCT00159263|19668907|P6|NOT COMPLETED|Sixth Intervention||0
7988286|NCT00159263|19668908|P5|NOT COMPLETED|Sixth Intervention||0
7988287|NCT00159263|19668909|P4|NOT COMPLETED|Sixth Intervention||0
7988288|NCT00159263|19668910|P3|NOT COMPLETED|Sixth Intervention||0
7988289|NCT00159263|19668911|P2|NOT COMPLETED|Sixth Intervention||0
7988290|NCT00159263|19668912|P1|NOT COMPLETED|Sixth Intervention||0
7988291|NCT00159263|19668907|P6|COMPLETED|Sixth Intervention||2
7988292|NCT00159263|19668908|P5|COMPLETED|Sixth Intervention||2
7988293|NCT00159263|19668909|P4|COMPLETED|Sixth Intervention||2
7988294|NCT00159263|19668910|P3|COMPLETED|Sixth Intervention||2
7988295|NCT00159263|19668911|P2|COMPLETED|Sixth Intervention||1
7988296|NCT00159263|19668912|P1|COMPLETED|Sixth Intervention||1
7988297|NCT00159263|19668907|P6|STARTED|Sixth Intervention||2
7988298|NCT00159263|19668908|P5|STARTED|Sixth Intervention||2
7988299|NCT00159263|19668909|P4|STARTED|Sixth Intervention||2
7988300|NCT00159263|19668910|P3|STARTED|Sixth Intervention||2
7988301|NCT00159263|19668911|P2|STARTED|Sixth Intervention||1
7988302|NCT00159263|19668912|P1|STARTED|Sixth Intervention||1
7988303|NCT00159263|19668907|P6|NOT COMPLETED|Washout||0
7988304|NCT00159263|19668908|P5|NOT COMPLETED|Washout||0
7988305|NCT00159263|19668909|P4|NOT COMPLETED|Washout||0
7988306|NCT00159263|19668910|P3|NOT COMPLETED|Washout||0
7988307|NCT00159263|19668911|P2|NOT COMPLETED|Washout||0
7988308|NCT00159263|19668912|P1|NOT COMPLETED|Washout||0
7988309|NCT00159263|19668907|P6|COMPLETED|Washout||2
7988310|NCT00159263|19668908|P5|COMPLETED|Washout||2
7988311|NCT00159263|19668909|P4|COMPLETED|Washout||2
7988312|NCT00159263|19668910|P3|COMPLETED|Washout||2
7988313|NCT00159263|19668911|P2|COMPLETED|Washout||1
7988314|NCT00159263|19668912|P1|COMPLETED|Washout||1
7988315|NCT00159263|19668907|P6|STARTED|Washout||2
7988316|NCT00159263|19668908|P5|STARTED|Washout||2
7988317|NCT00159263|19668909|P4|STARTED|Washout||2
7988318|NCT00159263|19668910|P3|STARTED|Washout||2
7988319|NCT00159263|19668911|P2|STARTED|Washout||1
7988320|NCT00159263|19668912|P1|STARTED|Washout||1
7988321|NCT00159263|19668907|P6|NOT COMPLETED|Fifth Intervention||0
7988322|NCT00159263|19668908|P5|NOT COMPLETED|Fifth Intervention||0
7988323|NCT00159263|19668909|P4|NOT COMPLETED|Fifth Intervention||0
7988324|NCT00159263|19668910|P3|NOT COMPLETED|Fifth Intervention||0
7988325|NCT00159263|19668911|P2|NOT COMPLETED|Fifth Intervention||0
7988326|NCT00159263|19668912|P1|NOT COMPLETED|Fifth Intervention||0
7988327|NCT00159263|19668907|P6|COMPLETED|Fifth Intervention||2
7988328|NCT00159263|19668908|P5|COMPLETED|Fifth Intervention||2
7988329|NCT00159263|19668909|P4|COMPLETED|Fifth Intervention||2
7988330|NCT00159263|19668910|P3|COMPLETED|Fifth Intervention||2
7988331|NCT00159263|19668911|P2|COMPLETED|Fifth Intervention||1
7988332|NCT00159263|19668912|P1|COMPLETED|Fifth Intervention||1
7988333|NCT00159263|19668907|P6|STARTED|Fifth Intervention||2
7988334|NCT00159263|19668908|P5|STARTED|Fifth Intervention||2
7988335|NCT00159263|19668909|P4|STARTED|Fifth Intervention||2
7988336|NCT00159263|19668910|P3|STARTED|Fifth Intervention||2
7988337|NCT00159263|19668911|P2|STARTED|Fifth Intervention||1
7988338|NCT00159263|19668912|P1|STARTED|Fifth Intervention||1
7988339|NCT00159263|19668907|P6|NOT COMPLETED|Washout||0
7988340|NCT00159263|19668908|P5|NOT COMPLETED|Washout||0
7988341|NCT00159263|19668909|P4|NOT COMPLETED|Washout||0
7988342|NCT00159263|19668910|P3|NOT COMPLETED|Washout||0
7988343|NCT00159263|19668911|P2|NOT COMPLETED|Washout||0
7988344|NCT00159263|19668912|P1|NOT COMPLETED|Washout||0
7988345|NCT00159263|19668907|P6|COMPLETED|Washout||2
7988346|NCT00159263|19668908|P5|COMPLETED|Washout||2
7988347|NCT00159263|19668909|P4|COMPLETED|Washout||2
7988348|NCT00159263|19668910|P3|COMPLETED|Washout||2
7988349|NCT00159263|19668911|P2|COMPLETED|Washout||1
7988350|NCT00159263|19668912|P1|COMPLETED|Washout||1
7988351|NCT00159263|19668907|P6|STARTED|Washout||2
7988352|NCT00159263|19668908|P5|STARTED|Washout||2
7988353|NCT00159263|19668909|P4|STARTED|Washout||2
7988354|NCT00159263|19668910|P3|STARTED|Washout||2
7988355|NCT00159263|19668911|P2|STARTED|Washout||1
7988356|NCT00159263|19668912|P1|STARTED|Washout||1
7988357|NCT00159263|19668907|P6|NOT COMPLETED|Fourth Intervention||0
7988358|NCT00159263|19668908|P5|NOT COMPLETED|Fourth Intervention||0
7988359|NCT00159263|19668909|P4|NOT COMPLETED|Fourth Intervention||0
7988360|NCT00159263|19668910|P3|NOT COMPLETED|Fourth Intervention||0
7988361|NCT00159263|19668911|P2|NOT COMPLETED|Fourth Intervention||0
7988362|NCT00159263|19668912|P1|NOT COMPLETED|Fourth Intervention||0
7988363|NCT00159263|19668907|P6|COMPLETED|Fourth Intervention||2
7988364|NCT00159263|19668908|P5|COMPLETED|Fourth Intervention||2
7988365|NCT00159263|19668909|P4|COMPLETED|Fourth Intervention||2
7988366|NCT00159263|19668910|P3|COMPLETED|Fourth Intervention||2
7988367|NCT00159263|19668911|P2|COMPLETED|Fourth Intervention||1
7988368|NCT00159263|19668912|P1|COMPLETED|Fourth Intervention||1
7988369|NCT00159263|19668907|P6|STARTED|Fourth Intervention||2
7988370|NCT00159263|19668908|P5|STARTED|Fourth Intervention||2
7988371|NCT00159263|19668909|P4|STARTED|Fourth Intervention||2
7988372|NCT00159263|19668910|P3|STARTED|Fourth Intervention||2
7988373|NCT00159263|19668911|P2|STARTED|Fourth Intervention||1
7988374|NCT00159263|19668912|P1|STARTED|Fourth Intervention||1
7988375|NCT00159263|19668907|P6|NOT COMPLETED|Washout||0
7988376|NCT00159263|19668908|P5|NOT COMPLETED|Washout||0
7988377|NCT00159263|19668909|P4|NOT COMPLETED|Washout||0
7988378|NCT00159263|19668910|P3|NOT COMPLETED|Washout||0
7988379|NCT00159263|19668911|P2|NOT COMPLETED|Washout||0
7988380|NCT00159263|19668912|P1|NOT COMPLETED|Washout||0
7988381|NCT00159263|19668907|P6|COMPLETED|Washout||2
7988382|NCT00159263|19668908|P5|COMPLETED|Washout||2
7988383|NCT00159263|19668909|P4|COMPLETED|Washout||2
7988384|NCT00159263|19668910|P3|COMPLETED|Washout||2
7988385|NCT00159263|19668911|P2|COMPLETED|Washout||1
7988386|NCT00159263|19668912|P1|COMPLETED|Washout||1
7988387|NCT00159263|19668907|P6|STARTED|Washout||2
7988388|NCT00159263|19668908|P5|STARTED|Washout||2
7988389|NCT00159263|19668909|P4|STARTED|Washout||2
7988390|NCT00159263|19668910|P3|STARTED|Washout||2
7988391|NCT00159263|19668911|P2|STARTED|Washout||1
7988392|NCT00159263|19668912|P1|STARTED|Washout||1
7988393|NCT00159263|19668907|P6|NOT COMPLETED|Third Intervention||0
7988394|NCT00159263|19668908|P5|NOT COMPLETED|Third Intervention||0
7988395|NCT00159263|19668909|P4|NOT COMPLETED|Third Intervention||0
7988396|NCT00159263|19668910|P3|NOT COMPLETED|Third Intervention||0
7988397|NCT00159263|19668911|P2|NOT COMPLETED|Third Intervention||0
7988398|NCT00159263|19668912|P1|NOT COMPLETED|Third Intervention||0
7988399|NCT00159263|19668907|P6|COMPLETED|Third Intervention||2
7988400|NCT00159263|19668908|P5|COMPLETED|Third Intervention||2
7988401|NCT00159263|19668909|P4|COMPLETED|Third Intervention||2
7988402|NCT00159263|19668910|P3|COMPLETED|Third Intervention||2
7988403|NCT00159263|19668911|P2|COMPLETED|Third Intervention||1
7988404|NCT00159263|19668912|P1|COMPLETED|Third Intervention||1
7988405|NCT00159263|19668907|P6|STARTED|Third Intervention||2
7988406|NCT00159263|19668908|P5|STARTED|Third Intervention||2
7988407|NCT00159263|19668909|P4|STARTED|Third Intervention||2
7988408|NCT00159263|19668910|P3|STARTED|Third Intervention||2
7988409|NCT00159263|19668911|P2|STARTED|Third Intervention||1
7988410|NCT00159263|19668912|P1|STARTED|Third Intervention||1
7988411|NCT00159263|19668907|P6|NOT COMPLETED|Washout||0
7988412|NCT00159263|19668908|P5|NOT COMPLETED|Washout||0
7988413|NCT00159263|19668909|P4|NOT COMPLETED|Washout||0
7988414|NCT00159263|19668910|P3|NOT COMPLETED|Washout||0
7988415|NCT00159263|19668911|P2|NOT COMPLETED|Washout||0
7988416|NCT00159263|19668912|P1|NOT COMPLETED|Washout||0
7988417|NCT00159263|19668907|P6|COMPLETED|Washout||2
7988418|NCT00159263|19668908|P5|COMPLETED|Washout||2
7988419|NCT00159263|19668909|P4|COMPLETED|Washout||2
7988420|NCT00159263|19668910|P3|COMPLETED|Washout||2
7988421|NCT00159263|19668911|P2|COMPLETED|Washout||1
7988422|NCT00159263|19668912|P1|COMPLETED|Washout||1
7988423|NCT00159263|19668907|P6|STARTED|Washout||2
7988424|NCT00159263|19668908|P5|STARTED|Washout||2
7988425|NCT00159263|19668909|P4|STARTED|Washout||2
7988426|NCT00159263|19668910|P3|STARTED|Washout||2
7988427|NCT00159263|19668911|P2|STARTED|Washout||1
7988428|NCT00159263|19668912|P1|STARTED|Washout||1
7988429|NCT00159263|19668907|P6|NOT COMPLETED|Second Intervention||0
7988430|NCT00159263|19668908|P5|NOT COMPLETED|Second Intervention||0
7988431|NCT00159263|19668909|P4|NOT COMPLETED|Second Intervention||0
7988432|NCT00159263|19668910|P3|NOT COMPLETED|Second Intervention||0
7988433|NCT00159263|19668911|P2|NOT COMPLETED|Second Intervention||0
7988434|NCT00159263|19668912|P1|NOT COMPLETED|Second Intervention||0
7988435|NCT00159263|19668907|P6|COMPLETED|Second Intervention||2
7988436|NCT00159263|19668908|P5|COMPLETED|Second Intervention||2
7988437|NCT00159263|19668909|P4|COMPLETED|Second Intervention||2
7988438|NCT00159263|19668910|P3|COMPLETED|Second Intervention||2
7988439|NCT00159263|19668911|P2|COMPLETED|Second Intervention||1
7988440|NCT00159263|19668912|P1|COMPLETED|Second Intervention||1
7988441|NCT00159263|19668907|P6|STARTED|Second Intervention||2
7988442|NCT00159263|19668908|P5|STARTED|Second Intervention||2
7988443|NCT00159263|19668909|P4|STARTED|Second Intervention||2
7988444|NCT00159263|19668910|P3|STARTED|Second Intervention||2
7988445|NCT00159263|19668911|P2|STARTED|Second Intervention||1
7988446|NCT00159263|19668912|P1|STARTED|Second Intervention||1
7988447|NCT00159263|19668907|P6|NOT COMPLETED|Washout||0
7988448|NCT00159263|19668908|P5|NOT COMPLETED|Washout||0
7988449|NCT00159263|19668909|P4|NOT COMPLETED|Washout||0
7988450|NCT00159263|19668910|P3|NOT COMPLETED|Washout||0
7988451|NCT00159263|19668911|P2|NOT COMPLETED|Washout||0
7988452|NCT00159263|19668912|P1|NOT COMPLETED|Washout||0
7988453|NCT00159263|19668907|P6|COMPLETED|Washout||2
7988454|NCT00159263|19668908|P5|COMPLETED|Washout||2
7988455|NCT00159263|19668909|P4|COMPLETED|Washout||2
7988456|NCT00159263|19668910|P3|COMPLETED|Washout||2
7988457|NCT00159263|19668911|P2|COMPLETED|Washout||1
7988458|NCT00159263|19668912|P1|COMPLETED|Washout||1
7988459|NCT00159263|19668907|P6|STARTED|Washout||2
7988460|NCT00159263|19668908|P5|STARTED|Washout||2
7988461|NCT00159263|19668909|P4|STARTED|Washout||2
7988462|NCT00159263|19668910|P3|STARTED|Washout||2
7988463|NCT00159263|19668911|P2|STARTED|Washout||1
7988464|NCT00159263|19668912|P1|STARTED|Washout||1
7988465|NCT00159263|19668907|P6|NOT COMPLETED|First Intervention||0
7988466|NCT00159263|19668908|P5|NOT COMPLETED|First Intervention||0
7988467|NCT00159263|19668909|P4|NOT COMPLETED|First Intervention||0
7988468|NCT00159263|19668910|P3|NOT COMPLETED|First Intervention||0
7988469|NCT00159263|19668911|P2|NOT COMPLETED|First Intervention||0
7988470|NCT00159263|19668912|P1|NOT COMPLETED|First Intervention||0
7988471|NCT00159263|19668907|P6|COMPLETED|First Intervention||2
7988472|NCT00159263|19668908|P5|COMPLETED|First Intervention||2
7988473|NCT00159263|19668909|P4|COMPLETED|First Intervention||2
7988474|NCT00159263|19668910|P3|COMPLETED|First Intervention||2
7988475|NCT00159263|19668911|P2|COMPLETED|First Intervention||1
7988476|NCT00159263|19668912|P1|COMPLETED|First Intervention||1
7988477|NCT00159263|19668907|P6|STARTED|First Intervention||2
7988478|NCT00159263|19668908|P5|STARTED|First Intervention||2
7988479|NCT00159263|19668909|P4|STARTED|First Intervention||2
7988480|NCT00159263|19668910|P3|STARTED|First Intervention||2
7988481|NCT00159263|19668911|P2|STARTED|First Intervention||1
7988482|NCT00159263|19668912|P1|STARTED|First Intervention||1
7988483|NCT00159250|19668940|P2|NOT COMPLETED|Overall Study||0
7988484|NCT00159250|19668941|P1|NOT COMPLETED|Overall Study||0
7988485|NCT00159250|19668940|P2|COMPLETED|Overall Study||5
7988486|NCT00159250|19668941|P1|COMPLETED|Overall Study||2
7988487|NCT00159250|19668940|P2|STARTED|Overall Study||5
7988488|NCT00159250|19668941|P1|STARTED|Overall Study||2
7988489|NCT00158925|19668957|P1|NOT COMPLETED|Overall Study||12
7988490|NCT00158925|19668957|P1|COMPLETED|Overall Study||84
7988491|NCT00158925|19668957|P1|STARTED|Overall Study|96 subjects were implanted or attempted with the study lead|96
7988492|NCT00158860|19668967|P2|NOT COMPLETED|Overall Study||71
7988493|NCT00158860|19668968|P1|NOT COMPLETED|Overall Study||35
7988494|NCT00158860|19668967|P2|COMPLETED|Overall Study||184
7988495|NCT00158860|19668968|P1|COMPLETED|Overall Study||93
7988496|NCT00158860|19668967|P2|STARTED|Overall Study||255
7988497|NCT00158860|19668968|P1|STARTED|Overall Study||128
7988498|NCT00158756|19668987|P5|NOT COMPLETED|Overall Study||3
7988499|NCT00158756|19668988|P4|NOT COMPLETED|Overall Study||1
7988500|NCT00158756|19668989|P3|NOT COMPLETED|Overall Study||8
7988501|NCT00158756|19668990|P2|NOT COMPLETED|Overall Study||0
7988502|NCT00158756|19668991|P1|NOT COMPLETED|Overall Study||5
7988503|NCT00158756|19668987|P5|COMPLETED|Overall Study||96
7988504|NCT00158756|19668988|P4|COMPLETED|Overall Study||22
7988505|NCT00158756|19668989|P3|COMPLETED|Overall Study||73
7988506|NCT00158756|19668990|P2|COMPLETED|Overall Study||25
7988507|NCT00158756|19668991|P1|COMPLETED|Overall Study||75
7988508|NCT00158756|19668987|P5|STARTED|Overall Study||99
7988509|NCT00158756|19668988|P4|STARTED|Overall Study||23
7988510|NCT00158756|19668989|P3|STARTED|Overall Study||81
7988511|NCT00158756|19668990|P2|STARTED|Overall Study||25
7988512|NCT00158756|19668991|P1|STARTED|Overall Study||80
7988513|NCT00158743|19669088|P2|NOT COMPLETED|Overall Study||7
7988514|NCT00158743|19669089|P1|NOT COMPLETED|Overall Study||9
7988515|NCT00158743|19669088|P2|COMPLETED|Overall Study||20
7988516|NCT00158743|19669089|P1|COMPLETED|Overall Study||15
7988517|NCT00158743|19669088|P2|STARTED|Overall Study||27
7988518|NCT00158743|19669089|P1|STARTED|Overall Study||24
7988519|NCT00158600|19669097|P2|NOT COMPLETED|Overall Study||4
7988520|NCT00158600|19669098|P1|NOT COMPLETED|Overall Study||5
7988521|NCT00158600|19669097|P2|COMPLETED|Overall Study||26
7988522|NCT00158600|19669098|P1|COMPLETED|Overall Study||55
7988523|NCT00158600|19669097|P2|STARTED|Overall Study||30
7988524|NCT00158600|19669098|P1|STARTED|Overall Study||60
7988525|NCT00158379|19669116|P1|NOT COMPLETED|Overall Study||0
7988526|NCT00158379|19669116|P1|COMPLETED|Overall Study||105
7988527|NCT00158379|19669116|P1|STARTED|Overall Study||105
7988528|NCT00158262|19669123|P2|NOT COMPLETED|Overall Study||1
7988529|NCT00158262|19669124|P1|NOT COMPLETED|Overall Study||1
7988530|NCT00158262|19669123|P2|COMPLETED|Overall Study||21
7988531|NCT00158262|19669124|P1|COMPLETED|Overall Study||20
7988532|NCT00158262|19669123|P2|STARTED|Overall Study||22
7988533|NCT00158262|19669124|P1|STARTED|Overall Study||21
7988534|NCT00158249|19669136|P2|NOT COMPLETED|Overall Study||0
7988535|NCT00158249|19669137|P1|NOT COMPLETED|Overall Study||2
7988536|NCT00158249|19669136|P2|COMPLETED|Overall Study||10
7988537|NCT00158249|19669137|P1|COMPLETED|Overall Study||9
7988538|NCT00158249|19669136|P2|STARTED|Overall Study||10
7988539|NCT00158249|19669137|P1|STARTED|Overall Study||11
7988540|NCT00158223|19669147|P2|NOT COMPLETED|Overall Study||3
7988541|NCT00158223|19669148|P1|NOT COMPLETED|Overall Study||5
7988542|NCT00158223|19669147|P2|COMPLETED|Overall Study||22
7988543|NCT00158223|19669148|P1|COMPLETED|Overall Study||23
7988544|NCT00158223|19669147|P2|STARTED|Overall Study||25
7988545|NCT00158223|19669148|P1|STARTED|Overall Study||28
7988546|NCT00158197|19669162|P4|NOT COMPLETED|Overall Study||0
7988547|NCT00158197|19669163|P3|NOT COMPLETED|Overall Study||0
7988548|NCT00158197|19669164|P2|NOT COMPLETED|Overall Study||0
7988549|NCT00158197|19669165|P1|NOT COMPLETED|Overall Study||0
7988550|NCT00158197|19669162|P4|COMPLETED|Overall Study||29
7988551|NCT00158197|19669163|P3|COMPLETED|Overall Study||28
7988552|NCT00158197|19669164|P2|COMPLETED|Overall Study||30
7988553|NCT00158197|19669165|P1|COMPLETED|Overall Study||32
7988554|NCT00158197|19669162|P4|STARTED|Overall Study||29
7988555|NCT00158197|19669163|P3|STARTED|Overall Study||28
7988556|NCT00158197|19669164|P2|STARTED|Overall Study||30
7988557|NCT00158197|19669165|P1|STARTED|Overall Study||32
7988558|NCT00158184|19669185|P2|NOT COMPLETED|Overall Study||2
7988559|NCT00158184|19669186|P1|NOT COMPLETED|Overall Study||6
7988560|NCT00158184|19669185|P2|COMPLETED|Overall Study||9
7988561|NCT00158184|19669186|P1|COMPLETED|Overall Study||10
7988562|NCT00158184|19669185|P2|STARTED|Overall Study||11
7988563|NCT00158184|19669186|P1|STARTED|Overall Study||16
7988564|NCT00158054|19669196|P2|NOT COMPLETED|Overall Study||3
7988565|NCT00158054|19669197|P1|NOT COMPLETED|Overall Study||10
7988566|NCT00158054|19669196|P2|COMPLETED|Overall Study||74
7988567|NCT00158054|19669197|P1|COMPLETED|Overall Study||70
7988568|NCT00158054|19669196|P2|STARTED|Overall Study||77
7988569|NCT00158054|19669197|P1|STARTED|Overall Study||80
7988570|NCT00157950|19669211|P2|NOT COMPLETED|Overall Study||0
7988571|NCT00157950|19669212|P1|NOT COMPLETED|Overall Study||1
7988572|NCT00157950|19669211|P2|COMPLETED|Overall Study||59
7988573|NCT00157950|19669212|P1|COMPLETED|Overall Study||116
7988574|NCT00157950|19669211|P2|Vaccinated at Dose 3|Overall Study||59
7988575|NCT00157950|19669212|P1|Vaccinated at Dose 3|Overall Study||116
7988576|NCT00157950|19669211|P2|Vaccinated at Dose 2|Overall Study||59
7988577|NCT00157950|19669212|P1|Vaccinated at Dose 2|Overall Study||117
7988578|NCT00157950|19669211|P2|Vaccinated at Dose 1|Overall Study||59
7988579|NCT00157950|19669212|P1|Vaccinated at Dose 1|Overall Study||117
7988580|NCT00157950|19669211|P2|STARTED|Overall Study||59
7988581|NCT00157950|19669212|P1|STARTED|Overall Study||117
7988582|NCT00157820|19669229|P3|NOT COMPLETED|2nd 8 Months||14
7988583|NCT00157820|19669230|P2|NOT COMPLETED|2nd 8 Months||13
7988584|NCT00157820|19669231|P1|NOT COMPLETED|2nd 8 Months||5
7988585|NCT00157820|19669229|P3|COMPLETED|2nd 8 Months||94
7988586|NCT00157820|19669230|P2|COMPLETED|2nd 8 Months||88
7988587|NCT00157820|19669231|P1|COMPLETED|2nd 8 Months||98
7988588|NCT00157820|19669229|P3|STARTED|2nd 8 Months||108
7988589|NCT00157820|19669230|P2|STARTED|2nd 8 Months||101
7988590|NCT00157820|19669231|P1|STARTED|2nd 8 Months||103
7988591|NCT00157820|19669229|P3|NOT COMPLETED|1 Month Wash Out Period||0
7988592|NCT00157820|19669230|P2|NOT COMPLETED|1 Month Wash Out Period||0
7988593|NCT00157820|19669231|P1|NOT COMPLETED|1 Month Wash Out Period||0
7988594|NCT00157820|19669229|P3|COMPLETED|1 Month Wash Out Period||108
7988595|NCT00157820|19669230|P2|COMPLETED|1 Month Wash Out Period||101
7988596|NCT00157820|19669231|P1|COMPLETED|1 Month Wash Out Period||103
7988597|NCT00157820|19669229|P3|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108
7988598|NCT00157820|19669230|P2|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101
7988599|NCT00157820|19669231|P1|STARTED|1 Month Wash Out Period||103
7988600|NCT00157820|19669229|P3|NOT COMPLETED|1st 8 Month||6
7988601|NCT00157820|19669230|P2|NOT COMPLETED|1st 8 Month||12
7988602|NCT00157820|19669231|P1|NOT COMPLETED|1st 8 Month||8
7988603|NCT00157820|19669229|P3|COMPLETED|1st 8 Month||106
7988604|NCT00157820|19669230|P2|COMPLETED|1st 8 Month||99
7988605|NCT00157820|19669231|P1|COMPLETED|1st 8 Month||103
7988606|NCT00157820|19669229|P3|STARTED|1st 8 Month||112
7988607|NCT00157820|19669230|P2|STARTED|1st 8 Month||111
7988608|NCT00157820|19669231|P1|STARTED|1st 8 Month||111
7988609|NCT00157820|19669229|P3|NOT COMPLETED|Randomized||8
7988610|NCT00157820|19669230|P2|NOT COMPLETED|Randomized||5
7988611|NCT00157820|19669231|P1|NOT COMPLETED|Randomized||7
7988612|NCT00157820|19669229|P3|COMPLETED|Randomized||112
7988613|NCT00157820|19669230|P2|COMPLETED|Randomized||111
7988614|NCT00157820|19669231|P1|COMPLETED|Randomized||111
7988615|NCT00157820|19669229|P3|STARTED|Randomized||120
7988616|NCT00157820|19669230|P2|STARTED|Randomized||116
7988617|NCT00157820|19669231|P1|STARTED|Randomized||118
7988618|NCT00157755|19669244|P6|NOT COMPLETED|Overall Study||5
7988619|NCT00157755|19669245|P5|NOT COMPLETED|Overall Study||2
7988620|NCT00157755|19669246|P4|NOT COMPLETED|Overall Study||4
7988621|NCT00157755|19669247|P3|NOT COMPLETED|Overall Study||7
7988622|NCT00157755|19669248|P2|NOT COMPLETED|Overall Study||4
7988623|NCT00157755|19669249|P1|NOT COMPLETED|Overall Study||2
7988624|NCT00157755|19669244|P6|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0
7988625|NCT00157755|19669245|P5|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10
7988626|NCT00157755|19669246|P4|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11
7988627|NCT00157755|19669247|P3|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3
7988628|NCT00157755|19669248|P2|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15
7988629|NCT00157755|19669249|P1|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24
7988630|NCT00157755|19669244|P6|STARTED|Overall Study||5
7988631|NCT00157755|19669245|P5|STARTED|Overall Study||12
7988632|NCT00157755|19669246|P4|STARTED|Overall Study||15
7988633|NCT00157755|19669247|P3|STARTED|Overall Study||10
7988634|NCT00157755|19669248|P2|STARTED|Overall Study||19
7988635|NCT00157755|19669249|P1|STARTED|Overall Study||26
7988636|NCT00157573|19669271|P2|NOT COMPLETED|Overall Study||0
7988637|NCT00157573|19669272|P1|NOT COMPLETED|Overall Study||0
7988638|NCT00157573|19669271|P2|COMPLETED|Overall Study||37
7988639|NCT00157573|19669272|P1|COMPLETED|Overall Study||35
7988640|NCT00157573|19669271|P2|STARTED|Overall Study||37
7988641|NCT00157573|19669272|P1|STARTED|Overall Study||35
7988642|NCT00157248|19669285|P4|NOT COMPLETED|Overall Study||47
7988643|NCT00157248|19669286|P3|NOT COMPLETED|Overall Study||21
7988644|NCT00157248|19669287|P2|NOT COMPLETED|Overall Study||37
7988645|NCT00157248|19669288|P1|NOT COMPLETED|Overall Study||48
7988646|NCT00157248|19669285|P4|COMPLETED|Overall Study||77
7988647|NCT00157248|19669286|P3|COMPLETED|Overall Study||29
7988648|NCT00157248|19669287|P2|COMPLETED|Overall Study||52
7988649|NCT00157248|19669288|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50
7988650|NCT00157248|19669285|P4|STARTED|Overall Study||124
7988651|NCT00157248|19669286|P3|STARTED|Overall Study||50
7988652|NCT00157248|19669287|P2|STARTED|Overall Study||89
7988653|NCT00157248|19669288|P1|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98
7988654|NCT00157209|19669394|P2|NOT COMPLETED|Overall Study||0
7988655|NCT00157209|19669395|P1|NOT COMPLETED|Overall Study||10
7988656|NCT00157209|19669394|P2|COMPLETED|Overall Study||83
7988657|NCT00157209|19669395|P1|COMPLETED|Overall Study||78
7988658|NCT00157209|19669394|P2|STARTED|Overall Study||83
7988659|NCT00157209|19669395|P1|STARTED|Overall Study||88
7988660|NCT00157196|19669409|P1|NOT COMPLETED|Overall Study||9
7988661|NCT00157196|19669409|P1|COMPLETED|Overall Study||13
7988662|NCT00157196|19669409|P1|STARTED|Overall Study||22
7988663|NCT00157157|19669415|P1|NOT COMPLETED|Overall Study||11
7988664|NCT00157157|19669415|P1|COMPLETED|Overall Study||44
7988665|NCT00157157|19669415|P1|STARTED|Overall Study||55
7988666|NCT00157014|19669442|P4|NOT COMPLETED|Overall Study||1
7988667|NCT00157014|19669443|P3|NOT COMPLETED|Overall Study||1
7988668|NCT00157014|19669444|P2|NOT COMPLETED|Overall Study||5
7988669|NCT00157014|19669445|P1|NOT COMPLETED|Overall Study||7
7988670|NCT00157014|19669442|P4|COMPLETED|Overall Study||5
7988671|NCT00157014|19669443|P3|COMPLETED|Overall Study||4
7988672|NCT00157014|19669444|P2|COMPLETED|Overall Study||41
7988673|NCT00157014|19669445|P1|COMPLETED|Overall Study||45
7988674|NCT00157014|19669442|P4|STARTED|Overall Study||6
7988675|NCT00157014|19669443|P3|STARTED|Overall Study||5
7988676|NCT00157014|19669444|P2|STARTED|Overall Study||46
7988677|NCT00157014|19669445|P1|STARTED|Overall Study||52
7988678|NCT00156936|19669525|P2|NOT COMPLETED|Overall Study||11
7988679|NCT00156936|19669526|P1|NOT COMPLETED|Overall Study||72
7988680|NCT00156936|19669525|P2|COMPLETED|Overall Study||5
7988681|NCT00156936|19669526|P1|COMPLETED|Overall Study||20
7988682|NCT00156936|19669525|P2|STARTED|Overall Study||16
7988683|NCT00156936|19669526|P1|STARTED|Overall Study||92
7988684|NCT00156923|19669534|P2|NOT COMPLETED|Overall Study||32
7988685|NCT00156923|19669535|P1|NOT COMPLETED|Overall Study||34
7988686|NCT00156923|19669534|P2|COMPLETED|Overall Study||20
7988687|NCT00156923|19669535|P1|COMPLETED|Overall Study||22
7988688|NCT00156923|19669534|P2|STARTED|Overall Study||52
7988689|NCT00156923|19669535|P1|STARTED|Overall Study||56
7988690|NCT00156910|19669543|P2|NOT COMPLETED|Open-Label Phase (OL)||55
7988691|NCT00156910|19669544|P1|NOT COMPLETED|Open-Label Phase (OL)||33
7988692|NCT00156910|19669543|P2|COMPLETED|Open-Label Phase (OL)||231
7988693|NCT00156910|19669544|P1|COMPLETED|Open-Label Phase (OL)||252
7988694|NCT00156910|19669543|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286
7988695|NCT00156910|19669544|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285
7988696|NCT00156910|19669543|P2|NOT COMPLETED|Double-Blind Phase (DB)||43
7988697|NCT00156910|19669544|P1|NOT COMPLETED|Double-Blind Phase (DB)||45
7988698|NCT00156910|19669543|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295
7988699|NCT00156910|19669544|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296
7988700|NCT00156910|19669543|P2|STARTED|Double-Blind Phase (DB)||338
7988701|NCT00156910|19669544|P1|STARTED|Double-Blind Phase (DB)||341
7988702|NCT00156819|19669561|P3|NOT COMPLETED|Overall Study||3
7988703|NCT00156819|19669562|P2|NOT COMPLETED|Overall Study||1
7988704|NCT00156819|19669563|P1|NOT COMPLETED|Overall Study||1
7988705|NCT00156819|19669561|P3|COMPLETED|Overall Study||162
7988706|NCT00156819|19669562|P2|COMPLETED|Overall Study||165
7988707|NCT00156819|19669563|P1|COMPLETED|Overall Study||168
7988708|NCT00156819|19669561|P3|STARTED|Overall Study||165
7988709|NCT00156819|19669562|P2|STARTED|Overall Study||166
7988710|NCT00156819|19669563|P1|STARTED|Overall Study||169
7988711|NCT00156715|19669571|P1|NOT COMPLETED|Overall Study||7
7988712|NCT00156715|19669571|P1|COMPLETED|Overall Study||16
7988713|NCT00156715|19669571|P1|STARTED|Overall Study||23
7988714|NCT00156533|19669580|P4|NOT COMPLETED|Overall Study||2
7988715|NCT00156533|19669581|P3|NOT COMPLETED|Overall Study||2
7988716|NCT00156533|19669582|P2|NOT COMPLETED|Overall Study||2
7988717|NCT00156533|19669583|P1|NOT COMPLETED|Overall Study||2
7988718|NCT00156533|19669580|P4|COMPLETED|Overall Study||3
7988719|NCT00156533|19669581|P3|COMPLETED|Overall Study||3
7988720|NCT00156533|19669582|P2|COMPLETED|Overall Study||3
7988721|NCT00156533|19669583|P1|COMPLETED|Overall Study||3
7988722|NCT00156533|19669580|P4|STARTED|Overall Study||5
7988723|NCT00156533|19669581|P3|STARTED|Overall Study||5
7988724|NCT00156533|19669582|P2|STARTED|Overall Study||5
7988725|NCT00156533|19669583|P1|STARTED|Overall Study||5
7988726|NCT00156390|19669599|P2|NOT COMPLETED|Overall Study||8
7988727|NCT00156390|19669600|P1|NOT COMPLETED|Overall Study||14
7988728|NCT00156390|19669599|P2|COMPLETED|Overall Study||69
7988729|NCT00156390|19669600|P1|COMPLETED|Overall Study||96
7988730|NCT00156390|19669599|P2|STARTED|Overall Study||77
7988731|NCT00156390|19669600|P1|STARTED|Overall Study||110
7988732|NCT00156247|19669608|P1|NOT COMPLETED|Overall Study||4
7988733|NCT00156247|19669608|P1|COMPLETED|Overall Study||5
7988734|NCT00156247|19669608|P1|STARTED|Overall Study||9
7988735|NCT00156065|19669617|P3|NOT COMPLETED|Overall Study||27
7988736|NCT00156065|19669618|P2|NOT COMPLETED|Overall Study||63
7988737|NCT00156065|19669619|P1|NOT COMPLETED|Overall Study||31
7988738|NCT00156065|19669617|P3|COMPLETED|Overall Study||16
7988739|NCT00156065|19669618|P2|COMPLETED|Overall Study||30
7988740|NCT00156065|19669619|P1|COMPLETED|Overall Study||20
7988741|NCT00156065|19669617|P3|STARTED|Overall Study||43
7988742|NCT00156065|19669618|P2|STARTED|Overall Study||93
7988743|NCT00156065|19669619|P1|STARTED|Overall Study||51
7988744|NCT00156013|19669630|P1|NOT COMPLETED|Overall Study||2
7988745|NCT00156013|19669630|P1|COMPLETED|Overall Study||31
7988746|NCT00156013|19669630|P1|STARTED|Overall Study||33
7988747|NCT00154466|19669639|P3|NOT COMPLETED|Overall Study||0
7988748|NCT00154466|19669640|P2|NOT COMPLETED|Overall Study||0
7988749|NCT00154466|19669641|P1|NOT COMPLETED|Overall Study||0
7988750|NCT00154466|19669639|P3|COMPLETED|Overall Study||19
7988751|NCT00154466|19669640|P2|COMPLETED|Overall Study||19
7988752|NCT00154466|19669641|P1|COMPLETED|Overall Study||20
7988753|NCT00154466|19669639|P3|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19
7988754|NCT00154466|19669640|P2|STARTED|Overall Study||19
7988755|NCT00154466|19669641|P1|STARTED|Overall Study||20
7988756|NCT00154375|19669653|P2|NOT COMPLETED|Overall Study||106
7988757|NCT00154375|19669654|P1|NOT COMPLETED|Overall Study||113
7988758|NCT00154375|19669653|P2|COMPLETED|Overall Study||14
7988759|NCT00154375|19669654|P1|COMPLETED|Overall Study||7
7988760|NCT00154375|19669653|P2|Not Exposed to Study Treatment|Overall Study||2
7988761|NCT00154375|19669654|P1|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2
7988762|NCT00154375|19669653|P2|Discontinued Study Treatment|Overall Study||104
7988763|NCT00154375|19669654|P1|Discontinued Study Treatment|Overall Study||111
7988764|NCT00154375|19669653|P2|STARTED|Overall Study||120
7988765|NCT00154375|19669654|P1|STARTED|Overall Study||120
7988766|NCT00154310|19669665|P2|NOT COMPLETED|Overall Study||28
7988767|NCT00154310|19669666|P1|NOT COMPLETED|Overall Study||37
7988768|NCT00154310|19669665|P2|COMPLETED|Overall Study||117
7988769|NCT00154310|19669666|P1|COMPLETED|Overall Study||118
7988770|NCT00154310|19669665|P2|STARTED|Overall Study||145
7988771|NCT00154310|19669666|P1|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155
7988772|NCT00154297|19669682|P2|NOT COMPLETED|Overall Study||7
7988773|NCT00154297|19669683|P1|NOT COMPLETED|Overall Study||8
7988774|NCT00154297|19669682|P2|COMPLETED|Overall Study|Completed study by 12 month.|67
7988775|NCT00154297|19669683|P1|COMPLETED|Overall Study|Completed study by 12 month.|57
7988776|NCT00154297|19669682|P2|STARTED|Overall Study|Randomized population.|74
7988777|NCT00154297|19669683|P1|STARTED|Overall Study|Randomized population.|65
7988778|NCT00154284|19669701|P2|NOT COMPLETED|Overall Study||13
7988779|NCT00154284|19669702|P1|NOT COMPLETED|Overall Study||7
7988780|NCT00154284|19669701|P2|COMPLETED|Overall Study||42
7988781|NCT00154284|19669702|P1|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52
7988782|NCT00154284|19669701|P2|Intent to Treat (ITT) Population|Overall Study||53
7988783|NCT00154284|19669702|P1|Intent to Treat (ITT) Population|Overall Study||57
7988784|NCT00154284|19669701|P2|STARTED|Overall Study||55
7988785|NCT00154284|19669702|P1|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59
7988786|NCT00154102|19669716|P2|NOT COMPLETED|Overall Study||2
7988787|NCT00154102|19669717|P1|NOT COMPLETED|Overall Study||7
7988788|NCT00154102|19669716|P2|COMPLETED|Overall Study||597
7988789|NCT00154102|19669717|P1|COMPLETED|Overall Study||592
7988790|NCT00154102|19669716|P2|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599
7988791|NCT00154102|19669717|P1|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599
7988792|NCT00154063|19669753|P2|NOT COMPLETED|Overall Study||22
7988793|NCT00154063|19669754|P1|NOT COMPLETED|Overall Study||12
7988794|NCT00154063|19669753|P2|COMPLETED|Overall Study||80
7988795|NCT00154063|19669754|P1|COMPLETED|Overall Study||92
7988796|NCT00154063|19669753|P2|STARTED|Overall Study||102
7988797|NCT00154063|19669754|P1|STARTED|Overall Study||104
7988798|NCT00153985|19669810|P1|NOT COMPLETED|Overall Study||0
7988799|NCT00153985|19669810|P1|COMPLETED|Overall Study||2
7988800|NCT00153985|19669810|P1|STARTED|Overall Study||2
7988801|NCT00153920|19669816|P1|NOT COMPLETED|Overall Study||30
7988802|NCT00153920|19669816|P1|COMPLETED|Overall Study||36
7988803|NCT00153920|19669816|P1|Eligible and Treated|Overall Study||64
7988804|NCT00153920|19669816|P1|STARTED|Overall Study||66
7988805|NCT00153842|19669827|P2|NOT COMPLETED|Overall Study||0
7988806|NCT00153842|19669828|P1|NOT COMPLETED|Overall Study||0
7988807|NCT00153842|19669827|P2|COMPLETED|Overall Study||7
7988808|NCT00153842|19669828|P1|COMPLETED|Overall Study||26
7988809|NCT00153842|19669827|P2|STARTED|Overall Study||7
7988810|NCT00153842|19669828|P1|STARTED|Overall Study||26
7988811|NCT00153816|19669842|P6|NOT COMPLETED|Overall Study||27
7988812|NCT00153816|19669843|P5|NOT COMPLETED|Overall Study||17
7988813|NCT00153816|19669844|P4|NOT COMPLETED|Overall Study||31
7988814|NCT00153816|19669845|P3|NOT COMPLETED|Overall Study||32
7988815|NCT00153816|19669846|P2|NOT COMPLETED|Overall Study||32
7988816|NCT00153816|19669847|P1|NOT COMPLETED|Overall Study||32
7988817|NCT00153816|19669842|P6|COMPLETED|Overall Study||262
7988818|NCT00153816|19669843|P5|COMPLETED|Overall Study||278
7988819|NCT00153816|19669844|P4|COMPLETED|Overall Study||390
7988820|NCT00153816|19669845|P3|COMPLETED|Overall Study||388
7988821|NCT00153816|19669846|P2|COMPLETED|Overall Study||387
7988822|NCT00153816|19669847|P1|COMPLETED|Overall Study||383
7988823|NCT00153816|19669842|P6|STARTED|Overall Study||289
7988824|NCT00153816|19669843|P5|STARTED|Overall Study||295
7988825|NCT00153816|19669844|P4|STARTED|Overall Study||421
7988826|NCT00153816|19669845|P3|STARTED|Overall Study||420
7988827|NCT00153816|19669846|P2|STARTED|Overall Study||419
7988828|NCT00153816|19669847|P1|STARTED|Overall Study||415
7988829|NCT00153803|19669869|P2|NOT COMPLETED|Investigational Drug||42
7988830|NCT00153803|19669870|P1|NOT COMPLETED|Investigational Drug||41
7988831|NCT00153803|19669869|P2|COMPLETED|Investigational Drug||75
7988832|NCT00153803|19669870|P1|COMPLETED|Investigational Drug||77
7988833|NCT00153803|19669869|P2|Investigational Drug Dispensed|Investigational Drug||75
7988834|NCT00153803|19669870|P1|Investigational Drug Dispensed|Investigational Drug||77
7988835|NCT00153803|19669869|P2|STARTED|Investigational Drug||117
7988836|NCT00153803|19669870|P1|STARTED|Investigational Drug||118
7988837|NCT00153803|19669869|P2|NOT COMPLETED|Concurrent Chemoradiation||5
7988838|NCT00153803|19669870|P1|NOT COMPLETED|Concurrent Chemoradiation||5
7988839|NCT00153803|19669869|P2|COMPLETED|Concurrent Chemoradiation||117
7988840|NCT00153803|19669870|P1|COMPLETED|Concurrent Chemoradiation||118
7988841|NCT00153803|19669869|P2|Received Chemoradiation|Concurrent Chemoradiation||117
7988842|NCT00153803|19669870|P1|Received Chemoradiation|Concurrent Chemoradiation||118
7988843|NCT00153803|19669869|P2|STARTED|Concurrent Chemoradiation||122
7988844|NCT00153803|19669870|P1|STARTED|Concurrent Chemoradiation||123
7988845|NCT00153179|19669888|P4|NOT COMPLETED|Study Visit Day 2||2
7988846|NCT00153179|19669889|P3|NOT COMPLETED|Study Visit Day 2||2
7988847|NCT00153179|19669890|P2|NOT COMPLETED|Study Visit Day 2||0
7988848|NCT00153179|19669891|P1|NOT COMPLETED|Study Visit Day 2||1
7988849|NCT00153179|19669888|P4|COMPLETED|Study Visit Day 2||7
7988850|NCT00153179|19669889|P3|COMPLETED|Study Visit Day 2||11
7988851|NCT00153179|19669890|P2|COMPLETED|Study Visit Day 2||8
7988852|NCT00153179|19669891|P1|COMPLETED|Study Visit Day 2||9
7988853|NCT00153179|19669888|P4|STARTED|Study Visit Day 2||9
7988854|NCT00153179|19669889|P3|STARTED|Study Visit Day 2||13
7988855|NCT00153179|19669890|P2|STARTED|Study Visit Day 2||8
7988856|NCT00153179|19669891|P1|STARTED|Study Visit Day 2||10
7988857|NCT00153179|19669888|P4|NOT COMPLETED|Study Visit Day 1||0
7988858|NCT00153179|19669889|P3|NOT COMPLETED|Study Visit Day 1||0
7988859|NCT00153179|19669890|P2|NOT COMPLETED|Study Visit Day 1||0
7988860|NCT00153179|19669891|P1|NOT COMPLETED|Study Visit Day 1||0
7988861|NCT00153179|19669888|P4|COMPLETED|Study Visit Day 1||9
7988862|NCT00153179|19669889|P3|COMPLETED|Study Visit Day 1||13
7988863|NCT00153179|19669890|P2|COMPLETED|Study Visit Day 1||8
7988864|NCT00153179|19669891|P1|COMPLETED|Study Visit Day 1||10
7988865|NCT00153179|19669888|P4|STARTED|Study Visit Day 1||9
7988866|NCT00153179|19669889|P3|STARTED|Study Visit Day 1||13
7988867|NCT00153179|19669890|P2|STARTED|Study Visit Day 1||8
7988868|NCT00153179|19669891|P1|STARTED|Study Visit Day 1||10
7988869|NCT00153166|19669904|P3|NOT COMPLETED|Overall Study||0
7988870|NCT00153166|19669905|P2|NOT COMPLETED|Overall Study||0
7988871|NCT00153166|19669906|P1|NOT COMPLETED|Overall Study||0
7988872|NCT00153166|19669904|P3|COMPLETED|Overall Study||28
7988873|NCT00153166|19669905|P2|COMPLETED|Overall Study||37
7988874|NCT00153166|19669906|P1|COMPLETED|Overall Study||11
7988875|NCT00153166|19669904|P3|Received Placebo and Placebo|Overall Study||7
7988876|NCT00153166|19669905|P2|Received Placebo and Placebo|Overall Study||9
7988877|NCT00153166|19669906|P1|Received Placebo and Placebo|Overall Study||3
7988878|NCT00153166|19669904|P3|Received Placebo and Pioglitazone|Overall Study||7
7988879|NCT00153166|19669905|P2|Received Placebo and Pioglitazone|Overall Study||10
7988880|NCT00153166|19669906|P1|Received Placebo and Pioglitazone|Overall Study||3
7988881|NCT00153166|19669904|P3|Received Atorvastatin and Placebo|Overall Study||7
7988882|NCT00153166|19669905|P2|Received Atorvastatin and Placebo|Overall Study||9
7988883|NCT00153166|19669906|P1|Received Atorvastatin and Placebo|Overall Study||2
7988884|NCT00153166|19669904|P3|Received Atorvastatin and Pioglitazone|Overall Study||7
7988885|NCT00153166|19669905|P2|Received Atorvastatin and Pioglitazone|Overall Study||9
7988886|NCT00153166|19669906|P1|Received Atorvastatin and Pioglitazone|Overall Study||3
7988887|NCT00153166|19669904|P3|STARTED|Overall Study||28
7988888|NCT00153166|19669905|P2|STARTED|Overall Study||37
7988889|NCT00153166|19669906|P1|STARTED|Overall Study||11
7988890|NCT00153101|19669923|P5|NOT COMPLETED|Overall Study||10
7988891|NCT00153101|19669924|P4|NOT COMPLETED|Overall Study||8
7988892|NCT00153101|19669925|P3|NOT COMPLETED|Overall Study||15
7988893|NCT00153101|19669926|P2|NOT COMPLETED|Overall Study||18
7988894|NCT00153101|19669927|P1|NOT COMPLETED|Overall Study||17
7988895|NCT00153101|19669923|P5|COMPLETED|Overall Study||2962
7988896|NCT00153101|19669924|P4|COMPLETED|Overall Study||2946
7988897|NCT00153101|19669925|P3|COMPLETED|Overall Study||8561
7988898|NCT00153101|19669926|P2|COMPLETED|Overall Study||8524
7988899|NCT00153101|19669927|P1|COMPLETED|Overall Study||8485
7988900|NCT00153101|19669923|P5|STARTED|Overall Study||2972
7988901|NCT00153101|19669924|P4|STARTED|Overall Study||2954
7988902|NCT00153101|19669925|P3|STARTED|Overall Study||8576
7988903|NCT00153101|19669926|P2|STARTED|Overall Study||8542
7988904|NCT00153101|19669927|P1|STARTED|Overall Study||8502
7988905|NCT00153062|19670035|P4|NOT COMPLETED|Overall Study||411
7988906|NCT00153062|19670036|P3|NOT COMPLETED|Overall Study||415
7988907|NCT00153062|19670037|P2|NOT COMPLETED|Overall Study||406
7988908|NCT00153062|19670038|P1|NOT COMPLETED|Overall Study||387
7988909|NCT00153062|19670035|P4|COMPLETED|Overall Study||4680
7988910|NCT00153062|19670036|P3|COMPLETED|Overall Study||4645
7988911|NCT00153062|19670037|P2|COMPLETED|Overall Study||4689
7988912|NCT00153062|19670038|P1|COMPLETED|Overall Study||4699
7988913|NCT00153062|19670035|P4|STARTED|Overall Study||5091
7988914|NCT00153062|19670036|P3|STARTED|Overall Study||5060
7988915|NCT00153062|19670037|P2|STARTED|Overall Study||5095
7988916|NCT00153062|19670038|P1|STARTED|Overall Study||5086
7988917|NCT00152971|19670057|P3|NOT COMPLETED|Treatment||80
7988918|NCT00152971|19670058|P2|NOT COMPLETED|Treatment||63
7988919|NCT00152971|19670059|P1|NOT COMPLETED|Treatment||71
7988920|NCT00152971|19670057|P3|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788
7988921|NCT00152971|19670058|P2|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808
7988922|NCT00152971|19670059|P1|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786
7988923|NCT00152971|19670057|P3|STARTED|Treatment||868
7988924|NCT00152971|19670058|P2|STARTED|Treatment||871
7988925|NCT00152971|19670059|P1|STARTED|Treatment||857
7988926|NCT00152971|19670057|P3|NOT COMPLETED|Overall Study||49
7988927|NCT00152971|19670058|P2|NOT COMPLETED|Overall Study||48
7988928|NCT00152971|19670059|P1|NOT COMPLETED|Overall Study||51
7988929|NCT00152971|19670057|P3|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819
7988930|NCT00152971|19670058|P2|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823
7988931|NCT00152971|19670059|P1|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806
7988932|NCT00152971|19670057|P3|STARTED|Overall Study||868
7988933|NCT00152971|19670058|P2|STARTED|Overall Study||871
7988934|NCT00152971|19670059|P1|STARTED|Overall Study||857
7988935|NCT00152763|19670095|P4|NOT COMPLETED|Overall Study||14
7988936|NCT00152763|19670096|P3|NOT COMPLETED|Overall Study||4
7988937|NCT00152763|19670097|P2|NOT COMPLETED|Overall Study||5
7988938|NCT00152763|19670098|P1|NOT COMPLETED|Overall Study||10
7988939|NCT00152763|19670095|P4|COMPLETED|Overall Study||63
7988940|NCT00152763|19670096|P3|COMPLETED|Overall Study||16
7988941|NCT00152763|19670097|P2|COMPLETED|Overall Study||14
7988942|NCT00152763|19670098|P1|COMPLETED|Overall Study||67
7988943|NCT00152763|19670095|P4|STARTED|Overall Study||77
7988944|NCT00152763|19670096|P3|STARTED|Overall Study||20
7988945|NCT00152763|19670097|P2|STARTED|Overall Study||19
7988946|NCT00152763|19670098|P1|STARTED|Overall Study||77
7988947|NCT00152516|19670214|P1|NOT COMPLETED|Overall Study||75
7988948|NCT00152516|19670214|P1|COMPLETED|Overall Study|Subjects ongoing until study close-out|180
7988949|NCT00152516|19670214|P1|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255
7988950|NCT00152464|19670240|P2|NOT COMPLETED|Overall Study||36
7988951|NCT00152464|19670241|P1|NOT COMPLETED|Overall Study||40
7988952|NCT00152464|19670240|P2|COMPLETED|Overall Study||219
7988953|NCT00152464|19670241|P1|COMPLETED|Overall Study||215
7988954|NCT00152464|19670240|P2|STARTED|Overall Study||255
7988955|NCT00152464|19670241|P1|STARTED|Overall Study||255
7988956|NCT00152009|19670269|P4|NOT COMPLETED|Overall Study||33
7988957|NCT00152009|19670270|P3|NOT COMPLETED|Overall Study||37
7988958|NCT00152009|19670271|P2|NOT COMPLETED|Overall Study||31
7988959|NCT00152009|19670272|P1|NOT COMPLETED|Overall Study||29
7988960|NCT00152009|19670269|P4|COMPLETED|Overall Study||53
7988961|NCT00152009|19670270|P3|COMPLETED|Overall Study||49
7988962|NCT00152009|19670271|P2|COMPLETED|Overall Study||55
7988963|NCT00152009|19670272|P1|COMPLETED|Overall Study||58
7988964|NCT00152009|19670269|P4|STARTED|Overall Study||86
7988965|NCT00152009|19670270|P3|STARTED|Overall Study||86
7988966|NCT00152009|19670271|P2|STARTED|Overall Study||86
7988967|NCT00152009|19670272|P1|STARTED|Overall Study||87
7988968|NCT00151996|19670304|P2|NOT COMPLETED|Overall Study||7
7988969|NCT00151996|19670305|P1|NOT COMPLETED|Overall Study||5
7988970|NCT00151996|19670304|P2|COMPLETED|Overall Study||26
7988971|NCT00151996|19670305|P1|COMPLETED|Overall Study||37
7988972|NCT00151996|19670304|P2|STARTED|Overall Study||33
7988973|NCT00151996|19670305|P1|STARTED|Overall Study||42
7988974|NCT00151892|19670321|P2|NOT COMPLETED|Overall Study||83
7988975|NCT00151892|19670322|P1|NOT COMPLETED|Overall Study||76
7988976|NCT00151892|19670321|P2|COMPLETED|Overall Study||330
7988977|NCT00151892|19670322|P1|COMPLETED|Overall Study||340
7988978|NCT00151892|19670321|P2|STARTED|Overall Study||413
7988979|NCT00151892|19670322|P1|STARTED|Overall Study||416
7988980|NCT00151814|19670339|P3|NOT COMPLETED|Overall Study||0
7988981|NCT00151814|19670340|P2|NOT COMPLETED|Overall Study||0
7988982|NCT00151814|19670341|P1|NOT COMPLETED|Overall Study||0
7988983|NCT00151814|19670339|P3|COMPLETED|Overall Study||10
7988984|NCT00151814|19670340|P2|COMPLETED|Overall Study||10
7988985|NCT00151814|19670341|P1|COMPLETED|Overall Study||4
7988986|NCT00151814|19670339|P3|STARTED|Overall Study||10
7988987|NCT00151814|19670340|P2|STARTED|Overall Study||10
7988988|NCT00151814|19670341|P1|STARTED|Overall Study||4
7988989|NCT00151775|19670367|P12|NOT COMPLETED|Period 4: Open Label||0
7988990|NCT00151775|19670368|P11|NOT COMPLETED|Period 4: Open Label||0
7988991|NCT00151775|19670369|P10|NOT COMPLETED|Period 4: Open Label||21
7988992|NCT00151775|19670370|P9|NOT COMPLETED|Period 4: Open Label||0
7988993|NCT00151775|19670371|P8|NOT COMPLETED|Period 4: Open Label||0
7988994|NCT00151775|19670372|P7|NOT COMPLETED|Period 4: Open Label||0
7988995|NCT00151775|19670373|P6|NOT COMPLETED|Period 4: Open Label||0
7988996|NCT00151775|19670374|P5|NOT COMPLETED|Period 4: Open Label||30
7988997|NCT00151775|19670375|P4|NOT COMPLETED|Period 4: Open Label||0
7988998|NCT00151775|19670376|P3|NOT COMPLETED|Period 4: Open Label||0
7988999|NCT00151775|19670377|P2|NOT COMPLETED|Period 4: Open Label||0
7989000|NCT00151775|19670378|P1|NOT COMPLETED|Period 4: Open Label||0
7989001|NCT00151775|19670367|P12|COMPLETED|Period 4: Open Label||0
7989002|NCT00151775|19670368|P11|COMPLETED|Period 4: Open Label||57
7989003|NCT00151775|19670369|P10|COMPLETED|Period 4: Open Label||83
7989004|NCT00151775|19670370|P9|COMPLETED|Period 4: Open Label||0
7989005|NCT00151775|19670371|P8|COMPLETED|Period 4: Open Label||0
7989006|NCT00151775|19670372|P7|COMPLETED|Period 4: Open Label||0
7989007|NCT00151775|19670373|P6|COMPLETED|Period 4: Open Label||0
7989008|NCT00151775|19670374|P5|COMPLETED|Period 4: Open Label||149
7989009|NCT00151775|19670375|P4|COMPLETED|Period 4: Open Label||0
7989010|NCT00151775|19670376|P3|COMPLETED|Period 4: Open Label||0
7989011|NCT00151775|19670377|P2|COMPLETED|Period 4: Open Label||0
7989012|NCT00151775|19670378|P1|COMPLETED|Period 4: Open Label||0
7989013|NCT00151775|19670367|P12|STARTED|Period 4: Open Label||0
7989014|NCT00151775|19670368|P11|STARTED|Period 4: Open Label||57
7989015|NCT00151775|19670369|P10|STARTED|Period 4: Open Label||104
7989016|NCT00151775|19670370|P9|STARTED|Period 4: Open Label||0
7989017|NCT00151775|19670371|P8|STARTED|Period 4: Open Label||0
7989018|NCT00151775|19670372|P7|STARTED|Period 4: Open Label||0
7989019|NCT00151775|19670373|P6|STARTED|Period 4: Open Label||0
7989020|NCT00151775|19670374|P5|STARTED|Period 4: Open Label||179
7989021|NCT00151775|19670375|P4|STARTED|Period 4: Open Label||0
7989022|NCT00151775|19670376|P3|STARTED|Period 4: Open Label||0
7989023|NCT00151775|19670377|P2|STARTED|Period 4: Open Label||0
7989024|NCT00151775|19670378|P1|STARTED|Period 4: Open Label||0
7989025|NCT00151775|19670367|P12|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
7989026|NCT00151775|19670368|P11|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
7989027|NCT00151775|19670369|P10|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
7989028|NCT00151775|19670370|P9|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
7989029|NCT00151775|19670371|P8|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
7989030|NCT00151775|19670372|P7|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
7989031|NCT00151775|19670373|P6|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
7989032|NCT00151775|19670374|P5|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
7989033|NCT00151775|19670375|P4|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
7989034|NCT00151775|19670376|P3|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3
7989035|NCT00151775|19670377|P2|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
7989036|NCT00151775|19670378|P1|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
7989037|NCT00151775|19670367|P12|COMPLETED|Period 3: Double-blind, Withdrawal||28
7989038|NCT00151775|19670368|P11|COMPLETED|Period 3: Double-blind, Withdrawal||29
7989039|NCT00151775|19670369|P10|COMPLETED|Period 3: Double-blind, Withdrawal||0
7989040|NCT00151775|19670370|P9|COMPLETED|Period 3: Double-blind, Withdrawal||26
7989041|NCT00151775|19670371|P8|COMPLETED|Period 3: Double-blind, Withdrawal||27
7989042|NCT00151775|19670372|P7|COMPLETED|Period 3: Double-blind, Withdrawal||26
7989043|NCT00151775|19670373|P6|COMPLETED|Period 3: Double-blind, Withdrawal||25
7989044|NCT00151775|19670374|P5|COMPLETED|Period 3: Double-blind, Withdrawal||0
7989045|NCT00151775|19670375|P4|COMPLETED|Period 3: Double-blind, Withdrawal||44
7989046|NCT00151775|19670376|P3|COMPLETED|Period 3: Double-blind, Withdrawal||42
7989047|NCT00151775|19670377|P2|COMPLETED|Period 3: Double-blind, Withdrawal||45
7989048|NCT00151775|19670378|P1|COMPLETED|Period 3: Double-blind, Withdrawal||48
7989049|NCT00151775|19670367|P12|STARTED|Period 3: Double-blind, Withdrawal||29
7989050|NCT00151775|19670368|P11|STARTED|Period 3: Double-blind, Withdrawal||29
7989051|NCT00151775|19670369|P10|STARTED|Period 3: Double-blind, Withdrawal||0
7989052|NCT00151775|19670370|P9|STARTED|Period 3: Double-blind, Withdrawal||26
7989053|NCT00151775|19670371|P8|STARTED|Period 3: Double-blind, Withdrawal||28
7989054|NCT00151775|19670372|P7|STARTED|Period 3: Double-blind, Withdrawal||27
7989055|NCT00151775|19670373|P6|STARTED|Period 3: Double-blind, Withdrawal||26
7989056|NCT00151775|19670374|P5|STARTED|Period 3: Double-blind, Withdrawal||0
7989057|NCT00151775|19670375|P4|STARTED|Period 3: Double-blind, Withdrawal||44
7989058|NCT00151775|19670376|P3|STARTED|Period 3: Double-blind, Withdrawal||45
7989059|NCT00151775|19670377|P2|STARTED|Period 3: Double-blind, Withdrawal||45
7989060|NCT00151775|19670378|P1|STARTED|Period 3: Double-blind, Withdrawal||48
7989061|NCT00151775|19670367|P12|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
7989062|NCT00151775|19670368|P11|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1
7989063|NCT00151775|19670369|P10|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
7989064|NCT00151775|19670370|P9|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
7989065|NCT00151775|19670371|P8|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
7989066|NCT00151775|19670372|P7|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3
7989067|NCT00151775|19670373|P6|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
7989068|NCT00151775|19670374|P5|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
7989069|NCT00151775|19670375|P4|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
7989070|NCT00151775|19670376|P3|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
7989071|NCT00151775|19670377|P2|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6
7989072|NCT00151775|19670378|P1|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
7989073|NCT00151775|19670367|P12|COMPLETED|Period 2 - Double-Blind Dose Response||0
7989074|NCT00151775|19670368|P11|COMPLETED|Period 2 - Double-Blind Dose Response||59
7989075|NCT00151775|19670369|P10|COMPLETED|Period 2 - Double-Blind Dose Response||0
7989076|NCT00151775|19670370|P9|COMPLETED|Period 2 - Double-Blind Dose Response||0
7989077|NCT00151775|19670371|P8|COMPLETED|Period 2 - Double-Blind Dose Response||0
7989078|NCT00151775|19670372|P7|COMPLETED|Period 2 - Double-Blind Dose Response||53
7989079|NCT00151775|19670373|P6|COMPLETED|Period 2 - Double-Blind Dose Response||54
7989080|NCT00151775|19670374|P5|COMPLETED|Period 2 - Double-Blind Dose Response||0
7989081|NCT00151775|19670375|P4|COMPLETED|Period 2 - Double-Blind Dose Response||0
7989082|NCT00151775|19670376|P3|COMPLETED|Period 2 - Double-Blind Dose Response||0
7989083|NCT00151775|19670377|P2|COMPLETED|Period 2 - Double-Blind Dose Response||89
7989084|NCT00151775|19670378|P1|COMPLETED|Period 2 - Double-Blind Dose Response||93
7989085|NCT00151775|19670367|P12|STARTED|Period 2 - Double-Blind Dose Response||0
7989086|NCT00151775|19670368|P11|STARTED|Period 2 - Double-Blind Dose Response||60
7989087|NCT00151775|19670369|P10|STARTED|Period 2 - Double-Blind Dose Response||0
7989088|NCT00151775|19670370|P9|STARTED|Period 2 - Double-Blind Dose Response||0
7989089|NCT00151775|19670371|P8|STARTED|Period 2 - Double-Blind Dose Response||0
7989090|NCT00151775|19670372|P7|STARTED|Period 2 - Double-Blind Dose Response||56
7989091|NCT00151775|19670373|P6|STARTED|Period 2 - Double-Blind Dose Response||56
7989092|NCT00151775|19670374|P5|STARTED|Period 2 - Double-Blind Dose Response||0
7989093|NCT00151775|19670375|P4|STARTED|Period 2 - Double-Blind Dose Response||0
7989094|NCT00151775|19670376|P3|STARTED|Period 2 - Double-Blind Dose Response||0
7989095|NCT00151775|19670377|P2|STARTED|Period 2 - Double-Blind Dose Response||95
7989096|NCT00151775|19670378|P1|STARTED|Period 2 - Double-Blind Dose Response||95
7989097|NCT00151476|19670422|P2|NOT COMPLETED|FAP Analyzed Subjects||3
7989098|NCT00151476|19670423|P1|NOT COMPLETED|FAP Analyzed Subjects||0
7989099|NCT00151476|19670422|P2|COMPLETED|FAP Analyzed Subjects||51
7989100|NCT00151476|19670423|P1|COMPLETED|FAP Analyzed Subjects||13
7989101|NCT00151476|19670422|P2|STARTED|FAP Analyzed Subjects||54
7989102|NCT00151476|19670423|P1|STARTED|FAP Analyzed Subjects||13
7989103|NCT00151476|19670422|P2|NOT COMPLETED|FAP Identified Subjects||1
7989104|NCT00151476|19670423|P1|NOT COMPLETED|FAP Identified Subjects||0
7989105|NCT00151476|19670422|P2|COMPLETED|FAP Identified Subjects||54
7989106|NCT00151476|19670423|P1|COMPLETED|FAP Identified Subjects||13
7989107|NCT00151476|19670422|P2|STARTED|FAP Identified Subjects||55
7989108|NCT00151476|19670423|P1|STARTED|FAP Identified Subjects||13
7989109|NCT00151411|19670480|P2|NOT COMPLETED|Overall Study||43
7989110|NCT00151411|19670481|P1|NOT COMPLETED|Overall Study||33
7989111|NCT00151411|19670480|P2|COMPLETED|Overall Study||16
7989112|NCT00151411|19670481|P1|COMPLETED|Overall Study||22
7989113|NCT00151411|19670480|P2|STARTED|Overall Study||59
7989114|NCT00151411|19670481|P1|STARTED|Overall Study||55
7989115|NCT00151372|19670493|P2|NOT COMPLETED|Overall Study||29
7989116|NCT00151372|19670494|P1|NOT COMPLETED|Overall Study||29
7989117|NCT00151372|19670493|P2|COMPLETED|Overall Study||45
7989118|NCT00151372|19670494|P1|COMPLETED|Overall Study||38
7989119|NCT00151372|19670493|P2|STARTED|Overall Study||74
7989120|NCT00151372|19670494|P1|STARTED|Overall Study||67
7989121|NCT00151320|19670504|P1|NOT COMPLETED|Overall Study||0
7989122|NCT00151320|19670504|P1|COMPLETED|Overall Study||76
7989123|NCT00151320|19670504|P1|STARTED|Overall Study||76
7989124|NCT00151281|19670509|P1|NOT COMPLETED|Overall Study||3
7989125|NCT00151281|19670509|P1|COMPLETED|Overall Study||22
7989126|NCT00151281|19670509|P1|STARTED|Overall Study||25
7989127|NCT00150969|19670518|P2|NOT COMPLETED|24-48 Month Extension||100
7989128|NCT00150969|19670519|P1|NOT COMPLETED|24-48 Month Extension||88
7989129|NCT00150969|19670518|P2|COMPLETED|24-48 Month Extension||40
7989130|NCT00150969|19670519|P1|COMPLETED|24-48 Month Extension||33
7989131|NCT00150969|19670518|P2|STARTED|24-48 Month Extension||140
7989132|NCT00150969|19670519|P1|STARTED|24-48 Month Extension||121
7989133|NCT00150969|19670518|P2|NOT COMPLETED|24 Month Main Study||21
7989134|NCT00150969|19670519|P1|NOT COMPLETED|24 Month Main Study||19
7989135|NCT00150969|19670518|P2|COMPLETED|24 Month Main Study||202
7989136|NCT00150969|19670519|P1|COMPLETED|24 Month Main Study||198
7989137|NCT00150969|19670518|P2|STARTED|24 Month Main Study||223
7989138|NCT00150969|19670519|P1|STARTED|24 Month Main Study||217
7989139|NCT00150813|19670551|P1|NOT COMPLETED|Overall Study||18
7989140|NCT00150813|19670551|P1|COMPLETED|Overall Study||48
7989141|NCT00150813|19670551|P1|STARTED|Overall Study||66
7989142|NCT00150800|19670555|P1|NOT COMPLETED|Overall Study||496
7989143|NCT00150800|19670555|P1|COMPLETED|Overall Study||171
7989144|NCT00150800|19670555|P1|STARTED|Overall Study||667
7989145|NCT00150618|19670569|P5|NOT COMPLETED|Overall Study||25
7989146|NCT00150618|19670570|P4|NOT COMPLETED|Overall Study||26
7989147|NCT00150618|19670571|P3|NOT COMPLETED|Overall Study||27
7989148|NCT00150618|19670572|P2|NOT COMPLETED|Overall Study||18
7989149|NCT00150618|19670573|P1|NOT COMPLETED|Overall Study||17
7989150|NCT00150618|19670569|P5|COMPLETED|Overall Study||41
7989151|NCT00150618|19670570|P4|COMPLETED|Overall Study||40
7989152|NCT00150618|19670571|P3|COMPLETED|Overall Study||38
7989153|NCT00150618|19670572|P2|COMPLETED|Overall Study||47
7989154|NCT00150618|19670573|P1|COMPLETED|Overall Study||45
7989155|NCT00150618|19670569|P5|STARTED|Overall Study||66
7989156|NCT00150618|19670570|P4|STARTED|Overall Study||66
7989157|NCT00150618|19670571|P3|STARTED|Overall Study||65
7989158|NCT00150618|19670572|P2|STARTED|Overall Study||65
7989159|NCT00150618|19670573|P1|STARTED|Overall Study||62
7989160|NCT00150592|19670607|P2|NOT COMPLETED|Overall Study||3
7989161|NCT00150592|19670608|P1|NOT COMPLETED|Overall Study||7
7989162|NCT00150592|19670607|P2|COMPLETED|Overall Study||54
7989163|NCT00150592|19670608|P1|COMPLETED|Overall Study||114
7989164|NCT00150592|19670607|P2|STARTED|Overall Study||57
7989165|NCT00150592|19670608|P1|STARTED|Overall Study||121
7989166|NCT00150462|19670639|P11|NOT COMPLETED|Overall Study||3
7989167|NCT00150462|19670640|P10|NOT COMPLETED|Overall Study||6
7989168|NCT00150462|19670641|P9|NOT COMPLETED|Overall Study||6
7989169|NCT00150462|19670642|P8|NOT COMPLETED|Overall Study||8
7989170|NCT00150462|19670643|P7|NOT COMPLETED|Overall Study||3
7989171|NCT00150462|19670644|P6|NOT COMPLETED|Overall Study||4
7989172|NCT00150462|19670645|P5|NOT COMPLETED|Overall Study||3
7989173|NCT00150462|19670646|P4|NOT COMPLETED|Overall Study||3
7989174|NCT00150462|19670647|P3|NOT COMPLETED|Overall Study||4
7989175|NCT00150462|19670648|P2|NOT COMPLETED|Overall Study||3
7989176|NCT00150462|19670649|P1|NOT COMPLETED|Overall Study||3
7989177|NCT00150462|19670639|P11|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
7989178|NCT00150462|19670640|P10|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
7989179|NCT00150462|19670641|P9|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
7989180|NCT00150462|19670642|P8|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
7989181|NCT00150462|19670643|P7|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
7989182|NCT00150462|19670644|P6|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
7989183|NCT00150462|19670645|P5|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
7989184|NCT00150462|19670646|P4|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
7989185|NCT00150462|19670647|P3|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
7989186|NCT00150462|19670648|P2|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
7989187|NCT00150462|19670649|P1|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
7989188|NCT00150462|19670639|P11|STARTED|Overall Study||4
7989189|NCT00150462|19670640|P10|STARTED|Overall Study||7
7989190|NCT00150462|19670641|P9|STARTED|Overall Study||6
7989191|NCT00150462|19670642|P8|STARTED|Overall Study||8
7989192|NCT00150462|19670643|P7|STARTED|Overall Study||3
7989193|NCT00150462|19670644|P6|STARTED|Overall Study||4
7989194|NCT00150462|19670645|P5|STARTED|Overall Study||3
7989195|NCT00150462|19670646|P4|STARTED|Overall Study||3
7989196|NCT00150462|19670647|P3|STARTED|Overall Study||4
7989197|NCT00150462|19670648|P2|STARTED|Overall Study||3
7989198|NCT00150462|19670649|P1|STARTED|Overall Study||3
7989199|NCT00150345|19670759|P2|NOT COMPLETED|Overall Study||32
7989200|NCT00150345|19670760|P1|NOT COMPLETED|Overall Study||34
7989201|NCT00150345|19670759|P2|COMPLETED|Overall Study||34
7989202|NCT00150345|19670760|P1|COMPLETED|Overall Study||47
7989203|NCT00150345|19670759|P2|STARTED|Overall Study||66
7989204|NCT00150345|19670760|P1|STARTED|Overall Study||81
7989205|NCT00150176|19670824|P2|NOT COMPLETED|Overall Study||120
7989206|NCT00150176|19670825|P1|NOT COMPLETED|Overall Study||59
7989207|NCT00150176|19670824|P2|COMPLETED|Overall Study||72
7989208|NCT00150176|19670825|P1|COMPLETED|Overall Study||135
7989209|NCT00150176|19670824|P2|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192
7989210|NCT00150176|19670825|P1|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194
7989211|NCT00149994|19670836|P2|NOT COMPLETED|Overall Study||1
7989212|NCT00149994|19670837|P1|NOT COMPLETED|Overall Study||1
7989213|NCT00149994|19670836|P2|COMPLETED|Overall Study||85
7989214|NCT00149994|19670837|P1|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84
7989215|NCT00149994|19670836|P2|STARTED|Overall Study||86
7989216|NCT00149994|19670837|P1|STARTED|Overall Study|"Started indicates Safety population."|85
7989217|NCT00149890|19670845|P2|NOT COMPLETED|Overall Study||18
7989218|NCT00149890|19670846|P1|NOT COMPLETED|Overall Study||13
7989219|NCT00149890|19670845|P2|COMPLETED|Overall Study||20
7989220|NCT00149890|19670846|P1|COMPLETED|Overall Study||26
7989221|NCT00149890|19670845|P2|STARTED|Overall Study||38
7989222|NCT00149890|19670846|P1|STARTED|Overall Study|"Started indicates all screened and treated participants."|39
7989223|NCT00149838|19670866|P4|NOT COMPLETED|Phase III||24
7989224|NCT00149838|19670867|P3|NOT COMPLETED|Phase III||0
7989225|NCT00149838|19670868|P2|NOT COMPLETED|Phase III||0
7989226|NCT00149838|19670869|P1|NOT COMPLETED|Phase III||0
7989227|NCT00149838|19670866|P4|COMPLETED|Phase III||37
7989228|NCT00149838|19670867|P3|COMPLETED|Phase III||0
7989229|NCT00149838|19670868|P2|COMPLETED|Phase III||0
7989230|NCT00149838|19670869|P1|COMPLETED|Phase III||0
7989231|NCT00149838|19670866|P4|STARTED|Phase III||61
7989232|NCT00149838|19670867|P3|STARTED|Phase III||0
7989233|NCT00149838|19670868|P2|STARTED|Phase III||0
7989234|NCT00149838|19670869|P1|STARTED|Phase III||0
7989235|NCT00149838|19670866|P4|NOT COMPLETED|Phase II||0
7989236|NCT00149838|19670867|P3|NOT COMPLETED|Phase II||0
7989237|NCT00149838|19670868|P2|NOT COMPLETED|Phase II||0
7989238|NCT00149838|19670869|P1|NOT COMPLETED|Phase II||0
7989239|NCT00149838|19670866|P4|COMPLETED|Phase II||0
7989240|NCT00149838|19670867|P3|COMPLETED|Phase II||144
7989241|NCT00149838|19670868|P2|COMPLETED|Phase II||0
7989242|NCT00149838|19670869|P1|COMPLETED|Phase II||0
7989243|NCT00149838|19670866|P4|STARTED|Phase II||0
7989244|NCT00149838|19670867|P3|STARTED|Phase II||144
7989245|NCT00149838|19670868|P2|STARTED|Phase II||0
7989246|NCT00149838|19670869|P1|STARTED|Phase II||0
7989247|NCT00149838|19670866|P4|NOT COMPLETED|Phase I||0
7989248|NCT00149838|19670867|P3|NOT COMPLETED|Phase I||0
7989249|NCT00149838|19670868|P2|NOT COMPLETED|Phase I||16
7989250|NCT00149838|19670869|P1|NOT COMPLETED|Phase I||20
7989251|NCT00149838|19670866|P4|COMPLETED|Phase I||0
7989252|NCT00149838|19670867|P3|COMPLETED|Phase I||0
7989253|NCT00149838|19670868|P2|COMPLETED|Phase I||82
7989254|NCT00149838|19670869|P1|COMPLETED|Phase I||72
7989255|NCT00149838|19670866|P4|STARTED|Phase I||0
7989256|NCT00149838|19670867|P3|STARTED|Phase I||0
7989257|NCT00149838|19670868|P2|STARTED|Phase I||98
7989258|NCT00149838|19670869|P1|STARTED|Phase I||92
7989259|NCT00149825|19670881|P2|NOT COMPLETED|Overall Study||3
7989260|NCT00149825|19670882|P1|NOT COMPLETED|Overall Study||5
7989261|NCT00149825|19670881|P2|COMPLETED|Overall Study||12
7989262|NCT00149825|19670882|P1|COMPLETED|Overall Study||10
7989263|NCT00149825|19670881|P2|STARTED|Overall Study||15
7989264|NCT00149825|19670882|P1|STARTED|Overall Study||15
7989265|NCT00149799|19670892|P3|NOT COMPLETED|Discontinuation (Phase II)||9
7989266|NCT00149799|19670893|P2|NOT COMPLETED|Discontinuation (Phase II)||3
7989267|NCT00149799|19670894|P1|NOT COMPLETED|Discontinuation (Phase II)||0
7989268|NCT00149799|19670892|P3|COMPLETED|Discontinuation (Phase II)||21
7989269|NCT00149799|19670893|P2|COMPLETED|Discontinuation (Phase II)||25
7989270|NCT00149799|19670894|P1|COMPLETED|Discontinuation (Phase II)||0
7989271|NCT00149799|19670892|P3|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|30
7989361|NCT00148733|19671196|P1|STARTED|Overall Study||1314
7989272|NCT00149799|19670893|P2|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|28
7989273|NCT00149799|19670894|P1|STARTED|Discontinuation (Phase II)||0
7989274|NCT00149799|19670892|P3|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
7989275|NCT00149799|19670893|P2|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
7989276|NCT00149799|19670894|P1|NOT COMPLETED|Open Label Escitalopram (Phase I)||26
7989277|NCT00149799|19670892|P3|COMPLETED|Open Label Escitalopram (Phase I)||0
7989278|NCT00149799|19670893|P2|COMPLETED|Open Label Escitalopram (Phase I)||0
7989279|NCT00149799|19670894|P1|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74
7989280|NCT00149799|19670892|P3|STARTED|Open Label Escitalopram (Phase I)||0
7989281|NCT00149799|19670893|P2|STARTED|Open Label Escitalopram (Phase I)||0
7989282|NCT00149799|19670894|P1|STARTED|Open Label Escitalopram (Phase I)||100
7989283|NCT00149747|19670910|P2|NOT COMPLETED|Overall Study||3
7989284|NCT00149747|19670911|P1|NOT COMPLETED|Overall Study||4
7989285|NCT00149747|19670910|P2|COMPLETED|Overall Study||27
7989286|NCT00149747|19670911|P1|COMPLETED|Overall Study||32
7989287|NCT00149747|19670910|P2|STARTED|Overall Study||30
7989288|NCT00149747|19670911|P1|STARTED|Overall Study||36
7989289|NCT00149669|19670923|P2|NOT COMPLETED|Overall Study||5
7989290|NCT00149669|19670924|P1|NOT COMPLETED|Overall Study||3
7989291|NCT00149669|19670923|P2|COMPLETED|Overall Study||30
7989292|NCT00149669|19670924|P1|COMPLETED|Overall Study||29
7989293|NCT00149669|19670923|P2|STARTED|Overall Study||35
7989294|NCT00149669|19670924|P1|STARTED|Overall Study||32
7989295|NCT00149643|19670944|P2|NOT COMPLETED|Overall Study||36
7989296|NCT00149643|19670945|P1|NOT COMPLETED|Overall Study||34
7989297|NCT00149643|19670944|P2|COMPLETED|Overall Study||0
7989298|NCT00149643|19670945|P1|COMPLETED|Overall Study||0
7989299|NCT00149643|19670944|P2|STARTED|Overall Study||36
7989300|NCT00149643|19670945|P1|STARTED|Overall Study||34
7989301|NCT00149630|19670957|P2|NOT COMPLETED|Overall Study||5
7989302|NCT00149630|19670958|P1|NOT COMPLETED|Overall Study||8
7989303|NCT00149630|19670957|P2|COMPLETED|Overall Study||35
7989304|NCT00149630|19670958|P1|COMPLETED|Overall Study||26
7989305|NCT00149630|19670957|P2|STARTED|Overall Study||40
7989306|NCT00149630|19670958|P1|STARTED|Overall Study||34
7989307|NCT00149396|19670968|P1|NOT COMPLETED|Overall Study||23
7989308|NCT00149396|19670968|P1|COMPLETED|Overall Study||9
7989309|NCT00149396|19670968|P1|Completed NV1020 and Chemotherapy|Overall Study||9
7989310|NCT00149396|19670968|P1|Completed NV1020 Therapy|Overall Study||29
7989311|NCT00149396|19670968|P1|STARTED|Overall Study||32
7989312|NCT00149227|19671011|P2|NOT COMPLETED|Overall Study||0
7989313|NCT00149227|19671012|P1|NOT COMPLETED|Overall Study||0
7989314|NCT00149227|19671011|P2|COMPLETED|Overall Study||1514
7989315|NCT00149227|19671012|P1|COMPLETED|Overall Study||1517
7989316|NCT00149227|19671011|P2|STARTED|Overall Study||1514
7989317|NCT00149227|19671012|P1|STARTED|Overall Study||1517
7989318|NCT00149214|19671038|P2|NOT COMPLETED|Overall Study||17
7989319|NCT00149214|19671039|P1|NOT COMPLETED|Overall Study||26
7989320|NCT00149214|19671038|P2|COMPLETED|Overall Study||105
7989321|NCT00149214|19671039|P1|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109
7989322|NCT00149214|19671038|P2|STARTED|Overall Study||122
7989323|NCT00149214|19671039|P1|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135
7989324|NCT00148954|19671055|P2|NOT COMPLETED|Overall Study||300
7989325|NCT00148954|19671056|P1|NOT COMPLETED|Overall Study||307
7989326|NCT00148954|19671055|P2|COMPLETED|Overall Study||677
7989327|NCT00148954|19671056|P1|COMPLETED|Overall Study||678
7989328|NCT00148954|19671055|P2|STARTED|Overall Study||977
7989329|NCT00148954|19671056|P1|STARTED|Overall Study||985
7989330|NCT00148941|19671066|P4|NOT COMPLETED|Overall Study||24
7989331|NCT00148941|19671067|P3|NOT COMPLETED|Overall Study||20
7989332|NCT00148941|19671068|P2|NOT COMPLETED|Overall Study||24
7989333|NCT00148941|19671069|P1|NOT COMPLETED|Overall Study||18
7989334|NCT00148941|19671066|P4|COMPLETED|Overall Study||1029
7989335|NCT00148941|19671067|P3|COMPLETED|Overall Study||1032
7989336|NCT00148941|19671068|P2|COMPLETED|Overall Study||1027
7989337|NCT00148941|19671069|P1|COMPLETED|Overall Study||1035
7989338|NCT00148941|19671066|P4|STARTED|Overall Study||1053
7989339|NCT00148941|19671067|P3|STARTED|Overall Study||1052
7989340|NCT00148941|19671068|P2|STARTED|Overall Study||1051
7989341|NCT00148941|19671069|P1|STARTED|Overall Study||1053
7989342|NCT00148798|19671161|P2|NOT COMPLETED|Overall Study||0
7989343|NCT00148798|19671162|P1|NOT COMPLETED|Overall Study||0
7989344|NCT00148798|19671161|P2|COMPLETED|Overall Study||568
7989345|NCT00148798|19671162|P1|COMPLETED|Overall Study||557
7989346|NCT00148798|19671161|P2|STARTED|Overall Study|ITT Population|568
7989347|NCT00148798|19671162|P1|STARTED|Overall Study|Intent To Treat (ITT) Population|557
7989348|NCT00148759|19671184|P2|NOT COMPLETED|Overall Study||1
7989349|NCT00148759|19671185|P1|NOT COMPLETED|Overall Study||2
7989350|NCT00148759|19671184|P2|COMPLETED|Overall Study||11
7989351|NCT00148759|19671185|P1|COMPLETED|Overall Study||9
7989352|NCT00148759|19671184|P2|24-hr PK Sampling|Overall Study||11
7989353|NCT00148759|19671185|P1|24-hr PK Sampling|Overall Study||9
7989354|NCT00148759|19671184|P2|STARTED|Overall Study||12
7989355|NCT00148759|19671185|P1|STARTED|Overall Study||11
7989356|NCT00148733|19671195|P2|NOT COMPLETED|Overall Study||15
7989357|NCT00148733|19671196|P1|NOT COMPLETED|Overall Study||14
7989358|NCT00148733|19671195|P2|COMPLETED|Overall Study||1299
7989359|NCT00148733|19671196|P1|COMPLETED|Overall Study||1300
7989360|NCT00148733|19671195|P2|STARTED|Overall Study||1314
7989362|NCT00148668|19671204|P2|NOT COMPLETED|Overall Study||0
7989363|NCT00148668|19671205|P1|NOT COMPLETED|Overall Study||0
7989364|NCT00148668|19671204|P2|COMPLETED|Overall Study||40
7989365|NCT00148668|19671205|P1|COMPLETED|Overall Study||41
7989366|NCT00148668|19671204|P2|STARTED|Overall Study||40
7989367|NCT00148668|19671205|P1|STARTED|Overall Study||41
7989368|NCT00148343|19671213|P2|NOT COMPLETED|Overall Study||11
7989369|NCT00148343|19671214|P1|NOT COMPLETED|Overall Study||15
7989370|NCT00148343|19671213|P2|COMPLETED|Overall Study||45
7989371|NCT00148343|19671214|P1|COMPLETED|Overall Study||39
7989372|NCT00148343|19671213|P2|STARTED|Overall Study||56
7989373|NCT00148343|19671214|P1|STARTED|Overall Study||54
7989374|NCT00148317|19671228|P1|NOT COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||11
7989375|NCT00148317|19671228|P1|COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||27
7989376|NCT00148317|19671228|P1|STARTED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||38
7989377|NCT00148317|19671228|P1|NOT COMPLETED|Consolidation (VEL + DEX)||0
7989378|NCT00148317|19671228|P1|COMPLETED|Consolidation (VEL + DEX)||38
7989379|NCT00148317|19671228|P1|no DOXIL Added|Consolidation (VEL + DEX)||10
7989380|NCT00148317|19671228|P1|DOXIL Added at Cycle 5|Consolidation (VEL + DEX)||12
7989381|NCT00148317|19671228|P1|DOXIL Added at Cycle 3|Consolidation (VEL + DEX)||16
7989382|NCT00148317|19671228|P1|STARTED|Consolidation (VEL + DEX)||38
7989383|NCT00148122|19671235|P1|NOT COMPLETED|Overall Study||2
7989384|NCT00148122|19671235|P1|COMPLETED|Overall Study||38
7989385|NCT00148122|19671235|P1|STARTED|Overall Study||40
7989386|NCT00148109|19671243|P2|NOT COMPLETED|Overall Study||20
7989387|NCT00148109|19671244|P1|NOT COMPLETED|Overall Study||12
7989388|NCT00148109|19671243|P2|COMPLETED|Overall Study||1
7989389|NCT00148109|19671244|P1|COMPLETED|Overall Study||3
7989390|NCT00148109|19671243|P2|STARTED|Overall Study||21
7989391|NCT00148109|19671244|P1|STARTED|Overall Study||15
7989392|NCT00147966|19671254|P1|NOT COMPLETED|Overall Study||0
7989393|NCT00147966|19671254|P1|COMPLETED|Overall Study||24
7989394|NCT00147966|19671254|P1|STARTED|Overall Study||24
7989395|NCT00147823|19671260|P2|NOT COMPLETED|Overall Study||15
7989396|NCT00147823|19671261|P1|NOT COMPLETED|Overall Study||13
7989397|NCT00147823|19671260|P2|COMPLETED|Overall Study||16
7989398|NCT00147823|19671261|P1|COMPLETED|Overall Study||19
7989399|NCT00147823|19671260|P2|Month 24 Visit|Overall Study||18
7989400|NCT00147823|19671261|P1|Month 24 Visit|Overall Study||21
7989401|NCT00147823|19671260|P2|Month 18 Visit|Overall Study||20
7989402|NCT00147823|19671261|P1|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21
7989403|NCT00147823|19671260|P2|Month 12 CT Scan|Overall Study||25
7989404|NCT00147823|19671261|P1|Month 12 CT Scan|Overall Study||20
7989405|NCT00147823|19671260|P2|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25
7989406|NCT00147823|19671261|P1|Month 12 Visit|Overall Study||21
7989407|NCT00147823|19671260|P2|Month 6 Visit|Overall Study||21
7989408|NCT00147823|19671261|P1|Month 6 Visit|Overall Study||25
7989409|NCT00147823|19671260|P2|Month 3 Visit|Overall Study||24
7989410|NCT00147823|19671261|P1|Month 3 Visit|Overall Study||25
7989411|NCT00147823|19671260|P2|Week 6 Visit|Overall Study||28
7989412|NCT00147823|19671261|P1|Week 6 Visit|Overall Study||26
7989413|NCT00147823|19671260|P2|STARTED|Overall Study||31
7989414|NCT00147823|19671261|P1|STARTED|Overall Study||32
7989415|NCT00147745|19671292|P3|NOT COMPLETED|Overall Study||0
7989416|NCT00147745|19671293|P2|NOT COMPLETED|Overall Study||0
7989417|NCT00147745|19671294|P1|NOT COMPLETED|Overall Study||1
7989418|NCT00147745|19671292|P3|COMPLETED|Overall Study||6
7989419|NCT00147745|19671293|P2|COMPLETED|Overall Study||14
7989420|NCT00147745|19671294|P1|COMPLETED|Overall Study||15
7989421|NCT00147745|19671292|P3|STARTED|Overall Study||6
7989422|NCT00147745|19671293|P2|STARTED|Overall Study||14
7989423|NCT00147745|19671294|P1|STARTED|Overall Study||16
7989424|NCT00147537|19671316|P11|NOT COMPLETED|Phase 2||52
7989425|NCT00147537|19671317|P10|NOT COMPLETED|Phase 2||161
7989426|NCT00147537|19671318|P9|NOT COMPLETED|Phase 2||0
7989427|NCT00147537|19671319|P8|NOT COMPLETED|Phase 2||0
7989428|NCT00147537|19671320|P7|NOT COMPLETED|Phase 2||0
7989429|NCT00147537|19671321|P6|NOT COMPLETED|Phase 2||0
7989430|NCT00147537|19671322|P5|NOT COMPLETED|Phase 2||0
7989431|NCT00147537|19671323|P4|NOT COMPLETED|Phase 2||0
7989432|NCT00147537|19671324|P3|NOT COMPLETED|Phase 2||0
7989433|NCT00147537|19671325|P2|NOT COMPLETED|Phase 2||0
7989434|NCT00147537|19671326|P1|NOT COMPLETED|Phase 2||0
7989435|NCT00147537|19671316|P11|COMPLETED|Phase 2||3
7989436|NCT00147537|19671317|P10|COMPLETED|Phase 2||5
7989437|NCT00147537|19671318|P9|COMPLETED|Phase 2||0
7989438|NCT00147537|19671319|P8|COMPLETED|Phase 2||0
7989439|NCT00147537|19671320|P7|COMPLETED|Phase 2||0
7989440|NCT00147537|19671321|P6|COMPLETED|Phase 2||0
7989441|NCT00147537|19671322|P5|COMPLETED|Phase 2||0
7989442|NCT00147537|19671323|P4|COMPLETED|Phase 2||0
7989443|NCT00147537|19671324|P3|COMPLETED|Phase 2||0
7989444|NCT00147537|19671325|P2|COMPLETED|Phase 2||0
7989445|NCT00147537|19671326|P1|COMPLETED|Phase 2||0
7989446|NCT00147537|19671316|P11|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55
7989447|NCT00147537|19671317|P10|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166
7989448|NCT00147537|19671318|P9|STARTED|Phase 2||0
7989449|NCT00147537|19671319|P8|STARTED|Phase 2||0
7989450|NCT00147537|19671320|P7|STARTED|Phase 2||0
7989451|NCT00147537|19671321|P6|STARTED|Phase 2||0
7989452|NCT00147537|19671322|P5|STARTED|Phase 2||0
7989453|NCT00147537|19671323|P4|STARTED|Phase 2||0
7989454|NCT00147537|19671324|P3|STARTED|Phase 2||0
7989455|NCT00147537|19671325|P2|STARTED|Phase 2||0
7989456|NCT00147537|19671326|P1|STARTED|Phase 2||0
7989457|NCT00147537|19671316|P11|NOT COMPLETED|Phase 1b||0
7989458|NCT00147537|19671317|P10|NOT COMPLETED|Phase 1b||0
7989459|NCT00147537|19671318|P9|NOT COMPLETED|Phase 1b||17
7989460|NCT00147537|19671319|P8|NOT COMPLETED|Phase 1b||7
7989461|NCT00147537|19671320|P7|NOT COMPLETED|Phase 1b||18
7989462|NCT00147537|19671321|P6|NOT COMPLETED|Phase 1b||3
7989463|NCT00147537|19671322|P5|NOT COMPLETED|Phase 1b||3
7989464|NCT00147537|19671323|P4|NOT COMPLETED|Phase 1b||2
7989465|NCT00147537|19671324|P3|NOT COMPLETED|Phase 1b||4
7989466|NCT00147537|19671325|P2|NOT COMPLETED|Phase 1b||2
7989467|NCT00147537|19671326|P1|NOT COMPLETED|Phase 1b||2
7989468|NCT00147537|19671316|P11|COMPLETED|Phase 1b||0
7989469|NCT00147537|19671317|P10|COMPLETED|Phase 1b||0
7989470|NCT00147537|19671318|P9|COMPLETED|Phase 1b||1
7989471|NCT00147537|19671319|P8|COMPLETED|Phase 1b||0
7989472|NCT00147537|19671320|P7|COMPLETED|Phase 1b||0
7989473|NCT00147537|19671321|P6|COMPLETED|Phase 1b||0
7989474|NCT00147537|19671322|P5|COMPLETED|Phase 1b||0
7989475|NCT00147537|19671323|P4|COMPLETED|Phase 1b||1
7989476|NCT00147537|19671324|P3|COMPLETED|Phase 1b||0
7989477|NCT00147537|19671325|P2|COMPLETED|Phase 1b||0
7989478|NCT00147537|19671326|P1|COMPLETED|Phase 1b||1
7989479|NCT00147537|19671316|P11|STARTED|Phase 1b||0
7989480|NCT00147537|19671317|P10|STARTED|Phase 1b||0
7989481|NCT00147537|19671318|P9|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
7989482|NCT00147537|19671319|P8|STARTED|Phase 1b||7
7989483|NCT00147537|19671320|P7|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
7989484|NCT00147537|19671321|P6|STARTED|Phase 1b||3
7989485|NCT00147537|19671322|P5|STARTED|Phase 1b||3
7989486|NCT00147537|19671323|P4|STARTED|Phase 1b||3
7989487|NCT00147537|19671324|P3|STARTED|Phase 1b||4
7989488|NCT00147537|19671325|P2|STARTED|Phase 1b||2
7989489|NCT00147537|19671326|P1|STARTED|Phase 1b||3
7989490|NCT00147498|19671509|P4|NOT COMPLETED|Overall Study||17
7989491|NCT00147498|19671510|P3|NOT COMPLETED|Overall Study||17
7989492|NCT00147498|19671511|P2|NOT COMPLETED|Overall Study||9
7989493|NCT00147498|19671512|P1|NOT COMPLETED|Overall Study||3
7989494|NCT00147498|19671509|P4|COMPLETED|Overall Study||48
7989495|NCT00147498|19671510|P3|COMPLETED|Overall Study||52
7989496|NCT00147498|19671511|P2|COMPLETED|Overall Study||60
7989497|NCT00147498|19671512|P1|COMPLETED|Overall Study||58
7989498|NCT00147498|19671509|P4|STARTED|Overall Study||65
7989499|NCT00147498|19671510|P3|STARTED|Overall Study||69
7989500|NCT00147498|19671511|P2|STARTED|Overall Study||69
7989501|NCT00147498|19671512|P1|STARTED|Overall Study||61
7989502|NCT00147446|19671608|P2|NOT COMPLETED|Overall Study||0
7989503|NCT00147446|19671609|P1|NOT COMPLETED|Overall Study||0
7989504|NCT00147446|19671608|P2|COMPLETED|Overall Study||61
7989505|NCT00147446|19671609|P1|COMPLETED|Overall Study||60
7989506|NCT00147446|19671608|P2|STARTED|Overall Study||61
7989507|NCT00147446|19671609|P1|STARTED|Overall Study||60
7989508|NCT00147316|19671617|P1|NOT COMPLETED|Overall Study||0
7989509|NCT00147316|19671617|P1|COMPLETED|Overall Study||103
7989510|NCT00147316|19671617|P1|STARTED|Overall Study||103
7989511|NCT00147290|19671624|P2|NOT COMPLETED|Overall Study||0
7989512|NCT00147290|19671625|P1|NOT COMPLETED|Overall Study||0
7989513|NCT00147290|19671624|P2|COMPLETED|Overall Study||260
7989514|NCT00147290|19671625|P1|COMPLETED|Overall Study||266
7989515|NCT00147290|19671624|P2|STARTED|Overall Study||260
7989516|NCT00147290|19671625|P1|STARTED|Overall Study||266
7989517|NCT00147277|19671631|P2|NOT COMPLETED|Overall Study||0
7989518|NCT00147277|19671632|P1|NOT COMPLETED|Overall Study||0
7989519|NCT00147277|19671631|P2|COMPLETED|Overall Study||450
7989520|NCT00147277|19671632|P1|COMPLETED|Overall Study||475
7989521|NCT00147277|19671631|P2|STARTED|Overall Study||450
7989522|NCT00147277|19671632|P1|STARTED|Overall Study||475
7989523|NCT00147238|19671636|P1|NOT COMPLETED|Overall Study||8
7989524|NCT00147238|19671636|P1|COMPLETED|Overall Study||2
7989525|NCT00147238|19671636|P1|STARTED|Overall Study||10
7989526|NCT00147225|19671646|P6|NOT COMPLETED|Overall Study||2
7989527|NCT00147225|19671647|P5|NOT COMPLETED|Overall Study||1
7989528|NCT00147225|19671648|P4|NOT COMPLETED|Overall Study||1
7989529|NCT00147225|19671649|P3|NOT COMPLETED|Overall Study||2
7989530|NCT00147225|19671650|P2|NOT COMPLETED|Overall Study||0
7989531|NCT00147225|19671651|P1|NOT COMPLETED|Overall Study||1
7989532|NCT00147225|19671646|P6|COMPLETED|Overall Study||10
7989533|NCT00147225|19671647|P5|COMPLETED|Overall Study||10
7989534|NCT00147225|19671648|P4|COMPLETED|Overall Study||10
7989535|NCT00147225|19671649|P3|COMPLETED|Overall Study||6
7989536|NCT00147225|19671650|P2|COMPLETED|Overall Study||6
7989537|NCT00147225|19671651|P1|COMPLETED|Overall Study||6
7989538|NCT00147225|19671646|P6|STARTED|Overall Study||12
7989539|NCT00147225|19671647|P5|STARTED|Overall Study||11
7989540|NCT00147225|19671648|P4|STARTED|Overall Study||11
7989541|NCT00147225|19671649|P3|STARTED|Overall Study||8
7989542|NCT00147225|19671650|P2|STARTED|Overall Study||6
7989543|NCT00147225|19671651|P1|STARTED|Overall Study||7
7989544|NCT00147212|19671671|P1|NOT COMPLETED|Overall Study||0
7989545|NCT00147212|19671671|P1|COMPLETED|Overall Study||50
7989546|NCT00147212|19671671|P1|STARTED|Overall Study||50
7989547|NCT00147199|19671677|P2|NOT COMPLETED|Overall Study||10
7989548|NCT00147199|19671678|P1|NOT COMPLETED|Overall Study||13
7989549|NCT00147199|19671677|P2|COMPLETED|Overall Study||110
7989550|NCT00147199|19671678|P1|COMPLETED|Overall Study||102
7989551|NCT00147199|19671677|P2|STARTED|Overall Study||120
7989552|NCT00147199|19671678|P1|STARTED|Overall Study||115
7989553|NCT00147082|19671703|P3|NOT COMPLETED|Overall Study||0
7989554|NCT00147082|19671704|P2|NOT COMPLETED|Overall Study||0
7989555|NCT00147082|19671705|P1|NOT COMPLETED|Overall Study||0
7989556|NCT00147082|19671703|P3|COMPLETED|Overall Study||30
7989557|NCT00147082|19671704|P2|COMPLETED|Overall Study||33
7989558|NCT00147082|19671705|P1|COMPLETED|Overall Study||37
7989559|NCT00147082|19671703|P3|STARTED|Overall Study||30
7989560|NCT00147082|19671704|P2|STARTED|Overall Study||33
7989561|NCT00147082|19671705|P1|STARTED|Overall Study||37
7989562|NCT00147069|19671723|P4|NOT COMPLETED|Overall Study||0
7989563|NCT00147069|19671724|P3|NOT COMPLETED|Overall Study||0
7989564|NCT00147069|19671725|P2|NOT COMPLETED|Overall Study||0
7989565|NCT00147069|19671726|P1|NOT COMPLETED|Overall Study||0
7989566|NCT00147069|19671723|P4|COMPLETED|Overall Study||15
7989567|NCT00147069|19671724|P3|COMPLETED|Overall Study||15
7989568|NCT00147069|19671725|P2|COMPLETED|Overall Study||15
7989569|NCT00147069|19671726|P1|COMPLETED|Overall Study||15
7989570|NCT00147069|19671723|P4|STARTED|Overall Study||15
7989571|NCT00147069|19671724|P3|STARTED|Overall Study||15
7989572|NCT00147069|19671725|P2|STARTED|Overall Study||15
7989573|NCT00147069|19671726|P1|STARTED|Overall Study||15
7989574|NCT00147043|19671748|P1|NOT COMPLETED|Overall Study||0
7989575|NCT00147043|19671748|P1|COMPLETED|Overall Study||5
7989576|NCT00147043|19671748|P1|STARTED|Overall Study||5
7989577|NCT00147030|19671755|P2|NOT COMPLETED|Overall Study||0
7989578|NCT00147030|19671756|P1|NOT COMPLETED|Overall Study||0
7989579|NCT00147030|19671755|P2|COMPLETED|Overall Study||162
7989580|NCT00147030|19671756|P1|COMPLETED|Overall Study||163
7989581|NCT00147030|19671755|P2|STARTED|Overall Study||162
7989582|NCT00147030|19671756|P1|STARTED|Overall Study||163
7989583|NCT00147017|19671807|P3|NOT COMPLETED|Overall Study||0
7989584|NCT00147017|19671808|P2|NOT COMPLETED|Overall Study||0
7989585|NCT00147017|19671809|P1|NOT COMPLETED|Overall Study||0
7989586|NCT00147017|19671807|P3|COMPLETED|Overall Study||4
7989587|NCT00147017|19671808|P2|COMPLETED|Overall Study||7
7989588|NCT00147017|19671809|P1|COMPLETED|Overall Study||6
7989589|NCT00147017|19671807|P3|STARTED|Overall Study||4
7989590|NCT00147017|19671808|P2|STARTED|Overall Study||7
7989591|NCT00147017|19671809|P1|STARTED|Overall Study||6
7989592|NCT00146848|19671826|P3|NOT COMPLETED|Post-randomization||39
7989593|NCT00146848|19671827|P2|NOT COMPLETED|Post-randomization||47
7989594|NCT00146848|19671828|P1|NOT COMPLETED|Post-randomization||38
7989595|NCT00146848|19671826|P3|COMPLETED|Post-randomization||431
7989596|NCT00146848|19671827|P2|COMPLETED|Post-randomization||441
7989597|NCT00146848|19671828|P1|COMPLETED|Post-randomization||437
7989598|NCT00146848|19671826|P3|STARTED|Post-randomization||470
7989599|NCT00146848|19671827|P2|STARTED|Post-randomization||488
7989600|NCT00146848|19671828|P1|STARTED|Post-randomization||475
7989601|NCT00146848|19671826|P3|NOT COMPLETED|Pre-randomization||0
7989602|NCT00146848|19671827|P2|NOT COMPLETED|Pre-randomization||0
7989603|NCT00146848|19671828|P1|NOT COMPLETED|Pre-randomization||309
7989604|NCT00146848|19671826|P3|COMPLETED|Pre-randomization||0
7989605|NCT00146848|19671827|P2|COMPLETED|Pre-randomization||0
7989606|NCT00146848|19671828|P1|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433
7989607|NCT00146848|19671826|P3|STARTED|Pre-randomization||0
7989608|NCT00146848|19671827|P2|STARTED|Pre-randomization||0
7989609|NCT00146848|19671828|P1|STARTED|Pre-randomization|Registered|1742
7989610|NCT00146770|19671844|P2|NOT COMPLETED|Overall Study||0
7989611|NCT00146770|19671845|P1|NOT COMPLETED|Overall Study||5
7989612|NCT00146770|19671844|P2|COMPLETED|Overall Study||22
7989613|NCT00146770|19671845|P1|COMPLETED|Overall Study||18
7989614|NCT00146770|19671844|P2|STARTED|Overall Study||22
7989615|NCT00146770|19671845|P1|STARTED|Overall Study||23
7989616|NCT00146757|19671863|P2|NOT COMPLETED|Overall Study||0
7989617|NCT00146757|19671864|P1|NOT COMPLETED|Overall Study||2
7989618|NCT00146757|19671863|P2|COMPLETED|Overall Study||4
7989619|NCT00146757|19671864|P1|COMPLETED|Overall Study||14
7989620|NCT00146757|19671863|P2|STARTED|Overall Study||4
7989621|NCT00146757|19671864|P1|STARTED|Overall Study||16
7989622|NCT00146640|19671883|P2|NOT COMPLETED|Overall Study||14
7989623|NCT00146640|19671884|P1|NOT COMPLETED|Overall Study||23
7989624|NCT00146640|19671883|P2|COMPLETED|Overall Study||130
7989625|NCT00146640|19671884|P1|COMPLETED|Overall Study||121
7989626|NCT00146640|19671883|P2|STARTED|Overall Study||144
7989627|NCT00146640|19671884|P1|STARTED|Overall Study||144
7989628|NCT00146328|19671907|P3|NOT COMPLETED|Overall Study||291
7989629|NCT00146328|19671908|P2|NOT COMPLETED|Overall Study||154
7989630|NCT00146328|19671909|P1|NOT COMPLETED|Overall Study||141
7989631|NCT00146328|19671907|P3|COMPLETED|Overall Study||158
7989632|NCT00146328|19671908|P2|COMPLETED|Overall Study||101
7989633|NCT00146328|19671909|P1|COMPLETED|Overall Study||150
7989634|NCT00146328|19671907|P3|STARTED|Overall Study||449
7989635|NCT00146328|19671908|P2|STARTED|Overall Study||255
7989636|NCT00146328|19671909|P1|STARTED|Overall Study||291
7989637|NCT00146172|19672000|P8|NOT COMPLETED|Overall Study||40
7989638|NCT00146172|19672001|P7|NOT COMPLETED|Overall Study||6
7989639|NCT00146172|19672002|P6|NOT COMPLETED|Overall Study||7
7989640|NCT00146172|19672003|P5|NOT COMPLETED|Overall Study||3
7989641|NCT00146172|19672004|P4|NOT COMPLETED|Overall Study||6
7989642|NCT00146172|19672005|P3|NOT COMPLETED|Overall Study||4
7989643|NCT00146172|19672006|P2|NOT COMPLETED|Overall Study||4
7989644|NCT00146172|19672007|P1|NOT COMPLETED|Overall Study||3
7989645|NCT00146172|19672000|P8|COMPLETED|Overall Study||0
7989646|NCT00146172|19672001|P7|COMPLETED|Overall Study||0
7989647|NCT00146172|19672002|P6|COMPLETED|Overall Study||0
7989648|NCT00146172|19672003|P5|COMPLETED|Overall Study||0
7989649|NCT00146172|19672004|P4|COMPLETED|Overall Study||0
7989650|NCT00146172|19672005|P3|COMPLETED|Overall Study||0
7989651|NCT00146172|19672006|P2|COMPLETED|Overall Study||0
7989652|NCT00146172|19672007|P1|COMPLETED|Overall Study||0
7989653|NCT00146172|19672000|P8|Received Drug|Overall Study||39
7989654|NCT00146172|19672001|P7|Received Drug|Overall Study||6
7989655|NCT00146172|19672002|P6|Received Drug|Overall Study||7
7989656|NCT00146172|19672003|P5|Received Drug|Overall Study||3
7989657|NCT00146172|19672004|P4|Received Drug|Overall Study||6
7989658|NCT00146172|19672005|P3|Received Drug|Overall Study||4
7989659|NCT00146172|19672006|P2|Received Drug|Overall Study||4
7989660|NCT00146172|19672007|P1|Received Drug|Overall Study||3
7989661|NCT00146172|19672000|P8|STARTED|Overall Study||40
7989662|NCT00146172|19672001|P7|STARTED|Overall Study||6
7989663|NCT00146172|19672002|P6|STARTED|Overall Study||7
7989664|NCT00146172|19672003|P5|STARTED|Overall Study||3
7989665|NCT00146172|19672004|P4|STARTED|Overall Study||6
7989666|NCT00146172|19672005|P3|STARTED|Overall Study||4
7989667|NCT00146172|19672006|P2|STARTED|Overall Study||4
7989668|NCT00146172|19672007|P1|STARTED|Overall Study||3
7989669|NCT00145977|19672042|P2|NOT COMPLETED|Overall Study||4
7989670|NCT00145977|19672043|P1|NOT COMPLETED|Overall Study||2
7989671|NCT00145977|19672042|P2|COMPLETED|Overall Study||13
7989672|NCT00145977|19672043|P1|COMPLETED|Overall Study||17
7989673|NCT00145977|19672042|P2|STARTED|Overall Study||17
7989674|NCT00145977|19672043|P1|STARTED|Overall Study||19
7989675|NCT00145795|19672069|P2|NOT COMPLETED|Overall Study||0
7989676|NCT00145795|19672070|P1|NOT COMPLETED|Overall Study||1
7989677|NCT00145795|19672069|P2|COMPLETED|Overall Study||10
7989678|NCT00145795|19672070|P1|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9
7989679|NCT00145795|19672069|P2|STARTED|Overall Study||10
7989680|NCT00145795|19672070|P1|STARTED|Overall Study||10
7989681|NCT00145704|19672096|P2|NOT COMPLETED|Overall Study||3
7989682|NCT00145704|19672097|P1|NOT COMPLETED|Overall Study||3
7989683|NCT00145704|19672096|P2|COMPLETED|Overall Study||0
7989684|NCT00145704|19672097|P1|COMPLETED|Overall Study||0
7989685|NCT00145704|19672096|P2|STARTED|Overall Study||3
7989686|NCT00145704|19672097|P1|STARTED|Overall Study||3
7989687|NCT00145626|19672105|P1|NOT COMPLETED|Overall Study||5
7989688|NCT00145626|19672105|P1|COMPLETED|Overall Study||14
7989689|NCT00145626|19672105|P1|STARTED|Overall Study||19
7989690|NCT00145600|19672151|P4|NOT COMPLETED|Overall Study||16
7989691|NCT00145600|19672152|P3|NOT COMPLETED|Overall Study||5
7989692|NCT00145600|19672153|P2|NOT COMPLETED|Overall Study||10
7989693|NCT00145600|19672154|P1|NOT COMPLETED|Overall Study||8
7989694|NCT00145600|19672151|P4|COMPLETED|Overall Study||130
7989695|NCT00145600|19672152|P3|COMPLETED|Overall Study||8
7989696|NCT00145600|19672153|P2|COMPLETED|Overall Study||36
7989697|NCT00145600|19672154|P1|COMPLETED|Overall Study||83
7989698|NCT00145600|19672151|P4|STARTED|Overall Study||146
7989699|NCT00145600|19672152|P3|STARTED|Overall Study||13
7989700|NCT00145600|19672153|P2|STARTED|Overall Study||46
7989701|NCT00145600|19672154|P1|STARTED|Overall Study||91
7989702|NCT00145587|19672268|P2|NOT COMPLETED|Overall Study||0
7989703|NCT00145587|19672269|P1|NOT COMPLETED|Overall Study||0
7989704|NCT00145587|19672268|P2|COMPLETED|Overall Study||1
7989705|NCT00145587|19672269|P1|COMPLETED|Overall Study||5
7989706|NCT00145587|19672268|P2|STARTED|Overall Study||1
7989707|NCT00145587|19672269|P1|STARTED|Overall Study||5
7989708|NCT00145574|19672278|P3|NOT COMPLETED|Open Label Long-term Extension||11
7989709|NCT00145574|19672279|P2|NOT COMPLETED|Open Label Long-term Extension||0
7989710|NCT00145574|19672280|P1|NOT COMPLETED|Open Label Long-term Extension||0
7989711|NCT00145574|19672278|P3|COMPLETED|Open Label Long-term Extension||173
7989712|NCT00145574|19672279|P2|COMPLETED|Open Label Long-term Extension||0
7989713|NCT00145574|19672280|P1|COMPLETED|Open Label Long-term Extension||0
7989714|NCT00145574|19672278|P3|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184
7989715|NCT00145574|19672279|P2|STARTED|Open Label Long-term Extension||0
7989716|NCT00145574|19672280|P1|STARTED|Open Label Long-term Extension||0
7989717|NCT00145574|19672278|P3|NOT COMPLETED|Double Blind||2
7989718|NCT00145574|19672279|P2|NOT COMPLETED|Double Blind||5
7989719|NCT00145574|19672280|P1|NOT COMPLETED|Double Blind||1
7989720|NCT00145574|19672278|P3|COMPLETED|Double Blind||62
7989721|NCT00145574|19672279|P2|COMPLETED|Double Blind||60
7989722|NCT00145574|19672280|P1|COMPLETED|Double Blind||64
7989723|NCT00145574|19672278|P3|STARTED|Double Blind||64
7989724|NCT00145574|19672279|P2|STARTED|Double Blind||65
7989725|NCT00145574|19672280|P1|STARTED|Double Blind||65
7989726|NCT00145509|19672337|P2|NOT COMPLETED|Overall Study||21
7989727|NCT00145509|19672338|P1|NOT COMPLETED|Overall Study||22
7989728|NCT00145509|19672337|P2|COMPLETED|Overall Study||15
7989729|NCT00145509|19672338|P1|COMPLETED|Overall Study||19
7989730|NCT00145509|19672337|P2|STARTED|Overall Study||36
7989731|NCT00145509|19672338|P1|STARTED|Overall Study||41
7989732|NCT00145496|19672352|P2|NOT COMPLETED|Overall Study||81
7989733|NCT00145496|19672353|P1|NOT COMPLETED|Overall Study||123
7989734|NCT00145496|19672352|P2|COMPLETED|Overall Study||143
7989735|NCT00145496|19672353|P1|COMPLETED|Overall Study||121
7989736|NCT00145496|19672352|P2|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224
7989737|NCT00145496|19672353|P1|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244
7989738|NCT00145470|19672365|P2|NOT COMPLETED|Overall Study||98
7989739|NCT00145470|19672366|P1|NOT COMPLETED|Overall Study||112
7989740|NCT00145470|19672365|P2|COMPLETED|Overall Study||61
7989741|NCT00145470|19672366|P1|COMPLETED|Overall Study||55
7989742|NCT00145470|19672365|P2|Treated|Overall Study||158
7989743|NCT00145470|19672366|P1|Treated|Overall Study||166
7989744|NCT00145470|19672365|P2|STARTED|Overall Study||159
7989745|NCT00145470|19672366|P1|STARTED|Overall Study||167
7989746|NCT00145418|19672426|P1|NOT COMPLETED|Overall Study||0
7989747|NCT00145418|19672426|P1|COMPLETED|Overall Study||15
7989748|NCT00145418|19672426|P1|STARTED|Overall Study||15
7989749|NCT00145327|19672436|P3|NOT COMPLETED|Overall Study||248
7989750|NCT00145327|19672437|P2|NOT COMPLETED|Overall Study||124
7989751|NCT00145327|19672438|P1|NOT COMPLETED|Overall Study||142
7989752|NCT00145327|19672436|P3|COMPLETED|Overall Study||975
7989753|NCT00145327|19672437|P2|COMPLETED|Overall Study||493
7989754|NCT00145327|19672438|P1|COMPLETED|Overall Study||474
7989755|NCT00145327|19672436|P3|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223
7989756|NCT00145327|19672437|P2|STARTED|Overall Study||617
7989757|NCT00145327|19672438|P1|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616
7989758|NCT00145249|19672494|P3|NOT COMPLETED|Overall Study||17
7989759|NCT00145249|19672495|P2|NOT COMPLETED|Overall Study||15
7989760|NCT00145249|19672496|P1|NOT COMPLETED|Overall Study||11
7989761|NCT00145249|19672494|P3|COMPLETED|Overall Study||31
7989762|NCT00145249|19672495|P2|COMPLETED|Overall Study||33
7989763|NCT00145249|19672496|P1|COMPLETED|Overall Study||36
7989764|NCT00145249|19672494|P3|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48
7989765|NCT00145249|19672495|P2|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48
7989766|NCT00145249|19672496|P1|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47
7989767|NCT00145119|19672537|P1|NOT COMPLETED|Overall Study||45
7989768|NCT00145119|19672537|P1|COMPLETED|Overall Study||267
7989769|NCT00145119|19672537|P1|STARTED|Overall Study||312
7989770|NCT00145041|19672541|P1|NOT COMPLETED|Overall Study||0
7989771|NCT00145041|19672541|P1|COMPLETED|Overall Study||7
7989772|NCT00145041|19672541|P1|STARTED|Overall Study||7
7989773|NCT00144963|19672547|P1|NOT COMPLETED|Overall Study||0
7989774|NCT00144963|19672547|P1|COMPLETED|Overall Study||36
7989775|NCT00144963|19672547|P1|STARTED|Overall Study||36
7989776|NCT00144781|19672555|P4|NOT COMPLETED|Overall Study||0
7989777|NCT00144781|19672556|P3|NOT COMPLETED|Overall Study||0
7989778|NCT00144781|19672557|P2|NOT COMPLETED|Overall Study||2
7989779|NCT00144781|19672558|P1|NOT COMPLETED|Overall Study||0
7989780|NCT00144781|19672555|P4|COMPLETED|Overall Study||9
7989781|NCT00144781|19672556|P3|COMPLETED|Overall Study||8
7989782|NCT00144781|19672557|P2|COMPLETED|Overall Study||7
7989783|NCT00144781|19672558|P1|COMPLETED|Overall Study||8
7989784|NCT00144781|19672555|P4|STARTED|Overall Study||9
7989785|NCT00144781|19672556|P3|STARTED|Overall Study||8
7989786|NCT00144781|19672557|P2|STARTED|Overall Study||9
7989787|NCT00144781|19672558|P1|STARTED|Overall Study||8
7989788|NCT00144391|19672578|P2|NOT COMPLETED|Overall Study||0
7989789|NCT00144391|19672579|P1|NOT COMPLETED|Overall Study||0
7989790|NCT00144391|19672578|P2|COMPLETED|Overall Study||9
7989791|NCT00144391|19672579|P1|COMPLETED|Overall Study||11
7989792|NCT00144391|19672578|P2|STARTED|Overall Study||9
7989793|NCT00144391|19672579|P1|STARTED|Overall Study||11
7989794|NCT00144339|19672587|P2|NOT COMPLETED|Overall Study||1099
7989795|NCT00144339|19672588|P1|NOT COMPLETED|Overall Study||1358
7989796|NCT00144339|19672587|P2|COMPLETED|Overall Study||1887
7989797|NCT00144339|19672588|P1|COMPLETED|Overall Study||1648
7989798|NCT00144339|19672587|P2|STARTED|Overall Study||2986
7989799|NCT00144339|19672588|P1|STARTED|Overall Study||3006
7989800|NCT00144300|19672796|P2|NOT COMPLETED|Overall Study||28
7989801|NCT00144300|19672797|P1|NOT COMPLETED|Overall Study||29
7989802|NCT00144300|19672796|P2|COMPLETED|Overall Study||97
7989803|NCT00144300|19672797|P1|COMPLETED|Overall Study||92
7989804|NCT00144300|19672796|P2|STARTED|Overall Study||125
7989805|NCT00144300|19672797|P1|STARTED|Overall Study||121
7989806|NCT00144170|19672845|P2|NOT COMPLETED|Overall Study||396
7989807|NCT00144170|19672846|P1|NOT COMPLETED|Overall Study||352
7989808|NCT00144170|19672845|P2|COMPLETED|Overall Study||32
7989809|NCT00144170|19672846|P1|COMPLETED|Overall Study||86
7989810|NCT00144170|19672845|P2|STARTED|Overall Study||428
7989811|NCT00144170|19672846|P1|STARTED|Overall Study||438
7989812|NCT00144027|19673036|P2|NOT COMPLETED|Overall Study||11
7989813|NCT00144027|19673037|P1|NOT COMPLETED|Overall Study||3
7989814|NCT00144027|19673036|P2|COMPLETED|Overall Study|participants who completed 12-month follow-up|25
7989815|NCT00144027|19673037|P1|COMPLETED|Overall Study|participants who completed 12-month follow-up|36
7989816|NCT00144027|19673036|P2|Completed 6 Month Assessment|Overall Study||24
7989817|NCT00144027|19673037|P1|Completed 6 Month Assessment|Overall Study||37
7989818|NCT00144027|19673036|P2|Completed Baseline Assessment|Overall Study||29
7989819|NCT00144027|19673037|P1|Completed Baseline Assessment|Overall Study||39
7989820|NCT00144027|19673036|P2|STARTED|Overall Study|participants who consented|36
7989821|NCT00144027|19673037|P1|STARTED|Overall Study|participants who consented|39
7989822|NCT00143845|19673043|P1|NOT COMPLETED|Overall Study||0
7989823|NCT00143845|19673043|P1|COMPLETED|Overall Study||54
7989824|NCT00143845|19673043|P1|STARTED|Overall Study||54
7989825|NCT00143819|19673051|P2|NOT COMPLETED|Overall Study||3
7989826|NCT00143819|19673052|P1|NOT COMPLETED|Overall Study||2
7989827|NCT00143819|19673051|P2|COMPLETED|Overall Study||5
7989828|NCT00143819|19673052|P1|COMPLETED|Overall Study||3
7989829|NCT00143819|19673051|P2|STARTED|Overall Study||8
7989830|NCT00143819|19673052|P1|STARTED|Overall Study||5
7989831|NCT00143598|19673067|P2|NOT COMPLETED|Overall Study||94
7989832|NCT00143598|19673068|P1|NOT COMPLETED|Overall Study||92
7989833|NCT00143598|19673067|P2|COMPLETED|Overall Study||302
7989834|NCT00143598|19673068|P1|COMPLETED|Overall Study||318
7989835|NCT00143598|19673067|P2|STARTED|Overall Study||396
7989836|NCT00143598|19673068|P1|STARTED|Overall Study||410
7989837|NCT00143507|19673082|P2|NOT COMPLETED|Overall Study||652
7989838|NCT00143507|19673083|P1|NOT COMPLETED|Overall Study||687
7989839|NCT00143507|19673082|P2|COMPLETED|Overall Study||4786
7989840|NCT00143507|19673083|P1|COMPLETED|Overall Study||4792
7989841|NCT00143507|19673082|P2|STARTED|Overall Study||5438
7989842|NCT00143507|19673083|P1|STARTED|Overall Study||5479
7989843|NCT00143455|19673117|P4|NOT COMPLETED|Cohort 2||93
7989844|NCT00143455|19673118|P3|NOT COMPLETED|Cohort 2||106
7989845|NCT00143455|19673119|P2|NOT COMPLETED|Cohort 2||0
7989846|NCT00143455|19673120|P1|NOT COMPLETED|Cohort 2||0
7989847|NCT00143455|19673117|P4|COMPLETED|Cohort 2||111
7989848|NCT00143455|19673118|P3|COMPLETED|Cohort 2||97
7989849|NCT00143455|19673119|P2|COMPLETED|Cohort 2||0
7989850|NCT00143455|19673120|P1|COMPLETED|Cohort 2||0
7989851|NCT00143455|19673117|P4|Received Treatment|Cohort 2||203
7989852|NCT00143455|19673118|P3|Received Treatment|Cohort 2||202
7989853|NCT00143455|19673119|P2|Received Treatment|Cohort 2||0
7989854|NCT00143455|19673120|P1|Received Treatment|Cohort 2||0
7989855|NCT00143455|19673117|P4|STARTED|Cohort 2||204
7989856|NCT00143455|19673118|P3|STARTED|Cohort 2||203
7989857|NCT00143455|19673119|P2|STARTED|Cohort 2||0
7989858|NCT00143455|19673120|P1|STARTED|Cohort 2||0
7989859|NCT00143455|19673117|P4|NOT COMPLETED|Cohort 1||0
7989860|NCT00143455|19673118|P3|NOT COMPLETED|Cohort 1||0
7989861|NCT00143455|19673119|P2|NOT COMPLETED|Cohort 1||17
7989862|NCT00143455|19673120|P1|NOT COMPLETED|Cohort 1||14
7989863|NCT00143455|19673117|P4|COMPLETED|Cohort 1||0
7989864|NCT00143455|19673118|P3|COMPLETED|Cohort 1||0
7989865|NCT00143455|19673119|P2|COMPLETED|Cohort 1||22
7989866|NCT00143455|19673120|P1|COMPLETED|Cohort 1||25
7989867|NCT00143455|19673117|P4|Received Treatment|Cohort 1||0
7989868|NCT00143455|19673118|P3|Received Treatment|Cohort 1||0
7989869|NCT00143455|19673119|P2|Received Treatment|Cohort 1||38
7989870|NCT00143455|19673120|P1|Received Treatment|Cohort 1||39
7989871|NCT00143455|19673117|P4|STARTED|Cohort 1||0
7989872|NCT00143455|19673118|P3|STARTED|Cohort 1||0
7989873|NCT00143455|19673119|P2|STARTED|Cohort 1||39
7989874|NCT00143455|19673120|P1|STARTED|Cohort 1||39
7989875|NCT00143403|19673154|P2|NOT COMPLETED|Overall Study||46
7989876|NCT00143403|19673155|P1|NOT COMPLETED|Overall Study||35
7989877|NCT00143403|19673154|P2|COMPLETED|Overall Study|Received maximum number of cycles.|115
7989878|NCT00143403|19673155|P1|COMPLETED|Overall Study|Received maximum number of cycles.|125
7989879|NCT00143403|19673154|P2|Treated|Overall Study||153
7989880|NCT00143403|19673155|P1|Treated|Overall Study||153
7989881|NCT00143403|19673154|P2|STARTED|Overall Study||161
7989882|NCT00143403|19673155|P1|STARTED|Overall Study||160
7989883|NCT00143390|19673165|P2|NOT COMPLETED|Overall Study||149
7989884|NCT00143390|19673166|P1|NOT COMPLETED|Overall Study||149
7989885|NCT00143390|19673165|P2|COMPLETED|Overall Study||0
7989886|NCT00143390|19673166|P1|COMPLETED|Overall Study||0
7989887|NCT00143390|19673165|P2|STARTED|Overall Study||149
7989888|NCT00143390|19673166|P1|STARTED|Overall Study||149
7989889|NCT00143312|19673182|P1|NOT COMPLETED|Overall Study||16
7989890|NCT00143312|19673182|P1|COMPLETED|Overall Study||29
7989891|NCT00143312|19673182|P1|STARTED|Overall Study||45
7989892|NCT00143247|19673192|P1|NOT COMPLETED|Overall Study||156
7989893|NCT00143247|19673192|P1|COMPLETED|Overall Study||17
7989894|NCT00143247|19673192|P1|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173
7989895|NCT00142935|19673209|P3|NOT COMPLETED|Overall Study||7
7989896|NCT00142935|19673210|P2|NOT COMPLETED|Overall Study||8
7989897|NCT00142935|19673211|P1|NOT COMPLETED|Overall Study||3
7989898|NCT00142935|19673209|P3|COMPLETED|Overall Study||23
7989899|NCT00142935|19673210|P2|COMPLETED|Overall Study||20
7989900|NCT00142935|19673211|P1|COMPLETED|Overall Study||26
7989901|NCT00142935|19673209|P3|STARTED|Overall Study||30
7989902|NCT00142935|19673210|P2|STARTED|Overall Study||28
7989903|NCT00142935|19673211|P1|STARTED|Overall Study||29
7989904|NCT00142909|19673236|P2|NOT COMPLETED|Medications Begin||3
7989905|NCT00142909|19673237|P1|NOT COMPLETED|Medications Begin||9
7989906|NCT00142909|19673236|P2|COMPLETED|Medications Begin||31
7989907|NCT00142909|19673237|P1|COMPLETED|Medications Begin||26
7989908|NCT00142909|19673236|P2|STARTED|Medications Begin||34
7989909|NCT00142909|19673237|P1|STARTED|Medications Begin||35
7989910|NCT00142909|19673236|P2|NOT COMPLETED|Randomization||10
7989911|NCT00142909|19673237|P1|NOT COMPLETED|Randomization||7
7989912|NCT00142909|19673236|P2|COMPLETED|Randomization||34
7989913|NCT00142909|19673237|P1|COMPLETED|Randomization||35
7989914|NCT00142909|19673236|P2|STARTED|Randomization||44
7989915|NCT00142909|19673237|P1|STARTED|Randomization||42
7989916|NCT00142818|19673257|P4|NOT COMPLETED|Overall Study||22
7989917|NCT00142818|19673258|P3|NOT COMPLETED|Overall Study||13
7989918|NCT00142818|19673259|P2|NOT COMPLETED|Overall Study||21
7989919|NCT00142818|19673260|P1|NOT COMPLETED|Overall Study||17
7989920|NCT00142818|19673257|P4|COMPLETED|Overall Study||20
7989921|NCT00142818|19673258|P3|COMPLETED|Overall Study||24
7989922|NCT00142818|19673259|P2|COMPLETED|Overall Study||19
7989923|NCT00142818|19673260|P1|COMPLETED|Overall Study||28
7989924|NCT00142818|19673257|P4|STARTED|Overall Study||42
7989925|NCT00142818|19673258|P3|STARTED|Overall Study||37
7989926|NCT00142818|19673259|P2|STARTED|Overall Study||40
7989927|NCT00142818|19673260|P1|STARTED|Overall Study||45
7989928|NCT00142792|19673277|P3|NOT COMPLETED|Overall Study||12
7989929|NCT00142792|19673278|P2|NOT COMPLETED|Overall Study||15
7989930|NCT00142792|19673279|P1|NOT COMPLETED|Overall Study||12
7989931|NCT00142792|19673277|P3|COMPLETED|Overall Study||30
7989932|NCT00142792|19673278|P2|COMPLETED|Overall Study||26
7989933|NCT00142792|19673279|P1|COMPLETED|Overall Study||27
7989934|NCT00142792|19673277|P3|Completed Intervention|Overall Study||37
7989935|NCT00142792|19673278|P2|Completed Intervention|Overall Study||37
7989936|NCT00142792|19673279|P1|Completed Intervention|Overall Study||35
7989937|NCT00142792|19673277|P3|STARTED|Overall Study||42
7989938|NCT00142792|19673278|P2|STARTED|Overall Study||41
7989939|NCT00142792|19673279|P1|STARTED|Overall Study||39
7989940|NCT00142597|19673292|P2|NOT COMPLETED|Overall Study||1
7989941|NCT00142597|19673293|P1|NOT COMPLETED|Overall Study||3
7989942|NCT00142597|19673292|P2|COMPLETED|Overall Study|N=10 completed PET imaging|22
7989943|NCT00142597|19673293|P1|COMPLETED|Overall Study|N=10 completed PET imaging|20
7989944|NCT00142597|19673292|P2|STARTED|Overall Study|N=10 underwent PET imaging|23
7989945|NCT00142597|19673293|P1|STARTED|Overall Study|N=10 underwent PET imaging|23
7989946|NCT00142519|19673301|P2|NOT COMPLETED|Overall Study||16
7989947|NCT00142519|19673302|P1|NOT COMPLETED|Overall Study||18
7989948|NCT00142519|19673301|P2|COMPLETED|Overall Study||9
7989949|NCT00142519|19673302|P1|COMPLETED|Overall Study||7
7989950|NCT00142519|19673301|P2|STARTED|Overall Study||25
7989951|NCT00142519|19673302|P1|STARTED|Overall Study||25
7989952|NCT00142506|19673312|P2|NOT COMPLETED|Overall Study||29
7989953|NCT00142506|19673313|P1|NOT COMPLETED|Overall Study||72
7989954|NCT00142506|19673312|P2|COMPLETED|Overall Study||77
7989955|NCT00142506|19673313|P1|COMPLETED|Overall Study||112
7989956|NCT00142506|19673312|P2|STARTED|Overall Study||106
7989957|NCT00142506|19673313|P1|STARTED|Overall Study||184
7989958|NCT00142454|19673319|P1|NOT COMPLETED|Overall Study||0
7989959|NCT00142454|19673319|P1|COMPLETED|Overall Study||9
7989960|NCT00142454|19673319|P1|STARTED|Overall Study||9
7989961|NCT00142415|19673331|P6|NOT COMPLETED|Overall Study||2
7989962|NCT00142415|19673332|P5|NOT COMPLETED|Overall Study||1
7989963|NCT00142415|19673333|P4|NOT COMPLETED|Overall Study||0
7989964|NCT00142415|19673334|P3|NOT COMPLETED|Overall Study||0
7989965|NCT00142415|19673335|P2|NOT COMPLETED|Overall Study||0
7989966|NCT00142415|19673336|P1|NOT COMPLETED|Overall Study||0
7989967|NCT00142415|19673331|P6|COMPLETED|Overall Study||6
7989968|NCT00142415|19673332|P5|COMPLETED|Overall Study||2
7989969|NCT00142415|19673333|P4|COMPLETED|Overall Study||3
7989970|NCT00142415|19673334|P3|COMPLETED|Overall Study||6
7989971|NCT00142415|19673335|P2|COMPLETED|Overall Study||3
7989972|NCT00142415|19673336|P1|COMPLETED|Overall Study||3
7989973|NCT00142415|19673331|P6|STARTED|Overall Study||8
7989974|NCT00142415|19673332|P5|STARTED|Overall Study||3
7989975|NCT00142415|19673333|P4|STARTED|Overall Study||3
7989976|NCT00142415|19673334|P3|STARTED|Overall Study||6
7989977|NCT00142415|19673335|P2|STARTED|Overall Study||3
7989978|NCT00142415|19673336|P1|STARTED|Overall Study||3
7989979|NCT00142298|19673374|P10|NOT COMPLETED|Overall Study||0
7989980|NCT00142298|19673375|P9|NOT COMPLETED|Overall Study||5
7989981|NCT00142298|19673376|P8|NOT COMPLETED|Overall Study||8
7989982|NCT00142298|19673377|P7|NOT COMPLETED|Overall Study||8
7989983|NCT00142298|19673378|P6|NOT COMPLETED|Overall Study||16
7989984|NCT00142298|19673379|P5|NOT COMPLETED|Overall Study||10
7989985|NCT00142298|19673380|P4|NOT COMPLETED|Overall Study||85
7989986|NCT00142298|19673381|P3|NOT COMPLETED|Overall Study||33
7989987|NCT00142298|19673382|P2|NOT COMPLETED|Overall Study||176
7989988|NCT00142298|19673383|P1|NOT COMPLETED|Overall Study||160
7989989|NCT00142298|19673374|P10|COMPLETED|Overall Study||13
7989990|NCT00142298|19673375|P9|COMPLETED|Overall Study||52
7989991|NCT00142298|19673376|P8|COMPLETED|Overall Study||58
7989992|NCT00142298|19673377|P7|COMPLETED|Overall Study||15
7989993|NCT00142298|19673378|P6|COMPLETED|Overall Study||10
7989994|NCT00142298|19673379|P5|COMPLETED|Overall Study||46
7989995|NCT00142298|19673380|P4|COMPLETED|Overall Study||121
7989996|NCT00142298|19673381|P3|COMPLETED|Overall Study||90
7989997|NCT00142298|19673382|P2|COMPLETED|Overall Study||456
7989998|NCT00142298|19673383|P1|COMPLETED|Overall Study|Completed week 104/week 208.|507
7989999|NCT00142298|19673374|P10|Per Protocol Population|Overall Study||13
7990000|NCT00142298|19673375|P9|Per Protocol Population|Overall Study||56
7990001|NCT00142298|19673376|P8|Per Protocol Population|Overall Study||64
7990002|NCT00142298|19673377|P7|Per Protocol Population|Overall Study||19
7990003|NCT00142298|19673378|P6|Per Protocol Population|Overall Study||25
7990004|NCT00142298|19673379|P5|Per Protocol Population|Overall Study||50
7990005|NCT00142298|19673380|P4|Per Protocol Population|Overall Study||202
7990006|NCT00142298|19673381|P3|Per Protocol Population|Overall Study||120
7990007|NCT00142298|19673382|P2|Per Protocol Population|Overall Study||606
7990008|NCT00142298|19673383|P1|Per Protocol Population|Overall Study||635
7990009|NCT00142298|19673374|P10|Safety Population|Overall Study||13
7990010|NCT00142298|19673375|P9|Safety Population|Overall Study||57
7990011|NCT00142298|19673376|P8|Safety Population|Overall Study||66
7990012|NCT00142298|19673377|P7|Safety Population|Overall Study||23
7990013|NCT00142298|19673378|P6|Safety Population|Overall Study||26
7990014|NCT00142298|19673379|P5|Safety Population|Overall Study||50
7990015|NCT00142298|19673380|P4|Safety Population|Overall Study||206
7990016|NCT00142298|19673381|P3|Safety Population|Overall Study||122
7990017|NCT00142298|19673382|P2|Safety Population|Overall Study||626
7990018|NCT00142298|19673383|P1|Safety Population|Overall Study||655
7990019|NCT00142298|19673374|P10|STARTED|Overall Study||13
7990020|NCT00142298|19673375|P9|STARTED|Overall Study||57
7990021|NCT00142298|19673376|P8|STARTED|Overall Study||66
7990022|NCT00142298|19673377|P7|STARTED|Overall Study||23
7990023|NCT00142298|19673378|P6|STARTED|Overall Study||26
7990024|NCT00142298|19673379|P5|STARTED|Overall Study||56
7990025|NCT00142298|19673380|P4|STARTED|Overall Study||206
7990026|NCT00142298|19673381|P3|STARTED|Overall Study||123
7990027|NCT00142298|19673382|P2|STARTED|Overall Study||632
7990028|NCT00142298|19673383|P1|STARTED|Overall Study||667
7990029|NCT00142168|19673405|P1|NOT COMPLETED|Overall Study||0
7990030|NCT00142168|19673405|P1|COMPLETED|Overall Study||16
7990031|NCT00142168|19673405|P1|STARTED|Overall Study||16
7990032|NCT00142116|19673412|P1|NOT COMPLETED|Overall Study||0
7990033|NCT00142116|19673412|P1|COMPLETED|Overall Study||25
7990034|NCT00142116|19673412|P1|STARTED|Overall Study||25
7990035|NCT00141921|19673417|P1|NOT COMPLETED|Overall Study||141
7990036|NCT00141921|19673417|P1|COMPLETED|Overall Study||41
7990037|NCT00141921|19673417|P1|Received Treatment|Overall Study||181
7990038|NCT00141921|19673417|P1|STARTED|Overall Study||182
7990039|NCT00141817|19673443|P4|NOT COMPLETED|Overall Study||0
7990040|NCT00141817|19673444|P3|NOT COMPLETED|Overall Study||1
7990041|NCT00141817|19673445|P2|NOT COMPLETED|Overall Study||0
7990042|NCT00141817|19673446|P1|NOT COMPLETED|Overall Study||1
7990043|NCT00141817|19673443|P4|COMPLETED|Overall Study||13
7990044|NCT00141817|19673444|P3|COMPLETED|Overall Study||10
7990045|NCT00141817|19673445|P2|COMPLETED|Overall Study||10
7990046|NCT00141817|19673446|P1|COMPLETED|Overall Study||6
7990047|NCT00141817|19673443|P4|STARTED|Overall Study||13
7990048|NCT00141817|19673444|P3|STARTED|Overall Study||11
7990049|NCT00141817|19673445|P2|STARTED|Overall Study||10
7990050|NCT00141817|19673446|P1|STARTED|Overall Study||7
7990051|NCT00141778|19673487|P3|NOT COMPLETED|Started Study Medication||4
7990052|NCT00141778|19673488|P2|NOT COMPLETED|Started Study Medication||7
7990053|NCT00141778|19673489|P1|NOT COMPLETED|Started Study Medication||2
7990054|NCT00141778|19673487|P3|COMPLETED|Started Study Medication||143
7990055|NCT00141778|19673488|P2|COMPLETED|Started Study Medication||144
7990056|NCT00141778|19673489|P1|COMPLETED|Started Study Medication||145
7990057|NCT00141778|19673487|P3|STARTED|Started Study Medication||147
7990058|NCT00141778|19673488|P2|STARTED|Started Study Medication||151
7990059|NCT00141778|19673489|P1|STARTED|Started Study Medication||147
7990060|NCT00141778|19673487|P3|NOT COMPLETED|Randomization Prior to Study Med||6
7990061|NCT00141778|19673488|P2|NOT COMPLETED|Randomization Prior to Study Med||2
7990062|NCT00141778|19673489|P1|NOT COMPLETED|Randomization Prior to Study Med||5
7990063|NCT00141778|19673487|P3|COMPLETED|Randomization Prior to Study Med||147
7990064|NCT00141778|19673488|P2|COMPLETED|Randomization Prior to Study Med||151
7990065|NCT00141778|19673489|P1|COMPLETED|Randomization Prior to Study Med||147
7990066|NCT00141778|19673487|P3|STARTED|Randomization Prior to Study Med||153
7990067|NCT00141778|19673488|P2|STARTED|Randomization Prior to Study Med||153
7990068|NCT00141778|19673489|P1|STARTED|Randomization Prior to Study Med||152
7990069|NCT00141765|19673527|P1|NOT COMPLETED|Overall Study||0
7990070|NCT00141765|19673527|P1|COMPLETED|Overall Study||25
7990071|NCT00141765|19673527|P1|STARTED|Overall Study||25
7990072|NCT00141739|19673531|P1|NOT COMPLETED|Overall Study||0
7990073|NCT00141739|19673531|P1|COMPLETED|Overall Study||100
7990074|NCT00141739|19673531|P1|STARTED|Overall Study|Number of evaluable patients|100
7990075|NCT00141726|19673542|P1|NOT COMPLETED|Overall Study||3
7990076|NCT00141726|19673542|P1|COMPLETED|Overall Study||31
7990077|NCT00141726|19673542|P1|STARTED|Overall Study||34
7990078|NCT00141518|19673550|P3|NOT COMPLETED|Overall Study||6
7990079|NCT00141518|19673551|P2|NOT COMPLETED|Overall Study||6
7990080|NCT00141518|19673552|P1|NOT COMPLETED|Overall Study||16
7990081|NCT00141518|19673550|P3|COMPLETED|Overall Study||12
7990082|NCT00141518|19673551|P2|COMPLETED|Overall Study||16
7990083|NCT00141518|19673552|P1|COMPLETED|Overall Study||21
7990084|NCT00141518|19673550|P3|Full Analysis Sample|Overall Study||18
7990085|NCT00141518|19673551|P2|Full Analysis Sample|Overall Study||22
7990086|NCT00141518|19673552|P1|Full Analysis Sample|Overall Study||27
7990087|NCT00141518|19673550|P3|Safety Sample|Overall Study||18
7990088|NCT00141518|19673551|P2|Safety Sample|Overall Study||22
7990089|NCT00141518|19673552|P1|Safety Sample|Overall Study||36
7990090|NCT00141518|19673550|P3|STARTED|Overall Study||18
7990091|NCT00141518|19673551|P2|STARTED|Overall Study||22
7990092|NCT00141518|19673552|P1|STARTED|Overall Study||37
7990093|NCT00141453|19673741|P2|NOT COMPLETED|Overall Study||5
7990094|NCT00141453|19673742|P1|NOT COMPLETED|Overall Study||6
7990095|NCT00141453|19673741|P2|COMPLETED|Overall Study||284
7990096|NCT00141453|19673742|P1|COMPLETED|Overall Study||282
7990097|NCT00141453|19673741|P2|STARTED|Overall Study||289
7990098|NCT00141453|19673742|P1|STARTED|Overall Study||288
7990099|NCT00141297|19673756|P10|NOT COMPLETED|Overall Study||6
7990100|NCT00141297|19673757|P9|NOT COMPLETED|Overall Study||20
7990101|NCT00141297|19673758|P8|NOT COMPLETED|Overall Study||4
7990102|NCT00141297|19673759|P7|NOT COMPLETED|Overall Study||3
7990103|NCT00141297|19673760|P6|NOT COMPLETED|Overall Study||3
7990104|NCT00141297|19673761|P5|NOT COMPLETED|Overall Study||22
7990105|NCT00141297|19673762|P4|NOT COMPLETED|Overall Study||3
7990106|NCT00141297|19673763|P3|NOT COMPLETED|Overall Study||7
7990107|NCT00141297|19673764|P2|NOT COMPLETED|Overall Study||3
7990108|NCT00141297|19673765|P1|NOT COMPLETED|Overall Study||3
7990109|NCT00141297|19673756|P10|COMPLETED|Overall Study||0
7990110|NCT00141297|19673757|P9|COMPLETED|Overall Study||0
7990111|NCT00141297|19673758|P8|COMPLETED|Overall Study||0
7990112|NCT00141297|19673759|P7|COMPLETED|Overall Study||0
7990113|NCT00141297|19673760|P6|COMPLETED|Overall Study||0
7990114|NCT00141297|19673761|P5|COMPLETED|Overall Study||0
7990115|NCT00141297|19673762|P4|COMPLETED|Overall Study||0
7990116|NCT00141297|19673763|P3|COMPLETED|Overall Study||0
7990117|NCT00141297|19673764|P2|COMPLETED|Overall Study||0
7990118|NCT00141297|19673765|P1|COMPLETED|Overall Study||0
7990119|NCT00141297|19673756|P10|STARTED|Overall Study||6
7990120|NCT00141297|19673757|P9|STARTED|Overall Study||20
7990121|NCT00141297|19673758|P8|STARTED|Overall Study||4
7990122|NCT00141297|19673759|P7|STARTED|Overall Study||3
7990123|NCT00141297|19673760|P6|STARTED|Overall Study||3
7990124|NCT00141297|19673761|P5|STARTED|Overall Study||22
7990125|NCT00141297|19673762|P4|STARTED|Overall Study||3
7990126|NCT00141297|19673763|P3|STARTED|Overall Study||7
7990127|NCT00141297|19673764|P2|STARTED|Overall Study||3
7990128|NCT00141297|19673765|P1|STARTED|Overall Study||3
7990129|NCT00141271|19674043|P3|NOT COMPLETED|Overall Study||57
7990130|NCT00141271|19674044|P2|NOT COMPLETED|Overall Study||63
7990131|NCT00141271|19674045|P1|NOT COMPLETED|Overall Study||80
7990132|NCT00141271|19674043|P3|COMPLETED|Overall Study||111
7990133|NCT00141271|19674044|P2|COMPLETED|Overall Study||102
7990134|NCT00141271|19674045|P1|COMPLETED|Overall Study||91
7990135|NCT00141271|19674043|P3|STARTED|Overall Study||168
7990136|NCT00141271|19674044|P2|STARTED|Overall Study||165
7990137|NCT00141271|19674045|P1|STARTED|Overall Study||171
7990138|NCT00141219|19674166|P2|NOT COMPLETED|Overall Study||16
7990139|NCT00141219|19674167|P1|NOT COMPLETED|Overall Study||24
7990140|NCT00141219|19674166|P2|COMPLETED|Overall Study||62
7990141|NCT00141219|19674167|P1|COMPLETED|Overall Study||138
7990142|NCT00141219|19674166|P2|STARTED|Overall Study||78
7990143|NCT00141219|19674167|P1|STARTED|Overall Study||162
7990144|NCT00141115|19674217|P1|NOT COMPLETED|Overall Study||1
7990145|NCT00141115|19674217|P1|COMPLETED|Overall Study||2
7990146|NCT00141115|19674217|P1|STARTED|Overall Study||3
7990147|NCT00141102|19674224|P2|NOT COMPLETED|Overall Study||625
7990148|NCT00141102|19674225|P1|NOT COMPLETED|Overall Study||508
7990149|NCT00141102|19674224|P2|COMPLETED|Overall Study||1621
7990150|NCT00141102|19674225|P1|COMPLETED|Overall Study||1730
7990151|NCT00141102|19674224|P2|Received Treatment|Overall Study||2237
7990152|NCT00141102|19674225|P1|Received Treatment|Overall Study||2223
7990153|NCT00141102|19674224|P2|STARTED|Overall Study||2246
7990154|NCT00141102|19674225|P1|STARTED|Overall Study||2238
7990155|NCT00141037|19674265|P2|NOT COMPLETED|Overall Study||18
7990156|NCT00141037|19674266|P1|NOT COMPLETED|Overall Study||10
7990157|NCT00141037|19674265|P2|COMPLETED|Overall Study|8 subjects had reduced follow-up|52
7990158|NCT00141037|19674266|P1|COMPLETED|Overall Study|16 subjects had reduced follow-up|50
7990159|NCT00141037|19674265|P2|STARTED|Overall Study||70
7990160|NCT00141037|19674266|P1|STARTED|Overall Study||60
7990161|NCT00140842|19674276|P2|NOT COMPLETED|Overall Study||0
7990162|NCT00140842|19674277|P1|NOT COMPLETED|Overall Study||0
7990163|NCT00140842|19674276|P2|COMPLETED|Overall Study||15
7990164|NCT00140842|19674277|P1|COMPLETED|Overall Study||15
7990165|NCT00140842|19674276|P2|STARTED|Overall Study||15
7990166|NCT00140842|19674277|P1|STARTED|Overall Study||15
7990167|NCT00140621|19674285|P1|NOT COMPLETED|Overall Study||0
7990168|NCT00140621|19674285|P1|COMPLETED|Overall Study||6
7990169|NCT00140621|19674285|P1|STARTED|Overall Study||6
7990170|NCT00140556|19674295|P1|NOT COMPLETED|Chemoradiotherapy Period||0
7990171|NCT00140556|19674295|P1|COMPLETED|Chemoradiotherapy Period||28
7990172|NCT00140556|19674295|P1|STARTED|Chemoradiotherapy Period||28
7990173|NCT00140556|19674295|P1|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0
7990174|NCT00140556|19674295|P1|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28
7990175|NCT00140556|19674295|P1|STARTED|Pre Radiation Period: Avastin / Tarceva||28
7990176|NCT00140426|19674301|P2|NOT COMPLETED|Overall Study||3
7990177|NCT00140426|19674302|P1|NOT COMPLETED|Overall Study||0
7990178|NCT00140426|19674301|P2|COMPLETED|Overall Study||16
7990179|NCT00140426|19674302|P1|COMPLETED|Overall Study||22
7990180|NCT00140426|19674301|P2|STARTED|Overall Study||19
7990181|NCT00140426|19674302|P1|STARTED|Overall Study||22
7990182|NCT00140413|19674335|P2|NOT COMPLETED|Overall Study||0
7990183|NCT00140413|19674336|P1|NOT COMPLETED|Overall Study||3
7990184|NCT00140413|19674335|P2|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7
7990185|NCT00140413|19674336|P1|COMPLETED|Overall Study||10
7990186|NCT00140413|19674335|P2|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3
7990187|NCT00140413|19674336|P1|Received at Least One Dose of GH|Overall Study||13
7990188|NCT00140413|19674335|P2|STARTED|Overall Study||7
7990189|NCT00140413|19674336|P1|STARTED|Overall Study||13
7990190|NCT00140244|19674343|P2|NOT COMPLETED|Intervention 2||2
7990191|NCT00140244|19674344|P1|NOT COMPLETED|Intervention 2||0
7990192|NCT00140244|19674343|P2|COMPLETED|Intervention 2||2
7990193|NCT00140244|19674344|P1|COMPLETED|Intervention 2||3
7990194|NCT00140244|19674343|P2|STARTED|Intervention 2||4
7990195|NCT00140244|19674344|P1|STARTED|Intervention 2||3
7990196|NCT00140244|19674343|P2|NOT COMPLETED|Washout||0
7990197|NCT00140244|19674344|P1|NOT COMPLETED|Washout||0
7990198|NCT00140244|19674343|P2|COMPLETED|Washout||4
7990199|NCT00140244|19674344|P1|COMPLETED|Washout||3
7990200|NCT00140244|19674343|P2|STARTED|Washout||4
7990201|NCT00140244|19674344|P1|STARTED|Washout||3
7990202|NCT00140244|19674343|P2|NOT COMPLETED|Intervention 1||0
7990203|NCT00140244|19674344|P1|NOT COMPLETED|Intervention 1||0
7990204|NCT00140244|19674343|P2|COMPLETED|Intervention 1||4
7990205|NCT00140244|19674344|P1|COMPLETED|Intervention 1||3
7990206|NCT00140244|19674343|P2|STARTED|Intervention 1||4
7990207|NCT00140244|19674344|P1|STARTED|Intervention 1||3
7990208|NCT00140231|19674376|P2|NOT COMPLETED|Fasting State With Leptin and Crossover||0
7990209|NCT00140231|19674377|P1|NOT COMPLETED|Fasting State With Leptin and Crossover||0
7990210|NCT00140231|19674376|P2|COMPLETED|Fasting State With Leptin and Crossover||6
7990211|NCT00140231|19674377|P1|COMPLETED|Fasting State With Leptin and Crossover||7
7990212|NCT00140231|19674376|P2|STARTED|Fasting State With Leptin and Crossover||6
7990213|NCT00140231|19674377|P1|STARTED|Fasting State With Leptin and Crossover||7
7990214|NCT00140231|19674376|P2|NOT COMPLETED|Washout 8 Weeks||0
7990215|NCT00140231|19674377|P1|NOT COMPLETED|Washout 8 Weeks||0
7990216|NCT00140231|19674376|P2|COMPLETED|Washout 8 Weeks||6
7990217|NCT00140231|19674377|P1|COMPLETED|Washout 8 Weeks||7
7990218|NCT00140231|19674376|P2|STARTED|Washout 8 Weeks||6
7990219|NCT00140231|19674377|P1|STARTED|Washout 8 Weeks||7
7990220|NCT00140231|19674376|P2|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
7990221|NCT00140231|19674377|P1|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
7990222|NCT00140231|19674376|P2|COMPLETED|First Fasting State 3 Days With Placebo||6
7990223|NCT00140231|19674377|P1|COMPLETED|First Fasting State 3 Days With Placebo||7
7990224|NCT00140231|19674376|P2|STARTED|First Fasting State 3 Days With Placebo||6
7990225|NCT00140231|19674377|P1|STARTED|First Fasting State 3 Days With Placebo||7
7990226|NCT00140231|19674376|P2|NOT COMPLETED|Washout 8weeks||0
7990227|NCT00140231|19674377|P1|NOT COMPLETED|Washout 8weeks||0
7990228|NCT00140231|19674376|P2|COMPLETED|Washout 8weeks||6
7990229|NCT00140231|19674377|P1|COMPLETED|Washout 8weeks||7
7990230|NCT00140231|19674376|P2|STARTED|Washout 8weeks||6
7990231|NCT00140231|19674377|P1|STARTED|Washout 8weeks||7
7990232|NCT00140231|19674376|P2|NOT COMPLETED|Fed State 1 Day- day5||0
7990233|NCT00140231|19674377|P1|NOT COMPLETED|Fed State 1 Day- day5||0
7990234|NCT00140231|19674376|P2|COMPLETED|Fed State 1 Day- day5||6
7990235|NCT00140231|19674377|P1|COMPLETED|Fed State 1 Day- day5||7
7990236|NCT00140231|19674376|P2|STARTED|Fed State 1 Day- day5||6
7990237|NCT00140231|19674377|P1|STARTED|Fed State 1 Day- day5||7
7990238|NCT00140205|19674396|P3|NOT COMPLETED|Overall Study||0
7990239|NCT00140205|19674397|P2|NOT COMPLETED|Overall Study||0
7990240|NCT00140205|19674398|P1|NOT COMPLETED|Overall Study||0
7990241|NCT00140205|19674396|P3|COMPLETED|Overall Study||5
7990242|NCT00140205|19674397|P2|COMPLETED|Overall Study||5
7990243|NCT00140205|19674398|P1|COMPLETED|Overall Study||5
7990244|NCT00140205|19674396|P3|STARTED|Overall Study||5
7990245|NCT00140205|19674397|P2|STARTED|Overall Study||5
7990246|NCT00140205|19674398|P1|STARTED|Overall Study||5
7990247|NCT00140140|19674467|P3|NOT COMPLETED|Overall Study||2
7990248|NCT00140140|19674468|P2|NOT COMPLETED|Overall Study||2
7990249|NCT00140140|19674469|P1|NOT COMPLETED|Overall Study||2
7990250|NCT00140140|19674467|P3|COMPLETED|Overall Study|Progressive disease|4
7990251|NCT00140140|19674468|P2|COMPLETED|Overall Study|Progressive disease|4
7990252|NCT00140140|19674469|P1|COMPLETED|Overall Study|Progressive disease|2
7990253|NCT00140140|19674467|P3|STARTED|Overall Study||6
7990254|NCT00140140|19674468|P2|STARTED|Overall Study||6
7990255|NCT00140140|19674469|P1|STARTED|Overall Study||4
7990256|NCT00139997|19674508|P2|NOT COMPLETED|Overall Study||2
7990257|NCT00139997|19674509|P1|NOT COMPLETED|Overall Study||1
7990258|NCT00139997|19674508|P2|COMPLETED|Overall Study||9
7990259|NCT00139997|19674509|P1|COMPLETED|Overall Study||14
7990260|NCT00139997|19674508|P2|STARTED|Overall Study||11
7990261|NCT00139997|19674509|P1|STARTED|Overall Study||15
7990262|NCT00139776|19674519|P4|NOT COMPLETED|Period III||106
7990263|NCT00139776|19674520|P3|NOT COMPLETED|Period III||76
7990264|NCT00139776|19674521|P2|NOT COMPLETED|Period III||0
7990265|NCT00139776|19674522|P1|NOT COMPLETED|Period III||0
7990266|NCT00139776|19674519|P4|COMPLETED|Period III||321
7990267|NCT00139776|19674520|P3|COMPLETED|Period III||355
7990268|NCT00139776|19674521|P2|COMPLETED|Period III||0
7990269|NCT00139776|19674522|P1|COMPLETED|Period III||0
7990270|NCT00139776|19674519|P4|STARTED|Period III|Randomized 435: 8 participants not treated|427
7990271|NCT00139776|19674520|P3|STARTED|Period III|Randomized 440: 9 participants not treated|431
7990272|NCT00139776|19674521|P2|STARTED|Period III||0
7990273|NCT00139776|19674522|P1|STARTED|Period III||0
7990274|NCT00139776|19674519|P4|NOT COMPLETED|Period II||0
7990275|NCT00139776|19674520|P3|NOT COMPLETED|Period II||0
7990276|NCT00139776|19674521|P2|NOT COMPLETED|Period II||322
7990277|NCT00139776|19674522|P1|NOT COMPLETED|Period II||0
7990278|NCT00139776|19674519|P4|COMPLETED|Period II||0
7990279|NCT00139776|19674520|P3|COMPLETED|Period II||0
7990280|NCT00139776|19674521|P2|COMPLETED|Period II||875
7990281|NCT00139776|19674522|P1|COMPLETED|Period II||0
7990282|NCT00139776|19674519|P4|STARTED|Period II||0
7990283|NCT00139776|19674520|P3|STARTED|Period II||0
7990284|NCT00139776|19674521|P2|STARTED|Period II||1197
7990285|NCT00139776|19674522|P1|STARTED|Period II||0
7990286|NCT00139776|19674519|P4|NOT COMPLETED|Period I||0
7990287|NCT00139776|19674520|P3|NOT COMPLETED|Period I||0
7990288|NCT00139776|19674521|P2|NOT COMPLETED|Period I||0
7990289|NCT00139776|19674522|P1|NOT COMPLETED|Period I||575
7990290|NCT00139776|19674519|P4|COMPLETED|Period I||0
7990291|NCT00139776|19674520|P3|COMPLETED|Period I||0
7990292|NCT00139776|19674521|P2|COMPLETED|Period I||0
7990293|NCT00139776|19674522|P1|COMPLETED|Period I||1197
7990294|NCT00139776|19674519|P4|STARTED|Period I||0
7990295|NCT00139776|19674520|P3|STARTED|Period I||0
7990296|NCT00139776|19674521|P2|STARTED|Period I||0
7990297|NCT00139776|19674522|P1|STARTED|Period I||1772
7990298|NCT00139737|19674557|P1|NOT COMPLETED|Overall Study||341
7990299|NCT00139737|19674557|P1|COMPLETED|Overall Study||3
7990300|NCT00139737|19674557|P1|Received Treatment|Overall Study||331
7990301|NCT00139737|19674557|P1|STARTED|Overall Study||344
7990302|NCT00139659|19674563|P2|NOT COMPLETED|Overall Study||18
7990303|NCT00139659|19674564|P1|NOT COMPLETED|Overall Study||40
7990304|NCT00139659|19674563|P2|COMPLETED|Overall Study||123
7990305|NCT00139659|19674564|P1|COMPLETED|Overall Study||106
7990306|NCT00139659|19674563|P2|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141
7990307|NCT00139659|19674564|P1|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146
7990308|NCT00139477|19674642|P2|NOT COMPLETED|Second Intervention -6Months to 12Months||5
7990309|NCT00139477|19674643|P1|NOT COMPLETED|Second Intervention -6Months to 12Months||5
7990310|NCT00139477|19674642|P2|COMPLETED|Second Intervention -6Months to 12Months||18
7990311|NCT00139477|19674643|P1|COMPLETED|Second Intervention -6Months to 12Months||14
7990312|NCT00139477|19674642|P2|STARTED|Second Intervention -6Months to 12Months||23
7990313|NCT00139477|19674643|P1|STARTED|Second Intervention -6Months to 12Months||19
7990314|NCT00139477|19674642|P2|NOT COMPLETED|First Intervention -Baseline to 6Months||12
7990315|NCT00139477|19674643|P1|NOT COMPLETED|First Intervention -Baseline to 6Months||12
7990316|NCT00139477|19674642|P2|COMPLETED|First Intervention -Baseline to 6Months||23
7990317|NCT00139477|19674643|P1|COMPLETED|First Intervention -Baseline to 6Months||19
7990318|NCT00139477|19674642|P2|STARTED|First Intervention -Baseline to 6Months||35
7990319|NCT00139477|19674643|P1|STARTED|First Intervention -Baseline to 6Months||31
7990320|NCT00139399|19674665|P2|NOT COMPLETED|Overall Study||23
7990321|NCT00139399|19674666|P1|NOT COMPLETED|Overall Study||16
7990322|NCT00139399|19674665|P2|COMPLETED|Overall Study||59
7990323|NCT00139399|19674666|P1|COMPLETED|Overall Study||44
7990324|NCT00139399|19674665|P2|STARTED|Overall Study||82
7990325|NCT00139399|19674666|P1|STARTED|Overall Study||60
7990326|NCT00138671|19674678|P2|NOT COMPLETED|Overall Study||16
7990327|NCT00138671|19674679|P1|NOT COMPLETED|Overall Study||13
7990328|NCT00138671|19674678|P2|COMPLETED|Overall Study||30
7990329|NCT00138671|19674679|P1|COMPLETED|Overall Study||46
7990330|NCT00138671|19674678|P2|STARTED|Overall Study||46
7990331|NCT00138671|19674679|P1|STARTED|Overall Study||59
7990332|NCT00138658|19674729|P1|NOT COMPLETED|Overall Study||61
7990333|NCT00138658|19674729|P1|COMPLETED|Overall Study||20
7990334|NCT00138658|19674729|P1|STARTED|Overall Study||81
7990335|NCT00138645|19674741|P2|NOT COMPLETED|Overall Study||7
7990336|NCT00138645|19674742|P1|NOT COMPLETED|Overall Study||6
7990337|NCT00138645|19674741|P2|COMPLETED|Overall Study||23
7990338|NCT00138645|19674742|P1|COMPLETED|Overall Study||24
7990339|NCT00138645|19674741|P2|STARTED|Overall Study||30
7990340|NCT00138645|19674742|P1|STARTED|Overall Study||30
7990341|NCT00138424|19674752|P4|NOT COMPLETED|Overall Study||0
7990342|NCT00138424|19674753|P3|NOT COMPLETED|Overall Study||0
7990343|NCT00138424|19674754|P2|NOT COMPLETED|Overall Study||1
7990344|NCT00138424|19674755|P1|NOT COMPLETED|Overall Study||0
7990345|NCT00138424|19674752|P4|COMPLETED|Overall Study||3
7990346|NCT00138424|19674753|P3|COMPLETED|Overall Study||5
7990347|NCT00138424|19674754|P2|COMPLETED|Overall Study||4
7990348|NCT00138424|19674755|P1|COMPLETED|Overall Study||9
7990349|NCT00138424|19674752|P4|STARTED|Overall Study||3
7990350|NCT00138424|19674753|P3|STARTED|Overall Study||5
7990351|NCT00138424|19674754|P2|STARTED|Overall Study||5
7990352|NCT00138424|19674755|P1|STARTED|Overall Study||9
7990353|NCT00138294|19674821|P1|NOT COMPLETED|Overall Study||0
7990354|NCT00138294|19674821|P1|COMPLETED|Overall Study||29255
7990355|NCT00138294|19674821|P1|STARTED|Overall Study||29255
7990356|NCT00138203|19674831|P1|NOT COMPLETED|Overall Study||0
7990357|NCT00138203|19674831|P1|COMPLETED|Overall Study||16
7990358|NCT00138203|19674831|P1|STARTED|Overall Study||16
7990359|NCT00138151|19674838|P1|NOT COMPLETED|Overall Study||4
7990360|NCT00138151|19674838|P1|COMPLETED|Overall Study||29
7990361|NCT00138151|19674838|P1|STARTED|Overall Study||33
7990362|NCT00138125|19674844|P1|NOT COMPLETED|Overall Study||0
7990363|NCT00138125|19674844|P1|COMPLETED|Overall Study||2
7990364|NCT00138125|19674844|P1|STARTED|Overall Study||2
7990365|NCT00138073|19674853|P1|NOT COMPLETED|Overall Study||55
7990366|NCT00138073|19674853|P1|COMPLETED|Overall Study||0
7990367|NCT00138073|19674853|P1|Pre-intervention Testing|Overall Study||55
7990368|NCT00138073|19674853|P1|STARTED|Overall Study||55
7990369|NCT00138034|19674860|P2|NOT COMPLETED|Overall Study||3
7990370|NCT00138034|19674861|P1|NOT COMPLETED|Overall Study||3
7990371|NCT00138034|19674860|P2|COMPLETED|Overall Study||20
7990372|NCT00138034|19674861|P1|COMPLETED|Overall Study||23
7990373|NCT00138034|19674860|P2|STARTED|Overall Study||23
7990374|NCT00138034|19674861|P1|STARTED|Overall Study||26
7990375|NCT00137969|19674871|P2|NOT COMPLETED|Overall Study||21
7990376|NCT00137969|19674872|P1|NOT COMPLETED|Overall Study||67
7990377|NCT00137969|19674871|P2|COMPLETED|Overall Study||67
7990378|NCT00137969|19674872|P1|COMPLETED|Overall Study||107
7990379|NCT00137969|19674871|P2|Received Study Drug|Overall Study||88
7990380|NCT00137969|19674872|P1|Received Study Drug|Overall Study||169
7990381|NCT00137969|19674871|P2|STARTED|Overall Study||88
7990382|NCT00137969|19674872|P1|STARTED|Overall Study||174
7990383|NCT00137839|19674892|P1|NOT COMPLETED|Overall Study||84
7990384|NCT00137839|19674892|P1|COMPLETED|Overall Study|Data on Reason Not Completed reflects Reason Off-Study|0
7990385|NCT00137839|19674892|P1|Treated|Overall Study||83
7990386|NCT00137839|19674892|P1|STARTED|Overall Study||84
7990387|NCT00137631|19674905|P2|NOT COMPLETED|Overall Study||41
7990388|NCT00137631|19674906|P1|NOT COMPLETED|Overall Study||37
7990389|NCT00137631|19674905|P2|COMPLETED|Overall Study||133
7990390|NCT00137631|19674906|P1|COMPLETED|Overall Study||127
7990391|NCT00137631|19674905|P2|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133
7990392|NCT00137631|19674906|P1|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127
7990393|NCT00137631|19674905|P2|Complete 3-month Follow-up|Overall Study||125
7990394|NCT00137631|19674906|P1|Complete 3-month Follow-up|Overall Study||120
7990395|NCT00137631|19674905|P2|STARTED|Overall Study||174
7990396|NCT00137631|19674906|P1|STARTED|Overall Study||164
7990397|NCT00137449|19674922|P2|NOT COMPLETED|Overall Study||18
7990398|NCT00137449|19674923|P1|NOT COMPLETED|Overall Study||16
7990399|NCT00137449|19674922|P2|COMPLETED|Overall Study||12
7990400|NCT00137449|19674923|P1|COMPLETED|Overall Study||14
7990401|NCT00137449|19674922|P2|STARTED|Overall Study||30
7990402|NCT00137449|19674923|P1|STARTED|Overall Study||30
7990403|NCT00137436|19674960|P1|NOT COMPLETED|Overall Study||43
7990404|NCT00137436|19674960|P1|COMPLETED|Overall Study||12
7990405|NCT00137436|19674960|P1|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55
7990406|NCT00137423|19674979|P2|NOT COMPLETED|Overall Study||44
7990407|NCT00137423|19674980|P1|NOT COMPLETED|Overall Study||39
7990408|NCT00137423|19674979|P2|COMPLETED|Overall Study||9
7990409|NCT00137423|19674980|P1|COMPLETED|Overall Study||15
7990410|NCT00137423|19674979|P2|STARTED|Overall Study||53
7990411|NCT00137423|19674980|P1|STARTED|Overall Study||54
7990412|NCT00137280|19675002|P2|NOT COMPLETED|Overall Study||55
7990413|NCT00137280|19675003|P1|NOT COMPLETED|Overall Study||84
7990414|NCT00137280|19675002|P2|COMPLETED|Overall Study||357
7990415|NCT00137280|19675003|P1|COMPLETED|Overall Study||305
7990416|NCT00137280|19675002|P2|STARTED|Overall Study||412
7990417|NCT00137280|19675003|P1|STARTED|Overall Study||389
7990418|NCT00137267|19675017|P2|NOT COMPLETED|Overall Study||21
7990419|NCT00137267|19675018|P1|NOT COMPLETED|Overall Study||15
7990420|NCT00137267|19675017|P2|COMPLETED|Overall Study||26
7990421|NCT00137267|19675018|P1|COMPLETED|Overall Study||40
7990422|NCT00137267|19675017|P2|STARTED|Overall Study||47
7990423|NCT00137267|19675018|P1|STARTED|Overall Study||55
7990424|NCT00137111|19675030|P4|NOT COMPLETED|Total Therapy||0
7990425|NCT00137111|19675031|P3|NOT COMPLETED|Total Therapy||0
7990426|NCT00137111|19675032|P2|NOT COMPLETED|Total Therapy||0
7990427|NCT00137111|19675033|P1|NOT COMPLETED|Total Therapy||40
7990428|NCT00137111|19675030|P4|COMPLETED|Total Therapy||0
7990429|NCT00137111|19675031|P3|COMPLETED|Total Therapy||0
7990430|NCT00137111|19675032|P2|COMPLETED|Total Therapy||0
7990431|NCT00137111|19675033|P1|COMPLETED|Total Therapy||458
7990432|NCT00137111|19675030|P4|STARTED|Total Therapy||0
7990433|NCT00137111|19675031|P3|STARTED|Total Therapy||0
7990434|NCT00137111|19675032|P2|STARTED|Total Therapy||0
7990435|NCT00137111|19675033|P1|STARTED|Total Therapy||498
7990436|NCT00137111|19675030|P4|NOT COMPLETED|Window Therapy||0
7990437|NCT00137111|19675031|P3|NOT COMPLETED|Window Therapy||0
7990438|NCT00137111|19675032|P2|NOT COMPLETED|Window Therapy||0
7990439|NCT00137111|19675033|P1|NOT COMPLETED|Window Therapy||0
7990440|NCT00137111|19675030|P4|COMPLETED|Window Therapy||142
7990441|NCT00137111|19675031|P3|COMPLETED|Window Therapy||180
7990442|NCT00137111|19675032|P2|COMPLETED|Window Therapy||176
7990443|NCT00137111|19675033|P1|COMPLETED|Window Therapy||0
7990444|NCT00137111|19675030|P4|STARTED|Window Therapy||142
7990445|NCT00137111|19675031|P3|STARTED|Window Therapy||180
7990446|NCT00137111|19675032|P2|STARTED|Window Therapy||176
7990447|NCT00137111|19675033|P1|STARTED|Window Therapy||0
7990448|NCT00137046|19675047|P2|NOT COMPLETED|Overall Study||93
7990449|NCT00137046|19675048|P1|NOT COMPLETED|Overall Study||99
7990450|NCT00137046|19675047|P2|COMPLETED|Overall Study||198
7990451|NCT00137046|19675048|P1|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192
7990452|NCT00137046|19675047|P2|Received Study Treatment|Overall Study||290
7990453|NCT00137046|19675048|P1|Received Study Treatment|Overall Study||290
7990454|NCT00137046|19675047|P2|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291
7990455|NCT00137046|19675048|P1|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291
7990456|NCT00136955|19675096|P1|NOT COMPLETED|Overall Study||23
7990457|NCT00136955|19675096|P1|COMPLETED|Overall Study||18
7990458|NCT00136955|19675096|P1|STARTED|Overall Study||41
7990459|NCT00136916|19675105|P2|NOT COMPLETED|Overall Study||104
7990460|NCT00136916|19675106|P1|NOT COMPLETED|Overall Study||125
7990461|NCT00136916|19675105|P2|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212
7990462|NCT00136916|19675106|P1|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194
7990463|NCT00136916|19675105|P2|Received Treatment|Overall Study||311
7990464|NCT00136916|19675106|P1|Received Treatment|Overall Study||316
7990465|NCT00136916|19675105|P2|STARTED|Overall Study||316
7990466|NCT00136916|19675106|P1|STARTED|Overall Study||319
7990467|NCT00136838|19675160|P2|NOT COMPLETED|Second Intervention ( 5 Days)||0
7990468|NCT00136838|19675161|P1|NOT COMPLETED|Second Intervention ( 5 Days)||0
7990469|NCT00136838|19675160|P2|COMPLETED|Second Intervention ( 5 Days)||6
7990470|NCT00136838|19675161|P1|COMPLETED|Second Intervention ( 5 Days)||6
7990471|NCT00136838|19675160|P2|STARTED|Second Intervention ( 5 Days)||6
7990472|NCT00136838|19675161|P1|STARTED|Second Intervention ( 5 Days)||6
7990473|NCT00136838|19675160|P2|NOT COMPLETED|First Intervention ( 5 Days)||0
7990474|NCT00136838|19675161|P1|NOT COMPLETED|First Intervention ( 5 Days)||0
7990475|NCT00136838|19675160|P2|COMPLETED|First Intervention ( 5 Days)||6
7990476|NCT00136838|19675161|P1|COMPLETED|First Intervention ( 5 Days)||6
7990477|NCT00136838|19675160|P2|STARTED|First Intervention ( 5 Days)||6
7990478|NCT00136838|19675161|P1|STARTED|First Intervention ( 5 Days)||6
7990479|NCT00136812|19675171|P2|NOT COMPLETED|Overall Study||0
7990480|NCT00136812|19675172|P1|NOT COMPLETED|Overall Study||0
7990481|NCT00136812|19675171|P2|COMPLETED|Overall Study||113
7990482|NCT00136812|19675172|P1|COMPLETED|Overall Study||111
7990483|NCT00136812|19675171|P2|STARTED|Overall Study||113
7990484|NCT00136812|19675172|P1|STARTED|Overall Study||111
7990485|NCT00136760|19675182|P4|NOT COMPLETED|Overall Study||0
7990486|NCT00136760|19675183|P3|NOT COMPLETED|Overall Study||0
7990487|NCT00136760|19675184|P2|NOT COMPLETED|Overall Study||0
7990488|NCT00136760|19675185|P1|NOT COMPLETED|Overall Study||0
7990489|NCT00136760|19675182|P4|COMPLETED|Overall Study||13
7990490|NCT00136760|19675183|P3|COMPLETED|Overall Study||11
7990491|NCT00136760|19675184|P2|COMPLETED|Overall Study||16
7990492|NCT00136760|19675185|P1|COMPLETED|Overall Study||12
7990493|NCT00136760|19675182|P4|STARTED|Overall Study||13
7990494|NCT00136760|19675183|P3|STARTED|Overall Study||11
7990495|NCT00136760|19675184|P2|STARTED|Overall Study||16
7990496|NCT00136760|19675185|P1|STARTED|Overall Study||12
7990497|NCT00136695|19675201|P2|NOT COMPLETED|Overall Study||8
7990498|NCT00136695|19675202|P1|NOT COMPLETED|Overall Study||11
7990499|NCT00136695|19675201|P2|COMPLETED|Overall Study||35
7990500|NCT00136695|19675202|P1|COMPLETED|Overall Study||34
7990501|NCT00136695|19675201|P2|STARTED|Overall Study||43
7990502|NCT00136695|19675202|P1|STARTED|Overall Study||45
7990503|NCT00136604|19675213|P5|NOT COMPLETED|Overall Study||1
7990504|NCT00136604|19675214|P4|NOT COMPLETED|Overall Study||0
7990505|NCT00136604|19675215|P3|NOT COMPLETED|Overall Study||0
7990506|NCT00136604|19675216|P2|NOT COMPLETED|Overall Study||1
7990507|NCT00136604|19675217|P1|NOT COMPLETED|Overall Study||1
7990508|NCT00136604|19675213|P5|COMPLETED|Overall Study||124
7990509|NCT00136604|19675214|P4|COMPLETED|Overall Study||41
7990510|NCT00136604|19675215|P3|COMPLETED|Overall Study||79
7990511|NCT00136604|19675216|P2|COMPLETED|Overall Study||122
7990512|NCT00136604|19675217|P1|COMPLETED|Overall Study||248
7990513|NCT00136604|19675213|P5|STARTED|Overall Study||125
7990514|NCT00136604|19675214|P4|STARTED|Overall Study||41
7990515|NCT00136604|19675215|P3|STARTED|Overall Study||79
7990516|NCT00136604|19675216|P2|STARTED|Overall Study||123
7990517|NCT00136604|19675217|P1|STARTED|Overall Study||249
7990518|NCT00136357|19675325|P2|NOT COMPLETED|Overall Study||2
7990519|NCT00136357|19675326|P1|NOT COMPLETED|Overall Study||3
7990520|NCT00136357|19675325|P2|COMPLETED|Overall Study||39
7990521|NCT00136357|19675326|P1|COMPLETED|Overall Study||38
7990522|NCT00136357|19675325|P2|STARTED|Overall Study||41
7990523|NCT00136357|19675326|P1|STARTED|Overall Study||41
7990524|NCT00136318|19675334|P2|NOT COMPLETED|Overall Study||7
7990525|NCT00136318|19675335|P1|NOT COMPLETED|Overall Study||7
7990526|NCT00136318|19675334|P2|COMPLETED|Overall Study||84
7990527|NCT00136318|19675335|P1|COMPLETED|Overall Study|reached end-point of antiviral treatment|83
7990528|NCT00136318|19675334|P2|STARTED|Overall Study|Took first dose of study medication|91
7990529|NCT00136318|19675335|P1|STARTED|Overall Study|Took first dose of study medication|90
7990530|NCT00136214|19675351|P2|NOT COMPLETED|Overall Study||0
7990531|NCT00136214|19675352|P1|NOT COMPLETED|Overall Study||0
7990532|NCT00136214|19675351|P2|COMPLETED|Overall Study||7
7990533|NCT00136214|19675352|P1|COMPLETED|Overall Study||15
7990534|NCT00136214|19675351|P2|STARTED|Overall Study||7
7990535|NCT00136214|19675352|P1|STARTED|Overall Study||15
7990536|NCT00136084|19675362|P2|NOT COMPLETED|Overall Study||42
7990537|NCT00136084|19675363|P1|NOT COMPLETED|Overall Study||48
7990538|NCT00136084|19675362|P2|COMPLETED|Overall Study||72
7990539|NCT00136084|19675363|P1|COMPLETED|Overall Study||61
7990540|NCT00136084|19675362|P2|STARTED|Overall Study||114
7990541|NCT00136084|19675363|P1|STARTED|Overall Study||109
7990542|NCT00135798|19675379|P3|NOT COMPLETED|Overall Study||0
7990543|NCT00135798|19675380|P2|NOT COMPLETED|Overall Study||0
7990544|NCT00135798|19675381|P1|NOT COMPLETED|Overall Study||0
7990545|NCT00135798|19675379|P3|COMPLETED|Overall Study||32
7990546|NCT00135798|19675380|P2|COMPLETED|Overall Study||31
7990547|NCT00135798|19675381|P1|COMPLETED|Overall Study||16
7990548|NCT00135798|19675379|P3|STARTED|Overall Study||32
7990549|NCT00135798|19675380|P2|STARTED|Overall Study||31
7990550|NCT00135798|19675381|P1|STARTED|Overall Study||16
7990551|NCT00135707|19675399|P2|NOT COMPLETED|Overall Study||90
7990552|NCT00135707|19675400|P1|NOT COMPLETED|Overall Study||95
7990553|NCT00135707|19675399|P2|COMPLETED|Overall Study||4976
7990554|NCT00135707|19675400|P1|COMPLETED|Overall Study||4993
7990555|NCT00135707|19675399|P2|STARTED|Overall Study||5066
7990556|NCT00135707|19675400|P1|STARTED|Overall Study||5088
7990557|NCT00135694|19675483|P3|NOT COMPLETED|Overall Study||7
7990558|NCT00135694|19675484|P2|NOT COMPLETED|Overall Study||21
7990559|NCT00135694|19675485|P1|NOT COMPLETED|Overall Study||180
7990560|NCT00135694|19675483|P3|COMPLETED|Overall Study||11
7990561|NCT00135694|19675484|P2|COMPLETED|Overall Study||56
7990562|NCT00135694|19675485|P1|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0
7990563|NCT00135694|19675483|P3|STARTED|Overall Study||18
7990564|NCT00135694|19675484|P2|STARTED|Overall Study||77
7990565|NCT00135694|19675485|P1|STARTED|Overall Study||180
7990566|NCT00135512|19675503|P1|NOT COMPLETED|Overall Study||123
7990567|NCT00135512|19675503|P1|COMPLETED|Overall Study||111
7990568|NCT00135512|19675503|P1|STARTED|Overall Study||234
7990569|NCT00135356|19675515|P2|NOT COMPLETED|Overall Study||9
7990570|NCT00135356|19675516|P1|NOT COMPLETED|Overall Study||17
7990571|NCT00135356|19675515|P2|COMPLETED|Overall Study||60
7990572|NCT00135356|19675516|P1|COMPLETED|Overall Study||114
7990573|NCT00135356|19675515|P2|Discontinued on or After Week 96 Visit|Overall Study||0
7990574|NCT00135356|19675516|P1|Discontinued on or After Week 96 Visit|Overall Study||1
7990575|NCT00135356|19675515|P2|Discontinued Prior to Week 96 Visit|Overall Study||9
7990576|NCT00135356|19675516|P1|Discontinued Prior to Week 96 Visit|Overall Study||16
7990577|NCT00135356|19675515|P2|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69
7990578|NCT00135356|19675516|P1|STARTED|Overall Study|Number randomized and treated|131
7990579|NCT00135330|19675559|P3|NOT COMPLETED|Overall Study||11
7990580|NCT00135330|19675560|P2|NOT COMPLETED|Overall Study||13
7990581|NCT00135330|19675561|P1|NOT COMPLETED|Overall Study||12
7990582|NCT00135330|19675559|P3|COMPLETED|Overall Study||34
7990583|NCT00135330|19675560|P2|COMPLETED|Overall Study||34
7990584|NCT00135330|19675561|P1|COMPLETED|Overall Study||33
7990585|NCT00135330|19675559|P3|STARTED|Overall Study||45
7990586|NCT00135330|19675560|P2|STARTED|Overall Study||47
7990587|NCT00135330|19675561|P1|STARTED|Overall Study||45
7990588|NCT00135226|19675657|P4|NOT COMPLETED|Overall Study||36
7990589|NCT00135226|19675658|P3|NOT COMPLETED|Overall Study||34
7990590|NCT00135226|19675659|P2|NOT COMPLETED|Overall Study||35
7990591|NCT00135226|19675660|P1|NOT COMPLETED|Overall Study||34
7990592|NCT00135226|19675657|P4|COMPLETED|Overall Study||3834
7990593|NCT00135226|19675658|P3|COMPLETED|Overall Study||3836
7990594|NCT00135226|19675659|P2|COMPLETED|Overall Study||3835
7990595|NCT00135226|19675660|P1|COMPLETED|Overall Study||3836
7990596|NCT00135226|19675657|P4|STARTED|Overall Study||3870
7990597|NCT00135226|19675658|P3|STARTED|Overall Study||3870
7990598|NCT00135226|19675659|P2|STARTED|Overall Study||3870
7990599|NCT00135226|19675660|P1|STARTED|Overall Study||3870
7990600|NCT00135200|19675752|P1|NOT COMPLETED|Overall Study||0
7990601|NCT00135200|19675752|P1|COMPLETED|Overall Study||16
7990602|NCT00135200|19675752|P1|STARTED|Overall Study||16
7990603|NCT00134901|19675759|P2|NOT COMPLETED|Overall Study||15
7990604|NCT00134901|19675760|P1|NOT COMPLETED|Overall Study||17
7990605|NCT00134901|19675759|P2|COMPLETED|Overall Study||27
7990606|NCT00134901|19675760|P1|COMPLETED|Overall Study||22
7990607|NCT00134901|19675759|P2|STARTED|Overall Study||42
7990608|NCT00134901|19675760|P1|STARTED|Overall Study||39
7990609|NCT00134784|19675772|P4|NOT COMPLETED|Overall Study||1
7990610|NCT00134784|19675773|P3|NOT COMPLETED|Overall Study||2
7990611|NCT00134784|19675774|P2|NOT COMPLETED|Overall Study||2
7990612|NCT00134784|19675775|P1|NOT COMPLETED|Overall Study||2
7990613|NCT00134784|19675772|P4|COMPLETED|Overall Study||37
7990614|NCT00134784|19675773|P3|COMPLETED|Overall Study||35
7990615|NCT00134784|19675774|P2|COMPLETED|Overall Study||36
7990616|NCT00134784|19675775|P1|COMPLETED|Overall Study||27
7990617|NCT00134784|19675772|P4|STARTED|Overall Study||38
7990618|NCT00134784|19675773|P3|STARTED|Overall Study||37
7990619|NCT00134784|19675774|P2|STARTED|Overall Study||38
7990620|NCT00134784|19675775|P1|STARTED|Overall Study||29
7990621|NCT00134719|19675785|P3|NOT COMPLETED|Fourth Dose Vaccination Phase||1
7990622|NCT00134719|19675786|P2|NOT COMPLETED|Fourth Dose Vaccination Phase||3
7990623|NCT00134719|19675787|P1|NOT COMPLETED|Fourth Dose Vaccination Phase||2
7990624|NCT00134719|19675785|P3|COMPLETED|Fourth Dose Vaccination Phase||203
7990625|NCT00134719|19675786|P2|COMPLETED|Fourth Dose Vaccination Phase||203
7990626|NCT00134719|19675787|P1|COMPLETED|Fourth Dose Vaccination Phase||623
7990627|NCT00134719|19675785|P3|STARTED|Fourth Dose Vaccination Phase||204
7990628|NCT00134719|19675786|P2|STARTED|Fourth Dose Vaccination Phase||206
7990629|NCT00134719|19675787|P1|STARTED|Fourth Dose Vaccination Phase||625
7990630|NCT00134719|19675785|P3|NOT COMPLETED|Primary Vaccination Phase||5
7990631|NCT00134719|19675786|P2|NOT COMPLETED|Primary Vaccination Phase||6
7990632|NCT00134719|19675787|P1|NOT COMPLETED|Primary Vaccination Phase||14
7990633|NCT00134719|19675785|P3|COMPLETED|Primary Vaccination Phase||216
7990634|NCT00134719|19675786|P2|COMPLETED|Primary Vaccination Phase||215
7990635|NCT00134719|19675787|P1|COMPLETED|Primary Vaccination Phase||647
7990636|NCT00134719|19675785|P3|STARTED|Primary Vaccination Phase||221
7990637|NCT00134719|19675786|P2|STARTED|Primary Vaccination Phase||221
7990638|NCT00134719|19675787|P1|STARTED|Primary Vaccination Phase||661
7990639|NCT00134563|19675918|P3|NOT COMPLETED|Overall Study||96
7990640|NCT00134563|19675919|P2|NOT COMPLETED|Overall Study||92
7990641|NCT00134563|19675920|P1|NOT COMPLETED|Overall Study||104
7990642|NCT00134563|19675918|P3|COMPLETED|Overall Study|completed treatment period|263
7990643|NCT00134563|19675919|P2|COMPLETED|Overall Study|completed treatment period|274
7990644|NCT00134563|19675920|P1|COMPLETED|Overall Study|completed treatment period|259
7990645|NCT00134563|19675918|P3|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358
7990646|NCT00134563|19675919|P2|Treated|Overall Study||365
7990647|NCT00134563|19675920|P1|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363
7990648|NCT00134563|19675918|P3|STARTED|Overall Study|Randomized|359
7990649|NCT00134563|19675919|P2|STARTED|Overall Study|Randomized|366
7990650|NCT00134563|19675920|P1|STARTED|Overall Study|Randomized|363
7990651|NCT00134381|19675943|P6|NOT COMPLETED|Overall Study||2
7990652|NCT00134381|19675944|P5|NOT COMPLETED|Overall Study||0
7990653|NCT00134381|19675945|P4|NOT COMPLETED|Overall Study||0
7990654|NCT00134381|19675946|P3|NOT COMPLETED|Overall Study||0
7990655|NCT00134381|19675947|P2|NOT COMPLETED|Overall Study||0
7990656|NCT00134381|19675948|P1|NOT COMPLETED|Overall Study||0
7990657|NCT00134381|19675943|P6|COMPLETED|Overall Study||29
7990658|NCT00134381|19675944|P5|COMPLETED|Overall Study||31
7990659|NCT00134381|19675945|P4|COMPLETED|Overall Study||2
7990660|NCT00134381|19675946|P3|COMPLETED|Overall Study||1
7990661|NCT00134381|19675947|P2|COMPLETED|Overall Study||2
7990662|NCT00134381|19675948|P1|COMPLETED|Overall Study||1
7990663|NCT00134381|19675943|P6|STARTED|Overall Study||31
7990664|NCT00134381|19675944|P5|STARTED|Overall Study||31
7990665|NCT00134381|19675945|P4|STARTED|Overall Study||2
7990666|NCT00134381|19675946|P3|STARTED|Overall Study||1
7990667|NCT00134381|19675947|P2|STARTED|Overall Study||2
7990668|NCT00134381|19675948|P1|STARTED|Overall Study||1
7990669|NCT00134082|19675981|P1|NOT COMPLETED|Overall Study||3
7990670|NCT00134082|19675981|P1|COMPLETED|Overall Study||27
7990671|NCT00134082|19675981|P1|STARTED|Overall Study||30
7990672|NCT00134056|19675990|P2|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315
7990673|NCT00134056|19675991|P1|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327
7990674|NCT00134056|19675990|P2|COMPLETED|Eligible for Protocol Assigned Treatment||185
7990675|NCT00134056|19675991|P1|COMPLETED|Eligible for Protocol Assigned Treatment||169
7990676|NCT00134056|19675990|P2|STARTED|Eligible for Protocol Assigned Treatment||500
7990677|NCT00134056|19675991|P1|STARTED|Eligible for Protocol Assigned Treatment||496
7990678|NCT00134056|19675990|P2|NOT COMPLETED|Randomization||20
7990679|NCT00134056|19675991|P1|NOT COMPLETED|Randomization||22
7990680|NCT00134056|19675990|P2|COMPLETED|Randomization||500
7990681|NCT00134056|19675991|P1|COMPLETED|Randomization||496
7990682|NCT00134056|19675990|P2|STARTED|Randomization||520
7990683|NCT00134056|19675991|P1|STARTED|Randomization||518
7990684|NCT00134043|19676013|P2|NOT COMPLETED|Overall Study||0
7990685|NCT00134043|19676014|P1|NOT COMPLETED|Overall Study||0
7990686|NCT00134043|19676013|P2|COMPLETED|Overall Study||3
7990687|NCT00134043|19676014|P1|COMPLETED|Overall Study||16
7990688|NCT00134043|19676013|P2|STARTED|Overall Study||3
7990689|NCT00134043|19676014|P1|STARTED|Overall Study||16
7990690|NCT00134017|19676019|P1|NOT COMPLETED|Overall Study||0
7990691|NCT00134017|19676019|P1|COMPLETED|Overall Study||142
7990692|NCT00134017|19676019|P1|STARTED|Overall Study||142
7990693|NCT00134004|19676027|P1|NOT COMPLETED|Overall Study||0
7990694|NCT00134004|19676027|P1|COMPLETED|Overall Study||210
7990695|NCT00134004|19676027|P1|STARTED|Overall Study||210
7990696|NCT00133991|19676035|P1|NOT COMPLETED|Overall Study||4
7990697|NCT00133991|19676035|P1|COMPLETED|Overall Study||17
7990698|NCT00133991|19676035|P1|STARTED|Overall Study||21
7990699|NCT00133978|19676047|P4|NOT COMPLETED|Overall Study||2
7990700|NCT00133978|19676048|P3|NOT COMPLETED|Overall Study||0
7990701|NCT00133978|19676049|P2|NOT COMPLETED|Overall Study||1
7990702|NCT00133978|19676050|P1|NOT COMPLETED|Overall Study||2
7990703|NCT00133978|19676047|P4|COMPLETED|Overall Study||300
7990704|NCT00133978|19676048|P3|COMPLETED|Overall Study||310
7990705|NCT00133978|19676049|P2|COMPLETED|Overall Study||307
7990706|NCT00133978|19676050|P1|COMPLETED|Overall Study||301
7990707|NCT00133978|19676047|P4|STARTED|Overall Study||302
7990708|NCT00133978|19676048|P3|STARTED|Overall Study||310
7990709|NCT00133978|19676049|P2|STARTED|Overall Study||308
7990710|NCT00133978|19676050|P1|STARTED|Overall Study||303
7990711|NCT00133952|19676074|P2|NOT COMPLETED|Overall Study||28
7990712|NCT00133952|19676075|P1|NOT COMPLETED|Overall Study||42
7990713|NCT00133952|19676074|P2|COMPLETED|Overall Study||124
7990714|NCT00133952|19676075|P1|COMPLETED|Overall Study||115
7990715|NCT00133952|19676074|P2|Received at Least One Dose of Study Drug|Overall Study||149
7990716|NCT00133952|19676075|P1|Received at Least One Dose of Study Drug|Overall Study||153
7990717|NCT00133952|19676074|P2|STARTED|Overall Study||152
7990718|NCT00133952|19676075|P1|STARTED|Overall Study||157
7990719|NCT00133809|19676097|P1|NOT COMPLETED|Overall Study||0
7990720|NCT00133809|19676097|P1|COMPLETED|Overall Study||8
7990721|NCT00133809|19676097|P1|STARTED|Overall Study||8
7990722|NCT00133705|19676106|P2|NOT COMPLETED|Overall Study||3
7990723|NCT00133705|19676107|P1|NOT COMPLETED|Overall Study||2
7990724|NCT00133705|19676106|P2|COMPLETED|Overall Study||17
7990725|NCT00133705|19676107|P1|COMPLETED|Overall Study||20
7990726|NCT00133705|19676106|P2|STARTED|Overall Study||20
7990727|NCT00133705|19676107|P1|STARTED|Overall Study||22
7990728|NCT00133575|19676120|P7|NOT COMPLETED|Overall Study||3
7990729|NCT00133575|19676121|P6|NOT COMPLETED|Overall Study||1
7990730|NCT00133575|19676122|P5|NOT COMPLETED|Overall Study||4
7990731|NCT00133575|19676123|P4|NOT COMPLETED|Overall Study||1
7990732|NCT00133575|19676124|P3|NOT COMPLETED|Overall Study||2
7990733|NCT00133575|19676125|P2|NOT COMPLETED|Overall Study||0
7990734|NCT00133575|19676126|P1|NOT COMPLETED|Overall Study||0
7990735|NCT00133575|19676120|P7|COMPLETED|Overall Study||9
7990736|NCT00133575|19676121|P6|COMPLETED|Overall Study||9
7990737|NCT00133575|19676122|P5|COMPLETED|Overall Study||6
7990738|NCT00133575|19676123|P4|COMPLETED|Overall Study||9
7990739|NCT00133575|19676124|P3|COMPLETED|Overall Study||8
7990740|NCT00133575|19676125|P2|COMPLETED|Overall Study||10
7990741|NCT00133575|19676126|P1|COMPLETED|Overall Study||10
7990742|NCT00133575|19676120|P7|STARTED|Overall Study||12
7990743|NCT00133575|19676121|P6|STARTED|Overall Study||10
7990744|NCT00133575|19676122|P5|STARTED|Overall Study||10
7990745|NCT00133575|19676123|P4|STARTED|Overall Study||10
7990746|NCT00133575|19676124|P3|STARTED|Overall Study||10
7990747|NCT00133575|19676125|P2|STARTED|Overall Study||10
7990748|NCT00133575|19676126|P1|STARTED|Overall Study||10
7990749|NCT00132964|19676235|P2|NOT COMPLETED|Overall Study||3
7990750|NCT00132964|19676236|P1|NOT COMPLETED|Overall Study||4
7990751|NCT00132964|19676235|P2|COMPLETED|Overall Study||54
7990752|NCT00132964|19676236|P1|COMPLETED|Overall Study||50
7990753|NCT00132964|19676235|P2|STARTED|Overall Study||57
7990754|NCT00132964|19676236|P1|STARTED|Overall Study||54
7990755|NCT00132873|19676242|P1|NOT COMPLETED|Overall Study||9
7990756|NCT00132873|19676242|P1|COMPLETED|Overall Study||50
7990757|NCT00132873|19676242|P1|STARTED|Overall Study||59
7990758|NCT00132808|19676250|P3|NOT COMPLETED|Stratum II||9
7990759|NCT00132808|19676251|P2|NOT COMPLETED|Stratum II||15
7990760|NCT00132808|19676252|P1|NOT COMPLETED|Stratum II||8
7990761|NCT00132808|19676250|P3|COMPLETED|Stratum II||116
7990762|NCT00132808|19676251|P2|COMPLETED|Stratum II||96
7990763|NCT00132808|19676252|P1|COMPLETED|Stratum II||113
7990764|NCT00132808|19676250|P3|STARTED|Stratum II||125
7990765|NCT00132808|19676251|P2|STARTED|Stratum II||111
7990766|NCT00132808|19676252|P1|STARTED|Stratum II||121
7990767|NCT00132808|19676250|P3|NOT COMPLETED|Stratum I||5
7990768|NCT00132808|19676251|P2|NOT COMPLETED|Stratum I||12
7990769|NCT00132808|19676252|P1|NOT COMPLETED|Stratum I||9
7990770|NCT00132808|19676250|P3|COMPLETED|Stratum I||72
7990771|NCT00132808|19676251|P2|COMPLETED|Stratum I||58
7990772|NCT00132808|19676252|P1|COMPLETED|Stratum I||68
7990773|NCT00132808|19676250|P3|STARTED|Stratum I||77
7990774|NCT00132808|19676251|P2|STARTED|Stratum I||70
7990775|NCT00132808|19676252|P1|STARTED|Stratum I||77
7990776|NCT00132769|19676277|P2|NOT COMPLETED|Overall Study||11
7990777|NCT00132769|19676278|P1|NOT COMPLETED|Overall Study||11
7990778|NCT00132769|19676277|P2|COMPLETED|Overall Study||42
7990779|NCT00132769|19676278|P1|COMPLETED|Overall Study||42
7990780|NCT00132769|19676277|P2|STARTED|Overall Study||53
7990781|NCT00132769|19676278|P1|STARTED|Overall Study||53
7990782|NCT00132730|19676304|P6|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2
7990783|NCT00132730|19676305|P5|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7
7990784|NCT00132730|19676306|P4|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
7990785|NCT00132730|19676307|P3|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
7990786|NCT00132730|19676308|P2|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
7990787|NCT00132730|19676309|P1|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
7990788|NCT00132730|19676304|P6|COMPLETED|Period V - Open-label Extension (EXT2)||0
7990789|NCT00132730|19676305|P5|COMPLETED|Period V - Open-label Extension (EXT2)||0
7990790|NCT00132730|19676306|P4|COMPLETED|Period V - Open-label Extension (EXT2)||0
7990791|NCT00132730|19676307|P3|COMPLETED|Period V - Open-label Extension (EXT2)||0
7990792|NCT00132730|19676308|P2|COMPLETED|Period V - Open-label Extension (EXT2)||0
7990793|NCT00132730|19676309|P1|COMPLETED|Period V - Open-label Extension (EXT2)||0
7990794|NCT00132730|19676304|P6|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2
7990795|NCT00132730|19676305|P5|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7
7990796|NCT00132730|19676306|P4|STARTED|Period V - Open-label Extension (EXT2)||0
7990797|NCT00132730|19676307|P3|STARTED|Period V - Open-label Extension (EXT2)||0
7990798|NCT00132730|19676308|P2|STARTED|Period V - Open-label Extension (EXT2)||0
7990799|NCT00132730|19676309|P1|STARTED|Period V - Open-label Extension (EXT2)||0
7990800|NCT00132730|19676304|P6|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68
7990801|NCT00132730|19676305|P5|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179
7990802|NCT00132730|19676306|P4|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
7990803|NCT00132730|19676307|P3|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
7990804|NCT00132730|19676308|P2|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
7990805|NCT00132730|19676309|P1|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
7990806|NCT00132730|19676304|P6|COMPLETED|Period IV - Open-label Extension (EXT2)||3
7990807|NCT00132730|19676305|P5|COMPLETED|Period IV - Open-label Extension (EXT2)||8
7990808|NCT00132730|19676306|P4|COMPLETED|Period IV - Open-label Extension (EXT2)||0
7990809|NCT00132730|19676307|P3|COMPLETED|Period IV - Open-label Extension (EXT2)||0
7990810|NCT00132730|19676308|P2|COMPLETED|Period IV - Open-label Extension (EXT2)||0
7990811|NCT00132730|19676309|P1|COMPLETED|Period IV - Open-label Extension (EXT2)||0
7990812|NCT00132730|19676304|P6|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71
7990813|NCT00132730|19676305|P5|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187
7990814|NCT00132730|19676306|P4|STARTED|Period IV - Open-label Extension (EXT2)||0
7990815|NCT00132730|19676307|P3|STARTED|Period IV - Open-label Extension (EXT2)||0
7990816|NCT00132730|19676308|P2|STARTED|Period IV - Open-label Extension (EXT2)||0
7990817|NCT00132730|19676309|P1|STARTED|Period IV - Open-label Extension (EXT2)||0
7990818|NCT00132730|19676304|P6|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
7990819|NCT00132730|19676305|P5|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
7990820|NCT00132730|19676306|P4|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25
7990821|NCT00132730|19676307|P3|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82
7990822|NCT00132730|19676308|P2|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
7990823|NCT00132730|19676309|P1|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
7990824|NCT00132730|19676304|P6|COMPLETED|Period III - Blinded Extension (EXT1)||0
7990825|NCT00132730|19676305|P5|COMPLETED|Period III - Blinded Extension (EXT1)||0
7990826|NCT00132730|19676306|P4|COMPLETED|Period III - Blinded Extension (EXT1)||82
7990827|NCT00132730|19676307|P3|COMPLETED|Period III - Blinded Extension (EXT1)||235
7990828|NCT00132730|19676308|P2|COMPLETED|Period III - Blinded Extension (EXT1)||0
7990829|NCT00132730|19676309|P1|COMPLETED|Period III - Blinded Extension (EXT1)||0
7990830|NCT00132730|19676304|P6|STARTED|Period III - Blinded Extension (EXT1)||0
7990831|NCT00132730|19676305|P5|STARTED|Period III - Blinded Extension (EXT1)||0
7990832|NCT00132730|19676306|P4|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107
7990833|NCT00132730|19676307|P3|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317
7990834|NCT00132730|19676308|P2|STARTED|Period III - Blinded Extension (EXT1)||0
7990835|NCT00132730|19676309|P1|STARTED|Period III - Blinded Extension (EXT1)||0
7990836|NCT00132730|19676304|P6|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
7990837|NCT00132730|19676305|P5|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
7990838|NCT00132730|19676306|P4|NOT COMPLETED|Period II - 12-week Treatment (Base)||22
7990839|NCT00132730|19676307|P3|NOT COMPLETED|Period II - 12-week Treatment (Base)||18
7990840|NCT00132730|19676308|P2|NOT COMPLETED|Period II - 12-week Treatment (Base)||15
7990841|NCT00132730|19676309|P1|NOT COMPLETED|Period II - 12-week Treatment (Base)||23
7990842|NCT00132730|19676304|P6|COMPLETED|Period II - 12-week Treatment (Base)||0
7990843|NCT00132730|19676305|P5|COMPLETED|Period II - 12-week Treatment (Base)||0
7990844|NCT00132730|19676306|P4|COMPLETED|Period II - 12-week Treatment (Base)||131
7990845|NCT00132730|19676307|P3|COMPLETED|Period II - 12-week Treatment (Base)||135
7990846|NCT00132730|19676308|P2|COMPLETED|Period II - 12-week Treatment (Base)||133
7990847|NCT00132730|19676309|P1|COMPLETED|Period II - 12-week Treatment (Base)||127
7990848|NCT00132730|19676304|P6|STARTED|Period II - 12-week Treatment (Base)||0
7990849|NCT00132730|19676305|P5|STARTED|Period II - 12-week Treatment (Base)||0
7990850|NCT00132730|19676306|P4|STARTED|Period II - 12-week Treatment (Base)||153
7990851|NCT00132730|19676307|P3|STARTED|Period II - 12-week Treatment (Base)||153
7990852|NCT00132730|19676308|P2|STARTED|Period II - 12-week Treatment (Base)||148
7990853|NCT00132730|19676309|P1|STARTED|Period II - 12-week Treatment (Base)||150
7990854|NCT00132730|19676304|P6|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
7990855|NCT00132730|19676305|P5|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
7990856|NCT00132730|19676306|P4|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
7990857|NCT00132730|19676307|P3|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
7990858|NCT00132730|19676308|P2|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
7990859|NCT00132730|19676309|P1|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
7990860|NCT00132730|19676304|P6|COMPLETED|Period I - Placebo Run-in (Base)||0
7990861|NCT00132730|19676305|P5|COMPLETED|Period I - Placebo Run-in (Base)||0
7990862|NCT00132730|19676306|P4|COMPLETED|Period I - Placebo Run-in (Base)||153
7990863|NCT00132730|19676307|P3|COMPLETED|Period I - Placebo Run-in (Base)||153
7990864|NCT00132730|19676308|P2|COMPLETED|Period I - Placebo Run-in (Base)||148
7990865|NCT00132730|19676309|P1|COMPLETED|Period I - Placebo Run-in (Base)||150
7990866|NCT00132730|19676304|P6|STARTED|Period I - Placebo Run-in (Base)||0
7990867|NCT00132730|19676305|P5|STARTED|Period I - Placebo Run-in (Base)||0
7990868|NCT00132730|19676306|P4|STARTED|Period I - Placebo Run-in (Base)||153
7990869|NCT00132730|19676307|P3|STARTED|Period I - Placebo Run-in (Base)||153
7990870|NCT00132730|19676308|P2|STARTED|Period I - Placebo Run-in (Base)||148
7990871|NCT00132730|19676309|P1|STARTED|Period I - Placebo Run-in (Base)||150
7990872|NCT00132691|19676353|P2|NOT COMPLETED|Overall Study||12
7990873|NCT00132691|19676354|P1|NOT COMPLETED|Overall Study||11
7990874|NCT00132691|19676353|P2|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114
7990875|NCT00132691|19676354|P1|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118
7990876|NCT00132691|19676353|P2|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126
7990877|NCT00132691|19676354|P1|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129
7990878|NCT00132678|19676394|P3|NOT COMPLETED|Period IV (Double-Blind Treatment)||0
7990879|NCT00132678|19676395|P2|NOT COMPLETED|Period IV (Double-Blind Treatment)||40
7990880|NCT00132678|19676396|P1|NOT COMPLETED|Period IV (Double-Blind Treatment)||37
7990881|NCT00132678|19676394|P3|COMPLETED|Period IV (Double-Blind Treatment)||0
7990882|NCT00132678|19676395|P2|COMPLETED|Period IV (Double-Blind Treatment)||109
7990883|NCT00132678|19676396|P1|COMPLETED|Period IV (Double-Blind Treatment)||117
7990884|NCT00132678|19676394|P3|STARTED|Period IV (Double-Blind Treatment)||0
7990885|NCT00132678|19676395|P2|STARTED|Period IV (Double-Blind Treatment)||149
7990886|NCT00132678|19676396|P1|STARTED|Period IV (Double-Blind Treatment)||154
7990887|NCT00132678|19676394|P3|NOT COMPLETED|Period III (Open-Label Stabilization)||0
7990888|NCT00132678|19676395|P2|NOT COMPLETED|Period III (Open-Label Stabilization)||0
7990889|NCT00132678|19676396|P1|NOT COMPLETED|Period III (Open-Label Stabilization)||198
7990890|NCT00132678|19676394|P3|COMPLETED|Period III (Open-Label Stabilization)||0
7990891|NCT00132678|19676395|P2|COMPLETED|Period III (Open-Label Stabilization)||0
7990892|NCT00132678|19676396|P1|COMPLETED|Period III (Open-Label Stabilization)||303
7990893|NCT00132678|19676394|P3|STARTED|Period III (Open-Label Stabilization)||0
7990894|NCT00132678|19676395|P2|STARTED|Period III (Open-Label Stabilization)||0
7990895|NCT00132678|19676396|P1|STARTED|Period III (Open-Label Stabilization)||501
7990896|NCT00132678|19676394|P3|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58
7990897|NCT00132678|19676395|P2|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
7990898|NCT00132678|19676396|P1|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
7990899|NCT00132678|19676394|P3|COMPLETED|Period II (Open-Label Oral Risperidone)||382
7990900|NCT00132678|19676395|P2|COMPLETED|Period II (Open-Label Oral Risperidone)||0
7990901|NCT00132678|19676396|P1|COMPLETED|Period II (Open-Label Oral Risperidone)||0
7990902|NCT00132678|19676394|P3|STARTED|Period II (Open-Label Oral Risperidone)||440
7990903|NCT00132678|19676395|P2|STARTED|Period II (Open-Label Oral Risperidone)||0
7990904|NCT00132678|19676396|P1|STARTED|Period II (Open-Label Oral Risperidone)||0
7990905|NCT00132496|19676410|P2|NOT COMPLETED|Overall Study||2
7990906|NCT00132496|19676411|P1|NOT COMPLETED|Overall Study||2
7990907|NCT00132496|19676410|P2|COMPLETED|Overall Study||55
7990908|NCT00132496|19676411|P1|COMPLETED|Overall Study||52
7990909|NCT00132496|19676410|P2|STARTED|Overall Study||57
7990910|NCT00132496|19676411|P1|STARTED|Overall Study||54
7990911|NCT00132314|19676419|P2|NOT COMPLETED|Overall Study||72
7990912|NCT00132314|19676420|P1|NOT COMPLETED|Overall Study||73
7990913|NCT00132314|19676419|P2|COMPLETED|Overall Study||120
7990914|NCT00132314|19676420|P1|COMPLETED|Overall Study||117
7990915|NCT00132314|19676419|P2|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182
7990916|NCT00132314|19676420|P1|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187
7990917|NCT00132314|19676419|P2|Received Treatment|Overall Study||185
7990918|NCT00132314|19676420|P1|Received Treatment|Overall Study||188
7990919|NCT00132314|19676419|P2|STARTED|Overall Study||192
7990920|NCT00132314|19676420|P1|STARTED|Overall Study||190
7990921|NCT00132301|19676430|P2|NOT COMPLETED|Overall Study||13
7990922|NCT00132301|19676431|P1|NOT COMPLETED|Overall Study||20
7990923|NCT00132301|19676430|P2|COMPLETED|Overall Study||144
7990924|NCT00132301|19676431|P1|COMPLETED|Overall Study||121
7990925|NCT00132301|19676430|P2|STARTED|Overall Study||157
7990926|NCT00132301|19676431|P1|STARTED|Overall Study||141
7990927|NCT00132132|19676439|P2|NOT COMPLETED|Overall Study||2
7990928|NCT00132132|19676440|P1|NOT COMPLETED|Overall Study||7
7990929|NCT00132132|19676439|P2|COMPLETED|Overall Study||13
7990930|NCT00132132|19676440|P1|COMPLETED|Overall Study||8
7990931|NCT00132132|19676439|P2|STARTED|Overall Study||15
7990932|NCT00132132|19676440|P1|STARTED|Overall Study||15
7990933|NCT00132041|19676448|P1|NOT COMPLETED|18 Months Post Ablation||6
7990934|NCT00132041|19676448|P1|COMPLETED|18 Months Post Ablation||12
7990935|NCT00132041|19676448|P1|STARTED|18 Months Post Ablation||18
7990936|NCT00132041|19676448|P1|NOT COMPLETED|15 Months Post Ablation||8
7990937|NCT00132041|19676448|P1|COMPLETED|15 Months Post Ablation||18
7990938|NCT00132041|19676448|P1|STARTED|15 Months Post Ablation||26
7990939|NCT00132041|19676448|P1|NOT COMPLETED|12 Months Post Ablation||4
7990940|NCT00132041|19676448|P1|COMPLETED|12 Months Post Ablation||26
7990941|NCT00132041|19676448|P1|STARTED|12 Months Post Ablation||30
7990942|NCT00132041|19676448|P1|NOT COMPLETED|9 Months Post Ablation||2
7990943|NCT00132041|19676448|P1|COMPLETED|9 Months Post Ablation||30
7990944|NCT00132041|19676448|P1|STARTED|9 Months Post Ablation||32
7990945|NCT00132041|19676448|P1|NOT COMPLETED|6 Months Post Ablation||10
7990946|NCT00132041|19676448|P1|COMPLETED|6 Months Post Ablation||32
7990947|NCT00132041|19676448|P1|STARTED|6 Months Post Ablation||42
7990948|NCT00132041|19676448|P1|NOT COMPLETED|3 Months Post Ablation||3
7990949|NCT00132041|19676448|P1|COMPLETED|3 Months Post Ablation||42
7990950|NCT00132041|19676448|P1|STARTED|3 Months Post Ablation||45
7990951|NCT00132041|19676448|P1|NOT COMPLETED|Baseline||6
7990952|NCT00132041|19676448|P1|COMPLETED|Baseline||45
7990953|NCT00132041|19676448|P1|Eligible|Baseline||45
7990954|NCT00132041|19676448|P1|STARTED|Baseline||51
7990955|NCT00132028|19676463|P1|NOT COMPLETED|Overall Study||27
7990956|NCT00132028|19676463|P1|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0
7990957|NCT00132028|19676463|P1|Eligible and Began Protocol Therapy|Overall Study||25
7990958|NCT00132028|19676463|P1|Eligible|Overall Study||25
7990959|NCT00132028|19676463|P1|STARTED|Overall Study||27
7990960|NCT00132002|19676469|P1|NOT COMPLETED|Overall Study||0
7990961|NCT00132002|19676469|P1|COMPLETED|Overall Study||14
7990962|NCT00132002|19676469|P1|STARTED|Overall Study||14
7990963|NCT00131937|19676475|P1|NOT COMPLETED|Overall Study||14
7990964|NCT00131937|19676475|P1|COMPLETED|Overall Study||0
7990965|NCT00131937|19676475|P1|STARTED|Overall Study||14
7990966|NCT00131911|19676483|P2|NOT COMPLETED|Overall Study||0
7990967|NCT00131911|19676484|P1|NOT COMPLETED|Overall Study||1
7990968|NCT00131911|19676483|P2|COMPLETED|Overall Study||42
7990969|NCT00131911|19676484|P1|COMPLETED|Overall Study||50
7990970|NCT00131911|19676483|P2|STARTED|Overall Study||42
7990971|NCT00131911|19676484|P1|STARTED|Overall Study||51
7990972|NCT00131885|19676501|P4|NOT COMPLETED|Time 2: Second Intervention||0
7990973|NCT00131885|19676502|P3|NOT COMPLETED|Time 2: Second Intervention||0
7990974|NCT00131885|19676503|P2|NOT COMPLETED|Time 2: Second Intervention||0
7990975|NCT00131885|19676504|P1|NOT COMPLETED|Time 2: Second Intervention||0
7990976|NCT00131885|19676501|P4|COMPLETED|Time 2: Second Intervention||9
7990977|NCT00131885|19676502|P3|COMPLETED|Time 2: Second Intervention||9
7990978|NCT00131885|19676503|P2|COMPLETED|Time 2: Second Intervention||9
7990979|NCT00131885|19676504|P1|COMPLETED|Time 2: Second Intervention||9
7990980|NCT00131885|19676501|P4|STARTED|Time 2: Second Intervention||9
7990981|NCT00131885|19676502|P3|STARTED|Time 2: Second Intervention||9
7990982|NCT00131885|19676503|P2|STARTED|Time 2: Second Intervention||9
7990983|NCT00131885|19676504|P1|STARTED|Time 2: Second Intervention||9
7990984|NCT00131885|19676501|P4|NOT COMPLETED|Time 1: First Intervention||0
7990985|NCT00131885|19676502|P3|NOT COMPLETED|Time 1: First Intervention||0
7990986|NCT00131885|19676503|P2|NOT COMPLETED|Time 1: First Intervention||0
7990987|NCT00131885|19676504|P1|NOT COMPLETED|Time 1: First Intervention||0
7990988|NCT00131885|19676501|P4|COMPLETED|Time 1: First Intervention||9
7990989|NCT00131885|19676502|P3|COMPLETED|Time 1: First Intervention||9
7990990|NCT00131885|19676503|P2|COMPLETED|Time 1: First Intervention||9
7990991|NCT00131885|19676504|P1|COMPLETED|Time 1: First Intervention||9
7990992|NCT00131885|19676501|P4|STARTED|Time 1: First Intervention||9
7990993|NCT00131885|19676502|P3|STARTED|Time 1: First Intervention||9
7990994|NCT00131885|19676503|P2|STARTED|Time 1: First Intervention||9
7990995|NCT00131885|19676504|P1|STARTED|Time 1: First Intervention||9
7990996|NCT00131677|19676536|P2|NOT COMPLETED|Overall Study||39
7990997|NCT00131677|19676537|P1|NOT COMPLETED|Overall Study||30
7990998|NCT00131677|19676536|P2|COMPLETED|Overall Study||160
7990999|NCT00131677|19676537|P1|COMPLETED|Overall Study||171
7991000|NCT00131677|19676536|P2|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199
7991001|NCT00131677|19676537|P1|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201
7991002|NCT00131664|19676554|P6|NOT COMPLETED|Second Period (Additional Drug Added)||3
7991003|NCT00131664|19676555|P5|NOT COMPLETED|Second Period (Additional Drug Added)||1
7991004|NCT00131664|19676556|P4|NOT COMPLETED|Second Period (Additional Drug Added)||2
7991005|NCT00131664|19676557|P3|NOT COMPLETED|Second Period (Additional Drug Added)||3
7991006|NCT00131664|19676558|P2|NOT COMPLETED|Second Period (Additional Drug Added)||4
7991007|NCT00131664|19676559|P1|NOT COMPLETED|Second Period (Additional Drug Added)||9
7991008|NCT00131664|19676554|P6|COMPLETED|Second Period (Additional Drug Added)||22
7991009|NCT00131664|19676555|P5|COMPLETED|Second Period (Additional Drug Added)||15
7991010|NCT00131664|19676556|P4|COMPLETED|Second Period (Additional Drug Added)||19
7991011|NCT00131664|19676557|P3|COMPLETED|Second Period (Additional Drug Added)||76
7991012|NCT00131664|19676558|P2|COMPLETED|Second Period (Additional Drug Added)||97
7991013|NCT00131664|19676559|P1|COMPLETED|Second Period (Additional Drug Added)||81
7991014|NCT00131664|19676554|P6|STARTED|Second Period (Additional Drug Added)||25
7991015|NCT00131664|19676555|P5|STARTED|Second Period (Additional Drug Added)||16
7991016|NCT00131664|19676556|P4|STARTED|Second Period (Additional Drug Added)||21
7991017|NCT00131664|19676557|P3|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79
7991018|NCT00131664|19676558|P2|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101
7991019|NCT00131664|19676559|P1|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90
7991020|NCT00131664|19676554|P6|NOT COMPLETED|First Period (First 6 Months)||0
7991021|NCT00131664|19676555|P5|NOT COMPLETED|First Period (First 6 Months)||0
7991022|NCT00131664|19676556|P4|NOT COMPLETED|First Period (First 6 Months)||0
7991023|NCT00131664|19676557|P3|NOT COMPLETED|First Period (First 6 Months)||16
7991024|NCT00131664|19676558|P2|NOT COMPLETED|First Period (First 6 Months)||18
7991025|NCT00131664|19676559|P1|NOT COMPLETED|First Period (First 6 Months)||25
7991026|NCT00131664|19676554|P6|COMPLETED|First Period (First 6 Months)||0
7991027|NCT00131664|19676555|P5|COMPLETED|First Period (First 6 Months)||0
7991028|NCT00131664|19676556|P4|COMPLETED|First Period (First 6 Months)||0
7991029|NCT00131664|19676557|P3|COMPLETED|First Period (First 6 Months)||104
7991030|NCT00131664|19676558|P2|COMPLETED|First Period (First 6 Months)||117
7991031|NCT00131664|19676559|P1|COMPLETED|First Period (First 6 Months)||111
7991032|NCT00131664|19676554|P6|STARTED|First Period (First 6 Months)||0
7991033|NCT00131664|19676555|P5|STARTED|First Period (First 6 Months)||0
7991034|NCT00131664|19676556|P4|STARTED|First Period (First 6 Months)||0
7991035|NCT00131664|19676557|P3|STARTED|First Period (First 6 Months)||120
7991036|NCT00131664|19676558|P2|STARTED|First Period (First 6 Months)||135
7991037|NCT00131664|19676559|P1|STARTED|First Period (First 6 Months)||136
7991038|NCT00131573|19676620|P2|NOT COMPLETED|Overall Study||26
7991039|NCT00131573|19676621|P1|NOT COMPLETED|Overall Study||33
7991040|NCT00131573|19676620|P2|COMPLETED|Overall Study||13
7991041|NCT00131573|19676621|P1|COMPLETED|Overall Study||13
7991042|NCT00131573|19676620|P2|STARTED|Overall Study||39
7991043|NCT00131573|19676621|P1|STARTED|Overall Study||46
7991044|NCT00131508|19676631|P2|NOT COMPLETED|Overall Study||8
7991045|NCT00131508|19676632|P1|NOT COMPLETED|Overall Study||3
7991046|NCT00131508|19676631|P2|COMPLETED|Overall Study||5
7991047|NCT00131508|19676632|P1|COMPLETED|Overall Study||9
7991048|NCT00131508|19676631|P2|STARTED|Overall Study||13
7991049|NCT00131508|19676632|P1|STARTED|Overall Study||12
7991050|NCT00131469|19676656|P2|NOT COMPLETED|Overall Study||13
7991051|NCT00131469|19676657|P1|NOT COMPLETED|Overall Study||9
7991052|NCT00131469|19676656|P2|COMPLETED|Overall Study||27
7991053|NCT00131469|19676657|P1|COMPLETED|Overall Study||29
7991054|NCT00131469|19676656|P2|STARTED|Overall Study||40
7991055|NCT00131469|19676657|P1|STARTED|Overall Study||38
7991056|NCT00131456|19676667|P2|NOT COMPLETED|Overall Study||20
7991057|NCT00131456|19676668|P1|NOT COMPLETED|Overall Study||19
7991058|NCT00131456|19676667|P2|COMPLETED|Overall Study||31
7991059|NCT00131456|19676668|P1|COMPLETED|Overall Study||33
7991060|NCT00131456|19676667|P2|STARTED|Overall Study||51
7991061|NCT00131456|19676668|P1|STARTED|Overall Study||52
7991062|NCT00131378|19676678|P4|NOT COMPLETED|Overall Study||9
7991063|NCT00131378|19676679|P3|NOT COMPLETED|Overall Study||10
7991064|NCT00131378|19676680|P2|NOT COMPLETED|Overall Study||18
7991065|NCT00131378|19676681|P1|NOT COMPLETED|Overall Study||11
7991066|NCT00131378|19676678|P4|COMPLETED|Overall Study||21
7991067|NCT00131378|19676679|P3|COMPLETED|Overall Study||22
7991068|NCT00131378|19676680|P2|COMPLETED|Overall Study||22
7991069|NCT00131378|19676681|P1|COMPLETED|Overall Study||29
7991070|NCT00131378|19676678|P4|STARTED|Overall Study||30
7991071|NCT00131378|19676679|P3|STARTED|Overall Study||32
7991072|NCT00131378|19676680|P2|STARTED|Overall Study||40
7991073|NCT00131378|19676681|P1|STARTED|Overall Study||40
7991074|NCT00131365|19676703|P1|NOT COMPLETED|Overall Study||4
7991075|NCT00131365|19676703|P1|COMPLETED|Overall Study||5
7991076|NCT00131365|19676703|P1|STARTED|Overall Study|Only safety data was reported due to early closure of the study due to device obsolescence.|9
7991077|NCT00131352|19676710|P2|NOT COMPLETED|Repeat Treatment Period||0
7991078|NCT00131352|19676711|P1|NOT COMPLETED|Repeat Treatment Period||2
7991079|NCT00131352|19676710|P2|COMPLETED|Repeat Treatment Period||0
7991080|NCT00131352|19676711|P1|COMPLETED|Repeat Treatment Period||158
7991081|NCT00131352|19676710|P2|STARTED|Repeat Treatment Period||0
7991082|NCT00131352|19676711|P1|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160
7991083|NCT00131352|19676710|P2|NOT COMPLETED|Initial Treatment Period||12
7991084|NCT00131352|19676711|P1|NOT COMPLETED|Initial Treatment Period||9
7991085|NCT00131352|19676710|P2|COMPLETED|Initial Treatment Period||118
7991086|NCT00131352|19676711|P1|COMPLETED|Initial Treatment Period||114
7991087|NCT00131352|19676710|P2|Intent to Treat Population|Initial Treatment Period||129
7991088|NCT00131352|19676711|P1|Intent to Treat Population|Initial Treatment Period||124
7991089|NCT00131352|19676710|P2|STARTED|Initial Treatment Period|Safety population|130
7991090|NCT00131352|19676711|P1|STARTED|Initial Treatment Period|Safety population|123
7991091|NCT00131248|19676733|P2|NOT COMPLETED|Intervention 3 (4-day Course)||0
7991092|NCT00131248|19676734|P1|NOT COMPLETED|Intervention 3 (4-day Course)||0
7991093|NCT00131248|19676733|P2|COMPLETED|Intervention 3 (4-day Course)||9
7991094|NCT00131248|19676734|P1|COMPLETED|Intervention 3 (4-day Course)||8
7991095|NCT00131248|19676733|P2|STARTED|Intervention 3 (4-day Course)||9
7991096|NCT00131248|19676734|P1|STARTED|Intervention 3 (4-day Course)||8
7991097|NCT00131248|19676733|P2|NOT COMPLETED|Washout 2 (24 Hours)||0
7991098|NCT00131248|19676734|P1|NOT COMPLETED|Washout 2 (24 Hours)||0
7991099|NCT00131248|19676733|P2|COMPLETED|Washout 2 (24 Hours)||9
7991100|NCT00131248|19676734|P1|COMPLETED|Washout 2 (24 Hours)||8
7991101|NCT00131248|19676733|P2|STARTED|Washout 2 (24 Hours)||9
7991102|NCT00131248|19676734|P1|STARTED|Washout 2 (24 Hours)||8
7991103|NCT00131248|19676733|P2|NOT COMPLETED|Intervention 2 (7-day Course)||0
7991104|NCT00131248|19676734|P1|NOT COMPLETED|Intervention 2 (7-day Course)||0
7991105|NCT00131248|19676733|P2|COMPLETED|Intervention 2 (7-day Course)||9
7991106|NCT00131248|19676734|P1|COMPLETED|Intervention 2 (7-day Course)||8
7991107|NCT00131248|19676733|P2|STARTED|Intervention 2 (7-day Course)||9
7991108|NCT00131248|19676734|P1|STARTED|Intervention 2 (7-day Course)||8
7991109|NCT00131248|19676733|P2|NOT COMPLETED|Washout (24 Hour)||0
7991110|NCT00131248|19676734|P1|NOT COMPLETED|Washout (24 Hour)||0
7991111|NCT00131248|19676733|P2|COMPLETED|Washout (24 Hour)||9
7991112|NCT00131248|19676734|P1|COMPLETED|Washout (24 Hour)||8
7991113|NCT00131248|19676733|P2|STARTED|Washout (24 Hour)||9
7991114|NCT00131248|19676734|P1|STARTED|Washout (24 Hour)||8
7991115|NCT00131248|19676733|P2|NOT COMPLETED|Intervention 1 (3-day Course)||0
7991116|NCT00131248|19676734|P1|NOT COMPLETED|Intervention 1 (3-day Course)||1
7991117|NCT00131248|19676733|P2|COMPLETED|Intervention 1 (3-day Course)||9
7991118|NCT00131248|19676734|P1|COMPLETED|Intervention 1 (3-day Course)||8
7991119|NCT00131248|19676733|P2|STARTED|Intervention 1 (3-day Course)||9
7991120|NCT00131248|19676734|P1|STARTED|Intervention 1 (3-day Course)||9
7991121|NCT00130923|19676742|P2|NOT COMPLETED|Overall Study||14
7991122|NCT00130923|19676743|P1|NOT COMPLETED|Overall Study||13
7991123|NCT00130923|19676742|P2|COMPLETED|Overall Study||32
7991124|NCT00130923|19676743|P1|COMPLETED|Overall Study||36
7991125|NCT00130923|19676742|P2|STARTED|Overall Study||46
7991126|NCT00130923|19676743|P1|STARTED|Overall Study||49
7991127|NCT00130832|19676761|P2|NOT COMPLETED|Overall Study||17
7991128|NCT00130832|19676762|P1|NOT COMPLETED|Overall Study||16
7991129|NCT00130832|19676761|P2|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346
7991130|NCT00130832|19676762|P1|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356
7991131|NCT00130832|19676761|P2|STARTED|Overall Study||363
7991132|NCT00130832|19676762|P1|STARTED|Overall Study||372
7991133|NCT00130793|19676774|P2|NOT COMPLETED|Overall Study||4
7991134|NCT00130793|19676775|P1|NOT COMPLETED|Overall Study||3
7991135|NCT00130793|19676774|P2|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181
7991136|NCT00130793|19676775|P1|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180
7991137|NCT00130793|19676774|P2|Vaccinated|Overall Study||185
7991138|NCT00130793|19676775|P1|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182
7991139|NCT00130793|19676774|P2|STARTED|Overall Study||185
7991140|NCT00130793|19676775|P1|STARTED|Overall Study||183
7991141|NCT00130780|19676787|P2|NOT COMPLETED|Overall Study||0
7991142|NCT00130780|19676788|P1|NOT COMPLETED|Overall Study||0
7991143|NCT00130780|19676787|P2|COMPLETED|Overall Study||20
7991144|NCT00130780|19676788|P1|COMPLETED|Overall Study||51
7991145|NCT00130780|19676787|P2|STARTED|Overall Study||20
7991146|NCT00130780|19676788|P1|STARTED|Overall Study||51
7991147|NCT00130728|19676796|P2|NOT COMPLETED|Overall Study||213
7991148|NCT00130728|19676797|P1|NOT COMPLETED|Overall Study||211
7991149|NCT00130728|19676796|P2|COMPLETED|Overall Study||104
7991150|NCT00130728|19676797|P1|COMPLETED|Overall Study||108
7991151|NCT00130728|19676796|P2|Received Study Drug (Safety Population)|Overall Study||313
7991152|NCT00130728|19676797|P1|Received Study Drug (Safety Population)|Overall Study||313
7991153|NCT00130728|19676796|P2|STARTED|Overall Study||317
7991154|NCT00130728|19676797|P1|STARTED|Overall Study||319
7991155|NCT00130689|19676809|P1|NOT COMPLETED|Overall Study||43
7991156|NCT00130689|19676809|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
7991157|NCT00130689|19676809|P1|Treated|Overall Study||35
7991158|NCT00130689|19676809|P1|Eligible|Overall Study||37
7991159|NCT00130689|19676809|P1|STARTED|Overall Study||43
7991160|NCT00130637|19676813|P1|NOT COMPLETED|Overall Study||3
7991161|NCT00130637|19676813|P1|COMPLETED|Overall Study||3
7991162|NCT00130637|19676813|P1|STARTED|Overall Study||6
7991163|NCT00130533|19676820|P2|NOT COMPLETED|Overall Study||30
7991164|NCT00130533|19676821|P1|NOT COMPLETED|Overall Study||111
7991165|NCT00130533|19676820|P2|COMPLETED|Overall Study||398
7991166|NCT00130533|19676821|P1|COMPLETED|Overall Study||337
7991167|NCT00130533|19676820|P2|STARTED|Overall Study||428
7991168|NCT00130533|19676821|P1|STARTED|Overall Study||448
7991169|NCT00130520|19676833|P1|NOT COMPLETED|Overall Study||39
7991170|NCT00130520|19676833|P1|COMPLETED|Overall Study||1
7991171|NCT00130520|19676833|P1|Completion of at Least One Cycle|Overall Study||39
7991172|NCT00130520|19676833|P1|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40
7991173|NCT00130286|19676843|P4|NOT COMPLETED|Overall Study||2
7991174|NCT00130286|19676844|P3|NOT COMPLETED|Overall Study||4
7991175|NCT00130286|19676845|P2|NOT COMPLETED|Overall Study||3
7991176|NCT00130286|19676846|P1|NOT COMPLETED|Overall Study||0
7991177|NCT00130286|19676843|P4|COMPLETED|Overall Study||17
7991178|NCT00130286|19676844|P3|COMPLETED|Overall Study||13
7991179|NCT00130286|19676845|P2|COMPLETED|Overall Study||16
7991180|NCT00130286|19676846|P1|COMPLETED|Overall Study||22
7991181|NCT00130286|19676843|P4|STARTED|Overall Study||19
7991182|NCT00130286|19676844|P3|STARTED|Overall Study||17
7991183|NCT00130286|19676845|P2|STARTED|Overall Study||19
7991184|NCT00130286|19676846|P1|STARTED|Overall Study||22
7991185|NCT00130247|19676866|P2|NOT COMPLETED|Overall Study||4
7991186|NCT00130247|19676867|P1|NOT COMPLETED|Overall Study||2
7991187|NCT00130247|19676866|P2|COMPLETED|Overall Study||194
7991188|NCT00130247|19676867|P1|COMPLETED|Overall Study||194
7991189|NCT00130247|19676866|P2|STARTED|Overall Study||198
7991190|NCT00130247|19676867|P1|STARTED|Overall Study||196
7991191|NCT00130208|19676885|P2|NOT COMPLETED|Washout Period (8 Weeks)||12
7991192|NCT00130208|19676886|P1|NOT COMPLETED|Washout Period (8 Weeks)||6
7991193|NCT00130208|19676885|P2|COMPLETED|Washout Period (8 Weeks)||490
7991194|NCT00130208|19676886|P1|COMPLETED|Washout Period (8 Weeks)||494
7991195|NCT00130208|19676885|P2|STARTED|Washout Period (8 Weeks)||502
7991196|NCT00130208|19676886|P1|STARTED|Washout Period (8 Weeks)||500
7991197|NCT00130208|19676885|P2|NOT COMPLETED|Maintenance Period (26 Weeks)||30
7991198|NCT00130208|19676886|P1|NOT COMPLETED|Maintenance Period (26 Weeks)||24
7991199|NCT00130208|19676885|P2|COMPLETED|Maintenance Period (26 Weeks)||502
7991200|NCT00130208|19676886|P1|COMPLETED|Maintenance Period (26 Weeks)||500
7991201|NCT00130208|19676885|P2|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||494
7991202|NCT00130208|19676886|P1|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||492
7991203|NCT00130208|19676885|P2|STARTED|Maintenance Period (26 Weeks)||532
7991204|NCT00130208|19676886|P1|STARTED|Maintenance Period (26 Weeks)||524
7991205|NCT00130117|19676898|P2|NOT COMPLETED|Overall Study||3
7991206|NCT00130117|19676899|P1|NOT COMPLETED|Overall Study||4
7991207|NCT00130117|19676898|P2|COMPLETED|Overall Study||6
7991208|NCT00130117|19676899|P1|COMPLETED|Overall Study||7
7991209|NCT00130117|19676898|P2|STARTED|Overall Study||9
7991210|NCT00130117|19676899|P1|STARTED|Overall Study||11
7991211|NCT00130039|19676922|P2|NOT COMPLETED|Overall Study||18
7991212|NCT00130039|19676923|P1|NOT COMPLETED|Overall Study||30
7991213|NCT00130039|19676922|P2|COMPLETED|Overall Study|full analysis set|207
7991214|NCT00130039|19676923|P1|COMPLETED|Overall Study|full analysis set|202
7991215|NCT00130039|19676922|P2|STARTED|Overall Study||225
7991216|NCT00130039|19676923|P1|STARTED|Overall Study||232
7991217|NCT00129987|19676941|P2|NOT COMPLETED|1 Year||21
7991218|NCT00129987|19676942|P1|NOT COMPLETED|1 Year||32
7991219|NCT00129987|19676941|P2|COMPLETED|1 Year||150
7991220|NCT00129987|19676942|P1|COMPLETED|1 Year||114
7991221|NCT00129987|19676941|P2|STARTED|1 Year||171
7991222|NCT00129987|19676942|P1|STARTED|1 Year||146
7991223|NCT00129987|19676941|P2|NOT COMPLETED|1st Educational Session||109
7991224|NCT00129987|19676942|P1|NOT COMPLETED|1st Educational Session||141
7991225|NCT00129987|19676941|P2|COMPLETED|1st Educational Session||171
7991226|NCT00129987|19676942|P1|COMPLETED|1st Educational Session||146
7991227|NCT00129987|19676941|P2|STARTED|1st Educational Session||280
7991228|NCT00129987|19676942|P1|STARTED|1st Educational Session||287
7991229|NCT00129974|19676954|P1|NOT COMPLETED|Overall Study||1
7991230|NCT00129974|19676954|P1|COMPLETED|Overall Study||0
7991231|NCT00129974|19676954|P1|STARTED|Overall Study||1
7991232|NCT00129961|19676961|P2|NOT COMPLETED|Overall Study||23
7991233|NCT00129961|19676962|P1|NOT COMPLETED|Overall Study||19
7991234|NCT00129961|19676961|P2|COMPLETED|Overall Study||24
7991235|NCT00129961|19676962|P1|COMPLETED|Overall Study||20
7991236|NCT00129961|19676961|P2|STARTED|Overall Study||47
7991237|NCT00129961|19676962|P1|STARTED|Overall Study||39
7991238|NCT00129935|19676998|P2|NOT COMPLETED|Overall Study||92
7991239|NCT00129935|19676999|P1|NOT COMPLETED|Overall Study||36
7991240|NCT00129935|19676998|P2|COMPLETED|Overall Study|1 patient crossed from arm B to A by error.|623
7991241|NCT00129935|19676999|P1|COMPLETED|Overall Study|2 patients crossed from arm A to B by error, and 1 patient received other treatment by error.|633
7991242|NCT00129935|19676998|P2|STARTED|Overall Study||715
7991243|NCT00129935|19676999|P1|STARTED|Overall Study||669
7991244|NCT00129766|19677017|P2|NOT COMPLETED|Overall Study||59
7991245|NCT00129766|19677018|P1|NOT COMPLETED|Overall Study||60
7991246|NCT00129766|19677017|P2|COMPLETED|Overall Study||3270
7991247|NCT00129766|19677018|P1|COMPLETED|Overall Study||3246
7991248|NCT00129766|19677017|P2|STARTED|Overall Study||3329
7991249|NCT00129766|19677018|P1|STARTED|Overall Study||3306
7991250|NCT00129740|19677056|P1|NOT COMPLETED|Overall Study||0
7991251|NCT00129740|19677056|P1|COMPLETED|Overall Study||148
7991252|NCT00129740|19677056|P1|STARTED|Overall Study||148
7991253|NCT00129727|19677061|P1|NOT COMPLETED|Overall Study||5
7991254|NCT00129727|19677061|P1|COMPLETED|Overall Study||57
7991255|NCT00129727|19677061|P1|STARTED|Overall Study||62
7991256|NCT00129701|19677067|P1|NOT COMPLETED|Overall Study||33
7991257|NCT00129701|19677067|P1|COMPLETED|Overall Study||71
7991258|NCT00129701|19677067|P1|STARTED|Overall Study||104
7991259|NCT00129649|19677076|P2|NOT COMPLETED|Overall Study||65
7991260|NCT00129649|19677077|P1|NOT COMPLETED|Overall Study||76
7991261|NCT00129649|19677076|P2|COMPLETED|Overall Study||181
7991262|NCT00129649|19677077|P1|COMPLETED|Overall Study||182
7991263|NCT00129649|19677076|P2|STARTED|Overall Study||246
7991264|NCT00129649|19677077|P1|STARTED|Overall Study||258
7991265|NCT00129623|19677085|P2|NOT COMPLETED|Overall Study||12
7991266|NCT00129623|19677086|P1|NOT COMPLETED|Overall Study||10
7991267|NCT00129623|19677085|P2|COMPLETED|Overall Study||65
7991268|NCT00129623|19677086|P1|COMPLETED|Overall Study||73
7991269|NCT00129623|19677085|P2|Intent-to-treat (ITT)/ Safety Population|Overall Study||77
7991270|NCT00129623|19677086|P1|Intent-to-treat (ITT)/ Safety Population|Overall Study||83
7991271|NCT00129623|19677085|P2|STARTED|Overall Study||77
7991272|NCT00129623|19677086|P1|STARTED|Overall Study||83
7991273|NCT00129545|19677111|P3|NOT COMPLETED|Overall Study||111
7991274|NCT00129545|19677112|P2|NOT COMPLETED|Overall Study||164
7991275|NCT00129545|19677113|P1|NOT COMPLETED|Overall Study||26
7991276|NCT00129545|19677111|P3|COMPLETED|Overall Study||133
7991277|NCT00129545|19677112|P2|COMPLETED|Overall Study||299
7991278|NCT00129545|19677113|P1|COMPLETED|Overall Study||67
7991279|NCT00129545|19677111|P3|STARTED|Overall Study||244
7991280|NCT00129545|19677112|P2|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463
7991281|NCT00129545|19677113|P1|STARTED|Overall Study||93
7991282|NCT00129480|19677125|P2|NOT COMPLETED|Overall Study||0
7991283|NCT00129480|19677126|P1|NOT COMPLETED|Overall Study||0
7991284|NCT00129480|19677125|P2|COMPLETED|Overall Study||214
7991285|NCT00129480|19677126|P1|COMPLETED|Overall Study||187
7991286|NCT00129480|19677125|P2|STARTED|Overall Study||214
7991287|NCT00129480|19677126|P1|STARTED|Overall Study||187
7991288|NCT00129467|19677142|P2|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
7991289|NCT00129467|19677143|P1|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
7991290|NCT00129467|19677142|P2|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
7991291|NCT00129467|19677143|P1|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
7991292|NCT00129467|19677142|P2|STARTED|Open Label for SSRI+Methylphenidate Arm||0
7991293|NCT00129467|19677143|P1|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4
7991294|NCT00129467|19677142|P2|NOT COMPLETED|Received Intervention||4
7991295|NCT00129467|19677143|P1|NOT COMPLETED|Received Intervention||6
7991296|NCT00129467|19677142|P2|COMPLETED|Received Intervention||13
7991297|NCT00129467|19677143|P1|COMPLETED|Received Intervention||9
7991298|NCT00129467|19677142|P2|STARTED|Received Intervention||17
7991299|NCT00129467|19677143|P1|STARTED|Received Intervention||15
7991300|NCT00129441|19677151|P2|NOT COMPLETED|Overall Study||0
7991301|NCT00129441|19677152|P1|NOT COMPLETED|Overall Study||0
7991302|NCT00129441|19677151|P2|COMPLETED|Overall Study||6
7991303|NCT00129441|19677152|P1|COMPLETED|Overall Study||9
7991304|NCT00129441|19677151|P2|Year 1, Visit 8|Overall Study||6
7991305|NCT00129441|19677152|P1|Year 1, Visit 8|Overall Study||9
7991306|NCT00129441|19677151|P2|Week 26, Visit 7|Overall Study||6
7991307|NCT00129441|19677152|P1|Week 26, Visit 7|Overall Study||9
7991308|NCT00129441|19677151|P2|Week 5, Visit 6|Overall Study||6
7991309|NCT00129441|19677152|P1|Week 5, Visit 6|Overall Study||9
7991310|NCT00129441|19677151|P2|Week 4, Visit 5|Overall Study||6
7991311|NCT00129441|19677152|P1|Week 4, Visit 5|Overall Study||9
7991312|NCT00129441|19677151|P2|Week 3, Visit 4|Overall Study||6
7991313|NCT00129441|19677152|P1|Week 3, Visit 4|Overall Study||9
7991314|NCT00129441|19677151|P2|Week 2, Visit 3|Overall Study||6
7991315|NCT00129441|19677152|P1|Week 2, Visit 3|Overall Study||9
7991316|NCT00129441|19677151|P2|Week 1, Visit 2|Overall Study||6
7991317|NCT00129441|19677152|P1|Week 1, Visit 2|Overall Study||9
7991318|NCT00129441|19677151|P2|Baseline, Visit 1|Overall Study||6
7991319|NCT00129441|19677152|P1|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9
7991320|NCT00129441|19677151|P2|STARTED|Overall Study||6
7991321|NCT00129441|19677152|P1|STARTED|Overall Study||9
7991322|NCT00129402|19677174|P7|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6
7991323|NCT00129402|19677175|P6|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
7991324|NCT00129402|19677176|P5|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
7991325|NCT00129402|19677177|P4|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
7991326|NCT00129402|19677178|P3|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
7991327|NCT00129402|19677179|P2|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
7991328|NCT00129402|19677180|P1|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
7991329|NCT00129402|19677174|P7|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222
7991330|NCT00129402|19677175|P6|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
7991331|NCT00129402|19677176|P5|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
7991332|NCT00129402|19677177|P4|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
7991333|NCT00129402|19677178|P3|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
7991334|NCT00129402|19677179|P2|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
7991335|NCT00129402|19677180|P1|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
7991336|NCT00129402|19677174|P7|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228
7991337|NCT00129402|19677175|P6|STARTED|Start Period3 to End Period3(Week 34-53)||0
7991338|NCT00129402|19677176|P5|STARTED|Start Period3 to End Period3(Week 34-53)||0
7991339|NCT00129402|19677177|P4|STARTED|Start Period3 to End Period3(Week 34-53)||0
7991340|NCT00129402|19677178|P3|STARTED|Start Period3 to End Period3(Week 34-53)||0
7991341|NCT00129402|19677179|P2|STARTED|Start Period3 to End Period3(Week 34-53)||0
7991342|NCT00129402|19677180|P1|STARTED|Start Period3 to End Period3(Week 34-53)||0
7991343|NCT00129402|19677174|P7|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
7991344|NCT00129402|19677175|P6|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5
7991345|NCT00129402|19677176|P5|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
7991346|NCT00129402|19677177|P4|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
7991347|NCT00129402|19677178|P3|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8
7991348|NCT00129402|19677179|P2|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
7991349|NCT00129402|19677180|P1|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
7991350|NCT00129402|19677174|P7|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
7991351|NCT00129402|19677175|P6|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113
7991352|NCT00129402|19677176|P5|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
7991353|NCT00129402|19677177|P4|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
7991354|NCT00129402|19677178|P3|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114
7991355|NCT00129402|19677179|P2|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
7991356|NCT00129402|19677180|P1|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
7991357|NCT00129402|19677174|P7|STARTED|Start Period2 to End Period2 (Week 7-33)||0
7991358|NCT00129402|19677175|P6|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118
7991359|NCT00129402|19677176|P5|STARTED|Start Period2 to End Period2 (Week 7-33)||0
7991360|NCT00129402|19677177|P4|STARTED|Start Period2 to End Period2 (Week 7-33)||0
7991361|NCT00129402|19677178|P3|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122
7991362|NCT00129402|19677179|P2|STARTED|Start Period2 to End Period2 (Week 7-33)||0
7991363|NCT00129402|19677180|P1|STARTED|Start Period2 to End Period2 (Week 7-33)||0
7991364|NCT00129402|19677174|P7|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
7991365|NCT00129402|19677175|P6|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
7991366|NCT00129402|19677176|P5|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
7991367|NCT00129402|19677177|P4|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
7991368|NCT00129402|19677178|P3|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
7991369|NCT00129402|19677179|P2|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
7991370|NCT00129402|19677180|P1|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
7991371|NCT00129402|19677174|P7|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
7991372|NCT00129402|19677175|P6|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40
7991373|NCT00129402|19677176|P5|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
7991374|NCT00129402|19677177|P4|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
7991375|NCT00129402|19677178|P3|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41
7991376|NCT00129402|19677179|P2|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
7991377|NCT00129402|19677180|P1|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43
7991378|NCT00129402|19677174|P7|STARTED|Start Period1 to End Period1 (Week 1-6)||0
7991379|NCT00129402|19677175|P6|STARTED|Start Period1 to End Period1 (Week 1-6)||42
7991380|NCT00129402|19677176|P5|STARTED|Start Period1 to End Period1 (Week 1-6)||40
7991381|NCT00129402|19677177|P4|STARTED|Start Period1 to End Period1 (Week 1-6)||40
7991382|NCT00129402|19677178|P3|STARTED|Start Period1 to End Period1 (Week 1-6)||43
7991383|NCT00129402|19677179|P2|STARTED|Start Period1 to End Period1 (Week 1-6)||40
7991384|NCT00129402|19677180|P1|STARTED|Start Period1 to End Period1 (Week 1-6)||43
7991385|NCT00129389|19677199|P2|NOT COMPLETED|Overall Study||140
7991386|NCT00129389|19677200|P1|NOT COMPLETED|Overall Study||33
7991387|NCT00129389|19677199|P2|COMPLETED|Overall Study|16 patients were crossed from arm B to A by error. 1 patient was crossed from arm A to B by error.|811
7991388|NCT00129389|19677200|P1|COMPLETED|Overall Study|1 patient was crossed from arm A to B by error. 16 patients were crossed from arm B, to A by error.|941
7991389|NCT00129389|19677199|P2|STARTED|Overall Study||951
7991390|NCT00129389|19677200|P1|STARTED|Overall Study||974
7991391|NCT00129376|19677208|P1|NOT COMPLETED|Overall Study||2
7991392|NCT00129376|19677208|P1|COMPLETED|Overall Study||61
7991393|NCT00129376|19677208|P1|STARTED|Overall Study||63
7991394|NCT00129311|19677218|P2|NOT COMPLETED|Overall Study||19
7991395|NCT00129311|19677219|P1|NOT COMPLETED|Overall Study||12
7991396|NCT00129311|19677218|P2|COMPLETED|Overall Study||31
7991397|NCT00129311|19677219|P1|COMPLETED|Overall Study||39
7991398|NCT00129311|19677218|P2|STARTED|Overall Study||50
7991399|NCT00129311|19677219|P1|STARTED|Overall Study||51
7991400|NCT00129285|19677230|P3|NOT COMPLETED|Overall Study||38
7991401|NCT00129285|19677231|P2|NOT COMPLETED|Overall Study||27
7991402|NCT00129285|19677232|P1|NOT COMPLETED|Overall Study||25
7991403|NCT00129285|19677230|P3|COMPLETED|Overall Study||37
7991404|NCT00129285|19677231|P2|COMPLETED|Overall Study||43
7991405|NCT00129285|19677232|P1|COMPLETED|Overall Study||40
7991406|NCT00129285|19677230|P3|STARTED|Overall Study||75
7991407|NCT00129285|19677231|P2|STARTED|Overall Study||70
7991408|NCT00129285|19677232|P1|STARTED|Overall Study||65
7991409|NCT00129272|19677248|P2|NOT COMPLETED|Overall Study||22
7991410|NCT00129272|19677249|P1|NOT COMPLETED|Overall Study||17
7991411|NCT00129272|19677248|P2|COMPLETED|Overall Study||51
7991412|NCT00129272|19677249|P1|COMPLETED|Overall Study||54
7991413|NCT00129272|19677248|P2|STARTED|Overall Study||73
7991414|NCT00129272|19677249|P1|STARTED|Overall Study||71
7991415|NCT00129259|19677259|P2|NOT COMPLETED|Overall Study||3
7991416|NCT00129259|19677260|P1|NOT COMPLETED|Overall Study||3
7991417|NCT00129259|19677259|P2|COMPLETED|Overall Study||22
7991418|NCT00129259|19677260|P1|COMPLETED|Overall Study||49
7991419|NCT00129259|19677259|P2|Received All or Part of Cycle 2|Overall Study||0
7991420|NCT00129259|19677260|P1|Received All or Part of Cycle 2|Overall Study||40
7991421|NCT00129259|19677259|P2|Received All or Part of Cycle 1|Overall Study||0
7991422|NCT00129259|19677260|P1|Received All or Part of Cycle 1|Overall Study||52
7991423|NCT00129259|19677259|P2|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25
7991424|NCT00129259|19677260|P1|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52
7991425|NCT00129246|19677272|P2|NOT COMPLETED|Overall Study||0
7991426|NCT00129246|19677273|P1|NOT COMPLETED|Overall Study||0
7991427|NCT00129246|19677272|P2|COMPLETED|Overall Study||20
7991428|NCT00129246|19677273|P1|COMPLETED|Overall Study||20
7991429|NCT00129246|19677272|P2|STARTED|Overall Study||20
7991430|NCT00129246|19677273|P1|STARTED|Overall Study||20
7991431|NCT00129220|19677288|P3|NOT COMPLETED|Study Period III||10
7991432|NCT00129220|19677289|P2|NOT COMPLETED|Study Period III||1
7991433|NCT00129220|19677290|P1|NOT COMPLETED|Study Period III||13
7991434|NCT00129220|19677288|P3|COMPLETED|Study Period III||42
7991435|NCT00129220|19677289|P2|COMPLETED|Study Period III||7
7991436|NCT00129220|19677290|P1|COMPLETED|Study Period III||59
7991437|NCT00129220|19677288|P3|STARTED|Study Period III||52
7991438|NCT00129220|19677289|P2|STARTED|Study Period III||8
7991439|NCT00129220|19677290|P1|STARTED|Study Period III||72
7991440|NCT00129220|19677288|P3|NOT COMPLETED|Study Period II||47
7991441|NCT00129220|19677289|P2|NOT COMPLETED|Study Period II||12
7991442|NCT00129220|19677290|P1|NOT COMPLETED|Study Period II||33
7991443|NCT00129220|19677288|P3|COMPLETED|Study Period II||52
7991444|NCT00129220|19677289|P2|COMPLETED|Study Period II||8
7991445|NCT00129220|19677290|P1|COMPLETED|Study Period II||72
7991446|NCT00129220|19677288|P3|Received at Least One Dose of Study Drug|Study Period II||97
7991447|NCT00129220|19677289|P2|Received at Least One Dose of Study Drug|Study Period II||20
7991448|NCT00129220|19677290|P1|Received at Least One Dose of Study Drug|Study Period II||104
7991449|NCT00129220|19677288|P3|STARTED|Study Period II||99
7991450|NCT00129220|19677289|P2|STARTED|Study Period II||20
7991451|NCT00129220|19677290|P1|STARTED|Study Period II||105
7991452|NCT00129129|19677330|P5|NOT COMPLETED|Fourth Dose Phase||6
7991453|NCT00129129|19677331|P4|NOT COMPLETED|Fourth Dose Phase||4
7991454|NCT00129129|19677332|P3|NOT COMPLETED|Fourth Dose Phase||0
7991455|NCT00129129|19677333|P2|NOT COMPLETED|Fourth Dose Phase||0
7991456|NCT00129129|19677334|P1|NOT COMPLETED|Fourth Dose Phase||4
7991457|NCT00129129|19677330|P5|COMPLETED|Fourth Dose Phase||124
7991458|NCT00129129|19677331|P4|COMPLETED|Fourth Dose Phase||128
7991459|NCT00129129|19677332|P3|COMPLETED|Fourth Dose Phase||0
7991460|NCT00129129|19677333|P2|COMPLETED|Fourth Dose Phase||0
7991461|NCT00129129|19677334|P1|COMPLETED|Fourth Dose Phase||232
7991462|NCT00129129|19677330|P5|STARTED|Fourth Dose Phase||130
7991463|NCT00129129|19677331|P4|STARTED|Fourth Dose Phase||132
7991464|NCT00129129|19677332|P3|STARTED|Fourth Dose Phase||0
7991465|NCT00129129|19677333|P2|STARTED|Fourth Dose Phase||0
7991466|NCT00129129|19677334|P1|STARTED|Fourth Dose Phase||236
7991467|NCT00129129|19677330|P5|NOT COMPLETED|Primary Phase||0
7991468|NCT00129129|19677331|P4|NOT COMPLETED|Primary Phase||0
7991469|NCT00129129|19677332|P3|NOT COMPLETED|Primary Phase||0
7991470|NCT00129129|19677333|P2|NOT COMPLETED|Primary Phase||25
7991471|NCT00129129|19677334|P1|NOT COMPLETED|Primary Phase||25
7991472|NCT00129129|19677330|P5|COMPLETED|Primary Phase||0
7991473|NCT00129129|19677331|P4|COMPLETED|Primary Phase||0
7991474|NCT00129129|19677332|P3|COMPLETED|Primary Phase||150
7991475|NCT00129129|19677333|P2|COMPLETED|Primary Phase||294
7991476|NCT00129129|19677334|P1|COMPLETED|Primary Phase||262
7991477|NCT00129129|19677330|P5|STARTED|Primary Phase||0
7991478|NCT00129129|19677331|P4|STARTED|Primary Phase||0
7991479|NCT00129129|19677332|P3|STARTED|Primary Phase||150
7991480|NCT00129129|19677333|P2|STARTED|Primary Phase||319
7991481|NCT00129129|19677334|P1|STARTED|Primary Phase||287
7991482|NCT00129116|19677541|P5|NOT COMPLETED|Booster Phase||1
7991483|NCT00129116|19677542|P4|NOT COMPLETED|Booster Phase||0
7991484|NCT00129116|19677543|P3|NOT COMPLETED|Booster Phase||0
7991485|NCT00129116|19677544|P2|NOT COMPLETED|Booster Phase||0
7991486|NCT00129116|19677545|P1|NOT COMPLETED|Booster Phase||2
7991487|NCT00129116|19677541|P5|COMPLETED|Booster Phase||43
7991488|NCT00129116|19677542|P4|COMPLETED|Booster Phase||44
7991489|NCT00129116|19677543|P3|COMPLETED|Booster Phase||44
7991490|NCT00129116|19677544|P2|COMPLETED|Booster Phase||42
7991491|NCT00129116|19677545|P1|COMPLETED|Booster Phase||45
7991492|NCT00129116|19677541|P5|STARTED|Booster Phase||44
7991493|NCT00129116|19677542|P4|STARTED|Booster Phase||44
7991494|NCT00129116|19677543|P3|STARTED|Booster Phase||44
7991495|NCT00129116|19677544|P2|STARTED|Booster Phase||42
7991496|NCT00129116|19677545|P1|STARTED|Booster Phase||47
7991497|NCT00129116|19677541|P5|NOT COMPLETED|Primary Phase||1
7991498|NCT00129116|19677542|P4|NOT COMPLETED|Primary Phase||1
7991499|NCT00129116|19677543|P3|NOT COMPLETED|Primary Phase||1
7991500|NCT00129116|19677544|P2|NOT COMPLETED|Primary Phase||4
7991501|NCT00129116|19677545|P1|NOT COMPLETED|Primary Phase||2
7991502|NCT00129116|19677541|P5|COMPLETED|Primary Phase||76
7991503|NCT00129116|19677542|P4|COMPLETED|Primary Phase||77
7991504|NCT00129116|19677543|P3|COMPLETED|Primary Phase||77
7991505|NCT00129116|19677544|P2|COMPLETED|Primary Phase||73
7991506|NCT00129116|19677545|P1|COMPLETED|Primary Phase||76
7991507|NCT00129116|19677541|P5|STARTED|Primary Phase||77
7991508|NCT00129116|19677542|P4|STARTED|Primary Phase||78
7991509|NCT00129116|19677543|P3|STARTED|Primary Phase||78
7991510|NCT00129116|19677544|P2|STARTED|Primary Phase||77
7991511|NCT00129116|19677545|P1|STARTED|Primary Phase||78
7991512|NCT00128921|19677810|P3|NOT COMPLETED|Overall Study||0
7991513|NCT00128921|19677811|P2|NOT COMPLETED|Overall Study||5
7991514|NCT00128921|19677812|P1|NOT COMPLETED|Overall Study||5
7991515|NCT00128921|19677810|P3|COMPLETED|Overall Study||0
7991516|NCT00128921|19677811|P2|COMPLETED|Overall Study||3
7991517|NCT00128921|19677812|P1|COMPLETED|Overall Study||5
7991518|NCT00128921|19677810|P3|Received Bortezomib|Overall Study||0
7991519|NCT00128921|19677811|P2|Received Bortezomib|Overall Study||6
7991520|NCT00128921|19677812|P1|Received Bortezomib|Overall Study||10
7991521|NCT00128921|19677810|P3|STARTED|Overall Study||0
7991522|NCT00128921|19677811|P2|STARTED|Overall Study||8
7991523|NCT00128921|19677812|P1|STARTED|Overall Study||10
7991524|NCT00128830|19677829|P1|NOT COMPLETED|Overall Study||72
7991525|NCT00128830|19677829|P1|COMPLETED|Overall Study||139
7991526|NCT00128830|19677829|P1|STARTED|Overall Study||211
7991527|NCT00128713|19677847|P3|NOT COMPLETED|Overall Study||0
7991528|NCT00128713|19677848|P2|NOT COMPLETED|Overall Study||0
7991529|NCT00128713|19677849|P1|NOT COMPLETED|Overall Study||0
7991530|NCT00128713|19677847|P3|COMPLETED|Overall Study||449
7991531|NCT00128713|19677848|P2|COMPLETED|Overall Study||449
7991532|NCT00128713|19677849|P1|COMPLETED|Overall Study||453
7991533|NCT00128713|19677847|P3|STARTED|Overall Study||449
7991534|NCT00128713|19677848|P2|STARTED|Overall Study||449
7991535|NCT00128713|19677849|P1|STARTED|Overall Study||453
7991536|NCT00128661|19677871|P2|NOT COMPLETED|Overall Study||258
7991537|NCT00128661|19677872|P1|NOT COMPLETED|Overall Study||274
7991538|NCT00128661|19677871|P2|COMPLETED|Overall Study||3481
7991539|NCT00128661|19677872|P1|COMPLETED|Overall Study||3453
7991540|NCT00128661|19677871|P2|STARTED|Overall Study||3739
7991541|NCT00128661|19677872|P1|STARTED|Overall Study||3727
7991542|NCT00128492|19677918|P2|NOT COMPLETED|Overall Study||59
7991543|NCT00128492|19677919|P1|NOT COMPLETED|Overall Study||20
7991544|NCT00128492|19677918|P2|COMPLETED|Overall Study||130
7991545|NCT00128492|19677919|P1|COMPLETED|Overall Study||65
7991546|NCT00128492|19677918|P2|STARTED|Overall Study||189
7991547|NCT00128492|19677919|P1|STARTED|Overall Study||85
7991548|NCT00128401|19677979|P2|NOT COMPLETED|Overall Study||4
7991549|NCT00128401|19677980|P1|NOT COMPLETED|Overall Study||6
7991550|NCT00128401|19677979|P2|COMPLETED|Overall Study||15
7991551|NCT00128401|19677980|P1|COMPLETED|Overall Study||14
7991552|NCT00128401|19677979|P2|STARTED|Overall Study||19
7991553|NCT00128401|19677980|P1|STARTED|Overall Study||20
7991554|NCT00128219|19677991|P2|NOT COMPLETED|Overall Study||71
7991555|NCT00128219|19677992|P1|NOT COMPLETED|Overall Study||69
7991556|NCT00128219|19677991|P2|COMPLETED|Overall Study||263
7991557|NCT00128219|19677992|P1|COMPLETED|Overall Study||264
7991558|NCT00128219|19677991|P2|STARTED|Overall Study||334
7991559|NCT00128219|19677992|P1|STARTED|Overall Study||333
7991560|NCT00128206|19678076|P2|NOT COMPLETED|Overall Study||120
7991561|NCT00128206|19678077|P1|NOT COMPLETED|Overall Study||137
7991562|NCT00128206|19678076|P2|COMPLETED|Overall Study||60
7991563|NCT00128206|19678077|P1|COMPLETED|Overall Study||47
7991564|NCT00128206|19678076|P2|STARTED|Overall Study||180
7991565|NCT00128206|19678077|P1|STARTED|Overall Study||184
7991566|NCT00128193|19678099|P12|NOT COMPLETED|Overall Study||2
7991567|NCT00128193|19678100|P11|NOT COMPLETED|Overall Study||3
7991568|NCT00128193|19678101|P10|NOT COMPLETED|Overall Study||2
7991569|NCT00128193|19678102|P9|NOT COMPLETED|Overall Study||2
7991570|NCT00128193|19678103|P8|NOT COMPLETED|Overall Study||0
7991571|NCT00128193|19678104|P7|NOT COMPLETED|Overall Study||4
7991572|NCT00128193|19678105|P6|NOT COMPLETED|Overall Study||3
7991573|NCT00128193|19678106|P5|NOT COMPLETED|Overall Study||2
7991574|NCT00128193|19678107|P4|NOT COMPLETED|Overall Study||1
7991575|NCT00128193|19678108|P3|NOT COMPLETED|Overall Study||3
7991576|NCT00128193|19678109|P2|NOT COMPLETED|Overall Study||0
7991577|NCT00128193|19678110|P1|NOT COMPLETED|Overall Study||0
7991578|NCT00128193|19678099|P12|COMPLETED|Overall Study||18
7991579|NCT00128193|19678100|P11|COMPLETED|Overall Study||17
7991580|NCT00128193|19678101|P10|COMPLETED|Overall Study||18
7991581|NCT00128193|19678102|P9|COMPLETED|Overall Study||18
7991582|NCT00128193|19678103|P8|COMPLETED|Overall Study||20
7991583|NCT00128193|19678104|P7|COMPLETED|Overall Study||16
7991584|NCT00128193|19678105|P6|COMPLETED|Overall Study||17
7991585|NCT00128193|19678106|P5|COMPLETED|Overall Study||18
7991586|NCT00128193|19678107|P4|COMPLETED|Overall Study||44
7991587|NCT00128193|19678108|P3|COMPLETED|Overall Study||42
7991588|NCT00128193|19678109|P2|COMPLETED|Overall Study||5
7991589|NCT00128193|19678110|P1|COMPLETED|Overall Study||5
7991590|NCT00128193|19678099|P12|STARTED|Overall Study||20
7991591|NCT00128193|19678100|P11|STARTED|Overall Study||20
7991592|NCT00128193|19678101|P10|STARTED|Overall Study||20
7991593|NCT00128193|19678102|P9|STARTED|Overall Study||20
7991594|NCT00128193|19678103|P8|STARTED|Overall Study||20
7991595|NCT00128193|19678104|P7|STARTED|Overall Study||20
7991596|NCT00128193|19678105|P6|STARTED|Overall Study||20
7991597|NCT00128193|19678106|P5|STARTED|Overall Study||20
7991598|NCT00128193|19678107|P4|STARTED|Overall Study||45
7991599|NCT00128193|19678108|P3|STARTED|Overall Study||45
7991600|NCT00128193|19678109|P2|STARTED|Overall Study||5
7991601|NCT00128193|19678110|P1|STARTED|Overall Study||5
7991602|NCT00128180|19678346|P2|NOT COMPLETED|Overall Study||0
7991603|NCT00128180|19678347|P1|NOT COMPLETED|Overall Study||0
7991604|NCT00128180|19678346|P2|COMPLETED|Overall Study||34
7991605|NCT00128180|19678347|P1|COMPLETED|Overall Study||32
7991606|NCT00128180|19678346|P2|STARTED|Overall Study||34
7991607|NCT00128180|19678347|P1|STARTED|Overall Study||32
7991608|NCT00128102|19678373|P2|NOT COMPLETED|Overall Study||332
7991609|NCT00128102|19678374|P1|NOT COMPLETED|Overall Study||328
7991610|NCT00128102|19678373|P2|COMPLETED|Overall Study||0
7991611|NCT00128102|19678374|P1|COMPLETED|Overall Study||1
7991612|NCT00128102|19678373|P2|Treated|Overall Study||329
7991613|NCT00128102|19678374|P1|Treated|Overall Study||329
7991614|NCT00128102|19678373|P2|STARTED|Overall Study||332
7991615|NCT00128102|19678374|P1|STARTED|Overall Study||329
7991616|NCT00127933|19678400|P2|NOT COMPLETED|Overall Study||0
7991617|NCT00127933|19678401|P1|NOT COMPLETED|Overall Study||1
7991618|NCT00127933|19678400|P2|COMPLETED|Overall Study||34
7991619|NCT00127933|19678401|P1|COMPLETED|Overall Study||122
7991620|NCT00127933|19678400|P2|Postoperative|Overall Study||27
7991621|NCT00127933|19678401|P1|Postoperative|Overall Study||98
7991622|NCT00127933|19678400|P2|Quality of Life Population|Overall Study||33
7991623|NCT00127933|19678401|P1|Quality of Life Population|Overall Study||118
7991624|NCT00127933|19678400|P2|Safety Population|Overall Study||34
7991625|NCT00127933|19678401|P1|Safety Population|Overall Study||122
7991626|NCT00127933|19678400|P2|Clinical Response|Overall Study||34
7991627|NCT00127933|19678401|P1|Clinical Response|Overall Study||122
7991628|NCT00127933|19678400|P2|Pathological Response|Overall Study||28
7991629|NCT00127933|19678401|P1|Pathological Response|Overall Study||101
7991630|NCT00127933|19678400|P2|STARTED|Overall Study||34
7991631|NCT00127933|19678401|P1|STARTED|Overall Study||123
7991632|NCT00127855|19678422|P5|NOT COMPLETED|Polysaccharide Challenge Dose||0
7991633|NCT00127855|19678423|P4|NOT COMPLETED|Polysaccharide Challenge Dose||0
7991634|NCT00127855|19678424|P3|NOT COMPLETED|Polysaccharide Challenge Dose||0
7991635|NCT00127855|19678425|P2|NOT COMPLETED|Polysaccharide Challenge Dose||0
7991636|NCT00127855|19678426|P1|NOT COMPLETED|Polysaccharide Challenge Dose||0
7991637|NCT00127855|19678422|P5|COMPLETED|Polysaccharide Challenge Dose||77
7991638|NCT00127855|19678423|P4|COMPLETED|Polysaccharide Challenge Dose||81
7991639|NCT00127855|19678424|P3|COMPLETED|Polysaccharide Challenge Dose||77
7991640|NCT00127855|19678425|P2|COMPLETED|Polysaccharide Challenge Dose||79
7991641|NCT00127855|19678426|P1|COMPLETED|Polysaccharide Challenge Dose||80
7991642|NCT00127855|19678422|P5|STARTED|Polysaccharide Challenge Dose||77
7991643|NCT00127855|19678423|P4|STARTED|Polysaccharide Challenge Dose||81
7991644|NCT00127855|19678424|P3|STARTED|Polysaccharide Challenge Dose||77
7991645|NCT00127855|19678425|P2|STARTED|Polysaccharide Challenge Dose||79
7991646|NCT00127855|19678426|P1|STARTED|Polysaccharide Challenge Dose||80
7991647|NCT00127855|19678422|P5|NOT COMPLETED|Primary Vaccination Course||4
7991648|NCT00127855|19678423|P4|NOT COMPLETED|Primary Vaccination Course||0
7991649|NCT00127855|19678424|P3|NOT COMPLETED|Primary Vaccination Course||2
7991650|NCT00127855|19678425|P2|NOT COMPLETED|Primary Vaccination Course||1
7991651|NCT00127855|19678426|P1|NOT COMPLETED|Primary Vaccination Course||2
7991652|NCT00127855|19678422|P5|COMPLETED|Primary Vaccination Course||78
7991653|NCT00127855|19678423|P4|COMPLETED|Primary Vaccination Course||81
7991654|NCT00127855|19678424|P3|COMPLETED|Primary Vaccination Course||78
7991655|NCT00127855|19678425|P2|COMPLETED|Primary Vaccination Course||81
7991656|NCT00127855|19678426|P1|COMPLETED|Primary Vaccination Course||80
7991657|NCT00127855|19678422|P5|STARTED|Primary Vaccination Course||82
7991658|NCT00127855|19678423|P4|STARTED|Primary Vaccination Course||81
7991659|NCT00127855|19678424|P3|STARTED|Primary Vaccination Course||80
7991660|NCT00127855|19678425|P2|STARTED|Primary Vaccination Course||82
7991661|NCT00127855|19678426|P1|STARTED|Primary Vaccination Course||82
7991662|NCT00127842|19678608|P1|NOT COMPLETED|Overall Study||39
7991663|NCT00127842|19678608|P1|COMPLETED|Overall Study||71
7991664|NCT00127842|19678608|P1|STARTED|Overall Study||110
7991665|NCT00127803|19678626|P4|NOT COMPLETED|Overall Study||1
7991666|NCT00127803|19678627|P3|NOT COMPLETED|Overall Study||0
7991667|NCT00127803|19678628|P2|NOT COMPLETED|Overall Study||0
7991668|NCT00127803|19678629|P1|NOT COMPLETED|Overall Study||3
7991669|NCT00127803|19678626|P4|COMPLETED|Overall Study||11
7991670|NCT00127803|19678627|P3|COMPLETED|Overall Study||12
7991671|NCT00127803|19678628|P2|COMPLETED|Overall Study||13
7991672|NCT00127803|19678629|P1|COMPLETED|Overall Study||10
7991673|NCT00127803|19678626|P4|STARTED|Overall Study||12
7991674|NCT00127803|19678627|P3|STARTED|Overall Study||12
7991675|NCT00127803|19678628|P2|STARTED|Overall Study||13
7991676|NCT00127803|19678629|P1|STARTED|Overall Study||13
7991677|NCT00127790|19678651|P4|NOT COMPLETED|Post-Treatment||0
7991678|NCT00127790|19678652|P3|NOT COMPLETED|Post-Treatment||0
7991679|NCT00127790|19678653|P2|NOT COMPLETED|Post-Treatment||0
7991680|NCT00127790|19678654|P1|NOT COMPLETED|Post-Treatment||0
7991681|NCT00127790|19678651|P4|COMPLETED|Post-Treatment||4
7991682|NCT00127790|19678652|P3|COMPLETED|Post-Treatment||6
7991683|NCT00127790|19678653|P2|COMPLETED|Post-Treatment||5
7991684|NCT00127790|19678654|P1|COMPLETED|Post-Treatment||6
7991685|NCT00127790|19678651|P4|STARTED|Post-Treatment||4
7991686|NCT00127790|19678652|P3|STARTED|Post-Treatment||6
7991687|NCT00127790|19678653|P2|STARTED|Post-Treatment||5
7991688|NCT00127790|19678654|P1|STARTED|Post-Treatment||6
7991689|NCT00127790|19678651|P4|NOT COMPLETED|Pre-Treatment||0
7991690|NCT00127790|19678652|P3|NOT COMPLETED|Pre-Treatment||0
7991691|NCT00127790|19678653|P2|NOT COMPLETED|Pre-Treatment||0
7991692|NCT00127790|19678654|P1|NOT COMPLETED|Pre-Treatment||0
7991693|NCT00127790|19678651|P4|COMPLETED|Pre-Treatment||4
7991694|NCT00127790|19678652|P3|COMPLETED|Pre-Treatment||6
7991695|NCT00127790|19678653|P2|COMPLETED|Pre-Treatment||5
7991696|NCT00127790|19678654|P1|COMPLETED|Pre-Treatment||6
7991697|NCT00127790|19678651|P4|STARTED|Pre-Treatment||4
7991698|NCT00127790|19678652|P3|STARTED|Pre-Treatment||6
7991699|NCT00127790|19678653|P2|STARTED|Pre-Treatment||5
7991700|NCT00127790|19678654|P1|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6
7991701|NCT00127712|19678678|P2|NOT COMPLETED|Overall Study||0
7991702|NCT00127712|19678679|P1|NOT COMPLETED|Overall Study||5
7991703|NCT00127712|19678678|P2|COMPLETED|Overall Study||65
7991704|NCT00127712|19678679|P1|COMPLETED|Overall Study||60
7991705|NCT00127712|19678678|P2|STARTED|Overall Study||65
7991706|NCT00127712|19678679|P1|STARTED|Overall Study||65
7991707|NCT00127660|19678695|P4|NOT COMPLETED|Overall Study||0
7991708|NCT00127660|19678696|P3|NOT COMPLETED|Overall Study||5
7991709|NCT00127660|19678697|P2|NOT COMPLETED|Overall Study||3
7991710|NCT00127660|19678698|P1|NOT COMPLETED|Overall Study||3
7991711|NCT00127660|19678695|P4|COMPLETED|Overall Study||150
7991712|NCT00127660|19678696|P3|COMPLETED|Overall Study||143
7991713|NCT00127660|19678697|P2|COMPLETED|Overall Study||151
7991714|NCT00127660|19678698|P1|COMPLETED|Overall Study||150
7991715|NCT00127660|19678695|P4|STARTED|Overall Study||150
7991716|NCT00127660|19678696|P3|STARTED|Overall Study||148
7991717|NCT00127660|19678697|P2|STARTED|Overall Study||154
7991718|NCT00127660|19678698|P1|STARTED|Overall Study||153
7991719|NCT00127608|19678708|P1|NOT COMPLETED|Overall Study||1
7991720|NCT00127608|19678708|P1|COMPLETED|Overall Study||35
7991721|NCT00127608|19678708|P1|STARTED|Overall Study||36
7991722|NCT00127530|19678716|P2|NOT COMPLETED|Overall Study||21
7991723|NCT00127530|19678717|P1|NOT COMPLETED|Overall Study||1
7991724|NCT00127530|19678716|P2|COMPLETED|Overall Study||207
7991725|NCT00127530|19678717|P1|COMPLETED|Overall Study||71
7991726|NCT00127530|19678716|P2|STARTED|Overall Study||228
7991727|NCT00127530|19678717|P1|STARTED|Overall Study||72
7991728|NCT00127439|19678725|P2|NOT COMPLETED|Overall Study||0
7991729|NCT00127439|19678726|P1|NOT COMPLETED|Overall Study||0
7991730|NCT00127439|19678725|P2|COMPLETED|Overall Study||10
7991731|NCT00127439|19678726|P1|COMPLETED|Overall Study||9
7991732|NCT00127439|19678725|P2|STARTED|Overall Study||10
7991733|NCT00127439|19678726|P1|STARTED|Overall Study||9
7991734|NCT00127413|19678752|P4|NOT COMPLETED|Overall Study||2
7991735|NCT00127413|19678753|P3|NOT COMPLETED|Overall Study||8
7991736|NCT00127413|19678754|P2|NOT COMPLETED|Overall Study||4
7991737|NCT00127413|19678755|P1|NOT COMPLETED|Overall Study||6
7991738|NCT00127413|19678752|P4|COMPLETED|Overall Study||5
7991739|NCT00127413|19678753|P3|COMPLETED|Overall Study||5
7991740|NCT00127413|19678754|P2|COMPLETED|Overall Study||6
7991741|NCT00127413|19678755|P1|COMPLETED|Overall Study||6
7991742|NCT00127413|19678752|P4|STARTED|Overall Study||7
7991743|NCT00127413|19678753|P3|STARTED|Overall Study||13
7991744|NCT00127413|19678754|P2|STARTED|Overall Study||10
7991745|NCT00127413|19678755|P1|STARTED|Overall Study||12
7991746|NCT00127231|19678767|P2|NOT COMPLETED|Overall Study||6
7991747|NCT00127231|19678768|P1|NOT COMPLETED|Overall Study||6
7991748|NCT00127231|19678767|P2|COMPLETED|Overall Study||68
7991749|NCT00127231|19678768|P1|COMPLETED|Overall Study||68
7991750|NCT00127231|19678767|P2|STARTED|Overall Study||74
7991751|NCT00127231|19678768|P1|STARTED|Overall Study||74
7991752|NCT00127218|19678784|P2|NOT COMPLETED|Overall Study||15
7991753|NCT00127218|19678785|P1|NOT COMPLETED|Overall Study||13
7991754|NCT00127218|19678784|P2|COMPLETED|Overall Study||58
7991755|NCT00127218|19678785|P1|COMPLETED|Overall Study||59
7991756|NCT00127218|19678784|P2|STARTED|Overall Study||73
7991757|NCT00127218|19678785|P1|STARTED|Overall Study||72
7991758|NCT00127205|19678796|P3|NOT COMPLETED|Overall Study||617
7991759|NCT00127205|19678797|P2|NOT COMPLETED|Overall Study||980
7991760|NCT00127205|19678798|P1|NOT COMPLETED|Overall Study||835
7991761|NCT00127205|19678796|P3|COMPLETED|Overall Study||950
7991762|NCT00127205|19678797|P2|COMPLETED|Overall Study||1288
7991763|NCT00127205|19678798|P1|COMPLETED|Overall Study||1427
7991764|NCT00127205|19678796|P3|STARTED|Overall Study||1567
7991765|NCT00127205|19678797|P2|STARTED|Overall Study||2268
7991766|NCT00127205|19678798|P1|STARTED|Overall Study||2262
7991767|NCT00127192|19678820|P5|NOT COMPLETED|Overall Study||5
7991768|NCT00127192|19678821|P4|NOT COMPLETED|Overall Study||1
7991769|NCT00127192|19678822|P3|NOT COMPLETED|Overall Study||2
7991770|NCT00127192|19678823|P2|NOT COMPLETED|Overall Study||1
7991771|NCT00127192|19678824|P1|NOT COMPLETED|Overall Study||3
7991772|NCT00127192|19678820|P5|COMPLETED|Overall Study||68
7991773|NCT00127192|19678821|P4|COMPLETED|Overall Study||67
7991774|NCT00127192|19678822|P3|COMPLETED|Overall Study||68
7991775|NCT00127192|19678823|P2|COMPLETED|Overall Study||71
7991776|NCT00127192|19678824|P1|COMPLETED|Overall Study||77
7991777|NCT00127192|19678820|P5|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73
7991778|NCT00127192|19678821|P4|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68
7991779|NCT00127192|19678822|P3|STARTED|Overall Study|Study enrolled as per the target of N=70|70
7991780|NCT00127192|19678823|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72
7991781|NCT00127192|19678824|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80
7991782|NCT00127166|19678848|P2|NOT COMPLETED|Period II||0
7991783|NCT00127166|19678849|P1|NOT COMPLETED|Period II||3
7991784|NCT00127166|19678848|P2|COMPLETED|Period II||73
7991785|NCT00127166|19678849|P1|COMPLETED|Period II||72
7991786|NCT00127166|19678848|P2|STARTED|Period II||73
7991787|NCT00127166|19678849|P1|STARTED|Period II||75
7991788|NCT00127166|19678848|P2|NOT COMPLETED|Washout Period||1
7991789|NCT00127166|19678849|P1|NOT COMPLETED|Washout Period||0
7991790|NCT00127166|19678848|P2|COMPLETED|Washout Period||73
7991791|NCT00127166|19678849|P1|COMPLETED|Washout Period||75
7991792|NCT00127166|19678848|P2|STARTED|Washout Period||74
7991793|NCT00127166|19678849|P1|STARTED|Washout Period||75
7991794|NCT00127166|19678848|P2|NOT COMPLETED|Period I||2
7991795|NCT00127166|19678849|P1|NOT COMPLETED|Period I||3
7991796|NCT00127166|19678848|P2|COMPLETED|Period I||74
7991797|NCT00127166|19678849|P1|COMPLETED|Period I||75
7991798|NCT00127166|19678848|P2|STARTED|Period I||76
7991799|NCT00127166|19678849|P1|STARTED|Period I||78
7991800|NCT00127101|19678869|P6|NOT COMPLETED|Continuation Phase||3
7991801|NCT00127101|19678870|P5|NOT COMPLETED|Continuation Phase||3
7991802|NCT00127101|19678871|P4|NOT COMPLETED|Continuation Phase||0
7991803|NCT00127101|19678872|P3|NOT COMPLETED|Continuation Phase||1
7991804|NCT00127101|19678873|P2|NOT COMPLETED|Continuation Phase||0
7991805|NCT00127101|19678874|P1|NOT COMPLETED|Continuation Phase||0
7991806|NCT00127101|19678869|P6|COMPLETED|Continuation Phase||0
7991807|NCT00127101|19678870|P5|COMPLETED|Continuation Phase||0
7991808|NCT00127101|19678871|P4|COMPLETED|Continuation Phase||0
7991809|NCT00127101|19678872|P3|COMPLETED|Continuation Phase||0
7991810|NCT00127101|19678873|P2|COMPLETED|Continuation Phase||0
7991811|NCT00127101|19678874|P1|COMPLETED|Continuation Phase||0
7991812|NCT00127101|19678869|P6|STARTED|Continuation Phase||3
7991813|NCT00127101|19678870|P5|STARTED|Continuation Phase||3
7991814|NCT00127101|19678871|P4|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0
7991815|NCT00127101|19678872|P3|STARTED|Continuation Phase||1
7991816|NCT00127101|19678873|P2|STARTED|Continuation Phase||0
7991817|NCT00127101|19678874|P1|STARTED|Continuation Phase||0
7991818|NCT00127101|19678869|P6|NOT COMPLETED|Base Protocol||1
7991819|NCT00127101|19678870|P5|NOT COMPLETED|Base Protocol||2
7991820|NCT00127101|19678871|P4|NOT COMPLETED|Base Protocol||0
7991821|NCT00127101|19678872|P3|NOT COMPLETED|Base Protocol||2
7991822|NCT00127101|19678873|P2|NOT COMPLETED|Base Protocol||4
7991823|NCT00127101|19678874|P1|NOT COMPLETED|Base Protocol||2
7991824|NCT00127101|19678869|P6|COMPLETED|Base Protocol||3
7991825|NCT00127101|19678870|P5|COMPLETED|Base Protocol||3
7991826|NCT00127101|19678871|P4|COMPLETED|Base Protocol||3
7991827|NCT00127101|19678872|P3|COMPLETED|Base Protocol||1
7991828|NCT00127101|19678873|P2|COMPLETED|Base Protocol||1
7991829|NCT00127101|19678874|P1|COMPLETED|Base Protocol||1
7991830|NCT00127101|19678869|P6|STARTED|Base Protocol||4
7991831|NCT00127101|19678870|P5|STARTED|Base Protocol||5
7991832|NCT00127101|19678871|P4|STARTED|Base Protocol||3
7991833|NCT00127101|19678872|P3|STARTED|Base Protocol||3
7991834|NCT00127101|19678873|P2|STARTED|Base Protocol||5
7991835|NCT00127101|19678874|P1|STARTED|Base Protocol||3
7991836|NCT00127062|19678896|P2|NOT COMPLETED|Second intervention_Hyde Park||0
7991837|NCT00127062|19678897|P1|NOT COMPLETED|Second intervention_Hyde Park||0
7991838|NCT00127062|19678896|P2|COMPLETED|Second intervention_Hyde Park||29
7991839|NCT00127062|19678897|P1|COMPLETED|Second intervention_Hyde Park||31
7991840|NCT00127062|19678896|P2|STARTED|Second intervention_Hyde Park||29
7991841|NCT00127062|19678897|P1|STARTED|Second intervention_Hyde Park||31
7991842|NCT00127062|19678896|P2|NOT COMPLETED|First intervention_Oxford Street||0
7991843|NCT00127062|19678897|P1|NOT COMPLETED|First intervention_Oxford Street||0
7991844|NCT00127062|19678896|P2|COMPLETED|First intervention_Oxford Street||29
7991845|NCT00127062|19678897|P1|COMPLETED|First intervention_Oxford Street||31
7991846|NCT00127062|19678896|P2|STARTED|First intervention_Oxford Street||29
7991847|NCT00127062|19678897|P1|STARTED|First intervention_Oxford Street||31
7991848|NCT00127036|19678909|P2|NOT COMPLETED|Overall Study||11
7991849|NCT00127036|19678910|P1|NOT COMPLETED|Overall Study||8
7991850|NCT00127036|19678909|P2|COMPLETED|Overall Study|20 Participants were evaluable.|20
7991851|NCT00127036|19678910|P1|COMPLETED|Overall Study|26 Participants were evaluable.|26
7991852|NCT00127036|19678909|P2|STARTED|Overall Study||31
7991853|NCT00127036|19678910|P1|STARTED|Overall Study||34
7991854|NCT00126776|19678922|P2|NOT COMPLETED|Overall Study||0
7991855|NCT00126776|19678923|P1|NOT COMPLETED|Overall Study||0
7991856|NCT00126776|19678922|P2|COMPLETED|Overall Study||371
7991857|NCT00126776|19678923|P1|COMPLETED|Overall Study||372
7991858|NCT00126776|19678922|P2|STARTED|Overall Study||371
7991859|NCT00126776|19678923|P1|STARTED|Overall Study||372
7991860|NCT00126750|19678929|P2|NOT COMPLETED|Overall Study||266
7991861|NCT00126750|19678930|P1|NOT COMPLETED|Overall Study||180
7991862|NCT00126750|19678929|P2|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196
7991863|NCT00126750|19678930|P1|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205
7991864|NCT00126750|19678929|P2|STARTED|Overall Study|Number of providers from 84 clinics|462
7991865|NCT00126750|19678930|P1|STARTED|Overall Study|Number of providers from 84 clinics|385
7991866|NCT00126737|19678940|P4|NOT COMPLETED|Overall Study||7
7991867|NCT00126737|19678941|P3|NOT COMPLETED|Overall Study||6
7991868|NCT00126737|19678942|P2|NOT COMPLETED|Overall Study||3
7991869|NCT00126737|19678943|P1|NOT COMPLETED|Overall Study||6
7991870|NCT00126737|19678940|P4|COMPLETED|Overall Study||18
7991871|NCT00126737|19678941|P3|COMPLETED|Overall Study||24
7991872|NCT00126737|19678942|P2|COMPLETED|Overall Study||24
7991873|NCT00126737|19678943|P1|COMPLETED|Overall Study||22
7991874|NCT00126737|19678940|P4|STARTED|Overall Study||25
7991875|NCT00126737|19678941|P3|STARTED|Overall Study||30
7991876|NCT00126737|19678942|P2|STARTED|Overall Study||27
7991877|NCT00126737|19678943|P1|STARTED|Overall Study||28
7991878|NCT00126659|19678972|P3|NOT COMPLETED|Overall Study||2
7991879|NCT00126659|19678973|P2|NOT COMPLETED|Overall Study||0
7991880|NCT00126659|19678974|P1|NOT COMPLETED|Overall Study||0
7991881|NCT00126659|19678972|P3|COMPLETED|Overall Study||2
7991882|NCT00126659|19678973|P2|COMPLETED|Overall Study||3
7991883|NCT00126659|19678974|P1|COMPLETED|Overall Study||3
7991884|NCT00126659|19678972|P3|STARTED|Overall Study||4
7991885|NCT00126659|19678973|P2|STARTED|Overall Study||3
7991886|NCT00126659|19678974|P1|STARTED|Overall Study||3
7991887|NCT00126594|19678982|P2|NOT COMPLETED|Overall Study||37
7991888|NCT00126594|19678983|P1|NOT COMPLETED|Overall Study||39
7991889|NCT00126594|19678982|P2|COMPLETED|Overall Study||3
7991890|NCT00126594|19678983|P1|COMPLETED|Overall Study||1
7991891|NCT00126594|19678982|P2|STARTED|Overall Study||40
7991892|NCT00126594|19678983|P1|STARTED|Overall Study||40
7991893|NCT00126581|19679000|P2|NOT COMPLETED|Overall Study||20
7991894|NCT00126581|19679001|P1|NOT COMPLETED|Overall Study||13
7991895|NCT00126581|19679000|P2|COMPLETED|Overall Study||80
7991896|NCT00126581|19679001|P1|COMPLETED|Overall Study||68
7991897|NCT00126581|19679000|P2|STARTED|Overall Study||100
7991898|NCT00126581|19679001|P1|STARTED|Overall Study||81
7991899|NCT00126568|19679021|P1|NOT COMPLETED|Overall Study||2
7991900|NCT00126568|19679021|P1|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18
7991901|NCT00126568|19679021|P1|STARTED|Overall Study||20
7991902|NCT00126555|19679028|P1|NOT COMPLETED|Overall Study||6
7991903|NCT00126555|19679028|P1|COMPLETED|Overall Study||17
7991904|NCT00126555|19679028|P1|Stratum 2- Unresectable|Overall Study||4
7991905|NCT00126555|19679028|P1|Stratum 1- Resectable|Overall Study|1 participant did not participate|18
7991906|NCT00126555|19679028|P1|STARTED|Overall Study||23
7991907|NCT00126503|19679050|P2|NOT COMPLETED|Overall Study||21
7991908|NCT00126503|19679051|P1|NOT COMPLETED|Overall Study||47
7991909|NCT00126503|19679050|P2|COMPLETED|Overall Study||0
7991910|NCT00126503|19679051|P1|COMPLETED|Overall Study||1
7991911|NCT00126503|19679050|P2|STARTED|Overall Study||21
7991912|NCT00126503|19679051|P1|STARTED|Overall Study||48
7991913|NCT00126490|19679063|P1|NOT COMPLETED|Overall Study||1
7991914|NCT00126490|19679063|P1|COMPLETED|Overall Study||18
7991915|NCT00126490|19679063|P1|STARTED|Overall Study||19
7991916|NCT00126438|19679073|P2|NOT COMPLETED|Overall Study||10
7991917|NCT00126438|19679074|P1|NOT COMPLETED|Overall Study||34
7991918|NCT00126438|19679073|P2|COMPLETED|Overall Study||52
7991919|NCT00126438|19679074|P1|COMPLETED|Overall Study||419
7991920|NCT00126438|19679073|P2|STARTED|Overall Study||62
7991921|NCT00126438|19679074|P1|STARTED|Overall Study||453
7991922|NCT00126425|19679082|P2|NOT COMPLETED|Overall Study||11
7991923|NCT00126425|19679083|P1|NOT COMPLETED|Overall Study||41
7991924|NCT00126425|19679082|P2|COMPLETED|Overall Study||37
7991925|NCT00126425|19679083|P1|COMPLETED|Overall Study||498
7991926|NCT00126425|19679082|P2|STARTED|Overall Study||48
7991927|NCT00126425|19679083|P1|STARTED|Overall Study||539
7991928|NCT00126191|19679091|P2|NOT COMPLETED|Overall Study||2
7991929|NCT00126191|19679092|P1|NOT COMPLETED|Overall Study||0
7991930|NCT00126191|19679091|P2|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6
7991931|NCT00126191|19679092|P1|COMPLETED|Overall Study||2
7991932|NCT00126191|19679091|P2|STARTED|Overall Study||8
7991933|NCT00126191|19679092|P1|STARTED|Overall Study||2
7991934|NCT00126126|19679102|P2|NOT COMPLETED|Overall Study||2
7991935|NCT00126126|19679103|P1|NOT COMPLETED|Overall Study||0
7991936|NCT00126126|19679102|P2|COMPLETED|Overall Study||7
7991937|NCT00126126|19679103|P1|COMPLETED|Overall Study||9
7991938|NCT00126126|19679102|P2|STARTED|Overall Study||9
7991939|NCT00126126|19679103|P1|STARTED|Overall Study||9
7991940|NCT00126113|19679113|P2|NOT COMPLETED|Overall Study||2
7991941|NCT00126113|19679114|P1|NOT COMPLETED|Overall Study||3
7991942|NCT00126113|19679113|P2|COMPLETED|Overall Study||35
7991943|NCT00126113|19679114|P1|COMPLETED|Overall Study||34
7991944|NCT00126113|19679113|P2|STARTED|Overall Study||37
7991945|NCT00126113|19679114|P1|STARTED|Overall Study||37
7991946|NCT00125957|19679128|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
7991947|NCT00125957|19679129|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
7991948|NCT00125957|19679128|P2|COMPLETED|Second Intervention (3 Weeks)||17
7991949|NCT00125957|19679129|P1|COMPLETED|Second Intervention (3 Weeks)||15
7991950|NCT00125957|19679128|P2|STARTED|Second Intervention (3 Weeks)||17
7991951|NCT00125957|19679129|P1|STARTED|Second Intervention (3 Weeks)||15
7991952|NCT00125957|19679128|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
7991953|NCT00125957|19679129|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
7991954|NCT00125957|19679128|P2|COMPLETED|First Intervention (3 Weeks)||17
7991955|NCT00125957|19679129|P1|COMPLETED|First Intervention (3 Weeks)||15
7991956|NCT00125957|19679128|P2|STARTED|First Intervention (3 Weeks)||17
7991957|NCT00125957|19679129|P1|STARTED|First Intervention (3 Weeks)||15
7991958|NCT00125931|19679137|P1|NOT COMPLETED|Overall Study||0
7991959|NCT00125931|19679137|P1|COMPLETED|Overall Study||10
7991960|NCT00125931|19679137|P1|STARTED|Overall Study||10
7991961|NCT00125853|19679142|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
7991962|NCT00125853|19679143|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
7991963|NCT00125853|19679142|P2|COMPLETED|Second Intervention (8 Weeks)||20
7991964|NCT00125853|19679143|P1|COMPLETED|Second Intervention (8 Weeks)||24
7991965|NCT00125853|19679142|P2|STARTED|Second Intervention (8 Weeks)||20
7991966|NCT00125853|19679143|P1|STARTED|Second Intervention (8 Weeks)||24
7991967|NCT00125853|19679142|P2|NOT COMPLETED|Wash-out (4 Weeks)||7
7991968|NCT00125853|19679143|P1|NOT COMPLETED|Wash-out (4 Weeks)||3
7991969|NCT00125853|19679142|P2|COMPLETED|Wash-out (4 Weeks)||20
7991970|NCT00125853|19679143|P1|COMPLETED|Wash-out (4 Weeks)||24
7991971|NCT00125853|19679142|P2|STARTED|Wash-out (4 Weeks)||27
7991972|NCT00125853|19679143|P1|STARTED|Wash-out (4 Weeks)||27
7991973|NCT00125853|19679142|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
7991974|NCT00125853|19679143|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
7991975|NCT00125853|19679142|P2|COMPLETED|First Intervention (8 Weeks)||27
7991976|NCT00125853|19679143|P1|COMPLETED|First Intervention (8 Weeks)||27
7991977|NCT00125853|19679142|P2|STARTED|First Intervention (8 Weeks)||27
7991978|NCT00125853|19679143|P1|STARTED|First Intervention (8 Weeks)||27
7991979|NCT00125853|19679142|P2|NOT COMPLETED|Wash-out (4 Weeks)||0
7991980|NCT00125853|19679143|P1|NOT COMPLETED|Wash-out (4 Weeks)||0
7991981|NCT00125853|19679142|P2|COMPLETED|Wash-out (4 Weeks)||27
7991982|NCT00125853|19679143|P1|COMPLETED|Wash-out (4 Weeks)||27
7991983|NCT00125853|19679142|P2|STARTED|Wash-out (4 Weeks)||27
7991984|NCT00125853|19679143|P1|STARTED|Wash-out (4 Weeks)||27
7991985|NCT00125762|19679157|P1|NOT COMPLETED|Overall Study||159
7991986|NCT00125762|19679157|P1|COMPLETED|Overall Study||748
7991987|NCT00125762|19679157|P1|STARTED|Overall Study||907
7991988|NCT00125658|19679164|P2|NOT COMPLETED|Overall Study||0
7991989|NCT00125658|19679165|P1|NOT COMPLETED|Overall Study||0
7991990|NCT00125658|19679164|P2|COMPLETED|Overall Study||6
7991991|NCT00125658|19679165|P1|COMPLETED|Overall Study||8
7991992|NCT00125658|19679164|P2|STARTED|Overall Study||6
7991993|NCT00125658|19679165|P1|STARTED|Overall Study||8
7991994|NCT00125619|19679185|P2|NOT COMPLETED|Overall Study||0
7991995|NCT00125619|19679186|P1|NOT COMPLETED|Overall Study||0
7991996|NCT00125619|19679185|P2|COMPLETED|Overall Study||8
7991997|NCT00125619|19679186|P1|COMPLETED|Overall Study||8
7991998|NCT00125619|19679185|P2|STARTED|Overall Study||8
7991999|NCT00125619|19679186|P1|STARTED|Overall Study||8
7992000|NCT00125593|19679206|P2|NOT COMPLETED|Overall Study||103
7992001|NCT00125593|19679207|P1|NOT COMPLETED|Overall Study||101
7992002|NCT00125593|19679206|P2|COMPLETED|Overall Study||4517
7992003|NCT00125593|19679207|P1|COMPLETED|Overall Study||4549
7992004|NCT00125593|19679206|P2|STARTED|Overall Study||4620
7992005|NCT00125593|19679207|P1|STARTED|Overall Study||4650
7992006|NCT00125528|19679227|P2|NOT COMPLETED|Overall Study||1
7992007|NCT00125528|19679228|P1|NOT COMPLETED|Overall Study||2
7992008|NCT00125528|19679227|P2|COMPLETED|Overall Study||20
7992009|NCT00125528|19679228|P1|COMPLETED|Overall Study||18
7992010|NCT00125528|19679227|P2|STARTED|Overall Study||21
7992011|NCT00125528|19679228|P1|STARTED|Overall Study||20
7992012|NCT00125515|19679239|P3|NOT COMPLETED|Overall Study||21
7992013|NCT00125515|19679240|P2|NOT COMPLETED|Overall Study||20
7992014|NCT00125515|19679241|P1|NOT COMPLETED|Overall Study||20
7992015|NCT00125515|19679239|P3|COMPLETED|Overall Study||6
7992016|NCT00125515|19679240|P2|COMPLETED|Overall Study||7
7992017|NCT00125515|19679241|P1|COMPLETED|Overall Study||7
7992018|NCT00125515|19679239|P3|STARTED|Overall Study||27
7992019|NCT00125515|19679240|P2|STARTED|Overall Study||27
7992020|NCT00125515|19679241|P1|STARTED|Overall Study||27
7992021|NCT00125372|19679249|P1|NOT COMPLETED|Overall Study||2
7992022|NCT00125372|19679249|P1|COMPLETED|Overall Study||10
7992023|NCT00125372|19679249|P1|STARTED|Overall Study||12
7992024|NCT00125359|19679257|P1|NOT COMPLETED|Overall Study||23
7992025|NCT00125359|19679257|P1|COMPLETED|Overall Study||19
7992026|NCT00125359|19679257|P1|STARTED|Overall Study||42
7992027|NCT00125268|19679266|P2|NOT COMPLETED|Overall Study||1
7992028|NCT00125268|19679267|P1|NOT COMPLETED|Overall Study||1
7992029|NCT00125268|19679266|P2|COMPLETED|Overall Study||13
7992030|NCT00125268|19679267|P1|COMPLETED|Overall Study||15
7992031|NCT00125268|19679266|P2|STARTED|Overall Study||14
7992032|NCT00125268|19679267|P1|STARTED|Overall Study||16
7992033|NCT00125242|19679279|P2|NOT COMPLETED|Overall Study||2
7992034|NCT00125242|19679280|P1|NOT COMPLETED|Overall Study||7
7992035|NCT00125242|19679279|P2|COMPLETED|Overall Study||14
7992036|NCT00125242|19679280|P1|COMPLETED|Overall Study||87
7992037|NCT00125242|19679279|P2|STARTED|Overall Study||16
7992038|NCT00125242|19679280|P1|STARTED|Overall Study||94
7992039|NCT00125190|19679285|P1|NOT COMPLETED|Overall Study||15
7992040|NCT00125190|19679285|P1|COMPLETED|Overall Study||30
7992041|NCT00125190|19679285|P1|Completed 34 Weeks of Study|Overall Study||43
7992042|NCT00125190|19679285|P1|STARTED|Overall Study||45
7992043|NCT00125164|19679301|P4|NOT COMPLETED|Overall Study||6
7992044|NCT00125164|19679302|P3|NOT COMPLETED|Overall Study||4
7992045|NCT00125164|19679303|P2|NOT COMPLETED|Overall Study||0
7992046|NCT00125164|19679304|P1|NOT COMPLETED|Overall Study||2
7992047|NCT00125164|19679301|P4|COMPLETED|Overall Study||45
7992048|NCT00125164|19679302|P3|COMPLETED|Overall Study||40
7992049|NCT00125164|19679303|P2|COMPLETED|Overall Study||16
7992050|NCT00125164|19679304|P1|COMPLETED|Overall Study||23
7992051|NCT00125164|19679301|P4|STARTED|Overall Study||51
7992052|NCT00125164|19679302|P3|STARTED|Overall Study||44
7992053|NCT00125164|19679303|P2|STARTED|Overall Study||16
7992054|NCT00125164|19679304|P1|STARTED|Overall Study||25
7992055|NCT00125138|19679358|P4|NOT COMPLETED|Overall Study||5
7992056|NCT00125138|19679359|P3|NOT COMPLETED|Overall Study||4
7992057|NCT00125138|19679360|P2|NOT COMPLETED|Overall Study||3
7992058|NCT00125138|19679361|P1|NOT COMPLETED|Overall Study||3
7992059|NCT00125138|19679358|P4|COMPLETED|Overall Study||25
7992060|NCT00125138|19679359|P3|COMPLETED|Overall Study||21
7992061|NCT00125138|19679360|P2|COMPLETED|Overall Study||17
7992062|NCT00125138|19679361|P1|COMPLETED|Overall Study||12
7992063|NCT00125138|19679358|P4|STARTED|Overall Study||30
7992064|NCT00125138|19679359|P3|STARTED|Overall Study||25
7992065|NCT00125138|19679360|P2|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20
7992066|NCT00125138|19679361|P1|STARTED|Overall Study||15
7992067|NCT00125034|19679377|P2|NOT COMPLETED|Overall Study||0
7992068|NCT00125034|19679378|P1|NOT COMPLETED|Overall Study||0
7992069|NCT00125034|19679377|P2|COMPLETED|Overall Study||168
7992070|NCT00125034|19679378|P1|COMPLETED|Overall Study||170
7992071|NCT00125034|19679377|P2|STARTED|Overall Study|Randomized & treated|168
7992072|NCT00125034|19679378|P1|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170
7992073|NCT00124982|19679410|P3|NOT COMPLETED|Long-term Period||89
7992074|NCT00124982|19679411|P2|NOT COMPLETED|Long-term Period||0
7992075|NCT00124982|19679412|P1|NOT COMPLETED|Long-term Period||0
7992076|NCT00124982|19679410|P3|COMPLETED|Long-term Period||441
7992077|NCT00124982|19679411|P2|COMPLETED|Long-term Period||0
7992078|NCT00124982|19679412|P1|COMPLETED|Long-term Period||0
7992079|NCT00124982|19679410|P3|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530
7992080|NCT00124982|19679411|P2|STARTED|Long-term Period||0
7992081|NCT00124982|19679412|P1|STARTED|Long-term Period||0
7992082|NCT00124982|19679410|P3|NOT COMPLETED|Short-term Period||0
7992083|NCT00124982|19679411|P2|NOT COMPLETED|Short-term Period||114
7992084|NCT00124982|19679412|P1|NOT COMPLETED|Short-term Period||72
7992085|NCT00124982|19679410|P3|COMPLETED|Short-term Period||0
7992086|NCT00124982|19679411|P2|COMPLETED|Short-term Period||483
7992087|NCT00124982|19679412|P1|COMPLETED|Short-term Period||377
7992088|NCT00124982|19679410|P3|STARTED|Short-term Period||0
7992089|NCT00124982|19679411|P2|STARTED|Short-term Period||597
7992090|NCT00124982|19679412|P1|STARTED|Short-term Period||449
7992091|NCT00124943|19679494|P4|NOT COMPLETED|Phase II||5
7992092|NCT00124943|19679495|P3|NOT COMPLETED|Phase II||0
7992093|NCT00124943|19679496|P2|NOT COMPLETED|Phase II||2
7992094|NCT00124943|19679497|P1|NOT COMPLETED|Phase II||0
7992095|NCT00124943|19679494|P4|COMPLETED|Phase II||50
7992096|NCT00124943|19679495|P3|COMPLETED|Phase II||3
7992097|NCT00124943|19679496|P2|COMPLETED|Phase II||49
7992098|NCT00124943|19679497|P1|COMPLETED|Phase II||3
7992099|NCT00124943|19679494|P4|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55
7992100|NCT00124943|19679495|P3|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
7992101|NCT00124943|19679496|P2|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51
7992102|NCT00124943|19679497|P1|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
7992103|NCT00124943|19679494|P4|NOT COMPLETED|Phase I||0
7992104|NCT00124943|19679495|P3|NOT COMPLETED|Phase I||0
7992105|NCT00124943|19679496|P2|NOT COMPLETED|Phase I||0
7992106|NCT00124943|19679497|P1|NOT COMPLETED|Phase I||0
7992107|NCT00124943|19679494|P4|COMPLETED|Phase I||3
7992108|NCT00124943|19679495|P3|COMPLETED|Phase I||3
7992109|NCT00124943|19679496|P2|COMPLETED|Phase I||3
7992110|NCT00124943|19679497|P1|COMPLETED|Phase I||3
7992111|NCT00124943|19679494|P4|STARTED|Phase I||3
7992112|NCT00124943|19679495|P3|STARTED|Phase I||3
7992113|NCT00124943|19679496|P2|STARTED|Phase I||3
7992114|NCT00124943|19679497|P1|STARTED|Phase I||3
7992115|NCT00124917|19679535|P1|NOT COMPLETED|Overall Study||3
7992116|NCT00124917|19679535|P1|COMPLETED|Overall Study||3
7992117|NCT00124917|19679535|P1|STARTED|Overall Study||6
7992118|NCT00124748|19679545|P2|NOT COMPLETED|Overall Study||284
7992119|NCT00124748|19679546|P1|NOT COMPLETED|Overall Study||143
7992120|NCT00124748|19679545|P2|COMPLETED|Overall Study||35
7992121|NCT00124748|19679546|P1|COMPLETED|Overall Study||14
7992122|NCT00124748|19679545|P2|Safety Population|Overall Study||316
7992123|NCT00124748|19679546|P1|Safety Population|Overall Study||157
7992124|NCT00124748|19679545|P2|STARTED|Overall Study||319
7992125|NCT00124748|19679546|P1|STARTED|Overall Study||157
7992126|NCT00124735|19679598|P10|NOT COMPLETED|Overall Study||2
7992127|NCT00124735|19679599|P9|NOT COMPLETED|Overall Study||3
7992128|NCT00124735|19679600|P8|NOT COMPLETED|Overall Study||1
7992129|NCT00124735|19679601|P7|NOT COMPLETED|Overall Study||0
7992130|NCT00124735|19679602|P6|NOT COMPLETED|Overall Study||2
7992131|NCT00124735|19679603|P5|NOT COMPLETED|Overall Study||2
7992132|NCT00124735|19679604|P4|NOT COMPLETED|Overall Study||3
7992133|NCT00124735|19679605|P3|NOT COMPLETED|Overall Study||0
7992134|NCT00124735|19679606|P2|NOT COMPLETED|Overall Study||2
7992135|NCT00124735|19679607|P1|NOT COMPLETED|Overall Study||1
7992136|NCT00124735|19679598|P10|COMPLETED|Overall Study||18
7992137|NCT00124735|19679599|P9|COMPLETED|Overall Study||22
7992138|NCT00124735|19679600|P8|COMPLETED|Overall Study||19
7992139|NCT00124735|19679601|P7|COMPLETED|Overall Study||6
7992140|NCT00124735|19679602|P6|COMPLETED|Overall Study||5
7992141|NCT00124735|19679603|P5|COMPLETED|Overall Study||17
7992142|NCT00124735|19679604|P4|COMPLETED|Overall Study||18
7992143|NCT00124735|19679605|P3|COMPLETED|Overall Study||18
7992144|NCT00124735|19679606|P2|COMPLETED|Overall Study||6
7992145|NCT00124735|19679607|P1|COMPLETED|Overall Study||4
7992146|NCT00124735|19679598|P10|STARTED|Overall Study||20
7992147|NCT00124735|19679599|P9|STARTED|Overall Study||25
7992148|NCT00124735|19679600|P8|STARTED|Overall Study||20
7992149|NCT00124735|19679601|P7|STARTED|Overall Study||6
7992150|NCT00124735|19679602|P6|STARTED|Overall Study||7
7992151|NCT00124735|19679603|P5|STARTED|Overall Study||19
7992152|NCT00124735|19679604|P4|STARTED|Overall Study||21
7992153|NCT00124735|19679605|P3|STARTED|Overall Study||18
7992154|NCT00124735|19679606|P2|STARTED|Overall Study||8
7992155|NCT00124735|19679607|P1|STARTED|Overall Study||5
7992156|NCT00124709|19679653|P2|NOT COMPLETED|Overall Study||272
7992157|NCT00124709|19679654|P1|NOT COMPLETED|Overall Study||255
7992158|NCT00124709|19679653|P2|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273
7992159|NCT00124709|19679654|P1|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291
7992160|NCT00124709|19679653|P2|Patients Who Received Study Medication|Overall Study||544
7992161|NCT00124709|19679654|P1|Patients Who Received Study Medication|Overall Study||543
7992162|NCT00124709|19679653|P2|STARTED|Overall Study||545
7992163|NCT00124709|19679654|P1|STARTED|Overall Study||546
7992164|NCT00124657|19679671|P3|NOT COMPLETED|Overall Study||32
7992165|NCT00124657|19679672|P2|NOT COMPLETED|Overall Study||5
7992166|NCT00124657|19679673|P1|NOT COMPLETED|Overall Study||16
7992167|NCT00124657|19679671|P3|COMPLETED|Overall Study||7
7992168|NCT00124657|19679672|P2|COMPLETED|Overall Study||0
7992169|NCT00124657|19679673|P1|COMPLETED|Overall Study||2
7992170|NCT00124657|19679671|P3|STARTED|Overall Study||39
7992171|NCT00124657|19679672|P2|STARTED|Overall Study||5
7992172|NCT00124657|19679673|P1|STARTED|Overall Study||18
7992173|NCT00124618|19679708|P1|NOT COMPLETED|Overall Study||1
7992174|NCT00124618|19679708|P1|COMPLETED|Overall Study||57
7992175|NCT00124618|19679708|P1|STARTED|Overall Study||58
7992176|NCT00124579|19679715|P1|NOT COMPLETED|Maintenance||2
7992177|NCT00124579|19679715|P1|COMPLETED|Maintenance||0
7992178|NCT00124579|19679715|P1|STARTED|Maintenance||2
7992179|NCT00124579|19679715|P1|NOT COMPLETED|Induction||5
7992180|NCT00124579|19679715|P1|COMPLETED|Induction||2
7992181|NCT00124579|19679715|P1|STARTED|Induction||7
7992182|NCT00124462|19679723|P2|NOT COMPLETED|Overall Study||13
7992183|NCT00124462|19679724|P1|NOT COMPLETED|Overall Study||11
7992184|NCT00124462|19679723|P2|COMPLETED|Overall Study||27
7992185|NCT00124462|19679724|P1|COMPLETED|Overall Study||29
7992186|NCT00124462|19679723|P2|STARTED|Overall Study||40
7992187|NCT00124462|19679724|P1|STARTED|Overall Study||40
7992188|NCT00124449|19679734|P2|NOT COMPLETED|18-Month Untreated Observation Period||13
7992189|NCT00124449|19679735|P1|NOT COMPLETED|18-Month Untreated Observation Period||15
7992190|NCT00124449|19679734|P2|COMPLETED|18-Month Untreated Observation Period||4
7992191|NCT00124449|19679735|P1|COMPLETED|18-Month Untreated Observation Period||7
7992192|NCT00124449|19679734|P2|Completed Year 1 of Study|18-Month Untreated Observation Period||9
7992193|NCT00124449|19679735|P1|Completed Year 1 of Study|18-Month Untreated Observation Period||14
7992194|NCT00124449|19679734|P2|STARTED|18-Month Untreated Observation Period||17
7992195|NCT00124449|19679735|P1|STARTED|18-Month Untreated Observation Period||22
7992196|NCT00124449|19679734|P2|NOT COMPLETED|6-month Double-Blind Treatment Period||11
7992197|NCT00124449|19679735|P1|NOT COMPLETED|6-month Double-Blind Treatment Period||6
7992198|NCT00124449|19679734|P2|COMPLETED|6-month Double-Blind Treatment Period||17
7992199|NCT00124449|19679735|P1|COMPLETED|6-month Double-Blind Treatment Period||22
7992200|NCT00124449|19679734|P2|STARTED|6-month Double-Blind Treatment Period||28
7992201|NCT00124449|19679735|P1|STARTED|6-month Double-Blind Treatment Period||28
7992202|NCT00124176|19679770|P2|NOT COMPLETED|Overall Study||0
7992203|NCT00124176|19679771|P1|NOT COMPLETED|Overall Study||0
7992204|NCT00124176|19679770|P2|COMPLETED|Overall Study||41
7992205|NCT00124176|19679771|P1|COMPLETED|Overall Study||40
7992206|NCT00124176|19679770|P2|Received Study Drug|Overall Study||41
7992207|NCT00124176|19679771|P1|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37
7992208|NCT00124176|19679770|P2|STARTED|Overall Study||41
7992209|NCT00124176|19679771|P1|STARTED|Overall Study||40
7992210|NCT00124072|19679789|P4|NOT COMPLETED|Overall Study||500
7992211|NCT00124072|19679790|P3|NOT COMPLETED|Overall Study||492
7992212|NCT00124072|19679791|P2|NOT COMPLETED|Overall Study||512
7992213|NCT00124072|19679792|P1|NOT COMPLETED|Overall Study||514
7992214|NCT00124072|19679789|P4|COMPLETED|Overall Study||2515
7992215|NCT00124072|19679790|P3|COMPLETED|Overall Study||2524
7992216|NCT00124072|19679791|P2|COMPLETED|Overall Study||2504
7992217|NCT00124072|19679792|P1|COMPLETED|Overall Study||2503
7992218|NCT00124072|19679789|P4|STARTED|Overall Study||3015
7992219|NCT00124072|19679790|P3|STARTED|Overall Study||3016
7992220|NCT00124072|19679791|P2|STARTED|Overall Study||3016
7992221|NCT00124072|19679792|P1|STARTED|Overall Study||3017
7992222|NCT00124020|19679804|P2|NOT COMPLETED|Overall Study||91
7992223|NCT00124020|19679805|P1|NOT COMPLETED|Overall Study||88
7992224|NCT00124020|19679804|P2|COMPLETED|Overall Study||289
7992225|NCT00124020|19679805|P1|COMPLETED|Overall Study||289
7992226|NCT00124020|19679804|P2|STARTED|Overall Study||380
7992227|NCT00124020|19679805|P1|STARTED|Overall Study||377
7992228|NCT00123955|19679813|P2|NOT COMPLETED|Overall Study||4
7992229|NCT00123955|19679814|P1|NOT COMPLETED|Overall Study||5
7992230|NCT00123955|19679813|P2|COMPLETED|Overall Study||34
7992231|NCT00123955|19679814|P1|COMPLETED|Overall Study||37
7992232|NCT00123955|19679813|P2|STARTED|Overall Study||38
7992233|NCT00123955|19679814|P1|STARTED|Overall Study||42
7992234|NCT00123734|19679826|P1|NOT COMPLETED|Overall Study||8
7992235|NCT00123734|19679826|P1|COMPLETED|Overall Study||74
7992236|NCT00123734|19679826|P1|STARTED|Overall Study||82
7992237|NCT00123682|19679861|P4|NOT COMPLETED|Overall Study||95
7992238|NCT00123682|19679862|P3|NOT COMPLETED|Overall Study||154
7992239|NCT00123682|19679863|P2|NOT COMPLETED|Overall Study||203
7992240|NCT00123682|19679864|P1|NOT COMPLETED|Overall Study||320
7992241|NCT00123682|19679861|P4|COMPLETED|Overall Study||430
7992242|NCT00123682|19679862|P3|COMPLETED|Overall Study||438
7992243|NCT00123682|19679863|P2|COMPLETED|Overall Study||731
7992244|NCT00123682|19679864|P1|COMPLETED|Overall Study||749
7992245|NCT00123682|19679861|P4|STARTED|Overall Study||525
7992246|NCT00123682|19679862|P3|STARTED|Overall Study||592
7992247|NCT00123682|19679863|P2|STARTED|Overall Study||934
7992248|NCT00123682|19679864|P1|STARTED|Overall Study||1069
7992249|NCT00123643|19679884|P2|NOT COMPLETED|Overall Study||0
7992250|NCT00123643|19679885|P1|NOT COMPLETED|Overall Study||0
7992251|NCT00123643|19679884|P2|COMPLETED|Overall Study||16
7992252|NCT00123643|19679885|P1|COMPLETED|Overall Study||20
7992253|NCT00123643|19679884|P2|STARTED|Overall Study||16
7992254|NCT00123643|19679885|P1|STARTED|Overall Study||20
7992255|NCT00123630|19679893|P2|NOT COMPLETED|Overall Study||0
7992256|NCT00123630|19679894|P1|NOT COMPLETED|Overall Study||0
7992257|NCT00123630|19679893|P2|COMPLETED|Overall Study||15
7992258|NCT00123630|19679894|P1|COMPLETED|Overall Study||15
7992259|NCT00123630|19679893|P2|STARTED|Overall Study||15
7992260|NCT00123630|19679894|P1|STARTED|Overall Study||15
7992261|NCT00123604|19679902|P2|NOT COMPLETED|Overall Study||1
7992262|NCT00123604|19679903|P1|NOT COMPLETED|Overall Study||1
7992263|NCT00123604|19679902|P2|COMPLETED|Overall Study||16
7992264|NCT00123604|19679903|P1|COMPLETED|Overall Study||18
7992265|NCT00123604|19679902|P2|STARTED|Overall Study||17
7992266|NCT00123604|19679903|P1|STARTED|Overall Study||19
7992267|NCT00123487|19679911|P2|NOT COMPLETED|Treated With Study Drug||305
7992268|NCT00123487|19679912|P1|NOT COMPLETED|Treated With Study Drug||304
7992269|NCT00123487|19679911|P2|COMPLETED|Treated With Study Drug||0
7992270|NCT00123487|19679912|P1|COMPLETED|Treated With Study Drug||0
7992271|NCT00123487|19679911|P2|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305
7992272|NCT00123487|19679912|P1|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304
7992273|NCT00123487|19679911|P2|NOT COMPLETED|Randomized||1
7992274|NCT00123487|19679912|P1|NOT COMPLETED|Randomized||1
7992275|NCT00123487|19679911|P2|COMPLETED|Randomized||304
7992276|NCT00123487|19679912|P1|COMPLETED|Randomized||305
7992277|NCT00123487|19679911|P2|STARTED|Randomized||305
7992278|NCT00123487|19679912|P1|STARTED|Randomized||306
7992279|NCT00123474|19679956|P4|NOT COMPLETED|As Treated at Study Closure||167
7992280|NCT00123474|19679957|P3|NOT COMPLETED|As Treated at Study Closure||167
7992281|NCT00123474|19679958|P2|NOT COMPLETED|As Treated at Study Closure||163
7992282|NCT00123474|19679959|P1|NOT COMPLETED|As Treated at Study Closure||165
7992283|NCT00123474|19679956|P4|COMPLETED|As Treated at Study Closure||0
7992284|NCT00123474|19679957|P3|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0
7992285|NCT00123474|19679958|P2|COMPLETED|As Treated at Study Closure||0
7992286|NCT00123474|19679959|P1|COMPLETED|As Treated at Study Closure||0
7992287|NCT00123474|19679956|P4|STARTED|As Treated at Study Closure||167
7992288|NCT00123474|19679957|P3|STARTED|As Treated at Study Closure||167
7992289|NCT00123474|19679958|P2|STARTED|As Treated at Study Closure||163
7992290|NCT00123474|19679959|P1|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165
7992291|NCT00123474|19679956|P4|NOT COMPLETED|Randomized to Treatment||1
7992292|NCT00123474|19679957|P3|NOT COMPLETED|Randomized to Treatment||2
7992293|NCT00123474|19679958|P2|NOT COMPLETED|Randomized to Treatment||4
7992294|NCT00123474|19679959|P1|NOT COMPLETED|Randomized to Treatment||1
7992295|NCT00123474|19679956|P4|COMPLETED|Randomized to Treatment||167
7992296|NCT00123474|19679957|P3|COMPLETED|Randomized to Treatment||166
7992297|NCT00123474|19679958|P2|COMPLETED|Randomized to Treatment||163
7992298|NCT00123474|19679959|P1|COMPLETED|Randomized to Treatment||166
7992299|NCT00123474|19679956|P4|STARTED|Randomized to Treatment||168
7992300|NCT00123474|19679957|P3|STARTED|Randomized to Treatment||168
7992301|NCT00123474|19679958|P2|STARTED|Randomized to Treatment||167
7992302|NCT00123474|19679959|P1|STARTED|Randomized to Treatment||167
7992303|NCT00123422|19680053|P3|NOT COMPLETED|Overall Study||10
7992304|NCT00123422|19680054|P2|NOT COMPLETED|Overall Study||6
7992305|NCT00123422|19680055|P1|NOT COMPLETED|Overall Study||4
7992306|NCT00123422|19680053|P3|COMPLETED|Overall Study||25
7992307|NCT00123422|19680054|P2|COMPLETED|Overall Study||27
7992308|NCT00123422|19680055|P1|COMPLETED|Overall Study||31
7992309|NCT00123422|19680053|P3|8-week Testing|Overall Study||27
7992310|NCT00123422|19680054|P2|8-week Testing|Overall Study||30
7992311|NCT00123422|19680055|P1|8-week Testing|Overall Study||32
7992312|NCT00123422|19680053|P3|STARTED|Overall Study||35
7992313|NCT00123422|19680054|P2|STARTED|Overall Study||33
7992314|NCT00123422|19680055|P1|STARTED|Overall Study||35
7992315|NCT00123409|19680068|P2|NOT COMPLETED|Overall Study||3
7992316|NCT00123409|19680069|P1|NOT COMPLETED|Overall Study||4
7992317|NCT00123409|19680068|P2|COMPLETED|Overall Study||71
7992318|NCT00123409|19680069|P1|COMPLETED|Overall Study||68
7992319|NCT00123409|19680068|P2|STARTED|Overall Study||74
7992320|NCT00123409|19680069|P1|STARTED|Overall Study||72
7992321|NCT00123162|19680079|P2|NOT COMPLETED|Overall Study||0
7992322|NCT00123162|19680080|P1|NOT COMPLETED|Overall Study||0
7992323|NCT00123162|19680079|P2|COMPLETED|Overall Study||12
7992324|NCT00123162|19680080|P1|COMPLETED|Overall Study||13
7992325|NCT00123162|19680079|P2|STARTED|Overall Study||12
7992326|NCT00123162|19680080|P1|STARTED|Overall Study||13
7992327|NCT00123123|19680091|P3|NOT COMPLETED|Overall Study||0
7992328|NCT00123123|19680092|P2|NOT COMPLETED|Overall Study||0
7992329|NCT00123123|19680093|P1|NOT COMPLETED|Overall Study||0
7992330|NCT00123123|19680091|P3|COMPLETED|Overall Study||58
7992331|NCT00123123|19680092|P2|COMPLETED|Overall Study||58
7992332|NCT00123123|19680093|P1|COMPLETED|Overall Study||59
7992333|NCT00123123|19680091|P3|STARTED|Overall Study||58
7992334|NCT00123123|19680092|P2|STARTED|Overall Study||58
7992335|NCT00123123|19680093|P1|STARTED|Overall Study||59
7992336|NCT00123110|19680107|P3|NOT COMPLETED|Overall Study||0
7992337|NCT00123110|19680108|P2|NOT COMPLETED|Overall Study||0
7992338|NCT00123110|19680109|P1|NOT COMPLETED|Overall Study||0
7992339|NCT00123110|19680107|P3|COMPLETED|Overall Study||11
7992340|NCT00123110|19680108|P2|COMPLETED|Overall Study||12
7992341|NCT00123110|19680109|P1|COMPLETED|Overall Study||12
7992342|NCT00123110|19680107|P3|STARTED|Overall Study||11
7992343|NCT00123110|19680108|P2|STARTED|Overall Study||12
7992344|NCT00123110|19680109|P1|STARTED|Overall Study||12
7992345|NCT00122980|19680143|P2|NOT COMPLETED|Overall Study||40
7992346|NCT00122980|19680144|P1|NOT COMPLETED|Overall Study||43
7992347|NCT00122980|19680143|P2|COMPLETED|Overall Study|Study terminated early|26
7992348|NCT00122980|19680144|P1|COMPLETED|Overall Study|Study terminated early|24
7992349|NCT00122980|19680143|P2|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66
7992350|NCT00122980|19680144|P1|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67
7992351|NCT00122954|19680168|P2|NOT COMPLETED|Overall Study||3
7992352|NCT00122954|19680169|P1|NOT COMPLETED|Overall Study||2
7992353|NCT00122954|19680168|P2|COMPLETED|Overall Study||18
7992354|NCT00122954|19680169|P1|COMPLETED|Overall Study||16
7992355|NCT00122954|19680168|P2|STARTED|Overall Study||21
7992356|NCT00122954|19680169|P1|STARTED|Overall Study||18
7992357|NCT00122681|19680179|P2|NOT COMPLETED|Overall Study||1521
7992358|NCT00122681|19680180|P1|NOT COMPLETED|Overall Study||1514
7992359|NCT00122681|19680179|P2|COMPLETED|Overall Study||7798
7992360|NCT00122681|19680180|P1|COMPLETED|Overall Study||7811
7992361|NCT00122681|19680179|P2|STARTED|Overall Study||9319
7992362|NCT00122681|19680180|P1|STARTED|Overall Study||9325
7992363|NCT00122460|19680254|P2|NOT COMPLETED|Overall Study||1
7992364|NCT00122460|19680255|P1|NOT COMPLETED|Overall Study||7
7992365|NCT00122460|19680254|P2|COMPLETED|Overall Study||219
7992366|NCT00122460|19680255|P1|COMPLETED|Overall Study||215
7992367|NCT00122460|19680254|P2|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220
7992368|NCT00122460|19680255|P1|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222
7992369|NCT00122447|19680281|P4|NOT COMPLETED|Overall Study||3
7992370|NCT00122447|19680282|P3|NOT COMPLETED|Overall Study||1
7992371|NCT00122447|19680283|P2|NOT COMPLETED|Overall Study||5
7992372|NCT00122447|19680284|P1|NOT COMPLETED|Overall Study||1
7992373|NCT00122447|19680281|P4|COMPLETED|Overall Study||14
7992374|NCT00122447|19680282|P3|COMPLETED|Overall Study||16
7992375|NCT00122447|19680283|P2|COMPLETED|Overall Study||13
7992376|NCT00122447|19680284|P1|COMPLETED|Overall Study||17
7992377|NCT00122447|19680281|P4|STARTED|Overall Study||17
7992378|NCT00122447|19680282|P3|STARTED|Overall Study||17
7992379|NCT00122447|19680283|P2|STARTED|Overall Study||18
7992380|NCT00122447|19680284|P1|STARTED|Overall Study||18
7992381|NCT00122382|19680304|P3|NOT COMPLETED|Open-Label Study||26
7992382|NCT00122382|19680305|P2|NOT COMPLETED|Open-Label Study||0
7992383|NCT00122382|19680306|P1|NOT COMPLETED|Open-Label Study||0
7992384|NCT00122382|19680304|P3|COMPLETED|Open-Label Study||433
7992385|NCT00122382|19680305|P2|COMPLETED|Open-Label Study||0
7992386|NCT00122382|19680306|P1|COMPLETED|Open-Label Study||0
7992387|NCT00122382|19680304|P3|STARTED|Open-Label Study||459
7992388|NCT00122382|19680305|P2|STARTED|Open-Label Study||0
7992389|NCT00122382|19680306|P1|STARTED|Open-Label Study||0
7992390|NCT00122382|19680304|P3|NOT COMPLETED|Double-Blind Study||0
7992391|NCT00122382|19680305|P2|NOT COMPLETED|Double-Blind Study||28
7992392|NCT00122382|19680306|P1|NOT COMPLETED|Double-Blind Study||24
7992393|NCT00122382|19680304|P3|COMPLETED|Double-Blind Study||0
7992394|NCT00122382|19680305|P2|COMPLETED|Double-Blind Study||227
7992395|NCT00122382|19680306|P1|COMPLETED|Double-Blind Study||232
7992396|NCT00122382|19680304|P3|Treated|Double-Blind Study||0
7992397|NCT00122382|19680305|P2|Treated|Double-Blind Study||253
7992398|NCT00122382|19680306|P1|Treated|Double-Blind Study||256
7992399|NCT00122382|19680304|P3|STARTED|Double-Blind Study||0
7992400|NCT00122382|19680305|P2|STARTED|Double-Blind Study|participants randomized|255
7992401|NCT00122382|19680306|P1|STARTED|Double-Blind Study|participants randomized|256
7992402|NCT00122369|19680359|P3|NOT COMPLETED|Overall Study||0
7992403|NCT00122369|19680360|P2|NOT COMPLETED|Overall Study||0
7992404|NCT00122369|19680361|P1|NOT COMPLETED|Overall Study||0
7992405|NCT00122369|19680359|P3|COMPLETED|Overall Study||78
7992406|NCT00122369|19680360|P2|COMPLETED|Overall Study||82
7992407|NCT00122369|19680361|P1|COMPLETED|Overall Study||76
7992408|NCT00122369|19680359|P3|STARTED|Overall Study||78
7992409|NCT00122369|19680360|P2|STARTED|Overall Study||82
7992410|NCT00122369|19680361|P1|STARTED|Overall Study||76
7992411|NCT00122317|19680450|P1|NOT COMPLETED|Overall Study||11
7992412|NCT00122317|19680450|P1|COMPLETED|Overall Study||176
7992413|NCT00122317|19680450|P1|STARTED|Overall Study||187
7992414|NCT00122278|19680459|P2|NOT COMPLETED|Overall Study||0
7992415|NCT00122278|19680460|P1|NOT COMPLETED|Overall Study||2
7992416|NCT00122278|19680459|P2|COMPLETED|Overall Study||99
7992417|NCT00122278|19680460|P1|COMPLETED|Overall Study||104
7992418|NCT00122278|19680459|P2|STARTED|Overall Study||99
7992419|NCT00122278|19680460|P1|STARTED|Overall Study||106
7992420|NCT00122187|19680470|P2|NOT COMPLETED|Overall Study||2
7992421|NCT00122187|19680471|P1|NOT COMPLETED|Overall Study||2
7992422|NCT00122187|19680470|P2|COMPLETED|Overall Study||2
7992423|NCT00122187|19680471|P1|COMPLETED|Overall Study||2
7992424|NCT00122187|19680470|P2|Post-intervention Data Collection|Overall Study||2
7992425|NCT00122187|19680471|P1|Post-intervention Data Collection|Overall Study||2
7992426|NCT00122187|19680470|P2|Intervention Implemented|Overall Study||4
7992427|NCT00122187|19680471|P1|Intervention Implemented|Overall Study||3
7992428|NCT00122187|19680470|P2|Randomized to Intervention or Usual Care|Overall Study||4
7992429|NCT00122187|19680471|P1|Randomized to Intervention or Usual Care|Overall Study||4
7992430|NCT00122187|19680470|P2|Matched by Colonoscopy Volume|Overall Study||4
7992431|NCT00122187|19680471|P1|Matched by Colonoscopy Volume|Overall Study||4
7992432|NCT00122187|19680470|P2|STARTED|Overall Study||4
7992433|NCT00122187|19680471|P1|STARTED|Overall Study||4
7992434|NCT00122135|19680485|P2|NOT COMPLETED|Overall Study||0
7992435|NCT00122135|19680486|P1|NOT COMPLETED|Overall Study||3
7992436|NCT00122135|19680485|P2|COMPLETED|Overall Study||60
7992437|NCT00122135|19680486|P1|COMPLETED|Overall Study||57
7992438|NCT00122135|19680485|P2|STARTED|Overall Study||60
7992439|NCT00122135|19680486|P1|STARTED|Overall Study||60
7992440|NCT00122109|19680494|P2|NOT COMPLETED|Overall Study||7
7992441|NCT00122109|19680495|P1|NOT COMPLETED|Overall Study||6
7992442|NCT00122109|19680494|P2|COMPLETED|Overall Study||57
7992443|NCT00122109|19680495|P1|COMPLETED|Overall Study||55
7992444|NCT00122109|19680494|P2|STARTED|Overall Study|ITT|64
7992445|NCT00122109|19680495|P1|STARTED|Overall Study|ITT|61
7992446|NCT00121992|19680521|P2|NOT COMPLETED|Overall Study||11
7992447|NCT00121992|19680522|P1|NOT COMPLETED|Overall Study||2
7992448|NCT00121992|19680521|P2|COMPLETED|Overall Study||528
7992449|NCT00121992|19680522|P1|COMPLETED|Overall Study||519
7992450|NCT00121992|19680521|P2|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||103
7992451|NCT00121992|19680522|P1|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||92
7992452|NCT00121992|19680521|P2|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||220
7992453|NCT00121992|19680522|P1|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||209
7992454|NCT00121992|19680521|P2|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||22
7992455|NCT00121992|19680522|P1|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||24
7992456|NCT00121992|19680521|P2|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||30
7992457|NCT00121992|19680522|P1|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||28
7992458|NCT00121992|19680521|P2|STARTED|Overall Study||539
7992459|NCT00121992|19680522|P1|STARTED|Overall Study||521
7992460|NCT00121836|19680542|P1|NOT COMPLETED|Overall Study||55
7992461|NCT00121836|19680542|P1|COMPLETED|Overall Study||54
7992462|NCT00121836|19680542|P1|STARTED|Overall Study||109
7992463|NCT00121810|19680553|P2|NOT COMPLETED|Overall Study||39
7992464|NCT00121810|19680554|P1|NOT COMPLETED|Overall Study||30
7992465|NCT00121810|19680553|P2|COMPLETED|Overall Study||115
7992466|NCT00121810|19680554|P1|COMPLETED|Overall Study||121
7992467|NCT00121810|19680553|P2|Intent-to-Treat (ITT) Population|Overall Study||151
7992468|NCT00121810|19680554|P1|Intent-to-Treat (ITT) Population|Overall Study||148
7992469|NCT00121810|19680553|P2|Safety Population|Overall Study||153
7992470|NCT00121810|19680554|P1|Safety Population|Overall Study||148
7992471|NCT00121810|19680553|P2|STARTED|Overall Study||154
7992472|NCT00121810|19680554|P1|STARTED|Overall Study||151
7992473|NCT00121719|19680580|P14|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992474|NCT00121719|19680581|P13|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992475|NCT00121719|19680582|P12|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992476|NCT00121719|19680583|P11|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992477|NCT00121719|19680584|P10|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992478|NCT00121719|19680585|P9|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992479|NCT00121719|19680586|P8|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992480|NCT00121719|19680587|P7|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992481|NCT00121719|19680588|P6|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992482|NCT00121719|19680589|P5|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992483|NCT00121719|19680590|P4|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992484|NCT00121719|19680591|P3|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992485|NCT00121719|19680592|P2|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992486|NCT00121719|19680593|P1|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992487|NCT00121719|19680580|P14|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992488|NCT00121719|19680581|P13|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992489|NCT00121719|19680582|P12|COMPLETED|Food-Effect Pilot Study (4 Weeks)||5
7992490|NCT00121719|19680583|P11|COMPLETED|Food-Effect Pilot Study (4 Weeks)||6
7992491|NCT00121719|19680584|P10|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992492|NCT00121719|19680585|P9|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992493|NCT00121719|19680586|P8|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992494|NCT00121719|19680587|P7|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992495|NCT00121719|19680588|P6|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992496|NCT00121719|19680589|P5|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992497|NCT00121719|19680590|P4|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992498|NCT00121719|19680591|P3|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992499|NCT00121719|19680592|P2|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992500|NCT00121719|19680593|P1|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
7992501|NCT00121719|19680580|P14|STARTED|Food-Effect Pilot Study (4 Weeks)||0
7992502|NCT00121719|19680581|P13|STARTED|Food-Effect Pilot Study (4 Weeks)||0
7992503|NCT00121719|19680582|P12|STARTED|Food-Effect Pilot Study (4 Weeks)||5
7992504|NCT00121719|19680583|P11|STARTED|Food-Effect Pilot Study (4 Weeks)||6
7992505|NCT00121719|19680584|P10|STARTED|Food-Effect Pilot Study (4 Weeks)||0
7992506|NCT00121719|19680585|P9|STARTED|Food-Effect Pilot Study (4 Weeks)||0
7992507|NCT00121719|19680586|P8|STARTED|Food-Effect Pilot Study (4 Weeks)||0
7992508|NCT00121719|19680587|P7|STARTED|Food-Effect Pilot Study (4 Weeks)||0
7992509|NCT00121719|19680588|P6|STARTED|Food-Effect Pilot Study (4 Weeks)||0
7992510|NCT00121719|19680589|P5|STARTED|Food-Effect Pilot Study (4 Weeks)||0
7992511|NCT00121719|19680590|P4|STARTED|Food-Effect Pilot Study (4 Weeks)||0
7992512|NCT00121719|19680591|P3|STARTED|Food-Effect Pilot Study (4 Weeks)||0
7992513|NCT00121719|19680592|P2|STARTED|Food-Effect Pilot Study (4 Weeks)||0
7992514|NCT00121719|19680593|P1|STARTED|Food-Effect Pilot Study (4 Weeks)||0
7992515|NCT00121719|19680580|P14|NOT COMPLETED|Dose Escalation (4 Weeks)||0
7992516|NCT00121719|19680581|P13|NOT COMPLETED|Dose Escalation (4 Weeks)||0
7992517|NCT00121719|19680582|P12|NOT COMPLETED|Dose Escalation (4 Weeks)||0
7992518|NCT00121719|19680583|P11|NOT COMPLETED|Dose Escalation (4 Weeks)||0
7992519|NCT00121719|19680584|P10|NOT COMPLETED|Dose Escalation (4 Weeks)||0
7992520|NCT00121719|19680585|P9|NOT COMPLETED|Dose Escalation (4 Weeks)||0
7992521|NCT00121719|19680586|P8|NOT COMPLETED|Dose Escalation (4 Weeks)||0
7992522|NCT00121719|19680587|P7|NOT COMPLETED|Dose Escalation (4 Weeks)||0
7992523|NCT00121719|19680588|P6|NOT COMPLETED|Dose Escalation (4 Weeks)||0
7992524|NCT00121719|19680589|P5|NOT COMPLETED|Dose Escalation (4 Weeks)||0
7992525|NCT00121719|19680590|P4|NOT COMPLETED|Dose Escalation (4 Weeks)||0
7992526|NCT00121719|19680591|P3|NOT COMPLETED|Dose Escalation (4 Weeks)||0
7992527|NCT00121719|19680592|P2|NOT COMPLETED|Dose Escalation (4 Weeks)||0
7992528|NCT00121719|19680593|P1|NOT COMPLETED|Dose Escalation (4 Weeks)||0
7992529|NCT00121719|19680580|P14|COMPLETED|Dose Escalation (4 Weeks)||7
7992530|NCT00121719|19680581|P13|COMPLETED|Dose Escalation (4 Weeks)||24
7992531|NCT00121719|19680582|P12|COMPLETED|Dose Escalation (4 Weeks)||0
7992532|NCT00121719|19680583|P11|COMPLETED|Dose Escalation (4 Weeks)||0
7992533|NCT00121719|19680584|P10|COMPLETED|Dose Escalation (4 Weeks)||3
7992534|NCT00121719|19680585|P9|COMPLETED|Dose Escalation (4 Weeks)||6
7992535|NCT00121719|19680586|P8|COMPLETED|Dose Escalation (4 Weeks)||9
7992536|NCT00121719|19680587|P7|COMPLETED|Dose Escalation (4 Weeks)||12
7992537|NCT00121719|19680588|P6|COMPLETED|Dose Escalation (4 Weeks)||3
7992538|NCT00121719|19680589|P5|COMPLETED|Dose Escalation (4 Weeks)||3
7992539|NCT00121719|19680590|P4|COMPLETED|Dose Escalation (4 Weeks)||3
7992540|NCT00121719|19680591|P3|COMPLETED|Dose Escalation (4 Weeks)||4
7992541|NCT00121719|19680592|P2|COMPLETED|Dose Escalation (4 Weeks)||4
7992542|NCT00121719|19680593|P1|COMPLETED|Dose Escalation (4 Weeks)||4
7992543|NCT00121719|19680580|P14|STARTED|Dose Escalation (4 Weeks)||7
7992544|NCT00121719|19680581|P13|STARTED|Dose Escalation (4 Weeks)||24
7992545|NCT00121719|19680582|P12|STARTED|Dose Escalation (4 Weeks)||0
7992546|NCT00121719|19680583|P11|STARTED|Dose Escalation (4 Weeks)||0
7992547|NCT00121719|19680584|P10|STARTED|Dose Escalation (4 Weeks)||3
7992548|NCT00121719|19680585|P9|STARTED|Dose Escalation (4 Weeks)||6
7992549|NCT00121719|19680586|P8|STARTED|Dose Escalation (4 Weeks)||9
7992550|NCT00121719|19680587|P7|STARTED|Dose Escalation (4 Weeks)||12
7992551|NCT00121719|19680588|P6|STARTED|Dose Escalation (4 Weeks)||3
7992552|NCT00121719|19680589|P5|STARTED|Dose Escalation (4 Weeks)||3
7992553|NCT00121719|19680590|P4|STARTED|Dose Escalation (4 Weeks)||3
7992554|NCT00121719|19680591|P3|STARTED|Dose Escalation (4 Weeks)||4
7992555|NCT00121719|19680592|P2|STARTED|Dose Escalation (4 Weeks)||4
7992556|NCT00121719|19680593|P1|STARTED|Dose Escalation (4 Weeks)||4
7992557|NCT00121667|19680784|P4|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140
7992558|NCT00121667|19680785|P3|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113
7992559|NCT00121667|19680786|P2|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133
7992560|NCT00121667|19680787|P1|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128
7992561|NCT00121667|19680784|P4|COMPLETED|Short Term (ST) + Long Term (LT) Period||39
7992562|NCT00121667|19680785|P3|COMPLETED|Short Term (ST) + Long Term (LT) Period||68
7992563|NCT00121667|19680786|P2|COMPLETED|Short Term (ST) + Long Term (LT) Period||58
7992564|NCT00121667|19680787|P1|COMPLETED|Short Term (ST) + Long Term (LT) Period||64
7992565|NCT00121667|19680784|P4|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7
7992566|NCT00121667|19680785|P3|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23
7992567|NCT00121667|19680786|P2|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18
7992651|NCT00121134|19681108|P4|COMPLETED|Overall Study||31
7992568|NCT00121667|19680787|P1|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14
7992569|NCT00121667|19680784|P4|STARTED|Short Term (ST) + Long Term (LT) Period||179
7992570|NCT00121667|19680785|P3|STARTED|Short Term (ST) + Long Term (LT) Period||181
7992571|NCT00121667|19680786|P2|STARTED|Short Term (ST) + Long Term (LT) Period||191
7992572|NCT00121667|19680787|P1|STARTED|Short Term (ST) + Long Term (LT) Period||192
7992573|NCT00121667|19680784|P4|NOT COMPLETED|Short Term (ST) Period||67
7992574|NCT00121667|19680785|P3|NOT COMPLETED|Short Term (ST) Period||41
7992575|NCT00121667|19680786|P2|NOT COMPLETED|Short Term (ST) Period||48
7992576|NCT00121667|19680787|P1|NOT COMPLETED|Short Term (ST) Period||44
7992577|NCT00121667|19680784|P4|COMPLETED|Short Term (ST) Period||112
7992578|NCT00121667|19680785|P3|COMPLETED|Short Term (ST) Period||140
7992579|NCT00121667|19680786|P2|COMPLETED|Short Term (ST) Period||143
7992580|NCT00121667|19680787|P1|COMPLETED|Short Term (ST) Period||148
7992581|NCT00121667|19680784|P4|STARTED|Short Term (ST) Period||179
7992582|NCT00121667|19680785|P3|STARTED|Short Term (ST) Period||181
7992583|NCT00121667|19680786|P2|STARTED|Short Term (ST) Period||191
7992584|NCT00121667|19680787|P1|STARTED|Short Term (ST) Period||192
7992585|NCT00121641|19680885|P5|NOT COMPLETED|48-month Short Term + Long Term Period||58
7992586|NCT00121641|19680886|P4|NOT COMPLETED|48-month Short Term + Long Term Period||71
7992587|NCT00121641|19680887|P3|NOT COMPLETED|48-month Short Term + Long Term Period||70
7992588|NCT00121641|19680888|P2|NOT COMPLETED|48-month Short Term + Long Term Period||82
7992589|NCT00121641|19680889|P1|NOT COMPLETED|48-month Short Term + Long Term Period||79
7992590|NCT00121641|19680885|P5|COMPLETED|48-month Short Term + Long Term Period||8
7992591|NCT00121641|19680886|P4|COMPLETED|48-month Short Term + Long Term Period||24
7992592|NCT00121641|19680887|P3|COMPLETED|48-month Short Term + Long Term Period||28
7992593|NCT00121641|19680888|P2|COMPLETED|48-month Short Term + Long Term Period||24
7992594|NCT00121641|19680889|P1|COMPLETED|48-month Short Term + Long Term Period||23
7992595|NCT00121641|19680885|P5|STARTED|48-month Short Term + Long Term Period||66
7992596|NCT00121641|19680886|P4|STARTED|48-month Short Term + Long Term Period||95
7992597|NCT00121641|19680887|P3|STARTED|48-month Short Term + Long Term Period||98
7992598|NCT00121641|19680888|P2|STARTED|48-month Short Term + Long Term Period||106
7992599|NCT00121641|19680889|P1|STARTED|48-month Short Term + Long Term Period||102
7992600|NCT00121641|19680885|P5|NOT COMPLETED|24-week Short-term Treatment Period||41
7992601|NCT00121641|19680886|P4|NOT COMPLETED|24-week Short-term Treatment Period||40
7992602|NCT00121641|19680887|P3|NOT COMPLETED|24-week Short-term Treatment Period||29
7992603|NCT00121641|19680888|P2|NOT COMPLETED|24-week Short-term Treatment Period||38
7992604|NCT00121641|19680889|P1|NOT COMPLETED|24-week Short-term Treatment Period||29
7992605|NCT00121641|19680885|P5|COMPLETED|24-week Short-term Treatment Period||25
7992606|NCT00121641|19680886|P4|COMPLETED|24-week Short-term Treatment Period||55
7992607|NCT00121641|19680887|P3|COMPLETED|24-week Short-term Treatment Period||69
7992608|NCT00121641|19680888|P2|COMPLETED|24-week Short-term Treatment Period||68
7992609|NCT00121641|19680889|P1|COMPLETED|24-week Short-term Treatment Period||73
7992610|NCT00121641|19680885|P5|STARTED|24-week Short-term Treatment Period||66
7992611|NCT00121641|19680886|P4|STARTED|24-week Short-term Treatment Period||95
7992612|NCT00121641|19680887|P3|STARTED|24-week Short-term Treatment Period||98
7992613|NCT00121641|19680888|P2|STARTED|24-week Short-term Treatment Period||106
7992614|NCT00121641|19680889|P1|STARTED|24-week Short-term Treatment Period||102
7992615|NCT00121485|19681002|P2|NOT COMPLETED|Overall Study||7
7992616|NCT00121485|19681003|P1|NOT COMPLETED|Overall Study||1
7992617|NCT00121485|19681002|P2|COMPLETED|Overall Study||59
7992618|NCT00121485|19681003|P1|COMPLETED|Overall Study||133
7992619|NCT00121485|19681002|P2|STARTED|Overall Study||66
7992620|NCT00121485|19681003|P1|STARTED|Overall Study||134
7992621|NCT00121472|19681037|P1|NOT COMPLETED|Overall Study||0
7992622|NCT00121472|19681037|P1|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194
7992623|NCT00121472|19681037|P1|STARTED|Overall Study||194
7992624|NCT00121238|19681048|P1|NOT COMPLETED|Overall Study||3
7992625|NCT00121238|19681048|P1|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13
7992626|NCT00121238|19681048|P1|STARTED|Overall Study||16
7992627|NCT00121225|19681056|P1|NOT COMPLETED|Overall Study||0
7992628|NCT00121225|19681056|P1|COMPLETED|Overall Study||32
7992629|NCT00121225|19681056|P1|STARTED|Overall Study||32
7992630|NCT00121199|19681064|P1|NOT COMPLETED|Overall Study||28
7992631|NCT00121199|19681064|P1|COMPLETED|Overall Study||45
7992632|NCT00121199|19681064|P1|Eligible and Began Protocol Therapy|Overall Study||64
7992633|NCT00121199|19681064|P1|Eligible|Overall Study||64
7992634|NCT00121199|19681064|P1|STARTED|Overall Study||73
7992635|NCT00121186|19681071|P1|NOT COMPLETED|Overall Study||0
7992636|NCT00121186|19681071|P1|COMPLETED|Overall Study||1
7992637|NCT00121186|19681071|P1|STARTED|Overall Study||1
7992638|NCT00121173|19681079|P3|NOT COMPLETED|Overall Study||0
7992639|NCT00121173|19681080|P2|NOT COMPLETED|Overall Study||0
7992640|NCT00121173|19681081|P1|NOT COMPLETED|Overall Study||1
7992641|NCT00121173|19681079|P3|COMPLETED|Overall Study||9
7992642|NCT00121173|19681080|P2|COMPLETED|Overall Study||3
7992643|NCT00121173|19681081|P1|COMPLETED|Overall Study||3
7992644|NCT00121173|19681079|P3|STARTED|Overall Study||9
7992645|NCT00121173|19681080|P2|STARTED|Overall Study||3
7992646|NCT00121173|19681081|P1|STARTED|Overall Study||4
7992647|NCT00121134|19681108|P4|NOT COMPLETED|Overall Study||9
7992648|NCT00121134|19681109|P3|NOT COMPLETED|Overall Study||21
7992649|NCT00121134|19681110|P2|NOT COMPLETED|Overall Study||15
7992650|NCT00121134|19681111|P1|NOT COMPLETED|Overall Study||16
7992652|NCT00121134|19681109|P3|COMPLETED|Overall Study||20
7992653|NCT00121134|19681110|P2|COMPLETED|Overall Study||26
7992654|NCT00121134|19681111|P1|COMPLETED|Overall Study||24
7992655|NCT00121134|19681108|P4|STARTED|Overall Study||40
7992656|NCT00121134|19681109|P3|STARTED|Overall Study||41
7992657|NCT00121134|19681110|P2|STARTED|Overall Study||41
7992658|NCT00121134|19681111|P1|STARTED|Overall Study||40
7992659|NCT00120874|19681123|P2|NOT COMPLETED|Overall Study||1
7992660|NCT00120874|19681124|P1|NOT COMPLETED|Overall Study||0
7992661|NCT00120874|19681123|P2|COMPLETED|Overall Study||9
7992662|NCT00120874|19681124|P1|COMPLETED|Overall Study||10
7992663|NCT00120874|19681123|P2|Completed Study; Started Extension Study|Overall Study||10
7992664|NCT00120874|19681124|P1|Completed Study; Started Extension Study|Overall Study||10
7992665|NCT00120874|19681123|P2|STARTED|Overall Study||10
7992666|NCT00120874|19681124|P1|STARTED|Overall Study||10
7992667|NCT00120627|19681162|P2|NOT COMPLETED|Overall Study||5
7992668|NCT00120627|19681163|P1|NOT COMPLETED|Overall Study||5
7992669|NCT00120627|19681162|P2|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70
7992670|NCT00120627|19681163|P1|COMPLETED|Overall Study||66
7992671|NCT00120627|19681162|P2|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3
7992672|NCT00120627|19681163|P1|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3
7992673|NCT00120627|19681162|P2|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73
7992674|NCT00120627|19681163|P1|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69
7992675|NCT00120627|19681162|P2|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75
7992676|NCT00120627|19681163|P1|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71
7992677|NCT00120523|19681189|P2|NOT COMPLETED|Follow-Up Period||24
7992678|NCT00120523|19681190|P1|NOT COMPLETED|Follow-Up Period||30
7992679|NCT00120523|19681189|P2|COMPLETED|Follow-Up Period||46
7992680|NCT00120523|19681190|P1|COMPLETED|Follow-Up Period||90
7992681|NCT00120523|19681189|P2|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70
7992682|NCT00120523|19681190|P1|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120
7992683|NCT00120523|19681189|P2|NOT COMPLETED|Treatment Period||339
7992684|NCT00120523|19681190|P1|NOT COMPLETED|Treatment Period||369
7992685|NCT00120523|19681189|P2|COMPLETED|Treatment Period||874
7992686|NCT00120523|19681190|P1|COMPLETED|Treatment Period||836
7992687|NCT00120523|19681189|P2|STARTED|Treatment Period||1213
7992688|NCT00120523|19681190|P1|STARTED|Treatment Period||1205
7992689|NCT00120406|19681214|P2|NOT COMPLETED|Overall Study||16
7992690|NCT00120406|19681215|P1|NOT COMPLETED|Overall Study||19
7992691|NCT00120406|19681214|P2|COMPLETED|Overall Study||222
7992692|NCT00120406|19681215|P1|COMPLETED|Overall Study||217
7992693|NCT00120406|19681214|P2|STARTED|Overall Study||238
7992694|NCT00120406|19681215|P1|STARTED|Overall Study||236
7992695|NCT00120289|19681225|P2|NOT COMPLETED|Overall Study||109
7992696|NCT00120289|19681226|P1|NOT COMPLETED|Overall Study||121
7992697|NCT00120289|19681225|P2|COMPLETED|Overall Study||1587
7992698|NCT00120289|19681226|P1|COMPLETED|Overall Study||1597
7992699|NCT00120289|19681225|P2|STARTED|Overall Study||1696
7992700|NCT00120289|19681226|P1|STARTED|Overall Study||1718
7992701|NCT00120250|19681238|P2|NOT COMPLETED|Overall Study||2
7992702|NCT00120250|19681239|P1|NOT COMPLETED|Overall Study||1
7992703|NCT00120250|19681238|P2|COMPLETED|Overall Study||12
7992704|NCT00120250|19681239|P1|COMPLETED|Overall Study||12
7992705|NCT00120250|19681238|P2|STARTED|Overall Study||14
7992706|NCT00120250|19681239|P1|STARTED|Overall Study||13
7992707|NCT00120042|19681255|P3|NOT COMPLETED|Overall Study||0
7992708|NCT00120042|19681256|P2|NOT COMPLETED|Overall Study||0
7992709|NCT00120042|19681257|P1|NOT COMPLETED|Overall Study||0
7992710|NCT00120042|19681255|P3|COMPLETED|Overall Study||83
7992711|NCT00120042|19681256|P2|COMPLETED|Overall Study||83
7992712|NCT00120042|19681257|P1|COMPLETED|Overall Study||85
7992713|NCT00120042|19681255|P3|STARTED|Overall Study||83
7992714|NCT00120042|19681256|P2|STARTED|Overall Study||83
7992715|NCT00120042|19681257|P1|STARTED|Overall Study||85
7992716|NCT00119847|19681267|P2|NOT COMPLETED|Overall Study||32
7992717|NCT00119847|19681268|P1|NOT COMPLETED|Overall Study||31
7992718|NCT00119847|19681267|P2|COMPLETED|Overall Study||119
7992719|NCT00119847|19681268|P1|COMPLETED|Overall Study||118
7992720|NCT00119847|19681267|P2|STARTED|Overall Study||151
7992721|NCT00119847|19681268|P1|STARTED|Overall Study||149
7992722|NCT00119678|19681280|P2|NOT COMPLETED|Open-label Treatment Period||0
7992723|NCT00119678|19681281|P1|NOT COMPLETED|Open-label Treatment Period||110
7992724|NCT00119678|19681280|P2|COMPLETED|Open-label Treatment Period||0
7992725|NCT00119678|19681281|P1|COMPLETED|Open-label Treatment Period||0
7992726|NCT00119678|19681280|P2|STARTED|Open-label Treatment Period||0
7992727|NCT00119678|19681281|P1|STARTED|Open-label Treatment Period|Number of participants treated|110
7992728|NCT00119678|19681280|P2|NOT COMPLETED|Double-blind Treatment Period||26
7992729|NCT00119678|19681281|P1|NOT COMPLETED|Double-blind Treatment Period||41
7992730|NCT00119678|19681280|P2|COMPLETED|Double-blind Treatment Period||35
7992731|NCT00119678|19681281|P1|COMPLETED|Double-blind Treatment Period||81
7992732|NCT00119678|19681280|P2|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57
7992733|NCT00119678|19681281|P1|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118
7992734|NCT00119678|19681280|P2|RANDOMIZED AND TREATED|Double-blind Treatment Period||59
7992735|NCT00119678|19681281|P1|RANDOMIZED AND TREATED|Double-blind Treatment Period||121
7992736|NCT00119678|19681280|P2|STARTED|Double-blind Treatment Period||61
7992737|NCT00119678|19681281|P1|STARTED|Double-blind Treatment Period||122
7992738|NCT00119405|19681327|P1|NOT COMPLETED|Overall Study||1
7992739|NCT00119405|19681327|P1|COMPLETED|Overall Study||17
7992740|NCT00119405|19681327|P1|STARTED|Overall Study||18
7992741|NCT00119392|19681331|P1|NOT COMPLETED|Overall Study||5
7992742|NCT00119392|19681331|P1|COMPLETED|Overall Study||40
7992743|NCT00119392|19681331|P1|STARTED|Overall Study||45
7992744|NCT00119379|19681341|P2|NOT COMPLETED|Overall Study||1
7992745|NCT00119379|19681342|P1|NOT COMPLETED|Overall Study||4
7992746|NCT00119379|19681341|P2|COMPLETED|Overall Study||23
7992747|NCT00119379|19681342|P1|COMPLETED|Overall Study||22
7992748|NCT00119379|19681341|P2|STARTED|Overall Study||24
7992749|NCT00119379|19681342|P1|STARTED|Overall Study||26
7992750|NCT00119262|19681360|P2|NOT COMPLETED|Overall Study||58
7992751|NCT00119262|19681361|P1|NOT COMPLETED|Overall Study||46
7992752|NCT00119262|19681360|P2|COMPLETED|Overall Study||64
7992753|NCT00119262|19681361|P1|COMPLETED|Overall Study||58
7992754|NCT00119262|19681360|P2|Eligible and Treated|Overall Study||119
7992755|NCT00119262|19681361|P1|Eligible and Treated|Overall Study||102
7992756|NCT00119262|19681360|P2|Treated|Overall Study||120
7992757|NCT00119262|19681361|P1|Treated|Overall Study||103
7992758|NCT00119262|19681360|P2|Eligible|Overall Study||120
7992759|NCT00119262|19681361|P1|Eligible|Overall Study||103
7992760|NCT00119262|19681360|P2|STARTED|Overall Study||122
7992761|NCT00119262|19681361|P1|STARTED|Overall Study||104
7992762|NCT00119158|19681373|P2|NOT COMPLETED|Placebo Treatment||0
7992763|NCT00119158|19681374|P1|NOT COMPLETED|Placebo Treatment||0
7992764|NCT00119158|19681373|P2|COMPLETED|Placebo Treatment||45
7992765|NCT00119158|19681374|P1|COMPLETED|Placebo Treatment||45
7992766|NCT00119158|19681373|P2|STARTED|Placebo Treatment||45
7992767|NCT00119158|19681374|P1|STARTED|Placebo Treatment||45
7992768|NCT00119158|19681373|P2|NOT COMPLETED|Active Treatment||0
7992769|NCT00119158|19681374|P1|NOT COMPLETED|Active Treatment||0
7992770|NCT00119158|19681373|P2|COMPLETED|Active Treatment||45
7992771|NCT00119158|19681374|P1|COMPLETED|Active Treatment||45
7992772|NCT00119158|19681373|P2|STARTED|Active Treatment||45
7992773|NCT00119158|19681374|P1|STARTED|Active Treatment|patients are self controls|45
7992774|NCT00119041|19681385|P3|NOT COMPLETED|Overall Study||0
7992775|NCT00119041|19681386|P2|NOT COMPLETED|Overall Study||0
7992776|NCT00119041|19681387|P1|NOT COMPLETED|Overall Study||0
7992777|NCT00119041|19681385|P3|COMPLETED|Overall Study||22
7992778|NCT00119041|19681386|P2|COMPLETED|Overall Study||83
7992779|NCT00119041|19681387|P1|COMPLETED|Overall Study||199
7992780|NCT00119041|19681385|P3|STARTED|Overall Study||22
7992781|NCT00119041|19681386|P2|STARTED|Overall Study||83
7992782|NCT00119041|19681387|P1|STARTED|Overall Study||199
7992783|NCT00119015|19681398|P3|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
7992784|NCT00119015|19681399|P2|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
7992785|NCT00119015|19681400|P1|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
7992786|NCT00119015|19681398|P3|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26
7992787|NCT00119015|19681399|P2|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28
7992788|NCT00119015|19681400|P1|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
7992789|NCT00119015|19681398|P3|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26
7992790|NCT00119015|19681399|P2|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28
7992791|NCT00119015|19681400|P1|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0
7992792|NCT00119015|19681398|P3|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
7992793|NCT00119015|19681399|P2|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
7992794|NCT00119015|19681400|P1|NOT COMPLETED|Open-Label Phase (2 Weeks)||48
7992795|NCT00119015|19681398|P3|COMPLETED|Open-Label Phase (2 Weeks)||0
7992796|NCT00119015|19681399|P2|COMPLETED|Open-Label Phase (2 Weeks)||0
7992797|NCT00119015|19681400|P1|COMPLETED|Open-Label Phase (2 Weeks)||54
7992798|NCT00119015|19681398|P3|STARTED|Open-Label Phase (2 Weeks)||0
7992799|NCT00119015|19681399|P2|STARTED|Open-Label Phase (2 Weeks)||0
7992800|NCT00119015|19681400|P1|STARTED|Open-Label Phase (2 Weeks)||102
7992801|NCT00118911|19681416|P2|NOT COMPLETED|Overall Study||5
7992802|NCT00118911|19681417|P1|NOT COMPLETED|Overall Study||2
7992803|NCT00118911|19681416|P2|COMPLETED|Overall Study||38
7992804|NCT00118911|19681417|P1|COMPLETED|Overall Study||41
7992805|NCT00118911|19681416|P2|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32
7992806|NCT00118911|19681417|P1|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38
7992807|NCT00118911|19681416|P2|6 Month Follow-up|Overall Study||30
7992808|NCT00118911|19681417|P1|6 Month Follow-up|Overall Study||37
7992809|NCT00118911|19681416|P2|Completed Post-Treatment Assessment|Overall Study||37
7992810|NCT00118911|19681417|P1|Completed Post-Treatment Assessment|Overall Study||41
7992811|NCT00118911|19681416|P2|Received Intervention as Assigned|Overall Study||38
7992812|NCT00118911|19681417|P1|Received Intervention as Assigned|Overall Study||41
7992813|NCT00118911|19681416|P2|STARTED|Overall Study||43
7992814|NCT00118911|19681417|P1|STARTED|Overall Study||43
7992815|NCT00118898|19681429|P4|NOT COMPLETED|Overall Study||141
7992816|NCT00118898|19681430|P3|NOT COMPLETED|Overall Study||123
7992817|NCT00118898|19681431|P2|NOT COMPLETED|Overall Study||141
7992818|NCT00118898|19681432|P1|NOT COMPLETED|Overall Study||121
7992819|NCT00118898|19681429|P4|COMPLETED|Overall Study||322
7992820|NCT00118898|19681430|P3|COMPLETED|Overall Study||342
7992821|NCT00118898|19681431|P2|COMPLETED|Overall Study||324
7992822|NCT00118898|19681432|P1|COMPLETED|Overall Study||343
7992823|NCT00118898|19681429|P4|Initiated Treatment|Overall Study||462
7992824|NCT00118898|19681430|P3|Initiated Treatment|Overall Study||464
7992825|NCT00118898|19681431|P2|Initiated Treatment|Overall Study||461
7992826|NCT00118898|19681432|P1|Initiated Treatment|Overall Study||461
7992827|NCT00118898|19681429|P4|STARTED|Overall Study||463
7992828|NCT00118898|19681430|P3|STARTED|Overall Study||465
7992829|NCT00118898|19681431|P2|STARTED|Overall Study||465
7992830|NCT00118898|19681432|P1|STARTED|Overall Study||464
7992831|NCT00118755|19681528|P2|NOT COMPLETED|Overall Study||215
7992832|NCT00118755|19681529|P1|NOT COMPLETED|Overall Study||210
7992833|NCT00118755|19681528|P2|COMPLETED|Overall Study||3
7992834|NCT00118755|19681529|P1|COMPLETED|Overall Study||7
7992835|NCT00118755|19681528|P2|Safety Population|Overall Study||211
7992836|NCT00118755|19681529|P1|Safety Population|Overall Study||208
7992837|NCT00118755|19681528|P2|STARTED|Overall Study||218
7992838|NCT00118755|19681529|P1|STARTED|Overall Study||217
7992839|NCT00118742|19681543|P2|NOT COMPLETED|Overall Study||66
7992840|NCT00118742|19681544|P1|NOT COMPLETED|Overall Study||49
7992841|NCT00118742|19681543|P2|COMPLETED|Overall Study||82
7992842|NCT00118742|19681544|P1|COMPLETED|Overall Study||96
7992843|NCT00118742|19681543|P2|STARTED|Overall Study||148
7992844|NCT00118742|19681544|P1|STARTED|Overall Study||145
7992845|NCT00118716|19681558|P2|NOT COMPLETED|Overall Study||22
7992846|NCT00118716|19681559|P1|NOT COMPLETED|Overall Study||13
7992847|NCT00118716|19681558|P2|COMPLETED|Overall Study||102
7992848|NCT00118716|19681559|P1|COMPLETED|Overall Study||111
7992849|NCT00118716|19681558|P2|STARTED|Overall Study||124
7992850|NCT00118716|19681559|P1|STARTED|Overall Study||124
7992851|NCT00118703|19681579|P2|NOT COMPLETED|Overall Study||9
7992852|NCT00118703|19681580|P1|NOT COMPLETED|Overall Study||5
7992853|NCT00118703|19681579|P2|COMPLETED|Overall Study||165
7992854|NCT00118703|19681580|P1|COMPLETED|Overall Study||168
7992855|NCT00118703|19681579|P2|STARTED|Overall Study||174
7992856|NCT00118703|19681580|P1|STARTED|Overall Study||173
7992857|NCT00118534|19681592|P2|NOT COMPLETED|Overall Study||0
7992858|NCT00118534|19681593|P1|NOT COMPLETED|Overall Study||0
7992859|NCT00118534|19681592|P2|COMPLETED|Overall Study||471
7992860|NCT00118534|19681593|P1|COMPLETED|Overall Study||472
7992861|NCT00118534|19681592|P2|STARTED|Overall Study||471
7992862|NCT00118534|19681593|P1|STARTED|Overall Study||472
7992863|NCT00118482|19681677|P2|NOT COMPLETED|Overall Study||29
7992864|NCT00118482|19681678|P1|NOT COMPLETED|Overall Study||30
7992865|NCT00118482|19681677|P2|COMPLETED|Overall Study||76
7992866|NCT00118482|19681678|P1|COMPLETED|Overall Study|210 in the Intention To Treat analysis|75
7992867|NCT00118482|19681677|P2|STARTED|Overall Study||105
7992868|NCT00118482|19681678|P1|STARTED|Overall Study|3 patients signed the consent but did not take the study medication.|105
7992869|NCT00118430|19681693|P3|NOT COMPLETED|Overall Study||28
7992870|NCT00118430|19681694|P2|NOT COMPLETED|Overall Study||24
7992871|NCT00118430|19681695|P1|NOT COMPLETED|Overall Study||21
7992872|NCT00118430|19681693|P3|COMPLETED|Overall Study||222
7992873|NCT00118430|19681694|P2|COMPLETED|Overall Study|127 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|103
7992874|NCT00118430|19681695|P1|COMPLETED|Overall Study|123 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|102
7992875|NCT00118430|19681693|P3|STARTED|Overall Study||250
7992876|NCT00118430|19681694|P2|STARTED|Overall Study||127
7992877|NCT00118430|19681695|P1|STARTED|Overall Study||123
7992878|NCT00118417|19681710|P2|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
7992879|NCT00118417|19681711|P1|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
7992880|NCT00118417|19681710|P2|COMPLETED|Phase III (Weeks 12 to 24)||9
7992881|NCT00118417|19681711|P1|COMPLETED|Phase III (Weeks 12 to 24)||8
7992882|NCT00118417|19681710|P2|STARTED|Phase III (Weeks 12 to 24)||10
7992883|NCT00118417|19681711|P1|STARTED|Phase III (Weeks 12 to 24)||9
7992884|NCT00118417|19681710|P2|NOT COMPLETED|Phase II (Weeks 6 to 12)||3
7992885|NCT00118417|19681711|P1|NOT COMPLETED|Phase II (Weeks 6 to 12)||2
7992886|NCT00118417|19681710|P2|COMPLETED|Phase II (Weeks 6 to 12)||10
7992887|NCT00118417|19681711|P1|COMPLETED|Phase II (Weeks 6 to 12)||9
7992888|NCT00118417|19681710|P2|STARTED|Phase II (Weeks 6 to 12)||13
7992889|NCT00118417|19681711|P1|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11
7992890|NCT00118417|19681710|P2|NOT COMPLETED|Phase I (Weeks 0 to 6)||0
7992891|NCT00118417|19681711|P1|NOT COMPLETED|Phase I (Weeks 0 to 6)||18
7992892|NCT00118417|19681710|P2|COMPLETED|Phase I (Weeks 0 to 6)||0
7992893|NCT00118417|19681711|P1|COMPLETED|Phase I (Weeks 0 to 6)||21
7992894|NCT00118417|19681710|P2|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0
7992895|NCT00118417|19681711|P1|STARTED|Phase I (Weeks 0 to 6)||39
7992896|NCT00118404|19681724|P3|NOT COMPLETED|Overall Study||20
7992897|NCT00118404|19681725|P2|NOT COMPLETED|Overall Study||16
7992898|NCT00118404|19681726|P1|NOT COMPLETED|Overall Study||24
7992899|NCT00118404|19681724|P3|COMPLETED|Overall Study||49
7992900|NCT00118404|19681725|P2|COMPLETED|Overall Study||70
7992901|NCT00118404|19681726|P1|COMPLETED|Overall Study||62
7992902|NCT00118404|19681724|P3|STARTED|Overall Study||69
7992903|NCT00118404|19681725|P2|STARTED|Overall Study||86
7992904|NCT00118404|19681726|P1|STARTED|Overall Study||86
7992905|NCT00118378|19681742|P2|NOT COMPLETED|Overall Study||8
7992906|NCT00118378|19681743|P1|NOT COMPLETED|Overall Study||2
7992907|NCT00118378|19681742|P2|COMPLETED|Overall Study||45
7992908|NCT00118378|19681743|P1|COMPLETED|Overall Study||60
7992909|NCT00118378|19681742|P2|STARTED|Overall Study||53
7992910|NCT00118378|19681743|P1|STARTED|Overall Study||62
7992911|NCT00118365|19681757|P2|NOT COMPLETED|Overall Study||60
7992912|NCT00118365|19681758|P1|NOT COMPLETED|Overall Study||59
7992913|NCT00118365|19681757|P2|COMPLETED|Overall Study||124
7992914|NCT00118365|19681758|P1|COMPLETED|Overall Study||132
7992915|NCT00118365|19681757|P2|STARTED|Overall Study||184
7992916|NCT00118365|19681758|P1|STARTED|Overall Study||191
7992917|NCT00118352|19681827|P3|NOT COMPLETED|Overall Study||0
7992918|NCT00118352|19681828|P2|NOT COMPLETED|Overall Study||0
7992919|NCT00118352|19681829|P1|NOT COMPLETED|Overall Study||0
7992920|NCT00118352|19681827|P3|COMPLETED|Overall Study||0
7992921|NCT00118352|19681828|P2|COMPLETED|Overall Study||0
7992922|NCT00118352|19681829|P1|COMPLETED|Overall Study||12
7992923|NCT00118352|19681827|P3|STARTED|Overall Study||0
7992924|NCT00118352|19681828|P2|STARTED|Overall Study||0
7992925|NCT00118352|19681829|P1|STARTED|Overall Study||12
7992926|NCT00118287|19681855|P1|NOT COMPLETED|Overall Study||2
7992927|NCT00118287|19681855|P1|COMPLETED|Overall Study||30
7992928|NCT00118287|19681855|P1|STARTED|Overall Study||32
7992929|NCT00118248|19681861|P2|NOT COMPLETED|Overall Study||0
7992930|NCT00118248|19681862|P1|NOT COMPLETED|Overall Study||0
7992931|NCT00118248|19681861|P2|COMPLETED|Overall Study||24
7992932|NCT00118248|19681862|P1|COMPLETED|Overall Study||17
7992933|NCT00118248|19681861|P2|STARTED|Overall Study||24
7992934|NCT00118248|19681862|P1|STARTED|Overall Study||17
7992935|NCT00118209|19681877|P2|NOT COMPLETED|Overall Study||21
7992936|NCT00118209|19681878|P1|NOT COMPLETED|Overall Study||12
7992937|NCT00118209|19681877|P2|COMPLETED|Overall Study||241
7992938|NCT00118209|19681878|P1|COMPLETED|Overall Study||250
7992939|NCT00118209|19681877|P2|Evaluable for Safety Analysis|Overall Study||237
7992940|NCT00118209|19681878|P1|Evaluable for Safety Analysis|Overall Study||243
7992941|NCT00118209|19681877|P2|Evaluable for Primary Endpoint|Overall Study||241
7992942|NCT00118209|19681878|P1|Evaluable for Primary Endpoint|Overall Study||250
7992943|NCT00118209|19681877|P2|STARTED|Overall Study||262
7992944|NCT00118209|19681878|P1|STARTED|Overall Study||262
7992945|NCT00118157|19681888|P1|NOT COMPLETED|Overall Study||12
7992946|NCT00118157|19681888|P1|COMPLETED|Overall Study||7
7992947|NCT00118157|19681888|P1|STARTED|Overall Study||19
7992948|NCT00118144|19681893|P1|NOT COMPLETED|Overall Study||1
7992949|NCT00118144|19681893|P1|COMPLETED|Overall Study||41
7992950|NCT00118144|19681893|P1|STARTED|Overall Study||42
7992951|NCT00118131|19681899|P1|NOT COMPLETED|Overall Study||0
7992952|NCT00118131|19681899|P1|COMPLETED|Overall Study||49
7992953|NCT00118131|19681899|P1|STARTED|Overall Study||49
7992954|NCT00118092|19681906|P1|NOT COMPLETED|Overall Study||2
7992955|NCT00118092|19681906|P1|COMPLETED|Overall Study||15
7992956|NCT00118092|19681906|P1|STARTED|Overall Study||17
7992957|NCT00118053|19681914|P1|NOT COMPLETED|Overall Study||0
7992958|NCT00118053|19681914|P1|COMPLETED|Overall Study||5
7992959|NCT00118053|19681914|P1|STARTED|Overall Study||5
7992960|NCT00118040|19681924|P3|NOT COMPLETED|Overall Study||6
7992961|NCT00118040|19681925|P2|NOT COMPLETED|Overall Study||2
7992962|NCT00118040|19681926|P1|NOT COMPLETED|Overall Study||1
7992963|NCT00118040|19681924|P3|COMPLETED|Overall Study||14
7992964|NCT00118040|19681925|P2|COMPLETED|Overall Study||18
7992965|NCT00118040|19681926|P1|COMPLETED|Overall Study||19
7992966|NCT00118040|19681924|P3|STARTED|Overall Study||20
7992967|NCT00118040|19681925|P2|STARTED|Overall Study||20
7992968|NCT00118040|19681926|P1|STARTED|Overall Study||20
7992969|NCT00117988|19681987|P1|NOT COMPLETED|Overall Study||4
7992970|NCT00117988|19681987|P1|COMPLETED|Overall Study||18
7992971|NCT00117988|19681987|P1|STARTED|Overall Study||22
7992972|NCT00117962|19681993|P2|NOT COMPLETED|Overall Study||25
7992973|NCT00117962|19681994|P1|NOT COMPLETED|Overall Study||22
7992974|NCT00117962|19681993|P2|COMPLETED|Overall Study||28
7992975|NCT00117962|19681994|P1|COMPLETED|Overall Study||26
7992976|NCT00117962|19681993|P2|STARTED|Overall Study||53
7992977|NCT00117962|19681994|P1|STARTED|Overall Study||48
7992978|NCT00117949|19682010|P4|NOT COMPLETED|Overall Study||24
7992979|NCT00117949|19682011|P3|NOT COMPLETED|Overall Study||24
7992980|NCT00117949|19682012|P2|NOT COMPLETED|Overall Study||24
7992981|NCT00117949|19682013|P1|NOT COMPLETED|Overall Study||10
7992982|NCT00117949|19682010|P4|COMPLETED|Overall Study||0
7992983|NCT00117949|19682011|P3|COMPLETED|Overall Study||0
7992984|NCT00117949|19682012|P2|COMPLETED|Overall Study||0
7992985|NCT00117949|19682013|P1|COMPLETED|Overall Study||0
7992986|NCT00117949|19682010|P4|STARTED|Overall Study||24
7992987|NCT00117949|19682011|P3|STARTED|Overall Study||24
7992988|NCT00117949|19682012|P2|STARTED|Overall Study||24
7992989|NCT00117949|19682013|P1|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10
7992990|NCT00117845|19682047|P1|NOT COMPLETED|Overall Study||1
7992991|NCT00117845|19682047|P1|COMPLETED|Overall Study||16
7992992|NCT00117845|19682047|P1|STARTED|Overall Study||17
7992993|NCT00117806|19682054|P2|NOT COMPLETED|Overall Study||16
7992994|NCT00117806|19682055|P1|NOT COMPLETED|Overall Study||38
7992995|NCT00117806|19682054|P2|COMPLETED|Overall Study||60
7992996|NCT00117806|19682055|P1|COMPLETED|Overall Study||43
7992997|NCT00117806|19682054|P2|STARTED|Overall Study||76
7992998|NCT00117806|19682055|P1|STARTED|Overall Study||81
7992999|NCT00117793|19682065|P1|NOT COMPLETED|Overall Study||12
7993000|NCT00117793|19682065|P1|COMPLETED|Overall Study||5
7993001|NCT00117793|19682065|P1|STARTED|Overall Study||17
7993002|NCT00117715|19682080|P1|NOT COMPLETED|Overall Study||72
7993003|NCT00117715|19682080|P1|COMPLETED|Overall Study||49
7993004|NCT00117715|19682080|P1|5 Year|Overall Study||49
7993005|NCT00117715|19682080|P1|4.5 Year|Overall Study||55
7993006|NCT00117715|19682080|P1|4 Year|Overall Study||58
7993007|NCT00117715|19682080|P1|3.5 Year|Overall Study||60
7993008|NCT00117715|19682080|P1|3 Year|Overall Study||61
7993009|NCT00117715|19682080|P1|2.5 Year|Overall Study||70
7993010|NCT00117715|19682080|P1|2 Year|Overall Study||76
7993011|NCT00117715|19682080|P1|1.5 Year|Overall Study||85
7993012|NCT00117715|19682080|P1|1 Year|Overall Study||88
7993013|NCT00117715|19682080|P1|STARTED|Overall Study||121
7993014|NCT00117676|19682088|P2|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
7993015|NCT00117676|19682089|P1|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
7993016|NCT00117676|19682088|P2|COMPLETED|Open-label Period: Weeks 433 - 480||41
7993017|NCT00117676|19682089|P1|COMPLETED|Open-label Period: Weeks 433 - 480||80
7993018|NCT00117676|19682088|P2|STARTED|Open-label Period: Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|43
7993019|NCT00117676|19682089|P1|STARTED|Open-label Period: Weeks 433 - 480||82
7993020|NCT00117676|19682088|P2|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2
7993021|NCT00117676|19682089|P1|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0
7993022|NCT00117676|19682088|P2|COMPLETED|Open-label Period: Weeks 385 - 432||44
7993023|NCT00117676|19682089|P1|COMPLETED|Open-label Period: Weeks 385 - 432||82
7993024|NCT00117676|19682088|P2|STARTED|Open-label Period: Weeks 385 - 432|44 participants completed 384 weeks but did not continue on study.|46
7993025|NCT00117676|19682089|P1|STARTED|Open-label Period: Weeks 385 - 432|94 participants completed 384 weeks but did not continue on study.|82
7993026|NCT00117676|19682088|P2|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3
7993027|NCT00117676|19682089|P1|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7
7993028|NCT00117676|19682088|P2|COMPLETED|Open-label Period: Weeks 337 - 384||90
7993029|NCT00117676|19682089|P1|COMPLETED|Open-label Period: Weeks 337 - 384||176
7993030|NCT00117676|19682088|P2|STARTED|Open-label Period: Weeks 337 - 384||93
7993031|NCT00117676|19682089|P1|STARTED|Open-label Period: Weeks 337 - 384||183
7993032|NCT00117676|19682088|P2|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7
7993033|NCT00117676|19682089|P1|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9
7993034|NCT00117676|19682088|P2|COMPLETED|Open-label Period: Weeks 289 - 336||93
7993035|NCT00117676|19682089|P1|COMPLETED|Open-label Period: Weeks 289 - 336||183
7993036|NCT00117676|19682088|P2|STARTED|Open-label Period: Weeks 289 - 336||100
7993037|NCT00117676|19682089|P1|STARTED|Open-label Period: Weeks 289 - 336||192
7993038|NCT00117676|19682088|P2|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3
7993039|NCT00117676|19682089|P1|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10
7993040|NCT00117676|19682088|P2|COMPLETED|Open-label Period: Weeks 241 - 288||100
7993041|NCT00117676|19682089|P1|COMPLETED|Open-label Period: Weeks 241 - 288||192
7993042|NCT00117676|19682088|P2|STARTED|Open-label Period: Weeks 241 - 288||103
7993043|NCT00117676|19682089|P1|STARTED|Open-label Period: Weeks 241 - 288||202
7993044|NCT00117676|19682088|P2|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3
7993045|NCT00117676|19682089|P1|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7
7993046|NCT00117676|19682088|P2|COMPLETED|Open-label Period: Weeks 193 - 240||103
7993047|NCT00117676|19682089|P1|COMPLETED|Open-label Period: Weeks 193 - 240||202
7993048|NCT00117676|19682088|P2|STARTED|Open-label Period: Weeks 193 - 240||106
7993049|NCT00117676|19682089|P1|STARTED|Open-label Period: Weeks 193 - 240||209
7993050|NCT00117676|19682088|P2|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3
7993051|NCT00117676|19682089|P1|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10
7993052|NCT00117676|19682088|P2|COMPLETED|Open-label Period: Weeks 145 - 192||106
7993053|NCT00117676|19682089|P1|COMPLETED|Open-label Period: Weeks 145 - 192||209
7993054|NCT00117676|19682088|P2|STARTED|Open-label Period: Weeks 145 - 192||109
7993055|NCT00117676|19682089|P1|STARTED|Open-label Period: Weeks 145 - 192||219
7993056|NCT00117676|19682088|P2|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1
7993057|NCT00117676|19682089|P1|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6
7993058|NCT00117676|19682088|P2|COMPLETED|Open-label Period: Weeks 97 - 144||109
7993059|NCT00117676|19682089|P1|COMPLETED|Open-label Period: Weeks 97 - 144||219
7993060|NCT00117676|19682088|P2|STARTED|Open-label Period: Weeks 97 - 144||110
7993061|NCT00117676|19682089|P1|STARTED|Open-label Period: Weeks 97 - 144||225
7993062|NCT00117676|19682088|P2|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2
7993063|NCT00117676|19682089|P1|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10
7993064|NCT00117676|19682088|P2|COMPLETED|Open-label Period: Weeks 49 - 96||110
7993065|NCT00117676|19682089|P1|COMPLETED|Open-label Period: Weeks 49 - 96||225
7993066|NCT00117676|19682088|P2|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112
7993067|NCT00117676|19682089|P1|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235
7993068|NCT00117676|19682088|P2|NOT COMPLETED|Double-blind Period Through Week 48||7
7993069|NCT00117676|19682089|P1|NOT COMPLETED|Double-blind Period Through Week 48||10
7993070|NCT00117676|19682088|P2|COMPLETED|Double-blind Period Through Week 48||121
7993071|NCT00117676|19682089|P1|COMPLETED|Double-blind Period Through Week 48||244
7993072|NCT00117676|19682088|P2|STARTED|Double-blind Period Through Week 48||128
7993073|NCT00117676|19682089|P1|STARTED|Double-blind Period Through Week 48||254
7993074|NCT00117637|19682178|P2|NOT COMPLETED|Second Intervention (Period 2)||22
7993075|NCT00117637|19682179|P1|NOT COMPLETED|Second Intervention (Period 2)||10
7993076|NCT00117637|19682178|P2|COMPLETED|Second Intervention (Period 2)||39
7993077|NCT00117637|19682179|P1|COMPLETED|Second Intervention (Period 2)||39
7993078|NCT00117637|19682178|P2|Subjects Received Treatment|Second Intervention (Period 2)||61
7993079|NCT00117637|19682179|P1|Subjects Received Treatment|Second Intervention (Period 2)||49
7993080|NCT00117637|19682178|P2|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61
7993081|NCT00117637|19682179|P1|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49
7993082|NCT00117637|19682178|P2|NOT COMPLETED|First Intervention (Period 1)||25
7993083|NCT00117637|19682179|P1|NOT COMPLETED|First Intervention (Period 1)||18
7993084|NCT00117637|19682178|P2|COMPLETED|First Intervention (Period 1)||67
7993085|NCT00117637|19682179|P1|COMPLETED|First Intervention (Period 1)||79
7993086|NCT00117637|19682178|P2|Subjects Received Treatment|First Intervention (Period 1)||90
7993087|NCT00117637|19682179|P1|Subjects Received Treatment|First Intervention (Period 1)||97
7993088|NCT00117637|19682178|P2|STARTED|First Intervention (Period 1)||92
7993089|NCT00117637|19682179|P1|STARTED|First Intervention (Period 1)||97
7993090|NCT00117598|19682254|P5|NOT COMPLETED|After Treament Cross Over||4
7993091|NCT00117598|19682255|P4|NOT COMPLETED|After Treament Cross Over||3
7993092|NCT00117598|19682256|P3|NOT COMPLETED|After Treament Cross Over||0
7993093|NCT00117598|19682257|P2|NOT COMPLETED|After Treament Cross Over||0
7993094|NCT00117598|19682258|P1|NOT COMPLETED|After Treament Cross Over||0
7993095|NCT00117598|19682254|P5|COMPLETED|After Treament Cross Over||0
7993096|NCT00117598|19682255|P4|COMPLETED|After Treament Cross Over||0
7993097|NCT00117598|19682256|P3|COMPLETED|After Treament Cross Over||0
7993098|NCT00117598|19682257|P2|COMPLETED|After Treament Cross Over||0
7993099|NCT00117598|19682258|P1|COMPLETED|After Treament Cross Over||0
7993100|NCT00117598|19682254|P5|STARTED|After Treament Cross Over||4
7993101|NCT00117598|19682255|P4|STARTED|After Treament Cross Over||3
7993102|NCT00117598|19682256|P3|STARTED|After Treament Cross Over||0
7993103|NCT00117598|19682257|P2|STARTED|After Treament Cross Over||0
7993104|NCT00117598|19682258|P1|STARTED|After Treament Cross Over||0
7993105|NCT00117598|19682254|P5|NOT COMPLETED|Prior to Treatment Cross Over||0
7993106|NCT00117598|19682255|P4|NOT COMPLETED|Prior to Treatment Cross Over||0
7993107|NCT00117598|19682256|P3|NOT COMPLETED|Prior to Treatment Cross Over||52
7993108|NCT00117598|19682257|P2|NOT COMPLETED|Prior to Treatment Cross Over||53
7993109|NCT00117598|19682258|P1|NOT COMPLETED|Prior to Treatment Cross Over||57
7993110|NCT00117598|19682254|P5|COMPLETED|Prior to Treatment Cross Over||0
7993111|NCT00117598|19682255|P4|COMPLETED|Prior to Treatment Cross Over||0
7993112|NCT00117598|19682256|P3|COMPLETED|Prior to Treatment Cross Over||4
7993113|NCT00117598|19682257|P2|COMPLETED|Prior to Treatment Cross Over||3
7993114|NCT00117598|19682258|P1|COMPLETED|Prior to Treatment Cross Over||0
7993115|NCT00117598|19682254|P5|STARTED|Prior to Treatment Cross Over||0
7993116|NCT00117598|19682255|P4|STARTED|Prior to Treatment Cross Over||0
7993117|NCT00117598|19682256|P3|STARTED|Prior to Treatment Cross Over||56
7993118|NCT00117598|19682257|P2|STARTED|Prior to Treatment Cross Over||56
7993119|NCT00117598|19682258|P1|STARTED|Prior to Treatment Cross Over||57
7993120|NCT00117585|19682286|P1|NOT COMPLETED|Overall Study||0
7993121|NCT00117585|19682286|P1|COMPLETED|Overall Study||341
7993122|NCT00117585|19682286|P1|STARTED|Overall Study||341
7993123|NCT00117572|19682292|P2|NOT COMPLETED|Overall Study||6
7993124|NCT00117572|19682293|P1|NOT COMPLETED|Overall Study||6
7993125|NCT00117572|19682292|P2|COMPLETED|Overall Study||135
7993126|NCT00117572|19682293|P1|COMPLETED|Overall Study||138
7993127|NCT00117572|19682292|P2|STARTED|Overall Study||141
7993128|NCT00117572|19682293|P1|STARTED|Overall Study||144
7993129|NCT00117559|19682325|P2|NOT COMPLETED|Overall Study||1
7993130|NCT00117559|19682326|P1|NOT COMPLETED|Overall Study||1
7993131|NCT00117559|19682325|P2|COMPLETED|Overall Study||9
7993132|NCT00117559|19682326|P1|COMPLETED|Overall Study||8
7993133|NCT00117559|19682325|P2|STARTED|Overall Study||10
7993134|NCT00117559|19682326|P1|STARTED|Overall Study||9
7993135|NCT00117338|19682334|P2|NOT COMPLETED|Overall Study||4
7993136|NCT00117338|19682335|P1|NOT COMPLETED|Overall Study||5
7993137|NCT00117338|19682334|P2|COMPLETED|Overall Study||127
7993138|NCT00117338|19682335|P1|COMPLETED|Overall Study||140
7993139|NCT00117338|19682334|P2|STARTED|Overall Study||131
7993140|NCT00117338|19682335|P1|STARTED|Overall Study||145
7993141|NCT00117325|19682355|P2|NOT COMPLETED|Overall Study||12
7993142|NCT00117325|19682356|P1|NOT COMPLETED|Overall Study||13
7993143|NCT00117325|19682355|P2|COMPLETED|Overall Study||167
7993144|NCT00117325|19682356|P1|COMPLETED|Overall Study||160
7993145|NCT00117325|19682355|P2|STARTED|Overall Study||179
7993146|NCT00117325|19682356|P1|STARTED|Overall Study||173
7993147|NCT00117312|19682388|P4|NOT COMPLETED|Overall Study||21
7993148|NCT00117312|19682389|P3|NOT COMPLETED|Overall Study||24
7993149|NCT00117312|19682390|P2|NOT COMPLETED|Overall Study||20
7993150|NCT00117312|19682391|P1|NOT COMPLETED|Overall Study||10
7993151|NCT00117312|19682388|P4|COMPLETED|Overall Study||3
7993152|NCT00117312|19682389|P3|COMPLETED|Overall Study||0
7993153|NCT00117312|19682390|P2|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4
7993154|NCT00117312|19682391|P1|COMPLETED|Overall Study||0
7993155|NCT00117312|19682388|P4|Started FE200486 CS06A|Overall Study||9
7993156|NCT00117312|19682389|P3|Started FE200486 CS06A|Overall Study||16
7993157|NCT00117312|19682390|P2|Started FE200486 CS06A|Overall Study||11
7993158|NCT00117312|19682391|P1|Started FE200486 CS06A|Overall Study||1
7993159|NCT00117312|19682388|P4|STARTED|Overall Study||24
7993160|NCT00117312|19682389|P3|STARTED|Overall Study||24
7993161|NCT00117312|19682390|P2|STARTED|Overall Study||24
7993162|NCT00117312|19682391|P1|STARTED|Overall Study||10
7993163|NCT00117286|19682407|P2|NOT COMPLETED|Overall Study||21
7993164|NCT00117286|19682408|P1|NOT COMPLETED|Overall Study||28
7993165|NCT00117286|19682407|P2|COMPLETED|Overall Study||6
7993166|NCT00117286|19682408|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2
7993167|NCT00117286|19682407|P2|Switched to Higher Dose|Overall Study||17
7993168|NCT00117286|19682408|P1|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17
7993169|NCT00117286|19682407|P2|STARTED|Overall Study||27
7993170|NCT00117286|19682408|P1|STARTED|Overall Study|Safety analysis set|30
7993171|NCT00117156|19682416|P1|NOT COMPLETED|Overall Study||11
7993172|NCT00117156|19682416|P1|COMPLETED|Overall Study||15
7993173|NCT00117156|19682416|P1|STARTED|Overall Study||26
7993174|NCT00117143|19682428|P4|NOT COMPLETED|Overall Study||0
7993175|NCT00117143|19682429|P3|NOT COMPLETED|Overall Study||0
7993176|NCT00117143|19682430|P2|NOT COMPLETED|Overall Study||0
7993177|NCT00117143|19682431|P1|NOT COMPLETED|Overall Study||0
7993178|NCT00117143|19682428|P4|COMPLETED|Overall Study||1
7993179|NCT00117143|19682429|P3|COMPLETED|Overall Study||7
7993180|NCT00117143|19682430|P2|COMPLETED|Overall Study||4
7993181|NCT00117143|19682431|P1|COMPLETED|Overall Study||4
7993182|NCT00117143|19682428|P4|Received Second Dose|Overall Study||0
7993183|NCT00117143|19682429|P3|Received Second Dose|Overall Study||6
7993184|NCT00117143|19682430|P2|Received Second Dose|Overall Study||4
7993185|NCT00117143|19682431|P1|Received Second Dose|Overall Study||4
7993186|NCT00117143|19682428|P4|Received First Dose|Overall Study||1
7993187|NCT00117143|19682429|P3|Received First Dose|Overall Study||7
7993188|NCT00117143|19682430|P2|Received First Dose|Overall Study||4
7993189|NCT00117143|19682431|P1|Received First Dose|Overall Study||4
7993190|NCT00117143|19682428|P4|STARTED|Overall Study||1
7993191|NCT00117143|19682429|P3|STARTED|Overall Study||7
7993192|NCT00117143|19682430|P2|STARTED|Overall Study||4
7993193|NCT00117143|19682431|P1|STARTED|Overall Study||4
7993194|NCT00116857|19682475|P2|NOT COMPLETED|Overall Study||4
7993195|NCT00116857|19682476|P1|NOT COMPLETED|Overall Study||3
7993196|NCT00116857|19682475|P2|COMPLETED|Overall Study||56
7993197|NCT00116857|19682476|P1|COMPLETED|Overall Study||59
7993198|NCT00116857|19682475|P2|STARTED|Overall Study||60
7993199|NCT00116857|19682476|P1|STARTED|Overall Study||62
7993200|NCT00116844|19682484|P2|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||5
7993201|NCT00116844|19682485|P1|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||4
7993202|NCT00116844|19682484|P2|COMPLETED|Period 1: Treatment Period 2 (60 Days)||28
7993203|NCT00116844|19682485|P1|COMPLETED|Period 1: Treatment Period 2 (60 Days)||24
7993204|NCT00116844|19682484|P2|STARTED|Period 1: Treatment Period 2 (60 Days)||33
7993205|NCT00116844|19682485|P1|STARTED|Period 1: Treatment Period 2 (60 Days)||28
7993206|NCT00116844|19682484|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
7993207|NCT00116844|19682485|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
7993208|NCT00116844|19682484|P2|COMPLETED|Period 2: Washout Period (7 Days)||33
7993209|NCT00116844|19682485|P1|COMPLETED|Period 2: Washout Period (7 Days)||28
7993210|NCT00116844|19682484|P2|STARTED|Period 2: Washout Period (7 Days)||33
7993211|NCT00116844|19682485|P1|STARTED|Period 2: Washout Period (7 Days)||28
7993212|NCT00116844|19682484|P2|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||3
7993213|NCT00116844|19682485|P1|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||7
7993214|NCT00116844|19682484|P2|COMPLETED|Period 1: Treatment Period 1 (60 Days)||33
7993215|NCT00116844|19682485|P1|COMPLETED|Period 1: Treatment Period 1 (60 Days)||28
7993216|NCT00116844|19682484|P2|STARTED|Period 1: Treatment Period 1 (60 Days)||36
7993217|NCT00116844|19682485|P1|STARTED|Period 1: Treatment Period 1 (60 Days)||35
7993218|NCT00116831|19682503|P2|NOT COMPLETED|Overall Study||72
7993219|NCT00116831|19682504|P1|NOT COMPLETED|Overall Study||73
7993220|NCT00116831|19682503|P2|COMPLETED|Overall Study||259
7993221|NCT00116831|19682504|P1|COMPLETED|Overall Study||264
7993222|NCT00116831|19682503|P2|STARTED|Overall Study||331
7993223|NCT00116831|19682504|P1|STARTED|Overall Study||337
7993224|NCT00116805|19682582|P2|NOT COMPLETED|Open-label Period Weeks 433 - 480||0
7993225|NCT00116805|19682583|P1|NOT COMPLETED|Open-label Period Weeks 433 - 480||4
7993226|NCT00116805|19682582|P2|COMPLETED|Open-label Period Weeks 433 - 480||29
7993227|NCT00116805|19682583|P1|COMPLETED|Open-label Period Weeks 433 - 480||53
7993228|NCT00116805|19682582|P2|STARTED|Open-label Period Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|29
7993229|NCT00116805|19682583|P1|STARTED|Open-label Period Weeks 433 - 480||57
7993230|NCT00116805|19682582|P2|NOT COMPLETED|Open-label Period Weeks 385 - 432||0
7993231|NCT00116805|19682583|P1|NOT COMPLETED|Open-label Period Weeks 385 - 432||2
7993232|NCT00116805|19682582|P2|COMPLETED|Open-label Period Weeks 385 - 432||30
7993233|NCT00116805|19682583|P1|COMPLETED|Open-label Period Weeks 385 - 432||57
7993234|NCT00116805|19682582|P2|STARTED|Open-label Period Weeks 385 - 432|26 participants completed 384 weeks but did not continue on study.|30
7993235|NCT00116805|19682583|P1|STARTED|Open-label Period Weeks 385 - 432|31 participants completed 384 weeks but did not continue on study.|59
7993236|NCT00116805|19682582|P2|NOT COMPLETED|Open-label Period Weeks 337 - 384||1
7993237|NCT00116805|19682583|P1|NOT COMPLETED|Open-label Period Weeks 337 - 384||8
7993238|NCT00116805|19682582|P2|COMPLETED|Open-label Period Weeks 337 - 384||56
7993239|NCT00116805|19682583|P1|COMPLETED|Open-label Period Weeks 337 - 384||90
7993240|NCT00116805|19682582|P2|STARTED|Open-label Period Weeks 337 - 384||57
7993241|NCT00116805|19682583|P1|STARTED|Open-label Period Weeks 337 - 384||98
7993242|NCT00116805|19682582|P2|NOT COMPLETED|Open-label Period Weeks 289 - 336||7
7993243|NCT00116805|19682583|P1|NOT COMPLETED|Open-label Period Weeks 289 - 336||6
7993244|NCT00116805|19682582|P2|COMPLETED|Open-label Period Weeks 289 - 336||57
7993245|NCT00116805|19682583|P1|COMPLETED|Open-label Period Weeks 289 - 336||98
7993246|NCT00116805|19682582|P2|STARTED|Open-label Period Weeks 289 - 336||64
7993247|NCT00116805|19682583|P1|STARTED|Open-label Period Weeks 289 - 336||104
7993248|NCT00116805|19682582|P2|NOT COMPLETED|Open-label Period Weeks 241 - 288||0
7993249|NCT00116805|19682583|P1|NOT COMPLETED|Open-label Period Weeks 241 - 288||6
7993250|NCT00116805|19682582|P2|COMPLETED|Open-label Period Weeks 241 - 288||64
7993251|NCT00116805|19682583|P1|COMPLETED|Open-label Period Weeks 241 - 288||104
7993252|NCT00116805|19682582|P2|STARTED|Open-label Period Weeks 241 - 288||64
7993253|NCT00116805|19682583|P1|STARTED|Open-label Period Weeks 241 - 288||110
7993254|NCT00116805|19682582|P2|NOT COMPLETED|Open-label Period Weeks 193 - 240||4
7993255|NCT00116805|19682583|P1|NOT COMPLETED|Open-label Period Weeks 193 - 240||13
7993256|NCT00116805|19682582|P2|COMPLETED|Open-label Period Weeks 193 - 240||64
7993257|NCT00116805|19682583|P1|COMPLETED|Open-label Period Weeks 193 - 240||110
7993258|NCT00116805|19682582|P2|STARTED|Open-label Period Weeks 193 - 240||68
7993259|NCT00116805|19682583|P1|STARTED|Open-label Period Weeks 193 - 240||123
7993260|NCT00116805|19682582|P2|NOT COMPLETED|Open-label Period Weeks 145 - 192||6
7993261|NCT00116805|19682583|P1|NOT COMPLETED|Open-label Period Weeks 145 - 192||10
7993262|NCT00116805|19682582|P2|COMPLETED|Open-label Period Weeks 145 - 192||68
7993263|NCT00116805|19682583|P1|COMPLETED|Open-label Period Weeks 145 - 192||123
7993264|NCT00116805|19682582|P2|STARTED|Open-label Period Weeks 145 - 192||74
7993265|NCT00116805|19682583|P1|STARTED|Open-label Period Weeks 145 - 192||133
7993266|NCT00116805|19682582|P2|NOT COMPLETED|Open-label Period Weeks 97 - 144||9
7993267|NCT00116805|19682583|P1|NOT COMPLETED|Open-label Period Weeks 97 - 144||11
7993268|NCT00116805|19682582|P2|COMPLETED|Open-label Period Weeks 97 - 144||74
7993269|NCT00116805|19682583|P1|COMPLETED|Open-label Period Weeks 97 - 144||133
7993270|NCT00116805|19682582|P2|STARTED|Open-label Period Weeks 97 - 144||83
7993271|NCT00116805|19682583|P1|STARTED|Open-label Period Weeks 97 - 144||144
7993272|NCT00116805|19682582|P2|NOT COMPLETED|Open-label Period Weeks 49 - 96||1
7993273|NCT00116805|19682583|P1|NOT COMPLETED|Open-label Period Weeks 49 - 96||10
7993274|NCT00116805|19682582|P2|COMPLETED|Open-label Period Weeks 49 - 96||83
7993275|NCT00116805|19682583|P1|COMPLETED|Open-label Period Weeks 49 - 96||144
7993276|NCT00116805|19682582|P2|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84
7993277|NCT00116805|19682583|P1|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154
7993278|NCT00116805|19682582|P2|NOT COMPLETED|Double-blind Period Through Week 48||5
7993279|NCT00116805|19682583|P1|NOT COMPLETED|Double-blind Period Through Week 48||11
7993280|NCT00116805|19682582|P2|COMPLETED|Double-blind Period Through Week 48||85
7993281|NCT00116805|19682583|P1|COMPLETED|Double-blind Period Through Week 48||165
7993282|NCT00116805|19682582|P2|STARTED|Double-blind Period Through Week 48||90
7993283|NCT00116805|19682583|P1|STARTED|Double-blind Period Through Week 48||176
7993284|NCT00116779|19682676|P2|NOT COMPLETED|Overall Study||19
7993285|NCT00116779|19682677|P1|NOT COMPLETED|Overall Study||21
7993286|NCT00116779|19682676|P2|COMPLETED|Overall Study||45
7993287|NCT00116779|19682677|P1|COMPLETED|Overall Study||42
7993288|NCT00116779|19682676|P2|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64
7993289|NCT00116779|19682677|P1|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63
7993290|NCT00116753|19682710|P3|NOT COMPLETED|Overall Study||24
7993291|NCT00116753|19682711|P2|NOT COMPLETED|Overall Study||30
7993292|NCT00116753|19682712|P1|NOT COMPLETED|Overall Study||32
7993293|NCT00116753|19682710|P3|COMPLETED|Overall Study||128
7993294|NCT00116753|19682711|P2|COMPLETED|Overall Study||125
7993295|NCT00116753|19682712|P1|COMPLETED|Overall Study||121
7993296|NCT00116753|19682710|P3|ITT Population|Overall Study||147
7993297|NCT00116753|19682711|P2|ITT Population|Overall Study||150
7993298|NCT00116753|19682712|P1|ITT Population|Overall Study||150
7993299|NCT00116753|19682710|P3|STARTED|Overall Study||152
7993300|NCT00116753|19682711|P2|STARTED|Overall Study||155
7993301|NCT00116753|19682712|P1|STARTED|Overall Study|Randomised.|153
7993302|NCT00116688|19682734|P2|NOT COMPLETED|Overall Study||4
7993303|NCT00116688|19682735|P1|NOT COMPLETED|Overall Study||92
7993304|NCT00116688|19682734|P2|COMPLETED|Overall Study||17
7993305|NCT00116688|19682735|P1|COMPLETED|Overall Study||200
7993306|NCT00116688|19682734|P2|Received Study Medication|Overall Study||20
7993307|NCT00116688|19682735|P1|Received Study Medication|Overall Study||291
7993308|NCT00116688|19682734|P2|STARTED|Overall Study||21
7993309|NCT00116688|19682735|P1|STARTED|Overall Study||292
7993310|NCT00116649|19682750|P1|NOT COMPLETED|Overall Study||155
7993311|NCT00116649|19682750|P1|COMPLETED|Overall Study||396
7993312|NCT00116649|19682750|P1|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551
7993313|NCT00116584|19682757|P2|NOT COMPLETED|Overall Study||1
7993314|NCT00116584|19682758|P1|NOT COMPLETED|Overall Study||2
7993315|NCT00116584|19682757|P2|COMPLETED|Overall Study||35
7993316|NCT00116584|19682758|P1|COMPLETED|Overall Study||34
7993317|NCT00116584|19682757|P2|STARTED|Overall Study||36
7993318|NCT00116584|19682758|P1|STARTED|Overall Study||36
7993319|NCT00116558|19682771|P3|NOT COMPLETED|Overall Study||33
7993320|NCT00116558|19682772|P2|NOT COMPLETED|Overall Study||15
7993321|NCT00116558|19682773|P1|NOT COMPLETED|Overall Study||31
7993322|NCT00116558|19682771|P3|COMPLETED|Overall Study||14
7993323|NCT00116558|19682772|P2|COMPLETED|Overall Study||11
7993324|NCT00116558|19682773|P1|COMPLETED|Overall Study||49
7993325|NCT00116558|19682771|P3|STARTED|Overall Study||47
7993326|NCT00116558|19682772|P2|STARTED|Overall Study||26
7993327|NCT00116558|19682773|P1|STARTED|Overall Study||80
7993328|NCT00116428|19682784|P2|NOT COMPLETED|Overall Study||5
7993329|NCT00116428|19682785|P1|NOT COMPLETED|Overall Study||3
7993330|NCT00116428|19682784|P2|COMPLETED|Overall Study||56
7993331|NCT00116428|19682785|P1|COMPLETED|Overall Study||103
7993332|NCT00116428|19682784|P2|Underwent Study Ablation Procedure|Overall Study||36
7993333|NCT00116428|19682785|P1|Underwent Study Ablation Procedure|Overall Study||103
7993334|NCT00116428|19682784|P2|STARTED|Overall Study||61
7993335|NCT00116428|19682785|P1|STARTED|Overall Study||106
7993336|NCT00116337|19682801|P1|NOT COMPLETED|Overall Study||0
7993337|NCT00116337|19682801|P1|COMPLETED|Overall Study||17
7993338|NCT00116337|19682801|P1|STARTED|Overall Study||17
7993339|NCT00116272|19682814|P2|NOT COMPLETED|Overall Study||6
7993340|NCT00116272|19682815|P1|NOT COMPLETED|Overall Study||11
7993341|NCT00116272|19682814|P2|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158
7993342|NCT00116272|19682815|P1|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359
7993343|NCT00116272|19682814|P2|STARTED|Overall Study||164
7993344|NCT00116272|19682815|P1|STARTED|Overall Study||370
7993345|NCT00116207|19682867|P2|NOT COMPLETED|Overall Study||4
7993346|NCT00116207|19682868|P1|NOT COMPLETED|Overall Study||9
7993347|NCT00116207|19682867|P2|COMPLETED|Overall Study||18
7993348|NCT00116207|19682868|P1|COMPLETED|Overall Study||13
7993349|NCT00116207|19682867|P2|STARTED|Overall Study||22
7993350|NCT00116207|19682868|P1|STARTED|Overall Study||22
7993351|NCT00116168|19682884|P4|NOT COMPLETED|Overall Study||0
7993352|NCT00116168|19682885|P3|NOT COMPLETED|Overall Study||0
7993353|NCT00116168|19682886|P2|NOT COMPLETED|Overall Study||5
7993354|NCT00116168|19682887|P1|NOT COMPLETED|Overall Study||6
7993355|NCT00116168|19682884|P4|COMPLETED|Overall Study||6
7993356|NCT00116168|19682885|P3|COMPLETED|Overall Study||6
7993357|NCT00116168|19682886|P2|COMPLETED|Overall Study||6
7993358|NCT00116168|19682887|P1|COMPLETED|Overall Study||0
7993359|NCT00116168|19682884|P4|STARTED|Overall Study||6
7993360|NCT00116168|19682885|P3|STARTED|Overall Study||6
7993361|NCT00116168|19682886|P2|STARTED|Overall Study||11
7993362|NCT00116168|19682887|P1|STARTED|Overall Study||6
7993363|NCT00115934|19682951|P2|NOT COMPLETED|Overall Study||2
7993364|NCT00115934|19682952|P1|NOT COMPLETED|Overall Study||4
7993365|NCT00115934|19682951|P2|COMPLETED|Overall Study||274
7993366|NCT00115934|19682952|P1|COMPLETED|Overall Study||275
7993367|NCT00115934|19682951|P2|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276
7993368|NCT00115934|19682952|P1|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279
7993369|NCT00115869|19682992|P2|NOT COMPLETED|Overall Study||296
7993370|NCT00115869|19682993|P1|NOT COMPLETED|Overall Study||317
7993371|NCT00115869|19682992|P2|COMPLETED|Overall Study|Follow-up at two years post high school.|3881
7993372|NCT00115869|19682993|P1|COMPLETED|Overall Study||3894
7993373|NCT00115869|19682992|P2|Completed Data Collection at 12th Grade|Overall Study||3847
7993374|NCT00115869|19682993|P1|Completed Data Collection at 12th Grade|Overall Study||3876
7993375|NCT00115869|19682992|P2|STARTED|Overall Study||4177
7993376|NCT00115869|19682993|P1|STARTED|Overall Study||4211
7993377|NCT00115804|19683001|P1|NOT COMPLETED|Overall Study||2
7993378|NCT00115804|19683001|P1|COMPLETED|Overall Study||4
7993379|NCT00115804|19683001|P1|STARTED|Overall Study||6
7993380|NCT00115778|19683012|P2|NOT COMPLETED|Overall Study||1
7993381|NCT00115778|19683013|P1|NOT COMPLETED|Overall Study||0
7993382|NCT00115778|19683012|P2|COMPLETED|Overall Study||4
7993383|NCT00115778|19683013|P1|COMPLETED|Overall Study||6
7993384|NCT00115778|19683012|P2|STARTED|Overall Study||5
7993385|NCT00115778|19683013|P1|STARTED|Overall Study||6
7993386|NCT00115765|19683033|P4|NOT COMPLETED|Overall Study||31
7993387|NCT00115765|19683034|P3|NOT COMPLETED|Overall Study||121
7993388|NCT00115765|19683035|P2|NOT COMPLETED|Overall Study||100
7993389|NCT00115765|19683036|P1|NOT COMPLETED|Overall Study||35
7993390|NCT00115765|19683033|P4|COMPLETED|Overall Study|Participants who were on study at closure or died|84
7993391|NCT00115765|19683034|P3|COMPLETED|Overall Study|Participants who were on study at closure or died|289
7993392|NCT00115765|19683035|P2|COMPLETED|Overall Study|Participants who were on study at closure or died|313
7993393|NCT00115765|19683036|P1|COMPLETED|Overall Study|Participants who were on study at closure or died|80
7993394|NCT00115765|19683033|P4|STARTED|Overall Study||115
7993395|NCT00115765|19683034|P3|STARTED|Overall Study||410
7993396|NCT00115765|19683035|P2|STARTED|Overall Study||413
7993397|NCT00115765|19683036|P1|STARTED|Overall Study||115
7993398|NCT00115739|19683074|P1|NOT COMPLETED|Overall Study||3
7993399|NCT00115739|19683074|P1|COMPLETED|Overall Study||8
7993400|NCT00115739|19683074|P1|STARTED|Overall Study||11
7993401|NCT00115349|19683083|P2|NOT COMPLETED|Overall Study||9
7993402|NCT00115349|19683084|P1|NOT COMPLETED|Overall Study||11
7993403|NCT00115349|19683083|P2|COMPLETED|Overall Study|study closed due to low enrollment.|0
7993404|NCT00115349|19683084|P1|COMPLETED|Overall Study|Study closed due to low enrollment.|0
7993405|NCT00115349|19683083|P2|STARTED|Overall Study|Target was 43 subjects in this arm.|9
7993406|NCT00115349|19683084|P1|STARTED|Overall Study|Target was 43 subjects in this arm.|11
7993407|NCT00115336|19683092|P2|NOT COMPLETED|Overall Study||1
7993408|NCT00115336|19683093|P1|NOT COMPLETED|Overall Study||0
7993409|NCT00115336|19683092|P2|COMPLETED|Overall Study||3
7993410|NCT00115336|19683093|P1|COMPLETED|Overall Study||6
7993411|NCT00115336|19683092|P2|STARTED|Overall Study||4
7993412|NCT00115336|19683093|P1|STARTED|Overall Study||6
7993413|NCT00115297|19683117|P2|NOT COMPLETED|Overall Study||0
7993414|NCT00115297|19683118|P1|NOT COMPLETED|Overall Study||0
7993415|NCT00115297|19683117|P2|COMPLETED|Overall Study||32
7993416|NCT00115297|19683118|P1|COMPLETED|Overall Study||30
7993417|NCT00115297|19683117|P2|STARTED|Overall Study||32
7993418|NCT00115297|19683118|P1|STARTED|Overall Study||30
7993419|NCT00115063|19683130|P2|NOT COMPLETED|Overall Study||104
7993420|NCT00115063|19683131|P1|NOT COMPLETED|Overall Study||99
7993421|NCT00115063|19683130|P2|COMPLETED|Overall Study||86
7993422|NCT00115063|19683131|P1|COMPLETED|Overall Study||101
7993423|NCT00115063|19683130|P2|STARTED|Overall Study||190
7993424|NCT00115063|19683131|P1|STARTED|Overall Study||200
7993425|NCT00115037|19683149|P6|NOT COMPLETED|Phase2||12
7993426|NCT00115037|19683150|P5|NOT COMPLETED|Phase2||6
7993427|NCT00115037|19683151|P4|NOT COMPLETED|Phase2||15
7993428|NCT00115037|19683152|P3|NOT COMPLETED|Phase2||15
7993429|NCT00115037|19683153|P2|NOT COMPLETED|Phase2||0
7993430|NCT00115037|19683154|P1|NOT COMPLETED|Phase2||0
7993431|NCT00115037|19683149|P6|COMPLETED|Phase2||21
7993432|NCT00115037|19683150|P5|COMPLETED|Phase2||28
7993433|NCT00115037|19683151|P4|COMPLETED|Phase2||77
7993434|NCT00115037|19683152|P3|COMPLETED|Phase2||76
7993435|NCT00115037|19683153|P2|COMPLETED|Phase2||0
7993436|NCT00115037|19683154|P1|COMPLETED|Phase2||0
7993437|NCT00115037|19683149|P6|STARTED|Phase2||33
7993438|NCT00115037|19683150|P5|STARTED|Phase2||34
7993439|NCT00115037|19683151|P4|STARTED|Phase2||92
7993440|NCT00115037|19683152|P3|STARTED|Phase2||91
7993441|NCT00115037|19683153|P2|STARTED|Phase2||0
7993442|NCT00115037|19683154|P1|STARTED|Phase2||0
7993443|NCT00115037|19683149|P6|NOT COMPLETED|Phase1||0
7993444|NCT00115037|19683150|P5|NOT COMPLETED|Phase1||0
7993445|NCT00115037|19683151|P4|NOT COMPLETED|Phase1||0
7993446|NCT00115037|19683152|P3|NOT COMPLETED|Phase1||0
7993447|NCT00115037|19683153|P2|NOT COMPLETED|Phase1||27
7993448|NCT00115037|19683154|P1|NOT COMPLETED|Phase1||25
7993449|NCT00115037|19683149|P6|COMPLETED|Phase1||0
7993450|NCT00115037|19683150|P5|COMPLETED|Phase1||0
7993451|NCT00115037|19683151|P4|COMPLETED|Phase1||0
7993452|NCT00115037|19683152|P3|COMPLETED|Phase1||0
7993453|NCT00115037|19683153|P2|COMPLETED|Phase1||123
7993454|NCT00115037|19683154|P1|COMPLETED|Phase1||127
7993455|NCT00115037|19683149|P6|STARTED|Phase1||0
7993456|NCT00115037|19683150|P5|STARTED|Phase1||0
7993457|NCT00115037|19683151|P4|STARTED|Phase1||0
7993458|NCT00115037|19683152|P3|STARTED|Phase1||0
7993459|NCT00115037|19683153|P2|STARTED|Phase1||150
7993460|NCT00115037|19683154|P1|STARTED|Phase1||152
7993461|NCT00114972|19683170|P2|NOT COMPLETED|Overall Study||12
7993462|NCT00114972|19683171|P1|NOT COMPLETED|Overall Study||48
7993463|NCT00114972|19683170|P2|COMPLETED|Overall Study||891
7993464|NCT00114972|19683171|P1|COMPLETED|Overall Study||849
7993465|NCT00114972|19683170|P2|STARTED|Overall Study||903
7993466|NCT00114972|19683171|P1|STARTED|Overall Study||897
7993467|NCT00114959|19683191|P1|NOT COMPLETED|Overall Study||8
7993468|NCT00114959|19683191|P1|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7
7993469|NCT00114959|19683191|P1|STARTED|Overall Study||15
7993470|NCT00114777|19683201|P3|NOT COMPLETED|Long-Term Extension to Month 84||30
7993471|NCT00114777|19683202|P2|NOT COMPLETED|Long-Term Extension to Month 84||29
7993472|NCT00114777|19683203|P1|NOT COMPLETED|Long-Term Extension to Month 84||30
7993473|NCT00114777|19683201|P3|COMPLETED|Long-Term Extension to Month 84||57
7993474|NCT00114777|19683202|P2|COMPLETED|Long-Term Extension to Month 84||84
7993475|NCT00114777|19683203|P1|COMPLETED|Long-Term Extension to Month 84||74
7993476|NCT00114777|19683201|P3|STARTED|Long-Term Extension to Month 84||87
7993477|NCT00114777|19683202|P2|STARTED|Long-Term Extension to Month 84||113
7993478|NCT00114777|19683203|P1|STARTED|Long-Term Extension to Month 84||104
7993479|NCT00114777|19683201|P3|NOT COMPLETED|Randomization to Month 36||84
7993480|NCT00114777|19683202|P2|NOT COMPLETED|Randomization to Month 36||61
7993481|NCT00114777|19683203|P1|NOT COMPLETED|Randomization to Month 36||75
7993482|NCT00114777|19683201|P3|COMPLETED|Randomization to Month 36||100
7993483|NCT00114777|19683202|P2|COMPLETED|Randomization to Month 36||114
7993484|NCT00114777|19683203|P1|COMPLETED|Randomization to Month 36||109
7993485|NCT00114777|19683201|P3|STARTED|Randomization to Month 36||184
7993486|NCT00114777|19683202|P2|STARTED|Randomization to Month 36||175
7993487|NCT00114777|19683203|P1|STARTED|Randomization to Month 36||184
7993488|NCT00114738|19683277|P3|NOT COMPLETED|Randomization||0
7993489|NCT00114738|19683278|P2|NOT COMPLETED|Randomization||0
7993490|NCT00114738|19683279|P1|NOT COMPLETED|Randomization||0
7993491|NCT00114738|19683277|P3|COMPLETED|Randomization||16
7993492|NCT00114738|19683278|P2|COMPLETED|Randomization||14
7993493|NCT00114738|19683279|P1|COMPLETED|Randomization||0
7993494|NCT00114738|19683277|P3|STARTED|Randomization||16
7993495|NCT00114738|19683278|P2|STARTED|Randomization||14
7993496|NCT00114738|19683279|P1|STARTED|Randomization||0
7993497|NCT00114738|19683277|P3|NOT COMPLETED|Screening for Randomization||0
7993498|NCT00114738|19683278|P2|NOT COMPLETED|Screening for Randomization||0
7993499|NCT00114738|19683279|P1|NOT COMPLETED|Screening for Randomization||21
7993500|NCT00114738|19683277|P3|COMPLETED|Screening for Randomization||0
7993501|NCT00114738|19683278|P2|COMPLETED|Screening for Randomization||0
7993502|NCT00114738|19683279|P1|COMPLETED|Screening for Randomization||30
7993503|NCT00114738|19683277|P3|STARTED|Screening for Randomization||0
7993504|NCT00114738|19683278|P2|STARTED|Screening for Randomization||0
7993505|NCT00114738|19683279|P1|STARTED|Screening for Randomization||51
7993506|NCT00114738|19683277|P3|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
7993507|NCT00114738|19683278|P2|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
7993508|NCT00114738|19683279|P1|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||2
7993509|NCT00114738|19683277|P3|COMPLETED|Bortezomib Then Bortezomib + Induction||0
7993510|NCT00114738|19683278|P2|COMPLETED|Bortezomib Then Bortezomib + Induction||0
7993511|NCT00114738|19683279|P1|COMPLETED|Bortezomib Then Bortezomib + Induction||51
7993512|NCT00114738|19683277|P3|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
7993513|NCT00114738|19683278|P2|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
7993514|NCT00114738|19683279|P1|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||6
7993515|NCT00114738|19683277|P3|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
7993516|NCT00114738|19683278|P2|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
7993517|NCT00114738|19683279|P1|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||47
7993518|NCT00114738|19683277|P3|STARTED|Bortezomib Then Bortezomib + Induction||0
7993519|NCT00114738|19683278|P2|STARTED|Bortezomib Then Bortezomib + Induction||0
7993520|NCT00114738|19683279|P1|STARTED|Bortezomib Then Bortezomib + Induction||53
7993521|NCT00114634|19683292|P1|NOT COMPLETED|Overall Study||3
7993522|NCT00114634|19683292|P1|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10
7993523|NCT00114634|19683292|P1|STARTED|Overall Study||13
7993524|NCT00114530|19683308|P2|NOT COMPLETED|Overall Study||20
7993525|NCT00114530|19683309|P1|NOT COMPLETED|Overall Study||9
7993526|NCT00114530|19683308|P2|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|19
7993527|NCT00114530|19683309|P1|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|27
7993528|NCT00114530|19683308|P2|STARTED|Overall Study||39
7993529|NCT00114530|19683309|P1|STARTED|Overall Study||36
7993530|NCT00114517|19683418|P4|NOT COMPLETED|Overall Study||10
7993531|NCT00114517|19683419|P3|NOT COMPLETED|Overall Study||14
7993532|NCT00114517|19683420|P2|NOT COMPLETED|Overall Study||11
7993533|NCT00114517|19683421|P1|NOT COMPLETED|Overall Study||12
7993534|NCT00114517|19683418|P4|COMPLETED|Overall Study||176
7993535|NCT00114517|19683419|P3|COMPLETED|Overall Study||172
7993536|NCT00114517|19683420|P2|COMPLETED|Overall Study||123
7993537|NCT00114517|19683421|P1|COMPLETED|Overall Study||125
7993538|NCT00114517|19683418|P4|STARTED|Overall Study||186
7993539|NCT00114517|19683419|P3|STARTED|Overall Study||186
7993540|NCT00114517|19683420|P2|STARTED|Overall Study||134
7993541|NCT00114517|19683421|P1|STARTED|Overall Study||137
7993542|NCT00114504|19683433|P2|NOT COMPLETED|Overall Study||0
7993543|NCT00114504|19683434|P1|NOT COMPLETED|Overall Study||0
7993544|NCT00114504|19683433|P2|COMPLETED|Overall Study||22
7993545|NCT00114504|19683434|P1|COMPLETED|Overall Study||21
7993546|NCT00114504|19683433|P2|STARTED|Overall Study||22
7993547|NCT00114504|19683434|P1|STARTED|Overall Study||21
7993548|NCT00114244|19683446|P2|NOT COMPLETED|Overall Study||7
7993549|NCT00114244|19683447|P1|NOT COMPLETED|Overall Study||2
7993550|NCT00114244|19683446|P2|COMPLETED|Overall Study||30
7993551|NCT00114244|19683447|P1|COMPLETED|Overall Study||13
7993552|NCT00114244|19683446|P2|STARTED|Overall Study||37
7993553|NCT00114244|19683447|P1|STARTED|Overall Study||15
7993554|NCT00114231|19683459|P2|NOT COMPLETED|Overall Study||2
7993555|NCT00114231|19683460|P1|NOT COMPLETED|Overall Study||9
7993556|NCT00114231|19683459|P2|COMPLETED|Overall Study||26
7993557|NCT00114231|19683460|P1|COMPLETED|Overall Study||53
7993558|NCT00114231|19683459|P2|STARTED|Overall Study||28
7993559|NCT00114231|19683460|P1|STARTED|Overall Study||62
7993560|NCT00114218|19683469|P1|NOT COMPLETED|Overall Study||4
7993561|NCT00114218|19683469|P1|COMPLETED|Overall Study||24
7993562|NCT00114218|19683469|P1|STARTED|Overall Study||28
7993563|NCT00114166|19683476|P2|NOT COMPLETED|Overall Study||1
7993564|NCT00114166|19683477|P1|NOT COMPLETED|Overall Study||0
7993565|NCT00114166|19683476|P2|COMPLETED|Overall Study||65
7993566|NCT00114166|19683477|P1|COMPLETED|Overall Study||15
7993567|NCT00114166|19683476|P2|STARTED|Overall Study||66
7993568|NCT00114166|19683477|P1|STARTED|Overall Study||15
7993569|NCT00114140|19683487|P1|NOT COMPLETED|Overall Study||7
7993570|NCT00114140|19683487|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|129
7993571|NCT00114140|19683487|P1|STARTED|Overall Study||136
7993572|NCT00114127|19683501|P2|NOT COMPLETED|Overall Study||4
7993573|NCT00114127|19683502|P1|NOT COMPLETED|Overall Study||4
7993574|NCT00114127|19683501|P2|COMPLETED|Overall Study||11
7993575|NCT00114127|19683502|P1|COMPLETED|Overall Study||9
7993576|NCT00114127|19683501|P2|STARTED|Overall Study||15
7993577|NCT00114127|19683502|P1|STARTED|Overall Study||13
7993578|NCT00114114|19683516|P6|NOT COMPLETED|Overall Study||1
7993579|NCT00114114|19683517|P5|NOT COMPLETED|Overall Study||2
7993580|NCT00114114|19683518|P4|NOT COMPLETED|Overall Study||4
7993581|NCT00114114|19683519|P3|NOT COMPLETED|Overall Study||1
7993582|NCT00114114|19683520|P2|NOT COMPLETED|Overall Study||1
7993583|NCT00114114|19683521|P1|NOT COMPLETED|Overall Study||5
7993584|NCT00114114|19683516|P6|COMPLETED|Overall Study||30
7993585|NCT00114114|19683517|P5|COMPLETED|Overall Study||27
7993586|NCT00114114|19683518|P4|COMPLETED|Overall Study||31
7993587|NCT00114114|19683519|P3|COMPLETED|Overall Study||30
7993588|NCT00114114|19683520|P2|COMPLETED|Overall Study||24
7993589|NCT00114114|19683521|P1|COMPLETED|Overall Study||21
7993590|NCT00114114|19683516|P6|STARTED|Overall Study||31
7993591|NCT00114114|19683517|P5|STARTED|Overall Study||29
7993592|NCT00114114|19683518|P4|STARTED|Overall Study||35
7993593|NCT00114114|19683519|P3|STARTED|Overall Study||31
7993594|NCT00114114|19683520|P2|STARTED|Overall Study||25
7993595|NCT00114114|19683521|P1|STARTED|Overall Study||26
7993596|NCT00114101|19683561|P2|NOT COMPLETED|Overall Study||0
7993597|NCT00114101|19683562|P1|NOT COMPLETED|Overall Study||0
7993598|NCT00114101|19683561|P2|COMPLETED|Overall Study||229
7993599|NCT00114101|19683562|P1|COMPLETED|Overall Study||231
7993600|NCT00114101|19683561|P2|STARTED|Overall Study||229
7993601|NCT00114101|19683562|P1|STARTED|Overall Study||231
7993602|NCT00113919|19683574|P1|NOT COMPLETED|Overall Study||14
7993603|NCT00113919|19683574|P1|COMPLETED|Overall Study||0
7993604|NCT00113919|19683574|P1|STARTED|Overall Study||14
7993605|NCT00113880|19683581|P3|NOT COMPLETED|Overall Study||0
7993606|NCT00113880|19683582|P2|NOT COMPLETED|Overall Study||0
7993607|NCT00113880|19683583|P1|NOT COMPLETED|Overall Study||0
7993608|NCT00113880|19683581|P3|COMPLETED|Overall Study||62492
7993609|NCT00113880|19683582|P2|COMPLETED|Overall Study||71949
7993610|NCT00113880|19683583|P1|COMPLETED|Overall Study||63061
7993611|NCT00113880|19683581|P3|STARTED|Overall Study||62492
7993612|NCT00113880|19683582|P2|STARTED|Overall Study||71949
7993613|NCT00113880|19683583|P1|STARTED|Overall Study||63061
7993614|NCT00113841|19683642|P2|NOT COMPLETED|Overall Study||2
7993615|NCT00113841|19683643|P1|NOT COMPLETED|Overall Study||1
7993616|NCT00113841|19683642|P2|COMPLETED|Overall Study||15
7993617|NCT00113841|19683643|P1|COMPLETED|Overall Study||15
7993618|NCT00113841|19683642|P2|STARTED|Overall Study||17
7993619|NCT00113841|19683643|P1|STARTED|Overall Study||16
7993620|NCT00113763|19683651|P2|NOT COMPLETED|Overall Study||26
7993621|NCT00113763|19683652|P1|NOT COMPLETED|Overall Study||73
7993622|NCT00113763|19683651|P2|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206
7993623|NCT00113763|19683652|P1|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158
7993624|NCT00113763|19683651|P2|Received Study Drug|Overall Study||0
7993625|NCT00113763|19683652|P1|Received Study Drug|Overall Study||229
7993626|NCT00113763|19683651|P2|STARTED|Overall Study||232
7993627|NCT00113763|19683652|P1|STARTED|Overall Study||231
7993628|NCT00113607|19683678|P2|NOT COMPLETED|Overall Study||337
7993629|NCT00113607|19683679|P1|NOT COMPLETED|Overall Study||335
7993630|NCT00113607|19683678|P2|COMPLETED|Overall Study||0
7993631|NCT00113607|19683679|P1|COMPLETED|Overall Study||0
7993632|NCT00113607|19683678|P2|STARTED|Overall Study|Number of randomized participants|337
7993633|NCT00113607|19683679|P1|STARTED|Overall Study|Number of randomized participants|335
7993634|NCT00113568|19683693|P1|NOT COMPLETED|Overall Study||545
7993635|NCT00113568|19683693|P1|COMPLETED|Overall Study||239
7993636|NCT00113568|19683693|P1|Intent to Treat Population|Overall Study||723
7993637|NCT00113568|19683693|P1|STARTED|Overall Study||784
7993638|NCT00113555|19683705|P1|NOT COMPLETED|Overall Study||79
7993639|NCT00113555|19683705|P1|COMPLETED|Overall Study|All treated patients were considered in the Intent to Treat analysis.|142
7993640|NCT00113555|19683705|P1|TREATED|Overall Study|1 Additional Patient was treated on a compassionate use basis.|162
7993641|NCT00113555|19683705|P1|STARTED|Overall Study||221
7993642|NCT00113529|19683715|P1|NOT COMPLETED|Overall Study||34
7993643|NCT00113529|19683715|P1|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1
7993644|NCT00113529|19683715|P1|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35
7993645|NCT00113516|19683748|P2|NOT COMPLETED|Part 2||66
7993646|NCT00113516|19683749|P1|NOT COMPLETED|Part 2||0
7993647|NCT00113516|19683748|P2|COMPLETED|Part 2||0
7993648|NCT00113516|19683749|P1|COMPLETED|Part 2||0
7993649|NCT00113516|19683748|P2|STARTED|Part 2||66
7993650|NCT00113516|19683749|P1|STARTED|Part 2||0
7993651|NCT00113516|19683748|P2|NOT COMPLETED|Part 1||0
7993652|NCT00113516|19683749|P1|NOT COMPLETED|Part 1||84
7993653|NCT00113516|19683748|P2|COMPLETED|Part 1||0
7993654|NCT00113516|19683749|P1|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0
7993655|NCT00113516|19683748|P2|STARTED|Part 1||0
7993656|NCT00113516|19683749|P1|STARTED|Part 1||84
7993657|NCT00113490|19683792|P2|NOT COMPLETED|Overall Study||3
7993658|NCT00113490|19683793|P1|NOT COMPLETED|Overall Study||2
7993659|NCT00113490|19683792|P2|COMPLETED|Overall Study||67
7993660|NCT00113490|19683793|P1|COMPLETED|Overall Study||64
7993661|NCT00113490|19683792|P2|STARTED|Overall Study||70
7993662|NCT00113490|19683793|P1|STARTED|Overall Study||66
7993663|NCT00113425|19683806|P1|NOT COMPLETED|Overall Study||15
7993664|NCT00113425|19683806|P1|COMPLETED|Overall Study||29
7993665|NCT00113425|19683806|P1|STARTED|Overall Study||44
7993666|NCT00113399|19683826|P2|NOT COMPLETED|Overall Study||5
7993667|NCT00113399|19683827|P1|NOT COMPLETED|Overall Study||2
7993668|NCT00113399|19683826|P2|COMPLETED|Overall Study||3
7993669|NCT00113399|19683827|P1|COMPLETED|Overall Study||5
7993670|NCT00113399|19683826|P2|STARTED|Overall Study||8
7993671|NCT00113399|19683827|P1|STARTED|Overall Study||7
7993672|NCT00113386|19683835|P2|NOT COMPLETED|Overall Study||4
7993673|NCT00113386|19683836|P1|NOT COMPLETED|Overall Study||7
7993674|NCT00113386|19683835|P2|COMPLETED|Overall Study||5
7993675|NCT00113386|19683836|P1|COMPLETED|Overall Study||3
7993676|NCT00113386|19683835|P2|STARTED|Overall Study||9
7993677|NCT00113386|19683836|P1|STARTED|Overall Study||10
7993678|NCT00113373|19683842|P1|NOT COMPLETED|Overall Study||3
7993679|NCT00113373|19683842|P1|COMPLETED|Overall Study|Eligible and treated patients.|25
7993680|NCT00113373|19683842|P1|STARTED|Overall Study||28
7993681|NCT00113360|19683857|P1|NOT COMPLETED|Overall Study||7
7993682|NCT00113360|19683857|P1|COMPLETED|Overall Study||60
7993683|NCT00113360|19683857|P1|STARTED|Overall Study|67 participants were enrolled for screening.|67
7993684|NCT00113334|19683861|P1|NOT COMPLETED|Overall Study||0
7993685|NCT00113334|19683861|P1|COMPLETED|Overall Study||6
7993686|NCT00113334|19683861|P1|STARTED|Overall Study||6
7993687|NCT00113321|19683865|P1|NOT COMPLETED|Overall Study||0
7993688|NCT00113321|19683865|P1|COMPLETED|Overall Study||16
7993689|NCT00113321|19683865|P1|STARTED|Overall Study||16
7993690|NCT00113295|19683871|P2|NOT COMPLETED|Overall Study||1
7993691|NCT00113295|19683872|P1|NOT COMPLETED|Overall Study||5
7993692|NCT00113295|19683871|P2|COMPLETED|Overall Study||10
7993693|NCT00113295|19683872|P1|COMPLETED|Overall Study||6
7993694|NCT00113295|19683871|P2|STARTED|Overall Study||11
7993695|NCT00113295|19683872|P1|STARTED|Overall Study||11
7993696|NCT00113269|19683891|P4|NOT COMPLETED|Overall Study||40
7993697|NCT00113269|19683892|P3|NOT COMPLETED|Overall Study||41
7993698|NCT00113269|19683893|P2|NOT COMPLETED|Overall Study||22
7993699|NCT00113269|19683894|P1|NOT COMPLETED|Overall Study||25
7993700|NCT00113269|19683891|P4|COMPLETED|Overall Study||140
7993701|NCT00113269|19683892|P3|COMPLETED|Overall Study||134
7993702|NCT00113269|19683893|P2|COMPLETED|Overall Study||48
7993703|NCT00113269|19683894|P1|COMPLETED|Overall Study||51
7993704|NCT00113269|19683891|P4|Received Treatment|Overall Study||171
7993705|NCT00113269|19683892|P3|Received Treatment|Overall Study||164
7993706|NCT00113269|19683893|P2|Received Treatment|Overall Study||69
7993707|NCT00113269|19683894|P1|Received Treatment|Overall Study||70
7993708|NCT00113269|19683891|P4|STARTED|Overall Study||180
7993709|NCT00113269|19683892|P3|STARTED|Overall Study||175
7993710|NCT00113269|19683893|P2|STARTED|Overall Study||70
7993711|NCT00113269|19683894|P1|STARTED|Overall Study||76
7993712|NCT00113230|19683944|P1|NOT COMPLETED|Overall Study||0
7993713|NCT00113230|19683944|P1|COMPLETED|Overall Study||25
7993714|NCT00113230|19683944|P1|STARTED|Overall Study||25
7993715|NCT00113217|19683948|P1|NOT COMPLETED|Overall Study||0
7993716|NCT00113217|19683948|P1|COMPLETED|Overall Study||50
7993717|NCT00113217|19683948|P1|STARTED|Overall Study||50
7993718|NCT00113087|19683954|P2|NOT COMPLETED|Overall Study||21
7993719|NCT00113087|19683955|P1|NOT COMPLETED|Overall Study||24
7993720|NCT00113087|19683954|P2|COMPLETED|Overall Study||94
7993721|NCT00113087|19683955|P1|COMPLETED|Overall Study||91
7993722|NCT00113087|19683954|P2|STARTED|Overall Study||115
7993723|NCT00113087|19683955|P1|STARTED|Overall Study||115
7993724|NCT00113022|19684019|P2|NOT COMPLETED|Overall Study||2
7993725|NCT00113022|19684020|P1|NOT COMPLETED|Overall Study||3
7993726|NCT00113022|19684019|P2|COMPLETED|Overall Study||2
7993727|NCT00113022|19684020|P1|COMPLETED|Overall Study||2
7993728|NCT00113022|19684019|P2|STARTED|Overall Study||4
7993729|NCT00113022|19684020|P1|STARTED|Overall Study||5
7993730|NCT00112957|19684026|P1|NOT COMPLETED|Overall Study||19
7993731|NCT00112957|19684026|P1|COMPLETED|Overall Study||4
7993732|NCT00112957|19684026|P1|STARTED|Overall Study||23
7993733|NCT00112918|19684041|P3|NOT COMPLETED|Overall Study||299
7993734|NCT00112918|19684042|P2|NOT COMPLETED|Overall Study||345
7993735|NCT00112918|19684043|P1|NOT COMPLETED|Overall Study||297
7993736|NCT00112918|19684041|P3|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846
7993737|NCT00112918|19684042|P2|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810
7993738|NCT00112918|19684043|P1|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854
7993739|NCT00112918|19684041|P3|Stage III Disease Population|Overall Study||952
7993740|NCT00112918|19684042|P2|Stage III Disease Population|Overall Study||960
7993741|NCT00112918|19684043|P1|Stage III Disease Population|Overall Study||955
7993742|NCT00112918|19684041|P3|Received Treatment|Overall Study||1135
7993743|NCT00112918|19684042|P2|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145
7993744|NCT00112918|19684043|P1|Received Treatment|Overall Study||1126
7993745|NCT00112918|19684041|P3|STARTED|Overall Study||1145
7993746|NCT00112918|19684042|P2|STARTED|Overall Study||1155
7993747|NCT00112918|19684043|P1|STARTED|Overall Study||1151
7993748|NCT00112905|19684066|P1|NOT COMPLETED|Overall Study||12
7993749|NCT00112905|19684066|P1|COMPLETED|Overall Study||15
7993750|NCT00112905|19684066|P1|Eligible and Treated|Overall Study||22
7993751|NCT00112905|19684066|P1|STARTED|Overall Study||27
7993752|NCT00112866|19684075|P2|NOT COMPLETED|Overall Study||2
7993753|NCT00112866|19684076|P1|NOT COMPLETED|Overall Study||2
7993754|NCT00112866|19684075|P2|COMPLETED|Overall Study||13
7993755|NCT00112866|19684076|P1|COMPLETED|Overall Study||13
7993756|NCT00112866|19684075|P2|STARTED|Overall Study||15
7993757|NCT00112866|19684076|P1|STARTED|Overall Study||15
7993758|NCT00112840|19684098|P3|NOT COMPLETED|Overall Study||6
7993759|NCT00112840|19684099|P2|NOT COMPLETED|Overall Study||0
7993760|NCT00112840|19684100|P1|NOT COMPLETED|Overall Study||2
7993761|NCT00112840|19684098|P3|COMPLETED|Overall Study||40
7993762|NCT00112840|19684099|P2|COMPLETED|Overall Study||6
7993763|NCT00112840|19684100|P1|COMPLETED|Overall Study||6
7993764|NCT00112840|19684098|P3|STARTED|Overall Study||46
7993765|NCT00112840|19684099|P2|STARTED|Overall Study||6
7993766|NCT00112840|19684100|P1|STARTED|Overall Study||8
7993767|NCT00112736|19684119|P2|NOT COMPLETED|Overall Study||0
7993768|NCT00112736|19684120|P1|NOT COMPLETED|Overall Study||1
7993769|NCT00112736|19684119|P2|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47
7993770|NCT00112736|19684120|P1|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21
7993771|NCT00112736|19684119|P2|STARTED|Overall Study||47
7993772|NCT00112736|19684120|P1|STARTED|Overall Study||22
7993773|NCT00112723|19684133|P3|NOT COMPLETED|Overall Study||2
7993774|NCT00112723|19684134|P2|NOT COMPLETED|Overall Study||7
7993775|NCT00112723|19684135|P1|NOT COMPLETED|Overall Study||2
7993776|NCT00112723|19684133|P3|COMPLETED|Overall Study||12
7993777|NCT00112723|19684134|P2|COMPLETED|Overall Study||12
7993778|NCT00112723|19684135|P1|COMPLETED|Overall Study||11
7993779|NCT00112723|19684133|P3|Patients Evaluable for Toxicity|Overall Study||12
7993780|NCT00112723|19684134|P2|Patients Evaluable for Toxicity|Overall Study||12
7993781|NCT00112723|19684135|P1|Patients Evaluable for Toxicity|Overall Study||11
7993782|NCT00112723|19684133|P3|STARTED|Overall Study||14
7993783|NCT00112723|19684134|P2|STARTED|Overall Study||19
7993784|NCT00112723|19684135|P1|STARTED|Overall Study||13
7993785|NCT00112671|19684160|P1|NOT COMPLETED|Overall Study||0
7993786|NCT00112671|19684160|P1|COMPLETED|Overall Study||17
7993787|NCT00112671|19684160|P1|STARTED|Overall Study||17
7993788|NCT00112593|19684168|P1|NOT COMPLETED|Overall Study||0
7993789|NCT00112593|19684168|P1|COMPLETED|Overall Study||5
7993790|NCT00112593|19684168|P1|STARTED|Overall Study||5
7993791|NCT00112489|19684177|P1|NOT COMPLETED|Overall Study||40
7993792|NCT00112489|19684177|P1|COMPLETED|Overall Study|Completed regimen due to progression|15
7993793|NCT00112489|19684177|P1|STARTED|Overall Study|All patients enrolled on study|55
7993794|NCT00112463|19684187|P1|NOT COMPLETED|Overall Study||39
7993795|NCT00112463|19684187|P1|COMPLETED|Overall Study||1
7993796|NCT00112463|19684187|P1|STARTED|Overall Study||40
7993797|NCT00112437|19684199|P26|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
7993798|NCT00112437|19684200|P25|NOT COMPLETED|Years 6-10 (60-Month Extension)||1
7993799|NCT00112437|19684201|P24|NOT COMPLETED|Years 6-10 (60-Month Extension)||12
7993800|NCT00112437|19684202|P23|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
7993801|NCT00112437|19684203|P22|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993802|NCT00112437|19684204|P21|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993803|NCT00112437|19684205|P20|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993804|NCT00112437|19684206|P19|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993805|NCT00112437|19684207|P18|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993806|NCT00112437|19684208|P17|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993807|NCT00112437|19684209|P16|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993808|NCT00112437|19684210|P15|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993809|NCT00112437|19684211|P14|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993810|NCT00112437|19684212|P13|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993811|NCT00112437|19684213|P12|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993812|NCT00112437|19684214|P11|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993813|NCT00112437|19684215|P10|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993814|NCT00112437|19684216|P9|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993815|NCT00112437|19684217|P8|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993816|NCT00112437|19684218|P7|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993817|NCT00112437|19684219|P6|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993818|NCT00112437|19684220|P5|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993819|NCT00112437|19684221|P4|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993820|NCT00112437|19684222|P3|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993821|NCT00112437|19684223|P2|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993822|NCT00112437|19684224|P1|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
7993823|NCT00112437|19684199|P26|COMPLETED|Years 6-10 (60-Month Extension)||27
7993824|NCT00112437|19684200|P25|COMPLETED|Years 6-10 (60-Month Extension)||22
7993825|NCT00112437|19684201|P24|COMPLETED|Years 6-10 (60-Month Extension)||22
7993826|NCT00112437|19684202|P23|COMPLETED|Years 6-10 (60-Month Extension)||23
7993827|NCT00112437|19684203|P22|COMPLETED|Years 6-10 (60-Month Extension)||0
7993828|NCT00112437|19684204|P21|COMPLETED|Years 6-10 (60-Month Extension)||0
7993829|NCT00112437|19684205|P20|COMPLETED|Years 6-10 (60-Month Extension)||0
7993830|NCT00112437|19684206|P19|COMPLETED|Years 6-10 (60-Month Extension)||0
7993831|NCT00112437|19684207|P18|COMPLETED|Years 6-10 (60-Month Extension)||0
7993832|NCT00112437|19684208|P17|COMPLETED|Years 6-10 (60-Month Extension)||0
7993833|NCT00112437|19684209|P16|COMPLETED|Years 6-10 (60-Month Extension)||0
7993834|NCT00112437|19684210|P15|COMPLETED|Years 6-10 (60-Month Extension)||0
7993835|NCT00112437|19684211|P14|COMPLETED|Years 6-10 (60-Month Extension)||0
7993836|NCT00112437|19684212|P13|COMPLETED|Years 6-10 (60-Month Extension)||0
7993837|NCT00112437|19684213|P12|COMPLETED|Years 6-10 (60-Month Extension)||0
7993838|NCT00112437|19684214|P11|COMPLETED|Years 6-10 (60-Month Extension)||0
7993839|NCT00112437|19684215|P10|COMPLETED|Years 6-10 (60-Month Extension)||0
7993840|NCT00112437|19684216|P9|COMPLETED|Years 6-10 (60-Month Extension)||0
7993841|NCT00112437|19684217|P8|COMPLETED|Years 6-10 (60-Month Extension)||0
7993842|NCT00112437|19684218|P7|COMPLETED|Years 6-10 (60-Month Extension)||0
7993843|NCT00112437|19684219|P6|COMPLETED|Years 6-10 (60-Month Extension)||0
7993844|NCT00112437|19684220|P5|COMPLETED|Years 6-10 (60-Month Extension)||0
7993845|NCT00112437|19684221|P4|COMPLETED|Years 6-10 (60-Month Extension)||0
7993846|NCT00112437|19684222|P3|COMPLETED|Years 6-10 (60-Month Extension)||0
7993847|NCT00112437|19684223|P2|COMPLETED|Years 6-10 (60-Month Extension)||0
7993848|NCT00112437|19684224|P1|COMPLETED|Years 6-10 (60-Month Extension)||0
7993849|NCT00112437|19684199|P26|STARTED|Years 6-10 (60-Month Extension)||32
7993850|NCT00112437|19684200|P25|STARTED|Years 6-10 (60-Month Extension)||23
7993851|NCT00112437|19684201|P24|STARTED|Years 6-10 (60-Month Extension)||34
7993852|NCT00112437|19684202|P23|STARTED|Years 6-10 (60-Month Extension)||28
7993853|NCT00112437|19684203|P22|STARTED|Years 6-10 (60-Month Extension)||0
7993854|NCT00112437|19684204|P21|STARTED|Years 6-10 (60-Month Extension)||0
7993855|NCT00112437|19684205|P20|STARTED|Years 6-10 (60-Month Extension)||0
7993856|NCT00112437|19684206|P19|STARTED|Years 6-10 (60-Month Extension)||0
7993857|NCT00112437|19684207|P18|STARTED|Years 6-10 (60-Month Extension)||0
7993858|NCT00112437|19684208|P17|STARTED|Years 6-10 (60-Month Extension)||0
7993859|NCT00112437|19684209|P16|STARTED|Years 6-10 (60-Month Extension)||0
7993860|NCT00112437|19684210|P15|STARTED|Years 6-10 (60-Month Extension)||0
7993861|NCT00112437|19684211|P14|STARTED|Years 6-10 (60-Month Extension)||0
7993862|NCT00112437|19684212|P13|STARTED|Years 6-10 (60-Month Extension)||0
7993863|NCT00112437|19684213|P12|STARTED|Years 6-10 (60-Month Extension)||0
7993864|NCT00112437|19684214|P11|STARTED|Years 6-10 (60-Month Extension)||0
7993865|NCT00112437|19684215|P10|STARTED|Years 6-10 (60-Month Extension)||0
7993866|NCT00112437|19684216|P9|STARTED|Years 6-10 (60-Month Extension)||0
7993867|NCT00112437|19684217|P8|STARTED|Years 6-10 (60-Month Extension)||0
7993868|NCT00112437|19684218|P7|STARTED|Years 6-10 (60-Month Extension)||0
7993869|NCT00112437|19684219|P6|STARTED|Years 6-10 (60-Month Extension)||0
7993870|NCT00112437|19684220|P5|STARTED|Years 6-10 (60-Month Extension)||0
7993871|NCT00112437|19684221|P4|STARTED|Years 6-10 (60-Month Extension)||0
7993872|NCT00112437|19684222|P3|STARTED|Years 6-10 (60-Month Extension)||0
7993873|NCT00112437|19684223|P2|STARTED|Years 6-10 (60-Month Extension)||0
7993874|NCT00112437|19684224|P1|STARTED|Years 6-10 (60-Month Extension)||0
7993875|NCT00112437|19684199|P26|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993876|NCT00112437|19684200|P25|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993877|NCT00112437|19684201|P24|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993878|NCT00112437|19684202|P23|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993879|NCT00112437|19684203|P22|NOT COMPLETED|Years 4-5 (24-Month Extension)||8
7993880|NCT00112437|19684204|P21|NOT COMPLETED|Years 4-5 (24-Month Extension)||4
7993881|NCT00112437|19684205|P20|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993882|NCT00112437|19684206|P19|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993883|NCT00112437|19684207|P18|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993884|NCT00112437|19684208|P17|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993885|NCT00112437|19684209|P16|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993886|NCT00112437|19684210|P15|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993887|NCT00112437|19684211|P14|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993888|NCT00112437|19684212|P13|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993889|NCT00112437|19684213|P12|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993890|NCT00112437|19684214|P11|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993891|NCT00112437|19684215|P10|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993892|NCT00112437|19684216|P9|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993893|NCT00112437|19684217|P8|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993894|NCT00112437|19684218|P7|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993895|NCT00112437|19684219|P6|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993896|NCT00112437|19684220|P5|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993897|NCT00112437|19684221|P4|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993898|NCT00112437|19684222|P3|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993899|NCT00112437|19684223|P2|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993900|NCT00112437|19684224|P1|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
7993901|NCT00112437|19684199|P26|COMPLETED|Years 4-5 (24-Month Extension)||0
7993902|NCT00112437|19684200|P25|COMPLETED|Years 4-5 (24-Month Extension)||0
7993903|NCT00112437|19684201|P24|COMPLETED|Years 4-5 (24-Month Extension)||0
7993904|NCT00112437|19684202|P23|COMPLETED|Years 4-5 (24-Month Extension)||0
7993905|NCT00112437|19684203|P22|COMPLETED|Years 4-5 (24-Month Extension)||92
7993906|NCT00112437|19684204|P21|COMPLETED|Years 4-5 (24-Month Extension)||37
7993907|NCT00112437|19684205|P20|COMPLETED|Years 4-5 (24-Month Extension)||0
7993908|NCT00112437|19684206|P19|COMPLETED|Years 4-5 (24-Month Extension)||0
7993909|NCT00112437|19684207|P18|COMPLETED|Years 4-5 (24-Month Extension)||0
7993910|NCT00112437|19684208|P17|COMPLETED|Years 4-5 (24-Month Extension)||0
7993911|NCT00112437|19684209|P16|COMPLETED|Years 4-5 (24-Month Extension)||0
7993912|NCT00112437|19684210|P15|COMPLETED|Years 4-5 (24-Month Extension)||0
7993913|NCT00112437|19684211|P14|COMPLETED|Years 4-5 (24-Month Extension)||0
7993914|NCT00112437|19684212|P13|COMPLETED|Years 4-5 (24-Month Extension)||0
7993915|NCT00112437|19684213|P12|COMPLETED|Years 4-5 (24-Month Extension)||0
7993916|NCT00112437|19684214|P11|COMPLETED|Years 4-5 (24-Month Extension)||0
7993917|NCT00112437|19684215|P10|COMPLETED|Years 4-5 (24-Month Extension)||0
7993918|NCT00112437|19684216|P9|COMPLETED|Years 4-5 (24-Month Extension)||0
7993919|NCT00112437|19684217|P8|COMPLETED|Years 4-5 (24-Month Extension)||0
7993920|NCT00112437|19684218|P7|COMPLETED|Years 4-5 (24-Month Extension)||0
7993921|NCT00112437|19684219|P6|COMPLETED|Years 4-5 (24-Month Extension)||0
7993922|NCT00112437|19684220|P5|COMPLETED|Years 4-5 (24-Month Extension)||0
7993923|NCT00112437|19684221|P4|COMPLETED|Years 4-5 (24-Month Extension)||0
7993924|NCT00112437|19684222|P3|COMPLETED|Years 4-5 (24-Month Extension)||0
7993925|NCT00112437|19684223|P2|COMPLETED|Years 4-5 (24-Month Extension)||0
7993926|NCT00112437|19684224|P1|COMPLETED|Years 4-5 (24-Month Extension)||0
7993927|NCT00112437|19684199|P26|STARTED|Years 4-5 (24-Month Extension)||0
7993928|NCT00112437|19684200|P25|STARTED|Years 4-5 (24-Month Extension)||0
7993929|NCT00112437|19684201|P24|STARTED|Years 4-5 (24-Month Extension)||0
7993930|NCT00112437|19684202|P23|STARTED|Years 4-5 (24-Month Extension)||0
7993931|NCT00112437|19684203|P22|STARTED|Years 4-5 (24-Month Extension)||100
7993932|NCT00112437|19684204|P21|STARTED|Years 4-5 (24-Month Extension)||41
7993933|NCT00112437|19684205|P20|STARTED|Years 4-5 (24-Month Extension)||0
7993934|NCT00112437|19684206|P19|STARTED|Years 4-5 (24-Month Extension)||0
7993935|NCT00112437|19684207|P18|STARTED|Years 4-5 (24-Month Extension)||0
7993936|NCT00112437|19684208|P17|STARTED|Years 4-5 (24-Month Extension)||0
7993937|NCT00112437|19684209|P16|STARTED|Years 4-5 (24-Month Extension)||0
7993938|NCT00112437|19684210|P15|STARTED|Years 4-5 (24-Month Extension)||0
7993939|NCT00112437|19684211|P14|STARTED|Years 4-5 (24-Month Extension)||0
7993940|NCT00112437|19684212|P13|STARTED|Years 4-5 (24-Month Extension)||0
7993941|NCT00112437|19684213|P12|STARTED|Years 4-5 (24-Month Extension)||0
7993942|NCT00112437|19684214|P11|STARTED|Years 4-5 (24-Month Extension)||0
7993943|NCT00112437|19684215|P10|STARTED|Years 4-5 (24-Month Extension)||0
7993944|NCT00112437|19684216|P9|STARTED|Years 4-5 (24-Month Extension)||0
7993945|NCT00112437|19684217|P8|STARTED|Years 4-5 (24-Month Extension)||0
7993946|NCT00112437|19684218|P7|STARTED|Years 4-5 (24-Month Extension)||0
7993947|NCT00112437|19684219|P6|STARTED|Years 4-5 (24-Month Extension)||0
7993948|NCT00112437|19684220|P5|STARTED|Years 4-5 (24-Month Extension)||0
7993949|NCT00112437|19684221|P4|STARTED|Years 4-5 (24-Month Extension)||0
7993950|NCT00112437|19684222|P3|STARTED|Years 4-5 (24-Month Extension)||0
7993951|NCT00112437|19684223|P2|STARTED|Years 4-5 (24-Month Extension)||0
7993952|NCT00112437|19684224|P1|STARTED|Years 4-5 (24-Month Extension)||0
7993953|NCT00112437|19684199|P26|NOT COMPLETED|Year 3 (12-Month Extension)||0
7993954|NCT00112437|19684200|P25|NOT COMPLETED|Year 3 (12-Month Extension)||0
7993955|NCT00112437|19684201|P24|NOT COMPLETED|Year 3 (12-Month Extension)||0
7993956|NCT00112437|19684202|P23|NOT COMPLETED|Year 3 (12-Month Extension)||0
7993957|NCT00112437|19684203|P22|NOT COMPLETED|Year 3 (12-Month Extension)||0
7993958|NCT00112437|19684204|P21|NOT COMPLETED|Year 3 (12-Month Extension)||0
7993959|NCT00112437|19684205|P20|NOT COMPLETED|Year 3 (12-Month Extension)||1
7993960|NCT00112437|19684206|P19|NOT COMPLETED|Year 3 (12-Month Extension)||2
7993961|NCT00112437|19684207|P18|NOT COMPLETED|Year 3 (12-Month Extension)||1
7993962|NCT00112437|19684208|P17|NOT COMPLETED|Year 3 (12-Month Extension)||3
7993963|NCT00112437|19684209|P16|NOT COMPLETED|Year 3 (12-Month Extension)||4
7993964|NCT00112437|19684210|P15|NOT COMPLETED|Year 3 (12-Month Extension)||1
7993965|NCT00112437|19684211|P14|NOT COMPLETED|Year 3 (12-Month Extension)||1
7993966|NCT00112437|19684212|P13|NOT COMPLETED|Year 3 (12-Month Extension)||0
7993967|NCT00112437|19684213|P12|NOT COMPLETED|Year 3 (12-Month Extension)||5
7993968|NCT00112437|19684214|P11|NOT COMPLETED|Year 3 (12-Month Extension)||2
7993969|NCT00112437|19684215|P10|NOT COMPLETED|Year 3 (12-Month Extension)||0
7993970|NCT00112437|19684216|P9|NOT COMPLETED|Year 3 (12-Month Extension)||0
7993971|NCT00112437|19684217|P8|NOT COMPLETED|Year 3 (12-Month Extension)||0
7993972|NCT00112437|19684218|P7|NOT COMPLETED|Year 3 (12-Month Extension)||0
7993973|NCT00112437|19684219|P6|NOT COMPLETED|Year 3 (12-Month Extension)||0
7993974|NCT00112437|19684220|P5|NOT COMPLETED|Year 3 (12-Month Extension)||0
7993975|NCT00112437|19684221|P4|NOT COMPLETED|Year 3 (12-Month Extension)||0
7993976|NCT00112437|19684222|P3|NOT COMPLETED|Year 3 (12-Month Extension)||0
7993977|NCT00112437|19684223|P2|NOT COMPLETED|Year 3 (12-Month Extension)||0
7993978|NCT00112437|19684224|P1|NOT COMPLETED|Year 3 (12-Month Extension)||0
7993979|NCT00112437|19684199|P26|COMPLETED|Year 3 (12-Month Extension)||0
7993980|NCT00112437|19684200|P25|COMPLETED|Year 3 (12-Month Extension)||0
7993981|NCT00112437|19684201|P24|COMPLETED|Year 3 (12-Month Extension)||0
7993982|NCT00112437|19684202|P23|COMPLETED|Year 3 (12-Month Extension)||0
7993983|NCT00112437|19684203|P22|COMPLETED|Year 3 (12-Month Extension)||0
7993984|NCT00112437|19684204|P21|COMPLETED|Year 3 (12-Month Extension)||0
7993985|NCT00112437|19684205|P20|COMPLETED|Year 3 (12-Month Extension)||19
7993986|NCT00112437|19684206|P19|COMPLETED|Year 3 (12-Month Extension)||16
7993987|NCT00112437|19684207|P18|COMPLETED|Year 3 (12-Month Extension)||20
7993988|NCT00112437|19684208|P17|COMPLETED|Year 3 (12-Month Extension)||16
7993989|NCT00112437|19684209|P16|COMPLETED|Year 3 (12-Month Extension)||13
7993990|NCT00112437|19684210|P15|COMPLETED|Year 3 (12-Month Extension)||17
7993991|NCT00112437|19684211|P14|COMPLETED|Year 3 (12-Month Extension)||16
7993992|NCT00112437|19684212|P13|COMPLETED|Year 3 (12-Month Extension)||18
7993993|NCT00112437|19684213|P12|COMPLETED|Year 3 (12-Month Extension)||17
7993994|NCT00112437|19684214|P11|COMPLETED|Year 3 (12-Month Extension)||17
7993995|NCT00112437|19684215|P10|COMPLETED|Year 3 (12-Month Extension)||0
7993996|NCT00112437|19684216|P9|COMPLETED|Year 3 (12-Month Extension)||0
7993997|NCT00112437|19684217|P8|COMPLETED|Year 3 (12-Month Extension)||0
7993998|NCT00112437|19684218|P7|COMPLETED|Year 3 (12-Month Extension)||0
7993999|NCT00112437|19684219|P6|COMPLETED|Year 3 (12-Month Extension)||0
7994000|NCT00112437|19684220|P5|COMPLETED|Year 3 (12-Month Extension)||0
7994001|NCT00112437|19684221|P4|COMPLETED|Year 3 (12-Month Extension)||0
7994002|NCT00112437|19684222|P3|COMPLETED|Year 3 (12-Month Extension)||0
7994003|NCT00112437|19684223|P2|COMPLETED|Year 3 (12-Month Extension)||0
7994004|NCT00112437|19684224|P1|COMPLETED|Year 3 (12-Month Extension)||0
7994005|NCT00112437|19684199|P26|STARTED|Year 3 (12-Month Extension)||0
7994006|NCT00112437|19684200|P25|STARTED|Year 3 (12-Month Extension)||0
7994007|NCT00112437|19684201|P24|STARTED|Year 3 (12-Month Extension)||0
7994008|NCT00112437|19684202|P23|STARTED|Year 3 (12-Month Extension)||0
7994009|NCT00112437|19684203|P22|STARTED|Year 3 (12-Month Extension)||0
7994010|NCT00112437|19684204|P21|STARTED|Year 3 (12-Month Extension)||0
7994011|NCT00112437|19684205|P20|STARTED|Year 3 (12-Month Extension)||20
7994012|NCT00112437|19684206|P19|STARTED|Year 3 (12-Month Extension)||18
7994013|NCT00112437|19684207|P18|STARTED|Year 3 (12-Month Extension)||21
7994014|NCT00112437|19684208|P17|STARTED|Year 3 (12-Month Extension)||19
7994015|NCT00112437|19684209|P16|STARTED|Year 3 (12-Month Extension)||17
7994016|NCT00112437|19684210|P15|STARTED|Year 3 (12-Month Extension)||18
7994017|NCT00112437|19684211|P14|STARTED|Year 3 (12-Month Extension)||17
7994018|NCT00112437|19684212|P13|STARTED|Year 3 (12-Month Extension)||18
7994019|NCT00112437|19684213|P12|STARTED|Year 3 (12-Month Extension)||22
7994020|NCT00112437|19684214|P11|STARTED|Year 3 (12-Month Extension)||19
7994021|NCT00112437|19684215|P10|STARTED|Year 3 (12-Month Extension)||0
7994022|NCT00112437|19684216|P9|STARTED|Year 3 (12-Month Extension)||0
7994023|NCT00112437|19684217|P8|STARTED|Year 3 (12-Month Extension)||0
7994024|NCT00112437|19684218|P7|STARTED|Year 3 (12-Month Extension)||0
7994025|NCT00112437|19684219|P6|STARTED|Year 3 (12-Month Extension)||0
7994026|NCT00112437|19684220|P5|STARTED|Year 3 (12-Month Extension)||0
7994027|NCT00112437|19684221|P4|STARTED|Year 3 (12-Month Extension)||0
7994028|NCT00112437|19684222|P3|STARTED|Year 3 (12-Month Extension)||0
7994029|NCT00112437|19684223|P2|STARTED|Year 3 (12-Month Extension)||0
7994030|NCT00112437|19684224|P1|STARTED|Year 3 (12-Month Extension)||0
7994031|NCT00112437|19684199|P26|NOT COMPLETED|Year 2 (12-Month Extension)||0
7994032|NCT00112437|19684200|P25|NOT COMPLETED|Year 2 (12-Month Extension)||0
7994033|NCT00112437|19684201|P24|NOT COMPLETED|Year 2 (12-Month Extension)||0
7994034|NCT00112437|19684202|P23|NOT COMPLETED|Year 2 (12-Month Extension)||0
7994035|NCT00112437|19684203|P22|NOT COMPLETED|Year 2 (12-Month Extension)||0
7994036|NCT00112437|19684204|P21|NOT COMPLETED|Year 2 (12-Month Extension)||0
7994037|NCT00112437|19684205|P20|NOT COMPLETED|Year 2 (12-Month Extension)||0
7994038|NCT00112437|19684206|P19|NOT COMPLETED|Year 2 (12-Month Extension)||0
7994039|NCT00112437|19684207|P18|NOT COMPLETED|Year 2 (12-Month Extension)||0
7994040|NCT00112437|19684208|P17|NOT COMPLETED|Year 2 (12-Month Extension)||0
7994041|NCT00112437|19684209|P16|NOT COMPLETED|Year 2 (12-Month Extension)||0
7994042|NCT00112437|19684210|P15|NOT COMPLETED|Year 2 (12-Month Extension)||0
7994043|NCT00112437|19684211|P14|NOT COMPLETED|Year 2 (12-Month Extension)||0
7994044|NCT00112437|19684212|P13|NOT COMPLETED|Year 2 (12-Month Extension)||0
7994045|NCT00112437|19684213|P12|NOT COMPLETED|Year 2 (12-Month Extension)||0
7994046|NCT00112437|19684214|P11|NOT COMPLETED|Year 2 (12-Month Extension)||0
7994047|NCT00112437|19684215|P10|NOT COMPLETED|Year 2 (12-Month Extension)||13
7994048|NCT00112437|19684216|P9|NOT COMPLETED|Year 2 (12-Month Extension)||7
7994049|NCT00112437|19684217|P8|NOT COMPLETED|Year 2 (12-Month Extension)||8
7994050|NCT00112437|19684218|P7|NOT COMPLETED|Year 2 (12-Month Extension)||9
7994051|NCT00112437|19684219|P6|NOT COMPLETED|Year 2 (12-Month Extension)||3
7994052|NCT00112437|19684220|P5|NOT COMPLETED|Year 2 (12-Month Extension)||0
7994053|NCT00112437|19684221|P4|NOT COMPLETED|Year 2 (12-Month Extension)||0
7994054|NCT00112437|19684222|P3|NOT COMPLETED|Year 2 (12-Month Extension)||0
7994055|NCT00112437|19684223|P2|NOT COMPLETED|Year 2 (12-Month Extension)||0
7994056|NCT00112437|19684224|P1|NOT COMPLETED|Year 2 (12-Month Extension)||0
7994057|NCT00112437|19684199|P26|COMPLETED|Year 2 (12-Month Extension)||0
7994058|NCT00112437|19684200|P25|COMPLETED|Year 2 (12-Month Extension)||0
7994059|NCT00112437|19684201|P24|COMPLETED|Year 2 (12-Month Extension)||0
7994060|NCT00112437|19684202|P23|COMPLETED|Year 2 (12-Month Extension)||0
7994061|NCT00112437|19684203|P22|COMPLETED|Year 2 (12-Month Extension)||0
7994062|NCT00112437|19684204|P21|COMPLETED|Year 2 (12-Month Extension)||0
7994063|NCT00112437|19684205|P20|COMPLETED|Year 2 (12-Month Extension)||0
7994064|NCT00112437|19684206|P19|COMPLETED|Year 2 (12-Month Extension)||0
7994065|NCT00112437|19684207|P18|COMPLETED|Year 2 (12-Month Extension)||0
7994066|NCT00112437|19684208|P17|COMPLETED|Year 2 (12-Month Extension)||0
7994067|NCT00112437|19684209|P16|COMPLETED|Year 2 (12-Month Extension)||0
7994068|NCT00112437|19684210|P15|COMPLETED|Year 2 (12-Month Extension)||0
7994069|NCT00112437|19684211|P14|COMPLETED|Year 2 (12-Month Extension)||0
7994070|NCT00112437|19684212|P13|COMPLETED|Year 2 (12-Month Extension)||0
7994071|NCT00112437|19684213|P12|COMPLETED|Year 2 (12-Month Extension)||0
7994072|NCT00112437|19684214|P11|COMPLETED|Year 2 (12-Month Extension)||0
7994073|NCT00112437|19684215|P10|COMPLETED|Year 2 (12-Month Extension)||50
7994074|NCT00112437|19684216|P9|COMPLETED|Year 2 (12-Month Extension)||62
7994075|NCT00112437|19684217|P8|COMPLETED|Year 2 (12-Month Extension)||55
7994076|NCT00112437|19684218|P7|COMPLETED|Year 2 (12-Month Extension)||53
7994077|NCT00112437|19684219|P6|COMPLETED|Year 2 (12-Month Extension)||60
7994078|NCT00112437|19684220|P5|COMPLETED|Year 2 (12-Month Extension)||0
7994079|NCT00112437|19684221|P4|COMPLETED|Year 2 (12-Month Extension)||0
7994080|NCT00112437|19684222|P3|COMPLETED|Year 2 (12-Month Extension)||0
7994081|NCT00112437|19684223|P2|COMPLETED|Year 2 (12-Month Extension)||0
7994082|NCT00112437|19684224|P1|COMPLETED|Year 2 (12-Month Extension)||0
7994083|NCT00112437|19684199|P26|STARTED|Year 2 (12-Month Extension)||0
7994084|NCT00112437|19684200|P25|STARTED|Year 2 (12-Month Extension)||0
7994085|NCT00112437|19684201|P24|STARTED|Year 2 (12-Month Extension)||0
7994086|NCT00112437|19684202|P23|STARTED|Year 2 (12-Month Extension)||0
7994087|NCT00112437|19684203|P22|STARTED|Year 2 (12-Month Extension)||0
7994088|NCT00112437|19684204|P21|STARTED|Year 2 (12-Month Extension)||0
7994089|NCT00112437|19684205|P20|STARTED|Year 2 (12-Month Extension)||0
7994090|NCT00112437|19684206|P19|STARTED|Year 2 (12-Month Extension)||0
7994091|NCT00112437|19684207|P18|STARTED|Year 2 (12-Month Extension)||0
7994092|NCT00112437|19684208|P17|STARTED|Year 2 (12-Month Extension)||0
7994093|NCT00112437|19684209|P16|STARTED|Year 2 (12-Month Extension)||0
7994094|NCT00112437|19684210|P15|STARTED|Year 2 (12-Month Extension)||0
7994095|NCT00112437|19684211|P14|STARTED|Year 2 (12-Month Extension)||0
7994096|NCT00112437|19684212|P13|STARTED|Year 2 (12-Month Extension)||0
7994097|NCT00112437|19684213|P12|STARTED|Year 2 (12-Month Extension)||0
7994098|NCT00112437|19684214|P11|STARTED|Year 2 (12-Month Extension)||0
7994099|NCT00112437|19684215|P10|STARTED|Year 2 (12-Month Extension)||63
7994100|NCT00112437|19684216|P9|STARTED|Year 2 (12-Month Extension)||69
7994101|NCT00112437|19684217|P8|STARTED|Year 2 (12-Month Extension)||63
7994102|NCT00112437|19684218|P7|STARTED|Year 2 (12-Month Extension)||62
7994103|NCT00112437|19684219|P6|STARTED|Year 2 (12-Month Extension)||63
7994104|NCT00112437|19684220|P5|STARTED|Year 2 (12-Month Extension)||0
7994105|NCT00112437|19684221|P4|STARTED|Year 2 (12-Month Extension)||0
7994106|NCT00112437|19684222|P3|STARTED|Year 2 (12-Month Extension)||0
7994107|NCT00112437|19684223|P2|STARTED|Year 2 (12-Month Extension)||0
7994108|NCT00112437|19684224|P1|STARTED|Year 2 (12-Month Extension)||0
7994109|NCT00112437|19684199|P26|NOT COMPLETED|Year 1 (12-Month Base Study)||0
7994110|NCT00112437|19684200|P25|NOT COMPLETED|Year 1 (12-Month Base Study)||0
7994111|NCT00112437|19684201|P24|NOT COMPLETED|Year 1 (12-Month Base Study)||0
7994112|NCT00112437|19684202|P23|NOT COMPLETED|Year 1 (12-Month Base Study)||0
7994113|NCT00112437|19684203|P22|NOT COMPLETED|Year 1 (12-Month Base Study)||0
7994114|NCT00112437|19684204|P21|NOT COMPLETED|Year 1 (12-Month Base Study)||0
7994115|NCT00112437|19684205|P20|NOT COMPLETED|Year 1 (12-Month Base Study)||0
7994116|NCT00112437|19684206|P19|NOT COMPLETED|Year 1 (12-Month Base Study)||0
7994117|NCT00112437|19684207|P18|NOT COMPLETED|Year 1 (12-Month Base Study)||0
7994118|NCT00112437|19684208|P17|NOT COMPLETED|Year 1 (12-Month Base Study)||0
7994119|NCT00112437|19684209|P16|NOT COMPLETED|Year 1 (12-Month Base Study)||0
7994120|NCT00112437|19684210|P15|NOT COMPLETED|Year 1 (12-Month Base Study)||0
7994121|NCT00112437|19684211|P14|NOT COMPLETED|Year 1 (12-Month Base Study)||0
7994122|NCT00112437|19684212|P13|NOT COMPLETED|Year 1 (12-Month Base Study)||0
7994123|NCT00112437|19684213|P12|NOT COMPLETED|Year 1 (12-Month Base Study)||0
7994124|NCT00112437|19684214|P11|NOT COMPLETED|Year 1 (12-Month Base Study)||0
7994125|NCT00112437|19684215|P10|NOT COMPLETED|Year 1 (12-Month Base Study)||0
7994126|NCT00112437|19684216|P9|NOT COMPLETED|Year 1 (12-Month Base Study)||0
7994127|NCT00112437|19684217|P8|NOT COMPLETED|Year 1 (12-Month Base Study)||0
7994128|NCT00112437|19684218|P7|NOT COMPLETED|Year 1 (12-Month Base Study)||0
7994129|NCT00112437|19684219|P6|NOT COMPLETED|Year 1 (12-Month Base Study)||0
7994130|NCT00112437|19684220|P5|NOT COMPLETED|Year 1 (12-Month Base Study)||12
7994131|NCT00112437|19684221|P4|NOT COMPLETED|Year 1 (12-Month Base Study)||8
7994132|NCT00112437|19684222|P3|NOT COMPLETED|Year 1 (12-Month Base Study)||12
7994133|NCT00112437|19684223|P2|NOT COMPLETED|Year 1 (12-Month Base Study)||18
7994134|NCT00112437|19684224|P1|NOT COMPLETED|Year 1 (12-Month Base Study)||15
7994135|NCT00112437|19684199|P26|COMPLETED|Year 1 (12-Month Base Study)||0
7994136|NCT00112437|19684200|P25|COMPLETED|Year 1 (12-Month Base Study)||0
7994137|NCT00112437|19684201|P24|COMPLETED|Year 1 (12-Month Base Study)||0
7994138|NCT00112437|19684202|P23|COMPLETED|Year 1 (12-Month Base Study)||0
7994139|NCT00112437|19684203|P22|COMPLETED|Year 1 (12-Month Base Study)||0
7994140|NCT00112437|19684204|P21|COMPLETED|Year 1 (12-Month Base Study)||0
7994141|NCT00112437|19684205|P20|COMPLETED|Year 1 (12-Month Base Study)||0
7994142|NCT00112437|19684206|P19|COMPLETED|Year 1 (12-Month Base Study)||0
7994143|NCT00112437|19684207|P18|COMPLETED|Year 1 (12-Month Base Study)||0
7994144|NCT00112437|19684208|P17|COMPLETED|Year 1 (12-Month Base Study)||0
7994145|NCT00112437|19684209|P16|COMPLETED|Year 1 (12-Month Base Study)||0
7994146|NCT00112437|19684210|P15|COMPLETED|Year 1 (12-Month Base Study)||0
7994147|NCT00112437|19684211|P14|COMPLETED|Year 1 (12-Month Base Study)||0
7994148|NCT00112437|19684212|P13|COMPLETED|Year 1 (12-Month Base Study)||0
7994149|NCT00112437|19684213|P12|COMPLETED|Year 1 (12-Month Base Study)||0
7994150|NCT00112437|19684214|P11|COMPLETED|Year 1 (12-Month Base Study)||0
7994151|NCT00112437|19684215|P10|COMPLETED|Year 1 (12-Month Base Study)||0
7994152|NCT00112437|19684216|P9|COMPLETED|Year 1 (12-Month Base Study)||0
7994153|NCT00112437|19684217|P8|COMPLETED|Year 1 (12-Month Base Study)||0
7994154|NCT00112437|19684218|P7|COMPLETED|Year 1 (12-Month Base Study)||0
7994155|NCT00112437|19684219|P6|COMPLETED|Year 1 (12-Month Base Study)||0
7994156|NCT00112437|19684220|P5|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in the completed total.|66
7994157|NCT00112437|19684221|P4|COMPLETED|Year 1 (12-Month Base Study)||71
7994158|NCT00112437|19684222|P3|COMPLETED|Year 1 (12-Month Base Study)||65
7994159|NCT00112437|19684223|P2|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|64
7994160|NCT00112437|19684224|P1|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|68
7994161|NCT00112437|19684199|P26|STARTED|Year 1 (12-Month Base Study)||0
7994162|NCT00112437|19684200|P25|STARTED|Year 1 (12-Month Base Study)||0
7994163|NCT00112437|19684201|P24|STARTED|Year 1 (12-Month Base Study)||0
7994164|NCT00112437|19684202|P23|STARTED|Year 1 (12-Month Base Study)||0
7994165|NCT00112437|19684203|P22|STARTED|Year 1 (12-Month Base Study)||0
7994166|NCT00112437|19684204|P21|STARTED|Year 1 (12-Month Base Study)||0
7994167|NCT00112437|19684205|P20|STARTED|Year 1 (12-Month Base Study)||0
7994168|NCT00112437|19684206|P19|STARTED|Year 1 (12-Month Base Study)||0
7994169|NCT00112437|19684207|P18|STARTED|Year 1 (12-Month Base Study)||0
7994170|NCT00112437|19684208|P17|STARTED|Year 1 (12-Month Base Study)||0
7994171|NCT00112437|19684209|P16|STARTED|Year 1 (12-Month Base Study)||0
7994172|NCT00112437|19684210|P15|STARTED|Year 1 (12-Month Base Study)||0
7994173|NCT00112437|19684211|P14|STARTED|Year 1 (12-Month Base Study)||0
7994174|NCT00112437|19684212|P13|STARTED|Year 1 (12-Month Base Study)||0
7994175|NCT00112437|19684213|P12|STARTED|Year 1 (12-Month Base Study)||0
7994176|NCT00112437|19684214|P11|STARTED|Year 1 (12-Month Base Study)||0
7994177|NCT00112437|19684215|P10|STARTED|Year 1 (12-Month Base Study)||0
7994178|NCT00112437|19684216|P9|STARTED|Year 1 (12-Month Base Study)||0
7994179|NCT00112437|19684217|P8|STARTED|Year 1 (12-Month Base Study)||0
7994180|NCT00112437|19684218|P7|STARTED|Year 1 (12-Month Base Study)||0
7994181|NCT00112437|19684219|P6|STARTED|Year 1 (12-Month Base Study)||0
7994182|NCT00112437|19684220|P5|STARTED|Year 1 (12-Month Base Study)||78
7994183|NCT00112437|19684221|P4|STARTED|Year 1 (12-Month Base Study)||79
7994184|NCT00112437|19684222|P3|STARTED|Year 1 (12-Month Base Study)||77
7994185|NCT00112437|19684223|P2|STARTED|Year 1 (12-Month Base Study)||82
7994186|NCT00112437|19684224|P1|STARTED|Year 1 (12-Month Base Study)||83
7994187|NCT00112385|19684504|P2|NOT COMPLETED|Overall Study||1
7994188|NCT00112385|19684505|P1|NOT COMPLETED|Overall Study||1
7994189|NCT00112385|19684504|P2|COMPLETED|Overall Study||4
7994190|NCT00112385|19684505|P1|COMPLETED|Overall Study||10
7994191|NCT00112385|19684504|P2|STARTED|Overall Study||5
7994192|NCT00112385|19684505|P1|STARTED|Overall Study||11
7994193|NCT00112359|19684595|P2|NOT COMPLETED|Overall Study||13
7994194|NCT00112359|19684596|P1|NOT COMPLETED|Overall Study||27
7994195|NCT00112359|19684595|P2|COMPLETED|Overall Study||67
7994196|NCT00112359|19684596|P1|COMPLETED|Overall Study||57
7994197|NCT00112359|19684595|P2|STARTED|Overall Study||80
7994198|NCT00112359|19684596|P1|STARTED|Overall Study||84
7994199|NCT00112294|19684622|P2|NOT COMPLETED|Overall Study||0
7994200|NCT00112294|19684623|P1|NOT COMPLETED|Overall Study||5
7994201|NCT00112294|19684622|P2|COMPLETED|Overall Study|Off all study therapies.|320
7994202|NCT00112294|19684623|P1|COMPLETED|Overall Study|Off all study therapies.|320
7994203|NCT00112294|19684622|P2|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18
7994204|NCT00112294|19684623|P1|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13
7994205|NCT00112294|19684622|P2|STARTED|Overall Study|338 randomized and 320 treated.|320
7994206|NCT00112294|19684623|P1|STARTED|Overall Study|338 randomized and 325 treated.|325
7994207|NCT00112242|19684666|P5|NOT COMPLETED|Overall Study||7
7994208|NCT00112242|19684667|P4|NOT COMPLETED|Overall Study||6
7994209|NCT00112242|19684668|P3|NOT COMPLETED|Overall Study||1
7994210|NCT00112242|19684669|P2|NOT COMPLETED|Overall Study||2
7994211|NCT00112242|19684670|P1|NOT COMPLETED|Overall Study||5
7994212|NCT00112242|19684666|P5|COMPLETED|Overall Study||2
7994213|NCT00112242|19684667|P4|COMPLETED|Overall Study||4
7994214|NCT00112242|19684668|P3|COMPLETED|Overall Study||4
7994215|NCT00112242|19684669|P2|COMPLETED|Overall Study||3
7994216|NCT00112242|19684670|P1|COMPLETED|Overall Study||5
7994217|NCT00112242|19684666|P5|Cycle 3 Completed|Overall Study||2
7994218|NCT00112242|19684667|P4|Cycle 3 Completed|Overall Study||4
7994219|NCT00112242|19684668|P3|Cycle 3 Completed|Overall Study||4
7994220|NCT00112242|19684669|P2|Cycle 3 Completed|Overall Study||3
7994221|NCT00112242|19684670|P1|Cycle 3 Completed|Overall Study||5
7994222|NCT00112242|19684666|P5|Cycle 2 Completed|Overall Study||4
7994223|NCT00112242|19684667|P4|Cycle 2 Completed|Overall Study||8
7994224|NCT00112242|19684668|P3|Cycle 2 Completed|Overall Study||4
7994225|NCT00112242|19684669|P2|Cycle 2 Completed|Overall Study||3
7994226|NCT00112242|19684670|P1|Cycle 2 Completed|Overall Study||8
7994227|NCT00112242|19684666|P5|Cycle 1 Completed|Overall Study||7
7994228|NCT00112242|19684667|P4|Cycle 1 Completed|Overall Study||9
7994229|NCT00112242|19684668|P3|Cycle 1 Completed|Overall Study||5
7994230|NCT00112242|19684669|P2|Cycle 1 Completed|Overall Study||5
7994231|NCT00112242|19684670|P1|Cycle 1 Completed|Overall Study||10
7994232|NCT00112242|19684666|P5|STARTED|Overall Study|One patient received only 1 vaccine however this minimum dose allowed the safety evaluation|9
7994233|NCT00112242|19684667|P4|STARTED|Overall Study||10
7994234|NCT00112242|19684668|P3|STARTED|Overall Study||5
7994235|NCT00112242|19684669|P2|STARTED|Overall Study||5
7994236|NCT00112242|19684670|P1|STARTED|Overall Study||10
7994237|NCT00112151|19684733|P6|NOT COMPLETED|Overall Study||3
7994238|NCT00112151|19684734|P5|NOT COMPLETED|Overall Study||6
7994239|NCT00112151|19684735|P4|NOT COMPLETED|Overall Study||3
7994240|NCT00112151|19684736|P3|NOT COMPLETED|Overall Study||3
7994241|NCT00112151|19684737|P2|NOT COMPLETED|Overall Study||5
7994242|NCT00112151|19684738|P1|NOT COMPLETED|Overall Study||4
7994243|NCT00112151|19684733|P6|COMPLETED|Overall Study||25
7994244|NCT00112151|19684734|P5|COMPLETED|Overall Study||22
7994245|NCT00112151|19684735|P4|COMPLETED|Overall Study||24
7994246|NCT00112151|19684736|P3|COMPLETED|Overall Study||25
7994247|NCT00112151|19684737|P2|COMPLETED|Overall Study||23
7994248|NCT00112151|19684738|P1|COMPLETED|Overall Study||24
7994249|NCT00112151|19684733|P6|STARTED|Overall Study||28
7994250|NCT00112151|19684734|P5|STARTED|Overall Study||28
7994251|NCT00112151|19684735|P4|STARTED|Overall Study||27
7994252|NCT00112151|19684736|P3|STARTED|Overall Study||28
7994253|NCT00112151|19684737|P2|STARTED|Overall Study||28
7994254|NCT00112151|19684738|P1|STARTED|Overall Study||28
7994255|NCT00112125|19684769|P2|NOT COMPLETED|Overall Study||22
7994256|NCT00112125|19684770|P1|NOT COMPLETED|Overall Study||24
7994257|NCT00112125|19684769|P2|COMPLETED|Overall Study||193
7994258|NCT00112125|19684770|P1|COMPLETED|Overall Study||189
7994259|NCT00112125|19684769|P2|STARTED|Overall Study||215
7994260|NCT00112125|19684770|P1|STARTED|Overall Study||213
7994261|NCT00112112|19684788|P2|NOT COMPLETED|Overall Study||0
7994262|NCT00112112|19684789|P1|NOT COMPLETED|Overall Study||0
7994263|NCT00112112|19684788|P2|COMPLETED|Overall Study||10
7994264|NCT00112112|19684789|P1|COMPLETED|Overall Study||10
7994265|NCT00112112|19684788|P2|STARTED|Overall Study||10
7994266|NCT00112112|19684789|P1|STARTED|Overall Study||10
7994267|NCT00112047|19684931|P2|NOT COMPLETED|Atripla Phase||20
7994268|NCT00112047|19684932|P1|NOT COMPLETED|Atripla Phase||18
7994269|NCT00112047|19684931|P2|COMPLETED|Atripla Phase||106
7994270|NCT00112047|19684932|P1|COMPLETED|Atripla Phase||142
7994271|NCT00112047|19684931|P2|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126
7994272|NCT00112047|19684932|P1|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160
7994273|NCT00112047|19684931|P2|NOT COMPLETED|Randomized Phase||88
7994274|NCT00112047|19684932|P1|NOT COMPLETED|Randomized Phase||70
7994275|NCT00112047|19684931|P2|COMPLETED|Randomized Phase||166
7994276|NCT00112047|19684932|P1|COMPLETED|Randomized Phase||187
7994277|NCT00112047|19684931|P2|STARTED|Randomized Phase|ITT analysis population|254
7994278|NCT00112047|19684932|P1|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257
7994279|NCT00111917|19685032|P2|NOT COMPLETED|Overall Study||1
7994280|NCT00111917|19685033|P1|NOT COMPLETED|Overall Study||1
7994281|NCT00111917|19685032|P2|COMPLETED|Overall Study||3
7994282|NCT00111917|19685033|P1|COMPLETED|Overall Study||8
7994283|NCT00111917|19685032|P2|STARTED|Overall Study||4
7994284|NCT00111917|19685033|P1|STARTED|Overall Study||9
7994285|NCT00111839|19685048|P3|NOT COMPLETED|Overall Study||49
7994286|NCT00111839|19685049|P2|NOT COMPLETED|Overall Study||46
7994287|NCT00111839|19685050|P1|NOT COMPLETED|Overall Study||48
7994288|NCT00111839|19685048|P3|COMPLETED|Overall Study||0
7994289|NCT00111839|19685049|P2|COMPLETED|Overall Study||5
7994290|NCT00111839|19685050|P1|COMPLETED|Overall Study||2
7994291|NCT00111839|19685048|P3|Treated|Overall Study||47
7994292|NCT00111839|19685049|P2|Treated|Overall Study||51
7994293|NCT00111839|19685050|P1|Treated|Overall Study||50
7994294|NCT00111839|19685048|P3|STARTED|Overall Study||49
7994295|NCT00111839|19685049|P2|STARTED|Overall Study||51
7994296|NCT00111839|19685050|P1|STARTED|Overall Study||50
7994297|NCT00111813|19685070|P6|NOT COMPLETED|Overall Study||6
7994298|NCT00111813|19685071|P5|NOT COMPLETED|Overall Study||6
7994299|NCT00111813|19685072|P4|NOT COMPLETED|Overall Study||5
7994300|NCT00111813|19685073|P3|NOT COMPLETED|Overall Study||10
7994301|NCT00111813|19685074|P2|NOT COMPLETED|Overall Study||3
7994302|NCT00111813|19685075|P1|NOT COMPLETED|Overall Study||3
7994303|NCT00111813|19685070|P6|COMPLETED|Overall Study||0
7994304|NCT00111813|19685071|P5|COMPLETED|Overall Study||0
7994305|NCT00111813|19685072|P4|COMPLETED|Overall Study||1
7994306|NCT00111813|19685073|P3|COMPLETED|Overall Study||0
7994307|NCT00111813|19685074|P2|COMPLETED|Overall Study||0
7994308|NCT00111813|19685075|P1|COMPLETED|Overall Study||0
7994309|NCT00111813|19685070|P6|STARTED|Overall Study||6
7994310|NCT00111813|19685071|P5|STARTED|Overall Study||6
7994311|NCT00111813|19685072|P4|STARTED|Overall Study||6
7994312|NCT00111813|19685073|P3|STARTED|Overall Study||10
7994313|NCT00111813|19685074|P2|STARTED|Overall Study||3
7994314|NCT00111813|19685075|P1|STARTED|Overall Study||3
7994315|NCT00111800|19685114|P6|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
7994316|NCT00111800|19685115|P5|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||4
7994317|NCT00111800|19685116|P4|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||5
7994318|NCT00111800|19685117|P3|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
7994319|NCT00111800|19685118|P2|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
7994320|NCT00111800|19685119|P1|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
7994321|NCT00111800|19685114|P6|COMPLETED|Period 2: Extension Phase (12 Weeks)||53
7994322|NCT00111800|19685115|P5|COMPLETED|Period 2: Extension Phase (12 Weeks)||51
7994323|NCT00111800|19685116|P4|COMPLETED|Period 2: Extension Phase (12 Weeks)||54
7994324|NCT00111800|19685117|P3|COMPLETED|Period 2: Extension Phase (12 Weeks)||47
7994325|NCT00111800|19685118|P2|COMPLETED|Period 2: Extension Phase (12 Weeks)||40
7994326|NCT00111800|19685119|P1|COMPLETED|Period 2: Extension Phase (12 Weeks)||46
7994327|NCT00111800|19685114|P6|STARTED|Period 2: Extension Phase (12 Weeks)||55
7994328|NCT00111800|19685115|P5|STARTED|Period 2: Extension Phase (12 Weeks)||55
7994329|NCT00111800|19685116|P4|STARTED|Period 2: Extension Phase (12 Weeks)||59
7994330|NCT00111800|19685117|P3|STARTED|Period 2: Extension Phase (12 Weeks)||54
7994331|NCT00111800|19685118|P2|STARTED|Period 2: Extension Phase (12 Weeks)||47
7994332|NCT00111800|19685119|P1|STARTED|Period 2: Extension Phase (12 Weeks)||48
7994333|NCT00111800|19685114|P6|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
7994334|NCT00111800|19685115|P5|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
7994335|NCT00111800|19685116|P4|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||6
7994336|NCT00111800|19685117|P3|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||9
7994337|NCT00111800|19685118|P2|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||14
7994338|NCT00111800|19685119|P1|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||15
7994339|NCT00111800|19685114|P6|COMPLETED|Period 1: Main Phase (12 Weeks)||56
7994340|NCT00111800|19685115|P5|COMPLETED|Period 1: Main Phase (12 Weeks)||55
7994341|NCT00111800|19685116|P4|COMPLETED|Period 1: Main Phase (12 Weeks)||60
7994342|NCT00111800|19685117|P3|COMPLETED|Period 1: Main Phase (12 Weeks)||54
7994343|NCT00111800|19685118|P2|COMPLETED|Period 1: Main Phase (12 Weeks)||47
7994344|NCT00111800|19685119|P1|COMPLETED|Period 1: Main Phase (12 Weeks)||49
7994345|NCT00111800|19685114|P6|STARTED|Period 1: Main Phase (12 Weeks)||61
7994346|NCT00111800|19685115|P5|STARTED|Period 1: Main Phase (12 Weeks)||60
7994347|NCT00111800|19685116|P4|STARTED|Period 1: Main Phase (12 Weeks)||66
7994348|NCT00111800|19685117|P3|STARTED|Period 1: Main Phase (12 Weeks)||63
7994349|NCT00111800|19685118|P2|STARTED|Period 1: Main Phase (12 Weeks)||61
7994350|NCT00111800|19685119|P1|STARTED|Period 1: Main Phase (12 Weeks)||64
7994351|NCT00111761|19685289|P2|NOT COMPLETED|Part 2||0
7994352|NCT00111761|19685290|P1|NOT COMPLETED|Part 2||8
7994353|NCT00111761|19685289|P2|COMPLETED|Part 2||0
7994354|NCT00111761|19685290|P1|COMPLETED|Part 2||16
7994355|NCT00111761|19685289|P2|STARTED|Part 2|This treatment group was used in Part 1 only|0
7994356|NCT00111761|19685290|P1|STARTED|Part 2||24
7994357|NCT00111761|19685289|P2|NOT COMPLETED|Part 1||5
7994358|NCT00111761|19685290|P1|NOT COMPLETED|Part 1||0
7994359|NCT00111761|19685289|P2|COMPLETED|Part 1|Completed through safety followup|14
7994360|NCT00111761|19685290|P1|COMPLETED|Part 1||0
7994361|NCT00111761|19685289|P2|STARTED|Part 1||19
7994362|NCT00111761|19685290|P1|STARTED|Part 1|This treatment group was not initiated until Part 2|0
7994363|NCT00111657|19685307|P1|NOT COMPLETED|Overall Study||16
7994364|NCT00111657|19685307|P1|COMPLETED|Overall Study|Completed all intended doses.|21
7994365|NCT00111657|19685307|P1|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37
7994366|NCT00111475|19685327|P10|NOT COMPLETED|Overall Study||0
7994367|NCT00111475|19685328|P9|NOT COMPLETED|Overall Study||0
7994368|NCT00111475|19685329|P8|NOT COMPLETED|Overall Study||0
7994369|NCT00111475|19685330|P7|NOT COMPLETED|Overall Study||0
7994370|NCT00111475|19685331|P6|NOT COMPLETED|Overall Study||1
7994371|NCT00111475|19685332|P5|NOT COMPLETED|Overall Study||0
7994372|NCT00111475|19685333|P4|NOT COMPLETED|Overall Study||0
7994373|NCT00111475|19685334|P3|NOT COMPLETED|Overall Study||0
7994374|NCT00111475|19685335|P2|NOT COMPLETED|Overall Study||0
7994375|NCT00111475|19685336|P1|NOT COMPLETED|Overall Study||0
7994376|NCT00111475|19685327|P10|COMPLETED|Overall Study||1
7994377|NCT00111475|19685328|P9|COMPLETED|Overall Study||8
7994378|NCT00111475|19685329|P8|COMPLETED|Overall Study||8
7994379|NCT00111475|19685330|P7|COMPLETED|Overall Study||4
7994380|NCT00111475|19685331|P6|COMPLETED|Overall Study||3
7994381|NCT00111475|19685332|P5|COMPLETED|Overall Study||4
7994382|NCT00111475|19685333|P4|COMPLETED|Overall Study||4
7994383|NCT00111475|19685334|P3|COMPLETED|Overall Study||4
7994384|NCT00111475|19685335|P2|COMPLETED|Overall Study||4
7994385|NCT00111475|19685336|P1|COMPLETED|Overall Study||4
7994386|NCT00111475|19685327|P10|STARTED|Overall Study||1
7994387|NCT00111475|19685328|P9|STARTED|Overall Study||8
7994388|NCT00111475|19685329|P8|STARTED|Overall Study||8
7994389|NCT00111475|19685330|P7|STARTED|Overall Study||4
7994390|NCT00111475|19685331|P6|STARTED|Overall Study||4
7994391|NCT00111475|19685332|P5|STARTED|Overall Study||4
7994392|NCT00111475|19685333|P4|STARTED|Overall Study||4
7994393|NCT00111475|19685334|P3|STARTED|Overall Study||4
7994394|NCT00111475|19685335|P2|STARTED|Overall Study||4
7994395|NCT00111475|19685336|P1|STARTED|Overall Study||4
7994396|NCT00111241|19685454|P2|NOT COMPLETED|Overall Study||8
7994397|NCT00111241|19685455|P1|NOT COMPLETED|Overall Study||15
7994398|NCT00111241|19685454|P2|COMPLETED|Overall Study||62
7994399|NCT00111241|19685455|P1|COMPLETED|Overall Study||30
7994400|NCT00111241|19685454|P2|STARTED|Overall Study||70
7994401|NCT00111241|19685455|P1|STARTED|Overall Study||45
7994402|NCT00111228|19685466|P3|NOT COMPLETED|Overall Study||0
7994403|NCT00111228|19685467|P2|NOT COMPLETED|Overall Study||1
7994404|NCT00111228|19685468|P1|NOT COMPLETED|Overall Study||5
7994405|NCT00111228|19685466|P3|COMPLETED|Overall Study||54
7994406|NCT00111228|19685467|P2|COMPLETED|Overall Study||53
7994407|NCT00111228|19685468|P1|COMPLETED|Overall Study||49
7994408|NCT00111228|19685466|P3|STARTED|Overall Study||54
7994409|NCT00111228|19685467|P2|STARTED|Overall Study||54
7994410|NCT00111228|19685468|P1|STARTED|Overall Study||54
7994411|NCT00111007|19685481|P2|NOT COMPLETED|Long Term Follow-up||45
7994412|NCT00111007|19685482|P1|NOT COMPLETED|Long Term Follow-up||47
7994413|NCT00111007|19685481|P2|COMPLETED|Long Term Follow-up||62
7994414|NCT00111007|19685482|P1|COMPLETED|Long Term Follow-up||54
7994415|NCT00111007|19685481|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107
7994416|NCT00111007|19685482|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101
7994417|NCT00111007|19685481|P2|NOT COMPLETED|Active Follow-up||2
7994418|NCT00111007|19685482|P1|NOT COMPLETED|Active Follow-up||6
7994419|NCT00111007|19685481|P2|COMPLETED|Active Follow-up||2
7994420|NCT00111007|19685482|P1|COMPLETED|Active Follow-up||0
7994421|NCT00111007|19685481|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4
7994422|NCT00111007|19685482|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6
7994423|NCT00111007|19685481|P2|NOT COMPLETED|Double-blind (DB) Treatment||111
7994424|NCT00111007|19685482|P1|NOT COMPLETED|Double-blind (DB) Treatment||108
7994425|NCT00111007|19685481|P2|COMPLETED|Double-blind (DB) Treatment||24
7994426|NCT00111007|19685482|P1|COMPLETED|Double-blind (DB) Treatment||27
7994427|NCT00111007|19685481|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|134
7994428|NCT00111007|19685482|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|134
7994429|NCT00111007|19685481|P2|STARTED|Double-blind (DB) Treatment|ITT population|135
7994430|NCT00111007|19685482|P1|STARTED|Double-blind (DB) Treatment|ITT population|135
7994431|NCT00110994|19685498|P2|NOT COMPLETED|Long Term Follow-up||17
7994432|NCT00110994|19685499|P1|NOT COMPLETED|Long Term Follow-up||19
7994433|NCT00110994|19685498|P2|COMPLETED|Long Term Follow-up||30
7994434|NCT00110994|19685499|P1|COMPLETED|Long Term Follow-up||22
7994435|NCT00110994|19685498|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47
7994436|NCT00110994|19685499|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41
7994437|NCT00110994|19685498|P2|NOT COMPLETED|Active Follow-up||2
7994438|NCT00110994|19685499|P1|NOT COMPLETED|Active Follow-up||1
7994439|NCT00110994|19685498|P2|COMPLETED|Active Follow-up||0
7994440|NCT00110994|19685499|P1|COMPLETED|Active Follow-up||0
7994441|NCT00110994|19685498|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2
7994442|NCT00110994|19685499|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1
7994443|NCT00110994|19685498|P2|NOT COMPLETED|Double-blind (DB) Treatment||47
7994444|NCT00110994|19685499|P1|NOT COMPLETED|Double-blind (DB) Treatment||42
7994445|NCT00110994|19685498|P2|COMPLETED|Double-blind (DB) Treatment||3
7994446|NCT00110994|19685499|P1|COMPLETED|Double-blind (DB) Treatment||9
7994447|NCT00110994|19685498|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|50
7994448|NCT00110994|19685499|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|51
7994449|NCT00110994|19685498|P2|STARTED|Double-blind (DB) Treatment|ITT population|50
7994450|NCT00110994|19685499|P1|STARTED|Double-blind (DB) Treatment|ITT population|51
7994451|NCT00110890|19685525|P2|NOT COMPLETED|Overall Study||179
7994452|NCT00110890|19685526|P1|NOT COMPLETED|Overall Study||361
7994453|NCT00110890|19685525|P2|COMPLETED|Overall Study|Follow-up Phase|5
7994454|NCT00110890|19685526|P1|COMPLETED|Overall Study|Follow-up Phase|7
7994455|NCT00110890|19685525|P2|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150
7994456|NCT00110890|19685526|P1|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280
7994457|NCT00110890|19685525|P2|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170
7994458|NCT00110890|19685526|P1|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316
7994459|NCT00110890|19685525|P2|STARTED|Overall Study||184
7994460|NCT00110890|19685526|P1|STARTED|Overall Study||368
7994461|NCT00110812|19685543|P3|NOT COMPLETED|Extended Follow-up||4
7994462|NCT00110812|19685544|P2|NOT COMPLETED|Extended Follow-up||4
7994463|NCT00110812|19685545|P1|NOT COMPLETED|Extended Follow-up||2
7994464|NCT00110812|19685543|P3|COMPLETED|Extended Follow-up||69
7994465|NCT00110812|19685544|P2|COMPLETED|Extended Follow-up||65
7994466|NCT00110812|19685545|P1|COMPLETED|Extended Follow-up||78
7994467|NCT00110812|19685543|P3|STARTED|Extended Follow-up||73
7994468|NCT00110812|19685544|P2|STARTED|Extended Follow-up||69
7994469|NCT00110812|19685545|P1|STARTED|Extended Follow-up||80
7994470|NCT00110812|19685543|P3|NOT COMPLETED|Main Study||13
7994471|NCT00110812|19685544|P2|NOT COMPLETED|Main Study||11
7994472|NCT00110812|19685545|P1|NOT COMPLETED|Main Study||8
7994473|NCT00110812|19685543|P3|COMPLETED|Main Study||74
7994474|NCT00110812|19685544|P2|COMPLETED|Main Study||78
7994475|NCT00110812|19685545|P1|COMPLETED|Main Study||83
7994476|NCT00110812|19685543|P3|STARTED|Main Study||87
7994477|NCT00110812|19685544|P2|STARTED|Main Study||89
7994478|NCT00110812|19685545|P1|STARTED|Main Study||91
7994479|NCT00110617|19685590|P2|NOT COMPLETED|Overall Study||29
7994480|NCT00110617|19685591|P1|NOT COMPLETED|Overall Study||39
7994481|NCT00110617|19685590|P2|COMPLETED|Overall Study||39
7994482|NCT00110617|19685591|P1|COMPLETED|Overall Study||96
7994483|NCT00110617|19685590|P2|On Going at Week 24|Overall Study||53
7994484|NCT00110617|19685591|P1|On Going at Week 24|Overall Study||126
7994485|NCT00110617|19685590|P2|Full Analysis 2; Received ICL670|Overall Study||53
7994486|NCT00110617|19685591|P1|Full Analysis 2; Received ICL670|Overall Study||135
7994487|NCT00110617|19685590|P2|Safety Set 1; Received Study Drug|Overall Study||56
7994488|NCT00110617|19685591|P1|Safety Set 1; Received Study Drug|Overall Study||135
7994489|NCT00110617|19685590|P2|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68
7994490|NCT00110617|19685591|P1|STARTED|Overall Study||135
7994491|NCT00110513|19685604|P1|NOT COMPLETED|Overall Study||0
7994492|NCT00110513|19685604|P1|COMPLETED|Overall Study||18
7994493|NCT00110513|19685604|P1|STARTED|Overall Study||18
7994494|NCT00110461|19685611|P3|NOT COMPLETED|Acute Phase||23
7994495|NCT00110461|19685612|P2|NOT COMPLETED|Acute Phase||22
7994496|NCT00110461|19685613|P1|NOT COMPLETED|Acute Phase||14
7994497|NCT00110461|19685611|P3|COMPLETED|Acute Phase||76
7994498|NCT00110461|19685612|P2|COMPLETED|Acute Phase||77
7994499|NCT00110461|19685613|P1|COMPLETED|Acute Phase||84
7994500|NCT00110461|19685611|P3|STARTED|Acute Phase||99
7994501|NCT00110461|19685612|P2|STARTED|Acute Phase||99
7994502|NCT00110461|19685613|P1|STARTED|Acute Phase||98
7994503|NCT00110461|19685611|P3|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87
7994504|NCT00110461|19685612|P2|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77
7994505|NCT00110461|19685613|P1|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64
7994506|NCT00110461|19685611|P3|COMPLETED|30-Week, Double-blind Treatment Phase||12
7994507|NCT00110461|19685612|P2|COMPLETED|30-Week, Double-blind Treatment Phase||22
7994508|NCT00110461|19685613|P1|COMPLETED|30-Week, Double-blind Treatment Phase||34
7994509|NCT00110461|19685611|P3|STARTED|30-Week, Double-blind Treatment Phase||99
7994510|NCT00110461|19685612|P2|STARTED|30-Week, Double-blind Treatment Phase||99
7994511|NCT00110461|19685613|P1|STARTED|30-Week, Double-blind Treatment Phase||98
7994512|NCT00110396|19685708|P1|NOT COMPLETED|Overall Study||36
7994513|NCT00110396|19685708|P1|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224
7994514|NCT00110396|19685708|P1|STARTED|Overall Study||260
7994515|NCT00110357|19685716|P2|NOT COMPLETED|Overall Study||19
7994516|NCT00110357|19685717|P1|NOT COMPLETED|Overall Study||27
7994517|NCT00110357|19685716|P2|COMPLETED|Overall Study|Number Still on Study|0
7994518|NCT00110357|19685717|P1|COMPLETED|Overall Study|Number Still on Study|0
7994519|NCT00110357|19685716|P2|STARTED|Overall Study||19
7994520|NCT00110357|19685717|P1|STARTED|Overall Study||27
7994521|NCT00110305|19685805|P2|NOT COMPLETED|Overall Study||32
7994522|NCT00110305|19685806|P1|NOT COMPLETED|Overall Study||114
7994523|NCT00110305|19685805|P2|COMPLETED|Overall Study||57
7994524|NCT00110305|19685806|P1|COMPLETED|Overall Study||165
7994525|NCT00110305|19685805|P2|STARTED|Overall Study||89
7994526|NCT00110305|19685806|P1|STARTED|Overall Study||279
7994527|NCT00110214|19685859|P2|NOT COMPLETED|Overall Study||503
7994528|NCT00110214|19685860|P1|NOT COMPLETED|Overall Study||509
7994529|NCT00110214|19685859|P2|COMPLETED|Overall Study||21
7994530|NCT00110214|19685860|P1|COMPLETED|Overall Study||17
7994531|NCT00110214|19685859|P2|STARTED|Overall Study||524
7994532|NCT00110214|19685860|P1|STARTED|Overall Study||526
7994533|NCT00110149|19685872|P1|NOT COMPLETED|Overall Study||3
7994534|NCT00110149|19685872|P1|COMPLETED|Overall Study||9
7994535|NCT00110149|19685872|P1|Received Treatment|Overall Study|total number of patient that passed screening and received treatment.|9
7994536|NCT00110149|19685872|P1|STARTED|Overall Study|total number that signed consent to be screened.|12
7994537|NCT00110136|19685877|P1|NOT COMPLETED|Overall Study||0
7994538|NCT00110136|19685877|P1|COMPLETED|Overall Study||9
7994539|NCT00110136|19685877|P1|STARTED|Overall Study||9
7994540|NCT00110084|19685886|P1|NOT COMPLETED|Overall Study||28
7994541|NCT00110084|19685886|P1|COMPLETED|Overall Study||22
7994542|NCT00110084|19685886|P1|STARTED|Overall Study||50
7994543|NCT00110019|19685895|P2|NOT COMPLETED|Overall Study||413
7994544|NCT00110019|19685896|P1|NOT COMPLETED|Overall Study||406
7994545|NCT00110019|19685895|P2|COMPLETED|Overall Study||0
7994546|NCT00110019|19685896|P1|COMPLETED|Overall Study||4
7994547|NCT00110019|19685895|P2|Treated|Overall Study||397
7994548|NCT00110019|19685896|P1|Treated|Overall Study||393
7994549|NCT00110019|19685895|P2|Eligible|Overall Study||398
7994550|NCT00110019|19685896|P1|Eligible|Overall Study||395
7994551|NCT00110019|19685895|P2|STARTED|Overall Study||413
7994552|NCT00110019|19685896|P1|STARTED|Overall Study||410
7994553|NCT00109967|19685908|P2|NOT COMPLETED|Overall Study||6
7994554|NCT00109967|19685909|P1|NOT COMPLETED|Overall Study||20
7994555|NCT00109967|19685908|P2|COMPLETED|Overall Study||15
7994556|NCT00109967|19685909|P1|COMPLETED|Overall Study||30
7994557|NCT00109967|19685908|P2|STARTED|Overall Study||21
7994558|NCT00109967|19685909|P1|STARTED|Overall Study||50
7994559|NCT00109928|19685923|P1|NOT COMPLETED|Overall Study||13
7994560|NCT00109928|19685923|P1|COMPLETED|Overall Study||21
7994561|NCT00109928|19685923|P1|Eligible and Began Protocol Therapy|Overall Study||33
7994562|NCT00109928|19685923|P1|Eligible|Overall Study||33
7994563|NCT00109928|19685923|P1|STARTED|Overall Study||34
7994564|NCT00109876|19685930|P1|NOT COMPLETED|Overall Study||0
7994565|NCT00109876|19685930|P1|COMPLETED|Overall Study||51
7994566|NCT00109876|19685930|P1|STARTED|Overall Study||51
7994567|NCT00109850|19685940|P1|NOT COMPLETED|Overall Study||4
7994568|NCT00109850|19685940|P1|COMPLETED|Overall Study||18
7994569|NCT00109850|19685940|P1|Eligible and Began Protocol Therapy|Overall Study||21
7994570|NCT00109850|19685940|P1|Eligible|Overall Study||21
7994571|NCT00109850|19685940|P1|STARTED|Overall Study||22
7994572|NCT00109837|19685947|P1|NOT COMPLETED|Overall Study||23
7994573|NCT00109837|19685947|P1|COMPLETED|Overall Study||56
7994574|NCT00109837|19685947|P1|Eligible and Ph- and Treated|Overall Study||60
7994575|NCT00109837|19685947|P1|Eligible and Ph-|Overall Study||61
7994576|NCT00109837|19685947|P1|Eligible|Overall Study||78
7994577|NCT00109837|19685947|P1|STARTED|Overall Study||79
7994578|NCT00109772|19685957|P2|NOT COMPLETED|Open-label Extension||49
7994579|NCT00109772|19685958|P1|NOT COMPLETED|Open-label Extension||45
7994580|NCT00109772|19685957|P2|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29
7994581|NCT00109772|19685958|P1|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19
7994582|NCT00109772|19685957|P2|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78
7994583|NCT00109772|19685958|P1|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64
7994584|NCT00109772|19685957|P2|NOT COMPLETED|Double-blind Treatment||15
7994585|NCT00109772|19685958|P1|NOT COMPLETED|Double-blind Treatment||22
7994586|NCT00109772|19685957|P2|COMPLETED|Double-blind Treatment||79
7994587|NCT00109772|19685958|P1|COMPLETED|Double-blind Treatment||68
7994588|NCT00109772|19685957|P2|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93
7994589|NCT00109772|19685958|P1|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87
7994590|NCT00109772|19685957|P2|STARTED|Double-blind Treatment||94
7994591|NCT00109772|19685958|P1|STARTED|Double-blind Treatment||90
7994592|NCT00109733|19685998|P2|NOT COMPLETED|Overall Study||4
7994593|NCT00109733|19685999|P1|NOT COMPLETED|Overall Study||2
7994594|NCT00109733|19685998|P2|COMPLETED|Overall Study||12
7994595|NCT00109733|19685999|P1|COMPLETED|Overall Study||13
7994596|NCT00109733|19685998|P2|STARTED|Overall Study||16
7994597|NCT00109733|19685999|P1|STARTED|Overall Study||15
7994598|NCT00109590|19686016|P3|NOT COMPLETED|Overall Study||4
7994599|NCT00109590|19686017|P2|NOT COMPLETED|Overall Study||2
7994600|NCT00109590|19686018|P1|NOT COMPLETED|Overall Study||2
7994601|NCT00109590|19686016|P3|COMPLETED|Overall Study||56
7994602|NCT00109590|19686017|P2|COMPLETED|Overall Study||56
7994603|NCT00109590|19686018|P1|COMPLETED|Overall Study||55
7994604|NCT00109590|19686016|P3|RECEIVED TREATMENT|Overall Study||57
7994605|NCT00109590|19686017|P2|RECEIVED TREATMENT|Overall Study||56
7994606|NCT00109590|19686018|P1|RECEIVED TREATMENT|Overall Study||56
7994607|NCT00109590|19686016|P3|STARTED|Overall Study||60
7994608|NCT00109590|19686017|P2|STARTED|Overall Study||58
7994609|NCT00109590|19686018|P1|STARTED|Overall Study||57
7994610|NCT00109577|19686060|P2|NOT COMPLETED|Overall Study||3
7994611|NCT00109577|19686061|P1|NOT COMPLETED|Overall Study||3
7994612|NCT00109577|19686060|P2|COMPLETED|Overall Study||17
7994613|NCT00109577|19686061|P1|COMPLETED|Overall Study||17
7994614|NCT00109577|19686060|P2|STARTED|Overall Study||20
7994615|NCT00109577|19686061|P1|STARTED|Overall Study||20
7994616|NCT00109473|19686069|P2|NOT COMPLETED|52 Week Extension Phase||5
7994617|NCT00109473|19686070|P1|NOT COMPLETED|52 Week Extension Phase||4
7994618|NCT00109473|19686069|P2|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3
7994619|NCT00109473|19686070|P1|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5
7994620|NCT00109473|19686069|P2|Analyzed|52 Week Extension Phase||8
7994621|NCT00109473|19686070|P1|Analyzed|52 Week Extension Phase||9
7994622|NCT00109473|19686069|P2|STARTED|52 Week Extension Phase||8
7994623|NCT00109473|19686070|P1|STARTED|52 Week Extension Phase||9
7994624|NCT00109473|19686069|P2|NOT COMPLETED|Week 12 to Week 24||0
7994625|NCT00109473|19686070|P1|NOT COMPLETED|Week 12 to Week 24||1
7994626|NCT00109473|19686069|P2|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9
7994627|NCT00109473|19686070|P1|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9
7994628|NCT00109473|19686069|P2|Analyzed|Week 12 to Week 24||9
7994629|NCT00109473|19686070|P1|Analyzed|Week 12 to Week 24||9
7994630|NCT00109473|19686069|P2|STARTED|Week 12 to Week 24||9
7994631|NCT00109473|19686070|P1|STARTED|Week 12 to Week 24||10
7994632|NCT00109473|19686069|P2|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1
7994633|NCT00109473|19686070|P1|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0
7994634|NCT00109473|19686069|P2|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9
7994635|NCT00109473|19686070|P1|COMPLETED|Baseline (0 Through 12 Weeks)||10
7994636|NCT00109473|19686069|P2|Analyzed|Baseline (0 Through 12 Weeks)||10
7994637|NCT00109473|19686070|P1|Analyzed|Baseline (0 Through 12 Weeks)||10
7994638|NCT00109473|19686069|P2|STARTED|Baseline (0 Through 12 Weeks)||10
7994639|NCT00109473|19686070|P1|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10
7994640|NCT00109343|19686094|P3|NOT COMPLETED|Overall Study||30
7994641|NCT00109343|19686095|P2|NOT COMPLETED|Overall Study||37
7994642|NCT00109343|19686096|P1|NOT COMPLETED|Overall Study||64
7994643|NCT00109343|19686094|P3|COMPLETED|Overall Study||229
7994644|NCT00109343|19686095|P2|COMPLETED|Overall Study||221
7994645|NCT00109343|19686096|P1|COMPLETED|Overall Study||446
7994646|NCT00109343|19686094|P3|Vaccinated at Visit 4|Overall Study||240
7994647|NCT00109343|19686095|P2|Vaccinated at Visit 4|Overall Study||235
7994648|NCT00109343|19686096|P1|Vaccinated at Visit 4|Overall Study||466
7994649|NCT00109343|19686094|P3|Vaccinated at Visit 2|Overall Study||246
7994650|NCT00109343|19686095|P2|Vaccinated at Visit 2|Overall Study||246
7994651|NCT00109343|19686096|P1|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0
7994652|NCT00109343|19686094|P3|Vaccinated at Visit 1|Overall Study||259
7994653|NCT00109343|19686095|P2|Vaccinated at Visit 1|Overall Study||258
7994654|NCT00109343|19686096|P1|Vaccinated at Visit 1|Overall Study||510
7994655|NCT00109343|19686094|P3|STARTED|Overall Study||259
7994656|NCT00109343|19686095|P2|STARTED|Overall Study||258
7994657|NCT00109343|19686096|P1|STARTED|Overall Study||510
7994658|NCT00109031|19686141|P4|NOT COMPLETED|Overall Study||0
7994659|NCT00109031|19686142|P3|NOT COMPLETED|Overall Study||2
7994660|NCT00109031|19686143|P2|NOT COMPLETED|Overall Study||2
7994661|NCT00109031|19686144|P1|NOT COMPLETED|Overall Study||0
7994662|NCT00109031|19686141|P4|COMPLETED|Overall Study||12
7994663|NCT00109031|19686142|P3|COMPLETED|Overall Study||12
7994664|NCT00109031|19686143|P2|COMPLETED|Overall Study||8
7994665|NCT00109031|19686144|P1|COMPLETED|Overall Study||11
7994666|NCT00109031|19686141|P4|STARTED|Overall Study||12
7994667|NCT00109031|19686142|P3|STARTED|Overall Study||14
7994668|NCT00109031|19686143|P2|STARTED|Overall Study||10
7994669|NCT00109031|19686144|P1|STARTED|Overall Study||11
7994670|NCT00109005|19686180|P2|NOT COMPLETED|Overall Study||0
7994671|NCT00109005|19686181|P1|NOT COMPLETED|Overall Study||0
7994672|NCT00109005|19686180|P2|COMPLETED|Overall Study||9
7994673|NCT00109005|19686181|P1|COMPLETED|Overall Study||8
7994674|NCT00109005|19686180|P2|STARTED|Overall Study||9
7994675|NCT00109005|19686181|P1|STARTED|Overall Study||8
7994676|NCT00108953|19686195|P2|NOT COMPLETED|Follow-up||33
7994677|NCT00108953|19686196|P1|NOT COMPLETED|Follow-up||29
7994678|NCT00108953|19686195|P2|COMPLETED|Follow-up||12
7994679|NCT00108953|19686196|P1|COMPLETED|Follow-up||11
7994680|NCT00108953|19686195|P2|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45
7994681|NCT00108953|19686196|P1|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40
7994682|NCT00108953|19686195|P2|NOT COMPLETED|Treatment Period||0
7994683|NCT00108953|19686196|P1|NOT COMPLETED|Treatment Period||0
7994684|NCT00108953|19686195|P2|COMPLETED|Treatment Period|No patient under study medication anymore|49
7994685|NCT00108953|19686196|P1|COMPLETED|Treatment Period|No patient under study medication anymore|47
7994686|NCT00108953|19686195|P2|STARTED|Treatment Period|ITT population|49
7994687|NCT00108953|19686196|P1|STARTED|Treatment Period|ITT population|47
7994688|NCT00108862|19686218|P2|NOT COMPLETED|Overall Study||62
7994689|NCT00108862|19686219|P1|NOT COMPLETED|Overall Study||68
7994690|NCT00108862|19686218|P2|COMPLETED|Overall Study||339
7994691|NCT00108862|19686219|P1|COMPLETED|Overall Study||337
7994692|NCT00108862|19686218|P2|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401
7994693|NCT00108862|19686219|P1|STARTED|Overall Study||405
7994694|NCT00108732|19686247|P1|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5
7994695|NCT00108732|19686247|P1|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26
7994696|NCT00108732|19686247|P1|STARTED|Step 2 (Androgen Ablation and Vaccine)||31
7994697|NCT00108732|19686247|P1|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14
7994698|NCT00108732|19686247|P1|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36
7994699|NCT00108732|19686247|P1|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40
7994700|NCT00108732|19686247|P1|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50
7994701|NCT00108628|19686256|P2|NOT COMPLETED|Overall Study||10
7994702|NCT00108628|19686257|P1|NOT COMPLETED|Overall Study||20
7994703|NCT00108628|19686256|P2|COMPLETED|Overall Study||53
7994704|NCT00108628|19686257|P1|COMPLETED|Overall Study||41
7994705|NCT00108628|19686256|P2|Completed Treatment|Overall Study||57
7994706|NCT00108628|19686257|P1|Completed Treatment|Overall Study||42
7994707|NCT00108628|19686256|P2|Received One or More Sessions|Overall Study||58
7994708|NCT00108628|19686257|P1|Received One or More Sessions|Overall Study||53
7994709|NCT00108628|19686256|P2|STARTED|Overall Study||63
7994710|NCT00108628|19686257|P1|STARTED|Overall Study||61
7994711|NCT00108550|19686283|P2|NOT COMPLETED|Overall Study||16
7994712|NCT00108550|19686284|P1|NOT COMPLETED|Overall Study||16
7994713|NCT00108550|19686283|P2|COMPLETED|Overall Study||37
7994714|NCT00108550|19686284|P1|COMPLETED|Overall Study||39
7994715|NCT00108550|19686283|P2|STARTED|Overall Study||53
7994716|NCT00108550|19686284|P1|STARTED|Overall Study||55
7994717|NCT00108524|19686294|P2|NOT COMPLETED|Overall Study||18
7994718|NCT00108524|19686295|P1|NOT COMPLETED|Overall Study||29
7994719|NCT00108524|19686294|P2|COMPLETED|Overall Study||61
7994720|NCT00108524|19686295|P1|COMPLETED|Overall Study||52
7994721|NCT00108524|19686294|P2|STARTED|Overall Study||79
7994722|NCT00108524|19686295|P1|STARTED|Overall Study||81
7994723|NCT00108485|19686307|P2|NOT COMPLETED|Overall Study||2
7994724|NCT00108485|19686308|P1|NOT COMPLETED|Overall Study||3
7994725|NCT00108485|19686307|P2|COMPLETED|Overall Study||2
7994726|NCT00108485|19686308|P1|COMPLETED|Overall Study||2
7994727|NCT00108485|19686307|P2|STARTED|Overall Study||4
7994728|NCT00108485|19686308|P1|STARTED|Overall Study||5
7994729|NCT00108433|19686316|P2|NOT COMPLETED|Overall Study||17
7994730|NCT00108433|19686317|P1|NOT COMPLETED|Overall Study||21
7994731|NCT00108433|19686316|P2|COMPLETED|Overall Study||14
7994732|NCT00108433|19686317|P1|COMPLETED|Overall Study||9
7994733|NCT00108433|19686316|P2|STARTED|Overall Study||31
7994734|NCT00108433|19686317|P1|STARTED|Overall Study||30
7994735|NCT00108355|19686333|P2|NOT COMPLETED|Overall Study||2
7994736|NCT00108355|19686334|P1|NOT COMPLETED|Overall Study||2
7994737|NCT00108355|19686333|P2|COMPLETED|Overall Study||12
7994738|NCT00108355|19686334|P1|COMPLETED|Overall Study||13
7994739|NCT00108355|19686333|P2|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14
7994740|NCT00108355|19686334|P1|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15
7994741|NCT00108342|19686344|P2|NOT COMPLETED|Overall Study||0
7994742|NCT00108342|19686345|P1|NOT COMPLETED|Overall Study||1
7994743|NCT00108342|19686344|P2|COMPLETED|Overall Study||9
7994744|NCT00108342|19686345|P1|COMPLETED|Overall Study||7
7994745|NCT00108342|19686344|P2|STARTED|Overall Study||9
7994746|NCT00108342|19686345|P1|STARTED|Overall Study||8
7994747|NCT00108303|19686354|P3|NOT COMPLETED|Overall Study||0
7994748|NCT00108303|19686355|P2|NOT COMPLETED|Overall Study||0
7994749|NCT00108303|19686356|P1|NOT COMPLETED|Overall Study||0
7994750|NCT00108303|19686354|P3|COMPLETED|Overall Study||180
7994751|NCT00108303|19686355|P2|COMPLETED|Overall Study||179
7994752|NCT00108303|19686356|P1|COMPLETED|Overall Study||179
7994753|NCT00108303|19686354|P3|STARTED|Overall Study||180
7994754|NCT00108303|19686355|P2|STARTED|Overall Study||179
7994755|NCT00108303|19686356|P1|STARTED|Overall Study||179
7994756|NCT00108277|19686371|P3|NOT COMPLETED|Overall Study||16
7994757|NCT00108277|19686372|P2|NOT COMPLETED|Overall Study||12
7994758|NCT00108277|19686373|P1|NOT COMPLETED|Overall Study||10
7994759|NCT00108277|19686371|P3|COMPLETED|Overall Study||19
7994760|NCT00108277|19686372|P2|COMPLETED|Overall Study||16
7994761|NCT00108277|19686373|P1|COMPLETED|Overall Study||19
7994762|NCT00108277|19686371|P3|STARTED|Overall Study||35
7994763|NCT00108277|19686372|P2|STARTED|Overall Study||28
7994764|NCT00108277|19686373|P1|STARTED|Overall Study||29
7994765|NCT00108160|19686383|P2|NOT COMPLETED|Overall Study||21
7994766|NCT00108160|19686384|P1|NOT COMPLETED|Overall Study||39
7994767|NCT00108160|19686383|P2|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42
7994768|NCT00108160|19686384|P1|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44
7994769|NCT00108160|19686383|P2|Completed Visit 7 (18 mo)|Overall Study||31
7994770|NCT00108160|19686384|P1|Completed Visit 7 (18 mo)|Overall Study||34
7994771|NCT00108160|19686383|P2|Completed Visit 6 (15 mo)|Overall Study||33
7994772|NCT00108160|19686384|P1|Completed Visit 6 (15 mo)|Overall Study||36
7994773|NCT00108160|19686383|P2|Completed Visit 5 (12 mo)|Overall Study||37
7994774|NCT00108160|19686384|P1|Completed Visit 5 (12 mo)|Overall Study||37
7994775|NCT00108160|19686383|P2|Completed Visit 4 (9 mo)|Overall Study||37
7994776|NCT00108160|19686384|P1|Completed Visit 4 (9 mo)|Overall Study||38
7994777|NCT00108160|19686383|P2|Completed Visit 3 (6 mo)|Overall Study||38
7994778|NCT00108160|19686384|P1|Completed Visit 3 (6 mo)|Overall Study||44
7994779|NCT00108160|19686383|P2|Completed Visit 2 (3 mo)|Overall Study||46
7994780|NCT00108160|19686384|P1|Completed Visit 2 (3 mo)|Overall Study||54
7994781|NCT00108160|19686383|P2|Completed Visit 1 (2 Wks)|Overall Study||54
7994782|NCT00108160|19686384|P1|Completed Visit 1 (2 Wks)|Overall Study||72
7994783|NCT00108160|19686383|P2|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60
7994784|NCT00108160|19686384|P1|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79
7994785|NCT00108160|19686383|P2|STARTED|Overall Study||63
7994786|NCT00108160|19686384|P1|STARTED|Overall Study||83
7994787|NCT00108082|19686397|P3|NOT COMPLETED|Overall Study||43
7994788|NCT00108082|19686398|P2|NOT COMPLETED|Overall Study||32
7994789|NCT00108082|19686399|P1|NOT COMPLETED|Overall Study||38
7994790|NCT00108082|19686397|P3|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
7994791|NCT00108082|19686398|P2|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68
7994792|NCT00108082|19686399|P1|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
7994793|NCT00108082|19686397|P3|STARTED|Overall Study||96
7994794|NCT00108082|19686398|P2|STARTED|Overall Study||100
7994795|NCT00108082|19686399|P1|STARTED|Overall Study||91
7994796|NCT00108069|19686448|P2|NOT COMPLETED|Overall Study||13
7994797|NCT00108069|19686449|P1|NOT COMPLETED|Overall Study||30
7994798|NCT00108069|19686448|P2|COMPLETED|Overall Study||0
7994799|NCT00108069|19686449|P1|COMPLETED|Overall Study||0
7994800|NCT00108069|19686448|P2|STARTED|Overall Study||13
7994801|NCT00108069|19686449|P1|STARTED|Overall Study||30
7994802|NCT00107991|19686463|P1|NOT COMPLETED|18-Week Post Treatment Assessment||2
7994803|NCT00107991|19686463|P1|COMPLETED|18-Week Post Treatment Assessment||8
7994804|NCT00107991|19686463|P1|STARTED|18-Week Post Treatment Assessment||10
7994805|NCT00107991|19686463|P1|NOT COMPLETED|12 Week Treatment Period||5
7994806|NCT00107991|19686463|P1|COMPLETED|12 Week Treatment Period||10
7994807|NCT00107991|19686463|P1|STARTED|12 Week Treatment Period||15
7994808|NCT00107991|19686463|P1|NOT COMPLETED|Eligibility Assessment||23
7994809|NCT00107991|19686463|P1|COMPLETED|Eligibility Assessment||15
7994810|NCT00107991|19686463|P1|STARTED|Eligibility Assessment||38
7994811|NCT00107978|19686473|P2|NOT COMPLETED|Overall Study||50
7994812|NCT00107978|19686474|P1|NOT COMPLETED|Overall Study||33
7994813|NCT00107978|19686473|P2|COMPLETED|Overall Study||431
7994814|NCT00107978|19686474|P1|COMPLETED|Overall Study||425
7994815|NCT00107978|19686473|P2|STARTED|Overall Study||481
7994816|NCT00107978|19686474|P1|STARTED|Overall Study||458
7994817|NCT00107952|19686482|P2|NOT COMPLETED|Overall Study||81
7994818|NCT00107952|19686483|P1|NOT COMPLETED|Overall Study||95
7994819|NCT00107952|19686482|P2|COMPLETED|Overall Study||299
7994820|NCT00107952|19686483|P1|COMPLETED|Overall Study||286
7994821|NCT00107952|19686482|P2|STARTED|Overall Study||380
7994822|NCT00107952|19686483|P1|STARTED|Overall Study||381
7994823|NCT00107900|19686495|P6|NOT COMPLETED|Overall Study||9
7994824|NCT00107900|19686496|P5|NOT COMPLETED|Overall Study||21
7994825|NCT00107900|19686497|P4|NOT COMPLETED|Overall Study||12
7994826|NCT00107900|19686498|P3|NOT COMPLETED|Overall Study||25
7994827|NCT00107900|19686499|P2|NOT COMPLETED|Overall Study||3
7994828|NCT00107900|19686500|P1|NOT COMPLETED|Overall Study||10
7994829|NCT00107900|19686495|P6|COMPLETED|Overall Study||94
7994830|NCT00107900|19686496|P5|COMPLETED|Overall Study||94
7994831|NCT00107900|19686497|P4|COMPLETED|Overall Study||87
7994832|NCT00107900|19686498|P3|COMPLETED|Overall Study||104
7994833|NCT00107900|19686499|P2|COMPLETED|Overall Study||72
7994834|NCT00107900|19686500|P1|COMPLETED|Overall Study||75
7994835|NCT00107900|19686495|P6|STARTED|Overall Study||103
7994836|NCT00107900|19686496|P5|STARTED|Overall Study||115
7994837|NCT00107900|19686497|P4|STARTED|Overall Study||99
7994838|NCT00107900|19686498|P3|STARTED|Overall Study||129
7994839|NCT00107900|19686499|P2|STARTED|Overall Study||75
7994840|NCT00107900|19686500|P1|STARTED|Overall Study||85
7994841|NCT00107783|19686534|P2|NOT COMPLETED|Overall Study||4
7994842|NCT00107783|19686535|P1|NOT COMPLETED|Overall Study||3
7994843|NCT00107783|19686534|P2|COMPLETED|Overall Study||16
7994844|NCT00107783|19686535|P1|COMPLETED|Overall Study||17
7994845|NCT00107783|19686534|P2|STARTED|Overall Study||20
7994846|NCT00107783|19686535|P1|STARTED|Overall Study||20
7994847|NCT00107744|19686552|P3|NOT COMPLETED|Intervention 3 (8 Weeks)||0
7994848|NCT00107744|19686553|P2|NOT COMPLETED|Intervention 3 (8 Weeks)||0
7994849|NCT00107744|19686554|P1|NOT COMPLETED|Intervention 3 (8 Weeks)||0
7994850|NCT00107744|19686552|P3|COMPLETED|Intervention 3 (8 Weeks)||88
7994851|NCT00107744|19686553|P2|COMPLETED|Intervention 3 (8 Weeks)||92
7994852|NCT00107744|19686554|P1|COMPLETED|Intervention 3 (8 Weeks)||93
7994853|NCT00107744|19686552|P3|STARTED|Intervention 3 (8 Weeks)||88
7994854|NCT00107744|19686553|P2|STARTED|Intervention 3 (8 Weeks)||92
7994855|NCT00107744|19686554|P1|STARTED|Intervention 3 (8 Weeks)||93
7994856|NCT00107744|19686552|P3|NOT COMPLETED|Intervention 2 (8 Weeks)||13
7994857|NCT00107744|19686553|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||12
7994858|NCT00107744|19686554|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||8
7994859|NCT00107744|19686552|P3|COMPLETED|Intervention 2 (8 Weeks)||88
7994860|NCT00107744|19686553|P2|COMPLETED|Intervention 2 (8 Weeks)||92
7994861|NCT00107744|19686554|P1|COMPLETED|Intervention 2 (8 Weeks)||93
7994862|NCT00107744|19686552|P3|STARTED|Intervention 2 (8 Weeks)||101
7994863|NCT00107744|19686553|P2|STARTED|Intervention 2 (8 Weeks)||104
7994864|NCT00107744|19686554|P1|STARTED|Intervention 2 (8 Weeks)||101
7994865|NCT00107744|19686552|P3|NOT COMPLETED|Intervention 1 (8 Weeks)||17
7994866|NCT00107744|19686553|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||13
7994867|NCT00107744|19686554|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||16
7994868|NCT00107744|19686552|P3|COMPLETED|Intervention 1 (8 Weeks)||101
7994869|NCT00107744|19686553|P2|COMPLETED|Intervention 1 (8 Weeks)||104
7994870|NCT00107744|19686554|P1|COMPLETED|Intervention 1 (8 Weeks)||101
7994871|NCT00107744|19686552|P3|STARTED|Intervention 1 (8 Weeks)||118
7994872|NCT00107744|19686553|P2|STARTED|Intervention 1 (8 Weeks)||117
7994873|NCT00107744|19686554|P1|STARTED|Intervention 1 (8 Weeks)||117
7994874|NCT00107653|19686570|P2|NOT COMPLETED|Overall Study||76
7994875|NCT00107653|19686571|P1|NOT COMPLETED|Overall Study||79
7994876|NCT00107653|19686570|P2|COMPLETED|Overall Study||224
7994877|NCT00107653|19686571|P1|COMPLETED|Overall Study||190
7994878|NCT00107653|19686570|P2|STARTED|Overall Study||300
7994879|NCT00107653|19686571|P1|STARTED|Overall Study||269
7994880|NCT00107614|19686617|P1|NOT COMPLETED|Overall Study||12
7994881|NCT00107614|19686617|P1|COMPLETED|Overall Study||0
7994882|NCT00107614|19686617|P1|STARTED|Overall Study||12
7994883|NCT00107575|19686623|P2|NOT COMPLETED|Overall Study||10
7994884|NCT00107575|19686624|P1|NOT COMPLETED|Overall Study||11
7994885|NCT00107575|19686623|P2|COMPLETED|Overall Study||107
7994886|NCT00107575|19686624|P1|COMPLETED|Overall Study||108
7994887|NCT00107575|19686623|P2|STARTED|Overall Study||117
7994888|NCT00107575|19686624|P1|STARTED|Overall Study||119
7994889|NCT00107536|19686638|P1|NOT COMPLETED|Overall Study||0
7994890|NCT00107536|19686638|P1|COMPLETED|Overall Study||26
7994891|NCT00107536|19686638|P1|STARTED|Overall Study||26
7994892|NCT00107380|19686648|P1|NOT COMPLETED|Overall Study||30
7994893|NCT00107380|19686648|P1|COMPLETED|Overall Study||56
7994894|NCT00107380|19686648|P1|Eligible|Overall Study||84
7994895|NCT00107380|19686648|P1|STARTED|Overall Study||86
7994896|NCT00107315|19686654|P1|NOT COMPLETED|Overall Study||15
7994897|NCT00107315|19686654|P1|COMPLETED|Overall Study||1
7994898|NCT00107315|19686654|P1|STARTED|Overall Study||16
7994899|NCT00107276|19686661|P1|NOT COMPLETED|Overall Study||72
7994900|NCT00107276|19686661|P1|COMPLETED|Overall Study||40
7994901|NCT00107276|19686661|P1|Eligible|Overall Study||96
7994902|NCT00107276|19686661|P1|STARTED|Overall Study||112
7994903|NCT00107198|19686667|P1|NOT COMPLETED|Overall Study||52
7994904|NCT00107198|19686667|P1|COMPLETED|Overall Study||136
7994905|NCT00107198|19686667|P1|STARTED|Overall Study||188
7994906|NCT00107172|19686677|P2|NOT COMPLETED|Overall Study||5
7994907|NCT00107172|19686678|P1|NOT COMPLETED|Overall Study||5
7994908|NCT00107172|19686677|P2|COMPLETED|Overall Study||103
7994909|NCT00107172|19686678|P1|COMPLETED|Overall Study||109
7994910|NCT00107172|19686677|P2|STARTED|Overall Study||108
7994911|NCT00107172|19686678|P1|STARTED|Overall Study||114
7994912|NCT00107120|19686708|P2|NOT COMPLETED|Overall Study||24
7994913|NCT00107120|19686709|P1|NOT COMPLETED|Overall Study||29
7994914|NCT00107120|19686708|P2|COMPLETED|Overall Study||133
7994915|NCT00107120|19686709|P1|COMPLETED|Overall Study||126
7994916|NCT00107120|19686708|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157
7994917|NCT00107120|19686709|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155
7994918|NCT00107042|19686721|P2|NOT COMPLETED|Overall Study||16
7994919|NCT00107042|19686722|P1|NOT COMPLETED|Overall Study||22
7994920|NCT00107042|19686721|P2|COMPLETED|Overall Study||47
7994921|NCT00107042|19686722|P1|COMPLETED|Overall Study||38
7994922|NCT00107042|19686721|P2|STARTED|Overall Study||63
7994923|NCT00107042|19686722|P1|STARTED|Overall Study||60
7994924|NCT00106964|19686788|P3|NOT COMPLETED|Overall Study||7
7994925|NCT00106964|19686789|P2|NOT COMPLETED|Overall Study||15
7994926|NCT00106964|19686790|P1|NOT COMPLETED|Overall Study||13
7994927|NCT00106964|19686788|P3|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120
7994928|NCT00106964|19686789|P2|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111
7994929|NCT00106964|19686790|P1|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105
7994930|NCT00106964|19686788|P3|STARTED|Overall Study||127
7994931|NCT00106964|19686789|P2|STARTED|Overall Study||126
7994932|NCT00106964|19686790|P1|STARTED|Overall Study||118
7994933|NCT00106938|19686815|P2|NOT COMPLETED|Overall Study||71
7994934|NCT00106938|19686816|P1|NOT COMPLETED|Overall Study||176
7994935|NCT00106938|19686815|P2|COMPLETED|Overall Study||293
7994936|NCT00106938|19686816|P1|COMPLETED|Overall Study||913
7994937|NCT00106938|19686815|P2|STARTED|Overall Study||364
7994938|NCT00106938|19686816|P1|STARTED|Overall Study||1089
7994939|NCT00106704|19686885|P2|NOT COMPLETED|Overall Study||151
7994940|NCT00106704|19686886|P1|NOT COMPLETED|Overall Study||131
7994941|NCT00106704|19686885|P2|COMPLETED|Overall Study||68
7994942|NCT00106704|19686886|P1|COMPLETED|Overall Study||91
7994943|NCT00106704|19686885|P2|STARTED|Overall Study||219
7994944|NCT00106704|19686886|P1|STARTED|Overall Study||222
7994945|NCT00106639|19686897|P3|NOT COMPLETED|Overall Study||2
7994946|NCT00106639|19686898|P2|NOT COMPLETED|Overall Study||7
7994947|NCT00106639|19686899|P1|NOT COMPLETED|Overall Study||3
7994948|NCT00106639|19686897|P3|COMPLETED|Overall Study||19
7994949|NCT00106639|19686898|P2|COMPLETED|Overall Study||13
7994950|NCT00106639|19686899|P1|COMPLETED|Overall Study||17
7994951|NCT00106639|19686897|P3|STARTED|Overall Study||21
7994952|NCT00106639|19686898|P2|STARTED|Overall Study||20
7994953|NCT00106639|19686899|P1|STARTED|Overall Study||20
7994954|NCT00106626|19687026|P4|NOT COMPLETED|Overall Study||13
7994955|NCT00106626|19687027|P3|NOT COMPLETED|Overall Study||12
7994956|NCT00106626|19687028|P2|NOT COMPLETED|Overall Study||6
7994957|NCT00106626|19687029|P1|NOT COMPLETED|Overall Study||10
7994958|NCT00106626|19687026|P4|COMPLETED|Overall Study||3
7994959|NCT00106626|19687027|P3|COMPLETED|Overall Study||2
7994960|NCT00106626|19687028|P2|COMPLETED|Overall Study||3
7994961|NCT00106626|19687029|P1|COMPLETED|Overall Study||3
7994962|NCT00106626|19687026|P4|STARTED|Overall Study||16
7994963|NCT00106626|19687027|P3|STARTED|Overall Study||14
7994964|NCT00106626|19687028|P2|STARTED|Overall Study||9
7994965|NCT00106626|19687029|P1|STARTED|Overall Study||13
7994966|NCT00106535|19687047|P4|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190
7994967|NCT00106535|19687048|P3|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
7994968|NCT00106535|19687049|P2|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
7994969|NCT00106535|19687050|P1|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
7994970|NCT00106535|19687047|P4|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704
7994971|NCT00106535|19687048|P3|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
7994972|NCT00106535|19687049|P2|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
7994973|NCT00106535|19687050|P1|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
7994974|NCT00106535|19687047|P4|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894
7994975|NCT00106535|19687048|P3|STARTED|Long-term Extension Period (Year 3 to 5)||0
7994976|NCT00106535|19687049|P2|STARTED|Long-term Extension Period (Year 3 to 5)||0
7994977|NCT00106535|19687050|P1|STARTED|Long-term Extension Period (Year 3 to 5)||0
7994978|NCT00106535|19687047|P4|NOT COMPLETED|2-year Placebo Controlled Period||0
7994979|NCT00106535|19687048|P3|NOT COMPLETED|2-year Placebo Controlled Period||91
7994980|NCT00106535|19687049|P2|NOT COMPLETED|2-year Placebo Controlled Period||92
7994981|NCT00106535|19687050|P1|NOT COMPLETED|2-year Placebo Controlled Period||107
7994982|NCT00106535|19687047|P4|COMPLETED|2-year Placebo Controlled Period||0
7994983|NCT00106535|19687048|P3|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310
7994984|NCT00106535|19687049|P2|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309
7994985|NCT00106535|19687050|P1|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287
7994986|NCT00106535|19687047|P4|Completed Week 52|2-year Placebo Controlled Period||0
7994987|NCT00106535|19687048|P3|Completed Week 52|2-year Placebo Controlled Period||338
7994988|NCT00106535|19687049|P2|Completed Week 52|2-year Placebo Controlled Period||342
7994989|NCT00106535|19687050|P1|Completed Week 52|2-year Placebo Controlled Period||326
7994990|NCT00106535|19687047|P4|Completed Week 24|2-year Placebo Controlled Period||0
7994991|NCT00106535|19687048|P3|Completed Week 24|2-year Placebo Controlled Period||366
7994992|NCT00106535|19687049|P2|Completed Week 24|2-year Placebo Controlled Period||373
7994993|NCT00106535|19687050|P1|Completed Week 24|2-year Placebo Controlled Period||356
7994994|NCT00106535|19687047|P4|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0
7994995|NCT00106535|19687048|P3|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
7994996|NCT00106535|19687049|P2|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
7994997|NCT00106535|19687050|P1|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392
7994998|NCT00106535|19687047|P4|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0
7994999|NCT00106535|19687048|P3|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398
7995000|NCT00106535|19687049|P2|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399
7995001|NCT00106535|19687050|P1|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393
7995002|NCT00106535|19687047|P4|STARTED|2-year Placebo Controlled Period||0
7995003|NCT00106535|19687048|P3|STARTED|2-year Placebo Controlled Period||401
7995004|NCT00106535|19687049|P2|STARTED|2-year Placebo Controlled Period||401
7995005|NCT00106535|19687050|P1|STARTED|2-year Placebo Controlled Period||394
7995006|NCT00106431|19687343|P1|NOT COMPLETED|Overall Study||65
7995007|NCT00106431|19687343|P1|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37
7995008|NCT00106431|19687343|P1|STARTED|Overall Study||102
7995009|NCT00106392|19687355|P2|NOT COMPLETED|Overall Study||27
7995010|NCT00106392|19687356|P1|NOT COMPLETED|Overall Study||26
7995011|NCT00106392|19687355|P2|COMPLETED|Overall Study||42
7995012|NCT00106392|19687356|P1|COMPLETED|Overall Study||36
7995013|NCT00106392|19687355|P2|Full Analysis Set (FAS)|Overall Study||61
7995014|NCT00106392|19687356|P1|Full Analysis Set (FAS)|Overall Study||53
7995015|NCT00106392|19687355|P2|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65
7995016|NCT00106392|19687356|P1|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59
7995017|NCT00106392|19687355|P2|STARTED|Overall Study||69
7995018|NCT00106392|19687356|P1|STARTED|Overall Study||62
7995019|NCT00106353|19687374|P7|NOT COMPLETED|Part 2||16
7995020|NCT00106353|19687375|P6|NOT COMPLETED|Part 2||18
7995021|NCT00106353|19687376|P5|NOT COMPLETED|Part 2||16
7995022|NCT00106353|19687377|P4|NOT COMPLETED|Part 2||0
7995023|NCT00106353|19687378|P3|NOT COMPLETED|Part 2||0
7995024|NCT00106353|19687379|P2|NOT COMPLETED|Part 2||0
7995025|NCT00106353|19687380|P1|NOT COMPLETED|Part 2||0
7995026|NCT00106353|19687374|P7|COMPLETED|Part 2||0
7995027|NCT00106353|19687375|P6|COMPLETED|Part 2||1
7995028|NCT00106353|19687376|P5|COMPLETED|Part 2||1
7995029|NCT00106353|19687377|P4|COMPLETED|Part 2||0
7995030|NCT00106353|19687378|P3|COMPLETED|Part 2||0
7995031|NCT00106353|19687379|P2|COMPLETED|Part 2||0
7995032|NCT00106353|19687380|P1|COMPLETED|Part 2||0
7995033|NCT00106353|19687374|P7|STARTED|Part 2||16
7995034|NCT00106353|19687375|P6|STARTED|Part 2||19
7995035|NCT00106353|19687376|P5|STARTED|Part 2||17
7995036|NCT00106353|19687377|P4|STARTED|Part 2||0
7995037|NCT00106353|19687378|P3|STARTED|Part 2||0
7995038|NCT00106353|19687379|P2|STARTED|Part 2||0
7995039|NCT00106353|19687380|P1|STARTED|Part 2||0
7995040|NCT00106353|19687374|P7|NOT COMPLETED|Part 1||0
7995041|NCT00106353|19687375|P6|NOT COMPLETED|Part 1||0
7995042|NCT00106353|19687376|P5|NOT COMPLETED|Part 1||0
7995043|NCT00106353|19687377|P4|NOT COMPLETED|Part 1||7
7995044|NCT00106353|19687378|P3|NOT COMPLETED|Part 1||3
7995045|NCT00106353|19687379|P2|NOT COMPLETED|Part 1||5
7995046|NCT00106353|19687380|P1|NOT COMPLETED|Part 1||4
7995047|NCT00106353|19687374|P7|COMPLETED|Part 1||0
7995048|NCT00106353|19687375|P6|COMPLETED|Part 1||0
7995049|NCT00106353|19687376|P5|COMPLETED|Part 1||0
7995050|NCT00106353|19687377|P4|COMPLETED|Part 1||0
7995051|NCT00106353|19687378|P3|COMPLETED|Part 1||0
7995052|NCT00106353|19687379|P2|COMPLETED|Part 1||0
7995053|NCT00106353|19687380|P1|COMPLETED|Part 1||0
7995054|NCT00106353|19687374|P7|STARTED|Part 1||0
7995055|NCT00106353|19687375|P6|STARTED|Part 1||0
7995056|NCT00106353|19687376|P5|STARTED|Part 1||0
7995057|NCT00106353|19687377|P4|STARTED|Part 1||7
7995058|NCT00106353|19687378|P3|STARTED|Part 1||3
7995059|NCT00106353|19687379|P2|STARTED|Part 1||5
7995060|NCT00106353|19687380|P1|STARTED|Part 1||4
7995061|NCT00106249|19687507|P2|NOT COMPLETED|Overall Study||2
7995062|NCT00106249|19687508|P1|NOT COMPLETED|Overall Study||3
7995063|NCT00106249|19687507|P2|COMPLETED|Overall Study||11
7995064|NCT00106249|19687508|P1|COMPLETED|Overall Study||11
7995065|NCT00106249|19687507|P2|STARTED|Overall Study||13
7995066|NCT00106249|19687508|P1|STARTED|Overall Study||14
7995067|NCT00106184|19687520|P2|NOT COMPLETED|Overall Study||2
7995068|NCT00106184|19687521|P1|NOT COMPLETED|Overall Study||3
7995069|NCT00106184|19687520|P2|COMPLETED|Overall Study||102
7995070|NCT00106184|19687521|P1|COMPLETED|Overall Study||93
7995071|NCT00106184|19687520|P2|Treated|Overall Study|104 subjects were randomized.|102
7995072|NCT00106184|19687521|P1|Treated|Overall Study|96 subjects were randomized.|93
7995073|NCT00106184|19687520|P2|STARTED|Overall Study||104
7995074|NCT00106184|19687521|P1|STARTED|Overall Study||96
7995075|NCT00106119|19687531|P2|NOT COMPLETED|Second Intervention||0
7995076|NCT00106119|19687532|P1|NOT COMPLETED|Second Intervention||0
7995077|NCT00106119|19687531|P2|COMPLETED|Second Intervention||7
7995078|NCT00106119|19687532|P1|COMPLETED|Second Intervention||7
7995079|NCT00106119|19687531|P2|STARTED|Second Intervention||7
7995080|NCT00106119|19687532|P1|STARTED|Second Intervention||7
7995081|NCT00106119|19687531|P2|NOT COMPLETED|Washout Period of 30 Days||0
7995082|NCT00106119|19687532|P1|NOT COMPLETED|Washout Period of 30 Days||0
7995083|NCT00106119|19687531|P2|COMPLETED|Washout Period of 30 Days||7
7995084|NCT00106119|19687532|P1|COMPLETED|Washout Period of 30 Days||7
7995085|NCT00106119|19687531|P2|STARTED|Washout Period of 30 Days||7
7995086|NCT00106119|19687532|P1|STARTED|Washout Period of 30 Days||7
7995087|NCT00106119|19687531|P2|NOT COMPLETED|First Intervention||0
7995088|NCT00106119|19687532|P1|NOT COMPLETED|First Intervention||0
7995089|NCT00106119|19687531|P2|COMPLETED|First Intervention||7
7995090|NCT00106119|19687532|P1|COMPLETED|First Intervention||7
7995091|NCT00106119|19687531|P2|STARTED|First Intervention||7
7995092|NCT00106119|19687532|P1|STARTED|First Intervention||7
7995093|NCT00106106|19687552|P2|NOT COMPLETED|Overall Study||4
7995094|NCT00106106|19687553|P1|NOT COMPLETED|Overall Study||4
7995095|NCT00106106|19687552|P2|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19
7995096|NCT00106106|19687553|P1|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22
7995097|NCT00106106|19687552|P2|Completed Both MRS Scans|Overall Study||15
7995098|NCT00106106|19687553|P1|Completed Both MRS Scans|Overall Study||18
7995099|NCT00106106|19687552|P2|STARTED|Overall Study||23
7995100|NCT00106106|19687553|P1|STARTED|Overall Study||26
7995101|NCT00106080|19687563|P2|NOT COMPLETED|Overall Study||27
7995102|NCT00106080|19687564|P1|NOT COMPLETED|Overall Study||43
7995103|NCT00106080|19687563|P2|COMPLETED|Overall Study||155
7995104|NCT00106080|19687564|P1|COMPLETED|Overall Study||151
7995105|NCT00106080|19687563|P2|STARTED|Overall Study||182
7995106|NCT00106080|19687564|P1|STARTED|Overall Study||194
7995107|NCT00106028|19687574|P2|NOT COMPLETED|Overall Study||12
7995108|NCT00106028|19687575|P1|NOT COMPLETED|Overall Study||6
7995109|NCT00106028|19687574|P2|COMPLETED|Overall Study|Completed Month 36|82
7995110|NCT00106028|19687575|P1|COMPLETED|Overall Study|Completed Month 36|43
7995111|NCT00106028|19687574|P2|Month 12 Completed/Started Open Label|Overall Study||87
7995112|NCT00106028|19687575|P1|Month 12 Completed/Started Open Label|Overall Study||49
7995113|NCT00106028|19687574|P2|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94
7995114|NCT00106028|19687575|P1|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49
7995115|NCT00106002|19687669|P1|NOT COMPLETED|Overall Study||2
7995116|NCT00106002|19687669|P1|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35
7995117|NCT00106002|19687669|P1|STARTED|Overall Study||37
7995118|NCT00105989|19687677|P2|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69
7995119|NCT00105989|19687678|P1|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50
7995120|NCT00105989|19687677|P2|COMPLETED|Maintenance - Double-Blind:Week 34-86||73
7995121|NCT00105989|19687678|P1|COMPLETED|Maintenance - Double-Blind:Week 34-86||96
7995122|NCT00105989|19687677|P2|STARTED|Maintenance - Double-Blind:Week 34-86||142
7995123|NCT00105989|19687678|P1|STARTED|Maintenance - Double-Blind:Week 34-86||146
7995124|NCT00105989|19687677|P2|NOT COMPLETED|Continuation - Open Label:Week 10-34||0
7995125|NCT00105989|19687678|P1|NOT COMPLETED|Continuation - Open Label:Week 10-34||125
7995126|NCT00105989|19687677|P2|COMPLETED|Continuation - Open Label:Week 10-34||0
7995127|NCT00105989|19687678|P1|COMPLETED|Continuation - Open Label:Week 10-34||288
7995128|NCT00105989|19687677|P2|STARTED|Continuation - Open Label:Week 10-34||0
7995129|NCT00105989|19687678|P1|STARTED|Continuation - Open Label:Week 10-34||413
7995130|NCT00105989|19687677|P2|NOT COMPLETED|Acute - Open Label: Week 0-10||0
7995131|NCT00105989|19687678|P1|NOT COMPLETED|Acute - Open Label: Week 0-10||101
7995132|NCT00105989|19687677|P2|COMPLETED|Acute - Open Label: Week 0-10||0
7995133|NCT00105989|19687678|P1|COMPLETED|Acute - Open Label: Week 0-10||413
7995134|NCT00105989|19687677|P2|STARTED|Acute - Open Label: Week 0-10||0
7995135|NCT00105989|19687678|P1|STARTED|Acute - Open Label: Week 0-10||514
7995136|NCT00105586|19687794|P2|NOT COMPLETED|Overall Study||16
7995137|NCT00105586|19687795|P1|NOT COMPLETED|Overall Study||17
7995138|NCT00105586|19687794|P2|COMPLETED|Overall Study||69
7995139|NCT00105586|19687795|P1|COMPLETED|Overall Study||75
7995140|NCT00105586|19687794|P2|STARTED|Overall Study||85
7995141|NCT00105586|19687795|P1|STARTED|Overall Study||92
7995142|NCT00105560|19687803|P1|NOT COMPLETED|Overall Study||1
7995143|NCT00105560|19687803|P1|COMPLETED|Overall Study||58
7995144|NCT00105560|19687803|P1|STARTED|Overall Study||59
7995145|NCT00105534|19687825|P2|NOT COMPLETED|Overall Study||33
7995146|NCT00105534|19687826|P1|NOT COMPLETED|Overall Study||22
7995147|NCT00105534|19687825|P2|COMPLETED|Overall Study||317
7995148|NCT00105534|19687826|P1|COMPLETED|Overall Study||313
7995149|NCT00105534|19687825|P2|STARTED|Overall Study||350
7995150|NCT00105534|19687826|P1|STARTED|Overall Study||335
7995151|NCT00105521|19687838|P4|NOT COMPLETED|Overall Study||17
7995152|NCT00105521|19687839|P3|NOT COMPLETED|Overall Study||17
7995153|NCT00105521|19687840|P2|NOT COMPLETED|Overall Study||11
7995154|NCT00105521|19687841|P1|NOT COMPLETED|Overall Study||15
7995155|NCT00105521|19687838|P4|COMPLETED|Overall Study||85
7995156|NCT00105521|19687839|P3|COMPLETED|Overall Study||80
7995157|NCT00105521|19687840|P2|COMPLETED|Overall Study||90
7995158|NCT00105521|19687841|P1|COMPLETED|Overall Study||83
7995159|NCT00105521|19687838|P4|STARTED|Overall Study||102
7995160|NCT00105521|19687839|P3|STARTED|Overall Study||97
7995161|NCT00105521|19687840|P2|STARTED|Overall Study||101
7995162|NCT00105521|19687841|P1|STARTED|Overall Study||98
7995163|NCT00105508|19687865|P2|NOT COMPLETED|Overall Study||36
7995164|NCT00105508|19687866|P1|NOT COMPLETED|Overall Study||40
7995165|NCT00105508|19687865|P2|COMPLETED|Overall Study||217
7995166|NCT00105508|19687866|P1|COMPLETED|Overall Study||213
7995167|NCT00105508|19687865|P2|STARTED|Overall Study||253
7995168|NCT00105508|19687866|P1|STARTED|Overall Study||253
7995169|NCT00105482|19687880|P2|NOT COMPLETED|Overall Study||55
7995170|NCT00105482|19687881|P1|NOT COMPLETED|Overall Study||59
7995171|NCT00105482|19687880|P2|COMPLETED|Overall Study||30
7995172|NCT00105482|19687881|P1|COMPLETED|Overall Study||28
7995173|NCT00105482|19687880|P2|STARTED|Overall Study||85
7995174|NCT00105482|19687881|P1|STARTED|Overall Study||87
7995175|NCT00105469|19687897|P2|NOT COMPLETED|Overall Study||11
7995176|NCT00105469|19687898|P1|NOT COMPLETED|Overall Study||22
7995177|NCT00105469|19687897|P2|COMPLETED|Overall Study||367
7995178|NCT00105469|19687898|P1|COMPLETED|Overall Study||343
7995179|NCT00105469|19687897|P2|STARTED|Overall Study||378
7995180|NCT00105469|19687898|P1|STARTED|Overall Study||365
7995181|NCT00105443|19687908|P4|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47
7995182|NCT00105443|19687909|P3|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245
7995183|NCT00105443|19687910|P2|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57
7995184|NCT00105443|19687911|P1|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228
7995185|NCT00105443|19687908|P4|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0
7995186|NCT00105443|19687909|P3|COMPLETED|Follow-up and/or Open Label Nexavar||0
7995187|NCT00105443|19687910|P2|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0
7995188|NCT00105443|19687911|P1|COMPLETED|Follow-up and/or Open Label Nexavar||0
7995189|NCT00105443|19687908|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11
7995190|NCT00105443|19687909|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
7995191|NCT00105443|19687910|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10
7995192|NCT00105443|19687911|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
7995193|NCT00105443|19687908|P4|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36
7995194|NCT00105443|19687909|P3|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
7995195|NCT00105443|19687910|P2|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47
7995196|NCT00105443|19687911|P1|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
7995197|NCT00105443|19687908|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
7995198|NCT00105443|19687909|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245
7995199|NCT00105443|19687910|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
7995200|NCT00105443|19687911|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228
7995201|NCT00105443|19687908|P4|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47
7995202|NCT00105443|19687909|P3|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245
7995203|NCT00105443|19687910|P2|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57
7995204|NCT00105443|19687911|P1|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228
7995205|NCT00105443|19687908|P4|NOT COMPLETED|Double-Blind Treatment||0
7995206|NCT00105443|19687909|P3|NOT COMPLETED|Double-Blind Treatment||11
7995207|NCT00105443|19687910|P2|NOT COMPLETED|Double-Blind Treatment||0
7995208|NCT00105443|19687911|P1|NOT COMPLETED|Double-Blind Treatment||14
7995209|NCT00105443|19687908|P4|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47
7995210|NCT00105443|19687909|P3|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245
7995211|NCT00105443|19687910|P2|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57
7995212|NCT00105443|19687911|P1|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228
7995213|NCT00105443|19687908|P4|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47
7995214|NCT00105443|19687909|P3|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255
7995215|NCT00105443|19687910|P2|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57
7995216|NCT00105443|19687911|P1|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240
7995217|NCT00105443|19687908|P4|STARTED|Double-Blind Treatment||47
7995218|NCT00105443|19687909|P3|STARTED|Double-Blind Treatment||256
7995219|NCT00105443|19687910|P2|STARTED|Double-Blind Treatment||57
7995220|NCT00105443|19687911|P1|STARTED|Double-Blind Treatment||242
7995221|NCT00105235|19687938|P1|NOT COMPLETED|Overall Study||7
7995222|NCT00105235|19687938|P1|COMPLETED|Overall Study||20
7995223|NCT00105235|19687938|P1|STARTED|Overall Study||27
7995224|NCT00105196|19687951|P2|NOT COMPLETED|Overall Study||23
7995225|NCT00105196|19687952|P1|NOT COMPLETED|Overall Study||30
7995226|NCT00105196|19687951|P2|COMPLETED|Overall Study||149
7995227|NCT00105196|19687952|P1|COMPLETED|Overall Study||147
7995228|NCT00105196|19687951|P2|STARTED|Overall Study||172
7995229|NCT00105196|19687952|P1|STARTED|Overall Study||177
7995230|NCT00105183|19687975|P3|NOT COMPLETED|Overall Study||23
7995231|NCT00105183|19687976|P2|NOT COMPLETED|Overall Study||19
7995232|NCT00105183|19687977|P1|NOT COMPLETED|Overall Study||22
7995233|NCT00105183|19687975|P3|COMPLETED|Overall Study|Completed at least 12 months follow up|39
7995234|NCT00105183|19687976|P2|COMPLETED|Overall Study|Completed at least 12 months follow up|60
7995235|NCT00105183|19687977|P1|COMPLETED|Overall Study|Completed at least 12 months follow up|60
7995236|NCT00105183|19687975|P3|STARTED|Overall Study|Randomized|62
7995237|NCT00105183|19687976|P2|STARTED|Overall Study|Randomized|79
7995238|NCT00105183|19687977|P1|STARTED|Overall Study|Randomized|82
7995239|NCT00105157|19688013|P4|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18
7995240|NCT00105157|19688014|P3|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
7995241|NCT00105157|19688015|P2|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
7995242|NCT00105157|19688016|P1|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9
7995243|NCT00105157|19688013|P4|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19
7995244|NCT00105157|19688014|P3|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5
7995245|NCT00105157|19688015|P2|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7
7995246|NCT00105157|19688016|P1|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2
7995247|NCT00105157|19688013|P4|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37
7995248|NCT00105157|19688014|P3|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
7995249|NCT00105157|19688015|P2|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13
7995250|NCT00105157|19688016|P1|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
7995251|NCT00105157|19688013|P4|NOT COMPLETED|Open-Label Continuation of DB||1
7995252|NCT00105157|19688014|P3|NOT COMPLETED|Open-Label Continuation of DB||9
7995253|NCT00105157|19688015|P2|NOT COMPLETED|Open-Label Continuation of DB||10
7995254|NCT00105157|19688016|P1|NOT COMPLETED|Open-Label Continuation of DB||7
7995255|NCT00105157|19688013|P4|COMPLETED|Open-Label Continuation of DB||5
7995256|NCT00105157|19688014|P3|COMPLETED|Open-Label Continuation of DB||24
7995257|NCT00105157|19688015|P2|COMPLETED|Open-Label Continuation of DB||21
7995258|NCT00105157|19688016|P1|COMPLETED|Open-Label Continuation of DB||23
7995259|NCT00105157|19688013|P4|STARTED|Open-Label Continuation of DB||6
7995260|NCT00105157|19688014|P3|STARTED|Open-Label Continuation of DB||33
7995261|NCT00105157|19688015|P2|STARTED|Open-Label Continuation of DB||31
7995262|NCT00105157|19688016|P1|STARTED|Open-Label Continuation of DB||30
7995263|NCT00105157|19688013|P4|NOT COMPLETED|Double-Blind (DB)||39
7995264|NCT00105157|19688014|P3|NOT COMPLETED|Double-Blind (DB)||12
7995265|NCT00105157|19688015|P2|NOT COMPLETED|Double-Blind (DB)||14
7995266|NCT00105157|19688016|P1|NOT COMPLETED|Double-Blind (DB)||14
7995267|NCT00105157|19688013|P4|COMPLETED|Double-Blind (DB)||6
7995268|NCT00105157|19688014|P3|COMPLETED|Double-Blind (DB)||33
7995269|NCT00105157|19688015|P2|COMPLETED|Double-Blind (DB)||31
7995270|NCT00105157|19688016|P1|COMPLETED|Double-Blind (DB)||30
7995271|NCT00105157|19688013|P4|Treated|Double-Blind (DB)||45
7995272|NCT00105157|19688014|P3|Treated|Double-Blind (DB)||45
7995273|NCT00105157|19688015|P2|Treated|Double-Blind (DB)||45
7995274|NCT00105157|19688016|P1|Treated|Double-Blind (DB)||43
7995275|NCT00105157|19688013|P4|STARTED|Double-Blind (DB)||45
7995276|NCT00105157|19688014|P3|STARTED|Double-Blind (DB)||45
7995277|NCT00105157|19688015|P2|STARTED|Double-Blind (DB)||45
7995278|NCT00105157|19688016|P1|STARTED|Double-Blind (DB)||44
7995279|NCT00105079|19688210|P2|NOT COMPLETED|Overall Study||35
7995280|NCT00105079|19688211|P1|NOT COMPLETED|Overall Study||39
7995281|NCT00105079|19688210|P2|COMPLETED|Overall Study||135
7995282|NCT00105079|19688211|P1|COMPLETED|Overall Study||128
7995283|NCT00105079|19688210|P2|Safety Population|Overall Study||168
7995284|NCT00105079|19688211|P1|Safety Population|Overall Study||163
7995285|NCT00105079|19688210|P2|STARTED|Overall Study||170
7995286|NCT00105079|19688211|P1|STARTED|Overall Study||167
7995287|NCT00105066|19688229|P2|NOT COMPLETED|Overall Study||5
7995288|NCT00105066|19688230|P1|NOT COMPLETED|Overall Study||2
7995289|NCT00105066|19688229|P2|COMPLETED|Overall Study||45
7995290|NCT00105066|19688230|P1|COMPLETED|Overall Study||25
7995291|NCT00105066|19688229|P2|STARTED|Overall Study||50
7995292|NCT00105066|19688230|P1|STARTED|Overall Study||27
7995293|NCT00105027|19688246|P6|NOT COMPLETED|Overall Study||13
7995294|NCT00105027|19688247|P5|NOT COMPLETED|Overall Study||15
7995295|NCT00105027|19688248|P4|NOT COMPLETED|Overall Study||16
7995296|NCT00105027|19688249|P3|NOT COMPLETED|Overall Study||9
7995297|NCT00105027|19688250|P2|NOT COMPLETED|Overall Study||9
7995298|NCT00105027|19688251|P1|NOT COMPLETED|Overall Study||15
7995299|NCT00105027|19688246|P6|COMPLETED|Overall Study||125
7995300|NCT00105027|19688247|P5|COMPLETED|Overall Study||121
7995301|NCT00105027|19688248|P4|COMPLETED|Overall Study||121
7995302|NCT00105027|19688249|P3|COMPLETED|Overall Study||82
7995303|NCT00105027|19688250|P2|COMPLETED|Overall Study||83
7995304|NCT00105027|19688251|P1|COMPLETED|Overall Study||73
7995305|NCT00105027|19688246|P6|STARTED|Overall Study||138
7995306|NCT00105027|19688247|P5|STARTED|Overall Study||136
7995307|NCT00105027|19688248|P4|STARTED|Overall Study||137
7995308|NCT00105027|19688249|P3|STARTED|Overall Study||91
7995309|NCT00105027|19688250|P2|STARTED|Overall Study||92
7995310|NCT00105027|19688251|P1|STARTED|Overall Study||88
7995311|NCT00105001|19688286|P3|NOT COMPLETED|Overall Study||0
7995312|NCT00105001|19688287|P2|NOT COMPLETED|Overall Study||0
7995313|NCT00105001|19688288|P1|NOT COMPLETED|Overall Study||0
7995314|NCT00105001|19688286|P3|COMPLETED|Overall Study||69
7995315|NCT00105001|19688287|P2|COMPLETED|Overall Study||71
7995316|NCT00105001|19688288|P1|COMPLETED|Overall Study||70
7995317|NCT00105001|19688286|P3|STARTED|Overall Study||69
7995318|NCT00105001|19688287|P2|STARTED|Overall Study||71
7995319|NCT00105001|19688288|P1|STARTED|Overall Study||70
7995320|NCT00104884|19688308|P1|NOT COMPLETED|Overall Study||4
7995321|NCT00104884|19688308|P1|COMPLETED|Overall Study||0
7995322|NCT00104884|19688308|P1|STARTED|Overall Study||4
7995323|NCT00104871|19688312|P1|NOT COMPLETED|Overall Study||1
7995324|NCT00104871|19688312|P1|COMPLETED|Overall Study||21
7995325|NCT00104871|19688312|P1|STARTED|Overall Study||22
7995326|NCT00104858|19688318|P1|NOT COMPLETED|Overall Study||0
7995327|NCT00104858|19688318|P1|COMPLETED|Overall Study||52
7995328|NCT00104858|19688318|P1|STARTED|Overall Study||52
7995329|NCT00104728|19688333|P1|NOT COMPLETED|Overall Study||19
7995330|NCT00104728|19688333|P1|COMPLETED|Overall Study||23
7995331|NCT00104728|19688333|P1|STARTED|Overall Study|42 consented on study|42
7995332|NCT00104650|19688341|P3|NOT COMPLETED|Follow-up Period||10
7995333|NCT00104650|19688342|P2|NOT COMPLETED|Follow-up Period||13
7995334|NCT00104650|19688343|P1|NOT COMPLETED|Follow-up Period||11
7995335|NCT00104650|19688341|P3|COMPLETED|Follow-up Period||18
7995336|NCT00104650|19688342|P2|COMPLETED|Follow-up Period||12
7995337|NCT00104650|19688343|P1|COMPLETED|Follow-up Period||14
7995338|NCT00104650|19688341|P3|STARTED|Follow-up Period||28
7995339|NCT00104650|19688342|P2|STARTED|Follow-up Period||25
7995340|NCT00104650|19688343|P1|STARTED|Follow-up Period||25
7995341|NCT00104650|19688341|P3|NOT COMPLETED|Treatment Period (25 Weeks)||10
7995342|NCT00104650|19688342|P2|NOT COMPLETED|Treatment Period (25 Weeks)||11
7995343|NCT00104650|19688343|P1|NOT COMPLETED|Treatment Period (25 Weeks)||12
7995344|NCT00104650|19688341|P3|COMPLETED|Treatment Period (25 Weeks)||28
7995345|NCT00104650|19688342|P2|COMPLETED|Treatment Period (25 Weeks)||25
7995346|NCT00104650|19688343|P1|COMPLETED|Treatment Period (25 Weeks)||25
7995347|NCT00104650|19688341|P3|Received Investigational Product|Treatment Period (25 Weeks)||38
7995348|NCT00104650|19688342|P2|Received Investigational Product|Treatment Period (25 Weeks)||35
7995349|NCT00104650|19688343|P1|Received Investigational Product|Treatment Period (25 Weeks)||35
7995350|NCT00104650|19688341|P3|STARTED|Treatment Period (25 Weeks)||38
7995351|NCT00104650|19688342|P2|STARTED|Treatment Period (25 Weeks)||36
7995352|NCT00104650|19688343|P1|STARTED|Treatment Period (25 Weeks)||37
7995353|NCT00104637|19688375|P2|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
7995354|NCT00104637|19688376|P1|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
7995355|NCT00104637|19688375|P2|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4
7995356|NCT00104637|19688376|P1|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5
7995357|NCT00104637|19688375|P2|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4
7995358|NCT00104637|19688376|P1|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5
7995359|NCT00104637|19688375|P2|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
7995360|NCT00104637|19688376|P1|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
7995361|NCT00104637|19688375|P2|COMPLETED|Period 2 (WASHOUT: 1 Week)||4
7995362|NCT00104637|19688376|P1|COMPLETED|Period 2 (WASHOUT: 1 Week)||5
7995363|NCT00104637|19688375|P2|STARTED|Period 2 (WASHOUT: 1 Week)||4
7995364|NCT00104637|19688376|P1|STARTED|Period 2 (WASHOUT: 1 Week)||5
7995365|NCT00104637|19688375|P2|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0
7995366|NCT00104637|19688376|P1|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1
7995367|NCT00104637|19688375|P2|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4
7995368|NCT00104637|19688376|P1|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5
7995369|NCT00104637|19688375|P2|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4
7995370|NCT00104637|19688376|P1|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6
7995371|NCT00104572|19688405|P3|NOT COMPLETED|Overall Study||0
7995372|NCT00104572|19688406|P2|NOT COMPLETED|Overall Study||3
7995373|NCT00104572|19688407|P1|NOT COMPLETED|Overall Study||3
7995374|NCT00104572|19688405|P3|COMPLETED|Overall Study||9
7995375|NCT00104572|19688406|P2|COMPLETED|Overall Study||10
7995376|NCT00104572|19688407|P1|COMPLETED|Overall Study||10
7995377|NCT00104572|19688405|P3|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9
7995378|NCT00104572|19688406|P2|STARTED|Overall Study|These are the analysed subjects|13
7995379|NCT00104572|19688407|P1|STARTED|Overall Study|These are the analysed subjects|13
7995380|NCT00104520|19688426|P2|NOT COMPLETED|Overall Study||71
7995381|NCT00104520|19688427|P1|NOT COMPLETED|Overall Study||50
7995382|NCT00104520|19688426|P2|COMPLETED|Overall Study||64
7995383|NCT00104520|19688427|P1|COMPLETED|Overall Study||26
7995384|NCT00104520|19688426|P2|STARTED|Overall Study||135
7995385|NCT00104520|19688427|P1|STARTED|Overall Study||76
7995386|NCT00104416|19688447|P5|NOT COMPLETED|Continuation Phase||5
7995387|NCT00104416|19688448|P4|NOT COMPLETED|Continuation Phase||2
7995388|NCT00104416|19688449|P3|NOT COMPLETED|Continuation Phase||6
7995389|NCT00104416|19688450|P2|NOT COMPLETED|Continuation Phase||0
7995390|NCT00104416|19688451|P1|NOT COMPLETED|Continuation Phase||0
7995391|NCT00104416|19688447|P5|COMPLETED|Continuation Phase||27
7995392|NCT00104416|19688448|P4|COMPLETED|Continuation Phase||65
7995393|NCT00104416|19688449|P3|COMPLETED|Continuation Phase||63
7995394|NCT00104416|19688450|P2|COMPLETED|Continuation Phase||0
7995395|NCT00104416|19688451|P1|COMPLETED|Continuation Phase||0
7995396|NCT00104416|19688447|P5|STARTED|Continuation Phase||32
7995397|NCT00104416|19688448|P4|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67
7995398|NCT00104416|19688449|P3|STARTED|Continuation Phase||69
7995399|NCT00104416|19688450|P2|STARTED|Continuation Phase||0
7995400|NCT00104416|19688451|P1|STARTED|Continuation Phase||0
7995401|NCT00104416|19688447|P5|NOT COMPLETED|Double-Blind Phase||0
7995402|NCT00104416|19688448|P4|NOT COMPLETED|Double-Blind Phase||0
7995403|NCT00104416|19688449|P3|NOT COMPLETED|Double-Blind Phase||0
7995404|NCT00104416|19688450|P2|NOT COMPLETED|Double-Blind Phase||10
7995405|NCT00104416|19688451|P1|NOT COMPLETED|Double-Blind Phase||8
7995406|NCT00104416|19688447|P5|COMPLETED|Double-Blind Phase||0
7995407|NCT00104416|19688448|P4|COMPLETED|Double-Blind Phase||0
7995408|NCT00104416|19688449|P3|COMPLETED|Double-Blind Phase||0
7995409|NCT00104416|19688450|P2|COMPLETED|Double-Blind Phase||66
7995410|NCT00104416|19688451|P1|COMPLETED|Double-Blind Phase||69
7995411|NCT00104416|19688447|P5|STARTED|Double-Blind Phase||0
7995412|NCT00104416|19688448|P4|STARTED|Double-Blind Phase||0
7995413|NCT00104416|19688449|P3|STARTED|Double-Blind Phase||0
7995414|NCT00104416|19688450|P2|STARTED|Double-Blind Phase||76
7995415|NCT00104416|19688451|P1|STARTED|Double-Blind Phase||77
7995416|NCT00104299|19688496|P2|NOT COMPLETED|Overall Study||10
7995417|NCT00104299|19688497|P1|NOT COMPLETED|Overall Study||9
7995418|NCT00104299|19688496|P2|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88
7995419|NCT00104299|19688497|P1|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90
7995420|NCT00104299|19688496|P2|STARTED|Overall Study||98
7995421|NCT00104299|19688497|P1|STARTED|Overall Study||99
7995422|NCT00104247|19688519|P2|NOT COMPLETED|Overall Study||1
7995423|NCT00104247|19688520|P1|NOT COMPLETED|Overall Study||1
7995424|NCT00104247|19688519|P2|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46
7995425|NCT00104247|19688520|P1|COMPLETED|Overall Study|Subject withdrew prior to dosing|41
7995426|NCT00104247|19688519|P2|STARTED|Overall Study||47
7995427|NCT00104247|19688520|P1|STARTED|Overall Study||42
7995428|NCT00104234|19688528|P2|NOT COMPLETED|Overall Study||1
7995429|NCT00104234|19688529|P1|NOT COMPLETED|Overall Study||0
7995430|NCT00104234|19688528|P2|COMPLETED|Overall Study||19
7995431|NCT00104234|19688529|P1|COMPLETED|Overall Study||19
7995432|NCT00104234|19688528|P2|STARTED|Overall Study||20
7995433|NCT00104234|19688529|P1|STARTED|Overall Study||19
7995434|NCT00104104|19688539|P2|NOT COMPLETED|Overall Study||72
7995435|NCT00104104|19688540|P1|NOT COMPLETED|Overall Study||75
7995436|NCT00104104|19688539|P2|COMPLETED|Overall Study||17
7995437|NCT00104104|19688540|P1|COMPLETED|Overall Study||15
7995438|NCT00104104|19688539|P2|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84
7995439|NCT00104104|19688540|P1|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85
7995440|NCT00104104|19688539|P2|Safety Population (Including Site 74)|Overall Study||88
7995441|NCT00104104|19688540|P1|Safety Population (Including Site 74)|Overall Study||88
7995442|NCT00104104|19688539|P2|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89
7995443|NCT00104104|19688540|P1|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90
7995444|NCT00104052|19688554|P1|NOT COMPLETED|Overall Study||29
7995445|NCT00104052|19688554|P1|COMPLETED|Overall Study||78
7995446|NCT00104052|19688554|P1|STARTED|Overall Study||107
7995447|NCT00103857|19688565|P7|NOT COMPLETED|50-Week Extension Study||0
7995448|NCT00103857|19688566|P6|NOT COMPLETED|50-Week Extension Study||20
7995449|NCT00103857|19688567|P5|NOT COMPLETED|50-Week Extension Study||21
7995450|NCT00103857|19688568|P4|NOT COMPLETED|50-Week Extension Study||36
7995451|NCT00103857|19688569|P3|NOT COMPLETED|50-Week Extension Study||26
7995452|NCT00103857|19688570|P2|NOT COMPLETED|50-Week Extension Study||27
7995453|NCT00103857|19688571|P1|NOT COMPLETED|50-Week Extension Study||38
7995454|NCT00103857|19688565|P7|COMPLETED|50-Week Extension Study||0
7995455|NCT00103857|19688566|P6|COMPLETED|50-Week Extension Study||78
7995456|NCT00103857|19688567|P5|COMPLETED|50-Week Extension Study||101
7995457|NCT00103857|19688568|P4|COMPLETED|50-Week Extension Study||98
7995458|NCT00103857|19688569|P3|COMPLETED|50-Week Extension Study||95
7995459|NCT00103857|19688570|P2|COMPLETED|50-Week Extension Study||80
7995460|NCT00103857|19688571|P1|COMPLETED|50-Week Extension Study||65
7995461|NCT00103857|19688565|P7|STARTED|50-Week Extension Study||0
7995462|NCT00103857|19688566|P6|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98
7995463|NCT00103857|19688567|P5|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122
7995464|NCT00103857|19688568|P4|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134
7995465|NCT00103857|19688569|P3|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121
7995466|NCT00103857|19688570|P2|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107
7995467|NCT00103857|19688571|P1|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103
7995468|NCT00103857|19688565|P7|NOT COMPLETED|54-Week Base Study||38
7995469|NCT00103857|19688566|P6|NOT COMPLETED|54-Week Base Study||61
7995470|NCT00103857|19688567|P5|NOT COMPLETED|54-Week Base Study||41
7995471|NCT00103857|19688568|P4|NOT COMPLETED|54-Week Base Study||42
7995472|NCT00103857|19688569|P3|NOT COMPLETED|54-Week Base Study||47
7995473|NCT00103857|19688570|P2|NOT COMPLETED|54-Week Base Study||56
7995474|NCT00103857|19688571|P1|NOT COMPLETED|54-Week Base Study||57
7995475|NCT00103857|19688565|P7|COMPLETED|54-Week Base Study||79
7995476|NCT00103857|19688566|P6|COMPLETED|54-Week Base Study||115
7995477|NCT00103857|19688567|P5|COMPLETED|54-Week Base Study||141
7995478|NCT00103857|19688568|P4|COMPLETED|54-Week Base Study||148
7995479|NCT00103857|19688569|P3|COMPLETED|54-Week Base Study||135
7995480|NCT00103857|19688570|P2|COMPLETED|54-Week Base Study||126
7995481|NCT00103857|19688571|P1|COMPLETED|54-Week Base Study||122
7995482|NCT00103857|19688565|P7|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117
7995483|NCT00103857|19688566|P6|STARTED|54-Week Base Study||176
7995484|NCT00103857|19688567|P5|STARTED|54-Week Base Study||182
7995485|NCT00103857|19688568|P4|STARTED|54-Week Base Study||190
7995486|NCT00103857|19688569|P3|STARTED|54-Week Base Study||182
7995487|NCT00103857|19688570|P2|STARTED|54-Week Base Study||182
7995488|NCT00103857|19688571|P1|STARTED|54-Week Base Study||179
7995489|NCT00103844|19688636|P2|NOT COMPLETED|Overall Study||0
7995490|NCT00103844|19688637|P1|NOT COMPLETED|Overall Study||0
7995491|NCT00103844|19688636|P2|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49
7995492|NCT00103844|19688637|P1|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101
7995493|NCT00103844|19688636|P2|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40
7995494|NCT00103844|19688637|P1|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22
7995495|NCT00103844|19688636|P2|STARTED|Overall Study||49
7995496|NCT00103844|19688637|P1|STARTED|Overall Study||101
7995497|NCT00103740|19688670|P2|NOT COMPLETED|Period 2 - Extended Observation Period||36
7995498|NCT00103740|19688671|P1|NOT COMPLETED|Period 2 - Extended Observation Period||69
7995499|NCT00103740|19688670|P2|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27
7995500|NCT00103740|19688671|P1|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9
7995501|NCT00103740|19688670|P2|STARTED|Period 2 - Extended Observation Period||63
7995502|NCT00103740|19688671|P1|STARTED|Period 2 - Extended Observation Period||78
7995503|NCT00103740|19688670|P2|NOT COMPLETED|Period 1 - Core||4
7995504|NCT00103740|19688671|P1|NOT COMPLETED|Period 1 - Core||7
7995505|NCT00103740|19688670|P2|COMPLETED|Period 1 - Core||89
7995506|NCT00103740|19688671|P1|COMPLETED|Period 1 - Core||85
7995507|NCT00103740|19688670|P2|STARTED|Period 1 - Core||93
7995508|NCT00103740|19688671|P1|STARTED|Period 1 - Core||92
7995509|NCT00103662|19688699|P2|NOT COMPLETED|Overall Study||33
7995510|NCT00103662|19688700|P1|NOT COMPLETED|Overall Study||19
7995511|NCT00103662|19688699|P2|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121
7995512|NCT00103662|19688700|P1|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129
7995513|NCT00103662|19688699|P2|STARTED|Overall Study||154
7995514|NCT00103662|19688700|P1|STARTED|Overall Study||148
7995515|NCT00103610|19688726|P2|NOT COMPLETED|Overall Study||80
7995516|NCT00103610|19688727|P1|NOT COMPLETED|Overall Study||38
7995517|NCT00103610|19688726|P2|COMPLETED|Overall Study||68
7995518|NCT00103610|19688727|P1|COMPLETED|Overall Study||112
7995519|NCT00103610|19688726|P2|STARTED|Overall Study||148
7995520|NCT00103610|19688727|P1|STARTED|Overall Study||150
7995521|NCT00103506|19688751|P2|NOT COMPLETED|Overall Study||324
7995522|NCT00103506|19688752|P1|NOT COMPLETED|Overall Study||322
7995523|NCT00103506|19688751|P2|COMPLETED|Overall Study||0
7995524|NCT00103506|19688752|P1|COMPLETED|Overall Study||0
7995525|NCT00103506|19688751|P2|STARTED|Overall Study||324
7995526|NCT00103506|19688752|P1|STARTED|Overall Study||322
7995527|NCT00103402|19688764|P2|NOT COMPLETED|Overall Study||17
7995528|NCT00103402|19688765|P1|NOT COMPLETED|Overall Study||22
7995529|NCT00103402|19688764|P2|COMPLETED|Overall Study||117
7995530|NCT00103402|19688765|P1|COMPLETED|Overall Study||116
7995531|NCT00103402|19688764|P2|STARTED|Overall Study||134
7995532|NCT00103402|19688765|P1|STARTED|Overall Study||138
7995533|NCT00103376|19688788|P3|NOT COMPLETED|Overall Study||0
7995534|NCT00103376|19688789|P2|NOT COMPLETED|Overall Study||0
7995535|NCT00103376|19688790|P1|NOT COMPLETED|Overall Study||0
7995536|NCT00103376|19688788|P3|COMPLETED|Overall Study||8
7995537|NCT00103376|19688789|P2|COMPLETED|Overall Study||7
7995538|NCT00103376|19688790|P1|COMPLETED|Overall Study||8
7995539|NCT00103376|19688788|P3|STARTED|Overall Study||8
7995540|NCT00103376|19688789|P2|STARTED|Overall Study||7
7995541|NCT00103376|19688790|P1|STARTED|Overall Study||8
7995542|NCT00103311|19688806|P2|NOT COMPLETED|Overall Study||1
7995543|NCT00103311|19688807|P1|NOT COMPLETED|Overall Study||4
7995544|NCT00103311|19688806|P2|COMPLETED|Overall Study||30
7995545|NCT00103311|19688807|P1|COMPLETED|Overall Study||29
7995546|NCT00103311|19688806|P2|STARTED|Overall Study||31
7995547|NCT00103311|19688807|P1|STARTED|Overall Study||33
7995548|NCT00103285|19688817|P8|NOT COMPLETED|Response Assignment||120
7995549|NCT00103285|19688818|P7|NOT COMPLETED|Response Assignment||49
7995550|NCT00103285|19688819|P6|NOT COMPLETED|Response Assignment||48
7995551|NCT00103285|19688820|P5|NOT COMPLETED|Response Assignment||84
7995552|NCT00103285|19688821|P4|NOT COMPLETED|Response Assignment||62
7995553|NCT00103285|19688822|P3|NOT COMPLETED|Response Assignment||84
7995554|NCT00103285|19688823|P2|NOT COMPLETED|Response Assignment||132
7995555|NCT00103285|19688824|P1|NOT COMPLETED|Response Assignment||0
7995556|NCT00103285|19688817|P8|COMPLETED|Response Assignment||523
7995557|NCT00103285|19688818|P7|COMPLETED|Response Assignment||199
7995558|NCT00103285|19688819|P6|COMPLETED|Response Assignment||201
7995559|NCT00103285|19688820|P5|COMPLETED|Response Assignment||425
7995560|NCT00103285|19688821|P4|COMPLETED|Response Assignment||441
7995561|NCT00103285|19688822|P3|COMPLETED|Response Assignment||853
7995562|NCT00103285|19688823|P2|COMPLETED|Response Assignment||807
7995563|NCT00103285|19688824|P1|COMPLETED|Response Assignment||0
7995564|NCT00103285|19688817|P8|STARTED|Response Assignment||643
7995565|NCT00103285|19688818|P7|STARTED|Response Assignment||248
7995566|NCT00103285|19688819|P6|STARTED|Response Assignment||249
7995567|NCT00103285|19688820|P5|STARTED|Response Assignment||509
7995568|NCT00103285|19688821|P4|STARTED|Response Assignment||503
7995569|NCT00103285|19688822|P3|STARTED|Response Assignment||937
7995570|NCT00103285|19688823|P2|STARTED|Response Assignment||939
7995571|NCT00103285|19688824|P1|STARTED|Response Assignment||0
7995572|NCT00103285|19688817|P8|NOT COMPLETED|Induction||0
7995573|NCT00103285|19688818|P7|NOT COMPLETED|Induction||0
7995574|NCT00103285|19688819|P6|NOT COMPLETED|Induction||0
7995575|NCT00103285|19688820|P5|NOT COMPLETED|Induction||0
7995576|NCT00103285|19688821|P4|NOT COMPLETED|Induction||0
7995577|NCT00103285|19688822|P3|NOT COMPLETED|Induction||0
7995578|NCT00103285|19688823|P2|NOT COMPLETED|Induction||0
7995579|NCT00103285|19688824|P1|NOT COMPLETED|Induction||1349
7995580|NCT00103285|19688817|P8|COMPLETED|Induction||0
7995581|NCT00103285|19688818|P7|COMPLETED|Induction||0
7995582|NCT00103285|19688819|P6|COMPLETED|Induction||0
7995583|NCT00103285|19688820|P5|COMPLETED|Induction||0
7995584|NCT00103285|19688821|P4|COMPLETED|Induction||0
7995585|NCT00103285|19688822|P3|COMPLETED|Induction||0
7995586|NCT00103285|19688823|P2|COMPLETED|Induction||0
7995587|NCT00103285|19688824|P1|COMPLETED|Induction||4028
7995588|NCT00103285|19688817|P8|STARTED|Induction||0
7995589|NCT00103285|19688818|P7|STARTED|Induction||0
7995590|NCT00103285|19688819|P6|STARTED|Induction||0
7995591|NCT00103285|19688820|P5|STARTED|Induction||0
7995592|NCT00103285|19688821|P4|STARTED|Induction||0
7995593|NCT00103285|19688822|P3|STARTED|Induction||0
7995594|NCT00103285|19688823|P2|STARTED|Induction||0
7995595|NCT00103285|19688824|P1|STARTED|Induction||5377
7995596|NCT00103259|19688853|P2|NOT COMPLETED|Overall Study||12
7995597|NCT00103259|19688854|P1|NOT COMPLETED|Overall Study||12
7995598|NCT00103259|19688853|P2|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32
7995599|NCT00103259|19688854|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15
7995600|NCT00103259|19688853|P2|Eligible Patients Who Cross Over|Overall Study||10
7995601|NCT00103259|19688854|P1|Eligible Patients Who Cross Over|Overall Study||0
7995602|NCT00103259|19688853|P2|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11
7995603|NCT00103259|19688854|P1|Cross Over to the Other Arm|Overall Study||0
7995604|NCT00103259|19688853|P2|Eligible and Treated|Overall Study||38
7995605|NCT00103259|19688854|P1|Eligible and Treated|Overall Study||23
7995606|NCT00103259|19688853|P2|Treated|Overall Study||41
7995607|NCT00103259|19688854|P1|Treated|Overall Study||23
7995608|NCT00103259|19688853|P2|Eligible|Overall Study||41
7995609|NCT00103259|19688854|P1|Eligible|Overall Study||27
7995610|NCT00103259|19688853|P2|STARTED|Overall Study||44
7995611|NCT00103259|19688854|P1|STARTED|Overall Study||27
7995612|NCT00103207|19688866|P1|NOT COMPLETED|Overall Study||38
7995613|NCT00103207|19688866|P1|COMPLETED|Overall Study||34
7995614|NCT00103207|19688866|P1|Eligible Patients w/ Smoking Status Data|Overall Study||37
7995615|NCT00103207|19688866|P1|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41
7995616|NCT00103207|19688866|P1|STARTED|Overall Study||72
7995617|NCT00103194|19688876|P1|NOT COMPLETED|Overall Study||31
7995618|NCT00103194|19688876|P1|COMPLETED|Overall Study||18
7995619|NCT00103194|19688876|P1|Eligible and Treated|Overall Study||35
7995620|NCT00103194|19688876|P1|Eligible|Overall Study||35
7995621|NCT00103194|19688876|P1|Treated|Overall Study||49
7995622|NCT00103194|19688876|P1|STARTED|Overall Study||49
7995623|NCT00103142|19688885|P2|NOT COMPLETED|Overall Study||1
7995624|NCT00103142|19688886|P1|NOT COMPLETED|Overall Study||3
7995625|NCT00103142|19688885|P2|COMPLETED|Overall Study||36
7995626|NCT00103142|19688886|P1|COMPLETED|Overall Study||33
7995627|NCT00103142|19688885|P2|STARTED|Overall Study||37
7995628|NCT00103142|19688886|P1|STARTED|Overall Study||36
7995629|NCT00103116|19688894|P1|NOT COMPLETED|Overall Study||0
7995630|NCT00103116|19688894|P1|COMPLETED|Overall Study||32
7995631|NCT00103116|19688894|P1|STARTED|Overall Study||32
7995632|NCT00103012|19688902|P3|NOT COMPLETED|Overall Study||4
7995633|NCT00103012|19688903|P2|NOT COMPLETED|Overall Study||1
7995634|NCT00103012|19688904|P1|NOT COMPLETED|Overall Study||3
7995635|NCT00103012|19688902|P3|COMPLETED|Overall Study||12
7995636|NCT00103012|19688903|P2|COMPLETED|Overall Study||13
7995637|NCT00103012|19688904|P1|COMPLETED|Overall Study||14
7995638|NCT00103012|19688902|P3|STARTED|Overall Study||16
7995639|NCT00103012|19688903|P2|STARTED|Overall Study||14
7995640|NCT00103012|19688904|P1|STARTED|Overall Study||17
7995641|NCT00102960|19688915|P3|NOT COMPLETED|Overall Study||28
7995642|NCT00102960|19688916|P2|NOT COMPLETED|Overall Study||23
7995643|NCT00102960|19688917|P1|NOT COMPLETED|Overall Study||30
7995644|NCT00102960|19688915|P3|COMPLETED|Overall Study||98
7995645|NCT00102960|19688916|P2|COMPLETED|Overall Study||103
7995646|NCT00102960|19688917|P1|COMPLETED|Overall Study||95
7995647|NCT00102960|19688915|P3|STARTED|Overall Study||126
7995648|NCT00102960|19688916|P2|STARTED|Overall Study||126
7995649|NCT00102960|19688917|P1|STARTED|Overall Study||125
7995650|NCT00102804|19688966|P2|NOT COMPLETED|Overall Study||222
7995651|NCT00102804|19688967|P1|NOT COMPLETED|Overall Study||441
7995652|NCT00102804|19688966|P2|COMPLETED|Overall Study||0
7995653|NCT00102804|19688967|P1|COMPLETED|Overall Study||0
7995654|NCT00102804|19688966|P2|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222
7995655|NCT00102804|19688967|P1|Received at Least 1 Dose of Study Drug|Overall Study||434
7995656|NCT00102804|19688966|P2|STARTED|Overall Study||222
7995657|NCT00102804|19688967|P1|STARTED|Overall Study||441
7995658|NCT00102687|19688988|P5|NOT COMPLETED|Maintenance Period||13
7995659|NCT00102687|19688989|P4|NOT COMPLETED|Maintenance Period||10
7995660|NCT00102687|19688990|P3|NOT COMPLETED|Maintenance Period||6
7995661|NCT00102687|19688991|P2|NOT COMPLETED|Maintenance Period||4
7995662|NCT00102687|19688992|P1|NOT COMPLETED|Maintenance Period||7
7995663|NCT00102687|19688988|P5|COMPLETED|Maintenance Period||8
7995664|NCT00102687|19688989|P4|COMPLETED|Maintenance Period||12
7995665|NCT00102687|19688990|P3|COMPLETED|Maintenance Period||2
7995666|NCT00102687|19688991|P2|COMPLETED|Maintenance Period||2
7995667|NCT00102687|19688992|P1|COMPLETED|Maintenance Period||6
7995668|NCT00102687|19688988|P5|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21
7995669|NCT00102687|19688989|P4|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22
7995670|NCT00102687|19688990|P3|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8
7995671|NCT00102687|19688991|P2|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6
7995672|NCT00102687|19688992|P1|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13
7995673|NCT00102687|19688988|P5|NOT COMPLETED|Initial Period||0
7995674|NCT00102687|19688989|P4|NOT COMPLETED|Initial Period||0
7995675|NCT00102687|19688990|P3|NOT COMPLETED|Initial Period||26
7995676|NCT00102687|19688991|P2|NOT COMPLETED|Initial Period||28
7995677|NCT00102687|19688992|P1|NOT COMPLETED|Initial Period||18
7995678|NCT00102687|19688988|P5|COMPLETED|Initial Period||0
7995679|NCT00102687|19688989|P4|COMPLETED|Initial Period||0
7995680|NCT00102687|19688990|P3|COMPLETED|Initial Period||25
7995681|NCT00102687|19688991|P2|COMPLETED|Initial Period||22
7995682|NCT00102687|19688992|P1|COMPLETED|Initial Period||32
7995683|NCT00102687|19688988|P5|STARTED|Initial Period||0
7995684|NCT00102687|19688989|P4|STARTED|Initial Period||0
7995685|NCT00102687|19688990|P3|STARTED|Initial Period|3 randomized participants did not receive treatment.|51
7995686|NCT00102687|19688991|P2|STARTED|Initial Period||50
7995687|NCT00102687|19688992|P1|STARTED|Initial Period||50
7995688|NCT00102596|19689056|P2|NOT COMPLETED|Part C||0
7995689|NCT00102596|19689057|P1|NOT COMPLETED|Part C||0
7995690|NCT00102596|19689056|P2|COMPLETED|Part C||2
7995691|NCT00102596|19689057|P1|COMPLETED|Part C||0
7995692|NCT00102596|19689056|P2|STARTED|Part C|Only 2 patients participated in Part C|2
7995693|NCT00102596|19689057|P1|STARTED|Part C||0
7995694|NCT00102596|19689056|P2|NOT COMPLETED|Part B||0
7995695|NCT00102596|19689057|P1|NOT COMPLETED|Part B||0
7995696|NCT00102596|19689056|P2|COMPLETED|Part B||10
7995697|NCT00102596|19689057|P1|COMPLETED|Part B||0
7995698|NCT00102596|19689056|P2|STARTED|Part B||10
7995699|NCT00102596|19689057|P1|STARTED|Part B|Participants from Part A did not continue to Part B|0
7995700|NCT00102596|19689056|P2|NOT COMPLETED|Part A||0
7995701|NCT00102596|19689057|P1|NOT COMPLETED|Part A||7
7995702|NCT00102596|19689056|P2|COMPLETED|Part A||0
7995703|NCT00102596|19689057|P1|COMPLETED|Part A||4
7995704|NCT00102596|19689056|P2|Participants Assigned Treatment|Part A||0
7995705|NCT00102596|19689057|P1|Participants Assigned Treatment|Part A||5
7995706|NCT00102596|19689056|P2|STARTED|Part A||0
7995707|NCT00102596|19689057|P1|STARTED|Part A||11
7995708|NCT00102531|19689068|P2|NOT COMPLETED|Overall Study||11
7995709|NCT00102531|19689069|P1|NOT COMPLETED|Overall Study||5
7995710|NCT00102531|19689068|P2|COMPLETED|Overall Study||1
7995711|NCT00102531|19689069|P1|COMPLETED|Overall Study||2
7995712|NCT00102531|19689068|P2|STARTED|Overall Study||12
7995713|NCT00102531|19689069|P1|STARTED|Overall Study||7
7995714|NCT00102518|19689075|P1|NOT COMPLETED|Overall Study||87
7995715|NCT00102518|19689075|P1|COMPLETED|Overall Study||238
7995716|NCT00102518|19689075|P1|STARTED|Overall Study||325
7995717|NCT00102440|19689084|P3|NOT COMPLETED|Overall Study||66
7995718|NCT00102440|19689085|P2|NOT COMPLETED|Overall Study||98
7995719|NCT00102440|19689086|P1|NOT COMPLETED|Overall Study||88
7995720|NCT00102440|19689084|P3|COMPLETED|Overall Study||187
7995721|NCT00102440|19689085|P2|COMPLETED|Overall Study||153
7995722|NCT00102440|19689086|P1|COMPLETED|Overall Study||168
7995723|NCT00102440|19689084|P3|STARTED|Overall Study||253
7995724|NCT00102440|19689085|P2|STARTED|Overall Study||251
7995725|NCT00102440|19689086|P1|STARTED|Overall Study||256
7995726|NCT00102063|19689136|P3|NOT COMPLETED|Overall Study||10
7995727|NCT00102063|19689137|P2|NOT COMPLETED|Overall Study||18
7995728|NCT00102063|19689138|P1|NOT COMPLETED|Overall Study||16
7995729|NCT00102063|19689136|P3|COMPLETED|Overall Study||90
7995730|NCT00102063|19689137|P2|COMPLETED|Overall Study||84
7995731|NCT00102063|19689138|P1|COMPLETED|Overall Study||84
7995732|NCT00102063|19689136|P3|STARTED|Overall Study||100
7995733|NCT00102063|19689137|P2|STARTED|Overall Study||102
7995734|NCT00102063|19689138|P1|STARTED|Overall Study||100
7995735|NCT00101933|19689169|P2|NOT COMPLETED|Overall Study||0
7995736|NCT00101933|19689170|P1|NOT COMPLETED|Overall Study||0
7995737|NCT00101933|19689169|P2|COMPLETED|Overall Study||55
7995738|NCT00101933|19689170|P1|COMPLETED|Overall Study||54
7995739|NCT00101933|19689169|P2|STARTED|Overall Study||55
7995740|NCT00101933|19689170|P1|STARTED|Overall Study||54
7995741|NCT00101907|19689196|P6|NOT COMPLETED|Overall Study||0
7995742|NCT00101907|19689197|P5|NOT COMPLETED|Overall Study||5
7995743|NCT00101907|19689198|P4|NOT COMPLETED|Overall Study||1
7995744|NCT00101907|19689199|P3|NOT COMPLETED|Overall Study||1
7995745|NCT00101907|19689200|P2|NOT COMPLETED|Overall Study||1
7995746|NCT00101907|19689201|P1|NOT COMPLETED|Overall Study||2
7995747|NCT00101907|19689196|P6|COMPLETED|Overall Study||2
7995748|NCT00101907|19689197|P5|COMPLETED|Overall Study||6
7995749|NCT00101907|19689198|P4|COMPLETED|Overall Study||5
7995750|NCT00101907|19689199|P3|COMPLETED|Overall Study||5
7995751|NCT00101907|19689200|P2|COMPLETED|Overall Study||7
7995752|NCT00101907|19689201|P1|COMPLETED|Overall Study||6
7995753|NCT00101907|19689196|P6|STARTED|Overall Study||2
7995754|NCT00101907|19689197|P5|STARTED|Overall Study||11
7995755|NCT00101907|19689198|P4|STARTED|Overall Study||6
7995756|NCT00101907|19689199|P3|STARTED|Overall Study||6
7995757|NCT00101907|19689200|P2|STARTED|Overall Study||8
7995758|NCT00101907|19689201|P1|STARTED|Overall Study||8
7995759|NCT00101868|19689243|P2|NOT COMPLETED|Overall Study||32
7995760|NCT00101868|19689244|P1|NOT COMPLETED|Overall Study||29
7995761|NCT00101868|19689243|P2|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283
7995762|NCT00101868|19689244|P1|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287
7995763|NCT00101868|19689243|P2|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315
7995764|NCT00101868|19689244|P1|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316
7995765|NCT00101816|19689256|P2|NOT COMPLETED|Overall Study||0
7995766|NCT00101816|19689257|P1|NOT COMPLETED|Overall Study||0
7995767|NCT00101816|19689256|P2|COMPLETED|Overall Study||99
7995768|NCT00101816|19689257|P1|COMPLETED|Overall Study||10
7995769|NCT00101816|19689256|P2|STARTED|Overall Study||99
7995770|NCT00101816|19689257|P1|STARTED|Overall Study||10
7995771|NCT00101686|19689314|P10|NOT COMPLETED|Overall Study||30
7995772|NCT00101686|19689315|P9|NOT COMPLETED|Overall Study||30
7995773|NCT00101686|19689316|P8|NOT COMPLETED|Overall Study||30
7995774|NCT00101686|19689317|P7|NOT COMPLETED|Overall Study||27
7995775|NCT00101686|19689318|P6|NOT COMPLETED|Overall Study||72
7995776|NCT00101686|19689319|P5|NOT COMPLETED|Overall Study||73
7995777|NCT00101686|19689320|P4|NOT COMPLETED|Overall Study||72
7995778|NCT00101686|19689321|P3|NOT COMPLETED|Overall Study||69
7995779|NCT00101686|19689322|P2|NOT COMPLETED|Overall Study||73
7995780|NCT00101686|19689323|P1|NOT COMPLETED|Overall Study||71
7995781|NCT00101686|19689314|P10|COMPLETED|Overall Study|Patients treated until disease progression.|0
7995782|NCT00101686|19689315|P9|COMPLETED|Overall Study|Patients treated until disease progression.|0
7995783|NCT00101686|19689316|P8|COMPLETED|Overall Study|Patients treated until disease progression.|0
7995784|NCT00101686|19689317|P7|COMPLETED|Overall Study|Patients treated until disease progression.|0
7995785|NCT00101686|19689318|P6|COMPLETED|Overall Study|Patients treated until disease progression.|0
7995786|NCT00101686|19689319|P5|COMPLETED|Overall Study|Patients treated until disease progression.|0
7995787|NCT00101686|19689320|P4|COMPLETED|Overall Study|Patients treated until disease progression.|0
7995788|NCT00101686|19689321|P3|COMPLETED|Overall Study|Patients treated until disease progression.|0
7995789|NCT00101686|19689322|P2|COMPLETED|Overall Study|Patients treated until disease progression.|0
7995790|NCT00101686|19689323|P1|COMPLETED|Overall Study|Patients treated until disease progression.|0
7995791|NCT00101686|19689314|P10|Received Treatment|Overall Study||29
7995792|NCT00101686|19689315|P9|Received Treatment|Overall Study||30
7995793|NCT00101686|19689316|P8|Received Treatment|Overall Study||29
7995794|NCT00101686|19689317|P7|Received Treatment|Overall Study||27
7995795|NCT00101686|19689318|P6|Received Treatment|Overall Study||70
7995796|NCT00101686|19689319|P5|Received Treatment|Overall Study||71
7995797|NCT00101686|19689320|P4|Received Treatment|Overall Study||70
7995798|NCT00101686|19689321|P3|Received Treatment|Overall Study||67
7995799|NCT00101686|19689322|P2|Received Treatment|Overall Study||67
7995800|NCT00101686|19689323|P1|Received Treatment|Overall Study||70
7995801|NCT00101686|19689314|P10|STARTED|Overall Study||30
7995802|NCT00101686|19689315|P9|STARTED|Overall Study||30
7995803|NCT00101686|19689316|P8|STARTED|Overall Study||30
7995804|NCT00101686|19689317|P7|STARTED|Overall Study||27
7995805|NCT00101686|19689318|P6|STARTED|Overall Study||72
7995806|NCT00101686|19689319|P5|STARTED|Overall Study||73
7995807|NCT00101686|19689320|P4|STARTED|Overall Study||72
7995808|NCT00101686|19689321|P3|STARTED|Overall Study||69
7995809|NCT00101686|19689322|P2|STARTED|Overall Study||73
7995810|NCT00101686|19689323|P1|STARTED|Overall Study||71
7995811|NCT00101660|19689370|P2|NOT COMPLETED|Overall Study||0
7995812|NCT00101660|19689371|P1|NOT COMPLETED|Overall Study||0
7995813|NCT00101660|19689370|P2|COMPLETED|Overall Study||288
7995814|NCT00101660|19689371|P1|COMPLETED|Overall Study||99
7995815|NCT00101660|19689370|P2|STARTED|Overall Study||288
7995816|NCT00101660|19689371|P1|STARTED|Overall Study||99
7995817|NCT00101647|19689389|P2|NOT COMPLETED|Overall Study||0
7995818|NCT00101647|19689390|P1|NOT COMPLETED|Overall Study||0
7995819|NCT00101647|19689389|P2|COMPLETED|Overall Study||161
7995820|NCT00101647|19689390|P1|COMPLETED|Overall Study||13
7995821|NCT00101647|19689389|P2|STARTED|Overall Study|Randomized|161
7995822|NCT00101647|19689390|P1|STARTED|Overall Study|Randomized|13
7995823|NCT00101582|19689440|P2|NOT COMPLETED|Overall Study||15
7995824|NCT00101582|19689441|P1|NOT COMPLETED|Overall Study||11
7995825|NCT00101582|19689440|P2|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79
7995826|NCT00101582|19689441|P1|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83
7995827|NCT00101582|19689440|P2|Received Study Drug|Overall Study||94
7995828|NCT00101582|19689441|P1|Received Study Drug|Overall Study||91
7995829|NCT00101582|19689440|P2|STARTED|Overall Study||94
7995830|NCT00101582|19689441|P1|STARTED|Overall Study||94
7995831|NCT00101452|19689464|P3|NOT COMPLETED|Overall Study||43
7995832|NCT00101452|19689465|P2|NOT COMPLETED|Overall Study||43
7995833|NCT00101452|19689466|P1|NOT COMPLETED|Overall Study||44
7995834|NCT00101452|19689464|P3|COMPLETED|Overall Study||22
7995835|NCT00101452|19689465|P2|COMPLETED|Overall Study||26
7995836|NCT00101452|19689466|P1|COMPLETED|Overall Study||21
7995837|NCT00101452|19689464|P3|STARTED|Overall Study||65
7995838|NCT00101452|19689465|P2|STARTED|Overall Study||69
7995839|NCT00101452|19689466|P1|STARTED|Overall Study||65
7995840|NCT00101439|19689480|P2|NOT COMPLETED|Period 2||2
7995841|NCT00101439|19689481|P1|NOT COMPLETED|Period 2||0
7995842|NCT00101439|19689480|P2|COMPLETED|Period 2||28
7995843|NCT00101439|19689481|P1|COMPLETED|Period 2||28
7995844|NCT00101439|19689480|P2|STARTED|Period 2||30
7995845|NCT00101439|19689481|P1|STARTED|Period 2||28
7995846|NCT00101439|19689480|P2|NOT COMPLETED|Period 1||0
7995847|NCT00101439|19689481|P1|NOT COMPLETED|Period 1||0
7995848|NCT00101439|19689480|P2|COMPLETED|Period 1||30
7995849|NCT00101439|19689481|P1|COMPLETED|Period 1||28
7995850|NCT00101439|19689480|P2|STARTED|Period 1||30
7995851|NCT00101439|19689481|P1|STARTED|Period 1||28
7995852|NCT00101413|19689489|P1|NOT COMPLETED|Overall Study||0
7995853|NCT00101413|19689489|P1|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52
7995854|NCT00101413|19689489|P1|STARTED|Overall Study||52
7995855|NCT00101400|19689497|P1|NOT COMPLETED|Survival Follow-Up||7
7995856|NCT00101400|19689497|P1|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44
7995857|NCT00101400|19689497|P1|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51
7995858|NCT00101400|19689497|P1|NOT COMPLETED|Treatment||0
7995859|NCT00101400|19689497|P1|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54
7995860|NCT00101400|19689497|P1|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54
7995861|NCT00101361|19689508|P2|NOT COMPLETED|Overall Study||0
7995862|NCT00101361|19689509|P1|NOT COMPLETED|Overall Study||0
7995863|NCT00101361|19689508|P2|COMPLETED|Overall Study||104
7995864|NCT00101361|19689509|P1|COMPLETED|Overall Study||108
7995865|NCT00101361|19689508|P2|STARTED|Overall Study||104
7995866|NCT00101361|19689509|P1|STARTED|Overall Study||108
7995867|NCT00101283|19689517|P2|NOT COMPLETED|Overall Study||3
7995868|NCT00101283|19689518|P1|NOT COMPLETED|Overall Study||0
7995869|NCT00101283|19689517|P2|COMPLETED|Overall Study||13
7995870|NCT00101283|19689518|P1|COMPLETED|Overall Study||16
7995871|NCT00101283|19689517|P2|Began Treatment|Overall Study||13
7995872|NCT00101283|19689518|P1|Began Treatment|Overall Study||16
7995873|NCT00101283|19689517|P2|STARTED|Overall Study||16
7995874|NCT00101283|19689518|P1|STARTED|Overall Study||16
7995875|NCT00101192|19689528|P1|NOT COMPLETED|Overall Study||7
7995876|NCT00101192|19689528|P1|COMPLETED|Overall Study||69
7995877|NCT00101192|19689528|P1|STARTED|Overall Study||76
7995878|NCT00101166|19689532|P1|NOT COMPLETED|Overall Study||10
7995879|NCT00101166|19689532|P1|COMPLETED|Overall Study||18
7995880|NCT00101166|19689532|P1|STARTED|Overall Study||28
7995881|NCT00101101|19689540|P1|NOT COMPLETED|Overall Study||20
7995971|NCT00100165|19689692|P2|NOT COMPLETED|Washout (1 Week)||0
7995882|NCT00101101|19689540|P1|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23
7995883|NCT00101101|19689540|P1|STARTED|Overall Study||43
7995884|NCT00101036|19689548|P2|NOT COMPLETED|Overall Study||0
7995885|NCT00101036|19689549|P1|NOT COMPLETED|Overall Study||0
7995886|NCT00101036|19689548|P2|COMPLETED|Overall Study||40
7995887|NCT00101036|19689549|P1|COMPLETED|Overall Study||17
7995888|NCT00101036|19689548|P2|STARTED|Overall Study||40
7995889|NCT00101036|19689549|P1|STARTED|Overall Study||17
7995890|NCT00101010|19689561|P1|NOT COMPLETED|Overall Study||1
7995891|NCT00101010|19689561|P1|COMPLETED|Overall Study||79
7995892|NCT00101010|19689561|P1|STARTED|Overall Study||80
7995893|NCT00100932|19689568|P2|NOT COMPLETED|Overall Study||27
7995894|NCT00100932|19689569|P1|NOT COMPLETED|Overall Study||73
7995895|NCT00100932|19689568|P2|COMPLETED|Overall Study||1
7995896|NCT00100932|19689569|P1|COMPLETED|Overall Study||5
7995897|NCT00100932|19689568|P2|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28
7995898|NCT00100932|19689569|P1|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78
7995899|NCT00100841|19689579|P1|NOT COMPLETED|Overall Study||0
7995900|NCT00100841|19689579|P1|COMPLETED|Overall Study||66
7995901|NCT00100841|19689579|P1|STARTED|Overall Study||66
7995902|NCT00100828|19689584|P1|NOT COMPLETED|Overall Study||6
7995903|NCT00100828|19689584|P1|COMPLETED|Overall Study||0
7995904|NCT00100828|19689584|P1|STARTED|Overall Study||6
7995905|NCT00100815|19689588|P1|NOT COMPLETED|Overall Study||49
7995906|NCT00100815|19689588|P1|COMPLETED|Overall Study||1
7995907|NCT00100815|19689588|P1|STARTED|Overall Study||50
7995908|NCT00100802|19689596|P1|NOT COMPLETED|Overall Study||80
7995909|NCT00100802|19689596|P1|COMPLETED|Overall Study||38
7995910|NCT00100802|19689596|P1|STARTED|Overall Study||118
7995911|NCT00100789|19689601|P1|NOT COMPLETED|Overall Study||64
7995912|NCT00100789|19689601|P1|COMPLETED|Overall Study||3
7995913|NCT00100789|19689601|P1|Eligible and Began Protocol Therapy|Overall Study||63
7995914|NCT00100789|19689601|P1|Eligible|Overall Study||64
7995915|NCT00100789|19689601|P1|STARTED|Overall Study||67
7995916|NCT00100698|19689610|P2|NOT COMPLETED|Overall Study||2
7995917|NCT00100698|19689611|P1|NOT COMPLETED|Overall Study||6
7995918|NCT00100698|19689610|P2|COMPLETED|Overall Study||27
7995919|NCT00100698|19689611|P1|COMPLETED|Overall Study||21
7995920|NCT00100698|19689610|P2|STARTED|Overall Study||29
7995921|NCT00100698|19689611|P1|STARTED|Overall Study||27
7995922|NCT00100659|19689653|P2|NOT COMPLETED|Overall Study||2
7995923|NCT00100659|19689654|P1|NOT COMPLETED|Overall Study||3
7995924|NCT00100659|19689653|P2|COMPLETED|Overall Study||57
7995925|NCT00100659|19689654|P1|COMPLETED|Overall Study||52
7995926|NCT00100659|19689653|P2|STARTED|Overall Study||59
7995927|NCT00100659|19689654|P1|STARTED|Overall Study||55
7995928|NCT00100230|19689664|P2|NOT COMPLETED|Overall Study||15
7995929|NCT00100230|19689665|P1|NOT COMPLETED|Overall Study||12
7995930|NCT00100230|19689664|P2|COMPLETED|Overall Study||22
7995931|NCT00100230|19689665|P1|COMPLETED|Overall Study||29
7995932|NCT00100230|19689664|P2|STARTED|Overall Study||37
7995933|NCT00100230|19689665|P1|STARTED|Overall Study||41
7995934|NCT00100178|19689678|P3|NOT COMPLETED|Overall Study||10
7995935|NCT00100178|19689679|P2|NOT COMPLETED|Overall Study||10
7995936|NCT00100178|19689680|P1|NOT COMPLETED|Overall Study||9
7995937|NCT00100178|19689678|P3|COMPLETED|Overall Study||32
7995938|NCT00100178|19689679|P2|COMPLETED|Overall Study||21
7995939|NCT00100178|19689680|P1|COMPLETED|Overall Study||32
7995940|NCT00100178|19689678|P3|STARTED|Overall Study||42
7995941|NCT00100178|19689679|P2|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31
7995942|NCT00100178|19689680|P1|STARTED|Overall Study||41
7995943|NCT00100165|19689691|P3|NOT COMPLETED|Third Intervention (4 Weeks)||0
7995944|NCT00100165|19689692|P2|NOT COMPLETED|Third Intervention (4 Weeks)||0
7995945|NCT00100165|19689693|P1|NOT COMPLETED|Third Intervention (4 Weeks)||0
7995946|NCT00100165|19689691|P3|COMPLETED|Third Intervention (4 Weeks)||9
7995947|NCT00100165|19689692|P2|COMPLETED|Third Intervention (4 Weeks)||10
7995948|NCT00100165|19689693|P1|COMPLETED|Third Intervention (4 Weeks)||10
7995949|NCT00100165|19689691|P3|STARTED|Third Intervention (4 Weeks)||9
7995950|NCT00100165|19689692|P2|STARTED|Third Intervention (4 Weeks)||10
7995951|NCT00100165|19689693|P1|STARTED|Third Intervention (4 Weeks)||10
7995952|NCT00100165|19689691|P3|NOT COMPLETED|Washout (1 Week)||0
7995953|NCT00100165|19689692|P2|NOT COMPLETED|Washout (1 Week)||0
7995954|NCT00100165|19689693|P1|NOT COMPLETED|Washout (1 Week)||0
7995955|NCT00100165|19689691|P3|COMPLETED|Washout (1 Week)||9
7995956|NCT00100165|19689692|P2|COMPLETED|Washout (1 Week)||10
7995957|NCT00100165|19689693|P1|COMPLETED|Washout (1 Week)||10
7995958|NCT00100165|19689691|P3|STARTED|Washout (1 Week)||9
7995959|NCT00100165|19689692|P2|STARTED|Washout (1 Week)||10
7995960|NCT00100165|19689693|P1|STARTED|Washout (1 Week)||10
7995961|NCT00100165|19689691|P3|NOT COMPLETED|Second Intervention (4 Weeks)||0
7995962|NCT00100165|19689692|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
7995963|NCT00100165|19689693|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
7995964|NCT00100165|19689691|P3|COMPLETED|Second Intervention (4 Weeks)||9
7995965|NCT00100165|19689692|P2|COMPLETED|Second Intervention (4 Weeks)||10
7995966|NCT00100165|19689693|P1|COMPLETED|Second Intervention (4 Weeks)||10
7995967|NCT00100165|19689691|P3|STARTED|Second Intervention (4 Weeks)||9
7995968|NCT00100165|19689692|P2|STARTED|Second Intervention (4 Weeks)||10
7995969|NCT00100165|19689693|P1|STARTED|Second Intervention (4 Weeks)||10
7995970|NCT00100165|19689691|P3|NOT COMPLETED|Washout (1 Week)||0
7995972|NCT00100165|19689693|P1|NOT COMPLETED|Washout (1 Week)||0
7995973|NCT00100165|19689691|P3|COMPLETED|Washout (1 Week)||9
7995974|NCT00100165|19689692|P2|COMPLETED|Washout (1 Week)||10
7995975|NCT00100165|19689693|P1|COMPLETED|Washout (1 Week)||10
7995976|NCT00100165|19689691|P3|STARTED|Washout (1 Week)||9
7995977|NCT00100165|19689692|P2|STARTED|Washout (1 Week)||10
7995978|NCT00100165|19689693|P1|STARTED|Washout (1 Week)||10
7995979|NCT00100165|19689691|P3|NOT COMPLETED|First Intervention (4 Weeks)||0
7995980|NCT00100165|19689692|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
7995981|NCT00100165|19689693|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
7995982|NCT00100165|19689691|P3|COMPLETED|First Intervention (4 Weeks)||9
7995983|NCT00100165|19689692|P2|COMPLETED|First Intervention (4 Weeks)||10
7995984|NCT00100165|19689693|P1|COMPLETED|First Intervention (4 Weeks)||10
7995985|NCT00100165|19689691|P3|STARTED|First Intervention (4 Weeks)||9
7995986|NCT00100165|19689692|P2|STARTED|First Intervention (4 Weeks)||10
7995987|NCT00100165|19689693|P1|STARTED|First Intervention (4 Weeks)||10
7995988|NCT00100165|19689691|P3|NOT COMPLETED|Baseline||0
7995989|NCT00100165|19689692|P2|NOT COMPLETED|Baseline||0
7995990|NCT00100165|19689693|P1|NOT COMPLETED|Baseline||0
7995991|NCT00100165|19689691|P3|COMPLETED|Baseline||9
7995992|NCT00100165|19689692|P2|COMPLETED|Baseline||10
7995993|NCT00100165|19689693|P1|COMPLETED|Baseline||10
7995994|NCT00100165|19689691|P3|STARTED|Baseline||9
7995995|NCT00100165|19689692|P2|STARTED|Baseline||10
7995996|NCT00100165|19689693|P1|STARTED|Baseline||10
7995997|NCT00100048|19689709|P6|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
7995998|NCT00100048|19689710|P5|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0
7995999|NCT00100048|19689711|P4|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10
7996000|NCT00100048|19689712|P3|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
7996001|NCT00100048|19689713|P2|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9
7996002|NCT00100048|19689714|P1|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14
7996003|NCT00100048|19689709|P6|COMPLETED|Cohort I & II-Combination Therapy Phase||26
7996004|NCT00100048|19689710|P5|COMPLETED|Cohort I & II-Combination Therapy Phase||0
7996005|NCT00100048|19689711|P4|COMPLETED|Cohort I & II-Combination Therapy Phase||30
7996006|NCT00100048|19689712|P3|COMPLETED|Cohort I & II-Combination Therapy Phase||28
7996007|NCT00100048|19689713|P2|COMPLETED|Cohort I & II-Combination Therapy Phase||31
7996008|NCT00100048|19689714|P1|COMPLETED|Cohort I & II-Combination Therapy Phase||27
7996009|NCT00100048|19689709|P6|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1
7996010|NCT00100048|19689710|P5|Never Treated|Cohort I & II-Combination Therapy Phase||0
7996011|NCT00100048|19689711|P4|Never Treated|Cohort I & II-Combination Therapy Phase||0
7996012|NCT00100048|19689712|P3|Never Treated|Cohort I & II-Combination Therapy Phase||0
7996013|NCT00100048|19689713|P2|Never Treated|Cohort I & II-Combination Therapy Phase||0
7996014|NCT00100048|19689714|P1|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2
7996015|NCT00100048|19689709|P6|Treated|Cohort I & II-Combination Therapy Phase||38
7996016|NCT00100048|19689710|P5|Treated|Cohort I & II-Combination Therapy Phase||0
7996017|NCT00100048|19689711|P4|Treated|Cohort I & II-Combination Therapy Phase||40
7996018|NCT00100048|19689712|P3|Treated|Cohort I & II-Combination Therapy Phase||41
7996019|NCT00100048|19689713|P2|Treated|Cohort I & II-Combination Therapy Phase||40
7996020|NCT00100048|19689714|P1|Treated|Cohort I & II-Combination Therapy Phase||39
7996021|NCT00100048|19689709|P6|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39
7996022|NCT00100048|19689710|P5|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0
7996023|NCT00100048|19689711|P4|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40
7996024|NCT00100048|19689712|P3|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41
7996025|NCT00100048|19689713|P2|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40
7996026|NCT00100048|19689714|P1|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41
7996027|NCT00100048|19689709|P6|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
7996028|NCT00100048|19689710|P5|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
7996029|NCT00100048|19689711|P4|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
7996030|NCT00100048|19689712|P3|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
7996031|NCT00100048|19689713|P2|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
7996032|NCT00100048|19689714|P1|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
7996033|NCT00100048|19689709|P6|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
7996034|NCT00100048|19689710|P5|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7
7996035|NCT00100048|19689711|P4|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8
7996036|NCT00100048|19689712|P3|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6
7996037|NCT00100048|19689713|P2|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
7996038|NCT00100048|19689714|P1|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
7996039|NCT00100048|19689709|P6|Treated|Cohort I-Monotherapy Phase 10 Days||0
7996040|NCT00100048|19689710|P5|Treated|Cohort I-Monotherapy Phase 10 Days||7
7996041|NCT00100048|19689711|P4|Treated|Cohort I-Monotherapy Phase 10 Days||8
7996042|NCT00100048|19689712|P3|Treated|Cohort I-Monotherapy Phase 10 Days||6
7996043|NCT00100048|19689713|P2|Treated|Cohort I-Monotherapy Phase 10 Days||7
7996044|NCT00100048|19689714|P1|Treated|Cohort I-Monotherapy Phase 10 Days||7
7996045|NCT00100048|19689709|P6|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0
7996046|NCT00100048|19689710|P5|STARTED|Cohort I-Monotherapy Phase 10 Days||7
7996047|NCT00100048|19689711|P4|STARTED|Cohort I-Monotherapy Phase 10 Days||8
7996048|NCT00100048|19689712|P3|STARTED|Cohort I-Monotherapy Phase 10 Days||6
7996049|NCT00100048|19689713|P2|STARTED|Cohort I-Monotherapy Phase 10 Days||7
7996050|NCT00100048|19689714|P1|STARTED|Cohort I-Monotherapy Phase 10 Days||7
7996051|NCT00099983|19689823|P2|NOT COMPLETED|Overall Study||25
7996052|NCT00099983|19689824|P1|NOT COMPLETED|Overall Study||24
7996053|NCT00099983|19689823|P2|COMPLETED|Overall Study||124
7996054|NCT00099983|19689824|P1|COMPLETED|Overall Study||123
7996055|NCT00099983|19689823|P2|STARTED|Overall Study||149
7996056|NCT00099983|19689824|P1|STARTED|Overall Study||147
7996057|NCT00099632|19689836|P6|NOT COMPLETED|Overall Study||2
7996058|NCT00099632|19689837|P5|NOT COMPLETED|Overall Study||1
7996059|NCT00099632|19689838|P4|NOT COMPLETED|Overall Study||1
7996060|NCT00099632|19689839|P3|NOT COMPLETED|Overall Study||3
7996061|NCT00099632|19689840|P2|NOT COMPLETED|Overall Study||1
7996062|NCT00099632|19689841|P1|NOT COMPLETED|Overall Study||1
7996063|NCT00099632|19689836|P6|COMPLETED|Overall Study||66
7996064|NCT00099632|19689837|P5|COMPLETED|Overall Study||70
7996065|NCT00099632|19689838|P4|COMPLETED|Overall Study||66
7996066|NCT00099632|19689839|P3|COMPLETED|Overall Study||72
7996067|NCT00099632|19689840|P2|COMPLETED|Overall Study||67
7996068|NCT00099632|19689841|P1|COMPLETED|Overall Study||72
7996069|NCT00099632|19689836|P6|STARTED|Overall Study||68
7996070|NCT00099632|19689837|P5|STARTED|Overall Study||71
7996071|NCT00099632|19689838|P4|STARTED|Overall Study||67
7996072|NCT00099632|19689839|P3|STARTED|Overall Study||75
7996073|NCT00099632|19689840|P2|STARTED|Overall Study||68
7996074|NCT00099632|19689841|P1|STARTED|Overall Study||73
7996075|NCT00099437|19689881|P2|NOT COMPLETED|Overall Study||349
7996076|NCT00099437|19689882|P1|NOT COMPLETED|Overall Study||366
7996077|NCT00099437|19689881|P2|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13
7996078|NCT00099437|19689882|P1|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8
7996079|NCT00099437|19689881|P2|STARTED|Overall Study|randomised patients|362
7996080|NCT00099437|19689882|P1|STARTED|Overall Study|randomised patients|374
7996081|NCT00099359|19689905|P3|NOT COMPLETED|Overall Study||68
7996082|NCT00099359|19689906|P2|NOT COMPLETED|Overall Study||65
7996083|NCT00099359|19689907|P1|NOT COMPLETED|Overall Study||54
7996084|NCT00099359|19689905|P3|COMPLETED|Overall Study||506
7996085|NCT00099359|19689906|P2|COMPLETED|Overall Study||515
7996086|NCT00099359|19689907|P1|COMPLETED|Overall Study||527
7996087|NCT00099359|19689905|P3|STARTED|Overall Study||574
7996088|NCT00099359|19689906|P2|STARTED|Overall Study||580
7996089|NCT00099359|19689907|P1|STARTED|Overall Study||581
7996090|NCT00099268|19689930|P2|NOT COMPLETED|Overall Study||82
7996091|NCT00099268|19689931|P1|NOT COMPLETED|Overall Study||92
7996092|NCT00099268|19689930|P2|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291
7996093|NCT00099268|19689931|P1|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282
7996094|NCT00099268|19689930|P2|Intent-to-Treat|Overall Study||372
7996095|NCT00099268|19689931|P1|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373
7996096|NCT00099268|19689930|P2|STARTED|Overall Study||373
7996097|NCT00099268|19689931|P1|STARTED|Overall Study||374
7996098|NCT00099047|19689949|P2|NOT COMPLETED|Overall Study||0
7996099|NCT00099047|19689950|P1|NOT COMPLETED|Overall Study||0
7996100|NCT00099047|19689949|P2|COMPLETED|Overall Study||12
7996101|NCT00099047|19689950|P1|COMPLETED|Overall Study||11
7996102|NCT00099047|19689949|P2|STARTED|Overall Study||12
7996103|NCT00099047|19689950|P1|STARTED|Overall Study||11
7996104|NCT00099021|19689956|P1|NOT COMPLETED|Overall Study||0
7996105|NCT00099021|19689956|P1|COMPLETED|Overall Study||21
7996106|NCT00099021|19689956|P1|STARTED|Overall Study||21
7996107|NCT00098956|19689962|P1|NOT COMPLETED|Overall Study||0
7996108|NCT00098956|19689962|P1|COMPLETED|Overall Study||19
7996109|NCT00098956|19689962|P1|STARTED|Overall Study||19
7996110|NCT00098865|19689971|P1|NOT COMPLETED|Overall Study||9
7996111|NCT00098865|19689971|P1|COMPLETED|Overall Study||6
7996112|NCT00098865|19689971|P1|STARTED|Overall Study||15
7996113|NCT00098839|19689979|P2|NOT COMPLETED|Overall Study||33
7996114|NCT00098839|19689980|P1|NOT COMPLETED|Overall Study||32
7996115|NCT00098839|19689979|P2|COMPLETED|Overall Study||27
7996116|NCT00098839|19689980|P1|COMPLETED|Overall Study||24
7996117|NCT00098839|19689979|P2|STARTED|Overall Study||60
7996118|NCT00098839|19689980|P1|STARTED|Overall Study||56
7996119|NCT00098813|19689991|P1|NOT COMPLETED|Overall Study||19
7996120|NCT00098813|19689991|P1|COMPLETED|Overall Study||1
7996121|NCT00098813|19689991|P1|STARTED|Overall Study||20
7996122|NCT00098787|19689998|P3|NOT COMPLETED|Overall Study||63
7996123|NCT00098787|19689999|P2|NOT COMPLETED|Overall Study||75
7996124|NCT00098787|19690000|P1|NOT COMPLETED|Overall Study||73
7996125|NCT00098787|19689998|P3|COMPLETED|Overall Study||0
7996126|NCT00098787|19689999|P2|COMPLETED|Overall Study||0
7996127|NCT00098787|19690000|P1|COMPLETED|Overall Study||0
7996128|NCT00098787|19689998|P3|Eligible and Treated|Overall Study||59
7996129|NCT00098787|19689999|P2|Eligible and Treated|Overall Study||66
7996130|NCT00098787|19690000|P1|Eligible and Treated|Overall Study||61
7996131|NCT00098787|19689998|P3|Treated|Overall Study||62
7996132|NCT00098787|19689999|P2|Treated|Overall Study||73
7996133|NCT00098787|19690000|P1|Treated|Overall Study||70
7996134|NCT00098787|19689998|P3|STARTED|Overall Study||63
7996135|NCT00098787|19689999|P2|STARTED|Overall Study||75
7996136|NCT00098787|19690000|P1|STARTED|Overall Study||73
7996137|NCT00098774|19690014|P1|NOT COMPLETED|Overall Study||18
7996138|NCT00098774|19690014|P1|COMPLETED|Overall Study||26
7996139|NCT00098774|19690014|P1|STARTED|Overall Study||44
7996140|NCT00098748|19690024|P3|NOT COMPLETED|Continued on Open-Label Treatment||0
7996141|NCT00098748|19690025|P2|NOT COMPLETED|Continued on Open-Label Treatment||15
7996142|NCT00098748|19690026|P1|NOT COMPLETED|Continued on Open-Label Treatment||8
7996143|NCT00098748|19690024|P3|COMPLETED|Continued on Open-Label Treatment||0
7996144|NCT00098748|19690025|P2|COMPLETED|Continued on Open-Label Treatment||10
7996145|NCT00098748|19690026|P1|COMPLETED|Continued on Open-Label Treatment||7
7996146|NCT00098748|19690024|P3|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0
7996147|NCT00098748|19690025|P2|STARTED|Continued on Open-Label Treatment||25
7996148|NCT00098748|19690026|P1|STARTED|Continued on Open-Label Treatment||15
7996149|NCT00098748|19690024|P3|NOT COMPLETED|Received Study Treatment||44
7996150|NCT00098748|19690025|P2|NOT COMPLETED|Received Study Treatment||36
7996151|NCT00098748|19690026|P1|NOT COMPLETED|Received Study Treatment||48
7996152|NCT00098748|19690024|P3|COMPLETED|Received Study Treatment||18
7996153|NCT00098748|19690025|P2|COMPLETED|Received Study Treatment||25
7996154|NCT00098748|19690026|P1|COMPLETED|Received Study Treatment||15
7996155|NCT00098748|19690024|P3|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58
7996156|NCT00098748|19690025|P2|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52
7996157|NCT00098748|19690026|P1|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57
7996158|NCT00098748|19690024|P3|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62
7996159|NCT00098748|19690025|P2|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61
7996160|NCT00098748|19690026|P1|STARTED|Received Study Treatment||63
7996161|NCT00098748|19690024|P3|NOT COMPLETED|Assigned to Study Treatment||2
7996162|NCT00098748|19690025|P2|NOT COMPLETED|Assigned to Study Treatment||2
7996163|NCT00098748|19690026|P1|NOT COMPLETED|Assigned to Study Treatment||0
7996164|NCT00098748|19690024|P3|COMPLETED|Assigned to Study Treatment||62
7996165|NCT00098748|19690025|P2|COMPLETED|Assigned to Study Treatment||61
7996166|NCT00098748|19690026|P1|COMPLETED|Assigned to Study Treatment||63
7996167|NCT00098748|19690024|P3|STARTED|Assigned to Study Treatment||64
7996168|NCT00098748|19690025|P2|STARTED|Assigned to Study Treatment||63
7996169|NCT00098748|19690026|P1|STARTED|Assigned to Study Treatment||63
7996170|NCT00098722|19690082|P7|NOT COMPLETED|Observation Phase||17
7996171|NCT00098722|19690083|P6|NOT COMPLETED|Observation Phase||45
7996172|NCT00098722|19690084|P5|NOT COMPLETED|Observation Phase||0
7996173|NCT00098722|19690085|P4|NOT COMPLETED|Observation Phase||0
7996174|NCT00098722|19690086|P3|NOT COMPLETED|Observation Phase||0
7996175|NCT00098722|19690087|P2|NOT COMPLETED|Observation Phase||0
7996176|NCT00098722|19690088|P1|NOT COMPLETED|Observation Phase||0
7996177|NCT00098722|19690082|P7|COMPLETED|Observation Phase||48
7996178|NCT00098722|19690083|P6|COMPLETED|Observation Phase||160
7996179|NCT00098722|19690084|P5|COMPLETED|Observation Phase||0
7996180|NCT00098722|19690085|P4|COMPLETED|Observation Phase||0
7996181|NCT00098722|19690086|P3|COMPLETED|Observation Phase||0
7996182|NCT00098722|19690087|P2|COMPLETED|Observation Phase||0
7996183|NCT00098722|19690088|P1|COMPLETED|Observation Phase||0
7996184|NCT00098722|19690082|P7|STARTED|Observation Phase||65
7996185|NCT00098722|19690083|P6|STARTED|Observation Phase||205
7996186|NCT00098722|19690084|P5|STARTED|Observation Phase||0
7996187|NCT00098722|19690085|P4|STARTED|Observation Phase||0
7996188|NCT00098722|19690086|P3|STARTED|Observation Phase||0
7996189|NCT00098722|19690087|P2|STARTED|Observation Phase||0
7996190|NCT00098722|19690088|P1|STARTED|Observation Phase||0
7996191|NCT00098722|19690082|P7|NOT COMPLETED|Open Label Phase||0
7996192|NCT00098722|19690083|P6|NOT COMPLETED|Open Label Phase||0
7996193|NCT00098722|19690084|P5|NOT COMPLETED|Open Label Phase||50
7996194|NCT00098722|19690085|P4|NOT COMPLETED|Open Label Phase||272
7996195|NCT00098722|19690086|P3|NOT COMPLETED|Open Label Phase||0
7996196|NCT00098722|19690087|P2|NOT COMPLETED|Open Label Phase||0
7996197|NCT00098722|19690088|P1|NOT COMPLETED|Open Label Phase||0
7996198|NCT00098722|19690082|P7|COMPLETED|Open Label Phase||0
7996199|NCT00098722|19690083|P6|COMPLETED|Open Label Phase||0
7996200|NCT00098722|19690084|P5|COMPLETED|Open Label Phase||0
7996201|NCT00098722|19690085|P4|COMPLETED|Open Label Phase||0
7996202|NCT00098722|19690086|P3|COMPLETED|Open Label Phase||0
7996203|NCT00098722|19690087|P2|COMPLETED|Open Label Phase||0
7996204|NCT00098722|19690088|P1|COMPLETED|Open Label Phase||0
7996205|NCT00098722|19690082|P7|STARTED|Open Label Phase||0
7996206|NCT00098722|19690083|P6|STARTED|Open Label Phase||0
7996207|NCT00098722|19690084|P5|STARTED|Open Label Phase||50
7996208|NCT00098722|19690085|P4|STARTED|Open Label Phase||272
7996209|NCT00098722|19690086|P3|STARTED|Open Label Phase||0
7996210|NCT00098722|19690087|P2|STARTED|Open Label Phase||0
7996211|NCT00098722|19690088|P1|STARTED|Open Label Phase||0
7996212|NCT00098722|19690082|P7|NOT COMPLETED|Double Blind Phase||0
7996213|NCT00098722|19690083|P6|NOT COMPLETED|Double Blind Phase||0
7996214|NCT00098722|19690084|P5|NOT COMPLETED|Double Blind Phase||0
7996215|NCT00098722|19690085|P4|NOT COMPLETED|Double Blind Phase||0
7996216|NCT00098722|19690086|P3|NOT COMPLETED|Double Blind Phase||94
7996217|NCT00098722|19690087|P2|NOT COMPLETED|Double Blind Phase||194
7996218|NCT00098722|19690088|P1|NOT COMPLETED|Double Blind Phase||186
7996219|NCT00098722|19690082|P7|COMPLETED|Double Blind Phase||0
7996220|NCT00098722|19690083|P6|COMPLETED|Double Blind Phase||0
7996221|NCT00098722|19690084|P5|COMPLETED|Double Blind Phase||0
7996222|NCT00098722|19690085|P4|COMPLETED|Double Blind Phase||0
7996223|NCT00098722|19690086|P3|COMPLETED|Double Blind Phase||0
7996224|NCT00098722|19690087|P2|COMPLETED|Double Blind Phase||0
7996225|NCT00098722|19690088|P1|COMPLETED|Double Blind Phase||0
7996226|NCT00098722|19690082|P7|Treated|Double Blind Phase||0
7996227|NCT00098722|19690083|P6|Treated|Double Blind Phase||0
7996228|NCT00098722|19690084|P5|Treated|Double Blind Phase||0
7996229|NCT00098722|19690085|P4|Treated|Double Blind Phase||0
7996230|NCT00098722|19690086|P3|Treated|Double Blind Phase||91
7996231|NCT00098722|19690087|P2|Treated|Double Blind Phase||191
7996232|NCT00098722|19690088|P1|Treated|Double Blind Phase||182
7996233|NCT00098722|19690082|P7|STARTED|Double Blind Phase||0
7996234|NCT00098722|19690083|P6|STARTED|Double Blind Phase||0
7996235|NCT00098722|19690084|P5|STARTED|Double Blind Phase||0
7996236|NCT00098722|19690085|P4|STARTED|Double Blind Phase||0
7996237|NCT00098722|19690086|P3|STARTED|Double Blind Phase||94
7996238|NCT00098722|19690087|P2|STARTED|Double Blind Phase||194
7996239|NCT00098722|19690088|P1|STARTED|Double Blind Phase||186
7996240|NCT00098670|19690151|P1|NOT COMPLETED|Overall Study||0
7996241|NCT00098670|19690151|P1|COMPLETED|Overall Study||102
7996242|NCT00098670|19690151|P1|STARTED|Overall Study||102
7996243|NCT00098475|19690162|P4|NOT COMPLETED|Step 2||0
7996244|NCT00098475|19690163|P3|NOT COMPLETED|Step 2||0
7996245|NCT00098475|19690164|P2|NOT COMPLETED|Step 2||10
7996246|NCT00098475|19690165|P1|NOT COMPLETED|Step 2||5
7996247|NCT00098475|19690162|P4|COMPLETED|Step 2||0
7996248|NCT00098475|19690163|P3|COMPLETED|Step 2||0
7996249|NCT00098475|19690164|P2|COMPLETED|Step 2||5
7996250|NCT00098475|19690165|P1|COMPLETED|Step 2||0
7996251|NCT00098475|19690162|P4|Eligible|Step 2||0
7996252|NCT00098475|19690163|P3|Eligible|Step 2||0
7996253|NCT00098475|19690164|P2|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9
7996254|NCT00098475|19690165|P1|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2
7996255|NCT00098475|19690162|P4|Treated|Step 2||0
7996256|NCT00098475|19690163|P3|Treated|Step 2||0
7996257|NCT00098475|19690164|P2|Treated|Step 2||14
7996258|NCT00098475|19690165|P1|Treated|Step 2||4
7996259|NCT00098475|19690162|P4|STARTED|Step 2||0
7996260|NCT00098475|19690163|P3|STARTED|Step 2||0
7996261|NCT00098475|19690164|P2|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15
7996262|NCT00098475|19690165|P1|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5
7996263|NCT00098475|19690162|P4|NOT COMPLETED|Step 1||3
7996264|NCT00098475|19690163|P3|NOT COMPLETED|Step 1||4
7996265|NCT00098475|19690164|P2|NOT COMPLETED|Step 1||173
7996266|NCT00098475|19690165|P1|NOT COMPLETED|Step 1||171
7996267|NCT00098475|19690162|P4|COMPLETED|Step 1||0
7996268|NCT00098475|19690163|P3|COMPLETED|Step 1||0
7996269|NCT00098475|19690164|P2|COMPLETED|Step 1||49
7996270|NCT00098475|19690165|P1|COMPLETED|Step 1||52
7996271|NCT00098475|19690162|P4|Eligible|Step 1||3
7996272|NCT00098475|19690163|P3|Eligible|Step 1||4
7996273|NCT00098475|19690164|P2|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208
7996274|NCT00098475|19690165|P1|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214
7996275|NCT00098475|19690162|P4|Treated|Step 1||3
7996276|NCT00098475|19690163|P3|Treated|Step 1||4
7996277|NCT00098475|19690164|P2|Treated|Step 1||220
7996278|NCT00098475|19690165|P1|Treated|Step 1||223
7996279|NCT00098475|19690162|P4|STARTED|Step 1||3
7996280|NCT00098475|19690163|P3|STARTED|Step 1||4
7996281|NCT00098475|19690164|P2|STARTED|Step 1||222
7996282|NCT00098475|19690165|P1|STARTED|Step 1||223
7996283|NCT00098371|19690177|P1|NOT COMPLETED|Overall Study||0
7996284|NCT00098371|19690177|P1|COMPLETED|Overall Study||64
7996285|NCT00098371|19690177|P1|STARTED|Overall Study||64
7996286|NCT00098345|19690202|P1|NOT COMPLETED|Overall Study||13
7996287|NCT00098345|19690202|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17
7996288|NCT00098345|19690202|P1|STARTED|Overall Study||30
7996289|NCT00098306|19690215|P7|NOT COMPLETED|Observational Phase||26
7996290|NCT00098306|19690216|P6|NOT COMPLETED|Observational Phase||46
7996291|NCT00098306|19690217|P5|NOT COMPLETED|Observational Phase||0
7996292|NCT00098306|19690218|P4|NOT COMPLETED|Observational Phase||0
7996293|NCT00098306|19690219|P3|NOT COMPLETED|Observational Phase||0
7996294|NCT00098306|19690220|P2|NOT COMPLETED|Observational Phase||0
7996295|NCT00098306|19690221|P1|NOT COMPLETED|Observational Phase||0
7996296|NCT00098306|19690215|P7|COMPLETED|Observational Phase||55
7996297|NCT00098306|19690216|P6|COMPLETED|Observational Phase||204
7996298|NCT00098306|19690217|P5|COMPLETED|Observational Phase||0
7996299|NCT00098306|19690218|P4|COMPLETED|Observational Phase||0
7996300|NCT00098306|19690219|P3|COMPLETED|Observational Phase||0
7996301|NCT00098306|19690220|P2|COMPLETED|Observational Phase||0
7996302|NCT00098306|19690221|P1|COMPLETED|Observational Phase||0
7996303|NCT00098306|19690215|P7|STARTED|Observational Phase||81
7996304|NCT00098306|19690216|P6|STARTED|Observational Phase||250
7996305|NCT00098306|19690217|P5|STARTED|Observational Phase||0
7996306|NCT00098306|19690218|P4|STARTED|Observational Phase||0
7996307|NCT00098306|19690219|P3|STARTED|Observational Phase||0
7996308|NCT00098306|19690220|P2|STARTED|Observational Phase||0
7996309|NCT00098306|19690221|P1|STARTED|Observational Phase||0
7996310|NCT00098306|19690215|P7|NOT COMPLETED|Open Label||0
7996311|NCT00098306|19690216|P6|NOT COMPLETED|Open Label||0
7996312|NCT00098306|19690217|P5|NOT COMPLETED|Open Label||62
7996313|NCT00098306|19690218|P4|NOT COMPLETED|Open Label||327
7996314|NCT00098306|19690219|P3|NOT COMPLETED|Open Label||0
7996315|NCT00098306|19690220|P2|NOT COMPLETED|Open Label||0
7996316|NCT00098306|19690221|P1|NOT COMPLETED|Open Label||0
7996317|NCT00098306|19690215|P7|COMPLETED|Open Label||0
7996318|NCT00098306|19690216|P6|COMPLETED|Open Label||0
7996319|NCT00098306|19690217|P5|COMPLETED|Open Label||0
7996320|NCT00098306|19690218|P4|COMPLETED|Open Label||0
7996321|NCT00098306|19690219|P3|COMPLETED|Open Label||0
7996322|NCT00098306|19690220|P2|COMPLETED|Open Label||0
7996323|NCT00098306|19690221|P1|COMPLETED|Open Label||0
7996324|NCT00098306|19690215|P7|STARTED|Open Label||0
7996325|NCT00098306|19690216|P6|STARTED|Open Label||0
7996326|NCT00098306|19690217|P5|STARTED|Open Label||62
7996327|NCT00098306|19690218|P4|STARTED|Open Label||327
7996328|NCT00098306|19690219|P3|STARTED|Open Label||0
7996329|NCT00098306|19690220|P2|STARTED|Open Label||0
7996330|NCT00098306|19690221|P1|STARTED|Open Label||0
7996331|NCT00098306|19690215|P7|NOT COMPLETED|Double Blind||0
7996332|NCT00098306|19690216|P6|NOT COMPLETED|Double Blind||0
7996333|NCT00098306|19690217|P5|NOT COMPLETED|Double Blind||0
7996334|NCT00098306|19690218|P4|NOT COMPLETED|Double Blind||0
7996335|NCT00098306|19690219|P3|NOT COMPLETED|Double Blind||120
7996336|NCT00098306|19690220|P2|NOT COMPLETED|Double Blind||240
7996337|NCT00098306|19690221|P1|NOT COMPLETED|Double Blind||241
7996338|NCT00098306|19690215|P7|COMPLETED|Double Blind||0
7996339|NCT00098306|19690216|P6|COMPLETED|Double Blind||0
7996340|NCT00098306|19690217|P5|COMPLETED|Double Blind||0
7996341|NCT00098306|19690218|P4|COMPLETED|Double Blind||0
7996342|NCT00098306|19690219|P3|COMPLETED|Double Blind||0
7996343|NCT00098306|19690220|P2|COMPLETED|Double Blind||0
7996344|NCT00098306|19690221|P1|COMPLETED|Double Blind||0
7996345|NCT00098306|19690215|P7|Treated|Double Blind||0
7996346|NCT00098306|19690216|P6|Treated|Double Blind||0
7996347|NCT00098306|19690217|P5|Treated|Double Blind||0
7996348|NCT00098306|19690218|P4|Treated|Double Blind||0
7996349|NCT00098306|19690219|P3|Treated|Double Blind||118
7996350|NCT00098306|19690220|P2|Treated|Double Blind||235
7996351|NCT00098306|19690221|P1|Treated|Double Blind||232
7996352|NCT00098306|19690215|P7|STARTED|Double Blind||0
7996353|NCT00098306|19690216|P6|STARTED|Double Blind||0
7996354|NCT00098306|19690217|P5|STARTED|Double Blind||0
7996355|NCT00098306|19690218|P4|STARTED|Double Blind||0
7996356|NCT00098306|19690219|P3|STARTED|Double Blind||120
7996357|NCT00098306|19690220|P2|STARTED|Double Blind||240
7996358|NCT00098306|19690221|P1|STARTED|Double Blind||241
7996359|NCT00098293|19690287|P5|NOT COMPLETED|Supplemental Phase (SP)||33
7996360|NCT00098293|19690288|P4|NOT COMPLETED|Supplemental Phase (SP)||0
7996361|NCT00098293|19690289|P3|NOT COMPLETED|Supplemental Phase (SP)||0
7996362|NCT00098293|19690290|P2|NOT COMPLETED|Supplemental Phase (SP)||0
7996363|NCT00098293|19690291|P1|NOT COMPLETED|Supplemental Phase (SP)||0
7996364|NCT00098293|19690287|P5|COMPLETED|Supplemental Phase (SP)||94
7996365|NCT00098293|19690288|P4|COMPLETED|Supplemental Phase (SP)||0
7996366|NCT00098293|19690289|P3|COMPLETED|Supplemental Phase (SP)||0
7996367|NCT00098293|19690290|P2|COMPLETED|Supplemental Phase (SP)||0
7996368|NCT00098293|19690291|P1|COMPLETED|Supplemental Phase (SP)||0
7996369|NCT00098293|19690287|P5|STARTED|Supplemental Phase (SP)||127
7996370|NCT00098293|19690288|P4|STARTED|Supplemental Phase (SP)||0
7996371|NCT00098293|19690289|P3|STARTED|Supplemental Phase (SP)||0
7996372|NCT00098293|19690290|P2|STARTED|Supplemental Phase (SP)||0
7996373|NCT00098293|19690291|P1|STARTED|Supplemental Phase (SP)||0
7996374|NCT00098293|19690287|P5|NOT COMPLETED|Open-label (OL) Phase||0
7996375|NCT00098293|19690288|P4|NOT COMPLETED|Open-label (OL) Phase||65
7996376|NCT00098293|19690289|P3|NOT COMPLETED|Open-label (OL) Phase||41
7996377|NCT00098293|19690290|P2|NOT COMPLETED|Open-label (OL) Phase||25
7996378|NCT00098293|19690291|P1|NOT COMPLETED|Open-label (OL) Phase||0
7996379|NCT00098293|19690287|P5|COMPLETED|Open-label (OL) Phase||0
7996380|NCT00098293|19690288|P4|COMPLETED|Open-label (OL) Phase||65
7996381|NCT00098293|19690289|P3|COMPLETED|Open-label (OL) Phase||158
7996382|NCT00098293|19690290|P2|COMPLETED|Open-label (OL) Phase||177
7996383|NCT00098293|19690291|P1|COMPLETED|Open-label (OL) Phase||0
7996384|NCT00098293|19690287|P5|STARTED|Open-label (OL) Phase||0
7996385|NCT00098293|19690288|P4|STARTED|Open-label (OL) Phase||130
7996386|NCT00098293|19690289|P3|STARTED|Open-label (OL) Phase||199
7996387|NCT00098293|19690290|P2|STARTED|Open-label (OL) Phase||202
7996388|NCT00098293|19690291|P1|STARTED|Open-label (OL) Phase||0
7996389|NCT00098293|19690287|P5|NOT COMPLETED|Between DB and OL Phase||0
7996390|NCT00098293|19690288|P4|NOT COMPLETED|Between DB and OL Phase||0
7996391|NCT00098293|19690289|P3|NOT COMPLETED|Between DB and OL Phase||3
7996392|NCT00098293|19690290|P2|NOT COMPLETED|Between DB and OL Phase||0
7996393|NCT00098293|19690291|P1|NOT COMPLETED|Between DB and OL Phase||0
7996394|NCT00098293|19690287|P5|COMPLETED|Between DB and OL Phase||0
7996395|NCT00098293|19690288|P4|COMPLETED|Between DB and OL Phase||0
7996396|NCT00098293|19690289|P3|COMPLETED|Between DB and OL Phase||199
7996397|NCT00098293|19690290|P2|COMPLETED|Between DB and OL Phase||202
7996398|NCT00098293|19690291|P1|COMPLETED|Between DB and OL Phase||0
7996399|NCT00098293|19690287|P5|STARTED|Between DB and OL Phase||0
7996400|NCT00098293|19690288|P4|STARTED|Between DB and OL Phase||0
7996401|NCT00098293|19690289|P3|STARTED|Between DB and OL Phase||202
7996402|NCT00098293|19690290|P2|STARTED|Between DB and OL Phase||202
7996403|NCT00098293|19690291|P1|STARTED|Between DB and OL Phase||0
7996404|NCT00098293|19690287|P5|NOT COMPLETED|Double-blind (DB) Phase||0
7996405|NCT00098293|19690288|P4|NOT COMPLETED|Double-blind (DB) Phase||0
7996406|NCT00098293|19690289|P3|NOT COMPLETED|Double-blind (DB) Phase||170
7996407|NCT00098293|19690290|P2|NOT COMPLETED|Double-blind (DB) Phase||166
7996408|NCT00098293|19690291|P1|NOT COMPLETED|Double-blind (DB) Phase||177
7996409|NCT00098293|19690287|P5|COMPLETED|Double-blind (DB) Phase||0
7996410|NCT00098293|19690288|P4|COMPLETED|Double-blind (DB) Phase||0
7996411|NCT00098293|19690289|P3|COMPLETED|Double-blind (DB) Phase||202
7996412|NCT00098293|19690290|P2|COMPLETED|Double-blind (DB) Phase||202
7996413|NCT00098293|19690291|P1|COMPLETED|Double-blind (DB) Phase||0
7996414|NCT00098293|19690287|P5|Treated|Double-blind (DB) Phase||0
7996415|NCT00098293|19690288|P4|Treated|Double-blind (DB) Phase||0
7996416|NCT00098293|19690289|P3|Treated|Double-blind (DB) Phase||361
7996417|NCT00098293|19690290|P2|Treated|Double-blind (DB) Phase||360
7996418|NCT00098293|19690291|P1|Treated|Double-blind (DB) Phase||174
7996419|NCT00098293|19690287|P5|STARTED|Double-blind (DB) Phase||0
7996420|NCT00098293|19690288|P4|STARTED|Double-blind (DB) Phase||0
7996421|NCT00098293|19690289|P3|STARTED|Double-blind (DB) Phase||372
7996422|NCT00098293|19690290|P2|STARTED|Double-blind (DB) Phase||368
7996423|NCT00098293|19690291|P1|STARTED|Double-blind (DB) Phase||177
7996424|NCT00098254|19690344|P1|NOT COMPLETED|Overall Study||3
7996425|NCT00098254|19690344|P1|COMPLETED|Overall Study||34
7996426|NCT00098254|19690344|P1|STARTED|Overall Study||37
7996427|NCT00098059|19690365|P2|NOT COMPLETED|Overall Study||1
7996428|NCT00098059|19690366|P1|NOT COMPLETED|Overall Study||0
7996429|NCT00098059|19690365|P2|COMPLETED|Overall Study||46
7996430|NCT00098059|19690366|P1|COMPLETED|Overall Study||27
7996431|NCT00098059|19690365|P2|STARTED|Overall Study||47
7996432|NCT00098059|19690366|P1|STARTED|Overall Study||27
7996433|NCT00098020|19690410|P1|NOT COMPLETED|Overall Study||6
7996434|NCT00098020|19690410|P1|COMPLETED|Overall Study||6
7996435|NCT00098020|19690410|P1|Started Isotretinoin|Overall Study||8
7996436|NCT00098020|19690410|P1|STARTED|Overall Study||12
7996437|NCT00097981|19690417|P2|NOT COMPLETED|Overall Study||100
7996438|NCT00097981|19690418|P1|NOT COMPLETED|Overall Study||106
7996439|NCT00097981|19690417|P2|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12
7996440|NCT00097981|19690418|P1|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7
7996441|NCT00097981|19690417|P2|Received Study Medication|Overall Study||106
7996442|NCT00097981|19690418|P1|Received Study Medication|Overall Study||110
7996443|NCT00097981|19690417|P2|STARTED|Overall Study|Enrollment at randomization|112
7996444|NCT00097981|19690418|P1|STARTED|Overall Study|Enrollment at randomization|113
7996445|NCT00097786|19690440|P4|NOT COMPLETED|Overall Study||310
7996446|NCT00097786|19690441|P3|NOT COMPLETED|Overall Study||313
7996447|NCT00097786|19690442|P2|NOT COMPLETED|Overall Study||292
7996448|NCT00097786|19690443|P1|NOT COMPLETED|Overall Study||296
7996449|NCT00097786|19690440|P4|COMPLETED|Overall Study||2036
7996450|NCT00097786|19690441|P3|COMPLETED|Overall Study||2016
7996451|NCT00097786|19690442|P2|COMPLETED|Overall Study||2023
7996452|NCT00097786|19690443|P1|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020
7996453|NCT00097786|19690440|P4|Complete Follow-up for Core CV EPs|Overall Study||1988
7996454|NCT00097786|19690441|P3|Complete Follow-up for Core CV EPs|Overall Study||1966
7996455|NCT00097786|19690442|P2|Complete Follow-up for Core CV EPs|Overall Study||1963
7996456|NCT00097786|19690443|P1|Complete Follow-up for Core CV EPs|Overall Study||1948
7996457|NCT00097786|19690440|P4|Complete Follow-up for Extended CV EPs|Overall Study||2015
7996458|NCT00097786|19690441|P3|Complete Follow-up for Extended CV EPs|Overall Study||1987
7996459|NCT00097786|19690442|P2|Complete Follow-up for Extended CV EPs|Overall Study||1985
7996460|NCT00097786|19690443|P1|Complete Follow-up for Extended CV EPs|Overall Study||1969
7996461|NCT00097786|19690440|P4|Complete FU for Progression to Diabetes|Overall Study||1762
7996462|NCT00097786|19690441|P3|Complete FU for Progression to Diabetes|Overall Study||1734
7996463|NCT00097786|19690442|P2|Complete FU for Progression to Diabetes|Overall Study||1712
7996464|NCT00097786|19690443|P1|Complete FU for Progression to Diabetes|Overall Study||1709
7996465|NCT00097786|19690440|P4|STARTED|Overall Study||2346
7996466|NCT00097786|19690441|P3|STARTED|Overall Study||2329
7996467|NCT00097786|19690442|P2|STARTED|Overall Study||2315
7996468|NCT00097786|19690443|P1|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316
7996469|NCT00097773|19690465|P4|NOT COMPLETED|Overall Study||3
7996470|NCT00097773|19690466|P3|NOT COMPLETED|Overall Study||8
7996471|NCT00097773|19690467|P2|NOT COMPLETED|Overall Study||8
7996472|NCT00097773|19690468|P1|NOT COMPLETED|Overall Study||8
7996473|NCT00097773|19690465|P4|COMPLETED|Overall Study||73
7996474|NCT00097773|19690466|P3|COMPLETED|Overall Study||68
7996475|NCT00097773|19690467|P2|COMPLETED|Overall Study||68
7996476|NCT00097773|19690468|P1|COMPLETED|Overall Study||68
7996477|NCT00097773|19690465|P4|STARTED|Overall Study||76
7996478|NCT00097773|19690466|P3|STARTED|Overall Study||76
7996479|NCT00097773|19690467|P2|STARTED|Overall Study||76
7996480|NCT00097773|19690468|P1|STARTED|Overall Study||76
7996481|NCT00097721|19690488|P2|NOT COMPLETED|Overall Study||33
7996482|NCT00097721|19690489|P1|NOT COMPLETED|Overall Study||71
7996483|NCT00097721|19690488|P2|COMPLETED|Overall Study||0
7996484|NCT00097721|19690489|P1|COMPLETED|Overall Study||0
7996485|NCT00097721|19690488|P2|STARTED|Overall Study||33
7996486|NCT00097721|19690489|P1|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71
7996487|NCT00097708|19690506|P3|NOT COMPLETED|Overall Study||65
7996488|NCT00097708|19690507|P2|NOT COMPLETED|Overall Study||56
7996489|NCT00097708|19690508|P1|NOT COMPLETED|Overall Study||64
7996490|NCT00097708|19690506|P3|COMPLETED|Overall Study||97
7996491|NCT00097708|19690507|P2|COMPLETED|Overall Study||120
7996492|NCT00097708|19690508|P1|COMPLETED|Overall Study||109
7996493|NCT00097708|19690506|P3|Treated|Overall Study||160
7996494|NCT00097708|19690507|P2|Treated|Overall Study||176
7996495|NCT00097708|19690508|P1|Treated|Overall Study||171
7996496|NCT00097708|19690506|P3|Intent-to-Treat (ITT)|Overall Study||149
7996497|NCT00097708|19690507|P2|Intent-to-Treat (ITT)|Overall Study||169
7996498|NCT00097708|19690508|P1|Intent-to-Treat (ITT)|Overall Study||165
7996499|NCT00097708|19690506|P3|STARTED|Overall Study||162
7996500|NCT00097708|19690507|P2|STARTED|Overall Study||176
7996501|NCT00097708|19690508|P1|STARTED|Overall Study||173
7996502|NCT00097695|19690520|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||5
7996503|NCT00097695|19690521|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||2
7996504|NCT00097695|19690522|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||15
7996505|NCT00097695|19690523|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||13
7996506|NCT00097695|19690520|P4|COMPLETED|The Open Label Extension (OLE) Phase||15
7996507|NCT00097695|19690521|P3|COMPLETED|The Open Label Extension (OLE) Phase||1
7996508|NCT00097695|19690522|P2|COMPLETED|The Open Label Extension (OLE) Phase||11
7996509|NCT00097695|19690523|P1|COMPLETED|The Open Label Extension (OLE) Phase||10
7996510|NCT00097695|19690520|P4|STARTED|The Open Label Extension (OLE) Phase||20
7996511|NCT00097695|19690521|P3|STARTED|The Open Label Extension (OLE) Phase||3
7996512|NCT00097695|19690522|P2|STARTED|The Open Label Extension (OLE) Phase||26
7996513|NCT00097695|19690523|P1|STARTED|The Open Label Extension (OLE) Phase||23
7996514|NCT00097695|19690520|P4|NOT COMPLETED|The Controlled Phase||20
7996515|NCT00097695|19690521|P3|NOT COMPLETED|The Controlled Phase||5
7996516|NCT00097695|19690522|P2|NOT COMPLETED|The Controlled Phase||3
7996517|NCT00097695|19690523|P1|NOT COMPLETED|The Controlled Phase||4
7996518|NCT00097695|19690520|P4|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0
7996519|NCT00097695|19690521|P3|COMPLETED|The Controlled Phase||3
7996520|NCT00097695|19690522|P2|COMPLETED|The Controlled Phase||26
7996521|NCT00097695|19690523|P1|COMPLETED|The Controlled Phase||23
7996522|NCT00097695|19690520|P4|STARTED|The Controlled Phase||20
7996523|NCT00097695|19690521|P3|STARTED|The Controlled Phase||8
7996524|NCT00097695|19690522|P2|STARTED|The Controlled Phase||29
7996525|NCT00097695|19690523|P1|STARTED|The Controlled Phase||27
7996526|NCT00097669|19690539|P2|NOT COMPLETED|Overall Study||0
7996527|NCT00097669|19690540|P1|NOT COMPLETED|Overall Study||0
7996528|NCT00097669|19690539|P2|COMPLETED|Overall Study||4075
7996529|NCT00097669|19690540|P1|COMPLETED|Overall Study||4089
7996530|NCT00097669|19690539|P2|STARTED|Overall Study||4075
7996531|NCT00097669|19690540|P1|STARTED|Overall Study||4089
7996532|NCT00097591|19690548|P2|NOT COMPLETED|Overall Study||394
7996533|NCT00097591|19690549|P1|NOT COMPLETED|Overall Study||410
7996534|NCT00097591|19690548|P2|COMPLETED|Overall Study||6401
7996535|NCT00097591|19690549|P1|COMPLETED|Overall Study||6403
7996536|NCT00097591|19690548|P2|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795
7996537|NCT00097591|19690549|P1|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813
7996538|NCT00097539|19690572|P7|NOT COMPLETED|Overall Study||171
7996539|NCT00097539|19690573|P6|NOT COMPLETED|Overall Study||5892
7996540|NCT00097539|19690574|P5|NOT COMPLETED|Overall Study||1758
7996541|NCT00097539|19690575|P4|NOT COMPLETED|Overall Study||3585
7996542|NCT00097539|19690576|P3|NOT COMPLETED|Overall Study||9108
7996543|NCT00097539|19690577|P2|NOT COMPLETED|Overall Study||6531
7996544|NCT00097539|19690578|P1|NOT COMPLETED|Overall Study||19066
7996545|NCT00097539|19690572|P7|COMPLETED|Overall Study||68
7996546|NCT00097539|19690573|P6|COMPLETED|Overall Study||2118
7996547|NCT00097539|19690574|P5|COMPLETED|Overall Study||386
7996548|NCT00097539|19690575|P4|COMPLETED|Overall Study||2066
7996549|NCT00097539|19690576|P3|COMPLETED|Overall Study||3411
7996550|NCT00097539|19690577|P2|COMPLETED|Overall Study||2825
7996551|NCT00097539|19690578|P1|COMPLETED|Overall Study||8220
7996552|NCT00097539|19690572|P7|STARTED|Overall Study||239
7996553|NCT00097539|19690573|P6|STARTED|Overall Study||8010
7996554|NCT00097539|19690574|P5|STARTED|Overall Study||2144
7996555|NCT00097539|19690575|P4|STARTED|Overall Study||5651
7996556|NCT00097539|19690576|P3|STARTED|Overall Study||12519
7996557|NCT00097539|19690577|P2|STARTED|Overall Study||9356
7996558|NCT00097539|19690578|P1|STARTED|Overall Study||27286
7996559|NCT00097500|19690624|P2|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4
7996560|NCT00097500|19690625|P1|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5
7996561|NCT00097500|19690624|P2|COMPLETED|Off-drug Period (Week 52 to Week 64)||26
7996562|NCT00097500|19690625|P1|COMPLETED|Off-drug Period (Week 52 to Week 64)||25
7996563|NCT00097500|19690624|P2|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30
7996564|NCT00097500|19690625|P1|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30
7996565|NCT00097500|19690624|P2|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3
7996566|NCT00097500|19690625|P1|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6
7996567|NCT00097500|19690624|P2|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
7996568|NCT00097500|19690625|P1|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
7996569|NCT00097500|19690624|P2|STARTED|On-drug Period (Week 0 to Week 52)||33
7996570|NCT00097500|19690625|P1|STARTED|On-drug Period (Week 0 to Week 52)||36
7996571|NCT00097448|19690649|P2|NOT COMPLETED|Overall Study||1
7996572|NCT00097448|19690650|P1|NOT COMPLETED|Overall Study||4
7996573|NCT00097448|19690649|P2|COMPLETED|Overall Study||129
7996574|NCT00097448|19690650|P1|COMPLETED|Overall Study||121
7996575|NCT00097448|19690649|P2|STARTED|Overall Study||130
7996576|NCT00097448|19690650|P1|STARTED|Overall Study||125
7996577|NCT00097370|19690656|P1|NOT COMPLETED|Stage 3||59
7996578|NCT00097370|19690656|P1|COMPLETED|Stage 3||0
7996579|NCT00097370|19690656|P1|STARTED|Stage 3|Participants continued from Stage 2.|59
7996580|NCT00097370|19690656|P1|NOT COMPLETED|Stage 2||13
7996581|NCT00097370|19690656|P1|COMPLETED|Stage 2||59
7996582|NCT00097370|19690656|P1|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72
7996583|NCT00097370|19690656|P1|NOT COMPLETED|Stage 1||6
7996584|NCT00097370|19690656|P1|COMPLETED|Stage 1||31
7996585|NCT00097370|19690656|P1|STARTED|Stage 1|Participants entered from study MHE100185.|37
7996586|NCT00097253|19690673|P1|NOT COMPLETED|Water (Control)||0
7996587|NCT00097253|19690673|P1|COMPLETED|Water (Control)||56
7996588|NCT00097253|19690673|P1|STARTED|Water (Control)||56
7996589|NCT00097253|19690673|P1|NOT COMPLETED|Lemon||0
7996590|NCT00097253|19690673|P1|COMPLETED|Lemon||56
7996591|NCT00097253|19690673|P1|STARTED|Lemon||56
7996592|NCT00097253|19690673|P1|NOT COMPLETED|Lavender||0
7996593|NCT00097253|19690673|P1|COMPLETED|Lavender||56
7996594|NCT00097253|19690673|P1|STARTED|Lavender||56
7996595|NCT00096993|19690690|P2|NOT COMPLETED|Overall Study||65
7996596|NCT00096993|19690691|P1|NOT COMPLETED|Overall Study||65
7996597|NCT00096993|19690690|P2|COMPLETED|Overall Study||0
7996598|NCT00096993|19690691|P1|COMPLETED|Overall Study||1
7996599|NCT00096993|19690690|P2|STARTED|Overall Study||65
7996600|NCT00096993|19690691|P1|STARTED|Overall Study||66
7996601|NCT00096954|19690707|P2|NOT COMPLETED|Overall Study||20
7996602|NCT00096954|19690708|P1|NOT COMPLETED|Overall Study||24
7996603|NCT00096954|19690707|P2|COMPLETED|Overall Study||154
7996604|NCT00096954|19690708|P1|COMPLETED|Overall Study||135
7996605|NCT00096954|19690707|P2|Received Study Drug|Overall Study||171
7996606|NCT00096954|19690708|P1|Received Study Drug|Overall Study||157
7996607|NCT00096954|19690707|P2|STARTED|Overall Study||174
7996608|NCT00096954|19690708|P1|STARTED|Overall Study||159
7996609|NCT00096941|19690720|P1|NOT COMPLETED|Overall Study||3
7996610|NCT00096941|19690720|P1|COMPLETED|Overall Study||0
7996611|NCT00096941|19690720|P1|STARTED|Overall Study||3
7996612|NCT00096785|19690727|P2|NOT COMPLETED|Overall Study||1
7996613|NCT00096785|19690728|P1|NOT COMPLETED|Overall Study||2
7996614|NCT00096785|19690727|P2|COMPLETED|Overall Study|As randomized cohort|33
7996615|NCT00096785|19690728|P1|COMPLETED|Overall Study|As randomized cohort|33
7996616|NCT00096785|19690727|P2|As-Treated Population|Overall Study||33
7996617|NCT00096785|19690728|P1|As-Treated Population|Overall Study||36
7996618|NCT00096785|19690727|P2|As-Randomized Population|Overall Study||34
7996619|NCT00096785|19690728|P1|As-Randomized Population|Overall Study||35
7996620|NCT00096785|19690727|P2|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34
7996621|NCT00096785|19690728|P1|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35
7996622|NCT00096681|19690752|P1|NOT COMPLETED|Overall Study||0
7996623|NCT00096681|19690752|P1|COMPLETED|Overall Study||762
7996624|NCT00096681|19690752|P1|STARTED|Overall Study||762
7996625|NCT00096538|19690757|P1|NOT COMPLETED|Overall Study||1
7996626|NCT00096538|19690757|P1|COMPLETED|Overall Study||5
7996627|NCT00096538|19690757|P1|STARTED|Overall Study||6
7996628|NCT00096486|19690765|P4|NOT COMPLETED|Overall Study||2
7996629|NCT00096486|19690766|P3|NOT COMPLETED|Overall Study||2
7996630|NCT00096486|19690767|P2|NOT COMPLETED|Overall Study||0
7996631|NCT00096486|19690768|P1|NOT COMPLETED|Overall Study||0
7996632|NCT00096486|19690765|P4|COMPLETED|Overall Study||36
7996633|NCT00096486|19690766|P3|COMPLETED|Overall Study||24
7996634|NCT00096486|19690767|P2|COMPLETED|Overall Study||6
7996635|NCT00096486|19690768|P1|COMPLETED|Overall Study||4
7996636|NCT00096486|19690765|P4|STARTED|Overall Study||38
7996637|NCT00096486|19690766|P3|STARTED|Overall Study||26
7996638|NCT00096486|19690767|P2|STARTED|Overall Study||6
7996639|NCT00096486|19690768|P1|STARTED|Overall Study||4
7996640|NCT00096460|19690780|P2|NOT COMPLETED|Overall Study||1
7996641|NCT00096460|19690781|P1|NOT COMPLETED|Overall Study||7
7996642|NCT00096460|19690780|P2|COMPLETED|Overall Study||7
7996643|NCT00096460|19690781|P1|COMPLETED|Overall Study||15
7996644|NCT00096460|19690780|P2|STARTED|Overall Study||8
7996645|NCT00096460|19690781|P1|STARTED|Overall Study||22
7996646|NCT00096447|19690787|P1|NOT COMPLETED|Overall Study||1
7996647|NCT00096447|19690787|P1|COMPLETED|Overall Study|Eligible and treated patients.|30
7996648|NCT00096447|19690787|P1|STARTED|Overall Study||31
7996649|NCT00096382|19690803|P2|NOT COMPLETED|Overall Study||0
7996650|NCT00096382|19690804|P1|NOT COMPLETED|Overall Study||2
7996651|NCT00096382|19690803|P2|COMPLETED|Overall Study||3
7996652|NCT00096382|19690804|P1|COMPLETED|Overall Study||21
7996653|NCT00096382|19690803|P2|STARTED|Overall Study||3
7996654|NCT00096382|19690804|P1|STARTED|Overall Study||23
7996655|NCT00096356|19690814|P2|NOT COMPLETED|Overall Study||53
7996656|NCT00096356|19690815|P1|NOT COMPLETED|Overall Study||44
7996657|NCT00096356|19690814|P2|COMPLETED|Overall Study||61
7996658|NCT00096356|19690815|P1|COMPLETED|Overall Study||78
7996659|NCT00096356|19690814|P2|STARTED|Overall Study||114
7996660|NCT00096356|19690815|P1|STARTED|Overall Study||122
7996661|NCT00096278|19690827|P2|NOT COMPLETED|Overall Study||20
7996662|NCT00096278|19690828|P1|NOT COMPLETED|Overall Study||18
7996663|NCT00096278|19690827|P2|COMPLETED|Overall Study||1334
7996664|NCT00096278|19690828|P1|COMPLETED|Overall Study||1338
7996665|NCT00096278|19690827|P2|STARTED|Overall Study||1354
7996666|NCT00096278|19690828|P1|STARTED|Overall Study||1356
7996667|NCT00096265|19690847|P3|NOT COMPLETED|Overall Study||0
7996668|NCT00096265|19690848|P2|NOT COMPLETED|Overall Study||0
7996669|NCT00096265|19690849|P1|NOT COMPLETED|Overall Study||1
7996670|NCT00096265|19690847|P3|COMPLETED|Overall Study||41
7996671|NCT00096265|19690848|P2|COMPLETED|Overall Study||40
7996672|NCT00096265|19690849|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
7996673|NCT00096265|19690847|P3|STARTED|Overall Study||41
7996674|NCT00096265|19690848|P2|STARTED|Overall Study||40
7996675|NCT00096265|19690849|P1|STARTED|Overall Study||45
7996676|NCT00096226|19690875|P1|NOT COMPLETED|Overall Study||3
7996677|NCT00096226|19690875|P1|COMPLETED|Overall Study|Subjects contributing any data to analysis are considered to have completed the study|57
7996678|NCT00096226|19690875|P1|Eligible and Underwent Surgery|Overall Study||37
7996679|NCT00096226|19690875|P1|Eligible|Overall Study||57
7996680|NCT00096226|19690875|P1|STARTED|Overall Study||60
7996681|NCT00096200|19690889|P3|NOT COMPLETED|Overall Study||0
7996682|NCT00096200|19690890|P2|NOT COMPLETED|Overall Study||7
7996683|NCT00096200|19690891|P1|NOT COMPLETED|Overall Study||1
7996684|NCT00096200|19690889|P3|COMPLETED|Overall Study||5
7996685|NCT00096200|19690890|P2|COMPLETED|Overall Study||23
7996686|NCT00096200|19690891|P1|COMPLETED|Overall Study||8
7996687|NCT00096200|19690889|P3|STARTED|Overall Study||5
7996688|NCT00096200|19690890|P2|STARTED|Overall Study||30
7996689|NCT00096200|19690891|P1|STARTED|Overall Study||9
7996690|NCT00096174|19690905|P1|NOT COMPLETED|Overall Study||62
7996691|NCT00096174|19690905|P1|COMPLETED|Overall Study||7
7996692|NCT00096174|19690905|P1|Eligible and Treated|Overall Study|6 treated patients were ineligible|60
7996693|NCT00096174|19690905|P1|Began Protocol Therapy|Overall Study|3 patients never started treatment|66
7996694|NCT00096174|19690905|P1|STARTED|Overall Study||69
7996695|NCT00096161|19690915|P4|NOT COMPLETED|Overall Study||0
7996696|NCT00096161|19690916|P3|NOT COMPLETED|Overall Study||0
7996697|NCT00096161|19690917|P2|NOT COMPLETED|Overall Study||0
7996698|NCT00096161|19690918|P1|NOT COMPLETED|Overall Study||0
7996699|NCT00096161|19690915|P4|COMPLETED|Overall Study||0
7996700|NCT00096161|19690916|P3|COMPLETED|Overall Study||6
7996701|NCT00096161|19690917|P2|COMPLETED|Overall Study||10
7996702|NCT00096161|19690918|P1|COMPLETED|Overall Study||20
7996703|NCT00096161|19690915|P4|STARTED|Overall Study||0
7996704|NCT00096161|19690916|P3|STARTED|Overall Study||6
7996705|NCT00096161|19690917|P2|STARTED|Overall Study||10
7996706|NCT00096161|19690918|P1|STARTED|Overall Study||20
7996707|NCT00096135|19690950|P2|NOT COMPLETED|Overall Study||15
7996708|NCT00096135|19690951|P1|NOT COMPLETED|Overall Study||63
7996709|NCT00096135|19690950|P2|COMPLETED|Overall Study||27
7996710|NCT00096135|19690951|P1|COMPLETED|Overall Study||63
7996711|NCT00096135|19690950|P2|STARTED|Overall Study||42
7996712|NCT00096135|19690951|P1|STARTED|Overall Study||126
7996713|NCT00096122|19690957|P1|NOT COMPLETED|Overall Study||0
7996714|NCT00096122|19690957|P1|COMPLETED|Overall Study||95
7996715|NCT00096122|19690957|P1|STARTED|Overall Study||95
7996716|NCT00096109|19690961|P1|NOT COMPLETED|Overall Study||0
7996717|NCT00096109|19690961|P1|COMPLETED|Overall Study||11
7996718|NCT00096109|19690961|P1|STARTED|Overall Study||11
7996719|NCT00096044|19690967|P1|NOT COMPLETED|Overall Study||34
7996720|NCT00096044|19690967|P1|COMPLETED|Overall Study||11
7996721|NCT00096044|19690967|P1|STARTED|Overall Study||45
7996722|NCT00096031|19690976|P1|NOT COMPLETED|Overall Study||63
7996723|NCT00096031|19690976|P1|COMPLETED|Overall Study||0
7996724|NCT00096031|19690976|P1|Eligible and Began Protocol Therapy|Overall Study||55
7996725|NCT00096031|19690976|P1|Eligible|Overall Study||57
7996726|NCT00096031|19690976|P1|STARTED|Overall Study||63
7996727|NCT00096018|19690984|P2|NOT COMPLETED|Overall Study||14
7996728|NCT00096018|19690985|P1|NOT COMPLETED|Overall Study||2
7996729|NCT00096018|19690984|P2|COMPLETED|Overall Study||16
7996730|NCT00096018|19690985|P1|COMPLETED|Overall Study||11
7996731|NCT00096018|19690984|P2|Treated With Study Therapy|Overall Study||25
7996732|NCT00096018|19690985|P1|Treated With Study Therapy|Overall Study||13
7996733|NCT00096018|19690984|P2|STARTED|Overall Study||30
7996734|NCT00096018|19690985|P1|STARTED|Overall Study||13
7996735|NCT00095979|19690993|P1|NOT COMPLETED|Overall Study||2
7996736|NCT00095979|19690993|P1|COMPLETED|Overall Study||50
7996737|NCT00095979|19690993|P1|STARTED|Overall Study||52
7996738|NCT00095940|19691011|P9|NOT COMPLETED|Lapatinib Continuation/Phase II||13
7996739|NCT00095940|19691012|P8|NOT COMPLETED|Lapatinib Continuation/Phase II||2
7996740|NCT00095940|19691013|P7|NOT COMPLETED|Lapatinib Continuation/Phase II||2
7996741|NCT00095940|19691014|P6|NOT COMPLETED|Lapatinib Continuation/Phase II||13
7996742|NCT00095940|19691015|P5|NOT COMPLETED|Lapatinib Continuation/Phase II||0
7996743|NCT00095940|19691016|P4|NOT COMPLETED|Lapatinib Continuation/Phase II||0
7996744|NCT00095940|19691017|P3|NOT COMPLETED|Lapatinib Continuation/Phase II||16
7996745|NCT00095940|19691018|P2|NOT COMPLETED|Lapatinib Continuation/Phase II||2
7996746|NCT00095940|19691019|P1|NOT COMPLETED|Lapatinib Continuation/Phase II||2
7996747|NCT00095940|19691011|P9|COMPLETED|Lapatinib Continuation/Phase II||1
7996748|NCT00095940|19691012|P8|COMPLETED|Lapatinib Continuation/Phase II||0
7996749|NCT00095940|19691013|P7|COMPLETED|Lapatinib Continuation/Phase II||0
7996750|NCT00095940|19691014|P6|COMPLETED|Lapatinib Continuation/Phase II||0
7996751|NCT00095940|19691015|P5|COMPLETED|Lapatinib Continuation/Phase II||0
7996752|NCT00095940|19691016|P4|COMPLETED|Lapatinib Continuation/Phase II||0
7996753|NCT00095940|19691017|P3|COMPLETED|Lapatinib Continuation/Phase II||1
7996754|NCT00095940|19691018|P2|COMPLETED|Lapatinib Continuation/Phase II||0
7996755|NCT00095940|19691019|P1|COMPLETED|Lapatinib Continuation/Phase II||0
7996756|NCT00095940|19691011|P9|STARTED|Lapatinib Continuation/Phase II||14
7996757|NCT00095940|19691012|P8|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
7996758|NCT00095940|19691013|P7|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
7996759|NCT00095940|19691014|P6|STARTED|Lapatinib Continuation/Phase II||13
7996760|NCT00095940|19691015|P5|STARTED|Lapatinib Continuation/Phase II||0
7996761|NCT00095940|19691016|P4|STARTED|Lapatinib Continuation/Phase II||0
7996762|NCT00095940|19691017|P3|STARTED|Lapatinib Continuation/Phase II||17
7996763|NCT00095940|19691018|P2|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
7996764|NCT00095940|19691019|P1|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
7996765|NCT00095940|19691011|P9|NOT COMPLETED|Molecular Biology Phase||0
7996766|NCT00095940|19691012|P8|NOT COMPLETED|Molecular Biology Phase||0
7996767|NCT00095940|19691013|P7|NOT COMPLETED|Molecular Biology Phase||0
7996768|NCT00095940|19691014|P6|NOT COMPLETED|Molecular Biology Phase||0
7996769|NCT00095940|19691015|P5|NOT COMPLETED|Molecular Biology Phase||0
7996770|NCT00095940|19691016|P4|NOT COMPLETED|Molecular Biology Phase||0
7996771|NCT00095940|19691017|P3|NOT COMPLETED|Molecular Biology Phase||0
7996772|NCT00095940|19691018|P2|NOT COMPLETED|Molecular Biology Phase||0
7996773|NCT00095940|19691019|P1|NOT COMPLETED|Molecular Biology Phase||0
7996774|NCT00095940|19691011|P9|COMPLETED|Molecular Biology Phase||0
7996775|NCT00095940|19691012|P8|COMPLETED|Molecular Biology Phase||2
7996776|NCT00095940|19691013|P7|COMPLETED|Molecular Biology Phase||2
7996777|NCT00095940|19691014|P6|COMPLETED|Molecular Biology Phase||0
7996778|NCT00095940|19691015|P5|COMPLETED|Molecular Biology Phase||0
7996779|NCT00095940|19691016|P4|COMPLETED|Molecular Biology Phase||0
7996780|NCT00095940|19691017|P3|COMPLETED|Molecular Biology Phase||0
7996781|NCT00095940|19691018|P2|COMPLETED|Molecular Biology Phase||2
7996782|NCT00095940|19691019|P1|COMPLETED|Molecular Biology Phase||2
7996783|NCT00095940|19691011|P9|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
7996784|NCT00095940|19691012|P8|STARTED|Molecular Biology Phase||2
7996785|NCT00095940|19691013|P7|STARTED|Molecular Biology Phase||2
7996786|NCT00095940|19691014|P6|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
7996787|NCT00095940|19691015|P5|STARTED|Molecular Biology Phase||0
7996788|NCT00095940|19691016|P4|STARTED|Molecular Biology Phase||0
7996789|NCT00095940|19691017|P3|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
7996790|NCT00095940|19691018|P2|STARTED|Molecular Biology Phase||2
7996791|NCT00095940|19691019|P1|STARTED|Molecular Biology Phase||2
7996792|NCT00095875|19691043|P2|NOT COMPLETED|Overall Study||9
7996793|NCT00095875|19691044|P1|NOT COMPLETED|Overall Study||14
7996794|NCT00095875|19691043|P2|COMPLETED|Overall Study||66
7996795|NCT00095875|19691044|P1|COMPLETED|Overall Study||56
7996796|NCT00095875|19691043|P2|STARTED|Overall Study||75
7996797|NCT00095875|19691044|P1|STARTED|Overall Study||70
7996798|NCT00095836|19691052|P1|NOT COMPLETED|Overall Study||4
7996799|NCT00095836|19691052|P1|COMPLETED|Overall Study||23
7996800|NCT00095836|19691052|P1|STARTED|Overall Study||27
7996801|NCT00095784|19691059|P1|NOT COMPLETED|Overall Study||0
7996802|NCT00095784|19691059|P1|COMPLETED|Overall Study||21
7996803|NCT00095784|19691059|P1|STARTED|Overall Study||21
7996804|NCT00095628|19691082|P1|NOT COMPLETED|Overall Study||1
7996805|NCT00095628|19691082|P1|COMPLETED|Overall Study||20
7996806|NCT00095628|19691082|P1|STARTED|Overall Study||21
7996807|NCT00095576|19691093|P2|NOT COMPLETED|Overall Study||1481
7996808|NCT00095576|19691094|P1|NOT COMPLETED|Overall Study||1475
7996809|NCT00095576|19691093|P2|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14
7996810|NCT00095576|19691094|P1|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9
7996811|NCT00095576|19691093|P2|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361
7996812|NCT00095576|19691094|P1|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328
7996813|NCT00095576|19691093|P2|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443
7996814|NCT00095576|19691094|P1|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426
7996815|NCT00095576|19691093|P2|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495
7996816|NCT00095576|19691094|P1|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484
7996817|NCT00095576|19691093|P2|STARTED|Overall Study||1495
7996818|NCT00095576|19691094|P1|STARTED|Overall Study||1484
7996819|NCT00095563|19691106|P1|NOT COMPLETED|Overall Study||0
7996820|NCT00095563|19691106|P1|COMPLETED|Overall Study||39
7996821|NCT00095563|19691106|P1|STARTED|Overall Study||39
7996822|NCT00095498|19691118|P3|NOT COMPLETED|Overall Study||39
7996823|NCT00095498|19691119|P2|NOT COMPLETED|Overall Study||35
7996824|NCT00095498|19691120|P1|NOT COMPLETED|Overall Study||37
7996825|NCT00095498|19691118|P3|COMPLETED|Overall Study||39
7996826|NCT00095498|19691119|P2|COMPLETED|Overall Study||38
7996827|NCT00095498|19691120|P1|COMPLETED|Overall Study||39
7996828|NCT00095498|19691118|P3|Received Investigational Product|Overall Study||75
7996829|NCT00095498|19691119|P2|Received Investigational Product|Overall Study||71
7996830|NCT00095498|19691120|P1|Received Investigational Product|Overall Study||72
7996831|NCT00095498|19691118|P3|STARTED|Overall Study||78
7996832|NCT00095498|19691119|P2|STARTED|Overall Study||73
7996833|NCT00095498|19691120|P1|STARTED|Overall Study||76
7996834|NCT00095303|19691547|P2|NOT COMPLETED|Follow Up Study||58
7996835|NCT00095303|19691548|P1|NOT COMPLETED|Follow Up Study||59
7996836|NCT00095303|19691547|P2|COMPLETED|Follow Up Study||121
7996837|NCT00095303|19691548|P1|COMPLETED|Follow Up Study||140
7996838|NCT00095303|19691547|P2|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179
7996839|NCT00095303|19691548|P1|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199
7996840|NCT00095303|19691547|P2|NOT COMPLETED|Main Study||87
7996841|NCT00095303|19691548|P1|NOT COMPLETED|Main Study||91
7996842|NCT00095303|19691547|P2|COMPLETED|Main Study||148
7996843|NCT00095303|19691548|P1|COMPLETED|Main Study||154
7996844|NCT00095303|19691547|P2|STARTED|Main Study||235
7996845|NCT00095303|19691548|P1|STARTED|Main Study||245
7996846|NCT00095238|19691616|P2|NOT COMPLETED|Overall Study||852
7996847|NCT00095238|19691617|P1|NOT COMPLETED|Overall Study||857
7996848|NCT00095238|19691616|P2|COMPLETED|Overall Study|completed double-blind therapy|1209
7996849|NCT00095238|19691617|P1|COMPLETED|Overall Study|completed double-blind therapy|1210
7996850|NCT00095238|19691616|P2|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062
7996851|NCT00095238|19691617|P1|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064
7996852|NCT00095238|19691616|P2|STARTED|Overall Study|number randomized|2061
7996853|NCT00095238|19691617|P1|STARTED|Overall Study|number randomized|2067
7996854|NCT00095212|19691679|P2|NOT COMPLETED|Overall Study||3
7996855|NCT00095212|19691680|P1|NOT COMPLETED|Overall Study||1
7996856|NCT00095212|19691679|P2|COMPLETED|Overall Study||9
7996857|NCT00095212|19691680|P1|COMPLETED|Overall Study||12
7996858|NCT00095212|19691679|P2|STARTED|Overall Study||12
7996859|NCT00095212|19691680|P1|STARTED|Overall Study||13
7996860|NCT00095199|19691710|P4|NOT COMPLETED|Overall Study||143
7996861|NCT00095199|19691711|P3|NOT COMPLETED|Overall Study||160
7996862|NCT00095199|19691712|P2|NOT COMPLETED|Overall Study||242
7996863|NCT00095199|19691713|P1|NOT COMPLETED|Overall Study||296
7996864|NCT00095199|19691710|P4|COMPLETED|Overall Study||23
7996865|NCT00095199|19691711|P3|COMPLETED|Overall Study||7
7996866|NCT00095199|19691712|P2|COMPLETED|Overall Study||62
7996867|NCT00095199|19691713|P1|COMPLETED|Overall Study||6
7996868|NCT00095199|19691710|P4|STARTED|Overall Study||166
7996869|NCT00095199|19691711|P3|STARTED|Overall Study||167
7996870|NCT00095199|19691712|P2|STARTED|Overall Study||304
7996871|NCT00095199|19691713|P1|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302
7996872|NCT00095173|19691751|P6|NOT COMPLETED|Open-Label Extension Phase (Period C)||32
7996873|NCT00095173|19691752|P5|NOT COMPLETED|Open-Label Extension Phase (Period C)||29
7996874|NCT00095173|19691753|P4|NOT COMPLETED|Open-Label Extension Phase (Period C)||23
7996875|NCT00095173|19691754|P3|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
7996876|NCT00095173|19691755|P2|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
7996877|NCT00095173|19691756|P1|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
7996878|NCT00095173|19691751|P6|COMPLETED|Open-Label Extension Phase (Period C)||27
7996879|NCT00095173|19691752|P5|COMPLETED|Open-Label Extension Phase (Period C)||29
7996880|NCT00095173|19691753|P4|COMPLETED|Open-Label Extension Phase (Period C)||13
7996881|NCT00095173|19691754|P3|COMPLETED|Open-Label Extension Phase (Period C)||0
7996882|NCT00095173|19691755|P2|COMPLETED|Open-Label Extension Phase (Period C)||0
7996883|NCT00095173|19691756|P1|COMPLETED|Open-Label Extension Phase (Period C)||0
7996884|NCT00095173|19691751|P6|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59
7996885|NCT00095173|19691752|P5|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58
7996886|NCT00095173|19691753|P4|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36
7996887|NCT00095173|19691754|P3|STARTED|Open-Label Extension Phase (Period C)||0
7996888|NCT00095173|19691755|P2|STARTED|Open-Label Extension Phase (Period C)||0
7996889|NCT00095173|19691756|P1|STARTED|Open-Label Extension Phase (Period C)||0
7996890|NCT00095173|19691751|P6|NOT COMPLETED|Double-Blind Phase (Period B)||0
7996891|NCT00095173|19691752|P5|NOT COMPLETED|Double-Blind Phase (Period B)||0
7996892|NCT00095173|19691753|P4|NOT COMPLETED|Double-Blind Phase (Period B)||0
7996893|NCT00095173|19691754|P3|NOT COMPLETED|Double-Blind Phase (Period B)||31
7996894|NCT00095173|19691755|P2|NOT COMPLETED|Double-Blind Phase (Period B)||11
7996895|NCT00095173|19691756|P1|NOT COMPLETED|Double-Blind Phase (Period B)||0
7996896|NCT00095173|19691751|P6|COMPLETED|Double-Blind Phase (Period B)||0
7996897|NCT00095173|19691752|P5|COMPLETED|Double-Blind Phase (Period B)||0
7996898|NCT00095173|19691753|P4|COMPLETED|Double-Blind Phase (Period B)||0
7996899|NCT00095173|19691754|P3|COMPLETED|Double-Blind Phase (Period B)||31
7996900|NCT00095173|19691755|P2|COMPLETED|Double-Blind Phase (Period B)||49
7996901|NCT00095173|19691756|P1|COMPLETED|Double-Blind Phase (Period B)||0
7996902|NCT00095173|19691751|P6|STARTED|Double-Blind Phase (Period B)||0
7996903|NCT00095173|19691752|P5|STARTED|Double-Blind Phase (Period B)||0
7996904|NCT00095173|19691753|P4|STARTED|Double-Blind Phase (Period B)||0
7997063|NCT00094770|19692310|P1|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333
7996905|NCT00095173|19691754|P3|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62
7996906|NCT00095173|19691755|P2|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60
7996907|NCT00095173|19691756|P1|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0
7996908|NCT00095173|19691751|P6|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
7996909|NCT00095173|19691752|P5|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
7996910|NCT00095173|19691753|P4|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
7996911|NCT00095173|19691754|P3|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
7996912|NCT00095173|19691755|P2|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
7996913|NCT00095173|19691756|P1|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20
7996914|NCT00095173|19691751|P6|COMPLETED|Open-Label Lead-In Phase (Period A)||0
7996915|NCT00095173|19691752|P5|COMPLETED|Open-Label Lead-In Phase (Period A)||0
7996916|NCT00095173|19691753|P4|COMPLETED|Open-Label Lead-In Phase (Period A)||0
7996917|NCT00095173|19691754|P3|COMPLETED|Open-Label Lead-In Phase (Period A)||0
7996918|NCT00095173|19691755|P2|COMPLETED|Open-Label Lead-In Phase (Period A)||0
7996919|NCT00095173|19691756|P1|COMPLETED|Open-Label Lead-In Phase (Period A)||170
7996920|NCT00095173|19691751|P6|STARTED|Open-Label Lead-In Phase (Period A)||0
7996921|NCT00095173|19691752|P5|STARTED|Open-Label Lead-In Phase (Period A)||0
7996922|NCT00095173|19691753|P4|STARTED|Open-Label Lead-In Phase (Period A)||0
7996923|NCT00095173|19691754|P3|STARTED|Open-Label Lead-In Phase (Period A)||0
7996924|NCT00095173|19691755|P2|STARTED|Open-Label Lead-In Phase (Period A)||0
7996925|NCT00095173|19691756|P1|STARTED|Open-Label Lead-In Phase (Period A)||190
7996926|NCT00095147|19691794|P5|NOT COMPLETED|Long-term Extension Period||45
7996927|NCT00095147|19691795|P4|NOT COMPLETED|Long-term Extension Period||0
7996928|NCT00095147|19691796|P3|NOT COMPLETED|Long-term Extension Period||0
7996929|NCT00095147|19691797|P2|NOT COMPLETED|Long-term Extension Period||0
7996930|NCT00095147|19691798|P1|NOT COMPLETED|Long-term Extension Period||0
7996931|NCT00095147|19691794|P5|COMPLETED|Long-term Extension Period||327
7996932|NCT00095147|19691795|P4|COMPLETED|Long-term Extension Period||0
7996933|NCT00095147|19691796|P3|COMPLETED|Long-term Extension Period||0
7996934|NCT00095147|19691797|P2|COMPLETED|Long-term Extension Period||0
7996935|NCT00095147|19691798|P1|COMPLETED|Long-term Extension Period||0
7996936|NCT00095147|19691794|P5|STARTED|Long-term Extension Period||372
7996937|NCT00095147|19691795|P4|STARTED|Long-term Extension Period||0
7996938|NCT00095147|19691796|P3|STARTED|Long-term Extension Period||0
7996939|NCT00095147|19691797|P2|STARTED|Long-term Extension Period||0
7996940|NCT00095147|19691798|P1|STARTED|Long-term Extension Period||0
7996941|NCT00095147|19691794|P5|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
7996942|NCT00095147|19691795|P4|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3
7996943|NCT00095147|19691796|P3|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
7996944|NCT00095147|19691797|P2|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11
7996945|NCT00095147|19691798|P1|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8
7996946|NCT00095147|19691794|P5|COMPLETED|Double-blind Period 2 (Days 198-365)||0
7996947|NCT00095147|19691795|P4|COMPLETED|Double-blind Period 2 (Days 198-365)||104
7996948|NCT00095147|19691796|P3|COMPLETED|Double-blind Period 2 (Days 198-365)||0
7996949|NCT00095147|19691797|P2|COMPLETED|Double-blind Period 2 (Days 198-365)||141
7996950|NCT00095147|19691798|P1|COMPLETED|Double-blind Period 2 (Days 198-365)||139
7996951|NCT00095147|19691794|P5|STARTED|Double-blind Period 2 (Days 198-365)||0
7996952|NCT00095147|19691795|P4|STARTED|Double-blind Period 2 (Days 198-365)||107
7996953|NCT00095147|19691796|P3|STARTED|Double-blind Period 2 (Days 198-365)||0
7996954|NCT00095147|19691797|P2|STARTED|Double-blind Period 2 (Days 198-365)||152
7996955|NCT00095147|19691798|P1|STARTED|Double-blind Period 2 (Days 198-365)||147
7996956|NCT00095147|19691794|P5|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
7996957|NCT00095147|19691795|P4|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
7996958|NCT00095147|19691796|P3|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3
7996959|NCT00095147|19691797|P2|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13
7996960|NCT00095147|19691798|P1|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9
7996961|NCT00095147|19691794|P5|COMPLETED|Double-blind Period 1 (Days 1-197)||0
7996962|NCT00095147|19691795|P4|COMPLETED|Double-blind Period 1 (Days 1-197)||0
7996963|NCT00095147|19691796|P3|COMPLETED|Double-blind Period 1 (Days 1-197)||107
7996964|NCT00095147|19691797|P2|COMPLETED|Double-blind Period 1 (Days 1-197)||152
7996965|NCT00095147|19691798|P1|COMPLETED|Double-blind Period 1 (Days 1-197)||147
7996966|NCT00095147|19691794|P5|STARTED|Double-blind Period 1 (Days 1-197)||0
7996967|NCT00095147|19691795|P4|STARTED|Double-blind Period 1 (Days 1-197)||0
7996968|NCT00095147|19691796|P3|STARTED|Double-blind Period 1 (Days 1-197)||110
7996969|NCT00095147|19691797|P2|STARTED|Double-blind Period 1 (Days 1-197)||165
7996970|NCT00095147|19691798|P1|STARTED|Double-blind Period 1 (Days 1-197)||156
7996971|NCT00095121|19691993|P2|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19
7996972|NCT00095121|19691994|P1|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62
7996973|NCT00095121|19691993|P2|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35
7996974|NCT00095121|19691994|P1|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46
7996975|NCT00095121|19691993|P2|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11
7996976|NCT00095121|19691994|P1|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21
7996977|NCT00095121|19691993|P2|STARTED|Open-Label (Study Weeks 49 Through 240)||54
7996978|NCT00095121|19691994|P1|STARTED|Open-Label (Study Weeks 49 Through 240)||108
7996979|NCT00095121|19691993|P2|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0
7996980|NCT00095121|19691994|P1|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3
7996981|NCT00095121|19691993|P2|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58
7996982|NCT00095121|19691994|P1|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112
7996983|NCT00095121|19691993|P2|STARTED|Double-Blind (Study Weeks 0 Through 48)||58
7996984|NCT00095121|19691994|P1|STARTED|Double-Blind (Study Weeks 0 Through 48)||115
7996985|NCT00095056|19692040|P2|NOT COMPLETED|Phase B (Weeks 12-54)||5
7996986|NCT00095056|19692041|P1|NOT COMPLETED|Phase B (Weeks 12-54)||10
7996987|NCT00095056|19692040|P2|COMPLETED|Phase B (Weeks 12-54)||20
7996988|NCT00095056|19692041|P1|COMPLETED|Phase B (Weeks 12-54)||46
7996989|NCT00095056|19692040|P2|STARTED|Phase B (Weeks 12-54)||25
7996990|NCT00095056|19692041|P1|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56
7996991|NCT00095056|19692040|P2|NOT COMPLETED|Phase A (Weeks 0-12)||1
7996992|NCT00095056|19692041|P1|NOT COMPLETED|Phase A (Weeks 0-12)||7
7996993|NCT00095056|19692040|P2|COMPLETED|Phase A (Weeks 0-12)||25
7996994|NCT00095056|19692041|P1|COMPLETED|Phase A (Weeks 0-12)||58
7996995|NCT00095056|19692040|P2|STARTED|Phase A (Weeks 0-12)||26
7996996|NCT00095056|19692041|P1|STARTED|Phase A (Weeks 0-12)||65
7996997|NCT00094900|19692049|P1|NOT COMPLETED|Overall Study||1
7996998|NCT00094900|19692049|P1|COMPLETED|Overall Study||10
7996999|NCT00094900|19692049|P1|STARTED|Overall Study||11
7997000|NCT00094887|19692151|P2|NOT COMPLETED|Overall Study||4
7997001|NCT00094887|19692152|P1|NOT COMPLETED|Overall Study||4
7997002|NCT00094887|19692151|P2|COMPLETED|Overall Study||71
7997003|NCT00094887|19692152|P1|COMPLETED|Overall Study||71
7997004|NCT00094887|19692151|P2|Primary Efficacy Population|Overall Study||64
7997005|NCT00094887|19692152|P1|Primary Efficacy Population|Overall Study||65
7997006|NCT00094887|19692151|P2|Per Protocol Analysis Set|Overall Study||71
7997007|NCT00094887|19692152|P1|Per Protocol Analysis Set|Overall Study||71
7997008|NCT00094887|19692151|P2|Intent to Treat Population|Overall Study||75
7997009|NCT00094887|19692152|P1|Intent to Treat Population|Overall Study||75
7997010|NCT00094887|19692151|P2|Safety Population|Overall Study||75
7997011|NCT00094887|19692152|P1|Safety Population|Overall Study||75
7997012|NCT00094887|19692151|P2|STARTED|Overall Study||75
7997013|NCT00094887|19692152|P1|STARTED|Overall Study||75
7997014|NCT00094861|19692170|P2|NOT COMPLETED|Overall Study||9
7997015|NCT00094861|19692171|P1|NOT COMPLETED|Overall Study||18
7997016|NCT00094861|19692170|P2|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40
7997017|NCT00094861|19692171|P1|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28
7997018|NCT00094861|19692170|P2|Participants Treated|Overall Study||48
7997019|NCT00094861|19692171|P1|Participants Treated|Overall Study||46
7997020|NCT00094861|19692170|P2|STARTED|Overall Study||49
7997021|NCT00094861|19692171|P1|STARTED|Overall Study||46
7997022|NCT00094835|19692198|P7|NOT COMPLETED|Overall Study||2
7997023|NCT00094835|19692199|P6|NOT COMPLETED|Overall Study||3
7997024|NCT00094835|19692200|P5|NOT COMPLETED|Overall Study||4
7997025|NCT00094835|19692201|P4|NOT COMPLETED|Overall Study||1
7997026|NCT00094835|19692202|P3|NOT COMPLETED|Overall Study||3
7997027|NCT00094835|19692203|P2|NOT COMPLETED|Overall Study||3
7997028|NCT00094835|19692204|P1|NOT COMPLETED|Overall Study||4
7997029|NCT00094835|19692198|P7|COMPLETED|Overall Study||4
7997030|NCT00094835|19692199|P6|COMPLETED|Overall Study||3
7997031|NCT00094835|19692200|P5|COMPLETED|Overall Study||3
7997032|NCT00094835|19692201|P4|COMPLETED|Overall Study||4
7997033|NCT00094835|19692202|P3|COMPLETED|Overall Study||4
7997034|NCT00094835|19692203|P2|COMPLETED|Overall Study||8
7997035|NCT00094835|19692204|P1|COMPLETED|Overall Study||5
7997036|NCT00094835|19692198|P7|Treated With Motesanib|Overall Study||6
7997037|NCT00094835|19692199|P6|Treated With Motesanib|Overall Study||5
7997038|NCT00094835|19692200|P5|Treated With Motesanib|Overall Study||7
7997039|NCT00094835|19692201|P4|Treated With Motesanib|Overall Study||4
7997040|NCT00094835|19692202|P3|Treated With Motesanib|Overall Study||6
7997041|NCT00094835|19692203|P2|Treated With Motesanib|Overall Study||11
7997042|NCT00094835|19692204|P1|Treated With Motesanib|Overall Study||6
7997043|NCT00094835|19692198|P7|STARTED|Overall Study||6
7997044|NCT00094835|19692199|P6|STARTED|Overall Study||6
7997045|NCT00094835|19692200|P5|STARTED|Overall Study||7
7997046|NCT00094835|19692201|P4|STARTED|Overall Study||5
7997047|NCT00094835|19692202|P3|STARTED|Overall Study||7
7997048|NCT00094835|19692203|P2|STARTED|Overall Study||11
7997049|NCT00094835|19692204|P1|STARTED|Overall Study||9
7997050|NCT00094809|19692282|P2|NOT COMPLETED|Overall Study||65
7997051|NCT00094809|19692283|P1|NOT COMPLETED|Overall Study||52
7997052|NCT00094809|19692282|P2|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61
7997053|NCT00094809|19692283|P1|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74
7997054|NCT00094809|19692282|P2|Completed All 4 Cycles of Treatment|Overall Study||90
7997055|NCT00094809|19692283|P1|Completed All 4 Cycles of Treatment|Overall Study||98
7997056|NCT00094809|19692282|P2|Properly Consented; Received Study Drug|Overall Study||118
7997057|NCT00094809|19692283|P1|Properly Consented; Received Study Drug|Overall Study||123
7997058|NCT00094809|19692282|P2|Received Study Drug|Overall Study||118
7997059|NCT00094809|19692283|P1|Received Study Drug|Overall Study||124
7997060|NCT00094809|19692282|P2|STARTED|Overall Study||126
7997061|NCT00094809|19692283|P1|STARTED|Overall Study||126
7997062|NCT00094770|19692309|P2|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320
7997064|NCT00094770|19692309|P2|COMPLETED|Year 2 (Week 0 to Week 104)||264
7997065|NCT00094770|19692310|P1|COMPLETED|Year 2 (Week 0 to Week 104)||255
7997066|NCT00094770|19692309|P2|STARTED|Year 2 (Week 0 to Week 104)||584
7997067|NCT00094770|19692310|P1|STARTED|Year 2 (Week 0 to Week 104)||588
7997068|NCT00094770|19692309|P2|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172
7997069|NCT00094770|19692310|P1|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202
7997070|NCT00094770|19692309|P2|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412
7997071|NCT00094770|19692310|P1|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386
7997072|NCT00094770|19692309|P2|STARTED|Year 1 ( Week 0 to Week 52)||584
7997073|NCT00094770|19692310|P1|STARTED|Year 1 ( Week 0 to Week 52)||588
7997074|NCT00094757|19692341|P3|NOT COMPLETED|Overall Study||30
7997075|NCT00094757|19692342|P2|NOT COMPLETED|Overall Study||62
7997076|NCT00094757|19692343|P1|NOT COMPLETED|Overall Study||53
7997077|NCT00094757|19692341|P3|COMPLETED|Overall Study||80
7997078|NCT00094757|19692342|P2|COMPLETED|Overall Study||144
7997079|NCT00094757|19692343|P1|COMPLETED|Overall Study||152
7997080|NCT00094757|19692341|P3|STARTED|Overall Study||110
7997081|NCT00094757|19692342|P2|STARTED|Overall Study||206
7997082|NCT00094757|19692343|P1|STARTED|Overall Study||205
7997083|NCT00094653|19692363|P3|NOT COMPLETED|Overall Study||126
7997084|NCT00094653|19692364|P2|NOT COMPLETED|Overall Study||106
7997085|NCT00094653|19692365|P1|NOT COMPLETED|Overall Study||321
7997086|NCT00094653|19692363|P3|COMPLETED|Overall Study||10
7997087|NCT00094653|19692364|P2|COMPLETED|Overall Study||31
7997088|NCT00094653|19692365|P1|COMPLETED|Overall Study||82
7997089|NCT00094653|19692363|P3|Treated|Overall Study||131
7997090|NCT00094653|19692364|P2|Treated|Overall Study||131
7997091|NCT00094653|19692365|P1|Treated|Overall Study||381
7997092|NCT00094653|19692363|P3|STARTED|Overall Study||136
7997093|NCT00094653|19692364|P2|STARTED|Overall Study||137
7997094|NCT00094653|19692365|P1|STARTED|Overall Study||403
7997095|NCT00094575|19692428|P2|NOT COMPLETED|Overall Study||146
7997096|NCT00094575|19692429|P1|NOT COMPLETED|Overall Study||146
7997097|NCT00094575|19692428|P2|COMPLETED|Overall Study||291
7997098|NCT00094575|19692429|P1|COMPLETED|Overall Study||298
7997099|NCT00094575|19692428|P2|STARTED|Overall Study||437
7997100|NCT00094575|19692429|P1|STARTED|Overall Study||444
7997101|NCT00094536|19692449|P1|NOT COMPLETED|Treatment and Follow-up||31
7997102|NCT00094536|19692449|P1|COMPLETED|Treatment and Follow-up|51 subjects successfully completed the study.|51
7997103|NCT00094536|19692449|P1|36 Month Follow-up|Treatment and Follow-up||51
7997104|NCT00094536|19692449|P1|24 Month Follow-up|Treatment and Follow-up||53
7997105|NCT00094536|19692449|P1|12 Month Follow-up|Treatment and Follow-up|69 subjects were evaluated at 1-year post-treatment for the primary endpoint of success.|69
7997106|NCT00094536|19692449|P1|STARTED|Treatment and Follow-up|82 subjects qualified for and underwent the study treatment.|82
7997107|NCT00094536|19692449|P1|NOT COMPLETED|Inclusion Exclusion Evaluation||24
7997108|NCT00094536|19692449|P1|COMPLETED|Inclusion Exclusion Evaluation||82
7997109|NCT00094536|19692449|P1|STARTED|Inclusion Exclusion Evaluation||106
7997110|NCT00094497|19692455|P2|NOT COMPLETED|Overall Study||0
7997111|NCT00094497|19692456|P1|NOT COMPLETED|Overall Study||0
7997112|NCT00094497|19692455|P2|COMPLETED|Overall Study||153
7997113|NCT00094497|19692456|P1|COMPLETED|Overall Study||151
7997114|NCT00094497|19692455|P2|Received Second Line Therapy|Overall Study||101
7997115|NCT00094497|19692456|P1|Received Second Line Therapy|Overall Study||84
7997116|NCT00094497|19692455|P2|Treated|Overall Study||149
7997117|NCT00094497|19692456|P1|Treated|Overall Study||148
7997118|NCT00094497|19692455|P2|STARTED|Overall Study||153
7997119|NCT00094497|19692456|P1|STARTED|Overall Study||151
7997120|NCT00094458|19692473|P6|NOT COMPLETED|OLE: Open-Label Extension||4
7997121|NCT00094458|19692474|P5|NOT COMPLETED|OLE: Open-Label Extension||5
7997122|NCT00094458|19692475|P4|NOT COMPLETED|OLE: Open-Label Extension||1
7997123|NCT00094458|19692476|P3|NOT COMPLETED|OLE: Open-Label Extension||0
7997124|NCT00094458|19692477|P2|NOT COMPLETED|OLE: Open-Label Extension||0
7997125|NCT00094458|19692478|P1|NOT COMPLETED|OLE: Open-Label Extension||0
7997126|NCT00094458|19692473|P6|COMPLETED|OLE: Open-Label Extension||13
7997127|NCT00094458|19692474|P5|COMPLETED|OLE: Open-Label Extension||13
7997128|NCT00094458|19692475|P4|COMPLETED|OLE: Open-Label Extension||7
7997129|NCT00094458|19692476|P3|COMPLETED|OLE: Open-Label Extension||0
7997130|NCT00094458|19692477|P2|COMPLETED|OLE: Open-Label Extension||0
7997131|NCT00094458|19692478|P1|COMPLETED|OLE: Open-Label Extension||0
7997132|NCT00094458|19692473|P6|STARTED|OLE: Open-Label Extension||17
7997133|NCT00094458|19692474|P5|STARTED|OLE: Open-Label Extension||18
7997134|NCT00094458|19692475|P4|STARTED|OLE: Open-Label Extension||8
7997135|NCT00094458|19692476|P3|STARTED|OLE: Open-Label Extension||0
7997136|NCT00094458|19692477|P2|STARTED|OLE: Open-Label Extension||0
7997137|NCT00094458|19692478|P1|STARTED|OLE: Open-Label Extension||0
7997138|NCT00094458|19692473|P6|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
7997139|NCT00094458|19692474|P5|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
7997140|NCT00094458|19692475|P4|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
7997141|NCT00094458|19692476|P3|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18
7997142|NCT00094458|19692477|P2|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12
7997143|NCT00094458|19692478|P1|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8
7997144|NCT00094458|19692473|P6|COMPLETED|Study Extension: Week 30 Through Week 50||0
7997145|NCT00094458|19692474|P5|COMPLETED|Study Extension: Week 30 Through Week 50||0
7997146|NCT00094458|19692475|P4|COMPLETED|Study Extension: Week 30 Through Week 50||0
7997147|NCT00094458|19692476|P3|COMPLETED|Study Extension: Week 30 Through Week 50||90
7997148|NCT00094458|19692477|P2|COMPLETED|Study Extension: Week 30 Through Week 50||85
7997149|NCT00094458|19692478|P1|COMPLETED|Study Extension: Week 30 Through Week 50||67
7997150|NCT00094458|19692473|P6|STARTED|Study Extension: Week 30 Through Week 50||0
7997151|NCT00094458|19692474|P5|STARTED|Study Extension: Week 30 Through Week 50||0
7997152|NCT00094458|19692475|P4|STARTED|Study Extension: Week 30 Through Week 50||0
7997153|NCT00094458|19692476|P3|STARTED|Study Extension: Week 30 Through Week 50||108
7997154|NCT00094458|19692477|P2|STARTED|Study Extension: Week 30 Through Week 50||97
7997155|NCT00094458|19692478|P1|STARTED|Study Extension: Week 30 Through Week 50||75
7997156|NCT00094458|19692473|P6|NOT COMPLETED|Main Study: Through Week 30||0
7997157|NCT00094458|19692474|P5|NOT COMPLETED|Main Study: Through Week 30||0
7997158|NCT00094458|19692475|P4|NOT COMPLETED|Main Study: Through Week 30||0
7997159|NCT00094458|19692476|P3|NOT COMPLETED|Main Study: Through Week 30||48
7997160|NCT00094458|19692477|P2|NOT COMPLETED|Main Study: Through Week 30||58
7997161|NCT00094458|19692478|P1|NOT COMPLETED|Main Study: Through Week 30||84
7997162|NCT00094458|19692473|P6|COMPLETED|Main Study: Through Week 30||0
7997163|NCT00094458|19692474|P5|COMPLETED|Main Study: Through Week 30||0
7997164|NCT00094458|19692475|P4|COMPLETED|Main Study: Through Week 30||0
7997165|NCT00094458|19692476|P3|COMPLETED|Main Study: Through Week 30||121
7997166|NCT00094458|19692477|P2|COMPLETED|Main Study: Through Week 30||111
7997167|NCT00094458|19692478|P1|COMPLETED|Main Study: Through Week 30||86
7997168|NCT00094458|19692473|P6|STARTED|Main Study: Through Week 30||0
7997169|NCT00094458|19692474|P5|STARTED|Main Study: Through Week 30||0
7997170|NCT00094458|19692475|P4|STARTED|Main Study: Through Week 30||0
7997171|NCT00094458|19692476|P3|STARTED|Main Study: Through Week 30||169
7997172|NCT00094458|19692477|P2|STARTED|Main Study: Through Week 30||169
7997173|NCT00094458|19692478|P1|STARTED|Main Study: Through Week 30||170
7997174|NCT00094445|19692516|P1|NOT COMPLETED|Overall Study||6
7997175|NCT00094445|19692516|P1|COMPLETED|Overall Study||44
7997176|NCT00094445|19692516|P1|STARTED|Overall Study||50
7997177|NCT00094328|19692520|P1|NOT COMPLETED|Overall Study||1
7997178|NCT00094328|19692520|P1|COMPLETED|Overall Study|Completed 12 months on treatment|13
7997179|NCT00094328|19692520|P1|STARTED|Overall Study|Received treatment|14
7997180|NCT00094302|19692534|P2|NOT COMPLETED|Overall Study||406
7997181|NCT00094302|19692535|P1|NOT COMPLETED|Overall Study||417
7997182|NCT00094302|19692534|P2|COMPLETED|Overall Study||1316
7997183|NCT00094302|19692535|P1|COMPLETED|Overall Study||1306
7997184|NCT00094302|19692534|P2|STARTED|Overall Study||1722
7997185|NCT00094302|19692535|P1|STARTED|Overall Study||1723
7997186|NCT00094211|19692593|P4|NOT COMPLETED|Overall Study||7
7997187|NCT00094211|19692594|P3|NOT COMPLETED|Overall Study||10
7997188|NCT00094211|19692595|P2|NOT COMPLETED|Overall Study||8
7997189|NCT00094211|19692596|P1|NOT COMPLETED|Overall Study||9
7997190|NCT00094211|19692593|P4|COMPLETED|Overall Study||179
7997191|NCT00094211|19692594|P3|COMPLETED|Overall Study||220
7997192|NCT00094211|19692595|P2|COMPLETED|Overall Study||251
7997193|NCT00094211|19692596|P1|COMPLETED|Overall Study||212
7997194|NCT00094211|19692593|P4|STARTED|Overall Study||186
7997195|NCT00094211|19692594|P3|STARTED|Overall Study||230
7997196|NCT00094211|19692595|P2|STARTED|Overall Study||259
7997197|NCT00094211|19692596|P1|STARTED|Overall Study||221
7997198|NCT00094172|19692624|P2|NOT COMPLETED|Overall Study||7
7997199|NCT00094172|19692625|P1|NOT COMPLETED|Overall Study||14
7997200|NCT00094172|19692624|P2|COMPLETED|Overall Study||25
7997201|NCT00094172|19692625|P1|COMPLETED|Overall Study||36
7997202|NCT00094172|19692624|P2|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32
7997203|NCT00094172|19692625|P1|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50
7997204|NCT00094107|19692635|P1|NOT COMPLETED|Overall Study||32
7997205|NCT00094107|19692635|P1|COMPLETED|Overall Study||0
7997206|NCT00094107|19692635|P1|STARTED|Overall Study||32
7997207|NCT00094094|19692644|P1|NOT COMPLETED|Overall Study||32
7997208|NCT00094094|19692644|P1|COMPLETED|Overall Study||0
7997209|NCT00094094|19692644|P1|STARTED|Overall Study||32
7997210|NCT00094055|19692653|P1|NOT COMPLETED|Overall Study||60
7997211|NCT00094055|19692653|P1|COMPLETED|Overall Study||0
7997212|NCT00094055|19692653|P1|STARTED|Overall Study||60
7997213|NCT00093964|19692664|P2|NOT COMPLETED|Overall Study||0
7997214|NCT00093964|19692665|P1|NOT COMPLETED|Overall Study||0
7997215|NCT00093964|19692664|P2|COMPLETED|Overall Study||40
7997216|NCT00093964|19692665|P1|COMPLETED|Overall Study||41
7997217|NCT00093964|19692664|P2|STARTED|Overall Study||40
7997218|NCT00093964|19692665|P1|STARTED|Overall Study||41
7997219|NCT00093847|19692701|P2|NOT COMPLETED|Overall Study||10
7997220|NCT00093847|19692702|P1|NOT COMPLETED|Overall Study||8
7997221|NCT00093847|19692701|P2|COMPLETED|Overall Study||24
7997222|NCT00093847|19692702|P1|COMPLETED|Overall Study||31
7997223|NCT00093847|19692701|P2|STARTED|Overall Study||34
7997224|NCT00093847|19692702|P1|STARTED|Overall Study||39
7997225|NCT00093808|19692710|P1|NOT COMPLETED|Overall Study||2
7997226|NCT00093808|19692710|P1|COMPLETED|Overall Study||45
7997227|NCT00093808|19692710|P1|STARTED|Overall Study||47
7997228|NCT00093795|19692720|P3|NOT COMPLETED|Overall Study||17
7997229|NCT00093795|19692721|P2|NOT COMPLETED|Overall Study||16
7997230|NCT00093795|19692722|P1|NOT COMPLETED|Overall Study||20
7997231|NCT00093795|19692720|P3|COMPLETED|Overall Study||1613
7997232|NCT00093795|19692721|P2|COMPLETED|Overall Study||1618
7997233|NCT00093795|19692722|P1|COMPLETED|Overall Study||1610
7997234|NCT00093795|19692720|P3|STARTED|Overall Study||1630
7997235|NCT00093795|19692721|P2|STARTED|Overall Study||1634
7997236|NCT00093795|19692722|P1|STARTED|Overall Study||1630
7997237|NCT00093782|19692742|P1|NOT COMPLETED|Overall Study||0
7997238|NCT00093782|19692742|P1|COMPLETED|Overall Study||36
7997239|NCT00093782|19692742|P1|STARTED|Overall Study||36
7997240|NCT00093756|19692754|P2|NOT COMPLETED|Overall Study||0
7997241|NCT00093756|19692755|P1|NOT COMPLETED|Overall Study||0
7997242|NCT00093756|19692754|P2|COMPLETED|Overall Study||21
7997243|NCT00093756|19692755|P1|COMPLETED|Overall Study||27
7997244|NCT00093756|19692754|P2|STARTED|Overall Study||21
7997245|NCT00093756|19692755|P1|STARTED|Overall Study||27
7997246|NCT00093496|19692767|P2|NOT COMPLETED|Overall Study||3
7997247|NCT00093496|19692768|P1|NOT COMPLETED|Overall Study||1
7997248|NCT00093496|19692767|P2|COMPLETED|Overall Study||11
7997249|NCT00093496|19692768|P1|COMPLETED|Overall Study||14
7997250|NCT00093496|19692767|P2|STARTED|Overall Study||14
7997251|NCT00093496|19692768|P1|STARTED|Overall Study||15
7997252|NCT00093470|19692781|P2|NOT COMPLETED|Overall Study||0
7997253|NCT00093470|19692782|P1|NOT COMPLETED|Overall Study||73
7997254|NCT00093470|19692781|P2|COMPLETED|Overall Study|Patients underwent observation only.|71
7997255|NCT00093470|19692782|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
7997256|NCT00093470|19692781|P2|Patients With Toxicity Assessment|Overall Study||69
7997257|NCT00093470|19692782|P1|Patients With Toxicity Assessment|Overall Study||72
7997258|NCT00093470|19692781|P2|Treated|Overall Study||71
7997259|NCT00093470|19692782|P1|Treated|Overall Study||72
7997260|NCT00093470|19692781|P2|STARTED|Overall Study||71
7997261|NCT00093470|19692782|P1|STARTED|Overall Study||73
7997262|NCT00093379|19692790|P1|NOT COMPLETED|Overall Study||0
7997263|NCT00093379|19692790|P1|COMPLETED|Overall Study||20
7997264|NCT00093379|19692790|P1|STARTED|Overall Study||20
7997265|NCT00093145|19692796|P1|NOT COMPLETED|Overall Study||17
7997266|NCT00093145|19692796|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|15
7997267|NCT00093145|19692796|P1|At Least One Response Assessment|Overall Study||31
7997268|NCT00093145|19692796|P1|STARTED|Overall Study||32
7997269|NCT00093041|19692811|P6|NOT COMPLETED|Overall Study||3
7997270|NCT00093041|19692812|P5|NOT COMPLETED|Overall Study||1
7997271|NCT00093041|19692813|P4|NOT COMPLETED|Overall Study||1
7997272|NCT00093041|19692814|P3|NOT COMPLETED|Overall Study||2
7997273|NCT00093041|19692815|P2|NOT COMPLETED|Overall Study||3
7997274|NCT00093041|19692816|P1|NOT COMPLETED|Overall Study||2
7997275|NCT00093041|19692811|P6|COMPLETED|Overall Study|Three discontinued during multiple dose period|4
7997276|NCT00093041|19692812|P5|COMPLETED|Overall Study|One discontinued during multiple dose period|3
7997277|NCT00093041|19692813|P4|COMPLETED|Overall Study|One discontinued during single dose period|3
7997278|NCT00093041|19692814|P3|COMPLETED|Overall Study|Two discontinued during single dose period|3
7997279|NCT00093041|19692815|P2|COMPLETED|Overall Study|Three discontinued during single dose period|1
7997280|NCT00093041|19692816|P1|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2
7997281|NCT00093041|19692811|P6|STARTED|Overall Study||7
7997282|NCT00093041|19692812|P5|STARTED|Overall Study||4
7997283|NCT00093041|19692813|P4|STARTED|Overall Study||4
7997284|NCT00093041|19692814|P3|STARTED|Overall Study||5
7997285|NCT00093041|19692815|P2|STARTED|Overall Study||4
7997286|NCT00093041|19692816|P1|STARTED|Overall Study||4
7997287|NCT00093015|19692838|P2|NOT COMPLETED|Overall Study||664
7997288|NCT00093015|19692839|P1|NOT COMPLETED|Overall Study||665
7997289|NCT00093015|19692838|P2|COMPLETED|Overall Study||1348
7997290|NCT00093015|19692839|P1|COMPLETED|Overall Study||1361
7997291|NCT00093015|19692838|P2|Received Study Medication|Overall Study||2004
7997292|NCT00093015|19692839|P1|Received Study Medication|Overall Study||2019
7997293|NCT00093015|19692838|P2|STARTED|Overall Study||2012
7997294|NCT00093015|19692839|P1|STARTED|Overall Study||2026
7997295|NCT00092677|19692867|P2|NOT COMPLETED|Overall Study||11
7997296|NCT00092677|19692868|P1|NOT COMPLETED|Overall Study||5
7997297|NCT00092677|19692867|P2|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918
7997298|NCT00092677|19692868|P1|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939
7997299|NCT00092677|19692867|P2|STARTED|Overall Study||929
7997300|NCT00092677|19692868|P1|STARTED|Overall Study||944
7997301|NCT00092547|19692912|P3|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
7997302|NCT00092547|19692913|P2|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
7997303|NCT00092547|19692914|P1|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
7997304|NCT00092547|19692912|P3|COMPLETED|Long-term Follow-up (Month 126 Visit)||211
7997305|NCT00092547|19692913|P2|COMPLETED|Long-term Follow-up (Month 126 Visit)||0
7997306|NCT00092547|19692914|P1|COMPLETED|Long-term Follow-up (Month 126 Visit)||454
7997307|NCT00092547|19692912|P3|STARTED|Long-term Follow-up (Month 126 Visit)||211
7997308|NCT00092547|19692913|P2|STARTED|Long-term Follow-up (Month 126 Visit)||0
7997309|NCT00092547|19692914|P1|STARTED|Long-term Follow-up (Month 126 Visit)||454
7997310|NCT00092547|19692912|P3|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
7997311|NCT00092547|19692913|P2|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
7997312|NCT00092547|19692914|P1|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
7997313|NCT00092547|19692912|P3|COMPLETED|Long-term Follow-up (Month 96 Visit)||267
7997314|NCT00092547|19692913|P2|COMPLETED|Long-term Follow-up (Month 96 Visit)||0
7997315|NCT00092547|19692914|P1|COMPLETED|Long-term Follow-up (Month 96 Visit)||508
7997316|NCT00092547|19692912|P3|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267
7997317|NCT00092547|19692913|P2|STARTED|Long-term Follow-up (Month 96 Visit)||0
7997318|NCT00092547|19692914|P1|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508
7997319|NCT00092547|19692912|P3|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
7997320|NCT00092547|19692913|P2|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
7997321|NCT00092547|19692914|P1|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
7997322|NCT00092547|19692912|P3|COMPLETED|Long-term Follow-up (Month 72 Visit)||276
7997323|NCT00092547|19692913|P2|COMPLETED|Long-term Follow-up (Month 72 Visit)||0
7997324|NCT00092547|19692914|P1|COMPLETED|Long-term Follow-up (Month 72 Visit)||550
7997325|NCT00092547|19692912|P3|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276
7997326|NCT00092547|19692913|P2|STARTED|Long-term Follow-up (Month 72 Visit)||0
7997327|NCT00092547|19692914|P1|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550
7997328|NCT00092547|19692912|P3|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
7997329|NCT00092547|19692913|P2|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
7997330|NCT00092547|19692914|P1|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1
7997331|NCT00092547|19692912|P3|COMPLETED|Long-term Follow-up (Month 42 Visit)||308
7997332|NCT00092547|19692913|P2|COMPLETED|Long-term Follow-up (Month 42 Visit)||0
7997333|NCT00092547|19692914|P1|COMPLETED|Long-term Follow-up (Month 42 Visit)||611
7997334|NCT00092547|19692912|P3|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308
7997335|NCT00092547|19692913|P2|STARTED|Long-term Follow-up (Month 42 Visit)||0
7997336|NCT00092547|19692914|P1|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612
7997337|NCT00092547|19692912|P3|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16
7997338|NCT00092547|19692913|P2|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
7997339|NCT00092547|19692914|P1|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23
7997340|NCT00092547|19692912|P3|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469
7997341|NCT00092547|19692913|P2|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
7997342|NCT00092547|19692914|P1|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933
7997343|NCT00092547|19692912|P3|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482
7997344|NCT00092547|19692913|P2|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
7997345|NCT00092547|19692914|P1|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
7997346|NCT00092547|19692912|P3|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485
7997347|NCT00092547|19692913|P2|STARTED|Extension Vaccine Phase (Month 30 to 37)||0
7997348|NCT00092547|19692914|P1|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956
7997349|NCT00092547|19692912|P3|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
7997350|NCT00092547|19692913|P2|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5
7997351|NCT00092547|19692914|P1|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8
7997352|NCT00092547|19692912|P3|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
7997353|NCT00092547|19692913|P2|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485
7997354|NCT00092547|19692914|P1|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956
7997355|NCT00092547|19692912|P3|STARTED|Base Follow-up Phase (Month 18 to 30)||0
7997356|NCT00092547|19692913|P2|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490
7997357|NCT00092547|19692914|P1|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964
7997358|NCT00092547|19692912|P3|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
7997359|NCT00092547|19692913|P2|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14
7997360|NCT00092547|19692914|P1|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20
7997361|NCT00092547|19692912|P3|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
7997362|NCT00092547|19692913|P2|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551
7997363|NCT00092547|19692914|P1|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108
7997364|NCT00092547|19692912|P3|STARTED|Base Follow-up Phase (Month 7 to 18)||0
7997365|NCT00092547|19692913|P2|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565
7997366|NCT00092547|19692914|P1|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128
7997367|NCT00092547|19692912|P3|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
7997368|NCT00092547|19692913|P2|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36
7997369|NCT00092547|19692914|P1|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63
7997370|NCT00092547|19692912|P3|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
7997371|NCT00092547|19692913|P2|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561
7997372|NCT00092547|19692914|P1|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121
7997373|NCT00092547|19692912|P3|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0
7997374|NCT00092547|19692913|P2|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596
7997375|NCT00092547|19692914|P1|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179
7997376|NCT00092547|19692912|P3|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0
7997377|NCT00092547|19692913|P2|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597
7997378|NCT00092547|19692914|P1|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184
7997379|NCT00092534|19692958|P5|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
7997380|NCT00092534|19692959|P4|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||1
7997381|NCT00092534|19692960|P3|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
7997382|NCT00092534|19692961|P2|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
7997383|NCT00092534|19692962|P1|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
7997384|NCT00092534|19692958|P5|COMPLETED|Long-Term Follow-Up (LTFU) Study||2097
7997385|NCT00092534|19692959|P4|COMPLETED|Long-Term Follow-Up (LTFU) Study||2749
7997386|NCT00092534|19692960|P3|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
7997387|NCT00092534|19692961|P2|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
7997388|NCT00092534|19692962|P1|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
7997389|NCT00092534|19692958|P5|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||1888
7997390|NCT00092534|19692959|P4|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||2448
7997391|NCT00092534|19692960|P3|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
7997392|NCT00092534|19692961|P2|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
7997393|NCT00092534|19692962|P1|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
7997394|NCT00092534|19692958|P5|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||1849
7997395|NCT00092534|19692959|P4|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||2385
7997396|NCT00092534|19692960|P3|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
7997397|NCT00092534|19692961|P2|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
7997398|NCT00092534|19692962|P1|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
7997399|NCT00092534|19692958|P5|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2050
7997400|NCT00092534|19692959|P4|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2650
7997401|NCT00092534|19692960|P3|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
7997402|NCT00092534|19692961|P2|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
7997403|NCT00092534|19692962|P1|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
7997404|NCT00092534|19692958|P5|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2097
7997405|NCT00092534|19692959|P4|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2750
7997406|NCT00092534|19692960|P3|STARTED|Long-Term Follow-Up (LTFU) Study||0
7997407|NCT00092534|19692961|P2|STARTED|Long-Term Follow-Up (LTFU) Study||0
7997408|NCT00092534|19692962|P1|STARTED|Long-Term Follow-Up (LTFU) Study||0
7997409|NCT00092534|19692958|P5|NOT COMPLETED|Base Study EXT||0
7997410|NCT00092534|19692959|P4|NOT COMPLETED|Base Study EXT||0
7997411|NCT00092534|19692960|P3|NOT COMPLETED|Base Study EXT||145
7997412|NCT00092534|19692961|P2|NOT COMPLETED|Base Study EXT||0
7997413|NCT00092534|19692962|P1|NOT COMPLETED|Base Study EXT||0
7997414|NCT00092534|19692958|P5|COMPLETED|Base Study EXT||0
7997415|NCT00092534|19692959|P4|COMPLETED|Base Study EXT||0
7997416|NCT00092534|19692960|P3|COMPLETED|Base Study EXT||449
7997417|NCT00092534|19692961|P2|COMPLETED|Base Study EXT||0
7997418|NCT00092534|19692962|P1|COMPLETED|Base Study EXT||0
7997419|NCT00092534|19692958|P5|STARTED|Base Study EXT||0
7997420|NCT00092534|19692959|P4|STARTED|Base Study EXT||0
7997421|NCT00092534|19692960|P3|STARTED|Base Study EXT||594
7997422|NCT00092534|19692961|P2|STARTED|Base Study EXT||0
7997423|NCT00092534|19692962|P1|STARTED|Base Study EXT||0
7997424|NCT00092534|19692958|P5|NOT COMPLETED|Base Study Follow-Up Period||0
7997425|NCT00092534|19692959|P4|NOT COMPLETED|Base Study Follow-Up Period||0
7997426|NCT00092534|19692960|P3|NOT COMPLETED|Base Study Follow-Up Period||0
7997427|NCT00092534|19692961|P2|NOT COMPLETED|Base Study Follow-Up Period||694
7997428|NCT00092534|19692962|P1|NOT COMPLETED|Base Study Follow-Up Period||316
7997429|NCT00092534|19692958|P5|COMPLETED|Base Study Follow-Up Period||0
7997430|NCT00092534|19692959|P4|COMPLETED|Base Study Follow-Up Period||0
7997431|NCT00092534|19692960|P3|COMPLETED|Base Study Follow-Up Period||0
7997432|NCT00092534|19692961|P2|COMPLETED|Base Study Follow-Up Period||5277
7997433|NCT00092534|19692962|P1|COMPLETED|Base Study Follow-Up Period||5626
7997434|NCT00092534|19692958|P5|STARTED|Base Study Follow-Up Period||0
7997435|NCT00092534|19692959|P4|STARTED|Base Study Follow-Up Period||0
7997436|NCT00092534|19692960|P3|STARTED|Base Study Follow-Up Period||0
7997437|NCT00092534|19692961|P2|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971
7997438|NCT00092534|19692962|P1|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942
7997439|NCT00092534|19692958|P5|NOT COMPLETED|Base Study Vaccination Period||0
7997440|NCT00092534|19692959|P4|NOT COMPLETED|Base Study Vaccination Period||0
7997441|NCT00092534|19692960|P3|NOT COMPLETED|Base Study Vaccination Period||0
7997442|NCT00092534|19692961|P2|NOT COMPLETED|Base Study Vaccination Period||126
7997443|NCT00092534|19692962|P1|NOT COMPLETED|Base Study Vaccination Period||171
7997444|NCT00092534|19692958|P5|COMPLETED|Base Study Vaccination Period||0
7997445|NCT00092534|19692959|P4|COMPLETED|Base Study Vaccination Period||0
7997446|NCT00092534|19692960|P3|COMPLETED|Base Study Vaccination Period||0
7997447|NCT00092534|19692961|P2|COMPLETED|Base Study Vaccination Period||5954
7997448|NCT00092534|19692962|P1|COMPLETED|Base Study Vaccination Period||5916
7997449|NCT00092534|19692958|P5|STARTED|Base Study Vaccination Period||0
7997450|NCT00092534|19692959|P4|STARTED|Base Study Vaccination Period||0
7997451|NCT00092534|19692960|P3|STARTED|Base Study Vaccination Period||0
7997452|NCT00092534|19692961|P2|STARTED|Base Study Vaccination Period||6080
7997453|NCT00092534|19692962|P1|STARTED|Base Study Vaccination Period||6087
7997454|NCT00092521|19692993|P4|NOT COMPLETED|Extension Study (Group 4)||209
7997455|NCT00092521|19692994|P3|NOT COMPLETED|Extension Study (Group 4)||0
7997456|NCT00092521|19692995|P2|NOT COMPLETED|Extension Study (Group 4)||0
7997457|NCT00092521|19692996|P1|NOT COMPLETED|Extension Study (Group 4)||0
7997458|NCT00092521|19692993|P4|COMPLETED|Extension Study (Group 4)||635
7997459|NCT00092521|19692994|P3|COMPLETED|Extension Study (Group 4)||0
7997460|NCT00092521|19692995|P2|COMPLETED|Extension Study (Group 4)||0
7997461|NCT00092521|19692996|P1|COMPLETED|Extension Study (Group 4)||0
7997462|NCT00092521|19692993|P4|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801
7997463|NCT00092521|19692994|P3|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
7997464|NCT00092521|19692995|P2|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
7997465|NCT00092521|19692996|P1|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
7997466|NCT00092521|19692993|P4|Initiated Extension Study|Extension Study (Group 4)||829
7997467|NCT00092521|19692994|P3|Initiated Extension Study|Extension Study (Group 4)||0
7997468|NCT00092521|19692995|P2|Initiated Extension Study|Extension Study (Group 4)||0
7997469|NCT00092521|19692996|P1|Initiated Extension Study|Extension Study (Group 4)||0
7997470|NCT00092521|19692993|P4|STARTED|Extension Study (Group 4)||844
7997471|NCT00092521|19692994|P3|STARTED|Extension Study (Group 4)||0
7997472|NCT00092521|19692995|P2|STARTED|Extension Study (Group 4)||0
7997473|NCT00092521|19692996|P1|STARTED|Extension Study (Group 4)||0
7997474|NCT00092521|19692993|P4|NOT COMPLETED|Follow-Up (After Month 7)||0
7997475|NCT00092521|19692994|P3|NOT COMPLETED|Follow-Up (After Month 7)||648
7997476|NCT00092521|19692995|P2|NOT COMPLETED|Follow-Up (After Month 7)||136
7997477|NCT00092521|19692996|P1|NOT COMPLETED|Follow-Up (After Month 7)||246
7997478|NCT00092521|19692993|P4|COMPLETED|Follow-Up (After Month 7)||0
7997479|NCT00092521|19692994|P3|COMPLETED|Follow-Up (After Month 7)||1959
7997480|NCT00092521|19692995|P2|COMPLETED|Follow-Up (After Month 7)||155
7997481|NCT00092521|19692996|P1|COMPLETED|Follow-Up (After Month 7)||2353
7997482|NCT00092521|19692993|P4|STARTED|Follow-Up (After Month 7)||0
7997483|NCT00092521|19692994|P3|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607
7997484|NCT00092521|19692995|P2|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291
7997485|NCT00092521|19692996|P1|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599
7997486|NCT00092521|19692993|P4|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0
7997487|NCT00092521|19692994|P3|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146
7997488|NCT00092521|19692995|P2|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14
7997489|NCT00092521|19692996|P1|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140
7997490|NCT00092521|19692993|P4|COMPLETED|Vaccination (Day 1 Through Month 7)||0
7997491|NCT00092521|19692994|P3|COMPLETED|Vaccination (Day 1 Through Month 7)||2586
7997492|NCT00092521|19692995|P2|COMPLETED|Vaccination (Day 1 Through Month 7)||290
7997493|NCT00092521|19692996|P1|COMPLETED|Vaccination (Day 1 Through Month 7)||2583
7997494|NCT00092521|19692993|P4|STARTED|Vaccination (Day 1 Through Month 7)||0
7997495|NCT00092521|19692994|P3|STARTED|Vaccination (Day 1 Through Month 7)||2732
7997496|NCT00092521|19692995|P2|STARTED|Vaccination (Day 1 Through Month 7)||304
7997497|NCT00092521|19692996|P1|STARTED|Vaccination (Day 1 Through Month 7)||2723
7997498|NCT00092495|19693010|P5|NOT COMPLETED|Extension Study||0
7997499|NCT00092495|19693011|P4|NOT COMPLETED|Extension Study||0
7997500|NCT00092495|19693012|P3|NOT COMPLETED|Extension Study||0
7997501|NCT00092495|19693013|P2|NOT COMPLETED|Extension Study||0
7997502|NCT00092495|19693014|P1|NOT COMPLETED|Extension Study||0
7997503|NCT00092495|19693010|P5|COMPLETED|Extension Study||12
7997504|NCT00092495|19693011|P4|COMPLETED|Extension Study||0
7997505|NCT00092495|19693012|P3|COMPLETED|Extension Study||0
7997506|NCT00092495|19693013|P2|COMPLETED|Extension Study||0
7997507|NCT00092495|19693014|P1|COMPLETED|Extension Study||0
7997508|NCT00092495|19693010|P5|STARTED|Extension Study||12
7997509|NCT00092495|19693011|P4|STARTED|Extension Study||0
7997510|NCT00092495|19693012|P3|STARTED|Extension Study||0
7997511|NCT00092495|19693013|P2|STARTED|Extension Study||0
7997512|NCT00092495|19693014|P1|STARTED|Extension Study||0
7997513|NCT00092495|19693010|P5|NOT COMPLETED|Base Study Follow-up Period||0
7997514|NCT00092495|19693011|P4|NOT COMPLETED|Base Study Follow-up Period||14
7997515|NCT00092495|19693012|P3|NOT COMPLETED|Base Study Follow-up Period||4
7997516|NCT00092495|19693013|P2|NOT COMPLETED|Base Study Follow-up Period||3
7997517|NCT00092495|19693014|P1|NOT COMPLETED|Base Study Follow-up Period||3
7997518|NCT00092495|19693010|P5|COMPLETED|Base Study Follow-up Period||0
7997519|NCT00092495|19693011|P4|COMPLETED|Base Study Follow-up Period||446
7997520|NCT00092495|19693012|P3|COMPLETED|Base Study Follow-up Period||126
7997521|NCT00092495|19693013|P2|COMPLETED|Base Study Follow-up Period||122
7997522|NCT00092495|19693014|P1|COMPLETED|Base Study Follow-up Period||112
7997523|NCT00092495|19693010|P5|STARTED|Base Study Follow-up Period||0
7997524|NCT00092495|19693011|P4|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460
7997525|NCT00092495|19693012|P3|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130
7997526|NCT00092495|19693013|P2|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125
7997527|NCT00092495|19693014|P1|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115
7997528|NCT00092495|19693010|P5|NOT COMPLETED|Base Study Vaccination Period||0
7997529|NCT00092495|19693011|P4|NOT COMPLETED|Base Study Vaccination Period||88
7997530|NCT00092495|19693012|P3|NOT COMPLETED|Base Study Vaccination Period||34
7997531|NCT00092495|19693013|P2|NOT COMPLETED|Base Study Vaccination Period||22
7997532|NCT00092495|19693014|P1|NOT COMPLETED|Base Study Vaccination Period||37
7997533|NCT00092495|19693010|P5|COMPLETED|Base Study Vaccination Period||0
7997534|NCT00092495|19693011|P4|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441
7997597|NCT00092131|19693165|P2|NOT COMPLETED|Treatment Period II||1
7997535|NCT00092495|19693012|P3|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474
7997536|NCT00092495|19693013|P2|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492
7997537|NCT00092495|19693014|P1|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467
7997538|NCT00092495|19693010|P5|Without Long-term Follow-up|Base Study Vaccination Period||0
7997539|NCT00092495|19693011|P4|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73
7997540|NCT00092495|19693012|P3|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28
7997541|NCT00092495|19693013|P2|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20
7997542|NCT00092495|19693014|P1|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34
7997543|NCT00092495|19693010|P5|With Long-term Follow-up *|Base Study Vaccination Period||0
7997544|NCT00092495|19693011|P4|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10
7997545|NCT00092495|19693012|P3|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6
7997546|NCT00092495|19693013|P2|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
7997547|NCT00092495|19693014|P1|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
7997548|NCT00092495|19693010|P5|STARTED|Base Study Vaccination Period||0
7997549|NCT00092495|19693011|P4|STARTED|Base Study Vaccination Period||1529
7997550|NCT00092495|19693012|P3|STARTED|Base Study Vaccination Period||508
7997551|NCT00092495|19693013|P2|STARTED|Base Study Vaccination Period||514
7997552|NCT00092495|19693014|P1|STARTED|Base Study Vaccination Period||504
7997553|NCT00092456|19693080|P4|NOT COMPLETED|Overall Study||16
7997554|NCT00092456|19693081|P3|NOT COMPLETED|Overall Study||29
7997555|NCT00092456|19693082|P2|NOT COMPLETED|Overall Study||17
7997556|NCT00092456|19693083|P1|NOT COMPLETED|Overall Study||25
7997557|NCT00092456|19693080|P4|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97
7997558|NCT00092456|19693081|P3|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200
7997559|NCT00092456|19693082|P2|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208
7997560|NCT00092456|19693083|P1|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201
7997561|NCT00092456|19693080|P4|Vaccinated at Visit 3|Overall Study||98
7997562|NCT00092456|19693081|P3|Vaccinated at Visit 3|Overall Study||200
7997563|NCT00092456|19693082|P2|Vaccinated at Visit 3|Overall Study||210
7997564|NCT00092456|19693083|P1|Vaccinated at Visit 3|Overall Study||202
7997565|NCT00092456|19693080|P4|Vaccinated at Visit 2|Overall Study||104
7997566|NCT00092456|19693081|P3|Vaccinated at Visit 2|Overall Study||210
7997567|NCT00092456|19693082|P2|Vaccinated at Visit 2|Overall Study||217
7997568|NCT00092456|19693083|P1|Vaccinated at Visit 2|Overall Study||208
7997569|NCT00092456|19693080|P4|Vaccinated at Visit 1|Overall Study||113
7997570|NCT00092456|19693081|P3|Vaccinated at Visit 1|Overall Study||229
7997571|NCT00092456|19693082|P2|Vaccinated at Visit 1|Overall Study||225
7997572|NCT00092456|19693083|P1|Vaccinated at Visit 1|Overall Study||226
7997573|NCT00092456|19693080|P4|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113
7997574|NCT00092456|19693081|P3|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229
7997575|NCT00092456|19693082|P2|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225
7997576|NCT00092456|19693083|P1|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226
7997577|NCT00092443|19693131|P2|NOT COMPLETED|Overall Study||54
7997578|NCT00092443|19693132|P1|NOT COMPLETED|Overall Study||58
7997579|NCT00092443|19693131|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607
7997580|NCT00092443|19693132|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593
7997581|NCT00092443|19693131|P2|Vaccinated at Visit 3|Overall Study||608
7997582|NCT00092443|19693132|P1|Vaccinated at Visit 3|Overall Study||593
7997583|NCT00092443|19693131|P2|Vaccinated at Visit 2|Overall Study||627
7997584|NCT00092443|19693132|P1|Vaccinated at Visit 2|Overall Study||618
7997585|NCT00092443|19693131|P2|Vaccinated at Visit 1|Overall Study||660
7997586|NCT00092443|19693132|P1|Vaccinated at Visit 1|Overall Study||650
7997587|NCT00092443|19693131|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661
7997588|NCT00092443|19693132|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651
7997589|NCT00092417|19693150|P2|NOT COMPLETED|Overall Study||1
7997590|NCT00092417|19693151|P1|NOT COMPLETED|Overall Study||5
7997591|NCT00092417|19693150|P2|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233
7997592|NCT00092417|19693151|P1|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459
7997593|NCT00092417|19693150|P2|Vaccinated|Overall Study||234
7997594|NCT00092417|19693151|P1|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461
7997595|NCT00092417|19693150|P2|STARTED|Overall Study|Started Period Group 2|234
7997596|NCT00092417|19693151|P1|STARTED|Overall Study|Started Period Group 1|464
7997598|NCT00092131|19693166|P1|NOT COMPLETED|Treatment Period II||0
7997599|NCT00092131|19693165|P2|COMPLETED|Treatment Period II||25
7997600|NCT00092131|19693166|P1|COMPLETED|Treatment Period II||24
7997601|NCT00092131|19693165|P2|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26
7997602|NCT00092131|19693166|P1|STARTED|Treatment Period II||24
7997603|NCT00092131|19693165|P2|NOT COMPLETED|Treatment Period I||0
7997604|NCT00092131|19693166|P1|NOT COMPLETED|Treatment Period I||1
7997605|NCT00092131|19693165|P2|COMPLETED|Treatment Period I||26
7997606|NCT00092131|19693166|P1|COMPLETED|Treatment Period I||24
7997607|NCT00092131|19693165|P2|STARTED|Treatment Period I||26
7997608|NCT00092131|19693166|P1|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25
7997609|NCT00092118|19693196|P2|NOT COMPLETED|Overall Study||89
7997610|NCT00092118|19693197|P1|NOT COMPLETED|Overall Study||84
7997611|NCT00092118|19693196|P2|COMPLETED|Overall Study||913
7997612|NCT00092118|19693197|P1|COMPLETED|Overall Study||906
7997613|NCT00092118|19693196|P2|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002
7997614|NCT00092118|19693197|P1|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990
7997615|NCT00091962|19693210|P3|NOT COMPLETED|Overall Study||0
7997616|NCT00091962|19693211|P2|NOT COMPLETED|Overall Study||0
7997617|NCT00091962|19693212|P1|NOT COMPLETED|Overall Study||0
7997618|NCT00091962|19693210|P3|COMPLETED|Overall Study||151
7997619|NCT00091962|19693211|P2|COMPLETED|Overall Study||152
7997620|NCT00091962|19693212|P1|COMPLETED|Overall Study||150
7997621|NCT00091962|19693210|P3|STARTED|Overall Study||151
7997622|NCT00091962|19693211|P2|STARTED|Overall Study||152
7997623|NCT00091962|19693212|P1|STARTED|Overall Study||150
7997624|NCT00091949|19693231|P2|NOT COMPLETED|Overall Study||151
7997625|NCT00091949|19693232|P1|NOT COMPLETED|Overall Study||175
7997626|NCT00091949|19693231|P2|COMPLETED|Overall Study||1786
7997627|NCT00091949|19693232|P1|COMPLETED|Overall Study||1764
7997628|NCT00091949|19693231|P2|STARTED|Overall Study||1937
7997629|NCT00091949|19693232|P1|STARTED|Overall Study||1939
7997630|NCT00091832|19693256|P6|NOT COMPLETED|Overall Study||11
7997631|NCT00091832|19693257|P5|NOT COMPLETED|Overall Study||15
7997632|NCT00091832|19693258|P4|NOT COMPLETED|Overall Study||14
7997633|NCT00091832|19693259|P3|NOT COMPLETED|Overall Study||12
7997634|NCT00091832|19693260|P2|NOT COMPLETED|Overall Study||11
7997635|NCT00091832|19693261|P1|NOT COMPLETED|Overall Study||14
7997636|NCT00091832|19693256|P6|COMPLETED|Overall Study||32
7997637|NCT00091832|19693257|P5|COMPLETED|Overall Study||27
7997638|NCT00091832|19693258|P4|COMPLETED|Overall Study||29
7997639|NCT00091832|19693259|P3|COMPLETED|Overall Study||30
7997640|NCT00091832|19693260|P2|COMPLETED|Overall Study||31
7997641|NCT00091832|19693261|P1|COMPLETED|Overall Study||29
7997642|NCT00091832|19693256|P6|Received Study Medication|Overall Study||43
7997643|NCT00091832|19693257|P5|Received Study Medication|Overall Study||42
7997644|NCT00091832|19693258|P4|Received Study Medication|Overall Study||43
7997645|NCT00091832|19693259|P3|Received Study Medication|Overall Study||41
7997646|NCT00091832|19693260|P2|Received Study Medication|Overall Study||42
7997647|NCT00091832|19693261|P1|Received Study Medication|Overall Study||43
7997648|NCT00091832|19693256|P6|STARTED|Overall Study||43
7997649|NCT00091832|19693257|P5|STARTED|Overall Study||42
7997650|NCT00091832|19693258|P4|STARTED|Overall Study||43
7997651|NCT00091832|19693259|P3|STARTED|Overall Study||42
7997652|NCT00091832|19693260|P2|STARTED|Overall Study||42
7997653|NCT00091832|19693261|P1|STARTED|Overall Study||43
7997654|NCT00091819|19693379|P2|NOT COMPLETED|Overall Study||46
7997655|NCT00091819|19693380|P1|NOT COMPLETED|Overall Study||42
7997656|NCT00091819|19693379|P2|COMPLETED|Overall Study||387
7997657|NCT00091819|19693380|P1|COMPLETED|Overall Study||387
7997658|NCT00091819|19693379|P2|STARTED|Overall Study||433
7997659|NCT00091819|19693380|P1|STARTED|Overall Study||429
7997660|NCT00091793|19693388|P2|NOT COMPLETED|Overall Study||22
7997661|NCT00091793|19693389|P1|NOT COMPLETED|Overall Study||24
7997662|NCT00091793|19693388|P2|COMPLETED|Overall Study||144
7997663|NCT00091793|19693389|P1|COMPLETED|Overall Study||142
7997664|NCT00091793|19693388|P2|STARTED|Overall Study||166
7997665|NCT00091793|19693389|P1|STARTED|Overall Study||166
7997666|NCT00091572|19693413|P2|NOT COMPLETED|Overall Study||82
7997667|NCT00091572|19693414|P1|NOT COMPLETED|Overall Study||95
7997668|NCT00091572|19693413|P2|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348
7997669|NCT00091572|19693414|P1|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334
7997670|NCT00091572|19693413|P2|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430
7997671|NCT00091572|19693414|P1|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429
7997672|NCT00091507|19693428|P2|NOT COMPLETED|Overall Study||19
7997673|NCT00091507|19693429|P1|NOT COMPLETED|Overall Study||21
7997674|NCT00091507|19693428|P2|COMPLETED|Overall Study||460
7997675|NCT00091507|19693429|P1|COMPLETED|Overall Study||411
7997676|NCT00091507|19693428|P2|STARTED|Overall Study||479
7997677|NCT00091507|19693429|P1|STARTED|Overall Study||432
7997678|NCT00091442|19693445|P2|NOT COMPLETED|Overall Study||373
7997679|NCT00091442|19693446|P1|NOT COMPLETED|Overall Study||369
7997680|NCT00091442|19693445|P2|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5
7997681|NCT00091442|19693446|P1|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4
7997682|NCT00091442|19693445|P2|STARTED|Overall Study||378
7997683|NCT00091442|19693446|P1|STARTED|Overall Study||373
7997684|NCT00091390|19693456|P1|NOT COMPLETED|Overall Study||4
7997685|NCT00091390|19693456|P1|COMPLETED|Overall Study|Subjects contributing data to results are considered to have completed the study.|125
7997686|NCT00091390|19693456|P1|Eligible, Started Treatment, Has AE Data|Overall Study||115
7997687|NCT00091390|19693456|P1|Eligible and Started Study Treatment|Overall Study||125
7997688|NCT00091390|19693456|P1|STARTED|Overall Study||129
7997689|NCT00091273|19693467|P1|NOT COMPLETED|Overall Study||0
7997690|NCT00091273|19693467|P1|COMPLETED|Overall Study||9
7997691|NCT00091273|19693467|P1|STARTED|Overall Study||9
7997692|NCT00091260|19693473|P1|NOT COMPLETED|Overall Study||0
7997693|NCT00091260|19693473|P1|COMPLETED|Overall Study||82
7997694|NCT00091260|19693473|P1|STARTED|Overall Study||82
7997695|NCT00091169|19693481|P2|NOT COMPLETED|Overall Study||53
7997696|NCT00091169|19693482|P1|NOT COMPLETED|Overall Study||57
7997697|NCT00091169|19693481|P2|COMPLETED|Overall Study||134
7997698|NCT00091169|19693482|P1|COMPLETED|Overall Study||132
7997699|NCT00091169|19693481|P2|Treated|Overall Study||170
7997700|NCT00091169|19693482|P1|Treated|Overall Study||163
7997701|NCT00091169|19693481|P2|STARTED|Overall Study||187
7997702|NCT00091169|19693482|P1|STARTED|Overall Study||189
7997703|NCT00091026|19693500|P2|NOT COMPLETED|Overall Study||3
7997704|NCT00091026|19693501|P1|NOT COMPLETED|Overall Study||1
7997705|NCT00091026|19693500|P2|COMPLETED|Overall Study||68
7997706|NCT00091026|19693501|P1|COMPLETED|Overall Study||71
7997707|NCT00091026|19693500|P2|STARTED|Overall Study||71
7997708|NCT00091026|19693501|P1|STARTED|Overall Study||72
7997709|NCT00090987|19693511|P1|NOT COMPLETED|Overall Study||21
7997710|NCT00090987|19693511|P1|COMPLETED|Overall Study||9
7997711|NCT00090987|19693511|P1|STARTED|Overall Study||30
7997712|NCT00090870|19693515|P1|NOT COMPLETED|Overall Study||0
7997713|NCT00090870|19693515|P1|COMPLETED|Overall Study||10
7997714|NCT00090870|19693515|P1|STARTED|Overall Study||10
7997715|NCT00090857|19693524|P2|NOT COMPLETED|Overall Study||3
7997716|NCT00090857|19693525|P1|NOT COMPLETED|Overall Study||4
7997717|NCT00090857|19693524|P2|COMPLETED|Overall Study||13
7997718|NCT00090857|19693525|P1|COMPLETED|Overall Study||29
7997719|NCT00090857|19693524|P2|STARTED|Overall Study||16
7997720|NCT00090857|19693525|P1|STARTED|Overall Study||33
7997721|NCT00090844|19693555|P2|NOT COMPLETED|Overall Study||1
7997722|NCT00090844|19693556|P1|NOT COMPLETED|Overall Study||1
7997723|NCT00090844|19693555|P2|COMPLETED|Overall Study||21
7997724|NCT00090844|19693556|P1|COMPLETED|Overall Study||26
7997725|NCT00090844|19693555|P2|STARTED|Overall Study||22
7997726|NCT00090844|19693556|P1|STARTED|Overall Study||27
7997727|NCT00090779|19693564|P2|NOT COMPLETED|Step 3||5
7997728|NCT00090779|19693565|P1|NOT COMPLETED|Step 3||7
7997729|NCT00090779|19693564|P2|COMPLETED|Step 3||0
7997730|NCT00090779|19693565|P1|COMPLETED|Step 3||0
7997731|NCT00090779|19693564|P2|STARTED|Step 3||5
7997732|NCT00090779|19693565|P1|STARTED|Step 3||7
7997733|NCT00090779|19693564|P2|NOT COMPLETED|Step 2||18
7997734|NCT00090779|19693565|P1|NOT COMPLETED|Step 2||6
7997735|NCT00090779|19693564|P2|COMPLETED|Step 2||1
7997736|NCT00090779|19693565|P1|COMPLETED|Step 2||0
7997737|NCT00090779|19693564|P2|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19
7997738|NCT00090779|19693565|P1|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6
7997739|NCT00090779|19693564|P2|NOT COMPLETED|Step 1||15
7997740|NCT00090779|19693565|P1|NOT COMPLETED|Step 1||11
7997741|NCT00090779|19693564|P2|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49
7997742|NCT00090779|19693565|P1|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55
7997743|NCT00090779|19693564|P2|STARTED|Step 1||64
7997744|NCT00090779|19693565|P1|STARTED|Step 1||66
7997745|NCT00090766|19693589|P3|NOT COMPLETED|Overall Study||3
7997746|NCT00090766|19693590|P2|NOT COMPLETED|Overall Study||2
7997747|NCT00090766|19693591|P1|NOT COMPLETED|Overall Study||3
7997748|NCT00090766|19693589|P3|COMPLETED|Overall Study||22
7997749|NCT00090766|19693590|P2|COMPLETED|Overall Study||19
7997750|NCT00090766|19693591|P1|COMPLETED|Overall Study||14
7997751|NCT00090766|19693589|P3|STARTED|Overall Study||25
7997752|NCT00090766|19693590|P2|STARTED|Overall Study||21
7997753|NCT00090766|19693591|P1|STARTED|Overall Study||17
7997754|NCT00090753|19693633|P2|NOT COMPLETED|Extended Treatment Period||191
7997755|NCT00090753|19693634|P1|NOT COMPLETED|Extended Treatment Period||359
7997756|NCT00090753|19693633|P2|COMPLETED|Extended Treatment Period||59
7997757|NCT00090753|19693634|P1|COMPLETED|Extended Treatment Period||94
7997758|NCT00090753|19693633|P2|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250
7997759|NCT00090753|19693634|P1|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453
7997760|NCT00090753|19693633|P2|NOT COMPLETED|First Treatment Period||178
7997761|NCT00090753|19693634|P1|NOT COMPLETED|First Treatment Period||256
7997762|NCT00090753|19693633|P2|COMPLETED|First Treatment Period||302
7997763|NCT00090753|19693634|P1|COMPLETED|First Treatment Period||492
7997764|NCT00090753|19693633|P2|STARTED|First Treatment Period||480
7997765|NCT00090753|19693634|P1|STARTED|First Treatment Period||748
7997766|NCT00090610|19693644|P2|NOT COMPLETED|Overall Study||1
7997767|NCT00090610|19693645|P1|NOT COMPLETED|Overall Study||1
7997768|NCT00090610|19693644|P2|COMPLETED|Overall Study||74
7997769|NCT00090610|19693645|P1|COMPLETED|Overall Study||74
7997770|NCT00090610|19693644|P2|STARTED|Overall Study||75
7997771|NCT00090610|19693645|P1|STARTED|Overall Study||75
7997772|NCT00090584|19693661|P2|NOT COMPLETED|Baseline to 8 Months||41
7997773|NCT00090584|19693662|P1|NOT COMPLETED|Baseline to 8 Months||44
7997774|NCT00090584|19693661|P2|COMPLETED|Baseline to 8 Months||112
7997775|NCT00090584|19693662|P1|COMPLETED|Baseline to 8 Months||110
7997776|NCT00090584|19693661|P2|STARTED|Baseline to 8 Months||153
7997777|NCT00090584|19693662|P1|STARTED|Baseline to 8 Months||154
7997778|NCT00090584|19693661|P2|NOT COMPLETED|Baseline to 10 Weeks||12
7997779|NCT00090584|19693662|P1|NOT COMPLETED|Baseline to 10 Weeks||15
7997780|NCT00090584|19693661|P2|COMPLETED|Baseline to 10 Weeks||141
7997781|NCT00090584|19693662|P1|COMPLETED|Baseline to 10 Weeks||139
7997782|NCT00090584|19693661|P2|STARTED|Baseline to 10 Weeks||153
7997783|NCT00090584|19693662|P1|STARTED|Baseline to 10 Weeks||154
7997784|NCT00090519|19693694|P2|NOT COMPLETED|Overall Study||75
7997785|NCT00090519|19693695|P1|NOT COMPLETED|Overall Study||73
7997786|NCT00090519|19693694|P2|COMPLETED|Overall Study||285
7997787|NCT00090519|19693695|P1|COMPLETED|Overall Study||298
7997788|NCT00090519|19693694|P2|STARTED|Overall Study||360
7997789|NCT00090519|19693695|P1|STARTED|Overall Study||371
7997790|NCT00090493|19693719|P1|NOT COMPLETED|Overall Study||2
7997791|NCT00090493|19693719|P1|COMPLETED|Overall Study||2
7997792|NCT00090493|19693719|P1|STARTED|Overall Study||4
7997793|NCT00090363|19693726|P3|NOT COMPLETED|Overall Study||96
7997794|NCT00090363|19693727|P2|NOT COMPLETED|Overall Study||107
7997795|NCT00090363|19693728|P1|NOT COMPLETED|Overall Study||106
7997796|NCT00090363|19693726|P3|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2
7997797|NCT00090363|19693727|P2|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0
7997798|NCT00090363|19693728|P1|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1
7997799|NCT00090363|19693726|P3|Received Study Treatment.|Overall Study||98
7997800|NCT00090363|19693727|P2|Received Study Treatment.|Overall Study||107
7997801|NCT00090363|19693728|P1|Received Study Treatment.|Overall Study||107
7997802|NCT00090363|19693726|P3|STARTED|Overall Study||98
7997803|NCT00090363|19693727|P2|STARTED|Overall Study||107
7997804|NCT00090363|19693728|P1|STARTED|Overall Study||107
7997805|NCT00090545|19693750|P2|NOT COMPLETED|Overall Study||24
7997806|NCT00090545|19693751|P1|NOT COMPLETED|Overall Study||22
7997807|NCT00090545|19693750|P2|COMPLETED|Overall Study||0
7997808|NCT00090545|19693751|P1|COMPLETED|Overall Study||0
7997809|NCT00090545|19693750|P2|STARTED|Overall Study||24
7997810|NCT00090545|19693751|P1|STARTED|Overall Study||22
7997811|NCT00090285|19693771|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||203
7997812|NCT00090285|19693772|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||227
7997813|NCT00090285|19693773|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
7997814|NCT00090285|19693774|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
7997815|NCT00090285|19693775|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
7997816|NCT00090285|19693776|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
7997817|NCT00090285|19693771|P6|COMPLETED|Long-term Follow-up (EXT2)||664
7997818|NCT00090285|19693772|P5|COMPLETED|Long-term Follow-up (EXT2)||709
7997819|NCT00090285|19693773|P4|COMPLETED|Long-term Follow-up (EXT2)||0
7997820|NCT00090285|19693774|P3|COMPLETED|Long-term Follow-up (EXT2)||0
7997821|NCT00090285|19693775|P2|COMPLETED|Long-term Follow-up (EXT2)||0
7997822|NCT00090285|19693776|P1|COMPLETED|Long-term Follow-up (EXT2)||0
7997823|NCT00090285|19693771|P6|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|867
7997824|NCT00090285|19693772|P5|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|936
7997825|NCT00090285|19693773|P4|STARTED|Long-term Follow-up (EXT2)||0
7997826|NCT00090285|19693774|P3|STARTED|Long-term Follow-up (EXT2)||0
7997827|NCT00090285|19693775|P2|STARTED|Long-term Follow-up (EXT2)||0
7997828|NCT00090285|19693776|P1|STARTED|Long-term Follow-up (EXT2)||0
7997829|NCT00090285|19693771|P6|NOT COMPLETED|Extension 1||0
7997830|NCT00090285|19693772|P5|NOT COMPLETED|Extension 1||0
7997831|NCT00090285|19693773|P4|NOT COMPLETED|Extension 1||1
7997832|NCT00090285|19693774|P3|NOT COMPLETED|Extension 1||57
7997833|NCT00090285|19693775|P2|NOT COMPLETED|Extension 1||0
7997834|NCT00090285|19693776|P1|NOT COMPLETED|Extension 1||0
7997835|NCT00090285|19693771|P6|COMPLETED|Extension 1||0
7997836|NCT00090285|19693772|P5|COMPLETED|Extension 1||0
7997837|NCT00090285|19693773|P4|COMPLETED|Extension 1||15
7997838|NCT00090285|19693774|P3|COMPLETED|Extension 1||1041
7997839|NCT00090285|19693775|P2|COMPLETED|Extension 1||0
7997840|NCT00090285|19693776|P1|COMPLETED|Extension 1||0
7997841|NCT00090285|19693771|P6|STARTED|Extension 1||0
7997842|NCT00090285|19693772|P5|STARTED|Extension 1||0
7997843|NCT00090285|19693773|P4|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16
7997844|NCT00090285|19693774|P3|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098
7997845|NCT00090285|19693775|P2|STARTED|Extension 1||0
7997846|NCT00090285|19693776|P1|STARTED|Extension 1||0
7997847|NCT00090285|19693771|P6|NOT COMPLETED|Base Study Follow-up Period||0
7997848|NCT00090285|19693772|P5|NOT COMPLETED|Base Study Follow-up Period||0
7997849|NCT00090285|19693773|P4|NOT COMPLETED|Base Study Follow-up Period||0
7997850|NCT00090285|19693774|P3|NOT COMPLETED|Base Study Follow-up Period||0
7997851|NCT00090285|19693775|P2|NOT COMPLETED|Base Study Follow-up Period||342
7997852|NCT00090285|19693776|P1|NOT COMPLETED|Base Study Follow-up Period||335
7997853|NCT00090285|19693771|P6|COMPLETED|Base Study Follow-up Period||0
7997854|NCT00090285|19693772|P5|COMPLETED|Base Study Follow-up Period||0
7997855|NCT00090285|19693773|P4|COMPLETED|Base Study Follow-up Period||0
7997856|NCT00090285|19693774|P3|COMPLETED|Base Study Follow-up Period||0
7997857|NCT00090285|19693775|P2|COMPLETED|Base Study Follow-up Period||1479
7997858|NCT00090285|19693776|P1|COMPLETED|Base Study Follow-up Period||1487
7997859|NCT00090285|19693771|P6|STARTED|Base Study Follow-up Period||0
7997860|NCT00090285|19693772|P5|STARTED|Base Study Follow-up Period||0
7997861|NCT00090285|19693773|P4|STARTED|Base Study Follow-up Period||0
7997862|NCT00090285|19693774|P3|STARTED|Base Study Follow-up Period||0
7997863|NCT00090285|19693775|P2|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821
7997864|NCT00090285|19693776|P1|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822
7997865|NCT00090285|19693771|P6|NOT COMPLETED|Base Study Vaccination Period||0
7997866|NCT00090285|19693772|P5|NOT COMPLETED|Base Study Vaccination Period||0
7997867|NCT00090285|19693773|P4|NOT COMPLETED|Base Study Vaccination Period||0
7997868|NCT00090285|19693774|P3|NOT COMPLETED|Base Study Vaccination Period||0
7997869|NCT00090285|19693775|P2|NOT COMPLETED|Base Study Vaccination Period||219
7997870|NCT00090285|19693776|P1|NOT COMPLETED|Base Study Vaccination Period||214
7997871|NCT00090285|19693771|P6|COMPLETED|Base Study Vaccination Period||0
7997872|NCT00090285|19693772|P5|COMPLETED|Base Study Vaccination Period||0
7997873|NCT00090285|19693773|P4|COMPLETED|Base Study Vaccination Period||0
7997874|NCT00090285|19693774|P3|COMPLETED|Base Study Vaccination Period||0
7997875|NCT00090285|19693775|P2|COMPLETED|Base Study Vaccination Period||1814
7997876|NCT00090285|19693776|P1|COMPLETED|Base Study Vaccination Period||1818
7997877|NCT00090285|19693771|P6|Vaccinated|Base Study Vaccination Period||0
7997878|NCT00090285|19693772|P5|Vaccinated|Base Study Vaccination Period||0
7997879|NCT00090285|19693773|P4|Vaccinated|Base Study Vaccination Period||0
7997880|NCT00090285|19693774|P3|Vaccinated|Base Study Vaccination Period||0
7997881|NCT00090285|19693775|P2|Vaccinated|Base Study Vaccination Period||2030
7997882|NCT00090285|19693776|P1|Vaccinated|Base Study Vaccination Period||2025
7997883|NCT00090285|19693771|P6|STARTED|Base Study Vaccination Period||0
7997884|NCT00090285|19693772|P5|STARTED|Base Study Vaccination Period||0
7997885|NCT00090285|19693773|P4|STARTED|Base Study Vaccination Period||0
7997886|NCT00090285|19693774|P3|STARTED|Base Study Vaccination Period||0
7997887|NCT00090285|19693775|P2|STARTED|Base Study Vaccination Period||2033
7997888|NCT00090285|19693776|P1|STARTED|Base Study Vaccination Period||2032
7997889|NCT00090259|19693813|P2|NOT COMPLETED|Overall Study||48
7997890|NCT00090259|19693814|P1|NOT COMPLETED|Overall Study||62
7997891|NCT00090259|19693813|P2|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873
7997892|NCT00090259|19693814|P1|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851
7997893|NCT00090259|19693813|P2|STARTED|Overall Study||1921
7997894|NCT00090259|19693814|P1|STARTED|Overall Study||1913
7997895|NCT00090233|19693830|P2|NOT COMPLETED|Overall Study||5065
7997896|NCT00090233|19693831|P1|NOT COMPLETED|Overall Study||4999
7997897|NCT00090233|19693830|P2|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565
7997898|NCT00090233|19693831|P1|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645
7997899|NCT00090233|19693830|P2|Vaccinated at Visit 3|Overall Study||29598
7997900|NCT00090233|19693831|P1|Vaccinated at Visit 3|Overall Study||29667
7997901|NCT00090233|19693830|P2|Vaccinated at Visit 2|Overall Study||31066
7997902|NCT00090233|19693831|P1|Vaccinated at Visit 2|Overall Study||31052
7997903|NCT00090233|19693830|P2|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003
7997904|NCT00090233|19693831|P1|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035
7997905|NCT00090233|19693830|P2|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630
7997906|NCT00090233|19693831|P1|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644
7997907|NCT00090220|19693855|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||28
7997908|NCT00090220|19693856|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||44
7997909|NCT00090220|19693857|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
7997910|NCT00090220|19693858|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
7997911|NCT00090220|19693859|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
7997912|NCT00090220|19693860|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
7997913|NCT00090220|19693855|P6|COMPLETED|Long-term Follow-up (EXT2)||623
7997914|NCT00090220|19693856|P5|COMPLETED|Long-term Follow-up (EXT2)||641
7997915|NCT00090220|19693857|P4|COMPLETED|Long-term Follow-up (EXT2)||0
7997916|NCT00090220|19693858|P3|COMPLETED|Long-term Follow-up (EXT2)||0
7997917|NCT00090220|19693859|P2|COMPLETED|Long-term Follow-up (EXT2)||0
7997918|NCT00090220|19693860|P1|COMPLETED|Long-term Follow-up (EXT2)||0
7997919|NCT00090220|19693855|P6|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651
7997920|NCT00090220|19693856|P5|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685
7997921|NCT00090220|19693857|P4|STARTED|Long-term Follow-up (EXT2)||0
7997922|NCT00090220|19693858|P3|STARTED|Long-term Follow-up (EXT2)||0
7997923|NCT00090220|19693859|P2|STARTED|Long-term Follow-up (EXT2)||0
7997924|NCT00090220|19693860|P1|STARTED|Long-term Follow-up (EXT2)||0
7997925|NCT00090220|19693855|P6|NOT COMPLETED|Extension 1 (EXT1)||0
7997926|NCT00090220|19693856|P5|NOT COMPLETED|Extension 1 (EXT1)||0
7997927|NCT00090220|19693857|P4|NOT COMPLETED|Extension 1 (EXT1)||2
7997928|NCT00090220|19693858|P3|NOT COMPLETED|Extension 1 (EXT1)||55
7997929|NCT00090220|19693859|P2|NOT COMPLETED|Extension 1 (EXT1)||0
7997930|NCT00090220|19693860|P1|NOT COMPLETED|Extension 1 (EXT1)||0
7997931|NCT00090220|19693855|P6|COMPLETED|Extension 1 (EXT1)||0
7997932|NCT00090220|19693856|P5|COMPLETED|Extension 1 (EXT1)||0
7997933|NCT00090220|19693857|P4|COMPLETED|Extension 1 (EXT1)||5
7997934|NCT00090220|19693858|P3|COMPLETED|Extension 1 (EXT1)||1267
7997935|NCT00090220|19693859|P2|COMPLETED|Extension 1 (EXT1)||0
7997936|NCT00090220|19693860|P1|COMPLETED|Extension 1 (EXT1)||0
7997937|NCT00090220|19693855|P6|Vaccinated|Extension 1 (EXT1)||0
7997938|NCT00090220|19693856|P5|Vaccinated|Extension 1 (EXT1)||0
7997939|NCT00090220|19693857|P4|Vaccinated|Extension 1 (EXT1)||7
7997940|NCT00090220|19693858|P3|Vaccinated|Extension 1 (EXT1)||1321
7997941|NCT00090220|19693859|P2|Vaccinated|Extension 1 (EXT1)||0
7997942|NCT00090220|19693860|P1|Vaccinated|Extension 1 (EXT1)||0
7997943|NCT00090220|19693855|P6|STARTED|Extension 1 (EXT1)||0
7997944|NCT00090220|19693856|P5|STARTED|Extension 1 (EXT1)||0
7997945|NCT00090220|19693857|P4|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7
7997946|NCT00090220|19693858|P3|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322
7997947|NCT00090220|19693859|P2|STARTED|Extension 1 (EXT1)||0
7997948|NCT00090220|19693860|P1|STARTED|Extension 1 (EXT1)||0
7997949|NCT00090220|19693855|P6|NOT COMPLETED|Base Study Follow-up Period||0
7997950|NCT00090220|19693856|P5|NOT COMPLETED|Base Study Follow-up Period||0
7997951|NCT00090220|19693857|P4|NOT COMPLETED|Base Study Follow-up Period||0
7997952|NCT00090220|19693858|P3|NOT COMPLETED|Base Study Follow-up Period||0
7997953|NCT00090220|19693859|P2|NOT COMPLETED|Base Study Follow-up Period||164
7997954|NCT00090220|19693860|P1|NOT COMPLETED|Base Study Follow-up Period||160
7997955|NCT00090220|19693855|P6|COMPLETED|Base Study Follow-up Period||0
7997956|NCT00090220|19693856|P5|COMPLETED|Base Study Follow-up Period||0
7997957|NCT00090220|19693857|P4|COMPLETED|Base Study Follow-up Period||0
7997958|NCT00090220|19693858|P3|COMPLETED|Base Study Follow-up Period||0
7997959|NCT00090220|19693859|P2|COMPLETED|Base Study Follow-up Period||1687
7997960|NCT00090220|19693860|P1|COMPLETED|Base Study Follow-up Period||1695
7997961|NCT00090220|19693855|P6|STARTED|Base Study Follow-up Period||0
7997962|NCT00090220|19693856|P5|STARTED|Base Study Follow-up Period||0
7997963|NCT00090220|19693857|P4|STARTED|Base Study Follow-up Period||0
7997964|NCT00090220|19693858|P3|STARTED|Base Study Follow-up Period||0
7997965|NCT00090220|19693859|P2|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851
7997966|NCT00090220|19693860|P1|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855
7997967|NCT00090220|19693855|P6|NOT COMPLETED|Base Study Vaccination Period||0
7997968|NCT00090220|19693856|P5|NOT COMPLETED|Base Study Vaccination Period||0
7997969|NCT00090220|19693857|P4|NOT COMPLETED|Base Study Vaccination Period||0
7997970|NCT00090220|19693858|P3|NOT COMPLETED|Base Study Vaccination Period||0
7997971|NCT00090220|19693859|P2|NOT COMPLETED|Base Study Vaccination Period||63
7997972|NCT00090220|19693860|P1|NOT COMPLETED|Base Study Vaccination Period||64
7997973|NCT00090220|19693855|P6|COMPLETED|Base Study Vaccination Period||0
7997974|NCT00090220|19693856|P5|COMPLETED|Base Study Vaccination Period||0
7997975|NCT00090220|19693857|P4|COMPLETED|Base Study Vaccination Period||0
7997976|NCT00090220|19693858|P3|COMPLETED|Base Study Vaccination Period||0
7997977|NCT00090220|19693859|P2|COMPLETED|Base Study Vaccination Period||1845
7997978|NCT00090220|19693860|P1|COMPLETED|Base Study Vaccination Period||1847
7997979|NCT00090220|19693855|P6|Vaccinated|Base Study Vaccination Period||0
7997980|NCT00090220|19693856|P5|Vaccinated|Base Study Vaccination Period||0
7997981|NCT00090220|19693857|P4|Vaccinated|Base Study Vaccination Period||0
7997982|NCT00090220|19693858|P3|Vaccinated|Base Study Vaccination Period||0
7997983|NCT00090220|19693859|P2|Vaccinated|Base Study Vaccination Period||1907
7997984|NCT00090220|19693860|P1|Vaccinated|Base Study Vaccination Period||1910
7997985|NCT00090220|19693855|P6|STARTED|Base Study Vaccination Period||0
7997986|NCT00090220|19693856|P5|STARTED|Base Study Vaccination Period||0
7997987|NCT00090220|19693857|P4|STARTED|Base Study Vaccination Period||0
7997988|NCT00090220|19693858|P3|STARTED|Base Study Vaccination Period||0
7997989|NCT00090220|19693859|P2|STARTED|Base Study Vaccination Period||1908
7997990|NCT00090220|19693860|P1|STARTED|Base Study Vaccination Period||1911
7997991|NCT00090402|19693955|P3|NOT COMPLETED|Overall Study||1
7997992|NCT00090402|19693956|P2|NOT COMPLETED|Overall Study||2
7997993|NCT00090402|19693957|P1|NOT COMPLETED|Overall Study||2
7997994|NCT00090402|19693955|P3|COMPLETED|Overall Study||12
7997995|NCT00090402|19693956|P2|COMPLETED|Overall Study||11
7997996|NCT00090402|19693957|P1|COMPLETED|Overall Study||11
7997997|NCT00090402|19693955|P3|STARTED|Overall Study||13
7997998|NCT00090402|19693956|P2|STARTED|Overall Study||13
7997999|NCT00090402|19693957|P1|STARTED|Overall Study||13
7998000|NCT00090142|19693971|P2|NOT COMPLETED|Treatment Period II||0
7998001|NCT00090142|19693972|P1|NOT COMPLETED|Treatment Period II||1
7998002|NCT00090142|19693971|P2|COMPLETED|Treatment Period II||28
7998003|NCT00090142|19693972|P1|COMPLETED|Treatment Period II||25
7998004|NCT00090142|19693971|P2|STARTED|Treatment Period II||28
7998005|NCT00090142|19693972|P1|STARTED|Treatment Period II||26
7998006|NCT00090142|19693971|P2|NOT COMPLETED|Treatment Period I||3
7998007|NCT00090142|19693972|P1|NOT COMPLETED|Treatment Period I||5
7998008|NCT00090142|19693971|P2|COMPLETED|Treatment Period I||28
7998009|NCT00090142|19693972|P1|COMPLETED|Treatment Period I||26
7998010|NCT00090142|19693971|P2|STARTED|Treatment Period I||31
7998011|NCT00090142|19693972|P1|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31
7998012|NCT00090103|19694003|P3|NOT COMPLETED|16-Week Safety Follow-up Period||457
7998013|NCT00090103|19694004|P2|NOT COMPLETED|16-Week Safety Follow-up Period||410
7998014|NCT00090103|19694005|P1|NOT COMPLETED|16-Week Safety Follow-up Period||374
7998015|NCT00090103|19694003|P3|COMPLETED|16-Week Safety Follow-up Period||1143
7998016|NCT00090103|19694004|P2|COMPLETED|16-Week Safety Follow-up Period||1205
7998017|NCT00090103|19694005|P1|COMPLETED|16-Week Safety Follow-up Period||1224
7998018|NCT00090103|19694003|P3|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600
7998019|NCT00090103|19694004|P2|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615
7998020|NCT00090103|19694005|P1|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598
7998021|NCT00090103|19694003|P3|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622
7998022|NCT00090103|19694004|P2|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530
7998023|NCT00090103|19694005|P1|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497
7998024|NCT00090103|19694003|P3|COMPLETED|Four-Year Double-Blind Treatment Period||989
7998025|NCT00090103|19694004|P2|COMPLETED|Four-Year Double-Blind Treatment Period||1093
7998026|NCT00090103|19694005|P1|COMPLETED|Four-Year Double-Blind Treatment Period||1113
7998027|NCT00090103|19694003|P3|STARTED|Four-Year Double-Blind Treatment Period||1611
7998028|NCT00090103|19694004|P2|STARTED|Four-Year Double-Blind Treatment Period||1623
7998029|NCT00090103|19694005|P1|STARTED|Four-Year Double-Blind Treatment Period||1610
7998030|NCT00090051|19694105|P2|NOT COMPLETED|Overall Study||95
7998031|NCT00090051|19694106|P1|NOT COMPLETED|Overall Study||109
7998032|NCT00090051|19694105|P2|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181
7998033|NCT00090051|19694106|P1|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167
7998034|NCT00090051|19694105|P2|Safety Population; Received Study Drug|Overall Study||274
7998035|NCT00090051|19694106|P1|Safety Population; Received Study Drug|Overall Study||272
7998036|NCT00090051|19694105|P2|STARTED|Overall Study||276
7998037|NCT00090051|19694106|P1|STARTED|Overall Study||276
7998038|NCT00003224|19694146|P6|NOT COMPLETED|Overall Study||0
7998039|NCT00003224|19694147|P5|NOT COMPLETED|Overall Study||0
7998040|NCT00003224|19694148|P4|NOT COMPLETED|Overall Study||0
7998041|NCT00003224|19694149|P3|NOT COMPLETED|Overall Study||0
7998042|NCT00003224|19694150|P2|NOT COMPLETED|Overall Study||0
7998043|NCT00003224|19694151|P1|NOT COMPLETED|Overall Study||0
7998044|NCT00003224|19694146|P6|COMPLETED|Overall Study||3
7998045|NCT00003224|19694147|P5|COMPLETED|Overall Study||4
7998046|NCT00003224|19694148|P4|COMPLETED|Overall Study||2
7998047|NCT00003224|19694149|P3|COMPLETED|Overall Study||4
7998048|NCT00003224|19694150|P2|COMPLETED|Overall Study||5
7998049|NCT00003224|19694151|P1|COMPLETED|Overall Study||4
7998050|NCT00003224|19694146|P6|STARTED|Overall Study||3
7998051|NCT00003224|19694147|P5|STARTED|Overall Study||4
7998052|NCT00003224|19694148|P4|STARTED|Overall Study||2
7998053|NCT00003224|19694149|P3|STARTED|Overall Study||4
7998054|NCT00003224|19694150|P2|STARTED|Overall Study||5
7998055|NCT00003224|19694151|P1|STARTED|Overall Study||4
7998056|NCT00089999|19694171|P2|NOT COMPLETED|Overall Study||69
7998057|NCT00089999|19694172|P1|NOT COMPLETED|Overall Study||69
7998058|NCT00089999|19694171|P2|COMPLETED|Overall Study||0
7998059|NCT00089999|19694172|P1|COMPLETED|Overall Study||0
7998060|NCT00089999|19694171|P2|STARTED|Overall Study||69
7998061|NCT00089999|19694172|P1|STARTED|Overall Study||69
7998062|NCT00089986|19694195|P3|NOT COMPLETED|Overall Study||10
7998063|NCT00089986|19694196|P2|NOT COMPLETED|Overall Study||24
7998064|NCT00089986|19694197|P1|NOT COMPLETED|Overall Study||15
7998065|NCT00089986|19694195|P3|COMPLETED|Overall Study||172
7998066|NCT00089986|19694196|P2|COMPLETED|Overall Study||574
7998067|NCT00089986|19694197|P1|COMPLETED|Overall Study||584
7998068|NCT00089986|19694195|P3|STARTED|Overall Study||182
7998069|NCT00089986|19694196|P2|STARTED|Overall Study||598
7998070|NCT00089986|19694197|P1|STARTED|Overall Study||599
7998071|NCT00089973|19694214|P1|NOT COMPLETED|Overall Study||50
7998072|NCT00089973|19694214|P1|COMPLETED|Overall Study||0
7998073|NCT00089973|19694214|P1|STARTED|Overall Study||50
7998074|NCT00089895|19694229|P2|NOT COMPLETED|Overall Study||42
7998075|NCT00089895|19694230|P1|NOT COMPLETED|Overall Study||35
7998076|NCT00089895|19694229|P2|COMPLETED|Overall Study|Number of Subjects treated|4642
7998077|NCT00089895|19694230|P1|COMPLETED|Overall Study|Number of Subjects treated|4687
7998078|NCT00089895|19694229|P2|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684
7998079|NCT00089895|19694230|P1|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722
7998080|NCT00089843|19694242|P4|NOT COMPLETED|Overall Study||7
7998081|NCT00089843|19694243|P3|NOT COMPLETED|Overall Study||5
7998082|NCT00089843|19694244|P2|NOT COMPLETED|Overall Study||4
7998083|NCT00089843|19694245|P1|NOT COMPLETED|Overall Study||2
7998084|NCT00089843|19694242|P4|COMPLETED|Overall Study||11
7998085|NCT00089843|19694243|P3|COMPLETED|Overall Study||15
7998086|NCT00089843|19694244|P2|COMPLETED|Overall Study||16
7998087|NCT00089843|19694245|P1|COMPLETED|Overall Study||17
7998088|NCT00089843|19694242|P4|STARTED|Overall Study||18
7998089|NCT00089843|19694243|P3|STARTED|Overall Study||20
7998090|NCT00089843|19694244|P2|STARTED|Overall Study||20
7998091|NCT00089843|19694245|P1|STARTED|Overall Study||19
7998092|NCT00089791|19694257|P2|NOT COMPLETED|Overall Study||630
7998093|NCT00089791|19694258|P1|NOT COMPLETED|Overall Study||700
7998094|NCT00089791|19694257|P2|COMPLETED|Overall Study||3272
7998095|NCT00089791|19694258|P1|COMPLETED|Overall Study||3206
7998096|NCT00089791|19694257|P2|Safety Analysis Set|Overall Study||3886
7998097|NCT00089791|19694258|P1|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876
7998098|NCT00089791|19694257|P2|Received Study Medication|Overall Study||3879
7998099|NCT00089791|19694258|P1|Received Study Medication|Overall Study||3883
7998100|NCT00089791|19694257|P2|STARTED|Overall Study||3902
7998101|NCT00089791|19694258|P1|STARTED|Overall Study||3906
7998102|NCT00089752|19694270|P2|NOT COMPLETED|Overall Study||22
7998103|NCT00089752|19694271|P1|NOT COMPLETED|Overall Study||20
7998104|NCT00089752|19694270|P2|COMPLETED|Overall Study||118
7998105|NCT00089752|19694271|P1|COMPLETED|Overall Study||121
7998106|NCT00089752|19694270|P2|STARTED|Overall Study||140
7998107|NCT00089752|19694271|P1|STARTED|Overall Study||141
7998108|NCT00089778|19694292|P3|NOT COMPLETED|Overall Study||1
7998109|NCT00089778|19694293|P2|NOT COMPLETED|Overall Study||0
7998110|NCT00089778|19694294|P1|NOT COMPLETED|Overall Study||0
7998111|NCT00089778|19694292|P3|COMPLETED|Overall Study||7
7998112|NCT00089778|19694293|P2|COMPLETED|Overall Study||1
7998113|NCT00089778|19694294|P1|COMPLETED|Overall Study||2
7998114|NCT00089778|19694292|P3|STARTED|Overall Study||8
7998115|NCT00089778|19694293|P2|STARTED|Overall Study||1
7998116|NCT00089778|19694294|P1|STARTED|Overall Study||2
7998117|NCT00089674|19694307|P2|NOT COMPLETED|Overall Study||267
7998118|NCT00089674|19694308|P1|NOT COMPLETED|Overall Study||289
7998119|NCT00089674|19694307|P2|COMPLETED|Overall Study||467
7998120|NCT00089674|19694308|P1|COMPLETED|Overall Study||445
7998121|NCT00089674|19694307|P2|Received Study Drug|Overall Study||726
7998122|NCT00089674|19694308|P1|Received Study Drug|Overall Study||730
7998123|NCT00089674|19694307|P2|STARTED|Overall Study||734
7998124|NCT00089674|19694308|P1|STARTED|Overall Study||734
7998125|NCT00089661|19694334|P2|NOT COMPLETED|Overall Study||26
7998126|NCT00089661|19694335|P1|NOT COMPLETED|Overall Study||21
7998127|NCT00089661|19694334|P2|COMPLETED|Overall Study||99
7998128|NCT00089661|19694335|P1|COMPLETED|Overall Study||106
7998129|NCT00089661|19694334|P2|STARTED|Overall Study||125
7998130|NCT00089661|19694335|P1|STARTED|Overall Study||127
7998131|NCT00089648|19694351|P1|NOT COMPLETED|Overall Study||41
7998132|NCT00089648|19694351|P1|COMPLETED|Overall Study||20
7998133|NCT00089648|19694351|P1|STARTED|Overall Study||61
7998134|NCT00089635|19694367|P1|NOT COMPLETED|Overall Study||43
7998135|NCT00089635|19694367|P1|COMPLETED|Overall Study||160
7998136|NCT00089635|19694367|P1|STARTED|Overall Study||203
7998137|NCT00089583|19694381|P2|NOT COMPLETED|Overall Study||38
7998138|NCT00089583|19694382|P1|NOT COMPLETED|Overall Study||7
7998139|NCT00089583|19694381|P2|COMPLETED|Overall Study||51
7998140|NCT00089583|19694382|P1|COMPLETED|Overall Study||13
7998141|NCT00089583|19694381|P2|STARTED|Overall Study||89
7998142|NCT00089583|19694382|P1|STARTED|Overall Study||20
7998143|NCT00089609|19694476|P2|NOT COMPLETED|Overall Study||1
7998144|NCT00089609|19694477|P1|NOT COMPLETED|Overall Study||3
7998145|NCT00089609|19694476|P2|COMPLETED|Overall Study||12
7998146|NCT00089609|19694477|P1|COMPLETED|Overall Study||57
7998147|NCT00089609|19694476|P2|STARTED|Overall Study||13
7998148|NCT00089609|19694477|P1|STARTED|Overall Study||60
7998149|NCT00089544|19694496|P2|NOT COMPLETED|Overall Study||0
7998150|NCT00089544|19694497|P1|NOT COMPLETED|Overall Study||1
7998151|NCT00089544|19694496|P2|COMPLETED|Overall Study||7
7998152|NCT00089544|19694497|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15
7998153|NCT00089544|19694496|P2|STARTED|Overall Study||7
7998154|NCT00089544|19694497|P1|STARTED|Overall Study||16
7998155|NCT00089505|19694511|P4|NOT COMPLETED|Overall Study||21
7998156|NCT00089505|19694512|P3|NOT COMPLETED|Overall Study||21
7998157|NCT00089505|19694513|P2|NOT COMPLETED|Overall Study||2
7998158|NCT00089505|19694514|P1|NOT COMPLETED|Overall Study||9
7998159|NCT00089505|19694511|P4|COMPLETED|Overall Study||230
7998160|NCT00089505|19694512|P3|COMPLETED|Overall Study||228
7998161|NCT00089505|19694513|P2|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118
7998162|NCT00089505|19694514|P1|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112
7998163|NCT00089505|19694511|P4|STARTED|Overall Study||251
7998164|NCT00089505|19694512|P3|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249
7998165|NCT00089505|19694513|P2|STARTED|Overall Study||120
7998166|NCT00089505|19694514|P1|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121
7998167|NCT00089479|19694558|P2|NOT COMPLETED|Overall Study||289
7998168|NCT00089479|19694559|P1|NOT COMPLETED|Overall Study||331
7998169|NCT00089479|19694558|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018
7998170|NCT00089479|19694559|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973
7998171|NCT00089479|19694558|P2|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283
7998172|NCT00089479|19694559|P1|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305
7998173|NCT00089479|19694558|P2|STARTED|Overall Study||1307
7998174|NCT00089479|19694559|P1|STARTED|Overall Study||1304
7998175|NCT00089414|19694586|P3|NOT COMPLETED|Overall Study||0
7998176|NCT00089414|19694587|P2|NOT COMPLETED|Overall Study||0
7998177|NCT00089414|19694588|P1|NOT COMPLETED|Overall Study||0
7998178|NCT00089414|19694586|P3|COMPLETED|Overall Study||2
7998179|NCT00089414|19694587|P2|COMPLETED|Overall Study||1
7998180|NCT00089414|19694588|P1|COMPLETED|Overall Study||2
7998181|NCT00089414|19694586|P3|STARTED|Overall Study||2
7998182|NCT00089414|19694587|P2|STARTED|Overall Study||1
7998183|NCT00089414|19694588|P1|STARTED|Overall Study||2
7998184|NCT00089297|19694602|P1|NOT COMPLETED|Overall Study||38
7998185|NCT00089297|19694602|P1|COMPLETED|Overall Study||36
7998186|NCT00089297|19694602|P1|Eligible|Overall Study||63
7998187|NCT00089297|19694602|P1|Treated|Overall Study||70
7998188|NCT00089297|19694602|P1|STARTED|Overall Study||74
7998189|NCT00089284|19694614|P7|NOT COMPLETED|Overall Study||1
7998190|NCT00089284|19694615|P6|NOT COMPLETED|Overall Study||0
7998191|NCT00089284|19694616|P5|NOT COMPLETED|Overall Study||0
7998192|NCT00089284|19694617|P4|NOT COMPLETED|Overall Study||0
7998193|NCT00089284|19694618|P3|NOT COMPLETED|Overall Study||0
7998194|NCT00089284|19694619|P2|NOT COMPLETED|Overall Study||0
7998195|NCT00089284|19694620|P1|NOT COMPLETED|Overall Study||0
7998196|NCT00089284|19694614|P7|COMPLETED|Overall Study||7
7998197|NCT00089284|19694615|P6|COMPLETED|Overall Study||0
7998198|NCT00089284|19694616|P5|COMPLETED|Overall Study||0
7998199|NCT00089284|19694617|P4|COMPLETED|Overall Study||6
7998200|NCT00089284|19694618|P3|COMPLETED|Overall Study||6
7998201|NCT00089284|19694619|P2|COMPLETED|Overall Study||3
7998202|NCT00089284|19694620|P1|COMPLETED|Overall Study||7
7998203|NCT00089284|19694614|P7|STARTED|Overall Study||8
7998204|NCT00089284|19694615|P6|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
7998205|NCT00089284|19694616|P5|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
7998206|NCT00089284|19694617|P4|STARTED|Overall Study||6
7998207|NCT00089284|19694618|P3|STARTED|Overall Study||6
7998208|NCT00089284|19694619|P2|STARTED|Overall Study||3
7998209|NCT00089284|19694620|P1|STARTED|Overall Study||7
7998210|NCT00089141|19694657|P2|NOT COMPLETED|Overall Study||24
7998211|NCT00089141|19694658|P1|NOT COMPLETED|Overall Study||18
7998212|NCT00089141|19694657|P2|COMPLETED|Overall Study||53
7998213|NCT00089141|19694658|P1|COMPLETED|Overall Study||56
7998214|NCT00089141|19694657|P2|STARTED|Overall Study||77
7998215|NCT00089141|19694658|P1|STARTED|Overall Study||74
7998216|NCT00089128|19694680|P1|NOT COMPLETED|Overall Study||0
7998217|NCT00089128|19694680|P1|COMPLETED|Overall Study||16
7998218|NCT00089128|19694680|P1|STARTED|Overall Study||16
7998219|NCT00089102|19694687|P1|NOT COMPLETED|Overall Study||0
7998220|NCT00089102|19694687|P1|COMPLETED|Overall Study||9
7998221|NCT00089102|19694687|P1|STARTED|Overall Study||9
7998222|NCT00089076|19694694|P1|NOT COMPLETED|Overall Study||10
7998223|NCT00089076|19694694|P1|COMPLETED|Overall Study||8
7998224|NCT00089076|19694694|P1|STARTED|Overall Study||18
7998225|NCT00089024|19694705|P1|NOT COMPLETED|Overall Study||5
7998226|NCT00089024|19694705|P1|COMPLETED|Overall Study||24
7998227|NCT00089024|19694705|P1|Treated Subjects|Overall Study||29
7998228|NCT00089024|19694705|P1|STARTED|Overall Study||29
7998229|NCT00089011|19694712|P2|NOT COMPLETED|Overall Study||0
7998230|NCT00089011|19694713|P1|NOT COMPLETED|Overall Study||0
7998231|NCT00089011|19694712|P2|COMPLETED|Overall Study||50
7998232|NCT00089011|19694713|P1|COMPLETED|Overall Study||100
7998233|NCT00089011|19694712|P2|STARTED|Overall Study||50
7998234|NCT00089011|19694713|P1|STARTED|Overall Study||100
7998235|NCT00088985|19694733|P1|NOT COMPLETED|Overall Study||3
7998236|NCT00088985|19694733|P1|COMPLETED|Overall Study||4
7998237|NCT00088985|19694733|P1|STARTED|Overall Study||7
7998238|NCT00088972|19694740|P2|NOT COMPLETED|Overall Study||4
7998239|NCT00088972|19694741|P1|NOT COMPLETED|Overall Study||2
7998240|NCT00088972|19694740|P2|COMPLETED|Overall Study||1
7998241|NCT00088972|19694741|P1|COMPLETED|Overall Study||1
7998242|NCT00088972|19694740|P2|STARTED|Overall Study||5
7998243|NCT00088972|19694741|P1|STARTED|Overall Study||3
7998244|NCT00088907|19694751|P2|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0
7998245|NCT00088907|19694752|P1|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24
7998246|NCT00088907|19694751|P2|COMPLETED|Single Gefitinib Treatment (Step 2)||0
7998247|NCT00088907|19694752|P1|COMPLETED|Single Gefitinib Treatment (Step 2)||0
7998248|NCT00088907|19694751|P2|Treated|Single Gefitinib Treatment (Step 2)||0
7998249|NCT00088907|19694752|P1|Treated|Single Gefitinib Treatment (Step 2)||19
7998250|NCT00088907|19694751|P2|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0
7998251|NCT00088907|19694752|P1|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24
7998252|NCT00088907|19694751|P2|NOT COMPLETED|Randomized Study (Step 1)||134
7998253|NCT00088907|19694752|P1|NOT COMPLETED|Randomized Study (Step 1)||136
7998254|NCT00088907|19694751|P2|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0
7998255|NCT00088907|19694752|P1|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0
7998256|NCT00088907|19694751|P2|Eligible and Treated|Randomized Study (Step 1)||122
7998257|NCT00088907|19694752|P1|Eligible and Treated|Randomized Study (Step 1)||117
7998258|NCT00088907|19694751|P2|Eligible|Randomized Study (Step 1)||122
7998259|NCT00088907|19694752|P1|Eligible|Randomized Study (Step 1)||117
7998260|NCT00088907|19694751|P2|Treated|Randomized Study (Step 1)||124
7998261|NCT00088907|19694752|P1|Treated|Randomized Study (Step 1)||129
7998262|NCT00088907|19694751|P2|STARTED|Randomized Study (Step 1)||134
7998263|NCT00088907|19694752|P1|STARTED|Randomized Study (Step 1)||136
7998264|NCT00088881|19694763|P1|NOT COMPLETED|Step 3 - Radiation Therapy||0
7998265|NCT00088881|19694763|P1|COMPLETED|Step 3 - Radiation Therapy||1
7998266|NCT00088881|19694763|P1|STARTED|Step 3 - Radiation Therapy||1
7998267|NCT00088881|19694763|P1|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11
7998268|NCT00088881|19694763|P1|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45
7998269|NCT00088881|19694763|P1|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48
7998270|NCT00088881|19694763|P1|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56
7998271|NCT00088881|19694763|P1|NOT COMPLETED|Step 1 - R-CHOP||14
7998272|NCT00088881|19694763|P1|COMPLETED|Step 1 - R-CHOP||48
7998273|NCT00088881|19694763|P1|Eligible and Treated|Step 1 - R-CHOP||53
7998274|NCT00088881|19694763|P1|STARTED|Step 1 - R-CHOP||62
7998275|NCT00088829|19694772|P1|NOT COMPLETED|Overall Study||22
7998276|NCT00088829|19694772|P1|COMPLETED|Overall Study||0
7998277|NCT00088829|19694772|P1|STARTED|Overall Study||22
7998278|NCT00088699|19694778|P4|NOT COMPLETED|Infusion 2||1
7998279|NCT00088699|19694779|P3|NOT COMPLETED|Infusion 2||0
7998280|NCT00088699|19694780|P2|NOT COMPLETED|Infusion 2||0
7998281|NCT00088699|19694781|P1|NOT COMPLETED|Infusion 2||0
7998282|NCT00088699|19694778|P4|COMPLETED|Infusion 2||10
7998283|NCT00088699|19694779|P3|COMPLETED|Infusion 2||11
7998284|NCT00088699|19694780|P2|COMPLETED|Infusion 2||18
7998285|NCT00088699|19694781|P1|COMPLETED|Infusion 2||19
7998286|NCT00088699|19694778|P4|STARTED|Infusion 2||11
7998287|NCT00088699|19694779|P3|STARTED|Infusion 2||11
7998288|NCT00088699|19694780|P2|STARTED|Infusion 2||18
7998289|NCT00088699|19694781|P1|STARTED|Infusion 2||19
7998290|NCT00088699|19694778|P4|NOT COMPLETED|Infusion 1||2
7998291|NCT00088699|19694779|P3|NOT COMPLETED|Infusion 1||1
7998292|NCT00088699|19694780|P2|NOT COMPLETED|Infusion 1||0
7998293|NCT00088699|19694781|P1|NOT COMPLETED|Infusion 1||1
7998294|NCT00088699|19694778|P4|COMPLETED|Infusion 1||10
7998295|NCT00088699|19694779|P3|COMPLETED|Infusion 1||12
7998296|NCT00088699|19694780|P2|COMPLETED|Infusion 1||19
7998297|NCT00088699|19694781|P1|COMPLETED|Infusion 1||22
7998298|NCT00088699|19694778|P4|STARTED|Infusion 1||12
7998299|NCT00088699|19694779|P3|STARTED|Infusion 1||13
7998300|NCT00088699|19694780|P2|STARTED|Infusion 1||19
7998301|NCT00088699|19694781|P1|STARTED|Infusion 1||23
7998302|NCT00088634|19694797|P2|NOT COMPLETED|Overall Study||43
7998303|NCT00088634|19694798|P1|NOT COMPLETED|Overall Study||38
7998304|NCT00088634|19694797|P2|COMPLETED|Overall Study||47
7998305|NCT00088634|19694798|P1|COMPLETED|Overall Study||52
7998306|NCT00088634|19694797|P2|STARTED|Overall Study||90
7998307|NCT00088634|19694798|P1|STARTED|Overall Study||90
7998308|NCT00088621|19694810|P1|NOT COMPLETED|Overall Study||54
7998309|NCT00088621|19694810|P1|COMPLETED|Overall Study||7
7998310|NCT00088621|19694810|P1|STARTED|Overall Study||61
7998311|NCT00088595|19694814|P1|NOT COMPLETED|Overall Study||28
7998312|NCT00088595|19694814|P1|COMPLETED|Overall Study||17
7998313|NCT00088595|19694814|P1|STARTED|Overall Study||45
7998314|NCT00088530|19694832|P2|NOT COMPLETED|Overall Study||54
7998315|NCT00088530|19694833|P1|NOT COMPLETED|Overall Study||50
7998316|NCT00088530|19694832|P2|COMPLETED|Overall Study||16
7998317|NCT00088530|19694833|P1|COMPLETED|Overall Study||20
7998318|NCT00088530|19694832|P2|STARTED|Overall Study||70
7998319|NCT00088530|19694833|P1|STARTED|Overall Study||70
7998320|NCT00088465|19694845|P1|NOT COMPLETED|Overall Study||561
7998321|NCT00088465|19694845|P1|COMPLETED|Overall Study||370
7998322|NCT00088465|19694845|P1|STARTED|Overall Study||931
7998323|NCT00088452|19694871|P3|NOT COMPLETED|Overall Study||1
7998324|NCT00088452|19694872|P2|NOT COMPLETED|Overall Study||0
7998325|NCT00088452|19694873|P1|NOT COMPLETED|Overall Study||1
7998326|NCT00088452|19694871|P3|COMPLETED|Overall Study||147
7998327|NCT00088452|19694872|P2|COMPLETED|Overall Study||149
7998328|NCT00088452|19694873|P1|COMPLETED|Overall Study||155
7998329|NCT00088452|19694871|P3|STARTED|Overall Study||148
7998330|NCT00088452|19694872|P2|STARTED|Overall Study||149
7998331|NCT00088452|19694873|P1|STARTED|Overall Study||156
7998332|NCT00088413|19694891|P4|NOT COMPLETED|Overall Study||14
7998333|NCT00088413|19694892|P3|NOT COMPLETED|Overall Study||12
7998334|NCT00088413|19694893|P2|NOT COMPLETED|Overall Study||15
7998335|NCT00088413|19694894|P1|NOT COMPLETED|Overall Study||10
7998336|NCT00088413|19694891|P4|COMPLETED|Overall Study||0
7998337|NCT00088413|19694892|P3|COMPLETED|Overall Study||0
7998338|NCT00088413|19694893|P2|COMPLETED|Overall Study||0
7998339|NCT00088413|19694894|P1|COMPLETED|Overall Study||0
7998340|NCT00088413|19694891|P4|STARTED|Overall Study||14
7998341|NCT00088413|19694892|P3|STARTED|Overall Study||12
7998342|NCT00088413|19694893|P2|STARTED|Overall Study||15
7998343|NCT00088413|19694894|P1|STARTED|Overall Study||10
7998344|NCT00088374|19694908|P1|NOT COMPLETED|Overall Study||2
7998345|NCT00088374|19694908|P1|COMPLETED|Overall Study||7
7998346|NCT00088374|19694908|P1|STARTED|Overall Study||9
7998347|NCT00088218|19694919|P2|NOT COMPLETED|Overall Study||0
7998348|NCT00088218|19694920|P1|NOT COMPLETED|Overall Study||0
7998349|NCT00088218|19694919|P2|COMPLETED|Overall Study||79
7998350|NCT00088218|19694920|P1|COMPLETED|Overall Study||16
7998351|NCT00088218|19694919|P2|STARTED|Overall Study||79
7998352|NCT00088218|19694920|P1|STARTED|Overall Study||16
7998353|NCT00088205|19694926|P1|NOT COMPLETED|Overall Study||60
7998354|NCT00088205|19694926|P1|COMPLETED|Overall Study||0
7998355|NCT00088205|19694926|P1|Efficacy Population|Overall Study|Participants with diagnosis of relapsed mantle cell lymphoma.|59
7998356|NCT00088205|19694926|P1|Received at Least 1 Dose of Study Drug|Overall Study||60
7998357|NCT00088205|19694926|P1|STARTED|Overall Study||60
7998358|NCT00088166|19694943|P2|NOT COMPLETED|Overall Study||61
7998359|NCT00088166|19694944|P1|NOT COMPLETED|Overall Study||53
7998360|NCT00088166|19694943|P2|COMPLETED|Overall Study||39
7998361|NCT00088166|19694944|P1|COMPLETED|Overall Study||47
7998362|NCT00088166|19694943|P2|STARTED|Overall Study||100
7998363|NCT00088166|19694944|P1|STARTED|Overall Study||100
7998364|NCT00088153|19694968|P2|NOT COMPLETED|Overall Study||25
7998365|NCT00088153|19694969|P1|NOT COMPLETED|Overall Study||24
7998366|NCT00088153|19694968|P2|COMPLETED|Overall Study||30
7998367|NCT00088153|19694969|P1|COMPLETED|Overall Study||31
7998368|NCT00088153|19694968|P2|STARTED|Overall Study||55
7998369|NCT00088153|19694969|P1|STARTED|Overall Study||55
7998370|NCT00087698|19694979|P1|NOT COMPLETED|Overall Study||36
7998371|NCT00087698|19694979|P1|COMPLETED|Overall Study||41
7998372|NCT00087698|19694979|P1|STARTED|Overall Study||77
7998373|NCT00087685|19694988|P1|NOT COMPLETED|Overall Study||14
7998374|NCT00087685|19694988|P1|COMPLETED|Overall Study||21
7998375|NCT00087685|19694988|P1|STARTED|Overall Study||35
7998376|NCT00087672|19694993|P1|NOT COMPLETED|Overall Study||0
7998377|NCT00087672|19694993|P1|COMPLETED|Overall Study||41
7998378|NCT00087672|19694993|P1|STARTED|Overall Study||41
7998379|NCT00087646|19695001|P4|NOT COMPLETED|Overall Study||84
7998380|NCT00087646|19695002|P3|NOT COMPLETED|Overall Study||65
7998381|NCT00087646|19695003|P2|NOT COMPLETED|Overall Study||42
7998382|NCT00087646|19695004|P1|NOT COMPLETED|Overall Study||135
7998383|NCT00087646|19695001|P4|COMPLETED|Overall Study||229
7998384|NCT00087646|19695002|P3|COMPLETED|Overall Study||91
7998385|NCT00087646|19695003|P2|COMPLETED|Overall Study||114
7998386|NCT00087646|19695004|P1|COMPLETED|Overall Study||182
7998387|NCT00087646|19695001|P4|STARTED|Overall Study||313
7998388|NCT00087646|19695002|P3|STARTED|Overall Study||156
7998389|NCT00087646|19695003|P2|STARTED|Overall Study||156
7998390|NCT00087646|19695004|P1|STARTED|Overall Study||317
7998391|NCT00087633|19695032|P2|NOT COMPLETED|Overall Study||17
7998392|NCT00087633|19695033|P1|NOT COMPLETED|Overall Study||24
7998393|NCT00087633|19695032|P2|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43
7998394|NCT00087633|19695033|P1|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31
7998395|NCT00087633|19695032|P2|STARTED|Overall Study|Randomized|60
7998396|NCT00087633|19695033|P1|STARTED|Overall Study|Randomized|55
7998397|NCT00087607|19695043|P2|NOT COMPLETED|Overall Study||122
7998398|NCT00087607|19695044|P1|NOT COMPLETED|Overall Study||122
7998399|NCT00087607|19695043|P2|COMPLETED|Overall Study||71
7998400|NCT00087607|19695044|P1|COMPLETED|Overall Study||70
7998401|NCT00087607|19695043|P2|STARTED|Overall Study||193
7998402|NCT00087607|19695044|P1|STARTED|Overall Study||192
7998403|NCT00087594|19695084|P2|NOT COMPLETED|Overall Study||12
7998404|NCT00087594|19695085|P1|NOT COMPLETED|Overall Study||8
7998405|NCT00087594|19695084|P2|COMPLETED|Overall Study||12
7998406|NCT00087594|19695085|P1|COMPLETED|Overall Study||16
7998407|NCT00087594|19695084|P2|STARTED|Overall Study||24
7998408|NCT00087594|19695085|P1|STARTED|Overall Study||24
7998409|NCT00087568|19695119|P2|NOT COMPLETED|Overall Study||2
7998410|NCT00087568|19695120|P1|NOT COMPLETED|Overall Study||30
7998411|NCT00087568|19695119|P2|COMPLETED|Overall Study||23
7998412|NCT00087568|19695120|P1|COMPLETED|Overall Study||2
7998413|NCT00087568|19695119|P2|STARTED|Overall Study||25
7998414|NCT00087568|19695120|P1|STARTED|Overall Study||32
7998415|NCT00087555|19695147|P3|NOT COMPLETED|Overall Study||21
7998416|NCT00087555|19695148|P2|NOT COMPLETED|Overall Study||11
7998417|NCT00087555|19695149|P1|NOT COMPLETED|Overall Study||12
7998418|NCT00087555|19695147|P3|COMPLETED|Overall Study||46
7998419|NCT00087555|19695148|P2|COMPLETED|Overall Study||51
7998420|NCT00087555|19695149|P1|COMPLETED|Overall Study||54
7998421|NCT00087555|19695147|P3|Treated|Overall Study||67
7998422|NCT00087555|19695148|P2|Treated|Overall Study||60
7998423|NCT00087555|19695149|P1|Treated|Overall Study||65
7998424|NCT00087555|19695147|P3|STARTED|Overall Study||67
7998425|NCT00087555|19695148|P2|STARTED|Overall Study||62
7998426|NCT00087555|19695149|P1|STARTED|Overall Study||66
7998427|NCT00087529|19695159|P2|NOT COMPLETED|Overall Study||68
7998428|NCT00087529|19695160|P1|NOT COMPLETED|Overall Study||31
7998429|NCT00087529|19695159|P2|COMPLETED|Overall Study||224
7998430|NCT00087529|19695160|P1|COMPLETED|Overall Study||116
7998431|NCT00087529|19695159|P2|STARTED|Overall Study||292
7998432|NCT00087529|19695160|P1|STARTED|Overall Study||147
7998433|NCT00087516|19695175|P4|NOT COMPLETED|Overall Study||85
7998434|NCT00087516|19695176|P3|NOT COMPLETED|Overall Study||97
7998435|NCT00087516|19695177|P2|NOT COMPLETED|Overall Study||169
7998436|NCT00087516|19695178|P1|NOT COMPLETED|Overall Study||161
7998437|NCT00087516|19695175|P4|COMPLETED|Overall Study||38
7998438|NCT00087516|19695176|P3|COMPLETED|Overall Study||33
7998439|NCT00087516|19695177|P2|COMPLETED|Overall Study||81
7998440|NCT00087516|19695178|P1|COMPLETED|Overall Study||77
7998441|NCT00087516|19695175|P4|STARTED|Overall Study||123
7998442|NCT00087516|19695176|P3|STARTED|Overall Study||130
7998443|NCT00087516|19695177|P2|STARTED|Overall Study||250
7998444|NCT00087516|19695178|P1|STARTED|Overall Study||238
7998445|NCT00087490|19695207|P2|NOT COMPLETED|Overall Study||269
7998446|NCT00087490|19695208|P1|NOT COMPLETED|Overall Study||258
7998447|NCT00087490|19695207|P2|COMPLETED|Overall Study||264
7998448|NCT00087490|19695208|P1|COMPLETED|Overall Study||286
7998449|NCT00087490|19695207|P2|Treated|Overall Study||515
7998450|NCT00087490|19695208|P1|Treated|Overall Study||537
7998451|NCT00087490|19695207|P2|STARTED|Overall Study||533
7998452|NCT00087490|19695208|P1|STARTED|Overall Study||544
7998453|NCT00087438|19695242|P1|NOT COMPLETED|Overall Study||4
7998454|NCT00087438|19695242|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55
7998455|NCT00087438|19695242|P1|STARTED|Overall Study||59
7998456|NCT00087152|19695252|P1|NOT COMPLETED|Overall Study||6
7998457|NCT00087152|19695252|P1|COMPLETED|Overall Study||21
7998458|NCT00087152|19695252|P1|STARTED|Overall Study||27
7998459|NCT00087139|19695261|P3|NOT COMPLETED|Overall Study||36
7998460|NCT00087139|19695262|P2|NOT COMPLETED|Overall Study||49
7998461|NCT00087139|19695263|P1|NOT COMPLETED|Overall Study||39
7998462|NCT00087139|19695261|P3|COMPLETED|Overall Study||0
7998463|NCT00087139|19695262|P2|COMPLETED|Overall Study||0
7998464|NCT00087139|19695263|P1|COMPLETED|Overall Study||0
7998465|NCT00087139|19695261|P3|Patients w/ Measurable Disease Response|Overall Study||0
7998466|NCT00087139|19695262|P2|Patients w/ Measurable Disease Response|Overall Study||2
7998467|NCT00087139|19695263|P1|Patients w/ Measurable Disease Response|Overall Study||5
7998468|NCT00087139|19695261|P3|Patients With PSA Response|Overall Study||4
7998469|NCT00087139|19695262|P2|Patients With PSA Response|Overall Study||8
7998470|NCT00087139|19695263|P1|Patients With PSA Response|Overall Study||10
7998471|NCT00087139|19695261|P3|Patients With Measurable Disease|Overall Study||24
7998472|NCT00087139|19695262|P2|Patients With Measurable Disease|Overall Study||25
7998473|NCT00087139|19695263|P1|Patients With Measurable Disease|Overall Study||22
7998474|NCT00087139|19695261|P3|Patients for the Analysis of PSA Respons|Overall Study||22
7998475|NCT00087139|19695262|P2|Patients for the Analysis of PSA Respons|Overall Study||34
7998476|NCT00087139|19695263|P1|Patients for the Analysis of PSA Respons|Overall Study||30
7998477|NCT00087139|19695261|P3|Eligible and Treated|Overall Study||32
7998478|NCT00087139|19695262|P2|Eligible and Treated|Overall Study||42
7998479|NCT00087139|19695263|P1|Eligible and Treated|Overall Study||35
7998480|NCT00087139|19695261|P3|Treated|Overall Study||36
7998481|NCT00087139|19695262|P2|Treated|Overall Study||48
7998482|NCT00087139|19695263|P1|Treated|Overall Study||39
7998483|NCT00087139|19695261|P3|STARTED|Overall Study||36
7998484|NCT00087139|19695262|P2|STARTED|Overall Study||49
7998485|NCT00087139|19695263|P1|STARTED|Overall Study||39
7998486|NCT00087126|19695278|P1|NOT COMPLETED|Overall Study||2
7998487|NCT00087126|19695278|P1|COMPLETED|Overall Study||25
7998488|NCT00087126|19695278|P1|STARTED|Overall Study||27
7998489|NCT00087022|19695289|P2|NOT COMPLETED|Overall Study||55
7998490|NCT00087022|19695290|P1|NOT COMPLETED|Overall Study||54
7998491|NCT00087022|19695289|P2|COMPLETED|Overall Study||376
7998492|NCT00087022|19695290|P1|COMPLETED|Overall Study||379
7998493|NCT00087022|19695289|P2|Treated (Safety Population)|Overall Study||424
7998494|NCT00087022|19695290|P1|Treated (Safety Population)|Overall Study||431
7998495|NCT00087022|19695289|P2|STARTED|Overall Study||431
7998496|NCT00087022|19695290|P1|STARTED|Overall Study||433
7998497|NCT00086996|19695303|P1|NOT COMPLETED|Overall Study||64
7998498|NCT00086996|19695303|P1|COMPLETED|Overall Study||34
7998499|NCT00086996|19695303|P1|Eligible and Began Protocol Therapy|Overall Study||93
7998500|NCT00086996|19695303|P1|Eligible|Overall Study||93
7998501|NCT00086996|19695303|P1|STARTED|Overall Study||98
7998502|NCT00086957|19695310|P3|NOT COMPLETED|Overall Study||0
7998503|NCT00086957|19695311|P2|NOT COMPLETED|Overall Study||0
7998504|NCT00086957|19695312|P1|NOT COMPLETED|Overall Study||0
7998505|NCT00086957|19695310|P3|COMPLETED|Overall Study||22
7998506|NCT00086957|19695311|P2|COMPLETED|Overall Study||7
7998507|NCT00086957|19695312|P1|COMPLETED|Overall Study||2
7998508|NCT00086957|19695310|P3|STARTED|Overall Study||22
7998509|NCT00086957|19695311|P2|STARTED|Overall Study||7
7998510|NCT00086957|19695312|P1|STARTED|Overall Study||2
7998511|NCT00086684|19695325|P3|NOT COMPLETED|Overall Study||53
7998512|NCT00086684|19695326|P2|NOT COMPLETED|Overall Study||55
7998513|NCT00086684|19695327|P1|NOT COMPLETED|Overall Study||55
7998514|NCT00086684|19695325|P3|COMPLETED|Overall Study||69
7998515|NCT00086684|19695326|P2|COMPLETED|Overall Study||74
7998516|NCT00086684|19695327|P1|COMPLETED|Overall Study||63
7998517|NCT00086684|19695325|P3|STARTED|Overall Study||122
7998518|NCT00086684|19695326|P2|STARTED|Overall Study||129
7998519|NCT00086684|19695327|P1|STARTED|Overall Study||118
7998520|NCT00086619|19695340|P2|NOT COMPLETED|Overall Study||17
7998521|NCT00086619|19695341|P1|NOT COMPLETED|Overall Study||15
7998522|NCT00086619|19695340|P2|COMPLETED|Overall Study||23
7998523|NCT00086619|19695341|P1|COMPLETED|Overall Study||25
7998524|NCT00086619|19695340|P2|Completed 12 Month Visit|Overall Study||26
7998525|NCT00086619|19695341|P1|Completed 12 Month Visit|Overall Study||26
7998526|NCT00086619|19695340|P2|Completed Baseline Visit|Overall Study||36
7998527|NCT00086619|19695341|P1|Completed Baseline Visit|Overall Study||34
7998528|NCT00086619|19695340|P2|STARTED|Overall Study||40
7998529|NCT00086619|19695341|P1|STARTED|Overall Study||40
7998530|NCT00086580|19695351|P2|NOT COMPLETED|Observation Period||65
7998531|NCT00086580|19695352|P1|NOT COMPLETED|Observation Period||46
7998532|NCT00086580|19695351|P2|COMPLETED|Observation Period||56
7998533|NCT00086580|19695352|P1|COMPLETED|Observation Period||49
7998534|NCT00086580|19695351|P2|STARTED|Observation Period||121
7998535|NCT00086580|19695352|P1|STARTED|Observation Period||95
7998536|NCT00086580|19695351|P2|NOT COMPLETED|Follow-up Period||119
7998537|NCT00086580|19695352|P1|NOT COMPLETED|Follow-up Period||104
7998538|NCT00086580|19695351|P2|COMPLETED|Follow-up Period||18
7998539|NCT00086580|19695352|P1|COMPLETED|Follow-up Period||37
7998540|NCT00086580|19695351|P2|STARTED|Follow-up Period||137
7998541|NCT00086580|19695352|P1|STARTED|Follow-up Period||141
7998542|NCT00086580|19695351|P2|NOT COMPLETED|Treatment Period||60
7998543|NCT00086580|19695352|P1|NOT COMPLETED|Treatment Period||65
7998544|NCT00086580|19695351|P2|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107
7998545|NCT00086580|19695352|P1|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103
7998546|NCT00086580|19695351|P2|Safety Population|Treatment Period|Two participants did not receive treatment|165
7998547|NCT00086580|19695352|P1|Safety Population|Treatment Period|Four participants did not receive treatment|164
7998548|NCT00086580|19695351|P2|STARTED|Treatment Period||167
7998549|NCT00086580|19695352|P1|STARTED|Treatment Period||168
7998550|NCT00086411|19695400|P4|NOT COMPLETED|Overall Study||12
7998551|NCT00086411|19695401|P3|NOT COMPLETED|Overall Study||13
7998552|NCT00086411|19695402|P2|NOT COMPLETED|Overall Study||11
7998553|NCT00086411|19695403|P1|NOT COMPLETED|Overall Study||11
7998554|NCT00086411|19695400|P4|COMPLETED|Overall Study||53
7998555|NCT00086411|19695401|P3|COMPLETED|Overall Study||49
7998556|NCT00086411|19695402|P2|COMPLETED|Overall Study||52
7998557|NCT00086411|19695403|P1|COMPLETED|Overall Study||59
7998558|NCT00086411|19695400|P4|STARTED|Overall Study||65
7998559|NCT00086411|19695401|P3|STARTED|Overall Study||62
7998560|NCT00086411|19695402|P2|STARTED|Overall Study||63
7998561|NCT00086411|19695403|P1|STARTED|Overall Study||70
7998562|NCT00086385|19695421|P4|NOT COMPLETED|Overall Study||1
7998563|NCT00086385|19695422|P3|NOT COMPLETED|Overall Study||1
7998564|NCT00086385|19695423|P2|NOT COMPLETED|Overall Study||2
7998565|NCT00086385|19695424|P1|NOT COMPLETED|Overall Study||2
7998566|NCT00086385|19695421|P4|COMPLETED|Overall Study||98
7998567|NCT00086385|19695422|P3|COMPLETED|Overall Study||103
7998568|NCT00086385|19695423|P2|COMPLETED|Overall Study||97
7998569|NCT00086385|19695424|P1|COMPLETED|Overall Study||98
7998570|NCT00086385|19695421|P4|STARTED|Overall Study||99
7998571|NCT00086385|19695422|P3|STARTED|Overall Study||104
7998572|NCT00086385|19695423|P2|STARTED|Overall Study||99
7998573|NCT00086385|19695424|P1|STARTED|Overall Study||100
7998574|NCT00086515|19695436|P2|NOT COMPLETED|Phase B (Weeks 24-104)||55
7998575|NCT00086515|19695437|P1|NOT COMPLETED|Phase B (Weeks 24-104)||190
7998576|NCT00086515|19695436|P2|COMPLETED|Phase B (Weeks 24-104)||109
7998577|NCT00086515|19695437|P1|COMPLETED|Phase B (Weeks 24-104)||201
7998578|NCT00086515|19695436|P2|STARTED|Phase B (Weeks 24-104)||164
7998579|NCT00086515|19695437|P1|STARTED|Phase B (Weeks 24-104)||391
7998580|NCT00086515|19695436|P2|NOT COMPLETED|Phase A to Phase B Transition Period||28
7998581|NCT00086515|19695437|P1|NOT COMPLETED|Phase A to Phase B Transition Period||24
7998582|NCT00086515|19695436|P2|COMPLETED|Phase A to Phase B Transition Period||164
7998583|NCT00086515|19695437|P1|COMPLETED|Phase A to Phase B Transition Period||391
7998584|NCT00086515|19695436|P2|STARTED|Phase A to Phase B Transition Period||192
7998585|NCT00086515|19695437|P1|STARTED|Phase A to Phase B Transition Period||415
7998586|NCT00086515|19695436|P2|NOT COMPLETED|Phase A (Weeks 0-24)||45
7998587|NCT00086515|19695437|P1|NOT COMPLETED|Phase A (Weeks 0-24)||49
7998588|NCT00086515|19695436|P2|COMPLETED|Phase A (Weeks 0-24)||192
7998589|NCT00086515|19695437|P1|COMPLETED|Phase A (Weeks 0-24)||415
7998590|NCT00086515|19695436|P2|STARTED|Phase A (Weeks 0-24)||237
7998591|NCT00086515|19695437|P1|STARTED|Phase A (Weeks 0-24)||464
7998592|NCT00086502|19695449|P2|NOT COMPLETED|Overall Study||20
7998593|NCT00086502|19695450|P1|NOT COMPLETED|Overall Study||26
7998594|NCT00086502|19695449|P2|COMPLETED|Overall Study||158
7998595|NCT00086502|19695450|P1|COMPLETED|Overall Study||149
7998596|NCT00086502|19695449|P2|STARTED|Overall Study||178
7998597|NCT00086502|19695450|P1|STARTED|Overall Study||175
7998598|NCT00086450|19695460|P2|NOT COMPLETED|Overall Study||0
7998599|NCT00086450|19695461|P1|NOT COMPLETED|Overall Study||0
7998600|NCT00086450|19695460|P2|COMPLETED|Overall Study||947
7998601|NCT00086450|19695461|P1|COMPLETED|Overall Study||953
7998602|NCT00086450|19695460|P2|STARTED|Overall Study||947
7998603|NCT00086450|19695461|P1|STARTED|Overall Study||953
7998604|NCT00086346|19695475|P2|NOT COMPLETED|Patients Dosed With Test Article||23
7998605|NCT00086346|19695476|P1|NOT COMPLETED|Patients Dosed With Test Article||140
7998606|NCT00086346|19695475|P2|COMPLETED|Patients Dosed With Test Article||187
7998607|NCT00086346|19695476|P1|COMPLETED|Patients Dosed With Test Article||249
7998608|NCT00086346|19695475|P2|STARTED|Patients Dosed With Test Article||210
7998609|NCT00086346|19695476|P1|STARTED|Patients Dosed With Test Article||389
7998610|NCT00086346|19695475|P2|NOT COMPLETED|Randomization||4
7998611|NCT00086346|19695476|P1|NOT COMPLETED|Randomization||4
7998612|NCT00086346|19695475|P2|COMPLETED|Randomization||210
7998613|NCT00086346|19695476|P1|COMPLETED|Randomization||389
7998614|NCT00086346|19695475|P2|STARTED|Randomization||214
7998615|NCT00086346|19695476|P1|STARTED|Randomization||393
7998616|NCT00086281|19695503|P15|NOT COMPLETED|Phase 2||0
7998617|NCT00086281|19695504|P14|NOT COMPLETED|Phase 2||1
7998618|NCT00086281|19695505|P13|NOT COMPLETED|Phase 2||1
7998619|NCT00086281|19695506|P12|NOT COMPLETED|Phase 2||0
7998620|NCT00086281|19695507|P11|NOT COMPLETED|Phase 2||0
7998621|NCT00086281|19695508|P10|NOT COMPLETED|Phase 2||0
7998622|NCT00086281|19695509|P9|NOT COMPLETED|Phase 2||0
7998623|NCT00086281|19695510|P8|NOT COMPLETED|Phase 2||0
7998624|NCT00086281|19695511|P7|NOT COMPLETED|Phase 2||0
7998625|NCT00086281|19695512|P6|NOT COMPLETED|Phase 2||0
7998626|NCT00086281|19695513|P5|NOT COMPLETED|Phase 2||0
7998627|NCT00086281|19695514|P4|NOT COMPLETED|Phase 2||0
7998628|NCT00086281|19695515|P3|NOT COMPLETED|Phase 2||0
7998629|NCT00086281|19695516|P2|NOT COMPLETED|Phase 2||0
7998630|NCT00086281|19695517|P1|NOT COMPLETED|Phase 2||0
7998631|NCT00086281|19695503|P15|COMPLETED|Phase 2||0
7998632|NCT00086281|19695504|P14|COMPLETED|Phase 2||26
7998633|NCT00086281|19695505|P13|COMPLETED|Phase 2||22
7998634|NCT00086281|19695506|P12|COMPLETED|Phase 2||0
7998635|NCT00086281|19695507|P11|COMPLETED|Phase 2||0
7998636|NCT00086281|19695508|P10|COMPLETED|Phase 2||0
7998637|NCT00086281|19695509|P9|COMPLETED|Phase 2||0
7998638|NCT00086281|19695510|P8|COMPLETED|Phase 2||0
7998639|NCT00086281|19695511|P7|COMPLETED|Phase 2||0
7998640|NCT00086281|19695512|P6|COMPLETED|Phase 2||0
7998641|NCT00086281|19695513|P5|COMPLETED|Phase 2||0
7998642|NCT00086281|19695514|P4|COMPLETED|Phase 2||0
7998643|NCT00086281|19695515|P3|COMPLETED|Phase 2||0
7998644|NCT00086281|19695516|P2|COMPLETED|Phase 2||0
7998645|NCT00086281|19695517|P1|COMPLETED|Phase 2||0
7998646|NCT00086281|19695503|P15|STARTED|Phase 2||0
7998647|NCT00086281|19695504|P14|STARTED|Phase 2||27
7998648|NCT00086281|19695505|P13|STARTED|Phase 2||23
7998649|NCT00086281|19695506|P12|STARTED|Phase 2||0
7998650|NCT00086281|19695507|P11|STARTED|Phase 2||0
7998651|NCT00086281|19695508|P10|STARTED|Phase 2||0
7998652|NCT00086281|19695509|P9|STARTED|Phase 2||0
7998653|NCT00086281|19695510|P8|STARTED|Phase 2||0
7998654|NCT00086281|19695511|P7|STARTED|Phase 2||0
7998655|NCT00086281|19695512|P6|STARTED|Phase 2||0
7998656|NCT00086281|19695513|P5|STARTED|Phase 2||0
7998657|NCT00086281|19695514|P4|STARTED|Phase 2||0
7998658|NCT00086281|19695515|P3|STARTED|Phase 2||0
7998659|NCT00086281|19695516|P2|STARTED|Phase 2||0
7998660|NCT00086281|19695517|P1|STARTED|Phase 2||0
7998661|NCT00086281|19695503|P15|NOT COMPLETED|Phase 1||3
7998662|NCT00086281|19695504|P14|NOT COMPLETED|Phase 1||1
7998663|NCT00086281|19695505|P13|NOT COMPLETED|Phase 1||1
7998664|NCT00086281|19695506|P12|NOT COMPLETED|Phase 1||1
7998665|NCT00086281|19695507|P11|NOT COMPLETED|Phase 1||3
7998666|NCT00086281|19695508|P10|NOT COMPLETED|Phase 1||1
7998667|NCT00086281|19695509|P9|NOT COMPLETED|Phase 1||0
7998668|NCT00086281|19695510|P8|NOT COMPLETED|Phase 1||0
7998669|NCT00086281|19695511|P7|NOT COMPLETED|Phase 1||0
7998670|NCT00086281|19695512|P6|NOT COMPLETED|Phase 1||0
7998671|NCT00086281|19695513|P5|NOT COMPLETED|Phase 1||0
7998672|NCT00086281|19695514|P4|NOT COMPLETED|Phase 1||0
7998673|NCT00086281|19695515|P3|NOT COMPLETED|Phase 1||0
7998674|NCT00086281|19695516|P2|NOT COMPLETED|Phase 1||0
7998675|NCT00086281|19695517|P1|NOT COMPLETED|Phase 1||0
7998676|NCT00086281|19695503|P15|COMPLETED|Phase 1||0
7998677|NCT00086281|19695504|P14|COMPLETED|Phase 1||0
7998678|NCT00086281|19695505|P13|COMPLETED|Phase 1||0
7998679|NCT00086281|19695506|P12|COMPLETED|Phase 1||0
7998680|NCT00086281|19695507|P11|COMPLETED|Phase 1||0
7998681|NCT00086281|19695508|P10|COMPLETED|Phase 1||0
7998682|NCT00086281|19695509|P9|COMPLETED|Phase 1||2
7998683|NCT00086281|19695510|P8|COMPLETED|Phase 1||1
7998684|NCT00086281|19695511|P7|COMPLETED|Phase 1||1
7998685|NCT00086281|19695512|P6|COMPLETED|Phase 1||3
7998686|NCT00086281|19695513|P5|COMPLETED|Phase 1||1
7998687|NCT00086281|19695514|P4|COMPLETED|Phase 1||11
7998688|NCT00086281|19695515|P3|COMPLETED|Phase 1||8
7998689|NCT00086281|19695516|P2|COMPLETED|Phase 1||12
7998690|NCT00086281|19695517|P1|COMPLETED|Phase 1||11
7998691|NCT00086281|19695503|P15|STARTED|Phase 1||3
7998692|NCT00086281|19695504|P14|STARTED|Phase 1||1
7998693|NCT00086281|19695505|P13|STARTED|Phase 1||1
7998694|NCT00086281|19695506|P12|STARTED|Phase 1||1
7998695|NCT00086281|19695507|P11|STARTED|Phase 1||3
7998696|NCT00086281|19695508|P10|STARTED|Phase 1||1
7998697|NCT00086281|19695509|P9|STARTED|Phase 1||2
7998698|NCT00086281|19695510|P8|STARTED|Phase 1||1
7998699|NCT00086281|19695511|P7|STARTED|Phase 1||1
7998700|NCT00086281|19695512|P6|STARTED|Phase 1||3
7998701|NCT00086281|19695513|P5|STARTED|Phase 1||1
7998702|NCT00086281|19695514|P4|STARTED|Phase 1||11
7998703|NCT00086281|19695515|P3|STARTED|Phase 1||8
7998704|NCT00086281|19695516|P2|STARTED|Phase 1||12
7998705|NCT00086281|19695517|P1|STARTED|Phase 1||11
7998706|NCT00086307|19695530|P3|NOT COMPLETED|Overall Study||8
7998707|NCT00086307|19695531|P2|NOT COMPLETED|Overall Study||1
7998708|NCT00086307|19695532|P1|NOT COMPLETED|Overall Study||2
7998709|NCT00086307|19695530|P3|COMPLETED|Overall Study||5
7998710|NCT00086307|19695531|P2|COMPLETED|Overall Study||12
7998711|NCT00086307|19695532|P1|COMPLETED|Overall Study||11
7998712|NCT00086307|19695530|P3|STARTED|Overall Study||13
7998713|NCT00086307|19695531|P2|STARTED|Overall Study||13
7998714|NCT00086307|19695532|P1|STARTED|Overall Study||13
7998715|NCT00086190|19695543|P3|NOT COMPLETED|Overall Study||6
7998716|NCT00086190|19695544|P2|NOT COMPLETED|Overall Study||4
7998717|NCT00086190|19695545|P1|NOT COMPLETED|Overall Study||8
7998718|NCT00086190|19695543|P3|COMPLETED|Overall Study||33
7998719|NCT00086190|19695544|P2|COMPLETED|Overall Study||30
7998720|NCT00086190|19695545|P1|COMPLETED|Overall Study||34
7998721|NCT00086190|19695543|P3|STARTED|Overall Study||39
7998722|NCT00086190|19695544|P2|STARTED|Overall Study||34
7998723|NCT00086190|19695545|P1|STARTED|Overall Study||42
7998724|NCT00086138|19695603|P2|NOT COMPLETED|Overall Study||3
7998725|NCT00086138|19695604|P1|NOT COMPLETED|Overall Study||4
7998726|NCT00086138|19695603|P2|COMPLETED|Overall Study||64
7998727|NCT00086138|19695604|P1|COMPLETED|Overall Study||60
7998728|NCT00086138|19695603|P2|STARTED|Overall Study||67
7998729|NCT00086138|19695604|P1|STARTED|Overall Study||64
7998730|NCT00086047|19695614|P2|NOT COMPLETED|Overall Study||7
7998731|NCT00086047|19695615|P1|NOT COMPLETED|Overall Study||7
7998732|NCT00086047|19695614|P2|COMPLETED|Overall Study||50
7998733|NCT00086047|19695615|P1|COMPLETED|Overall Study||50
7998734|NCT00086047|19695614|P2|STARTED|Overall Study||57
7998735|NCT00086047|19695615|P1|STARTED|Overall Study||57
7998736|NCT00085917|19695623|P2|NOT COMPLETED|Overall Study||3
7998737|NCT00085917|19695624|P1|NOT COMPLETED|Overall Study||4
7998738|NCT00085917|19695623|P2|COMPLETED|Overall Study||11
7998739|NCT00085917|19695624|P1|COMPLETED|Overall Study||11
7998740|NCT00085917|19695623|P2|STARTED|Overall Study||14
7998741|NCT00085917|19695624|P1|STARTED|Overall Study||15
7998742|NCT00085839|19695636|P2|NOT COMPLETED|Overall Study||0
7998743|NCT00085839|19695637|P1|NOT COMPLETED|Overall Study||0
7998744|NCT00085839|19695636|P2|COMPLETED|Overall Study||51
7998745|NCT00085839|19695637|P1|COMPLETED|Overall Study||52
7998746|NCT00085839|19695636|P2|STARTED|Overall Study||51
7998747|NCT00085839|19695637|P1|STARTED|Overall Study||52
7998748|NCT00085735|19695653|P6|NOT COMPLETED|Overall Study||31
7998749|NCT00085735|19695654|P5|NOT COMPLETED|Overall Study||42
7998750|NCT00085735|19695655|P4|NOT COMPLETED|Overall Study||19
7998751|NCT00085735|19695656|P3|NOT COMPLETED|Overall Study||17
7998752|NCT00085735|19695657|P2|NOT COMPLETED|Overall Study||10
7998753|NCT00085735|19695658|P1|NOT COMPLETED|Overall Study||12
7998754|NCT00085735|19695653|P6|COMPLETED|Overall Study||115
7998755|NCT00085735|19695654|P5|COMPLETED|Overall Study||105
7998756|NCT00085735|19695655|P4|COMPLETED|Overall Study||46
7998757|NCT00085735|19695656|P3|COMPLETED|Overall Study||46
7998758|NCT00085735|19695657|P2|COMPLETED|Overall Study||54
7998759|NCT00085735|19695658|P1|COMPLETED|Overall Study||52
7998760|NCT00085735|19695653|P6|STARTED|Overall Study||146
7998761|NCT00085735|19695654|P5|STARTED|Overall Study||147
7998762|NCT00085735|19695655|P4|STARTED|Overall Study||65
7998763|NCT00085735|19695656|P3|STARTED|Overall Study||63
7998764|NCT00085735|19695657|P2|STARTED|Overall Study||64
7998765|NCT00085735|19695658|P1|STARTED|Overall Study||64
7998766|NCT00085709|19695713|P2|NOT COMPLETED|Overall Study||50
7998767|NCT00085709|19695714|P1|NOT COMPLETED|Overall Study||53
7998768|NCT00085709|19695713|P2|COMPLETED|Overall Study||270
7998769|NCT00085709|19695714|P1|COMPLETED|Overall Study||264
7998770|NCT00085709|19695713|P2|Eligible and Did Not Withdraw Consent|Overall Study||300
7998771|NCT00085709|19695714|P1|Eligible and Did Not Withdraw Consent|Overall Study||296
7998772|NCT00085709|19695713|P2|Eligible|Overall Study||301
7998773|NCT00085709|19695714|P1|Eligible|Overall Study||298
7998774|NCT00085709|19695713|P2|STARTED|Overall Study||320
7998775|NCT00085709|19695714|P1|STARTED|Overall Study||317
7998776|NCT00085644|19695730|P3|NOT COMPLETED|Open-Label Period||109
7998777|NCT00085644|19695731|P2|NOT COMPLETED|Open-Label Period||0
7998778|NCT00085644|19695732|P1|NOT COMPLETED|Open-Label Period||0
7998779|NCT00085644|19695730|P3|COMPLETED|Open-Label Period||202
7998780|NCT00085644|19695731|P2|COMPLETED|Open-Label Period||0
7998781|NCT00085644|19695732|P1|COMPLETED|Open-Label Period||0
7998782|NCT00085644|19695730|P3|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311
7998783|NCT00085644|19695731|P2|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
7998784|NCT00085644|19695732|P1|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
7998785|NCT00085644|19695730|P3|NOT COMPLETED|Double-Blind Period||0
7998786|NCT00085644|19695731|P2|NOT COMPLETED|Double-Blind Period||6
7998787|NCT00085644|19695732|P1|NOT COMPLETED|Double-Blind Period||13
7998788|NCT00085644|19695730|P3|COMPLETED|Double-Blind Period||0
7998789|NCT00085644|19695731|P2|COMPLETED|Double-Blind Period||101
7998790|NCT00085644|19695732|P1|COMPLETED|Double-Blind Period||195
7998791|NCT00085644|19695730|P3|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0
7998792|NCT00085644|19695731|P2|STARTED|Double-Blind Period||107
7998793|NCT00085644|19695732|P1|STARTED|Double-Blind Period||208
7998794|NCT00085631|19695773|P3|NOT COMPLETED|Overall Study||7
7998795|NCT00085631|19695774|P2|NOT COMPLETED|Overall Study||11
7998796|NCT00085631|19695775|P1|NOT COMPLETED|Overall Study||4
7998797|NCT00085631|19695773|P3|COMPLETED|Overall Study||32
7998798|NCT00085631|19695774|P2|COMPLETED|Overall Study||38
7998799|NCT00085631|19695775|P1|COMPLETED|Overall Study||9
7998800|NCT00085631|19695773|P3|STARTED|Overall Study||39
7998801|NCT00085631|19695774|P2|STARTED|Overall Study||49
7998802|NCT00085631|19695775|P1|STARTED|Overall Study||13
7998803|NCT00085566|19695785|P3|NOT COMPLETED|Overall Study||14
7998804|NCT00085566|19695786|P2|NOT COMPLETED|Overall Study||0
7998805|NCT00085566|19695787|P1|NOT COMPLETED|Overall Study||0
7998806|NCT00085566|19695785|P3|COMPLETED|Overall Study||43
7998807|NCT00085566|19695786|P2|COMPLETED|Overall Study||3
7998808|NCT00085566|19695787|P1|COMPLETED|Overall Study||3
7998809|NCT00085566|19695785|P3|STARTED|Overall Study||57
7998810|NCT00085566|19695786|P2|STARTED|Overall Study||3
7998811|NCT00085566|19695787|P1|STARTED|Overall Study||3
7998812|NCT00085540|19695797|P2|NOT COMPLETED|Overall Study||2
7998813|NCT00085540|19695798|P1|NOT COMPLETED|Overall Study||0
7998814|NCT00085540|19695797|P2|COMPLETED|Overall Study||40
7998815|NCT00085540|19695798|P1|COMPLETED|Overall Study||8
7998816|NCT00085540|19695797|P2|STARTED|Overall Study||42
7998817|NCT00085540|19695798|P1|STARTED|Overall Study||8
7998818|NCT00085436|19695805|P1|NOT COMPLETED|Overall Study||0
7998819|NCT00085436|19695805|P1|COMPLETED|Overall Study||18
7998820|NCT00085436|19695805|P1|STARTED|Overall Study||18
7998821|NCT00085423|19695810|P1|NOT COMPLETED|Overall Study||2
7998822|NCT00085423|19695810|P1|COMPLETED|Overall Study||18
7998823|NCT00085423|19695810|P1|STARTED|Overall Study||20
7998824|NCT00085410|19695816|P1|NOT COMPLETED|Overall Study||0
7998825|NCT00085410|19695816|P1|COMPLETED|Overall Study||20
7998826|NCT00085410|19695816|P1|STARTED|Overall Study||20
7998827|NCT00085293|19695830|P1|NOT COMPLETED|Overall Study||0
7998828|NCT00085293|19695830|P1|COMPLETED|Overall Study||12
7998829|NCT00085293|19695830|P1|STARTED|Overall Study||12
7998830|NCT00085254|19695843|P3|NOT COMPLETED|Overall Study||0
7998831|NCT00085254|19695844|P2|NOT COMPLETED|Overall Study||0
7998832|NCT00085254|19695845|P1|NOT COMPLETED|Overall Study||0
7998833|NCT00085254|19695843|P3|COMPLETED|Overall Study||48
7998834|NCT00085254|19695844|P2|COMPLETED|Overall Study||46
7998835|NCT00085254|19695845|P1|COMPLETED|Overall Study||18
7998836|NCT00085254|19695843|P3|STARTED|Overall Study||48
7998837|NCT00085254|19695844|P2|STARTED|Overall Study||46
7998838|NCT00085254|19695845|P1|STARTED|Overall Study||18
7998839|NCT00085202|19695861|P2|NOT COMPLETED|Overall Study||24
7998840|NCT00085202|19695862|P1|NOT COMPLETED|Overall Study||18
7998841|NCT00085202|19695861|P2|COMPLETED|Overall Study||120
7998842|NCT00085202|19695862|P1|COMPLETED|Overall Study||251
7998843|NCT00085202|19695861|P2|STARTED|Overall Study||144
7998844|NCT00085202|19695862|P1|STARTED|Overall Study||269
7998845|NCT00085098|19695883|P2|NOT COMPLETED|Overall Study||2
7998846|NCT00085098|19695884|P1|NOT COMPLETED|Overall Study||1
7998847|NCT00085098|19695883|P2|COMPLETED|Overall Study||11
7998848|NCT00085098|19695884|P1|COMPLETED|Overall Study||10
7998849|NCT00085098|19695883|P2|STARTED|Overall Study||13
7998850|NCT00085098|19695884|P1|STARTED|Overall Study||11
7998851|NCT00084929|19695894|P1|NOT COMPLETED|Overall Study||69
7998852|NCT00084929|19695894|P1|COMPLETED|Overall Study||2531
7998853|NCT00084929|19695894|P1|STARTED|Overall Study||2600
7998854|NCT00084864|19695916|P4|NOT COMPLETED|Overall Study||0
7998855|NCT00084864|19695917|P3|NOT COMPLETED|Overall Study||0
7998856|NCT00084864|19695918|P2|NOT COMPLETED|Overall Study||0
7998857|NCT00084864|19695919|P1|NOT COMPLETED|Overall Study||1
7998858|NCT00084864|19695916|P4|COMPLETED|Overall Study||4
7998859|NCT00084864|19695917|P3|COMPLETED|Overall Study||4
7998860|NCT00084864|19695918|P2|COMPLETED|Overall Study||7
7998861|NCT00084864|19695919|P1|COMPLETED|Overall Study||9
7998862|NCT00084864|19695916|P4|STARTED|Overall Study||4
7998863|NCT00084864|19695917|P3|STARTED|Overall Study||4
7998864|NCT00084864|19695918|P2|STARTED|Overall Study||7
7998865|NCT00084864|19695919|P1|STARTED|Overall Study||10
7998866|NCT00084838|19695945|P1|NOT COMPLETED|Overall Study||13
7998867|NCT00084838|19695945|P1|COMPLETED|Overall Study||12
7998868|NCT00084838|19695945|P1|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20
7998869|NCT00084838|19695945|P1|STARTED|Overall Study||25
7998870|NCT00084747|19695967|P1|NOT COMPLETED|Overall Study||13
7998871|NCT00084747|19695967|P1|COMPLETED|Overall Study||17
7998872|NCT00084747|19695967|P1|STARTED|Overall Study||30
7998873|NCT00084682|19695972|P1|NOT COMPLETED|Overall Study||1
7998874|NCT00084682|19695972|P1|COMPLETED|Overall Study||13
7998875|NCT00084682|19695972|P1|STARTED|Overall Study||14
7998876|NCT00084617|19695976|P1|NOT COMPLETED|Overall Study||9
7998877|NCT00084617|19695976|P1|COMPLETED|Overall Study||30
7998878|NCT00084617|19695976|P1|STARTED|Overall Study||39
7998879|NCT00084487|19695982|P1|NOT COMPLETED|Overall Study||1
7998880|NCT00084487|19695982|P1|COMPLETED|Overall Study||20
7998881|NCT00084487|19695982|P1|STARTED|Overall Study||21
7998882|NCT00084409|19695992|P2|NOT COMPLETED|Overall Study||12
7998883|NCT00084409|19695993|P1|NOT COMPLETED|Overall Study||15
7998884|NCT00084409|19695992|P2|COMPLETED|Overall Study|4 Current, 8 former|65
7998885|NCT00084409|19695993|P1|COMPLETED|Overall Study|9 current, 6 former|60
7998886|NCT00084409|19695992|P2|STARTED|Overall Study|41 current, 36 former|77
7998887|NCT00084409|19695993|P1|STARTED|Overall Study|40 Current, 35 former|75
7998888|NCT00084383|19696019|P1|NOT COMPLETED|Overall Study||47
7998889|NCT00084383|19696019|P1|COMPLETED|Overall Study||13
7998890|NCT00084383|19696019|P1|STARTED|Overall Study||60
7998891|NCT00084318|19696026|P2|NOT COMPLETED|Overall Study||13
7998892|NCT00084318|19696027|P1|NOT COMPLETED|Overall Study||22
7998893|NCT00084318|19696026|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106
7998894|NCT00084318|19696027|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97
7998895|NCT00084318|19696026|P2|STARTED|Overall Study||119
7998896|NCT00084318|19696027|P1|STARTED|Overall Study||119
7998897|NCT00084266|19696047|P2|NOT COMPLETED|Overall Study||423
7998898|NCT00084266|19696048|P1|NOT COMPLETED|Overall Study||441
7998899|NCT00084266|19696047|P2|COMPLETED|Overall Study||184
7998900|NCT00084266|19696048|P1|COMPLETED|Overall Study||177
7998901|NCT00084266|19696047|P2|Treated|Overall Study||587
7998902|NCT00084266|19696048|P1|Treated|Overall Study||597
7998903|NCT00084266|19696047|P2|STARTED|Overall Study||607
7998904|NCT00084266|19696048|P1|STARTED|Overall Study||618
7998905|NCT00084149|19696084|P2|NOT COMPLETED|Overall Study||5
7998906|NCT00084149|19696085|P1|NOT COMPLETED|Overall Study||8
7998907|NCT00084149|19696084|P2|COMPLETED|Overall Study||13
7998908|NCT00084149|19696085|P1|COMPLETED|Overall Study||28
7998909|NCT00084149|19696084|P2|STARTED|Overall Study||18
7998910|NCT00084149|19696085|P1|STARTED|Overall Study||36
7998911|NCT00084136|19696106|P3|NOT COMPLETED|NRTI Comparison||82
7998912|NCT00084136|19696107|P2|NOT COMPLETED|NRTI Comparison||0
7998913|NCT00084136|19696108|P1|NOT COMPLETED|NRTI Comparison||101
7998914|NCT00084136|19696106|P3|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444
7998915|NCT00084136|19696107|P2|COMPLETED|NRTI Comparison||0
7998916|NCT00084136|19696108|P1|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418
7998917|NCT00084136|19696106|P3|STARTED|NRTI Comparison||526
7998918|NCT00084136|19696107|P2|STARTED|NRTI Comparison||0
7998919|NCT00084136|19696108|P1|STARTED|NRTI Comparison||519
7998920|NCT00084136|19696106|P3|NOT COMPLETED|PI Comparison||0
7998921|NCT00084136|19696107|P2|NOT COMPLETED|PI Comparison||47
7998922|NCT00084136|19696108|P1|NOT COMPLETED|PI Comparison||55
7998923|NCT00084136|19696106|P3|COMPLETED|PI Comparison||0
7998924|NCT00084136|19696107|P2|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479
7998925|NCT00084136|19696108|P1|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464
7998926|NCT00084136|19696106|P3|STARTED|PI Comparison||0
7998927|NCT00084136|19696107|P2|STARTED|PI Comparison||526
7998928|NCT00084136|19696108|P1|STARTED|PI Comparison||519
7998929|NCT00084084|19696167|P1|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1
7998930|NCT00084084|19696167|P1|COMPLETED|Phase 2 (Transition to Replagal AF)||10
7998931|NCT00084084|19696167|P1|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11
7998932|NCT00084084|19696167|P1|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1
7998933|NCT00084084|19696167|P1|COMPLETED|Phase 1 (Treatment With Replagal RB)||16
7998934|NCT00084084|19696167|P1|STARTED|Phase 1 (Treatment With Replagal RB)||17
7998935|NCT00083915|19696177|P2|NOT COMPLETED|Overall Study||37
7998936|NCT00083915|19696178|P1|NOT COMPLETED|Overall Study||50
7998937|NCT00083915|19696177|P2|COMPLETED|Overall Study||8
7998938|NCT00083915|19696178|P1|COMPLETED|Overall Study||2
7998939|NCT00083915|19696177|P2|STARTED|Overall Study||45
7998940|NCT00083915|19696178|P1|STARTED|Overall Study||52
7998941|NCT00083889|19696186|P2|NOT COMPLETED|Overall Study||375
7998942|NCT00083889|19696187|P1|NOT COMPLETED|Overall Study||375
7998943|NCT00083889|19696186|P2|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0
7998944|NCT00083889|19696187|P1|COMPLETED|Overall Study||0
7998945|NCT00083889|19696186|P2|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360
7998946|NCT00083889|19696187|P1|Received Treatment|Overall Study||375
7998947|NCT00083889|19696186|P2|STARTED|Overall Study||375
7998948|NCT00083889|19696187|P1|STARTED|Overall Study||375
7998949|NCT00004146|19696236|P1|NOT COMPLETED|Overall Study||0
7998950|NCT00004146|19696236|P1|COMPLETED|Overall Study||55
7998951|NCT00004146|19696236|P1|STARTED|Overall Study||55
7998952|NCT00083759|19696245|P2|NOT COMPLETED|Overall Study||83
7998953|NCT00083759|19696246|P1|NOT COMPLETED|Overall Study||84
7998954|NCT00083759|19696245|P2|COMPLETED|Overall Study||66
7998955|NCT00083759|19696246|P1|COMPLETED|Overall Study||66
7998956|NCT00083759|19696245|P2|STARTED|Overall Study|149 subjects enrolled, 136 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|149
7998957|NCT00083759|19696246|P1|STARTED|Overall Study|150 subjects enrolled, 137 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|150
7998958|NCT00083720|19696254|P1|NOT COMPLETED|Overall Study||0
7998959|NCT00083720|19696254|P1|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85
7998960|NCT00083720|19696254|P1|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85
7998961|NCT00083616|19696264|P1|NOT COMPLETED|Overall Study||31
7998962|NCT00083616|19696264|P1|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154
7998963|NCT00083616|19696264|P1|Received Study Medication|Overall Study||182
7998964|NCT00083616|19696264|P1|STARTED|Overall Study||185
7998965|NCT00083551|19696278|P2|NOT COMPLETED|Overall Study||0
7998966|NCT00083551|19696279|P1|NOT COMPLETED|Overall Study||0
7998967|NCT00083551|19696278|P2|COMPLETED|Overall Study||345
7998968|NCT00083551|19696279|P1|COMPLETED|Overall Study||323
7998969|NCT00083551|19696278|P2|STARTED|Overall Study||345
7998970|NCT00083551|19696279|P1|STARTED|Overall Study||323
7998971|NCT00083382|19696285|P1|NOT COMPLETED|Overall Study||0
7998972|NCT00083382|19696285|P1|COMPLETED|Overall Study||83
7998973|NCT00083382|19696285|P1|STARTED|Overall Study||83
7998974|NCT00082888|19696292|P3|NOT COMPLETED|Overall Study||0
7998975|NCT00082888|19696293|P2|NOT COMPLETED|Overall Study||0
7998976|NCT00082888|19696294|P1|NOT COMPLETED|Overall Study||1
7998977|NCT00082888|19696292|P3|COMPLETED|Overall Study||36
7998978|NCT00082888|19696293|P2|COMPLETED|Overall Study||15
7998979|NCT00082888|19696294|P1|COMPLETED|Overall Study||41
7998980|NCT00082888|19696292|P3|STARTED|Overall Study||36
7998981|NCT00082888|19696293|P2|STARTED|Overall Study||15
7998982|NCT00082888|19696294|P1|STARTED|Overall Study||42
7998983|NCT00082810|19696314|P1|NOT COMPLETED|Overall Study||31
7998984|NCT00082810|19696314|P1|COMPLETED|Overall Study||2
7998985|NCT00082810|19696314|P1|STARTED|Overall Study||33
7998986|NCT00082758|19696325|P3|NOT COMPLETED|Overall Study||0
7998987|NCT00082758|19696326|P2|NOT COMPLETED|Overall Study||17
7998988|NCT00082758|19696327|P1|NOT COMPLETED|Overall Study||15
7998989|NCT00082758|19696325|P3|COMPLETED|Overall Study||0
7998990|NCT00082758|19696326|P2|COMPLETED|Overall Study||7
7998991|NCT00082758|19696327|P1|COMPLETED|Overall Study||0
7998992|NCT00082758|19696325|P3|STARTED|Overall Study||0
7998993|NCT00082758|19696326|P2|STARTED|Overall Study||24
7998994|NCT00082758|19696327|P1|STARTED|Overall Study||15
7998995|NCT00082641|19696337|P2|NOT COMPLETED|Overall Study||0
7998996|NCT00082641|19696338|P1|NOT COMPLETED|Overall Study||0
7998997|NCT00082641|19696337|P2|COMPLETED|Overall Study||12
7998998|NCT00082641|19696338|P1|COMPLETED|Overall Study||11
7998999|NCT00082641|19696337|P2|STARTED|Overall Study||12
7999000|NCT00082641|19696338|P1|STARTED|Overall Study||11
7999001|NCT00083226|19696347|P1|NOT COMPLETED|Overall Study||42
7999002|NCT00083226|19696347|P1|COMPLETED|Overall Study||0
7999003|NCT00083226|19696347|P1|STARTED|Overall Study||42
7999004|NCT00083174|19696355|P3|NOT COMPLETED|Open-label Extension||0
7999005|NCT00083174|19696356|P2|NOT COMPLETED|Open-label Extension||0
7999006|NCT00083174|19696357|P1|NOT COMPLETED|Open-label Extension||0
7999007|NCT00083174|19696355|P3|COMPLETED|Open-label Extension||2831
7999008|NCT00083174|19696356|P2|COMPLETED|Open-label Extension||0
7999009|NCT00083174|19696357|P1|COMPLETED|Open-label Extension||0
7999010|NCT00083174|19696355|P3|STARTED|Open-label Extension||2831
7999011|NCT00083174|19696356|P2|STARTED|Open-label Extension||0
7999012|NCT00083174|19696357|P1|STARTED|Open-label Extension||0
7999013|NCT00083174|19696355|P3|NOT COMPLETED|Randomization Period||0
7999014|NCT00083174|19696356|P2|NOT COMPLETED|Randomization Period||0
7999015|NCT00083174|19696357|P1|NOT COMPLETED|Randomization Period||0
7999016|NCT00083174|19696355|P3|COMPLETED|Randomization Period||0
7999017|NCT00083174|19696356|P2|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2275
7999018|NCT00083174|19696357|P1|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2285
7999019|NCT00083174|19696355|P3|STARTED|Randomization Period||0
7999020|NCT00083174|19696356|P2|STARTED|Randomization Period||2275
7999021|NCT00083174|19696357|P1|STARTED|Randomization Period||2285
7999022|NCT00083122|19696379|P2|NOT COMPLETED|Overall Study||0
7999023|NCT00083122|19696380|P1|NOT COMPLETED|Overall Study||0
7999024|NCT00083122|19696379|P2|COMPLETED|Overall Study||5
7999025|NCT00083122|19696380|P1|COMPLETED|Overall Study||40
7999026|NCT00083122|19696379|P2|STARTED|Overall Study||5
7999027|NCT00083122|19696380|P1|STARTED|Overall Study||40
7999028|NCT00082628|19696391|P5|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||18
7999029|NCT00082628|19696392|P4|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||16
7999030|NCT00082628|19696393|P3|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||15
7999031|NCT00082628|19696394|P2|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
7999032|NCT00082628|19696395|P1|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
7999033|NCT00082628|19696391|P5|COMPLETED|Treatment Period II: Week 12 to Week 36||55
7999034|NCT00082628|19696392|P4|COMPLETED|Treatment Period II: Week 12 to Week 36||76
7999035|NCT00082628|19696393|P3|COMPLETED|Treatment Period II: Week 12 to Week 36||78
7999036|NCT00082628|19696394|P2|COMPLETED|Treatment Period II: Week 12 to Week 36||0
7999037|NCT00082628|19696395|P1|COMPLETED|Treatment Period II: Week 12 to Week 36||0
7999038|NCT00082628|19696391|P5|STARTED|Treatment Period II: Week 12 to Week 36||73
7999039|NCT00082628|19696392|P4|STARTED|Treatment Period II: Week 12 to Week 36||92
7999040|NCT00082628|19696393|P3|STARTED|Treatment Period II: Week 12 to Week 36||93
7999041|NCT00082628|19696394|P2|STARTED|Treatment Period II: Week 12 to Week 36||0
7999042|NCT00082628|19696395|P1|STARTED|Treatment Period II: Week 12 to Week 36||0
7999043|NCT00082628|19696391|P5|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
7999044|NCT00082628|19696392|P4|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
7999045|NCT00082628|19696393|P3|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
7999046|NCT00082628|19696394|P2|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||60
7999047|NCT00082628|19696395|P1|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||8
7999048|NCT00082628|19696391|P5|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
7999049|NCT00082628|19696392|P4|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
7999050|NCT00082628|19696393|P3|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
7999051|NCT00082628|19696394|P2|COMPLETED|Treatment Period I (Week 1 to Week 12)||185
7999052|NCT00082628|19696395|P1|COMPLETED|Treatment Period I (Week 1 to Week 12)||73
7999053|NCT00082628|19696391|P5|STARTED|Treatment Period I (Week 1 to Week 12)||0
7999054|NCT00082628|19696392|P4|STARTED|Treatment Period I (Week 1 to Week 12)||0
7999055|NCT00082628|19696393|P3|STARTED|Treatment Period I (Week 1 to Week 12)||0
7999056|NCT00082628|19696394|P2|STARTED|Treatment Period I (Week 1 to Week 12)||245
7999057|NCT00082628|19696395|P1|STARTED|Treatment Period I (Week 1 to Week 12)||81
7999058|NCT00082433|19696415|P2|NOT COMPLETED|Overall Study||597
7999059|NCT00082433|19696416|P1|NOT COMPLETED|Overall Study||594
7999060|NCT00082433|19696415|P2|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
7999061|NCT00082433|19696416|P1|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
7999062|NCT00082433|19696415|P2|STARTED|Overall Study||612
7999063|NCT00082433|19696416|P1|STARTED|Overall Study||609
7999064|NCT00082381|19696436|P2|NOT COMPLETED|Overall Study||26
7999065|NCT00082381|19696437|P1|NOT COMPLETED|Overall Study||55
7999066|NCT00082381|19696436|P2|COMPLETED|Overall Study||242
7999067|NCT00082381|19696437|P1|COMPLETED|Overall Study||228
7999068|NCT00082381|19696436|P2|Received Treatment (Intent to Treat)|Overall Study||267
7999069|NCT00082381|19696437|P1|Received Treatment (Intent to Treat)|Overall Study||282
7999070|NCT00082381|19696436|P2|STARTED|Overall Study||268
7999071|NCT00082381|19696437|P1|STARTED|Overall Study||283
7999072|NCT00082407|19696457|P2|NOT COMPLETED|Overall Study||27
7999073|NCT00082407|19696458|P1|NOT COMPLETED|Overall Study||56
7999074|NCT00082407|19696457|P2|COMPLETED|Overall Study||223
7999075|NCT00082407|19696458|P1|COMPLETED|Overall Study||199
7999076|NCT00082407|19696457|P2|Received Treatment (Intent to Treat)|Overall Study||248
7999077|NCT00082407|19696458|P1|Received Treatment (Intent to Treat)|Overall Study||253
7999078|NCT00082407|19696457|P2|STARTED|Overall Study||250
7999079|NCT00082407|19696458|P1|STARTED|Overall Study||255
7999080|NCT00082368|19696476|P1|NOT COMPLETED|Overall Study||1
7999081|NCT00082368|19696476|P1|COMPLETED|Overall Study||11
7999082|NCT00082368|19696476|P1|STARTED|Overall Study||12
7999083|NCT00082355|19696481|P1|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28
7999084|NCT00082355|19696481|P1|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0
7999085|NCT00082355|19696481|P1|STARTED|5 Year Recurrent Thromboembolism Rate||28
7999086|NCT00082355|19696481|P1|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2
7999087|NCT00082355|19696481|P1|COMPLETED|Initial Results of Thrombolytic Therapy||28
7999088|NCT00082355|19696481|P1|STARTED|Initial Results of Thrombolytic Therapy||30
7999089|NCT00082342|19696488|P2|NOT COMPLETED|Overall Study||0
7999090|NCT00082342|19696489|P1|NOT COMPLETED|Overall Study||0
7999091|NCT00082342|19696488|P2|COMPLETED|Overall Study||12
7999092|NCT00082342|19696489|P1|COMPLETED|Overall Study||13
7999093|NCT00082342|19696488|P2|STARTED|Overall Study||12
7999094|NCT00082342|19696489|P1|STARTED|Overall Study||13
7999095|NCT00082329|19696509|P1|NOT COMPLETED|Overall Study||0
7999096|NCT00082329|19696509|P1|COMPLETED|Overall Study||9
7999097|NCT00082329|19696509|P1|STARTED|Overall Study||9
7999098|NCT00082173|19696515|P2|NOT COMPLETED|Overall Study||11
7999099|NCT00082173|19696516|P1|NOT COMPLETED|Overall Study||10
7999100|NCT00082173|19696515|P2|COMPLETED|Overall Study||61
7999101|NCT00082173|19696516|P1|COMPLETED|Overall Study||64
7999102|NCT00082173|19696515|P2|STARTED|Overall Study||72
7999103|NCT00082173|19696516|P1|STARTED|Overall Study||74
7999104|NCT00003726|19696524|P1|NOT COMPLETED|Overall Study||1
7999105|NCT00003726|19696524|P1|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0
7999106|NCT00003726|19696524|P1|STARTED|Overall Study||1
7999107|NCT00081939|19696528|P1|NOT COMPLETED|Overall Study||0
7999108|NCT00081939|19696528|P1|COMPLETED|Overall Study||303
7999109|NCT00081939|19696528|P1|STARTED|Overall Study||303
7999110|NCT00082017|19696532|P2|NOT COMPLETED|Overall Study||0
7999111|NCT00082017|19696533|P1|NOT COMPLETED|Overall Study||0
7999112|NCT00082017|19696532|P2|COMPLETED|Overall Study||9
7999113|NCT00082017|19696533|P1|COMPLETED|Overall Study||11
7999114|NCT00082017|19696532|P2|STARTED|Overall Study||9
7999115|NCT00082017|19696533|P1|STARTED|Overall Study||11
7999116|NCT00081861|19696549|P1|NOT COMPLETED|Overall Study||0
7999117|NCT00081861|19696549|P1|COMPLETED|Overall Study||13
7999118|NCT00081861|19696549|P1|STARTED|Overall Study||13
7999119|NCT00003270|19696553|P1|NOT COMPLETED|Overall Study||0
7999120|NCT00003270|19696553|P1|COMPLETED|Overall Study||20
7999121|NCT00003270|19696553|P1|STARTED|Overall Study||20
7999122|NCT00081770|19696561|P3|NOT COMPLETED|Overall Study||456
7999123|NCT00081770|19696562|P2|NOT COMPLETED|Overall Study||546
7999124|NCT00081770|19696563|P1|NOT COMPLETED|Overall Study||502
7999125|NCT00081770|19696561|P3|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579
7999126|NCT00081770|19696562|P2|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470
7999127|NCT00081770|19696563|P1|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517
7999128|NCT00081770|19696561|P3|STARTED|Overall Study||1035
7999129|NCT00081770|19696562|P2|STARTED|Overall Study||1016
7999130|NCT00081770|19696563|P1|STARTED|Overall Study||1019
7999131|NCT00081731|19696582|P2|NOT COMPLETED|Overall Study||8
7999132|NCT00081731|19696583|P1|NOT COMPLETED|Overall Study||8
7999133|NCT00081731|19696582|P2|COMPLETED|Overall Study||459
7999134|NCT00081731|19696583|P1|COMPLETED|Overall Study||472
7999135|NCT00081731|19696582|P2|STARTED|Overall Study||467
7999136|NCT00081731|19696583|P1|STARTED|Overall Study||480
7999137|NCT00081653|19696603|P2|NOT COMPLETED|Overall Study||37
7999138|NCT00081653|19696604|P1|NOT COMPLETED|Overall Study||47
7999139|NCT00081653|19696603|P2|COMPLETED|Overall Study|Completed 3 years of treatment|324
7999140|NCT00081653|19696604|P1|COMPLETED|Overall Study|Completed 3 years of treatment|311
7999141|NCT00081653|19696603|P2|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361
7999142|NCT00081653|19696604|P1|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358
7999143|NCT00081497|19696622|P2|NOT COMPLETED|Overall Study||2
7999144|NCT00081497|19696623|P1|NOT COMPLETED|Overall Study||3
7999145|NCT00081497|19696622|P2|COMPLETED|Overall Study||37
7999146|NCT00081497|19696623|P1|COMPLETED|Overall Study||25
7999147|NCT00081497|19696622|P2|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39
7999148|NCT00081497|19696623|P1|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28
7999149|NCT00081458|19696641|P3|NOT COMPLETED|Overall Study||4
7999150|NCT00081458|19696642|P2|NOT COMPLETED|Overall Study||8
7999151|NCT00081458|19696643|P1|NOT COMPLETED|Overall Study||1
7999152|NCT00081458|19696641|P3|COMPLETED|Overall Study||29
7999153|NCT00081458|19696642|P2|COMPLETED|Overall Study||27
7999154|NCT00081458|19696643|P1|COMPLETED|Overall Study||15
7999155|NCT00081458|19696641|P3|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32
7999156|NCT00081458|19696642|P2|Received Treatment|Overall Study||35
7999157|NCT00081458|19696643|P1|Received Treatment|Overall Study||16
7999158|NCT00081458|19696641|P3|STARTED|Overall Study||33
7999159|NCT00081458|19696642|P2|STARTED|Overall Study||35
7999160|NCT00081458|19696643|P1|STARTED|Overall Study||16
7999161|NCT00081328|19696657|P3|NOT COMPLETED|Overall Study||0
7999162|NCT00081328|19696658|P2|NOT COMPLETED|Overall Study||0
7999163|NCT00081328|19696659|P1|NOT COMPLETED|Overall Study||0
7999164|NCT00081328|19696657|P3|COMPLETED|Overall Study||234
7999165|NCT00081328|19696658|P2|COMPLETED|Overall Study||233
7999166|NCT00081328|19696659|P1|COMPLETED|Overall Study||232
7999167|NCT00081328|19696657|P3|STARTED|Overall Study||234
7999168|NCT00081328|19696658|P2|STARTED|Overall Study||233
7999169|NCT00081328|19696659|P1|STARTED|Overall Study||232
7999170|NCT00081289|19696699|P2|NOT COMPLETED|Overall Study||21
7999171|NCT00081289|19696700|P1|NOT COMPLETED|Overall Study||21
7999172|NCT00081289|19696699|P2|COMPLETED|Overall Study||52
7999173|NCT00081289|19696700|P1|COMPLETED|Overall Study||52
7999174|NCT00081289|19696699|P2|Defecation Symptom Score at Two Years|Overall Study||15
7999175|NCT00081289|19696700|P1|Defecation Symptom Score at Two Years|Overall Study||13
7999176|NCT00081289|19696699|P2|DS Score at End of Post-op CT|Overall Study||14
7999177|NCT00081289|19696700|P1|DS Score at End of Post-op CT|Overall Study||12
7999178|NCT00081289|19696699|P2|Defecation Symptom Score at End of CR|Overall Study||32
7999179|NCT00081289|19696700|P1|Defecation Symptom Score at End of CR|Overall Study||32
7999180|NCT00081289|19696699|P2|GI Symptom Score at Two Years|Overall Study||20
7999181|NCT00081289|19696700|P1|GI Symptom Score at Two Years|Overall Study||21
7999182|NCT00081289|19696699|P2|GI Symptom Score at End of Post-op CT|Overall Study||27
7999183|NCT00081289|19696700|P1|GI Symptom Score at End of Post-op CT|Overall Study||22
7999184|NCT00081289|19696699|P2|GI Symptom Score at End of CR|Overall Study||33
7999185|NCT00081289|19696700|P1|GI Symptom Score at End of CR|Overall Study||34
7999186|NCT00081289|19696699|P2|GHS at Two Years|Overall Study||20
7999187|NCT00081289|19696700|P1|GHS at Two Years|Overall Study||21
7999188|NCT00081289|19696699|P2|GHS at End of Post-op CT|Overall Study||28
7999189|NCT00081289|19696700|P1|GHS at End of Post-op CT|Overall Study||20
7999190|NCT00081289|19696699|P2|Global Health Status Score at End of CR|Overall Study||32
7999191|NCT00081289|19696700|P1|Global Health Status Score at End of CR|Overall Study|European Organization for Research & Treatment of Cancer Quality of Life Questionnaire [EORTC QLQ]|34
7999192|NCT00081289|19696699|P2|Surgery|Overall Study||51
7999193|NCT00081289|19696700|P1|Surgery|Overall Study||47
7999194|NCT00081289|19696699|P2|Full AE Population|Overall Study||68
7999195|NCT00081289|19696700|P1|Full AE Population|Overall Study||70
7999196|NCT00081289|19696699|P2|General Analysis Population|Overall Study||52
7999197|NCT00081289|19696700|P1|General Analysis Population|Overall Study||52
7999198|NCT00081289|19696699|P2|Primary Endpoint Population|Overall Study||48
7999199|NCT00081289|19696700|P1|Primary Endpoint Population|Overall Study||48
7999200|NCT00081289|19696699|P2|STARTED|Overall Study||73
7999201|NCT00081289|19696700|P1|STARTED|Overall Study||73
7999202|NCT00081263|19696744|P2|NOT COMPLETED|Overall Study||22
7999203|NCT00081263|19696745|P1|NOT COMPLETED|Overall Study||17
7999204|NCT00081263|19696744|P2|COMPLETED|Overall Study||41
7999205|NCT00081263|19696745|P1|COMPLETED|Overall Study||50
7999206|NCT00081263|19696744|P2|STARTED|Overall Study||63
7999207|NCT00081263|19696745|P1|STARTED|Overall Study||67
7999208|NCT00081159|19696755|P2|NOT COMPLETED|Overall Study||5
7999209|NCT00081159|19696756|P1|NOT COMPLETED|Overall Study||2
7999210|NCT00081159|19696755|P2|COMPLETED|Overall Study||35
7999211|NCT00081159|19696756|P1|COMPLETED|Overall Study||37
7999212|NCT00081159|19696755|P2|STARTED|Overall Study||40
7999213|NCT00081159|19696756|P1|STARTED|Overall Study||39
7999214|NCT00080938|19696766|P1|NOT COMPLETED|Overall Study||24
7999215|NCT00080938|19696766|P1|COMPLETED|Overall Study||2
7999216|NCT00080938|19696766|P1|Eligible and Treated|Overall Study||21
7999217|NCT00080938|19696766|P1|Began Protocol Therapy|Overall Study||25
7999218|NCT00080938|19696766|P1|STARTED|Overall Study||26
7999219|NCT00080912|19696775|P2|NOT COMPLETED|Overall Study||0
7999220|NCT00080912|19696776|P1|NOT COMPLETED|Overall Study||0
7999221|NCT00080912|19696775|P2|COMPLETED|Overall Study||425
7999222|NCT00080912|19696776|P1|COMPLETED|Overall Study||425
7999223|NCT00080912|19696775|P2|STARTED|Overall Study||425
7999224|NCT00080912|19696776|P1|STARTED|Overall Study||425
7999225|NCT00080899|19696782|P1|NOT COMPLETED|Overall Study||1
7999226|NCT00080899|19696782|P1|COMPLETED|Overall Study||22
7999227|NCT00080899|19696782|P1|STARTED|Overall Study||23
7999228|NCT00080535|19696787|P1|NOT COMPLETED|Overall Study||0
7999229|NCT00080535|19696787|P1|COMPLETED|Overall Study||10
7999230|NCT00080535|19696787|P1|STARTED|Overall Study||10
7999231|NCT00080483|19696794|P2|NOT COMPLETED|Overall Study||2
7999232|NCT00080483|19696795|P1|NOT COMPLETED|Overall Study||2
7999233|NCT00080483|19696794|P2|COMPLETED|Overall Study||16
7999234|NCT00080483|19696795|P1|COMPLETED|Overall Study||15
7999235|NCT00080483|19696794|P2|STARTED|Overall Study||18
7999236|NCT00080483|19696795|P1|STARTED|Overall Study||17
7999237|NCT00002525|19696803|P2|NOT COMPLETED|Overall Study||0
7999238|NCT00002525|19696804|P1|NOT COMPLETED|Overall Study||186
7999239|NCT00002525|19696803|P2|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428
7999240|NCT00002525|19696804|P1|COMPLETED|Overall Study||241
7999241|NCT00002525|19696803|P2|Dukes' B2 Stage|Overall Study||139
7999242|NCT00002525|19696804|P1|Dukes' B2 Stage|Overall Study||150
7999243|NCT00002525|19696803|P2|Dukes' B3 or C Stage|Overall Study||158
7999244|NCT00002525|19696804|P1|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156
7999245|NCT00002525|19696803|P2|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0
7999246|NCT00002525|19696804|P1|Treated|Overall Study||419
7999247|NCT00002525|19696803|P2|STARTED|Overall Study||428
7999248|NCT00002525|19696804|P1|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427
7999249|NCT00080470|19696820|P2|NOT COMPLETED|Overall Study||28
7999250|NCT00080470|19696821|P1|NOT COMPLETED|Overall Study||34
7999251|NCT00080470|19696820|P2|COMPLETED|Overall Study||14
7999252|NCT00080470|19696821|P1|COMPLETED|Overall Study||11
7999253|NCT00080470|19696820|P2|STARTED|Overall Study||42
7999254|NCT00080470|19696821|P1|STARTED|Overall Study||45
7999255|NCT00080301|19696831|P2|NOT COMPLETED|Overall Study||11
7999256|NCT00080301|19696832|P1|NOT COMPLETED|Overall Study||5
7999257|NCT00080301|19696831|P2|COMPLETED|Overall Study|Participants who are off treatment|366
7999258|NCT00080301|19696832|P1|COMPLETED|Overall Study|Participants who are off treatment|370
7999259|NCT00080301|19696831|P2|Still on Treatment|Overall Study||1
7999260|NCT00080301|19696832|P1|Still on Treatment|Overall Study||0
7999261|NCT00080301|19696831|P2|Never Treated|Overall Study||10
7999262|NCT00080301|19696832|P1|Never Treated|Overall Study||5
7999263|NCT00080301|19696831|P2|STARTED|Overall Study||377
7999264|NCT00080301|19696832|P1|STARTED|Overall Study||375
7999265|NCT00080288|19696852|P2|NOT COMPLETED|Overall Study||38
7999266|NCT00080288|19696853|P1|NOT COMPLETED|Overall Study||30
7999267|NCT00080288|19696852|P2|COMPLETED|Overall Study||89
7999268|NCT00080288|19696853|P1|COMPLETED|Overall Study||97
7999269|NCT00080288|19696852|P2|STARTED|Overall Study||127
7999270|NCT00080288|19696853|P1|STARTED|Overall Study||127
7999271|NCT00080223|19696861|P1|NOT COMPLETED|Overall Study||76
7999272|NCT00080223|19696861|P1|COMPLETED|Overall Study||7
7999273|NCT00080223|19696861|P1|STARTED|Overall Study||83
7999274|NCT00002540|19696871|P2|NOT COMPLETED|Overall Study||2464
7999275|NCT00002540|19696872|P1|NOT COMPLETED|Overall Study||801
7999276|NCT00002540|19696871|P2|COMPLETED|Overall Study||35876
7999277|NCT00002540|19696872|P1|COMPLETED|Overall Study||37544
7999278|NCT00002540|19696871|P2|STARTED|Overall Study||38340
7999279|NCT00002540|19696872|P1|STARTED|Overall Study||38345
7999280|NCT00080119|19696902|P4|NOT COMPLETED|Overall Study||163
7999281|NCT00080119|19696903|P3|NOT COMPLETED|Overall Study||165
7999282|NCT00080119|19696904|P2|NOT COMPLETED|Overall Study||62
7999283|NCT00080119|19696905|P1|NOT COMPLETED|Overall Study||56
7999284|NCT00080119|19696902|P4|COMPLETED|Overall Study||111
7999285|NCT00080119|19696903|P3|COMPLETED|Overall Study||108
7999286|NCT00080119|19696904|P2|COMPLETED|Overall Study||339
7999287|NCT00080119|19696905|P1|COMPLETED|Overall Study||347
7999288|NCT00080119|19696902|P4|STARTED|Overall Study||274
7999289|NCT00080119|19696903|P3|STARTED|Overall Study||273
7999290|NCT00080119|19696904|P2|STARTED|Overall Study||401
7999291|NCT00080119|19696905|P1|STARTED|Overall Study||403
7999292|NCT00079937|19696939|P2|NOT COMPLETED|Overall Study||32
7999293|NCT00079937|19696940|P1|NOT COMPLETED|Overall Study||69
7999294|NCT00079937|19696939|P2|COMPLETED|Overall Study||175
7999295|NCT00079937|19696940|P1|COMPLETED|Overall Study||352
7999296|NCT00079937|19696939|P2|STARTED|Overall Study||207
7999297|NCT00079937|19696940|P1|STARTED|Overall Study||421
7999298|NCT00009737|19696958|P2|NOT COMPLETED|Overall Study||123
7999299|NCT00009737|19696959|P1|NOT COMPLETED|Overall Study||170
7999300|NCT00009737|19696958|P2|COMPLETED|Overall Study||860
7999301|NCT00009737|19696959|P1|COMPLETED|Overall Study||834
7999302|NCT00009737|19696958|P2|STARTED|Overall Study||983
7999303|NCT00009737|19696959|P1|STARTED|Overall Study||1004
7999304|NCT00079781|19696978|P3|NOT COMPLETED|Follow-up Period||2
7999305|NCT00079781|19696979|P2|NOT COMPLETED|Follow-up Period||0
7999306|NCT00079781|19696980|P1|NOT COMPLETED|Follow-up Period||4
7999307|NCT00079781|19696978|P3|COMPLETED|Follow-up Period||12
7999308|NCT00079781|19696979|P2|COMPLETED|Follow-up Period||9
7999309|NCT00079781|19696980|P1|COMPLETED|Follow-up Period||38
7999310|NCT00079781|19696978|P3|STARTED|Follow-up Period||14
7999311|NCT00079781|19696979|P2|STARTED|Follow-up Period||9
7999312|NCT00079781|19696980|P1|STARTED|Follow-up Period||42
7999313|NCT00079781|19696978|P3|NOT COMPLETED|Evaluation Period||0
7999314|NCT00079781|19696979|P2|NOT COMPLETED|Evaluation Period||0
7999315|NCT00079781|19696980|P1|NOT COMPLETED|Evaluation Period||0
7999316|NCT00079781|19696978|P3|COMPLETED|Evaluation Period||14
7999317|NCT00079781|19696979|P2|COMPLETED|Evaluation Period||9
7999318|NCT00079781|19696980|P1|COMPLETED|Evaluation Period||42
7999319|NCT00079781|19696978|P3|STARTED|Evaluation Period||14
7999320|NCT00079781|19696979|P2|STARTED|Evaluation Period||9
7999321|NCT00079781|19696980|P1|STARTED|Evaluation Period||42
7999322|NCT00079781|19696978|P3|NOT COMPLETED|Pre-implant Period||1
7999323|NCT00079781|19696979|P2|NOT COMPLETED|Pre-implant Period||1
7999324|NCT00079781|19696980|P1|NOT COMPLETED|Pre-implant Period||3
7999325|NCT00079781|19696978|P3|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14
7999326|NCT00079781|19696979|P2|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9
7999327|NCT00079781|19696980|P1|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42
7999328|NCT00079781|19696978|P3|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15
7999329|NCT00079781|19696979|P2|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10
7999330|NCT00079781|19696980|P1|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45
7999331|NCT00079677|19696989|P2|NOT COMPLETED|Overall Study||14
7999332|NCT00079677|19696990|P1|NOT COMPLETED|Overall Study||20
7999333|NCT00079677|19696989|P2|COMPLETED|Overall Study||118
7999334|NCT00079677|19696990|P1|COMPLETED|Overall Study||111
7999335|NCT00079677|19696989|P2|STARTED|Overall Study||132
7999336|NCT00079677|19696990|P1|STARTED|Overall Study||131
7999337|NCT00002601|19696998|P1|NOT COMPLETED|Overall Study||0
7999338|NCT00002601|19696998|P1|COMPLETED|Overall Study||13
7999339|NCT00002601|19696998|P1|STARTED|Overall Study||13
7999340|NCT00079417|19697006|P1|NOT COMPLETED|Overall Study||9
7999341|NCT00079417|19697006|P1|COMPLETED|Overall Study||19
7999342|NCT00079417|19697006|P1|STARTED|Overall Study||28
7999343|NCT00079391|19697014|P1|NOT COMPLETED|Overall Study||1
7999344|NCT00079391|19697014|P1|COMPLETED|Overall Study||49
7999345|NCT00079391|19697014|P1|STARTED|Overall Study|1 of these withdrew after consent.|50
7999346|NCT00079339|19697026|P3|NOT COMPLETED|Overall Study||6
7999347|NCT00079339|19697027|P2|NOT COMPLETED|Overall Study||39
7999348|NCT00079339|19697028|P1|NOT COMPLETED|Overall Study||5
7999349|NCT00079339|19697026|P3|COMPLETED|Overall Study||0
7999350|NCT00079339|19697027|P2|COMPLETED|Overall Study||1
7999351|NCT00079339|19697028|P1|COMPLETED|Overall Study||0
7999352|NCT00079339|19697026|P3|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0
7999353|NCT00079339|19697027|P2|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40
7999354|NCT00079339|19697028|P1|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0
7999355|NCT00079339|19697026|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5
7999356|NCT00079339|19697027|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6
7999357|NCT00079339|19697028|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3
7999358|NCT00079339|19697026|P3|Enrolled in Phase I|Overall Study||6
7999359|NCT00079339|19697027|P2|Enrolled in Phase I|Overall Study||6
7999360|NCT00079339|19697028|P1|Enrolled in Phase I|Overall Study||5
7999361|NCT00079339|19697026|P3|STARTED|Overall Study||6
7999362|NCT00079339|19697027|P2|STARTED|Overall Study||40
7999363|NCT00079339|19697028|P1|STARTED|Overall Study||5
7999364|NCT00079326|19697044|P2|NOT COMPLETED|Overall Study||0
7999365|NCT00079326|19697045|P1|NOT COMPLETED|Overall Study||0
7999366|NCT00079326|19697044|P2|COMPLETED|Overall Study||24
7999367|NCT00079326|19697045|P1|COMPLETED|Overall Study||15
7999368|NCT00079326|19697044|P2|STARTED|Overall Study||24
7999369|NCT00079326|19697045|P1|STARTED|Overall Study||15
7999370|NCT00079274|19697059|P7|NOT COMPLETED|Overall Study||0
7999371|NCT00079274|19697060|P6|NOT COMPLETED|Overall Study||20
7999372|NCT00079274|19697061|P5|NOT COMPLETED|Overall Study||15
7999373|NCT00079274|19697062|P4|NOT COMPLETED|Overall Study||444
7999374|NCT00079274|19697063|P3|NOT COMPLETED|Overall Study||27
7999375|NCT00079274|19697064|P2|NOT COMPLETED|Overall Study||27
7999376|NCT00079274|19697065|P1|NOT COMPLETED|Overall Study||321
7999377|NCT00079274|19697059|P7|COMPLETED|Overall Study||332
7999378|NCT00079274|19697060|P6|COMPLETED|Overall Study||26
7999379|NCT00079274|19697061|P5|COMPLETED|Overall Study||30
7999380|NCT00079274|19697062|P4|COMPLETED|Overall Study||906
7999381|NCT00079274|19697063|P3|COMPLETED|Overall Study||84
7999382|NCT00079274|19697064|P2|COMPLETED|Overall Study||84
7999383|NCT00079274|19697065|P1|COMPLETED|Overall Study||1081
7999384|NCT00079274|19697059|P7|STARTED|Overall Study||332
7999385|NCT00079274|19697060|P6|STARTED|Overall Study||46
7999386|NCT00079274|19697061|P5|STARTED|Overall Study||45
7999387|NCT00079274|19697062|P4|STARTED|Overall Study||1350
7999388|NCT00079274|19697063|P3|STARTED|Overall Study||111
7999389|NCT00079274|19697064|P2|STARTED|Overall Study||111
7999390|NCT00079274|19697065|P1|STARTED|Overall Study||1402
7999391|NCT00079183|19697086|P1|NOT COMPLETED|Overall Study||7
7999392|NCT00079183|19697086|P1|COMPLETED|Overall Study||37
7999393|NCT00079183|19697086|P1|Drop Outs|Overall Study||7
7999394|NCT00079183|19697086|P1|STARTED|Overall Study||44
7999395|NCT00079040|19697101|P1|NOT COMPLETED|Overall Study||2
7999396|NCT00079040|19697101|P1|COMPLETED|Overall Study||63
7999397|NCT00079040|19697101|P1|STARTED|Overall Study||65
7999398|NCT00079001|19697109|P2|NOT COMPLETED|Overall Study||0
7999399|NCT00079001|19697110|P1|NOT COMPLETED|Overall Study||0
7999400|NCT00079001|19697109|P2|COMPLETED|Overall Study||322
7999401|NCT00079001|19697110|P1|COMPLETED|Overall Study||323
7999402|NCT00079001|19697109|P2|STARTED|Overall Study||322
7999403|NCT00079001|19697110|P1|STARTED|Overall Study||323
7999404|NCT00078949|19697124|P4|NOT COMPLETED|Overall Study||3
7999405|NCT00078949|19697125|P3|NOT COMPLETED|Overall Study||3
7999406|NCT00078949|19697126|P2|NOT COMPLETED|Overall Study||5
7999407|NCT00078949|19697127|P1|NOT COMPLETED|Overall Study||4
7999408|NCT00078949|19697124|P4|COMPLETED|Overall Study||112
7999409|NCT00078949|19697125|P3|COMPLETED|Overall Study||112
7999410|NCT00078949|19697126|P2|COMPLETED|Overall Study||304
7999411|NCT00078949|19697127|P1|COMPLETED|Overall Study||306
7999412|NCT00078949|19697124|P4|STARTED|Overall Study||115
7999413|NCT00078949|19697125|P3|STARTED|Overall Study||115
7999414|NCT00078949|19697126|P2|STARTED|Overall Study||309
7999415|NCT00078949|19697127|P1|STARTED|Overall Study||310
7999416|NCT00078897|19697145|P2|NOT COMPLETED|Overall Study||123
7999417|NCT00078897|19697146|P1|NOT COMPLETED|Overall Study||124
7999418|NCT00078897|19697145|P2|COMPLETED|Overall Study||689
7999419|NCT00078897|19697146|P1|COMPLETED|Overall Study||685
7999420|NCT00078897|19697145|P2|STARTED|Overall Study||812
7999421|NCT00078897|19697146|P1|STARTED|Overall Study||809
7999422|NCT00078819|19697156|P4|NOT COMPLETED|Re-treatment Period||0
7999423|NCT00078819|19697157|P3|NOT COMPLETED|Re-treatment Period||0
7999424|NCT00078819|19697158|P2|NOT COMPLETED|Re-treatment Period||0
7999425|NCT00078819|19697159|P1|NOT COMPLETED|Re-treatment Period||0
7999426|NCT00078819|19697156|P4|COMPLETED|Re-treatment Period||13
7999427|NCT00078819|19697157|P3|COMPLETED|Re-treatment Period||29
7999428|NCT00078819|19697158|P2|COMPLETED|Re-treatment Period||0
7999429|NCT00078819|19697159|P1|COMPLETED|Re-treatment Period||0
7999430|NCT00078819|19697156|P4|Received Study Drug|Re-treatment Period||12
7999431|NCT00078819|19697157|P3|Received Study Drug|Re-treatment Period|One additional participant received re-treatment without having disease relapse|30
7999432|NCT00078819|19697158|P2|Received Study Drug|Re-treatment Period||0
7999433|NCT00078819|19697159|P1|Received Study Drug|Re-treatment Period||0
7999434|NCT00078819|19697156|P4|STARTED|Re-treatment Period||13
7999435|NCT00078819|19697157|P3|STARTED|Re-treatment Period||29
7999436|NCT00078819|19697158|P2|STARTED|Re-treatment Period||0
7999437|NCT00078819|19697159|P1|STARTED|Re-treatment Period||0
7999438|NCT00078819|19697156|P4|NOT COMPLETED|Withdrawal Period: Weeks 37-48||14
7999439|NCT00078819|19697157|P3|NOT COMPLETED|Withdrawal Period: Weeks 37-48||29
7999440|NCT00078819|19697158|P2|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
7999441|NCT00078819|19697159|P1|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
7999442|NCT00078819|19697156|P4|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|55
7999443|NCT00078819|19697157|P3|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|40
7999444|NCT00078819|19697158|P2|COMPLETED|Withdrawal Period: Weeks 37-48||0
7999445|NCT00078819|19697159|P1|COMPLETED|Withdrawal Period: Weeks 37-48||0
7999446|NCT00078819|19697156|P4|Received Study Drug|Withdrawal Period: Weeks 37-48||68
7999447|NCT00078819|19697157|P3|Received Study Drug|Withdrawal Period: Weeks 37-48||69
7999448|NCT00078819|19697158|P2|Received Study Drug|Withdrawal Period: Weeks 37-48||0
7999449|NCT00078819|19697159|P1|Received Study Drug|Withdrawal Period: Weeks 37-48||0
7999450|NCT00078819|19697156|P4|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
7999451|NCT00078819|19697157|P3|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
7999452|NCT00078819|19697158|P2|STARTED|Withdrawal Period: Weeks 37-48||0
7999453|NCT00078819|19697159|P1|STARTED|Withdrawal Period: Weeks 37-48||0
7999454|NCT00078819|19697156|P4|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
7999455|NCT00078819|19697157|P3|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
7999456|NCT00078819|19697158|P2|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||30
7999457|NCT00078819|19697159|P1|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||40
7999458|NCT00078819|19697156|P4|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
7999459|NCT00078819|19697157|P3|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
7999460|NCT00078819|19697158|P2|COMPLETED|Open-label Treatment Period: Weeks 13-36||75
7999461|NCT00078819|19697159|P1|COMPLETED|Open-label Treatment Period: Weeks 13-36||63
7999462|NCT00078819|19697156|P4|STARTED|Open-label Treatment Period: Weeks 13-36||0
7999463|NCT00078819|19697157|P3|STARTED|Open-label Treatment Period: Weeks 13-36||0
7999464|NCT00078819|19697158|P2|STARTED|Open-label Treatment Period: Weeks 13-36||105
7999465|NCT00078819|19697159|P1|STARTED|Open-label Treatment Period: Weeks 13-36|One participant discontinued before starting the open-label period|103
7999466|NCT00078819|19697156|P4|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
7999467|NCT00078819|19697157|P3|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
7999468|NCT00078819|19697158|P2|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
7999469|NCT00078819|19697159|P1|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
7999470|NCT00078819|19697156|P4|COMPLETED|Double-blind Treatment Period: Week 1-12||0
7999471|NCT00078819|19697157|P3|COMPLETED|Double-blind Treatment Period: Week 1-12||0
7999472|NCT00078819|19697158|P2|COMPLETED|Double-blind Treatment Period: Week 1-12||105
7999473|NCT00078819|19697159|P1|COMPLETED|Double-blind Treatment Period: Week 1-12||104
7999474|NCT00078819|19697156|P4|Entered Escape|Double-blind Treatment Period: Week 1-12||0
7999475|NCT00078819|19697157|P3|Entered Escape|Double-blind Treatment Period: Week 1-12||0
7999476|NCT00078819|19697158|P2|Entered Escape|Double-blind Treatment Period: Week 1-12||5
7999477|NCT00078819|19697159|P1|Entered Escape|Double-blind Treatment Period: Week 1-12||27
7999478|NCT00078819|19697156|P4|STARTED|Double-blind Treatment Period: Week 1-12||0
7999479|NCT00078819|19697157|P3|STARTED|Double-blind Treatment Period: Week 1-12||0
7999480|NCT00078819|19697158|P2|STARTED|Double-blind Treatment Period: Week 1-12||106
7999481|NCT00078819|19697159|P1|STARTED|Double-blind Treatment Period: Week 1-12||105
7999482|NCT00078806|19697184|P4|NOT COMPLETED|Part 3||0
7999483|NCT00078806|19697185|P3|NOT COMPLETED|Part 3||0
7999484|NCT00078806|19697186|P2|NOT COMPLETED|Part 3||0
7999485|NCT00078806|19697187|P1|NOT COMPLETED|Part 3||0
7999486|NCT00078806|19697184|P4|COMPLETED|Part 3||9
7999487|NCT00078806|19697185|P3|COMPLETED|Part 3||0
7999488|NCT00078806|19697186|P2|COMPLETED|Part 3||0
7999489|NCT00078806|19697187|P1|COMPLETED|Part 3||0
7999490|NCT00078806|19697184|P4|STARTED|Part 3||9
7999491|NCT00078806|19697185|P3|STARTED|Part 3||0
7999492|NCT00078806|19697186|P2|STARTED|Part 3||0
7999493|NCT00078806|19697187|P1|STARTED|Part 3||0
7999494|NCT00078806|19697184|P4|NOT COMPLETED|Part 2||0
7999495|NCT00078806|19697185|P3|NOT COMPLETED|Part 2||0
7999496|NCT00078806|19697186|P2|NOT COMPLETED|Part 2||1
7999497|NCT00078806|19697187|P1|NOT COMPLETED|Part 2||0
7999498|NCT00078806|19697184|P4|COMPLETED|Part 2||0
7999499|NCT00078806|19697185|P3|COMPLETED|Part 2||4
7999500|NCT00078806|19697186|P2|COMPLETED|Part 2||5
7999501|NCT00078806|19697187|P1|COMPLETED|Part 2||0
7999502|NCT00078806|19697184|P4|Received Study Drug|Part 2||0
7999503|NCT00078806|19697185|P3|Received Study Drug|Part 2||4
7999504|NCT00078806|19697186|P2|Received Study Drug|Part 2||5
7999505|NCT00078806|19697187|P1|Received Study Drug|Part 2||0
7999506|NCT00078806|19697184|P4|STARTED|Part 2||0
7999507|NCT00078806|19697185|P3|STARTED|Part 2||4
7999508|NCT00078806|19697186|P2|STARTED|Part 2||6
7999509|NCT00078806|19697187|P1|STARTED|Part 2||0
7999510|NCT00078806|19697184|P4|NOT COMPLETED|Part 1B||0
7999511|NCT00078806|19697185|P3|NOT COMPLETED|Part 1B||0
7999512|NCT00078806|19697186|P2|NOT COMPLETED|Part 1B||0
7999513|NCT00078806|19697187|P1|NOT COMPLETED|Part 1B||8
7999514|NCT00078806|19697184|P4|COMPLETED|Part 1B||0
7999515|NCT00078806|19697185|P3|COMPLETED|Part 1B||0
7999516|NCT00078806|19697186|P2|COMPLETED|Part 1B||0
7999517|NCT00078806|19697187|P1|COMPLETED|Part 1B||2
7999518|NCT00078806|19697184|P4|STARTED|Part 1B||0
7999519|NCT00078806|19697185|P3|STARTED|Part 1B||0
7999520|NCT00078806|19697186|P2|STARTED|Part 1B||0
7999521|NCT00078806|19697187|P1|STARTED|Part 1B||10
7999522|NCT00078806|19697184|P4|NOT COMPLETED|Part 1A||0
7999523|NCT00078806|19697185|P3|NOT COMPLETED|Part 1A||0
7999524|NCT00078806|19697186|P2|NOT COMPLETED|Part 1A||0
7999525|NCT00078806|19697187|P1|NOT COMPLETED|Part 1A||10
7999526|NCT00078806|19697184|P4|COMPLETED|Part 1A||0
7999527|NCT00078806|19697185|P3|COMPLETED|Part 1A||0
7999528|NCT00078806|19697186|P2|COMPLETED|Part 1A||0
7999529|NCT00078806|19697187|P1|COMPLETED|Part 1A||9
7999530|NCT00078806|19697184|P4|STARTED|Part 1A||0
7999531|NCT00078806|19697185|P3|STARTED|Part 1A||0
7999532|NCT00078806|19697186|P2|STARTED|Part 1A||0
7999533|NCT00078806|19697187|P1|STARTED|Part 1A||19
7999534|NCT00078767|19697223|P2|NOT COMPLETED|Overall Study||1
7999535|NCT00078767|19697224|P1|NOT COMPLETED|Overall Study||1
7999536|NCT00078767|19697223|P2|COMPLETED|Overall Study||11
7999537|NCT00078767|19697224|P1|COMPLETED|Overall Study||11
7999538|NCT00078767|19697223|P2|STARTED|Overall Study||12
7999539|NCT00078767|19697224|P1|STARTED|Overall Study||12
7999540|NCT00078754|19697241|P3|NOT COMPLETED|Overall Study||15
7999541|NCT00078754|19697242|P2|NOT COMPLETED|Overall Study||19
7999542|NCT00078754|19697243|P1|NOT COMPLETED|Overall Study||15
7999543|NCT00078754|19697241|P3|COMPLETED|Overall Study||16
7999544|NCT00078754|19697242|P2|COMPLETED|Overall Study||11
7999545|NCT00078754|19697243|P1|COMPLETED|Overall Study||14
7999546|NCT00078754|19697241|P3|STARTED|Overall Study||31
7999547|NCT00078754|19697242|P2|STARTED|Overall Study||30
7999548|NCT00078754|19697243|P1|STARTED|Overall Study||29
7999549|NCT00078728|19697253|P2|NOT COMPLETED|Overall Study||3
7999550|NCT00078728|19697254|P1|NOT COMPLETED|Overall Study||4
7999551|NCT00078728|19697253|P2|COMPLETED|Overall Study||17
7999552|NCT00078728|19697254|P1|COMPLETED|Overall Study||16
7999553|NCT00078728|19697253|P2|STARTED|Overall Study||20
7999554|NCT00078728|19697254|P1|STARTED|Overall Study||20
7999555|NCT00078715|19697262|P2|NOT COMPLETED|Second Intervention||0
7999556|NCT00078715|19697263|P1|NOT COMPLETED|Second Intervention||0
7999557|NCT00078715|19697262|P2|COMPLETED|Second Intervention||4
7999558|NCT00078715|19697263|P1|COMPLETED|Second Intervention||2
7999559|NCT00078715|19697262|P2|STARTED|Second Intervention||4
7999560|NCT00078715|19697263|P1|STARTED|Second Intervention||2
7999561|NCT00078715|19697262|P2|NOT COMPLETED|First Intervention||0
7999562|NCT00078715|19697263|P1|NOT COMPLETED|First Intervention||0
7999563|NCT00078715|19697262|P2|COMPLETED|First Intervention||4
7999564|NCT00078715|19697263|P1|COMPLETED|First Intervention||2
7999565|NCT00078715|19697262|P2|STARTED|First Intervention||4
7999566|NCT00078715|19697263|P1|STARTED|First Intervention||2
7999567|NCT00005947|19697271|P2|NOT COMPLETED|Overall Study||41
7999568|NCT00005947|19697272|P1|NOT COMPLETED|Overall Study||57
7999569|NCT00005947|19697271|P2|COMPLETED|Overall Study||4
7999570|NCT00005947|19697272|P1|COMPLETED|Overall Study||25
7999571|NCT00005947|19697271|P2|STARTED|Overall Study||45
7999572|NCT00005947|19697272|P1|STARTED|Overall Study||82
7999573|NCT00078559|19697280|P1|NOT COMPLETED|Overall Study||0
7999574|NCT00078559|19697280|P1|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10
7999575|NCT00078559|19697280|P1|STARTED|Overall Study||10
7999576|NCT00002597|19697308|P2|NOT COMPLETED|Overall Study||23
7999577|NCT00002597|19697309|P1|NOT COMPLETED|Overall Study||26
7999578|NCT00002597|19697308|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|992
7999579|NCT00002597|19697309|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|987
7999580|NCT00002597|19697308|P2|STARTED|Overall Study||1015
7999581|NCT00002597|19697309|P1|STARTED|Overall Study||1013
7999582|NCT00078377|19697334|P3|NOT COMPLETED|Overall Study||9
7999583|NCT00078377|19697335|P2|NOT COMPLETED|Overall Study||16
7999584|NCT00078377|19697336|P1|NOT COMPLETED|Overall Study||11
7999585|NCT00078377|19697334|P3|COMPLETED|Overall Study||55
7999586|NCT00078377|19697335|P2|COMPLETED|Overall Study||49
7999587|NCT00078377|19697336|P1|COMPLETED|Overall Study||56
7999588|NCT00078377|19697334|P3|STARTED|Overall Study||64
7999589|NCT00078377|19697335|P2|STARTED|Overall Study||65
7999590|NCT00078377|19697336|P1|STARTED|Overall Study||67
7999591|NCT00078338|19697351|P2|NOT COMPLETED|Overall Study||54
7999592|NCT00078338|19697352|P1|NOT COMPLETED|Overall Study||85
7999593|NCT00078338|19697351|P2|COMPLETED|Overall Study||324
7999594|NCT00078338|19697352|P1|COMPLETED|Overall Study||301
7999595|NCT00078338|19697351|P2|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|375
7999596|NCT00078338|19697352|P1|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|381
7999597|NCT00078338|19697351|P2|STARTED|Overall Study||378
7999598|NCT00078338|19697352|P1|STARTED|Overall Study||386
7999599|NCT00076687|19697361|P3|NOT COMPLETED|Overall Study||4
7999600|NCT00076687|19697362|P2|NOT COMPLETED|Overall Study||5
7999601|NCT00076687|19697363|P1|NOT COMPLETED|Overall Study||6
7999602|NCT00076687|19697361|P3|COMPLETED|Overall Study||51
7999603|NCT00076687|19697362|P2|COMPLETED|Overall Study||47
7999604|NCT00076687|19697363|P1|COMPLETED|Overall Study||42
7999605|NCT00076687|19697361|P3|STARTED|Overall Study||55
7999606|NCT00076687|19697362|P2|STARTED|Overall Study||52
7999607|NCT00076687|19697363|P1|STARTED|Overall Study||48
7999608|NCT00078403|19697383|P3|NOT COMPLETED|Overall Study||28
7999609|NCT00078403|19697384|P2|NOT COMPLETED|Overall Study||16
7999610|NCT00078403|19697385|P1|NOT COMPLETED|Overall Study||18
7999611|NCT00078403|19697383|P3|COMPLETED|Overall Study||141
7999612|NCT00078403|19697384|P2|COMPLETED|Overall Study||26
7999613|NCT00078403|19697385|P1|COMPLETED|Overall Study||26
7999614|NCT00078403|19697383|P3|STARTED|Overall Study||169
7999615|NCT00078403|19697384|P2|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42
7999616|NCT00078403|19697385|P1|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44
7999617|NCT00078325|19697445|P3|NOT COMPLETED|Overall Study||11
7999618|NCT00078325|19697446|P2|NOT COMPLETED|Overall Study||19
7999619|NCT00078325|19697447|P1|NOT COMPLETED|Overall Study||21
7999620|NCT00078325|19697445|P3|COMPLETED|Overall Study||120
7999621|NCT00078325|19697446|P2|COMPLETED|Overall Study||114
7999622|NCT00078325|19697447|P1|COMPLETED|Overall Study||110
7999623|NCT00078325|19697445|P3|STARTED|Overall Study||131
7999624|NCT00078325|19697446|P2|STARTED|Overall Study||133
7999625|NCT00078325|19697447|P1|STARTED|Overall Study||131
7999626|NCT00078312|19697458|P1|NOT COMPLETED|Overall Study||177
7999627|NCT00078312|19697458|P1|COMPLETED|Overall Study||151
7999628|NCT00078312|19697458|P1|STARTED|Overall Study||328
7999629|NCT00078286|19697464|P2|NOT COMPLETED|Overall Study||83
7999630|NCT00078286|19697465|P1|NOT COMPLETED|Overall Study||96
7999631|NCT00078286|19697464|P2|COMPLETED|Overall Study||152
7999632|NCT00078286|19697465|P1|COMPLETED|Overall Study||138
7999633|NCT00078286|19697464|P2|STARTED|Overall Study||235
7999634|NCT00078286|19697465|P1|STARTED|Overall Study||234
7999635|NCT00077974|19697473|P1|NOT COMPLETED|Overall Study||104
7999636|NCT00077974|19697473|P1|COMPLETED|Overall Study||2
7999637|NCT00077974|19697473|P1|STARTED|Overall Study||106
7999638|NCT00077857|19697490|P2|NOT COMPLETED|Overall Study||204
7999639|NCT00077857|19697491|P1|NOT COMPLETED|Overall Study||201
7999640|NCT00077857|19697490|P2|COMPLETED|Overall Study||31
7999641|NCT00077857|19697491|P1|COMPLETED|Overall Study||34
7999642|NCT00077857|19697490|P2|Safety Population: Actual Dose Received|Overall Study||248
7999643|NCT00077857|19697491|P1|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217
7999644|NCT00077857|19697490|P2|Received Study Drug|Overall Study||234
7999645|NCT00077857|19697491|P1|Received Study Drug|Overall Study||231
7999646|NCT00077857|19697490|P2|STARTED|Overall Study||235
7999647|NCT00077857|19697491|P1|STARTED|Overall Study||235
7999648|NCT00077766|19697511|P2|NOT COMPLETED|Overall Study||25
7999649|NCT00077766|19697512|P1|NOT COMPLETED|Overall Study||39
7999650|NCT00077766|19697511|P2|COMPLETED|Overall Study||131
7999651|NCT00077766|19697512|P1|COMPLETED|Overall Study||118
7999652|NCT00077766|19697511|P2|STARTED|Overall Study||156
7999653|NCT00077766|19697512|P1|STARTED|Overall Study||157
7999654|NCT00077922|19697530|P1|NOT COMPLETED|Overall Study||0
7999655|NCT00077922|19697530|P1|COMPLETED|Overall Study||15
7999656|NCT00077922|19697530|P1|STARTED|Overall Study||15
7999657|NCT00077675|19697537|P2|NOT COMPLETED|Overall Study||9
7999658|NCT00077675|19697538|P1|NOT COMPLETED|Overall Study||11
7999659|NCT00077675|19697537|P2|COMPLETED|Overall Study||89
7999660|NCT00077675|19697538|P1|COMPLETED|Overall Study||92
7999661|NCT00077675|19697537|P2|STARTED|Overall Study||98
7999662|NCT00077675|19697538|P1|STARTED|Overall Study||103
7999663|NCT00077649|19697548|P4|NOT COMPLETED|Overall Study||17
7999664|NCT00077649|19697549|P3|NOT COMPLETED|Overall Study||15
7999665|NCT00077649|19697550|P2|NOT COMPLETED|Overall Study||9
7999666|NCT00077649|19697551|P1|NOT COMPLETED|Overall Study||14
7999667|NCT00077649|19697548|P4|COMPLETED|Overall Study||30
7999668|NCT00077649|19697549|P3|COMPLETED|Overall Study||32
7999669|NCT00077649|19697550|P2|COMPLETED|Overall Study||38
7999670|NCT00077649|19697551|P1|COMPLETED|Overall Study||33
7999671|NCT00077649|19697548|P4|Completed 24 Weeks of Follow-up|Overall Study||31
7999672|NCT00077649|19697549|P3|Completed 24 Weeks of Follow-up|Overall Study||36
7999673|NCT00077649|19697550|P2|Completed 24 Weeks of Follow-up|Overall Study||40
7999674|NCT00077649|19697551|P1|Completed 24 Weeks of Follow-up|Overall Study||36
7999675|NCT00077649|19697548|P4|STARTED|Overall Study||47
7999676|NCT00077649|19697549|P3|STARTED|Overall Study||47
7999677|NCT00077649|19697550|P2|STARTED|Overall Study||47
7999678|NCT00077649|19697551|P1|STARTED|Overall Study||47
7999679|NCT00077636|19697599|P2|NOT COMPLETED|Overall Study||92
7999680|NCT00077636|19697600|P1|NOT COMPLETED|Overall Study||44
7999681|NCT00077636|19697599|P2|COMPLETED|Overall Study||641
7999682|NCT00077636|19697600|P1|COMPLETED|Overall Study||692
7999683|NCT00077636|19697599|P2|STARTED|Overall Study||733
7999684|NCT00077636|19697600|P1|STARTED|Overall Study||736
7999685|NCT00077623|19697621|P3|NOT COMPLETED|Overall Study||32
7999686|NCT00077623|19697622|P2|NOT COMPLETED|Overall Study||43
7999687|NCT00077623|19697623|P1|NOT COMPLETED|Overall Study||36
7999688|NCT00077623|19697621|P3|COMPLETED|Overall Study||159
7999689|NCT00077623|19697622|P2|COMPLETED|Overall Study||148
7999690|NCT00077623|19697623|P1|COMPLETED|Overall Study||154
7999691|NCT00077623|19697621|P3|STARTED|Overall Study||191
7999692|NCT00077623|19697622|P2|STARTED|Overall Study||191
7999693|NCT00077623|19697623|P1|STARTED|Overall Study||190
7999694|NCT00077610|19697658|P3|NOT COMPLETED|Overall Study||46
7999695|NCT00077610|19697659|P2|NOT COMPLETED|Overall Study||56
7999696|NCT00077610|19697660|P1|NOT COMPLETED|Overall Study||54
7999697|NCT00077610|19697658|P3|COMPLETED|Overall Study||180
7999698|NCT00077610|19697659|P2|COMPLETED|Overall Study||168
7999699|NCT00077610|19697660|P1|COMPLETED|Overall Study||169
7999700|NCT00077610|19697658|P3|Started Treatment|Overall Study||225
7999701|NCT00077610|19697659|P2|Started Treatment|Overall Study||220
7999702|NCT00077610|19697660|P1|Started Treatment|Overall Study||221
7999703|NCT00077610|19697658|P3|STARTED|Overall Study||226
7999704|NCT00077610|19697659|P2|STARTED|Overall Study||224
7999705|NCT00077610|19697660|P1|STARTED|Overall Study||223
7999706|NCT00077376|19697689|P1|NOT COMPLETED|Overall Study||22
7999707|NCT00077376|19697689|P1|COMPLETED|Overall Study||39
7999708|NCT00077376|19697689|P1|HER2+ in Central Testing|Overall Study||39
7999709|NCT00077376|19697689|P1|Treated|Overall Study||59
7999710|NCT00077376|19697689|P1|STARTED|Overall Study||61
7999711|NCT00077207|19697700|P1|NOT COMPLETED|Overall Study||30
7999712|NCT00077207|19697700|P1|COMPLETED|Overall Study||36
7999713|NCT00077207|19697700|P1|STARTED|Overall Study||66
7999714|NCT00077064|19697712|P2|NOT COMPLETED|Overall Study||6
7999715|NCT00077064|19697713|P1|NOT COMPLETED|Overall Study||0
7999716|NCT00077064|19697712|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|10
7999717|NCT00077064|19697713|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|17
7999718|NCT00077064|19697712|P2|STARTED|Overall Study||16
7999719|NCT00077064|19697713|P1|STARTED|Overall Study||17
7999720|NCT00076999|19697729|P5|NOT COMPLETED|Overall Study||25
7999721|NCT00076999|19697730|P4|NOT COMPLETED|Overall Study||1
7999722|NCT00076999|19697731|P3|NOT COMPLETED|Overall Study||17
7999723|NCT00076999|19697732|P2|NOT COMPLETED|Overall Study||24
7999724|NCT00076999|19697733|P1|NOT COMPLETED|Overall Study||12
7999725|NCT00076999|19697729|P5|COMPLETED|Overall Study||9
7999726|NCT00076999|19697730|P4|COMPLETED|Overall Study||5
7999727|NCT00076999|19697731|P3|COMPLETED|Overall Study||2
7999728|NCT00076999|19697732|P2|COMPLETED|Overall Study||7
7999729|NCT00076999|19697733|P1|COMPLETED|Overall Study||13
7999730|NCT00076999|19697729|P5|STARTED|Overall Study||34
7999731|NCT00076999|19697730|P4|STARTED|Overall Study||6
7999732|NCT00076999|19697731|P3|STARTED|Overall Study||19
7999733|NCT00076999|19697732|P2|STARTED|Overall Study||31
7999734|NCT00076999|19697733|P1|STARTED|Overall Study||25
7999735|NCT00003222|19697852|P2|NOT COMPLETED|Overall Study||1
7999736|NCT00003222|19697853|P1|NOT COMPLETED|Overall Study||0
7999737|NCT00003222|19697852|P2|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27
7999738|NCT00003222|19697853|P1|COMPLETED|Overall Study||13
7999739|NCT00003222|19697852|P2|STARTED|Overall Study||28
7999740|NCT00003222|19697853|P1|STARTED|Overall Study||13
7999741|NCT00076804|19697865|P2|NOT COMPLETED|Overall Study||69
7999742|NCT00076804|19697866|P1|NOT COMPLETED|Overall Study||60
7999743|NCT00076804|19697865|P2|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68
7999744|NCT00076804|19697866|P1|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77
7999745|NCT00076804|19697865|P2|STARTED|Overall Study||137
7999746|NCT00076804|19697866|P1|STARTED|Overall Study||137
7999747|NCT00076752|19697878|P1|NOT COMPLETED|Overall Study||3
7999748|NCT00076752|19697878|P1|COMPLETED|Overall Study||6
7999749|NCT00076752|19697878|P1|STARTED|Overall Study||9
7999750|NCT00076622|19697901|P4|NOT COMPLETED|Overall Study||0
7999751|NCT00076622|19697902|P3|NOT COMPLETED|Overall Study||0
7999752|NCT00076622|19697903|P2|NOT COMPLETED|Overall Study||0
7999753|NCT00076622|19697904|P1|NOT COMPLETED|Overall Study||0
7999754|NCT00076622|19697901|P4|COMPLETED|Overall Study||18
7999755|NCT00076622|19697902|P3|COMPLETED|Overall Study||40
7999756|NCT00076622|19697903|P2|COMPLETED|Overall Study||13
7999757|NCT00076622|19697904|P1|COMPLETED|Overall Study||23
7999758|NCT00076622|19697901|P4|STARTED|Overall Study||18
7999759|NCT00076622|19697902|P3|STARTED|Overall Study||40
7999760|NCT00076622|19697903|P2|STARTED|Overall Study||13
7999761|NCT00076622|19697904|P1|STARTED|Overall Study||23
7999762|NCT00076570|19697924|P2|NOT COMPLETED|Overall Study||8
7999763|NCT00076570|19697925|P1|NOT COMPLETED|Overall Study||8
7999764|NCT00076570|19697924|P2|COMPLETED|Overall Study||8
7999765|NCT00076570|19697925|P1|COMPLETED|Overall Study||7
7999766|NCT00076570|19697924|P2|STARTED|Overall Study||16
7999767|NCT00076570|19697925|P1|STARTED|Overall Study||15
7999768|NCT00003298|19697933|P1|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6
7999769|NCT00003298|19697933|P1|COMPLETED|Step 2 (Adjuvant Therapy)||4
7999770|NCT00003298|19697933|P1|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7
7999771|NCT00003298|19697933|P1|STARTED|Step 2 (Adjuvant Therapy)||10
7999772|NCT00003298|19697933|P1|NOT COMPLETED|Re-register to Step 2 After Surgery||18
7999773|NCT00003298|19697933|P1|COMPLETED|Re-register to Step 2 After Surgery||10
7999774|NCT00003298|19697933|P1|STARTED|Re-register to Step 2 After Surgery||28
7999775|NCT00003298|19697933|P1|NOT COMPLETED|Surgery||7
7999776|NCT00003298|19697933|P1|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28
7999777|NCT00003298|19697933|P1|STARTED|Surgery||35
7999778|NCT00003298|19697933|P1|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4
7999779|NCT00003298|19697933|P1|COMPLETED|Step 1 (Neoadjuvant Therapy)||35
7999780|NCT00003298|19697933|P1|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35
7999781|NCT00003298|19697933|P1|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38
7999782|NCT00003298|19697933|P1|STARTED|Step 1 (Neoadjuvant Therapy)||39
7999783|NCT00076336|19697943|P2|NOT COMPLETED|Overall Study||56
7999784|NCT00076336|19697944|P1|NOT COMPLETED|Overall Study||52
7999785|NCT00076336|19697943|P2|COMPLETED|Overall Study||60
7999786|NCT00076336|19697944|P1|COMPLETED|Overall Study||64
7999787|NCT00076336|19697943|P2|Completed Week 104|Overall Study||62
7999788|NCT00076336|19697944|P1|Completed Week 104|Overall Study||70
7999789|NCT00076336|19697943|P2|Completed Week 52|Overall Study||94
7999790|NCT00076336|19697944|P1|Completed Week 52|Overall Study||97
7999791|NCT00076336|19697943|P2|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114
7999792|NCT00076336|19697944|P1|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114
7999793|NCT00076336|19697943|P2|Safety Population|Overall Study||116
7999794|NCT00076336|19697944|P1|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115
7999795|NCT00076336|19697943|P2|STARTED|Overall Study||116
7999796|NCT00076336|19697944|P1|STARTED|Overall Study||116
7999797|NCT00076258|19697960|P2|NOT COMPLETED|Overall Study||3
7999798|NCT00076258|19697961|P1|NOT COMPLETED|Overall Study||1
7999799|NCT00076258|19697960|P2|COMPLETED|Overall Study||61
7999800|NCT00076258|19697961|P1|COMPLETED|Overall Study||61
7999801|NCT00076258|19697960|P2|STARTED|Overall Study||64
7999802|NCT00076258|19697961|P1|STARTED|Overall Study||62
7999803|NCT00076245|19697971|P4|NOT COMPLETED|Overall Study||1
7999804|NCT00076245|19697972|P3|NOT COMPLETED|Overall Study||0
7999805|NCT00076245|19697973|P2|NOT COMPLETED|Overall Study||0
7999806|NCT00076245|19697974|P1|NOT COMPLETED|Overall Study||0
7999807|NCT00076245|19697971|P4|COMPLETED|Overall Study||14
7999808|NCT00076245|19697972|P3|COMPLETED|Overall Study||15
7999809|NCT00076245|19697973|P2|COMPLETED|Overall Study||15
7999810|NCT00076245|19697974|P1|COMPLETED|Overall Study||16
7999811|NCT00076245|19697971|P4|STARTED|Overall Study||15
7999812|NCT00076245|19697972|P3|STARTED|Overall Study||15
7999813|NCT00076245|19697973|P2|STARTED|Overall Study||15
7999814|NCT00076245|19697974|P1|STARTED|Overall Study||16
7999815|NCT00076219|19697990|P2|NOT COMPLETED|Overall Study||11
7999816|NCT00076219|19697991|P1|NOT COMPLETED|Overall Study||18
7999817|NCT00076219|19697990|P2|COMPLETED|Overall Study||550
7999818|NCT00076219|19697991|P1|COMPLETED|Overall Study||545
7999819|NCT00076219|19697990|P2|STARTED|Overall Study||561
7999820|NCT00076219|19697991|P1|STARTED|Overall Study||563
7999821|NCT00076102|19697997|P1|NOT COMPLETED|Overall Study||5
7999822|NCT00076102|19697997|P1|COMPLETED|Overall Study||31
7999823|NCT00076102|19697997|P1|STARTED|Overall Study||36
7999824|NCT00076050|19698011|P2|NOT COMPLETED|Overall Study||43
7999825|NCT00076050|19698012|P1|NOT COMPLETED|Overall Study||23
7999826|NCT00076050|19698011|P2|COMPLETED|Overall Study||83
7999827|NCT00076050|19698012|P1|COMPLETED|Overall Study||99
7999828|NCT00076050|19698011|P2|STARTED|Overall Study||126
7999829|NCT00076050|19698012|P1|STARTED|Overall Study||122
7999830|NCT00076024|19698025|P4|NOT COMPLETED|Phase 2, Open-label||16
7999831|NCT00076024|19698026|P3|NOT COMPLETED|Phase 2, Open-label||0
7999832|NCT00076024|19698027|P2|NOT COMPLETED|Phase 2, Open-label||0
7999833|NCT00076024|19698028|P1|NOT COMPLETED|Phase 2, Open-label||0
7999834|NCT00076024|19698025|P4|COMPLETED|Phase 2, Open-label||0
7999835|NCT00076024|19698026|P3|COMPLETED|Phase 2, Open-label||0
7999836|NCT00076024|19698027|P2|COMPLETED|Phase 2, Open-label||0
7999837|NCT00076024|19698028|P1|COMPLETED|Phase 2, Open-label||0
7999838|NCT00076024|19698025|P4|STARTED|Phase 2, Open-label||16
7999839|NCT00076024|19698026|P3|STARTED|Phase 2, Open-label||0
7999840|NCT00076024|19698027|P2|STARTED|Phase 2, Open-label||0
7999841|NCT00076024|19698028|P1|STARTED|Phase 2, Open-label||0
7999842|NCT00076024|19698025|P4|NOT COMPLETED|Phase 2, Double-blind||0
7999843|NCT00076024|19698026|P3|NOT COMPLETED|Phase 2, Double-blind||56
7999844|NCT00076024|19698027|P2|NOT COMPLETED|Phase 2, Double-blind||112
7999845|NCT00076024|19698028|P1|NOT COMPLETED|Phase 2, Double-blind||0
7999846|NCT00076024|19698025|P4|COMPLETED|Phase 2, Double-blind||0
7999847|NCT00076024|19698026|P3|COMPLETED|Phase 2, Double-blind||0
7999848|NCT00076024|19698027|P2|COMPLETED|Phase 2, Double-blind||0
7999849|NCT00076024|19698028|P1|COMPLETED|Phase 2, Double-blind||0
7999850|NCT00076024|19698025|P4|Treated|Phase 2, Double-blind||0
7999851|NCT00076024|19698026|P3|Treated|Phase 2, Double-blind||56
7999852|NCT00076024|19698027|P2|Treated|Phase 2, Double-blind||111
7999853|NCT00076024|19698028|P1|Treated|Phase 2, Double-blind||0
7999854|NCT00076024|19698025|P4|STARTED|Phase 2, Double-blind||0
7999855|NCT00076024|19698026|P3|STARTED|Phase 2, Double-blind||56
7999856|NCT00076024|19698027|P2|STARTED|Phase 2, Double-blind||112
7999857|NCT00076024|19698028|P1|STARTED|Phase 2, Double-blind||0
7999858|NCT00076024|19698025|P4|NOT COMPLETED|Phase 1, Lead-in||0
7999859|NCT00076024|19698026|P3|NOT COMPLETED|Phase 1, Lead-in||0
7999860|NCT00076024|19698027|P2|NOT COMPLETED|Phase 1, Lead-in||0
7999861|NCT00076024|19698028|P1|NOT COMPLETED|Phase 1, Lead-in||6
7999862|NCT00076024|19698025|P4|COMPLETED|Phase 1, Lead-in||0
7999863|NCT00076024|19698026|P3|COMPLETED|Phase 1, Lead-in||0
7999864|NCT00076024|19698027|P2|COMPLETED|Phase 1, Lead-in||0
7999865|NCT00076024|19698028|P1|COMPLETED|Phase 1, Lead-in||0
7999866|NCT00076024|19698025|P4|STARTED|Phase 1, Lead-in||0
7999867|NCT00076024|19698026|P3|STARTED|Phase 1, Lead-in||0
7999868|NCT00076024|19698027|P2|STARTED|Phase 1, Lead-in||0
7999869|NCT00076024|19698028|P1|STARTED|Phase 1, Lead-in||6
7999870|NCT00076011|19698042|P1|NOT COMPLETED|Overall Study||52
7999871|NCT00076011|19698042|P1|COMPLETED|Overall Study||0
7999872|NCT00076011|19698042|P1|STARTED|Overall Study||52
7999873|NCT00075946|19698054|P5|NOT COMPLETED|Overall Study||188
7999874|NCT00075946|19698055|P4|NOT COMPLETED|Overall Study||30
7999875|NCT00075946|19698056|P3|NOT COMPLETED|Overall Study||28
7999876|NCT00075946|19698057|P2|NOT COMPLETED|Overall Study||151
7999877|NCT00075946|19698058|P1|NOT COMPLETED|Overall Study||148
7999878|NCT00075946|19698054|P5|COMPLETED|Overall Study||0
7999879|NCT00075946|19698055|P4|COMPLETED|Overall Study||0
7999880|NCT00075946|19698056|P3|COMPLETED|Overall Study||0
7999881|NCT00075946|19698057|P2|COMPLETED|Overall Study||0
7999882|NCT00075946|19698058|P1|COMPLETED|Overall Study||0
7999883|NCT00075946|19698054|P5|Included in Primary Analysis|Overall Study||0
7999884|NCT00075946|19698055|P4|Included in Primary Analysis|Overall Study||29
7999885|NCT00075946|19698056|P3|Included in Primary Analysis|Overall Study||23
7999886|NCT00075946|19698057|P2|Included in Primary Analysis|Overall Study||146
7999887|NCT00075946|19698058|P1|Included in Primary Analysis|Overall Study||143
7999888|NCT00075946|19698054|P5|Treated and With Toxicity Data Available|Overall Study||154
7999889|NCT00075946|19698055|P4|Treated and With Toxicity Data Available|Overall Study||29
7999890|NCT00075946|19698056|P3|Treated and With Toxicity Data Available|Overall Study||27
7999891|NCT00075946|19698057|P2|Treated and With Toxicity Data Available|Overall Study||148
7999892|NCT00075946|19698058|P1|Treated and With Toxicity Data Available|Overall Study||142
7999893|NCT00075946|19698054|P5|STARTED|Overall Study||188
7999894|NCT00075946|19698055|P4|STARTED|Overall Study||30
7999895|NCT00075946|19698056|P3|STARTED|Overall Study||28
7999896|NCT00075946|19698057|P2|STARTED|Overall Study||151
7999897|NCT00075946|19698058|P1|STARTED|Overall Study||148
7999898|NCT00075881|19698073|P1|NOT COMPLETED|Overall Study||43
7999899|NCT00075881|19698073|P1|COMPLETED|Overall Study||1
7999900|NCT00075881|19698073|P1|Reinduction Treatment|Overall Study||7
7999901|NCT00075881|19698073|P1|Maintenance Treatment|Overall Study||15
7999902|NCT00075881|19698073|P1|Induction Treatment|Overall Study||42
7999903|NCT00075881|19698073|P1|Treated|Overall Study||42
7999904|NCT00075881|19698073|P1|Eligible|Overall Study||43
7999905|NCT00075881|19698073|P1|STARTED|Overall Study||44
7999906|NCT00075829|19698084|P4|NOT COMPLETED|Overall Study||24
7999907|NCT00075829|19698085|P3|NOT COMPLETED|Overall Study||34
7999908|NCT00075829|19698086|P2|NOT COMPLETED|Overall Study||118
7999909|NCT00075829|19698087|P1|NOT COMPLETED|Overall Study||258
7999910|NCT00075829|19698084|P4|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13
7999911|NCT00075829|19698085|P3|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14
7999912|NCT00075829|19698086|P2|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71
7999913|NCT00075829|19698087|P1|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178
7999914|NCT00075829|19698084|P4|STARTED|Overall Study||37
7999915|NCT00075829|19698085|P3|STARTED|Overall Study||48
7999916|NCT00075829|19698086|P2|STARTED|Overall Study||189
7999917|NCT00075829|19698087|P1|STARTED|Overall Study||436
7999918|NCT00075816|19698117|P2|NOT COMPLETED|Overall Study||11
7999919|NCT00075816|19698118|P1|NOT COMPLETED|Overall Study||14
7999920|NCT00075816|19698117|P2|COMPLETED|Overall Study||262
7999921|NCT00075816|19698118|P1|COMPLETED|Overall Study||264
7999922|NCT00075816|19698117|P2|STARTED|Overall Study||273
7999923|NCT00075816|19698118|P1|STARTED|Overall Study||278
7999924|NCT00075803|19698158|P2|NOT COMPLETED|Overall Study||0
7999925|NCT00075803|19698159|P1|NOT COMPLETED|Overall Study||0
7999926|NCT00075803|19698158|P2|COMPLETED|Overall Study||305
7999927|NCT00075803|19698159|P1|COMPLETED|Overall Study||295
7999928|NCT00075803|19698158|P2|STARTED|Overall Study||305
7999929|NCT00075803|19698159|P1|STARTED|Overall Study||295
7999930|NCT00075764|19698187|P2|NOT COMPLETED|Overall Study||349
7999931|NCT00075764|19698188|P1|NOT COMPLETED|Overall Study||345
7999932|NCT00075764|19698187|P2|COMPLETED|Overall Study||0
7999933|NCT00075764|19698188|P1|COMPLETED|Overall Study||0
7999934|NCT00075764|19698187|P2|STARTED|Overall Study||349
7999935|NCT00075764|19698188|P1|STARTED|Overall Study||345
7999936|NCT00075725|19698212|P12|NOT COMPLETED|Overall Study||18
7999937|NCT00075725|19698213|P11|NOT COMPLETED|Overall Study||9
7999938|NCT00075725|19698214|P10|NOT COMPLETED|Overall Study||18
7999939|NCT00075725|19698215|P9|NOT COMPLETED|Overall Study||117
7999940|NCT00075725|19698216|P8|NOT COMPLETED|Overall Study||295
7999941|NCT00075725|19698217|P7|NOT COMPLETED|Overall Study||75
7999942|NCT00075725|19698218|P6|NOT COMPLETED|Overall Study||313
7999943|NCT00075725|19698219|P5|NOT COMPLETED|Overall Study||66
7999944|NCT00075725|19698220|P4|NOT COMPLETED|Overall Study||78
7999945|NCT00075725|19698221|P3|NOT COMPLETED|Overall Study||121
7999946|NCT00075725|19698222|P2|NOT COMPLETED|Overall Study||49
7999947|NCT00075725|19698223|P1|NOT COMPLETED|Overall Study||74
7999948|NCT00075725|19698212|P12|COMPLETED|Overall Study||10
7999949|NCT00075725|19698213|P11|COMPLETED|Overall Study||3
7999950|NCT00075725|19698214|P10|COMPLETED|Overall Study||16
7999951|NCT00075725|19698215|P9|COMPLETED|Overall Study||185
7999952|NCT00075725|19698216|P8|COMPLETED|Overall Study||401
7999953|NCT00075725|19698217|P7|COMPLETED|Overall Study||171
7999954|NCT00075725|19698218|P6|COMPLETED|Overall Study||397
7999955|NCT00075725|19698219|P5|COMPLETED|Overall Study||166
7999956|NCT00075725|19698220|P4|COMPLETED|Overall Study||168
7999957|NCT00075725|19698221|P3|COMPLETED|Overall Study||175
7999958|NCT00075725|19698222|P2|COMPLETED|Overall Study||57
7999959|NCT00075725|19698223|P1|COMPLETED|Overall Study||172
7999960|NCT00075725|19698212|P12|STARTED|Overall Study||28
7999961|NCT00075725|19698213|P11|STARTED|Overall Study||12
7999962|NCT00075725|19698214|P10|STARTED|Overall Study||34
7999963|NCT00075725|19698215|P9|STARTED|Overall Study||302
7999964|NCT00075725|19698216|P8|STARTED|Overall Study||696
7999965|NCT00075725|19698217|P7|STARTED|Overall Study||246
7999966|NCT00075725|19698218|P6|STARTED|Overall Study||710
7999967|NCT00075725|19698219|P5|STARTED|Overall Study||232
7999968|NCT00075725|19698220|P4|STARTED|Overall Study||246
7999969|NCT00075725|19698221|P3|STARTED|Overall Study||296
7999970|NCT00075725|19698222|P2|STARTED|Overall Study||106
7999971|NCT00075725|19698223|P1|STARTED|Overall Study||246
7999972|NCT00075608|19698312|P1|NOT COMPLETED|Overall Study||0
7999973|NCT00075608|19698312|P1|COMPLETED|Overall Study||12
7999974|NCT00075608|19698312|P1|STARTED|Overall Study||12
7999975|NCT00075582|19698320|P2|NOT COMPLETED|Overall Study||35
7999976|NCT00075582|19698321|P1|NOT COMPLETED|Overall Study||50
7999977|NCT00075582|19698320|P2|COMPLETED|Overall Study||50
7999978|NCT00075582|19698321|P1|COMPLETED|Overall Study||255
7999979|NCT00075582|19698320|P2|STARTED|Overall Study||85
7999980|NCT00075582|19698321|P1|STARTED|Overall Study||305
7999981|NCT00075504|19698335|P2|NOT COMPLETED|Overall Study||7
7999982|NCT00075504|19698336|P1|NOT COMPLETED|Overall Study||9
7999983|NCT00075504|19698335|P2|COMPLETED|Overall Study||3
7999984|NCT00075504|19698336|P1|COMPLETED|Overall Study||14
7999985|NCT00075504|19698335|P2|STARTED|Overall Study||10
7999986|NCT00075504|19698336|P1|STARTED|Overall Study||23
7999987|NCT00075478|19698348|P2|NOT COMPLETED|Overall Study||1
7999988|NCT00075478|19698349|P1|NOT COMPLETED|Overall Study||1
7999989|NCT00075478|19698348|P2|COMPLETED|Overall Study||44
7999990|NCT00075478|19698349|P1|COMPLETED|Overall Study||41
7999991|NCT00075478|19698348|P2|STARTED|Overall Study||45
7999992|NCT00075478|19698349|P1|STARTED|Overall Study||42
7999993|NCT00075400|19698369|P1|NOT COMPLETED|Overall Study||3
7999994|NCT00075400|19698369|P1|COMPLETED|Overall Study|Eligible and treated patients.|23
7999995|NCT00075400|19698369|P1|STARTED|Overall Study||26
7999996|NCT00075335|19698383|P1|NOT COMPLETED|Overall Study||0
7999997|NCT00075335|19698383|P1|COMPLETED|Overall Study||8
7999998|NCT00075335|19698383|P1|STARTED|Overall Study||8
7999999|NCT00075270|19698390|P2|NOT COMPLETED|Overall Study||284
8000000|NCT00075270|19698391|P1|NOT COMPLETED|Overall Study||286
8000001|NCT00075270|19698390|P2|COMPLETED|Overall Study||4
8000002|NCT00075270|19698391|P1|COMPLETED|Overall Study||5
8000003|NCT00075270|19698390|P2|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13
8000004|NCT00075270|19698391|P1|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26
8000005|NCT00075270|19698390|P2|STARTED|Overall Study||288
8000006|NCT00075270|19698391|P1|STARTED|Overall Study||291
8000007|NCT00075218|19698437|P3|NOT COMPLETED|Open-Label Treatment||255
8000008|NCT00075218|19698438|P2|NOT COMPLETED|Open-Label Treatment||0
8000009|NCT00075218|19698439|P1|NOT COMPLETED|Open-Label Treatment||0
8000010|NCT00075218|19698437|P3|COMPLETED|Open-Label Treatment||0
8000011|NCT00075218|19698438|P2|COMPLETED|Open-Label Treatment||0
8000012|NCT00075218|19698439|P1|COMPLETED|Open-Label Treatment||0
8000013|NCT00075218|19698437|P3|STARTED|Open-Label Treatment||255
8000014|NCT00075218|19698438|P2|STARTED|Open-Label Treatment||0
8000015|NCT00075218|19698439|P1|STARTED|Open-Label Treatment||0
8000016|NCT00075218|19698437|P3|NOT COMPLETED|Double-Blind Treatment||0
8000017|NCT00075218|19698438|P2|NOT COMPLETED|Double-Blind Treatment||15
8000018|NCT00075218|19698439|P1|NOT COMPLETED|Double-Blind Treatment||91
8000019|NCT00075218|19698437|P3|COMPLETED|Double-Blind Treatment||0
8000020|NCT00075218|19698438|P2|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103
8000021|NCT00075218|19698439|P1|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152
8000022|NCT00075218|19698437|P3|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0
8000023|NCT00075218|19698438|P2|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103
8000024|NCT00075218|19698439|P1|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152
8000025|NCT00075218|19698437|P3|Received Double-Blind Treatment|Double-Blind Treatment||0
8000026|NCT00075218|19698438|P2|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114
8000027|NCT00075218|19698439|P1|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228
8000028|NCT00075218|19698437|P3|STARTED|Double-Blind Treatment||0
8000029|NCT00075218|19698438|P2|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118
8000030|NCT00075218|19698439|P1|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243
8000031|NCT00075088|19698474|P2|NOT COMPLETED|Overall Study||0
8000032|NCT00075088|19698475|P1|NOT COMPLETED|Overall Study||0
8000033|NCT00075088|19698474|P2|COMPLETED|Overall Study||391
8000034|NCT00075088|19698475|P1|COMPLETED|Overall Study||403
8000035|NCT00075088|19698474|P2|STARTED|Overall Study||391
8000036|NCT00075088|19698475|P1|STARTED|Overall Study||403
8000037|NCT00075023|19698488|P2|NOT COMPLETED|Part Two||0
8000038|NCT00075023|19698489|P1|NOT COMPLETED|Part Two||0
8000039|NCT00075023|19698488|P2|COMPLETED|Part Two||0
8000040|NCT00075023|19698489|P1|COMPLETED|Part Two||0
8000041|NCT00075023|19698488|P2|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
8000042|NCT00075023|19698489|P1|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
8000043|NCT00075023|19698488|P2|NOT COMPLETED|Pilot Study||2
8000044|NCT00075023|19698489|P1|NOT COMPLETED|Pilot Study||2
8000045|NCT00075023|19698488|P2|COMPLETED|Pilot Study||3
8000046|NCT00075023|19698489|P1|COMPLETED|Pilot Study||3
8000047|NCT00075023|19698488|P2|STARTED|Pilot Study||5
8000048|NCT00075023|19698489|P1|STARTED|Pilot Study||5
8000049|NCT00074984|19698498|P2|NOT COMPLETED|Overall Study||8
8000050|NCT00074984|19698499|P1|NOT COMPLETED|Overall Study||3
8000051|NCT00074984|19698498|P2|COMPLETED|Overall Study||43
8000052|NCT00074984|19698499|P1|COMPLETED|Overall Study||28
8000053|NCT00074984|19698498|P2|STARTED|Overall Study||51
8000054|NCT00074984|19698499|P1|STARTED|Overall Study||31
8000055|NCT00074958|19698514|P1|NOT COMPLETED|Overall Study||1
8000056|NCT00074958|19698514|P1|COMPLETED|Overall Study||15
8000057|NCT00074958|19698514|P1|STARTED|Overall Study||16
8000058|NCT00074815|19698522|P3|NOT COMPLETED|Overall Study||12
8000059|NCT00074815|19698523|P2|NOT COMPLETED|Overall Study||6
8000060|NCT00074815|19698524|P1|NOT COMPLETED|Overall Study||5
8000061|NCT00074815|19698522|P3|COMPLETED|Overall Study||30
8000062|NCT00074815|19698523|P2|COMPLETED|Overall Study||34
8000063|NCT00074815|19698524|P1|COMPLETED|Overall Study||37
8000064|NCT00074815|19698522|P3|STARTED|Overall Study||42
8000065|NCT00074815|19698523|P2|STARTED|Overall Study||40
8000066|NCT00074815|19698524|P1|STARTED|Overall Study||42
8000067|NCT00074802|19698534|P2|NOT COMPLETED|Overall Study||7
8000068|NCT00074802|19698535|P1|NOT COMPLETED|Overall Study||9
8000069|NCT00074802|19698534|P2|COMPLETED|Overall Study||25
8000070|NCT00074802|19698535|P1|COMPLETED|Overall Study||20
8000071|NCT00074802|19698534|P2|STARTED|Overall Study||32
8000072|NCT00074802|19698535|P1|STARTED|Overall Study||29
8000073|NCT00074711|19698555|P2|NOT COMPLETED|Overall Study||15
8000074|NCT00074711|19698556|P1|NOT COMPLETED|Overall Study||15
8000075|NCT00074711|19698555|P2|COMPLETED|Overall Study||106
8000076|NCT00074711|19698556|P1|COMPLETED|Overall Study||105
8000077|NCT00074711|19698555|P2|STARTED|Overall Study||121
8000078|NCT00074711|19698556|P1|STARTED|Overall Study||120
8000079|NCT00074581|19698574|P2|NOT COMPLETED|Overall Study||226
8000080|NCT00074581|19698575|P1|NOT COMPLETED|Overall Study||244
8000081|NCT00074581|19698574|P2|COMPLETED|Overall Study||1541
8000082|NCT00074581|19698575|P1|COMPLETED|Overall Study||1545
8000083|NCT00074581|19698574|P2|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767
8000084|NCT00074581|19698575|P1|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789
8000085|NCT00074490|19698588|P6|NOT COMPLETED|Overall Study||0
8000086|NCT00074490|19698589|P5|NOT COMPLETED|Overall Study||3
8000087|NCT00074490|19698590|P4|NOT COMPLETED|Overall Study||0
8000088|NCT00074490|19698591|P3|NOT COMPLETED|Overall Study||0
8000089|NCT00074490|19698592|P2|NOT COMPLETED|Overall Study||7
8000090|NCT00074490|19698593|P1|NOT COMPLETED|Overall Study||0
8000091|NCT00074490|19698588|P6|COMPLETED|Overall Study||221
8000092|NCT00074490|19698589|P5|COMPLETED|Overall Study||42
8000093|NCT00074490|19698590|P4|COMPLETED|Overall Study||44
8000094|NCT00074490|19698591|P3|COMPLETED|Overall Study||40
8000095|NCT00074490|19698592|P2|COMPLETED|Overall Study||27
8000096|NCT00074490|19698593|P1|COMPLETED|Overall Study||1
8000097|NCT00074490|19698588|P6|STARTED|Overall Study||221
8000098|NCT00074490|19698589|P5|STARTED|Overall Study||45
8000099|NCT00074490|19698590|P4|STARTED|Overall Study||44
8000100|NCT00074490|19698591|P3|STARTED|Overall Study||40
8000101|NCT00074490|19698592|P2|STARTED|Overall Study||34
8000102|NCT00074490|19698593|P1|STARTED|Overall Study||1
8000103|NCT00074412|19698627|P2|NOT COMPLETED|Overall Study||84
8000104|NCT00074412|19698628|P1|NOT COMPLETED|Overall Study||82
8000105|NCT00074412|19698627|P2|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675
8000106|NCT00074412|19698628|P1|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681
8000107|NCT00074412|19698627|P2|Month 12 Visit|Overall Study||735
8000108|NCT00074412|19698628|P1|Month 12 Visit|Overall Study||733
8000109|NCT00074412|19698627|P2|Month 9 Visit|Overall Study||741
8000110|NCT00074412|19698628|P1|Month 9 Visit|Overall Study||741
8000111|NCT00074412|19698627|P2|Month 6 Visit|Overall Study||748
8000112|NCT00074412|19698628|P1|Month 6 Visit|Overall Study||748
8000113|NCT00074412|19698627|P2|Month 5 Visit|Overall Study||750
8000114|NCT00074412|19698628|P1|Month 5 Visit|Overall Study||756
8000115|NCT00074412|19698627|P2|Month 4 Visit|Overall Study||752
8000116|NCT00074412|19698628|P1|Month 4 Visit|Overall Study||758
8000117|NCT00074412|19698627|P2|Month 3 Visit|Overall Study||755
8000118|NCT00074412|19698628|P1|Month 3 Visit|Overall Study||759
8000119|NCT00074412|19698627|P2|Week 8 Visit|Overall Study||759
8000120|NCT00074412|19698628|P1|Week 8 Visit|Overall Study||759
8000121|NCT00074412|19698627|P2|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759
8000122|NCT00074412|19698628|P1|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763
8000123|NCT00074308|19698644|P5|NOT COMPLETED|Overall Study||0
8000124|NCT00074308|19698645|P4|NOT COMPLETED|Overall Study||0
8000125|NCT00074308|19698646|P3|NOT COMPLETED|Overall Study||0
8000126|NCT00074308|19698647|P2|NOT COMPLETED|Overall Study||0
8000127|NCT00074308|19698648|P1|NOT COMPLETED|Overall Study||0
8000128|NCT00074308|19698644|P5|COMPLETED|Overall Study||23
8000129|NCT00074308|19698645|P4|COMPLETED|Overall Study||8
8000130|NCT00074308|19698646|P3|COMPLETED|Overall Study||3
8000131|NCT00074308|19698647|P2|COMPLETED|Overall Study||3
8000132|NCT00074308|19698648|P1|COMPLETED|Overall Study||3
8000133|NCT00074308|19698644|P5|STARTED|Overall Study||23
8000134|NCT00074308|19698645|P4|STARTED|Overall Study||8
8000135|NCT00074308|19698646|P3|STARTED|Overall Study||3
8000136|NCT00074308|19698647|P2|STARTED|Overall Study||3
8000137|NCT00074308|19698648|P1|STARTED|Overall Study||3
8000138|NCT00074282|19698659|P3|NOT COMPLETED|Step 2||24
8000139|NCT00074282|19698660|P2|NOT COMPLETED|Step 2||2
8000140|NCT00074282|19698661|P1|NOT COMPLETED|Step 2||0
8000141|NCT00074282|19698659|P3|COMPLETED|Step 2||7
8000142|NCT00074282|19698660|P2|COMPLETED|Step 2||7
8000143|NCT00074282|19698661|P1|COMPLETED|Step 2||0
8000144|NCT00074282|19698659|P3|STARTED|Step 2||31
8000145|NCT00074282|19698660|P2|STARTED|Step 2||9
8000146|NCT00074282|19698661|P1|STARTED|Step 2||0
8000147|NCT00074282|19698659|P3|NOT COMPLETED|Step 1||0
8000148|NCT00074282|19698660|P2|NOT COMPLETED|Step 1||0
8000149|NCT00074282|19698661|P1|NOT COMPLETED|Step 1||58
8000150|NCT00074282|19698659|P3|COMPLETED|Step 1||0
8000151|NCT00074282|19698660|P2|COMPLETED|Step 1||0
8000152|NCT00074282|19698661|P1|COMPLETED|Step 1||44
8000153|NCT00074282|19698659|P3|Started Treatment|Step 1||0
8000154|NCT00074282|19698660|P2|Started Treatment|Step 1||0
8000155|NCT00074282|19698661|P1|Started Treatment|Step 1||96
8000156|NCT00074282|19698659|P3|Eligible|Step 1||0
8000157|NCT00074282|19698660|P2|Eligible|Step 1||0
8000158|NCT00074282|19698661|P1|Eligible|Step 1||98
8000159|NCT00074282|19698659|P3|STARTED|Step 1||0
8000160|NCT00074282|19698660|P2|STARTED|Step 1||0
8000161|NCT00074282|19698661|P1|STARTED|Step 1||102
8000162|NCT00074269|19698671|P1|NOT COMPLETED|Overall Study||0
8000163|NCT00074269|19698671|P1|COMPLETED|Overall Study||5
8000164|NCT00074269|19698671|P1|STARTED|Overall Study||5
8000165|NCT00074165|19698681|P1|NOT COMPLETED|Overall Study||0
8000166|NCT00074165|19698681|P1|COMPLETED|Overall Study||17
8000167|NCT00074165|19698681|P1|STARTED|Overall Study||17
8000168|NCT00074152|19698688|P2|NOT COMPLETED|Overall Study||33
8000169|NCT00074152|19698689|P1|NOT COMPLETED|Overall Study||55
8000170|NCT00074152|19698688|P2|COMPLETED|Overall Study||52
8000171|NCT00074152|19698689|P1|COMPLETED|Overall Study||22
8000172|NCT00074152|19698688|P2|STARTED|Overall Study||85
8000173|NCT00074152|19698689|P1|STARTED|Overall Study||77
8000174|NCT00074035|19698699|P1|NOT COMPLETED|Overall Study||0
8000175|NCT00074035|19698699|P1|COMPLETED|Overall Study||38
8000176|NCT00074035|19698699|P1|STARTED|Overall Study||38
8000177|NCT00073983|19698706|P1|NOT COMPLETED|Overall Study||1
8000178|NCT00073983|19698706|P1|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53
8000179|NCT00073983|19698706|P1|STARTED|Overall Study||54
8000180|NCT00073957|19698721|P1|NOT COMPLETED|Overall Study||0
8000181|NCT00073957|19698721|P1|COMPLETED|Overall Study||25
8000182|NCT00073957|19698721|P1|STARTED|Overall Study||25
8000183|NCT00073918|19698727|P1|NOT COMPLETED|Overall Study||4
8000184|NCT00073918|19698727|P1|COMPLETED|Overall Study||107
8000185|NCT00073918|19698727|P1|STARTED|Overall Study||111
8000186|NCT00073749|19698741|P7|NOT COMPLETED|Overall Study||40
8000187|NCT00073749|19698742|P6|NOT COMPLETED|Overall Study||6
8000188|NCT00073749|19698743|P5|NOT COMPLETED|Overall Study||6
8000189|NCT00073749|19698744|P4|NOT COMPLETED|Overall Study||6
8000190|NCT00073749|19698745|P3|NOT COMPLETED|Overall Study||11
8000191|NCT00073749|19698746|P2|NOT COMPLETED|Overall Study||5
8000192|NCT00073749|19698747|P1|NOT COMPLETED|Overall Study||2
8000193|NCT00073749|19698741|P7|COMPLETED|Overall Study||3
8000194|NCT00073749|19698742|P6|COMPLETED|Overall Study||0
8000195|NCT00073749|19698743|P5|COMPLETED|Overall Study||0
8000196|NCT00073749|19698744|P4|COMPLETED|Overall Study||0
8000197|NCT00073749|19698745|P3|COMPLETED|Overall Study||0
8000198|NCT00073749|19698746|P2|COMPLETED|Overall Study||0
8000199|NCT00073749|19698747|P1|COMPLETED|Overall Study||0
8000200|NCT00073749|19698741|P7|STARTED|Overall Study||43
8000201|NCT00073749|19698742|P6|STARTED|Overall Study||6
8000202|NCT00073749|19698743|P5|STARTED|Overall Study||6
8000203|NCT00073749|19698744|P4|STARTED|Overall Study||6
8000204|NCT00073749|19698745|P3|STARTED|Overall Study||11
8000205|NCT00073749|19698746|P2|STARTED|Overall Study||5
8000206|NCT00073749|19698747|P1|STARTED|Overall Study||2
8000207|NCT00073528|19698778|P2|NOT COMPLETED|Overall Study||642
8000208|NCT00073528|19698779|P1|NOT COMPLETED|Overall Study||644
8000209|NCT00073528|19698778|P2|COMPLETED|Overall Study||0
8000210|NCT00073528|19698779|P1|COMPLETED|Overall Study||0
8000211|NCT00073528|19698778|P2|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|344
8000212|NCT00073528|19698779|P1|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|349
8000213|NCT00073528|19698778|P2|STARTED|Overall Study||642
8000214|NCT00073528|19698779|P1|STARTED|Overall Study||644
8000215|NCT00073333|19698856|P3|NOT COMPLETED|Overall Study||0
8000216|NCT00073333|19698857|P2|NOT COMPLETED|Overall Study||14
8000217|NCT00073333|19698858|P1|NOT COMPLETED|Overall Study||14
8000218|NCT00073333|19698856|P3|COMPLETED|Overall Study||19
8000219|NCT00073333|19698857|P2|COMPLETED|Overall Study||27
8000220|NCT00073333|19698858|P1|COMPLETED|Overall Study||32
8000221|NCT00073333|19698856|P3|STARTED|Overall Study||19
8000222|NCT00073333|19698857|P2|STARTED|Overall Study||41
8000223|NCT00073333|19698858|P1|STARTED|Overall Study||46
8000224|NCT00073307|19698868|P3|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156
8000225|NCT00073307|19698869|P2|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
8000226|NCT00073307|19698870|P1|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134
8000227|NCT00073307|19698868|P3|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143
8000228|NCT00073307|19698869|P2|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
8000229|NCT00073307|19698870|P1|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120
8000230|NCT00073307|19698868|P3|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216
8000231|NCT00073307|19698869|P2|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0
8000232|NCT00073307|19698870|P1|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219
8000233|NCT00073307|19698868|P3|STARTED|Open Label-Sorafenib Only [30Jun2008]||299
8000234|NCT00073307|19698869|P2|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0
8000235|NCT00073307|19698870|P1|STARTED|Open Label-Sorafenib Only [30Jun2008]||254
8000326|NCT00071981|19699041|P3|Treated|Overall Study||36
8000236|NCT00073307|19698868|P3|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0
8000237|NCT00073307|19698869|P2|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153
8000238|NCT00073307|19698870|P1|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197
8000239|NCT00073307|19698868|P3|COMPLETED|Double-Blind (DB, as of ~31May2005)||0
8000240|NCT00073307|19698869|P2|COMPLETED|Double-Blind (DB, as of ~31May2005)||299
8000241|NCT00073307|19698870|P1|COMPLETED|Double-Blind (DB, as of ~31May2005)||254
8000242|NCT00073307|19698868|P3|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0
8000243|NCT00073307|19698869|P2|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
8000244|NCT00073307|19698870|P1|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
8000245|NCT00073307|19698868|P3|STARTED|Double-Blind (DB, as of ~31May2005)||0
8000246|NCT00073307|19698869|P2|STARTED|Double-Blind (DB, as of ~31May2005)||452
8000247|NCT00073307|19698870|P1|STARTED|Double-Blind (DB, as of ~31May2005)||451
8000248|NCT00073073|19698888|P1|NOT COMPLETED|Overall Study||4
8000249|NCT00073073|19698888|P1|COMPLETED|Overall Study||42
8000250|NCT00073073|19698888|P1|STARTED|Overall Study||46
8000251|NCT00073021|19698901|P2|NOT COMPLETED|Overall Study||16
8000252|NCT00073021|19698902|P1|NOT COMPLETED|Overall Study||26
8000253|NCT00073021|19698901|P2|COMPLETED|Overall Study||113
8000254|NCT00073021|19698902|P1|COMPLETED|Overall Study||113
8000255|NCT00073021|19698901|P2|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129
8000256|NCT00073021|19698902|P1|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139
8000257|NCT00073008|19698932|P2|NOT COMPLETED|Overall Study||63
8000258|NCT00073008|19698933|P1|NOT COMPLETED|Overall Study||62
8000259|NCT00073008|19698932|P2|COMPLETED|Overall Study||3
8000260|NCT00073008|19698933|P1|COMPLETED|Overall Study||3
8000261|NCT00073008|19698932|P2|STARTED|Overall Study||66
8000262|NCT00073008|19698933|P1|STARTED|Overall Study||65
8000263|NCT00072761|19698965|P2|NOT COMPLETED|Overall Study||2
8000264|NCT00072761|19698966|P1|NOT COMPLETED|Overall Study||9
8000265|NCT00072761|19698965|P2|COMPLETED|Overall Study||95
8000266|NCT00072761|19698966|P1|COMPLETED|Overall Study||90
8000267|NCT00072761|19698965|P2|STARTED|Overall Study||97
8000268|NCT00072761|19698966|P1|STARTED|Overall Study||99
8000269|NCT00072475|19698972|P1|NOT COMPLETED|Overall Study||97
8000270|NCT00072475|19698972|P1|COMPLETED|Overall Study||45
8000271|NCT00072475|19698972|P1|STARTED|Overall Study||142
8000272|NCT00072449|19698980|P1|NOT COMPLETED|Overall Study||0
8000273|NCT00072449|19698980|P1|COMPLETED|Overall Study||12
8000274|NCT00072449|19698980|P1|STARTED|Overall Study||12
8000275|NCT00072384|19698987|P1|NOT COMPLETED|Overall Study||9
8000276|NCT00072384|19698987|P1|COMPLETED|Overall Study||21
8000277|NCT00072384|19698987|P1|STARTED|Overall Study||30
8000278|NCT00072293|19699000|P2|NOT COMPLETED|Overall Study||2
8000279|NCT00072293|19699001|P1|NOT COMPLETED|Overall Study||1
8000280|NCT00072293|19699000|P2|COMPLETED|Overall Study||467
8000281|NCT00072293|19699001|P1|COMPLETED|Overall Study||464
8000282|NCT00072293|19699000|P2|STARTED|Overall Study||469
8000283|NCT00072293|19699001|P1|STARTED|Overall Study||465
8000284|NCT00072280|19699013|P2|NOT COMPLETED|Follow-up||2
8000285|NCT00072280|19699014|P1|NOT COMPLETED|Follow-up||2
8000286|NCT00072280|19699013|P2|COMPLETED|Follow-up||0
8000287|NCT00072280|19699014|P1|COMPLETED|Follow-up||0
8000288|NCT00072280|19699013|P2|STARTED|Follow-up||2
8000289|NCT00072280|19699014|P1|STARTED|Follow-up||2
8000290|NCT00072280|19699013|P2|NOT COMPLETED|Treatment||2
8000291|NCT00072280|19699014|P1|NOT COMPLETED|Treatment||1
8000292|NCT00072280|19699013|P2|COMPLETED|Treatment||2
8000293|NCT00072280|19699014|P1|COMPLETED|Treatment||2
8000294|NCT00072280|19699013|P2|STARTED|Treatment||4
8000295|NCT00072280|19699014|P1|STARTED|Treatment||3
8000296|NCT00072189|19699019|P1|NOT COMPLETED|Overall Study||1
8000297|NCT00072189|19699019|P1|COMPLETED|Overall Study||16
8000298|NCT00072189|19699019|P1|STARTED|Overall Study||17
8000299|NCT00072176|19699027|P2|NOT COMPLETED|Overall Study||1
8000300|NCT00072176|19699028|P1|NOT COMPLETED|Overall Study||1
8000301|NCT00072176|19699027|P2|COMPLETED|Overall Study||27
8000302|NCT00072176|19699028|P1|COMPLETED|Overall Study||33
8000303|NCT00072176|19699027|P2|STARTED|Overall Study||28
8000304|NCT00072176|19699028|P1|STARTED|Overall Study||34
8000305|NCT00071981|19699040|P4|NOT COMPLETED|Overall Study||45
8000306|NCT00071981|19699041|P3|NOT COMPLETED|Overall Study||37
8000307|NCT00071981|19699042|P2|NOT COMPLETED|Overall Study||41
8000308|NCT00071981|19699043|P1|NOT COMPLETED|Overall Study||46
8000309|NCT00071981|19699040|P4|COMPLETED|Overall Study||3
8000310|NCT00071981|19699041|P3|COMPLETED|Overall Study||0
8000311|NCT00071981|19699042|P2|COMPLETED|Overall Study||2
8000312|NCT00071981|19699043|P1|COMPLETED|Overall Study||1
8000313|NCT00071981|19699040|P4|Have Helper T Cell Response Data|Overall Study||39
8000314|NCT00071981|19699041|P3|Have Helper T Cell Response Data|Overall Study||25
8000315|NCT00071981|19699042|P2|Have Helper T Cell Response Data|Overall Study||27
8000316|NCT00071981|19699043|P1|Have Helper T Cell Response Data|Overall Study||37
8000317|NCT00071981|19699040|P4|Have CTL Response Data|Overall Study||41
8000318|NCT00071981|19699041|P3|Have CTL Response Data|Overall Study||29
8000319|NCT00071981|19699042|P2|Have CTL Response Data|Overall Study||30
8000320|NCT00071981|19699043|P1|Have CTL Response Data|Overall Study||40
8000321|NCT00071981|19699040|P4|Eligible and Treated|Overall Study||42
8000322|NCT00071981|19699041|P3|Eligible and Treated|Overall Study||32
8000323|NCT00071981|19699042|P2|Eligible and Treated|Overall Study||33
8000324|NCT00071981|19699043|P1|Eligible and Treated|Overall Study||41
8000325|NCT00071981|19699040|P4|Treated|Overall Study||48
8000327|NCT00071981|19699042|P2|Treated|Overall Study||38
8000328|NCT00071981|19699043|P1|Treated|Overall Study||45
8000329|NCT00071981|19699040|P4|Eligible|Overall Study||42
8000330|NCT00071981|19699041|P3|Eligible|Overall Study||33
8000331|NCT00071981|19699042|P2|Eligible|Overall Study||36
8000332|NCT00071981|19699043|P1|Eligible|Overall Study||43
8000333|NCT00071981|19699040|P4|STARTED|Overall Study||48
8000334|NCT00071981|19699041|P3|STARTED|Overall Study||37
8000335|NCT00071981|19699042|P2|STARTED|Overall Study||43
8000336|NCT00071981|19699043|P1|STARTED|Overall Study||47
8000337|NCT00072566|19699069|P1|NOT COMPLETED|Overall Study||0
8000338|NCT00072566|19699069|P1|COMPLETED|Overall Study||70
8000339|NCT00072566|19699069|P1|STARTED|Overall Study||70
8000340|NCT00072514|19699075|P1|NOT COMPLETED|Overall Study||4
8000341|NCT00072514|19699075|P1|COMPLETED|Overall Study||51
8000342|NCT00072514|19699075|P1|STARTED|Overall Study||55
8000343|NCT00071812|19699086|P4|NOT COMPLETED|24-Week Open-Label Extension Period||40
8000344|NCT00071812|19699087|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
8000345|NCT00071812|19699088|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
8000346|NCT00071812|19699089|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
8000347|NCT00071812|19699086|P4|COMPLETED|24-Week Open-Label Extension Period||178
8000348|NCT00071812|19699087|P3|COMPLETED|24-Week Open-Label Extension Period||7
8000349|NCT00071812|19699088|P2|COMPLETED|24-Week Open-Label Extension Period||11
8000350|NCT00071812|19699089|P1|COMPLETED|24-Week Open-Label Extension Period||0
8000351|NCT00071812|19699086|P4|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218
8000352|NCT00071812|19699087|P3|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8
8000353|NCT00071812|19699088|P2|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11
8000354|NCT00071812|19699089|P1|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0
8000355|NCT00071812|19699086|P4|NOT COMPLETED|24-Week Double-Blind Period||11
8000356|NCT00071812|19699087|P3|NOT COMPLETED|24-Week Double-Blind Period||8
8000357|NCT00071812|19699088|P2|NOT COMPLETED|24-Week Double-Blind Period||6
8000358|NCT00071812|19699089|P1|NOT COMPLETED|24-Week Double-Blind Period||10
8000359|NCT00071812|19699086|P4|COMPLETED|24-Week Double-Blind Period||60
8000360|NCT00071812|19699087|P3|COMPLETED|24-Week Double-Blind Period||63
8000361|NCT00071812|19699088|P2|COMPLETED|24-Week Double-Blind Period||66
8000362|NCT00071812|19699089|P1|COMPLETED|24-Week Double-Blind Period||59
8000363|NCT00071812|19699086|P4|STARTED|24-Week Double-Blind Period||71
8000364|NCT00071812|19699087|P3|STARTED|24-Week Double-Blind Period||71
8000365|NCT00071812|19699088|P2|STARTED|24-Week Double-Blind Period||72
8000366|NCT00071812|19699089|P1|STARTED|24-Week Double-Blind Period||69
8000367|NCT00071799|19699131|P2|NOT COMPLETED|Overall Study||98
8000368|NCT00071799|19699132|P1|NOT COMPLETED|Overall Study||70
8000369|NCT00071799|19699131|P2|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81
8000370|NCT00071799|19699132|P1|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109
8000371|NCT00071799|19699131|P2|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179
8000372|NCT00071799|19699132|P1|STARTED|Overall Study||179
8000373|NCT00071890|19699174|P2|NOT COMPLETED|Overall Study||0
8000374|NCT00071890|19699175|P1|NOT COMPLETED|Overall Study||0
8000375|NCT00071890|19699174|P2|COMPLETED|Overall Study|"1 withdrawal
~1 lost of follow-up
~1 death 67 patients analysed"|67
8000376|NCT00071890|19699175|P1|COMPLETED|Overall Study|"1 withdrawal
~1 death 81 patients analysed"|81
8000377|NCT00071890|19699174|P2|STARTED|Overall Study|1 patients stopped HAART at week 0|67
8000378|NCT00071890|19699175|P1|STARTED|Overall Study|3 patients did not received Interleukin-2|81
8000379|NCT00071760|19699185|P1|NOT COMPLETED|Overall Study||54
8000380|NCT00071760|19699185|P1|COMPLETED|Overall Study||0
8000381|NCT00071760|19699185|P1|Ongoing|Overall Study||25
8000382|NCT00071760|19699185|P1|STARTED|Overall Study||54
8000383|NCT00071721|19699246|P2|NOT COMPLETED|Overall Study||91
8000384|NCT00071721|19699247|P1|NOT COMPLETED|Overall Study||72
8000385|NCT00071721|19699246|P2|COMPLETED|Overall Study||69
8000386|NCT00071721|19699247|P1|COMPLETED|Overall Study||81
8000387|NCT00071721|19699246|P2|STARTED|Overall Study||160
8000388|NCT00071721|19699247|P1|STARTED|Overall Study||153
8000389|NCT00071513|19699265|P2|NOT COMPLETED|Follow-up Assessment||6
8000390|NCT00071513|19699266|P1|NOT COMPLETED|Follow-up Assessment||6
8000391|NCT00071513|19699265|P2|COMPLETED|Follow-up Assessment||247
8000392|NCT00071513|19699266|P1|COMPLETED|Follow-up Assessment||233
8000393|NCT00071513|19699265|P2|STARTED|Follow-up Assessment||253
8000394|NCT00071513|19699266|P1|STARTED|Follow-up Assessment||239
8000395|NCT00071513|19699265|P2|NOT COMPLETED|Intervention Component||3
8000396|NCT00071513|19699266|P1|NOT COMPLETED|Intervention Component||2
8000397|NCT00071513|19699265|P2|COMPLETED|Intervention Component||253
8000398|NCT00071513|19699266|P1|COMPLETED|Intervention Component||239
8000399|NCT00071513|19699265|P2|STARTED|Intervention Component||256
8000400|NCT00071513|19699266|P1|STARTED|Intervention Component||241
8000401|NCT00071487|19699278|P4|NOT COMPLETED|24-Week Open-Label Extension Period||23
8000402|NCT00071487|19699279|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
8000403|NCT00071487|19699280|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
8000404|NCT00071487|19699281|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
8000405|NCT00071487|19699278|P4|COMPLETED|24-Week Open-Label Extension Period||279
8000406|NCT00071487|19699279|P3|COMPLETED|24-Week Open-Label Extension Period||23
8000407|NCT00071487|19699280|P2|COMPLETED|24-Week Open-Label Extension Period||19
8000408|NCT00071487|19699281|P1|COMPLETED|24-Week Open-Label Extension Period||0
8000409|NCT00071487|19699278|P4|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302
8000410|NCT00071487|19699279|P3|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24
8000411|NCT00071487|19699280|P2|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19
8000412|NCT00071487|19699281|P1|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0
8000413|NCT00071487|19699278|P4|NOT COMPLETED|52-Week Double-Blind Period||21
8000414|NCT00071487|19699279|P3|NOT COMPLETED|52-Week Double-Blind Period||17
8000415|NCT00071487|19699280|P2|NOT COMPLETED|52-Week Double-Blind Period||27
8000416|NCT00071487|19699281|P1|NOT COMPLETED|52-Week Double-Blind Period||20
8000417|NCT00071487|19699278|P4|COMPLETED|52-Week Double-Blind Period||90
8000418|NCT00071487|19699279|P3|COMPLETED|52-Week Double-Blind Period||94
8000419|NCT00071487|19699280|P2|COMPLETED|52-Week Double-Blind Period||87
8000420|NCT00071487|19699281|P1|COMPLETED|52-Week Double-Blind Period||93
8000421|NCT00071487|19699278|P4|STARTED|52-Week Double-Blind Period||111
8000422|NCT00071487|19699279|P3|STARTED|52-Week Double-Blind Period||111
8000423|NCT00071487|19699280|P2|STARTED|52-Week Double-Blind Period||114
8000424|NCT00071487|19699281|P1|STARTED|52-Week Double-Blind Period||113
8000425|NCT00071396|19699325|P1|NOT COMPLETED|Overall Study||3
8000426|NCT00071396|19699325|P1|COMPLETED|Overall Study|Evaluable for response.|41
8000427|NCT00071396|19699325|P1|STARTED|Overall Study||44
8000428|NCT00071110|19699331|P2|NOT COMPLETED|Overall Study||4
8000429|NCT00071110|19699332|P1|NOT COMPLETED|Overall Study||0
8000430|NCT00071110|19699331|P2|COMPLETED|Overall Study||25
8000431|NCT00071110|19699332|P1|COMPLETED|Overall Study||28
8000432|NCT00071110|19699331|P2|STARTED|Overall Study||29
8000433|NCT00071110|19699332|P1|STARTED|Overall Study||28
8000434|NCT00071032|19699346|P2|NOT COMPLETED|Overall Study||8
8000435|NCT00071032|19699347|P1|NOT COMPLETED|Overall Study||9
8000436|NCT00071032|19699346|P2|COMPLETED|Overall Study||1001
8000437|NCT00071032|19699347|P1|COMPLETED|Overall Study||998
8000438|NCT00071032|19699346|P2|STARTED|Overall Study||1009
8000439|NCT00071032|19699347|P1|STARTED|Overall Study||1007
8000440|NCT00071006|19699383|P1|NOT COMPLETED|Overall Study||12
8000441|NCT00071006|19699383|P1|COMPLETED|Overall Study||0
8000442|NCT00071006|19699383|P1|STARTED|Overall Study||12
8000443|NCT00070941|19699396|P3|NOT COMPLETED|Overall Study||4
8000444|NCT00070941|19699397|P2|NOT COMPLETED|Overall Study||8
8000445|NCT00070941|19699398|P1|NOT COMPLETED|Overall Study||10
8000446|NCT00070941|19699396|P3|COMPLETED|Overall Study||2
8000447|NCT00070941|19699397|P2|COMPLETED|Overall Study||3
8000448|NCT00070941|19699398|P1|COMPLETED|Overall Study||2
8000449|NCT00070941|19699396|P3|STARTED|Overall Study||6
8000450|NCT00070941|19699397|P2|STARTED|Overall Study||11
8000451|NCT00070941|19699398|P1|STARTED|Overall Study||12
8000452|NCT00071058|19699406|P1|NOT COMPLETED|Overall Study||1
8000453|NCT00071058|19699406|P1|COMPLETED|Overall Study||49
8000454|NCT00071058|19699406|P1|STARTED|Overall Study||50
8000455|NCT00070707|19699413|P2|NOT COMPLETED|Overall Study||7
8000456|NCT00070707|19699414|P1|NOT COMPLETED|Overall Study||14
8000457|NCT00070707|19699413|P2|COMPLETED|Overall Study||68
8000458|NCT00070707|19699414|P1|COMPLETED|Overall Study||99
8000459|NCT00070707|19699413|P2|STARTED|Overall Study||75
8000460|NCT00070707|19699414|P1|STARTED|Overall Study||113
8000461|NCT00003907|19699462|P2|NOT COMPLETED|Overall Study||23
8000462|NCT00003907|19699463|P1|NOT COMPLETED|Overall Study||13
8000463|NCT00003907|19699462|P2|COMPLETED|Overall Study||8
8000464|NCT00003907|19699463|P1|COMPLETED|Overall Study||6
8000465|NCT00003907|19699462|P2|Eligible and Treated|Overall Study||29
8000466|NCT00003907|19699463|P1|Eligible and Treated|Overall Study||17
8000467|NCT00003907|19699462|P2|Received Protocol Therapy (Treated)|Overall Study||31
8000468|NCT00003907|19699463|P1|Received Protocol Therapy (Treated)|Overall Study||18
8000469|NCT00003907|19699462|P2|Eligible|Overall Study||29
8000470|NCT00003907|19699463|P1|Eligible|Overall Study||18
8000471|NCT00003907|19699462|P2|STARTED|Overall Study||31
8000472|NCT00003907|19699463|P1|STARTED|Overall Study||19
8000473|NCT00070564|19699479|P6|NOT COMPLETED|Overall Study||52
8000474|NCT00070564|19699480|P5|NOT COMPLETED|Overall Study||79
8000475|NCT00070564|19699481|P4|NOT COMPLETED|Overall Study||167
8000476|NCT00070564|19699482|P3|NOT COMPLETED|Overall Study||171
8000477|NCT00070564|19699483|P2|NOT COMPLETED|Overall Study||203
8000478|NCT00070564|19699484|P1|NOT COMPLETED|Overall Study||200
8000479|NCT00070564|19699479|P6|COMPLETED|Overall Study||244
8000480|NCT00070564|19699480|P5|COMPLETED|Overall Study||203
8000481|NCT00070564|19699481|P4|COMPLETED|Overall Study||481
8000482|NCT00070564|19699482|P3|COMPLETED|Overall Study||526
8000483|NCT00070564|19699483|P2|COMPLETED|Overall Study||490
8000484|NCT00070564|19699484|P1|COMPLETED|Overall Study||478
8000485|NCT00070564|19699479|P6|STARTED|Overall Study||296
8000486|NCT00070564|19699480|P5|STARTED|Overall Study||282
8000487|NCT00070564|19699481|P4|STARTED|Overall Study||648
8000488|NCT00070564|19699482|P3|STARTED|Overall Study||697
8000489|NCT00070564|19699483|P2|STARTED|Overall Study||693
8000490|NCT00070564|19699484|P1|STARTED|Overall Study||678
8000491|NCT00070499|19699538|P4|NOT COMPLETED|Overall Study||110
8000492|NCT00070499|19699539|P3|NOT COMPLETED|Overall Study||120
8000493|NCT00070499|19699540|P2|NOT COMPLETED|Overall Study||26
8000494|NCT00070499|19699541|P1|NOT COMPLETED|Overall Study||38
8000495|NCT00070499|19699538|P4|COMPLETED|Overall Study||17
8000496|NCT00070499|19699539|P3|COMPLETED|Overall Study||6
8000497|NCT00070499|19699540|P2|COMPLETED|Overall Study||52
8000498|NCT00070499|19699541|P1|COMPLETED|Overall Study||37
8000499|NCT00070499|19699538|P4|Eligible and Treated|Overall Study||123
8000500|NCT00070499|19699539|P3|Eligible and Treated|Overall Study||123
8000501|NCT00070499|19699540|P2|Eligible and Treated|Overall Study||73
8000502|NCT00070499|19699541|P1|Eligible and Treated|Overall Study||72
8000503|NCT00070499|19699538|P4|Eligible|Overall Study||125
8000504|NCT00070499|19699539|P3|Eligible|Overall Study||123
8000505|NCT00070499|19699540|P2|Eligible|Overall Study||73
8000506|NCT00070499|19699541|P1|Eligible|Overall Study||73
8000507|NCT00070499|19699538|P4|STARTED|Overall Study||127
8000508|NCT00070499|19699539|P3|STARTED|Overall Study||126
8000509|NCT00070499|19699540|P2|STARTED|Overall Study||78
8000510|NCT00070499|19699541|P1|STARTED|Overall Study||75
8000511|NCT00070317|19699567|P1|NOT COMPLETED|Overall Study||13
8000512|NCT00070317|19699567|P1|COMPLETED|Overall Study||89
8000513|NCT00070317|19699567|P1|STARTED|Overall Study||102
8000514|NCT00070291|19699572|P1|NOT COMPLETED|Step 2||1
8000515|NCT00070291|19699572|P1|COMPLETED|Step 2||0
8000516|NCT00070291|19699572|P1|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1
8000517|NCT00070291|19699572|P1|NOT COMPLETED|Step 1||2
8000518|NCT00070291|19699572|P1|COMPLETED|Step 1||2
8000519|NCT00070291|19699572|P1|Treated|Step 1||3
8000520|NCT00070291|19699572|P1|STARTED|Step 1||4
8000521|NCT00070135|19699577|P1|NOT COMPLETED|Overall Study||0
8000522|NCT00070135|19699577|P1|COMPLETED|Overall Study||114
8000523|NCT00070135|19699577|P1|STARTED|Overall Study||114
8000524|NCT00070109|19699588|P5|NOT COMPLETED|Overall Study||8
8000525|NCT00070109|19699589|P4|NOT COMPLETED|Overall Study||20
8000526|NCT00070109|19699590|P3|NOT COMPLETED|Overall Study||8
8000527|NCT00070109|19699591|P2|NOT COMPLETED|Overall Study||6
8000528|NCT00070109|19699592|P1|NOT COMPLETED|Overall Study||8
8000529|NCT00070109|19699588|P5|COMPLETED|Overall Study||0
8000530|NCT00070109|19699589|P4|COMPLETED|Overall Study||0
8000531|NCT00070109|19699590|P3|COMPLETED|Overall Study||0
8000532|NCT00070109|19699591|P2|COMPLETED|Overall Study||0
8000533|NCT00070109|19699592|P1|COMPLETED|Overall Study||0
8000534|NCT00070109|19699588|P5|STARTED|Overall Study||8
8000535|NCT00070109|19699589|P4|STARTED|Overall Study||20
8000536|NCT00070109|19699590|P3|STARTED|Overall Study||8
8000537|NCT00070109|19699591|P2|STARTED|Overall Study||6
8000538|NCT00070109|19699592|P1|STARTED|Overall Study||8
8000539|NCT00070018|19699620|P1|NOT COMPLETED|Overall Study||4
8000540|NCT00070018|19699620|P1|COMPLETED|Overall Study||42
8000541|NCT00070018|19699620|P1|Eligible and Began Protocol Therapy|Overall Study||46
8000542|NCT00070018|19699620|P1|Eligible|Overall Study||46
8000543|NCT00070018|19699620|P1|STARTED|Overall Study||46
8000544|NCT00069953|19699624|P1|NOT COMPLETED|Overall Study||2
8000545|NCT00069953|19699624|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41
8000546|NCT00069953|19699624|P1|STARTED|Overall Study||43
8000547|NCT00069784|19699630|P2|NOT COMPLETED|Overall Study||0
8000548|NCT00069784|19699631|P1|NOT COMPLETED|Overall Study||1212
8000549|NCT00069784|19699630|P2|COMPLETED|Overall Study|not applicable (no treatment)|6273
8000550|NCT00069784|19699631|P1|COMPLETED|Overall Study|completed study treatment|5052
8000551|NCT00069784|19699630|P2|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273
8000552|NCT00069784|19699631|P1|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231
8000553|NCT00069784|19699630|P2|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273
8000554|NCT00069784|19699631|P1|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264
8000555|NCT00069823|19699651|P2|NOT COMPLETED|Overall Study||3
8000556|NCT00069823|19699652|P1|NOT COMPLETED|Overall Study||6
8000557|NCT00069823|19699651|P2|COMPLETED|Overall Study||200
8000558|NCT00069823|19699652|P1|COMPLETED|Overall Study||193
8000559|NCT00069823|19699651|P2|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203
8000560|NCT00069823|19699652|P1|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199
8000561|NCT00069641|19699695|P3|NOT COMPLETED|Overall Study||1
8000562|NCT00069641|19699696|P2|NOT COMPLETED|Overall Study||0
8000563|NCT00069641|19699697|P1|NOT COMPLETED|Overall Study||1
8000564|NCT00069641|19699695|P3|COMPLETED|Overall Study||31
8000565|NCT00069641|19699696|P2|COMPLETED|Overall Study||32
8000566|NCT00069641|19699697|P1|COMPLETED|Overall Study||31
8000567|NCT00069641|19699695|P3|STARTED|Overall Study||32
8000568|NCT00069641|19699696|P2|STARTED|Overall Study||32
8000569|NCT00069641|19699697|P1|STARTED|Overall Study||32
8000570|NCT00069576|19699724|P2|NOT COMPLETED|Follow-up Study at 5-10 Years||204
8000571|NCT00069576|19699725|P1|NOT COMPLETED|Follow-up Study at 5-10 Years||196
8000572|NCT00069576|19699724|P2|COMPLETED|Follow-up Study at 5-10 Years||236
8000573|NCT00069576|19699725|P1|COMPLETED|Follow-up Study at 5-10 Years||264
8000574|NCT00069576|19699724|P2|STARTED|Follow-up Study at 5-10 Years||440
8000575|NCT00069576|19699725|P1|STARTED|Follow-up Study at 5-10 Years||460
8000576|NCT00069576|19699724|P2|NOT COMPLETED|Original Trial||33
8000577|NCT00069576|19699725|P1|NOT COMPLETED|Original Trial||25
8000578|NCT00069576|19699724|P2|COMPLETED|Original Trial||440
8000579|NCT00069576|19699725|P1|COMPLETED|Original Trial||460
8000580|NCT00069576|19699724|P2|STARTED|Original Trial||473
8000581|NCT00069576|19699725|P1|STARTED|Original Trial||485
8000582|NCT00069277|19699775|P1|NOT COMPLETED|Overall Study||21
8000583|NCT00069277|19699775|P1|COMPLETED|Overall Study||0
8000584|NCT00069277|19699775|P1|STARTED|Overall Study||21
8000585|NCT00069264|19699779|P1|NOT COMPLETED|Overall Study||32
8000586|NCT00069264|19699779|P1|COMPLETED|Overall Study||0
8000587|NCT00069264|19699779|P1|STARTED|Overall Study||32
8000588|NCT00069329|19699783|P1|NOT COMPLETED|Overall Study||2
8000589|NCT00069329|19699783|P1|COMPLETED|Overall Study||41
8000590|NCT00069329|19699783|P1|STARTED|Overall Study||43
8000591|NCT00069238|19699807|P3|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2
8000592|NCT00069238|19699808|P2|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8000593|NCT00069238|19699809|P1|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8000594|NCT00069238|19699807|P3|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1
8000595|NCT00069238|19699808|P2|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8000596|NCT00069238|19699809|P1|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8000597|NCT00069238|19699807|P3|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3
8000598|NCT00069238|19699808|P2|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8000599|NCT00069238|19699809|P1|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8000600|NCT00069238|19699807|P3|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8000601|NCT00069238|19699808|P2|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2
8000602|NCT00069238|19699809|P1|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8000603|NCT00069238|19699807|P3|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8000604|NCT00069238|19699808|P2|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1
8000605|NCT00069238|19699809|P1|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8000606|NCT00069238|19699807|P3|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8000607|NCT00069238|19699808|P2|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3
8000608|NCT00069238|19699809|P1|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8000609|NCT00069238|19699807|P3|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8000610|NCT00069238|19699808|P2|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8000611|NCT00069238|19699809|P1|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9
8000612|NCT00069238|19699807|P3|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8000613|NCT00069238|19699808|P2|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8000614|NCT00069238|19699809|P1|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16
8000615|NCT00069238|19699807|P3|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8000616|NCT00069238|19699808|P2|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8000617|NCT00069238|19699809|P1|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25
8000618|NCT00069121|19699817|P2|NOT COMPLETED|Overall Study||325
8000619|NCT00069121|19699818|P1|NOT COMPLETED|Overall Study||367
8000620|NCT00069121|19699817|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|619
8000621|NCT00069121|19699818|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|575
8000622|NCT00069121|19699817|P2|Received Treatment|Overall Study|Safety Population|938
8000623|NCT00069121|19699818|P1|Received Treatment|Overall Study|Safety Population|926
8000624|NCT00069121|19699817|P2|STARTED|Overall Study||944
8000625|NCT00069121|19699818|P1|STARTED|Overall Study||942
8000626|NCT00069108|19699840|P2|NOT COMPLETED|Overall Study||219
8000627|NCT00069108|19699841|P1|NOT COMPLETED|Overall Study||213
8000628|NCT00069108|19699840|P2|COMPLETED|Overall Study||95
8000629|NCT00069108|19699841|P1|COMPLETED|Overall Study||100
8000630|NCT00069108|19699840|P2|STARTED|Overall Study||314
8000631|NCT00069108|19699841|P1|STARTED|Overall Study||313
8000632|NCT00069095|19699873|P6|NOT COMPLETED|Follow-up Phase||101
8000633|NCT00069095|19699874|P5|NOT COMPLETED|Follow-up Phase||92
8000634|NCT00069095|19699875|P4|NOT COMPLETED|Follow-up Phase||112
8000635|NCT00069095|19699876|P3|NOT COMPLETED|Follow-up Phase||120
8000636|NCT00069095|19699877|P2|NOT COMPLETED|Follow-up Phase||206
8000637|NCT00069095|19699878|P1|NOT COMPLETED|Follow-up Phase||174
8000638|NCT00069095|19699873|P6|COMPLETED|Follow-up Phase||171
8000639|NCT00069095|19699874|P5|COMPLETED|Follow-up Phase||186
8000640|NCT00069095|19699875|P4|COMPLETED|Follow-up Phase||187
8000641|NCT00069095|19699876|P3|COMPLETED|Follow-up Phase||178
8000642|NCT00069095|19699877|P2|COMPLETED|Follow-up Phase||93
8000643|NCT00069095|19699878|P1|COMPLETED|Follow-up Phase||110
8000644|NCT00069095|19699873|P6|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272
8000645|NCT00069095|19699874|P5|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278
8000646|NCT00069095|19699875|P4|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
8000647|NCT00069095|19699876|P3|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298
8000648|NCT00069095|19699877|P2|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
8000649|NCT00069095|19699878|P1|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284
8000650|NCT00069095|19699873|P6|NOT COMPLETED|Post-study Treatment Phase||29
8000651|NCT00069095|19699874|P5|NOT COMPLETED|Post-study Treatment Phase||36
8000652|NCT00069095|19699875|P4|NOT COMPLETED|Post-study Treatment Phase||17
8000653|NCT00069095|19699876|P3|NOT COMPLETED|Post-study Treatment Phase||21
8000654|NCT00069095|19699877|P2|NOT COMPLETED|Post-study Treatment Phase||13
8000655|NCT00069095|19699878|P1|NOT COMPLETED|Post-study Treatment Phase||8
8000656|NCT00069095|19699873|P6|COMPLETED|Post-study Treatment Phase||0
8000657|NCT00069095|19699874|P5|COMPLETED|Post-study Treatment Phase||0
8000658|NCT00069095|19699875|P4|COMPLETED|Post-study Treatment Phase||0
8000659|NCT00069095|19699876|P3|COMPLETED|Post-study Treatment Phase||0
8000660|NCT00069095|19699877|P2|COMPLETED|Post-study Treatment Phase||0
8000661|NCT00069095|19699878|P1|COMPLETED|Post-study Treatment Phase||0
8000662|NCT00069095|19699873|P6|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29
8000663|NCT00069095|19699874|P5|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36
8000664|NCT00069095|19699875|P4|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17
8000665|NCT00069095|19699876|P3|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21
8000666|NCT00069095|19699877|P2|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13
8000667|NCT00069095|19699878|P1|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8
8000668|NCT00069095|19699873|P6|NOT COMPLETED|Primary Treatment Phase||301
8000669|NCT00069095|19699874|P5|NOT COMPLETED|Primary Treatment Phase||302
8000670|NCT00069095|19699875|P4|NOT COMPLETED|Primary Treatment Phase||320
8000671|NCT00069095|19699876|P3|NOT COMPLETED|Primary Treatment Phase||314
8000672|NCT00069095|19699877|P2|NOT COMPLETED|Primary Treatment Phase||302
8000673|NCT00069095|19699878|P1|NOT COMPLETED|Primary Treatment Phase||295
8000674|NCT00069095|19699873|P6|COMPLETED|Primary Treatment Phase||48
8000675|NCT00069095|19699874|P5|COMPLETED|Primary Treatment Phase||48
8000676|NCT00069095|19699875|P4|COMPLETED|Primary Treatment Phase||31
8000677|NCT00069095|19699876|P3|COMPLETED|Primary Treatment Phase||36
8000678|NCT00069095|19699877|P2|COMPLETED|Primary Treatment Phase||15
8000679|NCT00069095|19699878|P1|COMPLETED|Primary Treatment Phase||22
8000680|NCT00069095|19699873|P6|STARTED|Primary Treatment Phase||349
8000681|NCT00069095|19699874|P5|STARTED|Primary Treatment Phase||350
8000682|NCT00069095|19699875|P4|STARTED|Primary Treatment Phase||351
8000683|NCT00069095|19699876|P3|STARTED|Primary Treatment Phase||350
8000684|NCT00069095|19699877|P2|STARTED|Primary Treatment Phase||317
8000685|NCT00069095|19699878|P1|STARTED|Primary Treatment Phase||317
8000686|NCT00069160|19699932|P2|NOT COMPLETED|Overall Study||0
8000687|NCT00069160|19699933|P1|NOT COMPLETED|Overall Study||0
8000688|NCT00069160|19699932|P2|COMPLETED|Overall Study||25
8000689|NCT00069160|19699933|P1|COMPLETED|Overall Study||23
8000690|NCT00069160|19699932|P2|STARTED|Overall Study||25
8000691|NCT00069160|19699933|P1|STARTED|Overall Study||23
8000692|NCT00068822|19699948|P2|NOT COMPLETED|Optional Crossover Intervention||0
8000693|NCT00068822|19699949|P1|NOT COMPLETED|Optional Crossover Intervention||0
8000694|NCT00068822|19699948|P2|COMPLETED|Optional Crossover Intervention||29
8000695|NCT00068822|19699949|P1|COMPLETED|Optional Crossover Intervention||9
8000696|NCT00068822|19699948|P2|Crossover at Month 3|Optional Crossover Intervention||27
8000697|NCT00068822|19699949|P1|Crossover at Month 3|Optional Crossover Intervention||8
8000698|NCT00068822|19699948|P2|Crossover at Month 1|Optional Crossover Intervention||2
8000699|NCT00068822|19699949|P1|Crossover at Month 1|Optional Crossover Intervention||1
8000700|NCT00068822|19699948|P2|STARTED|Optional Crossover Intervention||29
8000701|NCT00068822|19699949|P1|STARTED|Optional Crossover Intervention||9
8000702|NCT00068822|19699948|P2|NOT COMPLETED|First Randomized Intervention||2
8000703|NCT00068822|19699949|P1|NOT COMPLETED|First Randomized Intervention||1
8000704|NCT00068822|19699948|P2|COMPLETED|First Randomized Intervention||61
8000705|NCT00068822|19699949|P1|COMPLETED|First Randomized Intervention||67
8000706|NCT00068822|19699948|P2|STARTED|First Randomized Intervention||63
8000707|NCT00068822|19699949|P1|STARTED|First Randomized Intervention||68
8000708|NCT00068770|19699961|P2|NOT COMPLETED|Overall Study||0
8000709|NCT00068770|19699962|P1|NOT COMPLETED|Overall Study||0
8000710|NCT00068770|19699961|P2|COMPLETED|Overall Study||22
8000711|NCT00068770|19699962|P1|COMPLETED|Overall Study||13
8000712|NCT00068770|19699961|P2|STARTED|Overall Study||22
8000713|NCT00068770|19699962|P1|STARTED|Overall Study||13
8000714|NCT00068718|19699970|P1|NOT COMPLETED|Overall Study||0
8000715|NCT00068718|19699970|P1|COMPLETED|Overall Study||35
8000716|NCT00068718|19699970|P1|STARTED|Overall Study||35
8000717|NCT00068692|19699983|P8|NOT COMPLETED|Step 2: Randomization||8
8000718|NCT00068692|19699984|P7|NOT COMPLETED|Step 2: Randomization||4
8000719|NCT00068692|19699985|P6|NOT COMPLETED|Step 2: Randomization||6
8000720|NCT00068692|19699986|P5|NOT COMPLETED|Step 2: Randomization||9
8000721|NCT00068692|19699987|P4|NOT COMPLETED|Step 2: Randomization||12
8000722|NCT00068692|19699988|P3|NOT COMPLETED|Step 2: Randomization||10
8000723|NCT00068692|19699989|P2|NOT COMPLETED|Step 2: Randomization||0
8000724|NCT00068692|19699990|P1|NOT COMPLETED|Step 2: Randomization||0
8000725|NCT00068692|19699983|P8|COMPLETED|Step 2: Randomization||24
8000726|NCT00068692|19699984|P7|COMPLETED|Step 2: Randomization||29
8000727|NCT00068692|19699985|P6|COMPLETED|Step 2: Randomization||25
8000728|NCT00068692|19699986|P5|COMPLETED|Step 2: Randomization||21
8000729|NCT00068692|19699987|P4|COMPLETED|Step 2: Randomization||13
8000730|NCT00068692|19699988|P3|COMPLETED|Step 2: Randomization||18
8000731|NCT00068692|19699989|P2|COMPLETED|Step 2: Randomization||0
8000732|NCT00068692|19699990|P1|COMPLETED|Step 2: Randomization||0
8000733|NCT00068692|19699983|P8|Reported AE Data|Step 2: Randomization||32
8000734|NCT00068692|19699984|P7|Reported AE Data|Step 2: Randomization||33
8000735|NCT00068692|19699985|P6|Reported AE Data|Step 2: Randomization||31
8000736|NCT00068692|19699986|P5|Reported AE Data|Step 2: Randomization||28
8000737|NCT00068692|19699987|P4|Reported AE Data|Step 2: Randomization||22
8000738|NCT00068692|19699988|P3|Reported AE Data|Step 2: Randomization||27
8000739|NCT00068692|19699989|P2|Reported AE Data|Step 2: Randomization||0
8000740|NCT00068692|19699990|P1|Reported AE Data|Step 2: Randomization||0
8000741|NCT00068692|19699983|P8|Had Sphincter Preservation|Step 2: Randomization||30
8000742|NCT00068692|19699984|P7|Had Sphincter Preservation|Step 2: Randomization||33
8000743|NCT00068692|19699985|P6|Had Sphincter Preservation|Step 2: Randomization||31
8000744|NCT00068692|19699986|P5|Had Sphincter Preservation|Step 2: Randomization||28
8000745|NCT00068692|19699987|P4|Had Sphincter Preservation|Step 2: Randomization||25
8000746|NCT00068692|19699988|P3|Had Sphincter Preservation|Step 2: Randomization||28
8000747|NCT00068692|19699989|P2|Had Sphincter Preservation|Step 2: Randomization||0
8000748|NCT00068692|19699990|P1|Had Sphincter Preservation|Step 2: Randomization||0
8000749|NCT00068692|19699983|P8|Treated|Step 2: Randomization||32
8000750|NCT00068692|19699984|P7|Treated|Step 2: Randomization||33
8000751|NCT00068692|19699985|P6|Treated|Step 2: Randomization||31
8000752|NCT00068692|19699986|P5|Treated|Step 2: Randomization||29
8000753|NCT00068692|19699987|P4|Treated|Step 2: Randomization||25
8000754|NCT00068692|19699988|P3|Treated|Step 2: Randomization||27
8000755|NCT00068692|19699989|P2|Treated|Step 2: Randomization||0
8000756|NCT00068692|19699990|P1|Treated|Step 2: Randomization||0
8000757|NCT00068692|19699983|P8|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|32
8000758|NCT00068692|19699984|P7|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|33
8000759|NCT00068692|19699985|P6|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|31
8000760|NCT00068692|19699986|P5|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|30
8000761|NCT00068692|19699987|P4|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|25
8000762|NCT00068692|19699988|P3|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|28
8000763|NCT00068692|19699989|P2|STARTED|Step 2: Randomization|Group II patients were registered and randomized at the same time, reported as arms I,II,III here.|0
8000764|NCT00068692|19699990|P1|STARTED|Step 2: Randomization|Patients on arm S completing step 1 treatment were randomized to step 2 (Arms I-III).|0
8000765|NCT00068692|19699983|P8|NOT COMPLETED|Step 1: Registration||0
8000766|NCT00068692|19699984|P7|NOT COMPLETED|Step 1: Registration||0
8000767|NCT00068692|19699985|P6|NOT COMPLETED|Step 1: Registration||0
8000768|NCT00068692|19699986|P5|NOT COMPLETED|Step 1: Registration||0
8000769|NCT00068692|19699987|P4|NOT COMPLETED|Step 1: Registration||0
8000770|NCT00068692|19699988|P3|NOT COMPLETED|Step 1: Registration||0
8000771|NCT00068692|19699989|P2|NOT COMPLETED|Step 1: Registration||1
8000772|NCT00068692|19699990|P1|NOT COMPLETED|Step 1: Registration||40
8000773|NCT00068692|19699983|P8|COMPLETED|Step 1: Registration||0
8000774|NCT00068692|19699984|P7|COMPLETED|Step 1: Registration||0
8000775|NCT00068692|19699985|P6|COMPLETED|Step 1: Registration||0
8000776|NCT00068692|19699986|P5|COMPLETED|Step 1: Registration||0
8000777|NCT00068692|19699987|P4|COMPLETED|Step 1: Registration||0
8000778|NCT00068692|19699988|P3|COMPLETED|Step 1: Registration||0
8000779|NCT00068692|19699989|P2|COMPLETED|Step 1: Registration|Case 32191 entered the study as Group II patient but was never randomized.|96
8000780|NCT00068692|19699990|P1|COMPLETED|Step 1: Registration||88
8000781|NCT00068692|19699983|P8|Reported AE Data|Step 1: Registration||0
8000782|NCT00068692|19699984|P7|Reported AE Data|Step 1: Registration||0
8000783|NCT00068692|19699985|P6|Reported AE Data|Step 1: Registration||0
8000784|NCT00068692|19699986|P5|Reported AE Data|Step 1: Registration||0
8000785|NCT00068692|19699987|P4|Reported AE Data|Step 1: Registration||0
8000786|NCT00068692|19699988|P3|Reported AE Data|Step 1: Registration||0
8000787|NCT00068692|19699989|P2|Reported AE Data|Step 1: Registration||0
8000788|NCT00068692|19699990|P1|Reported AE Data|Step 1: Registration||123
8000789|NCT00068692|19699983|P8|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8000790|NCT00068692|19699984|P7|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8000791|NCT00068692|19699985|P6|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8000792|NCT00068692|19699986|P5|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8000793|NCT00068692|19699987|P4|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8000794|NCT00068692|19699988|P3|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8000795|NCT00068692|19699989|P2|Started Concurrent Chemo/Radiation|Step 1: Registration|Group II patients receive protocol therapy in Step 2 after randomization|0
8000796|NCT00068692|19699990|P1|Started Concurrent Chemo/Radiation|Step 1: Registration||125
8000797|NCT00068692|19699983|P8|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
8000798|NCT00068692|19699984|P7|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
8000799|NCT00068692|19699985|P6|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
8000800|NCT00068692|19699986|P5|STARTED|Step 1: Registration||0
8000801|NCT00068692|19699987|P4|STARTED|Step 1: Registration||0
8000802|NCT00068692|19699988|P3|STARTED|Step 1: Registration||0
8000803|NCT00068692|19699989|P2|STARTED|Step 1: Registration|Group II patients were registered and randomized at the same time, and were reported in Step 2.|97
8000804|NCT00068692|19699990|P1|STARTED|Step 1: Registration||128
8000805|NCT00068601|19700013|P2|NOT COMPLETED|Overall Study||60
8000806|NCT00068601|19700014|P1|NOT COMPLETED|Overall Study||62
8000807|NCT00068601|19700013|P2|COMPLETED|Overall Study||66
8000808|NCT00068601|19700014|P1|COMPLETED|Overall Study||69
8000809|NCT00068601|19700013|P2|STARTED|Overall Study||126
8000810|NCT00068601|19700014|P1|STARTED|Overall Study||131
8000811|NCT00068588|19700027|P3|NOT COMPLETED|Overall Study||4
8000812|NCT00068588|19700028|P2|NOT COMPLETED|Overall Study||0
8000813|NCT00068588|19700029|P1|NOT COMPLETED|Overall Study||0
8000814|NCT00068588|19700027|P3|COMPLETED|Overall Study||17
8000815|NCT00068588|19700028|P2|COMPLETED|Overall Study||3
8000816|NCT00068588|19700029|P1|COMPLETED|Overall Study||0
8000817|NCT00068588|19700027|P3|STARTED|Overall Study||21
8000818|NCT00068588|19700028|P2|STARTED|Overall Study||3
8000819|NCT00068588|19700029|P1|STARTED|Overall Study||0
8000820|NCT00068575|19700039|P1|NOT COMPLETED|Overall Study||0
8000821|NCT00068575|19700039|P1|COMPLETED|Overall Study||28
8000822|NCT00068575|19700039|P1|STARTED|Overall Study||28
8000823|NCT00068445|19700045|P2|NOT COMPLETED|Treatment||16
8000824|NCT00068445|19700046|P1|NOT COMPLETED|Treatment||29
8000825|NCT00068445|19700045|P2|COMPLETED|Treatment||46
8000826|NCT00068445|19700046|P1|COMPLETED|Treatment||34
8000827|NCT00068445|19700045|P2|STARTED|Treatment||62
8000828|NCT00068445|19700046|P1|STARTED|Treatment||63
8000829|NCT00068445|19700045|P2|NOT COMPLETED|Randomization||4
8000830|NCT00068445|19700046|P1|NOT COMPLETED|Randomization||2
8000831|NCT00068445|19700045|P2|COMPLETED|Randomization||62
8000832|NCT00068445|19700046|P1|COMPLETED|Randomization||63
8000833|NCT00068445|19700045|P2|STARTED|Randomization||66
8000834|NCT00068445|19700046|P1|STARTED|Randomization||65
8000835|NCT00068419|19700070|P1|NOT COMPLETED|Overall Study||60
8000836|NCT00068419|19700070|P1|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10
8000837|NCT00068419|19700070|P1|STARTED|Overall Study||70
8000838|NCT00068406|19700079|P1|NOT COMPLETED|Overall Study||3
8000839|NCT00068406|19700079|P1|COMPLETED|Overall Study||58
8000840|NCT00068406|19700079|P1|STARTED|Overall Study||61
8000841|NCT00068393|19700084|P1|NOT COMPLETED|Overall Study||10
8000842|NCT00068393|19700084|P1|COMPLETED|Overall Study||29
8000843|NCT00068393|19700084|P1|Eligible and Treated|Overall Study||38
8000844|NCT00068393|19700084|P1|STARTED|Overall Study||39
8000845|NCT00068380|19700090|P1|NOT COMPLETED|Overall Study||5
8000846|NCT00068380|19700090|P1|COMPLETED|Overall Study||12
8000847|NCT00068380|19700090|P1|STARTED|Overall Study||17
8000848|NCT00068367|19700099|P1|NOT COMPLETED|Overall Study||0
8000849|NCT00068367|19700099|P1|COMPLETED|Overall Study||20
8000850|NCT00068367|19700099|P1|STARTED|Overall Study||20
8000851|NCT00068341|19700108|P3|NOT COMPLETED|Overall Study||0
8000852|NCT00068341|19700109|P2|NOT COMPLETED|Overall Study||0
8000853|NCT00068341|19700110|P1|NOT COMPLETED|Overall Study||0
8000854|NCT00068341|19700108|P3|COMPLETED|Overall Study||44
8000855|NCT00068341|19700109|P2|COMPLETED|Overall Study||15
8000856|NCT00068341|19700110|P1|COMPLETED|Overall Study||15
8000857|NCT00068341|19700108|P3|STARTED|Overall Study||44
8000858|NCT00068341|19700109|P2|STARTED|Overall Study||15
8000859|NCT00068341|19700110|P1|STARTED|Overall Study||15
8000860|NCT00068250|19700134|P4|NOT COMPLETED|Phase II: Dose Level 2||0
8000861|NCT00068250|19700135|P3|NOT COMPLETED|Phase II: Dose Level 2||0
8000862|NCT00068250|19700136|P2|NOT COMPLETED|Phase II: Dose Level 2||0
8000863|NCT00068250|19700137|P1|NOT COMPLETED|Phase II: Dose Level 2||0
8000864|NCT00068250|19700134|P4|COMPLETED|Phase II: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|47
8000865|NCT00068250|19700135|P3|COMPLETED|Phase II: Dose Level 2||0
8000866|NCT00068250|19700136|P2|COMPLETED|Phase II: Dose Level 2||0
8000867|NCT00068250|19700137|P1|COMPLETED|Phase II: Dose Level 2||0
8000868|NCT00068250|19700134|P4|STARTED|Phase II: Dose Level 2||47
8000869|NCT00068250|19700135|P3|STARTED|Phase II: Dose Level 2||0
8000870|NCT00068250|19700136|P2|STARTED|Phase II: Dose Level 2||0
8000871|NCT00068250|19700137|P1|STARTED|Phase II: Dose Level 2||0
8000872|NCT00068250|19700134|P4|NOT COMPLETED|Phase I: Dose Level 2||0
8000873|NCT00068250|19700135|P3|NOT COMPLETED|Phase I: Dose Level 2||0
8000874|NCT00068250|19700136|P2|NOT COMPLETED|Phase I: Dose Level 2||1
8000875|NCT00068250|19700137|P1|NOT COMPLETED|Phase I: Dose Level 2||0
8000876|NCT00068250|19700134|P4|COMPLETED|Phase I: Dose Level 2||0
8000877|NCT00068250|19700135|P3|COMPLETED|Phase I: Dose Level 2||0
8000878|NCT00068250|19700136|P2|COMPLETED|Phase I: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|6
8000879|NCT00068250|19700137|P1|COMPLETED|Phase I: Dose Level 2||0
8000880|NCT00068250|19700134|P4|STARTED|Phase I: Dose Level 2||0
8000881|NCT00068250|19700135|P3|STARTED|Phase I: Dose Level 2||0
8000882|NCT00068250|19700136|P2|STARTED|Phase I: Dose Level 2||7
8000883|NCT00068250|19700137|P1|STARTED|Phase I: Dose Level 2||0
8000884|NCT00068250|19700134|P4|NOT COMPLETED|Phase I: Dose Level 1||0
8000885|NCT00068250|19700135|P3|NOT COMPLETED|Phase I: Dose Level 1||0
8000886|NCT00068250|19700136|P2|NOT COMPLETED|Phase I: Dose Level 1||0
8000887|NCT00068250|19700137|P1|NOT COMPLETED|Phase I: Dose Level 1||0
8000888|NCT00068250|19700134|P4|COMPLETED|Phase I: Dose Level 1||0
8000889|NCT00068250|19700135|P3|COMPLETED|Phase I: Dose Level 1||0
8000890|NCT00068250|19700136|P2|COMPLETED|Phase I: Dose Level 1||0
8000891|NCT00068250|19700137|P1|COMPLETED|Phase I: Dose Level 1|Subjects with data available for the primary analysis are considered to have completed the study.|6
8000892|NCT00068250|19700134|P4|STARTED|Phase I: Dose Level 1||0
8000893|NCT00068250|19700135|P3|STARTED|Phase I: Dose Level 1||0
8000894|NCT00068250|19700136|P2|STARTED|Phase I: Dose Level 1||0
8000895|NCT00068250|19700137|P1|STARTED|Phase I: Dose Level 1||6
8000896|NCT00068237|19700147|P1|NOT COMPLETED|Overall Study||5
8000897|NCT00068237|19700147|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
8000898|NCT00068237|19700147|P1|STARTED|Overall Study||49
8000899|NCT00068107|19700159|P1|NOT COMPLETED|Overall Study||9
8000900|NCT00068107|19700159|P1|COMPLETED|Overall Study||3
8000901|NCT00068107|19700159|P1|STARTED|Overall Study||12
8000902|NCT00067990|19700172|P2|NOT COMPLETED|Overall Study||22
8000903|NCT00067990|19700173|P1|NOT COMPLETED|Overall Study||10
8000904|NCT00067990|19700172|P2|COMPLETED|Overall Study||54
8000905|NCT00067990|19700173|P1|COMPLETED|Overall Study||67
8000906|NCT00067990|19700172|P2|STARTED|Overall Study||76
8000907|NCT00067990|19700173|P1|STARTED|Overall Study||77
8000908|NCT00067808|19700184|P3|NOT COMPLETED|Overall Study||0
8000909|NCT00067808|19700185|P2|NOT COMPLETED|Overall Study||0
8000910|NCT00067808|19700186|P1|NOT COMPLETED|Overall Study||0
8000911|NCT00067808|19700184|P3|COMPLETED|Overall Study||14
8000912|NCT00067808|19700185|P2|COMPLETED|Overall Study||93
8000913|NCT00067808|19700186|P1|COMPLETED|Overall Study||17
8000914|NCT00067808|19700184|P3|STARTED|Overall Study||14
8000915|NCT00067808|19700185|P2|STARTED|Overall Study||93
8000916|NCT00067808|19700186|P1|STARTED|Overall Study||17
8000917|NCT00067470|19700196|P2|NOT COMPLETED|Overall Study||1
8000918|NCT00067470|19700197|P1|NOT COMPLETED|Overall Study||0
8000919|NCT00067470|19700196|P2|COMPLETED|Overall Study||19
8000920|NCT00067470|19700197|P1|COMPLETED|Overall Study||19
8000921|NCT00067470|19700196|P2|STARTED|Overall Study||20
8000922|NCT00067470|19700197|P1|STARTED|Overall Study||19
8000923|NCT00067236|19700209|P2|NOT COMPLETED|Overall Study||26
8000924|NCT00067236|19700210|P1|NOT COMPLETED|Overall Study||20
8000925|NCT00067236|19700209|P2|COMPLETED|Overall Study||99
8000926|NCT00067236|19700210|P1|COMPLETED|Overall Study||108
8000927|NCT00067236|19700209|P2|STARTED|Overall Study||125
8000928|NCT00067236|19700210|P1|STARTED|Overall Study||128
8000929|NCT00067028|19700219|P3|NOT COMPLETED|Overall Study||0
8000930|NCT00067028|19700220|P2|NOT COMPLETED|Overall Study||0
8000931|NCT00067028|19700221|P1|NOT COMPLETED|Overall Study||0
8000932|NCT00067028|19700219|P3|COMPLETED|Overall Study||63
8000933|NCT00067028|19700220|P2|COMPLETED|Overall Study||36
8000934|NCT00067028|19700221|P1|COMPLETED|Overall Study||17
8000935|NCT00067028|19700219|P3|STARTED|Overall Study||63
8000936|NCT00067028|19700220|P2|STARTED|Overall Study||36
8000937|NCT00067028|19700221|P1|STARTED|Overall Study||17
8000938|NCT00067002|19700234|P2|NOT COMPLETED|Overall Study||9
8000939|NCT00067002|19700235|P1|NOT COMPLETED|Overall Study||7
8000940|NCT00067002|19700234|P2|COMPLETED|Overall Study||44
8000941|NCT00067002|19700235|P1|COMPLETED|Overall Study||45
8000942|NCT00067002|19700234|P2|STARTED|Overall Study||53
8000943|NCT00067002|19700235|P1|STARTED|Overall Study||52
8000944|NCT00066963|19700252|P3|NOT COMPLETED|Overall Study||39
8000945|NCT00066963|19700253|P2|NOT COMPLETED|Overall Study||31
8000946|NCT00066963|19700254|P1|NOT COMPLETED|Overall Study||26
8000947|NCT00066963|19700252|P3|COMPLETED|Overall Study||87
8000948|NCT00066963|19700253|P2|COMPLETED|Overall Study||93
8000949|NCT00066963|19700254|P1|COMPLETED|Overall Study|any follow-up|100
8000950|NCT00066963|19700252|P3|STARTED|Overall Study||126
8000951|NCT00066963|19700253|P2|STARTED|Overall Study||124
8000952|NCT00066963|19700254|P1|STARTED|Overall Study||126
8000953|NCT00066937|19700266|P4|NOT COMPLETED|6 Month Follow-up||1
8000954|NCT00066937|19700267|P3|NOT COMPLETED|6 Month Follow-up||3
8000955|NCT00066937|19700268|P2|NOT COMPLETED|6 Month Follow-up||3
8000956|NCT00066937|19700269|P1|NOT COMPLETED|6 Month Follow-up||7
8000957|NCT00066937|19700266|P4|COMPLETED|6 Month Follow-up||14
8000958|NCT00066937|19700267|P3|COMPLETED|6 Month Follow-up||22
8000959|NCT00066937|19700268|P2|COMPLETED|6 Month Follow-up||29
8000960|NCT00066937|19700269|P1|COMPLETED|6 Month Follow-up||26
8000961|NCT00066937|19700266|P4|STARTED|6 Month Follow-up||15
8000962|NCT00066937|19700267|P3|STARTED|6 Month Follow-up||25
8000963|NCT00066937|19700268|P2|STARTED|6 Month Follow-up||32
8000964|NCT00066937|19700269|P1|STARTED|6 Month Follow-up||33
8000965|NCT00066937|19700266|P4|NOT COMPLETED|3 Month Follow-up||4
8000966|NCT00066937|19700267|P3|NOT COMPLETED|3 Month Follow-up||1
8000967|NCT00066937|19700268|P2|NOT COMPLETED|3 Month Follow-up||1
8000968|NCT00066937|19700269|P1|NOT COMPLETED|3 Month Follow-up||5
8000969|NCT00066937|19700266|P4|COMPLETED|3 Month Follow-up||15
8000970|NCT00066937|19700267|P3|COMPLETED|3 Month Follow-up||25
8000971|NCT00066937|19700268|P2|COMPLETED|3 Month Follow-up||32
8000972|NCT00066937|19700269|P1|COMPLETED|3 Month Follow-up||33
8000973|NCT00066937|19700266|P4|STARTED|3 Month Follow-up||19
8000974|NCT00066937|19700267|P3|STARTED|3 Month Follow-up||26
8000975|NCT00066937|19700268|P2|STARTED|3 Month Follow-up||33
8000976|NCT00066937|19700269|P1|STARTED|3 Month Follow-up||38
8000977|NCT00066937|19700266|P4|NOT COMPLETED|Treatment Phase||5
8000978|NCT00066937|19700267|P3|NOT COMPLETED|Treatment Phase||11
8000979|NCT00066937|19700268|P2|NOT COMPLETED|Treatment Phase||5
8000980|NCT00066937|19700269|P1|NOT COMPLETED|Treatment Phase||3
8000981|NCT00066937|19700266|P4|COMPLETED|Treatment Phase||19
8000982|NCT00066937|19700267|P3|COMPLETED|Treatment Phase||26
8000983|NCT00066937|19700268|P2|COMPLETED|Treatment Phase||33
8000984|NCT00066937|19700269|P1|COMPLETED|Treatment Phase||38
8000985|NCT00066937|19700266|P4|STARTED|Treatment Phase||24
8000986|NCT00066937|19700267|P3|STARTED|Treatment Phase||37
8000987|NCT00066937|19700268|P2|STARTED|Treatment Phase||38
8000988|NCT00066937|19700269|P1|STARTED|Treatment Phase||41
8000989|NCT00066807|19700293|P2|NOT COMPLETED|Overall Study||15
8000990|NCT00066807|19700294|P1|NOT COMPLETED|Overall Study||14
8000991|NCT00066807|19700293|P2|COMPLETED|Overall Study||0
8000992|NCT00066807|19700294|P1|COMPLETED|Overall Study||0
8000993|NCT00066807|19700293|P2|STARTED|Overall Study||15
8000994|NCT00066807|19700294|P1|STARTED|Overall Study||14
8000995|NCT00066781|19700308|P2|NOT COMPLETED|Overall Study||0
8000996|NCT00066781|19700309|P1|NOT COMPLETED|Overall Study||0
8000997|NCT00066781|19700308|P2|COMPLETED|Overall Study||17
8000998|NCT00066781|19700309|P1|COMPLETED|Overall Study||14
8000999|NCT00066781|19700308|P2|STARTED|Overall Study||17
8001000|NCT00066781|19700309|P1|STARTED|Overall Study||14
8001001|NCT00066742|19700319|P1|NOT COMPLETED|Consolidation Chemotherapy||3
8001002|NCT00066742|19700319|P1|COMPLETED|Consolidation Chemotherapy||39
8001003|NCT00066742|19700319|P1|Eligible|Consolidation Chemotherapy||40
8001004|NCT00066742|19700319|P1|STARTED|Consolidation Chemotherapy||42
8001005|NCT00066742|19700319|P1|NOT COMPLETED|Induction Chemoradiotherapy||29
8001006|NCT00066742|19700319|P1|COMPLETED|Induction Chemoradiotherapy||43
8001007|NCT00066742|19700319|P1|Began Protocol Treatment|Induction Chemoradiotherapy||68
8001008|NCT00066742|19700319|P1|Eligible|Induction Chemoradiotherapy||69
8001009|NCT00066742|19700319|P1|STARTED|Induction Chemoradiotherapy||72
8001010|NCT00066703|19700328|P2|NOT COMPLETED|Overall Study||582
8001011|NCT00066703|19700329|P1|NOT COMPLETED|Overall Study||612
8001012|NCT00066703|19700328|P2|COMPLETED|Overall Study||756
8001013|NCT00066703|19700329|P1|COMPLETED|Overall Study||722
8001014|NCT00066703|19700328|P2|STARTED|Overall Study||1338
8001015|NCT00066703|19700329|P1|STARTED|Overall Study||1334
8001016|NCT00066690|19700344|P3|NOT COMPLETED|Overall Study||564
8001017|NCT00066690|19700345|P2|NOT COMPLETED|Overall Study||522
8001018|NCT00066690|19700346|P1|NOT COMPLETED|Overall Study||598
8001019|NCT00066690|19700344|P3|COMPLETED|Overall Study||457
8001020|NCT00066690|19700345|P2|COMPLETED|Overall Study||502
8001021|NCT00066690|19700346|P1|COMPLETED|Overall Study||423
8001022|NCT00066690|19700344|P3|STARTED|Overall Study||1021
8001023|NCT00066690|19700345|P2|STARTED|Overall Study||1024
8001024|NCT00066690|19700346|P1|STARTED|Overall Study||1021
8001025|NCT00066573|19700365|P2|NOT COMPLETED|Overall Study||28
8001026|NCT00066573|19700366|P1|NOT COMPLETED|Overall Study||28
8001027|NCT00066573|19700365|P2|COMPLETED|Overall Study||3759
8001028|NCT00066573|19700366|P1|COMPLETED|Overall Study||3761
8001029|NCT00066573|19700365|P2|STARTED|Overall Study||3787
8001030|NCT00066573|19700366|P1|STARTED|Overall Study||3789
8001031|NCT00066469|19700378|P1|NOT COMPLETED|Overall Study||16
8001032|NCT00066469|19700378|P1|COMPLETED|Overall Study||39
8001033|NCT00066469|19700378|P1|STARTED|Overall Study||55
8001034|NCT00066365|19700384|P2|NOT COMPLETED|Overall Study||14
8001035|NCT00066365|19700385|P1|NOT COMPLETED|Overall Study||23
8001036|NCT00066365|19700384|P2|COMPLETED|Overall Study||4
8001037|NCT00066365|19700385|P1|COMPLETED|Overall Study||8
8001038|NCT00066365|19700384|P2|STARTED|Overall Study||18
8001039|NCT00066365|19700385|P1|STARTED|Overall Study||31
8001040|NCT00066222|19700413|P1|NOT COMPLETED|Overall Study||1
8001041|NCT00066222|19700413|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71
8001042|NCT00066222|19700413|P1|STARTED|Overall Study||72
8001043|NCT00066170|19700426|P4|NOT COMPLETED|Overall Study||9
8001044|NCT00066170|19700427|P3|NOT COMPLETED|Overall Study||4
8001045|NCT00066170|19700428|P2|NOT COMPLETED|Overall Study||10
8001046|NCT00066170|19700429|P1|NOT COMPLETED|Overall Study||7
8001047|NCT00066170|19700426|P4|COMPLETED|Overall Study||48
8001048|NCT00066170|19700427|P3|COMPLETED|Overall Study||59
8001049|NCT00066170|19700428|P2|COMPLETED|Overall Study||45
8001050|NCT00066170|19700429|P1|COMPLETED|Overall Study||49
8001051|NCT00066170|19700426|P4|Intent to Treat|Overall Study||54
8001052|NCT00066170|19700427|P3|Intent to Treat|Overall Study||63
8001053|NCT00066170|19700428|P2|Intent to Treat|Overall Study||50
8001054|NCT00066170|19700429|P1|Intent to Treat|Overall Study||55
8001055|NCT00066170|19700426|P4|STARTED|Overall Study||57
8001056|NCT00066170|19700427|P3|STARTED|Overall Study||63
8001057|NCT00066170|19700428|P2|STARTED|Overall Study||55
8001058|NCT00066170|19700429|P1|STARTED|Overall Study||56
8001059|NCT00066066|19700442|P6|NOT COMPLETED|Overall Study||5
8001060|NCT00066066|19700443|P5|NOT COMPLETED|Overall Study||3
8001061|NCT00066066|19700444|P4|NOT COMPLETED|Overall Study||4
8001062|NCT00066066|19700445|P3|NOT COMPLETED|Overall Study||7
8001063|NCT00066066|19700446|P2|NOT COMPLETED|Overall Study||4
8001064|NCT00066066|19700447|P1|NOT COMPLETED|Overall Study||6
8001065|NCT00066066|19700442|P6|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15
8001066|NCT00066066|19700443|P5|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24
8001067|NCT00066066|19700444|P4|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16
8001068|NCT00066066|19700445|P3|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23
8001069|NCT00066066|19700446|P2|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18
8001070|NCT00066066|19700447|P1|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21
8001071|NCT00066066|19700442|P6|12 Month|Overall Study||9
8001072|NCT00066066|19700443|P5|12 Month|Overall Study||19
8001073|NCT00066066|19700444|P4|12 Month|Overall Study||11
8001074|NCT00066066|19700445|P3|12 Month|Overall Study||21
8001075|NCT00066066|19700446|P2|12 Month|Overall Study||11
8001076|NCT00066066|19700447|P1|12 Month|Overall Study||18
8001077|NCT00066066|19700442|P6|6 Month|Overall Study||14
8001078|NCT00066066|19700443|P5|6 Month|Overall Study||21
8001079|NCT00066066|19700444|P4|6 Month|Overall Study||13
8001080|NCT00066066|19700445|P3|6 Month|Overall Study||23
8001081|NCT00066066|19700446|P2|6 Month|Overall Study||13
8001082|NCT00066066|19700447|P1|6 Month|Overall Study||19
8001083|NCT00066066|19700442|P6|3 Month|Overall Study||15
8001084|NCT00066066|19700443|P5|3 Month|Overall Study||22
8001085|NCT00066066|19700444|P4|3 Month|Overall Study||16
8001086|NCT00066066|19700445|P3|3 Month|Overall Study||23
8001087|NCT00066066|19700446|P2|3 Month|Overall Study||17
8001088|NCT00066066|19700447|P1|3 Month|Overall Study||21
8001089|NCT00066066|19700442|P6|Baseline|Overall Study||20
8001090|NCT00066066|19700443|P5|Baseline|Overall Study||27
8001091|NCT00066066|19700444|P4|Baseline|Overall Study||20
8001092|NCT00066066|19700445|P3|Baseline|Overall Study||30
8001093|NCT00066066|19700446|P2|Baseline|Overall Study||22
8001094|NCT00066066|19700447|P1|Baseline|Overall Study||27
8001095|NCT00066066|19700442|P6|STARTED|Overall Study||20
8001096|NCT00066066|19700443|P5|STARTED|Overall Study||27
8001097|NCT00066066|19700444|P4|STARTED|Overall Study||20
8001098|NCT00066066|19700445|P3|STARTED|Overall Study||30
8001099|NCT00066066|19700446|P2|STARTED|Overall Study||22
8001100|NCT00066066|19700447|P1|STARTED|Overall Study||27
8001101|NCT00065806|19700463|P2|NOT COMPLETED|Overall Study||19
8001102|NCT00065806|19700464|P1|NOT COMPLETED|Overall Study||20
8001103|NCT00065806|19700463|P2|COMPLETED|Overall Study||89
8001104|NCT00065806|19700464|P1|COMPLETED|Overall Study||93
8001105|NCT00065806|19700463|P2|STARTED|Overall Study||108
8001106|NCT00065806|19700464|P1|STARTED|Overall Study||113
8001107|NCT00014560|19700506|P1|NOT COMPLETED|Overall Study||3
8001108|NCT00014560|19700506|P1|COMPLETED|Overall Study||0
8001109|NCT00014560|19700506|P1|STARTED|Overall Study||3
8001110|NCT00065611|19700512|P2|NOT COMPLETED|Overall Study||1
8001111|NCT00065611|19700513|P1|NOT COMPLETED|Overall Study||0
8001112|NCT00065611|19700512|P2|COMPLETED|Overall Study||3
8001113|NCT00065611|19700513|P1|COMPLETED|Overall Study||4
8001114|NCT00065611|19700512|P2|STARTED|Overall Study||4
8001115|NCT00065611|19700513|P1|STARTED|Overall Study||4
8001116|NCT00065507|19700525|P2|NOT COMPLETED|Overall Study||29
8001117|NCT00065507|19700526|P1|NOT COMPLETED|Overall Study||29
8001118|NCT00065507|19700525|P2|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62
8001119|NCT00065507|19700526|P1|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71
8001120|NCT00065507|19700525|P2|Treated, 24-Week Follow-Up Population|Overall Study||28
8001121|NCT00065507|19700526|P1|Treated, 24-Week Follow-Up Population|Overall Study||25
8001122|NCT00065507|19700525|P2|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
8001123|NCT00065507|19700526|P1|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
8001124|NCT00065507|19700525|P2|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
8001125|NCT00065507|19700526|P1|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
8001126|NCT00065507|19700525|P2|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91
8001127|NCT00065507|19700526|P1|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100
8001128|NCT00065507|19700525|P2|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91
8001129|NCT00065507|19700526|P1|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100
8001130|NCT00065468|19700591|P3|NOT COMPLETED|Overall Study||210
8001131|NCT00065468|19700592|P2|NOT COMPLETED|Overall Study||209
8001132|NCT00065468|19700593|P1|NOT COMPLETED|Overall Study||207
8001133|NCT00065468|19700591|P3|COMPLETED|Overall Study||0
8001134|NCT00065468|19700592|P2|COMPLETED|Overall Study||0
8001135|NCT00065468|19700593|P1|COMPLETED|Overall Study||0
8001136|NCT00065468|19700591|P3|Received Treatment|Overall Study||208
8001137|NCT00065468|19700592|P2|Received Treatment|Overall Study||208
8001138|NCT00065468|19700593|P1|Received Treatment|Overall Study||200
8001139|NCT00065468|19700591|P3|STARTED|Overall Study||210
8001140|NCT00065468|19700592|P2|STARTED|Overall Study||209
8001141|NCT00065468|19700593|P1|STARTED|Overall Study||207
8001142|NCT00065442|19700624|P2|NOT COMPLETED|Overall Study||220
8001143|NCT00065442|19700625|P1|NOT COMPLETED|Overall Study||125
8001144|NCT00065442|19700624|P2|COMPLETED|Overall Study||121
8001145|NCT00065442|19700625|P1|COMPLETED|Overall Study||46
8001146|NCT00065442|19700624|P2|STARTED|Overall Study||341
8001147|NCT00065442|19700625|P1|STARTED|Overall Study||171
8001148|NCT00065429|19700640|P7|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8001149|NCT00065429|19700641|P6|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8001150|NCT00065429|19700642|P5|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6
8001151|NCT00065429|19700643|P4|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8001152|NCT00065429|19700644|P3|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8001153|NCT00065429|19700645|P2|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8001154|NCT00065429|19700646|P1|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8001155|NCT00065429|19700640|P7|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8001156|NCT00065429|19700641|P6|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8001157|NCT00065429|19700642|P5|COMPLETED|Phase II - Apr 2003 - Aug 2008||26
8001158|NCT00065429|19700643|P4|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8001159|NCT00065429|19700644|P3|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8001160|NCT00065429|19700645|P2|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8001161|NCT00065429|19700646|P1|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8001162|NCT00065429|19700640|P7|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8001163|NCT00065429|19700641|P6|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8001164|NCT00065429|19700642|P5|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32
8001165|NCT00065429|19700643|P4|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8001166|NCT00065429|19700644|P3|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8001167|NCT00065429|19700645|P2|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8001168|NCT00065429|19700646|P1|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8001169|NCT00065429|19700640|P7|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
8001170|NCT00065429|19700641|P6|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
8001171|NCT00065429|19700642|P5|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
8001172|NCT00065429|19700643|P4|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
8001173|NCT00065429|19700644|P3|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
8001174|NCT00065429|19700645|P2|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0
8001175|NCT00065429|19700646|P1|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
8001176|NCT00065429|19700640|P7|COMPLETED|Phase I - May 2001 - Oct 2002||2
8001177|NCT00065429|19700641|P6|COMPLETED|Phase I - May 2001 - Oct 2002||2
8001178|NCT00065429|19700642|P5|COMPLETED|Phase I - May 2001 - Oct 2002||8
8001179|NCT00065429|19700643|P4|COMPLETED|Phase I - May 2001 - Oct 2002||3
8001180|NCT00065429|19700644|P3|COMPLETED|Phase I - May 2001 - Oct 2002||3
8001181|NCT00065429|19700645|P2|COMPLETED|Phase I - May 2001 - Oct 2002||3
8001182|NCT00065429|19700646|P1|COMPLETED|Phase I - May 2001 - Oct 2002||3
8001183|NCT00065429|19700640|P7|STARTED|Phase I - May 2001 - Oct 2002||4
8001184|NCT00065429|19700641|P6|STARTED|Phase I - May 2001 - Oct 2002||4
8001185|NCT00065429|19700642|P5|STARTED|Phase I - May 2001 - Oct 2002||9
8001186|NCT00065429|19700643|P4|STARTED|Phase I - May 2001 - Oct 2002||4
8001187|NCT00065429|19700644|P3|STARTED|Phase I - May 2001 - Oct 2002||4
8001188|NCT00065429|19700645|P2|STARTED|Phase I - May 2001 - Oct 2002||3
8001189|NCT00065429|19700646|P1|STARTED|Phase I - May 2001 - Oct 2002||4
8001190|NCT00065260|19700660|P2|NOT COMPLETED|Overall Study||1
8001191|NCT00065260|19700661|P1|NOT COMPLETED|Overall Study||0
8001192|NCT00065260|19700660|P2|COMPLETED|Overall Study||26
8001193|NCT00065260|19700661|P1|COMPLETED|Overall Study||27
8001194|NCT00065260|19700660|P2|STARTED|Overall Study||27
8001195|NCT00065260|19700661|P1|STARTED|Overall Study||27
8001196|NCT00065182|19700669|P2|NOT COMPLETED|Overall Study||37
8001197|NCT00065182|19700670|P1|NOT COMPLETED|Overall Study||48
8001198|NCT00065182|19700669|P2|COMPLETED|Overall Study||160
8001199|NCT00065182|19700670|P1|COMPLETED|Overall Study||154
8001200|NCT00065182|19700669|P2|STARTED|Overall Study||197
8001201|NCT00065182|19700670|P1|STARTED|Overall Study||202
8001202|NCT00065156|19700696|P1|NOT COMPLETED|Overall Study||124
8001203|NCT00065156|19700696|P1|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24
8001204|NCT00065156|19700696|P1|Modified Intent to Treat Population|Overall Study||94
8001205|NCT00065156|19700696|P1|STARTED|Overall Study||148
8001206|NCT00065065|19700713|P2|NOT COMPLETED|Overall Study||20
8001207|NCT00065065|19700714|P1|NOT COMPLETED|Overall Study||10
8001208|NCT00065065|19700713|P2|COMPLETED|Overall Study||33
8001209|NCT00065065|19700714|P1|COMPLETED|Overall Study||42
8001210|NCT00065065|19700713|P2|STARTED|Overall Study||53
8001211|NCT00065065|19700714|P1|STARTED|Overall Study||52
8001212|NCT00003895|19700726|P2|NOT COMPLETED|Overall Study||4
8001213|NCT00003895|19700727|P1|NOT COMPLETED|Overall Study||7
8001214|NCT00003895|19700726|P2|COMPLETED|Overall Study||14
8001215|NCT00003895|19700727|P1|COMPLETED|Overall Study||11
8001216|NCT00003895|19700726|P2|STARTED|Overall Study||18
8001217|NCT00003895|19700727|P1|STARTED|Overall Study||18
8001218|NCT00064987|19700735|P2|NOT COMPLETED|Overall Study||0
8001219|NCT00064987|19700736|P1|NOT COMPLETED|Overall Study||3
8001220|NCT00064987|19700735|P2|COMPLETED|Overall Study||6
8001221|NCT00064987|19700736|P1|COMPLETED|Overall Study||7
8001222|NCT00064987|19700735|P2|STARTED|Overall Study||6
8001223|NCT00064987|19700736|P1|STARTED|Overall Study||10
8001224|NCT00064844|19700756|P2|NOT COMPLETED|Overall Study||19
8001225|NCT00064844|19700757|P1|NOT COMPLETED|Overall Study||8
8001226|NCT00064844|19700756|P2|COMPLETED|Overall Study||32
8001227|NCT00064844|19700757|P1|COMPLETED|Overall Study||37
8001228|NCT00064844|19700756|P2|12 Month Follow-up|Overall Study||32
8001229|NCT00064844|19700757|P1|12 Month Follow-up|Overall Study||37
8001230|NCT00064844|19700756|P2|6 Month Follow-up|Overall Study||40
8001231|NCT00064844|19700757|P1|6 Month Follow-up|Overall Study||39
8001232|NCT00064844|19700756|P2|3 Month Follow-up|Overall Study||47
8001233|NCT00064844|19700757|P1|3 Month Follow-up|Overall Study||40
8001234|NCT00064844|19700756|P2|2 Week Follow-up|Overall Study||51
8001235|NCT00064844|19700757|P1|2 Week Follow-up|Overall Study||45
8001236|NCT00064844|19700756|P2|STARTED|Overall Study||51
8001237|NCT00064844|19700757|P1|STARTED|Overall Study||45
8001238|NCT00064753|19700767|P2|NOT COMPLETED|Overall Study||648
8001239|NCT00064753|19700768|P1|NOT COMPLETED|Overall Study||674
8001240|NCT00064753|19700767|P2|COMPLETED|Overall Study||1406
8001241|NCT00064753|19700768|P1|COMPLETED|Overall Study||1382
8001242|NCT00064753|19700767|P2|STARTED|Overall Study||2054
8001243|NCT00064753|19700768|P1|STARTED|Overall Study||2056
8001244|NCT00003645|19700798|P2|NOT COMPLETED|Overall Study||12
8001245|NCT00003645|19700799|P1|NOT COMPLETED|Overall Study||12
8001246|NCT00003645|19700798|P2|COMPLETED|Overall Study||22
8001247|NCT00003645|19700799|P1|COMPLETED|Overall Study||18
8001248|NCT00003645|19700798|P2|STARTED|Overall Study||34
8001249|NCT00003645|19700799|P1|STARTED|Overall Study||30
8001250|NCT00064792|19700813|P2|NOT COMPLETED|Overall Study||0
8001251|NCT00064792|19700814|P1|NOT COMPLETED|Overall Study||5
8001252|NCT00064792|19700813|P2|COMPLETED|Overall Study||10
8001253|NCT00064792|19700814|P1|COMPLETED|Overall Study||8
8001254|NCT00064792|19700813|P2|STARTED|Overall Study||10
8001255|NCT00064792|19700814|P1|STARTED|Overall Study||13
8001256|NCT00064701|19700825|P3|NOT COMPLETED|Clinical Continuation Phase||140
8001257|NCT00064701|19700826|P2|NOT COMPLETED|Clinical Continuation Phase||178
8001258|NCT00064701|19700827|P1|NOT COMPLETED|Clinical Continuation Phase||170
8001259|NCT00064701|19700825|P3|COMPLETED|Clinical Continuation Phase||11
8001260|NCT00064701|19700826|P2|COMPLETED|Clinical Continuation Phase||4
8001261|NCT00064701|19700827|P1|COMPLETED|Clinical Continuation Phase||9
8001262|NCT00064701|19700825|P3|STARTED|Clinical Continuation Phase||151
8001263|NCT00064701|19700826|P2|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182
8001264|NCT00064701|19700827|P1|STARTED|Clinical Continuation Phase||179
8001265|NCT00064701|19700825|P3|NOT COMPLETED|One Year Post-transplant||72
8001266|NCT00064701|19700826|P2|NOT COMPLETED|One Year Post-transplant||43
8001267|NCT00064701|19700827|P1|NOT COMPLETED|One Year Post-transplant||40
8001268|NCT00064701|19700825|P3|COMPLETED|One Year Post-transplant||151
8001269|NCT00064701|19700826|P2|COMPLETED|One Year Post-transplant||183
8001270|NCT00064701|19700827|P1|COMPLETED|One Year Post-transplant||179
8001271|NCT00064701|19700825|P3|Received Study Drug|One Year Post-transplant||212
8001272|NCT00064701|19700826|P2|Received Study Drug|One Year Post-transplant||214
8001273|NCT00064701|19700827|P1|Received Study Drug|One Year Post-transplant||212
8001274|NCT00064701|19700825|P3|STARTED|One Year Post-transplant||223
8001275|NCT00064701|19700826|P2|STARTED|One Year Post-transplant||226
8001276|NCT00064701|19700827|P1|STARTED|One Year Post-transplant||219
8001277|NCT00064662|19700879|P2|NOT COMPLETED|Overall Study||61
8001278|NCT00064662|19700880|P1|NOT COMPLETED|Overall Study||74
8001279|NCT00064662|19700879|P2|COMPLETED|Overall Study||265
8001280|NCT00064662|19700880|P1|COMPLETED|Overall Study||255
8001281|NCT00064662|19700879|P2|STARTED|Overall Study||326
8001282|NCT00064662|19700880|P1|STARTED|Overall Study||329
8001283|NCT00064350|19700891|P3|NOT COMPLETED|Cross-Over||0
8001284|NCT00064350|19700892|P2|NOT COMPLETED|Cross-Over||14
8001285|NCT00064350|19700893|P1|NOT COMPLETED|Cross-Over||6
8001286|NCT00064350|19700891|P3|COMPLETED|Cross-Over||0
8001287|NCT00064350|19700892|P2|COMPLETED|Cross-Over||13
8001288|NCT00064350|19700893|P1|COMPLETED|Cross-Over||4
8001289|NCT00064350|19700891|P3|Eligible and Treated|Cross-Over||0
8001290|NCT00064350|19700892|P2|Eligible and Treated|Cross-Over||21
8001291|NCT00064350|19700893|P1|Eligible and Treated|Cross-Over||7
8001292|NCT00064350|19700891|P3|Treated|Cross-Over||0
8001293|NCT00064350|19700892|P2|Treated|Cross-Over||26
8001294|NCT00064350|19700893|P1|Treated|Cross-Over||9
8001295|NCT00064350|19700891|P3|STARTED|Cross-Over||0
8001296|NCT00064350|19700892|P2|STARTED|Cross-Over||27
8001297|NCT00064350|19700893|P1|STARTED|Cross-Over||10
8001298|NCT00064350|19700891|P3|NOT COMPLETED|Randomization||0
8001299|NCT00064350|19700892|P2|NOT COMPLETED|Randomization||18
8001300|NCT00064350|19700893|P1|NOT COMPLETED|Randomization||26
8001301|NCT00064350|19700891|P3|COMPLETED|Randomization||0
8001302|NCT00064350|19700892|P2|COMPLETED|Randomization||28
8001303|NCT00064350|19700893|P1|COMPLETED|Randomization||33
8001304|NCT00064350|19700891|P3|Eligible and Treated|Randomization||0
8001305|NCT00064350|19700892|P2|Eligible and Treated|Randomization||31
8001306|NCT00064350|19700893|P1|Eligible and Treated|Randomization||50
8001307|NCT00064350|19700891|P3|Treated|Randomization||0
8001308|NCT00064350|19700892|P2|Treated|Randomization||40
8001309|NCT00064350|19700893|P1|Treated|Randomization||55
8001310|NCT00064350|19700891|P3|STARTED|Randomization||0
8001311|NCT00064350|19700892|P2|STARTED|Randomization||46
8001312|NCT00064350|19700893|P1|STARTED|Randomization||59
8001313|NCT00064350|19700891|P3|NOT COMPLETED|Induction Treatment||236
8001314|NCT00064350|19700892|P2|NOT COMPLETED|Induction Treatment||9
8001315|NCT00064350|19700893|P1|NOT COMPLETED|Induction Treatment||8
8001316|NCT00064350|19700891|P3|COMPLETED|Induction Treatment||1
8001317|NCT00064350|19700892|P2|COMPLETED|Induction Treatment||37
8001318|NCT00064350|19700893|P1|COMPLETED|Induction Treatment||51
8001319|NCT00064350|19700891|P3|Eligible and Treated|Induction Treatment||194
8001320|NCT00064350|19700892|P2|Eligible and Treated|Induction Treatment||46
8001321|NCT00064350|19700893|P1|Eligible and Treated|Induction Treatment||59
8001322|NCT00064350|19700891|P3|Treated|Induction Treatment||228
8001323|NCT00064350|19700892|P2|Treated|Induction Treatment||46
8001324|NCT00064350|19700893|P1|Treated|Induction Treatment||59
8001325|NCT00064350|19700891|P3|STARTED|Induction Treatment||237
8001326|NCT00064350|19700892|P2|STARTED|Induction Treatment||46
8001327|NCT00064350|19700893|P1|STARTED|Induction Treatment||59
8001328|NCT00064337|19700908|P1|NOT COMPLETED|Maintenance||10
8001329|NCT00064337|19700908|P1|COMPLETED|Maintenance||3
8001330|NCT00064337|19700908|P1|STARTED|Maintenance|Only patients with High Risk MM or AL + MM were allowed to enroll to Maintenance treatment.|13
8001331|NCT00064337|19700908|P1|NOT COMPLETED|Transplant||21
8001332|NCT00064337|19700908|P1|COMPLETED|Transplant||46
8001333|NCT00064337|19700908|P1|STARTED|Transplant|6 patients who completed PBSCC or Induction/PBSCC did not begin Transplant|67
8001334|NCT00064337|19700908|P1|NOT COMPLETED|PBSCC or Induction/PBSCC||20
8001335|NCT00064337|19700908|P1|COMPLETED|PBSCC or Induction/PBSCC||73
8001336|NCT00064337|19700908|P1|STARTED|PBSCC or Induction/PBSCC|104 patients were registered, 93 of whom were eligible and analyzable.|93
8001337|NCT00064298|19700917|P2|NOT COMPLETED|Overall Study||5
8001338|NCT00064298|19700918|P1|NOT COMPLETED|Overall Study||6
8001339|NCT00064298|19700917|P2|COMPLETED|Overall Study||57
8001340|NCT00064298|19700918|P1|COMPLETED|Overall Study||66
8001341|NCT00064298|19700917|P2|STARTED|Overall Study||62
8001342|NCT00064298|19700918|P1|STARTED|Overall Study||72
8001343|NCT00064259|19700926|P4|NOT COMPLETED|Overall Study||1
8001344|NCT00064259|19700927|P3|NOT COMPLETED|Overall Study||0
8001345|NCT00064259|19700928|P2|NOT COMPLETED|Overall Study||0
8001346|NCT00064259|19700929|P1|NOT COMPLETED|Overall Study||1
8001347|NCT00064259|19700926|P4|COMPLETED|Overall Study||0
8001348|NCT00064259|19700927|P3|COMPLETED|Overall Study||6
8001349|NCT00064259|19700928|P2|COMPLETED|Overall Study||4
8001350|NCT00064259|19700929|P1|COMPLETED|Overall Study||3
8001351|NCT00064259|19700926|P4|STARTED|Overall Study||1
8001352|NCT00064259|19700927|P3|STARTED|Overall Study||6
8001353|NCT00064259|19700928|P2|STARTED|Overall Study||4
8001354|NCT00064259|19700929|P1|STARTED|Overall Study||4
8001355|NCT00064077|19700937|P4|NOT COMPLETED|Overall Study||7
8001356|NCT00064077|19700938|P3|NOT COMPLETED|Overall Study||7
8001357|NCT00064077|19700939|P2|NOT COMPLETED|Overall Study||9
8001358|NCT00064077|19700940|P1|NOT COMPLETED|Overall Study||15
8001359|NCT00064077|19700937|P4|COMPLETED|Overall Study|Evaluable (treatment)|111
8001360|NCT00064077|19700938|P3|COMPLETED|Overall Study|Evaluable (treatment)|112
8001361|NCT00064077|19700939|P2|COMPLETED|Overall Study|Evaluable (treatment)|108
8001362|NCT00064077|19700940|P1|COMPLETED|Overall Study|Evaluable (treatment)|103
8001363|NCT00064077|19700937|P4|STARTED|Overall Study||118
8001364|NCT00064077|19700938|P3|STARTED|Overall Study||119
8001365|NCT00064077|19700939|P2|STARTED|Overall Study||117
8001366|NCT00064077|19700940|P1|STARTED|Overall Study||118
8001367|NCT00064038|19700972|P3|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2
8001368|NCT00064038|19700973|P2|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
8001369|NCT00064038|19700974|P1|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
8001370|NCT00064038|19700972|P3|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40
8001371|NCT00064038|19700973|P2|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
8001372|NCT00064038|19700974|P1|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
8001373|NCT00064038|19700972|P3|Safety Population|Crossover to Lenalidomide+Dexamethasone||40
8001374|NCT00064038|19700973|P2|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
8001375|NCT00064038|19700974|P1|Safety Population|Crossover to Lenalidomide+Dexamethasone||0
8001376|NCT00064038|19700972|P3|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40
8001377|NCT00064038|19700973|P2|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
8001378|NCT00064038|19700974|P1|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0
8001379|NCT00064038|19700972|P3|STARTED|Crossover to Lenalidomide+Dexamethasone||42
8001380|NCT00064038|19700973|P2|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
8001381|NCT00064038|19700974|P1|STARTED|Crossover to Lenalidomide+Dexamethasone||0
8001382|NCT00064038|19700972|P3|NOT COMPLETED|Initial Randomization||0
8001383|NCT00064038|19700973|P2|NOT COMPLETED|Initial Randomization||98
8001384|NCT00064038|19700974|P1|NOT COMPLETED|Initial Randomization||100
8001385|NCT00064038|19700972|P3|COMPLETED|Initial Randomization||0
8001386|NCT00064038|19700973|P2|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
8001387|NCT00064038|19700974|P1|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
8001388|NCT00064038|19700972|P3|Safety Population|Initial Randomization||0
8001389|NCT00064038|19700973|P2|Safety Population|Initial Randomization||94
8001390|NCT00064038|19700974|P1|Safety Population|Initial Randomization||96
8001391|NCT00064038|19700972|P3|Eligible and Analyzable|Initial Randomization||0
8001392|NCT00064038|19700973|P2|Eligible and Analyzable|Initial Randomization||95
8001393|NCT00064038|19700974|P1|Eligible and Analyzable|Initial Randomization||97
8001394|NCT00064038|19700972|P3|STARTED|Initial Randomization||0
8001395|NCT00064038|19700973|P2|STARTED|Initial Randomization||98
8001396|NCT00064038|19700974|P1|STARTED|Initial Randomization||100
8001397|NCT00064025|19700984|P1|NOT COMPLETED|Overall Study||7
8001398|NCT00064025|19700984|P1|COMPLETED|Overall Study||68
8001399|NCT00064025|19700984|P1|STARTED|Overall Study||75
8001400|NCT00063999|19700993|P2|NOT COMPLETED|Overall Study||24
8001401|NCT00063999|19700994|P1|NOT COMPLETED|Overall Study||45
8001402|NCT00063999|19700993|P2|COMPLETED|Overall Study||665
8001403|NCT00063999|19700994|P1|COMPLETED|Overall Study||647
8001404|NCT00063999|19700993|P2|STARTED|Overall Study||689
8001405|NCT00063999|19700994|P1|STARTED|Overall Study||692
8001406|NCT00063986|19701010|P1|NOT COMPLETED|Overall Study||6
8001407|NCT00063986|19701010|P1|COMPLETED|Overall Study||104
8001408|NCT00063986|19701010|P1|Eligible and Treated|Overall Study||104
8001409|NCT00063986|19701010|P1|Treated|Overall Study||105
8001410|NCT00063986|19701010|P1|STARTED|Overall Study||110
8001411|NCT00063934|19701022|P1|NOT COMPLETED|Overall Study||1
8001412|NCT00063934|19701022|P1|COMPLETED|Overall Study||30
8001413|NCT00063934|19701022|P1|STARTED|Overall Study||31
8001414|NCT00063882|19701031|P2|NOT COMPLETED|Overall Study||4
8001415|NCT00063882|19701032|P1|NOT COMPLETED|Overall Study||5
8001416|NCT00063882|19701031|P2|COMPLETED|Overall Study||292
8001417|NCT00063882|19701032|P1|COMPLETED|Overall Study||287
8001418|NCT00063882|19701031|P2|Eligible Patients|Overall Study||292
8001419|NCT00063882|19701032|P1|Eligible Patients|Overall Study||287
8001420|NCT00063882|19701031|P2|Has Baseline/24-month EPIC Data|Overall Study||219
8001421|NCT00063882|19701032|P1|Has Baseline/24-month EPIC Data|Overall Study||201
8001422|NCT00063882|19701031|P2|Has Baseline/4-month EPIC Data|Overall Study||241
8001423|NCT00063882|19701032|P1|Has Baseline/4-month EPIC Data|Overall Study||222
8001424|NCT00063882|19701031|P2|Has Late Adverse Event Data|Overall Study||287
8001425|NCT00063882|19701032|P1|Has Late Adverse Event Data|Overall Study||282
8001426|NCT00063882|19701031|P2|Has Acute Adverse Event Data|Overall Study||288
8001427|NCT00063882|19701032|P1|Has Acute Adverse Event Data|Overall Study||282
8001428|NCT00063882|19701031|P2|STARTED|Overall Study||296
8001429|NCT00063882|19701032|P1|STARTED|Overall Study||292
8001430|NCT00063635|19701063|P3|NOT COMPLETED|Overall Study||9
8001431|NCT00063635|19701064|P2|NOT COMPLETED|Overall Study||8
8001432|NCT00063635|19701065|P1|NOT COMPLETED|Overall Study||6
8001433|NCT00063635|19701063|P3|COMPLETED|Overall Study||49
8001434|NCT00063635|19701064|P2|COMPLETED|Overall Study||50
8001435|NCT00063635|19701065|P1|COMPLETED|Overall Study||51
8001436|NCT00063635|19701063|P3|STARTED|Overall Study||58
8001437|NCT00063635|19701064|P2|STARTED|Overall Study||58
8001438|NCT00063635|19701065|P1|STARTED|Overall Study||57
8001439|NCT00063622|19701106|P3|NOT COMPLETED|Overall Study||11
8001440|NCT00063622|19701107|P2|NOT COMPLETED|Overall Study||4
8001441|NCT00063622|19701108|P1|NOT COMPLETED|Overall Study||10
8001442|NCT00063622|19701106|P3|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72
8001443|NCT00063622|19701107|P2|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80
8001444|NCT00063622|19701108|P1|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70
8001445|NCT00063622|19701106|P3|STARTED|Overall Study||83
8001446|NCT00063622|19701107|P2|STARTED|Overall Study||84
8001447|NCT00063622|19701108|P1|STARTED|Overall Study||80
8001448|NCT00063570|19701133|P2|NOT COMPLETED|Overall Study||0
8001449|NCT00063570|19701134|P1|NOT COMPLETED|Overall Study||0
8001450|NCT00063570|19701133|P2|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21
8001451|NCT00063570|19701134|P1|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52
8001452|NCT00063570|19701133|P2|STARTED|Overall Study||21
8001453|NCT00063570|19701134|P1|STARTED|Overall Study||52
8001454|NCT00063362|19701150|P2|NOT COMPLETED|Overall Study||4
8001455|NCT00063362|19701151|P1|NOT COMPLETED|Overall Study||4
8001456|NCT00063362|19701150|P2|COMPLETED|Overall Study||22
8001457|NCT00063362|19701151|P1|COMPLETED|Overall Study||19
8001458|NCT00063362|19701150|P2|STARTED|Overall Study||26
8001459|NCT00063362|19701151|P1|STARTED|Overall Study||23
8001460|NCT00063258|19701159|P2|NOT COMPLETED|Overall Study||0
8001461|NCT00063258|19701160|P1|NOT COMPLETED|Overall Study||4
8001462|NCT00063258|19701159|P2|COMPLETED|Overall Study||0
8001463|NCT00063258|19701160|P1|COMPLETED|Overall Study||1
8001464|NCT00063258|19701159|P2|STARTED|Overall Study||0
8001465|NCT00063258|19701160|P1|STARTED|Overall Study||5
8001466|NCT00063154|19701166|P1|NOT COMPLETED|Overall Study||51
8001467|NCT00063154|19701166|P1|COMPLETED|Overall Study||0
8001468|NCT00063154|19701166|P1|STARTED|Overall Study||51
8001469|NCT00063232|19701173|P1|NOT COMPLETED|Overall Study||0
8001470|NCT00063232|19701173|P1|COMPLETED|Overall Study||26
8001471|NCT00063232|19701173|P1|STARTED|Overall Study||26
8001472|NCT00062868|19701200|P21|NOT COMPLETED|Dose Level 3||0
8001473|NCT00062868|19701201|P20|NOT COMPLETED|Dose Level 3||0
8001474|NCT00062868|19701202|P19|NOT COMPLETED|Dose Level 3||0
8001475|NCT00062868|19701203|P18|NOT COMPLETED|Dose Level 3||1
8001476|NCT00062868|19701204|P17|NOT COMPLETED|Dose Level 3||0
8001477|NCT00062868|19701205|P16|NOT COMPLETED|Dose Level 3||0
8001478|NCT00062868|19701206|P15|NOT COMPLETED|Dose Level 3||1
8001479|NCT00062868|19701207|P14|NOT COMPLETED|Dose Level 3||0
8001480|NCT00062868|19701208|P13|NOT COMPLETED|Dose Level 3||0
8001481|NCT00062868|19701209|P12|NOT COMPLETED|Dose Level 3||1
8001482|NCT00062868|19701210|P11|NOT COMPLETED|Dose Level 3||0
8001483|NCT00062868|19701211|P10|NOT COMPLETED|Dose Level 3||0
8001484|NCT00062868|19701212|P9|NOT COMPLETED|Dose Level 3||0
8001485|NCT00062868|19701213|P8|NOT COMPLETED|Dose Level 3||0
8001486|NCT00062868|19701214|P7|NOT COMPLETED|Dose Level 3||0
8001487|NCT00062868|19701215|P6|NOT COMPLETED|Dose Level 3||0
8001488|NCT00062868|19701216|P5|NOT COMPLETED|Dose Level 3||0
8001489|NCT00062868|19701217|P4|NOT COMPLETED|Dose Level 3||0
8001490|NCT00062868|19701218|P3|NOT COMPLETED|Dose Level 3||2
8001491|NCT00062868|19701219|P2|NOT COMPLETED|Dose Level 3||0
8001492|NCT00062868|19701220|P1|NOT COMPLETED|Dose Level 3||0
8001493|NCT00062868|19701200|P21|COMPLETED|Dose Level 3||0
8001494|NCT00062868|19701201|P20|COMPLETED|Dose Level 3||0
8001495|NCT00062868|19701202|P19|COMPLETED|Dose Level 3||0
8001496|NCT00062868|19701203|P18|COMPLETED|Dose Level 3||3
8001497|NCT00062868|19701204|P17|COMPLETED|Dose Level 3||0
8001498|NCT00062868|19701205|P16|COMPLETED|Dose Level 3||0
8001499|NCT00062868|19701206|P15|COMPLETED|Dose Level 3||2
8001500|NCT00062868|19701207|P14|COMPLETED|Dose Level 3||0
8001501|NCT00062868|19701208|P13|COMPLETED|Dose Level 3||0
8001502|NCT00062868|19701209|P12|COMPLETED|Dose Level 3||4
8001503|NCT00062868|19701210|P11|COMPLETED|Dose Level 3||0
8001504|NCT00062868|19701211|P10|COMPLETED|Dose Level 3||0
8001505|NCT00062868|19701212|P9|COMPLETED|Dose Level 3||0
8001506|NCT00062868|19701213|P8|COMPLETED|Dose Level 3||0
8001507|NCT00062868|19701214|P7|COMPLETED|Dose Level 3||0
8001508|NCT00062868|19701215|P6|COMPLETED|Dose Level 3||0
8001509|NCT00062868|19701216|P5|COMPLETED|Dose Level 3||0
8001510|NCT00062868|19701217|P4|COMPLETED|Dose Level 3||0
8001511|NCT00062868|19701218|P3|COMPLETED|Dose Level 3||1
8001512|NCT00062868|19701219|P2|COMPLETED|Dose Level 3||0
8001513|NCT00062868|19701220|P1|COMPLETED|Dose Level 3||0
8001514|NCT00062868|19701200|P21|STARTED|Dose Level 3||0
8001515|NCT00062868|19701201|P20|STARTED|Dose Level 3||0
8001516|NCT00062868|19701202|P19|STARTED|Dose Level 3||0
8001517|NCT00062868|19701203|P18|STARTED|Dose Level 3||4
8001518|NCT00062868|19701204|P17|STARTED|Dose Level 3||0
8001519|NCT00062868|19701205|P16|STARTED|Dose Level 3||0
8001520|NCT00062868|19701206|P15|STARTED|Dose Level 3||3
8001521|NCT00062868|19701207|P14|STARTED|Dose Level 3||0
8001522|NCT00062868|19701208|P13|STARTED|Dose Level 3||0
8001523|NCT00062868|19701209|P12|STARTED|Dose Level 3||5
8001524|NCT00062868|19701210|P11|STARTED|Dose Level 3||0
8001525|NCT00062868|19701211|P10|STARTED|Dose Level 3||0
8001526|NCT00062868|19701212|P9|STARTED|Dose Level 3||0
8001527|NCT00062868|19701213|P8|STARTED|Dose Level 3||0
8001528|NCT00062868|19701214|P7|STARTED|Dose Level 3||0
8001529|NCT00062868|19701215|P6|STARTED|Dose Level 3||0
8001530|NCT00062868|19701216|P5|STARTED|Dose Level 3||0
8001531|NCT00062868|19701217|P4|STARTED|Dose Level 3||0
8001532|NCT00062868|19701218|P3|STARTED|Dose Level 3||3
8001533|NCT00062868|19701219|P2|STARTED|Dose Level 3||0
8001534|NCT00062868|19701220|P1|STARTED|Dose Level 3||0
8001535|NCT00062868|19701200|P21|NOT COMPLETED|Dose Level 2||0
8001536|NCT00062868|19701201|P20|NOT COMPLETED|Dose Level 2||0
8001537|NCT00062868|19701202|P19|NOT COMPLETED|Dose Level 2||0
8001538|NCT00062868|19701203|P18|NOT COMPLETED|Dose Level 2||0
8001539|NCT00062868|19701204|P17|NOT COMPLETED|Dose Level 2||3
8001540|NCT00062868|19701205|P16|NOT COMPLETED|Dose Level 2||0
8001541|NCT00062868|19701206|P15|NOT COMPLETED|Dose Level 2||0
8001542|NCT00062868|19701207|P14|NOT COMPLETED|Dose Level 2||1
8001543|NCT00062868|19701208|P13|NOT COMPLETED|Dose Level 2||0
8001544|NCT00062868|19701209|P12|NOT COMPLETED|Dose Level 2||0
8001545|NCT00062868|19701210|P11|NOT COMPLETED|Dose Level 2||1
8001546|NCT00062868|19701211|P10|NOT COMPLETED|Dose Level 2||0
8001547|NCT00062868|19701212|P9|NOT COMPLETED|Dose Level 2||0
8001548|NCT00062868|19701213|P8|NOT COMPLETED|Dose Level 2||0
8001549|NCT00062868|19701214|P7|NOT COMPLETED|Dose Level 2||0
8001550|NCT00062868|19701215|P6|NOT COMPLETED|Dose Level 2||0
8001551|NCT00062868|19701216|P5|NOT COMPLETED|Dose Level 2||2
8001552|NCT00062868|19701217|P4|NOT COMPLETED|Dose Level 2||0
8001553|NCT00062868|19701218|P3|NOT COMPLETED|Dose Level 2||0
8001554|NCT00062868|19701219|P2|NOT COMPLETED|Dose Level 2||3
8001555|NCT00062868|19701220|P1|NOT COMPLETED|Dose Level 2||0
8001556|NCT00062868|19701200|P21|COMPLETED|Dose Level 2||0
8001557|NCT00062868|19701201|P20|COMPLETED|Dose Level 2||0
8001558|NCT00062868|19701202|P19|COMPLETED|Dose Level 2||0
8001559|NCT00062868|19701203|P18|COMPLETED|Dose Level 2||0
8001560|NCT00062868|19701204|P17|COMPLETED|Dose Level 2||0
8001561|NCT00062868|19701205|P16|COMPLETED|Dose Level 2||0
8001562|NCT00062868|19701206|P15|COMPLETED|Dose Level 2||0
8001563|NCT00062868|19701207|P14|COMPLETED|Dose Level 2||2
8001564|NCT00062868|19701208|P13|COMPLETED|Dose Level 2||0
8001565|NCT00062868|19701209|P12|COMPLETED|Dose Level 2||0
8001566|NCT00062868|19701210|P11|COMPLETED|Dose Level 2||3
8001567|NCT00062868|19701211|P10|COMPLETED|Dose Level 2||0
8001568|NCT00062868|19701212|P9|COMPLETED|Dose Level 2||0
8001569|NCT00062868|19701213|P8|COMPLETED|Dose Level 2||0
8001570|NCT00062868|19701214|P7|COMPLETED|Dose Level 2||0
8001571|NCT00062868|19701215|P6|COMPLETED|Dose Level 2||0
8001572|NCT00062868|19701216|P5|COMPLETED|Dose Level 2||1
8001573|NCT00062868|19701217|P4|COMPLETED|Dose Level 2||0
8001574|NCT00062868|19701218|P3|COMPLETED|Dose Level 2||0
8001575|NCT00062868|19701219|P2|COMPLETED|Dose Level 2||3
8001576|NCT00062868|19701220|P1|COMPLETED|Dose Level 2||0
8001577|NCT00062868|19701200|P21|STARTED|Dose Level 2||0
8001578|NCT00062868|19701201|P20|STARTED|Dose Level 2||0
8001579|NCT00062868|19701202|P19|STARTED|Dose Level 2||0
8001580|NCT00062868|19701203|P18|STARTED|Dose Level 2||0
8001581|NCT00062868|19701204|P17|STARTED|Dose Level 2||3
8001582|NCT00062868|19701205|P16|STARTED|Dose Level 2||0
8001583|NCT00062868|19701206|P15|STARTED|Dose Level 2||0
8001584|NCT00062868|19701207|P14|STARTED|Dose Level 2||3
8001585|NCT00062868|19701208|P13|STARTED|Dose Level 2||0
8001586|NCT00062868|19701209|P12|STARTED|Dose Level 2||0
8001587|NCT00062868|19701210|P11|STARTED|Dose Level 2||4
8001588|NCT00062868|19701211|P10|STARTED|Dose Level 2||0
8001589|NCT00062868|19701212|P9|STARTED|Dose Level 2||0
8001590|NCT00062868|19701213|P8|STARTED|Dose Level 2||0
8001591|NCT00062868|19701214|P7|STARTED|Dose Level 2||0
8001592|NCT00062868|19701215|P6|STARTED|Dose Level 2||0
8001593|NCT00062868|19701216|P5|STARTED|Dose Level 2||3
8001594|NCT00062868|19701217|P4|STARTED|Dose Level 2||0
8001595|NCT00062868|19701218|P3|STARTED|Dose Level 2||0
8001596|NCT00062868|19701219|P2|STARTED|Dose Level 2||6
8001597|NCT00062868|19701220|P1|STARTED|Dose Level 2||0
8001598|NCT00062868|19701200|P21|NOT COMPLETED|Dose Level 1||2
8001599|NCT00062868|19701201|P20|NOT COMPLETED|Dose Level 1||0
8001600|NCT00062868|19701202|P19|NOT COMPLETED|Dose Level 1||9
8001601|NCT00062868|19701203|P18|NOT COMPLETED|Dose Level 1||0
8001602|NCT00062868|19701204|P17|NOT COMPLETED|Dose Level 1||0
8001603|NCT00062868|19701205|P16|NOT COMPLETED|Dose Level 1||0
8001604|NCT00062868|19701206|P15|NOT COMPLETED|Dose Level 1||0
8001605|NCT00062868|19701207|P14|NOT COMPLETED|Dose Level 1||0
8001606|NCT00062868|19701208|P13|NOT COMPLETED|Dose Level 1||1
8001607|NCT00062868|19701209|P12|NOT COMPLETED|Dose Level 1||0
8001608|NCT00062868|19701210|P11|NOT COMPLETED|Dose Level 1||0
8001609|NCT00062868|19701211|P10|NOT COMPLETED|Dose Level 1||0
8001610|NCT00062868|19701212|P9|NOT COMPLETED|Dose Level 1||0
8001611|NCT00062868|19701213|P8|NOT COMPLETED|Dose Level 1||0
8001612|NCT00062868|19701214|P7|NOT COMPLETED|Dose Level 1||3
8001613|NCT00062868|19701215|P6|NOT COMPLETED|Dose Level 1||0
8001614|NCT00062868|19701216|P5|NOT COMPLETED|Dose Level 1||0
8001615|NCT00062868|19701217|P4|NOT COMPLETED|Dose Level 1||2
8001616|NCT00062868|19701218|P3|NOT COMPLETED|Dose Level 1||0
8001617|NCT00062868|19701219|P2|NOT COMPLETED|Dose Level 1||0
8001618|NCT00062868|19701220|P1|NOT COMPLETED|Dose Level 1||2
8001619|NCT00062868|19701200|P21|COMPLETED|Dose Level 1||1
8001620|NCT00062868|19701201|P20|COMPLETED|Dose Level 1||2
8001621|NCT00062868|19701202|P19|COMPLETED|Dose Level 1||7
8001622|NCT00062868|19701203|P18|COMPLETED|Dose Level 1||0
8001623|NCT00062868|19701204|P17|COMPLETED|Dose Level 1||0
8001624|NCT00062868|19701205|P16|COMPLETED|Dose Level 1||3
8001625|NCT00062868|19701206|P15|COMPLETED|Dose Level 1||0
8001626|NCT00062868|19701207|P14|COMPLETED|Dose Level 1||0
8001627|NCT00062868|19701208|P13|COMPLETED|Dose Level 1||2
8001628|NCT00062868|19701209|P12|COMPLETED|Dose Level 1||0
8001629|NCT00062868|19701210|P11|COMPLETED|Dose Level 1||0
8001630|NCT00062868|19701211|P10|COMPLETED|Dose Level 1||3
8001631|NCT00062868|19701212|P9|COMPLETED|Dose Level 1||0
8001632|NCT00062868|19701213|P8|COMPLETED|Dose Level 1||0
8001633|NCT00062868|19701214|P7|COMPLETED|Dose Level 1||1
8001634|NCT00062868|19701215|P6|COMPLETED|Dose Level 1||0
8001635|NCT00062868|19701216|P5|COMPLETED|Dose Level 1||0
8001636|NCT00062868|19701217|P4|COMPLETED|Dose Level 1||1
8001637|NCT00062868|19701218|P3|COMPLETED|Dose Level 1||0
8001638|NCT00062868|19701219|P2|COMPLETED|Dose Level 1||0
8001639|NCT00062868|19701220|P1|COMPLETED|Dose Level 1||1
8001640|NCT00062868|19701200|P21|STARTED|Dose Level 1||3
8001641|NCT00062868|19701201|P20|STARTED|Dose Level 1||2
8001642|NCT00062868|19701202|P19|STARTED|Dose Level 1||16
8001643|NCT00062868|19701203|P18|STARTED|Dose Level 1||0
8001644|NCT00062868|19701204|P17|STARTED|Dose Level 1||0
8001645|NCT00062868|19701205|P16|STARTED|Dose Level 1||3
8001646|NCT00062868|19701206|P15|STARTED|Dose Level 1||0
8001647|NCT00062868|19701207|P14|STARTED|Dose Level 1||0
8001648|NCT00062868|19701208|P13|STARTED|Dose Level 1||3
8001649|NCT00062868|19701209|P12|STARTED|Dose Level 1||0
8001650|NCT00062868|19701210|P11|STARTED|Dose Level 1||0
8001651|NCT00062868|19701211|P10|STARTED|Dose Level 1||3
8001652|NCT00062868|19701212|P9|STARTED|Dose Level 1||0
8001653|NCT00062868|19701213|P8|STARTED|Dose Level 1||0
8001654|NCT00062868|19701214|P7|STARTED|Dose Level 1||4
8001655|NCT00062868|19701215|P6|STARTED|Dose Level 1||0
8001656|NCT00062868|19701216|P5|STARTED|Dose Level 1||0
8001657|NCT00062868|19701217|P4|STARTED|Dose Level 1||3
8001658|NCT00062868|19701218|P3|STARTED|Dose Level 1||0
8001659|NCT00062868|19701219|P2|STARTED|Dose Level 1||0
8001660|NCT00062868|19701220|P1|STARTED|Dose Level 1||3
8001661|NCT00062764|19701306|P1|NOT COMPLETED|Overall Study||0
8001662|NCT00062764|19701306|P1|COMPLETED|Overall Study||18
8001663|NCT00062764|19701306|P1|STARTED|Overall Study||18
8001664|NCT00062751|19701319|P5|NOT COMPLETED|Overall Study||6
8001665|NCT00062751|19701320|P4|NOT COMPLETED|Overall Study||5
8001666|NCT00062751|19701321|P3|NOT COMPLETED|Overall Study||30
8001667|NCT00062751|19701322|P2|NOT COMPLETED|Overall Study||30
8001668|NCT00062751|19701323|P1|NOT COMPLETED|Overall Study||33
8001669|NCT00062751|19701319|P5|COMPLETED|Overall Study||0
8001670|NCT00062751|19701320|P4|COMPLETED|Overall Study||1
8001671|NCT00062751|19701321|P3|COMPLETED|Overall Study||3
8001672|NCT00062751|19701322|P2|COMPLETED|Overall Study||0
8001673|NCT00062751|19701323|P1|COMPLETED|Overall Study||0
8001674|NCT00062751|19701319|P5|STARTED|Overall Study||6
8001675|NCT00062751|19701320|P4|STARTED|Overall Study||6
8001676|NCT00062751|19701321|P3|STARTED|Overall Study||33
8001677|NCT00062751|19701322|P2|STARTED|Overall Study||30
8001678|NCT00062751|19701323|P1|STARTED|Overall Study||33
8001679|NCT00062738|19701394|P3|NOT COMPLETED|Overall Study||0
8001680|NCT00062738|19701395|P2|NOT COMPLETED|Overall Study||0
8001681|NCT00062738|19701396|P1|NOT COMPLETED|Overall Study||0
8001682|NCT00062738|19701394|P3|COMPLETED|Overall Study||17
8001683|NCT00062738|19701395|P2|COMPLETED|Overall Study||18
8001684|NCT00062738|19701396|P1|COMPLETED|Overall Study||17
8001685|NCT00062738|19701394|P3|STARTED|Overall Study||17
8001686|NCT00062738|19701395|P2|STARTED|Overall Study||18
8001687|NCT00062738|19701396|P1|STARTED|Overall Study||17
8001688|NCT00062647|19701409|P2|NOT COMPLETED|Overall Study||13
8001689|NCT00062647|19701410|P1|NOT COMPLETED|Overall Study||16
8001690|NCT00062647|19701409|P2|COMPLETED|Overall Study||17
8001691|NCT00062647|19701410|P1|COMPLETED|Overall Study||14
8001692|NCT00062647|19701409|P2|STARTED|Overall Study||30
8001693|NCT00062647|19701410|P1|STARTED|Overall Study||30
8001694|NCT00062439|19701416|P1|NOT COMPLETED|Consolidation Chemotherapy||2
8001695|NCT00062439|19701416|P1|COMPLETED|Consolidation Chemotherapy||20
8001696|NCT00062439|19701416|P1|STARTED|Consolidation Chemotherapy||22
8001697|NCT00062439|19701416|P1|NOT COMPLETED|Surgery||7
8001698|NCT00062439|19701416|P1|COMPLETED|Surgery||22
8001699|NCT00062439|19701416|P1|STARTED|Surgery||29
8001700|NCT00062439|19701416|P1|NOT COMPLETED|Post Chemoradiation Assessment||9
8001701|NCT00062439|19701416|P1|COMPLETED|Post Chemoradiation Assessment||29
8001702|NCT00062439|19701416|P1|STARTED|Post Chemoradiation Assessment||38
8001703|NCT00062439|19701416|P1|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8
8001704|NCT00062439|19701416|P1|COMPLETED|Induction Chemotherapy + Radiotherapy||38
8001705|NCT00062439|19701416|P1|STARTED|Induction Chemotherapy + Radiotherapy||46
8001706|NCT00062374|19701428|P1|NOT COMPLETED|Overall Study||12
8001707|NCT00062374|19701428|P1|COMPLETED|Overall Study||43
8001708|NCT00062374|19701428|P1|STARTED|Overall Study||55
8001709|NCT00062166|19701433|P1|NOT COMPLETED|Overall Study||6
8001710|NCT00062166|19701433|P1|COMPLETED|Overall Study||334
8001711|NCT00062166|19701433|P1|STARTED|Overall Study||340
8001712|NCT00062010|19701441|P1|NOT COMPLETED|Overall Study||3
8001713|NCT00062010|19701441|P1|COMPLETED|Overall Study||34
8001714|NCT00062010|19701441|P1|Eligible and Treated|Overall Study||34
8001715|NCT00062010|19701441|P1|STARTED|Overall Study||37
8001716|NCT00061945|19701449|P2|NOT COMPLETED|Course IV: Alemtuzumab||16
8001717|NCT00061945|19701450|P1|NOT COMPLETED|Course IV: Alemtuzumab||7
8001718|NCT00061945|19701449|P2|COMPLETED|Course IV: Alemtuzumab||50
8001719|NCT00061945|19701450|P1|COMPLETED|Course IV: Alemtuzumab||18
8001720|NCT00061945|19701449|P2|STARTED|Course IV: Alemtuzumab||66
8001721|NCT00061945|19701450|P1|STARTED|Course IV: Alemtuzumab||25
8001722|NCT00061945|19701449|P2|NOT COMPLETED|Registration Through Course 3||115
8001723|NCT00061945|19701450|P1|NOT COMPLETED|Registration Through Course 3||94
8001724|NCT00061945|19701449|P2|COMPLETED|Registration Through Course 3||66
8001725|NCT00061945|19701450|P1|COMPLETED|Registration Through Course 3||25
8001726|NCT00061945|19701449|P2|STARTED|Registration Through Course 3||181
8001727|NCT00061945|19701450|P1|STARTED|Registration Through Course 3||119
8001728|NCT00061932|19701460|P2|NOT COMPLETED|Overall Study||4
8001729|NCT00061932|19701461|P1|NOT COMPLETED|Overall Study||13
8001730|NCT00061932|19701460|P2|COMPLETED|Overall Study||8
8001731|NCT00061932|19701461|P1|COMPLETED|Overall Study||16
8001732|NCT00061932|19701460|P2|STARTED|Overall Study||12
8001733|NCT00061932|19701461|P1|STARTED|Overall Study||29
8001734|NCT00061893|19701467|P1|NOT COMPLETED|Overall Study||18
8001735|NCT00061893|19701467|P1|COMPLETED|Overall Study||20
8001736|NCT00061893|19701467|P1|STARTED|Overall Study||38
8001737|NCT00061633|19701474|P2|NOT COMPLETED|Overall Study||11
8001738|NCT00061633|19701475|P1|NOT COMPLETED|Overall Study||5
8001739|NCT00061633|19701474|P2|COMPLETED|Overall Study||74
8001740|NCT00061633|19701475|P1|COMPLETED|Overall Study||79
8001741|NCT00061633|19701474|P2|STARTED|Overall Study||85
8001742|NCT00061633|19701475|P1|STARTED|Overall Study||84
8001743|NCT00061373|19701483|P2|NOT COMPLETED|Overall Study||0
8001744|NCT00061373|19701484|P1|NOT COMPLETED|Overall Study||0
8001745|NCT00061373|19701483|P2|COMPLETED|Overall Study||3
8001746|NCT00061373|19701484|P1|COMPLETED|Overall Study||15
8001747|NCT00061373|19701483|P2|Aspirin and Tinzaparin|Overall Study||3
8001748|NCT00061373|19701484|P1|Aspirin and Tinzaparin|Overall Study||15
8001749|NCT00061373|19701483|P2|STARTED|Overall Study||3
8001750|NCT00061373|19701484|P1|STARTED|Overall Study||15
8001751|NCT00061048|19701500|P1|NOT COMPLETED|Overall Study||22
8001752|NCT00061048|19701500|P1|COMPLETED|Overall Study|Began protocol specified follow-up period.|7
8001753|NCT00061048|19701500|P1|STARTED|Overall Study||29
8001754|NCT00060944|19701510|P2|NOT COMPLETED|Overall Study||134
8001755|NCT00060944|19701511|P1|NOT COMPLETED|Overall Study||136
8001756|NCT00060944|19701510|P2|COMPLETED|Overall Study||0
8001757|NCT00060944|19701511|P1|COMPLETED|Overall Study||0
8001758|NCT00060944|19701510|P2|Treated|Overall Study||130
8001759|NCT00060944|19701511|P1|Treated|Overall Study||130
8001760|NCT00060944|19701510|P2|STARTED|Overall Study||134
8001761|NCT00060944|19701511|P1|STARTED|Overall Study||136
8001762|NCT00060840|19701527|P2|NOT COMPLETED|Overall Study||9
8001763|NCT00060840|19701528|P1|NOT COMPLETED|Overall Study||4
8001764|NCT00060840|19701527|P2|COMPLETED|Overall Study||68
8001765|NCT00060840|19701528|P1|COMPLETED|Overall Study||69
8001766|NCT00060840|19701527|P2|STARTED|Overall Study||77
8001767|NCT00060840|19701528|P1|STARTED|Overall Study||73
8001768|NCT00060606|19701536|P2|NOT COMPLETED|Overall Study||1
8001769|NCT00060606|19701537|P1|NOT COMPLETED|Overall Study||0
8001770|NCT00060606|19701536|P2|COMPLETED|Overall Study||91
8001771|NCT00060606|19701537|P1|COMPLETED|Overall Study||91
8001772|NCT00060606|19701536|P2|First Primary Outcome - Shunt at 12 Mont|Overall Study||92
8001773|NCT00060606|19701537|P1|First Primary Outcome - Shunt at 12 Mont|Overall Study||91
8001774|NCT00060606|19701536|P2|STARTED|Overall Study||92
8001775|NCT00060606|19701537|P1|STARTED|Overall Study||91
8001776|NCT00060528|19701547|P4|NOT COMPLETED|Overall Study||0
8001777|NCT00060528|19701548|P3|NOT COMPLETED|Overall Study||0
8001778|NCT00060528|19701549|P2|NOT COMPLETED|Overall Study||0
8001779|NCT00060528|19701550|P1|NOT COMPLETED|Overall Study||0
8001780|NCT00060528|19701547|P4|COMPLETED|Overall Study||8
8001781|NCT00060528|19701548|P3|COMPLETED|Overall Study||7
8001782|NCT00060528|19701549|P2|COMPLETED|Overall Study||9
8001783|NCT00060528|19701550|P1|COMPLETED|Overall Study||8
8001784|NCT00060528|19701547|P4|STARTED|Overall Study||8
8001785|NCT00060528|19701548|P3|STARTED|Overall Study||7
8001786|NCT00060528|19701549|P2|STARTED|Overall Study||9
8001787|NCT00060528|19701550|P1|STARTED|Overall Study|32 participants are reported for the phase II portion.|8
8001788|NCT00060424|19701564|P1|NOT COMPLETED|Overall Study||0
8001789|NCT00060424|19701564|P1|COMPLETED|Overall Study||21
8001790|NCT00060424|19701564|P1|STARTED|Overall Study||21
8001791|NCT00060346|19701572|P1|NOT COMPLETED|Overall Study||0
8001792|NCT00060346|19701572|P1|COMPLETED|Overall Study||16
8001793|NCT00060346|19701572|P1|Eligible and Treated|Overall Study||16
8001794|NCT00060346|19701572|P1|STARTED|Overall Study||16
8001795|NCT00060333|19701576|P1|NOT COMPLETED|Overall Study||0
8001796|NCT00060333|19701576|P1|COMPLETED|Overall Study||20
8001797|NCT00060333|19701576|P1|STARTED|Overall Study||20
8001798|NCT00060008|19701587|P1|NOT COMPLETED|Overall Study||0
8001799|NCT00060008|19701587|P1|COMPLETED|Overall Study||18
8001800|NCT00060008|19701587|P1|STARTED|Overall Study||18
8001801|NCT00059839|19701594|P2|NOT COMPLETED|Overall Study||17
8001802|NCT00059839|19701595|P1|NOT COMPLETED|Overall Study||12
8001803|NCT00059839|19701594|P2|COMPLETED|Overall Study||47
8001804|NCT00059839|19701595|P1|COMPLETED|Overall Study||53
8001805|NCT00059839|19701594|P2|STARTED|Overall Study||64
8001806|NCT00059839|19701595|P1|STARTED|Overall Study||65
8001807|NCT00059787|19701601|P1|NOT COMPLETED|Overall Study||20
8001808|NCT00059787|19701601|P1|COMPLETED|Overall Study||36
8001809|NCT00059787|19701601|P1|STARTED|Overall Study||56
8001810|NCT00059475|19701617|P8|NOT COMPLETED|Overall Study||0
8001811|NCT00059475|19701618|P7|NOT COMPLETED|Overall Study||0
8001812|NCT00059475|19701619|P6|NOT COMPLETED|Overall Study||0
8001813|NCT00059475|19701620|P5|NOT COMPLETED|Overall Study||0
8001814|NCT00059475|19701621|P4|NOT COMPLETED|Overall Study||0
8001815|NCT00059475|19701622|P3|NOT COMPLETED|Overall Study||0
8001816|NCT00059475|19701623|P2|NOT COMPLETED|Overall Study||0
8001817|NCT00059475|19701624|P1|NOT COMPLETED|Overall Study||0
8001818|NCT00059475|19701617|P8|COMPLETED|Overall Study||7
8001819|NCT00059475|19701618|P7|COMPLETED|Overall Study||34
8001820|NCT00059475|19701619|P6|COMPLETED|Overall Study||2
8001821|NCT00059475|19701620|P5|COMPLETED|Overall Study||33
8001822|NCT00059475|19701621|P4|COMPLETED|Overall Study||3
8001823|NCT00059475|19701622|P3|COMPLETED|Overall Study||24
8001824|NCT00059475|19701623|P2|COMPLETED|Overall Study||2
8001825|NCT00059475|19701624|P1|COMPLETED|Overall Study||33
8001826|NCT00059475|19701617|P8|STARTED|Overall Study||7
8001827|NCT00059475|19701618|P7|STARTED|Overall Study||34
8001828|NCT00059475|19701619|P6|STARTED|Overall Study||2
8001829|NCT00059475|19701620|P5|STARTED|Overall Study||33
8001830|NCT00059475|19701621|P4|STARTED|Overall Study||3
8001831|NCT00059475|19701622|P3|STARTED|Overall Study||24
8001832|NCT00059475|19701623|P2|STARTED|Overall Study||2
8001833|NCT00059475|19701624|P1|STARTED|Overall Study||33
8001834|NCT00059332|19701652|P2|NOT COMPLETED|Overall Study||2
8001835|NCT00059332|19701653|P1|NOT COMPLETED|Overall Study||3
8001836|NCT00059332|19701652|P2|COMPLETED|Overall Study||855
8001837|NCT00059332|19701653|P1|COMPLETED|Overall Study||840
8001838|NCT00059332|19701652|P2|STARTED|Overall Study||857
8001839|NCT00059332|19701653|P1|STARTED|Overall Study||843
8001840|NCT00059215|19701679|P4|NOT COMPLETED|Overall Study||15
8001841|NCT00059215|19701680|P3|NOT COMPLETED|Overall Study||15
8001842|NCT00059215|19701681|P2|NOT COMPLETED|Overall Study||14
8001843|NCT00059215|19701682|P1|NOT COMPLETED|Overall Study||13
8001844|NCT00059215|19701679|P4|COMPLETED|Overall Study||239
8001845|NCT00059215|19701680|P3|COMPLETED|Overall Study||236
8001846|NCT00059215|19701681|P2|COMPLETED|Overall Study||186
8001847|NCT00059215|19701682|P1|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187
8001848|NCT00059215|19701679|P4|STARTED|Overall Study||254
8001849|NCT00059215|19701680|P3|STARTED|Overall Study||251
8001850|NCT00059215|19701681|P2|STARTED|Overall Study||200
8001851|NCT00059215|19701682|P1|STARTED|Overall Study||200
8001852|NCT00059228|19701710|P2|NOT COMPLETED|Overall Study||1
8001853|NCT00059228|19701711|P1|NOT COMPLETED|Overall Study||0
8001854|NCT00059228|19701710|P2|COMPLETED|Overall Study||5
8001855|NCT00059228|19701711|P1|COMPLETED|Overall Study||6
8001856|NCT00059228|19701710|P2|STARTED|Overall Study||6
8001857|NCT00059228|19701711|P1|STARTED|Overall Study||6
8001858|NCT00058825|19701719|P1|NOT COMPLETED|Overall Study||22
8001859|NCT00058825|19701719|P1|COMPLETED|Overall Study||5
8001860|NCT00058825|19701719|P1|STARTED|Overall Study||27
8001861|NCT00058552|19701735|P2|NOT COMPLETED|Overall Study||62
8001862|NCT00058552|19701736|P1|NOT COMPLETED|Overall Study||65
8001863|NCT00058552|19701735|P2|COMPLETED|Overall Study||2
8001864|NCT00058552|19701736|P1|COMPLETED|Overall Study||0
8001865|NCT00058552|19701735|P2|STARTED|Overall Study||64
8001866|NCT00058552|19701736|P1|STARTED|Overall Study||65
8001867|NCT00058539|19701754|P1|NOT COMPLETED|Overall Study||42
8001868|NCT00058539|19701754|P1|COMPLETED|Overall Study||0
8001869|NCT00058539|19701754|P1|STARTED|Overall Study||42
8001870|NCT00058422|19701764|P1|NOT COMPLETED|Overall Study||2
8001871|NCT00058422|19701764|P1|COMPLETED|Overall Study||63
8001872|NCT00058422|19701764|P1|STARTED|Overall Study||65
8001873|NCT00058370|19701772|P1|NOT COMPLETED|Overall Study||0
8001874|NCT00058370|19701772|P1|COMPLETED|Overall Study||6
8001875|NCT00058370|19701772|P1|STARTED|Overall Study||6
8001876|NCT00058240|19701782|P4|NOT COMPLETED|Second Dose Level||0
8001877|NCT00058240|19701783|P3|NOT COMPLETED|Second Dose Level||0
8001878|NCT00058240|19701784|P2|NOT COMPLETED|Second Dose Level||0
8001879|NCT00058240|19701785|P1|NOT COMPLETED|Second Dose Level||0
8001880|NCT00058240|19701782|P4|COMPLETED|Second Dose Level||4
8001881|NCT00058240|19701783|P3|COMPLETED|Second Dose Level||2
8001882|NCT00058240|19701784|P2|COMPLETED|Second Dose Level||0
8001883|NCT00058240|19701785|P1|COMPLETED|Second Dose Level||0
8001884|NCT00058240|19701782|P4|STARTED|Second Dose Level|4 patients previously relapsed on a different Dose level and were retreated at Dose level 4.|4
8001978|NCT00057746|19701920|P2|COMPLETED|Overall Study||67
8001885|NCT00058240|19701783|P3|STARTED|Second Dose Level|2 patients were previously treated at Dose level 1, relapsed, and retreated at Dose level 3.|2
8001886|NCT00058240|19701784|P2|STARTED|Second Dose Level||0
8001887|NCT00058240|19701785|P1|STARTED|Second Dose Level||0
8001888|NCT00058240|19701782|P4|NOT COMPLETED|First Dose Level||0
8001889|NCT00058240|19701783|P3|NOT COMPLETED|First Dose Level||0
8001890|NCT00058240|19701784|P2|NOT COMPLETED|First Dose Level||0
8001891|NCT00058240|19701785|P1|NOT COMPLETED|First Dose Level||0
8001892|NCT00058240|19701782|P4|COMPLETED|First Dose Level||12
8001893|NCT00058240|19701783|P3|COMPLETED|First Dose Level||17
8001894|NCT00058240|19701784|P2|COMPLETED|First Dose Level||3
8001895|NCT00058240|19701785|P1|COMPLETED|First Dose Level||20
8001896|NCT00058240|19701782|P4|Treated|First Dose Level||12
8001897|NCT00058240|19701783|P3|Treated|First Dose Level||17
8001898|NCT00058240|19701784|P2|Treated|First Dose Level||3
8001899|NCT00058240|19701785|P1|Treated|First Dose Level||20
8001900|NCT00058240|19701782|P4|STARTED|First Dose Level||12
8001901|NCT00058240|19701783|P3|STARTED|First Dose Level||17
8001902|NCT00058240|19701784|P2|STARTED|First Dose Level||3
8001903|NCT00058240|19701785|P1|STARTED|First Dose Level||20
8001904|NCT00058214|19701795|P1|NOT COMPLETED|Overall Study||1
8001905|NCT00058214|19701795|P1|COMPLETED|Overall Study||24
8001906|NCT00058214|19701795|P1|STARTED|Overall Study||25
8001907|NCT00058188|19701802|P2|NOT COMPLETED|Overall Study||0
8001908|NCT00058188|19701803|P1|NOT COMPLETED|Overall Study||0
8001909|NCT00058188|19701802|P2|COMPLETED|Overall Study||0
8001910|NCT00058188|19701803|P1|COMPLETED|Overall Study||0
8001911|NCT00058188|19701802|P2|STARTED|Overall Study||0
8001912|NCT00058188|19701803|P1|STARTED|Overall Study||0
8001913|NCT00058123|19701817|P1|NOT COMPLETED|Overall Study||10
8001914|NCT00058123|19701817|P1|COMPLETED|Overall Study||45
8001915|NCT00058123|19701817|P1|STARTED|Overall Study||55
8001916|NCT00058058|19701824|P1|NOT COMPLETED|Overall Study||38
8001917|NCT00058058|19701824|P1|COMPLETED|Overall Study||969
8001918|NCT00058058|19701824|P1|STARTED|Overall Study||1007
8001919|NCT00058019|19701835|P2|NOT COMPLETED|Overall Study||0
8001920|NCT00058019|19701836|P1|NOT COMPLETED|Overall Study||0
8001921|NCT00058019|19701835|P2|COMPLETED|Overall Study||12
8001922|NCT00058019|19701836|P1|COMPLETED|Overall Study||39
8001923|NCT00058019|19701835|P2|STARTED|Overall Study||12
8001924|NCT00058019|19701836|P1|STARTED|Overall Study||39
8001925|NCT00057954|19701849|P1|NOT COMPLETED|Overall Study||2
8001926|NCT00057954|19701849|P1|COMPLETED|Overall Study||4
8001927|NCT00057954|19701849|P1|STARTED|Overall Study||6
8001928|NCT00057941|19701857|P2|NOT COMPLETED|Overall Study||74
8001929|NCT00057941|19701858|P1|NOT COMPLETED|Overall Study||74
8001930|NCT00057941|19701857|P2|COMPLETED|Overall Study||0
8001931|NCT00057941|19701858|P1|COMPLETED|Overall Study||0
8001932|NCT00057941|19701857|P2|Eligible|Overall Study||69
8001933|NCT00057941|19701858|P1|Eligible|Overall Study||72
8001934|NCT00057941|19701857|P2|Treated|Overall Study||74
8001935|NCT00057941|19701858|P1|Treated|Overall Study||74
8001936|NCT00057941|19701857|P2|STARTED|Overall Study||74
8001937|NCT00057941|19701858|P1|STARTED|Overall Study||74
8001938|NCT00057876|19701866|P2|NOT COMPLETED|Overall Study||27
8001939|NCT00057876|19701867|P1|NOT COMPLETED|Overall Study||29
8001940|NCT00057876|19701866|P2|COMPLETED|Overall Study||9
8001941|NCT00057876|19701867|P1|COMPLETED|Overall Study||9
8001942|NCT00057876|19701866|P2|Eligible and Treated|Overall Study||34
8001943|NCT00057876|19701867|P1|Eligible and Treated|Overall Study||34
8001944|NCT00057876|19701866|P2|Began Protocol Therapy|Overall Study||34
8001945|NCT00057876|19701867|P1|Began Protocol Therapy|Overall Study||35
8001946|NCT00057876|19701866|P2|Eligible|Overall Study||34
8001947|NCT00057876|19701867|P1|Eligible|Overall Study||37
8001948|NCT00057876|19701866|P2|STARTED|Overall Study||36
8001949|NCT00057876|19701867|P1|STARTED|Overall Study||38
8001950|NCT00057863|19701877|P1|NOT COMPLETED|Overall Study||3
8001951|NCT00057863|19701877|P1|COMPLETED|Overall Study||32
8001952|NCT00057863|19701877|P1|STARTED|Overall Study||35
8001953|NCT00057837|19701886|P2|NOT COMPLETED|Overall Study||39
8001954|NCT00057837|19701887|P1|NOT COMPLETED|Overall Study||31
8001955|NCT00057837|19701886|P2|COMPLETED|Overall Study||31
8001956|NCT00057837|19701887|P1|COMPLETED|Overall Study||39
8001957|NCT00057837|19701886|P2|Patients With Response|Overall Study||38
8001958|NCT00057837|19701887|P1|Patients With Response|Overall Study||46
8001959|NCT00057837|19701886|P2|Eligible and Treated|Overall Study||66
8001960|NCT00057837|19701887|P1|Eligible and Treated|Overall Study||66
8001961|NCT00057837|19701886|P2|Treated|Overall Study||68
8001962|NCT00057837|19701887|P1|Treated|Overall Study||69
8001963|NCT00057837|19701886|P2|STARTED|Overall Study||70
8001964|NCT00057837|19701887|P1|STARTED|Overall Study||70
8001965|NCT00057811|19701899|P2|NOT COMPLETED|Overall Study||12
8001966|NCT00057811|19701900|P1|NOT COMPLETED|Overall Study||10
8001967|NCT00057811|19701899|P2|COMPLETED|Overall Study||34
8001968|NCT00057811|19701900|P1|COMPLETED|Overall Study||41
8001969|NCT00057811|19701899|P2|STARTED|Overall Study||46
8001970|NCT00057811|19701900|P1|STARTED|Overall Study||51
8001971|NCT00057785|19701912|P1|NOT COMPLETED|Overall Study||0
8001972|NCT00057785|19701912|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68
8001973|NCT00057785|19701912|P1|STARTED|Overall Study||68
8001974|NCT00057746|19701919|P3|NOT COMPLETED|Overall Study||1
8001975|NCT00057746|19701920|P2|NOT COMPLETED|Overall Study||0
8001976|NCT00057746|19701921|P1|NOT COMPLETED|Overall Study||0
8001977|NCT00057746|19701919|P3|COMPLETED|Overall Study||66
8001979|NCT00057746|19701921|P1|COMPLETED|Overall Study||131
8001980|NCT00057746|19701919|P3|STARTED|Overall Study||67
8001981|NCT00057746|19701920|P2|STARTED|Overall Study||67
8001982|NCT00057746|19701921|P1|STARTED|Overall Study||131
8001983|NCT00023673|19701932|P4|NOT COMPLETED|Overall Study||2
8001984|NCT00023673|19701933|P3|NOT COMPLETED|Overall Study||0
8001985|NCT00023673|19701934|P2|NOT COMPLETED|Overall Study||0
8001986|NCT00023673|19701935|P1|NOT COMPLETED|Overall Study||0
8001987|NCT00023673|19701932|P4|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44
8001988|NCT00023673|19701933|P3|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0
8001989|NCT00023673|19701934|P2|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9
8001990|NCT00023673|19701935|P1|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8
8001991|NCT00023673|19701932|P4|STARTED|Overall Study||46
8001992|NCT00023673|19701933|P3|STARTED|Overall Study||0
8001993|NCT00023673|19701934|P2|STARTED|Overall Study||9
8001994|NCT00023673|19701935|P1|STARTED|Overall Study||8
8001995|NCT00057681|19701951|P3|NOT COMPLETED|Overall Study||34
8001996|NCT00057681|19701952|P2|NOT COMPLETED|Overall Study||72
8001997|NCT00057681|19701953|P1|NOT COMPLETED|Overall Study||65
8001998|NCT00057681|19701951|P3|COMPLETED|Overall Study||69
8001999|NCT00057681|19701952|P2|COMPLETED|Overall Study||67
8002000|NCT00057681|19701953|P1|COMPLETED|Overall Study||72
8002001|NCT00057681|19701951|P3|STARTED|Overall Study||103
8002002|NCT00057681|19701952|P2|STARTED|Overall Study||139
8002003|NCT00057681|19701953|P1|STARTED|Overall Study||137
8002004|NCT00057577|19701969|P2|NOT COMPLETED|Overall Study||0
8002005|NCT00057577|19701970|P1|NOT COMPLETED|Overall Study||0
8002006|NCT00057577|19701969|P2|COMPLETED|Overall Study||225
8002007|NCT00057577|19701970|P1|COMPLETED|Overall Study||227
8002008|NCT00057577|19701969|P2|STARTED|Overall Study||225
8002009|NCT00057577|19701970|P1|STARTED|Overall Study||227
8002010|NCT00057551|19701987|P3|NOT COMPLETED|Overall Study||16
8002011|NCT00057551|19701988|P2|NOT COMPLETED|Overall Study||27
8002012|NCT00057551|19701989|P1|NOT COMPLETED|Overall Study||25
8002013|NCT00057551|19701987|P3|COMPLETED|Overall Study||80
8002014|NCT00057551|19701988|P2|COMPLETED|Overall Study||168
8002015|NCT00057551|19701989|P1|COMPLETED|Overall Study||175
8002016|NCT00057551|19701987|P3|STARTED|Overall Study||96
8002017|NCT00057551|19701988|P2|STARTED|Overall Study||195
8002018|NCT00057551|19701989|P1|STARTED|Overall Study||200
8002019|NCT00057330|19701999|P2|NOT COMPLETED|Overall Study||920
8002020|NCT00057330|19702000|P1|NOT COMPLETED|Overall Study||1132
8002021|NCT00057330|19701999|P2|COMPLETED|Overall Study||2826
8002022|NCT00057330|19702000|P1|COMPLETED|Overall Study||3445
8002023|NCT00057330|19701999|P2|STARTED|Overall Study||3746
8002024|NCT00057330|19702000|P1|STARTED|Overall Study||4577
8002025|NCT00056862|19702030|P2|NOT COMPLETED|Overall Study||0
8002026|NCT00056862|19702031|P1|NOT COMPLETED|Overall Study||1
8002027|NCT00056862|19702030|P2|COMPLETED|Overall Study||27
8002028|NCT00056862|19702031|P1|COMPLETED|Overall Study||30
8002029|NCT00056862|19702030|P2|STARTED|Overall Study||27
8002030|NCT00056862|19702031|P1|STARTED|Overall Study||31
8002031|NCT00056563|19702047|P2|NOT COMPLETED|Overall Study||0
8002032|NCT00056563|19702048|P1|NOT COMPLETED|Overall Study||0
8002033|NCT00056563|19702047|P2|COMPLETED|Overall Study||134
8002034|NCT00056563|19702048|P1|COMPLETED|Overall Study||121
8002035|NCT00056563|19702047|P2|STARTED|Overall Study||134
8002036|NCT00056563|19702048|P1|STARTED|Overall Study||121
8002037|NCT00056550|19702056|P1|NOT COMPLETED|Overall Study||0
8002038|NCT00056550|19702056|P1|COMPLETED|Overall Study||14
8002039|NCT00056550|19702056|P1|STARTED|Overall Study||14
8002040|NCT00056498|19702063|P2|NOT COMPLETED|Overall Study||7
8002041|NCT00056498|19702064|P1|NOT COMPLETED|Overall Study||5
8002042|NCT00056498|19702063|P2|COMPLETED|Overall Study||28
8002043|NCT00056498|19702064|P1|COMPLETED|Overall Study||25
8002044|NCT00056498|19702063|P2|STARTED|Overall Study||35
8002045|NCT00056498|19702064|P1|STARTED|Overall Study||30
8002046|NCT00056472|19702076|P2|NOT COMPLETED|Overall Study||69
8002047|NCT00056472|19702077|P1|NOT COMPLETED|Overall Study||48
8002048|NCT00056472|19702076|P2|COMPLETED|Overall Study||61
8002049|NCT00056472|19702077|P1|COMPLETED|Overall Study||81
8002050|NCT00056472|19702076|P2|STARTED|Overall Study||130
8002051|NCT00056472|19702077|P1|STARTED|Overall Study||129
8002052|NCT00056407|19702089|P2|NOT COMPLETED|Overall Study||1193
8002053|NCT00056407|19702090|P1|NOT COMPLETED|Overall Study||1211
8002054|NCT00056407|19702089|P2|COMPLETED|Overall Study||2912
8002055|NCT00056407|19702090|P1|COMPLETED|Overall Study||2915
8002056|NCT00056407|19702089|P2|STARTED|Overall Study||4105
8002057|NCT00056407|19702090|P1|STARTED|Overall Study||4126
8002058|NCT00056316|19702148|P2|NOT COMPLETED|Overall Study||3
8002059|NCT00056316|19702149|P1|NOT COMPLETED|Overall Study||3
8002060|NCT00056316|19702148|P2|COMPLETED|Overall Study||38
8002061|NCT00056316|19702149|P1|COMPLETED|Overall Study||30
8002062|NCT00056316|19702148|P2|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41
8002063|NCT00056316|19702149|P1|STARTED|Overall Study||33
8002064|NCT00056160|19702163|P2|NOT COMPLETED|Final Follow-up||0
8002065|NCT00056160|19702164|P1|NOT COMPLETED|Final Follow-up||6
8002066|NCT00056160|19702163|P2|COMPLETED|Final Follow-up||0
8002067|NCT00056160|19702164|P1|COMPLETED|Final Follow-up||0
8002068|NCT00056160|19702163|P2|STARTED|Final Follow-up||0
8002069|NCT00056160|19702164|P1|STARTED|Final Follow-up||6
8002149|NCT00054691|19702503|P1|COMPLETED|Overall Study||37
8002070|NCT00056160|19702163|P2|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
8002071|NCT00056160|19702164|P1|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171
8002072|NCT00056160|19702163|P2|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
8002073|NCT00056160|19702164|P1|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6
8002074|NCT00056160|19702163|P2|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0
8002075|NCT00056160|19702164|P1|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177
8002076|NCT00056160|19702163|P2|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163
8002077|NCT00056160|19702164|P1|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113
8002078|NCT00056160|19702163|P2|COMPLETED|Up to Unblinding (07 Jun 2005)||13
8002079|NCT00056160|19702164|P1|COMPLETED|Up to Unblinding (07 Jun 2005)||64
8002080|NCT00056160|19702163|P2|STARTED|Up to Unblinding (07 Jun 2005)||176
8002081|NCT00056160|19702164|P1|STARTED|Up to Unblinding (07 Jun 2005)||177
8002082|NCT00055692|19702176|P1|NOT COMPLETED|Overall Study||0
8002083|NCT00055692|19702176|P1|COMPLETED|Overall Study||46
8002084|NCT00055692|19702176|P1|STARTED|Overall Study||46
8002085|NCT00055601|19702187|P2|NOT COMPLETED|Overall Study||2
8002086|NCT00055601|19702188|P1|NOT COMPLETED|Overall Study||2
8002087|NCT00055601|19702187|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
8002088|NCT00055601|19702188|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46
8002089|NCT00055601|19702187|P2|STARTED|Overall Study||49
8002090|NCT00055601|19702188|P1|STARTED|Overall Study||48
8002091|NCT00055497|19702202|P4|NOT COMPLETED|Overall Study||90
8002092|NCT00055497|19702203|P3|NOT COMPLETED|Overall Study||2
8002093|NCT00055497|19702204|P2|NOT COMPLETED|Overall Study||3
8002094|NCT00055497|19702205|P1|NOT COMPLETED|Overall Study||5
8002095|NCT00055497|19702202|P4|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131
8002096|NCT00055497|19702203|P3|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
8002097|NCT00055497|19702204|P2|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
8002098|NCT00055497|19702205|P1|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13
8002099|NCT00055497|19702202|P4|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221
8002100|NCT00055497|19702203|P3|STARTED|Overall Study||18
8002101|NCT00055497|19702204|P2|STARTED|Overall Study||19
8002102|NCT00055497|19702205|P1|STARTED|Overall Study||18
8002103|NCT00055471|19702250|P3|NOT COMPLETED|Period 2: Extension Period||0
8002104|NCT00055471|19702251|P2|NOT COMPLETED|Period 2: Extension Period||0
8002105|NCT00055471|19702252|P1|NOT COMPLETED|Period 2: Extension Period||0
8002106|NCT00055471|19702250|P3|COMPLETED|Period 2: Extension Period||0
8002107|NCT00055471|19702251|P2|COMPLETED|Period 2: Extension Period||6
8002108|NCT00055471|19702252|P1|COMPLETED|Period 2: Extension Period||3
8002109|NCT00055471|19702250|P3|STARTED|Period 2: Extension Period||0
8002110|NCT00055471|19702251|P2|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6
8002111|NCT00055471|19702252|P1|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3
8002112|NCT00055471|19702250|P3|NOT COMPLETED|Period 1: Dose Escalation Period||3
8002113|NCT00055471|19702251|P2|NOT COMPLETED|Period 1: Dose Escalation Period||2
8002114|NCT00055471|19702252|P1|NOT COMPLETED|Period 1: Dose Escalation Period||0
8002115|NCT00055471|19702250|P3|COMPLETED|Period 1: Dose Escalation Period||0
8002116|NCT00055471|19702251|P2|COMPLETED|Period 1: Dose Escalation Period||8
8002117|NCT00055471|19702252|P1|COMPLETED|Period 1: Dose Escalation Period||3
8002118|NCT00055471|19702250|P3|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3
8002119|NCT00055471|19702251|P2|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10
8002120|NCT00055471|19702252|P1|STARTED|Period 1: Dose Escalation Period||3
8002121|NCT00055237|19702280|P2|NOT COMPLETED|Overall Study||0
8002122|NCT00055237|19702281|P1|NOT COMPLETED|Overall Study||0
8002123|NCT00055237|19702280|P2|COMPLETED|Overall Study||2
8002124|NCT00055237|19702281|P1|COMPLETED|Overall Study||17
8002125|NCT00055237|19702280|P2|STARTED|Overall Study||2
8002126|NCT00055237|19702281|P1|STARTED|Overall Study||17
8002127|NCT00054847|19702288|P2|NOT COMPLETED|Overall Study||100
8002128|NCT00054847|19702289|P1|NOT COMPLETED|Overall Study||98
8002129|NCT00054847|19702288|P2|COMPLETED|Overall Study||266
8002130|NCT00054847|19702289|P1|COMPLETED|Overall Study||269
8002131|NCT00054847|19702288|P2|STARTED|Overall Study||366
8002132|NCT00054847|19702289|P1|STARTED|Overall Study||367
8002133|NCT00054756|19702301|P1|NOT COMPLETED|Overall Study||2
8002134|NCT00054756|19702301|P1|COMPLETED|Overall Study||94
8002135|NCT00054756|19702301|P1|STARTED|Overall Study||96
8002136|NCT00054717|19702307|P2|NOT COMPLETED|Overall Study||299
8002137|NCT00054717|19702308|P1|NOT COMPLETED|Overall Study||262
8002138|NCT00054717|19702307|P2|COMPLETED|Overall Study||18
8002139|NCT00054717|19702308|P1|COMPLETED|Overall Study||51
8002140|NCT00054717|19702307|P2|STARTED|Overall Study||317
8002141|NCT00054717|19702308|P1|STARTED|Overall Study||313
8002142|NCT00054704|19702496|P2|NOT COMPLETED|Overall Study||5
8002143|NCT00054704|19702497|P1|NOT COMPLETED|Overall Study||5
8002144|NCT00054704|19702496|P2|COMPLETED|Overall Study||6
8002145|NCT00054704|19702497|P1|COMPLETED|Overall Study||3
8002146|NCT00054704|19702496|P2|STARTED|Overall Study||11
8002147|NCT00054704|19702497|P1|STARTED|Overall Study||8
8002148|NCT00054691|19702503|P1|NOT COMPLETED|Overall Study||3
8002150|NCT00054691|19702503|P1|STARTED|Overall Study||40
8002151|NCT00054665|19702508|P2|NOT COMPLETED|Part B||0
8002152|NCT00054665|19702509|P1|NOT COMPLETED|Part B||0
8002153|NCT00054665|19702508|P2|COMPLETED|Part B||44
8002154|NCT00054665|19702509|P1|COMPLETED|Part B||0
8002155|NCT00054665|19702508|P2|STARTED|Part B|26 participants received only Part B|44
8002156|NCT00054665|19702509|P1|STARTED|Part B||0
8002157|NCT00054665|19702508|P2|NOT COMPLETED|Part A||0
8002158|NCT00054665|19702509|P1|NOT COMPLETED|Part A||0
8002159|NCT00054665|19702508|P2|COMPLETED|Part A||0
8002160|NCT00054665|19702509|P1|COMPLETED|Part A||23
8002161|NCT00054665|19702508|P2|STARTED|Part A||0
8002162|NCT00054665|19702509|P1|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23
8002163|NCT00054639|19702517|P1|NOT COMPLETED|Overall Study||2
8002164|NCT00054639|19702517|P1|COMPLETED|Overall Study||46
8002165|NCT00054639|19702517|P1|STARTED|Overall Study||48
8002166|NCT00054353|19702523|P2|NOT COMPLETED|Overall Study||0
8002167|NCT00054353|19702524|P1|NOT COMPLETED|Overall Study||0
8002168|NCT00054353|19702523|P2|COMPLETED|Overall Study||4
8002169|NCT00054353|19702524|P1|COMPLETED|Overall Study||12
8002170|NCT00054353|19702523|P2|STARTED|Overall Study||4
8002171|NCT00054353|19702524|P1|STARTED|Overall Study||12
8002172|NCT00054327|19702550|P6|NOT COMPLETED|Overall Study||0
8002173|NCT00054327|19702551|P5|NOT COMPLETED|Overall Study||0
8002174|NCT00054327|19702552|P4|NOT COMPLETED|Overall Study||0
8002175|NCT00054327|19702553|P3|NOT COMPLETED|Overall Study||0
8002176|NCT00054327|19702554|P2|NOT COMPLETED|Overall Study||0
8002177|NCT00054327|19702555|P1|NOT COMPLETED|Overall Study||1
8002178|NCT00054327|19702550|P6|COMPLETED|Overall Study||2
8002179|NCT00054327|19702551|P5|COMPLETED|Overall Study||10
8002180|NCT00054327|19702552|P4|COMPLETED|Overall Study||4
8002181|NCT00054327|19702553|P3|COMPLETED|Overall Study||3
8002182|NCT00054327|19702554|P2|COMPLETED|Overall Study||4
8002183|NCT00054327|19702555|P1|COMPLETED|Overall Study||10
8002184|NCT00054327|19702550|P6|STARTED|Overall Study||2
8002185|NCT00054327|19702551|P5|STARTED|Overall Study||10
8002186|NCT00054327|19702552|P4|STARTED|Overall Study||4
8002187|NCT00054327|19702553|P3|STARTED|Overall Study||3
8002188|NCT00054327|19702554|P2|STARTED|Overall Study||4
8002189|NCT00054327|19702555|P1|STARTED|Overall Study||11
8002190|NCT00054275|19702593|P1|NOT COMPLETED|Overall Study||11
8002191|NCT00054275|19702593|P1|COMPLETED|Overall Study||28
8002192|NCT00054275|19702593|P1|STARTED|Overall Study||39
8002193|NCT00054132|19702599|P1|NOT COMPLETED|Overall Study||1
8002194|NCT00054132|19702599|P1|COMPLETED|Overall Study||37
8002195|NCT00054132|19702599|P1|STARTED|Overall Study||38
8002196|NCT00054028|19702610|P1|NOT COMPLETED|Overall Study||0
8002197|NCT00054028|19702610|P1|COMPLETED|Overall Study||31
8002198|NCT00054028|19702610|P1|Phase II|Overall Study||22
8002199|NCT00054028|19702610|P1|Phase I|Overall Study||9
8002200|NCT00054028|19702610|P1|STARTED|Overall Study||31
8002201|NCT00053989|19702616|P1|NOT COMPLETED|Overall Study||0
8002202|NCT00053989|19702616|P1|COMPLETED|Overall Study||41
8002203|NCT00053989|19702616|P1|STARTED|Overall Study||41
8002204|NCT00053898|19702626|P2|NOT COMPLETED|Overall Study||13
8002205|NCT00053898|19702627|P1|NOT COMPLETED|Overall Study||14
8002206|NCT00053898|19702626|P2|COMPLETED|Overall Study||1539
8002207|NCT00053898|19702627|P1|COMPLETED|Overall Study||1538
8002208|NCT00053898|19702626|P2|STARTED|Overall Study||1552
8002209|NCT00053898|19702627|P1|STARTED|Overall Study||1552
8002210|NCT00053846|19702653|P2|NOT COMPLETED|Overall Study||27
8002211|NCT00053846|19702654|P1|NOT COMPLETED|Overall Study||26
8002212|NCT00053846|19702653|P2|COMPLETED|Overall Study||192
8002213|NCT00053846|19702654|P1|COMPLETED|Overall Study||187
8002214|NCT00053846|19702653|P2|STARTED|Overall Study||219
8002215|NCT00053846|19702654|P1|STARTED|Overall Study||213
8002216|NCT00053703|19702663|P3|NOT COMPLETED|Overall Study||15
8002217|NCT00053703|19702664|P2|NOT COMPLETED|Overall Study||13
8002218|NCT00053703|19702665|P1|NOT COMPLETED|Overall Study||18
8002219|NCT00053703|19702663|P3|COMPLETED|Overall Study||25
8002220|NCT00053703|19702664|P2|COMPLETED|Overall Study||28
8002221|NCT00053703|19702665|P1|COMPLETED|Overall Study||17
8002222|NCT00053703|19702663|P3|STARTED|Overall Study||40
8002223|NCT00053703|19702664|P2|STARTED|Overall Study||41
8002224|NCT00053703|19702665|P1|STARTED|Overall Study||35
8002225|NCT00053677|19702690|P2|NOT COMPLETED|Overall Study||6
8002226|NCT00053677|19702691|P1|NOT COMPLETED|Overall Study||22
8002227|NCT00053677|19702690|P2|COMPLETED|Overall Study||13
8002228|NCT00053677|19702691|P1|COMPLETED|Overall Study||36
8002229|NCT00053677|19702690|P2|STARTED|Overall Study||19
8002230|NCT00053677|19702691|P1|STARTED|Overall Study||58
8002231|NCT00053495|19702702|P5|NOT COMPLETED|Overall Study||0
8002232|NCT00053495|19702703|P4|NOT COMPLETED|Overall Study||0
8002233|NCT00053495|19702704|P3|NOT COMPLETED|Overall Study||0
8002234|NCT00053495|19702705|P2|NOT COMPLETED|Overall Study||0
8002235|NCT00053495|19702706|P1|NOT COMPLETED|Overall Study||0
8002236|NCT00053495|19702702|P5|COMPLETED|Overall Study||49
8002237|NCT00053495|19702703|P4|COMPLETED|Overall Study||51
8002238|NCT00053495|19702704|P3|COMPLETED|Overall Study||101
8002239|NCT00053495|19702705|P2|COMPLETED|Overall Study||101
8002240|NCT00053495|19702706|P1|COMPLETED|Overall Study||51
8002241|NCT00053495|19702702|P5|STARTED|Overall Study||49
8002242|NCT00053495|19702703|P4|STARTED|Overall Study||51
8002243|NCT00053495|19702704|P3|STARTED|Overall Study||101
8002244|NCT00053495|19702705|P2|STARTED|Overall Study||101
8002245|NCT00053495|19702706|P1|STARTED|Overall Study||51
8002246|NCT00053482|19702758|P5|NOT COMPLETED|Overall Study||0
8002247|NCT00053482|19702759|P4|NOT COMPLETED|Overall Study||0
8002248|NCT00053482|19702760|P3|NOT COMPLETED|Overall Study||0
8002249|NCT00053482|19702761|P2|NOT COMPLETED|Overall Study||0
8002250|NCT00053482|19702762|P1|NOT COMPLETED|Overall Study||0
8002251|NCT00053482|19702758|P5|COMPLETED|Overall Study||52
8002252|NCT00053482|19702759|P4|COMPLETED|Overall Study||50
8002253|NCT00053482|19702760|P3|COMPLETED|Overall Study||102
8002254|NCT00053482|19702761|P2|COMPLETED|Overall Study||102
8002255|NCT00053482|19702762|P1|COMPLETED|Overall Study||51
8002256|NCT00053482|19702758|P5|STARTED|Overall Study||52
8002257|NCT00053482|19702759|P4|STARTED|Overall Study||50
8002258|NCT00053482|19702760|P3|STARTED|Overall Study||102
8002259|NCT00053482|19702761|P2|STARTED|Overall Study||102
8002260|NCT00053482|19702762|P1|STARTED|Overall Study||51
8002261|NCT00053417|19702813|P4|NOT COMPLETED|Overall Study||6
8002262|NCT00053417|19702814|P3|NOT COMPLETED|Overall Study||1
8002263|NCT00053417|19702815|P2|NOT COMPLETED|Overall Study||2
8002264|NCT00053417|19702816|P1|NOT COMPLETED|Overall Study||2
8002265|NCT00053417|19702813|P4|COMPLETED|Overall Study||51
8002266|NCT00053417|19702814|P3|COMPLETED|Overall Study||49
8002267|NCT00053417|19702815|P2|COMPLETED|Overall Study||50
8002268|NCT00053417|19702816|P1|COMPLETED|Overall Study||45
8002269|NCT00053417|19702813|P4|STARTED|Overall Study||57
8002270|NCT00053417|19702814|P3|STARTED|Overall Study||50
8002271|NCT00053417|19702815|P2|STARTED|Overall Study||52
8002272|NCT00053417|19702816|P1|STARTED|Overall Study||47
8002273|NCT00053365|19702826|P1|NOT COMPLETED|Overall Study||6
8002274|NCT00053365|19702826|P1|COMPLETED|Overall Study||55
8002275|NCT00053365|19702826|P1|STARTED|Overall Study||61
8002276|NCT00053352|19702835|P2|NOT COMPLETED|Overall Study||10
8002277|NCT00053352|19702836|P1|NOT COMPLETED|Overall Study||21
8002278|NCT00053352|19702835|P2|COMPLETED|Overall Study||102
8002279|NCT00053352|19702836|P1|COMPLETED|Overall Study||169
8002280|NCT00053352|19702835|P2|STARTED|Overall Study||112
8002281|NCT00053352|19702836|P1|STARTED|Overall Study||190
8002282|NCT00053014|19702845|P1|NOT COMPLETED|Overall Study||0
8002283|NCT00053014|19702845|P1|COMPLETED|Overall Study||5
8002284|NCT00053014|19702845|P1|STARTED|Overall Study||5
8002285|NCT00003830|19702852|P2|NOT COMPLETED|Overall Study||793
8002286|NCT00003830|19702853|P1|NOT COMPLETED|Overall Study||832
8002287|NCT00003830|19702852|P2|COMPLETED|Overall Study||2011
8002288|NCT00003830|19702853|P1|COMPLETED|Overall Study||1975
8002289|NCT00003830|19702852|P2|STARTED|Overall Study||2804
8002290|NCT00003830|19702853|P1|STARTED|Overall Study||2807
8002291|NCT00052962|19702879|P2|NOT COMPLETED|Overall Study||2
8002292|NCT00052962|19702880|P1|NOT COMPLETED|Overall Study||1
8002293|NCT00052962|19702879|P2|COMPLETED|Overall Study||15
8002294|NCT00052962|19702880|P1|COMPLETED|Overall Study||12
8002295|NCT00052962|19702879|P2|STARTED|Overall Study||17
8002296|NCT00052962|19702880|P1|STARTED|Overall Study||13
8002297|NCT00052910|19702890|P2|NOT COMPLETED|Overall Study||0
8002298|NCT00052910|19702891|P1|NOT COMPLETED|Overall Study||0
8002299|NCT00052910|19702890|P2|COMPLETED|Overall Study||266
8002300|NCT00052910|19702891|P1|COMPLETED|Overall Study||280
8002301|NCT00052910|19702890|P2|STARTED|Overall Study||266
8002302|NCT00052910|19702891|P1|STARTED|Overall Study||280
8002303|NCT00052715|19702899|P1|NOT COMPLETED|Overall Study||1
8002304|NCT00052715|19702899|P1|COMPLETED|Overall Study||30
8002305|NCT00052715|19702899|P1|STARTED|Overall Study||31
8002306|NCT00052429|19702908|P1|NOT COMPLETED|Overall Study||0
8002307|NCT00052429|19702908|P1|COMPLETED|Overall Study||25
8002308|NCT00052429|19702908|P1|STARTED|Overall Study||25
8002309|NCT00049673|19702915|P2|NOT COMPLETED|Overall Study||3
8002310|NCT00049673|19702916|P1|NOT COMPLETED|Overall Study||1
8002311|NCT00049673|19702915|P2|COMPLETED|Overall Study||163
8002312|NCT00049673|19702916|P1|COMPLETED|Overall Study||165
8002313|NCT00049673|19702915|P2|STARTED|Overall Study||166
8002314|NCT00049673|19702916|P1|STARTED|Overall Study||166
8002315|NCT00049543|19702926|P2|NOT COMPLETED|Overall Study||9
8002316|NCT00049543|19702927|P1|NOT COMPLETED|Overall Study||2
8002317|NCT00049543|19702926|P2|COMPLETED|Overall Study||243
8002318|NCT00049543|19702927|P1|COMPLETED|Overall Study||249
8002319|NCT00049543|19702926|P2|STARTED|Overall Study||252
8002320|NCT00049543|19702927|P1|STARTED|Overall Study||251
8002321|NCT00049530|19702937|P1|NOT COMPLETED|Overall Study||32
8002322|NCT00049530|19702937|P1|COMPLETED|Overall Study||0
8002323|NCT00049530|19702937|P1|Eligible and Treated|Overall Study||29
8002324|NCT00049530|19702937|P1|STARTED|Overall Study||32
8002325|NCT00049517|19702946|P6|NOT COMPLETED|Conditioning/Transplant||6
8002326|NCT00049517|19702947|P5|NOT COMPLETED|Conditioning/Transplant||6
8002327|NCT00049517|19702948|P4|NOT COMPLETED|Conditioning/Transplant||43
8002328|NCT00049517|19702949|P3|NOT COMPLETED|Conditioning/Transplant||38
8002329|NCT00049517|19702950|P2|NOT COMPLETED|Conditioning/Transplant||50
8002330|NCT00049517|19702951|P1|NOT COMPLETED|Conditioning/Transplant||52
8002331|NCT00049517|19702946|P6|COMPLETED|Conditioning/Transplant||18
8002332|NCT00049517|19702947|P5|COMPLETED|Conditioning/Transplant||15
8002333|NCT00049517|19702948|P4|COMPLETED|Conditioning/Transplant||32
8002334|NCT00049517|19702949|P3|COMPLETED|Conditioning/Transplant||25
8002335|NCT00049517|19702950|P2|COMPLETED|Conditioning/Transplant||40
8002336|NCT00049517|19702951|P1|COMPLETED|Conditioning/Transplant||27
8002337|NCT00049517|19702946|P6|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0
8002338|NCT00049517|19702947|P5|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0
8002339|NCT00049517|19702948|P4|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75
8002340|NCT00049517|19702949|P3|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63
8002341|NCT00049517|19702950|P2|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73
8002342|NCT00049517|19702951|P1|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59
8002343|NCT00049517|19702946|P6|STARTED|Conditioning/Transplant||24
8002344|NCT00049517|19702947|P5|STARTED|Conditioning/Transplant||21
8002345|NCT00049517|19702948|P4|STARTED|Conditioning/Transplant||75
8002346|NCT00049517|19702949|P3|STARTED|Conditioning/Transplant||63
8002347|NCT00049517|19702950|P2|STARTED|Conditioning/Transplant||90
8002348|NCT00049517|19702951|P1|STARTED|Conditioning/Transplant||79
8002349|NCT00049517|19702946|P6|NOT COMPLETED|Induction||54
8002350|NCT00049517|19702947|P5|NOT COMPLETED|Induction||60
8002351|NCT00049517|19702948|P4|NOT COMPLETED|Induction||0
8002352|NCT00049517|19702949|P3|NOT COMPLETED|Induction||0
8002353|NCT00049517|19702950|P2|NOT COMPLETED|Induction||0
8002354|NCT00049517|19702951|P1|NOT COMPLETED|Induction||0
8002355|NCT00049517|19702946|P6|COMPLETED|Induction||108
8002356|NCT00049517|19702947|P5|COMPLETED|Induction||128
8002357|NCT00049517|19702948|P4|COMPLETED|Induction||75
8002358|NCT00049517|19702949|P3|COMPLETED|Induction||63
8002359|NCT00049517|19702950|P2|COMPLETED|Induction||90
8002360|NCT00049517|19702951|P1|COMPLETED|Induction||79
8002361|NCT00049517|19702946|P6|Treated|Induction||160
8002362|NCT00049517|19702947|P5|Treated|Induction||186
8002363|NCT00049517|19702948|P4|Treated|Induction||75
8002364|NCT00049517|19702949|P3|Treated|Induction||63
8002365|NCT00049517|19702950|P2|Treated|Induction||90
8002366|NCT00049517|19702951|P1|Treated|Induction||79
8002367|NCT00049517|19702946|P6|STARTED|Induction||162
8002368|NCT00049517|19702947|P5|STARTED|Induction||188
8002369|NCT00049517|19702948|P4|STARTED|Induction||75
8002370|NCT00049517|19702949|P3|STARTED|Induction||63
8002371|NCT00049517|19702950|P2|STARTED|Induction||90
8002372|NCT00049517|19702951|P1|STARTED|Induction||79
8002373|NCT00049504|19702961|P1|NOT COMPLETED|Overall Study||0
8002374|NCT00049504|19702961|P1|COMPLETED|Overall Study||55
8002375|NCT00049504|19702961|P1|STARTED|Overall Study||55
8002376|NCT00049322|19702969|P2|NOT COMPLETED|Overall Study||6
8002377|NCT00049322|19702970|P1|NOT COMPLETED|Overall Study||1
8002378|NCT00049322|19702969|P2|COMPLETED|Overall Study||9
8002379|NCT00049322|19702970|P1|COMPLETED|Overall Study||14
8002380|NCT00049322|19702969|P2|STARTED|Overall Study||15
8002381|NCT00049322|19702970|P1|STARTED|Overall Study||15
8002382|NCT00049257|19702982|P1|NOT COMPLETED|Follow-up Period for Survival Status||4
8002383|NCT00049257|19702982|P1|COMPLETED|Follow-up Period for Survival Status||41
8002384|NCT00049257|19702982|P1|STARTED|Follow-up Period for Survival Status||45
8002385|NCT00049257|19702982|P1|NOT COMPLETED|Carboplatin, Paclitaxel||13
8002386|NCT00049257|19702982|P1|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45
8002387|NCT00049257|19702982|P1|STARTED|Carboplatin, Paclitaxel||58
8002388|NCT00049127|19702994|P5|NOT COMPLETED|Overall Study||0
8002389|NCT00049127|19702995|P4|NOT COMPLETED|Overall Study||0
8002390|NCT00049127|19702996|P3|NOT COMPLETED|Overall Study||1
8002391|NCT00049127|19702997|P2|NOT COMPLETED|Overall Study||0
8002392|NCT00049127|19702998|P1|NOT COMPLETED|Overall Study||0
8002393|NCT00049127|19702994|P5|COMPLETED|Overall Study||12
8002394|NCT00049127|19702995|P4|COMPLETED|Overall Study||0
8002395|NCT00049127|19702996|P3|COMPLETED|Overall Study||39
8002396|NCT00049127|19702997|P2|COMPLETED|Overall Study||0
8002397|NCT00049127|19702998|P1|COMPLETED|Overall Study||12
8002398|NCT00049127|19702994|P5|STARTED|Overall Study||12
8002399|NCT00049127|19702995|P4|STARTED|Overall Study||0
8002400|NCT00049127|19702996|P3|STARTED|Overall Study||40
8002401|NCT00049127|19702997|P2|STARTED|Overall Study||0
8002402|NCT00049127|19702998|P1|STARTED|Overall Study||12
8002403|NCT00049036|19703027|P2|NOT COMPLETED|Overall Study||0
8002404|NCT00049036|19703028|P1|NOT COMPLETED|Overall Study||0
8002405|NCT00049036|19703027|P2|COMPLETED|Overall Study||55
8002406|NCT00049036|19703028|P1|COMPLETED|Overall Study||51
8002407|NCT00049036|19703027|P2|STARTED|Overall Study||55
8002408|NCT00049036|19703028|P1|STARTED|Overall Study||51
8002409|NCT00048997|19703036|P2|NOT COMPLETED|Overall Study||3
8002410|NCT00048997|19703037|P1|NOT COMPLETED|Overall Study||13
8002411|NCT00048997|19703036|P2|COMPLETED|Overall Study||177
8002412|NCT00048997|19703037|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163
8002413|NCT00048997|19703036|P2|STARTED|Overall Study||180
8002414|NCT00048997|19703037|P1|STARTED|Overall Study||176
8002415|NCT00047385|19703060|P2|NOT COMPLETED|Overall Study||500
8002416|NCT00047385|19703061|P1|NOT COMPLETED|Overall Study||267
8002417|NCT00047385|19703060|P2|COMPLETED|Overall Study||26232
8002418|NCT00047385|19703061|P1|COMPLETED|Overall Study|Had at least one screening exam.|26455
8002419|NCT00047385|19703060|P2|STARTED|Overall Study||26732
8002420|NCT00047385|19703061|P1|STARTED|Overall Study||26722
8002421|NCT00047320|19703079|P1|NOT COMPLETED|Overall Study||28
8002422|NCT00047320|19703079|P1|COMPLETED|Overall Study||76
8002423|NCT00047320|19703079|P1|STARTED|Overall Study||104
8002424|NCT00047060|19703088|P1|NOT COMPLETED|Overall Study||2
8002425|NCT00047060|19703088|P1|COMPLETED|Overall Study||3
8002426|NCT00047060|19703088|P1|STARTED|Overall Study||5
8002427|NCT00047008|19703094|P2|NOT COMPLETED|Overall Study||11
8002428|NCT00047008|19703095|P1|NOT COMPLETED|Overall Study||11
8002429|NCT00047008|19703094|P2|COMPLETED|Overall Study||360
8002430|NCT00047008|19703095|P1|COMPLETED|Overall Study||361
8002431|NCT00047008|19703094|P2|STARTED|Overall Study||371
8002432|NCT00047008|19703095|P1|STARTED|Overall Study||372
8002433|NCT00046930|19703103|P2|NOT COMPLETED|Overall Study||4
8002434|NCT00046930|19703104|P1|NOT COMPLETED|Overall Study||12
8002435|NCT00046930|19703103|P2|COMPLETED|Overall Study||221
8002436|NCT00046930|19703104|P1|COMPLETED|Overall Study||212
8002437|NCT00046930|19703103|P2|STARTED|Overall Study||225
8002438|NCT00046930|19703104|P1|STARTED|Overall Study||224
8002439|NCT00046891|19703119|P2|NOT COMPLETED|Overall Study||30
8002440|NCT00046891|19703120|P1|NOT COMPLETED|Overall Study||29
8002441|NCT00046891|19703119|P2|COMPLETED|Overall Study||83
8002442|NCT00046891|19703120|P1|COMPLETED|Overall Study||84
8002443|NCT00046891|19703119|P2|STARTED|Overall Study||113
8002444|NCT00046891|19703120|P1|STARTED|Overall Study||113
8002445|NCT00046839|19703140|P2|NOT COMPLETED|Overall Study||2
8002446|NCT00046839|19703141|P1|NOT COMPLETED|Overall Study||1
8002447|NCT00046839|19703140|P2|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11
8002448|NCT00046839|19703141|P1|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7
8002449|NCT00046839|19703140|P2|STARTED|Overall Study||13
8002450|NCT00046839|19703141|P1|STARTED|Overall Study||8
8002451|NCT00045734|19703148|P1|NOT COMPLETED|Overall Study||1
8002452|NCT00045734|19703148|P1|COMPLETED|Overall Study||22
8002453|NCT00045734|19703148|P1|STARTED|Overall Study||23
8002454|NCT00045708|19703163|P3|NOT COMPLETED|Phase 2||0
8002455|NCT00045708|19703164|P2|NOT COMPLETED|Phase 2||0
8002456|NCT00045708|19703165|P1|NOT COMPLETED|Phase 2||0
8002457|NCT00045708|19703163|P3|COMPLETED|Phase 2||19
8002458|NCT00045708|19703164|P2|COMPLETED|Phase 2||0
8002459|NCT00045708|19703165|P1|COMPLETED|Phase 2||0
8002460|NCT00045708|19703163|P3|STARTED|Phase 2||19
8002461|NCT00045708|19703164|P2|STARTED|Phase 2||0
8002462|NCT00045708|19703165|P1|STARTED|Phase 2||0
8002463|NCT00045708|19703163|P3|NOT COMPLETED|Phase 1||0
8002464|NCT00045708|19703164|P2|NOT COMPLETED|Phase 1||1
8002465|NCT00045708|19703165|P1|NOT COMPLETED|Phase 1||0
8002466|NCT00045708|19703163|P3|COMPLETED|Phase 1||0
8002467|NCT00045708|19703164|P2|COMPLETED|Phase 1||16
8002468|NCT00045708|19703165|P1|COMPLETED|Phase 1||21
8002469|NCT00045708|19703163|P3|STARTED|Phase 1||0
8002470|NCT00045708|19703164|P2|STARTED|Phase 1||17
8002471|NCT00045708|19703165|P1|STARTED|Phase 1||21
8002472|NCT00045630|19703190|P1|NOT COMPLETED|Overall Study||6
8002473|NCT00045630|19703190|P1|COMPLETED|Overall Study||71
8002474|NCT00045630|19703190|P1|Eligible and Began Protocol Therapy|Overall Study||74
8002475|NCT00045630|19703190|P1|Eligible|Overall Study||75
8002476|NCT00045630|19703190|P1|STARTED|Overall Study||77
8002477|NCT00045487|19703196|P1|NOT COMPLETED|Overall Study||11
8002478|NCT00045487|19703196|P1|COMPLETED|Overall Study||30
8002479|NCT00045487|19703196|P1|STARTED|Overall Study||41
8002480|NCT00045435|19703200|P1|NOT COMPLETED|Overall Study||0
8002481|NCT00045435|19703200|P1|COMPLETED|Overall Study||17
8002482|NCT00045435|19703200|P1|STARTED|Overall Study||17
8002483|NCT00045305|19703209|P1|NOT COMPLETED|Overall Study||14
8002484|NCT00045305|19703209|P1|COMPLETED|Overall Study||3
8002485|NCT00045305|19703209|P1|Eligible and Treated|Overall Study||17
8002486|NCT00045305|19703209|P1|STARTED|Overall Study||17
8002487|NCT00045162|19703220|P2|NOT COMPLETED|Overall Study||118
8002488|NCT00045162|19703221|P1|NOT COMPLETED|Overall Study||142
8002489|NCT00045162|19703220|P2|COMPLETED|Overall Study||217
8002490|NCT00045162|19703221|P1|COMPLETED|Overall Study||194
8002491|NCT00045162|19703220|P2|STARTED|Overall Study||335
8002492|NCT00045162|19703221|P1|STARTED|Overall Study||336
8002493|NCT00045110|19703236|P3|NOT COMPLETED|775mg Dose Escalation||0
8002494|NCT00045110|19703237|P2|NOT COMPLETED|775mg Dose Escalation||0
8002495|NCT00045110|19703238|P1|NOT COMPLETED|775mg Dose Escalation||0
8002496|NCT00045110|19703236|P3|COMPLETED|775mg Dose Escalation||0
8002497|NCT00045110|19703237|P2|COMPLETED|775mg Dose Escalation||0
8002498|NCT00045110|19703238|P1|COMPLETED|775mg Dose Escalation||7
8002499|NCT00045110|19703236|P3|STARTED|775mg Dose Escalation||0
8002500|NCT00045110|19703237|P2|STARTED|775mg Dose Escalation||0
8002501|NCT00045110|19703238|P1|STARTED|775mg Dose Escalation||7
8002502|NCT00045110|19703236|P3|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
8002503|NCT00045110|19703237|P2|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
8002504|NCT00045110|19703238|P1|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
8002505|NCT00045110|19703236|P3|COMPLETED|650mg Phase 1 Dose Escalation||0
8002506|NCT00045110|19703237|P2|COMPLETED|650mg Phase 1 Dose Escalation||0
8002507|NCT00045110|19703238|P1|COMPLETED|650mg Phase 1 Dose Escalation||6
8002508|NCT00045110|19703236|P3|STARTED|650mg Phase 1 Dose Escalation||0
8002509|NCT00045110|19703237|P2|STARTED|650mg Phase 1 Dose Escalation||0
8002510|NCT00045110|19703238|P1|STARTED|650mg Phase 1 Dose Escalation||6
8002511|NCT00045110|19703236|P3|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
8002512|NCT00045110|19703237|P2|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
8002513|NCT00045110|19703238|P1|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
8002514|NCT00045110|19703236|P3|COMPLETED|525mg Phase 1 Dose Escalation||0
8002515|NCT00045110|19703237|P2|COMPLETED|525mg Phase 1 Dose Escalation||0
8002516|NCT00045110|19703238|P1|COMPLETED|525mg Phase 1 Dose Escalation||3
8002517|NCT00045110|19703236|P3|STARTED|525mg Phase 1 Dose Escalation||0
8002518|NCT00045110|19703237|P2|STARTED|525mg Phase 1 Dose Escalation||0
8002519|NCT00045110|19703238|P1|STARTED|525mg Phase 1 Dose Escalation||3
8002520|NCT00045110|19703236|P3|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
8002521|NCT00045110|19703237|P2|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
8002522|NCT00045110|19703238|P1|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
8002523|NCT00045110|19703236|P3|COMPLETED|400mg Phase 1 Dose Escalation||0
8002524|NCT00045110|19703237|P2|COMPLETED|400mg Phase 1 Dose Escalation||0
8002525|NCT00045110|19703238|P1|COMPLETED|400mg Phase 1 Dose Escalation||3
8002526|NCT00045110|19703236|P3|STARTED|400mg Phase 1 Dose Escalation||0
8002527|NCT00045110|19703237|P2|STARTED|400mg Phase 1 Dose Escalation||0
8002528|NCT00045110|19703238|P1|STARTED|400mg Phase 1 Dose Escalation||3
8002529|NCT00045110|19703236|P3|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
8002530|NCT00045110|19703237|P2|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
8002531|NCT00045110|19703238|P1|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
8002532|NCT00045110|19703236|P3|COMPLETED|275mg Phase 1 Dose Escalation||0
8002533|NCT00045110|19703237|P2|COMPLETED|275mg Phase 1 Dose Escalation||0
8002534|NCT00045110|19703238|P1|COMPLETED|275mg Phase 1 Dose Escalation||3
8002535|NCT00045110|19703236|P3|STARTED|275mg Phase 1 Dose Escalation||0
8002536|NCT00045110|19703237|P2|STARTED|275mg Phase 1 Dose Escalation||0
8002537|NCT00045110|19703238|P1|STARTED|275mg Phase 1 Dose Escalation||3
8002538|NCT00045110|19703236|P3|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
8002539|NCT00045110|19703237|P2|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
8002540|NCT00045110|19703238|P1|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
8002541|NCT00045110|19703236|P3|COMPLETED|200mg Phase 1 Dose Escalation||0
8002542|NCT00045110|19703237|P2|COMPLETED|200mg Phase 1 Dose Escalation||0
8002543|NCT00045110|19703238|P1|COMPLETED|200mg Phase 1 Dose Escalation||4
8002544|NCT00045110|19703236|P3|STARTED|200mg Phase 1 Dose Escalation||0
8002545|NCT00045110|19703237|P2|STARTED|200mg Phase 1 Dose Escalation||0
8002546|NCT00045110|19703238|P1|STARTED|200mg Phase 1 Dose Escalation||4
8002547|NCT00045110|19703236|P3|NOT COMPLETED|100mg Phase 1 Dose Escalalation||2
8002548|NCT00045110|19703237|P2|NOT COMPLETED|100mg Phase 1 Dose Escalalation||6
8002549|NCT00045110|19703238|P1|NOT COMPLETED|100mg Phase 1 Dose Escalalation||0
8002550|NCT00045110|19703236|P3|COMPLETED|100mg Phase 1 Dose Escalalation||43
8002551|NCT00045110|19703237|P2|COMPLETED|100mg Phase 1 Dose Escalalation||53
8002552|NCT00045110|19703238|P1|COMPLETED|100mg Phase 1 Dose Escalalation||6
8002553|NCT00045110|19703236|P3|STARTED|100mg Phase 1 Dose Escalalation||45
8002554|NCT00045110|19703237|P2|STARTED|100mg Phase 1 Dose Escalalation||59
8002555|NCT00045110|19703238|P1|STARTED|100mg Phase 1 Dose Escalalation||6
8002556|NCT00045032|19703287|P3|NOT COMPLETED|Overall Study||726
8002557|NCT00045032|19703288|P2|NOT COMPLETED|Overall Study||708
8002558|NCT00045032|19703289|P1|NOT COMPLETED|Overall Study||863
8002559|NCT00045032|19703287|P3|COMPLETED|Overall Study||974
8002560|NCT00045032|19703288|P2|COMPLETED|Overall Study||994
8002561|NCT00045032|19703289|P1|COMPLETED|Overall Study||834
8002562|NCT00045032|19703287|P3|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
8002563|NCT00045032|19703288|P2|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
8002564|NCT00045032|19703289|P1|Crossover to Adjuvant Herceptin|Overall Study||888
8002565|NCT00045032|19703287|P3|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1700
8002566|NCT00045032|19703288|P2|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1702
8002567|NCT00045032|19703289|P1|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1697
8002568|NCT00042991|19703423|P7|NOT COMPLETED|Overall Study||2
8002569|NCT00042991|19703424|P6|NOT COMPLETED|Overall Study||5
8002570|NCT00042991|19703425|P5|NOT COMPLETED|Overall Study||3
8002571|NCT00042991|19703426|P4|NOT COMPLETED|Overall Study||2
8002572|NCT00042991|19703427|P3|NOT COMPLETED|Overall Study||6
8002573|NCT00042991|19703428|P2|NOT COMPLETED|Overall Study||40
8002574|NCT00042991|19703429|P1|NOT COMPLETED|Overall Study||6
8002575|NCT00042991|19703423|P7|COMPLETED|Overall Study||1
8002576|NCT00042991|19703424|P6|COMPLETED|Overall Study||0
8002577|NCT00042991|19703425|P5|COMPLETED|Overall Study||0
8002578|NCT00042991|19703426|P4|COMPLETED|Overall Study||0
8002579|NCT00042991|19703427|P3|COMPLETED|Overall Study||1
8002580|NCT00042991|19703428|P2|COMPLETED|Overall Study||3
8002581|NCT00042991|19703429|P1|COMPLETED|Overall Study||0
8002582|NCT00042991|19703423|P7|Phase-II Trial|Overall Study||0
8002583|NCT00042991|19703424|P6|Phase-II Trial|Overall Study||0
8002584|NCT00042991|19703425|P5|Phase-II Trial|Overall Study||0
8002585|NCT00042991|19703426|P4|Phase-II Trial|Overall Study||0
8002586|NCT00042991|19703427|P3|Phase-II Trial|Overall Study||0
8002587|NCT00042991|19703428|P2|Phase-II Trial|Overall Study||36
8002588|NCT00042991|19703429|P1|Phase-II Trial|Overall Study||0
8002589|NCT00042991|19703423|P7|Phase-I Trial|Overall Study||3
8002590|NCT00042991|19703424|P6|Phase-I Trial|Overall Study||5
8002591|NCT00042991|19703425|P5|Phase-I Trial|Overall Study||3
8002592|NCT00042991|19703426|P4|Phase-I Trial|Overall Study||2
8002593|NCT00042991|19703427|P3|Phase-I Trial|Overall Study||7
8002594|NCT00042991|19703428|P2|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7
8002595|NCT00042991|19703429|P1|Phase-I Trial|Overall Study||6
8002596|NCT00042991|19703423|P7|STARTED|Overall Study||3
8002597|NCT00042991|19703424|P6|STARTED|Overall Study||5
8002598|NCT00042991|19703425|P5|STARTED|Overall Study||3
8002599|NCT00042991|19703426|P4|STARTED|Overall Study||2
8002600|NCT00042991|19703427|P3|STARTED|Overall Study||7
8002601|NCT00042991|19703428|P2|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43
8002602|NCT00042991|19703429|P1|STARTED|Overall Study||6
8002603|NCT00042939|19703472|P2|NOT COMPLETED|Overall Study||21
8002604|NCT00042939|19703473|P1|NOT COMPLETED|Overall Study||24
8002605|NCT00042939|19703472|P2|COMPLETED|Overall Study||25
8002606|NCT00042939|19703473|P1|COMPLETED|Overall Study||24
8002607|NCT00042939|19703472|P2|Patients With EGFR Results Available|Overall Study||31
8002608|NCT00042939|19703473|P1|Patients With EGFR Results Available|Overall Study||30
8002609|NCT00042939|19703472|P2|Eligible and Began Protocol Therapy|Overall Study||43
8002610|NCT00042939|19703473|P1|Eligible and Began Protocol Therapy|Overall Study||44
8002611|NCT00042939|19703472|P2|Treated|Overall Study||45
8002612|NCT00042939|19703473|P1|Treated|Overall Study||46
8002613|NCT00042939|19703472|P2|STARTED|Overall Study||46
8002614|NCT00042939|19703473|P1|STARTED|Overall Study||48
8002615|NCT00041132|19703487|P1|NOT COMPLETED|Overall Study||30
8002616|NCT00041132|19703487|P1|COMPLETED|Overall Study||26
8002617|NCT00041132|19703487|P1|Eligible and Began Protocol Therapy|Overall Study||49
8002618|NCT00041132|19703487|P1|Eligible|Overall Study||49
8002619|NCT00041132|19703487|P1|STARTED|Overall Study||56
8002620|NCT00041119|19703497|P4|NOT COMPLETED|Overall Study||0
8002621|NCT00041119|19703498|P3|NOT COMPLETED|Overall Study||0
8002622|NCT00041119|19703499|P2|NOT COMPLETED|Overall Study||0
8002623|NCT00041119|19703500|P1|NOT COMPLETED|Overall Study||0
8002624|NCT00041119|19703497|P4|COMPLETED|Overall Study||789
8002625|NCT00041119|19703498|P3|COMPLETED|Overall Study||1151
8002626|NCT00041119|19703499|P2|COMPLETED|Overall Study||789
8002627|NCT00041119|19703500|P1|COMPLETED|Overall Study||1142
8002628|NCT00041119|19703497|P4|STARTED|Overall Study||789
8002629|NCT00041119|19703498|P3|STARTED|Overall Study||1151
8002630|NCT00041119|19703499|P2|STARTED|Overall Study||789
8002631|NCT00041119|19703500|P1|STARTED|Overall Study||1142
8002632|NCT00041080|19703522|P2|NOT COMPLETED|Overall Study||10
8002633|NCT00041080|19703523|P1|NOT COMPLETED|Overall Study||30
8002634|NCT00041080|19703522|P2|COMPLETED|Overall Study||60
8002635|NCT00041080|19703523|P1|COMPLETED|Overall Study||39
8002636|NCT00041080|19703522|P2|STARTED|Overall Study|number patients enrolled on study|70
8002637|NCT00041080|19703523|P1|STARTED|Overall Study|number patients enrolled on study|69
8002638|NCT00041067|19703529|P1|NOT COMPLETED|Overall Study||76
8002639|NCT00041067|19703529|P1|COMPLETED|Overall Study||0
8002640|NCT00041067|19703529|P1|Eligible|Overall Study||74
8002641|NCT00041067|19703529|P1|STARTED|Overall Study||76
8002642|NCT00040937|19703536|P1|NOT COMPLETED|Maintenance||0
8002643|NCT00040937|19703536|P1|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76
8002644|NCT00040937|19703536|P1|STARTED|Maintenance||76
8002645|NCT00040937|19703536|P1|NOT COMPLETED|Autologous PBSCT||31
8002646|NCT00040937|19703536|P1|COMPLETED|Autologous PBSCT||77
8002647|NCT00040937|19703536|P1|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108
8002648|NCT00040937|19703536|P1|NOT COMPLETED|Induction/PBSC Mobilization||37
8002649|NCT00040937|19703536|P1|COMPLETED|Induction/PBSC Mobilization||110
8002650|NCT00040937|19703536|P1|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147
8002651|NCT00040846|19703549|P6|NOT COMPLETED|Overall Study||0
8002652|NCT00040846|19703550|P5|NOT COMPLETED|Overall Study||0
8002653|NCT00040846|19703551|P4|NOT COMPLETED|Overall Study||0
8002654|NCT00040846|19703552|P3|NOT COMPLETED|Overall Study||0
8002655|NCT00040846|19703553|P2|NOT COMPLETED|Overall Study||0
8002656|NCT00040846|19703554|P1|NOT COMPLETED|Overall Study||0
8002657|NCT00040846|19703549|P6|COMPLETED|Overall Study||0
8002658|NCT00040846|19703550|P5|COMPLETED|Overall Study||0
8002659|NCT00040846|19703551|P4|COMPLETED|Overall Study||0
8002660|NCT00040846|19703552|P3|COMPLETED|Overall Study||0
8002661|NCT00040846|19703553|P2|COMPLETED|Overall Study||0
8002662|NCT00040846|19703554|P1|COMPLETED|Overall Study||60
8002663|NCT00040846|19703549|P6|STARTED|Overall Study||0
8002664|NCT00040846|19703550|P5|STARTED|Overall Study||0
8002665|NCT00040846|19703551|P4|STARTED|Overall Study||0
8002666|NCT00040846|19703552|P3|STARTED|Overall Study||0
8002667|NCT00040846|19703553|P2|STARTED|Overall Study||0
8002668|NCT00040846|19703554|P1|STARTED|Overall Study||60
8002669|NCT00040742|19703596|P4|NOT COMPLETED|Overall Study||34
8002670|NCT00040742|19703597|P3|NOT COMPLETED|Overall Study||46
8002671|NCT00040742|19703598|P2|NOT COMPLETED|Overall Study||49
8002672|NCT00040742|19703599|P1|NOT COMPLETED|Overall Study||39
8002673|NCT00040742|19703596|P4|COMPLETED|Overall Study||152
8002674|NCT00040742|19703597|P3|COMPLETED|Overall Study||141
8002675|NCT00040742|19703598|P2|COMPLETED|Overall Study||134
8002676|NCT00040742|19703599|P1|COMPLETED|Overall Study||149
8002677|NCT00040742|19703596|P4|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186
8002678|NCT00040742|19703597|P3|STARTED|Overall Study||187
8002679|NCT00040742|19703598|P2|STARTED|Overall Study||183
8002680|NCT00040742|19703599|P1|STARTED|Overall Study||188
8002681|NCT00039377|19703613|P4|NOT COMPLETED|Course 5 (Transplant Assignments)||0
8002682|NCT00039377|19703614|P3|NOT COMPLETED|Course 5 (Transplant Assignments)||0
8002683|NCT00039377|19703615|P2|NOT COMPLETED|Course 5 (Transplant Assignments)||0
8002684|NCT00039377|19703616|P1|NOT COMPLETED|Course 5 (Transplant Assignments)||0
8002685|NCT00039377|19703613|P4|COMPLETED|Course 5 (Transplant Assignments)||1
8002686|NCT00039377|19703614|P3|COMPLETED|Course 5 (Transplant Assignments)||19
8002687|NCT00039377|19703615|P2|COMPLETED|Course 5 (Transplant Assignments)||15
8002688|NCT00039377|19703616|P1|COMPLETED|Course 5 (Transplant Assignments)||0
8002689|NCT00039377|19703613|P4|STARTED|Course 5 (Transplant Assignments)||1
8002690|NCT00039377|19703614|P3|STARTED|Course 5 (Transplant Assignments)||19
8002691|NCT00039377|19703615|P2|STARTED|Course 5 (Transplant Assignments)||15
8002692|NCT00039377|19703616|P1|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0
8002693|NCT00039377|19703613|P4|NOT COMPLETED|Initial Registration||0
8002694|NCT00039377|19703614|P3|NOT COMPLETED|Initial Registration||0
8002695|NCT00039377|19703615|P2|NOT COMPLETED|Initial Registration||0
8002696|NCT00039377|19703616|P1|NOT COMPLETED|Initial Registration||22
8002697|NCT00039377|19703613|P4|COMPLETED|Initial Registration||0
8002698|NCT00039377|19703614|P3|COMPLETED|Initial Registration||0
8002699|NCT00039377|19703615|P2|COMPLETED|Initial Registration||0
8002700|NCT00039377|19703616|P1|COMPLETED|Initial Registration||35
8002701|NCT00039377|19703613|P4|STARTED|Initial Registration||0
8002702|NCT00039377|19703614|P3|STARTED|Initial Registration||0
8002703|NCT00039377|19703615|P2|STARTED|Initial Registration||0
8002704|NCT00039377|19703616|P1|STARTED|Initial Registration||57
8002705|NCT00039195|19703628|P1|NOT COMPLETED|Overall Study||0
8002706|NCT00039195|19703628|P1|COMPLETED|Overall Study||98
8002707|NCT00039195|19703628|P1|STARTED|Overall Study||98
8002708|NCT00039130|19703632|P1|NOT COMPLETED|Overall Study||30
8002709|NCT00039130|19703632|P1|COMPLETED|Overall Study||75
8002710|NCT00039130|19703632|P1|STARTED|Overall Study||105
8002711|NCT00036738|19703638|P1|NOT COMPLETED|Overall Study||0
8002712|NCT00036738|19703638|P1|COMPLETED|Overall Study||28
8002713|NCT00036738|19703638|P1|STARTED|Overall Study||28
8002714|NCT00033657|19703648|P2|NOT COMPLETED|Adjuvant Chemotherapy||17
8002715|NCT00033657|19703649|P1|NOT COMPLETED|Adjuvant Chemotherapy||18
8002716|NCT00033657|19703648|P2|COMPLETED|Adjuvant Chemotherapy||16
8002717|NCT00033657|19703649|P1|COMPLETED|Adjuvant Chemotherapy||18
8002718|NCT00033657|19703648|P2|STARTED|Adjuvant Chemotherapy||33
8002719|NCT00033657|19703649|P1|STARTED|Adjuvant Chemotherapy||36
8002720|NCT00033657|19703648|P2|NOT COMPLETED|Surgical Resection||3
8002721|NCT00033657|19703649|P1|NOT COMPLETED|Surgical Resection||0
8002722|NCT00033657|19703648|P2|COMPLETED|Surgical Resection||33
8002723|NCT00033657|19703649|P1|COMPLETED|Surgical Resection||36
8002724|NCT00033657|19703648|P2|STARTED|Surgical Resection||36
8002725|NCT00033657|19703649|P1|STARTED|Surgical Resection||36
8002726|NCT00033657|19703648|P2|NOT COMPLETED|Neoadjuvant Chemotherapy||11
8002727|NCT00033657|19703649|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||14
8002728|NCT00033657|19703648|P2|COMPLETED|Neoadjuvant Chemotherapy||36
8002729|NCT00033657|19703649|P1|COMPLETED|Neoadjuvant Chemotherapy||36
8002730|NCT00033657|19703648|P2|Eligible and Treated|Neoadjuvant Chemotherapy||42
8002731|NCT00033657|19703649|P1|Eligible and Treated|Neoadjuvant Chemotherapy||39
8002732|NCT00033657|19703648|P2|Eligible|Neoadjuvant Chemotherapy||43
8002733|NCT00033657|19703649|P1|Eligible|Neoadjuvant Chemotherapy||42
8002734|NCT00033657|19703648|P2|STARTED|Neoadjuvant Chemotherapy||47
8002735|NCT00033657|19703649|P1|STARTED|Neoadjuvant Chemotherapy||50
8002736|NCT00033631|19703663|P2|NOT COMPLETED|Overall Study||15
8002737|NCT00033631|19703664|P1|NOT COMPLETED|Overall Study||18
8002738|NCT00033631|19703663|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748
8002739|NCT00033631|19703664|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751
8002740|NCT00033631|19703663|P2|STARTED|Overall Study||763
8002741|NCT00033631|19703664|P1|STARTED|Overall Study||769
8002742|NCT00033540|19703682|P1|NOT COMPLETED|Overall Study||57
8002743|NCT00033540|19703682|P1|COMPLETED|Overall Study||0
8002744|NCT00033540|19703682|P1|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52
8002745|NCT00033540|19703682|P1|Eligible|Overall Study||54
8002746|NCT00033540|19703682|P1|STARTED|Overall Study||57
8002747|NCT00033514|19703692|P2|NOT COMPLETED|Overall Study||4
8002748|NCT00033514|19703693|P1|NOT COMPLETED|Overall Study||1
8002749|NCT00033514|19703692|P2|COMPLETED|Overall Study||7
8002750|NCT00033514|19703693|P1|COMPLETED|Overall Study||15
8002751|NCT00033514|19703692|P2|STARTED|Overall Study||11
8002752|NCT00033514|19703693|P1|STARTED|Overall Study||16
8002753|NCT00033371|19703703|P2|NOT COMPLETED|Overall Study||10
8002754|NCT00033371|19703704|P1|NOT COMPLETED|Overall Study||6
8002755|NCT00033371|19703703|P2|COMPLETED|Overall Study||47
8002756|NCT00033371|19703704|P1|COMPLETED|Overall Study||49
8002757|NCT00033371|19703703|P2|STARTED|Overall Study||57
8002758|NCT00033371|19703704|P1|STARTED|Overall Study||55
8002759|NCT00033293|19703722|P2|NOT COMPLETED|Overall Study||18
8002760|NCT00033293|19703723|P1|NOT COMPLETED|Overall Study||10
8002761|NCT00033293|19703722|P2|COMPLETED|Overall Study||9
8002762|NCT00033293|19703723|P1|COMPLETED|Overall Study||16
8002763|NCT00033293|19703722|P2|STARTED|Overall Study||27
8002764|NCT00033293|19703723|P1|STARTED|Overall Study||26
8002765|NCT00031694|19703741|P1|NOT COMPLETED|Overall Study||19
8002766|NCT00031694|19703741|P1|COMPLETED|Overall Study||0
8002767|NCT00031694|19703741|P1|STARTED|Overall Study||19
8002768|NCT00031590|19703745|P1|NOT COMPLETED|Overall Study||3
8002769|NCT00031590|19703745|P1|COMPLETED|Overall Study||25
8002770|NCT00031590|19703745|P1|STARTED|Overall Study||28
8002771|NCT00030901|19703752|P3|NOT COMPLETED|Randomization||88
8002772|NCT00030901|19703753|P2|NOT COMPLETED|Randomization||101
8002773|NCT00030901|19703754|P1|NOT COMPLETED|Randomization||0
8002774|NCT00030901|19703752|P3|COMPLETED|Randomization||137
8002775|NCT00030901|19703753|P2|COMPLETED|Randomization||126
8002776|NCT00030901|19703754|P1|COMPLETED|Randomization||0
8002777|NCT00030901|19703752|P3|Eligible|Randomization||211
8002778|NCT00030901|19703753|P2|Eligible|Randomization||212
8002779|NCT00030901|19703754|P1|Eligible|Randomization||0
8002780|NCT00030901|19703752|P3|STARTED|Randomization||225
8002781|NCT00030901|19703753|P2|STARTED|Randomization||227
8002782|NCT00030901|19703754|P1|STARTED|Randomization||0
8002783|NCT00030901|19703752|P3|NOT COMPLETED|Initial Registration||0
8002784|NCT00030901|19703753|P2|NOT COMPLETED|Initial Registration||0
8002785|NCT00030901|19703754|P1|NOT COMPLETED|Initial Registration||167
8002786|NCT00030901|19703752|P3|COMPLETED|Initial Registration||0
8002787|NCT00030901|19703753|P2|COMPLETED|Initial Registration||0
8002788|NCT00030901|19703754|P1|COMPLETED|Initial Registration||452
8002789|NCT00030901|19703752|P3|STARTED|Initial Registration||0
8002790|NCT00030901|19703753|P2|STARTED|Initial Registration||0
8002791|NCT00030901|19703754|P1|STARTED|Initial Registration||619
8002792|NCT00030823|19703762|P1|NOT COMPLETED|Overall Study||1
8002793|NCT00030823|19703762|P1|COMPLETED|Overall Study||13
8002794|NCT00030823|19703762|P1|STARTED|Overall Study||14
8002795|NCT00030264|19703766|P1|NOT COMPLETED|Overall Study||0
8002796|NCT00030264|19703766|P1|COMPLETED|Overall Study||23
8002797|NCT00030264|19703766|P1|STARTED|Overall Study||23
8002798|NCT00028769|19703770|P1|NOT COMPLETED|Overall Study||41
8002799|NCT00028769|19703770|P1|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0
8002800|NCT00028769|19703770|P1|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35
8002801|NCT00028769|19703770|P1|Eligible|Overall Study||36
8002802|NCT00028769|19703770|P1|STARTED|Overall Study||41
8002803|NCT00028002|19703776|P1|NOT COMPLETED|Overall Study||11
8002804|NCT00028002|19703776|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
8002805|NCT00028002|19703776|P1|STARTED|Overall Study||63
8002806|NCT00027846|19703786|P3|NOT COMPLETED|Overall Study||37
8002807|NCT00027846|19703787|P2|NOT COMPLETED|Overall Study||68
8002808|NCT00027846|19703788|P1|NOT COMPLETED|Overall Study||2
8002809|NCT00027846|19703786|P3|COMPLETED|Overall Study||41
8002810|NCT00027846|19703787|P2|COMPLETED|Overall Study||219
8002811|NCT00027846|19703788|P1|COMPLETED|Overall Study||11
8002812|NCT00027846|19703786|P3|STARTED|Overall Study||78
8002813|NCT00027846|19703787|P2|STARTED|Overall Study||287
8002814|NCT00027846|19703788|P1|STARTED|Overall Study||13
8002815|NCT00027560|19703806|P1|NOT COMPLETED|Overall Study||1
8002816|NCT00027560|19703806|P1|COMPLETED|Overall Study||50
8002817|NCT00027560|19703806|P1|STARTED|Overall Study||51
8002818|NCT00026494|19703819|P4|NOT COMPLETED|Overall Study||0
8002819|NCT00026494|19703820|P3|NOT COMPLETED|Overall Study||6
8002820|NCT00026494|19703821|P2|NOT COMPLETED|Overall Study||0
8002821|NCT00026494|19703822|P1|NOT COMPLETED|Overall Study||2
8002822|NCT00026494|19703819|P4|COMPLETED|Overall Study||16
8002823|NCT00026494|19703820|P3|COMPLETED|Overall Study||16
8002824|NCT00026494|19703821|P2|COMPLETED|Overall Study||4
8002825|NCT00026494|19703822|P1|COMPLETED|Overall Study||5
8002826|NCT00026494|19703819|P4|STARTED|Overall Study||16
8002827|NCT00026494|19703820|P3|STARTED|Overall Study||22
8002828|NCT00026494|19703821|P2|STARTED|Overall Study||4
8002829|NCT00026494|19703822|P1|STARTED|Overall Study||7
8002830|NCT00026312|19703834|P2|NOT COMPLETED|Overall Study||269
8002831|NCT00026312|19703835|P1|NOT COMPLETED|Overall Study||34
8002832|NCT00026312|19703834|P2|COMPLETED|Overall Study||1064
8002833|NCT00026312|19703835|P1|COMPLETED|Overall Study||82
8002834|NCT00026312|19703834|P2|STARTED|Overall Study||1333
8002835|NCT00026312|19703835|P1|STARTED|Overall Study||116
8002836|NCT00026221|19703853|P3|NOT COMPLETED|Overall Study||0
8002837|NCT00026221|19703854|P2|NOT COMPLETED|Overall Study||0
8002838|NCT00026221|19703855|P1|NOT COMPLETED|Overall Study||0
8002839|NCT00026221|19703853|P3|COMPLETED|Overall Study||25
8002840|NCT00026221|19703854|P2|COMPLETED|Overall Study||16
8002841|NCT00026221|19703855|P1|COMPLETED|Overall Study||16
8002842|NCT00026221|19703853|P3|STARTED|Overall Study||25
8002843|NCT00026221|19703854|P2|STARTED|Overall Study||16
8002844|NCT00026221|19703855|P1|STARTED|Overall Study||16
8002845|NCT00026208|19703874|P2|NOT COMPLETED|Overall Study||0
8002846|NCT00026208|19703875|P1|NOT COMPLETED|Overall Study||1
8002847|NCT00026208|19703874|P2|COMPLETED|Overall Study||4
8002848|NCT00026208|19703875|P1|COMPLETED|Overall Study||71
8002849|NCT00026208|19703874|P2|STARTED|Overall Study||4
8002850|NCT00026208|19703875|P1|STARTED|Overall Study||72
8002851|NCT00025662|19703893|P1|NOT COMPLETED|Overall Study||3
8002852|NCT00025662|19703893|P1|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22
8002853|NCT00025662|19703893|P1|STARTED|Overall Study||25
8002854|NCT00025506|19703901|P1|NOT COMPLETED|Overall Study||10
8002855|NCT00025506|19703901|P1|COMPLETED|Overall Study|Eligible and treated patients.|45
8002856|NCT00025506|19703901|P1|STARTED|Overall Study||55
8002857|NCT00025259|19703922|P7|NOT COMPLETED|Overall Study||51
8002858|NCT00025259|19703923|P6|NOT COMPLETED|Overall Study||52
8002859|NCT00025259|19703924|P5|NOT COMPLETED|Overall Study||36
8002860|NCT00025259|19703925|P4|NOT COMPLETED|Overall Study||114
8002861|NCT00025259|19703926|P3|NOT COMPLETED|Overall Study||81
8002862|NCT00025259|19703927|P2|NOT COMPLETED|Overall Study||89
8002863|NCT00025259|19703928|P1|NOT COMPLETED|Overall Study||45
8002864|NCT00025259|19703922|P7|COMPLETED|Overall Study||102
8002865|NCT00025259|19703923|P6|COMPLETED|Overall Study||101
8002866|NCT00025259|19703924|P5|COMPLETED|Overall Study||6
8002867|NCT00025259|19703925|P4|COMPLETED|Overall Study||457
8002868|NCT00025259|19703926|P3|COMPLETED|Overall Study||301
8002869|NCT00025259|19703927|P2|COMPLETED|Overall Study||292
8002870|NCT00025259|19703928|P1|COMPLETED|Overall Study||7
8002871|NCT00025259|19703922|P7|STARTED|Overall Study||153
8002872|NCT00025259|19703923|P6|STARTED|Overall Study||153
8002873|NCT00025259|19703924|P5|STARTED|Overall Study||42
8002874|NCT00025259|19703925|P4|STARTED|Overall Study||571
8002875|NCT00025259|19703926|P3|STARTED|Overall Study||382
8002876|NCT00025259|19703927|P2|STARTED|Overall Study||381
8002877|NCT00025259|19703928|P1|STARTED|Overall Study||52
8002878|NCT00025233|19703964|P1|NOT COMPLETED|Overall Study||4
8002879|NCT00025233|19703964|P1|COMPLETED|Overall Study||46
8002880|NCT00025233|19703964|P1|STARTED|Overall Study||50
8002881|NCT00025155|19703979|P1|NOT COMPLETED|Overall Study||2
8002882|NCT00025155|19703979|P1|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49
8002883|NCT00025155|19703979|P1|STARTED|Overall Study||51
8002884|NCT00024258|19703990|P1|NOT COMPLETED|Overall Study||9
8002885|NCT00024258|19703990|P1|COMPLETED|Overall Study||13
8002886|NCT00024258|19703990|P1|STARTED|Overall Study||22
8002887|NCT00024167|19703997|P2|NOT COMPLETED|Overall Study||47
8002888|NCT00024167|19703998|P1|NOT COMPLETED|Overall Study||53
8002889|NCT00024167|19703997|P2|COMPLETED|Overall Study||15
8002890|NCT00024167|19703998|P1|COMPLETED|Overall Study||12
8002891|NCT00024167|19703997|P2|Induction Treatment Option 2 Completed|Overall Study||41
8002892|NCT00024167|19703998|P1|Induction Treatment Option 2 Completed|Overall Study||43
8002893|NCT00024167|19703997|P2|Induction Treatment Option 1 Completed|Overall Study||21
8002894|NCT00024167|19703998|P1|Induction Treatment Option 1 Completed|Overall Study||22
8002895|NCT00024167|19703997|P2|STARTED|Overall Study||62
8002896|NCT00024167|19703998|P1|STARTED|Overall Study||65
8002897|NCT00024102|19704009|P2|NOT COMPLETED|Overall Study||0
8002898|NCT00024102|19704010|P1|NOT COMPLETED|Overall Study||0
8002899|NCT00024102|19704009|P2|COMPLETED|Overall Study||307
8002900|NCT00024102|19704010|P1|COMPLETED|Overall Study||326
8002901|NCT00024102|19704009|P2|STARTED|Overall Study||307
8002902|NCT00024102|19704010|P1|STARTED|Overall Study||326
8002903|NCT00023764|19704022|P1|NOT COMPLETED|Overall Study||14
8002904|NCT00023764|19704022|P1|COMPLETED|Overall Study||89
8002905|NCT00023764|19704022|P1|STARTED|Overall Study||103
8002906|NCT00023712|19704029|P2|NOT COMPLETED|Overall Study||1
8002907|NCT00023712|19704030|P1|NOT COMPLETED|Overall Study||2
8002908|NCT00023712|19704029|P2|COMPLETED|Overall Study|total number of participants eligible and evaluable|29
8002909|NCT00023712|19704030|P1|COMPLETED|Overall Study|total number of participants eligible and evaluable|26
8002910|NCT00023712|19704029|P2|STARTED|Overall Study|total number of participants enrolled on study|30
8002911|NCT00023712|19704030|P1|STARTED|Overall Study|total number of participants enrolled on study|28
8002912|NCT00022698|19704054|P2|NOT COMPLETED|Overall Study||35
8002913|NCT00022698|19704055|P1|NOT COMPLETED|Overall Study||8
8002914|NCT00022698|19704054|P2|COMPLETED|Overall Study||17
8002915|NCT00022698|19704055|P1|COMPLETED|Overall Study||7
8002916|NCT00022698|19704054|P2|STARTED|Overall Study||52
8002917|NCT00022698|19704055|P1|STARTED|Overall Study||15
8002918|NCT00022672|19704080|P2|NOT COMPLETED|Extension Phase||51
8002919|NCT00022672|19704081|P1|NOT COMPLETED|Extension Phase||3
8002920|NCT00022672|19704080|P2|COMPLETED|Extension Phase||7
8002921|NCT00022672|19704081|P1|COMPLETED|Extension Phase||11
8002922|NCT00022672|19704080|P2|Safety Set: Received Study Drug|Extension Phase||58
8002923|NCT00022672|19704081|P1|Safety Set: Received Study Drug|Extension Phase||14
8002924|NCT00022672|19704080|P2|STARTED|Extension Phase||58
8002925|NCT00022672|19704081|P1|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14
8002926|NCT00022672|19704080|P2|NOT COMPLETED|Main Phase: 24 Months||100
8002927|NCT00022672|19704081|P1|NOT COMPLETED|Main Phase: 24 Months||87
8002928|NCT00022672|19704080|P2|COMPLETED|Main Phase: 24 Months||4
8002929|NCT00022672|19704081|P1|COMPLETED|Main Phase: 24 Months||16
8002930|NCT00022672|19704080|P2|Safety Set: Received Study Drug|Main Phase: 24 Months||104
8002931|NCT00022672|19704081|P1|Safety Set: Received Study Drug|Main Phase: 24 Months||103
8002932|NCT00022672|19704080|P2|STARTED|Main Phase: 24 Months||104
8002933|NCT00022672|19704081|P1|STARTED|Main Phase: 24 Months||103
8002934|NCT00022659|19704114|P1|NOT COMPLETED|Overall Study||2
8002935|NCT00022659|19704114|P1|COMPLETED|Overall Study|Eligible and treated patients.|62
8002936|NCT00022659|19704114|P1|STARTED|Overall Study||64
8002937|NCT00022633|19704127|P2|NOT COMPLETED|Overall Study||5
8002938|NCT00022633|19704128|P1|NOT COMPLETED|Overall Study||32
8002939|NCT00022633|19704127|P2|COMPLETED|Overall Study||5
8002940|NCT00022633|19704128|P1|COMPLETED|Overall Study||23
8002941|NCT00022633|19704127|P2|Eligible|Overall Study||10
8002942|NCT00022633|19704128|P1|Eligible|Overall Study||51
8002943|NCT00022633|19704127|P2|STARTED|Overall Study||10
8002944|NCT00022633|19704128|P1|STARTED|Overall Study||55
8002945|NCT00022516|19704141|P2|NOT COMPLETED|Overall Study||230
8002946|NCT00022516|19704142|P1|NOT COMPLETED|Overall Study||3
8002947|NCT00022516|19704141|P2|COMPLETED|Overall Study||314
8002948|NCT00022516|19704142|P1|COMPLETED|Overall Study||539
8002949|NCT00022516|19704141|P2|STARTED|Overall Study||544
8002950|NCT00022516|19704142|P1|STARTED|Overall Study||542
8002951|NCT00022490|19704154|P1|NOT COMPLETED|Overall Study||0
8002952|NCT00022490|19704154|P1|COMPLETED|Overall Study||24
8002953|NCT00022490|19704154|P1|STARTED|Overall Study||24
8002954|NCT00021255|19704161|P3|NOT COMPLETED|Overall Study||149
8002955|NCT00021255|19704162|P2|NOT COMPLETED|Overall Study||270
8002956|NCT00021255|19704163|P1|NOT COMPLETED|Overall Study||121
8002957|NCT00021255|19704161|P3|COMPLETED|Overall Study||926
8002958|NCT00021255|19704162|P2|COMPLETED|Overall Study||804
8002959|NCT00021255|19704163|P1|COMPLETED|Overall Study||952
8002960|NCT00021255|19704161|P3|Safety Population|Overall Study|1056 participants received TCH.|1056
8002961|NCT00021255|19704162|P2|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100
8002962|NCT00021255|19704163|P1|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018
8002963|NCT00021255|19704161|P3|Treated|Overall Study||1057
8002964|NCT00021255|19704162|P2|Treated|Overall Study||1072
8002965|NCT00021255|19704163|P1|Treated|Overall Study||1045
8002966|NCT00021255|19704161|P3|STARTED|Overall Study|Randomized|1075
8002967|NCT00021255|19704162|P2|STARTED|Overall Study|Randomized|1074
8002968|NCT00021255|19704163|P1|STARTED|Overall Study|Randomized|1073
8002969|NCT00021229|19704180|P3|NOT COMPLETED|Overall Study||16
8002970|NCT00021229|19704181|P2|NOT COMPLETED|Overall Study||33
8002971|NCT00021229|19704182|P1|NOT COMPLETED|Overall Study||35
8002972|NCT00021229|19704180|P3|COMPLETED|Overall Study||0
8002973|NCT00021229|19704181|P2|COMPLETED|Overall Study||0
8002974|NCT00021229|19704182|P1|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1
8002975|NCT00021229|19704180|P3|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0
8002976|NCT00021229|19704181|P2|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0
8002977|NCT00021229|19704182|P1|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14
8002978|NCT00021229|19704180|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12
8002979|NCT00021229|19704181|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20
8002980|NCT00021229|19704182|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23
8002981|NCT00021229|19704180|P3|Enrolled in Phase I|Overall Study||16
8002982|NCT00021229|19704181|P2|Enrolled in Phase I|Overall Study||33
8002983|NCT00021229|19704182|P1|Enrolled in Phase I|Overall Study||35
8002984|NCT00021229|19704180|P3|STARTED|Overall Study||16
8002985|NCT00021229|19704181|P2|STARTED|Overall Study||33
8002986|NCT00021229|19704182|P1|STARTED|Overall Study||36
8002987|NCT00020722|19704208|P1|NOT COMPLETED|Overall Study||0
8002988|NCT00020722|19704208|P1|COMPLETED|Overall Study||7
8002989|NCT00020722|19704208|P1|STARTED|Overall Study||7
8002990|NCT00019747|19704215|P2|NOT COMPLETED|Overall Study||0
8002991|NCT00019747|19704216|P1|NOT COMPLETED|Overall Study||0
8002992|NCT00019747|19704215|P2|COMPLETED|Overall Study||16
8002993|NCT00019747|19704216|P1|COMPLETED|Overall Study||23
8002994|NCT00019747|19704215|P2|STARTED|Overall Study||16
8002995|NCT00019747|19704216|P1|STARTED|Overall Study||23
8002996|NCT00019682|19704224|P2|NOT COMPLETED|Overall Study||6
8002997|NCT00019682|19704225|P1|NOT COMPLETED|Overall Study||1
8002998|NCT00019682|19704224|P2|COMPLETED|Overall Study||85
8002999|NCT00019682|19704225|P1|COMPLETED|Overall Study||93
8003000|NCT00019682|19704224|P2|STARTED|Overall Study||91
8003001|NCT00019682|19704225|P1|STARTED|Overall Study||94
8003002|NCT00019604|19704237|P1|NOT COMPLETED|Overall Study||39
8003003|NCT00019604|19704237|P1|COMPLETED|Overall Study||5
8003004|NCT00019604|19704237|P1|STARTED|Overall Study||44
8003005|NCT00017563|19704250|P1|NOT COMPLETED|Overall Study||1
8003006|NCT00017563|19704250|P1|COMPLETED|Overall Study||56
8003007|NCT00017563|19704250|P1|STARTED|Overall Study||57
8003008|NCT00016913|19704254|P1|NOT COMPLETED|Overall Study||0
8003009|NCT00016913|19704254|P1|COMPLETED|Overall Study||27
8003010|NCT00016913|19704254|P1|STARTED|Overall Study||27
8003011|NCT00016354|19704260|P8|NOT COMPLETED|Overall Study||1
8003012|NCT00016354|19704261|P7|NOT COMPLETED|Overall Study||0
8003013|NCT00016354|19704262|P6|NOT COMPLETED|Overall Study||0
8003014|NCT00016354|19704263|P5|NOT COMPLETED|Overall Study||0
8003015|NCT00016354|19704264|P4|NOT COMPLETED|Overall Study||0
8003016|NCT00016354|19704265|P3|NOT COMPLETED|Overall Study||0
8003017|NCT00016354|19704266|P2|NOT COMPLETED|Overall Study||0
8003018|NCT00016354|19704267|P1|NOT COMPLETED|Overall Study||0
8003019|NCT00016354|19704260|P8|COMPLETED|Overall Study||6
8003020|NCT00016354|19704261|P7|COMPLETED|Overall Study||6
8003021|NCT00016354|19704262|P6|COMPLETED|Overall Study||1
8003022|NCT00016354|19704263|P5|COMPLETED|Overall Study||1
8003023|NCT00016354|19704264|P4|COMPLETED|Overall Study||1
8003024|NCT00016354|19704265|P3|COMPLETED|Overall Study||1
8003025|NCT00016354|19704266|P2|COMPLETED|Overall Study||1
8003026|NCT00016354|19704267|P1|COMPLETED|Overall Study||1
8003027|NCT00016354|19704260|P8|STARTED|Overall Study||7
8003028|NCT00016354|19704261|P7|STARTED|Overall Study||6
8003029|NCT00016354|19704262|P6|STARTED|Overall Study||1
8003030|NCT00016354|19704263|P5|STARTED|Overall Study||1
8003031|NCT00016354|19704264|P4|STARTED|Overall Study||1
8003032|NCT00016354|19704265|P3|STARTED|Overall Study||1
8003033|NCT00016354|19704266|P2|STARTED|Overall Study||1
8003034|NCT00016354|19704267|P1|STARTED|Overall Study||1
8003035|NCT00015847|19704271|P1|NOT COMPLETED|Overall Study||0
8003036|NCT00015847|19704271|P1|COMPLETED|Overall Study||25
8003037|NCT00015847|19704271|P1|STARTED|Overall Study||25
8003038|NCT00014495|19704281|P4|NOT COMPLETED|Overall Study||1
8003039|NCT00014495|19704282|P3|NOT COMPLETED|Overall Study||1
8003040|NCT00014495|19704283|P2|NOT COMPLETED|Overall Study||0
8003041|NCT00014495|19704284|P1|NOT COMPLETED|Overall Study||0
8003042|NCT00014495|19704281|P4|COMPLETED|Overall Study||5
8003043|NCT00014495|19704282|P3|COMPLETED|Overall Study||19
8003044|NCT00014495|19704283|P2|COMPLETED|Overall Study||3
8003045|NCT00014495|19704284|P1|COMPLETED|Overall Study||3
8003046|NCT00014495|19704281|P4|STARTED|Overall Study||6
8003047|NCT00014495|19704282|P3|STARTED|Overall Study||20
8003048|NCT00014495|19704283|P2|STARTED|Overall Study||3
8003049|NCT00014495|19704284|P1|STARTED|Overall Study||3
8003050|NCT00014222|19704294|P3|NOT COMPLETED|Overall Study||27
8003051|NCT00014222|19704295|P2|NOT COMPLETED|Overall Study||13
8003052|NCT00014222|19704296|P1|NOT COMPLETED|Overall Study||21
8003053|NCT00014222|19704294|P3|COMPLETED|Overall Study||675
8003054|NCT00014222|19704295|P2|COMPLETED|Overall Study||688
8003055|NCT00014222|19704296|P1|COMPLETED|Overall Study||680
8003056|NCT00014222|19704294|P3|STARTED|Overall Study||702
8003057|NCT00014222|19704295|P2|STARTED|Overall Study||701
8003058|NCT00014222|19704296|P1|STARTED|Overall Study||701
8003059|NCT00012298|19704314|P7|NOT COMPLETED|Overall Study||0
8003060|NCT00012298|19704315|P6|NOT COMPLETED|Overall Study||0
8003061|NCT00012298|19704316|P5|NOT COMPLETED|Overall Study||0
8003062|NCT00012298|19704317|P4|NOT COMPLETED|Overall Study||0
8003063|NCT00012298|19704318|P3|NOT COMPLETED|Overall Study||0
8003064|NCT00012298|19704319|P2|NOT COMPLETED|Overall Study||0
8003065|NCT00012298|19704320|P1|NOT COMPLETED|Overall Study||0
8003066|NCT00012298|19704314|P7|COMPLETED|Overall Study||39
8003067|NCT00012298|19704315|P6|COMPLETED|Overall Study||6
8003068|NCT00012298|19704316|P5|COMPLETED|Overall Study||5
8003069|NCT00012298|19704317|P4|COMPLETED|Overall Study||4
8003070|NCT00012298|19704318|P3|COMPLETED|Overall Study||9
8003071|NCT00012298|19704319|P2|COMPLETED|Overall Study||7
8003072|NCT00012298|19704320|P1|COMPLETED|Overall Study||11
8003073|NCT00012298|19704314|P7|STARTED|Overall Study||39
8003074|NCT00012298|19704315|P6|STARTED|Overall Study||6
8003075|NCT00012298|19704316|P5|STARTED|Overall Study||5
8003076|NCT00012298|19704317|P4|STARTED|Overall Study||4
8003077|NCT00012298|19704318|P3|STARTED|Overall Study||9
8003078|NCT00012298|19704319|P2|STARTED|Overall Study||7
8003079|NCT00012298|19704320|P1|STARTED|Overall Study||11
8003080|NCT00012012|19704350|P2|NOT COMPLETED|Overall Study||3
8003081|NCT00012012|19704351|P1|NOT COMPLETED|Overall Study||1
8003082|NCT00012012|19704350|P2|COMPLETED|Overall Study||15
8003083|NCT00012012|19704351|P1|COMPLETED|Overall Study||26
8003084|NCT00012012|19704350|P2|STARTED|Overall Study||18
8003085|NCT00012012|19704351|P1|STARTED|Overall Study||27
8003086|NCT00011986|19704362|P5|NOT COMPLETED|Overall Study||0
8003087|NCT00011986|19704363|P4|NOT COMPLETED|Overall Study||0
8003088|NCT00011986|19704364|P3|NOT COMPLETED|Overall Study||0
8003089|NCT00011986|19704365|P2|NOT COMPLETED|Overall Study||0
8003090|NCT00011986|19704366|P1|NOT COMPLETED|Overall Study||0
8003091|NCT00011986|19704362|P5|COMPLETED|Overall Study||861
8003092|NCT00011986|19704363|P4|COMPLETED|Overall Study||861
8003093|NCT00011986|19704364|P3|COMPLETED|Overall Study||862
8003094|NCT00011986|19704365|P2|COMPLETED|Overall Study||864
8003095|NCT00011986|19704366|P1|COMPLETED|Overall Study||864
8003096|NCT00011986|19704362|P5|Initiated Treatment|Overall Study||851
8003097|NCT00011986|19704363|P4|Initiated Treatment|Overall Study||846
8003098|NCT00011986|19704364|P3|Initiated Treatment|Overall Study||854
8003099|NCT00011986|19704365|P2|Initiated Treatment|Overall Study||860
8003100|NCT00011986|19704366|P1|Initiated Treatment|Overall Study||862
8003101|NCT00011986|19704362|P5|STARTED|Overall Study||861
8003102|NCT00011986|19704363|P4|STARTED|Overall Study||861
8003103|NCT00011986|19704364|P3|STARTED|Overall Study||862
8003104|NCT00011986|19704365|P2|STARTED|Overall Study||864
8003105|NCT00011986|19704366|P1|STARTED|Overall Study||864
8003106|NCT00010257|19704390|P2|NOT COMPLETED|Overall Study||0
8003107|NCT00010257|19704391|P1|NOT COMPLETED|Overall Study||1
8003108|NCT00010257|19704390|P2|COMPLETED|Overall Study||21
8003109|NCT00010257|19704391|P1|COMPLETED|Overall Study||24
8003110|NCT00010257|19704390|P2|STARTED|Overall Study||21
8003111|NCT00010257|19704391|P1|STARTED|Overall Study||25
8003112|NCT00009945|19704401|P2|NOT COMPLETED|Overall Study||5
8003113|NCT00009945|19704402|P1|NOT COMPLETED|Overall Study||7
8003114|NCT00009945|19704401|P2|COMPLETED|Overall Study||1656
8003115|NCT00009945|19704402|P1|COMPLETED|Overall Study||1655
8003116|NCT00009945|19704401|P2|STARTED|Overall Study||1661
8003117|NCT00009945|19704402|P1|STARTED|Overall Study||1662
8003118|NCT00008385|19704418|P2|NOT COMPLETED|Overall Study||802
8003119|NCT00008385|19704419|P1|NOT COMPLETED|Overall Study||387
8003120|NCT00008385|19704418|P2|COMPLETED|Overall Study||238
8003121|NCT00008385|19704419|P1|COMPLETED|Overall Study||134
8003122|NCT00008385|19704418|P2|Off Treatment Reasons Reported|Overall Study||795
8003123|NCT00008385|19704419|P1|Off Treatment Reasons Reported|Overall Study||398
8003124|NCT00008385|19704418|P2|Treated|Overall Study||865
8003125|NCT00008385|19704419|P1|Treated|Overall Study||477
8003126|NCT00008385|19704418|P2|STARTED|Overall Study||1040
8003127|NCT00008385|19704419|P1|STARTED|Overall Study||521
8003128|NCT00008138|19704429|P1|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8
8003129|NCT00008138|19704429|P1|COMPLETED|Post-Cytoreduction Chemotherapy||18
8003130|NCT00008138|19704429|P1|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26
8003131|NCT00008138|19704429|P1|NOT COMPLETED|Interval Debulking||2
8003132|NCT00008138|19704429|P1|COMPLETED|Interval Debulking||36
8003133|NCT00008138|19704429|P1|Received Protocol Surgery|Interval Debulking||36
8003134|NCT00008138|19704429|P1|STARTED|Interval Debulking||38
8003135|NCT00008138|19704429|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||20
8003136|NCT00008138|19704429|P1|COMPLETED|Neoadjuvant Chemotherapy||38
8003137|NCT00008138|19704429|P1|Eligible|Neoadjuvant Chemotherapy||58
8003138|NCT00008138|19704429|P1|STARTED|Neoadjuvant Chemotherapy||58
8003139|NCT00006916|19704435|P1|NOT COMPLETED|Overall Study||5
8003140|NCT00006916|19704435|P1|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14
8003141|NCT00006916|19704435|P1|STARTED|Overall Study||19
8003142|NCT00006903|19704441|P3|NOT COMPLETED|Overall Study||6
8003143|NCT00006903|19704442|P2|NOT COMPLETED|Overall Study||4
8003144|NCT00006903|19704443|P1|NOT COMPLETED|Overall Study||10
8003145|NCT00006903|19704441|P3|COMPLETED|Overall Study||27
8003146|NCT00006903|19704442|P2|COMPLETED|Overall Study||20
8003147|NCT00006903|19704443|P1|COMPLETED|Overall Study||0
8003148|NCT00006903|19704441|P3|STARTED|Overall Study||33
8003149|NCT00006903|19704442|P2|STARTED|Overall Study||24
8003150|NCT00006903|19704443|P1|STARTED|Overall Study||10
8003151|NCT00006721|19704456|P3|NOT COMPLETED|Overall Study||33
8003152|NCT00006721|19704457|P2|NOT COMPLETED|Overall Study||25
8003153|NCT00006721|19704458|P1|NOT COMPLETED|Overall Study||4
8003154|NCT00006721|19704456|P3|COMPLETED|Overall Study||242
8003155|NCT00006721|19704457|P2|COMPLETED|Overall Study||254
8003156|NCT00006721|19704458|P1|COMPLETED|Overall Study||13
8003157|NCT00006721|19704456|P3|Eligible and Began Protocol Therapy|Overall Study||265
8003158|NCT00006721|19704457|P2|Eligible and Began Protocol Therapy|Overall Study||267
8003159|NCT00006721|19704458|P1|Eligible and Began Protocol Therapy|Overall Study||14
8003160|NCT00006721|19704456|P3|Eligible|Overall Study||265
8003161|NCT00006721|19704457|P2|Eligible|Overall Study||267
8003162|NCT00006721|19704458|P1|Eligible|Overall Study||15
8003163|NCT00006721|19704456|P3|STARTED|Overall Study||275
8003164|NCT00006721|19704457|P2|STARTED|Overall Study||279
8003165|NCT00006721|19704458|P1|STARTED|Overall Study||17
8003166|NCT00006478|19704476|P1|NOT COMPLETED|Overall Study||7
8003167|NCT00006478|19704476|P1|COMPLETED|Overall Study||12
8003168|NCT00006478|19704476|P1|STARTED|Overall Study||19
8003169|NCT00006392|19704487|P4|NOT COMPLETED|Overall Study||160
8003170|NCT00006392|19704488|P3|NOT COMPLETED|Overall Study||160
8003171|NCT00006392|19704489|P2|NOT COMPLETED|Overall Study||158
8003172|NCT00006392|19704490|P1|NOT COMPLETED|Overall Study||167
8003173|NCT00006392|19704487|P4|COMPLETED|Overall Study||8696
8003174|NCT00006392|19704488|P3|COMPLETED|Overall Study||8703
8003175|NCT00006392|19704489|P2|COMPLETED|Overall Study||8752
8003176|NCT00006392|19704490|P1|COMPLETED|Overall Study||8737
8003177|NCT00006392|19704487|P4|STARTED|Overall Study||8856
8003178|NCT00006392|19704488|P3|STARTED|Overall Study||8863
8003179|NCT00006392|19704489|P2|STARTED|Overall Study||8910
8003180|NCT00006392|19704490|P1|STARTED|Overall Study||8904
8003181|NCT00006389|19704520|P1|NOT COMPLETED|Overall Study||1
8003182|NCT00006389|19704520|P1|COMPLETED|Overall Study||11
8003183|NCT00006389|19704520|P1|STARTED|Overall Study||12
8003184|NCT00006244|19704526|P1|NOT COMPLETED|Overall Study||0
8003185|NCT00006244|19704526|P1|COMPLETED|Overall Study||36
8003186|NCT00006244|19704526|P1|STARTED|Overall Study||36
8003187|NCT00006237|19704537|P2|NOT COMPLETED|Overall Study||61
8003188|NCT00006237|19704538|P1|NOT COMPLETED|Overall Study||125
8003189|NCT00006237|19704537|P2|COMPLETED|Overall Study||159
8003190|NCT00006237|19704538|P1|COMPLETED|Overall Study||87
8003191|NCT00006237|19704537|P2|Eligible and Treated|Overall Study||199
8003192|NCT00006237|19704538|P1|Eligible and Treated|Overall Study||203
8003193|NCT00006237|19704537|P2|Eligible|Overall Study||200
8003194|NCT00006237|19704538|P1|Eligible|Overall Study||203
8003195|NCT00006237|19704537|P2|STARTED|Overall Study||220
8003196|NCT00006237|19704538|P1|STARTED|Overall Study||212
8003197|NCT00006227|19704548|P1|NOT COMPLETED|Overall Study||0
8003198|NCT00006227|19704548|P1|COMPLETED|Overall Study||31
8003199|NCT00006227|19704548|P1|STARTED|Overall Study||31
8003200|NCT00006110|19704556|P2|NOT COMPLETED|Overall Study||0
8003201|NCT00006110|19704557|P1|NOT COMPLETED|Overall Study||0
8003202|NCT00006110|19704556|P2|COMPLETED|Overall Study||30
8003203|NCT00006110|19704557|P1|COMPLETED|Overall Study||52
8003204|NCT00006110|19704556|P2|STARTED|Overall Study||30
8003205|NCT00006110|19704557|P1|STARTED|Overall Study||52
8003206|NCT00006101|19704571|P2|NOT COMPLETED|Overall Study||5
8003207|NCT00006101|19704572|P1|NOT COMPLETED|Overall Study||5
8003208|NCT00006101|19704571|P2|COMPLETED|Overall Study||33
8003209|NCT00006101|19704572|P1|COMPLETED|Overall Study||33
8003210|NCT00006101|19704571|P2|STARTED|Overall Study||38
8003211|NCT00006101|19704572|P1|STARTED|Overall Study||38
8003212|NCT00006011|19704581|P3|NOT COMPLETED|Overall Study||73
8003213|NCT00006011|19704582|P2|NOT COMPLETED|Overall Study||77
8003214|NCT00006011|19704583|P1|NOT COMPLETED|Overall Study||65
8003215|NCT00006011|19704581|P3|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0
8003216|NCT00006011|19704582|P2|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221
8003217|NCT00006011|19704583|P1|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223
8003218|NCT00006011|19704581|P3|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73
8003219|NCT00006011|19704582|P2|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298
8003220|NCT00006011|19704583|P1|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288
8003221|NCT00005957|19704591|P2|NOT COMPLETED|Overall Study||28
8003222|NCT00005957|19704592|P1|NOT COMPLETED|Overall Study||8
8003223|NCT00005957|19704591|P2|COMPLETED|Overall Study||888
8003224|NCT00005957|19704592|P1|COMPLETED|Overall Study||908
8003225|NCT00005957|19704591|P2|STARTED|Overall Study||916
8003226|NCT00005957|19704592|P1|STARTED|Overall Study||916
8003227|NCT00005879|19704602|P2|NOT COMPLETED|Overall Study||10
8003228|NCT00005879|19704603|P1|NOT COMPLETED|Overall Study||8
8003229|NCT00005879|19704602|P2|COMPLETED|Overall Study||88
8003230|NCT00005879|19704603|P1|COMPLETED|Overall Study||93
8003231|NCT00005879|19704602|P2|STARTED|Overall Study||98
8003232|NCT00005879|19704603|P1|STARTED|Overall Study||101
8003233|NCT00005803|19704611|P1|NOT COMPLETED|Overall Study||22
8003234|NCT00005803|19704611|P1|COMPLETED|Overall Study||54
8003235|NCT00005803|19704611|P1|STARTED|Overall Study||76
8003236|NCT00005047|19704626|P4|NOT COMPLETED|Overall Study||0
8003237|NCT00005047|19704627|P3|NOT COMPLETED|Overall Study||0
8003238|NCT00005047|19704628|P2|NOT COMPLETED|Overall Study||0
8003239|NCT00005047|19704629|P1|NOT COMPLETED|Overall Study||19
8003240|NCT00005047|19704626|P4|COMPLETED|Overall Study||158
8003241|NCT00005047|19704627|P3|COMPLETED|Overall Study||227
8003242|NCT00005047|19704628|P2|COMPLETED|Overall Study||56
8003243|NCT00005047|19704629|P1|COMPLETED|Overall Study||39
8003244|NCT00005047|19704626|P4|STARTED|Overall Study||158
8003245|NCT00005047|19704627|P3|STARTED|Overall Study||227
8003246|NCT00005047|19704628|P2|STARTED|Overall Study||56
8003247|NCT00005047|19704629|P1|STARTED|Overall Study||58
8003248|NCT00005044|19704645|P2|NOT COMPLETED|Overall Study||52
8003249|NCT00005044|19704646|P1|NOT COMPLETED|Overall Study||38
8003250|NCT00005044|19704645|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|737
8003251|NCT00005044|19704646|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|752
8003252|NCT00005044|19704645|P2|STARTED|Overall Study||789
8003253|NCT00005044|19704646|P1|STARTED|Overall Study||790
8003254|NCT00004888|19704666|P2|NOT COMPLETED|Overall Study||24
8003255|NCT00004888|19704667|P1|NOT COMPLETED|Overall Study||11
8003256|NCT00004888|19704666|P2|COMPLETED|Overall Study||22
8003257|NCT00004888|19704667|P1|COMPLETED|Overall Study||27
8003258|NCT00004888|19704666|P2|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46
8003259|NCT00004888|19704667|P1|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38
8003260|NCT00004859|19704685|P2|NOT COMPLETED|Overall Study||282
8003261|NCT00004859|19704686|P1|NOT COMPLETED|Overall Study||118
8003262|NCT00004859|19704685|P2|COMPLETED|Overall Study||12
8003263|NCT00004859|19704686|P1|COMPLETED|Overall Study||177
8003264|NCT00004859|19704685|P2|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288
8003265|NCT00004859|19704686|P1|Treated and Having Toxicity Data|Overall Study||289
8003266|NCT00004859|19704685|P2|Treated|Overall Study||289
8003267|NCT00004859|19704686|P1|Treated|Overall Study||289
8003268|NCT00004859|19704685|P2|Eligible|Overall Study||271
8003269|NCT00004859|19704686|P1|Eligible|Overall Study||275
8003270|NCT00004859|19704685|P2|STARTED|Overall Study||294
8003271|NCT00004859|19704686|P1|STARTED|Overall Study||295
8003272|NCT00004259|19704700|P4|NOT COMPLETED|Overall Study||0
8003273|NCT00004259|19704701|P3|NOT COMPLETED|Overall Study||0
8003274|NCT00004259|19704702|P2|NOT COMPLETED|Overall Study||4
8003275|NCT00004259|19704703|P1|NOT COMPLETED|Overall Study||1
8003276|NCT00004259|19704700|P4|COMPLETED|Overall Study||14
8003277|NCT00004259|19704701|P3|COMPLETED|Overall Study||15
8003278|NCT00004259|19704702|P2|COMPLETED|Overall Study||99
8003279|NCT00004259|19704703|P1|COMPLETED|Overall Study||97
8003280|NCT00004259|19704700|P4|STARTED|Overall Study||14
8003281|NCT00004259|19704701|P3|STARTED|Overall Study||15
8003282|NCT00004259|19704702|P2|STARTED|Overall Study||103
8003283|NCT00004259|19704703|P1|STARTED|Overall Study||98
8003284|NCT00004228|19704728|P7|NOT COMPLETED|Overall Study||12
8003285|NCT00004228|19704729|P6|NOT COMPLETED|Overall Study||14
8003286|NCT00004228|19704730|P5|NOT COMPLETED|Overall Study||16
8003287|NCT00004228|19704731|P4|NOT COMPLETED|Overall Study||7
8003288|NCT00004228|19704732|P3|NOT COMPLETED|Overall Study||19
8003289|NCT00004228|19704733|P2|NOT COMPLETED|Overall Study||15
8003290|NCT00004228|19704734|P1|NOT COMPLETED|Overall Study||9
8003291|NCT00004228|19704728|P7|COMPLETED|Overall Study||45
8003292|NCT00004228|19704729|P6|COMPLETED|Overall Study||51
8003293|NCT00004228|19704730|P5|COMPLETED|Overall Study||51
8003294|NCT00004228|19704731|P4|COMPLETED|Overall Study||6
8003295|NCT00004228|19704732|P3|COMPLETED|Overall Study||46
8003296|NCT00004228|19704733|P2|COMPLETED|Overall Study||51
8003297|NCT00004228|19704734|P1|COMPLETED|Overall Study||51
8003298|NCT00004228|19704728|P7|STARTED|Overall Study||57
8003299|NCT00004228|19704729|P6|STARTED|Overall Study||65
8003300|NCT00004228|19704730|P5|STARTED|Overall Study||67
8003301|NCT00004228|19704731|P4|STARTED|Overall Study||13
8003302|NCT00004228|19704732|P3|STARTED|Overall Study||65
8003303|NCT00004228|19704733|P2|STARTED|Overall Study||66
8003304|NCT00004228|19704734|P1|STARTED|Overall Study||60
8003305|NCT00004143|19704757|P1|NOT COMPLETED|Overall Study||0
8003306|NCT00004143|19704757|P1|COMPLETED|Overall Study||2
8003307|NCT00004143|19704757|P1|STARTED|Overall Study||2
8003308|NCT00004124|19704768|P2|NOT COMPLETED|Overall Study||20
8003309|NCT00004124|19704769|P1|NOT COMPLETED|Overall Study||12
8003310|NCT00004124|19704768|P2|COMPLETED|Overall Study||460
8003311|NCT00004124|19704769|P1|COMPLETED|Overall Study||469
8003312|NCT00004124|19704768|P2|STARTED|Overall Study||480
8003313|NCT00004124|19704769|P1|STARTED|Overall Study||481
8003314|NCT00004092|19704785|P2|NOT COMPLETED|Overall Study||0
8003315|NCT00004092|19704786|P1|NOT COMPLETED|Overall Study||0
8003316|NCT00004092|19704785|P2|COMPLETED|Overall Study||51
8003317|NCT00004092|19704786|P1|COMPLETED|Overall Study||21
8003318|NCT00004092|19704785|P2|STARTED|Overall Study||51
8003319|NCT00004092|19704786|P1|STARTED|Overall Study||21
8003320|NCT00004088|19704794|P1|NOT COMPLETED|Overall Study||9
8003321|NCT00004088|19704794|P1|COMPLETED|Overall Study||68
8003322|NCT00004088|19704794|P1|STARTED|Overall Study||77
8003323|NCT00004054|19704805|P2|NOT COMPLETED|Overall Study||0
8003324|NCT00004054|19704806|P1|NOT COMPLETED|Overall Study||0
8003325|NCT00004054|19704805|P2|COMPLETED|Overall Study||200
8003326|NCT00004054|19704806|P1|COMPLETED|Overall Study||197
8003327|NCT00004054|19704805|P2|STARTED|Overall Study||200
8003328|NCT00004054|19704806|P1|STARTED|Overall Study||197
8003329|NCT00003910|19704820|P2|NOT COMPLETED|Step 2||0
8003330|NCT00003910|19704821|P1|NOT COMPLETED|Step 2||0
8003331|NCT00003910|19704820|P2|COMPLETED|Step 2||16
8003332|NCT00003910|19704821|P1|COMPLETED|Step 2||0
8003333|NCT00003910|19704820|P2|STARTED|Step 2|The 16 includes 2 ineligible pts.|16
8003334|NCT00003910|19704821|P1|STARTED|Step 2||0
8003335|NCT00003910|19704820|P2|NOT COMPLETED|Step 1||0
8003336|NCT00003910|19704821|P1|NOT COMPLETED|Step 1||0
8003337|NCT00003910|19704820|P2|COMPLETED|Step 1||0
8003338|NCT00003910|19704821|P1|COMPLETED|Step 1||55
8003339|NCT00003910|19704820|P2|STARTED|Step 1||0
8003340|NCT00003910|19704821|P1|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55
8003341|NCT00003901|19704827|P1|NOT COMPLETED|Overall Study||17
8003342|NCT00003901|19704827|P1|COMPLETED|Overall Study||1030
8003343|NCT00003901|19704827|P1|STARTED|Overall Study||1047
8003344|NCT00003896|19704838|P1|NOT COMPLETED|Overall Study||29
8003345|NCT00003896|19704838|P1|COMPLETED|Overall Study||39
8003346|NCT00003896|19704838|P1|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63
8003347|NCT00003896|19704838|P1|STARTED|Overall Study||68
8003348|NCT00003875|19704844|P1|NOT COMPLETED|Overall Study||1
8003349|NCT00003875|19704844|P1|COMPLETED|Overall Study||29
8003350|NCT00003875|19704844|P1|STARTED|Overall Study||30
8003351|NCT00003869|19704853|P2|NOT COMPLETED|Overall Study||12
8003352|NCT00003869|19704854|P1|NOT COMPLETED|Overall Study||41
8003353|NCT00003869|19704853|P2|COMPLETED|Overall Study||80
8003354|NCT00003869|19704854|P1|COMPLETED|Overall Study||53
8003355|NCT00003869|19704853|P2|STARTED|Overall Study||92
8003356|NCT00003869|19704854|P1|STARTED|Overall Study||94
8003357|NCT00003820|19704870|P2|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
8003358|NCT00003820|19704871|P1|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
8003359|NCT00003820|19704870|P2|COMPLETED|Cycle 4 (Maintenance Treatment)|Patients with treatment assessment at 24 months|16
8003360|NCT00003820|19704871|P1|COMPLETED|Cycle 4 (Maintenance Treatment)||0
8003361|NCT00003820|19704870|P2|STARTED|Cycle 4 (Maintenance Treatment)|Patients with treatment response/stable disease at 18 months|16
8003362|NCT00003820|19704871|P1|STARTED|Cycle 4 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
8003363|NCT00003820|19704870|P2|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
8003364|NCT00003820|19704871|P1|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
8003365|NCT00003820|19704870|P2|COMPLETED|Cycle 3 (Maintenance Treatment)|Patients with treatment assessment at 18 months|16
8003366|NCT00003820|19704871|P1|COMPLETED|Cycle 3 (Maintenance Treatment)||0
8003367|NCT00003820|19704870|P2|STARTED|Cycle 3 (Maintenance Treatment)|Patients with treatment response/stable disease at 12 months|16
8003368|NCT00003820|19704871|P1|STARTED|Cycle 3 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
8003369|NCT00003820|19704870|P2|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
8003370|NCT00003820|19704871|P1|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
8003371|NCT00003820|19704870|P2|COMPLETED|Cycle 2 (Maintenance Treatment)|Patients with treatment assessment at 12 months|16
8003372|NCT00003820|19704871|P1|COMPLETED|Cycle 2 (Maintenance Treatment)||0
8003373|NCT00003820|19704870|P2|STARTED|Cycle 2 (Maintenance Treatment)|Pts with treatment response/stable disease at 6 mos, & eligible to continue.|16
8003374|NCT00003820|19704871|P1|STARTED|Cycle 2 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
8003375|NCT00003820|19704870|P2|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
8003376|NCT00003820|19704871|P1|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
8003377|NCT00003820|19704870|P2|COMPLETED|Cycle 1 (Initial Treatment)||16
8003378|NCT00003820|19704871|P1|COMPLETED|Cycle 1 (Initial Treatment)||23
8003379|NCT00003820|19704870|P2|STARTED|Cycle 1 (Initial Treatment)||16
8003380|NCT00003820|19704871|P1|STARTED|Cycle 1 (Initial Treatment)||23
8003381|NCT00003782|19704880|P3|NOT COMPLETED|Overall Study||26
8003382|NCT00003782|19704881|P2|NOT COMPLETED|Overall Study||31
8003383|NCT00003782|19704882|P1|NOT COMPLETED|Overall Study||30
8003384|NCT00003782|19704880|P3|COMPLETED|Overall Study||1758
8003385|NCT00003782|19704881|P2|COMPLETED|Overall Study||1753
8003386|NCT00003782|19704882|P1|COMPLETED|Overall Study||1753
8003387|NCT00003782|19704880|P3|STARTED|Overall Study||1784
8003388|NCT00003782|19704881|P2|STARTED|Overall Study||1784
8003389|NCT00003782|19704882|P1|STARTED|Overall Study||1783
8003390|NCT00003702|19704892|P2|NOT COMPLETED|Overall Study||11
8003391|NCT00003702|19704893|P1|NOT COMPLETED|Overall Study||13
8003392|NCT00003702|19704892|P2|COMPLETED|Overall Study||109
8003393|NCT00003702|19704893|P1|COMPLETED|Overall Study||107
8003394|NCT00003702|19704892|P2|STARTED|Overall Study||120
8003395|NCT00003702|19704893|P1|STARTED|Overall Study||120
8003396|NCT00003659|19704902|P1|NOT COMPLETED|Overall Study||3
8003397|NCT00003659|19704902|P1|COMPLETED|Overall Study||36
8003398|NCT00003659|19704902|P1|STARTED|Overall Study||39
8003399|NCT00003644|19704910|P2|NOT COMPLETED|Overall Study||14
8003400|NCT00003644|19704911|P1|NOT COMPLETED|Overall Study||15
8003401|NCT00003644|19704910|P2|COMPLETED|Overall Study||268
8003402|NCT00003644|19704911|P1|COMPLETED|Overall Study||274
8003403|NCT00003644|19704910|P2|STARTED|Overall Study||282
8003404|NCT00003644|19704911|P1|STARTED|Overall Study||289
8003405|NCT00003641|19704923|P2|NOT COMPLETED|Overall Study||174
8003406|NCT00003641|19704924|P1|NOT COMPLETED|Overall Study||569
8003407|NCT00003641|19704923|P2|COMPLETED|Overall Study||407
8003408|NCT00003641|19704924|P1|COMPLETED|Overall Study||0
8003409|NCT00003641|19704923|P2|Toxicity Assessed|Overall Study||568
8003410|NCT00003641|19704924|P1|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439
8003411|NCT00003641|19704923|P2|Treated|Overall Study||569
8003412|NCT00003641|19704924|P1|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2
8003413|NCT00003641|19704923|P2|STARTED|Overall Study||581
8003414|NCT00003641|19704924|P1|STARTED|Overall Study||569
8003415|NCT00003631|19704935|P3|NOT COMPLETED|Overall Study||9
8003416|NCT00003631|19704936|P2|NOT COMPLETED|Overall Study||1
8003417|NCT00003631|19704937|P1|NOT COMPLETED|Overall Study||3
8003418|NCT00003631|19704935|P3|COMPLETED|Overall Study||15
8003419|NCT00003631|19704936|P2|COMPLETED|Overall Study||43
8003420|NCT00003631|19704937|P1|COMPLETED|Overall Study||47
8003421|NCT00003631|19704935|P3|STARTED|Overall Study||24
8003422|NCT00003631|19704936|P2|STARTED|Overall Study||44
8003423|NCT00003631|19704937|P1|STARTED|Overall Study||50
8003424|NCT00003590|19704945|P1|NOT COMPLETED|Overall Study||22
8003425|NCT00003590|19704945|P1|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7
8003426|NCT00003590|19704945|P1|Eligible and Began Protocol Therapy|Overall Study||28
8003427|NCT00003590|19704945|P1|Eligible|Overall Study||28
8003428|NCT00003590|19704945|P1|STARTED|Overall Study||29
8003429|NCT00003537|19704950|P1|NOT COMPLETED|Overall Study||1
8003430|NCT00003537|19704950|P1|COMPLETED|Overall Study||18
8003431|NCT00003537|19704950|P1|STARTED|Overall Study||19
8003432|NCT00003535|19704955|P1|NOT COMPLETED|Overall Study||5
8003433|NCT00003535|19704955|P1|COMPLETED|Overall Study||4
8003434|NCT00003535|19704955|P1|STARTED|Overall Study||9
8003435|NCT00003531|19704960|P1|NOT COMPLETED|Overall Study||10
8003436|NCT00003531|19704960|P1|COMPLETED|Overall Study||5
8003437|NCT00003531|19704960|P1|STARTED|Overall Study||15
8003438|NCT00003526|19704964|P1|NOT COMPLETED|Overall Study||6
8003439|NCT00003526|19704964|P1|COMPLETED|Overall Study||2
8003440|NCT00003526|19704964|P1|STARTED|Overall Study||8
8003441|NCT00003509|19704968|P1|NOT COMPLETED|Overall Study||5
8003442|NCT00003509|19704968|P1|COMPLETED|Overall Study||8
8003443|NCT00003509|19704968|P1|STARTED|Overall Study||13
8003444|NCT00003499|19704972|P1|NOT COMPLETED|Overall Study||8
8003445|NCT00003499|19704972|P1|COMPLETED|Overall Study||23
8003446|NCT00003499|19704972|P1|STARTED|Overall Study||31
8003447|NCT00003498|19704977|P1|NOT COMPLETED|Overall Study||4
8003448|NCT00003498|19704977|P1|COMPLETED|Overall Study||1
8003449|NCT00003498|19704977|P1|STARTED|Overall Study||5
8003450|NCT00003492|19704981|P1|NOT COMPLETED|Overall Study||6
8003451|NCT00003492|19704981|P1|COMPLETED|Overall Study||3
8003452|NCT00003492|19704981|P1|STARTED|Overall Study||9
8003453|NCT00003483|19704985|P1|NOT COMPLETED|Overall Study||1
8003454|NCT00003483|19704985|P1|COMPLETED|Overall Study||2
8003455|NCT00003483|19704985|P1|STARTED|Overall Study||3
8003456|NCT00003479|19704990|P1|NOT COMPLETED|Overall Study||3
8003457|NCT00003479|19704990|P1|COMPLETED|Overall Study||6
8003458|NCT00003479|19704990|P1|STARTED|Overall Study||9
8003459|NCT00003477|19704995|P1|NOT COMPLETED|Overall Study||4
8003460|NCT00003477|19704995|P1|COMPLETED|Overall Study||8
8003461|NCT00003477|19704995|P1|STARTED|Overall Study||12
8003462|NCT00003476|19705000|P1|NOT COMPLETED|Overall Study||1
8003463|NCT00003476|19705000|P1|COMPLETED|Overall Study||7
8003464|NCT00003476|19705000|P1|STARTED|Overall Study||8
8003465|NCT00003475|19705005|P1|NOT COMPLETED|Overall Study||13
8003466|NCT00003475|19705005|P1|COMPLETED|Overall Study||27
8003467|NCT00003475|19705005|P1|STARTED|Overall Study||40
8003468|NCT00003474|19705010|P1|NOT COMPLETED|Overall Study||14
8003469|NCT00003474|19705010|P1|COMPLETED|Overall Study||26
8003470|NCT00003474|19705010|P1|STARTED|Overall Study||40
8003471|NCT00003473|19705015|P1|NOT COMPLETED|Overall Study||3
8003472|NCT00003473|19705015|P1|COMPLETED|Overall Study||17
8003473|NCT00003473|19705015|P1|STARTED|Overall Study||20
8003474|NCT00003472|19705020|P1|NOT COMPLETED|Overall Study||3
8003475|NCT00003472|19705020|P1|COMPLETED|Overall Study||10
8003476|NCT00003472|19705020|P1|STARTED|Overall Study||13
8003477|NCT00003471|19705025|P1|NOT COMPLETED|Overall Study||4
8003478|NCT00003471|19705025|P1|COMPLETED|Overall Study||3
8003479|NCT00003471|19705025|P1|STARTED|Overall Study||7
8003480|NCT00003470|19705030|P1|NOT COMPLETED|Overall Study||6
8003481|NCT00003470|19705030|P1|COMPLETED|Overall Study||21
8003482|NCT00003470|19705030|P1|STARTED|Overall Study||27
8003483|NCT00003469|19705035|P1|NOT COMPLETED|Overall Study||0
8003484|NCT00003469|19705035|P1|COMPLETED|Overall Study||4
8003485|NCT00003469|19705035|P1|STARTED|Overall Study||4
8003486|NCT00003468|19705040|P1|NOT COMPLETED|Overall Study||2
8003487|NCT00003468|19705040|P1|COMPLETED|Overall Study|Two patients were not evaluable.|9
8003488|NCT00003468|19705040|P1|STARTED|Overall Study||11
8003489|NCT00003460|19705045|P1|NOT COMPLETED|Overall Study||1
8003490|NCT00003460|19705045|P1|COMPLETED|Overall Study|One patient was not evaluable.|12
8003491|NCT00003460|19705045|P1|STARTED|Overall Study||13
8003492|NCT00003459|19705050|P1|NOT COMPLETED|Overall Study||9
8003493|NCT00003459|19705050|P1|COMPLETED|Overall Study|Nine patients were not evaluable.|31
8003494|NCT00003459|19705050|P1|STARTED|Overall Study||40
8003495|NCT00003458|19705055|P1|NOT COMPLETED|Overall Study||4
8003496|NCT00003458|19705055|P1|COMPLETED|Overall Study||30
8003497|NCT00003458|19705055|P1|STARTED|Overall Study||34
8003498|NCT00003457|19705060|P1|NOT COMPLETED|Overall Study||9
8003499|NCT00003457|19705060|P1|COMPLETED|Overall Study||31
8003500|NCT00003457|19705060|P1|STARTED|Overall Study||40
8003501|NCT00003456|19705065|P1|NOT COMPLETED|Overall Study||8
8003502|NCT00003456|19705065|P1|COMPLETED|Overall Study||32
8003503|NCT00003456|19705065|P1|STARTED|Overall Study||40
8003504|NCT00003453|19705070|P1|NOT COMPLETED|Overall Study||1
8003505|NCT00003453|19705070|P1|COMPLETED|Overall Study|One patient was not evaluable|5
8003506|NCT00003453|19705070|P1|STARTED|Overall Study||6
8003507|NCT00003404|19705075|P1|NOT COMPLETED|Overall Study||0
8003508|NCT00003404|19705075|P1|COMPLETED|Overall Study||46
8003509|NCT00003404|19705075|P1|STARTED|Overall Study||46
8003510|NCT00003389|19705082|P2|NOT COMPLETED|Overall Study||60
8003511|NCT00003389|19705083|P1|NOT COMPLETED|Overall Study||98
8003512|NCT00003389|19705082|P2|COMPLETED|Overall Study||366
8003513|NCT00003389|19705083|P1|COMPLETED|Overall Study||330
8003514|NCT00003389|19705082|P2|Eligible Patients|Overall Study||399
8003515|NCT00003389|19705083|P1|Eligible Patients|Overall Study||395
8003516|NCT00003389|19705082|P2|Treated Pts w/ Toxicity Data Available|Overall Study||422
8003517|NCT00003389|19705083|P1|Treated Pts w/ Toxicity Data Available|Overall Study||414
8003518|NCT00003389|19705082|P2|STARTED|Overall Study||426
8003519|NCT00003389|19705083|P1|STARTED|Overall Study||428
8003520|NCT00003377|19705098|P5|NOT COMPLETED|Period II||1
8003521|NCT00003377|19705099|P4|NOT COMPLETED|Period II||0
8003522|NCT00003377|19705100|P3|NOT COMPLETED|Period II||0
8003523|NCT00003377|19705101|P2|NOT COMPLETED|Period II||0
8003524|NCT00003377|19705102|P1|NOT COMPLETED|Period II||0
8003525|NCT00003377|19705098|P5|COMPLETED|Period II||16
8003526|NCT00003377|19705099|P4|COMPLETED|Period II||0
8003527|NCT00003377|19705100|P3|COMPLETED|Period II||0
8003528|NCT00003377|19705101|P2|COMPLETED|Period II||0
8003529|NCT00003377|19705102|P1|COMPLETED|Period II||0
8003530|NCT00003377|19705098|P5|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17
8003531|NCT00003377|19705099|P4|STARTED|Period II|Patients participated at this dose level only in Period I.|0
8003532|NCT00003377|19705100|P3|STARTED|Period II|Patients participated at this dose level only in Period I.|0
8003533|NCT00003377|19705101|P2|STARTED|Period II|Patients participated at this dose level only in Period I.|0
8003534|NCT00003377|19705102|P1|STARTED|Period II|Patients participated at this dose level only in Period I.|0
8003535|NCT00003377|19705098|P5|NOT COMPLETED|Period I||0
8003536|NCT00003377|19705099|P4|NOT COMPLETED|Period I||1
8003537|NCT00003377|19705100|P3|NOT COMPLETED|Period I||1
8003538|NCT00003377|19705101|P2|NOT COMPLETED|Period I||0
8003539|NCT00003377|19705102|P1|NOT COMPLETED|Period I||0
8003540|NCT00003377|19705098|P5|COMPLETED|Period I||0
8003541|NCT00003377|19705099|P4|COMPLETED|Period I||2
8003542|NCT00003377|19705100|P3|COMPLETED|Period I||2
8003543|NCT00003377|19705101|P2|COMPLETED|Period I||3
8003544|NCT00003377|19705102|P1|COMPLETED|Period I||3
8003545|NCT00003377|19705098|P5|STARTED|Period I||0
8003546|NCT00003377|19705099|P4|STARTED|Period I||3
8003547|NCT00003377|19705100|P3|STARTED|Period I||3
8003548|NCT00003377|19705101|P2|STARTED|Period I||3
8003549|NCT00003377|19705102|P1|STARTED|Period I||3
8003550|NCT00003199|19705116|P1|NOT COMPLETED|Overall Study||22
8003551|NCT00003199|19705116|P1|COMPLETED|Overall Study||28
8003552|NCT00003199|19705116|P1|STARTED|Overall Study||50
8003553|NCT00003138|19705124|P2|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7
8003554|NCT00003138|19705125|P1|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6
8003555|NCT00003138|19705124|P2|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
8003556|NCT00003138|19705125|P1|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
8003557|NCT00003138|19705124|P2|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7
8003558|NCT00003138|19705125|P1|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6
8003559|NCT00003138|19705124|P2|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20
8003560|NCT00003138|19705125|P1|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12
8003561|NCT00003138|19705124|P2|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
8003562|NCT00003138|19705125|P1|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
8003563|NCT00003138|19705124|P2|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19
8003564|NCT00003138|19705125|P1|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12
8003565|NCT00003138|19705124|P2|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20
8003566|NCT00003138|19705125|P1|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12
8003567|NCT00003138|19705124|P2|NOT COMPLETED|Step 2 (Cross Over)||0
8003568|NCT00003138|19705125|P1|NOT COMPLETED|Step 2 (Cross Over)||26
8003569|NCT00003138|19705124|P2|COMPLETED|Step 2 (Cross Over)||0
8003570|NCT00003138|19705125|P1|COMPLETED|Step 2 (Cross Over)||0
8003571|NCT00003138|19705124|P2|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0
8003572|NCT00003138|19705125|P1|STARTED|Step 2 (Cross Over)||26
8003573|NCT00003138|19705124|P2|NOT COMPLETED|Step 1||57
8003574|NCT00003138|19705125|P1|NOT COMPLETED|Step 1||61
8003575|NCT00003138|19705124|P2|COMPLETED|Step 1||0
8003576|NCT00003138|19705125|P1|COMPLETED|Step 1||0
8003577|NCT00003138|19705124|P2|Patients With Transfusion Data|Step 1||42
8003578|NCT00003138|19705125|P1|Patients With Transfusion Data|Step 1||37
8003579|NCT00003138|19705124|P2|Patients With QOL Data at 4 Months|Step 1||42
8003580|NCT00003138|19705125|P1|Patients With QOL Data at 4 Months|Step 1||42
8003581|NCT00003138|19705124|P2|Eligible and Treated|Step 1||50
8003582|NCT00003138|19705125|P1|Eligible and Treated|Step 1||52
8003583|NCT00003138|19705124|P2|Treated|Step 1||53
8003584|NCT00003138|19705125|P1|Treated|Step 1||56
8003585|NCT00003138|19705124|P2|Patients With Complete Data|Step 1||53
8003586|NCT00003138|19705125|P1|Patients With Complete Data|Step 1||57
8003587|NCT00003138|19705124|P2|STARTED|Step 1||57
8003588|NCT00003138|19705125|P1|STARTED|Step 1||61
8003589|NCT00002975|19705138|P1|NOT COMPLETED|Overall Study||5
8003590|NCT00002975|19705138|P1|COMPLETED|Overall Study||175
8003591|NCT00002975|19705138|P1|Treated With Study Therapy|Overall Study||175
8003592|NCT00002975|19705138|P1|STARTED|Overall Study||180
8003593|NCT00002931|19705142|P1|NOT COMPLETED|Overall Study||2
8003594|NCT00002931|19705142|P1|COMPLETED|Overall Study||46
8003595|NCT00002931|19705142|P1|STARTED|Overall Study||48
8003596|NCT00002874|19705150|P2|NOT COMPLETED|Overall Study||35
8003597|NCT00002874|19705151|P1|NOT COMPLETED|Overall Study||45
8003598|NCT00002874|19705150|P2|COMPLETED|Overall Study||384
8003599|NCT00002874|19705151|P1|COMPLETED|Overall Study||376
8003600|NCT00002874|19705150|P2|STARTED|Overall Study||419
8003601|NCT00002874|19705151|P1|STARTED|Overall Study||421
8003602|NCT00002850|19705176|P3|NOT COMPLETED|Overall Study||4
8003603|NCT00002850|19705177|P2|NOT COMPLETED|Overall Study||2
8003604|NCT00002850|19705178|P1|NOT COMPLETED|Overall Study||5
8003605|NCT00002850|19705176|P3|COMPLETED|Overall Study||63
8003606|NCT00002850|19705177|P2|COMPLETED|Overall Study||74
8003607|NCT00002850|19705178|P1|COMPLETED|Overall Study||64
8003608|NCT00002850|19705176|P3|STARTED|Overall Study||67
8003609|NCT00002850|19705177|P2|STARTED|Overall Study||76
8003610|NCT00002850|19705178|P1|STARTED|Overall Study||69
8003611|NCT00002842|19705186|P1|NOT COMPLETED|Overall Study||27
8003612|NCT00002842|19705186|P1|COMPLETED|Overall Study||22
8003613|NCT00002842|19705186|P1|STARTED|Overall Study||49
8003614|NCT00002766|19705192|P2|NOT COMPLETED|Overall Study||4
8003615|NCT00002766|19705193|P1|NOT COMPLETED|Overall Study||3
8003616|NCT00002766|19705192|P2|COMPLETED|Overall Study||85
8003617|NCT00002766|19705193|P1|COMPLETED|Overall Study||78
8003618|NCT00002766|19705192|P2|STARTED|Overall Study||89
8003619|NCT00002766|19705193|P1|STARTED|Overall Study||81
8003620|NCT00002651|19705201|P3|NOT COMPLETED|Consolidation and Randomization||860
8003621|NCT00002651|19705202|P2|NOT COMPLETED|Consolidation and Randomization||838
8003622|NCT00002651|19705203|P1|NOT COMPLETED|Consolidation and Randomization||0
8003623|NCT00002651|19705201|P3|COMPLETED|Consolidation and Randomization||22
8003624|NCT00002651|19705202|P2|COMPLETED|Consolidation and Randomization||29
8003625|NCT00002651|19705203|P1|COMPLETED|Consolidation and Randomization||0
8003626|NCT00002651|19705201|P3|Assessable for Toxicity|Consolidation and Randomization||702
8003627|NCT00002651|19705202|P2|Assessable for Toxicity|Consolidation and Randomization||732
8003628|NCT00002651|19705203|P1|Assessable for Toxicity|Consolidation and Randomization||0
8003629|NCT00002651|19705201|P3|Eligible|Consolidation and Randomization||770
8003630|NCT00002651|19705202|P2|Eligible|Consolidation and Randomization||765
8003631|NCT00002651|19705203|P1|Eligible|Consolidation and Randomization||0
8003632|NCT00002651|19705201|P3|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|882
8003633|NCT00002651|19705202|P2|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|867
8003634|NCT00002651|19705203|P1|STARTED|Consolidation and Randomization||0
8003635|NCT00002651|19705201|P3|NOT COMPLETED|Induction||0
8003636|NCT00002651|19705202|P2|NOT COMPLETED|Induction||0
8003637|NCT00002651|19705203|P1|NOT COMPLETED|Induction||1343
8003638|NCT00002651|19705201|P3|COMPLETED|Induction||0
8003639|NCT00002651|19705202|P2|COMPLETED|Induction||0
8003640|NCT00002651|19705203|P1|COMPLETED|Induction||1697
8003641|NCT00002651|19705201|P3|Eligible and Began Protocol Therapy|Induction||0
8003642|NCT00002651|19705202|P2|Eligible and Began Protocol Therapy|Induction||0
8003643|NCT00002651|19705203|P1|Eligible and Began Protocol Therapy|Induction||2950
8003644|NCT00002651|19705201|P3|Eligible|Induction||0
8003645|NCT00002651|19705202|P2|Eligible|Induction||0
8003646|NCT00002651|19705203|P1|Eligible|Induction||2950
8003647|NCT00002651|19705201|P3|STARTED|Induction||0
8003648|NCT00002651|19705202|P2|STARTED|Induction||0
8003649|NCT00002651|19705203|P1|STARTED|Induction||3040
8003650|NCT00002558|19705221|P2|NOT COMPLETED|Overall Study||1
8003651|NCT00002558|19705222|P1|NOT COMPLETED|Overall Study||0
8003652|NCT00002558|19705221|P2|COMPLETED|Overall Study||15
8003653|NCT00002558|19705222|P1|COMPLETED|Overall Study||92
8003654|NCT00002558|19705221|P2|STARTED|Overall Study||16
8003655|NCT00002558|19705222|P1|STARTED|Overall Study||92
8003656|NCT00052078|19705232|P4|NOT COMPLETED|Overall Study||15
8003657|NCT00052078|19705233|P3|NOT COMPLETED|Overall Study||13
8003658|NCT00052078|19705234|P2|NOT COMPLETED|Overall Study||6
8003659|NCT00052078|19705235|P1|NOT COMPLETED|Overall Study||23
8003660|NCT00052078|19705232|P4|COMPLETED|Overall Study||61
8003661|NCT00052078|19705233|P3|COMPLETED|Overall Study||127
8003662|NCT00052078|19705234|P2|COMPLETED|Overall Study||133
8003663|NCT00052078|19705235|P1|COMPLETED|Overall Study||110
8003664|NCT00052078|19705232|P4|STARTED|Overall Study||76
8003665|NCT00052078|19705233|P3|STARTED|Overall Study||140
8003666|NCT00052078|19705234|P2|STARTED|Overall Study||139
8003667|NCT00052078|19705235|P1|STARTED|Overall Study||133
8003668|NCT00051636|19705247|P2|NOT COMPLETED|Period 2- Extended Observation Period||30
8003669|NCT00051636|19705248|P1|NOT COMPLETED|Period 2- Extended Observation Period||70
8003670|NCT00051636|19705247|P2|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22
8003671|NCT00051636|19705248|P1|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5
8003672|NCT00051636|19705247|P2|STARTED|Period 2- Extended Observation Period||52
8003673|NCT00051636|19705248|P1|STARTED|Period 2- Extended Observation Period||75
8003674|NCT00051636|19705247|P2|NOT COMPLETED|Period 1 - Core||6
8003675|NCT00051636|19705248|P1|NOT COMPLETED|Period 1 - Core||4
8003676|NCT00051636|19705247|P2|COMPLETED|Period 1 - Core||76
8003677|NCT00051636|19705248|P1|COMPLETED|Period 1 - Core||86
8003678|NCT00051636|19705247|P2|STARTED|Period 1 - Core||82
8003679|NCT00051636|19705248|P1|STARTED|Period 1 - Core||90
8003680|NCT00051558|19705276|P2|NOT COMPLETED|Overall Study||96
8003681|NCT00051558|19705277|P1|NOT COMPLETED|Overall Study||91
8003682|NCT00051558|19705276|P2|COMPLETED|Overall Study||118
8003683|NCT00051558|19705277|P1|COMPLETED|Overall Study||123
8003684|NCT00051558|19705276|P2|STARTED|Overall Study||214
8003685|NCT00051558|19705277|P1|STARTED|Overall Study||214
8003686|NCT00051363|19705313|P2|NOT COMPLETED|Overall Study||144
8003687|NCT00051363|19705314|P1|NOT COMPLETED|Overall Study||115
8003688|NCT00051363|19705313|P2|COMPLETED|Overall Study||403
8003689|NCT00051363|19705314|P1|COMPLETED|Overall Study||443
8003690|NCT00051363|19705313|P2|Completed 6M Vist On-Study|Overall Study||403
8003691|NCT00051363|19705314|P1|Completed 6M Vist On-Study|Overall Study||443
8003692|NCT00051363|19705313|P2|Completed 6M Visit On-Treatment|Overall Study||372
8003693|NCT00051363|19705314|P1|Completed 6M Visit On-Treatment|Overall Study||427
8003694|NCT00051363|19705313|P2|Completed 2M Visit On-Study|Overall Study||432
8003695|NCT00051363|19705314|P1|Completed 2M Visit On-Study|Overall Study||468
8003696|NCT00051363|19705313|P2|Completed 2M Visit On-Treatment|Overall Study||417
8003697|NCT00051363|19705314|P1|Completed 2M Visit On-Treatment|Overall Study||456
8003698|NCT00051363|19705313|P2|Randomized & Analyzed|Overall Study||542
8003699|NCT00051363|19705314|P1|Randomized & Analyzed|Overall Study||556
8003700|NCT00051363|19705313|P2|STARTED|Overall Study||547
8003701|NCT00051363|19705314|P1|STARTED|Overall Study||558
8003702|NCT00051168|19705348|P1|NOT COMPLETED|Overall Study||135
8003703|NCT00051168|19705348|P1|COMPLETED|Overall Study||367
8003704|NCT00051168|19705348|P1|STARTED|Overall Study||502
8003705|NCT00051025|19705354|P2|NOT COMPLETED|Overall Study||4
8003706|NCT00051025|19705355|P1|NOT COMPLETED|Overall Study||2
8003707|NCT00051025|19705354|P2|COMPLETED|Overall Study||0
8003708|NCT00051025|19705355|P1|COMPLETED|Overall Study||3
8003709|NCT00051025|19705354|P2|STARTED|Overall Study||4
8003710|NCT00051025|19705355|P1|STARTED|Overall Study||5
8003711|NCT00050986|19705363|P1|NOT COMPLETED|Overall Study||2
8003712|NCT00050986|19705363|P1|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53
8003713|NCT00050986|19705363|P1|STARTED|Overall Study||55
8003714|NCT00050960|19705369|P2|NOT COMPLETED|Overall Study||304
8003715|NCT00050960|19705370|P1|NOT COMPLETED|Overall Study||302
8003716|NCT00050960|19705369|P2|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2
8003717|NCT00050960|19705370|P1|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4
8003718|NCT00050960|19705369|P2|STARTED|Overall Study||306
8003719|NCT00050960|19705370|P1|STARTED|Overall Study||306
8003720|NCT00050778|19705379|P3|NOT COMPLETED|Overall Study||18
8003721|NCT00050778|19705380|P2|NOT COMPLETED|Overall Study||21
8003722|NCT00050778|19705381|P1|NOT COMPLETED|Overall Study||45
8003723|NCT00050778|19705379|P3|COMPLETED|Overall Study||92
8003724|NCT00050778|19705380|P2|COMPLETED|Overall Study||92
8003725|NCT00050778|19705381|P1|COMPLETED|Overall Study||66
8003726|NCT00050778|19705379|P3|Treated|Overall Study||108
8003727|NCT00050778|19705380|P2|Treated|Overall Study||108
8003728|NCT00050778|19705381|P1|Treated|Overall Study||107
8003729|NCT00050778|19705379|P3|STARTED|Overall Study||110
8003730|NCT00050778|19705380|P2|STARTED|Overall Study||113
8003731|NCT00050778|19705381|P1|STARTED|Overall Study|Randomized.|111
8003732|NCT00050622|19705407|P1|NOT COMPLETED|Overall Study||1
8003733|NCT00050622|19705407|P1|COMPLETED|Overall Study||153
8003734|NCT00050622|19705407|P1|STARTED|Overall Study||154
8003735|NCT00050167|19705445|P2|NOT COMPLETED|Overall Study||1
8003736|NCT00050167|19705446|P1|NOT COMPLETED|Overall Study||1
8003737|NCT00050167|19705445|P2|COMPLETED|Overall Study||300
8003738|NCT00050167|19705446|P1|COMPLETED|Overall Study||301
8003739|NCT00050167|19705445|P2|STARTED|Overall Study||301
8003740|NCT00050167|19705446|P1|STARTED|Overall Study||302
8003741|NCT00050089|19705456|P4|NOT COMPLETED|Overall Study||0
8003742|NCT00050089|19705457|P3|NOT COMPLETED|Overall Study||0
8003743|NCT00050089|19705458|P2|NOT COMPLETED|Overall Study||0
8003744|NCT00050089|19705459|P1|NOT COMPLETED|Overall Study||0
8003745|NCT00050089|19705456|P4|COMPLETED|Overall Study|For primary outcome assessment|78
8003746|NCT00050089|19705457|P3|COMPLETED|Overall Study|For primary outcome assessment|86
8003747|NCT00050089|19705458|P2|COMPLETED|Overall Study|For primary outcome assessment|98
8003748|NCT00050089|19705459|P1|COMPLETED|Overall Study|For primary outcome assessment|106
8003749|NCT00050089|19705456|P4|Baseline|Overall Study||78
8003750|NCT00050089|19705457|P3|Baseline|Overall Study||86
8003751|NCT00050089|19705458|P2|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84
8003752|NCT00050089|19705459|P1|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91
8003753|NCT00050089|19705456|P4|STARTED|Overall Study||78
8003754|NCT00050089|19705457|P3|STARTED|Overall Study||86
8003755|NCT00050089|19705458|P2|STARTED|Overall Study||98
8003756|NCT00050089|19705459|P1|STARTED|Overall Study||106
8003757|NCT00050011|19705479|P2|NOT COMPLETED|Overall Study||126
8003758|NCT00050011|19705480|P1|NOT COMPLETED|Overall Study||121
8003759|NCT00050011|19705479|P2|COMPLETED|Overall Study||175
8003760|NCT00050011|19705480|P1|COMPLETED|Overall Study||180
8003761|NCT00050011|19705479|P2|Intent-to-treat Population|Overall Study||300
8003762|NCT00050011|19705480|P1|Intent-to-treat Population|Overall Study||300
8003763|NCT00050011|19705479|P2|STARTED|Overall Study||301
8003764|NCT00050011|19705480|P1|STARTED|Overall Study||301
8003765|NCT00049842|19705502|P2|NOT COMPLETED|Follow-up Phase||5
8003766|NCT00049842|19705503|P1|NOT COMPLETED|Follow-up Phase||7
8003767|NCT00049842|19705502|P2|COMPLETED|Follow-up Phase||189
8003768|NCT00049842|19705503|P1|COMPLETED|Follow-up Phase||211
8003769|NCT00049842|19705502|P2|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194
8003770|NCT00049842|19705503|P1|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218
8003771|NCT00049842|19705502|P2|NOT COMPLETED|Treatment Phase||78
8003772|NCT00049842|19705503|P1|NOT COMPLETED|Treatment Phase||93
8003773|NCT00049842|19705502|P2|COMPLETED|Treatment Phase||192
8003774|NCT00049842|19705503|P1|COMPLETED|Treatment Phase||177
8003775|NCT00049842|19705502|P2|STARTED|Treatment Phase||270
8003776|NCT00049842|19705503|P1|STARTED|Treatment Phase||270
8003777|NCT00048932|19705521|P3|NOT COMPLETED|Open Label Period (OL)||441
8003778|NCT00048932|19705522|P2|NOT COMPLETED|Open Label Period (OL)||0
8003779|NCT00048932|19705523|P1|NOT COMPLETED|Open Label Period (OL)||0
8003780|NCT00048932|19705521|P3|COMPLETED|Open Label Period (OL)||743
8003781|NCT00048932|19705522|P2|COMPLETED|Open Label Period (OL)||0
8003782|NCT00048932|19705523|P1|COMPLETED|Open Label Period (OL)||0
8003783|NCT00048932|19705521|P3|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184
8003784|NCT00048932|19705522|P2|STARTED|Open Label Period (OL)||0
8003785|NCT00048932|19705523|P1|STARTED|Open Label Period (OL)||0
8003786|NCT00048932|19705521|P3|NOT COMPLETED|Double Blind Period (DB)||0
8003787|NCT00048932|19705522|P2|NOT COMPLETED|Double Blind Period (DB)||87
8003788|NCT00048932|19705523|P1|NOT COMPLETED|Double Blind Period (DB)||123
8003789|NCT00048932|19705521|P3|COMPLETED|Double Blind Period (DB)||0
8003790|NCT00048932|19705522|P2|COMPLETED|Double Blind Period (DB)||395
8003791|NCT00048932|19705523|P1|COMPLETED|Double Blind Period (DB)||836
8003792|NCT00048932|19705521|P3|STARTED|Double Blind Period (DB)||0
8003793|NCT00048932|19705522|P2|STARTED|Double Blind Period (DB)|Number Treated|482
8003794|NCT00048932|19705523|P1|STARTED|Double Blind Period (DB)|Number Treated|959
8003795|NCT00048815|19705550|P3|NOT COMPLETED|Overall Study||4
8003796|NCT00048815|19705551|P2|NOT COMPLETED|Overall Study||4
8003797|NCT00048815|19705552|P1|NOT COMPLETED|Overall Study||6
8003798|NCT00048815|19705550|P3|COMPLETED|Overall Study||19
8003799|NCT00048815|19705551|P2|COMPLETED|Overall Study||22
8003800|NCT00048815|19705552|P1|COMPLETED|Overall Study||18
8003801|NCT00048815|19705550|P3|STARTED|Overall Study||23
8003802|NCT00048815|19705551|P2|STARTED|Overall Study||26
8003803|NCT00048815|19705552|P1|STARTED|Overall Study||24
8003804|NCT00048581|19705565|P3|NOT COMPLETED|Open-Label Period||167
8003805|NCT00048581|19705566|P2|NOT COMPLETED|Open-Label Period||0
8003806|NCT00048581|19705567|P1|NOT COMPLETED|Open-Label Period||0
8003807|NCT00048581|19705565|P3|COMPLETED|Open-Label Period||150
8003808|NCT00048581|19705566|P2|COMPLETED|Open-Label Period||0
8003809|NCT00048581|19705567|P1|COMPLETED|Open-Label Period||0
8003810|NCT00048581|19705565|P3|STARTED|Open-Label Period||317
8003811|NCT00048581|19705566|P2|STARTED|Open-Label Period||0
8003812|NCT00048581|19705567|P1|STARTED|Open-Label Period||0
8003813|NCT00048581|19705565|P3|NOT COMPLETED|Double-Blind Period||0
8003814|NCT00048581|19705566|P2|NOT COMPLETED|Double-Blind Period||34
8003815|NCT00048581|19705567|P1|NOT COMPLETED|Double-Blind Period||35
8003816|NCT00048581|19705565|P3|COMPLETED|Double-Blind Period||0
8003817|NCT00048581|19705566|P2|COMPLETED|Double-Blind Period||99
8003818|NCT00048581|19705567|P1|COMPLETED|Double-Blind Period||223
8003819|NCT00048581|19705565|P3|STARTED|Double-Blind Period||0
8003820|NCT00048581|19705566|P2|STARTED|Double-Blind Period||133
8003821|NCT00048581|19705567|P1|STARTED|Double-Blind Period||258
8003822|NCT00048568|19705734|P3|NOT COMPLETED|Open-Label Period||160
8003823|NCT00048568|19705735|P2|NOT COMPLETED|Open-Label Period||0
8003824|NCT00048568|19705736|P1|NOT COMPLETED|Open-Label Period||0
8003825|NCT00048568|19705734|P3|COMPLETED|Open-Label Period||379
8003826|NCT00048568|19705735|P2|COMPLETED|Open-Label Period||0
8003827|NCT00048568|19705736|P1|COMPLETED|Open-Label Period||0
8003828|NCT00048568|19705734|P3|STARTED|Open-Label Period||539
8003829|NCT00048568|19705735|P2|STARTED|Open-Label Period||0
8003830|NCT00048568|19705736|P1|STARTED|Open-Label Period||0
8003831|NCT00048568|19705734|P3|NOT COMPLETED|Double-Blind Period Days 170 to 365||0
8003832|NCT00048568|19705735|P2|NOT COMPLETED|Double-Blind Period Days 170 to 365||12
8003833|NCT00048568|19705736|P1|NOT COMPLETED|Double-Blind Period Days 170 to 365||16
8003834|NCT00048568|19705734|P3|COMPLETED|Double-Blind Period Days 170 to 365||0
8003835|NCT00048568|19705735|P2|COMPLETED|Double-Blind Period Days 170 to 365||162
8003836|NCT00048568|19705736|P1|COMPLETED|Double-Blind Period Days 170 to 365||385
8003837|NCT00048568|19705734|P3|STARTED|Double-Blind Period Days 170 to 365||0
8003838|NCT00048568|19705735|P2|STARTED|Double-Blind Period Days 170 to 365||174
8003839|NCT00048568|19705736|P1|STARTED|Double-Blind Period Days 170 to 365||401
8003840|NCT00048568|19705734|P3|NOT COMPLETED|Double-Blind Period Days 1 to 169||0
8003841|NCT00048568|19705735|P2|NOT COMPLETED|Double-Blind Period Days 1 to 169||45
8003842|NCT00048568|19705736|P1|NOT COMPLETED|Double-Blind Period Days 1 to 169||32
8003843|NCT00048568|19705734|P3|COMPLETED|Double-Blind Period Days 1 to 169||0
8003844|NCT00048568|19705735|P2|COMPLETED|Double-Blind Period Days 1 to 169||174
8003845|NCT00048568|19705736|P1|COMPLETED|Double-Blind Period Days 1 to 169||401
8003846|NCT00048568|19705734|P3|STARTED|Double-Blind Period Days 1 to 169||0
8003847|NCT00048568|19705735|P2|STARTED|Double-Blind Period Days 1 to 169||219
8003848|NCT00048568|19705736|P1|STARTED|Double-Blind Period Days 1 to 169||433
8003849|NCT00048893|19706024|P1|NOT COMPLETED|Overall Study||0
8003850|NCT00048893|19706024|P1|COMPLETED|Overall Study||37
8003851|NCT00048893|19706024|P1|STARTED|Overall Study||37
8003852|NCT00048737|19706035|P1|NOT COMPLETED|Overall Study||0
8003853|NCT00048737|19706035|P1|COMPLETED|Overall Study||70
8003854|NCT00048737|19706035|P1|STARTED|Overall Study||70
8003855|NCT00048724|19706041|P2|NOT COMPLETED|Overall Study||118
8003856|NCT00048724|19706042|P1|NOT COMPLETED|Overall Study||116
8003857|NCT00048724|19706041|P2|COMPLETED|Overall Study||197
8003858|NCT00048724|19706042|P1|COMPLETED|Overall Study||195
8003859|NCT00048724|19706041|P2|STARTED|Overall Study||315
8003860|NCT00048724|19706042|P1|STARTED|Overall Study||311
8003861|NCT00048542|19706054|P8|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
8003862|NCT00048542|19706055|P7|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
8003863|NCT00048542|19706056|P6|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8003864|NCT00048542|19706057|P5|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8003865|NCT00048542|19706058|P4|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8003866|NCT00048542|19706059|P3|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8003867|NCT00048542|19706060|P2|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8003868|NCT00048542|19706061|P1|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8003869|NCT00048542|19706054|P8|COMPLETED|Open-Label Extension Fixed Dose Phase||25
8003870|NCT00048542|19706055|P7|COMPLETED|Open-Label Extension Fixed Dose Phase||37
8003871|NCT00048542|19706056|P6|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8003872|NCT00048542|19706057|P5|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8003873|NCT00048542|19706058|P4|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8003874|NCT00048542|19706059|P3|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8003875|NCT00048542|19706060|P2|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8003876|NCT00048542|19706061|P1|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8003877|NCT00048542|19706054|P8|STARTED|Open-Label Extension Fixed Dose Phase||47
8003878|NCT00048542|19706055|P7|STARTED|Open-Label Extension Fixed Dose Phase||59
8003879|NCT00048542|19706056|P6|STARTED|Open-Label Extension Fixed Dose Phase||0
8003880|NCT00048542|19706057|P5|STARTED|Open-Label Extension Fixed Dose Phase||0
8003881|NCT00048542|19706058|P4|STARTED|Open-Label Extension Fixed Dose Phase||0
8003882|NCT00048542|19706059|P3|STARTED|Open-Label Extension Fixed Dose Phase||0
8003883|NCT00048542|19706060|P2|STARTED|Open-Label Extension Fixed Dose Phase||0
8003884|NCT00048542|19706061|P1|STARTED|Open-Label Extension Fixed Dose Phase||0
8003885|NCT00048542|19706054|P8|NOT COMPLETED|Open-Label Extension BSA Phase||0
8003886|NCT00048542|19706055|P7|NOT COMPLETED|Open-Label Extension BSA Phase||0
8003887|NCT00048542|19706056|P6|NOT COMPLETED|Open-Label Extension BSA Phase||10
8003888|NCT00048542|19706057|P5|NOT COMPLETED|Open-Label Extension BSA Phase||12
8003889|NCT00048542|19706058|P4|NOT COMPLETED|Open-Label Extension BSA Phase||0
8003890|NCT00048542|19706059|P3|NOT COMPLETED|Open-Label Extension BSA Phase||0
8003891|NCT00048542|19706060|P2|NOT COMPLETED|Open-Label Extension BSA Phase||0
8003892|NCT00048542|19706061|P1|NOT COMPLETED|Open-Label Extension BSA Phase||0
8003893|NCT00048542|19706054|P8|COMPLETED|Open-Label Extension BSA Phase||0
8003894|NCT00048542|19706055|P7|COMPLETED|Open-Label Extension BSA Phase||0
8003895|NCT00048542|19706056|P6|COMPLETED|Open-Label Extension BSA Phase||47
8003896|NCT00048542|19706057|P5|COMPLETED|Open-Label Extension BSA Phase||59
8003897|NCT00048542|19706058|P4|COMPLETED|Open-Label Extension BSA Phase||0
8003898|NCT00048542|19706059|P3|COMPLETED|Open-Label Extension BSA Phase||0
8003899|NCT00048542|19706060|P2|COMPLETED|Open-Label Extension BSA Phase||0
8003900|NCT00048542|19706061|P1|COMPLETED|Open-Label Extension BSA Phase||0
8003901|NCT00048542|19706054|P8|STARTED|Open-Label Extension BSA Phase||0
8003902|NCT00048542|19706055|P7|STARTED|Open-Label Extension BSA Phase||0
8003903|NCT00048542|19706056|P6|STARTED|Open-Label Extension BSA Phase||57
8003904|NCT00048542|19706057|P5|STARTED|Open-Label Extension BSA Phase||71
8003905|NCT00048542|19706058|P4|STARTED|Open-Label Extension BSA Phase||0
8003906|NCT00048542|19706059|P3|STARTED|Open-Label Extension BSA Phase||0
8003907|NCT00048542|19706060|P2|STARTED|Open-Label Extension BSA Phase||0
8003908|NCT00048542|19706061|P1|STARTED|Open-Label Extension BSA Phase||0
8003909|NCT00048542|19706054|P8|NOT COMPLETED|Double-Blind Phase||0
8003910|NCT00048542|19706055|P7|NOT COMPLETED|Double-Blind Phase||0
8003911|NCT00048542|19706056|P6|NOT COMPLETED|Double-Blind Phase||0
8003912|NCT00048542|19706057|P5|NOT COMPLETED|Double-Blind Phase||0
8003913|NCT00048542|19706058|P4|NOT COMPLETED|Double-Blind Phase||0
8003914|NCT00048542|19706059|P3|NOT COMPLETED|Double-Blind Phase||1
8003915|NCT00048542|19706060|P2|NOT COMPLETED|Double-Blind Phase||1
8003916|NCT00048542|19706061|P1|NOT COMPLETED|Double-Blind Phase||3
8003917|NCT00048542|19706054|P8|COMPLETED|Double-Blind Phase||0
8003918|NCT00048542|19706055|P7|COMPLETED|Double-Blind Phase||0
8003919|NCT00048542|19706056|P6|COMPLETED|Double-Blind Phase||0
8003920|NCT00048542|19706057|P5|COMPLETED|Double-Blind Phase||0
8003921|NCT00048542|19706058|P4|COMPLETED|Double-Blind Phase||28
8003922|NCT00048542|19706059|P3|COMPLETED|Double-Blind Phase||29
8003923|NCT00048542|19706060|P2|COMPLETED|Double-Blind Phase||36
8003924|NCT00048542|19706061|P1|COMPLETED|Double-Blind Phase||35
8003925|NCT00048542|19706054|P8|STARTED|Double-Blind Phase||0
8003926|NCT00048542|19706055|P7|STARTED|Double-Blind Phase||0
8003927|NCT00048542|19706056|P6|STARTED|Double-Blind Phase||0
8003928|NCT00048542|19706057|P5|STARTED|Double-Blind Phase||0
8003929|NCT00048542|19706058|P4|STARTED|Double-Blind Phase||28
8003930|NCT00048542|19706059|P3|STARTED|Double-Blind Phase||30
8003931|NCT00048542|19706060|P2|STARTED|Double-Blind Phase||37
8003932|NCT00048542|19706061|P1|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38
8003933|NCT00048347|19706127|P1|NOT COMPLETED|Overall Study||2
8003934|NCT00048347|19706127|P1|COMPLETED|Overall Study||16
8003935|NCT00048347|19706127|P1|STARTED|Overall Study||18
8003936|NCT00048165|19706133|P2|NOT COMPLETED|Completed 12 Months Study||3
8003937|NCT00048165|19706134|P1|NOT COMPLETED|Completed 12 Months Study||3
8003938|NCT00048165|19706133|P2|COMPLETED|Completed 12 Months Study||167
8003939|NCT00048165|19706134|P1|COMPLETED|Completed 12 Months Study||162
8003940|NCT00048165|19706133|P2|STARTED|Completed 12 Months Study||170
8003941|NCT00048165|19706134|P1|STARTED|Completed 12 Months Study||165
8003942|NCT00048165|19706133|P2|NOT COMPLETED|Completed 6 Months Study||48
8003943|NCT00048165|19706134|P1|NOT COMPLETED|Completed 6 Months Study||51
8003944|NCT00048165|19706133|P2|COMPLETED|Completed 6 Months Study||170
8003945|NCT00048165|19706134|P1|COMPLETED|Completed 6 Months Study||165
8003946|NCT00048165|19706133|P2|STARTED|Completed 6 Months Study||218
8003947|NCT00048165|19706134|P1|STARTED|Completed 6 Months Study||216
8003948|NCT00048074|19706169|P3|NOT COMPLETED|Overall Study||97
8003949|NCT00048074|19706170|P2|NOT COMPLETED|Overall Study||87
8003950|NCT00048074|19706171|P1|NOT COMPLETED|Overall Study||81
8003951|NCT00048074|19706169|P3|COMPLETED|Overall Study||372
8003952|NCT00048074|19706170|P2|COMPLETED|Overall Study||361
8003953|NCT00048074|19706171|P1|COMPLETED|Overall Study||384
8003954|NCT00048074|19706169|P3|STARTED|Overall Study||469
8003955|NCT00048074|19706170|P2|STARTED|Overall Study||448
8003956|NCT00048074|19706171|P1|STARTED|Overall Study||465
8003957|NCT00048061|19706228|P4|NOT COMPLETED|Overall Study||79
8003958|NCT00048061|19706229|P3|NOT COMPLETED|Overall Study||84
8003959|NCT00048061|19706230|P2|NOT COMPLETED|Overall Study||73
8003960|NCT00048061|19706231|P1|NOT COMPLETED|Overall Study||75
8003961|NCT00048061|19706228|P4|COMPLETED|Overall Study||322
8003962|NCT00048061|19706229|P3|COMPLETED|Overall Study||316
8003963|NCT00048061|19706230|P2|COMPLETED|Overall Study||328
8003964|NCT00048061|19706231|P1|COMPLETED|Overall Study||325
8003965|NCT00048061|19706228|P4|STARTED|Overall Study||401
8003966|NCT00048061|19706229|P3|STARTED|Overall Study||400
8003967|NCT00048061|19706230|P2|STARTED|Overall Study||401
8003968|NCT00048061|19706231|P1|STARTED|Overall Study||400
8003969|NCT00048048|19706310|P12|NOT COMPLETED|Extension Year 2||2
8003970|NCT00048048|19706311|P11|NOT COMPLETED|Extension Year 2||4
8003971|NCT00048048|19706312|P10|NOT COMPLETED|Extension Year 2||0
8003972|NCT00048048|19706313|P9|NOT COMPLETED|Extension Year 2||0
8003973|NCT00048048|19706314|P8|NOT COMPLETED|Extension Year 2||0
8003974|NCT00048048|19706315|P7|NOT COMPLETED|Extension Year 2||0
8003975|NCT00048048|19706316|P6|NOT COMPLETED|Extension Year 2||0
8003976|NCT00048048|19706317|P5|NOT COMPLETED|Extension Year 2||0
8003977|NCT00048048|19706318|P4|NOT COMPLETED|Extension Year 2||0
8003978|NCT00048048|19706319|P3|NOT COMPLETED|Extension Year 2||0
8003979|NCT00048048|19706320|P2|NOT COMPLETED|Extension Year 2||0
8003980|NCT00048048|19706321|P1|NOT COMPLETED|Extension Year 2||0
8003981|NCT00048048|19706310|P12|COMPLETED|Extension Year 2||13
8003982|NCT00048048|19706311|P11|COMPLETED|Extension Year 2||19
8003983|NCT00048048|19706312|P10|COMPLETED|Extension Year 2||2
8003984|NCT00048048|19706313|P9|COMPLETED|Extension Year 2||0
8003985|NCT00048048|19706314|P8|COMPLETED|Extension Year 2||0
8003986|NCT00048048|19706315|P7|COMPLETED|Extension Year 2||0
8003987|NCT00048048|19706316|P6|COMPLETED|Extension Year 2||0
8003988|NCT00048048|19706317|P5|COMPLETED|Extension Year 2||0
8003989|NCT00048048|19706318|P4|COMPLETED|Extension Year 2||0
8003990|NCT00048048|19706319|P3|COMPLETED|Extension Year 2||0
8003991|NCT00048048|19706320|P2|COMPLETED|Extension Year 2||0
8003992|NCT00048048|19706321|P1|COMPLETED|Extension Year 2||0
8003993|NCT00048048|19706310|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|15
8003994|NCT00048048|19706311|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1 + 12 participants from RO0503821 (1X/Week).|23
8003995|NCT00048048|19706312|P10|STARTED|Extension Year 2|Twelve participants who completed Extension Year 1 were switched to RO0503821 (1x/2Week).|2
8003996|NCT00048048|19706313|P9|STARTED|Extension Year 2||0
8003997|NCT00048048|19706314|P8|STARTED|Extension Year 2||0
8003998|NCT00048048|19706315|P7|STARTED|Extension Year 2||0
8003999|NCT00048048|19706316|P6|STARTED|Extension Year 2||0
8004000|NCT00048048|19706317|P5|STARTED|Extension Year 2||0
8004001|NCT00048048|19706318|P4|STARTED|Extension Year 2||0
8004002|NCT00048048|19706319|P3|STARTED|Extension Year 2||0
8004003|NCT00048048|19706320|P2|STARTED|Extension Year 2||0
8004004|NCT00048048|19706321|P1|STARTED|Extension Year 2||0
8004005|NCT00048048|19706310|P12|NOT COMPLETED|Extension Year 1||4
8004006|NCT00048048|19706311|P11|NOT COMPLETED|Extension Year 1||2
8004007|NCT00048048|19706312|P10|NOT COMPLETED|Extension Year 1||2
8004008|NCT00048048|19706313|P9|NOT COMPLETED|Extension Year 1||0
8004009|NCT00048048|19706314|P8|NOT COMPLETED|Extension Year 1||0
8004010|NCT00048048|19706315|P7|NOT COMPLETED|Extension Year 1||0
8004011|NCT00048048|19706316|P6|NOT COMPLETED|Extension Year 1||0
8004012|NCT00048048|19706317|P5|NOT COMPLETED|Extension Year 1||0
8004013|NCT00048048|19706318|P4|NOT COMPLETED|Extension Year 1||0
8004014|NCT00048048|19706319|P3|NOT COMPLETED|Extension Year 1||0
8004015|NCT00048048|19706320|P2|NOT COMPLETED|Extension Year 1||0
8004016|NCT00048048|19706321|P1|NOT COMPLETED|Extension Year 1||0
8004017|NCT00048048|19706310|P12|COMPLETED|Extension Year 1||15
8004018|NCT00048048|19706311|P11|COMPLETED|Extension Year 1||14
8004019|NCT00048048|19706312|P10|COMPLETED|Extension Year 1||14
8004020|NCT00048048|19706313|P9|COMPLETED|Extension Year 1||0
8004021|NCT00048048|19706314|P8|COMPLETED|Extension Year 1||0
8004022|NCT00048048|19706315|P7|COMPLETED|Extension Year 1||0
8004023|NCT00048048|19706316|P6|COMPLETED|Extension Year 1||0
8004024|NCT00048048|19706317|P5|COMPLETED|Extension Year 1||0
8004025|NCT00048048|19706318|P4|COMPLETED|Extension Year 1||0
8004026|NCT00048048|19706319|P3|COMPLETED|Extension Year 1||0
8004027|NCT00048048|19706320|P2|COMPLETED|Extension Year 1||0
8004028|NCT00048048|19706321|P1|COMPLETED|Extension Year 1||0
8004029|NCT00048048|19706310|P12|STARTED|Extension Year 1|Participants (Cohorts 7, 8, and 9) who completed core, entered extension period (entry optional).|19
8004030|NCT00048048|19706311|P11|STARTED|Extension Year 1|Participants (Cohorts 4, 5, and 6) who completed core, entered extension period (entry optional).|16
8004031|NCT00048048|19706312|P10|STARTED|Extension Year 1|Participants (Cohorts 1, 2, and 3) who completed core, entered extension period (entry optional).|16
8004032|NCT00048048|19706313|P9|STARTED|Extension Year 1||0
8004033|NCT00048048|19706314|P8|STARTED|Extension Year 1||0
8004034|NCT00048048|19706315|P7|STARTED|Extension Year 1||0
8004035|NCT00048048|19706316|P6|STARTED|Extension Year 1||0
8004036|NCT00048048|19706317|P5|STARTED|Extension Year 1||0
8004037|NCT00048048|19706318|P4|STARTED|Extension Year 1||0
8004038|NCT00048048|19706319|P3|STARTED|Extension Year 1||0
8004039|NCT00048048|19706320|P2|STARTED|Extension Year 1||0
8004040|NCT00048048|19706321|P1|STARTED|Extension Year 1||0
8004041|NCT00048048|19706310|P12|NOT COMPLETED|Core Treatment||0
8004042|NCT00048048|19706311|P11|NOT COMPLETED|Core Treatment||0
8004043|NCT00048048|19706312|P10|NOT COMPLETED|Core Treatment||0
8004044|NCT00048048|19706313|P9|NOT COMPLETED|Core Treatment||0
8004045|NCT00048048|19706314|P8|NOT COMPLETED|Core Treatment||1
8004046|NCT00048048|19706315|P7|NOT COMPLETED|Core Treatment||0
8004047|NCT00048048|19706316|P6|NOT COMPLETED|Core Treatment||0
8004048|NCT00048048|19706317|P5|NOT COMPLETED|Core Treatment||0
8004049|NCT00048048|19706318|P4|NOT COMPLETED|Core Treatment||0
8004050|NCT00048048|19706319|P3|NOT COMPLETED|Core Treatment||1
8004051|NCT00048048|19706320|P2|NOT COMPLETED|Core Treatment||0
8004052|NCT00048048|19706321|P1|NOT COMPLETED|Core Treatment||0
8004053|NCT00048048|19706310|P12|COMPLETED|Core Treatment||0
8004054|NCT00048048|19706311|P11|COMPLETED|Core Treatment||0
8004055|NCT00048048|19706312|P10|COMPLETED|Core Treatment||0
8004056|NCT00048048|19706313|P9|COMPLETED|Core Treatment||10
8004057|NCT00048048|19706314|P8|COMPLETED|Core Treatment||5
8004058|NCT00048048|19706315|P7|COMPLETED|Core Treatment||6
8004059|NCT00048048|19706316|P6|COMPLETED|Core Treatment||9
8004060|NCT00048048|19706317|P5|COMPLETED|Core Treatment||6
8004061|NCT00048048|19706318|P4|COMPLETED|Core Treatment||6
8004062|NCT00048048|19706319|P3|COMPLETED|Core Treatment||9
8004063|NCT00048048|19706320|P2|COMPLETED|Core Treatment||6
8004064|NCT00048048|19706321|P1|COMPLETED|Core Treatment||6
8004065|NCT00048048|19706310|P12|STARTED|Core Treatment||0
8004066|NCT00048048|19706311|P11|STARTED|Core Treatment||0
8004067|NCT00048048|19706312|P10|STARTED|Core Treatment||0
8004068|NCT00048048|19706313|P9|STARTED|Core Treatment||10
8004069|NCT00048048|19706314|P8|STARTED|Core Treatment||6
8004070|NCT00048048|19706315|P7|STARTED|Core Treatment||6
8004071|NCT00048048|19706316|P6|STARTED|Core Treatment||9
8004072|NCT00048048|19706317|P5|STARTED|Core Treatment||6
8004073|NCT00048048|19706318|P4|STARTED|Core Treatment||6
8004074|NCT00048048|19706319|P3|STARTED|Core Treatment||10
8004075|NCT00048048|19706320|P2|STARTED|Core Treatment||6
8004076|NCT00048048|19706321|P1|STARTED|Core Treatment||6
8004077|NCT00048035|19706377|P8|NOT COMPLETED|Extension Year 2||3
8004078|NCT00048035|19706378|P7|NOT COMPLETED|Extension Year 2||3
8004079|NCT00048035|19706379|P6|NOT COMPLETED|Extension Year 2||0
8004080|NCT00048035|19706380|P5|NOT COMPLETED|Extension Year 2||0
8004081|NCT00048035|19706381|P4|NOT COMPLETED|Extension Year 2||0
8004082|NCT00048035|19706382|P3|NOT COMPLETED|Extension Year 2||0
8004083|NCT00048035|19706383|P2|NOT COMPLETED|Extension Year 2||0
8004084|NCT00048035|19706384|P1|NOT COMPLETED|Extension Year 2||0
8004085|NCT00048035|19706377|P8|COMPLETED|Extension Year 2||10
8004086|NCT00048035|19706378|P7|COMPLETED|Extension Year 2||11
8004087|NCT00048035|19706379|P6|COMPLETED|Extension Year 2||0
8004088|NCT00048035|19706380|P5|COMPLETED|Extension Year 2||0
8004089|NCT00048035|19706381|P4|COMPLETED|Extension Year 2||0
8004090|NCT00048035|19706382|P3|COMPLETED|Extension Year 2||0
8004091|NCT00048035|19706383|P2|COMPLETED|Extension Year 2||0
8004092|NCT00048035|19706384|P1|COMPLETED|Extension Year 2||0
8004093|NCT00048035|19706377|P8|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13
8004094|NCT00048035|19706378|P7|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
8004095|NCT00048035|19706379|P6|STARTED|Extension Year 2||0
8004096|NCT00048035|19706380|P5|STARTED|Extension Year 2||0
8004097|NCT00048035|19706381|P4|STARTED|Extension Year 2||0
8004098|NCT00048035|19706382|P3|STARTED|Extension Year 2||0
8004099|NCT00048035|19706383|P2|STARTED|Extension Year 2||0
8004100|NCT00048035|19706384|P1|STARTED|Extension Year 2||0
8004101|NCT00048035|19706377|P8|NOT COMPLETED|Extension Year 1||11
8004102|NCT00048035|19706378|P7|NOT COMPLETED|Extension Year 1||11
8004103|NCT00048035|19706379|P6|NOT COMPLETED|Extension Year 1||0
8004104|NCT00048035|19706380|P5|NOT COMPLETED|Extension Year 1||0
8004105|NCT00048035|19706381|P4|NOT COMPLETED|Extension Year 1||0
8004106|NCT00048035|19706382|P3|NOT COMPLETED|Extension Year 1||0
8004107|NCT00048035|19706383|P2|NOT COMPLETED|Extension Year 1||0
8004108|NCT00048035|19706384|P1|NOT COMPLETED|Extension Year 1||0
8004109|NCT00048035|19706377|P8|COMPLETED|Extension Year 1||15
8004110|NCT00048035|19706378|P7|COMPLETED|Extension Year 1||16
8004111|NCT00048035|19706379|P6|COMPLETED|Extension Year 1||0
8004112|NCT00048035|19706380|P5|COMPLETED|Extension Year 1||0
8004113|NCT00048035|19706381|P4|COMPLETED|Extension Year 1||0
8004114|NCT00048035|19706382|P3|COMPLETED|Extension Year 1||0
8004115|NCT00048035|19706383|P2|COMPLETED|Extension Year 1||0
8004116|NCT00048035|19706384|P1|COMPLETED|Extension Year 1||0
8004117|NCT00048035|19706377|P8|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26
8004118|NCT00048035|19706378|P7|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27
8004119|NCT00048035|19706379|P6|STARTED|Extension Year 1||0
8004120|NCT00048035|19706380|P5|STARTED|Extension Year 1||0
8004121|NCT00048035|19706381|P4|STARTED|Extension Year 1||0
8004122|NCT00048035|19706382|P3|STARTED|Extension Year 1||0
8004123|NCT00048035|19706383|P2|STARTED|Extension Year 1||0
8004124|NCT00048035|19706384|P1|STARTED|Extension Year 1||0
8004125|NCT00048035|19706377|P8|NOT COMPLETED|Core Period||0
8004126|NCT00048035|19706378|P7|NOT COMPLETED|Core Period||0
8004127|NCT00048035|19706379|P6|NOT COMPLETED|Core Period||1
8004128|NCT00048035|19706380|P5|NOT COMPLETED|Core Period||1
8004129|NCT00048035|19706381|P4|NOT COMPLETED|Core Period||1
8004130|NCT00048035|19706382|P3|NOT COMPLETED|Core Period||1
8004131|NCT00048035|19706383|P2|NOT COMPLETED|Core Period||2
8004132|NCT00048035|19706384|P1|NOT COMPLETED|Core Period||4
8004133|NCT00048035|19706377|P8|COMPLETED|Core Period||0
8004134|NCT00048035|19706378|P7|COMPLETED|Core Period||0
8004135|NCT00048035|19706379|P6|COMPLETED|Core Period||14
8004136|NCT00048035|19706380|P5|COMPLETED|Core Period||15
8004137|NCT00048035|19706381|P4|COMPLETED|Core Period||14
8004138|NCT00048035|19706382|P3|COMPLETED|Core Period||14
8004139|NCT00048035|19706383|P2|COMPLETED|Core Period||13
8004140|NCT00048035|19706384|P1|COMPLETED|Core Period||11
8004141|NCT00048035|19706377|P8|STARTED|Core Period||0
8004142|NCT00048035|19706378|P7|STARTED|Core Period||0
8004143|NCT00048035|19706379|P6|STARTED|Core Period||15
8004144|NCT00048035|19706380|P5|STARTED|Core Period||16
8004145|NCT00048035|19706381|P4|STARTED|Core Period||15
8004146|NCT00048035|19706382|P3|STARTED|Core Period||15
8004147|NCT00048035|19706383|P2|STARTED|Core Period||15
8004148|NCT00048035|19706384|P1|STARTED|Core Period||15
8004149|NCT00047879|19706422|P2|NOT COMPLETED|Overall Study||3
8004150|NCT00047879|19706423|P1|NOT COMPLETED|Overall Study||4
8004151|NCT00047879|19706422|P2|COMPLETED|Overall Study||0
8004152|NCT00047879|19706423|P1|COMPLETED|Overall Study||0
8004153|NCT00047879|19706422|P2|STARTED|Overall Study||3
8004154|NCT00047879|19706423|P1|STARTED|Overall Study||4
8004155|NCT00047697|19706435|P2|NOT COMPLETED|Overall Study||2
8004156|NCT00047697|19706436|P1|NOT COMPLETED|Overall Study||0
8004157|NCT00047697|19706435|P2|COMPLETED|Overall Study||14
8004158|NCT00047697|19706436|P1|COMPLETED|Overall Study||18
8004159|NCT00047697|19706435|P2|STARTED|Overall Study||16
8004160|NCT00047697|19706436|P1|STARTED|Overall Study||18
8004161|NCT00047619|19706448|P2|NOT COMPLETED|Overall Study||0
8004162|NCT00047619|19706449|P1|NOT COMPLETED|Overall Study||0
8004163|NCT00047619|19706448|P2|COMPLETED|Overall Study||14
8004164|NCT00047619|19706449|P1|COMPLETED|Overall Study||14
8004165|NCT00047619|19706448|P2|STARTED|Overall Study||14
8004166|NCT00047619|19706449|P1|STARTED|Overall Study||14
8004167|NCT00047463|19706459|P2|NOT COMPLETED|Overall Study||3
8004168|NCT00047463|19706460|P1|NOT COMPLETED|Overall Study||0
8004169|NCT00047463|19706459|P2|COMPLETED|Overall Study||19
8004170|NCT00047463|19706460|P1|COMPLETED|Overall Study||13
8004171|NCT00047463|19706459|P2|STARTED|Overall Study||22
8004172|NCT00047463|19706460|P1|STARTED|Overall Study||13
8004173|NCT00046475|19706471|P3|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
8004174|NCT00046475|19706472|P2|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1
8004175|NCT00046475|19706473|P1|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
8004176|NCT00046475|19706471|P3|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59
8004177|NCT00046475|19706472|P2|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44
8004178|NCT00046475|19706473|P1|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
8004179|NCT00046475|19706471|P3|STARTED|Treatment Period 2 (Up to 2 Weeks)||59
8004180|NCT00046475|19706472|P2|STARTED|Treatment Period 2 (Up to 2 Weeks)||45
8004181|NCT00046475|19706473|P1|STARTED|Treatment Period 2 (Up to 2 Weeks)||0
8004182|NCT00046475|19706471|P3|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1
8004183|NCT00046475|19706472|P2|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
8004184|NCT00046475|19706473|P1|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
8004185|NCT00046475|19706471|P3|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59
8004186|NCT00046475|19706472|P2|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45
8004187|NCT00046475|19706473|P1|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
8004188|NCT00046475|19706471|P3|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60
8004189|NCT00046475|19706472|P2|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45
8004190|NCT00046475|19706473|P1|STARTED|Treatment Period 1 (Up to 2 Weeks)||0
8004191|NCT00046475|19706471|P3|NOT COMPLETED|Titration (1 Week)||0
8004192|NCT00046475|19706472|P2|NOT COMPLETED|Titration (1 Week)||0
8004193|NCT00046475|19706473|P1|NOT COMPLETED|Titration (1 Week)||0
8004194|NCT00046475|19706471|P3|COMPLETED|Titration (1 Week)||0
8004195|NCT00046475|19706472|P2|COMPLETED|Titration (1 Week)||0
8004196|NCT00046475|19706473|P1|COMPLETED|Titration (1 Week)||136
8004197|NCT00046475|19706471|P3|STARTED|Titration (1 Week)||0
8004198|NCT00046475|19706472|P2|STARTED|Titration (1 Week)||0
8004199|NCT00046475|19706473|P1|STARTED|Titration (1 Week)||136
8004200|NCT00046475|19706471|P3|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
8004201|NCT00046475|19706472|P2|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
8004202|NCT00046475|19706473|P1|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4
8004203|NCT00046475|19706471|P3|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
8004204|NCT00046475|19706472|P2|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
8004205|NCT00046475|19706473|P1|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136
8004206|NCT00046475|19706471|P3|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
8004207|NCT00046475|19706472|P2|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
8004208|NCT00046475|19706473|P1|STARTED|Screening/Washout Period (Up to 2 Weeks)||140
8004209|NCT00046566|19706512|P3|NOT COMPLETED|Intervention 3 (8 Weeks)||0
8004210|NCT00046566|19706513|P2|NOT COMPLETED|Intervention 3 (8 Weeks)||0
8004211|NCT00046566|19706514|P1|NOT COMPLETED|Intervention 3 (8 Weeks)||0
8004212|NCT00046566|19706512|P3|COMPLETED|Intervention 3 (8 Weeks)||88
8004213|NCT00046566|19706513|P2|COMPLETED|Intervention 3 (8 Weeks)||92
8004214|NCT00046566|19706514|P1|COMPLETED|Intervention 3 (8 Weeks)||93
8004215|NCT00046566|19706512|P3|STARTED|Intervention 3 (8 Weeks)||88
8004216|NCT00046566|19706513|P2|STARTED|Intervention 3 (8 Weeks)||92
8004217|NCT00046566|19706514|P1|STARTED|Intervention 3 (8 Weeks)||93
8004218|NCT00046566|19706512|P3|NOT COMPLETED|Intervention 2 (8 Weeks)||13
8004219|NCT00046566|19706513|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||12
8004220|NCT00046566|19706514|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||8
8004221|NCT00046566|19706512|P3|COMPLETED|Intervention 2 (8 Weeks)||88
8004222|NCT00046566|19706513|P2|COMPLETED|Intervention 2 (8 Weeks)||92
8004223|NCT00046566|19706514|P1|COMPLETED|Intervention 2 (8 Weeks)||93
8004224|NCT00046566|19706512|P3|STARTED|Intervention 2 (8 Weeks)|Soy protein 8 weeks|101
8004225|NCT00046566|19706513|P2|STARTED|Intervention 2 (8 Weeks)|Carbohydrate 8 weeks|104
8004226|NCT00046566|19706514|P1|STARTED|Intervention 2 (8 Weeks)|Milk protein 8 weeks|101
8004227|NCT00046566|19706512|P3|NOT COMPLETED|Intervention 1 (8 Weeks)||17
8004228|NCT00046566|19706513|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||13
8004229|NCT00046566|19706514|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||16
8004230|NCT00046566|19706512|P3|COMPLETED|Intervention 1 (8 Weeks)||101
8004231|NCT00046566|19706513|P2|COMPLETED|Intervention 1 (8 Weeks)||104
8004232|NCT00046566|19706514|P1|COMPLETED|Intervention 1 (8 Weeks)||101
8004233|NCT00046566|19706512|P3|STARTED|Intervention 1 (8 Weeks)|Carbohydrate 8 weeks|118
8004234|NCT00046566|19706513|P2|STARTED|Intervention 1 (8 Weeks)|Milk protein 8 weeks|117
8004235|NCT00046566|19706514|P1|STARTED|Intervention 1 (8 Weeks)|Soy protein 8 weeks|117
8004236|NCT00046228|19706531|P3|NOT COMPLETED|1 Year||12
8004237|NCT00046228|19706532|P2|NOT COMPLETED|1 Year||14
8004238|NCT00046228|19706533|P1|NOT COMPLETED|1 Year||19
8004239|NCT00046228|19706531|P3|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816
8004240|NCT00046228|19706532|P2|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804
8004241|NCT00046228|19706533|P1|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787
8004242|NCT00046228|19706531|P3|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828
8004243|NCT00046228|19706532|P2|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818
8004244|NCT00046228|19706533|P1|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806
8004245|NCT00046228|19706531|P3|NOT COMPLETED|90 Days||15
8004246|NCT00046228|19706532|P2|NOT COMPLETED|90 Days||8
8004247|NCT00046228|19706533|P1|NOT COMPLETED|90 Days||13
8004248|NCT00046228|19706531|P3|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813
8004249|NCT00046228|19706532|P2|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810
8004250|NCT00046228|19706533|P1|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793
8004251|NCT00046228|19706531|P3|STARTED|90 Days||828
8004252|NCT00046228|19706532|P2|STARTED|90 Days||818
8004253|NCT00046228|19706533|P1|STARTED|90 Days||806
8004254|NCT00045942|19706577|P9|NOT COMPLETED|PKC412A2104E2||6
8004255|NCT00045942|19706578|P8|NOT COMPLETED|PKC412A2104E2||7
8004256|NCT00045942|19706579|P7|NOT COMPLETED|PKC412A2104E2||7
8004257|NCT00045942|19706580|P6|NOT COMPLETED|PKC412A2104E2||9
8004258|NCT00045942|19706581|P5|NOT COMPLETED|PKC412A2104E2||0
8004259|NCT00045942|19706582|P4|NOT COMPLETED|PKC412A2104E2||0
8004260|NCT00045942|19706583|P3|NOT COMPLETED|PKC412A2104E2||0
8004261|NCT00045942|19706584|P2|NOT COMPLETED|PKC412A2104E2||0
8004262|NCT00045942|19706585|P1|NOT COMPLETED|PKC412A2104E2||0
8004263|NCT00045942|19706577|P9|COMPLETED|PKC412A2104E2||0
8004264|NCT00045942|19706578|P8|COMPLETED|PKC412A2104E2||0
8004265|NCT00045942|19706579|P7|COMPLETED|PKC412A2104E2||0
8004266|NCT00045942|19706580|P6|COMPLETED|PKC412A2104E2||0
8004267|NCT00045942|19706581|P5|COMPLETED|PKC412A2104E2||0
8004268|NCT00045942|19706582|P4|COMPLETED|PKC412A2104E2||0
8004269|NCT00045942|19706583|P3|COMPLETED|PKC412A2104E2||0
8004270|NCT00045942|19706584|P2|COMPLETED|PKC412A2104E2||0
8004271|NCT00045942|19706585|P1|COMPLETED|PKC412A2104E2||0
8004272|NCT00045942|19706577|P9|Primary Efficacy|PKC412A2104E2||6
8004273|NCT00045942|19706578|P8|Primary Efficacy|PKC412A2104E2||7
8004274|NCT00045942|19706579|P7|Primary Efficacy|PKC412A2104E2||7
8004275|NCT00045942|19706580|P6|Primary Efficacy|PKC412A2104E2||9
8004276|NCT00045942|19706581|P5|Primary Efficacy|PKC412A2104E2||0
8004277|NCT00045942|19706582|P4|Primary Efficacy|PKC412A2104E2||0
8004278|NCT00045942|19706583|P3|Primary Efficacy|PKC412A2104E2||0
8004279|NCT00045942|19706584|P2|Primary Efficacy|PKC412A2104E2||0
8004280|NCT00045942|19706585|P1|Primary Efficacy|PKC412A2104E2||0
8004281|NCT00045942|19706577|P9|STARTED|PKC412A2104E2||6
8004282|NCT00045942|19706578|P8|STARTED|PKC412A2104E2||7
8004283|NCT00045942|19706579|P7|STARTED|PKC412A2104E2||7
8004284|NCT00045942|19706580|P6|STARTED|PKC412A2104E2||9
8004285|NCT00045942|19706581|P5|STARTED|PKC412A2104E2||0
8004286|NCT00045942|19706582|P4|STARTED|PKC412A2104E2||0
8004287|NCT00045942|19706583|P3|STARTED|PKC412A2104E2||0
8004288|NCT00045942|19706584|P2|STARTED|PKC412A2104E2||0
8004289|NCT00045942|19706585|P1|STARTED|PKC412A2104E2||0
8004290|NCT00045942|19706577|P9|NOT COMPLETED|PKC412A2104E1||0
8004291|NCT00045942|19706578|P8|NOT COMPLETED|PKC412A2104E1||0
8004292|NCT00045942|19706579|P7|NOT COMPLETED|PKC412A2104E1||0
8004293|NCT00045942|19706580|P6|NOT COMPLETED|PKC412A2104E1||0
8004294|NCT00045942|19706581|P5|NOT COMPLETED|PKC412A2104E1||27
8004295|NCT00045942|19706582|P4|NOT COMPLETED|PKC412A2104E1||33
8004296|NCT00045942|19706583|P3|NOT COMPLETED|PKC412A2104E1||17
8004297|NCT00045942|19706584|P2|NOT COMPLETED|PKC412A2104E1||18
8004298|NCT00045942|19706585|P1|NOT COMPLETED|PKC412A2104E1||0
8004299|NCT00045942|19706577|P9|COMPLETED|PKC412A2104E1||0
8004300|NCT00045942|19706578|P8|COMPLETED|PKC412A2104E1||0
8004301|NCT00045942|19706579|P7|COMPLETED|PKC412A2104E1||0
8004302|NCT00045942|19706580|P6|COMPLETED|PKC412A2104E1||0
8004303|NCT00045942|19706581|P5|COMPLETED|PKC412A2104E1||0
8004304|NCT00045942|19706582|P4|COMPLETED|PKC412A2104E1||0
8004305|NCT00045942|19706583|P3|COMPLETED|PKC412A2104E1||0
8004306|NCT00045942|19706584|P2|COMPLETED|PKC412A2104E1||0
8004307|NCT00045942|19706585|P1|COMPLETED|PKC412A2104E1||0
8004308|NCT00045942|19706577|P9|Primary Efficacy|PKC412A2104E1||0
8004309|NCT00045942|19706578|P8|Primary Efficacy|PKC412A2104E1||0
8004310|NCT00045942|19706579|P7|Primary Efficacy|PKC412A2104E1||0
8004311|NCT00045942|19706580|P6|Primary Efficacy|PKC412A2104E1||0
8004312|NCT00045942|19706581|P5|Primary Efficacy|PKC412A2104E1||25
8004313|NCT00045942|19706582|P4|Primary Efficacy|PKC412A2104E1||32
8004314|NCT00045942|19706583|P3|Primary Efficacy|PKC412A2104E1||17
8004315|NCT00045942|19706584|P2|Primary Efficacy|PKC412A2104E1||18
8004316|NCT00045942|19706585|P1|Primary Efficacy|PKC412A2104E1||0
8004317|NCT00045942|19706577|P9|STARTED|PKC412A2104E1||0
8004318|NCT00045942|19706578|P8|STARTED|PKC412A2104E1||0
8004319|NCT00045942|19706579|P7|STARTED|PKC412A2104E1||0
8004320|NCT00045942|19706580|P6|STARTED|PKC412A2104E1||0
8004321|NCT00045942|19706581|P5|STARTED|PKC412A2104E1||27
8004322|NCT00045942|19706582|P4|STARTED|PKC412A2104E1||33
8004323|NCT00045942|19706583|P3|STARTED|PKC412A2104E1||17
8004324|NCT00045942|19706584|P2|STARTED|PKC412A2104E1||18
8004325|NCT00045942|19706585|P1|STARTED|PKC412A2104E1||0
8004326|NCT00045942|19706577|P9|NOT COMPLETED|PKC412A2104 (Core)||0
8004327|NCT00045942|19706578|P8|NOT COMPLETED|PKC412A2104 (Core)||0
8004328|NCT00045942|19706579|P7|NOT COMPLETED|PKC412A2104 (Core)||0
8004329|NCT00045942|19706580|P6|NOT COMPLETED|PKC412A2104 (Core)||0
8004330|NCT00045942|19706581|P5|NOT COMPLETED|PKC412A2104 (Core)||0
8004331|NCT00045942|19706582|P4|NOT COMPLETED|PKC412A2104 (Core)||0
8004332|NCT00045942|19706583|P3|NOT COMPLETED|PKC412A2104 (Core)||0
8004333|NCT00045942|19706584|P2|NOT COMPLETED|PKC412A2104 (Core)||0
8004334|NCT00045942|19706585|P1|NOT COMPLETED|PKC412A2104 (Core)||20
8004335|NCT00045942|19706577|P9|COMPLETED|PKC412A2104 (Core)||0
8004336|NCT00045942|19706578|P8|COMPLETED|PKC412A2104 (Core)||0
8004337|NCT00045942|19706579|P7|COMPLETED|PKC412A2104 (Core)||0
8004338|NCT00045942|19706580|P6|COMPLETED|PKC412A2104 (Core)||0
8004339|NCT00045942|19706581|P5|COMPLETED|PKC412A2104 (Core)||0
8004340|NCT00045942|19706582|P4|COMPLETED|PKC412A2104 (Core)||0
8004341|NCT00045942|19706583|P3|COMPLETED|PKC412A2104 (Core)||0
8004342|NCT00045942|19706584|P2|COMPLETED|PKC412A2104 (Core)||0
8004343|NCT00045942|19706585|P1|COMPLETED|PKC412A2104 (Core)||0
8004344|NCT00045942|19706577|P9|Core Primary Efficacy|PKC412A2104 (Core)||0
8004345|NCT00045942|19706578|P8|Core Primary Efficacy|PKC412A2104 (Core)||0
8004346|NCT00045942|19706579|P7|Core Primary Efficacy|PKC412A2104 (Core)||0
8004347|NCT00045942|19706580|P6|Core Primary Efficacy|PKC412A2104 (Core)||0
8004348|NCT00045942|19706581|P5|Core Primary Efficacy|PKC412A2104 (Core)||0
8004349|NCT00045942|19706582|P4|Core Primary Efficacy|PKC412A2104 (Core)||0
8004350|NCT00045942|19706583|P3|Core Primary Efficacy|PKC412A2104 (Core)||0
8004351|NCT00045942|19706584|P2|Core Primary Efficacy|PKC412A2104 (Core)||0
8004352|NCT00045942|19706585|P1|Core Primary Efficacy|PKC412A2104 (Core)||20
8004353|NCT00045942|19706577|P9|STARTED|PKC412A2104 (Core)||0
8004354|NCT00045942|19706578|P8|STARTED|PKC412A2104 (Core)||0
8004355|NCT00045942|19706579|P7|STARTED|PKC412A2104 (Core)||0
8004356|NCT00045942|19706580|P6|STARTED|PKC412A2104 (Core)||0
8004357|NCT00045942|19706581|P5|STARTED|PKC412A2104 (Core)||0
8004358|NCT00045942|19706582|P4|STARTED|PKC412A2104 (Core)||0
8004359|NCT00045942|19706583|P3|STARTED|PKC412A2104 (Core)||0
8004360|NCT00045942|19706584|P2|STARTED|PKC412A2104 (Core)||0
8004361|NCT00045942|19706585|P1|STARTED|PKC412A2104 (Core)||20
8004362|NCT00044655|19706667|P2|NOT COMPLETED|Overall Study||38
8004363|NCT00044655|19706668|P1|NOT COMPLETED|Overall Study||20
8004364|NCT00044655|19706667|P2|COMPLETED|Overall Study||79
8004365|NCT00044655|19706668|P1|COMPLETED|Overall Study||82
8004366|NCT00044655|19706667|P2|STARTED|Overall Study||117
8004367|NCT00044655|19706668|P1|STARTED|Overall Study||102
8004368|NCT00044512|19706674|P1|NOT COMPLETED|Follow Up||2
8004369|NCT00044512|19706674|P1|COMPLETED|Follow Up||135
8004370|NCT00044512|19706674|P1|STARTED|Follow Up||137
8004371|NCT00044512|19706674|P1|NOT COMPLETED|Treatment||0
8004372|NCT00044512|19706674|P1|COMPLETED|Treatment||137
8004373|NCT00044512|19706674|P1|STARTED|Treatment||137
8004374|NCT00044213|19706689|P4|NOT COMPLETED|Overall Study||136
8004375|NCT00044213|19706690|P3|NOT COMPLETED|Overall Study||138
8004376|NCT00044213|19706691|P2|NOT COMPLETED|Overall Study||112
8004377|NCT00044213|19706692|P1|NOT COMPLETED|Overall Study||100
8004378|NCT00044213|19706689|P4|COMPLETED|Overall Study||301
8004379|NCT00044213|19706690|P3|COMPLETED|Overall Study||294
8004380|NCT00044213|19706691|P2|COMPLETED|Overall Study||306
8004381|NCT00044213|19706692|P1|COMPLETED|Overall Study||321
8004382|NCT00044213|19706689|P4|STARTED|Overall Study||437
8004383|NCT00044213|19706690|P3|STARTED|Overall Study||432
8004384|NCT00044213|19706691|P2|STARTED|Overall Study||418
8004385|NCT00044213|19706692|P1|STARTED|Overall Study||421
8004386|NCT00044044|19706711|P5|NOT COMPLETED|Overall Study||36
8004387|NCT00044044|19706712|P4|NOT COMPLETED|Overall Study||44
8004388|NCT00044044|19706713|P3|NOT COMPLETED|Overall Study||40
8004389|NCT00044044|19706714|P2|NOT COMPLETED|Overall Study||41
8004390|NCT00044044|19706715|P1|NOT COMPLETED|Overall Study||44
8004391|NCT00044044|19706711|P5|COMPLETED|Overall Study||36
8004392|NCT00044044|19706712|P4|COMPLETED|Overall Study||29
8004393|NCT00044044|19706713|P3|COMPLETED|Overall Study||31
8004394|NCT00044044|19706714|P2|COMPLETED|Overall Study||28
8004395|NCT00044044|19706715|P1|COMPLETED|Overall Study||27
8004396|NCT00044044|19706711|P5|STARTED|Overall Study||72
8004397|NCT00044044|19706712|P4|STARTED|Overall Study||73
8004398|NCT00044044|19706713|P3|STARTED|Overall Study||71
8004399|NCT00044044|19706714|P2|STARTED|Overall Study||69
8004400|NCT00044044|19706715|P1|STARTED|Overall Study||71
8004401|NCT00044005|19706745|P3|NOT COMPLETED|Overall Study||22
8004402|NCT00044005|19706746|P2|NOT COMPLETED|Overall Study||14
8004403|NCT00044005|19706747|P1|NOT COMPLETED|Overall Study||19
8004404|NCT00044005|19706745|P3|COMPLETED|Overall Study||11
8004405|NCT00044005|19706746|P2|COMPLETED|Overall Study||19
8004406|NCT00044005|19706747|P1|COMPLETED|Overall Study||13
8004407|NCT00044005|19706745|P3|STARTED|Overall Study||33
8004408|NCT00044005|19706746|P2|STARTED|Overall Study||33
8004409|NCT00044005|19706747|P1|STARTED|Overall Study||32
8004410|NCT00044083|19706757|P2|NOT COMPLETED|Second Intervention (One Week) Patients||1
8004411|NCT00044083|19706758|P1|NOT COMPLETED|Second Intervention (One Week) Patients||0
8004412|NCT00044083|19706757|P2|COMPLETED|Second Intervention (One Week) Patients||29
8004413|NCT00044083|19706758|P1|COMPLETED|Second Intervention (One Week) Patients||30
8004414|NCT00044083|19706757|P2|STARTED|Second Intervention (One Week) Patients||30
8004415|NCT00044083|19706758|P1|STARTED|Second Intervention (One Week) Patients||30
8004416|NCT00044083|19706757|P2|NOT COMPLETED|First Intervention (One Week) Patients||2
8004417|NCT00044083|19706758|P1|NOT COMPLETED|First Intervention (One Week) Patients||1
8004418|NCT00044083|19706757|P2|COMPLETED|First Intervention (One Week) Patients||30
8004419|NCT00044083|19706758|P1|COMPLETED|First Intervention (One Week) Patients||30
8004420|NCT00044083|19706757|P2|STARTED|First Intervention (One Week) Patients||32
8004421|NCT00044083|19706758|P1|STARTED|First Intervention (One Week) Patients||31
8004422|NCT00044083|19706757|P2|NOT COMPLETED|Second Intervention (One Week) HV's||0
8004423|NCT00044083|19706758|P1|NOT COMPLETED|Second Intervention (One Week) HV's||0
8004424|NCT00044083|19706757|P2|COMPLETED|Second Intervention (One Week) HV's||66
8004425|NCT00044083|19706758|P1|COMPLETED|Second Intervention (One Week) HV's||64
8004426|NCT00044083|19706757|P2|STARTED|Second Intervention (One Week) HV's||66
8004427|NCT00044083|19706758|P1|STARTED|Second Intervention (One Week) HV's||64
8004428|NCT00044083|19706757|P2|NOT COMPLETED|First Intervention (One Week)- HV's||7
8004429|NCT00044083|19706758|P1|NOT COMPLETED|First Intervention (One Week)- HV's||10
8004430|NCT00044083|19706757|P2|COMPLETED|First Intervention (One Week)- HV's||66
8004431|NCT00044083|19706758|P1|COMPLETED|First Intervention (One Week)- HV's||64
8004432|NCT00044083|19706757|P2|STARTED|First Intervention (One Week)- HV's||73
8004433|NCT00044083|19706758|P1|STARTED|First Intervention (One Week)- HV's||74
8004434|NCT00043979|19706796|P3|NOT COMPLETED|Period 2||0
8004435|NCT00043979|19706797|P2|NOT COMPLETED|Period 2||0
8004436|NCT00043979|19706798|P1|NOT COMPLETED|Period 2||0
8004437|NCT00043979|19706796|P3|COMPLETED|Period 2||10
8004438|NCT00043979|19706797|P2|COMPLETED|Period 2||13
8004439|NCT00043979|19706798|P1|COMPLETED|Period 2||0
8004440|NCT00043979|19706796|P3|STARTED|Period 2||10
8004441|NCT00043979|19706797|P2|STARTED|Period 2||13
8004442|NCT00043979|19706798|P1|STARTED|Period 2||0
8004443|NCT00043979|19706796|P3|NOT COMPLETED|Period 1||3
8004444|NCT00043979|19706797|P2|NOT COMPLETED|Period 1||4
8004445|NCT00043979|19706798|P1|NOT COMPLETED|Period 1||7
8004446|NCT00043979|19706796|P3|COMPLETED|Period 1||10
8004447|NCT00043979|19706797|P2|COMPLETED|Period 1||13
8004448|NCT00043979|19706798|P1|COMPLETED|Period 1||23
8004449|NCT00043979|19706796|P3|STARTED|Period 1||13
8004450|NCT00043979|19706797|P2|STARTED|Period 1||17
8004451|NCT00043979|19706798|P1|STARTED|Period 1||30
8004452|NCT00043550|19706819|P3|NOT COMPLETED|Overall Study||20
8004453|NCT00043550|19706820|P2|NOT COMPLETED|Overall Study||12
8004454|NCT00043550|19706821|P1|NOT COMPLETED|Overall Study||22
8004455|NCT00043550|19706819|P3|COMPLETED|Overall Study||30
8004456|NCT00043550|19706820|P2|COMPLETED|Overall Study||39
8004457|NCT00043550|19706821|P1|COMPLETED|Overall Study||33
8004458|NCT00043550|19706819|P3|Week 8 Completed|Overall Study||35
8004459|NCT00043550|19706820|P2|Week 8 Completed|Overall Study||40
8004460|NCT00043550|19706821|P1|Week 8 Completed|Overall Study||35
8004461|NCT00043550|19706819|P3|STARTED|Overall Study||50
8004462|NCT00043550|19706820|P2|STARTED|Overall Study||51
8004463|NCT00043550|19706821|P1|STARTED|Overall Study||55
8004464|NCT00043186|19706838|P9|NOT COMPLETED|Overall Study||17
8004465|NCT00043186|19706839|P8|NOT COMPLETED|Overall Study||16
8004466|NCT00043186|19706840|P7|NOT COMPLETED|Overall Study||17
8004467|NCT00043186|19706841|P6|NOT COMPLETED|Overall Study||8
8004468|NCT00043186|19706842|P5|NOT COMPLETED|Overall Study||18
8004469|NCT00043186|19706843|P4|NOT COMPLETED|Overall Study||22
8004470|NCT00043186|19706844|P3|NOT COMPLETED|Overall Study||20
8004471|NCT00043186|19706845|P2|NOT COMPLETED|Overall Study||15
8004472|NCT00043186|19706846|P1|NOT COMPLETED|Overall Study||17
8004473|NCT00043186|19706838|P9|COMPLETED|Overall Study||30
8004474|NCT00043186|19706839|P8|COMPLETED|Overall Study||31
8004475|NCT00043186|19706840|P7|COMPLETED|Overall Study||25
8004476|NCT00043186|19706841|P6|COMPLETED|Overall Study||39
8004477|NCT00043186|19706842|P5|COMPLETED|Overall Study||36
8004478|NCT00043186|19706843|P4|COMPLETED|Overall Study||19
8004479|NCT00043186|19706844|P3|COMPLETED|Overall Study||24
8004480|NCT00043186|19706845|P2|COMPLETED|Overall Study||29
8004481|NCT00043186|19706846|P1|COMPLETED|Overall Study||29
8004482|NCT00043186|19706838|P9|STARTED|Overall Study||47
8004483|NCT00043186|19706839|P8|STARTED|Overall Study||47
8004484|NCT00043186|19706840|P7|STARTED|Overall Study||42
8004485|NCT00043186|19706841|P6|STARTED|Overall Study||47
8004486|NCT00043186|19706842|P5|STARTED|Overall Study||54
8004487|NCT00043186|19706843|P4|STARTED|Overall Study||41
8004488|NCT00043186|19706844|P3|STARTED|Overall Study||44
8004489|NCT00043186|19706845|P2|STARTED|Overall Study||44
8004490|NCT00043186|19706846|P1|STARTED|Overall Study||46
8004491|NCT00042666|19707172|P1|NOT COMPLETED|Overall Study||54
8004492|NCT00042666|19707172|P1|COMPLETED|Overall Study||1
8004493|NCT00042666|19707172|P1|Completed at Least 1 Cycle of Study Drug|Overall Study||42
8004494|NCT00042666|19707172|P1|Received at Least 1 Dose of Study Drug|Overall Study||55
8004495|NCT00042666|19707172|P1|STARTED|Overall Study||55
8004496|NCT00042432|19707184|P2|NOT COMPLETED|Overall Study||7
8004497|NCT00042432|19707185|P1|NOT COMPLETED|Overall Study||9
8004498|NCT00042432|19707184|P2|COMPLETED|Overall Study||20
8004499|NCT00042432|19707185|P1|COMPLETED|Overall Study||18
8004500|NCT00042432|19707184|P2|STARTED|Overall Study||27
8004501|NCT00042432|19707185|P1|STARTED|Overall Study||27
8004502|NCT00042224|19707195|P2|NOT COMPLETED|Overall Study||3
8004503|NCT00042224|19707196|P1|NOT COMPLETED|Overall Study||3
8004504|NCT00042224|19707195|P2|COMPLETED|Overall Study||16
8004505|NCT00042224|19707196|P1|COMPLETED|Overall Study||17
8004506|NCT00042224|19707195|P2|STARTED|Overall Study||19
8004507|NCT00042224|19707196|P1|STARTED|Overall Study||20
8004508|NCT00041938|19707204|P2|NOT COMPLETED|Overall Study||31
8004509|NCT00041938|19707205|P1|NOT COMPLETED|Overall Study||38
8004510|NCT00041938|19707204|P2|COMPLETED|Overall Study||1111
8004511|NCT00041938|19707205|P1|COMPLETED|Overall Study||1125
8004512|NCT00041938|19707204|P2|Withdrew Consent|Overall Study||14
8004513|NCT00041938|19707205|P1|Withdrew Consent|Overall Study||20
8004514|NCT00041938|19707204|P2|Lost to Follow-up|Overall Study||17
8004515|NCT00041938|19707205|P1|Lost to Follow-up|Overall Study||18
8004516|NCT00041938|19707204|P2|Only Vital Status Known|Overall Study||46
8004517|NCT00041938|19707205|P1|Only Vital Status Known|Overall Study||44
8004518|NCT00041938|19707204|P2|Primary Endpoint|Overall Study||302
8004519|NCT00041938|19707205|P1|Primary Endpoint|Overall Study||320
8004520|NCT00041938|19707204|P2|Completed Follow-up|Overall Study||745
8004521|NCT00041938|19707205|P1|Completed Follow-up|Overall Study||761
8004522|NCT00041938|19707204|P2|STARTED|Overall Study||1142
8004523|NCT00041938|19707205|P1|STARTED|Overall Study||1163
8004524|NCT00041756|19707238|P5|NOT COMPLETED|Overall Study||60
8004525|NCT00041756|19707239|P4|NOT COMPLETED|Overall Study||16
8004526|NCT00041756|19707240|P3|NOT COMPLETED|Overall Study||13
8004527|NCT00041756|19707241|P2|NOT COMPLETED|Overall Study||15
8004528|NCT00041756|19707242|P1|NOT COMPLETED|Overall Study||8
8004529|NCT00041756|19707238|P5|COMPLETED|Overall Study||19
8004530|NCT00041756|19707239|P4|COMPLETED|Overall Study||64
8004531|NCT00041756|19707240|P3|COMPLETED|Overall Study||66
8004532|NCT00041756|19707241|P2|COMPLETED|Overall Study||65
8004533|NCT00041756|19707242|P1|COMPLETED|Overall Study||69
8004534|NCT00041756|19707238|P5|STARTED|Overall Study||79
8004535|NCT00041756|19707239|P4|STARTED|Overall Study||80
8004536|NCT00041756|19707240|P3|STARTED|Overall Study||79
8004537|NCT00041756|19707241|P2|STARTED|Overall Study||80
8004538|NCT00041756|19707242|P1|STARTED|Overall Study||77
8004539|NCT00041717|19707261|P2|NOT COMPLETED|Overall Study||12
8004540|NCT00041717|19707262|P1|NOT COMPLETED|Overall Study||33
8004541|NCT00041717|19707261|P2|COMPLETED|Overall Study||86
8004542|NCT00041717|19707262|P1|COMPLETED|Overall Study||81
8004543|NCT00041717|19707261|P2|STARTED|Overall Study||98
8004544|NCT00041717|19707262|P1|STARTED|Overall Study||114
8004545|NCT00041470|19707270|P1|NOT COMPLETED|Overall Study||38
8004546|NCT00041470|19707270|P1|COMPLETED|Overall Study||0
8004547|NCT00041470|19707270|P1|STARTED|Overall Study||38
8004548|NCT00040664|19707275|P4|NOT COMPLETED|Overall Study||27
8004549|NCT00040664|19707276|P3|NOT COMPLETED|Overall Study||13
8004550|NCT00040664|19707277|P2|NOT COMPLETED|Overall Study||13
8004551|NCT00040664|19707278|P1|NOT COMPLETED|Overall Study||53
8004552|NCT00040664|19707275|P4|COMPLETED|Overall Study||8
8004553|NCT00040664|19707276|P3|COMPLETED|Overall Study||4
8004554|NCT00040664|19707277|P2|COMPLETED|Overall Study||4
8004555|NCT00040664|19707278|P1|COMPLETED|Overall Study||16
8004556|NCT00040664|19707275|P4|STARTED|Overall Study||35
8004557|NCT00040664|19707276|P3|STARTED|Overall Study||17
8004558|NCT00040664|19707277|P2|STARTED|Overall Study||17
8004559|NCT00040664|19707278|P1|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69
8004560|NCT00041392|19707328|P2|NOT COMPLETED|Overall Study||0
8004561|NCT00041392|19707329|P1|NOT COMPLETED|Overall Study||0
8004562|NCT00041392|19707328|P2|COMPLETED|Overall Study||191
8004563|NCT00041392|19707329|P1|COMPLETED|Overall Study||198
8004564|NCT00041392|19707328|P2|STARTED|Overall Study||191
8004565|NCT00041392|19707329|P1|STARTED|Overall Study||198
8004566|NCT00040443|19707337|P2|NOT COMPLETED|Overall Study||0
8004567|NCT00040443|19707338|P1|NOT COMPLETED|Overall Study||0
8004568|NCT00040443|19707337|P2|COMPLETED|Overall Study||91
8004569|NCT00040443|19707338|P1|COMPLETED|Overall Study||84
8004570|NCT00040443|19707337|P2|STARTED|Overall Study||91
8004571|NCT00040443|19707338|P1|STARTED|Overall Study||84
8004572|NCT00040365|19707344|P1|NOT COMPLETED|Overall Study||11
8004573|NCT00040365|19707344|P1|COMPLETED|Overall Study||19
8004574|NCT00040365|19707344|P1|Completed Follow Up Phase|Overall Study||19
8004575|NCT00040365|19707344|P1|STARTED|Overall Study||30
8004576|NCT00039871|19707353|P1|NOT COMPLETED|Overall Study||1384
8004577|NCT00039871|19707353|P1|COMPLETED|Overall Study||928
8004578|NCT00039871|19707353|P1|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312
8004579|NCT00039741|19707363|P4|NOT COMPLETED|Overall Study||14
8004580|NCT00039741|19707364|P3|NOT COMPLETED|Overall Study||11
8004581|NCT00039741|19707365|P2|NOT COMPLETED|Overall Study||12
8004582|NCT00039741|19707366|P1|NOT COMPLETED|Overall Study||15
8004583|NCT00039741|19707363|P4|COMPLETED|Overall Study||50
8004584|NCT00039741|19707364|P3|COMPLETED|Overall Study||54
8004585|NCT00039741|19707365|P2|COMPLETED|Overall Study||56
8004586|NCT00039741|19707366|P1|COMPLETED|Overall Study||51
8004587|NCT00039741|19707363|P4|Death|Overall Study||0
8004588|NCT00039741|19707364|P3|Death|Overall Study||0
8004589|NCT00039741|19707365|P2|Death|Overall Study||1
8004590|NCT00039741|19707366|P1|Death|Overall Study||0
8004591|NCT00039741|19707363|P4|STARTED|Overall Study||64
8004592|NCT00039741|19707364|P3|STARTED|Overall Study||65
8004593|NCT00039741|19707365|P2|STARTED|Overall Study||68
8004594|NCT00039741|19707366|P1|STARTED|Overall Study||66
8004595|NCT00038948|19707410|P2|NOT COMPLETED|Overall Study||77
8004596|NCT00038948|19707411|P1|NOT COMPLETED|Overall Study||169
8004597|NCT00038948|19707410|P2|COMPLETED|Overall Study||198
8004598|NCT00038948|19707411|P1|COMPLETED|Overall Study||386
8004599|NCT00038948|19707410|P2|STARTED|Overall Study||275
8004600|NCT00038948|19707411|P1|STARTED|Overall Study||555
8004601|NCT00038857|19707423|P1|NOT COMPLETED|Overall Study||1
8004602|NCT00038857|19707423|P1|COMPLETED|Overall Study||28
8004603|NCT00038857|19707423|P1|STARTED|Overall Study||29
8004604|NCT00038727|19707430|P3|NOT COMPLETED|Overall Study||0
8004605|NCT00038727|19707431|P2|NOT COMPLETED|Overall Study||0
8004606|NCT00038727|19707432|P1|NOT COMPLETED|Overall Study||0
8004607|NCT00038727|19707430|P3|COMPLETED|Overall Study||936
8004608|NCT00038727|19707431|P2|COMPLETED|Overall Study||927
8004609|NCT00038727|19707432|P1|COMPLETED|Overall Study||916
8004610|NCT00038727|19707430|P3|DPPOS Phase 3 Enrolled|Overall Study||936
8004611|NCT00038727|19707431|P2|DPPOS Phase 3 Enrolled|Overall Study||927
8004612|NCT00038727|19707432|P1|DPPOS Phase 3 Enrolled|Overall Study||916
8004613|NCT00038727|19707430|P3|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|780
8004614|NCT00038727|19707431|P2|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|772
8004615|NCT00038727|19707432|P1|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|751
8004616|NCT00038727|19707430|P3|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|935
8004617|NCT00038727|19707431|P2|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|926
8004618|NCT00038727|19707432|P1|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|915
8004619|NCT00038727|19707430|P3|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|932
8004620|NCT00038727|19707431|P2|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|924
8004621|NCT00038727|19707432|P1|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|910
8004622|NCT00038727|19707430|P3|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|936
8004623|NCT00038727|19707431|P2|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|927
8004624|NCT00038727|19707432|P1|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|916
8004625|NCT00038649|19707446|P1|NOT COMPLETED|Overall Study||9
8004626|NCT00038649|19707446|P1|COMPLETED|Overall Study||105
8004627|NCT00038649|19707446|P1|STARTED|Overall Study||114
8004628|NCT00038610|19707451|P1|NOT COMPLETED|Overall Study||0
8004629|NCT00038610|19707451|P1|COMPLETED|Overall Study||54
8004630|NCT00038610|19707451|P1|STARTED|Overall Study||54
8004631|NCT00038467|19707459|P2|NOT COMPLETED|Overall Study||542
8004632|NCT00038467|19707460|P1|NOT COMPLETED|Overall Study||542
8004633|NCT00038467|19707459|P2|COMPLETED|Overall Study||1830
8004634|NCT00038467|19707460|P1|COMPLETED|Overall Study||1810
8004635|NCT00038467|19707459|P2|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337
8004636|NCT00038467|19707460|P1|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321
8004637|NCT00038467|19707459|P2|STARTED|Overall Study||2372
8004638|NCT00038467|19707460|P1|STARTED|Overall Study||2352
8004639|NCT00038142|19707522|P2|NOT COMPLETED|Overall Study||7
8004640|NCT00038142|19707523|P1|NOT COMPLETED|Overall Study||22
8004641|NCT00038142|19707522|P2|COMPLETED|Overall Study||7
8004642|NCT00038142|19707523|P1|COMPLETED|Overall Study||10
8004643|NCT00038142|19707522|P2|STARTED|Overall Study||14
8004644|NCT00038142|19707523|P1|STARTED|Overall Study||32
8004645|NCT00038103|19707531|P2|NOT COMPLETED|Overall Study||56
8004646|NCT00038103|19707532|P1|NOT COMPLETED|Overall Study||55
8004647|NCT00038103|19707531|P2|COMPLETED|Overall Study||0
8004648|NCT00038103|19707532|P1|COMPLETED|Overall Study||0
8004649|NCT00038103|19707531|P2|End of Treatment|Overall Study|patients remained on treatment until discontinued|56
8004650|NCT00038103|19707532|P1|End of Treatment|Overall Study|patients remained on treatment until discontinued|53
8004651|NCT00038103|19707531|P2|STARTED|Overall Study||56
8004652|NCT00038103|19707532|P1|STARTED|Overall Study||55
8004653|NCT00037830|19707555|P3|NOT COMPLETED|Overall Study||1
8004654|NCT00037830|19707556|P2|NOT COMPLETED|Overall Study||7
8004655|NCT00037830|19707557|P1|NOT COMPLETED|Overall Study||10
8004656|NCT00037830|19707555|P3|COMPLETED|Overall Study||16
8004657|NCT00037830|19707556|P2|COMPLETED|Overall Study||31
8004658|NCT00037830|19707557|P1|COMPLETED|Overall Study||29
8004659|NCT00037830|19707555|P3|STARTED|Overall Study||17
8004660|NCT00037830|19707556|P2|STARTED|Overall Study||38
8004661|NCT00037830|19707557|P1|STARTED|Overall Study||39
8004662|NCT00036569|19707578|P1|NOT COMPLETED|Overall Study||0
8004663|NCT00036569|19707578|P1|COMPLETED|Overall Study||32
8004664|NCT00036569|19707578|P1|STARTED|Overall Study||32
8004665|NCT00036270|19707589|P2|NOT COMPLETED|Study Treatment to 5 Year Report||3488
8004666|NCT00036270|19707590|P1|NOT COMPLETED|Study Treatment to 5 Year Report||2565
8004667|NCT00036270|19707589|P2|COMPLETED|Study Treatment to 5 Year Report||1380
8004668|NCT00036270|19707590|P1|COMPLETED|Study Treatment to 5 Year Report||2333
8004669|NCT00036270|19707589|P2|Treated|Study Treatment to 5 Year Report||4814
8004670|NCT00036270|19707590|P1|Treated|Study Treatment to 5 Year Report||4852
8004671|NCT00036270|19707589|P2|STARTED|Study Treatment to 5 Year Report||4868
8004672|NCT00036270|19707590|P1|STARTED|Study Treatment to 5 Year Report||4898
8004673|NCT00036270|19707589|P2|NOT COMPLETED|Randomized to Study Treatment||7
8004674|NCT00036270|19707590|P1|NOT COMPLETED|Randomized to Study Treatment||6
8004675|NCT00036270|19707589|P2|COMPLETED|Randomized to Study Treatment||4868
8004676|NCT00036270|19707590|P1|COMPLETED|Randomized to Study Treatment||4898
8004677|NCT00036270|19707589|P2|STARTED|Randomized to Study Treatment||4875
8004678|NCT00036270|19707590|P1|STARTED|Randomized to Study Treatment||4904
8004679|NCT00035932|19707609|P3|NOT COMPLETED|Overall Study||49
8004680|NCT00035932|19707610|P2|NOT COMPLETED|Overall Study||60
8004681|NCT00035932|19707611|P1|NOT COMPLETED|Overall Study||56
8004682|NCT00035932|19707609|P3|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69
8004683|NCT00035932|19707610|P2|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50
8004684|NCT00035932|19707611|P1|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63
8004685|NCT00035932|19707609|P3|Discontinued on or After Week 96|Overall Study||6
8004686|NCT00035932|19707610|P2|Discontinued on or After Week 96|Overall Study||4
8004687|NCT00035932|19707611|P1|Discontinued on or After Week 96|Overall Study||4
8004688|NCT00035932|19707609|P3|Discontinued Between Weeks 48 and 96|Overall Study||30
8004689|NCT00035932|19707610|P2|Discontinued Between Weeks 48 and 96|Overall Study||27
8004690|NCT00035932|19707611|P1|Discontinued Between Weeks 48 and 96|Overall Study||26
8004691|NCT00035932|19707609|P3|Discontinued Prior to Week 48 Visit|Overall Study||13
8004692|NCT00035932|19707610|P2|Discontinued Prior to Week 48 Visit|Overall Study||29
8004693|NCT00035932|19707611|P1|Discontinued Prior to Week 48 Visit|Overall Study||26
8004694|NCT00035932|19707609|P3|STARTED|Overall Study|123 randomized, 118 treated|118
8004695|NCT00035932|19707610|P2|STARTED|Overall Study|115 randomized, 110 treated|110
8004696|NCT00035932|19707611|P1|STARTED|Overall Study|120 randomized, 119 treated|119
8004697|NCT00035815|19707737|P2|NOT COMPLETED|Overall Study||11
8004698|NCT00035815|19707738|P1|NOT COMPLETED|Overall Study||17
8004699|NCT00035815|19707737|P2|COMPLETED|Overall Study||152
8004700|NCT00035815|19707738|P1|COMPLETED|Overall Study||150
8004701|NCT00035815|19707737|P2|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163
8004702|NCT00035815|19707738|P1|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167
8004703|NCT00035555|19707751|P3|NOT COMPLETED|Overall Study||22
8004704|NCT00035555|19707752|P2|NOT COMPLETED|Overall Study||16
8004705|NCT00035555|19707753|P1|NOT COMPLETED|Overall Study||16
8004706|NCT00035555|19707751|P3|COMPLETED|Overall Study||51
8004707|NCT00035555|19707752|P2|COMPLETED|Overall Study||55
8004708|NCT00035555|19707753|P1|COMPLETED|Overall Study||58
8004709|NCT00035555|19707751|P3|Number Who Received Study Drug|Overall Study||71
8004710|NCT00035555|19707752|P2|Number Who Received Study Drug|Overall Study||71
8004711|NCT00035555|19707753|P1|Number Who Received Study Drug|Overall Study||74
8004712|NCT00035555|19707751|P3|Number Who Had Undergone Transplantation|Overall Study||73
8004713|NCT00035555|19707752|P2|Number Who Had Undergone Transplantation|Overall Study||71
8004714|NCT00035555|19707753|P1|Number Who Had Undergone Transplantation|Overall Study||74
8004715|NCT00035555|19707751|P3|STARTED|Overall Study|Randomized patients|73
8004716|NCT00035555|19707752|P2|STARTED|Overall Study|Randomized patients|71
8004717|NCT00035555|19707753|P1|STARTED|Overall Study|Randomized patients|74
8004718|NCT00033917|19707796|P2|NOT COMPLETED|Overall Study||0
8004719|NCT00033917|19707797|P1|NOT COMPLETED|Overall Study||0
8004720|NCT00033917|19707796|P2|COMPLETED|Overall Study||222
8004721|NCT00033917|19707797|P1|COMPLETED|Overall Study||209
8004722|NCT00033917|19707796|P2|STARTED|Overall Study||222
8004723|NCT00033917|19707797|P1|STARTED|Overall Study||209
8004724|NCT00032630|19707809|P2|NOT COMPLETED|Overall Study||43
8004725|NCT00032630|19707810|P1|NOT COMPLETED|Overall Study||49
8004726|NCT00032630|19707809|P2|COMPLETED|Overall Study||1061
8004727|NCT00032630|19707810|P1|COMPLETED|Overall Study||1050
8004728|NCT00032630|19707809|P2|STARTED|Overall Study||1104
8004729|NCT00032630|19707810|P1|STARTED|Overall Study||1099
8004730|NCT00032591|19707820|P2|NOT COMPLETED|Follow-up||5
8004731|NCT00032591|19707821|P1|NOT COMPLETED|Follow-up||2
8004732|NCT00032591|19707820|P2|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452
8004733|NCT00032591|19707821|P1|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463
8004734|NCT00032591|19707820|P2|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457
8004735|NCT00032591|19707821|P1|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465
8004736|NCT00032591|19707820|P2|NOT COMPLETED|Randomization||0
8004737|NCT00032591|19707821|P1|NOT COMPLETED|Randomization||0
8004738|NCT00032591|19707820|P2|COMPLETED|Randomization|1457 were assigned to clinic testing|1457
8004739|NCT00032591|19707821|P1|COMPLETED|Randomization|1465 were assigned to self-testing|1465
8004740|NCT00032591|19707820|P2|STARTED|Randomization||1457
8004741|NCT00032591|19707821|P1|STARTED|Randomization|2922 underwent randomization|1465
8004742|NCT00032591|19707820|P2|NOT COMPLETED|Screening||415
8004743|NCT00032591|19707821|P1|NOT COMPLETED|Screening||408
8004744|NCT00032591|19707820|P2|COMPLETED|Screening||1457
8004745|NCT00032591|19707821|P1|COMPLETED|Screening|823 were excluded from the study|1465
8004746|NCT00032591|19707820|P2|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872
8004747|NCT00032591|19707821|P1|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873
8004748|NCT00032487|19707837|P2|NOT COMPLETED|Overall Study||120
8004749|NCT00032487|19707838|P1|NOT COMPLETED|Overall Study||139
8004750|NCT00032487|19707837|P2|COMPLETED|Overall Study||772
8004751|NCT00032487|19707838|P1|COMPLETED|Overall Study||760
8004752|NCT00032487|19707837|P2|STARTED|Overall Study||892
8004753|NCT00032487|19707838|P1|STARTED|Overall Study||899
8004754|NCT00031551|19707848|P2|NOT COMPLETED|Overall Study||0
8004755|NCT00031551|19707849|P1|NOT COMPLETED|Overall Study||2
8004756|NCT00031551|19707848|P2|COMPLETED|Overall Study||25
8004757|NCT00031551|19707849|P1|COMPLETED|Overall Study||0
8004758|NCT00031551|19707848|P2|STARTED|Overall Study||25
8004759|NCT00031551|19707849|P1|STARTED|Overall Study||2
8004760|NCT00031486|19707861|P2|NOT COMPLETED|Overall Study||12
8004761|NCT00031486|19707862|P1|NOT COMPLETED|Overall Study||7
8004762|NCT00031486|19707861|P2|COMPLETED|Overall Study||35
8004763|NCT00031486|19707862|P1|COMPLETED|Overall Study||33
8004764|NCT00031486|19707861|P2|STARTED|Overall Study||47
8004765|NCT00031486|19707862|P1|STARTED|Overall Study||40
8004766|NCT00031460|19707888|P2|NOT COMPLETED|Overall Study||14
8004767|NCT00031460|19707889|P1|NOT COMPLETED|Overall Study||9
8004768|NCT00031460|19707888|P2|COMPLETED|Overall Study||8
8004769|NCT00031460|19707889|P1|COMPLETED|Overall Study||15
8004770|NCT00031460|19707888|P2|STARTED|Overall Study||22
8004771|NCT00031460|19707889|P1|STARTED|Overall Study||24
8004772|NCT00031447|19707903|P2|NOT COMPLETED|Overall Study||7
8004773|NCT00031447|19707904|P1|NOT COMPLETED|Overall Study||10
8004774|NCT00031447|19707903|P2|COMPLETED|Overall Study||8
8004775|NCT00031447|19707904|P1|COMPLETED|Overall Study||4
8004776|NCT00031447|19707903|P2|STARTED|Overall Study||15
8004777|NCT00031447|19707904|P1|STARTED|Overall Study||14
8004778|NCT00030992|19707916|P1|NOT COMPLETED|Overall Study||0
8004779|NCT00030992|19707916|P1|COMPLETED|Overall Study||102
8004780|NCT00030992|19707916|P1|STARTED|Overall Study||102
8004781|NCT00030147|19707925|P4|NOT COMPLETED|Overall Study||0
8004782|NCT00030147|19707926|P3|NOT COMPLETED|Overall Study||0
8004783|NCT00030147|19707927|P2|NOT COMPLETED|Overall Study||1
8004784|NCT00030147|19707928|P1|NOT COMPLETED|Overall Study||0
8004785|NCT00030147|19707925|P4|COMPLETED|Overall Study||11
8004786|NCT00030147|19707926|P3|COMPLETED|Overall Study||16
8004787|NCT00030147|19707927|P2|COMPLETED|Overall Study||18
8004788|NCT00030147|19707928|P1|COMPLETED|Overall Study||17
8004789|NCT00030147|19707925|P4|STARTED|Overall Study||11
8004790|NCT00030147|19707926|P3|STARTED|Overall Study||16
8004791|NCT00030147|19707927|P2|STARTED|Overall Study||19
8004792|NCT00030147|19707928|P1|STARTED|Overall Study||17
8004793|NCT00029536|19707946|P4|NOT COMPLETED|Overall Study||0
8004794|NCT00029536|19707947|P3|NOT COMPLETED|Overall Study||0
8004795|NCT00029536|19707948|P2|NOT COMPLETED|Overall Study||0
8004796|NCT00029536|19707949|P1|NOT COMPLETED|Overall Study||0
8004797|NCT00029536|19707946|P4|COMPLETED|Overall Study||59
8004798|NCT00029536|19707947|P3|COMPLETED|Overall Study||105
8004799|NCT00029536|19707948|P2|COMPLETED|Overall Study||45
8004800|NCT00029536|19707949|P1|COMPLETED|Overall Study||85
8004801|NCT00029536|19707946|P4|STARTED|Overall Study||59
8004802|NCT00029536|19707947|P3|STARTED|Overall Study||105
8004803|NCT00029536|19707948|P2|STARTED|Overall Study||45
8004804|NCT00029536|19707949|P1|STARTED|Overall Study||85
8004805|NCT00029172|19707973|P1|NOT COMPLETED|Overall Study||6
8004806|NCT00029172|19707973|P1|COMPLETED|Overall Study||182
8004807|NCT00029172|19707973|P1|STARTED|Overall Study||188
8004808|NCT00029146|19707979|P2|NOT COMPLETED|Overall Study||1
8004809|NCT00029146|19707980|P1|NOT COMPLETED|Overall Study||2
8004810|NCT00029146|19707979|P2|COMPLETED|Overall Study||97
8004811|NCT00029146|19707980|P1|COMPLETED|Overall Study||95
8004812|NCT00029146|19707979|P2|STARTED|Overall Study||98
8004813|NCT00029146|19707980|P1|STARTED|Overall Study||97
8004814|NCT00029107|19708009|P2|NOT COMPLETED|Overall Study||0
8004815|NCT00029107|19708010|P1|NOT COMPLETED|Overall Study||0
8004816|NCT00029107|19708009|P2|COMPLETED|Overall Study||12
8004817|NCT00029107|19708010|P1|COMPLETED|Overall Study||12
8004818|NCT00029107|19708009|P2|STARTED|Overall Study||12
8004819|NCT00029107|19708010|P1|STARTED|Overall Study||12
8004820|NCT00028262|19708016|P1|NOT COMPLETED|Overall Study||1
8004821|NCT00028262|19708016|P1|COMPLETED|Overall Study||9
8004822|NCT00028262|19708016|P1|STARTED|Overall Study||10
8004823|NCT00028093|19708022|P2|NOT COMPLETED|Overall Study||0
8004824|NCT00028093|19708023|P1|NOT COMPLETED|Overall Study||0
8004825|NCT00028093|19708022|P2|COMPLETED|Overall Study||25
8004826|NCT00028093|19708023|P1|COMPLETED|Overall Study||25
8004827|NCT00028093|19708022|P2|STARTED|Overall Study||25
8004828|NCT00028093|19708023|P1|STARTED|Overall Study||25
8004829|NCT00027378|19708031|P2|NOT COMPLETED|Overall Study||3
8004830|NCT00027378|19708032|P1|NOT COMPLETED|Overall Study||0
8004831|NCT00027378|19708031|P2|COMPLETED|Overall Study||23
8004832|NCT00027378|19708032|P1|COMPLETED|Overall Study||24
8004833|NCT00027378|19708031|P2|STARTED|Overall Study||26
8004834|NCT00027378|19708032|P1|STARTED|Overall Study||24
8004835|NCT00027027|19708045|P5|NOT COMPLETED|Overall Study||8
8004836|NCT00027027|19708046|P4|NOT COMPLETED|Overall Study||3
8004837|NCT00027027|19708047|P3|NOT COMPLETED|Overall Study||4
8004838|NCT00027027|19708048|P2|NOT COMPLETED|Overall Study||3
8004839|NCT00027027|19708049|P1|NOT COMPLETED|Overall Study||3
8004840|NCT00027027|19708045|P5|COMPLETED|Overall Study||0
8004841|NCT00027027|19708046|P4|COMPLETED|Overall Study||0
8004842|NCT00027027|19708047|P3|COMPLETED|Overall Study||0
8004843|NCT00027027|19708048|P2|COMPLETED|Overall Study||0
8004844|NCT00027027|19708049|P1|COMPLETED|Overall Study||0
8004845|NCT00027027|19708045|P5|Treated Beyond Cycle 2|Overall Study||4
8004846|NCT00027027|19708046|P4|Treated Beyond Cycle 2|Overall Study||2
8004847|NCT00027027|19708047|P3|Treated Beyond Cycle 2|Overall Study||2
8004848|NCT00027027|19708048|P2|Treated Beyond Cycle 2|Overall Study||1
8004849|NCT00027027|19708049|P1|Treated Beyond Cycle 2|Overall Study||1
8004850|NCT00027027|19708045|P5|Discontinued at Cycle 2|Overall Study||3
8004851|NCT00027027|19708046|P4|Discontinued at Cycle 2|Overall Study||1
8004852|NCT00027027|19708047|P3|Discontinued at Cycle 2|Overall Study||1
8004853|NCT00027027|19708048|P2|Discontinued at Cycle 2|Overall Study||2
8004854|NCT00027027|19708049|P1|Discontinued at Cycle 2|Overall Study||2
8004855|NCT00027027|19708045|P5|Completed 2 Cycles of Treatment|Overall Study||7
8004856|NCT00027027|19708046|P4|Completed 2 Cycles of Treatment|Overall Study||3
8004857|NCT00027027|19708047|P3|Completed 2 Cycles of Treatment|Overall Study||3
8004858|NCT00027027|19708048|P2|Completed 2 Cycles of Treatment|Overall Study||3
8004859|NCT00027027|19708049|P1|Completed 2 Cycles of Treatment|Overall Study||3
8004860|NCT00027027|19708045|P5|Discontinued Before 2 Treatment Cycles|Overall Study||1
8004861|NCT00027027|19708046|P4|Discontinued Before 2 Treatment Cycles|Overall Study||0
8004862|NCT00027027|19708047|P3|Discontinued Before 2 Treatment Cycles|Overall Study||1
8004863|NCT00027027|19708048|P2|Discontinued Before 2 Treatment Cycles|Overall Study||0
8004864|NCT00027027|19708049|P1|Discontinued Before 2 Treatment Cycles|Overall Study||0
8004865|NCT00027027|19708045|P5|STARTED|Overall Study||8
8004866|NCT00027027|19708046|P4|STARTED|Overall Study||3
8004867|NCT00027027|19708047|P3|STARTED|Overall Study||4
8004868|NCT00027027|19708048|P2|STARTED|Overall Study||3
8004869|NCT00027027|19708049|P1|STARTED|Overall Study||3
8004870|NCT00026793|19708094|P1|NOT COMPLETED|Overall Study||8
8004871|NCT00026793|19708094|P1|COMPLETED|Overall Study||21
8004872|NCT00026793|19708094|P1|STARTED|Overall Study||29
8004873|NCT00025883|19708104|P1|NOT COMPLETED|Overall Study||17
8004874|NCT00025883|19708104|P1|COMPLETED|Overall Study||86
8004875|NCT00025883|19708104|P1|Partial Lipodystrophy|Overall Study||40
8004876|NCT00025883|19708104|P1|Generalized Lipodystrophy|Overall Study||63
8004877|NCT00025883|19708104|P1|STARTED|Overall Study||103
8004878|NCT00023595|19708116|P5|NOT COMPLETED|10 Year Follow up||0
8004879|NCT00023595|19708117|P4|NOT COMPLETED|10 Year Follow up||0
8004880|NCT00023595|19708118|P3|NOT COMPLETED|10 Year Follow up||3
8004881|NCT00023595|19708119|P2|NOT COMPLETED|10 Year Follow up||10
8004882|NCT00023595|19708120|P1|NOT COMPLETED|10 Year Follow up||12
8004883|NCT00023595|19708116|P5|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
8004884|NCT00023595|19708117|P4|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
8004885|NCT00023595|19708118|P3|COMPLETED|10 Year Follow up||73
8004886|NCT00023595|19708119|P2|COMPLETED|10 Year Follow up||524
8004887|NCT00023595|19708120|P1|COMPLETED|10 Year Follow up||590
8004888|NCT00023595|19708116|P5|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
8004889|NCT00023595|19708117|P4|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
8004890|NCT00023595|19708118|P3|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|76
8004891|NCT00023595|19708119|P2|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|534
8004892|NCT00023595|19708120|P1|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|602
8004893|NCT00023595|19708116|P5|NOT COMPLETED|5 Year Follow up||3
8004894|NCT00023595|19708117|P4|NOT COMPLETED|5 Year Follow up||7
8004895|NCT00023595|19708118|P3|NOT COMPLETED|5 Year Follow up||1
8004896|NCT00023595|19708119|P2|NOT COMPLETED|5 Year Follow up||2
8004897|NCT00023595|19708120|P1|NOT COMPLETED|5 Year Follow up||2
8004898|NCT00023595|19708116|P5|COMPLETED|5 Year Follow up||498
8004899|NCT00023595|19708117|P4|COMPLETED|5 Year Follow up||416
8004900|NCT00023595|19708118|P3|COMPLETED|5 Year Follow up||75
8004901|NCT00023595|19708119|P2|COMPLETED|5 Year Follow up||532
8004902|NCT00023595|19708120|P1|COMPLETED|5 Year Follow up||600
8004903|NCT00023595|19708116|P5|STARTED|5 Year Follow up||501
8004904|NCT00023595|19708117|P4|STARTED|5 Year Follow up|76 of stratum B pts who were randomized to med therapy + CABG group belong to both H01 and H02.|423
8004905|NCT00023595|19708118|P3|STARTED|5 Year Follow up||76
8004906|NCT00023595|19708119|P2|STARTED|5 Year Follow up||534
8004907|NCT00023595|19708120|P1|STARTED|5 Year Follow up||602
8004908|NCT00023452|19708331|P2|NOT COMPLETED|Overall Study||872
8004909|NCT00023452|19708332|P1|NOT COMPLETED|Overall Study||1323
8004910|NCT00023452|19708331|P2|COMPLETED|Overall Study||3273
8004911|NCT00023452|19708332|P1|COMPLETED|Overall Study||2585
8004912|NCT00023452|19708331|P2|Completed Study|Overall Study||3475
8004913|NCT00023452|19708332|P1|Completed Study|Overall Study||3174
8004914|NCT00023452|19708331|P2|Not Treated|Overall Study||105
8004915|NCT00023452|19708332|P1|Not Treated|Overall Study||149
8004916|NCT00023452|19708331|P2|Completed Treatment|Overall Study||3273
8004917|NCT00023452|19708332|P1|Completed Treatment|Overall Study||2585
8004918|NCT00023452|19708331|P2|Enrolled as Part of a Cluster|Overall Study||971
8004919|NCT00023452|19708332|P1|Enrolled as Part of a Cluster|Overall Study||718
8004920|NCT00023452|19708331|P2|Randomized|Overall Study||3174
8004921|NCT00023452|19708332|P1|Randomized|Overall Study||3190
8004922|NCT00023452|19708331|P2|STARTED|Overall Study||4145
8004923|NCT00023452|19708332|P1|STARTED|Overall Study||3908
8004924|NCT00023322|19708356|P1|NOT COMPLETED|Overall Study||1
8004925|NCT00023322|19708356|P1|COMPLETED|Overall Study||12
8004926|NCT00023322|19708356|P1|STARTED|Overall Study||13
8004927|NCT00023309|19708363|P2|NOT COMPLETED|Overall Study||0
8004928|NCT00023309|19708364|P1|NOT COMPLETED|Overall Study||0
8004929|NCT00023309|19708363|P2|COMPLETED|Overall Study||19
8004930|NCT00023309|19708364|P1|COMPLETED|Overall Study||22
8004931|NCT00023309|19708363|P2|STARTED|Overall Study||19
8004932|NCT00023309|19708364|P1|STARTED|Overall Study||22
8004933|NCT00022763|19708380|P2|NOT COMPLETED|Overall Study||17
8004934|NCT00022763|19708381|P1|NOT COMPLETED|Overall Study||9
8004935|NCT00022763|19708380|P2|COMPLETED|Overall Study||11
8004936|NCT00022763|19708381|P1|COMPLETED|Overall Study||15
8004937|NCT00022763|19708380|P2|STARTED|Overall Study||28
8004938|NCT00022763|19708381|P1|STARTED|Overall Study||24
8004939|NCT00016718|19708407|P3|NOT COMPLETED|Overall Study||0
8004940|NCT00016718|19708408|P2|NOT COMPLETED|Overall Study||0
8004941|NCT00016718|19708409|P1|NOT COMPLETED|Overall Study||0
8004942|NCT00016718|19708407|P3|COMPLETED|Overall Study||16
8004943|NCT00016718|19708408|P2|COMPLETED|Overall Study||21
8004944|NCT00016718|19708409|P1|COMPLETED|Overall Study||6
8004945|NCT00016718|19708407|P3|STARTED|Overall Study||16
8004946|NCT00016718|19708408|P2|STARTED|Overall Study||21
8004947|NCT00016718|19708409|P1|STARTED|Overall Study||6
8004948|NCT00014911|19708423|P1|NOT COMPLETED|Overall Study||11
8004949|NCT00014911|19708423|P1|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25
8004950|NCT00014911|19708423|P1|STARTED|Overall Study||36
8004951|NCT00006604|19708439|P17|NOT COMPLETED|Overall Study||9
8004952|NCT00006604|19708440|P16|NOT COMPLETED|Overall Study||5
8004953|NCT00006604|19708441|P15|NOT COMPLETED|Overall Study||10
8004954|NCT00006604|19708442|P14|NOT COMPLETED|Overall Study||6
8004955|NCT00006604|19708443|P13|NOT COMPLETED|Overall Study||4
8004956|NCT00006604|19708444|P12|NOT COMPLETED|Overall Study||6
8004957|NCT00006604|19708445|P11|NOT COMPLETED|Overall Study||8
8004958|NCT00006604|19708446|P10|NOT COMPLETED|Overall Study||19
8004959|NCT00006604|19708447|P9|NOT COMPLETED|Overall Study||1
8004960|NCT00006604|19708448|P8|NOT COMPLETED|Overall Study||3
8004961|NCT00006604|19708449|P7|NOT COMPLETED|Overall Study||9
8004962|NCT00006604|19708450|P6|NOT COMPLETED|Overall Study||3
8004963|NCT00006604|19708451|P5|NOT COMPLETED|Overall Study||2
8004964|NCT00006604|19708452|P4|NOT COMPLETED|Overall Study||5
8004965|NCT00006604|19708453|P3|NOT COMPLETED|Overall Study||4
8004966|NCT00006604|19708454|P2|NOT COMPLETED|Overall Study||0
8004967|NCT00006604|19708455|P1|NOT COMPLETED|Overall Study||2
8004968|NCT00006604|19708439|P17|COMPLETED|Overall Study||6
8004969|NCT00006604|19708440|P16|COMPLETED|Overall Study||1
8004970|NCT00006604|19708441|P15|COMPLETED|Overall Study||14
8004971|NCT00006604|19708442|P14|COMPLETED|Overall Study||0
8004972|NCT00006604|19708443|P13|COMPLETED|Overall Study||22
8004973|NCT00006604|19708444|P12|COMPLETED|Overall Study||6
8004974|NCT00006604|19708445|P11|COMPLETED|Overall Study||13
8004975|NCT00006604|19708446|P10|COMPLETED|Overall Study||6
8004976|NCT00006604|19708447|P9|COMPLETED|Overall Study||4
8004977|NCT00006604|19708448|P8|COMPLETED|Overall Study||2
8004978|NCT00006604|19708449|P7|COMPLETED|Overall Study||12
8004979|NCT00006604|19708450|P6|COMPLETED|Overall Study||2
8004980|NCT00006604|19708451|P5|COMPLETED|Overall Study||3
8004981|NCT00006604|19708452|P4|COMPLETED|Overall Study||1
8004982|NCT00006604|19708453|P3|COMPLETED|Overall Study||1
8004983|NCT00006604|19708454|P2|COMPLETED|Overall Study||2
8004984|NCT00006604|19708455|P1|COMPLETED|Overall Study||4
8004985|NCT00006604|19708439|P17|STARTED|Overall Study||15
8004986|NCT00006604|19708440|P16|STARTED|Overall Study||6
8004987|NCT00006604|19708441|P15|STARTED|Overall Study||24
8004988|NCT00006604|19708442|P14|STARTED|Overall Study||6
8004989|NCT00006604|19708443|P13|STARTED|Overall Study||26
8004990|NCT00006604|19708444|P12|STARTED|Overall Study||12
8004991|NCT00006604|19708445|P11|STARTED|Overall Study||21
8004992|NCT00006604|19708446|P10|STARTED|Overall Study||25
8004993|NCT00006604|19708447|P9|STARTED|Overall Study||5
8004994|NCT00006604|19708448|P8|STARTED|Overall Study||5
8004995|NCT00006604|19708449|P7|STARTED|Overall Study||21
8004996|NCT00006604|19708450|P6|STARTED|Overall Study||5
8004997|NCT00006604|19708451|P5|STARTED|Overall Study||5
8004998|NCT00006604|19708452|P4|STARTED|Overall Study||6
8004999|NCT00006604|19708453|P3|STARTED|Overall Study||5
8005000|NCT00006604|19708454|P2|STARTED|Overall Study||2
8005001|NCT00006604|19708455|P1|STARTED|Overall Study||6
8005002|NCT00004978|19708571|P2|NOT COMPLETED|Overall Study||270
8005003|NCT00004978|19708572|P1|NOT COMPLETED|Overall Study||244
8005004|NCT00004978|19708571|P2|COMPLETED|Overall Study||1790
8005005|NCT00004978|19708572|P1|COMPLETED|Overall Study||1846
8005006|NCT00004978|19708571|P2|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060
8005007|NCT00004978|19708572|P1|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090
8005008|NCT00021541|19708598|P2|NOT COMPLETED|Period 2-crossover||11
8005009|NCT00021541|19708599|P1|NOT COMPLETED|Period 2-crossover||10
8005010|NCT00021541|19708598|P2|COMPLETED|Period 2-crossover||12
8005011|NCT00021541|19708599|P1|COMPLETED|Period 2-crossover||10
8005012|NCT00021541|19708598|P2|STARTED|Period 2-crossover||23
8005013|NCT00021541|19708599|P1|STARTED|Period 2-crossover||20
8005014|NCT00021541|19708598|P2|NOT COMPLETED|Period 1-First Treatment||8
8005015|NCT00021541|19708599|P1|NOT COMPLETED|Period 1-First Treatment||11
8005016|NCT00021541|19708598|P2|COMPLETED|Period 1-First Treatment||23
8005017|NCT00021541|19708599|P1|COMPLETED|Period 1-First Treatment||20
8005018|NCT00021541|19708598|P2|Ineligible Patients|Period 1-First Treatment||2
8005019|NCT00021541|19708599|P1|Ineligible Patients|Period 1-First Treatment||0
8005020|NCT00021541|19708598|P2|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23
8005021|NCT00021541|19708599|P1|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20
8005022|NCT00021541|19708598|P2|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31
8005023|NCT00021541|19708599|P1|STARTED|Period 1-First Treatment||31
8005024|NCT00018031|19708609|P1|NOT COMPLETED|Overall Study||0
8005025|NCT00018031|19708609|P1|COMPLETED|Overall Study||36
8005026|NCT00018031|19708609|P1|STARTED|Overall Study||36
8005027|NCT00015457|19708613|P2|NOT COMPLETED|Second Intervention||0
8005028|NCT00015457|19708614|P1|NOT COMPLETED|Second Intervention||1
8005029|NCT00015457|19708613|P2|COMPLETED|Second Intervention||5
8005030|NCT00015457|19708614|P1|COMPLETED|Second Intervention||7
8005031|NCT00015457|19708613|P2|STARTED|Second Intervention||5
8005032|NCT00015457|19708614|P1|STARTED|Second Intervention||8
8005033|NCT00015457|19708613|P2|NOT COMPLETED|First Intervention||3
8005034|NCT00015457|19708614|P1|NOT COMPLETED|First Intervention||0
8005035|NCT00015457|19708613|P2|COMPLETED|First Intervention||5
8005036|NCT00015457|19708614|P1|COMPLETED|First Intervention||8
8005037|NCT00015457|19708613|P2|STARTED|First Intervention||8
8005038|NCT00015457|19708614|P1|STARTED|First Intervention||8
8005039|NCT00013611|19708624|P2|NOT COMPLETED|Overall Study||100
8005040|NCT00013611|19708625|P1|NOT COMPLETED|Overall Study||91
8005041|NCT00013611|19708624|P2|COMPLETED|Overall Study||746
8005042|NCT00013611|19708625|P1|COMPLETED|Overall Study||758
8005043|NCT00013611|19708624|P2|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846
8005044|NCT00013611|19708625|P1|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849
8005045|NCT00010803|19708643|P2|NOT COMPLETED|Overall Study||98
8005046|NCT00010803|19708644|P1|NOT COMPLETED|Overall Study||97
8005047|NCT00010803|19708643|P2|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426
8005048|NCT00010803|19708644|P1|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448
8005049|NCT00010803|19708643|P2|STARTED|Overall Study|Randomized|1524
8005050|NCT00010803|19708644|P1|STARTED|Overall Study|Randomized|1545
8005051|NCT00010439|19708654|P1|NOT COMPLETED|Overall Study||0
8005052|NCT00010439|19708654|P1|COMPLETED|Overall Study||10
8005053|NCT00010439|19708654|P1|6 Months|Overall Study||10
8005054|NCT00010439|19708654|P1|STARTED|Overall Study||10
8005055|NCT00010374|19708659|P1|NOT COMPLETED|Overall Study||1
8005056|NCT00010374|19708659|P1|COMPLETED|Overall Study|One compassionate use participant was withheld from analysis per FDA instructions|53
8005057|NCT00010374|19708659|P1|STARTED|Overall Study||54
8005058|NCT00007644|19708667|P2|NOT COMPLETED|Overall Study||0
8005059|NCT00007644|19708668|P1|NOT COMPLETED|Overall Study||0
8005060|NCT00007644|19708667|P2|COMPLETED|Overall Study||367
8005061|NCT00007644|19708668|P1|COMPLETED|Overall Study||364
8005062|NCT00007644|19708667|P2|STARTED|Overall Study||367
8005063|NCT00007644|19708668|P1|STARTED|Overall Study||364
8005064|NCT00007475|19708677|P4|NOT COMPLETED|Overall Study||0
8005065|NCT00007475|19708678|P3|NOT COMPLETED|Overall Study||0
8005066|NCT00007475|19708679|P2|NOT COMPLETED|Overall Study||0
8005067|NCT00007475|19708680|P1|NOT COMPLETED|Overall Study||4
8005068|NCT00007475|19708677|P4|COMPLETED|Overall Study||0
8005069|NCT00007475|19708678|P3|COMPLETED|Overall Study||2
8005070|NCT00007475|19708679|P2|COMPLETED|Overall Study||1
8005071|NCT00007475|19708680|P1|COMPLETED|Overall Study||8
8005072|NCT00007475|19708677|P4|Initiate Cyclophosphamide|Overall Study||0
8005073|NCT00007475|19708678|P3|Initiate Cyclophosphamide|Overall Study||2
8005074|NCT00007475|19708679|P2|Initiate Cyclophosphamide|Overall Study||1
8005075|NCT00007475|19708680|P1|Initiate Cyclophosphamide|Overall Study||12
8005076|NCT00007475|19708677|P4|Initial Plasma Exchange|Overall Study||0
8005077|NCT00007475|19708678|P3|Initial Plasma Exchange|Overall Study||2
8005078|NCT00007475|19708679|P2|Initial Plasma Exchange|Overall Study||1
8005079|NCT00007475|19708680|P1|Initial Plasma Exchange|Overall Study||12
8005080|NCT00007475|19708677|P4|Post-initial Transplant Proteinuria|Overall Study||0
8005081|NCT00007475|19708678|P3|Post-initial Transplant Proteinuria|Overall Study||2
8005082|NCT00007475|19708679|P2|Post-initial Transplant Proteinuria|Overall Study||1
8005083|NCT00007475|19708680|P1|Post-initial Transplant Proteinuria|Overall Study||12
8005084|NCT00007475|19708677|P4|Initial Transplant|Overall Study||0
8005085|NCT00007475|19708678|P3|Initial Transplant|Overall Study||2
8005086|NCT00007475|19708679|P2|Initial Transplant|Overall Study||1
8005087|NCT00007475|19708680|P1|Initial Transplant|Overall Study||12
8005088|NCT00007475|19708677|P4|FSGS Permeability Factor (FPF) Assayed|Overall Study||0
8005089|NCT00007475|19708678|P3|FSGS Permeability Factor (FPF) Assayed|Overall Study||2
8005090|NCT00007475|19708679|P2|FSGS Permeability Factor (FPF) Assayed|Overall Study||1
8005091|NCT00007475|19708680|P1|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0
8005092|NCT00007475|19708677|P4|STARTED|Overall Study||0
8005093|NCT00007475|19708678|P3|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2
8005094|NCT00007475|19708679|P2|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1
8005095|NCT00007475|19708680|P1|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12
8005096|NCT00007345|19708702|P2|NOT COMPLETED|Overall Study||11
8005097|NCT00007345|19708703|P1|NOT COMPLETED|Overall Study||2
8005098|NCT00007345|19708702|P2|COMPLETED|Overall Study||73
8005099|NCT00007345|19708703|P1|COMPLETED|Overall Study||45
8005100|NCT00007345|19708702|P2|STARTED|Overall Study||84
8005101|NCT00007345|19708703|P1|STARTED|Overall Study||47
8005102|NCT00007020|19708721|P1|NOT COMPLETED|Overall Study||44
8005103|NCT00007020|19708721|P1|COMPLETED|Overall Study||41
8005104|NCT00007020|19708721|P1|STARTED|Overall Study||85
8005105|NCT00006489|19708734|P4|NOT COMPLETED|Overall Study||11
8005106|NCT00006489|19708735|P3|NOT COMPLETED|Overall Study||15
8005107|NCT00006489|19708736|P2|NOT COMPLETED|Overall Study||14
8005108|NCT00006489|19708737|P1|NOT COMPLETED|Overall Study||13
8005109|NCT00006489|19708734|P4|COMPLETED|Overall Study||32
8005110|NCT00006489|19708735|P3|COMPLETED|Overall Study||25
8005111|NCT00006489|19708736|P2|COMPLETED|Overall Study||26
8005112|NCT00006489|19708737|P1|COMPLETED|Overall Study||29
8005113|NCT00006489|19708734|P4|STARTED|Overall Study||43
8005114|NCT00006489|19708735|P3|STARTED|Overall Study||40
8005115|NCT00006489|19708736|P2|STARTED|Overall Study||40
8005116|NCT00006489|19708737|P1|STARTED|Overall Study||42
8005117|NCT00006411|19708757|P2|NOT COMPLETED|Overall Study||0
8005118|NCT00006411|19708758|P1|NOT COMPLETED|Overall Study||0
8005119|NCT00006411|19708757|P2|COMPLETED|Overall Study||383
8005120|NCT00006411|19708758|P1|COMPLETED|Overall Study||707
8005121|NCT00006411|19708757|P2|STARTED|Overall Study||383
8005122|NCT00006411|19708758|P1|STARTED|Overall Study||707
8005123|NCT00006409|19708772|P6|NOT COMPLETED|Post-3 Year Intervention||62
8005124|NCT00006409|19708773|P5|NOT COMPLETED|Post-3 Year Intervention||62
8005125|NCT00006409|19708774|P4|NOT COMPLETED|Post-3 Year Intervention||0
8005126|NCT00006409|19708775|P3|NOT COMPLETED|Post-3 Year Intervention||0
8005127|NCT00006409|19708776|P2|NOT COMPLETED|Post-3 Year Intervention||0
8005128|NCT00006409|19708777|P1|NOT COMPLETED|Post-3 Year Intervention||0
8005129|NCT00006409|19708772|P6|COMPLETED|Post-3 Year Intervention||1714
8005130|NCT00006409|19708773|P5|COMPLETED|Post-3 Year Intervention||1664
8005131|NCT00006409|19708774|P4|COMPLETED|Post-3 Year Intervention||0
8005132|NCT00006409|19708775|P3|COMPLETED|Post-3 Year Intervention||0
8005133|NCT00006409|19708776|P2|COMPLETED|Post-3 Year Intervention||0
8005134|NCT00006409|19708777|P1|COMPLETED|Post-3 Year Intervention||0
8005135|NCT00006409|19708772|P6|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776
8005136|NCT00006409|19708773|P5|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726
8005137|NCT00006409|19708774|P4|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
8005138|NCT00006409|19708775|P3|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
8005139|NCT00006409|19708776|P2|STARTED|Post-3 Year Intervention||0
8005140|NCT00006409|19708777|P1|STARTED|Post-3 Year Intervention||0
8005141|NCT00006409|19708772|P6|NOT COMPLETED|Post-2 Year Intervention||0
8005142|NCT00006409|19708773|P5|NOT COMPLETED|Post-2 Year Intervention||0
8005143|NCT00006409|19708774|P4|NOT COMPLETED|Post-2 Year Intervention||168
8005144|NCT00006409|19708775|P3|NOT COMPLETED|Post-2 Year Intervention||251
8005145|NCT00006409|19708776|P2|NOT COMPLETED|Post-2 Year Intervention||0
8005146|NCT00006409|19708777|P1|NOT COMPLETED|Post-2 Year Intervention||0
8005147|NCT00006409|19708772|P6|COMPLETED|Post-2 Year Intervention||0
8005148|NCT00006409|19708773|P5|COMPLETED|Post-2 Year Intervention||0
8005149|NCT00006409|19708774|P4|COMPLETED|Post-2 Year Intervention||1545
8005150|NCT00006409|19708775|P3|COMPLETED|Post-2 Year Intervention||1540
8005151|NCT00006409|19708776|P2|COMPLETED|Post-2 Year Intervention||0
8005152|NCT00006409|19708777|P1|COMPLETED|Post-2 Year Intervention||0
8005153|NCT00006409|19708772|P6|STARTED|Post-2 Year Intervention||0
8005154|NCT00006409|19708773|P5|STARTED|Post-2 Year Intervention||0
8005155|NCT00006409|19708774|P4|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713
8005156|NCT00006409|19708775|P3|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791
8005157|NCT00006409|19708776|P2|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
8005158|NCT00006409|19708777|P1|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
8005159|NCT00006409|19708772|P6|NOT COMPLETED|Baseline||0
8005160|NCT00006409|19708773|P5|NOT COMPLETED|Baseline||0
8005161|NCT00006409|19708774|P4|NOT COMPLETED|Baseline||0
8005162|NCT00006409|19708775|P3|NOT COMPLETED|Baseline||0
8005163|NCT00006409|19708776|P2|NOT COMPLETED|Baseline||70
8005164|NCT00006409|19708777|P1|NOT COMPLETED|Baseline||48
8005165|NCT00006409|19708772|P6|COMPLETED|Baseline||0
8005166|NCT00006409|19708773|P5|COMPLETED|Baseline||0
8005167|NCT00006409|19708774|P4|COMPLETED|Baseline||0
8005168|NCT00006409|19708775|P3|COMPLETED|Baseline||0
8005169|NCT00006409|19708776|P2|COMPLETED|Baseline||786
8005170|NCT00006409|19708777|P1|COMPLETED|Baseline||817
8005171|NCT00006409|19708772|P6|STARTED|Baseline||0
8005172|NCT00006409|19708773|P5|STARTED|Baseline||0
8005173|NCT00006409|19708774|P4|STARTED|Baseline||0
8005174|NCT00006409|19708775|P3|STARTED|Baseline||0
8005175|NCT00006409|19708776|P2|STARTED|Baseline||856
8005176|NCT00006409|19708777|P1|STARTED|Baseline||865
8005177|NCT00006400|19708799|P2|NOT COMPLETED|Overall Study||13
8005178|NCT00006400|19708800|P1|NOT COMPLETED|Overall Study||13
8005179|NCT00006400|19708799|P2|COMPLETED|Overall Study||84
8005180|NCT00006400|19708800|P1|COMPLETED|Overall Study||83
8005181|NCT00006400|19708799|P2|STARTED|Overall Study||97
8005182|NCT00006400|19708800|P1|STARTED|Overall Study||96
8005183|NCT00006305|19708816|P4|NOT COMPLETED|Overall Study||14
8005184|NCT00006305|19708817|P3|NOT COMPLETED|Overall Study||15
8005185|NCT00006305|19708818|P2|NOT COMPLETED|Overall Study||10
8005186|NCT00006305|19708819|P1|NOT COMPLETED|Overall Study||17
8005187|NCT00006305|19708816|P4|COMPLETED|Overall Study||585
8005188|NCT00006305|19708817|P3|COMPLETED|Overall Study||578
8005189|NCT00006305|19708818|P2|COMPLETED|Overall Study||574
8005190|NCT00006305|19708819|P1|COMPLETED|Overall Study||575
8005191|NCT00006305|19708816|P4|STARTED|Overall Study||599
8005192|NCT00006305|19708817|P3|STARTED|Overall Study||593
8005193|NCT00006305|19708818|P2|STARTED|Overall Study||584
8005194|NCT00006305|19708819|P1|STARTED|Overall Study||592
8005195|NCT00006289|19708835|P2|NOT COMPLETED|Second Intervention (5 Weeks)||1
8005196|NCT00006289|19708836|P1|NOT COMPLETED|Second Intervention (5 Weeks)||1
8005197|NCT00006289|19708835|P2|COMPLETED|Second Intervention (5 Weeks)||9
8005198|NCT00006289|19708836|P1|COMPLETED|Second Intervention (5 Weeks)||9
8005199|NCT00006289|19708835|P2|STARTED|Second Intervention (5 Weeks)||10
8005200|NCT00006289|19708836|P1|STARTED|Second Intervention (5 Weeks)||10
8005201|NCT00006289|19708835|P2|NOT COMPLETED|Washout (>= 1 Week)||0
8005202|NCT00006289|19708836|P1|NOT COMPLETED|Washout (>= 1 Week)||0
8005203|NCT00006289|19708835|P2|COMPLETED|Washout (>= 1 Week)||10
8005204|NCT00006289|19708836|P1|COMPLETED|Washout (>= 1 Week)||10
8005205|NCT00006289|19708835|P2|STARTED|Washout (>= 1 Week)||10
8005206|NCT00006289|19708836|P1|STARTED|Washout (>= 1 Week)||10
8005207|NCT00006289|19708835|P2|NOT COMPLETED|First Intervention (5 Weeks)||0
8005208|NCT00006289|19708836|P1|NOT COMPLETED|First Intervention (5 Weeks)||1
8005209|NCT00006289|19708835|P2|COMPLETED|First Intervention (5 Weeks)||10
8005210|NCT00006289|19708836|P1|COMPLETED|First Intervention (5 Weeks)||10
8005211|NCT00006289|19708835|P2|STARTED|First Intervention (5 Weeks)||10
8005212|NCT00006289|19708836|P1|STARTED|First Intervention (5 Weeks)||11
8005213|NCT00006184|19708854|P2|NOT COMPLETED|Overall Study||0
8005214|NCT00006184|19708855|P1|NOT COMPLETED|Overall Study||1
8005215|NCT00006184|19708854|P2|COMPLETED|Overall Study||10
8005216|NCT00006184|19708855|P1|COMPLETED|Overall Study||9
8005217|NCT00006184|19708854|P2|STARTED|Overall Study||10
8005218|NCT00006184|19708855|P1|STARTED|Overall Study||10
8005219|NCT00006178|19708862|P1|NOT COMPLETED|Overall Study||0
8005220|NCT00006178|19708862|P1|COMPLETED|Overall Study||12
8005221|NCT00006178|19708862|P1|STARTED|Overall Study||12
8005222|NCT00006170|19708873|P4|NOT COMPLETED|Overall Study||39
8005223|NCT00006170|19708874|P3|NOT COMPLETED|Overall Study||43
8005224|NCT00006170|19708875|P2|NOT COMPLETED|Overall Study||50
8005225|NCT00006170|19708876|P1|NOT COMPLETED|Overall Study||49
8005226|NCT00006170|19708873|P4|COMPLETED|Overall Study||28
8005227|NCT00006170|19708874|P3|COMPLETED|Overall Study||46
8005228|NCT00006170|19708875|P2|COMPLETED|Overall Study||37
8005229|NCT00006170|19708876|P1|COMPLETED|Overall Study||57
8005230|NCT00006170|19708873|P4|STARTED|Overall Study||67
8005231|NCT00006170|19708874|P3|STARTED|Overall Study||89
8005232|NCT00006170|19708875|P2|STARTED|Overall Study||87
8005233|NCT00006170|19708876|P1|STARTED|Overall Study||106
8005234|NCT00006156|19708896|P2|NOT COMPLETED|Overall Study||0
8005235|NCT00006156|19708897|P1|NOT COMPLETED|Overall Study||0
8005236|NCT00006156|19708896|P2|COMPLETED|Overall Study||7
8005237|NCT00006156|19708897|P1|COMPLETED|Overall Study||42
8005238|NCT00006156|19708896|P2|STARTED|Overall Study||7
8005239|NCT00006156|19708897|P1|STARTED|Overall Study||42
8005240|NCT00006164|19708906|P2|NOT COMPLETED|Overall Study||81
8005241|NCT00006164|19708907|P1|NOT COMPLETED|Overall Study||70
8005242|NCT00006164|19708906|P2|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452
8005243|NCT00006164|19708907|P1|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447
8005244|NCT00006164|19708906|P2|STARTED|Overall Study||533
8005245|NCT00006164|19708907|P1|STARTED|Overall Study||517
8005246|NCT00006151|19708943|P2|NOT COMPLETED|Overall Study||14
8005247|NCT00006151|19708944|P1|NOT COMPLETED|Overall Study||13
8005248|NCT00006151|19708943|P2|COMPLETED|Overall Study||16
8005249|NCT00006151|19708944|P1|COMPLETED|Overall Study||17
8005250|NCT00006151|19708943|P2|STARTED|Overall Study||30
8005251|NCT00006151|19708944|P1|STARTED|Overall Study||30
8005252|NCT00005937|19708950|P1|NOT COMPLETED|Overall Study||5
8005253|NCT00005937|19708950|P1|COMPLETED|Overall Study||37
8005254|NCT00005937|19708950|P1|STARTED|Overall Study||42
8005255|NCT00005908|19708954|P2|NOT COMPLETED|Overall Study||0
8005256|NCT00005908|19708955|P1|NOT COMPLETED|Overall Study||1
8005257|NCT00005908|19708954|P2|COMPLETED|Overall Study||20
8005258|NCT00005908|19708955|P1|COMPLETED|Overall Study||9
8005259|NCT00005908|19708954|P2|STARTED|Overall Study||20
8005260|NCT00005908|19708955|P1|STARTED|Overall Study||10
8005261|NCT00005906|19708964|P1|NOT COMPLETED|Overall Study||3
8005262|NCT00005906|19708964|P1|COMPLETED|Overall Study||1
8005263|NCT00005906|19708964|P1|STARTED|Overall Study||4
8005264|NCT00005901|19708972|P2|NOT COMPLETED|Overall Study||0
8005265|NCT00005901|19708973|P1|NOT COMPLETED|Overall Study||0
8005266|NCT00005901|19708972|P2|COMPLETED|Overall Study||15
8005267|NCT00005901|19708973|P1|COMPLETED|Overall Study||19
8005268|NCT00005901|19708972|P2|STARTED|Overall Study||15
8005269|NCT00005901|19708973|P1|STARTED|Overall Study||19
8005270|NCT00005669|19708991|P2|NOT COMPLETED|Overall Study||7
8005271|NCT00005669|19708992|P1|NOT COMPLETED|Overall Study||8
8005272|NCT00005669|19708991|P2|COMPLETED|Overall Study||40
8005273|NCT00005669|19708992|P1|COMPLETED|Overall Study||45
8005274|NCT00005669|19708991|P2|STARTED|Overall Study||47
8005275|NCT00005669|19708992|P1|STARTED|Overall Study||53
8005276|NCT00004980|19709008|P2|NOT COMPLETED|Overall Study||2
8005277|NCT00004980|19709009|P1|NOT COMPLETED|Overall Study||2
8005278|NCT00004980|19709008|P2|COMPLETED|Overall Study||21
8005279|NCT00004980|19709009|P1|COMPLETED|Overall Study||25
8005280|NCT00004980|19709008|P2|STARTED|Overall Study||23
8005281|NCT00004980|19709009|P1|STARTED|Overall Study||27
8005282|NCT00004732|19709023|P2|NOT COMPLETED|Overall Study||111
8005283|NCT00004732|19709024|P1|NOT COMPLETED|Overall Study||69
8005284|NCT00004732|19709023|P2|COMPLETED|Overall Study||1129
8005285|NCT00004732|19709024|P1|COMPLETED|Overall Study||1193
8005286|NCT00004732|19709023|P2|STARTED|Overall Study||1240
8005287|NCT00004732|19709024|P1|STARTED|Overall Study||1262
8005288|NCT00004635|19709034|P2|NOT COMPLETED|Period Two||9
8005289|NCT00004635|19709035|P1|NOT COMPLETED|Period Two||6
8005290|NCT00004635|19709034|P2|COMPLETED|Period Two||50
8005291|NCT00004635|19709035|P1|COMPLETED|Period Two||38
8005292|NCT00004635|19709034|P2|STARTED|Period Two||59
8005293|NCT00004635|19709035|P1|STARTED|Period Two||44
8005294|NCT00004635|19709034|P2|NOT COMPLETED|Period One||6
8005295|NCT00004635|19709035|P1|NOT COMPLETED|Period One||6
8005296|NCT00004635|19709034|P2|COMPLETED|Period One||74
8005297|NCT00004635|19709035|P1|COMPLETED|Period One||73
8005298|NCT00004635|19709034|P2|Received Treatment|Period One||75
8005299|NCT00004635|19709035|P1|Received Treatment|Period One||73
8005300|NCT00004635|19709034|P2|STARTED|Period One||80
8005301|NCT00004635|19709035|P1|STARTED|Period One||79
8005302|NCT00004563|19709047|P2|NOT COMPLETED|Overall Study||24
8005303|NCT00004563|19709048|P1|NOT COMPLETED|Overall Study||25
8005304|NCT00004563|19709047|P2|COMPLETED|Overall Study||55
8005305|NCT00004563|19709048|P1|COMPLETED|Overall Study||54
8005306|NCT00004563|19709047|P2|STARTED|Overall Study||79
8005307|NCT00004563|19709048|P1|STARTED|Overall Study||79
8005308|NCT00004562|19709060|P2|NOT COMPLETED|Overall Study||91
8005309|NCT00004562|19709061|P1|NOT COMPLETED|Overall Study||102
8005310|NCT00004562|19709060|P2|COMPLETED|Overall Study||1009
8005311|NCT00004562|19709061|P1|COMPLETED|Overall Study||999
8005312|NCT00004562|19709060|P2|STARTED|Overall Study||1100
8005313|NCT00004562|19709061|P1|STARTED|Overall Study||1101
8005314|NCT00004547|19709072|P3|NOT COMPLETED|Overall Study||22
8005315|NCT00004547|19709073|P2|NOT COMPLETED|Overall Study||9
8005316|NCT00004547|19709074|P1|NOT COMPLETED|Overall Study||22
8005317|NCT00004547|19709072|P3|COMPLETED|Overall Study||35
8005318|NCT00004547|19709073|P2|COMPLETED|Overall Study||39
8005319|NCT00004547|19709074|P1|COMPLETED|Overall Study||61
8005320|NCT00004547|19709072|P3|Not Evaluable|Overall Study||23
8005321|NCT00004547|19709073|P2|Not Evaluable|Overall Study||9
8005322|NCT00004547|19709074|P1|Not Evaluable|Overall Study||21
8005323|NCT00004547|19709072|P3|STARTED|Overall Study||57
8005324|NCT00004547|19709073|P2|STARTED|Overall Study||48
8005325|NCT00004547|19709074|P1|STARTED|Overall Study||83
8005326|NCT00001984|19709092|P1|NOT COMPLETED|Overall Study||0
8005327|NCT00001984|19709092|P1|COMPLETED|Overall Study||5
8005328|NCT00001984|19709092|P1|STARTED|Overall Study||5
8005329|NCT00001962|19709102|P1|NOT COMPLETED|Overall Study||28
8005330|NCT00001962|19709102|P1|COMPLETED|Overall Study||72
8005331|NCT00001962|19709102|P1|STARTED|Overall Study||100
8005332|NCT00001959|19709106|P1|NOT COMPLETED|Overall Study||3
8005333|NCT00001959|19709106|P1|COMPLETED|Overall Study||18
8005334|NCT00001959|19709106|P1|STARTED|Overall Study||21
8005335|NCT00001941|19709112|P5|NOT COMPLETED|Overall Study||1
8005336|NCT00001941|19709113|P4|NOT COMPLETED|Overall Study||0
8005337|NCT00001941|19709114|P3|NOT COMPLETED|Overall Study||0
8005338|NCT00001941|19709115|P2|NOT COMPLETED|Overall Study||0
8005339|NCT00001941|19709116|P1|NOT COMPLETED|Overall Study||0
8005340|NCT00001941|19709112|P5|COMPLETED|Overall Study||19
8005341|NCT00001941|19709113|P4|COMPLETED|Overall Study||3
8005342|NCT00001941|19709114|P3|COMPLETED|Overall Study||3
8005343|NCT00001941|19709115|P2|COMPLETED|Overall Study||5
8005344|NCT00001941|19709116|P1|COMPLETED|Overall Study||3
8005345|NCT00001941|19709112|P5|STARTED|Overall Study||20
8005346|NCT00001941|19709113|P4|STARTED|Overall Study||3
8005347|NCT00001941|19709114|P3|STARTED|Overall Study||3
8005348|NCT00001941|19709115|P2|STARTED|Overall Study||5
8005349|NCT00001941|19709116|P1|STARTED|Overall Study||3
8005350|NCT00000392|19709125|P2|NOT COMPLETED|Overall Study||32
8005351|NCT00000392|19709126|P1|NOT COMPLETED|Overall Study||40
8005352|NCT00000392|19709125|P2|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77
8005353|NCT00000392|19709126|P1|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66
8005354|NCT00000392|19709125|P2|STARTED|Overall Study||109
8005355|NCT00000392|19709126|P1|STARTED|Overall Study||106
8005356|NCT00001832|19709148|P15|NOT COMPLETED|Treatment Period||0
8005357|NCT00001832|19709149|P14|NOT COMPLETED|Treatment Period||0
8005358|NCT00001832|19709150|P13|NOT COMPLETED|Treatment Period||0
8005359|NCT00001832|19709151|P12|NOT COMPLETED|Treatment Period||0
8005360|NCT00001832|19709152|P11|NOT COMPLETED|Treatment Period||0
8005361|NCT00001832|19709153|P10|NOT COMPLETED|Treatment Period||0
8005362|NCT00001832|19709154|P9|NOT COMPLETED|Treatment Period||0
8005363|NCT00001832|19709155|P8|NOT COMPLETED|Treatment Period||1
8005364|NCT00001832|19709156|P7|NOT COMPLETED|Treatment Period||0
8005365|NCT00001832|19709157|P6|NOT COMPLETED|Treatment Period||1
8005366|NCT00001832|19709158|P5|NOT COMPLETED|Treatment Period||0
8005367|NCT00001832|19709159|P4|NOT COMPLETED|Treatment Period||0
8005368|NCT00001832|19709160|P3|NOT COMPLETED|Treatment Period||0
8005369|NCT00001832|19709161|P2|NOT COMPLETED|Treatment Period||0
8005370|NCT00001832|19709162|P1|NOT COMPLETED|Treatment Period||0
8005371|NCT00001832|19709148|P15|COMPLETED|Treatment Period||2
8005372|NCT00001832|19709149|P14|COMPLETED|Treatment Period||3
8005373|NCT00001832|19709150|P13|COMPLETED|Treatment Period||6
8005374|NCT00001832|19709151|P12|COMPLETED|Treatment Period||7
8005375|NCT00001832|19709152|P11|COMPLETED|Treatment Period||1
8005376|NCT00001832|19709153|P10|COMPLETED|Treatment Period||6
8005377|NCT00001832|19709154|P9|COMPLETED|Treatment Period||8
8005378|NCT00001832|19709155|P8|COMPLETED|Treatment Period||6
8005379|NCT00001832|19709156|P7|COMPLETED|Treatment Period||4
8005380|NCT00001832|19709157|P6|COMPLETED|Treatment Period||50
8005381|NCT00001832|19709158|P5|COMPLETED|Treatment Period||6
8005382|NCT00001832|19709159|P4|COMPLETED|Treatment Period||3
8005383|NCT00001832|19709160|P3|COMPLETED|Treatment Period||3
8005384|NCT00001832|19709161|P2|COMPLETED|Treatment Period||3
8005385|NCT00001832|19709162|P1|COMPLETED|Treatment Period||0
8005386|NCT00001832|19709148|P15|STARTED|Treatment Period||2
8005387|NCT00001832|19709149|P14|STARTED|Treatment Period||3
8005388|NCT00001832|19709150|P13|STARTED|Treatment Period||6
8005389|NCT00001832|19709151|P12|STARTED|Treatment Period||7
8005390|NCT00001832|19709152|P11|STARTED|Treatment Period||1
8005391|NCT00001832|19709153|P10|STARTED|Treatment Period||6
8005392|NCT00001832|19709154|P9|STARTED|Treatment Period||8
8005393|NCT00001832|19709155|P8|STARTED|Treatment Period||7
8005394|NCT00001832|19709156|P7|STARTED|Treatment Period||4
8005395|NCT00001832|19709157|P6|STARTED|Treatment Period||51
8005396|NCT00001832|19709158|P5|STARTED|Treatment Period||6
8005397|NCT00001832|19709159|P4|STARTED|Treatment Period||3
8005398|NCT00001832|19709160|P3|STARTED|Treatment Period||3
8005399|NCT00001832|19709161|P2|STARTED|Treatment Period||3
8005400|NCT00001832|19709162|P1|STARTED|Treatment Period||0
8005401|NCT00001832|19709148|P15|NOT COMPLETED|Apheresis Period||0
8005402|NCT00001832|19709149|P14|NOT COMPLETED|Apheresis Period||0
8005403|NCT00001832|19709150|P13|NOT COMPLETED|Apheresis Period||0
8005404|NCT00001832|19709151|P12|NOT COMPLETED|Apheresis Period||0
8005405|NCT00001832|19709152|P11|NOT COMPLETED|Apheresis Period||0
8005406|NCT00001832|19709153|P10|NOT COMPLETED|Apheresis Period||0
8005407|NCT00001832|19709154|P9|NOT COMPLETED|Apheresis Period||0
8005408|NCT00001832|19709155|P8|NOT COMPLETED|Apheresis Period||0
8005409|NCT00001832|19709156|P7|NOT COMPLETED|Apheresis Period||0
8005410|NCT00001832|19709157|P6|NOT COMPLETED|Apheresis Period||0
8005411|NCT00001832|19709158|P5|NOT COMPLETED|Apheresis Period||0
8005412|NCT00001832|19709159|P4|NOT COMPLETED|Apheresis Period||0
8005413|NCT00001832|19709160|P3|NOT COMPLETED|Apheresis Period||0
8005414|NCT00001832|19709161|P2|NOT COMPLETED|Apheresis Period||0
8005415|NCT00001832|19709162|P1|NOT COMPLETED|Apheresis Period||60
8005416|NCT00001832|19709148|P15|COMPLETED|Apheresis Period||0
8005417|NCT00001832|19709149|P14|COMPLETED|Apheresis Period||0
8005418|NCT00001832|19709150|P13|COMPLETED|Apheresis Period||0
8005419|NCT00001832|19709151|P12|COMPLETED|Apheresis Period||0
8005420|NCT00001832|19709152|P11|COMPLETED|Apheresis Period||0
8005421|NCT00001832|19709153|P10|COMPLETED|Apheresis Period||0
8005422|NCT00001832|19709154|P9|COMPLETED|Apheresis Period||0
8005423|NCT00001832|19709155|P8|COMPLETED|Apheresis Period||0
8005424|NCT00001832|19709156|P7|COMPLETED|Apheresis Period||0
8005425|NCT00001832|19709157|P6|COMPLETED|Apheresis Period||0
8005426|NCT00001832|19709158|P5|COMPLETED|Apheresis Period||0
8005427|NCT00001832|19709159|P4|COMPLETED|Apheresis Period||0
8005428|NCT00001832|19709160|P3|COMPLETED|Apheresis Period||0
8005429|NCT00001832|19709161|P2|COMPLETED|Apheresis Period||0
8005430|NCT00001832|19709162|P1|COMPLETED|Apheresis Period||110
8005431|NCT00001832|19709148|P15|STARTED|Apheresis Period||0
8005432|NCT00001832|19709149|P14|STARTED|Apheresis Period||0
8005433|NCT00001832|19709150|P13|STARTED|Apheresis Period||0
8005434|NCT00001832|19709151|P12|STARTED|Apheresis Period||0
8005435|NCT00001832|19709152|P11|STARTED|Apheresis Period||0
8005436|NCT00001832|19709153|P10|STARTED|Apheresis Period||0
8005437|NCT00001832|19709154|P9|STARTED|Apheresis Period||0
8005438|NCT00001832|19709155|P8|STARTED|Apheresis Period||0
8005439|NCT00001832|19709156|P7|STARTED|Apheresis Period||0
8005440|NCT00001832|19709157|P6|STARTED|Apheresis Period||0
8005441|NCT00001832|19709158|P5|STARTED|Apheresis Period||0
8005442|NCT00001832|19709159|P4|STARTED|Apheresis Period||0
8005443|NCT00001832|19709160|P3|STARTED|Apheresis Period||0
8005444|NCT00001832|19709161|P2|STARTED|Apheresis Period||0
8005445|NCT00001832|19709162|P1|STARTED|Apheresis Period||170
8005446|NCT00001723|19709208|P2|NOT COMPLETED|Overall Study||16
8005447|NCT00001723|19709209|P1|NOT COMPLETED|Overall Study||13
8005448|NCT00001723|19709208|P2|COMPLETED|Overall Study||84
8005449|NCT00001723|19709209|P1|COMPLETED|Overall Study||87
8005450|NCT00001723|19709208|P2|STARTED|Overall Study||100
8005451|NCT00001723|19709209|P1|STARTED|Overall Study||100
8005452|NCT00001703|19709225|P1|NOT COMPLETED|Overall Study||5
8005453|NCT00001703|19709225|P1|COMPLETED|Overall Study||1
8005454|NCT00001703|19709225|P1|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3
8005455|NCT00001703|19709225|P1|STARTED|Overall Study||6
8005456|NCT00001656|19709232|P2|NOT COMPLETED|Overall Study||0
8005457|NCT00001656|19709233|P1|NOT COMPLETED|Overall Study||1
8005458|NCT00001656|19709232|P2|COMPLETED|Overall Study||12
8005459|NCT00001656|19709233|P1|COMPLETED|Overall Study||12
8005460|NCT00001656|19709232|P2|STARTED|Overall Study||12
8005461|NCT00001656|19709233|P1|STARTED|Overall Study||13
8005462|NCT00001596|19709263|P2|NOT COMPLETED|Overall Study||10
8005463|NCT00001596|19709264|P1|NOT COMPLETED|Overall Study||17
8005464|NCT00001596|19709263|P2|COMPLETED|Overall Study||2
8005465|NCT00001596|19709264|P1|COMPLETED|Overall Study||6
8005466|NCT00001596|19709263|P2|STARTED|Overall Study||12
8005467|NCT00001596|19709264|P1|STARTED|Overall Study||23
8005468|NCT00001586|19709286|P2|NOT COMPLETED|Overall Study||0
8005469|NCT00001586|19709287|P1|NOT COMPLETED|Overall Study||0
8005470|NCT00001586|19709286|P2|COMPLETED|Overall Study||56
8005471|NCT00001586|19709287|P1|COMPLETED|Overall Study||49
8005472|NCT00001586|19709286|P2|STARTED|Overall Study||56
8005473|NCT00001586|19709287|P1|STARTED|Overall Study||49
8005474|NCT00001575|19709295|P1|NOT COMPLETED|Overall Study||45
8005475|NCT00001575|19709295|P1|COMPLETED|Overall Study||42
8005476|NCT00001575|19709295|P1|Treated|Overall Study||65
8005477|NCT00001575|19709295|P1|STARTED|Overall Study||87
8005478|NCT00001566|19709301|P1|NOT COMPLETED|Overall Study||19
8005479|NCT00001566|19709301|P1|COMPLETED|Overall Study||23
8005480|NCT00001566|19709301|P1|Completed Immunotherapy|Overall Study||23
8005481|NCT00001566|19709301|P1|STARTED|Overall Study||42
8005482|NCT00001305|19709313|P1|NOT COMPLETED|Overall Study||0
8005483|NCT00001305|19709313|P1|COMPLETED|Overall Study||42
8005484|NCT00001305|19709313|P1|STARTED|Overall Study||42
8005485|NCT00001304|19709319|P2|NOT COMPLETED|Overall Study||0
8005486|NCT00001304|19709320|P1|NOT COMPLETED|Overall Study||0
8005487|NCT00001304|19709319|P2|COMPLETED|Overall Study||14
8005488|NCT00001304|19709320|P1|COMPLETED|Overall Study||13
8005489|NCT00001304|19709319|P2|STARTED|Overall Study||14
8005490|NCT00001304|19709320|P1|STARTED|Overall Study||13
8005491|NCT00001262|19709341|P3|NOT COMPLETED|Overall Study||0
8005492|NCT00001262|19709342|P2|NOT COMPLETED|Overall Study||14
8005493|NCT00001262|19709343|P1|NOT COMPLETED|Overall Study||10
8005494|NCT00001262|19709341|P3|COMPLETED|Overall Study||3
8005495|NCT00001262|19709342|P2|COMPLETED|Overall Study||8
8005496|NCT00001262|19709343|P1|COMPLETED|Overall Study||25
8005497|NCT00001262|19709341|P3|STARTED|Overall Study||3
8005498|NCT00001262|19709342|P2|STARTED|Overall Study||22
8005499|NCT00001262|19709343|P1|STARTED|Overall Study||35
8005500|NCT00001213|19709369|P1|NOT COMPLETED|Overall Study||18
8005501|NCT00001213|19709369|P1|COMPLETED|Overall Study||310
8005502|NCT00001213|19709369|P1|STARTED|Overall Study||328
8005503|NCT00001151|19709374|P1|NOT COMPLETED|Overall Study||5
8005504|NCT00001151|19709374|P1|COMPLETED|Overall Study||1
8005505|NCT00001151|19709374|P1|STARTED|Overall Study||6
8005506|NCT00000378|19709380|P2|NOT COMPLETED|Overall Study||14
8005507|NCT00000378|19709381|P1|NOT COMPLETED|Overall Study||16
8005508|NCT00000378|19709380|P2|COMPLETED|Overall Study||38
8005509|NCT00000378|19709381|P1|COMPLETED|Overall Study||42
8005510|NCT00000378|19709380|P2|STARTED|Overall Study||52
8005511|NCT00000378|19709381|P1|STARTED|Overall Study||58
8005512|NCT00000371|19709389|P2|NOT COMPLETED|Overall Study||16
8005513|NCT00000371|19709390|P1|NOT COMPLETED|Overall Study||13
8005514|NCT00000371|19709389|P2|COMPLETED|Overall Study||12
8005515|NCT00000371|19709390|P1|COMPLETED|Overall Study||14
8005516|NCT00000371|19709389|P2|STARTED|Overall Study||28
8005517|NCT00000371|19709390|P1|STARTED|Overall Study||27
8005518|NCT00000620|19709398|P8|NOT COMPLETED|Overall Study||146
8005519|NCT00000620|19709399|P7|NOT COMPLETED|Overall Study||149
8005520|NCT00000620|19709400|P6|NOT COMPLETED|Overall Study||152
8005521|NCT00000620|19709401|P5|NOT COMPLETED|Overall Study||135
8005522|NCT00000620|19709402|P4|NOT COMPLETED|Overall Study||178
8005523|NCT00000620|19709403|P3|NOT COMPLETED|Overall Study||170
8005524|NCT00000620|19709404|P2|NOT COMPLETED|Overall Study||136
8005525|NCT00000620|19709405|P1|NOT COMPLETED|Overall Study||162
8005526|NCT00000620|19709398|P8|COMPLETED|Overall Study||1224
8005527|NCT00000620|19709399|P7|COMPLETED|Overall Study||1242
8005528|NCT00000620|19709400|P6|COMPLETED|Overall Study||1026
8005529|NCT00000620|19709401|P5|COMPLETED|Overall Study||1049
8005530|NCT00000620|19709402|P4|COMPLETED|Overall Study||1205
8005531|NCT00000620|19709403|P3|COMPLETED|Overall Study||1204
8005532|NCT00000620|19709404|P2|COMPLETED|Overall Study||1057
8005533|NCT00000620|19709405|P1|COMPLETED|Overall Study||1016
8005534|NCT00000620|19709398|P8|STARTED|Overall Study||1370
8005535|NCT00000620|19709399|P7|STARTED|Overall Study||1391
8005536|NCT00000620|19709400|P6|STARTED|Overall Study||1178
8005537|NCT00000620|19709401|P5|STARTED|Overall Study||1184
8005538|NCT00000620|19709402|P4|STARTED|Overall Study||1383
8005539|NCT00000620|19709403|P3|STARTED|Overall Study||1374
8005540|NCT00000620|19709404|P2|STARTED|Overall Study||1193
8005541|NCT00000620|19709405|P1|STARTED|Overall Study||1178
8005542|NCT00000575|19709424|P3|NOT COMPLETED|Overall Study||0
8005543|NCT00000575|19709425|P2|NOT COMPLETED|Overall Study||0
8005544|NCT00000575|19709426|P1|NOT COMPLETED|Overall Study||0
8005545|NCT00000575|19709424|P3|COMPLETED|Overall Study||418
8005546|NCT00000575|19709425|P2|COMPLETED|Overall Study||312
8005547|NCT00000575|19709426|P1|COMPLETED|Overall Study||311
8005548|NCT00000575|19709424|P3|STARTED|Overall Study||418
8005549|NCT00000575|19709425|P2|STARTED|Overall Study||312
8005550|NCT00000575|19709426|P1|STARTED|Overall Study||311
8005551|NCT00000479|19709456|P4|NOT COMPLETED|Overall Study||0
8005552|NCT00000479|19709457|P3|NOT COMPLETED|Overall Study||0
8005553|NCT00000479|19709458|P2|NOT COMPLETED|Overall Study||0
8005554|NCT00000479|19709459|P1|NOT COMPLETED|Overall Study||0
8005555|NCT00000479|19709456|P4|COMPLETED|Overall Study||9971
8005556|NCT00000479|19709457|P3|COMPLETED|Overall Study||9966
8005557|NCT00000479|19709458|P2|COMPLETED|Overall Study||9971
8005558|NCT00000479|19709459|P1|COMPLETED|Overall Study||9968
8005559|NCT00000479|19709456|P4|STARTED|Overall Study||9971
8005560|NCT00000479|19709457|P3|STARTED|Overall Study||9966
8005561|NCT00000479|19709458|P2|STARTED|Overall Study||9971
8005562|NCT00000479|19709459|P1|STARTED|Overall Study||9968
8005563|NCT00004500|19709475|P2|NOT COMPLETED|Overall Study||0
8005564|NCT00004500|19709476|P1|NOT COMPLETED|Overall Study||0
8005565|NCT00004500|19709475|P2|COMPLETED|Overall Study||31
8005566|NCT00004500|19709476|P1|COMPLETED|Overall Study||38
8005567|NCT00004500|19709475|P2|1 Year Follow-Up|Overall Study||24
8005568|NCT00004500|19709476|P1|1 Year Follow-Up|Overall Study||24
8005569|NCT00004500|19709475|P2|STARTED|Overall Study||31
8005570|NCT00004500|19709476|P1|STARTED|Overall Study||38
8005571|NCT00004445|19709486|P1|NOT COMPLETED|Overall Study||3
8005572|NCT00004445|19709486|P1|COMPLETED|Overall Study||15
8005573|NCT00004445|19709486|P1|STARTED|Overall Study||18
8005574|NCT00004418|19709491|P1|NOT COMPLETED|Overall Study||0
8005575|NCT00004418|19709491|P1|COMPLETED|Overall Study|The definition of completed is until the subject wished to stop taking the oil.|126
8005576|NCT00004418|19709491|P1|STARTED|Overall Study||126
8005577|NCT00004412|19709499|P3|NOT COMPLETED|Crossover Period||0
8005578|NCT00004412|19709500|P2|NOT COMPLETED|Crossover Period||0
8005579|NCT00004412|19709501|P1|NOT COMPLETED|Crossover Period||0
8005580|NCT00004412|19709499|P3|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3
8005581|NCT00004412|19709500|P2|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12
8005582|NCT00004412|19709501|P1|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8
8005583|NCT00004412|19709499|P3|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3
8005584|NCT00004412|19709500|P2|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12
8005585|NCT00004412|19709501|P1|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8
8005586|NCT00004412|19709499|P3|NOT COMPLETED|Randomized Period||0
8005587|NCT00004412|19709500|P2|NOT COMPLETED|Randomized Period||0
8005588|NCT00004412|19709501|P1|NOT COMPLETED|Randomized Period||3
8005589|NCT00004412|19709499|P3|COMPLETED|Randomized Period||0
8005590|NCT00004412|19709500|P2|COMPLETED|Randomized Period||12
8005591|NCT00004412|19709501|P1|COMPLETED|Randomized Period||8
8005592|NCT00004412|19709499|P3|STARTED|Randomized Period||0
8005593|NCT00004412|19709500|P2|STARTED|Randomized Period||12
8005594|NCT00004412|19709501|P1|STARTED|Randomized Period||11
8005595|NCT00000143|19709511|P2|NOT COMPLETED|Overall Study||0
8005596|NCT00000143|19709512|P1|NOT COMPLETED|Overall Study||0
8005597|NCT00000143|19709511|P2|COMPLETED|Overall Study||30
8005598|NCT00000143|19709512|P1|COMPLETED|Overall Study||31
8005599|NCT00000143|19709511|P2|STARTED|Overall Study||30
8005600|NCT00000143|19709512|P1|STARTED|Overall Study||31
8005601|NCT00000142|19709521|P3|NOT COMPLETED|Overall Study||0
8005602|NCT00000142|19709522|P2|NOT COMPLETED|Overall Study||0
8005603|NCT00000142|19709523|P1|NOT COMPLETED|Overall Study||0
8005604|NCT00000142|19709521|P3|COMPLETED|Overall Study||12
8005605|NCT00000142|19709522|P2|COMPLETED|Overall Study||26
8005606|NCT00000142|19709523|P1|COMPLETED|Overall Study||26
8005607|NCT00000142|19709521|P3|STARTED|Overall Study||12
8005608|NCT00000142|19709522|P2|STARTED|Overall Study||26
8005609|NCT00000142|19709523|P1|STARTED|Overall Study||26
8005610|NCT00000136|19709533|P2|NOT COMPLETED|Overall Study||0
8005611|NCT00000136|19709534|P1|NOT COMPLETED|Overall Study||0
8005612|NCT00000136|19709533|P2|COMPLETED|Overall Study||127
8005613|NCT00000136|19709534|P1|COMPLETED|Overall Study||107
8005614|NCT00000136|19709533|P2|STARTED|Overall Study||127
8005615|NCT00000136|19709534|P1|STARTED|Overall Study||107
8005616|NCT00000135|19709542|P2|NOT COMPLETED|Overall Study||14
8005617|NCT00000135|19709543|P1|NOT COMPLETED|Overall Study||27
8005618|NCT00000135|19709542|P2|COMPLETED|Overall Study||91
8005619|NCT00000135|19709543|P1|COMPLETED|Overall Study||77
8005620|NCT00000135|19709542|P2|STARTED|Overall Study||105
8005621|NCT00000135|19709543|P1|STARTED|Overall Study||104
8005622|NCT00000134|19709552|P3|NOT COMPLETED|Overall Study||0
8005623|NCT00000134|19709553|P2|NOT COMPLETED|Overall Study||0
8005624|NCT00000134|19709554|P1|NOT COMPLETED|Overall Study||0
8005625|NCT00000134|19709552|P3|COMPLETED|Overall Study||96
8005626|NCT00000134|19709553|P2|COMPLETED|Overall Study||94
8005627|NCT00000134|19709554|P1|COMPLETED|Overall Study||89
8005628|NCT00000134|19709552|P3|STARTED|Overall Study||96
8005629|NCT00000134|19709553|P2|STARTED|Overall Study||94
8005630|NCT00000134|19709554|P1|STARTED|Overall Study||89
8005631|NCT00000125|19709564|P2|NOT COMPLETED|Overall Study||238
8005632|NCT00000125|19709565|P1|NOT COMPLETED|Overall Study||239
8005633|NCT00000125|19709564|P2|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579
8005634|NCT00000125|19709565|P1|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580
8005635|NCT00000125|19709564|P2|Completed OHTS Phase I, June 2002|Overall Study||702
8005636|NCT00000125|19709565|P1|Completed OHTS Phase I, June 2002|Overall Study||706
8005637|NCT00000125|19709564|P2|STARTED|Overall Study||817
8005638|NCT00000125|19709565|P1|STARTED|Overall Study||819
